,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
15559,GO:0071944,3.91182034720442e-15,1,420,2904,cell periphery,CC,NT5E;FLNC;FHL1;SH3KBP1;ITGB4;TSPAN1;NOS1;ADAM19;SH3TC2;CAPN2;F2R;MST1R;RAC2;ASAP2;SORL1;ADGRL1;SDC1;DVL1;MAP2K1;SHC1;KCNG1;DOCK4;WNT7A;SDK2;NEURL1;EPN3;SNX9;AP3D1;SCN8A;CRTC1;ARAP1;SLCO4A1;DLG4;OBSCN;SERPINE2;BSG;KLC2;DLG1;DYSF;SLC16A3;PITPNM1;IFI6;SLC9A3R2;FKBP1A;DGKA;DCBLD2;RAB3B;CKAP4;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRNP;CD68;AGPAT3;SSH1;SMURF2;BCORL1;PLCH2;PCDH1;MARVELD1;FAM129B;ABTB1;LY6K;SNPH;PLEK2;MRC2;BBS2;ADGRF1;BCR;RAB31;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;ITGB5;HTR7;KIAA1549;ADCY7;CSMD2;MARCKSL1;EGFR;RTN2;TTYH3;MMP14;SLC12A7;SEPT10;PRKACA;FCHO1;PTPRF;CORO1B;TUB;RHBDF2;MAP2K2;EPN1;LMBR1L;PARVB;SHANK3;ANKRD13D;TTC7B;ATF4;P4HB;AKT1;XPC;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;BAG3;APOE;EHD3;ATP13A2;UAP1;PKN1;PEAR1;COL13A1;RABGGTA;AP2A2;PRKCZ;ATP7B;ITPR3;DGKQ;FZD8;VPS4A;CTSZ;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;GRK6;PCSK9;FERMT1;RRAS;SEPT5;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;CD99;EPOR;MVB12B;RIN1;SERPINB6;STK39;DKK1;ARRDC1;PRSS8;AKAP12;SYMPK;PRKACB;SHC2;CD44;ESYT2;PLCG1;ABCB8;IDE;MC1R;SURF4;PSD3;TSPAN5;MALL;BIN1;FSCN1;HTRA1;PAK1;CERCAM;SLC29A4;NLGN2;SEMA4B;TNFSF15;PODXL;TUBB3;STOM;FARP1;GNB1;SYTL1;RET;RAB29;PTOV1;LAMC2;RHOC;NID1;GRB10;CYTH3;REEP2;PROCR;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;DLG3;ATP11A;NIPA1;NUCB2;GSDMA;SH2D5;ARL8A;ANO8;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;ADGRB2;ALOX15B;IL1RAP;SLC12A4;FAT1;EFS;ASPH;SDHA;FAM155B;SLC6A6;CNFN;PTPRU;ADAM8;TMEM8A;SLC13A3;C19ORF33;RHOBTB2;FAM110C;ARL2;LY6E;SLC43A1;NUMB;ARHGEF4;IGFBP2;CAP1;GPRC5C;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;B3GNT3;SRC;LDLRAP1;APLP2;TGM2;DNM2;UBR4;LRSAM1;TMEM25;CDC42BPB;NCS1;PAQR7;MARK3;CPTP;RGS19;EXOC2;STXBP1;PAG1;SH3BP1;SPINT2;PCSK6;FYN;RAB25;CLSTN1;AGRN;TMPRSS11D;LPAR3;WNT5B;SLC6A9;PFN1;NISCH;KIF17;TNFRSF1A;NRSN2;ANXA3;SLC33A1;ABHD17C;PLEKHG5;TSPAN33;GJC2;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;RAI14;PSKH1;COMT;NTSR1;LYPD5;AMIGO2;CRIM1;FRYL;MGLL;MISP;SEMA4G;WDFY3;FGFR1;LRRC8A;CEP170;TENM2;F12;SIGMAR1;RAB11FIP4;STK17A;ADIPOR1;TRIB3;TCIRG1;SLC27A1;TPCN1;PMEPA1;ARFIP2;LRCH4;PRRC2A;ST3GAL5;SLC6A14;LRP1;ROBO3;HSPA2;PLCD3;TNFRSF19;MGRN1;P2RX4;SMPD3;ZP3;SPIRE1;PRR9;KLHL17;EHD4;SHB;MAP3K12;VASP;HSPA13;ARAP3;MYO1D;ATXN10;SNTB2;ABCA7;ENTPD6;MSLN;APBB1;RHOBTB1;EPS8L1;HOMER2;SLC10A6;TGFA;NDE1;GSDMC;BAIAP2L1;TPBG;WIPF1;CASP4;SNAP29;KCNC4;EPHB2;CBL;GGT1;CIB1;SOCS7;RAB4B;MAPK3;NTNG1;MAPK10;CSNK1D;DRAM2;ARVCF;LITAF;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;MYZAP;SNX27;TMBIM1;LLGL1;OCRL;ADAM15;SRPX2;HM13;CEACAM1;APBA1;MINK1;SKAP2;ARHGAP44;CD59;SLC30A1;ADCY6;GRIP2;ITSN1;TGFB1;TM2D1;PCYOX1;SLC15A1;CAT;SPRED2;CAMK2N1;ERBB3;ANXA1;PODXL2;SLC45A3;RAB6A;GNAS;ITGA3;CLDN12;PLGRKT;PXN;PLEKHH2;RAP1GAP2;STIM1;RASA3;ASAP1;NIPSNAP1;TRAF7
2593,GO:0005886,1.40023963167279e-14,1,409,2831,plasma membrane,CC,NT5E;FLNC;FHL1;SH3KBP1;ITGB4;TSPAN1;NOS1;ADAM19;SH3TC2;CAPN2;F2R;MST1R;RAC2;ASAP2;SORL1;ADGRL1;SDC1;DVL1;MAP2K1;SHC1;KCNG1;DOCK4;WNT7A;SDK2;NEURL1;EPN3;SNX9;AP3D1;SCN8A;CRTC1;ARAP1;SLCO4A1;DLG4;OBSCN;SERPINE2;BSG;KLC2;DLG1;DYSF;SLC16A3;PITPNM1;IFI6;SLC9A3R2;FKBP1A;DGKA;DCBLD2;RAB3B;CKAP4;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRNP;CD68;AGPAT3;SSH1;SMURF2;BCORL1;PLCH2;PCDH1;MARVELD1;FAM129B;ABTB1;LY6K;SNPH;PLEK2;MRC2;BBS2;ADGRF1;BCR;RAB31;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;ITGB5;HTR7;KIAA1549;ADCY7;CSMD2;MARCKSL1;EGFR;RTN2;TTYH3;MMP14;SLC12A7;PRKACA;FCHO1;PTPRF;CORO1B;TUB;RHBDF2;MAP2K2;EPN1;LMBR1L;PARVB;SHANK3;ANKRD13D;TTC7B;ATF4;P4HB;AKT1;XPC;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;BAG3;APOE;EHD3;ATP13A2;UAP1;PKN1;PEAR1;COL13A1;RABGGTA;AP2A2;PRKCZ;ATP7B;ITPR3;DGKQ;FZD8;VPS4A;CTSZ;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;GRK6;PCSK9;FERMT1;RRAS;SEPT5;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;CD99;EPOR;MVB12B;RIN1;SERPINB6;STK39;DKK1;ARRDC1;PRSS8;AKAP12;SYMPK;PRKACB;SHC2;CD44;ESYT2;PLCG1;ABCB8;IDE;MC1R;SURF4;PSD3;TSPAN5;MALL;BIN1;FSCN1;HTRA1;PAK1;CERCAM;SLC29A4;NLGN2;SEMA4B;TNFSF15;PODXL;STOM;FARP1;GNB1;SYTL1;RET;RAB29;PTOV1;RHOC;GRB10;CYTH3;REEP2;PROCR;YIPF3;CEMIP;SHANK2;PKD1;DLG3;ATP11A;NIPA1;NUCB2;GSDMA;SH2D5;ARL8A;ANO8;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;ADGRB2;ALOX15B;IL1RAP;SLC12A4;FAT1;EFS;ASPH;SDHA;FAM155B;SLC6A6;CNFN;PTPRU;ADAM8;TMEM8A;SLC13A3;C19ORF33;RHOBTB2;ARL2;LY6E;SLC43A1;NUMB;ARHGEF4;IGFBP2;CAP1;GPRC5C;VAMP2;FLNB;PIP5K1C;TNFRSF6B;EDNRA;TULP3;B3GNT3;SRC;LDLRAP1;APLP2;TGM2;DNM2;UBR4;LRSAM1;TMEM25;CDC42BPB;NCS1;PAQR7;MARK3;CPTP;RGS19;EXOC2;STXBP1;PAG1;SH3BP1;SPINT2;PCSK6;FYN;RAB25;CLSTN1;AGRN;TMPRSS11D;LPAR3;WNT5B;SLC6A9;NISCH;KIF17;TNFRSF1A;NRSN2;ANXA3;SLC33A1;ABHD17C;PLEKHG5;TSPAN33;GJC2;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;PSKH1;COMT;NTSR1;LYPD5;AMIGO2;CRIM1;MGLL;MISP;SEMA4G;WDFY3;FGFR1;LRRC8A;CEP170;TENM2;F12;SIGMAR1;RAB11FIP4;STK17A;ADIPOR1;TRIB3;TCIRG1;SLC27A1;TPCN1;PMEPA1;ARFIP2;LRCH4;PRRC2A;ST3GAL5;SLC6A14;LRP1;ROBO3;HSPA2;PLCD3;TNFRSF19;MGRN1;P2RX4;SMPD3;ZP3;SPIRE1;PRR9;KLHL17;EHD4;SHB;MAP3K12;VASP;HSPA13;ARAP3;MYO1D;ATXN10;SNTB2;ABCA7;ENTPD6;MSLN;APBB1;RHOBTB1;EPS8L1;HOMER2;SLC10A6;TGFA;NDE1;GSDMC;BAIAP2L1;TPBG;CASP4;SNAP29;KCNC4;EPHB2;CBL;GGT1;CIB1;SOCS7;RAB4B;MAPK3;NTNG1;MAPK10;CSNK1D;DRAM2;ARVCF;LITAF;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;MYZAP;SNX27;TMBIM1;LLGL1;OCRL;ADAM15;SRPX2;HM13;CEACAM1;APBA1;MINK1;SKAP2;ARHGAP44;CD59;SLC30A1;ADCY6;GRIP2;ITSN1;TGFB1;TM2D1;PCYOX1;SLC15A1;CAT;SPRED2;CAMK2N1;ERBB3;ANXA1;PODXL2;SLC45A3;RAB6A;GNAS;ITGA3;CLDN12;PLGRKT;PXN;PLEKHH2;RAP1GAP2;STIM1;RASA3;ASAP1;NIPSNAP1;TRAF7
4809,GO:0012505,8.63996770134039e-12,1,430,3173,endomembrane system,CC,EDEM1;XDH;PYGB;NOS1;ADAM19;CHAC1;H1F0;SH3TC2;CAPN2;F2R;RAC2;ASAP2;SORL1;SDC1;MAP2K1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;CST3;LPCAT4;EPN3;SNX9;AP3D1;LMF1;NAPRT;BOK;ARAP1;DLG4;SERPINE2;BSG;DLG1;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;SLC9A3R2;PGM1;FKBP1A;POSTN;PSMD2;MTA1;RAB3B;CKAP4;SLC2A9;RAPGEF3;PTPRS;PRSS3;PRNP;BNIP3;PDZD2;CD68;SBF1;AGPAT3;TXNDC11;RAB43;DBNDD1;SCYL1;CRTAP;OCIAD2;COPG1;LCN2;CTSB;TMEM214;LY6K;MARCH9;FKBP9;SYNE3;RAB31;CHPF;LPCAT1;VLDLR;LRP5;H6PD;XYLT1;XBP1;EVI5L;EGFR;RTN2;LRP10;MMP14;LAMB1;FYCO1;THBS2;PRKACA;FCHO1;CRAT;RHBDF2;MAP2K2;FAM114A1;EPN1;XYLT2;STK25;ANKRD13D;P4HB;FBXW8;SNX33;PDIA5;CDS2;LRP3;GPC4;IRAK1;SERPING1;APOE;EHD3;ATP13A2;PKN1;AP1B1;SYVN1;YIF1A;COL13A1;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;FAM20C;ITPR3;DGKQ;RFNG;VPS11;FZD8;VPS4A;CTSZ;PI4K2A;TMEM129;FBXO2;RETSAT;PCSK9;SEPT5;HS1BP3;SEC23A;B4GALNT4;RABAC1;LAMB2;PLD3;GDI1;NDST2;MVB12B;SERPINB6;LIMK1;DKK1;CREB3L2;UBE2J1;BNIP3L;KDELR1;OBSL1;LTBP1;SIPA1;YIPF2;ZDHHC8;WASF2;CD44;SCRN1;IPO13;ESYT2;TBC1D16;RAP1GDS1;ATG13;SEC63;ELOVL1;OSBPL5;SLC38A10;SURF4;TBC1D14;CCND2;MALL;BIN1;PAK1;CERCAM;ERO1B;UBXN7;TNRC18;DDIT3;GLUL;PTDSS2;CUL7;DMXL2;TBC1D9B;GGA3;GGA1;ADAMTS7;STOM;SYTL1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;DNASE1L1;CORO7;IFI27;CYTH3;REEP2;TMED3;YIPF3;CEMIP;PKD1;ATP11A;NIPA1;PIGQ;NUCB2;UBXN4;ARL8A;DOPEY2;ANO8;MYOF;SLC2A3;ANTXR2;ASIC1;FNDC4;APPL2;WFS1;SRD5A3;ASPH;ADAM8;ARL2;NUMB;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;AKR7A2;VAMP2;PIP5K1C;GIPC1;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;SCG5;FKBP10;TGM2;DNM2;KLHDC2;SARAF;REEP6;UBR4;IRF7;NUCB1;RAB1B;NCS1;TMEM9;STK24;CPTP;RGS19;CARD19;STX5;C6ORF120;GARS;COG8;STXBP1;PCSK6;OAS1;FYN;RAB25;SPTLC2;CLSTN1;AGRN;YPEL5;REEP4;WNT5B;GRINA;NISCH;PSMD7;TNFRSF1A;NRSN2;ANXA3;HSD11B1;MBOAT7;SLC33A1;ABHD17C;VWA1;BRSK1;STX10;CHST14;GAL;ITGA1;SHISA5;PSKH1;CTSL;EHF;MCFD2;NTSR1;RCN1;TIMP1;UBA1;MGLL;SLC35B4;RNF32;LOXL1;LGALS3BP;WDFY3;SEC24C;TUBG1;RRBP1;ATP2C2;MIB2;TENM2;F12;MFNG;MIF;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;ST3GAL3;DNMBP;ZFPL1;PRAF2;ANGEL1;TCIRG1;PITPNM2;SNX25;SLC27A1;LEMD2;TPCN1;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;AGPAT4;ULK1;LRP1;PAK4;MGRN1;P2RX4;HPSE;USO1;SMPD3;TBC1D20;PNP;EHD4;MAP1LC3B;ST6GALNAC2;VAPB;COG1;SH3BGRL2;TMX4;HSPA13;MYO1D;SNTB2;ABCA7;LMAN1;ENTPD6;MSLN;UNC45A;INTS1;ARG1;TBC1D2B;VEGFB;NEURL1B;TGFA;SEC14L1;TPBG;ARSK;KLK6;VAT1;CASP4;SNAP29;SPESP1;HGS;GAS8;TRAPPC1;CIB1;USP32;RAB4B;PACS2;MAPK3;POMT1;CSNK1D;KIFC3;DRAM2;DNAJB9;LITAF;ALDOC;FURIN;SLC35G2;ARHGEF2;RNF103;SNX27;UGCG;TMBIM1;LLGL1;MPLKIP;B4GALT6;MATN3;OCRL;ADAM15;HM13;EHBP1L1;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;ARHGAP44;LPIN3;TFPT;ECM1;CD59;MAP6;SLC30A1;ITSN1;TGFB1;PPP6R1;MANF;CAT;SPRED2;AZIN2;ANXA1;ARSD;PODXL2;RAB6A;IKBIP;ZFYVE21;ARCN1;ERP44;WDFY2;RAP1GAP2;STIM1
7607,GO:0031982,9.158353198601e-12,1,408,3059,vesicle,CC,NT5E;SH3KBP1;ITGB4;PYGB;TSPAN1;NOS1;LTBP2;SH3TC2;CAPN2;F2R;THSD4;RAC2;LTBP4;SORL1;SDC1;DVL1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;AP3D1;SCN8A;NAPRT;BOK;PCK2;ARAP1;DLG4;SERPINE2;BSG;DLG1;DYSF;MXRA5;SLC9A3R2;PGM1;FKBP1A;PSMD2;RAB3B;CKAP4;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;CD68;LAMA5;RAB43;DBNDD1;SCYL1;OCIAD2;COPG1;FAM129B;LCN2;CTSB;ACOT7;LY6K;HAGH;TUBB6;HEBP1;BCR;RAB31;LPCAT1;AARS;FBLN1;ITGB5;MARCKSL1;PGLS;EGFR;TTYH3;MMP14;LAMB1;FYCO1;THBS2;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;MAP2K2;OAF;STK25;ANKRD13D;P4HB;PSAT1;SNX33;AKT1;XPC;MDH2;ACOT13;CARD11;GPC4;IRAK1;ARPC1A;SERPING1;ALDH1L2;EPN2;APOE;EHD3;ATP13A2;PKN1;AP1B1;YIF1A;CRYL1;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;FAM20C;ITPR3;NAGLU;DGKQ;RFNG;VPS11;VPS4A;HIST2H2BE;CTSZ;PI4K2A;UACA;PFKP;FBXO2;PCSK9;ABHD8;RRAS;SEPT5;SEC23A;RABAC1;MSN;LAMB2;PLD3;MVB12B;SERPINB6;DKK1;ARRDC1;KDELR1;PRSS8;TST;PRKACB;H2AFJ;SIPA1;YIPF2;ZDHHC8;WASF2;CD44;TBC1D16;RAP1GDS1;JADE2;TWF2;SURF4;TBC1D14;PRDX5;MALL;FSCN1;HTRA1;TSTA3;AHCY;CTBS;GAMT;DDIT3;PODXL;GLUL;DMXL2;GGA3;GGA1;TUBB3;STOM;GNB1;SYTL1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;CORO7;RHOC;NID1;REEP2;TMED3;PROCR;YIPF3;CEMIP;PKD1;ASS1;ATP11A;NIPA1;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GGACT;APPL2;PPCS;ALOX15B;CNDP2;FAT1;CNFN;ADAM8;TMEM8A;SLC13A3;RHOBTB2;BLMH;ARL2;NUMB;IGFBP2;CAP1;MYDGF;PLIN3;GPRC5C;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;SRC;LDLRAP1;CHMP5;APLP2;GLRX;CAPG;SCG5;TGM2;DNM2;UBR4;FAM162A;CAPN5;IRF7;HIST3H2A;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;TMEM9;STK24;CPTP;RGS19;STX5;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;TALDO1;PMVK;FYN;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;YPEL5;WNT5B;GALE;PFN1;NISCH;PSMD7;ALDH7A1;NRSN2;ANXA3;ABHD17C;VWA1;PLEKHG5;BRSK1;STX10;CHST14;GAL;ITGA1;GNB2;SHISA5;CTSL;COMT;MCFD2;TIMP1;CRIM1;SLC46A3;UBA1;RNF32;LOXL1;LGALS3BP;SEC24C;FGFR1;TUBG1;RREB1;HYAL1;MIB2;F12;MIF;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;PRAF2;TCIRG1;SNX25;CPNE8;TPCN1;PMEPA1;PRRC2A;ARFGEF2;SLC6A14;ULK1;LRP1;HSPA2;AOX1;MGRN1;P2RX4;HPSE;USO1;ULK2;SPIRE1;PNP;EHD4;MAP1LC3B;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;SNTB2;TAOK1;ABCA7;LMAN1;ENTPD6;RHOBTB1;EPS8L1;HIST2H2AC;ARG1;VEGFB;NEURL1B;TGFA;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;WIPF1;BPHL;KLK6;VAT1;ACY1;SNAP29;SPESP1;HGS;CARHSP1;TRAPPC1;GGT1;CIB1;RAB4B;MAPK3;POMT1;KIFC3;DNAJB9;LITAF;ALDOC;GLO1;FURIN;S100A16;SLC5A1;ARHGEF2;SNX27;TMBIM1;LLGL1;OCRL;ADAM15;HM13;EHBP1L1;CEACAM1;APBA1;GALNT3;MINK1;ARHGAP44;ECM1;CD59;MAP6;NAGA;ITSN1;TGFB1;PCYOX1;CAT;LDHA;SPRED2;AZIN2;ANXA1;ARSD;RAB6A;GNAS;ZFYVE21;ITGA3;ARCN1;ERP44;WDFY2;TRAF7
2407,GO:0005576,4.32970672414273e-11,1,372,2799,extracellular region,CC,NT5E;ANGPTL4;XDH;PGF;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;F2R;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;ADM2;PLAT;PYGL;QSOX1;WNT7A;PTHLH;CST3;EPN3;SNX9;NAPRT;PCK2;SERPINE2;BSG;DLG1;CMTM4;DYSF;IGFBP4;MMP1;MXRA5;SLC9A3R2;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;ITGA6;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;PDZD2;LAMA5;RAB43;CRTAP;FAM129B;LCN2;CTSB;ACOT7;LY6K;HAGH;SEMA3F;TUBB6;ADGRF1;HEBP1;BCR;VLDLR;AARS;FBLN1;ITGB5;XYLT1;MXRA7;MARCKSL1;PGLS;CMTM7;EGFR;TTYH3;MMP14;LAMB1;THBS2;ARHGAP23;PRKACA;PTPRF;CORO1B;TUB;ACTA2;MAP2K2;OAF;PPP1R13L;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;COL13A1;TMSB4X;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;PCSK9;ABHD8;RRAS;DEAF1;MSN;LAMB2;PLD3;EPOR;MVB12B;SERPINB6;DKK1;ARRDC1;FAM3A;PRSS8;TST;PRKACB;H2AFJ;LTBP1;WASF2;CD44;RAP1GDS1;IDE;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;TTBK2;MMP10;AHCY;ADM5;SEMA4B;CTBS;GAMT;TNFSF15;PODXL;GLUL;DMXL2;TUBB3;ADAMTS7;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;LAMC2;RHOC;PLEKHH3;NID1;NXPH4;REEP2;PROCR;CEMIP;PKD1;ASS1;DLG3;APLN;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GGACT;FNDC4;APPL2;PPCS;ALOX15B;IL1RAP;CNDP2;FAT1;CNFN;TMEM8A;TFPI2;SLC13A3;FAM131A;BLMH;ARL2;LY6E;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;TNFRSF6B;TULP3;SRC;CHMP5;APLP2;GLRX;CAPG;SCG5;TGM2;DNM2;NINL;FAM162A;CAPN5;TMEM25;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;SPINT2;PCSK6;TALDO1;PMVK;OAS1;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;YPEL5;WNT5B;GALE;PFN1;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;WISP1;BRPF3;VWA1;CHST14;CGREF1;GAL;ITGA1;GNB2;SHISA5;CTSL;COMT;PLTP;LYPD5;DHRS4L2;TIMP1;CRIM1;SLC46A3;UBA1;LAMB3;LOXL1;LGALS3BP;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;F12;MFNG;MIF;MTMR4;RAB11FIP4;STUB1;PCSK1N;ST3GAL3;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;ACP7;HPSE;ZP3;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;ATXN10;SNTB2;TAOK1;LMAN1;ENTPD6;MSLN;EPS8L1;SLIT3;HIST2H2AC;C1QTNF6;ARG1;VEGFB;TGFA;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;ARSK;KLK6;VAT1;CASP4;ACY1;EPHB2;HGS;CARHSP1;TRAPPC1;GGT1;CIB1;MAPK3;NTNG1;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;TGFB1;PCYOX1;MANF;CAT;LDHA;ERBB3;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44;THBS3;TP73-AS1
7371,GO:0031410,7.19892726902877e-11,1,243,1610,cytoplasmic vesicle,CC,SH3KBP1;PYGB;SH3TC2;F2R;RAC2;SORL1;DVL1;MAP2K1;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;AP3D1;SCN8A;NAPRT;BOK;ARAP1;DLG4;SERPINE2;BSG;DYSF;PGM1;PSMD2;RAB3B;CKAP4;PTPRS;PRSS3;CD68;RAB43;DBNDD1;SCYL1;OCIAD2;COPG1;LCN2;CTSB;LY6K;RAB31;LPCAT1;ITGB5;EGFR;MMP14;FYCO1;THBS2;PRKACA;MAP2K2;ANKRD13D;P4HB;SNX33;IRAK1;SERPING1;EPN2;APOE;EHD3;ATP13A2;PKN1;AP1B1;YIF1A;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;DGKQ;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SEPT5;SEC23A;RABAC1;MVB12B;SERPINB6;DKK1;ARRDC1;KDELR1;SIPA1;YIPF2;ZDHHC8;WASF2;CD44;TBC1D16;SURF4;TBC1D14;PRDX5;MALL;AHCY;DDIT3;DMXL2;GGA3;GGA1;STOM;SYTL1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;CORO7;RHOC;TMED3;YIPF3;CEMIP;PKD1;ATP11A;NIPA1;ARL8A;DOPEY2;MYOF;SLC2A3;ANTXR2;APPL2;ADAM8;RHOBTB2;NUMB;IGFBP2;CAP1;PLIN3;GPRC5C;VAMP2;FLNB;PIP5K1C;GIPC1;SRC;LDLRAP1;CHMP5;APLP2;CAPG;SCG5;DNM2;UBR4;IRF7;NUCB1;RAB1B;NCS1;TMEM9;CPTP;RGS19;STX5;C6ORF120;GARS;STXBP1;FYN;RAB25;YPEL5;WNT5B;NISCH;PSMD7;NRSN2;ANXA3;ABHD17C;PLEKHG5;BRSK1;GAL;ITGA1;CTSL;MCFD2;TIMP1;UBA1;RNF32;LOXL1;LGALS3BP;SEC24C;FGFR1;TUBG1;HYAL1;MIB2;MIF;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;PCSK1N;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;ARFGEF2;ULK1;LRP1;MGRN1;HPSE;USO1;ULK2;SPIRE1;PNP;EHD4;MAP1LC3B;MYO1D;SNTB2;ABCA7;LMAN1;RHOBTB1;ARG1;VEGFB;NEURL1B;TGFA;WIPF1;KLK6;VAT1;SNAP29;SPESP1;HGS;TRAPPC1;RAB4B;MAPK3;POMT1;KIFC3;LITAF;ALDOC;FURIN;ARHGEF2;SNX27;TMBIM1;LLGL1;OCRL;ADAM15;HM13;EHBP1L1;CEACAM1;APBA1;ARHGAP44;ECM1;CD59;MAP6;ITSN1;TGFB1;CAT;SPRED2;AZIN2;ANXA1;RAB6A;ZFYVE21;ARCN1;ERP44;WDFY2;TRAF7
6650,GO:0023052,7.61755345395104e-11,1,512,3942,signaling,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;SH3KBP1;ITGB4;TSPAN1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;IFI6;FKBP1A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;LAMA5;SSH1;WWC3;RAB43;SMURF2;NYAP1;TMOD2;PLCH2;PCDH1;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;SNPH;PLEK2;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;RAB31;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;CSNK1E;MKNK2;MMP14;SLC12A7;ARHGAP23;PRKACA;ADARB1;PTPRF;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;EHD3;RIN2;PKN1;PEAR1;SYVN1;ELK3;YIF1A;WWTR1;TMSB4X;AP2A2;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;SEPT5;SALL2;MSN;TGFBR2;GDI1;HADH;EPOR;MVB12B;RIN1;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;ARRDC1;CORO2A;BNIP3L;PPARA;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;TBC1D16;RAP1GDS1;SEC63;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;PSD3;TSPAN5;PPP1R12C;GIT1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;RHPN1;BCL9L;ZNF385A;NLGN2;SEMA4B;DDIT3;TNFSF15;GLUL;CUL7;ARHGAP39;FARP1;DUSP4;GNB1;SYTL1;DOCK9;RET;RAB29;RASGEF1A;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;PCBP4;SHANK2;PKD1;DLG3;GATA3;APLN;OASL;MYOF;DOCK6;GNAI2;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;SLC12A4;FAT1;EFS;ASPH;MT2A;PTPRU;ADAM8;MAPKBP1;RGL2;HMGA2;ARID5B;RHOBTB2;FAM110C;ARL2;LY6E;PLCB3;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;SCG5;TGM2;DNM2;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;RFXANK;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;ACADVL;RGS19;CARD19;PAK6;TOM1L2;ESRP1;GSK3A;STXBP1;PAG1;SH3BP1;PCSK6;TALDO1;DUSP6;OAS1;FYN;RAB25;ISG20;CLSTN1;FUZ;AGRN;ASNS;PPM1F;RALGDS;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NISCH;PSMD7;MICAL1;TNFRSF1A;WISP1;TLE4;FBXL15;SLC33A1;VDR;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;DLGAP4;GNB2;SHISA5;PSKH1;CTSL;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;MGLL;LGALS3BP;SEMA4G;FGFR1;RREB1;ADNP;LRRC8A;MIB2;TENM2;MFNG;MIF;SOCS2;MTMR4;ASB13;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;ARFIP2;LRCH4;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ULK2;SMPD3;ZP3;LRRK1;FGF2;VAPB;MAPK9;SHB;MAP3K12;ARAP3;CHD7;TAOK1;ABCA7;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;RXRA;ARG1;TAF6;VEGFB;NEURL1B;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;CNOT11;NDRG3;WIPF1;KLK6;CASP4;SNAP29;KCNC4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;CBL;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;OCRL;ADAM15;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ARHGAP44;AGAP1;TFPT;ECM1;CD59;MBD3;SLC30A1;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;TM2D1;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;RAB6A;GNAS;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;STIM1;RASA3;ASAP1;TRAF7
16735,GO:0097708,8.20785049325588e-11,1,243,1612,intracellular vesicle,CC,SH3KBP1;PYGB;SH3TC2;F2R;RAC2;SORL1;DVL1;MAP2K1;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;AP3D1;SCN8A;NAPRT;BOK;ARAP1;DLG4;SERPINE2;BSG;DYSF;PGM1;PSMD2;RAB3B;CKAP4;PTPRS;PRSS3;CD68;RAB43;DBNDD1;SCYL1;OCIAD2;COPG1;LCN2;CTSB;LY6K;RAB31;LPCAT1;ITGB5;EGFR;MMP14;FYCO1;THBS2;PRKACA;MAP2K2;ANKRD13D;P4HB;SNX33;IRAK1;SERPING1;EPN2;APOE;EHD3;ATP13A2;PKN1;AP1B1;YIF1A;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;DGKQ;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SEPT5;SEC23A;RABAC1;MVB12B;SERPINB6;DKK1;ARRDC1;KDELR1;SIPA1;YIPF2;ZDHHC8;WASF2;CD44;TBC1D16;SURF4;TBC1D14;PRDX5;MALL;AHCY;DDIT3;DMXL2;GGA3;GGA1;STOM;SYTL1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;CORO7;RHOC;TMED3;YIPF3;CEMIP;PKD1;ATP11A;NIPA1;ARL8A;DOPEY2;MYOF;SLC2A3;ANTXR2;APPL2;ADAM8;RHOBTB2;NUMB;IGFBP2;CAP1;PLIN3;GPRC5C;VAMP2;FLNB;PIP5K1C;GIPC1;SRC;LDLRAP1;CHMP5;APLP2;CAPG;SCG5;DNM2;UBR4;IRF7;NUCB1;RAB1B;NCS1;TMEM9;CPTP;RGS19;STX5;C6ORF120;GARS;STXBP1;FYN;RAB25;YPEL5;WNT5B;NISCH;PSMD7;NRSN2;ANXA3;ABHD17C;PLEKHG5;BRSK1;GAL;ITGA1;CTSL;MCFD2;TIMP1;UBA1;RNF32;LOXL1;LGALS3BP;SEC24C;FGFR1;TUBG1;HYAL1;MIB2;MIF;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;PCSK1N;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;ARFGEF2;ULK1;LRP1;MGRN1;HPSE;USO1;ULK2;SPIRE1;PNP;EHD4;MAP1LC3B;MYO1D;SNTB2;ABCA7;LMAN1;RHOBTB1;ARG1;VEGFB;NEURL1B;TGFA;WIPF1;KLK6;VAT1;SNAP29;SPESP1;HGS;TRAPPC1;RAB4B;MAPK3;POMT1;KIFC3;LITAF;ALDOC;FURIN;ARHGEF2;SNX27;TMBIM1;LLGL1;OCRL;ADAM15;HM13;EHBP1L1;CEACAM1;APBA1;ARHGAP44;ECM1;CD59;MAP6;ITSN1;TGFB1;CAT;SPRED2;AZIN2;ANXA1;RAB6A;ZFYVE21;ARCN1;ERP44;WDFY2;TRAF7
2433,GO:0005615,1.19858613289144e-10,1,325,2406,extracellular space,CC,NT5E;ANGPTL4;XDH;PGF;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;PTHLH;CST3;EPN3;SNX9;NAPRT;PCK2;SERPINE2;BSG;DLG1;CMTM4;DYSF;IGFBP4;MXRA5;SLC9A3R2;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;LAMA5;RAB43;CRTAP;FAM129B;LCN2;CTSB;ACOT7;HAGH;SEMA3F;TUBB6;HEBP1;BCR;VLDLR;AARS;FBLN1;ITGB5;MARCKSL1;PGLS;CMTM7;EGFR;TTYH3;MMP14;LAMB1;THBS2;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;OAF;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;TMSB4X;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;PCSK9;ABHD8;RRAS;MSN;LAMB2;PLD3;MVB12B;SERPINB6;DKK1;ARRDC1;FAM3A;PRSS8;TST;PRKACB;H2AFJ;LTBP1;WASF2;CD44;RAP1GDS1;IDE;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;TTBK2;MMP10;AHCY;SEMA4B;CTBS;GAMT;TNFSF15;PODXL;GLUL;DMXL2;TUBB3;ADAMTS7;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;LAMC2;RHOC;PLEKHH3;NID1;REEP2;PROCR;PKD1;ASS1;DLG3;APLN;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;GGACT;FNDC4;APPL2;PPCS;ALOX15B;IL1RAP;CNDP2;FAT1;CNFN;TMEM8A;SLC13A3;BLMH;ARL2;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;TNFRSF6B;SRC;CHMP5;APLP2;GLRX;CAPG;TGM2;DNM2;FAM162A;CAPN5;HIST3H2A;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;PCSK6;TALDO1;PMVK;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;WNT5B;GALE;PFN1;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;WISP1;VWA1;CHST14;GAL;ITGA1;GNB2;SHISA5;CTSL;COMT;PLTP;TIMP1;CRIM1;SLC46A3;UBA1;LOXL1;LGALS3BP;SEMA4G;RREB1;ADNP;HYAL1;F12;MFNG;MIF;MTMR4;RAB11FIP4;STUB1;PCSK1N;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;ZP3;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;ATXN10;SNTB2;TAOK1;LMAN1;ENTPD6;MSLN;EPS8L1;SLIT3;HIST2H2AC;C1QTNF6;ARG1;VEGFB;TGFA;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;KLK6;VAT1;ACY1;HGS;CARHSP1;GGT1;CIB1;MAPK3;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;OCRL;ADAM15;SRPX2;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;TGFB1;PCYOX1;MANF;CAT;LDHA;ERBB3;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44
3375,GO:0007154,1.9710601191135e-10,1,512,3967,cell communication,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;SH3KBP1;ITGB4;TSPAN1;CBS;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;IFI6;FKBP1A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;LAMA5;SSH1;WWC3;RAB43;SMURF2;NYAP1;TMOD2;PLCH2;PCDH1;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;SNPH;PLEK2;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;RAB31;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;CSNK1E;MKNK2;MMP14;SLC12A7;ARHGAP23;PRKACA;ADARB1;PTPRF;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;RIN2;PKN1;PEAR1;SYVN1;ELK3;YIF1A;WWTR1;TMSB4X;AP2A2;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;SEPT5;SALL2;MSN;TGFBR2;GDI1;HADH;EPOR;MVB12B;RIN1;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;ARRDC1;CORO2A;BNIP3L;PPARA;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;RAP1GDS1;SEC63;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;PSD3;TSPAN5;PPP1R12C;GIT1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;RHPN1;BCL9L;ZNF385A;NLGN2;SEMA4B;DDIT3;TNFSF15;GLUL;CUL7;ARHGAP39;FARP1;DUSP4;GNB1;SYTL1;DOCK9;RET;RAB29;RASGEF1A;GAS2L1;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;PCBP4;SHANK2;PKD1;DLG3;GATA3;APLN;OASL;MYOF;DOCK6;GNAI2;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;SLC12A4;FAT1;EFS;MT2A;PTPRU;ADAM8;MAPKBP1;RGL2;HMGA2;ARID5B;RHOBTB2;FAM110C;ARL2;LY6E;PLCB3;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;APLP2;SCG5;TGM2;DNM2;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;RFXANK;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;ACADVL;RGS19;CARD19;PAK6;TOM1L2;ESRP1;GSK3A;STXBP1;PAG1;SH3BP1;PCSK6;TALDO1;DUSP6;OAS1;FYN;RAB25;ISG20;CLSTN1;FUZ;AGRN;ASNS;PPM1F;RALGDS;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NISCH;PSMD7;MICAL1;TNFRSF1A;WISP1;TLE4;FBXL15;SLC33A1;VDR;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;MGLL;LGALS3BP;SEMA4G;FGFR1;RREB1;ADNP;LRRC8A;MIB2;TENM2;USF2;MFNG;MIF;SOCS2;MTMR4;ASB13;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;ARFIP2;LRCH4;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ULK2;SMPD3;ZP3;LRRK1;FGF2;MAP1LC3B;VAPB;MAPK9;SHB;MAP3K12;ARAP3;CHD7;TAOK1;ABCA7;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;RXRA;ARG1;TAF6;VEGFB;NEURL1B;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;CNOT11;NDRG3;WIPF1;IMPACT;KLK6;CASP4;SNAP29;KCNC4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;CBL;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;OCRL;ADAM15;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ARHGAP44;AGAP1;TFPT;ECM1;CD59;MBD3;SLC30A1;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;TM2D1;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;RAB6A;GNAS;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
7932,GO:0032501,2.00208166591034e-10,1,535,4183,multicellular organismal process,BP,ANGPTL4;XDH;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;DOCK4;PLAT;WNT7A;PTHLH;ERCC6;CST3;SDK2;CYP27B1;NEURL1;AP3D1;LMF1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;DLG1;DYSF;IGFBP4;PITPNM1;TEF;DNMT3A;FKBP1A;SOX12;DGKA;POSTN;PSMD2;MTA1;ITGA6;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;BNIP3;SBF1;LAMA5;SSH1;WWC3;MICALCL;DBNDD1;CCNI;SMARCA1;CRTAP;SMURF2;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;ESPN;CTSB;TNNT1;SNPH;MRC2;BBS2;SEMA3F;ADGRF1;BCR;LPCAT1;OSBP2;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;MMP14;LAMB1;THBS2;RFX2;PRKACA;ADARB1;PTPRF;CORO1B;TUB;ACTA2;HK1;EPN1;PPP1R13L;FAM50A;STK25;SHANK3;MN1;ATF4;P4HB;HECW2;FBXW8;AKT1;IFITM1;CARD11;GPC4;IRAK1;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;ARG2;METTL23;PKN1;AP1B1;ELK3;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;PRKCZ;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;VPS4A;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;PRR15;FERMT1;RRAS;EML2;DEAF1;SALL2;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;WASF2;CD44;ZNF516;PLCG1;RAP1GDS1;SEC63;IDE;MC1R;TWF2;SLC38A10;TFE3;CCND2;TACC1;MALL;BIN1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;SCMH1;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;DUSP4;GNB1;PTPN9;SATB1;DOCK9;RET;RAB29;LAMC2;NID1;GRB10;REEP2;PROCR;CEMIP;SHANK2;PKD1;DLG3;GATA3;APLN;TCFL5;DCAF7;DOPEY2;MYOF;DOCK6;ASIC1;GLUD1;HSF1;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;ASPH;SDHA;CNFN;PTPRU;ADAM8;MAPKBP1;TFPI2;RAI1;MYH15;HMGA2;ARID5B;DYNLRB1;TOP1;MICAL2;PLCB3;NUMB;IGFBP2;MYDGF;CLEC11A;B4GALT2;FLNB;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;TAZ;TGM2;DNM2;REEP6;AGO4;IRF7;NCS1;PAQR7;STK24;CPTP;ACADVL;PER3;SDCCAG8;RERE;GSK3A;STXBP1;CAMTA2;SH3BP1;SPINT2;PCSK6;DUSP6;FYN;RAB25;CLSTN1;FUZ;AGRN;ASNS;PPM1F;TMPRSS11D;LPAR3;WNT5B;PFN1;NISCH;PSMD7;MICAL1;KIF17;TNFRSF1A;ALDH7A1;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;VWA1;KIF13B;PLEKHG5;BRSK1;GJC2;GAL;PUM1;ITGA1;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;PLTP;NTSR1;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;MGLL;HSF4;LAMB3;LOXL1;SEMA4G;WDFY3;SEC24C;FGFR1;RRBP1;RREB1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;PCSK1N;ADIPOR1;SLC27A1;LEMD2;ZFPM1;LRCH4;ARFGEF2;UNC119B;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;P2RX4;HPSE;E2F5;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;SPIRE1;PRR9;PNP;FGF2;KLHL17;RNH1;MAPK9;SDHAF4;SHB;RCOR1;VASP;MYO1D;CHD7;ATXN10;TAOK1;ABCA7;LMAN1;BICC1;MSLN;APBB1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;VEGFB;NDE1;CAMSAP3;INVS;SEC14L1;TCF25;TPBG;NDRG3;IMPACT;KLK6;CAMK1;EPHB2;SPESP1;KRT23;HGS;POLM;MYL9;GAS8;CBL;GGT1;CIB1;SOCS7;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;GLO1;FURIN;SLC5A1;ARHGEF2;RNF103;TMBIM1;LLGL1;AIDA;MLF1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;PAIP2;APBA1;MINK1;ZNF256;ARHGAP44;SRGAP2B;ECM1;CD59;MBD3;MAP6;SLC30A1;ADCY6;IGF2BP3;TGFB1;SF3B6;SH3PXD2A;MANF;CAT;LDHA;SPRED2;AZIN2;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;PXN;ARCN1;EP300;THBS3;TCF7L1;RAP1GAP2;STIM1;ASAP1;NIPSNAP1;RNF10
10892,GO:0044421,2.79623748130705e-10,1,336,2516,extracellular region part,CC,NT5E;ANGPTL4;XDH;PGF;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;PTHLH;CST3;EPN3;SNX9;NAPRT;PCK2;SERPINE2;BSG;DLG1;CMTM4;DYSF;IGFBP4;MMP1;MXRA5;SLC9A3R2;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;ITGA6;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;LAMA5;RAB43;CRTAP;FAM129B;LCN2;CTSB;ACOT7;HAGH;SEMA3F;TUBB6;HEBP1;BCR;VLDLR;AARS;FBLN1;ITGB5;MXRA7;MARCKSL1;PGLS;CMTM7;EGFR;TTYH3;MMP14;LAMB1;THBS2;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;OAF;PPP1R13L;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;TMSB4X;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;PCSK9;ABHD8;RRAS;MSN;LAMB2;PLD3;MVB12B;SERPINB6;DKK1;ARRDC1;FAM3A;PRSS8;TST;PRKACB;H2AFJ;LTBP1;WASF2;CD44;RAP1GDS1;IDE;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;TTBK2;MMP10;AHCY;SEMA4B;CTBS;GAMT;TNFSF15;PODXL;GLUL;DMXL2;TUBB3;ADAMTS7;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;LAMC2;RHOC;PLEKHH3;NID1;REEP2;PROCR;PKD1;ASS1;DLG3;APLN;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;GGACT;FNDC4;APPL2;PPCS;ALOX15B;IL1RAP;CNDP2;FAT1;CNFN;TMEM8A;TFPI2;SLC13A3;BLMH;ARL2;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;TNFRSF6B;SRC;CHMP5;APLP2;GLRX;CAPG;TGM2;DNM2;NINL;FAM162A;CAPN5;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;PCSK6;TALDO1;PMVK;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;WNT5B;GALE;PFN1;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;WISP1;VWA1;CHST14;GAL;ITGA1;GNB2;SHISA5;CTSL;COMT;PLTP;TIMP1;CRIM1;SLC46A3;UBA1;LAMB3;LOXL1;LGALS3BP;SEMA4G;RREB1;ADNP;HYAL1;F12;MFNG;MIF;MTMR4;RAB11FIP4;STUB1;PCSK1N;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;HPSE;ZP3;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;ATXN10;SNTB2;TAOK1;LMAN1;ENTPD6;MSLN;EPS8L1;SLIT3;HIST2H2AC;C1QTNF6;ARG1;VEGFB;TGFA;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;KLK6;VAT1;ACY1;HGS;CARHSP1;GGT1;CIB1;MAPK3;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;TGFB1;PCYOX1;MANF;CAT;LDHA;ERBB3;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44;THBS3
6649,GO:0023051,1.22369005326704e-09,1,326,2353,regulation of signaling,BP,TNIP1;XDH;PGF;SH2D2A;SH3KBP1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;CMTM4;IGFBP4;IFI6;FKBP1A;POSTN;PSMD2;RAB3B;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;WWC3;SMURF2;TMOD2;FAM129B;G0S2;MAPKAPK3;SESN2;USP20;NACC2;BCR;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MMP14;ARHGAP23;PRKACA;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;P4HB;AKT1;CARD11;GPC4;IRAK1;EPN2;APOE;EHD3;PKN1;PEAR1;SYVN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;SEPT5;TGFBR2;GDI1;HADH;MVB12B;STK39;DKK1;SOX7;PPP2R5B;ARRDC1;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;CDC34;CD44;PLCG1;TBC1D16;MAP3K9;MC1R;DEDD2;PSD3;TSPAN5;GIT1;HTRA1;SUFU;PAK1;BCL9L;ZNF385A;NLGN2;DDIT3;TNFSF15;GLUL;ARHGAP39;FARP1;DUSP4;RET;RAB29;RASGEF1A;RHOC;GRB10;CYTH3;SHANK2;GATA3;APLN;MYOF;GNAI2;ASIC1;GLUD1;HSF1;APPL2;ANKS1A;ALOX15B;WFS1;ASPH;ADAM8;MAPKBP1;RGL2;RHOBTB2;FAM110C;ARL2;ARHGEF4;IGFBP2;MYDGF;CLEC11A;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;CHMP5;SCG5;TGM2;DNM2;FAM162A;IRF7;MARK3;STK24;RGS19;CARD19;PAK6;GSK3A;STXBP1;PAG1;SH3BP1;PCSK6;DUSP6;FYN;CLSTN1;FUZ;LPAR3;WNT5B;SLC6A9;GRINA;NISCH;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;MGLL;FGFR1;ADNP;MIB2;MFNG;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;DNMBP;TRIB3;AFAP1;SNX25;PTPN12;LEMD2;PMEPA1;ARFGEF2;LRP1;TRIB2;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;SHB;MAP3K12;ARAP3;CHD7;TAOK1;ABCA7;BICC1;RHOBTB1;EPS8L1;SLIT3;HOMER2;ARG1;TAF6;VEGFB;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;KLK6;CASP4;KCNC4;EPHB2;HGS;CBL;CIB1;SOCS7;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;TMBIM1;LLGL1;AIDA;OCRL;CEACAM1;PAIP2;APBA1;MINK1;SKAP2;ARHGAP44;AGAP1;ECM1;MBD3;SLC30A1;ITSN1;TGFB1;WBP2;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;GNAS;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;STIM1;RASA3;ASAP1;TRAF7
3386,GO:0007165,1.81665411225231e-09,1,474,3680,signal transduction,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;SH3KBP1;ITGB4;TSPAN1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;ARAP1;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;IFI6;FKBP1A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;LAMA5;SSH1;WWC3;RAB43;SMURF2;NYAP1;TMOD2;PLCH2;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;PLEK2;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;RAB31;VLDLR;LRP5;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MKNK2;MMP14;ARHGAP23;PRKACA;PTPRF;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;RIN2;PKN1;PEAR1;SYVN1;ELK3;YIF1A;WWTR1;TMSB4X;AP2A2;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;SALL2;MSN;TGFBR2;GDI1;EPOR;MVB12B;RIN1;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;ARRDC1;CORO2A;BNIP3L;PPARA;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;RAP1GDS1;SEC63;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;PSD3;TSPAN5;PPP1R12C;GIT1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;RHPN1;BCL9L;ZNF385A;NLGN2;SEMA4B;DDIT3;TNFSF15;CUL7;ARHGAP39;FARP1;DUSP4;GNB1;DOCK9;RET;RAB29;RASGEF1A;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;PCBP4;SHANK2;PKD1;GATA3;APLN;OASL;MYOF;DOCK6;GNAI2;ANTXR2;GRIN3B;ASIC1;HSF1;APPL2;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;EFS;MT2A;PTPRU;ADAM8;MAPKBP1;RGL2;ARID5B;RHOBTB2;FAM110C;LY6E;PLCB3;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;APLP2;SCG5;TGM2;DNM2;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;RFXANK;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;ACADVL;RGS19;CARD19;PAK6;TOM1L2;ESRP1;GSK3A;PAG1;SH3BP1;PCSK6;TALDO1;DUSP6;OAS1;FYN;RAB25;ISG20;FUZ;AGRN;ASNS;PPM1F;RALGDS;LPAR3;WNT5B;GRINA;PFN1;NISCH;PSMD7;MICAL1;TNFRSF1A;WISP1;TLE4;FBXL15;SLC33A1;VDR;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;MGLL;LGALS3BP;SEMA4G;FGFR1;RREB1;LRRC8A;MIB2;TENM2;MFNG;MIF;SOCS2;MTMR4;ASB13;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;ARFIP2;LRCH4;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ULK2;ZP3;LRRK1;FGF2;VAPB;MAPK9;SHB;MAP3K12;ARAP3;TAOK1;ABCA7;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;RXRA;ARG1;TAF6;VEGFB;NEURL1B;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;CNOT11;NDRG3;WIPF1;KLK6;CASP4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;CBL;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;OCRL;ADAM15;CEACAM1;GALNT3;MINK1;SKAP2;ARHGAP44;AGAP1;TFPT;ECM1;CD59;MBD3;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;TM2D1;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;RAB6A;GNAS;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
4567,GO:0010646,2.96617991450532e-09,1,320,2320,regulation of cell communication,BP,TNIP1;XDH;PGF;SH2D2A;SH3KBP1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;CMTM4;IGFBP4;IFI6;FKBP1A;POSTN;PSMD2;RAB3B;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;WWC3;SMURF2;TMOD2;FAM129B;G0S2;MAPKAPK3;SESN2;USP20;NACC2;BCR;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MMP14;ARHGAP23;PRKACA;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;P4HB;AKT1;CARD11;GPC4;IRAK1;EPN2;APOE;PKN1;PEAR1;SYVN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;SEPT5;TGFBR2;GDI1;HADH;MVB12B;STK39;DKK1;SOX7;PPP2R5B;ARRDC1;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;CDC34;CD44;PLCG1;MAP3K9;MC1R;DEDD2;PSD3;TSPAN5;GIT1;HTRA1;SUFU;PAK1;BCL9L;ZNF385A;NLGN2;DDIT3;TNFSF15;GLUL;ARHGAP39;FARP1;DUSP4;RET;RAB29;RASGEF1A;RHOC;GRB10;CYTH3;SHANK2;GATA3;APLN;MYOF;GNAI2;ASIC1;GLUD1;HSF1;APPL2;ANKS1A;ALOX15B;WFS1;ADAM8;MAPKBP1;RGL2;RHOBTB2;FAM110C;ARL2;ARHGEF4;IGFBP2;MYDGF;CLEC11A;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;SCG5;TGM2;DNM2;FAM162A;IRF7;MARK3;STK24;RGS19;CARD19;PAK6;GSK3A;STXBP1;PAG1;SH3BP1;PCSK6;DUSP6;FYN;CLSTN1;FUZ;LPAR3;WNT5B;SLC6A9;GRINA;NISCH;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;MGLL;FGFR1;ADNP;MIB2;MFNG;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;DNMBP;TRIB3;AFAP1;SNX25;PTPN12;LEMD2;PMEPA1;ARFGEF2;LRP1;TRIB2;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;SHB;MAP3K12;ARAP3;CHD7;TAOK1;ABCA7;BICC1;RHOBTB1;EPS8L1;SLIT3;HOMER2;ARG1;TAF6;VEGFB;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;KLK6;CASP4;KCNC4;EPHB2;HGS;CBL;CIB1;SOCS7;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;TMBIM1;LLGL1;AIDA;OCRL;CEACAM1;PAIP2;MINK1;SKAP2;ARHGAP44;AGAP1;ECM1;MBD3;SLC30A1;ITSN1;TGFB1;WBP2;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;GNAS;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
6689,GO:0030054,7.02463036840203e-09,1,143,872,cell junction,CC,FLNC;FHL1;SH3KBP1;ITGB4;TSPAN1;CCND1;CAPN2;MPRIP;RAC2;ADGRL1;MAP2K1;SDK2;NEURL1;SHARPIN;DLG4;BSG;DLG1;SLC9A3R2;ITGA6;PTPRS;PDZD2;PCDH1;FAM129B;SNPH;MRC2;BCR;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PPP1R13L;PARVB;SHANK3;P4HB;AKT1;EHD3;TNS4;AFAP1L1;COL13A1;PRKCZ;ARHGAP22;PI4K2A;SH3PXD2B;FERMT1;GIT2;RRAS;RABAC1;MSN;MAP1B;CD99;LIMK1;AKAP12;SYMPK;OBSL1;WASF2;CD44;PLCG1;PSD3;GIT1;FSCN1;PAK1;NLGN2;PODXL;DMXL2;FARP1;CYTH3;PROCR;SHANK2;DLG3;SH2D5;CADM4;GRIN3B;FAT1;PTPRU;ARL2;NUMB;CAP1;VAMP2;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;CDC42BPB;NCS1;PAK6;SDCCAG8;SPECC1L;SH3BP1;CLSTN1;AGRN;PFN1;ABHD17C;PLEKHG5;BRSK1;GJC2;ITGA1;GNB2;RAI14;UBA1;MISP;TENM2;SIGMAR1;BCL2L1;DNMBP;DDB2;AFAP1;PTPN12;ARFGEF2;LRP1;PAK4;P2RX4;KLHL17;PYM1;VASP;SNTB2;ABCA7;HOMER2;CAMSAP3;BAIAP2L1;CBL;MAPK3;KIFC3;ARHGEF2;MYZAP;ADAM15;SRPX2;CEACAM1;MINK1;ARHGAP44;CD59;ITSN1;SH3PXD2A;CAT;STARD10;CAMK2N1;ANXA1;ZFYVE21;ITGA3;CLDN12;PXN;FHOD1
10922,GO:0044459,7.31042569349833e-09,1,218,1455,plasma membrane part,CC,ITGB4;TSPAN1;NOS1;F2R;MST1R;SORL1;ADGRL1;SDC1;DVL1;SHC1;KCNG1;NEURL1;EPN3;SNX9;SCN8A;SLCO4A1;DLG4;SERPINE2;BSG;DLG1;DYSF;SLC16A3;PITPNM1;SLC9A3R2;FKBP1A;DCBLD2;ITGA6;SLC2A9;PTPRS;PRNP;SSH1;PCDH1;SNPH;PLEK2;MRC2;BBS2;BCR;LRP5;ACVR2B;ITGB5;HTR7;EGFR;RTN2;MMP14;SLC12A7;PRKACA;PTPRF;MAP2K2;LMBR1L;SHANK3;ATF4;P4HB;CARD11;GPC4;IRAK1;ARPC1A;EHD3;ATP13A2;PKN1;PEAR1;COL13A1;AP2A2;PRKCZ;ATP7B;ITPR3;FZD8;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;PCSK9;FERMT1;MSN;TGFBR2;CD99;EPOR;STK39;PRSS8;CD44;ESYT2;ABCB8;MC1R;PSD3;TSPAN5;BIN1;FSCN1;PAK1;SLC29A4;NLGN2;TNFSF15;PODXL;STOM;FARP1;GNB1;SYTL1;RET;RHOC;CYTH3;REEP2;PROCR;SHANK2;PKD1;DLG3;SH2D5;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;IL1RAP;SLC12A4;FAT1;SDHA;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;ARL2;LY6E;SLC43A1;NUMB;ARHGEF4;IGFBP2;GPRC5C;VAMP2;PIP5K1C;TNFRSF6B;EDNRA;B3GNT3;SRC;LDLRAP1;TGM2;DNM2;NCS1;RGS19;STXBP1;PAG1;SH3BP1;FYN;RAB25;CLSTN1;TMPRSS11D;LPAR3;SLC6A9;KIF17;TNFRSF1A;SLC33A1;ABHD17C;TSPAN33;GJC2;ITGA1;SLC13A5;COMT;NTSR1;FGFR1;TENM2;SIGMAR1;RAB11FIP4;ADIPOR1;TCIRG1;LRCH4;ST3GAL5;SLC6A14;LRP1;HSPA2;PLCD3;P2RX4;SPIRE1;KLHL17;VASP;MYO1D;SNTB2;ABCA7;APBB1;EPS8L1;HOMER2;TGFA;NDE1;TPBG;SNAP29;KCNC4;EPHB2;CBL;CIB1;MAPK3;NTNG1;DRAM2;LITAF;SLC35G2;SLC5A1;ARHGEF2;MYZAP;SNX27;SRPX2;CEACAM1;MINK1;ARHGAP44;CD59;SLC30A1;ADCY6;TM2D1;SLC15A1;CAMK2N1;ERBB3;ANXA1;PODXL2;GNAS;ITGA3;CLDN12;PLGRKT;STIM1;RASA3;ASAP1;NIPSNAP1
2491,GO:0005737,1.25812780839825e-08,1,945,8373,cytoplasm,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;PITPNM1;IFI6;DNMT3A;PGM1;FKBP1A;DGKA;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;TMOD2;PLCH2;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;HEBP1;BCR;SYNE3;RAB31;CHPF;LPCAT1;NUDCD3;VLDLR;MARK4;CCNG2;LRP5;AARS;ACVR2B;ITGB5;H6PD;XYLT1;GPT2;ADCY7;XBP1;MYCBPAP;MARCKSL1;PGLS;MAP4K4;EGFR;RTN2;CSNK1E;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;AP1B1;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;ENDOG;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;EML2;SEPT5;DEAF1;HS1BP3;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;LAMB2;CD99;PLD3;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;DHTKD1;KDELR1;NADK;AKAP12;SYMPK;OBSL1;TST;PRKACB;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;ISYNA1;ERO1B;AHCY;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;BAZ2A;CTBS;GAMT;NAV1;DDIT3;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;IFI27;GRB10;CYTH3;REEP2;TMED3;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;DOCK6;GNAI2;SLC2A3;ANTXR2;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;PPCS;SIN3B;ANKS1A;PANK4;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;CNFN;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;MYH15;ALAS1;C19ORF33;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;PLCB3;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;PAK6;PER3;STX5;C6ORF120;SDCCAG8;GARS;COG8;EXOC2;GSK3A;STXBP1;SPECC1L;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;PPM1F;RALGDS;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;EIF2S2;HEXIM1;TIMP1;FRYL;UBA1;MGLL;MISP;SLC35B4;RNF32;RNF187;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;ADNP;HYAL1;LRRC8A;MIB2;CEP170;TENM2;F12;USF2;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;ST3GAL3;DNMBP;TRIB3;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;PLCD3;PAK4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;COG1;SH3BGRL2;SDHAF4;SHB;PYM1;MAP3K12;VASP;ABHD14B;TMX4;HSPA13;ARAP3;MYO1D;ATXN10;SNTB2;TAOK1;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;UNC45A;ARG1;PBXIP1;TBC1D2B;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TPBG;NDRG3;WIPF1;IMPACT;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;MYL9;GAS8;CBL;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ADAM15;SRPX2;HM13;EHBP1L1;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;GRIP2;ITSN1;TGFB1;WBP2;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;ERBB3;ANXA1;ARSD;PODXL2;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;FHOD1;TRAF7;RNF10
4364,GO:0009966,1.498238015996e-08,1,296,2150,regulation of signal transduction,BP,TNIP1;XDH;PGF;SH2D2A;SH3KBP1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;ARAP1;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;CMTM4;IGFBP4;IFI6;FKBP1A;POSTN;PSMD2;ITGA6;NET1;PTPRS;PRNP;BNIP3;SSH1;WWC3;SMURF2;TMOD2;FAM129B;G0S2;MAPKAPK3;SESN2;USP20;NACC2;BCR;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MMP14;ARHGAP23;PRKACA;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;P4HB;AKT1;CARD11;GPC4;IRAK1;EPN2;APOE;PKN1;PEAR1;SYVN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;FAM20C;DGKQ;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;FERMT1;GIT2;RRAS;TGFBR2;GDI1;MVB12B;STK39;DKK1;SOX7;PPP2R5B;ARRDC1;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;CDC34;CD44;PLCG1;MAP3K9;MC1R;DEDD2;PSD3;TSPAN5;GIT1;HTRA1;SUFU;PAK1;BCL9L;ZNF385A;NLGN2;DDIT3;TNFSF15;ARHGAP39;FARP1;DUSP4;RET;RAB29;RASGEF1A;RHOC;GRB10;CYTH3;SHANK2;GATA3;APLN;MYOF;GNAI2;HSF1;APPL2;ANKS1A;ALOX15B;WFS1;ADAM8;MAPKBP1;RGL2;RHOBTB2;FAM110C;ARHGEF4;IGFBP2;MYDGF;CLEC11A;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;TGM2;DNM2;FAM162A;IRF7;MARK3;STK24;RGS19;CARD19;PAK6;GSK3A;PAG1;SH3BP1;PCSK6;DUSP6;FYN;FUZ;LPAR3;WNT5B;GRINA;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;MGLL;FGFR1;MIB2;MFNG;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;DNMBP;TRIB3;AFAP1;SNX25;PTPN12;LEMD2;PMEPA1;ARFGEF2;LRP1;TRIB2;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;SHB;MAP3K12;ARAP3;TAOK1;ABCA7;BICC1;RHOBTB1;EPS8L1;SLIT3;HOMER2;ARG1;TAF6;VEGFB;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;KLK6;CASP4;EPHB2;HGS;CBL;CIB1;SOCS7;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;TMBIM1;LLGL1;AIDA;OCRL;CEACAM1;MINK1;SKAP2;ARHGAP44;AGAP1;ECM1;MBD3;ITSN1;TGFB1;WBP2;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
11904,GO:0046903,2.10822377258042e-08,1,156,999,secretion,BP,XDH;PYGB;LTBP2;CCND1;F2R;RAC2;LTBP4;SDC1;DVL1;PYGL;QSOX1;WNT7A;CST3;NEURL1;LMF1;NAPRT;PCK2;SERPINE2;NR1D1;PGM1;POSTN;PSMD2;RAB3B;CKAP4;RAPGEF3;PRSS3;IDH2;CD68;COPG1;FAM129B;LCN2;CTSB;SNPH;BCR;RAB31;LPCAT1;LRP5;ACVR2B;XBP1;MAP4K4;EGFR;RHBDF2;HK1;CARD11;SERPING1;ATP13A2;ARG2;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;POU2F2;VPS11;VPS4A;CTSZ;PI4K2A;FERMT1;SEPT5;HADH;SERPINB6;STK39;CD44;SCRN1;SURF4;PAK1;NLGN2;GLUL;STOM;SYTL1;FUCA1;DNASE1L1;ATP11A;GATA3;APLN;ARL8A;SLC2A3;ASIC1;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;CAP1;VAMP2;PIP5K1C;GIPC1;SRC;APLP2;SCG5;UBR4;NCS1;CPTP;C6ORF120;EXOC2;STXBP1;PCSK6;RAB25;YPEL5;SLC6A9;NISCH;PSMD7;MICAL1;ANXA3;VDR;BRPF3;BRSK1;GAL;COMT;NTSR1;TIMP1;LGALS3BP;FGFR1;USF2;MIF;SOCS2;TCIRG1;ARFGEF2;P2RX4;HPSE;SMPD3;ZP3;PNP;CHD7;APBB1;ARG1;VEGFB;VAT1;SNAP29;KCNC4;HGS;CBL;TRAPPC1;RAB4B;MAPK3;ALDOC;FURIN;TMBIM1;LLGL1;CEACAM1;APBA1;ARHGAP44;ECM1;CD59;SLC30A1;TGFB1;MANF;CAT;STARD10;ERBB3;ANXA1;RAB6A;GNAS;ERP44
12878,GO:0051179,2.34094284171132e-08,1,533,4312,localization,BP,EDEM1;XDH;PGF;FHL1;SH3KBP1;ITGB4;PYGB;TSPAN1;MDFI;ZMYND8;NOS1;LTBP2;CCND1;SH3TC2;F2R;RAC2;LTBP4;ASAP2;SORL1;SDC1;DVL1;MAP2K1;SERINC2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;PCK2;ARAP1;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;KLC2;DLG1;DYSF;XPOT;SLC16A3;MMP1;PITPNM1;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;ITGA6;NET1;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;BNIP3;CD68;LAMA5;SSH1;RAB43;SCYL1;SMURF2;NME4;COPG1;MARVELD1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;SESN2;SNPH;MRC2;BBS2;SEMA3F;OSBPL10;USP20;NACC2;BCR;SYNE3;RAB31;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;LRP5;ACVR2B;FBLN1;XBP1;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;TTYH3;MMP14;LAMB1;FYCO1;SLC12A7;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CORO1B;TUB;RHBDF2;HK1;MAP2K2;EPN1;LMBR1L;STK25;SHANK3;TTC7B;ATF4;HECW2;SNX33;AKT1;IFITM1;LRP3;CARD11;ARPC1A;SERPING1;EPN2;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;RIN2;PKN1;AP1B1;PEAR1;SYVN1;TNS4;YIF1A;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;CTSZ;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;TMEM129;SH3PXD2B;PCSK9;FERMT1;GIT2;RRAS;SEPT5;SEC23A;TMCO3;MSN;MAP1B;TGFBR2;GDI1;HADH;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;UBE2J1;ARRDC1;BNIP3L;PPARA;KDELR1;PRSS8;AKAP12;SYMPK;OBSL1;TST;LTBP1;ZDHHC8;WASF2;CD44;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;ATG13;ABCB8;SEC63;OSBPL5;TWF2;SLC38A10;SURF4;TBC1D14;TSPAN5;MALL;GIT1;BIN1;FSCN1;SFXN3;SUFU;CCDC88C;PAK1;TTBK2;SLC29A4;MMP10;ZNF385A;NLGN2;SEMA4B;NAV1;DDIT3;PODXL;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;FUCA1;SDCCAG3;RET;RAB29;RASGEF1A;DNASE1L1;CORO7;LAMC2;RHOC;IFI27;GRB10;CYTH3;REEP2;TMED3;PROCR;CEMIP;SEPT8;SHANK2;PKD1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;OXA1L;ARL8A;DOPEY2;ANO8;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ANKS1A;ALOX15B;IL1RAP;WFS1;SLC12A4;FAT1;EFS;ASPH;FAM155B;SLC6A6;PTPRU;ADAM8;MAPKBP1;SLC13A3;ARID5B;RHOBTB2;DYNLRB1;FAM110C;ARL2;SLC43A1;NUMB;CAP1;PLIN3;VAMP2;FLNB;PIP5K1C;GIPC1;EDNRA;TULP3;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;SCG5;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;LRSAM1;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;STK24;CPTP;PAK6;STX5;TOM1L2;C6ORF120;SDCCAG8;COG8;RERE;EXOC2;GSK3A;STXBP1;SH3BP1;SPINT2;PCSK6;FYN;RAB25;FUZ;AGRN;PPM1F;YPEL5;LPAR3;WNT5B;SLC6A9;PFN1;NISCH;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ANXA3;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;KIF13B;ELMO3;PLEKHG5;TSPAN33;BRSK1;STX10;MOAP1;GJC2;GAL;ITGA1;FCGRT;SLC13A5;COMT;THRA;MCFD2;PLTP;NTSR1;EIF2S2;TIMP1;SLC46A3;SLC35B4;LGALS3BP;SEMA4G;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;ATP2C2;HYAL1;LRRC8A;USF2;GUK1;MIF;SOCS2;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;MAU2;VPS9D1;TRIB3;ZFPL1;PRAF2;TCIRG1;PITPNM2;SNX25;SLC27A1;LEMD2;TPCN1;ARFIP2;ARFGEF2;UNC119B;SLC6A14;ULK1;LRP1;HSPA2;ZNF609;PAK4;MGRN1;P2RX4;HPSE;USO1;SMPD3;ZP3;TBC1D20;SPIRE1;PNP;FGF2;EHD4;VAPB;MAPK9;COG1;HSPA13;ARAP3;MYO1D;CHD7;ABCA7;LMAN1;APBB1;RHOBTB1;HOMER2;RXRA;ARG1;SLC10A6;TBC1D2B;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;SEC14L1;ATP6V1C2;WIPF1;VAT1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;HGS;GAS8;CBL;TRAPPC1;CIB1;TMSB10;SOCS7;RAB4B;PACS2;MAPK3;CPT1B;CSNK1D;ALDOC;FURIN;SLC5A1;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;ADAM15;SRPX2;HM13;CEACAM1;APBA1;MINK1;ARHGAP44;AGAP1;SRGAP2B;ECM1;CD59;MAP6;SLC30A1;IGF2BP3;CCNE1;ITSN1;TGFB1;WBP2;PCYOX1;PPP6R1;MANF;SLC15A1;CAT;AZIN2;PIK3R2;STARD10;ERBB3;ANXA1;PODXL2;SLC45A3;PPP1R10;RAB6A;GNAS;ZFYVE21;ITGA3;PXN;ARCN1;ERP44;ORAI3;STIM1;RASA3;ASAP1;FHOD1
10310,GO:0043062,2.4745021552257e-08,1,55,242,extracellular structure organization,BP,ITGB4;ADAM19;CAPN2;THSD4;SDC1;CST3;BSG;MMP1;POSTN;ITGA6;LAMA5;FBLN1;ITGB5;MMP14;LAMB1;THBS2;PRKACA;P4HB;APOE;COL13A1;SH3PXD2B;FERMT1;LAMB2;PRKACB;ZDHHC8;CD44;FSCN1;HTRA1;ERO1B;MMP10;LAMC2;NID1;ADAM8;P4HA1;SPINT2;AGRN;VWA1;ITGA1;CTSL;PLTP;TIMP1;LAMB3;LOXL1;HYAL1;LRP1;FGF2;ABCA7;POMT1;FURIN;MATN3;ADAM15;TGFB1;SH3PXD2A;ITGA3;THBS3
10266,GO:0042995,4.55251792929759e-08,1,196,1314,cell projection,CC,SH3KBP1;ZMYND8;NOS1;CAPN2;RAC2;ADGRL1;DVL1;DOCK4;CST3;NEURL1;SNX9;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;DYSF;FKBP1A;ITGA6;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;TMOD2;CYGB;ESPN;SNPH;PLEK2;BBS2;OSBP2;MARK4;HTR7;PRKACA;PTPRF;CORO1B;TUB;ACTA2;HK1;PARVB;SHANK3;ATF4;AKT1;ARPC1A;BAG3;APOE;EHD3;STRN4;ATP13A2;AFAP1L1;PRKCZ;CTSZ;EPHA1;PI4K2A;PTK6;FBXO2;SH3PXD2B;FERMT1;SEPT5;MSN;MAP1B;GDI1;LIMK1;PRKACB;WASF2;CD44;PLCG1;TWF2;PSD3;BIN1;FSCN1;SUFU;PAK1;TTBK2;AHCY;ZNF385A;NAV1;PODXL;GLUL;TUBB3;FARP1;GNB1;SYTL1;PTPN9;RET;RHOC;CYTH3;SHANK2;PKD1;DLG3;WDR66;GNAI2;ANKS1A;WFS1;FAT1;DYNLRB1;ARHGEF4;ANKS6;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;DNM2;REEP6;CDC42BPB;NCS1;GARS;GSK3A;STXBP1;SH3BP1;FYN;RAB25;CLSTN1;FUZ;LPAR3;MICAL1;KIF17;ANXA3;ABHD17C;KIF13B;PLEKHG5;GJC2;ITGA1;COMT;NTSR1;WDFY3;TUBG1;ADNP;CEP170;TENM2;SIGMAR1;PTPN12;ARFIP2;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;SLC6A14;ULK1;LRP1;ROBO3;P2RX4;KLHL17;MAP1LC3B;MAPK9;MAP3K12;VASP;ARAP3;MYO1D;ATXN10;ABCA7;APBB1;EPS8L1;HOMER2;ARG1;RPL28;INVS;WIPF1;SNAP29;KCNC4;EPHB2;GAS8;CBL;CIB1;WRAP73;MAPK3;MAPK10;CSNK1D;ARHGEF2;LLGL1;OCRL;ADAM15;CEACAM1;APBA1;MINK1;ARHGAP44;MAP6;ADCY6;ITSN1;TGFB1;SH3PXD2A;AZIN2;STARD10;CAMK2N1;ANXA1;GNAS;ITGA3;PXN;PLEKHH2;RAP1GAP2;ASAP1;FHOD1
10908,GO:0044444,5.37091602109204e-08,1,822,7180,cytoplasmic part,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;PYGB;TSPAN1;CBS;ERCC1;NOS1;ADAM19;CHAC1;H1F0;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;CPT2;SERPINE2;BSG;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;PITPNM1;IFI6;PGM1;FKBP1A;DGKA;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;AGPAT3;SSH1;WWC3;TXNDC11;RAB43;DBNDD1;SCYL1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;TMOD2;CYGB;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;TNNT1;TMEM214;LY6K;SNPH;MARCH9;BBS2;FKBP9;HAGH;OSBPL10;USP20;NACC2;BCR;SYNE3;RAB31;CHPF;LPCAT1;VLDLR;MARK4;LRP5;AARS;ITGB5;H6PD;XYLT1;GPT2;ADCY7;XBP1;PGLS;EGFR;RTN2;CSNK1E;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;TUBG2;XYLT2;STK25;PARVB;SHANK3;ANKRD13D;TTC7B;P4HB;FBXW8;PSAT1;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;FMNL2;ATP13A2;ARG2;UAP1;RIN2;PKN1;AP1B1;SYVN1;ELK3;TNS4;YIF1A;WWTR1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;PRKCZ;GALNS;RNF135;ATP7B;FAM20C;ITPR3;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;UACA;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PCSK9;ENDOG;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;SEPT5;HS1BP3;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;LAMB2;PLD3;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;DHTKD1;KDELR1;NADK;AKAP12;SYMPK;OBSL1;TST;PRKACB;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;OSBPL5;IDE;MSRB2;COA5;TWF2;SLC38A10;SURF4;TMEM134;TBC1D14;TFE3;PRDX5;CCND2;CMIP;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;ISYNA1;ERO1B;AHCY;ACSF2;DTD1;UBXN7;TNRC18;BAZ2A;CTBS;GAMT;DDIT3;GLUL;BCDIN3D;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;ADAMTS7;STOM;FARP1;GNB1;SYTL1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;MLXIP;RHOC;IFI27;GRB10;CYTH3;REEP2;TMED3;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;APLN;NIPA1;WDR66;PIGQ;NUCB2;GSDMA;OXA1L;UBXN4;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;DOCK6;GNAI2;SLC2A3;ANTXR2;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;PPCS;ANKS1A;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;ASPH;MT2A;SDHA;CTBP1;CDCA7L;ADAM8;TMEM8A;RAI1;MPG;PYCR2;MYH15;ALAS1;C19ORF33;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;PLCB3;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;LRSAM1;RFXANK;NUCB1;STPG1;RAB1B;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;STX5;C6ORF120;SDCCAG8;GARS;COG8;EXOC2;GSK3A;STXBP1;SPECC1L;SH3BP1;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;PRIMPOL;MPI;SPTLC2;CLSTN1;SUGCT;AGRN;ASNS;PPM1F;RALGDS;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;MBOAT7;FBXL15;SLC33A1;BRPF3;ABHD17C;VWA1;KIF13B;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;EIF2S2;TIMP1;FRYL;UBA1;MGLL;MISP;SLC35B4;RNF32;RNF187;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;MIF4GD;ATP2C2;HYAL1;MIB2;CEP170;TENM2;F12;MFNG;GUK1;MIF;SOCS2;MTMR4;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;ST3GAL3;DNMBP;TRIB3;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;TPCN1;PMEPA1;ARFIP2;HLCS;SARS2;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;AGPAT4;ULK1;LRP1;HSPA2;AOX1;PLCD3;PAK4;MGRN1;P2RX4;HPSE;SAMD4B;USO1;ULK2;SMPD3;LRRK1;TBC1D20;SPIRE1;PNP;KLHL17;EHD4;MAP1LC3B;RNH1;ST6GALNAC2;VAPB;MAPK9;COG1;SDHAF4;SHB;PYM1;MAP3K12;VASP;ABHD14B;TMX4;HSPA13;ARAP3;MYO1D;ATXN10;SNTB2;TAOK1;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;UNC45A;ARG1;PBXIP1;TBC1D2B;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;RPL28;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TPBG;WIPF1;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;MYL9;GAS8;CBL;TRAPPC1;CIB1;LACTB2;SOCS7;USP32;RAB4B;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;KIFC3;DRAM2;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ADAM15;HM13;EHBP1L1;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ARHGAP44;LPIN3;AGAP1;UROS;ECM1;CD59;MAP6;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;GRIP2;ITSN1;TGFB1;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;ANXA1;ARSD;PODXL2;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;FHOD1;TRAF7
3460,GO:0007275,5.93167652601938e-08,1,424,3310,multicellular organism development,BP,ANGPTL4;XDH;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;SH3TC2;CAPN2;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;CST3;SDK2;CYP27B1;NEURL1;AP3D1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;DLG1;IGFBP4;PITPNM1;TEF;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;ITGA6;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;MICALCL;DBNDD1;SMARCA1;SMURF2;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;CTSB;SNPH;BBS2;SEMA3F;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;MMP14;LAMB1;THBS2;ADARB1;PTPRF;TUB;ACTA2;EPN1;PPP1R13L;STK25;SHANK3;MN1;HECW2;FBXW8;AKT1;CARD11;GPC4;EPN2;BAG3;APOE;FAM210B;ARG2;PKN1;AP1B1;ELK3;WWTR1;COL13A1;AP2A2;PRKCZ;PHC2;ATP7B;FAM20C;POU2F2;TFEB;NAGLU;RFNG;ARHGAP22;FZD8;VPS4A;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;PRR15;FERMT1;RRAS;DEAF1;SALL2;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;LIMK1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;PRKACB;LTBP1;WDTC1;WASF2;CD44;ZNF516;PLCG1;SEC63;IDE;MC1R;TWF2;SLC38A10;TFE3;TACC1;MALL;BIN1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;SCMH1;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;DUSP4;GNB1;PTPN9;SATB1;RET;RAB29;LAMC2;NID1;GRB10;SHANK2;PKD1;DLG3;GATA3;APLN;TCFL5;DCAF7;DOPEY2;GLUD1;HSF1;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;ASPH;SDHA;CNFN;PTPRU;ADAM8;RAI1;MYH15;HMGA2;ARID5B;TOP1;MICAL2;NUMB;MYDGF;B4GALT2;FLNB;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;DNM2;AGO4;IRF7;NCS1;PAQR7;STK24;SDCCAG8;RERE;GSK3A;STXBP1;SPINT2;PCSK6;DUSP6;FYN;CLSTN1;FUZ;AGRN;ASNS;LPAR3;WNT5B;PFN1;PSMD7;KIF17;TNFRSF1A;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;KIF13B;BRSK1;GJC2;GAL;ITGA1;PSKH1;CTSL;EHF;TNRC6B;THRA;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LAMB3;LOXL1;SEMA4G;WDFY3;SEC24C;FGFR1;RREB1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;USF2;PBX3;MFNG;SOCS2;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;LEMD2;ZFPM1;LRCH4;UNC119B;ULK1;LRP1;ROBO3;ZNF609;PLCD3;PAK4;TNFRSF19;HPSE;E2F5;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;KLHL17;RNH1;MAPK9;SDHAF4;SHB;VASP;MYO1D;CHD7;ATXN10;TAOK1;BICC1;MSLN;APBB1;WDR18;SLIT3;RXRA;UNC45A;ARG1;PBXIP1;L3MBTL3;TSHZ1;VEGFB;NDE1;CAMSAP3;INVS;TCF25;TPBG;IMPACT;KLK6;CAMK1;EPHB2;SPESP1;KRT23;HGS;POLM;MYL9;GAS8;CBL;CIB1;SOCS7;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DBP;ARVCF;DNAJB9;GLO1;FURIN;ARHGEF2;RNF103;LLGL1;AIDA;MLF1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;ZNF256;ARHGAP44;SRGAP2B;ECM1;MBD3;MAP6;SLC30A1;ADCY6;TGFB1;SF3B6;SH3PXD2A;MANF;CAT;LDHA;SPRED2;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;ARCN1;EP300;THBS3;TCF7L1;RAP1GAP2;STIM1;ASAP1;RNF10
10895,GO:0044425,6.14462886545884e-08,1,466,3707,membrane part,CC,NT5E;EDEM1;KIAA1549L;ITGB4;TSPAN1;NOS1;ADAM19;CAPN2;F2R;MST1R;SORL1;ADGRL1;SDC1;DVL1;SERINC2;SHC1;KCNG1;QSOX1;MBOAT2;SDK2;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;BOK;SLCO4A1;DLG4;SERPINE2;BSG;DLG1;CMTM4;DYSF;SLC16A3;PITPNM1;IFI6;SLC9A3R2;FKBP1A;DCBLD2;RAB3B;CKAP4;ITGA6;SLC2A9;PTPRS;PRNP;BNIP3;CD68;SBF1;AGPAT3;SSH1;TXNDC11;SCYL1;SMURF2;C2CD2;COPG1;PCDH1;MARVELD1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;MRC2;BBS2;ADGRF1;BCR;SYNE3;CHPF;LPCAT1;VLDLR;LRP5;ACVR2B;ITGB5;XYLT1;HTR7;KIAA1549;ADCY7;XBP1;CSMD2;MXRA7;CMTM7;EGFR;RTN2;LRP10;TTYH3;MMP14;SLC12A7;PRKACA;FCHO1;PTPRF;FAM189B;RHBDF2;HK1;MAP2K2;EPN1;LMBR1L;XYLT2;SHANK3;ATF4;P4HB;SNX33;PDIA5;IFITM1;CDS2;LRP3;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;EPN2;EHD3;FAM210B;ATP13A2;METTL23;PKN1;TMEM92;AP1B1;PEAR1;SYVN1;YIF1A;COL13A1;AP2A2;PRKCZ;ATP7B;ITPR3;RFNG;VPS11;FZD8;VPS4A;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;TMEM129;RETSAT;PCSK9;FERMT1;SEC23A;B4GALNT4;TMCO3;RABAC1;MSN;TGFBR2;CSMD3;CD99;PLD3;EPOR;NDST2;MVB12B;STK39;CREB3L2;UBE2J1;BNIP3L;KDELR1;PRSS8;TMEM125;YIPF2;ZDHHC8;CD44;ESYT2;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;MC1R;SLC38A10;FAM171A2;SURF4;RRNAD1;TMEM134;PSD3;TMEM245;TSPAN5;MALL;BIN1;FSCN1;SLC35E2B;SFXN3;PAK1;SLC29A4;ERO1B;NLGN2;GRAMD1A;UBXN7;SEMA4B;TNFSF15;PODXL;PTDSS2;TBC1D9B;GGA3;GGA1;TMTC4;STOM;FARP1;GNB1;SYTL1;SDCCAG3;RET;CORO7;RHOC;IFI27;CYTH3;REEP2;TMED3;PROCR;YIPF3;CEMIP;SHANK2;PKD1;TMEM200B;DLG3;ATP11A;TP53I11;NIPA1;PIGQ;OXA1L;UBXN4;SH2D5;ANO8;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;ADGRB2;ALOX15B;SLC35E4;IL1RAP;WFS1;SRD5A3;SLC12A4;FAT1;ASPH;SDHA;FAM155B;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;ARL2;LY6E;SLC43A1;NUMB;ARHGEF4;IGFBP2;B4GALT2;GPRC5C;VAMP2;FLNB;PIP5K1C;APCDD1L;TNFRSF6B;EDNRA;B3GNT3;SRC;LDLRAP1;APLP2;TAZ;PEX10;TGM2;DNM2;SARAF;REEP6;UBR4;FAM162A;TMEM25;NUCB1;RAB1B;DNAJC4;NDUFA4L2;NCS1;PAQR7;TMEM9;TMEM44;CPTP;RGS19;CARD19;STX5;STXBP1;PAG1;SH3BP1;SPINT2;FYN;RAB25;SPTLC2;CLSTN1;AGRN;TMEM154;TMPRSS11D;LPAR3;REEP4;SLC6A9;GRINA;TMEM200A;SLC25A43;KIF17;TNFRSF1A;NRSN2;HSD11B1;MBOAT7;SLC33A1;ABHD17C;TSPAN33;STX10;CHST14;GJC2;ITGA1;FCGRT;SLC13A5;SHISA5;PSKH1;COMT;MCFD2;NTSR1;LYPD5;AMIGO2;ITPRIPL2;CRIM1;SLC46A3;UBA1;MGLL;SLC35B4;SEMA4G;WDFY3;SEC24C;FGFR1;RRBP1;ATP2C2;C1ORF115;LRRC8A;TMEM128;TENM2;MFNG;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;ST3GAL3;ZFPL1;PRAF2;TCIRG1;C16ORF58;GRAMD1C;SLC27A1;LEMD2;TPCN1;PMEPA1;LRCH4;ST3GAL5;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;HSPA2;PLCD3;TNFRSF19;P2RX4;HPSE;ZP3;TBC1D20;SPIRE1;TMEM139;KLHL17;ST6GALNAC2;VAPB;SDHAF4;VASP;TMX4;MYO1D;SNTB2;RNF222;TMEM54;ABCA7;LMAN1;ENTPD6;MSLN;APBB1;EPS8L1;HOMER2;INTS1;SLC10A6;VSIG10L;TGFA;NDE1;ATP6V1C2;CYB561;TPBG;NYNRIN;VAT1;CASP4;SNAP29;KCNC4;EPHB2;CBL;GGT1;CIB1;MAPK3;CPT1B;NTNG1;POMT1;DRAM2;DNAJB9;LITAF;FURIN;SLC35G2;SLC5A1;ARHGEF2;RNF103;MYZAP;SNX27;UGCG;TMBIM1;NDUFS2;B4GALT6;OCRL;TMEM238;ADAM15;SRPX2;HM13;CEACAM1;PNPLA6;GALNT3;MINK1;ARHGAP44;LPIN3;CD59;SLC30A1;ADCY6;ITSN1;TM2D1;ADCK2;SLC15A1;PIK3R2;CAMK2N1;ERBB3;ANXA1;PODXL2;SLC45A3;RAB6A;COMTD1;GNAS;IKBIP;ITGA3;CLDN12;PLGRKT;ARCN1;ASPHD1;ERP44;ORAI3;STIM1;RASA3;ASAP1;NIPSNAP1
5314,GO:0016020,6.22272654901876e-08,1,680,5750,membrane,CC,NT5E;EDEM1;FLNC;PGF;FHL1;SH3KBP1;KIAA1549L;ITGB4;PYGB;TSPAN1;NOS1;ADAM19;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;ASAP2;SORL1;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;SHC1;KCNG1;DOCK4;QSOX1;WNT7A;MBOAT2;CST3;SDK2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;BOK;CRTC1;ARAP1;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;BSG;KLC2;DLG1;CMTM4;DYSF;SLC16A3;PITPNM1;IFI6;SLC9A3R2;FKBP1A;DGKA;DCBLD2;PSMD2;RAB3B;CKAP4;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;CD68;SBF1;AGPAT3;SSH1;TXNDC11;RAB43;DBNDD1;SCYL1;SMURF2;NME4;C2CD2;OCIAD2;COPG1;BCORL1;PLCH2;PCDH1;MARVELD1;FAM129B;ABTB1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;MRC2;BBS2;ADGRF1;BCR;SYNE3;RAB31;CHPF;LPCAT1;OSBP2;VLDLR;ETV5;LRP5;AARS;ACVR2B;ITGB5;XYLT1;HTR7;KIAA1549;ADCY7;XBP1;CSMD2;MXRA7;MYCBPAP;MARCKSL1;CMTM7;EGFR;RTN2;LRP10;TTYH3;MMP14;FYCO1;SLC12A7;PRKACA;FCHO1;PTPRF;OGFRL1;CRAT;CORO1B;TUB;FAM189B;RHBDF2;HK1;MAP2K2;EPN1;LMBR1L;XYLT2;STK25;PARVB;SHANK3;ANKRD13D;TTC7B;ATF4;P4HB;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;MDH2;LRP3;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;ATP13A2;UAP1;METTL23;PKN1;TMEM92;AP1B1;PEAR1;SYVN1;YIF1A;COL13A1;RABGGTA;AP2A2;PRKCZ;ATP7B;ITPR3;DGKQ;RFNG;VPS11;FZD8;VPS4A;CTSZ;EPHA1;PI4K2A;PTK6;SLC20A1;ORAI1;PFKP;TMEM129;FBXO2;RETSAT;GRK6;PCSK9;FERMT1;GIT2;TYSND1;RRAS;SEPT5;SEC23A;B4GALNT4;TMCO3;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;CD99;PLD3;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;UBE2J1;ARRDC1;BNIP3L;KDELR1;PRSS8;AKAP12;SYMPK;TST;PRKACB;TMEM125;SIPA1;YIPF2;ZDHHC8;SHC2;CD44;SCRN1;IPO13;ESYT2;PLCG1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;OSBPL5;IDE;MC1R;SLC38A10;FAM171A2;SURF4;RRNAD1;TMEM134;CCND2;PSD3;TMEM245;TACC1;TSPAN5;MALL;GIT1;BIN1;FSCN1;SLC35E2B;HMGCL;HTRA1;SFXN3;PAK1;CERCAM;SLC29A4;ERO1B;NLGN2;GRAMD1A;UBXN7;TNRC18;SEMA4B;TNFSF15;PODXL;PTDSS2;DMXL2;TBC1D9B;GGA3;GGA1;TMTC4;STOM;FARP1;GNB1;SYTL1;SDCCAG3;DOCK9;RET;RAB29;PTOV1;CORO7;LAMC2;MLXIP;RHOC;IFI27;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;YIPF3;CEMIP;SHANK2;PKD1;TMEM200B;DLG3;ATP11A;TP53I11;NIPA1;PIGQ;NUCB2;GSDMA;OXA1L;UBXN4;SH2D5;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;APPL2;ADGRB2;ALOX15B;SLC35E4;IL1RAP;WFS1;SRD5A3;SLC12A4;FAT1;EFS;ASPH;SDHA;FAM155B;SLC6A6;CNFN;PTPRU;ADAM8;TMEM8A;SLC13A3;C19ORF33;RHOBTB2;DYNLRB1;ARL2;LY6E;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;PLIN3;B4GALT2;GPRC5C;VAMP2;FLNB;PIP5K1C;APCDD1L;GIPC1;TNFRSF6B;EDNRA;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;TAZ;PEX10;TGM2;DNM2;KLHDC2;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;LRSAM1;TMEM25;NUCB1;RAB1B;CDC42BPB;DNAJC4;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;STX5;COG8;EXOC2;STXBP1;PAG1;SH3BP1;SPINT2;PCSK6;PMVK;OAS1;FYN;RAB25;SPTLC2;CLSTN1;AGRN;TMEM154;TMPRSS11D;LPAR3;REEP4;WNT5B;SLC6A9;GRINA;PFN1;NELFCD;NISCH;PSMD7;TMEM200A;SLC25A43;KIF17;TNFRSF1A;NRSN2;ANXA3;HSD11B1;MBOAT7;SLC33A1;ABHD17C;PLEKHG5;TSPAN33;STX10;CHST14;MOAP1;GJC2;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;PSKH1;COMT;MCFD2;NTSR1;LYPD5;AMIGO2;ITPRIPL2;CRIM1;SLC46A3;UBA1;MGLL;MISP;SLC35B4;LGALS3BP;SEMA4G;WDFY3;SEC24C;FGFR1;RRBP1;ATP2C2;C1ORF115;LRRC8A;TMEM128;CEP170;TENM2;F12;MFNG;MTMR4;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STK17A;ADIPOR1;ST3GAL3;TRIB3;ZFPL1;PRAF2;TCIRG1;C16ORF58;PITPNM2;SNX25;GRAMD1C;SLC27A1;LEMD2;TPCN1;PMEPA1;ARFIP2;LRCH4;PRRC2A;ST3GAL5;ARFGEF2;PIP5KL1;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;HSPA2;PLCD3;TNFRSF19;MGRN1;P2RX4;HPSE;USO1;ULK2;SMPD3;ZP3;TBC1D20;SPIRE1;PRR9;TMEM139;KLHL17;EHD4;MAP1LC3B;MED15;ST6GALNAC2;VAPB;COG1;SH3BGRL2;SDHAF4;SHB;MAP3K12;VASP;TMX4;HSPA13;ARAP3;MYO1D;ATXN10;SNTB2;RNF222;TMEM54;ABCA7;LMAN1;ENTPD6;MSLN;APBB1;RHOBTB1;EPS8L1;HOMER2;INTS1;ARG1;SLC10A6;VEGFB;VSIG10L;TGFA;NDE1;RPL28;INVS;GSDMC;BAIAP2L1;ATP6V1C2;CYB561;TPBG;NYNRIN;BPHL;VAT1;CASP4;SNAP29;LONP2;KCNC4;EPHB2;HGS;DRG2;CBL;TRAPPC1;GGT1;CIB1;SOCS7;USP32;RAB4B;IQSEC1;MAPK3;CPT1B;NTNG1;POMT1;MAPK10;CSNK1D;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;NDUFS2;B4GALT6;OCRL;TMEM238;ADAM15;SRPX2;HM13;EHBP1L1;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ARHGAP44;LPIN3;AGAP1;TFPT;CD59;MAP6;SLC30A1;ADCY6;GRIP2;ITSN1;TGFB1;TM2D1;PCYOX1;PPP6R1;ADCK2;SLC15A1;CAT;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;PODXL2;SLC45A3;RAB6A;COMTD1;GNAS;IKBIP;ZFYVE21;ITGA3;CLDN12;PLGRKT;PXN;ARCN1;ASPHD1;PLEKHH2;ERP44;ORAI3;RAP1GAP2;STIM1;RASA3;ASAP1;NIPSNAP1;FHOD1;TRAF7
17271,GO:0120025,6.60910312460496e-08,1,189,1264,plasma membrane bounded cell projection,CC,SH3KBP1;ZMYND8;NOS1;CAPN2;RAC2;ADGRL1;DVL1;DOCK4;CST3;NEURL1;SNX9;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;DYSF;FKBP1A;ITGA6;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;TMOD2;CYGB;ESPN;SNPH;PLEK2;BBS2;OSBP2;MARK4;HTR7;PRKACA;PTPRF;CORO1B;TUB;ACTA2;HK1;PARVB;SHANK3;ATF4;AKT1;ARPC1A;BAG3;APOE;EHD3;STRN4;ATP13A2;AFAP1L1;PRKCZ;CTSZ;EPHA1;PI4K2A;PTK6;FBXO2;FERMT1;SEPT5;MSN;MAP1B;GDI1;LIMK1;PRKACB;WASF2;CD44;PLCG1;TWF2;PSD3;BIN1;FSCN1;SUFU;PAK1;TTBK2;AHCY;ZNF385A;NAV1;PODXL;GLUL;TUBB3;FARP1;GNB1;SYTL1;PTPN9;RET;RHOC;CYTH3;SHANK2;PKD1;DLG3;WDR66;GNAI2;ANKS1A;WFS1;FAT1;DYNLRB1;ARHGEF4;ANKS6;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;DNM2;REEP6;CDC42BPB;NCS1;GARS;GSK3A;STXBP1;SH3BP1;FYN;RAB25;LPAR3;MICAL1;KIF17;ANXA3;ABHD17C;KIF13B;PLEKHG5;GJC2;ITGA1;COMT;NTSR1;WDFY3;TUBG1;ADNP;CEP170;TENM2;SIGMAR1;ARFIP2;ARFGEF2;UNC119B;TMEM185A;SLC6A14;ULK1;LRP1;ROBO3;P2RX4;KLHL17;MAP1LC3B;MAPK9;MAP3K12;VASP;ARAP3;MYO1D;ATXN10;ABCA7;APBB1;EPS8L1;HOMER2;ARG1;RPL28;INVS;WIPF1;SNAP29;KCNC4;EPHB2;GAS8;CBL;CIB1;WRAP73;MAPK3;MAPK10;CSNK1D;ARHGEF2;LLGL1;OCRL;CEACAM1;APBA1;MINK1;ARHGAP44;MAP6;ADCY6;ITSN1;TGFB1;AZIN2;STARD10;CAMK2N1;ANXA1;GNAS;ITGA3;PXN;PLEKHH2;RAP1GAP2;ASAP1;FHOD1
10275,GO:0043005,6.89761560649896e-08,1,125,757,neuron projection,CC,SH3KBP1;ZMYND8;NOS1;CAPN2;ADGRL1;DVL1;DOCK4;CST3;NEURL1;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;FKBP1A;PTPRS;PRNP;BNIP3;SSH1;TMOD2;CYGB;ESPN;SNPH;BBS2;OSBP2;MARK4;HTR7;PTPRF;SHANK3;ATF4;BAG3;APOE;STRN4;ATP13A2;PRKCZ;CTSZ;EPHA1;PI4K2A;FBXO2;SEPT5;MAP1B;GDI1;LIMK1;TWF2;BIN1;FSCN1;PAK1;AHCY;ZNF385A;NAV1;GLUL;TUBB3;FARP1;GNB1;PTPN9;RET;RHOC;SHANK2;DLG3;GNAI2;ANKS1A;WFS1;VAMP2;GIPC1;SRC;LDLRAP1;DNM2;REEP6;NCS1;GARS;GSK3A;STXBP1;FYN;LPAR3;MICAL1;KIF17;ANXA3;ABHD17C;KIF13B;GJC2;ITGA1;COMT;NTSR1;WDFY3;ADNP;TENM2;SIGMAR1;ARFGEF2;TMEM185A;ULK1;LRP1;ROBO3;P2RX4;KLHL17;MAPK9;MAP3K12;MYO1D;ATXN10;APBB1;HOMER2;ARG1;RPL28;KCNC4;EPHB2;CBL;CIB1;MAPK10;CSNK1D;ARHGEF2;LLGL1;OCRL;APBA1;MINK1;ARHGAP44;MAP6;ITSN1;TGFB1;AZIN2;CAMK2N1;GNAS;ITGA3;RAP1GAP2;ASAP1
12426,GO:0048856,7.81782501458364e-08,1,457,3619,anatomical structure development,BP,ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;CST3;SDK2;CYP27B1;NEURL1;AP3D1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;DLG1;IGFBP4;PITPNM1;TEF;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;MICALCL;DBNDD1;SMARCA1;SMURF2;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;CTSB;TNNT1;SNPH;BBS2;SEMA3F;ADGRF1;BCR;SYNE3;LPCAT1;OSBP2;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;MMP14;LAMB1;THBS2;RFX2;PRKACA;ADARB1;PTPRF;CORO1B;TUB;ACTA2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;MN1;HECW2;FBXW8;AKT1;CARD11;GPC4;EPN2;BAG3;APOE;FAM210B;FMNL2;ARG2;PKN1;AP1B1;ELK3;WWTR1;COL13A1;AP2A2;PRKCZ;PHC2;ATP7B;FAM20C;POU2F2;TFEB;NAGLU;RFNG;ARHGAP22;FZD8;VPS4A;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;PRR15;FERMT1;RRAS;DEAF1;SALL2;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;LIMK1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;TST;PRKACB;LTBP1;WDTC1;WASF2;CD44;ZNF516;PLCG1;SEC63;IDE;MC1R;TWF2;SLC38A10;TFE3;TACC1;MALL;BIN1;FSCN1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;SCMH1;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;DUSP4;GNB1;PTPN9;SATB1;RET;RAB29;LAMC2;RHOC;NID1;GRB10;SHANK2;PKD1;DLG3;GATA3;APLN;TCFL5;DCAF7;DOPEY2;MYOF;GLUD1;HSF1;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;FAT1;ASPH;SDHA;CNFN;PTPRU;ADAM8;RAI1;MYH15;HMGA2;ARID5B;RHOBTB2;TOP1;MICAL2;NUMB;CAP1;MYDGF;B4GALT2;FLNB;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;DNM2;AGO4;IRF7;NCS1;PAQR7;STK24;ACADVL;SDCCAG8;RERE;GSK3A;STXBP1;SH3BP1;SPINT2;PCSK6;DUSP6;FYN;RAB25;CLSTN1;FUZ;AGRN;ASNS;LPAR3;WNT5B;PFN1;PSMD7;KIF17;TNFRSF1A;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;KIF13B;BRSK1;GJC2;GAL;ITGA1;PSKH1;CTSL;EHF;TNRC6B;THRA;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LAMB3;LOXL1;SEMA4G;WDFY3;SEC24C;FGFR1;RREB1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;USF2;PBX3;MFNG;SOCS2;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;PTPN12;LEMD2;ZFPM1;LRCH4;UNC119B;ULK1;LRP1;ROBO3;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;HPSE;E2F5;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;KLHL17;RNH1;MAPK9;SDHAF4;SHB;VASP;ARAP3;MYO1D;CHD7;ATXN10;TAOK1;BICC1;MSLN;APBB1;RHOBTB1;WDR18;SLIT3;RXRA;UNC45A;ARG1;PBXIP1;L3MBTL3;TSHZ1;VEGFB;NDE1;CAMSAP3;INVS;TCF25;TPBG;WIPF1;IMPACT;KLK6;VAT1;CAMK1;EPHB2;SPESP1;KRT23;HGS;POLM;MYL9;GAS8;CBL;CIB1;SOCS7;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DBP;ARVCF;DNAJB9;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;ZNF256;ARHGAP44;SRGAP2B;ECM1;MBD3;MAP6;SLC30A1;ADCY6;IGF2BP3;TGFB1;SF3B6;SH3PXD2A;MANF;CAT;LDHA;SPRED2;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;ARCN1;EP300;THBS3;TCF7L1;RAP1GAP2;STIM1;ASAP1;RNF10
5381,GO:0016192,7.94857104977459e-08,1,208,1440,vesicle-mediated transport,BP,SH3KBP1;PYGB;TSPAN1;RAC2;ASAP2;SORL1;SDC1;MAP2K1;PYGL;QSOX1;CST3;SNX9;AP3D1;LMF1;NAPRT;ARAP1;DLG4;KLC2;DYSF;PGM1;PSMD2;RAB3B;CKAP4;PRSS3;CD68;RAB43;SCYL1;COPG1;LCN2;MAPKAPK3;CTSB;SNPH;MRC2;BBS2;USP20;BCR;RAB31;LPCAT1;VLDLR;LRP5;EVI5L;LRP10;CSNK1E;FCHO1;TUB;MAP2K2;EPN1;LMBR1L;SNX33;LRP3;ARPC1A;SERPING1;EPN2;APOE;EHD3;ATP13A2;RIN2;AP1B1;PEAR1;YIF1A;TMSB4X;AP2A2;GALNS;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;GIT2;SEPT5;SEC23A;MSN;TGFBR2;MVB12B;RIN1;SERPINB6;LIMK1;DKK1;CREB3L2;KDELR1;WASF2;CD44;SCRN1;ESYT2;PLCG1;TBC1D16;OSBPL5;SURF4;TBC1D14;GIT1;BIN1;PAK1;NLGN2;TBC1D9B;GGA3;GGA1;STOM;SYTL1;FUCA1;SDCCAG3;RAB29;DNASE1L1;CORO7;CYTH3;TMED3;ATP11A;APLN;ARL8A;DOPEY2;SLC2A3;APPL2;ADAM8;CAP1;PLIN3;VAMP2;PIP5K1C;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;TGM2;DNM2;UBR4;LRSAM1;RAB1B;NCS1;STX5;C6ORF120;COG8;EXOC2;STXBP1;SH3BP1;FYN;RAB25;YPEL5;PSMD7;MICAL1;KIF17;ANXA3;BRPF3;ELMO3;STX10;FCGRT;MCFD2;TIMP1;LGALS3BP;SEC24C;MIF;VPS37A;RAB11FIP4;BCL2L1;ZFPL1;TCIRG1;ARFGEF2;LRP1;HSPA2;MGRN1;HPSE;USO1;SMPD3;ZP3;TBC1D20;SPIRE1;PNP;EHD4;VAPB;COG1;HSPA13;ARAP3;MYO1D;ABCA7;LMAN1;ARG1;TBC1D2B;VEGFB;NEURL1B;TGFA;WIPF1;VAT1;SNAP29;HGS;CBL;TRAPPC1;RAB4B;MAPK3;CSNK1D;ALDOC;SNX27;TMBIM1;LLGL1;CEACAM1;ARHGAP44;AGAP1;ECM1;CD59;ITSN1;TGFB1;PPP6R1;MANF;CAT;PIK3R2;ANXA1;RAB6A;ZFYVE21;ARCN1;ERP44;ASAP1
12702,GO:0050896,8.13314256678481e-08,1,660,5546,response to stimulus,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;PGF;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;ERCC6;CST3;CYP27B1;NEURL1;AP3D1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;DAP;CMTM4;DYSF;IGFBP4;MMP1;MXRA5;PITPNM1;IFI6;DNMT3A;PGM1;FKBP1A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRSS3;PRNP;BNIP3;CD68;LAMA5;SSH1;WWC3;TXNDC11;RAB43;CITED4;SMURF2;NYAP1;TMOD2;PLCH2;CYGB;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;ABTB1;TNNT1;PLEK2;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;RAB31;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MKNK2;MMP14;RFX2;ARHGAP23;PRKACA;ADARB1;PTPRF;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;XPC;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;ATP13A2;ARG2;RIN2;PKN1;PEAR1;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;HIST2H2BE;CTSZ;EPHA1;PI4K2A;UACA;PTK6;SLC20A1;ORAI1;PFKP;TMEM129;FBXO2;GRK6;PCSK9;ENDOG;NSMCE4A;FERMT1;GIT2;RRAS;DEAF1;SALL2;MSN;TGFBR2;LAMB2;CD99;GDI1;HADH;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;FAM3A;KDELR1;AKAP12;PRKACB;LTBP1;SIPA1;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;ZNF516;PLCG1;RAP1GDS1;ATG13;SEC63;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;TWF2;SURF4;TFE3;PRDX5;CCND2;PSD3;TSPAN5;PPP1R12C;GIT1;FSCN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;RHPN1;BCL9L;AHCY;ZNF385A;NLGN2;RAG1;SEMA4B;DDIT3;TNFSF15;GLUL;BCDIN3D;CUL7;ARHGAP39;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;PTPN9;SATB1;FUCA1;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;GAS2L1;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;PROCR;PCBP4;SHANK2;PKD1;ASS1;ATP11A;GATA3;APLN;PHF1;GSDMA;UBXN4;ARL8A;OASL;MYOF;DOCK6;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;HSF1;APPL2;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;EFS;MT2A;PTPRU;ADAM8;MAPKBP1;NEIL1;TFPI2;MPG;PYCR2;RGL2;HMGA2;SLC13A3;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;LY6E;PLCB3;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;APLP2;POLD4;SCG5;TGM2;DNM2;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;DNAJC4;NCS1;PAQR7;MARK3;STK24;ACADVL;RGS19;CARD19;PAK6;PER3;YPEL3;TOM1L2;ESRP1;C6ORF120;GPX3;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;PRIMPOL;ISG20;FUZ;AGRN;ASNS;PPM1F;RALGDS;YPEL5;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NISCH;PSMD7;MICAL1;TNFRSF1A;ANXA3;WISP1;TLE4;FBXL15;SLC33A1;VDR;VWA1;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;SLC13A5;GNB2;SHISA5;PSKH1;CTSL;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;UBA1;MGLL;HSF4;LOXL1;LGALS3BP;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;LRRC8A;MIB2;TENM2;F12;USF2;MFNG;MIF;SOCS2;MTMR4;ASB13;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;DDB2;PRAF2;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ARFIP2;LRCH4;HLCS;NDOR1;RAD23A;ARFGEF2;SLC6A14;ULK1;LRP1;ROBO3;TRIB2;HSPA2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ULK2;ZP3;LRRK1;PNP;FGF2;EHD4;MAP1LC3B;RNASE7;VAPB;MAPK9;SDHAF4;SHB;RCOR1;MAP3K12;VASP;TMX4;HSPA13;ARAP3;CHD7;TAOK1;ABCA7;LMAN1;ENTPD6;MLYCD;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;RXRA;ARG1;TAF6;VEGFB;NEURL1B;TGFA;INVS;GSDMC;SEC14L1;ZBTB4;BAIAP2L1;ATP6V1C2;CNOT11;NDRG3;WIPF1;IMPACT;BPHL;KLK6;VAT1;CASP4;ACY1;SNAP29;LONP2;CAMK1;EPHB2;HGS;CARHSP1;DRG2;POLM;MYL9;CBL;TRAPPC1;GGT1;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;EEPD1;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;ALDOC;FURIN;S100A16;ARHGEF2;RNF103;C12ORF66;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;NDUFS2;OCRL;ADAM15;HM13;CEACAM1;GALNT3;MINK1;SKAP2;ARHGAP44;AGAP1;TFPT;UROS;ECM1;CD59;MBD3;SLC30A1;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;TM2D1;MANF;CAT;RMI2;LDHA;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;IKBIP;ITGA3;PLGRKT;PXN;ARHGEF10L;EP300;ERP44;TCF7L1;RAP1GAP2;STIM1;RASA3;ASAP1;TRAF7
3185,GO:0006810,1.0693975036191e-07,1,422,3352,transport,BP,EDEM1;XDH;FHL1;SH3KBP1;PYGB;TSPAN1;NOS1;LTBP2;CCND1;SH3TC2;F2R;RAC2;LTBP4;ASAP2;SORL1;SDC1;DVL1;MAP2K1;SERINC2;PITPNC1;KCNG1;PYGL;QSOX1;WNT7A;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;PCK2;ARAP1;SLCO4A1;DLG4;CPT2;SERPINE2;BSG;NR1D1;KLC2;DLG1;DYSF;XPOT;SLC16A3;PITPNM1;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;BNIP3;CD68;RAB43;SCYL1;NME4;COPG1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;SESN2;SNPH;MRC2;BBS2;OSBPL10;USP20;BCR;RAB31;LPCAT1;OSBP2;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;TTYH3;FYCO1;SLC12A7;PRKACA;FCHO1;TUB;RHBDF2;HK1;MAP2K2;EPN1;LMBR1L;SHANK3;ATF4;HECW2;SNX33;AKT1;LRP3;CARD11;ARPC1A;SERPING1;EPN2;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;RIN2;AP1B1;PEAR1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;CTSZ;PI4K2A;SLC20A1;ORAI1;TMEM129;PCSK9;FERMT1;GIT2;SEPT5;SEC23A;TMCO3;MSN;MAP1B;TGFBR2;GDI1;HADH;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;UBE2J1;ARRDC1;BNIP3L;PPARA;KDELR1;PRSS8;AKAP12;SYMPK;TST;ZDHHC8;WASF2;CD44;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;ATG13;ABCB8;SEC63;OSBPL5;SLC38A10;SURF4;TBC1D14;GIT1;BIN1;SFXN3;CCDC88C;PAK1;SLC29A4;NLGN2;DDIT3;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;FUCA1;SDCCAG3;RAB29;DNASE1L1;CORO7;IFI27;GRB10;CYTH3;REEP2;TMED3;CEMIP;SHANK2;PKD1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;ARL8A;DOPEY2;ANO8;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ALOX15B;IL1RAP;WFS1;SLC12A4;ASPH;FAM155B;SLC6A6;ADAM8;MAPKBP1;SLC13A3;DYNLRB1;ARL2;SLC43A1;CAP1;PLIN3;VAMP2;PIP5K1C;GIPC1;EDNRA;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;SCG5;PEX10;TGM2;DNM2;SARAF;REEP6;UBR4;LRSAM1;NUCB1;STPG1;RAB1B;NDUFA4L2;NCS1;CPTP;STX5;TOM1L2;C6ORF120;COG8;RERE;EXOC2;GSK3A;STXBP1;SH3BP1;PCSK6;FYN;RAB25;FUZ;YPEL5;LPAR3;SLC6A9;NISCH;PSMD7;MICAL1;SLC25A43;KIF17;ANXA3;SLC33A1;VDR;BRPF3;KIF13B;ELMO3;BRSK1;STX10;MOAP1;GJC2;GAL;FCGRT;SLC13A5;COMT;MCFD2;PLTP;NTSR1;EIF2S2;TIMP1;SLC46A3;SLC35B4;LGALS3BP;SEC24C;FGFR1;RRBP1;ATP2C2;LRRC8A;USF2;GUK1;MIF;SOCS2;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;VPS9D1;TRIB3;ZFPL1;PRAF2;TCIRG1;PITPNM2;SNX25;SLC27A1;TPCN1;ARFIP2;ARFGEF2;UNC119B;SLC6A14;LRP1;HSPA2;MGRN1;P2RX4;HPSE;USO1;SMPD3;ZP3;TBC1D20;SPIRE1;PNP;FGF2;EHD4;VAPB;COG1;HSPA13;ARAP3;MYO1D;CHD7;ABCA7;LMAN1;APBB1;HOMER2;RXRA;ARG1;SLC10A6;TBC1D2B;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;SEC14L1;ATP6V1C2;WIPF1;VAT1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;HGS;CBL;TRAPPC1;CIB1;RAB4B;MAPK3;CPT1B;CSNK1D;ALDOC;FURIN;SLC5A1;ARHGEF2;SNX27;UGCG;TMBIM1;LLGL1;HM13;CEACAM1;APBA1;MINK1;ARHGAP44;AGAP1;ECM1;CD59;SLC30A1;IGF2BP3;ITSN1;TGFB1;PCYOX1;PPP6R1;MANF;SLC15A1;CAT;AZIN2;PIK3R2;STARD10;ERBB3;ANXA1;SLC45A3;PPP1R10;RAB6A;GNAS;ZFYVE21;ARCN1;ERP44;ORAI3;STIM1;RASA3;ASAP1;FHOD1
16636,GO:0097458,1.07397921169527e-07,1,148,943,neuron part,CC,SH3KBP1;ZMYND8;NOS1;CAPN2;ADGRL1;DVL1;DOCK4;WNT7A;CST3;NEURL1;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;FKBP1A;RAB3B;PTPRS;PRNP;BNIP3;SSH1;DBNDD1;TMOD2;CYGB;ESPN;SNPH;BBS2;BCR;OSBP2;MARK4;HTR7;PTPRF;SHANK3;ATF4;BAG3;APOE;STRN4;ATP13A2;PRKCZ;ITPR3;CTSZ;EPHA1;PI4K2A;FBXO2;ENDOG;SEPT5;RABAC1;MAP1B;GDI1;LIMK1;TWF2;PSD3;BIN1;FSCN1;PAK1;AHCY;ZNF385A;NLGN2;NAV1;GLUL;DMXL2;TUBB3;FARP1;GNB1;SYTL1;PTPN9;RET;RHOC;SHANK2;DLG3;SH2D5;GNAI2;GRIN3B;ANKS1A;WFS1;TOP1;VAMP2;PIP5K1C;GIPC1;SRC;LDLRAP1;DNM2;REEP6;NCS1;GARS;GSK3A;STXBP1;FYN;CLSTN1;LPAR3;SLC6A9;MICAL1;KIF17;NRSN2;ANXA3;ABHD17C;KIF13B;BRSK1;GJC2;GAL;ITGA1;COMT;NTSR1;WDFY3;ADNP;TENM2;SIGMAR1;BCL2L1;ARFGEF2;TMEM185A;ULK1;LRP1;ROBO3;P2RX4;KLHL17;MAPK9;MAP3K12;MYO1D;ATXN10;APBB1;HOMER2;ARG1;RPL28;SNAP29;KCNC4;EPHB2;CBL;CIB1;MAPK10;CSNK1D;DRAM2;ARHGEF2;LLGL1;OCRL;APBA1;MINK1;ARHGAP44;MAP6;ITSN1;TGFB1;AZIN2;CAMK2N1;GNAS;ITGA3;RAP1GAP2;ASAP1
7933,GO:0032502,1.29547833842482e-07,1,486,3903,developmental process,BP,ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;SDK2;CYP27B1;NEURL1;AP3D1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;DLG1;IGFBP4;PITPNM1;TEF;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;LAMA5;SSH1;WWC3;MICALCL;DBNDD1;CITED4;SMARCA1;SMURF2;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;CTSB;TNNT1;SNPH;MRC2;BBS2;SEMA3F;ADGRF1;BCR;SYNE3;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;CCDC71L;MMP14;LAMB1;THBS2;RFX2;PRKACA;ADARB1;PTPRF;CORO1B;TUB;ACTA2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;MN1;HECW2;FBXW8;AKT1;IFITM1;CARD11;GPC4;IRAK1;SERPING1;EPN2;BAG3;APOE;FAM210B;FMNL2;ARG2;PKN1;AP1B1;ELK3;WWTR1;COL13A1;AP2A2;PRKCZ;PHC2;ATP7B;FAM20C;POU2F2;TFEB;NAGLU;RFNG;ARHGAP22;FZD8;VPS4A;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;PRR15;FERMT1;RRAS;DEAF1;SALL2;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;LIMK1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;TST;PRKACB;LTBP1;WDTC1;WASF2;CD44;ZNF516;PLCG1;SEC63;IDE;MC1R;TWF2;SLC38A10;TFE3;TACC1;MALL;BIN1;FSCN1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;SCMH1;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;DUSP4;GNB1;PTPN9;SATB1;RET;RAB29;LAMC2;RHOC;NID1;GRB10;YIPF3;SHANK2;PKD1;DLG3;GATA3;APLN;TCFL5;DCAF7;DOPEY2;MYOF;GLUD1;HSF1;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;FAT1;ASPH;SDHA;CNFN;CTBP1;PTPRU;ADAM8;RAI1;MYH15;HMGA2;ARID5B;RHOBTB2;TOP1;MICAL2;NUMB;IGFBP2;CAP1;MYDGF;B4GALT2;FLNB;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;DNM2;AGO4;IRF7;NCS1;PAQR7;STK24;ACADVL;YPEL3;SDCCAG8;RERE;GSK3A;STXBP1;SH3BP1;SPINT2;PCSK6;DUSP6;SLFN5;FYN;RAB25;CLSTN1;FUZ;AGRN;ASNS;LPAR3;WNT5B;PFN1;PSMD7;KIF17;TNFRSF1A;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;KIF13B;BRSK1;GJC2;GAL;PUM1;ITGA1;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LAMB3;LOXL1;SEMA4G;WDFY3;SEC24C;FGFR1;RRBP1;RREB1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;USF2;PBX3;MFNG;MIF;SOCS2;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;TRIB3;PTPN12;LEMD2;ZFPM1;LRCH4;PRRC2A;UNC119B;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;HPSE;E2F5;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;KLHL17;RNH1;MAPK9;SDHAF4;SHB;VASP;ARAP3;MYO1D;CHD7;ATXN10;TAOK1;BICC1;MSLN;APBB1;RHOBTB1;WDR18;SLIT3;RXRA;UNC45A;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;VEGFB;NDE1;CAMSAP3;INVS;TCF25;TPBG;NDRG3;WIPF1;IMPACT;KLK6;VAT1;CAMK1;EPHB2;SPESP1;KRT23;HGS;POLM;MYL9;GAS8;CBL;CIB1;SOCS7;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DBP;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MATN3;OCRL;ADAM15;SRPX2;CEACAM1;PNPLA6;APBA1;MINK1;ZNF256;ARHGAP44;SRGAP2B;ECM1;MBD3;MAP6;SLC30A1;ADCY6;IGF2BP3;TGFB1;SF3B6;SH3PXD2A;MANF;CAT;LDHA;SPRED2;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;ARCN1;EP300;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;ASAP1;RNF10
8202,GO:0032940,1.39850381400215e-07,1,144,934,secretion by cell,BP,PYGB;LTBP2;F2R;RAC2;LTBP4;SDC1;DVL1;PYGL;QSOX1;WNT7A;CST3;LMF1;NAPRT;PCK2;SERPINE2;NR1D1;PGM1;POSTN;PSMD2;RAB3B;CKAP4;RAPGEF3;PRSS3;IDH2;CD68;COPG1;FAM129B;LCN2;CTSB;SNPH;BCR;RAB31;LPCAT1;LRP5;ACVR2B;XBP1;MAP4K4;EGFR;RHBDF2;HK1;CARD11;SERPING1;ATP13A2;ARG2;TMSB4X;AP2A2;PRKCZ;GALNS;ITPR3;POU2F2;VPS11;VPS4A;CTSZ;PI4K2A;FERMT1;SEPT5;HADH;SERPINB6;CD44;SCRN1;SURF4;PAK1;NLGN2;GLUL;STOM;SYTL1;FUCA1;DNASE1L1;ATP11A;GATA3;APLN;ARL8A;SLC2A3;ASIC1;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;CAP1;VAMP2;PIP5K1C;GIPC1;SRC;APLP2;SCG5;UBR4;NCS1;CPTP;C6ORF120;EXOC2;STXBP1;PCSK6;RAB25;YPEL5;SLC6A9;NISCH;PSMD7;MICAL1;ANXA3;BRPF3;BRSK1;GAL;NTSR1;TIMP1;LGALS3BP;FGFR1;MIF;TCIRG1;ARFGEF2;HPSE;SMPD3;ZP3;PNP;CHD7;APBB1;ARG1;VEGFB;VAT1;SNAP29;KCNC4;HGS;CBL;TRAPPC1;RAB4B;MAPK3;ALDOC;FURIN;TMBIM1;LLGL1;CEACAM1;APBA1;ARHGAP44;ECM1;CD59;SLC30A1;TGFB1;MANF;CAT;ANXA1;RAB6A;GNAS;ERP44
14561,GO:0070062,1.83891477981603e-07,1,265,2038,extracellular exosome,CC,NT5E;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;NAPRT;PCK2;BSG;DLG1;DYSF;MXRA5;SLC9A3R2;PGM1;FKBP1A;PSMD2;RAB3B;CKAP4;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;LAMA5;RAB43;FAM129B;LCN2;CTSB;ACOT7;HAGH;TUBB6;HEBP1;BCR;AARS;FBLN1;ITGB5;MARCKSL1;PGLS;TTYH3;LAMB1;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;OAF;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;ABHD8;RRAS;MSN;LAMB2;PLD3;MVB12B;SERPINB6;ARRDC1;PRSS8;TST;PRKACB;H2AFJ;WASF2;CD44;RAP1GDS1;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;AHCY;CTBS;GAMT;PODXL;GLUL;TUBB3;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;RHOC;NID1;REEP2;PROCR;PKD1;ASS1;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;GGACT;APPL2;PPCS;ALOX15B;CNDP2;FAT1;CNFN;TMEM8A;SLC13A3;BLMH;ARL2;IGFBP2;CAP1;MYDGF;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;SRC;CHMP5;APLP2;GLRX;CAPG;TGM2;DNM2;FAM162A;CAPN5;HIST3H2A;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;TALDO1;PMVK;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;WNT5B;GALE;PFN1;PSMD7;ALDH7A1;ANXA3;VWA1;CHST14;ITGA1;GNB2;SHISA5;CTSL;COMT;TIMP1;CRIM1;SLC46A3;UBA1;LGALS3BP;RREB1;HYAL1;F12;MIF;STUB1;PCSK1N;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;PNP;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;SNTB2;TAOK1;LMAN1;ENTPD6;EPS8L1;HIST2H2AC;ARG1;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;VAT1;ACY1;HGS;CARHSP1;GGT1;CIB1;MAPK3;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;OCRL;ADAM15;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;PCYOX1;CAT;LDHA;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44
10408,GO:0043230,1.89333882876569e-07,1,266,2047,extracellular organelle,CC,NT5E;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;NAPRT;PCK2;SERPINE2;BSG;DLG1;DYSF;MXRA5;SLC9A3R2;PGM1;FKBP1A;PSMD2;RAB3B;CKAP4;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;LAMA5;RAB43;FAM129B;LCN2;CTSB;ACOT7;HAGH;TUBB6;HEBP1;BCR;AARS;FBLN1;ITGB5;MARCKSL1;PGLS;TTYH3;LAMB1;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;OAF;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;ABHD8;RRAS;MSN;LAMB2;PLD3;MVB12B;SERPINB6;ARRDC1;PRSS8;TST;PRKACB;H2AFJ;WASF2;CD44;RAP1GDS1;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;AHCY;CTBS;GAMT;PODXL;GLUL;TUBB3;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;RHOC;NID1;REEP2;PROCR;PKD1;ASS1;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;GGACT;APPL2;PPCS;ALOX15B;CNDP2;FAT1;CNFN;TMEM8A;SLC13A3;BLMH;ARL2;IGFBP2;CAP1;MYDGF;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;SRC;CHMP5;APLP2;GLRX;CAPG;TGM2;DNM2;FAM162A;CAPN5;HIST3H2A;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;TALDO1;PMVK;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;WNT5B;GALE;PFN1;PSMD7;ALDH7A1;ANXA3;VWA1;CHST14;ITGA1;GNB2;SHISA5;CTSL;COMT;TIMP1;CRIM1;SLC46A3;UBA1;LGALS3BP;RREB1;HYAL1;F12;MIF;STUB1;PCSK1N;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;PNP;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;SNTB2;TAOK1;LMAN1;ENTPD6;EPS8L1;HIST2H2AC;ARG1;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;VAT1;ACY1;HGS;CARHSP1;GGT1;CIB1;MAPK3;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;OCRL;ADAM15;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;PCYOX1;CAT;LDHA;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44
18491,GO:1903561,1.89333882876569e-07,1,266,2047,extracellular vesicle,CC,NT5E;ITGB4;PYGB;TSPAN1;LTBP2;CAPN2;THSD4;RAC2;LTBP4;SORL1;SDC1;MAP2K1;SERINC2;PLAT;PYGL;QSOX1;WNT7A;CST3;EPN3;SNX9;NAPRT;PCK2;SERPINE2;BSG;DLG1;DYSF;MXRA5;SLC9A3R2;PGM1;FKBP1A;PSMD2;RAB3B;CKAP4;RAPGEF3;PTPRS;PRSS3;PRNP;IDH2;LAMA5;RAB43;FAM129B;LCN2;CTSB;ACOT7;HAGH;TUBB6;HEBP1;BCR;AARS;FBLN1;ITGB5;MARCKSL1;PGLS;TTYH3;LAMB1;ARHGAP23;PRKACA;PTPRF;CORO1B;ACTA2;OAF;STK25;P4HB;PSAT1;XPC;MDH2;ACOT13;CARD11;GPC4;ARPC1A;SERPING1;ALDH1L2;APOE;CRYL1;PRKCZ;GALNS;FAM20C;NAGLU;RFNG;VPS4A;HIST2H2BE;CTSZ;UACA;PFKP;FBXO2;ABHD8;RRAS;MSN;LAMB2;PLD3;MVB12B;SERPINB6;ARRDC1;PRSS8;TST;PRKACB;H2AFJ;WASF2;CD44;RAP1GDS1;JADE2;TWF2;PRDX5;FSCN1;HTRA1;TSTA3;AHCY;CTBS;GAMT;PODXL;GLUL;TUBB3;STOM;GNB1;SYTL1;FUCA1;RAB29;DNASE1L1;RHOC;NID1;REEP2;PROCR;PKD1;ASS1;NUCB2;ARL8A;DOPEY2;CADM4;MYOF;GNAI2;SLC2A3;GGACT;APPL2;PPCS;ALOX15B;CNDP2;FAT1;CNFN;TMEM8A;SLC13A3;BLMH;ARL2;IGFBP2;CAP1;MYDGF;GPRC5C;AKR7A2;VAMP2;FLNB;GIPC1;SRC;CHMP5;APLP2;GLRX;CAPG;TGM2;DNM2;FAM162A;CAPN5;HIST3H2A;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;TOM1L2;C6ORF120;GPX3;GARS;STXBP1;TALDO1;PMVK;RAB25;MPI;CLSTN1;FUZ;AGRN;TMPRSS11D;WNT5B;GALE;PFN1;PSMD7;ALDH7A1;ANXA3;VWA1;CHST14;ITGA1;GNB2;SHISA5;CTSL;COMT;TIMP1;CRIM1;SLC46A3;UBA1;LGALS3BP;RREB1;HYAL1;F12;MIF;STUB1;PCSK1N;CPNE8;PRRC2A;SLC6A14;HSPA2;AOX1;MGRN1;P2RX4;PNP;EHD4;RNASE7;RNH1;SH3BGRL2;VASP;ABHD14B;HSPA13;MYO1D;SNTB2;TAOK1;LMAN1;ENTPD6;EPS8L1;HIST2H2AC;ARG1;RPL28;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;NDRG3;HIST1H2AG;BPHL;VAT1;ACY1;HGS;CARHSP1;GGT1;CIB1;MAPK3;KIFC3;DNAJB9;ALDOC;GLO1;FURIN;S100A16;SLC5A1;TMBIM1;OCRL;ADAM15;CEACAM1;GALNT3;MINK1;ECM1;CD59;NAGA;PCYOX1;CAT;LDHA;ANXA1;ARSD;RAB6A;GNAS;ITGA3;ERP44
14530,GO:0065009,2.32644109376312e-07,1,299,2250,regulation of molecular function,BP,ANGPTL4;XDH;PGF;FHL1;MDFI;NOS1;CCND1;F2R;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SERINC2;ADM2;SHC1;KCNG1;DOCK4;WNT7A;PTHLH;ERCC6;CST3;CYP27B1;NEURL1;SNX9;LMF1;BOK;CRTC1;ARAP1;DLG4;OBSCN;SERPINE2;DLG1;DAP;CMTM4;IFI6;FKBP1A;ITGA6;NET1;RAPGEF3;PRNP;SBF1;CYGB;FAM129B;MAPKAPK3;CTSB;SESN2;ADGRF1;BCR;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;EVI5L;MAP4K4;CMTM7;EGFR;CSNK1E;MMP14;ARHGAP23;PRKACA;ADARB1;PTPRF;MAP2K2;STK25;SHANK3;HECW2;AKT1;CARD11;IRAK1;SERPING1;BAG3;APOE;EHD3;ATP13A2;RIN2;PKN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;DGKQ;RFNG;ARHGAP22;PPP2R3B;FZD8;PITRM1;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;GIT2;PPP1R35;TGFBR2;GDI1;RIN1;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;PPARA;PRSS8;PRKACB;SIPA1;WDTC1;SHC2;CD44;PLCG1;TBC1D16;RAP1GDS1;ATG13;MAP3K9;LARP6;TBC1D14;PRDX5;CCND2;PSD3;PPP1R12C;GIT1;BIN1;SUFU;PAK1;TTBK2;NLGN2;RAG1;DDIT3;TNFSF15;TBC1D9B;ARHGAP39;STOM;FARP1;DUSP4;DOCK9;RET;RASGEF1A;RHOC;IFI27;CYTH3;CEMIP;SHANK2;PKD1;PARP10;DLG3;GATA3;APLN;OXA1L;OASL;DOCK6;GNAI2;HSF1;IL1RAP;WFS1;ASPH;ADAM8;NEIL1;TFPI2;RGL2;HMGA2;ARID5B;PPP1R14A;ARL2;ARHGEF4;CAP1;CLEC11A;VAMP2;TNFRSF6B;EDNRA;SRC;LDLRAP1;APLP2;DENND2A;GLRX;SCG5;DNM2;FAM162A;STPG1;STK24;RGS19;PAK6;RSF1;GSK3A;SH3BP1;SPINT2;PCSK6;DUSP6;OAS1;FYN;AGRN;PPM1F;RALGDS;LPAR3;PFN1;MICAL1;ANXA3;VDR;PLEKHG5;GAL;ITGA1;GNB2;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;FGFR1;ADNP;MFNG;MIF;SOCS2;STUB1;PCSK1N;MAU2;VPS9D1;DNMBP;TRIB3;SLC27A1;ZFPM1;ARFGEF2;LRP1;TRIB2;HSPA2;PAK4;ZP3;TBC1D20;FGF2;RNH1;VAPB;MAPK9;MAP3K12;ARAP3;MYO1D;TAOK1;EPS8L1;TBC1D2B;TAF6;VEGFB;TGFA;NDE1;CAMSAP3;SEC14L1;CASP4;TRPT1;CAMK1;EPHB2;HGS;GAS8;CBL;TRAPPC1;CIB1;SOCS7;IQSEC1;MAPK3;MAPK10;FURIN;ARHGEF2;TMBIM1;LLGL1;AIDA;OCRL;ADAM15;CEACAM1;MINK1;ARHGAP44;AGAP1;SRGAP2B;ECM1;SLC30A1;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;SH3PXD2A;MANF;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;ARHGEF10L;EP300;RAP1GAP2;STIM1;RASA3;ASAP1;TRAF7
12371,GO:0048731,2.46107419629342e-07,1,379,2946,system development,BP,ANGPTL4;XDH;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;SH3TC2;RAC2;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;CST3;SDK2;CYP27B1;NEURL1;AP3D1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;SERPINE2;SMTN;BSG;DLG1;IGFBP4;PITPNM1;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;ITGA6;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;DBNDD1;SMARCA1;SMURF2;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;CTSB;SNPH;BBS2;SEMA3F;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;XBP1;MAP4K4;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;MMP14;LAMB1;THBS2;ADARB1;PTPRF;TUB;ACTA2;EPN1;PPP1R13L;STK25;SHANK3;HECW2;FBXW8;AKT1;CARD11;GPC4;EPN2;BAG3;APOE;FAM210B;ARG2;PKN1;AP1B1;ELK3;WWTR1;COL13A1;AP2A2;PRKCZ;ATP7B;FAM20C;POU2F2;TFEB;NAGLU;RFNG;ARHGAP22;FZD8;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;FERMT1;RRAS;DEAF1;SALL2;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;LIMK1;DKK1;CREB3L2;PPP2R5B;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;PRKACB;LTBP1;WASF2;CD44;ZNF516;PLCG1;SEC63;TWF2;SLC38A10;TFE3;TACC1;MALL;BIN1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;GNB1;PTPN9;SATB1;RET;RAB29;LAMC2;NID1;GRB10;SHANK2;PKD1;DLG3;GATA3;APLN;GLUD1;HSF1;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;SDHA;CNFN;PTPRU;ADAM8;RAI1;MYH15;HMGA2;ARID5B;MICAL2;NUMB;MYDGF;B4GALT2;FLNB;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;DNM2;AGO4;IRF7;NCS1;STK24;SDCCAG8;RERE;GSK3A;STXBP1;SPINT2;PCSK6;DUSP6;FYN;CLSTN1;FUZ;AGRN;ASNS;LPAR3;WNT5B;PFN1;PSMD7;KIF17;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;KIF13B;BRSK1;GJC2;GAL;ITGA1;PSKH1;CTSL;TNRC6B;THRA;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LOXL1;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;USF2;PBX3;MFNG;SOCS2;SIGMAR1;RAB11FIP4;BCL2L1;ADIPOR1;LEMD2;ZFPM1;LRCH4;UNC119B;ULK1;LRP1;ROBO3;ZNF609;PLCD3;PAK4;TNFRSF19;HPSE;E2F5;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;KLHL17;RNH1;MAPK9;SDHAF4;SHB;VASP;MYO1D;CHD7;ATXN10;TAOK1;BICC1;MSLN;APBB1;SLIT3;RXRA;UNC45A;ARG1;L3MBTL3;TSHZ1;VEGFB;NDE1;CAMSAP3;TCF25;TPBG;IMPACT;KLK6;CAMK1;EPHB2;KRT23;HGS;POLM;MYL9;GAS8;CBL;CIB1;SOCS7;MAPK3;NTNG1;MAPK10;CSNK1D;DBP;DNAJB9;GLO1;FURIN;ARHGEF2;RNF103;LLGL1;MLF1;MATN3;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;ARHGAP44;SRGAP2B;ECM1;MBD3;MAP6;ADCY6;TGFB1;SH3PXD2A;MANF;CAT;LDHA;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;ARCN1;EP300;THBS3;TCF7L1;RAP1GAP2;STIM1;ASAP1;RNF10
4287,GO:0009653,2.67097944492798e-07,1,239,1704,anatomical structure morphogenesis,BP,ANGPTL4;XDH;PGF;FHL1;SH2D2A;SH3KBP1;ITGB4;ERCC1;MDFI;NOS1;CAPN2;F2R;RAC2;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;CST3;SDK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;BSG;DLG1;FKBP1A;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PTPRS;BNIP3;LAMA5;SSH1;SMURF2;NYAP1;TMOD2;FAM129B;TNNT1;BBS2;SEMA3F;BCR;SYNE3;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;LAMB1;THBS2;RFX2;ADARB1;CORO1B;ACTA2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;HECW2;FBXW8;GPC4;EPN2;APOE;FMNL2;PKN1;ELK3;WWTR1;COL13A1;AP2A2;PRKCZ;FAM20C;NAGLU;RFNG;ARHGAP22;FZD8;CTSZ;EPHA1;SH3PXD2B;RRAS;DEAF1;MSN;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;DKK1;SOX7;PPARA;OBSL1;PRKACB;WASF2;CD44;PLCG1;TWF2;FSCN1;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;ZNF385A;SEMA4B;GAMT;PODXL;CUL7;TUBB3;FARP1;DUSP4;RET;RHOC;GRB10;SHANK2;PKD1;DLG3;GATA3;APLN;MYOF;ADGRB2;FAT1;ASPH;ADAM8;HMGA2;ARID5B;RHOBTB2;MICAL2;NUMB;CAP1;MYDGF;FLNB;EDNRA;TULP3;ALDH1A2;SRC;TGM2;DNM2;AGO4;STK24;SDCCAG8;RERE;GSK3A;STXBP1;SH3BP1;SPINT2;DUSP6;FYN;RAB25;FUZ;LPAR3;PFN1;PSMD7;ANXA3;MBOAT7;VDR;KIF13B;BRSK1;GAL;ITGA1;THRA;FRYL;LAMB3;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;TENM2;BCL2L1;LEMD2;ZFPM1;ULK1;LRP1;ROBO3;PLCD3;PAK4;HPSE;E2F5;ULK2;ZP3;TBC1D20;FGF2;RNH1;SHB;VASP;ARAP3;CHD7;APBB1;RHOBTB1;SLIT3;RXRA;ARG1;TSHZ1;VEGFB;CAMSAP3;WIPF1;IMPACT;VAT1;CAMK1;EPHB2;HGS;CIB1;SOCS7;MAPK3;NTNG1;CSNK1D;ARHGEF2;TMBIM1;LLGL1;ADAM15;SRPX2;CEACAM1;MINK1;ARHGAP44;ECM1;MAP6;IGF2BP3;TGFB1;SF3B6;SH3PXD2A;ANXA1;GNAS;ITGA3;EP300;THBS3;STIM1
9622,GO:0036477,3.47393759851689e-07,1,85,477,somatodendritic compartment,CC,ZMYND8;NOS1;CAPN2;DVL1;CST3;NEURL1;SHARPIN;CRTC1;DLG4;NR1D1;PTPRS;PRNP;BNIP3;CYGB;SNPH;OSBP2;HTR7;PTPRF;SHANK3;ATF4;APOE;STRN4;ATP13A2;PRKCZ;ITPR3;PI4K2A;FBXO2;ENDOG;MAP1B;GDI1;PAK1;ZNF385A;GLUL;TUBB3;FARP1;GNB1;RET;SHANK2;DLG3;GNAI2;GRIN3B;WFS1;TOP1;GIPC1;DNM2;NCS1;GSK3A;FYN;KIF17;NRSN2;ANXA3;ABHD17C;KIF13B;GJC2;GAL;ITGA1;COMT;NTSR1;WDFY3;ADNP;TENM2;ARFGEF2;TMEM185A;LRP1;P2RX4;KLHL17;MYO1D;ATXN10;APBB1;HOMER2;ARG1;RPL28;KCNC4;EPHB2;CIB1;ARHGEF2;APBA1;MINK1;ARHGAP44;MAP6;TGFB1;AZIN2;CAMK2N1;GNAS;ASAP1
11165,GO:0045202,4.72354041807985e-07,1,90,514,synapse,CC,SH3KBP1;ZMYND8;NOS1;F2R;ADGRL1;DVL1;WNT7A;SDK2;NEURL1;AP3D1;SHARPIN;CRTC1;DLG4;SERPINE2;NR1D1;DLG1;FKBP1A;POSTN;RAB3B;PTPRS;PRNP;BNIP3;LAMA5;DBNDD1;SNPH;BCR;EGFR;SHANK3;AKT1;STRN4;COL13A1;PI4K2A;FBXO2;SEPT5;RABAC1;MAP1B;LAMB2;PSD3;NLGN2;GLUL;DMXL2;FARP1;SYTL1;SHANK2;DLG3;SH2D5;GRIN3B;ASIC1;VAMP2;PIP5K1C;GIPC1;SRC;DNM2;NCS1;GSK3A;STXBP1;FYN;CLSTN1;AGRN;SLC6A9;MICAL1;ABHD17C;BRSK1;DLGAP4;COMT;NTSR1;TENM2;SIGMAR1;BCL2L1;DNMBP;ARFGEF2;P2RX4;KLHL17;SNTB2;APBB1;HOMER2;NDE1;SNAP29;KCNC4;EPHB2;ARHGEF2;SRPX2;APBA1;MINK1;ARHGAP44;ITSN1;CAMK2N1;ITGA3;ASAP1;NIPSNAP1
6603,GO:0022617,4.81543280820917e-07,0.999999905434033,20,56,extracellular matrix disassembly,BP,CAPN2;CST3;BSG;MMP1;MMP14;SH3PXD2B;CD44;FSCN1;HTRA1;MMP10;LAMC2;NID1;ADAM8;CTSL;TIMP1;LAMB3;LRP1;FURIN;ADAM15;TGFB1
10920,GO:0044456,6.03022787125422e-07,1,77,423,synapse part,CC,ZMYND8;NOS1;F2R;ADGRL1;DVL1;WNT7A;NEURL1;AP3D1;SHARPIN;DLG4;NR1D1;DLG1;FKBP1A;RAB3B;PTPRS;PRNP;BNIP3;LAMA5;DBNDD1;SNPH;BCR;SHANK3;AKT1;STRN4;COL13A1;PI4K2A;FBXO2;SEPT5;RABAC1;MAP1B;LAMB2;PSD3;NLGN2;GLUL;DMXL2;FARP1;SYTL1;SHANK2;DLG3;SH2D5;GRIN3B;VAMP2;PIP5K1C;GIPC1;SRC;DNM2;NCS1;GSK3A;STXBP1;FYN;CLSTN1;SLC6A9;MICAL1;ABHD17C;BRSK1;COMT;NTSR1;TENM2;SIGMAR1;BCL2L1;ARFGEF2;P2RX4;KLHL17;APBB1;HOMER2;SNAP29;KCNC4;EPHB2;ARHGEF2;SRPX2;APBA1;MINK1;ARHGAP44;CAMK2N1;ITGA3;ASAP1;NIPSNAP1
12912,GO:0051234,7.13430561233199e-07,0.999999697136035,427,3436,establishment of localization,BP,EDEM1;XDH;FHL1;SH3KBP1;PYGB;TSPAN1;NOS1;LTBP2;CCND1;SH3TC2;F2R;RAC2;LTBP4;ASAP2;SORL1;SDC1;DVL1;MAP2K1;SERINC2;PITPNC1;KCNG1;PYGL;QSOX1;WNT7A;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;PCK2;ARAP1;SLCO4A1;DLG4;CPT2;SERPINE2;BSG;NR1D1;KLC2;DLG1;DYSF;XPOT;SLC16A3;PITPNM1;PGM1;FKBP1A;POSTN;PSMD2;RAB3B;CKAP4;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;BNIP3;CD68;RAB43;SCYL1;NME4;COPG1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;SESN2;SNPH;MRC2;BBS2;OSBPL10;USP20;BCR;SYNE3;RAB31;LPCAT1;OSBP2;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;TTYH3;FYCO1;SLC12A7;PRKACA;FCHO1;TUB;RHBDF2;HK1;MAP2K2;EPN1;LMBR1L;STK25;SHANK3;ATF4;HECW2;SNX33;AKT1;LRP3;CARD11;ARPC1A;SERPING1;EPN2;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;RIN2;AP1B1;PEAR1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;GALNS;ATP7B;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;CTSZ;PI4K2A;SLC20A1;ORAI1;TMEM129;PCSK9;FERMT1;GIT2;SEPT5;SEC23A;TMCO3;MSN;MAP1B;TGFBR2;GDI1;HADH;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;UBE2J1;ARRDC1;BNIP3L;PPARA;KDELR1;PRSS8;AKAP12;SYMPK;TST;ZDHHC8;WASF2;CD44;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;ATG13;ABCB8;SEC63;OSBPL5;SLC38A10;SURF4;TBC1D14;GIT1;BIN1;SFXN3;CCDC88C;PAK1;SLC29A4;NLGN2;DDIT3;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;FUCA1;SDCCAG3;RAB29;DNASE1L1;CORO7;IFI27;GRB10;CYTH3;REEP2;TMED3;CEMIP;SHANK2;PKD1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;OXA1L;ARL8A;DOPEY2;ANO8;GNAI2;SLC2A3;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ALOX15B;IL1RAP;WFS1;SLC12A4;ASPH;FAM155B;SLC6A6;ADAM8;MAPKBP1;SLC13A3;DYNLRB1;ARL2;SLC43A1;CAP1;PLIN3;VAMP2;PIP5K1C;GIPC1;EDNRA;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;SCG5;PEX10;TGM2;DNM2;SARAF;REEP6;UBR4;LRSAM1;NUCB1;STPG1;RAB1B;NDUFA4L2;NCS1;CPTP;STX5;TOM1L2;C6ORF120;COG8;RERE;EXOC2;GSK3A;STXBP1;SH3BP1;PCSK6;FYN;RAB25;FUZ;YPEL5;LPAR3;SLC6A9;NISCH;PSMD7;MICAL1;SLC25A43;KIF17;ANXA3;SLC33A1;VDR;BRPF3;KIF13B;ELMO3;BRSK1;STX10;MOAP1;GJC2;GAL;FCGRT;SLC13A5;COMT;MCFD2;PLTP;NTSR1;EIF2S2;TIMP1;SLC46A3;SLC35B4;LGALS3BP;SEC24C;FGFR1;RRBP1;ATP2C2;LRRC8A;USF2;GUK1;MIF;SOCS2;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;VPS9D1;TRIB3;ZFPL1;PRAF2;TCIRG1;PITPNM2;SNX25;SLC27A1;LEMD2;TPCN1;ARFIP2;ARFGEF2;UNC119B;SLC6A14;LRP1;HSPA2;MGRN1;P2RX4;HPSE;USO1;SMPD3;ZP3;TBC1D20;SPIRE1;PNP;FGF2;EHD4;VAPB;COG1;HSPA13;ARAP3;MYO1D;CHD7;ABCA7;LMAN1;APBB1;HOMER2;RXRA;ARG1;SLC10A6;TBC1D2B;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;SEC14L1;ATP6V1C2;WIPF1;VAT1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;HGS;CBL;TRAPPC1;CIB1;RAB4B;MAPK3;CPT1B;CSNK1D;ALDOC;FURIN;SLC5A1;ARHGEF2;SNX27;UGCG;TMBIM1;LLGL1;HM13;CEACAM1;APBA1;MINK1;ARHGAP44;AGAP1;ECM1;CD59;SLC30A1;IGF2BP3;ITSN1;TGFB1;WBP2;PCYOX1;PPP6R1;MANF;SLC15A1;CAT;AZIN2;PIK3R2;STARD10;ERBB3;ANXA1;SLC45A3;PPP1R10;RAB6A;GNAS;ZFYVE21;ARCN1;ERP44;ORAI3;STIM1;RASA3;ASAP1;FHOD1
2538,GO:0005794,9.26644648620573e-07,0.999999637296833,170,1150,Golgi apparatus,CC,EDEM1;ADAM19;CHAC1;H1F0;CAPN2;F2R;ASAP2;SORL1;SDC1;MAP2K1;DOCK4;QSOX1;WNT7A;PTHLH;SNX9;AP3D1;LMF1;BOK;ARAP1;BSG;DLG1;PITPNM1;POSTN;PRNP;AGPAT3;RAB43;SCYL1;COPG1;TMEM214;MARCH9;RAB31;CHPF;LPCAT1;XYLT1;EGFR;MMP14;FYCO1;MAP2K2;FAM114A1;XYLT2;STK25;FBXW8;GPC4;APOE;AP1B1;YIF1A;ATP7B;FAM20C;RFNG;FZD8;CTSZ;PI4K2A;PCSK9;SEC23A;B4GALNT4;RABAC1;GDI1;NDST2;LIMK1;KDELR1;OBSL1;YIPF2;ZDHHC8;CD44;SLC38A10;SURF4;TBC1D14;MALL;CUL7;GGA3;GGA1;RAB29;CORO7;CYTH3;TMED3;YIPF3;PKD1;NUCB2;DOPEY2;ASIC1;ARL2;PLIN3;B4GALT2;AKR7A2;VAMP2;B3GNT3;LDLRAP1;DNM2;NUCB1;RAB1B;NCS1;STK24;CPTP;RGS19;STX5;COG8;PCSK6;CLSTN1;AGRN;WNT5B;GRINA;TNFRSF1A;SLC33A1;STX10;CHST14;GAL;PSKH1;EHF;MCFD2;NTSR1;SLC35B4;SEC24C;ATP2C2;TENM2;MFNG;PCSK1N;ST3GAL3;DNMBP;ZFPL1;ANGEL1;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;PAK4;USO1;SMPD3;TBC1D20;ST6GALNAC2;VAPB;COG1;ABCA7;LMAN1;ENTPD6;MSLN;UNC45A;TGFA;SEC14L1;SNAP29;GAS8;TRAPPC1;CIB1;USP32;MAPK3;CSNK1D;KIFC3;DRAM2;LITAF;FURIN;SLC35G2;ARHGEF2;UGCG;TMBIM1;LLGL1;MPLKIP;B4GALT6;OCRL;APBA1;GALNT3;MINK1;CD59;MAP6;SLC30A1;TGFB1;PPP6R1;CAT;AZIN2;PODXL2;RAB6A;ARCN1
7339,GO:0031344,1.0885093847746e-06,0.999999628452157,79,439,regulation of cell projection organization,BP,ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;ARAP1;DLG4;PTPRS;PRNP;SSH1;ESPN;PLEK2;SEMA3F;VLDLR;EVI5L;MAP4K4;PTPRF;CORO1B;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;PPP2R5B;OBSL1;WASF2;CD44;TWF2;FSCN1;PAK1;SEMA4B;PODXL;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;FAM110C;SRC;DNM2;NCS1;STK24;FYN;FUZ;AGRN;LPAR3;PFN1;KIF13B;SEMA4G;FGFR1;RREB1;ADNP;TENM2;LRP1;ULK2;APBB1;EPS8L1;KLK6;CAMK1;EPHB2;CIB1;WRAP73;ARHGAP44;ADCY6;ITGA3;RAP1GAP2;ASAP1
6768,GO:0030198,2.46614301685685e-06,0.999999084745361,46,213,extracellular matrix organization,BP,ITGB4;ADAM19;CAPN2;THSD4;CST3;BSG;MMP1;POSTN;ITGA6;LAMA5;FBLN1;ITGB5;MMP14;LAMB1;THBS2;COL13A1;SH3PXD2B;FERMT1;LAMB2;CD44;FSCN1;HTRA1;ERO1B;MMP10;LAMC2;NID1;ADAM8;P4HA1;SPINT2;AGRN;VWA1;ITGA1;CTSL;TIMP1;LAMB3;LOXL1;LRP1;FGF2;POMT1;FURIN;MATN3;ADAM15;TGFB1;SH3PXD2A;ITGA3;THBS3
17276,GO:0120035,2.50694768153613e-06,0.9999988892634,77,432,regulation of plasma membrane bounded cell projection organization,BP,ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;ARAP1;DLG4;PTPRS;PRNP;SSH1;ESPN;SEMA3F;VLDLR;EVI5L;MAP4K4;PTPRF;CORO1B;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;PPP2R5B;OBSL1;WASF2;CD44;TWF2;FSCN1;PAK1;SEMA4B;PODXL;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;SRC;DNM2;NCS1;STK24;FYN;FUZ;AGRN;LPAR3;PFN1;KIF13B;SEMA4G;FGFR1;RREB1;ADNP;TENM2;LRP1;ULK2;APBB1;EPS8L1;KLK6;CAMK1;EPHB2;CIB1;WRAP73;ARHGAP44;ADCY6;ITGA3;RAP1GAP2;ASAP1
11449,GO:0045860,2.54635142028354e-06,0.999998910377717,68,370,positive regulation of protein kinase activity,BP,CCND1;F2R;MST1R;MAP2K1;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;TGFBR2;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;CAMK1;CIB1;MAPK3;MAPK10;MINK1;ADCY6;TGFB1;ERBB3;TRAF7
17077,GO:0099537,2.62339975138989e-06,0.999998932975209,58,297,trans-synaptic signaling,BP,ZMYND8;NOS1;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;DLG1;RAB3B;PRNP;SSH1;TMOD2;SNPH;ETV5;HTR7;MYCBPAP;EGFR;SLC12A7;ADARB1;SHANK3;AKT1;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SYTL1;SHANK2;DLG3;GNAI2;GRIN3B;ASIC1;SLC12A4;VAMP2;PIP5K1C;GIPC1;GSK3A;STXBP1;CLSTN1;LPAR3;SLC6A9;NISCH;BRSK1;NTSR1;ADNP;P2RX4;SNAP29;KCNC4;EPHB2;PAIP2;APBA1;MINK1;SLC30A1
3497,GO:0007399,2.76161833543982e-06,0.999998368211595,208,1471,nervous system development,BP,BTBD2;SH3KBP1;ZMYND8;NOS1;CHAC1;SH3TC2;RAC2;SORL1;NFATC4;ADGRL1;DVL1;MAP2K1;SHC1;WNT7A;CST3;SDK2;NEURL1;SCN8A;BOK;SHARPIN;CRTC1;MEF2D;DLG4;SERPINE2;DLG1;PITPNM1;DNMT3A;SOX12;POSTN;PTPRS;IDH2;BNIP3;SSH1;DBNDD1;SMARCA1;NYAP1;TMOD2;PCDH1;MARVELD1;FAM129B;SNPH;BBS2;SEMA3F;ADGRF1;BCR;VLDLR;ETV5;MARK4;AARS;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;LAMB1;THBS2;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;BAG3;APOE;PRKCZ;NAGLU;RFNG;FZD8;CTSZ;PTK6;PCSK9;DEAF1;SALL2;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;EPOR;LIMK1;DKK1;PPP2R5B;OBSL1;PRKACB;PLCG1;TWF2;TACC1;MALL;BIN1;SUFU;PAK1;TTBK2;NLGN2;SEMA4B;NAV1;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;PKD1;DLG3;GATA3;GLUD1;ADGRB2;ANKS1A;IL1RAP;SDHA;NUMB;B4GALT2;EDNRA;TULP3;ALDH1A2;SRC;DNM2;NCS1;STK24;SDCCAG8;RERE;GSK3A;STXBP1;SPINT2;FYN;CLSTN1;FUZ;AGRN;LPAR3;WNT5B;PFN1;KIF17;ANXA3;MBOAT7;KIF13B;BRSK1;GJC2;GAL;ITGA1;THRA;AMIGO2;CRIM1;FRYL;SEMA4G;FGFR1;ADNP;TENM2;PBX3;SOCS2;SIGMAR1;LEMD2;LRCH4;UNC119B;ULK1;LRP1;ROBO3;ZNF609;PAK4;ULK2;FGF2;KLHL17;MAPK9;VASP;MYO1D;CHD7;ATXN10;TAOK1;APBB1;SLIT3;NDE1;CAMSAP3;TPBG;IMPACT;KLK6;CAMK1;EPHB2;GAS8;CIB1;SOCS7;MAPK3;NTNG1;MAPK10;CSNK1D;ARHGEF2;RNF103;LLGL1;SRPX2;APBA1;MINK1;ARHGAP44;SRGAP2B;MBD3;MAP6;ADCY6;TGFB1;MANF;ERBB3;ANXA1;SLC45A3;ITGA3;ARCN1;EP300;TCF7L1;RAP1GAP2;ASAP1;RNF10
17076,GO:0099536,2.9410294305288e-06,0.999998799607298,58,298,synaptic signaling,BP,ZMYND8;NOS1;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;DLG1;RAB3B;PRNP;SSH1;TMOD2;SNPH;ETV5;HTR7;MYCBPAP;EGFR;SLC12A7;ADARB1;SHANK3;AKT1;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SYTL1;SHANK2;DLG3;GNAI2;GRIN3B;ASIC1;SLC12A4;VAMP2;PIP5K1C;GIPC1;GSK3A;STXBP1;CLSTN1;LPAR3;SLC6A9;NISCH;BRSK1;NTSR1;ADNP;P2RX4;SNAP29;KCNC4;EPHB2;PAIP2;APBA1;MINK1;SLC30A1
3454,GO:0007268,3.97324467250525e-06,0.999998372784155,57,294,chemical synaptic transmission,BP,ZMYND8;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;DLG1;RAB3B;PRNP;SSH1;TMOD2;SNPH;ETV5;HTR7;MYCBPAP;EGFR;SLC12A7;ADARB1;SHANK3;AKT1;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SYTL1;SHANK2;DLG3;GNAI2;GRIN3B;ASIC1;SLC12A4;VAMP2;PIP5K1C;GIPC1;GSK3A;STXBP1;CLSTN1;LPAR3;SLC6A9;NISCH;BRSK1;NTSR1;ADNP;P2RX4;SNAP29;KCNC4;EPHB2;PAIP2;APBA1;MINK1;SLC30A1
16958,GO:0098916,3.97324467250525e-06,0.999998372784155,57,294,anterograde trans-synaptic signaling,BP,ZMYND8;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;DLG1;RAB3B;PRNP;SSH1;TMOD2;SNPH;ETV5;HTR7;MYCBPAP;EGFR;SLC12A7;ADARB1;SHANK3;AKT1;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SYTL1;SHANK2;DLG3;GNAI2;GRIN3B;ASIC1;SLC12A4;VAMP2;PIP5K1C;GIPC1;GSK3A;STXBP1;CLSTN1;LPAR3;SLC6A9;NISCH;BRSK1;NTSR1;ADNP;P2RX4;SNAP29;KCNC4;EPHB2;PAIP2;APBA1;MINK1;SLC30A1
16884,GO:0098794,6.69917179045291e-06,0.999997093125244,52,261,postsynapse,CC,ZMYND8;NOS1;F2R;DVL1;NEURL1;AP3D1;SHARPIN;DLG4;NR1D1;DLG1;PTPRS;PRNP;BNIP3;BCR;SHANK3;AKT1;STRN4;COL13A1;FBXO2;MAP1B;PSD3;NLGN2;FARP1;SHANK2;DLG3;SH2D5;GRIN3B;GIPC1;SRC;DNM2;NCS1;GSK3A;STXBP1;FYN;CLSTN1;ABHD17C;COMT;NTSR1;TENM2;SIGMAR1;ARFGEF2;P2RX4;KLHL17;APBB1;HOMER2;EPHB2;ARHGEF2;APBA1;MINK1;ARHGAP44;CAMK2N1;ASAP1
11448,GO:0045859,7.02340562088285e-06,0.999996326791841,95,585,regulation of protein kinase activity,BP,CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;DUSP4;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;DUSP6;PPM1F;LPAR3;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;TRIB3;SLC27A1;TRIB2;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;SPRED2;CAMK2N1;ERBB3;TRAF7
10435,GO:0043269,8.01048600510529e-06,0.999996397316133,56,298,regulation of ion transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG4;SERPINE2;DLG1;FKBP1A;RAB3B;PRNP;PRKACA;SHANK3;ATF4;HECW2;AKT1;APOE;EHD3;TMSB4X;ORAI1;PCSK9;STK39;PRSS8;PLCG1;NLGN2;STOM;CEMIP;SHANK2;GNAI2;GRIN3B;WFS1;VAMP2;GLRX;DNM2;SARAF;STXBP1;FYN;LPAR3;GJC2;GAL;NTSR1;FGFR1;MIF;TPCN1;HSPA2;P2RX4;CHD7;ABCA7;HOMER2;ARG1;KCNC4;EPHB2;MINK1;SLC30A1;TGFB1;STIM1
13292,GO:0051960,8.99792562943395e-06,0.999995123639288,91,547,regulation of nervous system development,BP,ZMYND8;NOS1;SORL1;NFATC4;ADGRL1;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;DLG1;PTPRS;IDH2;SSH1;SEMA3F;VLDLR;ETV5;MAP4K4;CSNK1E;THBS2;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PRKACB;TWF2;BIN1;SUFU;PAK1;NLGN2;SEMA4B;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;ADGRB2;IL1RAP;NUMB;TULP3;DNM2;NCS1;STK24;FYN;CLSTN1;AGRN;LPAR3;KIF13B;GJC2;AMIGO2;SEMA4G;FGFR1;ADNP;SOCS2;LRP1;ZNF609;ULK2;CHD7;APBB1;TPBG;IMPACT;KLK6;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;SRPX2;ARHGAP44;ADCY6;TGFB1;SLC45A3;ITGA3;RAP1GAP2;ASAP1;RNF10
12629,GO:0050790,9.21016669779343e-06,0.999993846169167,219,1617,regulation of catalytic activity,BP,ANGPTL4;XDH;NOS1;CCND1;F2R;MST1R;RAC2;ASAP2;SORL1;DVL1;MAP2K1;SERINC2;SHC1;DOCK4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;LMF1;BOK;ARAP1;DLG4;SERPINE2;DLG1;DAP;IFI6;FKBP1A;ITGA6;NET1;RAPGEF3;PRNP;SBF1;CYGB;MAPKAPK3;CTSB;SESN2;BCR;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;EVI5L;MAP4K4;EGFR;MMP14;ARHGAP23;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;SERPING1;BAG3;APOE;ATP13A2;RIN2;PKN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;DGKQ;ARHGAP22;PPP2R3B;FZD8;PITRM1;EPHA1;PTK6;SH3PXD2B;GIT2;PPP1R35;TGFBR2;GDI1;RIN1;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;PRKACB;SIPA1;WDTC1;SHC2;CD44;PLCG1;TBC1D16;RAP1GDS1;ATG13;MAP3K9;TBC1D14;PRDX5;CCND2;PPP1R12C;GIT1;BIN1;PAK1;RAG1;TNFSF15;TBC1D9B;ARHGAP39;FARP1;DUSP4;DOCK9;RET;RHOC;IFI27;CEMIP;PKD1;DLG3;OXA1L;OASL;GNAI2;HSF1;ASPH;ADAM8;NEIL1;TFPI2;PPP1R14A;ARL2;CAP1;TNFRSF6B;EDNRA;SRC;APLP2;SCG5;DNM2;FAM162A;STK24;RGS19;PAK6;GSK3A;SH3BP1;SPINT2;PCSK6;DUSP6;OAS1;FYN;AGRN;PPM1F;RALGDS;LPAR3;PFN1;MICAL1;ANXA3;VDR;ITGA1;MAP3K10;HEXIM1;TIMP1;CRIM1;FGFR1;ADNP;MIF;SOCS2;STUB1;PCSK1N;VPS9D1;DNMBP;TRIB3;SLC27A1;LRP1;TRIB2;HSPA2;PAK4;TBC1D20;FGF2;RNH1;VAPB;MAP3K12;ARAP3;MYO1D;TAOK1;TBC1D2B;TGFA;NDE1;CAMSAP3;CASP4;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;IQSEC1;MAPK3;MAPK10;FURIN;TMBIM1;LLGL1;AIDA;OCRL;CEACAM1;MINK1;ARHGAP44;AGAP1;SRGAP2B;ECM1;ADCY6;CCNE1;TGFB1;PPP6R1;SH3PXD2A;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;RAP1GAP2;RASA3;ASAP1;TRAF7
10436,GO:0043270,1.00272138093235e-05,0.999996607185453,29,121,positive regulation of ion transport,BP,FHL1;NOS1;F2R;DLG1;RAB3B;SHANK3;AKT1;APOE;EHD3;TMSB4X;ORAI1;STK39;PRSS8;PLCG1;CEMIP;WFS1;GLRX;DNM2;STXBP1;LPAR3;GJC2;GAL;NTSR1;MIF;HSPA2;P2RX4;ABCA7;EPHB2;STIM1
10742,GO:0044089,1.00710262314884e-05,0.999994964952299,68,383,positive regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;RAC2;ADGRL1;SDC1;WNT7A;NEURL1;SNX9;ARAP1;DLG1;MMP1;RAPGEF3;ESPN;THBS2;CORO1B;ARPC1A;ATP13A2;VPS4A;EPHA1;SH3PXD2B;MSN;LIMK1;PPP2R5B;WASF2;CDC34;IDE;TWF2;FSCN1;PAK1;NLGN2;RHOC;HSF1;ADGRB2;IL1RAP;ARL2;SRC;DNM2;LRSAM1;CLSTN1;FUZ;AGRN;PPM1F;PFN1;AMIGO2;ADNP;HYAL1;TENM2;STUB1;DDB2;ARFIP2;ULK1;SMPD3;SPIRE1;MAPK9;VASP;EPS8L1;BAIAP2L1;TPBG;WIPF1;EPHB2;HGS;WRAP73;SRPX2;TGFB1;PXN;ARHGEF10L;ASAP1;FHOD1
16894,GO:0098805,1.12948537039703e-05,0.999992715357222,170,1197,whole membrane,CC,TSPAN1;NOS1;CAPN2;F2R;RAC2;SORL1;WNT7A;CYP27B1;AP3D1;BOK;DLG4;BSG;DLG1;RAB3B;CKAP4;PTPRS;PRNP;BNIP3;CD68;RAB43;DBNDD1;SCYL1;SMURF2;COPG1;MARVELD1;LY6K;MARCH9;SYNE3;RAB31;LPCAT1;VLDLR;EGFR;PRKACA;HK1;MAP2K2;CARD11;ARMCX2;IRAK1;EPN2;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;AP1B1;AP2A2;PRKCZ;ITPR3;VPS11;VPS4A;PI4K2A;RETSAT;PCSK9;SEC23A;TGFBR2;MVB12B;SERPINB6;DKK1;BNIP3L;KDELR1;YIPF2;CD44;SURF4;MALL;PODXL;DMXL2;GGA3;GGA1;STOM;GNB1;RET;MLXIP;IFI27;TMED3;CEMIP;PKD1;ATP11A;ARL8A;MYOF;GNAI2;SLC2A3;ANTXR2;APPL2;SLC12A4;ADAM8;TMEM8A;PLIN3;VAMP2;PIP5K1C;SRC;LDLRAP1;CHMP5;APLP2;PEX10;DNM2;UBR4;IRF7;RAB1B;TMEM9;TMEM44;CPTP;RGS19;STX5;PAG1;FYN;WNT5B;TNFRSF1A;ANXA3;ABHD17C;MOAP1;ITGA1;GNB2;MCFD2;NTSR1;UBA1;WDFY3;SEC24C;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;ULK1;LRP1;P2RX4;HPSE;USO1;ULK2;EHD4;MAP1LC3B;MYO1D;SNTB2;ABCA7;LMAN1;ARG1;TGFA;ATP6V1C2;CYB561;BPHL;VAT1;SNAP29;HGS;CBL;RAB4B;MAPK3;CPT1B;DRAM2;LITAF;FURIN;C12ORF66;SNX27;TMBIM1;LLGL1;OCRL;HM13;CEACAM1;CD59;MAP6;PCYOX1;CAT;SPRED2;ANXA1;RAB6A;ZFYVE21;ARCN1
3388,GO:0007167,1.15160709410974e-05,0.999993294687467,109,694,enzyme linked receptor protein signaling pathway,BP,XDH;PGF;SH2D2A;SH3KBP1;FAM83A;LTBP2;SH3TC2;MST1R;LTBP4;SHC1;PLAT;NEURL1;ARAP1;IGFBP4;FKBP1A;SMURF2;FAM129B;MAPKAPK3;BCR;ACVR2B;ITGB5;EGFR;PTPRF;RHBDF2;EPN1;AKT1;IRAK1;ARPC1A;EPN2;WWTR1;AP2A2;PRKCZ;FAM20C;DGKQ;MAPK13;EPHA1;PTK6;FERMT1;TGFBR2;MVB12B;DKK1;PPP2R5B;LTBP1;SHC2;WASF2;PLCG1;IDE;GIT1;HTRA1;PAK1;BCL9L;RET;GRB10;GATA3;APLN;MYOF;ANKS1A;EFS;PTPRU;ARID5B;IGFBP2;EIF4EBP1;GIPC1;SRC;DNM2;ESRP1;GSK3A;PAG1;PCSK6;DUSP6;FYN;FUZ;FBXL15;SLC33A1;ITGA1;CRIM1;FGFR1;SOCS2;MTMR4;STUB1;ADIPOR1;TCIRG1;SNX25;PTPN12;LEMD2;PMEPA1;LRP1;FGF2;SHB;VEGFB;TGFA;BAIAP2L1;ATP6V1C2;EPHB2;HGS;CBL;SOCS7;MAPK3;FURIN;GIGYF1;CEACAM1;GALNT3;ITSN1;TGFB1;SPRED2;PIK3R2;ERBB3;ITGA3;PXN
12642,GO:0050807,1.25863682570694e-05,0.99999612359758,25,94,regulation of synapse organization,BP,ZMYND8;NFATC4;ADGRL1;WNT7A;NEURL1;PRNP;SSH1;ETV5;THBS2;SHANK3;APOE;DKK1;NLGN2;ADGRB2;IL1RAP;FYN;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;CAMK1;EPHB2;SRPX2;ARHGAP44
12291,GO:0048583,1.38151102934999e-05,0.999990017196841,345,2725,regulation of response to stimulus,BP,TNIP1;NT5E;EDEM1;XDH;PGF;SH2D2A;SH3KBP1;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;ADM2;SHC1;PLAT;WNT7A;PTHLH;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;ARAP1;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;CMTM4;IGFBP4;IFI6;FKBP1A;POSTN;PSMD2;RAB3B;ITGA6;NET1;PTPRS;PRNP;BNIP3;SSH1;WWC3;SMURF2;TMOD2;FAM129B;G0S2;MAPKAPK3;CTSB;SESN2;TNNT1;BBS2;SEMA3F;USP20;NACC2;BCR;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MMP14;ARHGAP23;PRKACA;PTPRF;CORO1B;RHBDF2;HK1;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;AKT1;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;SERPING1;EPN2;BAG3;APOE;ARG2;PKN1;PEAR1;SYVN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GRK6;PCSK9;ENDOG;NSMCE4A;FERMT1;GIT2;RRAS;TGFBR2;CD99;GDI1;MVB12B;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;PPARA;FAM3A;AKAP12;PRKACB;LTBP1;SIPA1;SHC2;WASF2;CDC34;CD44;PLCG1;MAP3K9;MC1R;DEDD2;PSD3;TSPAN5;GIT1;HTRA1;SUFU;PAK1;BCL9L;ZNF385A;NLGN2;RAG1;SEMA4B;DDIT3;TNFSF15;BCDIN3D;ARHGAP39;FARP1;DUSP4;RET;RAB29;RASGEF1A;RHOC;GRB10;CYTH3;SHANK2;GATA3;APLN;MYOF;GNAI2;FNDC4;HSF1;APPL2;ANKS1A;ALOX15B;WFS1;ADAM8;MAPKBP1;RGL2;HMGA2;RHOBTB2;FAM110C;ARHGEF4;IGFBP2;MYDGF;CLEC11A;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;TGM2;DNM2;FAM162A;IRF7;LRSAM1;MARK3;STK24;RGS19;CARD19;PAK6;YPEL3;GSK3A;STXBP1;PAG1;SH3BP1;PCSK6;DUSP6;FYN;FUZ;PPM1F;LPAR3;WNT5B;GRINA;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;FCGRT;SHISA5;CTSL;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;MGLL;SEMA4G;FGFR1;RREB1;MIB2;F12;MFNG;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;DNMBP;TRIB3;AFAP1;SNX25;PTPN12;LEMD2;PMEPA1;ARFGEF2;LRP1;TRIB2;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;SHB;MAP3K12;ARAP3;TAOK1;ABCA7;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;ARG1;TAF6;VEGFB;TGFA;INVS;SEC14L1;BAIAP2L1;ATP6V1C2;WIPF1;IMPACT;KLK6;CASP4;EPHB2;HGS;CBL;GGT1;CIB1;SOCS7;IQSEC1;MAPK3;KANK2;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;C12ORF66;TMBIM1;LLGL1;AIDA;OCRL;CEACAM1;MINK1;SKAP2;ARHGAP44;AGAP1;ECM1;CD59;MBD3;ITSN1;TGFB1;WBP2;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;PPP1R10;ITGA3;PXN;ARHGEF10L;EP300;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
4788,GO:0010975,1.46417812123833e-05,0.999992937387672,59,319,regulation of neuron projection development,BP,ZMYND8;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;PTPRS;SSH1;SEMA3F;VLDLR;MAP4K4;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;PPP2R5B;OBSL1;TWF2;PAK1;SEMA4B;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;DNM2;NCS1;STK24;FYN;LPAR3;KIF13B;SEMA4G;FGFR1;ADNP;LRP1;ULK2;APBB1;KLK6;CAMK1;EPHB2;CIB1;ARHGAP44;ADCY6;ITGA3;RAP1GAP2;ASAP1
6898,GO:0030425,1.50170953935013e-05,0.999992388578949,65,364,dendrite,CC,ZMYND8;NOS1;CAPN2;DVL1;NEURL1;SHARPIN;CRTC1;DLG4;NR1D1;PRNP;BNIP3;OSBP2;HTR7;SHANK3;ATF4;APOE;STRN4;PI4K2A;FBXO2;MAP1B;PAK1;ZNF385A;TUBB3;FARP1;GNB1;RET;SHANK2;DLG3;GNAI2;WFS1;GIPC1;DNM2;NCS1;GSK3A;FYN;KIF17;ANXA3;ABHD17C;KIF13B;COMT;NTSR1;ADNP;TENM2;ARFGEF2;TMEM185A;LRP1;P2RX4;KLHL17;MYO1D;ATXN10;APBB1;HOMER2;RPL28;KCNC4;EPHB2;CIB1;ARHGEF2;APBA1;MINK1;ARHGAP44;MAP6;AZIN2;CAMK2N1;GNAS;ASAP1
16629,GO:0097447,1.50170953935013e-05,0.999992388578949,65,364,dendritic tree,CC,ZMYND8;NOS1;CAPN2;DVL1;NEURL1;SHARPIN;CRTC1;DLG4;NR1D1;PRNP;BNIP3;OSBP2;HTR7;SHANK3;ATF4;APOE;STRN4;PI4K2A;FBXO2;MAP1B;PAK1;ZNF385A;TUBB3;FARP1;GNB1;RET;SHANK2;DLG3;GNAI2;WFS1;GIPC1;DNM2;NCS1;GSK3A;FYN;KIF17;ANXA3;ABHD17C;KIF13B;COMT;NTSR1;ADNP;TENM2;ARFGEF2;TMEM185A;LRP1;P2RX4;KLHL17;MYO1D;ATXN10;APBB1;HOMER2;RPL28;KCNC4;EPHB2;CIB1;ARHGEF2;APBA1;MINK1;ARHGAP44;MAP6;AZIN2;CAMK2N1;GNAS;ASAP1
13167,GO:0051716,1.67518605080937e-05,0.999987403660319,555,4677,cellular response to stimulus,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;SH3KBP1;ITGB4;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;WNT7A;PTHLH;ERCC6;CST3;CYP27B1;NEURL1;AP3D1;BOK;SHARPIN;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;IFI6;DNMT3A;FKBP1A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;CD68;LAMA5;SSH1;WWC3;TXNDC11;RAB43;SMURF2;NYAP1;TMOD2;PLCH2;CYGB;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;SESN2;PLEK2;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;RAB31;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;HTR7;ADCY7;XBP1;MAP4K4;CMTM7;EGFR;CSNK1E;MKNK2;MMP14;RFX2;ARHGAP23;PRKACA;PTPRF;CORO1B;RHBDF2;MAP2K2;EPN1;PPP1R13L;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;XPC;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;FAM210B;ATP13A2;ARG2;RIN2;PKN1;PEAR1;SYVN1;ELK3;YIF1A;WWTR1;TMSB4X;AP2A2;TSPYL2;PRKCZ;FAM20C;ITPR3;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;PFKP;TMEM129;FBXO2;GRK6;PCSK9;ENDOG;NSMCE4A;FERMT1;GIT2;RRAS;SALL2;MSN;TGFBR2;LAMB2;GDI1;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;AKAP12;PRKACB;LTBP1;SIPA1;WDTC1;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;RAP1GDS1;ATG13;SEC63;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;TWF2;PRDX5;CCND2;PSD3;TSPAN5;PPP1R12C;GIT1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;RHPN1;BCL9L;ZNF385A;NLGN2;SEMA4B;DDIT3;TNFSF15;GLUL;BCDIN3D;CUL7;ARHGAP39;ADAMTS7;FARP1;DUSP4;GNB1;PTPN9;DOCK9;RET;RAB29;RASGEF1A;GAS2L1;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;PCBP4;SHANK2;PKD1;ASS1;GATA3;APLN;PHF1;UBXN4;OASL;MYOF;DOCK6;GNAI2;ANTXR2;GRIN3B;ASIC1;HSF1;APPL2;ADGRB2;ANKS1A;ALOX15B;IL1RAP;WFS1;EFS;MT2A;PTPRU;ADAM8;MAPKBP1;NEIL1;TFPI2;MPG;PYCR2;RGL2;HMGA2;ARID5B;RHOBTB2;PPP1R14A;FAM110C;LY6E;PLCB3;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;APLP2;POLD4;SCG5;TGM2;DNM2;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;ACADVL;RGS19;CARD19;PAK6;YPEL3;TOM1L2;ESRP1;GPX3;GSK3A;STXBP1;PAG1;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;OAS1;FYN;RAB25;PRIMPOL;ISG20;FUZ;AGRN;ASNS;PPM1F;RALGDS;LPAR3;WNT5B;GRINA;PFN1;NISCH;PSMD7;MICAL1;TNFRSF1A;WISP1;TLE4;FBXL15;SLC33A1;VDR;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;UBA1;MGLL;HSF4;LGALS3BP;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;LRRC8A;MIB2;TENM2;USF2;MFNG;MIF;SOCS2;MTMR4;ASB13;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;DDB2;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;ARFIP2;LRCH4;NDOR1;RAD23A;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;HSPA2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ULK2;ZP3;LRRK1;FGF2;EHD4;MAP1LC3B;VAPB;MAPK9;SHB;MAP3K12;TMX4;HSPA13;ARAP3;TAOK1;ABCA7;BICC1;APBB1;RHOBTB1;EPS8L1;SLIT3;HOMER2;RXRA;ARG1;TAF6;VEGFB;NEURL1B;TGFA;INVS;SEC14L1;ZBTB4;BAIAP2L1;ATP6V1C2;CNOT11;NDRG3;WIPF1;IMPACT;BPHL;KLK6;CASP4;ACY1;CAMK1;EPHB2;HGS;CARHSP1;DRG2;POLM;CBL;GGT1;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;EEPD1;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;RNF103;C12ORF66;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;OCRL;ADAM15;HM13;CEACAM1;GALNT3;MINK1;SKAP2;ARHGAP44;AGAP1;TFPT;UROS;ECM1;CD59;MBD3;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;TM2D1;MANF;CAT;RMI2;SPRED2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;PPP1R10;ASH2L;RAB6A;GNAS;ITGA3;PXN;ARHGEF10L;EP300;ERP44;TCF7L1;RAP1GAP2;RASA3;ASAP1;TRAF7
7699,GO:0032147,1.70426883050827e-05,0.999992341879757,47,238,activation of protein kinase activity,BP,F2R;MAP2K1;SHC1;ERCC6;DLG1;PRNP;MAPKAPK3;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;TGFBR2;STK39;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;PAK1;TNFSF15;GNAI2;SRC;STK24;PAK6;DUSP6;LPAR3;ITGA1;MAP3K10;ADNP;PAK4;FGF2;MAP3K12;TAOK1;TGFA;MAPK3;MAPK10;MINK1;ADCY6;TRAF7
10902,GO:0044433,1.81343288152468e-05,0.999988461594132,149,1043,cytoplasmic vesicle part,CC,SH3KBP1;PYGB;RAC2;SORL1;PYGL;QSOX1;WNT7A;CST3;SNX9;AP3D1;NAPRT;BOK;DLG4;BSG;DYSF;PGM1;PSMD2;RAB3B;CKAP4;PTPRS;PRSS3;CD68;RAB43;DBNDD1;SCYL1;COPG1;LCN2;CTSB;RAB31;LPCAT1;EGFR;SNX33;IRAK1;SERPING1;EPN2;APOE;EHD3;ATP13A2;AP1B1;TMSB4X;AP2A2;GALNS;ITPR3;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SEC23A;MVB12B;SERPINB6;DKK1;KDELR1;YIPF2;ZDHHC8;CD44;SURF4;DMXL2;GGA3;GGA1;STOM;FUCA1;RET;DNASE1L1;TMED3;CEMIP;PKD1;ATP11A;ARL8A;MYOF;SLC2A3;ANTXR2;APPL2;ADAM8;CAP1;PLIN3;GPRC5C;VAMP2;PIP5K1C;LDLRAP1;CHMP5;APLP2;DNM2;UBR4;IRF7;TMEM9;CPTP;STX5;C6ORF120;YPEL5;WNT5B;PSMD7;ANXA3;ABHD17C;CTSL;MCFD2;TIMP1;UBA1;LGALS3BP;SEC24C;MIF;MTMR4;VPS37A;RAB11FIP4;BCL2L1;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;LRP1;HPSE;USO1;ULK2;SPIRE1;PNP;EHD4;SNTB2;ABCA7;LMAN1;ARG1;VEGFB;TGFA;VAT1;SNAP29;HGS;TRAPPC1;RAB4B;KIFC3;LITAF;ALDOC;FURIN;SNX27;TMBIM1;LLGL1;OCRL;HM13;CEACAM1;ECM1;CD59;MAP6;TGFB1;CAT;SPRED2;ANXA1;RAB6A;ZFYVE21;ARCN1;ERP44
2397,GO:0005539,1.89267579331687e-05,0.999993807790993,26,105,glycosaminoglycan binding,MF,PGF;LTBP2;LTBP4;SERPINE2;POSTN;PTPRS;PRNP;THBS2;PTPRF;HK1;APOE;COL13A1;TGFBR2;CD44;LAMC2;CEMIP;APLP2;PCSK6;AGRN;WISP1;FGFR1;FGF2;RNASE7;VEGFB;PODXL2;THBS3
9844,GO:0042060,1.91571376465948e-05,0.999990548547738,61,346,wound healing,BP,F2R;RAC2;SDC1;PLAT;WNT7A;SERPINE2;DYSF;DGKA;DCBLD2;POSTN;FBLN1;XBP1;EGFR;PRKACA;CORO1B;AKT1;SERPING1;APOE;EHD3;ELK3;PHF21A;ITPR3;DGKQ;TGFBR2;PPARA;PRKACB;CD44;PAK1;GNB1;DOCK9;RHOC;PROCR;GATA3;MYOF;DOCK6;TFPI2;SRC;STXBP1;FYN;WNT5B;MICAL1;TIMP1;RREB1;F12;PTPN12;ZFPM1;P2RX4;HPSE;FGF2;RCOR1;LMAN1;KLK6;MYL9;MAPK3;ADAM15;CEACAM1;CD59;TGFB1;ERBB3;ANXA1;GNAS
12638,GO:0050803,1.96393427282844e-05,0.999993583246289,26,102,regulation of synapse structure or activity,BP,ZMYND8;NFATC4;ADGRL1;WNT7A;NEURL1;PRNP;SSH1;ETV5;THBS2;SHANK3;APOE;DKK1;NLGN2;ADGRB2;IL1RAP;DNM2;FYN;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;CAMK1;EPHB2;SRPX2;ARHGAP44
6565,GO:0022008,2.04971599896244e-05,0.999986933443642,149,1018,neurogenesis,BP,BTBD2;SH3KBP1;ZMYND8;NOS1;CHAC1;SH3TC2;RAC2;SORL1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;SDK2;NEURL1;BOK;CRTC1;DLG4;SERPINE2;DNMT3A;POSTN;PTPRS;IDH2;BNIP3;SSH1;DBNDD1;SMARCA1;NYAP1;FAM129B;SNPH;SEMA3F;ADGRF1;VLDLR;ETV5;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;LAMB1;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;PRKCZ;NAGLU;FZD8;CTSZ;PTK6;PCSK9;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PLCG1;TWF2;BIN1;SUFU;PAK1;SEMA4B;NAV1;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;ANKS1A;IL1RAP;NUMB;TULP3;ALDH1A2;SRC;DNM2;NCS1;STK24;SDCCAG8;RERE;STXBP1;FYN;AGRN;LPAR3;WNT5B;KIF17;MBOAT7;KIF13B;BRSK1;GJC2;ITGA1;FRYL;SEMA4G;FGFR1;ADNP;TENM2;PBX3;SOCS2;LEMD2;UNC119B;ULK1;LRP1;ROBO3;ZNF609;PAK4;ULK2;MAPK9;VASP;CHD7;ATXN10;APBB1;SLIT3;NDE1;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;SOCS7;MAPK3;NTNG1;MAPK10;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;TGFB1;MANF;ERBB3;ANXA1;SLC45A3;ITGA3;TCF7L1;RAP1GAP2;ASAP1;RNF10
13297,GO:0051965,2.06713089717871e-05,0.999996491573819,13,33,positive regulation of synapse assembly,BP,ADGRL1;WNT7A;THBS2;NLGN2;ADGRB2;IL1RAP;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;EPHB2;SRPX2
8504,GO:0033674,2.08375604875921e-05,0.999989006950683,71,413,positive regulation of kinase activity,BP,CCND1;F2R;MST1R;MAP2K1;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;EPHA1;TGFBR2;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;MINK1;ADCY6;TGFB1;ERBB3;TRAF7
4776,GO:0010959,2.17912497354859e-05,0.999990866252758,39,188,regulation of metal ion transport,BP,FHL1;NOS1;F2R;KCNG1;SERPINE2;DLG1;FKBP1A;PRNP;PRKACA;ATF4;HECW2;AKT1;EHD3;ORAI1;PCSK9;STK39;PRSS8;PLCG1;STOM;CEMIP;GNAI2;GRIN3B;WFS1;VAMP2;GLRX;DNM2;SARAF;FYN;LPAR3;GJC2;GAL;NTSR1;HSPA2;P2RX4;CHD7;HOMER2;SLC30A1;TGFB1;STIM1
8159,GO:0032879,2.19871909998609e-05,0.999984741425114,227,1693,regulation of localization,BP,EDEM1;PGF;FHL1;TSPAN1;ZMYND8;NOS1;SH3TC2;F2R;RAC2;SORL1;SDC1;DVL1;MAP2K1;KCNG1;DOCK4;WNT7A;AP3D1;SCN8A;BOK;PCK2;ARAP1;DLG4;SERPINE2;NR1D1;DLG1;FKBP1A;POSTN;RAB3B;ITGA6;RAPGEF3;PRNP;IDH2;LAMA5;SSH1;SMURF2;CYGB;SESN2;BBS2;SEMA3F;BCR;LRP5;FBLN1;XBP1;EVI5L;MAP4K4;EGFR;RTN2;CSNK1E;MMP14;LAMB1;PRKACA;ADARB1;CORO1B;TUB;RHBDF2;HK1;MAP2K2;SHANK3;ATF4;HECW2;SNX33;AKT1;IFITM1;BAG3;APOE;EHD3;ATP13A2;ARG2;PKN1;TMSB4X;PRKCZ;ITPR3;VPS11;VPS4A;EPHA1;ORAI1;PCSK9;FERMT1;RRAS;SEPT5;MSN;MAP1B;TGFBR2;GDI1;HADH;STK39;DKK1;UBE2J1;BNIP3L;PPARA;PRSS8;ZDHHC8;PLCG1;TBC1D16;ATG13;TBC1D14;BIN1;PAK1;TTBK2;MMP10;NLGN2;SEMA4B;DDIT3;PODXL;GLUL;TBC1D9B;STOM;SYTL1;PTPN9;RET;RAB29;LAMC2;RHOC;IFI27;GRB10;REEP2;CEMIP;SHANK2;PARP10;GATA3;APLN;GNAI2;GRIN3B;ASIC1;GLUD1;ALOX15B;IL1RAP;WFS1;PTPRU;ADAM8;MAPKBP1;RHOBTB2;FAM110C;ARL2;NUMB;VAMP2;SRC;LDLRAP1;GLRX;SCG5;DNM2;SARAF;REEP6;LRSAM1;NUCB1;NCS1;STK24;CPTP;GSK3A;STXBP1;SH3BP1;SPINT2;FYN;RAB25;FUZ;PPM1F;LPAR3;WNT5B;PFN1;NISCH;MICAL1;ANXA3;ABHD17C;STX10;GJC2;GAL;COMT;PLTP;NTSR1;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;BCL2L1;ADIPOR1;TRIB3;TPCN1;LRP1;HSPA2;ZNF609;P2RX4;SMPD3;ZP3;TBC1D20;FGF2;EHD4;ARAP3;CHD7;ABCA7;APBB1;RHOBTB1;HOMER2;ARG1;TBC1D2B;VEGFB;CAMSAP3;KCNC4;CAMK1;EPHB2;HGS;CBL;CIB1;RAB4B;MAPK3;ARHGEF2;UGCG;TMBIM1;LLGL1;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;SLC30A1;CCNE1;TGFB1;AZIN2;PIK3R2;ERBB3;ANXA1;GNAS;ITGA3;STIM1;RASA3
3292,GO:0006986,2.56918493000831e-05,0.999989890161416,34,157,response to unfolded protein,BP,EDEM1;CHAC1;CCND1;SHC1;BOK;XBP1;ATF4;PDIA5;SYVN1;YIF1A;TSPYL2;TMEM129;CREB3L2;PPP2R5B;DNAJB5;SEC63;DDIT3;CUL7;UBXN4;HSF1;WFS1;MYDGF;DNAJC4;ACADVL;GSK3A;ASNS;STUB1;HSPA2;VAPB;HSPA13;DNAJB9;MANF;EP300;ERP44
323,GO:0000902,2.67472694094191e-05,0.999983936589523,108,692,cell morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ARAP1;DLG4;DLG1;POSTN;NET1;PTPRS;LAMA5;SSH1;NYAP1;FAM129B;SEMA3F;SYNE3;VLDLR;FBLN1;MAP4K4;EGFR;CSNK1E;LAMB1;ADARB1;CORO1B;STK25;PARVB;SHANK3;HECW2;FBXW8;APOE;FMNL2;PRKCZ;EPHA1;MSN;MAP1B;LAMB2;GDI1;LIMK1;DKK1;OBSL1;WASF2;CD44;PLCG1;TWF2;PAK1;TTBK2;BCL9L;ZNF385A;SEMA4B;CUL7;TUBB3;FARP1;RET;RHOC;GRB10;SHANK2;GATA3;ADAM8;RHOBTB2;NUMB;CAP1;FLNB;SRC;DNM2;AGO4;STK24;RERE;STXBP1;SPINT2;FYN;RAB25;LPAR3;VDR;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;RREB1;ADNP;TENM2;ZFPM1;ULK1;ROBO3;ULK2;TBC1D20;VASP;ARAP3;APBB1;RHOBTB1;SLIT3;WIPF1;IMPACT;EPHB2;CIB1;MAPK3;NTNG1;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ANXA1;EP300
3403,GO:0007186,2.692687027118e-05,0.999986058068664,65,377,G-protein coupled receptor signaling pathway,BP,NOS1;F2R;RAC2;ADGRL1;ADM2;PTHLH;OBSCN;DGKA;NET1;TMOD2;USP20;ADGRF1;HEBP1;HTR7;ADCY7;ATF4;AKT1;APOE;ITPR3;DGKQ;FZD8;GRK6;GIT2;AKAP12;PRKACB;WASF2;MC1R;GIT1;GNB1;RHOC;NXPH4;APLN;GNAI2;ADGRB2;PLCB3;ARHGEF4;GPRC5C;GIPC1;EDNRA;TULP3;SRC;APLP2;SCG5;TGM2;RGS19;GSK3A;AGRN;LPAR3;PLEKHG5;GAL;GNB2;NTSR1;MGLL;SIGMAR1;PCSK1N;LRP1;MGRN1;HOMER2;KLK6;ARHGEF2;ADCY6;ITSN1;TM2D1;ANXA1;GNAS
3390,GO:0007169,2.98360460278668e-05,0.99998323349318,82,500,transmembrane receptor protein tyrosine kinase signaling pathway,BP,XDH;PGF;SH2D2A;SH3KBP1;FAM83A;SH3TC2;MST1R;SHC1;PLAT;NEURL1;ARAP1;IGFBP4;FAM129B;MAPKAPK3;BCR;EGFR;RHBDF2;EPN1;AKT1;ARPC1A;EPN2;AP2A2;PRKCZ;FAM20C;DGKQ;MAPK13;EPHA1;PTK6;MVB12B;PPP2R5B;SHC2;WASF2;PLCG1;IDE;GIT1;PAK1;RET;GRB10;GATA3;APLN;MYOF;ANKS1A;EFS;ARID5B;IGFBP2;EIF4EBP1;SRC;ESRP1;GSK3A;PAG1;DUSP6;FYN;FUZ;ITGA1;CRIM1;FGFR1;SOCS2;STUB1;ADIPOR1;TCIRG1;PTPN12;LRP1;FGF2;SHB;VEGFB;TGFA;BAIAP2L1;ATP6V1C2;EPHB2;HGS;CBL;SOCS7;MAPK3;GIGYF1;CEACAM1;GALNT3;ITSN1;TGFB1;SPRED2;PIK3R2;ERBB3;PXN
12660,GO:0050839,2.99980348192063e-05,0.999984128278299,67,394,cell adhesion molecule binding,MF,MPRIP;LTBP4;ADGRL1;SNX9;BSG;KLC2;DLG1;SLC9A3R2;POSTN;ITGA6;LAMA5;SCYL1;FAM129B;EGFR;MMP14;CORO1B;PPP1R13L;P4HB;EPN2;BAG3;FMNL2;PFKP;MSN;LAMB2;WASF2;ESYT2;TWF2;FSCN1;NLGN2;DOCK9;CADM4;SH3GLB2;ADAM8;PLCB3;NUMB;PLIN3;FLNB;GIPC1;SRC;CHMP5;CAPG;STK24;PAK6;STX5;PFN1;NISCH;WISP1;TENM2;ARFIP2;PAK4;P2RX4;USO1;FGF2;EHD4;VAPB;VASP;EPS8L1;UNC45A;BAIAP2L1;CBL;CSNK1D;ADAM15;LDHA;ANXA1;ITGA3;PXN;ASAP1
18728,GO:1904062,3.03620061476268e-05,0.999987939130851,34,158,regulation of cation transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;DLG4;DLG1;FKBP1A;PRNP;PRKACA;SHANK3;HECW2;EHD3;TMSB4X;PCSK9;STK39;PLCG1;NLGN2;STOM;CEMIP;SHANK2;VAMP2;GLRX;DNM2;FYN;GJC2;GAL;NTSR1;HSPA2;CHD7;EPHB2;MINK1;SLC30A1;TGFB1;STIM1
3450,GO:0007264,3.06615341766079e-05,0.999983230546532,77,457,small GTPase mediated signal transduction,BP,F2R;RAC2;ASAP2;SHC1;DOCK4;ARAP1;OBSCN;RAB3B;NET1;RAPGEF3;RAB43;MAPKAPK3;BCR;RAB31;ARHGAP23;APOE;RIN2;ARHGAP22;GIT2;RRAS;GDI1;LIMK1;SIPA1;SHC2;WASF2;RAP1GDS1;PSD3;GIT1;PAK1;ARHGAP39;FARP1;GNB1;DOCK9;RAB29;RASGEF1A;RHOC;CYTH3;DOCK6;APPL2;RGL2;RHOBTB2;ARHGEF4;SRC;DNM2;RFXANK;RAB1B;RGS19;PAK6;SH3BP1;RAB25;RALGDS;NISCH;PLEKHG5;RREB1;DNMBP;ARFIP2;ARFGEF2;PAK4;FGF2;ARAP3;RHOBTB1;EPS8L1;EPHB2;RAB4B;IQSEC1;ARHGEF2;OCRL;ARHGAP44;AGAP1;ITSN1;PIK3R2;RAB6A;ITGA3;ARHGEF10L;RAP1GAP2;RASA3;ASAP1
6593,GO:0022603,3.13882175140769e-05,0.999981022005858,109,714,regulation of anatomical structure morphogenesis,BP,ANGPTL4;XDH;PGF;SH3KBP1;NFATC4;DVL1;MAP2K1;ADM2;WNT7A;CST3;ARAP1;DLG4;DLG1;POSTN;PSMD2;NET1;RAPGEF3;PTPRS;BNIP3;SSH1;SMURF2;FAM129B;SEMA3F;BCR;SYNE3;ETV5;FBLN1;XBP1;CSNK1E;THBS2;CORO1B;EPN1;STK25;PARVB;SHANK3;HECW2;FBXW8;GPC4;EPN2;APOE;FMNL2;PKN1;AP2A2;EPHA1;RRAS;MSN;MAP1B;TGFBR2;GDI1;LIMK1;DKK1;OBSL1;CD44;PLCG1;TWF2;PAK1;SP6;TTBK2;BCL9L;SEMA4B;CUL7;RET;RHOC;GATA3;ADGRB2;HMGA2;RHOBTB2;MYDGF;SRC;DNM2;AGO4;DUSP6;FYN;FUZ;LPAR3;PFN1;PSMD7;ANXA3;VDR;KIF13B;GAL;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PAK4;ULK2;FGF2;RNH1;ARAP3;RHOBTB1;RXRA;VEGFB;WIPF1;VAT1;CAMK1;EPHB2;HGS;CIB1;CSNK1D;TMBIM1;SRPX2;CEACAM1;ARHGAP44;ECM1;TGFB1;ANXA1;STIM1
12819,GO:0051094,3.14158871296711e-05,0.999980317817653,124,831,positive regulation of developmental process,BP,ANGPTL4;PGF;ZMYND8;CCND1;CTNNBIP1;ADGRL1;DVL1;MAP2K1;ADM2;WNT7A;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;NET1;RAPGEF3;BNIP3;SMURF2;FAM129B;BBS2;VLDLR;ETV5;LRP5;ACVR2B;XBP1;CSNK1E;CCDC71L;MMP14;THBS2;CORO1B;PPP1R13L;STK25;SHANK3;FBXW8;AKT1;IFITM1;APOE;FAM210B;ARG2;WWTR1;PRKCZ;FAM20C;EPHA1;PTK6;SH3PXD2B;RRAS;MAP1B;TGFBR2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PLCG1;TWF2;BIN1;PAK1;BCL9L;ZNF385A;NLGN2;RAG1;CUL7;RET;SHANK2;GATA3;HSF1;ADGRB2;ALOX15B;IL1RAP;ADAM8;HMGA2;NUMB;MYDGF;SRC;DNM2;YPEL3;FYN;CLSTN1;AGRN;LPAR3;WNT5B;ANXA3;VDR;GJC2;GAL;THRA;AMIGO2;HSF4;FGFR1;RREB1;ADNP;HYAL1;SOCS2;ZNF609;PAK4;HPSE;ZP3;PNP;FGF2;MAPK9;CHD7;APBB1;ZHX3;VEGFB;TPBG;IMPACT;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;SRPX2;CEACAM1;ECM1;TGFB1;ERBB3;ANXA1;GNAS;ITGA3;WDFY2;STIM1;RNF10
12917,GO:0051240,3.14543943164755e-05,0.999979751925307,142,981,positive regulation of multicellular organismal process,BP,ANGPTL4;PGF;ZMYND8;NOS1;CCND1;F2R;CTNNBIP1;NFATC4;ADGRL1;DVL1;MAP2K1;ADM2;WNT7A;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;POSTN;RAPGEF3;SMURF2;FAM129B;BBS2;VLDLR;ETV5;ACVR2B;XBP1;EGFR;CSNK1E;MMP14;THBS2;HK1;STK25;SHANK3;ATF4;FBXW8;AKT1;IFITM1;CARD11;IRAK1;APOE;FAM210B;WWTR1;TMSB4X;PRKCZ;RNF135;FAM20C;MAPK13;EPHA1;PTK6;SH3PXD2B;FERMT1;RRAS;MAP1B;TGFBR2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PLCG1;TWF2;BIN1;PAK1;BCL9L;NLGN2;RAG1;DDIT3;CUL7;RET;SHANK2;GATA3;APLN;HSF1;ADGRB2;ALOX15B;IL1RAP;ADAM8;HMGA2;NUMB;MYDGF;SRC;IRF7;GSK3A;FYN;RAB25;CLSTN1;AGRN;PPM1F;LPAR3;PFN1;ANXA3;VDR;GJC2;GAL;PUM1;AMIGO2;FGFR1;RREB1;ADNP;HYAL1;F12;MIF;SOCS2;SLC27A1;ZFPM1;ARFGEF2;LRP1;ZNF609;PAK4;P2RX4;HPSE;ZP3;PNP;FGF2;CHD7;ABCA7;APBB1;ZHX3;VEGFB;SEC14L1;TPBG;IMPACT;CAMK1;EPHB2;CIB1;MAPK3;CSNK1D;ARHGEF2;TMBIM1;SRPX2;CEACAM1;ECM1;TGFB1;ERBB3;ANXA1;GNAS;ITGA3;EP300;STIM1;RNF10
19788,GO:2000145,3.21298966830908e-05,0.999981388004527,91,572,regulation of cell motility,BP,PGF;ZMYND8;F2R;RAC2;SORL1;DOCK4;WNT7A;SERPINE2;POSTN;ITGA6;IDH2;LAMA5;SSH1;SMURF2;CYGB;BBS2;SEMA3F;BCR;FBLN1;XBP1;EGFR;MMP14;LAMB1;ADARB1;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;EPHA1;RRAS;MSN;TGFBR2;PLCG1;PAK1;TTBK2;MMP10;SEMA4B;PODXL;RET;LAMC2;RHOC;CEMIP;GATA3;ALOX15B;PTPRU;ADAM8;RHOBTB2;FAM110C;NUMB;SRC;STK24;SH3BP1;SPINT2;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;CAMSAP3;CIB1;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;ERBB3;ANXA1;ITGA3
12437,GO:0048870,3.36394596281561e-05,0.999978401179737,139,956,cell motility,BP,PGF;SH3KBP1;ITGB4;TSPAN1;ZMYND8;F2R;RAC2;SORL1;SDC1;MAP2K1;SHC1;DOCK4;PLAT;WNT7A;NEURL1;SERPINE2;BSG;SLC16A3;MMP1;POSTN;ITGA6;NET1;PRSS3;IDH2;LAMA5;SSH1;SMURF2;CYGB;BBS2;SEMA3F;BCR;LRP5;FBLN1;XBP1;EGFR;MMP14;LAMB1;ADARB1;PTPRF;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;RRAS;MSN;TGFBR2;WASF2;CD44;PLCG1;FSCN1;PAK1;TTBK2;MMP10;SEMA4B;NAV1;PODXL;RET;RASGEF1A;LAMC2;RHOC;PROCR;CEMIP;GATA3;ANKS1A;ALOX15B;FAT1;EFS;PTPRU;ADAM8;ARID5B;RHOBTB2;FAM110C;NUMB;CAP1;PIP5K1C;GIPC1;SRC;CDC42BPB;STK24;PAK6;SDCCAG8;RERE;SH3BP1;SPINT2;FYN;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;MBOAT7;ELMO3;PLEKHG5;ITGA1;PLTP;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;PAK4;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;NDE1;CAMSAP3;GAS8;CIB1;SOCS7;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;PIK3R2;ERBB3;ANXA1;PODXL2;ITGA3;PXN
13147,GO:0051674,3.36394596281561e-05,0.999978401179737,139,956,localization of cell,BP,PGF;SH3KBP1;ITGB4;TSPAN1;ZMYND8;F2R;RAC2;SORL1;SDC1;MAP2K1;SHC1;DOCK4;PLAT;WNT7A;NEURL1;SERPINE2;BSG;SLC16A3;MMP1;POSTN;ITGA6;NET1;PRSS3;IDH2;LAMA5;SSH1;SMURF2;CYGB;BBS2;SEMA3F;BCR;LRP5;FBLN1;XBP1;EGFR;MMP14;LAMB1;ADARB1;PTPRF;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;RRAS;MSN;TGFBR2;WASF2;CD44;PLCG1;FSCN1;PAK1;TTBK2;MMP10;SEMA4B;NAV1;PODXL;RET;RASGEF1A;LAMC2;RHOC;PROCR;CEMIP;GATA3;ANKS1A;ALOX15B;FAT1;EFS;PTPRU;ADAM8;ARID5B;RHOBTB2;FAM110C;NUMB;CAP1;PIP5K1C;GIPC1;SRC;CDC42BPB;STK24;PAK6;SDCCAG8;RERE;SH3BP1;SPINT2;FYN;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;MBOAT7;ELMO3;PLEKHG5;ITGA1;PLTP;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;PAK4;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;NDE1;CAMSAP3;GAS8;CIB1;SOCS7;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;PIK3R2;ERBB3;ANXA1;PODXL2;ITGA3;PXN
12631,GO:0050793,3.41666719326195e-05,0.999976070563357,221,1658,regulation of developmental process,BP,ANGPTL4;XDH;PGF;SH3KBP1;ZMYND8;NOS1;CCND1;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;DVL1;MAP2K1;ADM2;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;AP3D1;CRTC1;ARAP1;DLG4;SERPINE2;NR1D1;DLG1;POSTN;PSMD2;NET1;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;WWC3;SMURF2;FAM129B;BBS2;SEMA3F;BCR;SYNE3;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;EGFR;CSNK1E;CCDC71L;MMP14;THBS2;PRKACA;PTPRF;CORO1B;EPN1;PPP1R13L;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;IFITM1;CARD11;GPC4;EPN2;APOE;FAM210B;FMNL2;ARG2;PKN1;WWTR1;AP2A2;PRKCZ;FAM20C;CTSZ;EPHA1;PTK6;SH3PXD2B;FERMT1;RRAS;DEAF1;MSN;MAP1B;TGFBR2;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;PPARA;OBSL1;PRKACB;CD44;PLCG1;TWF2;TFE3;BIN1;SUFU;PAK1;SP6;TTBK2;BCL9L;ZNF385A;NLGN2;RAG1;SEMA4B;GAMT;DDIT3;CUL7;ADAMTS7;PTPN9;RET;RAB29;RHOC;SHANK2;GATA3;TCFL5;HSF1;ADGRB2;ALOX15B;IL1RAP;ADAM8;RAI1;HMGA2;RHOBTB2;NUMB;MYDGF;TULP3;SRC;DNM2;AGO4;IRF7;NCS1;STK24;YPEL3;GSK3A;DUSP6;FYN;CLSTN1;FUZ;AGRN;LPAR3;WNT5B;PFN1;PSMD7;TNFRSF1A;ANXA3;VDR;KIF13B;GJC2;GAL;CTSL;TNRC6B;THRA;AMIGO2;TIMP1;HSF4;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;MIF;SOCS2;ADIPOR1;TRIB3;ZFPM1;LRP1;TRIB2;ZNF609;PAK4;HPSE;ULK2;ZP3;PNP;FGF2;RNH1;MAPK9;ARAP3;CHD7;APBB1;RHOBTB1;RXRA;ZHX3;VEGFB;TPBG;WIPF1;IMPACT;KLK6;VAT1;CAMK1;EPHB2;HGS;MYL9;CIB1;CSNK1D;ARHGEF2;TMBIM1;SRPX2;CEACAM1;ARHGAP44;ECM1;ADCY6;TGFB1;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;WDFY2;RAP1GAP2;STIM1;ASAP1;RNF10
3186,GO:0006811,3.54890126303461e-05,0.999977616604788,126,862,ion transport,BP,FHL1;NOS1;F2R;SERINC2;PITPNC1;KCNG1;CYP27B1;SCN8A;SLCO4A1;DLG4;CPT2;SERPINE2;BSG;DLG1;SLC16A3;PITPNM1;FKBP1A;RAB3B;SLC2A9;PRNP;LCN2;OSBPL10;TTYH3;SLC12A7;PRKACA;SHANK3;ATF4;HECW2;AKT1;APOE;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PPARA;PRSS8;PLCG1;OSBPL5;SLC38A10;SFXN3;NLGN2;DDIT3;STOM;CEMIP;SHANK2;PKD1;DLG3;ATP11A;NIPA1;ANO8;GNAI2;SLC2A3;GRIN3B;ASIC1;WFS1;SLC12A4;ASPH;FAM155B;SLC6A6;SLC13A3;SLC43A1;VAMP2;GIPC1;GLRX;DNM2;SARAF;NDUFA4L2;NCS1;CPTP;STXBP1;FYN;LPAR3;SLC6A9;SLC33A1;VDR;GJC2;GAL;SLC13A5;PLTP;NTSR1;SLC35B4;FGFR1;ATP2C2;LRRC8A;MIF;VPS9D1;PRAF2;TCIRG1;PITPNM2;SLC27A1;TPCN1;SLC6A14;HSPA2;P2RX4;FGF2;CHD7;ABCA7;HOMER2;RXRA;ARG1;SLC10A6;SEC14L1;ATP6V1C2;KCNC4;EPHB2;CPT1B;SLC5A1;CEACAM1;APBA1;MINK1;SLC30A1;TGFB1;PCYOX1;SLC15A1;AZIN2;STARD10;ANXA1;ORAI3;STIM1;RASA3
10819,GO:0044297,3.68281346922878e-05,0.999981553171081,56,312,cell body,CC,DVL1;CST3;NEURL1;CRTC1;PITPNM1;PTPRS;CYGB;SNPH;PTPRF;ACTA2;APOE;ATP13A2;PRKCZ;ITPR3;PI4K2A;ENDOG;MAP1B;GDI1;ZNF385A;GLUL;TUBB3;GNB1;RET;SHANK2;DLG3;GNAI2;GRIN3B;TOP1;GSK3A;NRSN2;ANXA3;GJC2;GAL;ITGA1;GNB2;COMT;NTSR1;WDFY3;ADNP;PITPNM2;LRP1;P2RX4;KLHL17;MYO1D;ATXN10;APBB1;HOMER2;ARG1;RPL28;KCNC4;EPHB2;CIB1;ARHGEF2;TGFB1;AZIN2;CAMK2N1
5518,GO:0016477,3.83213556563039e-05,0.999975517225752,130,884,cell migration,BP,PGF;SH3KBP1;TSPAN1;ZMYND8;F2R;RAC2;SORL1;SDC1;SHC1;DOCK4;PLAT;WNT7A;SERPINE2;BSG;SLC16A3;MMP1;POSTN;ITGA6;NET1;PRSS3;IDH2;LAMA5;SSH1;SMURF2;CYGB;SEMA3F;BCR;LRP5;XBP1;EGFR;MMP14;LAMB1;ADARB1;PTPRF;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;RRAS;MSN;TGFBR2;WASF2;CD44;PLCG1;FSCN1;PAK1;TTBK2;MMP10;SEMA4B;NAV1;PODXL;RET;RASGEF1A;LAMC2;RHOC;PROCR;CEMIP;GATA3;ANKS1A;ALOX15B;FAT1;EFS;PTPRU;ADAM8;ARID5B;RHOBTB2;FAM110C;NUMB;CAP1;PIP5K1C;GIPC1;SRC;CDC42BPB;STK24;PAK6;SDCCAG8;RERE;SH3BP1;FYN;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;MBOAT7;ELMO3;PLEKHG5;ITGA1;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;PAK4;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;NDE1;CAMSAP3;CIB1;SOCS7;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;PIK3R2;ANXA1;PODXL2;ITGA3;PXN
6690,GO:0030055,3.97996807831793e-05,0.999979357001681,61,360,cell-substrate junction,CC,FLNC;FHL1;SH3KBP1;ITGB4;CAPN2;MPRIP;RAC2;MAP2K1;BSG;SLC9A3R2;ITGA6;MRC2;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PARVB;P4HB;EHD3;TNS4;ARHGAP22;FERMT1;GIT2;RRAS;MSN;CD99;LIMK1;AKAP12;CD44;GIT1;PAK1;PROCR;FAT1;ARL2;NUMB;CAP1;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;PFN1;ITGA1;GNB2;MISP;AFAP1;PTPN12;LRP1;PAK4;VASP;SNTB2;CBL;MAPK3;ARHGEF2;CD59;CAT;ANXA1;ZFYVE21;ITGA3;PXN
9416,GO:0035966,4.21787476330091e-05,0.9999824061689,36,174,response to topologically incorrect protein,BP,EDEM1;CHAC1;CCND1;SHC1;BOK;XBP1;ATF4;PDIA5;SYVN1;YIF1A;TSPYL2;TMEM129;CREB3L2;PPP2R5B;DNAJB5;SEC63;DDIT3;CUL7;UBXN4;HSF1;WFS1;MYDGF;DNAJC4;ACADVL;GSK3A;ASNS;F12;STUB1;HSPA2;VAPB;HSPA13;POMT1;DNAJB9;MANF;EP300;ERP44
12793,GO:0051049,4.31237751026467e-05,0.99997136216735,157,1117,regulation of transport,BP,EDEM1;FHL1;TSPAN1;NOS1;SH3TC2;F2R;RAC2;SORL1;SDC1;MAP2K1;KCNG1;SCN8A;BOK;PCK2;DLG4;SERPINE2;NR1D1;DLG1;FKBP1A;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;BCR;LRP5;XBP1;EVI5L;MAP4K4;EGFR;RTN2;PRKACA;TUB;RHBDF2;HK1;MAP2K2;SHANK3;ATF4;HECW2;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS11;VPS4A;ORAI1;PCSK9;FERMT1;SEPT5;MSN;MAP1B;GDI1;HADH;STK39;DKK1;UBE2J1;BNIP3L;PPARA;PRSS8;ZDHHC8;PLCG1;TBC1D16;ATG13;TBC1D14;BIN1;PAK1;NLGN2;GLUL;TBC1D9B;STOM;SYTL1;RAB29;IFI27;GRB10;REEP2;CEMIP;SHANK2;PARP10;GATA3;APLN;GNAI2;GRIN3B;ASIC1;GLUD1;ALOX15B;IL1RAP;WFS1;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;LDLRAP1;GLRX;SCG5;DNM2;SARAF;REEP6;LRSAM1;NUCB1;NCS1;CPTP;GSK3A;STXBP1;FYN;RAB25;LPAR3;MICAL1;GJC2;GAL;COMT;PLTP;NTSR1;FGFR1;MIF;TRIB3;TPCN1;LRP1;HSPA2;P2RX4;SMPD3;ZP3;TBC1D20;EHD4;ARAP3;CHD7;ABCA7;APBB1;HOMER2;ARG1;TBC1D2B;KCNC4;CAMK1;EPHB2;HGS;CBL;CIB1;RAB4B;MAPK3;UGCG;LLGL1;CEACAM1;MINK1;SLC30A1;TGFB1;AZIN2;PIK3R2;ERBB3;ANXA1;GNAS;STIM1
2617,GO:0005925,4.82673842746027e-05,0.999974919292817,60,355,focal adhesion,CC,FLNC;FHL1;SH3KBP1;CAPN2;MPRIP;RAC2;MAP2K1;BSG;SLC9A3R2;ITGA6;MRC2;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PARVB;P4HB;EHD3;TNS4;ARHGAP22;FERMT1;GIT2;RRAS;MSN;CD99;LIMK1;AKAP12;CD44;GIT1;PAK1;PROCR;FAT1;ARL2;NUMB;CAP1;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;PFN1;ITGA1;GNB2;MISP;AFAP1;PTPN12;LRP1;PAK4;VASP;SNTB2;CBL;MAPK3;ARHGEF2;CD59;CAT;ANXA1;ZFYVE21;ITGA3;PXN
4267,GO:0009611,5.04007023719605e-05,0.999972574070267,69,419,response to wounding,BP,ITGB4;F2R;RAC2;SDC1;MAP2K1;PLAT;WNT7A;CST3;SERPINE2;DYSF;DGKA;DCBLD2;POSTN;PTPRS;FBLN1;XBP1;EGFR;PRKACA;PTPRF;CORO1B;AKT1;SERPING1;APOE;EHD3;ELK3;PHF21A;ITPR3;DGKQ;TGFBR2;LAMB2;PPARA;PRKACB;CD44;PAK1;GNB1;DOCK9;RHOC;PROCR;GATA3;MYOF;DOCK6;TFPI2;SRC;STK24;STXBP1;FYN;WNT5B;MICAL1;TIMP1;RREB1;F12;PTPN12;ZFPM1;P2RX4;HPSE;FGF2;RCOR1;LMAN1;ARG1;KLK6;MYL9;MAPK3;ADAM15;CEACAM1;CD59;TGFB1;ERBB3;ANXA1;GNAS
2616,GO:0005924,5.21594597915107e-05,0.999972814838062,60,356,cell-substrate adherens junction,CC,FLNC;FHL1;SH3KBP1;CAPN2;MPRIP;RAC2;MAP2K1;BSG;SLC9A3R2;ITGA6;MRC2;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PARVB;P4HB;EHD3;TNS4;ARHGAP22;FERMT1;GIT2;RRAS;MSN;CD99;LIMK1;AKAP12;CD44;GIT1;PAK1;PROCR;FAT1;ARL2;NUMB;CAP1;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;PFN1;ITGA1;GNB2;MISP;AFAP1;PTPN12;LRP1;PAK4;VASP;SNTB2;CBL;MAPK3;ARHGEF2;CD59;CAT;ANXA1;ZFYVE21;ITGA3;PXN
7287,GO:0031267,5.23097414465728e-05,0.999970692153127,75,447,small GTPase binding,MF,ASAP2;SORL1;DVL1;SHC1;DOCK4;ARAP1;DLG4;OBSCN;XPOT;NET1;RAPGEF3;SBF1;BCR;EVI5L;EGFR;FMNL2;RIN2;PKN1;RABGGTA;GIT2;GDI1;RIN1;YIPF2;SHC2;IPO13;TBC1D16;TBC1D14;GIT1;PAK1;DMXL2;TBC1D9B;GGA3;GGA1;FARP1;SYTL1;RET;RAB29;RASGEF1A;APPL2;RGL2;ARHGEF4;DENND2A;CDC42BPB;PAK6;EXOC2;SH3BP1;FYN;PFN1;MICAL1;PLEKHG5;FGFR1;RAB11FIP4;DNMBP;ARFIP2;ULK1;PAK4;TBC1D20;FGF2;ARAP3;EPS8L1;TBC1D2B;GAS8;TRAPPC1;CIB1;ARHGEF2;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;ITSN1;PPP6R1;ERBB3;ARHGEF10L;ASAP1
6869,GO:0030334,5.35990315952743e-05,0.999968748042692,86,540,regulation of cell migration,BP,PGF;ZMYND8;F2R;RAC2;SORL1;DOCK4;WNT7A;SERPINE2;POSTN;ITGA6;IDH2;LAMA5;SSH1;SMURF2;CYGB;SEMA3F;BCR;XBP1;EGFR;MMP14;LAMB1;ADARB1;CORO1B;AKT1;IFITM1;APOE;TMSB4X;EPHA1;RRAS;MSN;TGFBR2;PLCG1;PAK1;TTBK2;MMP10;SEMA4B;PODXL;RET;LAMC2;RHOC;CEMIP;GATA3;ALOX15B;PTPRU;ADAM8;RHOBTB2;FAM110C;NUMB;SRC;STK24;SH3BP1;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;CAMSAP3;CIB1;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;ANXA1;ITGA3
12771,GO:0051020,5.50625030477329e-05,0.999967987485602,85,524,GTPase binding,MF,ASAP2;SORL1;DVL1;SHC1;DOCK4;ARAP1;DLG4;OBSCN;XPOT;NET1;RAPGEF3;BNIP3;SBF1;BCR;EVI5L;EGFR;FMNL2;RIN2;PKN1;RABGGTA;GIT2;GDI1;RIN1;YIPF2;SHC2;IPO13;TBC1D16;TBC1D14;PSD3;GIT1;PAK1;DMXL2;TBC1D9B;GGA3;GGA1;FARP1;GNB1;SYTL1;DOCK9;RET;RAB29;RASGEF1A;CYTH3;DOCK6;APPL2;RGL2;ARHGEF4;DENND2A;CDC42BPB;PAK6;EXOC2;SH3BP1;FYN;RALGDS;PFN1;MICAL1;PLEKHG5;GNB2;FGFR1;RAB11FIP4;DNMBP;ARFIP2;ARFGEF2;ULK1;PAK4;TBC1D20;FGF2;ARAP3;EPS8L1;TBC1D2B;GAS8;TRAPPC1;CIB1;IQSEC1;ARHGEF2;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;ITSN1;PPP6R1;ERBB3;ARHGEF10L;ASAP1
12641,GO:0050806,5.66624415717266e-05,0.999982183112989,22,85,positive regulation of synaptic transmission,BP,DVL1;WNT7A;CRTC1;DLG4;SERPINE2;RAB3B;PRNP;SSH1;EGFR;SHANK3;APOE;PRKCZ;ITPR3;NLGN2;GLUL;SHANK2;VAMP2;STXBP1;CLSTN1;NTSR1;EPHB2;PAIP2
13760,GO:0060312,5.90860355440338e-05,0.999998911082714,5,6,regulation of blood vessel remodeling,BP,CST3;BCR;TMBIM1;CEACAM1;TGFB1
10746,GO:0044093,6.29342193300762e-05,0.999956877722738,173,1259,positive regulation of molecular function,BP,XDH;NOS1;CCND1;F2R;MST1R;RBCK1;ASAP2;SORL1;MAP2K1;SERINC2;SHC1;DOCK4;ERCC6;CYP27B1;NEURL1;SNX9;LMF1;BOK;CRTC1;ARAP1;DLG4;DLG1;DAP;FKBP1A;ITGA6;NET1;RAPGEF3;PRNP;FAM129B;MAPKAPK3;ADGRF1;BCR;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;EVI5L;MAP4K4;EGFR;MMP14;ARHGAP23;PRKACA;MAP2K2;STK25;SHANK3;AKT1;CARD11;IRAK1;APOE;EHD3;RIN2;PKN1;TMSB4X;PRKCZ;DGKQ;RFNG;ARHGAP22;FZD8;PITRM1;EPHA1;SH3PXD2B;GIT2;TGFBR2;GDI1;RIN1;STK39;DKK1;SOX7;PPP2R5B;PRKACB;SIPA1;SHC2;PLCG1;TBC1D16;RAP1GDS1;ATG13;MAP3K9;LARP6;TBC1D14;CCND2;GIT1;PAK1;DDIT3;TNFSF15;TBC1D9B;ARHGAP39;DOCK9;RET;RHOC;IFI27;CEMIP;PKD1;DLG3;GATA3;GNAI2;HSF1;IL1RAP;ASPH;ADAM8;HMGA2;ARID5B;EDNRA;SRC;GLRX;DNM2;FAM162A;STPG1;STK24;RGS19;PAK6;GSK3A;SH3BP1;DUSP6;FYN;AGRN;PPM1F;LPAR3;PFN1;ANXA3;VDR;GAL;ITGA1;NTSR1;MAP3K10;FGFR1;ADNP;MFNG;MIF;STUB1;MAU2;VPS9D1;DNMBP;TRIB3;SLC27A1;LRP1;HSPA2;PAK4;TBC1D20;FGF2;VAPB;MAP3K12;ARAP3;TAOK1;TBC1D2B;TGFA;CASP4;CAMK1;EPHB2;CIB1;IQSEC1;MAPK3;MAPK10;ARHGEF2;LLGL1;OCRL;MINK1;ARHGAP44;AGAP1;SRGAP2B;ADCY6;TGFB1;SH3PXD2A;CAT;AZIN2;PIK3R2;ERBB3;EP300;RAP1GAP2;STIM1;RASA3;ASAP1;TRAF7
17711,GO:1901565,6.85298950861871e-05,0.999954897207005,138,980,organonitrogen compound catabolic process,BP,NT5E;EDEM1;XDH;BTBD2;CBS;NOS1;CHAC1;GID4;CAPN2;RBCK1;SORL1;SDC1;DVL1;CST3;SNX9;SHARPIN;SERPINE2;NR1D1;PSMD2;MTA1;RAPGEF3;BNIP3;SMURF2;CTSB;ABTB1;RNPEPL1;USP20;LPCAT1;VLDLR;GPT2;XBP1;EGFR;CSNK1E;PANO1;PRKACA;HECW2;SNX33;AKT1;GPC4;ALDH1L2;APOE;ATP13A2;ARG2;SYVN1;WWTR1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;TMEM129;FBXO2;PCSK9;FBXW5;MSN;MVB12B;UBE2J1;ARRDC1;BNIP3L;TST;CDC34;CD44;IDE;ANKIB1;HMGCL;SUFU;AHCY;CTBS;DDIT3;GLUL;CUL7;GGA3;GGA1;ADAMTS7;FUCA1;CEMIP;PKD1;UBXN4;GGACT;GLUD1;WFS1;ADAM8;NEIL1;BLMH;GIPC1;UBR4;LRSAM1;STX5;GSK3A;FYN;AGRN;RMND5A;ALDH4A1;PSMD7;ALDH7A1;FBXL15;ABHD17C;RNF44;CTSL;COMT;TIMP1;UBA1;RNF187;HYAL1;VPS37A;STUB1;TRIB3;TCIRG1;RMND5B;RAD23A;LRP1;TRIB2;AOX1;HPSE;SMPD3;PNP;FGF2;RNF222;ARG1;SPSB3;LONP2;HGS;CBL;GGT1;USP32;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;HM13;CEACAM1;NAGA;TGFB1;PCYOX1;AZIN2;APOBEC3C
9801,GO:0040011,6.87520479032795e-05,0.999953685411428,155,1101,locomotion,BP,PGF;SH3KBP1;ITGB4;TSPAN1;ZMYND8;F2R;RAC2;SORL1;SDC1;DVL1;MAP2K1;SHC1;DOCK4;PLAT;WNT7A;NEURL1;SERPINE2;BSG;CMTM4;SLC16A3;MMP1;POSTN;ITGA6;NET1;PRSS3;IDH2;PC;LAMA5;SSH1;SMURF2;CYGB;FAM129B;BBS2;SEMA3F;BCR;VLDLR;LRP5;FBLN1;XBP1;CMTM7;EGFR;MMP14;LAMB1;ADARB1;PTPRF;CORO1B;SHANK3;AKT1;IFITM1;APOE;PKN1;TMSB4X;PRKCZ;VPS4A;EPHA1;PTK6;FERMT1;RRAS;MSN;TGFBR2;LAMB2;WASF2;CD44;PLCG1;FSCN1;PAK1;TTBK2;MMP10;SEMA4B;NAV1;PODXL;TUBB3;RET;RASGEF1A;LAMC2;RHOC;GRB10;PROCR;CEMIP;GATA3;ANKS1A;ALOX15B;FAT1;EFS;PTPRU;ADAM8;ARID5B;RHOBTB2;FAM110C;NUMB;CAP1;PIP5K1C;GIPC1;SRC;CDC42BPB;STK24;PAK6;SDCCAG8;RERE;SH3BP1;SPINT2;FYN;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;MBOAT7;ELMO3;PLEKHG5;ITGA1;PLTP;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ROBO3;ZNF609;PAK4;P2RX4;ZP3;FGF2;VASP;ARAP3;RHOBTB1;SLIT3;VEGFB;NDE1;CAMSAP3;EPHB2;GAS8;CIB1;SOCS7;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;PIK3R2;ERBB3;ANXA1;PODXL2;ITGA3;PLGRKT;PXN
3565,GO:0007610,7.11160637146822e-05,0.999963530551452,55,311,behavior,BP,DVL1;ADM2;CST3;CRTC1;DLG4;SERPINE2;MTA1;PRNP;TMOD2;ESPN;BBS2;ADGRF1;VLDLR;ETV5;EGFR;ADARB1;SHANK3;APOE;PRKCZ;ITPR3;NAGLU;DEAF1;DKK1;PPARA;ZDHHC8;CCND2;AHCY;ZNF385A;NLGN2;RAG1;SHANK2;APLN;ASIC1;WFS1;DYNLRB1;B4GALT2;PER3;FYN;VWA1;GAL;PUM1;COMT;THRA;NTSR1;ADNP;PBX3;CHD7;ABCA7;HOMER2;EPHB2;SRPX2;PAIP2;APBA1;ITGA3;ARCN1
8235,GO:0032989,7.81377142472546e-05,0.999950510889331,113,751,cellular component morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ARAP1;DLG4;OBSCN;DLG1;POSTN;NET1;PTPRS;LAMA5;SSH1;NYAP1;TMOD2;FAM129B;TNNT1;SEMA3F;SYNE3;VLDLR;FBLN1;MAP4K4;EGFR;CSNK1E;LAMB1;RFX2;ADARB1;CORO1B;STK25;PARVB;SHANK3;HECW2;FBXW8;APOE;FMNL2;PRKCZ;EPHA1;MSN;MAP1B;LAMB2;GDI1;LIMK1;DKK1;OBSL1;WASF2;CD44;PLCG1;TWF2;PAK1;TTBK2;BCL9L;ZNF385A;SEMA4B;CUL7;TUBB3;FARP1;RET;RHOC;GRB10;SHANK2;GATA3;ADAM8;RHOBTB2;NUMB;CAP1;FLNB;SRC;DNM2;AGO4;STK24;RERE;STXBP1;SPINT2;FYN;RAB25;LPAR3;VDR;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;RREB1;ADNP;TENM2;BCL2L1;ZFPM1;ULK1;ROBO3;ULK2;TBC1D20;VASP;ARAP3;APBB1;RHOBTB1;SLIT3;WIPF1;IMPACT;EPHB2;CIB1;MAPK3;NTNG1;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ANXA1;EP300
12354,GO:0048699,8.22570587993295e-05,0.999945737171612,137,946,generation of neurons,BP,SH3KBP1;ZMYND8;NOS1;RAC2;SORL1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;SDK2;NEURL1;CRTC1;DLG4;SERPINE2;DNMT3A;POSTN;PTPRS;IDH2;SSH1;DBNDD1;SMARCA1;NYAP1;FAM129B;SNPH;SEMA3F;ADGRF1;VLDLR;ETV5;XBP1;MAP4K4;EGFR;CSNK1E;LAMB1;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;PRKCZ;NAGLU;FZD8;CTSZ;PTK6;PCSK9;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PLCG1;TWF2;BIN1;SUFU;PAK1;SEMA4B;NAV1;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;ANKS1A;IL1RAP;NUMB;TULP3;ALDH1A2;SRC;DNM2;NCS1;STK24;SDCCAG8;RERE;STXBP1;FYN;AGRN;LPAR3;WNT5B;KIF13B;BRSK1;GJC2;ITGA1;FRYL;SEMA4G;FGFR1;ADNP;TENM2;PBX3;SOCS2;UNC119B;ULK1;LRP1;ROBO3;ZNF609;PAK4;ULK2;MAPK9;VASP;CHD7;ATXN10;APBB1;SLIT3;NDE1;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;MAPK3;NTNG1;MAPK10;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;TGFB1;MANF;SLC45A3;ITGA3;TCF7L1;RAP1GAP2;ASAP1;RNF10
2214,GO:0005102,8.71521921498975e-05,0.999943201566313,126,884,signaling receptor binding,MF,PGF;ITGB4;CHAC1;F2R;LTBP4;NFATC4;DVL1;ADM2;SHC1;DOCK4;PLAT;WNT7A;PTHLH;BOK;ARAP1;DLG4;SERPINE2;DLG1;CMTM4;IGFBP4;PITPNM1;SLC9A3R2;FKBP1A;ITGA6;PRNP;LAMA5;SMURF2;SEMA3F;USP20;CMTM7;EGFR;MMP14;CRAT;SHANK3;P4HB;APOE;PKN1;FZD8;PTK6;PCSK9;EML2;MSN;TGFBR2;LAMB2;DKK1;SHC2;PLCG1;IDE;PRDX5;HMGCL;NLGN2;SEMA4B;BAZ2A;TNFSF15;GNB1;SYTL1;GAS2L1;NXPH4;GRB10;REEP2;SHANK2;DLG3;GATA3;APLN;OASL;CADM4;GNAI2;ANKS1A;IGFBP2;CLEC11A;GIPC1;SRC;LDLRAP1;DNM2;GSK3A;PAG1;SH3BP1;FYN;WNT5B;NISCH;WISP1;VDR;GAL;ITGA1;TIMP1;SEMA4G;FGFR1;MIF;SOCS2;STUB1;PCSK1N;PITPNM2;SNX25;ARFGEF2;LRP1;P2RX4;ZP3;FGF2;MLYCD;EPS8L1;SLIT3;HOMER2;RXRA;TAF6;VEGFB;TGFA;SEC14L1;LONP2;EPHB2;CBL;TMBIM1;ADAM15;SRPX2;ECM1;CCNE1;TGFB1;WBP2;MANF;CAT;SPRED2;PIK3R2;ANXA1;GNAS;ITGA3;PXN;EP300
16990,GO:0098984,8.72061312676615e-05,0.999963821436862,33,154,neuron to neuron synapse,CC,NOS1;DVL1;NEURL1;SHARPIN;DLG4;DLG1;PTPRS;PRNP;BNIP3;BCR;SHANK3;MAP1B;PSD3;NLGN2;SHANK2;DLG3;SH2D5;SRC;DNM2;NCS1;FYN;CLSTN1;ABHD17C;NTSR1;SIGMAR1;ARFGEF2;P2RX4;KLHL17;HOMER2;ARHGEF2;MINK1;ARHGAP44;CAMK2N1
3387,GO:0007166,8.9201759990333e-05,0.999935032672594,243,1880,cell surface receptor signaling pathway,BP,XDH;PGF;SH2D2A;SH3KBP1;ITGB4;TSPAN1;MDFI;ZMYND8;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;MST1R;LTBP4;RBCK1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;SHC1;PLAT;WNT7A;NEURL1;BOK;SHARPIN;ARAP1;DLG4;SERPINE2;BSG;IGFBP4;MMP1;IFI6;FKBP1A;POSTN;PSMD2;ITGA6;PRNP;LAMA5;SSH1;SMURF2;FAM129B;LCN2;G0S2;MAPKAPK3;BBS2;SEMA3F;ADGRF1;BCR;VLDLR;LRP5;ACVR2B;ITGB5;EGFR;CSNK1E;MKNK2;MMP14;PRKACA;PTPRF;RHBDF2;EPN1;SHANK3;P4HB;AKT1;IFITM1;CARD11;GPC4;IRAK1;ARPC1A;EPN2;BAG3;APOE;PEAR1;WWTR1;TMSB4X;AP2A2;PRKCZ;FAM20C;DGKQ;MAPK13;RFNG;FZD8;EPHA1;PTK6;GRK6;FERMT1;MSN;TGFBR2;EPOR;MVB12B;LIMK1;DKK1;SOX7;PPP2R5B;ARRDC1;PRKACB;LTBP1;SHC2;WASF2;CD44;PLCG1;IDE;DEDD2;TSPAN5;GIT1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;BCL9L;NLGN2;SEMA4B;DDIT3;TNFSF15;GNB1;RET;RAB29;IFI27;GRB10;SHANK2;GATA3;APLN;OASL;MYOF;GNAI2;GRIN3B;ADGRB2;ANKS1A;IL1RAP;EFS;MT2A;PTPRU;ARID5B;LY6E;PLCB3;IGFBP2;EIF4EBP1;GIPC1;TNFRSF6B;TULP3;SRC;DNM2;AGO4;IRF7;ESRP1;GSK3A;PAG1;SH3BP1;PCSK6;TALDO1;DUSP6;OAS1;FYN;ISG20;FUZ;WNT5B;PFN1;PSMD7;TNFRSF1A;WISP1;TLE4;FBXL15;SLC33A1;TSPAN33;MOAP1;ITGA1;FCGRT;TNRC6B;NTSR1;MAP3K10;TIMP1;CRIM1;SEMA4G;FGFR1;MIB2;MFNG;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;LRP1;ROBO3;TNFRSF19;MGRN1;P2RX4;LRRK1;FGF2;MAPK9;SHB;ABCA7;BICC1;SLIT3;HOMER2;ARG1;VEGFB;NEURL1B;TGFA;INVS;BAIAP2L1;ATP6V1C2;WIPF1;CASP4;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;FURIN;ARHGEF2;GIGYF1;TMBIM1;LLGL1;ADAM15;CEACAM1;GALNT3;MINK1;ECM1;CD59;CCNE1;ITSN1;TGFB1;SPRED2;PIK3R2;ERBB3;ANXA1;ITGA3;PXN;EP300;TCF7L1
2533,GO:0005788,8.9805791362117e-05,0.999960428184411,37,185,endoplasmic reticulum lumen,CC,QSOX1;WNT7A;CST3;IGFBP4;CKAP4;CRTAP;H6PD;LAMB1;P4HB;PDIA5;APOE;COL13A1;FAM20C;CTSZ;PCSK9;LAMB2;LTBP1;CERCAM;ADAMTS7;ANO8;WFS1;P4HA1;MYDGF;APLP2;FKBP10;NUCB1;WNT5B;VWA1;SHISA5;RCN1;TIMP1;MSLN;ARSK;DNAJB9;MATN3;ARSD;ERP44
6673,GO:0030030,9.01491300505948e-05,0.999939321674489,149,1051,cell projection organization,BP,SH3KBP1;ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;NEURL1;CRTC1;ARAP1;DLG4;POSTN;ITGA6;PTPRS;PRNP;LAMA5;SSH1;DBNDD1;NYAP1;FAM129B;ESPN;PLEK2;BBS2;SEMA3F;ADGRF1;NUDCD3;VLDLR;MARK4;EVI5L;MAP4K4;EGFR;CSNK1E;LAMB1;RFX2;SEPT10;PRKACA;ADARB1;PTPRF;CORO1B;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;APOE;EHD3;WWTR1;PRKCZ;CTSZ;PTK6;DNAAF5;PTPDC1;SEPT5;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;PPP2R5B;OBSL1;WASF2;CD44;PLCG1;TWF2;FSCN1;PAK1;TTBK2;SEMA4B;PODXL;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SEPT8;SHANK2;GATA3;IL1RAP;DYNLRB1;FAM110C;NUMB;ARHGEF4;SRC;DNM2;NINL;NCS1;STK24;SDCCAG8;RERE;STXBP1;SH3BP1;FYN;RAB25;FUZ;AGRN;LPAR3;PFN1;KIF17;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;FGFR1;TUBG1;RREB1;ADNP;TENM2;ARFIP2;UNC119B;ULK1;LRP1;ROBO3;PAK4;E2F5;ULK2;VASP;ATXN10;APBB1;EPS8L1;SLIT3;NDE1;CAMSAP3;IMPACT;KLK6;SNAP29;CAMK1;EPHB2;GAS8;CIB1;WRAP73;MAPK3;NTNG1;CSNK1D;LLGL1;OCRL;MINK1;ARHGAP44;MAP6;ADCY6;MANF;CCDC113;ITGA3;RAP1GAP2;ASAP1
16798,GO:0098590,9.52137546707204e-05,0.999941445899719,97,627,plasma membrane region,CC,NOS1;F2R;MST1R;ADGRL1;NEURL1;DLG4;DLG1;PITPNM1;SLC9A3R2;ITGA6;SLC2A9;PTPRS;SSH1;SNPH;PLEK2;BBS2;BCR;EGFR;PRKACA;SHANK3;ATF4;ARPC1A;EHD3;PKN1;COL13A1;PRKCZ;ATP7B;PI4K2A;FERMT1;MSN;TGFBR2;STK39;CD44;PSD3;FSCN1;PAK1;SLC29A4;NLGN2;PODXL;GNB1;SYTL1;RHOC;SHANK2;PKD1;DLG3;SH2D5;MYOF;GRIN3B;NUMB;ARHGEF4;IGFBP2;PIP5K1C;SRC;LDLRAP1;DNM2;NCS1;STXBP1;RAB25;CLSTN1;KIF17;ABHD17C;COMT;TENM2;SIGMAR1;RAB11FIP4;TCIRG1;LRCH4;SLC6A14;LRP1;PLCD3;SPIRE1;KLHL17;VASP;MYO1D;ABCA7;APBB1;EPS8L1;HOMER2;TGFA;NDE1;SNAP29;KCNC4;CBL;CIB1;MAPK3;DRAM2;ARHGEF2;SRPX2;CEACAM1;MINK1;CAMK2N1;ERBB3;ANXA1;GNAS;ITGA3;ASAP1;NIPSNAP1
10319,GO:0043085,9.57159208327426e-05,0.999935859950311,144,1024,positive regulation of catalytic activity,BP,XDH;NOS1;CCND1;F2R;MST1R;ASAP2;SORL1;MAP2K1;SERINC2;SHC1;DOCK4;ERCC6;CYP27B1;NEURL1;SNX9;LMF1;BOK;ARAP1;DLG4;DLG1;DAP;ITGA6;NET1;RAPGEF3;PRNP;MAPKAPK3;BCR;VLDLR;ACVR2B;FBLN1;ADCY7;EVI5L;MAP4K4;EGFR;MMP14;ARHGAP23;PRKACA;MAP2K2;STK25;AKT1;IRAK1;APOE;RIN2;PKN1;TMSB4X;PRKCZ;DGKQ;ARHGAP22;FZD8;PITRM1;EPHA1;SH3PXD2B;GIT2;TGFBR2;GDI1;RIN1;STK39;DKK1;SOX7;PRKACB;SIPA1;SHC2;PLCG1;TBC1D16;RAP1GDS1;ATG13;MAP3K9;TBC1D14;CCND2;GIT1;PAK1;TNFSF15;TBC1D9B;ARHGAP39;DOCK9;RET;RHOC;IFI27;CEMIP;PKD1;DLG3;GNAI2;HSF1;ASPH;ADAM8;EDNRA;SRC;DNM2;FAM162A;STK24;RGS19;PAK6;GSK3A;SH3BP1;DUSP6;FYN;AGRN;PPM1F;LPAR3;PFN1;VDR;ITGA1;MAP3K10;FGFR1;ADNP;MIF;STUB1;VPS9D1;DNMBP;TRIB3;SLC27A1;HSPA2;PAK4;TBC1D20;FGF2;VAPB;MAP3K12;ARAP3;TAOK1;TBC1D2B;TGFA;CASP4;CAMK1;EPHB2;CIB1;IQSEC1;MAPK3;MAPK10;LLGL1;OCRL;MINK1;ARHGAP44;AGAP1;SRGAP2B;ADCY6;TGFB1;SH3PXD2A;AZIN2;PIK3R2;ERBB3;RAP1GAP2;RASA3;ASAP1;TRAF7
7158,GO:0031012,0.000100904900571348,0.99995131819229,45,241,extracellular matrix,CC,ANGPTL4;LTBP2;THSD4;LTBP4;WNT7A;CST3;SERPINE2;DLG1;MMP1;POSTN;ITGA6;LAMA5;CRTAP;FBLN1;MXRA7;MMP14;LAMB1;THBS2;GPC4;APOE;LAMB2;LTBP1;HTRA1;MMP10;ADAMTS7;LAMC2;NID1;TFPI2;TGM2;PCSK6;AGRN;WNT5B;WISP1;VWA1;TIMP1;LAMB3;LOXL1;LGALS3BP;HPSE;ZP3;SLIT3;MATN3;ECM1;TGFB1;THBS3
19969,GO:2000463,0.00010374828130822,0.999989183465958,8,16,positive regulation of excitatory postsynaptic potential,BP,DVL1;WNT7A;DLG4;SSH1;SHANK3;PRKCZ;NLGN2;SHANK2
17277,GO:0120036,0.000109436145548493,0.999926153008184,146,1030,plasma membrane bounded cell projection organization,BP,SH3KBP1;ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;NEURL1;CRTC1;ARAP1;DLG4;POSTN;ITGA6;PTPRS;PRNP;LAMA5;SSH1;DBNDD1;NYAP1;FAM129B;ESPN;BBS2;SEMA3F;ADGRF1;NUDCD3;VLDLR;MARK4;EVI5L;MAP4K4;EGFR;CSNK1E;LAMB1;RFX2;SEPT10;PRKACA;ADARB1;PTPRF;CORO1B;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;APOE;EHD3;WWTR1;PRKCZ;CTSZ;PTK6;DNAAF5;PTPDC1;SEPT5;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;PPP2R5B;OBSL1;WASF2;CD44;PLCG1;TWF2;FSCN1;PAK1;TTBK2;SEMA4B;PODXL;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SEPT8;SHANK2;GATA3;IL1RAP;DYNLRB1;NUMB;ARHGEF4;SRC;DNM2;NINL;NCS1;STK24;SDCCAG8;RERE;STXBP1;SH3BP1;FYN;RAB25;FUZ;AGRN;LPAR3;PFN1;KIF17;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;FGFR1;TUBG1;RREB1;ADNP;TENM2;ARFIP2;UNC119B;ULK1;LRP1;ROBO3;PAK4;ULK2;VASP;ATXN10;APBB1;EPS8L1;SLIT3;NDE1;CAMSAP3;IMPACT;KLK6;SNAP29;CAMK1;EPHB2;GAS8;CIB1;WRAP73;MAPK3;NTNG1;CSNK1D;LLGL1;OCRL;MINK1;ARHGAP44;MAP6;ADCY6;MANF;CCDC113;ITGA3;RAP1GAP2;ASAP1
10740,GO:0044087,0.000109976222745341,0.999931395314569,101,668,regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;RAC2;SORL1;CTNNBIP1;ADGRL1;SDC1;WNT7A;NEURL1;SNX9;ARAP1;DLG1;MMP1;RAPGEF3;SSH1;TMOD2;ESPN;EVI5L;MMP14;THBS2;PRKACA;CORO1B;SHANK3;ARPC1A;APOE;ATP13A2;TMSB4X;PRKCZ;VPS11;VPS4A;EPHA1;SH3PXD2B;EML2;MSN;LIMK1;DKK1;PPP2R5B;WASF2;CDC34;IDE;TWF2;TBC1D14;FSCN1;PAK1;NLGN2;PODXL;RHOC;PARP10;HSF1;ADGRB2;IL1RAP;FAM110C;ARL2;SRC;CHMP5;CAPG;DNM2;LRSAM1;RAB1B;CPTP;STXBP1;CLSTN1;FUZ;AGRN;PPM1F;PFN1;TNFRSF1A;THRA;AMIGO2;ADNP;HYAL1;TENM2;STUB1;DDB2;PMEPA1;ARFIP2;ULK1;HSPA2;SMPD3;SPIRE1;MAPK9;VASP;EPS8L1;CAMSAP3;BAIAP2L1;TPBG;WIPF1;IMPACT;EPHB2;HGS;TMSB10;WRAP73;KANK2;ARHGEF2;SRPX2;TGFB1;PXN;ARHGEF10L;EP300;ASAP1;FHOD1
3506,GO:0007416,0.00011190458215396,0.999965369723894,20,75,synapse assembly,BP,ADGRL1;DVL1;WNT7A;SDK2;ADGRF1;THBS2;SHANK3;NLGN2;FARP1;RAB29;SHANK2;ADGRB2;IL1RAP;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;EPHB2;SRPX2
12842,GO:0051128,0.000115862122998817,0.999915519587893,236,1809,regulation of cellular component organization,BP,FHL1;SH3KBP1;TSPAN1;ERCC1;ZMYND8;NOS1;CAPN2;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;WNT7A;CST3;CYP27B1;NEURL1;SNX9;BOK;CRTC1;ARAP1;DLG4;SERPINE2;DLG1;IGFBP4;MMP1;DCBLD2;POSTN;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;TMOD2;ESPN;SESN2;PLEK2;SEMA3F;BCR;SYNE3;VLDLR;ETV5;LRP5;FBLN1;EVI5L;MAP4K4;EGFR;CSNK1E;MMP14;FYCO1;THBS2;PRKACA;PTPRF;CORO1B;TUB;MAP2K2;STK25;PARVB;SHANK3;HECW2;FBXW8;SNX33;AKT1;ARPC1A;APOE;EHD3;FMNL2;ATP13A2;TMSB4X;TSPYL2;PRKCZ;VPS11;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;FBXW5;EML2;MSN;MAP1B;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;BNIP3L;OBSL1;SIPA1;ZDHHC8;WASF2;CDC34;CD44;TBC1D16;ATG13;IDE;TWF2;SURF4;TBC1D14;BIN1;FSCN1;HTRA1;PAK1;TTBK2;BCL9L;NLGN2;SEMA4B;PODXL;CUL7;TBC1D9B;PTPN9;RET;RAB29;RHOC;SHANK2;PKD1;PARP10;GATA3;APLN;PHF1;HSF1;ADGRB2;IL1RAP;ASPH;CTBP1;RHOBTB2;FAM110C;ARL2;IGFBP2;SRC;LDLRAP1;CHMP5;CAPG;DNM2;AGO4;FAM162A;LRSAM1;RAB1B;NCS1;STK24;CPTP;STX5;TOM1L2;GSK3A;STXBP1;SH3BP1;FYN;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;PFN1;WISP1;KIF13B;MOAP1;GAL;THRA;AMIGO2;CRIM1;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PHF2;TENM2;SOCS2;BCL2L1;STUB1;ADIPOR1;DDB2;AFAP1;PMEPA1;ARFIP2;ULK1;LRP1;HSPA2;ULK2;SPIRE1;EHD4;MAPK9;VASP;ARAP3;TAOK1;ABCA7;LMAN1;APBB1;RHOBTB1;EPS8L1;SLIT3;TBC1D2B;TGFA;CAMSAP3;BAIAP2L1;TPBG;NDRG3;WIPF1;IMPACT;KLK6;VAT1;CAMK1;EPHB2;CBL;CIB1;TMSB10;RAB4B;WRAP73;MAPK3;KANK2;CSNK1D;ARHGEF2;UGCG;ADAM15;SRPX2;CEACAM1;ARHGAP44;ADCY6;TGFB1;WBP2;RMI2;ANXA1;PPP1R10;ITGA3;PXN;ARHGEF10L;PLEKHH2;EP300;RAP1GAP2;ASAP1;FHOD1
1985,GO:0004702,0.000116776818526834,0.999961169171469,22,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MST1R;ACVR2B;MAP4K4;EGFR;STK25;IRAK1;MAPK13;EPHA1;TGFBR2;MAP3K9;RET;STK24;MAP3K10;FGFR1;MAPK9;MAP3K12;TAOK1;EPHB2;MAPK3;MAPK10;MINK1;ERBB3
6678,GO:0030036,0.000125109363392819,0.999927231549992,76,472,actin cytoskeleton organization,BP,RAC2;SHC1;ARAP1;OBSCN;DLG1;RAPGEF3;SSH1;TMOD2;ESPN;TNNT1;PLEK2;BCR;ITGB5;CORO1B;PARVB;SHANK3;ARPC1A;FMNL2;TMSB4X;PRKCZ;VPS4A;EPHA1;SH3PXD2B;LIMK1;CORO2A;OBSL1;WASF2;RAP1GDS1;MSRB2;TWF2;FSCN1;PAK1;CORO7;RHOC;FAT1;EFS;RHOBTB2;MICAL2;CAP1;FLNB;PIP5K1C;SRC;CAPG;CDC42BPB;PAK6;SPECC1L;SH3BP1;PPM1F;PFN1;NISCH;MICAL1;FRYL;ARFIP2;LRP1;PAK4;SPIRE1;KLHL17;VASP;TAOK1;RHOBTB1;EPS8L1;BAIAP2L1;WIPF1;TMSB10;IQSEC1;KANK2;ARHGEF2;LLGL1;MINK1;ARHGAP44;TGFB1;ANXA1;PXN;ARHGEF10L;PLEKHH2;FHOD1
1485,GO:0003779,0.000131607505807403,0.999932098390556,52,292,actin binding,MF,FLNC;MPRIP;SMTN;SSH1;TMOD2;ESPN;SYNE3;MARCKSL1;EGFR;CORO1B;PARVB;SHANK3;ARPC1A;FMNL2;TNS4;TMSB4X;MSN;MAP1B;CORO2A;OBSL1;WASF2;MSRB2;TWF2;BIN1;FSCN1;CORO7;MYH15;MICAL2;CAP1;FLNB;GIPC1;CAPG;PFN1;MICAL1;MISP;MIB2;AFAP1;SPIRE1;KLHL17;VASP;MYO1D;SNTB2;EPS8L1;HOMER2;CAMSAP3;BAIAP2L1;WIPF1;IMPACT;TMSB10;CEACAM1;PLEKHH2;FHOD1
10595,GO:0043549,0.000134064921668938,0.999916636423963,97,643,regulation of kinase activity,BP,CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;DUSP4;RET;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;DUSP6;PPM1F;LPAR3;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;TRIB3;SLC27A1;TRIB2;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;TRAF7
1710,GO:0004252,0.000136999545998586,0.999958150752096,19,74,serine-type endopeptidase activity,MF,PLAT;MMP1;PRSS3;CTSB;MMP14;RHBDF2;PCSK9;TYSND1;PRSS8;HTRA1;MMP10;ADAM8;PCSK6;TMPRSS11D;CTSL;F12;KLK6;LONP2;FURIN
2105,GO:0004871,0.000137101290112885,0.99991358432857,102,680,signal transducer activity,MF,F2R;MST1R;RAC2;LTBP4;SORL1;ADGRL1;MAP2K1;SHC1;NR1D1;FKBP1A;PRNP;PLCH2;MAPKAPK3;MRC2;ADGRF1;VLDLR;LRP5;ACVR2B;HTR7;MAP4K4;EGFR;PTPRF;MAP2K2;STK25;IFITM1;GPC4;IRAK1;ITPR3;DGKQ;MAPK13;FZD8;EPHA1;SLC20A1;TGFBR2;EPOR;LIMK1;DKK1;PPARA;LTBP1;CD44;PLCG1;MAP3K9;MC1R;SUFU;GNB1;RET;RHOC;TMED3;GNAI2;ANTXR2;GRIN3B;ADGRB2;IL1RAP;PTPRU;RHOBTB2;PLCB3;GPRC5C;TNFRSF6B;EDNRA;PAQR7;STK24;PAG1;FYN;LPAR3;TNFRSF1A;VDR;PLEKHG5;GAL;FCGRT;GNB2;SHISA5;THRA;NTSR1;MAP3K10;CRIM1;FGFR1;MIB2;SIGMAR1;ADIPOR1;TPCN1;PLCD3;TNFRSF19;P2RX4;LRRK1;MAPK9;MAP3K12;TAOK1;ABCA7;RHOBTB1;RXRA;CASP4;EPHB2;CBL;MAPK3;MAPK10;LITAF;MINK1;ECM1;TM2D1;ERBB3;GNAS;RASA3
1257,GO:0003008,0.000138408827731445,0.999910080961744,117,804,system process,BP,NOS1;F2R;CTNNBIP1;DVL1;ADM2;DOCK4;SCN8A;CRTC1;DLG4;SERPINE2;SMTN;DLG1;DYSF;FKBP1A;POSTN;PRNP;TMOD2;FAM129B;ESPN;TNNT1;BBS2;ADGRF1;BCR;VLDLR;LRP5;AARS;ITGB5;HTR7;ADCY7;EGFR;PRKACA;ADARB1;TUB;ACTA2;PPP1R13L;SHANK3;AKT1;SERPING1;APOE;EHD3;ARG2;METTL23;PKN1;RABGGTA;PRKCZ;ITPR3;CTSZ;EML2;DEAF1;LAMB2;SERPINB6;STK39;DKK1;PPARA;OBSL1;PRKACB;RAP1GDS1;CCND2;PAK1;ZNF385A;NLGN2;RAG1;GAMT;GNB1;REEP2;CEMIP;SHANK2;GATA3;APLN;DOPEY2;MYOF;ASIC1;WFS1;ASPH;PLCB3;B4GALT2;EDNRA;SRC;TAZ;REEP6;GSK3A;CAMTA2;FYN;NISCH;ALDH7A1;VDR;GAL;ITGA1;COMT;THRA;NTSR1;MGLL;HSF4;FGFR1;ADNP;PBX3;P2RX4;CHD7;ABCA7;HOMER2;VEGFB;EPHB2;MYL9;MAPK3;KIFC3;DRAM2;SLC5A1;CEACAM1;PAIP2;ADCY6;TGFB1;GNAS;ITGA3;PXN;STIM1;NIPSNAP1;RNF10
3451,GO:0007265,0.000140998966307239,0.999922457670208,62,366,Ras protein signal transduction,BP,F2R;RAC2;ASAP2;SHC1;ARAP1;OBSCN;RAB3B;NET1;RAPGEF3;RAB43;MAPKAPK3;BCR;RAB31;APOE;GIT2;RRAS;GDI1;LIMK1;SHC2;WASF2;PSD3;GIT1;PAK1;FARP1;GNB1;RAB29;RASGEF1A;RHOC;CYTH3;APPL2;RGL2;RHOBTB2;ARHGEF4;DNM2;RFXANK;RAB1B;PAK6;SH3BP1;RAB25;RALGDS;NISCH;PLEKHG5;RREB1;DNMBP;ARFGEF2;PAK4;FGF2;ARAP3;RHOBTB1;EPS8L1;EPHB2;RAB4B;IQSEC1;ARHGEF2;ARHGAP44;AGAP1;ITSN1;RAB6A;ITGA3;ARHGEF10L;RASA3;ASAP1
7264,GO:0031226,0.000143136100241749,0.999907449715162,114,773,intrinsic component of plasma membrane,CC,ITGB4;TSPAN1;F2R;MST1R;SORL1;SDC1;KCNG1;SCN8A;SLCO4A1;DLG4;BSG;DLG1;SLC16A3;DCBLD2;ITGA6;SLC2A9;PTPRS;PRNP;PCDH1;MRC2;ACVR2B;ITGB5;HTR7;EGFR;MMP14;SLC12A7;PTPRF;LMBR1L;SHANK3;GPC4;IRAK1;ATP13A2;COL13A1;ATP7B;ITPR3;EPHA1;PI4K2A;SLC20A1;ORAI1;TGFBR2;CD99;EPOR;PRSS8;CD44;ESYT2;MC1R;TSPAN5;NLGN2;TNFSF15;PODXL;STOM;RET;REEP2;PROCR;SHANK2;PKD1;DLG3;CADM4;SLC2A3;GRIN3B;ASIC1;IL1RAP;SLC12A4;FAT1;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;LY6E;SLC43A1;GPRC5C;VAMP2;TNFRSF6B;EDNRA;B3GNT3;TGM2;PAG1;TMPRSS11D;LPAR3;SLC6A9;TNFRSF1A;SLC33A1;TSPAN33;ITGA1;SLC13A5;NTSR1;FGFR1;TENM2;SIGMAR1;ADIPOR1;TCIRG1;ST3GAL5;SLC6A14;LRP1;P2RX4;TGFA;TPBG;KCNC4;EPHB2;NTNG1;SLC35G2;SLC5A1;CEACAM1;CD59;ADCY6;TM2D1;SLC15A1;ERBB3;PODXL2;ITGA3;PLGRKT;STIM1;RASA3
14529,GO:0065008,0.000144096326323133,0.999891426165736,298,2395,regulation of biological quality,BP,ANGPTL4;XDH;FHL1;SH3KBP1;TSPAN1;ERCC1;MDFI;ZMYND8;NOS1;CCND1;F2R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;DVL1;ADM2;DOCK4;PLAT;PYGL;QSOX1;WNT7A;ERCC6;CYP27B1;NEURL1;AP3D1;SCN8A;BOK;CRTC1;PCK2;ARAP1;SLCO4A1;DLG4;SERPINE2;NR1D1;DLG1;IFI6;FKBP1A;DGKA;POSTN;PSMD2;RAB3B;RAPGEF3;PTPRS;PRNP;BNIP3;SSH1;TXNDC11;CRTAP;TMOD2;FAM129B;LCN2;SESN2;SNPH;BBS2;SEMA3F;BCR;SYNE3;LPCAT1;ETV5;LRP5;AARS;ACVR2B;FBLN1;HTR7;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;THBS2;SLC12A7;PRKACA;CORO1B;TUB;HK1;PPP1R13L;PARVB;SHANK3;P4HB;PDIA5;AKT1;CARD11;ARPC1A;SERPING1;BAG3;APOE;EHD3;FAM210B;ATP13A2;ARG2;PKN1;SYVN1;PHF21A;TMSB4X;PRKCZ;ATP7B;ITPR3;DGKQ;VPS11;CTSZ;RETSAT;SH3PXD2B;PCSK9;ENDOG;SEPT5;MSN;MAP1B;GDI1;HADH;LIMK1;STK39;DKK1;BNIP3L;PPARA;KDELR1;PRKACB;LTBP1;WDTC1;PLCG1;RAP1GDS1;IDE;DEDD2;TWF2;PRDX5;MALL;SFXN3;SUFU;CCDC88C;PAK1;TTBK2;ERO1B;ZNF385A;NLGN2;DTD1;RAG1;SEMA4B;DDIT3;GLUL;DMXL2;GNB1;SYTL1;DOCK9;RET;RHOC;PROCR;PCBP4;CEMIP;SHANK2;PKD1;ASS1;ATP11A;GATA3;APLN;DOCK6;GRIN3B;ASIC1;GLUD1;ADGRB2;IL1RAP;WFS1;SRD5A3;SLC12A4;ASPH;MT2A;FAM155B;ADAM8;TFPI2;RHOBTB2;ARL2;PLCB3;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;EDNRA;ALDH1A2;SRC;LDLRAP1;GLRX;CAPG;POLD4;SCG5;TGM2;DNM2;STPG1;ACADVL;PER3;GSK3A;STXBP1;SH3BP1;PCSK6;OAS1;FYN;CLSTN1;AGRN;LPAR3;SLC6A9;GRINA;PFN1;NISCH;PSMD7;MICAL1;ALDH7A1;HSD11B1;VDR;BRSK1;MOAP1;GAL;PUM1;ITGA1;COMT;THRA;NTSR1;AMIGO2;SEMA4G;FGFR1;ATP2C2;ADNP;LRRC8A;F12;USF2;MIF;SOCS2;AMPD2;BCL2L1;STUB1;PCSK1N;ADIPOR1;TCIRG1;SLC27A1;ZFPM1;TPCN1;ARFIP2;RAD23A;P2RX4;HPSE;SAMD4B;ULK2;SMPD3;LRRK1;TBC1D20;SPIRE1;FGF2;VAPB;RCOR1;VASP;TMX4;ARAP3;CHD7;ABCA7;LMAN1;RHOBTB1;EPS8L1;HOMER2;L3MBTL3;BAIAP2L1;ATP6V1C2;TPBG;WIPF1;KLK6;SNAP29;KCNC4;CAMK1;EPHB2;CARHSP1;MYL9;TMSB10;MAPK3;KANK2;CSNK1D;DRAM2;FURIN;SRPX2;CEACAM1;PAIP2;APBA1;ARHGAP44;CD59;SLC30A1;ADCY6;IGF2BP3;CCNE1;TGFB1;PIK3R2;ANXA1;PPP1R10;GNAS;PLEKHH2;EP300;ERP44;RAP1GAP2;STIM1;RASA3
10290,GO:0043025,0.000145391906891082,0.999926671959203,48,268,neuronal cell body,CC,DVL1;CST3;NEURL1;CRTC1;PTPRS;CYGB;SNPH;PTPRF;APOE;ATP13A2;PRKCZ;ITPR3;PI4K2A;ENDOG;MAP1B;GDI1;ZNF385A;GLUL;TUBB3;RET;SHANK2;DLG3;GRIN3B;TOP1;GSK3A;NRSN2;ANXA3;GJC2;GAL;ITGA1;NTSR1;WDFY3;ADNP;LRP1;P2RX4;KLHL17;MYO1D;ATXN10;APBB1;HOMER2;ARG1;KCNC4;EPHB2;CIB1;ARHGEF2;TGFB1;AZIN2;CAMK2N1
3384,GO:0007163,0.000146558023790221,0.999937201697848,33,159,establishment or maintenance of cell polarity,BP,WNT7A;DLG4;DLG1;MARK4;STK25;PARVB;PRKCZ;FERMT1;MSN;MAP1B;FSCN1;PAK1;RHOC;CYTH3;PKD1;DLG3;GATA3;FAT1;RHOBTB2;CAP1;CDC42BPB;MARK3;SDCCAG8;SH3BP1;SPINT2;BRSK1;LRCH4;RHOBTB1;NDE1;CAMSAP3;ARHGEF2;SNX27;LLGL1
10386,GO:0043197,0.000147140571684796,0.999947142120277,24,102,dendritic spine,CC,ZMYND8;NOS1;DVL1;NEURL1;DLG4;NR1D1;SHANK3;STRN4;FBXO2;MAP1B;FARP1;SHANK2;GIPC1;DNM2;ABHD17C;COMT;NTSR1;TENM2;ARFGEF2;P2RX4;APBB1;APBA1;ARHGAP44;ASAP1
12698,GO:0050890,0.000149173131581558,0.999936903458469,32,155,cognition,BP,CRTC1;DLG4;PRNP;TMOD2;ADGRF1;VLDLR;EGFR;SHANK3;APOE;METTL23;PRKCZ;ITPR3;DEAF1;DKK1;CCND2;ZNF385A;RAG1;SHANK2;DOPEY2;ASIC1;B4GALT2;FYN;COMT;THRA;NTSR1;ADNP;CHD7;ABCA7;EPHB2;PAIP2;GNAS;ITGA3
19730,GO:2000026,0.000152997782313762,0.999892740713298,172,1277,regulation of multicellular organismal development,BP,ANGPTL4;XDH;PGF;ZMYND8;NOS1;CCND1;SORL1;CTNNBIP1;NFATC4;ADGRL1;DVL1;MAP2K1;ADM2;WNT7A;PTHLH;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;DLG1;PSMD2;RAPGEF3;PTPRS;IDH2;LAMA5;SSH1;SMURF2;FAM129B;SEMA3F;VLDLR;ETV5;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;THBS2;PTPRF;EPN1;STK25;SHANK3;HECW2;FBXW8;AKT1;CARD11;GPC4;EPN2;APOE;FAM210B;WWTR1;AP2A2;PRKCZ;FAM20C;CTSZ;EPHA1;PTK6;SH3PXD2B;FERMT1;RRAS;DEAF1;MAP1B;TGFBR2;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PRKACB;PLCG1;TWF2;TFE3;BIN1;SUFU;PAK1;SP6;BCL9L;NLGN2;RAG1;SEMA4B;DDIT3;CUL7;ADAMTS7;PTPN9;RET;RAB29;SHANK2;GATA3;ADGRB2;ALOX15B;IL1RAP;ADAM8;HMGA2;NUMB;MYDGF;TULP3;SRC;DNM2;AGO4;IRF7;NCS1;STK24;GSK3A;DUSP6;FYN;CLSTN1;FUZ;AGRN;LPAR3;PFN1;PSMD7;TNFRSF1A;ANXA3;VDR;KIF13B;GJC2;GAL;CTSL;TNRC6B;AMIGO2;TIMP1;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;SOCS2;ADIPOR1;ZFPM1;LRP1;ZNF609;PAK4;HPSE;ULK2;ZP3;PNP;FGF2;RNH1;CHD7;APBB1;RXRA;VEGFB;TPBG;IMPACT;KLK6;CAMK1;EPHB2;HGS;MYL9;CIB1;CSNK1D;ARHGEF2;SRPX2;CEACAM1;ARHGAP44;ECM1;ADCY6;TGFB1;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;RAP1GAP2;STIM1;ASAP1;RNF10
15480,GO:0071800,0.00015749964074966,0.999981892549247,8,17,podosome assembly,BP,SH3PXD2B;MSN;FSCN1;SRC;MAPK9;ARHGEF2;SH3PXD2A;ASAP1
12323,GO:0048646,0.000160601069189819,0.999897861659869,104,694,anatomical structure formation involved in morphogenesis,BP,ANGPTL4;PGF;SH2D2A;ITGB4;ERCC1;NOS1;CAPN2;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;SDK2;OBSCN;FKBP1A;ITGA6;RAPGEF3;LAMA5;TMOD2;FAM129B;TNNT1;ACVR2B;ITGB5;XBP1;MMP14;LAMB1;THBS2;RFX2;EPN1;EPN2;PKN1;ELK3;FAM20C;ARHGAP22;FZD8;EPHA1;RRAS;DEAF1;TGFBR2;DKK1;SOX7;PPARA;OBSL1;PRKACB;WASF2;PLCG1;HTRA1;SUFU;ZNF385A;PODXL;DUSP4;RET;GATA3;APLN;MYOF;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;TULP3;TGM2;SDCCAG8;SPINT2;DUSP6;FUZ;PFN1;ANXA3;MBOAT7;LAMB3;FGFR1;HYAL1;LEMD2;ZFPM1;PLCD3;PAK4;HPSE;ZP3;TBC1D20;FGF2;RNH1;SHB;VASP;VEGFB;CAMK1;EPHB2;HGS;CIB1;SOCS7;MAPK3;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;SF3B6;SH3PXD2A;ANXA1;GNAS;ITGA3;EP300;THBS3;STIM1
2516,GO:0005768,0.00016130019504437,0.999898030813058,101,680,endosome,CC,SH3TC2;F2R;SORL1;MAP2K1;CST3;SNX9;AP3D1;BOK;DYSF;CD68;RAB43;OCIAD2;CTSB;RAB31;EGFR;MMP14;FYCO1;MAP2K2;ANKRD13D;SNX33;IRAK1;APOE;EHD3;ATP13A2;PKN1;AP2A2;PRKCZ;ATP7B;DGKQ;VPS11;VPS4A;PI4K2A;PCSK9;MVB12B;DKK1;YIPF2;WASF2;TBC1D16;TBC1D14;DDIT3;GGA3;GGA1;SDCCAG3;RET;RAB29;ATP11A;NIPA1;ARL8A;DOPEY2;ANTXR2;APPL2;NUMB;PLIN3;PIP5K1C;SRC;LDLRAP1;CHMP5;DNM2;IRF7;NUCB1;TMEM9;CPTP;FYN;RAB25;NISCH;ABHD17C;CTSL;UBA1;RNF32;TUBG1;MIB2;MTMR4;VPS37A;RAB11FIP4;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;ARFGEF2;ULK1;LRP1;MGRN1;EHD4;MYO1D;ABCA7;NEURL1B;HGS;RAB4B;MAPK3;LITAF;FURIN;SNX27;TMBIM1;LLGL1;OCRL;EHBP1L1;ARHGAP44;ANXA1;ZFYVE21;WDFY2
4568,GO:0010647,0.000161754572850692,0.999888225068105,157,1152,positive regulation of cell communication,BP,XDH;SH2D2A;NOS1;F2R;MST1R;RBCK1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;SERPINE2;IGFBP4;FKBP1A;PSMD2;RAB3B;PRNP;BNIP3;SSH1;SMURF2;TMOD2;G0S2;MAPKAPK3;NACC2;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;MAP2K2;STK25;SHANK3;AKT1;CARD11;IRAK1;EPN2;APOE;PKN1;PRKCZ;ITPR3;RFNG;FZD8;EPHA1;PTK6;SLC20A1;FERMT1;STK39;DKK1;PPP2R5B;AKAP12;SHC2;CD44;PLCG1;MAP3K9;MC1R;DEDD2;TSPAN5;PAK1;ZNF385A;NLGN2;DDIT3;TNFSF15;GLUL;RET;RAB29;RASGEF1A;RHOC;GRB10;SHANK2;GATA3;APLN;GNAI2;GLUD1;HSF1;ALOX15B;ADAM8;RGL2;FAM110C;MYDGF;VAMP2;GIPC1;SRC;LDLRAP1;TGM2;FAM162A;IRF7;STK24;GSK3A;STXBP1;PAG1;DUSP6;FYN;CLSTN1;LPAR3;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;NTSR1;MAP3K10;HEXIM1;FGFR1;MIB2;MFNG;MIF;SOCS2;BCL2L1;ADIPOR1;TNFRSF19;P2RX4;HPSE;LRRK1;FGF2;MAPK9;SHB;MAP3K12;TAOK1;ABCA7;TGFA;ATP6V1C2;KLK6;CASP4;EPHB2;CBL;CIB1;MAPK3;MAPK10;CSNK1D;LITAF;PAIP2;MINK1;SKAP2;ECM1;ITSN1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;STARD10;ERBB3;EP300;TRAF7
10512,GO:0043405,0.000166800903429704,0.999916007460887,47,261,regulation of MAP kinase activity,BP,F2R;MST1R;SORL1;MAP2K1;SHC1;ERCC6;MAPKAPK3;MAP4K4;EGFR;MAP2K2;STK25;IRAK1;APOE;PKN1;FZD8;STK39;DKK1;SHC2;PLCG1;MAP3K9;PAK1;DUSP4;GNAI2;ADAM8;SRC;STK24;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;MIF;TRIB3;TRIB2;FGF2;MAP3K12;TAOK1;TGFA;EPHB2;HGS;MAPK3;MAPK10;AIDA;MINK1;TGFB1;SPRED2;TRAF7
2409,GO:0005578,0.000168592906006386,0.999923082827043,37,188,proteinaceous extracellular matrix,CC,ANGPTL4;LTBP2;THSD4;LTBP4;WNT7A;CST3;DLG1;MMP1;POSTN;ITGA6;LAMA5;CRTAP;FBLN1;LAMB1;THBS2;GPC4;LAMB2;LTBP1;MMP10;ADAMTS7;LAMC2;NID1;TFPI2;AGRN;WNT5B;WISP1;VWA1;TIMP1;LAMB3;LOXL1;LGALS3BP;HPSE;ZP3;SLIT3;MATN3;ECM1;TGFB1
12639,GO:0050804,0.000175090101924757,0.999920885923163,36,183,modulation of chemical synaptic transmission,BP,ZMYND8;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;RAB3B;PRNP;SSH1;EGFR;SHANK3;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SHANK2;GNAI2;ASIC1;VAMP2;GIPC1;STXBP1;CLSTN1;SLC6A9;NISCH;NTSR1;ADNP;KCNC4;EPHB2;PAIP2;SLC30A1
17046,GO:0099177,0.000175090101924757,0.999920885923163,36,183,regulation of trans-synaptic signaling,BP,ZMYND8;F2R;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;RAB3B;PRNP;SSH1;EGFR;SHANK3;APOE;PRKCZ;ITPR3;SEPT5;DKK1;NLGN2;GLUL;SHANK2;GNAI2;ASIC1;VAMP2;GIPC1;STXBP1;CLSTN1;SLC6A9;NISCH;NTSR1;ADNP;KCNC4;EPHB2;PAIP2;SLC30A1
10923,GO:0044463,0.000175180897148483,0.999883244174866,128,896,cell projection part,CC,ZMYND8;NOS1;CAPN2;ADGRL1;DVL1;NEURL1;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;FKBP1A;PRNP;BNIP3;SSH1;TMOD2;ESPN;PLEK2;BBS2;OSBP2;MARK4;HTR7;PRKACA;HK1;SHANK3;ATF4;AKT1;ARPC1A;APOE;EHD3;STRN4;PRKCZ;CTSZ;PI4K2A;FBXO2;FERMT1;SEPT5;MSN;MAP1B;PRKACB;CD44;TWF2;PSD3;BIN1;FSCN1;SUFU;PAK1;TTBK2;ZNF385A;NAV1;PODXL;GLUL;TUBB3;FARP1;GNB1;SYTL1;PTPN9;RET;SHANK2;PKD1;DLG3;WDR66;GNAI2;WFS1;DYNLRB1;ARHGEF4;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;DNM2;NCS1;GSK3A;STXBP1;FYN;RAB25;MICAL1;KIF17;ANXA3;ABHD17C;KIF13B;GJC2;COMT;NTSR1;TUBG1;ADNP;CEP170;TENM2;SIGMAR1;ARFGEF2;UNC119B;TMEM185A;SLC6A14;LRP1;P2RX4;KLHL17;MAP1LC3B;MAP3K12;VASP;MYO1D;ATXN10;ABCA7;APBB1;EPS8L1;HOMER2;RPL28;SNAP29;KCNC4;EPHB2;GAS8;CBL;CIB1;WRAP73;ARHGEF2;OCRL;CEACAM1;APBA1;MINK1;ARHGAP44;MAP6;AZIN2;CAMK2N1;GNAS;ITGA3;ASAP1
17278,GO:0120038,0.000175180897148483,0.999883244174866,128,896,plasma membrane bounded cell projection part,CC,ZMYND8;NOS1;CAPN2;ADGRL1;DVL1;NEURL1;AP3D1;SCN8A;SHARPIN;CRTC1;DLG4;NR1D1;DLG1;FKBP1A;PRNP;BNIP3;SSH1;TMOD2;ESPN;PLEK2;BBS2;OSBP2;MARK4;HTR7;PRKACA;HK1;SHANK3;ATF4;AKT1;ARPC1A;APOE;EHD3;STRN4;PRKCZ;CTSZ;PI4K2A;FBXO2;FERMT1;SEPT5;MSN;MAP1B;PRKACB;CD44;TWF2;PSD3;BIN1;FSCN1;SUFU;PAK1;TTBK2;ZNF385A;NAV1;PODXL;GLUL;TUBB3;FARP1;GNB1;SYTL1;PTPN9;RET;SHANK2;PKD1;DLG3;WDR66;GNAI2;WFS1;DYNLRB1;ARHGEF4;VAMP2;PIP5K1C;GIPC1;TULP3;SRC;DNM2;NCS1;GSK3A;STXBP1;FYN;RAB25;MICAL1;KIF17;ANXA3;ABHD17C;KIF13B;GJC2;COMT;NTSR1;TUBG1;ADNP;CEP170;TENM2;SIGMAR1;ARFGEF2;UNC119B;TMEM185A;SLC6A14;LRP1;P2RX4;KLHL17;MAP1LC3B;MAP3K12;VASP;MYO1D;ATXN10;ABCA7;APBB1;EPS8L1;HOMER2;RPL28;SNAP29;KCNC4;EPHB2;GAS8;CBL;CIB1;WRAP73;ARHGEF2;OCRL;CEACAM1;APBA1;MINK1;ARHGAP44;MAP6;AZIN2;CAMK2N1;GNAS;ITGA3;ASAP1
12984,GO:0051347,0.000175286375446291,0.999896605987893,76,481,positive regulation of transferase activity,BP,CCND1;F2R;MST1R;SORL1;MAP2K1;SERINC2;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;EPHA1;TGFBR2;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;GSK3A;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;ADNP;MIF;STUB1;TRIB3;SLC27A1;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;MINK1;ADCY6;TGFB1;ERBB3;TRAF7
12939,GO:0051270,0.000175977177249266,0.999890581727836,93,615,regulation of cellular component movement,BP,PGF;ZMYND8;F2R;RAC2;SORL1;DOCK4;WNT7A;ARAP1;SERPINE2;DLG1;POSTN;ITGA6;IDH2;LAMA5;SSH1;SMURF2;CYGB;BBS2;SEMA3F;BCR;FBLN1;XBP1;EGFR;MMP14;LAMB1;ADARB1;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;EPHA1;RRAS;MSN;TGFBR2;PLCG1;PAK1;TTBK2;MMP10;SEMA4B;PODXL;RET;LAMC2;RHOC;CEMIP;GATA3;ALOX15B;PTPRU;ADAM8;RHOBTB2;FAM110C;NUMB;SRC;STK24;SH3BP1;SPINT2;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;CAMSAP3;CIB1;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;ERBB3;ANXA1;ITGA3
10513,GO:0043406,0.00017862849388748,0.999917211547233,38,197,positive regulation of MAP kinase activity,BP,F2R;MST1R;MAP2K1;SHC1;ERCC6;MAPKAPK3;MAP4K4;EGFR;MAP2K2;STK25;IRAK1;PKN1;FZD8;STK39;DKK1;SHC2;PLCG1;MAP3K9;PAK1;GNAI2;ADAM8;SRC;STK24;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;MIF;FGF2;MAP3K12;TAOK1;TGFA;MAPK3;MAPK10;MINK1;TGFB1;TRAF7
2380,GO:0005509,0.00018288032163465,0.999898695454853,61,367,calcium ion binding,MF,EDEM1;LTBP2;CAPN2;LTBP4;DYSF;PITPNM1;DGKA;PRSS3;PLCH2;PCDH1;TNNT1;FKBP9;LPCAT1;VLDLR;FBLN1;THBS2;EHD3;FAM20C;ITPR3;PPP2R3B;LTBP1;ESYT2;PLCG1;TBC1D9B;SYTL1;RET;NID1;NUCB2;ALOX15B;FAT1;ASPH;ADAM8;PLCB3;FKBP10;NINL;NUCB1;NCS1;CLSTN1;AGRN;ANXA3;CGREF1;MCFD2;RCN1;TENM2;F12;RAB11FIP4;PITPNM2;LRP1;EHD4;SLIT3;MYL9;CBL;CIB1;USP32;S100A16;MATN3;GALNT3;ITSN1;ANXA1;THBS3;STIM1
16442,GO:0097060,0.00018303620549202,0.999920514221629,33,160,synaptic membrane,CC,F2R;ADGRL1;NEURL1;DLG4;DLG1;PTPRS;SNPH;BCR;SHANK3;COL13A1;PI4K2A;PSD3;NLGN2;SHANK2;DLG3;SH2D5;GRIN3B;DNM2;NCS1;STXBP1;CLSTN1;ABHD17C;COMT;TENM2;SIGMAR1;KLHL17;APBB1;HOMER2;SRPX2;MINK1;CAMK2N1;ITGA3;NIPSNAP1
16106,GO:0090066,0.000186175209463814,0.999899712819576,56,329,regulation of anatomical structure size,BP,NOS1;F2R;RAC2;DOCK4;WNT7A;DLG1;RAB3B;PTPRS;SSH1;TMOD2;BBS2;SEMA3F;HTR7;EGFR;SLC12A7;CORO1B;SHANK3;AKT1;ARPC1A;APOE;ATP13A2;TMSB4X;MSN;MAP1B;GDI1;LIMK1;WDTC1;RAP1GDS1;TWF2;PAK1;SEMA4B;RET;APLN;SLC12A4;EDNRA;CAPG;DNM2;SH3BP1;LPAR3;PFN1;ITGA1;SEMA4G;ADNP;LRRC8A;ARFIP2;ULK2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;ADCY6;PLEKHH2;RAP1GAP2
2427,GO:0005605,0.000191111444690019,0.999977362347396,8,17,basal lamina,CC,DLG1;LAMA5;LAMB1;LAMB2;LAMC2;NID1;AGRN;LAMB3
2609,GO:0005912,0.000199278564649756,0.999884455445178,70,447,adherens junction,CC,FLNC;FHL1;SH3KBP1;CAPN2;MPRIP;RAC2;MAP2K1;BSG;DLG1;SLC9A3R2;ITGA6;FAM129B;MRC2;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PARVB;P4HB;EHD3;TNS4;ARHGAP22;FERMT1;GIT2;RRAS;MSN;CD99;LIMK1;AKAP12;CD44;GIT1;PAK1;CYTH3;PROCR;CADM4;FAT1;ARL2;NUMB;CAP1;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;SH3BP1;PFN1;ITGA1;GNB2;MISP;AFAP1;PTPN12;LRP1;PAK4;VASP;SNTB2;CAMSAP3;BAIAP2L1;CBL;MAPK3;KIFC3;ARHGEF2;ADAM15;CEACAM1;CD59;CAT;ANXA1;ZFYVE21;ITGA3;PXN
10830,GO:0044309,0.00020475091701664,0.999924542814151,24,104,neuron spine,CC,ZMYND8;NOS1;DVL1;NEURL1;DLG4;NR1D1;SHANK3;STRN4;FBXO2;MAP1B;FARP1;SHANK2;GIPC1;DNM2;ABHD17C;COMT;NTSR1;TENM2;ARFGEF2;P2RX4;APBB1;APBA1;ARHGAP44;ASAP1
12643,GO:0050808,0.000207518183026537,0.999906601606969,35,175,synapse organization,BP,ZMYND8;F2R;NFATC4;ADGRL1;DVL1;WNT7A;SDK2;NEURL1;DLG4;PRNP;SSH1;ADGRF1;ETV5;THBS2;SHANK3;APOE;LAMB2;DKK1;NLGN2;FARP1;RAB29;SHANK2;ADGRB2;IL1RAP;FYN;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;CAMK1;EPHB2;SRPX2;ARHGAP44;ITGA3
17056,GO:0099503,0.00020783846213549,0.999870962035961,90,611,secretory vesicle,CC,PYGB;PLAT;PYGL;QSOX1;CST3;NAPRT;DLG4;SERPINE2;BSG;PGM1;PSMD2;RAB3B;CKAP4;PTPRS;PRSS3;CD68;DBNDD1;LCN2;CTSB;LY6K;RAB31;LPCAT1;THBS2;PRKACA;SERPING1;TMSB4X;AP2A2;GALNS;ITPR3;CTSZ;PI4K2A;SEPT5;RABAC1;SERPINB6;CD44;SURF4;DMXL2;STOM;SYTL1;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;GIPC1;APLP2;SCG5;UBR4;NCS1;C6ORF120;GARS;STXBP1;YPEL5;PSMD7;ANXA3;BRSK1;GAL;ITGA1;TIMP1;LOXL1;LGALS3BP;MIF;BCL2L1;PCSK1N;TCIRG1;HPSE;PNP;ARG1;VEGFB;KLK6;VAT1;SNAP29;SPESP1;TRAPPC1;RAB4B;POMT1;ALDOC;TMBIM1;ADAM15;CEACAM1;APBA1;ECM1;CD59;TGFB1;CAT;RAB6A;ERP44
14527,GO:0065005,0.000208818727966922,0.999974215118661,8,18,protein-lipid complex assembly,BP,SNX9;PRKACA;P4HB;APOE;PRKACB;ZDHHC8;BIN1;ABCA7
6651,GO:0023056,0.000210307752908882,0.999853630634876,157,1158,positive regulation of signaling,BP,XDH;SH2D2A;NOS1;F2R;MST1R;RBCK1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;SERPINE2;IGFBP4;FKBP1A;PSMD2;RAB3B;PRNP;BNIP3;SSH1;SMURF2;TMOD2;G0S2;MAPKAPK3;NACC2;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;MAP2K2;STK25;SHANK3;AKT1;CARD11;IRAK1;EPN2;APOE;PKN1;PRKCZ;ITPR3;RFNG;FZD8;EPHA1;PTK6;SLC20A1;FERMT1;STK39;DKK1;PPP2R5B;AKAP12;SHC2;CD44;PLCG1;MAP3K9;MC1R;DEDD2;TSPAN5;PAK1;ZNF385A;NLGN2;DDIT3;TNFSF15;GLUL;RET;RAB29;RASGEF1A;RHOC;GRB10;SHANK2;GATA3;APLN;GNAI2;GLUD1;HSF1;ALOX15B;ADAM8;RGL2;FAM110C;MYDGF;VAMP2;GIPC1;SRC;LDLRAP1;TGM2;FAM162A;IRF7;STK24;GSK3A;STXBP1;PAG1;DUSP6;FYN;CLSTN1;LPAR3;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;NTSR1;MAP3K10;HEXIM1;FGFR1;MIB2;MFNG;MIF;SOCS2;BCL2L1;ADIPOR1;TNFRSF19;P2RX4;HPSE;LRRK1;FGF2;MAPK9;SHB;MAP3K12;TAOK1;ABCA7;TGFA;ATP6V1C2;KLK6;CASP4;EPHB2;CBL;CIB1;MAPK3;MAPK10;CSNK1D;LITAF;PAIP2;MINK1;SKAP2;ECM1;ITSN1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;STARD10;ERBB3;EP300;TRAF7
15540,GO:0071902,0.000215545321344286,0.999890081853903,47,264,positive regulation of protein serine/threonine kinase activity,BP,CCND1;F2R;MST1R;MAP2K1;SHC1;ERCC6;MAPKAPK3;MAP4K4;EGFR;MAP2K2;STK25;AKT1;IRAK1;PKN1;FZD8;STK39;DKK1;SHC2;PLCG1;MAP3K9;CCND2;PAK1;TNFSF15;CEMIP;PKD1;GNAI2;ADAM8;SRC;STK24;DUSP6;LPAR3;ITGA1;MAP3K10;FGFR1;MIF;SLC27A1;FGF2;MAP3K12;TAOK1;TGFA;CAMK1;CIB1;MAPK3;MAPK10;MINK1;TGFB1;TRAF7
10502,GO:0043393,0.000227562098849171,0.999899493417087,33,169,regulation of protein binding,BP,SORL1;CTNNBIP1;NFATC4;DVL1;FKBP1A;CSNK1E;PRKACA;PTPRF;AKT1;APOE;RFNG;CTSZ;PCSK9;DKK1;PPARA;TTBK2;PKD1;HSF1;SRC;LDLRAP1;STPG1;ADNP;MFNG;STUB1;TRIB3;ZFPM1;LRP1;CAMK1;GAS8;MAPK3;AIDA;ADAM15;EP300
11355,GO:0045664,0.000240803867175955,0.9998612066727,67,411,regulation of neuron differentiation,BP,ZMYND8;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;PTPRS;SSH1;SEMA3F;VLDLR;ETV5;MAP4K4;CSNK1E;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;SEMA4B;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;DNM2;NCS1;STK24;FYN;LPAR3;KIF13B;SEMA4G;FGFR1;ADNP;SOCS2;LRP1;ULK2;APBB1;IMPACT;KLK6;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;ARHGAP44;ADCY6;ITGA3;RAP1GAP2;ASAP1
10812,GO:0044282,0.000241619968150406,0.999872262309712,51,302,small molecule catabolic process,BP,NT5E;CBS;NOS1;CYP27B1;PCK2;CPT2;PGM1;SESN2;HAGH;LRP5;GPT2;CRAT;HK1;AKT1;ALDH1L2;APOE;ARG2;CRYL1;PFKP;ACAD10;TYSND1;HADH;PPARA;CD44;HMGCL;AHCY;GLUL;CEMIP;GLUD1;SRD5A3;BLMH;ACADVL;GSK3A;GALE;ALDH4A1;ALDH7A1;NTSR1;HYAL1;PNP;FGF2;ENTPD6;MLYCD;PHYH;ARG1;LONP2;CPT1B;ALDOC;LPIN3;TGFB1;PCYOX1;APOBEC3C
6761,GO:0030182,0.000245035803745719,0.999836335577853,123,854,neuron differentiation,BP,SH3KBP1;ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;SDK2;NEURL1;CRTC1;DLG4;DNMT3A;POSTN;PTPRS;SSH1;DBNDD1;SMARCA1;NYAP1;FAM129B;SNPH;SEMA3F;ADGRF1;VLDLR;ETV5;XBP1;MAP4K4;EGFR;CSNK1E;LAMB1;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;PRKCZ;NAGLU;FZD8;CTSZ;PTK6;PCSK9;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;PLCG1;TWF2;BIN1;SUFU;PAK1;SEMA4B;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;ANKS1A;IL1RAP;NUMB;TULP3;ALDH1A2;SRC;DNM2;NCS1;STK24;RERE;STXBP1;FYN;AGRN;LPAR3;WNT5B;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;FGFR1;ADNP;TENM2;PBX3;SOCS2;UNC119B;ULK1;LRP1;ROBO3;PAK4;ULK2;MAPK9;VASP;ATXN10;APBB1;SLIT3;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;MAPK3;NTNG1;MAPK10;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;MANF;ITGA3;RAP1GAP2;ASAP1
12331,GO:0048666,0.000246301941849182,0.999840820662745,105,709,neuron development,BP,SH3KBP1;ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;NEURL1;CRTC1;DLG4;POSTN;PTPRS;SSH1;DBNDD1;NYAP1;FAM129B;SEMA3F;ADGRF1;VLDLR;XBP1;MAP4K4;EGFR;LAMB1;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;PRKCZ;NAGLU;CTSZ;PTK6;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;PPP2R5B;OBSL1;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;ANKS1A;IL1RAP;NUMB;SRC;DNM2;NCS1;STK24;RERE;STXBP1;FYN;AGRN;LPAR3;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;FGFR1;ADNP;TENM2;PBX3;ULK1;LRP1;ROBO3;PAK4;ULK2;MAPK9;VASP;ATXN10;APBB1;SLIT3;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;MAPK3;NTNG1;MAPK10;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;MANF;ITGA3;RAP1GAP2;ASAP1
9802,GO:0040012,0.00024811062062191,0.999843876018619,93,620,regulation of locomotion,BP,PGF;ZMYND8;F2R;RAC2;SORL1;DOCK4;WNT7A;SERPINE2;POSTN;ITGA6;IDH2;PC;LAMA5;SSH1;SMURF2;CYGB;BBS2;SEMA3F;BCR;FBLN1;XBP1;EGFR;MMP14;LAMB1;ADARB1;CORO1B;AKT1;IFITM1;APOE;PKN1;TMSB4X;VPS4A;EPHA1;RRAS;MSN;TGFBR2;PLCG1;PAK1;TTBK2;MMP10;SEMA4B;PODXL;RET;LAMC2;RHOC;CEMIP;GATA3;ALOX15B;PTPRU;ADAM8;RHOBTB2;FAM110C;NUMB;SRC;STK24;SH3BP1;SPINT2;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;ANXA3;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ZNF609;P2RX4;ZP3;FGF2;ARAP3;RHOBTB1;VEGFB;CAMSAP3;CIB1;MAPK3;ARHGEF2;ADAM15;SRPX2;CEACAM1;MINK1;SRGAP2B;ECM1;TGFB1;ERBB3;ANXA1;ITGA3
12263,GO:0048522,0.000248557478917155,0.999805054488648,419,3491,positive regulation of cellular process,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;TSPAN1;ERCC1;ZMYND8;NOS1;CCND1;F2R;MST1R;RAC2;RBCK1;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SHC1;DOCK4;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;AP3D1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;TRIM65;DAP;IGFBP4;MMP1;TEF;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PRNP;BNIP3;SSH1;CITED4;SMARCA1;SMURF2;TMOD2;FAM129B;ESPN;G0S2;MAPKAPK3;SESN2;PLEK2;SEMA3F;NACC2;BCR;VLDLR;ETV5;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MARCKSL1;MAP4K4;EGFR;CSNK1E;PANO1;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;RFX2;PRKACA;CORO1B;TUB;HK1;MAP2K2;PPP1R13L;STK25;SHANK3;ATF4;FBXW8;SNX33;AKT1;IFITM1;CARD11;IRAK1;ARPC1A;PEG3;EPN2;APOE;FAM210B;ATP13A2;ARG2;METTL23;PKN1;ELK3;WWTR1;TMSB4X;PRKCZ;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;RFNG;VPS11;FZD8;VPS4A;CTSZ;EPHA1;ZMIZ2;PTK6;SLC20A1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FERMT1;DEAF1;SALL2;MSN;MAP1B;TGFBR2;GDI1;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;BNIP3L;PPARA;AKAP12;SYMPK;OBSL1;PRKACB;ZDHHC8;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;ANKIB1;TWF2;SURF4;LARP6;TFE3;CCND2;TSPAN5;BIN1;FSCN1;HTRA1;PAK1;SP6;BCL9L;ZNF385A;NLGN2;RAG1;SEMA4B;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;CUL7;RET;RAB29;RASGEF1A;LAMC2;MLXIP;RHOC;IFI27;GRB10;HLTF;PCBP4;CEMIP;SHANK2;PKD1;ASS1;DLG3;GATA3;APLN;PHF1;GNAI2;GLUD1;HSF1;ADGRB2;ALOX15B;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;RAI1;RGL2;HMGA2;FAM110C;ARL2;MICAL2;NUMB;ARHGEF4;IGFBP2;MYDGF;CLEC11A;EIF4EBP1;VAMP2;GIPC1;ALDH1A2;SRC;LDLRAP1;TAZ;TGM2;DNM2;FAM162A;IRF7;LRSAM1;RFXANK;STPG1;RAB1B;NCS1;STK24;PAK6;YPEL3;RERE;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;DUSP6;FYN;RAB25;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;PPM1F;LPAR3;WNT5B;PFN1;PSMD7;TNFRSF1A;ANXA3;FBXL15;VDR;PLEKHG5;MOAP1;GJC2;GAL;PUM1;ITGA1;SHISA5;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;RNF187;HSF4;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;RAB11FIP4;BCL2L1;STUB1;STK17A;ADIPOR1;TRIB3;DDB2;TCIRG1;SLC27A1;ZFPM1;TPCN1;ARFIP2;RAD23A;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;P2RX4;HPSE;E2F5;SMPD3;ZP3;LRRK1;SPIRE1;PNP;FGF2;EHD4;VAPB;MAPK9;SHB;PYM1;MAP3K12;VASP;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;LMAN1;MLYCD;APBB1;EPS8L1;RXRA;ARG1;ZHX3;VEGFB;TGFA;NCCRP1;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;TPBG;WIPF1;IMPACT;KLK6;CASP4;CAMK1;EPHB2;HGS;CBL;CIB1;WRAP73;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;UGCG;SRPX2;CEACAM1;PAIP2;MINK1;SKAP2;LPIN3;ECM1;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;CAT;LDHA;SPRED2;PIK3R2;STARD10;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;GNAS;ITGA3;PLGRKT;PXN;ZNF318;ARHGEF10L;EP300;WDFY2;ASAP1;FHOD1;TRAF7;RNF10
9070,GO:0035295,0.000261479487823211,0.999833246614582,98,654,tube development,BP,ANGPTL4;XDH;PGF;SH2D2A;ITGB4;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;SERPINE2;DLG1;ITGA6;RAPGEF3;LAMA5;FAM129B;ETV5;LRP5;ACVR2B;XBP1;EGFR;MMP14;THBS2;EPN1;EPN2;APOE;ARG2;ELK3;WWTR1;ARHGAP22;FZD8;CTSZ;EPHA1;PTK6;RRAS;DEAF1;SALL2;TGFBR2;PRKACB;WASF2;PLCG1;SUFU;PAK1;PODXL;CUL7;RET;PKD1;GATA3;APLN;ADGRB2;ADAM8;HMGA2;MICAL2;MYDGF;EDNRA;TULP3;ALDH1A2;SRC;TGM2;SDCCAG8;SPINT2;FUZ;PFN1;ANXA3;HSD11B1;VDR;THRA;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;TBC1D20;FGF2;RNH1;SHB;VASP;CHD7;ARG1;VEGFB;EPHB2;HGS;CIB1;MAPK3;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;CAT;ANXA1;ITGA3;EP300;STIM1
9190,GO:0035556,0.000262535108575354,0.999803414794803,253,1987,intracellular signal transduction,BP,TNIP1;XDH;NOS1;CHAC1;F2R;MST1R;RAC2;RBCK1;ASAP2;SORL1;NFATC4;ADGRL1;DVL1;MAP2K1;ADM2;SHC1;DOCK4;WNT7A;PTHLH;ERCC6;BOK;SHARPIN;ARAP1;DLG4;OBSCN;SERPINE2;DLG1;IGFBP4;FKBP1A;DGKA;PSMD2;RAB3B;RPS6KA2;NET1;RAPGEF3;PRNP;BNIP3;WWC3;RAB43;NYAP1;PLCH2;MAPKAPK3;SESN2;PLEK2;NACC2;ADGRF1;BCR;RAB31;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;MKNK2;ARHGAP23;PRKACA;MAP2K2;PPP1R13L;STK25;SHANK3;ATF4;P4HB;AKT1;CARD11;IRAK1;APOE;RIN2;PKN1;SYVN1;WWTR1;TMSB4X;PRKCZ;ITPR3;DGKQ;MAPK13;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GIT2;RRAS;GDI1;LIMK1;STK39;DKK1;PPP2R5B;CORO2A;AKAP12;SIPA1;SHC2;WASF2;CDC34;CD44;PLCG1;RAP1GDS1;MAP3K9;MC1R;DEDD2;PSD3;GIT1;CCDC88C;PAK1;ZNF385A;DDIT3;TNFSF15;ARHGAP39;FARP1;DUSP4;GNB1;DOCK9;RET;RAB29;RASGEF1A;RHOC;CYTH3;PCBP4;PKD1;GATA3;DOCK6;GNAI2;HSF1;APPL2;ADGRB2;WFS1;EFS;ADAM8;MAPKBP1;RGL2;RHOBTB2;FAM110C;PLCB3;ARHGEF4;MYDGF;EIF4EBP1;PIP5K1C;SRC;TGM2;DNM2;IRF7;RFXANK;RAB1B;CDC42BPB;NCS1;MARK3;STK24;RGS19;CARD19;PAK6;GSK3A;PAG1;SH3BP1;DUSP6;FYN;RAB25;PPM1F;RALGDS;LPAR3;GRINA;NISCH;PSMD7;TNFRSF1A;PLEKHG5;BRSK1;MOAP1;GAL;PUM1;ITGA1;SHISA5;PSKH1;MAP3K10;HEXIM1;FGFR1;RREB1;MIB2;MIF;SOCS2;ASB13;BCL2L1;STK17A;ADIPOR1;DNMBP;TRIB3;PITPNM2;LEMD2;ARFIP2;ARFGEF2;TRIB2;PLCD3;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;MAP3K12;ARAP3;TAOK1;ABCA7;RHOBTB1;EPS8L1;HOMER2;TAF6;TGFA;SEC14L1;CNOT11;CASP4;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;RAB4B;IQSEC1;MAPK3;MAPK10;LITAF;ARHGEF2;C12ORF66;MYZAP;AIDA;OCRL;ADAM15;CEACAM1;MINK1;ARHGAP44;AGAP1;ECM1;MBD3;ADCY6;ITSN1;TGFB1;CAT;RMI2;SPRED2;PIK3R2;CAMK2N1;ERBB3;RAB6A;GNAS;ITGA3;ARHGEF10L;EP300;RAP1GAP2;RASA3;ASAP1;TRAF7
11170,GO:0045211,0.000264778282315046,0.999895874640151,26,117,postsynaptic membrane,CC,F2R;NEURL1;DLG4;DLG1;PTPRS;BCR;SHANK3;COL13A1;PSD3;NLGN2;SHANK2;DLG3;SH2D5;GRIN3B;DNM2;NCS1;CLSTN1;ABHD17C;COMT;TENM2;SIGMAR1;KLHL17;APBB1;HOMER2;MINK1;CAMK2N1
13525,GO:0055074,0.000266411571068396,0.999873611459222,38,203,calcium ion homeostasis,BP,NOS1;F2R;CYP27B1;BOK;DLG4;FKBP1A;PRNP;BNIP3;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;GNB1;CEMIP;PKD1;WFS1;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
12259,GO:0048518,0.000270158658557818,0.999786489535156,462,3907,positive regulation of biological process,BP,TNIP1;EDEM1;ANGPTL4;XDH;PGF;FHL1;SH2D2A;TSPAN1;ERCC1;ZMYND8;NOS1;CCND1;F2R;MST1R;RAC2;RBCK1;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;DOCK4;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;AP3D1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;TRIM65;DAP;IGFBP4;MMP1;TEF;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;BNIP3;PC;SSH1;CITED4;SMARCA1;SMURF2;TMOD2;FAM129B;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;PLEK2;BBS2;SEMA3F;NACC2;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MARCKSL1;MAP4K4;EGFR;CSNK1E;PANO1;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;RFX2;PRKACA;ADARB1;CORO1B;TUB;ACTA2;HK1;MAP2K2;PPP1R13L;STK25;SHANK3;ATF4;P4HB;HECW2;FBXW8;SNX33;AKT1;IFITM1;CARD11;IRAK1;ARPC1A;PEG3;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;ATP13A2;ARG2;METTL23;PKN1;ELK3;WWTR1;TMSB4X;PRKCZ;RNF135;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;FZD8;VPS4A;CTSZ;EPHA1;ZMIZ2;PTK6;SLC20A1;ORAI1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FERMT1;RRAS;DEAF1;SALL2;MSN;MAP1B;TGFBR2;GDI1;MVB12B;LIMK1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;BNIP3L;PPARA;PRSS8;AKAP12;SYMPK;OBSL1;PRKACB;ZDHHC8;SHC2;WASF2;CDC34;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MC1R;DEDD2;ANKIB1;TWF2;SURF4;LARP6;TFE3;CCND2;TSPAN5;BIN1;FSCN1;HTRA1;PAK1;SP6;BCL9L;ZNF385A;NLGN2;RAG1;SEMA4B;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;CUL7;GGA3;GGA1;STOM;PTPN9;RET;RAB29;RASGEF1A;LAMC2;MLXIP;RHOC;IFI27;NID1;GRB10;CYTH3;HLTF;PCBP4;CEMIP;SHANK2;PKD1;ASS1;DLG3;GATA3;APLN;PHF1;GNAI2;GLUD1;HSF1;ADGRB2;ALOX15B;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;RAI1;RGL2;HMGA2;ARID5B;FAM110C;ARL2;MICAL2;NUMB;ARHGEF4;IGFBP2;MYDGF;CLEC11A;EIF4EBP1;VAMP2;GIPC1;ALDH1A2;SRC;LDLRAP1;GLRX;TAZ;TGM2;DNM2;FAM162A;IRF7;LRSAM1;RFXANK;STPG1;RAB1B;NCS1;STK24;PAK6;YPEL3;STX5;RERE;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;DUSP6;FYN;RAB25;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;PPM1F;LPAR3;WNT5B;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;FBXL15;VDR;ABHD17C;PLEKHG5;MOAP1;GJC2;GAL;PUM1;ITGA1;SHISA5;CTSL;EHF;COMT;TNRC6B;THRA;PLTP;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;RNF187;HSF4;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;RAB11FIP4;BCL2L1;STUB1;STK17A;ADIPOR1;TRIB3;DDB2;TCIRG1;SLC27A1;ZFPM1;TPCN1;ARFIP2;RAD23A;ARFGEF2;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;P2RX4;HPSE;E2F5;SMPD3;ZP3;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;VAPB;MAPK9;SHB;PYM1;MAP3K12;VASP;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;LMAN1;MLYCD;APBB1;EPS8L1;RXRA;ARG1;ZHX3;VEGFB;TGFA;NCCRP1;SEC14L1;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;TPBG;WIPF1;IMPACT;KLK6;CASP4;CAMK1;EPHB2;HGS;CBL;CIB1;WRAP73;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;UGCG;TMBIM1;SRPX2;CEACAM1;PAIP2;MINK1;SKAP2;LPIN3;ECM1;CD59;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;CAT;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;GNAS;ITGA3;PLGRKT;PXN;ZNF318;ARHGEF10L;EP300;WDFY2;STIM1;ASAP1;FHOD1;TRAF7;RNF10
7341,GO:0031346,0.00027748376040851,0.999857833422612,46,257,positive regulation of cell projection organization,BP,ZMYND8;RAC2;DVL1;MAP2K1;NEURL1;CRTC1;ARAP1;DLG4;ESPN;PLEK2;VLDLR;CORO1B;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;PPP2R5B;OBSL1;WASF2;TWF2;FSCN1;PAK1;CUL7;RET;SHANK2;IL1RAP;SRC;DNM2;FYN;FUZ;AGRN;LPAR3;PFN1;FGFR1;RREB1;ADNP;TENM2;APBB1;EPS8L1;CAMK1;WRAP73;ITGA3
17092,GO:0099565,0.000285612611988907,0.999927167525668,14,47,chemical synaptic transmission, postsynaptic,BP,ZMYND8;DVL1;WNT7A;DLG4;SSH1;SHANK3;AKT1;PRKCZ;NLGN2;SHANK2;GRIN3B;GSK3A;NTSR1;P2RX4
12610,GO:0050767,0.000287990439500347,0.999825734432567,78,498,regulation of neurogenesis,BP,ZMYND8;NOS1;SORL1;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;PTPRS;IDH2;SSH1;SEMA3F;VLDLR;ETV5;MAP4K4;CSNK1E;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;SEMA4B;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;NUMB;DNM2;NCS1;STK24;FYN;LPAR3;KIF13B;GJC2;SEMA4G;FGFR1;ADNP;SOCS2;LRP1;ZNF609;ULK2;CHD7;APBB1;IMPACT;KLK6;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;ARHGAP44;ADCY6;TGFB1;SLC45A3;ITGA3;RAP1GAP2;ASAP1;RNF10
3566,GO:0007611,0.000292076062093081,0.999879392744827,28,133,learning or memory,BP,CRTC1;DLG4;PRNP;TMOD2;ADGRF1;VLDLR;EGFR;SHANK3;APOE;PRKCZ;ITPR3;DEAF1;DKK1;CCND2;ZNF385A;RAG1;SHANK2;ASIC1;B4GALT2;FYN;COMT;THRA;NTSR1;ADNP;ABCA7;EPHB2;PAIP2;ITGA3
15828,GO:0072507,0.000292728722920728,0.99985596192214,41,227,divalent inorganic cation homeostasis,BP,NOS1;F2R;CYP27B1;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;EGFR;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
13629,GO:0060079,0.000297140911149637,0.999928909438038,13,42,excitatory postsynaptic potential,BP,ZMYND8;DVL1;WNT7A;DLG4;SSH1;SHANK3;AKT1;PRKCZ;NLGN2;SHANK2;GRIN3B;GSK3A;P2RX4
7249,GO:0031175,0.000297601398583218,0.999809845536813,97,649,neuron projection development,BP,SH3KBP1;ZMYND8;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;NEURL1;CRTC1;DLG4;POSTN;PTPRS;SSH1;DBNDD1;NYAP1;FAM129B;SEMA3F;ADGRF1;VLDLR;MAP4K4;EGFR;LAMB1;ADARB1;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;PRKCZ;CTSZ;PTK6;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;PPP2R5B;OBSL1;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;IL1RAP;NUMB;SRC;DNM2;NCS1;STK24;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;ITGA1;FRYL;SEMA4G;FGFR1;ADNP;ULK1;LRP1;ROBO3;PAK4;ULK2;VASP;ATXN10;APBB1;SLIT3;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;MANF;ITGA3;RAP1GAP2;ASAP1
3222,GO:0006874,0.000298595874862585,0.999858990753542,37,197,cellular calcium ion homeostasis,BP,NOS1;F2R;BOK;DLG4;FKBP1A;PRNP;BNIP3;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;GNB1;CEMIP;PKD1;WFS1;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
16796,GO:0098588,0.000318414818581748,0.999767745947928,199,1522,bounding membrane of organelle,CC,EDEM1;TSPAN1;NOS1;RAC2;ASAP2;SORL1;QSOX1;WNT7A;CYP27B1;AP3D1;BOK;ARAP1;DLG4;BSG;PITPNM1;FKBP1A;RAB3B;CKAP4;PTPRS;BNIP3;CD68;AGPAT3;RAB43;DBNDD1;SCYL1;COPG1;MARCH9;BBS2;SYNE3;RAB31;CHPF;LPCAT1;VLDLR;XYLT1;EGFR;HK1;MAP2K2;XYLT2;STK25;SHANK3;ARMCX2;IRAK1;EPN2;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;AP1B1;YIF1A;AP2A2;ATP7B;ITPR3;RFNG;VPS11;VPS4A;CTSZ;PI4K2A;RETSAT;PCSK9;SEC23A;B4GALNT4;NDST2;MVB12B;SERPINB6;DKK1;BNIP3L;KDELR1;YIPF2;CD44;SURF4;MALL;DMXL2;GGA3;GGA1;STOM;GNB1;RET;CORO7;MLXIP;IFI27;CYTH3;TMED3;CEMIP;SHANK2;PKD1;ATP11A;ARL8A;DOPEY2;SLC2A3;ANTXR2;APPL2;SLC12A4;ASPH;ADAM8;TMEM8A;PLIN3;B4GALT2;VAMP2;PIP5K1C;B3GNT3;LDLRAP1;CHMP5;APLP2;PEX10;DNM2;UBR4;IRF7;NUCB1;RAB1B;TMEM9;TMEM44;CPTP;STX5;COG8;CLSTN1;WNT5B;TNFRSF1A;ANXA3;SLC33A1;ABHD17C;STX10;CHST14;MOAP1;GNB2;MCFD2;UBA1;SLC35B4;WDFY3;SEC24C;ATP2C2;MFNG;MTMR4;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;ST3GAL3;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;ULK1;LRP1;P2RX4;HPSE;USO1;SMPD3;TBC1D20;EHD4;MAP1LC3B;ST6GALNAC2;VAPB;COG1;SNTB2;ABCA7;LMAN1;ENTPD6;ARG1;TGFA;ATP6V1C2;CYB561;BPHL;VAT1;SNAP29;HGS;TRAPPC1;RAB4B;CPT1B;CSNK1D;DRAM2;LITAF;FURIN;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;B4GALT6;OCRL;HM13;CEACAM1;GALNT3;CD59;MAP6;PCYOX1;PPP6R1;CAT;SPRED2;AZIN2;ANXA1;RAB6A;ZFYVE21;ARCN1;STIM1
3187,GO:0006812,0.00031910065868065,0.999801099068333,86,578,cation transport,BP,FHL1;NOS1;F2R;SERINC2;KCNG1;CYP27B1;SCN8A;DLG4;SERPINE2;DLG1;FKBP1A;RAB3B;SLC2A9;PRNP;SLC12A7;PRKACA;SHANK3;ATF4;HECW2;AKT1;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PRSS8;PLCG1;SLC38A10;NLGN2;DDIT3;STOM;CEMIP;SHANK2;PKD1;NIPA1;GNAI2;GRIN3B;ASIC1;WFS1;SLC12A4;FAM155B;SLC13A3;VAMP2;GLRX;DNM2;SARAF;NDUFA4L2;NCS1;FYN;LPAR3;SLC6A9;SLC33A1;VDR;GJC2;GAL;SLC13A5;NTSR1;ATP2C2;VPS9D1;TCIRG1;TPCN1;HSPA2;P2RX4;FGF2;CHD7;HOMER2;ARG1;SLC10A6;SEC14L1;ATP6V1C2;KCNC4;EPHB2;SLC5A1;MINK1;SLC30A1;TGFB1;SLC15A1;AZIN2;ORAI3;STIM1;RASA3
6594,GO:0022604,0.000328801671557928,0.999817189149998,57,339,regulation of cell morphogenesis,BP,SH3KBP1;NFATC4;DVL1;MAP2K1;WNT7A;ARAP1;DLG4;DLG1;POSTN;NET1;PTPRS;SSH1;SEMA3F;SYNE3;FBLN1;CSNK1E;CORO1B;STK25;PARVB;SHANK3;HECW2;FBXW8;APOE;FMNL2;MSN;MAP1B;GDI1;LIMK1;OBSL1;CD44;TWF2;PAK1;TTBK2;BCL9L;SEMA4B;CUL7;RET;RHOC;RHOBTB2;SRC;DNM2;AGO4;FYN;LPAR3;KIF13B;SEMA4G;RREB1;ADNP;ULK2;ARAP3;RHOBTB1;WIPF1;EPHB2;CIB1;CSNK1D;ARHGAP44;ANXA1
10811,GO:0044281,0.000346838134940082,0.999747655863418,192,1504,small molecule metabolic process,BP,NT5E;XDH;CBS;NOS1;SORL1;PTHLH;CYP27B1;LMF1;NAPRT;PCK2;DLG4;CPT2;BSG;NR1D1;DLG1;IGFBP4;SLC16A3;PGM1;PSMD2;SLC2A9;RAPGEF3;PRSS3;NAGS;IDH2;PC;CRTAP;NME4;PLCH2;CYGB;SESN2;ACOT7;HAGH;CHPF;VLDLR;LRP5;AARS;H6PD;XYLT1;GPT2;ADCY7;XBP1;PGLS;TK2;ACOT1;CRAT;CARS;HK1;XYLT2;ATF4;P4HB;PSAT1;AKT1;MDH2;CARD11;ALDH1L2;APOE;ARG2;UAP1;CRYL1;TMSB4X;GALNS;FAM20C;DGKQ;PFKP;RETSAT;PCSK9;ACAD10;NMRK1;TYSND1;HADH;NDST2;PPARA;DHTKD1;NADK;TST;WDTC1;CD44;PLCG1;GTPBP1;ELOVL1;OSBPL5;HMGCL;TSTA3;ISYNA1;ERO1B;AHCY;ACSF2;GAMT;GLUL;FUCA1;CEMIP;ASS1;PARP10;DLG3;GNAI2;SLC2A3;GLUD1;PPCS;PANK4;ALOX15B;SRD5A3;SDHA;SLC6A6;NEIL1;PYCR2;BLMH;PLCB3;CAP1;P4HA1;B4GALT2;AKR7A2;ALDH1A2;B3GNT3;SRC;LDLRAP1;GLRX;CBR4;TAZ;ACADVL;GARS;GSK3A;TALDO1;PMVK;OAS1;MPI;SPTLC2;ASNS;GALE;NISCH;ALDH4A1;PSMD7;TNFRSF1A;ALDH7A1;VDR;UCKL1;CHST14;COMT;PLTP;NTSR1;MGLL;SLC35B4;LHPP;FGFR1;ADNP;HYAL1;GUK1;MIF;AMPD2;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;TCIRG1;SLC27A1;HLCS;SARS2;SLC6A14;AOX1;PLCD3;PNP;FGF2;ABHD14B;ENTPD6;MLYCD;PHYH;RXRA;ARG1;SEC14L2;BPHL;ACY1;LONP2;GGT1;MAPK3;CPT1B;ALDOC;GLO1;NDUFS2;B4GALT6;OCRL;CEACAM1;LPIN3;UROS;ADCY6;TGFB1;PCYOX1;CAT;LDHA;AZIN2;ANXA1;PODXL2;SLC45A3;APOBEC3C
10639,GO:0043627,0.000348978641250426,0.999908449116282,14,49,response to estrogen,BP,CCND1;WNT7A;CYP27B1;CITED4;MMP14;TGFBR2;GATA3;IGFBP2;GAL;COMT;WBP2;LDHA;ASH2L;EP300
10900,GO:0044431,0.000351996172057893,0.999769758784967,105,723,Golgi apparatus part,CC,EDEM1;CHAC1;ASAP2;SORL1;SDC1;QSOX1;WNT7A;SNX9;AP3D1;BOK;ARAP1;BSG;PITPNM1;POSTN;AGPAT3;RAB43;SCYL1;COPG1;MARCH9;RAB31;CHPF;LPCAT1;XYLT1;EGFR;MMP14;XYLT2;STK25;GPC4;AP1B1;YIF1A;ATP7B;RFNG;CTSZ;PI4K2A;SEC23A;B4GALNT4;NDST2;KDELR1;YIPF2;SURF4;MALL;GGA3;RAB29;CORO7;CYTH3;TMED3;PKD1;DOPEY2;B4GALT2;VAMP2;B3GNT3;LDLRAP1;DNM2;NUCB1;RAB1B;STX5;COG8;PCSK6;CLSTN1;AGRN;WNT5B;TNFRSF1A;SLC33A1;STX10;CHST14;MCFD2;SLC35B4;SEC24C;ATP2C2;MFNG;PCSK1N;ST3GAL3;DNMBP;ANGEL1;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;USO1;SMPD3;TBC1D20;ST6GALNAC2;VAPB;COG1;ABCA7;LMAN1;ENTPD6;TGFA;SNAP29;TRAPPC1;CSNK1D;LITAF;FURIN;UGCG;LLGL1;B4GALT6;OCRL;GALNT3;CD59;TGFB1;PPP6R1;AZIN2;PODXL2;RAB6A;ARCN1
7768,GO:0032279,0.000355315445228022,0.999843753671169,31,152,asymmetric synapse,CC,NOS1;DVL1;NEURL1;SHARPIN;DLG4;DLG1;PTPRS;PRNP;BNIP3;BCR;SHANK3;MAP1B;PSD3;SHANK2;DLG3;SH2D5;SRC;DNM2;NCS1;FYN;CLSTN1;ABHD17C;SIGMAR1;ARFGEF2;P2RX4;KLHL17;HOMER2;ARHGEF2;MINK1;ARHGAP44;CAMK2N1
12212,GO:0048365,0.000358725712626818,0.999900383628367,15,53,Rac GTPase binding,MF,DVL1;DOCK4;PKN1;PAK1;FARP1;ARHGEF4;PAK6;SH3BP1;ARFIP2;PAK4;EPS8L1;ARHGEF2;OCRL;ARHGAP44;SRGAP2B
13628,GO:0060078,0.000366928927845516,0.999903583895266,14,48,regulation of postsynaptic membrane potential,BP,ZMYND8;DVL1;WNT7A;DLG4;SSH1;SHANK3;AKT1;PRKCZ;NLGN2;SHANK2;GRIN3B;GSK3A;NTSR1;P2RX4
17279,GO:0120039,0.000367381607870889,0.999781182502272,71,445,plasma membrane bounded cell projection morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;POSTN;PTPRS;SSH1;NYAP1;FAM129B;SEMA3F;VLDLR;MAP4K4;EGFR;ADARB1;CORO1B;STK25;SHANK3;HECW2;FBXW8;APOE;PRKCZ;MAP1B;LAMB2;GDI1;LIMK1;OBSL1;WASF2;CD44;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;SRC;DNM2;STK24;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;ITGA1;SEMA4G;RREB1;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;IMPACT;EPHB2;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6
18530,GO:1903649,0.000376472058339376,0.999947833689991,8,19,regulation of cytoplasmic transport,BP,SORL1;MAP2K1;MAP2K2;VPS11;MSN;RAB29;SRC;MAPK3
16900,GO:0098815,0.000380211386544325,0.999937970863223,9,23,modulation of excitatory postsynaptic potential,BP,ZMYND8;DVL1;WNT7A;DLG4;SSH1;SHANK3;PRKCZ;NLGN2;SHANK2
12916,GO:0051239,0.000381131102521014,0.999715070692801,233,1834,regulation of multicellular organismal process,BP,ANGPTL4;XDH;PGF;ZMYND8;NOS1;CCND1;F2R;SORL1;CTNNBIP1;NFATC4;ADGRL1;DVL1;MAP2K1;ADM2;DOCK4;PLAT;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;DLG1;POSTN;PSMD2;RAPGEF3;PTPRS;PRNP;IDH2;LAMA5;SSH1;WWC3;SMURF2;FAM129B;TNNT1;BBS2;SEMA3F;BCR;VLDLR;ETV5;LRP5;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;THBS2;PRKACA;PTPRF;HK1;EPN1;STK25;SHANK3;ATF4;HECW2;FBXW8;AKT1;IFITM1;CARD11;GPC4;IRAK1;SERPING1;EPN2;APOE;EHD3;FAM210B;ARG2;WWTR1;TMSB4X;AP2A2;PRKCZ;RNF135;FAM20C;ITPR3;MAPK13;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;FERMT1;RRAS;DEAF1;MAP1B;TGFBR2;CSMD3;GDI1;LIMK1;STK39;DKK1;PPP2R5B;UBE2J1;OBSL1;PRKACB;PLCG1;MC1R;TWF2;TFE3;BIN1;SUFU;PAK1;SP6;BCL9L;NLGN2;RAG1;SEMA4B;GAMT;DDIT3;CUL7;ADAMTS7;PTPN9;RET;RAB29;PROCR;SHANK2;GATA3;APLN;HSF1;ADGRB2;ALOX15B;IL1RAP;ASPH;ADAM8;MAPKBP1;RAI1;HMGA2;NUMB;MYDGF;TULP3;SRC;DNM2;AGO4;IRF7;NCS1;STK24;CPTP;PER3;GSK3A;SH3BP1;DUSP6;FYN;RAB25;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;PFN1;PSMD7;TNFRSF1A;ANXA3;VDR;KIF13B;GJC2;GAL;PUM1;CTSL;COMT;TNRC6B;THRA;NTSR1;AMIGO2;TIMP1;MGLL;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;F12;PBX3;MIF;SOCS2;MTMR4;ADIPOR1;SLC27A1;ZFPM1;ARFGEF2;LRP1;TRIB2;ZNF609;PAK4;P2RX4;HPSE;ULK2;ZP3;PNP;FGF2;RNH1;CHD7;ABCA7;APBB1;RXRA;ARG1;ZHX3;VEGFB;SEC14L1;TPBG;IMPACT;KLK6;CAMK1;EPHB2;HGS;MYL9;CIB1;MAPK3;CSNK1D;LITAF;FURIN;ARHGEF2;TMBIM1;SRPX2;CEACAM1;ARHGAP44;ECM1;ADCY6;IGF2BP3;TGFB1;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;RAP1GAP2;STIM1;ASAP1;RNF10
3310,GO:0007015,0.000382190555004204,0.999796419272654,49,284,actin filament organization,BP,RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;ESPN;ITGB5;CORO1B;SHANK3;ARPC1A;TMSB4X;EPHA1;SH3PXD2B;LIMK1;OBSL1;WASF2;MSRB2;TWF2;FSCN1;PAK1;CORO7;RHOC;FAT1;EFS;RHOBTB2;MICAL2;CAP1;SRC;CAPG;SH3BP1;PPM1F;PFN1;MICAL1;FRYL;ARFIP2;SPIRE1;VASP;RHOBTB1;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;ARHGEF2;PXN;ARHGEF10L;PLEKHH2;FHOD1
14615,GO:0070161,0.000390273448334279,0.999766536493345,71,464,anchoring junction,CC,FLNC;FHL1;SH3KBP1;CAPN2;MPRIP;RAC2;MAP2K1;BSG;DLG1;SLC9A3R2;ITGA6;FAM129B;MRC2;ITGB5;EGFR;MMP14;CORO1B;MAP2K2;PARVB;P4HB;EHD3;TNS4;ARHGAP22;FERMT1;GIT2;RRAS;MSN;CD99;LIMK1;AKAP12;CD44;GIT1;PAK1;CYTH3;PROCR;CADM4;FAT1;ARL2;NUMB;CAP1;FLNB;PIP5K1C;TGM2;DNM2;CAPN5;SH3BP1;PFN1;ITGA1;GNB2;UBA1;MISP;AFAP1;PTPN12;LRP1;PAK4;VASP;SNTB2;CAMSAP3;BAIAP2L1;CBL;MAPK3;KIFC3;ARHGEF2;ADAM15;CEACAM1;CD59;CAT;ANXA1;ZFYVE21;ITGA3;PXN
4373,GO:0009991,0.000390748672650573,0.999782127686765,56,342,response to extracellular stimulus,BP,CBS;ERCC1;CCND1;CST3;CYP27B1;PCK2;DAP;DNMT3A;POSTN;ITGA6;SSH1;SESN2;BBS2;XBP1;EGFR;ATF4;AKT1;APOE;DGKQ;PCSK9;TGFBR2;PPARA;SIPA1;HMGCL;AHCY;DDIT3;GLUL;GAS2L1;GNAI2;HSF1;IGFBP2;ALDH1A2;SRC;STK24;FYN;ASNS;VDR;COMT;ADNP;USF2;PCSK1N;HLCS;ULK1;P2RX4;ULK2;MAP1LC3B;ARG1;IMPACT;CBL;MAPK3;KANK2;C12ORF66;MBD3;TGFB1;CAT;LDHA
10503,GO:0043394,0.000390926360076959,0.999935966570562,9,23,proteoglycan binding,MF,PTPRS;CTSB;PTPRF;GPC4;NID1;AGRN;CTSL;LRP1;HPSE
12428,GO:0048858,0.000391670760639883,0.999766123617561,71,446,cell projection morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;POSTN;PTPRS;SSH1;NYAP1;FAM129B;SEMA3F;VLDLR;MAP4K4;EGFR;ADARB1;CORO1B;STK25;SHANK3;HECW2;FBXW8;APOE;PRKCZ;MAP1B;LAMB2;GDI1;LIMK1;OBSL1;WASF2;CD44;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;SRC;DNM2;STK24;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;ITGA1;SEMA4G;RREB1;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;IMPACT;EPHB2;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6
13145,GO:0051668,0.000393476245013413,0.999863260412058,20,84,localization within membrane,BP,DVL1;AP3D1;DLG4;DLG1;SSH1;MARVELD1;ETV5;SHANK3;APOE;SEC23A;MALL;REEP2;DLG3;DNM2;AGRN;KIF17;SEC24C;TBC1D20;ARHGAP44;TGFB1
6258,GO:0019838,0.000404421410196571,0.999858947442845,20,85,growth factor binding,MF,ITGB4;LTBP2;LTBP4;SHC1;IGFBP4;ITGA6;ACVR2B;EGFR;RHBDF2;TGFBR2;LTBP1;HTRA1;IGFBP2;PCSK6;WISP1;CRIM1;FGFR1;FURIN;SRPX2;ERBB3
15497,GO:0071825,0.000410630559121641,0.99993131012437,9,24,protein-lipid complex subunit organization,BP,SNX9;PRKACA;P4HB;APOE;PRKACB;ZDHHC8;BIN1;PLTP;ABCA7
3258,GO:0006928,0.000410739194912761,0.999705410096121,170,1270,movement of cell or subcellular component,BP,PGF;SH3KBP1;ITGB4;TSPAN1;ZMYND8;F2R;RAC2;SORL1;SDC1;DVL1;MAP2K1;SHC1;DOCK4;PLAT;WNT7A;NEURL1;AP3D1;ARAP1;SERPINE2;BSG;KLC2;DLG1;SLC16A3;MMP1;POSTN;ITGA6;NET1;PRSS3;IDH2;LAMA5;SSH1;SMURF2;COPG1;CYGB;FAM129B;TNNT1;BBS2;SEMA3F;BCR;VLDLR;LRP5;FBLN1;XBP1;EGFR;MMP14;LAMB1;FYCO1;ADARB1;PTPRF;CORO1B;SHANK3;AKT1;IFITM1;APOE;PKN1;TMSB4X;AP2A2;PRKCZ;EPHA1;PTK6;DNAAF5;FERMT1;RRAS;MSN;MAP1B;TGFBR2;LAMB2;WASF2;CD44;PLCG1;FSCN1;PAK1;TTBK2;MMP10;SEMA4B;NAV1;PODXL;TUBB3;RET;RASGEF1A;LAMC2;RHOC;GRB10;PROCR;CEMIP;GATA3;WDR66;ANKS1A;ALOX15B;FAT1;EFS;PTPRU;ADAM8;MYH15;ARID5B;RHOBTB2;DYNLRB1;FAM110C;NUMB;CAP1;PIP5K1C;GIPC1;SRC;CDC42BPB;STK24;PAK6;SDCCAG8;RERE;SH3BP1;SPINT2;FYN;RAB25;FUZ;PPM1F;WNT5B;PFN1;NISCH;KIF17;ANXA3;MBOAT7;KIF13B;ELMO3;PLEKHG5;ITGA1;PLTP;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;MIF;ADIPOR1;LRP1;ROBO3;ZNF609;PAK4;P2RX4;ZP3;FGF2;VASP;ARAP3;MYO1D;RHOBTB1;SLIT3;VEGFB;NDE1;CAMSAP3;WIPF1;EPHB2;GAS8;CIB1;SOCS7;MAPK3;KIFC3;ARHGEF2;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;SRGAP2B;ECM1;TGFB1;PIK3R2;ERBB3;ANXA1;PODXL2;RAB6A;ITGA3;PXN
18131,GO:1902745,0.000420166198767063,0.999940762510409,8,19,positive regulation of lamellipodium organization,BP,RAC2;CORO1B;WASF2;TWF2;FSCN1;SRC;DNM2;RREB1
12690,GO:0050878,0.000427347070269422,0.99976771592981,51,308,regulation of body fluid levels,BP,XDH;CCND1;F2R;RAC2;PLAT;NEURL1;SERPINE2;DGKA;FBLN1;ADCY7;XBP1;PRKACA;AKT1;SERPING1;APOE;EHD3;PHF21A;ATP7B;ITPR3;DGKQ;STK39;PRKACB;ZNF385A;GNB1;DOCK9;PROCR;GATA3;APLN;DOCK6;WFS1;TFPI2;SRC;STXBP1;FYN;MICAL1;VDR;F12;USF2;SOCS2;ZFPM1;P2RX4;HPSE;RCOR1;LMAN1;EPHB2;MYL9;MAPK3;CEACAM1;CD59;ADCY6;GNAS
8842,GO:0034620,0.000432883562818617,0.99981935957629,27,131,cellular response to unfolded protein,BP,EDEM1;CCND1;SHC1;BOK;XBP1;ATF4;PDIA5;SYVN1;YIF1A;TSPYL2;CREB3L2;PPP2R5B;SEC63;DDIT3;CUL7;HSF1;WFS1;MYDGF;ACADVL;GSK3A;ASNS;STUB1;HSPA2;VAPB;HSPA13;DNAJB9;EP300
16874,GO:0098772,0.000435854844841543,0.999692763434521,151,1130,molecular function regulator,MF,ANGPTL4;PGF;NOS1;CCND1;RAC2;ASAP2;MAP2K1;ADM2;SHC1;DOCK4;WNT7A;PTHLH;ERCC6;CST3;ARAP1;DLG4;OBSCN;SERPINE2;DLG1;CMTM4;PSMD2;NET1;RAPGEF3;SBF1;SESN2;SEMA3F;BCR;FBLN1;EVI5L;CMTM7;EGFR;MMP14;ARHGAP23;MAP2K2;AKT1;SERPING1;BAG3;APOE;RIN2;PRKCZ;DGKQ;ARHGAP22;PPP2R3B;PITRM1;SH3PXD2B;PCSK9;GIT2;PPP1R35;GDI1;RIN1;SERPINB6;DKK1;PPP2R5B;PRSS8;SIPA1;WDTC1;SHC2;TBC1D16;RAP1GDS1;ATG13;TBC1D14;PRDX5;PSD3;PPP1R12C;GIT1;SEMA4B;TNFSF15;TBC1D9B;ARHGAP39;FARP1;DOCK9;RET;RASGEF1A;CYTH3;APLN;DOCK6;APPL2;TFPI2;RGL2;PPP1R14A;ARL2;LY6E;ARHGEF4;CLEC11A;APLP2;DENND2A;SCG5;RGS19;SH3BP1;SPINT2;FYN;RALGDS;PFN1;ANXA3;PLEKHG5;GAL;GNB2;HEXIM1;TIMP1;CRIM1;SEMA4G;FGFR1;MIF;SOCS2;PCSK1N;VPS9D1;DNMBP;TRIB3;ARFGEF2;TRIB2;ZP3;TBC1D20;FGF2;RNH1;ARAP3;TAOK1;EPS8L1;TBC1D2B;VEGFB;TGFA;SEC14L1;TRAPPC1;CIB1;SOCS7;IQSEC1;FURIN;ARHGEF2;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;SLC30A1;CCNE1;ITSN1;TGFB1;SH3PXD2A;MANF;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;ARHGEF10L;RAP1GAP2;STIM1;RASA3;ASAP1
15825,GO:0072503,0.00044056802791387,0.999782457177201,39,217,cellular divalent inorganic cation homeostasis,BP,NOS1;F2R;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
6652,GO:0023057,0.000464988404139674,0.999679972368156,130,945,negative regulation of signaling,BP,TNIP1;XDH;SH3KBP1;MDFI;CHAC1;CCND1;MST1R;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;NEURL1;BOK;SERPINE2;NR1D1;DLG1;IGFBP4;IFI6;PSMD2;ITGA6;PTPRS;PRNP;WWC3;SMURF2;FAM129B;SESN2;FBLN1;XBP1;MAP4K4;EGFR;MMP14;EPN1;SHANK3;AKT1;EPN2;APOE;PEAR1;SYVN1;WWTR1;TMSB4X;PRKCZ;EPHA1;PTK6;PCSK9;FERMT1;TGFBR2;HADH;DKK1;PPP2R5B;ARRDC1;PRKACB;LTBP1;CDC34;CD44;HTRA1;SUFU;BCL9L;ZNF385A;DDIT3;DUSP4;RET;GRB10;SHANK2;GATA3;APLN;GNAI2;ASIC1;WFS1;MAPKBP1;IGFBP2;TULP3;SRC;DNM2;MARK3;RGS19;CARD19;GSK3A;STXBP1;SH3BP1;DUSP6;FYN;FUZ;WNT5B;GRINA;PSMD7;ITGA1;FGFR1;ADNP;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;SNX25;PTPN12;LEMD2;PMEPA1;LRP1;MGRN1;ARAP3;BICC1;SLIT3;ARG1;INVS;SEC14L1;EPHB2;HGS;CBL;CIB1;SOCS7;KANK2;DNAJB9;ARHGEF2;C12ORF66;TMBIM1;AIDA;CEACAM1;ARHGAP44;ECM1;SLC30A1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;ITGA3;RASA3
18390,GO:1903358,0.00046635386898327,0.99994597103837,7,15,regulation of Golgi organization,BP,MAP2K1;MAP2K2;EHD3;DNM2;STX5;CAMSAP3;MAPK3
2675,GO:0006026,0.000471617766211301,0.999880184405351,13,44,aminoglycan catabolic process,BP,SDC1;GPC4;GALNS;NAGLU;CD44;CTBS;FUCA1;CEMIP;AGRN;HYAL1;HPSE;FGF2;TGFB1
7329,GO:0031333,0.000476669017855497,0.999825874985001,21,93,negative regulation of protein complex assembly,BP,SORL1;CTNNBIP1;TMOD2;TMSB4X;PRKCZ;EML2;DKK1;TWF2;SRC;CAPG;CPTP;STXBP1;PFN1;THRA;PMEPA1;ULK1;IMPACT;TMSB10;KANK2;ARHGEF2;EP300
13295,GO:0051963,0.000478840203844252,0.99987867094159,13,43,regulation of synapse assembly,BP,ADGRL1;WNT7A;THBS2;NLGN2;ADGRB2;IL1RAP;CLSTN1;AGRN;AMIGO2;ADNP;TPBG;EPHB2;SRPX2
18052,GO:1902531,0.000491676226711373,0.999644536647851,174,1313,regulation of intracellular signal transduction,BP,TNIP1;XDH;NOS1;F2R;MST1R;RAC2;RBCK1;ASAP2;SORL1;MAP2K1;SHC1;WNT7A;ERCC6;BOK;SHARPIN;ARAP1;OBSCN;SERPINE2;DLG1;IGFBP4;FKBP1A;NET1;PRNP;WWC3;MAPKAPK3;SESN2;NACC2;BCR;FBLN1;XBP1;MAP4K4;EGFR;ARHGAP23;PRKACA;MAP2K2;PPP1R13L;STK25;P4HB;AKT1;CARD11;IRAK1;APOE;PKN1;SYVN1;TMSB4X;PRKCZ;DGKQ;ARHGAP22;FZD8;EPHA1;UACA;PTK6;SLC20A1;GIT2;RRAS;GDI1;STK39;DKK1;PPP2R5B;AKAP12;SIPA1;SHC2;CDC34;CD44;PLCG1;MAP3K9;MC1R;PSD3;GIT1;PAK1;ZNF385A;DDIT3;TNFSF15;ARHGAP39;FARP1;DUSP4;RET;RASGEF1A;RHOC;CYTH3;GATA3;GNAI2;HSF1;APPL2;WFS1;ADAM8;MAPKBP1;RGL2;RHOBTB2;FAM110C;ARHGEF4;MYDGF;PIP5K1C;SRC;TGM2;DNM2;MARK3;STK24;CARD19;PAK6;GSK3A;SH3BP1;DUSP6;FYN;LPAR3;GRINA;TNFRSF1A;PLEKHG5;PUM1;ITGA1;SHISA5;MAP3K10;HEXIM1;FGFR1;MIB2;MIF;SOCS2;BCL2L1;ADIPOR1;DNMBP;TRIB3;LEMD2;ARFGEF2;TRIB2;PAK4;TNFRSF19;MGRN1;P2RX4;HPSE;LRRK1;FGF2;MAP3K12;ARAP3;TAOK1;ABCA7;RHOBTB1;EPS8L1;TAF6;TGFA;SEC14L1;EPHB2;HGS;CBL;CIB1;SOCS7;IQSEC1;MAPK3;MAPK10;LITAF;ARHGEF2;C12ORF66;AIDA;OCRL;CEACAM1;MINK1;ARHGAP44;AGAP1;ECM1;MBD3;ITSN1;TGFB1;CAT;RMI2;SPRED2;PIK3R2;CAMK2N1;ERBB3;ITGA3;ARHGEF10L;EP300;RAP1GAP2;RASA3;ASAP1;TRAF7
17770,GO:1901681,0.000500657628042274,0.999784692189888,28,141,sulfur compound binding,MF,PGF;CBS;LTBP2;SERPINE2;POSTN;PTPRS;PC;ACOT7;THBS2;PTPRF;GPC4;APOE;COL13A1;DHTKD1;HMGCL;LAMC2;ACBD4;APLP2;ACADVL;PCSK6;AGRN;WISP1;FGFR1;HLCS;LRP1;FGF2;VEGFB;THBS3
5331,GO:0016054,0.000501777413095858,0.999760957593426,35,191,organic acid catabolic process,BP,CBS;NOS1;PCK2;CPT2;SESN2;GPT2;CRAT;AKT1;ALDH1L2;ARG2;CRYL1;ACAD10;TYSND1;HADH;PPARA;CD44;HMGCL;AHCY;GLUL;CEMIP;GLUD1;BLMH;ACADVL;ALDH4A1;ALDH7A1;HYAL1;FGF2;MLYCD;PHYH;ARG1;LONP2;CPT1B;LPIN3;TGFB1;PCYOX1
11671,GO:0046395,0.000501777413095858,0.999760957593426,35,191,carboxylic acid catabolic process,BP,CBS;NOS1;PCK2;CPT2;SESN2;GPT2;CRAT;AKT1;ALDH1L2;ARG2;CRYL1;ACAD10;TYSND1;HADH;PPARA;CD44;HMGCL;AHCY;GLUL;CEMIP;GLUD1;BLMH;ACADVL;ALDH4A1;ALDH7A1;HYAL1;FGF2;MLYCD;PHYH;ARG1;LONP2;CPT1B;LPIN3;TGFB1;PCYOX1
13739,GO:0060284,0.000502525510812597,0.999681811909265,86,571,regulation of cell development,BP,ZMYND8;NOS1;SORL1;NFATC4;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;POSTN;NET1;PTPRS;IDH2;SSH1;FAM129B;SEMA3F;VLDLR;ETV5;FBLN1;MAP4K4;CSNK1E;PTPRF;STK25;SHANK3;HECW2;FBXW8;AKT1;APOE;CTSZ;PTK6;MAP1B;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;SEMA4B;CUL7;PTPN9;RET;RAB29;SHANK2;GATA3;IL1RAP;NUMB;DNM2;NCS1;STK24;GSK3A;FYN;LPAR3;TNFRSF1A;KIF13B;GJC2;GAL;SEMA4G;FGFR1;RREB1;ADNP;SOCS2;LRP1;ZNF609;ULK2;CHD7;APBB1;IMPACT;KLK6;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;ARHGAP44;ADCY6;TGFB1;SLC45A3;ITGA3;RAP1GAP2;ASAP1;RNF10
3453,GO:0007267,0.000517439303937775,0.999644801201312,126,911,cell-cell signaling,BP,PGF;SH3KBP1;MDFI;ZMYND8;NOS1;CCND1;F2R;LTBP4;CTNNBIP1;NFATC4;SDC1;DVL1;WNT7A;PTHLH;NEURL1;CRTC1;PCK2;DLG4;SERPINE2;NR1D1;DLG1;IGFBP4;PSMD2;RAB3B;RAPGEF3;PRNP;SSH1;SMURF2;TMOD2;PCDH1;FAM129B;SNPH;ETV5;LRP5;ACVR2B;HTR7;MYCBPAP;MAP4K4;EGFR;CSNK1E;SLC12A7;ADARB1;SHANK3;AKT1;GPC4;APOE;WWTR1;AP2A2;PRKCZ;ITPR3;FZD8;GRK6;FERMT1;SEPT5;HADH;DKK1;SOX7;CCDC88C;BCL9L;NLGN2;DDIT3;GLUL;GNB1;SYTL1;GRB10;SHANK2;DLG3;GATA3;APLN;GNAI2;GRIN3B;ASIC1;GLUD1;SLC12A4;FAT1;PTPRU;HMGA2;ARL2;PLCB3;IGFBP2;VAMP2;PIP5K1C;GIPC1;SRC;SCG5;AGO4;GSK3A;STXBP1;CLSTN1;FUZ;LPAR3;WNT5B;SLC6A9;PFN1;NISCH;PSMD7;WISP1;TLE4;BRSK1;GJC2;GAL;TNRC6B;NTSR1;FGFR1;ADNP;LRP1;P2RX4;SMPD3;LRRK1;CHD7;BICC1;INVS;ATP6V1C2;SNAP29;KCNC4;EPHB2;CSNK1D;PAIP2;APBA1;MINK1;SLC30A1;CCNE1;ANXA1;GNAS;ITGA3;TCF7L1
12234,GO:0048468,0.000521408420699959,0.999622572917831,174,1300,cell development,BP,FLNC;SH3KBP1;ERCC1;ZMYND8;NOS1;SH3TC2;RAC2;SORL1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;CST3;NEURL1;CRTC1;DLG4;OBSCN;SERPINE2;POSTN;NET1;RAPGEF3;PTPRS;IDH2;LAMA5;SSH1;DBNDD1;NYAP1;TMOD2;FAM129B;TNNT1;BBS2;SEMA3F;ADGRF1;OSBP2;VLDLR;ETV5;LRP5;FBLN1;XBP1;MAP4K4;EGFR;CSNK1E;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;ACTA2;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;APOE;FAM210B;PRKCZ;FAM20C;POU2F2;NAGLU;CTSZ;EPHA1;PTK6;DEAF1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;UBE2J1;OBSL1;WASF2;PLCG1;TWF2;BIN1;PAK1;ZNF385A;SEMA4B;PODXL;CUL7;TUBB3;FARP1;PTPN9;RET;RAB29;GRB10;SHANK2;GATA3;ANKS1A;IL1RAP;ARID5B;NUMB;FLNB;EDNRA;ALDH1A2;SRC;DNM2;NCS1;PAQR7;STK24;RERE;GSK3A;STXBP1;SPINT2;FYN;RAB25;AGRN;LPAR3;WNT5B;TNFRSF1A;KIF13B;BRSK1;GJC2;GAL;ITGA1;FRYL;HSF4;SEMA4G;FGFR1;RREB1;ADNP;TENM2;PBX3;SOCS2;BCL2L1;ZFPM1;ULK1;LRP1;ROBO3;HSPA2;ZNF609;PAK4;ULK2;ZP3;LRRK1;TBC1D20;MAPK9;VASP;CHD7;ATXN10;APBB1;SLIT3;L3MBTL3;CAMSAP3;IMPACT;KLK6;CAMK1;EPHB2;CIB1;MAPK3;NTNG1;MAPK10;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;ADCY6;TGFB1;MANF;SLC45A3;ITGA3;EP300;RAP1GAP2;ASAP1;RNF10
16255,GO:0090287,0.000529564541944559,0.999753670344734,33,172,regulation of cellular response to growth factor stimulus,BP,XDH;LTBP4;SMURF2;FAM129B;EPN2;FAM20C;FERMT1;TGFBR2;DKK1;PPP2R5B;LTBP1;HTRA1;BCL9L;GRB10;GATA3;APLN;MYOF;GIPC1;DNM2;PCSK6;DUSP6;FUZ;FBXL15;FGFR1;MTMR4;STUB1;SNX25;LEMD2;PMEPA1;FGF2;HGS;TGFB1;ITGA3
2517,GO:0005769,0.00053393704671584,0.999719049237946,45,259,early endosome,CC,F2R;SORL1;MAP2K1;BOK;DYSF;RAB31;EGFR;MAP2K2;APOE;VPS11;VPS4A;PI4K2A;PCSK9;MVB12B;DKK1;WASF2;TBC1D16;GGA3;GGA1;SDCCAG3;RET;RAB29;ATP11A;NIPA1;APPL2;NUMB;LDLRAP1;NUCB1;NISCH;MIB2;MTMR4;PMEPA1;LRP1;MGRN1;EHD4;ABCA7;NEURL1B;HGS;MAPK3;LITAF;SNX27;LLGL1;OCRL;ANXA1;WDFY2
6739,GO:0030154,0.000534595660164674,0.999585006062275,310,2526,cell differentiation,BP,ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;CAPN2;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;CST3;SDK2;CYP27B1;NEURL1;AP3D1;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DNMT3A;SOX12;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;MICALCL;DBNDD1;SMARCA1;NYAP1;TMOD2;FAM129B;CTSB;TNNT1;SNPH;MRC2;BBS2;SEMA3F;ADGRF1;OSBP2;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;CSNK1E;CCDC71L;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;ACTA2;PPP1R13L;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;IFITM1;CARD11;APOE;FAM210B;ELK3;WWTR1;COL13A1;PRKCZ;FAM20C;POU2F2;NAGLU;RFNG;ARHGAP22;FZD8;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;RRAS;DEAF1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;LIMK1;DKK1;CREB3L2;PPP2R5B;UBE2J1;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;TST;WASF2;ZNF516;PLCG1;TWF2;TFE3;BIN1;HTRA1;SUFU;PAK1;BCL9L;ZNF385A;RAG1;SEMA4B;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;PTPN9;SATB1;RET;RAB29;GRB10;YIPF3;SHANK2;GATA3;TCFL5;MYOF;ANKS1A;ALOX15B;IL1RAP;CNFN;CTBP1;PTPRU;ADAM8;HMGA2;ARID5B;NUMB;FLNB;EDNRA;TULP3;ALDH1A2;SRC;DNM2;AGO4;IRF7;NCS1;PAQR7;STK24;ACADVL;SDCCAG8;RERE;GSK3A;STXBP1;SH3BP1;SPINT2;PCSK6;DUSP6;SLFN5;FYN;RAB25;FUZ;AGRN;LPAR3;WNT5B;PSMD7;KIF17;TNFRSF1A;MBOAT7;VDR;KIF13B;BRSK1;GJC2;GAL;PUM1;ITGA1;RAI14;CTSL;EHF;TNRC6B;THRA;FRYL;HSF4;LAMB3;SEMA4G;FGFR1;RRBP1;RREB1;ADNP;LRRC8A;TENM2;PBX3;MFNG;SOCS2;BCL2L1;ADIPOR1;TRIB3;LEMD2;ZFPM1;PRRC2A;UNC119B;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PAK4;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;MAPK9;SHB;VASP;CHD7;ATXN10;APBB1;SLIT3;RXRA;UNC45A;PBXIP1;L3MBTL3;ZHX3;NDE1;CAMSAP3;NDRG3;IMPACT;KLK6;CAMK1;EPHB2;KRT23;POLM;MYL9;CIB1;SOCS7;MAPK3;NTNG1;MAPK10;CSNK1D;DNAJB9;ALDOC;GLO1;FURIN;ARHGEF2;LLGL1;MLF1;ADAM15;CEACAM1;MINK1;ARHGAP44;MAP6;ADCY6;TGFB1;SH3PXD2A;MANF;CAT;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;TCF7L1;WDFY2;RAP1GAP2;ASAP1;RNF10
16470,GO:0097113,0.000543660737420514,0.999987643183987,4,5,AMPA glutamate receptor clustering,BP,DLG4;SSH1;SHANK3;APOE
16727,GO:0097688,0.000543660737420514,0.999987643183987,4,5,glutamate receptor clustering,BP,DLG4;SSH1;SHANK3;APOE
8927,GO:0034762,0.000551790098914746,0.999706880520226,46,267,regulation of transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;PRNP;RTN2;PRKACA;SHANK3;HECW2;AKT1;EHD3;TMSB4X;PRKCZ;PCSK9;STK39;PLCG1;PAK1;NLGN2;STOM;GRB10;CEMIP;SHANK2;VAMP2;GLRX;DNM2;GSK3A;FYN;GJC2;GAL;NTSR1;TRIB3;TPCN1;HSPA2;CHD7;KCNC4;EPHB2;MINK1;SLC30A1;TGFB1;AZIN2;PIK3R2;STIM1
4514,GO:0010562,0.000561098698745263,0.999630267431024,101,701,positive regulation of phosphorus metabolic process,BP,XDH;NOS1;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;ITGA6;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;TMSB4X;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;MYDGF;SRC;TAZ;STK24;PAK6;DUSP6;FYN;LPAR3;TNFRSF1A;ITGA1;NTSR1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;HSPA2;PAK4;TNFRSF19;ZP3;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;CSNK1D;ARHGEF2;MINK1;ADCY6;ITSN1;TGFB1;ERBB3;WDFY2;TRAF7
11495,GO:0045937,0.000561098698745263,0.999630267431024,101,701,positive regulation of phosphate metabolic process,BP,XDH;NOS1;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;ITGA6;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;TMSB4X;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;MYDGF;SRC;TAZ;STK24;PAK6;DUSP6;FYN;LPAR3;TNFRSF1A;ITGA1;NTSR1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;HSPA2;PAK4;TNFRSF19;ZP3;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;CSNK1D;ARHGEF2;MINK1;ADCY6;ITSN1;TGFB1;ERBB3;WDFY2;TRAF7
18018,GO:1902430,0.000562308351756366,0.999967665072111,5,8,negative regulation of amyloid-beta formation,BP,SORL1;PRNP;APOE;BIN1;ABCA7
719,GO:0001941,0.000569679165002776,0.999914032852202,8,20,postsynaptic membrane organization,BP,ZMYND8;DVL1;DLG4;SSH1;ETV5;SHANK3;APOE;NLGN2
10697,GO:0043954,0.00057070163242065,0.999899861599328,9,24,cellular component maintenance,BP,ZMYND8;F2R;PRNP;APOE;NLGN2;FYN;CAMSAP3;KIFC3;ITGA3
8930,GO:0034765,0.000577542932229759,0.99971344767803,38,210,regulation of ion transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;PRNP;PRKACA;SHANK3;HECW2;AKT1;EHD3;TMSB4X;PCSK9;STK39;PLCG1;NLGN2;STOM;CEMIP;SHANK2;VAMP2;GLRX;DNM2;FYN;GJC2;GAL;NTSR1;TPCN1;HSPA2;CHD7;KCNC4;EPHB2;MINK1;SLC30A1;TGFB1;STIM1
7857,GO:0032412,0.000583595353665702,0.999755853446309,26,126,regulation of ion transmembrane transporter activity,BP,FHL1;NOS1;KCNG1;DLG4;DLG1;FKBP1A;PRNP;PRKACA;SHANK3;HECW2;EHD3;TMSB4X;PCSK9;STK39;NLGN2;STOM;SHANK2;VAMP2;GLRX;DNM2;GAL;NTSR1;HSPA2;EPHB2;MINK1;STIM1
4569,GO:0010648,0.000586353705847142,0.999594188922087,129,942,negative regulation of cell communication,BP,TNIP1;XDH;SH3KBP1;MDFI;CHAC1;CCND1;MST1R;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;NEURL1;BOK;SERPINE2;NR1D1;DLG1;IGFBP4;IFI6;PSMD2;ITGA6;PTPRS;PRNP;WWC3;SMURF2;FAM129B;SESN2;FBLN1;XBP1;MAP4K4;EGFR;MMP14;EPN1;SHANK3;AKT1;EPN2;APOE;PEAR1;SYVN1;WWTR1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;TGFBR2;HADH;DKK1;PPP2R5B;ARRDC1;PRKACB;LTBP1;CDC34;CD44;HTRA1;SUFU;BCL9L;ZNF385A;DDIT3;DUSP4;RET;GRB10;SHANK2;GATA3;APLN;GNAI2;ASIC1;WFS1;MAPKBP1;IGFBP2;TULP3;SRC;DNM2;MARK3;RGS19;CARD19;GSK3A;STXBP1;SH3BP1;DUSP6;FYN;FUZ;WNT5B;GRINA;PSMD7;ITGA1;FGFR1;ADNP;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;SNX25;PTPN12;LEMD2;PMEPA1;LRP1;MGRN1;ARAP3;BICC1;SLIT3;ARG1;INVS;SEC14L1;EPHB2;HGS;CBL;CIB1;SOCS7;KANK2;DNAJB9;ARHGEF2;C12ORF66;TMBIM1;AIDA;CEACAM1;ARHGAP44;ECM1;SLC30A1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;ITGA3;RASA3
3232,GO:0006887,0.000595493874243151,0.999619221532927,87,602,exocytosis,BP,PYGB;RAC2;SDC1;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;RAB3B;CKAP4;PRSS3;CD68;LCN2;CTSB;SNPH;BCR;RAB31;LPCAT1;SERPING1;ATP13A2;TMSB4X;AP2A2;GALNS;VPS11;VPS4A;CTSZ;PI4K2A;SEPT5;SERPINB6;CD44;SCRN1;SURF4;PAK1;STOM;SYTL1;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;PIP5K1C;APLP2;UBR4;NCS1;C6ORF120;EXOC2;STXBP1;RAB25;YPEL5;PSMD7;MICAL1;ANXA3;BRPF3;TIMP1;LGALS3BP;MIF;TCIRG1;ARFGEF2;HPSE;SMPD3;ZP3;PNP;ARG1;VEGFB;VAT1;SNAP29;HGS;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;LLGL1;CEACAM1;ARHGAP44;ECM1;CD59;TGFB1;MANF;CAT;ANXA1;RAB6A;ERP44
11207,GO:0045296,0.000598754665288992,0.999673253056286,49,298,cadherin binding,MF,MPRIP;SNX9;BSG;KLC2;DLG1;SLC9A3R2;ITGA6;SCYL1;FAM129B;EGFR;CORO1B;PPP1R13L;EPN2;BAG3;FMNL2;PFKP;WASF2;ESYT2;TWF2;FSCN1;DOCK9;SH3GLB2;PLCB3;NUMB;PLIN3;FLNB;GIPC1;SRC;CHMP5;CAPG;STK24;PAK6;STX5;PFN1;ARFIP2;PAK4;P2RX4;USO1;EHD4;VAPB;VASP;EPS8L1;UNC45A;BAIAP2L1;CBL;CSNK1D;LDHA;ANXA1;ASAP1
12689,GO:0050877,0.000606053528419726,0.99964139785089,64,407,nervous system process,BP,F2R;DVL1;SCN8A;CRTC1;DLG4;SERPINE2;PRNP;TMOD2;ESPN;BBS2;ADGRF1;BCR;VLDLR;AARS;EGFR;ADARB1;TUB;SHANK3;APOE;METTL23;RABGGTA;PRKCZ;ITPR3;EML2;DEAF1;LAMB2;SERPINB6;DKK1;CCND2;ZNF385A;NLGN2;RAG1;GNB1;REEP2;CEMIP;SHANK2;DOPEY2;ASIC1;WFS1;B4GALT2;REEP6;FYN;ALDH7A1;COMT;THRA;NTSR1;MGLL;HSF4;FGFR1;ADNP;PBX3;P2RX4;CHD7;ABCA7;HOMER2;EPHB2;MAPK3;KIFC3;DRAM2;PAIP2;GNAS;ITGA3;NIPSNAP1;RNF10
2528,GO:0005783,0.000607147115161232,0.999559243151492,172,1325,endoplasmic reticulum,CC,EDEM1;XDH;NOS1;CAPN2;SORL1;MAP2K1;QSOX1;WNT7A;MBOAT2;CST3;LPCAT4;LMF1;BOK;DLG4;DLG1;IGFBP4;PITPNM1;FKBP1A;CKAP4;PRNP;BNIP3;PDZD2;SBF1;AGPAT3;TXNDC11;CRTAP;COPG1;TMEM214;FKBP9;SYNE3;LPCAT1;LRP5;H6PD;XYLT1;XBP1;EGFR;RTN2;LAMB1;CRAT;RHBDF2;MAP2K2;XYLT2;P4HB;PDIA5;CDS2;APOE;SYVN1;YIF1A;COL13A1;FAM20C;ITPR3;CTSZ;TMEM129;FBXO2;RETSAT;PCSK9;HS1BP3;SEC23A;LAMB2;PLD3;CREB3L2;UBE2J1;BNIP3L;KDELR1;LTBP1;ESYT2;RAP1GDS1;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;CERCAM;ERO1B;UBXN7;GLUL;PTDSS2;ADAMTS7;STOM;DNASE1L1;REEP2;TMED3;CEMIP;ATP11A;PIGQ;NUCB2;UBXN4;ANO8;ANTXR2;FNDC4;WFS1;SRD5A3;ASPH;P4HA1;MYDGF;B3GNT3;APLP2;FKBP10;TGM2;SARAF;REEP6;NUCB1;RAB1B;CARD19;STX5;PCSK6;OAS1;SPTLC2;CLSTN1;REEP4;WNT5B;GRINA;HSD11B1;MBOAT7;SLC33A1;VWA1;SHISA5;PSKH1;MCFD2;NTSR1;RCN1;TIMP1;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;TENM2;F12;SIGMAR1;BCL2L1;STUB1;ANGEL1;SLC27A1;LEMD2;AGPAT4;ULK1;USO1;TBC1D20;EHD4;VAPB;TMX4;HSPA13;MYO1D;LMAN1;MSLN;TGFA;TPBG;ARSK;KLK6;CASP4;TRAPPC1;CIB1;PACS2;POMT1;DNAJB9;FURIN;RNF103;MATN3;HM13;PNPLA6;LPIN3;CD59;SLC30A1;MANF;CAT;ARSD;RAB6A;IKBIP;ARCN1;ERP44;STIM1
2594,GO:0005887,0.000612999149111328,0.999590999613171,106,736,integral component of plasma membrane,CC,ITGB4;TSPAN1;F2R;MST1R;SORL1;SDC1;KCNG1;SCN8A;SLCO4A1;DLG4;BSG;DLG1;SLC16A3;DCBLD2;ITGA6;SLC2A9;PTPRS;PCDH1;MRC2;ACVR2B;ITGB5;HTR7;EGFR;MMP14;SLC12A7;PTPRF;LMBR1L;SHANK3;GPC4;IRAK1;ATP13A2;COL13A1;ATP7B;ITPR3;EPHA1;PI4K2A;SLC20A1;ORAI1;TGFBR2;CD99;EPOR;CD44;ESYT2;MC1R;TSPAN5;NLGN2;TNFSF15;PODXL;STOM;RET;REEP2;PROCR;SHANK2;PKD1;DLG3;CADM4;SLC2A3;GRIN3B;ASIC1;IL1RAP;SLC12A4;FAT1;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;LY6E;SLC43A1;GPRC5C;VAMP2;TNFRSF6B;EDNRA;B3GNT3;PAG1;TMPRSS11D;LPAR3;SLC6A9;TNFRSF1A;SLC33A1;TSPAN33;ITGA1;SLC13A5;NTSR1;FGFR1;TENM2;SIGMAR1;TCIRG1;ST3GAL5;SLC6A14;LRP1;P2RX4;TGFA;TPBG;KCNC4;EPHB2;SLC35G2;SLC5A1;CEACAM1;TM2D1;SLC15A1;ERBB3;PODXL2;ITGA3;PLGRKT;STIM1
2386,GO:0005520,0.000614312046551248,0.999922923060248,7,16,insulin-like growth factor binding,MF,ITGB4;IGFBP4;ITGA6;HTRA1;IGFBP2;WISP1;CRIM1
4859,GO:0014069,0.000617532802988312,0.999722340012257,30,150,postsynaptic density,CC,NOS1;DVL1;NEURL1;SHARPIN;DLG4;DLG1;PTPRS;PRNP;BNIP3;BCR;SHANK3;MAP1B;PSD3;SHANK2;DLG3;SH2D5;SRC;DNM2;NCS1;FYN;CLSTN1;ABHD17C;SIGMAR1;P2RX4;KLHL17;HOMER2;ARHGEF2;MINK1;ARHGAP44;CAMK2N1
488,GO:0001540,0.000630557609643227,0.999844515714536,12,41,amyloid-beta binding,MF,SORL1;CST3;PRNP;APOE;FBXO2;IDE;LDLRAP1;CLSTN1;APBB1;EPHB2;APBA1;TM2D1
324,GO:0000904,0.000653245784017862,0.999596066227577,75,485,cell morphogenesis involved in differentiation,BP,SH3KBP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;POSTN;NET1;PTPRS;LAMA5;SSH1;FAM129B;SEMA3F;VLDLR;FBLN1;LAMB1;ADARB1;STK25;PARVB;SHANK3;HECW2;FBXW8;APOE;EPHA1;MAP1B;LAMB2;GDI1;LIMK1;DKK1;OBSL1;PLCG1;TWF2;PAK1;ZNF385A;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;FLNB;SRC;DNM2;RERE;STXBP1;SPINT2;FYN;RAB25;LPAR3;KIF13B;BRSK1;SEMA4G;RREB1;ADNP;ZFPM1;ULK1;ROBO3;ULK2;TBC1D20;VASP;APBB1;SLIT3;EPHB2;CIB1;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6;EP300
12293,GO:0048585,0.000668352908151241,0.999524761469815,148,1109,negative regulation of response to stimulus,BP,TNIP1;NT5E;XDH;SH3KBP1;ERCC1;MDFI;CHAC1;CCND1;MST1R;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;PLAT;NEURL1;BOK;SHARPIN;SERPINE2;NR1D1;DLG1;IGFBP4;IFI6;PSMD2;ITGA6;PTPRS;PRNP;WWC3;SMURF2;FAM129B;SESN2;BBS2;SEMA3F;BCR;FBLN1;XBP1;MAP4K4;EGFR;MMP14;CORO1B;EPN1;ATF4;AKT1;SERPING1;EPN2;APOE;ARG2;PEAR1;SYVN1;WWTR1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;TGFBR2;STK39;DKK1;PPP2R5B;UBE2J1;ARRDC1;PPARA;FAM3A;PRKACB;LTBP1;CDC34;CD44;HTRA1;SUFU;BCL9L;ZNF385A;SEMA4B;DDIT3;BCDIN3D;DUSP4;RET;GRB10;GATA3;APLN;FNDC4;HSF1;WFS1;MAPKBP1;HMGA2;IGFBP2;TULP3;SRC;DNM2;MARK3;RGS19;CARD19;GSK3A;SH3BP1;DUSP6;FYN;FUZ;WNT5B;GRINA;PSMD7;TNFRSF1A;ITGA1;SEMA4G;FGFR1;F12;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;SNX25;PTPN12;LEMD2;PMEPA1;LRP1;MGRN1;FGF2;ARAP3;BICC1;SLIT3;ARG1;INVS;SEC14L1;EPHB2;HGS;CBL;CIB1;SOCS7;KANK2;DNAJB9;ARHGEF2;C12ORF66;TMBIM1;AIDA;CEACAM1;ARHGAP44;ECM1;CD59;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;ANXA1;PPP1R10;ITGA3;RASA3
7667,GO:0032091,0.000668972759113429,0.999770809454136,18,78,negative regulation of protein binding,BP,SORL1;CTNNBIP1;NFATC4;DVL1;CSNK1E;PTPRF;AKT1;CTSZ;PCSK9;DKK1;PPARA;TTBK2;ADNP;STUB1;ZFPM1;CAMK1;MAPK3;ADAM15
3190,GO:0006816,0.000673465018910348,0.999662793518561,38,211,calcium ion transport,BP,NOS1;F2R;CYP27B1;FKBP1A;PRNP;PRKACA;EHD3;ATP13A2;ITPR3;ORAI1;PLCG1;DDIT3;CEMIP;PKD1;GNAI2;GRIN3B;ASIC1;WFS1;FAM155B;SARAF;NCS1;FYN;LPAR3;VDR;GJC2;NTSR1;ATP2C2;TPCN1;HSPA2;P2RX4;FGF2;CHD7;HOMER2;SLC30A1;TGFB1;ORAI3;STIM1;RASA3
8236,GO:0032990,0.000679905790800451,0.999583033366645,72,464,cell part morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;POSTN;PTPRS;SSH1;NYAP1;FAM129B;SEMA3F;VLDLR;MAP4K4;EGFR;ADARB1;CORO1B;STK25;SHANK3;HECW2;FBXW8;APOE;PRKCZ;MAP1B;LAMB2;GDI1;LIMK1;OBSL1;WASF2;CD44;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;SRC;DNM2;STK24;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;ITGA1;SEMA4G;RREB1;ADNP;BCL2L1;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;IMPACT;EPHB2;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6
3568,GO:0007613,0.000683873810126814,0.999784722026247,16,63,memory,BP,CRTC1;PRNP;ADGRF1;VLDLR;SHANK3;APOE;PRKCZ;ITPR3;CCND2;ASIC1;B4GALT2;COMT;ADNP;ABCA7;PAIP2;ITGA3
17096,GO:0099572,0.000694635542346096,0.99968509769019,30,151,postsynaptic specialization,CC,NOS1;DVL1;NEURL1;SHARPIN;DLG4;DLG1;PTPRS;PRNP;BNIP3;BCR;SHANK3;MAP1B;PSD3;SHANK2;DLG3;SH2D5;SRC;DNM2;NCS1;FYN;CLSTN1;ABHD17C;SIGMAR1;P2RX4;KLHL17;HOMER2;ARHGEF2;MINK1;ARHGAP44;CAMK2N1
12436,GO:0048869,0.000700401560423912,0.999450875527296,326,2682,cellular developmental process,BP,ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;SH3TC2;CAPN2;MST1R;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;CST3;SDK2;CYP27B1;NEURL1;AP3D1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DNMT3A;SOX12;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PTPRS;IDH2;BNIP3;LAMA5;SSH1;MICALCL;DBNDD1;SMARCA1;NYAP1;TMOD2;FAM129B;CTSB;TNNT1;SNPH;MRC2;BBS2;SEMA3F;ADGRF1;SYNE3;OSBP2;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MAP4K4;CMTM7;EGFR;CSNK1E;CCDC71L;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CORO1B;ACTA2;PPP1R13L;STK25;PARVB;SHANK3;HECW2;FBXW8;AKT1;IFITM1;CARD11;APOE;FAM210B;FMNL2;ARG2;ELK3;WWTR1;COL13A1;PRKCZ;FAM20C;POU2F2;NAGLU;RFNG;ARHGAP22;FZD8;CTSZ;EPHA1;PTK6;SH3PXD2B;PCSK9;RRAS;DEAF1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;GDI1;LIMK1;DKK1;CREB3L2;PPP2R5B;UBE2J1;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;TST;WASF2;CD44;ZNF516;PLCG1;TWF2;TFE3;BIN1;HTRA1;SUFU;PAK1;TTBK2;BCL9L;ZNF385A;RAG1;SEMA4B;NAV1;DDIT3;PODXL;CUL7;TUBB3;ADAMTS7;FARP1;PTPN9;SATB1;RET;RAB29;RHOC;GRB10;YIPF3;SHANK2;GATA3;TCFL5;MYOF;ANKS1A;ALOX15B;IL1RAP;CNFN;CTBP1;PTPRU;ADAM8;HMGA2;ARID5B;RHOBTB2;NUMB;CAP1;FLNB;EDNRA;TULP3;ALDH1A2;SRC;DNM2;AGO4;IRF7;NCS1;PAQR7;STK24;ACADVL;YPEL3;SDCCAG8;RERE;GSK3A;STXBP1;SH3BP1;SPINT2;PCSK6;DUSP6;SLFN5;FYN;RAB25;FUZ;AGRN;LPAR3;WNT5B;PSMD7;KIF17;TNFRSF1A;MBOAT7;VDR;KIF13B;BRSK1;GJC2;GAL;PUM1;ITGA1;RAI14;CTSL;EHF;TNRC6B;THRA;FRYL;HSF4;LAMB3;SEMA4G;FGFR1;RRBP1;RREB1;ADNP;LRRC8A;TENM2;PBX3;MFNG;MIF;SOCS2;BCL2L1;ADIPOR1;TRIB3;LEMD2;ZFPM1;PRRC2A;UNC119B;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PAK4;ULK2;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;MAPK9;SHB;VASP;ARAP3;CHD7;ATXN10;APBB1;RHOBTB1;SLIT3;RXRA;UNC45A;PBXIP1;L3MBTL3;ZHX3;NDE1;CAMSAP3;NDRG3;WIPF1;IMPACT;KLK6;CAMK1;EPHB2;KRT23;POLM;MYL9;CIB1;SOCS7;MAPK3;NTNG1;MAPK10;CSNK1D;DNAJB9;ALDOC;GLO1;FURIN;ARHGEF2;LLGL1;MLF1;ADAM15;CEACAM1;MINK1;ARHGAP44;MAP6;ADCY6;TGFB1;SH3PXD2A;MANF;CAT;ERBB3;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;TCF7L1;WDFY2;RAP1GAP2;ASAP1;RNF10
10333,GO:0043113,0.000701198634000007,0.999854780260802,10,30,receptor clustering,BP,DVL1;DLG4;DLG1;SSH1;ETV5;SHANK3;APOE;DLG3;AGRN;TGFB1
10427,GO:0043256,0.00071516718732468,0.999956513629505,5,8,laminin complex,CC,LAMA5;LAMB1;LAMB2;LAMC2;LAMB3
7501,GO:0031667,0.000738822765607837,0.999585012059023,52,319,response to nutrient levels,BP,ERCC1;CCND1;CST3;CYP27B1;PCK2;DAP;DNMT3A;POSTN;SSH1;SESN2;BBS2;XBP1;EGFR;ATF4;AKT1;APOE;DGKQ;PCSK9;TGFBR2;PPARA;HMGCL;AHCY;DDIT3;GLUL;GAS2L1;GNAI2;HSF1;IGFBP2;ALDH1A2;SRC;STK24;FYN;ASNS;VDR;COMT;USF2;PCSK1N;HLCS;ULK1;P2RX4;ULK2;MAP1LC3B;ARG1;IMPACT;CBL;MAPK3;KANK2;C12ORF66;MBD3;TGFB1;CAT;LDHA
14973,GO:0070848,0.000739688417427686,0.999544617798247,72,471,response to growth factor,BP,XDH;NOS1;LTBP2;LTBP4;SHC1;WNT7A;MXRA5;FKBP1A;POSTN;SMURF2;FAM129B;ACVR2B;ITGB5;EGFR;CORO1B;AKT1;EPN2;PRKCZ;FAM20C;FERMT1;TGFBR2;DKK1;PPP2R5B;LTBP1;CDC34;CD44;PLCG1;TWF2;HTRA1;BCL9L;ADAMTS7;GRB10;GATA3;APLN;MYOF;FNDC4;GIPC1;SRC;DNM2;ESRP1;SPINT2;PCSK6;DUSP6;FYN;FUZ;ANXA3;FBXL15;SLC33A1;FGFR1;HYAL1;MTMR4;STUB1;SNX25;PTPN12;LEMD2;PMEPA1;FGF2;EHD4;ARG1;HGS;CBL;CIB1;MAPK3;CSNK1D;FURIN;GALNT3;TGFB1;CAT;SPRED2;ANXA1;ITGA3;PXN
7479,GO:0031638,0.000744817903643856,0.999843261442926,10,31,zymogen activation,BP,PLAT;SERPINE2;PRSS3;MMP14;CTSZ;ASPH;F12;GGT1;FURIN;PLGRKT
1991,GO:0004708,0.000760937723816872,0.99992468061723,6,12,MAP kinase kinase activity,MF,MAP2K1;MAPKAPK3;MAP2K2;MAP3K9;MAPK3;MAPK10
13294,GO:0051962,0.000764260993650023,0.999565335319312,54,327,positive regulation of nervous system development,BP,ZMYND8;ADGRL1;DVL1;MAP2K1;WNT7A;NEURL1;CRTC1;DLG4;SERPINE2;VLDLR;ETV5;CSNK1E;THBS2;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;NLGN2;CUL7;RET;SHANK2;ADGRB2;IL1RAP;NUMB;FYN;CLSTN1;AGRN;LPAR3;GJC2;AMIGO2;FGFR1;ADNP;SOCS2;ZNF609;APBB1;TPBG;IMPACT;CAMK1;EPHB2;CSNK1D;ARHGEF2;SRPX2;ITGA3;RNF10
16828,GO:0098655,0.000776861558256483,0.999535129121576,64,416,cation transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;SLC2A9;PRNP;SLC12A7;PRKACA;SHANK3;HECW2;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PLCG1;NLGN2;DDIT3;STOM;CEMIP;SHANK2;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;VAMP2;GLRX;DNM2;NDUFA4L2;NCS1;FYN;SLC33A1;GJC2;GAL;NTSR1;ATP2C2;VPS9D1;TCIRG1;TPCN1;HSPA2;P2RX4;FGF2;CHD7;ATP6V1C2;KCNC4;EPHB2;MINK1;SLC30A1;TGFB1;SLC15A1;ORAI3;STIM1;RASA3
10808,GO:0044273,0.000804228907824125,0.999828978107183,10,31,sulfur compound catabolic process,BP,CBS;CHAC1;ACOT7;GALNS;AHCY;BLMH;HYAL1;MLYCD;GGT1;PCYOX1
4294,GO:0009719,0.000812214978104247,0.999421993476178,144,1069,response to endogenous stimulus,BP,PGF;NOS1;LTBP2;CCND1;CAPN2;LTBP4;SDC1;SHC1;WNT7A;CST3;NEURL1;PCK2;BSG;NR1D1;MXRA5;DNMT3A;FKBP1A;POSTN;RAPGEF3;PRNP;SSH1;SMURF2;CTSB;SESN2;BBS2;RAB31;LRP5;ACVR2B;ITGB5;ADCY7;XBP1;EGFR;MMP14;PRKACA;CORO1B;TUB;ATF4;AKT1;APOE;FAM210B;PRKCZ;FAM20C;MAPK13;PCSK9;ENDOG;FERMT1;MSN;TGFBR2;HADH;DKK1;PPARA;PRKACB;LTBP1;WDTC1;CD44;PLCG1;IDE;HTRA1;PAK1;BCL9L;ADAMTS7;GNB1;GAS2L1;GRB10;GATA3;APLN;GNAI2;FNDC4;HSF1;PTPRU;IGFBP2;EIF4EBP1;VAMP2;GIPC1;ALDH1A2;SRC;DNM2;PAQR7;ESRP1;GSK3A;STXBP1;SPINT2;PCSK6;DUSP6;FYN;FUZ;AGRN;ASNS;ANXA3;FBXL15;SLC33A1;VDR;GAL;GNB2;CTSL;THRA;TIMP1;FGFR1;HYAL1;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;LRP1;P2RX4;FGF2;SLIT3;RXRA;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;CBL;CIB1;SOCS7;MAPK3;KANK2;CSNK1D;FURIN;ARHGEF2;CEACAM1;GALNT3;UROS;MBD3;ADCY6;CCNE1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;ANXA1;ITGA3;PXN;EP300
6634,GO:0022898,0.000824101066564518,0.999645919674367,26,129,regulation of transmembrane transporter activity,BP,FHL1;NOS1;KCNG1;DLG4;DLG1;FKBP1A;PRNP;PRKACA;SHANK3;HECW2;EHD3;TMSB4X;PCSK9;STK39;NLGN2;STOM;SHANK2;VAMP2;GLRX;DNM2;GAL;NTSR1;HSPA2;EPHB2;MINK1;STIM1
6897,GO:0030424,0.000831590900242091,0.999514782345527,58,362,axon,CC,ADGRL1;DVL1;CST3;AP3D1;SCN8A;DLG4;DLG1;FKBP1A;PTPRS;SSH1;TMOD2;PRKCZ;CTSZ;SEPT5;MAP1B;GDI1;TWF2;BIN1;FSCN1;PAK1;NAV1;GLUL;TUBB3;RET;SHANK2;DLG3;LDLRAP1;DNM2;NCS1;GARS;STXBP1;LPAR3;MICAL1;ANXA3;KIF13B;GJC2;COMT;NTSR1;WDFY3;ADNP;TENM2;SIGMAR1;ULK1;ROBO3;P2RX4;MAP3K12;MYO1D;APBB1;KCNC4;EPHB2;CBL;CIB1;LLGL1;MINK1;MAP6;TGFB1;AZIN2;ITGA3
9046,GO:0035254,0.000838486861784926,0.999822052991306,10,30,glutamate receptor binding,MF,DLG4;DLG1;PRNP;SHANK3;PLCG1;SHANK2;DLG3;FYN;HOMER2;GNAS
2197,GO:0005057,0.000842644013840347,0.9996452355183,25,119,signal transducer activity, downstream of receptor,MF,MST1R;MAP2K1;ACVR2B;MAP4K4;EGFR;STK25;IFITM1;IRAK1;MAPK13;EPHA1;TGFBR2;PLCG1;MAP3K9;RET;STK24;MAP3K10;FGFR1;MAPK9;MAP3K12;TAOK1;EPHB2;MAPK3;MAPK10;MINK1;ERBB3
2676,GO:0006027,0.000846260050397239,0.999783848417962,12,41,glycosaminoglycan catabolic process,BP,SDC1;GPC4;GALNS;NAGLU;CD44;FUCA1;CEMIP;AGRN;HYAL1;HPSE;FGF2;TGFB1
14859,GO:0070588,0.000872704268699324,0.999597417195537,30,156,calcium ion transmembrane transport,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;EHD3;ATP13A2;ITPR3;ORAI1;PLCG1;DDIT3;CEMIP;PKD1;GRIN3B;ASIC1;FAM155B;NCS1;FYN;GJC2;NTSR1;ATP2C2;TPCN1;HSPA2;P2RX4;FGF2;CHD7;TGFB1;ORAI3;STIM1;RASA3
12843,GO:0051129,0.000895726734953051,0.999440376597622,74,492,negative regulation of cellular component organization,BP,ERCC1;SORL1;CTNNBIP1;NFATC4;CST3;BOK;ARAP1;DLG4;POSTN;RAPGEF3;PTPRS;PRNP;BNIP3;TMOD2;ESPN;SEMA3F;FBLN1;EVI5L;MAP4K4;MMP14;CORO1B;SHANK3;SNX33;AKT1;APOE;TMSB4X;PRKCZ;CTSZ;PCSK9;EML2;GDI1;DKK1;WASF2;TWF2;TTBK2;SEMA4B;PTPN9;RAB29;PHF1;HSF1;CTBP1;SRC;CAPG;DNM2;LRSAM1;CPTP;TOM1L2;STXBP1;FYN;PFN1;THRA;SEMA4G;PHF2;BCL2L1;PMEPA1;ULK1;LRP1;HSPA2;ULK2;CAMSAP3;IMPACT;VAT1;EPHB2;CIB1;TMSB10;KANK2;ARHGEF2;ADCY6;TGFB1;ITGA3;PLEKHH2;EP300;RAP1GAP2;ASAP1
7141,GO:0030968,0.000909233211165414,0.999621761461567,24,117,endoplasmic reticulum unfolded protein response,BP,EDEM1;CCND1;SHC1;BOK;XBP1;ATF4;PDIA5;SYVN1;YIF1A;TSPYL2;CREB3L2;PPP2R5B;SEC63;DDIT3;CUL7;WFS1;MYDGF;ACADVL;GSK3A;ASNS;STUB1;VAPB;DNAJB9;EP300
3589,GO:0008015,0.000913349783204723,0.999512907840793,43,251,blood circulation,BP,NOS1;F2R;CTNNBIP1;ADM2;DOCK4;DLG1;POSTN;TNNT1;BBS2;BCR;LRP5;HTR7;EGFR;PRKACA;PPP1R13L;AKT1;SERPING1;APOE;EHD3;ITPR3;CTSZ;STK39;PPARA;RAP1GDS1;APLN;MYOF;ASPH;PLCB3;EDNRA;SRC;TAZ;GSK3A;NISCH;ITGA1;THRA;NTSR1;P2RX4;CHD7;VEGFB;CEACAM1;ADCY6;TGFB1;STIM1
9910,GO:0042219,0.000917255157048215,0.99987320880317,7,17,cellular modified amino acid catabolic process,BP,CHAC1;ALDH1L2;AHCY;GGACT;ALDH4A1;GGT1;PCYOX1
4365,GO:0009967,0.000924935613794524,0.999340578022599,142,1067,positive regulation of signal transduction,BP,XDH;SH2D2A;NOS1;F2R;MST1R;RBCK1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;ARAP1;DLG4;IGFBP4;FKBP1A;PSMD2;BNIP3;SSH1;SMURF2;TMOD2;G0S2;MAPKAPK3;NACC2;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;MAP2K2;STK25;SHANK3;AKT1;CARD11;IRAK1;EPN2;PKN1;PRKCZ;RFNG;FZD8;EPHA1;PTK6;SLC20A1;FERMT1;STK39;DKK1;PPP2R5B;AKAP12;SHC2;CD44;PLCG1;MAP3K9;MC1R;DEDD2;TSPAN5;PAK1;ZNF385A;NLGN2;DDIT3;TNFSF15;RET;RAB29;RASGEF1A;RHOC;GRB10;SHANK2;GATA3;GNAI2;HSF1;ALOX15B;ADAM8;RGL2;FAM110C;MYDGF;GIPC1;SRC;LDLRAP1;TGM2;FAM162A;IRF7;STK24;GSK3A;PAG1;DUSP6;FYN;LPAR3;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;PUM1;ITGA1;SHISA5;NTSR1;MAP3K10;HEXIM1;FGFR1;MIB2;MFNG;MIF;SOCS2;BCL2L1;ADIPOR1;TNFRSF19;P2RX4;HPSE;LRRK1;FGF2;MAPK9;SHB;MAP3K12;TAOK1;ABCA7;TGFA;ATP6V1C2;KLK6;CASP4;EPHB2;CBL;CIB1;MAPK3;MAPK10;CSNK1D;LITAF;MINK1;SKAP2;ECM1;ITSN1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;STARD10;ERBB3;EP300;TRAF7
12800,GO:0051056,0.000933103015970739,0.99949087635033,46,267,regulation of small GTPase mediated signal transduction,BP,F2R;RAC2;ASAP2;ARAP1;OBSCN;NET1;BCR;ARHGAP23;APOE;ARHGAP22;GIT2;GDI1;SIPA1;PSD3;GIT1;ARHGAP39;FARP1;RASGEF1A;RHOC;CYTH3;APPL2;RGL2;RHOBTB2;ARHGEF4;SRC;DNM2;SH3BP1;PLEKHG5;DNMBP;ARFGEF2;ARAP3;RHOBTB1;EPS8L1;EPHB2;IQSEC1;ARHGEF2;OCRL;ARHGAP44;AGAP1;ITSN1;PIK3R2;ITGA3;ARHGEF10L;RAP1GAP2;RASA3;ASAP1
12790,GO:0051046,0.000934031326537118,0.999434178448829,65,425,regulation of secretion,BP,F2R;RAC2;SDC1;PCK2;NR1D1;POSTN;RAB3B;RAPGEF3;IDH2;BCR;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS4A;FERMT1;SEPT5;HADH;STK39;NLGN2;GLUL;SYTL1;GATA3;APLN;ASIC1;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;SCG5;NCS1;CPTP;STXBP1;MICAL1;GAL;COMT;NTSR1;FGFR1;MIF;P2RX4;SMPD3;ZP3;CHD7;APBB1;KCNC4;HGS;MAPK3;LLGL1;CEACAM1;SLC30A1;TGFB1;ERBB3;ANXA1;GNAS
13252,GO:0051896,0.000948900191344393,0.999595842134721,25,123,regulation of protein kinase B signaling,BP,XDH;MST1R;DLG1;EGFR;AKT1;RRAS;PPP2R5B;MC1R;DDIT3;GATA3;ADAM8;FAM110C;MYDGF;SRC;FYN;FGFR1;TRIB3;LEMD2;HPSE;FGF2;CIB1;ITSN1;TGFB1;PIK3R2;ERBB3
712,GO:0001934,0.000959288099940124,0.999371340688235,90,622,positive regulation of protein phosphorylation,BP,XDH;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;GNAI2;HSF1;ADAM8;MYDGF;SRC;STK24;PAK6;DUSP6;FYN;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;CSNK1D;ARHGEF2;MINK1;ADCY6;TGFB1;ERBB3;WDFY2;TRAF7
7950,GO:0032535,0.000959618999427489,0.999478687946852,45,267,regulation of cellular component size,BP,RAC2;WNT7A;DLG1;RAB3B;PTPRS;SSH1;TMOD2;SEMA3F;SLC12A7;CORO1B;SHANK3;AKT1;ARPC1A;APOE;ATP13A2;TMSB4X;MSN;MAP1B;GDI1;LIMK1;WDTC1;TWF2;PAK1;SEMA4B;RET;SLC12A4;CAPG;DNM2;SH3BP1;LPAR3;PFN1;SEMA4G;ADNP;LRRC8A;ARFIP2;ULK2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;PLEKHH2;RAP1GAP2
6732,GO:0030141,0.000959784052632374,0.999390384910659,78,541,secretory granule,CC,PYGB;PLAT;PYGL;QSOX1;CST3;NAPRT;SERPINE2;BSG;PGM1;PSMD2;RAB3B;CKAP4;PRSS3;CD68;LCN2;CTSB;LY6K;RAB31;LPCAT1;THBS2;PRKACA;SERPING1;TMSB4X;AP2A2;GALNS;ITPR3;CTSZ;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;APLP2;SCG5;UBR4;NCS1;C6ORF120;GARS;STXBP1;YPEL5;PSMD7;ANXA3;GAL;ITGA1;TIMP1;LOXL1;LGALS3BP;MIF;PCSK1N;TCIRG1;HPSE;PNP;ARG1;VEGFB;KLK6;VAT1;SNAP29;SPESP1;TRAPPC1;RAB4B;POMT1;ALDOC;TMBIM1;ADAM15;CEACAM1;ECM1;CD59;TGFB1;CAT;RAB6A;ERP44
1968,GO:0004674,0.000962314458069771,0.999421857262513,63,396,protein serine/threonine kinase activity,MF,CCND1;MST1R;LTBP4;MAP2K1;OBSCN;RPS6KA2;MAPKAPK3;BCR;MARK4;ACVR2B;MAP4K4;EGFR;CSNK1E;MKNK2;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;FAM20C;MAPK13;EPHA1;GRK6;TGFBR2;LIMK1;STK39;PRKACB;LTBP1;MAP3K9;PAK1;TTBK2;RET;NEK9;HMGA2;TOP1;CDC42BPB;MARK3;STK24;PAK6;GSK3A;BRSK1;PSKH1;MAP3K10;FGFR1;CDK18;STK17A;ULK1;PAK4;ULK2;LRRK1;MAPK9;MAP3K12;TAOK1;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;MINK1;ADCK2;ERBB3
5168,GO:0015711,0.000987966081149449,0.999462565616927,45,266,organic anion transport,BP,SERINC2;PITPNC1;SLCO4A1;CPT2;BSG;SLC16A3;PITPNM1;SLC2A9;OSBPL10;AKT1;APOE;STK39;PPARA;OSBPL5;SLC38A10;ATP11A;SLC2A3;SLC6A6;SLC13A3;SLC43A1;VAMP2;GIPC1;CPTP;STXBP1;SLC6A9;SLC33A1;SLC13A5;PLTP;NTSR1;SLC35B4;MIF;PRAF2;PITPNM2;SLC27A1;SLC6A14;P2RX4;ABCA7;RXRA;ARG1;SLC10A6;CPT1B;CEACAM1;APBA1;STARD10;ANXA1
12794,GO:0051050,0.00100235756132172,0.999345059982075,88,612,positive regulation of transport,BP,EDEM1;FHL1;TSPAN1;NOS1;F2R;RAC2;SORL1;SDC1;BOK;PCK2;DLG1;POSTN;RAB3B;RAPGEF3;PRNP;BCR;XBP1;EGFR;TUB;HK1;SHANK3;AKT1;BAG3;APOE;EHD3;ATP13A2;TMSB4X;PRKCZ;VPS11;VPS4A;ORAI1;PCSK9;FERMT1;MSN;STK39;PRSS8;ZDHHC8;PLCG1;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;CEMIP;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;WFS1;ADAM8;VAMP2;SRC;LDLRAP1;GLRX;DNM2;NCS1;GSK3A;STXBP1;FYN;LPAR3;GJC2;GAL;PLTP;NTSR1;FGFR1;MIF;LRP1;HSPA2;P2RX4;SMPD3;ZP3;TBC1D20;ABCA7;APBB1;CAMK1;EPHB2;HGS;CBL;CIB1;MAPK3;UGCG;TGFB1;AZIN2;PIK3R2;ANXA1;STIM1
16924,GO:0098858,0.00101741098202427,0.999564394103007,25,123,actin-based cell projection,CC,DOCK4;ITGA6;RAPGEF3;ESPN;BBS2;ACTA2;MSN;CD44;TWF2;FSCN1;PODXL;FARP1;SYTL1;RHOC;FAT1;KIF13B;TENM2;VASP;APBB1;HOMER2;CIB1;CEACAM1;TGFB1;STARD10;ITGA3
16834,GO:0098662,0.00103447659175503,0.999389520444758,58,374,inorganic cation transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG1;FKBP1A;SLC2A9;PRNP;SLC12A7;PRKACA;HECW2;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PLCG1;DDIT3;STOM;CEMIP;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;VAMP2;GLRX;DNM2;NDUFA4L2;NCS1;FYN;SLC33A1;GJC2;GAL;NTSR1;ATP2C2;VPS9D1;TCIRG1;TPCN1;HSPA2;P2RX4;FGF2;CHD7;ATP6V1C2;KCNC4;SLC30A1;TGFB1;SLC15A1;ORAI3;STIM1;RASA3
8739,GO:0034380,0.00104466506435287,0.999922007242704,5,9,high-density lipoprotein particle assembly,BP,PRKACA;APOE;PRKACB;ZDHHC8;ABCA7
7269,GO:0031232,0.00104533134826377,1,3,3,extrinsic component of external side of plasma membrane,CC,SERPINE2;PCSK9;ANXA1
16687,GO:0097553,0.00104687921689308,0.999639789111392,17,72,calcium ion transmembrane import into cytosol,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;FAM155B;FYN;NTSR1;TPCN1;FGF2;CHD7;TGFB1;RASA3
10365,GO:0043168,0.00105148196120299,0.999189008023661,252,2004,anion binding,MF,XDH;PGF;PYGB;CBS;NOS1;LTBP2;MST1R;RAC2;MAP2K1;SHC1;PITPNC1;PYGL;ERCC6;SNX9;SCN8A;PCK2;ARAP1;OBSCN;SERPINE2;DYSF;PITPNM1;DGKA;POSTN;RAB3B;RPS6KA2;RAPGEF3;PTPRS;NAGS;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;SESN2;ACOT7;PLEK2;OSBPL10;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;GPT2;ADCY7;ZCCHC14;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;THBS2;SEPT10;PRKACA;PTPRF;CARS;TUB;ACTA2;HK1;MAP2K2;TUBG2;STK25;SNX33;AKT1;GPC4;IRAK1;APOE;EHD3;ATP13A2;PKN1;CRYL1;COL13A1;PRKCZ;ATP7B;FAM20C;ITPR3;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;SH3PXD2B;GRK6;ACAD10;NMRK1;RRAS;SEPT5;HS1BP3;TGFBR2;HADH;LIMK1;STK39;UBE2J1;PPARA;DHTKD1;NADK;PRKACB;CDC34;CD44;ESYT2;ABCB8;GTPBP1;MAP3K9;OSBPL5;IDE;TWF2;HMGCL;PAK1;TTBK2;ACSF2;GLUL;TUBB3;SYTL1;RET;RAB29;LAMC2;RHOC;CYTH3;HLTF;CEMIP;SEPT8;ASS1;ATP11A;GSDMA;ARL8A;OASL;MYOF;ACBD4;GNAI2;GRIN3B;GLUD1;PANK4;NEK9;SDHA;MYH15;ALAS1;RHOBTB2;TOP1;ARL2;MICAL2;P4HA1;VAMP2;PIP5K1C;TULP3;SRC;LDLRAP1;APLP2;CBR4;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;CPTP;ACADVL;PAK6;GARS;GSK3A;PCSK6;PMVK;OAS1;SLFN5;FYN;RAB25;SPTLC2;AGRN;ASNS;LPAR3;PFN1;NISCH;MICAL1;KIF17;ANXA3;WISP1;VDR;KIF13B;UCKL1;BRSK1;CHST14;PSKH1;PLTP;MAP3K10;UBA1;WDFY3;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;SNX25;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;LRP1;HSPA2;AOX1;PAK4;P2RX4;ULK2;LRRK1;PNP;FGF2;EHD4;MAPK9;MAP3K12;HSPA13;ARAP3;MYO1D;CHD7;TAOK1;ABCA7;PHYH;RHOBTB1;RXRA;VEGFB;GSDMC;SEC14L2;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;SNX27;AIDA;MINK1;ARHGAP44;AGAP1;ADCY6;SH3PXD2A;ADCK2;ERBB3;ANXA1;RAB6A;GNAS;THBS3;ASAP1
13268,GO:0051924,0.00106454007008193,0.99955144592585,24,118,regulation of calcium ion transport,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;EHD3;ORAI1;PLCG1;CEMIP;GNAI2;GRIN3B;WFS1;SARAF;FYN;LPAR3;GJC2;NTSR1;HSPA2;P2RX4;CHD7;HOMER2;SLC30A1;TGFB1;STIM1
5790,GO:0017016,0.00106460113467744,0.99935469237558,64,407,Ras GTPase binding,MF,DVL1;SHC1;DOCK4;DLG4;OBSCN;XPOT;NET1;RAPGEF3;SBF1;BCR;EVI5L;EGFR;FMNL2;RIN2;PKN1;RABGGTA;GDI1;RIN1;YIPF2;SHC2;IPO13;TBC1D16;TBC1D14;PAK1;DMXL2;TBC1D9B;FARP1;SYTL1;RET;RAB29;RASGEF1A;RGL2;ARHGEF4;DENND2A;CDC42BPB;PAK6;EXOC2;SH3BP1;FYN;PFN1;MICAL1;PLEKHG5;FGFR1;RAB11FIP4;DNMBP;ARFIP2;ULK1;PAK4;TBC1D20;FGF2;EPS8L1;TBC1D2B;GAS8;TRAPPC1;CIB1;ARHGEF2;LLGL1;OCRL;ARHGAP44;SRGAP2B;ITSN1;PPP6R1;ERBB3;ARHGEF10L
3404,GO:0007187,0.00107821180650398,0.999614102016726,18,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,NOS1;ADM2;PTHLH;ADGRF1;HTR7;ADCY7;AKAP12;PRKACB;WASF2;MC1R;GNB1;GNAI2;EDNRA;GSK3A;LPAR3;ADCY6;ANXA1;GNAS
1482,GO:0003756,0.00108491310926774,0.999845448087976,7,17,protein disulfide isomerase activity,MF,QSOX1;TXNDC11;P4HB;PDIA5;ERO1B;TMX4;ERP44
5728,GO:0016864,0.00108491310926774,0.999845448087976,7,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,QSOX1;TXNDC11;P4HB;PDIA5;ERO1B;TMX4;ERP44
1262,GO:0003013,0.00108612586185618,0.999415093307174,43,253,circulatory system process,BP,NOS1;F2R;CTNNBIP1;ADM2;DOCK4;DLG1;POSTN;TNNT1;BBS2;BCR;LRP5;HTR7;EGFR;PRKACA;PPP1R13L;AKT1;SERPING1;APOE;EHD3;ITPR3;CTSZ;STK39;PPARA;RAP1GDS1;APLN;MYOF;ASPH;PLCB3;EDNRA;SRC;TAZ;GSK3A;NISCH;ITGA1;THRA;NTSR1;P2RX4;CHD7;VEGFB;CEACAM1;ADCY6;TGFB1;STIM1
7626,GO:0032011,0.00108796848216725,0.999713516349943,12,41,ARF protein signal transduction,BP,ASAP2;ARAP1;GIT2;PSD3;GIT1;CYTH3;APPL2;ARFGEF2;ARAP3;IQSEC1;AGAP1;ASAP1
7627,GO:0032012,0.00108796848216725,0.999713516349943,12,41,regulation of ARF protein signal transduction,BP,ASAP2;ARAP1;GIT2;PSD3;GIT1;CYTH3;APPL2;ARFGEF2;ARAP3;IQSEC1;AGAP1;ASAP1
18826,GO:1904340,0.00109122516534569,1,3,3,positive regulation of dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D
19105,GO:1904958,0.00109122516534569,1,3,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D
2544,GO:0005802,0.00109281596735666,0.999480092372099,31,167,trans-Golgi network,CC,CHAC1;SORL1;SNX9;BOK;ARAP1;POSTN;RAB43;MARCH9;RAB31;AP1B1;ATP7B;PI4K2A;YIPF2;GGA3;RAB29;CORO7;DOPEY2;VAMP2;DNM2;NUCB1;COG8;STX10;PCSK1N;ARFIP2;ARFGEF2;COG1;FURIN;LLGL1;OCRL;AZIN2;RAB6A
12077,GO:0048010,0.00109958135728148,0.999619863378753,17,72,vascular endothelial growth factor receptor signaling pathway,BP,PGF;SH2D2A;FAM129B;MAPKAPK3;EPN2;MAPK13;SHC2;WASF2;GRB10;MYOF;SRC;FYN;SHB;VEGFB;HGS;PIK3R2;PXN
3192,GO:0006820,0.00110931371394716,0.999357169605469,54,336,anion transport,BP,SERINC2;PITPNC1;SLCO4A1;CPT2;BSG;SLC16A3;PITPNM1;SLC2A9;PRNP;OSBPL10;TTYH3;SLC12A7;AKT1;APOE;SLC20A1;STK39;PPARA;OSBPL5;SLC38A10;ATP11A;ANO8;SLC2A3;SLC12A4;SLC6A6;SLC13A3;SLC43A1;VAMP2;GIPC1;CPTP;STXBP1;SLC6A9;SLC33A1;SLC13A5;PLTP;NTSR1;SLC35B4;FGFR1;LRRC8A;MIF;PRAF2;PITPNM2;SLC27A1;SLC6A14;P2RX4;ABCA7;RXRA;ARG1;SLC10A6;CPT1B;CEACAM1;APBA1;PCYOX1;STARD10;ANXA1
9417,GO:0035967,0.00111324780971034,0.999492905338723,28,146,cellular response to topologically incorrect protein,BP,EDEM1;CCND1;SHC1;BOK;XBP1;ATF4;PDIA5;SYVN1;YIF1A;TSPYL2;CREB3L2;PPP2R5B;SEC63;DDIT3;CUL7;HSF1;WFS1;MYDGF;ACADVL;GSK3A;ASNS;STUB1;HSPA2;VAPB;HSPA13;POMT1;DNAJB9;EP300
11405,GO:0045766,0.00114264446799335,0.999549119272525,21,98,positive regulation of angiogenesis,BP,ANGPTL4;PGF;ADM2;RAPGEF3;XBP1;EPHA1;RRAS;TGFBR2;PLCG1;HMGA2;MYDGF;ANXA3;HYAL1;PAK4;FGF2;VEGFB;CIB1;SRPX2;ECM1;ANXA1;STIM1
10745,GO:0044092,0.00114656523080197,0.999220872170181,104,755,negative regulation of molecular function,BP,ANGPTL4;MDFI;NOS1;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;CST3;CYP27B1;SERPINE2;DAP;IFI6;FKBP1A;PRNP;LRP5;CSNK1E;ADARB1;PTPRF;HECW2;AKT1;IRAK1;SERPING1;APOE;PKN1;WWTR1;TMSB4X;PRKCZ;CTSZ;EPHA1;PTK6;PCSK9;PPP1R35;SERPINB6;LIMK1;STK39;DKK1;PPARA;WDTC1;CD44;PRDX5;PPP1R12C;BIN1;SUFU;TTBK2;RAG1;DDIT3;FARP1;DUSP4;PKD1;PARP10;DLG3;OXA1L;GNAI2;WFS1;NEIL1;TFPI2;HMGA2;PPP1R14A;ARL2;TNFRSF6B;SRC;APLP2;SCG5;RSF1;GSK3A;SPINT2;DUSP6;PPM1F;MICAL1;ANXA3;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;ADNP;SOCS2;STUB1;PCSK1N;TRIB3;ZFPM1;TRIB2;RNH1;MYO1D;CAMSAP3;CAMK1;EPHB2;CBL;CIB1;SOCS7;MAPK3;FURIN;TMBIM1;AIDA;ADAM15;CEACAM1;ECM1;CAT;SPRED2;CAMK2N1;PPP1R37;ANXA1;PPP1R10
5073,GO:0015294,0.00116009914033679,0.999649505576753,14,53,solute:cation symporter activity,MF,SLC2A9;SLC12A7;SLC20A1;SLC12A4;SLC6A6;SLC13A3;SLC6A9;SLC33A1;SLC13A5;SLC6A14;SLC10A6;SLC5A1;SLC15A1;SLC45A3
829,GO:0002102,0.00117633523912511,0.999764929410989,9,26,podosome,CC,AFAP1L1;SH3PXD2B;FSCN1;ADAM8;SRC;PTPN12;ARHGEF2;SH3PXD2A;ASAP1
15481,GO:0071801,0.0011798128453337,0.99986645900165,6,13,regulation of podosome assembly,BP,MSN;FSCN1;SRC;MAPK9;ARHGEF2;ASAP1
6309,GO:0019935,0.00119081552169239,0.999600805888871,16,67,cyclic-nucleotide-mediated signaling,BP,NOS1;ADM2;PTHLH;RAPGEF3;ADGRF1;ADCY7;APOE;DGKQ;CDC34;MC1R;GNB1;GSK3A;GAL;MGRN1;ADCY6;GNAS
13113,GO:0051604,0.00121535963178952,0.999380495062975,36,211,protein maturation,BP,CHAC1;CAPN2;SORL1;PLAT;LMF1;SERPINE2;FKBP1A;PRSS3;PRNP;MMP14;RHBDF2;SERPING1;CTSZ;PCSK9;TYSND1;PRKACB;TSPAN5;ERO1B;WFS1;ASPH;ADAM8;SRC;SCG5;PCSK6;TSPAN33;F12;STUB1;PCSK1N;KLK6;LONP2;GGT1;FURIN;HM13;CD59;PLGRKT;EP300
9382,GO:0035898,0.00121555714526342,1,3,3,parathyroid hormone secretion,BP,GATA3;FGFR1;GNAS
14650,GO:0070207,0.00121848952627819,0.99981893233229,7,18,protein homotrimerization,BP,ASIC1;HSF1;HSF4;MIF;SIGMAR1;ATXN10;ARG1
12768,GO:0051017,0.00121893563458781,0.999492656062268,23,110,actin filament bundle assembly,BP,ARAP1;RAPGEF3;ESPN;ITGB5;CORO1B;SHANK3;EPHA1;SH3PXD2B;LIMK1;WASF2;FSCN1;PAK1;RHOC;RHOBTB2;SRC;PPM1F;PFN1;SPIRE1;RHOBTB1;BAIAP2L1;PXN;ARHGEF10L;FHOD1
12404,GO:0048812,0.00122005983920464,0.999247086759168,67,433,neuron projection morphogenesis,BP,SH3KBP1;RAC2;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;POSTN;PTPRS;SSH1;NYAP1;FAM129B;SEMA3F;VLDLR;MAP4K4;EGFR;ADARB1;STK25;SHANK3;HECW2;FBXW8;APOE;PRKCZ;MAP1B;LAMB2;GDI1;LIMK1;OBSL1;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;SRC;DNM2;STK24;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;ITGA1;SEMA4G;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;IMPACT;EPHB2;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6
3557,GO:0007599,0.00122226600556456,0.999370571939275,37,217,hemostasis,BP,F2R;RAC2;PLAT;SERPINE2;DGKA;FBLN1;PRKACA;AKT1;SERPING1;APOE;EHD3;PHF21A;ITPR3;DGKQ;PRKACB;ZNF385A;GNB1;DOCK9;PROCR;GATA3;DOCK6;TFPI2;SRC;STXBP1;FYN;MICAL1;F12;ZFPM1;P2RX4;HPSE;RCOR1;LMAN1;MYL9;MAPK3;CEACAM1;CD59;GNAS
8948,GO:0034976,0.00123873708930471,0.999338366200012,41,242,response to endoplasmic reticulum stress,BP,EDEM1;CHAC1;CCND1;SHC1;BOK;TXNDC11;SESN2;XBP1;ATF4;P4HB;PDIA5;SYVN1;YIF1A;TSPYL2;TMEM129;FBXO2;CREB3L2;PPP2R5B;UBE2J1;SEC63;DDIT3;CUL7;UBXN4;WFS1;MYDGF;ACADVL;GSK3A;ASNS;GRINA;STUB1;TRIB3;VAPB;TMX4;CASP4;POMT1;DNAJB9;RNF103;HM13;PIK3R2;EP300;ERP44
8669,GO:0034220,0.00125632539535313,0.999180426303991,84,583,ion transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG4;CPT2;DLG1;SLC16A3;FKBP1A;SLC2A9;PRNP;TTYH3;SLC12A7;PRKACA;SHANK3;HECW2;AKT1;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PLCG1;SLC38A10;SFXN3;NLGN2;DDIT3;STOM;CEMIP;SHANK2;PKD1;DLG3;NIPA1;ANO8;GRIN3B;ASIC1;SLC12A4;ASPH;FAM155B;SLC6A6;SLC13A3;SLC43A1;VAMP2;GLRX;DNM2;NDUFA4L2;NCS1;FYN;SLC6A9;SLC33A1;GJC2;GAL;SLC13A5;NTSR1;SLC35B4;ATP2C2;LRRC8A;VPS9D1;PRAF2;TCIRG1;TPCN1;SLC6A14;HSPA2;P2RX4;FGF2;CHD7;ATP6V1C2;KCNC4;EPHB2;CPT1B;MINK1;SLC30A1;TGFB1;PCYOX1;SLC15A1;ORAI3;STIM1;RASA3
6745,GO:0030160,0.00125951292299163,1,3,3,GKAP/Homer scaffold activity,MF,SHANK3;SHANK2;HOMER2
12145,GO:0048207,0.00126246408276009,0.99961202638585,14,56,vesicle targeting, rough ER to cis-Golgi,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
12146,GO:0048208,0.00126246408276009,0.99961202638585,14,56,COPII vesicle coating,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
9033,GO:0035239,0.00128593308053985,0.999169909821738,80,539,tube morphogenesis,BP,ANGPTL4;XDH;PGF;SH2D2A;CTNNBIP1;NFATC4;DVL1;ADM2;SHC1;WNT7A;DLG1;RAPGEF3;LAMA5;FAM129B;ETV5;LRP5;ACVR2B;XBP1;EGFR;MMP14;THBS2;EPN1;EPN2;APOE;ELK3;ARHGAP22;FZD8;CTSZ;EPHA1;RRAS;DEAF1;TGFBR2;PRKACB;WASF2;PLCG1;SUFU;PAK1;PODXL;CUL7;RET;PKD1;GATA3;APLN;ADGRB2;ADAM8;HMGA2;MICAL2;MYDGF;EDNRA;TULP3;SRC;TGM2;SDCCAG8;SPINT2;FUZ;PFN1;ANXA3;VDR;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;VASP;CHD7;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;ANXA1;STIM1
506,GO:0001568,0.00128746204388181,0.999203355792865,67,436,blood vessel development,BP,ANGPTL4;XDH;PGF;SH2D2A;NFATC4;MAP2K1;ADM2;SHC1;WNT7A;RAPGEF3;LAMA5;FAM129B;LRP5;ACVR2B;XBP1;MMP14;THBS2;ACTA2;EPN1;FBXW8;AKT1;EPN2;APOE;ELK3;ARHGAP22;FZD8;EPHA1;RRAS;TGFBR2;LTBP1;WASF2;PLCG1;SUFU;DDIT3;CUL7;PKD1;APLN;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;ALDH1A2;DNM2;ANXA3;LOXL1;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;CHD7;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;ANXA1;STIM1
9332,GO:0035799,0.00129754656007206,1,3,3,ureter maturation,BP,RET;GATA3;ALDH1A2
6870,GO:0030335,0.00132744346625359,0.99923663599524,51,317,positive regulation of cell migration,BP,PGF;F2R;RAC2;DOCK4;WNT7A;POSTN;ITGA6;SSH1;SMURF2;SEMA3F;XBP1;EGFR;MMP14;LAMB1;AKT1;TMSB4X;EPHA1;TGFBR2;PLCG1;PAK1;SEMA4B;PODXL;RET;LAMC2;CEMIP;GATA3;ADAM8;FAM110C;NUMB;SRC;RAB25;PPM1F;WNT5B;PFN1;ANXA3;SEMA4G;FGFR1;RREB1;HYAL1;ZNF609;P2RX4;ZP3;FGF2;VEGFB;CIB1;MAPK3;ARHGEF2;SRPX2;TGFB1;ANXA1;ITGA3
5135,GO:0015629,0.00135742451647444,0.999201133412376,55,347,actin cytoskeleton,CC,H1F0;CAPN2;MPRIP;MST1R;RAC2;SMTN;PGM1;RAPGEF3;TMOD2;ESPN;TNNT1;CORO1B;PARVB;ARPC1A;AFAP1L1;TMSB4X;PRKCZ;SH3PXD2B;FERMT1;CORO2A;OBSL1;WASF2;TWF2;BIN1;FSCN1;PAK1;MYH16;ADAM8;MYH15;CAP1;FLNB;SRC;DENND2A;CAPG;CDC42BPB;SPECC1L;FYN;AFAP1;PTPN12;KLHL17;VASP;MYO1D;BAIAP2L1;WIPF1;MYL9;TMSB10;ARHGEF2;MYZAP;LLGL1;SH3PXD2A;ANXA1;PXN;PLEKHH2;ASAP1;FHOD1
5441,GO:0016301,0.00136206162539698,0.999092116236863,92,634,kinase activity,MF,CCND1;MST1R;LTBP4;MAP2K1;DLG4;OBSCN;DLG1;DGKA;RPS6KA2;NAGS;SCYL1;NME4;MAPKAPK3;BCR;MARK4;ACVR2B;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;PRKACA;HK1;MAP2K2;STK25;AKT1;CARD11;IRAK1;PKN1;PRKCZ;FAM20C;DGKQ;MAPK13;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;NADK;PRKACB;LTBP1;MAP3K9;PAK1;TTBK2;RET;DLG3;PANK4;NEK9;HMGA2;TOP1;PIP5K1C;SRC;CDC42BPB;MARK3;STK24;PAK6;GSK3A;PMVK;FYN;UCKL1;BRSK1;PSKH1;MAP3K10;CRIM1;FGFR1;GUK1;CDK18;STK17A;PIP5KL1;ULK1;PAK4;ULK2;LRRK1;FGF2;MAPK9;MAP3K12;TAOK1;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;MINK1;CCNE1;ADCK2;PIK3R2;ERBB3;ZFYVE21
548,GO:0001667,0.00136572498184025,0.999243524495358,45,271,ameboidal-type cell migration,BP,WNT7A;PRSS3;LAMA5;SMURF2;CYGB;SEMA3F;LRP5;CORO1B;AKT1;APOE;PKN1;TMSB4X;FERMT1;TGFBR2;WASF2;PLCG1;PAK1;SEMA4B;RET;GATA3;ARID5B;CAP1;GIPC1;SRC;SH3BP1;RAB25;PPM1F;PFN1;ANXA3;PLEKHG5;TIMP1;SEMA4G;FGFR1;RREB1;HYAL1;ADIPOR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;ITGA3;PXN
2710,GO:0006082,0.00136813070352773,0.999051650105252,112,829,organic acid metabolic process,BP,CBS;NOS1;PCK2;CPT2;BSG;NR1D1;SLC16A3;PGM1;PSMD2;SLC2A9;NAGS;IDH2;PC;CRTAP;CYGB;SESN2;ACOT7;HAGH;CHPF;AARS;XYLT1;GPT2;XBP1;ACOT1;CRAT;CARS;HK1;XYLT2;ATF4;P4HB;PSAT1;AKT1;MDH2;ALDH1L2;ARG2;CRYL1;GALNS;PFKP;ACAD10;TYSND1;HADH;NDST2;PPARA;DHTKD1;TST;WDTC1;CD44;ELOVL1;HMGCL;ERO1B;AHCY;ACSF2;GAMT;GLUL;CEMIP;ASS1;SLC2A3;GLUD1;ALOX15B;SDHA;SLC6A6;PYCR2;BLMH;P4HA1;B4GALT2;ALDH1A2;B3GNT3;CBR4;ACADVL;GARS;ASNS;ALDH4A1;PSMD7;TNFRSF1A;ALDH7A1;CHST14;COMT;MGLL;HYAL1;MIF;ADIPOR1;ST3GAL3;TRIB3;SLC27A1;HLCS;SARS2;SLC6A14;PNP;FGF2;ABHD14B;MLYCD;PHYH;ARG1;BPHL;ACY1;LONP2;GGT1;MAPK3;CPT1B;ALDOC;GLO1;B4GALT6;CEACAM1;LPIN3;UROS;TGFB1;PCYOX1;LDHA;AZIN2;ANXA1;PODXL2;SLC45A3
14371,GO:0061572,0.00138521460879775,0.999417062794597,23,111,actin filament bundle organization,BP,ARAP1;RAPGEF3;ESPN;ITGB5;CORO1B;SHANK3;EPHA1;SH3PXD2B;LIMK1;WASF2;FSCN1;PAK1;RHOC;RHOBTB2;SRC;PPM1F;PFN1;SPIRE1;RHOBTB1;BAIAP2L1;PXN;ARHGEF10L;FHOD1
13833,GO:0060402,0.00138718100143911,0.99949033543038,18,80,calcium ion transport into cytosol,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;FAM155B;FYN;NTSR1;TPCN1;P2RX4;FGF2;CHD7;TGFB1;RASA3
17595,GO:1901184,0.00138986489969808,0.999489256659493,18,80,regulation of ERBB signaling pathway,BP,SH3KBP1;SH3TC2;SHC1;NEURL1;ARAP1;EGFR;RHBDF2;EPN1;AKT1;PTK6;MVB12B;ITGA1;PTPN12;TGFA;HGS;CBL;CEACAM1;ERBB3
18471,GO:1903530,0.00139497406865638,0.999153885801045,61,399,regulation of secretion by cell,BP,F2R;RAC2;SDC1;PCK2;NR1D1;POSTN;RAB3B;RAPGEF3;IDH2;BCR;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS4A;FERMT1;SEPT5;HADH;NLGN2;GLUL;SYTL1;GATA3;APLN;ASIC1;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;SCG5;NCS1;CPTP;STXBP1;MICAL1;GAL;NTSR1;FGFR1;MIF;SMPD3;ZP3;CHD7;APBB1;KCNC4;HGS;MAPK3;LLGL1;CEACAM1;SLC30A1;TGFB1;ANXA1;GNAS
3376,GO:0007155,0.00140316285659996,0.999028715431759,111,800,cell adhesion,BP,TNIP1;NT5E;ITGB4;RAC2;ADGRL1;SHC1;SDK2;AP3D1;SERPINE2;DLG1;POSTN;ITGA6;NET1;PTPRS;PRNP;PDZD2;LAMA5;PCDH1;FBLN1;ITGB5;XBP1;EGFR;MMP14;LAMB1;THBS2;PTPRF;PARVB;AKT1;CARD11;ARG2;COL13A1;PRKCZ;EPHA1;FERMT1;MSN;TGFBR2;LAMB2;CD99;PPARA;SYMPK;SIPA1;CD44;TFE3;PAK1;TSTA3;CERCAM;NLGN2;RAG1;PODXL;RET;LAMC2;NID1;CYTH3;PKD1;ASS1;GATA3;CADM4;FAT1;EFS;PTPRU;ADAM8;ARL2;IGFBP2;PIP5K1C;SRC;TGM2;DNM2;STXBP1;PAG1;SPECC1L;SPINT2;FYN;CLSTN1;PPM1F;WISP1;CGREF1;ITGA1;LYPD5;AMIGO2;LAMB3;LGALS3BP;RREB1;HYAL1;TENM2;PAK4;HPSE;ZP3;PNP;MSLN;ARG1;CAMSAP3;BAIAP2L1;TPBG;MYL9;CIB1;KIFC3;ARVCF;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;TGFB1;ERBB3;ANXA1;PODXL2;GNAS;ITGA3;CLDN12;PXN;THBS3
15782,GO:0072359,0.001403464309252,0.999053174030453,97,680,circulatory system development,BP,ANGPTL4;XDH;PGF;SH2D2A;ADAM19;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;MEF2D;FKBP1A;RAPGEF3;LAMA5;FAM129B;LRP5;ACVR2B;XBP1;EGFR;MMP14;THBS2;ACTA2;EPN1;PPP1R13L;FBXW8;AKT1;EPN2;APOE;AP1B1;ELK3;ARHGAP22;FZD8;EPHA1;SH3PXD2B;RRAS;TGFBR2;EPOR;DKK1;PPARA;OBSL1;LTBP1;WASF2;PLCG1;SUFU;PAK1;DDIT3;CUL7;PKD1;GATA3;APLN;ADGRB2;ADAM8;HMGA2;MICAL2;MYDGF;EDNRA;ALDH1A2;TAZ;DNM2;GSK3A;DUSP6;ANXA3;PSKH1;HEXIM1;LOXL1;FGFR1;HYAL1;LEMD2;ZFPM1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;CHD7;BICC1;RXRA;VEGFB;TCF25;EPHB2;HGS;CIB1;MAPK3;ADAM15;SRPX2;CEACAM1;ECM1;MBD3;TGFB1;ERBB3;ANXA1;ITGA3;EP300;STIM1
18205,GO:1902950,0.00143493633908817,0.999935795415392,4,6,regulation of dendritic spine maintenance,BP,ZMYND8;PRNP;APOE;FYN
6307,GO:0019933,0.0014462820858528,0.999525897933689,15,62,cAMP-mediated signaling,BP,NOS1;ADM2;PTHLH;RAPGEF3;ADGRF1;ADCY7;DGKQ;CDC34;MC1R;GNB1;GSK3A;GAL;MGRN1;ADCY6;GNAS
13300,GO:0051968,0.00145474697194126,0.999828144203953,6,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;SHANK3;NLGN2;GLUL;SHANK2;STXBP1
9722,GO:0038127,0.00147987224759165,0.999346909079899,25,126,ERBB signaling pathway,BP,SH3KBP1;FAM83A;SH3TC2;SHC1;NEURL1;ARAP1;EGFR;RHBDF2;EPN1;AKT1;PTK6;MVB12B;PLCG1;SRC;PAG1;ITGA1;STUB1;PTPN12;TGFA;HGS;CBL;CEACAM1;TGFB1;ERBB3;PXN
9798,GO:0040007,0.00148785125377251,0.99900224641919,93,655,growth,BP,FHL1;ERCC1;LTBP4;DVL1;SHC1;WNT7A;ERCC6;CYP27B1;SERPINE2;IGFBP4;DCBLD2;POSTN;NET1;PTPRS;WWC3;SESN2;BBS2;SEMA3F;ACVR2B;EGFR;MMP14;ADARB1;PPP1R13L;SHANK3;AKT1;APOE;WWTR1;TSPYL2;PRKCZ;PTK6;SH3PXD2B;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;SIPA1;WDTC1;TWF2;HTRA1;PAK1;SEMA4B;GAMT;SHANK2;GATA3;HSF1;ALOX15B;WFS1;MT2A;RAI1;HMGA2;ARID5B;IGFBP2;SRC;DNM2;GSK3A;DUSP6;CLSTN1;AGRN;PPM1F;LPAR3;WISP1;GAL;CRIM1;SEMA4G;FGFR1;ADNP;HYAL1;SOCS2;BCL2L1;ADIPOR1;PTPN12;ULK1;PAK4;ULK2;ZP3;FGF2;CHD7;APBB1;SLIT3;RXRA;NDRG3;IMPACT;KLK6;CIB1;SOCS7;ADAM15;CEACAM1;APBA1;TGFB1;ANXA1;GNAS;THBS3
7262,GO:0031224,0.0015412696063322,0.998770626154493,332,2772,intrinsic component of membrane,CC,NT5E;EDEM1;KIAA1549L;ITGB4;TSPAN1;NOS1;ADAM19;F2R;MST1R;SORL1;ADGRL1;SDC1;SERINC2;KCNG1;QSOX1;MBOAT2;SDK2;LPCAT4;LMF1;SCN8A;BOK;SLCO4A1;DLG4;BSG;DLG1;CMTM4;DYSF;SLC16A3;IFI6;FKBP1A;DCBLD2;RAB3B;CKAP4;ITGA6;SLC2A9;PTPRS;PRNP;BNIP3;CD68;SBF1;AGPAT3;TXNDC11;C2CD2;PCDH1;MARVELD1;TMEM214;LY6K;SNPH;MARCH9;MRC2;ADGRF1;SYNE3;CHPF;LPCAT1;VLDLR;LRP5;ACVR2B;ITGB5;XYLT1;HTR7;KIAA1549;ADCY7;XBP1;CSMD2;MXRA7;CMTM7;EGFR;RTN2;LRP10;TTYH3;MMP14;SLC12A7;PRKACA;PTPRF;FAM189B;RHBDF2;LMBR1L;XYLT2;SHANK3;IFITM1;CDS2;LRP3;ARMCX2;GPC4;IRAK1;FAM210B;ATP13A2;METTL23;TMEM92;PEAR1;SYVN1;YIF1A;COL13A1;ATP7B;ITPR3;RFNG;FZD8;EPHA1;PI4K2A;SLC20A1;ORAI1;TMEM129;B4GALNT4;TMCO3;RABAC1;TGFBR2;CSMD3;CD99;PLD3;EPOR;NDST2;CREB3L2;UBE2J1;BNIP3L;KDELR1;PRSS8;TMEM125;YIPF2;ZDHHC8;CD44;ESYT2;ABCB8;SEC63;ELOVL1;OSBPL5;MC1R;SLC38A10;FAM171A2;SURF4;RRNAD1;TMEM134;TMEM245;TSPAN5;MALL;SLC35E2B;SFXN3;SLC29A4;NLGN2;GRAMD1A;SEMA4B;TNFSF15;PODXL;PTDSS2;TBC1D9B;TMTC4;STOM;RET;CORO7;IFI27;REEP2;TMED3;PROCR;YIPF3;SHANK2;PKD1;TMEM200B;DLG3;ATP11A;TP53I11;NIPA1;PIGQ;OXA1L;ANO8;CADM4;MYOF;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;ADGRB2;SLC35E4;IL1RAP;WFS1;SRD5A3;SLC12A4;FAT1;ASPH;FAM155B;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;LY6E;SLC43A1;B4GALT2;GPRC5C;VAMP2;FLNB;APCDD1L;TNFRSF6B;EDNRA;B3GNT3;APLP2;TAZ;PEX10;TGM2;SARAF;REEP6;UBR4;FAM162A;TMEM25;DNAJC4;PAQR7;TMEM9;TMEM44;CARD19;STX5;PAG1;SPINT2;SPTLC2;CLSTN1;AGRN;TMEM154;TMPRSS11D;LPAR3;REEP4;SLC6A9;GRINA;TMEM200A;SLC25A43;TNFRSF1A;NRSN2;HSD11B1;MBOAT7;SLC33A1;TSPAN33;STX10;CHST14;GJC2;ITGA1;FCGRT;SLC13A5;SHISA5;COMT;NTSR1;LYPD5;AMIGO2;ITPRIPL2;CRIM1;SLC46A3;SLC35B4;SEMA4G;FGFR1;RRBP1;ATP2C2;C1ORF115;LRRC8A;TMEM128;TENM2;MFNG;SIGMAR1;BCL2L1;ADIPOR1;ST3GAL3;ZFPL1;PRAF2;TCIRG1;C16ORF58;GRAMD1C;SLC27A1;LEMD2;TPCN1;PMEPA1;ST3GAL5;TMEM185A;SLC6A14;AGPAT4;LRP1;ROBO3;HSPA2;TNFRSF19;P2RX4;ZP3;TBC1D20;TMEM139;ST6GALNAC2;VAPB;TMX4;RNF222;TMEM54;ABCA7;LMAN1;ENTPD6;MSLN;INTS1;SLC10A6;VSIG10L;TGFA;CYB561;TPBG;NYNRIN;VAT1;KCNC4;EPHB2;GGT1;CPT1B;NTNG1;POMT1;DRAM2;FURIN;SLC35G2;SLC5A1;RNF103;UGCG;TMBIM1;B4GALT6;TMEM238;ADAM15;HM13;CEACAM1;PNPLA6;GALNT3;CD59;SLC30A1;ADCY6;TM2D1;ADCK2;SLC15A1;ERBB3;PODXL2;SLC45A3;COMTD1;IKBIP;ITGA3;CLDN12;PLGRKT;ASPHD1;ORAI3;STIM1;RASA3
15878,GO:0072578,0.00155419615028295,0.999928861609553,4,6,neurotransmitter-gated ion channel clustering,BP,DLG4;SSH1;SHANK3;APOE
6725,GO:0030133,0.00155824827284049,0.999149219532005,42,254,transport vesicle,CC,DLG4;RAB3B;PTPRS;DBNDD1;COPG1;ATP13A2;PI4K2A;SEPT5;SEC23A;RABAC1;KDELR1;SIPA1;YIPF2;SURF4;DMXL2;SYTL1;TMED3;YIPF3;PLIN3;VAMP2;GIPC1;LDLRAP1;RAB1B;STX5;NRSN2;BRSK1;MCFD2;SEC24C;BCL2L1;USO1;SNTB2;LMAN1;TGFA;FURIN;CEACAM1;APBA1;CD59;MAP6;SPRED2;AZIN2;RAB6A;ARCN1
6297,GO:0019904,0.00155973731408034,0.998981968249469,81,562,protein domain specific binding,MF,SH2D2A;SH3KBP1;ERCC1;ADAM19;CTNNBIP1;DOCK4;EPN3;BOK;DLG4;DLG1;DAP;RAPGEF3;ESPN;FAM189B;MAP2K2;SHANK3;ATF4;CARD11;STRN4;AP2A2;PRKCZ;POU2F2;VPS11;FZD8;VPS4A;SH3PXD2B;PPARA;WASF2;CCDC88C;DDIT3;SHANK2;PKD1;DLG3;GATA3;EFS;CTBP1;HMGA2;TOP1;ARHGEF4;GIPC1;SRC;CAPG;TGM2;DNM2;CARD19;STXBP1;PAG1;SH3BP1;FYN;MICAL1;ELMO3;DLGAP4;THRA;CRIM1;BCL2L1;STUB1;ANGEL1;PTPN12;PMEPA1;ARFIP2;HSPA2;KLHL17;VAPB;SH3BGRL2;VASP;MYO1D;HOMER2;RXRA;NDE1;WIPF1;CASP4;HGS;CBL;SOCS7;LITAF;AIDA;MLF1;ADAM15;RAB6A;ITGA3;FHOD1
6746,GO:0030162,0.00157476635371056,0.998991541613189,74,520,regulation of proteolysis,BP,TNIP1;EDEM1;XDH;BTBD2;CHAC1;F2R;LTBP4;SORL1;DVL1;PLAT;CST3;SNX9;BOK;SERPINE2;DAP;IFI6;PRNP;ABTB1;FBLN1;XBP1;CSNK1E;PANO1;MMP14;PRKACA;SNX33;AKT1;SERPING1;APOE;ATP13A2;CTSZ;SERPINB6;SOX7;UBE2J1;PRKACB;CD44;IDE;ANKIB1;PRDX5;BIN1;SUFU;RAG1;TNFSF15;IFI27;PKD1;HSF1;ASPH;ADAM8;TFPI2;GIPC1;TNFRSF6B;SRC;APLP2;FAM162A;GSK3A;SPINT2;FYN;PPM1F;MICAL1;TIMP1;CRIM1;F12;STUB1;PCSK1N;TRIB3;RAD23A;TRIB2;CASP4;MAPK3;CSNK1D;FURIN;ECM1;CD59;CAMK2N1;PLGRKT
16142,GO:0090114,0.00157949359158036,0.99947634030768,15,63,COPII-coated vesicle budding,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;VAPB;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
9967,GO:0042327,0.00158407755832975,0.998935266750968,93,656,positive regulation of phosphorylation,BP,XDH;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;ITGA6;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;MYDGF;SRC;STK24;PAK6;DUSP6;FYN;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;ADNP;MIF;SLC27A1;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;CAMK1;EPHB2;CIB1;MAPK3;MAPK10;CSNK1D;ARHGEF2;MINK1;ADCY6;ITSN1;TGFB1;ERBB3;WDFY2;TRAF7
6597,GO:0022610,0.00159056958798614,0.998894251149711,111,803,biological adhesion,BP,TNIP1;NT5E;ITGB4;RAC2;ADGRL1;SHC1;SDK2;AP3D1;SERPINE2;DLG1;POSTN;ITGA6;NET1;PTPRS;PRNP;PDZD2;LAMA5;PCDH1;FBLN1;ITGB5;XBP1;EGFR;MMP14;LAMB1;THBS2;PTPRF;PARVB;AKT1;CARD11;ARG2;COL13A1;PRKCZ;EPHA1;FERMT1;MSN;TGFBR2;LAMB2;CD99;PPARA;SYMPK;SIPA1;CD44;TFE3;PAK1;TSTA3;CERCAM;NLGN2;RAG1;PODXL;RET;LAMC2;NID1;CYTH3;PKD1;ASS1;GATA3;CADM4;FAT1;EFS;PTPRU;ADAM8;ARL2;IGFBP2;PIP5K1C;SRC;TGM2;DNM2;STXBP1;PAG1;SPECC1L;SPINT2;FYN;CLSTN1;PPM1F;WISP1;CGREF1;ITGA1;LYPD5;AMIGO2;LAMB3;LGALS3BP;RREB1;HYAL1;TENM2;PAK4;HPSE;ZP3;PNP;MSLN;ARG1;CAMSAP3;BAIAP2L1;TPBG;MYL9;CIB1;KIFC3;ARVCF;ADAM15;SRPX2;CEACAM1;APBA1;MINK1;TGFB1;ERBB3;ANXA1;PODXL2;GNAS;ITGA3;CLDN12;PXN;THBS3
18054,GO:1902533,0.00159293164321545,0.998928797821944,93,663,positive regulation of intracellular signal transduction,BP,XDH;NOS1;F2R;MST1R;RBCK1;MAP2K1;SHC1;WNT7A;ERCC6;BOK;SHARPIN;IGFBP4;FKBP1A;MAPKAPK3;NACC2;MAP4K4;EGFR;MAP2K2;STK25;AKT1;CARD11;IRAK1;PKN1;PRKCZ;FZD8;EPHA1;PTK6;SLC20A1;STK39;DKK1;AKAP12;SHC2;CD44;PLCG1;MAP3K9;MC1R;PAK1;ZNF385A;DDIT3;TNFSF15;RET;RASGEF1A;RHOC;GATA3;GNAI2;HSF1;ADAM8;RGL2;FAM110C;MYDGF;SRC;TGM2;STK24;GSK3A;DUSP6;FYN;LPAR3;TNFRSF1A;PLEKHG5;PUM1;ITGA1;SHISA5;MAP3K10;HEXIM1;FGFR1;MIB2;MIF;BCL2L1;ADIPOR1;TNFRSF19;P2RX4;HPSE;LRRK1;FGF2;MAP3K12;TAOK1;ABCA7;TGFA;EPHB2;CBL;CIB1;MAPK3;MAPK10;LITAF;MINK1;ECM1;ITSN1;TGFB1;CAT;SPRED2;PIK3R2;ERBB3;TRAF7
2382,GO:0005515,0.00162778881930622,0.998687336861172,905,8319,protein binding,MF,TNIP1;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;CAPN2;F2R;MPRIP;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;UHRF1BP1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CLIP2;EPN3;SNX9;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;DAP;CMTM4;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRSS3;HYI;PRNP;LRRC20;BNIP3;SBF1;PC;LAMA5;SSH1;WWC3;MICALCL;TXNDC11;RAB43;SCYL1;SMARCA1;SMURF2;NME4;COPG1;TMOD2;CYGB;FAM129B;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;SNPH;MRC2;BBS2;HAGH;SEMA3F;USP20;NACC2;BCR;SYNE3;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;LRP5;ACVR2B;FBLN1;ITGB5;XBP1;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;CSNK1E;MKNK2;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;FAM189B;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;UBTD1;PPP1R13L;LMBR1L;STK25;PARVB;SHANK3;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;BRD3;MDH2;CARD11;GPC4;IRAK1;ARPC1A;SERPING1;EPN2;BAG3;APOE;EHD3;STRN4;FMNL2;ATP13A2;UAP1;METTL23;RIN2;PKN1;AP1B1;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;ORAI1;DNAAF5;PFKP;FBXO2;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;GIT2;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;SALL2;SEC23A;RABAC1;MSN;PPP1R35;MAP1B;TGFBR2;LAMB2;CD99;PLD3;DRAP1;GDI1;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;NADK;PRSS8;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;ELOVL1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;TSTA3;TTBK2;RHPN1;ISYNA1;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;NLGN2;GRAMD1A;UBXN7;RAG1;SEMA4B;BAZ2A;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;CUL7;FAM167A;DMXL2;TBC1D9B;GGA3;GGA1;TUBB3;ADAMTS7;STOM;FARP1;GNB1;SYTL1;PTPN9;SATB1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;CORO7;GAS2L1;MLXIP;RHOC;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;PROCR;HLTF;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NUCB2;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;OASL;CADM4;MYOF;DOCK6;GNAI2;ZNF165;ANTXR2;GGACT;ASIC1;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;BCL7A;IL1RAP;WFS1;NEK9;SH3GLB2;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;RGL2;INTS8;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;SRC;LDLRAP1;CHMP5;APLP2;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;DNAJC4;NCS1;MARK3;STK24;RGS19;CARD19;RALY;PAK6;PER3;STX5;TOM1L2;ESRP1;ERICH2;SDCCAG8;GPX3;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;OAS1;FYN;RAB25;PRIMPOL;CLSTN1;FUZ;AGRN;ASNS;PPM1F;RALGDS;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;KIF17;TNFRSF1A;ALDH7A1;ANXA3;WISP1;TLE4;MBOAT7;FBXL15;VDR;BRPF3;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;MOAP1;GAL;PUM1;ITGA1;FCGRT;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;AMIGO2;TIMP1;SIMC1;CRIM1;FRYL;UBA1;MGLL;MISP;SLC35B4;RNF32;RNF187;LAMB3;LGALS3BP;SEMA4G;LHPP;WDFY3;SECISBP2L;SEC24C;FGFR1;TUBG1;MIF4GD;ZBED4;ATP2C2;ADNP;HYAL1;LRRC8A;PHF2;TMEM128;JMJD7;MIB2;CEP170;TENM2;F12;USF2;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;ADIPOR1;MAU2;DNMBP;TRIB3;DDB2;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;GRAMD1C;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;RMND5B;PRRC2A;NDOR1;RAD23A;ARFGEF2;UNC119B;TMEM185A;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;GPATCH8;ZNF419;LRRK1;TBC1D20;SPIRE1;FGF2;TMEM139;KLHL17;EHD4;MAP1LC3B;RNH1;MED15;VAPB;MAPK9;COG1;SH3BGRL2;CDYL2;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ZNF687;LMAN1;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;SEC14L1;ZBTB4;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;HIST1H2AG;WIPF1;IMPACT;ZNF624;KLK6;NOL4L;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;HGS;CARHSP1;DRG2;POLM;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;NTNG1;MAPK10;CSNK1D;KIFC3;ARVCF;DNAJB9;LITAF;ALDOC;FURIN;S100A16;SLC5A1;ARHGEF2;RNF103;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;MATN3;OCRL;ADAM15;SRPX2;HM13;MED29;CEACAM1;PAIP2;APBA1;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;AGAP1;SRGAP2B;TFPT;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;PPP6R1;SH3PXD2A;MANF;CAT;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARHGEF10L;PLEKHH2;EP300;ERP44;ORAI3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;KIAA0930;FHOD1;TRAF7;RNF10
2537,GO:0005793,0.00163319712394166,0.999333322552514,21,102,endoplasmic reticulum-Golgi intermediate compartment,CC,SCYL1;COPG1;P4HB;YIF1A;CTSZ;KDELR1;SURF4;TMED3;NUCB2;MYDGF;NUCB1;RAB1B;STX5;MCFD2;TBC1D20;LMAN1;TGFA;CSNK1D;CD59;AZIN2;ERP44
12844,GO:0051130,0.00164628353223618,0.998833495407247,123,910,positive regulation of cellular component organization,BP,TSPAN1;ERCC1;ZMYND8;NOS1;RAC2;ADGRL1;SDC1;DVL1;MAP2K1;WNT7A;NEURL1;SNX9;BOK;CRTC1;ARAP1;DLG4;DLG1;MMP1;NET1;RAPGEF3;BNIP3;SSH1;ESPN;PLEK2;BCR;VLDLR;LRP5;FYCO1;THBS2;CORO1B;TUB;STK25;SHANK3;FBXW8;ARPC1A;APOE;VPS11;EPHA1;PTK6;SH3PXD2B;PCSK9;ENDOG;MSN;MAP1B;GDI1;LIMK1;PPP2R5B;OBSL1;ZDHHC8;WASF2;CDC34;ATG13;IDE;TWF2;SURF4;FSCN1;PAK1;NLGN2;CUL7;RET;RHOC;SHANK2;GATA3;APLN;PHF1;HSF1;ADGRB2;IL1RAP;CTBP1;ARL2;SRC;LDLRAP1;DNM2;FAM162A;LRSAM1;GSK3A;FYN;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;PFN1;MOAP1;AMIGO2;FGFR1;RREB1;ADNP;HYAL1;TENM2;STUB1;DDB2;ARFIP2;ULK1;LRP1;SPIRE1;MAPK9;VASP;ABCA7;LMAN1;APBB1;EPS8L1;TGFA;BAIAP2L1;TPBG;WIPF1;CAMK1;EPHB2;CBL;CIB1;WRAP73;MAPK3;UGCG;SRPX2;TGFB1;WBP2;ANXA1;PPP1R10;ITGA3;PXN;ARHGEF10L;ASAP1;FHOD1
16830,GO:0098657,0.00173430666877567,0.998886244238647,74,501,import into cell,BP,SH3KBP1;TSPAN1;NOS1;RAC2;SORL1;SNX9;DLG4;RAB3B;PRNP;MAPKAPK3;MRC2;USP20;BCR;RAB31;VLDLR;LRP5;LRP10;CSNK1E;FCHO1;TUB;EPN1;LMBR1L;SNX33;LRP3;ARPC1A;EPN2;APOE;RIN2;PEAR1;AP2A2;PCSK9;TGFBR2;RIN1;LIMK1;DKK1;WASF2;ESYT2;PLCG1;BIN1;PAK1;NLGN2;GLUL;APLN;FAM155B;CAP1;PIP5K1C;SRC;LDLRAP1;TGM2;DNM2;LRSAM1;SH3BP1;FYN;ANXA3;ELMO3;NTSR1;LGALS3BP;BCL2L1;LRP1;EHD4;ARAP3;ABCA7;NEURL1B;WIPF1;CBL;RAB4B;MAPK3;CSNK1D;CEACAM1;SLC30A1;ITSN1;TGFB1;PIK3R2;ANXA1
10515,GO:0043408,0.00173781501853381,0.998894621928355,71,478,regulation of MAPK cascade,BP,TNIP1;XDH;F2R;MST1R;SORL1;MAP2K1;SHC1;WNT7A;ERCC6;DLG1;IGFBP4;MAPKAPK3;FBLN1;MAP4K4;EGFR;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;PRKCZ;FZD8;EPHA1;RRAS;STK39;DKK1;SHC2;CD44;PLCG1;MAP3K9;PAK1;DUSP4;RET;GNAI2;ADAM8;MYDGF;SRC;STK24;PAK6;DUSP6;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;MIF;TRIB3;LEMD2;TRIB2;PAK4;TNFRSF19;FGF2;MAP3K12;TAOK1;ABCA7;TGFA;EPHB2;HGS;CIB1;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;TRAF7
11174,GO:0045217,0.00177340246757761,0.999915710882922,4,6,cell-cell junction maintenance,BP,F2R;NLGN2;CAMSAP3;KIFC3
15233,GO:0071363,0.00177455336047641,0.998881688907329,68,454,cellular response to growth factor stimulus,BP,XDH;NOS1;LTBP2;LTBP4;SHC1;WNT7A;FKBP1A;POSTN;SMURF2;FAM129B;ACVR2B;ITGB5;EGFR;CORO1B;AKT1;EPN2;PRKCZ;FAM20C;FERMT1;TGFBR2;DKK1;PPP2R5B;LTBP1;CD44;PLCG1;TWF2;HTRA1;BCL9L;ADAMTS7;GRB10;GATA3;APLN;MYOF;GIPC1;SRC;DNM2;ESRP1;SPINT2;PCSK6;DUSP6;FYN;FUZ;FBXL15;SLC33A1;FGFR1;HYAL1;MTMR4;STUB1;SNX25;PTPN12;LEMD2;PMEPA1;FGF2;EHD4;ARG1;HGS;CBL;CIB1;MAPK3;CSNK1D;FURIN;GALNT3;TGFB1;CAT;SPRED2;ANXA1;ITGA3;PXN
11486,GO:0045926,0.00178554742670544,0.999131821883188,30,166,negative regulation of growth,BP,FHL1;CYP27B1;SERPINE2;DCBLD2;PTPRS;WWC3;SESN2;BBS2;SEMA3F;TSPYL2;PTK6;TGFBR2;SIPA1;PAK1;SEMA4B;ALOX15B;MT2A;RAI1;GSK3A;GAL;SEMA4G;HYAL1;SOCS2;ADIPOR1;ULK2;APBB1;SLIT3;NDRG3;ADAM15;TGFB1
1499,GO:0003841,0.00178857645194666,0.999715007486064,7,18,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;LPCAT4;AGPAT3;LPCAT1;TAZ;MBOAT7;AGPAT4
3220,GO:0006869,0.00179032822388222,0.999076243828001,35,199,lipid transport,BP,SORL1;PITPNC1;CPT2;PITPNM1;NME4;OSBPL10;OSBP2;VLDLR;LRP10;AKT1;APOE;VPS4A;PCSK9;PPARA;ESYT2;OSBPL5;ATP11A;LDLRAP1;CPTP;GAL;PLTP;NTSR1;MIF;SIGMAR1;PITPNM2;SLC27A1;LRP1;P2RX4;ABCA7;RXRA;SLC10A6;CPT1B;CEACAM1;STARD10;ANXA1
3554,GO:0007596,0.00179065174514359,0.999064630730099,36,214,blood coagulation,BP,F2R;RAC2;PLAT;SERPINE2;DGKA;FBLN1;PRKACA;AKT1;SERPING1;APOE;EHD3;PHF21A;ITPR3;DGKQ;PRKACB;GNB1;DOCK9;PROCR;GATA3;DOCK6;TFPI2;SRC;STXBP1;FYN;MICAL1;F12;ZFPM1;P2RX4;HPSE;RCOR1;LMAN1;MYL9;MAPK3;CEACAM1;CD59;GNAS
3749,GO:0008289,0.00181377102672709,0.998855644969301,68,457,lipid binding,MF,SHC1;PITPNC1;EPN3;SNX9;ARAP1;DYSF;PITPNM1;DGKA;NME4;PLEK2;OSBPL10;OSBP2;ZCCHC14;TUB;EPN1;SNX33;AKT1;EPN2;APOE;ATP13A2;AP2A2;ITPR3;SH3PXD2B;HS1BP3;MVB12B;PPARA;ESYT2;OSBPL5;TWF2;SYTL1;CYTH3;GSDMA;MYOF;ACBD4;ALOX15B;VAMP2;TULP3;ALDH1A2;LDLRAP1;PAQR7;CPTP;LPAR3;PFN1;NISCH;ANXA3;HSD11B1;VDR;PLTP;WDFY3;PITPNM2;SNX25;ARFIP2;UNC119B;HSPA2;RNASE7;ARAP3;RXRA;GSDMC;SEC14L2;IQSEC1;SNX27;AIDA;ARHGAP44;AGAP1;SH3PXD2A;STARD10;ANXA1;ASAP1
6672,GO:0030029,0.00184635218594671,0.998804116164727,76,516,actin filament-based process,BP,RAC2;SHC1;ARAP1;OBSCN;DLG1;RAPGEF3;SSH1;TMOD2;ESPN;TNNT1;PLEK2;BCR;ITGB5;CORO1B;PARVB;SHANK3;ARPC1A;FMNL2;TMSB4X;PRKCZ;VPS4A;EPHA1;SH3PXD2B;LIMK1;CORO2A;OBSL1;WASF2;RAP1GDS1;MSRB2;TWF2;FSCN1;PAK1;CORO7;RHOC;FAT1;EFS;RHOBTB2;MICAL2;CAP1;FLNB;PIP5K1C;SRC;CAPG;CDC42BPB;PAK6;SPECC1L;SH3BP1;PPM1F;PFN1;NISCH;MICAL1;FRYL;ARFIP2;LRP1;PAK4;SPIRE1;KLHL17;VASP;TAOK1;RHOBTB1;EPS8L1;BAIAP2L1;WIPF1;TMSB10;IQSEC1;KANK2;ARHGEF2;LLGL1;MINK1;ARHGAP44;TGFB1;ANXA1;PXN;ARHGEF10L;PLEKHH2;FHOD1
6845,GO:0030306,0.0018465739335291,0.999911210355797,4,6,ADP-ribosylation factor binding,MF,SORL1;GGA3;GGA1;RAB11FIP4
4366,GO:0009968,0.00184972743374266,0.998689599081364,120,894,negative regulation of signal transduction,BP,TNIP1;XDH;SH3KBP1;MDFI;CHAC1;CCND1;MST1R;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;NEURL1;BOK;SERPINE2;NR1D1;DLG1;IGFBP4;IFI6;PSMD2;ITGA6;PTPRS;PRNP;WWC3;SMURF2;FAM129B;SESN2;FBLN1;XBP1;EGFR;MMP14;EPN1;AKT1;EPN2;APOE;PEAR1;SYVN1;WWTR1;TMSB4X;PRKCZ;EPHA1;PTK6;FERMT1;TGFBR2;DKK1;PPP2R5B;ARRDC1;PRKACB;LTBP1;CDC34;CD44;HTRA1;SUFU;BCL9L;ZNF385A;DDIT3;DUSP4;RET;GRB10;GATA3;APLN;WFS1;MAPKBP1;IGFBP2;TULP3;SRC;DNM2;MARK3;RGS19;CARD19;GSK3A;SH3BP1;DUSP6;FYN;FUZ;WNT5B;GRINA;PSMD7;ITGA1;FGFR1;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;SNX25;PTPN12;LEMD2;PMEPA1;LRP1;MGRN1;ARAP3;BICC1;SLIT3;ARG1;INVS;SEC14L1;EPHB2;HGS;CBL;CIB1;SOCS7;KANK2;DNAJB9;ARHGEF2;C12ORF66;TMBIM1;AIDA;CEACAM1;ARHGAP44;ECM1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;ITGA3;RASA3
2400,GO:0005543,0.00190001860655641,0.998906539873112,48,297,phospholipid binding,MF,SHC1;PITPNC1;SNX9;ARAP1;DYSF;PITPNM1;DGKA;NME4;PLEK2;OSBPL10;ZCCHC14;TUB;SNX33;AKT1;APOE;ATP13A2;ITPR3;SH3PXD2B;HS1BP3;ESYT2;OSBPL5;TWF2;SYTL1;CYTH3;GSDMA;MYOF;VAMP2;TULP3;LDLRAP1;CPTP;LPAR3;PFN1;NISCH;ANXA3;PLTP;WDFY3;SNX25;ARFIP2;ARAP3;GSDMC;SEC14L2;SNX27;AIDA;ARHGAP44;AGAP1;SH3PXD2A;ANXA1;ASAP1
19790,GO:2000147,0.00190457870409216,0.998883654051904,51,323,positive regulation of cell motility,BP,PGF;F2R;RAC2;DOCK4;WNT7A;POSTN;ITGA6;SSH1;SMURF2;SEMA3F;XBP1;EGFR;MMP14;LAMB1;AKT1;TMSB4X;EPHA1;TGFBR2;PLCG1;PAK1;SEMA4B;PODXL;RET;LAMC2;CEMIP;GATA3;ADAM8;FAM110C;NUMB;SRC;RAB25;PPM1F;WNT5B;PFN1;ANXA3;SEMA4G;FGFR1;RREB1;HYAL1;ZNF609;P2RX4;ZP3;FGF2;VEGFB;CIB1;MAPK3;ARHGEF2;SRPX2;TGFB1;ANXA1;ITGA3
13743,GO:0060291,0.00190513048289663,0.999493282686739,11,39,long-term synaptic potentiation,BP,CRTC1;SERPINE2;PRNP;SHANK3;APOE;PRKCZ;ITPR3;SHANK2;VAMP2;EPHB2;PAIP2
15483,GO:0071803,0.00192570131859779,0.999820521105421,5,10,positive regulation of podosome assembly,BP,MSN;FSCN1;SRC;MAPK9;ASAP1
16623,GO:0097435,0.00195548044967454,0.998753942268942,70,470,supramolecular fiber organization,BP,LTBP2;RAC2;DVL1;CST3;ARAP1;OBSCN;DLG1;FKBP1A;RAPGEF3;SSH1;TMOD2;ESPN;TNNT1;ITGB5;CORO1B;TUBG2;SHANK3;ARPC1A;APOE;TMSB4X;VPS4A;EPHA1;SH3PXD2B;EML2;MAP1B;LIMK1;OBSL1;WASF2;MSRB2;TWF2;FSCN1;CCDC88C;PAK1;TTBK2;CORO7;RHOC;FAT1;EFS;RHOBTB2;ARL2;MICAL2;CAP1;P4HA1;SRC;CAPG;SH3BP1;PPM1F;PFN1;MICAL1;FRYL;LOXL1;TUBG1;ARFIP2;SPIRE1;VASP;RHOBTB1;EPS8L1;NDE1;CAMSAP3;BAIAP2L1;WIPF1;CIB1;TMSB10;KANK2;CSNK1D;ARHGEF2;PXN;ARHGEF10L;PLEKHH2;FHOD1
12649,GO:0050817,0.00195989084822873,0.998970217020806,36,215,coagulation,BP,F2R;RAC2;PLAT;SERPINE2;DGKA;FBLN1;PRKACA;AKT1;SERPING1;APOE;EHD3;PHF21A;ITPR3;DGKQ;PRKACB;GNB1;DOCK9;PROCR;GATA3;DOCK6;TFPI2;SRC;STXBP1;FYN;MICAL1;F12;ZFPM1;P2RX4;HPSE;RCOR1;LMAN1;MYL9;MAPK3;CEACAM1;CD59;GNAS
4555,GO:0010634,0.0019795982789394,0.999178400128409,21,102,positive regulation of epithelial cell migration,BP,WNT7A;AKT1;TMSB4X;TGFBR2;PLCG1;GATA3;SRC;RAB25;PPM1F;PFN1;ANXA3;FGFR1;RREB1;HYAL1;P2RX4;FGF2;CIB1;SRPX2;TGFB1;ANXA1;ITGA3
15322,GO:0071495,0.00198473791653647,0.998585334964606,123,910,cellular response to endogenous stimulus,BP,PGF;LTBP2;CAPN2;LTBP4;SHC1;WNT7A;NEURL1;PCK2;NR1D1;DNMT3A;FKBP1A;POSTN;RAPGEF3;PRNP;SSH1;SMURF2;CTSB;SESN2;BBS2;RAB31;ACVR2B;ITGB5;ADCY7;XBP1;EGFR;PRKACA;CORO1B;ATF4;AKT1;FAM210B;PRKCZ;FAM20C;MAPK13;PCSK9;FERMT1;MSN;TGFBR2;DKK1;PPARA;PRKACB;LTBP1;WDTC1;CD44;PLCG1;IDE;HTRA1;PAK1;BCL9L;ADAMTS7;GNB1;GAS2L1;GRB10;GATA3;APLN;GNAI2;HSF1;IGFBP2;EIF4EBP1;VAMP2;GIPC1;SRC;DNM2;PAQR7;ESRP1;GSK3A;SPINT2;PCSK6;DUSP6;FYN;FUZ;AGRN;ASNS;FBXL15;SLC33A1;VDR;GNB2;CTSL;THRA;FGFR1;HYAL1;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;LRP1;P2RX4;FGF2;SLIT3;RXRA;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;CBL;CIB1;SOCS7;MAPK3;KANK2;CSNK1D;FURIN;ARHGEF2;CEACAM1;GALNT3;UROS;ADCY6;CCNE1;TGFB1;WBP2;SPRED2;PIK3R2;ANXA1;ITGA3;PXN;EP300
4810,GO:0012506,0.00199053400663896,0.998706087534698,76,525,vesicle membrane,CC,SH3KBP1;NOS1;RAC2;WNT7A;SNX9;DLG4;BSG;DYSF;RAB3B;CKAP4;PTPRS;CD68;RAB43;DBNDD1;SCYL1;COPG1;RAB31;LPCAT1;EGFR;SNX33;EPN2;APOE;ATP13A2;AP1B1;AP2A2;ITPR3;DGKQ;PI4K2A;SEC23A;SERPINB6;KDELR1;ZDHHC8;CD44;SURF4;DMXL2;STOM;TMED3;CEMIP;ATP11A;ARL8A;MYOF;SLC2A3;ADAM8;GPRC5C;VAMP2;GIPC1;LDLRAP1;APLP2;DNM2;UBR4;STX5;WNT5B;ANXA3;MCFD2;SEC24C;BCL2L1;TCIRG1;LRP1;USO1;ULK2;SPIRE1;SNTB2;LMAN1;TGFA;SNAP29;RAB4B;KIFC3;TMBIM1;OCRL;CEACAM1;CD59;MAP6;SPRED2;ANXA1;RAB6A;ARCN1
16881,GO:0098791,0.00202945723872019,0.998623240380471,93,661,Golgi subcompartment,CC,EDEM1;CHAC1;ASAP2;SORL1;QSOX1;SNX9;AP3D1;BOK;ARAP1;BSG;PITPNM1;POSTN;AGPAT3;RAB43;COPG1;MARCH9;RAB31;CHPF;LPCAT1;XYLT1;EGFR;XYLT2;STK25;AP1B1;YIF1A;ATP7B;RFNG;CTSZ;PI4K2A;SEC23A;B4GALNT4;NDST2;KDELR1;YIPF2;SURF4;MALL;GGA3;RAB29;CORO7;CYTH3;TMED3;PKD1;DOPEY2;B4GALT2;VAMP2;B3GNT3;DNM2;NUCB1;RAB1B;STX5;COG8;CLSTN1;TNFRSF1A;SLC33A1;STX10;CHST14;MCFD2;SLC35B4;SEC24C;ATP2C2;MFNG;PCSK1N;ST3GAL3;DNMBP;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;USO1;SMPD3;TBC1D20;ST6GALNAC2;VAPB;COG1;ABCA7;LMAN1;ENTPD6;TGFA;SNAP29;TRAPPC1;CSNK1D;LITAF;FURIN;UGCG;LLGL1;B4GALT6;OCRL;GALNT3;CD59;PPP6R1;AZIN2;RAB6A;ARCN1
13688,GO:0060191,0.00203109637229445,0.999411253712131,12,46,regulation of lipase activity,BP,ANGPTL4;LMF1;EGFR;PRKCZ;RHOC;EDNRA;PCSK6;FGFR1;LRP1;FGF2;FURIN;ANXA1
12975,GO:0051338,0.00204988302246663,0.99858650712629,101,733,regulation of transferase activity,BP,CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SERINC2;SHC1;ERCC6;NEURL1;SNX9;DLG4;DLG1;PRNP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;LIMK1;STK39;DKK1;PRKACB;SHC2;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;DUSP4;RET;CEMIP;PKD1;DLG3;GNAI2;ADAM8;SRC;STK24;PAK6;GSK3A;DUSP6;PPM1F;LPAR3;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;STUB1;TRIB3;SLC27A1;TRIB2;PAK4;FGF2;VAPB;MAP3K12;TAOK1;TGFA;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;TRAF7
16256,GO:0090288,0.00205309668092838,0.999167301459255,20,95,negative regulation of cellular response to growth factor stimulus,BP,XDH;SMURF2;FAM129B;EPN2;TGFBR2;DKK1;LTBP1;HTRA1;BCL9L;GATA3;APLN;DNM2;FUZ;MTMR4;STUB1;SNX25;LEMD2;PMEPA1;HGS;TGFB1
9842,GO:0042058,0.0020615088836341,0.999265465190472,16,70,regulation of epidermal growth factor receptor signaling pathway,BP,SH3KBP1;SHC1;NEURL1;ARAP1;EGFR;RHBDF2;EPN1;AKT1;PTK6;MVB12B;ITGA1;PTPN12;TGFA;HGS;CBL;CEACAM1
2969,GO:0006508,0.00206872533255375,0.998463396342839,160,1256,proteolysis,BP,TNIP1;EDEM1;XDH;BTBD2;ADAM19;CHAC1;GID4;CAPN2;F2R;THSD4;LTBP4;RBCK1;SORL1;DVL1;MAP2K1;PLAT;CST3;SNX9;BOK;SHARPIN;SERPINE2;NR1D1;DAP;MMP1;IFI6;PSMD2;MTA1;PRSS3;PRNP;SMURF2;CTSB;ABTB1;RNPEPL1;USP20;FBLN1;XBP1;CSNK1E;PANO1;MMP14;PRKACA;JOSD2;RHBDF2;MAP2K2;HECW2;SNX33;AKT1;SERPING1;APOE;ATP13A2;SYVN1;WWTR1;NPEPL1;RNF135;VPS4A;PITRM1;CTSZ;TMEM129;FBXO2;PCSK9;FBXW5;TYSND1;MVB12B;SERPINB6;SOX7;UBE2J1;ARRDC1;PRSS8;PRKACB;OTUB2;CDC34;CD44;SCRN1;IDE;ANKIB1;PRDX5;BIN1;HTRA1;SUFU;ERO1B;MMP10;RAG1;DDIT3;TNFSF15;CUL7;ADAMTS7;RET;FBXL6;IFI27;PKD1;GATA3;UBXN4;HSF1;WFS1;CNDP2;ASPH;ADAM8;TFPI2;BLMH;GIPC1;TNFRSF6B;SRC;APLP2;MBD6;SCG5;UBR4;FAM162A;CAPN5;GSK3A;SPINT2;PCSK6;FYN;PPM1F;TMPRSS11D;RMND5A;PSMD7;MICAL1;THOP1;FBXL15;RNF44;CTSL;TIMP1;CRIM1;UBA1;RNF187;TENM2;F12;VPS37A;STUB1;PCSK1N;TRIB3;DDB2;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;KLK6;CASP4;ACY1;LONP2;HGS;CBL;GGT1;USP32;MAPK3;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;ADAM15;HM13;TFPT;ECM1;CD59;TGFB1;PCYOX1;CAMK2N1;PLGRKT;EP300
5801,GO:0017048,0.00213525457791262,0.998996326605478,27,140,Rho GTPase binding,MF,DVL1;DOCK4;OBSCN;NET1;BCR;FMNL2;PKN1;PAK1;FARP1;RGL2;ARHGEF4;CDC42BPB;PAK6;SH3BP1;PFN1;PLEKHG5;DNMBP;ARFIP2;PAK4;EPS8L1;ARHGEF2;OCRL;ARHGAP44;SRGAP2B;ITSN1;PPP6R1;ARHGEF10L
8932,GO:0034767,0.00214167420543322,0.999232705209304,16,71,positive regulation of ion transmembrane transport,BP,NOS1;F2R;SHANK3;EHD3;TMSB4X;STK39;PLCG1;CEMIP;GLRX;DNM2;GJC2;GAL;NTSR1;HSPA2;EPHB2;STIM1
18228,GO:1902992,0.0021500531908508,0.999794267247714,5,10,negative regulation of amyloid precursor protein catabolic process,BP,SORL1;PRNP;APOE;BIN1;ABCA7
3393,GO:0007173,0.00218051899917296,0.999065293249363,22,109,epidermal growth factor receptor signaling pathway,BP,SH3KBP1;FAM83A;SHC1;NEURL1;ARAP1;EGFR;RHBDF2;EPN1;AKT1;PTK6;MVB12B;PLCG1;SRC;PAG1;ITGA1;PTPN12;TGFA;HGS;CBL;CEACAM1;TGFB1;PXN
3694,GO:0008201,0.00221163783045592,0.999174155634508,17,78,heparin binding,MF,PGF;LTBP2;SERPINE2;POSTN;PTPRS;THBS2;PTPRF;APOE;COL13A1;LAMC2;APLP2;PCSK6;WISP1;FGFR1;FGF2;VEGFB;THBS3
710,GO:0001932,0.00225919970517744,0.998376488358054,126,943,regulation of protein phosphorylation,BP,TNIP1;XDH;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;RAPGEF3;PRNP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;RRAS;TGFBR2;STK39;DKK1;PPP2R5B;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;CCDC88C;PAK1;TNFSF15;DUSP4;RET;CEMIP;PKD1;DLG3;GNAI2;HSF1;ADAM8;MYDGF;SRC;STK24;PAK6;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ARHGEF2;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;WDFY2;TRAF7
18129,GO:1902743,0.00226018136340032,0.999433913438149,10,34,regulation of lamellipodium organization,BP,RAC2;SSH1;CORO1B;WASF2;CD44;TWF2;FSCN1;SRC;DNM2;RREB1
5522,GO:0016485,0.00226879778838495,0.998908117155839,28,155,protein processing,BP,CHAC1;CAPN2;PLAT;SERPINE2;PRSS3;PRNP;MMP14;RHBDF2;SERPING1;CTSZ;PCSK9;TYSND1;PRKACB;ERO1B;ASPH;ADAM8;SRC;SCG5;PCSK6;F12;PCSK1N;KLK6;LONP2;GGT1;FURIN;HM13;CD59;PLGRKT
6293,GO:0019900,0.00229385712101674,0.998468106361008,84,586,kinase binding,MF,TNIP1;FAM83A;CCND1;MST1R;RAC2;DVL1;SHC1;DOCK4;DLG4;DLG1;PITPNM1;WWC3;MICALCL;MAPKAPK3;EGFR;SLC12A7;PRKACA;ACTA2;ATF4;AKT1;PKN1;AP1B1;AP2A2;PRKCZ;DGKQ;EPHA1;FBXW5;MSN;TGFBR2;STK39;SHC2;PLCG1;ATG13;TWF2;TBC1D14;CCND2;PPP1R12C;SUFU;PAK1;RET;RHOC;PKD1;DLG3;HSF1;IL1RAP;NEK9;SLC12A4;RHOBTB2;SRC;DNM2;NCS1;PER3;TOM1L2;EXOC2;GSK3A;STXBP1;PAG1;MICAL1;KIF13B;BRSK1;FGFR1;BCL2L1;STUB1;ADIPOR1;TRIB3;PITPNM2;RAD23A;TRIB2;MAP3K12;RHOBTB1;ZBTB4;EPHB2;CBL;CIB1;LLGL1;CEACAM1;ADCY6;CCNE1;LDHA;SPRED2;PIK3R2;CAMK2N1;ERBB3;PXN
3716,GO:0008236,0.00229557668389308,0.999082169918834,19,92,serine-type peptidase activity,MF,PLAT;MMP1;PRSS3;CTSB;MMP14;RHBDF2;PCSK9;TYSND1;PRSS8;HTRA1;MMP10;ADAM8;PCSK6;TMPRSS11D;CTSL;F12;KLK6;LONP2;FURIN
18699,GO:1904018,0.00230177528524333,0.999008049066592,22,110,positive regulation of vasculature development,BP,ANGPTL4;PGF;ADM2;RAPGEF3;XBP1;EPHA1;RRAS;TGFBR2;PLCG1;HMGA2;MYDGF;ANXA3;HYAL1;PAK4;FGF2;VEGFB;CIB1;SRPX2;CEACAM1;ECM1;ANXA1;STIM1
6655,GO:0030001,0.00231643372689452,0.998527550574238,67,453,metal ion transport,BP,FHL1;NOS1;F2R;KCNG1;CYP27B1;SCN8A;SERPINE2;DLG1;FKBP1A;PRNP;SLC12A7;PRKACA;ATF4;HECW2;AKT1;EHD3;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;STK39;PRSS8;PLCG1;SLC38A10;DDIT3;STOM;CEMIP;PKD1;NIPA1;GNAI2;GRIN3B;ASIC1;WFS1;SLC12A4;FAM155B;SLC13A3;VAMP2;GLRX;DNM2;SARAF;NCS1;FYN;LPAR3;VDR;GJC2;GAL;SLC13A5;NTSR1;ATP2C2;TCIRG1;TPCN1;HSPA2;P2RX4;FGF2;CHD7;HOMER2;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;SLC30A1;TGFB1;ORAI3;STIM1;RASA3
16806,GO:0098609,0.00233802322403402,0.998518622747772,66,444,cell-cell adhesion,BP,TNIP1;NT5E;RAC2;ADGRL1;SHC1;SDK2;AP3D1;SERPINE2;DLG1;ITGA6;PRNP;PCDH1;ITGB5;XBP1;EGFR;LAMB1;AKT1;CARD11;ARG2;COL13A1;PRKCZ;MSN;TGFBR2;PPARA;CD44;PAK1;TSTA3;CERCAM;NLGN2;RAG1;PODXL;RET;PKD1;ASS1;GATA3;CADM4;FAT1;PTPRU;ADAM8;IGFBP2;PIP5K1C;SRC;STXBP1;PAG1;SPINT2;FYN;CLSTN1;AMIGO2;TENM2;PAK4;ZP3;PNP;ARG1;CAMSAP3;BAIAP2L1;MYL9;KIFC3;ARVCF;SRPX2;CEACAM1;MINK1;TGFB1;ANXA1;PODXL2;GNAS;CLDN12
5840,GO:0017124,0.00240078457603025,0.999011551448293,20,96,SH3 domain binding,MF,SH2D2A;SH3KBP1;ADAM19;DOCK4;ESPN;SHANK3;WASF2;SHANK2;EFS;DNM2;SH3BP1;MICAL1;ELMO3;PTPN12;SH3BGRL2;VASP;WIPF1;CBL;SOCS7;ADAM15
4263,GO:0009605,0.00242447139159251,0.998176470011491,170,1341,response to external stimulus,BP,TNIP1;NT5E;PGF;SH3KBP1;CBS;ERCC1;NOS1;CCND1;F2R;MST1R;RAC2;DVL1;MAP2K1;SHC1;DOCK4;PLAT;CST3;CYP27B1;AP3D1;SHARPIN;CRTC1;PCK2;SERPINE2;NR1D1;DAP;CMTM4;PITPNM1;DNMT3A;POSTN;MTA1;ITGA6;PTPRS;PRSS3;BNIP3;SSH1;FAM129B;LCN2;MAPKAPK3;SESN2;BBS2;SEMA3F;BCR;VLDLR;XBP1;CMTM7;EGFR;MMP14;ADARB1;PTPRF;CORO1B;ACTA2;SHANK3;ATF4;AKT1;XPC;IFITM1;IRAK1;SERPING1;BAG3;APOE;ARG2;TMSB4X;DGKQ;MAPK13;HIST2H2BE;PCSK9;ENDOG;TGFBR2;LAMB2;STK39;BNIP3L;PPARA;FAM3A;SIPA1;PLCG1;HMGCL;HTRA1;AHCY;SEMA4B;DDIT3;GLUL;TUBB3;GNB1;SATB1;RET;RAB29;GAS2L1;GRB10;PKD1;GATA3;GSDMA;OASL;GNAI2;FNDC4;HSF1;ADAM8;MAPKBP1;HMGA2;IGFBP2;PIP5K1C;TNFRSF6B;ALDH1A2;SRC;TGM2;REEP6;IRF7;LRSAM1;STK24;PER3;OAS1;FYN;ISG20;ASNS;PPM1F;TNFRSF1A;ANXA3;VDR;PLEKHG5;PUM1;ITGA1;COMT;NTSR1;MGLL;LOXL1;SEMA4G;FGFR1;ADNP;HYAL1;F12;USF2;MIF;BCL2L1;PCSK1N;HLCS;ULK1;ROBO3;P2RX4;HPSE;ULK2;ZP3;FGF2;MAP1LC3B;RNASE7;MAPK9;VASP;SLIT3;ARG1;VEGFB;GSDMC;SEC14L1;BAIAP2L1;WIPF1;IMPACT;CASP4;EPHB2;CBL;GGT1;MAPK3;KANK2;LITAF;C12ORF66;CEACAM1;CD59;MBD3;TGFB1;CAT;LDHA;ANXA1;APOBEC3C;PLGRKT
8210,GO:0032956,0.00245287925662547,0.998646242685321,40,242,regulation of actin cytoskeleton organization,BP,RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;CORO1B;SHANK3;ARPC1A;TMSB4X;EPHA1;SH3PXD2B;LIMK1;WASF2;TWF2;FSCN1;PAK1;RHOC;RHOBTB2;CAPG;SH3BP1;PPM1F;PFN1;ARFIP2;LRP1;SPIRE1;VASP;TAOK1;RHOBTB1;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;ARHGAP44;TGFB1;PXN;ARHGEF10L;PLEKHH2;FHOD1
3380,GO:0007159,0.00245709647176353,0.998731094956501,33,192,leukocyte cell-cell adhesion,BP,TNIP1;NT5E;RAC2;AP3D1;DLG1;PRNP;XBP1;AKT1;CARD11;ARG2;PRKCZ;MSN;TGFBR2;PPARA;CD44;PAK1;TSTA3;CERCAM;RAG1;ASS1;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1;PODXL2
15538,GO:0071900,0.00249450102102265,0.998457601001772,59,391,regulation of protein serine/threonine kinase activity,BP,CCND1;F2R;MST1R;SORL1;MAP2K1;SHC1;ERCC6;MAPKAPK3;SESN2;LRP5;MAP4K4;EGFR;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;FZD8;STK39;DKK1;SHC2;PLCG1;MAP3K9;CCND2;PAK1;TNFSF15;DUSP4;CEMIP;PKD1;GNAI2;ADAM8;SRC;STK24;DUSP6;LPAR3;ITGA1;MAP3K10;HEXIM1;FGFR1;MIF;TRIB3;SLC27A1;TRIB2;FGF2;MAP3K12;TAOK1;TGFA;CAMK1;EPHB2;HGS;CIB1;MAPK3;MAPK10;AIDA;MINK1;TGFB1;SPRED2;TRAF7
18279,GO:1903076,0.00250228689148238,0.999125072291568,15,65,regulation of protein localization to plasma membrane,BP,DLG1;PRNP;EGFR;AKT1;VPS4A;PTPN9;NUMB;LDLRAP1;BCL2L1;LRP1;EPHB2;CIB1;TMBIM1;TGFB1;ITGA3
13298,GO:0051966,0.00251178957226487,0.999489383869931,8,24,regulation of synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;SHANK3;DKK1;NLGN2;GLUL;SHANK2;STXBP1
3630,GO:0008092,0.00252659994637514,0.998268188658623,94,671,cytoskeletal protein binding,MF,FLNC;CAPN2;MPRIP;CLIP2;OBSCN;SMTN;KLC2;DLG1;RAB3B;PRNP;SSH1;TMOD2;ESPN;TNNT1;SYNE3;MARK4;MARCKSL1;EGFR;CORO1B;PARVB;SHANK3;ARPC1A;APOE;FMNL2;TNS4;TMSB4X;EML2;MSN;MAP1B;CORO2A;OBSL1;WASF2;MSRB2;TWF2;LARP6;BIN1;FSCN1;CCDC88C;TTBK2;FARP1;GNB1;RAB29;CORO7;GAS2L1;ARL8A;MYH15;FAM110C;MICAL2;CAP1;FLNB;GIPC1;CAPG;DNM2;FYN;RAB25;CLSTN1;REEP4;PFN1;MICAL1;KIF17;KIF13B;BRSK1;MISP;ADNP;MIB2;AFAP1;ARFGEF2;SPIRE1;KLHL17;MAP1LC3B;VAPB;VASP;MYO1D;SNTB2;APBB1;EPS8L1;HOMER2;NDE1;CAMSAP3;BAIAP2L1;WIPF1;IMPACT;GAS8;TMSB10;KIFC3;ALDOC;ARHGEF2;CEACAM1;MAP6;RAB6A;PXN;PLEKHH2;STIM1;FHOD1
6953,GO:0030574,0.00256465182140586,0.999287183148535,11,40,collagen catabolic process,BP,CST3;MMP1;CTSB;MRC2;MMP14;COL13A1;MMP10;CTSL;KLK6;FURIN;ADAM15
9901,GO:0042171,0.00256731816988527,0.999554815242752,7,19,lysophosphatidic acid acyltransferase activity,MF,MBOAT2;LPCAT4;AGPAT3;LPCAT1;TAZ;MBOAT7;AGPAT4
15393,GO:0071617,0.00256731816988527,0.999554815242752,7,19,lysophospholipid acyltransferase activity,MF,MBOAT2;LPCAT4;AGPAT3;LPCAT1;TAZ;MBOAT7;AGPAT4
3243,GO:0006901,0.00257208490572979,0.999136453188239,14,60,vesicle coating,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
18730,GO:1904064,0.00257859756443366,0.999093892630622,15,66,positive regulation of cation transmembrane transport,BP,NOS1;F2R;SHANK3;EHD3;TMSB4X;PLCG1;CEMIP;GLRX;DNM2;GJC2;GAL;NTSR1;HSPA2;EPHB2;STIM1
1267,GO:0003018,0.00259511359590657,0.998982858677873,18,84,vascular process in circulatory system,BP,NOS1;F2R;CTNNBIP1;DOCK4;BBS2;BCR;HTR7;EGFR;AKT1;APOE;RAP1GDS1;APLN;EDNRA;SRC;ITGA1;CEACAM1;ADCY6;TGFB1
12292,GO:0048584,0.00261119990969899,0.998015033021812,182,1447,positive regulation of response to stimulus,BP,TNIP1;EDEM1;XDH;PGF;SH2D2A;NOS1;F2R;MST1R;RAC2;RBCK1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;CYP27B1;NEURL1;BOK;SHARPIN;ARAP1;DLG4;NR1D1;IGFBP4;FKBP1A;PSMD2;RAB3B;PTPRS;PRNP;BNIP3;SSH1;SMURF2;TMOD2;G0S2;MAPKAPK3;CTSB;NACC2;ACVR2B;XBP1;MAP4K4;EGFR;CSNK1E;PRKACA;HK1;MAP2K2;STK25;SHANK3;AKT1;CARD11;IRAK1;ARPC1A;SERPING1;EPN2;ARG2;PKN1;TMSB4X;PRKCZ;MAPK13;RFNG;FZD8;EPHA1;PTK6;SLC20A1;ENDOG;NSMCE4A;FERMT1;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;AKAP12;PRKACB;SHC2;WASF2;CD44;PLCG1;MAP3K9;MC1R;DEDD2;TSPAN5;PAK1;ZNF385A;NLGN2;DDIT3;TNFSF15;RET;RAB29;RASGEF1A;RHOC;GRB10;SHANK2;GATA3;GNAI2;HSF1;ALOX15B;ADAM8;RGL2;HMGA2;FAM110C;MYDGF;GIPC1;SRC;LDLRAP1;TGM2;FAM162A;IRF7;LRSAM1;STK24;YPEL3;GSK3A;STXBP1;PAG1;DUSP6;FYN;PPM1F;LPAR3;PSMD7;TNFRSF1A;FBXL15;PLEKHG5;MOAP1;GAL;PUM1;ITGA1;SHISA5;CTSL;NTSR1;MAP3K10;HEXIM1;FGFR1;RREB1;MIB2;F12;MFNG;MIF;SOCS2;BCL2L1;ADIPOR1;TNFRSF19;P2RX4;HPSE;ZP3;LRRK1;FGF2;MAPK9;SHB;MAP3K12;TAOK1;ABCA7;APBB1;ARG1;VEGFB;TGFA;SEC14L1;ATP6V1C2;WIPF1;KLK6;CASP4;EPHB2;CBL;CIB1;MAPK3;MAPK10;CSNK1D;LITAF;CEACAM1;MINK1;SKAP2;ECM1;CD59;ITSN1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;STARD10;ERBB3;ANXA1;EP300;TRAF7
2607,GO:0005905,0.00262582795166266,0.999119912888008,14,58,clathrin-coated pit,CC,EPN3;VLDLR;EGFR;LRP10;FCHO1;EPN1;LRP3;AP2A2;CEMIP;LDLRAP1;DNM2;LRP1;OCRL;ITSN1
6306,GO:0019932,0.00264975941188241,0.998691698989364,29,162,second-messenger-mediated signaling,BP,NOS1;NFATC4;ADGRL1;ADM2;PTHLH;FKBP1A;RAPGEF3;PRNP;ADGRF1;ADCY7;EGFR;PRKACA;APOE;ITPR3;DGKQ;CDC34;PLCG1;MC1R;GNB1;ADGRB2;GSK3A;GAL;MGRN1;P2RX4;HOMER2;CIB1;ADCY6;ERBB3;GNAS
11820,GO:0046686,0.00265041958144667,0.999249221606748,11,44,response to cadmium ion,BP,ERCC1;PRNP;EGFR;AKT1;HSF1;MT2A;MAPK9;ARG1;MAPK3;SLC30A1;CAT
12825,GO:0051100,0.00268064188857194,0.998800561903448,23,122,negative regulation of binding,BP,MDFI;SORL1;CTNNBIP1;NFATC4;DVL1;CSNK1E;PTPRF;AKT1;TMSB4X;CTSZ;PCSK9;DKK1;PPARA;TTBK2;DDIT3;HMGA2;RSF1;ADNP;STUB1;ZFPM1;CAMK1;MAPK3;ADAM15
12256,GO:0048513,0.00269405998685608,0.997870879406783,259,2137,animal organ development,BP,XDH;PGF;FHL1;ITGB4;ERCC1;MDFI;ADAM19;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;CST3;SDK2;CYP27B1;NEURL1;AP3D1;BOK;SHARPIN;PCK2;MEF2D;SERPINE2;SMTN;BSG;DLG1;PITPNM1;FKBP1A;SOX12;PSMD2;ITGA6;PTPRS;BNIP3;LAMA5;SMARCA1;SMURF2;FAM129B;CTSB;SNPH;BBS2;SEMA3F;BCR;LPCAT1;VLDLR;ETV5;LRP5;AARS;ACVR2B;XBP1;CMTM7;EGFR;LRP10;CSNK1E;MKNK2;MMP14;LAMB1;ADARB1;TUB;ACTA2;EPN1;PPP1R13L;SHANK3;FBXW8;AKT1;CARD11;GPC4;BAG3;FAM210B;ARG2;PKN1;AP1B1;WWTR1;COL13A1;AP2A2;PRKCZ;ATP7B;FAM20C;POU2F2;TFEB;NAGLU;RFNG;FZD8;CTSZ;SH3PXD2B;PCSK9;FERMT1;RRAS;DEAF1;SALL2;MSN;TGFBR2;LAMB2;EPOR;DKK1;CREB3L2;PPARA;DHTKD1;KDELR1;PRSS8;OBSL1;LTBP1;WASF2;CD44;ZNF516;SEC63;SLC38A10;TFE3;TACC1;HMGCL;HTRA1;SUFU;PAK1;SP6;TTBK2;BCL9L;ZNF385A;RAG1;SEMA4B;GAMT;PODXL;CUL7;ADAMTS7;GNB1;SATB1;RET;NID1;SHANK2;PKD1;GATA3;APLN;GLUD1;HSF1;ALOX15B;WFS1;CNFN;PTPRU;ADAM8;MYH15;HMGA2;ARID5B;MICAL2;NUMB;B4GALT2;FLNB;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;DNM2;AGO4;IRF7;RERE;GSK3A;SPINT2;PCSK6;DUSP6;FYN;FUZ;ASNS;WNT5B;PFN1;PSMD7;ANXA3;HSD11B1;MBOAT7;FBXL15;VDR;GJC2;GAL;PSKH1;CTSL;TNRC6B;THRA;RCN1;EIF2S2;HEXIM1;AMIGO2;TIMP1;HSF4;SEMA4G;FGFR1;RREB1;HYAL1;LRRC8A;PHF2;USF2;PBX3;MFNG;SOCS2;RAB11FIP4;BCL2L1;ADIPOR1;LEMD2;ZFPM1;LRP1;ZNF609;PLCD3;TNFRSF19;HPSE;E2F5;SMPD3;ZP3;LRRK1;TBC1D20;PRR9;PNP;FGF2;KLHL17;SDHAF4;MYO1D;CHD7;BICC1;MSLN;SLIT3;RXRA;UNC45A;ARG1;L3MBTL3;TSHZ1;VEGFB;NDE1;TCF25;EPHB2;KRT23;POLM;MYL9;GAS8;CBL;CIB1;SOCS7;MAPK3;CSNK1D;DBP;DNAJB9;GLO1;FURIN;MLF1;ADAM15;CEACAM1;ECM1;MBD3;TGFB1;SH3PXD2A;CAT;LDHA;ERBB3;ANXA1;ASH2L;GNAS;ITGA3;ARCN1;EP300;THBS3;STIM1
6773,GO:0030203,0.00271579450924274,0.998812961120546,22,110,glycosaminoglycan metabolic process,BP,SDC1;CHPF;XYLT1;XYLT2;AKT1;GPC4;GALNS;NAGLU;NDST2;CD44;FUCA1;CEMIP;B4GALT2;B3GNT3;AGRN;CHST14;HYAL1;ST3GAL3;HPSE;FGF2;B4GALT6;TGFB1
12236,GO:0048471,0.00273684340706648,0.998206925819521,74,515,perinuclear region of cytoplasm,CC,TSPAN1;NOS1;CAPN2;CST3;NEURL1;EPN3;DLG1;RAB3B;CKAP4;CTSB;USP20;EGFR;LAMB1;PRKACA;CORO1B;MAP2K2;FBXW8;EHD3;PRKCZ;ATP7B;VPS4A;PCSK9;SEC23A;MSN;OBSL1;PRKACB;SIPA1;TWF2;TMEM134;PRDX5;CUL7;STOM;RAB29;PTOV1;LAMC2;APLN;GSDMA;DOCK6;HSF1;FAT1;MT2A;VAMP2;ALDH1A2;SRC;DNM2;NCS1;STXBP1;PPM1F;PLEKHG5;STX10;GNB2;RAB11FIP4;ANGEL1;NDOR1;ARFGEF2;P2RX4;USO1;SPIRE1;EHD4;ATXN10;APBB1;UNC45A;TGFA;CBL;CIB1;RAB4B;CSNK1D;APBA1;GALNT3;MAP6;AZIN2;ITGA3;THBS3;RAP1GAP2
3242,GO:0006900,0.00274187738302183,0.998917220369826,18,86,vesicle budding from membrane,BP,AP3D1;VPS4A;CTSZ;SEC23A;DNM2;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;VAPB;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
6734,GO:0030145,0.00274476599080425,0.999227045228132,11,41,manganese ion binding,MF,PCK2;ATP13A2;ARG2;NPEPL1;FAM20C;HMGCL;GLUL;PPM1M;PRIMPOL;ARG1;GALNT3
3240,GO:0006897,0.00277933469732401,0.998218648174196,67,454,endocytosis,BP,SH3KBP1;TSPAN1;RAC2;SORL1;SNX9;DLG4;MAPKAPK3;MRC2;USP20;BCR;RAB31;VLDLR;LRP5;LRP10;CSNK1E;FCHO1;TUB;EPN1;LMBR1L;SNX33;LRP3;ARPC1A;EPN2;APOE;RIN2;PEAR1;AP2A2;PCSK9;TGFBR2;RIN1;LIMK1;DKK1;WASF2;ESYT2;PLCG1;BIN1;PAK1;NLGN2;APLN;CAP1;PIP5K1C;SRC;LDLRAP1;TGM2;DNM2;LRSAM1;SH3BP1;FYN;ANXA3;ELMO3;LGALS3BP;BCL2L1;LRP1;EHD4;ARAP3;ABCA7;NEURL1B;WIPF1;CBL;RAB4B;MAPK3;CSNK1D;CEACAM1;ITSN1;TGFB1;PIK3R2;ANXA1
8929,GO:0034764,0.00286204126410086,0.998770193898184,21,105,positive regulation of transmembrane transport,BP,NOS1;F2R;SHANK3;AKT1;EHD3;TMSB4X;PRKCZ;STK39;PLCG1;PAK1;CEMIP;GLRX;DNM2;GJC2;GAL;NTSR1;HSPA2;EPHB2;AZIN2;PIK3R2;STIM1
12974,GO:0051336,0.0028658355948556,0.997942536499415,119,900,regulation of hydrolase activity,BP,ANGPTL4;XDH;NOS1;F2R;ASAP2;SORL1;DOCK4;CST3;SNX9;LMF1;BOK;ARAP1;SERPINE2;DAP;IFI6;FKBP1A;ITGA6;NET1;RAPGEF3;SBF1;BCR;FBLN1;EVI5L;EGFR;MMP14;ARHGAP23;AKT1;SERPING1;ATP13A2;RIN2;TMSB4X;PRKCZ;ARHGAP22;PPP2R3B;EPHA1;GIT2;PPP1R35;GDI1;RIN1;SERPINB6;SOX7;PPP2R5B;SIPA1;CD44;TBC1D16;RAP1GDS1;TBC1D14;PRDX5;PPP1R12C;GIT1;BIN1;RAG1;TNFSF15;TBC1D9B;ARHGAP39;FARP1;DOCK9;RHOC;IFI27;DLG3;OXA1L;OASL;HSF1;ASPH;NEIL1;TFPI2;PPP1R14A;ARL2;TNFRSF6B;EDNRA;SRC;APLP2;DNM2;FAM162A;RGS19;SH3BP1;SPINT2;PCSK6;OAS1;FYN;AGRN;PPM1F;PFN1;MICAL1;ITGA1;TIMP1;CRIM1;FGFR1;PCSK1N;VPS9D1;DNMBP;LRP1;HSPA2;TBC1D20;FGF2;VAPB;ARAP3;MYO1D;TBC1D2B;NDE1;CAMSAP3;CASP4;IQSEC1;MAPK3;FURIN;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;ECM1;PPP6R1;PIK3R2;PPP1R37;ANXA1;PPP1R10;RAP1GAP2;RASA3;ASAP1
7854,GO:0032409,0.00287647938626376,0.998634665396476,26,140,regulation of transporter activity,BP,FHL1;NOS1;KCNG1;DLG4;DLG1;FKBP1A;PRNP;PRKACA;SHANK3;HECW2;EHD3;TMSB4X;PCSK9;STK39;NLGN2;STOM;SHANK2;VAMP2;GLRX;DNM2;GAL;NTSR1;HSPA2;EPHB2;MINK1;STIM1
17582,GO:1901136,0.00288042511411499,0.998677917330495,24,129,carbohydrate derivative catabolic process,BP,NT5E;EDEM1;SDC1;CST3;RAPGEF3;GPC4;GALNS;NAGLU;FBXO2;CD44;AHCY;CTBS;FUCA1;CEMIP;NEIL1;GSK3A;AGRN;HYAL1;HPSE;PNP;FGF2;NAGA;TGFB1;APOBEC3C
5235,GO:0015849,0.00289854974472235,0.998522356058858,31,175,organic acid transport,BP,SERINC2;CPT2;BSG;SLC16A3;AKT1;APOE;STK39;PPARA;SLC38A10;SLC6A6;SLC13A3;SLC43A1;VAMP2;GIPC1;STXBP1;SLC6A9;SLC13A5;NTSR1;MIF;PRAF2;SLC27A1;SLC6A14;P2RX4;RXRA;ARG1;SLC10A6;CPT1B;CEACAM1;APBA1;STARD10;ANXA1
11925,GO:0046942,0.00289854974472235,0.998522356058858,31,175,carboxylic acid transport,BP,SERINC2;CPT2;BSG;SLC16A3;AKT1;APOE;STK39;PPARA;SLC38A10;SLC6A6;SLC13A3;SLC43A1;VAMP2;GIPC1;STXBP1;SLC6A9;SLC13A5;NTSR1;MIF;PRAF2;SLC27A1;SLC6A14;P2RX4;RXRA;ARG1;SLC10A6;CPT1B;CEACAM1;APBA1;STARD10;ANXA1
6727,GO:0030135,0.00293962185200477,0.99843049902157,35,208,coated vesicle,CC,DVL1;EPN3;SNX9;SCYL1;COPG1;EGFR;EPN2;APOE;AP1B1;YIF1A;AP2A2;VPS11;CTSZ;PCSK9;SEC23A;KDELR1;MALL;TMED3;CEMIP;NUMB;VAMP2;LDLRAP1;DNM2;RGS19;STX5;MCFD2;SEC24C;LRP1;USO1;LMAN1;TGFA;FURIN;OCRL;CD59;ARCN1
10531,GO:0043436,0.00295518751088752,0.9979062800498,109,822,oxoacid metabolic process,BP,CBS;NOS1;PCK2;CPT2;BSG;NR1D1;SLC16A3;PGM1;PSMD2;NAGS;IDH2;PC;CRTAP;CYGB;SESN2;ACOT7;HAGH;CHPF;AARS;XYLT1;GPT2;XBP1;ACOT1;CRAT;CARS;HK1;XYLT2;ATF4;P4HB;PSAT1;AKT1;MDH2;ALDH1L2;ARG2;CRYL1;GALNS;PFKP;ACAD10;TYSND1;HADH;NDST2;PPARA;DHTKD1;WDTC1;CD44;ELOVL1;HMGCL;ERO1B;AHCY;ACSF2;GAMT;GLUL;CEMIP;ASS1;SLC2A3;GLUD1;ALOX15B;SDHA;SLC6A6;PYCR2;BLMH;P4HA1;B4GALT2;ALDH1A2;B3GNT3;CBR4;ACADVL;GARS;ASNS;ALDH4A1;PSMD7;TNFRSF1A;ALDH7A1;CHST14;COMT;MGLL;HYAL1;MIF;ADIPOR1;ST3GAL3;TRIB3;SLC27A1;HLCS;SARS2;SLC6A14;FGF2;ABHD14B;MLYCD;PHYH;ARG1;BPHL;ACY1;LONP2;GGT1;MAPK3;CPT1B;ALDOC;GLO1;B4GALT6;CEACAM1;LPIN3;UROS;TGFB1;PCYOX1;LDHA;AZIN2;ANXA1;PODXL2;SLC45A3
5315,GO:0016021,0.00296080623299696,0.997611415467652,322,2707,integral component of membrane,CC,EDEM1;KIAA1549L;ITGB4;TSPAN1;NOS1;ADAM19;F2R;MST1R;SORL1;ADGRL1;SDC1;SERINC2;KCNG1;QSOX1;MBOAT2;SDK2;LPCAT4;LMF1;SCN8A;BOK;SLCO4A1;DLG4;BSG;DLG1;CMTM4;DYSF;SLC16A3;IFI6;FKBP1A;DCBLD2;CKAP4;ITGA6;SLC2A9;PTPRS;BNIP3;CD68;SBF1;AGPAT3;TXNDC11;C2CD2;PCDH1;MARVELD1;TMEM214;SNPH;MARCH9;MRC2;ADGRF1;SYNE3;CHPF;LPCAT1;VLDLR;LRP5;ACVR2B;ITGB5;XYLT1;HTR7;KIAA1549;ADCY7;XBP1;CSMD2;MXRA7;CMTM7;EGFR;RTN2;LRP10;TTYH3;MMP14;SLC12A7;PRKACA;PTPRF;FAM189B;RHBDF2;LMBR1L;XYLT2;SHANK3;IFITM1;CDS2;LRP3;ARMCX2;GPC4;IRAK1;FAM210B;ATP13A2;METTL23;TMEM92;PEAR1;SYVN1;YIF1A;COL13A1;ATP7B;ITPR3;RFNG;FZD8;EPHA1;PI4K2A;SLC20A1;ORAI1;TMEM129;B4GALNT4;TMCO3;RABAC1;TGFBR2;CSMD3;CD99;PLD3;EPOR;NDST2;CREB3L2;UBE2J1;BNIP3L;KDELR1;PRSS8;TMEM125;YIPF2;ZDHHC8;CD44;ESYT2;ABCB8;SEC63;ELOVL1;OSBPL5;MC1R;SLC38A10;FAM171A2;SURF4;RRNAD1;TMEM134;TMEM245;TSPAN5;MALL;SLC35E2B;SFXN3;SLC29A4;NLGN2;GRAMD1A;SEMA4B;TNFSF15;PODXL;PTDSS2;TBC1D9B;TMTC4;STOM;RET;CORO7;IFI27;REEP2;TMED3;PROCR;YIPF3;SHANK2;PKD1;TMEM200B;DLG3;ATP11A;TP53I11;NIPA1;PIGQ;OXA1L;ANO8;CADM4;MYOF;SLC2A3;ANTXR2;GRIN3B;ASIC1;FNDC4;ADGRB2;SLC35E4;IL1RAP;WFS1;SRD5A3;SLC12A4;FAT1;ASPH;FAM155B;SLC6A6;PTPRU;ADAM8;TMEM8A;SLC13A3;LY6E;SLC43A1;B4GALT2;GPRC5C;VAMP2;FLNB;APCDD1L;TNFRSF6B;EDNRA;B3GNT3;APLP2;TAZ;PEX10;SARAF;REEP6;UBR4;FAM162A;TMEM25;DNAJC4;PAQR7;TMEM9;TMEM44;CARD19;STX5;PAG1;SPINT2;SPTLC2;CLSTN1;AGRN;TMEM154;TMPRSS11D;LPAR3;REEP4;SLC6A9;GRINA;TMEM200A;SLC25A43;TNFRSF1A;NRSN2;HSD11B1;MBOAT7;SLC33A1;TSPAN33;STX10;CHST14;GJC2;ITGA1;FCGRT;SLC13A5;SHISA5;COMT;NTSR1;AMIGO2;ITPRIPL2;CRIM1;SLC46A3;SLC35B4;SEMA4G;FGFR1;RRBP1;ATP2C2;C1ORF115;LRRC8A;TMEM128;TENM2;MFNG;SIGMAR1;BCL2L1;ADIPOR1;ST3GAL3;ZFPL1;PRAF2;TCIRG1;C16ORF58;GRAMD1C;SLC27A1;LEMD2;TPCN1;PMEPA1;ST3GAL5;TMEM185A;SLC6A14;AGPAT4;LRP1;ROBO3;HSPA2;TNFRSF19;P2RX4;ZP3;TBC1D20;TMEM139;ST6GALNAC2;VAPB;TMX4;RNF222;TMEM54;ABCA7;LMAN1;ENTPD6;INTS1;SLC10A6;VSIG10L;TGFA;CYB561;TPBG;NYNRIN;VAT1;KCNC4;EPHB2;GGT1;CPT1B;POMT1;DRAM2;FURIN;SLC35G2;SLC5A1;RNF103;UGCG;TMBIM1;B4GALT6;TMEM238;ADAM15;HM13;CEACAM1;PNPLA6;GALNT3;SLC30A1;ADCY6;TM2D1;ADCK2;SLC15A1;ERBB3;PODXL2;SLC45A3;COMTD1;IKBIP;ITGA3;CLDN12;PLGRKT;ASPHD1;ORAI3;STIM1
7583,GO:0031941,0.0030043441893949,0.999358595198001,8,26,filamentous actin,CC,ESPN;TMSB4X;PRKCZ;FERMT1;FSCN1;PAK1;SPECC1L;TMSB10
6294,GO:0019901,0.0030439502064443,0.99798566559265,76,526,protein kinase binding,MF,TNIP1;FAM83A;CCND1;MST1R;RAC2;DVL1;SHC1;DOCK4;DLG1;PITPNM1;MICALCL;MAPKAPK3;EGFR;SLC12A7;PRKACA;ACTA2;ATF4;AKT1;PKN1;AP1B1;AP2A2;PRKCZ;EPHA1;FBXW5;MSN;TGFBR2;STK39;SHC2;PLCG1;ATG13;TWF2;TBC1D14;CCND2;PPP1R12C;SUFU;PAK1;RET;RHOC;PKD1;HSF1;IL1RAP;NEK9;SLC12A4;RHOBTB2;SRC;DNM2;NCS1;TOM1L2;EXOC2;GSK3A;STXBP1;PAG1;MICAL1;KIF13B;BRSK1;FGFR1;BCL2L1;ADIPOR1;TRIB3;PITPNM2;TRIB2;MAP3K12;RHOBTB1;ZBTB4;EPHB2;CBL;CIB1;LLGL1;CEACAM1;ADCY6;CCNE1;SPRED2;PIK3R2;CAMK2N1;ERBB3;PXN
15012,GO:0070914,0.00304515884469893,0.999665302244088,5,11,UV-damage excision repair,BP,ERCC1;XPC;MC1R;HIST3H2A;DDB2
12082,GO:0048015,0.00304596197583851,0.998684902932425,21,104,phosphatidylinositol-mediated signaling,BP,F2R;SERPINE2;NYAP1;EGFR;AKT1;PPP2R5B;GATA3;RGL2;MYDGF;PIP5K1C;NCS1;FYN;FGFR1;PITPNM2;ZP3;CBL;MAPK3;CEACAM1;CAT;PIK3R2;ERBB3
16832,GO:0098660,0.00306047381914551,0.998079649869904,60,407,inorganic ion transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;DLG1;FKBP1A;SLC2A9;PRNP;TTYH3;SLC12A7;PRKACA;HECW2;EHD3;ATP13A2;TMSB4X;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;PLCG1;DDIT3;STOM;CEMIP;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;VAMP2;GLRX;DNM2;NDUFA4L2;NCS1;FYN;SLC33A1;GJC2;GAL;NTSR1;ATP2C2;VPS9D1;TCIRG1;TPCN1;HSPA2;P2RX4;FGF2;CHD7;ATP6V1C2;KCNC4;SLC30A1;TGFB1;PCYOX1;SLC15A1;ORAI3;STIM1;RASA3
2672,GO:0006022,0.00306897201333652,0.998614493403757,23,118,aminoglycan metabolic process,BP,SDC1;CHPF;XYLT1;XYLT2;AKT1;GPC4;GALNS;NAGLU;NDST2;CD44;CTBS;FUCA1;CEMIP;B4GALT2;B3GNT3;AGRN;CHST14;HYAL1;ST3GAL3;HPSE;FGF2;B4GALT6;TGFB1
6200,GO:0019674,0.00308391734369924,0.999051843912582,12,48,NAD metabolic process,BP,NT5E;NAPRT;PCK2;HK1;MDH2;PFKP;NMRK1;NADK;PARP10;PNP;ALDOC;LDHA
746,GO:0001974,0.00309272164986028,0.99934231763896,8,25,blood vessel remodeling,BP,CST3;BCR;ACVR2B;TGM2;CHD7;TMBIM1;CEACAM1;TGFB1
9639,GO:0036498,0.00311775153561609,0.998879540112197,15,67,IRE1-mediated unfolded protein response,BP,EDEM1;SHC1;XBP1;PDIA5;SYVN1;YIF1A;TSPYL2;PPP2R5B;SEC63;CUL7;WFS1;MYDGF;ACADVL;GSK3A;DNAJB9
14332,GO:0061448,0.00311864870776391,0.998511056028186,26,139,connective tissue development,BP,WNT7A;PTHLH;MEF2D;BBS2;LRP5;XBP1;ACTA2;SH3PXD2B;TGFBR2;CREB3L2;CD44;ZNF516;ADAMTS7;PKD1;HMGA2;ARID5B;WNT5B;THRA;TIMP1;FGFR1;HYAL1;FGF2;MAPK3;TGFB1;GNAS;THBS3
4635,GO:0010755,0.00314378242058541,0.99978850034665,4,7,regulation of plasminogen activation,BP,SERPINE2;CTSZ;F12;PLGRKT
11259,GO:0045444,0.00315309448867703,0.998467959695147,27,148,fat cell differentiation,BP,CCND1;NR1D1;ITGA6;BNIP3;BBS2;LRP5;XBP1;CCDC71L;AKT1;WWTR1;SH3PXD2B;ZNF516;ZNF385A;DDIT3;GATA3;CTBP1;HMGA2;ARID5B;WNT5B;LAMB3;TRIB3;ZFPM1;TRIB2;SOCS7;TGFB1;EP300;WDFY2
18227,GO:1902991,0.00316804166510443,0.999419874096228,7,20,regulation of amyloid precursor protein catabolic process,BP,SORL1;FKBP1A;PRNP;APOE;BIN1;GSK3A;ABCA7
18599,GO:1903800,0.00320683936635661,0.999783012528945,4,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;TGFB1
3201,GO:0006836,0.00321310701247718,0.99851355088279,24,127,neurotransmitter transport,BP,NOS1;DVL1;WNT7A;RAB3B;SNPH;SEPT5;GLUL;SYTL1;APLN;ASIC1;SLC6A6;VAMP2;PIP5K1C;STXBP1;SLC6A9;BRSK1;NTSR1;PRAF2;SLC6A14;SEC14L1;SNAP29;KCNC4;APBA1;SLC30A1
10517,GO:0043410,0.00324758866525499,0.998031138407754,52,337,positive regulation of MAPK cascade,BP,XDH;F2R;MST1R;MAP2K1;SHC1;WNT7A;ERCC6;IGFBP4;MAPKAPK3;MAP4K4;EGFR;MAP2K2;STK25;IRAK1;PKN1;PRKCZ;FZD8;EPHA1;STK39;DKK1;SHC2;CD44;PLCG1;MAP3K9;PAK1;RET;GNAI2;ADAM8;MYDGF;SRC;STK24;DUSP6;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;MIF;TNFRSF19;FGF2;MAP3K12;TAOK1;ABCA7;TGFA;EPHB2;CIB1;MAPK3;MAPK10;MINK1;TGFB1;ERBB3;TRAF7
7277,GO:0031252,0.00334490888081018,0.998013770186406,48,303,cell leading edge,CC,ITGB4;RAC2;SNX9;DYSF;RAPGEF3;SSH1;PLEK2;CORO1B;ACTA2;PARVB;ATF4;PRKCZ;PTK6;FERMT1;LIMK1;WASF2;CD44;PLCG1;TWF2;PSD3;FSCN1;PAK1;PODXL;CYTH3;FAT1;ARHGEF4;PIP5K1C;SRC;DNM2;CDC42BPB;SH3BP1;PLEKHG5;TUBG1;ARFIP2;VASP;ARAP3;MYO1D;ABCA7;APBB1;EPS8L1;WIPF1;KCNC4;CIB1;ARHGEF2;ARHGAP44;ITSN1;PXN;PLEKHH2
20318,GO:2001257,0.00334990759807321,0.998693895254203,17,79,regulation of cation channel activity,BP,NOS1;KCNG1;DLG4;DLG1;FKBP1A;PRKACA;SHANK3;EHD3;NLGN2;STOM;SHANK2;VAMP2;GAL;NTSR1;EPHB2;MINK1;STIM1
12941,GO:0051272,0.00336336021293643,0.997967086883815,51,332,positive regulation of cellular component movement,BP,PGF;F2R;RAC2;DOCK4;WNT7A;POSTN;ITGA6;SSH1;SMURF2;SEMA3F;XBP1;EGFR;MMP14;LAMB1;AKT1;TMSB4X;EPHA1;TGFBR2;PLCG1;PAK1;SEMA4B;PODXL;RET;LAMC2;CEMIP;GATA3;ADAM8;FAM110C;NUMB;SRC;RAB25;PPM1F;WNT5B;PFN1;ANXA3;SEMA4G;FGFR1;RREB1;HYAL1;ZNF609;P2RX4;ZP3;FGF2;VEGFB;CIB1;MAPK3;ARHGEF2;SRPX2;TGFB1;ANXA1;ITGA3
4855,GO:0014065,0.00336923220894609,0.998643750647808,18,85,phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;NYAP1;EGFR;AKT1;PPP2R5B;GATA3;RGL2;MYDGF;PIP5K1C;FYN;FGFR1;CBL;MAPK3;CEACAM1;CAT;PIK3R2;ERBB3
8297,GO:0033116,0.00339475884567768,0.998878091515017,13,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,CTSZ;KDELR1;SURF4;TMED3;RAB1B;STX5;MCFD2;TBC1D20;LMAN1;TGFA;CSNK1D;CD59;AZIN2
5869,GO:0017171,0.00343620891697395,0.998568993599516,19,95,serine hydrolase activity,MF,PLAT;MMP1;PRSS3;CTSB;MMP14;RHBDF2;PCSK9;TYSND1;PRSS8;HTRA1;MMP10;ADAM8;PCSK6;TMPRSS11D;CTSL;F12;KLK6;LONP2;FURIN
9807,GO:0040017,0.00344335826195734,0.997894655681493,53,348,positive regulation of locomotion,BP,PGF;F2R;RAC2;DOCK4;WNT7A;POSTN;ITGA6;PC;SSH1;SMURF2;SEMA3F;XBP1;EGFR;MMP14;LAMB1;AKT1;TMSB4X;VPS4A;EPHA1;TGFBR2;PLCG1;PAK1;SEMA4B;PODXL;RET;LAMC2;CEMIP;GATA3;ADAM8;FAM110C;NUMB;SRC;RAB25;PPM1F;WNT5B;PFN1;ANXA3;SEMA4G;FGFR1;RREB1;HYAL1;ZNF609;P2RX4;ZP3;FGF2;VEGFB;CIB1;MAPK3;ARHGEF2;SRPX2;TGFB1;ANXA1;ITGA3
7822,GO:0032370,0.00345663948334638,0.99914729682372,9,32,positive regulation of lipid transport,BP,APOE;LDLRAP1;GAL;PLTP;NTSR1;MIF;LRP1;P2RX4;ABCA7
7278,GO:0031253,0.00347917829636159,0.998123153557292,35,205,cell projection membrane,CC,DLG1;PLEK2;BBS2;SHANK3;ATF4;ARPC1A;EHD3;FERMT1;MSN;CD44;PSD3;FSCN1;PAK1;PODXL;GNB1;SYTL1;SHANK2;PKD1;ARHGEF4;PIP5K1C;SRC;DNM2;RAB25;SLC6A14;VASP;MYO1D;ABCA7;EPS8L1;SNAP29;KCNC4;CIB1;ARHGEF2;CEACAM1;ITGA3;ASAP1
12264,GO:0048523,0.00348493346982852,0.997145078477604,383,3293,negative regulation of cellular process,BP,TNIP1;ANGPTL4;XDH;FHL1;SH3KBP1;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RBCK1;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;SHC1;PLAT;QSOX1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;ARAP1;DLG4;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;IFI6;DNMT3A;FKBP1A;DCBLD2;POSTN;PSMD2;MTA1;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;WWC3;CRTAP;SMURF2;TMOD2;CYGB;FAM129B;ESPN;SESN2;ZC3H6;SEMA3F;NACC2;BCR;LPCAT1;VLDLR;LRP5;AARS;ACVR2B;FBLN1;XBP1;EVI5L;MAP4K4;EGFR;PANO1;MMP14;PRKACA;ADARB1;CORO1B;RHBDF2;MAP2K2;EPN1;PPP1R13L;SHANK3;ATF4;SNX33;AKT1;XPC;IFITM1;IRAK1;PEG3;SERPING1;EPN2;BAG3;APOE;ATP13A2;ARG2;PKN1;PEAR1;SYVN1;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;ITPR3;DGKQ;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;PTK6;FBXO2;PCSK9;FERMT1;RRAS;EML2;DEAF1;SALL2;PPP1R35;TGFBR2;DRAP1;GDI1;HADH;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;PPARA;PRKACB;H2AFJ;LTBP1;SIPA1;WDTC1;WASF2;CDC34;CD44;DNAJB5;PLCG1;IDE;DEDD2;TWF2;TBC1D14;PRDX5;CCND2;PPP1R12C;BIN1;HTRA1;SUFU;PAK1;TTBK2;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;SEMA4B;BAZ2A;DDIT3;PODXL;BCDIN3D;ADAMTS7;FARP1;DUSP4;PTPN9;SATB1;RET;RAB29;GAS2L1;IFI27;GRB10;PCBP4;CEMIP;SHANK2;PKD1;ASS1;PARP10;DLG3;GATA3;TP53I11;APLN;PHF1;TCFL5;GNAI2;ASIC1;HSF1;SIN3B;BCL7A;ALOX15B;WFS1;ASPH;CTBP1;PTPRU;ADAM8;MAPKBP1;NEIL1;TFPI2;RGL2;HMGA2;ARID5B;PPP1R14A;IGFBP2;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;SRC;APLP2;CAPG;DNM2;AGO4;IRF7;LRSAM1;HIST3H2A;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;PER3;TOM1L2;RERE;RSF1;GSK3A;STXBP1;PAG1;SH3BP1;SPINT2;DUSP6;FYN;FUZ;ASNS;ZNF692;PPM1F;WNT5B;GRINA;PFN1;NELFCD;NISCH;PSMD7;MICAL1;WISP1;TLE4;VDR;BRSK1;CGREF1;GJC2;GAL;PUM1;ITGA1;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;CRIM1;HSF4;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PHF2;TENM2;MIF;SOCS2;MTMR4;HES2;BCL2L1;STUB1;PCSK1N;ADIPOR1;TRIB3;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ULK1;LRP1;TRIB2;HSPA2;PAK4;MXD4;MGRN1;SAMD4B;ULK2;ZP3;LRRK1;FGF2;RCOR1;MAP3K12;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;BICC1;APBB1;SLIT3;RXRA;HIST2H2AC;ARG1;PBXIP1;ZHX3;TSHZ1;TAF6;CAMSAP3;INVS;BAHCC1;SEC14L1;ZBTB4;CNOT11;TCF25;NDRG3;HIST1H2AG;IMPACT;VAT1;EPHB2;HGS;GAS8;CBL;CIB1;TMSB10;SOCS7;KANK2;DNAJB9;GLO1;FURIN;ARHGEF2;C12ORF66;TMBIM1;AIDA;MLF1;ADAM15;CEACAM1;PAIP2;SKAP2;ZNF256;ARHGAP44;SRGAP2B;ECM1;CD59;MBD3;SLC30A1;ADCY6;IGF2BP3;CCNE1;ITSN1;TGFB1;CAT;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;APOBEC3C;KLF12;ITGA3;ZNF318;PLEKHH2;EP300;RAP1GAP2;RASA3;ASAP1;RNF10
1994,GO:0004712,0.0034893387215268,0.999059855633192,10,36,protein serine/threonine/tyrosine kinase activity,MF,MAP2K1;RPS6KA2;MAPKAPK3;ACVR2B;PRKACA;MAP2K2;AKT1;MAP3K9;MAPK3;MAPK10
6671,GO:0030027,0.00351870682571869,0.998250475937462,28,155,lamellipodium,CC,RAC2;DYSF;RAPGEF3;SSH1;PLEK2;CORO1B;ACTA2;PARVB;LIMK1;WASF2;CD44;PLCG1;TWF2;FSCN1;PAK1;PODXL;FAT1;DNM2;CDC42BPB;SH3BP1;PLEKHG5;VASP;ARAP3;APBB1;CIB1;ITSN1;PXN;PLEKHH2
16914,GO:0098839,0.00355709938968094,0.99975195026212,4,7,postsynaptic density membrane,CC,DLG4;DLG1;PTPRS;DLG3
17119,GO:0099634,0.00355709938968094,0.99975195026212,4,7,postsynaptic specialization membrane,CC,DLG4;DLG1;PTPRS;DLG3
18438,GO:1903441,0.00357833298240752,0.999750036495189,4,7,protein localization to ciliary membrane,BP,BBS2;TUB;RAB29;TULP3
3405,GO:0007188,0.00359568345221296,0.998635683361142,16,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,NOS1;ADM2;PTHLH;ADGRF1;HTR7;ADCY7;AKAP12;PRKACB;WASF2;MC1R;GNB1;GNAI2;EDNRA;GSK3A;ADCY6;GNAS
721,GO:0001944,0.00363491765553924,0.997641541686057,67,455,vasculature development,BP,ANGPTL4;XDH;PGF;SH2D2A;NFATC4;MAP2K1;ADM2;SHC1;WNT7A;RAPGEF3;LAMA5;FAM129B;LRP5;ACVR2B;XBP1;MMP14;THBS2;ACTA2;EPN1;FBXW8;AKT1;EPN2;APOE;ELK3;ARHGAP22;FZD8;EPHA1;RRAS;TGFBR2;LTBP1;WASF2;PLCG1;SUFU;DDIT3;CUL7;PKD1;APLN;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;ALDH1A2;DNM2;ANXA3;LOXL1;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;CHD7;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;ANXA1;STIM1
8736,GO:0034377,0.0036656669945686,0.999427746755985,6,16,plasma lipoprotein particle assembly,BP,PRKACA;P4HB;APOE;PRKACB;ZDHHC8;ABCA7
12486,GO:0050321,0.00368484058332719,0.999575812534431,5,11,tau-protein kinase activity,MF,MARK4;TTBK2;GSK3A;BRSK1;CSNK1D
1780,GO:0004385,0.00368681540376598,0.999575529759895,5,11,guanylate kinase activity,MF,DLG4;DLG1;CARD11;DLG3;GUK1
10134,GO:0042659,0.00369728196236607,0.99973925275292,4,7,regulation of cell fate specification,BP,DKK1;DUSP6;FGFR1;FGF2
19053,GO:1904861,0.0037067967253917,0.999738385583397,4,7,excitatory synapse assembly,BP,WNT7A;SHANK3;NLGN2;SHANK2
2605,GO:0005902,0.00371135969330563,0.998828212005071,12,49,microvillus,CC,RAPGEF3;ESPN;BBS2;MSN;CD44;FSCN1;PODXL;SYTL1;KIF13B;CEACAM1;TGFB1;STARD10
11299,GO:0045595,0.00374572031109729,0.997198446085775,148,1157,regulation of cell differentiation,BP,XDH;ZMYND8;NOS1;CCND1;LTBP4;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;WNT7A;PTHLH;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;NR1D1;POSTN;PSMD2;NET1;PTPRS;IDH2;SSH1;FAM129B;SEMA3F;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;XBP1;MAP4K4;EGFR;CSNK1E;CCDC71L;MMP14;PRKACA;PTPRF;PPP1R13L;STK25;SHANK3;HECW2;FBXW8;AKT1;IFITM1;CARD11;APOE;FAM210B;WWTR1;PRKCZ;FAM20C;CTSZ;PTK6;SH3PXD2B;MAP1B;TGFBR2;CSMD3;GDI1;LIMK1;DKK1;PPP2R5B;PPARA;OBSL1;TWF2;TFE3;BIN1;SUFU;PAK1;BCL9L;ZNF385A;RAG1;SEMA4B;DDIT3;CUL7;ADAMTS7;PTPN9;RET;RAB29;SHANK2;GATA3;TCFL5;ALOX15B;IL1RAP;ADAM8;NUMB;DNM2;AGO4;IRF7;NCS1;STK24;GSK3A;DUSP6;FYN;FUZ;LPAR3;WNT5B;PSMD7;TNFRSF1A;VDR;KIF13B;GJC2;GAL;CTSL;TNRC6B;THRA;HSF4;SEMA4G;FGFR1;RREB1;ADNP;SOCS2;ADIPOR1;TRIB3;ZFPM1;LRP1;TRIB2;ZNF609;ULK2;PNP;FGF2;MAPK9;CHD7;APBB1;ZHX3;IMPACT;KLK6;CAMK1;EPHB2;MYL9;CIB1;CSNK1D;ARHGEF2;CEACAM1;ARHGAP44;ADCY6;TGFB1;ANXA1;SLC45A3;ASH2L;GNAS;ITGA3;EP300;WDFY2;RAP1GAP2;ASAP1;RNF10
10452,GO:0043299,0.00375894133718651,0.997665958119286,55,378,leukocyte degranulation,BP,PYGB;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
7811,GO:0032355,0.00378110552780048,0.998502180265001,17,82,response to estradiol,BP,CCND1;WNT7A;CST3;DNMT3A;POSTN;EGFR;FAM210B;ENDOG;HSF1;IGFBP2;ALDH1A2;STXBP1;SOCS2;MBD3;TGFB1;CAT;ANXA1
6432,GO:0021695,0.00379643206101984,0.999055125825183,9,31,cerebellar cortex development,BP,MAP2K1;WNT7A;SERPINE2;AARS;NAGLU;TTBK2;B4GALT2;RERE;ARCN1
3548,GO:0007584,0.00382011614587006,0.998141795142803,26,145,response to nutrient,BP,ERCC1;CCND1;CYP27B1;DNMT3A;POSTN;SSH1;XBP1;EGFR;DGKQ;TGFBR2;HMGCL;AHCY;GNAI2;HSF1;IGFBP2;ALDH1A2;FYN;VDR;USF2;HLCS;P2RX4;ARG1;KANK2;TGFB1;CAT;LDHA
8704,GO:0034331,0.00382373278556691,0.999727673541132,4,7,cell junction maintenance,BP,F2R;NLGN2;CAMSAP3;KIFC3
16463,GO:0097106,0.00384651924531299,0.999725574516168,4,7,postsynaptic density organization,BP,ZMYND8;SHANK3;NLGN2;SHANK2
17022,GO:0099084,0.00384651924531299,0.999725574516168,4,7,postsynaptic specialization organization,BP,ZMYND8;SHANK3;NLGN2;SHANK2
11119,GO:0045121,0.00389665249083383,0.997901722223482,34,200,membrane raft,CC,NOS1;CAPN2;F2R;BSG;DLG1;PRNP;SMURF2;MARVELD1;LY6K;EGFR;PRKACA;HK1;CARD11;PRKCZ;PI4K2A;TGFBR2;MALL;PODXL;STOM;RET;MYOF;GNAI2;SRC;RGS19;PAG1;FYN;TNFRSF1A;ITGA1;NTSR1;HPSE;MYO1D;CBL;MAPK3;FURIN
3321,GO:0007030,0.00391422732877925,0.998230275895024,22,113,Golgi organization,BP,MAP2K1;RAB43;MAP2K2;STK25;FBXW8;EHD3;PI4K2A;OBSL1;SURF4;CUL7;RAB29;TMED3;DNM2;STX5;USO1;TBC1D20;COG1;LMAN1;CAMSAP3;MAPK3;CSNK1D;KIFC3
12260,GO:0048519,0.00398753642954871,0.996708284592246,417,3642,negative regulation of biological process,BP,TNIP1;NT5E;ANGPTL4;XDH;FHL1;SH3KBP1;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RBCK1;SORL1;CTNNBIP1;DDIT4L;NFATC4;DVL1;MAP2K1;SHC1;DOCK4;PLAT;QSOX1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;SHARPIN;CRTC1;ARAP1;DLG4;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;IFI6;DNMT3A;FKBP1A;DCBLD2;POSTN;PSMD2;MTA1;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;PC;WWC3;CRTAP;SMURF2;TMOD2;CYGB;FAM129B;ESPN;SESN2;TNNT1;ZC3H6;BBS2;SEMA3F;NACC2;BCR;LPCAT1;VLDLR;LRP5;AARS;ACVR2B;FBLN1;XBP1;EVI5L;MAP4K4;EGFR;PANO1;MMP14;THBS2;PRKACA;ADARB1;CORO1B;RHBDF2;MAP2K2;EPN1;PPP1R13L;SHANK3;ATF4;HECW2;SNX33;AKT1;XPC;IFITM1;IRAK1;PEG3;SERPING1;EPN2;BAG3;APOE;ATP13A2;ARG2;PKN1;PEAR1;SYVN1;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;RNF135;ITPR3;DGKQ;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;PTK6;FBXO2;PCSK9;FERMT1;RRAS;EML2;DEAF1;SALL2;PPP1R35;MAP1B;TGFBR2;DRAP1;GDI1;HADH;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;PPARA;FAM3A;PRKACB;H2AFJ;LTBP1;SIPA1;WDTC1;WASF2;CDC34;CD44;DNAJB5;PLCG1;GTPBP1;IDE;MC1R;DEDD2;TWF2;TBC1D14;PRDX5;CCND2;PPP1R12C;BIN1;HTRA1;SUFU;PAK1;TTBK2;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;SEMA4B;BAZ2A;DDIT3;PODXL;BCDIN3D;ADAMTS7;FARP1;DUSP4;PTPN9;SATB1;RET;RAB29;GAS2L1;IFI27;GRB10;PROCR;PCBP4;CEMIP;SHANK2;PKD1;ASS1;PARP10;DLG3;GATA3;TP53I11;APLN;PHF1;OXA1L;TCFL5;OASL;GNAI2;ASIC1;FNDC4;HSF1;ADGRB2;SIN3B;BCL7A;ALOX15B;WFS1;ASPH;MT2A;CTBP1;PTPRU;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;RGL2;HMGA2;ARID5B;PPP1R14A;ARL2;NUMB;IGFBP2;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;SRC;APLP2;CAPG;DNM2;AGO4;IRF7;LRSAM1;HIST3H2A;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;PER3;TOM1L2;RERE;RSF1;GSK3A;STXBP1;PAG1;SH3BP1;SPINT2;DUSP6;OAS1;FYN;ISG20;FUZ;ASNS;ZNF692;PPM1F;WNT5B;GRINA;PFN1;NELFCD;NISCH;PSMD7;MICAL1;TNFRSF1A;WISP1;TLE4;VDR;ABHD17C;BRSK1;CGREF1;GJC2;GAL;PUM1;ITGA1;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;CRIM1;HSF4;SEMA4G;FGFR1;RREB1;ADNP;HYAL1;PHF2;TENM2;F12;MIF;SOCS2;MTMR4;HES2;BCL2L1;STUB1;PCSK1N;ADIPOR1;TRIB3;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ULK1;LRP1;TRIB2;HSPA2;PAK4;MXD4;MGRN1;P2RX4;SAMD4B;ULK2;ZP3;LRRK1;FGF2;RNH1;PYM1;RCOR1;MAP3K12;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;BICC1;APBB1;SLIT3;RXRA;HIST2H2AC;ARG1;PBXIP1;ZHX3;TSHZ1;TAF6;CAMSAP3;RPL28;INVS;BAHCC1;SEC14L1;ZBTB4;CNOT11;TCF25;NDRG3;HIST1H2AG;IMPACT;VAT1;EPHB2;HGS;CARHSP1;GAS8;CBL;CIB1;TMSB10;SOCS7;KANK2;DNAJB9;GLO1;FURIN;ARHGEF2;C12ORF66;TMBIM1;AIDA;MLF1;ADAM15;CEACAM1;PAIP2;SKAP2;ZNF256;ARHGAP44;SRGAP2B;ECM1;CD59;MBD3;SLC30A1;ADCY6;IGF2BP3;CCNE1;ITSN1;TGFB1;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;APOBEC3C;KLF12;ITGA3;ZNF318;PLEKHH2;EP300;RAP1GAP2;RASA3;ASAP1;RNF10
3253,GO:0006915,0.00403972179362925,0.996907994761253,174,1397,apoptotic process,BP,ANGPTL4;XDH;SH3KBP1;CHAC1;H1F0;F2R;MST1R;RBCK1;NFATC4;MAP2K1;SHC1;WNT7A;ERCC6;CST3;NEURL1;BOK;SHARPIN;MEF2D;OBSCN;DAP;IFI6;DNMT3A;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;NME4;FAM129B;LCN2;G0S2;CTSB;TMEM214;NACC2;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MKNK2;ADARB1;MAP2K2;PPP1R13L;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;PEG3;BAG3;APOE;ARG2;PKN1;SYVN1;TNS4;RABGGTA;PRKCZ;CTSZ;EPHA1;UACA;PCSK9;ENDOG;HS1BP3;TGFBR2;STK39;DKK1;SOX7;BNIP3L;KDELR1;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;GNB1;SATB1;RET;IFI27;GATA3;GSDMA;HSF1;ALOX15B;WFS1;ADAM8;RGL2;HMGA2;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;C6ORF120;GSK3A;STXBP1;DUSP6;FYN;ASNS;PPM1F;GRINA;NISCH;MICAL1;TNFRSF1A;VDR;ELMO3;PLEKHG5;MOAP1;GAL;ITGA1;SHISA5;CTSL;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;TRIB3;LRP1;PAK4;TNFRSF19;P2RX4;MAPK9;SHB;MAP3K12;TAOK1;APBB1;SLIT3;CASP4;EPHB2;CBL;CIB1;PACS2;MAPK3;KANK2;DRAM2;GLO1;ARHGEF2;TMBIM1;MINK1;TFPT;ITSN1;TGFB1;TM2D1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;EP300;TRAF7
16624,GO:0097440,0.00403990763394996,0.999524366797739,5,11,apical dendrite,CC,NEURL1;OSBP2;MAP1B;GSK3A;MYO1D
17043,GO:0099173,0.00409171545288702,0.998484315937757,15,67,postsynapse organization,BP,ZMYND8;DVL1;WNT7A;DLG4;PRNP;SSH1;ETV5;SHANK3;APOE;NLGN2;SHANK2;FYN;EPHB2;ARHGAP44;ITGA3
16172,GO:0090170,0.00411558346885551,0.999884471168155,3,4,regulation of Golgi inheritance,BP,MAP2K1;MAP2K2;MAPK3
9799,GO:0040008,0.00415031644627144,0.997306902246863,65,450,regulation of growth,BP,FHL1;LTBP4;SHC1;CYP27B1;SERPINE2;IGFBP4;DCBLD2;NET1;PTPRS;WWC3;SESN2;BBS2;SEMA3F;EGFR;MMP14;AKT1;APOE;TSPYL2;PTK6;SH3PXD2B;MAP1B;TGFBR2;GDI1;LIMK1;SIPA1;TWF2;HTRA1;PAK1;SEMA4B;GAMT;HSF1;ALOX15B;WFS1;MT2A;RAI1;HMGA2;IGFBP2;DNM2;GSK3A;DUSP6;CLSTN1;AGRN;PPM1F;LPAR3;WISP1;GAL;CRIM1;SEMA4G;FGFR1;ADNP;HYAL1;SOCS2;ADIPOR1;ULK2;ZP3;FGF2;CHD7;APBB1;SLIT3;NDRG3;CIB1;SOCS7;ADAM15;CEACAM1;TGFB1
7617,GO:0031998,0.0042015003437617,0.999500563507928,5,11,regulation of fatty acid beta-oxidation,BP,AKT1;TYSND1;PPARA;MLYCD;LONP2
16923,GO:0098857,0.00423658300396838,0.997705104457457,34,201,membrane microdomain,CC,NOS1;CAPN2;F2R;BSG;DLG1;PRNP;SMURF2;MARVELD1;LY6K;EGFR;PRKACA;HK1;CARD11;PRKCZ;PI4K2A;TGFBR2;MALL;PODXL;STOM;RET;MYOF;GNAI2;SRC;RGS19;PAG1;FYN;TNFRSF1A;ITGA1;NTSR1;HPSE;MYO1D;CBL;MAPK3;FURIN
19104,GO:1904956,0.00426280522747487,0.999878762710904,3,4,regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D
6988,GO:0030659,0.00430382892215197,0.997139311829489,72,508,cytoplasmic vesicle membrane,CC,SH3KBP1;RAC2;WNT7A;SNX9;DLG4;BSG;DYSF;RAB3B;CKAP4;PTPRS;CD68;RAB43;DBNDD1;SCYL1;COPG1;RAB31;LPCAT1;EGFR;SNX33;EPN2;APOE;AP1B1;AP2A2;ITPR3;PI4K2A;SEC23A;SERPINB6;KDELR1;ZDHHC8;CD44;SURF4;DMXL2;STOM;TMED3;CEMIP;ATP11A;ARL8A;MYOF;SLC2A3;ADAM8;GPRC5C;VAMP2;LDLRAP1;APLP2;DNM2;UBR4;STX5;WNT5B;ANXA3;MCFD2;SEC24C;BCL2L1;TCIRG1;LRP1;USO1;ULK2;SPIRE1;SNTB2;LMAN1;TGFA;SNAP29;RAB4B;KIFC3;TMBIM1;OCRL;CEACAM1;CD59;MAP6;SPRED2;ANXA1;RAB6A;ARCN1
12084,GO:0048017,0.0043468586231659,0.998057808142074,21,107,inositol lipid-mediated signaling,BP,F2R;SERPINE2;NYAP1;EGFR;AKT1;PPP2R5B;GATA3;RGL2;MYDGF;PIP5K1C;NCS1;FYN;FGFR1;PITPNM2;ZP3;CBL;MAPK3;CEACAM1;CAT;PIK3R2;ERBB3
684,GO:0001891,0.00434989604225623,0.999295811326097,6,16,phagocytic cup,CC,PEAR1;PIP5K1C;DNM2;SH3BP1;ABCA7;ANXA1
15355,GO:0071559,0.00437288734084956,0.997756597678629,29,166,response to transforming growth factor beta,BP,LTBP2;LTBP4;WNT7A;MXRA5;FKBP1A;POSTN;SMURF2;ITGB5;PRKCZ;FERMT1;TGFBR2;LTBP1;HTRA1;BCL9L;FNDC4;GIPC1;SRC;DNM2;FYN;MTMR4;STUB1;SNX25;PMEPA1;ARG1;CBL;FURIN;TGFB1;ITGA3;PXN
11301,GO:0045597,0.00442295229262565,0.99696490058693,84,601,positive regulation of cell differentiation,BP,ZMYND8;CTNNBIP1;DVL1;MAP2K1;CYP27B1;NEURL1;AP3D1;CRTC1;DLG4;SERPINE2;NET1;FAM129B;VLDLR;ETV5;LRP5;ACVR2B;XBP1;CSNK1E;CCDC71L;MMP14;PPP1R13L;STK25;SHANK3;FBXW8;AKT1;IFITM1;APOE;FAM210B;WWTR1;PRKCZ;FAM20C;PTK6;SH3PXD2B;MAP1B;TGFBR2;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;BCL9L;ZNF385A;RAG1;CUL7;RET;SHANK2;GATA3;ALOX15B;IL1RAP;ADAM8;NUMB;DNM2;FYN;LPAR3;WNT5B;VDR;GJC2;THRA;HSF4;FGFR1;RREB1;ADNP;SOCS2;ZNF609;PNP;FGF2;MAPK9;APBB1;ZHX3;IMPACT;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;CEACAM1;TGFB1;ANXA1;GNAS;ITGA3;WDFY2
3798,GO:0008374,0.00445681968891458,0.998749535646552,10,37,O-acyltransferase activity,MF,MBOAT2;LPCAT4;CPT2;AGPAT3;LPCAT1;CRAT;TAZ;MBOAT7;AGPAT4;CPT1B
2426,GO:0005604,0.0044752593028102,0.998325414286719,15,67,basement membrane,CC,CST3;DLG1;ITGA6;LAMA5;FBLN1;LAMB1;THBS2;LAMB2;LAMC2;NID1;AGRN;VWA1;TIMP1;LAMB3;LOXL1
17259,GO:0110053,0.00447954520673649,0.997613001734468,32,189,regulation of actin filament organization,BP,RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;CORO1B;SHANK3;ARPC1A;TMSB4X;EPHA1;SH3PXD2B;LIMK1;WASF2;TWF2;PAK1;CAPG;SH3BP1;PPM1F;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;PXN;ARHGEF10L;PLEKHH2;FHOD1
6290,GO:0019897,0.00448922306207876,0.99803358811146,20,101,extrinsic component of plasma membrane,CC,EPN3;SNX9;DLG4;SERPINE2;PTK6;PCSK9;PRSS8;ESYT2;FARP1;GNB1;SYTL1;CYTH3;GNAI2;NUMB;SRC;RGS19;FYN;MYZAP;ANXA1;GNAS
17862,GO:1902003,0.00451491155250117,0.999263266592345,6,16,regulation of amyloid-beta formation,BP,SORL1;PRNP;APOE;BIN1;GSK3A;ABCA7
5724,GO:0016860,0.00455909711781736,0.998701235476703,10,40,intramolecular oxidoreductase activity,MF,QSOX1;HYI;TXNDC11;P4HB;PDIA5;ERO1B;MPI;MIF;TMX4;ERP44
3264,GO:0006936,0.00457247934719815,0.997644000821978,29,169,muscle contraction,BP,NOS1;F2R;DOCK4;SMTN;DLG1;DYSF;FKBP1A;TMOD2;TNNT1;BBS2;ITGB5;HTR7;PRKACA;ACTA2;PPP1R13L;EHD3;ARG2;OBSL1;RAP1GDS1;GAMT;MYOF;ASPH;EDNRA;TAZ;ITGA1;P2RX4;VEGFB;MYL9;PXN
8216,GO:0032963,0.00460576217189429,0.998200485395476,16,75,collagen metabolic process,BP,F2R;CST3;MMP1;CYGB;CTSB;MRC2;MMP14;COL13A1;LARP6;MMP10;CTSL;ARG1;KLK6;FURIN;ADAM15;TGFB1
18181,GO:1902903,0.00462985331161726,0.997339489051164,40,251,regulation of supramolecular fiber organization,BP,RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;CORO1B;SHANK3;ARPC1A;APOE;TMSB4X;EPHA1;SH3PXD2B;EML2;MAP1B;LIMK1;WASF2;TWF2;PAK1;TTBK2;ARL2;CAPG;SH3BP1;PPM1F;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;CAMSAP3;BAIAP2L1;WIPF1;CIB1;TMSB10;KANK2;ARHGEF2;PXN;ARHGEF10L;PLEKHH2;FHOD1
11757,GO:0046578,0.00464598301188657,0.9974948130358,33,191,regulation of Ras protein signal transduction,BP,F2R;ASAP2;ARAP1;OBSCN;NET1;BCR;APOE;GIT2;PSD3;GIT1;FARP1;RASGEF1A;CYTH3;APPL2;RGL2;ARHGEF4;DNM2;SH3BP1;PLEKHG5;DNMBP;ARFGEF2;ARAP3;EPS8L1;EPHB2;IQSEC1;ARHGEF2;ARHGAP44;AGAP1;ITSN1;ITGA3;ARHGEF10L;RASA3;ASAP1
6654,GO:0023061,0.00465798102724144,0.997343090703341,39,243,signal release,BP,LTBP4;DVL1;WNT7A;PCK2;NR1D1;RAPGEF3;FAM129B;SNPH;LRP5;ACVR2B;MAP4K4;EGFR;ITPR3;SEPT5;HADH;NLGN2;GLUL;SYTL1;GATA3;APLN;ASIC1;GLUD1;ARL2;VAMP2;PIP5K1C;SCG5;STXBP1;SLC6A9;BRSK1;GAL;FGFR1;SMPD3;CHD7;SNAP29;KCNC4;APBA1;SLC30A1;ANXA1;GNAS
3417,GO:0007204,0.00469835315604358,0.997750793051112,24,132,positive regulation of cytosolic calcium ion concentration,BP,NOS1;F2R;DLG4;FKBP1A;PRNP;PRKACA;ITPR3;PLCG1;DDIT3;GNB1;CEMIP;PKD1;FAM155B;EDNRA;TGM2;FYN;LPAR3;NTSR1;TPCN1;P2RX4;FGF2;CHD7;TGFB1;RASA3
12133,GO:0048170,0.00472305914114287,0.999860432199584,3,4,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1;SHANK3;EPHB2
3176,GO:0006793,0.00472388726111667,0.996189877043241,281,2364,phosphorus metabolic process,BP,TNIP1;NT5E;XDH;NOS1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PYGL;WNT7A;PTHLH;MBOAT2;ERCC6;LPCAT4;NEURL1;SNX9;NAPRT;PCK2;DLG4;OBSCN;DLG1;IGFBP4;PITPNM1;PGM1;FKBP1A;DGKA;PSMD2;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRNP;IDH2;SBF1;AGPAT3;SSH1;SCYL1;NME4;PLCH2;MAPKAPK3;SESN2;ACOT7;OSBPL10;BCR;LPCAT1;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;H6PD;ADCY7;PGLS;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;ACOT1;PRKACA;ADARB1;PTPRF;HK1;MAP2K2;STK25;SHANK3;TTC7B;AKT1;CDS2;MDH2;ACOT13;CARD11;IRAK1;APOE;ATP13A2;UAP1;PKN1;WWTR1;CRYL1;TMSB4X;TSPYL2;PRKCZ;FAM20C;DGKQ;MAPK13;PPP2R3B;FZD8;EPHA1;PI4K2A;PTK6;SLC20A1;PFKP;PTPDC1;GRK6;PCSK9;NMRK1;RRAS;PPP1R35;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;GTPBP1;ELOVL1;MAP3K9;OSBPL5;CCND2;PPP1R12C;HMGCL;CCDC88C;PAK1;TSTA3;TTBK2;ISYNA1;ACSF2;TNFSF15;PTDSS2;FARP1;DUSP4;PTPN9;RET;RASGEF1A;GRB10;CEMIP;PKD1;PARP10;DLG3;APLN;PIGQ;GNAI2;PPM1M;HSF1;PPCS;PANK4;NEK9;SRD5A3;SDHA;CTBP1;PTPRU;ADAM8;NEIL1;HMGA2;TOP1;PPP1R14A;PLCB3;CAP1;MYDGF;PIP5K1C;SRC;CBR4;TAZ;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;TALDO1;DUSP6;PMVK;FYN;MPI;SPTLC2;PPM1F;LPAR3;PSMD7;MICAL1;TNFRSF1A;MBOAT7;UCKL1;BRSK1;SSU72;GJC2;ITGA1;PSKH1;NTSR1;MAP3K10;HEXIM1;LHPP;FGFR1;ADNP;GUK1;CDK18;MIF;SOCS2;MTMR4;AMPD2;STK17A;NT5DC2;VPS9D1;TRIB3;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;PIP5KL1;AGPAT4;ULK1;TRIB2;HSPA2;PLCD3;PAK4;TNFRSF19;ACP7;ULK2;SMPD3;ZP3;LRRK1;PNP;FGF2;EHD4;VAPB;MAPK9;MAP3K12;ABHD14B;MYO1D;TAOK1;ABCA7;MLYCD;TGFA;CAMSAP3;IMPACT;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ALDOC;ARHGEF2;AIDA;NDUFS2;OCRL;SRPX2;CEACAM1;PNPLA6;MINK1;LPIN3;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;ADCK2;LDHA;SPRED2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;PODXL2;PPP1R10;ZFYVE21;WDFY2;RASA3;TRAF7
5467,GO:0016358,0.00476617148143272,0.997540619567373,29,164,dendrite development,BP,ZMYND8;NFATC4;DVL1;WNT7A;NEURL1;CRTC1;DLG4;PTPRS;VLDLR;SHANK3;HECW2;FBXW8;APOE;MAP1B;CSMD3;OBSL1;CUL7;FARP1;SHANK2;IL1RAP;RERE;FYN;PAK4;CAMK1;EPHB2;MINK1;ARHGAP44;MAP6;ASAP1
899,GO:0002275,0.00477870067205622,0.996994704381827,55,382,myeloid cell activation involved in immune response,BP,PYGB;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
10412,GO:0043235,0.0048193639162848,0.997421409623811,32,185,receptor complex,CC,ITGB4;MST1R;DLG4;DLG1;ITGA6;VLDLR;LRP5;ACVR2B;ITGB5;EGFR;SHANK3;CARD11;IRAK1;ITPR3;EPHA1;TGFBR2;CD44;RET;SHANK2;DLG3;GRIN3B;GPRC5C;TNFRSF1A;VDR;ITGA1;FGFR1;LRP1;RXRA;EPHB2;CEACAM1;ERBB3;ITGA3
3553,GO:0007595,0.00482401842126973,0.998745556234268,9,32,lactation,BP,XDH;CCND1;NEURL1;XBP1;ATP7B;APLN;VDR;USF2;SOCS2
15781,GO:0072358,0.00487568131341537,0.996791664574251,67,461,cardiovascular system development,BP,ANGPTL4;XDH;PGF;SH2D2A;NFATC4;MAP2K1;ADM2;SHC1;WNT7A;RAPGEF3;LAMA5;FAM129B;LRP5;ACVR2B;XBP1;MMP14;THBS2;ACTA2;EPN1;FBXW8;AKT1;EPN2;APOE;ELK3;ARHGAP22;FZD8;EPHA1;RRAS;TGFBR2;LTBP1;WASF2;PLCG1;SUFU;DDIT3;CUL7;PKD1;APLN;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;ALDH1A2;DNM2;ANXA3;LOXL1;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;CHD7;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;ANXA1;STIM1
4856,GO:0014066,0.00491197460148926,0.99821524669594,14,62,regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;EGFR;PPP2R5B;RGL2;MYDGF;PIP5K1C;FYN;FGFR1;CBL;MAPK3;CEACAM1;CAT;ERBB3
12141,GO:0048199,0.00491817234138713,0.998206740294777,14,64,vesicle targeting, to, from or within Golgi,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
5147,GO:0015672,0.004976878052278,0.997145785694609,39,250,monovalent inorganic cation transport,BP,FHL1;NOS1;KCNG1;SCN8A;SERPINE2;DLG1;SLC2A9;PRNP;SLC12A7;ATF4;HECW2;AKT1;TMSB4X;SLC20A1;PCSK9;TMCO3;STK39;PRSS8;SLC38A10;STOM;ASIC1;SLC12A4;SLC13A3;VAMP2;GLRX;DNM2;NDUFA4L2;SLC33A1;GAL;SLC13A5;VPS9D1;TCIRG1;P2RX4;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;TGFB1;SLC15A1
9726,GO:0038132,0.0049783424173055,0.999849959732841,3,4,neuregulin binding,MF,ITGB4;ITGA6;ERBB3
6291,GO:0019898,0.00500045378252779,0.997314496842849,32,189,extrinsic component of membrane,CC,EPN3;SNX9;DLG4;SERPINE2;FKBP1A;PRNP;SNX33;PTK6;PCSK9;SEC23A;STK39;PRSS8;ESYT2;ATG13;FARP1;GNB1;SYTL1;CYTH3;GNAI2;ALOX15B;NUMB;SRC;NUCB1;RGS19;FYN;MGLL;WDFY3;ULK1;MYZAP;PIK3R2;ANXA1;GNAS
13968,GO:0060627,0.00500544813918007,0.996891923693107,52,345,regulation of vesicle-mediated transport,BP,TSPAN1;RAC2;SORL1;SDC1;MAP2K1;DLG4;RAB3B;BCR;EVI5L;TUB;MAP2K2;SNX33;APOE;ATP13A2;VPS11;VPS4A;PCSK9;SEPT5;MSN;DKK1;TBC1D16;TBC1D14;BIN1;TBC1D9B;SYTL1;RAB29;APLN;VAMP2;SRC;LDLRAP1;DNM2;LRSAM1;NCS1;STXBP1;RAB25;MICAL1;LRP1;SMPD3;ZP3;TBC1D20;EHD4;ARAP3;ABCA7;TBC1D2B;HGS;CBL;RAB4B;MAPK3;LLGL1;CEACAM1;TGFB1;ANXA1
3406,GO:0007189,0.00501471128375812,0.998562133052507,10,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ADM2;PTHLH;ADGRF1;ADCY7;MC1R;GNB1;GSK3A;ADCY6;GNAS
3244,GO:0006903,0.00502135015495275,0.998014757983785,16,77,vesicle targeting,BP,CTSZ;SEPT5;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;SNAP29;TRAPPC1;CSNK1D;CD59;PPP6R1
7769,GO:0032280,0.0050381023408042,0.999847477688506,3,4,symmetric synapse,CC,NLGN2;NTSR1;ARFGEF2
7340,GO:0031345,0.00504387131744256,0.997615691316017,23,124,negative regulation of cell projection organization,BP,NFATC4;PTPRS;PRNP;SEMA3F;EVI5L;MAP4K4;APOE;CTSZ;GDI1;SEMA4B;PTPN9;RAB29;DNM2;FYN;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ADCY6;ITGA3;RAP1GAP2;ASAP1
12788,GO:0051044,0.00505950034981129,0.999344272156794,5,12,positive regulation of membrane protein ectodomain proteolysis,BP,SNX9;SNX33;APOE;ADAM8;FURIN
16464,GO:0097107,0.00507377419471327,0.99984599066268,3,4,postsynaptic density assembly,BP,SHANK3;NLGN2;SHANK2
16840,GO:0098698,0.00507377419471327,0.99984599066268,3,4,postsynaptic specialization assembly,BP,SHANK3;NLGN2;SHANK2
15499,GO:0071827,0.00517412442075297,0.998934287806221,7,22,plasma lipoprotein particle organization,BP,PRKACA;P4HB;APOE;PRKACB;ZDHHC8;PLTP;ABCA7
12596,GO:0050731,0.0052289795798892,0.997669456220383,20,105,positive regulation of peptidyl-tyrosine phosphorylation,BP,ERCC6;NEURL1;DLG4;PRNP;DGKQ;PTK6;CD44;DLG3;HSF1;SRC;FYN;TNFRSF1A;ADNP;MIF;LRRK1;EHD4;TGFA;ARHGEF2;TGFB1;ERBB3
11072,GO:0045055,0.00525194051940633,0.996485031350044,71,514,regulated exocytosis,BP,PYGB;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;SNPH;BCR;RAB31;LPCAT1;SERPING1;TMSB4X;AP2A2;GALNS;CTSZ;PI4K2A;SEPT5;SERPINB6;CD44;SURF4;STOM;SYTL1;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;PIP5K1C;APLP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;MICAL1;ANXA3;BRPF3;TIMP1;LGALS3BP;MIF;TCIRG1;HPSE;ZP3;PNP;ARG1;VEGFB;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;ECM1;CD59;TGFB1;MANF;CAT;RAB6A;ERP44
12332,GO:0048667,0.00532288397481049,0.996595999255543,58,387,cell morphogenesis involved in neuron differentiation,BP,SH3KBP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;DLG4;PTPRS;SSH1;FAM129B;SEMA3F;VLDLR;ADARB1;STK25;SHANK3;HECW2;FBXW8;APOE;MAP1B;LAMB2;GDI1;LIMK1;OBSL1;PLCG1;TWF2;PAK1;SEMA4B;CUL7;TUBB3;FARP1;RET;GRB10;SHANK2;GATA3;NUMB;SRC;DNM2;RERE;STXBP1;FYN;LPAR3;KIF13B;BRSK1;SEMA4G;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;EPHB2;MAPK3;NTNG1;LLGL1;MINK1;ARHGAP44;MAP6
12897,GO:0051208,0.00533445824944303,0.997954720492076,15,70,sequestering of calcium ion,BP,NOS1;F2R;FKBP1A;PRKACA;ATP7B;ITPR3;PLCG1;DDIT3;CEMIP;NTSR1;TPCN1;FGF2;CHD7;TGFB1;RASA3
12823,GO:0051098,0.00535565012280846,0.996824615195173,43,282,regulation of binding,BP,MDFI;SORL1;CTNNBIP1;NFATC4;DVL1;FKBP1A;FAM129B;CSNK1E;PRKACA;PTPRF;AKT1;APOE;TMSB4X;RFNG;CTSZ;PCSK9;DKK1;PPARA;LARP6;TTBK2;DDIT3;PKD1;GATA3;HSF1;HMGA2;SRC;LDLRAP1;STPG1;RSF1;ADNP;MFNG;STUB1;MAU2;TRIB3;ZFPM1;LRP1;CAMK1;GAS8;MAPK3;AIDA;ADAM15;TGFB1;EP300
12395,GO:0048771,0.00536023095640181,0.997665653941045,19,97,tissue remodeling,BP,F2R;RAC2;CST3;BCR;LRP5;ACVR2B;EGFR;MMP14;ADAM8;SRC;TGM2;VDR;LRRK1;CHD7;ARG1;TMBIM1;CEACAM1;TGFB1;ANXA1
10529,GO:0043434,0.00539464547892723,0.996742417883393,46,299,response to peptide hormone,BP,SHC1;PCK2;BSG;SESN2;RAB31;LRP5;ADCY7;XBP1;PRKACA;AKT1;PRKCZ;PCSK9;HADH;PPARA;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;HSF1;EIF4EBP1;VAMP2;SRC;GSK3A;FYN;GAL;GNB2;TIMP1;SOCS2;ADIPOR1;TRIB3;TCIRG1;SLC27A1;ARG1;BAIAP2L1;ATP6V1C2;SOCS7;MAPK3;CEACAM1;ADCY6;TGFB1;CAT;PIK3R2;ANXA1;PXN
3710,GO:0008219,0.00541312255950797,0.995774547298299,192,1571,cell death,BP,ANGPTL4;XDH;SH3KBP1;CHAC1;H1F0;F2R;MST1R;RBCK1;SORL1;NFATC4;MAP2K1;SHC1;PYGL;WNT7A;ERCC6;CST3;NEURL1;BOK;SHARPIN;MEF2D;OBSCN;DAP;IFI6;DNMT3A;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;SSH1;NME4;FAM129B;LCN2;G0S2;CTSB;TMEM214;NACC2;MARK4;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MKNK2;ADARB1;MAP2K2;PPP1R13L;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;PEG3;BAG3;APOE;ATP13A2;ARG2;PKN1;SYVN1;TNS4;RABGGTA;PRKCZ;CTSZ;EPHA1;UACA;PCSK9;ENDOG;HS1BP3;TGFBR2;STK39;DKK1;SOX7;BNIP3L;PPARA;KDELR1;PRSS8;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;GNB1;SATB1;RET;RAB29;IFI27;GATA3;GSDMA;HSF1;ALOX15B;WFS1;ADAM8;RGL2;HMGA2;TOP1;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;C6ORF120;GSK3A;STXBP1;PCSK6;DUSP6;FYN;ASNS;PPM1F;GRINA;NISCH;MICAL1;TNFRSF1A;WISP1;VDR;ELMO3;PLEKHG5;MOAP1;GAL;ITGA1;SHISA5;CTSL;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;TRIB3;NDOR1;LRP1;PAK4;TNFRSF19;P2RX4;FGF2;MAPK9;SHB;MAP3K12;TAOK1;APBB1;SLIT3;GSDMC;IMPACT;KLK6;CASP4;EPHB2;KRT23;CBL;CIB1;PACS2;MAPK3;KANK2;DRAM2;GLO1;FURIN;ARHGEF2;TMBIM1;MINK1;TFPT;ITSN1;TGFB1;TM2D1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;EP300;TRAF7
7480,GO:0031639,0.00545534021911756,0.999279701430121,5,12,plasminogen activation,BP,PLAT;SERPINE2;CTSZ;F12;PLGRKT
3795,GO:0008361,0.00546343488832629,0.997400672501916,23,123,regulation of cell size,BP,PTPRS;SEMA3F;SLC12A7;SHANK3;AKT1;APOE;MSN;MAP1B;GDI1;LIMK1;WDTC1;TWF2;PAK1;SEMA4B;RET;SLC12A4;DNM2;LPAR3;SEMA4G;ADNP;LRRC8A;ULK2;RAP1GAP2
11832,GO:0046710,0.00551154198320794,0.999270433307376,5,12,GDP metabolic process,BP,DLG4;DLG1;CARD11;DLG3;GUK1
5667,GO:0016773,0.00552541602610423,0.996191037446775,82,580,phosphotransferase activity, alcohol group as acceptor,MF,CCND1;MST1R;LTBP4;MAP2K1;OBSCN;DGKA;RPS6KA2;SCYL1;MAPKAPK3;BCR;MARK4;ACVR2B;MAP4K4;EGFR;CSNK1E;MKNK2;PRKACA;HK1;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;FAM20C;DGKQ;MAPK13;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;NADK;PRKACB;LTBP1;MAP3K9;PAK1;TTBK2;RET;PANK4;NEK9;HMGA2;TOP1;PIP5K1C;SRC;CDC42BPB;MARK3;STK24;PAK6;GSK3A;FYN;BRSK1;PSKH1;MAP3K10;CRIM1;FGFR1;CDK18;STK17A;PIP5KL1;ULK1;PAK4;ULK2;LRRK1;FGF2;MAPK9;MAP3K12;TAOK1;TRPT1;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;MINK1;ADCK2;PIK3R2;ERBB3;ZFYVE21
16410,GO:0097006,0.00555020351393041,0.998139313332691,12,52,regulation of plasma lipoprotein particle levels,BP,LMF1;VLDLR;PRKACA;P4HB;APOE;AP2A2;PCSK9;PRKACB;ZDHHC8;LDLRAP1;PLTP;ABCA7
13832,GO:0060401,0.00555527617007138,0.997637119202814,18,90,cytosolic calcium ion transport,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;FAM155B;FYN;NTSR1;TPCN1;P2RX4;FGF2;CHD7;TGFB1;RASA3
12140,GO:0048194,0.00555983514376347,0.997855296330123,15,71,Golgi vesicle budding,BP,CTSZ;SEC23A;RAB1B;STX5;MCFD2;SEC24C;USO1;TBC1D20;VAPB;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1
6070,GO:0019216,0.00559308783373118,0.99672315261014,41,260,regulation of lipid metabolic process,BP,ANGPTL4;CYP27B1;LMF1;CPT2;NR1D1;G0S2;LPCAT1;AKT1;APOE;DGKQ;TYSND1;PPARA;WDTC1;SIN3B;ALAS1;SRC;LDLRAP1;TAZ;ACADVL;PMVK;TNFRSF1A;VDR;GAL;THRA;MTMR4;STUB1;ADIPOR1;TRIB3;SLC27A1;SMPD3;ZP3;FGF2;MLYCD;RXRA;SEC14L2;LONP2;CEACAM1;TGFB1;PIK3R2;ANXA1;SLC45A3
1966,GO:0004672,0.00562947282169636,0.996247462914597,69,475,protein kinase activity,MF,CCND1;MST1R;LTBP4;MAP2K1;OBSCN;RPS6KA2;SCYL1;MAPKAPK3;BCR;MARK4;ACVR2B;MAP4K4;EGFR;CSNK1E;MKNK2;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;FAM20C;MAPK13;EPHA1;PTK6;GRK6;TGFBR2;LIMK1;STK39;PRKACB;LTBP1;MAP3K9;PAK1;TTBK2;RET;NEK9;HMGA2;TOP1;SRC;CDC42BPB;MARK3;STK24;PAK6;GSK3A;FYN;BRSK1;PSKH1;MAP3K10;CRIM1;FGFR1;CDK18;STK17A;ULK1;PAK4;ULK2;LRRK1;FGF2;MAPK9;MAP3K12;TAOK1;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;MINK1;ADCK2;ERBB3
5326,GO:0016049,0.00566456995816514,0.996457508925374,52,349,cell growth,BP,FHL1;LTBP4;DVL1;CYP27B1;SERPINE2;IGFBP4;DCBLD2;POSTN;NET1;PTPRS;SESN2;SEMA3F;EGFR;MMP14;AKT1;APOE;TSPYL2;PRKCZ;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;SIPA1;TWF2;HTRA1;PAK1;SEMA4B;IGFBP2;DNM2;GSK3A;CLSTN1;LPAR3;WISP1;GAL;CRIM1;SEMA4G;ADNP;HYAL1;SOCS2;ADIPOR1;ULK1;PAK4;ULK2;APBB1;SLIT3;NDRG3;IMPACT;CIB1;ADAM15;CEACAM1;TGFB1
16443,GO:0097061,0.00569078799094912,0.998094885710463,12,50,dendritic spine organization,BP,ZMYND8;DVL1;WNT7A;DLG4;PRNP;SHANK3;APOE;SHANK2;FYN;EPHB2;ARHGAP44;ITGA3
776,GO:0002028,0.00569580760056159,0.997984726929684,13,57,regulation of sodium ion transport,BP,NOS1;SERPINE2;DLG1;HECW2;AKT1;PCSK9;STK39;PRSS8;STOM;GLRX;DNM2;P2RX4;TGFB1
15241,GO:0071377,0.00570451921067641,0.99880281381496,7,22,cellular response to glucagon stimulus,BP,ADCY7;PRKACA;PRKACB;GNB1;GNB2;ARG1;ADCY6
8239,GO:0032994,0.00573296415329311,0.998980067695477,6,18,protein-lipid complex,CC,SORL1;VLDLR;APOE;BIN1;PLTP;PCYOX1
5523,GO:0016486,0.0057502985471696,0.998992694057119,6,17,peptide hormone processing,BP,CTSZ;ERO1B;SCG5;PCSK6;PCSK1N;FURIN
20054,GO:2000641,0.00575079660733157,0.998992587986733,6,17,regulation of early endosome to late endosome transport,BP,MAP2K1;MAP2K2;VPS11;MSN;SRC;MAPK3
12875,GO:0051174,0.00577943777689358,0.995596264213279,154,1211,regulation of phosphorus metabolic process,BP,TNIP1;XDH;NOS1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;ITGA6;RAPGEF3;PRNP;MAPKAPK3;SESN2;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;FAM20C;DGKQ;PPP2R3B;FZD8;EPHA1;PTK6;RRAS;PPP1R35;TGFBR2;STK39;DKK1;PPP2R5B;PPARA;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PPP1R12C;CCDC88C;PAK1;TNFSF15;FARP1;DUSP4;RET;GRB10;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;PPP1R14A;CAP1;MYDGF;SRC;TAZ;STK24;PAK6;GSK3A;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;ITGA1;NTSR1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;MTMR4;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;HSPA2;PAK4;TNFRSF19;ZP3;LRRK1;FGF2;EHD4;VAPB;MAP3K12;MYO1D;TAOK1;ABCA7;TGFA;CAMSAP3;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ARHGEF2;AIDA;SRPX2;CEACAM1;MINK1;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;WDFY2;TRAF7
4808,GO:0012501,0.00583243971277484,0.995464251117036,182,1485,programmed cell death,BP,ANGPTL4;XDH;SH3KBP1;CHAC1;H1F0;F2R;MST1R;RBCK1;NFATC4;MAP2K1;SHC1;PYGL;WNT7A;ERCC6;CST3;NEURL1;BOK;SHARPIN;MEF2D;OBSCN;DAP;IFI6;DNMT3A;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;NME4;FAM129B;LCN2;G0S2;CTSB;TMEM214;NACC2;MARK4;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MKNK2;ADARB1;MAP2K2;PPP1R13L;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;PEG3;BAG3;APOE;ARG2;PKN1;SYVN1;TNS4;RABGGTA;PRKCZ;CTSZ;EPHA1;UACA;PCSK9;ENDOG;HS1BP3;TGFBR2;STK39;DKK1;SOX7;BNIP3L;KDELR1;PRSS8;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;GNB1;SATB1;RET;IFI27;GATA3;GSDMA;HSF1;ALOX15B;WFS1;ADAM8;RGL2;HMGA2;TOP1;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;C6ORF120;GSK3A;STXBP1;PCSK6;DUSP6;FYN;ASNS;PPM1F;GRINA;NISCH;MICAL1;TNFRSF1A;VDR;ELMO3;PLEKHG5;MOAP1;GAL;ITGA1;SHISA5;CTSL;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;TRIB3;LRP1;PAK4;TNFRSF19;P2RX4;MAPK9;SHB;MAP3K12;TAOK1;APBB1;SLIT3;GSDMC;CASP4;EPHB2;KRT23;CBL;CIB1;PACS2;MAPK3;KANK2;DRAM2;GLO1;FURIN;ARHGEF2;TMBIM1;MINK1;TFPT;ITSN1;TGFB1;TM2D1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;EP300;TRAF7
2441,GO:0005640,0.00586903634588492,0.998967348383017,6,17,nuclear outer membrane,CC,BOK;SYNE3;ITPR3;RETSAT;CPTP;SIGMAR1
12295,GO:0048589,0.00587149423675187,0.996210149209901,59,398,developmental growth,BP,ERCC1;DVL1;WNT7A;ERCC6;POSTN;PTPRS;WWC3;BBS2;SEMA3F;ACVR2B;ADARB1;PPP1R13L;SHANK3;AKT1;APOE;WWTR1;PRKCZ;SH3PXD2B;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;WDTC1;TWF2;PAK1;SEMA4B;GAMT;SHANK2;GATA3;HSF1;RAI1;ARID5B;DNM2;GSK3A;DUSP6;AGRN;LPAR3;GAL;SEMA4G;FGFR1;ADNP;SOCS2;PTPN12;ULK1;ULK2;ZP3;FGF2;CHD7;SLIT3;RXRA;IMPACT;KLK6;ADAM15;APBA1;TGFB1;ANXA1;GNAS;THBS3
990,GO:0002444,0.00587712750676125,0.996262256351682,55,386,myeloid leukocyte mediated immunity,BP,PYGB;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
3065,GO:0006629,0.00589081521155459,0.995627057324106,126,977,lipid metabolic process,BP,ANGPTL4;SORL1;SDC1;SERINC2;MBOAT2;CYP27B1;LPCAT4;LMF1;PCK2;CPT2;NR1D1;PITPNM1;DGKA;SBF1;PC;AGPAT3;PLCH2;CYGB;G0S2;SESN2;ACOT7;OSBPL10;LPCAT1;VLDLR;LRP5;XBP1;EGFR;LRP10;ACOT1;CCDC71L;CRAT;TTC7B;AKT1;CDS2;GPC4;APOE;CRYL1;DGKQ;PI4K2A;RETSAT;PCSK9;ACAD10;TYSND1;PLD3;HADH;PLCXD1;PPARA;WDTC1;ESYT2;PLCG1;ELOVL1;OSBPL5;HMGCL;ISYNA1;ACSF2;PTDSS2;FUCA1;PIGQ;SIN3B;ALOX15B;SRD5A3;ALAS1;PLCB3;PIP5K1C;ALDH1A2;SRC;LDLRAP1;CBR4;TAZ;CPTP;ACADVL;PMVK;FYN;SPTLC2;AGRN;TNFRSF1A;HSD11B1;MBOAT7;VDR;GAL;COMT;THRA;PLTP;MGLL;FGFR1;MIF;MTMR4;STUB1;ADIPOR1;TRIB3;PITPNM2;SLC27A1;ST3GAL5;PIP5KL1;AGPAT4;LRP1;PLCD3;SMPD3;ZP3;FGF2;VAPB;MLYCD;PHYH;RXRA;SEC14L2;ARSK;LONP2;GGT1;MAPK3;CPT1B;UGCG;B4GALT6;OCRL;CEACAM1;PNPLA6;LPIN3;NAGA;TGFB1;CAT;PIK3R2;STARD10;ERBB3;ANXA1;ARSD;SLC45A3;ZFYVE21
9533,GO:0036230,0.005894452057646,0.996301224971023,52,362,granulocyte activation,BP,PYGB;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
17718,GO:1901575,0.00592698373786081,0.995350677177624,196,1628,organic substance catabolic process,BP,NT5E;EDEM1;XDH;BTBD2;PYGB;CBS;NOS1;CHAC1;H1F0;GID4;CAPN2;RBCK1;SORL1;SDC1;DVL1;PYGL;CST3;CYP27B1;SNX9;SHARPIN;PCK2;CPT2;SERPINE2;NR1D1;PGM1;PSMD2;MTA1;RAPGEF3;BNIP3;SMURF2;PLCH2;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;HAGH;USP20;LPCAT1;VLDLR;LRP5;GPT2;XBP1;EGFR;CSNK1E;PANO1;PRKACA;CRAT;HK1;HECW2;SNX33;AKT1;GPC4;ALDH1L2;APOE;ATP13A2;ARG2;SYVN1;WWTR1;CRYL1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;PFKP;TMEM129;FBXO2;PCSK9;ENDOG;FBXW5;ACAD10;TYSND1;MSN;PLD3;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;PPARA;DHTKD1;TST;CDC34;CD44;PLCG1;GTPBP1;IDE;DEDD2;ANKIB1;HMGCL;SUFU;AHCY;CTBS;DDIT3;GLUL;CUL7;GGA3;GGA1;ADAMTS7;FUCA1;DNASE1L1;PCBP4;CEMIP;PKD1;UBXN4;GGACT;GLUD1;HSF1;WFS1;SRD5A3;ADAM8;NEIL1;BLMH;PLCB3;GIPC1;UBR4;AGO4;LRSAM1;ACADVL;STX5;GSK3A;FYN;ISG20;AGRN;GALE;RMND5A;ALDH4A1;PSMD7;ALDH7A1;HSD11B1;FBXL15;ABHD17C;PUM1;RNF44;CTSL;COMT;TNRC6B;THRA;NTSR1;TIMP1;UBA1;MGLL;RNF187;HYAL1;VPS37A;STUB1;TRIB3;TCIRG1;SNX25;RMND5B;RAD23A;LRP1;TRIB2;AOX1;PLCD3;HPSE;SAMD4B;SMPD3;PNP;FGF2;RNH1;PYM1;RNF222;ENTPD6;MLYCD;PHYH;ARG1;SPSB3;RPL28;CNOT11;LONP2;HGS;CARHSP1;CBL;GGT1;USP32;CPT1B;POMT1;CSNK1D;DNAJB9;ALDOC;FURIN;RNF103;HM13;CEACAM1;PNPLA6;LPIN3;NAGA;IGF2BP3;TGFB1;PCYOX1;LDHA;AZIN2;APOBEC3C
14964,GO:0070838,0.00598862518771418,0.99652756484956,39,245,divalent metal ion transport,BP,NOS1;F2R;CYP27B1;FKBP1A;PRNP;PRKACA;EHD3;ATP13A2;ITPR3;ORAI1;PLCG1;DDIT3;CEMIP;PKD1;NIPA1;GNAI2;GRIN3B;ASIC1;WFS1;FAM155B;SARAF;NCS1;FYN;LPAR3;VDR;GJC2;NTSR1;ATP2C2;TPCN1;HSPA2;P2RX4;FGF2;CHD7;HOMER2;SLC30A1;TGFB1;ORAI3;STIM1;RASA3
7369,GO:0031406,0.00603323283538036,0.997268552869675,20,108,carboxylic acid binding,MF,NOS1;PYGL;NAGS;PC;SESN2;AARS;PPARA;CD44;HMGCL;GLUL;CEMIP;ASS1;GRIN3B;GLUD1;P4HA1;AGRN;VDR;HLCS;PHYH;RXRA
3177,GO:0006796,0.00606578762504361,0.995091112024622,272,2292,phosphate-containing compound metabolic process,BP,TNIP1;NT5E;XDH;NOS1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PYGL;WNT7A;PTHLH;MBOAT2;ERCC6;LPCAT4;NEURL1;SNX9;NAPRT;PCK2;DLG4;OBSCN;DLG1;IGFBP4;PITPNM1;PGM1;FKBP1A;DGKA;PSMD2;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRNP;IDH2;SBF1;AGPAT3;SSH1;SCYL1;NME4;PLCH2;MAPKAPK3;SESN2;ACOT7;OSBPL10;BCR;LPCAT1;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;H6PD;ADCY7;PGLS;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;PRKACA;ADARB1;PTPRF;HK1;MAP2K2;STK25;SHANK3;TTC7B;AKT1;CDS2;MDH2;CARD11;IRAK1;APOE;ATP13A2;PKN1;WWTR1;CRYL1;TMSB4X;TSPYL2;PRKCZ;FAM20C;DGKQ;MAPK13;PPP2R3B;FZD8;EPHA1;PI4K2A;PTK6;SLC20A1;PFKP;PTPDC1;GRK6;PCSK9;NMRK1;RRAS;PPP1R35;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;GTPBP1;MAP3K9;OSBPL5;CCND2;PPP1R12C;CCDC88C;PAK1;TTBK2;ISYNA1;TNFSF15;PTDSS2;FARP1;DUSP4;PTPN9;RET;RASGEF1A;GRB10;CEMIP;PKD1;PARP10;DLG3;APLN;PIGQ;GNAI2;PPM1M;HSF1;PPCS;PANK4;NEK9;SRD5A3;SDHA;CTBP1;PTPRU;ADAM8;NEIL1;HMGA2;TOP1;PPP1R14A;PLCB3;CAP1;MYDGF;PIP5K1C;SRC;TAZ;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;TALDO1;DUSP6;PMVK;FYN;MPI;SPTLC2;PPM1F;LPAR3;PSMD7;MICAL1;TNFRSF1A;MBOAT7;UCKL1;BRSK1;SSU72;GJC2;ITGA1;PSKH1;NTSR1;MAP3K10;HEXIM1;LHPP;FGFR1;ADNP;GUK1;CDK18;MIF;SOCS2;MTMR4;AMPD2;STK17A;NT5DC2;VPS9D1;TRIB3;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;PIP5KL1;AGPAT4;ULK1;TRIB2;HSPA2;PLCD3;PAK4;TNFRSF19;ACP7;ULK2;SMPD3;ZP3;LRRK1;PNP;FGF2;EHD4;VAPB;MAPK9;MAP3K12;ABHD14B;MYO1D;TAOK1;ABCA7;TGFA;CAMSAP3;IMPACT;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ALDOC;ARHGEF2;AIDA;NDUFS2;OCRL;SRPX2;CEACAM1;PNPLA6;MINK1;LPIN3;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;ADCK2;LDHA;SPRED2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;PODXL2;PPP1R10;ZFYVE21;WDFY2;RASA3;TRAF7
8902,GO:0034713,0.00611929611213981,0.999443882479712,4,8,type I transforming growth factor beta receptor binding,MF,FKBP1A;TGFBR2;SNX25;TGFB1
68,GO:0000139,0.00613546887066238,0.995758803904659,81,585,Golgi membrane,CC,EDEM1;ASAP2;SORL1;QSOX1;AP3D1;BOK;ARAP1;BSG;PITPNM1;AGPAT3;RAB43;COPG1;MARCH9;RAB31;CHPF;LPCAT1;XYLT1;EGFR;XYLT2;STK25;AP1B1;YIF1A;ATP7B;RFNG;CTSZ;SEC23A;B4GALNT4;NDST2;KDELR1;SURF4;MALL;CORO7;CYTH3;TMED3;PKD1;DOPEY2;B4GALT2;B3GNT3;DNM2;NUCB1;RAB1B;STX5;COG8;CLSTN1;TNFRSF1A;SLC33A1;STX10;CHST14;MCFD2;SLC35B4;SEC24C;ATP2C2;MFNG;ST3GAL3;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;USO1;SMPD3;TBC1D20;ST6GALNAC2;VAPB;COG1;ABCA7;LMAN1;ENTPD6;TGFA;SNAP29;TRAPPC1;CSNK1D;LITAF;FURIN;UGCG;LLGL1;B4GALT6;GALNT3;CD59;PPP6R1;RAB6A;ARCN1
609,GO:0001775,0.00624849159921032,0.995431048009509,112,865,cell activation,BP,PYGB;ERCC1;F2R;RAC2;PYGL;QSOX1;WNT7A;CST3;AP3D1;NAPRT;SERPINE2;DLG1;PGM1;FKBP1A;DGKA;PSMD2;CKAP4;PRSS3;PRNP;CD68;CYGB;LCN2;CTSB;BCR;RAB31;LPCAT1;XBP1;CMTM7;EGFR;MMP14;AKT1;CARD11;APOE;ARG2;PKN1;AP2A2;PRKCZ;GALNS;ITPR3;POU2F2;DGKQ;FZD8;CTSZ;PI4K2A;MSN;TGFBR2;SERPINB6;KDELR1;CD44;SURF4;PAK1;RAG1;STOM;GNB1;SATB1;FUCA1;RAB29;DNASE1L1;ATP11A;GATA3;ARL8A;SLC2A3;ADAM8;IGFBP2;CAP1;VAMP2;SRC;UBR4;C6ORF120;STXBP1;PAG1;FYN;YPEL5;PSMD7;ANXA3;KIF13B;GAL;TIMP1;LRRC8A;MFNG;MIF;TCIRG1;ZFPM1;LRP1;P2RX4;HPSE;ZP3;PNP;CHD7;ARG1;VAT1;SNAP29;POLM;MYL9;CBL;TRAPPC1;RAB4B;MAPK3;DNAJB9;ALDOC;SNX27;TMBIM1;CEACAM1;SKAP2;CD59;TGFB1;CAT;ANXA1;RAB6A;GNAS;EP300;ERP44
2555,GO:0005829,0.00628619582559778,0.994736822443925,463,4102,cytosol,CC,TNIP1;NT5E;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;CBS;ERCC1;NOS1;CHAC1;CCND1;CAPN2;MPRIP;RAC2;RBCK1;ASAP2;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PYGL;PTHLH;SNX9;NAPRT;SHARPIN;CRTC1;PCK2;ARAP1;DLG4;OBSCN;SERPINE2;KLC2;DLG1;TRIM65;XPOT;PITPNM1;PGM1;FKBP1A;DGKA;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;PRNP;IDH2;SBF1;PC;SSH1;WWC3;SCYL1;SMURF2;C2CD2;COPG1;CYGB;FAM129B;MAPKAPK3;SESN2;ACOT7;ABTB1;TNNT1;TMEM214;BBS2;HAGH;OSBPL10;USP20;BCR;RAB31;CHPF;MARK4;AARS;ADCY7;PGLS;CSNK1E;ACOT1;MMP14;FYCO1;ARHGAP23;PRKACA;ADARB1;FCHO1;CARS;CORO1B;TUB;JOSD2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;TUBG2;PARVB;SHANK3;TTC7B;FBXW8;PSAT1;SNX33;AKT1;ACOT13;CARD11;IRAK1;ARPC1A;EPN2;BAG3;EHD3;FMNL2;ARG2;UAP1;RIN2;PKN1;AP1B1;TNS4;WWTR1;CRYL1;RABGGTA;TMSB4X;AP2A2;PRKCZ;RNF135;DGKQ;MAPK13;ARHGAP22;VPS4A;HIST2H2BE;PI4K2A;UACA;PTK6;PFKP;FBXO2;ENDOG;FBXW5;FERMT1;GIT2;NMRK1;SEC23A;MSN;MAP1B;TGFBR2;GDI1;MVB12B;RIN1;SERPINB6;LIMK1;STK39;PPP2R5B;BNIP3L;DHTKD1;NADK;AKAP12;SYMPK;OBSL1;PRKACB;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;GTPBP1;OSBPL5;IDE;MSRB2;TBC1D14;TFE3;PRDX5;CCND2;CMIP;GIT1;BIN1;FSCN1;HTRA1;SUFU;PAK1;SP6;TSTA3;TTBK2;RHPN1;ISYNA1;AHCY;DTD1;UBXN7;TNRC18;BAZ2A;GAMT;DDIT3;GLUL;BCDIN3D;CUL7;ARHGAP39;FARP1;GNB1;DOCK9;RET;RAB29;RASGEF1A;CORO7;RHOC;GRB10;CYTH3;PCBP4;SHANK2;ASS1;PARP10;DLG3;NUCB2;GSDMA;UBXN4;DCAF7;DOPEY2;OASL;DOCK6;GNAI2;HSF1;APPL2;PPCS;ANKS1A;ALOX15B;NEK9;SH3GLB2;CNDP2;MT2A;CTBP1;CDCA7L;ALAS1;C19ORF33;RHOBTB2;PPP1R14A;BLMH;ARL2;PLCB3;ARHGEF4;PLIN3;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;ALDH1A2;SRC;LDLRAP1;CHMP5;DENND2A;GLRX;POLD4;TAZ;TGM2;DNM2;NINL;UBR4;AGO4;FAM162A;IRF7;LRSAM1;RFXANK;RAB1B;NCS1;MARK3;STK24;CPTP;ACADVL;CARD19;STX5;SDCCAG8;GARS;EXOC2;GSK3A;STXBP1;SPECC1L;SH3BP1;TALDO1;DUSP6;PMVK;OAS1;FYN;MPI;AGRN;ASNS;PPM1F;RALGDS;GALE;PFN1;NISCH;PSMD7;MICAL1;KIF17;ALDH7A1;THOP1;ANXA3;WISP1;FBXL15;BRPF3;KIF13B;PLEKHG5;UCKL1;SSU72;STX10;MOAP1;PUM1;GNB2;RAI14;COMT;TNRC6B;THRA;EIF2S2;UBA1;MGLL;RNF187;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;MIF4GD;MIB2;CEP170;GUK1;MIF;SOCS2;MTMR4;ASB13;VPS37A;AMPD2;BCL2L1;STUB1;TRIB3;AFAP1;ANGEL1;PITPNM2;PTPN12;SLC27A1;ARFIP2;HLCS;PRRC2A;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;ULK1;HSPA2;AOX1;PLCD3;MGRN1;SAMD4B;USO1;ULK2;LRRK1;SPIRE1;PNP;MAP1LC3B;RNH1;MAPK9;SHB;PYM1;MAP3K12;VASP;ABHD14B;HSPA13;ARAP3;MYO1D;ATXN10;TAOK1;ZNF687;MLYCD;RHOBTB1;EPS8L1;HOMER2;UNC45A;ARG1;PBXIP1;TBC1D2B;SPSB3;TAF6;NDE1;RPL28;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;WIPF1;NOL4L;CASP4;ACY1;SNAP29;EPHB2;KRT23;HGS;CARHSP1;DRG2;MYL9;CBL;TRAPPC1;SOCS7;USP32;MAPK3;MAPK10;CSNK1D;LITAF;ALDOC;GLO1;S100A16;ARHGEF2;SNX27;OCRL;APBA1;MINK1;SKAP2;ARHGAP44;AGAP1;UROS;ADCY6;IGF2BP3;CCNE1;EIF4G3;GRIP2;ITSN1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;ANXA1;RAB6A;GNAS;ZFYVE21;KLF12;CCDC113;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;TCF7L1;RAP1GAP2;MZT2B;RASA3;ASAP1;FHOD1
502,GO:0001558,0.00642041352239107,0.996127006085839,44,289,regulation of cell growth,BP,FHL1;LTBP4;CYP27B1;SERPINE2;IGFBP4;DCBLD2;NET1;PTPRS;SESN2;SEMA3F;EGFR;MMP14;AKT1;APOE;TSPYL2;MAP1B;GDI1;LIMK1;SIPA1;TWF2;HTRA1;PAK1;SEMA4B;IGFBP2;DNM2;GSK3A;CLSTN1;LPAR3;WISP1;GAL;CRIM1;SEMA4G;ADNP;HYAL1;SOCS2;ADIPOR1;ULK2;APBB1;SLIT3;NDRG3;CIB1;ADAM15;CEACAM1;TGFB1
6055,GO:0019199,0.00642481656922539,0.997814076082819,12,50,transmembrane receptor protein kinase activity,MF,MST1R;LTBP4;ACVR2B;EGFR;EPHA1;TGFBR2;LTBP1;RET;CRIM1;FGFR1;EPHB2;ERBB3
6747,GO:0030163,0.00643277624780309,0.995390305113236,98,742,protein catabolic process,BP,EDEM1;BTBD2;GID4;CAPN2;RBCK1;SORL1;DVL1;CST3;SNX9;SHARPIN;SERPINE2;NR1D1;PSMD2;MTA1;BNIP3;SMURF2;CTSB;ABTB1;USP20;LPCAT1;VLDLR;XBP1;EGFR;CSNK1E;PANO1;PRKACA;HECW2;SNX33;AKT1;APOE;ATP13A2;SYVN1;WWTR1;AP2A2;VPS11;VPS4A;CTSZ;TMEM129;FBXO2;PCSK9;FBXW5;MSN;MVB12B;UBE2J1;ARRDC1;BNIP3L;CDC34;IDE;ANKIB1;SUFU;DDIT3;CUL7;GGA3;GGA1;ADAMTS7;PKD1;UBXN4;WFS1;ADAM8;GIPC1;UBR4;LRSAM1;STX5;GSK3A;FYN;RMND5A;PSMD7;FBXL15;ABHD17C;RNF44;CTSL;TIMP1;UBA1;RNF187;VPS37A;STUB1;TRIB3;TCIRG1;RMND5B;RAD23A;LRP1;TRIB2;HPSE;RNF222;SPSB3;LONP2;HGS;CBL;USP32;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;HM13;CEACAM1;PCYOX1;AZIN2
15831,GO:0072511,0.00643645046629798,0.996249723886009,39,246,divalent inorganic cation transport,BP,NOS1;F2R;CYP27B1;FKBP1A;PRNP;PRKACA;EHD3;ATP13A2;ITPR3;ORAI1;PLCG1;DDIT3;CEMIP;PKD1;NIPA1;GNAI2;GRIN3B;ASIC1;WFS1;FAM155B;SARAF;NCS1;FYN;LPAR3;VDR;GJC2;NTSR1;ATP2C2;TPCN1;HSPA2;P2RX4;FGF2;CHD7;HOMER2;SLC30A1;TGFB1;ORAI3;STIM1;RASA3
5481,GO:0016411,0.00645875831832947,0.998611587746463,7,22,acylglycerol O-acyltransferase activity,MF,MBOAT2;LPCAT4;AGPAT3;LPCAT1;TAZ;MBOAT7;AGPAT4
4412,GO:0010165,0.00646747291354441,0.998227465848952,9,33,response to X-ray,BP,ERCC1;CCND1;ERCC6;CCND2;GATA3;HMGA2;DNM2;ANXA1;IKBIP
6074,GO:0019220,0.00656454613553494,0.9949858157742,152,1198,regulation of phosphate metabolic process,BP,TNIP1;XDH;NOS1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;ITGA6;RAPGEF3;PRNP;MAPKAPK3;SESN2;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TMSB4X;TSPYL2;PRKCZ;DGKQ;PPP2R3B;FZD8;EPHA1;PTK6;RRAS;PPP1R35;TGFBR2;STK39;DKK1;PPP2R5B;PPARA;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PPP1R12C;CCDC88C;PAK1;TNFSF15;FARP1;DUSP4;RET;GRB10;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;PPP1R14A;CAP1;MYDGF;SRC;TAZ;STK24;PAK6;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;ITGA1;NTSR1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;MTMR4;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;HSPA2;PAK4;TNFRSF19;ZP3;LRRK1;FGF2;EHD4;VAPB;MAP3K12;MYO1D;TAOK1;ABCA7;TGFA;CAMSAP3;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ARHGEF2;AIDA;SRPX2;CEACAM1;MINK1;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;WDFY2;TRAF7
12900,GO:0051216,0.00662564606152224,0.996981264062819,20,104,cartilage development,BP,WNT7A;PTHLH;MEF2D;BBS2;TGFBR2;CREB3L2;CD44;ADAMTS7;PKD1;HMGA2;WNT5B;THRA;TIMP1;FGFR1;HYAL1;FGF2;MAPK3;TGFB1;GNAS;THBS3
8122,GO:0032802,0.00673961768174869,0.999032084941664,5,13,low-density lipoprotein particle receptor catabolic process,BP,VLDLR;APOE;AP2A2;PCSK9;FURIN
10373,GO:0043177,0.00674514157853942,0.99691131778743,20,109,organic acid binding,MF,NOS1;PYGL;NAGS;PC;SESN2;AARS;PPARA;CD44;HMGCL;GLUL;CEMIP;ASS1;GRIN3B;GLUD1;P4HA1;AGRN;VDR;HLCS;PHYH;RXRA
17748,GO:1901653,0.00678546476430538,0.99600204336795,40,256,cellular response to peptide,BP,SHC1;PCK2;PRNP;RAB31;ADCY7;XBP1;PRKACA;AKT1;PRKCZ;PCSK9;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;HSF1;EIF4EBP1;VAMP2;SRC;GSK3A;FYN;GNB2;SOCS2;ADIPOR1;TRIB3;TCIRG1;LRP1;ARG1;BAIAP2L1;ATP6V1C2;CASP4;SOCS7;MAPK3;ARHGEF2;CEACAM1;ADCY6;TGFB1;PIK3R2;PXN
5270,GO:0015914,0.00680514972669476,0.997791377354314,11,46,phospholipid transport,BP,PITPNC1;PITPNM1;OSBPL10;APOE;OSBPL5;ATP11A;CPTP;PLTP;PITPNM2;ABCA7;STARD10
4649,GO:0010769,0.00690819747526478,0.996160936009608,33,199,regulation of cell morphogenesis involved in differentiation,BP,NFATC4;MAP2K1;WNT7A;POSTN;NET1;PTPRS;SSH1;SEMA3F;FBLN1;STK25;SHANK3;HECW2;FBXW8;APOE;MAP1B;GDI1;LIMK1;OBSL1;TWF2;PAK1;SEMA4B;CUL7;RET;DNM2;LPAR3;KIF13B;SEMA4G;RREB1;ADNP;ULK2;EPHB2;CIB1;ARHGAP44
13049,GO:0051480,0.00691110890140731,0.996518690223002,25,143,regulation of cytosolic calcium ion concentration,BP,NOS1;F2R;BOK;DLG4;FKBP1A;PRNP;PRKACA;ITPR3;PLCG1;DDIT3;GNB1;CEMIP;PKD1;FAM155B;EDNRA;TGM2;FYN;LPAR3;NTSR1;TPCN1;P2RX4;FGF2;CHD7;TGFB1;RASA3
11450,GO:0045861,0.00693174131644549,0.996135761358019,33,212,negative regulation of proteolysis,BP,CHAC1;SORL1;PLAT;CST3;SERPINE2;IFI6;PRNP;PANO1;AKT1;SERPING1;CTSZ;SERPINB6;UBE2J1;CD44;IDE;PRDX5;BIN1;SUFU;RAG1;TFPI2;GIPC1;TNFRSF6B;SRC;APLP2;SPINT2;MICAL1;TIMP1;CRIM1;PCSK1N;FURIN;ECM1;CD59;CAMK2N1
15067,GO:0070997,0.0071193954550087,0.99588590794335,37,235,neuron death,BP,F2R;SORL1;BOK;PRNP;BNIP3;SSH1;AARS;ADARB1;ATF4;AKT1;APOE;ATP13A2;CTSZ;PCSK9;ENDOG;DKK1;PPARA;CDC34;DDIT3;RAB29;GATA3;HSF1;WFS1;ADAM8;FAM162A;STXBP1;FYN;ITGA1;ADNP;SIGMAR1;BCL2L1;LRP1;MAP3K12;KLK6;CBL;ITSN1;ERBB3
11632,GO:0046320,0.00712433301250361,0.998692578067684,6,17,regulation of fatty acid oxidation,BP,AKT1;TYSND1;PPARA;ACADVL;MLYCD;LONP2
9912,GO:0042221,0.00713722080083657,0.994125989527466,323,2783,response to chemical,BP,TNIP1;EDEM1;XDH;PGF;SH3KBP1;ERCC1;NOS1;CHAC1;LTBP2;CCND1;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;DOCK4;WNT7A;ERCC6;CST3;CYP27B1;NEURL1;BOK;SHARPIN;PCK2;BSG;NR1D1;CMTM4;MMP1;MXRA5;IFI6;DNMT3A;FKBP1A;POSTN;PSMD2;RAB3B;ITGA6;NET1;RAPGEF3;PRNP;BNIP3;CD68;LAMA5;SSH1;RAB43;SMURF2;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;SESN2;BBS2;SEMA3F;BCR;RAB31;VLDLR;ETV5;LRP5;ACVR2B;ITGB5;ADCY7;XBP1;MAP4K4;CMTM7;EGFR;MKNK2;MMP14;RFX2;PRKACA;CORO1B;TUB;MAP2K2;STK25;SHANK3;ATF4;P4HB;PDIA5;AKT1;XPC;IFITM1;IRAK1;EPN2;APOE;FAM210B;ATP13A2;SYVN1;YIF1A;TMSB4X;TSPYL2;PRKCZ;ATP7B;FAM20C;ITPR3;DGKQ;MAPK13;PTK6;PFKP;TMEM129;FBXO2;PCSK9;ENDOG;FERMT1;MSN;TGFBR2;LAMB2;GDI1;HADH;EPOR;STK39;DKK1;CREB3L2;PPP2R5B;UBE2J1;BNIP3L;PPARA;PRKACB;LTBP1;SIPA1;WDTC1;CDC34;CD44;DNAJB5;PLCG1;SEC63;IDE;TWF2;PRDX5;FSCN1;HMGCL;HTRA1;PAK1;BCL9L;AHCY;SEMA4B;DDIT3;TNFSF15;GLUL;BCDIN3D;CUL7;TUBB3;ADAMTS7;GNB1;PTPN9;RET;GAS2L1;IFI27;GRB10;GATA3;APLN;UBXN4;OASL;MYOF;GNAI2;FNDC4;HSF1;IL1RAP;WFS1;MT2A;PTPRU;ADAM8;PYCR2;HMGA2;SLC13A3;ARID5B;TOP1;PPP1R14A;BLMH;IGFBP2;MYDGF;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;ALDH1A2;SRC;DNM2;AGO4;FAM162A;IRF7;NUCB1;DNAJC4;PAQR7;STK24;ACADVL;ESRP1;GPX3;GSK3A;STXBP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;ISG20;FUZ;AGRN;ASNS;PPM1F;WNT5B;SLC6A9;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;PLEKHG5;GJC2;GAL;PUM1;ITGA1;SLC13A5;GNB2;CTSL;COMT;THRA;NTSR1;TIMP1;LOXL1;SEMA4G;FGFR1;ADNP;HYAL1;F12;USF2;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;PRAF2;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;NDOR1;SLC6A14;LRP1;ROBO3;HSPA2;PAK4;TNFRSF19;P2RX4;PNP;FGF2;EHD4;VAPB;MAPK9;VASP;HSPA13;CHD7;ENTPD6;APBB1;SLIT3;HOMER2;RXRA;ARG1;VEGFB;BAIAP2L1;ATP6V1C2;IMPACT;BPHL;CASP4;ACY1;LONP2;EPHB2;HGS;CBL;GGT1;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;S100A16;ARHGEF2;RNF103;HM13;CEACAM1;GALNT3;UROS;ECM1;MBD3;SLC30A1;ADCY6;CCNE1;TGFB1;WBP2;MANF;CAT;LDHA;SPRED2;PIK3R2;ANXA1;GNAS;ITGA3;PLGRKT;PXN;EP300;ERP44;STIM1
13054,GO:0051491,0.0071674785629264,0.998427682706335,7,22,positive regulation of filopodium assembly,BP,ZMYND8;NEURL1;ARAP1;ESPN;FSCN1;AGRN;TENM2
6661,GO:0030010,0.00722830038959668,0.996678720742005,20,104,establishment of cell polarity,BP,WNT7A;MARK4;PRKCZ;FERMT1;MSN;MAP1B;FSCN1;PAK1;CYTH3;PKD1;GATA3;MARK3;SDCCAG8;SH3BP1;BRSK1;NDE1;CAMSAP3;ARHGEF2;SNX27;LLGL1
6847,GO:0030308,0.00723833842511886,0.9965233593653,22,122,negative regulation of cell growth,BP,FHL1;CYP27B1;SERPINE2;DCBLD2;PTPRS;SESN2;SEMA3F;TSPYL2;SIPA1;PAK1;SEMA4B;GSK3A;GAL;SEMA4G;HYAL1;ADIPOR1;ULK2;APBB1;SLIT3;NDRG3;ADAM15;TGFB1
9682,GO:0038034,0.00724726772799833,0.997471591535039,12,54,signal transduction in absence of ligand,BP,BOK;IFI6;MKNK2;AKT1;BAG3;RET;GSK3A;FYN;MOAP1;FGFR1;BCL2L1;ERBB3
16514,GO:0097192,0.00724726772799833,0.997471591535039,12,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,BOK;IFI6;MKNK2;AKT1;BAG3;RET;GSK3A;FYN;MOAP1;FGFR1;BCL2L1;ERBB3
15239,GO:0071375,0.00725083840224009,0.995841215420081,36,225,cellular response to peptide hormone stimulus,BP,SHC1;PCK2;RAB31;ADCY7;XBP1;PRKACA;AKT1;PRKCZ;PCSK9;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;HSF1;EIF4EBP1;VAMP2;SRC;GSK3A;FYN;GNB2;SOCS2;ADIPOR1;TRIB3;TCIRG1;ARG1;BAIAP2L1;ATP6V1C2;SOCS7;MAPK3;CEACAM1;ADCY6;TGFB1;PIK3R2;PXN
16797,GO:0098589,0.00728118105279545,0.99589780459493,34,208,membrane region,CC,NOS1;CAPN2;F2R;BSG;DLG1;PRNP;SMURF2;MARVELD1;LY6K;EGFR;PRKACA;HK1;CARD11;PRKCZ;PI4K2A;TGFBR2;MALL;PODXL;STOM;RET;MYOF;GNAI2;SRC;RGS19;PAG1;FYN;TNFRSF1A;ITGA1;NTSR1;HPSE;MYO1D;CBL;MAPK3;FURIN
19608,GO:1990617,0.00728870675751325,1,2,2,CHOP-ATF4 complex,CC,ATF4;DDIT3
12920,GO:0051247,0.00733159543032874,0.994412064121435,145,1151,positive regulation of protein metabolic process,BP,TNIP1;EDEM1;XDH;NOS1;CCND1;F2R;MST1R;SORL1;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;BOK;DLG4;DLG1;DAP;IGFBP4;FKBP1A;MTA1;RAPGEF3;PRNP;SMURF2;MAPKAPK3;LPCAT1;VLDLR;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;PRKACA;MAP2K2;STK25;HECW2;SNX33;AKT1;CARD11;IRAK1;APOE;PKN1;PRKCZ;DGKQ;VPS11;FZD8;EPHA1;PTK6;PCSK9;MSN;TGFBR2;STK39;DKK1;SOX7;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;IDE;ANKIB1;LARP6;CCND2;PAK1;TNFSF15;BCDIN3D;GGA3;GGA1;RET;IFI27;CEMIP;PKD1;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;MYDGF;SRC;FAM162A;RAB1B;STK24;PAK6;STX5;GSK3A;DUSP6;FYN;PPM1F;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;ADNP;F12;MIF;STUB1;TRIB3;SLC27A1;ZFPM1;RAD23A;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;TAOK1;ABCA7;RXRA;TGFA;IMPACT;CASP4;CAMK1;EPHB2;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;FURIN;ARHGEF2;MINK1;ADCY6;TGFB1;WBP2;ERBB3;PLGRKT;WDFY2;TRAF7
9318,GO:0035767,0.00733332236932107,0.998623916497012,6,18,endothelial cell chemotaxis,BP,CORO1B;TMSB4X;PLEKHG5;FGFR1;P2RX4;FGF2
17710,GO:1901564,0.00736382099867207,0.993782450658637,543,4911,organonitrogen compound metabolic process,BP,TNIP1;NT5E;EDEM1;XDH;BTBD2;CBS;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;QSOX1;WNT7A;PTHLH;MBOAT2;ERCC6;CST3;LPCAT4;NEURL1;SNX9;LMF1;NAPRT;BOK;SHARPIN;PCK2;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;IFI6;PGM1;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;SSH1;SCYL1;CRTAP;SMURF2;NME4;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;FKBP9;HAGH;OSBPL10;USP20;NACC2;BCR;CHPF;LPCAT1;VLDLR;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;ADCY7;XBP1;PGLS;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;HK1;MAP2K2;XYLT2;STK25;SHANK3;MIER2;ATF4;P4HB;HECW2;FBXW8;PSAT1;SNX33;MRPS6;AKT1;MDH2;CARD11;GPC4;IRAK1;SERPING1;ALDH1L2;APOE;ATP13A2;ARG2;PKN1;SYVN1;WWTR1;PHF21A;NPEPL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;NAGLU;DGKQ;MAPK13;RFNG;VPS11;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;PTK6;PFKP;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;NMRK1;TYSND1;RRAS;MSN;PPP1R35;TGFBR2;LAMB2;NDST2;MVB12B;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;PRSS8;SYMPK;OBSL1;TST;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;SCRN1;ESYT2;PLCG1;ATG13;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;JADE2;ANKIB1;LARP6;PRDX5;CCND2;TSPAN5;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;ERO1B;MMP10;AHCY;ZNF385A;UBXN7;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;RET;RASGEF1A;FBXL6;IFI27;HLTF;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;PIGQ;PHF1;UBXN4;DCAF7;ANO8;GNAI2;PPM1M;GGACT;GLUD1;HSF1;PPCS;SIN3B;PANK4;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;ADAM8;NEIL1;TFPI2;PYCR2;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;GIPC1;TNFRSF6B;B3GNT3;SRC;LDLRAP1;APLP2;MBD6;KDM4B;GLRX;SCG5;TAZ;FKBP10;PEX10;TGM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;CPTP;PAK6;STX5;GARS;GSK3A;SPINT2;PCSK6;TALDO1;DUSP6;FYN;MPI;SPTLC2;AGRN;ASNS;PPM1F;TMPRSS11D;ZNF862;LPAR3;RMND5A;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;TSPAN33;UCKL1;BRSK1;SSU72;CHST14;GJC2;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;COMT;TNRC6B;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;UBA1;RNF187;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;MIF4GD;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;ASB13;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ST3GAL3;VPS9D1;TRIB3;DDB2;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;SLC6A14;ULK1;LRP1;TRIB2;HSPA2;AOX1;PAK4;TNFRSF19;MGRN1;HPSE;SAMD4B;ULK2;SMPD3;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;PYM1;RCOR1;MAP3K12;ABHD14B;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;RXRA;ARG1;SPSB3;VEGFB;NEURL1B;TGFA;RPL28;CNOT11;IMPACT;BPHL;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;GGT1;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DNAJB9;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;UGCG;AIDA;NDUFS2;B4GALT6;MATN3;ADAM15;HM13;CEACAM1;PNPLA6;PAIP2;GALNT3;MINK1;LPIN3;TFPT;UROS;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;TGFB1;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;APOBEC3C;PLGRKT;ASPHD1;EP300;ERP44;WDFY2;RASA3;TRAF7;RNF10
12538,GO:0050662,0.0073972540856827,0.995785010752821,35,221,coenzyme binding,MF,XDH;PYGB;CBS;NOS1;PYGL;IDH2;PC;ACOT7;H6PD;GPT2;CRYL1;ACAD10;HADH;DHTKD1;HMGCL;TSTA3;AHCY;ACBD4;GLUD1;SDHA;CTBP1;ALAS1;MICAL2;P4HA1;CBR4;ACADVL;SPTLC2;MICAL1;HLCS;NDOR1;AOX1;PHYH;NDUFS2;CAT;LDHA
7820,GO:0032368,0.00740760234751823,0.997408032208635,12,54,regulation of lipid transport,BP,AKT1;APOE;PCSK9;PPARA;LDLRAP1;GAL;PLTP;NTSR1;MIF;LRP1;P2RX4;ABCA7
10967,GO:0044706,0.0074261713279083,0.996295737202598,24,136,multi-multicellular organism process,BP,PGF;PTHLH;CST3;CYP27B1;SERPINE2;BSG;SMURF2;CTSB;FBLN1;ADCY7;EPN1;AKT1;SH3PXD2B;TGFBR2;EPOR;HSF1;IGFBP2;VDR;COMT;TIMP1;RXRA;ARG1;TGFB1;ITGA3
7090,GO:0030879,0.00748719666493493,0.99662391221031,19,99,mammary gland development,BP,XDH;CCND1;NEURL1;ETV5;LRP5;XBP1;AKT1;ATP7B;DEAF1;TGFBR2;GATA3;APLN;SRC;VDR;RREB1;USF2;SOCS2;ARG1;TGFB1
5902,GO:0018105,0.00750307360461067,0.995762832651791,34,209,peptidyl-serine phosphorylation,BP,RAPGEF3;MAPKAPK3;EGFR;CSNK1E;MKNK2;PRKACA;MAP2K2;AKT1;PKN1;PRKCZ;DGKQ;MAPK13;TGFBR2;STK39;DKK1;CD44;PAK1;TTBK2;RET;PKD1;HMGA2;TOP1;SRC;PPM1F;PSKH1;MAP3K10;MIF;ULK1;MAPK9;MAP3K12;CAMK1;MAPK3;CSNK1D;TGFB1
19980,GO:2000483,0.00755895103640333,0.999613030396368,3,5,negative regulation of interleukin-8 secretion,BP,TMSB4X;MAPKBP1;ANXA1
10553,GO:0043491,0.00756950856577357,0.996099996675314,26,150,protein kinase B signaling,BP,XDH;MST1R;DLG1;SESN2;EGFR;AKT1;RRAS;PPP2R5B;MC1R;DDIT3;GATA3;ADAM8;FAM110C;MYDGF;SRC;FYN;FGFR1;TRIB3;LEMD2;HPSE;FGF2;CIB1;ITSN1;TGFB1;PIK3R2;ERBB3
12898,GO:0051209,0.00757589496646715,0.997081321514322,14,66,release of sequestered calcium ion into cytosol,BP,NOS1;F2R;FKBP1A;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;NTSR1;TPCN1;FGF2;CHD7;TGFB1;RASA3
12947,GO:0051283,0.00757589496646715,0.997081321514322,14,66,negative regulation of sequestering of calcium ion,BP,NOS1;F2R;FKBP1A;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;NTSR1;TPCN1;FGF2;CHD7;TGFB1;RASA3
3541,GO:0007565,0.00759177680383469,0.996337579038978,22,122,female pregnancy,BP,PGF;PTHLH;CST3;CYP27B1;BSG;SMURF2;CTSB;FBLN1;ADCY7;EPN1;AKT1;TGFBR2;EPOR;HSF1;IGFBP2;VDR;COMT;TIMP1;RXRA;ARG1;TGFB1;ITGA3
12933,GO:0051260,0.00760213203819461,0.995697458796464,34,215,protein homooligomerization,BP,ANGPTL4;KCNG1;SHARPIN;CRTC1;PRNP;NACC2;ACOT13;APOE;EHD3;ITPR3;TYSND1;IDE;CCDC88C;GLUL;STOM;RHOC;ASIC1;HSF1;SRC;CBR4;TGM2;GPX3;HSF4;MIF;SIGMAR1;P2RX4;EHD4;VASP;ATXN10;RXRA;ARG1;KCNC4;HM13;CAT
3398,GO:0007179,0.00760923164425651,0.996262295659414,23,128,transforming growth factor beta receptor signaling pathway,BP,LTBP2;LTBP4;FKBP1A;SMURF2;ITGB5;PRKCZ;FERMT1;TGFBR2;LTBP1;HTRA1;BCL9L;GIPC1;SRC;DNM2;MTMR4;STUB1;SNX25;PMEPA1;CBL;FURIN;TGFB1;ITGA3;PXN
2591,GO:0005884,0.00762003508352866,0.996943667635609,15,73,actin filament,CC,RAC2;ESPN;CORO1B;TMSB4X;PRKCZ;FERMT1;TWF2;FSCN1;PAK1;SRC;SPECC1L;FYN;WIPF1;TMSB10;ANXA1
10891,GO:0044420,0.00762624573973186,0.996740094315809,17,84,extracellular matrix component,CC,THSD4;CST3;DLG1;ITGA6;LAMA5;FBLN1;LAMB1;THBS2;LAMB2;LTBP1;LAMC2;NID1;AGRN;VWA1;TIMP1;LAMB3;LOXL1
17275,GO:0120034,0.00765540112138538,0.996931623577068,15,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;RAC2;NEURL1;ARAP1;ESPN;WASF2;TWF2;FSCN1;DNM2;FUZ;AGRN;PFN1;TENM2;EPS8L1;WRAP73
3949,GO:0008645,0.00767734870624202,0.996925733408118,15,71,hexose transmembrane transport,BP,SLC2A9;SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;SLC2A3;EDNRA;GSK3A;TRIB3;RAB4B;SLC5A1;PIK3R2;SLC45A3
18456,GO:1903510,0.0077053203862179,0.996802062637921,16,78,mucopolysaccharide metabolic process,BP,CHPF;XYLT1;XYLT2;AKT1;GALNS;NDST2;CD44;CEMIP;B4GALT2;B3GNT3;CHST14;HYAL1;ST3GAL3;FGF2;B4GALT6;TGFB1
4623,GO:0010739,0.00773555441747134,0.999600530804866,3,5,positive regulation of protein kinase A signaling,BP,AKAP12;MC1R;MIF
14649,GO:0070206,0.00783876875772696,0.99776229571097,9,35,protein trimerization,BP,GNB1;ASIC1;HSF1;HSF4;MIF;SIGMAR1;ATXN10;C1QTNF6;ARG1
3028,GO:0006575,0.00787358684071617,0.996109930503555,23,134,cellular modified amino acid metabolic process,BP,CHAC1;SERINC2;LPCAT4;CRTAP;HAGH;OSBPL10;P4HB;ALDH1L2;OSBPL5;ERO1B;AHCY;GAMT;PTDSS2;ASS1;GATA3;CNDP2;P4HA1;ALDH4A1;ALDH7A1;SLC27A1;GGT1;GLO1;PCYOX1
6019,GO:0019068,0.00789162163176284,0.99773530771491,9,36,virion assembly,BP,PC;RAB43;APOE;VPS4A;CHMP5;LRSAM1;RAB1B;VPS37A;TBC1D20
10738,GO:0044070,0.00796834788060362,0.997347870631982,11,47,regulation of anion transport,BP,PRNP;AKT1;APOE;STK39;STXBP1;NTSR1;FGFR1;MIF;P2RX4;ABCA7;ARG1
17221,GO:0106027,0.00797616539165357,0.997192922562538,12,52,neuron projection organization,BP,ZMYND8;DVL1;WNT7A;DLG4;PRNP;SHANK3;APOE;SHANK2;FYN;EPHB2;ARHGAP44;ITGA3
8991,GO:0035091,0.00798135811592436,0.995606384226387,31,186,phosphatidylinositol binding,MF,PITPNC1;SNX9;ARAP1;PITPNM1;PLEK2;ZCCHC14;TUB;SNX33;AKT1;ATP13A2;ITPR3;SH3PXD2B;HS1BP3;ESYT2;OSBPL5;TWF2;CYTH3;GSDMA;TULP3;LDLRAP1;PFN1;NISCH;WDFY3;SNX25;ARFIP2;ARAP3;GSDMC;SNX27;AIDA;SH3PXD2A;ASAP1
10464,GO:0043312,0.00800150634413186,0.994938812960174,50,351,neutrophil degranulation,BP,PYGB;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;UBR4;C6ORF120;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
6292,GO:0019899,0.00801539165864373,0.993582558400509,222,1826,enzyme binding,MF,TNIP1;BTBD2;CBS;FAM83A;CCND1;MST1R;RAC2;ASAP2;SORL1;DVL1;SHC1;DOCK4;UHRF1BP1;CST3;SNX9;BOK;ARAP1;MEF2D;DLG4;OBSCN;DLG1;XPOT;PITPNM1;SLC9A3R2;FKBP1A;NET1;RAPGEF3;PRNP;BNIP3;SBF1;WWC3;MICALCL;MAPKAPK3;ABTB1;NACC2;BCR;EVI5L;EGFR;SLC12A7;PRKACA;ACTA2;MIER2;ATF4;P4HB;AKT1;STRN4;FMNL2;RIN2;PKN1;AP1B1;SYVN1;RABGGTA;TMSB4X;AP2A2;PRKCZ;DGKQ;FZD8;EPHA1;FBXW5;GIT2;TYSND1;MSN;PPP1R35;TGFBR2;GDI1;RIN1;SERPINB6;STK39;UBE2J1;ARRDC1;PPARA;AKAP12;PRKACB;YIPF2;WDTC1;SHC2;CDC34;IPO13;PLCG1;TBC1D16;ATG13;MC1R;ANKIB1;TWF2;TBC1D14;CCND2;PSD3;TSPAN5;PPP1R12C;GIT1;BIN1;SUFU;PAK1;UBXN7;CUL7;DMXL2;TBC1D9B;GGA3;GGA1;STOM;FARP1;GNB1;SYTL1;DOCK9;RET;RAB29;RASGEF1A;RHOC;CYTH3;HLTF;PKD1;DLG3;DOCK6;HSF1;APPL2;IL1RAP;WFS1;NEK9;SLC12A4;RGL2;RHOBTB2;ARHGEF4;CAP1;TULP3;SRC;DENND2A;DNM2;RFXANK;CDC42BPB;NCS1;PAK6;PER3;TOM1L2;EXOC2;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;FYN;RALGDS;PFN1;MICAL1;KIF13B;PLEKHG5;TSPAN33;BRSK1;MOAP1;ITGA1;GNB2;TIMP1;FGFR1;MIF;MTMR4;RAB11FIP4;BCL2L1;STUB1;ADIPOR1;DNMBP;TRIB3;TCIRG1;PITPNM2;ARFIP2;HLCS;RAD23A;ARFGEF2;ULK1;LRP1;TRIB2;HSPA2;PAK4;ZP3;TBC1D20;FGF2;MAP1LC3B;VAPB;MAP3K12;ARAP3;ATXN10;RHOBTB1;EPS8L1;RXRA;TBC1D2B;ZBTB4;HIST1H2AG;LONP2;EPHB2;HGS;CARHSP1;GAS8;CBL;TRAPPC1;CIB1;IQSEC1;MAPK3;FURIN;ARHGEF2;LLGL1;NDUFS2;OCRL;HM13;CEACAM1;ARHGAP44;AGAP1;SRGAP2B;ECM1;ADCY6;CCNE1;ITSN1;TGFB1;PPP6R1;CAT;LDHA;SPRED2;PIK3R2;CAMK2N1;ERBB3;ITGA3;PXN;ARHGEF10L;STIM1;ASAP1
16148,GO:0090130,0.00811931027907969,0.995429537727605,33,204,tissue migration,BP,WNT7A;PRSS3;CORO1B;ACTA2;AKT1;APOE;PKN1;TMSB4X;FERMT1;TGFBR2;PLCG1;GATA3;GIPC1;SRC;SH3BP1;RAB25;PPM1F;PFN1;ANXA3;PLEKHG5;FGFR1;RREB1;HYAL1;ADIPOR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;ITGA3;PXN
3829,GO:0008427,0.00818941001439338,1,2,2,calcium-dependent protein kinase inhibitor activity,MF,CIB1;CAMK2N1
4702,GO:0010858,0.00818941001439338,1,2,2,calcium-dependent protein kinase regulator activity,MF,CIB1;CAMK2N1
18836,GO:1904375,0.00820840083825017,0.996678838961686,15,73,regulation of protein localization to cell periphery,BP,DLG1;PRNP;EGFR;AKT1;VPS4A;PTPN9;NUMB;LDLRAP1;BCL2L1;LRP1;EPHB2;CIB1;TMBIM1;TGFB1;ITGA3
4132,GO:0009190,0.00823009803415894,0.997631693809071,9,35,cyclic nucleotide biosynthetic process,BP,NOS1;PTHLH;ADCY7;APOE;GNAI2;CAP1;ADNP;AMPD2;ADCY6
13403,GO:0052652,0.00823009803415894,0.997631693809071,9,35,cyclic purine nucleotide metabolic process,BP,NOS1;PTHLH;ADCY7;APOE;GNAI2;CAP1;ADNP;AMPD2;ADCY6
7896,GO:0032459,0.00823821049111507,0.997846567631898,8,30,regulation of protein oligomerization,BP,SORL1;SNX9;MMP1;APOE;IDE;RHOC;SRC;EP300
831,GO:0002115,0.00827426805448175,0.998749039343863,5,13,store-operated calcium entry,BP,ORAI1;SARAF;HOMER2;ORAI3;STIM1
20005,GO:2000551,0.00832101263119549,0.999558303043675,3,5,regulation of T-helper 2 cell cytokine production,BP,PRKCZ;GATA3;ARG1
20216,GO:2001028,0.00832716809251569,0.999111288126332,4,9,positive regulation of endothelial cell chemotaxis,BP,TMSB4X;FGFR1;P2RX4;FGF2
11357,GO:0045666,0.00833560211490019,0.995133782278965,37,232,positive regulation of neuron differentiation,BP,ZMYND8;DVL1;MAP2K1;NEURL1;CRTC1;DLG4;VLDLR;ETV5;CSNK1E;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;PAK1;CUL7;RET;SHANK2;IL1RAP;FYN;LPAR3;FGFR1;ADNP;SOCS2;APBB1;IMPACT;CAMK1;CSNK1D;ARHGEF2;ITGA3
7364,GO:0031401,0.00833745968905002,0.993906983739951,104,791,positive regulation of protein modification process,BP,TNIP1;XDH;NOS1;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;MTA1;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;ADCY7;MAP4K4;EGFR;PRKACA;MAP2K2;STK25;AKT1;IRAK1;PKN1;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;TGFBR2;STK39;DKK1;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;PAK1;TNFSF15;RET;CEMIP;PKD1;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;CTBP1;ADAM8;MYDGF;SRC;STK24;PAK6;GSK3A;DUSP6;FYN;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;ADNP;MIF;STUB1;TRIB3;SLC27A1;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;CAMK1;EPHB2;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;ARHGEF2;MINK1;ADCY6;TGFB1;WBP2;ERBB3;WDFY2;TRAF7
6783,GO:0030214,0.00834605076213903,0.998735437232761,5,13,hyaluronan catabolic process,BP,CD44;CEMIP;HYAL1;FGF2;TGFB1
6811,GO:0030258,0.00834852319950406,0.995337559395693,32,196,lipid modification,BP,CPT2;DGKA;CYGB;SESN2;EGFR;CRAT;TTC7B;AKT1;APOE;DGKQ;PI4K2A;ACAD10;TYSND1;HADH;PPARA;PIP5K1C;SRC;ACADVL;FYN;FGFR1;MTMR4;ADIPOR1;PIP5KL1;FGF2;MLYCD;PHYH;LONP2;CPT1B;OCRL;PIK3R2;ERBB3;ZFYVE21
6222,GO:0019752,0.00836401689747491,0.993940938081344,98,756,carboxylic acid metabolic process,BP,CBS;NOS1;PCK2;CPT2;BSG;NR1D1;SLC16A3;PGM1;PSMD2;NAGS;IDH2;PC;CRTAP;CYGB;SESN2;ACOT7;HAGH;AARS;GPT2;XBP1;ACOT1;CRAT;CARS;HK1;ATF4;P4HB;PSAT1;AKT1;MDH2;ALDH1L2;ARG2;CRYL1;PFKP;ACAD10;TYSND1;HADH;PPARA;DHTKD1;WDTC1;CD44;ELOVL1;HMGCL;ERO1B;AHCY;ACSF2;GAMT;GLUL;CEMIP;ASS1;SLC2A3;GLUD1;ALOX15B;SDHA;SLC6A6;PYCR2;BLMH;P4HA1;ALDH1A2;CBR4;ACADVL;GARS;ASNS;ALDH4A1;PSMD7;TNFRSF1A;ALDH7A1;CHST14;COMT;MGLL;HYAL1;MIF;ADIPOR1;TRIB3;SLC27A1;HLCS;SARS2;SLC6A14;FGF2;MLYCD;PHYH;ARG1;BPHL;ACY1;LONP2;GGT1;MAPK3;CPT1B;ALDOC;GLO1;CEACAM1;LPIN3;UROS;TGFB1;PCYOX1;LDHA;AZIN2;ANXA1;SLC45A3
10332,GO:0043112,0.00836621544870625,0.995851296774922,23,130,receptor metabolic process,BP,ARAP1;DLG4;NR1D1;RAB31;VLDLR;APOE;EHD3;AP2A2;PCSK9;DKK1;PPARA;TBC1D16;RAB29;APLN;LDLRAP1;CHMP5;DNM2;SNX25;ARFGEF2;LRP1;FURIN;CEACAM1;TGFB1
9208,GO:0035584,0.00836737393219993,0.999060780674269,4,10,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;PRNP;PRKACA;HOMER2
2663,GO:0006006,0.00839308478910488,0.995766426232368,24,137,glucose metabolic process,BP,PCK2;NR1D1;IGFBP4;PGM1;PC;LRP5;H6PD;HK1;ATF4;AKT1;MDH2;DGKQ;PFKP;PPARA;WDTC1;SRC;GSK3A;OAS1;NISCH;SLC35B4;ADIPOR1;MLYCD;ALDOC;SLC45A3
17074,GO:0099531,0.00844972009683252,0.996448849237001,16,80,presynaptic process involved in chemical synaptic transmission,BP,DVL1;WNT7A;RAB3B;SNPH;SEPT5;SYTL1;ASIC1;VAMP2;PIP5K1C;STXBP1;SLC6A9;BRSK1;SNAP29;KCNC4;APBA1;SLC30A1
4499,GO:0010522,0.00845257164104418,0.996989088501471,12,54,regulation of calcium ion transport into cytosol,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;PLCG1;CEMIP;FYN;NTSR1;P2RX4;CHD7;TGFB1
10583,GO:0043536,0.00845850042949932,0.997346500509286,10,41,positive regulation of blood vessel endothelial cell migration,BP,AKT1;TMSB4X;PLCG1;FGFR1;P2RX4;FGF2;CIB1;SRPX2;TGFB1;ANXA1
905,GO:0002283,0.00846826107063282,0.994625603849672,50,352,neutrophil activation involved in immune response,BP,PYGB;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;UBR4;C6ORF120;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
17357,GO:1900006,0.00847657167113848,0.996992016752734,12,52,positive regulation of dendrite development,BP,ZMYND8;NEURL1;CRTC1;VLDLR;SHANK3;FBXW8;APOE;OBSL1;CUL7;SHANK2;IL1RAP;CAMK1
3381,GO:0007160,0.00848230792235673,0.995589460212384,26,149,cell-matrix adhesion,BP,ITGB4;POSTN;ITGA6;LAMA5;ITGB5;MMP14;COL13A1;PRKCZ;EPHA1;FERMT1;CD44;NID1;PKD1;SRC;PPM1F;ITGA1;LYPD5;HPSE;MSLN;CAMSAP3;CIB1;ADAM15;MINK1;ITGA3;PXN;THBS3
16444,GO:0097062,0.00854577787328928,0.998697428781496,5,13,dendritic spine maintenance,BP,ZMYND8;PRNP;APOE;FYN;ITGA3
4338,GO:0009888,0.00862690291925138,0.993340667514112,154,1231,tissue development,BP,XDH;PGF;ITGB4;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;SHARPIN;PCK2;MEF2D;SERPINE2;BSG;DLG1;FKBP1A;POSTN;PSMD2;ITGA6;RAPGEF3;PTPRS;LAMA5;SMURF2;FAM129B;CTSB;BBS2;SEMA3F;ETV5;LRP5;ACVR2B;ITGB5;XBP1;EGFR;MMP14;LAMB1;ADARB1;ACTA2;PPP1R13L;FBXW8;AKT1;GPC4;ARG2;WWTR1;AP2A2;FAM20C;CTSZ;PTK6;SH3PXD2B;FERMT1;DEAF1;SALL2;MSN;TGFBR2;LAMB2;EPOR;DKK1;CREB3L2;SOX7;PPARA;PRSS8;OBSL1;TST;PRKACB;CD44;ZNF516;SUFU;PAK1;BCL9L;SEMA4B;PODXL;CUL7;ADAMTS7;DUSP4;SATB1;RET;LAMC2;RHOC;PKD1;DLG3;GATA3;ALOX15B;CNFN;MYH15;HMGA2;ARID5B;MICAL2;FLNB;EDNRA;TULP3;ALDH1A2;SRC;TAZ;TGM2;ACADVL;GSK3A;SH3BP1;SPINT2;PCSK6;DUSP6;RAB25;FUZ;WNT5B;PFN1;PSMD7;TNFRSF1A;FBXL15;VDR;GAL;CTSL;EHF;THRA;TIMP1;LAMB3;SEMA4G;FGFR1;RREB1;HYAL1;ADIPOR1;PTPN12;LEMD2;ZFPM1;TNFRSF19;HPSE;TBC1D20;PRR9;FGF2;VASP;CHD7;RXRA;CAMSAP3;KLK6;KRT23;MAPK3;ALDOC;FURIN;UGCG;ADAM15;CEACAM1;ECM1;MBD3;TGFB1;CAT;ERBB3;ANXA1;GNAS;ITGA3;EP300;THBS3;STIM1
11404,GO:0045765,0.00865883615776433,0.995306505856928,29,174,regulation of angiogenesis,BP,ANGPTL4;PGF;ADM2;RAPGEF3;FAM129B;XBP1;THBS2;EPN1;EPN2;EPHA1;RRAS;TGFBR2;PLCG1;ADGRB2;HMGA2;MYDGF;ANXA3;HYAL1;PAK4;FGF2;RNH1;VEGFB;HGS;CIB1;SRPX2;CEACAM1;ECM1;ANXA1;STIM1
4025,GO:0009056,0.00867122212721194,0.993007296860392,234,1987,catabolic process,BP,NT5E;EDEM1;XDH;BTBD2;ITGB4;PYGB;CBS;NOS1;CHAC1;H1F0;GID4;CAPN2;RBCK1;SORL1;SDC1;DVL1;PYGL;QSOX1;CST3;CYP27B1;SNX9;BOK;SHARPIN;PCK2;CPT2;SERPINE2;NR1D1;TRIM65;DAP;MMP1;PGM1;PSMD2;MTA1;RAPGEF3;BNIP3;SMURF2;PLCH2;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;MRC2;HAGH;USP20;LPCAT1;VLDLR;LRP5;GPT2;XBP1;EGFR;CSNK1E;PANO1;MMP14;FYCO1;PRKACA;CRAT;HK1;HECW2;SNX33;AKT1;GPC4;ALDH1L2;APOE;ATG16L2;ATP13A2;ARG2;SYVN1;WWTR1;CRYL1;COL13A1;AP2A2;GALNS;TFEB;NAGLU;VPS11;VPS4A;CTSZ;PFKP;TMEM129;FBXO2;PCSK9;ENDOG;FBXW5;ACAD10;TYSND1;MSN;PLD3;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;PPARA;DHTKD1;TST;ZDHHC8;CDC34;CD44;PLCG1;ATG13;GTPBP1;IDE;DEDD2;ANKIB1;TBC1D14;PRDX5;HMGCL;SUFU;MMP10;AHCY;CTBS;DDIT3;GLUL;CUL7;GGA3;GGA1;ADAMTS7;FUCA1;DNASE1L1;PCBP4;CEMIP;PKD1;UBXN4;GGACT;GLUD1;HSF1;WFS1;SRD5A3;ADAM8;NEIL1;BLMH;PLCB3;GIPC1;SRC;UBR4;AGO4;LRSAM1;RAB1B;CPTP;ACADVL;RGS19;STX5;GPX3;GSK3A;FYN;ISG20;SPTLC2;AGRN;GALE;RMND5A;ALDH4A1;PSMD7;ALDH7A1;HSD11B1;FBXL15;ABHD17C;PUM1;RNF44;CTSL;COMT;TNRC6B;THRA;NTSR1;TIMP1;UBA1;MGLL;RNF187;WDFY3;HYAL1;VPS37A;STUB1;TRIB3;TCIRG1;SNX25;TPCN1;RMND5B;RAD23A;ULK1;LRP1;TRIB2;AOX1;PLCD3;HPSE;SAMD4B;ULK2;SMPD3;PNP;FGF2;MAP1LC3B;RNH1;PYM1;RNF222;ENTPD6;MLYCD;PHYH;ARG1;SPSB3;RPL28;ATP6V1C2;CNOT11;KLK6;SNAP29;LONP2;HGS;CARHSP1;CBL;GGT1;USP32;PACS2;MAPK3;CPT1B;POMT1;CSNK1D;DRAM2;DNAJB9;ALDOC;FURIN;RNF103;ADAM15;HM13;CEACAM1;PNPLA6;LPIN3;NAGA;IGF2BP3;TGFB1;PCYOX1;CAT;LDHA;AZIN2;PIK3R2;APOBEC3C;EP300
2330,GO:0005343,0.00867220314720653,0.998673247791282,5,13,organic acid:sodium symporter activity,MF,SLC6A6;SLC13A3;SLC6A9;SLC13A5;SLC10A6
13258,GO:0051902,0.00868993326938532,0.999531085757238,3,5,negative regulation of mitochondrial depolarization,BP,BOK;IFI6;SRC
18755,GO:1904180,0.00868993326938532,0.999531085757238,3,5,negative regulation of membrane depolarization,BP,BOK;IFI6;SRC
82,GO:0000165,0.00869906667770771,0.993876439914123,82,609,MAPK cascade,BP,TNIP1;XDH;F2R;MST1R;SORL1;MAP2K1;SHC1;WNT7A;ERCC6;DLG4;DLG1;IGFBP4;PSMD2;MAPKAPK3;FBLN1;MAP4K4;EGFR;MAP2K2;STK25;SHANK3;AKT1;IRAK1;APOE;PKN1;PRKCZ;MAPK13;FZD8;EPHA1;RRAS;STK39;DKK1;SHC2;CD44;PLCG1;MAP3K9;PAK1;DUSP4;RET;RASGEF1A;GNAI2;HSF1;ADAM8;MYDGF;SRC;MARK3;STK24;PAK6;DUSP6;FYN;LPAR3;PSMD7;TNFRSF1A;ITGA1;MAP3K10;FGFR1;MIF;TRIB3;LEMD2;TRIB2;PAK4;TNFRSF19;FGF2;MAPK9;MAP3K12;TAOK1;ABCA7;TGFA;EPHB2;HGS;CIB1;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;RASA3;TRAF7
12946,GO:0051282,0.00872024699615493,0.996577061816397,14,67,regulation of sequestering of calcium ion,BP,NOS1;F2R;FKBP1A;PRKACA;ITPR3;PLCG1;DDIT3;CEMIP;NTSR1;TPCN1;FGF2;CHD7;TGFB1;RASA3
10798,GO:0044255,0.00876678990912958,0.993618883753198,100,761,cellular lipid metabolic process,BP,SDC1;SERINC2;MBOAT2;LPCAT4;LMF1;PCK2;CPT2;PITPNM1;DGKA;SBF1;AGPAT3;PLCH2;CYGB;SESN2;ACOT7;OSBPL10;LPCAT1;XBP1;EGFR;ACOT1;CCDC71L;CRAT;TTC7B;AKT1;CDS2;GPC4;APOE;CRYL1;DGKQ;PI4K2A;RETSAT;PCSK9;ACAD10;TYSND1;HADH;PPARA;WDTC1;ESYT2;PLCG1;ELOVL1;OSBPL5;ISYNA1;ACSF2;PTDSS2;FUCA1;PIGQ;ALOX15B;SRD5A3;PIP5K1C;ALDH1A2;SRC;CBR4;TAZ;CPTP;ACADVL;PMVK;FYN;SPTLC2;AGRN;TNFRSF1A;MBOAT7;MGLL;FGFR1;MIF;MTMR4;ADIPOR1;TRIB3;PITPNM2;SLC27A1;ST3GAL5;PIP5KL1;AGPAT4;LRP1;SMPD3;ZP3;FGF2;VAPB;MLYCD;PHYH;ARSK;LONP2;GGT1;MAPK3;CPT1B;UGCG;B4GALT6;OCRL;CEACAM1;PNPLA6;LPIN3;NAGA;TGFB1;CAT;PIK3R2;STARD10;ERBB3;ANXA1;ARSD;SLC45A3;ZFYVE21
17747,GO:1901652,0.00879898398491281,0.994409567109322,50,340,response to peptide,BP,SHC1;PCK2;BSG;PRNP;SESN2;RAB31;LRP5;ADCY7;XBP1;PRKACA;AKT1;PRKCZ;PCSK9;HADH;PPARA;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;HSF1;EIF4EBP1;VAMP2;SRC;GSK3A;FYN;GAL;GNB2;TIMP1;SOCS2;ADIPOR1;TRIB3;TCIRG1;SLC27A1;LRP1;ARG1;BAIAP2L1;ATP6V1C2;CASP4;SOCS7;MAPK3;ARHGEF2;CEACAM1;ADCY6;TGFB1;CAT;PIK3R2;ANXA1;PXN
5188,GO:0015749,0.00879909648181494,0.996414943599602,15,72,monosaccharide transmembrane transport,BP,SLC2A9;SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;SLC2A3;EDNRA;GSK3A;TRIB3;RAB4B;SLC5A1;PIK3R2;SLC45A3
8123,GO:0032803,0.00890269346224982,0.999515180977014,3,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9;FURIN
15280,GO:0071437,0.00890748767306072,0.998627997362451,5,13,invadopodium,CC,AFAP1L1;MSN;FSCN1;PAK1;ITGA3
10264,GO:0042989,0.00890982793764712,0.999427639770056,3,6,sequestering of actin monomers,BP,TMSB4X;TWF2;TMSB10
12257,GO:0048514,0.00896440405427024,0.994171794053563,55,376,blood vessel morphogenesis,BP,ANGPTL4;XDH;PGF;SH2D2A;NFATC4;ADM2;SHC1;WNT7A;RAPGEF3;LAMA5;FAM129B;LRP5;XBP1;MMP14;THBS2;EPN1;EPN2;APOE;ELK3;ARHGAP22;FZD8;EPHA1;RRAS;TGFBR2;WASF2;PLCG1;CUL7;APLN;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;ANXA3;FGFR1;HYAL1;LRP1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;CHD7;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;TGFB1;ANXA1;STIM1
5807,GO:0017057,0.00896645859996109,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
480,GO:0001525,0.00915783387982178,0.994227354152102,48,321,angiogenesis,BP,ANGPTL4;PGF;SH2D2A;NFATC4;ADM2;SHC1;WNT7A;RAPGEF3;LAMA5;FAM129B;XBP1;MMP14;THBS2;EPN1;EPN2;ELK3;ARHGAP22;FZD8;EPHA1;RRAS;TGFBR2;WASF2;PLCG1;APLN;ADGRB2;ADAM8;HMGA2;MYDGF;EDNRA;ANXA3;FGFR1;HYAL1;PLCD3;PAK4;HPSE;FGF2;RNH1;SHB;VEGFB;EPHB2;HGS;CIB1;ADAM15;SRPX2;CEACAM1;ECM1;ANXA1;STIM1
17776,GO:1901700,0.00919906829257641,0.993039630307094,129,1020,response to oxygen-containing compound,BP,TNIP1;EDEM1;ERCC1;NOS1;CCND1;CAPN2;F2R;NFATC4;SDC1;SHC1;WNT7A;ERCC6;CST3;CYP27B1;NEURL1;PCK2;BSG;NR1D1;DNMT3A;POSTN;NET1;RAPGEF3;PRNP;BNIP3;SSH1;MAPKAPK3;SESN2;BCR;RAB31;LRP5;ACVR2B;ADCY7;XBP1;MAP4K4;EGFR;PRKACA;STK25;ATF4;AKT1;IRAK1;APOE;FAM210B;PRKCZ;DGKQ;MAPK13;PTK6;PCSK9;ENDOG;MSN;TGFBR2;HADH;DKK1;PPARA;PRKACB;SIPA1;WDTC1;IDE;TWF2;PRDX5;HMGCL;PAK1;GLUL;GNB1;RET;GRB10;GATA3;GNAI2;HSF1;IGFBP2;EIF4EBP1;VAMP2;TNFRSF6B;ALDH1A2;SRC;DNM2;STK24;GPX3;GSK3A;STXBP1;PMVK;FYN;AGRN;ASNS;WNT5B;TNFRSF1A;VDR;GAL;GNB2;COMT;TIMP1;LOXL1;ADNP;HYAL1;MIF;SOCS2;BCL2L1;ADIPOR1;TRIB3;TCIRG1;SLC27A1;HLCS;NDOR1;LRP1;P2RX4;MAPK9;SLIT3;HOMER2;RXRA;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;CBL;SOCS7;MAPK3;KANK2;LITAF;ARHGEF2;CEACAM1;MBD3;ADCY6;TGFB1;WBP2;CAT;LDHA;PIK3R2;ANXA1;PXN
5170,GO:0015718,0.00920798319518987,0.995971004888561,17,87,monocarboxylic acid transport,BP,CPT2;BSG;SLC16A3;AKT1;APOE;PPARA;NTSR1;MIF;SLC27A1;P2RX4;RXRA;SLC10A6;CPT1B;CEACAM1;APBA1;STARD10;ANXA1
11873,GO:0046847,0.0092171599734988,0.997079721260081,10,40,filopodium assembly,BP,ZMYND8;NEURL1;ARAP1;ITGA6;ESPN;FSCN1;ARHGEF4;SH3BP1;AGRN;TENM2
10432,GO:0043266,0.00923474002193544,0.997063523640909,10,41,regulation of potassium ion transport,BP,FHL1;NOS1;KCNG1;DLG1;PRNP;ATF4;STK39;VAMP2;DNM2;GAL
8125,GO:0032805,0.00925595623069194,1,2,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
11384,GO:0045732,0.00930322272417447,0.99492560608364,29,176,positive regulation of protein catabolic process,BP,EDEM1;SORL1;DVL1;SNX9;SMURF2;LPCAT1;XBP1;CSNK1E;HECW2;SNX33;AKT1;APOE;VPS11;PCSK9;MSN;IDE;ANKIB1;GGA3;GGA1;ADAM8;STX5;GSK3A;STUB1;TRIB3;RAD23A;LRP1;TRIB2;CSNK1D;FURIN
9965,GO:0042325,0.0093660157269988,0.992881632280492,133,1044,regulation of phosphorylation,BP,TNIP1;XDH;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;ITGA6;RAPGEF3;PRNP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;FZD8;EPHA1;PTK6;RRAS;TGFBR2;STK39;DKK1;PPP2R5B;PPARA;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;CCDC88C;PAK1;TNFSF15;DUSP4;RET;GRB10;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;ADAM8;PPP1R14A;MYDGF;SRC;STK24;PAK6;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;ABCA7;TGFA;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ARHGEF2;AIDA;SRPX2;CEACAM1;MINK1;ADCY6;CCNE1;ITSN1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;WDFY2;TRAF7
6637,GO:0023014,0.0093851798805924,0.993342843725913,84,627,signal transduction by protein phosphorylation,BP,TNIP1;XDH;F2R;MST1R;SORL1;MAP2K1;SHC1;WNT7A;ERCC6;DLG4;DLG1;IGFBP4;PSMD2;MAPKAPK3;ACVR2B;FBLN1;MAP4K4;EGFR;MAP2K2;STK25;SHANK3;AKT1;IRAK1;APOE;PKN1;PRKCZ;MAPK13;FZD8;EPHA1;RRAS;TGFBR2;STK39;DKK1;SHC2;CD44;PLCG1;MAP3K9;PAK1;DUSP4;RET;RASGEF1A;GNAI2;HSF1;ADAM8;MYDGF;SRC;MARK3;STK24;PAK6;DUSP6;FYN;LPAR3;PSMD7;TNFRSF1A;ITGA1;MAP3K10;FGFR1;MIF;TRIB3;LEMD2;TRIB2;PAK4;TNFRSF19;FGF2;MAPK9;MAP3K12;TAOK1;ABCA7;TGFA;EPHB2;HGS;CIB1;MAPK3;MAPK10;AIDA;CEACAM1;MINK1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3;RASA3;TRAF7
1623,GO:0004053,0.00938733370344317,1,2,2,arginase activity,MF,ARG2;ARG1
6181,GO:0019547,0.00938733370344317,1,2,2,arginine catabolic process to ornithine,BP,ARG2;ARG1
18207,GO:1902952,0.00943406263342804,1,2,2,positive regulation of dendritic spine maintenance,BP,ZMYND8;APOE
8053,GO:0032700,0.00944492204923664,0.999473973684929,3,5,negative regulation of interleukin-17 production,BP,PRNP;ARG2;TGFB1
16471,GO:0097114,0.00947369471283942,1,2,2,NMDA glutamate receptor clustering,BP,SHANK3;APOE
18230,GO:1902994,0.00947369471283942,1,2,2,regulation of phospholipid efflux,BP,APOE;ABCA7
18231,GO:1902995,0.00947369471283942,1,2,2,positive regulation of phospholipid efflux,BP,APOE;ABCA7
7613,GO:0031994,0.00953890766108216,0.998939622140738,4,9,insulin-like growth factor I binding,MF,ITGB4;IGFBP4;ITGA6;IGFBP2
13270,GO:0051928,0.00953982075426129,0.996538417631345,12,55,positive regulation of calcium ion transport,BP,F2R;EHD3;ORAI1;PLCG1;CEMIP;WFS1;LPAR3;GJC2;NTSR1;HSPA2;P2RX4;STIM1
4033,GO:0009064,0.00959400261701388,0.996711802561951,11,48,glutamine family amino acid metabolic process,BP,NOS1;NAGS;ARG2;GLUL;ASS1;GLUD1;PYCR2;ASNS;ALDH4A1;ARG1;GGT1
17332,GO:0140112,0.00961003493013499,0.998060042818332,6,19,extracellular vesicle biogenesis,BP,SDC1;ATP13A2;VPS4A;ARRDC1;SMPD3;HGS
10257,GO:0042982,0.0096391292206077,0.996904856970779,10,42,amyloid precursor protein metabolic process,BP,SORL1;DLG1;FKBP1A;PRNP;APOE;BIN1;LDLRAP1;GSK3A;ABCA7;KLK6
13534,GO:0055085,0.00974809028608252,0.992750914718766,112,875,transmembrane transport,BP,FHL1;NOS1;F2R;KCNG1;SCN8A;SLCO4A1;DLG4;CPT2;DLG1;SLC16A3;FKBP1A;PSMD2;SLC2A9;PRNP;SESN2;BCR;RTN2;TTYH3;SLC12A7;PRKACA;SHANK3;HECW2;AKT1;EHD3;ATP13A2;TMSB4X;PRKCZ;ATP7B;ITPR3;SLC20A1;ORAI1;PCSK9;TMCO3;STK39;TST;PLCG1;ABCB8;SEC63;SLC38A10;SFXN3;PAK1;SLC29A4;NLGN2;DDIT3;STOM;GRB10;CEMIP;SHANK2;PKD1;DLG3;NIPA1;ANO8;SLC2A3;GRIN3B;ASIC1;SLC12A4;ASPH;FAM155B;SLC6A6;SLC13A3;SLC43A1;VAMP2;EDNRA;GLRX;PEX10;DNM2;NDUFA4L2;NCS1;GSK3A;FYN;SLC6A9;PSMD7;SLC25A43;SLC33A1;GJC2;GAL;SLC13A5;NTSR1;EIF2S2;SLC46A3;SLC35B4;ATP2C2;LRRC8A;VPS9D1;TRIB3;PRAF2;TCIRG1;TPCN1;SLC6A14;HSPA2;P2RX4;FGF2;CHD7;ABCA7;SLC10A6;ATP6V1C2;KCNC4;EPHB2;RAB4B;CPT1B;SLC5A1;MINK1;SLC30A1;TGFB1;PCYOX1;SLC15A1;AZIN2;PIK3R2;SLC45A3;ORAI3;STIM1;RASA3
17435,GO:1900150,0.00988374442166981,1,2,2,regulation of defense response to fungus,BP,FAM3A;ARG1
4765,GO:0010942,0.00999082307427468,0.99316125906791,68,500,positive regulation of cell death,BP,XDH;F2R;RBCK1;NFATC4;NEURL1;BOK;OBSCN;DAP;DNMT3A;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;SSH1;G0S2;NACC2;MARK4;PANO1;ATF4;AKT1;CTSZ;PCSK9;ENDOG;DKK1;SOX7;BNIP3L;CDC34;MAP3K9;DEDD2;BIN1;DDIT3;TNFSF15;RET;IFI27;HSF1;ADAM8;HMGA2;ARHGEF4;ALDH1A2;SRC;TGM2;DNM2;FAM162A;STPG1;GSK3A;DUSP6;FYN;PPM1F;VDR;PLEKHG5;MOAP1;GAL;ITGA1;NTSR1;MAP3K10;BCL2L1;STK17A;LRP1;MAPK9;APBB1;CASP4;ARHGEF2;ITSN1;TGFB1;LDHA;ANXA1;TRAF7
11982,GO:0047184,0.0100267737262093,0.999428707269978,3,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT4;LPCAT1;TAZ
19812,GO:2000196,0.0100291901207893,1,2,2,positive regulation of female gonad development,BP,SRC;ZP3
19930,GO:2000386,0.0100291901207893,1,2,2,positive regulation of ovarian follicle development,BP,SRC;ZP3
14166,GO:0061024,0.010122341886598,0.992738352724485,88,664,membrane organization,BP,SH3KBP1;ZMYND8;SH3TC2;RAC2;DVL1;SNX9;AP3D1;BOK;DLG4;DLG1;DYSF;BNIP3;SSH1;MARVELD1;ETV5;EVI5L;EGFR;FCHO1;EPN1;SHANK3;SNX33;AKT1;ARPC1A;EPN2;APOE;AP2A2;VPS11;VPS4A;CTSZ;SEC23A;BNIP3L;TBC1D16;TBC1D14;MALL;BIN1;NLGN2;TBC1D9B;SYTL1;REEP2;ATP11A;OXA1L;MYOF;GRIN3B;NEK9;VAMP2;PIP5K1C;LDLRAP1;TAZ;DNM2;STPG1;RAB1B;CPTP;STX5;GSK3A;STXBP1;SH3BP1;AGRN;REEP4;STX10;MOAP1;MCFD2;SEC24C;BCL2L1;LEMD2;USO1;TBC1D20;SPIRE1;VAPB;ABCA7;LMAN1;TBC1D2B;TGFA;BAIAP2L1;VAT1;SNAP29;SPESP1;HGS;CBL;TRAPPC1;CSNK1D;OCRL;ARHGAP44;CD59;ITSN1;PPP6R1;AZIN2;ANXA1;ASAP1
12787,GO:0051043,0.0101439808562202,0.997927575796726,6,19,regulation of membrane protein ectodomain proteolysis,BP,SNX9;SNX33;APOE;ADAM8;TIMP1;FURIN
15900,GO:0072611,0.0101795776577672,0.99941664395814,3,5,interleukin-13 secretion,BP,ARG2;PRKCZ;GATA3
20076,GO:2000665,0.0101795776577672,0.99941664395814,3,5,regulation of interleukin-13 secretion,BP,ARG2;PRKCZ;GATA3
4370,GO:0009986,0.0101945627322443,0.993348777557612,54,374,cell surface,CC,NT5E;ITGB4;F2R;MST1R;SDC1;PLAT;WNT7A;SERPINE2;DCBLD2;ITGA6;PRNP;ITGB5;EGFR;P4HB;GPC4;CTSZ;PCSK9;MSN;TGFBR2;CD44;IDE;NLGN2;ADAMTS7;PROCR;PKD1;ANTXR2;ASIC1;ADAM8;CAPN5;PCSK6;CLSTN1;WNT5B;TNFRSF1A;TSPAN33;ITGA1;NTSR1;LRRC8A;MIF;HSPA2;ABCA7;ENTPD6;MSLN;TGFA;TPBG;FURIN;ADAM15;SRPX2;HM13;CEACAM1;CD59;TGFB1;ANXA1;ITGA3;ERP44
18479,GO:1903541,0.0102217300905068,0.998328415969623,5,14,regulation of exosomal secretion,BP,SDC1;ATP13A2;VPS4A;SMPD3;HGS
18481,GO:1903543,0.0102217300905068,0.998328415969623,5,14,positive regulation of exosomal secretion,BP,SDC1;ATP13A2;VPS4A;SMPD3;HGS
8028,GO:0032656,0.0103119467899104,0.998826414513454,4,9,regulation of interleukin-13 production,BP,ARG2;PRKCZ;GATA3;IL1RAP
14608,GO:0070141,0.0104112261914649,0.999398219247591,3,5,response to UV-A,BP,CCND1;EGFR;AKT1
10901,GO:0044432,0.0105242458927055,0.99205673978477,122,965,endoplasmic reticulum part,CC,EDEM1;NOS1;CAPN2;QSOX1;WNT7A;MBOAT2;CST3;LPCAT4;LMF1;BOK;DLG1;IGFBP4;PITPNM1;FKBP1A;CKAP4;SBF1;AGPAT3;TXNDC11;CRTAP;COPG1;TMEM214;LPCAT1;H6PD;XYLT1;XBP1;EGFR;RTN2;LAMB1;RHBDF2;XYLT2;P4HB;PDIA5;CDS2;APOE;SYVN1;YIF1A;COL13A1;FAM20C;ITPR3;CTSZ;TMEM129;RETSAT;PCSK9;SEC23A;LAMB2;PLD3;CREB3L2;UBE2J1;KDELR1;LTBP1;ESYT2;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;CERCAM;ERO1B;UBXN7;PTDSS2;ADAMTS7;REEP2;TMED3;PIGQ;UBXN4;ANO8;ANTXR2;WFS1;SRD5A3;ASPH;P4HA1;MYDGF;APLP2;FKBP10;SARAF;REEP6;NUCB1;RAB1B;CARD19;STX5;SPTLC2;CLSTN1;REEP4;WNT5B;HSD11B1;MBOAT7;SLC33A1;VWA1;SHISA5;PSKH1;MCFD2;RCN1;TIMP1;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;SIGMAR1;AGPAT4;ULK1;TBC1D20;VAPB;LMAN1;MSLN;TGFA;ARSK;CASP4;POMT1;DNAJB9;RNF103;MATN3;HM13;PNPLA6;LPIN3;CD59;ARSD;RAB6A;IKBIP;ARCN1;ERP44;STIM1
19268,GO:1905384,0.0105265615328022,1,2,2,regulation of protein localization to presynapse,BP,DVL1;WNT7A
19269,GO:1905386,0.0105265615328022,1,2,2,positive regulation of protein localization to presynapse,BP,DVL1;WNT7A
19310,GO:1905475,0.0105404405669596,0.994746616235711,22,126,regulation of protein localization to membrane,BP,ZMYND8;DLG1;PRNP;SSH1;EGFR;AKT1;VPS4A;GDI1;PAK1;STOM;PTPN9;CEMIP;NUMB;LDLRAP1;FYN;BCL2L1;LRP1;EPHB2;CIB1;TMBIM1;TGFB1;ITGA3
10138,GO:0042663,0.0106061741524843,1,2,2,regulation of endodermal cell fate specification,BP,DKK1;DUSP6
12200,GO:0048313,0.0106200559900228,0.998246305970931,5,14,Golgi inheritance,BP,MAP2K1;MAP2K2;STK25;STX5;MAPK3
11291,GO:0045582,0.0106871318172977,0.996502586968917,10,43,positive regulation of T cell differentiation,BP,AP3D1;XBP1;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1
19556,GO:1990418,0.0106871805091392,1,2,2,response to insulin-like growth factor stimulus,BP,XBP1;AKT1
17487,GO:1900271,0.0107419426881924,0.997777280474513,6,19,regulation of long-term synaptic potentiation,BP,CRTC1;PRNP;SHANK3;APOE;EPHB2;PAIP2
4716,GO:0010876,0.0108271606886981,0.993659014772426,35,223,lipid localization,BP,SORL1;PITPNC1;CPT2;PITPNM1;NME4;OSBPL10;OSBP2;VLDLR;LRP10;AKT1;APOE;VPS4A;PCSK9;PPARA;ESYT2;OSBPL5;ATP11A;LDLRAP1;CPTP;GAL;PLTP;NTSR1;MIF;SIGMAR1;PITPNM2;SLC27A1;LRP1;P2RX4;ABCA7;RXRA;SLC10A6;CPT1B;CEACAM1;STARD10;ANXA1
4384,GO:0010033,0.0108459622397344,0.991137833057811,255,2171,response to organic substance,BP,TNIP1;EDEM1;XDH;PGF;ERCC1;NOS1;CHAC1;LTBP2;CCND1;CAPN2;F2R;MST1R;LTBP4;RBCK1;NFATC4;SDC1;MAP2K1;SHC1;WNT7A;CST3;CYP27B1;NEURL1;BOK;SHARPIN;PCK2;BSG;NR1D1;MMP1;MXRA5;IFI6;DNMT3A;FKBP1A;POSTN;PSMD2;ITGA6;RAPGEF3;PRNP;CD68;LAMA5;SSH1;RAB43;SMURF2;FAM129B;LCN2;MAPKAPK3;CTSB;SESN2;BBS2;BCR;RAB31;LRP5;ACVR2B;ITGB5;ADCY7;XBP1;MAP4K4;EGFR;MMP14;RFX2;PRKACA;CORO1B;TUB;MAP2K2;ATF4;P4HB;PDIA5;AKT1;IFITM1;IRAK1;EPN2;APOE;FAM210B;SYVN1;YIF1A;TMSB4X;TSPYL2;PRKCZ;FAM20C;DGKQ;MAPK13;PTK6;PFKP;TMEM129;FBXO2;PCSK9;ENDOG;FERMT1;MSN;TGFBR2;HADH;EPOR;DKK1;CREB3L2;PPP2R5B;UBE2J1;PPARA;PRKACB;LTBP1;WDTC1;CDC34;CD44;DNAJB5;PLCG1;SEC63;IDE;TWF2;FSCN1;HMGCL;HTRA1;PAK1;BCL9L;DDIT3;TNFSF15;GLUL;BCDIN3D;CUL7;ADAMTS7;GNB1;PTPN9;RET;GAS2L1;IFI27;GRB10;GATA3;APLN;UBXN4;OASL;MYOF;GNAI2;FNDC4;HSF1;IL1RAP;WFS1;MT2A;PTPRU;ARID5B;IGFBP2;MYDGF;EIF4EBP1;VAMP2;FLNB;GIPC1;TNFRSF6B;ALDH1A2;SRC;DNM2;AGO4;IRF7;DNAJC4;PAQR7;ACADVL;ESRP1;GPX3;GSK3A;STXBP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;ISG20;FUZ;AGRN;ASNS;WNT5B;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;GAL;PUM1;GNB2;CTSL;COMT;THRA;NTSR1;TIMP1;LOXL1;FGFR1;ADNP;HYAL1;F12;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;NDOR1;LRP1;HSPA2;PAK4;TNFRSF19;P2RX4;FGF2;EHD4;VAPB;MAPK9;HSPA13;SLIT3;HOMER2;RXRA;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;LONP2;HGS;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;RNF103;HM13;CEACAM1;GALNT3;UROS;ECM1;MBD3;ADCY6;CCNE1;TGFB1;WBP2;MANF;CAT;LDHA;SPRED2;PIK3R2;ANXA1;ITGA3;PXN;EP300;ERP44
18951,GO:1904659,0.0108676209913919,0.995615623392531,14,67,glucose transmembrane transport,BP,SLC2A9;SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;SLC2A3;EDNRA;GSK3A;TRIB3;RAB4B;SLC5A1;PIK3R2
4296,GO:0009725,0.0108806393872135,0.99218538453328,87,652,response to hormone,BP,PGF;NOS1;CCND1;SDC1;SHC1;WNT7A;CST3;PCK2;BSG;NR1D1;DNMT3A;POSTN;CTSB;SESN2;BBS2;RAB31;LRP5;ADCY7;XBP1;EGFR;MMP14;PRKACA;TUB;AKT1;FAM210B;PRKCZ;PCSK9;ENDOG;MSN;TGFBR2;HADH;PPARA;PRKACB;WDTC1;IDE;PAK1;GNB1;GAS2L1;GRB10;GNAI2;HSF1;PTPRU;IGFBP2;EIF4EBP1;VAMP2;ALDH1A2;SRC;PAQR7;GSK3A;STXBP1;FYN;AGRN;ASNS;ANXA3;VDR;GAL;GNB2;CTSL;THRA;TIMP1;SOCS2;ADIPOR1;TRIB3;TCIRG1;SLC27A1;PMEPA1;SLIT3;RXRA;ARG1;BAIAP2L1;ATP6V1C2;CBL;SOCS7;MAPK3;KANK2;CEACAM1;MBD3;ADCY6;CCNE1;TGFB1;WBP2;CAT;PIK3R2;ANXA1;ITGA3;PXN;EP300
17631,GO:1901293,0.0108946547221239,0.993557283136506,36,237,nucleoside phosphate biosynthetic process,BP,NOS1;PTHLH;NAPRT;PGM1;IDH2;NME4;ACOT7;ADCY7;TK2;HK1;APOE;TMSB4X;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;GNAI2;PPCS;PANK4;CAP1;TAZ;GARS;UCKL1;LHPP;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ALDOC;ADCY6;TGFB1;LDHA
19937,GO:2000394,0.0108989905157396,0.999358892388842,3,5,positive regulation of lamellipodium morphogenesis,BP,CORO1B;SRC;RREB1
7496,GO:0031659,0.0109464487601832,0.999355028014264,3,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;AKT1;PKD1
19284,GO:1905424,0.0109579828664248,1,2,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E;CSNK1D
19285,GO:1905426,0.0109579828664248,1,2,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E;CSNK1D
17735,GO:1901621,0.010959449617002,0.999353968231302,3,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;SUFU;TULP3
19541,GO:1990393,0.0109705673082058,0.999353061560466,3,5,3M complex,CC,FBXW8;OBSL1;CUL7
11977,GO:0047144,0.0109905533095123,0.998724794829586,4,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;LPCAT4;LPCAT1;MBOAT7
18206,GO:1902951,0.0110301259172903,1,2,2,negative regulation of dendritic spine maintenance,BP,PRNP;FYN
19367,GO:1905664,0.0110301259172903,1,2,2,regulation of calcium ion import across plasma membrane,BP,PRNP;FYN
14563,GO:0070064,0.011082985503288,0.997690669038421,6,19,proline-rich region binding,MF,CCND1;RABAC1;PFN1;APBB1;BAIAP2L1;ITSN1
17725,GO:1901605,0.011119584038751,0.994148821242812,25,150,alpha-amino acid metabolic process,BP,CBS;NOS1;NAGS;CRTAP;GPT2;P4HB;PSAT1;ARG2;HMGCL;ERO1B;AHCY;GAMT;GLUL;ASS1;GLUD1;PYCR2;BLMH;P4HA1;ASNS;ALDH4A1;ALDH7A1;COMT;ARG1;GGT1;AZIN2
16005,GO:0080184,0.0111703624724731,1,2,2,response to phenylpropanoid,BP,EGFR;CAT
8604,GO:0034103,0.0111904844712618,0.996311444936211,10,43,regulation of tissue remodeling,BP,CST3;BCR;LRP5;EGFR;ADAM8;SRC;VDR;TMBIM1;CEACAM1;TGFB1
12339,GO:0048675,0.0112001463672221,0.994992037509529,17,87,axon extension,BP,DVL1;PTPRS;SEMA3F;APOE;MAP1B;LAMB2;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;SEMA4G;ADNP;ULK1;ULK2;SLIT3
20170,GO:2000828,0.0113030233340069,1,2,2,regulation of parathyroid hormone secretion,BP,FGFR1;GNAS
19935,GO:2000392,0.0113158264265107,0.998675368199288,4,9,regulation of lamellipodium morphogenesis,BP,CORO1B;CD44;SRC;RREB1
8668,GO:0034219,0.0113520306154928,0.995220438072231,15,74,carbohydrate transmembrane transport,BP,SLC2A9;SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;SLC2A3;EDNRA;GSK3A;TRIB3;RAB4B;SLC5A1;PIK3R2;SLC45A3
5393,GO:0016222,0.0113822633548901,1,2,2,procollagen-proline 4-dioxygenase complex,CC,P4HB;P4HA1
18306,GO:1903169,0.0114541304802239,0.995161526450558,15,76,regulation of calcium ion transmembrane transport,BP,NOS1;F2R;FKBP1A;PRNP;PRKACA;EHD3;PLCG1;CEMIP;FYN;GJC2;NTSR1;HSPA2;CHD7;TGFB1;STIM1
2187,GO:0005041,0.0114940993511533,0.998648085802191,4,9,low-density lipoprotein particle receptor activity,MF,SORL1;VLDLR;LRP10;LRP1
9875,GO:0042119,0.0115082356932755,0.992560086818128,50,358,neutrophil activation,BP,PYGB;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;UBR4;C6ORF120;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
20090,GO:2000683,0.0115172697103097,1,2,2,regulation of cellular response to X-ray,BP,GATA3;HMGA2
14774,GO:0070435,0.0115225679645064,1,2,2,Shc-EGFR complex,CC,SHC1;EGFR
3455,GO:0007269,0.0115419715370313,0.99512524188679,15,75,neurotransmitter secretion,BP,DVL1;WNT7A;SNPH;SEPT5;SYTL1;ASIC1;VAMP2;PIP5K1C;STXBP1;SLC6A9;BRSK1;SNAP29;KCNC4;APBA1;SLC30A1
17125,GO:0099643,0.0115419715370313,0.99512524188679,15,75,signal release from synapse,BP,DVL1;WNT7A;SNPH;SEPT5;SYTL1;ASIC1;VAMP2;PIP5K1C;STXBP1;SLC6A9;BRSK1;SNAP29;KCNC4;APBA1;SLC30A1
4529,GO:0010592,0.011633211927035,0.998033770111944,5,14,positive regulation of lamellipodium assembly,BP,RAC2;WASF2;TWF2;FSCN1;DNM2
14145,GO:0060988,0.0116516928330757,1,2,2,lipid tube assembly,BP,SNX9;BIN1
17011,GO:0099068,0.0116708083843728,0.998620909449359,4,9,postsynapse assembly,BP,WNT7A;SHANK3;NLGN2;SHANK2
15356,GO:0071560,0.0117369378179557,0.99362842055488,27,163,cellular response to transforming growth factor beta stimulus,BP,LTBP2;LTBP4;WNT7A;FKBP1A;POSTN;SMURF2;ITGB5;PRKCZ;FERMT1;TGFBR2;LTBP1;HTRA1;BCL9L;GIPC1;SRC;DNM2;FYN;MTMR4;STUB1;SNX25;PMEPA1;ARG1;CBL;FURIN;TGFB1;ITGA3;PXN
18573,GO:1903756,0.0117446771816658,1,2,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8;CTBP1
18574,GO:1903758,0.0117446771816658,1,2,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8;CTBP1
18215,GO:1902960,0.0117490677967042,1,2,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1;BIN1
19210,GO:1905246,0.0117490677967042,1,2,2,negative regulation of aspartic-type peptidase activity,BP,SORL1;BIN1
10425,GO:0043254,0.0117511358638701,0.992436470803528,49,339,regulation of protein complex assembly,BP,ERCC1;RAC2;SORL1;CTNNBIP1;SNX9;DLG1;MMP1;TMOD2;CORO1B;ARPC1A;APOE;TMSB4X;PRKCZ;VPS11;EML2;MSN;DKK1;PPP2R5B;IDE;TWF2;FSCN1;PAK1;RHOC;ARL2;SRC;CAPG;CPTP;STXBP1;PFN1;THRA;STUB1;DDB2;PMEPA1;ARFIP2;ULK1;SPIRE1;MAPK9;VASP;EPS8L1;CAMSAP3;BAIAP2L1;WIPF1;IMPACT;TMSB10;KANK2;ARHGEF2;TGFB1;EP300;ASAP1
4048,GO:0009084,0.0117761112630536,0.998003380265644,5,14,glutamine family amino acid biosynthetic process,BP,NAGS;GLUL;ASS1;GLUD1;PYCR2
4791,GO:0010979,0.0118042601669033,1,2,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1;VDR
4792,GO:0010980,0.0118042601669033,1,2,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1;VDR
18182,GO:1902904,0.0118179783123784,0.994670578233113,17,90,negative regulation of supramolecular fiber organization,BP,ARAP1;TMOD2;CORO1B;SHANK3;TMSB4X;EML2;WASF2;TWF2;TTBK2;CAPG;PFN1;CAMSAP3;CIB1;TMSB10;KANK2;ARHGEF2;PLEKHH2
3681,GO:0008184,0.0118249210724868,1,2,2,glycogen phosphorylase activity,MF,PYGB;PYGL
17155,GO:0102250,0.0118249210724868,1,2,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB;PYGL
17177,GO:0102499,0.0118249210724868,1,2,2,SHG alpha-glucan phosphorylase activity,MF,PYGB;PYGL
13855,GO:0060434,0.011825834980523,1,2,2,bronchus morphogenesis,BP,TGFBR2;TULP3
894,GO:0002263,0.0118327099978951,0.99192405278351,64,474,cell activation involved in immune response,BP,PYGB;ERCC1;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;XBP1;AP2A2;PRKCZ;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;GATA3;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MFNG;MIF;TCIRG1;ZFPM1;LRP1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;TGFB1;CAT;ANXA1;RAB6A;ERP44
6680,GO:0030038,0.0119030169974726,0.995136025352232,14,68,contractile actin filament bundle assembly,BP,ARAP1;RAPGEF3;ITGB5;EPHA1;SH3PXD2B;LIMK1;WASF2;PAK1;SRC;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
10357,GO:0043149,0.0119030169974726,0.995136025352232,14,68,stress fiber assembly,BP,ARAP1;RAPGEF3;ITGB5;EPHA1;SH3PXD2B;LIMK1;WASF2;PAK1;SRC;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
97,GO:0000187,0.0119128421620017,0.994346851945673,19,104,activation of MAPK activity,BP,MAP2K1;SHC1;ERCC6;MAPKAPK3;MAP2K2;IRAK1;PKN1;STK39;SHC2;MAP3K9;DUSP6;LPAR3;ITGA1;MAP3K10;FGF2;TAOK1;TGFA;MAPK3;MAPK10
8654,GO:0034189,0.0119465037309517,1,2,2,very-low-density lipoprotein particle binding,MF,VLDLR;PCSK9
8174,GO:0032902,0.0119885095331742,1,2,2,nerve growth factor production,BP,PCSK6;FURIN
6145,GO:0019417,0.0120035013464965,1,2,2,sulfur oxidation,BP,MICAL2;MICAL1
463,GO:0001501,0.0120437707822897,0.992357111206135,46,309,skeletal system development,BP,MDFI;WNT7A;PTHLH;MEF2D;DLG1;IGFBP4;POSTN;BBS2;LRP5;ACVR2B;MMP14;COL13A1;FAM20C;SH3PXD2B;DEAF1;TGFBR2;CREB3L2;WASF2;CD44;SLC38A10;SUFU;ZNF385A;ADAMTS7;PKD1;RAI1;HMGA2;ARID5B;TULP3;SRC;FUZ;WNT5B;VDR;THRA;TIMP1;FGFR1;HYAL1;ZFPM1;LRRK1;FGF2;CHD7;MAPK3;MATN3;TGFB1;GNAS;EP300;THBS3
3774,GO:0008328,0.0121182411666213,0.997423945456698,6,19,ionotropic glutamate receptor complex,CC,DLG4;DLG1;SHANK3;SHANK2;DLG3;GRIN3B
16933,GO:0098878,0.0121182411666213,0.997423945456698,6,19,neurotransmitter receptor complex,CC,DLG4;DLG1;SHANK3;SHANK2;DLG3;GRIN3B
1184,GO:0002828,0.0121270274767698,0.997391370499612,6,20,regulation of type 2 immune response,BP,ARG2;PRKCZ;GATA3;ARG1;ECM1;ANXA1
18597,GO:1903798,0.0121384891506001,0.997925869944425,5,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;TGFB1
17585,GO:1901143,0.0121418947350237,1,2,2,insulin catabolic process,BP,IDE;CEACAM1
11522,GO:0045992,0.0121555555305248,0.997414227702808,6,19,negative regulation of embryonic development,BP,DKK1;PRKACB;SUFU;GATA3;TULP3;FUZ
16635,GO:0097457,0.0121662937907489,1,2,2,hippocampal mossy fiber,CC,MAP1B;MICAL1
7859,GO:0032414,0.0121977563055097,0.995649828648468,11,50,positive regulation of ion transmembrane transporter activity,BP,SHANK3;EHD3;TMSB4X;STK39;GLRX;DNM2;GAL;NTSR1;HSPA2;EPHB2;STIM1
4552,GO:0010631,0.0122064671642438,0.992974965024622,32,202,epithelial cell migration,BP,WNT7A;PRSS3;CORO1B;AKT1;APOE;PKN1;TMSB4X;FERMT1;TGFBR2;PLCG1;GATA3;GIPC1;SRC;SH3BP1;RAB25;PPM1F;PFN1;ANXA3;PLEKHG5;FGFR1;RREB1;HYAL1;ADIPOR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;ITGA3;PXN
2766,GO:0006182,0.012248210581955,0.997902276780922,5,14,cGMP biosynthetic process,BP,NOS1;ADCY7;APOE;ADNP;ADCY6
6394,GO:0021590,0.0122718596275939,1,2,2,cerebellum maturation,BP,RERE;ARCN1
6428,GO:0021691,0.0122718596275939,1,2,2,cerebellar Purkinje cell layer maturation,BP,RERE;ARCN1
6436,GO:0021699,0.0122718596275939,1,2,2,cerebellar cortex maturation,BP,RERE;ARCN1
3664,GO:0008154,0.0122920137072683,0.993474330975437,25,150,actin polymerization or depolymerization,BP,RAC2;DLG1;SSH1;TMOD2;CORO1B;ARPC1A;TMSB4X;MSRB2;TWF2;CORO7;MICAL2;CAP1;CAPG;SH3BP1;PFN1;MICAL1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;PLEKHH2
16510,GO:0097186,0.0123191868681758,0.997886984386974,5,14,amelogenesis,BP,ITGB4;ITGA6;FAM20C;PPARA;STIM1
16707,GO:0097635,0.0124056132525455,1,2,2,extrinsic component of autophagosome membrane,CC,WDFY3;ULK1
16970,GO:0098936,0.012408537883941,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
17008,GO:0099055,0.012408537883941,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
17049,GO:0099240,0.012408537883941,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17126,GO:0099699,0.012408537883941,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
2092,GO:0004854,0.0124323857983523,1,2,2,xanthine dehydrogenase activity,MF,XDH;AOX1
4066,GO:0009115,0.0124323857983523,1,2,2,xanthine catabolic process,BP,XDH;AOX1
5644,GO:0016726,0.0124323857983523,1,2,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH;AOX1
2429,GO:0005607,0.0124380367800941,1,2,2,laminin-2 complex,CC,LAMB1;LAMC2
16397,GO:0090722,0.0124469414188333,1,2,2,receptor-receptor interaction,MF,FGFR1;FGF2
19049,GO:1904849,0.0124469414188333,1,2,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
20004,GO:2000546,0.0124469414188333,1,2,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
16887,GO:0098797,0.0124495177856569,0.992258093343451,42,280,plasma membrane protein complex,CC,ITGB4;NOS1;SHC1;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;ITGA6;LRP5;ITGB5;EGFR;SHANK3;CARD11;IRAK1;COL13A1;AP2A2;FZD8;TGFBR2;ABCB8;GNB1;RET;SHANK2;DLG3;GNAI2;GRIN3B;SDHA;ADAM8;VAMP2;LDLRAP1;RGS19;GJC2;ITGA1;LRP1;HSPA2;SNTB2;ABCA7;KCNC4;CBL;CEACAM1;GNAS;ITGA3
12913,GO:0051235,0.0125303190689078,0.992637419158566,34,221,maintenance of location,BP,MDFI;NOS1;F2R;SORL1;AP3D1;FKBP1A;SYNE3;PRKACA;HK1;AKT1;APOE;TMSB4X;ATP7B;ITPR3;PPARA;KDELR1;LTBP1;PLCG1;TWF2;SUFU;DDIT3;CEMIP;PKD1;ARL2;FLNB;THRA;NTSR1;TPCN1;FGF2;CHD7;TMSB10;SLC30A1;TGFB1;RASA3
6744,GO:0030159,0.0125361504670545,0.997314707248543,6,19,receptor signaling complex scaffold activity,MF,SHANK3;DEDD2;SHANK2;LDLRAP1;HOMER2;GRIP2
7743,GO:0032233,0.0125399211748368,0.995792025047144,10,43,positive regulation of actin filament bundle assembly,BP,RAPGEF3;EPHA1;SH3PXD2B;LIMK1;PAK1;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
6757,GO:0030175,0.0126019676720721,0.994813021332656,14,68,filopodium,CC,ITGA6;RAPGEF3;ACTA2;MSN;TWF2;FSCN1;PODXL;FARP1;FAT1;TENM2;VASP;APBB1;CIB1;ITGA3
1800,GO:0004435,0.0127129199492303,0.997801720510926,5,14,phosphatidylinositol phospholipase C activity,MF,PLCH2;PLCG1;PLCB3;EDNRA;PLCD3
15193,GO:0071310,0.0127143805536056,0.989715396370231,215,1808,cellular response to organic substance,BP,TNIP1;EDEM1;XDH;PGF;NOS1;LTBP2;CCND1;CAPN2;MST1R;LTBP4;RBCK1;NFATC4;SDC1;MAP2K1;SHC1;WNT7A;CYP27B1;NEURL1;BOK;SHARPIN;PCK2;NR1D1;MMP1;IFI6;DNMT3A;FKBP1A;POSTN;PSMD2;ITGA6;RAPGEF3;PRNP;CD68;LAMA5;SSH1;RAB43;SMURF2;FAM129B;LCN2;CTSB;SESN2;BBS2;BCR;RAB31;LRP5;ACVR2B;ITGB5;ADCY7;XBP1;MAP4K4;EGFR;RFX2;PRKACA;CORO1B;MAP2K2;ATF4;P4HB;PDIA5;AKT1;IFITM1;IRAK1;EPN2;FAM210B;SYVN1;YIF1A;TMSB4X;TSPYL2;PRKCZ;FAM20C;MAPK13;PTK6;PFKP;PCSK9;ENDOG;FERMT1;MSN;TGFBR2;EPOR;DKK1;CREB3L2;PPP2R5B;PPARA;PRKACB;LTBP1;WDTC1;CDC34;CD44;PLCG1;SEC63;IDE;TWF2;FSCN1;HTRA1;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;CUL7;ADAMTS7;GNB1;PTPN9;RET;GAS2L1;IFI27;GRB10;GATA3;APLN;OASL;MYOF;GNAI2;HSF1;IL1RAP;WFS1;MT2A;ARID5B;IGFBP2;MYDGF;EIF4EBP1;VAMP2;FLNB;GIPC1;TNFRSF6B;ALDH1A2;SRC;DNM2;AGO4;IRF7;PAQR7;ACADVL;ESRP1;GSK3A;STXBP1;SPINT2;PCSK6;TALDO1;DUSP6;OAS1;FYN;ISG20;FUZ;AGRN;ASNS;WNT5B;PSMD7;TNFRSF1A;TLE4;FBXL15;SLC33A1;VDR;PUM1;GNB2;CTSL;THRA;TIMP1;FGFR1;HYAL1;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;NDOR1;LRP1;HSPA2;PAK4;TNFRSF19;P2RX4;FGF2;EHD4;VAPB;MAPK9;HSPA13;SLIT3;RXRA;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;HGS;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;CEACAM1;GALNT3;UROS;ECM1;ADCY6;CCNE1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;ANXA1;ITGA3;PXN;EP300
11302,GO:0045598,0.012756505911472,0.994362413797394,16,83,regulation of fat cell differentiation,BP,NR1D1;LRP5;XBP1;CCDC71L;AKT1;WWTR1;SH3PXD2B;ZNF385A;DDIT3;GATA3;WNT5B;TRIB3;ZFPM1;TRIB2;TGFB1;WDFY2
5072,GO:0015293,0.0128721168860861,0.994491046581707,15,75,symporter activity,MF,SLC16A3;SLC2A9;SLC12A7;SLC20A1;SLC12A4;SLC6A6;SLC13A3;SLC6A9;SLC33A1;SLC13A5;SLC6A14;SLC10A6;SLC5A1;SLC15A1;SLC45A3
16318,GO:0090407,0.0128846212718628,0.991067062699834,68,500,organophosphate biosynthetic process,BP,NOS1;PYGL;PTHLH;MBOAT2;LPCAT4;NAPRT;PITPNM1;PGM1;DGKA;IDH2;SBF1;AGPAT3;NME4;ACOT7;LPCAT1;ADCY7;TK2;HK1;CDS2;APOE;CRYL1;TMSB4X;DGKQ;PI4K2A;PFKP;NMRK1;PPARA;DHTKD1;NADK;ISYNA1;PTDSS2;PARP10;PIGQ;GNAI2;PPCS;PANK4;SRD5A3;CAP1;PIP5K1C;TAZ;GARS;PMVK;SPTLC2;MBOAT7;UCKL1;NTSR1;LHPP;FGFR1;ADNP;GUK1;MTMR4;AMPD2;VPS9D1;TCIRG1;PITPNM2;SLC27A1;AGPAT4;ZP3;PNP;FGF2;ALDOC;OCRL;LPIN3;ADCY6;TGFB1;LDHA;PIK3R2;STARD10
6798,GO:0030234,0.0129047777967545,0.990527126158654,95,734,enzyme regulator activity,MF,ANGPTL4;CCND1;RAC2;ASAP2;MAP2K1;DOCK4;ERCC6;CST3;ARAP1;SERPINE2;PSMD2;SBF1;SESN2;BCR;FBLN1;EVI5L;EGFR;MMP14;ARHGAP23;MAP2K2;AKT1;SERPING1;BAG3;APOE;RIN2;DGKQ;ARHGAP22;PPP2R3B;PITRM1;SH3PXD2B;GIT2;PPP1R35;GDI1;RIN1;SERPINB6;PPP2R5B;SIPA1;WDTC1;TBC1D16;RAP1GDS1;ATG13;TBC1D14;PRDX5;PPP1R12C;GIT1;TBC1D9B;ARHGAP39;APPL2;TFPI2;PPP1R14A;ARL2;APLP2;SCG5;RGS19;SH3BP1;SPINT2;RALGDS;PFN1;ANXA3;HEXIM1;TIMP1;CRIM1;SOCS2;PCSK1N;VPS9D1;TRIB3;TRIB2;TBC1D20;RNH1;ARAP3;TAOK1;TBC1D2B;CIB1;SOCS7;FURIN;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;CCNE1;ITSN1;TGFB1;SH3PXD2A;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;PPP1R10;RAP1GAP2;RASA3;ASAP1
12372,GO:0048732,0.012909455799183,0.991857202028901,44,297,gland development,BP,XDH;CCND1;MAP2K1;CST3;NEURL1;PCK2;SERPINE2;LAMA5;ETV5;LRP5;XBP1;EGFR;AKT1;ATP7B;PCSK9;DEAF1;MSN;TGFBR2;SEC63;HMGCL;RAG1;PKD1;GATA3;APLN;ALOX15B;ARID5B;ALDH1A2;SRC;TGM2;ASNS;VDR;THRA;FGFR1;RREB1;PHF2;USF2;SOCS2;RXRA;ARG1;MAPK3;DBP;CEACAM1;TGFB1;ANXA1
7387,GO:0031434,0.0129218160234819,0.99565583989221,10,42,mitogen-activated protein kinase kinase binding,MF,MST1R;DLG1;EGFR;EPHA1;RET;FGFR1;TRIB3;TRIB2;EPHB2;ERBB3
15448,GO:0071702,0.0130969530514032,0.989345434725554,227,1934,organic substance transport,BP,EDEM1;NOS1;LTBP2;SH3TC2;F2R;RAC2;LTBP4;SORL1;SERINC2;PITPNC1;SNX9;AP3D1;LMF1;PCK2;SLCO4A1;CPT2;BSG;NR1D1;XPOT;SLC16A3;PITPNM1;POSTN;RAB3B;SLC2A9;RAPGEF3;PRNP;IDH2;RAB43;NME4;COPG1;SESN2;BBS2;OSBPL10;BCR;RAB31;OSBP2;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;LRP10;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;PCSK9;FERMT1;SEC23A;TGFBR2;GDI1;HADH;MVB12B;STK39;UBE2J1;ARRDC1;BNIP3L;PPARA;KDELR1;AKAP12;SYMPK;TST;ZDHHC8;IPO13;ESYT2;TBC1D16;ATG13;SEC63;OSBPL5;SLC38A10;TBC1D14;PAK1;SLC29A4;NLGN2;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;GRB10;REEP2;TMED3;CEMIP;PKD1;PARP10;ATP11A;GATA3;APLN;DOPEY2;SLC2A3;GLUD1;HSF1;ALOX15B;IL1RAP;SLC6A6;ADAM8;MAPKBP1;SLC13A3;ARL2;SLC43A1;VAMP2;GIPC1;EDNRA;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;SLC6A9;NISCH;KIF17;SLC33A1;KIF13B;STX10;GAL;SLC13A5;MCFD2;PLTP;NTSR1;SLC35B4;SEC24C;RRBP1;GUK1;MIF;VPS37A;SIGMAR1;TRIB3;PRAF2;TCIRG1;PITPNM2;SNX25;SLC27A1;ARFIP2;ARFGEF2;UNC119B;SLC6A14;LRP1;P2RX4;USO1;SMPD3;SPIRE1;PNP;COG1;CHD7;ABCA7;APBB1;RXRA;ARG1;SLC10A6;TBC1D2B;NEURL1B;CAMSAP3;RPL28;SEC14L1;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;CPT1B;SLC5A1;ARHGEF2;SNX27;UGCG;LLGL1;HM13;CEACAM1;APBA1;ARHGAP44;AGAP1;IGF2BP3;TGFB1;SLC15A1;AZIN2;PIK3R2;STARD10;ANXA1;SLC45A3;PPP1R10;RAB6A;ARCN1
16150,GO:0090132,0.0131259919713676,0.992401734421475,32,203,epithelium migration,BP,WNT7A;PRSS3;CORO1B;AKT1;APOE;PKN1;TMSB4X;FERMT1;TGFBR2;PLCG1;GATA3;GIPC1;SRC;SH3BP1;RAB25;PPM1F;PFN1;ANXA3;PLEKHG5;FGFR1;RREB1;HYAL1;ADIPOR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;ITGA3;PXN
10320,GO:0043086,0.0131757412535069,0.990754464334392,72,542,negative regulation of catalytic activity,BP,ANGPTL4;NOS1;SORL1;DVL1;CST3;CYP27B1;SERPINE2;IFI6;FKBP1A;PRNP;LRP5;ADARB1;AKT1;SERPING1;APOE;PKN1;WWTR1;PRKCZ;EPHA1;PTK6;PPP1R35;SERPINB6;LIMK1;WDTC1;CD44;PRDX5;PPP1R12C;BIN1;RAG1;FARP1;DUSP4;DLG3;OXA1L;GNAI2;NEIL1;TFPI2;PPP1R14A;ARL2;TNFRSF6B;SRC;APLP2;SCG5;GSK3A;SPINT2;DUSP6;PPM1F;MICAL1;ANXA3;HEXIM1;TIMP1;CRIM1;SOCS2;PCSK1N;TRIB3;TRIB2;RNH1;MYO1D;CAMSAP3;EPHB2;CBL;CIB1;SOCS7;FURIN;TMBIM1;AIDA;CEACAM1;ECM1;SPRED2;CAMK2N1;PPP1R37;ANXA1;PPP1R10
13057,GO:0051494,0.0131838553926015,0.993819219263118,18,98,negative regulation of cytoskeleton organization,BP,ARAP1;TMOD2;ESPN;CORO1B;SHANK3;TMSB4X;EML2;WASF2;TWF2;TTBK2;CAPG;PFN1;CAMSAP3;CIB1;TMSB10;KANK2;ARHGEF2;PLEKHH2
12758,GO:0051004,0.0131878009166889,0.998302420748837,4,10,regulation of lipoprotein lipase activity,BP,ANGPTL4;LMF1;PCSK6;FURIN
5905,GO:0018108,0.013195009406923,0.992092936519506,36,234,peptidyl-tyrosine phosphorylation,BP,MST1R;MAP2K1;SHC1;ERCC6;NEURL1;DLG4;PRNP;SCYL1;BCR;EGFR;MAP2K2;PRKCZ;DGKQ;EPHA1;PTK6;PPP2R5B;CD44;RET;DLG3;HSF1;SRC;FYN;TNFRSF1A;FGFR1;ADNP;MIF;LRRK1;FGF2;EHD4;TGFA;EPHB2;CBL;MAPK3;ARHGEF2;TGFB1;ERBB3
17607,GO:1901214,0.0133963818372945,0.992229747743244,32,205,regulation of neuron death,BP,F2R;SORL1;BOK;PRNP;SSH1;AARS;ATF4;AKT1;APOE;ATP13A2;CTSZ;PCSK9;DKK1;PPARA;CDC34;DDIT3;RAB29;GATA3;HSF1;WFS1;ADAM8;STXBP1;FYN;ITGA1;ADNP;SIGMAR1;BCL2L1;LRP1;MAP3K12;CBL;ITSN1;ERBB3
8222,GO:0032970,0.0134327324618788,0.991705939811028,40,267,regulation of actin filament-based process,BP,RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;CORO1B;SHANK3;ARPC1A;TMSB4X;EPHA1;SH3PXD2B;LIMK1;WASF2;TWF2;FSCN1;PAK1;RHOC;RHOBTB2;CAPG;SH3BP1;PPM1F;PFN1;ARFIP2;LRP1;SPIRE1;VASP;TAOK1;RHOBTB1;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;ARHGAP44;TGFB1;PXN;ARHGEF10L;PLEKHH2;FHOD1
12539,GO:0050663,0.0134469115729828,0.993525353877948,19,107,cytokine secretion,BP,F2R;POSTN;XBP1;HK1;CARD11;ARG2;TMSB4X;PRKCZ;FERMT1;GATA3;ALOX15B;IL1RAP;MAPKBP1;SRC;CPTP;MIF;PNP;MAPK3;ANXA1
992,GO:0002446,0.0134968165926423,0.991188839021235,50,361,neutrophil mediated immunity,BP,PYGB;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;UBR4;C6ORF120;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;CAT;RAB6A;ERP44
3502,GO:0007409,0.0135600278287351,0.991330481350627,46,309,axonogenesis,BP,SH3KBP1;DVL1;MAP2K1;SHC1;WNT7A;PTPRS;SSH1;FAM129B;SEMA3F;VLDLR;ADARB1;STK25;SHANK3;APOE;MAP1B;LAMB2;GDI1;LIMK1;PLCG1;TWF2;PAK1;SEMA4B;TUBB3;RET;GRB10;GATA3;NUMB;SRC;DNM2;STXBP1;FYN;LPAR3;KIF13B;BRSK1;SEMA4G;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;EPHB2;MAPK3;NTNG1;LLGL1
11435,GO:0045834,0.0137432940263998,0.994058384621526,15,77,positive regulation of lipid metabolic process,BP,NR1D1;AKT1;APOE;PPARA;SRC;LDLRAP1;TAZ;TNFRSF1A;SMPD3;ZP3;FGF2;MLYCD;TGFB1;ANXA1;SLC45A3
4789,GO:0010976,0.0137665606972231,0.99216081430461,30,186,positive regulation of neuron projection development,BP,ZMYND8;DVL1;MAP2K1;NEURL1;CRTC1;DLG4;VLDLR;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;PPP2R5B;OBSL1;TWF2;PAK1;CUL7;RET;SHANK2;IL1RAP;FYN;LPAR3;FGFR1;ADNP;APBB1;CAMK1;ITGA3
8988,GO:0035088,0.0138486664779933,0.996001124859267,8,31,establishment or maintenance of apical/basal cell polarity,BP,DLG4;DLG1;MSN;FSCN1;DLG3;SH3BP1;LRCH4;CAMSAP3
14265,GO:0061245,0.0138486664779933,0.996001124859267,8,31,establishment or maintenance of bipolar cell polarity,BP,DLG4;DLG1;MSN;FSCN1;DLG3;SH3BP1;LRCH4;CAMSAP3
13059,GO:0051496,0.0138666137238825,0.995610570568367,9,37,positive regulation of stress fiber assembly,BP,RAPGEF3;EPHA1;SH3PXD2B;LIMK1;PAK1;PPM1F;PXN;ARHGEF10L;FHOD1
2203,GO:0005085,0.0139066553086533,0.991638882793583,36,231,guanyl-nucleotide exchange factor activity,MF,SHC1;DOCK4;DLG4;OBSCN;NET1;RAPGEF3;SBF1;BCR;EGFR;RIN2;RIN1;SHC2;PSD3;FARP1;DOCK9;RET;RASGEF1A;CYTH3;DOCK6;RGL2;ARHGEF4;DENND2A;FYN;RALGDS;PLEKHG5;FGFR1;DNMBP;ARFGEF2;FGF2;EPS8L1;TRAPPC1;IQSEC1;ARHGEF2;ITSN1;ERBB3;ARHGEF10L
12595,GO:0050730,0.0139229484446196,0.992520793747635,25,152,regulation of peptidyl-tyrosine phosphorylation,BP,SHC1;ERCC6;NEURL1;DLG4;PRNP;EGFR;PRKCZ;DGKQ;PTK6;PPP2R5B;CD44;DLG3;HSF1;SRC;FYN;TNFRSF1A;ADNP;MIF;LRRK1;EHD4;TGFA;CBL;ARHGEF2;TGFB1;ERBB3
19168,GO:1905114,0.0139395459091586,0.990528689053889,60,434,cell surface receptor signaling pathway involved in cell-cell signaling,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;WNT7A;DLG4;IGFBP4;PSMD2;SSH1;SMURF2;LRP5;CSNK1E;SHANK3;AKT1;GPC4;APOE;WWTR1;AP2A2;PRKCZ;FZD8;GRK6;FERMT1;DKK1;SOX7;CCDC88C;BCL9L;NLGN2;DDIT3;GNB1;GRB10;SHANK2;GATA3;GRIN3B;PTPRU;PLCB3;IGFBP2;SRC;AGO4;GSK3A;FUZ;WNT5B;PFN1;PSMD7;WISP1;TLE4;TNRC6B;NTSR1;LRP1;P2RX4;LRRK1;BICC1;INVS;ATP6V1C2;CSNK1D;CCNE1;ITGA3;TCF7L1
4764,GO:0010941,0.0139673585343062,0.989107126404853,146,1190,regulation of cell death,BP,ANGPTL4;XDH;F2R;MST1R;RBCK1;SORL1;NFATC4;MAP2K1;SHC1;WNT7A;CST3;NEURL1;BOK;OBSCN;DAP;IFI6;DNMT3A;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;SSH1;NME4;FAM129B;G0S2;CTSB;NACC2;MARK4;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MAP2K2;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;BAG3;APOE;ATP13A2;ARG2;SYVN1;RABGGTA;PRKCZ;CTSZ;EPHA1;PCSK9;ENDOG;HS1BP3;STK39;DKK1;SOX7;BNIP3L;PPARA;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;RET;RAB29;IFI27;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;GSK3A;STXBP1;DUSP6;FYN;ASNS;PPM1F;GRINA;MICAL1;TNFRSF1A;WISP1;VDR;PLEKHG5;MOAP1;GAL;ITGA1;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;LRP1;PAK4;FGF2;MAPK9;MAP3K12;TAOK1;APBB1;IMPACT;CASP4;EPHB2;CBL;CIB1;KANK2;GLO1;ARHGEF2;TMBIM1;MINK1;ITSN1;TGFB1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;TRAF7
15267,GO:0071417,0.01398547066528,0.990705187229441,54,379,cellular response to organonitrogen compound,BP,CAPN2;SHC1;NEURL1;PCK2;DNMT3A;RAPGEF3;PRNP;SSH1;SESN2;RAB31;ADCY7;XBP1;EGFR;PRKACA;ATF4;AKT1;PRKCZ;MAPK13;PCSK9;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;HSF1;EIF4EBP1;VAMP2;SRC;DNM2;GSK3A;FYN;GNB2;SOCS2;BCL2L1;ADIPOR1;TRIB3;TCIRG1;LRP1;P2RX4;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;SOCS7;MAPK3;ARHGEF2;CEACAM1;UROS;ADCY6;TGFB1;PIK3R2;PXN
2572,GO:0005856,0.014010769382739,0.988760233167492,191,1566,cytoskeleton,CC,FLNC;SH3KBP1;NOS1;H1F0;CAPN2;MPRIP;MST1R;RAC2;DVL1;MAP2K1;CLIP2;DLG4;SMTN;KLC2;DLG1;DYSF;PITPNM1;PGM1;MTA1;CKAP4;RAPGEF3;SSH1;SCYL1;TMOD2;MARVELD1;ESPN;TNNT1;TMEM214;SNPH;PLEK2;BBS2;OSBPL10;TUBB6;USP20;NUDCD3;MARK4;MMP14;SEPT10;PRKACA;CORO1B;ACTA2;MAP2K2;TUBG2;PARVB;ATF4;HECW2;AKT1;ACOT13;ARPC1A;TNS4;AFAP1L1;TMSB4X;PRKCZ;DGKQ;VPS4A;CCDC92;UACA;SH3PXD2B;FERMT1;EML2;SEPT5;MSN;MAP1B;RIN1;STK39;CORO2A;AKAP12;SYMPK;OBSL1;PRKACB;WASF2;TWF2;TACC1;BIN1;FSCN1;CCDC88C;PAK1;TTBK2;NAV1;PODXL;CUL7;ARHGAP39;TUBB3;STOM;FARP1;RAB29;GAS2L1;PLEKHH3;REEP2;PROCR;SEPT8;SHANK2;WDR66;PHF1;ARL8A;GNAI2;MYH16;HSF1;ADGRB2;ALOX15B;NEK9;ADAM8;MAPKBP1;NEIL1;MYH15;DYNLRB1;FAM110C;ARL2;CAP1;FLNB;TULP3;SRC;LDLRAP1;DENND2A;CAPG;DNM2;NINL;UBR4;CDC42BPB;SDCCAG8;STXBP1;SPECC1L;FYN;FUZ;REEP4;PFN1;MICAL1;KIF17;KIF13B;BRSK1;RAI14;PSKH1;MISP;TUBG1;CEP170;TTC19;VPS37A;RAB11FIP4;BCL2L1;DNMBP;AFAP1;PTPN12;NDOR1;RAD23A;ARFGEF2;TRIB2;HSPA2;SPIRE1;PNP;KLHL17;MAP1LC3B;VASP;ARAP3;MYO1D;SNTB2;PBXIP1;NDE1;CAMSAP3;INVS;GSDMC;BAIAP2L1;WIPF1;SNAP29;KRT23;MYL9;GAS8;CIB1;TMSB10;WRAP73;MAPK3;KANK2;CSNK1D;KIFC3;ALDOC;ARHGEF2;MYZAP;LLGL1;MPLKIP;ENKD1;MAP6;SAC3D1;SH3PXD2A;ANXA1;CCDC113;PXN;PLEKHH2;RAP1GAP2;STIM1;MZT2B;ASAP1;FHOD1
10000,GO:0042398,0.0140288861635381,0.995902017232448,8,33,cellular modified amino acid biosynthetic process,BP,CHAC1;HAGH;GAMT;PTDSS2;CNDP2;ALDH7A1;SLC27A1;GGT1
10574,GO:0043523,0.0140410094372514,0.992674591289249,23,137,regulation of neuron apoptotic process,BP,F2R;BOK;PRNP;AARS;ATF4;APOE;CTSZ;PCSK9;CDC34;DDIT3;GATA3;WFS1;ADAM8;STXBP1;FYN;ITGA1;ADNP;SIGMAR1;BCL2L1;LRP1;MAP3K12;ITSN1;ERBB3
26,GO:0000050,0.0140817425993377,0.998150645759395,4,10,urea cycle,BP,NAGS;ARG2;ASS1;ARG1
6191,GO:0019627,0.0140817425993377,0.998150645759395,4,10,urea metabolic process,BP,NAGS;ARG2;ASS1;ARG1
13010,GO:0051402,0.0141229070622724,0.992299149547686,26,160,neuron apoptotic process,BP,F2R;BOK;PRNP;BNIP3;AARS;ADARB1;ATF4;APOE;CTSZ;PCSK9;CDC34;DDIT3;GATA3;WFS1;ADAM8;FAM162A;STXBP1;FYN;ITGA1;ADNP;SIGMAR1;BCL2L1;LRP1;MAP3K12;ITSN1;ERBB3
4034,GO:0009065,0.0141465438077538,0.99684952702697,6,20,glutamine family amino acid catabolic process,BP,NOS1;ARG2;GLUL;GLUD1;ALDH4A1;ARG1
7213,GO:0031099,0.0141624171573816,0.992857436744038,21,122,regeneration,BP,PGF;CCND1;MAP2K1;WNT7A;POSTN;PTPRS;MAP4K4;EGFR;PTPRF;APOE;TGFBR2;LAMB2;PTPRU;STK24;ANXA3;PTPN12;ULK1;KLK6;ADAM15;TGFB1;ANXA1
15015,GO:0070920,0.0141666487350565,0.99742946822976,5,15,regulation of production of small RNA involved in gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;TGFB1
16276,GO:0090313,0.0141961361333973,0.99631053366014,7,26,regulation of protein targeting to membrane,BP,PRNP;GDI1;PAK1;STOM;CEMIP;FYN;CIB1
9041,GO:0035249,0.0142272303050242,0.995871250264143,8,31,synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;SHANK3;DKK1;NLGN2;GLUL;SHANK2;STXBP1
5550,GO:0016540,0.0144367479954935,0.998089498497314,4,10,protein autoprocessing,BP,CAPN2;PCSK9;F12;KLK6
2981,GO:0006525,0.0144585384957443,0.997362625757328,5,15,arginine metabolic process,BP,NOS1;NAGS;ARG2;ASS1;ARG1
8003,GO:0032616,0.0145496054962096,0.99806995749998,4,10,interleukin-13 production,BP,ARG2;PRKCZ;GATA3;IL1RAP
6136,GO:0019395,0.0145515246031587,0.993652141871693,15,79,fatty acid oxidation,BP,CPT2;CYGB;SESN2;CRAT;AKT1;ACAD10;TYSND1;HADH;PPARA;ACADVL;ADIPOR1;MLYCD;PHYH;LONP2;CPT1B
16864,GO:0098751,0.0145596810108506,0.996222921735739,7,25,bone cell development,BP,FAM20C;WASF2;ZNF385A;SRC;ZFPM1;LRRK1;EP300
10661,GO:0043687,0.0146306927392544,0.990634081958473,45,317,post-translational protein modification,BP,QSOX1;CST3;IGFBP4;PSMD2;CKAP4;CRTAP;LY6K;LAMB1;P4HB;FBXW8;APOE;RABGGTA;FAM20C;FBXO2;PCSK9;FBXW5;LAMB2;OBSL1;LTBP1;WDTC1;UBXN7;CUL7;DCAF7;ANO8;WFS1;LY6E;APLP2;NUCB1;RAB1B;PSMD7;FBXL15;VWA1;SHISA5;RCN1;LYPD5;TIMP1;SOCS2;ASB13;DDB2;MSLN;SPSB3;ARSK;NTNG1;MATN3;ARSD
12197,GO:0048308,0.0147378431897645,0.997298319221098,5,15,organelle inheritance,BP,MAP2K1;MAP2K2;STK25;STX5;MAPK3
18593,GO:1903793,0.0147652387869776,0.996645785365414,6,21,positive regulation of anion transport,BP,APOE;STXBP1;NTSR1;MIF;P2RX4;ABCA7
11482,GO:0045922,0.0148580918432488,0.997270530261611,5,15,negative regulation of fatty acid metabolic process,BP,AKT1;WDTC1;ACADVL;TRIB3;CEACAM1
8721,GO:0034358,0.0148704161557593,0.997221272941241,5,16,plasma lipoprotein particle,CC,SORL1;VLDLR;APOE;PLTP;PCYOX1
19654,GO:1990777,0.0148704161557593,0.997221272941241,5,16,lipoprotein particle,CC,SORL1;VLDLR;APOE;PLTP;PCYOX1
950,GO:0002366,0.0148797045634643,0.989749271604266,63,471,leukocyte activation involved in immune response,BP,PYGB;ERCC1;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;XBP1;AP2A2;PRKCZ;GALNS;CTSZ;PI4K2A;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;GATA3;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MFNG;MIF;TCIRG1;ZFPM1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;TGFB1;CAT;ANXA1;RAB6A;ERP44
4646,GO:0010766,0.0149842139954333,0.997994251870708,4,10,negative regulation of sodium ion transport,BP,SERPINE2;HECW2;PCSK9;STK39
5934,GO:0018209,0.0149952026829,0.990999289522153,35,227,peptidyl-serine modification,BP,RAPGEF3;MAPKAPK3;EGFR;CSNK1E;MKNK2;PRKACA;MAP2K2;AKT1;PKN1;PRKCZ;DGKQ;MAPK13;TGFBR2;STK39;DKK1;CD44;PAK1;TTBK2;RET;PKD1;HMGA2;TOP1;SRC;PPM1F;PSKH1;MAP3K10;MIF;ULK1;MAPK9;MAP3K12;CAMK1;MAPK3;CSNK1D;GALNT3;TGFB1
8167,GO:0032890,0.0149959899099573,0.996058980812771,7,26,regulation of organic acid transport,BP,AKT1;STK39;STXBP1;NTSR1;MIF;P2RX4;ARG1
13520,GO:0055065,0.0150040834482721,0.990331652060787,46,323,metal ion homeostasis,BP,NOS1;F2R;CYP27B1;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;EGFR;SLC12A7;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;SFXN3;DDIT3;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;COMT;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
4111,GO:0009165,0.015064372955297,0.990944143089388,35,234,nucleotide biosynthetic process,BP,NOS1;PTHLH;NAPRT;PGM1;IDH2;NME4;ACOT7;ADCY7;TK2;HK1;APOE;TMSB4X;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;GNAI2;PPCS;PANK4;CAP1;TAZ;GARS;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ALDOC;ADCY6;TGFB1;LDHA
10313,GO:0043067,0.0151209593537961,0.988261490036338,137,1113,regulation of programmed cell death,BP,ANGPTL4;XDH;F2R;MST1R;RBCK1;NFATC4;MAP2K1;SHC1;WNT7A;CST3;NEURL1;BOK;OBSCN;DAP;IFI6;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;NME4;FAM129B;G0S2;CTSB;NACC2;MARK4;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MAP2K2;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;BAG3;APOE;ARG2;SYVN1;RABGGTA;PRKCZ;CTSZ;EPHA1;PCSK9;ENDOG;HS1BP3;STK39;DKK1;SOX7;BNIP3L;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;RET;IFI27;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;GSK3A;STXBP1;DUSP6;FYN;ASNS;PPM1F;GRINA;MICAL1;TNFRSF1A;VDR;PLEKHG5;MOAP1;GAL;ITGA1;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;LRP1;PAK4;MAPK9;MAP3K12;TAOK1;APBB1;CASP4;EPHB2;CBL;CIB1;KANK2;GLO1;ARHGEF2;TMBIM1;MINK1;ITSN1;TGFB1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;TRAF7
5098,GO:0015370,0.0153159961929899,0.995493949862325,8,31,solute:sodium symporter activity,MF,SLC20A1;SLC6A6;SLC13A3;SLC6A9;SLC13A5;SLC6A14;SLC10A6;SLC5A1
14048,GO:0060753,0.0154851881656033,0.998772242123796,3,6,regulation of mast cell chemotaxis,BP,PGF;RAC2;VEGFB
3952,GO:0008652,0.0155038442401026,0.993947791625716,12,58,cellular amino acid biosynthetic process,BP,CBS;NAGS;GPT2;PSAT1;AHCY;GAMT;GLUL;ASS1;GLUD1;PYCR2;ASNS;GGT1
12574,GO:0050707,0.0155141838215613,0.992763311444981,17,94,regulation of cytokine secretion,BP,F2R;POSTN;XBP1;HK1;ARG2;TMSB4X;PRKCZ;FERMT1;GATA3;ALOX15B;IL1RAP;MAPKBP1;SRC;CPTP;MIF;MAPK3;ANXA1
3740,GO:0008277,0.0156069601417594,0.993132721615805,15,79,regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2;USP20;DGKQ;GRK6;GIT2;GIT1;APLN;TULP3;DNM2;GSK3A;MGLL;MGRN1;HOMER2;KLK6
3558,GO:0007600,0.0156416079074221,0.99081159654184,32,208,sensory perception,BP,F2R;SERPINE2;ESPN;BBS2;TUB;RABGGTA;ITPR3;EML2;LAMB2;SERPINB6;NLGN2;GNB1;REEP2;CEMIP;ASIC1;WFS1;REEP6;FYN;ALDH7A1;COMT;NTSR1;MGLL;HSF4;FGFR1;P2RX4;CHD7;HOMER2;MAPK3;KIFC3;DRAM2;GNAS;NIPSNAP1
3189,GO:0006814,0.0157044938424941,0.992004844430487,21,120,sodium ion transport,BP,NOS1;SCN8A;SERPINE2;DLG1;HECW2;AKT1;SLC20A1;PCSK9;STK39;PRSS8;SLC38A10;STOM;ASIC1;SLC13A3;GLRX;DNM2;SLC13A5;P2RX4;SLC10A6;SLC5A1;TGFB1
15160,GO:0071243,0.0157283320191462,0.997017951991001,5,16,cellular response to arsenic-containing substance,BP,MKNK2;ATF4;MAPK13;HSF1;UROS
14150,GO:0060996,0.0157369711889043,0.993318872759864,14,70,dendritic spine development,BP,ZMYND8;DVL1;WNT7A;NEURL1;DLG4;PTPRS;SHANK3;APOE;SHANK2;PAK4;CAMK1;EPHB2;ARHGAP44;ASAP1
13656,GO:0060135,0.0158447178770416,0.994466184047558,10,44,maternal process involved in female pregnancy,BP,CYP27B1;BSG;CTSB;ADCY7;AKT1;EPOR;VDR;RXRA;ARG1;ITGA3
5937,GO:0018212,0.015897744081281,0.990338093960716,36,237,peptidyl-tyrosine modification,BP,MST1R;MAP2K1;SHC1;ERCC6;NEURL1;DLG4;PRNP;SCYL1;BCR;EGFR;MAP2K2;PRKCZ;DGKQ;EPHA1;PTK6;PPP2R5B;CD44;RET;DLG3;HSF1;SRC;FYN;TNFRSF1A;FGFR1;ADNP;MIF;LRRK1;FGF2;EHD4;TGFA;EPHB2;CBL;MAPK3;ARHGEF2;TGFB1;ERBB3
1170,GO:0002790,0.0160154405413952,0.989488317231343,49,346,peptide secretion,BP,LTBP2;F2R;LTBP4;LMF1;PCK2;NR1D1;POSTN;RAB3B;RAPGEF3;IDH2;COPG1;LRP5;ACVR2B;XBP1;MAP4K4;EGFR;RHBDF2;HK1;CARD11;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;POU2F2;FERMT1;HADH;NLGN2;GLUL;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;SRC;CPTP;GAL;MIF;SMPD3;PNP;CHD7;APBB1;MAPK3;LLGL1;TGFB1;ANXA1
15866,GO:0072562,0.0160304667140305,0.994762566506361,9,39,blood microparticle,CC,ANGPTL4;SERPING1;APOE;MSN;STOM;PFN1;LGALS3BP;HSPA2;TGFB1
14867,GO:0070613,0.0160960716419283,0.993992373310123,11,52,regulation of protein processing,BP,CHAC1;SERPINE2;PRNP;SERPING1;CTSZ;PRKACB;ADAM8;SRC;F12;CD59;PLGRKT
8774,GO:0034440,0.0161847394089495,0.992839650674359,15,80,lipid oxidation,BP,CPT2;CYGB;SESN2;CRAT;AKT1;ACAD10;TYSND1;HADH;PPARA;ACADVL;ADIPOR1;MLYCD;PHYH;LONP2;CPT1B
12885,GO:0051187,0.0162131206857254,0.995096924534759,8,35,cofactor catabolic process,BP,CHAC1;ACOT7;ALDH1L2;PRDX5;AHCY;GPX3;GGT1;CAT
17655,GO:1901342,0.0162132537946857,0.990635195547742,30,190,regulation of vasculature development,BP,ANGPTL4;XDH;PGF;ADM2;RAPGEF3;FAM129B;XBP1;THBS2;EPN1;EPN2;EPHA1;RRAS;TGFBR2;PLCG1;ADGRB2;HMGA2;MYDGF;ANXA3;HYAL1;PAK4;FGF2;RNH1;VEGFB;HGS;CIB1;SRPX2;CEACAM1;ECM1;ANXA1;STIM1
7759,GO:0032270,0.016263377457297,0.987375209572361,134,1081,positive regulation of cellular protein metabolic process,BP,TNIP1;EDEM1;XDH;NOS1;CCND1;F2R;MST1R;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;BOK;DLG4;DLG1;DAP;IGFBP4;FKBP1A;MTA1;RAPGEF3;PRNP;MAPKAPK3;VLDLR;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;PRKACA;MAP2K2;STK25;SNX33;AKT1;IRAK1;APOE;PKN1;PRKCZ;DGKQ;VPS11;FZD8;EPHA1;PTK6;PCSK9;MSN;TGFBR2;STK39;DKK1;SOX7;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;ANKIB1;LARP6;CCND2;PAK1;TNFSF15;BCDIN3D;RET;IFI27;CEMIP;PKD1;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;MYDGF;SRC;FAM162A;STK24;PAK6;GSK3A;DUSP6;FYN;PPM1F;LPAR3;TNFRSF1A;ITGA1;MAP3K10;FGFR1;ADNP;F12;MIF;STUB1;TRIB3;SLC27A1;RAD23A;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;TAOK1;ABCA7;RXRA;TGFA;IMPACT;CASP4;CAMK1;EPHB2;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;FURIN;ARHGEF2;MINK1;ADCY6;TGFB1;WBP2;ERBB3;PLGRKT;WDFY2;TRAF7
5666,GO:0016772,0.0163071016267222,0.987802462490013,101,777,transferase activity, transferring phosphorus-containing groups,MF,CCND1;MST1R;LTBP4;MAP2K1;DLG4;OBSCN;DLG1;DGKA;RPS6KA2;NAGS;SCYL1;NME4;MAPKAPK3;BCR;MARK4;ACVR2B;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;PRKACA;HK1;MAP2K2;STK25;AKT1;CDS2;CARD11;IRAK1;UAP1;PKN1;PRKCZ;FAM20C;DGKQ;MAPK13;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;NADK;PRKACB;LTBP1;MAP3K9;PAK1;TTBK2;PTDSS2;RET;DLG3;OASL;PANK4;NEK9;HMGA2;TOP1;PIP5K1C;SRC;POLD4;CDC42BPB;MARK3;STK24;PAK6;GSK3A;PMVK;OAS1;FYN;PRIMPOL;UCKL1;BRSK1;PSKH1;MAP3K10;CRIM1;FGFR1;GUK1;CDK18;STK17A;PIP5KL1;ULK1;PAK4;ULK2;LRRK1;FGF2;MAPK9;MAP3K12;TAOK1;TRPT1;CAMK1;EPHB2;POLM;MAPK3;MAPK10;CSNK1D;MINK1;CCNE1;ADCK2;PIK3R2;ERBB3;ZFYVE21
10434,GO:0043268,0.0163170231770961,0.996928558169216,5,15,positive regulation of potassium ion transport,BP,FHL1;DLG1;STK39;DNM2;GAL
2103,GO:0004867,0.0163251235190431,0.994617710059072,9,41,serine-type endopeptidase inhibitor activity,MF,SERPINE2;SERPING1;SERPINB6;TFPI2;APLP2;SPINT2;CRIM1;PCSK1N;FURIN
9958,GO:0042310,0.0163885600322445,0.994642559050376,9,38,vasoconstriction,BP,F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;RAP1GDS1;APLN;EDNRA
686,GO:0001893,0.0164393702068408,0.995597701309603,7,26,maternal placenta development,BP,CYP27B1;BSG;CTSB;AKT1;EPOR;VDR;RXRA
19874,GO:2000311,0.0165819146661121,0.997709916369441,4,10,regulation of AMPA receptor activity,BP,SHANK3;NLGN2;SHANK2;MINK1
10504,GO:0043395,0.0166689888835744,0.997694155026368,4,10,heparan sulfate proteoglycan binding,MF,PTPRS;GPC4;AGRN;LRP1
6989,GO:0030660,0.0167462532776791,0.992325030766045,16,88,Golgi-associated vesicle membrane,CC,SCYL1;COPG1;SEC23A;KDELR1;TMED3;PKD1;LDLRAP1;STX5;MCFD2;SEC24C;USO1;LMAN1;TGFA;HM13;CD59;ARCN1
19489,GO:1990138,0.0167623999199728,0.991575010682666,20,112,neuron projection extension,BP,DVL1;POSTN;PTPRS;SEMA3F;APOE;PRKCZ;MAP1B;LAMB2;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;SEMA4G;ADNP;ULK1;ULK2;SLIT3;IMPACT
10862,GO:0044351,0.0170085814812749,0.998601545662793,3,6,macropinocytosis,BP,MAPKAPK3;SNX33;DNM2
4671,GO:0010817,0.0170145386943474,0.989246183026084,41,282,regulation of hormone levels,BP,LTBP4;CYP27B1;PCK2;SLCO4A1;NR1D1;RAPGEF3;FAM129B;LRP5;ACVR2B;MAP4K4;EGFR;ITPR3;DGKQ;CTSZ;RETSAT;HADH;IDE;ERO1B;NLGN2;GLUL;GATA3;APLN;GLUD1;SRD5A3;ARL2;ALDH1A2;SCG5;PCSK6;HSD11B1;VDR;GAL;COMT;FGFR1;STUB1;PCSK1N;SMPD3;CHD7;KLK6;FURIN;ANXA1;GNAS
15668,GO:0072163,0.0171203634164374,0.992923322107291,13,64,mesonephric epithelium development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ARG2;RET;PKD1;GATA3;FGFR1;FGF2;TGFB1;CAT
15669,GO:0072164,0.0171203634164374,0.992923322107291,13,64,mesonephric tubule development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ARG2;RET;PKD1;GATA3;FGFR1;FGF2;TGFB1;CAT
7058,GO:0030828,0.0171547195262227,0.99858483454881,3,6,positive regulation of cGMP biosynthetic process,BP,NOS1;APOE;ADNP
2660,GO:0006002,0.0172295608821662,0.998576253935067,3,6,fructose 6-phosphate metabolic process,BP,PFKP;TALDO1;MPI
148,GO:0000302,0.0172540673053034,0.990404322080468,26,167,response to reactive oxygen species,BP,SDC1;ERCC6;CST3;NET1;BNIP3;SESN2;EGFR;STK25;AKT1;APOE;MAPK13;ENDOG;PRDX5;HSF1;SRC;DNM2;STK24;HYAL1;MAPK9;ARG1;IMPACT;MAPK3;CAT;LDHA;ANXA1;PXN
6071,GO:0019217,0.0172918997725068,0.993143569441462,12,58,regulation of fatty acid metabolic process,BP,AKT1;TYSND1;PPARA;WDTC1;ACADVL;ADIPOR1;TRIB3;MLYCD;LONP2;CEACAM1;ANXA1;SLC45A3
4472,GO:0010466,0.0172955646311472,0.990913148005589,22,138,negative regulation of peptidase activity,BP,SORL1;CST3;SERPINE2;IFI6;AKT1;SERPING1;SERPINB6;CD44;PRDX5;BIN1;RAG1;TFPI2;TNFRSF6B;SRC;APLP2;SPINT2;MICAL1;TIMP1;CRIM1;PCSK1N;FURIN;ECM1
16883,GO:0098793,0.0173049497655129,0.98975103826016,32,209,presynapse,CC,ADGRL1;DVL1;WNT7A;AP3D1;DLG4;FKBP1A;RAB3B;PTPRS;DBNDD1;SNPH;PI4K2A;SEPT5;RABAC1;NLGN2;GLUL;DMXL2;SYTL1;VAMP2;PIP5K1C;GIPC1;STXBP1;SLC6A9;MICAL1;BRSK1;NTSR1;BCL2L1;P2RX4;APBB1;SNAP29;KCNC4;APBA1;ARHGAP44
10025,GO:0042445,0.0173078908199087,0.991244992337565,20,118,hormone metabolic process,BP,CYP27B1;DGKQ;CTSZ;RETSAT;IDE;ERO1B;GATA3;SRD5A3;ALDH1A2;SCG5;PCSK6;HSD11B1;VDR;GAL;COMT;FGFR1;STUB1;PCSK1N;KLK6;FURIN
6795,GO:0030228,0.0173559337451823,0.997568876906428,4,10,lipoprotein particle receptor activity,MF,SORL1;VLDLR;LRP10;LRP1
15920,GO:0072673,0.0173571461737775,0.996679504420149,5,15,lamellipodium morphogenesis,BP,CORO1B;WASF2;CD44;SRC;RREB1
1933,GO:0004629,0.0173851236377083,0.996672746894535,5,15,phospholipase C activity,MF,PLCH2;PLCG1;PLCB3;EDNRA;PLCD3
2206,GO:0005088,0.0174680213183806,0.990065498281799,28,173,Ras guanyl-nucleotide exchange factor activity,MF,SHC1;DLG4;OBSCN;NET1;RAPGEF3;SBF1;BCR;EGFR;RIN2;RIN1;SHC2;FARP1;RET;RASGEF1A;RGL2;ARHGEF4;DENND2A;FYN;PLEKHG5;FGFR1;DNMBP;FGF2;EPS8L1;TRAPPC1;ARHGEF2;ITSN1;ERBB3;ARHGEF10L
12205,GO:0048333,0.0175173858489178,0.99664076016741,5,15,mesodermal cell differentiation,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA3
8660,GO:0034199,0.0175278077545532,0.997537275785729,4,10,activation of protein kinase A activity,BP,ADCY7;PRKACA;PRKACB;ADCY6
13253,GO:0051897,0.0175743062921382,0.991911785503079,16,86,positive regulation of protein kinase B signaling,BP,MST1R;EGFR;MC1R;GATA3;ADAM8;FAM110C;MYDGF;SRC;FYN;FGFR1;HPSE;FGF2;ITSN1;TGFB1;PIK3R2;ERBB3
12294,GO:0048588,0.0176146446113314,0.990472509968416,24,143,developmental cell growth,BP,DVL1;POSTN;PTPRS;SEMA3F;APOE;PRKCZ;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;GSK3A;LPAR3;GAL;SEMA4G;ADNP;ULK1;ULK2;SLIT3;IMPACT
3787,GO:0008349,0.0176242747453428,0.997519494668789,4,10,MAP kinase kinase kinase kinase activity,MF,MAP4K4;STK25;STK24;MINK1
6420,GO:0021680,0.0176944229060873,0.996597839888083,5,15,cerebellar Purkinje cell layer development,BP,AARS;NAGLU;B4GALT2;RERE;ARCN1
17738,GO:1901626,0.0177033391261013,0.998521585507445,3,6,regulation of postsynaptic membrane organization,BP,ZMYND8;SSH1;APOE
14243,GO:0061162,0.0178030121212449,0.996571454666595,5,15,establishment of monopolar cell polarity,BP,MSN;MAP1B;FSCN1;SH3BP1;CAMSAP3
14290,GO:0061339,0.0178030121212449,0.996571454666595,5,15,establishment or maintenance of monopolar cell polarity,BP,MSN;MAP1B;FSCN1;SH3BP1;CAMSAP3
9903,GO:0042176,0.0178293358114907,0.98856074310121,43,301,regulation of protein catabolic process,BP,EDEM1;SORL1;DVL1;CST3;SNX9;SERPINE2;SMURF2;LPCAT1;XBP1;EGFR;CSNK1E;PANO1;PRKACA;HECW2;SNX33;AKT1;APOE;ATP13A2;VPS11;PCSK9;MSN;UBE2J1;IDE;ANKIB1;SUFU;GGA3;GGA1;PKD1;ADAM8;GIPC1;STX5;GSK3A;FYN;TIMP1;STUB1;TRIB3;RAD23A;LRP1;TRIB2;HGS;CSNK1D;FURIN;AZIN2
8664,GO:0034205,0.0178593178627771,0.995762886568747,6,21,amyloid-beta formation,BP,SORL1;PRNP;APOE;BIN1;GSK3A;ABCA7
12613,GO:0050770,0.0178758525000694,0.990774677583027,21,121,regulation of axonogenesis,BP,MAP2K1;WNT7A;PTPRS;SSH1;SEMA3F;STK25;APOE;MAP1B;GDI1;LIMK1;TWF2;PAK1;SEMA4B;RET;DNM2;LPAR3;KIF13B;SEMA4G;ADNP;ULK2;EPHB2
11318,GO:0045621,0.0179101216414359,0.99319348966137,11,53,positive regulation of lymphocyte differentiation,BP,AP3D1;XBP1;MMP14;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1
9048,GO:0035256,0.017983282518065,0.998489001987708,3,6,G-protein coupled glutamate receptor binding,MF,PRNP;FYN;HOMER2
3428,GO:0007218,0.0180406891726563,0.996404422737705,5,17,neuropeptide signaling pathway,BP,NXPH4;SCG5;GAL;NTSR1;PCSK1N
9071,GO:0035296,0.0181158120922212,0.992433913050945,13,66,regulation of tube diameter,BP,NOS1;F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;APOE;RAP1GDS1;APLN;EDNRA;ITGA1;ADCY6
16752,GO:0097746,0.0181158120922212,0.992433913050945,13,66,regulation of blood vessel diameter,BP,NOS1;F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;APOE;RAP1GDS1;APLN;EDNRA;ITGA1;ADCY6
12130,GO:0048167,0.0183069588163624,0.991302376603443,17,93,regulation of synaptic plasticity,BP,NFATC4;NEURL1;CRTC1;DLG4;SERPINE2;PRNP;SSH1;SHANK3;APOE;PRKCZ;ITPR3;SHANK2;VAMP2;GIPC1;STXBP1;EPHB2;PAIP2
10413,GO:0043236,0.0183901416802205,0.995607441337396,6,21,laminin binding,MF,ITGA6;NID1;AGRN;LYPD5;ECM1;ITGA3
598,GO:0001763,0.0184156230499466,0.990143606843492,23,136,morphogenesis of a branching structure,BP,PGF;CTNNBIP1;NFATC4;DLG1;LAMA5;ETV5;LRP5;MMP14;COL13A1;CTSZ;TGFBR2;PAK1;PKD1;EDNRA;SRC;TGM2;RERE;SPINT2;VDR;FGFR1;FGF2;RXRA;TGFB1
8073,GO:0032736,0.0185595585845057,0.998421277771179,3,6,positive regulation of interleukin-13 production,BP,PRKCZ;GATA3;IL1RAP
13860,GO:0060440,0.0185933554739932,0.998417279028515,3,6,trachea formation,BP,MAP2K1;TGFBR2;MAPK3
18373,GO:1903317,0.0186404675234499,0.992872610516736,11,53,regulation of protein maturation,BP,CHAC1;SERPINE2;PRNP;SERPING1;CTSZ;PRKACB;ADAM8;SRC;F12;CD59;PLGRKT
18281,GO:1903078,0.0187104992411282,0.993720857676411,9,39,positive regulation of protein localization to plasma membrane,BP,DLG1;PRNP;EGFR;AKT1;PTPN9;LRP1;EPHB2;CIB1;ITGA3
6082,GO:0019233,0.0187416367259227,0.993689557286429,9,40,sensory perception of pain,BP,F2R;NLGN2;FYN;COMT;NTSR1;MGLL;P2RX4;MAPK3;NIPSNAP1
15911,GO:0072659,0.0188131890109138,0.989103701155505,29,185,protein localization to plasma membrane,BP,BSG;DLG1;PRNP;LAMA5;BBS2;RAB31;EGFR;TTC7B;AKT1;EHD3;PRKCZ;VPS4A;TSPAN5;PTPN9;NUMB;VAMP2;LDLRAP1;STXBP1;TNFRSF1A;TSPAN33;BCL2L1;LRP1;EPHB2;CIB1;PACS2;TMBIM1;ARHGAP44;TGFB1;ITGA3
16693,GO:0097581,0.0188719345578196,0.992083874938722,13,65,lamellipodium organization,BP,RAC2;SSH1;CORO1B;PARVB;WASF2;CD44;TWF2;FSCN1;ARHGEF4;SRC;DNM2;RREB1;ARFIP2
6192,GO:0019637,0.0188968096885828,0.985688943826424,105,847,organophosphate metabolic process,BP,NT5E;XDH;NOS1;SERINC2;PYGL;PTHLH;MBOAT2;LPCAT4;NAPRT;PCK2;DLG4;DLG1;PITPNM1;PGM1;DGKA;RAPGEF3;IDH2;SBF1;AGPAT3;NME4;PLCH2;ACOT7;OSBPL10;LPCAT1;H6PD;ADCY7;PGLS;EGFR;TK2;HK1;TTC7B;CDS2;MDH2;CARD11;APOE;CRYL1;TMSB4X;FAM20C;DGKQ;PI4K2A;PFKP;PCSK9;NMRK1;PPARA;DHTKD1;NADK;PLCG1;GTPBP1;OSBPL5;ISYNA1;PTDSS2;PARP10;DLG3;PIGQ;GNAI2;PPCS;PANK4;SRD5A3;SDHA;NEIL1;PLCB3;CAP1;PIP5K1C;SRC;TAZ;GARS;TALDO1;PMVK;FYN;MPI;SPTLC2;MBOAT7;UCKL1;NTSR1;LHPP;FGFR1;ADNP;GUK1;MTMR4;AMPD2;VPS9D1;TCIRG1;PITPNM2;SLC27A1;PIP5KL1;AGPAT4;PLCD3;SMPD3;ZP3;PNP;FGF2;ABHD14B;ALDOC;NDUFS2;OCRL;PNPLA6;LPIN3;ADCY6;TGFB1;LDHA;PIK3R2;STARD10;ERBB3;PODXL2;ZFYVE21
8149,GO:0032868,0.0188987392038846,0.988937769507007,30,193,response to insulin,BP,SHC1;PCK2;SESN2;RAB31;XBP1;AKT1;PRKCZ;PCSK9;HADH;PPARA;WDTC1;IDE;PAK1;GRB10;EIF4EBP1;VAMP2;SRC;GSK3A;GAL;SOCS2;ADIPOR1;TRIB3;TCIRG1;SLC27A1;BAIAP2L1;ATP6V1C2;SOCS7;CEACAM1;CAT;PIK3R2
16146,GO:0090128,0.018986022218946,0.998370603321581,3,6,regulation of synapse maturation,BP,NFATC4;ADGRL1;NEURL1
17727,GO:1901607,0.0190289144357261,0.99270109418701,11,53,alpha-amino acid biosynthetic process,BP,CBS;NAGS;PSAT1;AHCY;GAMT;GLUL;ASS1;GLUD1;PYCR2;ASNS;GGT1
16594,GO:0097367,0.0190324862417458,0.984569775695857,193,1586,carbohydrate derivative binding,MF,PGF;NOS1;LTBP2;MST1R;RAC2;LTBP4;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;SERPINE2;DGKA;POSTN;RAB3B;RPS6KA2;RAPGEF3;PTPRS;PRNP;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;CTSB;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;THBS2;SEPT10;PRKACA;PTPRF;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;GPC4;IRAK1;APOE;EHD3;ATP13A2;PKN1;COL13A1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;SEPT5;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;CD44;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;CTBS;GLUL;TUBB3;RET;RAB29;LAMC2;RHOC;NID1;HLTF;CEMIP;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;MYH15;RHOBTB2;TOP1;ARL2;PIP5K1C;SRC;APLP2;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PCSK6;PMVK;OAS1;SLFN5;FYN;RAB25;AGRN;ASNS;KIF17;WISP1;KIF13B;UCKL1;BRSK1;PSKH1;CTSL;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;LRP1;HSPA2;PAK4;P2RX4;HPSE;ULK2;LRRK1;PNP;FGF2;EHD4;RNASE7;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;VEGFB;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;AGAP1;ADCY6;ADCK2;ERBB3;PODXL2;RAB6A;GNAS;THBS3
14213,GO:0061098,0.0190708619735367,0.994701290344788,7,27,positive regulation of protein tyrosine kinase activity,BP,ERCC6;NEURL1;DLG4;PRNP;DLG3;TGFA;ERBB3
12317,GO:0048640,0.0190996485789984,0.991975107039441,13,65,negative regulation of developmental growth,BP,PTPRS;WWC3;BBS2;SEMA3F;TGFBR2;PAK1;SEMA4B;RAI1;GSK3A;GAL;SEMA4G;SOCS2;ULK2
18824,GO:1904338,0.0191777413716754,0.998347669845451,3,6,regulation of dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D
636,GO:0001823,0.019208763772868,0.991922919215931,13,65,mesonephros development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ARG2;RET;PKD1;GATA3;FGFR1;FGF2;TGFB1;CAT
7504,GO:0031670,0.0192209222954592,0.993039586311022,10,46,cellular response to nutrient,BP,CYP27B1;POSTN;SSH1;XBP1;HSF1;FYN;VDR;USF2;P2RX4;KANK2
12616,GO:0050773,0.0192415885609506,0.990580894801741,18,100,regulation of dendrite development,BP,ZMYND8;NFATC4;NEURL1;CRTC1;PTPRS;VLDLR;SHANK3;HECW2;FBXW8;APOE;CSMD3;OBSL1;CUL7;SHANK2;IL1RAP;CAMK1;ARHGAP44;ASAP1
3084,GO:0006658,0.0192509649869351,0.995353021936411,6,21,phosphatidylserine metabolic process,BP,SERINC2;LPCAT4;OSBPL10;OSBPL5;PTDSS2;SLC27A1
7825,GO:0032373,0.0193307661145611,0.996131903500676,5,16,positive regulation of sterol transport,BP,APOE;LDLRAP1;PLTP;LRP1;ABCA7
7828,GO:0032376,0.0193307661145611,0.996131903500676,5,16,positive regulation of cholesterol transport,BP,APOE;LDLRAP1;PLTP;LRP1;ABCA7
5476,GO:0016406,0.0194529236855126,0.998314588497327,3,6,carnitine O-acyltransferase activity,MF,CPT2;CRAT;CPT1B
5482,GO:0016413,0.0194664146495722,0.998312961716207,3,6,O-acetyltransferase activity,MF,LPCAT4;LPCAT1;CRAT
5789,GO:0017015,0.019512743021743,0.991163033115024,15,80,regulation of transforming growth factor beta receptor signaling pathway,BP,LTBP4;SMURF2;FERMT1;TGFBR2;LTBP1;HTRA1;BCL9L;GIPC1;DNM2;MTMR4;STUB1;SNX25;PMEPA1;TGFB1;ITGA3
3068,GO:0006635,0.0196401092815885,0.992032284664707,12,61,fatty acid beta-oxidation,BP,CPT2;SESN2;CRAT;AKT1;ACAD10;TYSND1;HADH;PPARA;ACADVL;MLYCD;LONP2;CPT1B
10314,GO:0043068,0.0196709372162805,0.986238877333158,63,474,positive regulation of programmed cell death,BP,XDH;F2R;RBCK1;NFATC4;NEURL1;BOK;OBSCN;DAP;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;G0S2;NACC2;MARK4;PANO1;ATF4;AKT1;CTSZ;PCSK9;ENDOG;SOX7;BNIP3L;CDC34;MAP3K9;DEDD2;BIN1;DDIT3;TNFSF15;RET;IFI27;HSF1;ADAM8;HMGA2;ARHGEF4;ALDH1A2;SRC;TGM2;DNM2;FAM162A;STPG1;GSK3A;DUSP6;PPM1F;VDR;PLEKHG5;MOAP1;GAL;ITGA1;NTSR1;MAP3K10;BCL2L1;STK17A;MAPK9;APBB1;CASP4;ARHGEF2;ITSN1;TGFB1;LDHA;ANXA1;TRAF7
8081,GO:0032754,0.0197291949585417,0.998281183044878,3,6,positive regulation of interleukin-5 production,BP,PRKCZ;GATA3;IL1RAP
18030,GO:1902474,0.0197297619962198,0.998281114283182,3,6,positive regulation of protein localization to synapse,BP,DVL1;WNT7A;NLGN2
19655,GO:1990778,0.0197421435419251,0.988183767678426,32,209,protein localization to cell periphery,BP,BSG;DLG1;PRNP;LAMA5;BBS2;RAB31;EGFR;TUB;TTC7B;AKT1;EHD3;PRKCZ;VPS4A;TSPAN5;PTPN9;RAB29;NUMB;VAMP2;TULP3;LDLRAP1;STXBP1;TNFRSF1A;TSPAN33;BCL2L1;LRP1;EPHB2;CIB1;PACS2;TMBIM1;ARHGAP44;TGFB1;ITGA3
12315,GO:0048638,0.0198275973777952,0.988240324315927,31,199,regulation of developmental growth,BP,PTPRS;WWC3;BBS2;SEMA3F;AKT1;APOE;SH3PXD2B;MAP1B;TGFBR2;GDI1;LIMK1;TWF2;PAK1;SEMA4B;GAMT;HSF1;RAI1;DNM2;GSK3A;DUSP6;AGRN;LPAR3;GAL;SEMA4G;FGFR1;ADNP;SOCS2;ULK2;ZP3;FGF2;CHD7
16842,GO:0098703,0.019937271894539,0.998255896377146,3,6,calcium ion import across plasma membrane,BP,PRNP;FAM155B;FYN
18098,GO:1902656,0.019937271894539,0.998255896377146,3,6,calcium ion import into cytosol,BP,PRNP;FAM155B;FYN
4337,GO:0009887,0.0199447968323897,0.985348052083451,84,642,animal organ morphogenesis,BP,PGF;FHL1;ITGB4;MDFI;CTNNBIP1;SDC1;DVL1;MAP2K1;WNT7A;SDK2;MEF2D;BSG;DLG1;FKBP1A;PSMD2;ITGA6;LAMA5;SMURF2;BBS2;BCR;ETV5;LRP5;ACVR2B;XBP1;EGFR;MMP14;LAMB1;ADARB1;ACTA2;PPP1R13L;SHANK3;GPC4;WWTR1;COL13A1;AP2A2;FAM20C;NAGLU;RFNG;CTSZ;SH3PXD2B;MSN;TGFBR2;DKK1;PPARA;HTRA1;SUFU;SP6;GAMT;SHANK2;PKD1;GATA3;ARID5B;MICAL2;TULP3;ALDH1A2;SRC;TGM2;GSK3A;FUZ;PFN1;PSMD7;VDR;THRA;FGFR1;HYAL1;LEMD2;ZFPM1;E2F5;TBC1D20;FGF2;CHD7;SLIT3;RXRA;ARG1;TSHZ1;EPHB2;MAPK3;ADAM15;CEACAM1;TGFB1;GNAS;EP300;THBS3;STIM1
17726,GO:1901606,0.0199732774724426,0.991877313122094,12,61,alpha-amino acid catabolic process,BP,CBS;NOS1;GPT2;ARG2;HMGCL;AHCY;GLUL;GLUD1;BLMH;ALDH4A1;ALDH7A1;ARG1
17584,GO:1901142,0.0201729098039208,0.998227129438446,3,6,insulin metabolic process,BP,IDE;ERO1B;CEACAM1
6990,GO:0030662,0.0203222191514362,0.989345139722238,21,127,coated vesicle membrane,CC,SCYL1;COPG1;EGFR;EPN2;APOE;AP1B1;AP2A2;SEC23A;KDELR1;TMED3;CEMIP;VAMP2;LDLRAP1;STX5;MCFD2;SEC24C;USO1;LMAN1;TGFA;CD59;ARCN1
3271,GO:0006950,0.020340547831736,0.982886705606894,304,2667,response to stress,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;PGF;BTBD2;ITGB4;CBS;ERCC1;NOS1;CHAC1;CCND1;CAPN2;F2R;MST1R;RAC2;CTNNBIP1;NFATC4;SDC1;MAP2K1;SHC1;PLAT;WNT7A;ERCC6;CST3;CYP27B1;NAPRT;BOK;SHARPIN;PCK2;SERPINE2;NR1D1;DLG1;DAP;DYSF;IGFBP4;IFI6;DNMT3A;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RPS6KA2;NET1;PTPRS;PRNP;BNIP3;TXNDC11;RAB43;CYGB;LCN2;MAPKAPK3;CTSB;SESN2;ABTB1;NACC2;BCR;ETV5;FBLN1;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;PRKACA;ADARB1;PTPRF;CORO1B;MAP2K2;STK25;ATF4;P4HB;PDIA5;AKT1;XPC;IFITM1;CARD11;IRAK1;SERPING1;BAG3;APOE;EHD3;ATP13A2;ARG2;PKN1;SYVN1;ELK3;YIF1A;PHF21A;TMSB4X;TSPYL2;PRKCZ;RNF135;ITPR3;DGKQ;MAPK13;FZD8;HIST2H2BE;PTK6;TMEM129;FBXO2;PCSK9;ENDOG;NSMCE4A;DEAF1;TGFBR2;LAMB2;SERPINB6;STK39;DKK1;CREB3L2;PPP2R5B;UBE2J1;BNIP3L;PPARA;FAM3A;PRKACB;SIPA1;CD44;DNAJB5;ZNF516;ATG13;SEC63;MAP3K9;MSRB2;MC1R;PRDX5;HMGCL;HTRA1;CCDC88C;PAK1;AHCY;ZNF385A;RAG1;DDIT3;GLUL;CUL7;GNB1;DOCK9;RET;GAS2L1;RHOC;IFI27;PROCR;PCBP4;PKD1;ASS1;GATA3;PHF1;GSDMA;UBXN4;OASL;MYOF;DOCK6;FNDC4;HSF1;IL1RAP;WFS1;MT2A;ADAM8;MAPKBP1;NEIL1;TFPI2;MPG;PYCR2;HMGA2;MYDGF;FLNB;TNFRSF6B;EDNRA;SRC;POLD4;TGM2;DNM2;FAM162A;IRF7;LRSAM1;HIST3H2A;DNAJC4;STK24;ACADVL;PAK6;YPEL3;GPX3;GSK3A;STXBP1;CAMTA2;DUSP6;OAS1;FYN;PRIMPOL;ISG20;ASNS;WNT5B;GRINA;PSMD7;MICAL1;TNFRSF1A;ANXA3;VWA1;BRSK1;MOAP1;GAL;PUM1;SHISA5;CTSL;COMT;THRA;MAP3K10;HEXIM1;TIMP1;UBA1;MGLL;HSF4;LGALS3BP;RREB1;HYAL1;LRRC8A;F12;MIF;BCL2L1;STUB1;PCSK1N;TRIB3;DDB2;TCIRG1;PTPN12;SLC27A1;ZFPM1;RAD23A;ULK1;HSPA2;PAK4;TNFRSF19;P2RX4;HPSE;ULK2;ZP3;FGF2;MAP1LC3B;RNASE7;VAPB;MAPK9;SDHAF4;RCOR1;MAP3K12;TMX4;HSPA13;TAOK1;LMAN1;MLYCD;APBB1;ARG1;VEGFB;GSDMC;SEC14L1;ZBTB4;CNOT11;IMPACT;KLK6;CASP4;POLM;MYL9;CBL;GGT1;CIB1;MAPK3;EEPD1;POMT1;MAPK10;DNAJB9;ARHGEF2;RNF103;C12ORF66;AIDA;NDUFS2;ADAM15;HM13;CEACAM1;MINK1;TFPT;ECM1;CD59;SLC30A1;TGFB1;MANF;CAT;RMI2;LDHA;SPRED2;PIK3R2;ERBB3;ANXA1;PPP1R10;ASH2L;APOBEC3C;GNAS;PLGRKT;PXN;ARHGEF10L;EP300;ERP44
18043,GO:1902512,0.0203695951207689,0.99939020395726,2,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG;HSF1
11264,GO:0045454,0.0203738531260808,0.992050528975221,11,57,cell redox homeostasis,BP,NOS1;QSOX1;TXNDC11;P4HB;PDIA5;PRDX5;ERO1B;DDIT3;GLRX;TMX4;ERP44
7502,GO:0031668,0.020470095125695,0.98805315333969,29,187,cellular response to extracellular stimulus,BP,CBS;CYP27B1;DAP;POSTN;ITGA6;SSH1;SESN2;XBP1;ATF4;PCSK9;SIPA1;GLUL;GAS2L1;HSF1;STK24;FYN;ASNS;VDR;COMT;ADNP;USF2;ULK1;P2RX4;MAP1LC3B;IMPACT;CBL;MAPK3;KANK2;C12ORF66
853,GO:0002176,0.0204900556739938,0.999384618056608,2,3,male germ cell proliferation,BP,EIF2S2;CIB1
9482,GO:0036093,0.0204900556739938,0.999384618056608,2,3,germ cell proliferation,BP,EIF2S2;CIB1
4346,GO:0009896,0.0204926855371709,0.986462222482378,47,330,positive regulation of catabolic process,BP,EDEM1;SORL1;DVL1;SNX9;TRIM65;RAPGEF3;BNIP3;SMURF2;SESN2;LPCAT1;XBP1;CSNK1E;FYCO1;HECW2;SNX33;AKT1;APOE;TFEB;VPS11;PCSK9;ENDOG;MSN;BNIP3L;PPARA;GTPBP1;IDE;ANKIB1;GGA3;GGA1;HSF1;ADAM8;LRSAM1;STX5;GSK3A;SPTLC2;PUM1;TNRC6B;STUB1;TRIB3;TPCN1;RAD23A;ULK1;LRP1;TRIB2;MAPK3;CSNK1D;FURIN
15557,GO:0071941,0.020503862159895,0.996865254414228,4,11,nitrogen cycle metabolic process,BP,NAGS;ARG2;ASS1;ARG1
14370,GO:0061564,0.0205090639445479,0.98639325985475,48,334,axon development,BP,SH3KBP1;DVL1;MAP2K1;SHC1;WNT7A;PTPRS;SSH1;FAM129B;SEMA3F;VLDLR;ADARB1;PTPRF;STK25;SHANK3;APOE;MAP1B;LAMB2;GDI1;LIMK1;PLCG1;TWF2;PAK1;SEMA4B;TUBB3;RET;GRB10;GATA3;NUMB;SRC;DNM2;STK24;STXBP1;FYN;LPAR3;KIF13B;BRSK1;SEMA4G;ADNP;ULK1;ROBO3;ULK2;VASP;APBB1;SLIT3;EPHB2;MAPK3;NTNG1;LLGL1
4354,GO:0009925,0.0205523423582261,0.994963070726725,6,21,basal plasma membrane,CC,MST1R;ITGA6;EGFR;LDLRAP1;CEACAM1;ERBB3
14995,GO:0070887,0.0205961838027937,0.982916244869514,246,2123,cellular response to chemical stimulus,BP,TNIP1;EDEM1;XDH;PGF;NOS1;LTBP2;CCND1;CAPN2;MST1R;RAC2;LTBP4;RBCK1;NFATC4;SDC1;MAP2K1;SHC1;DOCK4;WNT7A;CST3;CYP27B1;NEURL1;BOK;SHARPIN;PCK2;NR1D1;MMP1;IFI6;DNMT3A;FKBP1A;POSTN;PSMD2;ITGA6;NET1;RAPGEF3;PRNP;BNIP3;CD68;LAMA5;SSH1;RAB43;SMURF2;CYGB;FAM129B;LCN2;CTSB;SESN2;BBS2;BCR;RAB31;ETV5;LRP5;ACVR2B;ITGB5;ADCY7;XBP1;MAP4K4;EGFR;MKNK2;RFX2;PRKACA;CORO1B;MAP2K2;STK25;ATF4;P4HB;PDIA5;AKT1;IFITM1;IRAK1;EPN2;APOE;FAM210B;ATP13A2;SYVN1;YIF1A;TMSB4X;TSPYL2;PRKCZ;FAM20C;MAPK13;PTK6;PFKP;PCSK9;ENDOG;FERMT1;MSN;TGFBR2;EPOR;DKK1;CREB3L2;PPP2R5B;BNIP3L;PPARA;PRKACB;LTBP1;SIPA1;WDTC1;CDC34;CD44;PLCG1;SEC63;IDE;TWF2;PRDX5;FSCN1;HTRA1;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;CUL7;ADAMTS7;GNB1;PTPN9;RET;GAS2L1;IFI27;GRB10;GATA3;APLN;OASL;MYOF;GNAI2;HSF1;IL1RAP;WFS1;MT2A;ADAM8;PYCR2;HMGA2;ARID5B;PPP1R14A;IGFBP2;MYDGF;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;GIPC1;TNFRSF6B;ALDH1A2;SRC;DNM2;AGO4;FAM162A;IRF7;PAQR7;STK24;ACADVL;ESRP1;GPX3;GSK3A;STXBP1;SPINT2;PCSK6;TALDO1;DUSP6;OAS1;FYN;ISG20;FUZ;AGRN;ASNS;PPM1F;WNT5B;PSMD7;TNFRSF1A;TLE4;FBXL15;SLC33A1;VDR;PLEKHG5;PUM1;ITGA1;GNB2;CTSL;THRA;TIMP1;FGFR1;HYAL1;USF2;MIF;SOCS2;MTMR4;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;NDOR1;LRP1;HSPA2;PAK4;TNFRSF19;P2RX4;FGF2;EHD4;VAPB;MAPK9;HSPA13;SLIT3;RXRA;ARG1;VEGFB;BAIAP2L1;ATP6V1C2;IMPACT;BPHL;CASP4;ACY1;HGS;CBL;GGT1;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DNAJB9;LITAF;FURIN;ARHGEF2;CEACAM1;GALNT3;UROS;ECM1;ADCY6;CCNE1;TGFB1;WBP2;CAT;SPRED2;PIK3R2;ANXA1;ITGA3;PXN;EP300
17514,GO:1900449,0.0206412594834653,0.99493619898682,6,21,regulation of glutamate receptor signaling pathway,BP,DLG4;SHANK3;NLGN2;SHANK2;EPHB2;MINK1
6925,GO:0030512,0.0206451562608702,0.991981320891134,11,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,SMURF2;TGFBR2;LTBP1;HTRA1;BCL9L;DNM2;MTMR4;STUB1;SNX25;PMEPA1;TGFB1
9483,GO:0036094,0.0206765064990426,0.983020248568385,217,1813,small molecule binding,MF,NT5E;XDH;PYGB;CBS;NOS1;MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;BSG;DGKA;RAB3B;RPS6KA2;RAPGEF3;NAGS;IDH2;PC;RAB43;SCYL1;SMARCA1;NME4;LCN2;MAPKAPK3;SESN2;OSBPL10;TUBB6;BCR;RAB31;OSBP2;MARK4;AARS;ACVR2B;H6PD;GPT2;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;BAG3;APOE;EHD3;ATP13A2;PKN1;CRYL1;PRKCZ;ATP7B;FAM20C;ITPR3;DGKQ;MAPK13;VPS11;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;ACAD10;NMRK1;RRAS;SEPT5;TGFBR2;HADH;LIMK1;STK39;UBE2J1;PPARA;DHTKD1;NADK;PRKACB;CDC34;CD44;ABCB8;GTPBP1;MAP3K9;OSBPL5;IDE;TWF2;HMGCL;PAK1;TTBK2;AHCY;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;CEMIP;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;SLC2A3;GRIN3B;GLUD1;PANK4;NEK9;SDHA;CTBP1;MYH15;ALAS1;RHOBTB2;TOP1;ARL2;MICAL2;P4HA1;PIP5K1C;ALDH1A2;SRC;CBR4;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;ACADVL;PAK6;GARS;GSK3A;TALDO1;PMVK;OAS1;SLFN5;FYN;RAB25;SPTLC2;AGRN;ASNS;PFN1;MICAL1;KIF17;VDR;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;SLC27A1;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;HSPA2;AOX1;PAK4;P2RX4;ULK2;LRRK1;PNP;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;LMAN1;PHYH;RHOBTB1;RXRA;ZBTB4;SEC14L2;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;NDUFS2;MINK1;AGAP1;MBD3;ADCY6;ADCK2;CAT;LDHA;ERBB3;RAB6A;GNAS
8208,GO:0032947,0.0207425426248441,0.9908485919721,14,72,protein-containing complex scaffold activity,MF,DLG1;SLC9A3R2;WWC3;SEPT10;SHANK3;SEPT5;DEDD2;SEPT8;SHANK2;LDLRAP1;KLHL17;HOMER2;GRIP2;ITSN1
16277,GO:0090314,0.0207547679311398,0.994856806166609,6,22,positive regulation of protein targeting to membrane,BP,PRNP;PAK1;STOM;CEMIP;FYN;CIB1
13055,GO:0051492,0.0207795916216103,0.991525198479176,12,59,regulation of stress fiber assembly,BP,ARAP1;RAPGEF3;EPHA1;SH3PXD2B;LIMK1;WASF2;PAK1;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
1992,GO:0004709,0.0207976871701132,0.991943208959658,11,51,MAP kinase kinase kinase activity,MF,MST1R;EGFR;EPHA1;MAP3K9;RET;MAP3K10;FGFR1;MAP3K12;TAOK1;EPHB2;ERBB3
8722,GO:0034361,0.0208401797136868,0.997964750711756,3,7,very-low-density lipoprotein particle,CC,VLDLR;APOE;PCYOX1
8744,GO:0034385,0.0208401797136868,0.997964750711756,3,7,triglyceride-rich plasma lipoprotein particle,CC,VLDLR;APOE;PCYOX1
3923,GO:0008593,0.020845866431619,0.990777586752774,14,74,regulation of Notch signaling pathway,BP,CHAC1;NEURL1;POSTN;FAM129B;EGFR;MMP14;EPN2;PEAR1;RFNG;ARRDC1;TSPAN5;MFNG;LLGL1;EP300
6199,GO:0019673,0.0209153569583922,0.997954537991113,3,7,GDP-mannose metabolic process,BP,TSTA3;MPI;GUK1
3444,GO:0007256,0.0209403929847441,0.998132480025394,3,6,activation of JNKK activity,BP,ERCC6;MAP3K9;MAP3K10
9047,GO:0035255,0.0211293299950921,0.994788189197067,6,21,ionotropic glutamate receptor binding,MF,DLG4;DLG1;SHANK3;SHANK2;DLG3;GNAS
12838,GO:0051124,0.021157346447962,0.998105462288246,3,6,synaptic growth at neuromuscular junction,BP,SHANK3;SHANK2;AGRN
7609,GO:0031984,0.0212105161961348,0.983102137610626,155,1278,organelle subcompartment,CC,EDEM1;NOS1;CHAC1;ASAP2;SORL1;QSOX1;MBOAT2;LPCAT4;SNX9;AP3D1;LMF1;BOK;ARAP1;BSG;DLG1;PITPNM1;FKBP1A;POSTN;CKAP4;SBF1;AGPAT3;TXNDC11;RAB43;COPG1;TMEM214;MARCH9;RAB31;CHPF;LPCAT1;XYLT1;XBP1;EGFR;RTN2;RHBDF2;XYLT2;STK25;PDIA5;CDS2;AP1B1;SYVN1;YIF1A;ATP7B;ITPR3;RFNG;CTSZ;PI4K2A;TMEM129;RETSAT;SEC23A;B4GALNT4;PLD3;NDST2;CREB3L2;UBE2J1;KDELR1;YIPF2;ESYT2;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;MALL;ERO1B;UBXN7;PTDSS2;GGA3;RAB29;CORO7;CYTH3;REEP2;TMED3;PKD1;PIGQ;UBXN4;DOPEY2;ANTXR2;WFS1;SRD5A3;ASPH;B4GALT2;VAMP2;B3GNT3;DNM2;SARAF;REEP6;NUCB1;RAB1B;CARD19;STX5;COG8;SPTLC2;CLSTN1;REEP4;TNFRSF1A;HSD11B1;MBOAT7;SLC33A1;STX10;CHST14;SHISA5;PSKH1;MCFD2;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;ATP2C2;MFNG;SIGMAR1;PCSK1N;ST3GAL3;DNMBP;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;AGPAT4;ULK1;USO1;SMPD3;TBC1D20;ST6GALNAC2;VAPB;COG1;ABCA7;LMAN1;ENTPD6;TGFA;CASP4;SNAP29;TRAPPC1;POMT1;CSNK1D;DNAJB9;LITAF;FURIN;RNF103;UGCG;LLGL1;B4GALT6;OCRL;HM13;PNPLA6;GALNT3;LPIN3;CD59;PPP6R1;AZIN2;RAB6A;IKBIP;ARCN1;ERP44;STIM1
7741,GO:0032231,0.0212528114503059,0.990925815572015,13,66,regulation of actin filament bundle assembly,BP,ARAP1;RAPGEF3;SHANK3;EPHA1;SH3PXD2B;LIMK1;WASF2;PAK1;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
16355,GO:0090568,0.0213070541649325,0.993941696552069,7,27,nuclear transcriptional repressor complex,CC,NACC2;SALL2;TNRC18;BAZ2A;APPL2;BAHCC1;MBD3
15508,GO:0071855,0.0213129693422003,0.997900274679973,3,7,neuropeptide receptor binding,MF,APLN;GAL;GNAS
7677,GO:0032101,0.0214992944206663,0.985069659545274,59,438,regulation of response to external stimulus,BP,TNIP1;NT5E;PGF;F2R;RAC2;DVL1;MAP2K1;PLAT;CYP27B1;SHARPIN;SERPINE2;PTPRS;BBS2;SEMA3F;BCR;EGFR;PTPRF;CORO1B;SERPING1;APOE;ARG2;TMSB4X;MAPK13;TGFBR2;STK39;PPARA;FAM3A;HTRA1;SEMA4B;GATA3;FNDC4;ADAM8;MAPKBP1;TGM2;LRSAM1;STK24;PPM1F;TNFRSF1A;PUM1;MGLL;SEMA4G;FGFR1;F12;MIF;P2RX4;HPSE;ZP3;FGF2;ARG1;VEGFB;SEC14L1;CASP4;GGT1;MAPK3;KANK2;CEACAM1;CD59;TGFB1;ANXA1
8349,GO:0033189,0.0215248517161393,0.996658733335448,4,11,response to vitamin A,BP,DNMT3A;ALDH1A2;ARG1;CAT
9954,GO:0042304,0.0215492046101665,0.993823828735385,7,28,regulation of fatty acid biosynthetic process,BP,WDTC1;ACADVL;ADIPOR1;TRIB3;CEACAM1;ANXA1;SLC45A3
95,GO:0000185,0.0215814339804083,0.995553872724674,5,16,activation of MAPKKK activity,BP,MAP4K4;STK25;STK24;MINK1;TRAF7
11670,GO:0046394,0.0217004324212091,0.986041780998263,41,287,carboxylic acid biosynthetic process,BP,CBS;NR1D1;PGM1;NAGS;ACOT7;GPT2;XBP1;HK1;PSAT1;PFKP;PPARA;DHTKD1;WDTC1;ELOVL1;AHCY;GAMT;GLUL;CEMIP;ASS1;GLUD1;ALOX15B;PYCR2;ALDH1A2;CBR4;ACADVL;ASNS;CHST14;MGLL;HYAL1;MIF;ADIPOR1;TRIB3;MLYCD;GGT1;ALDOC;CEACAM1;UROS;TGFB1;LDHA;ANXA1;SLC45A3
2542,GO:0005798,0.0217852009554805,0.988296334911167,22,136,Golgi-associated vesicle,CC,SCYL1;COPG1;YIF1A;CTSZ;PCSK9;SEC23A;KDELR1;TMED3;PKD1;LDLRAP1;NUCB1;STX5;MCFD2;SEC24C;USO1;LMAN1;TGFA;FURIN;OCRL;HM13;CD59;ARCN1
12126,GO:0048156,0.0217919822348671,0.996604156668836,4,11,tau protein binding,MF,APOE;BIN1;FYN;APBB1
3223,GO:0006875,0.0218463090295435,0.98602032780475,40,281,cellular metal ion homeostasis,BP,NOS1;F2R;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TPCN1;P2RX4;FGF2;VAPB;CHD7;SLC30A1;TGFB1;STIM1;RASA3
4790,GO:0010977,0.0219148687825572,0.989092924484509,18,103,negative regulation of neuron projection development,BP,NFATC4;PTPRS;SEMA3F;MAP4K4;APOE;CTSZ;GDI1;SEMA4B;PTPN9;RAB29;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ADCY6;RAP1GAP2;ASAP1
12405,GO:0048813,0.0219168831308342,0.989104828084186,18,101,dendrite morphogenesis,BP,NFATC4;DVL1;WNT7A;DLG4;VLDLR;SHANK3;HECW2;FBXW8;OBSL1;CUL7;FARP1;SHANK2;RERE;FYN;EPHB2;MINK1;ARHGAP44;MAP6
4602,GO:0010715,0.0219209943503488,0.996577718986492,4,11,regulation of extracellular matrix disassembly,BP,CST3;FSCN1;LRP1;TGFB1
14736,GO:0070372,0.0220752130613144,0.987306899592799,27,172,regulation of ERK1 and ERK2 cascade,BP,TNIP1;F2R;MST1R;MAP2K1;SHC1;DLG1;FBLN1;EGFR;PRKCZ;EPHA1;RRAS;CD44;DUSP4;RET;SRC;DUSP6;FGFR1;MIF;FGF2;ABCA7;EPHB2;CIB1;MAPK3;CEACAM1;TGFB1;CAMK2N1;ERBB3
12543,GO:0050667,0.0221977031246508,0.996520840908211,4,11,homocysteine metabolic process,BP,CBS;AHCY;BLMH;COMT
5583,GO:0016597,0.0222103841548148,0.992898821900042,8,34,amino acid binding,MF,NOS1;NAGS;SESN2;AARS;GLUL;ASS1;GRIN3B;GLUD1
13254,GO:0051898,0.0222627315976409,0.992878876648436,8,34,negative regulation of protein kinase B signaling,BP,XDH;DLG1;AKT1;PPP2R5B;DDIT3;TRIB3;LEMD2;CIB1
14521,GO:0062013,0.0223903154771857,0.989085857150892,17,96,positive regulation of small molecule metabolic process,BP,NOS1;PTHLH;NR1D1;RAPGEF3;AKT1;APOE;TMSB4X;PPARA;SRC;LDLRAP1;TAZ;COMT;NTSR1;ADNP;MLYCD;ANXA1;SLC45A3
12550,GO:0050679,0.0223961845622844,0.988347034128696,20,120,positive regulation of epithelial cell proliferation,BP,PGF;CCND1;WNT7A;XBP1;EGFR;LAMB1;AKT1;HTRA1;GLUL;APLN;MYDGF;FGFR1;RREB1;HYAL1;FGF2;ARG1;VEGFB;TGFA;ECM1;TGFB1
898,GO:0002274,0.022409910090986,0.984493593239401,57,430,myeloid leukocyte activation,BP,PYGB;RAC2;PYGL;QSOX1;CST3;NAPRT;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;AP2A2;GALNS;CTSZ;PI4K2A;TGFBR2;SERPINB6;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;TGFB1;CAT;RAB6A;ERP44
9446,GO:0036015,0.0224396404932133,0.999291663248226,2,3,response to interleukin-3,BP,MT2A;GSK3A
9447,GO:0036016,0.0224396404932133,0.999291663248226,2,3,cellular response to interleukin-3,BP,MT2A;GSK3A
11827,GO:0046697,0.0224452942137431,0.995327360254277,5,16,decidualization,BP,CYP27B1;BSG;CTSB;EPOR;VDR
19400,GO:1905809,0.0224547069121801,0.996467802099997,4,11,negative regulation of synapse organization,BP,NFATC4;PRNP;APOE;FYN
12612,GO:0050769,0.0224670489157057,0.985363458905517,43,296,positive regulation of neurogenesis,BP,ZMYND8;DVL1;MAP2K1;NEURL1;CRTC1;DLG4;SERPINE2;VLDLR;ETV5;CSNK1E;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;CUL7;RET;SHANK2;IL1RAP;NUMB;FYN;LPAR3;GJC2;FGFR1;ADNP;SOCS2;ZNF609;APBB1;IMPACT;CAMK1;EPHB2;CSNK1D;ARHGEF2;ITGA3
3708,GO:0008217,0.0225396522739597,0.989585310999763,15,82,regulation of blood pressure,BP,NOS1;F2R;ADM2;POSTN;LRP5;CTSZ;STK39;PPARA;APLN;PLCB3;EDNRA;GSK3A;NISCH;NTSR1;P2RX4
19656,GO:1990782,0.0228235888774637,0.990996289959365,11,53,protein tyrosine kinase binding,MF,SHC1;DOCK4;PITPNM1;SHC2;PLCG1;IL1RAP;PAG1;PITPNM2;CBL;CEACAM1;PIK3R2
10256,GO:0042981,0.0228317731764843,0.982044150829797,134,1101,regulation of apoptotic process,BP,ANGPTL4;XDH;F2R;MST1R;RBCK1;NFATC4;MAP2K1;SHC1;WNT7A;NEURL1;BOK;OBSCN;DAP;IFI6;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;NME4;FAM129B;G0S2;CTSB;NACC2;LRP5;AARS;XBP1;MAP4K4;EGFR;PANO1;MAP2K2;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;BAG3;APOE;ARG2;SYVN1;RABGGTA;PRKCZ;CTSZ;EPHA1;PCSK9;ENDOG;HS1BP3;STK39;DKK1;SOX7;BNIP3L;CDC34;CD44;MAP3K9;DEDD2;PRDX5;CCND2;BIN1;PAK1;ZNF385A;RAG1;DDIT3;TNFSF15;RET;IFI27;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;ARHGEF4;MYDGF;TSC22D4;TNFRSF6B;ALDH1A2;SRC;TGM2;DNM2;AGO4;FAM162A;IRF7;STPG1;STK24;PAK6;GSK3A;STXBP1;DUSP6;FYN;ASNS;PPM1F;GRINA;MICAL1;TNFRSF1A;VDR;PLEKHG5;MOAP1;GAL;ITGA1;THRA;NTSR1;MAP3K10;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;SIGMAR1;BCL2L1;STK17A;LRP1;PAK4;MAPK9;MAP3K12;TAOK1;APBB1;CASP4;EPHB2;CBL;CIB1;GLO1;ARHGEF2;TMBIM1;MINK1;ITSN1;TGFB1;CAT;LDHA;ERBB3;ANXA1;PPP1R10;TRAF7
5330,GO:0016053,0.0228842805811224,0.985223174634911,41,288,organic acid biosynthetic process,BP,CBS;NR1D1;PGM1;NAGS;ACOT7;GPT2;XBP1;HK1;PSAT1;PFKP;PPARA;DHTKD1;WDTC1;ELOVL1;AHCY;GAMT;GLUL;CEMIP;ASS1;GLUD1;ALOX15B;PYCR2;ALDH1A2;CBR4;ACADVL;ASNS;CHST14;MGLL;HYAL1;MIF;ADIPOR1;TRIB3;MLYCD;GGT1;ALDOC;CEACAM1;UROS;TGFB1;LDHA;ANXA1;SLC45A3
16758,GO:0097756,0.0229603251199981,0.991987949186834,9,40,negative regulation of blood vessel diameter,BP,F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;RAP1GDS1;APLN;EDNRA
12940,GO:0051271,0.0230684966966707,0.986260333090984,30,196,negative regulation of cellular component movement,BP,ZMYND8;IDH2;CYGB;SEMA3F;BCR;FBLN1;ADARB1;CORO1B;IFITM1;APOE;EPHA1;RRAS;SEMA4B;GATA3;ALOX15B;PTPRU;STK24;SPINT2;FUZ;NISCH;TIMP1;SEMA4G;MIF;ADIPOR1;LRP1;FGF2;ARAP3;ADAM15;SRGAP2B;TGFB1
17324,GO:0140096,0.0230821843027853,0.981077681127361,204,1701,catalytic activity, acting on a protein,MF,ADAM19;CCND1;GID4;CAPN2;THSD4;MST1R;LTBP4;RBCK1;MAP2K1;PLAT;QSOX1;NEURL1;SHARPIN;OBSCN;DLG1;MMP1;FKBP1A;PSMD2;MTA1;RPS6KA2;PTPRS;PRSS3;SBF1;SSH1;TXNDC11;SCYL1;SMURF2;MAPKAPK3;CTSB;RNPEPL1;FKBP9;USP20;NACC2;BCR;MARK4;ACVR2B;XYLT1;MAP4K4;EGFR;CSNK1E;MKNK2;MMP14;PRKACA;PTPRF;JOSD2;RHBDF2;MAP2K2;XYLT2;STK25;MIER2;P4HB;HECW2;FBXW8;PDIA5;AKT1;IRAK1;PKN1;SYVN1;PHF21A;NPEPL1;RABGGTA;PRKCZ;RNF135;FAM20C;MAPK13;PPP2R3B;VPS4A;PITRM1;CTSZ;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;TYSND1;B4GALNT4;TGFBR2;LIMK1;STK39;UBE2J1;KLHL29;PRSS8;PRKACB;LTBP1;ZDHHC8;OTUB2;CDC34;SCRN1;MAP3K9;IDE;ANKIB1;HTRA1;PAK1;TTBK2;ERO1B;MMP10;RAG1;ADAMTS7;DUSP4;PTPN9;RET;FBXL6;HLTF;PPM1M;SIN3B;NEK9;CNDP2;ASPH;PTPRU;ADAM8;HMGA2;ARID5B;TOP1;BLMH;P4HA1;B3GNT3;SRC;KDM4B;FKBP10;TGM2;UBR4;CAPN5;LRSAM1;CDC42BPB;MARK3;STK24;PAK6;GSK3A;PCSK6;DUSP6;FYN;PPM1F;TMPRSS11D;ZNF862;RMND5A;THOP1;FBXL15;ABHD17C;BRSK1;SSU72;RNF44;PSKH1;CTSL;MAP3K10;CRIM1;RNF187;LOXL1;LHPP;FGFR1;PHF2;MIB2;F12;CDK18;MTMR4;STUB1;STK17A;DDB2;PTPN12;HLCS;RMND5B;ULK1;PAK4;MGRN1;ULK2;LRRK1;PCMTD2;FGF2;KLHL17;MAPK9;RCOR1;MAP3K12;TMX4;TAOK1;RNF222;SPSB3;KLK6;CASP4;ACY1;LONP2;CAMK1;EPHB2;CBL;GGT1;USP32;MAPK3;MAPK10;CSNK1D;FURIN;RNF103;ADAM15;HM13;GALNT3;MINK1;MBD3;ADCK2;ERBB3;ASH2L;ERP44;TRAF7;RNF10
7458,GO:0031589,0.0231068686491638,0.985760894057296,34,225,cell-substrate adhesion,BP,ITGB4;RAC2;POSTN;ITGA6;NET1;LAMA5;FBLN1;ITGB5;MMP14;LAMB1;PARVB;COL13A1;PRKCZ;EPHA1;FERMT1;CD44;NID1;PKD1;ARL2;SRC;DNM2;PPM1F;ITGA1;LYPD5;RREB1;HPSE;MSLN;CAMSAP3;CIB1;ADAM15;MINK1;ITGA3;PXN;THBS3
16925,GO:0098862,0.0231090283116526,0.989288074347048,15,82,cluster of actin-based cell projections,CC,DOCK4;ESPN;BBS2;ITPR3;TWF2;RHOC;SHANK2;FLNB;GIPC1;RGS19;RALGDS;SLC6A14;MYO1D;HOMER2;SLC15A1
6437,GO:0021700,0.0234355676963642,0.986947599180514,24,149,developmental maturation,BP,NFATC4;ADGRL1;NEURL1;AP3D1;DLG4;XBP1;PRKACA;FAM210B;FAM20C;POU2F2;FERMT1;DDIT3;RET;GATA3;ANKS1A;ALDH1A2;RERE;STXBP1;AGRN;GAL;FGFR1;L3MBTL3;ARCN1;THBS3
12503,GO:0050435,0.0234848637815302,0.993146484749907,7,28,amyloid-beta metabolic process,BP,SORL1;PRNP;APOE;IDE;BIN1;GSK3A;ABCA7
9494,GO:0036120,0.023506570373546,0.99504568984428,5,16,cellular response to platelet-derived growth factor stimulus,BP,CORO1B;SRC;FYN;HYAL1;CBL
8265,GO:0033036,0.0236240636319189,0.980242652928488,261,2268,macromolecule localization,BP,EDEM1;MDFI;ZMYND8;LTBP2;SH3TC2;F2R;RAC2;SORL1;DVL1;PITPNC1;WNT7A;SNX9;AP3D1;LMF1;PCK2;DLG4;OBSCN;CPT2;BSG;NR1D1;DLG1;XPOT;PITPNM1;FKBP1A;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;LAMA5;SSH1;RAB43;NME4;COPG1;MARVELD1;SESN2;BBS2;OSBPL10;NACC2;BCR;SYNE3;RAB31;NUDCD3;OSBP2;VLDLR;ETV5;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;SEPT10;CORO1B;TUB;RHBDF2;HK1;SHANK3;TTC7B;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;TNS4;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;SH3PXD2B;PCSK9;FERMT1;SEPT5;SEC23A;MSN;TGFBR2;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;PPARA;KDELR1;AKAP12;SYMPK;OBSL1;TST;LTBP1;ZDHHC8;IPO13;ESYT2;TBC1D16;ATG13;SEC63;OSBPL5;TWF2;TBC1D14;TSPAN5;MALL;SUFU;PAK1;TTBK2;ZNF385A;NLGN2;DDIT3;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;SEPT8;PKD1;PARP10;DLG3;ATP11A;GATA3;OXA1L;DOPEY2;GRIN3B;GLUD1;HSF1;ALOX15B;IL1RAP;PTPRU;ADAM8;MAPKBP1;ARL2;NUMB;VAMP2;FLNB;GIPC1;TULP3;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;AGRN;KIF17;TNFRSF1A;ABHD17C;KIF13B;TSPAN33;STX10;MOAP1;GAL;THRA;MCFD2;PLTP;NTSR1;SEC24C;RRBP1;GUK1;MIF;VPS37A;SIGMAR1;BCL2L1;MAU2;PRAF2;TCIRG1;PITPNM2;SNX25;SLC27A1;LEMD2;ARFIP2;ARFGEF2;UNC119B;ULK1;LRP1;P2RX4;USO1;SPIRE1;PNP;MAPK9;COG1;ABCA7;APBB1;RXRA;SLC10A6;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;EPHB2;HGS;GAS8;CIB1;TMSB10;RAB4B;PACS2;MAPK3;CPT1B;CSNK1D;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;HM13;CEACAM1;APBA1;ARHGAP44;AGAP1;IGF2BP3;CCNE1;TGFB1;WBP2;SLC15A1;PIK3R2;STARD10;ANXA1;PPP1R10;RAB6A;ITGA3;ARCN1
14313,GO:0061387,0.0236594917633585,0.989354642087996,14,74,regulation of extent of cell growth,BP,PTPRS;SEMA3F;APOE;MAP1B;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;LPAR3;SEMA4G;ADNP;ULK2
7271,GO:0031234,0.0236634845728083,0.989731134560442,13,67,extrinsic component of cytoplasmic side of plasma membrane,CC,SNX9;DLG4;PTK6;ESYT2;FARP1;GNB1;CYTH3;GNAI2;SRC;RGS19;FYN;MYZAP;GNAS
15323,GO:0071496,0.0237054036778695,0.985242299599697,35,237,cellular response to external stimulus,BP,CBS;CYP27B1;DAP;POSTN;ITGA6;BNIP3;SSH1;SESN2;XBP1;EGFR;ATF4;AKT1;BAG3;PCSK9;SIPA1;GLUL;GAS2L1;HSF1;STK24;FYN;ASNS;TNFRSF1A;VDR;COMT;ADNP;USF2;ULK1;P2RX4;MAP1LC3B;IMPACT;CBL;MAPK3;KANK2;C12ORF66;TGFB1
674,GO:0001881,0.0237078752491942,0.993067614333705,7,28,receptor recycling,BP,ARAP1;EHD3;PCSK9;TBC1D16;RAB29;CHMP5;ARFGEF2
15176,GO:0071276,0.0237168010504292,0.993846842481707,6,24,cellular response to cadmium ion,BP,EGFR;AKT1;HSF1;MT2A;MAPK9;MAPK3
7452,GO:0031581,0.0238967634022337,0.996166490598731,4,11,hemidesmosome assembly,BP,ITGB4;ITGA6;LAMC2;LAMB3
5327,GO:0016050,0.0239245001278667,0.984175774423862,45,319,vesicle organization,BP,F2R;SDC1;SNX9;AP3D1;DLG4;SERPINE2;DYSF;EVI5L;RFX2;SNX33;VPS11;VPS4A;CTSZ;PI4K2A;SEC23A;TBC1D16;TBC1D14;ZNF385A;TBC1D9B;SYTL1;RAB29;VAMP2;CHMP5;DNM2;RAB1B;STX5;STXBP1;STX10;MCFD2;SEC24C;VPS37A;ARFGEF2;USO1;TBC1D20;VAPB;LMAN1;TBC1D2B;TGFA;SNAP29;HGS;TRAPPC1;CSNK1D;CD59;PPP6R1;ANXA1
18615,GO:1903844,0.0239268912504046,0.988859327659206,15,82,regulation of cellular response to transforming growth factor beta stimulus,BP,LTBP4;SMURF2;FERMT1;TGFBR2;LTBP1;HTRA1;BCL9L;GIPC1;DNM2;MTMR4;STUB1;SNX25;PMEPA1;TGFB1;ITGA3
2654,GO:0005996,0.024067032102264,0.985608085970557,30,198,monosaccharide metabolic process,BP,PCK2;NR1D1;IGFBP4;PGM1;PC;LRP5;H6PD;HK1;ATF4;AKT1;MDH2;CRYL1;DGKQ;PFKP;PPARA;WDTC1;FUCA1;SLC2A3;SRC;GSK3A;TALDO1;OAS1;MPI;GALE;NISCH;SLC35B4;ADIPOR1;MLYCD;ALDOC;SLC45A3
19267,GO:1905383,0.0240941949055817,0.999209084686434,2,3,protein localization to presynapse,BP,DVL1;WNT7A
3397,GO:0007178,0.0241393994745622,0.985308072861214,32,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LTBP2;LTBP4;FKBP1A;SMURF2;ACVR2B;ITGB5;IRAK1;WWTR1;PRKCZ;FERMT1;TGFBR2;DKK1;LTBP1;HTRA1;BCL9L;GIPC1;SRC;DNM2;PCSK6;FBXL15;SLC33A1;MTMR4;STUB1;SNX25;LEMD2;PMEPA1;CBL;MAPK3;FURIN;TGFB1;ITGA3;PXN
2674,GO:0006024,0.0242286652242964,0.988710204268575,15,81,glycosaminoglycan biosynthetic process,BP,SDC1;CHPF;XYLT1;XYLT2;GPC4;NDST2;CEMIP;B4GALT2;B3GNT3;AGRN;CHST14;HYAL1;ST3GAL3;B4GALT6;TGFB1
16749,GO:0097734,0.0242465276400758,0.99477500290436,5,17,extracellular exosome biogenesis,BP,SDC1;ATP13A2;VPS4A;SMPD3;HGS
19505,GO:1990182,0.0242465276400758,0.99477500290436,5,17,exosomal secretion,BP,SDC1;ATP13A2;VPS4A;SMPD3;HGS
793,GO:0002054,0.0242699348865722,0.999200118426685,2,3,nucleobase binding,MF,PYGL;PNP
795,GO:0002060,0.0242699348865722,0.999200118426685,2,3,purine nucleobase binding,MF,PYGL;PNP
4603,GO:0010716,0.0242985308168798,0.999198655950278,2,3,negative regulation of extracellular matrix disassembly,BP,CST3;TGFB1
10311,GO:0043065,0.0244481806448703,0.98273204375079,62,471,positive regulation of apoptotic process,BP,XDH;F2R;RBCK1;NFATC4;NEURL1;BOK;OBSCN;DAP;RPS6KA2;ITGA6;NET1;PRNP;BNIP3;G0S2;NACC2;PANO1;ATF4;AKT1;CTSZ;PCSK9;ENDOG;SOX7;BNIP3L;CDC34;MAP3K9;DEDD2;BIN1;DDIT3;TNFSF15;RET;IFI27;HSF1;ADAM8;HMGA2;ARHGEF4;ALDH1A2;SRC;TGM2;DNM2;FAM162A;STPG1;GSK3A;DUSP6;PPM1F;VDR;PLEKHG5;MOAP1;GAL;ITGA1;NTSR1;MAP3K10;BCL2L1;STK17A;MAPK9;APBB1;CASP4;ARHGEF2;ITSN1;TGFB1;LDHA;ANXA1;TRAF7
700,GO:0001917,0.0245122357347256,0.993684861224159,6,22,photoreceptor inner segment,CC,NOS1;GNB1;SHANK2;DNM2;REEP6;DRAM2
5065,GO:0015276,0.0246147261011544,0.991303500591623,9,40,ligand-gated ion channel activity,MF,DLG4;DLG1;ITPR3;DLG3;GRIN3B;ASIC1;TPCN1;P2RX4;RASA3
6616,GO:0022834,0.0246147261011544,0.991303500591623,9,40,ligand-gated channel activity,MF,DLG4;DLG1;ITPR3;DLG3;GRIN3B;ASIC1;TPCN1;P2RX4;RASA3
4893,GO:0014812,0.0246262952051408,0.990152001004068,11,54,muscle cell migration,BP,SORL1;DOCK4;PLAT;POSTN;NET1;SSH1;CORO1B;PAK1;SRC;LRP1;ANXA1
19789,GO:2000146,0.0246920546663369,0.985650769665729,27,174,negative regulation of cell motility,BP,ZMYND8;IDH2;CYGB;BCR;FBLN1;ADARB1;CORO1B;IFITM1;APOE;EPHA1;RRAS;GATA3;ALOX15B;PTPRU;STK24;SPINT2;FUZ;NISCH;TIMP1;MIF;ADIPOR1;LRP1;FGF2;ARAP3;ADAM15;SRGAP2B;TGFB1
4575,GO:0010658,0.0247031918869593,0.993624029006467,6,22,striated muscle cell apoptotic process,BP,BNIP3;BAG3;GNB1;HSF1;RGL2;PPP1R10
13382,GO:0052547,0.0247171472913676,0.984115434284614,39,285,regulation of peptidase activity,BP,XDH;F2R;SORL1;CST3;BOK;SERPINE2;DAP;IFI6;FBLN1;MMP14;AKT1;SERPING1;ATP13A2;SERPINB6;SOX7;CD44;PRDX5;BIN1;RAG1;TNFSF15;IFI27;HSF1;ASPH;TFPI2;TNFRSF6B;SRC;APLP2;FAM162A;SPINT2;FYN;PPM1F;MICAL1;TIMP1;CRIM1;PCSK1N;CASP4;MAPK3;FURIN;ECM1
10825,GO:0044304,0.0247419203537421,0.991250502627769,9,40,main axon,CC,SCN8A;DLG4;DLG1;BIN1;NAV1;KIF13B;GJC2;MYO1D;APBB1
12799,GO:0051055,0.0247452729154901,0.99189266758378,8,35,negative regulation of lipid biosynthetic process,BP,CYP27B1;LPCAT1;APOE;WDTC1;ACADVL;TRIB3;SLC27A1;CEACAM1
6256,GO:0019834,0.0249379122101536,0.999165700606845,2,3,phospholipase A2 inhibitor activity,MF,ANXA3;ANXA1
12711,GO:0050909,0.0249474749080333,0.995830667984925,4,12,sensory perception of taste,BP,ITPR3;GNB1;REEP2;ASIC1
4607,GO:0010720,0.0251120007097742,0.983109177180492,48,340,positive regulation of cell development,BP,ZMYND8;DVL1;MAP2K1;NEURL1;CRTC1;DLG4;SERPINE2;NET1;FAM129B;VLDLR;ETV5;CSNK1E;STK25;SHANK3;FBXW8;APOE;PTK6;MAP1B;GDI1;LIMK1;DKK1;PPP2R5B;OBSL1;TWF2;BIN1;PAK1;CUL7;RET;SHANK2;IL1RAP;NUMB;DNM2;FYN;LPAR3;GJC2;FGFR1;RREB1;ADNP;SOCS2;ZNF609;APBB1;IMPACT;CAMK1;EPHB2;CIB1;CSNK1D;ARHGEF2;ITGA3
15838,GO:0072522,0.025156428651932,0.985183542666157,28,186,purine-containing compound biosynthetic process,BP,NT5E;NOS1;PTHLH;PGM1;NME4;ACOT7;ADCY7;HK1;APOE;TMSB4X;PFKP;PPARA;DHTKD1;GNAI2;PPCS;PANK4;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ALDOC;ADCY6;TGFB1;LDHA
15313,GO:0071481,0.0252229892207581,0.995883958284033,4,11,cellular response to X-ray,BP,CCND2;GATA3;HMGA2;DNM2
6101,GO:0019318,0.0252290312641397,0.985309998184791,27,174,hexose metabolic process,BP,PCK2;NR1D1;IGFBP4;PGM1;PC;LRP5;H6PD;HK1;ATF4;AKT1;MDH2;DGKQ;PFKP;PPARA;WDTC1;FUCA1;SRC;GSK3A;OAS1;MPI;GALE;NISCH;SLC35B4;ADIPOR1;MLYCD;ALDOC;SLC45A3
5454,GO:0016323,0.0254657266617375,0.986341565520417,21,125,basolateral plasma membrane,CC,MST1R;DLG4;DLG1;ITGA6;SLC2A9;EGFR;ATP7B;MSN;STK39;PKD1;DLG3;NUMB;LDLRAP1;LRCH4;LRP1;MYO1D;TGFA;CEACAM1;ERBB3;ANXA1;ITGA3
12076,GO:0048009,0.0254852080728162,0.993373673543539,6,22,insulin-like growth factor receptor signaling pathway,BP,IGFBP4;AKT1;GRB10;IGFBP2;CRIM1;GIGYF1
15399,GO:0071625,0.0256496023095277,0.995791997477622,4,11,vocalization behavior,BP,DLG4;SHANK3;SHANK2;SRPX2
2207,GO:0005089,0.0256986797025427,0.98918501498573,12,59,Rho guanyl-nucleotide exchange factor activity,MF,OBSCN;NET1;BCR;FARP1;RGL2;ARHGEF4;PLEKHG5;DNMBP;EPS8L1;ARHGEF2;ITSN1;ARHGEF10L
14715,GO:0070326,0.0257376084777677,0.99912379837314,2,3,very-low-density lipoprotein particle receptor binding,MF,APOE;PCSK9
14558,GO:0070059,0.0258573147114146,0.99010376105478,10,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CHAC1;BOK;XBP1;ATF4;SYVN1;DDIT3;WFS1;GRINA;TRIB3;CASP4
989,GO:0002443,0.0258615857228315,0.981517477347633,65,503,leukocyte mediated immunity,BP,PYGB;ERCC1;RAC2;PYGL;QSOX1;CST3;NAPRT;DLG1;PGM1;PSMD2;CKAP4;PRSS3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;SERPING1;AP2A2;PRKCZ;GALNS;POU2F2;CTSZ;PI4K2A;SERPINB6;KDELR1;CD44;SURF4;STOM;FUCA1;DNASE1L1;ATP11A;GATA3;ARL8A;SLC2A3;ADAM8;CAP1;VAMP2;UBR4;IRF7;C6ORF120;STXBP1;YPEL5;PSMD7;ANXA3;MIF;TCIRG1;HPSE;ZP3;PNP;ARG1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;ALDOC;TMBIM1;CEACAM1;CD59;TGFB1;CAT;RAB6A;ERP44
6339,GO:0021510,0.026039912819677,0.990062673164542,10,47,spinal cord development,BP,SOX12;PTPRS;VLDLR;ADARB1;AKT1;BAG3;SUFU;PKD1;TULP3;PBX3
16266,GO:0090303,0.0260832518920549,0.992177873696828,7,29,positive regulation of wound healing,BP,F2R;XBP1;TGFBR2;RREB1;F12;HPSE;ANXA1
4426,GO:0010243,0.0261460068394371,0.980532464890808,84,653,response to organonitrogen compound,BP,EDEM1;CCND1;CAPN2;SDC1;SHC1;NEURL1;PCK2;BSG;DNMT3A;FKBP1A;RAPGEF3;PRNP;SSH1;SESN2;RAB31;LRP5;ADCY7;XBP1;EGFR;PRKACA;ATF4;AKT1;APOE;SYVN1;PRKCZ;DGKQ;MAPK13;TMEM129;FBXO2;PCSK9;HADH;UBE2J1;PPARA;PRKACB;WDTC1;IDE;PAK1;GNB1;GRB10;UBXN4;HSF1;WFS1;EIF4EBP1;VAMP2;SRC;DNM2;GSK3A;FYN;ASNS;GAL;GNB2;TIMP1;SOCS2;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SLC27A1;HLCS;LRP1;P2RX4;HOMER2;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;SOCS7;MAPK3;POMT1;DNAJB9;ARHGEF2;RNF103;HM13;CEACAM1;UROS;ADCY6;TGFB1;CAT;LDHA;PIK3R2;ANXA1;PXN
7014,GO:0030695,0.0262145245998435,0.983331184376223,37,249,GTPase regulator activity,MF,ASAP2;DOCK4;ARAP1;SESN2;BCR;EVI5L;ARHGAP23;RIN2;ARHGAP22;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;APPL2;ARL2;RGS19;SH3BP1;RALGDS;VPS9D1;TBC1D20;ARAP3;TBC1D2B;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
4553,GO:0010632,0.0262478612944355,0.985020074613524,25,158,regulation of epithelial cell migration,BP,WNT7A;AKT1;APOE;TMSB4X;TGFBR2;PLCG1;GATA3;SRC;SH3BP1;RAB25;PPM1F;PFN1;ANXA3;FGFR1;RREB1;HYAL1;ADIPOR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;ITGA3
13761,GO:0060313,0.0263529930789788,0.999091041114656,2,3,negative regulation of blood vessel remodeling,BP,CST3;BCR
9308,GO:0035745,0.0263707787960007,0.997175068838244,3,7,T-helper 2 cell cytokine production,BP,PRKCZ;GATA3;ARG1
18295,GO:1903135,0.0264106309483985,0.999087950340687,2,3,cupric ion binding,MF,PRNP;ATP13A2
10262,GO:0042987,0.026483176593418,0.99203223909662,7,29,amyloid precursor protein catabolic process,BP,SORL1;FKBP1A;PRNP;APOE;BIN1;GSK3A;ABCA7
1652,GO:0004096,0.0265143737087469,0.999082377483327,2,3,catalase activity,MF,CYGB;CAT
17775,GO:1901699,0.0265380780730195,0.981231580251824,61,452,cellular response to nitrogen compound,BP,CAPN2;MAP2K1;SHC1;NEURL1;PCK2;DNMT3A;RAPGEF3;PRNP;SSH1;SESN2;RAB31;ADCY7;XBP1;EGFR;PRKACA;MAP2K2;ATF4;AKT1;PRKCZ;MAPK13;PCSK9;PRKACB;WDTC1;IDE;PAK1;BCDIN3D;GNB1;GRB10;GNAI2;HSF1;EIF4EBP1;VAMP2;SRC;DNM2;AGO4;GSK3A;FYN;AGRN;PUM1;GNB2;SOCS2;BCL2L1;ADIPOR1;TRIB3;TCIRG1;LRP1;P2RX4;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;SOCS7;MAPK3;ARHGEF2;CEACAM1;UROS;ADCY6;TGFB1;PIK3R2;PXN
15793,GO:0072378,0.0265442062215814,0.997149097902447,3,7,blood coagulation, fibrin clot formation,BP,FBLN1;SERPING1;F12
18616,GO:1903845,0.026587951898344,0.989220863113858,11,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,SMURF2;TGFBR2;LTBP1;HTRA1;BCL9L;DNM2;MTMR4;STUB1;SNX25;PMEPA1;TGFB1
7873,GO:0032429,0.0266685001448847,0.99713044129353,3,7,regulation of phospholipase A2 activity,BP,EGFR;LRP1;ANXA1
13056,GO:0051493,0.0267292715797436,0.981508576559092,54,396,regulation of cytoskeleton organization,BP,CAPN2;RAC2;ARAP1;DLG1;RAPGEF3;SSH1;TMOD2;ESPN;CORO1B;SHANK3;ARPC1A;TMSB4X;EPHA1;SH3PXD2B;FBXW5;EML2;MAP1B;LIMK1;WASF2;TWF2;FSCN1;PAK1;TTBK2;RHOC;PKD1;RHOBTB2;ARL2;CHMP5;CAPG;SH3BP1;PPM1F;PFN1;AFAP1;ARFIP2;LRP1;SPIRE1;VASP;TAOK1;RHOBTB1;EPS8L1;CAMSAP3;BAIAP2L1;WIPF1;CIB1;TMSB10;MAPK3;KANK2;ARHGEF2;ARHGAP44;TGFB1;PXN;ARHGEF10L;PLEKHH2;FHOD1
8772,GO:0034436,0.0267404375638008,0.999070190413526,2,3,glycoprotein transport,BP,VLDLR;GUK1
11211,GO:0045321,0.0267956827273062,0.979639112521352,96,770,leukocyte activation,BP,PYGB;ERCC1;RAC2;PYGL;QSOX1;CST3;AP3D1;NAPRT;DLG1;PGM1;FKBP1A;PSMD2;CKAP4;PRSS3;PRNP;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;XBP1;CMTM7;MMP14;AKT1;CARD11;ARG2;PKN1;AP2A2;PRKCZ;GALNS;POU2F2;FZD8;CTSZ;PI4K2A;MSN;TGFBR2;SERPINB6;KDELR1;CD44;SURF4;PAK1;RAG1;STOM;SATB1;FUCA1;RAB29;DNASE1L1;ATP11A;GATA3;ARL8A;SLC2A3;ADAM8;IGFBP2;CAP1;VAMP2;SRC;UBR4;C6ORF120;STXBP1;PAG1;FYN;YPEL5;PSMD7;ANXA3;KIF13B;GAL;LRRC8A;MFNG;MIF;TCIRG1;ZFPM1;HPSE;ZP3;PNP;CHD7;ARG1;VAT1;SNAP29;POLM;CBL;TRAPPC1;RAB4B;DNAJB9;ALDOC;SNX27;TMBIM1;CEACAM1;SKAP2;CD59;TGFB1;CAT;ANXA1;RAB6A;EP300;ERP44
11668,GO:0046390,0.0269103680239243,0.984051390944287,28,187,ribose phosphate biosynthetic process,BP,NOS1;PYGL;PTHLH;PGM1;NME4;ACOT7;ADCY7;HK1;APOE;TMSB4X;PFKP;PPARA;DHTKD1;GNAI2;PPCS;PANK4;CAP1;TAZ;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;ADCY6;TGFB1;LDHA
4359,GO:0009953,0.0269477602488756,0.989635338501643,10,48,dorsal/ventral pattern formation,BP,MDFI;WNT7A;LRP5;PRKACB;SUFU;DDIT3;TULP3;DUSP6;FBXL15;AIDA
8011,GO:0032633,0.0270044246686648,0.994009946492623,5,17,interleukin-4 production,BP,PRKCZ;GATA3;IL1RAP;ZFPM1;ZP3
7436,GO:0031532,0.0270332162522363,0.987580454954005,14,77,actin cytoskeleton reorganization,BP,RAC2;SHC1;ARAP1;RAPGEF3;PARVB;PRKCZ;PAK1;EFS;CDC42BPB;FRYL;BAIAP2L1;MINK1;TGFB1;ANXA1
12934,GO:0051261,0.0271754767876126,0.987529425975015,14,75,protein depolymerization,BP,TMOD2;VPS4A;MAP1B;TWF2;TTBK2;ASPH;MICAL2;CAPG;SH3BP1;MICAL1;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
2825,GO:0006290,0.0271932334541951,0.997051280435533,3,7,pyrimidine dimer repair,BP,ERCC1;ERCC6;DDB2
10793,GO:0044242,0.0272482347868519,0.984783117886191,23,147,cellular lipid catabolic process,BP,PCK2;CPT2;SESN2;CRAT;AKT1;APOE;ACAD10;TYSND1;HADH;PPARA;PLCG1;FUCA1;SRD5A3;ACADVL;MGLL;SMPD3;MLYCD;PHYH;LONP2;CPT1B;PNPLA6;LPIN3;NAGA
8490,GO:0033630,0.0272906081550922,0.995307618969881,4,12,positive regulation of cell adhesion mediated by integrin,BP,FERMT1;PODXL;RET;CIB1
4769,GO:0010951,0.0274005208935351,0.985127668286208,21,136,negative regulation of endopeptidase activity,BP,SORL1;CST3;SERPINE2;IFI6;AKT1;SERPING1;SERPINB6;CD44;PRDX5;BIN1;RAG1;TFPI2;TNFRSF6B;SRC;APLP2;SPINT2;MICAL1;TIMP1;CRIM1;PCSK1N;FURIN
9254,GO:0035641,0.0274298991512737,0.997015367779056,3,7,locomotory exploration behavior,BP,DLG4;APOE;NLGN2
3452,GO:0007266,0.0274340989033413,0.984483790485566,24,149,Rho protein signal transduction,BP,F2R;RAC2;ARAP1;OBSCN;NET1;BCR;APOE;LIMK1;PAK1;FARP1;RHOC;RHOBTB2;ARHGEF4;PAK6;PLEKHG5;DNMBP;PAK4;ARAP3;RHOBTB1;EPS8L1;ARHGEF2;ITSN1;ITGA3;ARHGEF10L
19445,GO:1905954,0.0275013110686814,0.990010534127974,9,43,positive regulation of lipid localization,BP,APOE;LDLRAP1;GAL;PLTP;NTSR1;MIF;LRP1;P2RX4;ABCA7
17086,GO:0099550,0.0275791304328948,0.999024459848549,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,F2R;EPHB2
6421,GO:0021681,0.027709088029997,0.996972836116521,3,7,cerebellar granular layer development,BP,WNT7A;SERPINE2;TTBK2
567,GO:0001706,0.0278434868975055,0.989914631006003,9,41,endoderm formation,BP,ITGB5;MMP14;LAMB1;DKK1;SOX7;DUSP4;HMGA2;DUSP6;LAMB3
8382,GO:0033273,0.0278624324351138,0.988066975544232,12,63,response to vitamin,BP,CCND1;CYP27B1;DNMT3A;POSTN;EGFR;ALDH1A2;VDR;HLCS;ARG1;KANK2;TGFB1;CAT
20214,GO:2001026,0.0280479250203724,0.99513524931571,4,12,regulation of endothelial cell chemotaxis,BP,TMSB4X;FGFR1;P2RX4;FGF2
625,GO:0001806,0.0280907447878757,0.998996166475705,2,3,type IV hypersensitivity,BP,GATA3;ZP3
17739,GO:1901628,0.0280953144395378,0.998995912416006,2,3,positive regulation of postsynaptic membrane organization,BP,SSH1;APOE
11374,GO:0045717,0.0281206540187828,0.995118612372302,4,12,negative regulation of fatty acid biosynthetic process,BP,WDTC1;ACADVL;TRIB3;CEACAM1
4886,GO:0014802,0.0281395800870155,0.998993450138615,2,3,terminal cisterna,CC,FKBP1A;RTN2
2940,GO:0006468,0.0281471242471877,0.977274931041835,160,1324,protein phosphorylation,BP,TNIP1;XDH;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;OBSCN;DLG1;IGFBP4;FKBP1A;PSMD2;RPS6KA2;RAPGEF3;PRNP;SCYL1;MAPKAPK3;SESN2;BCR;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;PRKACA;ADARB1;MAP2K2;STK25;SHANK3;AKT1;IRAK1;APOE;ATP13A2;PKN1;WWTR1;TSPYL2;PRKCZ;FAM20C;DGKQ;MAPK13;FZD8;EPHA1;PTK6;GRK6;RRAS;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;CCDC88C;PAK1;TTBK2;TNFSF15;DUSP4;RET;RASGEF1A;CEMIP;PKD1;DLG3;GNAI2;HSF1;NEK9;CTBP1;ADAM8;HMGA2;TOP1;MYDGF;SRC;CDC42BPB;MARK3;STK24;PAK6;GSK3A;DUSP6;FYN;PPM1F;LPAR3;PSMD7;MICAL1;TNFRSF1A;BRSK1;GJC2;ITGA1;PSKH1;MAP3K10;HEXIM1;FGFR1;ADNP;CDK18;MIF;SOCS2;STK17A;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;ULK1;TRIB2;HSPA2;PAK4;TNFRSF19;ULK2;LRRK1;FGF2;EHD4;VAPB;MAPK9;MAP3K12;TAOK1;ABCA7;TGFA;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ARHGEF2;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;ADCK2;SPRED2;PIK3R2;CAMK2N1;ERBB3;WDFY2;RASA3;TRAF7
8737,GO:0034378,0.0281855954458226,0.998990888165526,2,3,chylomicron assembly,BP,P4HB;APOE
1620,GO:0004046,0.0282275185184507,0.99898855193624,2,3,aminoacylase activity,MF,ACY1;CAT
3039,GO:0006591,0.0283398148714302,0.996876092682773,3,7,ornithine metabolic process,BP,ARG2;ARG1;AZIN2
3248,GO:0006909,0.028405348881925,0.983864640878367,24,152,phagocytosis,BP,RAC2;BCR;TUB;ARPC1A;PEAR1;LIMK1;WASF2;PLCG1;PAK1;PIP5K1C;SRC;TGM2;DNM2;SH3BP1;FYN;ANXA3;ELMO3;LRP1;ABCA7;WIPF1;MAPK3;TGFB1;PIK3R2;ANXA1
160,GO:0000323,0.0284146261922575,0.979438435183316,68,519,lytic vacuole,CC,PYGB;TSPAN1;CAPN2;SDC1;CST3;AP3D1;NAPRT;CKAP4;CD68;CTSB;MARCH9;LPCAT1;VLDLR;FYCO1;GPC4;ATP13A2;AP1B1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SURF4;CTBS;STOM;GNB1;FUCA1;ATP11A;ARL8A;SLC12A4;ADAM8;TMEM8A;CAP1;SRC;TMEM9;TMEM44;C6ORF120;AGRN;GNB2;CTSL;UBA1;HYAL1;TCIRG1;TPCN1;LRP1;P2RX4;HPSE;ARG1;ATP6V1C2;CYB561;VAT1;SNAP29;HGS;CBL;TRAPPC1;DRAM2;LITAF;C12ORF66;TMBIM1;HM13;NAGA;PCYOX1;CAT;ANXA1;ARSD
2512,GO:0005764,0.0284146261922575,0.979438435183316,68,519,lysosome,CC,PYGB;TSPAN1;CAPN2;SDC1;CST3;AP3D1;NAPRT;CKAP4;CD68;CTSB;MARCH9;LPCAT1;VLDLR;FYCO1;GPC4;ATP13A2;AP1B1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SURF4;CTBS;STOM;GNB1;FUCA1;ATP11A;ARL8A;SLC12A4;ADAM8;TMEM8A;CAP1;SRC;TMEM9;TMEM44;C6ORF120;AGRN;GNB2;CTSL;UBA1;HYAL1;TCIRG1;TPCN1;LRP1;P2RX4;HPSE;ARG1;ATP6V1C2;CYB561;VAT1;SNAP29;HGS;CBL;TRAPPC1;DRAM2;LITAF;C12ORF66;TMBIM1;HM13;NAGA;PCYOX1;CAT;ANXA1;ARSD
7806,GO:0032350,0.028414853830169,0.992360364416434,6,23,regulation of hormone metabolic process,BP,CYP27B1;DGKQ;GATA3;VDR;GAL;STUB1
13201,GO:0051787,0.0284481662839643,0.992349276386141,6,23,misfolded protein binding,MF,EDEM1;F12;STUB1;HSPA2;HSPA13;DNAJB9
18395,GO:1903365,0.0284592877962359,0.998975600137114,2,3,regulation of fear response,BP,APOE;RAG1
20165,GO:2000822,0.0284592877962359,0.998975600137114,2,3,regulation of behavioral fear response,BP,APOE;RAG1
4099,GO:0009152,0.0285054754628475,0.983379038953092,26,172,purine ribonucleotide biosynthetic process,BP,NOS1;PTHLH;PGM1;NME4;ACOT7;ADCY7;HK1;APOE;TMSB4X;PFKP;PPARA;DHTKD1;GNAI2;PPCS;PANK4;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;ADCY6;TGFB1;LDHA
2213,GO:0005096,0.0285357520319409,0.982112772578683,34,226,GTPase activator activity,MF,ASAP2;DOCK4;ARAP1;BCR;EVI5L;ARHGAP23;RIN2;ARHGAP22;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;APPL2;RGS19;SH3BP1;VPS9D1;TBC1D20;ARAP3;TBC1D2B;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
7057,GO:0030826,0.0285739364888319,0.996839951402737,3,7,regulation of cGMP biosynthetic process,BP,NOS1;APOE;ADNP
5322,GO:0016042,0.0285933559066413,0.982629538974842,30,203,lipid catabolic process,BP,CYP27B1;PCK2;CPT2;PLCH2;SESN2;CRAT;AKT1;APOE;ACAD10;TYSND1;PLD3;HADH;PPARA;PLCG1;FUCA1;SRD5A3;PLCB3;ACADVL;HSD11B1;THRA;MGLL;PLCD3;SMPD3;MLYCD;PHYH;LONP2;CPT1B;PNPLA6;LPIN3;NAGA
5909,GO:0018125,0.0286611094974484,0.998964272184587,2,3,peptidyl-cysteine methylation,BP,RAB3B;RAB6A
9013,GO:0035150,0.0286993989582657,0.987157494301908,13,70,regulation of tube size,BP,NOS1;F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;APOE;RAP1GDS1;APLN;EDNRA;ITGA1;ADCY6
12692,GO:0050880,0.0286993989582657,0.987157494301908,13,70,regulation of blood vessel size,BP,NOS1;F2R;DOCK4;BBS2;HTR7;EGFR;AKT1;APOE;RAP1GDS1;APLN;EDNRA;ITGA1;ADCY6
13825,GO:0060394,0.0287318769931277,0.996815500020188,3,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1;SNX25;PMEPA1
7206,GO:0031090,0.0287401941314438,0.975869963674391,254,2227,organelle membrane,CC,EDEM1;SH3KBP1;TSPAN1;NOS1;RAC2;ASAP2;SORL1;QSOX1;WNT7A;CST3;CYP27B1;SNX9;AP3D1;BOK;ARAP1;DLG4;CPT2;BSG;DYSF;SLC16A3;PITPNM1;FKBP1A;RAB3B;CKAP4;PTPRS;PRNP;IDH2;BNIP3;CD68;AGPAT3;RAB43;DBNDD1;SCYL1;NME4;OCIAD2;COPG1;SNPH;MARCH9;BBS2;SYNE3;RAB31;CHPF;LPCAT1;VLDLR;XYLT1;EGFR;CRAT;HK1;MAP2K2;XYLT2;STK25;SHANK3;SNX33;MRPS6;CDS2;MDH2;ARMCX2;IRAK1;EPN2;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;AP1B1;YIF1A;AP2A2;ATP7B;ITPR3;DGKQ;RFNG;VPS11;VPS4A;CTSZ;PI4K2A;FBXO2;RETSAT;PCSK9;SEC23A;B4GALNT4;HADH;NDST2;MVB12B;SERPINB6;DKK1;BNIP3L;KDELR1;TST;YIPF2;ZDHHC8;CD44;SCRN1;IPO13;ABCB8;SURF4;CCND2;MALL;HMGCL;SFXN3;PAK1;TNRC18;DMXL2;GGA3;GGA1;STOM;GNB1;RET;CORO7;MLXIP;IFI27;CYTH3;TMED3;CEMIP;SHANK2;PKD1;ATP11A;OXA1L;ARL8A;DOPEY2;MYOF;SLC2A3;ANTXR2;APPL2;SLC12A4;ASPH;SDHA;ADAM8;TMEM8A;PLIN3;B4GALT2;GPRC5C;VAMP2;PIP5K1C;GIPC1;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;TAZ;PEX10;DNM2;KLHDC2;UBR4;IRF7;NUCB1;RAB1B;NDUFA4L2;TMEM9;TMEM44;CPTP;ACADVL;CARD19;STX5;COG8;CLSTN1;WNT5B;SLC25A43;TNFRSF1A;ANXA3;SLC33A1;ABHD17C;STX10;CHST14;MOAP1;GNB2;SHISA5;MCFD2;UBA1;SLC35B4;WDFY3;SEC24C;ATP2C2;MFNG;MTMR4;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;ST3GAL3;PRAF2;TCIRG1;SNX25;LEMD2;TPCN1;PMEPA1;ARFIP2;ST3GAL5;ARFGEF2;ULK1;LRP1;P2RX4;HPSE;USO1;ULK2;SMPD3;TBC1D20;SPIRE1;EHD4;MAP1LC3B;ST6GALNAC2;VAPB;COG1;SH3BGRL2;SDHAF4;SNTB2;ABCA7;LMAN1;ENTPD6;INTS1;ARG1;TGFA;ATP6V1C2;CYB561;BPHL;VAT1;SNAP29;HGS;TRAPPC1;RAB4B;CPT1B;CSNK1D;KIFC3;DRAM2;LITAF;FURIN;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;NDUFS2;B4GALT6;OCRL;HM13;CEACAM1;GALNT3;TFPT;CD59;MAP6;SLC30A1;PCYOX1;PPP6R1;CAT;SPRED2;AZIN2;ANXA1;RAB6A;ZFYVE21;ARCN1;RAP1GAP2;STIM1;NIPSNAP1
6667,GO:0030018,0.0287493102643238,0.987131962068383,13,70,Z disc,CC,FLNC;NOS1;SCN8A;OBSCN;FKBP1A;PARVB;BAG3;OBSL1;BIN1;PAK1;FLNB;STUB1;MYZAP
12983,GO:0051346,0.0288868613774751,0.981227618885053,39,281,negative regulation of hydrolase activity,BP,ANGPTL4;NOS1;SORL1;CST3;SERPINE2;IFI6;FKBP1A;AKT1;SERPING1;PRKCZ;PPP1R35;SERPINB6;CD44;PRDX5;PPP1R12C;BIN1;RAG1;FARP1;DLG3;OXA1L;NEIL1;TFPI2;PPP1R14A;ARL2;TNFRSF6B;SRC;APLP2;SPINT2;MICAL1;TIMP1;CRIM1;PCSK1N;MYO1D;CAMSAP3;FURIN;ECM1;PPP1R37;ANXA1;PPP1R10
12628,GO:0050789,0.0289708353310418,0.974912036695998,813,7519,regulation of biological process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;TSPAN1;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;DLG1;TRIM65;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;PC;LAMA5;SSH1;WWC3;TXNDC11;RAB43;CCNI;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;TMOD2;BCORL1;PLCH2;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;ABTB1;TNNT1;PLEK2;ZC3H6;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;LPCAT1;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;HTR7;KIAA1549;ADCY7;XBP1;MARCKSL1;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;CSNK1E;PANO1;MKNK2;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;PRKACA;ADARB1;PTPRF;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;PDIA5;AKT1;XPC;IFITM1;BRD3;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;FMNL2;ATP13A2;ARG2;METTL23;RIN2;PKN1;PEAR1;ZSCAN30;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;RNF135;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;FBXO2;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;GIT2;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;MSN;PPP1R35;MAP1B;TGFBR2;CSMD3;CD99;DRAP1;GDI1;HADH;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;FAM3A;PRSS8;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;TWF2;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TSPAN5;PPP1R12C;GIT1;BIN1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;TTBK2;RHPN1;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;NLGN2;TNRC18;RAG1;SEMA4B;BAZ2A;GAMT;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;CUL7;TBC1D9B;GGA3;ARHGAP39;GGA1;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;PTOV1;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;PROCR;HLTF;PCBP4;CEMIP;SHANK2;PKD1;ASS1;PARP10;DLG3;GATA3;TP53I11;APLN;PHF1;OXA1L;TCFL5;OASL;MYOF;DOCK6;GNAI2;ZNF165;ANTXR2;GRIN3B;ASIC1;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;BCL7A;ALOX15B;IL1RAP;WFS1;EFS;ASPH;MT2A;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;RGL2;HMGA2;ALAS1;ARID5B;RHOBTB2;TOP1;PPP1R14A;FAM110C;ARL2;LY6E;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;KDM4B;GLRX;CAPG;SCG5;TAZ;TGM2;DNM2;NINL;SARAF;REEP6;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;ESRP1;SDCCAG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;ISG20;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NELFCD;NISCH;PSMD7;MICAL1;TNFRSF1A;ANXA3;WISP1;TLE4;FBXL15;SLC33A1;VDR;ABHD17C;KIF13B;PLEKHG5;TSPAN33;BRSK1;SSU72;STX10;CGREF1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;PLTP;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LGALS3BP;SEMA4G;SECISBP2L;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;LRRC8A;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;MTMR4;HES2;ASB13;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;DDB2;ZFPL1;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;RAD23A;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;RNH1;MED15;VAPB;MAPK9;ZNF570;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;BICC1;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;HIST2H2AC;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;BAHCC1;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;KLK6;VAT1;CASP4;LONP2;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;MYL9;GAS8;CBL;GGT1;CIB1;TMSB10;SOCS7;RAB4B;IQSEC1;WRAP73;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;DRAM2;DNAJB9;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;OCRL;ZFP30;ADAM15;SRPX2;MED29;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;ECM1;CD59;MBD3;SLC30A1;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;WBP2;TM2D1;PPP6R1;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;PXN;ZNF318;ARHGEF10L;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;STIM1;RASA3;ASAP1;FHOD1;TRAF7;RNF10
6991,GO:0030663,0.0289972009726759,0.99336492415996,5,18,COPI-coated vesicle membrane,CC,SCYL1;COPG1;KDELR1;TMED3;ARCN1
16124,GO:0090087,0.029040533464561,0.979168966026644,64,489,regulation of peptide transport,BP,EDEM1;SH3TC2;F2R;RAC2;SORL1;PCK2;NR1D1;POSTN;RAPGEF3;PRNP;IDH2;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;BAG3;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS11;FERMT1;GDI1;HADH;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;IFI27;CEMIP;PARP10;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;NUCB1;CPTP;GSK3A;FYN;MIF;LRP1;CHD7;APBB1;CAMK1;CIB1;MAPK3;UGCG;LLGL1;TGFB1;ANXA1
10108,GO:0042608,0.0291238223842632,0.998938126810089,2,3,T cell receptor binding,MF,FYN;EPS8L1
4715,GO:0010875,0.0291569320002759,0.994879992862161,4,12,positive regulation of cholesterol efflux,BP,APOE;PLTP;LRP1;ABCA7
15909,GO:0072657,0.0292431610597456,0.979413726322041,57,454,protein localization to membrane,BP,ZMYND8;DVL1;AP3D1;DLG4;BSG;DLG1;PRNP;LAMA5;SSH1;BBS2;SYNE3;RAB31;ETV5;EGFR;TUB;SHANK3;TTC7B;AKT1;APOE;EHD3;PRKCZ;VPS4A;SH3PXD2B;GDI1;SEC63;TSPAN5;PAK1;NLGN2;STOM;PTPN9;RAB29;REEP2;CEMIP;DLG3;OXA1L;GRIN3B;NUMB;VAMP2;TULP3;LDLRAP1;STXBP1;FYN;AGRN;TNFRSF1A;TSPAN33;MOAP1;BCL2L1;LRP1;RPL28;EPHB2;HGS;CIB1;PACS2;TMBIM1;ARHGAP44;TGFB1;ITGA3
6157,GO:0019471,0.0292441243772635,0.994859782788964,4,12,4-hydroxyproline metabolic process,BP,P4HB;ERO1B;P4HA1;ALDH4A1
8539,GO:0033829,0.0293777271282699,0.998923677459898,2,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,RFNG;MFNG
11161,GO:0045197,0.0294126343312256,0.990950410687783,7,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG4;DLG1;MSN;DLG3;SH3BP1;LRCH4;CAMSAP3
17819,GO:1901879,0.0294418212978277,0.987869242872369,11,55,regulation of protein depolymerization,BP,TMOD2;MAP1B;TWF2;TTBK2;ASPH;CAPG;SH3BP1;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
9478,GO:0036089,0.0294435964946722,0.996704619056723,3,7,cleavage furrow formation,BP,SNX9;SNX33;SPIRE1
13226,GO:0051835,0.0295288441215152,0.99891504322132,2,3,positive regulation of synapse structural plasticity,BP,SHANK3;CAMK1
9253,GO:0035640,0.0295561572403769,0.994787290450536,4,12,exploration behavior,BP,DLG4;APOE;NLGN2;ITGA3
14143,GO:0060986,0.0296317596891008,0.991953184643009,6,23,endocrine hormone secretion,BP,FAM129B;GATA3;APLN;GAL;FGFR1;GNAS
19559,GO:1990425,0.0296719055101382,0.998906845651858,2,3,ryanodine receptor complex,CC,NOS1;FKBP1A
9856,GO:0042092,0.02975903573048,0.991854664059831,6,24,type 2 immune response,BP,ARG2;PRKCZ;GATA3;ARG1;ECM1;ANXA1
10265,GO:0042994,0.0297900490771611,0.993133534847305,5,18,cytoplasmic sequestering of transcription factor,BP,MDFI;TMSB4X;SUFU;PKD1;THRA
2265,GO:0005178,0.0298452750293381,0.986114726116778,14,76,integrin binding,MF,LTBP4;ITGA6;LAMA5;EGFR;MMP14;P4HB;LAMB2;SRC;NISCH;WISP1;FGF2;ADAM15;ITGA3;PXN
4636,GO:0010756,0.0298596061655662,0.998896055459307,2,3,positive regulation of plasminogen activation,BP,F12;PLGRKT
9448,GO:0036017,0.0298942744771762,0.99845572490475,2,4,response to erythropoietin,BP,EPOR;MT2A
9449,GO:0036018,0.0298942744771762,0.99845572490475,2,4,cellular response to erythropoietin,BP,EPOR;MT2A
6110,GO:0019344,0.0298986454963497,0.998893806290584,2,3,cysteine biosynthetic process,BP,CBS;GGT1
16129,GO:0090092,0.0299291023640588,0.983382023914793,22,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LTBP4;FKBP1A;SMURF2;ACVR2B;WWTR1;FERMT1;TGFBR2;DKK1;LTBP1;HTRA1;BCL9L;GIPC1;DNM2;PCSK6;FBXL15;MTMR4;STUB1;SNX25;LEMD2;PMEPA1;TGFB1;ITGA3
3294,GO:0006990,0.0301488761171906,0.998879349400833,2,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,XBP1;EP300
1988,GO:0004705,0.0301689209798138,0.998878188304904,2,3,JUN kinase activity,MF,MAPK9;MAPK10
5759,GO:0016909,0.0301689209798138,0.998878188304904,2,3,SAP kinase activity,MF,MAPK9;MAPK10
9493,GO:0036119,0.0303257467536618,0.993058405456986,5,17,response to platelet-derived growth factor,BP,CORO1B;SRC;FYN;HYAL1;CBL
19350,GO:1905600,0.0303814929967707,0.998865847596791,2,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9;LDLRAP1
14880,GO:0070640,0.0304679106068585,0.998860816333483,2,3,vitamin D3 metabolic process,BP,CYP27B1;FGFR1
46,GO:0000098,0.0304731890245799,0.996542218112165,3,7,sulfur amino acid catabolic process,BP,CBS;BLMH;PCYOX1
1990,GO:0004707,0.0305258002324715,0.994560367192,4,12,MAP kinase activity,MF,MAPK13;MAPK9;MAPK3;MAPK10
5719,GO:0016853,0.0305513565199284,0.983796006374693,19,121,isomerase activity,MF,QSOX1;PGM1;FKBP1A;HYI;TXNDC11;FKBP9;P4HB;PDIA5;TSTA3;ISYNA1;ERO1B;RPUSD3;TOP1;FKBP10;MPI;GALE;MIF;TMX4;ERP44
15375,GO:0071593,0.0305587996657463,0.998855515801063,2,3,lymphocyte aggregation,BP,RAC2;MSN
1700,GO:0004175,0.0305908718559941,0.980825595106534,33,230,endopeptidase activity,MF,ADAM19;CAPN2;PLAT;MMP1;PSMD2;PRSS3;CTSB;USP20;MMP14;RHBDF2;PITRM1;CTSZ;PCSK9;TYSND1;PRSS8;IDE;HTRA1;MMP10;ADAMTS7;ADAM8;BLMH;CAPN5;PCSK6;TMPRSS11D;THOP1;CTSL;F12;KLK6;CASP4;LONP2;FURIN;ADAM15;HM13
7241,GO:0031143,0.0305984267078517,0.994543270738292,4,12,pseudopodium,CC,CAPN2;MSN;RAB25;MAPK3
7856,GO:0032411,0.0306070778588449,0.987272096390726,11,57,positive regulation of transporter activity,BP,SHANK3;EHD3;TMSB4X;STK39;GLRX;DNM2;GAL;NTSR1;HSPA2;EPHB2;STIM1
10334,GO:0043114,0.0306723754606422,0.992957283286539,5,17,regulation of vascular permeability,BP,CTNNBIP1;BCR;SRC;CEACAM1;TGFB1
5281,GO:0015929,0.030799499131359,0.994495865740855,4,12,hexosaminidase activity,MF,NAGLU;CEMIP;HYAL1;NAGA
17608,GO:1901215,0.0309297929202723,0.983023260417905,21,131,negative regulation of neuron death,BP,F2R;SORL1;BOK;AARS;ATF4;AKT1;APOE;ATP13A2;PPARA;HSF1;WFS1;ADAM8;STXBP1;FYN;ADNP;BCL2L1;LRP1;MAP3K12;CBL;ITSN1;ERBB3
2232,GO:0005134,0.0309378170665696,0.998833313396698,2,3,interleukin-2 receptor binding,MF,GATA3;ECM1
9238,GO:0035620,0.0309391721815011,0.998833233730754,2,3,ceramide transporter activity,MF,CPTP;PLTP
14317,GO:0061408,0.0311281294543723,0.998822105275619,2,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,HSF1;HSF4
11579,GO:0046110,0.0311384719315445,0.998821495029471,2,3,xanthine metabolic process,BP,XDH;AOX1
17581,GO:1901135,0.0312887862739681,0.975631247884516,110,912,carbohydrate derivative metabolic process,BP,TNIP1;NT5E;EDEM1;NOS1;SDC1;PYGL;PTHLH;CST3;LMF1;DLG4;DLG1;PGM1;RAPGEF3;NME4;ACOT7;CHPF;H6PD;XYLT1;ADCY7;PGLS;TK2;HK1;XYLT2;AKT1;CARD11;GPC4;APOE;UAP1;SYVN1;CRYL1;TMSB4X;GALNS;FAM20C;NAGLU;RFNG;PFKP;FBXO2;NDST2;UBE2J1;PPARA;DHTKD1;NADK;CD44;ESYT2;GTPBP1;TSTA3;AHCY;CTBS;GAMT;ADAMTS7;FUCA1;CEMIP;DLG3;PIGQ;GNAI2;PPCS;PANK4;SRD5A3;SDHA;NEIL1;CAP1;B4GALT2;AKR7A2;B3GNT3;CBR4;TAZ;RAB1B;CPTP;GSK3A;PCSK6;TALDO1;MPI;AGRN;UCKL1;CHST14;MCFD2;ADNP;HYAL1;MFNG;GUK1;AMPD2;ST3GAL3;VPS9D1;TCIRG1;ST3GAL5;HPSE;SMPD3;PNP;FGF2;ST6GALNAC2;ABHD14B;ABCA7;LMAN1;VEGFB;ARSK;POMT1;ALDOC;RNF103;UGCG;NDUFS2;B4GALT6;GALNT3;NAGA;ADCY6;TGFB1;LDHA;ARSD;PODXL2;APOBEC3C;ERP44
1955,GO:0004656,0.0313474923744741,0.998809136782476,2,3,procollagen-proline 4-dioxygenase activity,MF,P4HB;P4HA1
13770,GO:0060324,0.0313887283950221,0.988350308537961,9,42,face development,BP,MAP2K1;RRAS;DKK1;ASPH;ARID5B;ALDH1A2;CHD7;MAPK3;TGFB1
3080,GO:0006654,0.0314021200678264,0.990201206856209,7,29,phosphatidic acid biosynthetic process,BP,LPCAT4;DGKA;AGPAT3;LPCAT1;DGKQ;SLC27A1;AGPAT4
16511,GO:0097187,0.0314229029134874,0.998804666374353,2,3,dentinogenesis,BP,FAM20C;HTRA1
12139,GO:0048193,0.0314673812505583,0.978980358585756,43,309,Golgi vesicle transport,BP,SORL1;AP3D1;LMF1;KLC2;SCYL1;COPG1;BBS2;RAB31;EHD3;YIF1A;CTSZ;SEC23A;CREB3L2;KDELR1;OSBPL5;SURF4;TBC1D14;CORO7;CYTH3;TMED3;DOPEY2;VAMP2;DNM2;RAB1B;STX5;COG8;EXOC2;MCFD2;SEC24C;ARFGEF2;USO1;TBC1D20;VAPB;COG1;LMAN1;TGFA;TRAPPC1;CSNK1D;LLGL1;CD59;PPP6R1;RAB6A;ARCN1
4771,GO:0010954,0.0315395697686584,0.994320479750012,4,12,positive regulation of protein processing,BP,ADAM8;SRC;F12;PLGRKT
15285,GO:0071442,0.0315789377583124,0.998795396659317,2,3,positive regulation of histone H3-K14 acetylation,BP,GATA3;WBP2
10090,GO:0042581,0.0316139064807212,0.983878866698839,17,102,specific granule,CC,QSOX1;CKAP4;LCN2;CTSZ;STOM;DNASE1L1;ATP11A;SLC2A3;ADAM8;UBR4;ANXA3;HPSE;ARG1;TMBIM1;CEACAM1;CD59;ERP44
5001,GO:0015141,0.0316154432129311,0.998793224089729,2,3,succinate transmembrane transporter activity,MF,SLC13A3;SLC13A5
5184,GO:0015744,0.0316154432129311,0.998793224089729,2,3,succinate transport,BP,SLC13A3;SLC13A5
15271,GO:0071422,0.0316154432129311,0.998793224089729,2,3,succinate transmembrane transport,BP,SLC13A3;SLC13A5
3217,GO:0006865,0.0316193579969071,0.985158522823144,14,77,amino acid transport,BP,SERINC2;STK39;SLC38A10;SLC6A6;SLC43A1;VAMP2;GIPC1;STXBP1;SLC6A9;NTSR1;PRAF2;SLC6A14;ARG1;APBA1
17058,GO:0099512,0.0316219336179565,0.976529756568826,77,596,supramolecular fiber,CC,FLNC;NOS1;THSD4;RAC2;DVL1;CST3;CLIP2;SCN8A;OBSCN;KLC2;DLG1;FKBP1A;MTA1;TMOD2;ESPN;TNNT1;TMEM214;SNPH;TUBB6;CORO1B;MAP2K2;TUBG2;PARVB;BAG3;TMSB4X;PRKCZ;FERMT1;EML2;MAP1B;OBSL1;LTBP1;TWF2;BIN1;FSCN1;PAK1;NAV1;TUBB3;REEP2;SHANK2;MYH15;DYNLRB1;FAM110C;FLNB;SRC;LDLRAP1;DNM2;NINL;SPECC1L;FYN;REEP4;MICAL1;KIF17;KIF13B;TUBG1;CEP170;STUB1;ARFGEF2;MAP1LC3B;SNTB2;LMAN1;PBXIP1;NDE1;CAMSAP3;INVS;WIPF1;KRT23;MYL9;GAS8;TMSB10;CSNK1D;KIFC3;ARHGEF2;MYZAP;ENKD1;MAP6;ANXA1;STIM1
18029,GO:1902473,0.0316488557432976,0.996353932533607,3,7,regulation of protein localization to synapse,BP,DVL1;WNT7A;NLGN2
11476,GO:0045916,0.0316510162351996,0.998791105607633,2,3,negative regulation of complement activation,BP,SERPING1;CD59
19843,GO:2000258,0.0316510162351996,0.998791105607633,2,3,negative regulation of protein activation cascade,BP,SERPING1;CD59
2405,GO:0005548,0.0316672916834241,0.988227933730583,9,42,phospholipid transporter activity,MF,PITPNC1;PITPNM1;OSBPL10;OSBPL5;ATP11A;CPTP;PLTP;PITPNM2;ABCA7
17734,GO:1901620,0.0317233786759195,0.996341896536381,3,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;SUFU;TULP3
20075,GO:2000664,0.0317286758873854,0.998786475922627,2,3,positive regulation of interleukin-5 secretion,BP,PRKCZ;GATA3
20078,GO:2000667,0.0317286758873854,0.998786475922627,2,3,positive regulation of interleukin-13 secretion,BP,PRKCZ;GATA3
10523,GO:0043418,0.0317907278262424,0.998782771947786,2,3,homocysteine catabolic process,BP,CBS;BLMH
3525,GO:0007501,0.0318047165143798,0.99878193635982,2,3,mesodermal cell fate specification,BP,DKK1;FGFR1
10136,GO:0042661,0.0318047165143798,0.99878193635982,2,3,regulation of mesodermal cell fate specification,BP,DKK1;FGFR1
19388,GO:1905770,0.0318047165143798,0.99878193635982,2,3,regulation of mesodermal cell differentiation,BP,DKK1;FGFR1
19426,GO:1905902,0.0318047165143798,0.99878193635982,2,3,regulation of mesoderm formation,BP,DKK1;FGFR1
4858,GO:0014068,0.0319263200538872,0.988969409619686,8,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;RGL2;MYDGF;FYN;FGFR1;CBL;CAT;ERBB3
15685,GO:0072189,0.0319583856247247,0.996303862946758,3,7,ureter development,BP,RET;GATA3;ALDH1A2
12717,GO:0050916,0.03197164094152,0.998771948938698,2,3,sensory perception of sweet taste,BP,ITPR3;REEP2
11413,GO:0045785,0.0319820507451547,0.979593720261052,35,243,positive regulation of cell adhesion,BP,AP3D1;ITGA6;NET1;XBP1;AKT1;CARD11;PRKCZ;EPHA1;FERMT1;TGFBR2;CD44;TFE3;PAK1;RAG1;PODXL;RET;NID1;CYTH3;GATA3;ADAM8;ARL2;IGFBP2;SRC;TGM2;DNM2;FYN;PPM1F;RREB1;HYAL1;ZP3;PNP;CIB1;TGFB1;ANXA1;ITGA3
7545,GO:0031802,0.0320202464693228,0.99876903505226,2,3,type 5 metabotropic glutamate receptor binding,MF,PRNP;FYN
18650,GO:1903911,0.0320558783393272,0.998766897294926,2,3,positive regulation of receptor clustering,BP,SSH1;TGFB1
11868,GO:0046834,0.0320864025224724,0.984922322003532,14,76,lipid phosphorylation,BP,DGKA;EGFR;TTC7B;DGKQ;PI4K2A;PIP5K1C;SRC;FYN;FGFR1;PIP5KL1;FGF2;PIK3R2;ERBB3;ZFYVE21
3580,GO:0007626,0.032112326343538,0.983611565311187,17,100,locomotory behavior,BP,DLG4;MTA1;ESPN;ETV5;APOE;NAGLU;ZDHHC8;CCND2;ZNF385A;NLGN2;B4GALT2;PUM1;NTSR1;PBX3;CHD7;APBA1;ARCN1
17668,GO:1901379,0.0321233388508574,0.988887839310231,8,36,regulation of potassium ion transmembrane transport,BP,FHL1;KCNG1;DLG1;PRNP;STK39;VAMP2;DNM2;GAL
4532,GO:0010595,0.0322002091271057,0.985335330749507,13,71,positive regulation of endothelial cell migration,BP,WNT7A;AKT1;TMSB4X;PLCG1;GATA3;ANXA3;FGFR1;P2RX4;FGF2;CIB1;SRPX2;TGFB1;ANXA1
6541,GO:0021942,0.0322425413700019,0.998755675705553,2,3,radial glia guided migration of Purkinje cell,BP,RERE;SOCS7
15488,GO:0071813,0.0322448578813748,0.994152022992231,4,12,lipoprotein particle binding,MF,SORL1;VLDLR;APOE;PCSK9
15489,GO:0071814,0.0322448578813748,0.994152022992231,4,12,protein-lipid complex binding,MF,SORL1;VLDLR;APOE;PCSK9
11985,GO:0047192,0.0323038354545775,0.998751982622966,2,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT4;LPCAT1
1019,GO:0002513,0.0323417677668865,0.99874969508289,2,3,tolerance induction to self antigen,BP,TGFBR2;TGFB1
7678,GO:0032102,0.0323473473528381,0.980502584363909,28,188,negative regulation of response to external stimulus,BP,NT5E;DVL1;PLAT;SHARPIN;SERPINE2;PTPRS;BBS2;SEMA3F;BCR;CORO1B;SERPING1;APOE;ARG2;PPARA;FAM3A;HTRA1;SEMA4B;GATA3;FNDC4;MAPKBP1;TNFRSF1A;SEMA4G;F12;MIF;FGF2;SEC14L1;KANK2;CEACAM1
12918,GO:0051241,0.0323519591033856,0.975603678997547,85,677,negative regulation of multicellular organismal process,BP,XDH;F2R;SORL1;NFATC4;DOCK4;PLAT;WNT7A;PTHLH;CST3;SERPINE2;PTPRS;PRNP;IDH2;WWC3;FAM129B;TNNT1;BBS2;SEMA3F;BCR;LRP5;MAP4K4;EGFR;THBS2;EPN1;SERPING1;EPN2;APOE;ARG2;TMSB4X;RNF135;CTSZ;PCSK9;FERMT1;TGFBR2;GDI1;STK39;DKK1;PRKACB;MC1R;SUFU;PAK1;SEMA4B;DDIT3;ADAMTS7;PTPN9;RAB29;PROCR;GATA3;APLN;HSF1;ADGRB2;MAPKBP1;RAI1;TULP3;CPTP;GSK3A;FUZ;GAL;COMT;TIMP1;SEMA4G;FGFR1;F12;SOCS2;ADIPOR1;ZFPM1;LRP1;TRIB2;P2RX4;ULK2;FGF2;ARG1;EPHB2;HGS;CIB1;FURIN;ARHGEF2;CEACAM1;ECM1;ADCY6;TGFB1;ANXA1;RAP1GAP2;ASAP1;RNF10
19979,GO:2000482,0.0323627088715082,0.993995687374996,4,13,regulation of interleukin-8 secretion,BP,F2R;TMSB4X;MAPKBP1;ANXA1
2527,GO:0005782,0.0323675689986882,0.989744052431952,7,31,peroxisomal matrix,CC,CRAT;IDE;PRDX5;MLYCD;PHYH;LONP2;CAT
7570,GO:0031907,0.0323675689986882,0.989744052431952,7,31,microbody lumen,CC,CRAT;IDE;PRDX5;MLYCD;PHYH;LONP2;CAT
8759,GO:0034405,0.0323971833583027,0.989775747218842,7,30,response to fluid shear stress,BP,AKT1;PKD1;ASS1;TFPI2;SRC;P2RX4;TGFB1
13052,GO:0051489,0.0324342163798046,0.989808112309252,7,29,regulation of filopodium assembly,BP,ZMYND8;NEURL1;ARAP1;ESPN;FSCN1;AGRN;TENM2
18473,GO:1903532,0.0325022782910631,0.979689368042185,32,220,positive regulation of secretion by cell,BP,F2R;SDC1;PCK2;POSTN;XBP1;EGFR;HK1;ATP13A2;PRKCZ;VPS4A;FERMT1;NLGN2;GLUL;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;SRC;NCS1;STXBP1;GAL;NTSR1;FGFR1;MIF;SMPD3;ZP3;APBB1;HGS;MAPK3;TGFB1
3761,GO:0008305,0.0326041203609807,0.992387680345851,5,17,integrin complex,CC,ITGB4;ITGA6;ITGB5;ITGA1;ITGA3
16816,GO:0098636,0.0326041203609807,0.992387680345851,5,17,protein complex involved in cell adhesion,CC,ITGB4;ITGA6;ITGB5;ITGA1;ITGA3
8532,GO:0033762,0.032615915323524,0.989691727484097,7,30,response to glucagon,BP,ADCY7;PRKACA;PRKACB;GNB1;GNB2;ARG1;ADCY6
16658,GO:0097500,0.0326647849375513,0.998730151919927,2,3,receptor localization to non-motile cilium,BP,TUB;TULP3
11848,GO:0046777,0.0326804303634631,0.980515144746885,27,173,protein autophosphorylation,BP,MAPKAPK3;BCR;EGFR;MKNK2;MAP2K2;STK25;AKT1;IRAK1;ATP13A2;EPHA1;PTK6;STK39;PPP2R5B;MAP3K9;PAK1;SRC;STK24;FYN;MAP3K10;FGFR1;ULK1;ULK2;MAP3K12;TAOK1;IMPACT;MAPK3;MINK1
3519,GO:0007494,0.0327289854487248,0.99617831969153,3,7,midgut development,BP,EGFR;RET;ALDH1A2
467,GO:0001505,0.0327377475334884,0.980667751552336,26,170,regulation of neurotransmitter levels,BP,NOS1;DVL1;WNT7A;RAB3B;SNPH;AKT1;ARG2;SEPT5;GLUL;SYTL1;ASS1;ASIC1;VAMP2;PIP5K1C;DNM2;STXBP1;SLC6A9;ALDH7A1;BRSK1;COMT;NTSR1;P2RX4;SNAP29;KCNC4;APBA1;SLC30A1
4379,GO:0010008,0.0328207187330865,0.97732221614551,50,369,endosome membrane,CC,SORL1;AP3D1;BOK;CD68;RAB31;EGFR;IRAK1;EHD3;ATP13A2;AP2A2;VPS11;VPS4A;PI4K2A;PCSK9;MVB12B;DKK1;YIPF2;GGA3;GGA1;RET;ARL8A;ANTXR2;APPL2;PLIN3;PIP5K1C;CHMP5;IRF7;TMEM9;CPTP;ABHD17C;UBA1;MTMR4;VPS37A;RAB11FIP4;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;EHD4;ABCA7;HGS;LITAF;FURIN;SNX27;TMBIM1;LLGL1;OCRL;ANXA1;ZFYVE21
6371,GO:0021549,0.0329458167101596,0.986157144673895,11,56,cerebellum development,BP,MAP2K1;WNT7A;SERPINE2;PTPRS;AARS;NAGLU;PAK1;TTBK2;B4GALT2;RERE;ARCN1
15524,GO:0071879,0.0329493527182208,0.99871284129534,2,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1;GSK3A
3534,GO:0007528,0.0330679483929424,0.989565281302376,7,29,neuromuscular junction development,BP,F2R;DVL1;ETV5;SHANK3;LAMB2;SHANK2;AGRN
11175,GO:0045218,0.0330750631996698,0.998705166275521,2,3,zonula adherens maintenance,BP,CAMSAP3;KIFC3
13808,GO:0060374,0.0331313776152633,0.998701722569235,2,3,mast cell differentiation,BP,GATA3;ZFPM1
17234,GO:0106071,0.0331407913638523,0.998701146571323,2,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;GSK3A
14735,GO:0070371,0.0331532312671099,0.97997980123204,28,186,ERK1 and ERK2 cascade,BP,TNIP1;F2R;MST1R;MAP2K1;SHC1;DLG1;FBLN1;EGFR;MAP2K2;PRKCZ;EPHA1;RRAS;CD44;DUSP4;RET;SRC;DUSP6;FGFR1;MIF;FGF2;ABCA7;EPHB2;CIB1;MAPK3;CEACAM1;TGFB1;CAMK2N1;ERBB3
4903,GO:0014829,0.0331570659851542,0.993932267842115,4,12,vascular smooth muscle contraction,BP,DOCK4;BBS2;RAP1GDS1;EDNRA
7893,GO:0032455,0.0331577701425022,0.998700107451105,2,3,nerve growth factor processing,BP,PCSK6;FURIN
5542,GO:0016528,0.0332137742727417,0.987514696410821,9,43,sarcoplasm,CC,XDH;FLNC;NOS1;FKBP1A;RTN2;ITPR3;ASPH;POMT1;STIM1
12632,GO:0050794,0.0332267148870834,0.971062283894267,774,7127,regulation of cellular process,BP,TNIP1;EDEM1;ANGPTL4;XDH;PGF;FHL1;SH2D2A;SH3KBP1;ITGB4;TSPAN1;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;BSG;NR1D1;DLG1;TRIM65;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;LAMA5;SSH1;WWC3;TXNDC11;RAB43;CCNI;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;TMOD2;BCORL1;PLCH2;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;PLEK2;ZC3H6;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;LPCAT1;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;HTR7;KIAA1549;ADCY7;XBP1;MARCKSL1;EVI5L;MAP4K4;CMTM7;EGFR;CSNK1E;PANO1;MKNK2;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;PRKACA;ADARB1;PTPRF;CORO1B;TUB;RHBDF2;HK1;MAP2K2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;PDIA5;AKT1;XPC;IFITM1;BRD3;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;FMNL2;ATP13A2;ARG2;METTL23;RIN2;PKN1;PEAR1;ZSCAN30;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;UACA;ZMIZ2;PTK6;SLC20A1;FBXO2;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;GIT2;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;MSN;PPP1R35;MAP1B;TGFBR2;CSMD3;DRAP1;GDI1;HADH;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;TWF2;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TSPAN5;PPP1R12C;GIT1;BIN1;FSCN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;TTBK2;RHPN1;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;NLGN2;TNRC18;RAG1;SEMA4B;BAZ2A;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;CUL7;TBC1D9B;ARHGAP39;ADAMTS7;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;PTOV1;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NXPH4;GRB10;CYTH3;HLTF;PCBP4;CEMIP;SHANK2;PKD1;ASS1;PARP10;DLG3;GATA3;TP53I11;APLN;PHF1;TCFL5;OASL;MYOF;DOCK6;GNAI2;ZNF165;ANTXR2;GRIN3B;ASIC1;GLUD1;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;BCL7A;ALOX15B;IL1RAP;WFS1;EFS;ASPH;MT2A;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;RGL2;HMGA2;ARID5B;RHOBTB2;PPP1R14A;FAM110C;ARL2;LY6E;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;KDM4B;GLRX;CAPG;SCG5;TAZ;TGM2;DNM2;NINL;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;STPG1;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;ESRP1;SDCCAG8;RERE;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;OAS1;FYN;RAB25;ISG20;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NELFCD;NISCH;PSMD7;MICAL1;TNFRSF1A;ANXA3;WISP1;TLE4;FBXL15;SLC33A1;VDR;KIF13B;PLEKHG5;TSPAN33;BRSK1;SSU72;CGREF1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LGALS3BP;SEMA4G;SECISBP2L;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;LRRC8A;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;MTMR4;HES2;ASB13;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;DNMBP;TRIB3;DDB2;ZFPL1;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;RAD23A;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;MED15;VAPB;MAPK9;ZNF570;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;BICC1;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;HIST2H2AC;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;INVS;NCCRP1;BAHCC1;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;KLK6;VAT1;CASP4;LONP2;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;MYL9;GAS8;CBL;CIB1;TMSB10;SOCS7;RAB4B;IQSEC1;WRAP73;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;DRAM2;DNAJB9;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;OCRL;ZFP30;ADAM15;SRPX2;MED29;CEACAM1;PAIP2;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;ECM1;CD59;MBD3;SLC30A1;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;WBP2;TM2D1;PPP6R1;MANF;CAT;RMI2;LDHA;SPRED2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;PXN;ZNF318;ARHGEF10L;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;RASA3;ASAP1;FHOD1;TRAF7;RNF10
6743,GO:0030158,0.0332270220599025,0.998695865936273,2,3,protein xylosyltransferase activity,MF,XYLT1;XYLT2
18256,GO:1903034,0.0332367591770274,0.98295615556951,17,101,regulation of response to wounding,BP,F2R;MAP2K1;PLAT;SERPINE2;PTPRS;XBP1;PTPRF;SERPING1;APOE;TGFBR2;STK24;RREB1;F12;HPSE;FGF2;CEACAM1;ANXA1
889,GO:0002252,0.0332697333846761,0.974563750365619,93,753,immune effector process,BP,PYGB;ERCC1;RAC2;PYGL;QSOX1;CST3;NAPRT;DLG1;PGM1;PSMD2;CKAP4;PRSS3;BNIP3;CD68;LCN2;CTSB;BCR;RAB31;LPCAT1;XBP1;ADARB1;HK1;IFITM1;ARPC1A;SERPING1;PKN1;AP2A2;PRKCZ;GALNS;POU2F2;CTSZ;PI4K2A;SERPINB6;LIMK1;BNIP3L;KDELR1;WASF2;CD44;PLCG1;SURF4;HTRA1;PAK1;STOM;FUCA1;DNASE1L1;ATP11A;GATA3;ARL8A;OASL;SLC2A3;ADAM8;CAP1;VAMP2;SRC;UBR4;IRF7;C6ORF120;STXBP1;OAS1;FYN;ISG20;YPEL5;PSMD7;ANXA3;PUM1;MFNG;MIF;TCIRG1;ZFPM1;LRP1;HPSE;ZP3;PNP;ARG1;SEC14L1;WIPF1;VAT1;SNAP29;CBL;TRAPPC1;RAB4B;MAPK3;ALDOC;TMBIM1;CEACAM1;CD59;TGFB1;CAT;PIK3R2;ANXA1;RAB6A;APOBEC3C;ERP44
10824,GO:0044302,0.0332936059319378,0.99869178295819,2,3,dentate gyrus mossy fiber,CC,MAP1B;MICAL1
12336,GO:0048671,0.0333704639595155,0.998687064022637,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
12658,GO:0050832,0.0334059403301405,0.993627308509139,4,14,defense response to fungus,BP,FAM3A;RNASE7;ARG1;TGFB1
6684,GO:0030046,0.0334084249690296,0.998684730943306,2,3,parallel actin filament bundle assembly,BP,ESPN;SPIRE1
8171,GO:0032898,0.0334413913023384,0.99868270357823,2,3,neurotrophin production,BP,PCSK6;FURIN
2539,GO:0005795,0.0334789437985621,0.982101966624575,19,115,Golgi stack,CC,ASAP2;SORL1;ARAP1;PITPNM1;MARCH9;CHPF;B4GALNT4;YIPF2;TMED3;B4GALT2;NUCB1;ST3GAL3;DNMBP;USO1;SMPD3;LLGL1;B4GALT6;OCRL;GALNT3
1989,GO:0004706,0.0335412974514841,0.998676552407352,2,3,JUN kinase kinase kinase activity,MF,MAP3K9;MAP3K10
6330,GO:0020016,0.0335620393938983,0.998675273991566,2,3,ciliary pocket,CC,EHD3;SNAP29
6331,GO:0020018,0.0335620393938983,0.998675273991566,2,3,ciliary pocket membrane,CC,EHD3;SNAP29
7865,GO:0032420,0.0336102067450359,0.990528340307399,6,24,stereocilium,CC,DOCK4;ESPN;BBS2;TWF2;RHOC;HOMER2
12904,GO:0051223,0.0336335207642987,0.975793931468117,62,475,regulation of protein transport,BP,EDEM1;SH3TC2;F2R;RAC2;SORL1;PCK2;NR1D1;POSTN;RAPGEF3;PRNP;IDH2;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;BAG3;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS11;FERMT1;GDI1;HADH;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;IFI27;CEMIP;PARP10;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;NUCB1;CPTP;GSK3A;FYN;MIF;LRP1;APBB1;CAMK1;CIB1;MAPK3;UGCG;LLGL1;TGFB1;ANXA1
14714,GO:0070325,0.033650074714798,0.9919819193326,5,18,lipoprotein particle receptor binding,MF,APOE;PCSK9;DKK1;LDLRAP1;LRP1
17251,GO:0110020,0.0337023082746821,0.985143878095076,12,63,regulation of actomyosin structure organization,BP,ARAP1;RAPGEF3;EPHA1;SH3PXD2B;LIMK1;WASF2;PAK1;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
11838,GO:0046717,0.0337476722540807,0.986462793584423,10,50,acid secretion,BP,VAMP2;GIPC1;STXBP1;SLC6A9;NTSR1;MIF;P2RX4;APBA1;STARD10;ANXA1
2180,GO:0005024,0.0338240394481464,0.995997753839371,3,7,transforming growth factor beta-activated receptor activity,MF,LTBP4;TGFBR2;LTBP1
19677,GO:1990851,0.0338493773393081,0.998657516596346,2,3,Wnt-Frizzled-LRP5/6 complex,CC,LRP5;FZD8
5925,GO:0018197,0.0338672526296718,0.998656408983821,2,3,peptidyl-aspartic acid modification,BP,ATP13A2;ASPH
6390,GO:0021578,0.0339271633003328,0.998652694223454,2,3,hindbrain maturation,BP,RERE;ARCN1
6408,GO:0021626,0.0339271633003328,0.998652694223454,2,3,central nervous system maturation,BP,RERE;ARCN1
3270,GO:0006949,0.0339694859018996,0.989168879004489,7,30,syncytium formation,BP,ERCC1;NOS1;CAPN2;RAPGEF3;MYOF;CAMK1;SH3PXD2A
12582,GO:0050715,0.0339830160506153,0.984965519074422,12,65,positive regulation of cytokine secretion,BP,F2R;POSTN;XBP1;HK1;PRKCZ;FERMT1;GATA3;ALOX15B;IL1RAP;SRC;MIF;MAPK3
539,GO:0001657,0.0340029919950802,0.98499094155317,12,63,ureteric bud development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ARG2;RET;GATA3;FGFR1;FGF2;TGFB1;CAT
9355,GO:0035855,0.0340297343800382,0.993720084980199,4,12,megakaryocyte development,BP,WASF2;ZNF385A;ZFPM1;EP300
14228,GO:0061138,0.0340597237553221,0.981122864553614,21,129,morphogenesis of a branching epithelium,BP,PGF;CTNNBIP1;NFATC4;DLG1;LAMA5;ETV5;LRP5;MMP14;CTSZ;TGFBR2;PAK1;PKD1;EDNRA;SRC;TGM2;SPINT2;VDR;FGFR1;FGF2;RXRA;TGFB1
7564,GO:0031901,0.0341206394562395,0.982069320620168,18,108,early endosome membrane,CC,BOK;RAB31;EGFR;PI4K2A;DKK1;GGA3;GGA1;APPL2;MTMR4;PMEPA1;EHD4;ABCA7;HGS;LITAF;SNX27;LLGL1;OCRL;ANXA1
5364,GO:0016137,0.0341855272469153,0.993544803867675,4,13,glycoside metabolic process,BP,FUCA1;AKR7A2;CBR4;NAGA
9896,GO:0042165,0.034192985790594,0.99181671364305,5,18,neurotransmitter binding,MF,CBS;HTR7;IDE;GRIN3B;NIPSNAP1
12850,GO:0051138,0.0342054072387654,0.998635391381387,2,3,positive regulation of NK T cell differentiation,BP,AP3D1;TGFBR2
9317,GO:0035766,0.0342213325272,0.998634398550311,2,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
9319,GO:0035768,0.0342213325272,0.998634398550311,2,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
19048,GO:1904847,0.0342213325272,0.998634398550311,2,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
20003,GO:2000544,0.0342213325272,0.998634398550311,2,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1;FGF2
1171,GO:0002791,0.0342948819322986,0.977557518201626,38,271,regulation of peptide secretion,BP,F2R;PCK2;NR1D1;POSTN;RAPGEF3;IDH2;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;FERMT1;HADH;NLGN2;GLUL;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;SRC;CPTP;MIF;CHD7;APBB1;MAPK3;LLGL1;TGFB1;ANXA1
4031,GO:0009062,0.0343168054876469,0.98317300802166,15,88,fatty acid catabolic process,BP,PCK2;CPT2;SESN2;CRAT;AKT1;ACAD10;TYSND1;HADH;PPARA;ACADVL;MLYCD;PHYH;LONP2;CPT1B;LPIN3
3425,GO:0007215,0.0343245266854037,0.987969295326402,8,36,glutamate receptor signaling pathway,BP,DLG4;SHANK3;NLGN2;SHANK2;GRIN3B;HOMER2;EPHB2;MINK1
2431,GO:0005610,0.0343392604799802,0.99862703813875,2,3,laminin-5 complex,CC,LAMA5;LAMB3
14882,GO:0070644,0.0343517773932851,0.998626256031278,2,3,vitamin D response element binding,MF,VDR;RXRA
10429,GO:0043259,0.0345666958717132,0.998612801011023,2,3,laminin-10 complex,CC,LAMA5;LAMB1
10430,GO:0043260,0.0345666958717132,0.998612801011023,2,3,laminin-11 complex,CC,LAMA5;LAMB2
6794,GO:0030226,0.0345666958717283,0.998612801011023,2,3,apolipoprotein receptor activity,MF,LRP1;ABCA7
3308,GO:0007010,0.0347368913834763,0.972510291079656,122,984,cytoskeleton organization,BP,SH3KBP1;CAPN2;RAC2;DVL1;SHC1;NEURL1;ARAP1;OBSCN;DLG1;RAPGEF3;LAMA5;SSH1;TMOD2;ESPN;TNNT1;PLEK2;BBS2;TUBB6;BCR;SYNE3;MARK4;ITGB5;SEPT10;CORO1B;TUBG2;PARVB;SHANK3;ARPC1A;APOE;FMNL2;TMSB4X;PRKCZ;VPS4A;EPHA1;DNAAF5;SH3PXD2B;FBXW5;EML2;SEPT5;MSN;MAP1B;LIMK1;CORO2A;OBSL1;SIPA1;WASF2;RAP1GDS1;MSRB2;TWF2;TACC1;BIN1;FSCN1;CCDC88C;PAK1;TTBK2;NAV1;CUL7;TUBB3;CORO7;RHOC;SEPT8;PKD1;FAT1;EFS;RHOBTB2;ARL2;MICAL2;CAP1;FLNB;PIP5K1C;SRC;CHMP5;CAPG;NINL;CDC42BPB;MARK3;PAK6;SDCCAG8;SPECC1L;SH3BP1;AGRN;PPM1F;PFN1;NISCH;MICAL1;BRSK1;FRYL;TUBG1;AFAP1;ARFIP2;LRP1;PAK4;SPIRE1;KLHL17;VASP;ARAP3;TAOK1;RHOBTB1;EPS8L1;NDE1;CAMSAP3;BAIAP2L1;WIPF1;GAS8;CIB1;TMSB10;IQSEC1;WRAP73;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;MINK1;ARHGAP44;MAP6;TGFB1;ANXA1;PXN;ARHGEF10L;PLEKHH2;FHOD1
7000,GO:0030676,0.0349724432382807,0.993488757948541,4,12,Rac guanyl-nucleotide exchange factor activity,MF,FARP1;ARHGEF4;EPS8L1;ARHGEF2
10593,GO:0043547,0.034984249819622,0.976464364029703,43,303,positive regulation of GTPase activity,BP,F2R;ASAP2;DOCK4;SNX9;ARAP1;ITGA6;NET1;RAPGEF3;BCR;EVI5L;ARHGAP23;RIN2;ARHGAP22;EPHA1;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;DOCK9;RGS19;SH3BP1;AGRN;VPS9D1;DNMBP;TBC1D20;ARAP3;TBC1D2B;IQSEC1;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
1969,GO:0004675,0.035001933139353,0.993481486479371,4,12,transmembrane receptor protein serine/threonine kinase activity,MF,LTBP4;ACVR2B;TGFBR2;LTBP1
17549,GO:1901016,0.0351033201252357,0.98872711509225,7,30,regulation of potassium ion transmembrane transporter activity,BP,FHL1;KCNG1;DLG1;STK39;VAMP2;DNM2;GAL
8169,GO:0032892,0.0353536552319123,0.993251472233703,4,13,positive regulation of organic acid transport,BP,STXBP1;NTSR1;MIF;P2RX4
15610,GO:0072073,0.0357452873615148,0.981951476863554,16,92,kidney epithelium development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ARG2;WWTR1;LAMB2;PODXL;RET;PKD1;GATA3;FGFR1;FGF2;TGFB1;CAT
7701,GO:0032153,0.035837088417991,0.983422768578736,13,71,cell division site,CC,PITPNM1;SSH1;SEPT10;PKN1;SEPT5;RHOC;SEPT8;RHOBTB2;RAB11FIP4;PLCD3;SPIRE1;RHOBTB1;NDE1
5670,GO:0016776,0.0358491426929748,0.988341497513277,7,32,phosphotransferase activity, phosphate group as acceptor,MF,DLG4;DLG1;NME4;CARD11;DLG3;PMVK;GUK1
10582,GO:0043535,0.0359257127914545,0.983969965488205,12,65,regulation of blood vessel endothelial cell migration,BP,AKT1;APOE;TMSB4X;PLCG1;SH3BP1;FGFR1;P2RX4;FGF2;CIB1;SRPX2;TGFB1;ANXA1
7610,GO:0031985,0.0361376778112904,0.982182182510553,15,86,Golgi cisterna,CC,ASAP2;SORL1;ARAP1;PITPNM1;CHPF;B4GALNT4;YIPF2;TMED3;B4GALT2;NUCB1;ST3GAL3;SMPD3;LLGL1;B4GALT6;GALNT3
5543,GO:0016529,0.0362231263164284,0.987127215983913,8,37,sarcoplasmic reticulum,CC,XDH;NOS1;FKBP1A;RTN2;ITPR3;ASPH;POMT1;STIM1
10813,GO:0044283,0.0363146808040921,0.973280346072168,69,542,small molecule biosynthetic process,BP,NT5E;XDH;CBS;CYP27B1;PCK2;NR1D1;PGM1;RAPGEF3;NAGS;PC;NME4;ACOT7;GPT2;XBP1;TK2;HK1;ATF4;PSAT1;MDH2;APOE;DGKQ;PFKP;PPARA;DHTKD1;WDTC1;ELOVL1;HMGCL;ISYNA1;AHCY;GAMT;GLUL;CEMIP;ASS1;GLUD1;ALOX15B;SRD5A3;NEIL1;PYCR2;ALDH1A2;CBR4;ACADVL;TALDO1;PMVK;SPTLC2;ASNS;VDR;UCKL1;CHST14;PLTP;NTSR1;MGLL;SLC35B4;HYAL1;GUK1;MIF;ADIPOR1;TRIB3;PNP;FGF2;MLYCD;SEC14L2;GGT1;ALDOC;CEACAM1;UROS;TGFB1;LDHA;ANXA1;SLC45A3
14738,GO:0070374,0.0363750310834552,0.980348379331217,19,117,positive regulation of ERK1 and ERK2 cascade,BP,F2R;MST1R;MAP2K1;SHC1;EGFR;PRKCZ;EPHA1;CD44;RET;SRC;FGFR1;MIF;FGF2;ABCA7;EPHB2;CIB1;MAPK3;TGFB1;ERBB3
15514,GO:0071868,0.0363904595264493,0.989545739997201,6,24,cellular response to monoamine stimulus,BP,PRKACA;ATF4;GNB1;DNM2;MAPK3;ADCY6
15516,GO:0071870,0.0363904595264493,0.989545739997201,6,24,cellular response to catecholamine stimulus,BP,PRKACA;ATF4;GNB1;DNM2;MAPK3;ADCY6
770,GO:0002020,0.0364585371914632,0.981965410792984,15,89,protease binding,MF,CST3;PRNP;SYVN1;TYSND1;SERPINB6;BIN1;TIMP1;MIF;RAD23A;LRP1;LONP2;FURIN;ECM1;ITGA3;STIM1
3702,GO:0008211,0.0364944326856557,0.992961771042664,4,13,glucocorticoid metabolic process,BP,DGKQ;HSD11B1;GAL;STUB1
6987,GO:0030658,0.0365939253109006,0.979853198798071,20,126,transport vesicle membrane,CC,RAB3B;PTPRS;DBNDD1;PI4K2A;SEC23A;DMXL2;VAMP2;LDLRAP1;STX5;MCFD2;SEC24C;BCL2L1;USO1;SNTB2;LMAN1;TGFA;CEACAM1;CD59;MAP6;SPRED2
4184,GO:0009260,0.0366036226508429,0.977888050553734,27,184,ribonucleotide biosynthetic process,BP,NOS1;PTHLH;PGM1;NME4;ACOT7;ADCY7;HK1;APOE;TMSB4X;PFKP;PPARA;DHTKD1;GNAI2;PPCS;PANK4;CAP1;TAZ;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;ADCY6;TGFB1;LDHA
17946,GO:1902235,0.0366371634266056,0.989393230790126,6,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK;XBP1;SYVN1;DDIT3;WFS1;GRINA
2755,GO:0006164,0.0366611686555026,0.978083414592636,26,176,purine nucleotide biosynthetic process,BP,NOS1;PTHLH;PGM1;NME4;ACOT7;ADCY7;HK1;APOE;TMSB4X;PFKP;PPARA;DHTKD1;GNAI2;PPCS;PANK4;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;ADCY6;TGFB1;LDHA
18259,GO:1903037,0.0367107827753972,0.978060540730765,26,174,regulation of leukocyte cell-cell adhesion,BP,AP3D1;DLG1;PRNP;XBP1;AKT1;CARD11;ARG2;PRKCZ;TGFBR2;PPARA;CD44;PAK1;RAG1;ASS1;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1
5267,GO:0015909,0.0368055010425668,0.986878466003947,8,37,long-chain fatty acid transport,BP,CPT2;AKT1;APOE;NTSR1;MIF;SLC27A1;CPT1B;ANXA1
11083,GO:0045069,0.0371530717378147,0.982658702572831,13,75,regulation of viral genome replication,BP,TNIP1;ADARB1;IFITM1;STOM;PARP10;OASL;HMGA2;OAS1;ISG20;RAD23A;TBC1D20;VAPB;APOBEC3C
17947,GO:1902236,0.0373400861213995,0.992744984643056,4,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,XBP1;SYVN1;WFS1;GRINA
11703,GO:0046473,0.0374127023022194,0.987816946500286,7,30,phosphatidic acid metabolic process,BP,LPCAT4;DGKA;AGPAT3;LPCAT1;DGKQ;SLC27A1;AGPAT4
11898,GO:0046890,0.0374609630383696,0.979321103881271,20,126,regulation of lipid biosynthetic process,BP,CYP27B1;NR1D1;LPCAT1;AKT1;APOE;DGKQ;WDTC1;ACADVL;PMVK;TNFRSF1A;VDR;ADIPOR1;TRIB3;SLC27A1;SMPD3;ZP3;SEC14L2;CEACAM1;ANXA1;SLC45A3
7786,GO:0032305,0.037513581712367,0.995089622830988,3,8,positive regulation of icosanoid secretion,BP,NTSR1;MIF;P2RX4
19809,GO:2000193,0.037513581712367,0.995089622830988,3,8,positive regulation of fatty acid transport,BP,NTSR1;MIF;P2RX4
11004,GO:0044794,0.0375602435982681,0.992688265664671,4,13,positive regulation by host of viral process,BP,PC;APOE;STOM;TBC1D20
13851,GO:0060429,0.0375929447616843,0.970824051012537,100,810,epithelium development,BP,XDH;PGF;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;WNT7A;CST3;CYP27B1;SHARPIN;PCK2;SERPINE2;DLG1;PSMD2;RAPGEF3;PTPRS;LAMA5;SMURF2;CTSB;ETV5;LRP5;ACVR2B;XBP1;EGFR;MMP14;ACTA2;AKT1;GPC4;ARG2;WWTR1;AP2A2;FAM20C;CTSZ;PTK6;FERMT1;DEAF1;SALL2;MSN;TGFBR2;LAMB2;DKK1;PRSS8;TST;PRKACB;CD44;SUFU;PAK1;PODXL;RET;RHOC;PKD1;DLG3;GATA3;ALOX15B;CNFN;MICAL2;FLNB;EDNRA;TULP3;ALDH1A2;SRC;TGM2;ACADVL;GSK3A;SH3BP1;SPINT2;PCSK6;RAB25;FUZ;WNT5B;PFN1;PSMD7;TNFRSF1A;VDR;GAL;CTSL;EHF;THRA;FGFR1;RREB1;TNFRSF19;HPSE;TBC1D20;PRR9;FGF2;VASP;CHD7;RXRA;CAMSAP3;KRT23;ALDOC;FURIN;CEACAM1;TGFB1;CAT;ANXA1;GNAS;EP300
8378,GO:0033267,0.0376212766903484,0.975672451934989,35,244,axon part,CC,ADGRL1;DVL1;AP3D1;SCN8A;DLG4;DLG1;FKBP1A;SSH1;TMOD2;PRKCZ;CTSZ;SEPT5;TWF2;BIN1;FSCN1;NAV1;GLUL;SHANK2;DLG3;DNM2;STXBP1;MICAL1;KIF13B;GJC2;NTSR1;TENM2;SIGMAR1;P2RX4;MAP3K12;MYO1D;APBB1;KCNC4;CBL;CIB1;ITGA3
13690,GO:0060193,0.0376474710570107,0.987672623208621,7,31,positive regulation of lipase activity,BP,LMF1;EGFR;PRKCZ;RHOC;EDNRA;FGFR1;FGF2
10393,GO:0043204,0.0377718016764637,0.983726781516263,11,58,perikaryon,CC,NEURL1;PTPRS;PI4K2A;ENDOG;GLUL;TOP1;GJC2;ITGA1;NTSR1;WDFY3;AZIN2
13894,GO:0060491,0.0378295127812307,0.97910238291919,20,125,regulation of cell projection assembly,BP,ZMYND8;RAC2;NEURL1;ARAP1;SSH1;ESPN;EVI5L;WASF2;TWF2;FSCN1;PODXL;FAM110C;SRC;DNM2;FUZ;AGRN;PFN1;TENM2;EPS8L1;WRAP73
13439,GO:0052813,0.0378413157804284,0.986475339228868,8,36,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;PIP5K1C;SRC;FYN;FGFR1;FGF2;PIK3R2;ERBB3
6024,GO:0019079,0.0378824263706571,0.980669558035173,16,97,viral genome replication,BP,TNIP1;ADARB1;IFITM1;ATG16L2;STOM;RAB29;PARP10;OASL;CTBP1;HMGA2;OAS1;ISG20;RAD23A;TBC1D20;VAPB;APOBEC3C
9723,GO:0038128,0.0379023077994018,0.987570813531968,7,31,ERBB2 signaling pathway,BP,SHC1;EGFR;PTK6;SRC;STUB1;PTPN12;ERBB3
12791,GO:0051047,0.037950988136611,0.975770584593463,33,232,positive regulation of secretion,BP,F2R;SDC1;PCK2;POSTN;XBP1;EGFR;HK1;ATP13A2;PRKCZ;VPS4A;FERMT1;NLGN2;GLUL;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;SRC;NCS1;STXBP1;GAL;NTSR1;FGFR1;MIF;P2RX4;SMPD3;ZP3;APBB1;HGS;MAPK3;TGFB1
8119,GO:0032799,0.0379920932177007,0.990544725235644,5,19,low-density lipoprotein receptor particle metabolic process,BP,VLDLR;APOE;AP2A2;PCSK9;FURIN
7681,GO:0032105,0.0381155096597863,0.9949786558327,3,8,negative regulation of response to extracellular stimulus,BP,BBS2;PPARA;KANK2
7684,GO:0032108,0.0381155096597863,0.9949786558327,3,8,negative regulation of response to nutrient levels,BP,BBS2;PPARA;KANK2
3255,GO:0006921,0.0381925283208784,0.988830657667219,6,25,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;BOK;SHARPIN;ENDOG;DEDD2;HSF1
11391,GO:0045742,0.0382270691014353,0.988818094945881,6,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1;ARAP1;AKT1;PTK6;TGFA;CBL
17752,GO:1901657,0.0383182722973082,0.979515048920512,18,115,glycosyl compound metabolic process,BP,NT5E;DLG4;DLG1;NME4;TK2;CARD11;GTPBP1;AHCY;GAMT;FUCA1;DLG3;AKR7A2;CBR4;UCKL1;GUK1;PNP;NAGA;APOBEC3C
713,GO:0001935,0.0384380764968592,0.98086322503075,15,88,endothelial cell proliferation,BP,XDH;PGF;DLG1;XBP1;MMP14;AKT1;APOE;APLN;MYDGF;ALDH1A2;FGFR1;FGF2;ARG1;VEGFB;ECM1
8777,GO:0034447,0.0386847911786164,0.997694391950996,2,4,very-low-density lipoprotein particle clearance,BP,VLDLR;APOE
1261,GO:0003012,0.038689864673206,0.975446744816697,32,223,muscle system process,BP,NOS1;F2R;DOCK4;SMTN;DLG1;DYSF;FKBP1A;TMOD2;TNNT1;BBS2;ITGB5;HTR7;PRKACA;ACTA2;PPP1R13L;EHD3;ARG2;OBSL1;RAP1GDS1;PAK1;GAMT;MYOF;ASPH;EDNRA;TAZ;GSK3A;CAMTA2;ITGA1;P2RX4;VEGFB;MYL9;PXN
4200,GO:0009306,0.0387404922424749,0.973471574091658,45,331,protein secretion,BP,LTBP2;F2R;LMF1;PCK2;NR1D1;POSTN;RAB3B;RAPGEF3;IDH2;COPG1;LRP5;ACVR2B;XBP1;MAP4K4;EGFR;RHBDF2;HK1;CARD11;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;POU2F2;FERMT1;HADH;NLGN2;GLUL;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;SRC;CPTP;GAL;MIF;PNP;APBB1;MAPK3;LLGL1;TGFB1;ANXA1
2673,GO:0006023,0.0387536636440051,0.980711503423781,15,86,aminoglycan biosynthetic process,BP,SDC1;CHPF;XYLT1;XYLT2;GPC4;NDST2;CEMIP;B4GALT2;B3GNT3;AGRN;CHST14;HYAL1;ST3GAL3;B4GALT6;TGFB1
15577,GO:0072006,0.0388582341308428,0.980652399705047,15,86,nephron development,BP,PGF;CTNNBIP1;DLG1;LAMA5;ACTA2;WWTR1;LAMB2;PODXL;RET;NID1;PKD1;GATA3;FGF2;TGFB1;ITGA3
17019,GO:0099081,0.0389546907110707,0.970757817236532,77,602,supramolecular polymer,CC,FLNC;NOS1;THSD4;RAC2;DVL1;CST3;CLIP2;SCN8A;OBSCN;KLC2;DLG1;FKBP1A;MTA1;TMOD2;ESPN;TNNT1;TMEM214;SNPH;TUBB6;CORO1B;MAP2K2;TUBG2;PARVB;BAG3;TMSB4X;PRKCZ;FERMT1;EML2;MAP1B;OBSL1;LTBP1;TWF2;BIN1;FSCN1;PAK1;NAV1;TUBB3;REEP2;SHANK2;MYH15;DYNLRB1;FAM110C;FLNB;SRC;LDLRAP1;DNM2;NINL;SPECC1L;FYN;REEP4;MICAL1;KIF17;KIF13B;TUBG1;CEP170;STUB1;ARFGEF2;MAP1LC3B;SNTB2;LMAN1;PBXIP1;NDE1;CAMSAP3;INVS;WIPF1;KRT23;MYL9;GAS8;TMSB10;CSNK1D;KIFC3;ARHGEF2;MYZAP;ENKD1;MAP6;ANXA1;STIM1
6598,GO:0022612,0.039010627859405,0.980566223426658,15,86,gland morphogenesis,BP,LAMA5;ETV5;LRP5;XBP1;EGFR;MSN;TGFBR2;SRC;TGM2;VDR;FGFR1;RXRA;ARG1;CEACAM1;TGFB1
11712,GO:0046486,0.0391100222516023,0.973329075568951,44,319,glycerolipid metabolic process,BP,SERINC2;MBOAT2;LPCAT4;LMF1;PCK2;PITPNM1;DGKA;SBF1;AGPAT3;PLCH2;OSBPL10;LPCAT1;EGFR;TTC7B;CDS2;APOE;DGKQ;PI4K2A;PCSK9;OSBPL5;PTDSS2;PIGQ;PIP5K1C;SRC;TAZ;FYN;MBOAT7;MGLL;FGFR1;MTMR4;PITPNM2;SLC27A1;PIP5KL1;AGPAT4;ZP3;FGF2;OCRL;PNPLA6;LPIN3;CAT;PIK3R2;STARD10;ERBB3;ZFYVE21
11154,GO:0045185,0.0392065336432848,0.980415317041296,15,89,maintenance of protein location,BP,MDFI;SORL1;SYNE3;HK1;AKT1;TMSB4X;KDELR1;LTBP1;TWF2;SUFU;PKD1;ARL2;FLNB;THRA;TMSB10
2718,GO:0006094,0.0392535245891792,0.983782252605601,10,52,gluconeogenesis,BP,PCK2;NR1D1;PGM1;PC;ATF4;MDH2;DGKQ;PPARA;SLC35B4;ALDOC
6713,GO:0030120,0.0392918854897875,0.983763642019092,10,52,vesicle coat,CC,SCYL1;COPG1;EGFR;EPN2;AP2A2;SEC23A;TMED3;LDLRAP1;SEC24C;ARCN1
3512,GO:0007431,0.0394454072340601,0.98695087257191,7,31,salivary gland development,BP,CST3;LAMA5;XBP1;EGFR;TGM2;FGFR1;TGFB1
15840,GO:0072524,0.0394841657136063,0.977718173631998,21,134,pyridine-containing compound metabolic process,BP,NT5E;NAPRT;PCK2;PGM1;IDH2;H6PD;PGLS;HK1;PSAT1;MDH2;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;TALDO1;AOX1;PNP;ALDOC;LDHA
1041,GO:0002551,0.0396072067302999,0.994700434522807,3,8,mast cell chemotaxis,BP,PGF;RAC2;VEGFB
4462,GO:0010453,0.0397913130440081,0.992107034385194,4,13,regulation of cell fate commitment,BP,DKK1;DUSP6;FGFR1;FGF2
12818,GO:0051093,0.0399325908934703,0.970272043148365,72,564,negative regulation of developmental process,BP,XDH;CCND1;SORL1;NFATC4;WNT7A;PTHLH;CST3;POSTN;RAPGEF3;PTPRS;IDH2;BNIP3;WWC3;FAM129B;BBS2;SEMA3F;BCR;LRP5;FBLN1;XBP1;MAP4K4;EGFR;THBS2;EPN1;EPN2;APOE;WWTR1;CTSZ;FERMT1;TGFBR2;GDI1;DKK1;PPARA;PRKACB;SUFU;PAK1;SEMA4B;DDIT3;ADAMTS7;PTPN9;RAB29;GATA3;ADGRB2;RAI1;HMGA2;TULP3;GSK3A;FUZ;GAL;TIMP1;SEMA4G;MIF;SOCS2;ADIPOR1;TRIB3;ZFPM1;LRP1;TRIB2;ULK2;VAT1;EPHB2;HGS;CIB1;ARHGEF2;CEACAM1;ECM1;ADCY6;TGFB1;ANXA1;RAP1GAP2;ASAP1;RNF10
682,GO:0001889,0.0399442819922598,0.979019760851341,17,103,liver development,BP,CCND1;PCK2;XBP1;EGFR;PCSK9;SEC63;HMGCL;PKD1;ARID5B;ALDH1A2;ASNS;PHF2;ARG1;DBP;CEACAM1;TGFB1;ANXA1
18862,GO:1904427,0.0399604690795769,0.985474817966049,8,38,positive regulation of calcium ion transmembrane transport,BP,F2R;EHD3;PLCG1;CEMIP;GJC2;NTSR1;HSPA2;STIM1
12982,GO:0051345,0.0402165044292211,0.97005069542018,72,562,positive regulation of hydrolase activity,BP,XDH;F2R;ASAP2;DOCK4;SNX9;LMF1;BOK;ARAP1;DAP;ITGA6;NET1;RAPGEF3;BCR;FBLN1;EVI5L;EGFR;MMP14;ARHGAP23;AKT1;RIN2;TMSB4X;PRKCZ;ARHGAP22;EPHA1;GIT2;GDI1;RIN1;SOX7;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TNFSF15;TBC1D9B;ARHGAP39;DOCK9;RHOC;IFI27;HSF1;ASPH;EDNRA;DNM2;FAM162A;RGS19;SH3BP1;FYN;AGRN;PPM1F;PFN1;ITGA1;FGFR1;VPS9D1;DNMBP;HSPA2;TBC1D20;FGF2;VAPB;ARAP3;TBC1D2B;CASP4;IQSEC1;MAPK3;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
18606,GO:1903825,0.0402240060243005,0.980439955826911,14,79,organic acid transmembrane transport,BP,CPT2;SLC16A3;AKT1;STK39;SLC38A10;SLC6A6;SLC13A3;SLC43A1;SLC6A9;SLC13A5;NTSR1;PRAF2;SLC6A14;CPT1B
19138,GO:1905039,0.0402240060243005,0.980439955826911,14,79,carboxylic acid transmembrane transport,BP,CPT2;SLC16A3;AKT1;STK39;SLC38A10;SLC6A6;SLC13A3;SLC43A1;SLC6A9;SLC13A5;NTSR1;PRAF2;SLC6A14;CPT1B
2095,GO:0004857,0.0402385488004224,0.974343939171731,32,232,enzyme inhibitor activity,MF,ANGPTL4;CST3;SERPINE2;SERPING1;PPP1R35;SERPINB6;WDTC1;PRDX5;PPP1R12C;TFPI2;PPP1R14A;ARL2;APLP2;SCG5;SPINT2;ANXA3;HEXIM1;TIMP1;CRIM1;SOCS2;PCSK1N;TRIB3;TRIB2;RNH1;CIB1;SOCS7;FURIN;SPRED2;CAMK2N1;PPP1R37;ANXA1;PPP1R10
17018,GO:0099080,0.0403065496747834,0.969686011992659,77,603,supramolecular complex,CC,FLNC;NOS1;THSD4;RAC2;DVL1;CST3;CLIP2;SCN8A;OBSCN;KLC2;DLG1;FKBP1A;MTA1;TMOD2;ESPN;TNNT1;TMEM214;SNPH;TUBB6;CORO1B;MAP2K2;TUBG2;PARVB;BAG3;TMSB4X;PRKCZ;FERMT1;EML2;MAP1B;OBSL1;LTBP1;TWF2;BIN1;FSCN1;PAK1;NAV1;TUBB3;REEP2;SHANK2;MYH15;DYNLRB1;FAM110C;FLNB;SRC;LDLRAP1;DNM2;NINL;SPECC1L;FYN;REEP4;MICAL1;KIF17;KIF13B;TUBG1;CEP170;STUB1;ARFGEF2;MAP1LC3B;SNTB2;LMAN1;PBXIP1;NDE1;CAMSAP3;INVS;WIPF1;KRT23;MYL9;GAS8;TMSB10;CSNK1D;KIFC3;ARHGEF2;MYZAP;ENKD1;MAP6;ANXA1;STIM1
3552,GO:0007589,0.0403173348318321,0.983264871697479,10,52,body fluid secretion,BP,XDH;CCND1;NEURL1;XBP1;ATP7B;STK39;APLN;VDR;USF2;SOCS2
7584,GO:0031943,0.0403994224480177,0.994550829929141,3,8,regulation of glucocorticoid metabolic process,BP,DGKQ;GAL;STUB1
7215,GO:0031102,0.0404993829973315,0.985239079841698,8,38,neuron projection regeneration,BP,MAP2K1;PTPRS;MAP4K4;PTPRF;APOE;LAMB2;STK24;ULK1
13287,GO:0051955,0.0406344954867041,0.991884363248002,4,13,regulation of amino acid transport,BP,STK39;STXBP1;NTSR1;ARG1
10903,GO:0044437,0.040699124796102,0.970609117625428,59,452,vacuolar part,CC,PYGB;TSPAN1;SDC1;AP3D1;NAPRT;CKAP4;CD68;CTSB;MARCH9;LPCAT1;VLDLR;GPC4;ATG16L2;ATP13A2;AP1B1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;PI4K2A;PCSK9;SURF4;STOM;GNB1;FUCA1;ATP11A;ARL8A;SLC12A4;TMEM8A;CAP1;TMEM9;TMEM44;C6ORF120;AGRN;GNB2;CTSL;UBA1;WDFY3;HYAL1;TCIRG1;TPCN1;ULK1;LRP1;P2RX4;HPSE;MAP1LC3B;ARG1;ATP6V1C2;CYB561;VAT1;SNAP29;TRAPPC1;DRAM2;LITAF;C12ORF66;TMBIM1;HM13;PCYOX1
3175,GO:0006790,0.0410253926327582,0.972902376630766,37,273,sulfur compound metabolic process,BP,CBS;CHAC1;PC;ACOT7;HAGH;CHPF;XYLT1;ACOT1;XYLT2;ACOT13;GALNS;NDST2;ELOVL1;HMGCL;AHCY;ACSF2;GAMT;CNDP2;BLMH;MICAL2;B4GALT2;B3GNT3;CBR4;PMVK;MICAL1;CHST14;COMT;HYAL1;ST3GAL3;HLCS;ABHD14B;MLYCD;GGT1;GLO1;B4GALT6;PCYOX1;PODXL2
12903,GO:0051222,0.041146190551684,0.972226103259942,41,300,positive regulation of protein transport,BP,EDEM1;F2R;RAC2;SORL1;PCK2;POSTN;RAPGEF3;PRNP;XBP1;EGFR;HK1;BAG3;ATP13A2;PRKCZ;VPS11;FERMT1;ZDHHC8;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;CEMIP;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;VAMP2;SRC;GSK3A;FYN;MIF;LRP1;APBB1;CAMK1;CIB1;MAPK3;UGCG;TGFB1
13530,GO:0055080,0.0412351128115582,0.971047100285797,50,379,cation homeostasis,BP,NOS1;F2R;CYP27B1;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;EGFR;SLC12A7;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;SFXN3;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;COMT;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;STIM1;RASA3
16134,GO:0090101,0.0414353043551875,0.980380846819948,13,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SMURF2;TGFBR2;DKK1;LTBP1;HTRA1;BCL9L;DNM2;MTMR4;STUB1;SNX25;LEMD2;PMEPA1;TGFB1
7823,GO:0032371,0.0414837383317544,0.987552662423069,6,26,regulation of sterol transport,BP,APOE;PCSK9;LDLRAP1;PLTP;LRP1;ABCA7
7826,GO:0032374,0.0414837383317544,0.987552662423069,6,26,regulation of cholesterol transport,BP,APOE;PCSK9;LDLRAP1;PLTP;LRP1;ABCA7
11395,GO:0045746,0.0415273180296197,0.986052321781509,7,32,negative regulation of Notch signaling pathway,BP,CHAC1;NEURL1;FAM129B;EGFR;MMP14;PEAR1;ARRDC1
11659,GO:0046364,0.0415774382171312,0.981755161869047,11,60,monosaccharide biosynthetic process,BP,PCK2;NR1D1;PGM1;PC;ATF4;MDH2;DGKQ;PPARA;TALDO1;SLC35B4;ALDOC
7167,GO:0031032,0.041678453384035,0.976728754647518,20,124,actomyosin structure organization,BP,ARAP1;OBSCN;RAPGEF3;TMOD2;TNNT1;ITGB5;VPS4A;EPHA1;SH3PXD2B;LIMK1;OBSL1;WASF2;PAK1;SRC;CDC42BPB;PPM1F;PFN1;PXN;ARHGEF10L;FHOD1
3449,GO:0007263,0.0416993529472607,0.994302610592505,3,8,nitric oxide mediated signal transduction,BP,NOS1;EGFR;APOE
6721,GO:0030128,0.0417229538371051,0.991594523807474,4,13,clathrin coat of endocytic vesicle,CC,EGFR;EPN2;AP2A2;LDLRAP1
8741,GO:0034382,0.0417637881147895,0.997401740592953,2,4,chylomicron remnant clearance,BP,LMF1;APOE
15500,GO:0071830,0.0417637881147895,0.997401740592953,2,4,triglyceride-rich lipoprotein particle clearance,BP,LMF1;APOE
12173,GO:0048265,0.0418999082209845,0.994264014769609,3,8,response to pain,BP,RET;VWA1;COMT
7056,GO:0030825,0.0420833796972115,0.994228636793241,3,8,positive regulation of cGMP metabolic process,BP,NOS1;APOE;ADNP
6726,GO:0030134,0.0421314650133509,0.980668854678484,12,68,COPII-coated ER to Golgi transport vesicle,CC,YIF1A;CTSZ;PCSK9;SEC23A;TMED3;STX5;MCFD2;SEC24C;USO1;LMAN1;TGFA;CD59
4032,GO:0009063,0.0421667131912994,0.979947059228266,13,75,cellular amino acid catabolic process,BP,CBS;NOS1;GPT2;ARG2;HMGCL;AHCY;GLUL;GLUD1;BLMH;ALDH4A1;ALDH7A1;ARG1;PCYOX1
1185,GO:0002829,0.0421670393013847,0.994212482974657,3,8,negative regulation of type 2 immune response,BP,ARG2;ARG1;ANXA1
12651,GO:0050819,0.0422674948019138,0.985748127907064,7,32,negative regulation of coagulation,BP,PLAT;SERPINE2;SERPING1;APOE;PROCR;F12;CEACAM1
18375,GO:1903319,0.0422835884792182,0.991444193726407,4,13,positive regulation of protein maturation,BP,ADAM8;SRC;F12;PLGRKT
12704,GO:0050900,0.0423883978523359,0.972868594462574,32,227,leukocyte migration,BP,PGF;RAC2;SDC1;SHC1;BSG;SLC16A3;MMP1;ITGA6;BCR;MMP14;MSN;CD44;PLCG1;RET;PROCR;GATA3;ADAM8;PIP5K1C;SRC;FYN;ITGA1;MIF;ZP3;VEGFB;MAPK3;CEACAM1;ECM1;TGFB1;PIK3R2;ANXA1;PODXL2;ITGA3
11537,GO:0046037,0.0424866920128314,0.989092454287922,5,19,GMP metabolic process,BP,DLG4;DLG1;CARD11;DLG3;GUK1
426,GO:0001133,0.0425948586194997,0.991360425600948,4,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1;PPARA;VDR;THRA
15897,GO:0072606,0.0426268735695174,0.991200573478282,4,14,interleukin-8 secretion,BP,F2R;TMSB4X;MAPKBP1;ANXA1
6213,GO:0019725,0.0427901446380413,0.968211394970139,69,548,cellular homeostasis,BP,NOS1;F2R;QSOX1;AP3D1;BOK;PCK2;DLG4;NR1D1;FKBP1A;PRNP;BNIP3;TXNDC11;LCN2;LRP5;XBP1;MAP4K4;SLC12A7;PRKACA;HK1;SHANK3;P4HB;PDIA5;APOE;ATP13A2;ATP7B;ITPR3;ENDOG;WDTC1;PLCG1;RAP1GDS1;IDE;DEDD2;PRDX5;ERO1B;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;GLRX;POLD4;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;LRRC8A;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;TMX4;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;PIK3R2;ERP44;STIM1;RASA3
8150,GO:0032869,0.0428742937654769,0.974568152670365,24,158,cellular response to insulin stimulus,BP,SHC1;PCK2;RAB31;XBP1;AKT1;PRKCZ;PCSK9;WDTC1;IDE;PAK1;GRB10;EIF4EBP1;VAMP2;SRC;GSK3A;SOCS2;ADIPOR1;TRIB3;TCIRG1;BAIAP2L1;ATP6V1C2;SOCS7;CEACAM1;PIK3R2
3151,GO:0006750,0.0431033850617988,0.991069761096722,4,14,glutathione biosynthetic process,BP,CHAC1;HAGH;CNDP2;GGT1
7129,GO:0030947,0.043113745497858,0.988886037655921,5,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FAM129B;EPN2;GRB10;MYOF;HGS
8444,GO:0033555,0.0431183119658133,0.985396874789497,7,32,multicellular organismal response to stress,BP,NOS1;APOE;DEAF1;RAG1;RET;VWA1;COMT
1609,GO:0004029,0.0432652634548915,0.991179277346886,4,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH1L2;ALDH1A2;ALDH4A1;ALDH7A1
4528,GO:0010591,0.0432712738294485,0.986952208901674,6,25,regulation of lamellipodium assembly,BP,RAC2;SSH1;WASF2;TWF2;FSCN1;DNM2
7503,GO:0031669,0.0433690352034404,0.973940922795346,25,166,cellular response to nutrient levels,BP,CYP27B1;DAP;POSTN;SSH1;SESN2;XBP1;ATF4;PCSK9;GLUL;GAS2L1;HSF1;STK24;FYN;ASNS;VDR;COMT;USF2;ULK1;P2RX4;MAP1LC3B;IMPACT;CBL;MAPK3;KANK2;C12ORF66
6781,GO:0030212,0.0433889022448859,0.98690797488047,6,25,hyaluronan metabolic process,BP,AKT1;CD44;CEMIP;HYAL1;FGF2;TGFB1
3227,GO:0006882,0.0434382808329142,0.988592669181313,5,21,cellular zinc ion homeostasis,BP,AP3D1;ATP13A2;ATP7B;MT2A;SLC30A1
13522,GO:0055069,0.0434382808329142,0.988592669181313,5,21,zinc ion homeostasis,BP,AP3D1;ATP13A2;ATP7B;MT2A;SLC30A1
4772,GO:0010955,0.0435141991649307,0.986789231008567,6,26,negative regulation of protein processing,BP,CHAC1;SERPINE2;PRNP;SERPING1;CTSZ;CD59
18374,GO:1903318,0.0435141991649307,0.986789231008567,6,26,negative regulation of protein maturation,BP,CHAC1;SERPINE2;PRNP;SERPING1;CTSZ;CD59
15513,GO:0071867,0.0436044128555712,0.986826849120117,6,25,response to monoamine,BP,PRKACA;ATF4;GNB1;DNM2;MAPK3;ADCY6
15515,GO:0071869,0.0436044128555712,0.986826849120117,6,25,response to catecholamine,BP,PRKACA;ATF4;GNB1;DNM2;MAPK3;ADCY6
15103,GO:0071071,0.0437358819483744,0.993907006806784,3,8,regulation of phospholipid biosynthetic process,BP,LPCAT1;SLC27A1;ZP3
19198,GO:1905208,0.043836989743732,0.991024009110224,4,13,negative regulation of cardiocyte differentiation,BP,EGFR;DKK1;PAK1;GSK3A
4026,GO:0009057,0.0438388216098236,0.964647987875545,132,1128,macromolecule catabolic process,BP,EDEM1;BTBD2;PYGB;H1F0;GID4;CAPN2;RBCK1;SORL1;SDC1;DVL1;PYGL;CST3;SNX9;SHARPIN;SERPINE2;NR1D1;PGM1;PSMD2;MTA1;BNIP3;SMURF2;CTSB;ABTB1;USP20;LPCAT1;VLDLR;XBP1;EGFR;CSNK1E;PANO1;PRKACA;HECW2;SNX33;AKT1;GPC4;APOE;ATP13A2;SYVN1;WWTR1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;TMEM129;FBXO2;PCSK9;ENDOG;FBXW5;MSN;MVB12B;UBE2J1;ARRDC1;BNIP3L;CDC34;CD44;GTPBP1;IDE;DEDD2;ANKIB1;SUFU;CTBS;DDIT3;CUL7;GGA3;GGA1;ADAMTS7;FUCA1;DNASE1L1;PCBP4;CEMIP;PKD1;UBXN4;HSF1;WFS1;ADAM8;GIPC1;UBR4;AGO4;LRSAM1;STX5;GSK3A;FYN;ISG20;AGRN;RMND5A;PSMD7;FBXL15;ABHD17C;PUM1;RNF44;CTSL;TNRC6B;TIMP1;UBA1;RNF187;HYAL1;VPS37A;STUB1;TRIB3;TCIRG1;SNX25;RMND5B;RAD23A;LRP1;TRIB2;HPSE;SAMD4B;FGF2;RNH1;PYM1;RNF222;SPSB3;RPL28;CNOT11;LONP2;HGS;CARHSP1;CBL;USP32;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;HM13;CEACAM1;IGF2BP3;TGFB1;PCYOX1;AZIN2
8805,GO:0034498,0.0438544005633328,0.993883734165339,3,8,early endosome to Golgi transport,BP,EHD3;STX5;RAB6A
8989,GO:0035089,0.0439781932980207,0.990985550875668,4,13,establishment of apical/basal cell polarity,BP,MSN;FSCN1;SH3BP1;CAMSAP3
2540,GO:0005796,0.0440111164942684,0.981448326327254,10,52,Golgi lumen,CC,SDC1;WNT7A;MMP14;GPC4;PCSK6;AGRN;WNT5B;FURIN;TGFB1;PODXL2
6590,GO:0022417,0.0441550157847499,0.993564134643525,3,9,protein maturation by protein folding,BP,FKBP1A;ERO1B;WFS1
9920,GO:0042246,0.0441573806166226,0.984965627701279,7,32,tissue regeneration,BP,WNT7A;POSTN;TGFBR2;PTPN12;KLK6;ADAM15;ANXA1
3577,GO:0007623,0.0441609162987184,0.974757160496221,21,135,circadian rhythm,BP,CST3;CRTC1;NR1D1;MTA1;HEBP1;HTR7;EGFR;CSNK1E;ATF4;NAGLU;PPARA;AHCY;ASS1;RAI1;TOP1;PER3;MAPK9;MAPK10;CSNK1D;DBP;EP300
11589,GO:0046128,0.0442846457058583,0.980316363620009,11,62,purine ribonucleoside metabolic process,BP,NT5E;DLG4;DLG1;NME4;CARD11;GTPBP1;AHCY;GAMT;DLG3;GUK1;PNP
12943,GO:0051279,0.0443303388790227,0.98230389489731,9,46,regulation of release of sequestered calcium ion into cytosol,BP,NOS1;F2R;FKBP1A;PRKACA;PLCG1;CEMIP;NTSR1;CHD7;TGFB1
18523,GO:1903626,0.0444027073222847,0.997140632468117,2,4,positive regulation of DNA catabolic process,BP,ENDOG;HSF1
12575,GO:0050708,0.0444537488069199,0.970642454671441,36,259,regulation of protein secretion,BP,F2R;PCK2;NR1D1;POSTN;RAPGEF3;IDH2;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;FERMT1;HADH;NLGN2;GLUL;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;SRC;CPTP;MIF;APBB1;MAPK3;LLGL1;TGFB1;ANXA1
11304,GO:0045600,0.0444558197834163,0.983487574576544,8,38,positive regulation of fat cell differentiation,BP,LRP5;XBP1;CCDC71L;AKT1;SH3PXD2B;ZNF385A;WNT5B;WDFY2
13539,GO:0055090,0.0445436498682593,0.990671303398482,4,14,acylglycerol homeostasis,BP,ANGPTL4;SESN2;XBP1;APOE
14717,GO:0070328,0.0445436498682593,0.990671303398482,4,14,triglyceride homeostasis,BP,ANGPTL4;SESN2;XBP1;APOE
3948,GO:0008643,0.0445479553930807,0.976807656993717,16,95,carbohydrate transport,BP,SLC2A9;SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;SLC2A3;EDNRA;GSK3A;SLC35B4;TRIB3;RAB4B;SLC5A1;PIK3R2;SLC45A3
2520,GO:0005773,0.0446895321604412,0.966254386427769,76,601,vacuole,CC,PYGB;TSPAN1;CAPN2;MST1R;SDC1;CST3;AP3D1;NAPRT;CKAP4;CD68;CTSB;MARCH9;LPCAT1;VLDLR;FYCO1;GPC4;PEG3;ATG16L2;ATP13A2;AP1B1;AP2A2;GALNS;NAGLU;VPS11;VPS4A;CTSZ;PI4K2A;PCSK9;SURF4;TBC1D14;CTBS;STOM;GNB1;FUCA1;RAB29;ATP11A;ARL8A;SLC12A4;ADAM8;TMEM8A;CAP1;SRC;TMEM9;TMEM44;C6ORF120;AGRN;GNB2;CTSL;UBA1;WDFY3;HYAL1;TCIRG1;TPCN1;ULK1;LRP1;P2RX4;HPSE;MAP1LC3B;ARG1;ATP6V1C2;CYB561;VAT1;SNAP29;HGS;CBL;TRAPPC1;DRAM2;LITAF;C12ORF66;TMBIM1;HM13;NAGA;PCYOX1;CAT;ANXA1;ARSD
20317,GO:2001256,0.0447125627058131,0.993714411505264,3,8,regulation of store-operated calcium entry,BP,SARAF;HOMER2;STIM1
5266,GO:0015908,0.0447197511739368,0.981096365556309,10,52,fatty acid transport,BP,CPT2;AKT1;APOE;PPARA;NTSR1;MIF;SLC27A1;P2RX4;CPT1B;ANXA1
4974,GO:0015085,0.0447395072246088,0.979342997826034,12,65,calcium ion transmembrane transporter activity,MF,ATP13A2;ITPR3;ORAI1;PKD1;GRIN3B;FAM155B;NCS1;ATP2C2;TPCN1;P2RX4;ORAI3;RASA3
7130,GO:0030948,0.0448032789967309,0.993696429365856,3,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,FAM129B;EPN2;HGS
1498,GO:0003839,0.0448693284622913,0.997093490304658,2,4,gamma-glutamylcyclotransferase activity,MF,CHAC1;GGACT
17102,GO:0099601,0.0448862338628005,0.986342117114286,6,25,regulation of neurotransmitter receptor activity,BP,DLG4;SHANK3;NLGN2;SHANK2;EPHB2;MINK1
10612,GO:0043576,0.0448995942717198,0.990733530436714,4,13,regulation of respiratory gaseous exchange,BP,NLGN2;APLN;NTSR1;PBX3
14705,GO:0070307,0.0449643721486616,0.993664457859512,3,8,lens fiber cell development,BP,WNT7A;WNT5B;TBC1D20
4475,GO:0010469,0.0449896603007767,0.971472095973838,30,218,regulation of signaling receptor activity,BP,PGF;ADM2;SHC1;WNT7A;PTHLH;NEURL1;DLG4;CMTM4;CMTM7;SHANK3;PCSK9;DKK1;PPP2R5B;NLGN2;TNFSF15;SHANK2;APLN;CLEC11A;GAL;TIMP1;MIF;ZP3;FGF2;VEGFB;TGFA;EPHB2;CBL;MINK1;TGFB1;MANF
1495,GO:0003831,0.0450035460141093,0.993656675647736,3,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT2;WDFY3;B4GALT6
18838,GO:1904377,0.0450050225101739,0.982018908479929,9,45,positive regulation of protein localization to cell periphery,BP,DLG1;PRNP;EGFR;AKT1;PTPN9;LRP1;EPHB2;CIB1;ITGA3
9275,GO:0035690,0.045078869725965,0.970576029399676,34,243,cellular response to drug,BP,CST3;PCK2;DNMT3A;NET1;PRNP;BNIP3;SSH1;ADCY7;EGFR;STK25;ATF4;MAPK13;ENDOG;GNB1;GNAI2;HSF1;MT2A;HMGA2;PPP1R14A;EIF4EBP1;SRC;DNM2;FYN;AGRN;PPM1F;NDOR1;P2RX4;ARG1;IMPACT;MAPK3;ARHGEF2;ADCY6;TGFB1;ANXA1
15762,GO:0072329,0.0451499904021564,0.976399826619512,16,99,monocarboxylic acid catabolic process,BP,PCK2;CPT2;SESN2;CRAT;AKT1;CRYL1;ACAD10;TYSND1;HADH;PPARA;ACADVL;MLYCD;PHYH;LONP2;CPT1B;LPIN3
7034,GO:0030802,0.0451849011619962,0.986153871807642,6,26,regulation of cyclic nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;GNAI2;CAP1;ADNP
9706,GO:0038094,0.0453659566144207,0.979828274615836,11,59,Fc-gamma receptor signaling pathway,BP,ARPC1A;LIMK1;WASF2;PLCG1;PAK1;SRC;FYN;FCGRT;WIPF1;MAPK3;PIK3R2
3078,GO:0006650,0.0454299325359387,0.969598426000218,38,272,glycerophospholipid metabolic process,BP,SERINC2;MBOAT2;LPCAT4;PITPNM1;DGKA;SBF1;AGPAT3;PLCH2;OSBPL10;LPCAT1;EGFR;TTC7B;CDS2;DGKQ;PI4K2A;OSBPL5;PTDSS2;PIGQ;PIP5K1C;SRC;TAZ;FYN;MBOAT7;FGFR1;MTMR4;PITPNM2;SLC27A1;PIP5KL1;AGPAT4;ZP3;FGF2;OCRL;PNPLA6;LPIN3;PIK3R2;STARD10;ERBB3;ZFYVE21
20051,GO:2000637,0.045432384597947,0.988114948928663,5,19,positive regulation of gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;PUM1;TGFB1
3233,GO:0006888,0.0454495066047234,0.97253536971965,25,170,ER to Golgi vesicle-mediated transport,BP,SORL1;LMF1;COPG1;YIF1A;CTSZ;SEC23A;CREB3L2;KDELR1;TMED3;RAB1B;STX5;COG8;MCFD2;SEC24C;USO1;TBC1D20;VAPB;COG1;LMAN1;TGFA;TRAPPC1;CSNK1D;CD59;PPP6R1;ARCN1
8121,GO:0032801,0.0454796343239968,0.984413285394941,7,32,receptor catabolic process,BP,VLDLR;APOE;AP2A2;PCSK9;SNX25;FURIN;TGFB1
7144,GO:0030971,0.0455702066800949,0.981750012316006,9,45,receptor tyrosine kinase binding,MF,SHC1;DOCK4;PITPNM1;SHC2;PLCG1;PAG1;PITPNM2;CBL;PIK3R2
13929,GO:0060560,0.0455730505090314,0.972808939565348,24,156,developmental growth involved in morphogenesis,BP,DVL1;POSTN;PTPRS;SEMA3F;APOE;PRKCZ;MAP1B;TGFBR2;LAMB2;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;LPAR3;GAL;SEMA4G;ADNP;ULK1;ULK2;SLIT3;IMPACT;TGFB1
14953,GO:0070820,0.0455920697876594,0.975589278483009,17,108,tertiary granule,CC,QSOX1;CST3;PGM1;PRSS3;AP2A2;SERPINB6;STOM;ATP11A;ARL8A;SLC2A3;ADAM8;UBR4;YPEL5;TCIRG1;ALDOC;CEACAM1;CD59
14817,GO:0070528,0.0456379995208263,0.988045982590367,5,19,protein kinase C signaling,BP,PRKCZ;DGKQ;AKAP12;MC1R;ADAM15
7207,GO:0031091,0.0456953798012212,0.980579918249165,10,53,platelet alpha granule,CC,QSOX1;SERPINE2;THBS2;SERPING1;TMSB4X;APLP2;STXBP1;TIMP1;VEGFB;TGFB1
3066,GO:0006631,0.0459505979789709,0.969560247546759,36,262,fatty acid metabolic process,BP,PCK2;CPT2;CYGB;SESN2;ACOT7;XBP1;ACOT1;CRAT;AKT1;CRYL1;ACAD10;TYSND1;HADH;PPARA;WDTC1;ELOVL1;ACSF2;ALOX15B;CBR4;ACADVL;TNFRSF1A;MGLL;MIF;ADIPOR1;TRIB3;SLC27A1;MLYCD;PHYH;LONP2;GGT1;MAPK3;CPT1B;CEACAM1;LPIN3;ANXA1;SLC45A3
4843,GO:0014047,0.0461187592637324,0.987884360096222,5,19,glutamate secretion,BP,VAMP2;GIPC1;STXBP1;NTSR1;APBA1
10799,GO:0044257,0.0461351247340861,0.964906497072105,79,634,cellular protein catabolic process,BP,EDEM1;BTBD2;GID4;CAPN2;RBCK1;DVL1;SHARPIN;NR1D1;PSMD2;MTA1;BNIP3;SMURF2;CTSB;ABTB1;USP20;VLDLR;XBP1;CSNK1E;PANO1;PRKACA;HECW2;AKT1;APOE;ATP13A2;SYVN1;WWTR1;AP2A2;VPS11;VPS4A;CTSZ;TMEM129;FBXO2;PCSK9;FBXW5;MSN;MVB12B;UBE2J1;ARRDC1;BNIP3L;CDC34;IDE;ANKIB1;SUFU;DDIT3;CUL7;ADAMTS7;PKD1;UBXN4;WFS1;GIPC1;UBR4;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;CTSL;UBA1;RNF187;VPS37A;STUB1;TRIB3;TCIRG1;RMND5B;RAD23A;LRP1;TRIB2;RNF222;SPSB3;LONP2;CBL;USP32;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;HM13;PCYOX1
14620,GO:0070166,0.0461420638951902,0.993429217900248,3,8,enamel mineralization,BP,FAM20C;PPARA;STIM1
953,GO:0002369,0.0463054486909284,0.987715254866955,5,20,T cell cytokine production,BP,DLG1;PRKCZ;KDELR1;GATA3;ARG1
7033,GO:0030801,0.0465657892593173,0.987626698490339,5,20,positive regulation of cyclic nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;ADNP
17753,GO:1901658,0.0465799419502843,0.985547557214111,6,27,glycosyl compound catabolic process,BP,NT5E;AHCY;FUCA1;PNP;NAGA;APOBEC3C
3893,GO:0008526,0.0468637216661764,0.993283766838353,3,8,phosphatidylinositol transporter activity,MF,PITPNC1;PITPNM1;PITPNM2
3634,GO:0008104,0.0469553733911655,0.960189363028706,234,2059,protein localization,BP,EDEM1;MDFI;ZMYND8;LTBP2;SH3TC2;F2R;RAC2;SORL1;DVL1;WNT7A;SNX9;AP3D1;LMF1;PCK2;DLG4;OBSCN;BSG;NR1D1;DLG1;XPOT;PITPNM1;FKBP1A;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;LAMA5;SSH1;RAB43;COPG1;MARVELD1;SESN2;BBS2;NACC2;BCR;SYNE3;RAB31;NUDCD3;VLDLR;ETV5;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;CSNK1E;SEPT10;CORO1B;TUB;RHBDF2;HK1;SHANK3;TTC7B;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;TNS4;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;SH3PXD2B;FERMT1;SEPT5;SEC23A;MSN;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;OBSL1;LTBP1;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TWF2;TBC1D14;TSPAN5;MALL;SUFU;PAK1;TTBK2;NLGN2;DDIT3;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;SEPT8;PKD1;PARP10;DLG3;GATA3;OXA1L;DOPEY2;GRIN3B;GLUD1;ALOX15B;IL1RAP;PTPRU;ADAM8;MAPKBP1;ARL2;NUMB;VAMP2;FLNB;GIPC1;TULP3;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;AGRN;KIF17;TNFRSF1A;ABHD17C;KIF13B;TSPAN33;STX10;MOAP1;GAL;THRA;MCFD2;SEC24C;RRBP1;GUK1;MIF;VPS37A;BCL2L1;MAU2;PRAF2;TCIRG1;SNX25;LEMD2;ARFIP2;ARFGEF2;UNC119B;ULK1;LRP1;USO1;SPIRE1;PNP;MAPK9;COG1;ABCA7;APBB1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;EPHB2;HGS;GAS8;CIB1;TMSB10;RAB4B;PACS2;MAPK3;CSNK1D;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;CCNE1;TGFB1;WBP2;SLC15A1;PIK3R2;ANXA1;PPP1R10;RAB6A;ITGA3;ARCN1
12795,GO:0051051,0.0469673977045175,0.96882993909067,36,262,negative regulation of transport,BP,NOS1;F2R;BOK;DLG4;SERPINE2;IDH2;BCR;MAP4K4;RHBDF2;ATF4;HECW2;SNX33;AKT1;ARG2;TMSB4X;PCSK9;MAP1B;GDI1;HADH;STK39;UBE2J1;GRB10;PARP10;ASIC1;MAPKBP1;LRSAM1;CPTP;GSK3A;COMT;NTSR1;EPHB2;CEACAM1;SLC30A1;TGFB1;ERBB3;ANXA1
14160,GO:0061008,0.0470052448086294,0.974769834414633,17,105,hepaticobiliary system development,BP,CCND1;PCK2;XBP1;EGFR;PCSK9;SEC63;HMGCL;PKD1;ARID5B;ALDH1A2;ASNS;PHF2;ARG1;DBP;CEACAM1;TGFB1;ANXA1
8012,GO:0032634,0.0470464339286606,0.993246784995944,3,8,interleukin-5 production,BP,PRKCZ;GATA3;IL1RAP
8036,GO:0032674,0.0470464339286606,0.993246784995944,3,8,regulation of interleukin-5 production,BP,PRKCZ;GATA3;IL1RAP
4515,GO:0010563,0.0472789708126401,0.965625969566905,58,445,negative regulation of phosphorus metabolic process,BP,TNIP1;XDH;SORL1;DVL1;DLG1;FKBP1A;PRNP;LPCAT1;LRP5;FBLN1;ADARB1;AKT1;APOE;PKN1;WWTR1;PRKCZ;DGKQ;EPHA1;PTK6;PPP1R35;STK39;DKK1;PPARA;PPP1R12C;FARP1;DUSP4;GRB10;DLG3;GNAI2;PPP1R14A;GSK3A;DUSP6;PPM1F;MICAL1;HEXIM1;SOCS2;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;LRRK1;MYO1D;CAMSAP3;IMPACT;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;TGFB1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10
7507,GO:0031674,0.0474519254385363,0.977030518701708,13,75,I band,CC,FLNC;NOS1;SCN8A;OBSCN;FKBP1A;PARVB;BAG3;OBSL1;BIN1;PAK1;FLNB;STUB1;MYZAP
12302,GO:0048608,0.0474931439060925,0.967585632573742,41,300,reproductive structure development,BP,ERCC1;MDFI;CCND1;SDC1;MAP2K1;WNT7A;CST3;CYP27B1;BOK;SERPINE2;BSG;DLG1;CTSB;EGFR;MMP14;FBXW8;AKT1;TFEB;EPOR;HTRA1;CUL7;PKD1;GATA3;HSF1;ALOX15B;ARID5B;SRC;AGO4;SPINT2;VDR;EIF2S2;BCL2L1;PLCD3;ZP3;TBC1D20;CHD7;SLIT3;RXRA;CBL;ADAM15;ANXA1
8151,GO:0032870,0.0475206380425724,0.965070820282369,62,476,cellular response to hormone stimulus,BP,PGF;SHC1;PCK2;NR1D1;CTSB;BBS2;RAB31;ADCY7;XBP1;EGFR;PRKACA;AKT1;FAM210B;PRKCZ;PCSK9;MSN;PPARA;PRKACB;WDTC1;IDE;PAK1;GNB1;GAS2L1;GRB10;GNAI2;HSF1;IGFBP2;EIF4EBP1;VAMP2;SRC;PAQR7;GSK3A;FYN;AGRN;ASNS;VDR;GNB2;CTSL;THRA;SOCS2;ADIPOR1;TRIB3;TCIRG1;SLC27A1;PMEPA1;SLIT3;RXRA;ARG1;BAIAP2L1;ATP6V1C2;SOCS7;MAPK3;KANK2;CEACAM1;ADCY6;CCNE1;TGFB1;WBP2;PIK3R2;ANXA1;PXN;EP300
12233,GO:0048408,0.0475794804308336,0.996813989616168,2,4,epidermal growth factor binding,MF,SHC1;EGFR
9803,GO:0040013,0.0477140961464362,0.969626657412665,30,208,negative regulation of locomotion,BP,ZMYND8;IDH2;CYGB;SEMA3F;BCR;FBLN1;ADARB1;CORO1B;IFITM1;APOE;EPHA1;RRAS;SEMA4B;GATA3;ALOX15B;PTPRU;STK24;SPINT2;FUZ;NISCH;TIMP1;SEMA4G;MIF;ADIPOR1;LRP1;FGF2;ARAP3;ADAM15;SRGAP2B;TGFB1
6633,GO:0022890,0.0478227401440786,0.96802913891782,37,269,inorganic cation transmembrane transporter activity,MF,KCNG1;SCN8A;SLC2A9;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;NDUFA4L2;NCS1;SLC6A9;SLC33A1;SLC13A5;ATP2C2;TCIRG1;TPCN1;SLC6A14;P2RX4;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;SLC30A1;SLC15A1;SLC45A3;ORAI3;RASA3
6740,GO:0030155,0.0478706152579023,0.965375031953876,56,425,regulation of cell adhesion,BP,RAC2;AP3D1;SERPINE2;DLG1;POSTN;ITGA6;NET1;PRNP;LAMA5;FBLN1;XBP1;MMP14;AKT1;CARD11;ARG2;PRKCZ;EPHA1;FERMT1;TGFBR2;PPARA;SIPA1;CD44;TFE3;PAK1;RAG1;PODXL;RET;NID1;CYTH3;PKD1;ASS1;GATA3;ADAM8;ARL2;IGFBP2;SRC;TGM2;DNM2;PAG1;SPINT2;FYN;PPM1F;RREB1;HYAL1;ZP3;PNP;ARG1;CAMSAP3;CIB1;ADAM15;CEACAM1;MINK1;TGFB1;ERBB3;ANXA1;ITGA3
19529,GO:1990316,0.0479737382712914,0.993058128301535,3,8,Atg1/ULK1 kinase complex,CC,SESN2;ATG13;ULK1
10207,GO:0042802,0.0481928802106941,0.960843713468958,137,1162,identical protein binding,MF,TNIP1;ANGPTL4;XDH;PGF;CBS;MDFI;MPRIP;SDC1;DVL1;PYGL;UHRF1BP1;CST3;SNX9;BOK;SHARPIN;MEF2D;DNMT3A;FKBP1A;PRNP;BNIP3;PC;SMURF2;ACOT7;NACC2;FBLN1;XBP1;EGFR;CARS;CORO1B;PPP1R13L;STK25;SNX33;AKT1;IRAK1;APOE;UAP1;WWTR1;CRYL1;PHC2;RNF135;PTK6;ORAI1;RABAC1;DRAP1;EPOR;SCAND1;ARRDC1;BNIP3L;ESYT2;MAP3K9;IDE;BIN1;HMGCL;HTRA1;TSTA3;AHCY;NLGN2;RAG1;DDIT3;GLUL;STOM;ASS1;OXA1L;CADM4;GLUD1;HSF1;SH3GLB2;CTBP1;PTPRU;ALAS1;BLMH;P4HA1;FLNB;GIPC1;APLP2;GARS;STXBP1;FYN;ASNS;GALE;NISCH;ALDH4A1;PSMD7;TNFRSF1A;VWA1;NTSR1;MAP3K10;MGLL;LHPP;FGFR1;TUBG1;LRRC8A;TENM2;USF2;MIF;RAB11FIP4;BCL2L1;STUB1;ADIPOR1;SLC27A1;TPCN1;ZNF783;ARFIP2;HLCS;ULK1;AOX1;P2RX4;ZP3;LRRK1;VAPB;MAP3K12;ATXN10;MLYCD;HOMER2;C1QTNF6;ZHX3;VEGFB;NDE1;ZBTB4;ACY1;EPHB2;MAPK3;S100A16;SRPX2;HM13;CEACAM1;NAGA;TGFB1;CAT;LDHA;ERBB3;ANXA1;CLDN12;ZNF318;PLEKHH2;STIM1;FHOD1
12443,GO:0048878,0.0482610951858419,0.963133742054726,80,645,chemical homeostasis,BP,ANGPTL4;FHL1;NOS1;F2R;PYGL;CYP27B1;AP3D1;BOK;PCK2;DLG4;NR1D1;IFI6;FKBP1A;PRNP;BNIP3;LCN2;SESN2;LPCAT1;LRP5;ADCY7;XBP1;MAP4K4;EGFR;SLC12A7;PRKACA;HK1;AKT1;APOE;ATP13A2;ATP7B;ITPR3;PCSK9;ENDOG;PRKACB;WDTC1;PLCG1;RAP1GDS1;MALL;SFXN3;ERO1B;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;SRC;LDLRAP1;TGM2;OAS1;FYN;LPAR3;GRINA;VDR;COMT;NTSR1;ATP2C2;ADNP;USF2;ADIPOR1;TCIRG1;TPCN1;P2RX4;TBC1D20;FGF2;VAPB;CHD7;HOMER2;ATP6V1C2;MAPK3;SLC30A1;ADCY6;TGFB1;PIK3R2;STIM1;RASA3
6060,GO:0019205,0.0482698396731943,0.981629953502686,8,41,nucleobase-containing compound kinase activity,MF,DLG4;DLG1;NME4;TK2;CARD11;DLG3;UCKL1;GUK1
6261,GO:0019842,0.0482785300011939,0.975811484465974,14,84,vitamin binding,MF,PYGB;CBS;PYGL;PC;GPT2;DHTKD1;ALAS1;P4HA1;ALDH1A2;SPTLC2;VDR;HLCS;PHYH;SEC14L2
20063,GO:2000650,0.0482868219585871,0.992994069791106,3,8,negative regulation of sodium ion transmembrane transporter activity,BP,HECW2;PCSK9;STK39
10906,GO:0044440,0.0484531131566056,0.965357709264885,52,396,endosomal part,CC,SORL1;AP3D1;BOK;CD68;CTSB;RAB31;EGFR;IRAK1;EHD3;ATP13A2;AP2A2;VPS11;VPS4A;PI4K2A;PCSK9;MVB12B;DKK1;YIPF2;GGA3;GGA1;RET;ARL8A;ANTXR2;APPL2;PLIN3;PIP5K1C;CHMP5;IRF7;TMEM9;CPTP;ABHD17C;CTSL;UBA1;MTMR4;VPS37A;RAB11FIP4;PRAF2;TCIRG1;SNX25;TPCN1;PMEPA1;EHD4;ABCA7;HGS;LITAF;FURIN;SNX27;TMBIM1;LLGL1;OCRL;ANXA1;ZFYVE21
13271,GO:0051930,0.0485271672299843,0.989545723603082,4,14,regulation of sensory perception of pain,BP,F2R;COMT;NTSR1;MGLL
13272,GO:0051931,0.0485271672299843,0.989545723603082,4,14,regulation of sensory perception,BP,F2R;COMT;NTSR1;MGLL
7680,GO:0032104,0.0486307726138079,0.989515997556355,4,14,regulation of response to extracellular stimulus,BP,CYP27B1;BBS2;PPARA;KANK2
7683,GO:0032107,0.0486307726138079,0.989515997556355,4,14,regulation of response to nutrient levels,BP,CYP27B1;BBS2;PPARA;KANK2
17507,GO:1900402,0.0487238108769519,0.992904355032757,3,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;PPARA;MLXIP
1996,GO:0004714,0.0488098101056464,0.981519470227357,8,38,transmembrane receptor protein tyrosine kinase activity,MF,MST1R;EGFR;EPHA1;RET;CRIM1;FGFR1;EPHB2;ERBB3
11879,GO:0046854,0.0488888821168984,0.977082516812668,12,66,phosphatidylinositol phosphorylation,BP,EGFR;TTC7B;PI4K2A;PIP5K1C;SRC;FYN;FGFR1;PIP5KL1;FGF2;PIK3R2;ERBB3;ZFYVE21
5323,GO:0016043,0.0489901304950576,0.956910584043963,503,4601,cellular component organization,BP,ANGPTL4;FLNC;FHL1;SH3KBP1;ITGB4;TSPAN1;ERCC1;ZMYND8;NOS1;ADAM19;H1F0;LTBP2;SH3TC2;CAPN2;F2R;THSD4;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SHC1;KCNG1;WNT7A;CST3;SDK2;CYP27B1;NEURL1;SNX9;AP3D1;BOK;SHARPIN;CRTC1;ARAP1;DLG4;OBSCN;SERPINE2;BSG;DLG1;DYSF;IGFBP4;MMP1;IFI6;SLC9A3R2;DNMT3A;FKBP1A;SOX12;DCBLD2;POSTN;MTA1;RAB3B;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;LAMA5;SSH1;RAB43;DBNDD1;SMARCA1;NYAP1;TMOD2;BCORL1;MARVELD1;FAM129B;ESPN;SESN2;TNNT1;PLEK2;BBS2;SEMA3F;TUBB6;NACC2;ADGRF1;BCR;SYNE3;RAB31;NUDCD3;VLDLR;ETV5;MARK4;LRP5;FBLN1;ITGB5;EVI5L;MAP4K4;EGFR;CSNK1E;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CORO1B;TUB;MAP2K2;EPN1;TUBG2;STK25;PARVB;SHANK3;MIER2;P4HB;HECW2;FBXW8;SNX33;MRPS6;AKT1;XPC;BRD3;ACOT13;IRAK1;ARPC1A;EPN2;APOE;ATG16L2;EHD3;FMNL2;ATP13A2;PKN1;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;ITPR3;TFEB;NAGLU;DGKQ;VPS11;VPS4A;HIST2H2BE;PITRM1;CTSZ;EPHA1;PI4K2A;PTK6;DNAAF5;PTPDC1;SH3PXD2B;PCSK9;ENDOG;FBXW5;FERMT1;TYSND1;EML2;SEPT5;SEC23A;MSN;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;CORO2A;BNIP3L;OBSL1;PRKACB;H2AFJ;SIPA1;ZDHHC8;WDTC1;WASF2;CDC34;CD44;PLCG1;TBC1D16;RAP1GDS1;ATG13;IDE;MSRB2;DEDD2;JADE2;COA5;TWF2;SURF4;TBC1D14;TACC1;MALL;BIN1;FSCN1;HMGCL;HTRA1;CCDC88C;PAK1;TTBK2;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;NLGN2;TNRC18;RAG1;SEMA4B;BAZ2A;NAV1;DDIT3;PODXL;GLUL;CUL7;DMXL2;TBC1D9B;TUBB3;STOM;FARP1;GNB1;SYTL1;PTPN9;SATB1;RET;RAB29;CORO7;LAMC2;RHOC;NID1;GRB10;REEP2;TMED3;HLTF;SEPT8;SHANK2;PKD1;PARP10;ATP11A;GATA3;APLN;PHF1;OXA1L;DOPEY2;MYOF;GRIN3B;ASIC1;GLUD1;HSF1;ADGRB2;SIN3B;IL1RAP;NEK9;SLC12A4;FAT1;EFS;ASPH;CTBP1;ADAM8;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;FAM110C;ARL2;MICAL2;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;VAMP2;FLNB;PIP5K1C;SRC;LDLRAP1;CHMP5;KDM4B;CBR4;CAPG;POLD4;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;AGO4;FAM162A;LRSAM1;HIST3H2A;STPG1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;CPTP;PAK6;STX5;TOM1L2;SDCCAG8;GPX3;RERE;EXOC2;RSF1;GSK3A;STXBP1;SPECC1L;SH3BP1;SPINT2;FYN;RAB25;PRIMPOL;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;REEP4;PFN1;NISCH;MICAL1;KIF17;TNFRSF1A;WISP1;TLE4;VDR;BRPF3;VWA1;KIF13B;BRSK1;STX10;MOAP1;GAL;ITGA1;CTSL;THRA;MCFD2;PLTP;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LAMB3;LOXL1;SEMA4G;SEC24C;FGFR1;TUBG1;RREB1;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;PSMG4;MIF;SOCS2;TTC19;VPS37A;SIGMAR1;BCL2L1;STUB1;ADIPOR1;MAU2;DDB2;AFAP1;TCIRG1;LEMD2;ZFPM1;PMEPA1;ARFIP2;HLCS;ARFGEF2;UNC119B;ULK1;LRP1;ROBO3;HSPA2;PAK4;P2RX4;E2F5;USO1;ULK2;TBC1D20;SPIRE1;FGF2;KLHL17;EHD4;MAP1LC3B;VAPB;MAPK9;COG1;SDHAF4;PYM1;RCOR1;MAP3K12;VASP;ARAP3;CHD7;ATXN10;TAOK1;ABCA7;LMAN1;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;RXRA;HIST2H2AC;C1QTNF6;ARG1;L3MBTL3;TBC1D2B;TAF6;TGFA;NDE1;CAMSAP3;BAHCC1;BAIAP2L1;ATP6V1C2;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;KLK6;VAT1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;SPESP1;HGS;GAS8;CBL;TRAPPC1;CIB1;TMSB10;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;KANK2;NTNG1;POMT1;CSNK1D;KIFC3;FURIN;ARHGEF2;UGCG;LLGL1;NDUFS2;MATN3;OCRL;ADAM15;SRPX2;HM13;CEACAM1;APBA1;MINK1;SKAP2;ARHGAP44;CD59;MBD3;MAP6;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;AZIN2;ANXA1;PPP1R10;ASH2L;CCDC113;ITGA3;PXN;ARHGEF10L;PLEKHH2;EP300;THBS3;TCF7L1;RAP1GAP2;ASAP1;FHOD1
541,GO:0001659,0.0490512873934833,0.986773728645344,5,20,temperature homeostasis,BP,NR1D1;APLN;ACADVL;NTSR1;SLC27A1
20137,GO:2000774,0.0490821635032415,0.992530070889612,3,9,positive regulation of cellular senescence,BP,ARG2;HMGA2;YPEL3
4624,GO:0010742,0.0491699531847068,0.986732668683122,5,20,macrophage derived foam cell differentiation,BP,PPARA;ALOX15B;MAPK9;TGFB1;EP300
16115,GO:0090077,0.0491699531847068,0.986732668683122,5,20,foam cell differentiation,BP,PPARA;ALOX15B;MAPK9;TGFB1;EP300
8966,GO:0035023,0.0492717524101886,0.974001761117491,16,95,regulation of Rho protein signal transduction,BP,F2R;ARAP1;OBSCN;NET1;BCR;APOE;FARP1;ARHGEF4;PLEKHG5;DNMBP;ARAP3;EPS8L1;ARHGEF2;ITSN1;ITGA3;ARHGEF10L
16223,GO:0090238,0.0494915920368208,0.996611009199962,2,4,positive regulation of arachidonic acid secretion,BP,NTSR1;MIF
14247,GO:0061180,0.0496265901837733,0.978597179040113,10,53,mammary gland epithelium development,BP,CCND1;ETV5;LRP5;AKT1;DEAF1;GATA3;SRC;VDR;RREB1;TGFB1
3067,GO:0006633,0.049732402760337,0.974270702724812,15,93,fatty acid biosynthetic process,BP,ACOT7;XBP1;WDTC1;ELOVL1;ALOX15B;CBR4;ACADVL;MGLL;MIF;ADIPOR1;TRIB3;MLYCD;CEACAM1;ANXA1;SLC45A3
12919,GO:0051246,0.0498279448311709,0.957719694712715,230,2022,regulation of protein metabolic process,BP,TNIP1;EDEM1;XDH;BTBD2;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;LTBP4;SORL1;DVL1;MAP2K1;SHC1;PLAT;WNT7A;ERCC6;CST3;NEURL1;SNX9;BOK;DLG4;SERPINE2;DLG1;DAP;IGFBP4;IFI6;FKBP1A;MTA1;RAPGEF3;PRNP;SSH1;CRTAP;SMURF2;MAPKAPK3;SESN2;ABTB1;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;PRKACA;ADARB1;MAP2K2;STK25;ATF4;HECW2;SNX33;AKT1;CARD11;IRAK1;SERPING1;APOE;ATP13A2;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;VPS11;PPP2R3B;FZD8;CTSZ;EPHA1;PTK6;FBXO2;PCSK9;ZNF598;RRAS;MSN;PPP1R35;TGFBR2;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;IDE;ANKIB1;LARP6;PRDX5;CCND2;BIN1;SUFU;CCDC88C;PAK1;ZNF385A;RAG1;TNFSF15;BCDIN3D;GGA3;GGA1;DUSP4;RET;IFI27;CEMIP;PKD1;PARP10;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;TFPI2;PPP1R14A;MYDGF;EIF4EBP1;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;FAM162A;RAB1B;STK24;PAK6;STX5;GSK3A;SPINT2;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;PUM1;ITGA1;TNRC6B;MAP3K10;HEXIM1;TIMP1;CRIM1;SECISBP2L;FGFR1;MIF4GD;ADNP;F12;MIF;SOCS2;STUB1;PCSK1N;TRIB3;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;RAD23A;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;SAMD4B;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;TAOK1;RNF222;ABCA7;APBB1;RXRA;TGFA;CNOT11;IMPACT;CASP4;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;POMT1;MAPK10;CSNK1D;FURIN;ARHGEF2;AIDA;CEACAM1;PAIP2;MINK1;ECM1;CD59;ADCY6;IGF2BP3;CCNE1;EIF4G3;TGFB1;WBP2;PPP6R1;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;PLGRKT;EP300;WDFY2;TRAF7
17851,GO:1901985,0.0498353250478782,0.9825059425646,7,33,positive regulation of protein acetylation,BP,NOS1;RAPGEF3;GATA3;CAMK1;MAPK3;TGFB1;WBP2
14575,GO:0070086,0.0499593638147506,0.996560632443755,2,4,ubiquitin-dependent endocytosis,BP,LRSAM1;NEURL1B
16237,GO:0090261,0.0499968083116094,0.996556587672175,2,4,positive regulation of inclusion body assembly,BP,CDC34;HSF1
16892,GO:0098802,0.0501665184987151,0.974077388926769,15,89,plasma membrane receptor complex,CC,ITGB4;DLG4;DLG1;ITGA6;ITGB5;SHANK3;CARD11;IRAK1;TGFBR2;SHANK2;DLG3;GRIN3B;ITGA1;CEACAM1;ITGA3
10050,GO:0042493,0.0502731311039878,0.96177698170933,76,610,response to drug,BP,PGF;NOS1;CCND1;SDC1;CST3;PCK2;DNMT3A;FKBP1A;RAB3B;NET1;PRNP;BNIP3;SSH1;CYGB;ADCY7;EGFR;STK25;ATF4;XPC;DGKQ;MAPK13;ENDOG;TGFBR2;HADH;STK39;PPARA;PRKACB;GNB1;RET;GATA3;GNAI2;HSF1;MT2A;HMGA2;SLC13A3;TOP1;PPP1R14A;BLMH;IGFBP2;EIF4EBP1;SRC;DNM2;NUCB1;STK24;DUSP6;FYN;AGRN;ASNS;PPM1F;SLC6A9;GAL;SLC13A5;COMT;NTSR1;BCL2L1;PRAF2;HLCS;NDOR1;P2RX4;PNP;SLIT3;HOMER2;ARG1;VEGFB;IMPACT;CBL;MAPK3;ARHGEF2;ADCY6;TGFB1;WBP2;CAT;LDHA;ANXA1;GNAS;ITGA3
19807,GO:2000191,0.0503641741025844,0.98901533295138,4,14,regulation of fatty acid transport,BP,AKT1;NTSR1;MIF;P2RX4
96,GO:0000186,0.0504366948006205,0.979406482094243,9,45,activation of MAPKK activity,BP,F2R;ERCC6;EGFR;PLCG1;MAP3K9;GNAI2;MAP3K10;MAP3K12;TAOK1
18562,GO:1903725,0.0505713187558018,0.979300539177951,9,46,regulation of phospholipid metabolic process,BP,LPCAT1;SRC;TAZ;MTMR4;SLC27A1;ZP3;FGF2;TGFB1;PIK3R2
7432,GO:0031528,0.0505769709834901,0.988953440810275,4,14,microvillus membrane,CC,MSN;PODXL;SYTL1;CEACAM1
8035,GO:0032673,0.0505840341075587,0.988951384896242,4,14,regulation of interleukin-4 production,BP,PRKCZ;GATA3;ZFPM1;ZP3
2977,GO:0006520,0.0507905150670737,0.96584476784105,37,278,cellular amino acid metabolic process,BP,CBS;NOS1;PSMD2;NAGS;CRTAP;AARS;GPT2;CARS;ATF4;P4HB;PSAT1;ARG2;HMGCL;ERO1B;AHCY;GAMT;GLUL;ASS1;GLUD1;SLC6A6;PYCR2;BLMH;P4HA1;GARS;ASNS;ALDH4A1;PSMD7;ALDH7A1;COMT;SARS2;SLC6A14;ARG1;BPHL;ACY1;GGT1;PCYOX1;AZIN2
9997,GO:0042391,0.0508080196585877,0.968007664769896,28,194,regulation of membrane potential,BP,FHL1;ZMYND8;DVL1;WNT7A;SCN8A;BOK;CRTC1;DLG4;DLG1;IFI6;BNIP3;SSH1;SHANK3;AKT1;EHD3;PRKCZ;BNIP3L;NLGN2;SHANK2;GRIN3B;ASIC1;SRC;GLRX;GSK3A;NTSR1;BCL2L1;TPCN1;P2RX4
16120,GO:0090083,0.050841958635679,0.988876238704958,4,14,regulation of inclusion body assembly,BP,SORL1;CDC34;HSF1;HSPA2
10681,GO:0043902,0.0508772169116219,0.97038434859743,21,142,positive regulation of multi-organism process,BP,PC;SMURF2;ADARB1;P4HB;APOE;VPS4A;MVB12B;STOM;LRSAM1;RSF1;NELFCD;PUM1;MIF;RAD23A;ZP3;TBC1D20;VAPB;ARG1;CIB1;MAPK3;EP300
4714,GO:0010874,0.0509666968593326,0.988839847280863,4,14,regulation of cholesterol efflux,BP,APOE;PLTP;LRP1;ABCA7
14846,GO:0070570,0.0510046369276906,0.986094007461043,5,20,regulation of neuron projection regeneration,BP,MAP2K1;PTPRS;MAP4K4;PTPRF;STK24
18251,GO:1903026,0.0510894750340062,0.995898707714136,2,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,TMSB4X;DDIT3
20087,GO:2000677,0.051151548373441,0.981879922270926,7,34,regulation of transcription regulatory region DNA binding,BP,FAM129B;TMSB4X;PPARA;DDIT3;GATA3;HMGA2;TGFB1
12792,GO:0051048,0.0511692075415785,0.97219363061182,17,108,negative regulation of secretion,BP,F2R;IDH2;BCR;MAP4K4;RHBDF2;ARG2;TMSB4X;HADH;STK39;ASIC1;MAPKBP1;CPTP;COMT;CEACAM1;SLC30A1;ERBB3;ANXA1
11915,GO:0046923,0.051305411093116,0.996414101803236,2,4,ER retention sequence binding,MF,KDELR1;CEMIP
18195,GO:1902936,0.0513571265515709,0.97568583936054,12,68,phosphatidylinositol bisphosphate binding,MF,PLEK2;AKT1;ATP13A2;SH3PXD2B;TWF2;GSDMA;TULP3;LDLRAP1;PFN1;ARAP3;GSDMC;ASAP1
4946,GO:0014909,0.0513917810156963,0.978899662575421,9,46,smooth muscle cell migration,BP,SORL1;DOCK4;PLAT;POSTN;SSH1;CORO1B;PAK1;SRC;LRP1
3895,GO:0008528,0.0514087416473293,0.983652806025369,6,27,G-protein coupled peptide receptor activity,MF,F2R;MC1R;EDNRA;GAL;NTSR1;SIGMAR1
7327,GO:0031331,0.0516682754256862,0.964861436205819,39,283,positive regulation of cellular catabolic process,BP,EDEM1;DVL1;SNX9;TRIM65;RAPGEF3;BNIP3;SESN2;XBP1;CSNK1E;FYCO1;SNX33;AKT1;APOE;TFEB;VPS11;PCSK9;ENDOG;MSN;BNIP3L;PPARA;GTPBP1;ANKIB1;HSF1;ADAM8;LRSAM1;GSK3A;SPTLC2;PUM1;TNRC6B;STUB1;TRIB3;TPCN1;RAD23A;ULK1;LRP1;TRIB2;MAPK3;CSNK1D;FURIN
12316,GO:0048639,0.0519893126104126,0.971728984862866,17,105,positive regulation of developmental growth,BP,BBS2;AKT1;SH3PXD2B;MAP1B;TGFBR2;GDI1;LIMK1;TWF2;PAK1;HSF1;AGRN;LPAR3;FGFR1;ADNP;ZP3;FGF2;CHD7
4608,GO:0010721,0.0520822517858573,0.96684382219484,29,201,negative regulation of cell development,BP,SORL1;NFATC4;WNT7A;POSTN;PTPRS;IDH2;SEMA3F;FBLN1;MAP4K4;APOE;CTSZ;GDI1;PAK1;SEMA4B;PTPN9;RAB29;GSK3A;GAL;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ARHGEF2;ADCY6;TGFB1;RAP1GAP2;ASAP1;RNF10
6057,GO:0019201,0.0520872829774315,0.985713790581565,5,20,nucleotide kinase activity,MF,DLG4;DLG1;CARD11;DLG3;GUK1
537,GO:0001655,0.0522127121262614,0.966224725125729,31,215,urogenital system development,BP,PGF;ITGB4;CTNNBIP1;SDC1;DLG1;ITGA6;LAMA5;ACVR2B;ACTA2;ARG2;WWTR1;PCSK9;LAMB2;SEC63;PODXL;RET;NID1;PKD1;GATA3;ALOX15B;WFS1;ARID5B;ALDH1A2;FGFR1;FGF2;RXRA;EPHB2;TGFB1;CAT;ANXA1;ITGA3
574,GO:0001714,0.0522161290243193,0.996313648372405,2,4,endodermal cell fate specification,BP,DKK1;DUSP6
19909,GO:2000354,0.0522831728842101,0.996306211663351,2,4,regulation of ovarian follicle development,BP,SRC;ZP3
4494,GO:0010517,0.0522908207816683,0.981443535737143,7,33,regulation of phospholipase activity,BP,EGFR;PRKCZ;EDNRA;FGFR1;LRP1;FGF2;ANXA1
9306,GO:0035743,0.0523630888051932,0.991815703311721,3,9,CD4-positive, alpha-beta T cell cytokine production,BP,PRKCZ;GATA3;ARG1
6789,GO:0030220,0.0524915021533233,0.988392431224177,4,14,platelet formation,BP,ZNF385A;ZFPM1;CIB1;EP300
6929,GO:0030516,0.0526843098859818,0.97498000958549,12,67,regulation of axon extension,BP,PTPRS;SEMA3F;APOE;MAP1B;GDI1;LIMK1;TWF2;PAK1;SEMA4B;DNM2;SEMA4G;ADNP
13080,GO:0051561,0.0528111870180369,0.991716577868545,3,9,positive regulation of mitochondrial calcium ion concentration,BP,BNIP3;RAP1GDS1;TGM2
7608,GO:0031983,0.052869289108772,0.965684671340661,31,231,vesicle lumen,CC,PYGB;PYGL;QSOX1;NAPRT;PSMD2;LCN2;EGFR;SERPING1;APOE;TMSB4X;GALNS;CTSZ;FUCA1;DNASE1L1;CAP1;C6ORF120;PSMD7;TIMP1;LGALS3BP;MIF;HPSE;PNP;ARG1;VEGFB;VAT1;TRAPPC1;ALDOC;ECM1;TGFB1;CAT;ERP44
10734,GO:0044060,0.0528800186680768,0.98543383518787,5,20,regulation of endocrine process,BP,F2R;APLN;GAL;FGFR1;GNAS
11394,GO:0045745,0.0528858794699951,0.988275944110461,4,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2;GSK3A;KLK6
5633,GO:0016709,0.0529992142098819,0.985391628427198,5,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS1;CYP27B1;MICAL2;MICAL1;NDOR1
20007,GO:2000553,0.0531930213899632,0.996204725395988,2,4,positive regulation of T-helper 2 cell cytokine production,BP,PRKCZ;GATA3
7742,GO:0032232,0.053236936199248,0.988171989361017,4,14,negative regulation of actin filament bundle assembly,BP,ARAP1;SHANK3;WASF2;PFN1
14334,GO:0061458,0.0532672893803837,0.963306597557401,41,303,reproductive system development,BP,ERCC1;MDFI;CCND1;SDC1;MAP2K1;WNT7A;CST3;CYP27B1;BOK;SERPINE2;BSG;DLG1;CTSB;EGFR;MMP14;FBXW8;AKT1;TFEB;EPOR;HTRA1;CUL7;PKD1;GATA3;HSF1;ALOX15B;ARID5B;SRC;AGO4;SPINT2;VDR;EIF2S2;BCL2L1;PLCD3;ZP3;TBC1D20;CHD7;SLIT3;RXRA;CBL;ADAM15;ANXA1
17774,GO:1901698,0.0533019057862056,0.958389486565612,91,738,response to nitrogen compound,BP,EDEM1;CCND1;CAPN2;SDC1;MAP2K1;SHC1;NEURL1;PCK2;BSG;DNMT3A;FKBP1A;RAPGEF3;PRNP;SSH1;SESN2;RAB31;LRP5;ADCY7;XBP1;EGFR;PRKACA;MAP2K2;ATF4;AKT1;APOE;SYVN1;PRKCZ;DGKQ;MAPK13;TMEM129;FBXO2;PCSK9;HADH;UBE2J1;PPARA;PRKACB;WDTC1;IDE;PAK1;BCDIN3D;GNB1;GRB10;UBXN4;GNAI2;HSF1;WFS1;EIF4EBP1;VAMP2;SRC;DNM2;AGO4;GSK3A;FYN;AGRN;ASNS;GAL;PUM1;GNB2;TIMP1;SOCS2;BCL2L1;STUB1;ADIPOR1;TRIB3;TCIRG1;SLC27A1;HLCS;LRP1;P2RX4;HOMER2;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;SOCS7;MAPK3;POMT1;DNAJB9;ARHGEF2;RNF103;HM13;CEACAM1;UROS;ADCY6;TGFB1;CAT;LDHA;PIK3R2;ANXA1;PXN
3526,GO:0007507,0.0533487425877709,0.962152954590264,48,356,heart development,BP,ADAM19;NFATC4;DVL1;MAP2K1;SHC1;MEF2D;FKBP1A;ACVR2B;EGFR;PPP1R13L;AP1B1;SH3PXD2B;TGFBR2;EPOR;DKK1;PPARA;OBSL1;LTBP1;SUFU;PAK1;PKD1;GATA3;APLN;MICAL2;EDNRA;ALDH1A2;TAZ;DNM2;GSK3A;DUSP6;PSKH1;HEXIM1;FGFR1;LEMD2;ZFPM1;FGF2;CHD7;BICC1;RXRA;VEGFB;TCF25;MAPK3;ADAM15;MBD3;TGFB1;ERBB3;ITGA3;EP300
17977,GO:1902305,0.0533890058930496,0.979302318886014,8,40,regulation of sodium ion transmembrane transport,BP,NOS1;DLG1;HECW2;PCSK9;STK39;STOM;GLRX;DNM2
9941,GO:0042278,0.0535389942220217,0.975379934019998,11,64,purine nucleoside metabolic process,BP,NT5E;DLG4;DLG1;NME4;CARD11;GTPBP1;AHCY;GAMT;DLG3;GUK1;PNP
11073,GO:0045056,0.0536204164147078,0.988058151067116,4,14,transcytosis,BP,SRC;FCGRT;LRP1;USO1
13132,GO:0051648,0.0537902638212919,0.965941062319554,28,194,vesicle localization,BP,AP3D1;SNPH;BBS2;FYCO1;PRKCZ;CTSZ;SEPT5;SEC23A;NLGN2;SYTL1;VAMP2;PIP5K1C;DNM2;RAB1B;STX5;STXBP1;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;NDE1;SNAP29;TRAPPC1;CSNK1D;CD59;PPP6R1
5083,GO:0015318,0.0538463598597859,0.961215625665317,52,398,inorganic molecular entity transmembrane transporter activity,MF,SERINC2;KCNG1;SCN8A;DLG4;BSG;DLG1;SLC16A3;SLC2A9;TTYH3;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;SLC38A10;PKD1;DLG3;NIPA1;ANO8;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;SLC43A1;NDUFA4L2;NCS1;TMEM44;SLC6A9;SLC33A1;SLC13A5;ATP2C2;LRRC8A;TCIRG1;SLC27A1;TPCN1;SLC6A14;P2RX4;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;CEACAM1;SLC30A1;PCYOX1;SLC15A1;SLC45A3;ORAI3;RASA3
3076,GO:0006644,0.0538831674142061,0.962028292940135,46,344,phospholipid metabolic process,BP,SERINC2;MBOAT2;LPCAT4;PITPNM1;DGKA;SBF1;AGPAT3;PLCH2;OSBPL10;LPCAT1;EGFR;TTC7B;CDS2;DGKQ;PI4K2A;PCSK9;PLCG1;OSBPL5;ISYNA1;PTDSS2;PIGQ;SRD5A3;PIP5K1C;SRC;TAZ;PMVK;FYN;SPTLC2;MBOAT7;FGFR1;MTMR4;PITPNM2;SLC27A1;PIP5KL1;AGPAT4;SMPD3;ZP3;FGF2;OCRL;PNPLA6;LPIN3;TGFB1;PIK3R2;STARD10;ERBB3;ZFYVE21
17728,GO:1901611,0.0538860789753625,0.991477289973212,3,9,phosphatidylglycerol binding,MF,PITPNC1;NME4;PLTP
17597,GO:1901186,0.0539529998647351,0.982634508248961,6,27,positive regulation of ERBB signaling pathway,BP,NEURL1;ARAP1;AKT1;PTK6;TGFA;CBL
12697,GO:0050886,0.0539748942005524,0.979027616136974,8,40,endocrine process,BP,F2R;FAM129B;CTSZ;GATA3;APLN;GAL;FGFR1;GNAS
13553,GO:0055114,0.0539802018409317,0.958157372832308,85,718,oxidation-reduction process,BP,XDH;PYGB;CBS;NOS1;NFATC4;PYGL;QSOX1;CYP27B1;PCK2;CPT2;NR1D1;PGM1;IDH2;BNIP3;CYGB;SESN2;H6PD;CRAT;HK1;P4HB;PDIA5;AKT1;MDH2;ALDH1L2;CRYL1;PFKP;RETSAT;SH3PXD2B;ACAD10;TYSND1;HADH;PPARA;DHTKD1;MSRB2;PRDX5;TSTA3;ERO1B;KIAA1191;OXA1L;GLUD1;ALOX15B;SRD5A3;ASPH;SDHA;CTBP1;PYCR2;MICAL2;P4HA1;AKR7A2;ALDH1A2;KDM4B;GLRX;CBR4;TAZ;NDUFA4L2;ACADVL;GPX3;GSK3A;ALDH4A1;MICAL1;ALDH7A1;HSD11B1;DHRS4L2;LOXL1;PHF2;TTC19;ADIPOR1;NDOR1;AOX1;SDHAF4;TMX4;MLYCD;PHYH;CYB561;VAT1;LONP2;CPT1B;ALDOC;NDUFS2;PCYOX1;SH3PXD2A;CAT;LDHA;GNAS;ASPHD1
7784,GO:0032303,0.0540007901972739,0.99145162838031,3,9,regulation of icosanoid secretion,BP,NTSR1;MIF;P2RX4
12884,GO:0051186,0.054140179651414,0.960711416698265,54,430,cofactor metabolic process,BP,NT5E;CHAC1;RAC2;NAPRT;PCK2;PGM1;PRSS3;IDH2;PC;ACOT7;HAGH;H6PD;GPT2;PGLS;EGFR;ACOT1;HK1;PSAT1;AKT1;MDH2;ACOT13;ALDH1L2;PFKP;NMRK1;PPARA;DHTKD1;NADK;ELOVL1;PRDX5;HMGCL;AHCY;ACSF2;GAMT;PARP10;SLC2A3;PPCS;PANK4;CNDP2;ALAS1;AKR7A2;CBR4;GPX3;TALDO1;PMVK;HLCS;PNP;MLYCD;PHYH;GGT1;ALDOC;GLO1;UROS;CAT;LDHA
6596,GO:0022607,0.054170773747854,0.95366855534571,249,2216,cellular component assembly,BP,ANGPTL4;FLNC;ITGB4;ERCC1;ZMYND8;H1F0;THSD4;RAC2;SORL1;CTNNBIP1;ADGRL1;SDC1;DVL1;KCNG1;WNT7A;SDK2;NEURL1;SNX9;BOK;SHARPIN;CRTC1;ARAP1;DLG4;OBSCN;DLG1;MMP1;SLC9A3R2;FKBP1A;SOX12;ITGA6;RAPGEF3;PRNP;LAMA5;SSH1;TMOD2;ESPN;TNNT1;BBS2;NACC2;ADGRF1;NUDCD3;MARK4;ITGB5;EVI5L;CSNK1E;MMP14;THBS2;RFX2;SEPT10;PRKACA;FCHO1;CORO1B;TUBG2;STK25;PARVB;SHANK3;P4HB;XPC;ACOT13;IRAK1;ARPC1A;APOE;ATG16L2;EHD3;WWTR1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;ITPR3;DGKQ;VPS11;VPS4A;HIST2H2BE;CTSZ;EPHA1;DNAAF5;PTPDC1;SH3PXD2B;TYSND1;EML2;SEPT5;SEC23A;MSN;LIMK1;DKK1;PPP2R5B;OBSL1;PRKACB;ZDHHC8;WASF2;CDC34;RAP1GDS1;ATG13;IDE;MSRB2;COA5;TWF2;TBC1D14;BIN1;FSCN1;HMGCL;CCDC88C;PAK1;TTBK2;BCL9L;NLGN2;TNRC18;BAZ2A;DDIT3;PODXL;GLUL;DMXL2;STOM;FARP1;GNB1;RAB29;CORO7;LAMC2;RHOC;SEPT8;SHANK2;PARP10;OXA1L;ASIC1;HSF1;ADGRB2;IL1RAP;HMGA2;RHOBTB2;DYNLRB1;FAM110C;ARL2;ARHGEF4;VAMP2;PIP5K1C;SRC;CHMP5;CBR4;CAPG;TAZ;TGM2;DNM2;NINL;AGO4;LRSAM1;RAB1B;CPTP;STX5;SDCCAG8;GPX3;EXOC2;RSF1;STXBP1;SH3BP1;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;PFN1;KIF17;TNFRSF1A;TLE4;THRA;MCFD2;AMIGO2;HSF4;LAMB3;LOXL1;SEC24C;TUBG1;ADNP;HYAL1;TENM2;PSMG4;MIF;TTC19;VPS37A;SIGMAR1;STUB1;DDB2;TCIRG1;PMEPA1;ARFIP2;UNC119B;ULK1;HSPA2;P2RX4;USO1;ULK2;TBC1D20;SPIRE1;EHD4;MAP1LC3B;MAPK9;SDHAF4;VASP;ATXN10;ABCA7;LMAN1;RHOBTB1;EPS8L1;WDR18;RXRA;C1QTNF6;ARG1;TAF6;TGFA;NDE1;CAMSAP3;BAHCC1;BAIAP2L1;TPBG;WIPF1;IMPACT;SNAP29;KCNC4;EPHB2;HGS;GAS8;TRAPPC1;TMSB10;PACS2;WRAP73;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;NDUFS2;OCRL;SRPX2;HM13;APBA1;SKAP2;CD59;TGFB1;PPP6R1;SH3PXD2A;CAT;ASH2L;CCDC113;PXN;ARHGEF10L;EP300;TCF7L1;ASAP1;FHOD1
5904,GO:0018107,0.054190007620799,0.971676124585356,15,90,peptidyl-threonine phosphorylation,BP,MAP2K1;AKT1;PKN1;DGKQ;TGFBR2;STK39;CEMIP;GSK3A;PSKH1;MAP3K10;ULK1;MAP3K12;CAMK1;TGFB1;SPRED2
6102,GO:0019319,0.0546070414850989,0.975972305746054,10,55,hexose biosynthetic process,BP,PCK2;NR1D1;PGM1;PC;ATF4;MDH2;DGKQ;PPARA;SLC35B4;ALDOC
378,GO:0001010,0.0547384793473042,0.987724574833344,4,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1;PPARA;VDR;THRA
16516,GO:0097194,0.0547628485237028,0.973755057933597,12,70,execution phase of apoptosis,BP,H1F0;BOK;SHARPIN;AKT1;ENDOG;DEDD2;SATB1;HSF1;STK24;BCL2L1;TAOK1;CASP4
13022,GO:0051428,0.0548185829771369,0.991267988063784,3,9,peptide hormone receptor binding,MF,PTHLH;FYN;GNAS
4579,GO:0010662,0.0548458010763843,0.984734028553462,5,20,regulation of striated muscle cell apoptotic process,BP,BNIP3;BAG3;HSF1;RGL2;PPP1R10
6587,GO:0022411,0.0549472179301698,0.95951083894645,59,475,cellular component disassembly,BP,H1F0;CAPN2;DVL1;CST3;BOK;SHARPIN;BSG;MMP1;BNIP3;TMOD2;LRP5;MMP14;FYCO1;MRPS6;ATP13A2;VPS4A;SH3PXD2B;ENDOG;MAP1B;DKK1;BNIP3L;ZDHHC8;CD44;ATG13;DEDD2;TWF2;FSCN1;HTRA1;TTBK2;MMP10;LAMC2;NID1;HSF1;NEK9;ASPH;ADAM8;MICAL2;CHMP5;CAPG;HIST3H2A;STX5;GSK3A;SH3BP1;MICAL1;CTSL;TIMP1;LAMB3;LRP1;HSPA2;MAP1LC3B;PYM1;CAMSAP3;SNAP29;CIB1;FURIN;ARHGEF2;ADAM15;TGFB1;PLEKHH2
2299,GO:0005262,0.0549779763770194,0.975848166676512,10,53,calcium channel activity,MF,ITPR3;ORAI1;PKD1;GRIN3B;FAM155B;NCS1;TPCN1;P2RX4;ORAI3;RASA3
17689,GO:1901522,0.0551007138588847,0.984642703681524,5,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,SESN2;XBP1;ATF4;RXRA;EP300
4576,GO:0010659,0.0551081257301342,0.984640046341153,5,20,cardiac muscle cell apoptotic process,BP,BNIP3;GNB1;HSF1;RGL2;PPP1R10
6657,GO:0030003,0.055123368148761,0.961385773088079,44,335,cellular cation homeostasis,BP,NOS1;F2R;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;STIM1;RASA3
4993,GO:0015125,0.0552523216374766,0.995971175133351,2,4,bile acid transmembrane transporter activity,MF,SLC10A6;CEACAM1
2983,GO:0006527,0.0552654549741671,0.99116712699366,3,9,arginine catabolic process,BP,NOS1;ARG2;ARG1
1026,GO:0002524,0.0552699966912397,0.9959691475608,2,4,hypersensitivity,BP,GATA3;ZP3
9673,GO:0038023,0.0553648292067275,0.960184435153857,51,386,signaling receptor activity,MF,F2R;MST1R;LTBP4;SORL1;ADGRL1;NR1D1;MRC2;ADGRF1;VLDLR;LRP5;ACVR2B;HTR7;EGFR;PTPRF;GPC4;FZD8;EPHA1;TGFBR2;EPOR;PPARA;LTBP1;CD44;MC1R;RET;ANTXR2;GRIN3B;ADGRB2;IL1RAP;PTPRU;GPRC5C;TNFRSF6B;EDNRA;PAQR7;LPAR3;TNFRSF1A;VDR;GAL;FCGRT;THRA;NTSR1;CRIM1;FGFR1;SIGMAR1;ADIPOR1;TNFRSF19;P2RX4;ABCA7;RXRA;EPHB2;TM2D1;ERBB3
13637,GO:0060089,0.0553648292067275,0.960184435153857,51,386,molecular transducer activity,MF,F2R;MST1R;LTBP4;SORL1;ADGRL1;NR1D1;MRC2;ADGRF1;VLDLR;LRP5;ACVR2B;HTR7;EGFR;PTPRF;GPC4;FZD8;EPHA1;TGFBR2;EPOR;PPARA;LTBP1;CD44;MC1R;RET;ANTXR2;GRIN3B;ADGRB2;IL1RAP;PTPRU;GPRC5C;TNFRSF6B;EDNRA;PAQR7;LPAR3;TNFRSF1A;VDR;GAL;FCGRT;THRA;NTSR1;CRIM1;FGFR1;SIGMAR1;ADIPOR1;TNFRSF19;P2RX4;ABCA7;RXRA;EPHB2;TM2D1;ERBB3
580,GO:0001730,0.0554924393688566,0.995943596986823,2,4,2'-5'-oligoadenylate synthetase activity,MF,OASL;OAS1
12833,GO:0051119,0.0554943024370237,0.987497672075829,4,14,sugar transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC5A1;SLC45A3
4845,GO:0014049,0.0555252654691391,0.995939821235371,2,4,positive regulation of glutamate secretion,BP,STXBP1;NTSR1
13383,GO:0052548,0.0555908154610033,0.962747039706242,35,268,regulation of endopeptidase activity,BP,XDH;F2R;SORL1;CST3;BOK;SERPINE2;DAP;IFI6;AKT1;SERPING1;ATP13A2;SERPINB6;SOX7;CD44;PRDX5;BIN1;RAG1;TNFSF15;IFI27;HSF1;ASPH;TFPI2;TNFRSF6B;SRC;APLP2;FAM162A;SPINT2;FYN;PPM1F;MICAL1;TIMP1;CRIM1;PCSK1N;CASP4;FURIN
3407,GO:0007190,0.0556911024118477,0.987438407166665,4,14,activation of adenylate cyclase activity,BP,ADCY7;CAP1;EDNRA;ADCY6
13663,GO:0060148,0.0558337848262409,0.984379342608974,5,20,positive regulation of posttranscriptional gene silencing,BP,MAP2K1;EGFR;MAP2K2;PUM1;TGFB1
16547,GO:0097242,0.0558419908836058,0.987392916765529,4,14,amyloid-beta clearance,BP,APOE;IDE;LRP1;ABCA7
16570,GO:0097320,0.0559242562852023,0.987368096322303,4,14,plasma membrane tubulation,BP,SNX9;SNX33;DNM2;ASAP1
8191,GO:0032922,0.0559260978062034,0.976660072618575,9,46,circadian regulation of gene expression,BP,NR1D1;MTA1;CSNK1E;ATF4;PPARA;RAI1;TOP1;PER3;CSNK1D
13221,GO:0051823,0.0561249398509831,0.995870608765582,2,4,regulation of synapse structural plasticity,BP,SHANK3;CAMK1
19312,GO:1905477,0.0561568054913869,0.970448002903197,15,93,positive regulation of protein localization to membrane,BP,DLG1;PRNP;SSH1;EGFR;AKT1;PAK1;STOM;PTPN9;CEMIP;FYN;LRP1;EPHB2;CIB1;TGFB1;ITGA3
18258,GO:1903036,0.0561854545669947,0.979668551707234,7,34,positive regulation of response to wounding,BP,F2R;XBP1;TGFBR2;RREB1;F12;HPSE;ANXA1
16476,GO:0097120,0.0562505868660773,0.984229121544694,5,20,receptor localization to synapse,BP,DLG4;DLG1;DLG3;KIF17;ARHGAP44
7280,GO:0031256,0.0562584475579967,0.968486292194092,18,113,leading edge membrane,CC,PLEK2;ATF4;FERMT1;CD44;PSD3;PAK1;ARHGEF4;PIP5K1C;SRC;DNM2;VASP;MYO1D;ABCA7;EPS8L1;KCNC4;CIB1;ARHGEF2;ARHGAP44
4348,GO:0009898,0.0562715717376679,0.967918129155416,19,121,cytoplasmic side of plasma membrane,CC,SNX9;DLG4;DLG1;MAP2K2;PTK6;ESYT2;FARP1;GNB1;CYTH3;GNAI2;SRC;LDLRAP1;RGS19;FYN;NTSR1;LITAF;MYZAP;GNAS;RASA3
13864,GO:0060444,0.056372030265091,0.984185286254121,5,20,branching involved in mammary gland duct morphogenesis,BP,ETV5;LRP5;SRC;VDR;TGFB1
702,GO:0001919,0.0563856452478524,0.984180370054892,5,20,regulation of receptor recycling,BP,ARAP1;PCSK9;TBC1D16;RAB29;CHMP5
9877,GO:0042127,0.0564380143112535,0.954314572964913,123,1035,regulation of cell proliferation,BP,XDH;PGF;CCND1;F2R;MST1R;RAC2;CTNNBIP1;MAP2K1;SHC1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;MEF2D;SERPINE2;NR1D1;DLG1;RPS6KA2;PRNP;IDH2;LAMA5;FAM129B;NACC2;ETV5;LRP5;FBLN1;XBP1;MARCKSL1;EGFR;LAMB1;ADARB1;AKT1;IFITM1;CARD11;IRAK1;APOE;ARG2;PKN1;WWTR1;PRKCZ;CTSZ;EPHA1;PTK6;FBXO2;FERMT1;DEAF1;TGFBR2;SOX7;CCND2;HTRA1;PAK1;SP6;GLUL;LAMC2;PARP10;DLG3;GATA3;TP53I11;APLN;TCFL5;GNAI2;HSF1;ALOX15B;ASPH;CTBP1;PTPRU;CDCA7L;HMGA2;IGFBP2;MYDGF;CLEC11A;TNFRSF6B;ALDH1A2;SRC;TGM2;SPINT2;FYN;RAB25;FUZ;TNFRSF1A;VDR;CGREF1;GJC2;GAL;ITGA1;COMT;TIMP1;RNF187;HSF4;FGFR1;RREB1;HYAL1;MIF;BCL2L1;TCIRG1;ZNF609;PLCD3;MXD4;HPSE;ZP3;PNP;FGF2;SLIT3;ARG1;VEGFB;TGFA;NCCRP1;HGS;GAS8;CIB1;KANK2;ARHGEF2;CEACAM1;SKAP2;ECM1;TGFB1;CAMK2N1;ERBB3;ANXA1;ASH2L;RNF10
9983,GO:0042362,0.0565293368003828,0.990879912334937,3,9,fat-soluble vitamin biosynthetic process,BP,CYP27B1;VDR;PLTP
16675,GO:0097531,0.0565534826252762,0.990874397310853,3,9,mast cell migration,BP,PGF;RAC2;VEGFB
4637,GO:0010757,0.0565971935246681,0.995815788116851,2,4,negative regulation of plasminogen activation,BP,SERPINE2;CTSZ
14053,GO:0060762,0.0566623729280161,0.995808200160949,2,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5;TGFB1
16873,GO:0098771,0.0567077668946929,0.959265772996301,50,387,inorganic ion homeostasis,BP,NOS1;F2R;CYP27B1;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;EGFR;SLC12A7;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;SFXN3;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;COMT;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;STIM1;RASA3
1287,GO:0003091,0.0567216611001542,0.984058921696475,5,20,renal water homeostasis,BP,ADCY7;PRKACA;PRKACB;WFS1;ADCY6
9452,GO:0036021,0.056836545706918,0.995787897749669,2,4,endolysosome lumen,CC,CTSB;CTSL
10447,GO:0043292,0.0570246282012263,0.96686534003208,20,133,contractile fiber,CC,FLNC;NOS1;CST3;SCN8A;OBSCN;FKBP1A;TMOD2;TNNT1;PARVB;BAG3;OBSL1;TWF2;BIN1;PAK1;MYH15;FLNB;STUB1;LMAN1;MYL9;MYZAP
8160,GO:0032880,0.057026845195744,0.955691369188716,85,690,regulation of protein localization,BP,EDEM1;ZMYND8;SH3TC2;F2R;RAC2;SORL1;DVL1;WNT7A;PCK2;NR1D1;DLG1;FKBP1A;POSTN;RAPGEF3;PRNP;IDH2;SSH1;SESN2;LRP5;XBP1;MAP4K4;EGFR;CSNK1E;RHBDF2;HK1;SNX33;AKT1;BAG3;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS11;VPS4A;FERMT1;MSN;GDI1;HADH;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;TTBK2;NLGN2;GLUL;STOM;PTPN9;RAB29;IFI27;CEMIP;PARP10;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;NUMB;VAMP2;SRC;LDLRAP1;NUCB1;CPTP;GSK3A;FYN;ABHD17C;STX10;MIF;BCL2L1;LRP1;APBB1;CAMK1;EPHB2;CIB1;MAPK3;UGCG;TMBIM1;LLGL1;CCNE1;TGFB1;ANXA1;ITGA3
2709,GO:0006081,0.0570379788783424,0.974670328564757,10,56,cellular aldehyde metabolic process,BP,IDH2;HAGH;H6PD;PGLS;AKR7A2;ALDH1A2;TALDO1;ALDH4A1;ALDH7A1;GLO1
3446,GO:0007258,0.0571246447147434,0.995754233103639,2,4,JUN phosphorylation,BP,MAPK9;MAPK10
14201,GO:0061078,0.0572738525357553,1,1,1,positive regulation of prostaglandin secretion involved in immune response,BP,MIF
16282,GO:0090323,0.0572738525357553,1,1,1,prostaglandin secretion involved in immune response,BP,MIF
683,GO:0001890,0.0573406465499178,0.967762957955572,18,116,placenta development,BP,MDFI;MAP2K1;CYP27B1;BSG;CTSB;EGFR;FBXW8;AKT1;TFEB;EPOR;HTRA1;CUL7;PKD1;HSF1;SPINT2;VDR;PLCD3;RXRA
6575,GO:0022037,0.0573722347098789,0.973391934541999,11,61,metencephalon development,BP,MAP2K1;WNT7A;SERPINE2;PTPRS;AARS;NAGLU;PAK1;TTBK2;B4GALT2;RERE;ARCN1
13785,GO:0060341,0.0573735495492447,0.955972852759721,77,618,regulation of cellular localization,BP,EDEM1;ZMYND8;NOS1;SH3TC2;F2R;RAC2;SORL1;DVL1;MAP2K1;NR1D1;DLG1;FKBP1A;RAB3B;RAPGEF3;PRNP;SSH1;SESN2;LRP5;MAP4K4;EGFR;CSNK1E;PRKACA;MAP2K2;SNX33;AKT1;BAG3;ATP13A2;VPS11;VPS4A;PCSK9;SEPT5;MSN;MAP1B;GDI1;UBE2J1;BNIP3L;ZDHHC8;PLCG1;ATG13;PAK1;TTBK2;NLGN2;STOM;PTPN9;RAB29;IFI27;REEP2;CEMIP;PARP10;ASIC1;NUMB;VAMP2;SRC;LDLRAP1;REEP6;NUCB1;GSK3A;STXBP1;FYN;ABHD17C;NTSR1;BCL2L1;LRP1;P2RX4;TBC1D20;CHD7;KCNC4;CAMK1;EPHB2;CIB1;MAPK3;UGCG;TMBIM1;SLC30A1;CCNE1;TGFB1;ITGA3
5236,GO:0015850,0.057409058910047,0.968976629112598,16,101,organic hydroxy compound transport,BP,NOS1;SLC16A3;RAB3B;APOE;VPS4A;PCSK9;OSBPL5;LDLRAP1;NISCH;GAL;PLTP;LRP1;ABCA7;RXRA;SLC10A6;CEACAM1
10588,GO:0043542,0.0575780791208477,0.966021778328296,21,140,endothelial cell migration,BP,WNT7A;PRSS3;CORO1B;AKT1;APOE;TMSB4X;PLCG1;GATA3;GIPC1;SH3BP1;ANXA3;PLEKHG5;FGFR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1;PXN
1255,GO:0003006,0.0577151122143954,0.957964180322001,54,415,developmental process involved in reproduction,BP,ERCC1;MDFI;CCND1;SDC1;MAP2K1;WNT7A;CST3;CYP27B1;NEURL1;BOK;SERPINE2;BSG;DLG1;CTSB;BBS2;OSBP2;ETV5;EGFR;MMP14;RFX2;PRKACA;FBXW8;AKT1;TFEB;DEAF1;EPOR;UBE2J1;HTRA1;CUL7;PKD1;GATA3;HSF1;ALOX15B;ARID5B;SRC;AGO4;PAQR7;STXBP1;SPINT2;VDR;EIF2S2;BCL2L1;HSPA2;PLCD3;ZP3;TBC1D20;CHD7;SLIT3;RXRA;CBL;CIB1;ADAM15;TGFB1;ANXA1
3145,GO:0006741,0.0578262120748578,0.995671825281042,2,4,NADP biosynthetic process,BP,IDH2;NADK
7679,GO:0032103,0.0579424968651202,0.964837893068188,23,161,positive regulation of response to external stimulus,BP,TNIP1;PGF;RAC2;CYP27B1;EGFR;TMSB4X;MAPK13;ADAM8;TGM2;LRSAM1;PPM1F;TNFRSF1A;PUM1;FGFR1;F12;MIF;P2RX4;ZP3;FGF2;ARG1;VEGFB;MAPK3;TGFB1
18474,GO:1903533,0.0579782822632869,0.969317555381932,15,95,regulation of protein targeting,BP,RAC2;PRNP;VPS11;GDI1;BNIP3L;ZDHHC8;ATG13;PAK1;STOM;CEMIP;NUCB1;GSK3A;FYN;CIB1;UGCG
15477,GO:0071797,0.0579783361849433,0.995653876320243,2,4,LUBAC complex,CC,RBCK1;SHARPIN
11795,GO:0046638,0.0580293332062547,0.983460261565637,5,21,positive regulation of alpha-beta T cell differentiation,BP,AP3D1;PRKCZ;TGFBR2;PNP;ANXA1
3542,GO:0007566,0.0580478562526599,0.978774948552272,7,35,embryo implantation,BP,CST3;BSG;SMURF2;FBLN1;TGFBR2;TIMP1;RXRA
8868,GO:0034657,0.0581019661387205,0.995639268363809,2,4,GID complex,CC,RMND5A;RMND5B
7036,GO:0030804,0.0582104916333823,0.986483699839785,4,15,positive regulation of cyclic nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;ADNP
9279,GO:0035694,0.0582314813316599,0.995623944841576,2,4,mitochondrial protein catabolic process,BP,BNIP3;BNIP3L
6719,GO:0030126,0.0583498614266556,0.98644043670173,4,15,COPI vesicle coat,CC,SCYL1;COPG1;TMED3;ARCN1
3204,GO:0006842,0.0584308850872771,0.995600312163835,2,4,tricarboxylic acid transport,BP,SLC13A3;SLC13A5
4999,GO:0015137,0.0584308850872771,0.995600312163835,2,4,citrate transmembrane transporter activity,MF,SLC13A3;SLC13A5
5002,GO:0015142,0.0584308850872771,0.995600312163835,2,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A3;SLC13A5
5185,GO:0015746,0.0584308850872771,0.995600312163835,2,4,citrate transport,BP,SLC13A3;SLC13A5
3615,GO:0008064,0.0584406838634974,0.965942693762375,20,133,regulation of actin polymerization or depolymerization,BP,RAC2;DLG1;SSH1;TMOD2;CORO1B;ARPC1A;TMSB4X;TWF2;CAPG;SH3BP1;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;PLEKHH2
8841,GO:0034618,0.0584603492910526,0.995596816019446,2,4,arginine binding,MF,NOS1;NAGS
5446,GO:0016310,0.0584963494555648,0.950754598821397,190,1649,phosphorylation,BP,TNIP1;XDH;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;ADM2;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;OBSCN;DLG1;IGFBP4;PGM1;FKBP1A;DGKA;PSMD2;RPS6KA2;ITGA6;RAPGEF3;PRNP;SCYL1;NME4;MAPKAPK3;SESN2;BCR;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;PRKACA;ADARB1;HK1;MAP2K2;STK25;SHANK3;TTC7B;AKT1;IRAK1;APOE;ATP13A2;PKN1;WWTR1;TSPYL2;PRKCZ;FAM20C;DGKQ;MAPK13;FZD8;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;PPARA;DHTKD1;NADK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;CCDC88C;PAK1;TTBK2;TNFSF15;DUSP4;RET;RASGEF1A;GRB10;CEMIP;PKD1;DLG3;APLN;GNAI2;HSF1;PANK4;NEK9;SDHA;CTBP1;ADAM8;HMGA2;TOP1;PPP1R14A;MYDGF;PIP5K1C;SRC;TAZ;CDC42BPB;MARK3;STK24;PAK6;GSK3A;DUSP6;PMVK;FYN;PPM1F;LPAR3;PSMD7;MICAL1;TNFRSF1A;UCKL1;BRSK1;GJC2;ITGA1;PSKH1;MAP3K10;HEXIM1;FGFR1;ADNP;GUK1;CDK18;MIF;SOCS2;STK17A;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;PIP5KL1;ULK1;TRIB2;HSPA2;PAK4;TNFRSF19;ULK2;LRRK1;FGF2;EHD4;VAPB;MAPK9;MAP3K12;TAOK1;ABCA7;TGFA;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;MAPK10;CSNK1D;ALDOC;ARHGEF2;AIDA;NDUFS2;SRPX2;CEACAM1;MINK1;ADCY6;CCNE1;ITSN1;TGFB1;ADCK2;LDHA;SPRED2;PIK3R2;CAMK2N1;ERBB3;ZFYVE21;WDFY2;RASA3;TRAF7
9480,GO:0036091,0.0586016086182284,0.995580039751305,2,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2;ATF4
3085,GO:0006659,0.0586653252585735,0.99557246460535,2,4,phosphatidylserine biosynthetic process,BP,PTDSS2;SLC27A1
8482,GO:0033619,0.0586684585458389,0.973846980927058,10,55,membrane protein proteolysis,BP,ADAM19;SNX9;SNX33;APOE;RET;ADAM8;TIMP1;FURIN;HM13;TGFB1
18484,GO:1903546,0.0586988937353395,0.995568471711192,2,4,protein localization to photoreceptor outer segment,BP,TUB;TULP3
1946,GO:0004645,0.0587289338253692,0.995564897338282,2,4,phosphorylase activity,MF,PYGB;PYGL
11884,GO:0046873,0.0587918308359559,0.962139089376237,29,200,metal ion transmembrane transporter activity,MF,KCNG1;SCN8A;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;NCS1;SLC6A9;SLC13A5;ATP2C2;TPCN1;SLC6A14;P2RX4;SLC10A6;KCNC4;SLC5A1;SLC30A1;ORAI3;RASA3
6901,GO:0030430,0.0587936996778664,0.995557187293057,2,4,host cell cytoplasm,CC,RAB29;LMAN1
8501,GO:0033655,0.0587936996778664,0.995557187293057,2,4,host cell cytoplasm part,CC,RAB29;LMAN1
12401,GO:0048799,0.0588615571926241,0.986473277343457,4,14,animal organ maturation,BP,RET;GATA3;ALDH1A2;THBS3
18037,GO:1902495,0.0589072819623045,0.966794750593455,18,114,transmembrane transporter complex,CC,NOS1;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;TTYH3;PRKACA;SHANK3;ABCB8;SHANK2;DLG3;GRIN3B;VAMP2;LRRC8A;HSPA2;ABCA7;KCNC4
4899,GO:0014824,0.0589664985240559,0.995536591299445,2,4,artery smooth muscle contraction,BP,BBS2;EDNRA
12385,GO:0048754,0.0590090296994461,0.967359052220771,17,106,branching morphogenesis of an epithelial tube,BP,PGF;CTNNBIP1;NFATC4;DLG1;LAMA5;ETV5;LRP5;MMP14;CTSZ;TGFBR2;PAK1;PKD1;EDNRA;SRC;VDR;FGF2;TGFB1
8108,GO:0032787,0.0590400078075632,0.956918839010388,54,421,monocarboxylic acid metabolic process,BP,PCK2;CPT2;BSG;NR1D1;SLC16A3;PGM1;IDH2;PC;CYGB;SESN2;ACOT7;HAGH;XBP1;ACOT1;CRAT;HK1;AKT1;CRYL1;PFKP;ACAD10;TYSND1;HADH;PPARA;DHTKD1;WDTC1;ELOVL1;ACSF2;ALOX15B;ALDH1A2;CBR4;ACADVL;ASNS;ALDH4A1;TNFRSF1A;CHST14;MGLL;MIF;ADIPOR1;TRIB3;SLC27A1;HLCS;MLYCD;PHYH;LONP2;GGT1;MAPK3;CPT1B;ALDOC;GLO1;CEACAM1;LPIN3;LDHA;ANXA1;SLC45A3
9549,GO:0036293,0.0590505408507231,0.960240442540486,35,263,response to decreased oxygen levels,BP,ANGPTL4;PGF;NOS1;CAPN2;PLAT;CST3;DNMT3A;POSTN;PSMD2;BNIP3;CYGB;MMP14;P4HB;AKT1;IRAK1;ENDOG;TGFBR2;BNIP3L;PPARA;PAK1;AHCY;GNB1;HSF1;ADAM8;EDNRA;SRC;FAM162A;PSMD7;STUB1;VEGFB;CBL;TGFB1;CAT;LDHA;EP300
3437,GO:0007229,0.0590830435308491,0.972459808149667,11,61,integrin-mediated signaling pathway,BP,ITGB4;ITGA6;LAMA5;ITGB5;FERMT1;SRC;ITGA1;TIMP1;ADAM15;CEACAM1;ITGA3
4238,GO:0009435,0.059130457376015,0.978351375659984,7,34,NAD biosynthetic process,BP,NAPRT;HK1;PFKP;NMRK1;PARP10;PNP;ALDOC
11457,GO:0045879,0.0592066583806973,0.983153818611546,5,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;PRKACB;SUFU;TULP3;MGRN1
547,GO:0001666,0.0592342462334107,0.960349940144092,34,255,response to hypoxia,BP,ANGPTL4;PGF;NOS1;CAPN2;PLAT;CST3;DNMT3A;POSTN;PSMD2;BNIP3;CYGB;MMP14;P4HB;AKT1;IRAK1;ENDOG;TGFBR2;BNIP3L;PPARA;PAK1;AHCY;GNB1;HSF1;ADAM8;EDNRA;SRC;FAM162A;PSMD7;STUB1;VEGFB;TGFB1;CAT;LDHA;EP300
6871,GO:0030336,0.0592481063716218,0.963578982093987,24,164,negative regulation of cell migration,BP,ZMYND8;IDH2;CYGB;BCR;ADARB1;CORO1B;IFITM1;APOE;EPHA1;RRAS;ALOX15B;PTPRU;STK24;FUZ;NISCH;TIMP1;MIF;ADIPOR1;LRP1;FGF2;ARAP3;ADAM15;SRGAP2B;TGFB1
14190,GO:0061052,0.0592678263104713,0.99550058834461,2,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,PAK1;GSK3A
12636,GO:0050801,0.0593199578145879,0.956696166029145,54,423,ion homeostasis,BP,FHL1;NOS1;F2R;CYP27B1;AP3D1;BOK;DLG4;IFI6;FKBP1A;PRNP;BNIP3;LCN2;XBP1;EGFR;SLC12A7;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;SFXN3;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;SLC12A4;MT2A;FAM155B;EDNRA;SRC;TGM2;FYN;LPAR3;GRINA;VDR;COMT;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;STIM1;RASA3
17978,GO:1902306,0.0594190194199626,0.990212534956706,3,9,negative regulation of sodium ion transmembrane transport,BP,HECW2;PCSK9;STK39
18208,GO:1902953,0.0595304581162394,0.995469118194619,2,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1;TBC1D20
18333,GO:1903224,0.0595900349955911,0.995461967593802,2,4,regulation of endodermal cell differentiation,BP,DKK1;DUSP6
11634,GO:0046322,0.0596584823323609,0.995453746979876,2,4,negative regulation of fatty acid oxidation,BP,AKT1;ACADVL
15895,GO:0072603,0.0596635631822351,0.995453136535038,2,4,interleukin-5 secretion,BP,PRKCZ;GATA3
20073,GO:2000662,0.0596635631822351,0.995453136535038,2,4,regulation of interleukin-5 secretion,BP,PRKCZ;GATA3
13134,GO:0051650,0.0597317257479903,0.962113762445972,27,188,establishment of vesicle localization,BP,AP3D1;SNPH;BBS2;FYCO1;PRKCZ;CTSZ;SEPT5;SEC23A;SYTL1;VAMP2;PIP5K1C;DNM2;RAB1B;STX5;STXBP1;MCFD2;SEC24C;USO1;TBC1D20;LMAN1;TGFA;NDE1;SNAP29;TRAPPC1;CSNK1D;CD59;PPP6R1
2112,GO:0004888,0.059742904731079,0.95808637880026,43,321,transmembrane signaling receptor activity,MF,F2R;MST1R;LTBP4;SORL1;ADGRL1;MRC2;ADGRF1;VLDLR;LRP5;ACVR2B;HTR7;EGFR;PTPRF;FZD8;EPHA1;TGFBR2;EPOR;LTBP1;CD44;MC1R;RET;ANTXR2;GRIN3B;ADGRB2;IL1RAP;PTPRU;GPRC5C;TNFRSF6B;EDNRA;LPAR3;TNFRSF1A;GAL;FCGRT;NTSR1;CRIM1;FGFR1;SIGMAR1;TNFRSF19;P2RX4;ABCA7;EPHB2;TM2D1;ERBB3
7757,GO:0032268,0.0597517425046673,0.949195379681461,216,1903,regulation of cellular protein metabolic process,BP,TNIP1;EDEM1;XDH;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;PLAT;WNT7A;ERCC6;CST3;NEURL1;SNX9;BOK;DLG4;SERPINE2;DLG1;DAP;IGFBP4;IFI6;FKBP1A;MTA1;RAPGEF3;PRNP;SSH1;CRTAP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;PRKACA;ADARB1;MAP2K2;STK25;ATF4;SNX33;AKT1;IRAK1;SERPING1;APOE;ATP13A2;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;VPS11;PPP2R3B;FZD8;CTSZ;EPHA1;PTK6;FBXO2;PCSK9;ZNF598;RRAS;MSN;PPP1R35;TGFBR2;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;IDE;ANKIB1;LARP6;PRDX5;CCND2;BIN1;SUFU;CCDC88C;PAK1;ZNF385A;RAG1;TNFSF15;BCDIN3D;DUSP4;RET;IFI27;CEMIP;PKD1;PARP10;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;TFPI2;PPP1R14A;MYDGF;EIF4EBP1;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;FAM162A;STK24;PAK6;GSK3A;SPINT2;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;PUM1;ITGA1;TNRC6B;MAP3K10;HEXIM1;TIMP1;CRIM1;SECISBP2L;FGFR1;MIF4GD;ADNP;F12;MIF;SOCS2;STUB1;PCSK1N;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;RAD23A;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;SAMD4B;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;TAOK1;RNF222;ABCA7;RXRA;TGFA;CNOT11;IMPACT;CASP4;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;POMT1;MAPK10;CSNK1D;FURIN;ARHGEF2;AIDA;CEACAM1;PAIP2;MINK1;ECM1;CD59;ADCY6;IGF2BP3;CCNE1;EIF4G3;TGFB1;WBP2;PPP6R1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;PLGRKT;EP300;WDFY2;TRAF7
12369,GO:0048729,0.0597861195662116,0.955847940858213,58,450,tissue morphogenesis,BP,PGF;ITGB4;CTNNBIP1;NFATC4;DVL1;WNT7A;DLG1;FKBP1A;PSMD2;LAMA5;SMURF2;ETV5;LRP5;EGFR;MMP14;ADARB1;ACTA2;GPC4;AP2A2;CTSZ;DEAF1;MSN;TGFBR2;DKK1;PRKACB;CD44;SUFU;PAK1;PODXL;RET;RHOC;PKD1;DLG3;GATA3;HMGA2;MICAL2;EDNRA;TULP3;ALDH1A2;SRC;TGM2;SH3BP1;SPINT2;FUZ;PFN1;PSMD7;VDR;FGFR1;RREB1;ZFPM1;FGF2;VASP;CHD7;RXRA;CAMSAP3;CEACAM1;TGFB1;ITGA3
13099,GO:0051588,0.0598046499506437,0.974623184517482,9,48,regulation of neurotransmitter transport,BP,NOS1;RAB3B;SEPT5;APLN;ASIC1;STXBP1;NTSR1;KCNC4;SLC30A1
9304,GO:0035739,0.0598662941648102,0.995428753454746,2,4,CD4-positive, alpha-beta T cell proliferation,BP,ARG2;TGFBR2
20008,GO:2000561,0.0598662941648102,0.995428753454746,2,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,ARG2;TGFBR2
8413,GO:0033363,0.0598708881198803,0.982781273089494,5,21,secretory granule organization,BP,F2R;SERPINE2;RFX2;ZNF385A;TBC1D20
4969,GO:0015075,0.0599243069103288,0.955854325358769,57,444,ion transmembrane transporter activity,MF,SERINC2;KCNG1;SCN8A;SLCO4A1;DLG4;BSG;DLG1;SLC16A3;SLC2A9;TTYH3;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;SLC38A10;SFXN3;PKD1;DLG3;NIPA1;ANO8;SLC2A3;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;SLC43A1;NDUFA4L2;NCS1;TMEM44;SLC6A9;SLC33A1;SLC13A5;SLC35B4;ATP2C2;LRRC8A;TCIRG1;SLC27A1;TPCN1;SLC6A14;P2RX4;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;CEACAM1;SLC30A1;PCYOX1;SLC15A1;AZIN2;SLC45A3;ORAI3;RASA3
4711,GO:0010871,0.0599406245953254,0.995419800936942,2,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARA
12359,GO:0048705,0.0599497995127949,0.964989608884033,20,130,skeletal system morphogenesis,BP,MDFI;WNT7A;MEF2D;DLG1;LRP5;ACVR2B;MMP14;COL13A1;SH3PXD2B;TGFBR2;PKD1;ARID5B;TULP3;FUZ;THRA;FGFR1;HYAL1;TGFB1;GNAS;THBS3
13859,GO:0060439,0.05998634575083,0.990079781353826,3,9,trachea morphogenesis,BP,MAP2K1;TGFBR2;MAPK3
14346,GO:0061502,0.0600021827434284,0.995412381638299,2,4,early endosome to recycling endosome transport,BP,SORL1;MYO1D
1651,GO:0004095,0.0601633837824306,0.995392930983432,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1B
5485,GO:0016416,0.0601633837824306,0.995392930983432,2,4,O-palmitoyltransferase activity,MF,CPT2;CPT1B
11386,GO:0045737,0.0601653737854672,0.980005567835758,6,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCND1;EGFR;AKT1;CCND2;PKD1;SRC
19218,GO:1905271,0.0603637567110401,1,1,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
19219,GO:1905273,0.0603637567110401,1,1,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
17387,GO:1900078,0.060548483102443,0.982660074995136,5,20,positive regulation of cellular response to insulin stimulus,BP,PRKCZ;PAK1;SRC;ADIPOR1;PIK3R2
535,GO:0001653,0.0605487978679962,0.979845586605576,6,28,peptide receptor activity,MF,F2R;MC1R;EDNRA;GAL;NTSR1;SIGMAR1
18151,GO:1902816,0.0605966715696319,0.995340493230517,2,4,regulation of protein localization to microtubule,BP,TTBK2;ABHD17C
18152,GO:1902817,0.0605966715696319,0.995340493230517,2,4,negative regulation of protein localization to microtubule,BP,TTBK2;ABHD17C
15104,GO:0071072,0.0606357988396011,0.995335746687426,2,4,negative regulation of phospholipid biosynthetic process,BP,LPCAT1;SLC27A1
16966,GO:0098927,0.0606401623094902,0.975800615346887,8,41,vesicle-mediated transport between endosomal compartments,BP,SORL1;MAP2K1;MAP2K2;VPS11;MSN;SRC;MYO1D;MAPK3
16475,GO:0097119,0.0606659442604806,0.995332088466031,2,4,postsynaptic density protein 95 clustering,BP,ZMYND8;NLGN2
13972,GO:0060633,0.060671749529637,0.995331383855395,2,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
19786,GO:2000143,0.060671749529637,0.995331383855395,2,4,negative regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
20057,GO:2000644,0.0606784300326878,0.989917073959655,3,9,regulation of receptor catabolic process,BP,APOE;PCSK9;FURIN
16786,GO:0098562,0.0608025445983826,0.963889846315291,21,140,cytoplasmic side of membrane,CC,SNX9;DLG4;DLG1;FKBP1A;MAP2K2;PTK6;ESYT2;FARP1;GNB1;CYTH3;GNAI2;SRC;LDLRAP1;RGS19;FYN;NTSR1;LITAF;MYZAP;HM13;GNAS;RASA3
6728,GO:0030136,0.0608221128279215,0.964950620873433,19,124,clathrin-coated vesicle,CC,DVL1;EPN3;SNX9;EGFR;EPN2;APOE;AP1B1;AP2A2;VPS11;MALL;CEMIP;NUMB;VAMP2;LDLRAP1;DNM2;RGS19;LRP1;FURIN;OCRL
2974,GO:0006516,0.0609081967829818,0.985639658074265,4,15,glycoprotein catabolic process,BP,EDEM1;CST3;FBXO2;HPSE
15894,GO:0072602,0.060955328118799,0.995296914832477,2,4,interleukin-4 secretion,BP,GATA3;IL1RAP
7161,GO:0031016,0.0609555176907202,0.975648127822213,8,41,pancreas development,BP,ACVR2B;XBP1;AKT1;WFS1;ALDH1A2;GSK3A;MSLN;ANXA1
17466,GO:1900221,0.0609848270388196,0.989844774752669,3,9,regulation of amyloid-beta clearance,BP,APOE;LRP1;ABCA7
5858,GO:0017153,0.0610158012743852,0.995289551675621,2,4,sodium:dicarboxylate symporter activity,MF,SLC13A3;SLC13A5
8964,GO:0035021,0.0611207417242828,0.995276763686716,2,4,negative regulation of Rac protein signal transduction,BP,ARAP3;ARHGAP44
151,GO:0000306,0.0611501929625574,0.995273172372772,2,4,extrinsic component of vacuolar membrane,CC,WDFY3;ULK1
17361,GO:1900019,0.0612145847399652,0.995265316709,2,4,regulation of protein kinase C activity,BP,EGFR;CEMIP
17362,GO:1900020,0.0612145847399652,0.995265316709,2,4,positive regulation of protein kinase C activity,BP,EGFR;CEMIP
5374,GO:0016176,0.0612437961538465,0.995261751318803,2,4,superoxide-generating NADPH oxidase activator activity,MF,SH3PXD2B;SH3PXD2A
9805,GO:0040015,0.0613115290557229,0.989767504979223,3,9,negative regulation of multicellular organism growth,BP,BBS2;RAI1;SOCS2
13947,GO:0060589,0.0613400916997546,0.95768901628108,39,284,nucleoside-triphosphatase regulator activity,MF,ASAP2;DOCK4;ARAP1;SESN2;BCR;EVI5L;ARHGAP23;BAG3;RIN2;ARHGAP22;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;APPL2;ARL2;RGS19;SH3BP1;RALGDS;PFN1;VPS9D1;TBC1D20;ARAP3;TBC1D2B;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
536,GO:0001654,0.0614921665897783,0.959587798360139,31,219,eye development,BP,WNT7A;CST3;SDK2;DLG1;LPCAT1;LRP5;ACVR2B;EGFR;TUB;PPP1R13L;NAGLU;SH3PXD2B;SALL2;TGFBR2;LAMB2;GNB1;RET;GATA3;MYH15;TULP3;ALDH1A2;WNT5B;RCN1;HSF4;RAB11FIP4;TBC1D20;SDHAF4;CHD7;RXRA;EPHB2;TGFB1
4268,GO:0009612,0.0617222845933571,0.963804275822807,20,132,response to mechanical stimulus,BP,SERPINE2;POSTN;BNIP3;EGFR;MMP14;SHANK3;AKT1;XPC;BAG3;ENDOG;TGFBR2;PKD1;IGFBP2;SRC;FYN;ASNS;TNFRSF1A;MAPK9;MAPK3;TGFB1
11494,GO:0045936,0.0617797055057871,0.954393636994608,57,444,negative regulation of phosphate metabolic process,BP,TNIP1;XDH;SORL1;DVL1;DLG1;FKBP1A;PRNP;LPCAT1;LRP5;FBLN1;ADARB1;AKT1;APOE;PKN1;WWTR1;PRKCZ;DGKQ;EPHA1;PTK6;PPP1R35;STK39;DKK1;PPARA;PPP1R12C;FARP1;DUSP4;GRB10;DLG3;GNAI2;PPP1R14A;DUSP6;PPM1F;MICAL1;HEXIM1;SOCS2;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;LRRK1;MYO1D;CAMSAP3;IMPACT;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;TGFB1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10
18895,GO:1904526,0.0619127249029864,0.989624831263757,3,9,regulation of microtubule binding,BP,TTBK2;HSF1;GAS8
3241,GO:0006898,0.0619792963451396,0.96170477832564,24,165,receptor-mediated endocytosis,BP,SORL1;SNX9;DLG4;RAB31;VLDLR;LRP10;FCHO1;LMBR1L;LRP3;APOE;AP2A2;PCSK9;TGFBR2;DKK1;APLN;CAP1;PIP5K1C;LDLRAP1;DNM2;LGALS3BP;LRP1;ARAP3;CBL;CEACAM1
8707,GO:0034334,0.0620529738570826,0.995162576554665,2,4,adherens junction maintenance,BP,CAMSAP3;KIFC3
5757,GO:0016903,0.0620749978103011,0.977017742327295,7,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,XDH;ALDH1L2;DHTKD1;ALDH1A2;ALDH4A1;ALDH7A1;AOX1
6942,GO:0030545,0.062174697262709,0.961083846954032,25,183,receptor regulator activity,MF,PGF;ADM2;WNT7A;PTHLH;CMTM4;SEMA3F;CMTM7;DGKQ;PCSK9;DKK1;SEMA4B;TNFSF15;APLN;LY6E;CLEC11A;GAL;TIMP1;SEMA4G;MIF;ZP3;FGF2;VEGFB;TGFA;TGFB1;MANF
12231,GO:0048406,0.0621941640207565,0.995145190809491,2,4,nerve growth factor binding,MF,PCSK6;FURIN
10383,GO:0043194,0.0622490607641296,0.989544741439748,3,9,axon initial segment,CC,SCN8A;BIN1;NAV1
18053,GO:1902532,0.0623565424046666,0.954756691995939,51,393,negative regulation of intracellular signal transduction,BP,TNIP1;XDH;SORL1;SERPINE2;DLG1;PRNP;WWC3;SESN2;FBLN1;XBP1;AKT1;APOE;SYVN1;TMSB4X;PPP2R5B;CDC34;CD44;ZNF385A;DDIT3;DUSP4;WFS1;MAPKBP1;SRC;MARK3;CARD19;GSK3A;SH3BP1;DUSP6;GRINA;MIF;SOCS2;BCL2L1;ADIPOR1;TRIB3;LEMD2;MGRN1;ARAP3;SEC14L1;EPHB2;HGS;CIB1;SOCS7;ARHGEF2;C12ORF66;AIDA;ARHGAP44;SPRED2;PIK3R2;CAMK2N1;ITGA3;RASA3
2621,GO:0005938,0.0623654757053511,0.958666726853874,32,227,cell cortex,CC,CAPN2;DLG4;RAPGEF3;SEPT10;PRKCZ;CTSZ;SEPT5;AKAP12;LAMC2;RHOC;SEPT8;ASPH;RHOBTB2;FAM110C;CAP1;FLNB;GIPC1;EXOC2;SH3BP1;PFN1;RAI14;FRYL;MISP;ARFIP2;SPIRE1;RHOBTB1;WIPF1;MYZAP;LLGL1;PXN;PLEKHH2;STIM1
1327,GO:0003175,0.0624751629465853,0.995110517813808,2,4,tricuspid valve development,BP,TGFBR2;ZFPM1
1335,GO:0003186,0.0624751629465853,0.995110517813808,2,4,tricuspid valve morphogenesis,BP,TGFBR2;ZFPM1
5586,GO:0016601,0.0625334622221891,0.97680862746831,7,34,Rac protein signal transduction,BP,RAC2;WASF2;DNM2;SH3BP1;NISCH;ARAP3;ARHGAP44
7059,GO:0030832,0.06255498515449,0.963233718223837,20,134,regulation of actin filament length,BP,RAC2;DLG1;SSH1;TMOD2;CORO1B;ARPC1A;TMSB4X;TWF2;CAPG;SH3BP1;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2;PLEKHH2
13293,GO:0051961,0.0625954211565948,0.960107877461821,27,188,negative regulation of nervous system development,BP,SORL1;NFATC4;WNT7A;PTPRS;IDH2;SEMA3F;MAP4K4;APOE;CTSZ;GDI1;PRKACB;SUFU;SEMA4B;PTPN9;RAB29;TULP3;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ARHGEF2;ADCY6;TGFB1;RAP1GAP2;ASAP1;RNF10
13140,GO:0051660,0.0626220969535046,0.995092349424226,2,4,establishment of centrosome localization,BP,DLG1;FHOD1
16757,GO:0097755,0.0626622494991593,0.976681676016311,7,35,positive regulation of blood vessel diameter,BP,NOS1;DOCK4;BBS2;EGFR;APOE;APLN;ITGA1
17353,GO:0150034,0.0626886911087083,0.960416066203738,26,180,distal axon,CC,ADGRL1;DVL1;AP3D1;FKBP1A;SSH1;TMOD2;CTSZ;SEPT5;TWF2;FSCN1;GLUL;SHANK2;DLG3;DNM2;STXBP1;MICAL1;NTSR1;TENM2;SIGMAR1;P2RX4;MAP3K12;APBB1;KCNC4;CBL;CIB1;ITGA3
2383,GO:0005516,0.0629202769585464,0.963039378461206,20,130,calmodulin binding,MF,NOS1;OBSCN;MAPKAPK3;MARCKSL1;EGFR;MKNK2;STRN4;ORAI1;WFS1;MYH15;PLCB3;VAMP2;UBR4;MYO1D;SNTB2;CAMSAP3;INVS;CAMK1;CEACAM1;MAP6
5852,GO:0017145,0.0629487619261592,0.978929897721708,6,27,stem cell division,BP,WNT7A;ETV5;WWTR1;NUMB;FGFR1;ARHGEF2
10648,GO:0043648,0.0629506623713805,0.968076594430831,13,79,dicarboxylic acid metabolic process,BP,PCK2;NAGS;IDH2;GPT2;MDH2;ALDH1L2;GLUL;ASS1;GLUD1;SDHA;ALDH4A1;PHYH;GGT1
2748,GO:0006145,0.0630264226041623,0.995042220299705,2,4,purine nucleobase catabolic process,BP,XDH;AOX1
6772,GO:0030202,0.0630445145178371,0.995039972627455,2,4,heparin metabolic process,BP,XYLT2;NDST2
6780,GO:0030210,0.0630445145178371,0.995039972627455,2,4,heparin biosynthetic process,BP,XYLT2;NDST2
15964,GO:0075044,0.0631138134480469,0.995031359543069,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK1;ULK2
15965,GO:0075071,0.0631138134480469,0.995031359543069,2,4,autophagy involved in symbiotic interaction,BP,ULK1;ULK2
10317,GO:0043083,0.0632445388818439,0.995015096107598,2,4,synaptic cleft,CC,LAMA5;LAMB2
7169,GO:0031034,0.0635010058932407,0.994983129607878,2,4,myosin filament assembly,BP,OBSL1;RAP1GDS1
664,GO:0001865,0.0635260137015754,0.994980008363678,2,4,NK T cell differentiation,BP,AP3D1;TGFBR2
12849,GO:0051136,0.0635260137015754,0.994980008363678,2,4,regulation of NK T cell differentiation,BP,AP3D1;TGFBR2
2337,GO:0005355,0.0636135551938811,0.989217831951693,3,9,glucose transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC5A1
577,GO:0001726,0.0636195650949524,0.962025874271135,21,139,ruffle,CC,SNX9;PTK6;FERMT1;WASF2;PLCG1;PSD3;FSCN1;PAK1;PODXL;CYTH3;ARHGEF4;PIP5K1C;SRC;DNM2;ARFIP2;ARAP3;ABCA7;EPS8L1;WIPF1;CIB1;ARHGEF2
4387,GO:0010038,0.0636250464218681,0.95831532181349,30,219,response to metal ion,BP,ERCC1;CCND1;NFATC4;SDC1;BSG;DNMT3A;FKBP1A;PRNP;BNIP3;EGFR;ATF4;AKT1;ATP13A2;ATP7B;ITPR3;ENDOG;GDI1;HSF1;MT2A;IGFBP2;MAPK9;ENTPD6;APBB1;ARG1;MAPK3;S100A16;UROS;SLC30A1;CAT;STIM1
13922,GO:0060546,0.0636718928666694,0.98920378435148,3,9,negative regulation of necroptotic process,BP,RBCK1;BOK;ARHGEF2
3576,GO:0007622,0.0637247274497059,0.981214958906438,5,22,rhythmic behavior,BP,CST3;MTA1;NAGLU;AHCY;PER3
12255,GO:0048512,0.0637247274497059,0.981214958906438,5,22,circadian behavior,BP,CST3;MTA1;NAGLU;AHCY;PER3
4237,GO:0009416,0.0637969158608614,0.957904114907527,31,223,response to light stimulus,BP,ERCC1;CCND1;NFATC4;ERCC6;CRTC1;PITPNM1;MTA1;EGFR;ATF4;AKT1;XPC;MAPK13;DEAF1;MC1R;RAG1;GNB1;DYNLRB1;B4GALT2;DNM2;REEP6;HIST3H2A;PER3;PRIMPOL;ASNS;BRSK1;HYAL1;DDB2;IMPACT;MAPK10;CAT;EP300
934,GO:0002329,0.0638679656247939,0.99493725379027,2,4,pre-B cell differentiation,BP,RAG1;LRRC8A
2395,GO:0005536,0.0638703311762919,0.989155957420443,3,9,glucose binding,MF,PYGL;HK1;SLC2A3
612,GO:0001778,0.0639180719609474,0.994930977168399,2,4,plasma membrane repair,BP,DYSF;MYOF
3402,GO:0007185,0.0640476795145626,0.994914727788491,2,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,PTPRF;PTPRU
3275,GO:0006955,0.0640539226712358,0.947138267225523,142,1231,immune response,BP,TNIP1;PYGB;ERCC1;MST1R;RAC2;RBCK1;SHC1;PYGL;QSOX1;CST3;CYP27B1;NAPRT;NR1D1;DLG1;IFI6;PGM1;FKBP1A;PSMD2;CKAP4;PTPRS;PRSS3;PRNP;CD68;RAB43;LCN2;MAPKAPK3;CTSB;BCR;RAB31;LPCAT1;XBP1;PRKACA;ADARB1;HK1;IFITM1;CARD11;IRAK1;ARPC1A;SERPING1;ARG2;PKN1;AP2A2;PRKCZ;GALNS;RNF135;POU2F2;TFEB;HIST2H2BE;CTSZ;PI4K2A;PTK6;ORAI1;CD99;SERPINB6;LIMK1;FAM3A;KDELR1;PRKACB;WASF2;CD44;PLCG1;GTPBP1;SURF4;TFE3;PAK1;AHCY;RAG1;TNFSF15;STOM;FUCA1;RAB29;DNASE1L1;IFI27;ATP11A;GATA3;APLN;ARL8A;OASL;SLC2A3;IL1RAP;MT2A;ADAM8;CAP1;VAMP2;FLNB;TNFRSF6B;SRC;UBR4;IRF7;C6ORF120;STXBP1;PAG1;OAS1;FYN;ISG20;YPEL5;PSMD7;TNFRSF1A;ANXA3;PUM1;FCGRT;CTSL;HEXIM1;F12;MFNG;MIF;TCIRG1;ZFPM1;LRP1;HPSE;ZP3;PNP;RNASE7;MAPK9;SDHAF4;ARG1;SEC14L1;WIPF1;VAT1;CASP4;SNAP29;CBL;TRAPPC1;RAB4B;MAPK3;MAPK10;ALDOC;ARHGEF2;TMBIM1;ADAM15;CEACAM1;SKAP2;ECM1;CD59;TGFB1;CAT;PIK3R2;ANXA1;RAB6A;APOBEC3C;EP300;ERP44
16102,GO:0090050,0.0640800534589176,0.984629683126989,4,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,FGF2;CIB1;SRPX2;ANXA1
13624,GO:0060074,0.0640985361702147,0.989100873449787,3,9,synapse maturation,BP,NFATC4;ADGRL1;NEURL1
2464,GO:0005677,0.0641347781394889,0.98909211724729,3,9,chromatin silencing complex,CC,TNRC18;BAZ2A;BAHCC1
14838,GO:0070561,0.0643265464662118,0.989045748164475,3,9,vitamin D receptor signaling pathway,BP,CYP27B1;VDR;KANK2
6730,GO:0030139,0.0644610585088076,0.958054098517765,29,209,endocytic vesicle,CC,SH3KBP1;RAC2;WNT7A;DLG4;DYSF;RAB43;RAB31;ITGB5;EGFR;EPN2;APOE;EHD3;AP2A2;VPS11;CEMIP;ADAM8;FLNB;GIPC1;LDLRAP1;DNM2;STXBP1;WNT5B;ANXA3;PLEKHG5;RAB11FIP4;TCIRG1;LRP1;OCRL;ITSN1
12254,GO:0048511,0.0645003637765575,0.958760374445262,27,189,rhythmic process,BP,CST3;CRTC1;NR1D1;TEF;MTA1;HEBP1;HTR7;EGFR;CSNK1E;ATF4;NAGLU;PPARA;AHCY;ASS1;RAI1;TOP1;SRC;PER3;ADNP;ZP3;MAPK9;SLIT3;MAPK10;CSNK1D;DBP;ANXA1;EP300
7362,GO:0031399,0.0647765795234819,0.94630497504067,149,1266,regulation of protein modification process,BP,TNIP1;XDH;NOS1;CCND1;F2R;MST1R;RAC2;SORL1;DVL1;MAP2K1;SHC1;WNT7A;ERCC6;NEURL1;SNX9;DLG4;DLG1;IGFBP4;FKBP1A;MTA1;RAPGEF3;PRNP;CRTAP;MAPKAPK3;SESN2;VLDLR;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;PRKACA;ADARB1;MAP2K2;STK25;AKT1;IRAK1;APOE;PKN1;WWTR1;TSPYL2;PRKCZ;DGKQ;PPP2R3B;FZD8;EPHA1;PTK6;FBXO2;RRAS;PPP1R35;TGFBR2;LIMK1;STK39;DKK1;PPP2R5B;SYMPK;PRKACB;SHC2;CD44;PLCG1;ATG13;MAP3K9;CCND2;CCDC88C;PAK1;TNFSF15;DUSP4;RET;CEMIP;PKD1;PARP10;DLG3;GATA3;PHF1;GNAI2;HSF1;WFS1;CTBP1;ADAM8;PPP1R14A;MYDGF;SRC;STK24;PAK6;GSK3A;DUSP6;FYN;PPM1F;LPAR3;MICAL1;TNFRSF1A;GJC2;ITGA1;MAP3K10;HEXIM1;FGFR1;ADNP;MIF;SOCS2;STUB1;TRIB3;SNX25;SLC27A1;LEMD2;PMEPA1;TRIB2;HSPA2;PAK4;TNFRSF19;LRRK1;FGF2;EHD4;VAPB;MAP3K12;TAOK1;RNF222;ABCA7;TGFA;IMPACT;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;MAPK3;POMT1;MAPK10;CSNK1D;ARHGEF2;AIDA;CEACAM1;MINK1;ADCY6;CCNE1;TGFB1;WBP2;PPP6R1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;EP300;WDFY2;TRAF7
8495,GO:0033643,0.0647946155225773,0.988932308621695,3,9,host cell part,CC,PI4K2A;RAB29;LMAN1
5181,GO:0015740,0.064902226686326,0.988906175966151,3,9,C4-dicarboxylate transport,BP,SLC13A3;SLC13A5;NTSR1
11434,GO:0045833,0.0650060399885331,0.971914892650259,9,49,negative regulation of lipid metabolic process,BP,CYP27B1;LPCAT1;AKT1;APOE;WDTC1;ACADVL;TRIB3;SLC27A1;CEACAM1
9572,GO:0036344,0.0650371452699414,0.984321262552374,4,15,platelet morphogenesis,BP,ZNF385A;ZFPM1;CIB1;EP300
14352,GO:0061515,0.0650547774413324,0.971935460306589,9,48,myeloid cell development,BP,FAM210B;FAM20C;WASF2;ZNF385A;SRC;ZFPM1;LRRK1;L3MBTL3;EP300
4705,GO:0010863,0.0651313072853913,0.984290828226076,4,15,positive regulation of phospholipase C activity,BP,EGFR;EDNRA;FGFR1;FGF2
8258,GO:0033028,0.0652185438871131,0.980644959537159,5,22,myeloid cell apoptotic process,BP,IRF7;CTSL;THRA;MIF;ANXA1
4643,GO:0010763,0.065234988938728,0.988825243157523,3,9,positive regulation of fibroblast migration,BP,AKT1;PAK1;TGFB1
14522,GO:0062014,0.0653107694388394,0.968923826292363,11,64,negative regulation of small molecule metabolic process,BP,CYP27B1;AKT1;APOE;PPARA;WDTC1;GNAI2;ACADVL;GSK3A;TRIB3;CEACAM1;TGFB1
4947,GO:0014910,0.0655037272237568,0.973428663444629,8,41,regulation of smooth muscle cell migration,BP,SORL1;DOCK4;POSTN;SSH1;CORO1B;PAK1;SRC;LRP1
2622,GO:0005940,0.065824398490226,0.988681431988989,3,9,septin ring,CC,SEPT10;SEPT5;SEPT8
7218,GO:0031105,0.065824398490226,0.988681431988989,3,9,septin complex,CC,SEPT10;SEPT5;SEPT8
7705,GO:0032160,0.065824398490226,0.988681431988989,3,9,septin filament array,CC,SEPT10;SEPT5;SEPT8
7866,GO:0032421,0.0658707697658889,0.977596251278991,6,28,stereocilium bundle,CC,DOCK4;ESPN;BBS2;TWF2;RHOC;HOMER2
618,GO:0001784,0.0663712294801425,0.977479819736459,6,27,phosphotyrosine residue binding,MF,SHC1;LDLRAP1;SHB;CBL;MAPK3;PIK3R2
19368,GO:1905666,0.0664518252556056,0.988527703878182,3,9,regulation of protein localization to endosome,BP,SORL1;MSN;ABHD17C
19369,GO:1905668,0.0664518252556056,0.988527703878182,3,9,positive regulation of protein localization to endosome,BP,SORL1;MSN;ABHD17C
11786,GO:0046628,0.0665061576432133,0.988514360682533,3,9,positive regulation of insulin receptor signaling pathway,BP,PRKCZ;SRC;ADIPOR1
16342,GO:0090527,0.0665631499944112,0.988500358935733,3,9,actin filament reorganization,BP,ARAP1;EFS;FRYL
9559,GO:0036312,0.066860088872187,0.988427319886553,3,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,FAM83A;DNM2;CBL
4598,GO:0010711,0.0669103680974095,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13757,GO:0060309,0.0669103680974095,1,1,1,elastin catabolic process,BP,CST3
13758,GO:0060310,0.0669103680974095,1,1,1,regulation of elastin catabolic process,BP,CST3
13759,GO:0060311,0.0669103680974095,1,1,1,negative regulation of elastin catabolic process,BP,CST3
3459,GO:0007274,0.0670022737936556,0.988392294074751,3,9,neuromuscular synaptic transmission,BP,ETV5;ADARB1;STXBP1
16295,GO:0090343,0.0670052269005713,0.988039057621649,3,10,positive regulation of cell aging,BP,ARG2;HMGA2;YPEL3
19443,GO:1905952,0.0670492080410143,0.966701730857477,12,73,regulation of lipid localization,BP,AKT1;APOE;PCSK9;PPARA;LDLRAP1;GAL;PLTP;NTSR1;MIF;LRP1;P2RX4;ABCA7
18532,GO:1903651,0.0671217320440378,0.988362840690888,3,9,positive regulation of cytoplasmic transport,BP,SORL1;VPS11;MSN
4381,GO:0010015,0.0671269431871072,1,1,1,root morphogenesis,BP,GAL
4395,GO:0010053,0.0671269431871072,1,1,1,root epidermal cell differentiation,BP,GAL
4396,GO:0010054,0.0671269431871072,1,1,1,trichoblast differentiation,BP,GAL
6605,GO:0022622,0.0671269431871072,1,1,1,root system development,BP,GAL
7539,GO:0031763,0.0671269431871072,1,1,1,galanin receptor binding,MF,GAL
7540,GO:0031764,0.0671269431871072,1,1,1,type 1 galanin receptor binding,MF,GAL
7541,GO:0031765,0.0671269431871072,1,1,1,type 2 galanin receptor binding,MF,GAL
7542,GO:0031766,0.0671269431871072,1,1,1,type 3 galanin receptor binding,MF,GAL
12211,GO:0048364,0.0671269431871072,1,1,1,root development,BP,GAL
12390,GO:0048764,0.0671269431871072,1,1,1,trichoblast maturation,BP,GAL
12391,GO:0048765,0.0671269431871072,1,1,1,root hair cell differentiation,BP,GAL
12392,GO:0048767,0.0671269431871072,1,1,1,root hair elongation,BP,GAL
13047,GO:0051464,0.0671269431871072,1,1,1,positive regulation of cortisol secretion,BP,GAL
16000,GO:0080147,0.0671269431871072,1,1,1,root hair cell development,BP,GAL
16352,GO:0090558,0.0671269431871072,1,1,1,plant epidermis development,BP,GAL
16370,GO:0090627,0.0671269431871072,1,1,1,plant epidermal cell differentiation,BP,GAL
17051,GO:0099402,0.0671269431871072,1,1,1,plant organ development,BP,GAL
18081,GO:1902606,0.0671269431871072,1,1,1,regulation of large conductance calcium-activated potassium channel activity,BP,GAL
18082,GO:1902608,0.0671269431871072,1,1,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,GAL
18173,GO:1902890,0.0671269431871072,1,1,1,regulation of root hair elongation,BP,GAL
18174,GO:1902891,0.0671269431871072,1,1,1,negative regulation of root hair elongation,BP,GAL
18632,GO:1903888,0.0671269431871072,1,1,1,regulation of plant epidermal cell differentiation,BP,GAL
18633,GO:1903889,0.0671269431871072,1,1,1,negative regulation of plant epidermal cell differentiation,BP,GAL
19270,GO:1905392,0.0671269431871072,1,1,1,plant organ morphogenesis,BP,GAL
19282,GO:1905421,0.0671269431871072,1,1,1,regulation of plant organ morphogenesis,BP,GAL
19283,GO:1905422,0.0671269431871072,1,1,1,negative regulation of plant organ morphogenesis,BP,GAL
19753,GO:2000067,0.0671269431871072,1,1,1,regulation of root morphogenesis,BP,GAL
19855,GO:2000280,0.0671269431871072,1,1,1,regulation of root development,BP,GAL
20184,GO:2000851,0.0671269431871072,1,1,1,positive regulation of glucocorticoid secretion,BP,GAL
8963,GO:0035020,0.0671935315336787,0.983620242198584,4,15,regulation of Rac protein signal transduction,BP,DNM2;SH3BP1;ARAP3;ARHGAP44
12750,GO:0050994,0.0673701310596622,0.9769530549889,6,28,regulation of lipid catabolic process,BP,AKT1;TYSND1;PPARA;THRA;MLYCD;LONP2
19004,GO:1904754,0.0674360483875404,0.988285229958637,3,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
1348,GO:0003208,0.0675150277690971,0.972435375406909,8,41,cardiac ventricle morphogenesis,BP,FKBP1A;PPP1R13L;TGFBR2;GATA3;GSK3A;CHD7;RXRA;TGFB1
11451,GO:0045862,0.0677036267370043,0.953336504750698,37,281,positive regulation of proteolysis,BP,TNIP1;EDEM1;XDH;F2R;DVL1;SNX9;BOK;DAP;FBLN1;XBP1;CSNK1E;MMP14;SNX33;AKT1;APOE;SOX7;ANKIB1;TNFSF15;IFI27;HSF1;ASPH;ADAM8;SRC;FAM162A;GSK3A;FYN;PPM1F;F12;STUB1;TRIB3;RAD23A;TRIB2;CASP4;MAPK3;CSNK1D;FURIN;PLGRKT
4581,GO:0010664,0.0678142775249354,0.98341688394299,4,15,negative regulation of striated muscle cell apoptotic process,BP,BAG3;HSF1;RGL2;PPP1R10
8379,GO:0033268,0.0678509945006107,0.988182520258834,3,9,node of Ranvier,CC,SCN8A;DLG1;BIN1
4429,GO:0010256,0.0682329772660302,0.95085123732102,47,357,endomembrane system organization,BP,SH3TC2;F2R;MAP2K1;SNX9;AP3D1;SERPINE2;DYSF;RAB43;RFX2;MAP2K2;STK25;FBXW8;SNX33;AKT1;EHD3;VPS11;VPS4A;PI4K2A;OBSL1;SURF4;ZNF385A;CUL7;RAB29;REEP2;TMED3;DOPEY2;MYOF;NEK9;CHMP5;DNM2;STX5;REEP4;VPS37A;LEMD2;ARFGEF2;USO1;TBC1D20;VAPB;COG1;LMAN1;CAMSAP3;BAIAP2L1;HGS;MAPK3;CSNK1D;KIFC3;ASAP1
13535,GO:0055086,0.06833612705782,0.948163642561946,65,544,nucleobase-containing small molecule metabolic process,BP,NT5E;XDH;NOS1;PTHLH;NAPRT;PCK2;DLG4;DLG1;PGM1;RAPGEF3;IDH2;NME4;ACOT7;H6PD;ADCY7;PGLS;TK2;HK1;MDH2;CARD11;APOE;UAP1;TMSB4X;FAM20C;PFKP;NMRK1;PPARA;DHTKD1;NADK;GTPBP1;TSTA3;AHCY;GAMT;PARP10;DLG3;GNAI2;PPCS;PANK4;SDHA;NEIL1;CAP1;GLRX;TAZ;GARS;GSK3A;TALDO1;MPI;UCKL1;LHPP;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;AOX1;PNP;ABHD14B;ENTPD6;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2;APOBEC3C
9429,GO:0035987,0.0684785984121636,0.974062112033558,7,34,endodermal cell differentiation,BP,ITGB5;MMP14;LAMB1;DKK1;HMGA2;DUSP6;LAMB3
11303,GO:0045599,0.0687354816844171,0.973866520269645,7,35,negative regulation of fat cell differentiation,BP,WWTR1;DDIT3;GATA3;TRIB3;ZFPM1;TRIB2;TGFB1
7898,GO:0032461,0.0689443807249986,0.982844199446364,4,16,positive regulation of protein oligomerization,BP,SNX9;MMP1;IDE;RHOC
8838,GO:0034614,0.0689971360381045,0.960173495730692,18,123,cellular response to reactive oxygen species,BP,CST3;NET1;BNIP3;EGFR;STK25;AKT1;MAPK13;ENDOG;PRDX5;HSF1;SRC;DNM2;MAPK9;ARG1;IMPACT;MAPK3;ANXA1;PXN
6051,GO:0019184,0.0691967849924078,0.982759887788929,4,16,nonribosomal peptide biosynthetic process,BP,CHAC1;HAGH;CNDP2;GGT1
8893,GO:0034702,0.0693473731958199,0.961533788316274,16,101,ion channel complex,CC,NOS1;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;TTYH3;PRKACA;SHANK3;SHANK2;DLG3;GRIN3B;VAMP2;LRRC8A;HSPA2;KCNC4
15450,GO:0071705,0.069358278815076,0.941179989241735,192,1703,nitrogen compound transport,BP,EDEM1;NOS1;LTBP2;SH3TC2;F2R;RAC2;LTBP4;SORL1;SERINC2;SNX9;AP3D1;LMF1;PCK2;NR1D1;XPOT;PITPNM1;POSTN;RAB3B;SLC2A9;RAPGEF3;PRNP;IDH2;RAB43;COPG1;BBS2;BCR;RAB31;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;FERMT1;SEC23A;TGFBR2;GDI1;HADH;MVB12B;STK39;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;TST;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;SLC38A10;TBC1D14;PAK1;SLC29A4;NLGN2;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;GATA3;APLN;DOPEY2;GLUD1;HSF1;ALOX15B;IL1RAP;SLC6A6;ADAM8;MAPKBP1;ARL2;SLC43A1;VAMP2;GIPC1;SRC;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;SLC6A9;NISCH;KIF17;KIF13B;STX10;GAL;MCFD2;PLTP;NTSR1;SLC35B4;SEC24C;RRBP1;GUK1;MIF;VPS37A;PRAF2;TCIRG1;SNX25;ARFIP2;ARFGEF2;UNC119B;SLC6A14;LRP1;USO1;SMPD3;SPIRE1;PNP;COG1;CHD7;APBB1;ARG1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;SEC14L1;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;IGF2BP3;TGFB1;SLC15A1;AZIN2;PIK3R2;ANXA1;PPP1R10;RAB6A;ARCN1
4351,GO:0009914,0.0695123320381711,0.956024877055065,25,176,hormone transport,BP,LTBP4;PCK2;SLCO4A1;NR1D1;RAPGEF3;FAM129B;LRP5;ACVR2B;MAP4K4;EGFR;ITPR3;HADH;NLGN2;GLUL;GATA3;APLN;GLUD1;ARL2;SCG5;GAL;FGFR1;SMPD3;CHD7;ANXA1;GNAS
17750,GO:1901655,0.069889731221735,0.966348638935238,11,64,cellular response to ketone,BP,PCK2;EGFR;AKT1;MSN;GNB1;EIF4EBP1;SRC;NDOR1;ARG1;ADCY6;TGFB1
13817,GO:0060384,0.0698947731424307,0.982730280712186,4,15,innervation,BP,SERPINE2;ADARB1;RET;CHD7
10837,GO:0044321,0.0701578929492842,0.982642898373762,4,15,response to leptin,BP,CCND1;NR1D1;BBS2;ADIPOR1
6681,GO:0030041,0.0702959143794508,0.958693488007016,19,128,actin filament polymerization,BP,RAC2;DLG1;TMOD2;CORO1B;ARPC1A;TMSB4X;MSRB2;TWF2;CORO7;CAPG;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2
6723,GO:0030131,0.0706098339944106,0.975549436511621,6,28,clathrin adaptor complex,CC,EGFR;AP1B1;AP2A2;GGA3;GGA1;LDLRAP1
4069,GO:0009119,0.0708422030262678,0.963301456922862,13,83,ribonucleoside metabolic process,BP,NT5E;DLG4;DLG1;NME4;CARD11;GTPBP1;AHCY;GAMT;DLG3;UCKL1;GUK1;PNP;APOBEC3C
12650,GO:0050818,0.0709306987058114,0.96877233630581,9,50,regulation of coagulation,BP,F2R;PLAT;SERPINE2;SERPING1;APOE;PROCR;F12;HPSE;CEACAM1
10041,GO:0042476,0.0715268213490334,0.962989048674389,13,79,odontogenesis,BP,ITGB4;SDC1;BSG;ITGA6;LAMA5;ACVR2B;LAMB1;FAM20C;PPARA;HTRA1;SP6;TGFB1;STIM1
7787,GO:0032306,0.0715813351335918,0.993031869544809,2,5,regulation of prostaglandin secretion,BP,MIF;P2RX4
7788,GO:0032308,0.0715813351335918,0.993031869544809,2,5,positive regulation of prostaglandin secretion,BP,MIF;P2RX4
5572,GO:0016581,0.0716142686125136,0.982157029123329,4,15,NuRD complex,CC,NACC2;SALL2;APPL2;MBD3
16348,GO:0090545,0.0716142686125136,0.982157029123329,4,15,CHD-type complex,CC,NACC2;SALL2;APPL2;MBD3
11085,GO:0045071,0.0716380095224151,0.97014746020669,8,45,negative regulation of viral genome replication,BP,TNIP1;IFITM1;PARP10;OASL;HMGA2;OAS1;ISG20;APOBEC3C
11921,GO:0046934,0.0718162268954437,0.972492654895457,7,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;SRC;FYN;FGFR1;FGF2;PIK3R2;ERBB3
14212,GO:0061097,0.0722877173249486,0.966423445207093,10,57,regulation of protein tyrosine kinase activity,BP,SHC1;ERCC6;NEURL1;DLG4;PRNP;PTK6;DLG3;TGFA;CBL;ERBB3
12737,GO:0050954,0.0724002674553238,0.963582082403639,12,73,sensory perception of mechanical stimulus,BP,SERPINE2;ESPN;TUB;EML2;SERPINB6;CEMIP;WFS1;FYN;ALDH7A1;FGFR1;CHD7;HOMER2
17416,GO:1900121,0.0724811780632377,0.986625377647211,3,10,negative regulation of receptor binding,BP,PTPRF;PCSK9;ADAM15
10796,GO:0044248,0.0725768467304741,0.938126453492473,202,1801,cellular catabolic process,BP,NT5E;EDEM1;XDH;BTBD2;ITGB4;PYGB;CBS;NOS1;CHAC1;H1F0;GID4;CAPN2;RBCK1;DVL1;PYGL;QSOX1;CST3;CYP27B1;SNX9;BOK;SHARPIN;PCK2;CPT2;NR1D1;TRIM65;DAP;PGM1;PSMD2;MTA1;RAPGEF3;BNIP3;SMURF2;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;HAGH;USP20;VLDLR;GPT2;XBP1;CSNK1E;PANO1;FYCO1;PRKACA;CRAT;HK1;HECW2;SNX33;AKT1;ALDH1L2;APOE;ATG16L2;ATP13A2;ARG2;SYVN1;WWTR1;CRYL1;AP2A2;GALNS;TFEB;VPS11;VPS4A;CTSZ;PFKP;TMEM129;FBXO2;PCSK9;ENDOG;FBXW5;ACAD10;TYSND1;MSN;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;PPARA;DHTKD1;TST;ZDHHC8;CDC34;CD44;PLCG1;ATG13;GTPBP1;IDE;DEDD2;ANKIB1;TBC1D14;PRDX5;HMGCL;SUFU;AHCY;CTBS;DDIT3;GLUL;CUL7;ADAMTS7;FUCA1;DNASE1L1;PCBP4;CEMIP;PKD1;UBXN4;GLUD1;HSF1;WFS1;SRD5A3;ADAM8;NEIL1;BLMH;GIPC1;SRC;UBR4;AGO4;LRSAM1;RAB1B;CPTP;ACADVL;RGS19;GPX3;GSK3A;ISG20;SPTLC2;RMND5A;ALDH4A1;PSMD7;ALDH7A1;FBXL15;PUM1;RNF44;CTSL;COMT;TNRC6B;TIMP1;UBA1;MGLL;RNF187;WDFY3;HYAL1;VPS37A;STUB1;TRIB3;TCIRG1;SNX25;TPCN1;RMND5B;RAD23A;ULK1;LRP1;TRIB2;AOX1;HPSE;SAMD4B;ULK2;SMPD3;PNP;FGF2;MAP1LC3B;RNH1;PYM1;RNF222;ENTPD6;MLYCD;PHYH;ARG1;SPSB3;RPL28;ATP6V1C2;CNOT11;SNAP29;LONP2;HGS;CARHSP1;CBL;GGT1;USP32;PACS2;MAPK3;CPT1B;POMT1;CSNK1D;DRAM2;DNAJB9;ALDOC;FURIN;RNF103;HM13;PNPLA6;LPIN3;NAGA;IGF2BP3;TGFB1;PCYOX1;CAT;LDHA;PIK3R2;APOBEC3C;EP300
10840,GO:0044324,0.0726031026674647,1,1,1,regulation of transcription involved in anterior/posterior axis specification,BP,DDIT3
19725,GO:2000016,0.0726031026674647,1,1,1,negative regulation of determination of dorsal identity,BP,DDIT3
9674,GO:0038024,0.0727238190387137,0.969767416807506,8,42,cargo receptor activity,MF,SORL1;VLDLR;LRP10;AP2A2;LDLRAP1;LGALS3BP;LRP1;ABCA7
738,GO:0001965,0.0727488877036172,0.981561358764537,4,16,G-protein alpha-subunit binding,MF,F2R;NUCB1;RGS19;LPAR3
6675,GO:0030032,0.0729561734572601,0.967748811402273,9,49,lamellipodium assembly,BP,RAC2;SSH1;PARVB;WASF2;TWF2;FSCN1;ARHGEF4;DNM2;ARFIP2
6980,GO:0030638,0.073004344910891,0.992811760637219,2,5,polyketide metabolic process,BP,AKR7A2;CBR4
6984,GO:0030647,0.073004344910891,0.992811760637219,2,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2;CBR4
10948,GO:0044597,0.073004344910891,0.992811760637219,2,5,daunorubicin metabolic process,BP,AKR7A2;CBR4
10949,GO:0044598,0.073004344910891,0.992811760637219,2,5,doxorubicin metabolic process,BP,AKR7A2;CBR4
3279,GO:0006959,0.0730112371660927,0.962970848505215,12,83,humoral immune response,BP,PRSS3;LCN2;SERPING1;POU2F2;TFEB;HIST2H2BE;FAM3A;TFE3;GATA3;ZP3;RNASE7;CD59
5287,GO:0015937,0.073102291293978,0.986461876846683,3,10,coenzyme A biosynthetic process,BP,ACOT7;PPCS;PANK4
13863,GO:0060443,0.0732007552111426,0.971755036402233,7,35,mammary gland morphogenesis,BP,ETV5;LRP5;TGFBR2;SRC;VDR;ARG1;TGFB1
7980,GO:0032588,0.0732247781876139,0.964417080217636,11,65,trans-Golgi network membrane,CC,BOK;RAB43;RAB31;AP1B1;ATP7B;COG8;STX10;ARFIP2;COG1;LLGL1;RAB6A
17045,GO:0099175,0.0735047846773526,0.97161002420546,7,35,regulation of postsynapse organization,BP,ZMYND8;PRNP;SSH1;SHANK3;APOE;FYN;ARHGAP44
6682,GO:0030042,0.0737114033472941,0.971511384271159,7,35,actin filament depolymerization,BP,TMOD2;TWF2;MICAL2;CAPG;SH3BP1;MICAL1;PLEKHH2
18096,GO:1902652,0.0737404003941467,0.958685259316947,16,104,secondary alcohol metabolic process,BP,SORL1;CYP27B1;LMF1;VLDLR;LRP5;APOE;DGKQ;PCSK9;OSBPL5;LDLRAP1;ACADVL;PMVK;FGFR1;RXRA;SEC14L2;CAT
15454,GO:0071711,0.0740055896704125,0.981351217112339,4,15,basement membrane organization,BP,FERMT1;LAMC2;NID1;SPINT2
10123,GO:0042632,0.0741183679586525,0.971239961058448,7,36,cholesterol homeostasis,BP,LRP5;XBP1;APOE;PCSK9;MALL;LDLRAP1;VDR
13541,GO:0055092,0.0741183679586525,0.971239961058448,7,36,sterol homeostasis,BP,LRP5;XBP1;APOE;PCSK9;MALL;LDLRAP1;VDR
11886,GO:0046875,0.0741924322525516,0.977134993411735,5,22,ephrin receptor binding,MF,SHC1;ANKS1A;SRC;FYN;CBL
2102,GO:0004866,0.0742554718215185,0.962352830568422,12,78,endopeptidase inhibitor activity,MF,CST3;SERPINE2;SERPING1;SERPINB6;PRDX5;TFPI2;APLP2;SPINT2;TIMP1;CRIM1;PCSK1N;FURIN
6893,GO:0030414,0.0742554718215185,0.962352830568422,12,78,peptidase inhibitor activity,MF,CST3;SERPINE2;SERPING1;SERPINB6;PRDX5;TFPI2;APLP2;SPINT2;TIMP1;CRIM1;PCSK1N;FURIN
7422,GO:0031507,0.0744062644242127,0.986116559873569,3,10,heterochromatin assembly,BP,TNRC18;HMGA2;BAHCC1
3990,GO:0008859,0.0745053522126624,1,1,1,exoribonuclease II activity,MF,ISG20
11080,GO:0045064,0.0745870878324811,0.986068454757819,3,10,T-helper 2 cell differentiation,BP,PRKCZ;GATA3;ANXA1
17848,GO:1901981,0.0746610299432725,0.957300475628209,17,110,phosphatidylinositol phosphate binding,MF,ARAP1;PLEK2;AKT1;ATP13A2;SH3PXD2B;OSBPL5;TWF2;CYTH3;GSDMA;TULP3;LDLRAP1;PFN1;ARFIP2;ARAP3;GSDMC;SNX27;ASAP1
3423,GO:0007213,0.0748239060139325,0.986005372490059,3,10,G-protein coupled acetylcholine receptor signaling pathway,BP,GNB1;GNAI2;AGRN
466,GO:0001504,0.0748491691448018,0.980842285069971,4,16,neurotransmitter uptake,BP,NOS1;RAB3B;GLUL;NTSR1
5722,GO:0016857,0.0752196355321423,0.985899756493568,3,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,HYI;TSTA3;GALE
2384,GO:0005518,0.0752945454405814,0.968462599227224,8,42,collagen binding,MF,CTSB;MRC2;CD44;PAK1;NID1;ITGA1;CTSL;ITGA3
13697,GO:0060205,0.075297289545647,0.949781920645114,30,230,cytoplasmic vesicle lumen,CC,PYGB;PYGL;QSOX1;NAPRT;PSMD2;LCN2;SERPING1;APOE;TMSB4X;GALNS;CTSZ;FUCA1;DNASE1L1;CAP1;C6ORF120;PSMD7;TIMP1;LGALS3BP;MIF;HPSE;PNP;ARG1;VEGFB;VAT1;TRAPPC1;ALDOC;ECM1;TGFB1;CAT;ERP44
2199,GO:0005070,0.0754142386336678,0.97069570559425,7,35,SH3/SH2 adaptor activity,MF,SH2D2A;GRB10;SRC;PAG1;SOCS2;SHB;SKAP2
9733,GO:0038163,0.0754203326902861,1,1,1,thrombopoietin-mediated signaling pathway,BP,CIB1
19437,GO:1905938,0.0754203326902861,1,1,1,positive regulation of germ cell proliferation,BP,CIB1
19841,GO:2000256,0.0754203326902861,1,1,1,positive regulation of male germ cell proliferation,BP,CIB1
8080,GO:0032753,0.0754718917846339,0.985832299084714,3,10,positive regulation of interleukin-4 production,BP,PRKCZ;GATA3;ZP3
3221,GO:0006873,0.0754847622960541,0.9457769883077,44,343,cellular ion homeostasis,BP,NOS1;F2R;AP3D1;BOK;DLG4;FKBP1A;PRNP;BNIP3;LCN2;PRKACA;APOE;ATP13A2;ATP7B;ITPR3;PLCG1;RAP1GDS1;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;STIM1;RASA3
18183,GO:1902905,0.0755781314520136,0.953874438318957,21,145,positive regulation of supramolecular fiber organization,BP,RAC2;DLG1;RAPGEF3;CORO1B;ARPC1A;APOE;EPHA1;SH3PXD2B;LIMK1;PAK1;ARL2;PPM1F;PFN1;ARFIP2;SPIRE1;VASP;BAIAP2L1;WIPF1;PXN;ARHGEF10L;FHOD1
7409,GO:0031467,0.0757463062832322,0.992380196158875,2,5,Cul7-RING ubiquitin ligase complex,CC,FBXW8;CUL7
17820,GO:1901880,0.0758549118867636,0.968176732066208,8,42,negative regulation of protein depolymerization,BP,TMOD2;TWF2;TTBK2;CAPG;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
2768,GO:0006185,0.0758934693627181,1,1,1,dGDP biosynthetic process,BP,GUK1
4116,GO:0009170,0.0758934693627181,1,1,1,purine deoxyribonucleoside monophosphate metabolic process,BP,GUK1
4125,GO:0009183,0.0758934693627181,1,1,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,GUK1
11545,GO:0046054,0.0758934693627181,1,1,1,dGMP metabolic process,BP,GUK1
11833,GO:0046711,0.0758934693627181,1,1,1,GDP biosynthetic process,BP,GUK1
2319,GO:0005319,0.0759288011968521,0.96030681659588,13,80,lipid transporter activity,MF,PITPNC1;PITPNM1;OSBPL10;APOE;OSBPL5;ATP11A;CPTP;PLTP;PITPNM2;SLC27A1;ABCA7;SLC10A6;CEACAM1
3684,GO:0008188,0.0759458810814171,0.992348403970969,2,5,neuropeptide receptor activity,MF,GAL;NTSR1
10418,GO:0043244,0.0760220085710628,0.960277622312647,13,79,regulation of protein complex disassembly,BP,BNIP3;TMOD2;FYCO1;MAP1B;TWF2;TTBK2;ASPH;CAPG;SH3BP1;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
6937,GO:0030534,0.0761458159122806,0.962740175778953,11,65,adult behavior,BP,BBS2;SHANK3;PPARA;CCND2;SHANK2;PUM1;NTSR1;PBX3;CHD7;HOMER2;ARCN1
2970,GO:0006509,0.0761997386875311,0.970238492246016,7,36,membrane protein ectodomain proteolysis,BP,ADAM19;SNX9;SNX33;APOE;ADAM8;TIMP1;FURIN
9641,GO:0036500,0.076358164593467,0.98559447717065,3,10,ATF6-mediated unfolded protein response,BP,XBP1;DDIT3;WFS1
4241,GO:0009438,0.0763970351907624,0.992276345716259,2,5,methylglyoxal metabolic process,BP,HAGH;GLO1
3046,GO:0006601,0.076519728247096,1,1,1,creatine biosynthetic process,BP,GAMT
7024,GO:0030731,0.076519728247096,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
7397,GO:0031444,0.0765976388126705,1,1,1,slow-twitch skeletal muscle fiber contraction,BP,TNNT1
4129,GO:0009187,0.0766374498053606,0.964009853931141,10,57,cyclic nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;ADCY7;APOE;GNAI2;CAP1;ADNP;AMPD2;ADCY6
5935,GO:0018210,0.0766825852936181,0.956836854928255,16,102,peptidyl-threonine modification,BP,MAP2K1;AKT1;PKN1;DGKQ;TGFBR2;STK39;CEMIP;GSK3A;PSKH1;MAP3K10;ULK1;MAP3K12;CAMK1;GALNT3;TGFB1;SPRED2
6751,GO:0030168,0.0767339286907593,0.956765079997812,16,104,platelet activation,BP,F2R;RAC2;SERPINE2;DGKA;AKT1;APOE;ITPR3;DGKQ;GNB1;SRC;STXBP1;FYN;MYL9;MAPK3;CEACAM1;GNAS
6900,GO:0030427,0.0769274503190003,0.954302647517838,19,126,site of polarized growth,CC,ADGRL1;DVL1;SSH1;TMOD2;CTSZ;PI4K2A;TWF2;FSCN1;SHANK2;DLG3;DNM2;FRYL;TENM2;SIGMAR1;MAP3K12;APBB1;CBL;CIB1;ITGA3
20089,GO:2000679,0.0770761417817363,0.980071527293829,4,16,positive regulation of transcription regulatory region DNA binding,BP,FAM129B;GATA3;HMGA2;TGFB1
14781,GO:0070459,0.077265286940851,0.992136930208089,2,5,prolactin secretion,BP,EGFR;ANXA1
9450,GO:0036019,0.0773316066322719,0.979982568964474,4,16,endolysosome,CC,CTSB;AP2A2;PCSK9;CTSL
6729,GO:0030137,0.0776793273766443,0.975591246124138,5,23,COPI-coated vesicle,CC,SCYL1;COPG1;KDELR1;TMED3;ARCN1
9817,GO:0040036,0.0777176747874624,0.975717289296572,5,22,regulation of fibroblast growth factor receptor signaling pathway,BP,FAM20C;GATA3;APLN;DUSP6;FUZ
7647,GO:0032052,0.0780150283371387,0.992015763752782,2,5,bile acid binding,MF,PYGL;VDR
5949,GO:0018279,0.0780765253526371,0.969180702604152,7,38,protein N-linked glycosylation via asparagine,BP,SYVN1;UBE2J1;MCFD2;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1
17199,GO:0102991,0.0781677124436361,0.991990999877051,2,5,myristoyl-CoA hydrolase activity,MF,ACOT7;ACOT1
15155,GO:0071230,0.0784256515373635,0.964769159258006,9,50,cellular response to amino acid stimulus,BP,CAPN2;NEURL1;DNMT3A;SESN2;XBP1;EGFR;HSF1;FYN;BCL2L1
3569,GO:0007614,0.0785568562415723,0.991927749387936,2,5,short-term memory,BP,COMT;ADNP
8935,GO:0034774,0.0786567229750275,0.947698818889194,29,222,secretory granule lumen,CC,PYGB;PYGL;QSOX1;NAPRT;PSMD2;LCN2;SERPING1;TMSB4X;GALNS;CTSZ;FUCA1;DNASE1L1;CAP1;C6ORF120;PSMD7;TIMP1;LGALS3BP;MIF;HPSE;PNP;ARG1;VEGFB;VAT1;TRAPPC1;ALDOC;ECM1;TGFB1;CAT;ERP44
19311,GO:1905476,0.0786592533517,0.97533502939714,5,22,negative regulation of protein localization to membrane,BP,GDI1;NUMB;BCL2L1;TMBIM1;TGFB1
18270,GO:1903054,0.0786950957198069,0.991905233580975,2,5,negative regulation of extracellular matrix organization,BP,CST3;TGFB1
50,GO:0000104,0.0787156901082098,0.991901877168259,2,5,succinate dehydrogenase activity,MF,SDHA;SDHAF4
2501,GO:0005749,0.0787156901082098,0.991901877168259,2,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHA;SDHAF4
3678,GO:0008177,0.0787156901082098,0.991901877168259,2,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHA;SDHAF4
11191,GO:0045257,0.0787156901082098,0.991901877168259,2,5,succinate dehydrogenase complex (ubiquinone),CC,SDHA;SDHAF4
11196,GO:0045273,0.0787156901082098,0.991901877168259,2,5,respiratory chain complex II,CC,SDHA;SDHAF4
11200,GO:0045281,0.0787156901082098,0.991901877168259,2,5,succinate dehydrogenase complex,CC,SDHA;SDHAF4
11202,GO:0045283,0.0787156901082098,0.991901877168259,2,5,fumarate reductase complex,CC,SDHA;SDHAF4
13255,GO:0051899,0.0787533787470363,0.964540900183889,9,51,membrane depolarization,BP,FHL1;SCN8A;BOK;IFI6;PRKCZ;SRC;NTSR1;TPCN1;P2RX4
3247,GO:0006907,0.0789186189023823,0.97942746017413,4,16,pinocytosis,BP,MAPKAPK3;SNX33;DNM2;EHD4
711,GO:0001933,0.078943156844471,0.943330143399054,43,330,negative regulation of protein phosphorylation,BP,TNIP1;XDH;SORL1;DVL1;DLG1;FKBP1A;PRNP;LRP5;FBLN1;ADARB1;AKT1;APOE;PKN1;WWTR1;PRKCZ;DGKQ;EPHA1;PTK6;STK39;DKK1;DUSP4;DUSP6;PPM1F;MICAL1;HEXIM1;SOCS2;TRIB3;SNX25;LEMD2;PMEPA1;TRIB2;LRRK1;IMPACT;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;TGFB1;SPRED2;PIK3R2;CAMK2N1
7263,GO:0031225,0.0790165347821368,0.960941187848032,11,69,anchored component of membrane,CC,NT5E;RAB3B;PRNP;LY6K;GPC4;PRSS8;LY6E;LYPD5;MSLN;NTNG1;CD59
10279,GO:0043010,0.0790837423177939,0.948334262418697,27,191,camera-type eye development,BP,WNT7A;SDK2;DLG1;LPCAT1;LRP5;ACVR2B;EGFR;TUB;PPP1R13L;TGFBR2;LAMB2;GNB1;RET;GATA3;MYH15;TULP3;ALDH1A2;WNT5B;RCN1;HSF4;RAB11FIP4;TBC1D20;SDHAF4;CHD7;RXRA;EPHB2;TGFB1
12438,GO:0048871,0.0793065656508714,0.94771660917495,28,202,multicellular organismal homeostasis,BP,F2R;RAC2;ERCC6;CRTC1;NR1D1;BBS2;LPCAT1;ADCY7;EGFR;PRKACA;TUB;PPP1R13L;STK39;PRKACB;APLN;WFS1;ADAM8;SRC;ACADVL;NTSR1;AMPD2;SLC27A1;P2RX4;LRRK1;HOMER2;DRAM2;ADCY6;GNAS
10634,GO:0043621,0.0793305912817394,0.966326625056519,8,43,protein self-association,MF,SHANK3;MDH2;PCSK9;CCDC88C;HSF1;ADAM8;VAMP2;FHOD1
270,GO:0000768,0.0793950708017649,0.971540541802162,6,29,syncytium formation by plasma membrane fusion,BP,NOS1;CAPN2;RAPGEF3;MYOF;CAMK1;SH3PXD2A
7134,GO:0030952,0.0794041410844581,0.979256784529553,4,16,establishment or maintenance of cytoskeleton polarity,BP,RHOC;RHOBTB2;RHOBTB1;CAMSAP3
5227,GO:0015833,0.0794286303046934,0.932841124304331,171,1519,peptide transport,BP,EDEM1;LTBP2;SH3TC2;F2R;RAC2;LTBP4;SORL1;SNX9;AP3D1;LMF1;PCK2;NR1D1;XPOT;PITPNM1;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;RAB43;COPG1;BBS2;BCR;RAB31;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;FERMT1;SEC23A;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;PAK1;NLGN2;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;GATA3;APLN;DOPEY2;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;GIPC1;SRC;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;KIF17;KIF13B;STX10;GAL;MCFD2;SEC24C;RRBP1;GUK1;MIF;VPS37A;PRAF2;TCIRG1;SNX25;ARFIP2;ARFGEF2;UNC119B;LRP1;USO1;SMPD3;SPIRE1;PNP;COG1;CHD7;APBB1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;TGFB1;SLC15A1;PIK3R2;ANXA1;PPP1R10;RAB6A;ARCN1
7282,GO:0031260,0.0794581777137097,1,1,1,pseudopodium membrane,CC,RAB25
14179,GO:0061041,0.0795630670767282,0.958064562300325,13,81,regulation of wound healing,BP,F2R;PLAT;SERPINE2;XBP1;SERPING1;APOE;TGFBR2;RREB1;F12;HPSE;FGF2;CEACAM1;ANXA1
1529,GO:0003905,0.0795700722890683,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3962,GO:0008725,0.0795700722890683,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10665,GO:0043733,0.0795700722890683,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10684,GO:0043916,0.0795700722890683,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13441,GO:0052821,0.0795700722890683,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13442,GO:0052822,0.0795700722890683,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
3588,GO:0008013,0.0797291884966002,0.960703386629189,11,64,beta-catenin binding,MF,CTNNBIP1;DVL1;SLC9A3R2;SUFU;BCL9L;PTPRU;NUMB;ASH2L;PXN;EP300;TCF7L1
6118,GO:0019362,0.0798030844017226,0.952324594315516,19,129,pyridine nucleotide metabolic process,BP,NT5E;NAPRT;PCK2;PGM1;IDH2;H6PD;PGLS;HK1;MDH2;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;TALDO1;PNP;ALDOC;LDHA
11719,GO:0046496,0.0798030844017226,0.952324594315516,19,129,nicotinamide nucleotide metabolic process,BP,NT5E;NAPRT;PCK2;PGM1;IDH2;H6PD;PGLS;HK1;MDH2;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;TALDO1;PNP;ALDOC;LDHA
12950,GO:0051287,0.0800584757165565,0.963783325937298,9,52,NAD binding,MF,IDH2;CRYL1;HADH;AHCY;GLUD1;CTBP1;AOX1;NDUFS2;LDHA
4645,GO:0010765,0.080138874021674,0.974731312045701,5,22,positive regulation of sodium ion transport,BP,NOS1;AKT1;PRSS8;GLRX;DNM2
10171,GO:0042745,0.0802646888172825,0.98417428515515,3,11,circadian sleep/wake cycle,BP,CST3;AHCY;PER3
18711,GO:1904031,0.0802913102080046,0.971030485343456,6,30,positive regulation of cyclin-dependent protein kinase activity,BP,CCND1;EGFR;AKT1;CCND2;PKD1;SRC
7225,GO:0031114,0.0803790803390399,0.974632955849817,5,22,regulation of microtubule depolymerization,BP,MAP1B;TTBK2;CAMSAP3;CIB1;ARHGEF2
4000,GO:0008903,0.0804213089048728,1,1,1,hydroxypyruvate isomerase activity,MF,HYI
13923,GO:0060547,0.0805560671460958,0.984450864776134,3,10,negative regulation of necrotic cell death,BP,RBCK1;BOK;ARHGEF2
3555,GO:0007597,0.0806012522345227,0.991592278024083,2,5,blood coagulation, intrinsic pathway,BP,SERPING1;F12
3162,GO:0006775,0.0806600652138673,0.974235605779267,5,24,fat-soluble vitamin metabolic process,BP,CYP27B1;ALDH1A2;VDR;PLTP;FGFR1
3152,GO:0006751,0.0806657137920488,0.99158161365806,2,5,glutathione catabolic process,BP,CHAC1;GGT1
15154,GO:0071229,0.0807266162455168,0.951008669434551,20,136,cellular response to acid chemical,BP,CAPN2;NFATC4;NEURL1;DNMT3A;SESN2;XBP1;EGFR;AKT1;PTK6;SIPA1;TWF2;GNB1;RET;HSF1;ALDH1A2;SRC;FYN;WNT5B;BCL2L1;ADCY6
12640,GO:0050805,0.0807809587877965,0.968008956771036,7,36,negative regulation of synaptic transmission,BP,SHANK3;SHANK2;GNAI2;ASIC1;STXBP1;ADNP;SLC30A1
10387,GO:0043198,0.0808286849311311,0.974448599100429,5,22,dendritic shaft,CC,ZMYND8;DLG3;GIPC1;NTSR1;ARHGEF2
11554,GO:0046068,0.0808968388937128,0.974420623672097,5,22,cGMP metabolic process,BP,NOS1;ADCY7;APOE;ADNP;ADCY6
3744,GO:0008283,0.0813014310344139,0.931753422167419,154,1333,cell proliferation,BP,XDH;PGF;SH2D2A;TSPAN1;ERCC1;FAM83A;CCND1;F2R;MST1R;RAC2;CTNNBIP1;MAP2K1;SHC1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;MEF2D;SERPINE2;NR1D1;DLG1;IGFBP4;FKBP1A;RPS6KA2;RAPGEF3;PRNP;IDH2;LAMA5;FAM129B;NACC2;ETV5;LRP5;FBLN1;XBP1;MARCKSL1;EGFR;MMP14;LAMB1;ADARB1;FBXW8;AKT1;IFITM1;CARD11;GPC4;IRAK1;APOE;ARG2;PKN1;WWTR1;PRKCZ;CTSZ;EPHA1;PTK6;FBXO2;FERMT1;DEAF1;MSN;TGFBR2;SOX7;SIPA1;CCND2;TACC1;BIN1;FSCN1;HTRA1;PAK1;SP6;GLUL;GNB1;SATB1;LAMC2;PARP10;DLG3;GATA3;TP53I11;APLN;TCFL5;GNAI2;HSF1;APPL2;ALOX15B;ASPH;CTBP1;PTPRU;CDCA7L;HMGA2;NUMB;IGFBP2;MYDGF;CLEC11A;TNFRSF6B;EDNRA;ALDH1A2;SRC;TGM2;RERE;SPINT2;FYN;RAB25;ISG20;FUZ;TNFRSF1A;VDR;CGREF1;GJC2;GAL;ITGA1;EHF;COMT;EIF2S2;TIMP1;RNF187;HSF4;FGFR1;RREB1;HYAL1;MIF;BCL2L1;TCIRG1;HLCS;LRP1;ZNF609;PLCD3;PAK4;MXD4;HPSE;ZP3;PNP;FGF2;SLIT3;RXRA;ARG1;VEGFB;TGFA;NDE1;NCCRP1;CNOT11;HGS;GAS8;CIB1;KANK2;FURIN;ARHGEF2;CEACAM1;SKAP2;ECM1;TGFB1;CAMK2N1;ERBB3;ANXA1;ASH2L;RNF10
12170,GO:0048262,0.0813387408735314,0.991469954141525,2,5,determination of dorsal/ventral asymmetry,BP,DDIT3;AIDA
1173,GO:0002793,0.0814048019838858,0.94922251214829,22,155,positive regulation of peptide secretion,BP,F2R;PCK2;POSTN;XBP1;EGFR;HK1;ATP13A2;PRKCZ;FERMT1;NLGN2;GLUL;GATA3;APLN;GLUD1;ALOX15B;IL1RAP;ADAM8;SRC;MIF;APBB1;MAPK3;TGFB1
16222,GO:0090237,0.0814303576597004,0.991454709833147,2,5,regulation of arachidonic acid secretion,BP,NTSR1;MIF
20060,GO:2000647,0.0815531210368234,0.98417512237115,3,10,negative regulation of stem cell proliferation,BP,FBLN1;FERMT1;TGFB1
6815,GO:0030262,0.0817240841665345,0.973930138839753,5,23,apoptotic nuclear changes,BP,H1F0;SHARPIN;ENDOG;DEDD2;HSF1
16448,GO:0097067,0.081727219905951,0.984126813285414,3,10,cellular response to thyroid hormone stimulus,BP,CTSB;GAS2L1;CTSL
10694,GO:0043949,0.0818565437452094,0.978388667974383,4,16,regulation of cAMP-mediated signaling,BP,NOS1;CDC34;GSK3A;MGRN1
3081,GO:0006655,0.0819176658093221,0.984073913579309,3,10,phosphatidylglycerol biosynthetic process,BP,CDS2;TAZ;SLC27A1
15908,GO:0072656,0.0820850579384523,0.99134546299065,2,5,maintenance of protein location in mitochondrion,BP,HK1;AKT1
16121,GO:0090084,0.0821906069666812,0.98399799993353,3,10,negative regulation of inclusion body assembly,BP,SORL1;HSF1;HSPA2
732,GO:0001958,0.0822348515841128,0.978253862580032,4,16,endochondral ossification,BP,MEF2D;MMP14;COL13A1;GNAS
9475,GO:0036075,0.0822348515841128,0.978253862580032,4,16,replacement ossification,BP,MEF2D;MMP14;COL13A1;GNAS
4948,GO:0014911,0.0822790078330689,0.973851613132552,5,22,positive regulation of smooth muscle cell migration,BP,DOCK4;POSTN;SSH1;PAK1;SRC
9440,GO:0036003,0.0823429778965423,0.973673554265885,5,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,SESN2;ATF4;DDIT3;HSF1;HSF4
14049,GO:0060754,0.0823713276342024,0.991297523808352,2,5,positive regulation of mast cell chemotaxis,BP,PGF;VEGFB
2204,GO:0005086,0.082481832663999,0.978165726309921,4,16,ARF guanyl-nucleotide exchange factor activity,MF,PSD3;CYTH3;ARFGEF2;IQSEC1
9861,GO:0042098,0.0826196914569371,0.952876442423307,16,108,T cell proliferation,BP,RAC2;DLG1;FKBP1A;PRNP;CARD11;ARG2;MSN;TGFBR2;SATB1;IGFBP2;FYN;ZP3;PNP;ARG1;TGFB1;ANXA1
16780,GO:0098552,0.0826296553939931,0.942662062601528,35,263,side of membrane,CC,SDC1;SNX9;DLG4;SERPINE2;DLG1;FKBP1A;ITGA6;PRNP;MAP2K2;P4HB;GPC4;PTK6;PCSK9;TGFBR2;ESYT2;FARP1;GNB1;CYTH3;GNAI2;ANTXR2;SRC;LDLRAP1;NUCB1;RGS19;FYN;ITGA1;NTSR1;LITAF;MYZAP;HM13;CD59;ANXA1;GNAS;ITGA3;RASA3
8724,GO:0034363,0.0829030949355999,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8726,GO:0034365,0.0829030949355999,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8732,GO:0034371,0.0829030949355999,1,1,1,chylomicron remodeling,BP,APOE
11907,GO:0046911,0.0829030949355999,1,1,1,metal chelating activity,MF,APOE
16401,GO:0090731,0.0829030949355999,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17741,GO:1901630,0.0829030949355999,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18235,GO:1903000,0.0829030949355999,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18236,GO:1903002,0.0829030949355999,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19408,GO:1905853,0.0829030949355999,1,1,1,regulation of heparan sulfate binding,BP,APOE
19409,GO:1905855,0.0829030949355999,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19410,GO:1905858,0.0829030949355999,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19411,GO:1905860,0.0829030949355999,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19419,GO:1905890,0.0829030949355999,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17132,GO:0101003,0.0829442835735487,0.966862520481672,7,37,ficolin-1-rich granule membrane,CC,AP2A2;SERPINB6;ARL8A;SLC2A3;ADAM8;UBR4;TCIRG1
14954,GO:0070821,0.0829619299416965,0.964373149152932,8,44,tertiary granule membrane,CC,SERPINB6;STOM;ATP11A;SLC2A3;ADAM8;UBR4;CEACAM1;CD59
17489,GO:1900273,0.0831496706232185,0.983730326890518,3,10,positive regulation of long-term synaptic potentiation,BP,CRTC1;SHANK3;EPHB2
4970,GO:0015077,0.0835010877731896,0.947129393361324,23,166,monovalent inorganic cation transmembrane transporter activity,MF,KCNG1;SCN8A;SLC2A9;SLC12A7;SLC20A1;TMCO3;ASIC1;SLC12A4;SLC6A6;SLC13A3;NDUFA4L2;SLC6A9;SLC33A1;SLC13A5;ATP2C2;TCIRG1;SLC6A14;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;SLC15A1;SLC45A3
5006,GO:0015149,0.0835012341036588,0.983631845566519,3,10,hexose transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC5A1
3429,GO:0007219,0.0835100232613974,0.949815304408798,19,129,Notch signaling pathway,BP,CHAC1;NEURL1;POSTN;FAM129B;EGFR;MMP14;EPN1;EPN2;PEAR1;RFNG;TGFBR2;ARRDC1;TSPAN5;MIB2;MFNG;NEURL1B;LLGL1;TGFB1;EP300
12623,GO:0050780,0.0836404830852127,0.98359278524058,3,10,dopamine receptor binding,MF,DLG4;DNM2;GNAS
7952,GO:0032541,0.0837611892254528,0.991063302805461,2,5,cortical endoplasmic reticulum,CC,ASPH;STIM1
14796,GO:0070486,0.0838280118705616,0.983161849437242,3,11,leukocyte aggregation,BP,RAC2;MSN;CD44
12242,GO:0048484,0.0838491231280115,0.991048402088477,2,5,enteric nervous system development,BP,RET;EDNRA
11162,GO:0045198,0.0840634406018991,0.983473957258323,3,10,establishment of epithelial cell apical/basal polarity,BP,MSN;SH3BP1;CAMSAP3
1263,GO:0003014,0.084085052820329,0.959763535980261,10,58,renal system process,BP,F2R;BCR;ADCY7;PRKACA;PKN1;PRKACB;WFS1;COMT;ADCY6;ITGA3
11218,GO:0045334,0.0841428601522165,0.966268158649855,7,37,clathrin-coated endocytic vesicle,CC,EGFR;EPN2;APOE;AP2A2;CEMIP;LDLRAP1;DNM2
33,GO:0000062,0.084337214637192,0.977276811310885,4,17,fatty-acyl-CoA binding,MF,ACOT7;HMGCL;ACBD4;ACADVL
16931,GO:0098876,0.0845780184586274,0.957789015623993,11,66,vesicle-mediated transport to the plasma membrane,BP,BBS2;RAB31;OSBPL5;SDCCAG3;VAMP2;DNM2;EXOC2;ARFGEF2;SNX27;LLGL1;ARHGAP44
15574,GO:0072001,0.0847389587108677,0.94422239459978,27,192,renal system development,BP,PGF;ITGB4;CTNNBIP1;SDC1;DLG1;ITGA6;LAMA5;ACVR2B;ACTA2;ARG2;WWTR1;PCSK9;LAMB2;SEC63;PODXL;RET;NID1;PKD1;GATA3;WFS1;ARID5B;ALDH1A2;FGFR1;FGF2;TGFB1;CAT;ITGA3
19743,GO:2000052,0.0848144795667694,0.983262270181748,3,10,positive regulation of non-canonical Wnt signaling pathway,BP,CSNK1E;DKK1;CSNK1D
7947,GO:0032530,0.0848152048235454,0.983262065338097,3,10,regulation of microvillus organization,BP,TWF2;FSCN1;PODXL
17881,GO:1902047,0.0848878662405504,0.990871646626224,2,5,polyamine transmembrane transport,BP,ATP13A2;AZIN2
545,GO:0001664,0.0849989449497404,0.949531233060458,18,125,G-protein coupled receptor binding,MF,ITGB4;DVL1;WNT7A;ARAP1;DLG4;PRNP;USP20;GNB1;REEP2;APLN;GNAI2;DNM2;FYN;WNT5B;GAL;STUB1;HOMER2;GNAS
2054,GO:0004801,0.0852057987044914,1,1,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,TALDO1
20220,GO:2001033,0.0852781752765291,0.990804879940977,2,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HSF1;HMGA2
982,GO:0002433,0.0853953160920367,0.959015388476979,10,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,ARPC1A;LIMK1;WASF2;PLCG1;PAK1;SRC;FYN;WIPF1;MAPK3;PIK3R2
9708,GO:0038096,0.0853953160920367,0.959015388476979,10,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,ARPC1A;LIMK1;WASF2;PLCG1;PAK1;SRC;FYN;WIPF1;MAPK3;PIK3R2
8359,GO:0033211,0.0857308948726721,0.990727197767559,2,5,adiponectin-activated signaling pathway,BP,ADIPOR1;SLC27A1
1936,GO:0004632,0.0858223634478556,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
4561,GO:0010640,0.0858485390854951,0.97695432506047,4,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,SRC;PTPN12;LRP1;HGS
12581,GO:0050714,0.0858532593523623,0.94675465257256,21,147,positive regulation of protein secretion,BP,F2R;PCK2;POSTN;XBP1;EGFR;HK1;ATP13A2;PRKCZ;FERMT1;NLGN2;GLUL;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;SRC;MIF;APBB1;MAPK3;TGFB1
19333,GO:1905564,0.0858651127925914,0.982964671678987,3,10,positive regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1;FGF2
11148,GO:0045178,0.0859821500437113,0.96543676418233,7,36,basal part of cell,CC,MST1R;ITGA6;EGFR;LDLRAP1;ITGA1;CEACAM1;ERBB3
6766,GO:0030195,0.0859955880752502,0.968404515936184,6,30,negative regulation of blood coagulation,BP,PLAT;SERPINE2;SERPING1;APOE;F12;CEACAM1
17380,GO:1900047,0.0859955880752502,0.968404515936184,6,30,negative regulation of hemostasis,BP,PLAT;SERPINE2;SERPING1;APOE;F12;CEACAM1
3772,GO:0008324,0.086011465792951,0.938580285941813,40,308,cation transmembrane transporter activity,MF,SERINC2;KCNG1;SCN8A;SLC2A9;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;PKD1;NIPA1;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;NDUFA4L2;NCS1;TMEM44;SLC6A9;SLC33A1;SLC13A5;ATP2C2;TCIRG1;TPCN1;SLC6A14;P2RX4;SLC10A6;ATP6V1C2;KCNC4;SLC5A1;SLC30A1;SLC15A1;AZIN2;SLC45A3;ORAI3;RASA3
11897,GO:0046889,0.0860252335130753,0.962761913885718,8,44,positive regulation of lipid biosynthetic process,BP,NR1D1;AKT1;APOE;TNFRSF1A;SMPD3;ZP3;ANXA1;SLC45A3
13790,GO:0060348,0.0863632445314721,0.948712071064528,18,119,bone development,BP,MEF2D;LRP5;MMP14;COL13A1;FAM20C;SH3PXD2B;TGFBR2;WASF2;SLC38A10;ZNF385A;TULP3;SRC;ZFPM1;LRRK1;TGFB1;GNAS;EP300;THBS3
10230,GO:0042886,0.0865621407174407,0.926516210199999,172,1533,amide transport,BP,EDEM1;LTBP2;SH3TC2;F2R;RAC2;LTBP4;SORL1;SNX9;AP3D1;LMF1;PCK2;NR1D1;XPOT;PITPNM1;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;RAB43;COPG1;BBS2;BCR;RAB31;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;FERMT1;SEC23A;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;PAK1;NLGN2;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;GATA3;APLN;DOPEY2;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;GIPC1;SRC;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;KIF17;KIF13B;STX10;GAL;MCFD2;PLTP;SEC24C;RRBP1;GUK1;MIF;VPS37A;PRAF2;TCIRG1;SNX25;ARFIP2;ARFGEF2;UNC119B;LRP1;USO1;SMPD3;SPIRE1;PNP;COG1;CHD7;APBB1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;TGFB1;SLC15A1;PIK3R2;ANXA1;PPP1R10;RAB6A;ARCN1
15141,GO:0071214,0.0866120202952763,0.941078974599803,31,230,cellular response to abiotic stimulus,BP,ERCC1;NFATC4;NET1;BNIP3;EGFR;ATF4;AKT1;XPC;BAG3;MAPK13;SERPINB6;STK39;SIPA1;MC1R;CCND2;GNB1;GATA3;ASIC1;HSF1;HMGA2;DNM2;HIST3H2A;TNFRSF1A;HYAL1;BCL2L1;DDB2;IMPACT;MAPK3;ARHGEF2;TGFB1;EP300
17208,GO:0104004,0.0866120202952763,0.941078974599803,31,230,cellular response to environmental stimulus,BP,ERCC1;NFATC4;NET1;BNIP3;EGFR;ATF4;AKT1;XPC;BAG3;MAPK13;SERPINB6;STK39;SIPA1;MC1R;CCND2;GNB1;GATA3;ASIC1;HSF1;HMGA2;DNM2;HIST3H2A;TNFRSF1A;HYAL1;BCL2L1;DDB2;IMPACT;MAPK3;ARHGEF2;TGFB1;EP300
14151,GO:0060997,0.086612056095183,0.965122363264768,7,36,dendritic spine morphogenesis,BP,DVL1;WNT7A;DLG4;SHANK3;SHANK2;EPHB2;ARHGAP44
5187,GO:0015748,0.08663421806485,0.956536051476408,11,67,organophosphate ester transport,BP,PITPNC1;PITPNM1;OSBPL10;APOE;OSBPL5;ATP11A;CPTP;PLTP;PITPNM2;ABCA7;STARD10
13927,GO:0060558,0.0867021771538931,0.990559669032979,2,5,regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1;VDR
2322,GO:0005328,0.0869146774118172,0.982665673398436,3,10,neurotransmitter:sodium symporter activity,MF,SLC6A6;SLC6A9;SLC6A14
1935,GO:0004631,0.086949324658314,1,1,1,phosphomevalonate kinase activity,MF,PMVK
7704,GO:0032156,0.0869501104909801,0.982655549679177,3,10,septin cytoskeleton,CC,SEPT10;SEPT5;SEPT8
18663,GO:1903936,0.0869530660431894,0.990516203434735,2,5,cellular response to sodium arsenite,BP,MAPK13;HSF1
331,GO:0000921,0.0870737212318502,0.982620217275403,3,10,septin ring assembly,BP,SEPT10;SEPT5;SEPT8
6666,GO:0030017,0.0870884059671461,0.949969230895811,16,107,sarcomere,CC,FLNC;NOS1;SCN8A;OBSCN;FKBP1A;TMOD2;TNNT1;PARVB;BAG3;OBSL1;BIN1;PAK1;FLNB;STUB1;LMAN1;MYZAP
4558,GO:0010637,0.0870922052242723,0.990492064173008,2,5,negative regulation of mitochondrial fusion,BP,BNIP3;VAT1
5378,GO:0016188,0.087220280481547,0.990469823023999,2,5,synaptic vesicle maturation,BP,DLG4;STXBP1
6357,GO:0021535,0.0872329917291144,0.982574657414339,3,10,cell migration in hindbrain,BP,TTBK2;RERE;SOCS7
11753,GO:0046554,0.0872383574135472,1,1,1,malate dehydrogenase (NADP+) activity,MF,MDH2
10576,GO:0043525,0.0873489156868137,0.964585744864763,7,38,positive regulation of neuron apoptotic process,BP,PRNP;ATF4;CTSZ;PCSK9;CDC34;DDIT3;ITGA1
885,GO:0002248,0.0874438225472745,0.990430954353573,2,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R;TGFB1
9054,GO:0035264,0.0876518784563758,0.949639841825577,16,105,multicellular organism growth,BP,ERCC1;ERCC6;BBS2;ADARB1;PPP1R13L;WWTR1;SH3PXD2B;WDTC1;GAMT;HSF1;RAI1;ARID5B;SOCS2;CHD7;APBA1;GNAS
4844,GO:0014048,0.0876971966370152,0.990386823228619,2,5,regulation of glutamate secretion,BP,STXBP1;NTSR1
5804,GO:0017053,0.0877058180891715,0.954423898204968,12,73,transcriptional repressor complex,CC,CCND1;NACC2;SALL2;CORO2A;TNRC18;BAZ2A;APPL2;CTBP1;ZFPM1;RCOR1;BAHCC1;MBD3
4234,GO:0009411,0.087747963055772,0.947707832653114,18,123,response to UV,BP,ERCC1;CCND1;NFATC4;ERCC6;EGFR;ATF4;AKT1;XPC;MAPK13;MC1R;HIST3H2A;PRIMPOL;BRSK1;HYAL1;DDB2;IMPACT;CAT;EP300
10039,GO:0042474,0.0878692110820644,0.981989326561643,3,11,middle ear morphogenesis,BP,NAGLU;FGFR1;TSHZ1
5861,GO:0017157,0.0879020896890666,0.947620487926741,18,122,regulation of exocytosis,BP,RAC2;SDC1;RAB3B;BCR;ATP13A2;VPS4A;SEPT5;SYTL1;VAMP2;NCS1;STXBP1;MICAL1;SMPD3;ZP3;HGS;LLGL1;CEACAM1;ANXA1
11794,GO:0046637,0.0879951583482975,0.967471638174677,6,30,regulation of alpha-beta T cell differentiation,BP,AP3D1;PRKCZ;TGFBR2;GATA3;PNP;ANXA1
7205,GO:0031089,0.088037134266529,0.990327489293381,2,5,platelet dense granule lumen,CC,LGALS3BP;ECM1
15179,GO:0071280,0.0880656772436025,0.981603042764476,3,12,cellular response to copper ion,BP,PRNP;HSF1;MT2A
1709,GO:0004222,0.0882368350889554,0.957384393319217,10,58,metalloendopeptidase activity,MF,ADAM19;MMP1;MMP14;PITRM1;IDE;MMP10;ADAMTS7;ADAM8;THOP1;ADAM15
2991,GO:0006536,0.0883319786785003,0.971158169164903,5,23,glutamate metabolic process,BP,NAGS;GLUL;GLUD1;ALDH4A1;GGT1
44,GO:0000096,0.0883346187817901,0.96731263913795,6,30,sulfur amino acid metabolic process,BP,CBS;AHCY;BLMH;COMT;GGT1;PCYOX1
9127,GO:0035418,0.0883742816851943,0.971140195445927,5,23,protein localization to synapse,BP,DVL1;WNT7A;DLG4;NLGN2;ARHGAP44
9601,GO:0036445,0.0884676909019234,0.982220148116493,3,10,neuronal stem cell division,BP,NUMB;FGFR1;ARHGEF2
13516,GO:0055057,0.0884676909019234,0.982220148116493,3,10,neuroblast division,BP,NUMB;FGFR1;ARHGEF2
5924,GO:0018196,0.0885293767580707,0.963913097644438,7,39,peptidyl-asparagine modification,BP,SYVN1;UBE2J1;MCFD2;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1
20059,GO:2000646,0.0886151708806565,0.990226266317854,2,5,positive regulation of receptor catabolic process,BP,APOE;PCSK9
3528,GO:0007512,0.0887907174793811,0.990195443157369,2,5,adult heart development,BP,MEF2D;CHD7
2090,GO:0004852,0.0888366908317584,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15268,GO:0071418,0.0888366908317584,1,1,1,cellular response to amine stimulus,BP,UROS
15987,GO:0080058,0.0888979840509024,1,1,1,protein deglutathionylation,BP,GLRX
16688,GO:0097573,0.0888979840509024,1,1,1,glutathione oxidoreductase activity,MF,GLRX
4332,GO:0009855,0.0889147276550628,0.953651605281167,12,74,determination of bilateral symmetry,BP,ACVR2B;AP1B1;TGFBR2;SUFU;DDIT3;MICAL2;ALDH1A2;PCSK6;PSKH1;BICC1;GAS8;AIDA
15028,GO:0070940,0.0889598691872266,0.990165706597174,2,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,SSU72;RPRD1A
6040,GO:0019118,0.0890202529036539,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6041,GO:0019119,0.0890202529036539,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
9978,GO:0042356,0.0890202529036539,1,1,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,TSTA3
12521,GO:0050577,0.0890202529036539,1,1,1,GDP-L-fucose synthase activity,MF,TSTA3
2608,GO:0005911,0.0890433425786214,0.93625794982928,40,301,cell-cell junction,CC,SH3KBP1;CCND1;DLG1;ITGA6;PDZD2;PCDH1;MAP2K2;AKT1;COL13A1;PRKCZ;SYMPK;OBSL1;WASF2;PLCG1;FSCN1;PAK1;PODXL;CYTH3;DLG3;CADM4;FAT1;PTPRU;CDC42BPB;SDCCAG8;SPECC1L;SH3BP1;PLEKHG5;GJC2;UBA1;PAK4;VASP;CAMSAP3;BAIAP2L1;KIFC3;ARHGEF2;CEACAM1;STARD10;ANXA1;CLDN12;FHOD1
8468,GO:0033599,0.0890530320447535,0.975545014874997,4,17,regulation of mammary gland epithelial cell proliferation,BP,CCND1;DEAF1;GATA3;RREB1
10834,GO:0044317,0.0892635166762106,1,1,1,rod spherule,CC,REEP6
1790,GO:0004415,0.0895483251917444,0.990061980240429,2,5,hyalurononglucosaminidase activity,MF,CEMIP;HYAL1
9381,GO:0035897,0.0895539123262825,0.990060993343795,2,5,proteolysis in other organism,BP,MAP2K1;MAP2K2
14683,GO:0070273,0.0897160404351174,0.970568626536875,5,23,phosphatidylinositol-4-phosphate binding,MF,SH3PXD2B;OSBPL5;GSDMA;ARFIP2;GSDMC
2606,GO:0005903,0.0898310821273724,0.956416447428426,10,59,brush border,CC,ESPN;ITPR3;SHANK2;FLNB;GIPC1;RGS19;RALGDS;SLC6A14;MYO1D;SLC15A1
628,GO:0001809,0.0898344180714365,1,1,1,positive regulation of type IV hypersensitivity,BP,ZP3
19931,GO:2000387,0.0898344180714365,1,1,1,regulation of antral ovarian follicle growth,BP,ZP3
19932,GO:2000388,0.0898344180714365,1,1,1,positive regulation of antral ovarian follicle growth,BP,ZP3
8030,GO:0032660,0.0898991599322775,0.981390742513824,3,11,regulation of interleukin-17 production,BP,PRNP;ARG2;TGFB1
6957,GO:0030579,0.0899216615691536,0.989995949954673,2,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF2;STUB1
12931,GO:0051258,0.0900443825733495,0.939800392582123,28,207,protein polymerization,BP,RAC2;DLG1;TMOD2;CORO1B;TUBG2;ARPC1A;TMSB4X;EML2;MSRB2;TWF2;PAK1;CORO7;ARL2;CAPG;DNM2;PFN1;TUBG1;ARFIP2;SPIRE1;VASP;EPS8L1;NDE1;CAMSAP3;BAIAP2L1;WIPF1;TMSB10;KANK2;CSNK1D
2982,GO:0006526,0.0900521207374519,0.989972835502915,2,5,arginine biosynthetic process,BP,NAGS;ASS1
16500,GO:0097165,0.0900545352842423,0.98997240750034,2,5,nuclear stress granule,CC,SYMPK;HSF1
16455,GO:0097090,0.090131107522531,0.989958830558818,2,5,presynaptic membrane organization,BP,APOE;NLGN2
765,GO:0002009,0.0901557228179207,0.932945019893,50,394,morphogenesis of an epithelium,BP,PGF;CTNNBIP1;NFATC4;DVL1;WNT7A;DLG1;PSMD2;LAMA5;SMURF2;ETV5;LRP5;EGFR;MMP14;GPC4;AP2A2;CTSZ;DEAF1;MSN;TGFBR2;DKK1;PRKACB;CD44;SUFU;PAK1;PODXL;RET;RHOC;PKD1;DLG3;GATA3;MICAL2;EDNRA;TULP3;ALDH1A2;SRC;TGM2;SH3BP1;SPINT2;FUZ;PFN1;PSMD7;VDR;FGFR1;RREB1;FGF2;VASP;RXRA;CAMSAP3;CEACAM1;TGFB1
16147,GO:0090129,0.090184533663266,0.989949353325094,2,5,positive regulation of synapse maturation,BP,ADGRL1;NEURL1
6760,GO:0030178,0.0902857489885637,0.943565494300796,21,154,negative regulation of Wnt signaling pathway,BP,MDFI;CCND1;CTNNBIP1;NFATC4;DVL1;IGFBP4;PSMD2;APOE;WWTR1;FERMT1;DKK1;DDIT3;GRB10;IGFBP2;GSK3A;FUZ;WNT5B;PSMD7;LRP1;BICC1;INVS
8505,GO:0033676,0.090307635162186,1,1,1,double-stranded DNA-dependent ATPase activity,MF,ANXA1
14814,GO:0070524,0.0904102252031402,1,1,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,HSD11B1
17512,GO:1900425,0.0904825364345723,0.989896425932854,2,5,negative regulation of defense response to bacterium,BP,ARG2;MAPKBP1
1051,GO:0002576,0.0904842195797885,0.952622793910963,12,76,platelet degranulation,BP,QSOX1;SERPING1;TMSB4X;APLP2;STXBP1;BRPF3;TIMP1;LGALS3BP;VEGFB;ECM1;TGFB1;MANF
14152,GO:0060998,0.090493456462132,0.958081919185457,9,51,regulation of dendritic spine development,BP,ZMYND8;NEURL1;PTPRS;SHANK3;APOE;SHANK2;CAMK1;ARHGAP44;ASAP1
7064,GO:0030837,0.0905311225351107,0.962977765322521,7,38,negative regulation of actin filament polymerization,BP,TMOD2;TMSB4X;TWF2;CAPG;PFN1;TMSB10;KANK2
3745,GO:0008284,0.0905984564718001,0.929874610529763,66,543,positive regulation of cell proliferation,BP,PGF;CCND1;F2R;MST1R;RAC2;SHC1;WNT7A;PTHLH;CST3;MEF2D;DLG1;NACC2;ETV5;LRP5;XBP1;MARCKSL1;EGFR;LAMB1;AKT1;CARD11;IRAK1;WWTR1;PRKCZ;CTSZ;EPHA1;TGFBR2;CCND2;HTRA1;PAK1;SP6;GLUL;LAMC2;APLN;GNAI2;HSF1;CDCA7L;HMGA2;IGFBP2;MYDGF;CLEC11A;ALDH1A2;TGM2;RAB25;GJC2;TIMP1;RNF187;HSF4;FGFR1;RREB1;HYAL1;MIF;BCL2L1;TCIRG1;HPSE;ZP3;PNP;FGF2;ARG1;VEGFB;TGFA;NCCRP1;CIB1;ECM1;TGFB1;ANXA1;ASH2L
3518,GO:0007492,0.0906182572574595,0.956008638978857,10,58,endoderm development,BP,ITGB5;MMP14;LAMB1;DKK1;SOX7;DUSP4;HMGA2;DUSP6;LAMB3;TGFB1
5067,GO:0015279,0.0906329717417832,0.989869665809518,2,5,store-operated calcium channel activity,MF,ORAI1;ORAI3
11887,GO:0046879,0.0906553040168539,0.941455056825604,24,173,hormone secretion,BP,LTBP4;PCK2;NR1D1;RAPGEF3;FAM129B;LRP5;ACVR2B;MAP4K4;EGFR;ITPR3;HADH;NLGN2;GLUL;GATA3;APLN;GLUD1;ARL2;SCG5;GAL;FGFR1;SMPD3;CHD7;ANXA1;GNAS
7934,GO:0032504,0.0906627884389573,0.931050393567693,58,465,multicellular organism reproduction,BP,ERCC1;CYP27B1;NEURL1;SERPINE2;BSG;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;CTSB;BBS2;OSBP2;ETV5;ADCY7;MYCBPAP;EGFR;RFX2;PRKACA;FAM50A;AKT1;PHC2;SH3PXD2B;DEAF1;EPOR;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;SRC;DNM2;AGO4;PAQR7;VDR;PUM1;RAI14;COMT;THRA;EIF2S2;ADNP;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;SLIT3;RXRA;ARG1;NDRG3;SPESP1;GGT1;CIB1;PAIP2;TGFB1;AZIN2;ANXA1;ITGA3
20025,GO:2000587,0.090736613250093,0.989851213291763,2,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
9104,GO:0035360,0.0908047088544774,0.989839082197097,2,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;STARD10
7936,GO:0032507,0.0908146707317142,0.955754997003179,10,61,maintenance of protein location in cell,BP,SORL1;SYNE3;HK1;AKT1;TMSB4X;KDELR1;TWF2;ARL2;FLNB;TMSB10
16829,GO:0098656,0.0908886013497431,0.942576349053832,22,153,anion transmembrane transport,BP,CPT2;SLC16A3;PRNP;TTYH3;SLC12A7;AKT1;SLC20A1;STK39;SLC38A10;SLC12A4;SLC6A6;SLC13A3;SLC43A1;SLC6A9;SLC13A5;NTSR1;SLC35B4;LRRC8A;PRAF2;SLC6A14;CPT1B;PCYOX1
11675,GO:0046415,0.0909098063587475,0.989820348033853,2,5,urate metabolic process,BP,SLC2A9;PNP
11808,GO:0046658,0.0909602279394504,0.969881545258268,5,24,anchored component of plasma membrane,CC,PRNP;GPC4;PRSS8;NTNG1;CD59
7572,GO:0031915,0.0910707685437267,0.989791629235494,2,5,positive regulation of synaptic plasticity,BP,SSH1;EPHB2
7533,GO:0031748,0.0910739980202504,0.989791052706097,2,5,D1 dopamine receptor binding,MF,DLG4;GNAS
18202,GO:1902947,0.0912400437434956,0.989761392690523,2,5,regulation of tau-protein kinase activity,BP,SORL1;DKK1
4964,GO:0015037,0.0913650477876168,0.980609329351069,3,12,peptide disulfide oxidoreductase activity,MF,P4HB;PDIA5;GLRX
12567,GO:0050700,0.091450480745753,0.980929009080912,3,11,CARD domain binding,MF,CARD11;CARD19;CASP4
1486,GO:0003785,0.0915191484956834,0.974408540704306,4,18,actin monomer binding,MF,TMSB4X;TWF2;PFN1;TMSB10
4780,GO:0010963,0.0915447096274432,1,1,1,regulation of L-arginine import,BP,ARG1
15033,GO:0070947,0.0915447096274432,1,1,1,neutrophil mediated killing of fungus,BP,ARG1
15038,GO:0070953,0.0915447096274432,1,1,1,regulation of neutrophil mediated killing of fungus,BP,ARG1
15043,GO:0070965,0.0915447096274432,1,1,1,positive regulation of neutrophil mediated killing of fungus,BP,ARG1
20006,GO:2000552,0.0915447096274432,1,1,1,negative regulation of T-helper 2 cell cytokine production,BP,ARG1
1236,GO:0002921,0.0915948808641253,0.98969789555571,2,5,negative regulation of humoral immune response,BP,SERPING1;CD59
7789,GO:0032309,0.0916982711683567,0.974557944599742,4,17,icosanoid secretion,BP,NTSR1;MIF;P2RX4;ANXA1
10454,GO:0043301,0.0917681924753431,0.98966682541943,2,5,negative regulation of leukocyte degranulation,BP,BCR;CEACAM1
12548,GO:0050673,0.0920023192229934,0.935858014992864,34,257,epithelial cell proliferation,BP,XDH;PGF;CCND1;MAP2K1;WNT7A;NR1D1;DLG1;IGFBP4;XBP1;EGFR;MMP14;LAMB1;AKT1;APOE;FERMT1;DEAF1;HTRA1;GLUL;GATA3;APLN;MYDGF;ALDH1A2;VDR;EHF;FGFR1;RREB1;HYAL1;FGF2;ARG1;VEGFB;TGFA;CEACAM1;ECM1;TGFB1
5972,GO:0018401,0.0920312927900628,0.98961958774782,2,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,P4HB;P4HA1
4599,GO:0010712,0.0920383293969348,0.969415950144357,5,24,regulation of collagen metabolic process,BP,F2R;CST3;CYGB;LARP6;TGFB1
18890,GO:1904502,0.0921717869264531,0.989594328129861,2,5,regulation of lipophagy,BP,SESN2;SPTLC2
18891,GO:1904504,0.0921717869264531,0.989594328129861,2,5,positive regulation of lipophagy,BP,SESN2;SPTLC2
6423,GO:0021683,0.0922054505271022,0.989588272095406,2,5,cerebellar granular layer morphogenesis,BP,WNT7A;SERPINE2
16144,GO:0090118,0.0922570984684828,0.989578977988318,2,5,receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9;LDLRAP1
15283,GO:0071440,0.0923383454736496,0.989564350843014,2,5,regulation of histone H3-K14 acetylation,BP,GATA3;WBP2
12333,GO:0048668,0.0924698960198065,0.974267921499543,4,17,collateral sprouting,BP,DVL1;PTPRS;LPAR3;ULK2
16433,GO:0097049,0.0925959324584937,0.989517922919087,2,5,motor neuron apoptotic process,BP,ADARB1;MAP3K12
12746,GO:0050974,0.0927409802431361,0.989491743299541,2,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;FYN
6176,GO:0019538,0.0928347663381093,0.917110651528138,454,4213,protein metabolic process,BP,TNIP1;EDEM1;XDH;BTBD2;ZMYND8;NOS1;ADAM19;CHAC1;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;ERCC6;CST3;NEURL1;SNX9;LMF1;BOK;SHARPIN;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;IFI6;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;PTPRS;PRSS3;PRNP;BNIP3;SBF1;SSH1;SCYL1;CRTAP;SMURF2;MAPKAPK3;CTSB;SESN2;ABTB1;RNPEPL1;LY6K;MARCH9;FKBP9;USP20;NACC2;BCR;CHPF;LPCAT1;VLDLR;MARK4;LRP5;AARS;ACVR2B;FBLN1;XYLT1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;LAMB1;PRKACA;ADARB1;PTPRF;CARS;JOSD2;RHBDF2;MAP2K2;XYLT2;STK25;SHANK3;MIER2;ATF4;P4HB;HECW2;FBXW8;SNX33;MRPS6;AKT1;MDH2;CARD11;IRAK1;SERPING1;APOE;ATP13A2;PKN1;SYVN1;WWTR1;PHF21A;NPEPL1;RABGGTA;AP2A2;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;VPS11;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;TYSND1;RRAS;MSN;PPP1R35;TGFBR2;LAMB2;NDST2;MVB12B;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;PRSS8;SYMPK;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;SCRN1;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;JADE2;ANKIB1;LARP6;PRDX5;CCND2;TSPAN5;BIN1;HTRA1;SUFU;CCDC88C;PAK1;TTBK2;ERO1B;MMP10;ZNF385A;UBXN7;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RASGEF1A;FBXL6;IFI27;HLTF;CEMIP;PKD1;PARP10;DLG3;GATA3;PIGQ;PHF1;UBXN4;DCAF7;ANO8;GNAI2;PPM1M;HSF1;SIN3B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;CTBP1;PTPRU;ADAM8;TFPI2;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;IGFBP2;P4HA1;MYDGF;B4GALT2;EIF4EBP1;GIPC1;TNFRSF6B;B3GNT3;SRC;LDLRAP1;APLP2;MBD6;KDM4B;GLRX;SCG5;FKBP10;PEX10;TGM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;PAK6;STX5;GARS;GSK3A;SPINT2;PCSK6;DUSP6;FYN;MPI;PPM1F;TMPRSS11D;ZNF862;LPAR3;RMND5A;PSMD7;MICAL1;TNFRSF1A;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;TSPAN33;BRSK1;SSU72;CHST14;GJC2;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;TNRC6B;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;UBA1;RNF187;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;MIF4GD;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;MFNG;CDK18;MIF;SOCS2;MTMR4;ASB13;VPS37A;STUB1;PCSK1N;STK17A;ST3GAL3;TRIB3;DDB2;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ULK1;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;MGRN1;HPSE;SAMD4B;ULK2;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;PYM1;RCOR1;MAP3K12;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;RXRA;SPSB3;VEGFB;NEURL1B;TGFA;RPL28;CNOT11;IMPACT;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;GGT1;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DNAJB9;FURIN;ARHGEF2;RNF103;AIDA;B4GALT6;MATN3;ADAM15;HM13;CEACAM1;PAIP2;GALNT3;MINK1;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;TGFB1;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;PLGRKT;ASPHD1;EP300;ERP44;WDFY2;RASA3;TRAF7;RNF10
10213,GO:0042816,0.0928676759995797,0.989468854842994,2,5,vitamin B6 metabolic process,BP,PSAT1;AOX1
8352,GO:0033197,0.0929124084273782,0.980490507869313,3,11,response to vitamin E,BP,CCND1;ARG1;CAT
12459,GO:0050104,0.0929449648449674,1,1,1,L-gulonate 3-dehydrogenase activity,MF,CRYL1
2627,GO:0005952,0.092949055992898,0.989454142571716,2,5,cAMP-dependent protein kinase complex,CC,PRKACA;PRKACB
6665,GO:0030016,0.0929805624106162,0.944133882566322,18,124,myofibril,CC,FLNC;NOS1;SCN8A;OBSCN;FKBP1A;TMOD2;TNNT1;PARVB;BAG3;OBSL1;TWF2;BIN1;PAK1;MYH15;FLNB;STUB1;LMAN1;MYZAP
10422,GO:0043250,0.0929983687815992,1,1,1,sodium-dependent organic anion transmembrane transporter activity,MF,SLC10A6
10423,GO:0043251,0.0929983687815992,1,1,1,sodium-dependent organic anion transport,BP,SLC10A6
1793,GO:0004419,0.0930117018034716,1,1,1,hydroxymethylglutaryl-CoA lyase activity,MF,HMGCL
16430,GO:0097039,0.0930892071954856,0.989428786258925,2,5,protein linear polyubiquitination,BP,RBCK1;SHARPIN
19531,GO:1990351,0.0931815911638686,0.944032077476948,18,122,transporter complex,CC,NOS1;KCNG1;SCN8A;DLG4;DLG1;FKBP1A;TTYH3;PRKACA;SHANK3;ABCB8;SHANK2;DLG3;GRIN3B;VAMP2;LRRC8A;HSPA2;ABCA7;KCNC4
17233,GO:0106070,0.0933456096630417,0.989382335123226,2,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;GSK3A
13101,GO:0051590,0.0933470438014201,0.973937097105009,4,17,positive regulation of neurotransmitter transport,BP,RAB3B;APLN;STXBP1;NTSR1
17516,GO:1900451,0.0933622048034666,0.989379325881197,2,5,positive regulation of glutamate receptor signaling pathway,BP,SHANK3;EPHB2
18649,GO:1903909,0.0934911078443938,0.989355940018181,2,5,regulation of receptor clustering,BP,SSH1;TGFB1
14707,GO:0070314,0.0935103017716285,0.989352456068905,2,5,G1 to G0 transition,BP,CYP27B1;RAB11FIP4
12602,GO:0050750,0.0935415534709278,0.973863572230118,4,17,low-density lipoprotein particle receptor binding,MF,APOE;PCSK9;DKK1;LDLRAP1
9488,GO:0036114,0.0937209567653024,1,1,1,medium-chain fatty-acyl-CoA catabolic process,BP,ACOT7
9489,GO:0036115,0.0937209567653024,1,1,1,fatty-acyl-CoA catabolic process,BP,ACOT7
9490,GO:0036116,0.0937209567653024,1,1,1,long-chain fatty-acyl-CoA catabolic process,BP,ACOT7
17521,GO:1900533,0.0937209567653024,1,1,1,palmitic acid metabolic process,BP,ACOT7
17522,GO:1900535,0.0937209567653024,1,1,1,palmitic acid biosynthetic process,BP,ACOT7
4062,GO:0009110,0.0937751168900476,0.973775206607657,4,17,vitamin biosynthetic process,BP,CYP27B1;PSAT1;VDR;PLTP
11682,GO:0046439,0.0939264329439155,0.989276811568234,2,5,L-cysteine metabolic process,BP,CBS;AHCY
13051,GO:0051482,0.0939822278454653,0.980167554820231,3,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;TGM2;LPAR3
10695,GO:0043950,0.0940241470403959,0.989259018238905,2,5,positive regulation of cAMP-mediated signaling,BP,NOS1;GSK3A
7212,GO:0031098,0.0940671879978138,0.935476561246958,31,230,stress-activated protein kinase signaling cascade,BP,XDH;MAP2K1;WNT7A;ERCC6;DLG1;MAP4K4;EGFR;MAP2K2;STK25;AKT1;IRAK1;PKN1;MAPK13;FZD8;STK39;DKK1;MAP3K9;CCDC88C;PAK1;STK24;PAK6;MAP3K10;PAK4;TNFRSF19;MAPK9;MAP3K12;TAOK1;MAPK3;MAPK10;AIDA;MINK1
17273,GO:0120032,0.0941239269085772,0.94337009382639,18,123,regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;RAC2;NEURL1;ARAP1;SSH1;ESPN;EVI5L;WASF2;TWF2;FSCN1;PODXL;DNM2;FUZ;AGRN;PFN1;TENM2;EPS8L1;WRAP73
13098,GO:0051586,0.0941439351758499,1,1,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13281,GO:0051944,0.0941439351758499,1,1,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
1562,GO:0003958,0.0944483787450734,0.989181631601269,2,5,NADPH-hemoprotein reductase activity,MF,NOS1;NDOR1
951,GO:0002367,0.0944754506882392,0.955674869425743,9,54,cytokine production involved in immune response,BP,DLG1;HK1;PRKCZ;KDELR1;GATA3;MIF;ARG1;MAPK3;TGFB1
7463,GO:0031594,0.094675016436814,0.960949856254277,7,37,neuromuscular junction,CC,F2R;DLG4;SERPINE2;DLG1;POSTN;DLG3;KCNC4
2329,GO:0005342,0.0946922124968285,0.947277060116508,14,90,organic acid transmembrane transporter activity,MF,SERINC2;BSG;SLC16A3;SLC38A10;SLC6A6;SLC13A3;SLC43A1;TMEM44;SLC6A9;SLC13A5;SLC27A1;SLC6A14;SLC10A6;CEACAM1
11926,GO:0046943,0.0946922124968285,0.947277060116508,14,90,carboxylic acid transmembrane transporter activity,MF,SERINC2;BSG;SLC16A3;SLC38A10;SLC6A6;SLC13A3;SLC43A1;TMEM44;SLC6A9;SLC13A5;SLC27A1;SLC6A14;SLC10A6;CEACAM1
17903,GO:1902117,0.0949173654709452,0.953454399762369,10,59,positive regulation of organelle assembly,BP,SDC1;MSN;FSCN1;SRC;LRSAM1;FUZ;ULK1;MAPK9;WRAP73;ASAP1
16149,GO:0090131,0.0950023468324095,1,1,1,mesenchyme migration,BP,ACTA2
10102,GO:0042594,0.0950358648470617,0.941065296198889,20,139,response to starvation,BP,PCK2;DAP;SESN2;XBP1;ATF4;PCSK9;HMGCL;DDIT3;GLUL;GAS2L1;STK24;ASNS;COMT;ULK1;ULK2;MAP1LC3B;IMPACT;CBL;MAPK3;C12ORF66
4216,GO:0009374,0.0951657829700381,0.989050263746639,2,5,biotin binding,MF,PC;HLCS
3763,GO:0008307,0.0952424740304429,0.968021445362376,5,24,structural constituent of muscle,MF,OBSCN;SMTN;OBSL1;ASPH;MYL9
12902,GO:0051220,0.0953375080230783,0.967979841068453,5,24,cytoplasmic sequestering of protein,BP,MDFI;TMSB4X;SUFU;PKD1;THRA
11582,GO:0046113,0.0955088367048882,0.988987222613553,2,5,nucleobase catabolic process,BP,XDH;AOX1
7838,GO:0032386,0.0956179313048529,0.930779188011276,41,320,regulation of intracellular transport,BP,EDEM1;SH3TC2;RAC2;SORL1;MAP2K1;RAPGEF3;PRNP;MAP2K2;BAG3;ATP13A2;VPS11;PCSK9;SEPT5;MSN;MAP1B;GDI1;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;STOM;RAB29;IFI27;REEP2;CEMIP;PARP10;VAMP2;SRC;LDLRAP1;REEP6;NUCB1;GSK3A;STXBP1;FYN;TBC1D20;CAMK1;CIB1;MAPK3;UGCG;TGFB1
4319,GO:0009799,0.0956992984788575,0.949438096440262,12,75,specification of symmetry,BP,ACVR2B;AP1B1;TGFBR2;SUFU;DDIT3;MICAL2;ALDH1A2;PCSK6;PSKH1;BICC1;GAS8;AIDA
1570,GO:0003974,0.0957549350956152,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1574,GO:0003978,0.0957549350956152,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
7168,GO:0031033,0.0958622951357075,0.988922118944554,2,5,myosin filament organization,BP,OBSL1;RAP1GDS1
7060,GO:0030833,0.0959225013215975,0.943045975565089,17,117,regulation of actin filament polymerization,BP,RAC2;DLG1;TMOD2;CORO1B;ARPC1A;TMSB4X;TWF2;CAPG;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;BAIAP2L1;WIPF1;TMSB10;KANK2
4741,GO:0010906,0.0959305297859346,0.950968755722079,11,67,regulation of glucose metabolic process,BP,NR1D1;IGFBP4;AKT1;DGKQ;PPARA;SRC;GSK3A;SLC35B4;ADIPOR1;MLYCD;SLC45A3
13792,GO:0060350,0.0960850634946219,0.963633821824556,6,30,endochondral bone morphogenesis,BP,MEF2D;MMP14;COL13A1;TGFBR2;GNAS;THBS3
14515,GO:0061971,0.0960850634946219,0.963633821824556,6,30,replacement bone morphogenesis,BP,MEF2D;MMP14;COL13A1;TGFBR2;GNAS;THBS3
2392,GO:0005527,0.0961303195928972,0.979144370821233,3,12,macrolide binding,MF,FKBP1A;FKBP9;FKBP10
2393,GO:0005528,0.0961303195928972,0.979144370821233,3,12,FK506 binding,MF,FKBP1A;FKBP9;FKBP10
4811,GO:0012507,0.0961721665802062,0.957182526731045,8,46,ER to Golgi transport vesicle membrane,CC,SEC23A;STX5;MCFD2;SEC24C;USO1;LMAN1;TGFA;CD59
3646,GO:0008120,0.0962170838211956,1,1,1,ceramide glucosyltransferase activity,MF,UGCG
17191,GO:0102769,0.0962170838211956,1,1,1,dihydroceramide glucosyltransferase activity,MF,UGCG
10338,GO:0043121,0.0962870127869733,0.988843688105904,2,5,neurotrophin binding,MF,PCSK6;FURIN
7975,GO:0032580,0.0963747990396659,0.950699786421024,11,67,Golgi cisterna membrane,CC,ASAP2;ARAP1;PITPNM1;CHPF;B4GALNT4;TMED3;B4GALT2;NUCB1;ST3GAL3;B4GALT6;GALNT3
6710,GO:0030117,0.096568815623219,0.946008512806369,14,92,membrane coat,CC,AP3D1;SCYL1;COPG1;EGFR;EPN2;AP1B1;AP2A2;SEC23A;GGA3;GGA1;TMED3;LDLRAP1;SEC24C;ARCN1
12237,GO:0048475,0.096568815623219,0.946008512806369,14,92,coated membrane,CC,AP3D1;SCYL1;COPG1;EGFR;EPN2;AP1B1;AP2A2;SEC23A;GGA3;GGA1;TMED3;LDLRAP1;SEC24C;ARCN1
9838,GO:0042048,0.0966753668030836,0.988771779663696,2,5,olfactory behavior,BP,WFS1;CHD7
16264,GO:0090299,0.0968871352446954,1,1,1,regulation of neural crest formation,BP,FUZ
16265,GO:0090301,0.0968871352446954,1,1,1,negative regulation of neural crest formation,BP,FUZ
19877,GO:2000314,0.0968871352446954,1,1,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
12157,GO:0048244,0.0969308077026345,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
16454,GO:0097089,0.0969308077026345,1,1,1,methyl-branched fatty acid metabolic process,BP,PHYH
14153,GO:0060999,0.0969668171834818,0.963209485539725,6,30,positive regulation of dendritic spine development,BP,ZMYND8;NEURL1;SHANK3;APOE;SHANK2;CAMK1
817,GO:0002087,0.0970842903612241,0.988695863712934,2,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2;PBX3
16407,GO:0095500,0.0970888453021368,0.979219927328628,3,11,acetylcholine receptor signaling pathway,BP,GNB1;GNAI2;AGRN
18612,GO:1903831,0.0970888453021368,0.979219927328628,3,11,signal transduction involved in cellular response to ammonium ion,BP,GNB1;GNAI2;AGRN
19173,GO:1905144,0.0970888453021368,0.979219927328628,3,11,response to acetylcholine,BP,GNB1;GNAI2;AGRN
19174,GO:1905145,0.0970888453021368,0.979219927328628,3,11,cellular response to acetylcholine,BP,GNB1;GNAI2;AGRN
4418,GO:0010189,0.0972009134337401,1,1,1,vitamin E biosynthetic process,BP,PLTP
9981,GO:0042360,0.0972009134337401,1,1,1,vitamin E metabolic process,BP,PLTP
18740,GO:1904121,0.0972009134337401,1,1,1,phosphatidylethanolamine transporter activity,MF,PLTP
9060,GO:0035272,0.0972398152283336,0.959537881938633,7,38,exocrine system development,BP,CST3;LAMA5;XBP1;EGFR;TGM2;FGFR1;TGFB1
12132,GO:0048169,0.0974620768237112,0.972369032407909,4,17,regulation of long-term neuronal synaptic plasticity,BP,NEURL1;DLG4;SHANK3;EPHB2
15342,GO:0071542,0.0974657089510239,0.972367636764097,4,17,dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D;MANF
17490,GO:1900274,0.0975959590056046,0.972317574790242,4,17,regulation of phospholipase C activity,BP,EGFR;EDNRA;FGFR1;FGF2
12040,GO:0047658,0.0976124189824732,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
8857,GO:0034644,0.09772991917279,0.949794793269231,11,69,cellular response to UV,BP,ERCC1;NFATC4;ATF4;XPC;MAPK13;MC1R;HIST3H2A;HYAL1;DDB2;IMPACT;EP300
18468,GO:1903525,0.0977766459883538,0.988566864645204,2,5,regulation of membrane tubulation,BP,DNM2;ASAP1
9959,GO:0042311,0.0978642324002231,0.971979074637524,4,18,vasodilation,BP,NOS1;BBS2;APOE;ITGA1
9261,GO:0035659,0.0979410161243197,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
11142,GO:0045167,0.0979410161243197,1,1,1,asymmetric protein localization involved in cell fate determination,BP,WNT7A
19073,GO:1904889,0.0979410161243197,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
19074,GO:1904891,0.0979410161243197,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
10170,GO:0042744,0.0979753345264738,0.978567853547838,3,12,hydrogen peroxide catabolic process,BP,PRDX5;GPX3;CAT
14315,GO:0061395,0.0980319544859047,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
18877,GO:1904464,0.0983793889610176,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18878,GO:1904465,0.0983793889610176,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19651,GO:1990773,0.0983793889610176,1,1,1,matrix metallopeptidase secretion,BP,IDH2
4846,GO:0014051,0.0984151877900857,0.988447375122724,2,5,gamma-aminobutyric acid secretion,BP,NTSR1;APBA1
18394,GO:1903364,0.0984936400912413,0.941318962061718,17,116,positive regulation of cellular protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;AKT1;APOE;VPS11;PCSK9;MSN;ANKIB1;GSK3A;STUB1;TRIB3;RAD23A;LRP1;TRIB2;CSNK1D
15567,GO:0071963,0.0985926876499116,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
3832,GO:0008430,0.0988584427325963,1,1,1,selenium binding,MF,GPX3
18387,GO:1903350,0.098904147014478,0.978659489294268,3,11,response to dopamine,BP,ATF4;DNM2;MAPK3
18388,GO:1903351,0.098904147014478,0.978659489294268,3,11,cellular response to dopamine,BP,ATF4;DNM2;MAPK3
972,GO:0002416,0.0989052269199602,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6225,GO:0019770,0.0989052269199602,1,1,1,IgG receptor activity,MF,FCGRT
6273,GO:0019864,0.0989052269199602,1,1,1,IgG binding,MF,FCGRT
4232,GO:0009409,0.0989216323421643,0.962142931141521,6,31,response to cold,BP,ZNF516;ACADVL;THRA;PCSK1N;SLC27A1;HSPA2
2597,GO:0005891,0.0989484305080194,0.978645756210752,3,11,voltage-gated calcium channel complex,CC,NOS1;FKBP1A;HSPA2
6844,GO:0030305,0.0989518087240486,1,1,1,heparanase activity,MF,HPSE
17,GO:0000032,0.0991178356522097,1,1,1,cell wall mannoprotein biosynthetic process,BP,MPI
1826,GO:0004476,0.0991178356522097,1,1,1,mannose-6-phosphate isomerase activity,MF,MPI
2693,GO:0006056,0.0991178356522097,1,1,1,mannoprotein metabolic process,BP,MPI
2694,GO:0006057,0.0991178356522097,1,1,1,mannoprotein biosynthetic process,BP,MPI
7421,GO:0031506,0.0991178356522097,1,1,1,cell wall glycoprotein biosynthetic process,BP,MPI
10070,GO:0042546,0.0991178356522097,1,1,1,cell wall biogenesis,BP,MPI
10729,GO:0044038,0.0991178356522097,1,1,1,cell wall macromolecule biosynthetic process,BP,MPI
14388,GO:0061611,0.0991178356522097,1,1,1,mannose to fructose-6-phosphate metabolic process,BP,MPI
14860,GO:0070589,0.0991178356522097,1,1,1,cellular component macromolecule biosynthetic process,BP,MPI
3880,GO:0008509,0.0991309990172928,0.934136398956332,26,188,anion transmembrane transporter activity,MF,SERINC2;SLCO4A1;BSG;SLC16A3;SLC2A9;TTYH3;SLC12A7;SLC20A1;SLC38A10;ANO8;SLC2A3;SLC12A4;SLC6A6;SLC13A3;SLC43A1;TMEM44;SLC6A9;SLC33A1;SLC13A5;SLC35B4;LRRC8A;SLC27A1;SLC6A14;SLC10A6;CEACAM1;PCYOX1
12685,GO:0050870,0.0992658048476565,0.940753212111872,17,118,positive regulation of T cell activation,BP,AP3D1;XBP1;AKT1;CARD11;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;FYN;ZP3;PNP;TGFB1;ANXA1
5457,GO:0016328,0.0994881950364857,0.955439852340777,8,45,lateral plasma membrane,CC,DVL1;DLG1;PKD1;ARL2;CEACAM1;ERBB3;ANXA1;CLDN12
9204,GO:0035580,0.0995511070172393,0.958165116686332,7,40,specific granule lumen,CC,QSOX1;LCN2;CTSZ;DNASE1L1;HPSE;ARG1;ERP44
3921,GO:0008591,0.0996353072276955,1,1,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
10137,GO:0042662,0.0996353072276955,1,1,1,negative regulation of mesodermal cell fate specification,BP,DKK1
11423,GO:0045813,0.0996353072276955,1,1,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
14450,GO:0061743,0.0996353072276955,1,1,1,motor learning,BP,DKK1
16118,GO:0090081,0.0996353072276955,1,1,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,DKK1
16119,GO:0090082,0.0996353072276955,1,1,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,DKK1
16305,GO:0090381,0.0996353072276955,1,1,1,regulation of heart induction,BP,DKK1
16935,GO:0098883,0.0996353072276955,1,1,1,synapse disassembly,BP,DKK1
17129,GO:0100012,0.0996353072276955,1,1,1,regulation of heart induction by canonical Wnt signaling pathway,BP,DKK1
17633,GO:1901296,0.0996353072276955,1,1,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17646,GO:1901321,0.0996353072276955,1,1,1,positive regulation of heart induction,BP,DKK1
18973,GO:1904701,0.0996353072276955,1,1,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18978,GO:1904711,0.0996353072276955,1,1,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18988,GO:1904723,0.0996353072276955,1,1,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
19154,GO:1905067,0.0996353072276955,1,1,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
19389,GO:1905771,0.0996353072276955,1,1,1,negative regulation of mesodermal cell differentiation,BP,DKK1
19427,GO:1905903,0.0996353072276955,1,1,1,negative regulation of mesoderm formation,BP,DKK1
796,GO:0002062,0.0996611411362146,0.950660006927487,10,59,chondrocyte differentiation,BP,WNT7A;PTHLH;MEF2D;TGFBR2;CREB3L2;ADAMTS7;HMGA2;WNT5B;FGFR1;TGFB1
9145,GO:0035470,0.0996959804023858,1,1,1,positive regulation of vascular wound healing,BP,XBP1
14000,GO:0060690,0.0996959804023858,1,1,1,epithelial cell differentiation involved in salivary gland development,BP,XBP1
14001,GO:0060691,0.0996959804023858,1,1,1,epithelial cell maturation involved in salivary gland development,BP,XBP1
17396,GO:1900098,0.0996959804023858,1,1,1,regulation of plasma cell differentiation,BP,XBP1
17397,GO:1900100,0.0996959804023858,1,1,1,positive regulation of plasma cell differentiation,BP,XBP1
18449,GO:1903489,0.0996959804023858,1,1,1,positive regulation of lactation,BP,XBP1
2522,GO:0005775,0.0998191376376815,0.939400762921306,18,126,vacuolar lumen,CC,PYGB;SDC1;NAPRT;CTSB;GPC4;ATP13A2;GALNS;NAGLU;FUCA1;CAP1;C6ORF120;AGRN;CTSL;HYAL1;HPSE;ARG1;VAT1;TRAPPC1
11408,GO:0045776,0.0999590204902429,0.96593989845574,5,24,negative regulation of blood pressure,BP,NOS1;ADM2;PPARA;APLN;NTSR1
325,GO:0000910,0.0999594685422883,0.937588809058408,20,140,cytokinesis,BP,SNX9;SEPT10;SNX33;VPS4A;SEPT5;GIT1;PAK1;CUL7;SDCCAG3;RHOC;SEPT8;RHOBTB2;GIPC1;PAK6;TTC19;RAB11FIP4;BCL2L1;PAK4;SPIRE1;RHOBTB1
9966,GO:0042326,0.0999639808901149,0.926242206733304,45,354,negative regulation of phosphorylation,BP,TNIP1;XDH;SORL1;DVL1;DLG1;FKBP1A;PRNP;LRP5;FBLN1;ADARB1;AKT1;APOE;PKN1;WWTR1;PRKCZ;DGKQ;EPHA1;PTK6;STK39;DKK1;PPARA;DUSP4;GRB10;DUSP6;PPM1F;MICAL1;HEXIM1;SOCS2;TRIB3;SNX25;LEMD2;PMEPA1;TRIB2;LRRK1;IMPACT;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;TGFB1;SPRED2;PIK3R2;CAMK2N1
3229,GO:0006884,0.0999795484073503,0.971396837526084,4,17,cell volume homeostasis,BP,SLC12A7;SHANK3;SLC12A4;LRRC8A
28,GO:0000053,0.100035466507489,1,1,1,argininosuccinate metabolic process,BP,ASS1
1624,GO:0004055,0.100035466507489,1,1,1,argininosuccinate synthase activity,MF,ASS1
18261,GO:1903039,0.100056919739642,0.939236436743728,18,126,positive regulation of leukocyte cell-cell adhesion,BP,AP3D1;XBP1;AKT1;CARD11;PRKCZ;TGFBR2;CD44;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;FYN;ZP3;PNP;TGFB1;ANXA1
6583,GO:0022407,0.100076793534686,0.930891282421954,31,234,regulation of cell-cell adhesion,BP,AP3D1;SERPINE2;DLG1;ITGA6;PRNP;XBP1;AKT1;CARD11;ARG2;PRKCZ;TGFBR2;PPARA;CD44;PAK1;RAG1;PODXL;ASS1;GATA3;ADAM8;IGFBP2;SRC;PAG1;SPINT2;FYN;ZP3;PNP;ARG1;CEACAM1;MINK1;TGFB1;ANXA1
13768,GO:0060322,0.100371728690442,0.922755572944353,60,481,head development,BP,MAP2K1;WNT7A;CST3;NEURL1;BOK;SHARPIN;SERPINE2;PITPNM1;PTPRS;BNIP3;SMARCA1;SNPH;BBS2;BCR;AARS;EGFR;CSNK1E;MMP14;LAMB1;SHANK3;BAG3;NAGLU;RRAS;TGFBR2;EPOR;DKK1;TACC1;PAK1;TTBK2;SHANK2;GLUD1;ASPH;ARID5B;NUMB;B4GALT2;EDNRA;TULP3;ALDH1A2;SRC;RERE;FYN;ANXA3;MBOAT7;GJC2;THRA;AMIGO2;FGFR1;LRP1;KLHL17;MYO1D;CHD7;NDE1;EPHB2;GAS8;SOCS7;MAPK3;CSNK1D;MBD3;TGFB1;ARCN1
6674,GO:0030031,0.100388447539373,0.923656771677402,55,438,cell projection assembly,BP,ZMYND8;RAC2;NEURL1;ARAP1;ITGA6;LAMA5;SSH1;ESPN;BBS2;NUDCD3;MARK4;EVI5L;CSNK1E;RFX2;SEPT10;PRKACA;PARVB;EHD3;WWTR1;DNAAF5;PTPDC1;SEPT5;WASF2;TWF2;FSCN1;TTBK2;PODXL;SEPT8;DYNLRB1;FAM110C;ARHGEF4;SRC;DNM2;NINL;SDCCAG8;SH3BP1;FUZ;AGRN;LPAR3;PFN1;KIF17;TUBG1;TENM2;ARFIP2;UNC119B;ATXN10;EPS8L1;NDE1;SNAP29;GAS8;WRAP73;CSNK1D;OCRL;CCDC113;ASAP1
3567,GO:0007612,0.100413859567334,0.946498583119239,12,75,learning,BP,DLG4;SHANK3;DEAF1;DKK1;RAG1;SHANK2;ASIC1;B4GALT2;FYN;COMT;NTSR1;EPHB2
2116,GO:0004900,0.100434886232604,1,1,1,erythropoietin receptor activity,MF,EPOR
9732,GO:0038162,0.100434886232604,1,1,1,erythropoietin-mediated signaling pathway,BP,EPOR
714,GO:0001936,0.100579887418652,0.946321263432839,12,77,regulation of endothelial cell proliferation,BP,XDH;PGF;AKT1;APOE;APLN;MYDGF;ALDH1A2;FGFR1;FGF2;ARG1;VEGFB;ECM1
8092,GO:0032768,0.100633860416262,0.957682736505352,7,39,regulation of monooxygenase activity,BP,CYP27B1;CYGB;EGFR;AKT1;APOE;DNM2;VDR
5003,GO:0015143,0.100701630912121,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
17778,GO:1901702,0.100701630912121,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
20068,GO:2000656,0.100869778244114,1,1,1,regulation of apolipoprotein binding,BP,MAPK3
20069,GO:2000657,0.100869778244114,1,1,1,negative regulation of apolipoprotein binding,BP,MAPK3
667,GO:0001868,0.101071435877264,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
668,GO:0001869,0.101071435877264,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
9814,GO:0040032,0.101071435877264,1,1,1,post-embryonic body morphogenesis,BP,GNAS
15957,GO:0072740,0.10109352544756,1,1,1,cellular response to anisomycin,BP,MAPK13
2391,GO:0005525,0.101155422856489,0.928039631219973,36,280,GTP binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
16659,GO:0097501,0.101179533925458,0.986307756207123,2,7,stress response to metal ion,BP,MT2A;SLC30A1
4621,GO:0010737,0.101271690625876,0.970648617290893,4,18,protein kinase A signaling,BP,AKAP12;MC1R;GAL;MIF
18280,GO:1903077,0.10134721230021,0.970864618632016,4,17,negative regulation of protein localization to plasma membrane,BP,NUMB;BCL2L1;TMBIM1;TGFB1
4460,GO:0010447,0.101371581148251,0.977889856659904,3,11,response to acidic pH,BP,ASIC1;SRC;IMPACT
12085,GO:0048018,0.101380811849174,0.934900961587715,22,167,receptor ligand activity,MF,PGF;ADM2;WNT7A;PTHLH;CMTM4;SEMA3F;CMTM7;DKK1;SEMA4B;TNFSF15;APLN;CLEC11A;GAL;TIMP1;SEMA4G;MIF;ZP3;FGF2;VEGFB;TGFA;TGFB1;MANF
11980,GO:0047166,0.101410331277891,1,1,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,LPCAT4
14424,GO:0061687,0.101603445471182,0.986216379393053,2,7,detoxification of inorganic compound,BP,MT2A;SLC30A1
15442,GO:0071695,0.101727212552774,0.941389441479519,15,99,anatomical structure maturation,BP,XBP1;FAM210B;FAM20C;FERMT1;DDIT3;RET;GATA3;ANKS1A;ALDH1A2;RERE;AGRN;GAL;L3MBTL3;ARCN1;THBS3
2331,GO:0005344,0.101874120874748,1,1,1,oxygen carrier activity,MF,CYGB
12063,GO:0047888,0.101874120874748,1,1,1,fatty acid peroxidase activity,MF,CYGB
10575,GO:0043524,0.101954487596603,0.942472292526611,14,93,negative regulation of neuron apoptotic process,BP,F2R;BOK;AARS;APOE;WFS1;ADAM8;STXBP1;FYN;ADNP;BCL2L1;LRP1;MAP3K12;ITSN1;ERBB3
1921,GO:0004611,0.102100978456836,1,1,1,phosphoenolpyruvate carboxykinase activity,MF,PCK2
1922,GO:0004613,0.102100978456836,1,1,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,PCK2
6179,GO:0019543,0.102100978456836,1,1,1,propionate catabolic process,BP,PCK2
11639,GO:0046327,0.102100978456836,1,1,1,glycerol biosynthetic process from pyruvate,BP,PCK2
20320,GO:2001259,0.102130053515492,0.960575381389088,6,31,positive regulation of cation channel activity,BP,SHANK3;EHD3;GAL;NTSR1;EPHB2;STIM1
15310,GO:0071478,0.102216056891971,0.935962056691592,20,142,cellular response to radiation,BP,ERCC1;NFATC4;NET1;ATF4;XPC;MAPK13;MC1R;CCND2;GNB1;GATA3;HSF1;HMGA2;DNM2;HIST3H2A;HYAL1;BCL2L1;DDB2;IMPACT;TGFB1;EP300
15385,GO:0071606,0.102270625718582,1,1,1,chemokine (C-C motif) ligand 4 production,BP,ARG2
15412,GO:0071643,0.102270625718582,1,1,1,regulation of chemokine (C-C motif) ligand 4 production,BP,ARG2
15413,GO:0071644,0.102270625718582,1,1,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,ARG2
15901,GO:0072615,0.102270625718582,1,1,1,interleukin-17 secretion,BP,ARG2
19160,GO:1905076,0.102270625718582,1,1,1,regulation of interleukin-17 secretion,BP,ARG2
19161,GO:1905077,0.102270625718582,1,1,1,negative regulation of interleukin-17 secretion,BP,ARG2
19275,GO:1905403,0.102270625718582,1,1,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
8776,GO:0034446,0.102283976319618,0.947053659933338,11,68,substrate adhesion-dependent cell spreading,BP,POSTN;NET1;LAMA5;FBLN1;LAMB1;PARVB;EPHA1;SRC;DNM2;RREB1;CIB1
2989,GO:0006534,0.10235075883173,0.977581940031775,3,11,cysteine metabolic process,BP,CBS;AHCY;GGT1
12932,GO:0051259,0.10243958835697,0.923931677703047,46,380,protein complex oligomerization,BP,ANGPTL4;SORL1;KCNG1;SNX9;BOK;SHARPIN;CRTC1;MMP1;PRNP;NACC2;ACOT13;IRAK1;APOE;EHD3;PRKCZ;ITPR3;TYSND1;IDE;HMGCL;CCDC88C;DDIT3;GLUL;STOM;GNB1;RHOC;OXA1L;ASIC1;HSF1;SRC;CBR4;TGM2;GPX3;HSF4;MIF;SIGMAR1;P2RX4;EHD4;VASP;ATXN10;RXRA;C1QTNF6;ARG1;KCNC4;HM13;CAT;EP300
15367,GO:0071579,0.102677785375485,1,1,1,regulation of zinc ion transport,BP,SLC30A1
15368,GO:0071580,0.102677785375485,1,1,1,regulation of zinc ion transmembrane transport,BP,SLC30A1
15369,GO:0071581,0.102677785375485,1,1,1,regulation of zinc ion transmembrane import,BP,SLC30A1
15370,GO:0071582,0.102677785375485,1,1,1,negative regulation of zinc ion transport,BP,SLC30A1
15371,GO:0071583,0.102677785375485,1,1,1,negative regulation of zinc ion transmembrane transport,BP,SLC30A1
15372,GO:0071584,0.102677785375485,1,1,1,negative regulation of zinc ion transmembrane import,BP,SLC30A1
15373,GO:0071585,0.102677785375485,1,1,1,detoxification of cadmium ion,BP,SLC30A1
19498,GO:1990170,0.102677785375485,1,1,1,stress response to cadmium ion,BP,SLC30A1
3109,GO:0006687,0.102726472843355,0.951014192578215,9,53,glycosphingolipid metabolic process,BP,ESYT2;CPTP;ST3GAL5;SMPD3;ARSK;UGCG;B4GALT6;NAGA;ARSD
11635,GO:0046323,0.102783659408852,0.951043180385781,9,52,glucose import,BP,SESN2;RTN2;AKT1;PRKCZ;PAK1;GRB10;GSK3A;RAB4B;PIK3R2
2132,GO:0004931,0.102882025136464,1,1,1,extracellularly ATP-gated cation channel activity,MF,P2RX4
9113,GO:0035381,0.102882025136464,1,1,1,ATP-gated ion channel activity,MF,P2RX4
3401,GO:0007183,0.102892733768645,0.977410901387028,3,11,SMAD protein complex assembly,BP,FKBP1A;PMEPA1;TGFB1
5332,GO:0016055,0.10290264422818,0.92287255094235,49,393,Wnt signaling pathway,BP,MDFI;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;WNT7A;IGFBP4;PSMD2;SMURF2;LRP5;CSNK1E;GPC4;APOE;WWTR1;AP2A2;FZD8;GRK6;FERMT1;DKK1;SOX7;CCDC88C;BCL9L;DDIT3;GNB1;GRB10;GATA3;PTPRU;PLCB3;IGFBP2;SRC;AGO4;GSK3A;FUZ;WNT5B;PFN1;PSMD7;WISP1;TLE4;TNRC6B;LRP1;LRRK1;BICC1;INVS;ATP6V1C2;CSNK1D;CCNE1;ITGA3;TCF7L1
13532,GO:0055082,0.102905418139631,0.921969026539244,53,432,cellular chemical homeostasis,BP,NOS1;F2R;AP3D1;BOK;PCK2;DLG4;NR1D1;FKBP1A;PRNP;BNIP3;LCN2;LRP5;XBP1;MAP4K4;PRKACA;HK1;APOE;ATP13A2;ATP7B;ITPR3;ENDOG;WDTC1;PLCG1;RAP1GDS1;DDIT3;DMXL2;GNB1;CEMIP;PKD1;WFS1;MT2A;FAM155B;EDNRA;TGM2;FYN;LPAR3;GRINA;VDR;NTSR1;ATP2C2;TCIRG1;TPCN1;P2RX4;FGF2;VAPB;CHD7;ATP6V1C2;MAPK3;SLC30A1;TGFB1;PIK3R2;STIM1;RASA3
10679,GO:0043900,0.102975371718819,0.926592523696157,36,285,regulation of multi-organism process,BP,TNIP1;PC;SMURF2;ADARB1;P4HB;IFITM1;APOE;ARG2;VPS4A;MVB12B;FAM3A;HTRA1;STOM;PARP10;OASL;MAPKBP1;HMGA2;LRSAM1;EXOC2;RSF1;OAS1;ISG20;NELFCD;PUM1;TIMP1;MIF;RAD23A;ZP3;TBC1D20;VAPB;ARG1;SEC14L1;CIB1;MAPK3;APOBEC3C;EP300
6993,GO:0030666,0.102986186086732,0.93924978406915,16,112,endocytic vesicle membrane,CC,RAC2;WNT7A;DLG4;RAB43;RAB31;EGFR;EPN2;APOE;AP2A2;LDLRAP1;DNM2;WNT5B;ANXA3;TCIRG1;LRP1;OCRL
1815,GO:0004462,0.103013958170272,1,1,1,lactoylglutathione lyase activity,MF,GLO1
1036,GO:0002542,0.103153145572802,1,1,1,Factor XII activation,BP,F12
13265,GO:0051919,0.103153145572802,1,1,1,positive regulation of fibrinolysis,BP,F12
12303,GO:0048609,0.103247600295283,0.92091366501729,57,460,multicellular organismal reproductive process,BP,ERCC1;CYP27B1;NEURL1;SERPINE2;BSG;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;CTSB;BBS2;OSBP2;ETV5;ADCY7;MYCBPAP;EGFR;RFX2;PRKACA;FAM50A;AKT1;PHC2;SH3PXD2B;DEAF1;EPOR;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;SRC;DNM2;AGO4;PAQR7;VDR;PUM1;RAI14;COMT;THRA;EIF2S2;ADNP;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;SLIT3;RXRA;ARG1;NDRG3;GGT1;CIB1;PAIP2;TGFB1;AZIN2;ANXA1;ITGA3
1584,GO:0003991,0.10330900413384,1,1,1,acetylglutamate kinase activity,MF,NAGS
1616,GO:0004042,0.10330900413384,1,1,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,NAGS
17201,GO:0103045,0.10330900413384,1,1,1,methione N-acyltransferase activity,MF,NAGS
10110,GO:0042610,0.103349721448722,1,1,1,CD8 receptor binding,MF,FYN
19286,GO:1905429,0.103349721448722,1,1,1,response to glycine,BP,FYN
19287,GO:1905430,0.103349721448722,1,1,1,cellular response to glycine,BP,FYN
17519,GO:1900477,0.103359845728133,1,1,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,NACC2
6782,GO:0030213,0.103567554878829,0.977197335778787,3,11,hyaluronan biosynthetic process,BP,CEMIP;HYAL1;TGFB1
7561,GO:0031883,0.103586710197079,1,1,1,taste receptor binding,MF,REEP2
18643,GO:1903900,0.103651969738694,0.938798464967528,16,112,regulation of viral life cycle,BP,TNIP1;PC;ADARB1;P4HB;IFITM1;VPS4A;STOM;PARP10;OASL;HMGA2;OAS1;ISG20;RAD23A;TBC1D20;VAPB;APOBEC3C
8262,GO:0033032,0.10367336787395,0.969700238262642,4,18,regulation of myeloid cell apoptotic process,BP,IRF7;THRA;MIF;ANXA1
1948,GO:0004648,0.103770247249659,1,1,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,PSAT1
14226,GO:0061135,0.103786392157292,0.944100308392956,12,83,endopeptidase regulator activity,MF,CST3;SERPINE2;SERPING1;SERPINB6;PRDX5;TFPI2;APLP2;SPINT2;TIMP1;CRIM1;PCSK1N;FURIN
6620,GO:0022839,0.103848394635332,0.93877845943968,16,107,ion gated channel activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;TPCN1;P2RX4;KCNC4;RASA3
1134,GO:0002720,0.103855007817004,0.964030776084255,5,25,positive regulation of cytokine production involved in immune response,BP,HK1;PRKCZ;GATA3;MIF;MAPK3
18564,GO:1903727,0.103919154814721,0.96416617398385,5,24,positive regulation of phospholipid metabolic process,BP,SRC;TAZ;ZP3;FGF2;TGFB1
19097,GO:1904948,0.104008558093864,0.977057407646883,3,11,midbrain dopaminergic neuron differentiation,BP,CSNK1E;DKK1;CSNK1D
14464,GO:0061770,0.104109866286476,1,1,1,translation elongation factor binding,MF,HSF1
19044,GO:1904842,0.104109866286476,1,1,1,response to nitroglycerin,BP,HSF1
19045,GO:1904843,0.104109866286476,1,1,1,cellular response to nitroglycerin,BP,HSF1
328,GO:0000916,0.10429094685464,1,1,1,actomyosin contractile ring contraction,BP,VPS4A
9526,GO:0036213,0.10429094685464,1,1,1,contractile ring contraction,BP,VPS4A
4739,GO:0010904,0.104322891791087,1,1,1,regulation of UDP-glucose catabolic process,BP,GSK3A
4740,GO:0010905,0.104322891791087,1,1,1,negative regulation of UDP-glucose catabolic process,BP,GSK3A
18777,GO:1904226,0.104322891791087,1,1,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,GSK3A
18778,GO:1904227,0.104322891791087,1,1,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,GSK3A
12458,GO:0050080,0.104385895643888,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20336,GO:2001294,0.104385895643888,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
9609,GO:0036458,0.104393688687674,1,1,1,hepatocyte growth factor binding,MF,SRPX2
4323,GO:0009814,0.104447731844444,1,1,1,defense response, incompatible interaction,BP,TGFB1
4324,GO:0009817,0.104447731844444,1,1,1,defense response to fungus, incompatible interaction,BP,TGFB1
19237,GO:1905313,0.104447731844444,1,1,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,TGFB1
19544,GO:1990402,0.104447731844444,1,1,1,embryonic liver development,BP,TGFB1
6838,GO:0030296,0.104472041120889,0.976910040122399,3,11,protein tyrosine kinase activator activity,MF,ERCC6;DGKQ;ERBB3
6859,GO:0030323,0.104482496598302,0.937243614843862,17,115,respiratory tube development,BP,MAP2K1;LAMA5;ACVR2B;EGFR;MMP14;CTSZ;TGFBR2;PKD1;TULP3;ALDH1A2;HSD11B1;THRA;FGFR1;ARG1;MAPK3;ITGA3;EP300
3732,GO:0008269,0.104500893605646,1,1,1,JAK pathway signal transduction adaptor activity,MF,SOCS2
12241,GO:0048483,0.104526585680184,0.963892038783425,5,24,autonomic nervous system development,BP,SEMA3F;ADARB1;RET;GATA3;EDNRA
3644,GO:0008118,0.104622779366481,1,1,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,ST3GAL3
8336,GO:0033173,0.104720169825189,0.963804558861827,5,24,calcineurin-NFAT signaling cascade,BP,NFATC4;PRNP;ADGRB2;CIB1;ERBB3
1588,GO:0003996,0.10480197101819,1,1,1,acyl-CoA ligase activity,MF,ACSF2
16779,GO:0098547,0.10480197101819,1,1,1,lumenal side of Golgi membrane,CC,NUCB1
20213,GO:2001025,0.104834722742056,0.976379629093351,3,12,positive regulation of response to drug,BP,RAB3B;ENDOG;GAL
10120,GO:0042628,0.104879258419316,1,1,1,mating plug formation,BP,SERPINE2
11208,GO:0045297,0.104879258419316,1,1,1,post-mating behavior,BP,SERPINE2
14219,GO:0061107,0.104879258419316,1,1,1,seminal vesicle development,BP,SERPINE2
14220,GO:0061108,0.104879258419316,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1852,GO:0004512,0.104889181866135,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5731,GO:0016872,0.104889181866135,1,1,1,intramolecular lyase activity,MF,ISYNA1
5321,GO:0016036,0.104931768824978,1,1,1,cellular response to phosphate starvation,BP,COMT
7331,GO:0031335,0.104931768824978,1,1,1,regulation of sulfur amino acid metabolic process,BP,COMT
7332,GO:0031337,0.104931768824978,1,1,1,positive regulation of sulfur amino acid metabolic process,BP,COMT
9343,GO:0035814,0.104931768824978,1,1,1,negative regulation of renal sodium excretion,BP,COMT
12542,GO:0050666,0.104931768824978,1,1,1,regulation of homocysteine metabolic process,BP,COMT
12544,GO:0050668,0.104931768824978,1,1,1,positive regulation of homocysteine metabolic process,BP,COMT
6164,GO:0019510,0.105074088264199,1,1,1,S-adenosylhomocysteine catabolic process,BP,AHCY
15174,GO:0071268,0.105074088264199,1,1,1,homocysteine biosynthetic process,BP,AHCY
1853,GO:0004513,0.105182431710629,1,1,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
11999,GO:0047291,0.105182431710629,1,1,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
1363,GO:0003231,0.105189347106468,0.94349266948848,12,75,cardiac ventricle development,BP,FKBP1A;PPP1R13L;TGFBR2;LTBP1;SUFU;GATA3;DNM2;GSK3A;ZFPM1;CHD7;RXRA;TGFB1
12095,GO:0048029,0.105207379139839,0.95220256408557,8,46,monosaccharide binding,MF,PYGL;BSG;HK1;SLC2A3;P4HA1;TALDO1;LMAN1;PHYH
14144,GO:0060987,0.105246316981168,1,1,1,lipid tube,CC,BIN1
15054,GO:0070981,0.105286077174098,1,1,1,L-asparagine biosynthetic process,BP,ASNS
15055,GO:0070982,0.105286077174098,1,1,1,L-asparagine metabolic process,BP,ASNS
1513,GO:0003870,0.105347183020538,1,1,1,5-aminolevulinate synthase activity,MF,ALAS1
5657,GO:0016749,0.105347183020538,1,1,1,N-succinyltransferase activity,MF,ALAS1
17880,GO:1902045,0.105438403557773,1,1,1,negative regulation of Fas signaling pathway,BP,TMBIM1
19987,GO:2000504,0.105438403557773,1,1,1,positive regulation of blood vessel remodeling,BP,TMBIM1
4563,GO:0010642,0.105449929976405,0.976598084893913,3,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PTPN12;LRP1;HGS
5948,GO:0018277,0.10547486119104,1,1,1,protein deamination,BP,LOXL1
24,GO:0000048,0.10548772907591,1,1,1,peptidyltransferase activity,MF,GGT1
1253,GO:0002951,0.10548772907591,1,1,1,leukotriene-C(4) hydrolase,MF,GGT1
10677,GO:0043890,0.105515759029692,1,1,1,N-acetylgalactosamine-6-sulfatase activity,MF,GALNS
4030,GO:0009061,0.105643211400233,1,1,1,anaerobic respiration,BP,SDHA
11197,GO:0045274,0.105643211400233,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11201,GO:0045282,0.105643211400233,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
2750,GO:0006148,0.105722223599243,1,1,1,inosine catabolic process,BP,PNP
3142,GO:0006738,0.105722223599243,1,1,1,nicotinamide riboside catabolic process,BP,PNP
11718,GO:0046495,0.105722223599243,1,1,1,nicotinamide riboside metabolic process,BP,PNP
14878,GO:0070637,0.105722223599243,1,1,1,pyridine nucleoside metabolic process,BP,PNP
14879,GO:0070638,0.105722223599243,1,1,1,pyridine nucleoside catabolic process,BP,PNP
843,GO:0002153,0.105751571063974,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11485,GO:0045925,0.105751571063974,1,1,1,positive regulation of female receptivity,BP,THRA
6165,GO:0019511,0.105812445965804,0.976482085051421,3,11,peptidyl-proline hydroxylation,BP,CRTAP;P4HB;P4HA1
3918,GO:0008584,0.10583451000654,0.939894038260679,14,94,male gonad development,BP,ERCC1;CCND1;SDC1;CST3;BOK;MMP14;GATA3;ARID5B;AGO4;EIF2S2;BCL2L1;TBC1D20;CBL;ADAM15
18984,GO:1904719,0.105862304460991,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
1523,GO:0003882,0.105883224639474,1,1,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,PTDSS2
15528,GO:0071887,0.105919756221468,0.944685091856282,11,71,leukocyte apoptotic process,BP,AKT1;ARG2;PKN1;KDELR1;RAG1;ADAM8;TSC22D4;IRF7;CTSL;MIF;ANXA1
1845,GO:0004498,0.106041906016926,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
464,GO:0001502,0.106043365741552,0.976408094412746,3,11,cartilage condensation,BP,WNT7A;PKD1;THRA
16859,GO:0098743,0.106043365741552,0.976408094412746,3,11,cell aggregation,BP,WNT7A;PKD1;THRA
4517,GO:0010565,0.106262002392437,0.935855335256848,17,123,regulation of cellular ketone metabolic process,BP,NR1D1;PSMD2;AKT1;DGKQ;TYSND1;PPARA;WDTC1;ACADVL;PSMD7;COMT;ADIPOR1;TRIB3;MLYCD;LONP2;CEACAM1;ANXA1;SLC45A3
3747,GO:0008286,0.106284050852218,0.938293932345443,15,101,insulin receptor signaling pathway,BP,SHC1;AKT1;PRKCZ;IDE;GRB10;EIF4EBP1;SRC;GSK3A;SOCS2;ADIPOR1;TCIRG1;BAIAP2L1;ATP6V1C2;SOCS7;PIK3R2
4631,GO:0010750,0.10629039156593,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8464,GO:0033594,0.10629039156593,1,1,1,response to hydroxyisoflavone,BP,EGFR
10276,GO:0043006,0.10629039156593,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16650,GO:0097489,0.10629039156593,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
2007,GO:0004728,0.106381821870774,1,1,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,MAP2K1
18972,GO:1904700,0.106406185456153,1,1,1,granulosa cell apoptotic process,BP,BOK
18977,GO:1904708,0.106406185456153,1,1,1,regulation of granulosa cell apoptotic process,BP,BOK
1666,GO:0004122,0.106415233041481,1,1,1,cystathionine beta-synthase activity,MF,CBS
2990,GO:0006535,0.106415233041481,1,1,1,cysteine biosynthetic process from serine,BP,CBS
4053,GO:0009093,0.106415233041481,1,1,1,cysteine catabolic process,BP,CBS
5617,GO:0016662,0.106415233041481,1,1,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,CBS
6154,GO:0019448,0.106415233041481,1,1,1,L-cysteine catabolic process,BP,CBS
12496,GO:0050421,0.106415233041481,1,1,1,nitrite reductase (NO-forming) activity,MF,CBS
14542,GO:0070025,0.106415233041481,1,1,1,carbon monoxide binding,MF,CBS
16896,GO:0098809,0.106415233041481,1,1,1,nitrite reductase activity,MF,CBS
3237,GO:0006893,0.106427785427793,0.951521273358649,8,46,Golgi to plasma membrane transport,BP,BBS2;RAB31;OSBPL5;VAMP2;DNM2;EXOC2;ARFGEF2;LLGL1
4207,GO:0009314,0.106457699600628,0.921590762197543,43,339,response to radiation,BP,ERCC1;CCND1;NFATC4;ERCC6;CRTC1;PITPNM1;DNMT3A;MTA1;NET1;LRP5;EGFR;ATF4;AKT1;XPC;MAPK13;DEAF1;MC1R;CCND2;RAG1;GNB1;GATA3;HSF1;HMGA2;DYNLRB1;B4GALT2;DNM2;REEP6;HIST3H2A;PER3;PRIMPOL;ASNS;BRSK1;HYAL1;BCL2L1;DDB2;IMPACT;CBL;MAPK10;TGFB1;CAT;ANXA1;IKBIP;EP300
19506,GO:1990188,0.106484544045645,1,1,1,euchromatin binding,MF,ASH2L
9593,GO:0036403,0.106488879642594,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
13931,GO:0060562,0.106521887688184,0.926476924784123,30,222,epithelial tube morphogenesis,BP,PGF;CTNNBIP1;NFATC4;DVL1;DLG1;LAMA5;ETV5;LRP5;MMP14;CTSZ;DEAF1;TGFBR2;PRKACB;SUFU;PAK1;PODXL;RET;PKD1;GATA3;MICAL2;EDNRA;TULP3;SRC;SPINT2;FUZ;PFN1;VDR;FGF2;VASP;TGFB1
12604,GO:0050757,0.106524631152193,1,1,1,thymidylate synthase biosynthetic process,BP,APBB1
12605,GO:0050758,0.106524631152193,1,1,1,regulation of thymidylate synthase biosynthetic process,BP,APBB1
12606,GO:0050760,0.106524631152193,1,1,1,negative regulation of thymidylate synthase biosynthetic process,BP,APBB1
3890,GO:0008521,0.10658192354739,1,1,1,acetyl-CoA transmembrane transporter activity,MF,SLC33A1
5252,GO:0015876,0.10658192354739,1,1,1,acetyl-CoA transport,BP,SLC33A1
5271,GO:0015916,0.10658192354739,1,1,1,fatty-acyl-CoA transport,BP,SLC33A1
5350,GO:0016095,0.10658192354739,1,1,1,polyprenol catabolic process,BP,SRD5A3
17166,GO:0102389,0.10658192354739,1,1,1,polyprenol reductase activity,MF,SRD5A3
17650,GO:1901337,0.10658192354739,1,1,1,thioester transport,BP,SLC33A1
7790,GO:0032310,0.106652067935732,0.985821132200375,2,6,prostaglandin secretion,BP,MIF;P2RX4
3493,GO:0007387,0.106720158222863,1,1,1,anterior compartment pattern formation,BP,PBX3
3494,GO:0007388,0.106720158222863,1,1,1,posterior compartment specification,BP,PBX3
200,GO:0000421,0.106745943203699,0.962716137592287,5,25,autophagosome membrane,CC,ATG16L2;WDFY3;ULK1;MAP1LC3B;SNAP29
3997,GO:0008894,0.106786596737149,1,1,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,ENTPD6
9522,GO:0036179,0.106835662553931,1,1,1,osteoclast maturation,BP,FAM20C
5005,GO:0015145,0.106849399441371,0.976149220451412,3,11,monosaccharide transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC5A1
9025,GO:0035196,0.106866907388647,0.954487342771696,7,38,production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TGFB1
2350,GO:0005402,0.106878015375325,0.976140012541774,3,11,carbohydrate:cation symporter activity,MF,SLC2A9;SLC5A1;SLC45A3
1885,GO:0004561,0.106900055996233,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
12115,GO:0048103,0.106921378732914,0.968666309950133,4,17,somatic stem cell division,BP,WNT7A;NUMB;FGFR1;ARHGEF2
10501,GO:0043392,0.106968620670655,0.9542469801553,7,40,negative regulation of DNA binding,BP,MDFI;CTNNBIP1;TMSB4X;PPARA;DDIT3;HMGA2;RSF1
1650,GO:0004092,0.107009082442732,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
17723,GO:1901585,0.107011706203254,1,1,1,regulation of acid-sensing ion channel activity,BP,STOM
1301,GO:0003131,0.107023532760583,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7174,GO:0031049,0.107023532760583,1,1,1,programmed DNA elimination,BP,HMGA2
7176,GO:0031052,0.107023532760583,1,1,1,chromosome breakage,BP,HMGA2
9157,GO:0035501,0.107023532760583,1,1,1,MH1 domain binding,MF,HMGA2
9423,GO:0035978,0.107023532760583,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20091,GO:2000685,0.107023532760583,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
18041,GO:1902510,0.107048427353203,0.985736851201857,2,6,regulation of apoptotic DNA fragmentation,BP,ENDOG;HSF1
18039,GO:1902499,0.107072484920321,1,1,1,positive regulation of protein autoubiquitination,BP,MTA1
14015,GO:0060709,0.107120611456652,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
17128,GO:0100002,0.107120611456652,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
4664,GO:0010810,0.107155854085852,0.932483559572669,20,140,regulation of cell-substrate adhesion,BP,RAC2;POSTN;ITGA6;NET1;FBLN1;MMP14;PRKCZ;EPHA1;FERMT1;NID1;ARL2;SRC;DNM2;PPM1F;RREB1;CAMSAP3;CIB1;ADAM15;MINK1;ITGA3
17136,GO:0101023,0.107160846641663,0.976048940514731,3,11,vascular endothelial cell proliferation,BP,APLN;FGFR1;FGF2
19331,GO:1905562,0.107160846641663,0.976048940514731,3,11,regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1;FGF2
194,GO:0000412,0.107182789132157,1,1,1,histone peptidyl-prolyl isomerization,BP,FKBP10
1856,GO:0004516,0.107199130799221,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
3976,GO:0008792,0.107199130799221,1,1,1,arginine decarboxylase activity,MF,AZIN2
5034,GO:0015203,0.107199130799221,1,1,1,polyamine transmembrane transporter activity,MF,AZIN2
5124,GO:0015489,0.107199130799221,1,1,1,putrescine transmembrane transporter activity,MF,AZIN2
5234,GO:0015847,0.107199130799221,1,1,1,putrescine transport,BP,AZIN2
6115,GO:0019357,0.107199130799221,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6116,GO:0019358,0.107199130799221,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6121,GO:0019365,0.107199130799221,1,1,1,pyridine nucleotide salvage,BP,NAPRT
6328,GO:0020003,0.107199130799221,1,1,1,symbiont-containing vacuole,CC,RAB29
8476,GO:0033608,0.107199130799221,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8719,GO:0034355,0.107199130799221,1,1,1,NAD salvage,BP,NAPRT
10980,GO:0044736,0.107199130799221,1,1,1,acid-sensing ion channel activity,MF,ASIC1
11152,GO:0045183,0.107199130799221,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
11720,GO:0046497,0.107199130799221,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
12008,GO:0047369,0.107199130799221,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12477,GO:0050262,0.107199130799221,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12716,GO:0050915,0.107199130799221,1,1,1,sensory perception of sour taste,BP,ASIC1
14463,GO:0061769,0.107199130799221,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14531,GO:0065010,0.107199130799221,1,1,1,extracellular membrane-bounded organelle,CC,RAB29
16720,GO:0097655,0.107199130799221,1,1,1,serpin family protein binding,MF,CTSL
16811,GO:0098629,0.107199130799221,1,1,1,trans-Golgi network membrane organization,BP,AZIN2
18003,GO:1902387,0.107199130799221,1,1,1,ceramide 1-phosphate binding,MF,CPTP
18004,GO:1902388,0.107199130799221,1,1,1,ceramide 1-phosphate transporter activity,MF,CPTP
18005,GO:1902389,0.107199130799221,1,1,1,ceramide 1-phosphate transport,BP,CPTP
18347,GO:1903259,0.107199130799221,1,1,1,exon-exon junction complex disassembly,BP,PYM1
19224,GO:1905279,0.107199130799221,1,1,1,regulation of retrograde transport, endosome to Golgi,BP,RAB29
14458,GO:0061760,0.107292634736804,1,1,1,antifungal innate immune response,BP,FAM3A
19134,GO:1905034,0.107292634736804,1,1,1,regulation of antifungal innate immune response,BP,FAM3A
19135,GO:1905035,0.107292634736804,1,1,1,negative regulation of antifungal innate immune response,BP,FAM3A
13284,GO:0051952,0.107294905905762,0.96246510795822,5,25,regulation of amine transport,BP,RAB3B;STK39;STXBP1;NTSR1;ARG1
19564,GO:1990439,0.107346918685309,1,1,1,MAP kinase serine/threonine phosphatase activity,MF,DUSP4
5768,GO:0016938,0.107360910764073,1,1,1,kinesin I complex,CC,KLC2
1929,GO:0004620,0.107409712214435,0.945923190109948,10,61,phospholipase activity,MF,PLCH2;PLD3;PLCG1;TMEM8A;PLCB3;EDNRA;MGLL;PLCD3;SMPD3;PNPLA6
20110,GO:2000726,0.107435217117688,0.975960482172119,3,11,negative regulation of cardiac muscle cell differentiation,BP,DKK1;PAK1;GSK3A
8524,GO:0033700,0.107520441355631,0.985636222908922,2,6,phospholipid efflux,BP,APOE;ABCA7
12172,GO:0048264,0.107520938523987,1,1,1,determination of ventral identity,BP,AIDA
3833,GO:0008431,0.107643391379203,1,1,1,vitamin E binding,MF,SEC14L2
20246,GO:2001138,0.107655434130011,0.985607391908101,2,6,regulation of phospholipid transport,BP,APOE;ABCA7
20247,GO:2001140,0.107655434130011,0.985607391908101,2,6,positive regulation of phospholipid transport,BP,APOE;ABCA7
2425,GO:0005600,0.107668070113257,1,1,1,collagen type XIII trimer,CC,COL13A1
7126,GO:0030936,0.107668070113257,1,1,1,transmembrane collagen trimer,CC,COL13A1
19222,GO:1905277,0.107689893648286,1,1,1,negative regulation of epithelial tube formation,BP,GATA3
20032,GO:2000606,0.107689893648286,1,1,1,regulation of cell proliferation involved in mesonephros development,BP,GATA3
20033,GO:2000607,0.107689893648286,1,1,1,negative regulation of cell proliferation involved in mesonephros development,BP,GATA3
20097,GO:2000699,0.107689893648286,1,1,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
20098,GO:2000701,0.107689893648286,1,1,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
20099,GO:2000702,0.107689893648286,1,1,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
20100,GO:2000703,0.107689893648286,1,1,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
20112,GO:2000733,0.107689893648286,1,1,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
20113,GO:2000734,0.107689893648286,1,1,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,GATA3
2159,GO:0004980,0.107767343937937,1,1,1,melanocyte-stimulating hormone receptor activity,MF,MC1R
8395,GO:0033293,0.107778637446529,0.957429761606404,6,34,monocarboxylic acid binding,MF,PYGL;PC;PPARA;VDR;HLCS;RXRA
2354,GO:0005427,0.107911781136243,1,1,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,SLC15A1
5086,GO:0015322,0.107911781136243,1,1,1,secondary active oligopeptide transmembrane transporter activity,MF,SLC15A1
7688,GO:0032127,0.107932527083561,1,1,1,dense core granule membrane,CC,ADAM8
15102,GO:0071065,0.107932527083561,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15116,GO:0071133,0.107932527083561,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15849,GO:0072535,0.107932527083561,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15927,GO:0072680,0.107932527083561,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15928,GO:0072681,0.107932527083561,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19871,GO:2000307,0.107932527083561,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19872,GO:2000309,0.107932527083561,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19948,GO:2000410,0.107932527083561,1,1,1,regulation of thymocyte migration,BP,ADAM8
19949,GO:2000412,0.107932527083561,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19950,GO:2000413,0.107932527083561,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19951,GO:2000415,0.107932527083561,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
12083,GO:0048016,0.107977860540881,0.957679726618738,6,31,inositol phosphate-mediated signaling,BP,NFATC4;PRNP;ITPR3;ADGRB2;CIB1;ERBB3
2310,GO:0005295,0.1081411501045,1,1,1,neutral amino acid:sodium symporter activity,MF,SLC6A9
5100,GO:0015375,0.1081411501045,1,1,1,glycine:sodium symporter activity,MF,SLC6A9
7523,GO:0031704,0.1081411501045,1,1,1,apelin receptor binding,MF,APLN
10505,GO:0043396,0.1081411501045,1,1,1,corticotropin-releasing hormone secretion,BP,APLN
10506,GO:0043397,0.1081411501045,1,1,1,regulation of corticotropin-releasing hormone secretion,BP,APLN
13048,GO:0051466,0.1081411501045,1,1,1,positive regulation of corticotropin-releasing hormone secretion,BP,APLN
13571,GO:0060012,0.1081411501045,1,1,1,synaptic transmission, glycinergic,BP,SLC6A9
13640,GO:0060092,0.1081411501045,1,1,1,regulation of synaptic transmission, glycinergic,BP,SLC6A9
13685,GO:0060183,0.1081411501045,1,1,1,apelin receptor signaling pathway,BP,APLN
14361,GO:0061536,0.1081411501045,1,1,1,glycine secretion,BP,SLC6A9
14362,GO:0061537,0.1081411501045,1,1,1,glycine secretion, neurotransmission,BP,SLC6A9
18703,GO:1904022,0.1081411501045,1,1,1,positive regulation of G-protein coupled receptor internalization,BP,APLN
19585,GO:1990523,0.108162103618809,1,1,1,bone regeneration,BP,POSTN
5204,GO:0015800,0.10816216613395,0.95758766604718,6,31,acidic amino acid transport,BP,VAMP2;GIPC1;STXBP1;NTSR1;PRAF2;APBA1
1340,GO:0003195,0.108216036503579,1,1,1,tricuspid valve formation,BP,ZFPM1
11247,GO:0045403,0.108216036503579,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13809,GO:0060375,0.108216036503579,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13810,GO:0060377,0.108216036503579,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
20049,GO:2000631,0.108216036503579,1,1,1,regulation of pre-miRNA processing,BP,BCDIN3D
20050,GO:2000632,0.108216036503579,1,1,1,negative regulation of pre-miRNA processing,BP,BCDIN3D
1500,GO:0003842,0.108234028428773,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
7143,GO:0030970,0.108304782910743,0.962002158723002,5,25,retrograde protein transport, ER to cytosol,BP,EDEM1;SYVN1;TMEM129;UBE2J1;HM13
18457,GO:1903513,0.108304782910743,0.962002158723002,5,25,endoplasmic reticulum to cytosol transport,BP,EDEM1;SYVN1;TMEM129;UBE2J1;HM13
17414,GO:1900119,0.108317591614379,0.975241874857259,3,12,positive regulation of execution phase of apoptosis,BP,BOK;ENDOG;HSF1
16008,GO:0085032,0.108318057798516,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
19279,GO:1905407,0.108339076824815,1,1,1,regulation of creatine transmembrane transporter activity,BP,STK39
19280,GO:1905408,0.108339076824815,1,1,1,negative regulation of creatine transmembrane transporter activity,BP,STK39
2318,GO:0005316,0.108345082749923,1,1,1,high-affinity inorganic phosphate:sodium symporter activity,MF,SLC20A1
8327,GO:0033157,0.108348633625702,0.926060129820924,28,212,regulation of intracellular protein transport,BP,EDEM1;SH3TC2;RAC2;SORL1;RAPGEF3;PRNP;BAG3;ATP13A2;VPS11;GDI1;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;STOM;RAB29;IFI27;CEMIP;PARP10;VAMP2;NUCB1;GSK3A;FYN;CAMK1;CIB1;UGCG;TGFB1
3409,GO:0007193,0.108415134722721,0.957461229681263,6,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,HTR7;ADCY7;AKAP12;GNAI2;EDNRA;ADCY6
8810,GO:0034505,0.108426517065875,0.975639975339102,3,11,tooth mineralization,BP,FAM20C;PPARA;STIM1
13200,GO:0051786,0.10842917128741,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
13512,GO:0055037,0.108574976900612,0.931420625169316,20,143,recycling endosome,CC,SH3TC2;SORL1;BOK;EHD3;TBC1D14;GGA3;SDCCAG3;RAB29;ATP11A;LDLRAP1;RAB25;NISCH;ABHD17C;TUBG1;RAB11FIP4;ARFGEF2;ULK1;EHD4;RAB4B;ARHGAP44
6784,GO:0030215,0.108637391810603,0.967980240849603,4,17,semaphorin receptor binding,MF,SEMA3F;SEMA4B;SH3BP1;SEMA4G
12549,GO:0050678,0.108705656636579,0.925269970425219,29,219,regulation of epithelial cell proliferation,BP,XDH;PGF;CCND1;WNT7A;NR1D1;DLG1;XBP1;EGFR;LAMB1;AKT1;APOE;DEAF1;HTRA1;GLUL;GATA3;APLN;MYDGF;ALDH1A2;VDR;FGFR1;RREB1;HYAL1;FGF2;ARG1;VEGFB;TGFA;CEACAM1;ECM1;TGFB1
3968,GO:0008753,0.108838662695746,1,1,1,NADPH dehydrogenase (quinone) activity,MF,CBR4
10469,GO:0043317,0.10889785100157,1,1,1,regulation of cytotoxic T cell degranulation,BP,CEACAM1
10470,GO:0043318,0.10889785100157,1,1,1,negative regulation of cytotoxic T cell degranulation,BP,CEACAM1
1755,GO:0004352,0.108930308629325,1,1,1,glutamate dehydrogenase (NAD+) activity,MF,GLUD1
1756,GO:0004353,0.108930308629325,1,1,1,glutamate dehydrogenase [NAD(P)+] activity,MF,GLUD1
5604,GO:0016639,0.108930308629325,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,GLUD1
17864,GO:1902010,0.108945037995315,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
19456,GO:1990026,0.109072478463354,1,1,1,hippocampal mossy fiber expansion,CC,MICAL1
1617,GO:0004043,0.109163868968729,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3980,GO:0008802,0.109163868968729,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6096,GO:0019285,0.109163868968729,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7400,GO:0031455,0.109163868968729,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7401,GO:0031456,0.109163868968729,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
10122,GO:0042631,0.109199900322422,1,1,1,cellular response to water deprivation,BP,SIPA1
14525,GO:0065003,0.109200591437196,0.90695851427362,157,1423,protein-containing complex assembly,BP,ANGPTL4;ERCC1;H1F0;RAC2;SORL1;CTNNBIP1;KCNG1;SNX9;BOK;SHARPIN;CRTC1;DLG4;DLG1;MMP1;SLC9A3R2;FKBP1A;SOX12;PRNP;TMOD2;NACC2;SEPT10;PRKACA;FCHO1;CORO1B;TUBG2;P4HB;XPC;ACOT13;IRAK1;ARPC1A;APOE;EHD3;RABGGTA;TMSB4X;TSPYL2;PRKCZ;ITPR3;DGKQ;VPS11;HIST2H2BE;CTSZ;DNAAF5;SH3PXD2B;TYSND1;EML2;SEPT5;SEC23A;MSN;DKK1;PPP2R5B;OBSL1;PRKACB;ZDHHC8;RAP1GDS1;IDE;MSRB2;COA5;TWF2;BIN1;FSCN1;HMGCL;CCDC88C;PAK1;BCL9L;BAZ2A;DDIT3;GLUL;DMXL2;STOM;GNB1;CORO7;RHOC;SEPT8;OXA1L;ASIC1;HSF1;IL1RAP;ARL2;VAMP2;SRC;CBR4;CAPG;TAZ;TGM2;DNM2;AGO4;RAB1B;CPTP;STX5;GPX3;EXOC2;RSF1;STXBP1;PFN1;TNFRSF1A;TLE4;THRA;MCFD2;HSF4;SEC24C;TUBG1;PSMG4;MIF;TTC19;SIGMAR1;STUB1;DDB2;TCIRG1;PMEPA1;ARFIP2;ULK1;P2RX4;USO1;TBC1D20;SPIRE1;EHD4;MAPK9;SDHAF4;VASP;ATXN10;ABCA7;LMAN1;EPS8L1;WDR18;RXRA;C1QTNF6;ARG1;TAF6;TGFA;NDE1;CAMSAP3;BAIAP2L1;WIPF1;IMPACT;SNAP29;KCNC4;TRAPPC1;TMSB10;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;NDUFS2;HM13;APBA1;SKAP2;CD59;TGFB1;PPP6R1;SH3PXD2A;CAT;ASH2L;PXN;EP300;TCF7L1;ASAP1
7257,GO:0031210,0.109241651685274,0.974937031931459,3,12,phosphatidylcholine binding,MF,PITPNM1;ESYT2;PLTP
12753,GO:0050997,0.109241651685274,0.974937031931459,3,12,quaternary ammonium group binding,MF,PITPNM1;ESYT2;PLTP
54,GO:0000111,0.109318462178178,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
11095,GO:0045081,0.109319880048058,1,1,1,negative regulation of interleukin-10 biosynthetic process,BP,TRIB2
1912,GO:0004597,0.109359471793395,1,1,1,peptide-aspartate beta-dioxygenase activity,MF,ASPH
15161,GO:0071245,0.109387619957469,1,1,1,cellular response to carbon monoxide,BP,DNM2
18416,GO:1903406,0.109387619957469,1,1,1,regulation of sodium:potassium-exchanging ATPase activity,BP,DNM2
18417,GO:1903408,0.109387619957469,1,1,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,DNM2
7830,GO:0032378,0.109389024414724,1,1,1,negative regulation of intracellular lipid transport,BP,PCSK9
7833,GO:0032381,0.109389024414724,1,1,1,negative regulation of intracellular sterol transport,BP,PCSK9
7836,GO:0032384,0.109389024414724,1,1,1,negative regulation of intracellular cholesterol transport,BP,PCSK9
19346,GO:1905596,0.109389024414724,1,1,1,negative regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19348,GO:1905598,0.109389024414724,1,1,1,negative regulation of low-density lipoprotein receptor activity,BP,PCSK9
19351,GO:1905601,0.109389024414724,1,1,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
11792,GO:0046635,0.109389988386026,0.96150301861886,5,25,positive regulation of alpha-beta T cell activation,BP,AP3D1;PRKCZ;TGFBR2;PNP;ANXA1
9746,GO:0038191,0.109480674850522,0.967641502087582,4,17,neuropilin binding,MF,SEMA3F;SEMA4B;SEMA4G;PXN
7672,GO:0032096,0.109483950796008,0.98521459277828,2,6,negative regulation of response to food,BP,BBS2;PPARA
7675,GO:0032099,0.109483950796008,0.98521459277828,2,6,negative regulation of appetite,BP,BBS2;PPARA
16723,GO:0097677,0.109484891871846,0.985214389528345,2,6,STAT family protein binding,MF,HSF1;EP300
4642,GO:0010762,0.109526721765105,0.961614835685466,5,24,regulation of fibroblast migration,BP,CYGB;AKT1;PAK1;FGF2;TGFB1
3848,GO:0008456,0.109626013505746,1,1,1,alpha-N-acetylgalactosaminidase activity,MF,NAGA
17354,GO:0198738,0.109669500802623,0.917370971099821,49,395,cell-cell signaling by wnt,BP,MDFI;CCND1;CTNNBIP1;NFATC4;SDC1;DVL1;WNT7A;IGFBP4;PSMD2;SMURF2;LRP5;CSNK1E;GPC4;APOE;WWTR1;AP2A2;FZD8;GRK6;FERMT1;DKK1;SOX7;CCDC88C;BCL9L;DDIT3;GNB1;GRB10;GATA3;PTPRU;PLCB3;IGFBP2;SRC;AGO4;GSK3A;FUZ;WNT5B;PFN1;PSMD7;WISP1;TLE4;TNRC6B;LRP1;LRRK1;BICC1;INVS;ATP6V1C2;CSNK1D;CCNE1;ITGA3;TCF7L1
15962,GO:0072755,0.109714275801307,1,1,1,cellular response to benomyl,BP,IMPACT
17708,GO:1901561,0.109714275801307,1,1,1,response to benomyl,BP,IMPACT
484,GO:0001534,0.109732787889799,1,1,1,radial spoke,CC,WDR66
485,GO:0001536,0.109732787889799,1,1,1,radial spoke stalk,CC,WDR66
17088,GO:0099552,0.109829346128225,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17089,GO:0099553,0.109829346128225,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17424,GO:1900134,0.109829346128225,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
13218,GO:0051817,0.109832022628724,0.940425424690707,12,78,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;PC;APOE;STOM;HMGA2;BCL2L1;TBC1D20;VAPB;RXRA;ARG1;TGFB1;EP300
830,GO:0002114,0.109838363864367,1,1,1,interleukin-33 receptor activity,MF,IL1RAP
9737,GO:0038172,0.109838363864367,1,1,1,interleukin-33-mediated signaling pathway,BP,IL1RAP
2149,GO:0004962,0.109875501279313,1,1,1,endothelin receptor activity,MF,EDNRA
16074,GO:0086100,0.109875501279313,1,1,1,endothelin receptor signaling pathway,BP,EDNRA
1090,GO:0002675,0.110006619715035,0.974683732734205,3,12,positive regulation of acute inflammatory response,BP,ADAM8;F12;ZP3
15335,GO:0071528,0.110027620666708,1,1,1,tRNA re-export from nucleus,BP,XPOT
7546,GO:0031811,0.110057927455066,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7547,GO:0031812,0.110057927455066,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
7477,GO:0031630,0.110108143732766,1,1,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,STXBP1
17220,GO:0106022,0.110108143732766,1,1,1,positive regulation of vesicle docking,BP,STXBP1
1605,GO:0004021,0.110116426148194,1,1,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,GPT2
2979,GO:0006522,0.110116426148194,1,1,1,alanine metabolic process,BP,GPT2
2980,GO:0006524,0.110116426148194,1,1,1,alanine catabolic process,BP,GPT2
4043,GO:0009078,0.110116426148194,1,1,1,pyruvate family amino acid metabolic process,BP,GPT2
4044,GO:0009080,0.110116426148194,1,1,1,pyruvate family amino acid catabolic process,BP,GPT2
10227,GO:0042851,0.110116426148194,1,1,1,L-alanine metabolic process,BP,GPT2
10228,GO:0042853,0.110116426148194,1,1,1,L-alanine catabolic process,BP,GPT2
12039,GO:0047635,0.110116426148194,1,1,1,alanine-oxo-acid transaminase activity,MF,GPT2
10683,GO:0043914,0.110125860870217,1,1,1,NADPH:sulfur oxidoreductase activity,MF,MICAL2
15349,GO:0071549,0.110131912205735,0.961160785780829,5,25,cellular response to dexamethasone stimulus,BP,PCK2;EGFR;EIF4EBP1;ARG1;TGFB1
19502,GO:1990175,0.110137607619598,1,1,1,EH domain binding,MF,EPN3
17007,GO:0099054,0.11018128240247,0.975069152390082,3,11,presynapse assembly,BP,DVL1;WNT7A;NLGN2
11979,GO:0047159,0.110188667356453,1,1,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
11984,GO:0047191,0.110188667356453,1,1,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
20312,GO:2001246,0.110188667356453,1,1,1,negative regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
14799,GO:0070489,0.110243174487472,1,1,1,T cell aggregation,BP,MSN
5408,GO:0016243,0.110305131603541,1,1,1,regulation of autophagosome size,BP,ATP13A2
5940,GO:0018217,0.110305131603541,1,1,1,peptidyl-aspartic acid phosphorylation,BP,ATP13A2
19167,GO:1905103,0.110305131603541,1,1,1,integral component of lysosomal membrane,CC,ATP13A2
19703,GO:1990938,0.110305131603541,1,1,1,peptidyl-aspartic acid autophosphorylation,BP,ATP13A2
2013,GO:0004736,0.110339718993633,1,1,1,pyruvate carboxylase activity,MF,PC
493,GO:0001545,0.110412216868227,1,1,1,primary ovarian follicle growth,BP,SRC
15253,GO:0071393,0.110412216868227,1,1,1,cellular response to progesterone stimulus,BP,SRC
5094,GO:0015362,0.110429642689054,1,1,1,high-affinity sodium:dicarboxylate symporter activity,MF,SLC13A3
10439,GO:0043274,0.110458395565704,0.9749786033015,3,11,phospholipase binding,MF,PRKCZ;DGKQ;STXBP1
12342,GO:0048679,0.110462855155762,0.966972433124948,4,18,regulation of axon regeneration,BP,MAP2K1;PTPRS;PTPRF;STK24
14868,GO:0070615,0.110472959810918,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16345,GO:0090537,0.110472959810918,1,1,1,CERF complex,CC,SMARCA1
14698,GO:0070300,0.110489513114238,0.966961588247575,4,18,phosphatidic acid binding,MF,PITPNC1;PITPNM1;ATP13A2;PLTP
6618,GO:0022836,0.110495929400414,0.934225701075491,16,108,gated channel activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;TPCN1;P2RX4;KCNC4;RASA3
4961,GO:0015031,0.110496869725098,0.905402728661726,167,1501,protein transport,BP,EDEM1;LTBP2;SH3TC2;F2R;RAC2;SORL1;SNX9;AP3D1;LMF1;PCK2;NR1D1;XPOT;PITPNM1;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;RAB43;COPG1;BBS2;BCR;RAB31;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;FERMT1;SEC23A;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;PAK1;NLGN2;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;GATA3;DOPEY2;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;GIPC1;SRC;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;KIF17;KIF13B;STX10;GAL;MCFD2;SEC24C;RRBP1;GUK1;MIF;VPS37A;PRAF2;TCIRG1;SNX25;ARFIP2;ARFGEF2;UNC119B;LRP1;USO1;SPIRE1;PNP;COG1;APBB1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;TGFB1;SLC15A1;PIK3R2;ANXA1;PPP1R10;RAB6A;ARCN1
11721,GO:0046498,0.110518145026533,0.984990556481982,2,6,S-adenosylhomocysteine metabolic process,BP,AHCY;GAMT
9640,GO:0036499,0.110532786325212,0.966943981802277,4,18,PERK-mediated unfolded protein response,BP,BOK;ATF4;DDIT3;ASNS
4849,GO:0014054,0.110559205991501,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
5525,GO:0016492,0.110559205991501,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
8361,GO:0033218,0.110604286452105,0.925497718383765,26,197,amide binding,MF,SORL1;CST3;PRNP;PC;RNPEPL1;APOE;FBXO2;KDELR1;IPO13;IDE;TUBB3;CEMIP;LDLRAP1;CPTP;CLSTN1;THOP1;PLTP;ADNP;HLCS;APBB1;RXRA;EPHB2;CSNK1D;FURIN;APBA1;TM2D1
1044,GO:0002560,0.110666639716165,1,1,1,basophil mediated immunity,BP,PI4K2A
1045,GO:0002561,0.110666639716165,1,1,1,basophil degranulation,BP,PI4K2A
8496,GO:0033644,0.110666639716165,1,1,1,host cell membrane,CC,PI4K2A
10782,GO:0044218,0.110666639716165,1,1,1,other organism cell membrane,CC,PI4K2A
10784,GO:0044221,0.110666639716165,1,1,1,host cell synapse,CC,PI4K2A
10787,GO:0044231,0.110666639716165,1,1,1,host cell presynaptic membrane,CC,PI4K2A
10810,GO:0044279,0.110666639716165,1,1,1,other organism membrane,CC,PI4K2A
15861,GO:0072556,0.110666639716165,1,1,1,other organism presynaptic membrane,CC,PI4K2A
6027,GO:0019082,0.110670146333781,1,1,1,viral protein processing,BP,FURIN
16327,GO:0090472,0.110670146333781,1,1,1,dibasic protein processing,BP,FURIN
15482,GO:0071802,0.110678874619422,1,1,1,negative regulation of podosome assembly,BP,ARHGEF2
8723,GO:0034362,0.110689469111337,0.984953312375782,2,6,low-density lipoprotein particle,CC,SORL1;APOE
1757,GO:0004356,0.110942932133308,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
2996,GO:0006542,0.110942932133308,1,1,1,glutamine biosynthetic process,BP,GLUL
5389,GO:0016211,0.110942932133308,1,1,1,ammonia ligase activity,MF,GLUL
6201,GO:0019676,0.110942932133308,1,1,1,ammonia assimilation cycle,BP,GLUL
16576,GO:0097338,0.111097415639025,1,1,1,response to clozapine,BP,PRKACB
961,GO:0002380,0.11111241714202,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
18806,GO:1904290,0.111150249109094,1,1,1,negative regulation of mitotic DNA damage checkpoint,BP,PPP1R10
15159,GO:0071242,0.111223508107317,0.955922423869441,6,32,cellular response to ammonium ion,BP,ATF4;GNB1;GNAI2;DNM2;AGRN;MAPK3
16472,GO:0097116,0.11126021068087,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
1020,GO:0002514,0.111279653091071,1,1,1,B cell tolerance induction,BP,TGFBR2
1079,GO:0002649,0.111279653091071,1,1,1,regulation of tolerance induction to self antigen,BP,TGFBR2
1080,GO:0002651,0.111279653091071,1,1,1,positive regulation of tolerance induction to self antigen,BP,TGFBR2
1082,GO:0002661,0.111279653091071,1,1,1,regulation of B cell tolerance induction,BP,TGFBR2
1083,GO:0002663,0.111279653091071,1,1,1,positive regulation of B cell tolerance induction,BP,TGFBR2
2182,GO:0005026,0.111279653091071,1,1,1,transforming growth factor beta receptor activity, type II,MF,TGFBR2
19239,GO:1905317,0.111279653091071,1,1,1,inferior endocardial cushion morphogenesis,BP,TGFBR2
6995,GO:0030669,0.111313365072272,0.960614163522363,5,25,clathrin-coated endocytic vesicle membrane,CC,EGFR;EPN2;APOE;AP2A2;LDLRAP1
3835,GO:0008434,0.111322282607344,1,1,1,calcitriol receptor activity,MF,VDR
9740,GO:0038181,0.111322282607344,1,1,1,bile acid receptor activity,MF,VDR
9741,GO:0038183,0.111322282607344,1,1,1,bile acid signaling pathway,BP,VDR
9742,GO:0038186,0.111322282607344,1,1,1,lithocholic acid receptor activity,MF,VDR
17889,GO:1902098,0.111322282607344,1,1,1,calcitriol binding,MF,VDR
17904,GO:1902121,0.111322282607344,1,1,1,lithocholic acid binding,MF,VDR
17964,GO:1902271,0.111322282607344,1,1,1,D3 vitamins binding,MF,VDR
2178,GO:0005011,0.111371601029378,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
509,GO:0001572,0.11139379100371,1,1,1,lactosylceramide biosynthetic process,BP,B4GALT6
11708,GO:0046478,0.11139379100371,1,1,1,lactosylceramide metabolic process,BP,B4GALT6
3135,GO:0006726,0.111400226858845,1,1,1,eye pigment biosynthetic process,BP,AP3D1
5376,GO:0016182,0.111400226858845,1,1,1,synaptic vesicle budding from endosome,BP,AP3D1
10024,GO:0042441,0.111400226858845,1,1,1,eye pigment metabolic process,BP,AP3D1
10474,GO:0043324,0.111400226858845,1,1,1,pigment metabolic process involved in developmental pigmentation,BP,AP3D1
10543,GO:0043474,0.111400226858845,1,1,1,pigment metabolic process involved in pigmentation,BP,AP3D1
16908,GO:0098830,0.111400226858845,1,1,1,presynaptic endosome,CC,AP3D1
10783,GO:0044220,0.11140839675238,1,1,1,host cell perinuclear region of cytoplasm,CC,LMAN1
19990,GO:2000514,0.111422205845672,0.960563704856872,5,25,regulation of CD4-positive, alpha-beta T cell activation,BP,ARG2;PRKCZ;TGFBR2;GATA3;ANXA1
17083,GO:0099545,0.111430743856495,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17090,GO:0099557,0.111430743856495,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17222,GO:0106028,0.111430743856495,1,1,1,neuron projection retraction,BP,EPHB2
17515,GO:1900450,0.111430743856495,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
19017,GO:1904782,0.111430743856495,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
2761,GO:0006171,0.111436046939443,0.9605572868919,5,25,cAMP biosynthetic process,BP,PTHLH;ADCY7;GNAI2;CAP1;ADCY6
3521,GO:0007497,0.111443576960022,1,1,1,posterior midgut development,BP,RET
6383,GO:0021566,0.111466593130595,1,1,1,hypoglossal nerve development,BP,ADARB1
6405,GO:0021618,0.111466593130595,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
1611,GO:0004031,0.111474302673892,1,1,1,aldehyde oxidase activity,MF,AOX1
5597,GO:0016623,0.111474302673892,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
17193,GO:0102797,0.111474302673892,1,1,1,geranial:oxygen oxidoreductase activity,MF,AOX1
17194,GO:0102798,0.111474302673892,1,1,1,heptaldehyde:oxygen oxidoreductase activity,MF,AOX1
6679,GO:0030037,0.111480810081469,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
3200,GO:0006835,0.111493850932233,0.948671730295803,8,46,dicarboxylic acid transport,BP,SLC13A3;VAMP2;GIPC1;STXBP1;SLC13A5;NTSR1;PRAF2;APBA1
17141,GO:0102008,0.111497796769801,1,1,1,cytosolic dipeptidase activity,MF,CNDP2
17202,GO:0103046,0.111497796769801,1,1,1,alanylglutamate dipeptidase activity,MF,CNDP2
16699,GO:0097623,0.111500672289182,1,1,1,potassium ion export across plasma membrane,BP,DLG1
18579,GO:1903764,0.111500672289182,1,1,1,regulation of potassium ion export across plasma membrane,BP,DLG1
11570,GO:0046092,0.111512980489549,1,1,1,deoxycytidine metabolic process,BP,TK2
7067,GO:0030849,0.111543203331522,1,1,1,autosome,CC,SIN3B
13245,GO:0051886,0.111547697397039,1,1,1,negative regulation of timing of anagen,BP,FERMT1
20285,GO:2001203,0.111547697397039,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
10263,GO:0042988,0.111555407937296,1,1,1,X11-like protein binding,MF,CLSTN1
7473,GO:0031626,0.111558695413779,1,1,1,beta-endorphin binding,MF,IDE
19863,GO:2000297,0.111578783899889,1,1,1,negative regulation of synapse maturation,BP,NFATC4
3909,GO:0008555,0.111589124734669,1,1,1,chloride-transporting ATPase activity,MF,PCYOX1
9782,GO:0039552,0.111599894559933,1,1,1,RIG-I binding,MF,SEC14L1
13979,GO:0060665,0.111604823853947,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
16244,GO:0090272,0.111604823853947,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
18447,GO:1903465,0.111604823853947,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
20171,GO:2000830,0.111604823853947,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
2093,GO:0004855,0.111605605337347,1,1,1,xanthine oxidase activity,MF,XDH
5645,GO:0016727,0.111605605337347,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
20290,GO:2001213,0.111605605337347,1,1,1,negative regulation of vasculogenesis,BP,XDH
8878,GO:0034676,0.111605622607734,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
743,GO:0001971,0.11160562813861,1,1,1,negative regulation of activation of membrane attack complex,BP,CD59
3731,GO:0008267,0.11160562813861,1,1,1,poly-glutamine tract binding,MF,RERE
5772,GO:0016964,0.11160562813861,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
10701,GO:0043969,0.11160562813861,1,1,1,histone H2B acetylation,BP,EP300
14507,GO:0061920,0.11160562813861,1,1,1,protein propionyltransferase activity,MF,EP300
14508,GO:0061921,0.11160562813861,1,1,1,peptidyl-lysine propionylation,BP,EP300
15741,GO:0072287,0.11160562813861,1,1,1,metanephric distal tubule morphogenesis,BP,PKD1
15785,GO:0072363,0.11160562813861,1,1,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15788,GO:0072366,0.11160562813861,1,1,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
16473,GO:0097117,0.11160562813861,1,1,1,guanylate kinase-associated protein clustering,BP,SHANK3
17315,GO:0140064,0.11160562813861,1,1,1,peptide crotonyltransferase activity,MF,EP300
17316,GO:0140065,0.11160562813861,1,1,1,peptide butyryltransferase activity,MF,EP300
17318,GO:0140067,0.11160562813861,1,1,1,peptidyl-lysine butyrylation,BP,EP300
17319,GO:0140068,0.11160562813861,1,1,1,histone crotonyltransferase activity,MF,EP300
17320,GO:0140069,0.11160562813861,1,1,1,histone butyryltransferase activity,MF,EP300
17568,GO:1901074,0.11160562813861,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17569,GO:1901076,0.11160562813861,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
18093,GO:1902630,0.11160562813861,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18094,GO:1902631,0.11160562813861,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
18138,GO:1902769,0.11160562813861,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18139,GO:1902771,0.11160562813861,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18203,GO:1902948,0.11160562813861,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18210,GO:1902955,0.11160562813861,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18233,GO:1902997,0.11160562813861,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
604,GO:0001770,0.11160562813861,1,1,1,establishment of natural killer cell polarity,BP,SNX27
1356,GO:0003221,0.11160562813861,1,1,1,right ventricular cardiac muscle tissue morphogenesis,BP,CHD7
1359,GO:0003226,0.11160562813861,1,1,1,right ventricular compact myocardium morphogenesis,BP,CHD7
1637,GO:0004077,0.11160562813861,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1638,GO:0004078,0.11160562813861,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1639,GO:0004079,0.11160562813861,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1640,GO:0004080,0.11160562813861,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
1747,GO:0004344,0.11160562813861,1,1,1,glucose dehydrogenase activity,MF,H6PD
2341,GO:0005368,0.11160562813861,1,1,1,taurine transmembrane transporter activity,MF,SLC6A6
2342,GO:0005369,0.11160562813861,1,1,1,taurine:sodium symporter activity,MF,SLC6A6
2364,GO:0005464,0.11160562813861,1,1,1,UDP-xylose transmembrane transporter activity,MF,SLC35B4
4182,GO:0009258,0.11160562813861,1,1,1,10-formyltetrahydrofolate catabolic process,BP,ALDH1L2
4199,GO:0009305,0.11160562813861,1,1,1,protein biotinylation,BP,HLCS
4458,GO:0010428,0.11160562813861,1,1,1,methyl-CpNpG binding,MF,ZBTB4
4911,GO:0014843,0.11160562813861,1,1,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,FGF2
5179,GO:0015734,0.11160562813861,1,1,1,taurine transport,BP,SLC6A6
5199,GO:0015790,0.11160562813861,1,1,1,UDP-xylose transmembrane transport,BP,SLC35B4
5369,GO:0016155,0.11160562813861,1,1,1,formyltetrahydrofolate dehydrogenase activity,MF,ALDH1L2
5946,GO:0018271,0.11160562813861,1,1,1,biotin-protein ligase activity,MF,HLCS
5971,GO:0018400,0.11160562813861,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
6372,GO:0021553,0.11160562813861,1,1,1,olfactory nerve development,BP,CHD7
6476,GO:0021812,0.11160562813861,1,1,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,LAMB1
7039,GO:0030807,0.11160562813861,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7054,GO:0030822,0.11160562813861,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
8302,GO:0033123,0.11160562813861,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
8645,GO:0034164,0.11160562813861,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
8797,GO:0034474,0.11160562813861,1,1,1,U2 snRNA 3'-end processing,BP,INTS1
9340,GO:0035811,0.11160562813861,1,1,1,negative regulation of urine volume,BP,ADCY6
10135,GO:0042660,0.11160562813861,1,1,1,positive regulation of cell fate specification,BP,FGF2
10428,GO:0043257,0.11160562813861,1,1,1,laminin-8 complex,CC,LAMB1
11459,GO:0045887,0.11160562813861,1,1,1,positive regulation of synaptic growth at neuromuscular junction,BP,AGRN
12067,GO:0047936,0.11160562813861,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
12340,GO:0048677,0.11160562813861,1,1,1,axon extension involved in regeneration,BP,LAMB2
13811,GO:0060378,0.11160562813861,1,1,1,regulation of brood size,BP,SH3PXD2B
14946,GO:0070781,0.11160562813861,1,1,1,response to biotin,BP,HLCS
15115,GO:0071110,0.11160562813861,1,1,1,histone biotinylation,BP,HLCS
15722,GO:0072244,0.11160562813861,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15723,GO:0072248,0.11160562813861,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15724,GO:0072249,0.11160562813861,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15735,GO:0072274,0.11160562813861,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15756,GO:0072312,0.11160562813861,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15757,GO:0072313,0.11160562813861,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
16963,GO:0098923,0.11160562813861,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16964,GO:0098924,0.11160562813861,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16974,GO:0098948,0.11160562813861,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
17009,GO:0099060,0.11160562813861,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
17010,GO:0099061,0.11160562813861,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
17038,GO:0099146,0.11160562813861,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
17040,GO:0099163,0.11160562813861,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17082,GO:0099543,0.11160562813861,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17085,GO:0099548,0.11160562813861,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17341,GO:0140196,0.11160562813861,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
18442,GO:1903450,0.11160562813861,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18443,GO:1903452,0.11160562813861,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
10899,GO:0044430,0.111847712821358,0.905551293898786,138,1189,cytoskeletal part,CC,CAPN2;MST1R;RAC2;DVL1;MAP2K1;CLIP2;KLC2;DLG1;DYSF;PITPNM1;MTA1;RAPGEF3;SCYL1;TMOD2;ESPN;TNNT1;TMEM214;SNPH;BBS2;TUBB6;USP20;NUDCD3;MARK4;SEPT10;PRKACA;CORO1B;MAP2K2;TUBG2;ATF4;HECW2;AKT1;ACOT13;ARPC1A;AFAP1L1;TMSB4X;PRKCZ;VPS4A;CCDC92;SH3PXD2B;FERMT1;EML2;SEPT5;MAP1B;OBSL1;PRKACB;TWF2;TACC1;FSCN1;CCDC88C;PAK1;TTBK2;NAV1;PODXL;CUL7;TUBB3;REEP2;PROCR;SEPT8;SHANK2;WDR66;PHF1;ARL8A;GNAI2;MYH16;HSF1;ADGRB2;NEK9;ADAM8;MAPKBP1;NEIL1;MYH15;DYNLRB1;FAM110C;ARL2;CAP1;FLNB;TULP3;SRC;LDLRAP1;CAPG;DNM2;NINL;UBR4;CDC42BPB;SDCCAG8;SPECC1L;FYN;REEP4;MICAL1;KIF17;KIF13B;BRSK1;PSKH1;TUBG1;CEP170;TTC19;VPS37A;RAB11FIP4;BCL2L1;PTPN12;RAD23A;ARFGEF2;HSPA2;MAP1LC3B;MYO1D;SNTB2;PBXIP1;NDE1;CAMSAP3;INVS;GSDMC;WIPF1;SNAP29;KRT23;MYL9;GAS8;CIB1;TMSB10;WRAP73;CSNK1D;KIFC3;ARHGEF2;MYZAP;LLGL1;MPLKIP;ENKD1;MAP6;SAC3D1;SH3PXD2A;ANXA1;CCDC113;PXN;PLEKHH2;RAP1GAP2;STIM1;MZT2B;ASAP1;FHOD1
6764,GO:0030193,0.11195475029368,0.948333302857248,8,47,regulation of blood coagulation,BP,F2R;PLAT;SERPINE2;SERPING1;APOE;F12;HPSE;CEACAM1
17379,GO:1900046,0.11195475029368,0.948333302857248,8,47,regulation of hemostasis,BP,F2R;PLAT;SERPINE2;SERPING1;APOE;F12;HPSE;CEACAM1
12034,GO:0047617,0.112012466590922,0.974015520913705,3,12,acyl-CoA hydrolase activity,MF,ACOT7;ACOT1;ACOT13
7292,GO:0031279,0.112018228594884,0.966337940435476,4,18,regulation of cyclase activity,BP,NOS1;GNAI2;CAP1;MAPK3
5618,GO:0016667,0.112061736800257,0.94806048644621,8,50,oxidoreductase activity, acting on a sulfur group of donors,MF,QSOX1;SESN2;P4HB;PDIA5;MSRB2;ERO1B;GLRX;PCYOX1
5602,GO:0016635,0.112239610222156,0.98461464590919,2,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHA;SDHAF4
2751,GO:0006152,0.112652386976017,0.984523954723324,2,6,purine nucleoside catabolic process,BP,AHCY;PNP
11591,GO:0046130,0.112652386976017,0.984523954723324,2,6,purine ribonucleoside catabolic process,BP,AHCY;PNP
7957,GO:0032550,0.113323838890268,0.918489664694535,36,283,purine ribonucleoside binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
8061,GO:0032717,0.11334231169077,0.973569305282652,3,12,negative regulation of interleukin-8 production,BP,TMSB4X;MAPKBP1;ANXA1
12874,GO:0051173,0.113355467522706,0.900797668823023,236,2098,positive regulation of nitrogen compound metabolic process,BP,TNIP1;EDEM1;XDH;ERCC1;NOS1;CCND1;F2R;MST1R;SORL1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;SNX9;BOK;CRTC1;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;FKBP1A;SOX12;MTA1;ITGA6;RAPGEF3;PRNP;CITED4;SMARCA1;SMURF2;FAM129B;MAPKAPK3;SESN2;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;RFX2;PRKACA;MAP2K2;STK25;ATF4;HECW2;SNX33;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;PKN1;ELK3;WWTR1;TMSB4X;PRKCZ;POU2F2;TFEB;DGKQ;VPS11;FZD8;EPHA1;ZMIZ2;PTK6;PCSK9;ENDOG;DEAF1;SALL2;MSN;TGFBR2;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;PRKACB;SHC2;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MC1R;ANKIB1;LARP6;TFE3;CCND2;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;RET;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;DLG3;GATA3;APLN;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;RAI1;HMGA2;MICAL2;MYDGF;SRC;TAZ;DNM2;FAM162A;IRF7;RFXANK;RAB1B;STK24;PAK6;STX5;RERE;RSF1;GSK3A;CAMTA2;DUSP6;FYN;AGRN;PPM1F;LPAR3;TNFRSF1A;ANXA3;VDR;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;MAP3K10;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;F12;USF2;PBX3;MIF;STUB1;TRIB3;SLC27A1;ZFPM1;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;P2RX4;E2F5;SMPD3;ZP3;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;APBB1;RXRA;TGFA;SEC14L2;IMPACT;CASP4;CAMK1;EPHB2;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;MINK1;LPIN3;ADCY6;CCNE1;TGFB1;WBP2;PIK3R2;ERBB3;PPP1R10;ASH2L;PLGRKT;ZNF318;ARHGEF10L;EP300;WDFY2;FHOD1;TRAF7;RNF10
6842,GO:0030301,0.113437323362026,0.947416025420268,8,48,cholesterol transport,BP,APOE;VPS4A;PCSK9;OSBPL5;LDLRAP1;PLTP;LRP1;ABCA7
11750,GO:0046546,0.113446137416052,0.93481004206934,14,95,development of primary male sexual characteristics,BP,ERCC1;CCND1;SDC1;CST3;BOK;MMP14;GATA3;ARID5B;AGO4;EIF2S2;BCL2L1;TBC1D20;CBL;ADAM15
7614,GO:0031995,0.114454947810323,0.9841254063055,2,6,insulin-like growth factor II binding,MF,IGFBP4;IGFBP2
13126,GO:0051641,0.114510936344991,0.899604020238967,242,2189,cellular localization,BP,EDEM1;ZMYND8;NOS1;LTBP2;SH3TC2;F2R;RAC2;SORL1;DVL1;MAP2K1;WNT7A;SNX9;AP3D1;LMF1;DLG4;OBSCN;CPT2;BSG;NR1D1;DLG1;XPOT;FKBP1A;RAB3B;RAPGEF3;PRNP;LAMA5;SSH1;RAB43;COPG1;MARVELD1;SESN2;SNPH;BBS2;NACC2;BCR;SYNE3;RAB31;NUDCD3;ETV5;MARK4;LRP5;EVI5L;MAP4K4;EGFR;RTN2;CSNK1E;FYCO1;SEPT10;PRKACA;CORO1B;TUB;HK1;MAP2K2;STK25;SHANK3;TTC7B;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ATP7B;ITPR3;VPS11;VPS4A;PITRM1;CTSZ;TMEM129;SH3PXD2B;PCSK9;SEPT5;SEC23A;MSN;MAP1B;GDI1;MVB12B;CREB3L2;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;OBSL1;ZDHHC8;IPO13;ESYT2;PLCG1;TBC1D16;ATG13;SEC63;TWF2;TBC1D14;TSPAN5;MALL;BIN1;CCDC88C;PAK1;TTBK2;ZNF385A;NLGN2;DDIT3;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;SEPT8;PKD1;PARP10;DLG3;OXA1L;DOPEY2;GRIN3B;ASIC1;FAM155B;PTPRU;DYNLRB1;ARL2;NUMB;VAMP2;FLNB;PIP5K1C;GIPC1;TULP3;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;NINL;REEP6;LRSAM1;NUCB1;RAB1B;STX5;TOM1L2;SDCCAG8;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;AGRN;SLC6A9;KIF17;TNFRSF1A;ABHD17C;KIF13B;TSPAN33;BRSK1;STX10;MOAP1;MCFD2;NTSR1;SEC24C;TUBG1;VPS37A;RAB11FIP4;BCL2L1;MAU2;LEMD2;TPCN1;ARFIP2;LRP1;MGRN1;P2RX4;USO1;TBC1D20;SPIRE1;FGF2;EHD4;VAPB;COG1;MYO1D;CHD7;ABCA7;LMAN1;TBC1D2B;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;WIPF1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;HGS;GAS8;CBL;TRAPPC1;CIB1;TMSB10;RAB4B;PACS2;MAPK3;CPT1B;CSNK1D;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;HM13;APBA1;ARHGAP44;CD59;MAP6;SLC30A1;CCNE1;ITSN1;TGFB1;PPP6R1;PPP1R10;RAB6A;ZFYVE21;ITGA3;ARCN1;RASA3;FHOD1
10169,GO:0042743,0.114550546305077,0.958783174202537,5,27,hydrogen peroxide metabolic process,BP,RAC2;EGFR;PRDX5;GPX3;CAT
12335,GO:0048670,0.1146110604449,0.973141221123124,3,12,regulation of collateral sprouting,BP,PTPRS;LPAR3;ULK2
3884,GO:0008514,0.11473117603135,0.927980962333725,19,133,organic anion transmembrane transporter activity,MF,SERINC2;SLCO4A1;BSG;SLC16A3;SLC2A9;SLC38A10;SLC2A3;SLC6A6;SLC13A3;SLC43A1;TMEM44;SLC6A9;SLC33A1;SLC13A5;SLC35B4;SLC27A1;SLC6A14;SLC10A6;CEACAM1
17911,GO:1902166,0.11481227643166,0.972684990898683,3,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44;ZNF385A;MIF
958,GO:0002376,0.114813981762813,0.900221279600494,206,1863,immune system process,BP,TNIP1;PGF;PYGB;ERCC1;MST1R;RAC2;RBCK1;CTNNBIP1;SDC1;MAP2K1;SHC1;PYGL;QSOX1;CST3;CYP27B1;AP3D1;NAPRT;BSG;NR1D1;KLC2;DLG1;SLC16A3;MMP1;IFI6;PGM1;FKBP1A;PSMD2;RAB3B;CKAP4;ITGA6;PTPRS;PRSS3;PRNP;BNIP3;CD68;RAB43;LCN2;MAPKAPK3;CTSB;BCR;RAB31;LPCAT1;LRP5;ITGB5;XBP1;CMTM7;MKNK2;MMP14;PRKACA;ADARB1;HK1;AKT1;IFITM1;CARD11;IRAK1;ARPC1A;SERPING1;FAM210B;ARG2;PKN1;AP1B1;AP2A2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;FZD8;HIST2H2BE;CTSZ;PI4K2A;PTK6;ORAI1;RRAS;SEC23A;MSN;TGFBR2;CD99;SERPINB6;LIMK1;BNIP3L;FAM3A;DHTKD1;KDELR1;PRKACB;WASF2;CD44;PLCG1;GTPBP1;SURF4;TFE3;HTRA1;PAK1;AHCY;ZNF385A;RAG1;TNFSF15;STOM;SATB1;FUCA1;RET;RAB29;DNASE1L1;IFI27;PROCR;ATP11A;GATA3;APLN;ARL8A;OASL;SLC2A3;IL1RAP;MT2A;ADAM8;IGFBP2;CAP1;VAMP2;FLNB;PIP5K1C;TSC22D4;TNFRSF6B;SRC;TAZ;DNM2;UBR4;AGO4;IRF7;C6ORF120;STXBP1;PAG1;OAS1;FYN;ISG20;YPEL5;PSMD7;TNFRSF1A;ANXA3;KIF13B;GAL;PUM1;ITGA1;FCGRT;CTSL;TNRC6B;THRA;HEXIM1;SEC24C;LRRC8A;F12;MFNG;MIF;TCIRG1;ZFPM1;LRP1;HPSE;SMPD3;ZP3;LRRK1;PNP;RNASE7;MAPK9;SDHAF4;CHD7;ARG1;L3MBTL3;VEGFB;SEC14L1;WIPF1;VAT1;CASP4;SNAP29;POLM;MYL9;CBL;TRAPPC1;GGT1;CIB1;RAB4B;MAPK3;MAPK10;DNAJB9;ALDOC;GLO1;ARHGEF2;SNX27;TMBIM1;MLF1;ADAM15;CEACAM1;SKAP2;ECM1;CD59;TGFB1;SH3PXD2A;CAT;PIK3R2;ANXA1;PODXL2;ASH2L;RAB6A;APOBEC3C;GNAS;ITGA3;EP300;ERP44
4531,GO:0010594,0.114826970849674,0.931198707241652,16,110,regulation of endothelial cell migration,BP,WNT7A;AKT1;APOE;TMSB4X;PLCG1;GATA3;SH3BP1;ANXA3;FGFR1;P2RX4;FGF2;CIB1;SRPX2;CEACAM1;TGFB1;ANXA1
1695,GO:0004167,0.114912849830872,0.996497204691754,1,2,dopachrome isomerase activity,MF,MIF
5726,GO:0016862,0.114912849830872,0.996497204691754,1,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,MIF
12469,GO:0050178,0.114912849830872,0.996497204691754,1,2,phenylpyruvate tautomerase activity,MF,MIF
18729,GO:1904063,0.115022101392101,0.949906339506363,7,40,negative regulation of cation transmembrane transport,BP,HECW2;PCSK9;STK39;NTSR1;EPHB2;SLC30A1;TGFB1
2521,GO:0005774,0.115116547575622,0.914620386802423,43,342,vacuolar membrane,CC,TSPAN1;AP3D1;CKAP4;CD68;MARCH9;LPCAT1;VLDLR;ATG16L2;ATP13A2;AP1B1;AP2A2;VPS11;VPS4A;PI4K2A;PCSK9;SURF4;STOM;GNB1;ATP11A;ARL8A;SLC12A4;TMEM8A;TMEM9;TMEM44;GNB2;UBA1;WDFY3;TCIRG1;TPCN1;ULK1;LRP1;P2RX4;HPSE;MAP1LC3B;ATP6V1C2;CYB561;SNAP29;DRAM2;LITAF;C12ORF66;TMBIM1;HM13;PCYOX1
13286,GO:0051954,0.115125867008965,0.972966864310229,3,12,positive regulation of amine transport,BP,RAB3B;STXBP1;NTSR1
14966,GO:0070841,0.115577795414489,0.964872605021411,4,18,inclusion body assembly,BP,SORL1;CDC34;HSF1;HSPA2
12611,GO:0050768,0.115678044750872,0.923077038506551,24,176,negative regulation of neurogenesis,BP,SORL1;NFATC4;WNT7A;PTPRS;IDH2;SEMA3F;MAP4K4;APOE;CTSZ;GDI1;SEMA4B;PTPN9;RAB29;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ARHGEF2;ADCY6;TGFB1;RAP1GAP2;ASAP1;RNF10
17897,GO:1902107,0.115735589910135,0.934848688707669,13,87,positive regulation of leukocyte differentiation,BP,CTNNBIP1;AP3D1;XBP1;MMP14;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1;GNAS
5696,GO:0016813,0.11582579288971,0.983819584410317,2,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,ARG2;ARG1
601,GO:0001766,0.115943706307181,0.983793169286171,2,6,membrane raft polarization,BP,MARVELD1;MALL
7451,GO:0031580,0.115943706307181,0.983793169286171,2,6,membrane raft distribution,BP,MARVELD1;MALL
3594,GO:0008022,0.11602565009564,0.924316408151451,22,161,protein C-terminus binding,MF,ERCC1;SDC1;MAP2K1;ERCC6;DLG4;DLG1;SLC9A3R2;FBLN1;SHANK3;ATF4;VPS4A;EML2;RABAC1;SIPA1;DLG3;CTBP1;NEIL1;SRC;MIF4GD;CIB1;ECM1;EP300
4495,GO:0010518,0.116365774478292,0.958253984474666,5,25,positive regulation of phospholipase activity,BP,EGFR;PRKCZ;EDNRA;FGFR1;FGF2
15580,GO:0072009,0.116446260378612,0.938187837733035,11,69,nephron epithelium development,BP,PGF;CTNNBIP1;DLG1;LAMA5;WWTR1;LAMB2;PODXL;PKD1;GATA3;FGF2;TGFB1
10913,GO:0044449,0.116453742933046,0.928825686280782,17,120,contractile fiber part,CC,FLNC;NOS1;SCN8A;OBSCN;FKBP1A;TMOD2;TNNT1;PARVB;BAG3;OBSL1;BIN1;PAK1;FLNB;STUB1;LMAN1;MYL9;MYZAP
4896,GO:0014820,0.11680801940418,0.983599014302522,2,6,tonic smooth muscle contraction,BP,BBS2;EDNRA
5849,GO:0017137,0.116993776477127,0.923649356173813,22,158,Rab GTPase binding,MF,SBF1;EVI5L;RIN2;RABGGTA;GDI1;RIN1;YIPF2;TBC1D16;TBC1D14;DMXL2;TBC1D9B;SYTL1;RAB29;DENND2A;MICAL1;RAB11FIP4;ULK1;TBC1D20;TBC1D2B;GAS8;TRAPPC1;LLGL1
4622,GO:0010738,0.117213870941074,0.972255811972597,3,12,regulation of protein kinase A signaling,BP,AKAP12;MC1R;MIF
16195,GO:0090197,0.117308012140786,0.983486272595079,2,6,positive regulation of chemokine secretion,BP,POSTN;ALOX15B
5074,GO:0015295,0.117443353902779,0.9640973158279,4,18,solute:proton symporter activity,MF,SLC2A9;SLC33A1;SLC15A1;SLC45A3
7111,GO:0030902,0.117551555203682,0.933719992358086,13,85,hindbrain development,BP,MAP2K1;WNT7A;SERPINE2;PTPRS;AARS;NAGLU;PAK1;TTBK2;B4GALT2;ALDH1A2;RERE;SOCS7;ARCN1
11713,GO:0046487,0.117598525117434,0.983420622550468,2,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1
4582,GO:0010665,0.117667342502838,0.964003894669287,4,18,regulation of cardiac muscle cell apoptotic process,BP,BNIP3;HSF1;RGL2;PPP1R10
14646,GO:0070201,0.11769494692061,0.907944523406445,62,514,regulation of establishment of protein localization,BP,EDEM1;SH3TC2;F2R;RAC2;SORL1;PCK2;NR1D1;POSTN;RAPGEF3;PRNP;IDH2;LRP5;XBP1;MAP4K4;EGFR;RHBDF2;HK1;BAG3;ATP13A2;ARG2;TMSB4X;PRKCZ;ITPR3;VPS11;FERMT1;GDI1;HADH;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;IFI27;CEMIP;PARP10;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;SRC;NUCB1;CPTP;GSK3A;FYN;MIF;LRP1;APBB1;CAMK1;CIB1;MAPK3;UGCG;LLGL1;TGFB1;ANXA1
17488,GO:1900272,0.11770232604121,0.983397140129324,2,6,negative regulation of long-term synaptic potentiation,BP,PRNP;APOE
20305,GO:2001239,0.117749385896249,0.952347427139938,6,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;AKT1;RET;FYN;FGFR1;BCL2L1
2250,GO:0005160,0.117834987364633,0.957560855470452,5,25,transforming growth factor beta receptor binding,MF,FKBP1A;SMURF2;TGFBR2;SNX25;TGFB1
3288,GO:0006979,0.11802163922129,0.913229896220471,40,324,response to oxidative stress,BP,ERCC1;SDC1;ERCC6;CST3;NAPRT;NET1;PRNP;BNIP3;CYGB;SESN2;ETV5;EGFR;MMP14;STK25;ATF4;P4HB;AKT1;APOE;ATP13A2;MAPK13;ENDOG;MSRB2;PRDX5;HSF1;NEIL1;PYCR2;SRC;DNM2;STK24;GPX3;HYAL1;MAPK9;ARG1;IMPACT;MAPK3;NDUFS2;CAT;LDHA;ANXA1;PXN
11483,GO:0045923,0.118052435487009,0.963843112215682,4,18,positive regulation of fatty acid metabolic process,BP,PPARA;MLYCD;ANXA1;SLC45A3
16740,GO:0097720,0.118121430577524,0.957425366523168,5,25,calcineurin-mediated signaling,BP,NFATC4;PRNP;ADGRB2;CIB1;ERBB3
10835,GO:0044319,0.118305311481424,0.957338329295073,5,25,wound healing, spreading of cells,BP,WNT7A;CD44;RHOC;RREB1;CEACAM1
16339,GO:0090505,0.118305311481424,0.957338329295073,5,25,epiboly involved in wound healing,BP,WNT7A;CD44;RHOC;RREB1;CEACAM1
7761,GO:0032272,0.118387831114017,0.944579150608841,8,48,negative regulation of protein polymerization,BP,TMOD2;TMSB4X;EML2;TWF2;CAPG;PFN1;TMSB10;KANK2
4386,GO:0010035,0.118475124647976,0.911872789101832,43,349,response to inorganic substance,BP,ERCC1;CCND1;NFATC4;SDC1;ERCC6;CST3;BSG;DNMT3A;FKBP1A;NET1;PRNP;BNIP3;EGFR;STK25;ATF4;AKT1;ATP13A2;ATP7B;ITPR3;MAPK13;ENDOG;GDI1;SIPA1;HSF1;MT2A;IGFBP2;SRC;DNM2;STK24;ADNP;MAPK9;ENTPD6;APBB1;ARG1;IMPACT;MAPK3;S100A16;UROS;SLC30A1;CAT;LDHA;ANXA1;STIM1
4067,GO:0009116,0.118566871556297,0.931254503897649,14,99,nucleoside metabolic process,BP,NT5E;DLG4;DLG1;NME4;TK2;CARD11;GTPBP1;AHCY;GAMT;DLG3;UCKL1;GUK1;PNP;APOBEC3C
12361,GO:0048708,0.118614452775875,0.947941910623715,7,40,astrocyte differentiation,BP,MAP2K1;SERPINE2;EGFR;LAMB2;BIN1;LRP1;MAPK3
7494,GO:0031657,0.118652932958018,0.97176214271881,3,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;AKT1;PKD1
675,GO:0001882,0.118820356494853,0.913734228893008,37,293,nucleoside binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;PNP;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
884,GO:0002246,0.119058859485475,0.983089023772447,2,6,wound healing involved in inflammatory response,BP,F2R;TGFB1
3601,GO:0008037,0.11932718072763,0.938532207911507,10,63,cell recognition,BP,DLG1;LAMA5;TUB;PEAR1;MSN;CADM4;ROBO3;ZP3;EPHB2;SPESP1
10391,GO:0043202,0.119372413569787,0.93623966394929,11,71,lysosomal lumen,CC,SDC1;CTSB;GPC4;ATP13A2;GALNS;NAGLU;FUCA1;AGRN;CTSL;HYAL1;HPSE
4391,GO:0010042,0.119430197343198,0.971494282751286,3,12,response to manganese ion,BP,ATF4;ATP13A2;ARG1
4665,GO:0010811,0.119486505768637,0.934201144794159,12,78,positive regulation of cell-substrate adhesion,BP,ITGA6;NET1;PRKCZ;EPHA1;FERMT1;NID1;ARL2;DNM2;PPM1F;RREB1;CIB1;ITGA3
3318,GO:0007026,0.119506741987542,0.963234005757332,4,18,negative regulation of microtubule depolymerization,BP,TTBK2;CAMSAP3;CIB1;ARHGEF2
13963,GO:0060612,0.119529836287058,0.956757510737624,5,25,adipose tissue development,BP,LRP5;XBP1;SH3PXD2B;ZNF516;ARID5B
5233,GO:0015846,0.119795749896393,0.982920690391128,2,6,polyamine transport,BP,ATP13A2;AZIN2
14750,GO:0070403,0.119949994522724,0.971314674562353,3,12,NAD+ binding,MF,CRYL1;HADH;GLUD1
11791,GO:0046634,0.119982874048599,0.947189111188926,7,40,regulation of alpha-beta T cell activation,BP,AP3D1;ARG2;PRKCZ;TGFBR2;GATA3;PNP;ANXA1
4285,GO:0009650,0.120005912862252,0.971295330096863,3,12,UV protection,BP,ERCC1;MC1R;CAT
14528,GO:0065007,0.120155136515798,0.892084856175298,842,7914,biological regulation,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;TSPAN1;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;CHAC1;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;AP3D1;LMF1;SCN8A;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;DLG1;TRIM65;DAP;CMTM4;IGFBP4;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;SBF1;PC;LAMA5;SSH1;WWC3;TXNDC11;RAB43;CCNI;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;TMOD2;BCORL1;PLCH2;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;ABTB1;TNNT1;SNPH;PLEK2;ZC3H6;MRC2;BBS2;SEMA3F;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;LPCAT1;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;HTR7;KIAA1549;ADCY7;XBP1;MARCKSL1;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;CSNK1E;PANO1;MKNK2;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;PRKACA;ADARB1;PTPRF;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;EPN1;PPP1R13L;STK25;PARVB;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;PDIA5;AKT1;XPC;IFITM1;BRD3;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;EPN2;BAG3;APOE;EHD3;FAM210B;FMNL2;ATP13A2;ARG2;METTL23;RIN2;PKN1;PEAR1;ZSCAN30;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;FBXO2;RETSAT;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;GIT2;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;MSN;PPP1R35;MAP1B;TGFBR2;CSMD3;CD99;DRAP1;GDI1;HADH;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;FAM3A;KDELR1;PRSS8;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;CDC34;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;TWF2;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TTBK2;RHPN1;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;NLGN2;DTD1;TNRC18;RAG1;SEMA4B;BAZ2A;GAMT;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;CUL7;DMXL2;TBC1D9B;GGA3;ARHGAP39;GGA1;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;PTOV1;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;PROCR;HLTF;PCBP4;CEMIP;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;TP53I11;APLN;PHF1;OXA1L;TCFL5;OASL;MYOF;DOCK6;GNAI2;ZNF165;ANTXR2;GRIN3B;ASIC1;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;BCL7A;ALOX15B;IL1RAP;WFS1;SRD5A3;SLC12A4;EFS;ASPH;MT2A;FAM155B;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;RGL2;HMGA2;ALAS1;ARID5B;RHOBTB2;TOP1;PPP1R14A;FAM110C;ARL2;LY6E;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;CAP1;MYDGF;CLEC11A;GPRC5C;EIF4EBP1;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;KDM4B;DENND2A;GLRX;CAPG;POLD4;SCG5;TAZ;TGM2;DNM2;NINL;SARAF;REEP6;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NCS1;PAQR7;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;ESRP1;SDCCAG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;ISG20;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;LPAR3;WNT5B;SLC6A9;GRINA;PFN1;NELFCD;NISCH;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;ANXA3;WISP1;HSD11B1;TLE4;FBXL15;SLC33A1;VDR;ABHD17C;KIF13B;PLEKHG5;TSPAN33;BRSK1;SSU72;STX10;CGREF1;MOAP1;GJC2;GAL;PUM1;ITGA1;FCGRT;GNB2;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;PLTP;NTSR1;MAP3K10;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LGALS3BP;SEMA4G;SECISBP2L;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;ATP2C2;ADNP;HYAL1;LRRC8A;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;MIF;SOCS2;MTMR4;HES2;ASB13;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;VPS9D1;DNMBP;TRIB3;DDB2;ZFPL1;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;RAD23A;ARFGEF2;ULK1;LRP1;ROBO3;TRIB2;HSPA2;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;RNH1;MED15;VAPB;MAPK9;ZNF570;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;BICC1;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;HIST2H2AC;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;BAHCC1;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;KLK6;VAT1;CASP4;SNAP29;LONP2;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;HGS;CARHSP1;DRG2;MYL9;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;SOCS7;RAB4B;IQSEC1;WRAP73;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;DRAM2;DNAJB9;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;OCRL;ZFP30;ADAM15;SRPX2;MED29;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;ECM1;CD59;MBD3;SLC30A1;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;WBP2;TM2D1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;PXN;ZNF318;ARHGEF10L;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;STIM1;RASA3;ASAP1;FHOD1;TRAF7;RNF10
12508,GO:0050482,0.120414687124638,0.971153784270755,3,12,arachidonic acid secretion,BP,NTSR1;MIF;ANXA1
18676,GO:1903963,0.120414687124638,0.971153784270755,3,12,arachidonate transport,BP,NTSR1;MIF;ANXA1
11390,GO:0045741,0.120432364556012,0.982774720525977,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1;TGFA
980,GO:0002431,0.120549074820196,0.937830654180648,10,62,Fc receptor mediated stimulatory signaling pathway,BP,ARPC1A;LIMK1;WASF2;PLCG1;PAK1;SRC;FYN;WIPF1;MAPK3;PIK3R2
10827,GO:0044306,0.121090358069708,0.93311580526541,12,79,neuron projection terminus,CC,AP3D1;DLG4;FKBP1A;SEPT5;GLUL;PTPN9;VAMP2;STXBP1;MICAL1;NTSR1;P2RX4;KCNC4
4276,GO:0009635,0.121133139092703,0.970904436361248,3,12,response to herbicide,BP,MAPK13;HSF1;ARG1
11702,GO:0046471,0.121236023367504,0.955944739023006,5,25,phosphatidylglycerol metabolic process,BP,LPCAT4;LPCAT1;CDS2;TAZ;SLC27A1
6072,GO:0019218,0.121275215518898,0.932955313238193,12,80,regulation of steroid metabolic process,BP,CYP27B1;LMF1;NR1D1;APOE;DGKQ;LDLRAP1;ACADVL;PMVK;VDR;GAL;STUB1;SEC14L2
13925,GO:0060556,0.121323241382079,0.982569606244872,2,6,regulation of vitamin D biosynthetic process,BP,CYP27B1;VDR
9203,GO:0035579,0.121336857949921,0.939911398122934,9,55,specific granule membrane,CC,CKAP4;STOM;ATP11A;SLC2A3;ADAM8;UBR4;TMBIM1;CEACAM1;CD59
7132,GO:0030950,0.121447816133819,0.97079499503196,3,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOC;RHOBTB2;RHOBTB1
676,GO:0001883,0.121455573989982,0.912040675536231,36,285,purine nucleoside binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
17104,GO:0099604,0.121465878670598,0.962408705571325,4,18,ligand-gated calcium channel activity,MF,ITPR3;TPCN1;P2RX4;RASA3
10038,GO:0042473,0.121499426829232,0.982528924979629,2,6,outer ear morphogenesis,BP,FGFR1;MAPK3
2640,GO:0005975,0.121517033741896,0.906196264660564,55,448,carbohydrate metabolic process,BP,PYGB;PYGL;PCK2;NR1D1;IGFBP4;PGM1;IDH2;PC;LRP5;H6PD;PGLS;HK1;ATF4;AKT1;MDH2;CRYL1;DGKQ;PFKP;PPARA;DHTKD1;WDTC1;ISYNA1;CTBS;FUCA1;MLXIP;PIGQ;SLC2A3;B4GALT2;AKR7A2;B3GNT3;SRC;GSK3A;TALDO1;OAS1;MPI;GALE;NISCH;CHST14;NTSR1;SLC35B4;HYAL1;ADIPOR1;ST3GAL3;ST3GAL5;ST6GALNAC2;MLYCD;POMT1;ALDOC;GLO1;B4GALT6;GALNT3;NAGA;TGFB1;LDHA;SLC45A3
4314,GO:0009790,0.121567518044305,0.901764043268939,81,671,embryo development,BP,ITGB4;ERCC1;MDFI;CAPN2;DVL1;MAP2K1;WNT7A;DLG4;DLG1;DNMT3A;LAMA5;FAM129B;SEMA3F;BCR;LRP5;ACVR2B;ITGB5;EGFR;MMP14;LAMB1;EPN1;PPP1R13L;FBXW8;AKT1;TFEB;NAGLU;ENDOG;DEAF1;SALL2;TGFBR2;DKK1;SOX7;PRKACB;WDTC1;PLCG1;SUFU;DUSP4;RET;PKD1;DLG3;GATA3;APLN;HSF1;HMGA2;TOP1;MICAL2;EDNRA;TULP3;ALDH1A2;SPINT2;PCSK6;DUSP6;FUZ;PFN1;RCN1;EIF2S2;LAMB3;SEC24C;FGFR1;HYAL1;BCL2L1;ZFPM1;PLCD3;ZP3;FGF2;VASP;CHD7;RXRA;TSHZ1;CAMSAP3;EPHB2;MAPK3;OCRL;APBA1;MBD3;SLC30A1;TGFB1;SF3B6;GNAS;ITGA3;EP300
10068,GO:0042542,0.121616585535936,0.927714358459477,15,107,response to hydrogen peroxide,BP,SDC1;CST3;NET1;BNIP3;STK25;MAPK13;ENDOG;HSF1;SRC;STK24;ARG1;IMPACT;CAT;LDHA;ANXA1
16657,GO:0097499,0.121673176671435,0.982488768420933,2,6,protein localization to non-motile cilium,BP,TUB;TULP3
3014,GO:0006560,0.121727823155182,0.982476130952106,2,6,proline metabolic process,BP,PYCR2;ALDH4A1
7042,GO:0030810,0.1218816492859,0.950325493776352,6,33,positive regulation of nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;TMSB4X;TAZ;ADNP
17501,GO:1900373,0.1218816492859,0.950325493776352,6,33,positive regulation of purine nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;TMSB4X;TAZ;ADNP
3606,GO:0008047,0.122063206740519,0.907237551408612,49,392,enzyme activator activity,MF,ASAP2;MAP2K1;DOCK4;ERCC6;ARAP1;BCR;FBLN1;EVI5L;MMP14;ARHGAP23;MAP2K2;APOE;RIN2;DGKQ;ARHGAP22;PITRM1;SH3PXD2B;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;APPL2;RGS19;SH3BP1;VPS9D1;TBC1D20;ARAP3;TAOK1;TBC1D2B;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;ITSN1;TGFB1;SH3PXD2A;AZIN2;PIK3R2;ERBB3;RAP1GAP2;RASA3;ASAP1
15615,GO:0072078,0.122068648776861,0.942530418174601,8,47,nephron tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;PKD1;GATA3;FGF2;TGFB1
10726,GO:0044033,0.122099889534669,0.982389989075197,2,6,multi-organism metabolic process,BP,MAP2K1;MAP2K2
8740,GO:0034381,0.122415228324333,0.949922065154865,6,34,plasma lipoprotein particle clearance,BP,LMF1;VLDLR;APOE;AP2A2;PCSK9;LDLRAP1
14704,GO:0070306,0.122484333401435,0.961977527853736,4,18,lens fiber cell differentiation,BP,WNT7A;WNT5B;TBC1D20;TGFB1
17886,GO:1902075,0.12253546865138,0.982288924757643,2,6,cellular response to salt,BP,MAPK13;HSF1
10437,GO:0043271,0.122572944765463,0.934198782333937,11,71,negative regulation of ion transport,BP,NOS1;SERPINE2;ATF4;HECW2;AKT1;PCSK9;STK39;NTSR1;EPHB2;SLC30A1;TGFB1
16373,GO:0090647,0.122606140270641,0.982272505185715,2,6,modulation of age-related behavioral decline,BP,PRNP;DKK1
1402,GO:0003333,0.122738306560883,0.942141583722638,8,47,amino acid transmembrane transport,BP,STK39;SLC38A10;SLC6A6;SLC43A1;SLC6A9;NTSR1;PRAF2;SLC6A14
3224,GO:0006878,0.123025227736332,0.969818792551576,3,13,cellular copper ion homeostasis,BP,PRNP;ATP7B;MT2A
6822,GO:0030276,0.123143440023007,0.941906070386772,8,47,clathrin binding,MF,AP1B1;AP2A2;BIN1;SYTL1;CEMIP;LDLRAP1;TOM1L2;LRP1
19145,GO:1905049,0.12320348694865,0.982133473155666,2,6,negative regulation of metallopeptidase activity,BP,SORL1;TIMP1
3327,GO:0007039,0.123230387186077,0.970172412808496,3,12,protein catabolic process in the vacuole,BP,ATP13A2;TCIRG1;LRP1
17609,GO:1901216,0.123251016559298,0.936039167082632,10,64,positive regulation of neuron death,BP,PRNP;SSH1;ATF4;CTSZ;PCSK9;DKK1;CDC34;DDIT3;FYN;ITGA1
938,GO:0002335,0.123278077540395,0.961364585019043,4,19,mature B cell differentiation,BP,XBP1;CMTM7;POU2F2;MFNG
1189,GO:0002833,0.123306063177325,0.954769783490758,5,26,positive regulation of response to biotic stimulus,BP,LRSAM1;PUM1;MIF;ARG1;MAPK3
3140,GO:0006734,0.1234137096492,0.954717874678454,5,26,NADH metabolic process,BP,PCK2;HK1;MDH2;PFKP;ALDOC
18662,GO:1903935,0.123517347952009,0.982060245420302,2,6,response to sodium arsenite,BP,MAPK13;HSF1
17777,GO:1901701,0.123715561016988,0.899509983439113,84,713,cellular response to oxygen-containing compound,BP,TNIP1;CAPN2;NFATC4;SHC1;CST3;CYP27B1;NEURL1;PCK2;NR1D1;DNMT3A;NET1;RAPGEF3;PRNP;BNIP3;SSH1;SESN2;BCR;RAB31;LRP5;ADCY7;XBP1;MAP4K4;EGFR;PRKACA;STK25;ATF4;AKT1;IRAK1;FAM210B;PRKCZ;MAPK13;PTK6;PCSK9;ENDOG;MSN;PRKACB;SIPA1;WDTC1;IDE;TWF2;PRDX5;PAK1;GNB1;RET;GRB10;GNAI2;HSF1;EIF4EBP1;VAMP2;ALDH1A2;SRC;DNM2;GSK3A;FYN;AGRN;WNT5B;VDR;GNB2;MIF;SOCS2;BCL2L1;ADIPOR1;TRIB3;TCIRG1;NDOR1;LRP1;P2RX4;MAPK9;ARG1;BAIAP2L1;ATP6V1C2;IMPACT;CASP4;SOCS7;MAPK3;KANK2;LITAF;ARHGEF2;CEACAM1;ADCY6;TGFB1;PIK3R2;ANXA1;PXN
7171,GO:0031045,0.123848974025657,0.981982740614448,2,6,dense core granule,CC,ADAM8;NCS1
6585,GO:0022409,0.123857928883326,0.920324813290745,20,146,positive regulation of cell-cell adhesion,BP,AP3D1;ITGA6;XBP1;AKT1;CARD11;PRKCZ;TGFBR2;CD44;PAK1;RAG1;PODXL;GATA3;ADAM8;IGFBP2;SRC;FYN;ZP3;PNP;TGFB1;ANXA1
10040,GO:0042475,0.123907452389293,0.938359669751096,9,55,odontogenesis of dentin-containing tooth,BP,ITGB4;BSG;ITGA6;LAMA5;ACVR2B;FAM20C;PPARA;HTRA1;STIM1
13289,GO:0051957,0.124067136634007,0.981931679442113,2,6,positive regulation of amino acid transport,BP,STXBP1;NTSR1
17885,GO:1902074,0.124263719209801,0.969809474366429,3,12,response to salt,BP,MAPK13;HSF1;TGFB1
8606,GO:0034105,0.124347117536541,0.960906289427671,4,19,positive regulation of tissue remodeling,BP,EGFR;ADAM8;VDR;TMBIM1
5352,GO:0016101,0.124405412583523,0.941088575681547,8,48,diterpenoid metabolic process,BP,SDC1;EGFR;GPC4;APOE;RETSAT;ALDH1A2;AGRN;LRP1
2379,GO:0005507,0.124519074252203,0.948587178043831,6,36,copper ion binding,MF,PRNP;ATP13A2;ATP7B;LOXL1;ADNP;P2RX4
16849,GO:0098722,0.124548383687784,0.981818835323276,2,6,asymmetric stem cell division,BP,ETV5;ARHGEF2
16167,GO:0090162,0.124607751170582,0.954326696167445,5,25,establishment of epithelial cell polarity,BP,FERMT1;MSN;CYTH3;SH3BP1;CAMSAP3
16736,GO:0097709,0.124761241173893,0.981768832756925,2,6,connective tissue replacement,BP,F2R;TGFB1
10233,GO:0042895,0.124866566654054,0.981744069971481,2,6,antibiotic transmembrane transporter activity,MF,SLC13A3;SLC13A5
3408,GO:0007191,0.124887126605304,0.981739234581476,2,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNB1;GNAS
8983,GO:0035066,0.124980340086893,0.953960614937457,5,26,positive regulation of histone acetylation,BP,NOS1;GATA3;MAPK3;TGFB1;WBP2
7760,GO:0032271,0.125237688345051,0.918357856313558,21,155,regulation of protein polymerization,BP,RAC2;DLG1;TMOD2;CORO1B;ARPC1A;TMSB4X;EML2;TWF2;PAK1;ARL2;CAPG;PFN1;ARFIP2;SPIRE1;VASP;EPS8L1;CAMSAP3;BAIAP2L1;WIPF1;TMSB10;KANK2
4644,GO:0010764,0.125308421855043,0.981640037528327,2,6,negative regulation of fibroblast migration,BP,CYGB;FGF2
17272,GO:0120031,0.12533945712185,0.903497170853726,53,428,plasma membrane bounded cell projection assembly,BP,ZMYND8;RAC2;NEURL1;ARAP1;ITGA6;LAMA5;SSH1;ESPN;BBS2;NUDCD3;MARK4;EVI5L;CSNK1E;RFX2;SEPT10;PRKACA;PARVB;EHD3;WWTR1;DNAAF5;PTPDC1;SEPT5;WASF2;TWF2;FSCN1;TTBK2;PODXL;SEPT8;DYNLRB1;ARHGEF4;DNM2;NINL;SDCCAG8;SH3BP1;FUZ;AGRN;LPAR3;PFN1;KIF17;TUBG1;TENM2;ARFIP2;UNC119B;ATXN10;EPS8L1;NDE1;SNAP29;GAS8;WRAP73;CSNK1D;OCRL;CCDC113;ASAP1
18472,GO:1903531,0.125424686268365,0.926660028931439,14,97,negative regulation of secretion by cell,BP,F2R;IDH2;BCR;MAP4K4;RHBDF2;ARG2;TMSB4X;HADH;ASIC1;MAPKBP1;CPTP;CEACAM1;SLC30A1;ANXA1
13507,GO:0055024,0.12549313713116,0.940536083151486,8,47,regulation of cardiac muscle tissue development,BP,TGFBR2;DKK1;PAK1;GSK3A;FGFR1;FGF2;TGFB1;ERBB3
605,GO:0001771,0.125613792827954,0.981567998926808,2,6,immunological synapse formation,BP,DLG1;MSN
571,GO:0001710,0.125760534723496,0.981533340875512,2,6,mesodermal cell fate commitment,BP,DKK1;FGFR1
1497,GO:0003836,0.125787521028393,0.981526964260995,2,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL3;ST3GAL5
3291,GO:0006984,0.125795776445288,0.943964049660536,7,40,ER-nucleus signaling pathway,BP,BOK;XBP1;ATF4;DDIT3;WFS1;ASNS;ARHGEF10L
11487,GO:0045927,0.126106346116143,0.915999570688485,23,171,positive regulation of growth,BP,BBS2;EGFR;MMP14;AKT1;SH3PXD2B;MAP1B;TGFBR2;GDI1;LIMK1;TWF2;PAK1;HSF1;WFS1;AGRN;PPM1F;LPAR3;FGFR1;ADNP;HYAL1;ZP3;FGF2;CHD7;CIB1
2558,GO:0005834,0.126121302404651,0.960142156072838,4,19,heterotrimeric G-protein complex,CC,GNB1;GNAI2;RGS19;GNAS
19259,GO:1905360,0.126121302404651,0.960142156072838,4,19,GTPase complex,CC,GNB1;GNAI2;RGS19;GNAS
11714,GO:0046488,0.126211026125942,0.916799678941824,22,160,phosphatidylinositol metabolic process,BP,PITPNM1;SBF1;PLCH2;EGFR;TTC7B;PI4K2A;PIGQ;PIP5K1C;SRC;FYN;MBOAT7;FGFR1;MTMR4;PITPNM2;SLC27A1;PIP5KL1;ZP3;FGF2;OCRL;PIK3R2;ERBB3;ZFYVE21
18260,GO:1903038,0.126352659295465,0.934097701897751,10,64,negative regulation of leukocyte cell-cell adhesion,BP,DLG1;PRNP;ARG2;PPARA;ASS1;PAG1;ARG1;CEACAM1;TGFB1;ANXA1
14180,GO:0061042,0.126380104136755,0.981386716274526,2,6,vascular wound healing,BP,XBP1;HPSE
14566,GO:0070071,0.126471052707697,0.969029205717567,3,12,proton-transporting two-sector ATPase complex assembly,BP,DMXL2;OXA1L;TCIRG1
9244,GO:0035627,0.126568587003269,0.9813420169903,2,6,ceramide transport,BP,CPTP;PLTP
7649,GO:0032055,0.126584559849522,0.981338226971844,2,6,negative regulation of translation in response to stress,BP,SESN2;ATF4
1452,GO:0003680,0.126714615521229,0.981307355828478,2,6,AT DNA binding,MF,H1F0;HMGA2
13129,GO:0051645,0.126727681107251,0.968938051014606,3,12,Golgi localization,BP,COPG1;STK25;ARCN1
6715,GO:0030122,0.126790079165994,0.968915873350013,3,12,AP-2 adaptor complex,CC,EGFR;AP2A2;LDLRAP1
4110,GO:0009164,0.126858452004793,0.959569416593099,4,20,nucleoside catabolic process,BP,NT5E;AHCY;PNP;APOBEC3C
13959,GO:0060603,0.126938541792504,0.9531990538163,5,25,mammary gland duct morphogenesis,BP,ETV5;LRP5;SRC;VDR;TGFB1
4584,GO:0010667,0.127105716885663,0.968803605960709,3,12,negative regulation of cardiac muscle cell apoptotic process,BP,HSF1;RGL2;PPP1R10
9952,GO:0042301,0.127247894758012,0.981180554473302,2,6,phosphate ion binding,MF,CHST14;PNP
6589,GO:0022414,0.127314566903969,0.89494374475078,97,828,reproductive process,BP,PGF;ERCC1;MDFI;CCND1;MST1R;SDC1;MAP2K1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;SERPINE2;BSG;DLG1;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;SMURF2;CTSB;BBS2;OSBP2;ETV5;FBLN1;ADCY7;MYCBPAP;EGFR;MMP14;RFX2;PRKACA;EPN1;FAM50A;TUBG2;FBXW8;AKT1;PHC2;TFEB;SH3PXD2B;DEAF1;TGFBR2;EPOR;UBE2J1;PRKACB;HTRA1;SCMH1;GAMT;CUL7;PKD1;GATA3;TCFL5;ANTXR2;HSF1;ALOX15B;ARID5B;IGFBP2;SRC;DNM2;AGO4;PAQR7;STXBP1;SPINT2;VDR;PUM1;RAI14;COMT;THRA;EIF2S2;TIMP1;TUBG1;ADNP;BCL2L1;LEMD2;HSPA2;PLCD3;ZP3;TBC1D20;SPIRE1;CHD7;SLIT3;RXRA;ARG1;NDRG3;SPESP1;CBL;GGT1;CIB1;ADAM15;PAIP2;CCNE1;TGFB1;AZIN2;ANXA1;ITGA3;ZNF318
15214,GO:0071340,0.127379315765471,0.981149251916843,2,6,skeletal muscle acetylcholine-gated channel clustering,BP,DVL1;ETV5
6242,GO:0019798,0.127518563665577,0.981116061944789,2,6,procollagen-proline dioxygenase activity,MF,P4HB;P4HA1
7343,GO:0031348,0.127524465963991,0.922249244422323,16,114,negative regulation of defense response,BP,NT5E;SHARPIN;BCR;SERPING1;APOE;ARG2;PPARA;FAM3A;HTRA1;GATA3;FNDC4;MAPKBP1;TNFRSF1A;ARG1;SEC14L1;CEACAM1
10249,GO:0042953,0.127599120215878,0.981096850273994,2,6,lipoprotein transport,BP,UNC119B;LRP1
11041,GO:0044872,0.127599120215878,0.981096850273994,2,6,lipoprotein localization,BP,UNC119B;LRP1
7441,GO:0031545,0.127690616806823,0.981075019875888,2,6,peptidyl-proline 4-dioxygenase activity,MF,P4HB;P4HA1
17385,GO:1900076,0.127778006373777,0.936008124401246,9,55,regulation of cellular response to insulin stimulus,BP,PRKCZ;PAK1;GRB10;SRC;GSK3A;SOCS2;ADIPOR1;BAIAP2L1;PIK3R2
14437,GO:0061724,0.127821072593417,0.981043876318235,2,6,lipophagy,BP,SESN2;SPTLC2
9044,GO:0035252,0.127916432689888,0.981021097886241,2,6,UDP-xylosyltransferase activity,MF,XYLT1;XYLT2
9945,GO:0042285,0.127916432689888,0.981021097886241,2,6,xylosyltransferase activity,MF,XYLT1;XYLT2
3892,GO:0008525,0.128021693465407,0.980995941533446,2,6,phosphatidylcholine transporter activity,MF,PLTP;ABCA7
8867,GO:0034656,0.128042654005729,0.946834725101134,6,35,nucleobase-containing small molecule catabolic process,BP,NT5E;AHCY;GSK3A;PNP;ENTPD6;APOBEC3C
11468,GO:0045906,0.128199282202749,0.980953468620355,2,6,negative regulation of vasoconstriction,BP,DOCK4;APLN
11782,GO:0046624,0.128200598154091,0.980953153747011,2,6,sphingolipid transporter activity,MF,CPTP;PLTP
15185,GO:0071287,0.128201208041319,0.980953007815955,2,6,cellular response to manganese ion,BP,ATF4;ATP13A2
13256,GO:0051900,0.128237569204625,0.967950255142095,3,13,regulation of mitochondrial depolarization,BP,BOK;IFI6;SRC
5444,GO:0016308,0.128403302348369,0.98090462645437,2,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,PIP5K1C;PIP5KL1
3131,GO:0006720,0.128519977705498,0.930279305573016,11,73,isoprenoid metabolic process,BP,SDC1;EGFR;GPC4;APOE;RETSAT;SRD5A3;ALDH1A2;PMVK;AGRN;LRP1;PHYH
18858,GO:1904415,0.128587271191444,0.980860540733075,2,6,regulation of xenophagy,BP,LRSAM1;MAPK3
18859,GO:1904417,0.128587271191444,0.980860540733075,2,6,positive regulation of xenophagy,BP,LRSAM1;MAPK3
4650,GO:0010770,0.128588215063681,0.921578246350008,16,111,positive regulation of cell morphogenesis involved in differentiation,BP,MAP2K1;NET1;STK25;FBXW8;MAP1B;GDI1;LIMK1;OBSL1;TWF2;PAK1;CUL7;DNM2;LPAR3;RREB1;ADNP;CIB1
3424,GO:0007214,0.128690963961774,0.980835673815307,2,6,gamma-aminobutyric acid signaling pathway,BP,ATF4;GNAI2
13577,GO:0060020,0.128956530410264,0.980771927252916,2,6,Bergmann glial cell differentiation,BP,MAP2K1;MAPK3
11000,GO:0044788,0.129166047471058,0.958820552746714,4,19,modulation by host of viral process,BP,PC;APOE;STOM;TBC1D20
4343,GO:0009893,0.12920265176656,0.885758403995504,262,2365,positive regulation of metabolic process,BP,TNIP1;EDEM1;XDH;ERCC1;NOS1;CCND1;F2R;MST1R;SORL1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;BOK;CRTC1;ARAP1;MEF2D;DLG4;NR1D1;DLG1;TRIM65;DAP;IGFBP4;TEF;FKBP1A;SOX12;MTA1;ITGA6;RAPGEF3;PRNP;BNIP3;CITED4;SMARCA1;SMURF2;FAM129B;MAPKAPK3;SESN2;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;FYCO1;RFX2;PRKACA;ACTA2;MAP2K2;STK25;ATF4;HECW2;SNX33;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;PKN1;ELK3;WWTR1;TMSB4X;PRKCZ;POU2F2;TFEB;DGKQ;VPS11;FZD8;EPHA1;ZMIZ2;PTK6;SH3PXD2B;PCSK9;ENDOG;DEAF1;SALL2;MSN;TGFBR2;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;BNIP3L;PPARA;SYMPK;PRKACB;SHC2;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MC1R;ANKIB1;LARP6;TFE3;CCND2;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;RET;RAB29;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;DLG3;GATA3;APLN;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;RAI1;HMGA2;MICAL2;MYDGF;ALDH1A2;SRC;LDLRAP1;TAZ;DNM2;FAM162A;IRF7;LRSAM1;RFXANK;RAB1B;STK24;PAK6;STX5;RERE;RSF1;GSK3A;CAMTA2;DUSP6;FYN;SPTLC2;AGRN;PPM1F;LPAR3;TNFRSF1A;ANXA3;VDR;GJC2;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;F12;USF2;PBX3;MIF;STUB1;TRIB3;SLC27A1;ZFPM1;TPCN1;RAD23A;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;P2RX4;E2F5;SMPD3;ZP3;LRRK1;FGF2;EHD4;VAPB;MAPK9;PYM1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;MLYCD;APBB1;RXRA;TGFA;SEC14L2;IMPACT;CASP4;CAMK1;EPHB2;HGS;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;MINK1;LPIN3;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;PIK3R2;CAMK2N1;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;WDFY2;FHOD1;TRAF7;RNF10
13988,GO:0060675,0.129245603482759,0.942029471640735,7,40,ureteric bud morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;GATA3;FGF2;TGFB1
15672,GO:0072171,0.129245603482759,0.942029471640735,7,40,mesonephric tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;GATA3;FGF2;TGFB1
6379,GO:0021561,0.129368299828626,0.980672915073651,2,6,facial nerve development,BP,SEMA3F;ADARB1
6402,GO:0021610,0.129368299828626,0.980672915073651,2,6,facial nerve morphogenesis,BP,SEMA3F;ADARB1
15457,GO:0071715,0.129480884403418,0.958683159648821,4,19,icosanoid transport,BP,NTSR1;MIF;P2RX4;ANXA1
17717,GO:1901571,0.129480884403418,0.958683159648821,4,19,fatty acid derivative transport,BP,NTSR1;MIF;P2RX4;ANXA1
3400,GO:0007182,0.129484571312199,0.980644919324575,2,6,common-partner SMAD protein phosphorylation,BP,TGFBR2;TGFB1
8720,GO:0034356,0.129655517862841,0.967891630290626,3,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT;PARP10;PNP
3249,GO:0006910,0.129685569012545,0.980596484181973,2,6,phagocytosis, recognition,BP,TUB;PEAR1
12288,GO:0048568,0.129691209368004,0.90595947356806,35,271,embryonic organ development,BP,ERCC1;MDFI;DVL1;MAP2K1;DLG1;BCR;EGFR;MMP14;EPN1;PPP1R13L;FBXW8;AKT1;TFEB;NAGLU;TGFBR2;SUFU;PKD1;GATA3;HSF1;MICAL2;TULP3;ALDH1A2;SPINT2;FUZ;FGFR1;HYAL1;ZFPM1;PLCD3;CHD7;TSHZ1;EPHB2;MAPK3;MBD3;TGFB1;GNAS
14209,GO:0061088,0.129735034891816,0.980584556617514,2,6,regulation of sequestering of zinc ion,BP,AP3D1;SLC30A1
2993,GO:0006538,0.129864971118071,0.980553211187274,2,6,glutamate catabolic process,BP,GLUL;GLUD1
2096,GO:0004859,0.129874780569503,0.979590369028176,2,7,phospholipase inhibitor activity,MF,ANXA3;ANXA1
15776,GO:0072350,0.12988423116337,0.945978891087474,6,34,tricarboxylic acid metabolic process,BP,IDH2;MDH2;DHTKD1;ASS1;GLUD1;SDHA
8518,GO:0033690,0.129888522868901,0.980547527417852,2,6,positive regulation of osteoblast proliferation,BP,LRP5;HPSE
14839,GO:0070562,0.129912385741918,0.980541767871821,2,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1;KANK2
2,GO:0000003,0.130050850304279,0.892549789457037,97,829,reproduction,BP,PGF;ERCC1;MDFI;CCND1;MST1R;SDC1;MAP2K1;WNT7A;PTHLH;CST3;CYP27B1;NEURL1;BOK;SERPINE2;BSG;DLG1;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;SMURF2;CTSB;BBS2;OSBP2;ETV5;FBLN1;ADCY7;MYCBPAP;EGFR;MMP14;RFX2;PRKACA;EPN1;FAM50A;TUBG2;FBXW8;AKT1;PHC2;TFEB;SH3PXD2B;DEAF1;TGFBR2;EPOR;UBE2J1;PRKACB;HTRA1;SCMH1;GAMT;CUL7;PKD1;GATA3;TCFL5;ANTXR2;HSF1;ALOX15B;ARID5B;IGFBP2;SRC;DNM2;AGO4;PAQR7;STXBP1;SPINT2;VDR;PUM1;RAI14;COMT;THRA;EIF2S2;TIMP1;TUBG1;ADNP;BCL2L1;LEMD2;HSPA2;PLCD3;ZP3;TBC1D20;SPIRE1;CHD7;SLIT3;RXRA;ARG1;NDRG3;SPESP1;CBL;GGT1;CIB1;ADAM15;PAIP2;CCNE1;TGFB1;AZIN2;ANXA1;ITGA3;ZNF318
6753,GO:0030170,0.130089982616505,0.946003143026216,6,33,pyridoxal phosphate binding,MF,PYGB;CBS;PYGL;GPT2;ALAS1;SPTLC2
14686,GO:0070279,0.130089982616505,0.946003143026216,6,33,vitamin B6 binding,MF,PYGB;CBS;PYGL;GPT2;ALAS1;SPTLC2
20062,GO:2000649,0.130221170676311,0.945933340282398,6,33,regulation of sodium ion transmembrane transporter activity,BP,HECW2;PCSK9;STK39;STOM;GLRX;DNM2
14794,GO:0070482,0.130603501485402,0.905143258851905,35,283,response to oxygen levels,BP,ANGPTL4;PGF;NOS1;CAPN2;PLAT;CST3;DNMT3A;POSTN;PSMD2;BNIP3;CYGB;MMP14;P4HB;AKT1;IRAK1;ENDOG;TGFBR2;BNIP3L;PPARA;PAK1;AHCY;GNB1;HSF1;ADAM8;EDNRA;SRC;FAM162A;PSMD7;STUB1;VEGFB;CBL;TGFB1;CAT;LDHA;EP300
12951,GO:0051289,0.130603588240229,0.934077852375343,9,58,protein homotetramerization,BP,CRTC1;ACOT13;IDE;CBR4;GPX3;VASP;RXRA;HM13;CAT
9345,GO:0035821,0.130694943034851,0.924682335765426,13,92,modification of morphology or physiology of other organism,BP,TNIP1;PC;APOE;STOM;HMGA2;BCL2L1;TBC1D20;RNASE7;VAPB;RXRA;ARG1;TGFB1;EP300
986,GO:0002440,0.13072228003686,0.919993569715552,16,114,production of molecular mediator of immune response,BP,ERCC1;DLG1;XBP1;HK1;CARD11;PKN1;PRKCZ;POU2F2;KDELR1;GATA3;MIF;ARG1;POLM;MAPK3;DNAJB9;TGFB1
9906,GO:0042180,0.130898637346142,0.914054401169035,21,162,cellular ketone metabolic process,BP,NR1D1;PSMD2;HAGH;AKT1;DGKQ;TYSND1;PPARA;WDTC1;AKR7A2;CBR4;ACADVL;PSMD7;COMT;ADIPOR1;TRIB3;MLYCD;LONP2;GLO1;CEACAM1;ANXA1;SLC45A3
14609,GO:0070142,0.131023567862054,0.980272800489144,2,6,synaptic vesicle budding,BP,AP3D1;DNM2
1352,GO:0003214,0.131025987459827,0.980272213163756,2,6,cardiac left ventricle morphogenesis,BP,TGFBR2;GSK3A
3143,GO:0006739,0.131085117157044,0.950797115352238,5,27,NADP metabolic process,BP,IDH2;H6PD;PGLS;NADK;TALDO1
14923,GO:0070728,0.131112565327106,0.980251192817612,2,6,leucine binding,MF,SESN2;GLUD1
7968,GO:0032561,0.13111860947613,0.904313579015655,36,287,guanyl ribonucleotide binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
1978,GO:0004691,0.131127214347096,0.980247635257,2,6,cAMP-dependent protein kinase activity,MF,PRKACA;PRKACB
13707,GO:0060228,0.131147258098437,0.995396509081238,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
2266,GO:0005179,0.131369231778836,0.957591177688599,4,20,hormone activity,MF,ADM2;PTHLH;APLN;GAL
17468,GO:1900223,0.131378144770747,0.980186655252123,2,6,positive regulation of amyloid-beta clearance,BP,LRP1;ABCA7
9111,GO:0035374,0.131442215324441,0.980171072765684,2,6,chondroitin sulfate binding,MF,PTPRS;AGRN
5316,GO:0016024,0.131572367834318,0.967200141930033,3,12,CDP-diacylglycerol biosynthetic process,BP,AGPAT3;CDS2;AGPAT4
9818,GO:0040037,0.131652311998303,0.967171193140734,3,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,GATA3;APLN;FUZ
7956,GO:0032549,0.131720514796785,0.90383083533834,36,287,ribonucleoside binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
19183,GO:1905165,0.131773197249862,0.98009049528935,2,6,regulation of lysosomal protein catabolic process,BP,ATP13A2;LRP1
18608,GO:1903827,0.131932463410977,0.898499277320547,51,417,regulation of cellular protein localization,BP,EDEM1;ZMYND8;SH3TC2;RAC2;SORL1;DVL1;DLG1;RAPGEF3;PRNP;SSH1;SESN2;EGFR;CSNK1E;SNX33;AKT1;BAG3;ATP13A2;VPS11;VPS4A;MSN;GDI1;UBE2J1;BNIP3L;ZDHHC8;ATG13;PAK1;TTBK2;STOM;PTPN9;RAB29;IFI27;CEMIP;PARP10;NUMB;VAMP2;SRC;LDLRAP1;NUCB1;GSK3A;FYN;ABHD17C;BCL2L1;LRP1;CAMK1;EPHB2;CIB1;UGCG;TMBIM1;CCNE1;TGFB1;ITGA3
7330,GO:0031334,0.132086684504025,0.909150357128083,26,199,positive regulation of protein complex assembly,BP,ERCC1;RAC2;SNX9;DLG1;MMP1;CORO1B;ARPC1A;MSN;PPP2R5B;IDE;FSCN1;PAK1;RHOC;ARL2;SRC;PFN1;STUB1;DDB2;ARFIP2;SPIRE1;MAPK9;VASP;BAIAP2L1;WIPF1;TGFB1;ASAP1
6860,GO:0030324,0.132117181881019,0.919086703534726,16,111,lung development,BP,MAP2K1;LAMA5;ACVR2B;EGFR;MMP14;CTSZ;TGFBR2;PKD1;ALDH1A2;HSD11B1;THRA;FGFR1;ARG1;MAPK3;ITGA3;EP300
9511,GO:0036150,0.132177045258964,0.966980963243727,3,12,phosphatidylserine acyl-chain remodeling,BP,LPCAT4;OSBPL10;OSBPL5
10592,GO:0043546,0.132232715828748,0.979978403572076,2,6,molybdopterin cofactor binding,MF,XDH;AOX1
4500,GO:0010523,0.132246314228366,0.966487417543435,3,13,negative regulation of calcium ion transport into cytosol,BP,NOS1;NTSR1;TGFB1
7915,GO:0032482,0.132415729282252,0.932961797436284,9,58,Rab protein signal transduction,BP,RAB3B;RAB43;RAB31;GDI1;RAB29;RAB1B;RAB25;RAB4B;RAB6A
18948,GO:1904645,0.132780121742126,0.957235159702951,4,19,response to amyloid-beta,BP,PRNP;FYN;LRP1;CASP4
8005,GO:0032620,0.132792653376936,0.966286330545008,3,13,interleukin-17 production,BP,PRNP;ARG2;TGFB1
9310,GO:0035748,0.132841753540258,0.979829441665354,2,6,myelin sheath abaxonal region,CC,DLG1;PRKCZ
8651,GO:0034185,0.132887048805734,0.966722967901296,3,12,apolipoprotein binding,MF,VLDLR;PCSK9;LRP1
12715,GO:0050913,0.132895082217248,0.978821644058809,2,7,sensory perception of bitter taste,BP,ITPR3;REEP2
7031,GO:0030799,0.132968259283525,0.939816781592957,7,41,regulation of cyclic nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;GNAI2;CAP1;ADNP
13135,GO:0051651,0.133293759053833,0.927130334770801,11,74,maintenance of location in cell,BP,SORL1;SYNE3;HK1;AKT1;APOE;TMSB4X;KDELR1;TWF2;ARL2;FLNB;TMSB10
10382,GO:0043190,0.133404535743485,0.979691390596168,2,6,ATP-binding cassette (ABC) transporter complex,CC,ABCB8;ABCA7
2611,GO:0005915,0.133449764618284,0.979680279125439,2,6,zonula adherens,CC,CAMSAP3;KIFC3
15713,GO:0072224,0.133457287564663,0.979678430705597,2,6,metanephric glomerulus development,BP,LAMB2;RET
3598,GO:0008028,0.133461104869956,0.949803269629075,5,26,monocarboxylic acid transmembrane transporter activity,MF,BSG;SLC16A3;SLC27A1;SLC10A6;CEACAM1
5215,GO:0015812,0.133999358637056,0.979545059843039,2,6,gamma-aminobutyric acid transport,BP,NTSR1;APBA1
7949,GO:0032534,0.134008662343872,0.979542767636244,2,6,regulation of microvillus assembly,BP,FSCN1;PODXL
9971,GO:0042339,0.134101603196579,0.949485360053071,5,26,keratan sulfate metabolic process,BP,GALNS;B4GALT2;B3GNT3;ST3GAL3;B4GALT6
5643,GO:0016725,0.134104977193711,0.979519031800715,2,6,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH;AOX1
1353,GO:0003215,0.134312070682438,0.966203076826141,3,12,cardiac right ventricle morphogenesis,BP,PPP1R13L;GATA3;CHD7
5592,GO:0016614,0.134411284884136,0.922124962993834,13,93,oxidoreductase activity, acting on CH-OH group of donors,MF,XDH;IDH2;H6PD;MDH2;CRYL1;HADH;TSTA3;CTBP1;AKR7A2;CBR4;HSD11B1;AOX1;LDHA
3866,GO:0008484,0.134572593599116,0.966107730770346,3,12,sulfuric ester hydrolase activity,MF,GALNS;ARSK;ARSD
7945,GO:0032527,0.134626191929328,0.943437429022786,6,34,protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;SYVN1;TMEM129;UBE2J1;HM13
6752,GO:0030169,0.13468214510372,0.979376557611077,2,6,low-density lipoprotein particle binding,MF,SORL1;PCSK9
6528,GO:0021910,0.134704689591981,0.979370984254804,2,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,SUFU;TULP3
18992,GO:1904738,0.134711331097858,0.966056917965745,3,12,vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
19002,GO:1904752,0.134711331097858,0.966056917965745,3,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
17596,GO:1901185,0.134711391774938,0.934920256007901,8,49,negative regulation of ERBB signaling pathway,BP,SH3KBP1;EGFR;EPN1;ITGA1;PTPN12;HGS;CBL;ERBB3
6507,GO:0021873,0.134780831770505,0.979352156119428,2,6,forebrain neuroblast division,BP,NUMB;FGFR1
3585,GO:0007635,0.134852347900851,0.979334465462708,2,6,chemosensory behavior,BP,WFS1;CHD7
9808,GO:0040018,0.134910077800471,0.956292404936357,4,19,positive regulation of multicellular organism growth,BP,BBS2;SH3PXD2B;HSF1;CHD7
7219,GO:0031106,0.135102986352328,0.965913332303091,3,12,septin ring organization,BP,SEPT10;SEPT5;SEPT8
13987,GO:0060674,0.135120544923091,0.948978485211917,5,26,placenta blood vessel development,BP,MAP2K1;FBXW8;AKT1;PKD1;PLCD3
16338,GO:0090504,0.135259083222115,0.948909462440923,5,26,epiboly,BP,WNT7A;CD44;RHOC;RREB1;CEACAM1
3624,GO:0008081,0.13539719357531,0.931254335040267,9,56,phosphoric diester hydrolase activity,MF,PLCH2;PLD3;PLCXD1;PLCG1;GNB1;PLCB3;EDNRA;PLCD3;SMPD3
2256,GO:0005168,0.135481773157494,0.97917849841969,2,6,neurotrophin TRKA receptor binding,MF,SHC1;PLCG1
3953,GO:0008654,0.135481918756623,0.903947397733622,30,231,phospholipid biosynthetic process,BP,MBOAT2;LPCAT4;PITPNM1;DGKA;SBF1;AGPAT3;LPCAT1;CDS2;DGKQ;PI4K2A;ISYNA1;PTDSS2;PIGQ;SRD5A3;PIP5K1C;TAZ;PMVK;SPTLC2;MBOAT7;FGFR1;MTMR4;PITPNM2;SLC27A1;AGPAT4;ZP3;FGF2;OCRL;LPIN3;PIK3R2;STARD10
6367,GO:0021545,0.1355529733322,0.948762955696406,5,26,cranial nerve development,BP,SEMA3F;ADARB1;CHD7;EPHB2;ERBB3
3379,GO:0007158,0.135575136840408,0.979155322491737,2,6,neuron cell-cell adhesion,BP,NLGN2;RET
12747,GO:0050982,0.1355988211017,0.965731253890083,3,12,detection of mechanical stimulus,BP,SERPINE2;PKD1;FYN
14660,GO:0070231,0.135623860623263,0.942767671534084,6,35,T cell apoptotic process,BP,AKT1;ARG2;KDELR1;RAG1;ADAM8;TSC22D4
5101,GO:0015377,0.135643407305938,0.979138368807742,2,6,cation:chloride symporter activity,MF,SLC12A7;SLC12A4
5103,GO:0015379,0.135643407305938,0.979138368807742,2,6,potassium:chloride symporter activity,MF,SLC12A7;SLC12A4
15244,GO:0071380,0.135801016518445,0.965656908606782,3,12,cellular response to prostaglandin E stimulus,BP,AKT1;GNB1;ADCY6
7758,GO:0032269,0.135812288125239,0.887465161573521,97,853,negative regulation of cellular protein metabolic process,BP,TNIP1;XDH;CHAC1;SORL1;DVL1;MAP2K1;PLAT;CST3;SERPINE2;DLG1;IFI6;FKBP1A;PRNP;CRTAP;SESN2;LRP5;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;ATF4;AKT1;SERPING1;APOE;ATP13A2;PKN1;WWTR1;PRKCZ;DGKQ;CTSZ;EPHA1;PTK6;PPP1R35;SERPINB6;LIMK1;STK39;DKK1;UBE2J1;CD44;IDE;PRDX5;BIN1;SUFU;RAG1;BCDIN3D;DUSP4;PARP10;PHF1;CTBP1;TFPI2;PPP1R14A;EIF4EBP1;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;SPINT2;DUSP6;FYN;PPM1F;MICAL1;PUM1;TNRC6B;HEXIM1;TIMP1;CRIM1;MIF;SOCS2;PCSK1N;TRIB3;SNX25;LEMD2;PMEPA1;TRIB2;SAMD4B;LRRK1;RNF222;IMPACT;EPHB2;CBL;CIB1;SOCS7;FURIN;AIDA;CEACAM1;PAIP2;ECM1;CD59;IGF2BP3;TGFB1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10
5720,GO:0016854,0.135820500922842,0.965164449915353,3,13,racemase and epimerase activity,MF,HYI;TSTA3;GALE
18219,GO:1902965,0.135839280704986,0.979089695856234,2,6,regulation of protein localization to early endosome,BP,SORL1;MSN
18220,GO:1902966,0.135839280704986,0.979089695856234,2,6,positive regulation of protein localization to early endosome,BP,SORL1;MSN
16152,GO:0090136,0.135851122530339,0.965638476528871,3,12,epithelial cell-cell adhesion,BP,ITGB5;CAMSAP3;KIFC3
5998,GO:0019001,0.135852044952372,0.900503114520906,36,288,guanyl nucleotide binding,MF,RAC2;PCK2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;EHD3;RRAS;SEPT5;GTPBP1;TUBB3;RAB29;RHOC;SEPT8;ARL8A;GNAI2;GLUD1;RHOBTB2;ARL2;SCG5;TGM2;DNM2;RAB1B;RAB25;TUBG1;ARFIP2;LRRK1;EHD4;RHOBTB1;DRG2;RAB4B;AGAP1;RAB6A;GNAS
83,GO:0000166,0.135853963907232,0.881840567626575,186,1629,nucleotide binding,MF,NT5E;XDH;NOS1;MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;RAPGEF3;IDH2;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;H6PD;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;BAG3;EHD3;ATP13A2;PKN1;CRYL1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS11;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;ACAD10;NMRK1;RRAS;SEPT5;TGFBR2;HADH;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;AHCY;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;SDHA;CTBP1;MYH15;RHOBTB2;TOP1;ARL2;MICAL2;PIP5K1C;SRC;CBR4;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;ACADVL;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;PFN1;MICAL1;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;SLC27A1;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;HSPA2;AOX1;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;ZBTB4;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;NDUFS2;MINK1;AGAP1;MBD3;ADCY6;ADCK2;CAT;LDHA;ERBB3;RAB6A;GNAS
7908,GO:0032471,0.136215807533721,0.977963125945374,2,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,RAP1GDS1;TGM2
13771,GO:0060325,0.136581704128339,0.948249222822262,5,26,face morphogenesis,BP,RRAS;DKK1;ASPH;ARID5B;TGFB1
1600,GO:0004016,0.136591004207482,0.978902465371865,2,6,adenylate cyclase activity,MF,ADCY7;ADCY6
1779,GO:0004383,0.136591004207482,0.978902465371865,2,6,guanylate cyclase activity,MF,ADCY7;ADCY6
3619,GO:0008074,0.136591004207482,0.978902465371865,2,6,guanylate cyclase complex, soluble,CC,ADCY7;ADCY6
7160,GO:0031014,0.136773007637886,0.994977375742326,1,2,troponin T binding,MF,TNNT1
9215,GO:0035591,0.136822291613824,0.930443964035109,9,55,signaling adaptor activity,MF,SH2D2A;SHC1;GRB10;SRC;LDLRAP1;PAG1;SOCS2;SHB;SKAP2
3126,GO:0006706,0.136864684876328,0.964774643503972,3,13,steroid catabolic process,BP,CYP27B1;APOE;HSD11B1
2274,GO:0005215,0.137077409580347,0.888472150776407,80,680,transporter activity,MF,SERINC2;PITPNC1;KCNG1;AP3D1;SCN8A;SLCO4A1;DLG4;BSG;DLG1;SLC16A3;PITPNM1;SLC2A9;OSBPL10;VLDLR;TTYH3;SLC12A7;APOE;ATP13A2;AP1B1;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;IPO13;ABCB8;OSBPL5;SLC38A10;SFXN3;SLC29A4;PKD1;DLG3;ATP11A;NIPA1;ANO8;SLC2A3;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;SLC43A1;NDUFA4L2;NCS1;TMEM44;CPTP;SLC6A9;SLC25A43;SLC33A1;GJC2;SLC13A5;PLTP;SLC35B4;ATP2C2;LRRC8A;VPS9D1;TCIRG1;PITPNM2;SLC27A1;TPCN1;SLC6A14;LRP1;P2RX4;USO1;ABCA7;SLC10A6;ATP6V1C2;KCNC4;SLC35G2;SLC5A1;CEACAM1;SLC30A1;PCYOX1;SLC15A1;AZIN2;STARD10;SLC45A3;ORAI3;RASA3
13630,GO:0060080,0.137226075236298,0.978743753915886,2,6,inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16488,GO:0097151,0.137226075236298,0.978743753915886,2,6,positive regulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
16906,GO:0098828,0.137226075236298,0.978743753915886,2,6,modulation of inhibitory postsynaptic potential,BP,NLGN2;NTSR1
7175,GO:0031050,0.137227736298036,0.937383852427863,7,41,dsRNA fragmentation,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TGFB1
15014,GO:0070918,0.137227736298036,0.937383852427863,7,41,production of small RNA involved in gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TGFB1
11515,GO:0045981,0.137273906432416,0.937251320638814,7,42,positive regulation of nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;TMSB4X;TAZ;ADNP
17525,GO:1900544,0.137273906432416,0.937251320638814,7,42,positive regulation of purine nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;TMSB4X;TAZ;ADNP
17626,GO:1901265,0.137339807179756,0.880490454877499,186,1630,nucleoside phosphate binding,MF,NT5E;XDH;NOS1;MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;RAPGEF3;IDH2;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;H6PD;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;BAG3;EHD3;ATP13A2;PKN1;CRYL1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS11;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;ACAD10;NMRK1;RRAS;SEPT5;TGFBR2;HADH;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;AHCY;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;SDHA;CTBP1;MYH15;RHOBTB2;TOP1;ARL2;MICAL2;PIP5K1C;SRC;CBR4;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;ACADVL;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;PFN1;MICAL1;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;SLC27A1;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;HSPA2;AOX1;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;ZBTB4;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;NDUFS2;MINK1;AGAP1;MBD3;ADCY6;ADCK2;CAT;LDHA;ERBB3;RAB6A;GNAS
932,GO:0002327,0.137529214265283,0.978667823240475,2,6,immature B cell differentiation,BP,RAG1;LRRC8A
1372,GO:0003254,0.137534502233675,0.947581194653516,5,27,regulation of membrane depolarization,BP,FHL1;BOK;IFI6;SRC;NTSR1
6691,GO:0030056,0.137766360188907,0.978608344796917,2,6,hemidesmosome,CC,ITGB4;ITGA6
10416,GO:0043242,0.137886099997641,0.933106222503652,8,48,negative regulation of protein complex disassembly,BP,TMOD2;TWF2;TTBK2;CAPG;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
11407,GO:0045773,0.138246617346465,0.941620771203619,6,33,positive regulation of axon extension,BP,MAP1B;GDI1;LIMK1;TWF2;PAK1;ADNP
10649,GO:0043649,0.138342395538346,0.964220452153617,3,13,dicarboxylic acid catabolic process,BP,ALDH1L2;GLUL;GLUD1
3315,GO:0007020,0.138374631955642,0.947350518807913,5,26,microtubule nucleation,BP,TUBG2;EML2;TUBG1;NDE1;CSNK1D
12863,GO:0051154,0.138730729748311,0.954585840034321,4,19,negative regulation of striated muscle cell differentiation,BP,XBP1;DKK1;PAK1;GSK3A
17713,GO:1901567,0.138897799356555,0.953973281024862,4,21,fatty acid derivative binding,MF,ACOT7;HMGCL;ACBD4;ACADVL
15186,GO:0071294,0.139011805034001,0.976456008290931,2,8,cellular response to zinc ion,BP,ATP13A2;MT2A
11269,GO:0045494,0.139085284026909,0.954426469502428,4,19,photoreceptor cell maintenance,BP,ERCC6;BBS2;TUB;DRAM2
2702,GO:0006066,0.139099542090315,0.901066039048636,30,234,alcohol metabolic process,BP,SORL1;CYP27B1;LMF1;PCK2;PLCH2;VLDLR;LRP5;APOE;DGKQ;RETSAT;PCSK9;PLCG1;OSBPL5;ISYNA1;SRD5A3;PLCB3;ALDH1A2;LDLRAP1;ACADVL;PMVK;SPTLC2;VDR;NTSR1;FGFR1;PLCD3;FGF2;RXRA;SEC14L2;OCRL;CAT
19100,GO:1904951,0.139254448488395,0.895648378544356,41,332,positive regulation of establishment of protein localization,BP,EDEM1;F2R;RAC2;SORL1;PCK2;POSTN;RAPGEF3;PRNP;XBP1;EGFR;HK1;BAG3;ATP13A2;PRKCZ;VPS11;FERMT1;ZDHHC8;ATG13;PAK1;NLGN2;GLUL;STOM;RAB29;CEMIP;GATA3;GLUD1;ALOX15B;IL1RAP;ADAM8;VAMP2;SRC;GSK3A;FYN;MIF;LRP1;APBB1;CAMK1;CIB1;MAPK3;UGCG;TGFB1
4600,GO:0010713,0.139345131961185,0.977141363096588,2,7,negative regulation of collagen metabolic process,BP,CST3;CYGB
17057,GO:0099504,0.139349416823449,0.921020055621092,12,79,synaptic vesicle cycle,BP,WNT7A;AP3D1;SNPH;SEPT5;NLGN2;SYTL1;VAMP2;PIP5K1C;DNM2;STXBP1;SNAP29;ITSN1
5004,GO:0015144,0.1395350915201,0.954224039091056,4,19,carbohydrate transmembrane transporter activity,MF,SLC2A9;SLC2A3;SLC5A1;SLC45A3
4501,GO:0010524,0.139598280146747,0.946540466896515,5,27,positive regulation of calcium ion transport into cytosol,BP,F2R;PLCG1;CEMIP;NTSR1;P2RX4
10581,GO:0043534,0.139670650644072,0.920713849322662,12,81,blood vessel endothelial cell migration,BP,AKT1;APOE;TMSB4X;PLCG1;SH3BP1;FGFR1;P2RX4;FGF2;CIB1;SRPX2;TGFB1;ANXA1
4271,GO:0009620,0.139694864166763,0.9536108253641,4,21,response to fungus,BP,FAM3A;RNASE7;ARG1;TGFB1
18837,GO:1904376,0.139712603685001,0.954144076858935,4,19,negative regulation of protein localization to cell periphery,BP,NUMB;BCL2L1;TMBIM1;TGFB1
17583,GO:1901137,0.140203563405416,0.888084891953786,66,557,carbohydrate derivative biosynthetic process,BP,TNIP1;NT5E;NOS1;SDC1;PYGL;PTHLH;LMF1;PGM1;NME4;ACOT7;CHPF;XYLT1;ADCY7;TK2;HK1;XYLT2;GPC4;APOE;UAP1;SYVN1;CRYL1;TMSB4X;RFNG;PFKP;NDST2;UBE2J1;PPARA;DHTKD1;TSTA3;ADAMTS7;CEMIP;PIGQ;GNAI2;PPCS;PANK4;SRD5A3;CAP1;B4GALT2;B3GNT3;TAZ;MPI;AGRN;UCKL1;CHST14;MCFD2;ADNP;HYAL1;MFNG;GUK1;AMPD2;ST3GAL3;VPS9D1;TCIRG1;ST3GAL5;ST6GALNAC2;ABCA7;LMAN1;VEGFB;POMT1;ALDOC;UGCG;B4GALT6;GALNT3;ADCY6;TGFB1;LDHA
5714,GO:0016842,0.140219786670967,0.976909475938559,2,7,amidine-lyase activity,MF,CHAC1;GGACT
7412,GO:0031489,0.14043233301161,0.96343158114483,3,13,myosin V binding,MF,RAB3B;RAB25;RAB6A
1542,GO:0003924,0.140434114731634,0.900605556778359,29,228,GTPase activity,MF,RAC2;RAB3B;RAB43;TUBB6;RAB31;SEPT10;TUBG2;RRAS;SEPT5;GTPBP1;TUBB3;GNB1;RAB29;RHOC;SEPT8;ARL8A;GNAI2;RHOBTB2;ARL2;DNM2;RAB1B;RAB25;GNB2;TUBG1;RHOBTB1;RAB4B;AGAP1;RAB6A;GNAS
3157,GO:0006766,0.140559513640326,0.917953465813637,13,92,vitamin metabolic process,BP,CYP27B1;PRSS3;PC;PSAT1;ALDH1L2;SLC2A3;ALDH1A2;VDR;PLTP;FGFR1;HLCS;AOX1;RXRA
3153,GO:0006753,0.140768984596079,0.889953544547941,55,479,nucleoside phosphate metabolic process,BP,NT5E;XDH;NOS1;PTHLH;NAPRT;PCK2;DLG4;DLG1;PGM1;RAPGEF3;IDH2;NME4;ACOT7;H6PD;ADCY7;PGLS;TK2;HK1;MDH2;CARD11;APOE;TMSB4X;FAM20C;PFKP;NMRK1;PPARA;DHTKD1;NADK;GTPBP1;PARP10;DLG3;GNAI2;PPCS;PANK4;SDHA;NEIL1;CAP1;TAZ;GARS;TALDO1;UCKL1;LHPP;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
4641,GO:0010761,0.140854931815572,0.940201414878643,6,33,fibroblast migration,BP,CYGB;AKT1;PAK1;ARID5B;FGF2;TGFB1
10682,GO:0043903,0.141001504204006,0.904618806326311,23,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,TNIP1;PC;ADARB1;P4HB;IFITM1;APOE;VPS4A;MVB12B;STOM;PARP10;OASL;HMGA2;EXOC2;RSF1;OAS1;ISG20;NELFCD;RAD23A;TBC1D20;VAPB;ARG1;APOBEC3C;EP300
17002,GO:0099024,0.141493393521229,0.939705730929105,6,34,plasma membrane invagination,BP,RAC2;SNX9;SNX33;SH3BP1;SPIRE1;ABCA7
6704,GO:0030100,0.141676406582574,0.906073918653779,21,157,regulation of endocytosis,BP,TSPAN1;DLG4;BCR;TUB;SNX33;APOE;PCSK9;DKK1;BIN1;APLN;SRC;LDLRAP1;DNM2;LRSAM1;LRP1;EHD4;ARAP3;ABCA7;CBL;RAB4B;TGFB1
11952,GO:0046983,0.141806555552043,0.882386494329221,95,854,protein dimerization activity,MF,XDH;PGF;CBS;CAPN2;PYGL;SNX9;BOK;MEF2D;FKBP1A;BNIP3;ACOT7;NACC2;XBP1;EGFR;CARS;STK25;ATF4;P4HB;AKT1;IRAK1;APOE;WWTR1;CRYL1;RABGGTA;TFEB;HIST2H2BE;DRAP1;LIMK1;BNIP3L;H2AFJ;MAP3K9;IDE;TFE3;PRDX5;HMGCL;RAG1;DDIT3;GGA1;STOM;MLXIP;GATA3;OXA1L;TCFL5;CADM4;HSF1;CTBP1;GIPC1;HIST3H2A;GARS;ASNS;ZNF862;GALE;PSMD7;NTSR1;MAP3K10;MGLL;LHPP;FGFR1;ZBED4;TENM2;USF2;HES2;RAB11FIP4;BCL2L1;STUB1;ADIPOR1;SLC27A1;HLCS;AOX1;MXD4;P2RX4;HPSE;E2F5;VAPB;MAP3K12;HOMER2;RXRA;HIST2H2AC;ZHX3;TAF6;VEGFB;ZBTB4;ATP6V1C2;HIST1H2AG;S100A16;HM13;CEACAM1;NAGA;TGFB1;CAT;PIK3R2;ERBB3;ANXA1;ITGA3;ZNF318
20128,GO:2000758,0.142287963395393,0.945175723722057,5,27,positive regulation of peptidyl-lysine acetylation,BP,NOS1;GATA3;MAPK3;TGFB1;WBP2
12921,GO:0051248,0.142342273608288,0.881295979789268,101,892,negative regulation of protein metabolic process,BP,TNIP1;XDH;CHAC1;SORL1;DVL1;MAP2K1;PLAT;CST3;SERPINE2;DLG1;IFI6;FKBP1A;PRNP;CRTAP;SESN2;LRP5;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;ATF4;AKT1;SERPING1;APOE;ATP13A2;PKN1;WWTR1;PRKCZ;DGKQ;CTSZ;EPHA1;PTK6;PPP1R35;SERPINB6;LIMK1;STK39;DKK1;UBE2J1;CD44;IDE;PRDX5;BIN1;SUFU;RAG1;BCDIN3D;DUSP4;PARP10;PHF1;CTBP1;TFPI2;PPP1R14A;EIF4EBP1;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;SPINT2;DUSP6;FYN;PPM1F;MICAL1;PUM1;TNRC6B;HEXIM1;TIMP1;CRIM1;MIF;SOCS2;PCSK1N;TRIB3;SNX25;LEMD2;ZFPM1;PMEPA1;TRIB2;SAMD4B;LRRK1;RNF222;ABCA7;APBB1;IMPACT;EPHB2;CBL;CIB1;SOCS7;FURIN;AIDA;CEACAM1;PAIP2;ECM1;CD59;IGF2BP3;TGFB1;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10
17412,GO:1900117,0.142403489266344,0.952634298879925,4,20,regulation of execution phase of apoptosis,BP,BOK;ENDOG;HSF1;BCL2L1
11822,GO:0046688,0.142739996299522,0.951982118622832,4,22,response to copper ion,BP,PRNP;ATP7B;HSF1;MT2A
19435,GO:1905936,0.143080001872458,0.994484035614982,1,2,regulation of germ cell proliferation,BP,CIB1
19839,GO:2000254,0.143080001872458,0.994484035614982,1,2,regulation of male germ cell proliferation,BP,CIB1
4442,GO:0010324,0.143227189553601,0.933808267699265,7,42,membrane invagination,BP,RAC2;SNX9;SNX33;SH3BP1;SPIRE1;ABCA7;HGS
7702,GO:0032154,0.143365158614863,0.929708173257024,8,49,cleavage furrow,CC,PITPNM1;SSH1;PKN1;RHOC;RAB11FIP4;PLCD3;SPIRE1;NDE1
1132,GO:0002718,0.143370591817127,0.933619452365354,7,43,regulation of cytokine production involved in immune response,BP,HK1;PRKCZ;GATA3;MIF;ARG1;MAPK3;TGFB1
7897,GO:0032460,0.143469770652913,0.962274514798162,3,13,negative regulation of protein oligomerization,BP,SORL1;SRC;EP300
9385,GO:0035904,0.143477344508349,0.938765730261765,6,33,aorta development,BP,LTBP1;SUFU;DNM2;LOXL1;LRP1;CHD7
13558,GO:0055123,0.143645620960613,0.918075388224637,12,80,digestive system development,BP,ITGB4;ITGA6;ACVR2B;XBP1;EGFR;PTK6;TGFBR2;RET;PKD1;GATA3;ALDH1A2;TGFB1
20088,GO:2000678,0.143757208310433,0.961723950460815,3,14,negative regulation of transcription regulatory region DNA binding,BP,TMSB4X;PPARA;DDIT3
17059,GO:0099513,0.143895775211142,0.886908572503233,57,470,polymeric cytoskeletal fiber,CC,RAC2;DVL1;CLIP2;KLC2;DLG1;MTA1;ESPN;TMEM214;SNPH;TUBB6;CORO1B;MAP2K2;TUBG2;TMSB4X;PRKCZ;FERMT1;EML2;MAP1B;TWF2;FSCN1;PAK1;NAV1;TUBB3;REEP2;SHANK2;DYNLRB1;FAM110C;SRC;LDLRAP1;DNM2;NINL;SPECC1L;FYN;REEP4;MICAL1;KIF17;KIF13B;TUBG1;CEP170;ARFGEF2;MAP1LC3B;SNTB2;PBXIP1;NDE1;CAMSAP3;INVS;WIPF1;KRT23;GAS8;TMSB10;CSNK1D;KIFC3;ARHGEF2;ENKD1;MAP6;ANXA1;STIM1
12766,GO:0051015,0.144161605282697,0.90900390263734,17,121,actin filament binding,MF,FLNC;ESPN;SYNE3;EGFR;CORO1B;ARPC1A;CORO2A;OBSL1;TWF2;BIN1;FSCN1;MYH15;CAPG;KLHL17;MYO1D;CAMSAP3;WIPF1
12432,GO:0048864,0.144240482733088,0.925657453752617,9,57,stem cell development,BP,WNT7A;LAMA5;SEMA3F;SEMA4B;RET;EDNRA;ALDH1A2;SEMA4G;MAPK3
15468,GO:0071772,0.14441984826275,0.913556705567572,14,96,response to BMP,BP,SMURF2;ACVR2B;DKK1;HTRA1;ADAMTS7;GATA3;SPINT2;PCSK6;FBXL15;SLC33A1;LEMD2;MAPK3;TGFB1;ITGA3
15469,GO:0071773,0.14441984826275,0.913556705567572,14,96,cellular response to BMP stimulus,BP,SMURF2;ACVR2B;DKK1;HTRA1;ADAMTS7;GATA3;SPINT2;PCSK6;FBXL15;SLC33A1;LEMD2;MAPK3;TGFB1;ITGA3
7321,GO:0031325,0.144562245011504,0.872084066238527,243,2181,positive regulation of cellular metabolic process,BP,TNIP1;EDEM1;XDH;ERCC1;NOS1;CCND1;F2R;MST1R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;SNX9;BOK;CRTC1;ARAP1;MEF2D;DLG4;NR1D1;DLG1;TRIM65;DAP;IGFBP4;TEF;FKBP1A;SOX12;MTA1;ITGA6;RAPGEF3;PRNP;BNIP3;CITED4;SMARCA1;FAM129B;MAPKAPK3;SESN2;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;FYCO1;RFX2;PRKACA;MAP2K2;STK25;ATF4;SNX33;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;PKN1;ELK3;WWTR1;TMSB4X;PRKCZ;POU2F2;TFEB;DGKQ;VPS11;FZD8;EPHA1;ZMIZ2;PTK6;PCSK9;ENDOG;DEAF1;SALL2;MSN;TGFBR2;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;BNIP3L;PPARA;SYMPK;PRKACB;SHC2;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;MC1R;ANKIB1;LARP6;TFE3;CCND2;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;RET;RAB29;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;DLG3;GATA3;APLN;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;RAI1;HMGA2;MICAL2;MYDGF;SRC;TAZ;DNM2;FAM162A;IRF7;LRSAM1;RFXANK;RAB1B;STK24;PAK6;RERE;RSF1;GSK3A;CAMTA2;DUSP6;FYN;SPTLC2;AGRN;PPM1F;LPAR3;TNFRSF1A;ANXA3;VDR;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;F12;USF2;PBX3;MIF;STUB1;TRIB3;SLC27A1;ZFPM1;TPCN1;RAD23A;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;P2RX4;E2F5;SMPD3;ZP3;LRRK1;FGF2;EHD4;VAPB;PYM1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;MLYCD;APBB1;RXRA;TGFA;SEC14L2;IMPACT;CASP4;CAMK1;EPHB2;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;MINK1;LPIN3;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;PIK3R2;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;PLGRKT;ZNF318;ARHGEF10L;EP300;WDFY2;FHOD1;TRAF7;RNF10
7906,GO:0032469,0.144692326381625,0.951585495021513,4,20,endoplasmic reticulum calcium ion homeostasis,BP,RAP1GDS1;WFS1;TGM2;GRINA
4651,GO:0010771,0.144970120051957,0.922213165413138,10,64,negative regulation of cell morphogenesis involved in differentiation,BP,NFATC4;POSTN;PTPRS;SEMA3F;FBLN1;GDI1;SEMA4B;SEMA4G;ULK2;EPHB2
11153,GO:0045184,0.145023206993318,0.873970124312752,174,1583,establishment of protein localization,BP,EDEM1;LTBP2;SH3TC2;F2R;RAC2;SORL1;SNX9;AP3D1;LMF1;PCK2;DLG4;NR1D1;XPOT;PITPNM1;POSTN;RAB3B;RAPGEF3;PRNP;IDH2;RAB43;COPG1;BBS2;BCR;SYNE3;RAB31;VLDLR;LRP5;ACVR2B;XBP1;EVI5L;MAP4K4;EGFR;RTN2;RHBDF2;HK1;SNX33;AKT1;CARD11;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;AP1B1;SYVN1;YIF1A;TMSB4X;AP2A2;PRKCZ;ITPR3;POU2F2;VPS11;VPS4A;PITRM1;TMEM129;FERMT1;SEC23A;GDI1;HADH;MVB12B;UBE2J1;ARRDC1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;PAK1;NLGN2;DDIT3;GLUL;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;GATA3;OXA1L;DOPEY2;GRIN3B;GLUD1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;ARL2;VAMP2;GIPC1;SRC;CHMP5;DENND2A;SCG5;PEX10;DNM2;LRSAM1;NUCB1;RAB1B;CPTP;STX5;TOM1L2;COG8;RERE;EXOC2;GSK3A;STXBP1;FYN;RAB25;FUZ;KIF17;KIF13B;STX10;MOAP1;GAL;MCFD2;SEC24C;RRBP1;GUK1;MIF;VPS37A;PRAF2;TCIRG1;SNX25;ARFIP2;ARFGEF2;UNC119B;LRP1;USO1;SPIRE1;PNP;COG1;APBB1;TBC1D2B;NEURL1B;CAMSAP3;RPL28;ATP6V1C2;SNAP29;LONP2;CAMK1;HGS;CIB1;RAB4B;MAPK3;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;AGAP1;TGFB1;WBP2;SLC15A1;PIK3R2;ANXA1;PPP1R10;RAB6A;ARCN1
11042,GO:0044877,0.145345846575416,0.881579381243336,78,666,protein-containing complex binding,MF,FLNC;LTBP4;SORL1;ADM2;SHC1;ERCC6;SNX9;DLG4;FKBP1A;ITGA6;PRNP;LAMA5;SMARCA1;CRTAP;ESPN;CTSB;MRC2;SYNE3;VLDLR;ACVR2B;FBLN1;EGFR;MMP14;FCHO1;CORO1B;P4HB;ARPC1A;APOE;STRN4;RNF135;PI4K2A;PCSK9;ZNF598;LAMB2;CORO2A;OBSL1;WASF2;CD44;TWF2;BIN1;FSCN1;PAK1;RAB29;NID1;GRB10;PHF1;OXA1L;GNAI2;MYH15;HMGA2;SRC;LDLRAP1;CAPG;CDC42BPB;FYN;NISCH;WISP1;ITGA1;FCGRT;CTSL;SECISBP2L;DDB2;ULK1;LRP1;FGF2;KLHL17;PYM1;MYO1D;EPS8L1;CAMSAP3;WIPF1;IMPACT;EPHB2;ADAM15;MBD3;GNAS;ITGA3;PXN
19144,GO:1905048,0.145470980147392,0.961505385432136,3,13,regulation of metallopeptidase activity,BP,SORL1;TIMP1;MAPK3
12661,GO:0050840,0.145526657097483,0.937486239290173,6,34,extracellular matrix binding,MF,ITGA6;NID1;AGRN;LYPD5;ECM1;ITGA3
17131,GO:0101002,0.14591486644665,0.904976775015291,19,146,ficolin-1-rich granule,CC,PYGL;CST3;PGM1;PSMD2;CTSB;AP2A2;CTSZ;SERPINB6;ARL8A;SLC2A3;ADAM8;UBR4;YPEL5;PSMD7;MIF;TCIRG1;PNP;ALDOC;CAT
3169,GO:0006782,0.145974981072637,0.975359758310891,2,7,protoporphyrinogen IX biosynthetic process,BP,ALAS1;UROS
18521,GO:1903624,0.145984712977939,0.975357102697846,2,7,regulation of DNA catabolic process,BP,ENDOG;HSF1
8928,GO:0034763,0.14635642075606,0.92118883724408,10,66,negative regulation of transmembrane transport,BP,HECW2;AKT1;PCSK9;STK39;GRB10;GSK3A;NTSR1;EPHB2;SLC30A1;TGFB1
15621,GO:0072088,0.146381846624298,0.927870576141371,8,49,nephron epithelium morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;PKD1;GATA3;FGF2;TGFB1
13924,GO:0060548,0.146414867865341,0.88033488984135,80,689,negative regulation of cell death,BP,ANGPTL4;F2R;MST1R;RBCK1;SORL1;SHC1;WNT7A;CST3;BOK;IFI6;ITGA6;PRNP;BNIP3;FAM129B;AARS;XBP1;MAP4K4;EGFR;ATF4;AKT1;IRAK1;BAG3;APOE;ATP13A2;ARG2;SYVN1;PRKCZ;EPHA1;DKK1;BNIP3L;PPARA;CD44;PRDX5;CCND2;ZNF385A;RAG1;RET;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;MYDGF;TSC22D4;TNFRSF6B;SRC;AGO4;IRF7;STXBP1;FYN;ASNS;GRINA;MICAL1;WISP1;NTSR1;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;BCL2L1;LRP1;PAK4;FGF2;MAP3K12;IMPACT;EPHB2;CBL;CIB1;KANK2;GLO1;ARHGEF2;TMBIM1;ITSN1;CAT;ERBB3;ANXA1;PPP1R10
19810,GO:2000194,0.146569506730333,0.975197309034501,2,7,regulation of female gonad development,BP,SRC;ZP3
12576,GO:0050709,0.146809533699511,0.920834618077393,10,67,negative regulation of protein secretion,BP,F2R;IDH2;MAP4K4;RHBDF2;ARG2;TMSB4X;HADH;MAPKBP1;CPTP;ANXA1
14288,GO:0061333,0.146817122164572,0.927604559912091,8,49,renal tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;PKD1;GATA3;FGF2;TGFB1
4626,GO:0010744,0.147044696600662,0.975067150269792,2,7,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B;MAPK9
16512,GO:0097190,0.147128801109928,0.884609060672363,55,469,apoptotic signaling pathway,BP,CHAC1;RBCK1;NFATC4;ERCC6;BOK;DAP;IFI6;ITGA6;BNIP3;G0S2;NACC2;XBP1;MKNK2;STK25;ATF4;P4HB;AKT1;BAG3;SYVN1;UACA;BNIP3L;CD44;DEDD2;ZNF385A;DDIT3;RET;IFI27;WFS1;TNFRSF6B;SRC;FAM162A;STK24;GSK3A;FYN;PPM1F;GRINA;TNFRSF1A;MOAP1;SHISA5;FGFR1;MIF;BCL2L1;TRIB3;P2RX4;MAPK9;CASP4;CIB1;ARHGEF2;TMBIM1;TFPT;TGFB1;TM2D1;ERBB3;EP300;TRAF7
18193,GO:1902931,0.147154113219174,0.975037140199423,2,7,negative regulation of alcohol biosynthetic process,BP,CYP27B1;APOE
12322,GO:0048645,0.147226185399398,0.936401135220186,6,35,animal organ formation,BP,MAP2K1;TGFBR2;DKK1;FGFR1;LEMD2;MAPK3
1995,GO:0004713,0.147289640715177,0.908208027406043,16,112,protein tyrosine kinase activity,MF,MST1R;MAP2K1;SCYL1;BCR;EGFR;MAP2K2;EPHA1;PTK6;RET;SRC;FYN;CRIM1;FGFR1;FGF2;EPHB2;ERBB3
5171,GO:0015721,0.147982416306331,0.960532555200138,3,13,bile acid and bile salt transport,BP,RXRA;SLC10A6;CEACAM1
13631,GO:0060081,0.148666887565802,0.974620697516135,2,7,membrane hyperpolarization,BP,CRTC1;PRKCZ
18645,GO:1903902,0.148729138562078,0.926255983214612,8,51,positive regulation of viral life cycle,BP,PC;ADARB1;P4HB;VPS4A;STOM;RAD23A;TBC1D20;VAPB
13726,GO:0060263,0.14917525854211,0.974480111360482,2,7,regulation of respiratory burst,BP,RAC2;BCR
1490,GO:0003824,0.149207413719549,0.864716738226353,469,4350,catalytic activity,MF,NT5E;EDEM1;XDH;PYGB;CBS;ERCC1;NOS1;ADAM19;CHAC1;CCND1;GID4;CAPN2;THSD4;MST1R;RAC2;LTBP4;RBCK1;MAP2K1;PLAT;PYGL;QSOX1;MBOAT2;ERCC6;CYP27B1;LPCAT4;NEURL1;NAPRT;SHARPIN;PCK2;DLG4;OBSCN;CPT2;KLC2;DLG1;MMP1;DNMT3A;PGM1;FKBP1A;DGKA;PSMD2;MTA1;RAB3B;RPS6KA2;PTPRS;PRSS3;HYI;NAGS;IDH2;SBF1;PC;AGPAT3;SSH1;TXNDC11;RAB43;SCYL1;SMARCA1;SMURF2;NME4;PLCH2;CYGB;MAPKAPK3;CTSB;SESN2;ACOT7;TNNT1;RNPEPL1;MARCH9;FKBP9;HAGH;TUBB6;USP20;NACC2;BCR;RAB31;CHPF;LPCAT1;MARK4;AARS;ACVR2B;H6PD;XYLT1;GPT2;ADCY7;PGLS;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;ACOT1;MMP14;SEPT10;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;HK1;MAP2K2;TUBG2;XYLT2;STK25;MIER2;P4HB;HECW2;FBXW8;PSAT1;PDIA5;AKT1;CDS2;MDH2;ACOT13;CARD11;IRAK1;ALDH1L2;ATP13A2;ARG2;UAP1;METTL23;PKN1;SYVN1;PHF21A;NPEPL1;CRYL1;RABGGTA;PRKCZ;GALNS;RNF135;ATP7B;FAM20C;NAGLU;DGKQ;MAPK13;RFNG;PPP2R3B;VPS4A;PITRM1;CTSZ;EPHA1;PI4K2A;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;GRK6;PCSK9;ENDOG;ZNF598;FBXW5;ABHD8;ACAD10;NMRK1;TYSND1;RRAS;SEPT5;B4GALNT4;TGFBR2;PLD3;HADH;NDST2;LIMK1;STK39;PLCXD1;UBE2J1;KLHL29;DHTKD1;NADK;PRSS8;TST;PRKACB;LTBP1;ZDHHC8;OTUB2;CDC34;SCRN1;PLCG1;ABCB8;GTPBP1;ELOVL1;MAP3K9;IDE;MSRB2;JADE2;ANKIB1;RRNAD1;PRDX5;HMGCL;HTRA1;PAK1;TSTA3;TTBK2;ISYNA1;ERO1B;MMP10;AHCY;ACSF2;NLGN2;DTD1;RAG1;CTBS;GAMT;GLUL;BCDIN3D;KIAA1191;PTDSS2;TUBB3;ADAMTS7;DUSP4;GNB1;PTPN9;FUCA1;RET;RAB29;DNASE1L1;FBXL6;RHOC;HLTF;CEMIP;SEPT8;ASS1;PARP10;DLG3;ATP11A;PIGQ;ARL8A;OASL;GNAI2;PPM1M;MYH16;GGACT;RPUSD3;GLUD1;PPCS;SIN3B;PANK4;ALOX15B;NEK9;CNDP2;SRD5A3;ASPH;SDHA;CTBP1;PTPRU;ADAM8;NEIL1;TMEM8A;MPG;PYCR2;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;BLMH;ARL2;MICAL2;PLCB3;P4HA1;B4GALT2;AKR7A2;PIP5K1C;EDNRA;ALDH1A2;B3GNT3;SRC;KDM4B;GLRX;CBR4;POLD4;TAZ;FKBP10;TGM2;DNM2;UBR4;CAPN5;LRSAM1;RAB1B;CDC42BPB;NDUFA4L2;MARK3;STK24;ACADVL;PAK6;NSUN7;GPX3;GARS;GSK3A;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;SUGCT;ASNS;PPM1F;TMPRSS11D;ZNF862;GALE;RMND5A;ALDH4A1;MICAL1;KIF17;ALDH7A1;THOP1;HSD11B1;MBOAT7;FBXL15;ABHD17C;KIF13B;UCKL1;BRSK1;SSU72;CHST14;RNF44;GNB2;PSKH1;CTSL;COMT;MAP3K10;DHRS4L2;CRIM1;UBA1;MGLL;RNF187;LOXL1;LHPP;WDFY3;FGFR1;TUBG1;ATP2C2;HYAL1;PHF2;MIB2;F12;MFNG;GUK1;CDK18;MIF;MTMR4;AMPD2;STUB1;STK17A;ST3GAL3;NT5DC2;DDB2;TPD52L2;TCIRG1;PTPN12;SLC27A1;HLCS;SARS2;RMND5B;ST3GAL5;NDOR1;PIP5KL1;AGPAT4;ULK1;HSPA2;AOX1;PLCD3;PAK4;MGRN1;ACP7;HPSE;ULK2;SMPD3;LRRK1;PCMTD2;PNP;FGF2;KLHL17;RNASE7;ST6GALNAC2;MAPK9;CDYL2;SDHAF4;RCOR1;MAP3K12;ABHD14B;TMX4;HSPA13;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ENTPD6;MLYCD;PHYH;RHOBTB1;ARG1;SPSB3;NEURL1B;ATP6V1C2;CYB561;BPHL;ARSK;KLK6;VAT1;CASP4;ACY1;LONP2;TRPT1;CAMK1;EPHB2;POLM;CBL;GGT1;LACTB2;USP32;RAB4B;MAPK3;CPT1B;POMT1;MAPK10;CSNK1D;KIFC3;ALDOC;GLO1;FURIN;RNF103;UGCG;NDUFS2;B4GALT6;OCRL;ADAM15;HM13;PNPLA6;GALNT3;MINK1;LPIN3;AGAP1;UROS;MBD3;NAGA;ADCY6;CCNE1;PCYOX1;ADCK2;CAT;LDHA;AZIN2;PIK3R2;ERBB3;ANXA1;ARSD;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;ZFYVE21;ASPHD1;EP300;ERP44;TRAF7;RNF10
10441,GO:0043277,0.149720211127823,0.941355841059808,5,27,apoptotic cell clearance,BP,RAC2;PEAR1;TGM2;LRP1;ABCA7
4277,GO:0009636,0.150185573784213,0.887429121049013,39,325,response to toxic substance,BP,CCND1;SDC1;ERCC6;CST3;DNMT3A;NET1;BNIP3;CYGB;SESN2;ADCY7;STK25;APOE;MAPK13;ENDOG;PPARA;PRDX5;GATA3;HSF1;MT2A;BLMH;SRC;DNM2;NUCB1;STK24;GPX3;FYN;ASNS;GJC2;BCL2L1;SLC6A14;ARG1;IMPACT;BPHL;CBL;MAPK3;SLC30A1;CAT;LDHA;ANXA1
19440,GO:1905941,0.150208371377284,0.974193421206738,2,7,positive regulation of gonad development,BP,SRC;ZP3
7073,GO:0030855,0.150556727921872,0.882560632575418,52,434,epithelial cell differentiation,BP,XDH;CCND1;SDC1;MAP2K1;WNT7A;CST3;CYP27B1;SHARPIN;PCK2;RAPGEF3;PTPRS;LAMA5;CTSB;ACVR2B;XBP1;ACTA2;AKT1;WWTR1;FAM20C;PTK6;MSN;LAMB2;PRSS8;TST;PODXL;GATA3;ALOX15B;CNFN;FLNB;ACADVL;GSK3A;SH3BP1;SPINT2;PCSK6;RAB25;WNT5B;TNFRSF1A;VDR;CTSL;EHF;THRA;FGFR1;TBC1D20;PRR9;RXRA;CAMSAP3;KRT23;ALDOC;FURIN;CEACAM1;TGFB1;ANXA1
9845,GO:0042063,0.150902696766318,0.89710230576161,23,174,gliogenesis,BP,SH3TC2;MAP2K1;BOK;SERPINE2;IDH2;BNIP3;ETV5;EGFR;MMP14;LAMB1;AKT1;LAMB2;BIN1;MBOAT7;GJC2;LRP1;SOCS7;MAPK3;TGFB1;ERBB3;ANXA1;SLC45A3;RNF10
3110,GO:0006688,0.151252813413385,0.959253107370272,3,13,glycosphingolipid biosynthetic process,BP,ST3GAL5;UGCG;B4GALT6
15301,GO:0071467,0.151311044384034,0.959230197221019,3,13,cellular response to pH,BP,ASIC1;HYAL1;IMPACT
11784,GO:0046626,0.151356045453405,0.929037917762697,7,42,regulation of insulin receptor signaling pathway,BP,PRKCZ;GRB10;SRC;GSK3A;SOCS2;ADIPOR1;BAIAP2L1
10031,GO:0042454,0.151376888007093,0.958732736647218,3,14,ribonucleoside catabolic process,BP,AHCY;PNP;APOBEC3C
6986,GO:0030656,0.151379006473542,0.973866965036036,2,7,regulation of vitamin metabolic process,BP,CYP27B1;VDR
5521,GO:0016482,0.151385983694906,0.902302924968822,18,131,cytosolic transport,BP,SORL1;MAP2K1;MAP2K2;EHD3;VPS11;MSN;TBC1D14;RAB29;CORO7;DOPEY2;SRC;DENND2A;STX5;STX10;MYO1D;MAPK3;RAB6A;ZFYVE21
13609,GO:0060056,0.151454895683449,0.97384574298072,2,7,mammary gland involution,BP,VDR;ARG1
2249,GO:0005159,0.151526748633932,0.959145292208431,3,13,insulin-like growth factor receptor binding,MF,SHC1;SOCS2;GNAS
13060,GO:0051497,0.151618495176822,0.959109160418338,3,13,negative regulation of stress fiber assembly,BP,ARAP1;WASF2;PFN1
3418,GO:0007205,0.151716563913622,0.948323357960558,4,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,F2R;DGKA;DGKQ;LRP1
7108,GO:0030899,0.151805741130466,0.99376012823089,1,2,calcium-dependent ATPase activity,MF,TNNT1
13100,GO:0051589,0.152029992255701,0.958946966473186,3,13,negative regulation of neurotransmitter transport,BP,NOS1;ASIC1;SLC30A1
14656,GO:0070227,0.15232331518544,0.923953645747554,8,52,lymphocyte apoptotic process,BP,AKT1;ARG2;PKN1;KDELR1;RAG1;ADAM8;TSC22D4;MIF
6899,GO:0030426,0.152380503518608,0.902965381595263,17,122,growth cone,CC,ADGRL1;DVL1;SSH1;TMOD2;CTSZ;TWF2;FSCN1;SHANK2;DLG3;DNM2;TENM2;SIGMAR1;MAP3K12;APBB1;CBL;CIB1;ITGA3
565,GO:0001704,0.152418056211329,0.912097057005441,12,80,formation of primary germ layer,BP,ITGB4;ITGB5;MMP14;LAMB1;DKK1;SOX7;DUSP4;HMGA2;DUSP6;LAMB3;FGFR1;ITGA3
2574,GO:0005859,0.152622952561505,0.973518199595036,2,7,muscle myosin complex,CC,OBSL1;MYL9
6698,GO:0030072,0.152880709745951,0.899852378436733,19,142,peptide hormone secretion,BP,LTBP4;PCK2;NR1D1;RAPGEF3;LRP5;ACVR2B;MAP4K4;EGFR;ITPR3;HADH;NLGN2;GLUL;APLN;GLUD1;ARL2;GAL;SMPD3;CHD7;ANXA1
7979,GO:0032587,0.153014764939607,0.914104439846243,11,73,ruffle membrane,CC,FERMT1;PSD3;PAK1;ARHGEF4;PIP5K1C;SRC;DNM2;ABCA7;EPS8L1;CIB1;ARHGEF2
10369,GO:0043173,0.153036072216165,0.958071078350329,3,14,nucleotide salvage,BP,NAPRT;UCKL1;AMPD2
12592,GO:0050727,0.153046461551074,0.895354513741445,23,180,regulation of inflammatory response,BP,TNIP1;NT5E;SHARPIN;BCR;EGFR;SERPING1;APOE;TMSB4X;MAPK13;STK39;PPARA;GATA3;FNDC4;ADAM8;TGM2;TNFRSF1A;MGLL;F12;ZP3;CASP4;GGT1;CD59;ANXA1
7055,GO:0030823,0.153142910414345,0.9585071786033,3,13,regulation of cGMP metabolic process,BP,NOS1;APOE;ADNP
716,GO:0001938,0.153169055277025,0.919838404154626,9,59,positive regulation of endothelial cell proliferation,BP,PGF;AKT1;APLN;MYDGF;FGFR1;FGF2;ARG1;VEGFB;ECM1
7333,GO:0031338,0.153232358603379,0.923658713144307,8,49,regulation of vesicle fusion,BP,EVI5L;VPS11;TBC1D16;TBC1D14;TBC1D9B;STXBP1;TBC1D2B;ANXA1
1788,GO:0004407,0.153337473519928,0.927863241601775,7,42,histone deacetylase activity,MF,MTA1;NACC2;MIER2;PHF21A;SIN3B;RCOR1;MBD3
12075,GO:0048008,0.153692242031799,0.927771997678874,7,41,platelet-derived growth factor receptor signaling pathway,BP,PLAT;BCR;ARID5B;SRC;PTPN12;LRP1;HGS
3236,GO:0006892,0.153799957042257,0.908847923231412,13,90,post-Golgi vesicle-mediated transport,BP,SORL1;AP3D1;BBS2;RAB31;EHD3;OSBPL5;CORO7;DOPEY2;VAMP2;DNM2;EXOC2;ARFGEF2;LLGL1
13143,GO:0051665,0.153983486274379,0.973134548631795,2,7,membrane raft localization,BP,MARVELD1;MALL
17910,GO:1902165,0.154341424818825,0.957135177774835,3,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44;ZNF385A;MIF
5434,GO:0016289,0.154458013754299,0.957501110340465,3,14,CoA hydrolase activity,MF,ACOT7;ACOT1;ACOT13
4414,GO:0010171,0.154816541031649,0.926983381906226,7,42,body morphogenesis,BP,RRAS;DKK1;ASPH;ARID5B;FUZ;TGFB1;GNAS
18989,GO:1904724,0.155418838561447,0.931400017218952,6,38,tertiary granule lumen,CC,QSOX1;CST3;PGM1;PRSS3;YPEL5;ALDOC
10858,GO:0044344,0.155441618277381,0.903817189101406,15,108,cellular response to fibroblast growth factor stimulus,BP,POSTN;FAM20C;CD44;GATA3;APLN;ESRP1;DUSP6;FUZ;FGFR1;HYAL1;FGF2;CBL;MAPK3;GALNT3;SPRED2
3513,GO:0007435,0.155448493510347,0.938363539303689,5,27,salivary gland morphogenesis,BP,LAMA5;EGFR;TGM2;FGFR1;TGFB1
17042,GO:0099172,0.15547894889229,0.957578724919852,3,13,presynapse organization,BP,DVL1;WNT7A;NLGN2
16194,GO:0090196,0.155541668744795,0.972692345978165,2,7,regulation of chemokine secretion,BP,POSTN;ALOX15B
7645,GO:0032050,0.155639601643507,0.972664452820556,2,7,clathrin heavy chain binding,MF,CEMIP;LRP1
9352,GO:0035850,0.155644942927978,0.938260183709643,5,27,epithelial cell differentiation involved in kidney development,BP,ACTA2;WWTR1;LAMB2;PODXL;GATA3
10223,GO:0042834,0.155678174654474,0.972653463233227,2,7,peptidoglycan binding,MF,HK1;RNASE7
3689,GO:0008194,0.155706165332532,0.905471393567546,14,99,UDP-glycosyltransferase activity,MF,CHPF;XYLT1;XYLT2;RFNG;B4GALNT4;PIGQ;B4GALT2;B3GNT3;WDFY3;HYAL1;MFNG;UGCG;B4GALT6;GALNT3
1172,GO:0002792,0.155719378647488,0.914922892481416,10,68,negative regulation of peptide secretion,BP,F2R;IDH2;MAP4K4;RHBDF2;ARG2;TMSB4X;HADH;MAPKBP1;CPTP;ANXA1
9987,GO:0042368,0.155810830577586,0.972615655037454,2,7,vitamin D biosynthetic process,BP,CYP27B1;VDR
5627,GO:0016684,0.156058204401677,0.93716519447696,5,32,oxidoreductase activity, acting on peroxide as acceptor,MF,CYGB;SESN2;PRDX5;GPX3;CAT
7222,GO:0031111,0.156132224447564,0.938003606592377,5,27,negative regulation of microtubule polymerization or depolymerization,BP,EML2;TTBK2;CAMSAP3;CIB1;ARHGEF2
7829,GO:0032377,0.15615259683567,0.972518148107814,2,7,regulation of intracellular lipid transport,BP,PCSK9;LDLRAP1
7832,GO:0032380,0.15615259683567,0.972518148107814,2,7,regulation of intracellular sterol transport,BP,PCSK9;LDLRAP1
7835,GO:0032383,0.15615259683567,0.972518148107814,2,7,regulation of intracellular cholesterol transport,BP,PCSK9;LDLRAP1
6799,GO:0030235,0.156164935877976,0.972514625039651,2,7,nitric-oxide synthase regulator activity,MF,EGFR;AKT1
11650,GO:0046341,0.156295910894153,0.957252325144619,3,13,CDP-diacylglycerol metabolic process,BP,AGPAT3;CDS2;AGPAT4
13578,GO:0060021,0.156342581305037,0.917951560454061,9,57,roof of mouth development,BP,WNT7A;DLG1;ACVR2B;TGFBR2;ASPH;ARID5B;CHD7;TSHZ1;EPHB2
12286,GO:0048565,0.156579585621632,0.911697829668773,11,73,digestive tract development,BP,ITGB4;ITGA6;ACVR2B;EGFR;PTK6;TGFBR2;RET;PKD1;GATA3;ALDH1A2;TGFB1
4068,GO:0009117,0.156905774653358,0.876518025346016,54,474,nucleotide metabolic process,BP,NT5E;XDH;NOS1;PTHLH;NAPRT;PCK2;DLG4;DLG1;PGM1;RAPGEF3;IDH2;NME4;ACOT7;H6PD;ADCY7;PGLS;TK2;HK1;MDH2;CARD11;APOE;TMSB4X;FAM20C;PFKP;NMRK1;PPARA;DHTKD1;NADK;GTPBP1;PARP10;DLG3;GNAI2;PPCS;PANK4;SDHA;NEIL1;CAP1;TAZ;GARS;TALDO1;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
12630,GO:0050792,0.157052941728341,0.894276912053487,21,164,regulation of viral process,BP,TNIP1;PC;ADARB1;P4HB;IFITM1;APOE;VPS4A;MVB12B;STOM;PARP10;OASL;HMGA2;RSF1;OAS1;ISG20;NELFCD;RAD23A;TBC1D20;VAPB;APOBEC3C;EP300
8959,GO:0035004,0.157234642334961,0.925661893501038,7,41,phosphatidylinositol 3-kinase activity,MF,EGFR;SRC;FYN;FGFR1;FGF2;PIK3R2;ERBB3
2403,GO:0005546,0.157318353564996,0.925373066310677,7,43,phosphatidylinositol-4,5-bisphosphate binding,MF,TWF2;GSDMA;TULP3;LDLRAP1;PFN1;GSDMC;ASAP1
10433,GO:0043267,0.157325576639751,0.956839692202061,3,13,negative regulation of potassium ion transport,BP,NOS1;ATF4;STK39
12678,GO:0050863,0.15740894766521,0.891081597123584,24,186,regulation of T cell activation,BP,RAC2;AP3D1;DLG1;PRNP;XBP1;AKT1;CARD11;ARG2;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1
17908,GO:1902162,0.157505872071346,0.993260980463353,1,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
17909,GO:1902164,0.157505872071346,0.993260980463353,1,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
16360,GO:0090594,0.157522721304929,0.97212579720757,2,7,inflammatory response to wounding,BP,F2R;TGFB1
11452,GO:0045869,0.157883654328904,0.972022053752884,2,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
479,GO:0001523,0.157932927701242,0.925004450813819,7,43,retinoid metabolic process,BP,SDC1;GPC4;APOE;RETSAT;ALDH1A2;AGRN;LRP1
16509,GO:0097180,0.158099691767252,0.993207777186479,1,2,serine protease inhibitor complex,CC,SERPINB6
13148,GO:0051683,0.158201766794278,0.971930484837473,2,7,establishment of Golgi localization,BP,COPG1;STK25
6211,GO:0019722,0.158289501039438,0.905613702526247,13,92,calcium-mediated signaling,BP,NOS1;NFATC4;ADGRL1;FKBP1A;PRNP;EGFR;PRKACA;PLCG1;ADGRB2;P2RX4;HOMER2;CIB1;ERBB3
12865,GO:0051156,0.158413406617869,0.944855245751922,4,21,glucose 6-phosphate metabolic process,BP,H6PD;PGLS;HK1;TALDO1
3696,GO:0008203,0.15845436952368,0.903473460764105,14,100,cholesterol metabolic process,BP,SORL1;LMF1;VLDLR;LRP5;APOE;DGKQ;PCSK9;OSBPL5;LDLRAP1;ACADVL;PMVK;RXRA;SEC14L2;CAT
619,GO:0001786,0.158694476762347,0.936649557224938,5,27,phosphatidylserine binding,MF,OSBPL10;OSBPL5;GSDMA;GSDMC;ASAP1
2513,GO:0005765,0.158729461183813,0.881391715958598,37,298,lysosomal membrane,CC,TSPAN1;AP3D1;CKAP4;CD68;MARCH9;LPCAT1;VLDLR;ATP13A2;AP1B1;AP2A2;VPS11;PI4K2A;PCSK9;SURF4;STOM;GNB1;ATP11A;ARL8A;SLC12A4;TMEM8A;TMEM9;TMEM44;GNB2;UBA1;TCIRG1;TPCN1;LRP1;P2RX4;HPSE;ATP6V1C2;CYB561;SNAP29;DRAM2;LITAF;C12ORF66;TMBIM1;HM13
16921,GO:0098852,0.158729461183813,0.881391715958598,37,298,lytic vacuole membrane,CC,TSPAN1;AP3D1;CKAP4;CD68;MARCH9;LPCAT1;VLDLR;ATP13A2;AP1B1;AP2A2;VPS11;PI4K2A;PCSK9;SURF4;STOM;GNB1;ATP11A;ARL8A;SLC12A4;TMEM8A;TMEM9;TMEM44;GNB2;UBA1;TCIRG1;TPCN1;LRP1;P2RX4;HPSE;ATP6V1C2;CYB561;SNAP29;DRAM2;LITAF;C12ORF66;TMBIM1;HM13
13918,GO:0060541,0.159031400126224,0.896606773032496,18,131,respiratory system development,BP,MAP2K1;LAMA5;ACVR2B;EGFR;MMP14;CTSZ;TGFBR2;PKD1;TULP3;ALDH1A2;HSD11B1;THRA;FGFR1;CHD7;ARG1;MAPK3;ITGA3;EP300
4587,GO:0010675,0.159216764895465,0.907311250466227,12,82,regulation of cellular carbohydrate metabolic process,BP,NR1D1;IGFBP4;AKT1;DGKQ;PPARA;SRC;GSK3A;NTSR1;SLC35B4;ADIPOR1;MLYCD;SLC45A3
15589,GO:0072028,0.159449215440676,0.91969298229968,8,50,nephron morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;PKD1;GATA3;FGF2;TGFB1
9457,GO:0036035,0.159478772806673,0.955972307946288,3,13,osteoclast development,BP,FAM20C;SRC;LRRK1
8206,GO:0032945,0.15953294244961,0.92404272682186,7,43,negative regulation of mononuclear cell proliferation,BP,DLG1;PRNP;ARG2;PKN1;GAL;ARG1;TGFB1
12547,GO:0050672,0.15953294244961,0.92404272682186,7,43,negative regulation of lymphocyte proliferation,BP,DLG1;PRNP;ARG2;PKN1;GAL;ARG1;TGFB1
9980,GO:0042359,0.159956998267135,0.955271678967017,3,14,vitamin D metabolic process,BP,CYP27B1;VDR;FGFR1
15862,GO:0072557,0.160103456287169,0.993026565157571,1,2,IPAF inflammasome complex,CC,CASP4
864,GO:0002192,0.16010364458374,0.993026548006502,1,2,IRES-dependent translational initiation of linear mRNA,BP,EIF4EBP1
17250,GO:0110017,0.16010364458374,0.993026548006502,1,2,cap-independent translational initiation of linear mRNA,BP,EIF4EBP1
5365,GO:0016139,0.160119881710506,0.971375706171684,2,7,glycoside catabolic process,BP,FUCA1;NAGA
8931,GO:0034766,0.160133334955796,0.91917062045522,8,51,negative regulation of ion transmembrane transport,BP,HECW2;AKT1;PCSK9;STK39;NTSR1;EPHB2;SLC30A1;TGFB1
11891,GO:0046883,0.160309087803142,0.894235211430608,19,143,regulation of hormone secretion,BP,PCK2;NR1D1;RAPGEF3;LRP5;MAP4K4;EGFR;ITPR3;HADH;NLGN2;GLUL;APLN;GLUD1;ARL2;SCG5;GAL;FGFR1;CHD7;ANXA1;GNAS
16140,GO:0090110,0.160407137614237,0.955596454016776,3,13,cargo loading into COPII-coated vesicle,BP,SEC23A;SEC24C;TBC1D20
3660,GO:0008144,0.16042385761909,0.861517458034542,146,1266,drug binding,MF,PYGB;CBS;NOS1;MST1R;MAP2K1;PYGL;ERCC6;SCN8A;OBSCN;FKBP1A;DGKA;RPS6KA2;PC;SCYL1;SMARCA1;NME4;CYGB;MAPKAPK3;FKBP9;BCR;MARK4;AARS;ACVR2B;GPT2;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;PRKACA;CARS;ACTA2;HK1;MAP2K2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;ITPR3;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;UBE2J1;PPARA;NADK;PRKACB;CDC34;ABCB8;MAP3K9;IDE;TWF2;FSCN1;PAK1;TTBK2;ACSF2;CTBS;GLUL;RET;HLTF;ASS1;ATP11A;OASL;GRIN3B;GLUD1;PANK4;NEK9;MT2A;MYH15;ALAS1;TOP1;PIP5K1C;SRC;FKBP10;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;SPTLC2;ASNS;KIF17;VDR;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;ATP2C2;TTLL12;GUK1;CDK18;SIGMAR1;STK17A;TRIB3;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;PNP;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;LONP2;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;ADCY6;ADCK2;ERBB3
11497,GO:0045940,0.160565183454247,0.955022652689444,3,14,positive regulation of steroid metabolic process,BP,NR1D1;APOE;LDLRAP1
8312,GO:0033138,0.16062745540241,0.914954044808924,9,60,positive regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;AKT1;CD44;PAK1;RET;MIF;CAMK1;TGFB1
19046,GO:1904844,0.160704523631395,0.99297169941073,1,2,response to L-glutamine,BP,HSF1
19047,GO:1904845,0.160704523631395,0.99297169941073,1,2,cellular response to L-glutamine,BP,HSF1
7637,GO:0032039,0.160745545373126,0.955459167122369,3,13,integrator complex,CC,INTS8;ZNF609;INTS1
13616,GO:0060065,0.160815641782815,0.955430711346794,3,13,uterus development,BP,WNT7A;GATA3;SRC
15763,GO:0072330,0.160924900019583,0.886578462383879,26,204,monocarboxylic acid biosynthetic process,BP,NR1D1;PGM1;ACOT7;XBP1;HK1;PFKP;PPARA;DHTKD1;WDTC1;ELOVL1;ALOX15B;ALDH1A2;CBR4;ACADVL;ASNS;CHST14;MGLL;MIF;ADIPOR1;TRIB3;MLYCD;ALDOC;CEACAM1;LDHA;ANXA1;SLC45A3
9109,GO:0035372,0.160925436288755,0.955386127137944,3,13,protein localization to microtubule,BP,DVL1;TTBK2;ABHD17C
3257,GO:0006925,0.161091994929806,0.954806552171415,3,14,inflammatory cell apoptotic process,BP,IRF7;CTSL;ANXA1
17093,GO:0099568,0.161146474313364,0.877144600083237,42,340,cytoplasmic region,CC,CAPN2;AP3D1;DLG4;RAPGEF3;SEPT10;PRKACA;PRKCZ;CTSZ;SEPT5;AKAP12;LAMC2;RHOC;SEPT8;WDR66;ASPH;RHOBTB2;DYNLRB1;FAM110C;CAP1;FLNB;GIPC1;TULP3;EXOC2;SH3BP1;PFN1;KIF17;RAI14;FRYL;MISP;ARFIP2;ARFGEF2;SPIRE1;KLHL17;MAP1LC3B;RHOBTB1;WIPF1;GAS8;MYZAP;LLGL1;PXN;PLEKHH2;STIM1
1555,GO:0003951,0.161168511891396,0.955287365465608,3,13,NAD+ kinase activity,MF,DGKA;DGKQ;NADK
15837,GO:0072521,0.161183935970581,0.875793021767289,45,392,purine-containing compound metabolic process,BP,NT5E;XDH;NOS1;PTHLH;DLG4;DLG1;PGM1;SLC2A9;RAPGEF3;NME4;ACOT7;ADCY7;HK1;CARD11;APOE;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;AHCY;GAMT;DLG3;GNAI2;PPCS;PANK4;SDHA;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;AOX1;PNP;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
14451,GO:0061744,0.161572794368602,0.99289202860562,1,2,motor behavior,BP,ADARB1
7711,GO:0032185,0.161632452254632,0.955098652080207,3,13,septin cytoskeleton organization,BP,SEPT10;SEPT5;SEPT8
5681,GO:0016790,0.161683865144538,0.934652225777804,5,29,thiolester hydrolase activity,MF,ACOT7;HAGH;ACOT1;ACOT13;ABHD17C
11019,GO:0044829,0.161695192263207,0.970916683145086,2,7,positive regulation by host of viral genome replication,BP,STOM;TBC1D20
16513,GO:0097191,0.162052008432387,0.889385167576463,22,171,extrinsic apoptotic signaling pathway,BP,RBCK1;BOK;IFI6;ITGA6;G0S2;MKNK2;AKT1;BAG3;DEDD2;RET;SRC;GSK3A;FYN;TNFRSF1A;MOAP1;FGFR1;BCL2L1;CIB1;ARHGEF2;TMBIM1;TGFB1;ERBB3
2389,GO:0005523,0.162148066051626,0.969807152004502,2,8,tropomyosin binding,MF,TMOD2;TNNT1
4124,GO:0009182,0.162230172646985,0.992831382540535,1,2,purine deoxyribonucleoside diphosphate metabolic process,BP,GUK1
11552,GO:0046066,0.162230172646985,0.992831382540535,1,2,dGDP metabolic process,BP,GUK1
3685,GO:0008190,0.162302141786665,0.970739010600158,2,7,eukaryotic initiation factor 4E binding,MF,EIF4EBP1;ANGEL1
5910,GO:0018126,0.162438747876373,0.94321934884107,4,20,protein hydroxylation,BP,CRTAP;P4HB;ASPH;P4HA1
7470,GO:0031623,0.162747566892511,0.913649813602952,9,59,receptor internalization,BP,DLG4;RAB31;PCSK9;DKK1;APLN;LDLRAP1;DNM2;LRP1;CEACAM1
14077,GO:0060831,0.162822708593716,0.954613215660108,3,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;SUFU;TULP3
6068,GO:0019213,0.163000738034313,0.917366228190546,8,51,deacetylase activity,MF,MTA1;NACC2;MIER2;PHF21A;NDST2;SIN3B;RCOR1;MBD3
2664,GO:0006007,0.163207617644819,0.942538978517761,4,21,glucose catabolic process,BP,LRP5;HK1;PFKP;ALDOC
6611,GO:0022804,0.163311778375555,0.884728176443079,26,201,active transmembrane transporter activity,MF,SLCO4A1;SLC16A3;SLC2A9;SLC12A7;ATP13A2;ATP7B;SLC20A1;TMCO3;ABCB8;SLC29A4;SLC12A4;SLC6A6;SLC13A3;SLC6A9;SLC33A1;SLC13A5;ATP2C2;TCIRG1;SLC6A14;ABCA7;SLC10A6;ATP6V1C2;SLC5A1;PCYOX1;SLC15A1;SLC45A3
635,GO:0001822,0.163416582406455,0.886442040149819,24,182,kidney development,BP,PGF;CTNNBIP1;SDC1;DLG1;LAMA5;ACVR2B;ACTA2;ARG2;WWTR1;PCSK9;LAMB2;PODXL;RET;NID1;PKD1;GATA3;WFS1;ARID5B;ALDH1A2;FGFR1;FGF2;TGFB1;CAT;ITGA3
6709,GO:0030111,0.163420745034442,0.880258827838446,32,260,regulation of Wnt signaling pathway,BP,MDFI;CCND1;CTNNBIP1;NFATC4;DVL1;WNT7A;IGFBP4;PSMD2;SMURF2;LRP5;CSNK1E;APOE;WWTR1;FERMT1;DKK1;SOX7;DDIT3;GRB10;IGFBP2;SRC;GSK3A;FUZ;WNT5B;PSMD7;LRP1;LRRK1;BICC1;INVS;ATP6V1C2;CSNK1D;ITGA3;TCF7L1
15187,GO:0071295,0.163696317468388,0.942610990228399,4,20,cellular response to vitamin,BP,CYP27B1;POSTN;VDR;KANK2
10874,GO:0044387,0.163855173728123,0.970282325848818,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1;PPM1F
3378,GO:0007157,0.163869517134965,0.942216865842217,4,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ADGRL1;CADM4;AMIGO2;TENM2
2253,GO:0005165,0.163874442813309,0.970276640936491,2,7,neurotrophin receptor binding,MF,SHC1;PLCG1
2255,GO:0005167,0.163874442813309,0.970276640936491,2,7,neurotrophin TRK receptor binding,MF,SHC1;PLCG1
7951,GO:0032536,0.163975694384896,0.970246761419892,2,7,regulation of cell projection size,BP,WNT7A;TWF2
12663,GO:0050848,0.164002442153285,0.92122528071448,7,44,regulation of calcium-mediated signaling,BP,NOS1;FKBP1A;PRNP;PRKACA;P2RX4;CIB1;ERBB3
6062,GO:0019207,0.164048223931412,0.888955815965995,21,161,kinase regulator activity,MF,CCND1;RAC2;MAP2K1;ERCC6;MAP2K2;DGKQ;ATG13;HEXIM1;SOCS2;TRIB3;TRIB2;TAOK1;CIB1;SOCS7;CCNE1;ITSN1;TGFB1;SPRED2;PIK3R2;CAMK2N1;ERBB3
8731,GO:0034370,0.164295957981989,0.992638970313168,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8733,GO:0034372,0.164295957981989,0.992638970313168,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
3289,GO:0006982,0.164547280094726,0.992615371337611,1,2,response to lipid hydroperoxide,BP,GPX3
3563,GO:0007606,0.164594560269162,0.933084939285894,5,29,sensory perception of chemical stimulus,BP,ITPR3;GNB1;REEP2;ASIC1;GNAS
9863,GO:0042101,0.1647032155682,0.970031697820816,2,7,T cell receptor complex,CC,CARD11;CEACAM1
6205,GO:0019693,0.164767069985721,0.873159269666763,44,383,ribose phosphate metabolic process,BP,NT5E;NOS1;PYGL;PTHLH;DLG4;DLG1;PGM1;RAPGEF3;NME4;ACOT7;H6PD;ADCY7;PGLS;HK1;CARD11;APOE;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;DLG3;GNAI2;PPCS;PANK4;SDHA;CAP1;TAZ;TALDO1;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
5608,GO:0016646,0.165018401272743,0.953184449143697,3,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,ALDH1L2;PYCR2;ALDH4A1
10232,GO:0042891,0.165062724599746,0.969925182547188,2,7,antibiotic transport,BP,SLC13A3;SLC13A5
19992,GO:2000516,0.165101329740276,0.953149971523753,3,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ;TGFBR2;ANXA1
3672,GO:0008171,0.16524870599996,0.94154388186821,4,21,O-methyltransferase activity,MF,BCDIN3D;COMT;PCMTD2;COMTD1
15839,GO:0072523,0.165336863201072,0.925834387400491,6,37,purine-containing compound catabolic process,BP,NT5E;XDH;RAPGEF3;AHCY;AOX1;PNP
8334,GO:0033169,0.165349641218906,0.953576508217045,3,13,histone H3-K9 demethylation,BP,KDM4B;HSF4;PHF2
12319,GO:0048642,0.165438455954755,0.969813691122712,2,7,negative regulation of skeletal muscle tissue development,BP,DKK1;TGFB1
9631,GO:0036488,0.165481032643678,0.992527330431595,1,2,CHOP-C/EBP complex,CC,DDIT3
5130,GO:0015556,0.165521178690678,0.969789121353035,2,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A3;SLC13A5
4242,GO:0009439,0.165767694361358,0.992500187298405,1,2,cyanate metabolic process,BP,TST
4243,GO:0009440,0.165767694361358,0.992500187298405,1,2,cyanate catabolic process,BP,TST
3138,GO:0006732,0.165911300167909,0.875928582283797,36,296,coenzyme metabolic process,BP,NT5E;NAPRT;PCK2;PGM1;IDH2;PC;ACOT7;H6PD;PGLS;ACOT1;HK1;MDH2;ACOT13;ALDH1L2;PFKP;NMRK1;PPARA;DHTKD1;NADK;ELOVL1;HMGCL;AHCY;ACSF2;GAMT;PARP10;SLC2A3;PPCS;PANK4;CBR4;TALDO1;PMVK;HLCS;PNP;MLYCD;ALDOC;LDHA
10321,GO:0043087,0.165994086699997,0.871902583387346,45,363,regulation of GTPase activity,BP,F2R;ASAP2;DOCK4;SNX9;ARAP1;ITGA6;NET1;RAPGEF3;SBF1;BCR;EVI5L;ARHGAP23;RIN2;ARHGAP22;EPHA1;GIT2;GDI1;RIN1;SIPA1;TBC1D16;RAP1GDS1;TBC1D14;GIT1;TBC1D9B;ARHGAP39;DOCK9;ARL2;RGS19;SH3BP1;AGRN;VPS9D1;DNMBP;TBC1D20;ARAP3;TBC1D2B;IQSEC1;LLGL1;OCRL;ARHGAP44;AGAP1;SRGAP2B;PIK3R2;RAP1GAP2;RASA3;ASAP1
12265,GO:0048524,0.166149124198291,0.899924209254546,13,95,positive regulation of viral process,BP,PC;ADARB1;P4HB;APOE;VPS4A;MVB12B;STOM;RSF1;NELFCD;RAD23A;TBC1D20;VAPB;EP300
5153,GO:0015688,0.166162971734717,0.992462671288369,1,2,iron chelate transport,BP,LCN2
5263,GO:0015891,0.166162971734717,0.992462671288369,1,2,siderophore transport,BP,LCN2
8218,GO:0032965,0.166192006158461,0.941082191892826,4,21,regulation of collagen biosynthetic process,BP,F2R;CYGB;LARP6;TGFB1
267,GO:0000737,0.166246634413063,0.941055419772282,4,21,DNA catabolic process, endonucleolytic,BP,H1F0;ENDOG;DNASE1L1;HSF1
8142,GO:0032835,0.166276288372678,0.925588206994511,6,35,glomerulus development,BP,ACTA2;WWTR1;LAMB2;PODXL;RET;NID1
12196,GO:0048306,0.166296500344252,0.925140817429955,6,38,calcium-dependent protein binding,MF,VLDLR;WFS1;VAMP2;ANXA3;MYO1D;ANXA1
5691,GO:0016805,0.166342621469076,0.969544685425692,2,7,dipeptidase activity,MF,SCRN1;CNDP2
4355,GO:0009931,0.166348945907298,0.969542800252858,2,7,calcium-dependent protein serine/threonine kinase activity,MF,MAPKAPK3;MKNK2
12442,GO:0048875,0.16635024339296,0.969542413495506,2,7,chemical homeostasis within a tissue,BP,LPCAT1;HOMER2
1135,GO:0002724,0.166440872227442,0.952591810874627,3,14,regulation of T cell cytokine production,BP,PRKCZ;GATA3;ARG1
20181,GO:2000848,0.166694803436996,0.992412033029997,1,2,positive regulation of corticosteroid hormone secretion,BP,GAL
20289,GO:2001212,0.166749544932018,0.96942329057932,2,7,regulation of vasculogenesis,BP,XDH;CEACAM1
12761,GO:0051010,0.166821982801622,0.952968634894166,3,13,microtubule plus-end binding,MF,CLIP2;TTBK2;STIM1
7602,GO:0031968,0.16694442068999,0.88668138211892,21,163,organelle outer membrane,CC,CYP27B1;BOK;BNIP3;SYNE3;HK1;ARMCX2;FAM210B;ITPR3;RETSAT;BNIP3L;MLXIP;IFI27;CPTP;MOAP1;SIGMAR1;BCL2L1;ULK1;ARG1;BPHL;VAT1;CPT1B
18500,GO:1903573,0.166990481204628,0.925019514302926,6,36,negative regulation of response to endoplasmic reticulum stress,BP,XBP1;SYVN1;UBE2J1;WFS1;GRINA;DNAJB9
7870,GO:0032426,0.166999225796234,0.969348704231587,2,7,stereocilium tip,CC,ESPN;HOMER2
9940,GO:0042277,0.167051010189827,0.885502104908211,22,171,peptide binding,MF,SORL1;CST3;PRNP;RNPEPL1;APOE;FBXO2;KDELR1;IPO13;IDE;TUBB3;CEMIP;LDLRAP1;CLSTN1;THOP1;ADNP;APBB1;RXRA;EPHB2;CSNK1D;FURIN;APBA1;TM2D1
10765,GO:0044154,0.167076485287668,0.969325609248146,2,7,histone H3-K14 acetylation,BP,GATA3;WBP2
6904,GO:0030433,0.167191059282108,0.907262575326962,10,68,ubiquitin-dependent ERAD pathway,BP,EDEM1;SYVN1;TMEM129;FBXO2;UBE2J1;UBXN4;WFS1;STUB1;DNAJB9;RNF103
6903,GO:0030432,0.167230668671422,0.992360822810602,1,2,peristalsis,BP,DLG1
1188,GO:0002832,0.167232473215536,0.92487891370353,6,36,negative regulation of response to biotic stimulus,BP,ARG2;FAM3A;HTRA1;MAPKBP1;SEC14L1;CEACAM1
3139,GO:0006733,0.167307605633732,0.888898806764575,19,144,oxidoreduction coenzyme metabolic process,BP,NT5E;NAPRT;PCK2;PGM1;IDH2;H6PD;PGLS;HK1;MDH2;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;TALDO1;PNP;ALDOC;LDHA
11819,GO:0046685,0.167501547359886,0.93150921703189,5,29,response to arsenic-containing substance,BP,MKNK2;ATF4;MAPK13;HSF1;UROS
10647,GO:0043647,0.167584077251694,0.914561330965059,8,50,inositol phosphate metabolic process,BP,PLCH2;PLCG1;ISYNA1;PLCB3;NTSR1;PLCD3;FGF2;OCRL
14802,GO:0070493,0.167595200492738,0.969170361259045,2,7,thrombin-activated receptor signaling pathway,BP,F2R;DGKQ
8446,GO:0033558,0.167653538696813,0.919116382829209,7,43,protein deacetylase activity,MF,MTA1;NACC2;MIER2;PHF21A;SIN3B;RCOR1;MBD3
6712,GO:0030119,0.167790555903817,0.919032617972074,7,43,AP-type membrane coat adaptor complex,CC,AP3D1;EGFR;AP1B1;AP2A2;GGA3;GGA1;LDLRAP1
19610,GO:1990622,0.168143518916904,0.992273150982974,1,2,CHOP-ATF3 complex,CC,DDIT3
6755,GO:0030173,0.168257221227471,0.924282757651674,6,36,integral component of Golgi membrane,CC,QSOX1;YIF1A;RFNG;SLC35B4;MFNG;TBC1D20
9102,GO:0035358,0.168322177733627,0.968952226070044,2,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;STARD10
9430,GO:0035988,0.168356621794838,0.968941874769536,2,7,chondrocyte proliferation,BP,MMP14;HMGA2
6629,GO:0022857,0.168364616736979,0.864430269310723,63,535,transmembrane transporter activity,MF,SERINC2;KCNG1;SCN8A;SLCO4A1;DLG4;BSG;DLG1;SLC16A3;SLC2A9;TTYH3;SLC12A7;ATP13A2;ATP7B;ITPR3;SLC20A1;ORAI1;TMCO3;ABCB8;SLC38A10;SFXN3;SLC29A4;PKD1;DLG3;NIPA1;ANO8;SLC2A3;GRIN3B;ASIC1;SLC12A4;FAM155B;SLC6A6;SLC13A3;SLC43A1;NDUFA4L2;NCS1;TMEM44;SLC6A9;SLC25A43;SLC33A1;GJC2;SLC13A5;SLC35B4;ATP2C2;LRRC8A;TCIRG1;SLC27A1;TPCN1;SLC6A14;P2RX4;ABCA7;SLC10A6;ATP6V1C2;KCNC4;SLC35G2;SLC5A1;CEACAM1;SLC30A1;PCYOX1;SLC15A1;AZIN2;SLC45A3;ORAI3;RASA3
16075,GO:0086103,0.168459298426433,0.968911009241067,2,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1;SRC
1148,GO:0002741,0.16857184976477,0.968877160426315,2,7,positive regulation of cytokine secretion involved in immune response,BP,HK1;MAPK3
8198,GO:0032930,0.168646413033133,0.967817714788998,2,8,positive regulation of superoxide anion generation,BP,EGFR;TGFB1
20309,GO:2001243,0.168648272367219,0.903121654155969,11,79,negative regulation of intrinsic apoptotic signaling pathway,BP,XBP1;AKT1;SYVN1;CD44;ZNF385A;WFS1;SRC;GRINA;MIF;BCL2L1;ARHGEF2
19925,GO:2000380,0.168887430418581,0.96878216947766,2,7,regulation of mesoderm development,BP,DKK1;FGFR1
6765,GO:0030194,0.168893263542834,0.951563888061052,3,14,positive regulation of blood coagulation,BP,F2R;F12;HPSE
17381,GO:1900048,0.168893263542834,0.951563888061052,3,14,positive regulation of hemostasis,BP,F2R;F12;HPSE
7791,GO:0032311,0.168900150339441,0.99220006678718,1,2,angiogenin-PRI complex,CC,RNH1
8497,GO:0033646,0.168992627042575,0.968750477755864,2,7,host intracellular part,CC,RAB29;LMAN1
10655,GO:0043656,0.168992627042575,0.968750477755864,2,7,intracellular region of host,CC,RAB29;LMAN1
19901,GO:2000345,0.168999878846595,0.968748292564403,2,7,regulation of hepatocyte proliferation,BP,XBP1;CEACAM1
20024,GO:2000586,0.169113409582716,0.968714073855366,2,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
5300,GO:0015985,0.169234711506104,0.967634990479018,2,8,energy coupled proton transport, down electrochemical gradient,BP,VPS9D1;TCIRG1
5301,GO:0015986,0.169234711506104,0.967634990479018,2,8,ATP synthesis coupled proton transport,BP,VPS9D1;TCIRG1
4918,GO:0014854,0.169473674495056,0.968605383617455,2,7,response to inactivity,BP,MTMR4;CAT
9372,GO:0035878,0.169615975916177,0.96856240809832,2,7,nail development,BP,ITGB4;ITGA6
8358,GO:0033210,0.169686122408112,0.96854121448046,2,7,leptin-mediated signaling pathway,BP,BBS2;ADIPOR1
3717,GO:0008237,0.169746354397331,0.895377755842655,14,99,metallopeptidase activity,MF,ADAM19;MMP1;RNPEPL1;MMP14;NPEPL1;PITRM1;IDE;MMP10;ADAMTS7;CNDP2;ADAM8;THOP1;ACY1;ADAM15
15554,GO:0071933,0.169834289171036,0.968496428482578,2,7,Arp2/3 complex binding,MF,SNX9;CORO1B
2406,GO:0005575,0.169959409687599,0.872234982242969,1216,11709,cellular_component,CC,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;KIAA1549L;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MPRIP;THSD4;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;SDK2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;CMTM4;DYSF;XPOT;IGFBP4;SLC16A3;MMP1;MXRA5;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;HYI;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;SEMA3F;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;CSMD2;MXRA7;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;LRP10;CSNK1E;TTYH3;PANO1;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;OGFRL1;CRAT;CARS;CORO1B;TUB;JOSD2;FAM189B;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;OAF;PPP1R13L;LMBR1L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MN1;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;LRP3;CARD11;SH3TC1;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;TMEM92;AP1B1;PEAR1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;NSMCE4A;FBXW5;FERMT1;ABHD8;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;TMCO3;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;FAM3A;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;TMEM125;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;FAM171A2;SURF4;RRNAD1;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TMEM245;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;SLC35E2B;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;SLC29A4;ISYNA1;LARP1B;ERO1B;MMP10;BCL9L;AHCY;ADM5;SCMH1;ACSF2;ZNF385A;NLGN2;GRAMD1A;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;TBC1D9B;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;TMTC4;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;TMEM200B;PARP10;DLG3;ATP11A;GATA3;TP53I11;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;SH2D5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;MYH16;GGACT;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;BCL7A;ALOX15B;SLC35E4;IL1RAP;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CNFN;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;TFPI2;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;FAM131A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;APCDD1L;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;DNAJC4;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GPX3;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;TMEM154;TMPRSS11D;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;TMEM200A;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;CGREF1;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;DHRS4L2;AMIGO2;TIMP1;ITPRIPL2;CRIM1;SLC46A3;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LAMB3;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;C1ORF115;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TMEM128;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;C16ORF58;PITPNM2;SNX25;PTPN12;GRAMD1C;SLC27A1;CPNE8;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;GPATCH8;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;TMEM139;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;TMEM54;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;INTS1;ARG1;PBXIP1;SLC10A6;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;NYNRIN;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;KCNC4;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;TMEM238;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;MANF;SLC15A1;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ASPHD1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;ORAI3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TP73-AS1;TRAF7;RNF10
17749,GO:1901654,0.169960694702205,0.889763635911883,17,127,response to ketone,BP,CCND1;PCK2;EGFR;AKT1;MSN;GNB1;HSF1;EIF4EBP1;SRC;BCL2L1;NDOR1;SLIT3;ARG1;CBL;ADCY6;TGFB1;WBP2
2283,GO:0005231,0.170017171529555,0.968441111978421,2,7,excitatory extracellular ligand-gated ion channel activity,MF,GRIN3B;P2RX4
13547,GO:0055102,0.170065873768133,0.967376093110486,2,8,lipase inhibitor activity,MF,ANXA3;ANXA1
3392,GO:0007172,0.17019535393198,0.968387177641148,2,7,signal complex assembly,BP,SRC;PXN
6588,GO:0022412,0.170287956216389,0.880966894098259,24,186,cellular process involved in reproduction in multicellular organism,BP,ERCC1;NEURL1;DNMT3A;BBS2;OSBP2;ETV5;RFX2;PRKACA;AKT1;DEAF1;UBE2J1;HSF1;SRC;AGO4;PAQR7;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;SLIT3;SPESP1;CIB1;TGFB1
6417,GO:0021675,0.17034637251121,0.917466250400125,7,43,nerve development,BP,SERPINE2;SEMA3F;ADARB1;RET;CHD7;EPHB2;ERBB3
12662,GO:0050847,0.170675250209204,0.968241723485697,2,7,progesterone receptor signaling pathway,BP,SRC;WBP2
12577,GO:0050710,0.170700001780631,0.929763537435518,5,29,negative regulation of cytokine secretion,BP,ARG2;TMSB4X;MAPKBP1;CPTP;ANXA1
11403,GO:0045764,0.170832717289515,0.992011682277029,1,2,positive regulation of cellular amino acid metabolic process,BP,COMT
5620,GO:0016670,0.170835660147019,0.968193041105533,2,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,QSOX1;PCYOX1
7687,GO:0032119,0.170869939624967,0.967124811570674,2,8,sequestering of zinc ion,BP,AP3D1;SLC30A1
9183,GO:0035542,0.170933336579603,0.968163382104292,2,7,regulation of SNARE complex assembly,BP,VPS11;STXBP1
2590,GO:0005883,0.170973797800335,0.968151092816062,2,7,neurofilament,CC,SHANK2;LDLRAP1
6286,GO:0019887,0.171053163413188,0.886015432159671,19,145,protein kinase regulator activity,MF,CCND1;RAC2;MAP2K1;ERCC6;MAP2K2;DGKQ;ATG13;HEXIM1;SOCS2;TRIB3;TRIB2;TAOK1;CIB1;SOCS7;CCNE1;TGFB1;SPRED2;CAMK2N1;ERBB3
15841,GO:0072525,0.171094076757485,0.894360247067994,14,100,pyridine-containing compound biosynthetic process,BP,NAPRT;PGM1;IDH2;HK1;PSAT1;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;PNP;ALDOC;LDHA
11660,GO:0046365,0.171152867241037,0.916735114952171,7,45,monosaccharide catabolic process,BP,PGM1;LRP5;HK1;CRYL1;PFKP;GALE;ALDOC
20164,GO:2000821,0.171179146081449,0.991977651783726,1,2,regulation of grooming behavior,BP,DLG4
4100,GO:0009153,0.171194417757223,0.99197614978349,1,2,purine deoxyribonucleotide biosynthetic process,BP,GUK1
10508,GO:0043400,0.171246428244906,0.991971033288013,1,2,cortisol secretion,BP,GAL
13045,GO:0051462,0.171246428244906,0.991971033288013,1,2,regulation of cortisol secretion,BP,GAL
1631,GO:0004065,0.171265674046193,0.968062381813895,2,7,arylsulfatase activity,MF,ARSK;ARSD
7655,GO:0032069,0.171336524656353,0.929414641516295,5,29,regulation of nuclease activity,BP,AKT1;OASL;NEIL1;OAS1;VAPB
1977,GO:0004690,0.171392158893156,0.968023906406067,2,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACA;PRKACB
16915,GO:0098840,0.171511752992478,0.991944904266195,1,2,protein transport along microtubule,BP,CAMSAP3
17032,GO:0099118,0.171511752992478,0.991944904266195,1,2,microtubule-based protein transport,BP,CAMSAP3
3905,GO:0008543,0.17169839614939,0.898433300093329,12,85,fibroblast growth factor receptor signaling pathway,BP,FAM20C;GATA3;APLN;ESRP1;DUSP6;FUZ;FGFR1;FGF2;CBL;MAPK3;GALNT3;SPRED2
8735,GO:0034375,0.171837324201082,0.966821416807179,2,8,high-density lipoprotein particle remodeling,BP,APOE;PLTP
6533,GO:0021932,0.171944293019329,0.967855723346311,2,7,hindbrain radial glia guided cell migration,BP,RERE;SOCS7
2839,GO:0006308,0.172111101926599,0.928989409495036,5,29,DNA catabolic process,BP,H1F0;ENDOG;DNASE1L1;HSF1;ISG20
5228,GO:0015837,0.172147126566117,0.92896961473508,5,29,amine transport,BP,RAB3B;STK39;STXBP1;NTSR1;ARG1
6994,GO:0030667,0.172409229670325,0.87832319359508,25,196,secretory granule membrane,CC,BSG;CKAP4;CD68;RAB31;LPCAT1;AP2A2;ITPR3;SERPINB6;CD44;SURF4;STOM;ATP11A;ARL8A;SLC2A3;ADAM8;VAMP2;APLP2;UBR4;TCIRG1;SNAP29;RAB4B;TMBIM1;CEACAM1;CD59;RAB6A
45,GO:0000097,0.172528038691372,0.950025999024153,3,14,sulfur amino acid biosynthetic process,BP,CBS;AHCY;GGT1
3489,GO:0007369,0.172577662563719,0.887909644333995,17,123,gastrulation,BP,ITGB4;DVL1;LRP5;ACVR2B;ITGB5;MMP14;LAMB1;TGFBR2;DKK1;SOX7;DUSP4;APLN;HMGA2;DUSP6;LAMB3;FGFR1;ITGA3
17580,GO:1901099,0.17275132320223,0.937543118286175,4,22,negative regulation of signal transduction in absence of ligand,BP,IFI6;AKT1;FYN;BCL2L1
20306,GO:2001240,0.17275132320223,0.937543118286175,4,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;AKT1;FYN;BCL2L1
7712,GO:0032190,0.17282581695363,0.991814808012874,1,2,acrosin binding,MF,ZP3
9336,GO:0035803,0.17282581695363,0.991814808012874,1,2,egg coat formation,BP,ZP3
15677,GO:0072176,0.17285515991839,0.967577452478708,2,7,nephric duct development,BP,PKD1;GATA3
10100,GO:0042592,0.172885818037565,0.851889477843948,123,1101,homeostatic process,BP,ANGPTL4;FHL1;ERCC1;NOS1;F2R;RAC2;PYGL;QSOX1;ERCC6;CYP27B1;AP3D1;BOK;CRTC1;PCK2;DLG4;NR1D1;IFI6;FKBP1A;PRNP;BNIP3;TXNDC11;LCN2;SESN2;BBS2;BCR;LPCAT1;LRP5;ADCY7;XBP1;MAP4K4;EGFR;SLC12A7;PRKACA;TUB;HK1;PPP1R13L;SHANK3;P4HB;PDIA5;AKT1;CARD11;APOE;FAM210B;ATP13A2;PKN1;ATP7B;ITPR3;PCSK9;ENDOG;STK39;PRKACB;WDTC1;PLCG1;RAP1GDS1;IDE;DEDD2;PRDX5;MALL;SFXN3;ERO1B;RAG1;DDIT3;DMXL2;GNB1;CEMIP;PKD1;GATA3;APLN;WFS1;SLC12A4;MT2A;FAM155B;ADAM8;TSC22D4;EDNRA;SRC;LDLRAP1;GLRX;POLD4;TGM2;ACADVL;OAS1;FYN;LPAR3;GRINA;VDR;COMT;THRA;NTSR1;ATP2C2;ADNP;LRRC8A;USF2;MIF;AMPD2;ADIPOR1;TCIRG1;SLC27A1;ZFPM1;TPCN1;P2RX4;LRRK1;TBC1D20;FGF2;VAPB;TMX4;CHD7;HOMER2;L3MBTL3;ATP6V1C2;MAPK3;DRAM2;SLC30A1;ADCY6;CCNE1;TGFB1;PIK3R2;ANXA1;PPP1R10;GNAS;ERP44;STIM1;RASA3
4083,GO:0009136,0.172958890236336,0.991801569453899,1,2,purine nucleoside diphosphate biosynthetic process,BP,GUK1
4122,GO:0009180,0.172958890236336,0.991801569453899,1,2,purine ribonucleoside diphosphate biosynthetic process,BP,GUK1
4130,GO:0009188,0.172958890236336,0.991801569453899,1,2,ribonucleoside diphosphate biosynthetic process,BP,GUK1
11267,GO:0045475,0.172985050482488,0.967537688023424,2,7,locomotor rhythm,BP,MTA1;NAGLU
14543,GO:0070026,0.173140853326668,0.991783448137028,1,2,nitric oxide binding,MF,CBS
7522,GO:0031702,0.173252052818542,0.96745588357919,2,7,type 1 angiotensin receptor binding,MF,ARAP1;GNB1
6080,GO:0019229,0.173472309395855,0.928452171158478,5,28,regulation of vasoconstriction,BP,F2R;DOCK4;EGFR;AKT1;APLN
2198,GO:0005068,0.173503814620437,0.9673786686332,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,SHC1;PAG1
5693,GO:0016810,0.173540328845193,0.890502665227038,15,111,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,MTA1;NACC2;ADARB1;MIER2;ARG2;PHF21A;NDST2;SIN3B;AMPD2;RCOR1;ARG1;ACY1;MBD3;CAT;APOBEC3C
7875,GO:0032431,0.173664854396215,0.991731141040928,1,2,activation of phospholipase A2 activity,BP,EGFR
2588,GO:0005881,0.173823691023669,0.910377096183051,8,52,cytoplasmic microtubule,CC,CLIP2;TMEM214;SNPH;TUBG2;REEP2;TUBG1;ARFGEF2;ENKD1
3562,GO:0007605,0.173999151864981,0.902587521315829,10,69,sensory perception of sound,BP,ESPN;TUB;EML2;SERPINB6;CEMIP;WFS1;ALDH7A1;FGFR1;CHD7;HOMER2
4039,GO:0009070,0.174088211414321,0.94936063804,3,14,serine family amino acid biosynthetic process,BP,CBS;PSAT1;GGT1
8831,GO:0034599,0.174264710512186,0.875021373092692,27,219,cellular response to oxidative stress,BP,CST3;NET1;BNIP3;SESN2;ETV5;EGFR;STK25;ATF4;P4HB;AKT1;ATP13A2;MAPK13;ENDOG;PRDX5;HSF1;PYCR2;SRC;DNM2;STK24;GPX3;MAPK9;ARG1;IMPACT;MAPK3;CAT;ANXA1;PXN
2387,GO:0005521,0.174300854768289,0.949269709452948,3,14,lamin binding,MF,PRNP;BNIP3L;IFI27
4507,GO:0010544,0.174325881777605,0.949259003797272,3,14,negative regulation of platelet activation,BP,SERPINE2;APOE;CEACAM1
6810,GO:0030252,0.174408692945004,0.967100503650746,2,7,growth hormone secretion,BP,LTBP4;CHD7
19899,GO:2000343,0.174418487052305,0.966006167844754,2,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
14333,GO:0061450,0.174495795370152,0.9659816217544,2,8,trophoblast cell migration,BP,SMURF2;TIMP1
17591,GO:1901163,0.174495795370152,0.9659816217544,2,8,regulation of trophoblast cell migration,BP,SMURF2;TIMP1
3529,GO:0007517,0.174505462740531,0.873358030045926,29,228,muscle organ development,BP,FHL1;NEURL1;MEF2D;SMTN;FKBP1A;LAMA5;FAM129B;XBP1;ADARB1;TGFBR2;DKK1;PAK1;BCL9L;MYH15;ARID5B;FLNB;TAZ;GSK3A;FGFR1;LEMD2;ZFPM1;ZNF609;FGF2;CHD7;RXRA;UNC45A;TGFB1;ERBB3;EP300
1641,GO:0004081,0.174563896994978,0.99164097074798,1,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,GARS
3978,GO:0008796,0.174563896994978,0.99164097074798,1,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,GARS
6342,GO:0021513,0.174613587952079,0.96703737864069,2,7,spinal cord dorsal/ventral patterning,BP,SUFU;TULP3
18026,GO:1902463,0.17517306344985,0.991579567825764,1,2,protein localization to cell leading edge,BP,CORO1B
4300,GO:0009743,0.175177479461453,0.882829249759752,19,146,response to carbohydrate,BP,ERCC1;CST3;PCK2;NR1D1;SESN2;LRP5;ACVR2B;XBP1;MAP4K4;PRKACA;MAPK13;ENDOG;TGFBR2;GLUL;VAMP2;ADNP;TGFB1;CAT;LDHA
9116,GO:0035385,0.175190516818637,0.966859359919909,2,7,Roundabout signaling pathway,BP,ROBO3;SLIT3
17346,GO:0150011,0.175413587131565,0.966790419651504,2,7,regulation of neuron projection arborization,BP,DVL1;DLG4
17347,GO:0150012,0.175413587131565,0.966790419651504,2,7,positive regulation of neuron projection arborization,BP,DVL1;DLG4
13241,GO:0051882,0.175446024612306,0.948290458778221,3,15,mitochondrial depolarization,BP,BOK;IFI6;SRC
104,GO:0000215,0.175539475685932,0.991542514907225,1,2,tRNA 2'-phosphotransferase activity,MF,TRPT1
419,GO:0001106,0.175964164533766,0.936232842214808,4,21,RNA polymerase II transcription corepressor activity,MF,ZMYND8;SIN3B;CTBP1;RERE
5075,GO:0015296,0.175982110249834,0.966614441534333,2,7,anion:cation symporter activity,MF,SLC12A7;SLC12A4
5912,GO:0018146,0.17624763526959,0.936090375076945,4,21,keratan sulfate biosynthetic process,BP,B4GALT2;B3GNT3;ST3GAL3;B4GALT6
2004,GO:0004725,0.176303425914798,0.897970965592143,11,76,protein tyrosine phosphatase activity,MF,MAP2K1;PTPRS;SSH1;PTPRF;PTPDC1;DUSP4;PTPN9;PTPRU;DUSP6;MTMR4;PTPN12
3831,GO:0008429,0.17637524066861,0.965382581633719,2,8,phosphatidylethanolamine binding,MF,ESYT2;PLTP
11964,GO:0047025,0.176583102201372,0.991436488345031,1,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,CBR4
8252,GO:0033017,0.177022022039451,0.935700669331571,4,21,sarcoplasmic reticulum membrane,CC,NOS1;FKBP1A;ASPH;STIM1
4422,GO:0010224,0.177153379911332,0.94804430544868,3,14,response to UV-B,BP,ERCC6;XPC;HYAL1
3263,GO:0006935,0.177363398337563,0.863037109585476,43,357,chemotaxis,BP,PGF;SH3KBP1;RAC2;DVL1;MAP2K1;SHC1;DOCK4;CMTM4;FAM129B;SEMA3F;VLDLR;CMTM7;CORO1B;SHANK3;TMSB4X;LAMB2;PLCG1;SEMA4B;TUBB3;RET;GRB10;GATA3;ADAM8;PIP5K1C;SRC;FYN;PPM1F;PLEKHG5;ITGA1;SEMA4G;FGFR1;MIF;ROBO3;P2RX4;FGF2;VASP;SLIT3;VEGFB;EPHB2;MAPK3;TGFB1;ANXA1;PLGRKT
9969,GO:0042330,0.177363398337563,0.863037109585476,43,357,taxis,BP,PGF;SH3KBP1;RAC2;DVL1;MAP2K1;SHC1;DOCK4;CMTM4;FAM129B;SEMA3F;VLDLR;CMTM7;CORO1B;SHANK3;TMSB4X;LAMB2;PLCG1;SEMA4B;TUBB3;RET;GRB10;GATA3;ADAM8;PIP5K1C;SRC;FYN;PPM1F;PLEKHG5;ITGA1;SEMA4G;FGFR1;MIF;ROBO3;P2RX4;FGF2;VASP;SLIT3;VEGFB;EPHB2;MAPK3;TGFB1;ANXA1;PLGRKT
17562,GO:1901068,0.177430333523067,0.912728762849001,7,46,guanosine-containing compound metabolic process,BP,DLG4;DLG1;NME4;CARD11;GTPBP1;DLG3;GUK1
9974,GO:0042351,0.177564919580813,0.991336076336213,1,2,'de novo' GDP-L-fucose biosynthetic process,BP,TSTA3
16575,GO:0097332,0.177615522003581,0.991330883656968,1,2,response to antipsychotic drug,BP,PRKACB
12099,GO:0048037,0.177687562392593,0.863154019317749,42,355,cofactor binding,MF,XDH;PYGB;CBS;NOS1;PYGL;CYP27B1;NR1D1;IDH2;PC;CYGB;ACOT7;HEBP1;H6PD;GPT2;CRYL1;ACAD10;HADH;DHTKD1;HMGCL;TSTA3;AHCY;ACBD4;GLUD1;SDHA;CTBP1;ALAS1;MICAL2;P4HA1;SRC;CBR4;ACADVL;SPTLC2;ASNS;MICAL1;HLCS;NDOR1;AOX1;PHYH;NDUFS2;UROS;CAT;LDHA
7232,GO:0031122,0.177860744262011,0.907871584485676,8,51,cytoplasmic microtubule organization,BP,DVL1;DLG1;TUBG2;VPS4A;CCDC88C;TUBG1;CAMSAP3;CIB1
4543,GO:0010614,0.178050735559606,0.94765664981889,3,14,negative regulation of cardiac muscle hypertrophy,BP,PAK1;GSK3A;P2RX4
4881,GO:0014741,0.178050735559606,0.94765664981889,3,14,negative regulation of muscle hypertrophy,BP,PAK1;GSK3A;P2RX4
17457,GO:1900208,0.178260502326026,0.991264547231192,1,2,regulation of cardiolipin metabolic process,BP,TAZ
17458,GO:1900210,0.178260502326026,0.991264547231192,1,2,positive regulation of cardiolipin metabolic process,BP,TAZ
2275,GO:0005216,0.178477390951026,0.879052414619393,20,150,ion channel activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;ORAI1;PKD1;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;LRRC8A;TPCN1;P2RX4;KCNC4;ORAI3;RASA3
19534,GO:1990379,0.178616289933908,0.991227834966094,1,2,lipid transport across blood brain barrier,BP,APOE
16897,GO:0098810,0.178654823543638,0.964650081636591,2,8,neurotransmitter reuptake,BP,NOS1;RAB3B
11636,GO:0046324,0.178726314520143,0.912279261577832,7,43,regulation of glucose import,BP,RTN2;AKT1;PRKCZ;PAK1;GRB10;GSK3A;PIK3R2
7209,GO:0031093,0.178820143744807,0.917909474592701,6,37,platelet alpha granule lumen,CC,QSOX1;SERPING1;TMSB4X;TIMP1;VEGFB;TGFB1
9891,GO:0042149,0.178971418839851,0.917976336632751,6,36,cellular response to glucose starvation,BP,SESN2;XBP1;ATF4;ASNS;IMPACT;C12ORF66
19849,GO:2000273,0.179099315764147,0.934341000739161,4,22,positive regulation of signaling receptor activity,BP,NEURL1;SHANK3;TGFA;EPHB2
4717,GO:0010877,0.179115110906333,0.991176220591644,1,2,lipid transport involved in lipid storage,BP,APOE
1259,GO:0003010,0.179660832337112,0.9911195618096,1,2,voluntary skeletal muscle contraction,BP,TNNT1
4870,GO:0014721,0.179660832337112,0.9911195618096,1,2,twitch skeletal muscle contraction,BP,TNNT1
549,GO:0001669,0.179720272159131,0.906469353799594,8,53,acrosomal vesicle,CC,BSG;LY6K;PRKACA;ITGA1;LOXL1;SPESP1;POMT1;ADAM15
12536,GO:0050660,0.179799416489559,0.902309970008812,9,60,flavin adenine dinucleotide binding,MF,XDH;NOS1;ACAD10;SDHA;MICAL2;ACADVL;MICAL1;NDOR1;AOX1
12635,GO:0050798,0.18002885258753,0.924396429643173,5,30,activated T cell proliferation,BP,PRNP;SATB1;IGFBP2;FYN;ARG1
2657,GO:0005999,0.180051193454512,0.991078910241027,1,2,xylulose biosynthetic process,BP,TALDO1
5653,GO:0016744,0.180051193454512,0.991078910241027,1,2,transferase activity, transferring aldehyde or ketonic groups,MF,TALDO1
2514,GO:0005766,0.180053812580004,0.883739607617807,16,122,primary lysosome,CC,PYGB;NAPRT;CKAP4;CD68;LPCAT1;GALNS;SURF4;STOM;FUCA1;ARL8A;CAP1;C6ORF120;ARG1;VAT1;SNAP29;TRAPPC1
10091,GO:0042582,0.180053812580004,0.883739607617807,16,122,azurophil granule,CC,PYGB;NAPRT;CKAP4;CD68;LPCAT1;GALNS;SURF4;STOM;FUCA1;ARL8A;CAP1;C6ORF120;ARG1;VAT1;SNAP29;TRAPPC1
2524,GO:0005777,0.18014312676141,0.887555295015004,14,105,peroxisome,CC,XDH;IDH2;CRAT;MAP2K2;TYSND1;IDE;PRDX5;HMGCL;PEX10;PMVK;MLYCD;PHYH;LONP2;CAT
10089,GO:0042579,0.18014312676141,0.887555295015004,14,105,microbody,CC,XDH;IDH2;CRAT;MAP2K2;TYSND1;IDE;PRDX5;HMGCL;PEX10;PMVK;MLYCD;PHYH;LONP2;CAT
8217,GO:0032964,0.180289504489844,0.924455337720303,5,29,collagen biosynthetic process,BP,F2R;CYGB;LARP6;ARG1;TGFB1
3797,GO:0008373,0.18031269107736,0.946674904798187,3,14,sialyltransferase activity,MF,ST3GAL3;ST3GAL5;ST6GALNAC2
16661,GO:0097503,0.18031269107736,0.946674904798187,3,14,sialylation,BP,ST3GAL3;ST3GAL5;ST6GALNAC2
9644,GO:0036503,0.180313431537895,0.892266255941549,12,86,ERAD pathway,BP,EDEM1;SYVN1;TMEM129;FBXO2;UBE2J1;UBXN4;WFS1;STUB1;POMT1;DNAJB9;RNF103;HM13
18136,GO:1902766,0.180445566505054,0.991037736738628,1,2,skeletal muscle satellite cell migration,BP,RHOC
3931,GO:0008610,0.180532880856922,0.854592067244826,60,511,lipid biosynthetic process,BP,MBOAT2;CYP27B1;LPCAT4;PCK2;NR1D1;PITPNM1;DGKA;SBF1;AGPAT3;ACOT7;LPCAT1;XBP1;AKT1;CDS2;APOE;DGKQ;PI4K2A;WDTC1;ELOVL1;ISYNA1;PTDSS2;PIGQ;ALOX15B;SRD5A3;PIP5K1C;ALDH1A2;CBR4;TAZ;ACADVL;PMVK;SPTLC2;TNFRSF1A;HSD11B1;MBOAT7;VDR;MGLL;FGFR1;MIF;MTMR4;ADIPOR1;TRIB3;PITPNM2;SLC27A1;ST3GAL5;AGPAT4;SMPD3;ZP3;FGF2;VAPB;MLYCD;SEC14L2;UGCG;B4GALT6;OCRL;CEACAM1;LPIN3;PIK3R2;STARD10;ANXA1;SLC45A3
5435,GO:0016290,0.180641375672248,0.964006452194163,2,8,palmitoyl-CoA hydrolase activity,MF,ACOT7;ACOT1
14225,GO:0061134,0.181015187434671,0.886772693105197,14,109,peptidase regulator activity,MF,CST3;SERPINE2;FBLN1;MMP14;SERPING1;SERPINB6;PRDX5;TFPI2;APLP2;SPINT2;TIMP1;CRIM1;PCSK1N;FURIN
4860,GO:0014070,0.181021478873687,0.850987924060858,74,636,response to organic cyclic compound,BP,CCND1;NFATC4;SDC1;MAP2K1;WNT7A;CST3;CYP27B1;PCK2;BSG;NR1D1;DNMT3A;FKBP1A;POSTN;ITGA6;RAPGEF3;SSH1;EGFR;MMP14;PRKACA;MAP2K2;ATF4;AKT1;FAM210B;DGKQ;ENDOG;MSN;TGFBR2;PPARA;PRKACB;PAK1;BCDIN3D;GNB1;HSF1;PTPRU;IGFBP2;EIF4EBP1;ALDH1A2;SRC;DNM2;AGO4;PAQR7;STXBP1;DUSP6;PMVK;ASNS;ANXA3;VDR;PUM1;COMT;THRA;SOCS2;BCL2L1;PMEPA1;HLCS;PAK4;P2RX4;SLIT3;HOMER2;RXRA;ARG1;IMPACT;LONP2;CBL;MAPK3;KANK2;MBD3;ADCY6;CCNE1;TGFB1;WBP2;CAT;LDHA;ANXA1;EP300
10377,GO:0043183,0.181022755675718,0.990977287935372,1,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFB
10396,GO:0043209,0.181338796003079,0.879495900048049,18,139,myelin sheath,CC,DLG1;MDH2;EHD3;PRKCZ;ITPR3;MSN;GDI1;FSCN1;GLUL;GNB1;ASS1;SDHA;STXBP1;GJC2;GNB2;MIF;HSPA2;MYO1D
1737,GO:0004332,0.181506239525114,0.990926479997267,1,2,fructose-bisphosphate aldolase activity,MF,ALDOC
4908,GO:0014839,0.181650060483879,0.990911335830002,1,2,myoblast migration involved in skeletal muscle regeneration,BP,ANXA1
14812,GO:0070513,0.181720223828546,0.963654850449375,2,8,death domain binding,MF,DAP;BCL2L1
3414,GO:0007198,0.181882119792596,0.990886870835901,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR7
19318,GO:1905521,0.181901449242873,0.945469150459689,3,15,regulation of macrophage migration,BP,MMP14;MIF;MAPK3
8411,GO:0033344,0.181958977468892,0.932882021363877,4,22,cholesterol efflux,BP,APOE;PLTP;LRP1;ABCA7
540,GO:0001658,0.182002727221007,0.916168053715431,6,36,branching involved in ureteric bud morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;FGF2;TGFB1
1502,GO:0003845,0.182180756358125,0.990855333383201,1,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,HSD11B1
9849,GO:0042078,0.182187645509971,0.99085460514487,1,2,germ-line stem cell division,BP,ETV5
12118,GO:0048133,0.182187645509971,0.99085460514487,1,2,male germ-line stem cell asymmetric division,BP,ETV5
16852,GO:0098728,0.182187645509971,0.99085460514487,1,2,germline stem cell asymmetric division,BP,ETV5
15470,GO:0071774,0.182228371933529,0.88405421359119,15,111,response to fibroblast growth factor,BP,POSTN;FAM20C;CD44;GATA3;APLN;ESRP1;DUSP6;FUZ;FGFR1;HYAL1;FGF2;CBL;MAPK3;GALNT3;SPRED2
3504,GO:0007412,0.182266432735527,0.990846274425625,1,2,axon target recognition,BP,STXBP1
6276,GO:0019867,0.182447100326544,0.874557684820148,21,165,outer membrane,CC,CYP27B1;BOK;BNIP3;SYNE3;HK1;ARMCX2;FAM210B;ITPR3;RETSAT;BNIP3L;MLXIP;IFI27;CPTP;MOAP1;SIGMAR1;BCL2L1;ULK1;ARG1;BPHL;VAT1;CPT1B
13882,GO:0060478,0.182454398808771,0.990826382528643,1,2,acrosomal vesicle exocytosis,BP,ZP3
19915,GO:2000367,0.182454398808771,0.990826382528643,1,2,regulation of acrosomal vesicle exocytosis,BP,ZP3
19916,GO:2000368,0.182454398808771,0.990826382528643,1,2,positive regulation of acrosomal vesicle exocytosis,BP,ZP3
13844,GO:0060420,0.182534937727884,0.915849487662191,6,36,regulation of heart growth,BP,TGFBR2;PAK1;GSK3A;DUSP6;FGFR1;FGF2
11802,GO:0046649,0.182745431145224,0.856827267270159,47,394,lymphocyte activation,BP,ERCC1;RAC2;AP3D1;DLG1;FKBP1A;PRNP;XBP1;CMTM7;MMP14;AKT1;CARD11;ARG2;PKN1;PRKCZ;POU2F2;FZD8;MSN;TGFBR2;KDELR1;PAK1;RAG1;SATB1;RAB29;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;KIF13B;GAL;LRRC8A;MFNG;MIF;ZFPM1;ZP3;PNP;CHD7;ARG1;POLM;DNAJB9;SNX27;CEACAM1;SKAP2;TGFB1;ANXA1;EP300
8295,GO:0033106,0.182999527962962,0.990768558015816,1,2,cis-Golgi network membrane,CC,BOK
5725,GO:0016861,0.1830273257498,0.963226916238992,2,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,HYI;MPI
13240,GO:0051881,0.183140697109473,0.908927530078136,7,48,regulation of mitochondrial membrane potential,BP,BOK;IFI6;BNIP3;AKT1;BNIP3L;SRC;BCL2L1
16248,GO:0090279,0.183304957677773,0.945366123488195,3,14,regulation of calcium ion import,BP,PRNP;FYN;SLC30A1
2800,GO:0006258,0.183344422513736,0.990731869526756,1,2,UDP-glucose catabolic process,BP,GSK3A
18535,GO:1903670,0.183476786382263,0.909174670456681,7,44,regulation of sprouting angiogenesis,BP,EPN1;EPN2;FGF2;CIB1;SRPX2;CEACAM1;ANXA1
17979,GO:1902307,0.183478529733784,0.945289854195586,3,14,positive regulation of sodium ion transmembrane transport,BP,NOS1;GLRX;DNM2
626,GO:0001807,0.183571190401015,0.990707702992563,1,2,regulation of type IV hypersensitivity,BP,ZP3
7739,GO:0032229,0.183607063323679,0.990703876843601,1,2,negative regulation of synaptic transmission, GABAergic,BP,STXBP1
8894,GO:0034703,0.18363648622292,0.892831377300086,11,76,cation channel complex,CC,NOS1;KCNG1;SCN8A;DLG4;FKBP1A;PRKACA;DLG3;GRIN3B;VAMP2;HSPA2;KCNC4
3167,GO:0006780,0.183780568416682,0.990685358760674,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11725,GO:0046502,0.183780568416682,0.990685358760674,1,2,uroporphyrinogen III metabolic process,BP,UROS
14682,GO:0070269,0.184144165694479,0.962859586024694,2,8,pyroptosis,BP,GSDMA;GSDMC
9014,GO:0035162,0.184269490848354,0.944941811456191,3,14,embryonic hemopoiesis,BP,TGFBR2;GATA3;ZFPM1
5694,GO:0016811,0.184429854211201,0.895364813818744,10,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,MTA1;NACC2;MIER2;PHF21A;NDST2;SIN3B;RCOR1;ACY1;MBD3;CAT
8263,GO:0033033,0.184448577504245,0.962759195180476,2,8,negative regulation of myeloid cell apoptotic process,BP,IRF7;MIF
5443,GO:0016307,0.184452696815213,0.944861082462905,3,14,phosphatidylinositol phosphate kinase activity,MF,PIP5K1C;PIP5KL1;ZFYVE21
8592,GO:0034067,0.184480414992497,0.931908976598498,4,21,protein localization to Golgi apparatus,BP,SORL1;OBSL1;CSNK1D;RAB6A
10036,GO:0042471,0.184587414984933,0.899093145325905,9,60,ear morphogenesis,BP,DVL1;BCR;NAGLU;GATA3;FGFR1;CHD7;TSHZ1;EPHB2;MAPK3
3879,GO:0008508,0.184643648666428,0.990592939539103,1,2,bile acid:sodium symporter activity,MF,SLC10A6
17036,GO:0099132,0.184800290955479,0.921709502839279,5,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP13A2;ATP7B;ATP2C2;TCIRG1;ATP6V1C2
14892,GO:0070664,0.185048904448508,0.908059138239454,7,45,negative regulation of leukocyte proliferation,BP,DLG1;PRNP;ARG2;PKN1;GAL;ARG1;TGFB1
13509,GO:0055026,0.185062085371756,0.931610363955561,4,21,negative regulation of cardiac muscle tissue development,BP,TGFBR2;DKK1;PAK1;GSK3A
4493,GO:0010513,0.185094825123029,0.99054442609,1,2,positive regulation of phosphatidylinositol biosynthetic process,BP,ZP3
13505,GO:0055022,0.185201719691311,0.944530583630643,3,14,negative regulation of cardiac muscle tissue growth,BP,TGFBR2;PAK1;GSK3A
14223,GO:0061117,0.185201719691311,0.944530583630643,3,14,negative regulation of heart growth,BP,TGFBR2;PAK1;GSK3A
10652,GO:0043652,0.185209537767023,0.962507736295417,2,8,engulfment of apoptotic cell,BP,RAC2;ABCA7
13880,GO:0060467,0.185209743943222,0.990532047175681,1,2,negative regulation of fertilization,BP,ZP3
19911,GO:2000359,0.185209743943222,0.990532047175681,1,2,regulation of binding of sperm to zona pellucida,BP,ZP3
19912,GO:2000360,0.185209743943222,0.990532047175681,1,2,negative regulation of binding of sperm to zona pellucida,BP,ZP3
17740,GO:1901629,0.185263020122603,0.990526305287161,1,2,regulation of presynaptic membrane organization,BP,APOE
1467,GO:0003714,0.185458699625972,0.869927858146022,23,179,transcription corepressor activity,MF,ZMYND8;CCND1;NR1D1;MTA1;PPP1R13L;ELK3;WWTR1;DRAP1;SUFU;DDIT3;SIN3B;CTBP1;RERE;TLE4;MAP3K10;HSF4;TRIB3;MXD4;CDYL2;RCOR1;PBXIP1;ZHX3;KLF12
205,GO:0000430,0.185593296003157,0.990490666461109,1,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,USF2
207,GO:0000432,0.185593296003157,0.990490666461109,1,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,USF2
3307,GO:0007009,0.185700195436413,0.898342206452183,9,60,plasma membrane organization,BP,SH3TC2;SNX9;DYSF;SNX33;AKT1;MYOF;DNM2;BAIAP2L1;ASAP1
4749,GO:0010917,0.185897218598223,0.962279872623666,2,8,negative regulation of mitochondrial membrane potential,BP,BNIP3;BNIP3L
11438,GO:0045837,0.185897218598223,0.962279872623666,2,8,negative regulation of membrane potential,BP,BNIP3;BNIP3L
11210,GO:0045309,0.185975727931598,0.913782153754122,6,36,protein phosphorylated amino acid binding,MF,SHC1;LDLRAP1;SHB;CBL;MAPK3;PIK3R2
7674,GO:0032098,0.186041428002712,0.962232014066532,2,8,regulation of appetite,BP,BBS2;PPARA
7671,GO:0032095,0.186041815232708,0.962231885522259,2,8,regulation of response to food,BP,BBS2;PPARA
13146,GO:0051673,0.186183799840288,0.990426762555084,1,2,membrane disruption in other organism,BP,RNASE7
9472,GO:0036066,0.186229486444422,0.944075929362248,3,14,protein O-linked fucosylation,BP,RFNG;ADAMTS7;MFNG
12731,GO:0050930,0.186304305728049,0.962144706661751,2,8,induction of positive chemotaxis,BP,PGF;VEGFB
5178,GO:0015732,0.186346656880362,0.962130632882764,2,8,prostaglandin transport,BP,MIF;P2RX4
7817,GO:0032365,0.186470734079849,0.920975367927307,5,29,intracellular lipid transport,BP,CPT2;VPS4A;PCSK9;LDLRAP1;CPT1B
15529,GO:0071888,0.18655500494998,0.96206136391436,2,8,macrophage apoptotic process,BP,IRF7;CTSL
19273,GO:1905397,0.18663316356617,0.990377973727067,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
19274,GO:1905402,0.18663316356617,0.990377973727067,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
13061,GO:0051499,0.18673786952072,0.990366585718515,1,2,D-aminoacyl-tRNA deacylase activity,MF,DTD1
13062,GO:0051500,0.18673786952072,0.990366585718515,1,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,DTD1
8152,GO:0032872,0.18687457566149,0.871155145027711,21,161,regulation of stress-activated MAPK cascade,BP,XDH;MAP2K1;WNT7A;ERCC6;DLG1;MAP4K4;EGFR;MAP2K2;STK25;AKT1;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;MAPK3;AIDA;MINK1
3445,GO:0007257,0.186875736791437,0.92097617493815,5,28,activation of JUN kinase activity,BP,ERCC6;PKN1;MAP3K9;MAP3K10;TAOK1
11289,GO:0045580,0.186924251137532,0.890391606434714,11,78,regulation of T cell differentiation,BP,AP3D1;XBP1;CARD11;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1
9101,GO:0035357,0.187016369008406,0.943726927142289,3,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;RXRA;STARD10
984,GO:0002438,0.187163762236668,0.961858662518538,2,8,acute inflammatory response to antigenic stimulus,BP,GATA3;ZP3
15190,GO:0071305,0.187249275770192,0.943623476185646,3,14,cellular response to vitamin D,BP,CYP27B1;VDR;KANK2
10888,GO:0044416,0.187256766756761,0.990310039259388,1,2,induction by symbiont of host defense response,BP,TGFB1
11844,GO:0046730,0.187256766756761,0.990310039259388,1,2,induction of host immune response by virus,BP,TGFB1
11845,GO:0046732,0.187256766756761,0.990310039259388,1,2,active induction of host immune response by virus,BP,TGFB1
13351,GO:0052251,0.187256766756761,0.990310039259388,1,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
13379,GO:0052509,0.187256766756761,0.990310039259388,1,2,positive regulation by symbiont of host defense response,BP,TGFB1
13380,GO:0052510,0.187256766756761,0.990310039259388,1,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
15617,GO:0072080,0.187467416947714,0.897147075176672,9,60,nephron tubule development,BP,PGF;CTNNBIP1;DLG1;LAMA5;WWTR1;PKD1;GATA3;FGF2;TGFB1
9879,GO:0042129,0.187560790102413,0.886965973359119,12,88,regulation of T cell proliferation,BP,RAC2;DLG1;PRNP;CARD11;ARG2;TGFBR2;IGFBP2;ZP3;PNP;ARG1;TGFB1;ANXA1
15243,GO:0071379,0.18775676816956,0.943397822965613,3,14,cellular response to prostaglandin stimulus,BP,AKT1;GNB1;ADCY6
9902,GO:0042175,0.187766887800158,0.841945470506043,92,813,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EDEM1;NOS1;MBOAT2;LPCAT4;LMF1;BOK;DLG1;PITPNM1;FKBP1A;CKAP4;SBF1;AGPAT3;TXNDC11;COPG1;TMEM214;SYNE3;LPCAT1;XYLT1;XBP1;EGFR;RTN2;RHBDF2;XYLT2;PDIA5;CDS2;SYVN1;YIF1A;ITPR3;TMEM129;RETSAT;SEC23A;PLD3;CREB3L2;UBE2J1;KDELR1;ESYT2;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;ERO1B;UBXN7;PTDSS2;REEP2;TMED3;PIGQ;UBXN4;ANTXR2;WFS1;SRD5A3;ASPH;SARAF;REEP6;RAB1B;CPTP;CARD19;STX5;SPTLC2;CLSTN1;REEP4;HSD11B1;MBOAT7;SLC33A1;SHISA5;PSKH1;MCFD2;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;SIGMAR1;AGPAT4;ULK1;TBC1D20;VAPB;LMAN1;TGFA;CASP4;POMT1;DNAJB9;RNF103;HM13;PNPLA6;LPIN3;CD59;RAB6A;IKBIP;ARCN1;ERP44;STIM1
939,GO:0002337,0.187848512333948,0.99024533009423,1,2,B-1a B cell differentiation,BP,CMTM7
14074,GO:0060825,0.188112952025306,0.990216335545301,1,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
19876,GO:2000313,0.188112952025306,0.990216335545301,1,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,FUZ
9286,GO:0035710,0.188127295543319,0.906108535978023,7,45,CD4-positive, alpha-beta T cell activation,BP,ARG2;PRKCZ;TGFBR2;SATB1;GATA3;ZFPM1;ANXA1
7314,GO:0031312,0.188268471518515,0.91995475863186,5,29,extrinsic component of organelle membrane,CC,FKBP1A;NUCB1;WDFY3;ULK1;ANXA1
12308,GO:0048627,0.188342804151139,0.990191094556874,1,2,myoblast development,BP,SDC1
16279,GO:0090316,0.188356668134348,0.871206422553034,20,156,positive regulation of intracellular protein transport,BP,EDEM1;RAC2;SORL1;RAPGEF3;PRNP;BAG3;VPS11;ZDHHC8;ATG13;PAK1;STOM;RAB29;CEMIP;VAMP2;GSK3A;FYN;CAMK1;CIB1;UGCG;TGFB1
5816,GO:0017075,0.18849948207027,0.943066990547338,3,14,syntaxin-1 binding,MF,SNPH;VAMP2;STXBP1
3256,GO:0006924,0.188570986140166,0.961388327209192,2,8,activation-induced cell death of T cells,BP,AKT1;TSC22D4
17827,GO:1901896,0.188648757222374,0.990157440604288,1,2,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
2260,GO:0005172,0.18868055940699,0.961351601312893,2,8,vascular endothelial growth factor receptor binding,MF,PGF;VEGFB
2012,GO:0004735,0.18873561101536,0.990147875276776,1,2,pyrroline-5-carboxylate reductase activity,MF,PYCR2
6944,GO:0030547,0.188834259455002,0.942379638277837,3,15,receptor inhibitor activity,MF,PCSK9;DKK1;LY6E
10966,GO:0044703,0.188877425109492,0.846257898025312,64,549,multi-organism reproductive process,BP,PGF;ERCC1;MST1R;PTHLH;CST3;CYP27B1;NEURL1;SERPINE2;BSG;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;SMURF2;CTSB;BBS2;OSBP2;ETV5;FBLN1;ADCY7;MYCBPAP;RFX2;PRKACA;EPN1;FAM50A;AKT1;PHC2;SH3PXD2B;DEAF1;TGFBR2;EPOR;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;IGFBP2;SRC;DNM2;AGO4;PAQR7;VDR;PUM1;RAI14;COMT;THRA;EIF2S2;TIMP1;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;RXRA;ARG1;NDRG3;SPESP1;GGT1;CIB1;PAIP2;TGFB1;AZIN2;ITGA3
15035,GO:0070949,0.188900405627297,0.990129712039772,1,2,regulation of neutrophil mediated killing of symbiont cell,BP,ARG1
15039,GO:0070960,0.188900405627297,0.990129712039772,1,2,positive regulation of neutrophil mediated cytotoxicity,BP,ARG1
15040,GO:0070961,0.188900405627297,0.990129712039772,1,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,ARG1
10594,GO:0043548,0.188974511276016,0.929590988237644,4,21,phosphatidylinositol 3-kinase binding,MF,FAM83A;DNM2;FYN;CBL
8889,GO:0034695,0.189078176978828,0.94280873315164,3,14,response to prostaglandin E,BP,AKT1;GNB1;ADCY6
13523,GO:0055070,0.189136410160345,0.941778409123711,3,16,copper ion homeostasis,BP,PRNP;ATP7B;MT2A
9277,GO:0035692,0.189176755679259,0.990099211751371,1,2,macrophage migration inhibitory factor receptor complex,CC,CD44
13094,GO:0051582,0.189177522236609,0.990099127075055,1,2,positive regulation of neurotransmitter uptake,BP,RAB3B
18250,GO:1903025,0.189201919738617,0.960240978310663,2,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,TMSB4X;DDIT3
818,GO:0002088,0.189206160677832,0.905549830301566,7,44,lens development in camera-type eye,BP,WNT7A;DLG1;TGFBR2;GATA3;WNT5B;TBC1D20;TGFB1
4973,GO:0015081,0.189268922962474,0.892220223292245,10,67,sodium ion transmembrane transporter activity,MF,SCN8A;SLC20A1;ASIC1;SLC6A6;SLC13A3;SLC6A9;SLC13A5;SLC6A14;SLC10A6;SLC5A1
7493,GO:0031652,0.18949610063465,0.961077785831846,2,8,positive regulation of heat generation,BP,APLN;SLC27A1
14055,GO:0060764,0.189677233293694,0.990043841823872,1,2,cell-cell signaling involved in mammary gland development,BP,LRP5
9548,GO:0036292,0.189991391757674,0.990008997514429,1,2,DNA rewinding,BP,ANXA1
14147,GO:0060993,0.190086891811369,0.895369838678542,9,60,kidney morphogenesis,BP,PGF;CTNNBIP1;DLG1;LAMA5;WWTR1;PKD1;GATA3;FGF2;TGFB1
17611,GO:1901223,0.190181584671402,0.960846997355672,2,8,negative regulation of NIK/NF-kappaB signaling,BP,TMSB4X;ADIPOR1
16467,GO:0097110,0.190283756725097,0.904736008887313,7,45,scaffold protein binding,MF,NOS1;MAP2K1;DLG4;MAP2K2;SHANK3;SRC;MAPK3
1881,GO:0004557,0.190378550246154,0.98996596348372,1,2,alpha-galactosidase activity,MF,NAGA
9487,GO:0036112,0.190397287683159,0.98996387814379,1,2,medium-chain fatty-acyl-CoA metabolic process,BP,ACOT7
17795,GO:1901798,0.190700285543667,0.94106738043067,3,16,positive regulation of signal transduction by p53 class mediator,BP,ZNF385A;HEXIM1;SPRED2
15792,GO:0072376,0.190702368343502,0.928358306491322,4,22,protein activation cascade,BP,FBLN1;SERPING1;F12;CD59
5070,GO:0015291,0.190715330162091,0.874029516046141,17,126,secondary active transmembrane transporter activity,MF,SLCO4A1;SLC16A3;SLC2A9;SLC12A7;SLC20A1;TMCO3;SLC12A4;SLC6A6;SLC13A3;SLC6A9;SLC33A1;SLC13A5;SLC6A14;SLC10A6;SLC5A1;SLC15A1;SLC45A3
14732,GO:0070365,0.190832747171034,0.960627223583531,2,8,hepatocyte differentiation,BP,PCK2;ANXA1
14314,GO:0061394,0.190954546398858,0.989901749195012,1,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
6133,GO:0019388,0.191044999362015,0.960555472554912,2,8,galactose catabolic process,BP,PGM1;GALE
2190,GO:0005046,0.191098258346262,0.989885692128069,1,2,KDEL sequence binding,MF,KDELR1
18563,GO:1903726,0.191160808039523,0.960516300287847,2,8,negative regulation of phospholipid metabolic process,BP,LPCAT1;SLC27A1
1218,GO:0002885,0.191362323099427,0.989856150950813,1,2,positive regulation of hypersensitivity,BP,ZP3
7358,GO:0031394,0.191390922498435,0.989852948633235,1,2,positive regulation of prostaglandin biosynthetic process,BP,ANXA1
20331,GO:2001280,0.191390922498435,0.989852948633235,1,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
19197,GO:1905207,0.191582376118677,0.918063418059569,5,29,regulation of cardiocyte differentiation,BP,EGFR;DKK1;PAK1;GSK3A;TGFB1
9584,GO:0036378,0.191712808500744,0.989816867803888,1,2,calcitriol biosynthetic process from calciol,BP,CYP27B1
13537,GO:0055088,0.191779762464601,0.890256340253031,10,70,lipid homeostasis,BP,ANGPTL4;SESN2;LRP5;XBP1;APOE;PCSK9;MALL;LDLRAP1;VDR;USF2
1124,GO:0002710,0.191789074260327,0.960303499059481,2,8,negative regulation of T cell mediated immunity,BP,ARG1;CEACAM1
16973,GO:0098943,0.191888673467867,0.989797124663809,1,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,AP3D1
1791,GO:0004416,0.191893255577801,0.989796609977769,1,2,hydroxyacylglutathione hydrolase activity,MF,HAGH
6089,GO:0019243,0.191893255577801,0.989796609977769,1,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,HAGH
13106,GO:0051596,0.191893255577801,0.989796609977769,1,2,methylglyoxal catabolic process,BP,HAGH
14439,GO:0061727,0.191893255577801,0.989796609977769,1,2,methylglyoxal catabolic process to lactate,BP,HAGH
13791,GO:0060349,0.191893505441728,0.898582375779449,8,52,bone morphogenesis,BP,MEF2D;LRP5;MMP14;COL13A1;TGFBR2;TGFB1;GNAS;THBS3
16581,GO:0097344,0.191918869587996,0.989793732615086,1,2,Rix1 complex,CC,WDR18
2069,GO:0004820,0.191994074275972,0.989785281850846,1,2,glycine-tRNA ligase activity,MF,GARS
2915,GO:0006426,0.191994074275972,0.989785281850846,1,2,glycyl-tRNA aminoacylation,BP,GARS
14612,GO:0070150,0.191994074275972,0.989785281850846,1,2,mitochondrial glycyl-tRNA aminoacylation,BP,GARS
2404,GO:0005547,0.192051166707749,0.917794824837265,5,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP1;AKT1;CYTH3;ARAP3;ASAP1
6214,GO:0019730,0.192203237565618,0.916052459377527,5,39,antimicrobial humoral response,BP,PRSS3;LCN2;HIST2H2BE;FAM3A;RNASE7
6494,GO:0021846,0.192324181218276,0.941352256835942,3,14,cell proliferation in forebrain,BP,WNT7A;NUMB;FGFR1
5286,GO:0015936,0.192823049630351,0.940574315535037,3,15,coenzyme A metabolic process,BP,ACOT7;PPCS;PANK4
12978,GO:0051341,0.192968631139339,0.897570962106062,8,55,regulation of oxidoreductase activity,BP,CYP27B1;CYGB;EGFR;AKT1;APOE;OXA1L;DNM2;VDR
12614,GO:0050771,0.193030763759554,0.903110373854872,7,44,negative regulation of axonogenesis,BP,PTPRS;SEMA3F;GDI1;SEMA4B;SEMA4G;ULK2;EPHB2
9804,GO:0040014,0.19306742205655,0.902956892473251,7,45,regulation of multicellular organism growth,BP,BBS2;SH3PXD2B;GAMT;HSF1;RAI1;SOCS2;CHD7
304,GO:0000813,0.19319538784252,0.959825387664185,2,8,ESCRT I complex,CC,MVB12B;VPS37A
11325,GO:0045628,0.19328008278596,0.959796515125367,2,8,regulation of T-helper 2 cell differentiation,BP,PRKCZ;ANXA1
19352,GO:1905602,0.193307681892918,0.989637043491247,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
9272,GO:0035674,0.193331535252965,0.989634340688332,1,2,tricarboxylic acid transmembrane transport,BP,SLC13A5
1808,GO:0004450,0.193340175848843,0.989633361533331,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2720,GO:0006097,0.193340175848843,0.989633361533331,1,2,glyoxylate cycle,BP,IDH2
6301,GO:0019911,0.193475475167546,0.959729871825449,2,8,structural constituent of myelin sheath,MF,MARVELD1;MALL
9534,GO:0036245,0.193481405446932,0.989617350051619,1,2,cellular response to menadione,BP,NDOR1
2492,GO:0005739,0.193487403180806,0.830879785564222,151,1426,mitochondrion,CC,NOS1;MAP2K1;SHC1;CYP27B1;BOK;PCK2;CPT2;BSG;KLC2;IFI6;NAGS;IDH2;BNIP3;PC;NME4;OCIAD2;G0S2;CTSB;SESN2;ACOT7;SNPH;HAGH;NACC2;CHPF;LRP5;AARS;GPT2;TK2;PRKACA;CRAT;HK1;MAP2K2;MRPS6;AKT1;XPC;CDS2;MDH2;ACOT13;ARMCX2;ALDH1L2;FAM210B;ARG2;ELK3;ATP7B;PITRM1;PI4K2A;ZMIZ2;ENDOG;ACAD10;HS1BP3;HADH;BNIP3L;DHTKD1;TST;ZDHHC8;RAP1GDS1;ATG13;ABCB8;IDE;MSRB2;COA5;PRDX5;HMGCL;SFXN3;ACSF2;TNRC18;GLUL;OXLD1;STOM;RAB29;MLXIP;IFI27;ASS1;OXA1L;RPUSD3;GLUD1;SDHA;RAI1;MPG;PYCR2;ALAS1;ARL2;P4HA1;SRC;GLRX;CBR4;POLD4;TAZ;TGM2;DNM2;FAM162A;STPG1;RAB1B;NDUFA4L2;ACADVL;CARD19;GARS;GSK3A;STXBP1;OAS1;FYN;PRIMPOL;SPTLC2;SUGCT;ALDH4A1;SLC25A43;TNFRSF1A;ALDH7A1;THOP1;MOAP1;RAI14;COMT;NTSR1;UBA1;TTC19;BCL2L1;TCIRG1;SLC27A1;HLCS;SARS2;ULK1;HSPA2;LRRK1;MAP1LC3B;MAPK9;SDHAF4;MLYCD;PHYH;SLIT3;ARG1;GSDMC;BPHL;KLK6;VAT1;CASP4;DRG2;LACTB2;PACS2;MAPK3;CPT1B;KANK2;MAPK10;ALDOC;NDUFS2;UROS;CAT;AZIN2;ANXA1;COMTD1;PLGRKT;NIPSNAP1
19601,GO:1990590,0.193500894095213,0.98961513950427,1,2,ATF1-ATF4 transcription factor complex,CC,ATF4
13626,GO:0060076,0.193519137495836,0.940812726380307,3,14,excitatory synapse,CC,DLG4;SRPX2;ITGA3
1888,GO:0004566,0.193696284708724,0.989592962364198,1,2,beta-glucuronidase activity,MF,HPSE
4681,GO:0010827,0.194050232895198,0.897151903208733,8,52,regulation of glucose transmembrane transport,BP,RTN2;AKT1;PRKCZ;PAK1;GRB10;GSK3A;TRIB3;PIK3R2
2077,GO:0004828,0.194062461265528,0.989551329785656,1,2,serine-tRNA ligase activity,MF,SARS2
2923,GO:0006434,0.194062461265528,0.989551329785656,1,2,seryl-tRNA aminoacylation,BP,SARS2
414,GO:0001101,0.194283481504713,0.85792112911307,28,226,response to acid chemical,BP,CAPN2;NFATC4;NEURL1;DNMT3A;SESN2;XBP1;EGFR;AKT1;PTK6;DKK1;SIPA1;TWF2;HMGCL;GNB1;RET;HSF1;IGFBP2;ALDH1A2;SRC;FYN;ASNS;WNT5B;BCL2L1;HLCS;RXRA;ARG1;ADCY6;CAT
10208,GO:0042803,0.19428652686519,0.842256848334281,61,530,protein homodimerization activity,MF,XDH;PGF;CBS;PYGL;SNX9;BOK;MEF2D;FKBP1A;BNIP3;ACOT7;NACC2;CARS;STK25;AKT1;IRAK1;APOE;WWTR1;CRYL1;BNIP3L;MAP3K9;IDE;HMGCL;RAG1;DDIT3;STOM;OXA1L;CADM4;CTBP1;GIPC1;ASNS;GALE;PSMD7;NTSR1;MAP3K10;MGLL;LHPP;FGFR1;TENM2;USF2;RAB11FIP4;BCL2L1;STUB1;SLC27A1;HLCS;AOX1;P2RX4;VAPB;MAP3K12;HOMER2;ZHX3;VEGFB;ZBTB4;S100A16;HM13;CEACAM1;NAGA;TGFB1;CAT;ERBB3;ANXA1;ZNF318
8103,GO:0032782,0.194427842523879,0.989509695327469,1,2,bile acid secretion,BP,STARD10
632,GO:0001819,0.194472345989958,0.855354537891758,31,256,positive regulation of cytokine production,BP,F2R;NFATC4;POSTN;XBP1;HK1;ATF4;CARD11;IRAK1;PRKCZ;RNF135;MAPK13;FERMT1;DDIT3;GATA3;ALOX15B;IL1RAP;ADAM8;SRC;IRF7;PUM1;MIF;ZFPM1;ARFGEF2;HPSE;ZP3;SEC14L1;MAPK3;ARHGEF2;TGFB1;ANXA1;EP300
6109,GO:0019343,0.194497915781116,0.989501700078964,1,2,cysteine biosynthetic process via cystathionine,BP,CBS
11027,GO:0044853,0.194544023006441,0.892330133431641,9,60,plasma membrane raft,CC,NOS1;F2R;PRKACA;TGFBR2;MYOF;SRC;MYO1D;CBL;MAPK3
14282,GO:0061317,0.194587665601748,0.989491454808187,1,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17632,GO:1901295,0.194587665601748,0.989491454808187,1,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
19153,GO:1905066,0.194587665601748,0.989491454808187,1,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
15148,GO:0071222,0.194588330772267,0.876799574637979,14,106,cellular response to lipopolysaccharide,BP,TNIP1;NR1D1;BCR;XBP1;AKT1;IRAK1;HSF1;SRC;VDR;MIF;ARG1;MAPK3;LITAF;TGFB1
19452,GO:1990005,0.1946303815039,0.989486576675723,1,2,granular vesicle,CC,AZIN2
14700,GO:0070302,0.194719564395888,0.864926128797989,21,162,regulation of stress-activated protein kinase signaling cascade,BP,XDH;MAP2K1;WNT7A;ERCC6;DLG1;MAP4K4;EGFR;MAP2K2;STK25;AKT1;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;MAPK3;AIDA;MINK1
14699,GO:0070301,0.194729848178441,0.888056609398843,10,72,cellular response to hydrogen peroxide,BP,CST3;NET1;BNIP3;STK25;MAPK13;ENDOG;HSF1;ARG1;IMPACT;ANXA1
14662,GO:0070233,0.194811479567124,0.939666811403186,3,15,negative regulation of T cell apoptotic process,BP,ARG2;RAG1;TSC22D4
16481,GO:0097134,0.194945562535545,0.989450544175715,1,2,cyclin E1-CDK2 complex,CC,CCNE1
9730,GO:0038158,0.195045496060526,0.98943910511002,1,2,granulocyte colony-stimulating factor signaling pathway,BP,CEACAM1
19345,GO:1905595,0.195179686421225,0.989423733906858,1,2,regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19618,GO:1990667,0.195179686421225,0.989423733906858,1,2,PCSK9-AnxA2 complex,CC,PCSK9
4192,GO:0009268,0.195233219531434,0.925977111438087,4,22,response to pH,BP,ASIC1;SRC;HYAL1;IMPACT
3784,GO:0008344,0.195365049717664,0.907737854804476,6,38,adult locomotory behavior,BP,CCND2;PUM1;NTSR1;PBX3;CHD7;ARCN1
7342,GO:0031347,0.195365944122597,0.843727689036713,53,458,regulation of defense response,BP,TNIP1;NT5E;SHARPIN;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;BCR;EGFR;PRKACA;CARD11;IRAK1;SERPING1;APOE;ARG2;TMSB4X;RNF135;MAPK13;STK39;PPARA;FAM3A;PRKACB;HTRA1;PAK1;RAG1;GATA3;FNDC4;ADAM8;MAPKBP1;SRC;TGM2;IRF7;LRSAM1;FYN;PSMD7;TNFRSF1A;PUM1;CTSL;HEXIM1;MGLL;F12;ZP3;ARG1;SEC14L1;CASP4;GGT1;MAPK3;CEACAM1;CD59;TGFB1;ANXA1;EP300
19708,GO:1990967,0.195450886346697,0.98939263052025,1,2,multi-organism toxin transport,BP,RAB29
16092,GO:0090034,0.195513534135501,0.989385438328493,1,2,regulation of chaperone-mediated protein complex assembly,BP,STUB1
16093,GO:0090035,0.195513534135501,0.989385438328493,1,2,positive regulation of chaperone-mediated protein complex assembly,BP,STUB1
15208,GO:0071332,0.195648539423467,0.989369929995462,1,2,cellular response to fructose stimulus,BP,XBP1
6711,GO:0030118,0.195667131335939,0.901287861143976,7,45,clathrin coat,CC,EGFR;EPN2;AP1B1;AP2A2;GGA3;GGA1;LDLRAP1
3272,GO:0006952,0.195707696960531,0.833421168762528,102,918,defense response,BP,TNIP1;NT5E;F2R;MST1R;CTNNBIP1;NFATC4;SDC1;SHC1;CST3;CYP27B1;SHARPIN;NR1D1;IGFBP4;IFI6;PSMD2;PTPRS;BNIP3;RAB43;LCN2;MAPKAPK3;CTSB;BCR;EGFR;PRKACA;ADARB1;AKT1;IFITM1;CARD11;IRAK1;SERPING1;APOE;ARG2;TMSB4X;PRKCZ;RNF135;MAPK13;HIST2H2BE;PTK6;DEAF1;STK39;BNIP3L;PPARA;FAM3A;PRKACB;CD44;PRDX5;HTRA1;PAK1;AHCY;RAG1;IFI27;GATA3;GSDMA;OASL;FNDC4;HSF1;IL1RAP;MT2A;ADAM8;MAPKBP1;FLNB;TNFRSF6B;SRC;TGM2;IRF7;LRSAM1;STXBP1;OAS1;FYN;ISG20;PSMD7;TNFRSF1A;ANXA3;GAL;PUM1;CTSL;HEXIM1;MGLL;LGALS3BP;HYAL1;F12;MIF;TCIRG1;ZP3;RNASE7;SDHAF4;ARG1;GSDMC;SEC14L1;CASP4;GGT1;MAPK3;ARHGEF2;ADAM15;CEACAM1;ECM1;CD59;TGFB1;ANXA1;APOBEC3C;PLGRKT;EP300
15314,GO:0071482,0.195735401198568,0.881089181341199,12,87,cellular response to light stimulus,BP,ERCC1;NFATC4;ATF4;XPC;MAPK13;MC1R;GNB1;HIST3H2A;HYAL1;DDB2;IMPACT;EP300
3657,GO:0008140,0.195758711235222,0.958947607770865,2,8,cAMP response element binding protein binding,MF,CRTC1;DDIT3
6103,GO:0019320,0.195770120680128,0.907488581451205,6,38,hexose catabolic process,BP,PGM1;LRP5;HK1;PFKP;GALE;ALDOC
11315,GO:0045618,0.196052991823182,0.939097656093123,3,15,positive regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B;VDR
13617,GO:0060066,0.196055191944691,0.989323140691051,1,2,oviduct development,BP,WNT7A
11847,GO:0046755,0.196056703407998,0.925228659764243,4,23,viral budding,BP,VPS4A;CHMP5;LRSAM1;VPS37A
5817,GO:0017076,0.196099388474999,0.827785024153891,163,1438,purine nucleotide binding,MF,MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;RAPGEF3;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;BAG3;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;SEPT5;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;AHCY;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;MYH15;RHOBTB2;TOP1;ARL2;PIP5K1C;SRC;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;PFN1;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;ARFIP2;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;AGAP1;ADCY6;ADCK2;ERBB3;RAB6A;GNAS
2051,GO:0004797,0.19626132760294,0.989299379014381,1,2,thymidine kinase activity,MF,TK2
15680,GO:0072179,0.196287246571379,0.989296389196941,1,2,nephric duct formation,BP,GATA3
5186,GO:0015747,0.196304808192652,0.989294363155495,1,2,urate transport,BP,SLC2A9
19692,GO:1990911,0.196328276587271,0.989291655330096,1,2,response to psychosocial stress,BP,HSF1
6762,GO:0030183,0.196330605598584,0.883690360050741,11,78,B cell differentiation,BP,XBP1;CMTM7;MMP14;CARD11;POU2F2;RAG1;LRRC8A;MFNG;POLM;DNAJB9;EP300
8124,GO:0032804,0.196337489867191,0.989290592180949,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,FURIN
7239,GO:0031133,0.196478058176833,0.989274364262686,1,2,regulation of axon diameter,BP,WNT7A
12012,GO:0047391,0.196479185936007,0.989274234013,1,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,GNB1
1884,GO:0004560,0.196551411695585,0.989265890517738,1,2,alpha-L-fucosidase activity,MF,FUCA1
5280,GO:0015928,0.196551411695585,0.989265890517738,1,2,fucosidase activity,MF,FUCA1
2066,GO:0004817,0.196590821727938,0.98926133635785,1,2,cysteine-tRNA ligase activity,MF,CARS
2912,GO:0006423,0.196590821727938,0.98926133635785,1,2,cysteinyl-tRNA aminoacylation,BP,CARS
5146,GO:0015671,0.196606885484372,0.989259479746873,1,2,oxygen transport,BP,CYGB
13009,GO:0051400,0.196671869576009,0.95863293844056,2,8,BH domain binding,MF,BOK;BCL2L1
891,GO:0002254,0.19667220254923,0.989251928710646,1,2,kinin cascade,BP,F12
945,GO:0002353,0.19667220254923,0.989251928710646,1,2,plasma kallikrein-kinin cascade,BP,F12
14082,GO:0060840,0.196771999079965,0.895339858441736,8,52,artery development,BP,ACVR2B;APOE;LTBP1;SUFU;DNM2;LOXL1;LRP1;CHD7
1397,GO:0003308,0.196816315147685,0.989235257974592,1,2,negative regulation of Wnt signaling pathway involved in heart development,BP,DKK1
14544,GO:0070032,0.196940859242567,0.989220839281192,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14545,GO:0070033,0.196940859242567,0.989220839281192,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
12681,GO:0050866,0.197023166278931,0.875054375321442,14,104,negative regulation of cell activation,BP,SERPINE2;DLG1;PRNP;CYGB;BCR;APOE;ARG2;PKN1;PAG1;GAL;ARG1;CEACAM1;TGFB1;ANXA1
3101,GO:0006679,0.197026591962631,0.989210907591774,1,2,glucosylceramide biosynthetic process,BP,UGCG
10691,GO:0043933,0.19708613783086,0.825952290340364,178,1673,protein-containing complex subunit organization,BP,ANGPTL4;ERCC1;H1F0;RAC2;SORL1;CTNNBIP1;DVL1;KCNG1;SNX9;BOK;SHARPIN;CRTC1;DLG4;DLG1;MMP1;SLC9A3R2;FKBP1A;SOX12;PRNP;BNIP3;TMOD2;NACC2;LRP5;FYCO1;SEPT10;PRKACA;FCHO1;CORO1B;TUBG2;P4HB;MRPS6;XPC;ACOT13;IRAK1;ARPC1A;APOE;EHD3;RABGGTA;TMSB4X;TSPYL2;PRKCZ;ITPR3;DGKQ;VPS11;VPS4A;HIST2H2BE;CTSZ;DNAAF5;SH3PXD2B;TYSND1;EML2;SEPT5;SEC23A;MSN;MAP1B;DKK1;PPP2R5B;OBSL1;PRKACB;ZDHHC8;RAP1GDS1;IDE;MSRB2;COA5;TWF2;BIN1;FSCN1;HMGCL;CCDC88C;PAK1;TTBK2;BCL9L;BAZ2A;DDIT3;GLUL;DMXL2;STOM;GNB1;CORO7;RHOC;SEPT8;OXA1L;ASIC1;HSF1;IL1RAP;ASPH;ARL2;MICAL2;P4HA1;VAMP2;SRC;CHMP5;CBR4;CAPG;TAZ;TGM2;DNM2;AGO4;HIST3H2A;RAB1B;CPTP;STX5;GPX3;EXOC2;RSF1;STXBP1;SH3BP1;PFN1;MICAL1;TNFRSF1A;TLE4;THRA;MCFD2;PLTP;HSF4;LOXL1;SEC24C;TUBG1;PSMG4;MIF;TTC19;SIGMAR1;STUB1;DDB2;TCIRG1;PMEPA1;ARFIP2;ULK1;P2RX4;USO1;TBC1D20;SPIRE1;EHD4;MAP1LC3B;MAPK9;SDHAF4;PYM1;VASP;ATXN10;ABCA7;LMAN1;EPS8L1;WDR18;RXRA;C1QTNF6;ARG1;TAF6;TGFA;NDE1;CAMSAP3;BAIAP2L1;WIPF1;IMPACT;SNAP29;KCNC4;TRAPPC1;CIB1;TMSB10;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;NDUFS2;HM13;APBA1;SKAP2;CD59;TGFB1;PPP6R1;SH3PXD2A;CAT;ASH2L;PXN;PLEKHH2;EP300;TCF7L1;ASAP1
2543,GO:0005801,0.197111714008523,0.900230848003076,7,46,cis-Golgi network,CC,BOK;SCYL1;KDELR1;RAB29;NUCB1;ANGEL1;AZIN2
4004,GO:0008941,0.197180770114021,0.989193034011128,1,2,nitric oxide dioxygenase activity,MF,CYGB
5632,GO:0016708,0.197180770114021,0.989193034011128,1,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,CYGB
9042,GO:0035250,0.19734776520773,0.924857228095036,4,22,UDP-galactosyltransferase activity,MF,B4GALT2;B3GNT3;WDFY3;B4GALT6
13035,GO:0051451,0.197456822786493,0.958361621450703,2,8,myoblast migration,BP,NET1;ANXA1
15956,GO:0072739,0.197463281915186,0.989160240100486,1,2,response to anisomycin,BP,MAPK13
18392,GO:1903362,0.197463679382109,0.858066894522352,25,202,regulation of cellular protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;PANO1;PRKACA;AKT1;APOE;ATP13A2;VPS11;PCSK9;MSN;UBE2J1;ANKIB1;SUFU;PKD1;GIPC1;GSK3A;STUB1;TRIB3;RAD23A;LRP1;TRIB2;CSNK1D;FURIN
2157,GO:0004977,0.197582942616128,0.989146333189319,1,2,melanocortin receptor activity,MF,MC1R
14743,GO:0070382,0.197596870038318,0.872383034994941,15,114,exocytic vesicle,CC,DLG4;RAB3B;PTPRS;DBNDD1;PI4K2A;SEPT5;RABAC1;DMXL2;SYTL1;VAMP2;GIPC1;BRSK1;BCL2L1;APBA1;RAB6A
9341,GO:0035812,0.197626480654884,0.989141270748995,1,2,renal sodium excretion,BP,COMT
9342,GO:0035813,0.197626480654884,0.989141270748995,1,2,regulation of renal sodium excretion,BP,COMT
9500,GO:0036128,0.197670615186671,0.989136137605673,1,2,CatSper complex,CC,HSPA2
1035,GO:0002541,0.197704092894415,0.98913224301945,1,2,activation of plasma proteins involved in acute inflammatory response,BP,F12
11524,GO:0045994,0.197741602098666,0.989127878508545,1,2,positive regulation of translational initiation by iron,BP,RXRA
3495,GO:0007389,0.197750556245289,0.852708271838756,31,249,pattern specification process,BP,MDFI;CTNNBIP1;WNT7A;SEMA3F;LRP5;ACVR2B;AP1B1;RFNG;TGFBR2;DKK1;PRKACB;SUFU;SCMH1;DDIT3;ASPH;MICAL2;TULP3;ALDH1A2;PCSK6;DUSP6;FUZ;FBXL15;PSKH1;FGFR1;PBX3;MFNG;BICC1;TSHZ1;GAS8;AIDA;EP300
4419,GO:0010193,0.197835311564133,0.989116970349736,1,2,response to ozone,BP,CAT
18448,GO:1903487,0.197932283450965,0.989105676001697,1,2,regulation of lactation,BP,XBP1
12755,GO:0050999,0.197980065998375,0.914147966430787,5,30,regulation of nitric-oxide synthase activity,BP,CYGB;EGFR;AKT1;APOE;DNM2
7220,GO:0031109,0.197992612366037,0.87949518187104,12,86,microtubule polymerization or depolymerization,BP,TUBG2;EML2;MAP1B;PAK1;TTBK2;ARL2;TUBG1;NDE1;CAMSAP3;CIB1;CSNK1D;ARHGEF2
9491,GO:0036117,0.198085352123828,0.989087834729654,1,2,hyaluranon cable,CC,HYAL1
9294,GO:0035725,0.198085804146441,0.882492790877184,11,77,sodium ion transmembrane transport,BP,NOS1;SCN8A;DLG1;HECW2;SLC20A1;PCSK9;STK39;STOM;ASIC1;GLRX;DNM2
12652,GO:0050820,0.198159985947342,0.938127272900441,3,15,positive regulation of coagulation,BP,F2R;F12;HPSE
11803,GO:0046651,0.19821900967113,0.864790084143381,19,151,lymphocyte proliferation,BP,RAC2;DLG1;FKBP1A;PRNP;CARD11;ARG2;PKN1;MSN;TGFBR2;SATB1;IGFBP2;FYN;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
16316,GO:0090402,0.19830658407147,0.989062019718713,1,2,oncogene-induced cell senescence,BP,HMGA2
4376,GO:0009996,0.198623527287052,0.989024977022899,1,2,negative regulation of cell fate specification,BP,DKK1
10912,GO:0044448,0.1986445058244,0.867885593477964,17,127,cell cortex part,CC,CAPN2;DLG4;RAPGEF3;SEPT10;PRKCZ;CTSZ;SEPT5;SEPT8;ASPH;CAP1;EXOC2;SH3BP1;WIPF1;MYZAP;LLGL1;PLEKHH2;STIM1
19600,GO:1990589,0.19870449394078,0.989015502837484,1,2,ATF4-CREB1 transcription factor complex,CC,ATF4
9725,GO:0038131,0.19875616836317,0.989009453848966,1,2,neuregulin receptor activity,MF,ERBB3
970,GO:0002414,0.198768724429415,0.989007983759589,1,2,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
6224,GO:0019763,0.198768724429415,0.989007983759589,1,2,immunoglobulin receptor activity,MF,FCGRT
8763,GO:0034418,0.198818101513318,0.989002201526534,1,2,urate biosynthetic process,BP,PNP
2534,GO:0005789,0.198842957516189,0.832279209839052,90,798,endoplasmic reticulum membrane,CC,EDEM1;NOS1;MBOAT2;LPCAT4;LMF1;BOK;DLG1;PITPNM1;FKBP1A;CKAP4;SBF1;AGPAT3;TXNDC11;COPG1;TMEM214;LPCAT1;XYLT1;XBP1;EGFR;RTN2;RHBDF2;XYLT2;PDIA5;CDS2;SYVN1;YIF1A;ITPR3;TMEM129;RETSAT;SEC23A;PLD3;CREB3L2;UBE2J1;KDELR1;ESYT2;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;ERO1B;UBXN7;PTDSS2;REEP2;TMED3;PIGQ;UBXN4;ANTXR2;WFS1;SRD5A3;ASPH;SARAF;REEP6;RAB1B;CARD19;STX5;SPTLC2;CLSTN1;REEP4;HSD11B1;MBOAT7;SLC33A1;SHISA5;PSKH1;MCFD2;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;SIGMAR1;AGPAT4;ULK1;TBC1D20;VAPB;LMAN1;TGFA;CASP4;POMT1;DNAJB9;RNF103;HM13;PNPLA6;LPIN3;CD59;RAB6A;IKBIP;ARCN1;ERP44;STIM1
14841,GO:0070564,0.198909503783816,0.988991493510742,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
9201,GO:0035577,0.198976517431899,0.898903382688206,7,47,azurophil granule membrane,CC,CKAP4;CD68;LPCAT1;SURF4;STOM;ARL8A;SNAP29
3725,GO:0008253,0.198991979658768,0.957828790816827,2,8,5'-nucleotidase activity,MF,NT5E;NT5DC2
9855,GO:0042091,0.199006923409287,0.988980074136181,1,2,interleukin-10 biosynthetic process,BP,TRIB2
11088,GO:0045074,0.199006923409287,0.988980074136181,1,2,regulation of interleukin-10 biosynthetic process,BP,TRIB2
514,GO:0001578,0.199347769669536,0.898912570381121,7,45,microtubule bundle formation,BP,NEURL1;BBS2;MARK4;DNAAF5;MAP1B;NAV1;GAS8
15954,GO:0072737,0.199397867283901,0.988934181760712,1,2,response to diamide,BP,HSF1
15955,GO:0072738,0.199397867283901,0.988934181760712,1,2,cellular response to diamide,BP,HSF1
3824,GO:0008420,0.199537146889123,0.957638868364989,2,8,CTD phosphatase activity,MF,PPM1M;SSU72
5594,GO:0016616,0.199541512581909,0.881097298315445,11,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,IDH2;H6PD;MDH2;CRYL1;HADH;TSTA3;CTBP1;AKR7A2;CBR4;HSD11B1;LDHA
18770,GO:1904211,0.199618326723001,0.988908255317643,1,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,HM13
15942,GO:0072709,0.199690838130015,0.988899720428698,1,2,cellular response to sorbitol,BP,MAPK13
11527,GO:0046007,0.199700969546777,0.957581724734821,2,8,negative regulation of activated T cell proliferation,BP,PRNP;ARG1
16420,GO:0097021,0.199827191469533,0.988883661144663,1,2,lymphocyte migration into lymphoid organs,BP,RET
13011,GO:0051403,0.199850663652877,0.855189477836584,26,207,stress-activated MAPK cascade,BP,XDH;MAP2K1;WNT7A;ERCC6;DLG1;MAP4K4;EGFR;MAP2K2;STK25;AKT1;IRAK1;PKN1;MAPK13;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;MAPK9;MAP3K12;TAOK1;MAPK3;MAPK10;AIDA;MINK1
19320,GO:1905523,0.199859707593112,0.957526322964305,2,8,positive regulation of macrophage migration,BP,MMP14;MAPK3
3132,GO:0006721,0.199918053293163,0.893025261516347,8,54,terpenoid metabolic process,BP,SDC1;EGFR;GPC4;APOE;RETSAT;ALDH1A2;AGRN;LRP1
14640,GO:0070194,0.199958150766599,0.988868224935284,1,2,synaptonemal complex disassembly,BP,HSPA2
5914,GO:0018153,0.199964309986678,0.988867498651447,1,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,TGM2
5945,GO:0018262,0.199964309986678,0.988867498651447,1,2,isopeptide cross-linking,BP,TGM2
1088,GO:0002673,0.199996942039454,0.912758954566893,5,31,regulation of acute inflammatory response,BP,SERPING1;ADAM8;F12;ZP3;CD59
1632,GO:0004066,0.200101904207905,0.98885126688856,1,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,ASNS
2985,GO:0006529,0.200101904207905,0.98885126688856,1,2,asparagine biosynthetic process,BP,ASNS
15410,GO:0071641,0.200121329181835,0.988848974291361,1,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,ARG2
648,GO:0001836,0.200162901646612,0.897798349675147,7,50,release of cytochrome c from mitochondria,BP,BOK;IFI6;BNIP3;AKT1;FAM162A;MOAP1;BCL2L1
8621,GO:0034124,0.200220879632911,0.988837220893852,1,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,IRF7
2210,GO:0005093,0.200253784140434,0.988833334509545,1,2,Rab GDP-dissociation inhibitor activity,MF,GDI1
1510,GO:0003865,0.200293887627018,0.988828596823805,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8534,GO:0033765,0.200293887627018,0.988828596823805,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9269,GO:0035671,0.200293887627018,0.988828596823805,1,2,enone reductase activity,MF,SRD5A3
12053,GO:0047751,0.200293887627018,0.988828596823805,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
19983,GO:2000490,0.200335203382677,0.988823714749654,1,2,negative regulation of hepatic stellate cell activation,BP,CYGB
685,GO:0001892,0.200387789200758,0.884207789474064,10,70,embryonic placenta development,BP,MDFI;MAP2K1;EGFR;FBXW8;AKT1;TFEB;PKD1;HSF1;SPINT2;PLCD3
16437,GO:0097055,0.20043756482349,0.988811614076546,1,2,agmatine biosynthetic process,BP,AZIN2
17590,GO:1901162,0.20043756482349,0.988811614076546,1,2,primary amino compound biosynthetic process,BP,AZIN2
11024,GO:0044848,0.200440333165008,0.957323410661121,2,8,biological phase,BP,FERMT1;GAL
11026,GO:0044851,0.200440333165008,0.957323410661121,2,8,hair cycle phase,BP,FERMT1;GAL
12409,GO:0048819,0.200440333165008,0.957323410661121,2,8,regulation of hair follicle maturation,BP,FERMT1;GAL
20077,GO:2000666,0.200457616357407,0.988809242823735,1,2,negative regulation of interleukin-13 secretion,BP,ARG2
14997,GO:0070889,0.200701596432207,0.98878036773084,1,2,platelet alpha granule organization,BP,ZNF385A
5371,GO:0016165,0.200753644239942,0.988774202475613,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
20009,GO:2000562,0.200755672817298,0.988773962144771,1,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,ARG2
6619,GO:0022838,0.200828850531362,0.861433829035236,20,153,substrate-specific channel activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;ORAI1;PKD1;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;LRRC8A;TPCN1;P2RX4;KCNC4;ORAI3;RASA3
12562,GO:0050692,0.200927008841931,0.988753653132307,1,2,DBD domain binding,MF,RXRA
4539,GO:0010609,0.200929118789224,0.988753402905444,1,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,ZNF385A
13594,GO:0060041,0.20104618152098,0.880363043350446,11,77,retina development in camera-type eye,BP,SDK2;LPCAT1;LRP5;ACVR2B;TUB;LAMB2;GNB1;RET;RAB11FIP4;SDHAF4;CHD7
14287,GO:0061326,0.201118454289793,0.887721657255479,9,61,renal tubule development,BP,PGF;CTNNBIP1;DLG1;LAMA5;WWTR1;PKD1;GATA3;FGF2;TGFB1
14779,GO:0070447,0.201131944112301,0.988729334520498,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
5656,GO:0016748,0.201159844861223,0.988726021409616,1,2,succinyltransferase activity,MF,ALAS1
13024,GO:0051430,0.201188269180147,0.988722645566493,1,2,corticotropin-releasing hormone receptor 1 binding,MF,GNAS
10690,GO:0043932,0.201208203021315,0.988720277766242,1,2,ossification involved in bone remodeling,BP,TGFB1
3093,GO:0006667,0.201232518522696,0.988717389122978,1,2,sphinganine metabolic process,BP,SPTLC2
11728,GO:0046511,0.201232518522696,0.988717389122978,1,2,sphinganine biosynthetic process,BP,SPTLC2
10161,GO:0042730,0.201262855297701,0.936688040219486,3,15,fibrinolysis,BP,PLAT;SERPING1;F12
5386,GO:0016206,0.201297092088197,0.988709715876247,1,2,catechol O-methyltransferase activity,MF,COMT
17144,GO:0102084,0.201297092088197,0.988709715876247,1,2,L-dopa O-methyltransferase activity,MF,COMT
17196,GO:0102938,0.201297092088197,0.988709715876247,1,2,orcinol O-methyltransferase activity,MF,COMT
19649,GO:1990769,0.201349042469823,0.988703540517776,1,2,proximal neuron projection,CC,GJC2
3934,GO:0008614,0.201357252629789,0.988702564400545,1,2,pyridoxine metabolic process,BP,PSAT1
3935,GO:0008615,0.201357252629789,0.988702564400545,1,2,pyridoxine biosynthetic process,BP,PSAT1
18179,GO:1902897,0.201357913971275,0.988702485770695,1,2,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19414,GO:1905874,0.201357913971275,0.988702485770695,1,2,regulation of postsynaptic density organization,BP,ZMYND8
3016,GO:0006562,0.201505371751186,0.988684946207511,1,2,proline catabolic process,BP,ALDH4A1
4403,GO:0010133,0.201505371751186,0.988684946207511,1,2,proline catabolic process to glutamate,BP,ALDH4A1
15563,GO:0071953,0.201557743576243,0.988678713106304,1,2,elastic fiber,CC,FBLN1
11474,GO:0045914,0.201595999779082,0.988674158780203,1,2,negative regulation of catecholamine metabolic process,BP,COMT
11508,GO:0045963,0.201595999779082,0.988674158780203,1,2,negative regulation of dopamine metabolic process,BP,COMT
16161,GO:0090154,0.201698312657852,0.956882349489655,2,8,positive regulation of sphingolipid biosynthetic process,BP,TNFRSF1A;SMPD3
19870,GO:2000304,0.201698312657852,0.956882349489655,2,8,positive regulation of ceramide biosynthetic process,BP,TNFRSF1A;SMPD3
18767,GO:1904207,0.201714335880303,0.98866006460881,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18768,GO:1904209,0.201714335880303,0.98866006460881,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
2173,GO:0005006,0.201716140593036,0.988659849586343,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
3570,GO:0007616,0.201723330595033,0.922522629842336,4,22,long-term memory,BP,PRNP;APOE;PRKCZ;CCND2
16408,GO:0097001,0.201884162589849,0.956817022303847,2,8,ceramide binding,MF,CPTP;PLTP
16785,GO:0098560,0.202060796670188,0.988618743710913,1,2,cytoplasmic side of late endosome membrane,CC,LITAF
6091,GO:0019254,0.202076937933767,0.988616816560262,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
8007,GO:0032623,0.202093303503478,0.903573835024149,6,38,interleukin-2 production,BP,PRNP;CARD11;GATA3;IL1RAP;PNP;ANXA1
11567,GO:0046086,0.202162290223519,0.988606623074636,1,2,adenosine biosynthetic process,BP,NT5E
8678,GO:0034242,0.202234158962243,0.988598035946301,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
434,GO:0001162,0.202275338850649,0.956679382096361,2,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;HSF1
1986,GO:0004703,0.202281556276635,0.988592370767275,1,2,G-protein coupled receptor kinase activity,MF,GRK6
12045,GO:0047696,0.202281556276635,0.988592370767275,1,2,beta-adrenergic receptor kinase activity,MF,GRK6
2737,GO:0006116,0.202319679023915,0.988587812990545,1,2,NADH oxidation,BP,PCK2
1573,GO:0003977,0.202461888651783,0.988570802080855,1,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,UAP1
4601,GO:0010714,0.20250105039706,0.936110333194607,3,15,positive regulation of collagen metabolic process,BP,F2R;LARP6;TGFB1
8220,GO:0032967,0.20250105039706,0.936110333194607,3,15,positive regulation of collagen biosynthetic process,BP,F2R;LARP6;TGFB1
18197,GO:1902938,0.202530120593505,0.988562635238155,1,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP
14350,GO:0061512,0.202537669806948,0.911486035055615,5,30,protein localization to cilium,BP,BBS2;TUB;RAB29;TULP3;CSNK1D
9988,GO:0042369,0.202599631536955,0.988554311949637,1,2,vitamin D catabolic process,BP,CYP27B1
16409,GO:0097003,0.202658417229421,0.988547270263749,1,2,adipokinetic hormone receptor activity,MF,ADIPOR1
9670,GO:0038016,0.20267585412544,0.988545181106411,1,2,insulin receptor internalization,BP,CEACAM1
1191,GO:0002835,0.202696327793768,0.988542727833561,1,2,negative regulation of response to tumor cell,BP,CEACAM1
1194,GO:0002838,0.202696327793768,0.988542727833561,1,2,negative regulation of immune response to tumor cell,BP,CEACAM1
1199,GO:0002856,0.202696327793768,0.988542727833561,1,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1202,GO:0002859,0.202696327793768,0.988542727833561,1,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
9119,GO:0035402,0.202764479468356,0.988534559387586,1,2,histone kinase activity (H3-T11 specific),MF,PKN1
9124,GO:0035407,0.202764479468356,0.988534559387586,1,2,histone H3-T11 phosphorylation,BP,PKN1
12688,GO:0050873,0.20276921309865,0.921635375523553,4,23,brown fat cell differentiation,BP,ITGA6;BNIP3;ZNF516;LAMB3
7972,GO:0032571,0.202795473054895,0.988530843515014,1,2,response to vitamin K,BP,POSTN
15192,GO:0071307,0.202795473054895,0.988530843515014,1,2,cellular response to vitamin K,BP,POSTN
1814,GO:0004461,0.202832177785135,0.988526442051739,1,2,lactose synthase activity,MF,B4GALT2
900,GO:0002276,0.202878325580224,0.988520906877137,1,2,basophil activation involved in immune response,BP,PI4K2A
11284,GO:0045575,0.202878325580224,0.988520906877137,1,2,basophil activation,BP,PI4K2A
5540,GO:0016524,0.202914785311445,0.988516532675277,1,2,latrotoxin receptor activity,MF,ADGRL1
6022,GO:0019075,0.202914785311445,0.988516532675277,1,2,virus maturation,BP,MVB12B
15504,GO:0071840,0.202929491757323,0.813840129452891,509,4810,cellular component organization or biogenesis,BP,ANGPTL4;FLNC;FHL1;SH3KBP1;ITGB4;TSPAN1;ERCC1;ZMYND8;NOS1;ADAM19;H1F0;LTBP2;SH3TC2;CAPN2;F2R;THSD4;RAC2;LTBP4;SORL1;CTNNBIP1;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SHC1;KCNG1;WNT7A;CST3;SDK2;CYP27B1;NEURL1;SNX9;AP3D1;BOK;SHARPIN;CRTC1;ARAP1;DLG4;OBSCN;SERPINE2;BSG;DLG1;DYSF;IGFBP4;MMP1;IFI6;SLC9A3R2;DNMT3A;FKBP1A;SOX12;DCBLD2;POSTN;MTA1;RAB3B;ITGA6;NET1;RAPGEF3;PTPRS;PRNP;IDH2;BNIP3;LAMA5;SSH1;RAB43;DBNDD1;SMARCA1;NYAP1;TMOD2;BCORL1;MARVELD1;FAM129B;ESPN;SESN2;TNNT1;PLEK2;BBS2;SEMA3F;TUBB6;NACC2;ADGRF1;BCR;SYNE3;RAB31;NUDCD3;VLDLR;ETV5;MARK4;LRP5;FBLN1;ITGB5;EVI5L;MAP4K4;EGFR;CSNK1E;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CORO1B;TUB;MAP2K2;EPN1;TUBG2;STK25;PARVB;SHANK3;MIER2;P4HB;HECW2;FBXW8;SNX33;MRPS6;AKT1;XPC;BRD3;ACOT13;IRAK1;ARPC1A;EPN2;APOE;ATG16L2;EHD3;FMNL2;ATP13A2;PKN1;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;ITPR3;TFEB;NAGLU;DGKQ;VPS11;VPS4A;HIST2H2BE;PITRM1;CTSZ;EPHA1;PI4K2A;PTK6;DNAAF5;PTPDC1;SH3PXD2B;PCSK9;ENDOG;FBXW5;FERMT1;TYSND1;EML2;SEPT5;SEC23A;MSN;MAP1B;CSMD3;LAMB2;GDI1;LIMK1;DKK1;PPP2R5B;ARRDC1;CORO2A;BNIP3L;OBSL1;PRKACB;H2AFJ;SIPA1;ZDHHC8;WDTC1;WASF2;CDC34;CD44;PLCG1;TBC1D16;RAP1GDS1;ATG13;IDE;MSRB2;DEDD2;JADE2;COA5;TWF2;SURF4;RRNAD1;TBC1D14;TACC1;MALL;BIN1;FSCN1;HMGCL;HTRA1;CCDC88C;PAK1;TTBK2;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;NLGN2;TNRC18;RAG1;SEMA4B;BAZ2A;NAV1;DDIT3;PODXL;GLUL;CUL7;DMXL2;TBC1D9B;TUBB3;STOM;FARP1;GNB1;SYTL1;PTPN9;SATB1;RET;RAB29;CORO7;LAMC2;RHOC;NID1;GRB10;REEP2;TMED3;HLTF;SEPT8;SHANK2;PKD1;PARP10;ATP11A;GATA3;APLN;PHF1;OXA1L;DOPEY2;MYOF;GRIN3B;ASIC1;GLUD1;HSF1;ADGRB2;SIN3B;IL1RAP;NEK9;SLC12A4;FAT1;EFS;ASPH;CTBP1;ADAM8;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;FAM110C;ARL2;MICAL2;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;VAMP2;FLNB;PIP5K1C;SRC;LDLRAP1;CHMP5;KDM4B;CBR4;CAPG;POLD4;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;AGO4;FAM162A;LRSAM1;HIST3H2A;STPG1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;CPTP;PAK6;STX5;TOM1L2;SDCCAG8;GPX3;RERE;EXOC2;RSF1;GSK3A;STXBP1;SPECC1L;SH3BP1;SPINT2;FYN;RAB25;PRIMPOL;MPI;ISG20;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;REEP4;PFN1;NISCH;MICAL1;KIF17;TNFRSF1A;WISP1;TLE4;VDR;BRPF3;VWA1;KIF13B;BRSK1;STX10;MOAP1;GAL;ITGA1;CTSL;THRA;MCFD2;PLTP;AMIGO2;TIMP1;CRIM1;FRYL;HSF4;LAMB3;LOXL1;SEMA4G;SEC24C;FGFR1;TUBG1;RREB1;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TENM2;PSMG4;MIF;SOCS2;TTC19;VPS37A;SIGMAR1;BCL2L1;STUB1;ADIPOR1;MAU2;DDB2;AFAP1;TCIRG1;LEMD2;ZFPM1;PMEPA1;ARFIP2;HLCS;ARFGEF2;UNC119B;ULK1;LRP1;ROBO3;HSPA2;PAK4;P2RX4;E2F5;USO1;ULK2;SMPD3;TBC1D20;SPIRE1;FGF2;KLHL17;EHD4;MAP1LC3B;VAPB;MAPK9;COG1;SDHAF4;PYM1;RCOR1;MAP3K12;VASP;ARAP3;CHD7;ATXN10;TAOK1;ABCA7;LMAN1;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;RXRA;HIST2H2AC;C1QTNF6;ARG1;L3MBTL3;TBC1D2B;TAF6;TGFA;NDE1;CAMSAP3;RPL28;BAHCC1;BAIAP2L1;ATP6V1C2;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;KLK6;VAT1;SNAP29;LONP2;KCNC4;CAMK1;EPHB2;SPESP1;HGS;GAS8;CBL;TRAPPC1;CIB1;TMSB10;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;KANK2;NTNG1;POMT1;CSNK1D;KIFC3;FURIN;ARHGEF2;UGCG;LLGL1;NDUFS2;MATN3;OCRL;ADAM15;SRPX2;HM13;CEACAM1;APBA1;MINK1;SKAP2;ARHGAP44;CD59;MBD3;MAP6;ADCY6;CCNE1;ITSN1;TGFB1;WBP2;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;AZIN2;ANXA1;PPP1R10;ASH2L;CCDC113;ITGA3;PXN;ARHGEF10L;PLEKHH2;EP300;THBS3;TCF7L1;RAP1GAP2;ASAP1;FHOD1
973,GO:0002418,0.202945874868813,0.956443004856558,2,8,immune response to tumor cell,BP,ADAM15;CEACAM1
19954,GO:2000418,0.202953905473678,0.9885118382541,1,2,positive regulation of eosinophil migration,BP,ADAM8
6216,GO:0019732,0.202998272017835,0.988506512966344,1,2,antifungal humoral response,BP,FAM3A
2373,GO:0005499,0.203000356433504,0.988506262741267,1,2,vitamin D binding,MF,VDR
5805,GO:0017055,0.203011494786861,0.988504925578501,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
10340,GO:0043123,0.203218533275373,0.862462120961154,18,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;RBCK1;SHARPIN;FKBP1A;AKT1;CARD11;IRAK1;SLC20A1;RHOC;TGM2;FYN;TNFRSF1A;PLEKHG5;SHISA5;MIB2;TNFRSF19;LITAF;ECM1
13634,GO:0060086,0.203219698451683,0.988479914625692,1,2,circadian temperature homeostasis,BP,NR1D1
10235,GO:0042904,0.203222730735257,0.988479550140542,1,2,9-cis-retinoic acid biosynthetic process,BP,ALDH1A2
10236,GO:0042905,0.203222730735257,0.988479550140542,1,2,9-cis-retinoic acid metabolic process,BP,ALDH1A2
12566,GO:0050699,0.203228934316102,0.921387282383605,4,23,WW domain binding,MF,FAM189B;DNM2;PMEPA1;LITAF
19492,GO:1990164,0.203268057475009,0.988474101026728,1,2,histone H2A phosphorylation,BP,HMGA2
2005,GO:0004726,0.203276381618932,0.956326289816797,2,8,non-membrane spanning protein tyrosine phosphatase activity,MF,PTPN9;PTPN12
4556,GO:0010635,0.203327534473539,0.956308213627845,2,8,regulation of mitochondrial fusion,BP,BNIP3;VAT1
12388,GO:0048762,0.203351224435845,0.862467923690503,18,137,mesenchymal cell differentiation,BP,LAMA5;SEMA3F;WWTR1;TGFBR2;BCL9L;SEMA4B;CUL7;RET;HMGA2;EDNRA;ALDH1A2;FUZ;SEMA4G;FGFR1;ADIPOR1;MAPK3;ADAM15;TGFB1
9860,GO:0042097,0.203404926185933,0.988457638110785,1,2,interleukin-4 biosynthetic process,BP,ZFPM1
11246,GO:0045402,0.203404926185933,0.988457638110785,1,2,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
17219,GO:0106020,0.203426822534323,0.988455003140892,1,2,regulation of vesicle docking,BP,STXBP1
12744,GO:0050966,0.203429143081043,0.988454723870413,1,2,detection of mechanical stimulus involved in sensory perception of pain,BP,FYN
7489,GO:0031648,0.203433240850085,0.902738602055717,6,38,protein destabilization,BP,PRNP;XBP1;CCDC88C;SRC;RAD23A;EP300
481,GO:0001527,0.20344734124831,0.956265864112998,2,8,microfibril,CC,THSD4;LTBP1
8535,GO:0033768,0.203474510677471,0.988449263263397,1,2,SUMO-targeted ubiquitin ligase complex,CC,RNF222
5143,GO:0015662,0.203484799646894,0.921576245331119,4,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP13A2;ATP7B;ATP2C2;ATP6V1C2
14840,GO:0070563,0.203524124322324,0.98844328993052,1,2,negative regulation of vitamin D receptor signaling pathway,BP,KANK2
13858,GO:0060438,0.203533495321811,0.935627150060583,3,15,trachea development,BP,MAP2K1;TGFBR2;MAPK3
12321,GO:0048644,0.20353698093139,0.896191646983243,7,45,muscle organ morphogenesis,BP,FKBP1A;ADARB1;ARID5B;ZFPM1;CHD7;RXRA;TGFB1
17699,GO:1901536,0.203543762069557,0.988440925127117,1,2,negative regulation of DNA demethylation,BP,GATA3
7953,GO:0032542,0.203658060989275,0.988427155719141,1,2,sulfiredoxin activity,MF,SESN2
2351,GO:0005412,0.203704623482739,0.988421543776834,1,2,glucose:sodium symporter activity,MF,SLC5A1
3188,GO:0006813,0.20374729065434,0.872539662732244,13,94,potassium ion transport,BP,FHL1;NOS1;KCNG1;DLG1;PRNP;SLC12A7;ATF4;STK39;SLC12A4;VAMP2;DNM2;GAL;KCNC4
16447,GO:0097066,0.20375692649138,0.935522408283032,3,15,response to thyroid hormone,BP,CTSB;GAS2L1;CTSL
13153,GO:0051694,0.203798671951356,0.988410203939641,1,2,pointed-end actin filament capping,BP,TMOD2
19646,GO:1990761,0.203838340455193,0.988405419068505,1,2,growth cone lamellipodium,CC,APBB1
13693,GO:0060199,0.203883397392223,0.988399982894292,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13696,GO:0060203,0.203883397392223,0.988399982894292,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
14483,GO:0061833,0.203925431732236,0.988394910112473,1,2,protein localization to tricellular tight junction,BP,MAPK9
8816,GO:0034515,0.203936269365039,0.988393602005376,1,2,proteasome storage granule,CC,PSMD2
15718,GO:0072237,0.20395103888424,0.988391819184774,1,2,metanephric proximal tubule development,BP,PKD1
2363,GO:0005462,0.20405158523163,0.988379678211279,1,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,SLC35B4
19591,GO:1990569,0.20405158523163,0.988379678211279,1,2,UDP-N-acetylglucosamine transmembrane transport,BP,SLC35B4
6999,GO:0030674,0.204077572454615,0.863605600046972,17,129,protein binding, bridging,MF,SH2D2A;SHC1;AP2A2;VPS11;ARRDC1;OBSL1;FSCN1;GAS2L1;GRB10;SRC;LDLRAP1;PAG1;SOCS2;STUB1;SHB;SKAP2;ANXA1
6586,GO:0022410,0.204157955935284,0.954964865364493,2,9,circadian sleep/wake cycle process,BP,CST3;PER3
12637,GO:0050802,0.204157955935284,0.954964865364493,2,9,circadian sleep/wake cycle, sleep,BP,CST3;PER3
9996,GO:0042383,0.204195203309075,0.878025186010061,11,78,sarcolemma,CC,FLNC;NOS1;OBSCN;BSG;DLG1;DYSF;RTN2;BIN1;CIB1;SLC30A1;ANXA1
14992,GO:0070884,0.204204918936455,0.935312206133038,3,15,regulation of calcineurin-NFAT signaling cascade,BP,PRNP;CIB1;ERBB3
17229,GO:0106056,0.204204918936455,0.935312206133038,3,15,regulation of calcineurin-mediated signaling,BP,PRNP;CIB1;ERBB3
15882,GO:0072584,0.20420740151162,0.955996782619764,2,8,caveolin-mediated endocytosis,BP,SRC;MAPK3
13854,GO:0060433,0.204212472930063,0.955994984800992,2,8,bronchus development,BP,TGFBR2;TULP3
10468,GO:0043316,0.204214515398064,0.988359989285977,1,2,cytotoxic T cell degranulation,BP,CEACAM1
18635,GO:1903892,0.204218319699083,0.988359529340648,1,2,negative regulation of ATF6-mediated unfolded protein response,BP,WFS1
19755,GO:2000077,0.2042937704736,0.988350405131594,1,2,negative regulation of type B pancreatic cell development,BP,GSK3A
486,GO:0001537,0.204342788600883,0.988344475256354,1,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,CHST14
11056,GO:0045022,0.204363651147557,0.90215748276459,6,38,early endosome to late endosome transport,BP,MAP2K1;MAP2K2;VPS11;MSN;SRC;MAPK3
3124,GO:0006704,0.204396143499665,0.955929852089861,2,8,glucocorticoid biosynthetic process,BP,DGKQ;HSD11B1
1550,GO:0003943,0.204405646520274,0.988336868662811,1,2,N-acetylgalactosamine-4-sulfatase activity,MF,GALNS
2396,GO:0005537,0.20440645986719,0.955926192491446,2,8,mannose binding,MF,BSG;LMAN1
3266,GO:0006939,0.204414013666333,0.889996459281986,8,54,smooth muscle contraction,BP,F2R;DOCK4;SMTN;DLG1;BBS2;HTR7;RAP1GDS1;EDNRA
7880,GO:0032436,0.204447941993466,0.881258980486587,10,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,DVL1;CSNK1E;AKT1;ANKIB1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
300,GO:0000806,0.20461770603517,0.988311186284807,1,2,Y chromosome,CC,SIN3B
14958,GO:0070828,0.20467737875006,0.935090250775628,3,15,heterochromatin organization,BP,TNRC18;HMGA2;BAHCC1
5524,GO:0016491,0.204711037688306,0.833848015867698,58,529,oxidoreductase activity,MF,XDH;CBS;NOS1;QSOX1;CYP27B1;IDH2;CYGB;SESN2;H6PD;P4HB;PDIA5;MDH2;ALDH1L2;CRYL1;RETSAT;ACAD10;HADH;DHTKD1;MSRB2;PRDX5;TSTA3;ERO1B;KIAA1191;GLUD1;ALOX15B;SRD5A3;ASPH;SDHA;CTBP1;PYCR2;MICAL2;P4HA1;AKR7A2;ALDH1A2;KDM4B;GLRX;CBR4;NDUFA4L2;ACADVL;GPX3;ALDH4A1;MICAL1;ALDH7A1;HSD11B1;DHRS4L2;LOXL1;PHF2;NDOR1;AOX1;SDHAF4;PHYH;CYB561;VAT1;NDUFS2;PCYOX1;CAT;LDHA;ASPHD1
16333,GO:0090498,0.204719415373342,0.988298857099187,1,2,extrinsic component of Golgi membrane,CC,NUCB1
1754,GO:0004351,0.204756269610388,0.988294387837048,1,2,glutamate decarboxylase activity,MF,GLUL
6529,GO:0021914,0.204763426848792,0.988293519777683,1,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,TULP3
5273,GO:0015918,0.204793120482233,0.889638717824127,8,55,sterol transport,BP,APOE;VPS4A;PCSK9;OSBPL5;LDLRAP1;PLTP;LRP1;ABCA7
515,GO:0001579,0.204793590493203,0.98828986101008,1,2,medium-chain fatty acid transport,BP,SLC27A1
4773,GO:0010956,0.204836613612824,0.988284641313927,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
7644,GO:0032049,0.20491053719331,0.955747217055217,2,8,cardiolipin biosynthetic process,BP,TAZ;SLC27A1
19780,GO:2000124,0.204911086915407,0.988275602902218,1,2,regulation of endocannabinoid signaling pathway,BP,MGLL
17879,GO:1902044,0.204923578934318,0.988274086432337,1,2,regulation of Fas signaling pathway,BP,TMBIM1
754,GO:0001991,0.20495688538213,0.955730745084045,2,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R;CTSZ
8773,GO:0034437,0.205007432723961,0.988263904145855,1,2,glycoprotein transporter activity,MF,VLDLR
9156,GO:0035500,0.205015949431239,0.988262869692843,1,2,MH2 domain binding,MF,HMGA2
7363,GO:0031400,0.20507427336241,0.834936981579069,54,462,negative regulation of protein modification process,BP,TNIP1;XDH;SORL1;DVL1;DLG1;FKBP1A;PRNP;CRTAP;LRP5;FBLN1;ADARB1;AKT1;APOE;PKN1;WWTR1;PRKCZ;DGKQ;EPHA1;PTK6;PPP1R35;LIMK1;STK39;DKK1;DUSP4;PARP10;PHF1;CTBP1;PPP1R14A;DUSP6;FYN;PPM1F;MICAL1;HEXIM1;SOCS2;TRIB3;SNX25;LEMD2;PMEPA1;TRIB2;LRRK1;RNF222;IMPACT;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;TGFB1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10
12149,GO:0048211,0.205110867446478,0.988251337336873,1,2,Golgi vesicle docking,BP,USO1
18701,GO:1904020,0.205112125482036,0.988251184445333,1,2,regulation of G-protein coupled receptor internalization,BP,APLN
8388,GO:0033280,0.205204403450768,0.920648740331874,4,22,response to vitamin D,BP,CYP27B1;VDR;KANK2;TGFB1
7772,GO:0032287,0.205207459680937,0.955641645874082,2,8,peripheral nervous system myelin maintenance,BP,SH3TC2;AKT1
1748,GO:0004345,0.205211106191991,0.988239151625889,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
16073,GO:0086098,0.205262566400685,0.988232893016574,1,2,angiotensin-activated signaling pathway involved in heart process,BP,SRC
7065,GO:0030838,0.205295749994816,0.880586234928593,10,72,positive regulation of actin filament polymerization,BP,RAC2;DLG1;CORO1B;ARPC1A;PFN1;ARFIP2;SPIRE1;VASP;BAIAP2L1;WIPF1
17598,GO:1901187,0.205296496038229,0.988228765460019,1,2,regulation of ephrin receptor signaling pathway,BP,ANKS1A
11810,GO:0046661,0.205396982028808,0.868704047504657,14,105,male sex differentiation,BP,ERCC1;CCND1;SDC1;CST3;BOK;MMP14;GATA3;ARID5B;AGO4;EIF2S2;BCL2L1;TBC1D20;CBL;ADAM15
2010,GO:0004731,0.205402305319021,0.988215888496048,1,2,purine-nucleoside phosphorylase activity,MF,PNP
3877,GO:0008506,0.205454704925299,0.988209508552465,1,2,sucrose:proton symporter activity,MF,SLC45A3
3885,GO:0008515,0.205454704925299,0.988209508552465,1,2,sucrose transmembrane transporter activity,MF,SLC45A3
4288,GO:0009669,0.205454704925299,0.988209508552465,1,2,sucrose:cation symporter activity,MF,SLC45A3
5008,GO:0015154,0.205454704925299,0.988209508552465,1,2,disaccharide transmembrane transporter activity,MF,SLC45A3
5009,GO:0015157,0.205454704925299,0.988209508552465,1,2,oligosaccharide transmembrane transporter activity,MF,SLC45A3
5191,GO:0015766,0.205454704925299,0.988209508552465,1,2,disaccharide transport,BP,SLC45A3
5192,GO:0015770,0.205454704925299,0.988209508552465,1,2,sucrose transport,BP,SLC45A3
5193,GO:0015772,0.205454704925299,0.988209508552465,1,2,oligosaccharide transport,BP,SLC45A3
13767,GO:0060319,0.205462262445006,0.988208588222558,1,2,primitive erythrocyte differentiation,BP,ZFPM1
3609,GO:0008050,0.20556310127054,0.988196304545436,1,2,female courtship behavior,BP,THRA
11484,GO:0045924,0.20556310127054,0.988196304545436,1,2,regulation of female receptivity,BP,THRA
12345,GO:0048682,0.205650223615592,0.988185685962787,1,2,sprouting of injured axon,BP,LAMB2
17246,GO:0106104,0.205661483953882,0.988184313147471,1,2,regulation of glutamate receptor clustering,BP,SSH1
18983,GO:1904717,0.205661483953882,0.988184313147471,1,2,regulation of AMPA glutamate receptor clustering,BP,SSH1
13678,GO:0060170,0.205714936338722,0.894769761774053,7,45,ciliary membrane,CC,BBS2;SHANK3;EHD3;GNB1;SHANK2;PKD1;SNAP29
1857,GO:0004517,0.205730941787045,0.98817584314796,1,2,nitric-oxide synthase activity,MF,NOS1
12507,GO:0050473,0.205775406371725,0.988170419149369,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
8486,GO:0033625,0.205783647737367,0.988169413675582,1,2,positive regulation of integrin activation,BP,SRC
7534,GO:0031749,0.205787910277297,0.988168893612844,1,2,D2 dopamine receptor binding,MF,DNM2
20035,GO:2000611,0.205846442453116,0.988161750938726,1,2,positive regulation of thyroid hormone generation,BP,GATA3
18214,GO:1902959,0.205860847350513,0.955408948723924,2,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1;BIN1
19209,GO:1905245,0.205860847350513,0.955408948723924,2,8,regulation of aspartic-type peptidase activity,BP,SORL1;BIN1
8540,GO:0033842,0.205879451787035,0.988157721747058,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
3759,GO:0008300,0.20589008193693,0.988156424043874,1,2,isoprenoid catabolic process,BP,SRD5A3
2356,GO:0005436,0.205933175869278,0.988151162422644,1,2,sodium:phosphate symporter activity,MF,SLC20A1
5084,GO:0015319,0.205933175869278,0.988151162422644,1,2,sodium:inorganic phosphate symporter activity,MF,SLC20A1
5085,GO:0015321,0.205933175869278,0.988151162422644,1,2,sodium-dependent phosphate transmembrane transporter activity,MF,SLC20A1
584,GO:0001735,0.205997971051809,0.988143248684862,1,2,prenylcysteine oxidase activity,MF,PCYOX1
6864,GO:0030328,0.205997971051809,0.988143248684862,1,2,prenylcysteine catabolic process,BP,PCYOX1
6865,GO:0030329,0.205997971051809,0.988143248684862,1,2,prenylcysteine metabolic process,BP,PCYOX1
5091,GO:0015349,0.206006061201949,0.988142260388858,1,2,thyroid hormone transmembrane transporter activity,MF,SLCO4A1
12718,GO:0050917,0.206033155347254,0.988138950220602,1,2,sensory perception of umami taste,BP,ITPR3
7255,GO:0031208,0.206056156955938,0.98813613964212,1,2,POZ domain binding,MF,KLHL17
1049,GO:0002572,0.206065398739871,0.988135010278506,1,2,pro-T cell differentiation,BP,GATA3
1676,GO:0004137,0.206077944058373,0.988133477120174,1,2,deoxycytidine kinase activity,MF,TK2
14553,GO:0070051,0.206102475507785,0.988130478820315,1,2,fibrinogen binding,MF,FBLN1
6143,GO:0019408,0.206104509135562,0.988130230245758,1,2,dolichol biosynthetic process,BP,SRD5A3
16589,GO:0097360,0.206144702849983,0.988125316685058,1,2,chorionic trophoblast cell proliferation,BP,BOK
17671,GO:1901382,0.206144702849983,0.988125316685058,1,2,regulation of chorionic trophoblast cell proliferation,BP,BOK
10254,GO:0042978,0.206147596185833,0.988124962939424,1,2,ornithine decarboxylase activator activity,MF,AZIN2
17963,GO:1902269,0.206147596185833,0.988124962939424,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN2
19018,GO:1904783,0.20614947863284,0.988124732784111,1,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2
5737,GO:0016880,0.206257506443974,0.988111520688336,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
3746,GO:0008285,0.206359224747998,0.833471065882595,55,472,negative regulation of cell proliferation,BP,XDH;F2R;CTNNBIP1;MAP2K1;PTHLH;CYP27B1;NEURL1;SERPINE2;DLG1;RPS6KA2;PRNP;IDH2;FAM129B;NACC2;FBLN1;ADARB1;IFITM1;APOE;ARG2;PKN1;FBXO2;FERMT1;TGFBR2;SOX7;PAK1;PARP10;DLG3;GATA3;TP53I11;APLN;HSF1;ALOX15B;ASPH;CTBP1;PTPRU;ALDH1A2;SPINT2;FUZ;VDR;CGREF1;GAL;ITGA1;COMT;MXD4;SLIT3;ARG1;HGS;GAS8;CIB1;KANK2;CEACAM1;SKAP2;TGFB1;CAMK2N1;RNF10
6013,GO:0019058,0.206374395256312,0.84542484975948,31,256,viral life cycle,BP,TNIP1;PC;RAB43;CTSB;ITGB5;EGFR;ADARB1;P4HB;IFITM1;APOE;ATG16L2;VPS4A;MVB12B;IDE;STOM;RAB29;PARP10;OASL;CTBP1;HMGA2;CHMP5;LRSAM1;RAB1B;OAS1;ISG20;VPS37A;RAD23A;TBC1D20;VAPB;FURIN;APOBEC3C
5064,GO:0015275,0.206379734231249,0.988096561953287,1,2,stretch-activated, cation-selective, calcium channel activity,MF,FAM155B
17335,GO:0140135,0.206379734231249,0.988096561953287,1,2,mechanosensitive cation channel activity,MF,FAM155B
6496,GO:0021849,0.206410424085546,0.988092804345391,1,2,neuroblast division in subventricular zone,BP,NUMB
6345,GO:0021516,0.206411406281878,0.988092684076125,1,2,dorsal spinal cord development,BP,PBX3
1445,GO:0003430,0.206414969678386,0.988092247734953,1,2,growth plate cartilage chondrocyte growth,BP,TGFBR2
18827,GO:1904350,0.206462945204548,0.955194050076684,2,8,regulation of protein catabolic process in the vacuole,BP,ATP13A2;LRP1
20010,GO:2000563,0.206472871109267,0.988085156394033,1,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
8322,GO:0033148,0.206491498455633,0.955183847807153,2,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PAK1;WBP2
9357,GO:0035860,0.206530538492197,0.988078091361973,1,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,GATA3
3246,GO:0006906,0.206557275337298,0.863543604658058,16,121,vesicle fusion,BP,DYSF;EVI5L;VPS11;VPS4A;TBC1D16;TBC1D14;TBC1D9B;SYTL1;VAMP2;STX5;STXBP1;STX10;USO1;TBC1D2B;SNAP29;ANXA1
14742,GO:0070381,0.206579166467311,0.988072131952101,1,2,endosome to plasma membrane transport vesicle,CC,RAB6A
8204,GO:0032943,0.206603024112971,0.858143175241534,19,152,mononuclear cell proliferation,BP,RAC2;DLG1;FKBP1A;PRNP;CARD11;ARG2;PKN1;MSN;TGFBR2;SATB1;IGFBP2;FYN;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
19902,GO:2000346,0.20662066227924,0.988067045274306,1,2,negative regulation of hepatocyte proliferation,BP,CEACAM1
19101,GO:1904953,0.206639972959049,0.955130780599403,2,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,CSNK1E;CSNK1D
10315,GO:0043069,0.206662317859825,0.828591749174812,72,632,negative regulation of programmed cell death,BP,ANGPTL4;F2R;MST1R;RBCK1;SHC1;WNT7A;BOK;IFI6;ITGA6;PRNP;BNIP3;FAM129B;AARS;XBP1;MAP4K4;EGFR;AKT1;IRAK1;BAG3;APOE;ARG2;SYVN1;PRKCZ;EPHA1;DKK1;BNIP3L;CD44;PRDX5;CCND2;ZNF385A;RAG1;RET;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;MYDGF;TSC22D4;TNFRSF6B;SRC;AGO4;IRF7;STXBP1;FYN;ASNS;GRINA;MICAL1;NTSR1;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;BCL2L1;LRP1;PAK4;MAP3K12;EPHB2;CBL;CIB1;KANK2;GLO1;ARHGEF2;TMBIM1;ITSN1;CAT;ERBB3;ANXA1;PPP1R10
18805,GO:1904289,0.206670403236553,0.988060946278019,1,2,regulation of mitotic DNA damage checkpoint,BP,PPP1R10
18232,GO:1902996,0.206734323292392,0.988053106140147,1,2,regulation of neurofibrillary tangle assembly,BP,SORL1
7618,GO:0031999,0.206779444870441,0.988047569996616,1,2,negative regulation of fatty acid beta-oxidation,BP,AKT1
16938,GO:0098886,0.206791519129254,0.988046088314169,1,2,modification of dendritic spine,BP,ARHGAP44
4701,GO:0010857,0.206801683709704,0.955072951501564,2,8,calcium-dependent protein kinase activity,MF,MAPKAPK3;MKNK2
2110,GO:0004886,0.206809115822379,0.988043928766221,1,2,9-cis retinoic acid receptor activity,MF,RXRA
16706,GO:0097632,0.206815425812971,0.988043154321504,1,2,extrinsic component of phagophore assembly site membrane,CC,ULK1
8143,GO:0032836,0.206820639441296,0.955066170656403,2,8,glomerular basement membrane development,BP,LAMB2;NID1
9252,GO:0035639,0.206831255461543,0.818116245330228,159,1405,purine ribonucleoside triphosphate binding,MF,MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;SEPT5;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;MYH15;RHOBTB2;TOP1;ARL2;PIP5K1C;SRC;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;ARFIP2;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;AGAP1;ADCY6;ADCK2;ERBB3;RAB6A;GNAS
7686,GO:0032116,0.206849206503064,0.988039007833631,1,2,SMC loading complex,CC,MAU2
16394,GO:0090694,0.206849206503064,0.988039007833631,1,2,Scc2-Scc4 cohesin loading complex,CC,MAU2
17817,GO:1901873,0.206849206503064,0.988039007833631,1,2,regulation of post-translational protein modification,BP,CRTAP
17818,GO:1901874,0.206849206503064,0.988039007833631,1,2,negative regulation of post-translational protein modification,BP,CRTAP
13655,GO:0060134,0.206941649578109,0.988027656570115,1,2,prepulse inhibition,BP,DVL1
465,GO:0001503,0.206952307687536,0.845788991007098,30,242,ossification,BP,CTNNBIP1;PTHLH;CYP27B1;MEF2D;MRC2;LRP5;ACVR2B;EGFR;MMP14;PRKACA;MN1;AKT1;IFITM1;WWTR1;COL13A1;FAM20C;SH3PXD2B;DKK1;SUFU;CLEC11A;FBXL15;THRA;RRBP1;ZHX3;MAPK3;ECM1;TGFB1;CAT;GNAS;THBS3
15791,GO:0072369,0.206996676707883,0.988020896812001,1,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
1028,GO:0002528,0.207057993113578,0.988013361929524,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
19806,GO:2000182,0.20715508014225,0.988001425922836,1,2,regulation of progesterone biosynthetic process,BP,DGKQ
14149,GO:0060995,0.207253980582703,0.987989260113042,1,2,cell-cell signaling involved in kidney development,BP,GATA3
14266,GO:0061289,0.207253980582703,0.987989260113042,1,2,Wnt signaling pathway involved in kidney development,BP,GATA3
14267,GO:0061290,0.207253980582703,0.987989260113042,1,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,GATA3
15698,GO:0072204,0.207253980582703,0.987989260113042,1,2,cell-cell signaling involved in metanephros development,BP,GATA3
15745,GO:0072300,0.20731149960995,0.987982181474088,1,2,positive regulation of metanephric glomerulus development,BP,RET
2733,GO:0006111,0.20747692192223,0.919417545175618,4,22,regulation of gluconeogenesis,BP,NR1D1;DGKQ;PPARA;SLC35B4
13042,GO:0051458,0.207529406269299,0.987955343315238,1,2,corticotropin secretion,BP,APLN
13043,GO:0051459,0.207529406269299,0.987955343315238,1,2,regulation of corticotropin secretion,BP,APLN
13044,GO:0051461,0.207529406269299,0.987955343315238,1,2,positive regulation of corticotropin secretion,BP,APLN
10723,GO:0044028,0.207536594019826,0.987954457473384,1,2,DNA hypomethylation,BP,FAM129B
10724,GO:0044029,0.207536594019826,0.987954457473384,1,2,hypomethylation of CpG island,BP,FAM129B
13118,GO:0051611,0.207549618587087,0.987952852189964,1,2,regulation of serotonin uptake,BP,NOS1
13119,GO:0051612,0.207549618587087,0.987952852189964,1,2,negative regulation of serotonin uptake,BP,NOS1
8397,GO:0033300,0.207589613942789,0.987947921994421,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14963,GO:0070837,0.207589613942789,0.987947921994421,1,2,dehydroascorbic acid transport,BP,SLC2A3
2360,GO:0005457,0.207662238866198,0.987938966681064,1,2,GDP-fucose transmembrane transporter activity,MF,SLC35B4
5196,GO:0015783,0.207662238866198,0.987938966681064,1,2,GDP-fucose transmembrane transport,BP,SLC35B4
9476,GO:0036080,0.207662238866198,0.987938966681064,1,2,purine nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
13058,GO:0051495,0.207683615916681,0.855858037865875,20,158,positive regulation of cytoskeleton organization,BP,RAC2;DLG1;RAPGEF3;CORO1B;ARPC1A;EPHA1;SH3PXD2B;LIMK1;PAK1;ARL2;PPM1F;PFN1;ARFIP2;SPIRE1;VASP;BAIAP2L1;WIPF1;PXN;ARHGEF10L;FHOD1
9614,GO:0036465,0.207712551116347,0.900231415605379,6,37,synaptic vesicle recycling,BP,WNT7A;AP3D1;NLGN2;PIP5K1C;DNM2;ITSN1
2284,GO:0005234,0.207719582109627,0.98793189309768,1,2,extracellularly glutamate-gated ion channel activity,MF,GRIN3B
9819,GO:0040038,0.207765352471811,0.987926245416516,1,2,polar body extrusion after meiotic divisions,BP,SPIRE1
14885,GO:0070649,0.207765352471811,0.987926245416516,1,2,formin-nucleated actin cable assembly,BP,SPIRE1
17248,GO:0110009,0.207765352471811,0.987926245416516,1,2,formin-nucleated actin cable organization,BP,SPIRE1
10927,GO:0044501,0.207803362435006,0.987921554175595,1,2,modulation of signal transduction in other organism,BP,TNIP1
13316,GO:0052027,0.207803362435006,0.987921554175595,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13350,GO:0052250,0.207803362435006,0.987921554175595,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
12379,GO:0048743,0.207823744716468,0.987919038145182,1,2,positive regulation of skeletal muscle fiber development,BP,FAM129B
6638,GO:0023016,0.20786200778676,0.987914314078549,1,2,signal transduction by trans-phosphorylation,BP,STK39
14942,GO:0070777,0.207892728029913,0.987910520519667,1,2,D-aspartate transport,BP,NTSR1
14944,GO:0070779,0.207892728029913,0.987910520519667,1,2,D-aspartate import across plasma membrane,BP,NTSR1
9675,GO:0038025,0.207925004594731,0.987906534054269,1,2,reelin receptor activity,MF,VLDLR
10839,GO:0044323,0.207947520625939,0.987903752671129,1,2,retinoic acid-responsive element binding,MF,RXRA
9558,GO:0036310,0.208023521966566,0.954634966061066,2,8,annealing helicase activity,MF,SMARCA1;ANXA1
17317,GO:0140066,0.208072670869222,0.987888286434362,1,2,peptidyl-lysine crotonylation,BP,EP300
8884,GO:0034684,0.208115239497333,0.987883023214547,1,2,integrin alphav-beta5 complex,CC,ITGB5
10017,GO:0042426,0.208204352512944,0.987872001048167,1,2,choline catabolic process,BP,ALDH7A1
18469,GO:1903526,0.208273482840489,0.987863446611357,1,2,negative regulation of membrane tubulation,BP,DNM2
18407,GO:1903385,0.208331412497009,0.987856275575632,1,2,regulation of homophilic cell adhesion,BP,CEACAM1
7089,GO:0030878,0.208403476145333,0.933329975143764,3,15,thyroid gland development,BP,MAP2K1;THRA;MAPK3
1518,GO:0003876,0.208427140619297,0.987844420300194,1,2,AMP deaminase activity,MF,AMPD2
12037,GO:0047623,0.208427140619297,0.987844420300194,1,2,adenosine-phosphate deaminase activity,MF,AMPD2
3535,GO:0007529,0.20846761238422,0.987839406192526,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
15298,GO:0071462,0.208548383416374,0.987829395873609,1,2,cellular response to water stimulus,BP,SIPA1
19561,GO:1990428,0.208619445280287,0.987820585027246,1,2,miRNA transport,BP,TGFBR2
18161,GO:1902856,0.208742002973253,0.987805380873943,1,2,negative regulation of non-motile cilium assembly,BP,DNM2
12214,GO:0048369,0.20874402683144,0.987805129710468,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12215,GO:0048370,0.20874402683144,0.987805129710468,1,2,lateral mesoderm formation,BP,FGFR1
12216,GO:0048371,0.20874402683144,0.987805129710468,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12217,GO:0048372,0.20874402683144,0.987805129710468,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12218,GO:0048377,0.20874402683144,0.987805129710468,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12219,GO:0048378,0.20874402683144,0.987805129710468,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
19617,GO:1990666,0.208766529059896,0.987802336958074,1,2,PCSK9-LDLR complex,CC,PCSK9
9928,GO:0042264,0.208768592133258,0.98780208089197,1,2,peptidyl-aspartic acid hydroxylation,BP,ASPH
10323,GO:0043094,0.208779099317043,0.907368213675546,5,32,cellular metabolic compound salvage,BP,NAPRT;TK2;UCKL1;AMPD2;PNP
20311,GO:2001245,0.208855456933977,0.987791296598501,1,2,regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
8323,GO:0033149,0.208871705255355,0.987789278769232,1,2,FFAT motif binding,MF,VAPB
8872,GO:0034665,0.208903426883898,0.987785338817074,1,2,integrin alpha1-beta1 complex,CC,ITGA1
17941,GO:1902229,0.20892818406267,0.907083931476577,5,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,NACC2;CD44;ZNF385A;MIF;BCL2L1
13438,GO:0052812,0.208942138252493,0.98778052974328,1,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,PIP5K1C
8874,GO:0034667,0.208979951831969,0.98777583117338,1,2,integrin alpha3-beta1 complex,CC,ITGA3
14706,GO:0070309,0.209032492317985,0.987769301008757,1,2,lens fiber cell morphogenesis,BP,TBC1D20
4209,GO:0009330,0.209048287665756,0.987767337449389,1,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,TOP1
14032,GO:0060733,0.209080724313359,0.987763304612577,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT
15169,GO:0071262,0.209080724313359,0.987763304612577,1,2,regulation of translational initiation in response to starvation,BP,IMPACT
15170,GO:0071264,0.209080724313359,0.987763304612577,1,2,positive regulation of translational initiation in response to starvation,BP,IMPACT
2773,GO:0006196,0.209094367709111,0.98776160811074,1,2,AMP catabolic process,BP,NT5E
4830,GO:0014032,0.20911503283374,0.886807795059113,8,54,neural crest cell development,BP,LAMA5;SEMA3F;SEMA4B;RET;EDNRA;ALDH1A2;SEMA4G;MAPK3
16982,GO:0098971,0.209136447045214,0.987756374880273,1,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,KIF17
18217,GO:1902962,0.20917228149571,0.987751917308187,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18218,GO:1902963,0.20917228149571,0.987751917308187,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
17415,GO:1900120,0.209173967909631,0.932433400651249,3,16,regulation of receptor binding,BP,PTPRF;PCSK9;ADAM15
2336,GO:0005351,0.209174283116658,0.954220770001684,2,8,carbohydrate:proton symporter activity,MF,SLC2A9;SLC45A3
16466,GO:0097109,0.209198866128228,0.987748609763627,1,2,neuroligin family protein binding,MF,DLG4
563,GO:0001701,0.209236907718735,0.843083369969232,31,251,in utero embryonic development,BP,MDFI;CAPN2;MAP2K1;EGFR;EPN1;FBXW8;AKT1;TFEB;ENDOG;TGFBR2;WDTC1;PLCG1;PKD1;GATA3;HSF1;EDNRA;SPINT2;RCN1;EIF2S2;SEC24C;FGFR1;BCL2L1;PLCD3;ZP3;CHD7;RXRA;OCRL;APBA1;MBD3;SLC30A1;SF3B6
14183,GO:0061045,0.209250527314775,0.892316517570517,7,46,negative regulation of wound healing,BP,PLAT;SERPINE2;SERPING1;APOE;F12;FGF2;CEACAM1
11917,GO:0046929,0.209257778623461,0.954190653521905,2,8,negative regulation of neurotransmitter secretion,BP,ASIC1;SLC30A1
7259,GO:0031213,0.209271797828522,0.987739533339493,1,2,RSF complex,CC,RSF1
18360,GO:1903294,0.209310024575745,0.987734774472121,1,2,regulation of glutamate secretion, neurotransmission,BP,STXBP1
18361,GO:1903296,0.209310024575745,0.987734774472121,1,2,positive regulation of glutamate secretion, neurotransmission,BP,STXBP1
12119,GO:0048143,0.209368805990079,0.954150593055341,2,8,astrocyte activation,BP,EGFR;LRP1
12504,GO:0050436,0.209370768476059,0.987727210296479,1,2,microfibril binding,MF,LTBP1
19169,GO:1905123,0.209382098330193,0.987725799148453,1,2,regulation of glucosylceramidase activity,BP,ATP13A2
158,GO:0000320,0.209400253287678,0.987723537734676,1,2,re-entry into mitotic cell cycle,BP,CCND1
17733,GO:1901618,0.209417344261257,0.93284799799887,3,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A3;SLC10A6;CEACAM1
16999,GO:0099011,0.209433760250955,0.98771936343259,1,2,neuronal dense core vesicle exocytosis,BP,STXBP1
17069,GO:0099525,0.209433760250955,0.98771936343259,1,2,presynaptic dense core vesicle exocytosis,BP,STXBP1
18576,GO:1903760,0.209458342377406,0.98771630048034,1,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,DLG1
19130,GO:1905024,0.209458342377406,0.98771630048034,1,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
8729,GO:0034368,0.20946660359429,0.953024449633288,2,9,protein-lipid complex remodeling,BP,APOE;PLTP
8730,GO:0034369,0.20946660359429,0.953024449633288,2,9,plasma lipoprotein particle remodeling,BP,APOE;PLTP
13620,GO:0060070,0.209470423341298,0.844415407186975,29,241,canonical Wnt signaling pathway,BP,CCND1;SDC1;DVL1;WNT7A;IGFBP4;PSMD2;SMURF2;LRP5;APOE;WWTR1;FZD8;FERMT1;DKK1;SOX7;BCL9L;DDIT3;GATA3;PTPRU;IGFBP2;SRC;GSK3A;FUZ;WNT5B;PSMD7;LRRK1;BICC1;INVS;CSNK1D;TCF7L1
709,GO:0001931,0.20956651338796,0.95407921927529,2,8,uropod,CC,MSN;PIP5K1C
7279,GO:0031254,0.20956651338796,0.95407921927529,2,8,cell trailing edge,CC,MSN;PIP5K1C
4955,GO:0015016,0.209610713163683,0.987697305375935,1,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,NDST2
12461,GO:0050119,0.209610713163683,0.987697305375935,1,2,N-acetylglucosamine deacetylase activity,MF,NDST2
6020,GO:0019072,0.209639506539396,0.987693714032921,1,2,viral genome packaging,BP,PC
6021,GO:0019074,0.209639506539396,0.987693714032921,1,2,viral RNA genome packaging,BP,PC
8519,GO:0033691,0.209749910745497,0.98767993806129,1,2,sialic acid binding,MF,AGRN
6495,GO:0021847,0.209779104942993,0.987676293830077,1,2,ventricular zone neuroblast division,BP,FGFR1
9227,GO:0035607,0.209779104942993,0.987676293830077,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
11059,GO:0045026,0.209838041797414,0.932115026011692,3,16,plasma membrane fusion,BP,STXBP1;SNAP29;SPESP1
9870,GO:0042110,0.209875860701635,0.841016123464131,33,273,T cell activation,BP,RAC2;AP3D1;DLG1;FKBP1A;PRNP;XBP1;AKT1;CARD11;ARG2;PRKCZ;FZD8;MSN;TGFBR2;KDELR1;PAK1;RAG1;SATB1;RAB29;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;KIF13B;ZFPM1;ZP3;PNP;CHD7;ARG1;CEACAM1;TGFB1;ANXA1
554,GO:0001675,0.209908936904144,0.953955487536284,2,8,acrosome assembly,BP,RFX2;TBC1D20
9348,GO:0035838,0.209929963832262,0.987657452868897,1,2,growing cell tip,CC,PI4K2A
12131,GO:0048168,0.209943910053473,0.907109310510306,5,30,regulation of neuronal synaptic plasticity,BP,NEURL1;DLG4;SHANK3;APOE;EPHB2
9179,GO:0035526,0.209954543119195,0.987654381596005,1,2,retrograde transport, plasma membrane to Golgi,BP,RAB43
12407,GO:0048817,0.210022146523134,0.987645932083182,1,2,negative regulation of hair follicle maturation,BP,FERMT1
13064,GO:0051525,0.210116727636308,0.987634105262373,1,2,NFAT protein binding,MF,PPARA
9615,GO:0036466,0.210191316516162,0.987624773863835,1,2,synaptic vesicle recycling via endosome,BP,AP3D1
14519,GO:0062009,0.210248715169556,0.953832568254421,2,8,secondary palate development,BP,DLG1;TSHZ1
4762,GO:0010939,0.210301549886154,0.917229276043998,4,24,regulation of necrotic cell death,BP,RBCK1;BOK;BNIP3;ARHGEF2
16515,GO:0097193,0.210322527027074,0.843666874924649,29,244,intrinsic apoptotic signaling pathway,BP,CHAC1;NFATC4;ERCC6;BOK;BNIP3;NACC2;XBP1;STK25;ATF4;P4HB;AKT1;SYVN1;CD44;ZNF385A;DDIT3;WFS1;SRC;STK24;PPM1F;GRINA;TNFRSF1A;MOAP1;SHISA5;MIF;BCL2L1;TRIB3;CASP4;ARHGEF2;EP300
4801,GO:0010991,0.210371072621881,0.987602269305268,1,2,negative regulation of SMAD protein complex assembly,BP,PMEPA1
16988,GO:0098982,0.210423886039082,0.987595652958374,1,2,GABA-ergic synapse,CC,NLGN2
16989,GO:0098983,0.210423886039082,0.987595652958374,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
14984,GO:0070863,0.210428460478075,0.953767485250763,2,8,positive regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
13744,GO:0060292,0.210453976903592,0.932353870701175,3,15,long term synaptic depression,BP,SHANK3;SHANK2;STXBP1
20157,GO:2000809,0.210457330241674,0.987591462116059,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
19054,GO:1904862,0.210457330241764,0.987591462116059,1,2,inhibitory synapse assembly,BP,NLGN2
15279,GO:0071435,0.210464254964649,0.987590594289968,1,2,potassium ion export,BP,DLG1
17975,GO:1902302,0.210464254964649,0.987590594289968,1,2,regulation of potassium ion export,BP,DLG1
16416,GO:0097016,0.210499002614312,0.987586239099488,1,2,L27 domain binding,MF,DLG1
11548,GO:0046058,0.210529176165249,0.898282678849668,6,38,cAMP metabolic process,BP,PTHLH;RAPGEF3;ADCY7;GNAI2;CAP1;ADCY6
17075,GO:0099532,0.210581729565022,0.987575866832279,1,2,synaptic vesicle endosomal processing,BP,AP3D1
13005,GO:0051389,0.210608842816248,0.987572466324422,1,2,inactivation of MAPKK activity,BP,EPHB2
15564,GO:0071955,0.210617570649209,0.987571371579795,1,2,recycling endosome to Golgi transport,BP,TBC1D14
19396,GO:1905793,0.210627604831624,0.987570112910842,1,2,protein localization to pericentriolar material,BP,NUDCD3
6550,GO:0021965,0.210640693602714,0.987568470972193,1,2,spinal cord ventral commissure morphogenesis,BP,ADARB1
1473,GO:0003726,0.210640693602894,0.987568470972193,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
836,GO:0002133,0.210685997689857,0.987562786797046,1,2,polycystin complex,CC,PKD1
15587,GO:0072021,0.210685997689857,0.987562786797046,1,2,ascending thin limb development,BP,PKD1
15678,GO:0072177,0.210685997689857,0.987562786797046,1,2,mesonephric duct development,BP,PKD1
15709,GO:0072218,0.210685997689857,0.987562786797046,1,2,metanephric ascending thin limb development,BP,PKD1
689,GO:0001905,0.21070668739695,0.987560190431798,1,2,activation of membrane attack complex,BP,CD59
741,GO:0001969,0.21070668739695,0.987560190431798,1,2,regulation of activation of membrane attack complex,BP,CD59
19961,GO:2000427,0.21070668739695,0.987560190431798,1,2,positive regulation of apoptotic cell clearance,BP,ABCA7
19091,GO:1904928,0.210708245843736,0.987559994848906,1,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,LRP5
20283,GO:2001201,0.210712751816482,0.987559429345896,1,2,regulation of transforming growth factor-beta secretion,BP,FERMT1
10466,GO:0043314,0.210734814708249,0.987556660227344,1,2,negative regulation of neutrophil degranulation,BP,BCR
18065,GO:1902564,0.210734814708249,0.987556660227344,1,2,negative regulation of neutrophil activation,BP,BCR
19185,GO:1905167,0.210735972111886,0.987556514951771,1,2,positive regulation of lysosomal protein catabolic process,BP,LRP1
14250,GO:0061187,0.210748145717543,0.987554986881246,1,2,regulation of chromatin silencing at rDNA,BP,PHF2
14251,GO:0061188,0.210748145717543,0.987554986881246,1,2,negative regulation of chromatin silencing at rDNA,BP,PHF2
6534,GO:0021934,0.210763403624806,0.987553071509977,1,2,hindbrain tangential cell migration,BP,TTBK2
6535,GO:0021935,0.210763403624806,0.987553071509977,1,2,cerebellar granule cell precursor tangential migration,BP,TTBK2
16117,GO:0090080,0.210763506611459,0.987553058581167,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
1596,GO:0004008,0.210764221189145,0.987552968873923,1,2,copper-exporting ATPase activity,MF,ATP7B
2430,GO:0005608,0.210764221189145,0.987552968873923,1,2,laminin-3 complex,CC,LAMB2
10659,GO:0043682,0.210764221189145,0.987552968873923,1,2,copper-transporting ATPase activity,MF,ATP7B
13563,GO:0060003,0.210764221189145,0.987552968873923,1,2,copper ion export,BP,ATP7B
17338,GO:0140192,0.210764221189145,0.987552968873923,1,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
935,GO:0002331,0.210764221189236,0.987552968873923,1,2,pre-B cell allelic exclusion,BP,RAG1
5469,GO:0016362,0.210764221189325,0.987552968873923,1,2,activin receptor activity, type II,MF,ACVR2B
10446,GO:0043291,0.210764221189325,0.987552968873923,1,2,RAVE complex,CC,DMXL2
9110,GO:0035373,0.210764221189325,0.987552968873923,1,2,chondroitin sulfate proteoglycan binding,MF,PTPRF
9557,GO:0036309,0.210764221189325,0.987552968873923,1,2,protein localization to M-band,BP,OBSCN
15664,GO:0072156,0.210764221189325,0.987552968873923,1,2,distal tubule morphogenesis,BP,PKD1
15786,GO:0072364,0.210764221189325,0.987552968873923,1,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
18209,GO:1902954,0.210764221189325,0.987552968873923,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
3917,GO:0008582,0.210764221189416,0.987552968873923,1,2,regulation of synaptic growth at neuromuscular junction,BP,AGRN
18545,GO:1903691,0.210764221189416,0.987552968873923,1,2,positive regulation of wound healing, spreading of epidermal cells,BP,RREB1
8653,GO:0034188,0.210764221189416,0.987552968873923,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
15783,GO:0072361,0.210764221189416,0.987552968873923,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
16349,GO:0090554,0.210764221189416,0.987552968873923,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16350,GO:0090556,0.210764221189416,0.987552968873923,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
16836,GO:0098679,0.210764221189416,0.987552968873923,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
18851,GO:1904398,0.210764221189416,0.987552968873923,1,2,positive regulation of neuromuscular junction development,BP,AGRN
1441,GO:0003417,0.211096882738961,0.953525109200928,2,8,growth plate cartilage development,BP,TGFBR2;THBS3
14565,GO:0070070,0.211381208291295,0.953421842599714,2,8,proton-transporting V-type ATPase complex assembly,BP,DMXL2;TCIRG1
14567,GO:0070072,0.211381208291295,0.953421842599714,2,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,DMXL2;TCIRG1
2721,GO:0006098,0.211592010639248,0.931271469954871,3,16,pentose-phosphate shunt,BP,H6PD;PGLS;TALDO1
11151,GO:0045182,0.21159831518655,0.897439646758164,6,39,translation regulator activity,MF,NEURL1;EIF4EBP1;MIF4GD;SAMD4B;PAIP2;IGF2BP3
10736,GO:0044065,0.211728503678086,0.953295569784467,2,8,regulation of respiratory system process,BP,NLGN2;PBX3
14154,GO:0061000,0.21173627487799,0.953292742554432,2,8,negative regulation of dendritic spine development,BP,PTPRS;ASAP1
3509,GO:0007420,0.211766479717842,0.82944008117162,53,448,brain development,BP,MAP2K1;WNT7A;CST3;NEURL1;BOK;SHARPIN;SERPINE2;PITPNM1;PTPRS;BNIP3;SMARCA1;SNPH;BBS2;BCR;AARS;EGFR;CSNK1E;LAMB1;SHANK3;BAG3;NAGLU;TGFBR2;EPOR;DKK1;TACC1;PAK1;TTBK2;SHANK2;GLUD1;NUMB;B4GALT2;TULP3;ALDH1A2;SRC;RERE;FYN;ANXA3;MBOAT7;GJC2;THRA;AMIGO2;FGFR1;LRP1;KLHL17;MYO1D;CHD7;NDE1;EPHB2;GAS8;SOCS7;CSNK1D;MBD3;ARCN1
19690,GO:1990909,0.211846151425251,0.953252760517173,2,8,Wnt signalosome,CC,DVL1;LRP5
11779,GO:0046621,0.212179378745042,0.916850180497924,4,22,negative regulation of organ growth,BP,WWC3;TGFBR2;PAK1;GSK3A
12162,GO:0048251,0.212266148303968,0.953099793812748,2,8,elastic fiber assembly,BP,THSD4;LOXL1
3268,GO:0006941,0.21228388708076,0.872013867140837,11,80,striated muscle contraction,BP,NOS1;DLG1;TNNT1;PRKACA;PPP1R13L;EHD3;ARG2;OBSL1;TAZ;P2RX4;VEGFB
3396,GO:0007176,0.212428888518588,0.916368912293215,4,23,regulation of epidermal growth factor-activated receptor activity,BP,SHC1;NEURL1;TGFA;CBL
1099,GO:0002685,0.212472325879409,0.865673871255835,13,101,regulation of leukocyte migration,BP,PGF;RAC2;BCR;MMP14;MSN;ADAM8;MIF;ZP3;VEGFB;MAPK3;ECM1;TGFB1;ANXA1
2440,GO:0005639,0.212700452670532,0.952941386737367,2,8,integral component of nuclear inner membrane,CC,LEMD2;P2RX4
7267,GO:0031229,0.212700452670532,0.952941386737367,2,8,intrinsic component of nuclear inner membrane,CC,LEMD2;P2RX4
10917,GO:0044453,0.212700452670532,0.952941386737367,2,8,nuclear membrane part,CC,LEMD2;P2RX4
18598,GO:1903799,0.212977847094713,0.952840088510078,2,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,BCDIN3D;TGFB1
7521,GO:0031701,0.213175338154859,0.952767911204137,2,8,angiotensin receptor binding,MF,ARAP1;GNB1
16905,GO:0098827,0.213288140582595,0.819221398846712,90,802,endoplasmic reticulum subcompartment,CC,EDEM1;NOS1;MBOAT2;LPCAT4;LMF1;BOK;DLG1;PITPNM1;FKBP1A;CKAP4;SBF1;AGPAT3;TXNDC11;COPG1;TMEM214;LPCAT1;XYLT1;XBP1;EGFR;RTN2;RHBDF2;XYLT2;PDIA5;CDS2;SYVN1;YIF1A;ITPR3;TMEM129;RETSAT;SEC23A;PLD3;CREB3L2;UBE2J1;KDELR1;ESYT2;ATG13;SEC63;ELOVL1;OSBPL5;SURF4;ERO1B;UBXN7;PTDSS2;REEP2;TMED3;PIGQ;UBXN4;ANTXR2;WFS1;SRD5A3;ASPH;SARAF;REEP6;RAB1B;CARD19;STX5;SPTLC2;CLSTN1;REEP4;HSD11B1;MBOAT7;SLC33A1;SHISA5;PSKH1;MCFD2;UBA1;MGLL;SLC35B4;SEC24C;RRBP1;SIGMAR1;AGPAT4;ULK1;TBC1D20;VAPB;LMAN1;TGFA;CASP4;POMT1;DNAJB9;RNF103;HM13;PNPLA6;LPIN3;CD59;RAB6A;IKBIP;ARCN1;ERP44;STIM1
2295,GO:0005251,0.213449681670788,0.952667566488081,2,8,delayed rectifier potassium channel activity,MF,KCNG1;KCNC4
358,GO:0000976,0.213556770332498,0.825901980111882,59,498,transcription regulatory region sequence-specific DNA binding,MF,ZMYND8;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;PPARA;ZNF516;TFE3;TNRC18;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;TOP1;IRF7;PER3;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300
10841,GO:0044325,0.213671904827356,0.870997415864263,11,80,ion channel binding,MF,FHL1;NOS1;DLG1;FKBP1A;PRNP;PKD1;SRC;FYN;GRINA;CIB1;PACS2
5382,GO:0016197,0.21374207695564,0.84826548523107,22,175,endosomal transport,BP,SORL1;SNX9;AP3D1;SNX33;EHD3;VPS4A;MVB12B;TBC1D14;SDCCAG3;RAB29;CHMP5;DENND2A;STX5;STX10;VPS37A;RAB11FIP4;EHD4;HGS;SNX27;ARHGAP44;RAB6A;ZFYVE21
8381,GO:0033270,0.213747836533575,0.95255840690945,2,8,paranode region of axon,CC,KIF13B;GJC2
15721,GO:0072243,0.213858984528952,0.930721382643266,3,15,metanephric nephron epithelium development,BP,WWTR1;LAMB2;PKD1
8470,GO:0033601,0.214292549676356,0.952358694239589,2,8,positive regulation of mammary gland epithelial cell proliferation,BP,CCND1;RREB1
9232,GO:0035612,0.214416774519008,0.952313097277831,2,8,AP-2 adaptor complex binding,MF,FCHO1;LDLRAP1
19907,GO:2000352,0.214519772898311,0.930402901592529,3,15,negative regulation of endothelial cell apoptotic process,BP,ANGPTL4;GATA3;PAK4
8986,GO:0035082,0.214526559923625,0.915210470202476,4,23,axoneme assembly,BP,NEURL1;BBS2;DNAAF5;GAS8
7960,GO:0032553,0.214624064906815,0.810694634342024,162,1435,ribonucleotide binding,MF,NOS1;MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;RAPGEF3;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;SEPT5;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;MYH15;RHOBTB2;TOP1;ARL2;PIP5K1C;SRC;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;AGAP1;ADCY6;ADCK2;ERBB3;RAB6A;GNAS
6399,GO:0021602,0.214651361405427,0.930339414787794,3,15,cranial nerve morphogenesis,BP,SEMA3F;ADARB1;EPHB2
15045,GO:0070970,0.214975397088855,0.952107817949617,2,8,interleukin-2 secretion,BP,CARD11;PNP
7738,GO:0032228,0.215126735037982,0.93010988422246,3,15,regulation of synaptic transmission, GABAergic,BP,NLGN2;STXBP1;NISCH
11366,GO:0045684,0.215156025506218,0.903543294594078,5,32,positive regulation of epidermis development,BP,CYP27B1;ALOX15B;VDR;GAL;HPSE
14365,GO:0061548,0.215177286474668,0.952033533891927,2,8,ganglion development,BP,SEMA3F;TULP3
11300,GO:0045596,0.215195321488023,0.827900136750752,49,421,negative regulation of cell differentiation,BP,XDH;CCND1;SORL1;NFATC4;WNT7A;PTHLH;POSTN;PTPRS;IDH2;SEMA3F;LRP5;FBLN1;XBP1;MAP4K4;EGFR;APOE;WWTR1;CTSZ;GDI1;DKK1;PPARA;SUFU;PAK1;SEMA4B;DDIT3;ADAMTS7;PTPN9;RAB29;GATA3;GSK3A;FUZ;GAL;SEMA4G;ADIPOR1;TRIB3;ZFPM1;LRP1;TRIB2;ULK2;EPHB2;CIB1;ARHGEF2;CEACAM1;ADCY6;TGFB1;ANXA1;RAP1GAP2;ASAP1;RNF10
5060,GO:0015267,0.215460851733088,0.84825542782298,21,164,channel activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;ORAI1;PKD1;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;GJC2;LRRC8A;TPCN1;P2RX4;KCNC4;ORAI3;RASA3
6610,GO:0022803,0.215460851733088,0.84825542782298,21,164,passive transmembrane transporter activity,MF,KCNG1;SCN8A;DLG4;DLG1;TTYH3;ITPR3;ORAI1;PKD1;DLG3;ANO8;GRIN3B;ASIC1;FAM155B;NCS1;GJC2;LRRC8A;TPCN1;P2RX4;KCNC4;ORAI3;RASA3
3549,GO:0007585,0.215551134635966,0.894925829540853,6,39,respiratory gaseous exchange,BP,NLGN2;APLN;EDNRA;TMPRSS11D;NTSR1;PBX3
8479,GO:0033613,0.215563256374411,0.882291532117425,8,55,activating transcription factor binding,MF,MEF2D;DGKQ;ZNF516;IFI27;WFS1;ZFPM1;TAF6;EP300
8168,GO:0032891,0.215942769954722,0.951751420715498,2,8,negative regulation of organic acid transport,BP,AKT1;STK39
12080,GO:0048013,0.215945140221229,0.872951778511931,10,72,ephrin receptor signaling pathway,BP,ARPC1A;AP2A2;EPHA1;GIT1;PAK1;ANKS1A;SRC;FYN;EPHB2;ITSN1
1116,GO:0002702,0.21601240123057,0.887582517835979,7,48,positive regulation of production of molecular mediator of immune response,BP,XBP1;HK1;PRKCZ;GATA3;MIF;MAPK3;TGFB1
7840,GO:0032388,0.216082109941709,0.843902367412743,24,194,positive regulation of intracellular transport,BP,EDEM1;RAC2;SORL1;RAPGEF3;PRNP;BAG3;VPS11;MSN;ZDHHC8;ATG13;PAK1;STOM;RAB29;CEMIP;VAMP2;LDLRAP1;GSK3A;STXBP1;FYN;TBC1D20;CAMK1;CIB1;UGCG;TGFB1
20056,GO:2000643,0.216337592993215,0.951605628406355,2,8,positive regulation of early endosome to late endosome transport,BP,VPS11;MSN
9087,GO:0035331,0.216547398770486,0.951528077117842,2,8,negative regulation of hippo signaling,BP,WWC3;MARK3
2935,GO:0006457,0.216731337225817,0.842141184670876,25,210,protein folding,BP,LTBP4;QSOX1;FKBP1A;TXNDC11;CRTAP;FKBP9;NUDCD3;FYCO1;P4HB;PDIA5;BAG3;DNAJB5;ERO1B;GNB1;GNAI2;WFS1;FKBP10;DNAJC4;GNB2;HSPA2;TMX4;HSPA13;LMAN1;UNC45A;ERP44
11084,GO:0045070,0.216957223128671,0.902672777657476,5,31,positive regulation of viral genome replication,BP,ADARB1;STOM;RAD23A;TBC1D20;VAPB
15556,GO:0071936,0.216988217011943,0.951364958509657,2,8,coreceptor activity involved in Wnt signaling pathway,MF,LRP5;GPC4
6340,GO:0021511,0.217000685499691,0.951360341226238,2,8,spinal cord patterning,BP,SUFU;TULP3
1681,GO:0004143,0.217132854224625,0.951311385183545,2,8,diacylglycerol kinase activity,MF,DGKA;DGKQ
7077,GO:0030859,0.217677305042526,0.928873560621178,3,15,polarized epithelial cell differentiation,BP,MSN;SH3BP1;CAMSAP3
1506,GO:0003857,0.217700819407355,0.949944680235595,2,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,CRYL1;HADH
18201,GO:1902946,0.217713565683072,0.95109603043183,2,8,protein localization to early endosome,BP,SORL1;MSN
17861,GO:1902001,0.218223094023558,0.928607953151624,3,15,fatty acid transmembrane transport,BP,CPT2;AKT1;CPT1B
2279,GO:0005225,0.218393497631701,0.950843350183785,2,8,volume-sensitive anion channel activity,MF,TTYH3;LRRC8A
7632,GO:0032026,0.218400182373098,0.950840863123735,2,8,response to magnesium ion,BP,CCND1;ENTPD6
14138,GO:0060976,0.218480601253314,0.901986930199401,5,30,coronary vasculature development,BP,LTBP1;SUFU;APLN;DNM2;VEGFB
7210,GO:0031094,0.21857524558817,0.950775711133329,2,8,platelet dense tubular network,CC,F2R;ITPR3
2348,GO:0005388,0.218772277041417,0.950702338059283,2,8,calcium-transporting ATPase activity,MF,ATP13A2;ATP2C2
15231,GO:0071361,0.219072990876105,0.950590261886332,2,8,cellular response to ethanol,BP,DNMT3A;ADCY7
10807,GO:0044272,0.219560044265914,0.849485666302716,18,143,sulfur compound biosynthetic process,BP,CBS;CHAC1;HAGH;CHPF;XYLT1;XYLT2;NDST2;ELOVL1;AHCY;CNDP2;B4GALT2;B3GNT3;CBR4;CHST14;ST3GAL3;MLYCD;GGT1;B4GALT6
9012,GO:0035148,0.219967452986879,0.855238697182826,15,113,tube formation,BP,DVL1;DEAF1;PRKACB;SUFU;PODXL;RET;GATA3;TULP3;TGM2;SDCCAG8;SPINT2;FUZ;PFN1;VASP;TGFB1
1463,GO:0003707,0.220524979573869,0.891913123820334,6,38,steroid hormone receptor activity,MF,NR1D1;PPARA;PAQR7;VDR;THRA;RXRA
16504,GO:0097169,0.220608182942999,0.981960599478259,1,3,AIM2 inflammasome complex,CC,CASP4
1024,GO:0002521,0.221154477541262,0.82938409637713,36,300,leukocyte differentiation,BP,CTNNBIP1;AP3D1;XBP1;CMTM7;MMP14;CARD11;PRKCZ;FAM20C;POU2F2;FZD8;RRAS;TGFBR2;KDELR1;TFE3;RAG1;SATB1;GATA3;ADAM8;SRC;IRF7;LRRC8A;MFNG;ZFPM1;LRRK1;PNP;CHD7;L3MBTL3;POLM;DNAJB9;GLO1;CEACAM1;TGFB1;SH3PXD2A;ANXA1;GNAS;EP300
14661,GO:0070232,0.221293277344441,0.91110952553906,4,24,regulation of T cell apoptotic process,BP,ARG2;RAG1;ADAM8;TSC22D4
4625,GO:0010743,0.221350687830461,0.92650795252355,3,16,regulation of macrophage derived foam cell differentiation,BP,PPARA;ALOX15B;MAPK9
4483,GO:0010498,0.221381660610478,0.82287066926749,48,416,proteasomal protein catabolic process,BP,EDEM1;BTBD2;GID4;RBCK1;DVL1;SHARPIN;NR1D1;PSMD2;MTA1;SMURF2;ABTB1;XBP1;CSNK1E;PANO1;PRKACA;HECW2;AKT1;SYVN1;WWTR1;TMEM129;FBXO2;FBXW5;UBE2J1;CDC34;ANKIB1;DDIT3;PKD1;UBXN4;WFS1;GIPC1;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;RNF187;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;POMT1;CSNK1D;DNAJB9;RNF103;HM13
18537,GO:1903672,0.221522493771377,0.911309062304489,4,23,positive regulation of sprouting angiogenesis,BP,FGF2;CIB1;SRPX2;ANXA1
8659,GO:0034198,0.221553795722012,0.891076226490251,6,39,cellular response to amino acid starvation,BP,DAP;SESN2;ATF4;IMPACT;MAPK3;C12ORF66
19567,GO:1990442,0.221663432308893,0.981777388471826,1,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,DDIT3
13012,GO:0051409,0.221836974337973,0.948365575131832,2,9,response to nitrosative stress,BP,DDIT3;DUSP6
2840,GO:0006309,0.221971722394651,0.926200791613893,3,16,apoptotic DNA fragmentation,BP,H1F0;ENDOG;HSF1
11481,GO:0045921,0.221995891941346,0.877743125570859,8,56,positive regulation of exocytosis,BP,SDC1;ATP13A2;VPS4A;NCS1;STXBP1;SMPD3;ZP3;HGS
20109,GO:2000725,0.222028419257292,0.911024670561727,4,23,regulation of cardiac muscle cell differentiation,BP,DKK1;PAK1;GSK3A;TGFB1
10119,GO:0042627,0.222049558825631,0.981710090836437,1,3,chylomicron,CC,APOE
10368,GO:0043171,0.222235572800936,0.910908137561099,4,23,peptide catabolic process,BP,CHAC1;RNPEPL1;IDE;GGT1
4713,GO:0010873,0.222301952277679,0.981666026385256,1,3,positive regulation of cholesterol esterification,BP,APOE
2941,GO:0006469,0.222542002282458,0.837425602956301,25,204,negative regulation of protein kinase activity,BP,SORL1;DVL1;LRP5;ADARB1;AKT1;APOE;PKN1;WWTR1;EPHA1;PTK6;DUSP4;DUSP6;PPM1F;HEXIM1;SOCS2;TRIB3;TRIB2;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;SPRED2;CAMK2N1
6806,GO:0030246,0.222572693283272,0.850982741565966,16,123,carbohydrate binding,MF,ADGRL1;PYGL;BSG;MRC2;HK1;UAP1;FBXO2;PKD1;SLC2A3;P4HA1;CLEC11A;TALDO1;ZP3;LMAN1;PHYH;GALNT3
12499,GO:0050431,0.22318745395146,0.926175085026411,3,15,transforming growth factor beta binding,MF,LTBP4;TGFBR2;LTBP1
11789,GO:0046632,0.223300032639883,0.876942958469698,8,55,alpha-beta T cell differentiation,BP,AP3D1;PRKCZ;TGFBR2;SATB1;GATA3;ZFPM1;PNP;ANXA1
14537,GO:0070011,0.223527719329948,0.82382175311962,42,359,peptidase activity, acting on L-amino acid peptides,MF,ADAM19;CAPN2;PLAT;MMP1;PSMD2;PRSS3;CTSB;RNPEPL1;USP20;MMP14;JOSD2;RHBDF2;NPEPL1;PITRM1;CTSZ;PCSK9;TYSND1;PRSS8;OTUB2;SCRN1;IDE;HTRA1;MMP10;ADAMTS7;CNDP2;ADAM8;BLMH;CAPN5;PCSK6;TMPRSS11D;THOP1;CTSL;F12;KLK6;CASP4;ACY1;LONP2;GGT1;USP32;FURIN;ADAM15;HM13
7069,GO:0030851,0.223567466645591,0.925409346570394,3,16,granulocyte differentiation,BP,ZFPM1;L3MBTL3;CEACAM1
12545,GO:0050670,0.224125004180658,0.851811216898238,15,118,regulation of lymphocyte proliferation,BP,RAC2;DLG1;PRNP;CARD11;ARG2;PKN1;TGFBR2;IGFBP2;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
4573,GO:0010656,0.224148718799121,0.909829508349792,4,23,negative regulation of muscle cell apoptotic process,BP,BAG3;HSF1;RGL2;PPP1R10
11120,GO:0045123,0.224415820190285,0.909678572610943,4,23,cellular extravasation,BP,BCR;ADAM8;ITGA1;PODXL2
5150,GO:0015680,0.2247191868399,0.981241000666014,1,3,intracellular copper ion transport,BP,ATP7B
3507,GO:0007417,0.22517871987537,0.8129973341257,68,587,central nervous system development,BP,MAP2K1;WNT7A;CST3;NEURL1;BOK;SHARPIN;SERPINE2;PITPNM1;SOX12;PTPRS;BNIP3;SMARCA1;SNPH;BBS2;SEMA3F;BCR;VLDLR;AARS;EGFR;CSNK1E;LAMB1;ADARB1;SHANK3;AKT1;BAG3;NAGLU;TGFBR2;LAMB2;EPOR;DKK1;TACC1;BIN1;SUFU;PAK1;TTBK2;SHANK2;PKD1;GLUD1;NUMB;B4GALT2;TULP3;ALDH1A2;SRC;RERE;FYN;ANXA3;MBOAT7;GJC2;THRA;AMIGO2;FGFR1;PBX3;LRP1;KLHL17;MYO1D;CHD7;NDE1;KLK6;EPHB2;GAS8;SOCS7;MAPK3;CSNK1D;RNF103;MBD3;TGFB1;SLC45A3;ARCN1
7320,GO:0031324,0.225196280906493,0.79840158342031,206,1895,negative regulation of cellular metabolic process,BP,TNIP1;XDH;ERCC1;MDFI;ZMYND8;CHAC1;CCND1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;QSOX1;CST3;CYP27B1;DLG4;SERPINE2;NR1D1;DLG1;DAP;IFI6;DNMT3A;FKBP1A;MTA1;PRNP;BNIP3;WWC3;CRTAP;SMURF2;FAM129B;SESN2;ZC3H6;NACC2;BCR;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;PPP1R13L;ATF4;AKT1;PEG3;SERPING1;BAG3;APOE;ATP13A2;PKN1;ELK3;WWTR1;PHF21A;TSPYL2;PRKCZ;DGKQ;FZD8;CTSZ;EPHA1;PTK6;PCSK9;DEAF1;SALL2;PPP1R35;DRAP1;SERPINB6;LIMK1;STK39;DKK1;SOX7;UBE2J1;PPARA;H2AFJ;WDTC1;CD44;DNAJB5;IDE;DEDD2;TBC1D14;PRDX5;PPP1R12C;BIN1;SUFU;SCMH1;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;FARP1;DUSP4;SATB1;IFI27;GRB10;PARP10;DLG3;GATA3;PHF1;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;NEIL1;TFPI2;HMGA2;ARID5B;PPP1R14A;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;IRF7;HIST3H2A;CPTP;ACADVL;PER3;RERE;RSF1;GSK3A;SPINT2;DUSP6;FYN;ZNF692;PPM1F;NELFCD;MICAL1;TLE4;VDR;PUM1;COMT;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;MIF;SOCS2;HES2;PCSK1N;TRIB3;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;TRIB2;MXD4;SAMD4B;ZP3;LRRK1;RCOR1;MYO1D;RNF222;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;CAMSAP3;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;EPHB2;CBL;CIB1;SOCS7;KANK2;FURIN;AIDA;CEACAM1;PAIP2;ZNF256;ECM1;CD59;MBD3;IGF2BP3;CCNE1;TGFB1;SPRED2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10;KLF12;ZNF318;EP300
6117,GO:0019359,0.225345562860352,0.856081839556042,13,97,nicotinamide nucleotide biosynthetic process,BP,NAPRT;PGM1;IDH2;HK1;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;PNP;ALDOC;LDHA
6119,GO:0019363,0.225345562860352,0.856081839556042,13,97,pyridine nucleotide biosynthetic process,BP,NAPRT;PGM1;IDH2;HK1;PFKP;NMRK1;PPARA;DHTKD1;NADK;PARP10;PNP;ALDOC;LDHA
8725,GO:0034364,0.225600817584256,0.945954365083561,2,10,high-density lipoprotein particle,CC,APOE;PLTP
10389,GO:0043200,0.225891363091807,0.861911687140993,11,81,response to amino acid,BP,CAPN2;NEURL1;DNMT3A;SESN2;XBP1;EGFR;HSF1;FYN;ASNS;BCL2L1;ARG1
12341,GO:0048678,0.226163855558376,0.880636974281547,7,49,response to axon injury,BP,MAP2K1;CST3;PTPRS;PTPRF;LAMB2;STK24;ARG1
2100,GO:0004864,0.226261155504234,0.908296503581556,4,24,protein phosphatase inhibitor activity,MF,PPP1R35;PPP1R14A;PPP1R37;PPP1R10
8547,GO:0033866,0.226835808364619,0.923778476640197,3,16,nucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS;PANK4
8571,GO:0034030,0.226835808364619,0.923778476640197,3,16,ribonucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS;PANK4
8574,GO:0034033,0.226835808364619,0.923778476640197,3,16,purine nucleoside bisphosphate biosynthetic process,BP,ACOT7;PPCS;PANK4
17797,GO:1901800,0.226904356930007,0.85778792404579,12,90,positive regulation of proteasomal protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;AKT1;ANKIB1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
12179,GO:0048278,0.227092725843546,0.874191780538043,8,56,vesicle docking,BP,RAB3B;SNPH;VPS11;STX5;EXOC2;STXBP1;STX10;USO1
13769,GO:0060323,0.227098496172536,0.89648594054703,5,31,head morphogenesis,BP,RRAS;DKK1;ASPH;ARID5B;TGFB1
7935,GO:0032506,0.227443111025205,0.907962000154629,4,23,cytokinetic process,BP,SNX9;SNX33;VPS4A;SPIRE1
18269,GO:1903053,0.228090444819496,0.907593538286644,4,23,regulation of extracellular matrix organization,BP,CST3;FSCN1;LRP1;TGFB1
7668,GO:0032092,0.228151387213034,0.863999420360213,10,73,positive regulation of protein binding,BP,FKBP1A;APOE;RFNG;PKD1;HSF1;STPG1;MFNG;TRIB3;LRP1;EP300
10426,GO:0043255,0.228491231604692,0.873434430649549,8,54,regulation of carbohydrate biosynthetic process,BP,NR1D1;AKT1;DGKQ;PPARA;GSK3A;NTSR1;SLC35B4;TGFB1
4273,GO:0009628,0.228761693385902,0.804041123093419,97,867,response to abiotic stimulus,BP,ANGPTL4;PGF;ERCC1;NOS1;CCND1;CAPN2;NFATC4;PLAT;ERCC6;CST3;CRTC1;SERPINE2;PITPNM1;DNMT3A;POSTN;PSMD2;MTA1;NET1;BNIP3;CYGB;LRP5;EGFR;MMP14;PRKACA;SHANK3;ATF4;P4HB;AKT1;XPC;IRAK1;BAG3;PKN1;MAPK13;ENDOG;DEAF1;TGFBR2;SERPINB6;STK39;BNIP3L;PPARA;SIPA1;ZNF516;MC1R;CCND2;PAK1;AHCY;RAG1;GNB1;PKD1;GATA3;MYOF;ASIC1;HSF1;ADAM8;HMGA2;DYNLRB1;IGFBP2;B4GALT2;EDNRA;SRC;DNM2;REEP6;FAM162A;HIST3H2A;ACADVL;PER3;FYN;PRIMPOL;ASNS;PSMD7;TNFRSF1A;BRSK1;THRA;NTSR1;HSF4;HYAL1;LRRC8A;BCL2L1;STUB1;PCSK1N;DDB2;SLC27A1;HSPA2;MAPK9;HSPA13;VEGFB;IMPACT;CBL;MAPK3;MAPK10;ARHGEF2;TGFB1;CAT;LDHA;ANXA1;IKBIP;EP300
18713,GO:1904036,0.229005128153792,0.907072060006077,4,23,negative regulation of epithelial cell apoptotic process,BP,ANGPTL4;GATA3;WFS1;PAK4
13092,GO:0051580,0.229057288772832,0.945557577065449,2,9,regulation of neurotransmitter uptake,BP,NOS1;RAB3B
19768,GO:2000107,0.229179055177743,0.894970576830316,5,32,negative regulation of leukocyte apoptotic process,BP,ARG2;RAG1;TSC22D4;IRF7;MIF
20140,GO:2000778,0.229552524717643,0.922412789988585,3,16,positive regulation of interleukin-6 secretion,BP,F2R;XBP1;IL1RAP
5933,GO:0018208,0.229597335275314,0.885368568346116,6,42,peptidyl-proline modification,BP,FKBP1A;CRTAP;FKBP9;P4HB;P4HA1;FKBP10
13000,GO:0051384,0.229699881150448,0.855616362892937,12,91,response to glucocorticoid,BP,CCND1;SDC1;PCK2;EGFR;PTPRU;IGFBP2;EIF4EBP1;ANXA3;SLIT3;ARG1;TGFB1;ANXA1
11724,GO:0046501,0.229887744012787,0.94523041842646,2,9,protoporphyrinogen IX metabolic process,BP,ALAS1;UROS
5232,GO:0015844,0.230233975161672,0.906025956759779,4,24,monoamine transport,BP,NOS1;RAB3B;SLC29A4;NISCH
12945,GO:0051281,0.230250328684251,0.906016571982156,4,24,positive regulation of release of sequestered calcium ion into cytosol,BP,F2R;PLCG1;CEMIP;NTSR1
2519,GO:0005771,0.230290877920094,0.905679378254731,4,25,multivesicular body,CC,CST3;EGFR;ATP13A2;HGS
10181,GO:0042759,0.230331915085201,0.94505508175511,2,9,long-chain fatty acid biosynthetic process,BP,ACOT7;ALOX15B
3462,GO:0007281,0.230368463760007,0.842744642477831,17,133,germ cell development,BP,ERCC1;NEURL1;BBS2;OSBP2;ETV5;RFX2;PRKACA;AKT1;DEAF1;UBE2J1;SRC;PAQR7;BCL2L1;HSPA2;ZP3;TBC1D20;CIB1
19565,GO:1990440,0.230759180670987,0.944886185021606,2,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,ATF4;DDIT3
4256,GO:0009581,0.230895216742543,0.877684542027363,7,47,detection of external stimulus,BP,SERPINE2;PITPNM1;GNB1;PKD1;REEP6;FYN;NTSR1
13112,GO:0051603,0.230971860500442,0.808005757522082,67,591,proteolysis involved in cellular protein catabolic process,BP,EDEM1;BTBD2;GID4;CAPN2;RBCK1;DVL1;SHARPIN;NR1D1;PSMD2;MTA1;SMURF2;CTSB;ABTB1;USP20;XBP1;CSNK1E;PANO1;PRKACA;HECW2;AKT1;SYVN1;WWTR1;VPS4A;CTSZ;TMEM129;FBXO2;FBXW5;MVB12B;UBE2J1;ARRDC1;CDC34;IDE;ANKIB1;SUFU;DDIT3;CUL7;ADAMTS7;PKD1;UBXN4;WFS1;GIPC1;UBR4;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;CTSL;UBA1;RNF187;VPS37A;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;LONP2;CBL;USP32;POMT1;CSNK1D;DNAJB9;RNF103;HM13;PCYOX1
427,GO:0001134,0.230991125555519,0.905936416764976,4,23,transcription factor activity, transcription factor recruiting,MF,NR1D1;PPARA;VDR;THRA
10312,GO:0043066,0.230992417616016,0.80721688011078,70,619,negative regulation of apoptotic process,BP,ANGPTL4;F2R;MST1R;SHC1;WNT7A;BOK;IFI6;ITGA6;PRNP;BNIP3;FAM129B;AARS;XBP1;MAP4K4;EGFR;AKT1;IRAK1;BAG3;APOE;ARG2;SYVN1;PRKCZ;EPHA1;DKK1;BNIP3L;CD44;PRDX5;CCND2;ZNF385A;RAG1;RET;GATA3;HSF1;WFS1;ADAM8;RGL2;HMGA2;MYDGF;TSC22D4;TNFRSF6B;SRC;AGO4;IRF7;STXBP1;FYN;ASNS;GRINA;MICAL1;NTSR1;AMIGO2;TIMP1;FGFR1;ADNP;MIF;SOCS2;BCL2L1;LRP1;PAK4;MAP3K12;EPHB2;CBL;CIB1;GLO1;ARHGEF2;TMBIM1;ITSN1;CAT;ERBB3;ANXA1;PPP1R10
7491,GO:0031650,0.231937557505719,0.944419189751638,2,9,regulation of heat generation,BP,APLN;SLC27A1
9843,GO:0042059,0.232007284152268,0.884106651696721,6,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,SH3KBP1;EGFR;EPN1;ITGA1;HGS;CBL
14974,GO:0070849,0.232325853830696,0.884071529247371,6,39,response to epidermal growth factor,BP,EGFR;AKT1;PLCG1;PTPN12;CBL;MAPK3
14021,GO:0060716,0.232413675928825,0.920964626730057,3,16,labyrinthine layer blood vessel development,BP,FBXW8;AKT1;PLCD3
10280,GO:0043011,0.23250276999586,0.944194575767658,2,9,myeloid dendritic cell differentiation,BP,TGFBR2;TGFB1
2965,GO:0006501,0.232835683182983,0.892478747356933,5,33,C-terminal protein lipidation,BP,LY6K;LY6E;LYPD5;MSLN;NTNG1
10911,GO:0044447,0.233054732929798,0.920638770731702,3,16,axoneme part,CC,WDR66;DYNLRB1;ARFGEF2
13721,GO:0060253,0.233126195944961,0.943946363111211,2,9,negative regulation of glial cell proliferation,BP,IDH2;RNF10
10146,GO:0042698,0.233405156191663,0.883362923117437,6,39,ovulation cycle,BP,EGFR;SRC;ADNP;ZP3;SLIT3;ANXA1
2268,GO:0005184,0.233553541715088,0.979640978231242,1,3,neuropeptide hormone activity,MF,GAL
6584,GO:0022408,0.233578638446885,0.849661015852823,13,99,negative regulation of cell-cell adhesion,BP,SERPINE2;DLG1;PRNP;ARG2;PPARA;PODXL;ASS1;PAG1;SPINT2;ARG1;CEACAM1;TGFB1;ANXA1
7345,GO:0031362,0.233757143800468,0.943694659221934,2,9,anchored component of external side of plasma membrane,CC,PRNP;CD59
4470,GO:0010464,0.233915478578237,0.904255765643559,4,23,regulation of mesenchymal cell proliferation,BP,CTNNBIP1;LRP5;TGFBR2;FGFR1
8205,GO:0032944,0.234291790958633,0.843796318884902,15,119,regulation of mononuclear cell proliferation,BP,RAC2;DLG1;PRNP;CARD11;ARG2;PKN1;TGFBR2;IGFBP2;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
1914,GO:0004601,0.234384668437046,0.902500892973834,4,28,peroxidase activity,MF,CYGB;PRDX5;GPX3;CAT
5913,GO:0018149,0.23451509798293,0.902424661268027,4,28,peptide cross-linking,BP,TGM2;PRR9;ABCA7;ANXA1
7899,GO:0032462,0.234585437412722,0.919322538049217,3,17,regulation of protein homooligomerization,BP,APOE;RHOC;SRC
11916,GO:0046928,0.235095310875678,0.891526244232657,5,31,regulation of neurotransmitter secretion,BP,SEPT5;ASIC1;STXBP1;KCNC4;SLC30A1
925,GO:0002317,0.23513131525591,0.979347452157763,1,3,plasma cell differentiation,BP,XBP1
4392,GO:0010043,0.235303600450266,0.902484732561036,4,26,response to zinc ion,BP,ATP13A2;MT2A;ARG1;SLC30A1
3943,GO:0008630,0.235511463214676,0.851033684012303,12,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,NFATC4;ERCC6;BOK;NACC2;CD44;ZNF385A;TNFRSF1A;MOAP1;SHISA5;MIF;BCL2L1;EP300
2725,GO:0006103,0.235542430342081,0.919369444924083,3,16,2-oxoglutarate metabolic process,BP,IDH2;GPT2;PHYH
15484,GO:0071804,0.235557867267095,0.854747497240579,11,80,cellular potassium ion transport,BP,FHL1;KCNG1;DLG1;PRNP;SLC12A7;STK39;SLC12A4;VAMP2;DNM2;GAL;KCNC4
15485,GO:0071805,0.235557867267095,0.854747497240579,11,80,potassium ion transmembrane transport,BP,FHL1;KCNG1;DLG1;PRNP;SLC12A7;STK39;SLC12A4;VAMP2;DNM2;GAL;KCNC4
11025,GO:0044849,0.235636596859406,0.942941929667987,2,9,estrous cycle,BP,ADNP;ANXA1
14195,GO:0061061,0.235680360982291,0.811724926077539,45,381,muscle structure development,BP,FLNC;FHL1;NOS1;CAPN2;NFATC4;SDC1;NEURL1;MEF2D;OBSCN;SMTN;FKBP1A;LAMA5;TMOD2;FAM129B;TNNT1;XBP1;MMP14;ADARB1;AKT1;TGFBR2;DKK1;OBSL1;BIN1;PAK1;BCL9L;DDIT3;MYOF;MYH15;ARID5B;FLNB;TAZ;GSK3A;THRA;FGFR1;LEMD2;ZFPM1;ZNF609;FGF2;CHD7;RXRA;UNC45A;CAMK1;TGFB1;ERBB3;EP300
3625,GO:0008083,0.235838831250678,0.862520100213366,9,68,growth factor activity,MF,PGF;DKK1;CLEC11A;TIMP1;FGF2;VEGFB;TGFA;TGFB1;MANF
13601,GO:0060048,0.235863447178074,0.862755240235866,9,65,cardiac muscle contraction,BP,NOS1;DLG1;TNNT1;PRKACA;PPP1R13L;EHD3;TAZ;P2RX4;VEGFB
15348,GO:0071548,0.236082510412422,0.89066952535972,5,32,response to dexamethasone,BP,PCK2;EGFR;EIF4EBP1;ARG1;TGFB1
9867,GO:0042107,0.236217720444742,0.862498195371928,9,65,cytokine metabolic process,BP,CARD11;UBE2J1;TNFSF15;GATA3;IL1RAP;IRF7;ZFPM1;TRIB2;IGF2BP3
7962,GO:0032555,0.236372301189481,0.790571099527625,160,1424,purine ribonucleotide binding,MF,MST1R;RAC2;MAP2K1;PYGL;ERCC6;SCN8A;PCK2;OBSCN;DGKA;RAB3B;RPS6KA2;RAPGEF3;PC;RAB43;SCYL1;SMARCA1;NME4;MAPKAPK3;TUBB6;BCR;RAB31;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;SEPT10;PRKACA;CARS;ACTA2;HK1;MAP2K2;TUBG2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;RRAS;SEPT5;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;GTPBP1;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;GLUL;TUBB3;RET;RAB29;RHOC;HLTF;SEPT8;ASS1;ATP11A;ARL8A;OASL;GNAI2;GLUD1;PANK4;NEK9;MYH15;RHOBTB2;TOP1;ARL2;PIP5K1C;SRC;SCG5;TGM2;DNM2;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;RAB25;ASNS;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;TUBG1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;ARFIP2;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;RHOBTB1;LONP2;CAMK1;EPHB2;DRG2;RAB4B;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;AGAP1;ADCY6;ADCK2;ERBB3;RAB6A;GNAS
19483,GO:1990126,0.236377958792084,0.918941411515415,3,16,retrograde transport, endosome to plasma membrane,BP,SDCCAG3;SNX27;ARHGAP44
3794,GO:0008360,0.236459406323225,0.839992496801667,16,123,regulation of cell shape,BP,SH3KBP1;ARAP1;DLG1;SYNE3;CSNK1E;PARVB;MSN;TTBK2;RHOC;RHOBTB2;FYN;ARAP3;RHOBTB1;WIPF1;CSNK1D;ANXA1
7266,GO:0031228,0.236726626989316,0.880997057980962,6,40,intrinsic component of Golgi membrane,CC,QSOX1;YIF1A;RFNG;SLC35B4;MFNG;TBC1D20
17592,GO:1901164,0.237138014026867,0.978970703120786,1,3,negative regulation of trophoblast cell migration,BP,TIMP1
18467,GO:1903524,0.237443118418232,0.889815592188592,5,32,positive regulation of blood circulation,BP,F2R;EGFR;AKT1;APLN;GSK3A
17363,GO:1900024,0.237596708814392,0.880421202525499,6,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;NET1;FBLN1;DNM2;RREB1;CIB1
3908,GO:0008553,0.237598918522449,0.94215128105434,2,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,ATP2C2;ATP6V1C2
4742,GO:0010907,0.237604704736645,0.902121240886827,4,23,positive regulation of glucose metabolic process,BP,AKT1;PPARA;SRC;SLC45A3
14008,GO:0060700,0.237931694355909,0.942016721473699,2,9,regulation of ribonuclease activity,BP,OASL;OAS1
16193,GO:0090195,0.23795390415143,0.942007735883536,2,9,chemokine secretion,BP,POSTN;ALOX15B
6718,GO:0030125,0.238032308816061,0.901515125596866,4,24,clathrin vesicle coat,CC,EGFR;EPN2;AP2A2;LDLRAP1
8837,GO:0034613,0.238385709210975,0.788779461597428,158,1462,cellular protein localization,BP,EDEM1;ZMYND8;LTBP2;SH3TC2;RAC2;SORL1;DVL1;SNX9;AP3D1;DLG4;OBSCN;BSG;DLG1;XPOT;RAB3B;RAPGEF3;PRNP;LAMA5;SSH1;RAB43;COPG1;SESN2;BBS2;NACC2;BCR;SYNE3;RAB31;NUDCD3;ETV5;EVI5L;EGFR;RTN2;CSNK1E;SEPT10;CORO1B;TUB;HK1;SHANK3;TTC7B;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;AP1B1;SYVN1;TMSB4X;AP2A2;PRKCZ;VPS11;VPS4A;PITRM1;TMEM129;SH3PXD2B;SEPT5;SEC23A;MSN;GDI1;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;OBSL1;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TWF2;TBC1D14;TSPAN5;PAK1;TTBK2;NLGN2;DDIT3;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;RAB29;IFI27;REEP2;TMED3;CEMIP;SEPT8;PKD1;PARP10;DLG3;OXA1L;GRIN3B;PTPRU;ARL2;NUMB;VAMP2;FLNB;GIPC1;TULP3;SRC;LDLRAP1;SCG5;PEX10;LRSAM1;NUCB1;RAB1B;STX5;TOM1L2;RERE;GSK3A;STXBP1;FYN;RAB25;AGRN;TNFRSF1A;ABHD17C;KIF13B;TSPAN33;STX10;MOAP1;SEC24C;BCL2L1;MAU2;LEMD2;ARFIP2;LRP1;USO1;ABCA7;TBC1D2B;NEURL1B;CAMSAP3;RPL28;LONP2;CAMK1;EPHB2;HGS;GAS8;CIB1;TMSB10;RAB4B;PACS2;CSNK1D;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;HM13;APBA1;ARHGAP44;CCNE1;TGFB1;PPP1R10;RAB6A;ITGA3;ARCN1
13228,GO:0051851,0.238697281280626,0.872066878056734,7,49,modification by host of symbiont morphology or physiology,BP,PC;APOE;STOM;HMGA2;TBC1D20;ARG1;EP300
17551,GO:1901018,0.238763330219134,0.941679837626185,2,9,positive regulation of potassium ion transmembrane transporter activity,BP,DNM2;GAL
1123,GO:0002709,0.239096846163156,0.888548199572165,5,33,regulation of T cell mediated immunity,BP,PRKCZ;GATA3;ZP3;ARG1;CEACAM1
14994,GO:0070886,0.239312058992742,0.941457080038581,2,9,positive regulation of calcineurin-NFAT signaling cascade,BP,CIB1;ERBB3
17231,GO:0106058,0.239312058992742,0.941457080038581,2,9,positive regulation of calcineurin-mediated signaling,BP,CIB1;ERBB3
17849,GO:1901983,0.239336055300583,0.865449341697067,8,57,regulation of protein acetylation,BP,NOS1;RAPGEF3;GATA3;CTBP1;CAMK1;MAPK3;TGFB1;WBP2
2754,GO:0006163,0.239668472049929,0.810116775113597,41,371,purine nucleotide metabolic process,BP,NT5E;XDH;NOS1;PTHLH;DLG4;DLG1;PGM1;RAPGEF3;NME4;ACOT7;ADCY7;HK1;CARD11;APOE;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;DLG3;GNAI2;PPCS;PANK4;SDHA;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;PNP;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
11378,GO:0045723,0.239686838930235,0.941304720106382,2,9,positive regulation of fatty acid biosynthetic process,BP,ANXA1;SLC45A3
14922,GO:0070727,0.239836761263114,0.787350830185894,159,1472,cellular macromolecule localization,BP,EDEM1;ZMYND8;LTBP2;SH3TC2;RAC2;SORL1;DVL1;SNX9;AP3D1;DLG4;OBSCN;BSG;DLG1;XPOT;RAB3B;RAPGEF3;PRNP;LAMA5;SSH1;RAB43;COPG1;SESN2;BBS2;NACC2;BCR;SYNE3;RAB31;NUDCD3;ETV5;EVI5L;EGFR;RTN2;CSNK1E;SEPT10;CORO1B;TUB;HK1;SHANK3;TTC7B;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;AP1B1;SYVN1;TMSB4X;AP2A2;PRKCZ;VPS11;VPS4A;PITRM1;TMEM129;SH3PXD2B;SEPT5;SEC23A;MSN;GDI1;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;OBSL1;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TWF2;TBC1D14;TSPAN5;PAK1;TTBK2;ZNF385A;NLGN2;DDIT3;TBC1D9B;GGA3;GGA1;STOM;SYTL1;PTPN9;RAB29;IFI27;REEP2;TMED3;CEMIP;SEPT8;PKD1;PARP10;DLG3;OXA1L;GRIN3B;PTPRU;ARL2;NUMB;VAMP2;FLNB;GIPC1;TULP3;SRC;LDLRAP1;SCG5;PEX10;LRSAM1;NUCB1;RAB1B;STX5;TOM1L2;RERE;GSK3A;STXBP1;FYN;RAB25;AGRN;TNFRSF1A;ABHD17C;KIF13B;TSPAN33;STX10;MOAP1;SEC24C;BCL2L1;MAU2;LEMD2;ARFIP2;LRP1;USO1;ABCA7;TBC1D2B;NEURL1B;CAMSAP3;RPL28;LONP2;CAMK1;EPHB2;HGS;GAS8;CIB1;TMSB10;RAB4B;PACS2;CSNK1D;ARHGEF2;C12ORF66;SNX27;UGCG;TMBIM1;HM13;APBA1;ARHGAP44;CCNE1;TGFB1;PPP1R10;RAB6A;ITGA3;ARCN1
14485,GO:0061844,0.239849988970761,0.914368021883696,3,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,HIST2H2BE;FAM3A;RNASE7
4829,GO:0014031,0.240011785389647,0.865077839392056,8,56,mesenchymal cell development,BP,LAMA5;SEMA3F;SEMA4B;RET;EDNRA;ALDH1A2;SEMA4G;MAPK3
18565,GO:1903729,0.240024902578178,0.94116713524751,2,9,regulation of plasma membrane organization,BP,DNM2;ASAP1
19924,GO:2000379,0.240052320277395,0.864834176522745,8,58,positive regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;AKT1;TGFBR2;ASS1;DNM2;P2RX4;TGFB1
12855,GO:0051146,0.240058464906416,0.831267347746373,19,150,striated muscle cell differentiation,BP,FLNC;NOS1;CAPN2;SDC1;OBSCN;TMOD2;FAM129B;TNNT1;XBP1;MMP14;AKT1;DKK1;OBSL1;PAK1;MYOF;GSK3A;THRA;RXRA;TGFB1
2298,GO:0005261,0.240265932922028,0.841817978822122,14,105,cation channel activity,MF,KCNG1;SCN8A;ITPR3;ORAI1;PKD1;GRIN3B;ASIC1;FAM155B;NCS1;TPCN1;P2RX4;KCNC4;ORAI3;RASA3
10696,GO:0043951,0.240787837628818,0.940856109301209,2,9,negative regulation of cAMP-mediated signaling,BP,CDC34;MGRN1
11469,GO:0045907,0.240981178844053,0.916567804955055,3,16,positive regulation of vasoconstriction,BP,F2R;EGFR;AKT1
2398,GO:0005540,0.240994135953617,0.940771882083679,2,9,hyaluronic acid binding,MF,CD44;CEMIP
13138,GO:0051656,0.241122521667646,0.809009909859722,41,349,establishment of organelle localization,BP,RAC2;AP3D1;DLG1;COPG1;SNPH;BBS2;FYCO1;STK25;PRKCZ;VPS4A;CTSZ;SEPT5;SEC23A;MAP1B;SYTL1;VAMP2;PIP5K1C;CHMP5;DNM2;RAB1B;STX5;STXBP1;MCFD2;SEC24C;LEMD2;USO1;TBC1D20;SPIRE1;LMAN1;TGFA;NDE1;SNAP29;CBL;TRAPPC1;CSNK1D;ARHGEF2;LLGL1;CD59;PPP6R1;RAB6A;FHOD1
16858,GO:0098742,0.241238972289983,0.841007246059694,14,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ADGRL1;SDK2;PCDH1;TGFBR2;RET;PKD1;CADM4;FAT1;CLSTN1;AMIGO2;TENM2;ARVCF;CEACAM1;CLDN12
11104,GO:0045091,0.241246171635029,0.940668908755472,2,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
3503,GO:0007411,0.241688468269765,0.825349162663116,22,173,axon guidance,BP,SH3KBP1;DVL1;SHC1;FAM129B;SEMA3F;VLDLR;SHANK3;LAMB2;PLCG1;SEMA4B;TUBB3;RET;GRB10;GATA3;SRC;FYN;SEMA4G;ROBO3;VASP;SLIT3;EPHB2;MAPK3
17012,GO:0099072,0.242168886007296,0.915951143046428,3,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DLG4;DNM2;ARHGAP44
15890,GO:0072593,0.242326248374996,0.827567214371721,20,166,reactive oxygen species metabolic process,BP,XDH;NOS1;RAC2;BNIP3;SESN2;BCR;EGFR;AKT1;ARG2;SH3PXD2B;TGFBR2;PRDX5;ASS1;DNM2;GPX3;STK17A;P2RX4;TGFB1;SH3PXD2A;CAT
4131,GO:0009189,0.242385335392625,0.97796731489952,1,3,deoxyribonucleoside diphosphate biosynthetic process,BP,GUK1
6064,GO:0019209,0.242590322676145,0.863129081369452,8,57,kinase activator activity,MF,MAP2K1;ERCC6;MAP2K2;DGKQ;TAOK1;ITSN1;TGFB1;ERBB3
12759,GO:0051005,0.242837108031302,0.977879688921158,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
12235,GO:0048469,0.242917437595308,0.845516859336658,12,91,cell maturation,BP,XBP1;PRKACA;FAM210B;FAM20C;POU2F2;RET;GATA3;ANKS1A;AGRN;GAL;FGFR1;L3MBTL3
17866,GO:1902018,0.242934322338242,0.939977130527272,2,9,negative regulation of cilium assembly,BP,EVI5L;DNM2
5659,GO:0016755,0.243034497045562,0.939935967980941,2,9,transferase activity, transferring amino-acyl groups,MF,TGM2;GGT1
10569,GO:0043516,0.243194701420043,0.898155271720709,4,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,CD44;ZNF385A;MIF;SPRED2
7294,GO:0031281,0.243227783795496,0.939856509369155,2,9,positive regulation of cyclase activity,BP,NOS1;MAPK3
13762,GO:0060314,0.243290371429071,0.914805430898996,3,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,NOS1;FKBP1A;PRKACA
13746,GO:0060294,0.243379258477535,0.939794206562386,2,9,cilium movement involved in cell motility,BP,BBS2;GAS8
4141,GO:0009201,0.24380711026408,0.838765043040796,14,111,ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;UCKL1;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
7216,GO:0031103,0.243870385906114,0.885754142155644,5,32,axon regeneration,BP,MAP2K1;PTPRS;PTPRF;LAMB2;STK24
17942,GO:1902230,0.244209261296322,0.897247436648659,4,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,CD44;ZNF385A;MIF;BCL2L1
11704,GO:0046474,0.244236535068498,0.82050525736803,24,194,glycerophospholipid biosynthetic process,BP,LPCAT4;PITPNM1;DGKA;SBF1;AGPAT3;LPCAT1;CDS2;DGKQ;PI4K2A;PTDSS2;PIGQ;PIP5K1C;TAZ;FGFR1;MTMR4;PITPNM2;SLC27A1;AGPAT4;ZP3;FGF2;OCRL;LPIN3;PIK3R2;STARD10
6852,GO:0030315,0.244298887028794,0.885730414135922,5,31,T-tubule,CC,NOS1;DYSF;RTN2;BIN1;SLC30A1
11637,GO:0046325,0.244432719807472,0.939360111859873,2,9,negative regulation of glucose import,BP,GRB10;GSK3A
8546,GO:0033865,0.244480434188277,0.885133960881718,5,33,nucleoside bisphosphate metabolic process,BP,ACOT7;PPCS;PANK4;ABHD14B;PODXL2
8552,GO:0033875,0.244480434188277,0.885133960881718,5,33,ribonucleoside bisphosphate metabolic process,BP,ACOT7;PPCS;PANK4;ABHD14B;PODXL2
8573,GO:0034032,0.244480434188277,0.885133960881718,5,33,purine nucleoside bisphosphate metabolic process,BP,ACOT7;PPCS;PANK4;ABHD14B;PODXL2
5705,GO:0016830,0.244572766191942,0.875601755253802,6,41,carbon-carbon lyase activity,MF,PCK2;HMGCL;GLUL;MLYCD;ALDOC;AZIN2
8582,GO:0034045,0.244581517194895,0.914693157618295,3,16,phagophore assembly site membrane,CC,RAB1B;ULK1;ULK2
19175,GO:1905146,0.244731219045952,0.939236857246953,2,9,lysosomal protein catabolic process,BP,ATP13A2;LRP1
9399,GO:0035928,0.244738777032703,0.977508678259993,1,3,rRNA import into mitochondrion,BP,TST
16289,GO:0090331,0.244753390620708,0.939227697819892,2,9,negative regulation of platelet aggregation,BP,SERPINE2;CEACAM1
13732,GO:0060271,0.245257493367474,0.809970594820233,34,285,cilium assembly,BP,NEURL1;LAMA5;BBS2;NUDCD3;MARK4;EVI5L;CSNK1E;RFX2;SEPT10;PRKACA;EHD3;WWTR1;DNAAF5;PTPDC1;SEPT5;TTBK2;SEPT8;DYNLRB1;DNM2;NINL;SDCCAG8;FUZ;KIF17;TUBG1;UNC119B;ATXN10;NDE1;SNAP29;GAS8;WRAP73;CSNK1D;OCRL;CCDC113;ASAP1
6086,GO:0019239,0.245477776369809,0.896803786135868,4,25,deaminase activity,MF,ADARB1;RPUSD3;AMPD2;APOBEC3C
4164,GO:0009225,0.245515886604789,0.884473629184108,5,33,nucleotide-sugar metabolic process,BP,UAP1;TSTA3;GSK3A;MPI;GUK1
2276,GO:0005217,0.245579126512119,0.914170898191475,3,16,intracellular ligand-gated ion channel activity,MF,ITPR3;TPCN1;RASA3
5066,GO:0015278,0.245579126512119,0.914170898191475,3,16,calcium-release channel activity,MF,ITPR3;TPCN1;RASA3
17211,GO:0106003,0.245765355348257,0.93880898181623,2,9,amyloid-beta complex,CC,PRNP;APOE
2947,GO:0006476,0.24600581062704,0.843194444584008,12,90,protein deacetylation,BP,MTA1;NACC2;MIER2;PHF21A;BAZ2A;SIN3B;CTBP1;RCOR1;MBD3;TGFB1;SPRED2;EP300
2151,GO:0004966,0.246076843807232,0.977245525963057,1,3,galanin receptor activity,MF,GAL
10421,GO:0043249,0.246433690163931,0.938531742435017,2,9,erythrocyte maturation,BP,FAM210B;L3MBTL3
20270,GO:2001181,0.246500727070204,0.977161800114666,1,3,positive regulation of interleukin-10 secretion,BP,PRKCZ
1410,GO:0003341,0.24655535435762,0.896163798781183,4,25,cilium movement,BP,BBS2;DNAAF5;WDR66;GAS8
5013,GO:0015171,0.246623233551117,0.866704200694063,7,48,amino acid transmembrane transporter activity,MF,SERINC2;SLC38A10;SLC6A6;SLC43A1;TMEM44;SLC6A9;SLC6A14
9791,GO:0039694,0.24691461352446,0.896290727990024,4,24,viral RNA genome replication,BP,ATG16L2;RAB29;HMGA2;APOBEC3C
6788,GO:0030219,0.247042619105472,0.853541047137538,9,79,megakaryocyte differentiation,BP,WASF2;ZNF385A;AGO4;TNRC6B;ZFPM1;MYL9;CIB1;ASH2L;EP300
15145,GO:0071219,0.247224969920661,0.836065734697554,14,111,cellular response to molecule of bacterial origin,BP,TNIP1;NR1D1;BCR;XBP1;AKT1;IRAK1;HSF1;SRC;VDR;MIF;ARG1;MAPK3;LITAF;TGFB1
4257,GO:0009582,0.248219386774021,0.865589846047173,7,48,detection of abiotic stimulus,BP,SERPINE2;PITPNM1;GNB1;PKD1;REEP6;FYN;NTSR1
5520,GO:0016480,0.248413002096609,0.976781913184558,1,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5
1448,GO:0003674,0.2487603592259,0.789471867793382,1176,11319,molecular_function,MF,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;GID4;CAPN2;F2R;MPRIP;THSD4;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;UHRF1BP1;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DAP;CMTM4;DYSF;XPOT;IGFBP4;SLC16A3;MMP1;MXRA5;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;HYI;NAGS;PRNP;IDH2;LRRC20;BNIP3;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;COPG1;TMOD2;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;SEMA3F;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;ZCCHC14;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;LRP10;CSNK1E;TTYH3;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;JOSD2;FAM189B;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;UBTD1;PPP1R13L;LMBR1L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;EHD3;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;LENG9;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;ABHD8;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;TMCO3;RABAC1;MSN;PPP1R35;MAP1B;TGFBR2;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;FAM3A;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;TMEM125;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;RRNAD1;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TMEM245;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;SLC29A4;ISYNA1;LARP1B;ERO1B;MMP10;BCL9L;AHCY;ADM5;SCMH1;ACSF2;ZNF385A;NLGN2;GRAMD1A;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;FAM167A;DMXL2;TBC1D9B;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;CORO7;LAMC2;FBXL6;GAS2L1;MLXIP;RHOC;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;ACBD4;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;MYH16;GGACT;ASIC1;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;TFPI2;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;DNAJC4;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;ZCCHC24;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;NSUN7;ERICH2;SDCCAG8;GPX3;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;TMPRSS11D;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;CGREF1;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;C11ORF95;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;DHRS4L2;AMIGO2;TIMP1;SIMC1;CRIM1;SLC46A3;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LAMB3;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SECISBP2L;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TMEM128;JMJD7;MIB2;CEP170;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;ZDBF2;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;NT5DC2;VPS9D1;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TPD52L2;TCIRG1;PITPNM2;SNX25;PTPN12;GRAMD1C;SLC27A1;CPNE8;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;GPATCH8;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;TMEM139;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;TMEM54;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;ARG1;PBXIP1;SLC10A6;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;NDRG3;HIST1H2AG;NYNRIN;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;MANF;SLC15A1;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ASPHD1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;ORAI3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;KIAA0930;FHOD1;TRAF7;RNF10
15874,GO:0072574,0.248983880694694,0.937468711475507,2,9,hepatocyte proliferation,BP,XBP1;CEACAM1
15875,GO:0072575,0.248983880694694,0.937468711475507,2,9,epithelial cell proliferation involved in liver morphogenesis,BP,XBP1;CEACAM1
18587,GO:1903779,0.248984549080077,0.872811380685614,6,40,regulation of cardiac conduction,BP,NOS1;PRKACA;EHD3;ITPR3;ASPH;STIM1
266,GO:0000733,0.249272729392387,0.937347791232527,2,9,DNA strand renaturation,BP,SMARCA1;ANXA1
17956,GO:1902259,0.249372587536581,0.937305963382396,2,9,regulation of delayed rectifier potassium channel activity,BP,KCNG1;VAMP2
9221,GO:0035601,0.24967303535313,0.837142354515457,13,99,protein deacylation,BP,MTA1;NACC2;MIER2;PHF21A;BAZ2A;SIN3B;CTBP1;ABHD17C;RCOR1;MBD3;TGFB1;SPRED2;EP300
12944,GO:0051280,0.24989211145384,0.935974494305674,2,10,negative regulation of release of sequestered calcium ion into cytosol,BP,NTSR1;TGFB1
12948,GO:0051284,0.24989211145384,0.935974494305674,2,10,positive regulation of sequestering of calcium ion,BP,NTSR1;TGFB1
14336,GO:0061462,0.249907595292851,0.881897821377236,5,32,protein localization to lysosome,BP,SORL1;AP3D1;VPS4A;HGS;C12ORF66
10632,GO:0043619,0.250041826282614,0.937025313917172,2,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2;ATF4
2518,GO:0005770,0.250052327092867,0.816813865154673,23,190,late endosome,CC,F2R;MAP2K1;CST3;DYSF;EGFR;FYCO1;MAP2K2;ANKRD13D;ATP13A2;ATP7B;VPS11;VPS4A;PCSK9;MVB12B;YIPF2;DDIT3;ARL8A;SRC;TMEM9;VPS37A;HGS;MAPK3;LITAF
19741,GO:2000050,0.250089252984141,0.911794555560054,3,16,regulation of non-canonical Wnt signaling pathway,BP,CSNK1E;DKK1;CSNK1D
18257,GO:1903035,0.250137175520147,0.857709677898202,8,57,negative regulation of response to wounding,BP,PLAT;SERPINE2;PTPRS;SERPING1;APOE;F12;FGF2;CEACAM1
16647,GO:0097485,0.250225619056965,0.818211234005099,22,174,neuron projection guidance,BP,SH3KBP1;DVL1;SHC1;FAM129B;SEMA3F;VLDLR;SHANK3;LAMB2;PLCG1;SEMA4B;TUBB3;RET;GRB10;GATA3;SRC;FYN;SEMA4G;ROBO3;VASP;SLIT3;EPHB2;MAPK3
12633,GO:0050795,0.250382851976624,0.893879699216903,4,25,regulation of behavior,BP,DLG4;APOE;RAG1;PER3
10680,GO:0043901,0.250449813865775,0.830877877011769,15,121,negative regulation of multi-organism process,BP,TNIP1;IFITM1;ARG2;FAM3A;HTRA1;PARP10;OASL;MAPKBP1;HMGA2;OAS1;ISG20;TIMP1;ZP3;SEC14L1;APOBEC3C
6067,GO:0019212,0.250658697401276,0.89371442916426,4,25,phosphatase inhibitor activity,MF,PPP1R35;PPP1R14A;PPP1R37;PPP1R10
10165,GO:0042734,0.250704372101687,0.871838792069099,6,39,presynaptic membrane,CC,ADGRL1;SNPH;PI4K2A;NLGN2;STXBP1;APBB1
1209,GO:0002866,0.250904468886589,0.976281614990349,1,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
8728,GO:0034367,0.250932409817678,0.935530380723892,2,10,protein-containing complex remodeling,BP,APOE;PLTP
11501,GO:0045947,0.250983375837141,0.910735742107641,3,17,negative regulation of translational initiation,BP,ATF4;EIF4EBP1;PAIP2
11444,GO:0045843,0.251168946168146,0.881087083702703,5,32,negative regulation of striated muscle tissue development,BP,TGFBR2;DKK1;PAK1;GSK3A;TGFB1
17815,GO:1901862,0.251168946168146,0.881087083702703,5,32,negative regulation of muscle tissue development,BP,TGFBR2;DKK1;PAK1;GSK3A;TGFB1
7061,GO:0030834,0.25129516056596,0.881005863304019,5,32,regulation of actin filament depolymerization,BP,TMOD2;TWF2;CAPG;SH3BP1;PLEKHH2
3141,GO:0006735,0.251522242895468,0.910447949656002,3,17,NADH regeneration,BP,HK1;PFKP;ALDOC
14394,GO:0061621,0.251522242895468,0.910447949656002,3,17,canonical glycolysis,BP,HK1;PFKP;ALDOC
14435,GO:0061718,0.251522242895468,0.910447949656002,3,17,glucose catabolic process to pyruvate,BP,HK1;PFKP;ALDOC
6693,GO:0030060,0.251554916987015,0.976150002326808,1,3,L-malate dehydrogenase activity,MF,MDH2
8567,GO:0033993,0.251565807200507,0.789398970896915,67,592,response to lipid,BP,TNIP1;NOS1;CCND1;F2R;NFATC4;SDC1;WNT7A;CST3;CYP27B1;PCK2;NR1D1;DNMT3A;POSTN;MAPKAPK3;BCR;XBP1;EGFR;AKT1;IRAK1;FAM210B;PTK6;ENDOG;MSN;TGFBR2;DKK1;PPARA;TWF2;HMGCL;PAK1;GNB1;RET;HSF1;PTPRU;IGFBP2;EIF4EBP1;TNFRSF6B;ALDH1A2;SRC;PAQR7;STXBP1;PMVK;WNT5B;TNFRSF1A;ANXA3;VDR;COMT;THRA;NTSR1;LOXL1;MIF;SOCS2;PMEPA1;SLIT3;RXRA;ARG1;CBL;MAPK3;KANK2;LITAF;MBD3;ADCY6;CCNE1;TGFB1;WBP2;CAT;ANXA1;EP300
5357,GO:0016125,0.251718616385231,0.832547028188997,14,110,sterol metabolic process,BP,SORL1;LMF1;VLDLR;LRP5;APOE;DGKQ;PCSK9;OSBPL5;LDLRAP1;ACADVL;PMVK;RXRA;SEC14L2;CAT
10658,GO:0043679,0.25195831680233,0.850869425410123,9,66,axon terminus,CC,AP3D1;FKBP1A;SEPT5;GLUL;STXBP1;MICAL1;NTSR1;P2RX4;KCNC4
7221,GO:0031110,0.252063907423176,0.8563174956799,8,57,regulation of microtubule polymerization or depolymerization,BP,EML2;MAP1B;PAK1;TTBK2;ARL2;CAMSAP3;CIB1;ARHGEF2
14206,GO:0061085,0.25207024290252,0.936171243450247,2,9,regulation of histone H3-K27 methylation,BP,GATA3;PHF1
3072,GO:0006639,0.252261351322557,0.850645032738773,9,66,acylglycerol metabolic process,BP,LMF1;PCK2;DGKA;APOE;DGKQ;PCSK9;MGLL;LPIN3;CAT
16179,GO:0090181,0.252552247589578,0.86241103697574,7,49,regulation of cholesterol metabolic process,BP,LMF1;APOE;DGKQ;LDLRAP1;ACADVL;PMVK;SEC14L2
359,GO:0000977,0.252693807748927,0.793917230403055,51,435,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZMYND8;NFATC4;ETV4;MEF2D;NR1D1;TEF;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;PPARA;TFE3;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;IRF7;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;CHD7;RXRA;ZHX3;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300
4435,GO:0010269,0.252724728040246,0.975912256736371,1,3,response to selenium ion,BP,ARG1
10088,GO:0042578,0.252774347571441,0.80504457865546,32,267,phosphoric ester hydrolase activity,MF,NT5E;MAP2K1;DLG1;PTPRS;SBF1;SSH1;PLCH2;PTPRF;PPP2R3B;PTPDC1;PLD3;PLCXD1;PLCG1;DUSP4;GNB1;PTPN9;PPM1M;PTPRU;PLCB3;EDNRA;DUSP6;PPM1F;SSU72;LHPP;MTMR4;NT5DC2;PTPN12;PLCD3;ACP7;SMPD3;OCRL;LPIN3
13827,GO:0060396,0.252890341760362,0.910306134992686,3,16,growth hormone receptor signaling pathway,BP,SOCS2;MAPK3;PXN
11356,GO:0045665,0.253147440578772,0.822321738671084,18,143,negative regulation of neuron differentiation,BP,NFATC4;PTPRS;SEMA3F;MAP4K4;APOE;CTSZ;GDI1;SEMA4B;PTPN9;RAB29;SEMA4G;LRP1;ULK2;EPHB2;CIB1;ADCY6;RAP1GAP2;ASAP1
12905,GO:0051224,0.253237794162095,0.83414093991475,13,103,negative regulation of protein transport,BP,F2R;IDH2;MAP4K4;RHBDF2;ARG2;TMSB4X;GDI1;HADH;UBE2J1;PARP10;MAPKBP1;CPTP;ANXA1
19515,GO:1990253,0.253680322671938,0.93548962950245,2,9,cellular response to leucine starvation,BP,SESN2;IMPACT
9328,GO:0035791,0.253715043157547,0.935474894935591,2,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
1798,GO:0004427,0.253787834261869,0.975695031097036,1,3,inorganic diphosphatase activity,MF,LHPP
2047,GO:0004792,0.254121521563215,0.975626619098317,1,3,thiosulfate sulfurtransferase activity,MF,TST
2282,GO:0005230,0.254217528396761,0.935261481988389,2,9,extracellular ligand-gated ion channel activity,MF,GRIN3B;P2RX4
19873,GO:2000310,0.254484314030577,0.935148044988919,2,9,regulation of NMDA receptor activity,BP,DLG4;EPHB2
12358,GO:0048704,0.254507424592029,0.854546899310935,8,57,embryonic skeletal system morphogenesis,BP,MDFI;DLG1;MMP14;TGFBR2;TULP3;FUZ;HYAL1;GNAS
14852,GO:0070577,0.254519144309656,0.909436216062468,3,16,lysine-acetylated histone binding,MF,ZMYND8;BRD3;BAZ2A
17305,GO:0140033,0.254519144309656,0.909436216062468,3,16,acetylation-dependent protein binding,MF,ZMYND8;BRD3;BAZ2A
13519,GO:0055064,0.254661320229966,0.935072732672752,2,9,chloride ion homeostasis,BP,SLC12A7;SLC12A4
10384,GO:0043195,0.254732123215756,0.868738256994267,6,41,terminal bouton,CC,AP3D1;SEPT5;STXBP1;MICAL1;NTSR1;P2RX4
5718,GO:0016849,0.254841451876803,0.934996050048795,2,9,phosphorus-oxygen lyase activity,MF,ADCY7;ADCY6
12722,GO:0050921,0.254913457631133,0.843756981718222,10,77,positive regulation of chemotaxis,BP,PGF;RAC2;TMSB4X;PPM1F;FGFR1;P2RX4;FGF2;VEGFB;MAPK3;TGFB1
16173,GO:0090174,0.254921052598755,0.82504747864929,16,126,organelle membrane fusion,BP,DYSF;EVI5L;VPS11;VPS4A;TBC1D16;TBC1D14;TBC1D9B;SYTL1;VAMP2;STX5;STXBP1;STX10;USO1;TBC1D2B;SNAP29;ANXA1
2820,GO:0006285,0.255238415520021,0.933677480941344,2,10,base-excision repair, AP site formation,BP,NEIL1;MPG
13504,GO:0055021,0.255258412576802,0.878446625951238,5,32,regulation of cardiac muscle tissue growth,BP,TGFBR2;PAK1;GSK3A;FGFR1;FGF2
7062,GO:0030835,0.255312765538054,0.89126682387761,4,24,negative regulation of actin filament depolymerization,BP,TMOD2;TWF2;CAPG;PLEKHH2
9835,GO:0042043,0.255500067216735,0.93471532759477,2,9,neurexin family protein binding,MF,NLGN2;SYTL1
7253,GO:0031204,0.25565565920298,0.975310680562701,1,3,posttranslational protein targeting to membrane, translocation,BP,SEC63
17860,GO:1901998,0.255689260885582,0.877923447899142,5,33,toxin transport,BP,BNIP3;RAB43;GGA1;RAB29;ANTXR2
19691,GO:1990910,0.255748868513308,0.975291410299736,1,3,response to hypobaric hypoxia,BP,HSF1
19897,GO:2000341,0.255834569033988,0.933419095382155,2,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
11049,GO:0045007,0.255880119584307,0.975264260661704,1,3,depurination,BP,MPG
1295,GO:0003105,0.256117804482872,0.975215051572928,1,3,negative regulation of glomerular filtration,BP,F2R
15143,GO:0071216,0.256200955566975,0.82390050732806,16,129,cellular response to biotic stimulus,BP,TNIP1;NR1D1;BCR;XBP1;AKT1;IRAK1;DDIT3;HSF1;WFS1;SRC;VDR;MIF;ARG1;MAPK3;LITAF;TGFB1
14889,GO:0070661,0.256265416513413,0.8177240401318,19,158,leukocyte proliferation,BP,RAC2;DLG1;FKBP1A;PRNP;CARD11;ARG2;PKN1;MSN;TGFBR2;SATB1;IGFBP2;FYN;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
9523,GO:0036194,0.25642023131589,0.975152357900786,1,3,muscle cell projection,CC,ARPC1A
9524,GO:0036195,0.25642023131589,0.975152357900786,1,3,muscle cell projection membrane,CC,ARPC1A
12723,GO:0050922,0.256505844319452,0.877392792681653,5,33,negative regulation of chemotaxis,BP,SEMA3F;CORO1B;SEMA4B;SEMA4G;MIF
17952,GO:1902254,0.256585215792709,0.907197942250635,3,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,CD44;ZNF385A;MIF
2107,GO:0004879,0.256892943224349,0.877386158432674,5,32,nuclear receptor activity,MF,NR1D1;PPARA;VDR;THRA;RXRA
16771,GO:0098531,0.256892943224349,0.877386158432674,5,32,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1;PPARA;VDR;THRA;RXRA
20174,GO:2000833,0.256964354520228,0.975039332272184,1,3,positive regulation of steroid hormone secretion,BP,GAL
6724,GO:0030132,0.256995245693133,0.90750480152851,3,17,clathrin coat of coated pit,CC,EGFR;AP2A2;LDLRAP1
15636,GO:0072106,0.257011822767075,0.975029458240086,1,3,regulation of ureteric bud formation,BP,GATA3
15637,GO:0072107,0.257011822767075,0.975029458240086,1,3,positive regulation of ureteric bud formation,BP,GATA3
19223,GO:1905278,0.257011822767075,0.975029458240086,1,3,positive regulation of epithelial tube formation,BP,GATA3
1361,GO:0003229,0.257294850512439,0.877124959875921,5,32,ventricular cardiac muscle tissue development,BP,FKBP1A;PPP1R13L;CHD7;RXRA;TGFB1
726,GO:0001952,0.257428308953337,0.837957791582144,11,82,regulation of cell-matrix adhesion,BP,POSTN;MMP14;PRKCZ;EPHA1;FERMT1;SRC;PPM1F;CAMSAP3;CIB1;ADAM15;MINK1
3314,GO:0007019,0.257628544678557,0.876907959467596,5,32,microtubule depolymerization,BP,MAP1B;TTBK2;CAMSAP3;CIB1;ARHGEF2
7818,GO:0032366,0.257661435932862,0.907144045562706,3,17,intracellular sterol transport,BP,VPS4A;PCSK9;LDLRAP1
7819,GO:0032367,0.257661435932862,0.907144045562706,3,17,intracellular cholesterol transport,BP,VPS4A;PCSK9;LDLRAP1
8467,GO:0033598,0.25767144086234,0.889483242272405,4,25,mammary gland epithelial cell proliferation,BP,CCND1;DEAF1;GATA3;RREB1
5780,GO:0016999,0.257683804923398,0.833783713531308,12,96,antibiotic metabolic process,BP,RAC2;PCK2;IDH2;EGFR;MDH2;DHTKD1;PRDX5;SDHA;AKR7A2;CBR4;GPX3;CAT
3511,GO:0007423,0.257706714459573,0.796964718893068,37,311,sensory organ development,BP,DVL1;WNT7A;CST3;SDK2;DLG1;BCR;LPCAT1;LRP5;ACVR2B;EGFR;LRP10;TUB;PPP1R13L;NAGLU;SH3PXD2B;SALL2;TGFBR2;LAMB2;GNB1;RET;GATA3;MYH15;TULP3;ALDH1A2;WNT5B;RCN1;HSF4;FGFR1;RAB11FIP4;TBC1D20;SDHAF4;CHD7;RXRA;TSHZ1;EPHB2;MAPK3;TGFB1
12708,GO:0050906,0.257757285387803,0.889103143217594,4,26,detection of stimulus involved in sensory perception,BP,SERPINE2;REEP6;FYN;NTSR1
13208,GO:0051795,0.257798946701908,0.974865400542529,1,3,positive regulation of timing of catagen,BP,GAL
15681,GO:0072182,0.257839143074694,0.933713924724814,2,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1;GATA3
11633,GO:0046321,0.257867511483512,0.933701737364483,2,9,positive regulation of fatty acid oxidation,BP,PPARA;MLYCD
6274,GO:0019865,0.257878156295202,0.974848857137631,1,3,immunoglobulin binding,MF,FCGRT
4368,GO:0009975,0.257918460735339,0.933679846495656,2,9,cyclase activity,MF,ADCY7;ADCY6
1113,GO:0002699,0.257947388231096,0.830422805490616,13,103,positive regulation of immune effector process,BP,RAC2;XBP1;HK1;PRKCZ;GATA3;STXBP1;PUM1;MIF;ZP3;ARG1;MAPK3;TGFB1;ANXA1
1282,GO:0003073,0.258038340140412,0.866481654618449,6,41,regulation of systemic arterial blood pressure,BP,F2R;POSTN;CTSZ;PLCB3;GSK3A;NTSR1
4597,GO:0010710,0.258152135203954,0.97479158699272,1,3,regulation of collagen catabolic process,BP,CST3
6771,GO:0030201,0.258156198154434,0.889547356189685,4,24,heparan sulfate proteoglycan metabolic process,BP,XYLT1;XYLT2;NDST2;HPSE
13689,GO:0060192,0.258508451399001,0.932254618519618,2,10,negative regulation of lipase activity,BP,ANGPTL4;ANXA1
9258,GO:0035651,0.258693678869015,0.974678168340015,1,3,AP-3 adaptor complex binding,MF,PI4K2A
3363,GO:0007113,0.258714395168084,0.974673823822475,1,3,endomitotic cell cycle,BP,CIB1
4022,GO:0009051,0.258741050635149,0.974668233145568,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
15584,GO:0072015,0.258760271555017,0.933317680298088,2,9,glomerular visceral epithelial cell development,BP,LAMB2;PODXL
15754,GO:0072310,0.258760271555017,0.933317680298088,2,9,glomerular epithelial cell development,BP,LAMB2;PODXL
19424,GO:1905897,0.258815715920752,0.845679554123595,9,67,regulation of response to endoplasmic reticulum stress,BP,EDEM1;BOK;XBP1;SYVN1;UBE2J1;DDIT3;WFS1;GRINA;DNAJB9
17899,GO:1902109,0.258905465293282,0.974633733464927,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3
6582,GO:0022406,0.25921456549253,0.813644515257625,20,163,membrane docking,BP,RAB3B;SNPH;MARK4;CSNK1E;PRKACA;VPS11;MSN;ESYT2;TTBK2;NINL;STX5;SDCCAG8;EXOC2;STXBP1;STX10;TUBG1;USO1;NDE1;SNAP29;CSNK1D
798,GO:0002064,0.259222069725287,0.817325305823988,18,143,epithelial cell development,BP,SDC1;WNT7A;CST3;RAPGEF3;PTPRS;XBP1;ACTA2;MSN;LAMB2;PODXL;FLNB;GSK3A;SPINT2;RAB25;WNT5B;TNFRSF1A;FGFR1;TBC1D20
17026,GO:0099094,0.259299349694014,0.87581962060452,5,32,ligand-gated cation channel activity,MF,ITPR3;ASIC1;TPCN1;P2RX4;RASA3
9362,GO:0035865,0.260015135069168,0.974400185020477,1,3,cellular response to potassium ion,BP,HSF1
12326,GO:0048661,0.260141561166883,0.850329322616264,8,58,positive regulation of smooth muscle cell proliferation,BP,MEF2D;EGFR;AKT1;IRAK1;TGFBR2;PAK1;TGM2;FGF2
16543,GO:0097237,0.260143140642814,0.814404613986747,19,162,cellular response to toxic substance,BP,CST3;DNMT3A;NET1;BNIP3;CYGB;SESN2;ADCY7;STK25;APOE;MAPK13;ENDOG;PRDX5;HSF1;DNM2;GPX3;ARG1;IMPACT;CAT;ANXA1
15926,GO:0072679,0.260224426913212,0.974355998748367,1,3,thymocyte migration,BP,ADAM8
13731,GO:0060268,0.260444014038723,0.974309592014819,1,3,negative regulation of respiratory burst,BP,BCR
18117,GO:1902722,0.260448688279894,0.974308603655809,1,3,positive regulation of prolactin secretion,BP,EGFR
9517,GO:0036157,0.26044973326586,0.974308382692668,1,3,outer dynein arm,CC,DYNLRB1
16853,GO:0098732,0.260469482853291,0.828577324700526,13,100,macromolecule deacylation,BP,MTA1;NACC2;MIER2;PHF21A;BAZ2A;SIN3B;CTBP1;ABHD17C;RCOR1;MBD3;TGFB1;SPRED2;EP300
11730,GO:0046513,0.260630834837208,0.864704337856468,6,41,ceramide biosynthetic process,BP,SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;UGCG;B4GALT6
10619,GO:0043588,0.260659692712212,0.801855389424307,28,238,skin development,BP,ITGB4;MAP2K1;CYP27B1;SHARPIN;ITGA6;LAMA5;EGFR;FERMT1;DKK1;PRSS8;SUFU;PKD1;ALOX15B;CNFN;FLNB;PCSK6;FUZ;VDR;GAL;CTSL;TNFRSF19;HPSE;PRR9;KRT23;FURIN;ANXA1;GNAS;ITGA3
14752,GO:0070405,0.260798107853573,0.887246008078697,4,26,ammonium ion binding,MF,PITPNM1;HTR7;ESYT2;PLTP
10475,GO:0043325,0.260935355811566,0.90536324878628,3,17,phosphatidylinositol-3,4-bisphosphate binding,MF,PLEK2;AKT1;ARAP3
16506,GO:0097177,0.260969658098823,0.974198309172643,1,3,mitochondrial ribosome binding,MF,OXA1L
9404,GO:0035933,0.26099340956609,0.974193274302309,1,3,glucocorticoid secretion,BP,GAL
20182,GO:2000849,0.26099340956609,0.974193274302309,1,3,regulation of glucocorticoid secretion,BP,GAL
7597,GO:0031960,0.261178202980407,0.827862202316763,13,103,response to corticosteroid,BP,CCND1;SDC1;PCK2;EGFR;PTPRU;IGFBP2;EIF4EBP1;SRC;ANXA3;SLIT3;ARG1;TGFB1;ANXA1
15426,GO:0071672,0.261185397210695,0.974152555829654,1,3,negative regulation of smooth muscle cell chemotaxis,BP,CORO1B
17134,GO:0101006,0.261205139187253,0.974148366688405,1,3,protein histidine phosphatase activity,MF,LHPP
8895,GO:0034704,0.261259206056585,0.88729658369427,4,25,calcium channel complex,CC,NOS1;FKBP1A;PRKACA;HSPA2
12721,GO:0050920,0.261432498406181,0.822036431882053,15,121,regulation of chemotaxis,BP,PGF;RAC2;SEMA3F;CORO1B;TMSB4X;SEMA4B;PPM1F;SEMA4G;FGFR1;MIF;P2RX4;FGF2;VEGFB;MAPK3;TGFB1
16649,GO:0097487,0.261438739023175,0.974098768535341,1,3,multivesicular body, internal vesicle,CC,EGFR
11608,GO:0046173,0.261504063741206,0.863927647099212,6,42,polyol biosynthetic process,BP,CYP27B1;PCK2;ISYNA1;SPTLC2;NTSR1;FGF2
6255,GO:0019829,0.261786770849406,0.873709388772685,5,34,cation-transporting ATPase activity,MF,ATP13A2;ATP7B;ATP2C2;TCIRG1;ATP6V1C2
17398,GO:1900101,0.261879549063641,0.886916995381838,4,25,regulation of endoplasmic reticulum unfolded protein response,BP,BOK;XBP1;WFS1;DNAJB9
11321,GO:0045624,0.261924003343592,0.930753912310187,2,10,positive regulation of T-helper cell differentiation,BP,PRKCZ;ANXA1
16480,GO:0097129,0.2622116899169,0.973934266450305,1,3,cyclin D2-CDK4 complex,CC,CCND2
19724,GO:2000015,0.262239524426914,0.973928331480035,1,3,regulation of determination of dorsal identity,BP,DDIT3
10775,GO:0044211,0.262436865481171,0.973886231530879,1,3,CTP salvage,BP,UCKL1
6061,GO:0019206,0.262488697688367,0.930504369322374,2,10,nucleoside kinase activity,MF,TK2;UCKL1
14268,GO:0061298,0.262584959415578,0.931660961380672,2,9,retina vasculature development in camera-type eye,BP,LRP5;ACVR2B
6097,GO:0019287,0.262829314367943,0.973802392332543,1,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,PMVK
3163,GO:0006776,0.262863471558009,0.973795088013919,1,3,vitamin A metabolic process,BP,ALDH1A2
6217,GO:0019740,0.26290498544052,0.973786208937288,1,3,nitrogen utilization,BP,GLUL
9384,GO:0035902,0.262919576460981,0.904277576681665,3,17,response to immobilization stress,BP,ERCC1;GAL;TGFB1
4709,GO:0010869,0.262933856335989,0.904269745944343,3,17,regulation of receptor biosynthetic process,BP,NR1D1;PPARA;FURIN
9005,GO:0035116,0.262953089264417,0.904259198678281,3,17,embryonic hindlimb morphogenesis,BP,WNT7A;CHD7;GNAS
8734,GO:0034374,0.262973796128868,0.973771487763787,1,3,low-density lipoprotein particle remodeling,BP,APOE
7485,GO:0031644,0.26315348535101,0.873045901448951,5,33,regulation of neurological system process,BP,F2R;COMT;NTSR1;MGLL;RNF10
15324,GO:0071498,0.263421546220206,0.904002158870187,3,17,cellular response to fluid shear stress,BP,ASS1;TFPI2;SRC
13842,GO:0060416,0.26351913106459,0.8862789414928,4,24,response to growth hormone,BP,AKT1;SOCS2;MAPK3;PXN
9194,GO:0035567,0.263539482150026,0.817819088260544,16,132,non-canonical Wnt signaling pathway,BP,DVL1;WNT7A;PSMD2;SMURF2;CSNK1E;GPC4;AP2A2;FZD8;DKK1;GNB1;PLCB3;AGO4;PFN1;PSMD7;TNRC6B;CSNK1D
13610,GO:0060057,0.26384329345957,0.973585061387803,1,3,apoptotic process involved in mammary gland involution,BP,VDR
13611,GO:0060058,0.26384329345957,0.973585061387803,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
17989,GO:1902339,0.26384329345957,0.973585061387803,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
18463,GO:1903519,0.26384329345957,0.973585061387803,1,3,regulation of mammary gland involution,BP,VDR
18464,GO:1903521,0.26384329345957,0.973585061387803,1,3,positive regulation of mammary gland involution,BP,VDR
18997,GO:1904747,0.26384329345957,0.973585061387803,1,3,positive regulation of apoptotic process involved in development,BP,VDR
630,GO:0001817,0.263975796850641,0.785543001245068,47,413,regulation of cytokine production,BP,F2R;NFATC4;POSTN;PTPRS;PRNP;XBP1;HK1;ATF4;CARD11;IRAK1;ARG2;TMSB4X;PRKCZ;RNF135;MAPK13;FERMT1;UBE2J1;MC1R;DDIT3;GATA3;HSF1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;SRC;IRF7;CPTP;PUM1;FGFR1;MIF;ZFPM1;ARFGEF2;TRIB2;HPSE;ZP3;ARG1;SEC14L1;MAPK3;LITAF;FURIN;ARHGEF2;CEACAM1;IGF2BP3;TGFB1;ANXA1;EP300
1813,GO:0004459,0.264016102902846,0.973547919583491,1,3,L-lactate dehydrogenase activity,MF,LDHA
9428,GO:0035986,0.264184557271264,0.973511684990827,1,3,senescence-associated heterochromatin focus assembly,BP,HMGA2
2536,GO:0005791,0.264504391392398,0.846707747977242,8,62,rough endoplasmic reticulum,CC,CKAP4;SYNE3;PCSK9;GLUL;NUCB1;UBA1;F12;HM13
10573,GO:0043522,0.264563358900803,0.929584072251768,2,10,leucine zipper domain binding,MF,ATF4;DDIT3
16685,GO:0097546,0.2646176031433,0.885236287438703,4,25,ciliary base,CC,PRKACA;PRKACB;SUFU;TULP3
4535,GO:0010604,0.265219737531916,0.759172391695497,240,2220,positive regulation of macromolecule metabolic process,BP,TNIP1;EDEM1;XDH;ERCC1;NOS1;CCND1;F2R;MST1R;SORL1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;ETV4;ERCC6;CST3;NEURL1;SNX9;BOK;CRTC1;ARAP1;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;FKBP1A;SOX12;MTA1;ITGA6;RAPGEF3;PRNP;CITED4;SMARCA1;SMURF2;FAM129B;MAPKAPK3;SESN2;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;MMP14;RFX2;PRKACA;ACTA2;MAP2K2;STK25;ATF4;HECW2;SNX33;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;PKN1;ELK3;WWTR1;PRKCZ;POU2F2;TFEB;DGKQ;VPS11;FZD8;EPHA1;ZMIZ2;PTK6;SH3PXD2B;PCSK9;ENDOG;DEAF1;SALL2;MSN;TGFBR2;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;PRKACB;SHC2;CD44;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MC1R;ANKIB1;LARP6;TFE3;CCND2;PAK1;BCL9L;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;RET;RAB29;MLXIP;IFI27;HLTF;CEMIP;PKD1;DLG3;GATA3;APLN;PHF1;GNAI2;HSF1;WFS1;ASPH;CTBP1;ADAM8;RAI1;HMGA2;MICAL2;MYDGF;ALDH1A2;SRC;DNM2;FAM162A;IRF7;RFXANK;RAB1B;STK24;PAK6;STX5;RERE;RSF1;GSK3A;CAMTA2;DUSP6;FYN;AGRN;PPM1F;LPAR3;TNFRSF1A;ANXA3;VDR;GJC2;GAL;PUM1;ITGA1;EHF;TNRC6B;THRA;MAP3K10;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;F12;USF2;PBX3;MIF;STUB1;TRIB3;SLC27A1;ZFPM1;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;E2F5;ZP3;LRRK1;FGF2;EHD4;VAPB;MAPK9;PYM1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;APBB1;RXRA;TGFA;SEC14L2;IMPACT;CASP4;CAMK1;EPHB2;HGS;CIB1;MAPK3;POMT1;MAPK10;CSNK1D;DBP;LITAF;FURIN;ARHGEF2;MINK1;LPIN3;ADCY6;CCNE1;TGFB1;WBP2;PIK3R2;CAMK2N1;ERBB3;PPP1R10;ASH2L;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;WDFY2;FHOD1;TRAF7;RNF10
6011,GO:0019050,0.265264546633008,0.973278702350505,1,3,suppression by virus of host apoptotic process,BP,BCL2L1
9772,GO:0039526,0.265264546633008,0.973278702350505,1,3,modulation by virus of host apoptotic process,BP,BCL2L1
8425,GO:0033484,0.265299261022318,0.973271194094458,1,3,nitric oxide homeostasis,BP,ADNP
7874,GO:0032430,0.265793700103556,0.973164122050386,1,3,positive regulation of phospholipase A2 activity,BP,EGFR
9605,GO:0036452,0.265847075143199,0.884138911290102,4,26,ESCRT complex,CC,VPS4A;MVB12B;VPS37A;HGS
2401,GO:0005544,0.265868344543848,0.871256892119571,5,33,calcium-dependent phospholipid binding,MF,DYSF;ESYT2;SYTL1;ANXA3;ANXA1
1703,GO:0004180,0.265884444055841,0.902646364376833,3,17,carboxypeptidase activity,MF,CTSZ;CNDP2;BLMH
8310,GO:0033135,0.265998037863009,0.831115884619208,11,85,regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;AKT1;DKK1;CD44;PAK1;RET;PPM1F;MIF;CAMK1;TGFB1
11778,GO:0046620,0.266325742638225,0.845904687535437,8,57,regulation of organ growth,BP,WWC3;AKT1;TGFBR2;PAK1;GSK3A;DUSP6;FGFR1;FGF2
4754,GO:0010923,0.26634842588804,0.835192297215702,10,75,negative regulation of phosphatase activity,BP,FKBP1A;PPP1R35;PPP1R12C;FARP1;DLG3;PPP1R14A;MYO1D;CAMSAP3;PPP1R37;PPP1R10
12985,GO:0051348,0.266384056109404,0.796898473330453,28,239,negative regulation of transferase activity,BP,SORL1;DVL1;LRP5;ADARB1;AKT1;APOE;PKN1;WWTR1;EPHA1;PTK6;LIMK1;DUSP4;SRC;GSK3A;DUSP6;PPM1F;HEXIM1;SOCS2;TRIB3;TRIB2;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;SPRED2;CAMK2N1
13719,GO:0060251,0.266388101875397,0.902368193416166,3,17,regulation of glial cell proliferation,BP,IDH2;ETV5;RNF10
7831,GO:0032379,0.266499694092693,0.973010810927631,1,3,positive regulation of intracellular lipid transport,BP,LDLRAP1
7834,GO:0032382,0.266499694092693,0.973010810927631,1,3,positive regulation of intracellular sterol transport,BP,LDLRAP1
7837,GO:0032385,0.266499694092693,0.973010810927631,1,3,positive regulation of intracellular cholesterol transport,BP,LDLRAP1
18466,GO:1903523,0.26653400677091,0.902287551986333,3,17,negative regulation of blood circulation,BP,F2R;DOCK4;APLN
4024,GO:0009055,0.266773016591214,0.833993391741235,10,88,electron transfer activity,MF,XDH;TSTA3;ASPH;SDHA;AKR7A2;GLRX;NDUFA4L2;ALDH4A1;AOX1;NDUFS2
3432,GO:0007223,0.266896805003418,0.870832590334709,5,32,Wnt signaling pathway, calcium modulating pathway,BP,DKK1;GNB1;PLCB3;AGO4;TNRC6B
12181,GO:0048284,0.266938662258544,0.810847606455724,18,146,organelle fusion,BP,DYSF;BNIP3;EVI5L;VPS11;VPS4A;TBC1D16;TBC1D14;TBC1D9B;SYTL1;VAMP2;STX5;STXBP1;STX10;USO1;TBC1D2B;VAT1;SNAP29;ANXA1
3071,GO:0006638,0.26698331849385,0.839550227720806,9,67,neutral lipid metabolic process,BP,LMF1;PCK2;DGKA;APOE;DGKQ;PCSK9;MGLL;LPIN3;CAT
4224,GO:0009397,0.266991480074767,0.972903719828295,1,3,folic acid-containing compound catabolic process,BP,ALDH1L2
10077,GO:0042560,0.266991480074767,0.972903719828295,1,3,pteridine-containing compound catabolic process,BP,ALDH1L2
4097,GO:0009150,0.267057741602645,0.787142269423625,39,356,purine ribonucleotide metabolic process,BP,NT5E;NOS1;PTHLH;DLG4;DLG1;PGM1;RAPGEF3;NME4;ACOT7;ADCY7;HK1;CARD11;APOE;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;DLG3;GNAI2;PPCS;PANK4;SDHA;CAP1;TAZ;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
2782,GO:0006213,0.267187771233547,0.869710013648023,5,36,pyrimidine nucleoside metabolic process,BP,NT5E;NME4;TK2;UCKL1;APOBEC3C
9090,GO:0035335,0.26724681720961,0.834502969404657,10,75,peptidyl-tyrosine dephosphorylation,BP,PTPRS;SSH1;PTPRF;PTPDC1;DUSP4;PTPN9;PTPRU;DUSP6;MTMR4;PTPN12
17312,GO:0140056,0.267263074480561,0.808660765795756,19,155,organelle localization by membrane tethering,BP,RAB3B;SNPH;MARK4;CSNK1E;PRKACA;VPS11;ESYT2;TTBK2;NINL;STX5;SDCCAG8;EXOC2;STXBP1;STX10;TUBG1;USO1;NDE1;SNAP29;CSNK1D
14066,GO:0060795,0.267339430469098,0.901841927066406,3,17,cell fate commitment involved in formation of primary germ layer,BP,DKK1;DUSP6;FGFR1
7978,GO:0032585,0.267408388401988,0.9283131289473,2,10,multivesicular body membrane,CC,ATP13A2;HGS
11825,GO:0046695,0.267415816267235,0.972811120619303,1,3,SLIK (SAGA-like) complex,CC,TAF6
2164,GO:0004993,0.267515497423945,0.97278934171947,1,3,G-protein coupled serotonin receptor activity,MF,HTR7
3421,GO:0007210,0.267515497423945,0.97278934171947,1,3,serotonin receptor signaling pathway,BP,HTR7
10372,GO:0043176,0.267515497423945,0.97278934171947,1,3,amine binding,MF,HTR7
12995,GO:0051378,0.267515497423945,0.97278934171947,1,3,serotonin binding,MF,HTR7
16835,GO:0098664,0.267515497423945,0.97278934171947,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR7
17100,GO:0099589,0.267515497423945,0.97278934171947,1,3,serotonin receptor activity,MF,HTR7
12615,GO:0050772,0.267580231608816,0.8391947507856,9,66,positive regulation of axonogenesis,BP,MAP2K1;STK25;MAP1B;GDI1;LIMK1;TWF2;PAK1;LPAR3;ADNP
14505,GO:0061912,0.267619039350367,0.859879229966843,6,41,selective autophagy,BP,SESN2;ATG13;LRSAM1;SPTLC2;WDFY3;MAPK3
9698,GO:0038083,0.267625717189836,0.870350845487958,5,32,peptidyl-tyrosine autophosphorylation,BP,EGFR;PTK6;SRC;FYN;MAPK3
10528,GO:0043433,0.267682531032971,0.817006102045825,15,120,negative regulation of DNA binding transcription factor activity,BP,MDFI;RBCK1;CTNNBIP1;DAP;PRNP;IRAK1;TMSB4X;SUFU;DDIT3;PKD1;PARP10;WFS1;THRA;MAP3K10;CAT
15030,GO:0070943,0.267796015230368,0.972727998793489,1,3,neutrophil mediated killing of symbiont cell,BP,ARG1
4869,GO:0014719,0.267843878710287,0.972717524195269,1,3,skeletal muscle satellite cell activation,BP,WNT7A
3785,GO:0008347,0.26788772412437,0.869921019448425,5,33,glial cell migration,BP,IDH2;MMP14;LAMB1;MBOAT7;SOCS7
4574,GO:0010657,0.268004981082138,0.859611298555787,6,41,muscle cell apoptotic process,BP,BNIP3;BAG3;GNB1;HSF1;RGL2;PPP1R10
9973,GO:0042350,0.268147775499372,0.972650964465858,1,3,GDP-L-fucose biosynthetic process,BP,TSTA3
17337,GO:0140161,0.268212541931531,0.972636767208317,1,3,monocarboxylate:sodium symporter activity,MF,SLC10A6
14465,GO:0061771,0.268218073378437,0.972635554479853,1,3,response to caloric restriction,BP,APOE
10179,GO:0042756,0.268313549650167,0.97261461714641,1,3,drinking behavior,BP,APLN
1559,GO:0003955,0.268345097919922,0.972607696788642,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,CBR4
14658,GO:0070229,0.268541899830909,0.882468543011302,4,26,negative regulation of lymphocyte apoptotic process,BP,ARG2;RAG1;TSC22D4;MIF
12251,GO:0048499,0.268753583902538,0.972518001368236,1,3,synaptic vesicle membrane organization,BP,AP3D1
20211,GO:2001023,0.268926749418062,0.858616793897919,6,43,regulation of response to drug,BP,RAB3B;ENDOG;STK39;HMGA2;GAL;ARG1
11723,GO:0046500,0.269015071063017,0.92759082416657,2,10,S-adenosylmethionine metabolic process,BP,AHCY;GAMT
3713,GO:0008233,0.269047821277664,0.783103371119206,43,376,peptidase activity,MF,ADAM19;CAPN2;THSD4;PLAT;MMP1;PSMD2;PRSS3;CTSB;RNPEPL1;USP20;MMP14;JOSD2;RHBDF2;NPEPL1;PITRM1;CTSZ;PCSK9;TYSND1;PRSS8;OTUB2;SCRN1;IDE;HTRA1;MMP10;ADAMTS7;CNDP2;ADAM8;BLMH;CAPN5;PCSK6;TMPRSS11D;THOP1;CTSL;F12;KLK6;CASP4;ACY1;LONP2;GGT1;USP32;FURIN;ADAM15;HM13
13667,GO:0060154,0.269053240512184,0.972452095419235,1,3,cellular process regulating host cell cycle in response to virus,BP,BCL2L1
2984,GO:0006528,0.269066110847745,0.972449262705407,1,3,asparagine metabolic process,BP,ASNS
593,GO:0001755,0.269146960647377,0.869085774620002,5,33,neural crest cell migration,BP,LAMA5;SEMA3F;SEMA4B;RET;SEMA4G
18557,GO:1903719,0.269179268567941,0.972424349888386,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
18558,GO:1903721,0.269179268567941,0.972424349888386,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
1283,GO:0003081,0.26919437588917,0.927510011081516,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;CTSZ
19771,GO:2000110,0.269444702610309,0.972365861036489,1,3,negative regulation of macrophage apoptotic process,BP,IRF7
985,GO:0002439,0.269543747745248,0.972344017992454,1,3,chronic inflammatory response to antigenic stimulus,BP,AHCY
9202,GO:0035578,0.269617437593128,0.837379048616018,9,69,azurophil granule lumen,CC,PYGB;NAPRT;GALNS;FUCA1;CAP1;C6ORF120;ARG1;VAT1;TRAPPC1
12915,GO:0051238,0.269767288699693,0.926247924559613,2,11,sequestering of metal ion,BP,AP3D1;SLC30A1
6334,GO:0020037,0.269899742887375,0.843034458795942,8,59,heme binding,MF,CBS;NOS1;CYP27B1;NR1D1;CYGB;HEBP1;SRC;CAT
380,GO:0001012,0.270087320609649,0.778276484609952,51,438,RNA polymerase II regulatory region DNA binding,MF,ZMYND8;NFATC4;ETV4;MEF2D;NR1D1;TEF;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;PPARA;TFE3;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;IRF7;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;CHD7;RXRA;ZHX3;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300
3213,GO:0006858,0.270125565530897,0.972215505399852,1,3,extracellular transport,BP,ARRDC1
2729,GO:0006107,0.27019024321462,0.927060424600447,2,10,oxaloacetate metabolic process,BP,PCK2;MDH2
19797,GO:2000171,0.270380155883054,0.900152406952487,3,17,negative regulation of dendrite development,BP,NFATC4;PTPRS;ASAP1
10804,GO:0044267,0.270480712407504,0.750185548857334,412,3921,cellular protein metabolic process,BP,TNIP1;EDEM1;XDH;BTBD2;ZMYND8;NOS1;CHAC1;CCND1;GID4;CAPN2;F2R;MST1R;RAC2;RBCK1;SORL1;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;ERCC6;CST3;NEURL1;SNX9;LMF1;BOK;SHARPIN;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;IFI6;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;PTPRS;PRNP;BNIP3;SBF1;SSH1;SCYL1;CRTAP;SMURF2;MAPKAPK3;CTSB;SESN2;ABTB1;LY6K;MARCH9;FKBP9;USP20;NACC2;BCR;VLDLR;MARK4;LRP5;AARS;ACVR2B;FBLN1;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;LAMB1;PRKACA;ADARB1;PTPRF;CARS;JOSD2;MAP2K2;STK25;SHANK3;MIER2;ATF4;P4HB;HECW2;FBXW8;SNX33;MRPS6;AKT1;MDH2;IRAK1;SERPING1;APOE;ATP13A2;PKN1;SYVN1;WWTR1;PHF21A;RABGGTA;AP2A2;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;VPS11;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;RRAS;MSN;PPP1R35;TGFBR2;LAMB2;MVB12B;SERPINB6;LIMK1;STK39;DKK1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;SYMPK;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;JADE2;ANKIB1;LARP6;PRDX5;CCND2;BIN1;SUFU;CCDC88C;PAK1;TTBK2;ERO1B;ZNF385A;UBXN7;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RASGEF1A;FBXL6;IFI27;HLTF;CEMIP;PKD1;PARP10;DLG3;GATA3;PIGQ;PHF1;UBXN4;DCAF7;ANO8;GNAI2;PPM1M;HSF1;SIN3B;WFS1;NEK9;SRD5A3;ASPH;CTBP1;PTPRU;ADAM8;TFPI2;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;IGFBP2;P4HA1;MYDGF;B4GALT2;EIF4EBP1;GIPC1;TNFRSF6B;B3GNT3;SRC;APLP2;MBD6;KDM4B;GLRX;FKBP10;PEX10;TGM2;UBR4;AGO4;FAM162A;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;SPINT2;DUSP6;FYN;MPI;PPM1F;ZNF862;LPAR3;RMND5A;PSMD7;MICAL1;TNFRSF1A;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;BRSK1;SSU72;GJC2;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;TNRC6B;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;UBA1;RNF187;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;MIF4GD;MSL1;ADNP;PHF2;MIB2;TTLL12;F12;MFNG;CDK18;MIF;SOCS2;MTMR4;ASB13;VPS37A;STUB1;PCSK1N;STK17A;ST3GAL3;TRIB3;DDB2;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ULK1;LRP1;TRIB2;HSPA2;PAK4;TNFRSF19;MGRN1;SAMD4B;ULK2;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;PYM1;RCOR1;MAP3K12;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;RXRA;SPSB3;VEGFB;NEURL1B;TGFA;RPL28;CNOT11;IMPACT;ARSK;CASP4;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;GGT1;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;DNAJB9;FURIN;ARHGEF2;RNF103;AIDA;B4GALT6;MATN3;HM13;CEACAM1;PAIP2;GALNT3;MINK1;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;TGFB1;WBP2;PCYOX1;PPP6R1;ADCK2;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;PLGRKT;ASPHD1;EP300;WDFY2;RASA3;TRAF7;RNF10
15558,GO:0071942,0.270616318543099,0.97210684046825,1,3,XPC complex,CC,XPC
15996,GO:0080134,0.270620175130856,0.763606755347318,109,991,regulation of response to stress,BP,TNIP1;NT5E;EDEM1;XDH;ERCC1;F2R;MAP2K1;PLAT;WNT7A;ERCC6;BOK;SHARPIN;SERPINE2;NR1D1;DLG1;PSMD2;PTPRS;MAPKAPK3;CTSB;SESN2;NACC2;BCR;XBP1;MAP4K4;EGFR;PRKACA;PTPRF;MAP2K2;STK25;ATF4;P4HB;AKT1;CARD11;IRAK1;SERPING1;BAG3;APOE;ARG2;PKN1;SYVN1;TMSB4X;RNF135;MAPK13;FZD8;ENDOG;NSMCE4A;TGFBR2;STK39;DKK1;UBE2J1;PPARA;FAM3A;PRKACB;CD44;MAP3K9;HTRA1;PAK1;ZNF385A;RAG1;DDIT3;GATA3;FNDC4;HSF1;WFS1;ADAM8;MAPKBP1;HMGA2;SRC;TGM2;IRF7;LRSAM1;STK24;YPEL3;FYN;GRINA;PSMD7;TNFRSF1A;PUM1;CTSL;MAP3K10;HEXIM1;MGLL;RREB1;F12;MIF;BCL2L1;TNFRSF19;HPSE;ZP3;FGF2;TAOK1;APBB1;ARG1;SEC14L1;IMPACT;CASP4;GGT1;MAPK3;DNAJB9;ARHGEF2;AIDA;CEACAM1;MINK1;CD59;TGFB1;SPRED2;ANXA1;PPP1R10;EP300
5595,GO:0016618,0.270708456132181,0.97208641166802,1,3,hydroxypyruvate reductase activity,MF,CTBP1
6818,GO:0030267,0.270708456132181,0.97208641166802,1,3,glyoxylate reductase (NADP) activity,MF,CTBP1
820,GO:0002090,0.270885719133139,0.881356282516306,4,25,regulation of receptor internalization,BP,DLG4;PCSK9;DKK1;APLN
15247,GO:0071385,0.270932459734005,0.85739104142168,6,42,cellular response to glucocorticoid stimulus,BP,PCK2;EGFR;EIF4EBP1;ARG1;TGFB1;ANXA1
11261,GO:0045446,0.270938903031447,0.836656446355738,9,66,endothelial cell differentiation,BP,XDH;WNT7A;RAPGEF3;PTPRS;LAMA5;ACVR2B;MSN;TNFRSF1A;CEACAM1
4166,GO:0009227,0.270963194575162,0.972029886062619,1,3,nucleotide-sugar catabolic process,BP,GSK3A
3593,GO:0008021,0.270975069726793,0.819998132845758,13,104,synaptic vesicle,CC,DLG4;RAB3B;PTPRS;DBNDD1;PI4K2A;SEPT5;RABAC1;DMXL2;VAMP2;GIPC1;BRSK1;BCL2L1;APBA1
2001,GO:0004721,0.270980816670356,0.807518384032689,18,145,phosphoprotein phosphatase activity,MF,MAP2K1;DLG1;PTPRS;SBF1;SSH1;PTPRF;PPP2R3B;PTPDC1;DUSP4;PTPN9;PPM1M;PTPRU;DUSP6;PPM1F;SSU72;LHPP;MTMR4;PTPN12
17948,GO:1902237,0.271070036775934,0.926662186533732,2,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK;DDIT3
11439,GO:0045838,0.27107192907237,0.926661328921654,2,10,positive regulation of membrane potential,BP,AKT1;GLRX
6001,GO:0019005,0.271130940618733,0.848884657905703,7,51,SCF ubiquitin ligase complex,CC,BTBD2;ABTB1;FBXW8;FBXO2;FBXW5;FBXL15;SPSB3
11788,GO:0046631,0.271159938948301,0.836393101089164,9,67,alpha-beta T cell activation,BP,AP3D1;ARG2;PRKCZ;TGFBR2;SATB1;GATA3;ZFPM1;PNP;ANXA1
771,GO:0002021,0.271408834706786,0.92650856624165,2,10,response to dietary excess,BP,APOE;PCSK1N
10728,GO:0044036,0.271785793657756,0.97184690396571,1,3,cell wall macromolecule metabolic process,BP,MPI
15351,GO:0071554,0.271785793657756,0.97184690396571,1,3,cell wall organization or biogenesis,BP,MPI
4831,GO:0014033,0.271848271617713,0.841703369178418,8,58,neural crest cell differentiation,BP,LAMA5;SEMA3F;SEMA4B;RET;EDNRA;ALDH1A2;SEMA4G;MAPK3
9059,GO:0035270,0.271870112778541,0.835854748866039,9,67,endocrine system development,BP,MAP2K1;AKT1;GATA3;ARID5B;ALDH1A2;GSK3A;THRA;MAPK3;ANXA1
14891,GO:0070663,0.271881428784698,0.813463488383782,15,123,regulation of leukocyte proliferation,BP,RAC2;DLG1;PRNP;CARD11;ARG2;PKN1;TGFBR2;IGFBP2;GAL;MIF;ZP3;PNP;ARG1;TGFB1;ANXA1
1136,GO:0002725,0.27197612175355,0.971804468657889,1,3,negative regulation of T cell cytokine production,BP,ARG1
778,GO:0002031,0.272149317184604,0.926172300764689,2,10,G-protein coupled receptor internalization,BP,APLN;DNM2
1137,GO:0002726,0.272201241561603,0.926148694757404,2,10,positive regulation of T cell cytokine production,BP,PRKCZ;GATA3
11422,GO:0045807,0.272523316619502,0.826018247536265,11,85,positive regulation of endocytosis,BP,TSPAN1;BCR;TUB;APOE;PCSK9;APLN;LDLRAP1;DNM2;LRP1;ABCA7;CBL
6475,GO:0021801,0.272674161596499,0.898870310939273,3,17,cerebral cortex radial glia guided migration,BP,LAMB1;MBOAT7;SOCS7
6574,GO:0022030,0.272674161596499,0.898870310939273,3,17,telencephalon glial cell migration,BP,LAMB1;MBOAT7;SOCS7
2161,GO:0004985,0.2726801660631,0.971647175437135,1,3,opioid receptor activity,MF,SIGMAR1
666,GO:0001867,0.272702608312754,0.971642153227914,1,3,complement activation, lectin pathway,BP,SERPING1
10563,GO:0043507,0.272736217583608,0.841162914363446,8,57,positive regulation of JUN kinase activity,BP,ERCC6;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TAOK1
13960,GO:0060605,0.272792241480158,0.971622089670608,1,3,tube lumen cavitation,BP,TGM2
13977,GO:0060662,0.272792241480158,0.971622089670608,1,3,salivary gland cavitation,BP,TGM2
12313,GO:0048635,0.272816419647498,0.866642101829032,5,33,negative regulation of muscle organ development,BP,TGFBR2;DKK1;PAK1;GSK3A;TGFB1
19079,GO:1904896,0.272850939570897,0.925853036014043,2,10,ESCRT complex disassembly,BP,VPS4A;CHMP5
19081,GO:1904903,0.272850939570897,0.925853036014043,2,10,ESCRT III complex disassembly,BP,VPS4A;CHMP5
5404,GO:0016239,0.272999155381728,0.840848534305579,8,58,positive regulation of macroautophagy,BP,BNIP3;SESN2;FYCO1;BNIP3L;LRSAM1;SPTLC2;ULK1;MAPK3
13508,GO:0055025,0.273026754909346,0.880020642893125,4,25,positive regulation of cardiac muscle tissue development,BP,FGFR1;FGF2;TGFB1;ERBB3
3019,GO:0006565,0.273065699482642,0.97156082803234,1,3,L-serine catabolic process,BP,CBS
3416,GO:0007202,0.273138146456626,0.92572216456726,2,10,activation of phospholipase C activity,BP,EGFR;EDNRA
1264,GO:0003015,0.273402171681566,0.809834964624098,16,129,heart process,BP,NOS1;DLG1;TNNT1;PRKACA;PPP1R13L;EHD3;ITPR3;APLN;ASPH;SRC;TAZ;GSK3A;THRA;P2RX4;VEGFB;STIM1
2448,GO:0005656,0.27354791744877,0.971452613025233,1,3,nuclear pre-replicative complex,CC,WDR18
2807,GO:0006267,0.27354791744877,0.971452613025233,1,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,WDR18
9586,GO:0036387,0.27354791744877,0.971452613025233,1,3,pre-replicative complex,CC,WDR18
9587,GO:0036388,0.27354791744877,0.971452613025233,1,3,pre-replicative complex assembly,BP,WDR18
17974,GO:1902299,0.27354791744877,0.971452613025233,1,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,WDR18
6947,GO:0030550,0.273548874308563,0.9714523980596,1,3,acetylcholine receptor inhibitor activity,MF,LY6E
17759,GO:1901664,0.27361900901831,0.971436639234394,1,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,TGFB1
17760,GO:1901666,0.27361900901831,0.971436639234394,1,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,TGFB1
18488,GO:1903555,0.27368256595413,0.834294470068524,9,69,regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ARG2;UBE2J1;MC1R;HSF1;ADAM8;MIF;ARFGEF2;ARHGEF2
8494,GO:0033634,0.273906091976051,0.971372081180942,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,PODXL
20308,GO:2001242,0.273937959323236,0.811629981734142,15,127,regulation of intrinsic apoptotic signaling pathway,BP,BOK;NACC2;XBP1;P4HB;AKT1;SYVN1;CD44;ZNF385A;DDIT3;WFS1;SRC;GRINA;MIF;BCL2L1;ARHGEF2
10337,GO:0043120,0.274033517288882,0.971343399331789,1,3,tumor necrosis factor binding,MF,TNFRSF1A
19776,GO:2000116,0.274106069898756,0.797678627117111,22,191,regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;CST3;BOK;DAP;IFI6;AKT1;SOX7;CD44;PRDX5;RAG1;TNFSF15;IFI27;HSF1;ASPH;TNFRSF6B;SRC;FAM162A;FYN;PPM1F;MICAL1;CASP4
19462,GO:1990037,0.27448038484773,0.971242683952282,1,3,Lewy body core,CC,ATF4
1527,GO:0003896,0.274480659585124,0.971242621968996,1,3,DNA primase activity,MF,PRIMPOL
12180,GO:0048280,0.274500790529265,0.92509981239409,2,10,vesicle fusion with Golgi apparatus,BP,STX5;USO1
15415,GO:0071650,0.274516165313499,0.971234610898491,1,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,ARG2
5144,GO:0015669,0.274545908989603,0.971227898913888,1,3,gas transport,BP,CYGB
1216,GO:0002883,0.274650322238723,0.971204329767133,1,3,regulation of hypersensitivity,BP,ZP3
15700,GO:0072207,0.27470249557743,0.897731342282466,3,17,metanephric epithelium development,BP,WWTR1;LAMB2;PKD1
16508,GO:0097179,0.274888631192438,0.967829569614586,1,4,protease inhibitor complex,CC,SERPINB6
18733,GO:1904090,0.274888631192438,0.967829569614586,1,4,peptidase inhibitor complex,CC,SERPINB6
10586,GO:0043539,0.274920170144382,0.87848183244856,4,26,protein serine/threonine kinase activator activity,MF,MAP2K1;MAP2K2;TAOK1;TGFB1
14045,GO:0060749,0.274943691501162,0.924897017750817,2,10,mammary gland alveolus development,BP,CCND1;SOCS2
14309,GO:0061377,0.274943691501162,0.924897017750817,2,10,mammary gland lobule development,BP,CCND1;SOCS2
11893,GO:0046885,0.274955815937656,0.897588742632843,3,17,regulation of hormone biosynthetic process,BP,CYP27B1;DGKQ;VDR
17426,GO:1900138,0.275036356118411,0.971117093747252,1,3,negative regulation of phospholipase A2 activity,BP,ANXA1
13023,GO:0051429,0.275036699893517,0.971117015993,1,3,corticotropin-releasing hormone receptor binding,MF,GNAS
12375,GO:0048738,0.275066796060929,0.808578431732423,16,126,cardiac muscle tissue development,BP,FKBP1A;PPP1R13L;TGFBR2;DKK1;OBSL1;PAK1;ALDH1A2;TAZ;GSK3A;FGFR1;ZFPM1;FGF2;CHD7;RXRA;TGFB1;ERBB3
18584,GO:1903774,0.275091816541787,0.971104548265795,1,3,positive regulation of viral budding via host ESCRT complex,BP,VPS4A
3017,GO:0006563,0.275328019137076,0.924720839276245,2,10,L-serine metabolic process,BP,CBS;PSAT1
15105,GO:0071073,0.275461706299912,0.971020796470122,1,3,positive regulation of phospholipid biosynthetic process,BP,ZP3
7476,GO:0031629,0.27547133376862,0.924655094492165,2,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,STXBP1;SNAP29
17054,GO:0099500,0.27547133376862,0.924655094492165,2,10,vesicle fusion to plasma membrane,BP,STXBP1;SNAP29
255,GO:0000720,0.275475634598644,0.971017640037422,1,3,pyrimidine dimer repair by nucleotide-excision repair,BP,ERCC1
13568,GO:0060009,0.275478638480018,0.924651742793247,2,10,Sertoli cell development,BP,SDC1;CST3
720,GO:0001942,0.27567643593996,0.83296178830366,9,67,hair follicle development,BP,LAMA5;EGFR;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
11229,GO:0045348,0.275711060848769,0.970964257653701,1,3,positive regulation of MHC class II biosynthetic process,BP,XBP1
552,GO:0001673,0.275750449063528,0.924526976510482,2,10,male germ cell nucleus,CC,TCFL5;HSPA2
4146,GO:0009206,0.27576973784283,0.816096507377298,13,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
11575,GO:0046102,0.275874919304775,0.97092706960104,1,3,inosine metabolic process,BP,PNP
3193,GO:0006821,0.275905905320991,0.853906582782886,6,42,chloride transport,BP,PRNP;TTYH3;SLC12A7;ANO8;SLC12A4;PCYOX1
11529,GO:0046016,0.275906148101014,0.970919979032952,1,3,positive regulation of transcription by glucose,BP,USF2
10175,GO:0042752,0.275967389138343,0.832740129211755,9,67,regulation of circadian rhythm,BP,CRTC1;NR1D1;MTA1;CSNK1E;PPARA;PER3;MAPK9;MAPK10;CSNK1D
10361,GO:0043161,0.276157828908889,0.777291315819247,42,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,EDEM1;BTBD2;GID4;RBCK1;DVL1;SHARPIN;PSMD2;MTA1;SMURF2;ABTB1;CSNK1E;PANO1;HECW2;AKT1;SYVN1;WWTR1;TMEM129;FBXO2;FBXW5;UBE2J1;CDC34;ANKIB1;DDIT3;UBXN4;WFS1;GIPC1;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;RNF187;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;CSNK1D;DNAJB9;RNF103
15034,GO:0070948,0.276340972128628,0.970821147406769,1,3,regulation of neutrophil mediated cytotoxicity,BP,ARG1
2290,GO:0005246,0.276430110174155,0.896176066985324,3,18,calcium channel regulator activity,MF,GNB2;SLC30A1;STIM1
740,GO:0001968,0.276437234095428,0.896753250749861,3,17,fibronectin binding,MF,FBLN1;CTSL;ITGA3
10362,GO:0043162,0.276461674129497,0.8961581524599,3,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,VPS4A;MVB12B;VPS37A
204,GO:0000429,0.276499751616876,0.970785009921902,1,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,USF2
209,GO:0000436,0.276499751616876,0.970785009921902,1,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,USF2
2995,GO:0006541,0.276533548209602,0.896698838653354,3,17,glutamine metabolic process,BP,GLUL;GLUD1;ASNS
1299,GO:0003129,0.276570735276945,0.970768846000632,1,3,heart induction,BP,DKK1
18746,GO:1904154,0.276580134697639,0.970766705240198,1,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
14390,GO:0061615,0.276702880695837,0.896021212385547,3,18,glycolytic process through fructose-6-phosphate,BP,HK1;PFKP;ALDOC
14393,GO:0061620,0.276702880695837,0.896021212385547,3,18,glycolytic process through glucose-6-phosphate,BP,HK1;PFKP;ALDOC
12991,GO:0051354,0.276757997579187,0.924063667868357,2,10,negative regulation of oxidoreductase activity,BP,CYP27B1;OXA1L
14737,GO:0070373,0.276991767453986,0.844773119198517,7,50,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;DLG1;FBLN1;DUSP4;DUSP6;EPHB2;CAMK2N1
9211,GO:0035587,0.276996330015772,0.92395388369747,2,10,purinergic receptor signaling pathway,BP,GNAI2;P2RX4
8460,GO:0033590,0.277361693694378,0.970588384378278,1,3,response to cobalamin,BP,EGFR
11324,GO:0045627,0.277390091587262,0.97058189329064,1,3,positive regulation of T-helper 1 cell differentiation,BP,ANXA1
14920,GO:0070723,0.277424590103381,0.896194912783642,3,17,response to cholesterol,BP,TGFBR2;PMVK;TGFB1
13318,GO:0052031,0.27794123852524,0.970455749958984,1,3,modulation by symbiont of host defense response,BP,TGFB1
13352,GO:0052255,0.27794123852524,0.970455749958984,1,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,TGFB1
13385,GO:0052552,0.27794123852524,0.970455749958984,1,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,TGFB1
13386,GO:0052553,0.27794123852524,0.970455749958984,1,3,modulation by symbiont of host immune response,BP,TGFB1
15977,GO:0075528,0.27794123852524,0.970455749958984,1,3,modulation by virus of host immune response,BP,TGFB1
14826,GO:0070541,0.278010325864835,0.970439915616082,1,3,response to platinum ion,BP,UROS
6837,GO:0030295,0.278414815600808,0.84359407764182,7,51,protein kinase activator activity,MF,MAP2K1;ERCC6;MAP2K2;DGKQ;TAOK1;TGFB1;ERBB3
706,GO:0001923,0.27841914938183,0.97034611556093,1,3,B-1 B cell differentiation,BP,CMTM7
52,GO:0000109,0.278493843791191,0.923262413396577,2,10,nucleotide-excision repair complex,CC,ERCC1;XPC
16625,GO:0097441,0.278508194219005,0.970325662387676,1,3,basal dendrite,CC,MAP1B
18686,GO:1903976,0.278729581051976,0.970274775505638,1,3,negative regulation of glial cell migration,BP,IDH2
7762,GO:0032273,0.278811448442187,0.817134026820952,12,95,positive regulation of protein polymerization,BP,RAC2;DLG1;CORO1B;ARPC1A;PAK1;ARL2;PFN1;ARFIP2;SPIRE1;VASP;BAIAP2L1;WIPF1
18946,GO:1904636,0.27893530756206,0.970227442972078,1,3,response to ionomycin,BP,NFATC4
18947,GO:1904637,0.27893530756206,0.970227442972078,1,3,cellular response to ionomycin,BP,NFATC4
9790,GO:0039692,0.279202605654601,0.922934144691301,2,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
17825,GO:1901894,0.279214395699009,0.97016316204117,1,3,regulation of calcium-transporting ATPase activity,BP,HSPA2
10607,GO:0043567,0.27922308087627,0.922924651867704,2,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4;IGFBP2
14263,GO:0061218,0.279273817999459,0.970149465241189,1,3,negative regulation of mesonephros development,BP,GATA3
2184,GO:0005031,0.279345586620605,0.894516213055669,3,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF6B;TNFRSF1A;TNFRSF19
2186,GO:0005035,0.279345586620605,0.894516213055669,3,18,death receptor activity,MF,TNFRSF6B;TNFRSF1A;TNFRSF19
16584,GO:0097350,0.279527572313198,0.970090934066963,1,3,neutrophil clearance,BP,ANXA1
7682,GO:0032106,0.279557005325835,0.970084140725924,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7685,GO:0032109,0.279557005325835,0.970084140725924,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
11326,GO:0045629,0.279572208294947,0.97008063142639,1,3,negative regulation of T-helper 2 cell differentiation,BP,ANXA1
19644,GO:1990756,0.279819169899947,0.970023591905667,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
136,GO:0000285,0.279926491855861,0.96999878465435,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
655,GO:0001843,0.28033214983864,0.824385349725719,10,75,neural tube closure,BP,DVL1;DEAF1;PRKACB;SUFU;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
13961,GO:0060606,0.28033214983864,0.824385349725719,10,75,tube closure,BP,DVL1;DEAF1;PRKACB;SUFU;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
16975,GO:0098953,0.280355044264586,0.969899607072531,1,3,receptor diffusion trapping,BP,DLG4
16981,GO:0098970,0.280355044264586,0.969899607072531,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17115,GO:0099628,0.280355044264586,0.969899607072531,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
18673,GO:1903959,0.280368463999046,0.894523124993595,3,17,regulation of anion transmembrane transport,BP,PRNP;AKT1;STK39
13210,GO:0051797,0.280416894364355,0.893903681023175,3,18,regulation of hair follicle development,BP,FERMT1;GAL;HPSE
3941,GO:0008626,0.280509803597114,0.969863745324447,1,3,granzyme-mediated apoptotic signaling pathway,BP,BNIP3
8480,GO:0033615,0.280728342662313,0.96981306200148,1,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,OXA1L
892,GO:0002260,0.280782762414341,0.850285408796567,6,43,lymphocyte homeostasis,BP,AKT1;PKN1;RAG1;TSC22D4;MIF;TGFB1
11360,GO:0045669,0.280802758594875,0.850451323075677,6,42,positive regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;IFITM1;FAM20C;ZHX3;GNAS
18773,GO:1904217,0.280838970456036,0.969787386509969,1,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18774,GO:1904219,0.280838970456036,0.969787386509969,1,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,SERINC2
18776,GO:1904222,0.280838970456036,0.969787386509969,1,3,positive regulation of serine C-palmitoyltransferase activity,BP,SERINC2
13865,GO:0060445,0.281189052819877,0.894055238424242,3,17,branching involved in salivary gland morphogenesis,BP,LAMA5;TGM2;FGFR1
1854,GO:0004514,0.281228289491908,0.969696929195169,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
15465,GO:0071733,0.281337575650052,0.969671508636113,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16200,GO:0090202,0.281337575650052,0.969671508636113,1,3,gene looping,BP,ZFPM1
16359,GO:0090579,0.281337575650052,0.969671508636113,1,3,dsDNA loop formation,BP,ZFPM1
11288,GO:0045579,0.281338221364435,0.921941126195579,2,10,positive regulation of B cell differentiation,BP,XBP1;MMP14
3422,GO:0007212,0.2814128478838,0.874375800129079,4,26,dopamine receptor signaling pathway,BP,GNB1;GSK3A;ADCY6;GNAS
18356,GO:1903286,0.281436195885877,0.969648558417571,1,3,regulation of potassium ion import,BP,DLG1
544,GO:0001662,0.281504131898175,0.893280607276859,3,18,behavioral fear response,BP,APOE;DEAF1;RAG1
871,GO:0002209,0.281504131898175,0.893280607276859,3,18,behavioral defense response,BP,APOE;DEAF1;RAG1
10104,GO:0042596,0.281504131898175,0.893280607276859,3,18,fear response,BP,APOE;DEAF1;RAG1
1396,GO:0003307,0.281527289993599,0.969627350681781,1,3,regulation of Wnt signaling pathway involved in heart development,BP,DKK1
5210,GO:0015807,0.281643442399454,0.849855694360228,6,42,L-amino acid transport,BP,SERINC2;SLC43A1;SLC6A9;NTSR1;PRAF2;ARG1
14168,GO:0061028,0.281738247405442,0.860640283895635,5,33,establishment of endothelial barrier,BP,WNT7A;RAPGEF3;PTPRS;MSN;TNFRSF1A
19637,GO:1990743,0.281793873918904,0.969565237566034,1,3,protein sialylation,BP,ST6GALNAC2
4372,GO:0009988,0.281883813950429,0.873741903662319,4,27,cell-cell recognition,BP,DLG1;MSN;ZP3;SPESP1
13888,GO:0060485,0.281983120025941,0.794485078638401,20,163,mesenchyme development,BP,LAMA5;SEMA3F;ACTA2;WWTR1;TGFBR2;BCL9L;SEMA4B;CUL7;RET;HMGA2;EDNRA;ALDH1A2;FUZ;SEMA4G;FGFR1;ADIPOR1;MAPK3;ADAM15;TGFB1;ERBB3
15578,GO:0072007,0.282179869663522,0.969475171431596,1,3,mesangial cell differentiation,BP,ACTA2
15579,GO:0072008,0.282179869663522,0.969475171431596,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15661,GO:0072143,0.282179869663522,0.969475171431596,1,3,mesangial cell development,BP,ACTA2
15662,GO:0072144,0.282179869663522,0.969475171431596,1,3,glomerular mesangial cell development,BP,ACTA2
18785,GO:1904238,0.282179869663522,0.969475171431596,1,3,pericyte cell differentiation,BP,ACTA2
2736,GO:0006114,0.282181937689084,0.96947468847402,1,3,glycerol biosynthetic process,BP,PCK2
14281,GO:0061316,0.282197365055093,0.969471085494437,1,3,canonical Wnt signaling pathway involved in heart development,BP,DKK1
10598,GO:0043552,0.282226782532983,0.893462365113413,3,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,SRC;FGF2;TGFB1
10030,GO:0042451,0.282236074910425,0.89186064593265,3,20,purine nucleoside biosynthetic process,BP,NT5E;NME4;GUK1
11590,GO:0046129,0.282236074910425,0.89186064593265,3,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4;GUK1
12862,GO:0051153,0.282291810170003,0.833783553785677,8,59,regulation of striated muscle cell differentiation,BP,FAM129B;XBP1;MMP14;DKK1;PAK1;GSK3A;THRA;TGFB1
18609,GO:1903828,0.282810716657907,0.822289110356554,10,77,negative regulation of cellular protein localization,BP,SNX33;GDI1;UBE2J1;TTBK2;PARP10;NUMB;ABHD17C;BCL2L1;TMBIM1;TGFB1
11577,GO:0046104,0.282968096159403,0.969290771093466,1,3,thymidine metabolic process,BP,TK2
11587,GO:0046125,0.282968096159403,0.969290771093466,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
14259,GO:0061209,0.283043541987254,0.969273087233919,1,3,cell proliferation involved in mesonephros development,BP,GATA3
9727,GO:0038145,0.283080000790352,0.969264539482789,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
321,GO:0000839,0.283109554985052,0.969257609501256,1,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,SYVN1
10078,GO:0042562,0.28313130113264,0.848618201026547,6,43,hormone binding,MF,SHC1;EGFR;IDE;VDR;THRA;ADIPOR1
15242,GO:0071378,0.283167806802006,0.892923605409886,3,17,cellular response to growth hormone stimulus,BP,SOCS2;MAPK3;PXN
18160,GO:1902855,0.283210902045838,0.921065555950241,2,10,regulation of non-motile cilium assembly,BP,DNM2;WRAP73
53,GO:0000110,0.283265401245412,0.969221051064689,1,3,nucleotide-excision repair factor 1 complex,CC,ERCC1
3724,GO:0008252,0.283294990127145,0.921026135114762,2,10,nucleotidase activity,MF,NT5E;NT5DC2
3486,GO:0007354,0.283310712980429,0.969210417097935,1,3,zygotic determination of anterior/posterior axis, embryo,BP,PCSK6
6750,GO:0030167,0.283401469852031,0.969189111442264,1,3,proteoglycan catabolic process,BP,HPSE
6770,GO:0030200,0.283401469852031,0.969189111442264,1,3,heparan sulfate proteoglycan catabolic process,BP,HPSE
14188,GO:0061050,0.283417758935737,0.920968564304935,2,10,regulation of cell growth involved in cardiac muscle cell development,BP,PAK1;GSK3A
13998,GO:0060688,0.283471394804026,0.859209517698581,5,34,regulation of morphogenesis of a branching structure,BP,PGF;ETV5;FGFR1;RXRA;TGFB1
572,GO:0001711,0.283561654558676,0.920901061737301,2,10,endodermal cell fate commitment,BP,DKK1;DUSP6
13714,GO:0060244,0.283654339912763,0.969129703709837,1,3,negative regulation of cell proliferation involved in contact inhibition,BP,PAK1
6465,GO:0021783,0.28367662396851,0.920847109588967,2,10,preganglionic parasympathetic fiber development,BP,SEMA3F;ADARB1
14446,GO:0061738,0.283761480051948,0.96910451281957,1,3,late endosomal microautophagy,BP,VPS4A
18642,GO:1903899,0.283763409561488,0.969104059042158,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
6628,GO:0022853,0.283915982706937,0.858667514741011,5,35,active ion transmembrane transporter activity,MF,ATP13A2;ATP7B;ATP2C2;TCIRG1;ATP6V1C2
10117,GO:0042625,0.283915982706937,0.858667514741011,5,35,ATPase coupled ion transmembrane transporter activity,MF,ATP13A2;ATP7B;ATP2C2;TCIRG1;ATP6V1C2
402,GO:0001078,0.284016486453467,0.809642078318505,13,101,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;NR1D1;NACC2;PPARA;GATA3;TCFL5;HSF1;HMGA2;ZNF692;HES2;ZFPM1;RCOR1;TSHZ1
18720,GO:1904047,0.28401807667417,0.969044133053767,1,3,S-adenosyl-L-methionine binding,MF,CBS
3819,GO:0008410,0.284235865329082,0.968992831456834,1,3,CoA-transferase activity,MF,SUGCT
698,GO:0001915,0.284340012718607,0.968968281386693,1,3,negative regulation of T cell mediated cytotoxicity,BP,CEACAM1
5344,GO:0016079,0.284367816749193,0.839377466654349,7,50,synaptic vesicle exocytosis,BP,SNPH;SEPT5;SYTL1;VAMP2;PIP5K1C;STXBP1;SNAP29
10014,GO:0042421,0.284382953068476,0.96895815601598,1,3,norepinephrine biosynthetic process,BP,GATA3
14572,GO:0070081,0.284507019586634,0.968928890241272,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14573,GO:0070083,0.284507019586634,0.968928890241272,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
11213,GO:0045323,0.28465405549003,0.96889418551713,1,3,interleukin-1 receptor complex,CC,IRAK1
18734,GO:1904098,0.284800703391463,0.968859549945067,1,3,regulation of protein O-linked glycosylation,BP,POMT1
18735,GO:1904100,0.284800703391463,0.968859549945067,1,3,positive regulation of protein O-linked glycosylation,BP,POMT1
1146,GO:0002739,0.284849824689236,0.920295587243924,2,10,regulation of cytokine secretion involved in immune response,BP,HK1;MAPK3
16151,GO:0090135,0.284856078037769,0.968846465632113,1,3,actin filament branching,BP,CORO1B
2669,GO:0006015,0.284925297462336,0.968830105484223,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PYGL
11669,GO:0046391,0.284925297462336,0.968830105484223,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PYGL
16250,GO:0090281,0.284943104891683,0.968825895855664,1,3,negative regulation of calcium ion import,BP,SLC30A1
12510,GO:0050501,0.284949615267931,0.968824356737728,1,3,hyaluronan synthase activity,MF,HYAL1
4463,GO:0010454,0.285085114611644,0.96879231331284,1,3,negative regulation of cell fate commitment,BP,DKK1
1330,GO:0003179,0.28514961976847,0.872359174351111,4,25,heart valve morphogenesis,BP,TGFBR2;GATA3;ZFPM1;TGFB1
7156,GO:0031010,0.285167386119722,0.920145997564717,2,10,ISWI-type complex,CC,SMARCA1;RSF1
7302,GO:0031295,0.285343321817759,0.857934168329946,5,34,T cell costimulation,BP,AKT1;CARD11;PAK1;SRC;FYN
8527,GO:0033745,0.285355124318674,0.968728403273345,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
5567,GO:0016576,0.285490757286965,0.968696270895892,1,3,histone dephosphorylation,BP,PPM1F
5668,GO:0016774,0.285499026899331,0.968694311147589,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,NAGS
13985,GO:0060671,0.285556182873273,0.968680764266818,1,3,epithelial cell differentiation involved in embryonic placenta development,BP,SPINT2
13986,GO:0060672,0.285556182873273,0.968680764266818,1,3,epithelial cell morphogenesis involved in placental branching,BP,SPINT2
11271,GO:0045499,0.2857576258416,0.891435292057753,3,17,chemorepellent activity,MF,SEMA3F;SEMA4B;SEMA4G
6481,GO:0021819,0.28577033319779,0.919861618492867,2,10,layer formation in cerebral cortex,BP,MBOAT7;SOCS7
9582,GO:0036374,0.285810231689286,0.968620509385203,1,3,glutathione hydrolase activity,MF,GGT1
17197,GO:0102953,0.285810231689286,0.968620509385203,1,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,GGT1
17206,GO:0103068,0.285810231689286,0.968620509385203,1,3,leukotriene C4 gamma-glutamyl transferase activity,MF,GGT1
17790,GO:1901748,0.285810231689286,0.968620509385203,1,3,leukotriene D4 metabolic process,BP,GGT1
17791,GO:1901750,0.285810231689286,0.968620509385203,1,3,leukotriene D4 biosynthetic process,BP,GGT1
14980,GO:0070859,0.28581101735251,0.968620322938462,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18792,GO:1904253,0.28581101735251,0.968620322938462,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
20058,GO:2000645,0.285829898010757,0.968615842150528,1,3,negative regulation of receptor catabolic process,BP,FURIN
13607,GO:0060054,0.285998004851061,0.968575930360835,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A
20034,GO:2000609,0.286014433155399,0.968572028383624,1,3,regulation of thyroid hormone generation,BP,GATA3
941,GO:0002347,0.286043541258643,0.919732606607802,2,10,response to tumor cell,BP,ADAM15;CEACAM1
3573,GO:0007619,0.28605096575065,0.968563350315263,1,3,courtship behavior,BP,THRA
2226,GO:0005126,0.286054961902184,0.799100424088516,16,136,cytokine receptor binding,MF,PGF;SHC1;FKBP1A;SMURF2;TGFBR2;PLCG1;TNFSF15;GATA3;MIF;SOCS2;SNX25;VEGFB;TMBIM1;ECM1;TGFB1;SPRED2
14181,GO:0061043,0.286091369855197,0.968553750973338,1,3,regulation of vascular wound healing,BP,XBP1
8840,GO:0034617,0.286179023651755,0.96853292003079,1,3,tetrahydrobiopterin binding,MF,NOS1
16784,GO:0098559,0.286229427969894,0.968520937800339,1,3,cytoplasmic side of early endosome membrane,CC,LITAF
14232,GO:0061146,0.286289678770475,0.968506611359426,1,3,Peyer's patch morphogenesis,BP,RET
1999,GO:0004719,0.286389734380007,0.968482811749008,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
9492,GO:0036118,0.286603577339371,0.968431911172866,1,3,hyaluranon cable assembly,BP,HYAL1
17401,GO:1900104,0.286603577339371,0.968431911172866,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17402,GO:1900106,0.286603577339371,0.968431911172866,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
13999,GO:0060689,0.286612961583137,0.968429676366989,1,3,cell differentiation involved in salivary gland development,BP,XBP1
3695,GO:0008202,0.28667581173738,0.785484220392149,23,197,steroid metabolic process,BP,SORL1;CYP27B1;LMF1;NR1D1;VLDLR;LRP5;APOE;DGKQ;PCSK9;OSBPL5;SRD5A3;LDLRAP1;ACADVL;PMVK;HSD11B1;VDR;GAL;COMT;FGFR1;STUB1;RXRA;SEC14L2;CAT
4685,GO:0010831,0.286677462629396,0.890296094893338,3,18,positive regulation of myotube differentiation,BP,FAM129B;MMP14;THRA
7625,GO:0032010,0.2866953640811,0.968410048713226,1,3,phagolysosome,CC,ADAM8
4082,GO:0009135,0.286704014869278,0.81086463521485,12,94,purine nucleoside diphosphate metabolic process,BP,DLG4;DLG1;PGM1;HK1;CARD11;PFKP;PPARA;DHTKD1;DLG3;GUK1;ALDOC;LDHA
4121,GO:0009179,0.286704014869278,0.81086463521485,12,94,purine ribonucleoside diphosphate metabolic process,BP,DLG4;DLG1;PGM1;HK1;CARD11;PFKP;PPARA;DHTKD1;DLG3;GUK1;ALDOC;LDHA
9713,GO:0038108,0.286707991493458,0.968407040331512,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
19982,GO:2000489,0.286711869673358,0.968406116352241,1,3,regulation of hepatic stellate cell activation,BP,CYGB
3830,GO:0008428,0.286756093027588,0.968395578992271,1,3,ribonuclease inhibitor activity,MF,RNH1
3290,GO:0006983,0.286803773859976,0.919373111667659,2,10,ER overload response,BP,DDIT3;WFS1
6424,GO:0021684,0.286804101256629,0.96838413747305,1,3,cerebellar granular layer formation,BP,WNT7A
6439,GO:0021707,0.286804101256629,0.96838413747305,1,3,cerebellar granule cell differentiation,BP,WNT7A
4971,GO:0015078,0.28682289161342,0.823714725088712,9,75,proton transmembrane transporter activity,MF,SLC2A9;TMCO3;NDUFA4L2;SLC33A1;ATP2C2;TCIRG1;ATP6V1C2;SLC15A1;SLC45A3
2929,GO:0006447,0.286871498052093,0.96836807112399,1,3,regulation of translational initiation by iron,BP,RXRA
3466,GO:0007288,0.286897781118211,0.919328606401077,2,10,sperm axoneme assembly,BP,NEURL1;BBS2
287,GO:0000791,0.286977887995657,0.870477032237032,4,27,euchromatin,CC,H1F0;DNMT3A;HSF1;ASH2L
11987,GO:0047223,0.287001532746608,0.968337059447654,1,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT3
9650,GO:0036510,0.287005254558655,0.968336171580893,1,3,trimming of terminal mannose on C branch,BP,EDEM1
16007,GO:0085029,0.287015821605585,0.871164864186956,4,25,extracellular matrix assembly,BP,THSD4;LAMC2;LOXL1;TGFB1
5328,GO:0016051,0.287088448291179,0.791918896469073,19,157,carbohydrate biosynthetic process,BP,PCK2;NR1D1;PGM1;PC;ATF4;AKT1;MDH2;DGKQ;PPARA;ISYNA1;B3GNT3;GSK3A;TALDO1;CHST14;NTSR1;SLC35B4;ALDOC;GALNT3;TGFB1
19633,GO:1990737,0.287097446078898,0.96831417396221,1,3,response to manganese-induced endoplasmic reticulum stress,BP,ATF4
4774,GO:0010957,0.287180809281259,0.968294275193366,1,3,negative regulation of vitamin D biosynthetic process,BP,CYP27B1
11598,GO:0046137,0.287180809281259,0.968294275193366,1,3,negative regulation of vitamin metabolic process,BP,CYP27B1
5295,GO:0015960,0.287181263264987,0.968294166807776,1,3,diadenosine polyphosphate biosynthetic process,BP,GARS
5297,GO:0015965,0.287181263264987,0.968294166807776,1,3,diadenosine tetraphosphate metabolic process,BP,GARS
5298,GO:0015966,0.287181263264987,0.968294166807776,1,3,diadenosine tetraphosphate biosynthetic process,BP,GARS
10278,GO:0043009,0.287344484877203,0.764047527882287,48,415,chordate embryonic development,BP,MDFI;CAPN2;DVL1;MAP2K1;DLG1;EGFR;MMP14;EPN1;FBXW8;AKT1;TFEB;ENDOG;DEAF1;SALL2;TGFBR2;DKK1;PRKACB;WDTC1;PLCG1;SUFU;PKD1;GATA3;HSF1;EDNRA;TULP3;ALDH1A2;SPINT2;FUZ;PFN1;RCN1;EIF2S2;SEC24C;FGFR1;HYAL1;BCL2L1;PLCD3;ZP3;VASP;CHD7;RXRA;OCRL;APBA1;MBD3;SLC30A1;TGFB1;SF3B6;GNAS;EP300
4092,GO:0009145,0.287386381316871,0.806640356035881,13,106,purine nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
18880,GO:1904468,0.287575053849135,0.96820007060929,1,3,negative regulation of tumor necrosis factor secretion,BP,ARG2
8052,GO:0032696,0.287611384873917,0.968191381136281,1,3,negative regulation of interleukin-13 production,BP,ARG2
8196,GO:0032928,0.287618158259137,0.917883586338051,2,11,regulation of superoxide anion generation,BP,EGFR;TGFB1
13079,GO:0051560,0.28763858571957,0.889738019159528,3,18,mitochondrial calcium ion homeostasis,BP,BNIP3;RAP1GDS1;TGM2
6177,GO:0019541,0.287650913888185,0.968181925213999,1,3,propionate metabolic process,BP,PCK2
10995,GO:0044782,0.2876958496158,0.772656809568623,34,291,cilium organization,BP,NEURL1;LAMA5;BBS2;NUDCD3;MARK4;EVI5L;CSNK1E;RFX2;SEPT10;PRKACA;EHD3;WWTR1;DNAAF5;PTPDC1;SEPT5;TTBK2;SEPT8;DYNLRB1;DNM2;NINL;SDCCAG8;FUZ;KIF17;TUBG1;UNC119B;ATXN10;NDE1;SNAP29;GAS8;WRAP73;CSNK1D;OCRL;CCDC113;ASAP1
2370,GO:0005488,0.287733739885305,0.739774251807237,1058,10146,binding,MF,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;CAPN2;F2R;MPRIP;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;UHRF1BP1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CLIP2;CYP27B1;NEURL1;EPN3;SNX9;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DAP;CMTM4;DYSF;XPOT;IGFBP4;SLC16A3;MMP1;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;RAPGEF3;PTPRS;PRSS3;HYI;NAGS;PRNP;IDH2;LRRC20;BNIP3;SBF1;PC;R3HDM4;LAMA5;SSH1;WWC3;MICALCL;TXNDC11;RAB43;SCYL1;SMARCA1;CRTAP;SMURF2;NME4;COPG1;TMOD2;PLCH2;PCDH1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;SEMA3F;OSBPL10;TUBB6;USP20;NACC2;HEBP1;BCR;SYNE3;RAB31;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;ITGB5;H6PD;HTR7;GPT2;ADCY7;XBP1;ZCCHC14;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;CSNK1E;MKNK2;TK2;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;FAM189B;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;UBTD1;PPP1R13L;LMBR1L;FAM50A;TUBG2;STK25;PARVB;SHANK3;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;BRD3;MDH2;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;EPN2;BAG3;APOE;EHD3;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;LENG9;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;RABAC1;MSN;PPP1R35;MAP1B;TGFBR2;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;ISYNA1;LARP1B;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;NLGN2;GRAMD1A;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;CUL7;FAM167A;DMXL2;TBC1D9B;GGA3;GGA1;TUBB3;ADAMTS7;STOM;FARP1;GNB1;SYTL1;PTPN9;SATB1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;OASL;CADM4;MYOF;ACBD4;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;GGACT;ASIC1;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;SH3GLB2;CNDP2;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;RGL2;INTS8;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;FKBP10;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;DNAJC4;NCS1;PAQR7;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;ZCCHC24;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;NSUN7;ERICH2;SDCCAG8;GPX3;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;KIF17;TNFRSF1A;ALDH7A1;THOP1;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;VDR;BRPF3;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;CGREF1;MOAP1;GAL;PUM1;RNF44;ITGA1;FCGRT;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;C11ORF95;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;AMIGO2;TIMP1;SIMC1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LAMB3;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SECISBP2L;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TMEM128;JMJD7;MIB2;CEP170;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;ZDBF2;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;NT5DC2;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TPD52L2;TCIRG1;PITPNM2;SNX25;PTPN12;GRAMD1C;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;GPATCH8;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;TMEM139;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;HIST1H2AG;NYNRIN;WIPF1;IMPACT;ZNF624;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;GIGYF1;MYZAP;SNX27;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;MED29;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PPP6R1;SH3PXD2A;ADCK2;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;ORAI3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;KIAA0930;FHOD1;TRAF7;RNF10
596,GO:0001758,0.287821612939024,0.96814107269343,1,3,retinal dehydrogenase activity,MF,ALDH1A2
9789,GO:0039689,0.287862105314885,0.968131377383281,1,3,negative stranded viral RNA replication,BP,ATG16L2
433,GO:0001161,0.287889918917493,0.918858212338497,2,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;HSF1
10777,GO:0044213,0.287889918917493,0.918858212338497,2,10,intronic transcription regulatory region DNA binding,MF,ZC3H6;HSF1
18644,GO:1903901,0.287928612004196,0.829193208728673,8,62,negative regulation of viral life cycle,BP,TNIP1;IFITM1;PARP10;OASL;HMGA2;OAS1;ISG20;APOBEC3C
11852,GO:0046785,0.287941982201768,0.829519116098173,8,59,microtubule polymerization,BP,TUBG2;EML2;PAK1;ARL2;TUBG1;NDE1;CAMSAP3;CSNK1D
2062,GO:0004813,0.288006467743352,0.968096797919573,1,3,alanine-tRNA ligase activity,MF,AARS
2908,GO:0006419,0.288006467743352,0.968096797919573,1,3,alanyl-tRNA aminoacylation,BP,AARS
1890,GO:0004568,0.288124565971052,0.968068493337782,1,3,chitinase activity,MF,CTBS
2678,GO:0006030,0.288124565971052,0.968068493337782,1,3,chitin metabolic process,BP,CTBS
2679,GO:0006032,0.288124565971052,0.968068493337782,1,3,chitin catabolic process,BP,CTBS
3613,GO:0008061,0.288124565971052,0.968068493337782,1,3,chitin binding,MF,CTBS
1904,GO:0004586,0.288141416521536,0.968064453577514,1,3,ornithine decarboxylase activity,MF,AZIN2
8420,GO:0033387,0.288141416521536,0.968064453577514,1,3,putrescine biosynthetic process from ornithine,BP,AZIN2
3465,GO:0007286,0.288198059671706,0.82316236317535,9,69,spermatid development,BP,NEURL1;BBS2;OSBP2;RFX2;PRKACA;UBE2J1;HSPA2;TBC1D20;CIB1
18445,GO:1903463,0.288234564575599,0.968042116840683,1,3,regulation of mitotic cell cycle DNA replication,BP,FGFR1
5155,GO:0015691,0.2883139097343,0.968023082838429,1,3,cadmium ion transport,BP,SLC30A1
14850,GO:0070574,0.2883139097343,0.968023082838429,1,3,cadmium ion transmembrane transport,BP,SLC30A1
845,GO:0002155,0.288410901539236,0.967999806638476,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
926,GO:0002318,0.288418213109399,0.967998051599976,1,3,myeloid progenitor cell differentiation,BP,MLF1
1488,GO:0003810,0.288418721193494,0.967997929639488,1,3,protein-glutamine gamma-glutamyltransferase activity,MF,TGM2
7670,GO:0032094,0.288486104726001,0.889244971627991,3,18,response to food,BP,BBS2;AKT1;PPARA
9653,GO:0036513,0.288486397923061,0.918574799613882,2,10,Derlin-1 retrotranslocation complex,CC,SYVN1;HM13
3679,GO:0008179,0.288585740142246,0.918527553427159,2,10,adenylate cyclase binding,MF,AKAP12;CAP1
20193,GO:2000969,0.288602996806349,0.967953678281515,1,3,positive regulation of AMPA receptor activity,BP,SHANK3
19672,GO:1990834,0.288623475189858,0.967948758468309,1,3,response to odorant,BP,MMP14
19043,GO:1904837,0.288639342849347,0.85424291208469,5,41,beta-catenin-TCF complex assembly,BP,BCL9L;TLE4;ASH2L;EP300;TCF7L1
7867,GO:0032422,0.288777052688714,0.967911848337629,1,3,purine-rich negative regulatory element binding,MF,ELK3
16227,GO:0090244,0.288987636366626,0.967861197351562,1,3,Wnt signaling pathway involved in somitogenesis,BP,DKK1
14639,GO:0070193,0.289100711356457,0.918282434724411,2,10,synaptonemal complex organization,BP,AGO4;HSPA2
4995,GO:0015129,0.289164719155753,0.967818568182936,1,3,lactate transmembrane transporter activity,MF,SLC16A3
1514,GO:0003872,0.289198892440498,0.96781033785165,1,3,6-phosphofructokinase activity,MF,PFKP
6221,GO:0019751,0.289227498515682,0.812741392966625,11,86,polyol metabolic process,BP,CYP27B1;PCK2;PLCH2;PLCG1;ISYNA1;PLCB3;SPTLC2;NTSR1;PLCD3;FGF2;OCRL
15676,GO:0072175,0.289263528934391,0.805321523014355,13,102,epithelial tube formation,BP,DVL1;DEAF1;PRKACB;SUFU;PODXL;RET;GATA3;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
4416,GO:0010181,0.289441965509955,0.918119814855265,2,10,FMN binding,MF,NOS1;NDOR1
4967,GO:0015057,0.289538716480474,0.96772842749631,1,3,thrombin-activated receptor activity,MF,F2R
10336,GO:0043117,0.289579781815957,0.96771852098985,1,3,positive regulation of vascular permeability,BP,TGFB1
4799,GO:0010989,0.289594633176522,0.96771493784557,1,3,negative regulation of low-density lipoprotein particle clearance,BP,PCSK9
19952,GO:2000416,0.289620946226616,0.967708588803665,1,3,regulation of eosinophil migration,BP,ADAM8
9904,GO:0042177,0.289625190672363,0.808275369270396,12,98,negative regulation of protein catabolic process,BP,CST3;SERPINE2;EGFR;PANO1;ATP13A2;UBE2J1;SUFU;GIPC1;FYN;TIMP1;FURIN;AZIN2
569,GO:0001708,0.289640146201674,0.854992585558924,5,34,cell fate specification,BP,DKK1;SUFU;DUSP6;FGFR1;FGF2
107,GO:0000221,0.289696291332597,0.967690404854433,1,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,ATP6V1C2
12876,GO:0051176,0.289766524334129,0.967673449296656,1,3,positive regulation of sulfur metabolic process,BP,COMT
18828,GO:1904351,0.289817286116073,0.967661191225696,1,3,negative regulation of protein catabolic process in the vacuole,BP,ATP13A2
19184,GO:1905166,0.289817286116073,0.967661191225696,1,3,negative regulation of lysosomal protein catabolic process,BP,ATP13A2
13093,GO:0051581,0.289822302133399,0.967659979799288,1,3,negative regulation of neurotransmitter uptake,BP,NOS1
10719,GO:0044003,0.289826611843733,0.854864486548747,5,34,modification by symbiont of host morphology or physiology,BP,TNIP1;BCL2L1;VAPB;RXRA;TGFB1
807,GO:0002074,0.289944190445311,0.967630534223016,1,3,extraocular skeletal muscle development,BP,MYH15
11751,GO:0046548,0.289953053190732,0.967628392566277,1,3,retinal rod cell development,BP,NAGLU
11799,GO:0046642,0.289970853353646,0.967624090958861,1,3,negative regulation of alpha-beta T cell proliferation,BP,ARG2
13288,GO:0051956,0.289980226804764,0.96762182562611,1,3,negative regulation of amino acid transport,BP,STK39
14476,GO:0061819,0.290096039049909,0.967593829027467,1,3,telomeric DNA-containing double minutes formation,BP,ERCC1
19384,GO:1905764,0.290096039049909,0.967593829027467,1,3,regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19385,GO:1905765,0.290096039049909,0.967593829027467,1,3,negative regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19604,GO:1990599,0.290096039049909,0.967593829027467,1,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
13546,GO:0055100,0.290299882893793,0.967544517277575,1,3,adiponectin binding,MF,ADIPOR1
7703,GO:0032155,0.290308585224751,0.827724330644385,8,59,cell division site part,CC,PITPNM1;SSH1;PKN1;RHOC;RAB11FIP4;PLCD3;SPIRE1;NDE1
8903,GO:0034714,0.290334355313624,0.967536173750675,1,3,type III transforming growth factor beta receptor binding,MF,TGFB1
19971,GO:2000466,0.290357168269258,0.967530651532648,1,3,negative regulation of glycogen (starch) synthase activity,BP,GSK3A
5773,GO:0016971,0.290456088299319,0.967506700117515,1,3,flavin-linked sulfhydryl oxidase activity,MF,QSOX1
10214,GO:0042819,0.290505329963325,0.967494773438468,1,3,vitamin B6 biosynthetic process,BP,PSAT1
9373,GO:0035879,0.290577697566233,0.967477240860191,1,3,plasma membrane lactate transport,BP,SLC16A3
6454,GO:0021769,0.290600086076979,0.967471815654174,1,3,orbitofrontal cortex development,BP,FGFR1
5782,GO:0017001,0.290711253084714,0.867746232690771,4,28,antibiotic catabolic process,BP,PCK2;PRDX5;GPX3;CAT
13684,GO:0060180,0.290740817013244,0.967437701505885,1,3,female mating behavior,BP,THRA
6696,GO:0030070,0.29077764949111,0.96742876961495,1,3,insulin processing,BP,ERO1B
3655,GO:0008138,0.290784594841018,0.853960192463283,5,35,protein tyrosine/serine/threonine phosphatase activity,MF,SBF1;SSH1;PTPDC1;DUSP4;DUSP6
10879,GO:0044393,0.290852612641213,0.967410586605961,1,3,microspike,CC,FSCN1
12873,GO:0051172,0.290855106624502,0.737100200918447,191,1780,negative regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;ERCC1;MDFI;ZMYND8;CHAC1;CCND1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;CST3;SERPINE2;NR1D1;DLG1;DAP;IFI6;DNMT3A;FKBP1A;MTA1;PRNP;WWC3;CRTAP;SMURF2;FAM129B;SESN2;ZC3H6;NACC2;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;PPP1R13L;ATF4;AKT1;PEG3;SERPING1;BAG3;APOE;ATP13A2;PKN1;ELK3;WWTR1;PHF21A;TSPYL2;PRKCZ;DGKQ;FZD8;CTSZ;EPHA1;PTK6;DEAF1;SALL2;PPP1R35;DRAP1;SERPINB6;LIMK1;STK39;DKK1;SOX7;UBE2J1;PPARA;H2AFJ;WDTC1;CD44;DNAJB5;IDE;DEDD2;PRDX5;BIN1;SUFU;SCMH1;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;DUSP4;SATB1;IFI27;PARP10;GATA3;PHF1;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;NEIL1;TFPI2;HMGA2;ARID5B;PPP1R14A;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;IRF7;HIST3H2A;PER3;RERE;RSF1;GSK3A;SPINT2;DUSP6;FYN;ZNF692;PPM1F;NELFCD;MICAL1;TLE4;VDR;PUM1;COMT;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;MIF;SOCS2;HES2;PCSK1N;TRIB3;SNX25;LEMD2;ZFPM1;PMEPA1;TRIB2;MXD4;SAMD4B;ZP3;LRRK1;RCOR1;RNF222;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;EPHB2;CBL;CIB1;SOCS7;KANK2;FURIN;AIDA;CEACAM1;PAIP2;ZNF256;ECM1;CD59;MBD3;IGF2BP3;CCNE1;TGFB1;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10;KLF12;ZNF318;EP300
7439,GO:0031543,0.290897367184619,0.917424581273176,2,10,peptidyl-proline dioxygenase activity,MF,P4HB;P4HA1
142,GO:0000293,0.29100567377606,0.967373441816408,1,3,ferric-chelate reductase activity,MF,CYB561
19673,GO:1990837,0.291017625050135,0.755290945657336,61,531,sequence-specific double-stranded DNA binding,MF,ZMYND8;H1F0;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;TSPYL2;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;PPARA;ZNF516;TFE3;TNRC18;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;TOP1;IRF7;PER3;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300
17423,GO:1900133,0.291055497955053,0.967361345186283,1,3,regulation of renin secretion into blood stream,BP,F2R
17419,GO:1900126,0.291080524012348,0.967355268214104,1,3,negative regulation of hyaluronan biosynthetic process,BP,TGFB1
1916,GO:0004605,0.291153089867336,0.967337643620403,1,3,phosphatidate cytidylyltransferase activity,MF,CDS2
4640,GO:0010760,0.291182887160066,0.963592158557274,1,4,negative regulation of macrophage chemotaxis,BP,MIF
19319,GO:1905522,0.291182887160066,0.963592158557274,1,4,negative regulation of macrophage migration,BP,MIF
13949,GO:0060591,0.291184943867779,0.967329905255789,1,3,chondroblast differentiation,BP,FGF2
12683,GO:0050868,0.291279340459285,0.826869317182425,8,60,negative regulation of T cell activation,BP,DLG1;PRNP;ARG2;PAG1;ARG1;CEACAM1;TGFB1;ANXA1
6997,GO:0030672,0.291315260274684,0.833957185255746,7,52,synaptic vesicle membrane,CC,RAB3B;PTPRS;DBNDD1;PI4K2A;DMXL2;VAMP2;BCL2L1
17055,GO:0099501,0.291315260274684,0.833957185255746,7,52,exocytic vesicle membrane,CC,RAB3B;PTPRS;DBNDD1;PI4K2A;DMXL2;VAMP2;BCL2L1
20082,GO:2000671,0.291467820153699,0.967261138537718,1,3,regulation of motor neuron apoptotic process,BP,MAP3K12
20083,GO:2000672,0.291467820153699,0.967261138537718,1,3,negative regulation of motor neuron apoptotic process,BP,MAP3K12
3804,GO:0008381,0.291469955053643,0.967260619226477,1,3,mechanosensitive ion channel activity,MF,FAM155B
9512,GO:0036151,0.291504328460915,0.887481984117132,3,18,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;LPCAT4;LPCAT1
11760,GO:0046581,0.291505429689426,0.967251989370568,1,3,intercellular canaliculus,CC,STARD10
14993,GO:0070885,0.291549534611174,0.967241258188014,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,PRNP
17230,GO:0106057,0.291549534611174,0.967241258188014,1,3,negative regulation of calcineurin-mediated signaling,BP,PRNP
4301,GO:0009744,0.291615152460798,0.967225288889905,1,3,response to sucrose,BP,ERCC1
8693,GO:0034285,0.291615152460798,0.967225288889905,1,3,response to disaccharide,BP,ERCC1
703,GO:0001920,0.291617120114708,0.967224809955364,1,3,negative regulation of receptor recycling,BP,PCSK9
9249,GO:0035635,0.29162097136107,0.887413628081959,3,18,entry of bacterium into host cell,BP,SRC;EXOC2;CBL
18552,GO:1903708,0.291713310847413,0.800035668677731,14,113,positive regulation of hemopoiesis,BP,CTNNBIP1;AP3D1;XBP1;MMP14;FAM210B;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1;GNAS
6863,GO:0030327,0.291730354232038,0.967197241451548,1,3,prenylated protein catabolic process,BP,PCYOX1
8329,GO:0033159,0.291758385852077,0.967190414653692,1,3,negative regulation of protein import into nucleus, translocation,BP,PARP10
18896,GO:1904527,0.291825215429199,0.96717413568746,1,3,negative regulation of microtubule binding,BP,TTBK2
3154,GO:0006754,0.291835922417932,0.806603137680493,12,96,ATP biosynthetic process,BP,PGM1;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
13841,GO:0060415,0.29204629070695,0.842426367760946,6,42,muscle tissue morphogenesis,BP,FKBP1A;ADARB1;ZFPM1;CHD7;RXRA;TGFB1
3801,GO:0008378,0.292078685460059,0.867526218963355,4,26,galactosyltransferase activity,MF,B4GALT2;B3GNT3;WDFY3;B4GALT6
8451,GO:0033565,0.292135143345066,0.967098578941739,1,3,ESCRT-0 complex,CC,HGS
10245,GO:0042940,0.29215129499953,0.96709463857933,1,3,D-amino acid transport,BP,NTSR1
5349,GO:0016094,0.292161546338549,0.967092137516683,1,3,polyprenol biosynthetic process,BP,SRD5A3
19663,GO:1990812,0.292192972704574,0.967084469601083,1,3,growth cone filopodium,CC,APBB1
5089,GO:0015333,0.2922349438935,0.96707422716125,1,3,peptide:proton symporter activity,MF,SLC15A1
4826,GO:0014022,0.292252169572547,0.967070022953809,1,3,neural plate elongation,BP,DVL1
6564,GO:0022007,0.292252169572547,0.967070022953809,1,3,convergent extension involved in neural plate elongation,BP,DVL1
19933,GO:2000389,0.292423071348428,0.96702829460757,1,3,regulation of neutrophil extravasation,BP,ADAM8
19934,GO:2000391,0.292423071348428,0.96702829460757,1,3,positive regulation of neutrophil extravasation,BP,ADAM8
9069,GO:0035290,0.292432539590437,0.96702598188563,1,3,trunk segmentation,BP,SEMA3F
9628,GO:0036484,0.292432539590437,0.96702598188563,1,3,trunk neural crest cell migration,BP,SEMA3F
9629,GO:0036486,0.292432539590437,0.96702598188563,1,3,ventral trunk neural crest cell migration,BP,SEMA3F
17594,GO:1901166,0.292432539590437,0.96702598188563,1,3,neural crest cell migration involved in autonomic nervous system development,BP,SEMA3F
17495,GO:1900365,0.29246482488632,0.9670180951359,1,3,positive regulation of mRNA polyadenylation,BP,HSF1
15876,GO:0072576,0.292465730284634,0.916672334117431,2,10,liver morphogenesis,BP,XBP1;CEACAM1
4610,GO:0010724,0.292482826390274,0.967013697195624,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
101,GO:0000212,0.292542817779054,0.916635278301644,2,10,meiotic spindle organization,BP,TUBG2;TUBG1
15743,GO:0072298,0.292544556644194,0.966998613301101,1,3,regulation of metanephric glomerulus development,BP,RET
18738,GO:1904116,0.292566368063874,0.96699328267981,1,3,response to vasopressin,BP,ADCY6
18739,GO:1904117,0.292566368063874,0.96699328267981,1,3,cellular response to vasopressin,BP,ADCY6
16328,GO:0090480,0.292615050654246,0.966981383041134,1,3,purine nucleotide-sugar transmembrane transport,BP,SLC35B4
7380,GO:0031427,0.292616766086073,0.966980963687107,1,3,response to methotrexate,BP,ASNS
1598,GO:0004013,0.292650137406164,0.966972805122478,1,3,adenosylhomocysteinase activity,MF,AHCY
5689,GO:0016802,0.292650137406164,0.966972805122478,1,3,trialkylsulfonium hydrolase activity,MF,AHCY
16566,GO:0097305,0.292675206030481,0.799242402918422,14,113,response to alcohol,BP,CCND1;DNMT3A;ADCY7;AKT1;TGFBR2;GNB1;GATA3;PMVK;FYN;BCL2L1;CBL;ADCY6;TGFB1;CAT
8181,GO:0032911,0.292678869788933,0.966965779734262,1,3,negative regulation of transforming growth factor beta1 production,BP,FURIN
4108,GO:0009162,0.292701733983342,0.915426285368055,2,11,deoxyribonucleoside monophosphate metabolic process,BP,TK2;GUK1
9015,GO:0035166,0.292727269154816,0.966953943575683,1,3,post-embryonic hemopoiesis,BP,ERCC1
19473,GO:1990075,0.292819398117846,0.96693140641449,1,3,periciliary membrane compartment,CC,KIF17
5068,GO:0015280,0.292910135281403,0.966909200950038,1,3,ligand-gated sodium channel activity,MF,ASIC1
10654,GO:0043654,0.293008557203503,0.966885105002717,1,3,recognition of apoptotic cell,BP,PEAR1
6457,GO:0021773,0.293025004274073,0.966881077382693,1,3,striatal medium spiny neuron differentiation,BP,SHANK3
707,GO:0001927,0.293047559478946,0.966875553514592,1,3,exocyst assembly,BP,EXOC2
19972,GO:2000467,0.293063226714646,0.966871716223469,1,3,positive regulation of glycogen (starch) synthase activity,BP,GSK3A
20335,GO:2001293,0.293164026245729,0.966847021729328,1,3,malonyl-CoA metabolic process,BP,MLYCD
5111,GO:0015410,0.293229807515664,0.966830900427989,1,3,manganese-transporting ATPase activity,MF,ATP2C2
7247,GO:0031166,0.293522498606765,0.966759113820085,1,3,integral component of vacuolar membrane,CC,ATP13A2
7313,GO:0031310,0.293522498606765,0.966759113820085,1,3,intrinsic component of vacuolar membrane,CC,ATP13A2
16818,GO:0098641,0.293622479648339,0.88568265544628,3,19,cadherin binding involved in cell-cell adhesion,MF,PAK4;BAIAP2L1;ANXA1
11882,GO:0046870,0.293622695403708,0.966734518304674,1,3,cadmium ion binding,MF,NOS1
17080,GO:0099541,0.293623642151279,0.966734285853913,1,3,trans-synaptic signaling by lipid,BP,F2R
17081,GO:0099542,0.293623642151279,0.966734285853913,1,3,trans-synaptic signaling by endocannabinoid,BP,F2R
10855,GO:0044341,0.293755412098292,0.966701923692043,1,3,sodium-dependent phosphate transport,BP,SLC20A1
6839,GO:0030297,0.293809634445763,0.966688601562533,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ
187,GO:0000404,0.293886025605327,0.966669827393062,1,3,heteroduplex DNA loop binding,MF,XPC
66,GO:0000137,0.293996882991314,0.915934877208116,2,10,Golgi cis cisterna,CC,SMPD3;LLGL1
13909,GO:0060528,0.294208218751933,0.966590575978325,1,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,RXRA
16957,GO:0098915,0.294220874518119,0.966587460731648,1,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
725,GO:0001951,0.294252575897562,0.966579656616912,1,3,intestinal D-glucose absorption,BP,SLC5A1
17210,GO:0106001,0.294252575897562,0.966579656616912,1,3,intestinal hexose absorption,BP,SLC5A1
16882,GO:0098792,0.294274999247727,0.9158006023189,2,10,xenophagy,BP,LRSAM1;MAPK3
18949,GO:1904646,0.294327831008672,0.885822665578839,3,18,cellular response to amyloid-beta,BP,PRNP;LRP1;CASP4
2388,GO:0005522,0.294446671629731,0.915717668883423,2,10,profilin binding,MF,VASP;WIPF1
8644,GO:0034163,0.294559745421456,0.966503983690803,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
14716,GO:0070327,0.294569341184734,0.966501618108715,1,3,thyroid hormone transport,BP,SLCO4A1
2317,GO:0005315,0.294570830798516,0.966501250875024,1,3,inorganic phosphate transmembrane transporter activity,MF,SLC20A1
5736,GO:0016879,0.294637349701247,0.840370042716633,6,43,ligase activity, forming carbon-nitrogen bonds,MF,NAPRT;GLUL;ASS1;PPCS;ASNS;HLCS
4630,GO:0010749,0.294667359815864,0.966477448606429,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
10600,GO:0043555,0.294669112434655,0.885621441562706,3,18,regulation of translation in response to stress,BP,SESN2;ATF4;IMPACT
19474,GO:1990086,0.2946870391993,0.966472594821353,1,3,lens fiber cell apoptotic process,BP,TGFBR2
4316,GO:0009792,0.29471775718974,0.75684985580916,49,425,embryo development ending in birth or egg hatching,BP,MDFI;CAPN2;DVL1;MAP2K1;DLG1;EGFR;MMP14;EPN1;FBXW8;AKT1;TFEB;ENDOG;DEAF1;SALL2;TGFBR2;DKK1;PRKACB;WDTC1;PLCG1;SUFU;PKD1;GATA3;HSF1;EDNRA;TULP3;ALDH1A2;SPINT2;FUZ;PFN1;RCN1;EIF2S2;SEC24C;FGFR1;HYAL1;BCL2L1;PLCD3;ZP3;VASP;CHD7;RXRA;CAMSAP3;OCRL;APBA1;MBD3;SLC30A1;TGFB1;SF3B6;GNAS;EP300
2408,GO:0005577,0.294721245830167,0.966464157012121,1,3,fibrinogen complex,CC,FBLN1
4270,GO:0009617,0.294760928709884,0.767045182516514,33,297,response to bacterium,BP,TNIP1;NOS1;F2R;SHC1;CYP27B1;PCK2;NR1D1;MAPKAPK3;BCR;XBP1;AKT1;IRAK1;ARG2;HIST2H2BE;RAB29;GSDMA;HSF1;MAPKBP1;TNFRSF6B;SRC;TNFRSF1A;ANXA3;VDR;COMT;LOXL1;MIF;RNASE7;ARG1;GSDMC;BAIAP2L1;MAPK3;LITAF;TGFB1
20245,GO:2001137,0.294800414365575,0.966444623608069,1,3,positive regulation of endocytic recycling,BP,SORL1
4061,GO:0009109,0.294882551983745,0.914361852604986,2,11,coenzyme catabolic process,BP,ACOT7;ALDH1L2
11258,GO:0045429,0.295041263479599,0.865600672277156,4,26,positive regulation of nitric oxide biosynthetic process,BP,AKT1;ASS1;DNM2;P2RX4
18854,GO:1904407,0.295041263479599,0.865600672277156,4,26,positive regulation of nitric oxide metabolic process,BP,AKT1;ASS1;DNM2;P2RX4
6677,GO:0030035,0.295052824597993,0.966382301522207,1,3,microspike assembly,BP,FSCN1
311,GO:0000822,0.295203746365538,0.966345005420301,1,3,inositol hexakisphosphate binding,MF,ITPR3
1381,GO:0003274,0.295233285574421,0.966337702798188,1,3,endocardial cushion fusion,BP,TGFBR2
1971,GO:0004677,0.29524607225428,0.966334541414109,1,3,DNA-dependent protein kinase activity,MF,HMGA2
15760,GO:0072320,0.295276633232752,0.966326984801268,1,3,volume-sensitive chloride channel activity,MF,TTYH3
18225,GO:1902988,0.295282610292762,0.966325506776843,1,3,neurofibrillary tangle assembly,BP,SORL1
18038,GO:1902498,0.295284713135053,0.966324986770974,1,3,regulation of protein autoubiquitination,BP,MTA1
12924,GO:0051251,0.295289669766474,0.784855179508098,19,160,positive regulation of lymphocyte activation,BP,AP3D1;XBP1;MMP14;AKT1;CARD11;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;FYN;MIF;ZP3;PNP;TGFB1;ANXA1
11421,GO:0045806,0.295297875278911,0.850839716990419,5,35,negative regulation of endocytosis,BP,DLG4;SNX33;PCSK9;LRSAM1;TGFB1
16998,GO:0099010,0.295333429730259,0.966312938467808,1,3,modification of postsynaptic structure,BP,ARHGAP44
18970,GO:1904694,0.295384682334645,0.966300260251552,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
7037,GO:0030805,0.295388990748234,0.966299194363888,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7052,GO:0030820,0.295388990748234,0.966299194363888,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8300,GO:0033121,0.295388990748234,0.966299194363888,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
8689,GO:0034274,0.295479958400599,0.966276684653882,1,3,Atg12-Atg5-Atg16 complex,CC,WDFY3
2575,GO:0005861,0.295593537603817,0.962392880831968,1,4,troponin complex,CC,TNNT1
2154,GO:0004970,0.295616138242456,0.966242970864911,1,3,ionotropic glutamate receptor activity,MF,GRIN3B
17674,GO:1901387,0.295619006754912,0.966242260500661,1,3,positive regulation of voltage-gated calcium channel activity,BP,EHD3
13117,GO:0051610,0.295652870426721,0.966233873770577,1,3,serotonin uptake,BP,NOS1
10126,GO:0042635,0.295715204913102,0.913953815746027,2,11,positive regulation of hair cycle,BP,GAL;HPSE
13211,GO:0051798,0.295715204913102,0.913953815746027,2,11,positive regulation of hair follicle development,BP,GAL;HPSE
1744,GO:0004340,0.29588351374224,0.966176719848648,1,3,glucokinase activity,MF,HK1
1785,GO:0004396,0.29588351374224,0.966176719848648,1,3,hexokinase activity,MF,HK1
3991,GO:0008865,0.29588351374224,0.966176719848648,1,3,fructokinase activity,MF,HK1
6048,GO:0019158,0.29588351374224,0.966176719848648,1,3,mannokinase activity,MF,HK1
3210,GO:0006853,0.295905711821756,0.9150112846735,2,10,carnitine shuttle,BP,CPT2;CPT1B
9676,GO:0038026,0.295937413486508,0.966163355217204,1,3,reelin-mediated signaling pathway,BP,VLDLR
17528,GO:1900623,0.29614178477832,0.966112652556794,1,3,regulation of monocyte aggregation,BP,CD44
17529,GO:1900625,0.29614178477832,0.966112652556794,1,3,positive regulation of monocyte aggregation,BP,CD44
1338,GO:0003192,0.296187386997956,0.96610133299534,1,3,mitral valve formation,BP,ZFPM1
12957,GO:0051295,0.296198636256525,0.966098540320051,1,3,establishment of meiotic spindle localization,BP,SPIRE1
12072,GO:0048003,0.296225752688348,0.966091807999102,1,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,AP3D1
12074,GO:0048007,0.296225752688348,0.966091807999102,1,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,AP3D1
7917,GO:0032484,0.296238298222728,0.966088692996914,1,3,Ral protein signal transduction,BP,RGL2
7918,GO:0032485,0.296238298222728,0.966088692996914,1,3,regulation of Ral protein signal transduction,BP,RGL2
6796,GO:0030229,0.296315291640604,0.966069572193629,1,3,very-low-density lipoprotein particle receptor activity,MF,VLDLR
7088,GO:0030877,0.296411090361766,0.914765968604832,2,10,beta-catenin destruction complex,CC,CTNNBIP1;GSK3A
13133,GO:0051649,0.296466795582917,0.732561196673995,178,1674,establishment of localization in cell,BP,EDEM1;NOS1;LTBP2;SH3TC2;F2R;RAC2;SORL1;DVL1;MAP2K1;WNT7A;SNX9;AP3D1;LMF1;CPT2;NR1D1;DLG1;XPOT;FKBP1A;RAB3B;RAPGEF3;PRNP;RAB43;COPG1;SNPH;BBS2;BCR;RAB31;LRP5;EVI5L;MAP4K4;RTN2;FYCO1;PRKACA;MAP2K2;STK25;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;AP1B1;SYVN1;YIF1A;AP2A2;PRKCZ;ATP7B;ITPR3;VPS11;VPS4A;PITRM1;CTSZ;TMEM129;PCSK9;SEPT5;SEC23A;MSN;MAP1B;GDI1;MVB12B;CREB3L2;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;PLCG1;TBC1D16;ATG13;SEC63;TBC1D14;BIN1;CCDC88C;PAK1;NLGN2;DDIT3;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;DOPEY2;ASIC1;FAM155B;DYNLRB1;VAMP2;PIP5K1C;GIPC1;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;REEP6;NUCB1;RAB1B;STX5;TOM1L2;COG8;RERE;GSK3A;STXBP1;FYN;RAB25;SLC6A9;KIF17;KIF13B;BRSK1;STX10;MOAP1;MCFD2;NTSR1;SEC24C;VPS37A;RAB11FIP4;LEMD2;TPCN1;ARFIP2;MGRN1;P2RX4;USO1;TBC1D20;SPIRE1;FGF2;EHD4;VAPB;COG1;MYO1D;CHD7;LMAN1;TBC1D2B;TGFA;NDE1;CAMSAP3;RPL28;SNAP29;LONP2;KCNC4;CAMK1;HGS;CBL;TRAPPC1;CIB1;RAB4B;MAPK3;CPT1B;CSNK1D;ARHGEF2;SNX27;UGCG;LLGL1;HM13;APBA1;ARHGAP44;CD59;SLC30A1;ITSN1;TGFB1;PPP6R1;PPP1R10;RAB6A;ZFYVE21;ARCN1;RASA3;FHOD1
19959,GO:2000425,0.296559559298906,0.966008868169743,1,3,regulation of apoptotic cell clearance,BP,ABCA7
18753,GO:1904177,0.296620683826361,0.965993667906445,1,3,regulation of adipose tissue development,BP,SH3PXD2B
18754,GO:1904179,0.296620683826361,0.965993667906445,1,3,positive regulation of adipose tissue development,BP,SH3PXD2B
5712,GO:0016840,0.296661878387454,0.913488809966453,2,11,carbon-nitrogen lyase activity,MF,CHAC1;GGACT
13212,GO:0051799,0.29666722152716,0.965982092382728,1,3,negative regulation of hair follicle development,BP,FERMT1
4619,GO:0010735,0.296729314240204,0.965966644200687,1,3,positive regulation of transcription via serum response element binding,BP,MICAL2
895,GO:0002265,0.296732577030047,0.965965832330466,1,3,astrocyte activation involved in immune response,BP,LRP1
2796,GO:0006241,0.296780160780328,0.912481461509645,2,12,CTP biosynthetic process,BP,NME4;UCKL1
11536,GO:0046036,0.296780160780328,0.912481461509645,2,12,CTP metabolic process,BP,NME4;UCKL1
5345,GO:0016080,0.2968267955475,0.965942383326091,1,3,synaptic vesicle targeting,BP,SEPT5
14651,GO:0070208,0.297108586584626,0.914426855013465,2,10,protein heterotrimerization,BP,GNB1;C1QTNF6
1525,GO:0003886,0.297123938175311,0.965868368816531,1,3,DNA (cytosine-5-)-methyltransferase activity,MF,DNMT3A
8099,GO:0032776,0.297123938175311,0.965868368816531,1,3,DNA methylation on cytosine,BP,DNMT3A
16143,GO:0090116,0.297123938175311,0.965868368816531,1,3,C-5 methylation of cytosine,BP,DNMT3A
10822,GO:0044300,0.297238979783837,0.965839688115531,1,3,cerebellar mossy fiber,CC,DLG4
4183,GO:0009259,0.297283569641092,0.759413336704215,40,370,ribonucleotide metabolic process,BP,NT5E;NOS1;PTHLH;DLG4;DLG1;PGM1;RAPGEF3;NME4;ACOT7;ADCY7;HK1;CARD11;APOE;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;DLG3;GNAI2;PPCS;PANK4;SDHA;CAP1;TAZ;UCKL1;ADNP;GUK1;AMPD2;VPS9D1;TCIRG1;ABHD14B;ALDOC;NDUFS2;ADCY6;TGFB1;LDHA;PODXL2
14159,GO:0061005,0.297345700883849,0.849668157201056,5,34,cell differentiation involved in kidney development,BP,ACTA2;WWTR1;LAMB2;PODXL;GATA3
16969,GO:0098935,0.297416791112851,0.965795330703765,1,3,dendritic transport,BP,KIF17
16971,GO:0098937,0.297416791112851,0.965795330703765,1,3,anterograde dendritic transport,BP,KIF17
4847,GO:0014052,0.297448634902512,0.96578738328417,1,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1
4800,GO:0010990,0.297481454556629,0.965779191180984,1,3,regulation of SMAD protein complex assembly,BP,PMEPA1
15716,GO:0072235,0.297520677498828,0.965769399247627,1,3,metanephric distal tubule development,BP,PKD1
14360,GO:0061535,0.297571006801343,0.965756832227835,1,3,glutamate secretion, neurotransmission,BP,STXBP1
15717,GO:0072236,0.29759724770913,0.96575027890905,1,3,metanephric loop of Henle development,BP,PKD1
19580,GO:1990504,0.297680940281362,0.96572937288939,1,3,dense core granule exocytosis,BP,STXBP1
19132,GO:1905031,0.29770278037461,0.965723916104543,1,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,DLG1
14475,GO:0061817,0.297710641040175,0.9657219519791,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2
11480,GO:0045920,0.297725325783462,0.883813118215626,3,18,negative regulation of exocytosis,BP,BCR;CEACAM1;ANXA1
11922,GO:0046935,0.297728551966714,0.965717476373041,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2
10326,GO:0043097,0.297944098385511,0.912857127093022,2,11,pyrimidine nucleoside salvage,BP,TK2;UCKL1
6503,GO:0021869,0.297987441741047,0.965652746400386,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR1
4436,GO:0010273,0.298018329029228,0.959408352450053,1,5,detoxification of copper ion,BP,MT2A
19497,GO:1990169,0.298018329029228,0.959408352450053,1,5,stress response to copper ion,BP,MT2A
18470,GO:1903527,0.298044416283026,0.965638491499478,1,3,positive regulation of membrane tubulation,BP,ASAP1
4782,GO:0010966,0.298051897333643,0.965636619500186,1,3,regulation of phosphate transport,BP,FGFR1
71,GO:0000147,0.298107634469443,0.965622670395092,1,3,actin cortical patch assembly,BP,WIPF1
10881,GO:0044396,0.298107634469443,0.965622670395092,1,3,actin cortical patch organization,BP,WIPF1
13144,GO:0051666,0.298107634469443,0.965622670395092,1,3,actin cortical patch localization,BP,WIPF1
59,GO:0000122,0.298180999293615,0.746382172492646,68,602,negative regulation of transcription by RNA polymerase II,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;NR1D1;DLG1;DNMT3A;WWC3;SMURF2;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;WWTR1;PHF21A;FZD8;DEAF1;SALL2;DRAP1;DKK1;PPARA;WDTC1;DNAJB5;SUFU;DDIT3;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;WFS1;CTBP1;HMGA2;ARID5B;IRF7;PER3;RERE;ZNF692;TLE4;VDR;THRA;HEXIM1;HSF4;FGFR1;RREB1;TENM2;HES2;TRIB3;ZFPM1;MXD4;RCOR1;APBB1;RXRA;ZHX3;TSHZ1;ZBTB4;TCF25;IMPACT;KANK2;MBD3;CCNE1;TGFB1;KLF12;EP300
2261,GO:0005173,0.298211356656986,0.965596703433235,1,3,stem cell factor receptor binding,MF,SPRED2
16241,GO:0090269,0.29847123143626,0.965531593018622,1,3,fibroblast growth factor production,BP,FGFR1
16242,GO:0090270,0.29847123143626,0.965531593018622,1,3,regulation of fibroblast growth factor production,BP,FGFR1
16855,GO:0098735,0.298540656239706,0.965514186740312,1,3,positive regulation of the force of heart contraction,BP,NOS1
20155,GO:2000807,0.298587717812213,0.965502384470343,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
16421,GO:0097025,0.29859340446132,0.965500958191727,1,3,MPP7-DLG1-LIN7 complex,CC,DLG1
3073,GO:0006641,0.298668866766772,0.828470749162096,7,52,triglyceride metabolic process,BP,LMF1;PCK2;APOE;PCSK9;MGLL;LPIN3;CAT
6409,GO:0021631,0.298724863900793,0.965467976975979,1,3,optic nerve morphogenesis,BP,EPHB2
6348,GO:0021521,0.298736999266543,0.965464931461697,1,3,ventral spinal cord interneuron specification,BP,SUFU
6458,GO:0021775,0.298736999266543,0.965464931461697,1,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,SUFU
6459,GO:0021776,0.298736999266543,0.965464931461697,1,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,SUFU
13936,GO:0060573,0.298736999266543,0.965464931461697,1,3,cell fate specification involved in pattern specification,BP,SUFU
13942,GO:0060579,0.298736999266543,0.965464931461697,1,3,ventral spinal cord interneuron fate commitment,BP,SUFU
13943,GO:0060581,0.298736999266543,0.965464931461697,1,3,cell fate commitment involved in pattern specification,BP,SUFU
14304,GO:0061364,0.29875679377214,0.9654599634572,1,3,apoptotic process involved in luteolysis,BP,SLIT3
9207,GO:0035583,0.298823056408083,0.96544332988009,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
2177,GO:0005010,0.29886157243084,0.965433659237682,1,3,insulin-like growth factor-activated receptor activity,MF,CRIM1
15438,GO:0071688,0.298862993790447,0.965433302330902,1,3,striated muscle myosin thick filament assembly,BP,OBSL1
18850,GO:1904396,0.298862993790447,0.965433302330902,1,3,regulation of neuromuscular junction development,BP,AGRN
2278,GO:0005220,0.298862993790567,0.965433302330902,1,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3
2428,GO:0005606,0.298862993790567,0.965433302330902,1,3,laminin-1 complex,CC,LAMB1
14520,GO:0062012,0.298973586552686,0.759400329051458,38,336,regulation of small molecule metabolic process,BP,NOS1;PTHLH;CYP27B1;LMF1;NR1D1;IGFBP4;PSMD2;RAPGEF3;AKT1;APOE;TMSB4X;DGKQ;TYSND1;PPARA;WDTC1;GNAI2;CAP1;SRC;LDLRAP1;TAZ;ACADVL;GSK3A;PMVK;PSMD7;VDR;COMT;NTSR1;SLC35B4;ADNP;ADIPOR1;TRIB3;MLYCD;SEC14L2;LONP2;CEACAM1;TGFB1;ANXA1;SLC45A3
5596,GO:0016620,0.299076304631606,0.862962022233279,4,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1L2;ALDH1A2;ALDH4A1;ALDH7A1
6702,GO:0030098,0.299209953061041,0.77323817502058,24,203,lymphocyte differentiation,BP,AP3D1;XBP1;CMTM7;MMP14;CARD11;PRKCZ;POU2F2;FZD8;TGFBR2;KDELR1;RAG1;SATB1;GATA3;ADAM8;LRRC8A;MFNG;ZFPM1;PNP;CHD7;POLM;DNAJB9;TGFB1;ANXA1;EP300
20209,GO:2001021,0.299365840441863,0.820460458430108,8,62,negative regulation of response to DNA damage stimulus,BP,ERCC1;CD44;ZNF385A;HSF1;HMGA2;MIF;BCL2L1;PPP1R10
18674,GO:1903960,0.29939659855032,0.913310041367898,2,10,negative regulation of anion transmembrane transport,BP,AKT1;STK39
14405,GO:0061640,0.299580885922676,0.81430496094293,9,69,cytoskeleton-dependent cytokinesis,BP,SNX9;SEPT10;SNX33;VPS4A;SEPT5;CUL7;RHOC;SEPT8;SPIRE1
8488,GO:0033628,0.3000028542574,0.861994792752025,4,27,regulation of cell adhesion mediated by integrin,BP,FERMT1;PODXL;RET;CIB1
14540,GO:0070016,0.300262732358626,0.912885502505237,2,10,armadillo repeat domain binding,MF,CTNNBIP1;STRN4
2281,GO:0005229,0.300355657554218,0.912839897224316,2,10,intracellular calcium activated chloride channel activity,MF,TTYH3;ANO8
14467,GO:0061778,0.300355657554218,0.912839897224316,2,10,intracellular chloride channel activity,MF,TTYH3;ANO8
19099,GO:1904950,0.30052480360784,0.795827695877291,13,107,negative regulation of establishment of protein localization,BP,F2R;IDH2;MAP4K4;RHBDF2;ARG2;TMSB4X;GDI1;HADH;UBE2J1;PARP10;MAPKBP1;CPTP;ANXA1
4264,GO:0009607,0.300571522749227,0.746717627618441,60,551,response to biotic stimulus,BP,TNIP1;NOS1;F2R;MST1R;SHC1;CYP27B1;PCK2;NR1D1;PRSS3;BNIP3;LCN2;MAPKAPK3;BCR;XBP1;ADARB1;ACTA2;AKT1;IFITM1;IRAK1;ARG2;HIST2H2BE;BNIP3L;FAM3A;HTRA1;DDIT3;RAB29;GATA3;GSDMA;OASL;HSF1;WFS1;MAPKBP1;HMGA2;TNFRSF6B;SRC;IRF7;LRSAM1;OAS1;ISG20;TNFRSF1A;ANXA3;VDR;PUM1;COMT;LOXL1;HYAL1;MIF;BCL2L1;RNASE7;ARG1;GSDMC;SEC14L1;BAIAP2L1;WIPF1;MAPK3;LITAF;ADAM15;CEACAM1;TGFB1;APOBEC3C
12325,GO:0048660,0.301078369322501,0.80316303194292,11,87,regulation of smooth muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;AKT1;IRAK1;TGFBR2;PAK1;APLN;TGM2;COMT;FGF2
8586,GO:0034058,0.301292134560914,0.912379674915194,2,10,endosomal vesicle fusion,BP,VPS11;VPS4A
15665,GO:0072160,0.301306945975178,0.912372386876234,2,10,nephron tubule epithelial cell differentiation,BP,WWTR1;GATA3
5516,GO:0016471,0.301390919285479,0.911148458637822,2,11,vacuolar proton-transporting V-type ATPase complex,CC,TCIRG1;ATP6V1C2
5439,GO:0016298,0.301738966705921,0.807351717622967,10,77,lipase activity,MF,PLCH2;PLD3;PLCG1;TMEM8A;PLCB3;EDNRA;MGLL;PLCD3;SMPD3;PNPLA6
7083,GO:0030866,0.302028883544824,0.84640132108198,5,34,cortical actin cytoskeleton organization,BP,DLG1;FMNL2;VPS4A;WIPF1;LLGL1
11343,GO:0045652,0.302186274339214,0.824269268234888,7,66,regulation of megakaryocyte differentiation,BP,AGO4;TNRC6B;ZFPM1;MYL9;CIB1;ASH2L;EP300
7301,GO:0031294,0.302279508039479,0.845970005162538,5,35,lymphocyte costimulation,BP,AKT1;CARD11;PAK1;SRC;FYN
17365,GO:1900026,0.30233364529453,0.860456576797656,4,27,positive regulation of substrate adhesion-dependent cell spreading,BP,NET1;DNM2;RREB1;CIB1
2202,GO:0005080,0.30260063868769,0.845744771879311,5,35,protein kinase C binding,MF,AKT1;PKN1;TWF2;SRC;ADCY6
1186,GO:0002830,0.302665413410316,0.910512745678347,2,11,positive regulation of type 2 immune response,BP,PRKCZ;GATA3
14109,GO:0060914,0.302851196895939,0.910419900816761,2,11,heart formation,BP,DKK1;LEMD2
18176,GO:1902894,0.302852455156492,0.911610349446579,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA
10489,GO:0043372,0.303004667123922,0.910343170500524,2,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;ANXA1
13411,GO:0052689,0.303220497451827,0.801362805817945,11,88,carboxylic ester hydrolase activity,MF,ACOT7;AARS;H6PD;PGLS;ACOT1;NLGN2;DTD1;TMEM8A;MGLL;BPHL;PNPLA6
13156,GO:0051702,0.303886836141712,0.82440474532114,7,53,interaction with symbiont,BP,PC;APOE;STOM;HMGA2;TBC1D20;ARG1;EP300
7260,GO:0031214,0.304027901712181,0.810913939569591,9,68,biomineral tissue development,BP,PTHLH;CYP27B1;ACVR2B;FAM20C;PPARA;FBXL15;ECM1;TGFB1;STIM1
4457,GO:0010421,0.304104749126025,0.909792265002728,2,11,hydrogen peroxide-mediated programmed cell death,BP,STK25;ENDOG
16639,GO:0097468,0.304104749126025,0.909792265002728,2,11,programmed cell death in response to reactive oxygen species,BP,STK25;ENDOG
1227,GO:0002901,0.304540434057518,0.959890577436437,1,4,mature B cell apoptotic process,BP,MIF
1231,GO:0002905,0.304540434057518,0.959890577436437,1,4,regulation of mature B cell apoptotic process,BP,MIF
1232,GO:0002906,0.304540434057518,0.959890577436437,1,4,negative regulation of mature B cell apoptotic process,BP,MIF
8888,GO:0034694,0.304776554390116,0.879597473156418,3,18,response to prostaglandin,BP,AKT1;GNB1;ADCY6
2169,GO:0005001,0.305181920283333,0.91045592292197,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRF;PTPRU
6054,GO:0019198,0.305181920283333,0.91045592292197,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRF;PTPRU
2716,GO:0006090,0.305316048501028,0.792030936860869,13,104,pyruvate metabolic process,BP,PCK2;BSG;SLC16A3;PGM1;PC;HAGH;HK1;PFKP;PPARA;DHTKD1;ALDOC;GLO1;LDHA
531,GO:0001649,0.305949060814468,0.780121125630174,17,140,osteoblast differentiation,BP,CTNNBIP1;PTHLH;MEF2D;MRC2;LRP5;ACVR2B;PRKACA;AKT1;IFITM1;WWTR1;FAM20C;SH3PXD2B;SUFU;RRBP1;ZHX3;CAT;GNAS
16875,GO:0098773,0.306070486648659,0.809205299251231,9,69,skin epidermis development,BP,LAMA5;EGFR;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
13920,GO:0060544,0.306154514192262,0.878181213113631,3,19,regulation of necroptotic process,BP,RBCK1;BOK;ARHGEF2
10121,GO:0042629,0.306556767040942,0.90855864803203,2,11,mast cell granule,CC,CBL;ANXA1
18610,GO:1903829,0.306689377391764,0.756506823684733,33,287,positive regulation of cellular protein localization,BP,EDEM1;RAC2;SORL1;DLG1;RAPGEF3;PRNP;SSH1;SESN2;EGFR;SNX33;AKT1;BAG3;VPS11;MSN;ZDHHC8;ATG13;PAK1;STOM;PTPN9;RAB29;CEMIP;VAMP2;SRC;GSK3A;FYN;ABHD17C;LRP1;CAMK1;EPHB2;CIB1;UGCG;TGFB1;ITGA3
6527,GO:0021904,0.306817452701246,0.878365968182024,3,18,dorsal/ventral neural tube patterning,BP,PRKACB;SUFU;TULP3
6580,GO:0022404,0.306936990997137,0.808521653810459,9,69,molting cycle process,BP,LAMA5;EGFR;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
6581,GO:0022405,0.306936990997137,0.808521653810459,9,69,hair cycle process,BP,LAMA5;EGFR;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
5511,GO:0016459,0.30717912025303,0.842521655925228,5,35,myosin complex,CC,OBSL1;MYH16;MYH15;MYO1D;MYL9
576,GO:0001725,0.307180486222628,0.83122758124962,6,43,stress fiber,CC,MST1R;CORO1B;FSCN1;FLNB;PXN;FHOD1
16668,GO:0097517,0.307180486222628,0.83122758124962,6,43,contractile actin filament bundle,CC,MST1R;CORO1B;FSCN1;FLNB;PXN;FHOD1
10570,GO:0043517,0.307224938269753,0.908221128358056,2,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,ZNF385A;SPRED2
13843,GO:0060419,0.307628943472066,0.821866491209365,7,51,heart growth,BP,TGFBR2;PAK1;GSK3A;DUSP6;FGFR1;FGF2;RXRA
12537,GO:0050661,0.307641224803596,0.841950325696882,5,36,NADP binding,MF,NOS1;H6PD;CBR4;NDOR1;CAT
7941,GO:0032515,0.307686423506455,0.841918336873637,5,36,negative regulation of phosphoprotein phosphatase activity,BP,FKBP1A;PPP1R35;PPP1R14A;PPP1R37;PPP1R10
5607,GO:0016645,0.307759836723343,0.877206423618725,3,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,ALDH1L2;PYCR2;ALDH4A1
12244,GO:0048486,0.308281835571663,0.907686056759829,2,11,parasympathetic nervous system development,BP,SEMA3F;ADARB1
3480,GO:0007342,0.308618518646573,0.95871874607222,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,SPESP1
12696,GO:0050885,0.308871782518477,0.856479511896444,4,26,neuromuscular process controlling balance,BP,DLG4;BCR;AARS;NLGN2
16210,GO:0090218,0.308885158072286,0.877113096681125,3,18,positive regulation of lipid kinase activity,BP,SRC;FGF2;TGFB1
5794,GO:0017022,0.308925533772131,0.829754989966889,6,44,myosin binding,MF,RAB3B;LARP6;GIPC1;RAB25;ARFGEF2;RAB6A
1112,GO:0002698,0.308985122443868,0.806710372747234,9,71,negative regulation of immune effector process,BP,BCR;SERPING1;HTRA1;ARG1;SEC14L1;CEACAM1;CD59;TGFB1;ANXA1
7049,GO:0030817,0.309558476737365,0.876110503054187,3,19,regulation of cAMP biosynthetic process,BP,PTHLH;GNAI2;CAP1
1219,GO:0002886,0.309646972010543,0.855590100637722,4,27,regulation of myeloid leukocyte mediated immunity,BP,RAC2;BCR;STXBP1;ARG1
14827,GO:0070542,0.309723723134161,0.820126799806338,7,52,response to fatty acid,BP,NFATC4;AKT1;HMGCL;GNB1;SRC;ADCY6;CAT
4127,GO:0009185,0.309724544971965,0.792005559419114,12,96,ribonucleoside diphosphate metabolic process,BP,DLG4;DLG1;PGM1;HK1;CARD11;PFKP;PPARA;DHTKD1;DLG3;GUK1;ALDOC;LDHA
11875,GO:0046849,0.309914089318788,0.81998210876434,7,52,bone remodeling,BP,RAC2;LRP5;EGFR;ADAM8;SRC;LRRK1;TGFB1
4813,GO:0014002,0.309934579922054,0.87588084119636,3,19,astrocyte development,BP,EGFR;LAMB2;LRP1
3500,GO:0007405,0.310064526500721,0.840741751878141,5,34,neuroblast proliferation,BP,NUMB;FGFR1;NDE1;ARHGEF2;TGFB1
12826,GO:0051101,0.310151431450617,0.79553446989723,11,91,regulation of DNA binding,BP,MDFI;CTNNBIP1;FAM129B;TMSB4X;PPARA;DDIT3;GATA3;HMGA2;RSF1;MAU2;TGFB1
272,GO:0000774,0.310178481442302,0.906722186771284,2,11,adenyl-nucleotide exchange factor activity,MF,BAG3;PFN1
16127,GO:0090090,0.310290147838781,0.781281049005673,15,130,negative regulation of canonical Wnt signaling pathway,BP,DVL1;IGFBP4;PSMD2;APOE;WWTR1;FERMT1;DKK1;DDIT3;IGFBP2;GSK3A;FUZ;WNT5B;PSMD7;BICC1;INVS
792,GO:0002053,0.310326182621677,0.876236855852936,3,18,positive regulation of mesenchymal cell proliferation,BP,LRP5;TGFBR2;FGFR1
6776,GO:0030206,0.310410122221156,0.876185736632977,3,18,chondroitin sulfate biosynthetic process,BP,CHPF;XYLT1;XYLT2
4400,GO:0010107,0.310499790714517,0.876131119000564,3,18,potassium ion import,BP,DLG1;SLC12A7;SLC12A4
12923,GO:0051250,0.31103291636389,0.799741330709534,10,79,negative regulation of lymphocyte activation,BP,DLG1;PRNP;ARG2;PKN1;PAG1;GAL;ARG1;CEACAM1;TGFB1;ANXA1
11396,GO:0045747,0.311421452907114,0.83951538115583,5,35,positive regulation of Notch signaling pathway,BP,EPN2;RFNG;TSPAN5;MFNG;EP300
14786,GO:0070470,0.3114878413799,0.957882407955143,1,4,plasma membrane respiratory chain,CC,SDHA
4075,GO:0009127,0.311706178395269,0.783266316558383,14,116,purine nucleoside monophosphate biosynthetic process,BP,PGM1;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;LHPP;AMPD2;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
4114,GO:0009168,0.311706178395269,0.783266316558383,14,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGM1;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;LHPP;AMPD2;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
3443,GO:0007254,0.311716599226055,0.770810365014737,19,158,JNK cascade,BP,WNT7A;ERCC6;MAP4K4;EGFR;AKT1;IRAK1;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;MAPK9;MAP3K12;TAOK1;MAPK10;AIDA;MINK1
6150,GO:0019433,0.311745584679249,0.90592223807378,2,11,triglyceride catabolic process,BP,APOE;MGLL
7450,GO:0031579,0.31178883702882,0.874746036612247,3,19,membrane raft organization,BP,DLG1;MARVELD1;MALL
3377,GO:0007156,0.31199405648454,0.80472620204938,9,67,homophilic cell adhesion via plasma membrane adhesion molecules,BP,SDK2;PCDH1;RET;PKD1;CADM4;FAT1;CLSTN1;AMIGO2;CEACAM1
18841,GO:1904380,0.312144473105898,0.874527906669498,3,19,endoplasmic reticulum mannose trimming,BP,EDEM1;SYVN1;RNF103
9461,GO:0036042,0.312200069512655,0.957673288246137,1,4,long-chain fatty acyl-CoA binding,MF,ACOT7
3488,GO:0007368,0.312396061860766,0.804199871690286,9,69,determination of left/right symmetry,BP,ACVR2B;AP1B1;TGFBR2;SUFU;MICAL2;PCSK6;PSKH1;BICC1;GAS8
12976,GO:0051339,0.312443730682852,0.874344236654946,3,19,regulation of lyase activity,BP,NOS1;GNAI2;CAP1
11815,GO:0046677,0.312463683526288,0.760084362901661,25,219,response to antibiotic,BP,CCND1;SDC1;CST3;DNMT3A;NET1;BNIP3;ADCY7;STK25;MAPK13;ENDOG;GATA3;HSF1;SRC;STK24;FYN;HYAL1;BCL2L1;ARG1;IMPACT;CBL;UROS;ADCY6;CAT;LDHA;ANXA1
597,GO:0001759,0.312626807080002,0.905470993634313,2,11,organ induction,BP,DKK1;FGFR1
17368,GO:1900029,0.312774611408707,0.905395208352699,2,11,positive regulation of ruffle assembly,BP,PFN1;EPS8L1
2715,GO:0006089,0.312906288423372,0.905327668085208,2,11,lactate metabolic process,BP,HAGH;LDHA
11797,GO:0046640,0.312956785654977,0.905301760827683,2,11,regulation of alpha-beta T cell proliferation,BP,ARG2;TGFBR2
12417,GO:0048843,0.313014218109246,0.874595562763965,3,18,negative regulation of axon extension involved in axon guidance,BP,SEMA3F;SEMA4B;SEMA4G
4128,GO:0009186,0.313178026116264,0.957385157854976,1,4,deoxyribonucleoside diphosphate metabolic process,BP,GUK1
9445,GO:0036010,0.313323757213247,0.874405993324067,3,18,protein localization to endosome,BP,SORL1;MSN;ABHD17C
10453,GO:0043300,0.313348468938337,0.853103914389411,4,27,regulation of leukocyte degranulation,BP,RAC2;BCR;STXBP1;CEACAM1
11785,GO:0046627,0.313476380491184,0.853017722404706,4,27,negative regulation of insulin receptor signaling pathway,BP,PRKCZ;GRB10;GSK3A;SOCS2
8353,GO:0033198,0.313543378168542,0.873668384248295,3,19,response to ATP,BP,SSH1;DGKQ;P2RX4
2666,GO:0006012,0.313545432520574,0.904999513011001,2,11,galactose metabolic process,BP,PGM1;GALE
12594,GO:0050729,0.313574695103864,0.809226380600145,8,64,positive regulation of inflammatory response,BP,TNIP1;EGFR;MAPK13;ADAM8;TGM2;TNFRSF1A;F12;ZP3
2722,GO:0006099,0.314255772925345,0.852143559921327,4,28,tricarboxylic acid cycle,BP,IDH2;MDH2;DHTKD1;SDHA
13232,GO:0051865,0.31436567186334,0.816588912011349,7,52,protein autoubiquitination,BP,MTA1;RAG1;LRSAM1;RNF187;STUB1;DDB2;RNF10
11525,GO:0045995,0.314372134531272,0.792435980273276,11,86,regulation of embryonic development,BP,DVL1;LAMA5;FAM129B;DKK1;PRKACB;SUFU;GATA3;TULP3;DUSP6;FUZ;FGFR1
12324,GO:0048659,0.314648312955507,0.79206540042651,11,88,smooth muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;AKT1;IRAK1;TGFBR2;PAK1;APLN;TGM2;COMT;FGF2
11951,GO:0046982,0.31474961151679,0.745641319278978,37,353,protein heterodimerization activity,MF,PGF;CAPN2;BOK;MEF2D;BNIP3;XBP1;EGFR;ATF4;P4HB;IRAK1;RABGGTA;HIST2H2BE;DRAP1;LIMK1;BNIP3L;H2AFJ;DDIT3;GGA1;HSF1;HIST3H2A;NTSR1;TENM2;USF2;BCL2L1;ADIPOR1;VAPB;HOMER2;RXRA;HIST2H2AC;ZHX3;TAF6;VEGFB;HIST1H2AG;TGFB1;PIK3R2;ERBB3;ITGA3
15258,GO:0071398,0.314999049985291,0.836965379115062,5,35,cellular response to fatty acid,BP,NFATC4;AKT1;GNB1;SRC;ADCY6
10221,GO:0042827,0.315022537216241,0.904239075102696,2,11,platelet dense granule,CC,LGALS3BP;ECM1
10597,GO:0043551,0.315218853435085,0.852221001844842,4,26,regulation of phosphatidylinositol 3-kinase activity,BP,SRC;FGF2;TGFB1;PIK3R2
9858,GO:0042094,0.315515537565705,0.903984633205031,2,11,interleukin-2 biosynthetic process,BP,CARD11;IL1RAP
10487,GO:0043370,0.315814019482258,0.872268145901303,3,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;GATA3;ANXA1
11638,GO:0046326,0.315977781086075,0.851708749704163,4,26,positive regulation of glucose import,BP,AKT1;PRKCZ;PAK1;PIK3R2
11054,GO:0045017,0.317372327862801,0.755878452400471,25,212,glycerolipid biosynthetic process,BP,LPCAT4;PCK2;PITPNM1;DGKA;SBF1;AGPAT3;LPCAT1;CDS2;DGKQ;PI4K2A;PTDSS2;PIGQ;PIP5K1C;TAZ;FGFR1;MTMR4;PITPNM2;SLC27A1;AGPAT4;ZP3;FGF2;OCRL;LPIN3;PIK3R2;STARD10
16891,GO:0098801,0.31752979064634,0.90294174341777,2,11,regulation of renal system process,BP,F2R;COMT
2248,GO:0005158,0.317560711843175,0.871799394467084,3,18,insulin receptor binding,MF,SHC1;GRB10;SRC
687,GO:0001894,0.317638911602955,0.775303611354362,15,124,tissue homeostasis,BP,F2R;RAC2;ERCC6;BBS2;LPCAT1;EGFR;TUB;STK39;ADAM8;SRC;P2RX4;LRRK1;HOMER2;DRAM2;GNAS
8120,GO:0032800,0.318017273998078,0.870903428727282,3,19,receptor biosynthetic process,BP,NR1D1;PPARA;FURIN
17410,GO:1900115,0.318218180835679,0.902584103611377,2,11,extracellular regulation of signal transduction,BP,DKK1;LTBP1
17411,GO:1900116,0.318218180835679,0.902584103611377,2,11,extracellular negative regulation of signal transduction,BP,DKK1;LTBP1
1050,GO:0002573,0.318734806151752,0.774416718115637,15,123,myeloid leukocyte differentiation,BP,CTNNBIP1;FAM20C;TGFBR2;TFE3;GATA3;SRC;IRF7;ZFPM1;LRRK1;L3MBTL3;GLO1;CEACAM1;TGFB1;SH3PXD2A;GNAS
12364,GO:0048711,0.31888556261175,0.90223678346789,2,11,positive regulation of astrocyte differentiation,BP,SERPINE2;BIN1
14667,GO:0070243,0.319131664131611,0.902108558983589,2,11,regulation of thymocyte apoptotic process,BP,RAG1;ADAM8
8503,GO:0033673,0.319603654280519,0.753821672400179,25,216,negative regulation of kinase activity,BP,SORL1;DVL1;LRP5;ADARB1;AKT1;APOE;PKN1;WWTR1;EPHA1;PTK6;DUSP4;DUSP6;PPM1F;HEXIM1;SOCS2;TRIB3;TRIB2;EPHB2;CBL;CIB1;SOCS7;AIDA;CEACAM1;SPRED2;CAMK2N1
10364,GO:0043167,0.319939688566777,0.701841829872677,469,4371,ion binding,MF,NT5E;EDEM1;XDH;PGF;FHL1;PYGB;CBS;ZMYND8;NOS1;ADAM19;LTBP2;CAPN2;MST1R;RAC2;LTBP4;RBCK1;ASAP2;MAP2K1;SHC1;PITPNC1;PYGL;ERCC6;CYP27B1;NEURL1;SNX9;SCN8A;SHARPIN;PCK2;ARAP1;OBSCN;SERPINE2;NR1D1;TRIM65;DYSF;MMP1;PITPNM1;ZKSCAN1;DNMT3A;PGM1;DGKA;POSTN;MTA1;RAB3B;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;PC;RAB43;SCYL1;SMARCA1;NME4;PLCH2;PCDH1;CYGB;LCN2;MAPKAPK3;SESN2;ACOT7;TNNT1;RNPEPL1;MARCH9;PLEK2;ZC3H6;FKBP9;HAGH;OSBPL10;TUBB6;USP20;BCR;RAB31;CHPF;LPCAT1;VLDLR;MARK4;AARS;ACVR2B;FBLN1;HTR7;GPT2;ADCY7;ZCCHC14;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;MMP14;FYCO1;THBS2;SEPT10;PRKACA;ADARB1;PTPRF;CARS;TUB;ACTA2;HK1;MAP2K2;TUBG2;STK25;SHANK3;ZKSCAN2;SNX33;AKT1;GPC4;IRAK1;PEG3;APOE;EHD3;ATP13A2;ARG2;PKN1;ZSCAN30;SYVN1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;DGKQ;MAPK13;RFNG;VPS11;PPP2R3B;VPS4A;PITRM1;EPHA1;PI4K2A;ZMIZ2;PTK6;PFKP;TMEM129;LENG9;SH3PXD2B;GRK6;ENDOG;ZNF598;GIT2;ACAD10;NMRK1;RRAS;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;TGFBR2;HADH;LIMK1;STK39;UBE2J1;PPARA;DHTKD1;NADK;PRKACB;LTBP1;CDC34;CD44;ZNF516;ESYT2;PLCG1;ABCB8;GTPBP1;MAP3K9;OSBPL5;IDE;MSRB2;JADE2;ANKIB1;TWF2;GIT1;HMGCL;PAK1;SP6;TTBK2;MMP10;ACSF2;ZNF385A;DTD1;RAG1;BAZ2A;GLUL;TBC1D9B;TUBB3;ADAMTS7;SYTL1;RET;RAB29;LAMC2;RHOC;NID1;CYTH3;HLTF;CEMIP;SEPT8;ASS1;ATP11A;GATA3;NUCB2;PHF1;GSDMA;ARL8A;OASL;MYOF;ACBD4;GNAI2;PPM1M;ZNF165;ANTXR2;GRIN3B;GLUD1;PANK4;ALOX15B;NEK9;CNDP2;FAT1;ASPH;MT2A;SDHA;ADAM8;NEIL1;RAI1;MYH15;ALAS1;RHOBTB2;TOP1;ARL2;MICAL2;PLCB3;P4HA1;B4GALT2;VAMP2;PIP5K1C;TULP3;SRC;LDLRAP1;APLP2;KDM4B;CBR4;SCG5;FKBP10;PEX10;TGM2;DNM2;NINL;UBR4;LRSAM1;NUCB1;RAB1B;CDC42BPB;NCS1;MARK3;STK24;CPTP;ACADVL;PAK6;ZCCHC24;YPEL3;GARS;RERE;RSF1;GSK3A;PCSK6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;AGRN;ASNS;ZNF692;PPM1F;ZNF862;YPEL5;LPAR3;PFN1;NISCH;MICAL1;KIF17;THOP1;ANXA3;WISP1;VDR;BRPF3;KIF13B;UCKL1;BRSK1;CHST14;CGREF1;RNF44;ITGA1;PSKH1;COMT;THRA;MCFD2;PLTP;RCN1;MAP3K10;EIF2S2;TIMP1;UBA1;ZSCAN18;RNF32;RNF187;ZNF71;LOXL1;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RREB1;ZBED4;ATP2C2;ADNP;PHF2;MIB2;TENM2;TTLL12;F12;MFNG;GUK1;CDK18;MTMR4;RAB11FIP4;AMPD2;ZDBF2;STK17A;ADIPOR1;NT5DC2;TRIB3;ZFPL1;PITPNM2;SNX25;ZFPM1;ARFIP2;HLCS;SARS2;NDOR1;PIP5KL1;ULK1;LRP1;HSPA2;AOX1;ZNF609;PLCD3;PAK4;MGRN1;P2RX4;ACP7;ULK2;SMPD3;GPATCH8;ZNF419;LRRK1;PNP;FGF2;EHD4;MAPK9;ZNF570;MAP3K12;ZNF398;HSPA13;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;PHYH;RHOBTB1;SLIT3;RXRA;ARG1;L3MBTL3;ZHX3;TSHZ1;VEGFB;NEURL1B;GSDMC;ZBTB4;SEC14L2;CYB561;ZNF624;ARSK;VAT1;ACY1;LONP2;CAMK1;EPHB2;HGS;DRG2;POLM;MYL9;CBL;CIB1;LACTB2;USP32;RAB4B;MAPK3;POMT1;MAPK10;CSNK1D;KIFC3;LITAF;GLO1;FURIN;S100A16;ARHGEF2;RNF103;ZNF444;SNX27;AIDA;NDUFS2;B4GALT6;MATN3;ZFP30;ADAM15;GALNT3;MINK1;ZNF256;ARHGAP44;AGAP1;ADCY6;ZFP28;ITSN1;SH3PXD2A;ADCK2;CAT;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PXN;ZNF318;EP300;THBS3;WDFY2;STIM1;RASA3;ASAP1;TRAF7;RNF10
589,GO:0001741,0.320370468349762,0.901461903550252,2,11,XY body,CC,DNMT3A;SIN3B
4191,GO:0009267,0.320464990984896,0.775987667479727,14,114,cellular response to starvation,BP,DAP;SESN2;XBP1;ATF4;PCSK9;GLUL;GAS2L1;STK24;ASNS;COMT;MAP1LC3B;IMPACT;MAPK3;C12ORF66
12137,GO:0048185,0.320476749820535,0.901406330565361,2,11,activin binding,MF,FKBP1A;ACVR2B
2655,GO:0005997,0.320561204173105,0.955172739565133,1,4,xylulose metabolic process,BP,TALDO1
13096,GO:0051584,0.321154993473965,0.954991940544235,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13279,GO:0051940,0.321154993473965,0.954991940544235,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
15896,GO:0072604,0.321407914074703,0.868791617245088,3,19,interleukin-6 secretion,BP,F2R;XBP1;IL1RAP
7438,GO:0031536,0.321534753358181,0.954876085081186,1,4,positive regulation of exit from mitosis,BP,TGFB1
405,GO:0001085,0.321793093189221,0.778189290005897,13,106,RNA polymerase II transcription factor binding,MF,ERCC1;MEF2D;MTA1;BBS2;XBP1;ATF4;PPARA;IFI27;GATA3;RERE;ZFPM1;TAF6;EP300
3281,GO:0006970,0.321934879946284,0.810626873726535,7,53,response to osmotic stress,BP,EGFR;PKN1;MAPK13;SERPINB6;STK39;LRRC8A;ARHGEF2
4080,GO:0009133,0.321974988211094,0.954741560438988,1,4,nucleoside diphosphate biosynthetic process,BP,GUK1
2620,GO:0005930,0.322387415577474,0.802527271316778,8,62,axoneme,CC,PRKACA;WDR66;DYNLRB1;TULP3;KIF17;ARFGEF2;MAP1LC3B;GAS8
6923,GO:0030510,0.322774348252649,0.810128796267644,7,52,regulation of BMP signaling pathway,BP,SMURF2;DKK1;HTRA1;PCSK6;FBXL15;LEMD2;ITGA3
15246,GO:0071384,0.323542668464074,0.818682043322216,6,45,cellular response to corticosteroid stimulus,BP,PCK2;EGFR;EIF4EBP1;ARG1;TGFB1;ANXA1
1206,GO:0002863,0.323547382982272,0.954259147107545,1,4,positive regulation of inflammatory response to antigenic stimulus,BP,ZP3
6132,GO:0019377,0.323561926371062,0.899786651639747,2,11,glycolipid catabolic process,BP,FUCA1;NAGA
4588,GO:0010676,0.323730029526509,0.830685491795546,5,35,positive regulation of cellular carbohydrate metabolic process,BP,AKT1;PPARA;SRC;NTSR1;SLC45A3
17564,GO:1901070,0.323927008688464,0.897613091119279,2,13,guanosine-containing compound biosynthetic process,BP,NME4;GUK1
11316,GO:0045619,0.323952932916958,0.780095379411157,12,98,regulation of lymphocyte differentiation,BP,AP3D1;XBP1;MMP14;CARD11;PRKCZ;TGFBR2;RAG1;GATA3;ADAM8;PNP;TGFB1;ANXA1
415,GO:0001102,0.324214370558664,0.830076278577208,5,36,RNA polymerase II activating transcription factor binding,MF,MEF2D;IFI27;ZFPM1;TAF6;EP300
7770,GO:0032281,0.32470267608557,0.899184593649973,2,11,AMPA glutamate receptor complex,CC,DLG4;DLG3
17670,GO:1901381,0.325306174064279,0.898865388303979,2,11,positive regulation of potassium ion transmembrane transport,BP,DNM2;GAL
9235,GO:0035615,0.325645983678389,0.898685442722773,2,11,clathrin adaptor activity,MF,AP2A2;LDLRAP1
16862,GO:0098748,0.325645983678389,0.898685442722773,2,11,endocytic adaptor activity,MF,AP2A2;LDLRAP1
10293,GO:0043029,0.325665023231371,0.844356756196175,4,28,T cell homeostasis,BP,AKT1;RAG1;TSC22D4;TGFB1
7599,GO:0031965,0.325750485693563,0.743397475113291,29,251,nuclear membrane,CC,CST3;BOK;SLC16A3;PRNP;SYNE3;EGFR;ITPR3;RETSAT;SCRN1;IPO13;CCND2;PAK1;TNRC18;IFI27;MYOF;KLHDC2;CPTP;SHISA5;WDFY3;SIGMAR1;BCL2L1;LEMD2;P2RX4;TBC1D20;SH3BGRL2;INTS1;TFPT;SLC30A1;RAP1GAP2
15157,GO:0071236,0.325848385980051,0.774669839868994,13,108,cellular response to antibiotic,BP,CST3;DNMT3A;NET1;BNIP3;ADCY7;STK25;MAPK13;ENDOG;HSF1;ARG1;IMPACT;ADCY6;ANXA1
20094,GO:2000696,0.325928121656334,0.898535921143534,2,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1;GATA3
11783,GO:0046625,0.326037889767294,0.898477720116896,2,11,sphingolipid binding,MF,CPTP;PLTP
16560,GO:0097284,0.326153102594824,0.898416615077098,2,11,hepatocyte apoptotic process,BP,DNMT3A;BCL2L1
14982,GO:0070861,0.326186327216374,0.86579152860206,3,19,regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;UBE2J1
11400,GO:0045761,0.32621969915333,0.898381286483542,2,11,regulation of adenylate cyclase activity,BP,GNAI2;CAP1
12079,GO:0048012,0.326301891853957,0.898337676261696,2,11,hepatocyte growth factor receptor signaling pathway,BP,MST1R;PAK1
12857,GO:0051148,0.326390003362918,0.844220608414734,4,27,negative regulation of muscle cell differentiation,BP,XBP1;DKK1;PAK1;GSK3A
9880,GO:0042130,0.326663420793281,0.828297066718267,5,36,negative regulation of T cell proliferation,BP,DLG1;PRNP;ARG2;ARG1;TGFB1
9398,GO:0035927,0.326800401340219,0.953251515215497,1,4,RNA import into mitochondrion,BP,TST
10339,GO:0043122,0.32684864178415,0.753666437575847,21,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;SHARPIN;FKBP1A;AKT1;CARD11;IRAK1;SLC20A1;RHOC;MAPKBP1;TGM2;CARD19;FYN;TNFRSF1A;PLEKHG5;SHISA5;MIB2;TNFRSF19;LITAF;ECM1
4072,GO:0009124,0.326948204259956,0.764459754617801,16,136,nucleoside monophosphate biosynthetic process,BP,PGM1;TK2;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;UCKL1;LHPP;AMPD2;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
20219,GO:2001032,0.327079506712088,0.897924643492981,2,11,regulation of double-strand break repair via nonhomologous end joining,BP,HSF1;HMGA2
335,GO:0000930,0.327452909026642,0.864991619927715,3,19,gamma-tubulin complex,CC,TUBG2;TUBG1;MZT2B
3159,GO:0006768,0.327469836888618,0.897717016893006,2,11,biotin metabolic process,BP,PC;HLCS
13538,GO:0055089,0.327491973758005,0.897705235687939,2,11,fatty acid homeostasis,BP,XBP1;APOE
5704,GO:0016829,0.327492043444906,0.766691580739395,15,129,lyase activity,MF,CBS;CHAC1;PCK2;ADCY7;HMGCL;GLUL;GGACT;NEIL1;HMGA2;MLYCD;ALDOC;GLO1;UROS;ADCY6;AZIN2
6251,GO:0019825,0.327555556172922,0.897671393627757,2,11,oxygen binding,MF,CBS;CYGB
12609,GO:0050766,0.327907496616999,0.842808939522029,4,28,positive regulation of phagocytosis,BP,BCR;TUB;DNM2;ABCA7
1109,GO:0002695,0.32794941308228,0.781042869597891,11,89,negative regulation of leukocyte activation,BP,DLG1;PRNP;BCR;ARG2;PKN1;PAG1;GAL;ARG1;CEACAM1;TGFB1;ANXA1
10166,GO:0042737,0.328058352983107,0.791174533794777,9,74,drug catabolic process,BP,NT5E;NOS1;PCK2;IDE;PRDX5;CTBS;GPX3;COMT;CAT
1207,GO:0002864,0.328064335077883,0.952856503178431,1,4,regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
5621,GO:0016671,0.328092985401979,0.896285460243874,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB2;ERO1B
18795,GO:1904262,0.328207499994055,0.897324084673331,2,11,negative regulation of TORC1 signaling,BP,SESN2;C12ORF66
8609,GO:0034111,0.328327798578023,0.897259936743171,2,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;CEACAM1
7497,GO:0031663,0.328417489763997,0.826772358021144,5,37,lipopolysaccharide-mediated signaling pathway,BP,AKT1;IRAK1;MIF;MAPK3;TGFB1
3906,GO:0008544,0.328931430828921,0.739322569023984,30,268,epidermis development,BP,MAP2K1;PTHLH;CYP27B1;SHARPIN;LAMA5;EGFR;FERMT1;DKK1;PPARA;PRSS8;SATB1;LAMC2;ALOX15B;CNFN;FLNB;PCSK6;FUZ;VDR;GAL;CTSL;LAMB3;FGFR1;TNFRSF19;HPSE;PRR9;KRT23;FURIN;UGCG;ANXA1;GNAS
8820,GO:0034552,0.329031278899587,0.952552979394768,1,4,respiratory chain complex II assembly,BP,SDHAF4
8821,GO:0034553,0.329031278899587,0.952552979394768,1,4,mitochondrial respiratory chain complex II assembly,BP,SDHAF4
8113,GO:0032793,0.329205264850853,0.896791457793141,2,11,positive regulation of CREB transcription factor activity,BP,CRTC1;ADGRF1
5566,GO:0016575,0.329361644324766,0.784848732901699,10,79,histone deacetylation,BP,MTA1;NACC2;MIER2;PHF21A;BAZ2A;SIN3B;CTBP1;RCOR1;MBD3;TGFB1
19749,GO:2000060,0.329453836957986,0.784688689120349,10,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,DVL1;CSNK1E;AKT1;ANKIB1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
4344,GO:0009894,0.329636942459011,0.712717117316896,84,770,regulation of catabolic process,BP,EDEM1;SORL1;DVL1;QSOX1;CST3;SNX9;BOK;SERPINE2;TRIM65;DAP;PSMD2;RAPGEF3;BNIP3;SMURF2;SESN2;LPCAT1;XBP1;EGFR;CSNK1E;PANO1;FYCO1;PRKACA;HECW2;SNX33;AKT1;APOE;ATP13A2;TFEB;VPS11;PCSK9;ENDOG;TYSND1;MSN;UBE2J1;BNIP3L;PPARA;ZDHHC8;ATG13;GTPBP1;IDE;ANKIB1;TBC1D14;SUFU;GGA3;GGA1;PCBP4;PKD1;HSF1;ADAM8;GIPC1;LRSAM1;RAB1B;CPTP;STX5;GSK3A;FYN;SPTLC2;PSMD7;PUM1;TNRC6B;THRA;TIMP1;STUB1;TRIB3;TPCN1;RAD23A;ULK1;LRP1;TRIB2;SAMD4B;ULK2;MLYCD;ATP6V1C2;LONP2;HGS;CARHSP1;MAPK3;CSNK1D;DRAM2;FURIN;IGF2BP3;AZIN2;PIK3R2;EP300
6882,GO:0030371,0.329839186805309,0.863479219172007,3,19,translation repressor activity,MF,EIF4EBP1;SAMD4B;PAIP2
13273,GO:0051932,0.329851278024353,0.863471538068748,3,19,synaptic transmission, GABAergic,BP,NLGN2;STXBP1;NISCH
5706,GO:0016831,0.330207948937764,0.841215188675073,4,28,carboxy-lyase activity,MF,PCK2;GLUL;MLYCD;AZIN2
6774,GO:0030204,0.330396192552465,0.841453097812686,4,27,chondroitin sulfate metabolic process,BP,CHPF;XYLT1;XYLT2;HYAL1
2170,GO:0005003,0.330465930479199,0.896116603876881,2,11,ephrin receptor activity,MF,EPHA1;EPHB2
2172,GO:0005005,0.330465930479199,0.896116603876881,2,11,transmembrane-ephrin receptor activity,MF,EPHA1;EPHB2
19317,GO:1905517,0.33048610435438,0.861979311708855,3,21,macrophage migration,BP,MMP14;MIF;MAPK3
9154,GO:0035497,0.330502408585201,0.896097045230083,2,11,cAMP response element binding,MF,CREB3L2;HMGA2
997,GO:0002456,0.33052113744861,0.803676423237943,7,55,T cell mediated immunity,BP,DLG1;PRKCZ;KDELR1;GATA3;ZP3;ARG1;CEACAM1
10358,GO:0043153,0.330599111606198,0.862996118176282,3,19,entrainment of circadian clock by photoperiod,BP,CRTC1;MTA1;PER3
16644,GO:0097479,0.33062636039223,0.783811066059293,10,79,synaptic vesicle localization,BP,AP3D1;SNPH;SEPT5;NLGN2;SYTL1;VAMP2;PIP5K1C;DNM2;STXBP1;SNAP29
11263,GO:0045453,0.330839759719008,0.825248431028823,5,36,bone resorption,BP,RAC2;EGFR;ADAM8;SRC;LRRK1
11077,GO:0045061,0.330910591310775,0.895878067575911,2,11,thymic T cell selection,BP,CARD11;GATA3
14298,GO:0061351,0.330945701761772,0.783548850256056,10,79,neural precursor cell proliferation,BP,WNT7A;CTSZ;NUMB;RERE;SPINT2;GJC2;FGFR1;NDE1;ARHGEF2;TGFB1
15311,GO:0071479,0.331122396402435,0.795481355120907,8,63,cellular response to ionizing radiation,BP,NET1;CCND2;GATA3;HSF1;HMGA2;DNM2;BCL2L1;TGFB1
6203,GO:0019682,0.331127299058903,0.86208465637997,3,20,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS;TALDO1
3383,GO:0007162,0.331308395946283,0.75168975330756,20,169,negative regulation of cell adhesion,BP,SERPINE2;DLG1;POSTN;PRNP;FBLN1;MMP14;ARG2;PPARA;SIPA1;PODXL;ASS1;SRC;PAG1;SPINT2;ARG1;ADAM15;CEACAM1;TGFB1;ERBB3;ANXA1
3571,GO:0007617,0.331361847618268,0.895635725148066,2,11,mating behavior,BP,SERPINE2;THRA
848,GO:0002161,0.33147368828799,0.895575620540034,2,11,aminoacyl-tRNA editing activity,MF,AARS;DTD1
17237,GO:0106074,0.33147368828799,0.895575620540034,2,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,AARS;DTD1
7281,GO:0031258,0.331473839111919,0.862439156501606,3,19,lamellipodium membrane,CC,PLEK2;CD44;VASP
2578,GO:0005865,0.331493980532608,0.89444834645378,2,12,striated muscle thin filament,CC,TMOD2;TNNT1
586,GO:0001738,0.331597393346387,0.766202156219928,14,121,morphogenesis of a polarized epithelium,BP,DVL1;PSMD2;LAMA5;SMURF2;GPC4;AP2A2;MSN;DKK1;DLG3;SH3BP1;FUZ;PFN1;PSMD7;CAMSAP3
4897,GO:0014821,0.331623245905011,0.9517336612585,1,4,phasic smooth muscle contraction,BP,DLG1
3077,GO:0006646,0.331688450389622,0.895460158118683,2,11,phosphatidylethanolamine biosynthetic process,BP,SLC27A1;LPIN3
13229,GO:0051852,0.331851326444037,0.95166116689638,1,4,disruption by host of symbiont cells,BP,ARG1
13235,GO:0051873,0.331851326444037,0.95166116689638,1,4,killing by host of symbiont cells,BP,ARG1
10042,GO:0042481,0.33199068794992,0.895297562673565,2,11,regulation of odontogenesis,BP,SP6;TGFB1
6930,GO:0030517,0.332015529699322,0.840329287178182,4,27,negative regulation of axon extension,BP,PTPRS;SEMA3F;SEMA4B;SEMA4G
13989,GO:0060676,0.332074246114744,0.951590250511488,1,4,ureteric bud formation,BP,GATA3
15673,GO:0072172,0.332074246114744,0.951590250511488,1,4,mesonephric tubule formation,BP,GATA3
7946,GO:0032528,0.332440872181921,0.861822327524823,3,19,microvillus organization,BP,TWF2;FSCN1;PODXL
6748,GO:0030165,0.332489684044447,0.794632188534068,8,61,PDZ domain binding,MF,DOCK4;DLG4;MAP2K2;FZD8;CCDC88C;DLG3;GIPC1;CRIM1
17552,GO:1901019,0.33259493247645,0.81182970682944,6,45,regulation of calcium ion transmembrane transporter activity,BP,NOS1;FKBP1A;PRKACA;EHD3;HSPA2;STIM1
3802,GO:0008379,0.332670788532173,0.948501855794368,1,5,thioredoxin peroxidase activity,MF,PRDX5
7162,GO:0031017,0.332716282939068,0.951385657551911,1,4,exocrine pancreas development,BP,XBP1
7824,GO:0032372,0.332723176132036,0.951383458171915,1,4,negative regulation of sterol transport,BP,PCSK9
7827,GO:0032375,0.332723176132036,0.951383458171915,1,4,negative regulation of cholesterol transport,BP,PCSK9
18976,GO:1904707,0.332812230753386,0.861585148454456,3,19,positive regulation of vascular smooth muscle cell proliferation,BP,MEF2D;PAK1;FGF2
6927,GO:0030514,0.332903673862239,0.839711659134858,4,27,negative regulation of BMP signaling pathway,BP,SMURF2;DKK1;HTRA1;LEMD2
4103,GO:0009156,0.332912916615254,0.76212387040503,15,127,ribonucleoside monophosphate biosynthetic process,BP,PGM1;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;UCKL1;LHPP;AMPD2;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
15451,GO:0071706,0.332913864391337,0.78733109703937,9,73,tumor necrosis factor superfamily cytokine production,BP,NFATC4;ARG2;UBE2J1;MC1R;HSF1;ADAM8;MIF;ARFGEF2;ARHGEF2
629,GO:0001816,0.333082454648601,0.720971682863761,50,453,cytokine production,BP,F2R;NFATC4;DLG1;POSTN;PTPRS;PRNP;XBP1;HK1;ATF4;CARD11;IRAK1;ARG2;TMSB4X;PRKCZ;RNF135;MAPK13;FERMT1;UBE2J1;KDELR1;MC1R;DDIT3;GATA3;HSF1;ALOX15B;IL1RAP;ADAM8;MAPKBP1;SRC;IRF7;CPTP;PUM1;FGFR1;MIF;ZFPM1;ARFGEF2;TRIB2;HPSE;ZP3;PNP;ARG1;SEC14L1;MAPK3;LITAF;FURIN;ARHGEF2;CEACAM1;IGF2BP3;TGFB1;ANXA1;EP300
17399,GO:1900102,0.333236818998433,0.894625898308025,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,WFS1;DNAJB9
2741,GO:0006121,0.333279868413807,0.951205641820216,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
11310,GO:0045606,0.333607110346966,0.860496323014911,3,20,positive regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B;VDR
16457,GO:0097094,0.333720048833775,0.894364882735455,2,11,craniofacial suture morphogenesis,BP,MMP14;TGFB1
6433,GO:0021696,0.333778196464488,0.860967412270304,3,19,cerebellar cortex morphogenesis,BP,MAP2K1;WNT7A;SERPINE2
15521,GO:0071875,0.333872113201474,0.89428268132555,2,11,adrenergic receptor signaling pathway,BP,NOS1;GSK3A
3631,GO:0008093,0.333885521249666,0.894275431865385,2,11,cytoskeletal adaptor activity,MF,OBSL1;GAS2L1
18428,GO:1903430,0.334004917113182,0.950973471519778,1,4,negative regulation of cell maturation,BP,GAL
4194,GO:0009298,0.334121593673663,0.950936048962319,1,4,GDP-mannose biosynthetic process,BP,MPI
10562,GO:0043506,0.334290104790421,0.786507872467772,9,70,regulation of JUN kinase activity,BP,ERCC6;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TAOK1;AIDA
7046,GO:0030814,0.334400381636529,0.83829526720621,4,28,regulation of cAMP metabolic process,BP,PTHLH;RAPGEF3;GNAI2;CAP1
3954,GO:0008655,0.334759105569924,0.892670130227085,2,12,pyrimidine-containing compound salvage,BP,TK2;UCKL1
727,GO:0001953,0.334795254013392,0.838393249726516,4,27,negative regulation of cell-matrix adhesion,BP,POSTN;MMP14;SRC;ADAM15
3662,GO:0008150,0.334969602336007,0.707142345582028,1165,11232,biological_process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;GID4;SH3TC2;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;SDK2;CYP27B1;LPCAT4;NEURL1;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DAP;CMTM4;DYSF;XPOT;IGFBP4;SLC16A3;MMP1;MXRA5;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;HYI;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;CCNI;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;COPG1;TMOD2;BCORL1;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;SEMA3F;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;RTN2;LRP10;CSNK1E;TTYH3;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;JOSD2;FAM189B;RHBDF2;ACTA2;HK1;MAP2K2;EPN1;PPP1R13L;LMBR1L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;LRP3;CARD11;SH3TC1;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;AP1B1;PEAR1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;PRR15;ZNF598;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;TMCO3;MSN;PPP1R35;MAP1B;TGFBR2;CSMD3;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;FAM3A;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;TMEM125;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;RRNAD1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TMEM245;TACC1;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;SLC29A4;ISYNA1;ERO1B;MMP10;BCL9L;AHCY;ADM5;SCMH1;ACSF2;ZNF385A;NLGN2;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;TBC1D9B;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;FBXL6;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;TP53I11;APLN;NIPA1;WDR66;PIGQ;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;GGACT;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CNFN;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;TFPI2;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;DNAJC4;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;NSUN7;SDCCAG8;GPX3;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;TMPRSS11D;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;CGREF1;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;DHRS4L2;AMIGO2;TIMP1;CRIM1;SLC46A3;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF187;ZNF71;HSF4;LAMB3;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SECISBP2L;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;TMEM128;MIB2;TENM2;TTLL12;F12;USF2;PBX3;PSMG4;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;NT5DC2;VPS9D1;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;CPNE8;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;GPATCH8;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;TAOK1;RNF222;TMEM54;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;INTS1;ARG1;PBXIP1;SLC10A6;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;NYNRIN;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;VAT1;CASP4;ACY1;SNAP29;LONP2;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;MANF;SLC15A1;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ASPHD1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;ORAI3;TCF7L1;WDFY2;RAP1GAP2;STIM1;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
7500,GO:0031666,0.334996100101365,0.950655021506213,1,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
14146,GO:0060992,0.335052191601849,0.893643721979805,2,11,response to fungicide,BP,BCL2L1;IMPACT
4524,GO:0010575,0.33505774364026,0.860147374421401,3,19,positive regulation of vascular endothelial growth factor production,BP,ATF4;HPSE;TGFB1
16245,GO:0090276,0.335098596879207,0.763396622126905,14,117,regulation of peptide hormone secretion,BP,PCK2;NR1D1;RAPGEF3;LRP5;MAP4K4;EGFR;ITPR3;HADH;NLGN2;GLUL;APLN;GLUD1;ARL2;CHD7
4357,GO:0009950,0.335208992518834,0.893558682002589,2,11,dorsal/ventral axis specification,BP,MDFI;LRP5
17730,GO:1901615,0.335479656497879,0.726997148410085,37,328,organic hydroxy compound metabolic process,BP,SORL1;CYP27B1;LMF1;PCK2;NR1D1;PLCH2;HAGH;VLDLR;LRP5;PSAT1;APOE;DGKQ;RETSAT;PCSK9;PLCG1;OSBPL5;ISYNA1;GATA3;SRD5A3;PLCB3;ALDH1A2;LDLRAP1;ACADVL;PMVK;SPTLC2;VDR;COMT;PLTP;NTSR1;FGFR1;PLCD3;FGF2;RXRA;SEC14L2;OCRL;CAT;LDHA
9953,GO:0042303,0.335838951942165,0.779434835850725,10,80,molting cycle,BP,LAMA5;EGFR;PPP1R13L;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
10124,GO:0042633,0.335838951942165,0.779434835850725,10,80,hair cycle,BP,LAMA5;EGFR;PPP1R13L;FERMT1;DKK1;FUZ;GAL;TNFRSF19;HPSE;GNAS
20064,GO:2000651,0.335919331765178,0.893173024411588,2,11,positive regulation of sodium ion transmembrane transporter activity,BP,GLRX;DNM2
4986,GO:0015108,0.335950246701999,0.821492918681107,5,36,chloride transmembrane transporter activity,MF,TTYH3;SLC12A7;ANO8;SLC12A4;PCYOX1
766,GO:0002011,0.335975544120409,0.809444307150582,6,44,morphogenesis of an epithelial sheet,BP,DVL1;WNT7A;CD44;RHOC;RREB1;CEACAM1
4404,GO:0010138,0.33604321281414,0.950317270038655,1,4,pyrimidine ribonucleotide salvage,BP,UCKL1
10770,GO:0044206,0.33604321281414,0.950317270038655,1,4,UMP salvage,BP,UCKL1
2437,GO:0005635,0.33619005730811,0.722728754502396,42,375,nuclear envelope,CC,RAC2;SORL1;CST3;BOK;XPOT;SLC16A3;MTA1;SLC2A9;PRNP;BNIP3;AGPAT3;SYNE3;EGFR;PRKCZ;ITPR3;RETSAT;BNIP3L;SCRN1;IPO13;CCND2;BIN1;PAK1;TNRC18;IFI27;NUCB2;UBXN4;MYOF;KLHDC2;CPTP;SHISA5;WDFY3;SIGMAR1;BCL2L1;LEMD2;P2RX4;TBC1D20;SH3BGRL2;INTS1;MAPK3;TFPT;SLC30A1;RAP1GAP2
10637,GO:0043625,0.336580372439996,0.950143474463704,1,4,delta DNA polymerase complex,CC,POLD4
4469,GO:0010463,0.336706388100832,0.837057095377418,4,27,mesenchymal cell proliferation,BP,CTNNBIP1;LRP5;TGFBR2;FGFR1
10732,GO:0044057,0.336729527542955,0.733482733522222,29,252,regulation of system process,BP,NOS1;F2R;DOCK4;DLG1;TNNT1;EGFR;PRKACA;AKT1;EHD3;ITPR3;STK39;PAK1;NLGN2;APLN;ASPH;GSK3A;GAL;COMT;THRA;NTSR1;MGLL;FGFR1;PBX3;MTMR4;P2RX4;MYL9;GNAS;STIM1;RNF10
16094,GO:0090036,0.336731954633831,0.892731011602344,2,11,regulation of protein kinase C signaling,BP,AKAP12;MC1R
6043,GO:0019136,0.336922322358342,0.950032649943702,1,4,deoxynucleoside kinase activity,MF,TK2
808,GO:0002076,0.336932337146313,0.892621881735613,2,11,osteoblast development,BP,PTHLH;LRP5
7465,GO:0031597,0.337093333851327,0.891390166548802,2,12,cytosolic proteasome complex,CC,PSMD2;IDE
2583,GO:0005874,0.337099106866049,0.724779030532148,38,333,microtubule,CC,DVL1;CLIP2;KLC2;DLG1;MTA1;TMEM214;SNPH;TUBB6;MAP2K2;TUBG2;EML2;MAP1B;NAV1;TUBB3;REEP2;DYNLRB1;FAM110C;DNM2;NINL;REEP4;KIF17;KIF13B;TUBG1;CEP170;ARFGEF2;MAP1LC3B;SNTB2;PBXIP1;NDE1;CAMSAP3;INVS;GAS8;CSNK1D;KIFC3;ARHGEF2;ENKD1;MAP6;STIM1
10172,GO:0042747,0.337130564396156,0.949965087815968,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
11412,GO:0045780,0.337217301501649,0.892466595861381,2,11,positive regulation of bone resorption,BP,EGFR;ADAM8
11878,GO:0046852,0.337217301501649,0.892466595861381,2,11,positive regulation of bone remodeling,BP,EGFR;ADAM8
3357,GO:0007095,0.337769624601811,0.858402724637914,3,19,mitotic G2 DNA damage checkpoint,BP,HMGA2;BRSK1;TAOK1
15234,GO:0071364,0.337795812081389,0.820129927985661,5,36,cellular response to epidermal growth factor stimulus,BP,EGFR;AKT1;PLCG1;PTPN12;CBL
9427,GO:0035985,0.337852268414732,0.9497305171609,1,4,senescence-associated heterochromatin focus,CC,HMGA2
5347,GO:0016082,0.33793217165331,0.892076565041653,2,11,synaptic vesicle priming,BP,STXBP1;SNAP29
12171,GO:0048263,0.338188070141873,0.949621150971997,1,4,determination of dorsal identity,BP,DDIT3
9538,GO:0036258,0.338202324499207,0.835280225910379,4,29,multivesicular body assembly,BP,VPS4A;CHMP5;VPS37A;HGS
8792,GO:0034465,0.338386555093835,0.949556440459759,1,4,response to carbon monoxide,BP,DNM2
9075,GO:0035305,0.338398470737657,0.777319560062161,10,80,negative regulation of dephosphorylation,BP,FKBP1A;PPP1R35;PPP1R12C;FARP1;DLG3;PPP1R14A;MYO1D;CAMSAP3;PPP1R37;PPP1R10
10836,GO:0044320,0.338441212034899,0.89179841920439,2,11,cellular response to leptin stimulus,BP,BBS2;ADIPOR1
5974,GO:0018410,0.338516724973903,0.819102566544478,5,38,C-terminal protein amino acid modification,BP,LY6K;LY6E;LYPD5;MSLN;NTNG1
9509,GO:0036148,0.33883519508039,0.891582904972602,2,11,phosphatidylglycerol acyl-chain remodeling,BP,LPCAT4;LPCAT1
18175,GO:1902893,0.338850649829094,0.835553026006938,4,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA;APLN;TGFB1
19438,GO:1905939,0.339121396083355,0.890272173324083,2,12,regulation of gonad development,BP,SRC;ZP3
15870,GO:0072567,0.339336092863533,0.890153496946212,2,12,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MIF
16415,GO:0097014,0.339399256130563,0.788852271305572,8,63,ciliary plasm,CC,PRKACA;WDR66;DYNLRB1;TULP3;KIF17;ARFGEF2;MAP1LC3B;GAS8
11460,GO:0045892,0.339449389929856,0.700907479806378,96,892,negative regulation of transcription, DNA-templated,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SHC1;NR1D1;DLG1;DAP;DNMT3A;WWC3;SMURF2;FAM129B;ZC3H6;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;ELK3;WWTR1;PHF21A;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;TSC22D4;SRC;IRF7;HIST3H2A;PER3;RERE;RSF1;ZNF692;PPM1F;NELFCD;TLE4;VDR;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;ZP3;RCOR1;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;ZNF256;MBD3;CCNE1;TGFB1;KLF12;ZNF318;EP300
4149,GO:0009209,0.339576510722716,0.889054663625306,2,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
3539,GO:0007548,0.339598719574202,0.744321026263595,20,171,sex differentiation,BP,ERCC1;CCND1;SDC1;WNT7A;CST3;BOK;MMP14;PKD1;GATA3;ARID5B;SRC;AGO4;EIF2S2;BCL2L1;ZP3;TBC1D20;CHD7;SLIT3;CBL;ADAM15
17959,GO:1902262,0.339609095633278,0.949156773051277,1,4,apoptotic process involved in blood vessel morphogenesis,BP,LRP5
2645,GO:0005980,0.339675542825573,0.857171164305486,3,19,glycogen catabolic process,BP,PYGB;PYGL;PGM1
12573,GO:0050706,0.339790827978652,0.856502668661727,3,20,regulation of interleukin-1 beta secretion,BP,HK1;ARG2;CPTP
17386,GO:1900077,0.339864330955388,0.83445989605898,4,28,negative regulation of cellular response to insulin stimulus,BP,PRKCZ;GRB10;GSK3A;SOCS2
9401,GO:0035930,0.339883274539497,0.949066881507506,1,4,corticosteroid hormone secretion,BP,GAL
20179,GO:2000846,0.339883274539497,0.949066881507506,1,4,regulation of corticosteroid hormone secretion,BP,GAL
19900,GO:2000344,0.339908584988938,0.949058578518653,1,4,positive regulation of acrosome reaction,BP,ZP3
15163,GO:0071248,0.339953452857784,0.766531476970552,12,100,cellular response to metal ion,BP,NFATC4;PRNP;BNIP3;EGFR;ATF4;AKT1;ATP13A2;ENDOG;HSF1;MT2A;MAPK9;MAPK3
9561,GO:0036314,0.339970531695999,0.85698014964525,3,19,response to sterol,BP,TGFBR2;PMVK;TGFB1
7663,GO:0032079,0.339985006777392,0.949033503767282,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
10128,GO:0042637,0.340074446471278,0.949004148364581,1,4,catagen,BP,GAL
13207,GO:0051794,0.340074446471278,0.949004148364581,1,4,regulation of timing of catagen,BP,GAL
11043,GO:0044878,0.340090070972583,0.948999019142515,1,4,mitotic cytokinesis checkpoint,BP,VPS4A
6951,GO:0030554,0.340119418776867,0.695137031614043,131,1180,adenyl nucleotide binding,MF,MST1R;MAP2K1;PYGL;ERCC6;SCN8A;OBSCN;DGKA;RPS6KA2;RAPGEF3;PC;SCYL1;SMARCA1;NME4;MAPKAPK3;BCR;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;PRKACA;CARS;ACTA2;HK1;MAP2K2;STK25;AKT1;IRAK1;BAG3;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;MAP3K9;IDE;TWF2;PAK1;TTBK2;AHCY;ACSF2;GLUL;RET;HLTF;ASS1;ATP11A;OASL;GLUD1;PANK4;NEK9;MYH15;TOP1;PIP5K1C;SRC;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;ASNS;PFN1;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;LONP2;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;ADCY6;ADCK2;ERBB3
4089,GO:0009142,0.340237213082782,0.758847083083682,14,120,nucleoside triphosphate biosynthetic process,BP,PGM1;NME4;HK1;TMSB4X;PFKP;PPARA;DHTKD1;TAZ;UCKL1;VPS9D1;TCIRG1;ALDOC;TGFB1;LDHA
13070,GO:0051541,0.340290170543261,0.948933303112109,1,4,elastin metabolic process,BP,CST3
13027,GO:0051434,0.340292908459376,0.948932403584798,1,4,BH3 domain binding,MF,BCL2L1
13205,GO:0051792,0.340298117040449,0.948930692307959,1,4,medium-chain fatty acid biosynthetic process,BP,ACOT7
3478,GO:0007340,0.340396574611557,0.889566396440698,2,12,acrosome reaction,BP,ZP3;SPESP1
8315,GO:0033141,0.340514068374096,0.948859711488159,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
12408,GO:0048818,0.340651438648966,0.948814528785135,1,4,positive regulation of hair follicle maturation,BP,GAL
5405,GO:0016240,0.340889162929257,0.948736282209839,1,4,autophagosome membrane docking,BP,SNAP29
15425,GO:0071671,0.340894445080584,0.948734542788009,1,4,regulation of smooth muscle cell chemotaxis,BP,CORO1B
6105,GO:0019322,0.341139253095845,0.948653888423777,1,4,pentose biosynthetic process,BP,TALDO1
12195,GO:0048305,0.341941494768933,0.888708404980107,2,12,immunoglobulin secretion,BP,XBP1;POU2F2
13493,GO:0055008,0.341970063701749,0.817033940391199,5,36,cardiac muscle tissue morphogenesis,BP,FKBP1A;ZFPM1;CHD7;RXRA;TGFB1
18268,GO:1903052,0.341999829815484,0.764860371545292,12,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;AKT1;ANKIB1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
4464,GO:0010455,0.342176918737508,0.948311178726185,1,4,positive regulation of cell fate commitment,BP,FGF2
1811,GO:0004457,0.342329634635953,0.948260626313852,1,4,lactate dehydrogenase activity,MF,LDHA
3544,GO:0007568,0.342405284160202,0.734839203405396,24,211,aging,BP,ERCC1;MAP2K1;DNMT3A;PRNP;AKT1;IRAK1;SERPING1;ARG2;ENDOG;TGFBR2;DKK1;SEC63;IDE;HMGA2;IGFBP2;YPEL3;TIMP1;MIF;LRP1;ARG1;LITAF;MBD3;TGFB1;CAT
16101,GO:0090049,0.342506601279954,0.832593048209977,4,28,regulation of cell migration involved in sprouting angiogenesis,BP,FGF2;CIB1;SRPX2;ANXA1
2371,GO:0005496,0.342598932694348,0.794180082828626,7,55,steroid binding,MF,OSBPL10;OSBP2;APOE;OSBPL5;PAQR7;HSD11B1;VDR
5458,GO:0016331,0.342688512068986,0.75698297235358,14,115,morphogenesis of embryonic epithelium,BP,DVL1;LAMA5;DEAF1;PRKACB;SUFU;RET;GATA3;TULP3;ALDH1A2;SPINT2;FUZ;PFN1;VASP;TGFB1
20145,GO:2000786,0.342908421893538,0.889342650765994,2,11,positive regulation of autophagosome assembly,BP,LRSAM1;ULK1
15321,GO:0071494,0.342920400724565,0.948064791342173,1,4,cellular response to UV-C,BP,IMPACT
2374,GO:0005501,0.343176803401236,0.888020056331754,2,12,retinoid binding,MF,ALDH1A2;RXRA
3184,GO:0006809,0.343419843608588,0.8033404413007,6,46,nitric oxide biosynthetic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;P2RX4
8461,GO:0033591,0.343788232156736,0.947776308934445,1,4,response to L-ascorbic acid,BP,CAT
17951,GO:1902253,0.343858644456765,0.852821804694485,3,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,CD44;ZNF385A;MIF
19689,GO:1990907,0.34389278421512,0.888797929754097,2,11,beta-catenin-TCF complex,CC,BCL9L;TLE4
15503,GO:0071839,0.343929537526443,0.947729246093389,1,4,apoptotic process in bone marrow,BP,BCL2L1
3816,GO:0008406,0.343939730960854,0.747121021175809,17,145,gonad development,BP,ERCC1;CCND1;SDC1;CST3;BOK;MMP14;GATA3;ARID5B;SRC;AGO4;EIF2S2;BCL2L1;ZP3;TBC1D20;SLIT3;CBL;ADAM15
10904,GO:0044438,0.344137229884638,0.778065224281073,9,74,microbody part,CC,CRAT;MAP2K2;IDE;PRDX5;PEX10;MLYCD;PHYH;LONP2;CAT
10905,GO:0044439,0.344137229884638,0.778065224281073,9,74,peroxisomal part,CC,CRAT;MAP2K2;IDE;PRDX5;PEX10;MLYCD;PHYH;LONP2;CAT
91,GO:0000179,0.344238193717553,0.947626357599833,1,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,RRNAD1
6802,GO:0030239,0.344274080121424,0.831339853205556,4,28,myofibril assembly,BP,OBSCN;TMOD2;TNNT1;OBSL1
4109,GO:0009163,0.344300427797293,0.814346903491874,5,40,nucleoside biosynthetic process,BP,NT5E;NME4;TK2;UCKL1;GUK1
8112,GO:0032792,0.34434368990767,0.947591163396405,1,4,negative regulation of CREB transcription factor activity,BP,DDIT3
8605,GO:0034104,0.34440743035724,0.88733227867601,2,12,negative regulation of tissue remodeling,BP,CST3;BCR
12300,GO:0048598,0.344539369712152,0.714421264981052,43,378,embryonic morphogenesis,BP,ITGB4;MDFI;DVL1;WNT7A;DLG1;LAMA5;BCR;LRP5;ACVR2B;ITGB5;MMP14;LAMB1;NAGLU;DEAF1;TGFBR2;DKK1;SOX7;PRKACB;SUFU;DUSP4;RET;GATA3;APLN;HMGA2;MICAL2;TULP3;ALDH1A2;SPINT2;DUSP6;FUZ;PFN1;LAMB3;FGFR1;HYAL1;FGF2;VASP;CHD7;TSHZ1;EPHB2;MAPK3;TGFB1;GNAS;ITGA3
3766,GO:0008310,0.344541275911572,0.947525209395036,1,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,ISG20
3463,GO:0007283,0.344568607937713,0.72411427488713,31,275,spermatogenesis,BP,ERCC1;NEURL1;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;BBS2;OSBP2;ETV5;MYCBPAP;RFX2;PRKACA;FAM50A;PHC2;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;DNM2;PUM1;RAI14;BCL2L1;HSPA2;TBC1D20;NDRG3;GGT1;CIB1;PAIP2;AZIN2
7431,GO:0031527,0.344647617836844,0.88837934554991,2,11,filopodium membrane,CC,VASP;ITGA3
2604,GO:0005901,0.344681701237874,0.792828856724184,7,53,caveola,CC,NOS1;F2R;TGFBR2;MYOF;SRC;CBL;MAPK3
268,GO:0000738,0.344771747874889,0.947448215393528,1,4,DNA catabolic process, exonucleolytic,BP,ISG20
9086,GO:0035330,0.344803234678595,0.88829295518194,2,11,regulation of hippo signaling,BP,WWC3;MARK3
1106,GO:0002692,0.344847900043961,0.947422760316521,1,4,negative regulation of cellular extravasation,BP,BCR
4347,GO:0009897,0.344878565313067,0.758501261520394,13,108,external side of plasma membrane,CC,SDC1;SERPINE2;ITGA6;PRNP;P4HB;GPC4;PCSK9;TGFBR2;ANTXR2;ITGA1;CD59;ANXA1;ITGA3
7927,GO:0032496,0.344936116083687,0.734085185317249,23,204,response to lipopolysaccharide,BP,TNIP1;NOS1;F2R;CYP27B1;PCK2;NR1D1;MAPKAPK3;BCR;XBP1;AKT1;IRAK1;HSF1;TNFRSF6B;SRC;TNFRSF1A;VDR;COMT;LOXL1;MIF;ARG1;MAPK3;LITAF;TGFB1
1659,GO:0004111,0.344939379761893,0.947392172009778,1,4,creatine kinase activity,MF,MAP4K4
10255,GO:0042979,0.344982464452221,0.947377761984637,1,4,ornithine decarboxylase regulator activity,MF,AZIN2
17961,GO:1902267,0.344982464452221,0.947377761984637,1,4,regulation of polyamine transmembrane transport,BP,AZIN2
18102,GO:1902668,0.345015976459612,0.853696463999399,3,19,negative regulation of axon guidance,BP,SEMA3F;SEMA4B;SEMA4G
17901,GO:1902115,0.345289883397935,0.746010927426807,17,143,regulation of organelle assembly,BP,SDC1;EVI5L;VPS11;MSN;TBC1D14;FSCN1;SRC;CHMP5;DNM2;LRSAM1;RAB1B;FUZ;ULK1;MAPK9;WRAP73;ARHGEF2;ASAP1
17731,GO:1901616,0.345317452514948,0.814278539514705,5,37,organic hydroxy compound catabolic process,BP,CYP27B1;APOE;SRD5A3;COMT;NTSR1
7048,GO:0030816,0.345398051387864,0.88677715763554,2,12,positive regulation of cAMP metabolic process,BP,PTHLH;RAPGEF3
12258,GO:0048515,0.345494015636297,0.777044452863709,9,73,spermatid differentiation,BP,NEURL1;BBS2;OSBP2;RFX2;PRKACA;UBE2J1;HSPA2;TBC1D20;CIB1
1962,GO:0004663,0.34579055047285,0.947107053318616,1,4,Rab geranylgeranyltransferase activity,MF,RABGGTA
11528,GO:0046015,0.346251698793166,0.946952195922647,1,4,regulation of transcription by glucose,BP,USF2
1819,GO:0004466,0.346368039680233,0.946913084866744,1,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
5828,GO:0017099,0.346368039680233,0.946913084866744,1,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
8502,GO:0033668,0.346535851566704,0.946856640064976,1,4,negative regulation by symbiont of host apoptotic process,BP,BCL2L1
13321,GO:0052041,0.346535851566704,0.946856640064976,1,4,negative regulation by symbiont of host programmed cell death,BP,BCL2L1
13376,GO:0052490,0.346535851566704,0.946856640064976,1,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
10571,GO:0043518,0.346593116896659,0.88610571366968,2,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,CD44;MIF
15029,GO:0070942,0.346737367368675,0.946788811213135,1,4,neutrophil mediated cytotoxicity,BP,ARG1
6138,GO:0019401,0.346938473768992,0.946721068486592,1,4,alditol biosynthetic process,BP,PCK2
3245,GO:0006904,0.347117381954512,0.812930201978097,5,37,vesicle docking involved in exocytosis,BP,RAB3B;SNPH;VPS11;EXOC2;STXBP1
3127,GO:0006707,0.347223819480277,0.946624861104652,1,4,cholesterol catabolic process,BP,APOE
5359,GO:0016127,0.347223819480277,0.946624861104652,1,4,sterol catabolic process,BP,APOE
7270,GO:0031233,0.347274093670757,0.885722248960004,2,12,intrinsic component of external side of plasma membrane,CC,PRNP;CD59
11661,GO:0046368,0.347463497857964,0.946543970572427,1,4,GDP-L-fucose metabolic process,BP,TSTA3
6854,GO:0030317,0.347590920624421,0.828618004170351,4,29,flagellated sperm motility,BP,NEURL1;BBS2;PLTP;GAS8
5568,GO:0016577,0.347845868371563,0.829186645538333,4,27,histone demethylation,BP,ARID5B;KDM4B;HSF4;PHF2
16833,GO:0098661,0.34797936451364,0.79999890592688,6,45,inorganic anion transmembrane transport,BP,PRNP;TTYH3;SLC12A7;SLC20A1;SLC12A4;PCYOX1
15502,GO:0071838,0.348001648256232,0.946362079304504,1,4,cell proliferation in bone marrow,BP,HMGA2
19767,GO:2000106,0.348047164655267,0.789709529600405,7,56,regulation of leukocyte apoptotic process,BP,ARG2;RAG1;ADAM8;TSC22D4;IRF7;MIF;ANXA1
5093,GO:0015355,0.348065244597988,0.946340559686705,1,4,secondary active monocarboxylate transmembrane transporter activity,MF,SLC10A6
6889,GO:0030388,0.348203804684026,0.946293656046147,1,4,fructose 1,6-bisphosphate metabolic process,BP,ALDOC
15986,GO:0080025,0.348235153156049,0.850972939735036,3,20,phosphatidylinositol-3,5-bisphosphate binding,MF,PLEK2;ATP13A2;SH3PXD2B
17637,GO:1901300,0.348284860880327,0.946266206515863,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
20329,GO:2001275,0.348306137220046,0.886339736100147,2,11,positive regulation of glucose import in response to insulin stimulus,BP,PAK1;PIK3R2
8526,GO:0033743,0.348349006631235,0.946244477714452,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
4052,GO:0009092,0.348444045418148,0.946212274486963,1,4,homoserine metabolic process,BP,CBS
6111,GO:0019346,0.348444045418148,0.946212274486963,1,4,transsulfuration,BP,CBS
11864,GO:0046827,0.348526901845429,0.850780316682361,3,20,positive regulation of protein export from nucleus,BP,RAPGEF3;BAG3;CAMK1
10536,GO:0043461,0.348605989073375,0.946157374364504,1,4,proton-transporting ATP synthase complex assembly,BP,OXA1L
16959,GO:0098917,0.348661191205085,0.946138652747596,1,4,retrograde trans-synaptic signaling,BP,NOS1
13600,GO:0060047,0.348871167879,0.74831704666557,15,127,heart contraction,BP,NOS1;DLG1;TNNT1;PRKACA;PPP1R13L;EHD3;ITPR3;APLN;ASPH;TAZ;GSK3A;THRA;P2RX4;VEGFB;STIM1
15178,GO:0071279,0.348913904744547,0.946052895950144,1,4,cellular response to cobalt ion,BP,BNIP3
983,GO:0002437,0.349170186662471,0.849804498364351,3,21,inflammatory response to antigenic stimulus,BP,AHCY;GATA3;ZP3
10511,GO:0043403,0.349345243117933,0.850239456949374,3,20,skeletal muscle tissue regeneration,BP,WNT7A;TGFBR2;ANXA1
13820,GO:0060389,0.349401409484485,0.811214324366999,5,37,pathway-restricted SMAD protein phosphorylation,BP,TGFBR2;DKK1;SNX25;PMEPA1;TGFB1
902,GO:0002278,0.34943910200441,0.945874411579419,1,4,eosinophil activation involved in immune response,BP,VAMP2
993,GO:0002447,0.34943910200441,0.945874411579419,1,4,eosinophil mediated immunity,BP,VAMP2
10460,GO:0043307,0.34943910200441,0.945874411579419,1,4,eosinophil activation,BP,VAMP2
10461,GO:0043308,0.34943910200441,0.945874411579419,1,4,eosinophil degranulation,BP,VAMP2
4825,GO:0014020,0.34957415959141,0.768021855968132,10,80,primary neural tube formation,BP,DVL1;DEAF1;PRKACB;SUFU;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
4079,GO:0009132,0.349698591707328,0.754254242709864,13,110,nucleoside diphosphate metabolic process,BP,DLG4;DLG1;PGM1;NME4;HK1;CARD11;PFKP;PPARA;DHTKD1;DLG3;GUK1;ALDOC;LDHA
4420,GO:0010212,0.350000817033966,0.744440327773695,16,136,response to ionizing radiation,BP,ERCC1;CCND1;ERCC6;DNMT3A;MTA1;NET1;CCND2;GATA3;HSF1;HMGA2;DNM2;BCL2L1;CBL;TGFB1;ANXA1;IKBIP
4491,GO:0010511,0.350210195660943,0.945611719795619,1,4,regulation of phosphatidylinositol biosynthetic process,BP,ZP3
14017,GO:0060711,0.35025245223708,0.810573576400189,5,37,labyrinthine layer development,BP,MAP2K1;FBXW8;AKT1;SPINT2;PLCD3
546,GO:0001665,0.350269141458185,0.945591607056978,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2
3150,GO:0006749,0.35028886814986,0.809432886533811,5,42,glutathione metabolic process,BP,CHAC1;HAGH;CNDP2;GGT1;GLO1
14949,GO:0070814,0.350424388573455,0.945538614233814,1,4,hydrogen sulfide biosynthetic process,BP,CBS
16206,GO:0090209,0.350633351714554,0.945467236795417,1,4,negative regulation of triglyceride metabolic process,BP,APOE
15858,GO:0072553,0.350650067575976,0.945461524581376,1,4,terminal button organization,BP,NLGN2
16226,GO:0090241,0.350718561106805,0.945438114932409,1,4,negative regulation of histone H4 acetylation,BP,CTBP1
12152,GO:0048232,0.350730705975588,0.717448235338487,32,285,male gamete generation,BP,ERCC1;NEURL1;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;BBS2;OSBP2;ETV5;MYCBPAP;RFX2;PRKACA;FAM50A;PHC2;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;DNM2;AGO4;PUM1;RAI14;BCL2L1;HSPA2;TBC1D20;NDRG3;GGT1;CIB1;PAIP2;AZIN2
10750,GO:0044107,0.350828192162604,0.945400632783414,1,4,cellular alcohol metabolic process,BP,CYP27B1
10751,GO:0044108,0.350828192162604,0.945400632783414,1,4,cellular alcohol biosynthetic process,BP,CYP27B1
3015,GO:0006561,0.351056039018009,0.945322683951217,1,4,proline biosynthetic process,BP,PYCR2
13559,GO:0055129,0.351056039018009,0.945322683951217,1,4,L-proline biosynthetic process,BP,PYCR2
13661,GO:0060143,0.351136357235553,0.88353554156045,2,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;CAMK1
16170,GO:0090168,0.351197641062109,0.945274206721363,1,4,Golgi reassembly,BP,STK25
16197,GO:0090199,0.351371351287687,0.809023687818058,5,40,regulation of release of cytochrome c from mitochondria,BP,BNIP3;AKT1;FAM162A;MOAP1;BCL2L1
777,GO:0002029,0.351404745363576,0.883382839321358,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,APLN;DNM2
6578,GO:0022401,0.351404745363576,0.883382839321358,2,12,negative adaptation of signaling pathway,BP,APLN;DNM2
16673,GO:0097529,0.351545840092378,0.765884029980222,10,86,myeloid leukocyte migration,BP,PGF;RAC2;MMP14;ADAM8;PIP5K1C;ITGA1;MIF;VEGFB;MAPK3;ANXA1
19430,GO:1905908,0.351757878557352,0.945082157150978,1,4,positive regulation of amyloid fibril formation,BP,APOE
15842,GO:0072526,0.352229011211037,0.944920339637015,1,4,pyridine-containing compound catabolic process,BP,PNP
15013,GO:0070915,0.352291477588729,0.944898863137667,1,4,lysophosphatidic acid receptor activity,MF,LPAR3
4930,GO:0014883,0.352338080769446,0.944882837268458,1,4,transition between fast and slow fiber,BP,TNNT1
1114,GO:0002700,0.352495256500866,0.771165191658844,9,74,regulation of production of molecular mediator of immune response,BP,XBP1;HK1;PKN1;PRKCZ;GATA3;MIF;ARG1;MAPK3;TGFB1
13495,GO:0055010,0.352590773515553,0.825395538586831,4,28,ventricular cardiac muscle tissue morphogenesis,BP,FKBP1A;CHD7;RXRA;TGFB1
3776,GO:0008330,0.352654996155591,0.944773782291688,1,4,protein tyrosine/threonine phosphatase activity,MF,DUSP4
1328,GO:0003176,0.352934818265258,0.944677383837814,1,4,aortic valve development,BP,GATA3
1331,GO:0003180,0.352934818265258,0.944677383837814,1,4,aortic valve morphogenesis,BP,GATA3
7922,GO:0032489,0.352960378314495,0.944668573384265,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
9668,GO:0038003,0.352999194603712,0.944655191940261,1,4,opioid receptor signaling pathway,BP,SIGMAR1
1085,GO:0002666,0.353216911302262,0.944580100672274,1,4,positive regulation of T cell tolerance induction,BP,TGFBR2
7755,GO:0032264,0.353314427039214,0.944546447282271,1,4,IMP salvage,BP,AMPD2
5927,GO:0018199,0.353380598168141,0.944523604143771,1,4,peptidyl-glutamine modification,BP,TGM2
9853,GO:0042089,0.353666101578726,0.777163122739683,8,64,cytokine biosynthetic process,BP,CARD11;UBE2J1;GATA3;IL1RAP;IRF7;ZFPM1;TRIB2;IGF2BP3
8438,GO:0033539,0.353790845946106,0.882020960060416,2,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACAD10;ACADVL
3082,GO:0006656,0.35379183299729,0.824163023556271,4,29,phosphatidylcholine biosynthetic process,BP,LPCAT1;SLC27A1;LPIN3;STARD10
19722,GO:2000010,0.35393342906806,0.881939336060347,2,12,positive regulation of protein localization to cell surface,BP,SNX33;AKT1
16438,GO:0097056,0.354048078644382,0.944292864480159,1,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,SARS2
11876,GO:0046850,0.35408138734653,0.824321839934094,4,28,regulation of bone remodeling,BP,LRP5;EGFR;ADAM8;SRC
763,GO:0002002,0.354528923596822,0.944126285029328,1,4,regulation of angiotensin levels in blood,BP,CTSZ
764,GO:0002003,0.354528923596822,0.944126285029328,1,4,angiotensin maturation,BP,CTSZ
6030,GO:0019086,0.354635226374335,0.944089418056746,1,4,late viral transcription,BP,USF2
10399,GO:0043219,0.35475678858467,0.944047240995431,1,4,lateral loop,CC,DLG1
6295,GO:0019902,0.354992388957606,0.73750965013214,17,142,phosphatase binding,MF,DLG4;DLG1;SLC9A3R2;EGFR;AKT1;STRN4;PPP1R35;PPARA;PPP1R12C;DLG3;ITGA1;MTMR4;CARHSP1;MAPK3;CEACAM1;PPP6R1;PIK3R2
12815,GO:0051090,0.355060759540539,0.711539041313047,34,304,regulation of DNA binding transcription factor activity,BP,MDFI;RBCK1;CTNNBIP1;CRTC1;DAP;PRNP;ADGRF1;LRP5;AKT1;CARD11;IRAK1;TMSB4X;PRKCZ;PPP2R5B;SUFU;DDIT3;PKD1;PARP10;IL1RAP;WFS1;ADAM8;ARID5B;ANXA3;THRA;MAP3K10;MAPK9;TAF6;CIB1;MAPK3;MAPK10;ARHGEF2;TGFB1;CAT;EP300
15583,GO:0072014,0.355083788273949,0.943933690537794,1,4,proximal tubule development,BP,PKD1
14975,GO:0070851,0.355091729832401,0.763222141235724,10,82,growth factor receptor binding,MF,PGF;SHC1;GATA3;SRC;FYN;FGF2;VEGFB;TGFA;CBL;ECM1
13195,GO:0051781,0.35510355859439,0.784205673862216,7,55,positive regulation of cell division,BP,PGF;GIPC1;FGF2;VEGFB;TGFA;TGFB1;CAT
18744,GO:1904152,0.355168556053415,0.881231115284933,2,12,regulation of retrograde protein transport, ER to cytosol,BP,EDEM1;UBE2J1
14018,GO:0060712,0.355258685822229,0.881179354022732,2,12,spongiotrophoblast layer development,BP,FBXW8;AKT1
12760,GO:0051006,0.355433584503349,0.943812070449797,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14305,GO:0061365,0.355433584503349,0.943812070449797,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
10013,GO:0042420,0.35567558321809,0.943727837365488,1,4,dopamine catabolic process,BP,COMT
10394,GO:0043207,0.355718439145318,0.696932372125701,56,524,response to external biotic stimulus,BP,TNIP1;NOS1;F2R;MST1R;SHC1;CYP27B1;PCK2;NR1D1;PRSS3;BNIP3;LCN2;MAPKAPK3;BCR;XBP1;ADARB1;ACTA2;AKT1;IFITM1;IRAK1;ARG2;HIST2H2BE;BNIP3L;FAM3A;HTRA1;RAB29;GATA3;GSDMA;OASL;HSF1;MAPKBP1;HMGA2;TNFRSF6B;SRC;IRF7;LRSAM1;OAS1;ISG20;TNFRSF1A;ANXA3;VDR;PUM1;COMT;LOXL1;HYAL1;MIF;BCL2L1;RNASE7;ARG1;GSDMC;SEC14L1;BAIAP2L1;WIPF1;MAPK3;LITAF;TGFB1;APOBEC3C
13160,GO:0051707,0.355718439145318,0.696932372125701,56,524,response to other organism,BP,TNIP1;NOS1;F2R;MST1R;SHC1;CYP27B1;PCK2;NR1D1;PRSS3;BNIP3;LCN2;MAPKAPK3;BCR;XBP1;ADARB1;ACTA2;AKT1;IFITM1;IRAK1;ARG2;HIST2H2BE;BNIP3L;FAM3A;HTRA1;RAB29;GATA3;GSDMA;OASL;HSF1;MAPKBP1;HMGA2;TNFRSF6B;SRC;IRF7;LRSAM1;OAS1;ISG20;TNFRSF1A;ANXA3;VDR;PUM1;COMT;LOXL1;HYAL1;MIF;BCL2L1;RNASE7;ARG1;GSDMC;SEC14L1;BAIAP2L1;WIPF1;MAPK3;LITAF;TGFB1;APOBEC3C
6298,GO:0019905,0.3557309070048,0.775595118059104,8,63,syntaxin binding,MF,SNPH;VPS11;SYTL1;VAMP2;STXBP1;STX10;SNAP29;LLGL1
8982,GO:0035065,0.355806504844425,0.793694899303597,6,46,regulation of histone acetylation,BP,NOS1;GATA3;CTBP1;MAPK3;TGFB1;WBP2
12530,GO:0050654,0.355846617775364,0.823047071968252,4,28,chondroitin sulfate proteoglycan metabolic process,BP,CHPF;XYLT1;XYLT2;HYAL1
17298,GO:0140007,0.356015012599318,0.943609563198506,1,4,KICSTOR complex,CC,C12ORF66
8261,GO:0033031,0.356543000767047,0.943425288113459,1,4,positive regulation of neutrophil apoptotic process,BP,ANXA1
16654,GO:0097494,0.356563171464819,0.94341824107523,1,4,regulation of vesicle size,BP,RAB3B
1879,GO:0004553,0.356662503218656,0.774831837694949,8,63,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,EDEM1;NAGLU;CTBS;FUCA1;CEMIP;HYAL1;HPSE;NAGA
11520,GO:0045990,0.35673874023736,0.943356880245246,1,4,carbon catabolite regulation of transcription,BP,USF2
11521,GO:0045991,0.35673874023736,0.943356880245246,1,4,carbon catabolite activation of transcription,BP,USF2
3121,GO:0006701,0.356841297417718,0.943321018218725,1,4,progesterone biosynthetic process,BP,DGKQ
14551,GO:0070044,0.357061694675913,0.943243903741741,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
2671,GO:0006021,0.357166556246878,0.943207191674415,1,4,inositol biosynthetic process,BP,ISYNA1
5388,GO:0016209,0.357177450700127,0.791467975467548,6,53,antioxidant activity,MF,CYGB;SESN2;APOE;PRDX5;GPX3;CAT
391,GO:0001046,0.357177627999744,0.767473133428402,9,72,core promoter sequence-specific DNA binding,MF,NR1D1;MTA1;ATF4;BAZ2A;GATA3;TOP1;IRF7;RREB1;WBP2
12707,GO:0050905,0.357178842586102,0.792813209725929,6,45,neuromuscular process,BP,DVL1;DLG4;BCR;AARS;ADARB1;NLGN2
15771,GO:0072344,0.357279565848218,0.943167610945764,1,4,rescue of stalled ribosome,BP,ZNF598
11701,GO:0046470,0.357294942793931,0.782296885936253,7,56,phosphatidylcholine metabolic process,BP,MBOAT2;LPCAT4;LPCAT1;SLC27A1;PNPLA6;LPIN3;STARD10
10521,GO:0043415,0.357333560604547,0.94314869383154,1,4,positive regulation of skeletal muscle tissue regeneration,BP,TGFBR2
10522,GO:0043416,0.357333560604547,0.94314869383154,1,4,regulation of skeletal muscle tissue regeneration,BP,TGFBR2
12922,GO:0051249,0.357402162329915,0.715778437049428,28,249,regulation of lymphocyte activation,BP,RAC2;AP3D1;DLG1;PRNP;XBP1;MMP14;AKT1;CARD11;ARG2;PKN1;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;PAG1;FYN;GAL;MIF;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1
511,GO:0001574,0.357428610677676,0.943115383719535,1,4,ganglioside biosynthetic process,BP,ST3GAL5
2637,GO:0005968,0.357428620826163,0.943115380162425,1,4,Rab-protein geranylgeranyltransferase complex,CC,RABGGTA
6558,GO:0021987,0.357523753115187,0.76125932076185,10,81,cerebral cortex development,BP,PTPRS;BNIP3;BBS2;EGFR;LAMB1;TACC1;MBOAT7;LRP1;NDE1;SOCS7
4195,GO:0009299,0.357717285173888,0.844658602263164,3,20,mRNA transcription,BP,ATF4;DDIT3;HSF1
6824,GO:0030278,0.357783641719113,0.743806983230805,14,117,regulation of ossification,BP,CTNNBIP1;CYP27B1;LRP5;ACVR2B;PRKACA;IFITM1;FAM20C;DKK1;SUFU;ZHX3;MAPK3;ECM1;TGFB1;GNAS
7356,GO:0031392,0.357935302455751,0.942937615875265,1,4,regulation of prostaglandin biosynthetic process,BP,ANXA1
20330,GO:2001279,0.357935302455751,0.942937615875265,1,4,regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
18775,GO:1904220,0.357951611608685,0.942931888407731,1,4,regulation of serine C-palmitoyltransferase activity,BP,SERINC2
14665,GO:0070236,0.357966655951007,0.942926604810218,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D4
18700,GO:1904019,0.35803621537652,0.773704932018696,8,63,epithelial cell apoptotic process,BP,ANGPTL4;BOK;DNMT3A;TGFBR2;GATA3;WFS1;BCL2L1;PAK4
14585,GO:0070100,0.358048996367657,0.942897681491711,1,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT3
15281,GO:0071438,0.358058635405507,0.942894295055423,1,4,invadopodium membrane,CC,ITGA3
10130,GO:0042641,0.358095502150407,0.781949800759885,7,54,actomyosin,CC,MST1R;CORO1B;FSCN1;FLNB;CDC42BPB;PXN;FHOD1
1908,GO:0004591,0.358227221108182,0.942835047057355,1,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1
15200,GO:0071318,0.358378229201255,0.879381017283401,2,12,cellular response to ATP,BP,SSH1;P2RX4
11507,GO:0045956,0.358482973412861,0.879320405630544,2,12,positive regulation of calcium ion-dependent exocytosis,BP,STXBP1;ZP3
6215,GO:0019731,0.358523616604238,0.87536789831274,2,17,antibacterial humoral response,BP,HIST2H2BE;RNASE7
5551,GO:0016553,0.358535657697071,0.879289913521448,2,12,base conversion or substitution editing,BP,ADARB1;APOBEC3C
8038,GO:0032677,0.3586412177376,0.80372296671186,5,39,regulation of interleukin-8 production,BP,F2R;TMSB4X;DDIT3;MAPKBP1;ANXA1
10316,GO:0043073,0.358675895806116,0.879208729455039,2,12,germ cell nucleus,CC,TCFL5;HSPA2
17869,GO:1902023,0.358684018804373,0.942674322978321,1,4,L-arginine transport,BP,ARG1
1125,GO:0002711,0.358710876776424,0.843421405722496,3,21,positive regulation of T cell mediated immunity,BP,PRKCZ;GATA3;ZP3
8025,GO:0032652,0.358720949847701,0.791036237296501,6,48,regulation of interleukin-1 production,BP,F2R;HK1;ARG2;CPTP;CEACAM1;ANXA1
16573,GO:0097327,0.35894852008512,0.765896135350176,9,73,response to antineoplastic agent,BP,PCK2;EGFR;MAPK13;HSF1;EIF4EBP1;NUCB1;ASNS;ARG1;TGFB1
1909,GO:0004594,0.358969720767897,0.942573660326799,1,4,pantothenate kinase activity,MF,PANK4
19926,GO:2000381,0.35900264464681,0.942562053255026,1,4,negative regulation of mesoderm development,BP,DKK1
606,GO:0001772,0.359165112701928,0.843684665766037,3,20,immunological synapse,CC,DLG1;CARD11;SNX27
11286,GO:0045577,0.359207327128034,0.843656229607956,3,20,regulation of B cell differentiation,BP,XBP1;MMP14;CARD11
16791,GO:0098576,0.359227716057541,0.942482668027614,1,4,lumenal side of membrane,CC,NUCB1
9894,GO:0042159,0.359320545008356,0.878835197045075,2,12,lipoprotein catabolic process,BP,APOE;ABHD17C
18204,GO:1902949,0.359352349741846,0.942438679825133,1,4,positive regulation of tau-protein kinase activity,BP,DKK1
1552,GO:0003945,0.359352373843399,0.942438671316758,1,4,N-acetyllactosamine synthase activity,MF,B4GALT2
11899,GO:0046898,0.359389538058799,0.942425550648189,1,4,response to cycloheximide,BP,BCL2L1
15232,GO:0071362,0.359429986530994,0.942411268433405,1,4,cellular response to ether,BP,NFATC4
4669,GO:0010815,0.359450623185185,0.942403980878274,1,4,bradykinin catabolic process,BP,IDE
16278,GO:0090315,0.359645453200795,0.942335151832032,1,4,negative regulation of protein targeting to membrane,BP,GDI1
8469,GO:0033600,0.359907449867027,0.942242516003151,1,4,negative regulation of mammary gland epithelial cell proliferation,BP,GATA3
18554,GO:1903715,0.359968137571095,0.942221045446324,1,4,regulation of aerobic respiration,BP,BNIP3
9451,GO:0036020,0.36000671628167,0.878436984282589,2,12,endolysosome membrane,CC,AP2A2;PCSK9
4965,GO:0015038,0.360157125782898,0.938745571951388,1,5,glutathione disulfide oxidoreductase activity,MF,GLRX
10735,GO:0044062,0.360239516613109,0.942124975894866,1,4,regulation of excretion,BP,COMT
7948,GO:0032532,0.360275325455327,0.942112292178707,1,4,regulation of microvillus length,BP,TWF2
17517,GO:1900452,0.360331346436711,0.942092445825812,1,4,regulation of long term synaptic depression,BP,SHANK3
17538,GO:1900747,0.3604035992981,0.942066842990052,1,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18058,GO:1902548,0.3604035992981,0.942066842990052,1,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
9927,GO:0042262,0.360457582594112,0.938633315299143,1,5,DNA protection,BP,CBS
12192,GO:0048298,0.360550299875417,0.942014838520087,1,4,positive regulation of isotype switching to IgA isotypes,BP,TGFB1
11410,GO:0045778,0.360558951479321,0.779808816026652,7,55,positive regulation of ossification,BP,CTNNBIP1;ACVR2B;IFITM1;FAM20C;ZHX3;TGFB1;GNAS
12383,GO:0048752,0.360567833968258,0.942008620902415,1,4,semicircular canal morphogenesis,BP,CHD7
18829,GO:1904352,0.360595298902662,0.941998880982076,1,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1
4304,GO:0009750,0.360654623861988,0.941977839130068,1,4,response to fructose,BP,XBP1
12563,GO:0050693,0.360695284364775,0.94196341467164,1,4,LBD domain binding,MF,RXRA
4683,GO:0010829,0.360803087084306,0.877974014925671,2,12,negative regulation of glucose transmembrane transport,BP,GRB10;GSK3A
7295,GO:0031282,0.360842676908383,0.941911108465151,1,4,regulation of guanylate cyclase activity,BP,NOS1
7296,GO:0031284,0.360842676908383,0.941911108465151,1,4,positive regulation of guanylate cyclase activity,BP,NOS1
9883,GO:0042135,0.360894566834557,0.877920777975095,2,12,neurotransmitter catabolic process,BP,ALDH7A1;COMT
7510,GO:0031683,0.360974180726768,0.87787443712551,2,12,G-protein beta/gamma-subunit complex binding,MF,GNAI2;GNAS
9106,GO:0035368,0.360989373087934,0.941859021086197,1,4,selenocysteine insertion sequence binding,MF,SECISBP2L
9020,GO:0035184,0.361096788261243,0.941820863297764,1,4,histone threonine kinase activity,MF,PKN1
9122,GO:0035405,0.361096788261243,0.941820863297764,1,4,histone-threonine phosphorylation,BP,PKN1
79,GO:0000159,0.361307423069857,0.842238787299679,3,20,protein phosphatase type 2A complex,CC,STRN4;PPP2R3B;PPP2R5B
8154,GO:0032874,0.361379856879756,0.744270517211276,13,108,positive regulation of stress-activated MAPK cascade,BP,XDH;WNT7A;ERCC6;STK25;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;MINK1
12710,GO:0050908,0.361388553665532,0.941717141144977,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12742,GO:0050962,0.361388553665532,0.941717141144977,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
19903,GO:2000347,0.361546816595419,0.941660832156708,1,4,positive regulation of hepatocyte proliferation,BP,XBP1
1324,GO:0003170,0.361633159320012,0.818843487925821,4,28,heart valve development,BP,TGFBR2;GATA3;ZFPM1;TGFB1
15941,GO:0072708,0.361707110591928,0.941603766989603,1,4,response to sorbitol,BP,MAPK13
4165,GO:0009226,0.361720277099919,0.841384595025252,3,21,nucleotide-sugar biosynthetic process,BP,UAP1;TSTA3;MPI
4841,GO:0014045,0.361784661813645,0.941576146392795,1,4,establishment of endothelial blood-brain barrier,BP,WNT7A
6566,GO:0022009,0.361784661813645,0.941576146392795,1,4,central nervous system vasculogenesis,BP,WNT7A
650,GO:0001838,0.361835479437882,0.747902428777407,12,99,embryonic epithelial tube formation,BP,DVL1;DEAF1;PRKACB;SUFU;RET;GATA3;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
12274,GO:0048539,0.361839608261822,0.941556571914916,1,4,bone marrow development,BP,LRP5
9597,GO:0036438,0.361895565834934,0.941536633148972,1,4,maintenance of lens transparency,BP,STK39
11305,GO:0045601,0.361924749260434,0.841821086742037,3,20,regulation of endothelial cell differentiation,BP,XDH;TNFRSF1A;CEACAM1
15933,GO:0072687,0.361994073434444,0.941501522984526,1,4,meiotic spindle,CC,HSPA2
20332,GO:2001286,0.362280260652831,0.941399447505372,1,4,regulation of caveolin-mediated endocytosis,BP,SRC
8442,GO:0033553,0.362324131927433,0.941383790248938,1,4,rDNA heterochromatin,CC,BAZ2A
2942,GO:0006470,0.362437280290249,0.711224415566689,28,246,protein dephosphorylation,BP,DLG1;FKBP1A;PTPRS;SBF1;SSH1;PTPRF;PPP2R3B;PTPDC1;PPP1R35;PPP2R5B;SYMPK;DUSP4;PTPN9;PPM1M;PTPRU;PPP1R14A;DUSP6;PPM1F;SSU72;ITGA1;LHPP;MTMR4;PTPN12;RPRD1A;TGFB1;PPP6R1;PPP1R37;PPP1R10
1220,GO:0002887,0.362539692204392,0.941306821969409,1,4,negative regulation of myeloid leukocyte mediated immunity,BP,BCR
14776,GO:0070444,0.36259532443957,0.941286947911799,1,4,oligodendrocyte progenitor proliferation,BP,GJC2
14777,GO:0070445,0.36259532443957,0.941286947911799,1,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2
13580,GO:0060023,0.362622021191907,0.941277409318497,1,4,soft palate development,BP,TSHZ1
6156,GO:0019470,0.362622363962577,0.941277286842509,1,4,4-hydroxyproline catabolic process,BP,ALDH4A1
4906,GO:0014834,0.362723937701889,0.941240986518356,1,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A
16186,GO:0090188,0.362783452088675,0.941219711013666,1,4,negative regulation of pancreatic juice secretion,BP,STK39
11127,GO:0045134,0.362801432244991,0.941213282459013,1,4,uridine-diphosphatase activity,MF,ENTPD6
18078,GO:1902600,0.362835240005079,0.761847963178361,9,82,proton transmembrane transport,BP,SLC2A9;TMSB4X;TMCO3;NDUFA4L2;SLC33A1;VPS9D1;TCIRG1;ATP6V1C2;SLC15A1
7796,GO:0032331,0.362870252139572,0.876768238764263,2,12,negative regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7
5791,GO:0017017,0.363068536352266,0.876652273473397,2,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP4;DUSP6
12835,GO:0051121,0.363086139396076,0.941111432627651,1,4,hepoxilin metabolic process,BP,ALOX15B
12836,GO:0051122,0.363086139396076,0.941111432627651,1,4,hepoxilin biosynthetic process,BP,ALOX15B
8701,GO:0034316,0.363261571718934,0.941048621097691,1,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
13772,GO:0060326,0.363272643343597,0.732483252898834,16,143,cell chemotaxis,BP,PGF;RAC2;DOCK4;CORO1B;TMSB4X;ADAM8;PIP5K1C;PLEKHG5;ITGA1;FGFR1;MIF;P2RX4;FGF2;VEGFB;MAPK3;ANXA1
15386,GO:0071608,0.363312192926931,0.941030489214605,1,4,macrophage inflammatory protein-1 alpha production,BP,ARG2
15409,GO:0071640,0.363312192926931,0.941030489214605,1,4,regulation of macrophage inflammatory protein 1 alpha production,BP,ARG2
7518,GO:0031698,0.363320381174626,0.941027555969523,1,4,beta-2 adrenergic receptor binding,MF,GNAS
13657,GO:0060136,0.36347410239714,0.94097247258837,1,4,embryonic process involved in female pregnancy,BP,HSF1
11052,GO:0045010,0.363492557126353,0.800249619482155,5,38,actin nucleation,BP,CORO1B;ARPC1A;ARFIP2;SPIRE1;WIPF1
9537,GO:0036257,0.363516999175895,0.816737050445015,4,30,multivesicular body organization,BP,VPS4A;CHMP5;VPS37A;HGS
9302,GO:0035733,0.363563050777019,0.940940585221794,1,4,hepatic stellate cell activation,BP,CYGB
12899,GO:0051213,0.363990669594759,0.761679289984214,9,73,dioxygenase activity,MF,CYGB;P4HB;ALOX15B;ASPH;P4HA1;KDM4B;PHF2;PHYH;ASPHD1
8622,GO:0034127,0.364217954547287,0.940705485496321,1,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,IRF7
1923,GO:0004614,0.364354875148454,0.940656261685883,1,4,phosphoglucomutase activity,MF,PGM1
8655,GO:0034190,0.364466912053677,0.940615965298842,1,4,apolipoprotein receptor binding,MF,PCSK9
14075,GO:0060828,0.364470122081141,0.718108868107871,22,198,regulation of canonical Wnt signaling pathway,BP,DVL1;WNT7A;IGFBP4;PSMD2;SMURF2;LRP5;APOE;WWTR1;FERMT1;DKK1;SOX7;DDIT3;IGFBP2;SRC;GSK3A;FUZ;WNT5B;PSMD7;LRRK1;BICC1;INVS;CSNK1D
14207,GO:0061086,0.364494652409725,0.940605985345723,1,4,negative regulation of histone H3-K27 methylation,BP,PHF1
13799,GO:0060364,0.364527322777021,0.940594230453103,1,4,frontal suture morphogenesis,BP,TGFB1
10863,GO:0044352,0.364527546883309,0.940594149814072,1,4,pinosome,CC,MMP14
10864,GO:0044354,0.364527546883309,0.940594149814072,1,4,macropinosome,CC,MMP14
8040,GO:0032680,0.364573834427845,0.767958898712554,8,66,regulation of tumor necrosis factor production,BP,NFATC4;ARG2;UBE2J1;MC1R;HSF1;MIF;ARFGEF2;ARHGEF2
4695,GO:0010847,0.364595444462033,0.940569715537805,1,4,regulation of chromatin assembly,BP,PARP10
9062,GO:0035278,0.364627289071716,0.875738777549713,2,12,miRNA mediated inhibition of translation,BP,AGO4;TNRC6B
9815,GO:0040033,0.364627289071716,0.875738777549713,2,12,negative regulation of translation, ncRNA-mediated,BP,AGO4;TNRC6B
11511,GO:0045974,0.364627289071716,0.875738777549713,2,12,regulation of translation, ncRNA-mediated,BP,AGO4;TNRC6B
7629,GO:0032021,0.364681269839374,0.940538820873719,1,4,NELF complex,CC,NELFCD
3329,GO:0007041,0.364778902756333,0.749923502825216,11,90,lysosomal transport,BP,SORL1;AP3D1;EHD3;VPS11;VPS4A;PCSK9;BIN1;CHMP5;MGRN1;HGS;SNX27
10856,GO:0044342,0.364816057992379,0.875627925620958,2,12,type B pancreatic cell proliferation,BP,NR1D1;IGFBP4
18974,GO:1904705,0.364831475284639,0.816123734087755,4,29,regulation of vascular smooth muscle cell proliferation,BP,MEF2D;PAK1;APLN;FGF2
19681,GO:1990874,0.364831475284639,0.816123734087755,4,29,vascular smooth muscle cell proliferation,BP,MEF2D;PAK1;APLN;FGF2
12769,GO:0051018,0.36488940228936,0.799434362259884,5,37,protein kinase A binding,MF,PRKACA;AKAP12;WASF2;GSK3A;ARFGEF2
19612,GO:1990635,0.364926142311265,0.940450620316091,1,4,proximal dendrite,CC,GSK3A
6915,GO:0030500,0.364932202269222,0.799401459863191,5,37,regulation of bone mineralization,BP,CYP27B1;ACVR2B;FAM20C;ECM1;TGFB1
1535,GO:0003917,0.365181370358971,0.94035860539462,1,4,DNA topoisomerase type I activity,MF,TOP1
17471,GO:1900226,0.365293493539311,0.940318155455384,1,4,negative regulation of NLRP3 inflammasome complex assembly,BP,CPTP
16789,GO:0098574,0.36529473775361,0.940317706495174,1,4,cytoplasmic side of lysosomal membrane,CC,LITAF
7475,GO:0031628,0.365427031530372,0.940269958130782,1,4,opioid receptor binding,MF,GNAS
7554,GO:0031852,0.365427031530372,0.940269958130782,1,4,mu-type opioid receptor binding,MF,GNAS
731,GO:0001957,0.365478044203786,0.940251540103418,1,4,intramembranous ossification,BP,MN1
9474,GO:0036072,0.365478044203786,0.940251540103418,1,4,direct ossification,BP,MN1
18866,GO:1904431,0.365552519432749,0.940224644779881,1,4,positive regulation of t-circle formation,BP,ERCC1
3274,GO:0006954,0.365576998669034,0.696801670797883,40,365,inflammatory response,BP,TNIP1;NT5E;F2R;CTNNBIP1;NFATC4;SDC1;SHARPIN;IGFBP4;BCR;EGFR;AKT1;SERPING1;APOE;TMSB4X;PRKCZ;MAPK13;STK39;PPARA;PRDX5;AHCY;GATA3;FNDC4;IL1RAP;ADAM8;TNFRSF6B;TGM2;TNFRSF1A;GAL;MGLL;HYAL1;F12;MIF;ZP3;CASP4;GGT1;ECM1;CD59;TGFB1;ANXA1;PLGRKT
18487,GO:1903553,0.365864763439344,0.940111803801374,1,4,positive regulation of extracellular exosome assembly,BP,SDC1
11905,GO:0046906,0.365950199573995,0.766935575071608,8,65,tetrapyrrole binding,MF,CBS;NOS1;CYP27B1;NR1D1;CYGB;HEBP1;SRC;CAT
3531,GO:0007519,0.365958587926574,0.748836826905466,11,91,skeletal muscle tissue development,BP,NEURL1;MEF2D;FAM129B;DKK1;BCL9L;MYH15;FLNB;TAZ;LEMD2;TGFB1;EP300
12767,GO:0051016,0.36616172886129,0.874836287907034,2,12,barbed-end actin filament capping,BP,TWF2;CAPG
1025,GO:0002523,0.366210660145558,0.93645996090308,1,5,leukocyte migration involved in inflammatory response,BP,ADAM8
14813,GO:0070522,0.366216788817778,0.939984431447937,1,4,ERCC4-ERCC1 complex,CC,ERCC1
18638,GO:1903895,0.366289412819695,0.939958133670914,1,4,negative regulation of IRE1-mediated unfolded protein response,BP,DNAJB9
3876,GO:0008504,0.366428217507389,0.939907851840866,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
2390,GO:0005524,0.366576640484545,0.670224594882602,127,1149,ATP binding,MF,MST1R;MAP2K1;PYGL;ERCC6;SCN8A;OBSCN;DGKA;RPS6KA2;PC;SCYL1;SMARCA1;NME4;MAPKAPK3;BCR;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;PRKACA;CARS;ACTA2;HK1;MAP2K2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;GLUL;RET;HLTF;ASS1;ATP11A;OASL;GLUD1;PANK4;NEK9;MYH15;TOP1;PIP5K1C;SRC;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;ASNS;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;LONP2;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;ADCY6;ADCK2;ERBB3
9422,GO:0035977,0.366599698211876,0.939845697878765,1,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1
16638,GO:0097466,0.366599698211876,0.939845697878765,1,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1
18843,GO:1904382,0.366599698211876,0.939845697878765,1,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1
18927,GO:1904587,0.366599698211876,0.939845697878765,1,4,response to glycoprotein,BP,EDEM1
9599,GO:0036442,0.366643074576696,0.837501465205507,3,22,proton-exporting ATPase activity,MF,ATP2C2;TCIRG1;ATP6V1C2
1530,GO:0003906,0.366653295031978,0.873467240384441,2,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1;HMGA2
7651,GO:0032057,0.366679123889831,0.93981689646146,1,4,negative regulation of translational initiation in response to stress,BP,ATF4
14130,GO:0060965,0.366732167173082,0.874499960269822,2,12,negative regulation of gene silencing by miRNA,BP,BCDIN3D;TGFB1
19904,GO:2000348,0.366773757621795,0.939782569356174,1,4,regulation of CD40 signaling pathway,BP,SHARPIN
4056,GO:0009100,0.366792514039461,0.699799543588833,35,312,glycoprotein metabolic process,BP,TNIP1;EDEM1;CST3;LMF1;CHPF;XYLT1;XYLT2;SYVN1;RFNG;FBXO2;NDST2;UBE2J1;ADAMTS7;SRD5A3;B4GALT2;B3GNT3;RAB1B;PCSK6;MPI;CHST14;MCFD2;HYAL1;MFNG;ST3GAL3;ST3GAL5;HPSE;ST6GALNAC2;ABCA7;LMAN1;VEGFB;POMT1;RNF103;B4GALT6;GALNT3;ERP44
3658,GO:0008142,0.366944560402767,0.93972058287281,1,4,oxysterol binding,MF,OSBPL5
5613,GO:0016653,0.36696501449674,0.874362546641086,2,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1;NDOR1
18634,GO:1903891,0.367068218570596,0.939675681594082,1,4,regulation of ATF6-mediated unfolded protein response,BP,WFS1
18578,GO:1903763,0.36708053298702,0.939671209018296,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
16996,GO:0099003,0.367136648846734,0.747900275728217,11,90,vesicle-mediated transport in synapse,BP,AP3D1;SNPH;SEPT5;NLGN2;SYTL1;VAMP2;PIP5K1C;DNM2;STXBP1;SNAP29;ITSN1
974,GO:0002420,0.367161555921396,0.939641776601351,1,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
975,GO:0002423,0.367161555921396,0.939641776601351,1,4,natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1198,GO:0002855,0.367161555921396,0.939641776601351,1,4,regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1201,GO:0002858,0.367161555921396,0.939641776601351,1,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
8058,GO:0032713,0.367271972238667,0.939601652696435,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
12526,GO:0050650,0.367321276074977,0.838149471129518,3,20,chondroitin sulfate proteoglycan biosynthetic process,BP,CHPF;XYLT1;XYLT2
5563,GO:0016572,0.367322061654737,0.814290896295355,4,29,histone phosphorylation,BP,PKN1;HMGA2;MAP3K12;MAPK3
56,GO:0000118,0.367453954339683,0.774212332312218,7,55,histone deacetylase complex,CC,NACC2;PHF21A;SALL2;APPL2;SIN3B;RERE;MBD3
16523,GO:0097201,0.367454889530738,0.87407320710546,2,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,BAG3;IMPACT
8703,GO:0034330,0.367480569691253,0.712301752578128,24,205,cell junction organization,BP,FLNC;ITGB4;F2R;SDK2;DLG1;ITGA6;LAMA5;MMP14;PRKACA;FSCN1;NLGN2;LAMC2;RHOC;ARL2;NUMB;PIP5K1C;SRC;SH3BP1;PPM1F;LAMB3;VASP;CAMSAP3;KIFC3;TGFB1
20001,GO:2000542,0.367551474781999,0.939500012579211,1,4,negative regulation of gastrulation,BP,DKK1
14177,GO:0061038,0.367551609832914,0.939499963443447,1,4,uterus morphogenesis,BP,WNT7A
6207,GO:0019695,0.367575895760432,0.939491127044363,1,4,choline metabolic process,BP,ALDH7A1
9984,GO:0042363,0.36784783751699,0.939392127887105,1,4,fat-soluble vitamin catabolic process,BP,CYP27B1
19206,GO:1905232,0.367968680187147,0.939348104102941,1,4,cellular response to L-glutamate,BP,FYN
3501,GO:0007406,0.367986138394471,0.939341742356772,1,4,negative regulation of neuroblast proliferation,BP,TGFB1
5175,GO:0015727,0.367991628164581,0.939339741808443,1,4,lactate transport,BP,SLC16A3
9370,GO:0035873,0.367991628164581,0.939339741808443,1,4,lactate transmembrane transport,BP,SLC16A3
761,GO:0001999,0.368052045618751,0.939317722201575,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
762,GO:0002001,0.368052045618751,0.939317722201575,1,4,renin secretion into blood stream,BP,F2R
18571,GO:1903753,0.368128361978151,0.939289901174347,1,4,negative regulation of p38MAPK cascade,BP,DLG1
16986,GO:0098976,0.368179575754437,0.939271226914639,1,4,excitatory chemical synaptic transmission,BP,SSH1
7133,GO:0030951,0.368318304040516,0.93922062439562,1,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,CAMSAP3
12156,GO:0048243,0.368347515593789,0.939209965926653,1,4,norepinephrine secretion,BP,NISCH
3865,GO:0008483,0.36844823299844,0.873485490202123,2,12,transaminase activity,MF,GPT2;PSAT1
1464,GO:0003708,0.368550530813381,0.939135860032904,1,4,retinoic acid receptor activity,MF,RXRA
11596,GO:0046135,0.368564096444252,0.872329492168546,2,13,pyrimidine nucleoside catabolic process,BP,NT5E;APOBEC3C
17302,GO:0140029,0.36860526130757,0.773123574061823,7,56,exocytic process,BP,RAB3B;SNPH;VPS11;SEPT5;EXOC2;STXBP1;SNAP29
6010,GO:0019049,0.368622647397529,0.939109522371567,1,4,evasion or tolerance of host defenses by virus,BP,TGFB1
10885,GO:0044413,0.368622647397529,0.939109522371567,1,4,avoidance of host defenses,BP,TGFB1
10887,GO:0044415,0.368622647397529,0.939109522371567,1,4,evasion or tolerance of host defenses,BP,TGFB1
13223,GO:0051832,0.368622647397529,0.939109522371567,1,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,TGFB1
13225,GO:0051834,0.368622647397529,0.939109522371567,1,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,TGFB1
1442,GO:0003418,0.368653481319879,0.93909825941616,1,4,growth plate cartilage chondrocyte differentiation,BP,TGFBR2
1446,GO:0003431,0.368653481319879,0.93909825941616,1,4,growth plate cartilage chondrocyte development,BP,TGFBR2
364,GO:0000982,0.368665576467212,0.702077019634796,31,270,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;NACC2;ATF4;ELK3;POU2F2;TFEB;CREB3L2;PPARA;TFE3;DDIT3;HLTF;GATA3;TCFL5;HSF1;HMGA2;IRF7;CAMTA2;ZNF692;EHF;USF2;HES2;ZFPM1;RCOR1;TSHZ1;DBP;LITAF
1701,GO:0004176,0.368683536501873,0.939087279698774,1,4,ATP-dependent peptidase activity,MF,LONP2
12249,GO:0048495,0.368716992025719,0.939075056357664,1,4,Roundabout binding,MF,SLIT3
9569,GO:0036337,0.368814149226472,0.939039550459827,1,4,Fas signaling pathway,BP,TMBIM1
8995,GO:0035095,0.368983214841998,0.938977735791188,1,4,behavioral response to nicotine,BP,PPARA
8487,GO:0033627,0.369002380986056,0.796002338610978,5,38,cell adhesion mediated by integrin,BP,ITGA6;FERMT1;PODXL;RET;CIB1
18892,GO:1904505,0.369056091188037,0.938951078603727,1,4,regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18893,GO:1904506,0.369056091188037,0.938951078603727,1,4,negative regulation of telomere maintenance in response to DNA damage,BP,ERCC1
9736,GO:0038171,0.369086936394162,0.938939793709526,1,4,cannabinoid signaling pathway,BP,MGLL
15550,GO:0071926,0.369086936394162,0.938939793709526,1,4,endocannabinoid signaling pathway,BP,MGLL
14595,GO:0070122,0.369094739382902,0.938936938740611,1,4,isopeptidase activity,MF,GGT1
957,GO:0002374,0.369204843424667,0.873036930283919,2,12,cytokine secretion involved in immune response,BP,HK1;MAPK3
4180,GO:0009256,0.369292112590413,0.938864696544639,1,4,10-formyltetrahydrofolate metabolic process,BP,ALDH1L2
8412,GO:0033353,0.369318614342147,0.938854992463425,1,4,S-adenosylmethionine cycle,BP,AHCY
5774,GO:0016972,0.369484246450504,0.938794322136681,1,4,thiol oxidase activity,MF,QSOX1
11016,GO:0044821,0.369595893349621,0.938753405706513,1,4,meiotic telomere tethering at nuclear periphery,BP,LEMD2
14642,GO:0070197,0.369595893349621,0.938753405706513,1,4,meiotic attachment of telomere to nuclear envelope,BP,LEMD2
16545,GO:0097240,0.369595893349621,0.938753405706513,1,4,chromosome attachment to the nuclear envelope,BP,LEMD2
16886,GO:0098796,0.369621506019132,0.676479853982506,77,730,membrane protein complex,CC,ITGB4;NOS1;SHC1;KCNG1;AP3D1;SCN8A;DLG4;DLG1;FKBP1A;ITGA6;SCYL1;COPG1;SYNE3;LRP5;ITGB5;EGFR;TTYH3;PRKACA;SHANK3;CARD11;IRAK1;EPN2;AP1B1;SYVN1;COL13A1;AP2A2;VPS11;FZD8;VPS4A;SEC23A;TGFBR2;MVB12B;ABCB8;UBXN7;GGA3;GGA1;GNB1;SDCCAG3;RET;TMED3;SHANK2;DLG3;PIGQ;GNAI2;GRIN3B;SDHA;ADAM8;VAMP2;LDLRAP1;NDUFA4L2;RGS19;STX5;SPTLC2;STX10;GJC2;ITGA1;SEC24C;LRRC8A;VPS37A;TCIRG1;LRP1;HSPA2;SDHAF4;SNTB2;ABCA7;ATP6V1C2;SNAP29;KCNC4;CBL;SNX27;NDUFS2;HM13;CEACAM1;PIK3R2;GNAS;ITGA3;ARCN1
2992,GO:0006537,0.369647138451065,0.938734619797571,1,4,glutamate biosynthetic process,BP,GLUD1
11017,GO:0044827,0.369732998593936,0.872723345771545,2,12,modulation by host of viral genome replication,BP,STOM;TBC1D20
2567,GO:0005850,0.369754809682779,0.938695137250067,1,4,eukaryotic translation initiation factor 2 complex,CC,EIF2S2
8368,GO:0033239,0.369829218761124,0.938667842738242,1,4,negative regulation of cellular amine metabolic process,BP,COMT
5123,GO:0015485,0.369904365641498,0.812025292959957,4,30,cholesterol binding,MF,OSBPL10;OSBP2;APOE;OSBPL5
18594,GO:1903795,0.369908881462222,0.938638612914464,1,4,regulation of inorganic anion transmembrane transport,BP,PRNP
13004,GO:0051388,0.369938202305102,0.938627852382556,1,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,PPP2R5B
5761,GO:0016918,0.369950739312571,0.935022555636035,1,5,retinal binding,MF,ALDH1A2
14653,GO:0070212,0.369972167189197,0.93861538608663,1,4,protein poly-ADP-ribosylation,BP,PARP10
9677,GO:0038027,0.370014229863608,0.938599945483982,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA7
12560,GO:0050690,0.370060655820717,0.835680856602824,3,21,regulation of defense response to virus by virus,BP,AP1B1;AP2A2;FYN
5377,GO:0016185,0.370096872200312,0.938569601787772,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM2
16918,GO:0098844,0.370096872200312,0.938569601787772,1,4,postsynaptic endocytic zone membrane,CC,DNM2
16936,GO:0098884,0.370096872200312,0.938569601787772,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM2
12397,GO:0048787,0.3701546798141,0.938548371206484,1,4,presynaptic active zone membrane,CC,STXBP1
12756,GO:0051000,0.370159335277645,0.872469935315078,2,12,positive regulation of nitric-oxide synthase activity,BP,AKT1;APOE
8634,GO:0034144,0.370279168499545,0.938502635992788,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
8356,GO:0033206,0.370299718854161,0.938495084119421,1,4,meiotic cytokinesis,BP,SPIRE1
16128,GO:0090091,0.370396887215745,0.938459368908674,1,4,positive regulation of extracellular matrix disassembly,BP,FSCN1
11990,GO:0047238,0.370635067884523,0.938371769813763,1,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,CHPF
14678,GO:0070265,0.370687459622157,0.794214602156522,5,40,necrotic cell death,BP,RBCK1;PYGL;BOK;BNIP3;ARHGEF2
7710,GO:0032184,0.371039400349505,0.938222888973376,1,4,SUMO polymer binding,MF,SIMC1
12513,GO:0050510,0.371068225246876,0.9382122668916,1,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,CHPF
20085,GO:2000675,0.371068380933784,0.938212209517368,1,4,negative regulation of type B pancreatic cell apoptotic process,BP,WFS1
6434,GO:0021697,0.37107072192319,0.871927378838798,2,12,cerebellar cortex formation,BP,MAP2K1;WNT7A
12420,GO:0048846,0.371107058652251,0.811879063148549,4,28,axon extension involved in axon guidance,BP,SEMA3F;SEMA4B;SEMA4G;SLIT3
17968,GO:1902284,0.371107058652251,0.811879063148549,4,28,neuron projection extension involved in neuron projection guidance,BP,SEMA3F;SEMA4B;SEMA4G;SLIT3
9142,GO:0035459,0.371173576667087,0.835506316172339,3,20,cargo loading into vesicle,BP,SEC23A;SEC24C;TBC1D20
12720,GO:0050919,0.371176526182461,0.811827619008262,4,28,negative chemotaxis,BP,SEMA3F;SEMA4B;SEMA4G;SLIT3
6600,GO:0022614,0.371193051788158,0.93816625500985,1,4,membrane to membrane docking,BP,MSN
13586,GO:0060029,0.37126129469012,0.938141091408925,1,4,convergent extension involved in organogenesis,BP,DVL1
3718,GO:0008238,0.371360087140477,0.762562939210311,8,64,exopeptidase activity,MF,RNPEPL1;MMP14;NPEPL1;CTSZ;SCRN1;CNDP2;BLMH;GGT1
11843,GO:0046726,0.371385388700072,0.938095317524819,1,4,positive regulation by virus of viral protein levels in host cell,BP,TBC1D20
15919,GO:0072672,0.371405294713312,0.938087972982177,1,4,neutrophil extravasation,BP,ADAM8
16651,GO:0097490,0.37141003061886,0.938086225539584,1,4,sympathetic neuron projection extension,BP,SEMA3F
16652,GO:0097491,0.37141003061886,0.938086225539584,1,4,sympathetic neuron projection guidance,BP,SEMA3F
6410,GO:0021636,0.371421543512644,0.938081977415511,1,4,trigeminal nerve morphogenesis,BP,SEMA3F
6411,GO:0021637,0.371421543512644,0.938081977415511,1,4,trigeminal nerve structural organization,BP,SEMA3F
2346,GO:0005384,0.371446015226521,0.938072947047633,1,4,manganese ion transmembrane transporter activity,MF,ATP2C2
13766,GO:0060318,0.371466220562975,0.938065490421577,1,4,definitive erythrocyte differentiation,BP,ZFPM1
2230,GO:0005131,0.371501256507595,0.938052559375861,1,4,growth hormone receptor binding,MF,SOCS2
14654,GO:0070213,0.371534648420014,0.938040233578086,1,4,protein auto-ADP-ribosylation,BP,PARP10
7652,GO:0032058,0.371556073618807,0.938032324209608,1,4,positive regulation of translational initiation in response to stress,BP,IMPACT
250,GO:0000710,0.371573206759545,0.938025998863295,1,4,meiotic mismatch repair,BP,ERCC1
4178,GO:0009251,0.37159397177689,0.835216753215038,3,20,glucan catabolic process,BP,PYGB;PYGL;PGM1
3475,GO:0007320,0.371599275434561,0.938016373872036,1,4,insemination,BP,SERPINE2
4562,GO:0010641,0.371604018042915,0.938014622723848,1,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,SRC
15921,GO:0072674,0.371621736817673,0.938008080023243,1,4,multinuclear osteoclast differentiation,BP,SH3PXD2A
15922,GO:0072675,0.371621736817673,0.938008080023243,1,4,osteoclast fusion,BP,SH3PXD2A
1821,GO:0004468,0.37176125268097,0.937956548753743,1,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,EP300
19586,GO:1990535,0.371841085748328,0.93792705005391,1,4,neuron projection maintenance,BP,PRNP
10635,GO:0043622,0.37189077512002,0.937908685279774,1,4,cortical microtubule organization,BP,DLG1
1439,GO:0003415,0.371924953968431,0.937896051143214,1,4,chondrocyte hypertrophy,BP,TGFBR2
7517,GO:0031697,0.372017373501875,0.937861880620696,1,4,beta-1 adrenergic receptor binding,MF,DLG4
15151,GO:0071225,0.372116841784111,0.937825091147374,1,4,cellular response to muramyl dipeptide,BP,ARHGEF2
13517,GO:0055059,0.37230181651521,0.937756640854809,1,4,asymmetric neuroblast division,BP,ARHGEF2
728,GO:0001954,0.372321597579184,0.793428298150321,5,38,positive regulation of cell-matrix adhesion,BP,PRKCZ;EPHA1;FERMT1;PPM1F;CIB1
4952,GO:0015012,0.372381820571761,0.834673498711419,3,20,heparan sulfate proteoglycan biosynthetic process,BP,XYLT1;XYLT2;NDST2
17933,GO:1902219,0.372386190443175,0.937725402857642,1,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
1018,GO:0002507,0.372391502697673,0.871139080948573,2,12,tolerance induction,BP,TGFBR2;TGFB1
1110,GO:0002696,0.372396259116485,0.714818045241491,20,177,positive regulation of leukocyte activation,BP,AP3D1;XBP1;MMP14;AKT1;CARD11;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;STXBP1;FYN;MIF;ZP3;PNP;TGFB1;ANXA1
8055,GO:0032703,0.37244530203173,0.871106920386929,2,12,negative regulation of interleukin-2 production,BP,PRNP;GATA3
9129,GO:0035426,0.372528335889796,0.93767275434164,1,4,extracellular matrix-cell signaling,BP,LRP5
7744,GO:0032237,0.372582283790652,0.937652765757803,1,4,activation of store-operated calcium channel activity,BP,STIM1
17654,GO:1901341,0.372582283790652,0.937652765757803,1,4,positive regulation of store-operated calcium channel activity,BP,STIM1
14078,GO:0060836,0.372656388767793,0.937625302276011,1,4,lymphatic endothelial cell differentiation,BP,ACVR2B
10327,GO:0043101,0.372664998342864,0.869870738849954,2,13,purine-containing compound salvage,BP,AMPD2;PNP
16036,GO:0086036,0.37267967957509,0.937616669124107,1,4,regulation of cardiac muscle cell membrane potential,BP,EHD3
9271,GO:0035673,0.372763046120126,0.937585761861878,1,4,oligopeptide transmembrane transporter activity,MF,SLC15A1
12167,GO:0048259,0.372800162400185,0.769691244475396,7,56,regulation of receptor-mediated endocytosis,BP,DLG4;PCSK9;DKK1;APLN;LDLRAP1;ARAP3;CBL
3382,GO:0007161,0.372831653688283,0.937560319332035,1,4,calcium-independent cell-matrix adhesion,BP,PKD1
4548,GO:0010624,0.372885250633813,0.937540438964536,1,4,regulation of Schwann cell proliferation,BP,RNF10
4549,GO:0010626,0.372885250633813,0.937540438964536,1,4,negative regulation of Schwann cell proliferation,BP,RNF10
10484,GO:0043367,0.372911716159123,0.79296945030931,5,38,CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;SATB1;GATA3;ZFPM1;ANXA1
9687,GO:0038044,0.372945167063572,0.937518209983243,1,4,transforming growth factor-beta secretion,BP,FERMT1
14200,GO:0061077,0.372952085817984,0.760880717017491,8,67,chaperone-mediated protein folding,BP,FKBP1A;CRTAP;FKBP9;FYCO1;FKBP10;HSPA2;HSPA13;UNC45A
9585,GO:0036379,0.372985773656306,0.869677436328915,2,13,myofilament,CC,TMOD2;TNNT1
15622,GO:0072089,0.373091805635262,0.754118829294185,9,72,stem cell proliferation,BP,FBLN1;FERMT1;HMGA2;NUMB;FGFR1;FGF2;NDE1;ARHGEF2;TGFB1
15798,GO:0072385,0.373115765207102,0.93745489169329,1,4,minus-end-directed organelle transport along microtubule,BP,RAB6A
10127,GO:0042636,0.373195491101374,0.937425287648592,1,4,negative regulation of hair cycle,BP,FERMT1
11549,GO:0046060,0.373291102223091,0.933722313673944,1,5,dATP metabolic process,BP,GUK1
9078,GO:0035308,0.3733849891369,0.792351488657805,5,39,negative regulation of protein dephosphorylation,BP,FKBP1A;PPP1R35;PPP1R14A;PPP1R37;PPP1R10
10882,GO:0044403,0.37343240190398,0.673649168714804,74,715,symbiont process,BP,TNIP1;RBCK1;SHC1;CRTC1;DLG1;MMP1;BNIP3;PC;RAB43;CTSB;FBLN1;ITGB5;EGFR;ADARB1;P4HB;IFITM1;IRAK1;APOE;ATG16L2;AP1B1;AP2A2;VPS4A;MVB12B;BNIP3L;WASF2;PLCG1;IDE;BIN1;CUL7;STOM;SATB1;RAB29;PARP10;OASL;CTBP1;HMGA2;TOP1;SRC;CHMP5;UBR4;IRF7;LRSAM1;RAB1B;EXOC2;RSF1;OAS1;FYN;ISG20;NELFCD;TNFRSF1A;UCKL1;USF2;VPS37A;RAB11FIP4;BCL2L1;RAD23A;ULK1;ULK2;TBC1D20;VAPB;RCOR1;RXRA;ARG1;RPL28;CBL;PACS2;MAPK3;FURIN;EIF4G3;ITSN1;TGFB1;RAB6A;APOBEC3C;EP300
5853,GO:0017146,0.373467987977054,0.937324038821778,1,4,NMDA selective glutamate receptor complex,CC,GRIN3B
19991,GO:2000515,0.373519263710079,0.870464086391874,2,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ARG2;ANXA1
10129,GO:0042640,0.37358475277485,0.937280623180107,1,4,anagen,BP,FERMT1
13243,GO:0051884,0.37358475277485,0.937280623180107,1,4,regulation of timing of anagen,BP,FERMT1
15789,GO:0072367,0.373646186150583,0.937257773577864,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,PPARA
10397,GO:0043217,0.373785056728668,0.870304747361883,2,12,myelin maintenance,BP,SH3TC2;AKT1
13797,GO:0060359,0.373818948899532,0.760389734965683,8,65,response to ammonium ion,BP,DNMT3A;ATF4;GNB1;GNAI2;DNM2;AGRN;HOMER2;MAPK3
10739,GO:0044085,0.373859429128792,0.653846814422839,257,2479,cellular component biogenesis,BP,ANGPTL4;FLNC;ITGB4;ERCC1;ZMYND8;H1F0;THSD4;RAC2;SORL1;CTNNBIP1;ADGRL1;SDC1;DVL1;KCNG1;WNT7A;SDK2;NEURL1;SNX9;BOK;SHARPIN;CRTC1;ARAP1;DLG4;OBSCN;DLG1;MMP1;SLC9A3R2;FKBP1A;SOX12;ITGA6;RAPGEF3;PRNP;LAMA5;SSH1;TMOD2;ESPN;TNNT1;BBS2;NACC2;ADGRF1;NUDCD3;MARK4;ITGB5;EVI5L;CSNK1E;MMP14;THBS2;RFX2;SEPT10;PRKACA;FCHO1;CORO1B;TUBG2;STK25;PARVB;SHANK3;P4HB;XPC;ACOT13;IRAK1;ARPC1A;APOE;ATG16L2;EHD3;ATP13A2;WWTR1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;ITPR3;DGKQ;VPS11;VPS4A;HIST2H2BE;CTSZ;EPHA1;DNAAF5;PTPDC1;SH3PXD2B;TYSND1;EML2;SEPT5;SEC23A;MSN;LIMK1;DKK1;PPP2R5B;ARRDC1;OBSL1;PRKACB;ZDHHC8;WASF2;CDC34;RAP1GDS1;ATG13;IDE;MSRB2;COA5;TWF2;RRNAD1;TBC1D14;BIN1;FSCN1;HMGCL;CCDC88C;PAK1;TTBK2;BCL9L;NLGN2;TNRC18;BAZ2A;DDIT3;PODXL;GLUL;DMXL2;STOM;FARP1;GNB1;RAB29;CORO7;LAMC2;RHOC;SEPT8;SHANK2;PARP10;OXA1L;ASIC1;HSF1;ADGRB2;IL1RAP;HMGA2;RHOBTB2;DYNLRB1;FAM110C;ARL2;ARHGEF4;VAMP2;PIP5K1C;SRC;CHMP5;CBR4;CAPG;TAZ;TGM2;DNM2;NINL;AGO4;LRSAM1;RAB1B;CPTP;STX5;SDCCAG8;GPX3;EXOC2;RSF1;STXBP1;SH3BP1;MPI;ISG20;CLSTN1;FUZ;AGRN;PPM1F;LPAR3;PFN1;KIF17;TNFRSF1A;TLE4;THRA;MCFD2;AMIGO2;HSF4;LAMB3;LOXL1;SEC24C;TUBG1;ADNP;HYAL1;TENM2;PSMG4;MIF;TTC19;VPS37A;SIGMAR1;STUB1;DDB2;TCIRG1;PMEPA1;ARFIP2;UNC119B;ULK1;HSPA2;P2RX4;USO1;ULK2;SMPD3;TBC1D20;SPIRE1;EHD4;MAP1LC3B;MAPK9;SDHAF4;VASP;CHD7;ATXN10;ABCA7;LMAN1;RHOBTB1;EPS8L1;WDR18;RXRA;C1QTNF6;ARG1;TAF6;TGFA;NDE1;CAMSAP3;RPL28;BAHCC1;BAIAP2L1;TPBG;WIPF1;IMPACT;SNAP29;KCNC4;EPHB2;HGS;GAS8;TRAPPC1;TMSB10;PACS2;WRAP73;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;NDUFS2;OCRL;SRPX2;HM13;APBA1;SKAP2;CD59;TGFB1;PPP6R1;SH3PXD2A;CAT;ASH2L;CCDC113;PXN;ARHGEF10L;EP300;TCF7L1;ASAP1;FHOD1
14292,GO:0061343,0.373909851528532,0.937159647896404,1,4,cell adhesion involved in heart morphogenesis,BP,TGFBR2
4628,GO:0010746,0.373966360961807,0.937138605175443,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4629,GO:0010748,0.373966360961807,0.937138605175443,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
3191,GO:0006817,0.373966383053385,0.870195989052325,2,12,phosphate ion transport,BP,SLC20A1;FGFR1
6075,GO:0019221,0.373973612798133,0.679657884746091,56,534,cytokine-mediated signaling pathway,BP,CCND1;MST1R;RBCK1;SDC1;SHC1;SHARPIN;MMP1;IFI6;FKBP1A;PSMD2;LAMA5;LCN2;BBS2;PRKACA;P4HB;AKT1;IFITM1;IRAK1;TMSB4X;MSN;EPOR;CD44;FSCN1;TNFSF15;IFI27;GATA3;OASL;IL1RAP;MT2A;TNFRSF6B;IRF7;TALDO1;OAS1;FYN;ISG20;PSMD7;TNFRSF1A;TIMP1;MIF;SOCS2;BCL2L1;ADIPOR1;SLC27A1;TNFRSF19;FGF2;SLIT3;ARG1;CASP4;CBL;CIB1;SOCS7;MAPK3;CEACAM1;ECM1;TGFB1;ANXA1
16741,GO:0097722,0.374029049339258,0.808957983873907,4,30,sperm motility,BP,NEURL1;BBS2;PLTP;GAS8
14541,GO:0070022,0.374033497840699,0.937113599467382,1,4,transforming growth factor beta receptor complex,CC,TGFBR2
13969,GO:0060628,0.374040456113538,0.870151547499959,2,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1;TBC1D20
790,GO:0002051,0.374180268162577,0.937058912461767,1,4,osteoblast fate commitment,BP,SH3PXD2B
3617,GO:0008066,0.374249994896363,0.937032921933398,1,4,glutamate receptor activity,MF,GRIN3B
14702,GO:0070304,0.374329725920028,0.732907709528236,13,109,positive regulation of stress-activated protein kinase signaling cascade,BP,XDH;WNT7A;ERCC6;STK25;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;MINK1
959,GO:0002377,0.374356694575487,0.759940420115617,8,65,immunoglobulin production,BP,ERCC1;XBP1;CARD11;PKN1;POU2F2;POLM;DNAJB9;TGFB1
11139,GO:0045162,0.374391597106676,0.936980119780493,1,4,clustering of voltage-gated sodium channels,BP,AGRN
16456,GO:0097091,0.374413341236333,0.936972009203256,1,4,synaptic vesicle clustering,BP,NLGN2
13437,GO:0052811,0.374503412212047,0.936938405873508,1,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,PIP5K1C
11383,GO:0045730,0.374541495155357,0.868737927704776,2,13,respiratory burst,BP,RAC2;BCR
13648,GO:0060123,0.374587540701137,0.936907009668256,1,4,regulation of growth hormone secretion,BP,CHD7
18368,GO:1903306,0.374622343825399,0.869802169870994,2,12,negative regulation of regulated secretory pathway,BP,BCR;CEACAM1
1337,GO:0003190,0.374757517710748,0.936843546241385,1,4,atrioventricular valve formation,BP,ZFPM1
19777,GO:2000117,0.374779536644177,0.752194675536969,9,77,negative regulation of cysteine-type endopeptidase activity,BP,CST3;IFI6;AKT1;CD44;PRDX5;RAG1;TNFRSF6B;SRC;MICAL1
1697,GO:0004169,0.374877582479507,0.933099304498728,1,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,POMT1
5384,GO:0016199,0.37495393109224,0.936770163885966,1,4,axon midline choice point recognition,BP,ROBO3
10414,GO:0043237,0.375446975123657,0.936585727504559,1,4,laminin-1 binding,MF,NID1
18963,GO:1904684,0.375465667995259,0.936578728476856,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
9951,GO:0042297,0.37558407464179,0.936534383430025,1,4,vocal learning,BP,SHANK3
16802,GO:0098596,0.37558407464179,0.936534383430025,1,4,imitative learning,BP,SHANK3
16804,GO:0098598,0.37558407464179,0.936534383430025,1,4,learned vocalization behavior or vocal learning,BP,SHANK3
16815,GO:0098634,0.375631321689766,0.936516683423968,1,4,cell-matrix adhesion mediator activity,MF,ITGA1
16817,GO:0098639,0.375631321689766,0.936516683423968,1,4,collagen binding involved in cell-matrix adhesion,MF,ITGA1
5838,GO:0017119,0.375679365329142,0.869166317900132,2,12,Golgi transport complex,CC,COG8;COG1
4838,GO:0014042,0.375847348206946,0.936435715705254,1,4,positive regulation of neuron maturation,BP,RET
14042,GO:0060745,0.375859469625308,0.936431170674307,1,4,mammary gland branching involved in pregnancy,BP,VDR
11418,GO:0045794,0.3760827258775,0.936347423295157,1,4,negative regulation of cell volume,BP,SHANK3
10465,GO:0043313,0.376322762012049,0.93625730630894,1,4,regulation of neutrophil degranulation,BP,BCR
18064,GO:1902563,0.376322762012049,0.93625730630894,1,4,regulation of neutrophil activation,BP,BCR
3605,GO:0008046,0.376402561036231,0.936227330028652,1,4,axon guidance receptor activity,MF,EPHB2
11147,GO:0045177,0.376421294802935,0.702506426033497,25,218,apical part of cell,CC,PLAT;DLG1;SLC9A3R2;SLC2A9;EGFR;PRKCZ;ITPR3;MSN;STK39;CD44;SLC29A4;PODXL;SHANK2;NUMB;IGFBP2;REEP6;TUBG1;TCIRG1;HOMER2;CIB1;DRAM2;CEACAM1;ERBB3;ANXA1;GNAS
17364,GO:1900025,0.376733421416007,0.868530714828881,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1
11129,GO:0045137,0.376813231726385,0.717855638353476,17,148,development of primary sexual characteristics,BP,ERCC1;CCND1;SDC1;CST3;BOK;MMP14;GATA3;ARID5B;SRC;AGO4;EIF2S2;BCL2L1;ZP3;TBC1D20;SLIT3;CBL;ADAM15
8804,GO:0034497,0.37684213356902,0.868465073397238,2,12,protein localization to phagophore assembly site,BP,ATG13;PACS2
16462,GO:0097105,0.376863679008181,0.936053943591352,1,4,presynaptic membrane assembly,BP,NLGN2
16461,GO:0097104,0.376866004578919,0.936053068416728,1,4,postsynaptic membrane assembly,BP,NLGN2
5897,GO:0018076,0.376869246188008,0.936051848499901,1,4,N-terminal peptidyl-lysine acetylation,BP,EP300
19072,GO:1904888,0.376963693264063,0.776871319415942,6,46,cranial skeletal system development,BP,MMP14;SH3PXD2B;TGFBR2;TULP3;TGFB1;GNAS
6343,GO:0021514,0.377013087803009,0.935997702168486,1,4,ventral spinal cord interneuron differentiation,BP,SUFU
4804,GO:0010996,0.377017763400975,0.868358991949685,2,12,response to auditory stimulus,BP,SHANK3;XPC
14274,GO:0061304,0.377048078239626,0.935984526472929,1,4,retinal blood vessel morphogenesis,BP,LRP5
14657,GO:0070228,0.377086018322669,0.789222659870582,5,40,regulation of lymphocyte apoptotic process,BP,ARG2;RAG1;ADAM8;TSC22D4;MIF
10890,GO:0044419,0.377094929051457,0.669855121078543,75,727,interspecies interaction between organisms,BP,TNIP1;RBCK1;SHC1;CRTC1;DLG1;MMP1;BNIP3;PC;RAB43;CTSB;FBLN1;ITGB5;EGFR;ADARB1;P4HB;IFITM1;IRAK1;APOE;ATG16L2;AP1B1;AP2A2;VPS4A;MVB12B;BNIP3L;WASF2;PLCG1;IDE;BIN1;CUL7;STOM;SATB1;RAB29;PARP10;OASL;CTBP1;HMGA2;TOP1;SRC;CHMP5;UBR4;IRF7;LRSAM1;RAB1B;EXOC2;RSF1;OAS1;FYN;ISG20;NELFCD;TNFRSF1A;UCKL1;USF2;VPS37A;RAB11FIP4;BCL2L1;RAD23A;ULK1;ULK2;TBC1D20;RNASE7;VAPB;RCOR1;RXRA;ARG1;RPL28;CBL;PACS2;MAPK3;FURIN;EIF4G3;ITSN1;TGFB1;RAB6A;APOBEC3C;EP300
4928,GO:0014877,0.377134511142474,0.935951972939828,1,4,response to muscle inactivity involved in regulation of muscle adaptation,BP,MTMR4
4936,GO:0014894,0.377134511142474,0.935951972939828,1,4,response to denervation involved in regulation of muscle adaptation,BP,MTMR4
16030,GO:0086023,0.37713464535755,0.935951922382155,1,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
3483,GO:0007350,0.377388813922738,0.868134735155584,2,12,blastoderm segmentation,BP,SEMA3F;PCSK6
18296,GO:1903136,0.37757445437729,0.932032123574203,1,5,cuprous ion binding,MF,PRNP
12824,GO:0051099,0.377582005434653,0.719866871455594,16,140,positive regulation of binding,BP,FKBP1A;FAM129B;APOE;RFNG;LARP6;PKD1;GATA3;HSF1;HMGA2;STPG1;MFNG;MAU2;TRIB3;LRP1;TGFB1;EP300
2938,GO:0006464,0.37765641970674,0.647947058772418,327,3084,cellular protein modification process,BP,TNIP1;EDEM1;XDH;ZMYND8;NOS1;CCND1;GID4;F2R;MST1R;RAC2;RBCK1;SORL1;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;ERCC6;CST3;NEURL1;SNX9;LMF1;SHARPIN;DLG4;OBSCN;DLG1;IGFBP4;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;PTPRS;PRNP;SBF1;SSH1;SCYL1;CRTAP;SMURF2;MAPKAPK3;SESN2;LY6K;MARCH9;FKBP9;USP20;NACC2;BCR;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;LAMB1;PRKACA;ADARB1;PTPRF;JOSD2;MAP2K2;STK25;SHANK3;MIER2;P4HB;HECW2;FBXW8;AKT1;MDH2;IRAK1;APOE;ATP13A2;PKN1;SYVN1;WWTR1;PHF21A;RABGGTA;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;PPP2R3B;FZD8;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;RRAS;PPP1R35;TGFBR2;LAMB2;LIMK1;STK39;DKK1;PPP2R5B;UBE2J1;ARRDC1;KLHL29;SYMPK;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;PLCG1;ATG13;MAP3K9;JADE2;ANKIB1;CCND2;CCDC88C;PAK1;TTBK2;ERO1B;UBXN7;RAG1;BAZ2A;TNFSF15;CUL7;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RASGEF1A;FBXL6;HLTF;CEMIP;PKD1;PARP10;DLG3;GATA3;PIGQ;PHF1;DCAF7;ANO8;GNAI2;PPM1M;HSF1;SIN3B;WFS1;NEK9;SRD5A3;ASPH;CTBP1;PTPRU;ADAM8;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;P4HA1;MYDGF;B4GALT2;B3GNT3;SRC;APLP2;MBD6;KDM4B;GLRX;FKBP10;PEX10;TGM2;UBR4;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GSK3A;DUSP6;FYN;MPI;PPM1F;ZNF862;LPAR3;RMND5A;PSMD7;MICAL1;TNFRSF1A;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;BRSK1;SSU72;GJC2;RNF44;ITGA1;SHISA5;PSKH1;MCFD2;RCN1;MAP3K10;LYPD5;HEXIM1;TIMP1;UBA1;RNF187;HSF4;LOXL1;LHPP;FGFR1;MSL1;ADNP;PHF2;MIB2;TTLL12;MFNG;CDK18;MIF;SOCS2;MTMR4;ASB13;STUB1;STK17A;ST3GAL3;TRIB3;DDB2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;RMND5B;ST3GAL5;RAD23A;ULK1;TRIB2;HSPA2;PAK4;TNFRSF19;MGRN1;ULK2;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;RCOR1;MAP3K12;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;SPSB3;VEGFB;NEURL1B;TGFA;IMPACT;ARSK;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;ARHGEF2;RNF103;AIDA;B4GALT6;MATN3;CEACAM1;GALNT3;MINK1;TFPT;MBD3;ADCY6;CCNE1;TGFB1;WBP2;PPP6R1;ADCK2;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;ASPHD1;EP300;WDFY2;RASA3;TRAF7;RNF10
9525,GO:0036211,0.37765641970674,0.647947058772418,327,3084,protein modification process,BP,TNIP1;EDEM1;XDH;ZMYND8;NOS1;CCND1;GID4;F2R;MST1R;RAC2;RBCK1;SORL1;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;ERCC6;CST3;NEURL1;SNX9;LMF1;SHARPIN;DLG4;OBSCN;DLG1;IGFBP4;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;PTPRS;PRNP;SBF1;SSH1;SCYL1;CRTAP;SMURF2;MAPKAPK3;SESN2;LY6K;MARCH9;FKBP9;USP20;NACC2;BCR;VLDLR;MARK4;LRP5;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;LAMB1;PRKACA;ADARB1;PTPRF;JOSD2;MAP2K2;STK25;SHANK3;MIER2;P4HB;HECW2;FBXW8;AKT1;MDH2;IRAK1;APOE;ATP13A2;PKN1;SYVN1;WWTR1;PHF21A;RABGGTA;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;PPP2R3B;FZD8;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;RRAS;PPP1R35;TGFBR2;LAMB2;LIMK1;STK39;DKK1;PPP2R5B;UBE2J1;ARRDC1;KLHL29;SYMPK;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;PLCG1;ATG13;MAP3K9;JADE2;ANKIB1;CCND2;CCDC88C;PAK1;TTBK2;ERO1B;UBXN7;RAG1;BAZ2A;TNFSF15;CUL7;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RASGEF1A;FBXL6;HLTF;CEMIP;PKD1;PARP10;DLG3;GATA3;PIGQ;PHF1;DCAF7;ANO8;GNAI2;PPM1M;HSF1;SIN3B;WFS1;NEK9;SRD5A3;ASPH;CTBP1;PTPRU;ADAM8;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;P4HA1;MYDGF;B4GALT2;B3GNT3;SRC;APLP2;MBD6;KDM4B;GLRX;FKBP10;PEX10;TGM2;UBR4;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GSK3A;DUSP6;FYN;MPI;PPM1F;ZNF862;LPAR3;RMND5A;PSMD7;MICAL1;TNFRSF1A;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;BRSK1;SSU72;GJC2;RNF44;ITGA1;SHISA5;PSKH1;MCFD2;RCN1;MAP3K10;LYPD5;HEXIM1;TIMP1;UBA1;RNF187;HSF4;LOXL1;LHPP;FGFR1;MSL1;ADNP;PHF2;MIB2;TTLL12;MFNG;CDK18;MIF;SOCS2;MTMR4;ASB13;STUB1;STK17A;ST3GAL3;TRIB3;DDB2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;RMND5B;ST3GAL5;RAD23A;ULK1;TRIB2;HSPA2;PAK4;TNFRSF19;MGRN1;ULK2;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;RCOR1;MAP3K12;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;SPSB3;VEGFB;NEURL1B;TGFA;IMPACT;ARSK;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;ARHGEF2;RNF103;AIDA;B4GALT6;MATN3;CEACAM1;GALNT3;MINK1;TFPT;MBD3;ADCY6;CCNE1;TGFB1;WBP2;PPP6R1;ADCK2;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;ASPHD1;EP300;WDFY2;RASA3;TRAF7;RNF10
18248,GO:1903019,0.378071540039758,0.866593704396766,2,13,negative regulation of glycoprotein metabolic process,BP,CST3;ABCA7
3620,GO:0008076,0.378310637572566,0.806120021062522,4,29,voltage-gated potassium channel complex,CC,KCNG1;DLG4;VAMP2;KCNC4
12700,GO:0050892,0.378473125348343,0.867478304767905,2,12,intestinal absorption,BP,VDR;SLC5A1
14283,GO:0061318,0.378490614405394,0.867467703760272,2,12,renal filtration cell differentiation,BP,LAMB2;PODXL
15642,GO:0072112,0.378490614405394,0.867467703760272,2,12,glomerular visceral epithelial cell differentiation,BP,LAMB2;PODXL
15755,GO:0072311,0.378490614405394,0.867467703760272,2,12,glomerular epithelial cell differentiation,BP,LAMB2;PODXL
1612,GO:0004032,0.378591348876354,0.931627063246872,1,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
6827,GO:0030282,0.378674605214836,0.765010955980945,7,55,bone mineralization,BP,PTHLH;CYP27B1;ACVR2B;FAM20C;FBXL15;ECM1;TGFB1
13598,GO:0060045,0.378751268446063,0.867309657935077,2,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR1;FGF2
10174,GO:0042749,0.37876835191072,0.931556408035865,1,5,regulation of circadian sleep/wake cycle,BP,PER3
11156,GO:0045187,0.37876835191072,0.931556408035865,1,5,regulation of circadian sleep/wake cycle, sleep,BP,PER3
12593,GO:0050728,0.379242964029544,0.755610048730234,8,67,negative regulation of inflammatory response,BP,NT5E;SHARPIN;BCR;APOE;PPARA;GATA3;FNDC4;TNFRSF1A
2523,GO:0005776,0.379331707845352,0.742508508073323,10,83,autophagosome,CC,FYCO1;PEG3;ATG16L2;ATP13A2;VPS11;TBC1D14;WDFY3;ULK1;MAP1LC3B;SNAP29
10743,GO:0044090,0.379339177361806,0.86695283817615,2,12,positive regulation of vacuole organization,BP,LRSAM1;ULK1
4577,GO:0010660,0.37934099061571,0.787946612893551,5,38,regulation of muscle cell apoptotic process,BP,BNIP3;BAG3;HSF1;RGL2;PPP1R10
5603,GO:0016638,0.37939222058254,0.866920621108366,2,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLUD1;LOXL1
610,GO:0001776,0.379580090493929,0.763961459763025,7,57,leukocyte homeostasis,BP,AKT1;PKN1;RAG1;TSC22D4;MIF;TGFB1;ANXA1
4148,GO:0009208,0.379642091678946,0.864672635069735,2,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4;UCKL1
8319,GO:0033145,0.379715658430382,0.865589140066019,2,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1;WBP2
7876,GO:0032432,0.379804009671422,0.774381225751117,6,47,actin filament bundle,CC,MST1R;CORO1B;FSCN1;FLNB;PXN;FHOD1
14679,GO:0070266,0.379982199131623,0.804496765032279,4,30,necroptotic process,BP,RBCK1;PYGL;BOK;ARHGEF2
631,GO:0001818,0.380251662868426,0.712140584449237,18,160,negative regulation of cytokine production,BP,PTPRS;PRNP;ARG2;TMSB4X;RNF135;MC1R;GATA3;HSF1;MAPKBP1;CPTP;FGFR1;ZFPM1;TRIB2;ARG1;FURIN;CEACAM1;TGFB1;ANXA1
4712,GO:0010872,0.380314116764519,0.930937490346061,1,5,regulation of cholesterol esterification,BP,APOE
11172,GO:0045214,0.38051059152473,0.82841199060558,3,21,sarcomere organization,BP,OBSCN;TNNT1;OBSL1
5599,GO:0016627,0.381524072320448,0.772617166268906,6,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,RETSAT;ACAD10;SRD5A3;SDHA;ACADVL;SDHAF4
7986,GO:0032594,0.381527435398199,0.82769738819993,3,21,protein transport within lipid bilayer,BP,AP3D1;REEP2;ARHGAP44
3447,GO:0007259,0.381601836750111,0.735095833261672,11,94,JAK-STAT cascade,BP,PTK6;RET;PKD1;HSF1;FYN;TNFRSF1A;SOCS2;ADIPOR1;HGS;SOCS7;MAPK3
401,GO:0001077,0.381830244643217,0.706408398921873,20,172,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ETV4;MEF2D;TEF;SOX12;ATF4;ELK3;POU2F2;TFEB;CREB3L2;PPARA;TFE3;DDIT3;HLTF;GATA3;HMGA2;CAMTA2;EHF;USF2;DBP;LITAF
18271,GO:1903055,0.381852781683568,0.865421856275557,2,12,positive regulation of extracellular matrix organization,BP,FSCN1;TGFB1
4763,GO:0010940,0.381903209877441,0.93029768709087,1,5,positive regulation of necrotic cell death,BP,BNIP3
16525,GO:0097205,0.381970453134799,0.865349970494978,2,12,renal filtration,BP,F2R;ITGA3
4283,GO:0009648,0.382247631371368,0.827190475034014,3,21,photoperiodism,BP,CRTC1;MTA1;PER3
12901,GO:0051219,0.382579098157175,0.753163662403904,8,64,phosphoprotein binding,MF,SHC1;PLAT;SRC;LDLRAP1;SHB;CBL;MAPK3;PIK3R2
6786,GO:0030217,0.382862315856901,0.715217402494123,16,138,T cell differentiation,BP,AP3D1;XBP1;CARD11;PRKCZ;FZD8;TGFBR2;KDELR1;RAG1;SATB1;GATA3;ADAM8;ZFPM1;PNP;CHD7;TGFB1;ANXA1
3532,GO:0007520,0.3829907849058,0.826666720761513,3,21,myoblast fusion,BP,NOS1;CAPN2;MYOF
8269,GO:0033043,0.383105630299589,0.656676639458914,110,1019,regulation of organelle organization,BP,ERCC1;ZMYND8;NOS1;CAPN2;RAC2;SDC1;MAP2K1;BOK;ARAP1;DLG1;RAPGEF3;BNIP3;SSH1;TMOD2;ESPN;LRP5;EVI5L;FYCO1;CORO1B;MAP2K2;SHANK3;HECW2;AKT1;ARPC1A;EHD3;ATP13A2;TMSB4X;VPS11;EPHA1;SH3PXD2B;FBXW5;EML2;MSN;MAP1B;LIMK1;BNIP3L;OBSL1;ZDHHC8;WASF2;TBC1D16;ATG13;TWF2;SURF4;TBC1D14;FSCN1;PAK1;TTBK2;CUL7;TBC1D9B;RHOC;PKD1;PARP10;GATA3;PHF1;CTBP1;RHOBTB2;ARL2;SRC;CHMP5;CAPG;DNM2;FAM162A;LRSAM1;RAB1B;STX5;TOM1L2;GSK3A;STXBP1;SH3BP1;FUZ;PPM1F;PFN1;MOAP1;PHF2;BCL2L1;AFAP1;ARFIP2;ULK1;LRP1;SPIRE1;MAPK9;VASP;TAOK1;LMAN1;RHOBTB1;EPS8L1;TBC1D2B;TGFA;CAMSAP3;BAIAP2L1;WIPF1;VAT1;CIB1;TMSB10;WRAP73;MAPK3;KANK2;ARHGEF2;UGCG;ARHGAP44;TGFB1;WBP2;RMI2;ANXA1;PPP1R10;PXN;ARHGEF10L;PLEKHH2;ASAP1;FHOD1
1982,GO:0004697,0.38311672380339,0.864648705307105,2,12,protein kinase C activity,MF,PKN1;PRKCZ
6259,GO:0019840,0.383369204464918,0.863343363233312,2,13,isoprenoid binding,MF,ALDH1A2;RXRA
15326,GO:0071500,0.383394189668042,0.929694115882614,1,5,cellular response to nitrosative stress,BP,DDIT3
9331,GO:0035795,0.383440692577329,0.929675239779207,1,5,negative regulation of mitochondrial membrane permeability,BP,BNIP3
19377,GO:1905709,0.383440692577329,0.929675239779207,1,5,negative regulation of membrane permeability,BP,BNIP3
9556,GO:0036303,0.383578849944669,0.86436546970773,2,12,lymph vessel morphogenesis,BP,ACVR2B;PKD1
11144,GO:0045171,0.383892332779235,0.770875315317474,6,48,intercellular bridge,CC,QSOX1;PRKACA;PPP1R13L;PRKACB;NINL;RFXANK
3235,GO:0006891,0.384429257487488,0.801137805725696,4,30,intra-Golgi vesicle-mediated transport,BP,COPG1;COG8;COG1;RAB6A
6922,GO:0030509,0.384680764299887,0.732633977850983,11,91,BMP signaling pathway,BP,SMURF2;ACVR2B;DKK1;HTRA1;PCSK6;FBXL15;SLC33A1;LEMD2;MAPK3;TGFB1;ITGA3
13251,GO:0051895,0.384710080669113,0.863670889268891,2,12,negative regulation of focal adhesion assembly,BP,MMP14;SRC
13781,GO:0060337,0.384724581744956,0.750765394355174,8,69,type I interferon signaling pathway,BP,IFI6;IFITM1;IRAK1;IFI27;OASL;IRF7;OAS1;ISG20
15228,GO:0071357,0.384724581744956,0.750765394355174,8,69,cellular response to type I interferon,BP,IFI6;IFITM1;IRAK1;IFI27;OASL;IRF7;OAS1;ISG20
19449,GO:1990000,0.38479320177136,0.862463022645345,2,13,amyloid fibril formation,BP,FKBP1A;APOE
3799,GO:0008375,0.384865639900995,0.770083268508302,6,48,acetylglucosaminyltransferase activity,MF,XYLT1;XYLT2;RFNG;PIGQ;B3GNT3;MFNG
14012,GO:0060706,0.384941634307811,0.825288515869179,3,21,cell differentiation involved in embryonic placenta development,BP,MDFI;AKT1;SPINT2
12100,GO:0048038,0.385725478124458,0.860901530936634,2,14,quinone binding,MF,CBR4;NDUFS2
19246,GO:1905332,0.386271424042087,0.824346326232995,3,21,positive regulation of morphogenesis of an epithelium,BP,GATA3;RREB1;TGFB1
17313,GO:0140058,0.386528153304032,0.862550853929078,2,12,neuron projection arborization,BP,DVL1;DLG4
14621,GO:0070167,0.386907390650697,0.781979637892104,5,38,regulation of biomineral tissue development,BP,CYP27B1;ACVR2B;FAM20C;ECM1;TGFB1
12246,GO:0048488,0.38740672934437,0.799252119840631,4,29,synaptic vesicle endocytosis,BP,NLGN2;PIP5K1C;DNM2;ITSN1
12284,GO:0048562,0.387687828838412,0.703222543488837,19,164,embryonic organ morphogenesis,BP,MDFI;DVL1;DLG1;BCR;MMP14;NAGLU;TGFBR2;SUFU;GATA3;MICAL2;TULP3;FUZ;FGFR1;HYAL1;CHD7;TSHZ1;EPHB2;MAPK3;GNAS
2402,GO:0005545,0.387709295365758,0.861820735507815,2,12,1-phosphatidylinositol binding,MF,SNX9;WDFY3
4431,GO:0010259,0.387903134535526,0.82318717903152,3,21,multicellular organism aging,BP,ERCC1;SEC63;IDE
288,GO:0000792,0.388095093891906,0.748253294599281,8,66,heterochromatin,CC,DNMT3A;PHC2;BAZ2A;SATB1;HSF1;HMGA2;UBA1;MBD3
17754,GO:1901659,0.38846151403212,0.779788547775567,5,42,glycosyl compound biosynthetic process,BP,NT5E;NME4;TK2;UCKL1;GUK1
7892,GO:0032454,0.388698729839722,0.861207622072654,2,12,histone demethylase activity (H3-K9 specific),MF,KDM4B;PHF2
11642,GO:0046330,0.388791071020725,0.728964408963177,11,92,positive regulation of JNK cascade,BP,WNT7A;ERCC6;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;MINK1
17610,GO:1901222,0.389247254037219,0.766506129360647,6,48,regulation of NIK/NF-kappaB signaling,BP,EGFR;IRAK1;TMSB4X;UACA;TNFSF15;ADIPOR1
15123,GO:0071156,0.389319435310192,0.728212494374311,11,96,regulation of cell cycle arrest,BP,CCND1;PRKACA;PPP2R5B;BIN1;ZNF385A;PCBP4;HMGA2;MIF;CNOT11;TGFB1;EP300
13660,GO:0060142,0.389372598109048,0.859612766944749,2,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;CAMK1
9010,GO:0035137,0.389678372712273,0.821922264256645,3,21,hindlimb morphogenesis,BP,WNT7A;CHD7;GNAS
17511,GO:1900424,0.389736819709819,0.859384812831482,2,13,regulation of defense response to bacterium,BP,ARG2;MAPKBP1
1221,GO:0002888,0.389799139220001,0.859345790512027,2,13,positive regulation of myeloid leukocyte mediated immunity,BP,STXBP1;ARG1
9864,GO:0042102,0.390020190606449,0.765510899444664,6,50,positive regulation of T cell proliferation,BP,CARD11;TGFBR2;IGFBP2;ZP3;PNP;ANXA1
2209,GO:0005092,0.390023443189707,0.859205294081698,2,13,GDP-dissociation inhibitor activity,MF,SESN2;GDI1
2700,GO:0006064,0.39017272904351,0.926909883023403,1,5,glucuronate catabolic process,BP,CRYL1
6193,GO:0019640,0.39017272904351,0.926909883023403,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,CRYL1
12868,GO:0051167,0.39017272904351,0.926909883023403,1,5,xylulose 5-phosphate metabolic process,BP,CRYL1
17588,GO:1901159,0.39017272904351,0.926909883023403,1,5,xylulose 5-phosphate biosynthetic process,BP,CRYL1
11698,GO:0046466,0.390635268929291,0.82067019969875,3,22,membrane lipid catabolic process,BP,FUCA1;SMPD3;NAGA
13638,GO:0060090,0.390641770883202,0.705423484790531,17,147,molecular adaptor activity,MF,SH2D2A;SHC1;AP2A2;VPS11;ARRDC1;OBSL1;FSCN1;GAS2L1;GRB10;SRC;LDLRAP1;PAG1;SOCS2;STUB1;SHB;SKAP2;ANXA1
4796,GO:0010985,0.390791966610423,0.926652233459343,1,5,negative regulation of lipoprotein particle clearance,BP,PCSK9
8692,GO:0034284,0.390836425602091,0.710963316561519,15,132,response to monosaccharide,BP,PCK2;NR1D1;SESN2;LRP5;ACVR2B;XBP1;MAP4K4;PRKACA;ENDOG;TGFBR2;GLUL;VAMP2;TGFB1;CAT;LDHA
6653,GO:0023058,0.391249095869923,0.85843634071006,2,13,adaptation of signaling pathway,BP,APLN;DNM2
5686,GO:0016798,0.391397771932057,0.731892887926091,10,85,hydrolase activity, acting on glycosyl bonds,MF,EDEM1;NAGLU;CTBS;FUCA1;CEMIP;NEIL1;MPG;HYAL1;HPSE;NAGA
16499,GO:0097164,0.391527601246881,0.710298068144575,15,133,ammonium ion metabolic process,BP,MBOAT2;LPCAT4;LPCAT1;CRAT;AKR7A2;CBR4;SPTLC2;ALDH7A1;COMT;SLC27A1;SMPD3;PNPLA6;LPIN3;AZIN2;STARD10
11790,GO:0046633,0.391877602792317,0.858041208733158,2,13,alpha-beta T cell proliferation,BP,ARG2;TGFBR2
4684,GO:0010830,0.391888607830861,0.79545281949064,4,30,regulation of myotube differentiation,BP,FAM129B;XBP1;MMP14;THRA
12775,GO:0051024,0.391908503972231,0.926186264662084,1,5,positive regulation of immunoglobulin secretion,BP,XBP1
6576,GO:0022038,0.391982602490468,0.857975143080688,2,13,corpus callosum development,BP,PTPRS;EPHB2
18490,GO:1903557,0.392026943003108,0.777398566918644,5,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ADAM8;MIF;ARFGEF2;ARHGEF2
3106,GO:0006684,0.392054438925611,0.857929934783417,2,13,sphingomyelin metabolic process,BP,SPTLC2;SMPD3
7490,GO:0031649,0.392910733063992,0.857390491211457,2,13,heat generation,BP,APLN;SLC27A1
19922,GO:2000377,0.393238299994749,0.715899795058289,13,114,regulation of reactive oxygen species metabolic process,BP,XDH;RAC2;BNIP3;BCR;EGFR;AKT1;ARG2;TGFBR2;ASS1;DNM2;STK17A;P2RX4;TGFB1
16160,GO:0090153,0.393663283188445,0.856915552810867,2,13,regulation of sphingolipid biosynthetic process,BP,TNFRSF1A;SMPD3
19137,GO:1905038,0.393663283188445,0.856915552810867,2,13,regulation of membrane lipid metabolic process,BP,TNFRSF1A;SMPD3
19869,GO:2000303,0.393663283188445,0.856915552810867,2,13,regulation of ceramide biosynthetic process,BP,TNFRSF1A;SMPD3
7214,GO:0031100,0.393804358323845,0.751961231395701,7,58,animal organ regeneration,BP,PGF;CCND1;EGFR;TGFBR2;PTPRU;ANXA3;TGFB1
11280,GO:0045541,0.39380464525833,0.925390789651218,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16203,GO:0090206,0.39380464525833,0.925390789651218,1,5,negative regulation of cholesterol metabolic process,BP,APOE
5512,GO:0016460,0.393821491268116,0.856815605520066,2,13,myosin II complex,CC,OBSL1;MYL9
7383,GO:0031430,0.394536425454077,0.856363509631801,2,13,M band,CC,OBSCN;OBSL1
3758,GO:0008299,0.394560357341934,0.817847816960458,3,22,isoprenoid biosynthetic process,BP,SRD5A3;ALDH1A2;PMVK
9773,GO:0039528,0.39464656831928,0.818361138548715,3,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,IRF7;PUM1;SEC14L1
16731,GO:0097696,0.394789429480756,0.723475415809931,11,95,STAT cascade,BP,PTK6;RET;PKD1;HSF1;FYN;TNFRSF1A;SOCS2;ADIPOR1;HGS;SOCS7;MAPK3
862,GO:0002190,0.394799740933073,0.924971227828539,1,5,cap-independent translational initiation,BP,EIF4EBP1
10118,GO:0042626,0.395097600519526,0.742293404505472,8,66,ATPase activity, coupled to transmembrane movement of substances,MF,ATP13A2;ATP7B;ABCB8;ATP2C2;TCIRG1;ABCA7;ATP6V1C2;PCYOX1
13152,GO:0051693,0.395292407423772,0.817895921371367,3,21,actin filament capping,BP,TMOD2;TWF2;CAPG
3059,GO:0006622,0.395483060973276,0.817758487095541,3,21,protein targeting to lysosome,BP,SORL1;VPS4A;HGS
6992,GO:0030665,0.395607186432367,0.741737863993036,8,67,clathrin-coated vesicle membrane,CC,EGFR;EPN2;APOE;AP1B1;AP2A2;CEMIP;VAMP2;LDLRAP1
7513,GO:0031690,0.396148393488853,0.855341523982488,2,13,adrenergic receptor binding,MF,DLG4;GNAS
13501,GO:0055017,0.396304795523664,0.760901240476127,6,47,cardiac muscle tissue growth,BP,TGFBR2;PAK1;GSK3A;FGFR1;FGF2;RXRA
2507,GO:0005759,0.396677956542814,0.667342454055096,40,393,mitochondrial matrix,CC,SHC1;PCK2;NAGS;IDH2;PC;NME4;HAGH;CHPF;GPT2;TK2;MRPS6;MDH2;ALDH1L2;ARG2;PITRM1;ACAD10;HADH;DHTKD1;TST;PRDX5;HMGCL;ACSF2;RPUSD3;GLUD1;MPG;PYCR2;ALAS1;ARL2;CBR4;ACADVL;GARS;PRIMPOL;ALDH4A1;ALDH7A1;BCL2L1;SARS2;SDHAF4;MLYCD;LACTB2;NDUFS2
20268,GO:2001179,0.396706500186909,0.924163237363795,1,5,regulation of interleukin-10 secretion,BP,PRKCZ
14167,GO:0061025,0.396751774045498,0.692621916798522,20,177,membrane fusion,BP,DYSF;BNIP3;EVI5L;VPS11;VPS4A;TBC1D16;TBC1D14;TBC1D9B;SYTL1;VAMP2;DNM2;STX5;STXBP1;STX10;USO1;TBC1D2B;VAT1;SNAP29;SPESP1;ANXA1
6009,GO:0019048,0.396786007648627,0.791685695739686,4,30,modulation by virus of host morphology or physiology,BP,BCL2L1;VAPB;RXRA;TGFB1
5688,GO:0016801,0.396787010542858,0.854935628507136,2,13,hydrolase activity, acting on ether bonds,MF,AHCY;AKR7A2
15334,GO:0071526,0.397089128510003,0.791837424173368,4,29,semaphorin-plexin signaling pathway,BP,SEMA3F;SEMA4B;SH3BP1;SEMA4G
5660,GO:0016757,0.397210175370808,0.686425285873985,23,206,transferase activity, transferring glycosyl groups,MF,PYGB;PYGL;NAPRT;CHPF;XYLT1;XYLT2;RFNG;B4GALNT4;PARP10;PIGQ;B4GALT2;B3GNT3;WDFY3;HYAL1;MFNG;ST3GAL3;ST3GAL5;PNP;ST6GALNAC2;POMT1;UGCG;B4GALT6;GALNT3
2953,GO:0006482,0.397485478512178,0.791531609576801,4,29,protein demethylation,BP,ARID5B;KDM4B;HSF4;PHF2
3705,GO:0008214,0.397485478512178,0.791531609576801,4,29,protein dealkylation,BP,ARID5B;KDM4B;HSF4;PHF2
9841,GO:0042056,0.397495603207766,0.853457988976706,2,14,chemoattractant activity,MF,MIF;FGF2
449,GO:0001222,0.397580291640392,0.854430629392296,2,13,transcription corepressor binding,MF,NR1D1;PER3
6473,GO:0021799,0.397709688405867,0.816149997897743,3,21,cerebral cortex radially oriented cell migration,BP,LAMB1;MBOAT7;SOCS7
1235,GO:0002920,0.39783827038208,0.815475876891464,3,22,regulation of humoral immune response,BP,SERPING1;ZP3;CD59
4173,GO:0009240,0.398155384435183,0.923545707796295,1,5,isopentenyl diphosphate biosynthetic process,BP,PMVK
11715,GO:0046490,0.398155384435183,0.923545707796295,1,5,isopentenyl diphosphate metabolic process,BP,PMVK
7662,GO:0032077,0.398218634696384,0.923518679607677,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
17400,GO:1900103,0.398941225290349,0.853562194707063,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK;XBP1
14948,GO:0070813,0.399071177796186,0.923153795201572,1,5,hydrogen sulfide metabolic process,BP,CBS
1973,GO:0004683,0.399260107438122,0.815026285426002,3,21,calmodulin-dependent protein kinase activity,MF,MAPKAPK3;MKNK2;CAMK1
7753,GO:0032262,0.399686916437426,0.922889596039002,1,5,pyrimidine nucleotide salvage,BP,UCKL1
106,GO:0000220,0.399788486996181,0.922845960746238,1,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,TCIRG1
6902,GO:0030431,0.400020319188127,0.851835885388504,2,14,sleep,BP,CST3;PER3
1187,GO:0002831,0.400127170850767,0.718762822665426,11,95,regulation of response to biotic stimulus,BP,ARG2;FAM3A;HTRA1;MAPKBP1;LRSAM1;PUM1;MIF;ARG1;SEC14L1;MAPK3;CEACAM1
16865,GO:0098754,0.400175759054645,0.736978598965055,8,75,detoxification,BP,CYGB;SESN2;APOE;PRDX5;MT2A;GPX3;SLC30A1;CAT
9421,GO:0035976,0.400314139268336,0.922619894211905,1,5,transcription factor AP-1 complex,CC,DDIT3
10445,GO:0043281,0.400711466611894,0.690946486302889,19,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;BOK;DAP;IFI6;AKT1;SOX7;CD44;PRDX5;RAG1;TNFSF15;IFI27;HSF1;TNFRSF6B;SRC;FAM162A;PPM1F;MICAL1;CASP4
19032,GO:1904813,0.400953537870546,0.712973158984848,12,109,ficolin-1-rich granule lumen,CC,PYGL;CST3;PGM1;PSMD2;CTSB;CTSZ;YPEL5;PSMD7;MIF;PNP;ALDOC;CAT
5665,GO:0016769,0.400956089683183,0.852271665247259,2,13,transferase activity, transferring nitrogenous groups,MF,GPT2;PSAT1
6884,GO:0030374,0.401263331906671,0.745817961214004,7,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1;PKN1;ZMIZ2;PPARA;VDR;THRA;FGF2
3779,GO:0008333,0.401321394095963,0.756551191110987,6,48,endosome to lysosome transport,BP,AP3D1;VPS11;BIN1;CHMP5;MGRN1;SNX27
18465,GO:1903522,0.401359001065548,0.701557469925837,15,130,regulation of blood circulation,BP,NOS1;F2R;DOCK4;DLG1;EGFR;PRKACA;AKT1;EHD3;ITPR3;APLN;ASPH;GSK3A;THRA;P2RX4;STIM1
16521,GO:0097199,0.401593032238215,0.922068177212213,1,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,CASP4
4371,GO:0009987,0.401985981353226,0.631962617121392,1087,10485,cellular process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;FLNC;PGF;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;GID4;SH3TC2;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;SDK2;CYP27B1;LPCAT4;NEURL1;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;KLC2;DLG1;TRIM65;DAP;CMTM4;DYSF;IGFBP4;SLC16A3;MMP1;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;CD68;SBF1;PC;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;CCNI;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;COPG1;TMOD2;BCORL1;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;SEMA3F;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;FBLN1;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;CMTM7;EGFR;CSNK1E;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;EPN1;PPP1R13L;TUBG2;XYLT2;STK25;PARVB;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;CARD11;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;PEAR1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;WWTR1;PHF21A;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;MSN;PPP1R35;MAP1B;TGFBR2;CSMD3;LAMB2;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SURF4;RRNAD1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;ISYNA1;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;NLGN2;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;PTDSS2;CUL7;DMXL2;TBC1D9B;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;FBXL6;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;NXPH4;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;TP53I11;APLN;WDR66;PIGQ;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;ASIC1;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CNFN;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;CAP1;P4HA1;MYDGF;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;NINL;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;DNAJC4;NDUFA4L2;NCS1;PAQR7;MARK3;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GPX3;GARS;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;KIF17;TNFRSF1A;ALDH7A1;THOP1;ANXA3;WISP1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;CGREF1;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF187;ZNF71;HSF4;LAMB3;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SECISBP2L;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;PSMG4;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;NT5DC2;VPS9D1;DNMBP;TRIB3;DDB2;ZFPL1;AFAP1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;C1QTNF6;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;NYNRIN;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;VAT1;CASP4;ACY1;SNAP29;LONP2;RPRD1A;TRPT1;KCNC4;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;C12ORF66;GIGYF1;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ASPHD1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;RASA3;ASAP1;FHOD1;TRAF7;RNF10
12990,GO:0051353,0.402066235790076,0.786890762896387,4,32,positive regulation of oxidoreductase activity,BP,CYP27B1;AKT1;APOE;VDR
5662,GO:0016763,0.402135327438088,0.769265403289033,5,40,transferase activity, transferring pentosyl groups,MF,NAPRT;XYLT1;XYLT2;PARP10;PNP
13125,GO:0051640,0.402314395987881,0.65234251716841,57,523,organelle localization,BP,RAC2;AP3D1;DLG1;RAB3B;COPG1;SNPH;BBS2;MARK4;CSNK1E;FYCO1;PRKACA;STK25;PRKCZ;VPS11;VPS4A;CTSZ;SEPT5;SEC23A;MAP1B;ESYT2;BIN1;TTBK2;NLGN2;SYTL1;VAMP2;PIP5K1C;CHMP5;DNM2;NINL;RAB1B;STX5;SDCCAG8;EXOC2;STXBP1;STX10;MCFD2;SEC24C;TUBG1;LEMD2;USO1;TBC1D20;SPIRE1;LMAN1;TGFA;NDE1;SNAP29;CBL;TRAPPC1;CSNK1D;ARHGEF2;LLGL1;CD59;MAP6;PPP6R1;RAB6A;ARCN1;FHOD1
132,GO:0000272,0.40231455571786,0.812803563005352,3,21,polysaccharide catabolic process,BP,PYGB;PYGL;PGM1
10795,GO:0044247,0.40231455571786,0.812803563005352,3,21,cellular polysaccharide catabolic process,BP,PYGB;PYGL;PGM1
7074,GO:0030856,0.402454649412364,0.716774271134549,11,94,regulation of epithelial cell differentiation,BP,XDH;CCND1;CYP27B1;WWTR1;GATA3;ALOX15B;GSK3A;TNFRSF1A;VDR;CTSL;CEACAM1
13269,GO:0051926,0.40259291222972,0.78681925407059,4,31,negative regulation of calcium ion transport,BP,NOS1;NTSR1;SLC30A1;TGFB1
16458,GO:0097100,0.402645809559446,0.921612189639907,1,5,supercoiled DNA binding,MF,TOP1
12955,GO:0051293,0.403061011126707,0.786818632033776,4,30,establishment of spindle localization,BP,SPIRE1;NDE1;ARHGEF2;LLGL1
4449,GO:0010369,0.40325655687868,0.850791171282623,2,13,chromocenter,CC,SCMH1;MBD6
1587,GO:0003995,0.403347177411931,0.850732697546193,2,13,acyl-CoA dehydrogenase activity,MF,ACAD10;ACADVL
7407,GO:0031465,0.403410396267081,0.921279994705072,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
1385,GO:0003281,0.403414770767998,0.755010311293165,6,47,ventricular septum development,BP,TGFBR2;LTBP1;SUFU;GATA3;DNM2;ZFPM1
1105,GO:0002691,0.403438859081729,0.850673527230323,2,13,regulation of cellular extravasation,BP,BCR;ADAM8
8014,GO:0032637,0.403478269869974,0.767935656359116,5,41,interleukin-8 production,BP,F2R;TMSB4X;DDIT3;MAPKBP1;ANXA1
12802,GO:0051058,0.403509568803299,0.754931430396112,6,47,negative regulation of small GTPase mediated signal transduction,BP,SH3BP1;ARAP3;EPHB2;ARHGAP44;ITGA3;RASA3
14816,GO:0070527,0.403754552605791,0.767952544731695,5,40,platelet aggregation,BP,SERPINE2;STXBP1;MYL9;CEACAM1;GNAS
8896,GO:0034705,0.403768342044015,0.786267164569518,4,30,potassium channel complex,CC,KCNG1;DLG4;VAMP2;KCNC4
11618,GO:0046209,0.40397832826675,0.754150285299713,6,49,nitric oxide metabolic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;P2RX4
10378,GO:0043184,0.403986998152992,0.921028900119346,1,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFB
12607,GO:0050764,0.404173384905801,0.767612506123639,5,40,regulation of phagocytosis,BP,BCR;TUB;DNM2;ABCA7;TGFB1
8440,GO:0033549,0.404228965197071,0.850163106614046,2,13,MAP kinase phosphatase activity,MF,DUSP4;DUSP6
4943,GO:0014902,0.404378267468112,0.743175855881304,7,57,myotube differentiation,BP,NOS1;CAPN2;FAM129B;XBP1;MMP14;MYOF;THRA
14847,GO:0070571,0.404745187427778,0.849829139780825,2,13,negative regulation of neuron projection regeneration,BP,PTPRS;MAP4K4
8009,GO:0032627,0.405126369254345,0.920531279501698,1,5,interleukin-23 production,BP,TGFB1
8033,GO:0032667,0.405126369254345,0.920531279501698,1,5,regulation of interleukin-23 production,BP,TGFB1
15168,GO:0071260,0.405516952254378,0.742057088133323,7,58,cellular response to mechanical stimulus,BP,BNIP3;EGFR;AKT1;BAG3;TNFRSF1A;MAPK3;TGFB1
13608,GO:0060055,0.405587508943148,0.849283390902482,2,13,angiogenesis involved in wound healing,BP,XBP1;HPSE
15923,GO:0072676,0.405699249074762,0.766129775826034,5,41,lymphocyte migration,BP,MSN;RET;GATA3;ADAM8;ECM1
5631,GO:0016706,0.405799428214921,0.76654654168626,5,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,P4HB;ASPH;P4HA1;KDM4B;PHYH
7966,GO:0032559,0.405939287291174,0.631980438005106,128,1168,adenyl ribonucleotide binding,MF,MST1R;MAP2K1;PYGL;ERCC6;SCN8A;OBSCN;DGKA;RPS6KA2;RAPGEF3;PC;SCYL1;SMARCA1;NME4;MAPKAPK3;BCR;MARK4;AARS;ACVR2B;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;PRKACA;CARS;ACTA2;HK1;MAP2K2;STK25;AKT1;IRAK1;EHD3;ATP13A2;PKN1;PRKCZ;ATP7B;FAM20C;DGKQ;MAPK13;VPS4A;EPHA1;PI4K2A;PTK6;PFKP;GRK6;NMRK1;TGFBR2;LIMK1;STK39;UBE2J1;NADK;PRKACB;CDC34;ABCB8;MAP3K9;IDE;TWF2;PAK1;TTBK2;ACSF2;GLUL;RET;HLTF;ASS1;ATP11A;OASL;GLUD1;PANK4;NEK9;MYH15;TOP1;PIP5K1C;SRC;CDC42BPB;MARK3;STK24;PAK6;GARS;GSK3A;PMVK;OAS1;SLFN5;FYN;ASNS;KIF17;KIF13B;UCKL1;BRSK1;PSKH1;MAP3K10;UBA1;FGFR1;ATP2C2;TTLL12;GUK1;CDK18;STK17A;TRIB3;HLCS;SARS2;PIP5KL1;ULK1;HSPA2;PAK4;P2RX4;ULK2;LRRK1;EHD4;MAPK9;MAP3K12;HSPA13;MYO1D;CHD7;TAOK1;ABCA7;LONP2;CAMK1;EPHB2;MAPK3;MAPK10;CSNK1D;KIFC3;MINK1;ADCY6;ADCK2;ERBB3
5818,GO:0017080,0.406033878790029,0.809485827082002,3,22,sodium channel regulator activity,MF,NOS1;PCSK9;PRSS8
6112,GO:0019348,0.406065402670347,0.920119701180241,1,5,dolichol metabolic process,BP,SRD5A3
5649,GO:0016740,0.406225206438178,0.625025574991661,202,1890,transferase activity,MF,PYGB;CCND1;GID4;MST1R;LTBP4;RBCK1;MAP2K1;PYGL;MBOAT2;LPCAT4;NEURL1;NAPRT;SHARPIN;DLG4;OBSCN;CPT2;DLG1;DNMT3A;DGKA;RPS6KA2;NAGS;AGPAT3;SCYL1;SMURF2;NME4;MAPKAPK3;MARCH9;BCR;CHPF;LPCAT1;MARK4;ACVR2B;XYLT1;GPT2;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;PRKACA;CRAT;HK1;MAP2K2;XYLT2;STK25;HECW2;FBXW8;PSAT1;AKT1;CDS2;CARD11;IRAK1;ALDH1L2;UAP1;METTL23;PKN1;SYVN1;RABGGTA;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;EPHA1;PI4K2A;PTK6;PFKP;TMEM129;FBXO2;GRK6;ZNF598;FBXW5;NMRK1;B4GALNT4;TGFBR2;NDST2;LIMK1;STK39;UBE2J1;KLHL29;NADK;TST;PRKACB;LTBP1;ZDHHC8;CDC34;ELOVL1;MAP3K9;JADE2;ANKIB1;RRNAD1;PAK1;TTBK2;RAG1;GAMT;BCDIN3D;PTDSS2;RET;FBXL6;HLTF;PARP10;DLG3;PIGQ;OASL;PANK4;NEK9;HMGA2;ALAS1;TOP1;B4GALT2;PIP5K1C;B3GNT3;SRC;POLD4;TAZ;TGM2;UBR4;LRSAM1;CDC42BPB;MARK3;STK24;PAK6;NSUN7;GSK3A;TALDO1;PMVK;OAS1;FYN;PRIMPOL;SPTLC2;SUGCT;ZNF862;RMND5A;MBOAT7;FBXL15;UCKL1;BRSK1;CHST14;RNF44;PSKH1;COMT;MAP3K10;CRIM1;RNF187;WDFY3;FGFR1;HYAL1;MIB2;MFNG;GUK1;CDK18;STUB1;STK17A;ST3GAL3;DDB2;RMND5B;ST3GAL5;PIP5KL1;AGPAT4;ULK1;PAK4;MGRN1;ULK2;LRRK1;PCMTD2;PNP;FGF2;KLHL17;ST6GALNAC2;MAPK9;MAP3K12;TAOK1;RNF222;SPSB3;NEURL1B;TRPT1;CAMK1;EPHB2;POLM;CBL;GGT1;MAPK3;CPT1B;POMT1;MAPK10;CSNK1D;RNF103;UGCG;B4GALT6;GALNT3;MINK1;CCNE1;ADCK2;PIK3R2;ERBB3;ASH2L;COMTD1;ZFYVE21;EP300;TRAF7;RNF10
3652,GO:0008134,0.406427365136159,0.649317862390859,55,506,transcription factor binding,MF,ERCC1;MDFI;ZMYND8;CCND1;NFATC4;CRTC1;MEF2D;NR1D1;MTA1;SMARCA1;BBS2;XBP1;PPP1R13L;ATF4;METTL23;PKN1;DGKQ;PPARA;ZNF516;SUFU;UBXN7;BAZ2A;DDIT3;GAS2L1;IFI27;GATA3;OASL;WFS1;CTBP1;HMGA2;SRC;PER3;GPX3;RERE;CAMTA2;TLE4;VDR;THRA;MAP3K10;HYAL1;USF2;HES2;ZFPM1;TRIB2;E2F5;MAPK9;RCOR1;RNF222;APBB1;RXRA;TAF6;ARHGEF2;CCNE1;WBP2;EP300
9259,GO:0035655,0.406985904549051,0.919714966353275,1,5,interleukin-18-mediated signaling pathway,BP,AKT1
15222,GO:0071351,0.406985904549051,0.919714966353275,1,5,cellular response to interleukin-18,BP,AKT1
9647,GO:0036507,0.407100358701113,0.808700074228707,3,22,protein demannosylation,BP,EDEM1;SYVN1;RNF103
9648,GO:0036508,0.407100358701113,0.808700074228707,3,22,protein alpha-1,2-demannosylation,BP,EDEM1;SYVN1;RNF103
18583,GO:1903772,0.407301316087749,0.919575991597108,1,5,regulation of viral budding via host ESCRT complex,BP,VPS4A
7178,GO:0031054,0.407351184956049,0.848137413513405,2,13,pre-miRNA processing,BP,BCDIN3D;AGO4
3792,GO:0008356,0.407436242017722,0.848082034197181,2,13,asymmetric cell division,BP,ETV5;ARHGEF2
14134,GO:0060969,0.40750055372776,0.808404847732898,3,22,negative regulation of gene silencing,BP,BCDIN3D;PHF2;TGFB1
4038,GO:0009069,0.407627511026264,0.782879477851939,4,31,serine family amino acid metabolic process,BP,CBS;PSAT1;AHCY;GGT1
1313,GO:0003158,0.407643858884868,0.724071638189818,9,75,endothelium development,BP,XDH;WNT7A;RAPGEF3;PTPRS;LAMA5;ACVR2B;MSN;TNFRSF1A;CEACAM1
1027,GO:0002526,0.407738042641672,0.739878306712137,7,60,acute inflammatory response,BP,CTNNBIP1;SERPING1;GATA3;ADAM8;F12;ZP3;CD59
11346,GO:0045655,0.407786470184104,0.847853897380136,2,13,regulation of monocyte differentiation,BP,CTNNBIP1;IRF7
607,GO:0001773,0.408045141286694,0.846619883437308,2,14,myeloid dendritic cell activation,BP,TGFBR2;TGFB1
9100,GO:0035356,0.408163231247847,0.919195459316108,1,5,cellular triglyceride homeostasis,BP,XBP1
11823,GO:0046689,0.408298590874063,0.919135597316024,1,5,response to mercury ion,BP,BSG
3415,GO:0007200,0.408347212550064,0.782313895071927,4,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;GNB1;TGM2;LPAR3
12360,GO:0048706,0.408517591991361,0.723306665273818,9,75,embryonic skeletal system development,BP,MDFI;DLG1;MMP14;DEAF1;TGFBR2;TULP3;FUZ;HYAL1;GNAS
12580,GO:0050713,0.40853286002201,0.919031928165593,1,5,negative regulation of interleukin-1 beta secretion,BP,CPTP
19536,GO:1990381,0.408644664378158,0.847294133920176,2,13,ubiquitin-specific protease binding,MF,SYVN1;RAD23A
11640,GO:0046328,0.408937259786204,0.694673506658246,15,130,regulation of JNK cascade,BP,WNT7A;ERCC6;MAP4K4;EGFR;AKT1;PKN1;FZD8;DKK1;MAP3K9;PAK1;MAP3K10;TNFRSF19;TAOK1;AIDA;MINK1
4638,GO:0010758,0.409097891290411,0.845928797906698,2,14,regulation of macrophage chemotaxis,BP,MIF;MAPK3
1806,GO:0004448,0.409215086315809,0.91872955867475,1,5,isocitrate dehydrogenase activity,MF,IDH2
4963,GO:0015036,0.409249000850981,0.780634258336031,4,34,disulfide oxidoreductase activity,MF,P4HB;PDIA5;ERO1B;GLRX
11648,GO:0046339,0.409311941366256,0.846858170593084,2,13,diacylglycerol metabolic process,BP,DGKA;DGKQ
2724,GO:0006102,0.409359684341017,0.918665381523295,1,5,isocitrate metabolic process,BP,IDH2
13202,GO:0051788,0.409450791093205,0.806963222609431,3,22,response to misfolded protein,BP,F12;STUB1;POMT1
4677,GO:0010823,0.40946777706675,0.763053632400229,5,41,negative regulation of mitochondrion organization,BP,BOK;BNIP3;AKT1;BCL2L1;VAT1
9908,GO:0042182,0.409569737326883,0.91857208503337,1,5,ketone catabolic process,BP,HAGH
4898,GO:0014823,0.409740615522843,0.763074969123452,5,40,response to activity,BP,POSTN;HADH;HSF1;CBL;CAT
11358,GO:0045667,0.409749535042331,0.722123932713072,9,76,regulation of osteoblast differentiation,BP,CTNNBIP1;LRP5;ACVR2B;PRKACA;IFITM1;FAM20C;SUFU;ZHX3;GNAS
1391,GO:0003298,0.409752505724814,0.846569980413298,2,13,physiological muscle hypertrophy,BP,PAK1;GSK3A
1394,GO:0003301,0.409752505724814,0.846569980413298,2,13,physiological cardiac muscle hypertrophy,BP,PAK1;GSK3A
14187,GO:0061049,0.409752505724814,0.846569980413298,2,13,cell growth involved in cardiac muscle cell development,BP,PAK1;GSK3A
5661,GO:0016758,0.409800927825432,0.6877958181454,17,151,transferase activity, transferring hexosyl groups,MF,PYGB;PYGL;CHPF;XYLT1;XYLT2;RFNG;B4GALNT4;PIGQ;B4GALT2;B3GNT3;WDFY3;HYAL1;MFNG;POMT1;UGCG;B4GALT6;GALNT3
17554,GO:1901021,0.410154475941555,0.806441863887365,3,22,positive regulation of calcium ion transmembrane transporter activity,BP,EHD3;HSPA2;STIM1
15229,GO:0071359,0.410448144480285,0.737849354801571,7,58,cellular response to dsRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TGFB1
6469,GO:0021795,0.410450360399045,0.781029079810981,4,30,cerebral cortex cell migration,BP,EGFR;LAMB1;MBOAT7;SOCS7
4328,GO:0009838,0.410854147105865,0.918000235511941,1,5,abscission,BP,VPS4A
12243,GO:0048485,0.410904800039566,0.845814907262276,2,13,sympathetic nervous system development,BP,SEMA3F;GATA3
3030,GO:0006577,0.411194263423327,0.845624929544487,2,13,amino-acid betaine metabolic process,BP,CRAT;ALDH7A1
20172,GO:2000831,0.41140437312849,0.917754500709616,1,5,regulation of steroid hormone secretion,BP,GAL
2088,GO:0004849,0.411421027714945,0.917747055533375,1,5,uridine kinase activity,MF,UCKL1
11595,GO:0046134,0.411465497046174,0.804422207126029,3,24,pyrimidine nucleoside biosynthetic process,BP,NME4;TK2;UCKL1
8839,GO:0034616,0.41155847187843,0.845385725368977,2,13,response to laminar fluid shear stress,BP,ASS1;TGFB1
9295,GO:0035726,0.411589093068846,0.917671900980835,1,5,common myeloid progenitor cell proliferation,BP,CEACAM1
15424,GO:0071670,0.411985695324627,0.917494381306026,1,5,smooth muscle cell chemotaxis,BP,CORO1B
10145,GO:0042695,0.412143025455171,0.917423894242468,1,5,thelarche,BP,TGFB1
14041,GO:0060744,0.412143025455171,0.917423894242468,1,5,mammary gland branching involved in thelarche,BP,TGFB1
17118,GO:0099632,0.412292860803138,0.844902816574649,2,13,protein transport within plasma membrane,BP,AP3D1;ARHGAP44
17120,GO:0099637,0.412292860803138,0.844902816574649,2,13,neurotransmitter receptor transport,BP,AP3D1;ARHGAP44
4023,GO:0009052,0.412389174704836,0.917313539303529,1,5,pentose-phosphate shunt, non-oxidative branch,BP,TALDO1
5216,GO:0015813,0.41248607465974,0.844775637321582,2,13,L-glutamate transmembrane transport,BP,NTSR1;PRAF2
3070,GO:0006637,0.412693885385182,0.719339263430053,9,78,acyl-CoA metabolic process,BP,ACOT7;ACOT1;ACOT13;ELOVL1;HMGCL;ACSF2;CBR4;PMVK;MLYCD
9114,GO:0035383,0.412693885385182,0.719339263430053,9,78,thioester metabolic process,BP,ACOT7;ACOT1;ACOT13;ELOVL1;HMGCL;ACSF2;CBR4;PMVK;MLYCD
6079,GO:0019228,0.412742597512503,0.844606703409486,2,13,neuronal action potential,BP,SCN8A;P2RX4
19803,GO:2000178,0.412881597687029,0.844515124976792,2,13,negative regulation of neural precursor cell proliferation,BP,SPINT2;TGFB1
10109,GO:0042609,0.412944471787334,0.917064248690916,1,5,CD4 receptor binding,MF,FYN
13599,GO:0060046,0.412994280220101,0.917041865256374,1,5,regulation of acrosome reaction,BP,ZP3
839,GO:0002138,0.41317028018781,0.9169627424681,1,5,retinoic acid biosynthetic process,BP,ALDH1A2
5353,GO:0016102,0.41317028018781,0.9169627424681,1,5,diterpenoid biosynthetic process,BP,ALDH1A2
8016,GO:0032640,0.413294717782137,0.72624383085345,8,69,tumor necrosis factor production,BP,NFATC4;ARG2;UBE2J1;MC1R;HSF1;MIF;ARFGEF2;ARHGEF2
19316,GO:1905516,0.41353805439021,0.916797253765508,1,5,positive regulation of fertilization,BP,ZP3
9752,GO:0038202,0.413876070224536,0.777949048218253,4,31,TORC1 signaling,BP,SESN2;CARD11;DGKQ;C12ORF66
11327,GO:0045630,0.413876672225243,0.916644703214434,1,5,positive regulation of T-helper 2 cell differentiation,BP,PRKCZ
7454,GO:0031584,0.41393270385834,0.916619443644368,1,5,activation of phospholipase D activity,BP,PRKCZ
16199,GO:0090201,0.414008860280168,0.842683966827768,2,14,negative regulation of release of cytochrome c from mitochondria,BP,AKT1;BCL2L1
20233,GO:2001056,0.414181181176446,0.696803668127391,13,119,positive regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;BOK;DAP;SOX7;TNFSF15;IFI27;HSF1;ASPH;FAM162A;FYN;PPM1F;CASP4
13158,GO:0051704,0.414303734014818,0.619875851769542,164,1585,multi-organism process,BP,TNIP1;PGF;ERCC1;NOS1;F2R;MST1R;RBCK1;DVL1;MAP2K1;SHC1;PTHLH;CST3;CYP27B1;NEURL1;CRTC1;PCK2;DLG4;SERPINE2;BSG;NR1D1;DLG1;MMP1;DNMT3A;PRSS3;BNIP3;SBF1;PC;MICALCL;RAB43;CCNI;CRTAP;SMURF2;LCN2;MAPKAPK3;CTSB;BBS2;BCR;OSBP2;ETV5;FBLN1;ITGB5;ADCY7;XBP1;MYCBPAP;EGFR;RFX2;PRKACA;ADARB1;ACTA2;MAP2K2;EPN1;FAM50A;SHANK3;P4HB;AKT1;IFITM1;IRAK1;APOE;ATG16L2;ARG2;AP1B1;AP2A2;PHC2;VPS4A;HIST2H2BE;SH3PXD2B;DEAF1;TGFBR2;EPOR;MVB12B;UBE2J1;BNIP3L;FAM3A;WASF2;PLCG1;IDE;BIN1;HTRA1;SCMH1;GAMT;CUL7;STOM;SATB1;RAB29;SHANK2;PARP10;GATA3;GSDMA;TCFL5;OASL;HSF1;CTBP1;MAPKBP1;HMGA2;TOP1;IGFBP2;TNFRSF6B;SRC;CHMP5;DNM2;UBR4;AGO4;IRF7;LRSAM1;RAB1B;PAQR7;EXOC2;RSF1;OAS1;FYN;ISG20;NELFCD;TNFRSF1A;ANXA3;VDR;UCKL1;PUM1;RAI14;COMT;THRA;EIF2S2;TIMP1;LOXL1;HYAL1;USF2;MIF;VPS37A;RAB11FIP4;BCL2L1;RAD23A;ULK1;HSPA2;ULK2;ZP3;TBC1D20;SPIRE1;RNASE7;VAPB;RCOR1;RXRA;ARG1;RPL28;GSDMC;SEC14L1;BAIAP2L1;NDRG3;WIPF1;SPESP1;CBL;GGT1;CIB1;PACS2;MAPK3;LITAF;FURIN;PAIP2;EIF4G3;ITSN1;TGFB1;AZIN2;RAB6A;APOBEC3C;ITGA3;EP300
17593,GO:1901165,0.414454574996509,0.916383950370631,1,5,positive regulation of trophoblast cell migration,BP,SMURF2
9735,GO:0038166,0.414619340723385,0.916309514212197,1,5,angiotensin-activated signaling pathway,BP,SRC
1298,GO:0003128,0.415180543486819,0.916055669998512,1,5,heart field specification,BP,DKK1
5708,GO:0016833,0.415367385186868,0.915971051082557,1,5,oxo-acid-lyase activity,MF,HMGCL
12665,GO:0050850,0.415421418310418,0.801965502039001,3,23,positive regulation of calcium-mediated signaling,BP,P2RX4;CIB1;ERBB3
8492,GO:0033632,0.415435491216649,0.915940193252431,1,5,regulation of cell-cell adhesion mediated by integrin,BP,PODXL
6445,GO:0021756,0.41547206901124,0.842803349135532,2,13,striatum development,BP,BBS2;SHANK3
745,GO:0001973,0.415491241159088,0.915914928528338,1,5,adenosine receptor signaling pathway,BP,GNAI2
1960,GO:0004661,0.415661943384322,0.915837540343777,1,5,protein geranylgeranyltransferase activity,MF,RABGGTA
17895,GO:1902105,0.415735077837094,0.679711231512833,18,160,regulation of leukocyte differentiation,BP,CTNNBIP1;AP3D1;XBP1;MMP14;CARD11;PRKCZ;TGFBR2;TFE3;RAG1;GATA3;ADAM8;IRF7;ZFPM1;PNP;CEACAM1;TGFB1;ANXA1;GNAS
6699,GO:0030073,0.41587670652898,0.691649878624491,14,124,insulin secretion,BP,PCK2;NR1D1;RAPGEF3;LRP5;ACVR2B;MAP4K4;ITPR3;HADH;NLGN2;GLUL;GLUD1;ARL2;GAL;ANXA1
3234,GO:0006890,0.416563033408041,0.716027110536344,9,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KLC2;SCYL1;COPG1;KDELR1;SURF4;TMED3;RAB1B;RAB6A;ARCN1
19737,GO:2000045,0.416576863486661,0.687467796335948,15,135,regulation of G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;NACC2;EGFR;AKT1;CCND2;ZNF385A;PCBP4;PKD1;GJC2;HYAL1;CNOT11;KANK2;ANXA1;EP300
16697,GO:0097617,0.416830767409698,0.841901665917071,2,13,annealing activity,MF,SMARCA1;ANXA1
9780,GO:0039535,0.416853163147041,0.841886780986554,2,13,regulation of RIG-I signaling pathway,BP,PUM1;SEC14L1
15769,GO:0072341,0.4173891495324,0.742516117260687,6,51,modified amino acid binding,MF,CBS;OSBPL10;OSBPL5;GSDMA;GSDMC;ASAP1
12174,GO:0048266,0.417389434898598,0.91505187775613,1,5,behavioral response to pain,BP,VWA1
19835,GO:2000249,0.417409447694499,0.800472665983902,3,23,regulation of actin cytoskeleton reorganization,BP,RAPGEF3;BAIAP2L1;TGFB1
887,GO:0002250,0.417516809922527,0.669314955882864,22,198,adaptive immune response,BP,ERCC1;DLG1;SERPING1;ARG2;PKN1;PRKCZ;POU2F2;TFEB;ORAI1;KDELR1;TFE3;RAG1;GATA3;IRF7;PAG1;FYN;CTSL;ZP3;ARG1;CEACAM1;TGFB1;ANXA1
8145,GO:0032839,0.417541635282847,0.800930510902643,3,22,dendrite cytoplasm,CC,DLG4;KIF17;KLHL17
729,GO:0001955,0.417610714952027,0.914950910281652,1,5,blood vessel maturation,BP,DDIT3
4506,GO:0010543,0.417718685857668,0.800797560259001,3,22,regulation of platelet activation,BP,SERPINE2;APOE;CEACAM1
13389,GO:0052564,0.417760750186585,0.914882408359249,1,5,response to immune response of other organism involved in symbiotic interaction,BP,TGFB1
13391,GO:0052572,0.417760750186585,0.914882408359249,1,5,response to host immune response,BP,TGFB1
10032,GO:0042455,0.417879221808377,0.773775478293879,4,34,ribonucleoside biosynthetic process,BP,NT5E;NME4;UCKL1;GUK1
10037,GO:0042472,0.417999897619566,0.742563786994849,6,48,inner ear morphogenesis,BP,DVL1;BCR;GATA3;FGFR1;CHD7;EPHB2
5616,GO:0016661,0.418375331686129,0.914601447802958,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,CBS
1428,GO:0003382,0.418433928514911,0.800260061157692,3,22,epithelial cell morphogenesis,BP,FLNB;SPINT2;RAB25
18128,GO:1902742,0.418434199514642,0.800259857379156,3,22,apoptotic process involved in development,BP,LRP5;VDR;SLIT3
10554,GO:0043492,0.418443236448344,0.714467249434528,9,76,ATPase activity, coupled to movement of substances,MF,ATP13A2;ATP7B;ABCB8;ATP11A;ATP2C2;TCIRG1;ABCA7;ATP6V1C2;PCYOX1
12247,GO:0048489,0.418576698925555,0.714349216688724,9,76,synaptic vesicle transport,BP,AP3D1;SNPH;SEPT5;SYTL1;VAMP2;PIP5K1C;DNM2;STXBP1;SNAP29
16645,GO:0097480,0.418576698925555,0.714349216688724,9,76,establishment of synaptic vesicle localization,BP,AP3D1;SNPH;SEPT5;SYTL1;VAMP2;PIP5K1C;DNM2;STXBP1;SNAP29
15581,GO:0072010,0.418605143334417,0.840720116575115,2,13,glomerular epithelium development,BP,LAMB2;PODXL
7736,GO:0032226,0.41861620997476,0.914491170642978,1,5,positive regulation of synaptic transmission, dopaminergic,BP,RAB3B
6825,GO:0030279,0.418701077052376,0.75570271431942,5,40,negative regulation of ossification,BP,LRP5;DKK1;SUFU;ECM1;TGFB1
704,GO:0001921,0.418710515111954,0.840649807023598,2,13,positive regulation of receptor recycling,BP,ARAP1;RAB29
17900,GO:1902110,0.418727752860574,0.741380825640971,6,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1
1345,GO:0003205,0.418742634453366,0.697430221333306,12,102,cardiac chamber development,BP,FKBP1A;PPP1R13L;TGFBR2;LTBP1;SUFU;GATA3;DNM2;GSK3A;ZFPM1;CHD7;RXRA;TGFB1
6916,GO:0030501,0.418961552658743,0.799863134644029,3,22,positive regulation of bone mineralization,BP,ACVR2B;FAM20C;TGFB1
14623,GO:0070169,0.418961552658743,0.799863134644029,3,22,positive regulation of biomineral tissue development,BP,ACVR2B;FAM20C;TGFB1
2723,GO:0006101,0.41912074570124,0.773422059512841,4,32,citrate metabolic process,BP,IDH2;MDH2;DHTKD1;SDHA
13332,GO:0052150,0.419390042681796,0.914136298005952,1,5,modulation by symbiont of host apoptotic process,BP,BCL2L1
16773,GO:0098533,0.419393453093609,0.840193726271943,2,13,ATPase dependent transmembrane transport complex,CC,ABCB8;ABCA7
16306,GO:0090382,0.419550213541343,0.772747552593742,4,33,phagosome maturation,BP,RAB43;RAB31;TCIRG1;ATP6V1C2
3006,GO:0006552,0.419591074731422,0.914043956134577,1,5,leucine catabolic process,BP,HMGCL
6920,GO:0030506,0.419703587170434,0.839986389473909,2,13,ankyrin binding,MF,FLNC;OBSCN
13793,GO:0060351,0.419740806765674,0.839961497368454,2,13,cartilage development involved in endochondral bone morphogenesis,BP,TGFBR2;THBS3
19196,GO:1905206,0.419985912066603,0.913862411171888,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
4682,GO:0010828,0.419997386411483,0.773455470161872,4,30,positive regulation of glucose transmembrane transport,BP,AKT1;PRKCZ;PAK1;PIK3R2
15509,GO:0071863,0.420069188270953,0.913824090439092,1,5,regulation of cell proliferation in bone marrow,BP,HMGA2
15510,GO:0071864,0.420069188270953,0.913824090439092,1,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2
7839,GO:0032387,0.420234991829685,0.753944041666806,5,42,negative regulation of intracellular transport,BP,PCSK9;MAP1B;GDI1;UBE2J1;PARP10
7878,GO:0032434,0.420415684416663,0.695654117575945,12,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,DVL1;CSNK1E;PANO1;AKT1;ANKIB1;GIPC1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
4227,GO:0009403,0.420517217450934,0.913617740328739,1,5,toxin biosynthetic process,BP,CBS
10500,GO:0043388,0.420658433012462,0.75359239188071,5,42,positive regulation of DNA binding,BP,FAM129B;GATA3;HMGA2;MAU2;TGFB1
4560,GO:0010639,0.420720497310621,0.6531735163701,31,282,negative regulation of organelle organization,BP,ERCC1;BOK;ARAP1;BNIP3;TMOD2;ESPN;EVI5L;CORO1B;SHANK3;AKT1;TMSB4X;EML2;WASF2;TWF2;TTBK2;PHF1;CTBP1;SRC;CAPG;DNM2;TOM1L2;PFN1;PHF2;BCL2L1;CAMSAP3;VAT1;CIB1;TMSB10;KANK2;ARHGEF2;PLEKHH2
8044,GO:0032687,0.420760565921959,0.91350553115926,1,5,negative regulation of interferon-alpha production,BP,PTPRS
1440,GO:0003416,0.420951615579629,0.839150627114607,2,13,endochondral bone growth,BP,TGFBR2;THBS3
1987,GO:0004704,0.421278555776773,0.91326637979779,1,5,NF-kappaB-inducing kinase activity,MF,IRAK1
2853,GO:0006342,0.421301315691405,0.703985937036685,10,107,chromatin silencing,BP,DNMT3A;H2AFJ;TNRC18;BAZ2A;HIST3H2A;PHF2;HIST2H2AC;BAHCC1;HIST1H2AG;MBD3
11121,GO:0045124,0.42150673257922,0.797943392171373,3,22,regulation of bone resorption,BP,EGFR;ADAM8;SRC
688,GO:0001895,0.421892217360059,0.771201518086416,4,32,retina homeostasis,BP,ERCC6;BBS2;TUB;DRAM2
11353,GO:0045662,0.421939246927124,0.837370766324367,2,14,negative regulation of myoblast differentiation,BP,DDIT3;TGFB1
9080,GO:0035313,0.422050460515137,0.838412900928038,2,13,wound healing, spreading of epidermal cells,BP,WNT7A;RREB1
6356,GO:0021534,0.422206941023724,0.912836717169959,1,5,cell proliferation in hindbrain,BP,RERE
6531,GO:0021924,0.422206941023724,0.912836717169959,1,5,cell proliferation in external granule layer,BP,RERE
6532,GO:0021930,0.422206941023724,0.912836717169959,1,5,cerebellar granule cell precursor proliferation,BP,RERE
4761,GO:0010936,0.422326132295683,0.912781458311057,1,5,negative regulation of macrophage cytokine production,BP,TGFB1
13916,GO:0060538,0.422395566319072,0.698868480066664,11,95,skeletal muscle organ development,BP,NEURL1;MEF2D;FAM129B;DKK1;BCL9L;MYH15;FLNB;TAZ;LEMD2;TGFB1;EP300
9705,GO:0038093,0.422530509435526,0.675872656690053,17,156,Fc receptor signaling pathway,BP,SHC1;PSMD2;CARD11;ARPC1A;LIMK1;WASF2;PLCG1;PAK1;SRC;FYN;PSMD7;FCGRT;MAPK9;WIPF1;MAPK3;MAPK10;PIK3R2
17227,GO:0106049,0.422541986154755,0.912681329368432,1,5,regulation of cellular response to osmotic stress,BP,ARHGEF2
17932,GO:1902218,0.422541986154755,0.912681329368432,1,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
5628,GO:0016701,0.422837155832354,0.836763447477189,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B;P4HA1
5629,GO:0016702,0.422837155832354,0.836763447477189,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B;P4HA1
14664,GO:0070235,0.423178200178811,0.91238578729509,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D4
1254,GO:0003002,0.42339394708848,0.663863859831917,22,196,regionalization,BP,MDFI;CTNNBIP1;WNT7A;SEMA3F;LRP5;ACVR2B;DKK1;PRKACB;SUFU;SCMH1;DDIT3;TULP3;ALDH1A2;PCSK6;DUSP6;FUZ;FBXL15;FGFR1;PBX3;TSHZ1;AIDA;EP300
16365,GO:0090611,0.423502575291638,0.912234863447674,1,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,VPS4A
6563,GO:0021999,0.423663345316761,0.912160000677695,1,5,neural plate anterior/posterior regionalization,BP,FUZ
3265,GO:0006937,0.423747874369425,0.709464879012722,9,79,regulation of muscle contraction,BP,NOS1;F2R;DOCK4;DLG1;TNNT1;PRKACA;EHD3;P2RX4;MYL9
14669,GO:0070245,0.423805602424851,0.912093725079808,1,5,positive regulation of thymocyte apoptotic process,BP,ADAM8
5860,GO:0017156,0.423899655670113,0.717202002085295,8,67,calcium ion regulated exocytosis,BP,SNPH;SEPT5;SYTL1;VAMP2;PIP5K1C;STXBP1;ZP3;SNAP29
14227,GO:0061136,0.423902948715647,0.674672190903569,17,154,regulation of proteasomal protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;PANO1;PRKACA;AKT1;UBE2J1;ANKIB1;PKD1;GIPC1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
13664,GO:0060149,0.424135828684535,0.835882991240707,2,14,negative regulation of posttranscriptional gene silencing,BP,BCDIN3D;TGFB1
14132,GO:0060967,0.424135828684535,0.835882991240707,2,14,negative regulation of gene silencing by RNA,BP,BCDIN3D;TGFB1
18592,GO:1903792,0.424192150898193,0.836970011784003,2,13,negative regulation of anion transport,BP,AKT1;STK39
6038,GO:0019104,0.424200156171489,0.834873981163189,2,15,DNA N-glycosylase activity,MF,NEIL1;MPG
9055,GO:0035265,0.424303768599735,0.697299671383823,11,93,organ growth,BP,WWC3;ACVR2B;AKT1;TGFBR2;PAK1;GSK3A;DUSP6;FGFR1;FGF2;RXRA;THBS3
17715,GO:1901569,0.424369378063401,0.911830761371967,1,5,fatty acid derivative catabolic process,BP,ACOT7
9519,GO:0036159,0.424726089936556,0.911664124399747,1,5,inner dynein arm assembly,BP,DNAAF5
4248,GO:0009446,0.424745823769763,0.911654900023438,1,5,putrescine biosynthetic process,BP,AZIN2
2120,GO:0004908,0.424926946940029,0.911570207671,1,5,interleukin-1 receptor activity,MF,IL1RAP
7887,GO:0032449,0.425019834083475,0.911526754306657,1,5,CBM complex,CC,CARD11
6107,GO:0019336,0.425062438232171,0.911506819253624,1,5,phenol-containing compound catabolic process,BP,COMT
6189,GO:0019614,0.425062438232171,0.911506819253624,1,5,catechol-containing compound catabolic process,BP,COMT
10016,GO:0042424,0.425062438232171,0.911506819253624,1,5,catecholamine catabolic process,BP,COMT
13127,GO:0051642,0.42515565429001,0.795176578003719,3,22,centrosome localization,BP,DLG1;NDE1;FHOD1
2030,GO:0004767,0.425156088052124,0.911462989333357,1,5,sphingomyelin phosphodiesterase activity,MF,SMPD3
8990,GO:0035090,0.425169392724999,0.911456761389145,1,5,maintenance of apical/basal cell polarity,BP,LRCH4
11163,GO:0045199,0.425169392724999,0.911456761389145,1,5,maintenance of epithelial cell apical/basal polarity,BP,LRCH4
2772,GO:0006195,0.425346576109294,0.768085694541873,4,33,purine nucleotide catabolic process,BP,NT5E;XDH;RAPGEF3;PNP
20291,GO:2001214,0.425381574224637,0.911357401538223,1,5,positive regulation of vasculogenesis,BP,CEACAM1
1021,GO:0002517,0.425425231364664,0.911336949186962,1,5,T cell tolerance induction,BP,TGFBR2
1078,GO:0002645,0.425425231364664,0.911336949186962,1,5,positive regulation of tolerance induction,BP,TGFBR2
1084,GO:0002664,0.425425231364664,0.911336949186962,1,5,regulation of T cell tolerance induction,BP,TGFBR2
14047,GO:0060751,0.42544322469101,0.911328518874018,1,5,branch elongation involved in mammary gland duct branching,BP,TGFB1
19647,GO:1990763,0.425453734942003,0.911323594329871,1,5,arrestin family protein binding,MF,ARRDC1
12272,GO:0048537,0.425482069547499,0.911310317398534,1,5,mucosal-associated lymphoid tissue development,BP,RET
12275,GO:0048541,0.425482069547499,0.911310317398534,1,5,Peyer's patch development,BP,RET
2809,GO:0006269,0.425488166281978,0.911307460442328,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
18410,GO:1903392,0.425496776792763,0.836087799484924,2,13,negative regulation of adherens junction organization,BP,MMP14;SRC
8292,GO:0033089,0.425623235531865,0.911244151682204,1,5,positive regulation of T cell differentiation in thymus,BP,ADAM8
18247,GO:1903018,0.425699575894751,0.768136456440084,4,32,regulation of glycoprotein metabolic process,BP,CST3;RAB1B;ABCA7;POMT1
1934,GO:0004630,0.425821493147737,0.911151174288787,1,5,phospholipase D activity,MF,PLD3
10189,GO:0042771,0.425842908970965,0.749042992251516,5,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44;ZNF385A;SHISA5;MIF;EP300
11322,GO:0045625,0.425866247037165,0.911130177477644,1,5,regulation of T-helper 1 cell differentiation,BP,ANXA1
11490,GO:0045932,0.425961654531341,0.834640992032607,2,14,negative regulation of muscle contraction,BP,DOCK4;TNNT1
3332,GO:0007044,0.425976778562935,0.707887526566827,9,75,cell-substrate junction assembly,BP,ITGB4;ITGA6;LAMA5;MMP14;LAMC2;SRC;PPM1F;LAMB3;CAMSAP3
14713,GO:0070324,0.426358651677952,0.910898954185629,1,5,thyroid hormone binding,MF,THRA
11306,GO:0045602,0.426419579166818,0.910870317609695,1,5,negative regulation of endothelial cell differentiation,BP,XDH
4353,GO:0009922,0.426423779992274,0.91086834296871,1,5,fatty acid elongase activity,MF,ELOVL1
6122,GO:0019367,0.426423779992274,0.91086834296871,1,5,fatty acid elongation, saturated fatty acid,BP,ELOVL1
6123,GO:0019368,0.426423779992274,0.91086834296871,1,5,fatty acid elongation, unsaturated fatty acid,BP,ELOVL1
8844,GO:0034625,0.426423779992274,0.91086834296871,1,5,fatty acid elongation, monounsaturated fatty acid,BP,ELOVL1
8845,GO:0034626,0.426423779992274,0.91086834296871,1,5,fatty acid elongation, polyunsaturated fatty acid,BP,ELOVL1
17156,GO:0102336,0.426423779992274,0.91086834296871,1,5,3-oxo-arachidoyl-CoA synthase activity,MF,ELOVL1
17157,GO:0102337,0.426423779992274,0.91086834296871,1,5,3-oxo-cerotoyl-CoA synthase activity,MF,ELOVL1
17158,GO:0102338,0.426423779992274,0.91086834296871,1,5,3-oxo-lignoceronyl-CoA synthase activity,MF,ELOVL1
17189,GO:0102756,0.426423779992274,0.91086834296871,1,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,ELOVL1
11706,GO:0046476,0.426469886848505,0.910846668105503,1,5,glycosylceramide biosynthetic process,BP,UGCG
6308,GO:0019934,0.42664506140443,0.910764288217209,1,5,cGMP-mediated signaling,BP,APOE
11224,GO:0045342,0.426811841556627,0.910685811542132,1,5,MHC class II biosynthetic process,BP,XBP1
11227,GO:0045346,0.426811841556627,0.910685811542132,1,5,regulation of MHC class II biosynthetic process,BP,XBP1
12190,GO:0048296,0.427006991384192,0.910593930726384,1,5,regulation of isotype switching to IgA isotypes,BP,TGFB1
13016,GO:0051414,0.42710481250379,0.910547852051593,1,5,response to cortisol,BP,SLIT3
2586,GO:0005879,0.427149123419785,0.910526974457325,1,5,axonemal microtubule,CC,ARFGEF2
5630,GO:0016705,0.427325937196997,0.694412665857317,11,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,NOS1;CYP27B1;CYGB;P4HB;ASPH;MICAL2;P4HA1;KDM4B;MICAL1;NDOR1;PHYH
10629,GO:0043615,0.427422392437357,0.910398152954101,1,5,astrocyte cell migration,BP,MMP14
4834,GO:0014037,0.427454915453892,0.767078619806213,4,31,Schwann cell differentiation,BP,SH3TC2;AKT1;LAMB2;ERBB3
13973,GO:0060638,0.427541498643589,0.910341968722406,1,5,mesenchymal-epithelial cell signaling,BP,FGFR1
7988,GO:0032596,0.427627830578521,0.910301230761671,1,5,protein transport into membrane raft,BP,REEP2
1346,GO:0003206,0.427666572159784,0.706275311958373,9,76,cardiac chamber morphogenesis,BP,FKBP1A;PPP1R13L;TGFBR2;GATA3;GSK3A;ZFPM1;CHD7;RXRA;TGFB1
12289,GO:0048569,0.427742321253804,0.833425030250902,2,14,post-embryonic animal organ development,BP,ERCC1;LDHA
4015,GO:0009008,0.427864821112809,0.91018934079856,1,5,DNA-methyltransferase activity,MF,DNMT3A
9889,GO:0042147,0.427958800862612,0.713500605416349,8,68,retrograde transport, endosome to Golgi,BP,EHD3;TBC1D14;RAB29;DENND2A;STX5;STX10;RAB6A;ZFYVE21
20126,GO:2000756,0.428029001952651,0.733627366320434,6,50,regulation of peptidyl-lysine acetylation,BP,NOS1;GATA3;CTBP1;MAPK3;TGFB1;WBP2
8259,GO:0033029,0.428380252592854,0.909945687801664,1,5,regulation of neutrophil apoptotic process,BP,ANXA1
12839,GO:0051125,0.428431749372456,0.792677813489778,3,22,regulation of actin nucleation,BP,CORO1B;ARFIP2;WIPF1
2327,GO:0005337,0.42851058517084,0.909884011612795,1,5,nucleoside transmembrane transporter activity,MF,SLC29A4
5240,GO:0015858,0.42851058517084,0.909884011612795,1,5,nucleoside transport,BP,SLC29A4
17746,GO:1901642,0.42851058517084,0.909884011612795,1,5,nucleoside transmembrane transport,BP,SLC29A4
19714,GO:2000002,0.428534114071144,0.909872874400562,1,5,negative regulation of DNA damage checkpoint,BP,PPP1R10
16184,GO:0090186,0.428623100642089,0.909830745489476,1,5,regulation of pancreatic juice secretion,BP,STK39
20295,GO:2001225,0.428703140618025,0.909792841564986,1,5,regulation of chloride transport,BP,PRNP
13887,GO:0060484,0.428708515787246,0.909790295729812,1,5,lung-associated mesenchyme development,BP,FGFR1
881,GO:0002237,0.428925479922376,0.656642261449092,23,213,response to molecule of bacterial origin,BP,TNIP1;NOS1;F2R;CYP27B1;PCK2;NR1D1;MAPKAPK3;BCR;XBP1;AKT1;IRAK1;HSF1;TNFRSF6B;SRC;TNFRSF1A;VDR;COMT;LOXL1;MIF;ARG1;MAPK3;LITAF;TGFB1
13554,GO:0055117,0.428933668058755,0.746923938783481,5,41,regulation of cardiac muscle contraction,BP,NOS1;DLG1;PRKACA;EHD3;P2RX4
18845,GO:1904385,0.428983365281404,0.832574821133434,2,14,cellular response to angiotensin,BP,HSF1;SRC
10043,GO:0042482,0.42906031947875,0.909623572838441,1,5,positive regulation of odontogenesis,BP,TGFB1
15533,GO:0071895,0.42921187747151,0.909551688408422,1,5,odontoblast differentiation,BP,FAM20C
6996,GO:0030670,0.42935685661936,0.720929456218784,7,62,phagocytic vesicle membrane,CC,RAC2;RAB43;RAB31;DNM2;ANXA3;TCIRG1;OCRL
10651,GO:0043651,0.429409993066947,0.832282028492621,2,14,linoleic acid metabolic process,BP,ELOVL1;ALOX15B
8458,GO:0033578,0.429730521852863,0.909305421254945,1,5,protein glycosylation in Golgi,BP,LMF1
18426,GO:1903428,0.429830319918706,0.76479196575051,4,32,positive regulation of reactive oxygen species biosynthetic process,BP,AKT1;ASS1;DNM2;P2RX4
14115,GO:0060923,0.429862871319963,0.90924251037302,1,5,cardiac muscle cell fate commitment,BP,DKK1
9415,GO:0035965,0.429961317116972,0.909195697409513,1,5,cardiolipin acyl-chain remodeling,BP,TAZ
17781,GO:1901723,0.430022376379109,0.909166654846125,1,5,negative regulation of cell proliferation involved in kidney development,BP,GATA3
15294,GO:0071458,0.430189322559333,0.909087217781741,1,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,HM13
12675,GO:0050860,0.430214684381272,0.831729047338217,2,14,negative regulation of T cell receptor signaling pathway,BP,PRNP;CEACAM1
14256,GO:0061200,0.430329800537023,0.90902034101678,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14257,GO:0061202,0.430329800537023,0.90902034101678,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
5580,GO:0016594,0.430676429450269,0.908855190187186,1,5,glycine binding,MF,GRIN3B
9442,GO:0036005,0.43095158153292,0.908723959896116,1,5,response to macrophage colony-stimulating factor,BP,MST1R
9443,GO:0036006,0.43095158153292,0.908723959896116,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R
13574,GO:0060017,0.430985847173605,0.908707608989102,1,5,parathyroid gland development,BP,GATA3
5053,GO:0015245,0.431000595772692,0.908700570684924,1,5,fatty acid transmembrane transporter activity,MF,SLC27A1
11282,GO:0045545,0.431051534396569,0.908676259162595,1,5,syndecan binding,MF,HPSE
16703,GO:0097629,0.43106871979839,0.908668056145139,1,5,extrinsic component of omegasome membrane,CC,ULK1
10182,GO:0042760,0.431072038955097,0.908666471784059,1,5,very long-chain fatty acid catabolic process,BP,ACADVL
4380,GO:0010009,0.431098827460126,0.908653683907275,1,5,cytoplasmic side of endosome membrane,CC,LITAF
1071,GO:0002634,0.431111929313955,0.908647429132101,1,5,regulation of germinal center formation,BP,PKN1
320,GO:0000836,0.431208647990587,0.908601247700632,1,5,Hrd1p ubiquitin ligase complex,CC,SYVN1
3107,GO:0006685,0.431262300721539,0.908575623143362,1,5,sphingomyelin catabolic process,BP,SMPD3
13596,GO:0060043,0.431322669942952,0.790461290389366,3,22,regulation of cardiac muscle cell proliferation,BP,TGFBR2;FGFR1;FGF2
17266,GO:0120009,0.43137038572388,0.908523987936077,1,5,intermembrane lipid transfer,BP,CPTP
17268,GO:0120013,0.43137038572388,0.908523987936077,1,5,intermembrane lipid transfer activity,MF,CPTP
4303,GO:0009749,0.431377414771743,0.677332100409518,14,126,response to glucose,BP,PCK2;NR1D1;SESN2;LRP5;ACVR2B;XBP1;MAP4K4;PRKACA;ENDOG;TGFBR2;GLUL;VAMP2;TGFB1;LDHA
6401,GO:0021604,0.431394384515652,0.908512520559033,1,5,cranial nerve structural organization,BP,SEMA3F
6403,GO:0021612,0.431394384515652,0.908512520559033,1,5,facial nerve structural organization,BP,SEMA3F
1418,GO:0003352,0.431480325606171,0.90847144773971,1,5,regulation of cilium movement,BP,BBS2
1419,GO:0003356,0.431480325606171,0.90847144773971,1,5,regulation of cilium beat frequency,BP,BBS2
13747,GO:0060295,0.431480325606171,0.90847144773971,1,5,regulation of cilium movement involved in cell motility,BP,BBS2
13748,GO:0060296,0.431480325606171,0.90847144773971,1,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2
17867,GO:1902019,0.431480325606171,0.90847144773971,1,5,regulation of cilium-dependent cell motility,BP,BBS2
10491,GO:0043374,0.43172509414475,0.908354404651024,1,5,CD8-positive, alpha-beta T cell differentiation,BP,SATB1
14094,GO:0060872,0.431956061832895,0.908243874259485,1,5,semicircular canal development,BP,CHD7
10345,GO:0043129,0.432026351579912,0.90821022017037,1,5,surfactant homeostasis,BP,LPCAT1
14797,GO:0070487,0.43204595481291,0.908200832934572,1,5,monocyte aggregation,BP,CD44
5026,GO:0015187,0.432085434737813,0.908181925658748,1,5,glycine transmembrane transporter activity,MF,SLC6A9
6971,GO:0030620,0.432169370070335,0.904895265417383,1,6,U2 snRNA binding,MF,ISG20
12169,GO:0048261,0.432293093634546,0.83029637953494,2,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;PCSK9
5020,GO:0015181,0.432343095250988,0.908058469521609,1,5,arginine transmembrane transporter activity,MF,TMEM44
5027,GO:0015189,0.432343095250988,0.908058469521609,1,5,L-lysine transmembrane transporter activity,MF,TMEM44
3492,GO:0007386,0.432503784327188,0.907981423508808,1,5,compartment pattern specification,BP,PBX3
12406,GO:0048814,0.432713957677711,0.71856950605207,7,58,regulation of dendrite morphogenesis,BP,NFATC4;SHANK3;HECW2;FBXW8;OBSL1;CUL7;ARHGAP44
14979,GO:0070857,0.432757726249051,0.907859582203176,1,5,regulation of bile acid biosynthetic process,BP,NR1D1
15851,GO:0072537,0.432791248492067,0.907843490628688,1,5,fibroblast activation,BP,CYGB
15440,GO:0071692,0.432835600327386,0.907822197827243,1,5,protein localization to extracellular region,BP,LTBP1
15441,GO:0071694,0.432835600327386,0.907822197827243,1,5,maintenance of protein location in extracellular region,BP,LTBP1
495,GO:0001547,0.432878053627952,0.90780181358381,1,5,antral ovarian follicle growth,BP,ZP3
7508,GO:0031681,0.433027156640296,0.907730198187448,1,5,G-protein beta-subunit binding,MF,F2R
2111,GO:0004887,0.433326524411724,0.907586303325465,1,5,thyroid hormone receptor activity,MF,THRA
9515,GO:0036155,0.433333676191597,0.907582863999901,1,5,acylglycerol acyl-chain remodeling,BP,MGLL
2028,GO:0004758,0.433362293375235,0.907569101055473,1,5,serine C-palmitoyltransferase activity,MF,SPTLC2
5509,GO:0016454,0.433362293375235,0.907569101055473,1,5,C-palmitoyltransferase activity,MF,SPTLC2
9397,GO:0035926,0.433464369382418,0.907519998788187,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
10803,GO:0044265,0.433486440128704,0.609634164346157,99,960,cellular macromolecule catabolic process,BP,EDEM1;BTBD2;H1F0;GID4;CAPN2;RBCK1;DVL1;CST3;SHARPIN;NR1D1;PSMD2;MTA1;BNIP3;SMURF2;CTSB;ABTB1;USP20;VLDLR;XBP1;CSNK1E;PANO1;PRKACA;HECW2;AKT1;APOE;ATP13A2;SYVN1;WWTR1;AP2A2;VPS11;VPS4A;CTSZ;TMEM129;FBXO2;PCSK9;ENDOG;FBXW5;MSN;MVB12B;UBE2J1;ARRDC1;BNIP3L;CDC34;GTPBP1;IDE;DEDD2;ANKIB1;SUFU;DDIT3;CUL7;ADAMTS7;DNASE1L1;PCBP4;PKD1;UBXN4;HSF1;WFS1;GIPC1;UBR4;AGO4;GSK3A;ISG20;RMND5A;PSMD7;FBXL15;PUM1;RNF44;CTSL;TNRC6B;UBA1;RNF187;VPS37A;STUB1;TRIB3;TCIRG1;RMND5B;RAD23A;LRP1;TRIB2;HPSE;SAMD4B;RNH1;PYM1;RNF222;SPSB3;RPL28;CNOT11;LONP2;CARHSP1;CBL;USP32;POMT1;CSNK1D;DNAJB9;FURIN;RNF103;HM13;IGF2BP3;PCYOX1
13899,GO:0060509,0.433546184439364,0.907480630874886,1,5,Type I pneumocyte differentiation,BP,THRA
1597,GO:0004012,0.433660095871603,0.830511213463568,2,13,phospholipid-translocating ATPase activity,MF,ATP11A;ABCA7
98,GO:0000188,0.43370862495514,0.788041483074521,3,23,inactivation of MAPK activity,BP,DUSP4;DUSP6;SPRED2
18591,GO:1903789,0.433768393534428,0.907373654473761,1,5,regulation of amino acid transmembrane transport,BP,STK39
17029,GO:0099106,0.433928822933372,0.728364169073383,6,51,ion channel regulator activity,MF,DLG1;PRKCZ;PCSK9;GNB2;SLC30A1;STIM1
13091,GO:0051575,0.433965009746406,0.907278933902024,1,5,5'-deoxyribose-5-phosphate lyase activity,MF,HMGA2
9019,GO:0035176,0.434020829745735,0.761745288283081,4,31,social behavior,BP,DVL1;DLG4;SHANK3;SHANK2
13157,GO:0051703,0.434020829745735,0.761745288283081,4,31,intraspecies interaction between organisms,BP,DVL1;DLG4;SHANK3;SHANK2
17943,GO:1902231,0.434402117801794,0.903787672032091,1,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,NACC2
12728,GO:0050927,0.434413558923505,0.828828183587066,2,14,positive regulation of positive chemotaxis,BP,PGF;VEGFB
1272,GO:0003056,0.434529614130305,0.907006593386597,1,5,regulation of vascular smooth muscle contraction,BP,DOCK4
4731,GO:0010891,0.434551964865716,0.90699580197344,1,5,negative regulation of sequestering of triglyceride,BP,PPARA
1447,GO:0003433,0.434623974470133,0.906961028809413,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,TGFBR2
3323,GO:0007032,0.434632474207836,0.707464363615646,8,69,endosome organization,BP,SNX33;VPS11;VPS4A;PI4K2A;CHMP5;VPS37A;ARFGEF2;HGS
16374,GO:0090649,0.43465817585215,0.906944510212417,1,5,response to oxygen-glucose deprivation,BP,CBL
16375,GO:0090650,0.43465817585215,0.906944510212417,1,5,cellular response to oxygen-glucose deprivation,BP,CBL
651,GO:0001839,0.43478929306635,0.906881165991918,1,5,neural plate morphogenesis,BP,DVL1
13285,GO:0051953,0.434963582256878,0.906796922679491,1,5,negative regulation of amine transport,BP,STK39
16939,GO:0098887,0.435056109233198,0.90675217986153,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,ARHGAP44
11149,GO:0045179,0.435160988763067,0.906701447342441,1,5,apical cortex,CC,PRKCZ
3122,GO:0006702,0.435227456060118,0.906669286614797,1,5,androgen biosynthetic process,BP,SRD5A3
7146,GO:0030976,0.435255617948732,0.906655658149112,1,5,thiamine pyrophosphate binding,MF,DHTKD1
15818,GO:0072487,0.435582619809881,0.906497318973426,1,5,MSL complex,CC,MSL1
2000,GO:0004720,0.435664905382994,0.906457448323461,1,5,protein-lysine 6-oxidase activity,MF,LOXL1
17393,GO:1900087,0.435762883310808,0.786450317895746,3,23,positive regulation of G1/S transition of mitotic cell cycle,BP,CCND2;HYAL1;ANXA1
13515,GO:0055056,0.435928353740822,0.906329724690776,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
2553,GO:0005827,0.436031206663979,0.906279830136777,1,5,polar microtubule,CC,TUBG1
15679,GO:0072178,0.436055865807086,0.906267865347874,1,5,nephric duct morphogenesis,BP,GATA3
4342,GO:0009892,0.43613597832695,0.594354216102961,224,2168,negative regulation of metabolic process,BP,TNIP1;XDH;ERCC1;MDFI;ZMYND8;CHAC1;CCND1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;QSOX1;CST3;CYP27B1;DLG4;SERPINE2;NR1D1;DLG1;DAP;IFI6;DNMT3A;FKBP1A;PSMD2;MTA1;PRNP;BNIP3;PC;WWC3;CRTAP;SMURF2;CYGB;FAM129B;SESN2;ZC3H6;BBS2;NACC2;BCR;LPCAT1;VLDLR;LRP5;ACVR2B;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;PPP1R13L;ATF4;AKT1;PEG3;SERPING1;BAG3;APOE;ATP13A2;PKN1;ELK3;WWTR1;PHF21A;TSPYL2;PRKCZ;DGKQ;FZD8;CTSZ;EPHA1;PTK6;PCSK9;FERMT1;DEAF1;SALL2;PPP1R35;DRAP1;SERPINB6;LIMK1;STK39;DKK1;SOX7;UBE2J1;PPARA;H2AFJ;WDTC1;CD44;DNAJB5;GTPBP1;IDE;DEDD2;TBC1D14;PRDX5;PPP1R12C;BIN1;SUFU;SCMH1;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;FARP1;DUSP4;SATB1;IFI27;GRB10;PCBP4;PARP10;DLG3;GATA3;APLN;PHF1;OXA1L;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;NEIL1;TFPI2;HMGA2;ARID5B;PPP1R14A;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;IRF7;HIST3H2A;CPTP;ACADVL;PER3;RERE;RSF1;GSK3A;SPINT2;DUSP6;FYN;ZNF692;PPM1F;NELFCD;PSMD7;MICAL1;TLE4;VDR;PUM1;COMT;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;HSF4;FGFR1;RREB1;ADNP;PHF2;TENM2;MIF;SOCS2;HES2;PCSK1N;TRIB3;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;TRIB2;MXD4;SAMD4B;ZP3;LRRK1;RNH1;PYM1;RCOR1;MYO1D;RNF222;ABCA7;APBB1;SLIT3;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;CAMSAP3;RPL28;BAHCC1;ZBTB4;CNOT11;TCF25;HIST1H2AG;IMPACT;EPHB2;CARHSP1;CBL;CIB1;SOCS7;KANK2;FURIN;AIDA;CEACAM1;PAIP2;ZNF256;ECM1;CD59;MBD3;IGF2BP3;CCNE1;TGFB1;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10;KLF12;ZNF318;EP300
15772,GO:0072345,0.436207380657375,0.906194328021561,1,5,NAADP-sensitive calcium-release channel activity,MF,TPCN1
5783,GO:0017002,0.43632770382661,0.906135903493538,1,5,activin-activated receptor activity,MF,ACVR2B
14260,GO:0061213,0.436354706295433,0.827478342307485,2,14,positive regulation of mesonephros development,BP,GATA3;TGFB1
10125,GO:0042634,0.436367587196798,0.785980886621779,3,23,regulation of hair cycle,BP,FERMT1;GAL;HPSE
10359,GO:0043154,0.436437350248201,0.705625494009469,8,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI6;AKT1;CD44;PRDX5;RAG1;TNFRSF6B;SRC;MICAL1
6905,GO:0030449,0.436568967178643,0.82732900835043,2,14,regulation of complement activation,BP,SERPING1;CD59
19842,GO:2000257,0.436568967178643,0.82732900835043,2,14,regulation of protein activation cascade,BP,SERPING1;CD59
5251,GO:0015874,0.436581694729478,0.90601249913735,1,5,norepinephrine transport,BP,NISCH
4523,GO:0010574,0.43663134470461,0.785775982642422,3,23,regulation of vascular endothelial growth factor production,BP,ATF4;HPSE;TGFB1
13702,GO:0060215,0.436747558098978,0.905931857120063,1,5,primitive hemopoiesis,BP,ZFPM1
15164,GO:0071253,0.436785895520944,0.905913211398913,1,5,connexin binding,MF,SRC
8632,GO:0034142,0.436802181043897,0.827166387661363,2,14,toll-like receptor 4 signaling pathway,BP,NR1D1;IRAK1
13641,GO:0060099,0.436825795524422,0.90589380323426,1,5,regulation of phagocytosis, engulfment,BP,ABCA7
13642,GO:0060100,0.436825795524422,0.90589380323426,1,5,positive regulation of phagocytosis, engulfment,BP,ABCA7
19180,GO:1905155,0.436825795524422,0.90589380323426,1,5,positive regulation of membrane invagination,BP,ABCA7
10450,GO:0043296,0.436973044772499,0.680750376996585,12,103,apical junction complex,CC,CCND1;DLG1;PRKCZ;SYMPK;CYTH3;DLG3;SH3BP1;VASP;CAMSAP3;KIFC3;ARHGEF2;CLDN12
15699,GO:0072205,0.437018301934144,0.905800128551575,1,5,metanephric collecting duct development,BP,PKD1
16411,GO:0097009,0.437336060949151,0.82679380930168,2,14,energy homeostasis,BP,CRTC1;AMPD2
12386,GO:0048755,0.437436467967533,0.905596443169432,1,5,branching morphogenesis of a nerve,BP,RERE
16274,GO:0090311,0.437573492427486,0.75846893677207,4,32,regulation of protein deacetylation,BP,CTBP1;TGFB1;SPRED2;EP300
6279,GO:0019871,0.43764675594605,0.905493908186606,1,5,sodium channel inhibitor activity,MF,PCSK9
15252,GO:0071392,0.437749135624335,0.784906603687614,3,23,cellular response to estradiol stimulus,BP,EGFR;FAM210B;HSF1
19136,GO:1905037,0.437754578067388,0.690500413293241,10,87,autophagosome organization,BP,ATG16L2;ATP13A2;ATG13;TBC1D14;LRSAM1;RAB1B;ULK1;ULK2;MAP1LC3B;PACS2
568,GO:0001707,0.437754773042608,0.739741559806088,5,40,mesoderm formation,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA3
13567,GO:0060008,0.437754822235134,0.826501273989009,2,14,Sertoli cell differentiation,BP,SDC1;CST3
10250,GO:0042954,0.437937429466509,0.905352061568567,1,5,lipoprotein transporter activity,MF,LRP1
14691,GO:0070290,0.438165294289608,0.905240770827937,1,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
7472,GO:0031625,0.438218594744823,0.638850356947623,29,268,ubiquitin protein ligase binding,MF,BTBD2;CBS;SNX9;BOK;ABTB1;EGFR;PRKACA;FZD8;UBE2J1;ARRDC1;PRKACB;CDC34;MC1R;UBXN7;CUL7;HLTF;DLG3;WFS1;SRC;PER3;MOAP1;STUB1;TRIB3;TRIB2;MAP1LC3B;NDUFS2;HM13;ERBB3;PXN
12779,GO:0051029,0.438251864055362,0.901858954858816,1,6,rRNA transport,BP,TST
11092,GO:0045078,0.438302110365242,0.905173909072209,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
16600,GO:0097381,0.43836083364108,0.905145201941023,1,5,photoreceptor disc membrane,CC,GNB1
844,GO:0002154,0.438424501592607,0.905114071365282,1,5,thyroid hormone mediated signaling pathway,BP,THRA
13579,GO:0060022,0.438584902948867,0.90503561406299,1,5,hard palate development,BP,DLG1
12108,GO:0048069,0.43860301781013,0.905026750933705,1,5,eye pigmentation,BP,AP3D1
10608,GO:0043568,0.43864241498296,0.905007473118907,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
8862,GO:0034650,0.438840294266898,0.904910609314176,1,5,cortisol metabolic process,BP,DGKQ
8863,GO:0034651,0.438840294266898,0.904910609314176,1,5,cortisol biosynthetic process,BP,DGKQ
19750,GO:2000064,0.438840294266898,0.904910609314176,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
9410,GO:0035947,0.43888352521509,0.904889439010897,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
13591,GO:0060038,0.439358097105103,0.757372754632416,4,31,cardiac muscle cell proliferation,BP,TGFBR2;FGFR1;FGF2;RXRA
89,GO:0000177,0.439418658158942,0.82432248163907,2,15,cytoplasmic exosome (RNase complex),CC,GTPBP1;CARHSP1
10580,GO:0043533,0.439537016960125,0.904569058160774,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3
2084,GO:0004839,0.439598347651073,0.904538955069573,1,5,ubiquitin activating enzyme activity,MF,UBA1
8350,GO:0033192,0.439638346827005,0.904519318935195,1,5,calmodulin-dependent protein phosphatase activity,MF,PPM1F
11375,GO:0045719,0.439680348861672,0.904498696815755,1,5,negative regulation of glycogen biosynthetic process,BP,GSK3A
14986,GO:0070874,0.439680348861672,0.904498696815755,1,5,negative regulation of glycogen metabolic process,BP,GSK3A
14176,GO:0061037,0.439691829092987,0.825144758601441,2,14,negative regulation of cartilage development,BP,PTHLH;ADAMTS7
4585,GO:0010668,0.439772048811257,0.904453664216013,1,5,ectodermal cell differentiation,BP,ITGA6
16831,GO:0098659,0.439784409223055,0.757022057515883,4,31,inorganic cation import across plasma membrane,BP,PRNP;FAM155B;FYN;SLC30A1
17099,GO:0099587,0.439784409223055,0.757022057515883,4,31,inorganic ion import across plasma membrane,BP,PRNP;FAM155B;FYN;SLC30A1
5797,GO:0017034,0.439817810014662,0.904431186473133,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3
508,GO:0001570,0.43984474989725,0.723621319002084,6,49,vasculogenesis,BP,XDH;WNT7A;TGFBR2;CUL7;CEACAM1;TGFB1
8755,GO:0034398,0.439952597205135,0.904364959975629,1,5,telomere tethering at nuclear periphery,BP,LEMD2
5269,GO:0015911,0.44004296586338,0.904320541813584,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
12378,GO:0048742,0.44010207312029,0.904291482227614,1,5,regulation of skeletal muscle fiber development,BP,FAM129B
7821,GO:0032369,0.440120042231018,0.824844124534584,2,14,negative regulation of lipid transport,BP,AKT1;PCSK9
7071,GO:0030853,0.44029639878629,0.904195904132446,1,5,negative regulation of granulocyte differentiation,BP,CEACAM1
11679,GO:0046427,0.440417598716058,0.736734860724705,5,43,positive regulation of JAK-STAT cascade,BP,PTK6;HSF1;FYN;TNFRSF1A;ADIPOR1
14023,GO:0060718,0.440547874182621,0.904072127297073,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
2880,GO:0006382,0.440605082918405,0.904043954822422,1,5,adenosine to inosine editing,BP,ADARB1
2174,GO:0005007,0.440611307453214,0.904040889233671,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR1
10199,GO:0042789,0.440691954519538,0.824442180122654,2,14,mRNA transcription by RNA polymerase II,BP,ATF4;DDIT3
9555,GO:0036302,0.440768242989816,0.903963577711936,1,5,atrioventricular canal development,BP,CHD7
11001,GO:0044789,0.440867093646475,0.90391486037591,1,5,modulation by host of viral release from host cell,BP,PC
11002,GO:0044791,0.440867093646475,0.90391486037591,1,5,positive regulation by host of viral release from host cell,BP,PC
5851,GO:0017144,0.440976382164627,0.615818779538737,55,537,drug metabolic process,BP,NT5E;CBS;NOS1;RAC2;CYP27B1;PCK2;PGM1;PRSS3;IDH2;PC;EGFR;HK1;PSAT1;AKT1;MDH2;ALDH1L2;ARG2;TMSB4X;FAM20C;DGKQ;PFKP;PPARA;DHTKD1;NADK;ELOVL1;IDE;PRDX5;HMGCL;AHCY;CTBS;GAMT;ASS1;SDHA;PYCR2;AKR7A2;ALDH1A2;CBR4;TAZ;DNM2;GPX3;ASNS;CHST14;COMT;GUK1;VPS9D1;TCIRG1;HLCS;AOX1;P2RX4;GGT1;ALDOC;NDUFS2;TGFB1;CAT;LDHA
13095,GO:0051583,0.441074377782601,0.900429517810876,1,6,dopamine uptake involved in synaptic transmission,BP,RAB3B
13275,GO:0051934,0.441074377782601,0.900429517810876,1,6,catecholamine uptake involved in synaptic transmission,BP,RAB3B
16331,GO:0090493,0.441074377782601,0.900429517810876,1,6,catecholamine uptake,BP,RAB3B
16332,GO:0090494,0.441074377782601,0.900429517810876,1,6,dopamine uptake,BP,RAB3B
10584,GO:0043537,0.441271701791097,0.782156207583998,3,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;FGF2;TGFB1
17378,GO:1900045,0.441278450445127,0.903711959574562,1,5,negative regulation of protein K63-linked ubiquitination,BP,PARP10
19129,GO:1905007,0.441484134067761,0.903610404576485,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
17698,GO:1901535,0.441604584252489,0.903550901446571,1,5,regulation of DNA demethylation,BP,GATA3
8956,GO:0034992,0.44175352561426,0.903477291218653,1,5,microtubule organizing center attachment site,CC,SYNE3
8957,GO:0034993,0.44175352561426,0.903477291218653,1,5,meiotic nuclear membrane microtubule tethering complex,CC,SYNE3
16254,GO:0090286,0.44175352561426,0.903477291218653,1,5,cytoskeletal anchoring at nuclear membrane,BP,SYNE3
17241,GO:0106083,0.44175352561426,0.903477291218653,1,5,nuclear membrane protein complex,CC,SYNE3
17244,GO:0106094,0.44175352561426,0.903477291218653,1,5,nuclear membrane microtubule tethering complex,CC,SYNE3
8032,GO:0032663,0.442178358838353,0.754675297355435,4,32,regulation of interleukin-2 production,BP,PRNP;CARD11;GATA3;ANXA1
1101,GO:0002687,0.442383840887349,0.700197057814377,8,72,positive regulation of leukocyte migration,BP,PGF;RAC2;MMP14;ADAM8;ZP3;VEGFB;MAPK3;TGFB1
5318,GO:0016032,0.44239227499509,0.608696153247615,69,680,viral process,BP,TNIP1;RBCK1;SHC1;CRTC1;DLG1;MMP1;BNIP3;PC;RAB43;CTSB;FBLN1;ITGB5;EGFR;ADARB1;P4HB;IFITM1;IRAK1;APOE;ATG16L2;AP1B1;AP2A2;VPS4A;MVB12B;BNIP3L;WASF2;PLCG1;IDE;BIN1;CUL7;STOM;SATB1;RAB29;PARP10;OASL;CTBP1;HMGA2;TOP1;SRC;CHMP5;UBR4;IRF7;LRSAM1;RAB1B;RSF1;OAS1;FYN;ISG20;NELFCD;TNFRSF1A;UCKL1;USF2;VPS37A;RAB11FIP4;BCL2L1;RAD23A;TBC1D20;VAPB;RCOR1;RXRA;RPL28;PACS2;MAPK3;FURIN;EIF4G3;ITSN1;TGFB1;RAB6A;APOBEC3C;EP300
3099,GO:0006677,0.442428936306047,0.823218439614224,2,14,glycosylceramide metabolic process,BP,UGCG;NAGA
5383,GO:0016198,0.442565435117511,0.903075398795918,1,5,axon choice point recognition,BP,ROBO3
4818,GO:0014010,0.442899293414099,0.902909831763199,1,5,Schwann cell proliferation,BP,RNF10
13128,GO:0051643,0.44301499562998,0.90285241075665,1,5,endoplasmic reticulum localization,BP,ESYT2
10601,GO:0043558,0.443055341785013,0.822776023732697,2,14,regulation of translational initiation in response to stress,BP,ATF4;IMPACT
3579,GO:0007625,0.443195118826327,0.899346883646279,1,6,grooming behavior,BP,DLG4
17535,GO:1900744,0.44323583152039,0.7806155825468,3,23,regulation of p38MAPK cascade,BP,XDH;DLG1;MINK1
12949,GO:0051286,0.443358694883121,0.902681711301457,1,5,cell tip,CC,PI4K2A
7643,GO:0032048,0.443470526700963,0.822482466442605,2,14,cardiolipin metabolic process,BP,TAZ;SLC27A1
17480,GO:1900246,0.443475963621814,0.902623425710335,1,5,positive regulation of RIG-I signaling pathway,BP,PUM1
13754,GO:0060304,0.443512085062277,0.90260546794485,1,5,regulation of phosphatidylinositol dephosphorylation,BP,MTMR4
12682,GO:0050867,0.443533059420604,0.648811316807643,20,184,positive regulation of cell activation,BP,AP3D1;XBP1;MMP14;AKT1;CARD11;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;STXBP1;FYN;MIF;ZP3;PNP;TGFB1;ANXA1
11070,GO:0045053,0.443570073721886,0.902576634488716,1,5,protein retention in Golgi apparatus,BP,SORL1
499,GO:0001554,0.443711136157604,0.902506471929335,1,5,luteolysis,BP,SLIT3
19808,GO:2000192,0.443799031075524,0.902462737902461,1,5,negative regulation of fatty acid transport,BP,AKT1
4925,GO:0014870,0.443928965876637,0.902398063150004,1,5,response to muscle inactivity,BP,MTMR4
10672,GO:0043813,0.444299765557484,0.902213348278116,1,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,OCRL
3112,GO:0006690,0.44431685474684,0.707747551787137,7,62,icosanoid metabolic process,BP,ALOX15B;TNFRSF1A;MGLL;MIF;GGT1;MAPK3;ANXA1
2734,GO:0006112,0.444506317869115,0.708015384285642,7,59,energy reserve metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;GSK3A;GNAS
13877,GO:0060462,0.444584665731683,0.902071273289392,1,5,lung lobe development,BP,TGFBR2
13878,GO:0060463,0.444584665731683,0.902071273289392,1,5,lung lobe morphogenesis,BP,TGFBR2
5682,GO:0016791,0.444619865816957,0.641897109304098,23,208,phosphatase activity,MF,NT5E;MAP2K1;DLG1;PTPRS;SBF1;SSH1;PTPRF;PPP2R3B;PTPDC1;DUSP4;PTPN9;PPM1M;PTPRU;DUSP6;PPM1F;SSU72;LHPP;MTMR4;NT5DC2;PTPN12;ACP7;OCRL;LPIN3
10602,GO:0043559,0.444733452181086,0.901997023721599,1,5,insulin binding,MF,IDE
12305,GO:0048617,0.444900632436206,0.901913552210416,1,5,embryonic foregut morphogenesis,BP,ACVR2B
6720,GO:0030127,0.444925118703322,0.82145196929472,2,14,COPII vesicle coat,CC,SEC23A;SEC24C
11678,GO:0046426,0.445217456990876,0.752157923535716,4,32,negative regulation of JAK-STAT cascade,BP,SOCS2;ADIPOR1;HGS;SOCS7
19076,GO:1904893,0.445217456990876,0.752157923535716,4,32,negative regulation of STAT cascade,BP,SOCS2;ADIPOR1;HGS;SOCS7
16803,GO:0098597,0.445297022202523,0.901715457513655,1,5,observational learning,BP,SHANK3
8200,GO:0032934,0.445469618883909,0.751596987815431,4,33,sterol binding,MF,OSBPL10;OSBP2;APOE;OSBPL5
5329,GO:0016052,0.445506170948122,0.660728593996713,15,134,carbohydrate catabolic process,BP,PYGB;PYGL;PGM1;LRP5;HK1;CRYL1;PFKP;PPARA;DHTKD1;CTBS;GSK3A;GALE;ALDOC;NAGA;LDHA
6909,GO:0030479,0.445771459899361,0.901478023466833,1,5,actin cortical patch,CC,WIPF1
14409,GO:0061645,0.445771459899361,0.901478023466833,1,5,endocytic patch,CC,WIPF1
7619,GO:0032000,0.445776447939497,0.901475525253853,1,5,positive regulation of fatty acid beta-oxidation,BP,PPARA
4817,GO:0014009,0.445992211242847,0.778445004552269,3,23,glial cell proliferation,BP,IDH2;ETV5;RNF10
10848,GO:0044332,0.446303181381743,0.901211487196682,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP5
18032,GO:1902476,0.446321466941303,0.751240743664144,4,32,chloride transmembrane transport,BP,TTYH3;SLC12A7;SLC12A4;PCYOX1
9468,GO:0036056,0.44649058810334,0.901117436224904,1,5,filtration diaphragm,CC,PODXL
9469,GO:0036057,0.44649058810334,0.901117436224904,1,5,slit diaphragm,CC,PODXL
10073,GO:0042554,0.446541217489981,0.819266601637487,2,15,superoxide anion generation,BP,EGFR;TGFB1
9152,GO:0035493,0.446584434189751,0.820272584190203,2,14,SNARE complex assembly,BP,VPS11;STXBP1
12993,GO:0051371,0.446609863550181,0.901057547519475,1,5,muscle alpha-actinin binding,MF,OBSL1
15696,GO:0072202,0.446673286919969,0.820209314709989,2,14,cell differentiation involved in metanephros development,BP,WWTR1;LAMB2
18104,GO:1902679,0.446949730842338,0.59689834152515,97,925,negative regulation of RNA biosynthetic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SHC1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;ZC3H6;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;ELK3;WWTR1;PHF21A;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;TSC22D4;SRC;IRF7;HIST3H2A;PER3;RERE;RSF1;ZNF692;PPM1F;NELFCD;TLE4;VDR;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;ZP3;RCOR1;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;ZNF256;MBD3;CCNE1;TGFB1;KLF12;ZNF318;EP300
18453,GO:1903507,0.446949730842338,0.59689834152515,97,925,negative regulation of nucleic acid-templated transcription,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SHC1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;ZC3H6;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;ELK3;WWTR1;PHF21A;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;TSC22D4;SRC;IRF7;HIST3H2A;PER3;RERE;RSF1;ZNF692;PPM1F;NELFCD;TLE4;VDR;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;ZP3;RCOR1;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;ZNF256;MBD3;CCNE1;TGFB1;KLF12;ZNF318;EP300
4284,GO:0009649,0.446992709098412,0.777654670648513,3,23,entrainment of circadian clock,BP,CRTC1;MTA1;PER3
13850,GO:0060428,0.447228289983295,0.777468384335054,3,23,lung epithelium development,BP,MAP2K1;PKD1;THRA
4029,GO:0009060,0.447416882199649,0.704237987400382,7,68,aerobic respiration,BP,IDH2;BNIP3;MDH2;DHTKD1;OXA1L;SDHA;CAT
15864,GO:0072559,0.447527374550839,0.897112182986306,1,6,NLRP3 inflammasome complex,CC,CASP4
12956,GO:0051294,0.447771854497348,0.777038280490634,3,23,establishment of spindle orientation,BP,NDE1;ARHGEF2;LLGL1
7700,GO:0032148,0.447828389304825,0.776443774950087,3,24,activation of protein kinase B activity,BP,AKT1;PRKCZ;SRC
11895,GO:0046887,0.447909798789833,0.695456985378129,8,70,positive regulation of hormone secretion,BP,PCK2;EGFR;NLGN2;GLUL;APLN;GLUD1;GAL;FGFR1
774,GO:0002026,0.447943098381106,0.819303828627449,2,14,regulation of the force of heart contraction,BP,NOS1;APLN
7640,GO:0032042,0.448290270497141,0.819055844724079,2,14,mitochondrial DNA metabolic process,BP,SESN2;PRIMPOL
5410,GO:0016247,0.448323471271577,0.694967522328341,8,71,channel regulator activity,MF,NOS1;DLG1;PRKCZ;PCSK9;PRSS8;GNB2;SLC30A1;STIM1
2217,GO:0005109,0.4490388401166,0.77603424894174,3,23,frizzled binding,MF,DVL1;WNT7A;WNT5B
4770,GO:0010952,0.449550161378794,0.653390405397175,16,151,positive regulation of peptidase activity,BP,XDH;F2R;BOK;DAP;FBLN1;MMP14;SOX7;TNFSF15;IFI27;HSF1;ASPH;FAM162A;FYN;PPM1F;CASP4;MAPK3
2378,GO:0005506,0.449572757274427,0.679544686829206,10,89,iron ion binding,MF,XDH;NOS1;CYP27B1;CYGB;LCN2;ALOX15B;P4HA1;PHF2;AOX1;PHYH
11767,GO:0046598,0.449768151350618,0.895944085784657,1,6,positive regulation of viral entry into host cell,BP,P4HB
11472,GO:0045912,0.449923761065132,0.775331733041449,3,23,negative regulation of carbohydrate metabolic process,BP,PPARA;GSK3A;TGFB1
4424,GO:0010226,0.450202965503632,0.817686374504691,2,14,response to lithium ion,BP,NFATC4;IGFBP2
2784,GO:0006216,0.450226810872921,0.895703956526149,1,6,cytidine catabolic process,BP,APOBEC3C
4367,GO:0009972,0.450226810872921,0.895703956526149,1,6,cytidine deamination,BP,APOBEC3C
11568,GO:0046087,0.450226810872921,0.895703956526149,1,6,cytidine metabolic process,BP,APOBEC3C
2289,GO:0005245,0.45033933527776,0.817588525564731,2,14,voltage-gated calcium channel activity,MF,NCS1;TPCN1
13821,GO:0060390,0.450357269546414,0.81757565517279,2,14,regulation of SMAD protein signal transduction,BP,WWTR1;TGFB1
3239,GO:0006896,0.450560187919462,0.817429998696192,2,14,Golgi to vacuole transport,BP,AP3D1;EHD3
3283,GO:0006972,0.452297295975794,0.816180544099633,2,14,hyperosmotic response,BP,PKN1;ARHGEF2
13550,GO:0055106,0.452326661333293,0.814189008371589,2,16,ubiquitin-protein transferase regulator activity,MF,TRIB3;TRIB2
11445,GO:0045844,0.452343094221141,0.726989575366841,5,41,positive regulation of striated muscle tissue development,BP,FAM129B;FGFR1;FGF2;TGFB1;ERBB3
12314,GO:0048636,0.452343094221141,0.726989575366841,5,41,positive regulation of muscle organ development,BP,FAM129B;FGFR1;FGF2;TGFB1;ERBB3
17816,GO:1901863,0.452343094221141,0.726989575366841,5,41,positive regulation of muscle tissue development,BP,FAM129B;FGFR1;FGF2;TGFB1;ERBB3
15715,GO:0072234,0.4524094040745,0.816099752674683,2,14,metanephric nephron tubule development,BP,WWTR1;PKD1
19834,GO:2000243,0.452808177504353,0.745465387519183,4,33,positive regulation of reproductive process,BP,SMURF2;SRC;ZP3;CIB1
17714,GO:1901568,0.453084660831985,0.670461067897344,11,100,fatty acid derivative metabolic process,BP,ACOT7;ELOVL1;HMGCL;ALOX15B;CBR4;TNFRSF1A;MGLL;MIF;GGT1;MAPK3;ANXA1
3090,GO:0006664,0.453209813060394,0.670345190346315,11,100,glycolipid metabolic process,BP,ESYT2;FUCA1;PIGQ;CPTP;ST3GAL5;SMPD3;ARSK;UGCG;B4GALT6;NAGA;ARSD
18455,GO:1903509,0.453209813060394,0.670345190346315,11,100,liposaccharide metabolic process,BP,ESYT2;FUCA1;PIGQ;CPTP;ST3GAL5;SMPD3;ARSK;UGCG;B4GALT6;NAGA;ARSD
135,GO:0000281,0.453576670082776,0.699773680486114,7,60,mitotic cytokinesis,BP,SNX9;SEPT10;SNX33;SEPT5;CUL7;RHOC;SEPT8
13219,GO:0051818,0.453785912018873,0.893828607857726,1,6,disruption of cells of other organism involved in symbiotic interaction,BP,ARG1
13242,GO:0051883,0.453785912018873,0.893828607857726,1,6,killing of cells in other organism involved in symbiotic interaction,BP,ARG1
878,GO:0002227,0.453838076160353,0.886777357266034,1,10,innate immune response in mucosa,BP,HIST2H2BE
14809,GO:0070509,0.453971456954504,0.744845764087291,4,32,calcium ion import,BP,PRNP;FAM155B;FYN;SLC30A1
6945,GO:0030548,0.454013500807489,0.893707962429117,1,6,acetylcholine receptor regulator activity,MF,LY6E
17103,GO:0099602,0.454013500807489,0.893707962429117,1,6,neurotransmitter receptor regulator activity,MF,LY6E
653,GO:0001841,0.454606885483264,0.675088244430274,10,87,neural tube formation,BP,DVL1;DEAF1;PRKACB;SUFU;TULP3;SPINT2;FUZ;PFN1;VASP;TGFB1
2835,GO:0006304,0.454680657709228,0.681458890175331,9,80,DNA modification,BP,DNMT3A;FAM129B;BAZ2A;GATA3;NEIL1;MPG;MBD3;APOBEC3C;GNAS
8700,GO:0034315,0.45490821674221,0.81429405186136,2,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B;ARFIP2
7081,GO:0030864,0.455186984027211,0.698482570720741,7,59,cortical actin cytoskeleton,CC,CAPN2;RAPGEF3;CAP1;WIPF1;MYZAP;LLGL1;PLEKHH2
11677,GO:0046425,0.455704794407039,0.680424322052285,9,81,regulation of JAK-STAT cascade,BP,PTK6;RET;HSF1;FYN;TNFRSF1A;SOCS2;ADIPOR1;HGS;SOCS7
2494,GO:0005741,0.455774010178624,0.647636062534504,16,148,mitochondrial outer membrane,CC,CYP27B1;BOK;BNIP3;HK1;ARMCX2;FAM210B;BNIP3L;MLXIP;IFI27;MOAP1;BCL2L1;ULK1;ARG1;BPHL;VAT1;CPT1B
5475,GO:0016405,0.45578981951754,0.813654736329213,2,14,CoA-ligase activity,MF,ACSF2;SLC27A1
12864,GO:0051155,0.455880396398441,0.74287951948675,4,33,positive regulation of striated muscle cell differentiation,BP,FAM129B;MMP14;THRA;TGFB1
5669,GO:0016775,0.455930797144258,0.892688124005762,1,6,phosphotransferase activity, nitrogenous group as acceptor,MF,MAP4K4
8643,GO:0034162,0.456081559066665,0.813442915663337,2,14,toll-like receptor 9 signaling pathway,BP,PTPRS;IRAK1
12355,GO:0048701,0.456100943818315,0.743053284062403,4,32,embryonic cranial skeleton morphogenesis,BP,MMP14;TGFBR2;TULP3;GNAS
1133,GO:0002719,0.456123441132647,0.812344951309725,2,15,negative regulation of cytokine production involved in immune response,BP,ARG1;TGFB1
12671,GO:0050856,0.456690801823194,0.769363347545306,3,24,regulation of T cell receptor signaling pathway,BP,PRNP;RAB29;CEACAM1
4488,GO:0010508,0.456728560854581,0.667300594560059,11,97,positive regulation of autophagy,BP,TRIM65;BNIP3;SESN2;FYCO1;TFEB;BNIP3L;LRSAM1;SPTLC2;TPCN1;ULK1;MAPK3
4302,GO:0009746,0.4567666744114,0.653585748565867,14,128,response to hexose,BP,PCK2;NR1D1;SESN2;LRP5;ACVR2B;XBP1;MAP4K4;PRKACA;ENDOG;TGFBR2;GLUL;VAMP2;TGFB1;LDHA
190,GO:0000407,0.456895344882225,0.742383222317233,4,32,phagophore assembly site,CC,ATG13;RAB1B;ULK1;ULK2
7944,GO:0032526,0.457099999065358,0.68701788415421,8,71,response to retinoic acid,BP,PTK6;DKK1;TWF2;RET;IGFBP2;ALDH1A2;WNT5B;RXRA
4476,GO:0010470,0.45725036339553,0.769475592485272,3,23,regulation of gastrulation,BP,DKK1;DUSP6;FGFR1
9871,GO:0042113,0.457345663857409,0.646271376705894,16,145,B cell activation,BP,ERCC1;XBP1;CMTM7;MMP14;CARD11;PKN1;POU2F2;RAG1;LRRC8A;MFNG;MIF;POLM;DNAJB9;SKAP2;TGFB1;EP300
507,GO:0001569,0.457394496826171,0.769359673744039,3,23,branching involved in blood vessel morphogenesis,BP,NFATC4;TGFBR2;EDNRA
18108,GO:1902686,0.45753649652018,0.707327970058235,6,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1
2369,GO:0005484,0.457689903916879,0.741013082991925,4,34,SNAP receptor activity,MF,VAMP2;STX5;STX10;SNAP29
8516,GO:0033688,0.457732841031087,0.812241556818422,2,14,regulation of osteoblast proliferation,BP,LRP5;HPSE
12962,GO:0051302,0.457955226649721,0.656544533870698,13,117,regulation of cell division,BP,PGF;VPS4A;GIT1;SDCCAG3;GIPC1;RAB11FIP4;BCL2L1;FGF2;VEGFB;TGFA;CIB1;TGFB1;CAT
5697,GO:0016814,0.45797961283315,0.768325027914189,3,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,ADARB1;AMPD2;APOBEC3C
19467,GO:1990050,0.45800112130434,0.891579891726514,1,6,phosphatidic acid transporter activity,MF,PLTP
13531,GO:0055081,0.458272859648042,0.741219535485692,4,32,anion homeostasis,BP,XBP1;SLC12A7;APOE;SLC12A4
9471,GO:0036065,0.458456605730948,0.768504626047538,3,23,fucosylation,BP,RFNG;ADAMTS7;MFNG
6853,GO:0030316,0.458685511024523,0.695182439701718,7,60,osteoclast differentiation,BP,FAM20C;TFE3;SRC;LRRK1;GLO1;SH3PXD2A;GNAS
4070,GO:0009120,0.459119456221872,0.890978220662607,1,6,deoxyribonucleoside metabolic process,BP,TK2
2677,GO:0006029,0.459325590643959,0.694759943370696,7,59,proteoglycan metabolic process,BP,CHPF;XYLT1;XYLT2;NDST2;CHST14;HYAL1;HPSE
4720,GO:0010880,0.459655760358094,0.809758449558247,2,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;CHD7
19906,GO:2000351,0.459657625591301,0.767535942025095,3,23,regulation of endothelial cell apoptotic process,BP,ANGPTL4;GATA3;PAK4
14203,GO:0061082,0.459762836154471,0.809679748736282,2,15,myeloid leukocyte cytokine production,BP,MIF;TGFB1
14202,GO:0061081,0.459981876167912,0.890512776281101,1,6,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,MIF
12060,GO:0047844,0.460180568802253,0.890405362581375,1,6,deoxycytidine deaminase activity,MF,APOBEC3C
9829,GO:0042026,0.460191869709224,0.766537599372441,3,24,protein refolding,BP,FKBP1A;HSPA2;HSPA13
1332,GO:0003181,0.460297167149856,0.810367734621806,2,14,atrioventricular valve morphogenesis,BP,TGFBR2;ZFPM1
16926,GO:0098868,0.460326416976092,0.810346303367921,2,14,bone growth,BP,TGFBR2;THBS3
9625,GO:0036481,0.460359877877577,0.890308369721825,1,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,STK25
19077,GO:1904894,0.460592608122589,0.719087333934035,5,44,positive regulation of STAT cascade,BP,PTK6;HSF1;FYN;TNFRSF1A;ADIPOR1
10725,GO:0044030,0.46090627554681,0.809921174201108,2,14,regulation of DNA methylation,BP,FAM129B;MBD3
2097,GO:0004860,0.461021982694957,0.683443381149344,8,71,protein kinase inhibitor activity,MF,HEXIM1;SOCS2;TRIB3;TRIB2;CIB1;SOCS7;SPRED2;CAMK2N1
5732,GO:0016874,0.461155948722045,0.645961630485203,15,135,ligase activity,MF,NAPRT;PC;AARS;CARS;ACSF2;GLUL;ASS1;PPCS;GARS;ASNS;UBA1;SLC27A1;HLCS;SARS2;NEURL1B
921,GO:0002313,0.461342349783732,0.80851677820783,2,15,mature B cell differentiation involved in immune response,BP,XBP1;MFNG
12886,GO:0051188,0.461344614093597,0.620773600646628,26,243,cofactor biosynthetic process,BP,CHAC1;NAPRT;PGM1;IDH2;ACOT7;HAGH;HK1;PSAT1;PFKP;NMRK1;PPARA;DHTKD1;NADK;ELOVL1;PARP10;PPCS;PANK4;CNDP2;ALAS1;CBR4;PNP;MLYCD;GGT1;ALDOC;UROS;LDHA
15898,GO:0072608,0.461379275705628,0.889755905419265,1,6,interleukin-10 secretion,BP,PRKCZ
5479,GO:0016409,0.461387233406782,0.738216372599414,4,33,palmitoyltransferase activity,MF,CPT2;ZDHHC8;SPTLC2;CPT1B
13703,GO:0060216,0.461573560202068,0.809431314409619,2,14,definitive hemopoiesis,BP,BCR;ZFPM1
12168,GO:0048260,0.461948045583923,0.737739454165203,4,33,positive regulation of receptor-mediated endocytosis,BP,PCSK9;APLN;LDLRAP1;CBL
13526,GO:0055075,0.462141995498113,0.809013485861111,2,14,potassium ion homeostasis,BP,SLC12A7;SLC12A4
4865,GO:0014704,0.462356011784965,0.737756912097707,4,32,intercalated disc,CC,DLG1;OBSL1;PAK1;FHOD1
11759,GO:0046580,0.46273178267334,0.717953351147793,5,41,negative regulation of Ras protein signal transduction,BP,ARAP3;EPHB2;ARHGAP44;ITGA3;RASA3
4388,GO:0010039,0.462776591397421,0.764440983211251,3,24,response to iron ion,BP,CCND1;FKBP1A;APBB1
20234,GO:2001057,0.462891485877657,0.702738419631767,6,52,reactive nitrogen species metabolic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;P2RX4
17794,GO:1901797,0.463122103917589,0.763638238153738,3,25,negative regulation of signal transduction by p53 class mediator,BP,CD44;ZNF385A;MIF
12569,GO:0050702,0.463132000870919,0.764151993827632,3,24,interleukin-1 beta secretion,BP,HK1;ARG2;CPTP
1237,GO:0002922,0.463319843972676,0.888699283399852,1,6,positive regulation of humoral immune response,BP,ZP3
11592,GO:0046131,0.463691236593122,0.762694955833859,3,26,pyrimidine ribonucleoside metabolic process,BP,NME4;UCKL1;APOBEC3C
8738,GO:0034379,0.463731514466819,0.888474299714013,1,6,very-low-density lipoprotein particle assembly,BP,P4HB
10876,GO:0044389,0.46391067014726,0.61283705294492,30,281,ubiquitin-like protein ligase binding,MF,BTBD2;CBS;SNX9;BOK;ABTB1;EGFR;PRKACA;FZD8;UBE2J1;ARRDC1;PRKACB;CDC34;MC1R;UBXN7;CUL7;HLTF;DLG3;WFS1;SRC;PER3;MOAP1;STUB1;TRIB3;TRIB2;MAP1LC3B;HGS;NDUFS2;HM13;ERBB3;PXN
21,GO:0000038,0.46416066457469,0.763314610820822,3,24,very long-chain fatty acid metabolic process,BP,ACOT1;ELOVL1;ACADVL
7901,GO:0032464,0.464424196419665,0.888095079989804,1,6,positive regulation of protein homooligomerization,BP,RHOC
10596,GO:0043550,0.464551566780267,0.735886789761669,4,32,regulation of lipid kinase activity,BP,SRC;FGF2;TGFB1;PIK3R2
9518,GO:0036158,0.465295647922257,0.887616813508928,1,6,outer dynein arm assembly,BP,DNAAF5
18430,GO:1903432,0.465345015314723,0.762348751298876,3,24,regulation of TORC1 signaling,BP,SESN2;DGKQ;C12ORF66
67,GO:0000138,0.465454205295049,0.887529653551301,1,6,Golgi trans cisterna,CC,YIPF2
13915,GO:0060537,0.465922617972146,0.618060043190065,25,227,muscle tissue development,BP,NEURL1;MEF2D;DLG1;FKBP1A;FAM129B;PPP1R13L;TGFBR2;DKK1;OBSL1;PAK1;BCL9L;MYH15;FLNB;ALDH1A2;TAZ;GSK3A;FGFR1;LEMD2;ZFPM1;FGF2;CHD7;RXRA;TGFB1;ERBB3;EP300
8447,GO:0033559,0.465928890326569,0.688194621984074,7,63,unsaturated fatty acid metabolic process,BP,ELOVL1;ALOX15B;TNFRSF1A;MGLL;MIF;MAPK3;ANXA1
1585,GO:0003993,0.465964976284194,0.887248583825573,1,6,acid phosphatase activity,MF,ACP7
457,GO:0001302,0.46598348051133,0.887238392738361,1,6,replicative cell aging,BP,ERCC1
6310,GO:0019941,0.466002636855389,0.591501749022484,55,522,modification-dependent protein catabolic process,BP,EDEM1;BTBD2;GID4;RBCK1;DVL1;SHARPIN;PSMD2;MTA1;SMURF2;ABTB1;USP20;XBP1;CSNK1E;PANO1;HECW2;AKT1;SYVN1;WWTR1;VPS4A;TMEM129;FBXO2;FBXW5;MVB12B;UBE2J1;ARRDC1;CDC34;ANKIB1;SUFU;DDIT3;CUL7;UBXN4;WFS1;GIPC1;UBR4;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;UBA1;RNF187;VPS37A;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;CBL;USP32;CSNK1D;DNAJB9;RNF103;PCYOX1
19770,GO:2000109,0.466333127938037,0.887045715238198,1,6,regulation of macrophage apoptotic process,BP,IRF7
17729,GO:1901612,0.466746437813637,0.886817682454344,1,6,cardiolipin binding,MF,NME4
2730,GO:0006108,0.467224746664777,0.886553418260157,1,6,malate metabolic process,BP,MDH2
7985,GO:0032593,0.46725232973119,0.886538166586869,1,6,insulin-responsive compartment,CC,RAB4B
17217,GO:0106018,0.46754425659498,0.805017913619368,2,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,MTMR4;OCRL
17536,GO:1900745,0.467697324324807,0.803799222855489,2,15,positive regulation of p38MAPK cascade,BP,XDH;MINK1
10873,GO:0044381,0.467698386928522,0.804903261147759,2,14,glucose import in response to insulin stimulus,BP,PAK1;PIK3R2
20327,GO:2001273,0.467698386928522,0.804903261147759,2,14,regulation of glucose import in response to insulin stimulus,BP,PAK1;PIK3R2
20294,GO:2001224,0.467716516969591,0.804889772411405,2,14,positive regulation of neuron migration,BP,ZNF609;ARHGEF2
10392,GO:0043203,0.467835665939123,0.886215309329334,1,6,axon hillock,CC,PRKCZ
4235,GO:0009414,0.467949561883162,0.886152202671481,1,6,response to water deprivation,BP,SIPA1
16533,GO:0097223,0.468040526532704,0.662296435141776,10,91,sperm part,CC,BSG;LY6K;PRKACA;HK1;ITGA1;LOXL1;SPESP1;GAS8;POMT1;ADAM15
13775,GO:0060331,0.468243952135997,0.885988984470161,1,6,negative regulation of response to interferon-gamma,BP,ARG1
13780,GO:0060336,0.468243952135997,0.885988984470161,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,ARG1
2344,GO:0005375,0.468402006518278,0.885901292455713,1,6,copper ion transmembrane transporter activity,MF,ATP7B
9130,GO:0035434,0.468402006518278,0.885901292455713,1,6,copper ion transmembrane transport,BP,ATP7B
1150,GO:0002755,0.468552253735603,0.75972376660218,3,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1;IRAK1;IRF7
12424,GO:0048854,0.468754045277822,0.76013671657541,3,23,brain morphogenesis,BP,BBS2;SHANK3;SHANK2
2973,GO:0006515,0.468947078650185,0.759399666578378,3,24,protein quality control for misfolded or incompletely synthesized proteins,BP,STUB1;LONP2;POMT1
14744,GO:0070383,0.468973660910117,0.88558376289516,1,6,DNA cytosine deamination,BP,APOBEC3C
8709,GO:0034340,0.469116221001437,0.675683189921995,8,74,response to type I interferon,BP,IFI6;IFITM1;IRAK1;IFI27;OASL;IRF7;OAS1;ISG20
5593,GO:0016615,0.469180534953632,0.885468712860537,1,6,malate dehydrogenase activity,MF,MDH2
16917,GO:0098843,0.469418118120937,0.885336492298038,1,6,postsynaptic endocytic zone,CC,DNM2
18427,GO:1903429,0.469604125931614,0.802371649256116,2,15,regulation of cell maturation,BP,RET;GAL
418,GO:0001105,0.469811311449454,0.731012865330858,4,33,RNA polymerase II transcription coactivator activity,MF,SOX12;CITED4;RERE;WBP2
7092,GO:0030881,0.469817793760759,0.885113841243301,1,6,beta-2-microglobulin binding,MF,FCGRT
4733,GO:0010894,0.469999063534719,0.802075269967023,2,15,negative regulation of steroid biosynthetic process,BP,CYP27B1;APOE
10931,GO:0044531,0.470192565245234,0.884904810316909,1,6,modulation of programmed cell death in other organism,BP,BCL2L1
10932,GO:0044532,0.470192565245234,0.884904810316909,1,6,modulation of apoptotic process in other organism,BP,BCL2L1
13320,GO:0052040,0.470192565245234,0.884904810316909,1,6,modulation by symbiont of host programmed cell death,BP,BCL2L1
13349,GO:0052248,0.470192565245234,0.884904810316909,1,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
13374,GO:0052433,0.470192565245234,0.884904810316909,1,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,BCL2L1
19075,GO:1904892,0.470302694342913,0.666862908552737,9,82,regulation of STAT cascade,BP,PTK6;RET;HSF1;FYN;TNFRSF1A;SOCS2;ADIPOR1;HGS;SOCS7
10924,GO:0044464,0.470304698178226,0.573305274704327,1149,11099,cell part,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;SDK2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;CSMD2;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;TTYH3;PANO1;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;LMBR1L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;LRP3;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;TMEM92;AP1B1;PEAR1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;SLC29A4;ISYNA1;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;NLGN2;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;TBC1D9B;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;SH2D5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;MYH16;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;ALOX15B;IL1RAP;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CNFN;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;TMPRSS11D;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;SLC10A6;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;KCNC4;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;SLC15A1;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
8313,GO:0033139,0.470329475375975,0.884828386695884,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
9361,GO:0035864,0.470447716376136,0.884762357850643,1,6,response to potassium ion,BP,HSF1
5348,GO:0016093,0.470461216653582,0.884754817398156,1,6,polyprenol metabolic process,BP,SRD5A3
8219,GO:0032966,0.470508137647145,0.884728607614589,1,6,negative regulation of collagen biosynthetic process,BP,CYGB
3108,GO:0006686,0.470603391830971,0.884675387356722,1,6,sphingomyelin biosynthetic process,BP,SPTLC2
12571,GO:0050704,0.470951309856856,0.757219659839491,3,25,regulation of interleukin-1 secretion,BP,HK1;ARG2;CPTP
17923,GO:1902188,0.471179618746391,0.80118789351543,2,15,positive regulation of viral release from host cell,BP,PC;VPS4A
12266,GO:0048525,0.471196108103296,0.673876313750276,8,73,negative regulation of viral process,BP,TNIP1;IFITM1;PARP10;OASL;HMGA2;OAS1;ISG20;APOBEC3C
5017,GO:0015175,0.471198756088904,0.757547330196333,3,24,neutral amino acid transmembrane transporter activity,MF,SERINC2;SLC43A1;SLC6A9
10370,GO:0043174,0.471821875525828,0.799734931632923,2,16,nucleoside salvage,BP,TK2;UCKL1
4949,GO:0014912,0.47187887647682,0.800661275004095,2,15,negative regulation of smooth muscle cell migration,BP,CORO1B;LRP1
11298,GO:0045591,0.472074776200564,0.883851279385744,1,6,positive regulation of regulatory T cell differentiation,BP,TGFB1
8851,GO:0034637,0.47220272140325,0.682764014584203,7,61,cellular carbohydrate biosynthetic process,BP,PCK2;NR1D1;PGM1;AKT1;ISYNA1;B3GNT3;GSK3A
13874,GO:0060457,0.472416492515684,0.883659344098541,1,6,negative regulation of digestive system process,BP,STK39
8813,GO:0034511,0.4726407897946,0.883533249275351,1,6,U3 snoRNA binding,MF,ISG20
11216,GO:0045332,0.472685766708459,0.801173579106245,2,14,phospholipid translocation,BP,ATP11A;ABCA7
10737,GO:0044068,0.472738025659838,0.756277130313484,3,24,modulation by symbiont of host cellular process,BP,TNIP1;BCL2L1;TGFB1
3316,GO:0007021,0.473010095667794,0.88057675598916,1,7,tubulin complex assembly,BP,ARL2
5498,GO:0016433,0.473305370083951,0.883159118051082,1,6,rRNA (adenine) methyltransferase activity,MF,RRNAD1
12727,GO:0050926,0.473471837226204,0.799458777253536,2,15,regulation of positive chemotaxis,BP,PGF;VEGFB
19490,GO:1990144,0.473900144704243,0.882823625383585,1,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,BNIP3
4095,GO:0009148,0.474013965009051,0.797219556634681,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
4784,GO:0010968,0.474046753874321,0.882740832250912,1,6,regulation of microtubule nucleation,BP,EML2
3550,GO:0007586,0.474048717867638,0.70745979896924,5,43,digestion,BP,ADM2;PRSS3;STK39;VDR;SLC5A1
15924,GO:0072677,0.474071334461568,0.882726947398085,1,6,eosinophil migration,BP,ADAM8
17898,GO:1902108,0.474194738559145,0.692217939697491,6,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1
16787,GO:0098563,0.474216090771646,0.798895607315479,2,15,intrinsic component of synaptic vesicle membrane,CC,RAB3B;PTPRS
8264,GO:0033034,0.474371668434639,0.882557211438516,1,6,positive regulation of myeloid cell apoptotic process,BP,ANXA1
1702,GO:0004177,0.474520436904201,0.726948943640893,4,33,aminopeptidase activity,MF,RNPEPL1;MMP14;NPEPL1;BLMH
16483,GO:0097136,0.474595438081751,0.882430642919775,1,6,Bcl-2 family protein complex,CC,BCL2L1
3510,GO:0007422,0.474644031103844,0.692171942257336,6,52,peripheral nervous system development,BP,SH3TC2;SCN8A;AKT1;LAMB2;ADGRB2;ERBB3
13487,GO:0055001,0.475062073094504,0.655897699624834,10,89,muscle cell development,BP,FLNC;NFATC4;SDC1;OBSCN;TMOD2;FAM129B;TNNT1;OBSL1;PAK1;GSK3A
4798,GO:0010988,0.475149081465388,0.882117111359472,1,6,regulation of low-density lipoprotein particle clearance,BP,PCSK9
15925,GO:0072678,0.475150210728168,0.753743403503062,3,25,T cell migration,BP,MSN;ADAM8;ECM1
4866,GO:0014706,0.475372389684252,0.610565011537235,24,219,striated muscle tissue development,BP,NEURL1;MEF2D;FKBP1A;FAM129B;PPP1R13L;TGFBR2;DKK1;OBSL1;PAK1;BCL9L;MYH15;FLNB;ALDH1A2;TAZ;GSK3A;FGFR1;LEMD2;ZFPM1;FGF2;CHD7;RXRA;TGFB1;ERBB3;EP300
8743,GO:0034384,0.475496218716146,0.881920249190368,1,6,high-density lipoprotein particle clearance,BP,APOE
615,GO:0001781,0.475870249055375,0.881707897338511,1,6,neutrophil apoptotic process,BP,ANXA1
14065,GO:0060789,0.47601259985968,0.881627014102291,1,6,hair follicle placode formation,BP,GNAS
11431,GO:0045824,0.47609178260619,0.725235741006249,4,34,negative regulation of innate immune response,BP,SERPING1;FAM3A;ARG1;CEACAM1
8320,GO:0033146,0.47622931156127,0.725467595515802,4,33,regulation of intracellular estrogen receptor signaling pathway,BP,PAK1;SRC;KANK2;WBP2
7082,GO:0030865,0.47687209484984,0.705198590487702,5,42,cortical cytoskeleton organization,BP,DLG1;FMNL2;VPS4A;WIPF1;LLGL1
4496,GO:0010519,0.476910210941908,0.881116167609901,1,6,negative regulation of phospholipase activity,BP,ANXA1
10776,GO:0044212,0.476924187980239,0.576114233081759,66,610,transcription regulatory region DNA binding,MF,ZMYND8;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;SOX7;PPARA;ZNF516;TFE3;PRDX5;TNRC18;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;RAI1;HMGA2;ARID5B;TOP1;IRF7;PER3;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;RCOR1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;ASH2L;EP300;TCF7L1;RNF10
1004,GO:0002475,0.477611477379565,0.880716069808412,1,6,antigen processing and presentation via MHC class Ib,BP,AP3D1
2971,GO:0006511,0.477799278059682,0.58041387660171,54,514,ubiquitin-dependent protein catabolic process,BP,EDEM1;BTBD2;GID4;RBCK1;DVL1;SHARPIN;PSMD2;MTA1;SMURF2;ABTB1;USP20;XBP1;CSNK1E;PANO1;HECW2;AKT1;SYVN1;WWTR1;VPS4A;TMEM129;FBXO2;FBXW5;MVB12B;UBE2J1;ARRDC1;CDC34;ANKIB1;SUFU;DDIT3;CUL7;UBXN4;WFS1;GIPC1;UBR4;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;UBA1;RNF187;VPS37A;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;CBL;USP32;CSNK1D;DNAJB9;RNF103
7903,GO:0032466,0.478042900447267,0.880469493270864,1,6,negative regulation of cytokinesis,BP,VPS4A
3756,GO:0008297,0.478101895090262,0.880435749616367,1,6,single-stranded DNA exodeoxyribonuclease activity,MF,ISG20
2939,GO:0006465,0.478217253350276,0.794866098456705,2,16,signal peptide processing,BP,FURIN;HM13
7894,GO:0032456,0.478524742518863,0.7234722348054,4,33,endocytic recycling,BP,SORL1;EHD3;RAB11FIP4;EHD4
8062,GO:0032720,0.478551089113589,0.750910390203823,3,25,negative regulation of tumor necrosis factor production,BP,ARG2;MC1R;HSF1
14246,GO:0061179,0.479858849493952,0.876599220187268,1,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,MAP4K4
9418,GO:0035970,0.480138476472129,0.794383520309581,2,15,peptidyl-threonine dephosphorylation,BP,DUSP4;PPM1F
1844,GO:0004497,0.480180222235734,0.701989496084944,5,43,monooxygenase activity,MF,NOS1;CYP27B1;MICAL2;MICAL1;NDOR1
8742,GO:0034383,0.480272894930042,0.749470114357845,3,25,low-density lipoprotein particle clearance,BP,AP2A2;PCSK9;LDLRAP1
13488,GO:0055002,0.480282815014043,0.657750063501776,9,80,striated muscle cell development,BP,FLNC;SDC1;OBSCN;TMOD2;FAM129B;TNNT1;OBSL1;PAK1;GSK3A
3800,GO:0008376,0.480500876727936,0.721749322215059,4,33,acetylgalactosaminyltransferase activity,MF,CHPF;B4GALNT4;B3GNT3;GALNT3
8241,GO:0033002,0.480507265789604,0.635160820418896,13,118,muscle cell proliferation,BP,CTNNBIP1;MEF2D;EGFR;AKT1;IRAK1;TGFBR2;PAK1;APLN;TGM2;COMT;FGFR1;FGF2;RXRA
19425,GO:1905898,0.480558567604674,0.721344635014158,4,34,positive regulation of response to endoplasmic reticulum stress,BP,EDEM1;BOK;XBP1;DDIT3
4657,GO:0010799,0.480641753364911,0.721626316762841,4,33,regulation of peptidyl-threonine phosphorylation,BP,DGKQ;CEMIP;TGFB1;SPRED2
14668,GO:0070244,0.480703505681495,0.878941515908284,1,6,negative regulation of thymocyte apoptotic process,BP,RAG1
9729,GO:0038155,0.480828300012908,0.878869536494863,1,6,interleukin-23-mediated signaling pathway,BP,P4HB
3018,GO:0006564,0.48087932367067,0.878840098825287,1,6,L-serine biosynthetic process,BP,PSAT1
5963,GO:0018344,0.480903750463083,0.878826004338539,1,6,protein geranylgeranylation,BP,RABGGTA
4840,GO:0014044,0.48099498928058,0.749408890322707,3,24,Schwann cell development,BP,SH3TC2;AKT1;LAMB2
5717,GO:0016846,0.481018111901791,0.875917597285034,1,7,carbon-sulfur lyase activity,MF,GLO1
3461,GO:0007276,0.481018991284738,0.586236094126801,40,376,gamete generation,BP,ERCC1;NEURL1;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;BBS2;OSBP2;ETV5;MYCBPAP;RFX2;PRKACA;FAM50A;AKT1;PHC2;DEAF1;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;SRC;DNM2;AGO4;PAQR7;PUM1;RAI14;EIF2S2;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;NDRG3;GGT1;CIB1;PAIP2;TGFB1;AZIN2
13964,GO:0060613,0.481118367109408,0.878702122634791,1,6,fat pad development,BP,ARID5B
16565,GO:0097300,0.481123584086856,0.720517847623715,4,35,programmed necrotic cell death,BP,RBCK1;PYGL;BOK;ARHGEF2
1175,GO:0002819,0.481139691446762,0.656749018295077,9,82,regulation of adaptive immune response,BP,PKN1;PRKCZ;GATA3;IRF7;ZP3;ARG1;CEACAM1;TGFB1;ANXA1
5291,GO:0015949,0.481170900997434,0.747758227911366,3,27,nucleobase-containing small molecule interconversion,BP,NME4;GLRX;GUK1
20302,GO:2001236,0.481434733044655,0.634108724544898,13,121,regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;IFI6;ITGA6;G0S2;AKT1;DEDD2;RET;SRC;FYN;FGFR1;BCL2L1;ARHGEF2;TMBIM1
3750,GO:0008290,0.48159903060987,0.878424373167435,1,6,F-actin capping protein complex,CC,CAPG
15158,GO:0071241,0.481635209766335,0.633972074999514,13,120,cellular response to inorganic substance,BP,NFATC4;PRNP;BNIP3;EGFR;ATF4;AKT1;ATP13A2;ENDOG;HSF1;MT2A;DNM2;MAPK9;MAPK3
15737,GO:0072282,0.481695047431627,0.878368840601797,1,6,metanephric nephron tubule morphogenesis,BP,PKD1
5212,GO:0015809,0.481876739459968,0.878263711434672,1,6,arginine transport,BP,ARG1
10027,GO:0042447,0.481881585886994,0.878260906431874,1,6,hormone catabolic process,BP,IDE
14484,GO:0061842,0.482146725255547,0.748443516407872,3,24,microtubule organizing center localization,BP,DLG1;NDE1;FHOD1
20226,GO:2001040,0.482188528338635,0.878083168656281,1,6,positive regulation of cellular response to drug,BP,ENDOG
523,GO:0001614,0.482207162456068,0.878072372957599,1,6,purinergic nucleotide receptor activity,MF,P2RX4
5529,GO:0016502,0.482207162456068,0.878072372957599,1,6,nucleotide receptor activity,MF,P2RX4
15530,GO:0071889,0.482307037085355,0.748309001499914,3,24,14-3-3 protein binding,MF,AKT1;PRKCZ;KIF13B
16246,GO:0090277,0.482364541942139,0.684967912832338,6,53,positive regulation of peptide hormone secretion,BP,PCK2;EGFR;NLGN2;GLUL;APLN;GLUD1
5455,GO:0016324,0.482477061593768,0.613945035232994,19,173,apical plasma membrane,CC,DLG1;SLC9A3R2;SLC2A9;EGFR;PRKCZ;MSN;STK39;CD44;SLC29A4;PODXL;SHANK2;IGFBP2;TCIRG1;CIB1;DRAM2;CEACAM1;ERBB3;ANXA1;GNAS
6373,GO:0021554,0.482488636814657,0.877909224613611,1,6,optic nerve development,BP,EPHB2
3091,GO:0006665,0.48252121371163,0.629143872667806,14,128,sphingolipid metabolic process,BP,SERINC2;ESYT2;ELOVL1;CPTP;SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;VAPB;ARSK;UGCG;B4GALT6;NAGA;ARSD
20039,GO:2000617,0.482649999071295,0.877815631536162,1,6,positive regulation of histone H3-K9 acetylation,BP,GATA3
8195,GO:0032927,0.482662900860954,0.877808146236261,1,6,positive regulation of activin receptor signaling pathway,BP,ACVR2B
16169,GO:0090166,0.482697513115882,0.877788063599092,1,6,Golgi disassembly,BP,STX5
13336,GO:0052173,0.482768390373755,0.877746932636629,1,6,response to defenses of other organism involved in symbiotic interaction,BP,TGFB1
13341,GO:0052200,0.482768390373755,0.877746932636629,1,6,response to host defenses,BP,TGFB1
15970,GO:0075136,0.482768390373755,0.877746932636629,1,6,response to host,BP,TGFB1
12204,GO:0048332,0.482837205416258,0.699861398193814,5,42,mesoderm morphogenesis,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA3
396,GO:0001067,0.482914652891176,0.570199990019828,66,611,regulatory region nucleic acid binding,MF,ZMYND8;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;SOX7;PPARA;ZNF516;TFE3;PRDX5;TNRC18;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;RAI1;HMGA2;ARID5B;TOP1;IRF7;PER3;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;RCOR1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;ASH2L;EP300;TCF7L1;RNF10
8406,GO:0033327,0.483021588837048,0.877599924632607,1,6,Leydig cell differentiation,BP,CCND1
555,GO:0001676,0.483124929341061,0.672430246005677,7,63,long-chain fatty acid metabolic process,BP,ACOT7;ACOT1;ELOVL1;ALOX15B;MGLL;SLC27A1;MAPK3
10260,GO:0042985,0.483153434177443,0.877523329068358,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
13824,GO:0060393,0.483394988539956,0.71886122894064,4,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1;SNX25;PMEPA1;TGFB1
10144,GO:0042693,0.48341526778997,0.877371124049452,1,6,muscle cell fate commitment,BP,DKK1
8000,GO:0032612,0.483818986232722,0.683286998350509,6,55,interleukin-1 production,BP,F2R;HK1;ARG2;CPTP;CEACAM1;ANXA1
18685,GO:1903975,0.483940984375853,0.877065149941996,1,6,regulation of glial cell migration,BP,IDH2
3202,GO:0006837,0.484065333735375,0.876992704105581,1,6,serotonin transport,BP,NOS1
5822,GO:0017085,0.484090559706864,0.791342081635467,2,15,response to insecticide,BP,MAPK13;HSF1
504,GO:0001561,0.484125523665863,0.876957627495572,1,6,fatty acid alpha-oxidation,BP,PHYH
4659,GO:0010801,0.484286076749479,0.791190979834359,2,15,negative regulation of peptidyl-threonine phosphorylation,BP,DGKQ;SPRED2
11931,GO:0046951,0.484373987910402,0.876812761950006,1,6,ketone body biosynthetic process,BP,HMGCL
9794,GO:0039706,0.484467651016565,0.876758123348965,1,6,co-receptor binding,MF,DKK1
7188,GO:0031065,0.484568514473129,0.790972596854459,2,15,positive regulation of histone deacetylation,BP,CTBP1;TGFB1
3269,GO:0006942,0.484726380763675,0.697663327385348,5,44,regulation of striated muscle contraction,BP,NOS1;DLG1;PRKACA;EHD3;P2RX4
5278,GO:0015925,0.48477626718044,0.876577979309057,1,6,galactosidase activity,MF,NAGA
12410,GO:0048820,0.484852000967916,0.7907532768079,2,15,hair follicle maturation,BP,FERMT1;GAL
2665,GO:0006011,0.484886607260775,0.87651353035585,1,6,UDP-glucose metabolic process,BP,GSK3A
12020,GO:0047484,0.484907193282037,0.876501503758474,1,6,regulation of response to osmotic stress,BP,ARHGEF2
17566,GO:1901072,0.484977343952084,0.876460515139984,1,6,glucosamine-containing compound catabolic process,BP,CTBS
11348,GO:0045657,0.485096879116003,0.876390650981156,1,6,positive regulation of monocyte differentiation,BP,CTNNBIP1
7335,GO:0031340,0.485319441792501,0.876260502015433,1,6,positive regulation of vesicle fusion,BP,ANXA1
6392,GO:0021587,0.485341579153388,0.745756163433617,3,24,cerebellum morphogenesis,BP,MAP2K1;WNT7A;SERPINE2
13787,GO:0060343,0.485410462496244,0.790320851712035,2,15,trabecula formation,BP,FKBP1A;THBS3
7982,GO:0032590,0.485475068697916,0.790270794483391,2,15,dendrite membrane,CC,ATF4;KCNC4
4727,GO:0010887,0.485582231069002,0.876106714236137,1,6,negative regulation of cholesterol storage,BP,PPARA
822,GO:0002092,0.485772849543358,0.790039987328389,2,15,positive regulation of receptor internalization,BP,PCSK9;APLN
2101,GO:0004865,0.485813717647359,0.873071916902602,1,7,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
11707,GO:0046477,0.485891300782455,0.875925682637559,1,6,glycosylceramide catabolic process,BP,NAGA
12840,GO:0051126,0.486157277244351,0.875769753625324,1,6,negative regulation of actin nucleation,BP,CORO1B
12719,GO:0050918,0.486169107429648,0.716086780280284,4,35,positive chemotaxis,BP,PGF;MIF;FGF2;VEGFB
12253,GO:0048505,0.486181684043388,0.875755438687331,1,6,regulation of timing of cell differentiation,BP,SERPINE2
18897,GO:1904528,0.486354897370044,0.875653815605694,1,6,positive regulation of microtubule binding,BP,HSF1
6756,GO:0030174,0.486535580924928,0.875547751845617,1,6,regulation of DNA-dependent DNA replication initiation,BP,WDR18
908,GO:0002287,0.486617551354958,0.716027878658106,4,34,alpha-beta T cell activation involved in immune response,BP,PRKCZ;GATA3;ZFPM1;ANXA1
911,GO:0002293,0.486617551354958,0.716027878658106,4,34,alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;GATA3;ZFPM1;ANXA1
912,GO:0002294,0.486617551354958,0.716027878658106,4,34,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;GATA3;ZFPM1;ANXA1
9857,GO:0042093,0.486617551354958,0.716027878658106,4,34,T-helper cell differentiation,BP,PRKCZ;GATA3;ZFPM1;ANXA1
5573,GO:0016584,0.486692079029048,0.872546149521544,1,7,nucleosome positioning,BP,RSF1
14100,GO:0060897,0.486701928127696,0.875450051393886,1,6,neural plate regionalization,BP,FUZ
5109,GO:0015399,0.486924959279585,0.659255568671346,8,73,primary active transmembrane transporter activity,MF,ATP13A2;ATP7B;ABCB8;ATP2C2;TCIRG1;ABCA7;ATP6V1C2;PCYOX1
5110,GO:0015405,0.486924959279585,0.659255568671346,8,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ATP13A2;ATP7B;ABCB8;ATP2C2;TCIRG1;ABCA7;ATP6V1C2;PCYOX1
19098,GO:1904949,0.487045404303063,0.651293832663145,9,81,ATPase complex,CC,SMARCA1;NACC2;SALL2;ABCB8;APPL2;RSF1;ABCA7;TFPT;MBD3
15568,GO:0071971,0.487172842863812,0.875173197521914,1,6,extracellular exosome assembly,BP,SDC1
18486,GO:1903551,0.487172842863812,0.875173197521914,1,6,regulation of extracellular exosome assembly,BP,SDC1
3180,GO:0006801,0.487194382176329,0.714865908303049,4,36,superoxide metabolic process,BP,EGFR;SH3PXD2B;TGFB1;SH3PXD2A
15936,GO:0072698,0.48721013718661,0.695923783474754,5,42,protein localization to microtubule cytoskeleton,BP,DVL1;NUDCD3;TTBK2;ABHD17C;CSNK1D
284,GO:0000786,0.487290082471601,0.676965075359292,6,84,nucleosome,CC,H1F0;HIST2H2BE;H2AFJ;HIST3H2A;HIST2H2AC;HIST1H2AG
11526,GO:0046006,0.487532081616163,0.742847055449899,3,26,regulation of activated T cell proliferation,BP,PRNP;IGFBP2;ARG1
11566,GO:0046085,0.487635132781753,0.87490102253837,1,6,adenosine metabolic process,BP,NT5E
487,GO:0001539,0.487669724754803,0.788566455492817,2,15,cilium or flagellum-dependent cell motility,BP,BBS2;GAS8
13740,GO:0060285,0.487669724754803,0.788566455492817,2,15,cilium-dependent cell motility,BP,BBS2;GAS8
6543,GO:0021952,0.487834674799377,0.788438050498397,2,15,central nervous system projection neuron axonogenesis,BP,ADARB1;EPHB2
15320,GO:0071493,0.487841120228817,0.874779621545218,1,6,cellular response to UV-B,BP,HYAL1
14389,GO:0061614,0.487858522416692,0.715292775127206,4,33,pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA;APLN;TGFB1
16191,GO:0090193,0.487927190238559,0.874728872376586,1,6,positive regulation of glomerulus development,BP,RET
13692,GO:0060198,0.488035621767475,0.8746649190775,1,6,clathrin-sculpted vesicle,CC,VAMP2
14584,GO:0070099,0.488049067329129,0.874656987350606,1,6,regulation of chemokine-mediated signaling pathway,BP,SLIT3
6700,GO:0030091,0.488092473574319,0.871704973809487,1,7,protein repair,BP,MSRB2
9513,GO:0036152,0.488165686154366,0.788180245743653,2,15,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;LPCAT4
16571,GO:0097322,0.488175469342335,0.874582404893931,1,6,7SK snRNA binding,MF,HEXIM1
8049,GO:0032692,0.4882189805851,0.787123702452701,2,16,negative regulation of interleukin-1 production,BP,CPTP;CEACAM1
6676,GO:0030033,0.488354596429976,0.788033037312674,2,15,microvillus assembly,BP,FSCN1;PODXL
1103,GO:0002689,0.488480336790644,0.871471357494339,1,7,negative regulation of leukocyte chemotaxis,BP,MIF
18791,GO:1904251,0.488901052246132,0.874153717970184,1,6,regulation of bile acid metabolic process,BP,NR1D1
7691,GO:0032135,0.488904912746296,0.8741514345552,1,6,DNA insertion or deletion binding,MF,XPC
6714,GO:0030121,0.48907089078279,0.874053235876594,1,6,AP-1 adaptor complex,CC,LDLRAP1
18237,GO:1903003,0.489132728000445,0.874016637865344,1,6,positive regulation of protein deubiquitination,BP,TNIP1
12185,GO:0048290,0.489209563169546,0.873971153686876,1,6,isotype switching to IgA isotypes,BP,TGFB1
18301,GO:1903146,0.489337886767786,0.693496656609495,5,44,regulation of autophagy of mitochondrion,BP,BNIP3;ATP13A2;BNIP3L;ZDHHC8;GSK3A
11646,GO:0046337,0.489408707269967,0.787210584539961,2,15,phosphatidylethanolamine metabolic process,BP,SLC27A1;LPIN3
3031,GO:0006578,0.489419662778228,0.873846725862532,1,6,amino-acid betaine biosynthetic process,BP,ALDH7A1
17844,GO:1901977,0.489497423299084,0.873800653123028,1,6,negative regulation of cell cycle checkpoint,BP,PPP1R10
16095,GO:0090037,0.489497699642577,0.873800489373542,1,6,positive regulation of protein kinase C signaling,BP,MC1R
19444,GO:1905953,0.489538260473953,0.741650448565151,3,25,negative regulation of lipid localization,BP,AKT1;PCSK9;PPARA
11793,GO:0046636,0.489606128607222,0.787056354204339,2,15,negative regulation of alpha-beta T cell activation,BP,ARG2;ANXA1
2321,GO:0005326,0.489669419014877,0.742093554470261,3,24,neurotransmitter transporter activity,MF,SLC6A6;SLC6A9;SLC6A14
11371,GO:0045714,0.489768924907771,0.873639703155826,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
12620,GO:0050777,0.489960897981545,0.648346645372988,9,83,negative regulation of immune response,BP,BCR;SERPING1;ARG2;FAM3A;ARG1;CEACAM1;CD59;TGFB1;ANXA1
3426,GO:0007216,0.48999004122851,0.87350852281474,1,6,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
11427,GO:0045820,0.490125934870405,0.873427857688207,1,6,negative regulation of glycolytic process,BP,PPARA
12894,GO:0051198,0.490125934870405,0.873427857688207,1,6,negative regulation of coenzyme metabolic process,BP,PPARA
10055,GO:0042500,0.49018086369226,0.873395242899548,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,HM13
15671,GO:0072170,0.490247475369657,0.786554892399726,2,15,metanephric tubule development,BP,WWTR1;PKD1
16519,GO:0097197,0.490316207733997,0.873314856865194,1,6,tetraspanin-enriched microdomain,CC,TSPAN33
3456,GO:0007270,0.490395659178942,0.873267651985089,1,6,neuron-neuron synaptic transmission,BP,TMOD2
10026,GO:0042446,0.490625024303716,0.692095313361235,5,45,hormone biosynthetic process,BP,CYP27B1;DGKQ;SRD5A3;HSD11B1;VDR
2986,GO:0006531,0.490711193956519,0.873080067745886,1,6,aspartate metabolic process,BP,ASS1
17101,GO:0099590,0.49112600984611,0.872833183945095,1,6,neurotransmitter receptor internalization,BP,DNM2
5870,GO:0017176,0.491159093688635,0.869850313402855,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGQ
7660,GO:0032075,0.491221857920298,0.784768393053478,2,16,positive regulation of nuclease activity,BP,AKT1;VAPB
18980,GO:1904714,0.49135864023851,0.872694592573916,1,6,regulation of chaperone-mediated autophagy,BP,ATP13A2
13263,GO:0051917,0.491499551018476,0.872610595627007,1,6,regulation of fibrinolysis,BP,F12
13589,GO:0060033,0.491641259703613,0.872526086326566,1,6,anatomical structure regression,BP,LRP5
14002,GO:0060693,0.491813627221845,0.872423243686337,1,6,regulation of branching involved in salivary gland morphogenesis,BP,FGFR1
10976,GO:0044728,0.491895749304937,0.664427239570396,7,62,DNA methylation or demethylation,BP,DNMT3A;FAM129B;BAZ2A;GATA3;MBD3;APOBEC3C;GNAS
13107,GO:0051597,0.491952437530015,0.872340383240551,1,6,response to methylmercury,BP,ARG1
4190,GO:0009266,0.492041521431871,0.604538274066316,19,177,response to temperature stimulus,BP,NOS1;PRKACA;AKT1;IRAK1;BAG3;ZNF516;MYOF;HSF1;ACADVL;THRA;NTSR1;HSF4;STUB1;PCSK1N;SLC27A1;HSPA2;HSPA13;MAPK3;EP300
18386,GO:1903349,0.492083621456932,0.872262042720445,1,6,omegasome membrane,CC,ULK1
7659,GO:0032074,0.492271373465258,0.872149865846955,1,6,negative regulation of nuclease activity,BP,NEIL1
6742,GO:0030157,0.492418605907357,0.872061853041918,1,6,pancreatic juice secretion,BP,STK39
6647,GO:0023035,0.492439876814649,0.872049134395963,1,6,CD40 signaling pathway,BP,SHARPIN
18192,GO:1902930,0.492621675356887,0.675547398342225,6,53,regulation of alcohol biosynthetic process,BP,CYP27B1;APOE;PMVK;VDR;NTSR1;SEC14L2
5651,GO:0016742,0.492664962658823,0.871914496475191,1,6,hydroxymethyl-, formyl- and related transferase activity,MF,ALDH1L2
16198,GO:0090200,0.492814263150777,0.73787333716482,3,27,positive regulation of release of cytochrome c from mitochondria,BP,BNIP3;FAM162A;MOAP1
1592,GO:0004000,0.492854855564382,0.871800837206624,1,6,adenosine deaminase activity,MF,ADARB1
12883,GO:0051185,0.492893153462118,0.871777906181969,1,6,coenzyme transmembrane transporter activity,MF,SLC33A1
8082,GO:0032755,0.493167373616008,0.690018625789339,5,44,positive regulation of interleukin-6 production,BP,F2R;XBP1;MAPK13;IL1RAP;ARHGEF2
9330,GO:0035794,0.493292182633358,0.674570975072331,6,55,positive regulation of mitochondrial membrane permeability,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1
19378,GO:1905710,0.493292182633358,0.674570975072331,6,55,positive regulation of membrane permeability,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1
20144,GO:2000785,0.493383255741254,0.710038102429749,4,34,regulation of autophagosome assembly,BP,TBC1D14;LRSAM1;RAB1B;ULK1
6347,GO:0021520,0.493500077292013,0.871414147776513,1,6,spinal cord motor neuron cell fate specification,BP,SUFU
12680,GO:0050865,0.493695913202278,0.580267683137387,33,312,regulation of cell activation,BP,RAC2;AP3D1;SERPINE2;DLG1;PRNP;CYGB;BCR;XBP1;MMP14;AKT1;CARD11;APOE;ARG2;PKN1;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;STXBP1;PAG1;FYN;GAL;MIF;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1
14535,GO:0070006,0.493953416206641,0.783644467479913,2,15,metalloaminopeptidase activity,MF,RNPEPL1;MMP14
9270,GO:0035672,0.494008496419295,0.871108905614464,1,6,oligopeptide transmembrane transport,BP,SLC15A1
9774,GO:0039529,0.494110928315499,0.783520282629958,2,15,RIG-I signaling pathway,BP,PUM1;SEC14L1
11424,GO:0045814,0.494142021212959,0.63053867739679,11,121,negative regulation of gene expression, epigenetic,BP,DNMT3A;H2AFJ;TNRC18;BAZ2A;PHF1;HIST3H2A;PHF2;HIST2H2AC;BAHCC1;HIST1H2AG;MBD3
15134,GO:0071203,0.494195142736665,0.870996728206874,1,6,WASH complex,CC,SNX27
9205,GO:0035581,0.494234717495985,0.870972934889791,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
15548,GO:0071921,0.494474833181049,0.870828509454024,1,6,cohesin loading,BP,MAU2
319,GO:0000835,0.494513112761928,0.870805475111677,1,6,ER ubiquitin ligase complex,CC,SYVN1
7650,GO:0032056,0.494668344134331,0.870712038494883,1,6,positive regulation of translation in response to stress,BP,IMPACT
1395,GO:0003306,0.494672957277849,0.870709261072765,1,6,Wnt signaling pathway involved in heart development,BP,DKK1
15366,GO:0071578,0.494731514866808,0.870674002121836,1,6,zinc ion import across plasma membrane,BP,SLC30A1
8175,GO:0032905,0.494787041693357,0.870640562216249,1,6,transforming growth factor beta1 production,BP,FURIN
8178,GO:0032908,0.494787041693357,0.870640562216249,1,6,regulation of transforming growth factor beta1 production,BP,FURIN
10305,GO:0043045,0.494823487595363,0.87061861031896,1,6,DNA methylation involved in embryo development,BP,DNMT3A
17701,GO:1901538,0.494823487595363,0.87061861031896,1,6,changes to DNA methylation involved in embryo development,BP,DNMT3A
6065,GO:0019210,0.494870869226472,0.651785051597751,8,73,kinase inhibitor activity,MF,HEXIM1;SOCS2;TRIB3;TRIB2;CIB1;SOCS7;SPRED2;CAMK2N1
2615,GO:0005923,0.494919904652973,0.637111841084032,10,89,bicellular tight junction,CC,CCND1;DLG1;PRKCZ;SYMPK;CYTH3;DLG3;SH3BP1;VASP;ARHGEF2;CLDN12
6821,GO:0030275,0.494977198210216,0.781802734137926,2,16,LRR domain binding,MF,ATF4;DDIT3
15302,GO:0071468,0.495083545177175,0.87046190254991,1,6,cellular response to acidic pH,BP,IMPACT
4580,GO:0010663,0.495253643109922,0.870359335803678,1,6,positive regulation of striated muscle cell apoptotic process,BP,BNIP3
4583,GO:0010666,0.495253643109922,0.870359335803678,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,BNIP3
1190,GO:0002834,0.495375543614993,0.870285798536218,1,6,regulation of response to tumor cell,BP,CEACAM1
1193,GO:0002837,0.495375543614993,0.870285798536218,1,6,regulation of immune response to tumor cell,BP,CEACAM1
2856,GO:0006346,0.495388006266568,0.782511954168009,2,15,methylation-dependent chromatin silencing,BP,DNMT3A;MBD3
3391,GO:0007171,0.495394753469094,0.870274207566273,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,DGKQ
4686,GO:0010832,0.495417947073992,0.870260211931329,1,6,negative regulation of myotube differentiation,BP,XBP1
5217,GO:0015816,0.495485723878244,0.870219307924963,1,6,glycine transport,BP,SLC6A9
4522,GO:0010573,0.495537119366321,0.736524908424689,3,25,vascular endothelial growth factor production,BP,ATF4;HPSE;TGFB1
10058,GO:0042531,0.495746512063222,0.707268602434926,4,36,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;HSF1;FYN;TNFRSF1A
4662,GO:0010807,0.495781406716059,0.870040760789318,1,6,regulation of synaptic vesicle priming,BP,STXBP1
1708,GO:0004198,0.495784006929892,0.781162649175375,2,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN2;CAPN5
15759,GO:0072319,0.496064188947082,0.869869852164487,1,6,vesicle uncoating,BP,VPS4A
4926,GO:0014874,0.496225875425014,0.869772065106522,1,6,response to stimulus involved in regulation of muscle adaptation,BP,MTMR4
15695,GO:0072201,0.496257375319756,0.869753008510478,1,6,negative regulation of mesenchymal cell proliferation,BP,CTNNBIP1
17121,GO:0099638,0.496303214697012,0.869725273622272,1,6,endosome to plasma membrane protein transport,BP,ARHGAP44
17122,GO:0099639,0.496303214697012,0.869725273622272,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,ARHGAP44
17413,GO:1900118,0.496319163231908,0.869715623124276,1,6,negative regulation of execution phase of apoptosis,BP,BCL2L1
15404,GO:0071635,0.496547777710037,0.869577236120993,1,6,negative regulation of transforming growth factor beta production,BP,FURIN
16550,GO:0097264,0.496557224096623,0.869571515860725,1,6,self proteolysis,BP,TENM2
2435,GO:0005623,0.496578467980573,0.547359434245755,1149,11105,cell,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;KCNG1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;SDK2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;SLCO4A1;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;DCBLD2;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;MRC2;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;OSBP2;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;ITGB5;H6PD;XYLT1;HTR7;GPT2;KIAA1549;ADCY7;XBP1;CSMD2;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;EGFR;RTN2;LRP10;CSNK1E;TTYH3;PANO1;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;SLC12A7;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;LMBR1L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;IFITM1;CDS2;BRD3;MDH2;ACOT13;LRP3;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;TMEM92;AP1B1;PEAR1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;SLC20A1;ORAI1;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;CSMD3;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;EPOR;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;DHTKD1;KDELR1;NADK;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;CMIP;TSPAN5;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;SLC29A4;ISYNA1;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;NLGN2;DTD1;UBXN7;TNRC18;RAG1;SEMA4B;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;TBC1D9B;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;SH2D5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GRIN3B;MYH16;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;ALOX15B;IL1RAP;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;FAM155B;SLC6A6;CNFN;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;LY6E;MICAL2;PLCB3;SLC43A1;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;EDNRA;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;TMEM25;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;PAQR7;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;TMPRSS11D;ZNF862;YPEL5;LPAR3;REEP4;WNT5B;SLC6A9;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;TSPAN33;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GJC2;GAL;PUM1;RNF44;ITGA1;FCGRT;SLC13A5;DLGAP4;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;AMIGO2;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;SEMA4G;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;ADIPOR1;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;TMEM185A;SLC6A14;AGPAT4;ULK1;LRP1;ROBO3;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;SLC10A6;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;KCNC4;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;SLC15A1;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;CLDN12;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
9546,GO:0036289,0.496604423410188,0.869542931845155,1,6,peptidyl-serine autophosphorylation,BP,MAP2K2
1479,GO:0003746,0.496612913094154,0.780503949565433,2,16,translation elongation factor activity,MF,ABTB1;GTPBP1
8769,GO:0034433,0.496729137103149,0.866436912198231,1,7,steroid esterification,BP,APOE
8770,GO:0034434,0.496729137103149,0.866436912198231,1,7,sterol esterification,BP,APOE
8771,GO:0034435,0.496729137103149,0.866436912198231,1,7,cholesterol esterification,BP,APOE
10072,GO:0042552,0.496753739865567,0.642100943431655,9,81,myelination,BP,SH3TC2;SCN8A;DLG1;MARVELD1;AKT1;MALL;KLK6;TGFB1;RNF10
11086,GO:0045072,0.496862059117909,0.869386834136304,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
14208,GO:0061087,0.496942027015128,0.869338357699128,1,6,positive regulation of histone H3-K27 methylation,BP,PHF1
13278,GO:0051938,0.497009532047203,0.869297426994752,1,6,L-glutamate import,BP,NTSR1
16846,GO:0098712,0.497009532047203,0.869297426994752,1,6,L-glutamate import across plasma membrane,BP,NTSR1
19760,GO:2000096,0.497082295522089,0.869253298424321,1,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1
13533,GO:0055083,0.497458751071521,0.780871438872951,2,15,monovalent inorganic anion homeostasis,BP,SLC12A7;SLC12A4
8607,GO:0034109,0.49746957754748,0.670874178117273,6,54,homotypic cell-cell adhesion,BP,SERPINE2;PTPRU;STXBP1;MYL9;CEACAM1;GNAS
15188,GO:0071300,0.497557641598498,0.686011174363781,5,44,cellular response to retinoic acid,BP,PTK6;TWF2;RET;ALDH1A2;WNT5B
4447,GO:0010359,0.497582930291756,0.868949413778923,1,6,regulation of anion channel activity,BP,PRNP
19127,GO:1905005,0.497921842605968,0.868743429895324,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
1799,GO:0004430,0.497969757673501,0.868714290863875,1,6,1-phosphatidylinositol 4-kinase activity,MF,PI4K2A
17418,GO:1900125,0.49802957087717,0.86867791011086,1,6,regulation of hyaluronan biosynthetic process,BP,TGFB1
19997,GO:2000535,0.498307023966687,0.868509065069711,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
2545,GO:0005811,0.498579016289993,0.658022507930306,7,63,lipid droplet,CC,PITPNM1;CKAP4;G0S2;LPCAT1;IRAK1;PLIN3;SIGMAR1
5346,GO:0016081,0.498880826170887,0.868159420659665,1,6,synaptic vesicle docking,BP,SNPH
10785,GO:0044224,0.49889290267376,0.868152055287142,1,6,juxtaparanode region of axon,CC,DLG4
12415,GO:0048841,0.498943686166076,0.734158089374796,3,24,regulation of axon extension involved in axon guidance,BP,SEMA3F;SEMA4B;SEMA4G
1534,GO:0003916,0.498997102016872,0.868088493559855,1,6,DNA topoisomerase activity,MF,TOP1
17307,GO:0140035,0.499065927562544,0.86804649877569,1,6,ubiquitination-like modification-dependent protein binding,MF,IDE
17308,GO:0140036,0.499065927562544,0.86804649877569,1,6,ubiquitin-dependent protein binding,MF,IDE
10114,GO:0042622,0.499088840565803,0.868032516156647,1,6,photoreceptor outer segment membrane,CC,GNB1
3254,GO:0006919,0.499285152538563,0.647171123457031,8,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;BOK;DAP;TNFSF15;IFI27;FAM162A;CASP4
8674,GO:0034237,0.499376925906975,0.779345664162268,2,15,protein kinase A regulatory subunit binding,MF,PRKACA;ARFGEF2
8306,GO:0033130,0.499381266522291,0.86785397766009,1,6,acetylcholine receptor binding,MF,DLG4
6377,GO:0021559,0.499408974069654,0.867837052733803,1,6,trigeminal nerve development,BP,SEMA3F
16812,GO:0098631,0.499529504594572,0.704203434715172,4,35,cell adhesion mediator activity,MF,ITGA1;PAK4;BAIAP2L1;ANXA1
3250,GO:0006911,0.499581928156963,0.733040923582109,3,25,phagocytosis, engulfment,BP,RAC2;SH3BP1;ABCA7
16202,GO:0090205,0.49960668550727,0.867716240757349,1,6,positive regulation of cholesterol metabolic process,BP,LDLRAP1
19178,GO:1905153,0.499685439355551,0.867668097717178,1,6,regulation of membrane invagination,BP,ABCA7
16674,GO:0097530,0.499718051471815,0.668273230051022,6,57,granulocyte migration,BP,RAC2;ADAM8;PIP5K1C;ITGA1;MAPK3;ANXA1
3839,GO:0008443,0.499822548882433,0.86758425358987,1,6,phosphofructokinase activity,MF,PFKP
15703,GO:0072210,0.499879576218282,0.73278365006524,3,25,metanephric nephron development,BP,LAMB2;RET;PKD1
5581,GO:0016595,0.499916329199995,0.867526885557176,1,6,glutamate binding,MF,GLUL
13997,GO:0060687,0.500012929812579,0.867467775077535,1,6,regulation of branching involved in prostate gland morphogenesis,BP,RXRA
13408,GO:0052658,0.500015631138415,0.86746612186813,1,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,OCRL
5453,GO:0016322,0.500031094634286,0.867456657964152,1,6,neuron remodeling,BP,ANKS1A
19970,GO:2000465,0.500057644255585,0.867440408141454,1,6,regulation of glycogen (starch) synthase activity,BP,GSK3A
2301,GO:0005272,0.500294780317766,0.77861348400189,2,15,sodium channel activity,MF,SCN8A;ASIC1
14031,GO:0060732,0.500337574142024,0.867268995397971,1,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1
8484,GO:0033623,0.500397759778865,0.867232122073224,1,6,regulation of integrin activation,BP,SRC
7587,GO:0031946,0.500426819189595,0.867214316099668,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
337,GO:0000932,0.500489340478697,0.646353546674175,8,74,P-body,CC,BTBD2;TOP1;AGO4;PUM1;TNRC6B;SAMD4B;CARHSP1;APOBEC3C
6917,GO:0030502,0.500548131875609,0.86713996546888,1,6,negative regulation of bone mineralization,BP,ECM1
13162,GO:0051709,0.500663668560882,0.863990700137611,1,7,regulation of killing of cells of other organism,BP,ARG1
13164,GO:0051712,0.500663668560882,0.863990700137611,1,7,positive regulation of killing of cells of other organism,BP,ARG1
14666,GO:0070242,0.501040077908545,0.776967201222369,2,16,thymocyte apoptotic process,BP,RAG1;ADAM8
4486,GO:0010506,0.501200600637743,0.577667659483944,29,272,regulation of autophagy,BP,QSOX1;BOK;TRIM65;DAP;BNIP3;SESN2;XBP1;FYCO1;PRKACA;AKT1;ATP13A2;TFEB;BNIP3L;ZDHHC8;ATG13;TBC1D14;LRSAM1;RAB1B;CPTP;GSK3A;SPTLC2;TPCN1;ULK1;ULK2;ATP6V1C2;MAPK3;DRAM2;PIK3R2;EP300
19092,GO:1904929,0.501209713938057,0.866734007050954,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,GPC4
16946,GO:0098903,0.501217799119945,0.866729040763473,1,6,regulation of membrane repolarization during action potential,BP,DLG1
1358,GO:0003223,0.50131498228371,0.866669336869196,1,6,ventricular compact myocardium morphogenesis,BP,CHD7
13425,GO:0052742,0.501367081521839,0.703266182204875,4,33,phosphatidylinositol kinase activity,MF,PI4K2A;FGFR1;FGF2;PIK3R2
13266,GO:0051920,0.501494710617168,0.861176313767805,1,8,peroxiredoxin activity,MF,PRDX5
14366,GO:0061549,0.501500686437247,0.866555201341173,1,6,sympathetic ganglion development,BP,SEMA3F
17579,GO:1901098,0.501800829349195,0.866370593814634,1,6,positive regulation of autophagosome maturation,BP,FYCO1
17652,GO:1901339,0.502235380458422,0.866103016610452,1,6,regulation of store-operated calcium channel activity,BP,STIM1
1998,GO:0004716,0.502345205865999,0.86603533482177,1,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR
5528,GO:0016500,0.502484765151406,0.865949296302199,1,6,protein-hormone receptor activity,MF,ADIPOR1
6125,GO:0019370,0.502592050596523,0.862781072438387,1,7,leukotriene biosynthetic process,BP,GGT1
602,GO:0001767,0.502697441346057,0.865818110634748,1,6,establishment of lymphocyte polarity,BP,SNX27
6063,GO:0019208,0.50279029962488,0.644282674476425,8,73,phosphatase regulator activity,MF,SBF1;PPP2R3B;PPP1R35;PPP2R5B;PPP1R12C;PPP1R14A;PPP1R37;PPP1R10
12673,GO:0050858,0.503024214492416,0.775371891945272,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP;CEACAM1
16079,GO:0089717,0.503032800912135,0.865611076844583,1,6,spanning component of membrane,CC,NLGN2
13705,GO:0060219,0.503044977839304,0.865603555450892,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
11319,GO:0045622,0.503195095233222,0.775234201140528,2,16,regulation of T-helper cell differentiation,BP,PRKCZ;ANXA1
443,GO:0001191,0.503227455644651,0.700875550666753,4,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;SIN3B;CTBP1;RERE
18489,GO:1903556,0.503239822162336,0.729346729930047,3,26,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ARG2;MC1R;HSF1
18190,GO:1902915,0.503269536284529,0.86546480102382,1,6,negative regulation of protein polyubiquitination,BP,PARP10
10478,GO:0043331,0.50327137335968,0.643825102684743,8,73,response to dsRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;MAPK3;TGFB1
18962,GO:1904683,0.503339221150763,0.86542172349893,1,6,regulation of metalloendopeptidase activity,BP,SORL1
4520,GO:0010571,0.503431995885862,0.865364358167728,1,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1
8961,GO:0035014,0.503732315659269,0.865178550341068,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2
10237,GO:0042908,0.503806923504521,0.865132364093366,1,6,xenobiotic transport,BP,SLC6A6
10238,GO:0042910,0.503806923504521,0.865132364093366,1,6,xenobiotic transmembrane transporter activity,MF,SLC6A6
15379,GO:0071599,0.503945477821673,0.865046563678422,1,6,otic vesicle development,BP,GATA3
6467,GO:0021785,0.50394682721824,0.865045727881022,1,6,branchiomotor neuron axon guidance,BP,SEMA3F
753,GO:0001990,0.503986551966092,0.77459585232333,2,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;CTSZ
13136,GO:0051653,0.503992132989001,0.700532733834772,4,34,spindle localization,BP,SPIRE1;NDE1;ARHGEF2;LLGL1
9164,GO:0035510,0.504211341099071,0.728500526098055,3,26,DNA dealkylation,BP,GATA3;MPG;APOBEC3C
8193,GO:0032925,0.504475119737271,0.774201292482948,2,16,regulation of activin receptor signaling pathway,BP,FKBP1A;ACVR2B
3060,GO:0006623,0.504509053019079,0.700066030049873,4,34,protein targeting to vacuole,BP,SORL1;AP3D1;VPS4A;HGS
9481,GO:0036092,0.504915561353816,0.700069662697213,4,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR1;FGF2;OCRL;PIK3R2
14269,GO:0061299,0.50497750136581,0.864406337226234,1,6,retina vasculature morphogenesis in camera-type eye,BP,LRP5
3442,GO:0007253,0.505175395769024,0.861149503312169,1,7,cytoplasmic sequestering of NF-kappaB,BP,TMSB4X
11689,GO:0046456,0.50521643570458,0.727139304224395,3,27,icosanoid biosynthetic process,BP,MIF;GGT1;ANXA1
15727,GO:0072257,0.505316371785658,0.864195676159905,1,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
15751,GO:0072307,0.505316371785658,0.864195676159905,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
11496,GO:0045939,0.505470343785196,0.773396368888711,2,16,negative regulation of steroid metabolic process,BP,CYP27B1;APOE
7261,GO:0031223,0.505487805051036,0.864089020703963,1,6,auditory behavior,BP,SHANK3
2225,GO:0005125,0.505495234535962,0.64106143116737,8,79,cytokine activity,MF,WNT7A;CMTM4;CMTM7;TNFSF15;TIMP1;MIF;FGF2;TGFB1
1100,GO:0002686,0.505534211432786,0.772414361109717,2,17,negative regulation of leukocyte migration,BP,BCR;MIF
4398,GO:0010092,0.505660752964754,0.773242185564249,2,16,specification of animal organ identity,BP,DKK1;FGFR1
9848,GO:0042074,0.50570298781474,0.863955068127411,1,6,cell migration involved in gastrulation,BP,LRP5
19653,GO:1990776,0.505714126288765,0.773198956105382,2,16,response to angiotensin,BP,HSF1;SRC
14262,GO:0061217,0.505729117394306,0.773186813301405,2,16,regulation of mesonephros development,BP,GATA3;TGFB1
13668,GO:0060155,0.506045575356098,0.860597048502371,1,7,platelet dense granule organization,BP,F2R
3087,GO:0006661,0.506285980801409,0.610277006053288,13,119,phosphatidylinositol biosynthetic process,BP,PITPNM1;SBF1;PI4K2A;PIGQ;PIP5K1C;FGFR1;MTMR4;PITPNM2;SLC27A1;ZP3;FGF2;OCRL;PIK3R2
16857,GO:0098739,0.506532247528491,0.678004370148125,5,43,import across plasma membrane,BP,PRNP;FAM155B;FYN;NTSR1;SLC30A1
1178,GO:0002822,0.506654042052916,0.6404860894046,8,74,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PKN1;PRKCZ;GATA3;ZP3;ARG1;CEACAM1;TGFB1;ANXA1
3686,GO:0008191,0.506735479436536,0.860158013559871,1,7,metalloendopeptidase inhibitor activity,MF,TIMP1
4821,GO:0014013,0.506857971595358,0.650209637848579,7,63,regulation of gliogenesis,BP,SERPINE2;IDH2;ETV5;BIN1;GJC2;SLC45A3;RNF10
3515,GO:0007440,0.506880181827987,0.863220703056799,1,6,foregut morphogenesis,BP,ACVR2B
14904,GO:0070679,0.506942053064254,0.863182033330951,1,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3
4559,GO:0010638,0.506970646516085,0.551556272905701,54,515,positive regulation of organelle organization,BP,ERCC1;NOS1;RAC2;SDC1;BOK;DLG1;RAPGEF3;BNIP3;LRP5;FYCO1;CORO1B;ARPC1A;VPS11;EPHA1;SH3PXD2B;MSN;LIMK1;ZDHHC8;ATG13;SURF4;FSCN1;PAK1;GATA3;PHF1;CTBP1;ARL2;SRC;FAM162A;LRSAM1;GSK3A;FUZ;PPM1F;PFN1;MOAP1;ARFIP2;ULK1;SPIRE1;MAPK9;VASP;LMAN1;TGFA;BAIAP2L1;WIPF1;WRAP73;MAPK3;UGCG;TGFB1;WBP2;ANXA1;PPP1R10;PXN;ARHGEF10L;ASAP1;FHOD1
1159,GO:0002764,0.507673772368325,0.562434058797335,37,355,immune response-regulating signaling pathway,BP,TNIP1;RBCK1;SHC1;NR1D1;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;ARPC1A;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;SRC;IRF7;PAG1;FYN;PSMD7;PUM1;FCGRT;CTSL;MAPK9;SEC14L1;WIPF1;MAPK3;MAPK10;CEACAM1;SKAP2;PIK3R2;EP300
14631,GO:0070181,0.50779750968035,0.857129177040526,1,8,small ribosomal subunit rRNA binding,MF,MRPS6
366,GO:0000987,0.507922702758092,0.567409697929281,32,297,proximal promoter sequence-specific DNA binding,MF,NFATC4;ETV4;MEF2D;NR1D1;NACC2;RFX2;ATF4;ELK3;POU2F2;TFEB;CREB3L2;PPARA;ZNF516;TFE3;DDIT3;HLTF;GATA3;TCFL5;HSF1;HMGA2;ZNF692;VDR;EHF;HSF4;USF2;HES2;ZFPM1;CHD7;RXRA;LITAF;MBD3;EP300
475,GO:0001518,0.508057670932601,0.862483518790485,1,6,voltage-gated sodium channel complex,CC,SCN8A
1118,GO:0002704,0.508163453405744,0.725044616465511,3,26,negative regulation of leukocyte mediated immunity,BP,BCR;ARG1;CEACAM1
9074,GO:0035304,0.508233970519757,0.618081908241582,11,102,regulation of protein dephosphorylation,BP,FKBP1A;PPP2R3B;PPP1R35;PPP2R5B;SYMPK;PPP1R14A;ITGA1;TGFB1;PPP6R1;PPP1R37;PPP1R10
18709,GO:1904029,0.508249028073242,0.638849842249485,8,75,regulation of cyclin-dependent protein kinase activity,BP,CCND1;EGFR;AKT1;CCND2;PKD1;SRC;HEXIM1;CAMK2N1
7120,GO:0030915,0.508385367744911,0.859104360232185,1,7,Smc5-Smc6 complex,CC,NSMCE4A
17232,GO:0106068,0.508385367744911,0.859104360232185,1,7,SUMO ligase complex,CC,NSMCE4A
18543,GO:1903689,0.508454385525919,0.862234554989318,1,6,regulation of wound healing, spreading of epidermal cells,BP,RREB1
16653,GO:0097493,0.508456220313445,0.862233402848735,1,6,structural molecule activity conferring elasticity,MF,OBSL1
2503,GO:0005751,0.508460606490013,0.85343232165365,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
9911,GO:0042220,0.508577580102181,0.725211014430386,3,25,response to cocaine,BP,DNMT3A;DNM2;HOMER2
7752,GO:0032261,0.508889793525985,0.858781176034571,1,7,purine nucleotide salvage,BP,AMPD2
473,GO:0001516,0.508975765027652,0.769609776765697,2,17,prostaglandin biosynthetic process,BP,MIF;ANXA1
11690,GO:0046457,0.508975765027652,0.769609776765697,2,17,prostanoid biosynthetic process,BP,MIF;ANXA1
11903,GO:0046902,0.509005929876941,0.64775312559883,7,66,regulation of mitochondrial membrane permeability,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1;BCL2L1
14431,GO:0061702,0.509210612153329,0.858575372783339,1,7,inflammasome complex,CC,CASP4
3591,GO:0008017,0.510014596148403,0.578404115854881,23,213,microtubule binding,MF,CLIP2;PRNP;MARK4;EML2;MAP1B;CCDC88C;TTBK2;GAS2L1;MYH15;DNM2;REEP4;KIF17;KIF13B;MAP1LC3B;VAPB;MYO1D;NDE1;CAMSAP3;GAS8;KIFC3;ARHGEF2;MAP6;STIM1
6573,GO:0022029,0.510161676429146,0.694940863756484,4,34,telencephalon cell migration,BP,EGFR;LAMB1;MBOAT7;SOCS7
8663,GO:0034204,0.510181442791733,0.770640454394663,2,15,lipid translocation,BP,ATP11A;ABCA7
4204,GO:0009311,0.510658226501699,0.658532429673481,6,54,oligosaccharide metabolic process,BP,CTBS;ST3GAL3;ST3GAL5;ST6GALNAC2;GALNT3;NAGA
3773,GO:0008327,0.510732483246362,0.769113664108575,2,16,methyl-CpG binding,MF,ZBTB4;MBD3
4247,GO:0009445,0.510835022513167,0.857530266189553,1,7,putrescine metabolic process,BP,AZIN2
6236,GO:0019784,0.510942511930315,0.857460929692631,1,7,NEDD8-specific protease activity,MF,OTUB2
5385,GO:0016202,0.511042919928419,0.628423245453367,9,81,regulation of striated muscle tissue development,BP,FAM129B;TGFBR2;DKK1;PAK1;GSK3A;FGFR1;FGF2;TGFB1;ERBB3
17814,GO:1901861,0.511042919928419,0.628423245453367,9,81,regulation of muscle tissue development,BP,FAM129B;TGFBR2;DKK1;PAK1;GSK3A;FGFR1;FGF2;TGFB1;ERBB3
11313,GO:0045616,0.511507794732581,0.693362386552484,4,35,regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B;VDR;CTSL
7075,GO:0030857,0.511580124043546,0.722572367658667,3,25,negative regulation of epithelial cell differentiation,BP,XDH;CCND1;GSK3A
10143,GO:0042692,0.511929233762664,0.578407771878525,22,205,muscle cell differentiation,BP,FLNC;NOS1;CAPN2;NFATC4;SDC1;OBSCN;TMOD2;FAM129B;TNNT1;XBP1;MMP14;AKT1;DKK1;OBSL1;BIN1;PAK1;MYOF;GSK3A;THRA;RXRA;CAMK1;TGFB1
18712,GO:1904035,0.51196804992164,0.672705335141312,5,44,regulation of epithelial cell apoptotic process,BP,ANGPTL4;BOK;GATA3;WFS1;PAK4
16567,GO:0097306,0.512771579729062,0.672211375428038,5,43,cellular response to alcohol,BP,DNMT3A;ADCY7;AKT1;GNB1;ADCY6
10071,GO:0042551,0.51288692088844,0.721419988515346,3,25,neuron maturation,BP,RET;ANKS1A;AGRN
8018,GO:0032642,0.512959025056272,0.671307660317916,5,46,regulation of chemokine production,BP,POSTN;ARG2;ALOX15B;MIF;ZFPM1
15706,GO:0072215,0.512982425449551,0.767268704832051,2,16,regulation of metanephros development,BP,WWTR1;RET
12155,GO:0048240,0.513383066269884,0.855880594540945,1,7,sperm capacitation,BP,PRKACA
1108,GO:0002694,0.513432651398738,0.564214509312566,30,286,regulation of leukocyte activation,BP,RAC2;AP3D1;DLG1;PRNP;BCR;XBP1;MMP14;AKT1;CARD11;ARG2;PKN1;PRKCZ;TGFBR2;PAK1;RAG1;GATA3;ADAM8;IGFBP2;SRC;STXBP1;PAG1;FYN;GAL;MIF;ZP3;PNP;ARG1;CEACAM1;TGFB1;ANXA1
15845,GO:0072529,0.513460802333665,0.719885378992252,3,27,pyrimidine-containing compound catabolic process,BP,NT5E;NEIL1;APOBEC3C
7344,GO:0031349,0.513492064016583,0.56284196541185,31,302,positive regulation of defense response,BP,TNIP1;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;EGFR;PRKACA;CARD11;IRAK1;MAPK13;PRKACB;PAK1;ADAM8;SRC;TGM2;IRF7;LRSAM1;FYN;PSMD7;TNFRSF1A;PUM1;CTSL;HEXIM1;F12;ZP3;ARG1;SEC14L1;MAPK3;TGFB1;EP300
3582,GO:0007631,0.51380103479471,0.690934155272268,4,36,feeding behavior,BP,ADM2;APLN;FYN;GAL
3871,GO:0008494,0.513831977100615,0.855588646821184,1,7,translation activator activity,MF,MIF4GD
2791,GO:0006228,0.513919208545075,0.853124483690315,1,8,UTP biosynthetic process,BP,NME4
7230,GO:0031119,0.514038253125665,0.855454363854319,1,7,tRNA pseudouridine synthesis,BP,RPUSD3
6288,GO:0019894,0.514087667893383,0.691357764943951,4,34,kinesin binding,MF,KLC2;TTBK2;RAB29;CLSTN1
678,GO:0001885,0.514264428304191,0.670563314281397,5,44,endothelial cell development,BP,WNT7A;RAPGEF3;PTPRS;MSN;TNFRSF1A
17561,GO:1901033,0.514822053899137,0.854943361054341,1,7,positive regulation of response to reactive oxygen species,BP,ENDOG
18249,GO:1903020,0.515141544973767,0.765490410974551,2,16,positive regulation of glycoprotein metabolic process,BP,RAB1B;POMT1
6970,GO:0030619,0.515260409708724,0.854657048323583,1,7,U1 snRNA binding,MF,ISG20
1526,GO:0003887,0.515409399361069,0.718651533074735,3,26,DNA-directed DNA polymerase activity,MF,POLD4;PRIMPOL;POLM
1476,GO:0003730,0.51546648492194,0.65398791915533,6,54,mRNA 3'-UTR binding,MF,ZNF385A;PCBP4;PUM1;SECISBP2L;CARHSP1;IGF2BP3
8024,GO:0032651,0.515651665104306,0.689236940185341,4,36,regulation of interleukin-1 beta production,BP,F2R;HK1;ARG2;CPTP
19428,GO:1905906,0.51567120530022,0.854388394651872,1,7,regulation of amyloid fibril formation,BP,APOE
8075,GO:0032740,0.515708134335691,0.854364227438675,1,7,positive regulation of interleukin-17 production,BP,TGFB1
785,GO:0002040,0.515864446189624,0.631892663983626,8,72,sprouting angiogenesis,BP,PGF;EPN1;EPN2;FGF2;CIB1;SRPX2;CEACAM1;ANXA1
2131,GO:0004930,0.515910914457943,0.596520234654421,14,133,G-protein coupled receptor activity,MF,F2R;ADGRL1;ADGRF1;HTR7;FZD8;MC1R;ADGRB2;GPRC5C;EDNRA;LPAR3;GAL;NTSR1;SIGMAR1;TM2D1
3114,GO:0006692,0.516317881635108,0.717349251175677,3,27,prostanoid metabolic process,BP,TNFRSF1A;MIF;ANXA1
3115,GO:0006693,0.516317881635108,0.717349251175677,3,27,prostaglandin metabolic process,BP,TNFRSF1A;MIF;ANXA1
18367,GO:1903305,0.516489567837651,0.631170116602114,8,73,regulation of regulated secretory pathway,BP,RAC2;BCR;SEPT5;SYTL1;STXBP1;MICAL1;ZP3;CEACAM1
4377,GO:0010001,0.51666946597743,0.595873540925786,14,131,glial cell differentiation,BP,SH3TC2;MAP2K1;BOK;SERPINE2;BNIP3;EGFR;AKT1;LAMB2;BIN1;LRP1;MAPK3;TGFB1;ERBB3;SLC45A3
3583,GO:0007632,0.516970362658724,0.688359112930961,4,35,visual behavior,BP,DEAF1;RAG1;DYNLRB1;B4GALT2
12159,GO:0048246,0.517178092544881,0.76200189663056,2,18,macrophage chemotaxis,BP,MIF;MAPK3
3559,GO:0007601,0.517258296125148,0.622316794159092,9,82,visual perception,BP,BBS2;RABGGTA;EML2;LAMB2;WFS1;REEP6;HSF4;KIFC3;DRAM2
12736,GO:0050953,0.517258296125148,0.622316794159092,9,82,sensory perception of light stimulus,BP,BBS2;RABGGTA;EML2;LAMB2;WFS1;REEP6;HSF4;KIFC3;DRAM2
15224,GO:0071353,0.517258830007083,0.717007925046851,3,26,cellular response to interleukin-4,BP,XBP1;GATA3;ARG1
7981,GO:0032589,0.517281069020967,0.717527388988613,3,25,neuron projection membrane,CC,ATF4;MYO1D;KCNC4
17557,GO:1901029,0.517395012951917,0.853257438061037,1,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
3057,GO:0006620,0.517489018083464,0.853195594991177,1,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,SEC63
10644,GO:0043632,0.518171393462689,0.539847487682158,55,531,modification-dependent macromolecule catabolic process,BP,EDEM1;BTBD2;GID4;RBCK1;DVL1;SHARPIN;PSMD2;MTA1;SMURF2;ABTB1;USP20;XBP1;CSNK1E;PANO1;HECW2;AKT1;SYVN1;WWTR1;VPS4A;TMEM129;FBXO2;FBXW5;MVB12B;UBE2J1;ARRDC1;CDC34;ANKIB1;SUFU;DDIT3;CUL7;UBXN4;WFS1;GIPC1;UBR4;GSK3A;RMND5A;PSMD7;FBXL15;RNF44;UBA1;RNF187;VPS37A;STUB1;TRIB3;RMND5B;RAD23A;TRIB2;RNF222;SPSB3;CBL;USP32;CSNK1D;DNAJB9;RNF103;PCYOX1
11798,GO:0046641,0.518458953083085,0.85255648702084,1,7,positive regulation of alpha-beta T cell proliferation,BP,TGFBR2
2613,GO:0005921,0.518549870039961,0.762667615668919,2,16,gap junction,CC,SPECC1L;GJC2
8369,GO:0033240,0.518877732724981,0.852279971265269,1,7,positive regulation of cellular amine metabolic process,BP,COMT
10838,GO:0044322,0.518946932888991,0.715503461195397,3,26,endoplasmic reticulum quality control compartment,CC,EDEM1;SYVN1;RNF103
330,GO:0000920,0.518986128185221,0.761342030996479,2,17,cell separation after cytokinesis,BP,VPS4A;CHMP5
72,GO:0000149,0.519907488822624,0.612667721912443,10,93,SNARE binding,MF,SNPH;VPS11;SYTL1;VAMP2;STX5;STXBP1;STX10;SEC24C;SNAP29;LLGL1
1931,GO:0004622,0.52012685782423,0.761355044272635,2,16,lysophospholipase activity,MF,MGLL;PNPLA6
5552,GO:0016554,0.520340045289174,0.851311699855854,1,7,cytidine to uridine editing,BP,APOBEC3C
659,GO:0001848,0.521275566303344,0.850690019193857,1,7,complement binding,MF,CD59
16413,GO:0097011,0.521399356837635,0.850607626507251,1,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,AKT1
16414,GO:0097012,0.521399356837635,0.850607626507251,1,7,response to granulocyte macrophage colony-stimulating factor,BP,AKT1
1183,GO:0002827,0.521454306063363,0.850571043554319,1,7,positive regulation of T-helper 1 type immune response,BP,ANXA1
2836,GO:0006305,0.521531647221406,0.663745033432592,5,44,DNA alkylation,BP,DNMT3A;FAM129B;BAZ2A;MBD3;GNAS
2837,GO:0006306,0.521531647221406,0.663745033432592,5,44,DNA methylation,BP,DNMT3A;FAM129B;BAZ2A;MBD3;GNAS
6190,GO:0019626,0.521831440495247,0.850319800675936,1,7,short-chain fatty acid catabolic process,BP,PCK2
19221,GO:1905276,0.521979555057762,0.759807718808253,2,16,regulation of epithelial tube formation,BP,DVL1;GATA3
15303,GO:0071470,0.521981514103613,0.712788815594294,3,26,cellular response to osmotic stress,BP,SERPINB6;STK39;ARHGEF2
12935,GO:0051262,0.52200469602642,0.60367336570817,11,118,protein tetramerization,BP,CRTC1;ACOT13;IDE;HMGCL;OXA1L;CBR4;GPX3;VASP;RXRA;HM13;CAT
10516,GO:0043409,0.522119777094952,0.590511449776497,14,131,negative regulation of MAPK cascade,BP,TNIP1;SORL1;DLG1;FBLN1;AKT1;APOE;DUSP4;DUSP6;LEMD2;EPHB2;AIDA;SPRED2;PIK3R2;CAMK2N1
11219,GO:0045335,0.52234744577244,0.604120003329138,11,105,phagocytic vesicle,CC,RAC2;RAB43;RAB31;ITGB5;ADAM8;FLNB;DNM2;STXBP1;ANXA3;TCIRG1;OCRL
3440,GO:0007250,0.522368476077474,0.759482176886454,2,16,activation of NF-kappaB-inducing kinase activity,BP,IRAK1;TNFSF15
4802,GO:0010992,0.522442749908126,0.849911951200181,1,7,ubiquitin recycling,BP,IDE
5868,GO:0017169,0.522537991853322,0.849848341220558,1,7,CDP-alcohol phosphatidyltransferase activity,MF,PTDSS2
16288,GO:0090330,0.522613234636665,0.75927717536028,2,16,regulation of platelet aggregation,BP,SERPINE2;CEACAM1
10809,GO:0044275,0.522854054059515,0.682928193694811,4,35,cellular carbohydrate catabolic process,BP,PYGB;PYGL;PGM1;GSK3A
591,GO:0001750,0.52309090001424,0.682708659439465,4,35,photoreceptor outer segment,CC,MAP1B;GNB1;SHANK2;OCRL
7657,GO:0032071,0.523131054279289,0.849451840695395,1,7,regulation of endodeoxyribonuclease activity,BP,AKT1
5406,GO:0016241,0.52321515729905,0.58229934876658,16,151,regulation of macroautophagy,BP,QSOX1;BNIP3;SESN2;FYCO1;PRKACA;AKT1;ATP13A2;BNIP3L;ATG13;TBC1D14;LRSAM1;RAB1B;SPTLC2;ULK1;ATP6V1C2;MAPK3
7567,GO:0031904,0.523236011477598,0.757781952308448,2,17,endosome lumen,CC,CTSB;CTSL
2642,GO:0005977,0.523270890253,0.646560012959344,6,54,glycogen metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;GSK3A
14278,GO:0061311,0.52327403226802,0.758723214871267,2,16,cell surface receptor signaling pathway involved in heart development,BP,DKK1;TGFB1
10168,GO:0042742,0.523367367280577,0.615332839700895,9,94,defense response to bacterium,BP,SHC1;ARG2;HIST2H2BE;GSDMA;MAPKBP1;TNFRSF1A;ANXA3;RNASE7;GSDMC
19805,GO:2000181,0.523470917812299,0.634331067878671,7,63,negative regulation of blood vessel morphogenesis,BP,XDH;FAM129B;THBS2;EPN1;EPN2;ADGRB2;HGS
7163,GO:0031018,0.523803841373273,0.711152311655799,3,26,endocrine pancreas development,BP,AKT1;GSK3A;ANXA1
8162,GO:0032885,0.523998040428012,0.71152411904458,3,25,regulation of polysaccharide biosynthetic process,BP,AKT1;GSK3A;TGFB1
1707,GO:0004197,0.524020767007204,0.623655537630101,8,75,cysteine-type endopeptidase activity,MF,CAPN2;CTSB;USP20;CTSZ;BLMH;CAPN5;CTSL;CASP4
2541,GO:0005797,0.524087844510188,0.848810683120789,1,7,Golgi medial cisterna,CC,YIPF2
12677,GO:0050862,0.524096328464385,0.848804989721217,1,7,positive regulation of T cell receptor signaling pathway,BP,RAB29
9900,GO:0042169,0.524114463783092,0.711419498604654,3,25,SH2 domain binding,MF,SH3PXD2B;SRC;PAG1
4159,GO:0009220,0.524300397610258,0.756024862749041,2,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4;UCKL1
11593,GO:0046132,0.524300397610258,0.756024862749041,2,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4;UCKL1
14614,GO:0070160,0.524331575145502,0.608516460404166,10,91,occluding junction,CC,CCND1;DLG1;PRKCZ;SYMPK;CYTH3;DLG3;SH3BP1;VASP;ARHGEF2;CLDN12
9550,GO:0036294,0.524873351490003,0.580388932514945,16,158,cellular response to decreased oxygen levels,BP,DNMT3A;PSMD2;BNIP3;P4HB;AKT1;IRAK1;ENDOG;BNIP3L;GNB1;ADAM8;SRC;FAM162A;PSMD7;STUB1;CBL;EP300
2246,GO:0005154,0.525516401949966,0.709610056913712,3,26,epidermal growth factor receptor binding,MF,SHC1;TGFA;CBL
360,GO:0000978,0.525611942530981,0.55095148420854,31,290,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;ETV4;MEF2D;NR1D1;NACC2;RFX2;ATF4;ELK3;POU2F2;TFEB;CREB3L2;PPARA;TFE3;DDIT3;HLTF;GATA3;TCFL5;HSF1;HMGA2;ZNF692;VDR;EHF;HSF4;USF2;HES2;ZFPM1;CHD7;RXRA;LITAF;MBD3;EP300
6366,GO:0021544,0.525788831162426,0.756608339062164,2,16,subpallium development,BP,BBS2;SHANK3
16613,GO:0097413,0.525931463552042,0.847570077821164,1,7,Lewy body,CC,ATF4
1713,GO:0004301,0.525936234217041,0.847566858702766,1,7,epoxide hydrolase activity,MF,AKR7A2
382,GO:0001016,0.526473037542556,0.847204345124256,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
12618,GO:0050775,0.526550151539274,0.709226286907993,3,25,positive regulation of dendrite morphogenesis,BP,FBXW8;OBSL1;CUL7
10380,GO:0043186,0.526637067470951,0.847093456855899,1,7,P granule,CC,CARHSP1
11270,GO:0045495,0.526637067470951,0.847093456855899,1,7,pole plasm,CC,CARHSP1
13745,GO:0060293,0.526637067470951,0.847093456855899,1,7,germ plasm,CC,CARHSP1
12312,GO:0048634,0.526653452868235,0.613175553834106,9,82,regulation of muscle organ development,BP,FAM129B;TGFBR2;DKK1;PAK1;GSK3A;FGFR1;FGF2;TGFB1;ERBB3
4890,GO:0014808,0.526731168753522,0.754831544204672,2,17,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,PRKACA;CHD7
18458,GO:1903514,0.526731168753522,0.754831544204672,2,17,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,PRKACA;CHD7
9776,GO:0039531,0.526739693512819,0.755805932906367,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,PUM1;SEC14L1
10987,GO:0044769,0.526784813679637,0.753920073389992,2,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,TCIRG1;ATP6V1C2
11934,GO:0046961,0.526784813679637,0.753920073389992,2,18,proton-transporting ATPase activity, rotational mechanism,MF,TCIRG1;ATP6V1C2
15395,GO:0071621,0.526906897390821,0.657532578458907,5,49,granulocyte chemotaxis,BP,RAC2;PIP5K1C;ITGA1;MAPK3;ANXA1
996,GO:0002455,0.52703808948238,0.754571483077293,2,17,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;ZP3
7193,GO:0031076,0.527155826110664,0.70867958684997,3,25,embryonic camera-type eye development,BP,PPP1R13L;TULP3;ALDH1A2
16347,GO:0090543,0.527301598011746,0.707997918744499,3,26,Flemming body,CC,VPS4A;CAPG;EXOC2
69,GO:0000145,0.527322870587216,0.755313055837802,2,16,exocyst,CC,EXOC2;SH3BP1
9073,GO:0035303,0.527389480712077,0.575148346046367,17,159,regulation of dephosphorylation,BP,FKBP1A;PPP2R3B;PPP1R35;PPP2R5B;SYMPK;PPP1R12C;FARP1;DLG3;PPP1R14A;ITGA1;MTMR4;MYO1D;CAMSAP3;TGFB1;PPP6R1;PPP1R37;PPP1R10
4750,GO:0010918,0.527406707035278,0.846572437416472,1,7,positive regulation of mitochondrial membrane potential,BP,AKT1
6395,GO:0021591,0.52741779716155,0.75424952918581,2,17,ventricular system development,BP,NUMB;MBOAT7
16616,GO:0097421,0.527543993043707,0.707272089025608,3,27,liver regeneration,BP,CCND1;EGFR;TGFB1
3458,GO:0007272,0.527676985385928,0.612074623101658,9,83,ensheathment of neurons,BP,SH3TC2;SCN8A;DLG1;MARVELD1;AKT1;MALL;KLK6;TGFB1;RNF10
3796,GO:0008366,0.527676985385928,0.612074623101658,9,83,axon ensheathment,BP,SH3TC2;SCN8A;DLG1;MARVELD1;AKT1;MALL;KLK6;TGFB1;RNF10
5208,GO:0015804,0.5277106552385,0.707627871910729,3,26,neutral amino acid transport,BP,SERINC2;SLC43A1;SLC6A9
11257,GO:0045428,0.527740357850653,0.678044419215993,4,36,regulation of nitric oxide biosynthetic process,BP,AKT1;ASS1;DNM2;P2RX4
10444,GO:0043280,0.527744470356437,0.598555435851779,11,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;BOK;DAP;SOX7;TNFSF15;IFI27;HSF1;FAM162A;PPM1F;CASP4
2731,GO:0006109,0.527827149351608,0.584924629172713,14,130,regulation of carbohydrate metabolic process,BP,NR1D1;IGFBP4;AKT1;DGKQ;PPARA;MLXIP;SRC;GSK3A;NTSR1;SLC35B4;ADIPOR1;MLYCD;TGFB1;SLC45A3
12644,GO:0050810,0.528187493641257,0.62948315507226,7,65,regulation of steroid biosynthetic process,BP,CYP27B1;NR1D1;APOE;DGKQ;PMVK;VDR;SEC14L2
10555,GO:0043495,0.528253841195065,0.845997574586699,1,7,protein membrane anchor,MF,CIB1
11840,GO:0046719,0.528334032055907,0.845943082146903,1,7,regulation by virus of viral protein levels in host cell,BP,TBC1D20
4040,GO:0009071,0.528439347328242,0.845871497047387,1,7,serine family amino acid catabolic process,BP,CBS
7858,GO:0032413,0.528490614725207,0.677343689667395,4,36,negative regulation of ion transmembrane transporter activity,BP,HECW2;PCSK9;STK39;EPHB2
3940,GO:0008625,0.528529547239454,0.629013482597096,7,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,BAG3;DEDD2;TNFRSF1A;MOAP1;BCL2L1;ARHGEF2;TMBIM1
8093,GO:0032769,0.529202769300158,0.845351911093076,1,7,negative regulation of monooxygenase activity,BP,CYP27B1
3158,GO:0006767,0.52987691274268,0.627706438069122,7,66,water-soluble vitamin metabolic process,BP,PRSS3;PC;PSAT1;ALDH1L2;SLC2A3;HLCS;AOX1
16424,GO:0097028,0.52991125967448,0.752129304590797,2,17,dendritic cell differentiation,BP,TGFBR2;TGFB1
6749,GO:0030166,0.529949474723306,0.655771628193387,5,44,proteoglycan biosynthetic process,BP,CHPF;XYLT1;XYLT2;NDST2;CHST14
13713,GO:0060242,0.530040519740045,0.844780377463735,1,7,contact inhibition,BP,PAK1
11430,GO:0045823,0.530101634116613,0.751966996636524,2,17,positive regulation of heart contraction,BP,APLN;GSK3A
13204,GO:0051791,0.530310420781907,0.844595940955694,1,7,medium-chain fatty acid metabolic process,BP,ACOT7
9816,GO:0040034,0.530897422546085,0.844194302790279,1,7,regulation of development, heterochronic,BP,SERPINE2
2381,GO:0005513,0.531127246919601,0.844036861421709,1,7,detection of calcium ion,BP,STIM1
1325,GO:0003171,0.531193846347504,0.752026965106738,2,16,atrioventricular valve development,BP,TGFBR2;ZFPM1
9043,GO:0035251,0.531292157310409,0.843923823149592,1,7,UDP-glucosyltransferase activity,MF,UGCG
15017,GO:0070925,0.531312721855615,0.521898218979914,66,636,organelle assembly,BP,SDC1;NEURL1;OBSCN;LAMA5;TMOD2;TNNT1;BBS2;NUDCD3;MARK4;EVI5L;CSNK1E;RFX2;SEPT10;PRKACA;TUBG2;SHANK3;ATG16L2;EHD3;WWTR1;VPS11;VPS4A;DNAAF5;PTPDC1;SH3PXD2B;SEPT5;MSN;OBSL1;ATG13;TBC1D14;FSCN1;TTBK2;NLGN2;SEPT8;SHANK2;DYNLRB1;SRC;CHMP5;DNM2;NINL;LRSAM1;RAB1B;SDCCAG8;FUZ;KIF17;TUBG1;VPS37A;UNC119B;ULK1;ULK2;TBC1D20;MAP1LC3B;MAPK9;ATXN10;WDR18;NDE1;SNAP29;HGS;GAS8;PACS2;WRAP73;CSNK1D;ARHGEF2;OCRL;SH3PXD2A;CCDC113;ASAP1
1204,GO:0002861,0.531373356008326,0.841297474910408,1,8,regulation of inflammatory response to antigenic stimulus,BP,ZP3
6921,GO:0030507,0.531424999172526,0.751829938665227,2,16,spectrin binding,MF,GNB1;CAMSAP3
5707,GO:0016832,0.531488089144115,0.843789449118632,1,7,aldehyde-lyase activity,MF,ALDOC
9400,GO:0035929,0.531637100720478,0.843687201570891,1,7,steroid hormone secretion,BP,GAL
23,GO:0000045,0.53170718624294,0.608027440696511,9,84,autophagosome assembly,BP,ATG16L2;ATG13;TBC1D14;LRSAM1;RAB1B;ULK1;ULK2;MAP1LC3B;PACS2
18014,GO:1902416,0.531742730996842,0.843614693624765,1,7,positive regulation of mRNA binding,BP,LARP6
14568,GO:0070076,0.531771915062069,0.704495617651523,3,25,histone lysine demethylation,BP,KDM4B;HSF4;PHF2
7482,GO:0031641,0.531975130319666,0.703755747345683,3,26,regulation of myelination,BP,DLG1;AKT1;RNF10
12816,GO:0051091,0.532113330796624,0.564874075739998,19,183,positive regulation of DNA binding transcription factor activity,BP,RBCK1;CRTC1;ADGRF1;LRP5;AKT1;CARD11;IRAK1;PRKCZ;PPP2R5B;DDIT3;IL1RAP;ADAM8;ARID5B;ANXA3;CIB1;ARHGEF2;TGFB1;CAT;EP300
7224,GO:0031113,0.532184640337989,0.673883071410811,4,36,regulation of microtubule polymerization,BP,EML2;PAK1;ARL2;CAMSAP3
12619,GO:0050776,0.532206074263984,0.523423250078839,60,584,regulation of immune response,BP,TNIP1;RAC2;RBCK1;SHC1;NR1D1;FKBP1A;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;BCR;XBP1;PRKACA;HK1;IFITM1;CARD11;IRAK1;ARPC1A;SERPING1;ARG2;PKN1;PRKCZ;RNF135;CD99;LIMK1;FAM3A;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;ADAM8;SRC;IRF7;STXBP1;PAG1;FYN;PSMD7;PUM1;FCGRT;CTSL;HEXIM1;MIF;ZP3;MAPK9;ARG1;SEC14L1;WIPF1;MAPK3;MAPK10;CEACAM1;SKAP2;ECM1;CD59;TGFB1;PIK3R2;ANXA1;EP300
2932,GO:0006450,0.532316943496342,0.749196048484637,2,18,regulation of translational fidelity,BP,AARS;DTD1
16001,GO:0080154,0.533150096784447,0.84264645958781,1,7,regulation of fertilization,BP,ZP3
12114,GO:0048102,0.533616979220719,0.842324360834678,1,7,autophagic cell death,BP,BNIP3
16294,GO:0090342,0.53365834922052,0.672174090614946,4,37,regulation of cell aging,BP,ARG2;HMGA2;YPEL3;MIF
18162,GO:1902857,0.533722136002117,0.842251752334281,1,7,positive regulation of non-motile cilium assembly,BP,WRAP73
11747,GO:0046543,0.533748065413146,0.842233845151692,1,7,development of secondary female sexual characteristics,BP,TGFB1
19146,GO:1905050,0.533834408509923,0.842174205559215,1,7,positive regulation of metallopeptidase activity,BP,MAPK3
7890,GO:0032452,0.533851932352255,0.702600256119508,3,25,histone demethylase activity,MF,ARID5B;KDM4B;PHF2
3005,GO:0006551,0.533881449657567,0.842141706497592,1,7,leucine metabolic process,BP,HMGCL
17823,GO:1901889,0.533884325980553,0.749728095472999,2,16,negative regulation of cell junction assembly,BP,MMP14;SRC
19747,GO:2000058,0.534080054269735,0.582632131779361,13,125,regulation of ubiquitin-dependent protein catabolic process,BP,DVL1;CSNK1E;PANO1;AKT1;ANKIB1;SUFU;GIPC1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
8046,GO:0032689,0.534109659800535,0.74853565055379,2,17,negative regulation of interferon-gamma production,BP,PRNP;GATA3
2581,GO:0005871,0.534171767227988,0.651741480653131,5,44,kinesin complex,CC,KLC2;KIF17;KIF13B;NDE1;KIFC3
11199,GO:0045277,0.534190740906513,0.834437355777053,1,11,respiratory chain complex IV,CC,NDUFA4L2
4074,GO:0009126,0.534335523417617,0.55188744355718,24,248,purine nucleoside monophosphate metabolic process,BP,NT5E;DLG4;DLG1;PGM1;HK1;CARD11;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;DLG3;SDHA;TAZ;LHPP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
4113,GO:0009167,0.534335523417617,0.55188744355718,24,248,purine ribonucleoside monophosphate metabolic process,BP,NT5E;DLG4;DLG1;PGM1;HK1;CARD11;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;DLG3;SDHA;TAZ;LHPP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
18090,GO:1902624,0.53442015640956,0.747386508831392,2,18,positive regulation of neutrophil migration,BP,RAC2;ADAM8
9210,GO:0035586,0.534486425381365,0.841723345579782,1,7,purinergic receptor activity,MF,P2RX4
12789,GO:0051045,0.534576541645829,0.841660962889914,1,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP1
5325,GO:0016048,0.534778265318341,0.84152125987483,1,7,detection of temperature stimulus,BP,NTSR1
12741,GO:0050961,0.534778265318341,0.84152125987483,1,7,detection of temperature stimulus involved in sensory perception,BP,NTSR1
12743,GO:0050965,0.534778265318341,0.84152125987483,1,7,detection of temperature stimulus involved in sensory perception of pain,BP,NTSR1
4729,GO:0010889,0.534948771908612,0.84140311092681,1,7,regulation of sequestering of triglyceride,BP,PPARA
910,GO:0002292,0.534982822040535,0.671250096783556,4,36,T cell differentiation involved in immune response,BP,PRKCZ;GATA3;ZFPM1;ANXA1
19940,GO:2000401,0.534995052197574,0.700483966272869,3,27,regulation of lymphocyte migration,BP,MSN;ADAM8;ECM1
12021,GO:0047485,0.5350336483357,0.597580964014286,10,96,protein N-terminus binding,MF,ZMYND8;MAP2K1;ERCC6;GLRX;STX5;EXOC2;STXBP1;NTSR1;MAU2;TGFB1
3410,GO:0007194,0.535095663052904,0.84130127788639,1,7,negative regulation of adenylate cyclase activity,BP,GNAI2
7293,GO:0031280,0.535095663052904,0.84130127788639,1,7,negative regulation of cyclase activity,BP,GNAI2
12124,GO:0048148,0.535137856067463,0.841272019156542,1,7,behavioral response to cocaine,BP,HOMER2
17877,GO:1902042,0.535188309234198,0.700306836843462,3,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1;ARHGEF2;TMBIM1
20303,GO:2001237,0.535216219263867,0.612618152577028,8,76,negative regulation of extrinsic apoptotic signaling pathway,BP,IFI6;ITGA6;AKT1;SRC;FYN;BCL2L1;ARHGEF2;TMBIM1
4639,GO:0010759,0.535229802296179,0.841208246402494,1,7,positive regulation of macrophage chemotaxis,BP,MAPK3
5575,GO:0016589,0.535336869820194,0.841133963786835,1,7,NURF complex,CC,SMARCA1
19754,GO:2000074,0.53545023580531,0.841055285637411,1,7,regulation of type B pancreatic cell development,BP,GSK3A
16098,GO:0090043,0.535530086053272,0.840999852172867,1,7,regulation of tubulin deacetylation,BP,EP300
3920,GO:0008589,0.535628068727351,0.634667333964821,6,54,regulation of smoothened signaling pathway,BP,SERPINE2;PRKACB;SUFU;TULP3;FUZ;MGRN1
1457,GO:0003690,0.535813734766253,0.518223294877264,64,603,double-stranded DNA binding,MF,ZMYND8;H1F0;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;EGFR;RFX2;ATF4;XPC;ELK3;PHF21A;TSPYL2;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;PPARA;ZNF516;TFE3;TNRC18;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;TOP1;IRF7;PER3;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;MAU2;ZFPM1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300
10098,GO:0042589,0.535834171793752,0.840788630228804,1,7,zymogen granule membrane,CC,VAMP2
4823,GO:0014015,0.535917824788439,0.670368062551546,4,36,positive regulation of gliogenesis,BP,SERPINE2;ETV5;BIN1;GJC2
15125,GO:0071158,0.536094518207095,0.611646421567621,8,77,positive regulation of cell cycle arrest,BP,PRKACA;PPP2R5B;ZNF385A;PCBP4;HMGA2;CNOT11;TGFB1;EP300
10212,GO:0042813,0.5362385713575,0.747706440062056,2,16,Wnt-activated receptor activity,MF,LRP5;FZD8
12023,GO:0047496,0.536265501137773,0.670039796288023,4,36,vesicle transport along microtubule,BP,AP3D1;FYCO1;PRKCZ;NDE1
15308,GO:0071476,0.536333882660776,0.840441110672946,1,7,cellular hypotonic response,BP,STK39
3769,GO:0008318,0.536482032760506,0.840337982012395,1,7,protein prenyltransferase activity,MF,RABGGTA
5294,GO:0015959,0.53658344720984,0.840267360365343,1,7,diadenosine polyphosphate metabolic process,BP,GARS
5549,GO:0016538,0.536741715611164,0.698404970899789,3,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CCND1;HEXIM1;CCNE1
17865,GO:1902017,0.536783166316519,0.669225610958815,4,37,regulation of cilium assembly,BP,EVI5L;DNM2;FUZ;WRAP73
12699,GO:0050891,0.53684607977424,0.648926881617784,5,45,multicellular organismal water homeostasis,BP,ADCY7;PRKACA;PRKACB;WFS1;ADCY6
570,GO:0001709,0.537060860365798,0.745991653347077,2,17,cell fate determination,BP,WNT7A;GATA3
7413,GO:0031490,0.537143647188357,0.601970705091895,9,92,chromatin DNA binding,MF,H1F0;HSF1;HMGA2;THRA;LEMD2;RXRA;MBD3;WBP2;EP300
20299,GO:2001233,0.537360749434445,0.538940776032675,31,307,regulation of apoptotic signaling pathway,BP,RBCK1;NFATC4;BOK;IFI6;ITGA6;BNIP3;G0S2;NACC2;XBP1;P4HB;AKT1;SYVN1;CD44;DEDD2;ZNF385A;DDIT3;RET;WFS1;SRC;FAM162A;GSK3A;FYN;GRINA;MOAP1;FGFR1;MIF;BCL2L1;MAPK9;ARHGEF2;TMBIM1;TRAF7
11780,GO:0046622,0.537377525647682,0.698812651698416,3,26,positive regulation of organ growth,BP,AKT1;FGFR1;FGF2
11014,GO:0044818,0.537681075248259,0.698533651606021,3,26,mitotic G2/M transition checkpoint,BP,HMGA2;BRSK1;TAOK1
6388,GO:0021575,0.537761630668618,0.698459588560547,3,26,hindbrain morphogenesis,BP,MAP2K1;WNT7A;SERPINE2
12327,GO:0048662,0.537953892018977,0.697766108402475,3,27,negative regulation of smooth muscle cell proliferation,BP,CTNNBIP1;APLN;COMT
9859,GO:0042095,0.538023488072643,0.839262270432793,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
12770,GO:0051019,0.538286954548137,0.697976371402047,3,26,mitogen-activated protein kinase binding,MF,TNIP1;MICALCL;MAPKAPK3
4445,GO:0010340,0.538512014732631,0.838920323668433,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13315,GO:0051998,0.538512014732631,0.838920323668433,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
10708,GO:0043983,0.538575495754447,0.838875853472413,1,7,histone H4-K12 acetylation,BP,JADE2
17987,GO:1902337,0.538579052463084,0.838873361655546,1,7,regulation of apoptotic process involved in morphogenesis,BP,VDR
18998,GO:1904748,0.538579052463084,0.838873361655546,1,7,regulation of apoptotic process involved in development,BP,VDR
15674,GO:0072173,0.538773734840626,0.838736927751365,1,7,metanephric tubule morphogenesis,BP,PKD1
4154,GO:0009215,0.538823783099831,0.836060116338236,1,8,purine deoxyribonucleoside triphosphate metabolic process,BP,GUK1
9458,GO:0036037,0.539264335784239,0.838392764429991,1,7,CD8-positive, alpha-beta T cell activation,BP,SATB1
4837,GO:0014041,0.539335326272023,0.838342922218363,1,7,regulation of neuron maturation,BP,RET
1180,GO:0002824,0.53937075479951,0.646028858080666,5,47,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PRKCZ;GATA3;ZP3;TGFB1;ANXA1
15325,GO:0071499,0.539711009811933,0.838078981522313,1,7,cellular response to laminar fluid shear stress,BP,ASS1
11693,GO:0046461,0.539712440068008,0.743693267258959,2,17,neutral lipid catabolic process,BP,APOE;MGLL
11696,GO:0046464,0.539712440068008,0.743693267258959,2,17,acylglycerol catabolic process,BP,APOE;MGLL
9214,GO:0035590,0.539903862940357,0.837943376368652,1,7,purinergic nucleotide receptor signaling pathway,BP,P2RX4
4666,GO:0010812,0.539935130825138,0.645954627665444,5,45,negative regulation of cell-substrate adhesion,BP,POSTN;FBLN1;MMP14;SRC;ADAM15
471,GO:0001514,0.540022587392555,0.837859856487817,1,7,selenocysteine incorporation,BP,SECISBP2L
2933,GO:0006451,0.540022587392555,0.837859856487817,1,7,translational readthrough,BP,SECISBP2L
3276,GO:0006956,0.540353590372551,0.743135712314601,2,17,complement activation,BP,SERPING1;CD59
19861,GO:2000291,0.540371377879329,0.837614320760625,1,7,regulation of myoblast proliferation,BP,ZNF609
15254,GO:0071394,0.540381665651387,0.837607074697558,1,7,cellular response to testosterone stimulus,BP,MSN
18266,GO:1903050,0.540429288173731,0.55909976346145,18,175,regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;DVL1;XBP1;CSNK1E;PANO1;PRKACA;AKT1;UBE2J1;ANKIB1;SUFU;PKD1;GIPC1;GSK3A;STUB1;TRIB3;RAD23A;TRIB2;CSNK1D
5031,GO:0015194,0.540440041982926,0.83756595389568,1,7,L-serine transmembrane transporter activity,MF,SERINC2
5224,GO:0015825,0.540440041982926,0.83756595389568,1,7,L-serine transport,BP,SERINC2
6632,GO:0022889,0.540440041982926,0.83756595389568,1,7,serine transmembrane transporter activity,MF,SERINC2
9781,GO:0039536,0.540585570012422,0.837463411739369,1,7,negative regulation of RIG-I signaling pathway,BP,SEC14L1
18146,GO:1902806,0.540643560259796,0.568147105444689,15,146,regulation of cell cycle G1/S phase transition,BP,FHL1;CCND1;NACC2;EGFR;AKT1;CCND2;ZNF385A;PCBP4;PKD1;GJC2;HYAL1;CNOT11;KANK2;ANXA1;EP300
11930,GO:0046950,0.54069727665439,0.837384670903853,1,7,cellular ketone body metabolic process,BP,HMGCL
17937,GO:1902224,0.54069727665439,0.837384670903853,1,7,ketone body metabolic process,BP,HMGCL
16181,GO:0090183,0.540755776707567,0.665786238526296,4,36,regulation of kidney development,BP,WWTR1;RET;GATA3;TGFB1
9957,GO:0042308,0.540835711609574,0.837287053462802,1,7,negative regulation of protein import into nucleus,BP,PARP10
18929,GO:1904590,0.540835711609574,0.837287053462802,1,7,negative regulation of protein import,BP,PARP10
903,GO:0002279,0.540861760897799,0.69508265787809,3,27,mast cell activation involved in immune response,BP,RAC2;STXBP1;CBL
10456,GO:0043303,0.540861760897799,0.69508265787809,3,27,mast cell degranulation,BP,RAC2;STXBP1;CBL
14845,GO:0070569,0.540882525374297,0.837254033678039,1,7,uridylyltransferase activity,MF,UAP1
11370,GO:0045713,0.54109272749297,0.837105712633997,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,FURIN
15428,GO:0071674,0.541156500897787,0.694329945312325,3,28,mononuclear cell migration,BP,MAPK3;TGFB1;ANXA1
4536,GO:0010605,0.541337044614745,0.490730534397244,205,2019,negative regulation of macromolecule metabolic process,BP,TNIP1;XDH;ERCC1;MDFI;ZMYND8;CHAC1;CCND1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;CST3;DLG4;SERPINE2;NR1D1;DLG1;DAP;IFI6;DNMT3A;FKBP1A;PSMD2;MTA1;PRNP;PC;WWC3;CRTAP;SMURF2;FAM129B;SESN2;ZC3H6;BBS2;NACC2;VLDLR;LRP5;ACVR2B;FBLN1;EGFR;PANO1;ADARB1;MAP2K2;PPP1R13L;ATF4;AKT1;PEG3;SERPING1;BAG3;APOE;ATP13A2;PKN1;ELK3;WWTR1;PHF21A;TSPYL2;PRKCZ;DGKQ;FZD8;CTSZ;EPHA1;PTK6;PCSK9;FERMT1;DEAF1;SALL2;PPP1R35;DRAP1;SERPINB6;LIMK1;STK39;DKK1;SOX7;UBE2J1;PPARA;H2AFJ;WDTC1;CD44;DNAJB5;GTPBP1;IDE;DEDD2;PRDX5;BIN1;SUFU;SCMH1;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;DUSP4;SATB1;IFI27;PCBP4;PARP10;GATA3;APLN;PHF1;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;NEIL1;TFPI2;HMGA2;ARID5B;PPP1R14A;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;SRC;APLP2;AGO4;IRF7;HIST3H2A;PER3;RERE;RSF1;GSK3A;SPINT2;DUSP6;FYN;ZNF692;PPM1F;NELFCD;PSMD7;MICAL1;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;HSF4;FGFR1;RREB1;ADNP;PHF2;TENM2;MIF;SOCS2;HES2;PCSK1N;TRIB3;SNX25;LEMD2;ZFPM1;PMEPA1;TRIB2;MXD4;SAMD4B;ZP3;LRRK1;RNH1;PYM1;RCOR1;RNF222;ABCA7;APBB1;SLIT3;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;RPL28;BAHCC1;ZBTB4;CNOT11;TCF25;HIST1H2AG;IMPACT;EPHB2;CARHSP1;CBL;CIB1;SOCS7;KANK2;FURIN;AIDA;CEACAM1;PAIP2;ZNF256;ECM1;CD59;MBD3;IGF2BP3;CCNE1;TGFB1;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;PPP1R10;KLF12;ZNF318;EP300
3942,GO:0008627,0.541614293504092,0.836737291200539,1,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
2957,GO:0006489,0.541683570233719,0.836688313061007,1,7,dolichyl diphosphate biosynthetic process,BP,SRD5A3
11697,GO:0046465,0.541683570233719,0.836688313061007,1,7,dolichyl diphosphate metabolic process,BP,SRD5A3
10009,GO:0042415,0.541732712986419,0.836653563414349,1,7,norepinephrine metabolic process,BP,GATA3
15306,GO:0071474,0.541807578132379,0.836600615337992,1,7,cellular hyperosmotic response,BP,ARHGEF2
11266,GO:0045472,0.541861719934765,0.836562316457572,1,7,response to ether,BP,NFATC4
10653,GO:0043653,0.541927552256594,0.833844181405225,1,8,mitochondrial fragmentation involved in apoptotic process,BP,BNIP3
3285,GO:0006975,0.541980691448648,0.836478136742619,1,7,DNA damage induced protein phosphorylation,BP,MAPK3
2643,GO:0005978,0.542275802946383,0.664340456138139,4,36,glycogen biosynthetic process,BP,NR1D1;PGM1;AKT1;GSK3A
4177,GO:0009250,0.542275802946383,0.664340456138139,4,36,glucan biosynthetic process,BP,NR1D1;PGM1;AKT1;GSK3A
7238,GO:0031128,0.542323160550814,0.741418527790858,2,17,developmental induction,BP,DKK1;FGFR1
10801,GO:0044262,0.542337370269623,0.552347969620758,20,189,cellular carbohydrate metabolic process,BP,PYGB;PYGL;PCK2;NR1D1;IGFBP4;PGM1;IDH2;HK1;AKT1;DGKQ;PPARA;ISYNA1;B3GNT3;SRC;GSK3A;NTSR1;SLC35B4;ADIPOR1;MLYCD;SLC45A3
7385,GO:0031432,0.542521391716616,0.836095184606405,1,7,titin binding,MF,OBSCN
2708,GO:0006073,0.542693715788434,0.627607165684971,6,55,cellular glucan metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;GSK3A
10730,GO:0044042,0.542693715788434,0.627607165684971,6,55,glucan metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;GSK3A
12363,GO:0048710,0.543103263347884,0.740736544545512,2,17,regulation of astrocyte differentiation,BP,SERPINE2;BIN1
11100,GO:0045086,0.543113318022811,0.835675249310594,1,7,positive regulation of interleukin-2 biosynthetic process,BP,CARD11
13798,GO:0060363,0.543154020847955,0.835646346164056,1,7,cranial suture morphogenesis,BP,TGFB1
4688,GO:0010835,0.543263576470611,0.835568533254291,1,7,regulation of protein ADP-ribosylation,BP,ADNP
2955,GO:0006487,0.543441820110254,0.604298316334552,8,78,protein N-linked glycosylation,BP,SYVN1;UBE2J1;SRD5A3;MCFD2;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1
9420,GO:0035973,0.543560977636293,0.835357174272309,1,7,aggrephagy,BP,WDFY3
27,GO:0000052,0.543853577901017,0.8351490459397,1,7,citrulline metabolic process,BP,ASS1
10518,GO:0043412,0.543962966907491,0.482809046793694,337,3243,macromolecule modification,BP,TNIP1;EDEM1;XDH;ZMYND8;NOS1;CCND1;GID4;F2R;MST1R;RAC2;RBCK1;SORL1;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;ERCC6;CST3;NEURL1;SNX9;LMF1;SHARPIN;DLG4;OBSCN;DLG1;IGFBP4;DNMT3A;FKBP1A;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;PTPRS;PRNP;SBF1;SSH1;SCYL1;CRTAP;SMURF2;FAM129B;MAPKAPK3;SESN2;LY6K;MARCH9;FKBP9;USP20;NACC2;BCR;VLDLR;MARK4;LRP5;AARS;ACVR2B;FBLN1;ADCY7;MAP4K4;EGFR;CSNK1E;MKNK2;LAMB1;PRKACA;ADARB1;PTPRF;JOSD2;MAP2K2;STK25;SHANK3;MIER2;P4HB;HECW2;FBXW8;AKT1;MDH2;IRAK1;APOE;ATP13A2;PKN1;SYVN1;WWTR1;PHF21A;RABGGTA;TSPYL2;PRKCZ;RNF135;FAM20C;DGKQ;MAPK13;RFNG;PPP2R3B;FZD8;EPHA1;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ZNF598;FBXW5;RRAS;PPP1R35;TGFBR2;LAMB2;LIMK1;STK39;DKK1;PPP2R5B;UBE2J1;ARRDC1;KLHL29;SYMPK;OBSL1;PRKACB;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;PLCG1;ATG13;MAP3K9;JADE2;ANKIB1;RRNAD1;CCND2;CCDC88C;PAK1;TTBK2;ERO1B;UBXN7;RAG1;BAZ2A;TNFSF15;BCDIN3D;CUL7;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RASGEF1A;FBXL6;HLTF;CEMIP;PKD1;PARP10;DLG3;GATA3;PIGQ;PHF1;DCAF7;ANO8;GNAI2;PPM1M;RPUSD3;HSF1;SIN3B;WFS1;NEK9;SRD5A3;ASPH;CTBP1;PTPRU;ADAM8;NEIL1;MPG;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;P4HA1;MYDGF;B4GALT2;B3GNT3;SRC;APLP2;MBD6;KDM4B;GLRX;FKBP10;PEX10;TGM2;UBR4;LRSAM1;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;PAK6;GSK3A;DUSP6;FYN;MPI;PPM1F;ZNF862;LPAR3;RMND5A;PSMD7;MICAL1;TNFRSF1A;THOP1;FBXL15;BRPF3;ABHD17C;VWA1;BRSK1;SSU72;GJC2;RNF44;ITGA1;SHISA5;PSKH1;MCFD2;RCN1;MAP3K10;LYPD5;HEXIM1;TIMP1;UBA1;RNF187;HSF4;LOXL1;LHPP;FGFR1;MSL1;ADNP;PHF2;MIB2;TTLL12;MFNG;CDK18;MIF;SOCS2;MTMR4;ASB13;STUB1;STK17A;ST3GAL3;TRIB3;DDB2;SNX25;PTPN12;SLC27A1;LEMD2;PMEPA1;HLCS;RMND5B;ST3GAL5;RAD23A;ULK1;TRIB2;HSPA2;PAK4;TNFRSF19;MGRN1;ULK2;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;ST6GALNAC2;VAPB;MAPK9;RCOR1;MAP3K12;TAOK1;RNF222;ABCA7;LMAN1;MSLN;APBB1;SPSB3;VEGFB;NEURL1B;TGFA;IMPACT;ARSK;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CBL;CIB1;SOCS7;USP32;MAPK3;NTNG1;POMT1;MAPK10;CSNK1D;ARHGEF2;RNF103;AIDA;B4GALT6;MATN3;CEACAM1;GALNT3;MINK1;TFPT;MBD3;ADCY6;CCNE1;TGFB1;WBP2;PPP6R1;ADCK2;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ASPHD1;EP300;WDFY2;RASA3;TRAF7;RNF10
3100,GO:0006678,0.543974722219757,0.835062822597897,1,7,glucosylceramide metabolic process,BP,UGCG
13542,GO:0055093,0.544113282778039,0.73985200470392,2,17,response to hyperoxia,BP,BNIP3;CAT
15414,GO:0071649,0.54428792972869,0.83483975702539,1,7,regulation of chemokine (C-C motif) ligand 5 production,BP,ARG2
18330,GO:1903214,0.544505982641773,0.613131343667112,7,68,regulation of protein targeting to mitochondrion,BP,RAC2;VPS11;BNIP3L;ZDHHC8;ATG13;GSK3A;UGCG
9064,GO:0035280,0.544534939617885,0.834663691658466,1,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,AGO4
15183,GO:0071285,0.544565584096247,0.834641839726345,1,7,cellular response to lithium ion,BP,NFATC4
9972,GO:0042340,0.544626665678904,0.834598277838738,1,7,keratan sulfate catabolic process,BP,GALNS
11189,GO:0045252,0.544672552943462,0.834565546997602,1,7,oxoglutarate dehydrogenase complex,CC,DHTKD1
4107,GO:0009161,0.545041352043211,0.539426604233626,25,259,ribonucleoside monophosphate metabolic process,BP,NT5E;DLG4;DLG1;PGM1;HK1;CARD11;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;DLG3;SDHA;TAZ;UCKL1;LHPP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
14106,GO:0060911,0.545355189744492,0.834078106318585,1,7,cardiac cell fate commitment,BP,DKK1
14898,GO:0070670,0.545391411117413,0.69087795610313,3,27,response to interleukin-4,BP,XBP1;GATA3;ARG1
6943,GO:0030546,0.545443003827658,0.834015330842928,1,7,receptor activator activity,MF,DGKQ
10631,GO:0043618,0.545495227459647,0.586755881445995,10,102,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMD2;SESN2;ATF4;BAG3;DDIT3;HSF1;PSMD7;HSF4;IMPACT;EP300
2287,GO:0005243,0.546050835911067,0.833580364844952,1,7,gap junction channel activity,MF,GJC2
3366,GO:0007130,0.546370741885021,0.833351125884383,1,7,synaptonemal complex assembly,BP,AGO4
6592,GO:0022602,0.546401174654228,0.690461263373164,3,26,ovulation cycle process,BP,SRC;ZP3;SLIT3
15881,GO:0072583,0.54647104552646,0.660334603347446,4,36,clathrin-dependent endocytosis,BP,FCHO1;AP2A2;PIP5K1C;ARAP3
19540,GO:1990391,0.546472494979695,0.660333215380476,4,36,DNA repair complex,CC,ERCC1;XPC;PHF21A;RCOR1
20301,GO:2001235,0.546764716818238,0.561848542597771,15,150,positive regulation of apoptotic signaling pathway,BP,RBCK1;NFATC4;BOK;BNIP3;G0S2;NACC2;DEDD2;DDIT3;RET;FAM162A;GSK3A;MOAP1;BCL2L1;MAPK9;TRAF7
19576,GO:1990462,0.547315648754378,0.832672757786689,1,7,omegasome,CC,ULK1
5447,GO:0016311,0.547450746040979,0.521766102513008,38,362,dephosphorylation,BP,NT5E;DLG1;FKBP1A;PTPRS;SBF1;SSH1;PTPRF;PPP2R3B;PTPDC1;PPP1R35;PPP2R5B;SYMPK;PPP1R12C;FARP1;DUSP4;PTPN9;DLG3;PPM1M;PTPRU;PPP1R14A;DUSP6;PPM1F;SSU72;ITGA1;LHPP;MTMR4;NT5DC2;PTPN12;ACP7;MYO1D;CAMSAP3;RPRD1A;OCRL;LPIN3;TGFB1;PPP6R1;PPP1R37;PPP1R10
9806,GO:0040016,0.547481603554675,0.832553420119371,1,7,embryonic cleavage,BP,TOP1
1608,GO:0004028,0.547780872121567,0.832338069209229,1,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A2
12881,GO:0051182,0.547888947993595,0.832260252089511,1,7,coenzyme transport,BP,SLC33A1
2442,GO:0005641,0.548121504273568,0.832092722102106,1,7,nuclear envelope lumen,CC,SORL1
9510,GO:0036149,0.548139980948399,0.832079406862863,1,7,phosphatidylinositol acyl-chain remodeling,BP,MBOAT7
999,GO:0002460,0.5482317895576,0.564332007291089,14,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ERCC1;DLG1;SERPING1;PKN1;PRKCZ;POU2F2;KDELR1;GATA3;IRF7;ZP3;ARG1;CEACAM1;TGFB1;ANXA1
7594,GO:0031957,0.548331325331192,0.831941471625452,1,7,very long-chain fatty acid-CoA ligase activity,MF,SLC27A1
12330,GO:0048665,0.548444554792981,0.831859810771142,1,7,neuron fate specification,BP,SUFU
7041,GO:0030809,0.548479428729265,0.736007982152692,2,17,negative regulation of nucleotide biosynthetic process,BP,PPARA;GNAI2
17500,GO:1900372,0.548479428729265,0.736007982152692,2,17,negative regulation of purine nucleotide biosynthetic process,BP,PPARA;GNAI2
16021,GO:0086013,0.548514213830504,0.831809559280547,1,7,membrane repolarization during cardiac muscle cell action potential,BP,DLG1
10335,GO:0043116,0.548677836659652,0.831691482440276,1,7,negative regulation of vascular permeability,BP,CEACAM1
821,GO:0002091,0.548832512985372,0.831579809388492,1,7,negative regulation of receptor internalization,BP,DLG4
1454,GO:0003684,0.548975749666022,0.608985354556083,7,66,damaged DNA binding,MF,ERCC1;XPC;NEIL1;MPG;DDB2;RAD23A;EP300
4358,GO:0009952,0.549032226035395,0.567867100381072,13,122,anterior/posterior pattern specification,BP,CTNNBIP1;LRP5;ACVR2B;DKK1;SCMH1;DDIT3;TULP3;ALDH1A2;PCSK6;FUZ;PBX3;TSHZ1;EP300
10306,GO:0043046,0.549138741095968,0.831358568922227,1,7,DNA methylation involved in gamete generation,BP,DNMT3A
7653,GO:0032059,0.549240995858849,0.831284648501971,1,7,bleb,CC,FHOD1
13103,GO:0051592,0.549383799808593,0.59043874577244,9,85,response to calcium ion,BP,CCND1;SDC1;EGFR;ITPR3;ENDOG;GDI1;ENTPD6;S100A16;STIM1
2220,GO:0005114,0.549443376980362,0.831138280611692,1,7,type II transforming growth factor beta receptor binding,MF,TGFB1
8594,GO:0034085,0.549705755620322,0.830948390809416,1,7,establishment of sister chromatid cohesion,BP,MAU2
7131,GO:0030949,0.54988591902597,0.830817917149376,1,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,GRB10
1242,GO:0002931,0.549942674524182,0.686622797296541,3,27,response to ischemia,BP,STUB1;MLYCD;CIB1
16927,GO:0098869,0.550008790143781,0.619155476415083,6,63,cellular oxidant detoxification,BP,CYGB;SESN2;APOE;PRDX5;GPX3;CAT
17589,GO:1901160,0.55002293062805,0.830718647493081,1,7,primary amino compound metabolic process,BP,AZIN2
15780,GO:0072357,0.550034988896082,0.830709908941163,1,7,PTW/PP1 phosphatase complex,CC,PPP1R10
14337,GO:0061469,0.550040881407646,0.830705638564323,1,7,regulation of type B pancreatic cell proliferation,BP,NR1D1
14800,GO:0070491,0.550238896354057,0.620025147344767,6,56,repressing transcription factor binding,MF,ZMYND8;MTA1;BBS2;PPARA;CTBP1;TLE4
3790,GO:0008354,0.550261270144144,0.830545866759631,1,7,germ cell migration,BP,TGFB1
11489,GO:0045931,0.550482756698348,0.57092760070213,12,115,positive regulation of mitotic cell cycle,BP,CCND1;LRP5;CCND2;HSF1;EIF4EBP1;ASNS;FGFR1;HYAL1;TGFA;TGFB1;ANXA1;PPP1R10
4279,GO:0009642,0.550484305948622,0.830384070326415,1,7,response to light intensity,BP,CAT
8340,GO:0033179,0.550486523847709,0.827627938809655,1,8,proton-transporting V-type ATPase, V0 domain,CC,TCIRG1
16182,GO:0090184,0.550694023449054,0.685917386969248,3,27,positive regulation of kidney development,BP,RET;GATA3;TGFB1
15293,GO:0071456,0.550972277192516,0.557576607494422,15,151,cellular response to hypoxia,BP,DNMT3A;PSMD2;BNIP3;P4HB;AKT1;IRAK1;ENDOG;BNIP3L;GNB1;ADAM8;SRC;FAM162A;PSMD7;STUB1;EP300
3098,GO:0006672,0.55101524141047,0.606964645198614,7,66,ceramide metabolic process,BP,SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;UGCG;B4GALT6;NAGA
15124,GO:0071157,0.551076268904978,0.732788770142048,2,18,negative regulation of cell cycle arrest,BP,CCND1;MIF
13066,GO:0051537,0.551117531578331,0.73193695206264,2,19,2 iron, 2 sulfur cluster binding,MF,XDH;AOX1
16596,GO:0097371,0.551180730174506,0.82987818011229,1,7,MDM2/MDM4 family protein binding,MF,PPARA
7740,GO:0032230,0.551201039542457,0.829863411591091,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
13002,GO:0051386,0.551216391449498,0.829852247437686,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,PPP2R5B
299,GO:0000805,0.55126848525903,0.829814360224059,1,7,X chromosome,CC,SIN3B
18864,GO:1904429,0.551409993188494,0.829711413841634,1,7,regulation of t-circle formation,BP,ERCC1
11416,GO:0045792,0.551411409747935,0.82971038308253,1,7,negative regulation of cell size,BP,AKT1
7,GO:0000014,0.551468834804997,0.829668594195301,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
16777,GO:0098542,0.551539421735222,0.531392131011015,26,262,defense response to other organism,BP,SHC1;BNIP3;ADARB1;IFITM1;ARG2;HIST2H2BE;BNIP3L;FAM3A;HTRA1;GSDMA;OASL;MAPKBP1;IRF7;LRSAM1;OAS1;ISG20;TNFRSF1A;ANXA3;PUM1;RNASE7;ARG1;GSDMC;SEC14L1;MAPK3;TGFB1;APOBEC3C
20210,GO:2001022,0.551720225170096,0.606127992557321,7,67,positive regulation of response to DNA damage stimulus,BP,NACC2;EGFR;NSMCE4A;ZNF385A;HMGA2;APBB1;SPRED2
2304,GO:0005283,0.552065523686562,0.829233958452162,1,7,amino acid:sodium symporter activity,MF,SLC6A9
11138,GO:0045161,0.552247562688956,0.829101206887675,1,7,neuronal ion channel clustering,BP,AGRN
6830,GO:0030285,0.552508339704245,0.828910911834242,1,7,integral component of synaptic vesicle membrane,CC,PTPRS
3062,GO:0006625,0.552534069895584,0.732408515597977,2,17,protein targeting to peroxisome,BP,PEX10;LONP2
15913,GO:0072662,0.552534069895584,0.732408515597977,2,17,protein localization to peroxisome,BP,PEX10;LONP2
15914,GO:0072663,0.552534069895584,0.732408515597977,2,17,establishment of protein localization to peroxisome,BP,PEX10;LONP2
11132,GO:0045143,0.552797043422769,0.683938496732145,3,27,homologous chromosome segregation,BP,AGO4;LEMD2;CCNE1
18045,GO:1902514,0.552849516527627,0.828661726562097,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
551,GO:0001672,0.552880666556143,0.82863896305227,1,7,regulation of chromatin assembly or disassembly,BP,PARP10
7807,GO:0032351,0.553046287925524,0.828517896873894,1,7,negative regulation of hormone metabolic process,BP,CYP27B1
7809,GO:0032353,0.553046287925524,0.828517896873894,1,7,negative regulation of hormone biosynthetic process,BP,CYP27B1
1438,GO:0003413,0.553087104355227,0.828488051751254,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,TGFBR2
14022,GO:0060717,0.553104225584466,0.828475531577335,1,7,chorion development,BP,HTRA1
11021,GO:0044837,0.553153013932191,0.828439850857717,1,7,actomyosin contractile ring organization,BP,VPS4A
11074,GO:0045058,0.55317708717602,0.68358018386006,3,27,T cell selection,BP,CARD11;GATA3;ZFPM1
1892,GO:0004571,0.553219307306335,0.828391359862788,1,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,EDEM1
7763,GO:0032274,0.55324867660887,0.828369874348694,1,7,gonadotropin secretion,BP,FAM129B
195,GO:0000413,0.553265848583373,0.682129254539615,3,30,protein peptidyl-prolyl isomerization,BP,FKBP1A;FKBP9;FKBP10
1481,GO:0003755,0.553265848583373,0.682129254539615,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP1A;FKBP9;FKBP10
3170,GO:0006783,0.553302637018585,0.73080113376144,2,18,heme biosynthetic process,BP,ALAS1;UROS
16089,GO:0090030,0.553463608867971,0.828212581200251,1,7,regulation of steroid hormone biosynthetic process,BP,DGKQ
4909,GO:0014841,0.553491598673431,0.828192090198502,1,7,skeletal muscle satellite cell proliferation,BP,FGF2
4910,GO:0014842,0.553491598673431,0.828192090198502,1,7,regulation of skeletal muscle satellite cell proliferation,BP,FGF2
4920,GO:0014856,0.553491598673431,0.828192090198502,1,7,skeletal muscle cell proliferation,BP,FGF2
4921,GO:0014857,0.553491598673431,0.828192090198502,1,7,regulation of skeletal muscle cell proliferation,BP,FGF2
14622,GO:0070168,0.553568414446509,0.828135845616837,1,7,negative regulation of biomineral tissue development,BP,ECM1
1993,GO:0004711,0.553582104842329,0.828125820157053,1,7,ribosomal protein S6 kinase activity,MF,RPS6KA2
12356,GO:0048702,0.553597822733282,0.828114309474159,1,7,embryonic neurocranium morphogenesis,BP,TULP3
12634,GO:0050796,0.553683016324396,0.572947706544645,11,106,regulation of insulin secretion,BP,PCK2;NR1D1;RAPGEF3;LRP5;MAP4K4;ITPR3;HADH;NLGN2;GLUL;GLUD1;ARL2
6613,GO:0022824,0.553748137275802,0.828004202718523,1,7,transmitter-gated ion channel activity,MF,GRIN3B
6617,GO:0022835,0.553748137275802,0.828004202718523,1,7,transmitter-gated channel activity,MF,GRIN3B
8085,GO:0032760,0.554144499921723,0.652299530208044,4,38,positive regulation of tumor necrosis factor production,BP,NFATC4;MIF;ARFGEF2;ARHGEF2
18429,GO:1903431,0.554158836876477,0.827703113236244,1,7,positive regulation of cell maturation,BP,RET
4989,GO:0015114,0.554358274808749,0.827556771327995,1,7,phosphate ion transmembrane transporter activity,MF,SLC20A1
5249,GO:0015871,0.554472588713684,0.827472852316234,1,7,choline transport,BP,SEC14L1
2003,GO:0004723,0.554748710758164,0.827270031889296,1,7,calcium-dependent protein serine/threonine phosphatase activity,MF,PPM1F
1668,GO:0004126,0.554768295371559,0.82445923851183,1,8,cytidine deaminase activity,MF,APOBEC3C
14940,GO:0070775,0.554888645326713,0.827167182610096,1,7,H3 histone acetyltransferase complex,CC,BRPF3
14941,GO:0070776,0.554888645326713,0.827167182610096,1,7,MOZ/MORF histone acetyltransferase complex,CC,BRPF3
6124,GO:0019369,0.555086177260167,0.681777001858664,3,27,arachidonic acid metabolic process,BP,ALOX15B;MGLL;MAPK3
5162,GO:0015698,0.555393052175705,0.584428614212876,9,85,inorganic anion transport,BP,PRNP;TTYH3;SLC12A7;SLC20A1;ANO8;SLC12A4;FGFR1;LRRC8A;PCYOX1
4751,GO:0010919,0.555789925591982,0.826503743698945,1,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1
4962,GO:0015035,0.556002210660432,0.726818208078878,2,20,protein disulfide oxidoreductase activity,MF,ERO1B;GLRX
6034,GO:0019098,0.556105825988339,0.729213863108083,2,17,reproductive behavior,BP,SERPINE2;THRA
8129,GO:0032809,0.556262288312988,0.826155331503095,1,7,neuronal cell body membrane,CC,KCNC4
10820,GO:0044298,0.556262288312988,0.826155331503095,1,7,cell body membrane,CC,KCNC4
188,GO:0000405,0.556271833209041,0.82614828625513,1,7,bubble DNA binding,MF,XPC
12686,GO:0050871,0.556292818359551,0.629324867508457,5,48,positive regulation of B cell activation,BP,XBP1;MMP14;CARD11;MIF;TGFB1
15892,GO:0072595,0.556349689518772,0.650160498274808,4,38,maintenance of protein localization in organelle,BP,HK1;AKT1;KDELR1;ARL2
13584,GO:0060027,0.556371265160265,0.826074882082147,1,7,convergent extension involved in gastrulation,BP,DVL1
13788,GO:0060346,0.556398620582482,0.826054683583195,1,7,bone trabecula formation,BP,THBS3
8094,GO:0032770,0.556441447685609,0.727984122998319,2,18,positive regulation of monooxygenase activity,BP,AKT1;APOE
7410,GO:0031468,0.556960078669289,0.727516993753573,2,18,nuclear envelope reassembly,BP,VPS4A;REEP4
737,GO:0001964,0.557729316702625,0.825070170973076,1,7,startle response,BP,DVL1
7135,GO:0030953,0.557918268422486,0.824930063169286,1,7,astral microtubule organization,BP,DLG1
15119,GO:0071141,0.558077476638232,0.824811949818947,1,7,SMAD protein complex,CC,HMGA2
6265,GO:0019855,0.558126539385799,0.821946120128974,1,8,calcium channel inhibitor activity,MF,SLC30A1
11765,GO:0046596,0.558190519642215,0.725578716824369,2,19,regulation of viral entry into host cell,BP,P4HB;IFITM1
7040,GO:0030808,0.558194178883179,0.581520450736326,9,86,regulation of nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;TMSB4X;PPARA;GNAI2;CAP1;TAZ;ADNP
17499,GO:1900371,0.558194178883179,0.581520450736326,9,86,regulation of purine nucleotide biosynthetic process,BP,NOS1;PTHLH;APOE;TMSB4X;PPARA;GNAI2;CAP1;TAZ;ADNP
11594,GO:0046133,0.558237198098561,0.821862889758033,1,8,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C
8341,GO:0033180,0.55829210296148,0.821821583883883,1,8,proton-transporting V-type ATPase, V1 domain,CC,ATP6V1C2
10374,GO:0043178,0.558373500681136,0.627274613760743,5,48,alcohol binding,MF,OSBPL10;OSBP2;APOE;ITPR3;OSBPL5
19847,GO:2000271,0.558407837486864,0.82456668554023,1,7,positive regulation of fibroblast apoptotic process,BP,STK17A
9292,GO:0035722,0.558629146279597,0.647359662909934,4,40,interleukin-12-mediated signaling pathway,BP,P4HB;MSN;TALDO1;MIF
15220,GO:0071349,0.558629146279597,0.647359662909934,4,40,cellular response to interleukin-12,BP,P4HB;MSN;TALDO1;MIF
2767,GO:0006183,0.558664560534236,0.819355594233013,1,9,GTP biosynthetic process,BP,NME4
5335,GO:0016064,0.558728176453308,0.61144674775058,6,57,immunoglobulin mediated immune response,BP,ERCC1;SERPING1;POU2F2;IRF7;ZP3;TGFB1
6212,GO:0019724,0.558728176453308,0.61144674775058,6,57,B cell mediated immunity,BP,ERCC1;SERPING1;POU2F2;IRF7;ZP3;TGFB1
8515,GO:0033687,0.558783670274516,0.726803992188536,2,17,osteoblast proliferation,BP,LRP5;HPSE
9603,GO:0036449,0.558999711209032,0.824126675227933,1,7,microtubule minus-end,CC,CAMSAP3
1265,GO:0003016,0.559234025193105,0.726397457675136,2,17,respiratory system process,BP,NLGN2;PBX3
4071,GO:0009123,0.55950857814085,0.523169627833979,26,271,nucleoside monophosphate metabolic process,BP,NT5E;DLG4;DLG1;PGM1;TK2;HK1;CARD11;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;DLG3;SDHA;TAZ;UCKL1;LHPP;GUK1;AMPD2;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
7211,GO:0031095,0.559815850725953,0.823518686034771,1,7,platelet dense tubular network membrane,CC,ITPR3
4777,GO:0010960,0.559867526159912,0.823480140984174,1,7,magnesium ion homeostasis,BP,EGFR
14925,GO:0070734,0.559873754079733,0.7248838172679,2,18,histone H3-K27 methylation,BP,GATA3;PHF1
15796,GO:0072383,0.560001583761606,0.823380119265894,1,7,plus-end-directed vesicle transport along microtubule,BP,FYCO1
6346,GO:0021517,0.560179261923531,0.725543023867523,2,17,ventral spinal cord development,BP,VLDLR;SUFU
14961,GO:0070831,0.561265964868835,0.822434813706043,1,7,basement membrane assembly,BP,LAMC2
11499,GO:0045944,0.561284357093713,0.4862851084882,83,793,positive regulation of transcription by RNA polymerase II,BP,TNIP1;NOS1;NFATC4;WNT7A;ETV4;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;ATF4;AKT1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;SALL2;CREB3L2;PPP2R5B;PPARA;MC1R;TFE3;BCL9L;DDIT3;MLXIP;HLTF;PKD1;GATA3;APLN;HSF1;RAI1;HMGA2;MICAL2;MYDGF;IRF7;RFXANK;RERE;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;HSF4;RREB1;USF2;PBX3;ZFPM1;ZNF609;E2F5;FGF2;ABHD14B;CHD7;RNF222;APBB1;RXRA;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;TGFB1;WBP2;PIK3R2;ASH2L;ARHGEF10L;EP300;FHOD1;RNF10
454,GO:0001227,0.561503313286445,0.540822628686517,17,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NFATC4;NR1D1;NACC2;DEAF1;PPARA;SATB1;GATA3;TCFL5;HSF1;HMGA2;ARID5B;ZNF692;HES2;ZFPM1;RCOR1;TSHZ1;ZBTB4
14697,GO:0070296,0.56151184114279,0.723396818438155,2,18,sarcoplasmic reticulum calcium ion transport,BP,PRKACA;CHD7
5442,GO:0016303,0.561607083122933,0.676115672989819,3,26,1-phosphatidylinositol-3-kinase activity,MF,FGFR1;FGF2;PIK3R2
5395,GO:0016229,0.561879610611578,0.722227406438093,2,19,steroid dehydrogenase activity,MF,SRD5A3;HSD11B1
15060,GO:0070988,0.562203669986158,0.608160277063582,6,56,demethylation,BP,GATA3;ARID5B;KDM4B;HSF4;PHF2;APOBEC3C
8231,GO:0032982,0.562351631155216,0.82162032028046,1,7,myosin filament,CC,MYH15
2272,GO:0005201,0.562367185035213,0.644947361373896,4,36,extracellular matrix structural constituent,MF,FBLN1;LAMB1;TFPI2;MATN3
15585,GO:0072017,0.56250820098993,0.821502643634582,1,7,distal tubule development,BP,PKD1
14864,GO:0070603,0.562596637059706,0.595271447156218,7,67,SWI/SNF superfamily-type complex,CC,SMARCA1;NACC2;SALL2;APPL2;RSF1;TFPT;MBD3
8967,GO:0035024,0.562711478161867,0.723246229846564,2,17,negative regulation of Rho protein signal transduction,BP,ARAP3;ITGA3
8576,GO:0034035,0.562785609586939,0.722237235604432,2,18,purine ribonucleoside bisphosphate metabolic process,BP,ABHD14B;PODXL2
12497,GO:0050427,0.562785609586939,0.722237235604432,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,ABHD14B;PODXL2
8430,GO:0033500,0.562854568967452,0.545720541834099,15,147,carbohydrate homeostasis,BP,PYGL;PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;HK1;AKT1;ENDOG;ERO1B;WFS1;OAS1;ADIPOR1;PIK3R2
10101,GO:0042593,0.562854568967452,0.545720541834099,15,147,glucose homeostasis,BP,PYGL;PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;HK1;AKT1;ENDOG;ERO1B;WFS1;OAS1;ADIPOR1;PIK3R2
4606,GO:0010719,0.563058100058023,0.721988796657227,2,18,negative regulation of epithelial to mesenchymal transition,BP,FUZ;ADIPOR1
849,GO:0002162,0.56333721617642,0.820878661245612,1,7,dystroglycan binding,MF,AGRN
8212,GO:0032958,0.563674376448585,0.722369851541107,2,17,inositol phosphate biosynthetic process,BP,NTSR1;FGF2
17716,GO:1901570,0.564197265940791,0.605656049768171,6,59,fatty acid derivative biosynthetic process,BP,ELOVL1;HMGCL;CBR4;MIF;GGT1;ANXA1
5018,GO:0015179,0.564379220943934,0.642637245891319,4,37,L-amino acid transmembrane transporter activity,MF,SERINC2;SLC43A1;TMEM44;SLC6A9
11393,GO:0045744,0.564599189123006,0.672210113638412,3,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,APLN;DNM2;MGRN1
14504,GO:0061900,0.564715052872037,0.721420818944312,2,17,glial cell activation,BP,EGFR;LRP1
6354,GO:0021532,0.565057467928377,0.672270126629735,3,27,neural tube patterning,BP,PRKACB;SUFU;TULP3
11473,GO:0045913,0.565112836024373,0.621061684235739,5,46,positive regulation of carbohydrate metabolic process,BP,AKT1;PPARA;SRC;NTSR1;SLC45A3
16582,GO:0097345,0.565124332141052,0.620370584054415,5,49,mitochondrial outer membrane permeabilization,BP,BOK;BNIP3;BNIP3L;GSK3A;MOAP1
8455,GO:0033572,0.565331313782401,0.671042131463363,3,29,transferrin transport,BP,DNM2;TCIRG1;ATP6V1C2
19315,GO:1905515,0.565457111709636,0.620482313482819,5,47,non-motile cilium assembly,BP,BBS2;DNM2;FUZ;WRAP73;CSNK1D
15436,GO:0071682,0.565513005080557,0.816331195891879,1,8,endocytic vesicle lumen,CC,APOE
11544,GO:0046051,0.565730809194553,0.81392459334616,1,9,UTP metabolic process,BP,NME4
20018,GO:2000574,0.565838935258244,0.816080643801299,1,8,regulation of microtubule motor activity,BP,NDE1
4094,GO:0009147,0.566197009471549,0.717520774850112,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4;UCKL1
8974,GO:0035036,0.566229727088068,0.718244468063867,2,19,sperm-egg recognition,BP,ZP3;SPESP1
787,GO:0002042,0.566754211096641,0.640302156987848,4,37,cell migration involved in sprouting angiogenesis,BP,FGF2;CIB1;SRPX2;ANXA1
994,GO:0002448,0.567943124769192,0.668987825939725,3,28,mast cell mediated immunity,BP,RAC2;STXBP1;CBL
10657,GO:0043666,0.567943601452946,0.57158119472782,9,87,regulation of phosphoprotein phosphatase activity,BP,FKBP1A;PPP2R3B;PPP1R35;PPP2R5B;PPP1R14A;ITGA1;PPP6R1;PPP1R37;PPP1R10
2928,GO:0006446,0.568306953328236,0.589257578143913,7,69,regulation of translational initiation,BP,ATF4;EIF4EBP1;MIF4GD;RXRA;IMPACT;PAIP2;EIF4G3
11050,GO:0045008,0.568477484513733,0.814043548701727,1,8,depyrimidination,BP,NEIL1
12273,GO:0048538,0.568651556110522,0.638431277752061,4,37,thymus development,BP,MAP2K1;RAG1;GATA3;MAPK3
1162,GO:0002768,0.569290101632464,0.51345266918503,26,257,immune response-regulating cell surface receptor signaling pathway,BP,RBCK1;SHC1;PSMD2;PRNP;PRKACA;CARD11;ARPC1A;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;SRC;PAG1;FYN;PSMD7;FCGRT;MAPK9;WIPF1;MAPK3;MAPK10;CEACAM1;PIK3R2;EP300
7462,GO:0031593,0.569338801810564,0.637752429893008,4,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;SHARPIN;PARP10;RAD23A
8161,GO:0032881,0.569373757679995,0.668108278572637,3,27,regulation of polysaccharide metabolic process,BP,AKT1;GSK3A;TGFB1
1465,GO:0003712,0.569386379957154,0.492713329158466,47,457,transcription cofactor activity,MF,ZMYND8;CCND1;NFATC4;NR1D1;SOX12;MTA1;CITED4;FAM129B;PPP1R13L;PKN1;ELK3;WWTR1;PHF21A;ZMIZ2;DRAP1;SCAND1;PPARA;SUFU;BCL9L;DDIT3;GATA3;SIN3B;CTBP1;ARID5B;RFXANK;RALY;RERE;TLE4;VDR;THRA;MAP3K10;HSF4;PHF2;TRIB3;MXD4;FGF2;MED15;CDYL2;RCOR1;RXRA;PBXIP1;ZHX3;LPIN3;CCNE1;WBP2;KLF12;EP300
907,GO:0002286,0.56947181537045,0.616251267597406,5,48,T cell activation involved in immune response,BP,PRKCZ;GATA3;ZFPM1;CEACAM1;ANXA1
4063,GO:0009111,0.569589125947911,0.813180616621638,1,8,vitamin catabolic process,BP,CYP27B1
11364,GO:0045682,0.569662200938436,0.588019048008706,7,68,regulation of epidermis development,BP,CYP27B1;FERMT1;ALOX15B;VDR;GAL;CTSL;HPSE
6735,GO:0030148,0.569839890882323,0.577970131678213,8,77,sphingolipid biosynthetic process,BP,ELOVL1;SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;VAPB;UGCG;B4GALT6
19981,GO:2000484,0.569903829668167,0.81293581552486,1,8,positive regulation of interleukin-8 secretion,BP,F2R
16795,GO:0098586,0.570183241349398,0.636917442213718,4,37,cellular response to virus,BP,IRF7;PUM1;BCL2L1;SEC14L1
3755,GO:0008296,0.570275506541629,0.81264640791536,1,8,3'-5'-exodeoxyribonuclease activity,MF,ISG20
11644,GO:0046332,0.570807524009326,0.599531156403218,6,56,SMAD binding,MF,FKBP1A;SMURF2;TGFBR2;HMGA2;STUB1;PMEPA1
12578,GO:0050711,0.571486776847453,0.811701076940454,1,8,negative regulation of interleukin-1 secretion,BP,CPTP
3371,GO:0007143,0.571735814709339,0.714007349535233,2,18,female meiotic nuclear division,BP,HSF1;SPIRE1
11729,GO:0046512,0.572466892963492,0.81093371220972,1,8,sphingosine biosynthetic process,BP,SPTLC2
16281,GO:0090322,0.572468118659261,0.712473322668245,2,19,regulation of superoxide metabolic process,BP,EGFR;TGFB1
8424,GO:0033483,0.572576978609113,0.810847386128682,1,8,gas homeostasis,BP,ADNP
16994,GO:0098993,0.572586978407267,0.810839543200512,1,8,anchored component of synaptic vesicle membrane,CC,RAB3B
18348,GO:1903265,0.572781007900262,0.810687319118751,1,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,CASP4
15652,GO:0072132,0.572788007792204,0.664796066165763,3,27,mesenchyme morphogenesis,BP,ACTA2;TGFBR2;FGFR1
4222,GO:0009395,0.57315370645651,0.663932875920887,3,28,phospholipid catabolic process,BP,PLCG1;SMPD3;PNPLA6
3045,GO:0006600,0.57402747793778,0.809707365713564,1,8,creatine metabolic process,BP,GAMT
3574,GO:0007620,0.574374642517378,0.80943379925089,1,8,copulation,BP,SERPINE2
3572,GO:0007618,0.574441147138973,0.711491253630235,2,18,mating,BP,SERPINE2;THRA
5723,GO:0016859,0.574443497865111,0.661359376336745,3,31,cis-trans isomerase activity,MF,FKBP1A;FKBP9;FKBP10
3069,GO:0006636,0.574472302911392,0.662176114579813,3,29,unsaturated fatty acid biosynthetic process,BP,ALOX15B;MIF;ANXA1
9138,GO:0035455,0.574528860525621,0.710551448114823,2,19,response to interferon-alpha,BP,IFITM1;GATA3
3326,GO:0007035,0.574857304002982,0.710244423354216,2,19,vacuolar acidification,BP,DMXL2;TCIRG1
8281,GO:0033077,0.57490428392663,0.610801436513025,5,48,T cell differentiation in thymus,BP,CARD11;FZD8;RAG1;GATA3;ADAM8
442,GO:0001190,0.574918669774107,0.611015863123438,5,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX12;CITED4;PPARA;RERE;WBP2
913,GO:0002295,0.575991594150277,0.808156001767752,1,8,T-helper cell lineage commitment,BP,ZFPM1
10490,GO:0043373,0.575991594150277,0.808156001767752,1,8,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
599,GO:0001764,0.576101729255359,0.563467156330784,9,85,neuron migration,BP,NAV1;GATA3;SDCCAG8;FYN;FGFR1;ZNF609;NDE1;ARHGEF2;ITGA3
11910,GO:0046915,0.576173012858116,0.660984722553288,3,28,transition metal ion transmembrane transporter activity,MF,ATP7B;ATP2C2;SLC30A1
4076,GO:0009128,0.576306508117585,0.807906442811353,1,8,purine nucleoside monophosphate catabolic process,BP,NT5E
4105,GO:0009158,0.576306508117585,0.807906442811353,1,8,ribonucleoside monophosphate catabolic process,BP,NT5E
4115,GO:0009169,0.576306508117585,0.807906442811353,1,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E
5355,GO:0016114,0.57633177930709,0.807886406347004,1,8,terpenoid biosynthetic process,BP,ALDH1A2
7433,GO:0031529,0.576423498577283,0.630392495659791,4,38,ruffle organization,BP,CORO1B;PFN1;ARFIP2;EPS8L1
3439,GO:0007249,0.576580414665682,0.515147094582683,21,207,I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;SHARPIN;FKBP1A;AKT1;CARD11;IRAK1;SLC20A1;RHOC;MAPKBP1;TGM2;CARD19;FYN;TNFRSF1A;PLEKHG5;SHISA5;MIB2;TNFRSF19;LITAF;ECM1
6530,GO:0021915,0.576599553702474,0.539790300020514,13,124,neural tube development,BP,DVL1;DEAF1;SALL2;PRKACB;SUFU;PKD1;TULP3;ALDH1A2;SPINT2;FUZ;PFN1;VASP;TGFB1
16280,GO:0090317,0.577006131182074,0.659695885285831,3,29,negative regulation of intracellular protein transport,BP,GDI1;UBE2J1;PARP10
11504,GO:0045953,0.577175409438061,0.807216684163929,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
4752,GO:0010921,0.57726854577791,0.534858712103903,14,135,regulation of phosphatase activity,BP,FKBP1A;PPP2R3B;PPP1R35;PPP2R5B;PPP1R12C;FARP1;DLG3;PPP1R14A;ITGA1;MYO1D;CAMSAP3;PPP6R1;PPP1R37;PPP1R10
8101,GO:0032780,0.577490433296423,0.806966179750758,1,8,negative regulation of ATPase activity,BP,OXA1L
65,GO:0000132,0.577509572846836,0.708621304724868,2,18,establishment of mitotic spindle orientation,BP,NDE1;ARHGEF2
9832,GO:0042035,0.577556125336516,0.592352807071501,6,58,regulation of cytokine biosynthetic process,BP,CARD11;UBE2J1;GATA3;ZFPM1;TRIB2;IGF2BP3
10028,GO:0042448,0.577599385096625,0.806879488909763,1,8,progesterone metabolic process,BP,DGKQ
10991,GO:0044773,0.578018399495837,0.554100465390626,10,99,mitotic DNA damage checkpoint,BP,CCND1;XPC;ZNF385A;PCBP4;HMGA2;BRSK1;TAOK1;CNOT11;PPP1R10;EP300
14901,GO:0070673,0.57807944320445,0.806497189706484,1,8,response to interleukin-18,BP,AKT1
1179,GO:0002823,0.578194152274349,0.707978653362776,2,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ARG1;CEACAM1
3944,GO:0008631,0.578469852142582,0.628039226961164,4,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,STK25;P4HB;AKT1;STK24
8247,GO:0033008,0.578479426022548,0.806178252784391,1,8,positive regulation of mast cell activation involved in immune response,BP,STXBP1
10459,GO:0043306,0.578479426022548,0.806178252784391,1,8,positive regulation of mast cell degranulation,BP,STXBP1
16275,GO:0090312,0.578592193764291,0.707604594781995,2,18,positive regulation of protein deacetylation,BP,CTBP1;TGFB1
11101,GO:0045087,0.578803006237226,0.478015220505523,56,561,innate immune response,BP,TNIP1;MST1R;CYP27B1;NR1D1;IFI6;PSMD2;PTPRS;RAB43;LCN2;MAPKAPK3;CTSB;PRKACA;ADARB1;IFITM1;CARD11;IRAK1;SERPING1;ARG2;RNF135;HIST2H2BE;PTK6;FAM3A;PRKACB;CD44;PAK1;IFI27;GATA3;OASL;IL1RAP;MT2A;ADAM8;FLNB;SRC;IRF7;STXBP1;OAS1;FYN;ISG20;PSMD7;PUM1;CTSL;HEXIM1;F12;MIF;RNASE7;SDHAF4;ARG1;SEC14L1;CASP4;ARHGEF2;ADAM15;CEACAM1;TGFB1;ANXA1;APOBEC3C;EP300
9212,GO:0035588,0.578872304152506,0.805864620840416,1,8,G-protein coupled purinergic receptor signaling pathway,BP,GNAI2
13930,GO:0060561,0.578938897558735,0.707278543351916,2,18,apoptotic process involved in morphogenesis,BP,LRP5;VDR
11862,GO:0046825,0.579000574517334,0.627507579149821,4,39,regulation of protein export from nucleus,BP,RAPGEF3;BAG3;IFI27;CAMK1
16112,GO:0090073,0.579080997362061,0.8056978771929,1,8,positive regulation of protein homodimerization activity,BP,STPG1
10060,GO:0042533,0.579109969282101,0.805674720966105,1,8,tumor necrosis factor biosynthetic process,BP,UBE2J1
10061,GO:0042534,0.579109969282101,0.805674720966105,1,8,regulation of tumor necrosis factor biosynthetic process,BP,UBE2J1
11232,GO:0045351,0.579145693290344,0.805646165357216,1,8,type I interferon biosynthetic process,BP,IRF7
9697,GO:0038066,0.579223842404382,0.657991519618454,3,28,p38MAPK cascade,BP,XDH;DLG1;MINK1
10083,GO:0042572,0.579230620059066,0.707004026801363,2,18,retinol metabolic process,BP,RETSAT;ALDH1A2
9139,GO:0035456,0.579445672887773,0.705159411141136,2,20,response to interferon-beta,BP,IFITM1;CDC34
6513,GO:0021885,0.57994939489313,0.627190769533109,4,37,forebrain cell migration,BP,EGFR;LAMB1;MBOAT7;SOCS7
1288,GO:0003093,0.579949602479344,0.805002786750335,1,8,regulation of glomerular filtration,BP,F2R
4407,GO:0010155,0.580018551301138,0.802598582910166,1,9,regulation of proton transport,BP,TMSB4X
11379,GO:0045724,0.580088889581601,0.706195469764928,2,18,positive regulation of cilium assembly,BP,FUZ;WRAP73
3721,GO:0008242,0.580376504893209,0.804660521728905,1,8,omega peptidase activity,MF,GGT1
14899,GO:0070671,0.580494776162554,0.625439927487473,4,41,response to interleukin-12,BP,P4HB;MSN;TALDO1;MIF
8614,GO:0034116,0.581471208756913,0.803780916382717,1,8,positive regulation of heterotypic cell-cell adhesion,BP,CD44
4919,GO:0014855,0.581809774262933,0.625323244250093,4,37,striated muscle cell proliferation,BP,TGFBR2;FGFR1;FGF2;RXRA
14913,GO:0070700,0.581886354542813,0.803446612587899,1,8,BMP receptor binding,MF,TGFB1
12961,GO:0051301,0.581890426021221,0.47699533739314,52,508,cell division,BP,PGF;CCND1;WNT7A;SNX9;ETV5;MARK4;CCNG2;SEPT10;SNX33;WWTR1;VPS4A;SEPT5;CCND2;TACC1;GIT1;PAK1;CUL7;SDCCAG3;RHOC;SEPT8;ARL8A;GNAI2;NEK9;HMGA2;RHOBTB2;TOP1;NUMB;GIPC1;CHMP5;PAK6;SPECC1L;REEP4;MISP;FGFR1;TTC19;RAB11FIP4;BCL2L1;MAU2;PAK4;SPIRE1;FGF2;RHOBTB1;VEGFB;TGFA;NDE1;CIB1;ARHGEF2;MPLKIP;SAC3D1;CCNE1;TGFB1;CAT
4098,GO:0009151,0.581933325808888,0.801044963513679,1,9,purine deoxyribonucleotide metabolic process,BP,GUK1
3058,GO:0006621,0.581984543723877,0.80336748514968,1,8,protein retention in ER lumen,BP,KDELR1
11906,GO:0046907,0.582010685697515,0.454385636380741,147,1460,intracellular transport,BP,EDEM1;LTBP2;SH3TC2;RAC2;SORL1;MAP2K1;SNX9;AP3D1;LMF1;CPT2;XPOT;RAB3B;RAPGEF3;PRNP;RAB43;COPG1;SNPH;BBS2;BCR;RAB31;EVI5L;RTN2;FYCO1;MAP2K2;SNX33;AKT1;BAG3;APOE;EHD3;ATP13A2;AP1B1;SYVN1;YIF1A;AP2A2;PRKCZ;ATP7B;VPS11;VPS4A;PITRM1;CTSZ;TMEM129;PCSK9;SEPT5;SEC23A;MSN;MAP1B;GDI1;MVB12B;CREB3L2;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;BIN1;CCDC88C;PAK1;TBC1D9B;GGA3;GGA1;STOM;SYTL1;SDCCAG3;RAB29;CORO7;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;DOPEY2;DYNLRB1;VAMP2;PIP5K1C;GIPC1;SRC;LDLRAP1;CHMP5;DENND2A;SCG5;PEX10;DNM2;REEP6;NUCB1;RAB1B;STX5;TOM1L2;COG8;RERE;GSK3A;STXBP1;FYN;RAB25;KIF17;KIF13B;STX10;MCFD2;SEC24C;VPS37A;RAB11FIP4;ARFIP2;MGRN1;USO1;TBC1D20;SPIRE1;EHD4;VAPB;COG1;MYO1D;LMAN1;TBC1D2B;TGFA;NDE1;CAMSAP3;RPL28;SNAP29;LONP2;CAMK1;HGS;CBL;TRAPPC1;CIB1;RAB4B;MAPK3;CPT1B;CSNK1D;ARHGEF2;SNX27;UGCG;HM13;APBA1;ARHGAP44;CD59;TGFB1;PPP6R1;PPP1R10;RAB6A;ZFYVE21;ARCN1;FHOD1
6416,GO:0021670,0.582172730041055,0.803215769071439,1,8,lateral ventricle development,BP,NUMB
7376,GO:0031418,0.582226636490951,0.70417563553274,2,18,L-ascorbic acid binding,MF,P4HA1;PHYH
10662,GO:0043691,0.582432875918731,0.80300590289593,1,8,reverse cholesterol transport,BP,APOE
13305,GO:0051974,0.58248869867518,0.802960848678629,1,8,negative regulation of telomerase activity,BP,SRC
4760,GO:0010935,0.582554517390638,0.802907717425152,1,8,regulation of macrophage cytokine production,BP,TGFB1
7349,GO:0031371,0.582662051094112,0.802820890532325,1,8,ubiquitin conjugating enzyme complex,CC,STUB1
10741,GO:0044088,0.582788632271014,0.624011250311042,4,38,regulation of vacuole organization,BP,TBC1D14;LRSAM1;RAB1B;ULK1
5598,GO:0016624,0.582803515896551,0.802706625166513,1,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1
6848,GO:0030309,0.582831939198925,0.802683661163603,1,8,poly-N-acetyllactosamine metabolic process,BP,B3GNT3
6849,GO:0030311,0.582831939198925,0.802683661163603,1,8,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT3
3711,GO:0008227,0.582895120315708,0.802632608555216,1,8,G-protein coupled amine receptor activity,MF,HTR7
20264,GO:2001171,0.583107590739877,0.703340812545488,2,18,positive regulation of ATP biosynthetic process,BP,TMSB4X;TAZ
3293,GO:0006987,0.583529896433706,0.802119168091695,1,8,activation of signaling protein activity involved in unfolded protein response,BP,VAPB
9338,GO:0035809,0.583631949461296,0.802036534126284,1,8,regulation of urine volume,BP,ADCY6
11265,GO:0045471,0.58389479011682,0.573263267840843,7,70,response to ethanol,BP,CCND1;DNMT3A;ADCY7;GATA3;FYN;CBL;CAT
15471,GO:0071782,0.583899874294744,0.702588787639127,2,18,endoplasmic reticulum tubular network,CC,ASPH;STIM1
12986,GO:0051349,0.58390289440467,0.801817027203615,1,8,positive regulation of lyase activity,BP,NOS1
19202,GO:1905216,0.584026008414873,0.801717229081276,1,8,positive regulation of RNA binding,BP,LARP6
13789,GO:0060347,0.584120401879357,0.801640688187823,1,8,heart trabecula formation,BP,FKBP1A
4258,GO:0009583,0.584337622412876,0.652941961332341,3,28,detection of light stimulus,BP,PITPNM1;GNB1;REEP6
12861,GO:0051152,0.58434882997928,0.801455375961812,1,8,positive regulation of smooth muscle cell differentiation,BP,TGFB1
13603,GO:0060050,0.584469266837037,0.801357622252542,1,8,positive regulation of protein glycosylation,BP,POMT1
3365,GO:0007129,0.584572540479679,0.70194938668508,2,18,synapsis,BP,AGO4;CCNE1
8337,GO:0033176,0.584579253805951,0.700283376498731,2,20,proton-transporting V-type ATPase complex,CC,TCIRG1;ATP6V1C2
7035,GO:0030803,0.584862513945142,0.801038202149209,1,8,negative regulation of cyclic nucleotide biosynthetic process,BP,GNAI2
7050,GO:0030818,0.584862513945142,0.801038202149209,1,8,negative regulation of cAMP biosynthetic process,BP,GNAI2
5808,GO:0017059,0.584978005373726,0.800944323636856,1,8,serine C-palmitoyltransferase complex,CC,SPTLC2
7258,GO:0031211,0.584978005373726,0.800944323636856,1,8,endoplasmic reticulum palmitoyltransferase complex,CC,SPTLC2
19448,GO:1905961,0.584978005373726,0.800944323636856,1,8,protein-cysteine S-palmitoyltransferase complex,CC,SPTLC2
10611,GO:0043574,0.585337428993051,0.701221301273939,2,18,peroxisomal transport,BP,PEX10;LONP2
15797,GO:0072384,0.585349953903476,0.572030414547772,7,68,organelle transport along microtubule,BP,AP3D1;COPG1;FYCO1;PRKCZ;MAP1B;NDE1;RAB6A
13733,GO:0060272,0.585371957076231,0.800623859361624,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
8102,GO:0032781,0.585446705177716,0.620447247138386,4,41,positive regulation of ATPase activity,BP,TMSB4X;DNM2;PFN1;HSPA2
18307,GO:1903170,0.585909408038494,0.699797597349959,2,19,negative regulation of calcium ion transmembrane transport,BP,NTSR1;TGFB1
6846,GO:0030307,0.585985847373857,0.534545798559196,12,119,positive regulation of cell growth,BP,EGFR;MMP14;AKT1;MAP1B;GDI1;LIMK1;TWF2;PAK1;LPAR3;ADNP;HYAL1;CIB1
5206,GO:0015802,0.586007486591018,0.800106110241184,1,8,basic amino acid transport,BP,ARG1
6056,GO:0019200,0.586034447312714,0.700556871273922,2,18,carbohydrate kinase activity,MF,HK1;PFKP
13720,GO:0060252,0.586676856946726,0.799559761312356,1,8,positive regulation of glial cell proliferation,BP,ETV5
12735,GO:0050951,0.586729530492069,0.799516723540261,1,8,sensory perception of temperature stimulus,BP,NTSR1
13506,GO:0055023,0.587060872886078,0.699576784558551,2,18,positive regulation of cardiac muscle tissue growth,BP,FGFR1;FGF2
7992,GO:0032602,0.587373940370077,0.597518273266636,5,51,chemokine production,BP,POSTN;ARG2;ALOX15B;MIF;ZFPM1
5735,GO:0016878,0.587380024694369,0.699271639894753,2,18,acid-thiol ligase activity,MF,ACSF2;SLC27A1
722,GO:0001945,0.588002470177267,0.698675964390635,2,18,lymph vessel development,BP,ACVR2B;PKD1
5734,GO:0016877,0.588044661805052,0.649255953896487,3,28,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;UBA1;SLC27A1
3282,GO:0006971,0.58811155567707,0.798385170706995,1,8,hypotonic response,BP,STK39
11090,GO:0045076,0.588150660900292,0.798353086885109,1,8,regulation of interleukin-2 biosynthetic process,BP,CARD11
5680,GO:0016788,0.588199840765109,0.468009190198091,57,556,hydrolase activity, acting on ester bonds,MF,NT5E;ERCC1;MAP2K1;DLG1;PTPRS;SBF1;SSH1;PLCH2;ACOT7;HAGH;AARS;H6PD;PGLS;ACOT1;PTPRF;ACOT13;GALNS;PPP2R3B;PTPDC1;ENDOG;PLD3;PLCXD1;PLCG1;NLGN2;DTD1;RAG1;DUSP4;GNB1;PTPN9;DNASE1L1;PPM1M;PTPRU;NEIL1;TMEM8A;PLCB3;EDNRA;DUSP6;ISG20;PPM1F;ABHD17C;SSU72;MGLL;LHPP;MTMR4;NT5DC2;PTPN12;PLCD3;ACP7;SMPD3;RNASE7;BPHL;ARSK;LACTB2;OCRL;PNPLA6;LPIN3;ARSD
14275,GO:0061307,0.588294296181867,0.798235210374432,1,8,cardiac neural crest cell differentiation involved in heart development,BP,MAPK3
14276,GO:0061308,0.588294296181867,0.798235210374432,1,8,cardiac neural crest cell development involved in heart development,BP,MAPK3
242,GO:0000506,0.588503743500436,0.795648260156662,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGQ
1119,GO:0002705,0.588582753339325,0.580755680762274,6,60,positive regulation of leukocyte mediated immunity,BP,PRKCZ;GATA3;STXBP1;ZP3;ARG1;TGFB1
15387,GO:0071609,0.588634503460087,0.797955818563863,1,8,chemokine (C-C motif) ligand 5 production,BP,ARG2
2573,GO:0005858,0.588705063428108,0.797897837466861,1,8,axonemal dynein complex,CC,DYNLRB1
6913,GO:0030496,0.588711252670826,0.515865318849888,16,156,midbody,CC,PITPNM1;SSH1;PKN1;VPS4A;GDI1;TACC1;SDCCAG3;ARL8A;GNAI2;CAPG;DNM2;EXOC2;MICAL1;TTC19;RAB11FIP4;MPLKIP
18262,GO:1903044,0.588967032865833,0.797682466299296,1,8,protein localization to membrane raft,BP,REEP2
8699,GO:0034314,0.589129101583537,0.647691688591299,3,29,Arp2/3 complex-mediated actin nucleation,BP,CORO1B;ARPC1A;ARFIP2
8305,GO:0033129,0.589160559215711,0.79752325894695,1,8,positive regulation of histone phosphorylation,BP,MAPK3
2667,GO:0006013,0.58917691578707,0.797509798884997,1,8,mannose metabolic process,BP,MPI
5835,GO:0017112,0.589301228208528,0.595961919921877,5,49,Rab guanyl-nucleotide exchange factor activity,MF,SBF1;RIN2;RIN1;DENND2A;TRAPPC1
7794,GO:0032329,0.589344809231796,0.797371600079122,1,8,serine transport,BP,SERINC2
4157,GO:0009218,0.589370786413876,0.695688100687887,2,20,pyrimidine ribonucleotide metabolic process,BP,NME4;UCKL1
381,GO:0001013,0.589484100809871,0.797256893499427,1,8,RNA polymerase I regulatory region DNA binding,MF,BAZ2A
435,GO:0001163,0.589484100809871,0.797256893499427,1,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,BAZ2A
436,GO:0001164,0.589484100809871,0.797256893499427,1,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,BAZ2A
441,GO:0001188,0.589484100809871,0.797256893499427,1,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,BAZ2A
7642,GO:0032045,0.58951178901992,0.7972340867592,1,8,guanyl-nucleotide exchange factor complex,CC,ULK1
16813,GO:0098632,0.589996261117484,0.646824220576489,3,29,cell-cell adhesion mediator activity,MF,PAK4;BAIAP2L1;ANXA1
6333,GO:0020027,0.59018751589226,0.796676924946333,1,8,hemoglobin metabolic process,BP,CAT
5865,GO:0017162,0.590220689564007,0.796649543980649,1,8,aryl hydrocarbon receptor binding,MF,TAF6
5763,GO:0016922,0.59041357319322,0.696361699204962,2,18,ligand-dependent nuclear receptor binding,MF,BAZ2A;RXRA
8338,GO:0033177,0.590933487803138,0.79362658656218,1,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,TCIRG1
7971,GO:0032570,0.591183043923855,0.64563509481781,3,29,response to progesterone,BP,SRC;TGFB1;WBP2
6327,GO:0019992,0.591518435831881,0.795576343121484,1,8,diacylglycerol binding,MF,PLTP
10872,GO:0044380,0.591604839885145,0.594054647558209,5,47,protein localization to cytoskeleton,BP,DVL1;NUDCD3;TTBK2;ABHD17C;CSNK1D
7107,GO:0030898,0.591619015342333,0.795492998330262,1,8,actin-dependent ATPase activity,MF,MYO1D
4518,GO:0010566,0.591849284583859,0.795302095397658,1,8,regulation of ketone biosynthetic process,BP,DGKQ
131,GO:0000271,0.591928602251969,0.577640339728936,6,58,polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;B3GNT3;GSK3A;TGFB1
14600,GO:0070127,0.592538165537827,0.794730224555738,1,8,tRNA aminoacylation for mitochondrial protein translation,BP,GARS
19071,GO:1904886,0.592639994468911,0.694214982300214,2,18,beta-catenin destruction complex disassembly,BP,DVL1;LRP5
5304,GO:0015991,0.59312277965518,0.692059769686137,2,20,ATP hydrolysis coupled proton transport,BP,TCIRG1;ATP6V1C2
9884,GO:0042136,0.593145979811255,0.576214448242499,6,59,neurotransmitter biosynthetic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;P2RX4
10843,GO:0044327,0.593578262883123,0.793864632582972,1,8,dendritic spine head,CC,DNM2
7315,GO:0031313,0.593598507185191,0.793847758993386,1,8,extrinsic component of endosome membrane,CC,ANXA1
15501,GO:0071837,0.59391865145064,0.7935807880218,1,8,HMG box domain binding,MF,GATA3
4874,GO:0014733,0.59399520491363,0.793516912841119,1,8,regulation of skeletal muscle adaptation,BP,TNNT1
19528,GO:1990314,0.59409752380724,0.793431517260592,1,8,cellular response to insulin-like growth factor stimulus,BP,TGFB1
9985,GO:0042364,0.594172745951719,0.793368720578925,1,8,water-soluble vitamin biosynthetic process,BP,PSAT1
12807,GO:0051082,0.594177615498966,0.53720513872638,10,102,unfolded protein binding,MF,NUDCD3;FYCO1;SYVN1;DNAJB5;ERO1B;SCG5;DNAJC4;HSPA2;HSPA13;LMAN1
10277,GO:0043008,0.59429321136757,0.793268125625042,1,8,ATP-dependent protein binding,MF,PRNP
10085,GO:0042574,0.594293549584942,0.793267843145661,1,8,retinal metabolic process,BP,ALDH1A2
16494,GO:0097157,0.59433355988284,0.793234424663034,1,8,pre-mRNA intronic binding,MF,EP300
361,GO:0000979,0.594417413101537,0.642383037603788,3,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,IRF7;RREB1;WBP2
3633,GO:0008097,0.594449292788473,0.788721764869869,1,10,5S rRNA binding,MF,TST
3212,GO:0006857,0.594506859294425,0.793089632210674,1,8,oligopeptide transport,BP,SLC15A1
5016,GO:0015174,0.594936782764106,0.792730115902251,1,8,basic amino acid transmembrane transporter activity,MF,TMEM44
14099,GO:0060896,0.594937842914126,0.792729228817325,1,8,neural plate pattern specification,BP,FUZ
10985,GO:0044764,0.594953416947191,0.641842500423733,3,29,multi-organism cellular process,BP,IRF7;PUM1;SEC14L1
17863,GO:1902004,0.594979361535435,0.792694485798159,1,8,positive regulation of amyloid-beta formation,BP,GSK3A
13159,GO:0051705,0.595439048513066,0.611163982655146,4,38,multi-organism behavior,BP,DVL1;DLG4;SHANK3;SHANK2
16353,GO:0090559,0.595534534459607,0.561123602015824,7,71,regulation of membrane permeability,BP,BOK;BNIP3;BNIP3L;STPG1;GSK3A;MOAP1;BCL2L1
12213,GO:0048368,0.595589468184601,0.792183464070362,1,8,lateral mesoderm development,BP,FGFR1
7044,GO:0030812,0.595645873964364,0.792136173403068,1,8,negative regulation of nucleotide catabolic process,BP,PPARA
14785,GO:0070469,0.595771434451933,0.571152825996644,6,78,respiratory chain,CC,OXA1L;SDHA;NDUFA4L2;TTC19;SDHAF4;NDUFS2
6736,GO:0030149,0.59581329191343,0.690242900076231,2,19,sphingolipid catabolic process,BP,SMPD3;NAGA
15596,GO:0072044,0.595817192388619,0.791992492583742,1,8,collecting duct development,BP,PKD1
6778,GO:0030208,0.596022125770977,0.791820526206533,1,8,dermatan sulfate biosynthetic process,BP,CHST14
12568,GO:0050701,0.596074424003322,0.640258262903555,3,30,interleukin-1 secretion,BP,HK1;ARG2;CPTP
15333,GO:0071514,0.596231938050681,0.690731850654278,2,18,genetic imprinting,BP,DNMT3A;GNAS
6635,GO:0022900,0.596259079136318,0.522794186414594,12,142,electron transport chain,BP,XDH;TSTA3;ASPH;SDHA;AKR7A2;GLRX;TAZ;NDUFA4L2;ALDH4A1;AOX1;CYB561;NDUFS2
5687,GO:0016799,0.596265002551122,0.689000666507428,2,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,NEIL1;MPG
9388,GO:0035909,0.59645787453513,0.690511938853611,2,18,aorta morphogenesis,BP,LRP1;CHD7
6707,GO:0030104,0.59648907970372,0.588790422331838,5,48,water homeostasis,BP,ADCY7;PRKACA;PRKACB;WFS1;ADCY6
3008,GO:0006554,0.596512619690572,0.791408522736821,1,8,lysine catabolic process,BP,ALDH7A1
592,GO:0001754,0.596545033201426,0.690427078305764,2,18,eye photoreceptor cell differentiation,BP,SDK2;NAGLU
1308,GO:0003149,0.596838037947485,0.79113485657216,1,8,membranous septum morphogenesis,BP,TGFBR2
13897,GO:0060502,0.596950933966759,0.791039854552918,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,MAP2K1
6834,GO:0030291,0.597057669226077,0.63926310631293,3,30,protein serine/threonine kinase inhibitor activity,MF,HEXIM1;CIB1;SPRED2
12546,GO:0050671,0.597166287041275,0.559305712467909,7,72,positive regulation of lymphocyte proliferation,BP,CARD11;TGFBR2;IGFBP2;MIF;ZP3;PNP;ANXA1
5741,GO:0016885,0.597186229347649,0.790841753821098,1,8,ligase activity, forming carbon-carbon bonds,MF,PC
4605,GO:0010718,0.59737040456505,0.609183062592578,4,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;BCL9L;TGFB1
16296,GO:0090344,0.597690527594624,0.688410945658855,2,19,negative regulation of cell aging,BP,HMGA2;MIF
8802,GO:0034483,0.597798023557705,0.79032603904393,1,8,heparan sulfate sulfotransferase activity,MF,NDST2
5921,GO:0018193,0.597933938049975,0.445632318379317,97,945,peptidyl-amino acid modification,BP,NOS1;MST1R;MAP2K1;SHC1;ERCC6;NEURL1;DLG4;FKBP1A;MTA1;RAB3B;RAPGEF3;PRNP;SCYL1;CRTAP;MAPKAPK3;FKBP9;BCR;EGFR;CSNK1E;MKNK2;PRKACA;MAP2K2;P4HB;AKT1;ATP13A2;PKN1;SYVN1;PRKCZ;DGKQ;MAPK13;EPHA1;PTK6;TGFBR2;STK39;DKK1;PPP2R5B;UBE2J1;CD44;JADE2;PAK1;TTBK2;RET;CEMIP;PKD1;DLG3;GATA3;PHF1;HSF1;ASPH;CTBP1;HMGA2;TOP1;P4HA1;SRC;FKBP10;TGM2;GSK3A;FYN;PPM1F;TNFRSF1A;BRPF3;PSKH1;MCFD2;MAP3K10;FGFR1;MSL1;ADNP;MIF;ST3GAL3;ST3GAL5;ULK1;LRRK1;FGF2;EHD4;ST6GALNAC2;MAPK9;MAP3K12;RNF222;LMAN1;APBB1;TGFA;CAMK1;EPHB2;CBL;MAPK3;CSNK1D;ARHGEF2;GALNT3;MBD3;TGFB1;WBP2;SPRED2;ERBB3;ASH2L;RAB6A;ASPHD1;EP300
2579,GO:0005868,0.597970371312163,0.687332561176709,2,20,cytoplasmic dynein complex,CC,NUDCD3;DYNLRB1
8199,GO:0032933,0.59832984877631,0.789876993248619,1,8,SREBP signaling pathway,BP,ARHGEF10L
15327,GO:0071501,0.59832984877631,0.789876993248619,1,8,cellular response to sterol depletion,BP,ARHGEF10L
15518,GO:0071872,0.598474870386833,0.789754424705534,1,8,cellular response to epinephrine stimulus,BP,PRKACA
1336,GO:0003188,0.598508441729634,0.789726043746751,1,8,heart valve formation,BP,ZFPM1
5148,GO:0015677,0.598539021227376,0.789700189675754,1,8,copper ion import,BP,ATP7B
8962,GO:0035019,0.598573630662387,0.586194998212321,5,50,somatic stem cell population maintenance,BP,WNT7A;LRP5;EPHA1;BCL9L;FGF2
923,GO:0002315,0.598647448386507,0.78960849927383,1,8,marginal zone B cell differentiation,BP,MFNG
20243,GO:2001135,0.59868177787354,0.789579462880645,1,8,regulation of endocytic recycling,BP,SORL1
5430,GO:0016281,0.598767410603421,0.789507020884045,1,8,eukaryotic translation initiation factor 4F complex,CC,EIF4G3
4443,GO:0010332,0.59896010572982,0.585794444027932,5,50,response to gamma radiation,BP,ERCC6;GATA3;HSF1;BCL2L1;CBL
1107,GO:0002693,0.598963209481638,0.789341315213401,1,8,positive regulation of cellular extravasation,BP,ADAM8
10650,GO:0043650,0.599221716189317,0.789122395940938,1,8,dicarboxylic acid biosynthetic process,BP,GLUD1
16165,GO:0090160,0.599328153961516,0.789032210406253,1,8,Golgi to lysosome transport,BP,EHD3
9131,GO:0035435,0.599411080324714,0.788961927046615,1,8,phosphate ion transmembrane transport,BP,SLC20A1
9874,GO:0042118,0.599436340798405,0.788940514451262,1,8,endothelial cell activation,BP,P2RX4
9833,GO:0042036,0.599612229573764,0.686528631639285,2,19,negative regulation of cytokine biosynthetic process,BP,ZFPM1;TRIB2
416,GO:0001103,0.599696742691838,0.637039105513244,3,29,RNA polymerase II repressing transcription factor binding,MF,MTA1;BBS2;PPARA
1333,GO:0003183,0.599792477514686,0.788638461013227,1,8,mitral valve morphogenesis,BP,ZFPM1
4768,GO:0010950,0.599998139396553,0.51503423931542,13,135,positive regulation of endopeptidase activity,BP,XDH;F2R;BOK;DAP;SOX7;TNFSF15;IFI27;HSF1;ASPH;FAM162A;FYN;PPM1F;CASP4
6263,GO:0019852,0.600003155253499,0.785954251795832,1,9,L-ascorbic acid metabolic process,BP,SLC2A3
17333,GO:0140115,0.600243818993184,0.788255213960019,1,8,export across plasma membrane,BP,DLG1
7117,GO:0030911,0.600409230451326,0.788114633160245,1,8,TPR domain binding,MF,STUB1
19475,GO:1990089,0.600500984425454,0.605644892887514,4,39,response to nerve growth factor,BP,AKT1;CBL;CIB1;CSNK1D
19476,GO:1990090,0.600500984425454,0.605644892887514,4,39,cellular response to nerve growth factor stimulus,BP,AKT1;CBL;CIB1;CSNK1D
14375,GO:0061577,0.600591995310063,0.787959225822307,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
11205,GO:0045294,0.600705857025203,0.787862366237128,1,8,alpha-catenin binding,MF,NUMB
9632,GO:0036490,0.600716392713098,0.787853402154962,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
11130,GO:0045141,0.60071952554963,0.787850736589603,1,8,meiotic telomere clustering,BP,LEMD2
16212,GO:0090220,0.60071952554963,0.787850736589603,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,LEMD2
11909,GO:0046914,0.600795785027404,0.448232618459151,75,734,transition metal ion binding,MF,XDH;NOS1;CYP27B1;PCK2;NR1D1;TRIM65;MMP1;MTA1;PRNP;CYGB;LCN2;RNPEPL1;MARCH9;USP20;ZCCHC14;MMP14;SHANK3;ATP13A2;ARG2;NPEPL1;RABGGTA;PHC2;ATP7B;FAM20C;ZMIZ2;SEC23A;PPARA;IDE;MSRB2;HMGCL;MMP10;ZNF385A;RAG1;GLUL;HLTF;GATA3;PPM1M;ALOX15B;MT2A;ADAM8;NEIL1;P4HA1;APLP2;PEX10;UBR4;ZCCHC24;RERE;PRIMPOL;MPI;VDR;THRA;TIMP1;LOXL1;SEC24C;ADNP;PHF2;MIB2;ZDBF2;ZFPL1;AOX1;P2RX4;PHYH;RXRA;ARG1;L3MBTL3;VAT1;LACTB2;LITAF;GLO1;ARHGEF2;GALNT3;APOBEC3C;ZNF318;EP300;TRAF7
2747,GO:0006144,0.600994398742359,0.685170418995275,2,19,purine nucleobase metabolic process,BP,XDH;AOX1
14513,GO:0061951,0.601288883252415,0.604831531300446,4,39,establishment of protein localization to plasma membrane,BP,BBS2;RAB31;VAMP2;ARHGAP44
13131,GO:0051647,0.601289276615152,0.685786009716332,2,18,nucleus localization,BP,BIN1;FHOD1
19833,GO:2000242,0.60163634946491,0.634608624111486,3,30,negative regulation of reproductive process,BP,PRKACB;TIMP1;ZP3
5585,GO:0016600,0.601897055519901,0.786847128357942,1,8,flotillin complex,CC,CBL
10537,GO:0043462,0.602200751261041,0.582024089521268,5,52,regulation of ATPase activity,BP,TMSB4X;OXA1L;DNM2;PFN1;HSPA2
16204,GO:0090207,0.602242519525418,0.683940777549868,2,19,regulation of triglyceride metabolic process,BP,LMF1;APOE
5727,GO:0016863,0.602422168605418,0.781869935078052,1,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,MIF
18626,GO:1903867,0.6024558487862,0.786369673526437,1,8,extraembryonic membrane development,BP,HTRA1
8443,GO:0033554,0.60246007003768,0.431831505793697,165,1621,cellular response to stress,BP,EDEM1;XDH;CBS;ERCC1;CHAC1;CCND1;NFATC4;MAP2K1;SHC1;WNT7A;ERCC6;CST3;BOK;DLG1;DAP;DNMT3A;PSMD2;MTA1;RPS6KA2;NET1;PTPRS;BNIP3;TXNDC11;SESN2;NACC2;ETV5;XBP1;MAP4K4;EGFR;CSNK1E;PRKACA;PTPRF;MAP2K2;STK25;ATF4;P4HB;PDIA5;AKT1;XPC;IRAK1;BAG3;APOE;ATP13A2;ARG2;PKN1;SYVN1;YIF1A;TSPYL2;MAPK13;FZD8;TMEM129;FBXO2;PCSK9;ENDOG;NSMCE4A;LAMB2;SERPINB6;STK39;DKK1;CREB3L2;PPP2R5B;UBE2J1;BNIP3L;SIPA1;CD44;ATG13;SEC63;MAP3K9;MC1R;PRDX5;CCDC88C;PAK1;ZNF385A;DDIT3;GLUL;CUL7;GNB1;GAS2L1;PCBP4;ASS1;PHF1;UBXN4;MYOF;HSF1;WFS1;ADAM8;NEIL1;TFPI2;MPG;PYCR2;HMGA2;MYDGF;SRC;POLD4;DNM2;FAM162A;IRF7;HIST3H2A;STK24;ACADVL;PAK6;YPEL3;GPX3;GSK3A;PRIMPOL;ASNS;GRINA;PSMD7;TNFRSF1A;BRSK1;MOAP1;SHISA5;COMT;MAP3K10;UBA1;HSF4;MIF;BCL2L1;STUB1;TRIB3;DDB2;RAD23A;ULK1;HSPA2;PAK4;TNFRSF19;MAP1LC3B;VAPB;MAPK9;MAP3K12;TMX4;HSPA13;TAOK1;APBB1;ARG1;ZBTB4;CNOT11;IMPACT;CASP4;POLM;CBL;CIB1;MAPK3;EEPD1;POMT1;MAPK10;DNAJB9;ARHGEF2;RNF103;C12ORF66;AIDA;HM13;MINK1;TFPT;CAT;RMI2;SPRED2;PIK3R2;ANXA1;PPP1R10;ASH2L;PXN;ARHGEF10L;EP300;ERP44
652,GO:0001840,0.602503224434819,0.786329158471305,1,8,neural plate development,BP,DVL1
8245,GO:0033006,0.602591676350059,0.683596253362684,2,19,regulation of mast cell activation involved in immune response,BP,RAC2;STXBP1
10457,GO:0043304,0.602591676350059,0.683596253362684,2,19,regulation of mast cell degranulation,BP,RAC2;STXBP1
14039,GO:0060742,0.603248413715683,0.785691152089346,1,8,epithelial cell differentiation involved in prostate gland development,BP,RXRA
564,GO:0001702,0.603382928630632,0.683724133669956,2,18,gastrulation with mouth forming second,BP,LRP5;ACVR2B
7579,GO:0031936,0.603487030415754,0.785486565957397,1,8,negative regulation of chromatin silencing,BP,PHF2
13155,GO:0051701,0.603493702979834,0.500354186402787,16,160,interaction with host,BP,TNIP1;PC;CTSB;ITGB5;EGFR;P4HB;IFITM1;VPS4A;IDE;SRC;EXOC2;BCL2L1;VAPB;RXRA;CBL;TGFB1
14663,GO:0070234,0.603500726921596,0.78294174451146,1,9,positive regulation of T cell apoptotic process,BP,ADAM8
336,GO:0000931,0.603619401830636,0.785373012012257,1,8,gamma-tubulin large complex,CC,MZT2B
3737,GO:0008274,0.603619401830636,0.785373012012257,1,8,gamma-tubulin ring complex,CC,MZT2B
1802,GO:0004439,0.603680684956175,0.785320425985325,1,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,OCRL
5387,GO:0016208,0.603688462394214,0.782779188550321,1,9,AMP binding,MF,PYGL
9715,GO:0038110,0.603914280473582,0.785119896192107,1,8,interleukin-2-mediated signaling pathway,BP,SHC1
9395,GO:0035924,0.603927096486274,0.632724759248225,3,29,cellular response to vascular endothelial growth factor stimulus,BP,XDH;AKT1;ANXA1
18012,GO:1902414,0.604074424818697,0.784982342282483,1,8,protein localization to cell junction,BP,MAPK9
1425,GO:0003373,0.604097653997011,0.784962384596368,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM2
1426,GO:0003374,0.604097653997011,0.784962384596368,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM2
18820,GO:1904321,0.604216795934775,0.784860001027019,1,8,response to forskolin,BP,ADCY6
18821,GO:1904322,0.604216795934775,0.784860001027019,1,8,cellular response to forskolin,BP,ADCY6
9192,GO:0035562,0.604598921757298,0.784531386791162,1,8,negative regulation of chromatin binding,BP,NFATC4
15156,GO:0071233,0.604719129316608,0.78442793767741,1,8,cellular response to leucine,BP,SESN2
12695,GO:0050884,0.604908071382105,0.784265263911054,1,8,neuromuscular process controlling posture,BP,ADARB1
15525,GO:0071880,0.605094344013365,0.784104801532611,1,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
18831,GO:1904354,0.605153986164132,0.784053405254405,1,8,negative regulation of telomere capping,BP,ERCC1
3611,GO:0008053,0.605567917421648,0.679833350449751,2,20,mitochondrial fusion,BP,BNIP3;VAT1
392,GO:0001047,0.605664280473389,0.514194890098967,12,117,core promoter binding,MF,NR1D1;MTA1;XBP1;ATF4;BAZ2A;GATA3;HMGA2;TOP1;IRF7;RREB1;WBP2;EP300
15433,GO:0071679,0.605911019206844,0.783400266522807,1,8,commissural neuron axon guidance,BP,EPHB2
16233,GO:0090257,0.606072711965433,0.513590215873288,12,120,regulation of muscle system process,BP,NOS1;F2R;DOCK4;DLG1;TNNT1;PRKACA;EHD3;PAK1;GSK3A;MTMR4;P2RX4;MYL9
7256,GO:0031209,0.606269964789224,0.783090082827016,1,8,SCAR complex,CC,WASF2
17656,GO:1901343,0.606484782393037,0.55008113128915,7,68,negative regulation of vasculature development,BP,XDH;FAM129B;THBS2;EPN1;EPN2;ADGRB2;HGS
7151,GO:0030991,0.606542061053985,0.782854735839298,1,8,intraciliary transport particle A,CC,TULP3
13848,GO:0060425,0.606571926670798,0.599355160072456,4,39,lung morphogenesis,BP,MAP2K1;CTSZ;TGFBR2;MAPK3
2432,GO:0005614,0.606974889075376,0.782479984241725,1,8,interstitial matrix,CC,VWA1
17377,GO:1900044,0.60724225018595,0.782248263232519,1,8,regulation of protein K63-linked ubiquitination,BP,PARP10
2774,GO:0006198,0.607308907520178,0.78219046366836,1,8,cAMP catabolic process,BP,RAPGEF3
8829,GO:0034596,0.60745170819877,0.782066601628099,1,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,OCRL
3590,GO:0008016,0.607470321542656,0.517473935724551,11,109,regulation of heart contraction,BP,NOS1;DLG1;PRKACA;EHD3;ITPR3;APLN;ASPH;GSK3A;THRA;P2RX4;STIM1
13231,GO:0051864,0.607647791881351,0.781896439885848,1,8,histone demethylase activity (H3-K36 specific),MF,KDM4B
14828,GO:0070544,0.607647791881351,0.781896439885848,1,8,histone H3-K36 demethylation,BP,KDM4B
19244,GO:1905330,0.607717859682759,0.50286935377126,14,144,regulation of morphogenesis of an epithelium,BP,DVL1;PSMD2;SMURF2;ETV5;GPC4;AP2A2;DKK1;GATA3;PFN1;PSMD7;FGFR1;RREB1;RXRA;TGFB1
5462,GO:0016338,0.607844052431031,0.779158439885023,1,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN12
12337,GO:0048672,0.607934674288051,0.779078999395342,1,9,positive regulation of collateral sprouting,BP,LPAR3
9091,GO:0035336,0.608085705132971,0.678144059937987,2,19,long-chain fatty-acyl-CoA metabolic process,BP,ACOT7;ELOVL1
17604,GO:1901203,0.608323998552155,0.781308887003884,1,8,positive regulation of extracellular matrix assembly,BP,TGFB1
16351,GO:0090557,0.608418999447726,0.781226249207194,1,8,establishment of endothelial intestinal barrier,BP,PTPRS
11604,GO:0046165,0.608558394785008,0.516199908034496,11,111,alcohol biosynthetic process,BP,CYP27B1;PCK2;APOE;ISYNA1;SRD5A3;PMVK;SPTLC2;VDR;NTSR1;FGF2;SEC14L2
13906,GO:0060525,0.60865521007548,0.781020679952043,1,8,prostate glandular acinus development,BP,RXRA
5402,GO:0016236,0.608754199123812,0.471203368964547,27,270,macroautophagy,BP,QSOX1;BNIP3;SESN2;FYCO1;PRKACA;AKT1;ATG16L2;ATP13A2;VPS4A;BNIP3L;ATG13;TBC1D14;SRC;LRSAM1;RAB1B;SPTLC2;WDFY3;VPS37A;TCIRG1;ULK1;ULK2;MAP1LC3B;ATP6V1C2;SNAP29;HGS;PACS2;MAPK3
4104,GO:0009157,0.608783934389397,0.778333520429846,1,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2
3311,GO:0007016,0.608930507591526,0.780780917169165,1,8,cytoskeletal anchoring at plasma membrane,BP,FLNB
1176,GO:0002820,0.608989239318335,0.677241786319349,2,19,negative regulation of adaptive immune response,BP,ARG1;CEACAM1
15799,GO:0072386,0.609138111476863,0.780599984184942,1,8,plus-end-directed organelle transport along microtubule,BP,FYCO1
4565,GO:0010644,0.60948880106168,0.676742236739148,2,19,cell communication by electrical coupling,BP,PRKACA;GJC2
7466,GO:0031616,0.60957757179979,0.777635223058325,1,9,spindle pole centrosome,CC,NDE1
6127,GO:0019372,0.609614779470701,0.777602446125337,1,9,lipoxygenase pathway,BP,ALOX15B
3586,GO:0007638,0.609765065328296,0.780052916312907,1,8,mechanosensory behavior,BP,SHANK3
10403,GO:0043225,0.609921020765657,0.779916678701019,1,8,ATPase-coupled anion transmembrane transporter activity,MF,PCYOX1
17037,GO:0099133,0.609921020765657,0.779916678701019,1,8,ATP hydrolysis coupled anion transmembrane transport,BP,PCYOX1
8897,GO:0034706,0.609921435840559,0.77991631602356,1,8,sodium channel complex,CC,SCN8A
7505,GO:0031672,0.609976490539074,0.676254088103207,2,19,A band,CC,OBSCN;OBSL1
9793,GO:0039702,0.610458770792509,0.674946730833853,2,20,viral budding via host ESCRT complex,BP,VPS4A;VPS37A
12896,GO:0051205,0.610677986884919,0.594482059234611,4,41,protein insertion into membrane,BP,EGFR;OXA1L;GRIN3B;MOAP1
556,GO:0001678,0.611029443069482,0.526571579100508,9,92,cellular glucose homeostasis,BP,PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;HK1;ENDOG;PIK3R2
17274,GO:0120033,0.611279266657492,0.674947799639796,2,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L;DNM2
7656,GO:0032070,0.611648517586751,0.775805555045581,1,9,regulation of deoxyribonuclease activity,BP,AKT1
13489,GO:0055003,0.611728915976062,0.778332873824281,1,8,cardiac myofibril assembly,BP,OBSL1
5302,GO:0015988,0.611994760490261,0.672659064151061,2,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,TCIRG1;ATP6V1C2
15350,GO:0071550,0.612129493695655,0.775379057647484,1,9,death-inducing signaling complex assembly,BP,TNFRSF1A
1177,GO:0002821,0.612461256422534,0.571474496438877,5,51,positive regulation of adaptive immune response,BP,PRKCZ;GATA3;ZP3;TGFB1;ANXA1
19640,GO:1990748,0.612674686981234,0.554639133285686,6,67,cellular detoxification,BP,CYGB;SESN2;APOE;PRDX5;GPX3;CAT
19943,GO:2000404,0.612712642099295,0.67267907324136,2,20,regulation of T cell migration,BP,ADAM8;ECM1
6544,GO:0021953,0.61277639147292,0.524990178143568,9,89,central nervous system neuron differentiation,BP,WNT7A;CSNK1E;ADARB1;SHANK3;DKK1;SUFU;TULP3;EPHB2;CSNK1D
8207,GO:0032946,0.612843193985376,0.542747176044649,7,73,positive regulation of mononuclear cell proliferation,BP,CARD11;TGFBR2;IGFBP2;MIF;ZP3;PNP;ANXA1
505,GO:0001562,0.612850828712598,0.77473832181911,1,9,response to protozoan,BP,ARG1
10222,GO:0042832,0.612850828712598,0.77473832181911,1,9,defense response to protozoan,BP,ARG1
12645,GO:0050811,0.612966211961983,0.774635707968966,1,9,GABA receptor binding,MF,ARFGEF2
2819,GO:0006284,0.613395184738374,0.591632399369889,4,41,base-excision repair,BP,ERCC6;NEIL1;MPG;HMGA2
1152,GO:0002757,0.613749766416769,0.458480234711117,33,331,immune response-activating signal transduction,BP,TNIP1;RBCK1;NR1D1;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;ARPC1A;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;SRC;IRF7;PAG1;FYN;PSMD7;PUM1;CTSL;SEC14L1;WIPF1;MAPK3;CEACAM1;SKAP2;PIK3R2;EP300
11128,GO:0045136,0.613807436626181,0.773886553619282,1,9,development of secondary sexual characteristics,BP,TGFB1
3946,GO:0008637,0.613874845016808,0.516354621460565,10,105,apoptotic mitochondrial changes,BP,BOK;IFI6;BNIP3;AKT1;BNIP3L;FAM162A;STPG1;GSK3A;MOAP1;BCL2L1
10556,GO:0043496,0.614323883472711,0.671051851700727,2,20,regulation of protein homodimerization activity,BP,STPG1;AIDA
20310,GO:2001244,0.614459161059887,0.589733430470804,4,44,positive regulation of intrinsic apoptotic signaling pathway,BP,BOK;NACC2;DDIT3;BCL2L1
3280,GO:0006968,0.614673600646763,0.671528631626244,2,19,cellular defense response,BP,LGALS3BP;TCIRG1
17712,GO:1901566,0.614738896255829,0.420646955467688,150,1533,organonitrogen compound biosynthetic process,BP,TNIP1;NT5E;CBS;NOS1;CHAC1;SDC1;MAP2K1;PTHLH;NEURL1;LMF1;NAPRT;PGM1;NAGS;IDH2;NME4;SESN2;ACOT7;ABTB1;LY6K;HAGH;CHPF;LPCAT1;AARS;XYLT1;GPT2;ADCY7;EGFR;MKNK2;TK2;CARS;HK1;MAP2K2;XYLT2;ATF4;PSAT1;MRPS6;AKT1;CARD11;GPC4;APOE;ARG2;SYVN1;TMSB4X;RFNG;PFKP;ZNF598;NMRK1;NDST2;UBE2J1;PPARA;DHTKD1;NADK;ZDHHC8;GTPBP1;ELOVL1;LARP6;AHCY;ZNF385A;GAMT;GLUL;BCDIN3D;PTDSS2;ADAMTS7;CEMIP;ASS1;PARP10;GATA3;PIGQ;GNAI2;GLUD1;PPCS;PANK4;IL1RAP;CNDP2;SRD5A3;PYCR2;ALAS1;LY6E;CAP1;B4GALT2;EIF4EBP1;B3GNT3;TAZ;AGO4;GARS;MPI;SPTLC2;AGRN;ASNS;TNFRSF1A;ALDH7A1;ABHD17C;UCKL1;CHST14;PUM1;TNRC6B;MCFD2;LYPD5;EIF2S2;SECISBP2L;RRBP1;MIF4GD;ADNP;HYAL1;MFNG;GUK1;AMPD2;ST3GAL3;VPS9D1;TCIRG1;SLC27A1;ZFPM1;SARS2;ST3GAL5;TRIB2;SAMD4B;SMPD3;PNP;ST6GALNAC2;VAPB;PYM1;ABCA7;LMAN1;MSLN;APBB1;RXRA;ARG1;VEGFB;RPL28;CNOT11;IMPACT;GGT1;MAPK3;NTNG1;POMT1;ALDOC;FURIN;UGCG;B4GALT6;PAIP2;GALNT3;LPIN3;UROS;ADCY6;IGF2BP3;EIF4G3;TGFB1;LDHA;AZIN2;STARD10
11613,GO:0046185,0.614786925107738,0.77301198672184,1,9,aldehyde catabolic process,BP,HAGH
10633,GO:0043620,0.614881165041136,0.515157241651496,10,107,regulation of DNA-templated transcription in response to stress,BP,PSMD2;SESN2;ATF4;BAG3;DDIT3;HSF1;PSMD7;HSF4;IMPACT;EP300
964,GO:0002385,0.614891677839076,0.766558318563225,1,13,mucosal immune response,BP,HIST2H2BE
8871,GO:0034663,0.615100683460439,0.772731317618155,1,9,endoplasmic reticulum chaperone complex,CC,P4HB
7051,GO:0030819,0.615300065814704,0.772552830974234,1,9,positive regulation of cAMP biosynthetic process,BP,PTHLH
18148,GO:1902808,0.615767184317227,0.620030186002128,3,30,positive regulation of cell cycle G1/S phase transition,BP,CCND2;HYAL1;ANXA1
39,GO:0000079,0.615987657329547,0.539537678261909,7,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCND1;EGFR;AKT1;CCND2;PKD1;SRC;HEXIM1
11285,GO:0045576,0.616248515753271,0.619527855719681,3,30,mast cell activation,BP,RAC2;STXBP1;CBL
7325,GO:0031329,0.616544322262805,0.433612484334491,70,692,regulation of cellular catabolic process,BP,EDEM1;DVL1;QSOX1;CST3;SNX9;BOK;TRIM65;DAP;PSMD2;RAPGEF3;BNIP3;SESN2;XBP1;CSNK1E;PANO1;FYCO1;PRKACA;SNX33;AKT1;APOE;ATP13A2;TFEB;VPS11;PCSK9;ENDOG;TYSND1;MSN;UBE2J1;BNIP3L;PPARA;ZDHHC8;ATG13;GTPBP1;ANKIB1;TBC1D14;SUFU;PCBP4;PKD1;HSF1;ADAM8;GIPC1;LRSAM1;RAB1B;CPTP;GSK3A;SPTLC2;PSMD7;PUM1;TNRC6B;TIMP1;STUB1;TRIB3;TPCN1;RAD23A;ULK1;LRP1;TRIB2;SAMD4B;ULK2;MLYCD;ATP6V1C2;LONP2;CARHSP1;MAPK3;CSNK1D;DRAM2;FURIN;IGF2BP3;PIK3R2;EP300
2641,GO:0005976,0.616567965228139,0.529288829398945,8,79,polysaccharide metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;B3GNT3;GSK3A;TGFB1
19731,GO:2000027,0.616873976764222,0.480324398334842,18,184,regulation of organ morphogenesis,BP,DVL1;PSMD2;SMURF2;ETV5;XBP1;GPC4;AP2A2;TGFBR2;DKK1;SP6;GATA3;PFN1;PSMD7;VDR;FGFR1;RXRA;CEACAM1;TGFB1
2559,GO:0005838,0.616915554885115,0.667673595417146,2,21,proteasome regulatory particle,CC,PSMD2;PSMD7
11533,GO:0046033,0.616954106088116,0.771068194020045,1,9,AMP metabolic process,BP,NT5E
17329,GO:0140103,0.617096184287379,0.669074389742001,2,19,catalytic activity, acting on a glycoprotein,MF,B4GALNT4;B3GNT3
20227,GO:2001044,0.617332671367395,0.77072740858864,1,9,regulation of integrin-mediated signaling pathway,BP,TIMP1
10035,GO:0042470,0.617406365291604,0.519826103633842,9,92,melanosome,CC,BSG;CTSB;MMP14;P4HB;AHCY;STOM;SYTL1;RAB29;CAPG
12394,GO:0048770,0.617406365291604,0.519826103633842,9,92,pigment granule,CC,BSG;CTSB;MMP14;P4HB;AHCY;STOM;SYTL1;RAB29;CAPG
15216,GO:0071345,0.617744673687328,0.431010121293174,74,749,cellular response to cytokine stimulus,BP,CCND1;MST1R;RBCK1;SDC1;SHC1;SHARPIN;PCK2;MMP1;IFI6;FKBP1A;POSTN;PSMD2;LAMA5;RAB43;LCN2;BBS2;XBP1;RFX2;PRKACA;P4HB;AKT1;IFITM1;IRAK1;TMSB4X;MAPK13;PFKP;MSN;EPOR;CDC34;CD44;FSCN1;TNFSF15;ADAMTS7;PTPN9;IFI27;GATA3;OASL;IL1RAP;MT2A;ARID5B;FLNB;TNFRSF6B;IRF7;GSK3A;STXBP1;TALDO1;OAS1;FYN;ISG20;PSMD7;TNFRSF1A;TLE4;TIMP1;HYAL1;MIF;SOCS2;BCL2L1;ADIPOR1;PTPN12;SLC27A1;TNFRSF19;FGF2;SLIT3;ARG1;CASP4;CBL;CIB1;SOCS7;MAPK3;ARHGEF2;CEACAM1;ECM1;TGFB1;ANXA1
5811,GO:0017062,0.617917407368393,0.770200299727226,1,9,respiratory chain complex III assembly,BP,TTC19
8819,GO:0034551,0.617917407368393,0.770200299727226,1,9,mitochondrial respiratory chain complex III assembly,BP,TTC19
15877,GO:0072577,0.618223805982023,0.617928871011337,3,29,endothelial cell apoptotic process,BP,ANGPTL4;GATA3;PAK4
11013,GO:0044815,0.618246025235607,0.54649875487284,6,91,DNA packaging complex,CC,H1F0;HIST2H2BE;H2AFJ;HIST3H2A;HIST2H2AC;HIST1H2AG
17635,GO:1901298,0.618261738707315,0.769889489074864,1,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
16307,GO:0090383,0.618558287025185,0.665998604430691,2,21,phagosome acidification,BP,TCIRG1;ATP6V1C2
11603,GO:0046164,0.618683724464071,0.616980534972393,3,30,alcohol catabolic process,BP,APOE;SRD5A3;NTSR1
17732,GO:1901617,0.618801786307127,0.484247778888119,16,161,organic hydroxy compound biosynthetic process,BP,CYP27B1;PCK2;NR1D1;PSAT1;APOE;DGKQ;ISYNA1;GATA3;SRD5A3;PMVK;SPTLC2;VDR;PLTP;NTSR1;FGF2;SEC14L2
20142,GO:2000780,0.61896410442308,0.66717409026361,2,19,negative regulation of double-strand break repair,BP,HSF1;HMGA2
12094,GO:0048027,0.619307111434272,0.664552118220027,2,22,mRNA 5'-UTR binding,MF,LARP6;IGF2BP3
15916,GO:0072666,0.619311607795783,0.585680373612596,4,40,establishment of protein localization to vacuole,BP,SORL1;AP3D1;VPS4A;HGS
11733,GO:0046520,0.619502681724021,0.768766800772893,1,9,sphingoid biosynthetic process,BP,SPTLC2
13277,GO:0051937,0.619710873206996,0.665574106431785,2,20,catecholamine transport,BP,RAB3B;NISCH
12318,GO:0048641,0.619811117301161,0.616265379543042,3,29,regulation of skeletal muscle tissue development,BP,FAM129B;DKK1;TGFB1
13765,GO:0060317,0.619824134964565,0.666296809654931,2,19,cardiac epithelial to mesenchymal transition,BP,TGFBR2;ADAM15
1311,GO:0003156,0.619866726636672,0.665414767436483,2,20,regulation of animal organ formation,BP,DKK1;FGFR1
12597,GO:0050732,0.619885274595693,0.5850726744103,4,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,PRKCZ;PTK6;LRRK1;CBL
5730,GO:0016868,0.620093205926946,0.768231144582455,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
6624,GO:0022843,0.6202972983115,0.584941638289805,4,39,voltage-gated cation channel activity,MF,KCNG1;NCS1;TPCN1;KCNC4
8702,GO:0034329,0.620447063002246,0.476841486661503,18,175,cell junction assembly,BP,FLNC;ITGB4;DLG1;ITGA6;LAMA5;MMP14;PRKACA;FSCN1;LAMC2;RHOC;ARL2;PIP5K1C;SRC;SH3BP1;PPM1F;LAMB3;VASP;CAMSAP3
12987,GO:0051350,0.620492552043221,0.767868388495047,1,9,negative regulation of lyase activity,BP,GNAI2
17771,GO:1901682,0.620552816722057,0.665552353777669,2,19,sulfur compound transmembrane transporter activity,MF,SLC6A6;SLC33A1
5010,GO:0015165,0.620816576385835,0.767573747170803,1,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
6006,GO:0019043,0.620888825506014,0.767508012344347,1,9,establishment of viral latency,BP,IRF7
3945,GO:0008635,0.62089729213954,0.767500308206228,1,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
13001,GO:0051385,0.621340110583162,0.663906030307768,2,20,response to mineralocorticoid,BP,CCND1;SRC
17902,GO:1902116,0.621480300964865,0.61404306789447,3,30,negative regulation of organelle assembly,BP,EVI5L;DNM2;ARHGEF2
10557,GO:0043497,0.621620384810116,0.766841645307195,1,9,regulation of protein heterodimerization activity,BP,HSF1
4073,GO:0009125,0.621755603071182,0.766718323631141,1,9,nucleoside monophosphate catabolic process,BP,NT5E
7026,GO:0030742,0.622152896118579,0.663071879723953,2,20,GTP-dependent protein binding,MF,RAB3B;ARFIP2
749,GO:0001977,0.62235434237446,0.766171686258458,1,9,renal system process involved in regulation of blood volume,BP,F2R
11048,GO:0045006,0.622704695721531,0.763719637826702,1,10,DNA deamination,BP,APOBEC3C
2788,GO:0006222,0.622970148085764,0.76560848679216,1,9,UMP biosynthetic process,BP,UCKL1
4117,GO:0009173,0.622970148085764,0.76560848679216,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UCKL1
4118,GO:0009174,0.622970148085764,0.76560848679216,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UCKL1
11543,GO:0046049,0.622970148085764,0.76560848679216,1,9,UMP metabolic process,BP,UCKL1
10220,GO:0042826,0.623204717429991,0.513832330314495,9,90,histone deacetylase binding,MF,CCND1;UHRF1BP1;MEF2D;NACC2;MIER2;PKN1;WDTC1;RFXANK;CAMTA2
1723,GO:0004312,0.623222252166837,0.765377631785758,1,9,fatty acid synthase activity,MF,ELOVL1
11651,GO:0046348,0.623230748249158,0.76536984890132,1,9,amino sugar catabolic process,BP,CTBS
18013,GO:1902415,0.623260825284548,0.765342295139004,1,9,regulation of mRNA binding,BP,LARP6
13034,GO:0051450,0.623468784188142,0.765151717572462,1,9,myoblast proliferation,BP,ZNF609
15429,GO:0071675,0.623640229353455,0.661542011160673,2,20,regulation of mononuclear cell migration,BP,MAPK3;TGFB1
7305,GO:0031298,0.623948864933578,0.764711327583778,1,9,replication fork protection complex,CC,TOP1
417,GO:0001104,0.62403409035495,0.521129076617445,8,81,RNA polymerase II transcription cofactor activity,MF,ZMYND8;SOX12;CITED4;SIN3B;CTBP1;RERE;MED15;WBP2
16380,GO:0090662,0.624056818756279,0.660352897383933,2,21,ATP hydrolysis coupled transmembrane transport,BP,TCIRG1;ATP6V1C2
17035,GO:0099131,0.624056818756279,0.660352897383933,2,21,ATP hydrolysis coupled ion transmembrane transport,BP,TCIRG1;ATP6V1C2
409,GO:0001094,0.624069039600741,0.764600993371773,1,9,TFIID-class transcription factor binding,MF,ERCC1
1130,GO:0002716,0.624170335067133,0.764507962876825,1,9,negative regulation of natural killer cell mediated immunity,BP,CEACAM1
1115,GO:0002701,0.624316092144127,0.660845346797379,2,20,negative regulation of production of molecular mediator of immune response,BP,ARG1;TGFB1
14843,GO:0070567,0.624510489895871,0.764195364186548,1,9,cytidylyltransferase activity,MF,CDS2
1121,GO:0002707,0.624886453061365,0.660256713814322,2,20,negative regulation of lymphocyte mediated immunity,BP,ARG1;CEACAM1
15991,GO:0080111,0.624894283683465,0.660248627755659,2,20,DNA demethylation,BP,GATA3;APOBEC3C
6296,GO:0019903,0.62502873551734,0.504946693273664,10,99,protein phosphatase binding,MF,DLG4;EGFR;AKT1;STRN4;DLG3;ITGA1;MTMR4;CEACAM1;PPP6R1;PIK3R2
18745,GO:1904153,0.62546079816681,0.763320421546889,1,9,negative regulation of retrograde protein transport, ER to cytosol,BP,UBE2J1
1286,GO:0003085,0.625904308691586,0.762911266591373,1,9,negative regulation of systemic arterial blood pressure,BP,NTSR1
10541,GO:0043471,0.626013611418037,0.762810350713409,1,9,regulation of cellular carbohydrate catabolic process,BP,GSK3A
19866,GO:2000300,0.626208166142391,0.659738250001777,2,19,regulation of synaptic vesicle exocytosis,BP,SEPT5;STXBP1
18177,GO:1902895,0.626299251045689,0.65964407891768,2,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,APLN;TGFB1
11344,GO:0045653,0.62658467960101,0.752271709717699,1,17,negative regulation of megakaryocyte differentiation,BP,CIB1
8238,GO:0032993,0.62660085400312,0.485924652577593,13,163,protein-DNA complex,CC,H1F0;SOX12;HIST2H2BE;H2AFJ;DDIT3;HMGA2;TOP1;POLD4;HIST3H2A;WDR18;HIST2H2AC;HIST1H2AG;EP300
2482,GO:0005719,0.62715577551319,0.657144191338318,2,21,nuclear euchromatin,CC,H1F0;ASH2L
114,GO:0000242,0.627471320440564,0.658430791895491,2,19,pericentriolar material,CC,TUBG2;TUBG1
5137,GO:0015631,0.627499608435541,0.450235362664026,28,276,tubulin binding,MF,CLIP2;PRNP;MARK4;EML2;MAP1B;CCDC88C;TTBK2;GAS2L1;ARL8A;MYH15;FAM110C;DNM2;FYN;REEP4;KIF17;KIF13B;BRSK1;ADNP;MAP1LC3B;VAPB;MYO1D;NDE1;CAMSAP3;GAS8;KIFC3;ARHGEF2;MAP6;STIM1
3897,GO:0008532,0.627581555819593,0.761359224241411,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT3
12608,GO:0050765,0.627723450109359,0.7612275789628,1,9,negative regulation of phagocytosis,BP,TGFB1
17767,GO:1901678,0.627799356366214,0.761157133380992,1,9,iron coordination entity transport,BP,LCN2
18031,GO:1902475,0.62822815501592,0.606901388323068,3,30,L-alpha-amino acid transmembrane transport,BP,SLC43A1;NTSR1;PRAF2
9775,GO:0039530,0.628309578095813,0.760683218145503,1,9,MDA-5 signaling pathway,BP,IRF7
9121,GO:0035404,0.628438382744721,0.760563469194727,1,9,histone-serine phosphorylation,BP,HMGA2
15011,GO:0070911,0.62851695313153,0.605742954907796,3,32,global genome nucleotide-excision repair,BP,ERCC1;XPC;DDB2
3762,GO:0008306,0.628717204197257,0.575656273591428,4,40,associative learning,BP,DEAF1;RAG1;ASIC1;B4GALT2
10258,GO:0042983,0.628722826690277,0.760298866295916,1,9,amyloid precursor protein biosynthetic process,BP,ABCA7
10259,GO:0042984,0.628722826690277,0.760298866295916,1,9,regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
18088,GO:1902622,0.628814719129345,0.655418494667554,2,21,regulation of neutrophil migration,BP,RAC2;ADAM8
890,GO:0002253,0.628920604635536,0.439606580306593,36,363,activation of immune response,BP,TNIP1;RBCK1;NR1D1;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;ARPC1A;SERPING1;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;SRC;IRF7;PAG1;FYN;PSMD7;PUM1;CTSL;HEXIM1;SEC14L1;WIPF1;MAPK3;CEACAM1;SKAP2;CD59;PIK3R2;EP300
3296,GO:0006995,0.62894392340306,0.75792163331707,1,10,cellular response to nitrogen starvation,BP,MAP1LC3B
10604,GO:0043562,0.62894392340306,0.75792163331707,1,10,cellular response to nitrogen levels,BP,MAP1LC3B
16097,GO:0090042,0.629000576791428,0.760040281648527,1,9,tubulin deacetylation,BP,EP300
18221,GO:1902969,0.629045204041757,0.759998714552461,1,9,mitotic DNA replication,BP,FGFR1
10097,GO:0042588,0.629168315573428,0.759884017329253,1,9,zymogen granule,CC,VAMP2
12617,GO:0050774,0.629196797510799,0.759857476271429,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
2687,GO:0006048,0.629539244820474,0.759538194715762,1,9,UDP-N-acetylglucosamine biosynthetic process,BP,UAP1
18101,GO:1902667,0.629816923556884,0.605682234557873,3,29,regulation of axon guidance,BP,SEMA3F;SEMA4B;SEMA4G
2592,GO:0005885,0.630039555301451,0.756892774393794,1,10,Arp2/3 protein complex,CC,ARPC1A
16434,GO:0097050,0.630115811157893,0.758999921724606,1,9,type B pancreatic cell apoptotic process,BP,WFS1
20084,GO:2000674,0.630115811157893,0.758999921724606,1,9,regulation of type B pancreatic cell apoptotic process,BP,WFS1
814,GO:0002084,0.630182211949896,0.758937873756826,1,9,protein depalmitoylation,BP,ABHD17C
12621,GO:0050778,0.630225153443153,0.431160725892145,45,454,positive regulation of immune response,BP,TNIP1;RBCK1;NR1D1;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;XBP1;PRKACA;HK1;CARD11;IRAK1;ARPC1A;SERPING1;PRKCZ;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;ADAM8;SRC;IRF7;STXBP1;PAG1;FYN;PSMD7;PUM1;CTSL;HEXIM1;MIF;ZP3;SEC14L1;WIPF1;MAPK3;CEACAM1;SKAP2;CD59;TGFB1;PIK3R2;ANXA1;EP300
4438,GO:0010288,0.630323474914612,0.65461236803925,2,20,response to lead ion,BP,DNMT3A;CAT
14853,GO:0070578,0.630391084701435,0.758742616223042,1,9,RISC-loading complex,CC,AGO4
18672,GO:1903955,0.630505234067676,0.536162597480315,6,63,positive regulation of protein targeting to mitochondrion,BP,RAC2;VPS11;ZDHHC8;ATG13;GSK3A;UGCG
10272,GO:0043001,0.630613033647133,0.604358956833527,3,30,Golgi to plasma membrane protein transport,BP,BBS2;RAB31;VAMP2
20135,GO:2000772,0.630737726168754,0.603784359041151,3,31,regulation of cellular senescence,BP,ARG2;HMGA2;YPEL3
2960,GO:0006493,0.630763276887798,0.505655669298141,9,91,protein O-linked glycosylation,BP,RFNG;ADAMTS7;B3GNT3;MFNG;ST3GAL3;ST6GALNAC2;VEGFB;POMT1;GALNT3
17072,GO:0099528,0.630906484001954,0.758260311337232,1,9,G-protein coupled neurotransmitter receptor activity,MF,HTR7
3238,GO:0006895,0.631007319002308,0.654753458172007,2,19,Golgi to endosome transport,BP,CORO7;DOPEY2
7080,GO:0030863,0.631027112169366,0.513845869663831,8,79,cortical cytoskeleton,CC,CAPN2;DLG4;RAPGEF3;CAP1;WIPF1;MYZAP;LLGL1;PLEKHH2
9077,GO:0035307,0.631070286947509,0.603870393038445,3,30,positive regulation of protein dephosphorylation,BP,SYMPK;ITGA1;TGFB1
2644,GO:0005979,0.631266128825196,0.65448329765778,2,19,regulation of glycogen biosynthetic process,BP,AKT1;GSK3A
4779,GO:0010962,0.631266128825196,0.65448329765778,2,19,regulation of glucan biosynthetic process,BP,AKT1;GSK3A
15639,GO:0072109,0.631480819522837,0.757722012644292,1,9,glomerular mesangium development,BP,ACTA2
19523,GO:1990266,0.632080507708122,0.570953115694401,4,44,neutrophil migration,BP,RAC2;ADAM8;PIP5K1C;ITGA1
5961,GO:0018342,0.632299087446964,0.756953551268497,1,9,protein prenylation,BP,RABGGTA
16586,GO:0097354,0.632299087446964,0.756953551268497,1,9,prenylation,BP,RABGGTA
4627,GO:0010745,0.632501724912273,0.756762968716429,1,9,negative regulation of macrophage derived foam cell differentiation,BP,PPARA
10907,GO:0044441,0.632632864409131,0.446189923351879,27,269,ciliary part,CC,BBS2;MARK4;PRKACA;HK1;SHANK3;AKT1;EHD3;MAP1B;PRKACB;SUFU;TTBK2;GNB1;SHANK2;PKD1;WDR66;DYNLRB1;TULP3;KIF17;TUBG1;CEP170;ARFGEF2;UNC119B;MAP1LC3B;SNAP29;GAS8;WRAP73;OCRL
10167,GO:0042738,0.632846971379593,0.756438005268736,1,9,exogenous drug catabolic process,BP,NOS1
15843,GO:0072527,0.63314709476784,0.533024691841348,6,65,pyrimidine-containing compound metabolic process,BP,NT5E;NME4;TK2;NEIL1;UCKL1;APOBEC3C
4035,GO:0009066,0.633242542422162,0.570493611093639,4,41,aspartate family amino acid metabolic process,BP,AHCY;ASS1;ASNS;ALDH7A1
8791,GO:0034464,0.633261452900015,0.756047448182526,1,9,BBSome,CC,BBS2
19781,GO:2000134,0.633362372729582,0.502690972203508,9,93,negative regulation of G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;NACC2;ZNF385A;PCBP4;GJC2;CNOT11;KANK2;EP300
11726,GO:0046503,0.633377346368794,0.600957089810084,3,31,glycerolipid catabolic process,BP,APOE;MGLL;PNPLA6
5151,GO:0015682,0.633424882437821,0.600492686827391,3,32,ferric iron transport,BP,DNM2;TCIRG1;ATP6V1C2
15832,GO:0072512,0.633424882437821,0.600492686827391,3,32,trivalent inorganic cation transport,BP,DNM2;TCIRG1;ATP6V1C2
12396,GO:0048786,0.633546965850192,0.652096468120093,2,19,presynaptic active zone,CC,STXBP1;ARHGAP44
14430,GO:0061700,0.633744213677971,0.755591966145152,1,9,GATOR2 complex,CC,SESN2
744,GO:0001972,0.633858967581055,0.755483603497911,1,9,retinoic acid binding,MF,RXRA
16190,GO:0090192,0.633859880557828,0.755482741226378,1,9,regulation of glomerulus development,BP,RET
15623,GO:0072091,0.634052902004011,0.569911894360156,4,40,regulation of stem cell proliferation,BP,FBLN1;FERMT1;HMGA2;TGFB1
16739,GO:0097718,0.634092423216404,0.6006323560973,3,30,disordered domain specific binding,MF,AP2A2;FYN;HSPA2
8491,GO:0033631,0.63415487652647,0.755204010339462,1,9,cell-cell adhesion mediated by integrin,BP,PODXL
4189,GO:0009265,0.634258830050026,0.752900420046657,1,10,2'-deoxyribonucleotide biosynthetic process,BP,GUK1
11666,GO:0046385,0.634258830050026,0.752900420046657,1,10,deoxyribose phosphate biosynthetic process,BP,GUK1
7070,GO:0030852,0.634310674370212,0.755056707267642,1,9,regulation of granulocyte differentiation,BP,CEACAM1
19769,GO:2000108,0.634566431296716,0.649391783509605,2,21,positive regulation of leukocyte apoptotic process,BP,ADAM8;ANXA1
6777,GO:0030207,0.63461207845635,0.754771549722763,1,9,chondroitin sulfate catabolic process,BP,HYAL1
15144,GO:0071218,0.63462918216747,0.650099569283255,2,20,cellular response to misfolded protein,BP,STUB1;POMT1
13497,GO:0055012,0.63466432308721,0.754722096098045,1,9,ventricular cardiac muscle cell differentiation,BP,RXRA
6287,GO:0019888,0.63484589034948,0.531624721014546,6,62,protein phosphatase regulator activity,MF,PPP2R3B;PPP1R35;PPP2R5B;PPP1R14A;PPP1R37;PPP1R10
4440,GO:0010310,0.634865756857062,0.754531353767435,1,9,regulation of hydrogen peroxide metabolic process,BP,RAC2
17882,GO:1902065,0.634885569811648,0.754512586452558,1,9,response to L-glutamate,BP,FYN
15608,GO:0072070,0.634913467690794,0.75448615908698,1,9,loop of Henle development,BP,PKD1
18424,GO:1903426,0.634971986179223,0.547215537344622,5,52,regulation of reactive oxygen species biosynthetic process,BP,AKT1;ARG2;ASS1;DNM2;P2RX4
5843,GO:0017127,0.635129985184009,0.752070103840171,1,10,cholesterol transporter activity,MF,APOE
7808,GO:0032352,0.635137659235109,0.754273707844257,1,9,positive regulation of hormone metabolic process,BP,GATA3
15016,GO:0070922,0.635174926429408,0.754238378957905,1,9,small RNA loading onto RISC,BP,AGO4
3457,GO:0007271,0.635242359734458,0.754174443312124,1,9,synaptic transmission, cholinergic,BP,APOE
2445,GO:0005652,0.63539417515522,0.75403045694814,1,9,nuclear lamina,CC,HLCS
8758,GO:0034404,0.635752471547772,0.466078333849514,16,166,nucleobase-containing small molecule biosynthetic process,BP,NT5E;XDH;PGM1;RAPGEF3;NME4;TK2;HK1;PFKP;PPARA;DHTKD1;NEIL1;UCKL1;GUK1;PNP;ALDOC;LDHA
4725,GO:0010885,0.635952022087082,0.75350083790122,1,9,regulation of cholesterol storage,BP,PPARA
8077,GO:0032743,0.635959664657737,0.648697358383002,2,20,positive regulation of interleukin-2 production,BP,CARD11;ANXA1
11923,GO:0046939,0.63601459374563,0.499832442358096,9,93,nucleotide phosphorylation,BP,PGM1;NME4;HK1;PFKP;PPARA;DHTKD1;GUK1;ALDOC;LDHA
14092,GO:0060856,0.636354172276971,0.753118509866074,1,9,establishment of blood-brain barrier,BP,WNT7A
18640,GO:1903897,0.637034324138653,0.752470875970034,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
17703,GO:1901550,0.63704229965395,0.752463274247579,1,9,regulation of endothelial cell development,BP,TNFRSF1A
18297,GO:1903140,0.63704229965395,0.752463274247579,1,9,regulation of establishment of endothelial barrier,BP,TNFRSF1A
9620,GO:0036475,0.637085062812179,0.647508421730141,2,20,neuron death in response to oxidative stress,BP,ATF4;ENDOG
8633,GO:0034143,0.637268000577173,0.75224807905958,1,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
1077,GO:0002643,0.637369505443997,0.752151253411558,1,9,regulation of tolerance induction,BP,TGFBR2
11417,GO:0045793,0.637600837784864,0.751930479496759,1,9,positive regulation of cell size,BP,RET
12245,GO:0048487,0.637685561683531,0.595901529795966,3,32,beta-tubulin binding,MF,ARL8A;ADNP;VAPB
1417,GO:0003351,0.637715396875691,0.749593681748983,1,10,epithelial cilium movement,BP,GAS8
12009,GO:0047372,0.637795590575972,0.751744501661572,1,9,acylglycerol lipase activity,MF,MGLL
2805,GO:0006265,0.637964500245754,0.75158311816087,1,9,DNA topological change,BP,TOP1
7113,GO:0030904,0.637988910262301,0.646551636922851,2,20,retromer complex,CC,SDCCAG3;SNX27
6662,GO:0030011,0.638097452220945,0.751456035020399,1,9,maintenance of cell polarity,BP,LRCH4
20263,GO:2001170,0.638109544785497,0.751444473840375,1,9,negative regulation of ATP biosynthetic process,BP,PPARA
7226,GO:0031115,0.638157578502853,0.751398546903013,1,9,negative regulation of microtubule polymerization,BP,EML2
6775,GO:0030205,0.638223803999452,0.751335215679438,1,9,dermatan sulfate metabolic process,BP,CHST14
8339,GO:0033178,0.638512290661602,0.748826682443453,1,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,ATP6V1C2
5788,GO:0017014,0.638686219877523,0.748659045395849,1,10,protein nitrosylation,BP,NOS1
5908,GO:0018119,0.638686219877523,0.748659045395849,1,10,peptidyl-cysteine S-nitrosylation,BP,NOS1
16183,GO:0090185,0.638927262453716,0.750661755476481,1,9,negative regulation of kidney development,BP,GATA3
6104,GO:0019321,0.638946424933787,0.748408097891685,1,10,pentose metabolic process,BP,TALDO1
8602,GO:0034098,0.638981256792885,0.750610007332097,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,UBXN7
13784,GO:0060340,0.639034712237685,0.750558767744166,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,IRF7
1111,GO:0002697,0.63911008710146,0.451856111142152,20,204,regulation of immune effector process,BP,RAC2;BCR;XBP1;HK1;SERPING1;PKN1;PRKCZ;HTRA1;GATA3;STXBP1;PUM1;MIF;ZP3;ARG1;SEC14L1;MAPK3;CEACAM1;CD59;TGFB1;ANXA1
12891,GO:0051195,0.639122300404762,0.750474793283933,1,9,negative regulation of cofactor metabolic process,BP,PPARA
4206,GO:0009313,0.639474680442609,0.75013673782299,1,9,oligosaccharide catabolic process,BP,CTBS
11320,GO:0045623,0.639559654236847,0.750055166992907,1,9,negative regulation of T-helper cell differentiation,BP,ANXA1
3007,GO:0006553,0.639760789656261,0.749862006999024,1,9,lysine metabolic process,BP,ALDH7A1
4060,GO:0009108,0.639771854451101,0.453531210196537,19,193,coenzyme biosynthetic process,BP,NAPRT;PGM1;IDH2;ACOT7;HK1;PFKP;NMRK1;PPARA;DHTKD1;NADK;ELOVL1;PARP10;PPCS;PANK4;CBR4;PNP;MLYCD;ALDOC;LDHA
7395,GO:0031442,0.639786648244878,0.749837165645743,1,9,positive regulation of mRNA 3'-end processing,BP,HSF1
15949,GO:0072718,0.639967953273986,0.749662940941908,1,9,response to cisplatin,BP,NUCB1
11274,GO:0045505,0.639997900648119,0.643637928630786,2,21,dynein intermediate chain binding,MF,DNAAF5;DYNLRB1
730,GO:0001956,0.640156107399688,0.749482038483775,1,9,positive regulation of neurotransmitter secretion,BP,STXBP1
6716,GO:0030123,0.640268319446094,0.749374104579943,1,9,AP-3 adaptor complex,CC,AP3D1
7565,GO:0031902,0.640362818724073,0.488107382558033,10,104,late endosome membrane,CC,ATP13A2;VPS11;VPS4A;MVB12B;YIPF2;ARL8A;TMEM9;VPS37A;HGS;LITAF
8985,GO:0035068,0.640431475551653,0.749217106695906,1,9,micro-ribonucleoprotein complex,CC,AGO4
12687,GO:0050872,0.640437648811901,0.749211164994566,1,9,white fat cell differentiation,BP,CTBP1
19238,GO:1905314,0.640551702544745,0.749101370413177,1,9,semi-lunar valve development,BP,GATA3
15517,GO:0071871,0.640711026550494,0.748947935760956,1,9,response to epinephrine,BP,PRKACA
9032,GO:0035235,0.640731051883343,0.748928645680112,1,9,ionotropic glutamate receptor signaling pathway,BP,GRIN3B
6012,GO:0019054,0.640731597838676,0.643637873151719,2,20,modulation by virus of host process,BP,BCL2L1;TGFB1
17322,GO:0140078,0.640767831186854,0.746646252797858,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
17323,GO:0140080,0.640767831186854,0.746646252797858,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
10252,GO:0042975,0.640920262647315,0.748746327108306,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
16980,GO:0098969,0.64094894964088,0.748718676400149,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,ARHGAP44
18477,GO:1903539,0.64094894964088,0.748718676400149,1,9,protein localization to postsynaptic membrane,BP,ARHGAP44
18478,GO:1903540,0.64094894964088,0.748718676400149,1,9,establishment of protein localization to postsynaptic membrane,BP,ARHGAP44
7999,GO:0032611,0.641056881379698,0.561731088187702,4,42,interleukin-1 beta production,BP,F2R;HK1;ARG2;CPTP
3484,GO:0007351,0.641268504392879,0.748410510792363,1,9,tripartite regional subdivision,BP,PCSK6
3925,GO:0008595,0.641268504392879,0.748410510792363,1,9,anterior/posterior axis specification, embryo,BP,PCSK6
2831,GO:0006298,0.641575697272873,0.592099796262712,3,31,mismatch repair,BP,ERCC1;XPC;POLD4
3295,GO:0006991,0.641611905650474,0.748079032485255,1,9,response to sterol depletion,BP,ARHGEF10L
3324,GO:0007033,0.641654685123647,0.466921908225677,14,142,vacuole organization,BP,ATG16L2;ATP13A2;TFEB;NAGLU;VPS11;ATG13;TBC1D14;CHMP5;LRSAM1;RAB1B;ULK1;ULK2;MAP1LC3B;PACS2
9293,GO:0035723,0.641787005458343,0.747909886005104,1,9,interleukin-15-mediated signaling pathway,BP,SHC1
15221,GO:0071350,0.641787005458343,0.747909886005104,1,9,cellular response to interleukin-15,BP,SHC1
4857,GO:0014067,0.641836085088213,0.747862459765027,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
482,GO:0001530,0.641864782087623,0.745580733612786,1,10,lipopolysaccharide binding,MF,RNASE7
15021,GO:0070933,0.641874107634391,0.747825713512168,1,9,histone H4 deacetylation,BP,RCOR1
7457,GO:0031588,0.642021254099516,0.74768346837016,1,9,nucleotide-activated protein kinase complex,CC,SESN2
20300,GO:2001234,0.642050945416713,0.459304808219203,16,167,negative regulation of apoptotic signaling pathway,BP,BOK;IFI6;ITGA6;XBP1;AKT1;SYVN1;CD44;ZNF385A;WFS1;SRC;FYN;GRINA;MIF;BCL2L1;ARHGEF2;TMBIM1
6355,GO:0021533,0.642238185361095,0.74747365298143,1,9,cell differentiation in hindbrain,BP,WNT7A
17550,GO:1901017,0.642826471913744,0.74690400372006,1,9,negative regulation of potassium ion transmembrane transporter activity,BP,STK39
17669,GO:1901380,0.642826471913744,0.74690400372006,1,9,negative regulation of potassium ion transmembrane transport,BP,STK39
11377,GO:0045722,0.642953332452312,0.746781035688565,1,9,positive regulation of gluconeogenesis,BP,PPARA
1326,GO:0003174,0.643033751304211,0.746703061092195,1,9,mitral valve development,BP,ZFPM1
4589,GO:0010677,0.64304306731814,0.641169971605968,2,20,negative regulation of cellular carbohydrate metabolic process,BP,PPARA;GSK3A
715,GO:0001937,0.643059372235552,0.641152523258522,2,20,negative regulation of endothelial cell proliferation,BP,XDH;APOE
13627,GO:0060077,0.643162515787386,0.746578172679754,1,9,inhibitory synapse,CC,NLGN2
3166,GO:0006779,0.643192218892608,0.640225246040903,2,21,porphyrin-containing compound biosynthetic process,BP,ALAS1;UROS
8520,GO:0033692,0.643538385904477,0.538088499484364,5,51,cellular polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;B3GNT3;GSK3A
1820,GO:0004467,0.643636529525503,0.746118028514188,1,9,long-chain fatty acid-CoA ligase activity,MF,SLC27A1
14341,GO:0061478,0.64371966470397,0.746037261100053,1,9,response to platelet aggregation inhibitor,BP,ADCY6
5090,GO:0015347,0.64394492265103,0.74581832149373,1,9,sodium-independent organic anion transmembrane transporter activity,MF,SLCO4A1
2002,GO:0004722,0.644077387484733,0.521577024692031,6,62,protein serine/threonine phosphatase activity,MF,PPP2R3B;DUSP4;PPM1M;PPM1F;SSU72;MTMR4
4057,GO:0009101,0.644112726576691,0.43550356805241,26,260,glycoprotein biosynthetic process,BP,TNIP1;LMF1;CHPF;XYLT1;XYLT2;SYVN1;RFNG;NDST2;UBE2J1;ADAMTS7;SRD5A3;B4GALT2;B3GNT3;MPI;CHST14;MCFD2;MFNG;ST3GAL3;ST3GAL5;ST6GALNAC2;ABCA7;LMAN1;VEGFB;POMT1;B4GALT6;GALNT3
10937,GO:0044546,0.644194269046172,0.745575803418362,1,9,NLRP3 inflammasome complex assembly,BP,CPTP
17470,GO:1900225,0.644194269046172,0.745575803418362,1,9,regulation of NLRP3 inflammasome complex assembly,BP,CPTP
7191,GO:0031072,0.644336806245624,0.483945588147104,10,102,heat shock protein binding,MF,FKBP1A;IRAK1;METTL23;LIMK1;HSF1;STUB1;HSPA2;HSPA13;UNC45A;DNAJB9
3690,GO:0008195,0.644774267859854,0.745011013593833,1,9,phosphatidate phosphatase activity,MF,LPIN3
2838,GO:0006307,0.644868494642344,0.742645904181135,1,10,DNA dealkylation involved in DNA repair,BP,MPG
19759,GO:2000095,0.644883449560269,0.744904589335648,1,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1
16746,GO:0097731,0.645060500136388,0.536420275158931,5,51,9+0 non-motile cilium,CC,MAP1B;GNB1;SHANK2;KIF17;OCRL
16748,GO:0097733,0.645060500136388,0.536420275158931,5,51,photoreceptor cell cilium,CC,MAP1B;GNB1;SHANK2;KIF17;OCRL
10802,GO:0044264,0.64507847244872,0.508343742468043,7,71,cellular polysaccharide metabolic process,BP,PYGB;PYGL;NR1D1;PGM1;AKT1;B3GNT3;GSK3A
9809,GO:0040019,0.645094285407352,0.638970494405511,2,20,positive regulation of embryonic development,BP,FAM129B;GATA3
15906,GO:0072643,0.645174337976752,0.744620884018811,1,9,interferon-gamma secretion,BP,GATA3
8754,GO:0034397,0.645296780258526,0.744501394170115,1,9,telomere localization,BP,LEMD2
3038,GO:0006590,0.645313462116161,0.744485111296701,1,9,thyroid hormone generation,BP,GATA3
6312,GO:0019953,0.645326079175914,0.416040267885643,44,440,sexual reproduction,BP,ERCC1;MST1R;NEURL1;SERPINE2;DNMT3A;SBF1;MICALCL;CCNI;CRTAP;BBS2;OSBP2;ETV5;MYCBPAP;RFX2;PRKACA;FAM50A;AKT1;PHC2;DEAF1;UBE2J1;SCMH1;GAMT;TCFL5;HSF1;SRC;DNM2;AGO4;PAQR7;PUM1;RAI14;THRA;EIF2S2;BCL2L1;HSPA2;ZP3;TBC1D20;SPIRE1;NDRG3;SPESP1;GGT1;CIB1;PAIP2;TGFB1;AZIN2
2353,GO:0005416,0.645392832443274,0.74440762857141,1,9,amino acid:cation symporter activity,MF,SLC6A9
12774,GO:0051023,0.645445261093389,0.742079469498206,1,10,regulation of immunoglobulin secretion,BP,XBP1
2515,GO:0005767,0.645616287691587,0.741911326559239,1,10,secondary lysosome,CC,ADAM8
9140,GO:0035457,0.645922822729158,0.743889788203202,1,9,cellular response to interferon-alpha,BP,GATA3
13862,GO:0060442,0.646093702051104,0.743722657600434,1,9,branching involved in prostate gland morphogenesis,BP,RXRA
8456,GO:0033574,0.646094494692743,0.586748462542189,3,32,response to testosterone,BP,MSN;HSF1;CBL
368,GO:0000989,0.646285085884881,0.4102627926265,52,517,transcription factor activity, transcription factor binding,MF,ZMYND8;CCND1;NFATC4;NR1D1;SOX12;MTA1;CITED4;FAM129B;NACC2;PPP1R13L;ATF4;PKN1;ELK3;WWTR1;PHF21A;ZMIZ2;DRAP1;SCAND1;PPARA;SUFU;BCL9L;DDIT3;MLXIP;GATA3;SIN3B;CTBP1;HMGA2;ARID5B;RFXANK;RALY;PER3;RERE;TLE4;VDR;THRA;MAP3K10;HSF4;PHF2;TRIB3;MXD4;FGF2;MED15;CDYL2;RCOR1;RXRA;PBXIP1;ZHX3;LPIN3;CCNE1;WBP2;KLF12;EP300
11911,GO:0046916,0.646293660000441,0.506314239108809,7,77,cellular transition metal ion homeostasis,BP,AP3D1;PRNP;LCN2;ATP13A2;ATP7B;MT2A;SLC30A1
13777,GO:0060333,0.646301758757115,0.51884148226474,6,64,interferon-gamma-mediated signaling pathway,BP,CD44;OASL;MT2A;IRF7;OAS1;ARG1
14897,GO:0070669,0.646532647079947,0.743292964666477,1,9,response to interleukin-2,BP,SHC1
15223,GO:0071352,0.646532647079947,0.743292964666477,1,9,cellular response to interleukin-2,BP,SHC1
446,GO:0001205,0.646591681562469,0.637359236543002,2,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D;PBX3
7484,GO:0031643,0.646715771455996,0.743113539446852,1,9,positive regulation of myelination,BP,RNF10
11141,GO:0045165,0.646721467051431,0.470215551821969,12,121,cell fate commitment,BP,WNT7A;SOX12;SH3PXD2B;DKK1;SUFU;GATA3;DUSP6;WNT5B;FGFR1;ZFPM1;FGF2;ARHGEF2
489,GO:0001541,0.646826056158709,0.555408560616136,4,42,ovarian follicle development,BP,MMP14;SRC;BCL2L1;ZP3
15227,GO:0071356,0.646982051675387,0.445560749884724,19,203,cellular response to tumor necrosis factor,BP,RBCK1;SHARPIN;PCK2;POSTN;PSMD2;AKT1;TMSB4X;TNFSF15;ADAMTS7;GATA3;TNFRSF6B;PSMD7;TNFRSF1A;HYAL1;TNFRSF19;CASP4;CIB1;MAPK3;ARHGEF2
723,GO:0001946,0.64735319528393,0.742488252717584,1,9,lymphangiogenesis,BP,ACVR2B
5277,GO:0015924,0.647413597526038,0.742428940975288,1,9,mannosyl-oligosaccharide mannosidase activity,MF,EDEM1
90,GO:0000178,0.647476741097204,0.63489933406593,2,22,exosome (RNase complex),CC,GTPBP1;CARHSP1
19256,GO:1905354,0.647476741097204,0.63489933406593,2,22,exoribonuclease complex,CC,GTPBP1;CARHSP1
6962,GO:0030594,0.647517648771743,0.635569817847278,2,21,neurotransmitter receptor activity,MF,HTR7;GRIN3B
17294,GO:0120103,0.647688707990978,0.742158666673102,1,9,centriolar subdistal appendage,CC,CEP170
6546,GO:0021955,0.647811688319204,0.636042933097559,2,20,central nervous system neuron axonogenesis,BP,ADARB1;EPHB2
13409,GO:0052659,0.648004023528498,0.741848630321337,1,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,OCRL
9368,GO:0035871,0.64827978124441,0.741577258377222,1,9,protein K11-linked deubiquitination,BP,OTUB2
15997,GO:0080135,0.648476226194366,0.40693573389043,54,538,regulation of cellular response to stress,BP,EDEM1;XDH;ERCC1;MAP2K1;WNT7A;ERCC6;BOK;DLG1;PTPRS;NACC2;XBP1;MAP4K4;EGFR;PTPRF;MAP2K2;STK25;ATF4;P4HB;AKT1;BAG3;ARG2;PKN1;SYVN1;FZD8;ENDOG;NSMCE4A;DKK1;UBE2J1;CD44;MAP3K9;PAK1;ZNF385A;DDIT3;HSF1;WFS1;HMGA2;STK24;YPEL3;GRINA;MAP3K10;MIF;BCL2L1;TNFRSF19;TAOK1;APBB1;IMPACT;MAPK3;DNAJB9;ARHGEF2;AIDA;MINK1;SPRED2;PPP1R10;EP300
19774,GO:2000113,0.648550369069339,0.390739320254598,112,1114,negative regulation of cellular macromolecule biosynthetic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;MAP2K1;SHC1;NR1D1;DLG1;DAP;DNMT3A;WWC3;SMURF2;FAM129B;SESN2;ZC3H6;NACC2;VLDLR;ACVR2B;EGFR;MAP2K2;PPP1R13L;ATF4;PEG3;BAG3;ELK3;WWTR1;PHF21A;TSPYL2;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;EIF4EBP1;TSC22D4;SRC;AGO4;IRF7;HIST3H2A;PER3;RERE;RSF1;GSK3A;ZNF692;PPM1F;NELFCD;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;SAMD4B;ZP3;RCOR1;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;PAIP2;ZNF256;MBD3;IGF2BP3;CCNE1;TGFB1;KLF12;ZNF318;EP300
1270,GO:0003044,0.648979571540129,0.633987370923785,2,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;CTSZ
2548,GO:0005815,0.649174371345704,0.402672378536941,62,610,microtubule organizing center,CC,MAP2K1;DYSF;PITPNM1;SCYL1;BBS2;USP20;MARK4;PRKACA;TUBG2;ATF4;AKT1;PRKCZ;VPS4A;CCDC92;OBSL1;PRKACB;TACC1;CCDC88C;TTBK2;PODXL;CUL7;PROCR;PHF1;GNAI2;HSF1;ADGRB2;NEK9;NEIL1;DYNLRB1;FAM110C;ARL2;CAPG;DNM2;NINL;UBR4;SDCCAG8;SPECC1L;KIF17;BRSK1;PSKH1;TUBG1;CEP170;TTC19;VPS37A;RAB11FIP4;BCL2L1;RAD23A;ARFGEF2;NDE1;CAMSAP3;GSDMC;SNAP29;GAS8;CIB1;WRAP73;CSNK1D;KIFC3;MPLKIP;SAC3D1;CCDC113;RAP1GAP2;MZT2B
4336,GO:0009886,0.649518299267768,0.738052631575282,1,10,post-embryonic animal morphogenesis,BP,GNAS
15256,GO:0071396,0.649638227473834,0.415233999101313,39,389,cellular response to lipid,BP,TNIP1;NFATC4;CYP27B1;PCK2;NR1D1;BCR;XBP1;EGFR;AKT1;IRAK1;FAM210B;PTK6;MSN;PPARA;TWF2;PAK1;GNB1;RET;HSF1;EIF4EBP1;ALDH1A2;SRC;PAQR7;WNT5B;VDR;THRA;MIF;PMEPA1;RXRA;ARG1;MAPK3;KANK2;LITAF;ADCY6;CCNE1;TGFB1;WBP2;ANXA1;EP300
3782,GO:0008340,0.649832958032699,0.740044746957416,1,9,determination of adult lifespan,BP,IDE
4755,GO:0010927,0.650454636856763,0.514732145961607,6,61,cellular component assembly involved in morphogenesis,BP,OBSCN;TMOD2;TNNT1;RFX2;OBSL1;TBC1D20
2292,GO:0005248,0.650470135052934,0.739414059112434,1,9,voltage-gated sodium channel activity,MF,SCN8A
12078,GO:0048011,0.65054637815644,0.633080831254258,2,20,neurotrophin TRK receptor signaling pathway,BP,PPP2R5B;SRC
19836,GO:2000251,0.65058586164886,0.736989377601013,1,10,positive regulation of actin cytoskeleton reorganization,BP,BAIAP2L1
3096,GO:0006670,0.650741279480834,0.736834315314306,1,10,sphingosine metabolic process,BP,SPTLC2
19802,GO:2000177,0.650876465020972,0.551222177206285,4,41,regulation of neural precursor cell proliferation,BP,CTSZ;SPINT2;GJC2;TGFB1
16954,GO:0098911,0.651015812780524,0.738873016348285,1,9,regulation of ventricular cardiac muscle cell action potential,BP,DLG1
2717,GO:0006091,0.651321030269777,0.4177057823853,34,365,generation of precursor metabolites and energy,BP,XDH;PYGB;NFATC4;PYGL;NR1D1;PGM1;IDH2;BNIP3;HK1;AKT1;MDH2;PFKP;PPARA;DHTKD1;HMGCL;TSTA3;OXA1L;ASPH;SDHA;AKR7A2;GLRX;TAZ;NDUFA4L2;ACADVL;GSK3A;ALDH4A1;AOX1;SDHAF4;CYB561;ALDOC;NDUFS2;CAT;LDHA;GNAS
4959,GO:0015026,0.651448096541117,0.632100608653269,2,20,coreceptor activity,MF,LRP5;GPC4
1877,GO:0004550,0.651614412174278,0.734080007093011,1,11,nucleoside diphosphate kinase activity,MF,NME4
12751,GO:0050995,0.651777826602904,0.73579836926711,1,10,negative regulation of lipid catabolic process,BP,AKT1
8050,GO:0032693,0.651815312918093,0.735760846930576,1,10,negative regulation of interleukin-10 production,BP,TRIB2
13021,GO:0051427,0.651962961252125,0.45575232429292,14,143,hormone receptor binding,MF,PTHLH;PKN1;BAZ2A;GAS2L1;OASL;SRC;FYN;VDR;SOCS2;RXRA;CCNE1;WBP2;GNAS;EP300
5541,GO:0016525,0.652111062054047,0.512905134733867,6,61,negative regulation of angiogenesis,BP,FAM129B;THBS2;EPN1;EPN2;ADGRB2;HGS
2826,GO:0006293,0.652120458658438,0.6305720672033,2,21,nucleotide-excision repair, preincision complex stabilization,BP,ERCC1;DDB2
2828,GO:0006295,0.652120458658438,0.6305720672033,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,ERCC1;DDB2
2085,GO:0004842,0.652126454037837,0.413466719707421,38,376,ubiquitin-protein transferase activity,MF,GID4;RBCK1;NEURL1;SHARPIN;SMURF2;HECW2;FBXW8;SYVN1;RNF135;TMEM129;FBXO2;ZNF598;FBXW5;UBE2J1;KLHL29;CDC34;ANKIB1;RAG1;FBXL6;HLTF;UBR4;LRSAM1;RMND5A;FBXL15;RNF44;RNF187;MIB2;STUB1;DDB2;RMND5B;MGRN1;KLHL17;RNF222;SPSB3;CBL;RNF103;TRAF7;RNF10
16018,GO:0086010,0.652243797182568,0.631234178969498,2,20,membrane depolarization during action potential,BP,SCN8A;TPCN1
13238,GO:0051879,0.652406683754486,0.580218950029694,3,31,Hsp90 protein binding,MF,HSF1;STUB1;UNC45A
10056,GO:0042501,0.652918029638198,0.734655262673652,1,10,serine phosphorylation of STAT protein,BP,RET
15915,GO:0072665,0.653095317841838,0.527355969146124,5,52,protein localization to vacuole,BP,SORL1;AP3D1;VPS4A;HGS;C12ORF66
2314,GO:0005310,0.653532543087252,0.629827976973442,2,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A3;SLC13A5
12086,GO:0048019,0.65359484013754,0.733974957040032,1,10,receptor antagonist activity,MF,DKK1
9881,GO:0042133,0.653644452027418,0.488829589746757,8,83,neurotransmitter metabolic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;ALDH7A1;COMT;P2RX4
11380,GO:0045725,0.653651095996229,0.736248089449642,1,9,positive regulation of glycogen biosynthetic process,BP,AKT1
3351,GO:0007084,0.654032782534016,0.733534048075123,1,10,mitotic nuclear envelope reassembly,BP,REEP4
18143,GO:1902803,0.654053994380059,0.629257979187513,2,20,regulation of synaptic vesicle transport,BP,SEPT5;STXBP1
13513,GO:0055038,0.654337471325035,0.510133550138415,6,63,recycling endosome membrane,CC,BOK;EHD3;GGA3;ABHD17C;RAB11FIP4;EHD4
873,GO:0002220,0.654713285221879,0.479010344153462,9,99,innate immune response activating cell surface receptor signaling pathway,BP,PSMD2;PRKACA;CARD11;PRKACB;PAK1;SRC;FYN;PSMD7;EP300
875,GO:0002223,0.654713285221879,0.479010344153462,9,99,stimulatory C-type lectin receptor signaling pathway,BP,PSMD2;PRKACA;CARD11;PRKACB;PAK1;SRC;FYN;PSMD7;EP300
14893,GO:0070665,0.655060132692583,0.496783014997646,7,76,positive regulation of leukocyte proliferation,BP,CARD11;TGFBR2;IGFBP2;MIF;ZP3;PNP;ANXA1
1153,GO:0002758,0.655429578171028,0.436583757230847,19,199,innate immune response-activating signal transduction,BP,TNIP1;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;PRKACB;PAK1;SRC;IRF7;FYN;PSMD7;PUM1;CTSL;SEC14L1;EP300
6785,GO:0030216,0.655706267183153,0.451441172523705,14,149,keratinocyte differentiation,BP,MAP2K1;CYP27B1;SHARPIN;PRSS8;ALOX15B;CNFN;FLNB;PCSK6;VDR;CTSL;PRR9;KRT23;FURIN;ANXA1
253,GO:0000717,0.656103779290941,0.625485620138944,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,XPC;DDB2
9256,GO:0035646,0.656137907068875,0.731406906566151,1,10,endosome to melanosome transport,BP,AP3D1
10547,GO:0043485,0.656137907068875,0.731406906566151,1,10,endosome to pigment granule transport,BP,AP3D1
12387,GO:0048757,0.656137907068875,0.731406906566151,1,10,pigment granule maturation,BP,AP3D1
4112,GO:0009166,0.656157580261419,0.459737777602233,12,125,nucleotide catabolic process,BP,NT5E;XDH;PGM1;RAPGEF3;HK1;PFKP;PPARA;DHTKD1;NEIL1;PNP;ALDOC;LDHA
9004,GO:0035115,0.65618406277039,0.626121865047854,2,21,embryonic forelimb morphogenesis,BP,WNT7A;ALDH1A2
585,GO:0001736,0.656335661186895,0.470379208497753,10,109,establishment of planar polarity,BP,DVL1;PSMD2;SMURF2;GPC4;AP2A2;DKK1;DLG3;FUZ;PFN1;PSMD7
3385,GO:0007164,0.656335661186895,0.470379208497753,10,109,establishment of tissue polarity,BP,DVL1;PSMD2;SMURF2;GPC4;AP2A2;DKK1;DLG3;FUZ;PFN1;PSMD7
7252,GO:0031201,0.656340031142106,0.544601154945065,4,43,SNARE complex,CC,VAMP2;STX5;STX10;SNAP29
10992,GO:0044774,0.656567693779235,0.470388836766625,10,105,mitotic DNA integrity checkpoint,BP,CCND1;XPC;ZNF385A;PCBP4;HMGA2;BRSK1;TAOK1;CNOT11;PPP1R10;EP300
4822,GO:0014014,0.656712890428613,0.625540090999197,2,21,negative regulation of gliogenesis,BP,IDH2;RNF10
8608,GO:0034110,0.656848508745933,0.625390796356736,2,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;CEACAM1
7243,GO:0031146,0.657338877116632,0.50586668377758,6,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMD2;WWTR1;FBXO2;FBXW5;PSMD7;FBXL15
6285,GO:0019886,0.65802978160402,0.493724750249236,7,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KLC2;AP1B1;AP2A2;SEC23A;DNM2;CTSL;SEC24C
7855,GO:0032410,0.658173723785276,0.542823977778879,4,42,negative regulation of transporter activity,BP,HECW2;PCSK9;STK39;EPHB2
4604,GO:0010717,0.658253268053487,0.505942018022677,6,62,regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;BCL9L;FUZ;ADIPOR1;TGFB1
5690,GO:0016803,0.659591091413525,0.727889616027018,1,10,ether hydrolase activity,MF,AKR7A2
1181,GO:0002825,0.659856020361899,0.727618323390372,1,10,regulation of T-helper 1 type immune response,BP,ANXA1
8158,GO:0032878,0.660291153798081,0.622394216377073,2,20,regulation of establishment or maintenance of cell polarity,BP,GATA3;LLGL1
6813,GO:0030260,0.660319168350065,0.473144697755671,9,95,entry into host cell,BP,CTSB;ITGB5;EGFR;P4HB;IFITM1;IDE;SRC;EXOC2;CBL
10884,GO:0044409,0.660319168350065,0.473144697755671,9,95,entry into host,BP,CTSB;ITGB5;EGFR;P4HB;IFITM1;IDE;SRC;EXOC2;CBL
13215,GO:0051806,0.660319168350065,0.473144697755671,9,95,entry into cell of other organism involved in symbiotic interaction,BP,CTSB;ITGB5;EGFR;P4HB;IFITM1;IDE;SRC;EXOC2;CBL
13222,GO:0051828,0.660319168350065,0.473144697755671,9,95,entry into other organism involved in symbiotic interaction,BP,CTSB;ITGB5;EGFR;P4HB;IFITM1;IDE;SRC;EXOC2;CBL
18393,GO:1903363,0.660386931963873,0.503123185899186,6,65,negative regulation of cellular protein catabolic process,BP,PANO1;ATP13A2;UBE2J1;SUFU;GIPC1;FURIN
694,GO:0001911,0.66046663848435,0.726992249827848,1,10,negative regulation of leukocyte mediated cytotoxicity,BP,CEACAM1
16329,GO:0090481,0.660635466997235,0.726818953853191,1,10,pyrimidine nucleotide-sugar transmembrane transport,BP,SLC35B4
3904,GO:0008542,0.660758193592992,0.57091572294213,3,31,visual learning,BP,DEAF1;RAG1;B4GALT2
949,GO:0002363,0.660947167526112,0.72649878392347,1,10,alpha-beta T cell lineage commitment,BP,ZFPM1
8624,GO:0034134,0.661061826631958,0.726380937063167,1,10,toll-like receptor 2 signaling pathway,BP,IRAK1
10002,GO:0042402,0.661264963015144,0.724240026001699,1,11,cellular biogenic amine catabolic process,BP,ALDH7A1
12221,GO:0048384,0.661647892842896,0.620081496509811,2,21,retinoic acid receptor signaling pathway,BP,ALDH1A2;RXRA
7023,GO:0030730,0.661649424757815,0.725776391713378,1,10,sequestering of triglyceride,BP,PPARA
15822,GO:0072498,0.661865154615966,0.725554183095705,1,10,embryonic skeletal joint development,BP,HYAL1
19721,GO:2000009,0.66186720065608,0.725552074948785,1,10,negative regulation of protein localization to cell surface,BP,SNX33
5740,GO:0016884,0.661944457410236,0.725472463993586,1,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,ASNS
8835,GO:0034605,0.662045250565737,0.458575149661986,11,113,cellular response to heat,BP,PRKACA;IRAK1;BAG3;MYOF;HSF1;HSF4;STUB1;HSPA2;HSPA13;MAPK3;EP300
15300,GO:0071466,0.662446113258797,0.463788943541527,10,107,cellular response to xenobiotic stimulus,BP,PCK2;EGFR;HSF1;EIF4EBP1;AKR7A2;ARG1;BPHL;ACY1;GGT1;TGFB1
14583,GO:0070098,0.662463281352462,0.618442846272315,2,22,chemokine-mediated signaling pathway,BP,SLIT3;CIB1
15707,GO:0072216,0.662731842526582,0.724660074433358,1,10,positive regulation of metanephros development,BP,RET
12557,GO:0050687,0.662853221596245,0.618740142143157,2,21,negative regulation of defense response to virus,BP,HTRA1;SEC14L1
7882,GO:0032438,0.662902572224911,0.617953075773332,2,22,melanosome organization,BP,AP3D1;RAB29
11516,GO:0045986,0.663236617334272,0.724138299889722,1,10,negative regulation of smooth muscle contraction,BP,DOCK4
15561,GO:0071949,0.663445055422654,0.618080340714803,2,21,FAD binding,MF,MICAL2;MICAL1
4526,GO:0010586,0.663451879758599,0.618072728127786,2,21,miRNA metabolic process,BP,BCDIN3D;AGO4
12411,GO:0048821,0.663491451704114,0.618028583352403,2,21,erythrocyte development,BP,FAM210B;L3MBTL3
6365,GO:0021543,0.663871867220891,0.45656555450198,11,113,pallium development,BP,PTPRS;BNIP3;BBS2;EGFR;LAMB1;TACC1;ANXA3;MBOAT7;LRP1;NDE1;SOCS7
16737,GO:0097711,0.663872776050729,0.469296781776133,9,94,ciliary basal body-plasma membrane docking,BP,MARK4;CSNK1E;PRKACA;TTBK2;NINL;SDCCAG8;TUBG1;NDE1;CSNK1D
9092,GO:0035337,0.663877095874863,0.566981496968018,3,32,fatty-acyl-CoA metabolic process,BP,ACOT7;ELOVL1;CBR4
5375,GO:0016180,0.663886107809972,0.616854972537663,2,22,snRNA processing,BP,INTS8;INTS1
15836,GO:0072520,0.663923606908835,0.723426953827558,1,10,seminiferous tubule development,BP,TBC1D20
3231,GO:0006886,0.663965463979129,0.378984186968422,89,919,intracellular protein transport,BP,EDEM1;LTBP2;SH3TC2;RAC2;SORL1;SNX9;AP3D1;XPOT;RAB3B;RAPGEF3;PRNP;RAB43;COPG1;BCR;RAB31;EVI5L;RTN2;SNX33;AKT1;BAG3;ATP13A2;AP1B1;SYVN1;AP2A2;VPS11;VPS4A;PITRM1;TMEM129;SEC23A;GDI1;UBE2J1;BNIP3L;KDELR1;AKAP12;SYMPK;ZDHHC8;IPO13;TBC1D16;ATG13;SEC63;TBC1D14;PAK1;TBC1D9B;GGA3;GGA1;STOM;SYTL1;RAB29;IFI27;REEP2;TMED3;CEMIP;PKD1;PARP10;VAMP2;GIPC1;SCG5;PEX10;NUCB1;RAB1B;STX5;TOM1L2;RERE;GSK3A;FYN;RAB25;KIF13B;STX10;SEC24C;ARFIP2;USO1;TBC1D2B;CAMSAP3;RPL28;LONP2;CAMK1;HGS;CIB1;RAB4B;ARHGEF2;SNX27;UGCG;HM13;APBA1;ARHGAP44;TGFB1;PPP1R10;RAB6A;ARCN1
2189,GO:0005044,0.664063897057796,0.617389598972711,2,21,scavenger receptor activity,MF,LGALS3BP;LRP1
9839,GO:0042053,0.664107402886791,0.723236402683128,1,10,regulation of dopamine metabolic process,BP,COMT
9846,GO:0042069,0.664107402886791,0.723236402683128,1,10,regulation of catecholamine metabolic process,BP,COMT
4236,GO:0009415,0.664156566645585,0.723185414866835,1,10,response to water,BP,SIPA1
7186,GO:0031063,0.664205438018187,0.617231493582837,2,21,regulation of histone deacetylation,BP,CTBP1;TGFB1
10560,GO:0043502,0.664262575830347,0.514894291498243,5,52,regulation of muscle adaptation,BP,TNNT1;PAK1;GSK3A;MTMR4;P2RX4
12667,GO:0050852,0.664801846800426,0.445461554261788,13,141,T cell receptor signaling pathway,BP,RBCK1;PSMD2;PRNP;CARD11;PLCG1;PAK1;RAB29;GATA3;PAG1;FYN;PSMD7;CEACAM1;PIK3R2
11387,GO:0045738,0.664867091057257,0.616491817021828,2,21,negative regulation of DNA repair,BP,HSF1;HMGA2
3137,GO:0006730,0.664901198385112,0.616453661286346,2,21,one-carbon metabolic process,BP,ALDH1L2;AHCY
1256,GO:0003007,0.665114059865784,0.437876435659716,15,151,heart morphogenesis,BP,FKBP1A;PPP1R13L;TGFBR2;DKK1;SUFU;GATA3;MICAL2;ALDH1A2;GSK3A;LEMD2;ZFPM1;CHD7;RXRA;ADAM15;TGFB1
3715,GO:0008235,0.665321458832051,0.565779185468339,3,31,metalloexopeptidase activity,MF,RNPEPL1;MMP14;NPEPL1
8977,GO:0035051,0.665384437107129,0.47594323526456,8,82,cardiocyte differentiation,BP,EGFR;DKK1;OBSL1;PAK1;GSK3A;RXRA;MAPK3;TGFB1
8365,GO:0033234,0.665401150366239,0.72189224547645,1,10,negative regulation of protein sumoylation,BP,RNF222
8244,GO:0033005,0.665459115324196,0.721831904548183,1,10,positive regulation of mast cell activation,BP,STXBP1
14983,GO:0070862,0.665463838638104,0.72182698718181,1,10,negative regulation of protein exit from endoplasmic reticulum,BP,UBE2J1
4293,GO:0009713,0.665562393495018,0.721724368033189,1,10,catechol-containing compound biosynthetic process,BP,GATA3
10015,GO:0042423,0.665562393495018,0.721724368033189,1,10,catecholamine biosynthetic process,BP,GATA3
18147,GO:1902807,0.665633834563511,0.467184986361819,9,96,negative regulation of cell cycle G1/S phase transition,BP,FHL1;CCND1;NACC2;ZNF385A;PCBP4;GJC2;CNOT11;KANK2;EP300
6914,GO:0030497,0.665794765776659,0.721482297506375,1,10,fatty acid elongation,BP,ELOVL1
10183,GO:0042761,0.665794765776659,0.721482297506375,1,10,very long-chain fatty acid biosynthetic process,BP,ELOVL1
17064,GO:0099518,0.666057087362352,0.533963375694454,4,42,vesicle cytoskeletal trafficking,BP,AP3D1;FYCO1;PRKCZ;NDE1
16429,GO:0097038,0.666145051657786,0.721117085454287,1,10,perinuclear endoplasmic reticulum,CC,CAPN2
2975,GO:0006517,0.666152943379063,0.564410565544918,3,32,protein deglycosylation,BP,EDEM1;SYVN1;RNF103
7631,GO:0032025,0.666405156152789,0.720845658736777,1,10,response to cobalt ion,BP,BNIP3
7654,GO:0032060,0.666697480901802,0.720540366090341,1,10,bleb assembly,BP,LPAR3
3858,GO:0008474,0.666755659478932,0.720479575914061,1,10,palmitoyl-(protein) hydrolase activity,MF,ABHD17C
16805,GO:0098599,0.666755659478932,0.720479575914061,1,10,palmitoyl hydrolase activity,MF,ABHD17C
16854,GO:0098734,0.666755659478932,0.720479575914061,1,10,macromolecule depalmitoylation,BP,ABHD17C
19509,GO:1990204,0.666835130283748,0.482557812295153,7,88,oxidoreductase complex,CC,P4HB;DHTKD1;SDHA;P4HA1;CBR4;SDHAF4;NDUFS2
14910,GO:0070696,0.667315400915325,0.719894186409552,1,10,transmembrane receptor protein serine/threonine kinase binding,MF,TGFB1
11389,GO:0045740,0.667332222355432,0.532248917616178,4,43,positive regulation of DNA replication,BP,SHC1;CST3;EGFR;FGFR1
19804,GO:2000179,0.667339176926905,0.61371958091343,2,21,positive regulation of neural precursor cell proliferation,BP,CTSZ;GJC2
10514,GO:0043407,0.667526493117054,0.495275143961883,6,64,negative regulation of MAP kinase activity,BP,SORL1;APOE;DUSP4;DUSP6;AIDA;SPRED2
19667,GO:1990825,0.667545053717049,0.719653736958297,1,10,sequence-specific mRNA binding,MF,LARP6
4759,GO:0010934,0.667921501017999,0.71925924689524,1,10,macrophage cytokine production,BP,TGFB1
1435,GO:0003407,0.667988717355989,0.562759206940494,3,31,neural retina development,BP,SDK2;RAB11FIP4;SDHAF4
7265,GO:0031227,0.668134715290397,0.44655034012659,12,126,intrinsic component of endoplasmic reticulum membrane,CC,EDEM1;RTN2;SYVN1;ESYT2;SEC63;ELOVL1;WFS1;SARAF;SLC35B4;RRBP1;HM13;STIM1
12705,GO:0050901,0.668160921069021,0.719008128586015,1,10,leukocyte tethering or rolling,BP,PODXL2
5802,GO:0017049,0.668327001358324,0.61260799483181,2,21,GTP-Rho binding,MF,NET1;PKN1
617,GO:0001783,0.668670566489172,0.61148250142162,2,22,B cell apoptotic process,BP,PKN1;MIF
3874,GO:0008499,0.668784132836929,0.718353651718439,1,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT3
17756,GO:1901661,0.6688990505307,0.610553791735814,2,23,quinone metabolic process,BP,AKR7A2;CBR4
2614,GO:0005922,0.669185835717994,0.717931171712888,1,10,connexin complex,CC,GJC2
2769,GO:0006188,0.669483562308727,0.717617729537346,1,10,IMP biosynthetic process,BP,AMPD2
8026,GO:0032653,0.669682168721674,0.610340012896865,2,22,regulation of interleukin-10 production,BP,PRKCZ;TRIB2
4162,GO:0009223,0.669701558433057,0.71541213733109,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,NEIL1
10766,GO:0044183,0.669743540598276,0.559932769611166,3,33,protein binding involved in protein folding,MF,FYCO1;HSPA2;HSPA13
4828,GO:0014029,0.669895243878537,0.717183872963838,1,10,neural crest formation,BP,FUZ
15290,GO:0071453,0.669897510336684,0.428986402051648,16,172,cellular response to oxygen levels,BP,DNMT3A;PSMD2;BNIP3;P4HB;AKT1;IRAK1;ENDOG;BNIP3L;GNB1;ADAM8;SRC;FAM162A;PSMD7;STUB1;CBL;EP300
13984,GO:0060670,0.66990137448332,0.717177408237326,1,10,branching involved in labyrinthine layer morphogenesis,BP,SPINT2
11709,GO:0046479,0.670453126746615,0.716595116045222,1,10,glycosphingolipid catabolic process,BP,NAGA
20037,GO:2000615,0.670491179067858,0.716554923269603,1,10,regulation of histone H3-K9 acetylation,BP,GATA3
614,GO:0001780,0.670677151177123,0.716358426580131,1,10,neutrophil homeostasis,BP,ANXA1
10686,GO:0043922,0.670750430556861,0.716280971147844,1,10,negative regulation by host of viral transcription,BP,HMGA2
7032,GO:0030800,0.670789029391733,0.716240166041674,1,10,negative regulation of cyclic nucleotide metabolic process,BP,GNAI2
7047,GO:0030815,0.670789029391733,0.716240166041674,1,10,negative regulation of cAMP metabolic process,BP,GNAI2
4101,GO:0009154,0.671018649906131,0.60882707777147,2,22,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3
10346,GO:0043130,0.671124617256754,0.491079600751238,6,65,ubiquitin binding,MF,RBCK1;SHARPIN;MARK4;UBTD1;OTUB2;UBXN7
4441,GO:0010314,0.671159363096205,0.715848433000759,1,10,phosphatidylinositol-5-phosphate binding,MF,SH3PXD2B
11122,GO:0045125,0.671387020400371,0.715607412565354,1,10,bioactive lipid receptor activity,MF,LPAR3
2556,GO:0005832,0.671549165509119,0.715435653048452,1,10,chaperonin-containing T-complex,CC,FYCO1
13845,GO:0060421,0.671865904372019,0.608607677028913,2,21,positive regulation of heart growth,BP,FGFR1;FGF2
4340,GO:0009890,0.672115772422786,0.364774325841792,122,1219,negative regulation of biosynthetic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;MAP2K1;SHC1;CYP27B1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;CYGB;FAM129B;SESN2;ZC3H6;NACC2;LPCAT1;VLDLR;ACVR2B;EGFR;MAP2K2;PPP1R13L;ATF4;PEG3;BAG3;APOE;ELK3;WWTR1;PHF21A;TSPYL2;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;EIF4EBP1;TSC22D4;SRC;AGO4;IRF7;HIST3H2A;ACADVL;PER3;RERE;RSF1;GSK3A;ZNF692;PPM1F;NELFCD;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;SLC27A1;ZFPM1;TRIB2;MXD4;SAMD4B;ZP3;RCOR1;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;CEACAM1;PAIP2;ZNF256;MBD3;IGF2BP3;CCNE1;TGFB1;KLF12;ZNF318;EP300
17537,GO:1900746,0.672141169297032,0.714807862236373,1,10,regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18057,GO:1902547,0.672141169297032,0.714807862236373,1,10,regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
510,GO:0001573,0.672439694794021,0.714490882840433,1,10,ganglioside metabolic process,BP,ST3GAL5
14064,GO:0060788,0.672536866759057,0.7143876449589,1,10,ectodermal placode formation,BP,GNAS
15444,GO:0071697,0.672536866759057,0.7143876449589,1,10,ectodermal placode morphogenesis,BP,GNAS
2499,GO:0005746,0.672631499453852,0.502558932238867,5,72,mitochondrial respiratory chain,CC,OXA1L;SDHA;NDUFA4L2;SDHAF4;NDUFS2
8020,GO:0032647,0.672651516055682,0.607715791332579,2,21,regulation of interferon-alpha production,BP,PTPRS;IRF7
252,GO:0000715,0.672809870495247,0.606118376819423,2,23,nucleotide-excision repair, DNA damage recognition,BP,XPC;DDB2
9777,GO:0039532,0.672879691422684,0.714023187768849,1,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,SEC14L1
6940,GO:0030540,0.673159746890811,0.71372519221996,1,10,female genitalia development,BP,CHD7
12527,GO:0050651,0.673193146329311,0.713689637128898,1,10,dermatan sulfate proteoglycan biosynthetic process,BP,CHST14
3259,GO:0006929,0.67354046662154,0.606704895720375,2,21,substrate-dependent cell migration,BP,ANKS1A;ADAM8
15982,GO:0080008,0.673712530936889,0.555802385228468,3,32,Cul4-RING E3 ubiquitin ligase complex,CC,FBXW5;DCAF7;DDB2
367,GO:0000988,0.673717189850211,0.381311916464577,52,522,transcription factor activity, protein binding,MF,ZMYND8;CCND1;NFATC4;NR1D1;SOX12;MTA1;CITED4;FAM129B;NACC2;PPP1R13L;ATF4;PKN1;ELK3;WWTR1;PHF21A;ZMIZ2;DRAP1;SCAND1;PPARA;SUFU;BCL9L;DDIT3;MLXIP;GATA3;SIN3B;CTBP1;HMGA2;ARID5B;RFXANK;RALY;PER3;RERE;TLE4;VDR;THRA;MAP3K10;HSF4;PHF2;TRIB3;MXD4;FGF2;MED15;CDYL2;RCOR1;RXRA;PBXIP1;ZHX3;LPIN3;CCNE1;WBP2;KLF12;EP300
9027,GO:0035198,0.67373408041159,0.606484483636319,2,21,miRNA binding,MF,AGO4;PUM1
14013,GO:0060707,0.674064163603808,0.712761188696233,1,10,trophoblast giant cell differentiation,BP,MDFI
18229,GO:1902993,0.674468946835684,0.712328918551862,1,10,positive regulation of amyloid precursor protein catabolic process,BP,GSK3A
7664,GO:0032088,0.674806016949725,0.486916142305018,6,65,negative regulation of NF-kappaB transcription factor activity,BP,RBCK1;DAP;IRAK1;TMSB4X;PARP10;CAT
1076,GO:0002639,0.675384682737025,0.603856403498559,2,22,positive regulation of immunoglobulin production,BP,XBP1;TGFB1
18536,GO:1903671,0.675509192196885,0.604459687933812,2,21,negative regulation of sprouting angiogenesis,BP,EPN1;EPN2
12801,GO:0051057,0.675724600738549,0.553493328113909,3,32,positive regulation of small GTPase mediated signal transduction,BP,F2R;RASGEF1A;SRC
15464,GO:0071732,0.675908911534628,0.710787059282256,1,10,cellular response to nitric oxide,BP,DNM2
4658,GO:0010800,0.676165153821817,0.603709635480983,2,21,positive regulation of peptidyl-threonine phosphorylation,BP,CEMIP;TGFB1
16522,GO:0097200,0.676271902669188,0.708387270308331,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
12856,GO:0051147,0.67630177373674,0.455451725713258,9,94,regulation of muscle cell differentiation,BP,FAM129B;XBP1;MMP14;DKK1;PAK1;GSK3A;THRA;CAMK1;TGFB1
13014,GO:0051412,0.676348734636054,0.710314829917163,1,10,response to corticosterone,BP,CCND1
9618,GO:0036473,0.676740216086546,0.484721566022355,6,65,cell death in response to oxidative stress,BP,STK25;ATF4;P4HB;AKT1;ENDOG;STK24
16745,GO:0097730,0.676773488738377,0.484976068747033,6,63,non-motile cilium,CC,MAP1B;GNB1;SHANK2;KIF17;TUBG1;OCRL
6568,GO:0022011,0.6768674284815,0.602905532448972,2,21,myelination in peripheral nervous system,BP,SH3TC2;AKT1
7777,GO:0032292,0.6768674284815,0.602905532448972,2,21,peripheral nervous system axon ensheathment,BP,SH3TC2;AKT1
2804,GO:0006264,0.676924415643906,0.70969582247733,1,10,mitochondrial DNA replication,BP,PRIMPOL
5641,GO:0016723,0.676928797106299,0.709691107299544,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYB561
5679,GO:0016787,0.677083637766549,0.353535401216695,185,1823,hydrolase activity,MF,NT5E;EDEM1;ERCC1;ADAM19;CAPN2;THSD4;RAC2;MAP2K1;PLAT;ERCC6;KLC2;DLG1;MMP1;PSMD2;MTA1;RAB3B;PTPRS;PRSS3;SBF1;SSH1;RAB43;SMARCA1;PLCH2;CTSB;ACOT7;TNNT1;RNPEPL1;HAGH;TUBB6;USP20;NACC2;RAB31;AARS;H6PD;PGLS;ACOT1;MMP14;SEPT10;ADARB1;PTPRF;JOSD2;RHBDF2;TUBG2;MIER2;ACOT13;ATP13A2;ARG2;PHF21A;NPEPL1;GALNS;ATP7B;NAGLU;PPP2R3B;VPS4A;PITRM1;CTSZ;PTPDC1;PCSK9;ENDOG;ABHD8;ACAD10;TYSND1;RRAS;SEPT5;PLD3;NDST2;PLCXD1;PRSS8;OTUB2;SCRN1;PLCG1;ABCB8;GTPBP1;IDE;HTRA1;MMP10;AHCY;NLGN2;DTD1;RAG1;CTBS;TUBB3;ADAMTS7;DUSP4;GNB1;PTPN9;FUCA1;RAB29;DNASE1L1;RHOC;HLTF;CEMIP;SEPT8;ATP11A;ARL8A;GNAI2;PPM1M;MYH16;RPUSD3;SIN3B;CNDP2;PTPRU;ADAM8;NEIL1;TMEM8A;MPG;MYH15;RHOBTB2;DYNLRB1;BLMH;ARL2;PLCB3;AKR7A2;EDNRA;DNM2;CAPN5;RAB1B;GARS;PCSK6;DUSP6;RAB25;ISG20;PPM1F;TMPRSS11D;KIF17;THOP1;ABHD17C;KIF13B;SSU72;GNB2;CTSL;MGLL;LHPP;TUBG1;ATP2C2;HYAL1;F12;MTMR4;AMPD2;NT5DC2;TCIRG1;PTPN12;HSPA2;PLCD3;ACP7;HPSE;SMPD3;RNASE7;RCOR1;ABHD14B;HSPA13;MYO1D;CHD7;ABCA7;ENTPD6;RHOBTB1;ARG1;ATP6V1C2;BPHL;ARSK;KLK6;CASP4;ACY1;LONP2;GGT1;LACTB2;USP32;RAB4B;KIFC3;FURIN;OCRL;ADAM15;HM13;PNPLA6;LPIN3;AGAP1;MBD3;NAGA;PCYOX1;CAT;ANXA1;ARSD;RAB6A;APOBEC3C;GNAS
3252,GO:0006914,0.67728636307501,0.383520752094302,42,427,autophagy,BP,ITGB4;QSOX1;BOK;TRIM65;DAP;BNIP3;SESN2;XBP1;FYCO1;PRKACA;AKT1;ATG16L2;ATP13A2;TFEB;VPS11;VPS4A;BNIP3L;ZDHHC8;ATG13;TBC1D14;SRC;LRSAM1;RAB1B;CPTP;RGS19;GSK3A;SPTLC2;WDFY3;VPS37A;TCIRG1;TPCN1;ULK1;ULK2;MAP1LC3B;ATP6V1C2;SNAP29;HGS;PACS2;MAPK3;DRAM2;PIK3R2;EP300
14506,GO:0061919,0.67728636307501,0.383520752094302,42,427,process utilizing autophagic mechanism,BP,ITGB4;QSOX1;BOK;TRIM65;DAP;BNIP3;SESN2;XBP1;FYCO1;PRKACA;AKT1;ATG16L2;ATP13A2;TFEB;VPS11;VPS4A;BNIP3L;ZDHHC8;ATG13;TBC1D14;SRC;LRSAM1;RAB1B;CPTP;RGS19;GSK3A;SPTLC2;WDFY3;VPS37A;TCIRG1;TPCN1;ULK1;ULK2;MAP1LC3B;ATP6V1C2;SNAP29;HGS;PACS2;MAPK3;DRAM2;PIK3R2;EP300
14422,GO:0061684,0.677288486680214,0.709303817544931,1,10,chaperone-mediated autophagy,BP,ATP13A2
4806,GO:0010998,0.677434651455532,0.709146321627442,1,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,IMPACT
14985,GO:0070873,0.677489605184872,0.602192194216252,2,21,regulation of glycogen metabolic process,BP,AKT1;GSK3A
7182,GO:0031058,0.677629854478291,0.471778485141558,7,74,positive regulation of histone modification,BP,NOS1;GATA3;PHF1;CTBP1;MAPK3;TGFB1;WBP2
3947,GO:0008641,0.677789438340904,0.70876375282975,1,10,ubiquitin-like modifier activating enzyme activity,MF,UBA1
810,GO:0002080,0.677867219851964,0.70867982795219,1,10,acrosomal membrane,CC,BSG
3913,GO:0008568,0.67811861917569,0.708408443009975,1,10,microtubule-severing ATPase activity,MF,VPS4A
649,GO:0001837,0.678249358012845,0.453267431519928,9,94,epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;BCL9L;CUL7;HMGA2;FUZ;ADIPOR1;ADAM15;TGFB1
4968,GO:0015074,0.678438568851547,0.708062771840506,1,10,DNA integration,BP,NYNRIN
10488,GO:0043371,0.678788576313895,0.707684258842558,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
1001,GO:0002467,0.678931857758036,0.707529197266011,1,10,germinal center formation,BP,PKN1
616,GO:0001782,0.679202132381562,0.599474595688713,2,22,B cell homeostasis,BP,PKN1;MIF
8619,GO:0034122,0.679364393989935,0.600037314031015,2,21,negative regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS
16019,GO:0086011,0.679386677179922,0.707036556738857,1,10,membrane repolarization during action potential,BP,DLG1
15245,GO:0071383,0.679528484026116,0.410541607373538,19,194,cellular response to steroid hormone stimulus,BP,PCK2;NR1D1;EGFR;PPARA;PAK1;EIF4EBP1;SRC;PAQR7;VDR;THRA;PMEPA1;RXRA;ARG1;KANK2;CCNE1;TGFB1;WBP2;ANXA1;EP300
7099,GO:0030889,0.679542159970357,0.706867995377592,1,10,negative regulation of B cell proliferation,BP,PKN1
7552,GO:0031848,0.679566311981748,0.70684180497244,1,10,protection from non-homologous end joining at telomere,BP,ERCC1
16932,GO:0098877,0.679887948377387,0.70649284784671,1,10,neurotransmitter receptor transport to plasma membrane,BP,ARHGAP44
2610,GO:0005913,0.679956376928428,0.469142775710204,7,74,cell-cell adherens junction,CC,ITGA6;CADM4;PAK4;CAMSAP3;BAIAP2L1;KIFC3;ANXA1
8891,GO:0034698,0.680107555616148,0.599180875272014,2,21,response to gonadotropin,BP,ASNS;ITGA3
10057,GO:0042509,0.680371449058896,0.516837409835081,4,45,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;HSF1;FYN;TNFRSF1A
5299,GO:0015980,0.68072792062215,0.408699300022608,19,216,energy derivation by oxidation of organic compounds,BP,PYGB;NFATC4;PYGL;NR1D1;PGM1;IDH2;BNIP3;AKT1;MDH2;DHTKD1;OXA1L;SDHA;TAZ;ACADVL;GSK3A;SDHAF4;NDUFS2;CAT;GNAS
13597,GO:0060044,0.680888129787966,0.70540562354839,1,10,negative regulation of cardiac muscle cell proliferation,BP,TGFBR2
5139,GO:0015645,0.681103699397471,0.70517087957485,1,10,fatty acid ligase activity,MF,SLC27A1
10420,GO:0043248,0.681229686960539,0.701312030991752,1,12,proteasome assembly,BP,PSMG4
638,GO:0001825,0.681342079096823,0.597003585275814,2,22,blastocyst formation,BP,ZP3;SF3B6
13033,GO:0051447,0.681485710543196,0.704754528270747,1,10,negative regulation of meiotic cell cycle,BP,PRKACB
7591,GO:0031953,0.681502667287645,0.704736036518673,1,10,negative regulation of protein autophosphorylation,BP,IMPACT
4721,GO:0010881,0.681670966770522,0.702514290637722,1,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,PRKACA
14900,GO:0070672,0.681778500624633,0.704435105413274,1,10,response to interleukin-15,BP,SHC1
4795,GO:0010984,0.681808627904954,0.7023633453372,1,11,regulation of lipoprotein particle clearance,BP,PCSK9
12268,GO:0048532,0.68188071263621,0.704323531978913,1,10,anatomical structure arrangement,BP,SEMA3F
5605,GO:0016641,0.681891515517922,0.704311737743271,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1
4196,GO:0009301,0.681985034322873,0.478471925888862,6,67,snRNA transcription,BP,POU2F2;INTS8;INTS1;TAF6;RPRD2;RPRD1A
10202,GO:0042795,0.681985034322873,0.478471925888862,6,67,snRNA transcription by RNA polymerase II,BP,POU2F2;INTS8;INTS1;TAF6;RPRD2;RPRD1A
15130,GO:0071168,0.68199090423066,0.596252283306351,2,22,protein localization to chromatin,BP,MAU2;LEMD2
92,GO:0000182,0.6820026173713,0.704190418855134,1,10,rDNA binding,MF,TSPYL2
6606,GO:0022624,0.682113710750439,0.594803034985372,2,24,proteasome accessory complex,CC,PSMD2;PSMD7
5854,GO:0017147,0.682205021874566,0.596756781303845,2,21,Wnt-protein binding,MF,LRP5;FZD8
12752,GO:0050996,0.682375607895845,0.703782841105688,1,10,positive regulation of lipid catabolic process,BP,PPARA
8836,GO:0034612,0.682516020818156,0.404677395899513,20,217,response to tumor necrosis factor,BP,RBCK1;SHARPIN;PCK2;POSTN;PSMD2;AKT1;TMSB4X;ENDOG;TNFSF15;ADAMTS7;GATA3;TNFRSF6B;PSMD7;TNFRSF1A;HYAL1;TNFRSF19;CASP4;CIB1;MAPK3;ARHGEF2
1014,GO:0002495,0.682610035570894,0.465899810168734,7,76,antigen processing and presentation of peptide antigen via MHC class II,BP,KLC2;AP1B1;AP2A2;SEC23A;DNM2;CTSL;SEC24C
2670,GO:0006020,0.682678421137192,0.703451622967836,1,10,inositol metabolic process,BP,ISYNA1
16585,GO:0097352,0.682942473375092,0.544358440493669,3,34,autophagosome maturation,BP,FYCO1;MAP1LC3B;SNAP29
7155,GO:0031005,0.682995100341435,0.703104926106745,1,10,filamin binding,MF,CEACAM1
17857,GO:1901992,0.683044778551475,0.492958301649921,5,55,positive regulation of mitotic cell cycle phase transition,BP,CCND1;CCND2;HYAL1;TGFB1;ANXA1
15431,GO:0071677,0.683128234200843,0.700913345346803,1,11,positive regulation of mononuclear cell migration,BP,TGFB1
17577,GO:1901096,0.68363335549503,0.702405200479508,1,10,regulation of autophagosome maturation,BP,FYCO1
10615,GO:0043584,0.683838589586622,0.702179924091001,1,10,nose development,BP,CHD7
10003,GO:0042403,0.683924001016176,0.702086132095315,1,10,thyroid hormone metabolic process,BP,GATA3
18505,GO:1903580,0.684897644712369,0.592874391128943,2,22,positive regulation of ATP metabolic process,BP,TMSB4X;TAZ
3320,GO:0007029,0.685000056098065,0.511990654648001,4,43,endoplasmic reticulum organization,BP,REEP2;DOPEY2;VAPB;LMAN1
5515,GO:0016469,0.685169331509613,0.591245334319965,2,24,proton-transporting two-sector ATPase complex,CC,TCIRG1;ATP6V1C2
13839,GO:0060413,0.685253531494105,0.700623138204484,1,10,atrial septum morphogenesis,BP,ZFPM1
19848,GO:2000272,0.685512306582217,0.592157564604912,2,22,negative regulation of signaling receptor activity,BP,EPHB2;CBL
18879,GO:1904467,0.685544923167528,0.700301738285119,1,10,regulation of tumor necrosis factor secretion,BP,ARG2
8048,GO:0032691,0.685562515449822,0.698223954108511,1,11,negative regulation of interleukin-1 beta production,BP,CPTP
9707,GO:0038095,0.685751005011305,0.437566888593204,10,111,Fc-epsilon receptor signaling pathway,BP,SHC1;PSMD2;CARD11;PLCG1;PAK1;PSMD7;MAPK9;MAPK3;MAPK10;PIK3R2
4415,GO:0010172,0.685756107802427,0.700068634804838,1,10,embryonic body morphogenesis,BP,FUZ
8242,GO:0033003,0.685778472766453,0.591846882695742,2,22,regulation of mast cell activation,BP,RAC2;STXBP1
888,GO:0002251,0.685969359010114,0.692348793464289,1,15,organ or tissue specific immune response,BP,HIST2H2BE
8042,GO:0032682,0.686303078413813,0.697402012084139,1,11,negative regulation of chemokine production,BP,ARG2
455,GO:0001228,0.686382258800547,0.390028908026331,26,262,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ETV4;MEF2D;TEF;SOX12;ETV5;ATF4;ELK3;POU2F2;TFEB;SALL2;CREB3L2;PPARA;TFE3;DDIT3;MLXIP;HLTF;GATA3;HMGA2;CAMTA2;EHF;RREB1;USF2;PBX3;DBP;LITAF;EP300
13756,GO:0060307,0.686401850986659,0.699354979742355,1,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,DLG1
13828,GO:0060397,0.686439644368814,0.69931317008142,1,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,MAPK3
10603,GO:0043560,0.686481620241169,0.69926672806314,1,10,insulin receptor substrate binding,MF,PRKCZ
2215,GO:0005104,0.686675652536841,0.699051977297366,1,10,fibroblast growth factor receptor binding,MF,FGF2
8192,GO:0032924,0.686705084743734,0.590763995825048,2,22,activin receptor signaling pathway,BP,FKBP1A;ACVR2B
10390,GO:0043201,0.686718601490293,0.699004425906528,1,10,response to leucine,BP,SESN2
17218,GO:0106019,0.68687139825613,0.698835207073705,1,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,OCRL
12762,GO:0051011,0.687000939855923,0.69869168375335,1,10,microtubule minus-end binding,MF,CAMSAP3
2098,GO:0004861,0.687093957676072,0.696522274166123,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,HEXIM1
17917,GO:1902175,0.687399259927848,0.589263095516357,2,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,P4HB;AKT1
10689,GO:0043931,0.687615796961305,0.698009724113785,1,10,ossification involved in bone maturation,BP,THBS3
5862,GO:0017158,0.687842160679061,0.508684160115322,4,43,regulation of calcium ion-dependent exocytosis,BP,SEPT5;SYTL1;STXBP1;ZP3
18329,GO:1903209,0.687867237776054,0.695660159761494,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
7227,GO:0031116,0.688106399456419,0.589122497232638,2,22,positive regulation of microtubule polymerization,BP,PAK1;ARL2
8848,GO:0034629,0.688129416441064,0.589095496387923,2,22,cellular protein-containing complex localization,BP,DLG1;NACC2
201,GO:0000422,0.688167583605804,0.459448954224341,7,77,autophagy of mitochondrion,BP,BNIP3;ATP13A2;BNIP3L;ZDHHC8;ATG13;GSK3A;MAP1LC3B
14438,GO:0061726,0.688167583605804,0.459448954224341,7,77,mitochondrion disassembly,BP,BNIP3;ATP13A2;BNIP3L;ZDHHC8;ATG13;GSK3A;MAP1LC3B
6998,GO:0030673,0.68819829408379,0.697362527283389,1,10,axolemma,CC,MYO1D
8311,GO:0033137,0.688329411720386,0.588860832401539,2,22,negative regulation of peptidyl-serine phosphorylation,BP,DKK1;PPM1F
5866,GO:0017166,0.688611845079512,0.696902374011828,1,10,vinculin binding,MF,PXN
14321,GO:0061430,0.688802776503087,0.696689739483919,1,10,bone trabecula morphogenesis,BP,THBS3
12384,GO:0048753,0.689274756693555,0.587060307191803,2,23,pigment granule organization,BP,AP3D1;RAB29
8063,GO:0032722,0.689414956647658,0.536785494550747,3,34,positive regulation of chemokine production,BP,POSTN;ALOX15B;MIF
11881,GO:0046856,0.689496142688048,0.588249994942212,2,21,phosphatidylinositol dephosphorylation,BP,MTMR4;OCRL
17303,GO:0140030,0.689878916813664,0.427546892002371,11,114,modification-dependent protein binding,MF,TNIP1;ZMYND8;SHARPIN;BRD3;IDE;BAZ2A;PARP10;PHF1;PHF2;RAD23A;CDYL2
7323,GO:0031327,0.68990618912436,0.346464633587781,120,1203,negative regulation of cellular biosynthetic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;MAP2K1;SHC1;CYP27B1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;SESN2;ZC3H6;NACC2;LPCAT1;VLDLR;ACVR2B;EGFR;MAP2K2;PPP1R13L;ATF4;PEG3;BAG3;ELK3;WWTR1;PHF21A;TSPYL2;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;EIF4EBP1;TSC22D4;SRC;AGO4;IRF7;HIST3H2A;ACADVL;PER3;RERE;RSF1;GSK3A;ZNF692;PPM1F;NELFCD;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;SLC27A1;ZFPM1;TRIB2;MXD4;SAMD4B;ZP3;RCOR1;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;CEACAM1;PAIP2;ZNF256;MBD3;IGF2BP3;CCNE1;TGFB1;KLF12;ZNF318;EP300
4153,GO:0009214,0.690113805435324,0.695226481752176,1,10,cyclic nucleotide catabolic process,BP,RAPGEF3
11731,GO:0046514,0.690438883756252,0.692779126993009,1,11,ceramide catabolic process,BP,NAGA
76,GO:0000153,0.690581267136879,0.692618984367177,1,11,cytoplasmic ubiquitin ligase complex,CC,SYVN1
15616,GO:0072079,0.690658511843581,0.692532077326772,1,11,nephron tubule formation,BP,GATA3
2212,GO:0005095,0.690787467520286,0.692386947448735,1,11,GTPase inhibitor activity,MF,ARL2
1384,GO:0003279,0.690902833201635,0.456771568844737,7,73,cardiac septum development,BP,TGFBR2;LTBP1;SUFU;GATA3;DNM2;ZFPM1;CHD7
15844,GO:0072528,0.691009543913932,0.534206794189653,3,36,pyrimidine-containing compound biosynthetic process,BP,NME4;TK2;UCKL1
17001,GO:0099023,0.691121718423317,0.468248370075592,6,65,tethering complex,CC,VPS11;COG8;EXOC2;SH3BP1;COG1;TRAPPC1
18975,GO:1904706,0.691131055977037,0.691999998933604,1,11,negative regulation of vascular smooth muscle cell proliferation,BP,APLN
2972,GO:0006513,0.691332159787764,0.468005259136612,6,65,protein monoubiquitination,BP,NEURL1;ZNF598;RAG1;DDB2;MGRN1;CBL
6924,GO:0030511,0.691531026413812,0.585091283098268,2,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1;GIPC1
18617,GO:1903846,0.691531026413812,0.585091283098268,2,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1;GIPC1
1997,GO:0004715,0.691728323022774,0.53485382825648,3,32,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;SRC;FYN
19832,GO:2000241,0.691753114131126,0.45533740443684,7,77,regulation of reproductive process,BP,SMURF2;PRKACB;SRC;TIMP1;ZP3;RXRA;CIB1
14987,GO:0070875,0.691829940870561,0.693302592127253,1,10,positive regulation of glycogen metabolic process,BP,AKT1
10084,GO:0042573,0.691853498257207,0.691185124259348,1,11,retinoic acid metabolic process,BP,ALDH1A2
6861,GO:0030325,0.691930264678505,0.69109843534891,1,11,adrenal gland development,BP,ARID5B
4318,GO:0009798,0.692149109950136,0.482603697537871,5,54,axis specification,BP,MDFI;WNT7A;LRP5;DDIT3;PCSK6
7100,GO:0030890,0.692256860538825,0.583540597115711,2,23,positive regulation of B cell proliferation,BP,CARD11;MIF
9619,GO:0036474,0.692393923721293,0.583378314421992,2,23,cell death in response to hydrogen peroxide,BP,STK25;ENDOG
8588,GO:0034061,0.692544803540041,0.533094493235945,3,34,DNA polymerase activity,MF,POLD4;PRIMPOL;POLM
7900,GO:0032463,0.692632317308833,0.690304739817683,1,11,negative regulation of protein homooligomerization,BP,SRC
9797,GO:0040001,0.692867964979151,0.583509941161142,2,22,establishment of mitotic spindle localization,BP,NDE1;ARHGEF2
7735,GO:0032225,0.692878076742429,0.690026516700233,1,11,regulation of synaptic transmission, dopaminergic,BP,RAB3B
15264,GO:0071407,0.693200305538678,0.366503112557689,42,423,cellular response to organic cyclic compound,BP,NFATC4;MAP2K1;CYP27B1;PCK2;NR1D1;ITGA6;RAPGEF3;SSH1;EGFR;PRKACA;MAP2K2;ATF4;AKT1;FAM210B;MSN;PPARA;PAK1;BCDIN3D;GNB1;HSF1;EIF4EBP1;SRC;DNM2;AGO4;PAQR7;VDR;PUM1;THRA;PMEPA1;PAK4;P2RX4;RXRA;ARG1;IMPACT;MAPK3;KANK2;ADCY6;CCNE1;TGFB1;WBP2;ANXA1;EP300
10614,GO:0043583,0.693228113474593,0.42370977122413,11,115,ear development,BP,DVL1;BCR;LRP10;NAGLU;GATA3;FGFR1;CHD7;TSHZ1;EPHB2;MAPK3;TGFB1
16122,GO:0090085,0.693651680973129,0.689149422590262,1,11,regulation of protein deubiquitination,BP,TNIP1
7995,GO:0032607,0.694109878545576,0.582037150736255,2,22,interferon-alpha production,BP,PTPRS;IRF7
5676,GO:0016783,0.694787682684785,0.686114358275597,1,12,sulfurtransferase activity,MF,TST
16224,GO:0090239,0.695166764464545,0.687425921812535,1,11,regulation of histone H4 acetylation,BP,CTBP1
9892,GO:0042157,0.695319610219735,0.416004401278159,12,131,lipoprotein metabolic process,BP,LY6K;APOE;PCSK9;PPARA;ZDHHC8;PIGQ;LY6E;ABHD17C;LYPD5;LRP1;MSLN;NTNG1
2061,GO:0004812,0.696040727404776,0.49880708364438,4,44,aminoacyl-tRNA ligase activity,MF,AARS;CARS;GARS;SARS2
5733,GO:0016875,0.696040727404776,0.49880708364438,4,44,ligase activity, forming carbon-oxygen bonds,MF,AARS;CARS;GARS;SARS2
6359,GO:0021537,0.696137332989402,0.403374972993065,15,157,telencephalon development,BP,PTPRS;BNIP3;BBS2;EGFR;LAMB1;SHANK3;TACC1;NUMB;ANXA3;MBOAT7;LRP1;CHD7;NDE1;EPHB2;SOCS7
4185,GO:0009261,0.696254557126696,0.578788788238752,2,23,ribonucleotide catabolic process,BP,NT5E;RAPGEF3
2756,GO:0006165,0.696261215872178,0.440567470100911,8,87,nucleoside diphosphate phosphorylation,BP,PGM1;NME4;HK1;PFKP;PPARA;DHTKD1;ALDOC;LDHA
4259,GO:0009584,0.696321107327204,0.579405635915735,2,22,detection of visible light,BP,GNB1;REEP6
4513,GO:0010561,0.696354218521699,0.686069789980812,1,11,negative regulation of glycoprotein biosynthetic process,BP,ABCA7
872,GO:0002218,0.696487846115785,0.389376070819991,20,214,activation of innate immune response,BP,TNIP1;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;PRKACB;PAK1;SRC;IRF7;FYN;PSMD7;PUM1;CTSL;HEXIM1;SEC14L1;EP300
7337,GO:0031342,0.696566241433351,0.685827154716216,1,11,negative regulation of cell killing,BP,CEACAM1
12858,GO:0051149,0.696597563806288,0.477223317204178,5,55,positive regulation of muscle cell differentiation,BP,FAM129B;MMP14;THRA;CAMK1;TGFB1
9485,GO:0036109,0.696634655162173,0.685748831226128,1,11,alpha-linolenic acid metabolic process,BP,ELOVL1
15455,GO:0071712,0.696635895475116,0.68574741110921,1,11,ER-associated misfolded protein catabolic process,BP,POMT1
1017,GO:0002504,0.696985069679622,0.449308970447337,7,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KLC2;AP1B1;AP2A2;SEC23A;DNM2;CTSL;SEC24C
400,GO:0001076,0.697172959736872,0.405749086267111,14,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;NR1D1;SOX12;CITED4;NACC2;ATF4;PPARA;SIN3B;CTBP1;RERE;VDR;THRA;MED15;WBP2
5654,GO:0016746,0.697329333328302,0.393240744596288,18,189,transferase activity, transferring acyl groups,MF,MBOAT2;LPCAT4;CPT2;NAGS;AGPAT3;LPCAT1;CRAT;ZDHHC8;ELOVL1;ALAS1;TAZ;TGM2;SPTLC2;MBOAT7;AGPAT4;GGT1;CPT1B;EP300
6722,GO:0030130,0.69742094952884,0.684847518307315,1,11,clathrin coat of trans-Golgi network vesicle,CC,LDLRAP1
1280,GO:0003071,0.697567299668167,0.684679531735238,1,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R
2706,GO:0006071,0.698028371467408,0.684149825475512,1,11,glycerol metabolic process,BP,PCK2
2328,GO:0005338,0.698121758961629,0.684042449576001,1,11,nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
12926,GO:0051253,0.69830735325561,0.341144273380727,98,991,negative regulation of RNA metabolic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SHC1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;ZC3H6;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;ELK3;WWTR1;PHF21A;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;TSC22D4;SRC;IRF7;HIST3H2A;PER3;RERE;RSF1;ZNF692;PPM1F;NELFCD;TLE4;VDR;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;ZP3;RCOR1;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;ZNF256;MBD3;CCNE1;TGFB1;KLF12;ZNF318;EP300
12672,GO:0050857,0.69856532374106,0.683532043637069,1,11,positive regulation of antigen receptor-mediated signaling pathway,BP,RAB29
15774,GO:0072348,0.698930273738386,0.57628528781496,2,22,sulfur compound transport,BP,SLC6A6;SLC33A1
4203,GO:0009310,0.699100685554634,0.681153314476303,1,12,amine catabolic process,BP,ALDH7A1
9058,GO:0035269,0.699123008214734,0.681127475653585,1,12,protein O-linked mannosylation,BP,POMT1
16490,GO:0097153,0.699610360940099,0.680562938856246,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP4
6961,GO:0030593,0.699688960932969,0.523570021655413,3,37,neutrophil chemotaxis,BP,RAC2;PIP5K1C;ITGA1
11814,GO:0046676,0.700067752416166,0.574220236744294,2,23,negative regulation of insulin secretion,BP,MAP4K4;HADH
16247,GO:0090278,0.700067752416166,0.574220236744294,2,23,negative regulation of peptide hormone secretion,BP,MAP4K4;HADH
5675,GO:0016782,0.700371318540335,0.493191780456899,4,46,transferase activity, transferring sulfur-containing groups,MF,NDST2;TST;SUGCT;CHST14
3278,GO:0006958,0.700446355890491,0.681360189993445,1,11,complement activation, classical pathway,BP,SERPING1
978,GO:0002429,0.700463513529096,0.38098702151006,22,234,immune response-activating cell surface receptor signaling pathway,BP,RBCK1;PSMD2;PRNP;PRKACA;CARD11;ARPC1A;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAB29;GATA3;SRC;PAG1;FYN;PSMD7;WIPF1;MAPK3;CEACAM1;PIK3R2;EP300
13698,GO:0060211,0.700525192788152,0.68126890324595,1,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B
13700,GO:0060213,0.700525192788152,0.68126890324595,1,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B
14689,GO:0070286,0.700687133372806,0.681081323101603,1,11,axonemal dynein complex assembly,BP,DNAAF5
8478,GO:0033612,0.700751236758322,0.681007045866254,1,11,receptor serine/threonine kinase binding,MF,TGFB1
12402,GO:0048806,0.700752420467569,0.574096288997128,2,22,genitalia development,BP,PKD1;CHD7
10486,GO:0043369,0.700804489625471,0.680945330638558,1,11,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
6005,GO:0019042,0.700846824331927,0.680896261704855,1,11,viral latency,BP,IRF7
7426,GO:0031514,0.700938973369706,0.444730163896235,7,77,motile cilium,CC,BBS2;PRKACA;HK1;PKD1;WDR66;GAS8;ANXA1
16188,GO:0090190,0.70095312092007,0.68077302960911,1,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,TGFB1
804,GO:0002070,0.701053682016054,0.680656411511223,1,11,epithelial cell maturation,BP,XBP1
2658,GO:0006000,0.701181121805361,0.680508573573105,1,11,fructose metabolic process,BP,ALDOC
8601,GO:0034097,0.70138963295233,0.342033374732432,79,815,response to cytokine,BP,CCND1;MST1R;RBCK1;SDC1;SHC1;CYP27B1;SHARPIN;PCK2;MMP1;IFI6;FKBP1A;POSTN;PSMD2;LAMA5;RAB43;LCN2;MAPKAPK3;BBS2;XBP1;RFX2;PRKACA;P4HB;AKT1;IFITM1;IRAK1;TMSB4X;MAPK13;PFKP;ENDOG;MSN;EPOR;CDC34;CD44;FSCN1;TNFSF15;ADAMTS7;PTPN9;IFI27;GATA3;OASL;IL1RAP;MT2A;ARID5B;FLNB;TNFRSF6B;ALDH1A2;SRC;IRF7;GSK3A;STXBP1;TALDO1;OAS1;FYN;ISG20;PSMD7;TNFRSF1A;TLE4;TIMP1;HYAL1;MIF;SOCS2;BCL2L1;ADIPOR1;PTPN12;SLC27A1;TNFRSF19;FGF2;SLIT3;ARG1;CASP4;CBL;CIB1;SOCS7;MAPK3;ARHGEF2;CEACAM1;ECM1;TGFB1;ANXA1
10526,GO:0043425,0.701651858402564,0.573012762031482,2,22,bHLH transcription factor binding,MF,MAP3K10;USF2
2865,GO:0006357,0.702067164947133,0.329288232072062,162,1595,regulation of transcription by RNA polymerase II,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;CTNNBIP1;NFATC4;WNT7A;ETV4;CRTC1;MEF2D;NR1D1;DLG1;TEF;DNMT3A;SOX12;PSMD2;ITGA6;WWC3;CITED4;SMURF2;SESN2;ZC3H6;NACC2;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;PPP1R13L;ATF4;ZKSCAN2;AKT1;BRD3;PEG3;BAG3;APOE;METTL23;PKN1;ELK3;WWTR1;PHF21A;POU2F2;TFEB;DGKQ;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;WDTC1;DNAJB5;MC1R;TFE3;HTRA1;SUFU;SP6;BCL9L;ZNF385A;DDIT3;SATB1;MLXIP;IFI27;HLTF;PKD1;GATA3;APLN;TCFL5;HSF1;SIN3B;WFS1;CTBP1;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;IRF7;RFXANK;PER3;RERE;CAMTA2;PCSK6;AGRN;ZNF692;PFN1;PSMD7;TNFRSF1A;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;HEXIM1;ZSCAN18;HSF4;FGFR1;RREB1;ZBED4;ADNP;TENM2;USF2;PBX3;HES2;TRIB3;LEMD2;ZFPM1;ZNF609;MXD4;E2F5;FGF2;MED15;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;ZHX3;TSHZ1;TGFA;ZBTB4;TCF25;IMPACT;RPRD1A;CAMK1;CARHSP1;MAPK3;KANK2;DBP;LITAF;GLO1;ARHGEF2;ZNF444;LPIN3;ECM1;MBD3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;KLF12;ITGA3;ARHGEF10L;EP300;TCF7L1;FHOD1;RNF10
2727,GO:0006105,0.702343101120524,0.679158059353382,1,11,succinate metabolic process,BP,SDHA
4933,GO:0014888,0.702356003430204,0.57216310765187,2,22,striated muscle adaptation,BP,TNNT1;CAMTA2
13602,GO:0060049,0.702631218302434,0.678822482550295,1,11,regulation of protein glycosylation,BP,POMT1
18418,GO:1903409,0.702664488977054,0.45454930818998,6,67,reactive oxygen species biosynthetic process,BP,NOS1;AKT1;ARG2;ASS1;DNM2;P2RX4
19200,GO:1905214,0.702714075520981,0.678725924358518,1,11,regulation of RNA binding,BP,LARP6
855,GO:0002178,0.702798997638339,0.678626935492858,1,11,palmitoyltransferase complex,CC,SPTLC2
241,GO:0000502,0.702885335534513,0.468567430400469,5,63,proteasome complex,CC,PSMD2;IDE;WFS1;PSMD7;RAD23A
2946,GO:0006475,0.703165829470694,0.40288166991871,13,138,internal protein amino acid acetylation,BP,NOS1;MDH2;JADE2;GATA3;CTBP1;BRPF3;MSL1;APBB1;MAPK3;MBD3;TGFB1;WBP2;EP300
7307,GO:0031301,0.703303032935955,0.402596542102056,13,141,integral component of organelle membrane,CC,QSOX1;PTPRS;BNIP3;ATP13A2;YIF1A;RFNG;OXA1L;PEX10;SLC35B4;MFNG;LEMD2;P2RX4;TBC1D20
3635,GO:0008106,0.70333407316492,0.676222931028002,1,12,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2
1878,GO:0004551,0.703366435873969,0.676185005186576,1,12,nucleotide diphosphatase activity,MF,GARS
17138,GO:0101031,0.703477347991716,0.677835336186247,1,11,chaperone complex,CC,FYCO1
4863,GO:0014075,0.703491950079907,0.570087411249925,2,23,response to amine,BP,ARG1;UROS
14659,GO:0070230,0.703494023212995,0.676035450750684,1,12,positive regulation of lymphocyte apoptotic process,BP,ADAM8
16398,GO:0090723,0.70403615658137,0.67718205222817,1,11,growth cone part,CC,APBB1
14402,GO:0061630,0.704055324518867,0.383363685330765,19,198,ubiquitin protein ligase activity,MF,GID4;NEURL1;SMURF2;HECW2;SYVN1;TMEM129;ZNF598;UBE2J1;CDC34;ANKIB1;RAG1;HLTF;LRSAM1;RNF44;MIB2;STUB1;MGRN1;RNF222;CBL
12344,GO:0048681,0.704119423058791,0.677084616562271,1,11,negative regulation of axon regeneration,BP,PTPRS
243,GO:0000578,0.704307113548487,0.569802401092985,2,22,embryonic axis specification,BP,WNT7A;PCSK6
17366,GO:1900027,0.70470531994929,0.568615993225962,2,23,regulation of ruffle assembly,BP,PFN1;EPS8L1
12669,GO:0050854,0.704742421909688,0.518525977876447,3,34,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;RAB29;CEACAM1
9132,GO:0035437,0.704787448409955,0.676302053443369,1,11,maintenance of protein localization in endoplasmic reticulum,BP,KDELR1
5421,GO:0016266,0.704958289935596,0.488219135860378,4,44,O-glycan processing,BP,B3GNT3;ST3GAL3;ST6GALNAC2;GALNT3
2797,GO:0006244,0.705173636200271,0.674061450663717,1,12,pyrimidine nucleotide catabolic process,BP,NEIL1
13724,GO:0060260,0.705493947602876,0.567657688385155,2,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
18059,GO:1902554,0.705593483535604,0.43931439294394,7,77,serine/threonine protein kinase complex,CC,CCND1;SESN2;TGFBR2;ATG13;CCND2;ULK1;CCNE1
8780,GO:0034451,0.705615800197777,0.568213685931854,2,22,centriolar satellite,CC,SDCCAG8;CCDC113
5590,GO:0016605,0.705749051785852,0.429712875027553,8,86,PML body,CC,MKNK2;SATB1;HSF1;ISG20;WDFY3;TENM2;LRCH4;RNF222
13556,GO:0055119,0.70579348946075,0.675120620327628,1,11,relaxation of cardiac muscle,BP,P2RX4
16782,GO:0098554,0.705917710367148,0.67167740185702,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,HM13
3369,GO:0007140,0.705950927098828,0.567101679333553,2,23,male meiotic nuclear division,BP,AGO4;HSPA2
10964,GO:0044666,0.706211921350827,0.67462821083511,1,11,MLL3/4 complex,CC,ASH2L
8673,GO:0034236,0.706239063389369,0.674596249249732,1,11,protein kinase A catalytic subunit binding,MF,GSK3A
11173,GO:0045216,0.706346131677157,0.385975409087445,17,174,cell-cell junction organization,BP,F2R;SDK2;DLG1;LAMA5;MMP14;PRKACA;FSCN1;NLGN2;RHOC;ARL2;NUMB;PIP5K1C;SRC;PPM1F;CAMSAP3;KIFC3;TGFB1
20304,GO:2001238,0.706910080717607,0.485391556986958,4,46,positive regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;G0S2;DEDD2;RET
2719,GO:0006096,0.706979018778388,0.437806372492634,7,76,glycolytic process,BP,PGM1;HK1;PFKP;PPARA;DHTKD1;ALDOC;LDHA
3155,GO:0006757,0.706979018778388,0.437806372492634,7,76,ATP generation from ADP,BP,PGM1;HK1;PFKP;PPARA;DHTKD1;ALDOC;LDHA
11652,GO:0046349,0.707069793148204,0.673616774737159,1,11,amino sugar biosynthetic process,BP,UAP1
11502,GO:0045948,0.707167104688236,0.565619412667059,2,23,positive regulation of translational initiation,BP,RXRA;IMPACT
15443,GO:0071696,0.707283509049341,0.673364405296385,1,11,ectodermal placode development,BP,GNAS
12531,GO:0050655,0.707338626146788,0.673299293764805,1,11,dermatan sulfate proteoglycan metabolic process,BP,CHST14
13030,GO:0051444,0.707356712381658,0.669969691966536,1,13,negative regulation of ubiquitin-protein transferase activity,BP,LIMK1
7630,GO:0032024,0.707605283329943,0.484798026927483,4,45,positive regulation of insulin secretion,BP,PCK2;NLGN2;GLUL;GLUD1
3902,GO:0008540,0.70767168478832,0.671107583830684,1,12,proteasome regulatory particle, base subcomplex,CC,PSMD2
10559,GO:0043501,0.707866833435388,0.672674770651147,1,11,skeletal muscle adaptation,BP,TNNT1
7590,GO:0031952,0.707921977435254,0.515068495434261,3,33,regulation of protein autophosphorylation,BP,PPP2R5B;SRC;IMPACT
17630,GO:1901292,0.707969488152189,0.40171689022252,12,130,nucleoside phosphate catabolic process,BP,NT5E;XDH;PGM1;RAPGEF3;HK1;PFKP;PPARA;DHTKD1;NEIL1;PNP;ALDOC;LDHA
4732,GO:0010893,0.708268911061005,0.67219872537885,1,11,positive regulation of steroid biosynthetic process,BP,NR1D1
17780,GO:1901722,0.708280176448755,0.672185379456186,1,11,regulation of cell proliferation involved in kidney development,BP,GATA3
11186,GO:0045240,0.708329653341766,0.672126759746006,1,11,dihydrolipoyl dehydrogenase complex,CC,DHTKD1
1038,GO:0002544,0.708451453236054,0.670181099929573,1,12,chronic inflammatory response,BP,AHCY
16839,GO:0098693,0.708492758441374,0.514375960057975,3,33,regulation of synaptic vesicle cycle,BP,SEPT5;NLGN2;STXBP1
7447,GO:0031572,0.708647503168771,0.514188091860956,3,33,G2 DNA damage checkpoint,BP,HMGA2;BRSK1;TAOK1
7921,GO:0032488,0.708900438766973,0.671449881450242,1,11,Cdc42 protein signal transduction,BP,APOE
3693,GO:0008200,0.708980538281338,0.562757526273723,2,24,ion channel inhibitor activity,MF,PCSK9;SLC30A1
2438,GO:0005637,0.709448324135095,0.482583935009989,4,45,nuclear inner membrane,CC,IFI27;SIGMAR1;LEMD2;P2RX4
4718,GO:0010878,0.70961500714192,0.670600889982019,1,11,cholesterol storage,BP,PPARA
12754,GO:0050998,0.709989600055206,0.670155114988315,1,11,nitric-oxide synthase binding,MF,DNM2
13492,GO:0055007,0.710002364040835,0.446193798534936,6,65,cardiac muscle cell differentiation,BP,DKK1;OBSL1;PAK1;GSK3A;RXRA;TGFB1
5571,GO:0016580,0.710341415783835,0.66973599708631,1,11,Sin3 complex,CC,SIN3B
1403,GO:0003334,0.710469780973693,0.669582967450321,1,11,keratinocyte development,BP,FLNB
7488,GO:0031647,0.710641444652028,0.373663050240777,20,214,regulation of protein stability,BP,TSPAN1;DVL1;PRNP;CRTAP;XBP1;PANO1;BAG3;SYVN1;VPS11;CCDC88C;WFS1;ASPH;GIPC1;SRC;PER3;STXBP1;PFN1;STUB1;RAD23A;EP300
16604,GO:0097386,0.7106415027695,0.66937815997634,1,11,glial cell projection,CC,GLUL
11461,GO:0045893,0.710667390284705,0.326589762608325,107,1059,positive regulation of transcription, DNA-templated,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;TFE3;BCL9L;DDIT3;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;RNF187;HSF4;RREB1;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
18454,GO:1903508,0.710667390284705,0.326589762608325,107,1059,positive regulation of nucleic acid-templated transcription,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;TFE3;BCL9L;DDIT3;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;RNF187;HSF4;RREB1;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
13644,GO:0060117,0.710716772564328,0.669288355240141,1,11,auditory receptor cell development,BP,FGFR1
5160,GO:0015696,0.710719090977277,0.480813444997724,4,46,ammonium transport,BP,NOS1;RAB3B;SEC14L1;AZIN2
7208,GO:0031092,0.711290715983976,0.668602924832329,1,11,platelet alpha granule membrane,CC,APLP2
3433,GO:0007224,0.711743788585591,0.414816906164374,9,97,smoothened signaling pathway,BP,SERPINE2;TGFBR2;PRKACB;SUFU;TTBK2;TULP3;FUZ;MAP3K10;MGRN1
15463,GO:0071731,0.712109926432903,0.667622572227461,1,11,response to nitric oxide,BP,DNM2
6464,GO:0021782,0.712125775197459,0.443407391115492,6,67,glial cell development,BP,SH3TC2;EGFR;AKT1;LAMB2;LRP1;TGFB1
3602,GO:0008038,0.712126781106408,0.560245664693905,2,22,neuron recognition,BP,ROBO3;EPHB2
3042,GO:0006596,0.712426207815573,0.66542542477225,1,12,polyamine biosynthetic process,BP,AZIN2
15203,GO:0071322,0.712605866385184,0.421384664447265,8,90,cellular response to carbohydrate stimulus,BP,PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;MAPK13;ENDOG
3113,GO:0006691,0.712844153585717,0.664922132612329,1,12,leukotriene metabolic process,BP,GGT1
13249,GO:0051893,0.712964173818063,0.478595980188438,4,44,regulation of focal adhesion assembly,BP,MMP14;SRC;PPM1F;CAMSAP3
16139,GO:0090109,0.712964173818063,0.478595980188438,4,44,regulation of cell-substrate junction assembly,BP,MMP14;SRC;PPM1F;CAMSAP3
7076,GO:0030858,0.713071160313611,0.508039902464147,3,35,positive regulation of epithelial cell differentiation,BP,CYP27B1;ALOX15B;VDR
12664,GO:0050849,0.713368438721776,0.664289910947197,1,12,negative regulation of calcium-mediated signaling,BP,PRNP
10417,GO:0043243,0.713585678873,0.557734882227842,2,23,positive regulation of protein complex disassembly,BP,BNIP3;FYCO1
6660,GO:0030008,0.713950268594786,0.662052491009155,1,13,TRAPP complex,CC,TRAPPC1
4533,GO:0010596,0.714050056531691,0.507207761258806,3,34,negative regulation of endothelial cell migration,BP,APOE;FGF2;TGFB1
14169,GO:0061029,0.714247979890997,0.665052754256371,1,11,eyelid development in camera-type eye,BP,EGFR
20307,GO:2001241,0.714339320793461,0.663116571863826,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,RET
18105,GO:1902680,0.714447426187678,0.322593940926152,107,1060,positive regulation of RNA biosynthetic process,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;TFE3;BCL9L;DDIT3;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;RNF187;HSF4;RREB1;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
4064,GO:0009112,0.714454616170616,0.506344895535634,3,35,nucleobase metabolic process,BP,XDH;UCKL1;AOX1
11796,GO:0046639,0.714668160270598,0.664545809157455,1,11,negative regulation of alpha-beta T cell differentiation,BP,ANXA1
16080,GO:0089718,0.714693796641443,0.664514858629639,1,11,amino acid import across plasma membrane,BP,NTSR1
8321,GO:0033147,0.715332195687806,0.663743368334675,1,11,negative regulation of intracellular estrogen receptor signaling pathway,BP,KANK2
10424,GO:0043252,0.715361001696367,0.66370852256468,1,11,sodium-independent organic anion transport,BP,SLCO4A1
5503,GO:0016442,0.715492851009971,0.66354899045067,1,11,RISC complex,CC,AGO4
7328,GO:0031332,0.715492851009971,0.66354899045067,1,11,RNAi effector complex,CC,AGO4
5655,GO:0016747,0.715537422955191,0.378271850077974,16,171,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2;LPCAT4;CPT2;NAGS;AGPAT3;LPCAT1;CRAT;ZDHHC8;ELOVL1;ALAS1;TAZ;SPTLC2;MBOAT7;AGPAT4;CPT1B;EP300
1342,GO:0003198,0.715542143927546,0.663489332102937,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
1229,GO:0002903,0.715936930452416,0.661178498589461,1,12,negative regulation of B cell apoptotic process,BP,MIF
3448,GO:0007260,0.716176168598616,0.473980021067659,4,47,tyrosine phosphorylation of STAT protein,BP,PTK6;HSF1;FYN;TNFRSF1A
3370,GO:0007141,0.71626183992136,0.660783230538562,1,12,male meiosis I,BP,HSPA2
8022,GO:0032649,0.716346798138092,0.473772679774361,4,47,regulation of interferon-gamma production,BP,PRNP;GATA3;ZFPM1;ZP3
14245,GO:0061178,0.71642266328365,0.503581177262609,3,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;MAP4K4
10281,GO:0043014,0.716576103963787,0.554025686853282,2,23,alpha-tubulin binding,MF,ARL8A;FAM110C
13822,GO:0060391,0.716927963143947,0.661808529992512,1,11,positive regulation of SMAD protein signal transduction,BP,TGFB1
7098,GO:0030888,0.716998356002828,0.503217955728761,3,35,regulation of B cell proliferation,BP,CARD11;PKN1;MIF
10105,GO:0042599,0.717215484853347,0.659620885683806,1,12,lamellar body,CC,CKAP4
3914,GO:0008569,0.717728764945996,0.660834119117484,1,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,KIFC3
19263,GO:1905369,0.717988065331125,0.450420714773893,5,64,endopeptidase complex,CC,PSMD2;IDE;WFS1;PSMD7;RAD23A
17510,GO:1900409,0.718156322058471,0.658470941282986,1,12,positive regulation of cellular response to oxidative stress,BP,ENDOG
18171,GO:1902884,0.718156322058471,0.658470941282986,1,12,positive regulation of response to oxidative stress,BP,ENDOG
15251,GO:0071391,0.718212466945545,0.660244431178246,1,11,cellular response to estrogen stimulus,BP,WBP2
1289,GO:0003094,0.718226122875648,0.660227770752893,1,11,glomerular filtration,BP,F2R
6963,GO:0030595,0.718347553526223,0.40664083729425,9,104,leukocyte chemotaxis,BP,PGF;RAC2;ADAM8;PIP5K1C;ITGA1;MIF;VEGFB;MAPK3;ANXA1
8001,GO:0032613,0.718578980965399,0.550876816389393,2,24,interleukin-10 production,BP,PRKCZ;TRIB2
3560,GO:0007602,0.718664604853998,0.551421547194782,2,23,phototransduction,BP,PITPNM1;GNB1
2936,GO:0006458,0.718808702283838,0.471005343647195,4,46,'de novo' protein folding,BP,FKBP1A;FYCO1;HSPA2;HSPA13
16135,GO:0090102,0.718865851926622,0.551170016945479,2,23,cochlea development,BP,DVL1;GATA3
8483,GO:0033622,0.719172231062251,0.65907185965599,1,11,integrin activation,BP,SRC
11530,GO:0046030,0.719555058962193,0.65860321451451,1,11,inositol trisphosphate phosphatase activity,MF,OCRL
19652,GO:1990774,0.719772475257993,0.658336823304951,1,11,tumor necrosis factor secretion,BP,ARG2
17113,GO:0099625,0.720049545970938,0.657997090446127,1,11,ventricular cardiac muscle cell membrane repolarization,BP,DLG1
14083,GO:0060841,0.72024388790244,0.657758629235419,1,11,venous blood vessel development,BP,ACVR2B
1074,GO:0002637,0.720369844902309,0.499052669112361,3,35,regulation of immunoglobulin production,BP,XBP1;PKN1;TGFB1
13583,GO:0060026,0.720489798046464,0.657456695302387,1,11,convergent extension,BP,DVL1
8250,GO:0033014,0.720733004880239,0.548178111912307,2,24,tetrapyrrole biosynthetic process,BP,ALAS1;UROS
13426,GO:0052743,0.720827307769252,0.65704193368697,1,11,inositol tetrakisphosphate phosphatase activity,MF,OCRL
1104,GO:0002690,0.721227597897568,0.467599662215681,4,48,positive regulation of leukocyte chemotaxis,BP,PGF;RAC2;VEGFB;MAPK3
306,GO:0000815,0.72123875914164,0.654680933807571,1,12,ESCRT III complex,CC,VPS4A
6949,GO:0030552,0.721341878922356,0.656408781374697,1,11,cAMP binding,MF,RAPGEF3
2377,GO:0005504,0.721352644180324,0.651649099810302,1,14,fatty acid binding,MF,PPARA
13564,GO:0060004,0.721374614845693,0.656368468758058,1,11,reflex,BP,SATB1
17111,GO:0099623,0.721431624005471,0.656298255513734,1,11,regulation of cardiac muscle cell membrane repolarization,BP,DLG1
13008,GO:0051393,0.72155351069425,0.656148098260058,1,11,alpha-actinin binding,MF,OBSL1
11680,GO:0046434,0.721605370548182,0.371363674020383,16,172,organophosphate catabolic process,BP,NT5E;XDH;PGM1;RAPGEF3;HK1;PFKP;PPARA;DHTKD1;PLCG1;NEIL1;NTSR1;SMPD3;PNP;ALDOC;PNPLA6;LDHA
8779,GO:0034450,0.721667491063751,0.654151042633612,1,12,ubiquitin-ubiquitin ligase activity,MF,STUB1
3325,GO:0007034,0.722196344350572,0.390342106864493,11,119,vacuolar transport,BP,SORL1;AP3D1;EHD3;VPS11;VPS4A;PCSK9;BIN1;CHMP5;MGRN1;HGS;SNX27
2944,GO:0006473,0.722207205334161,0.373772592357469,15,162,protein acetylation,BP,NOS1;RAPGEF3;MDH2;JADE2;GATA3;CTBP1;BRPF3;MSL1;APBB1;CAMK1;MAPK3;MBD3;TGFB1;WBP2;EP300
2699,GO:0006063,0.722226491504739,0.653459134223174,1,12,uronic acid metabolic process,BP,CRYL1
6187,GO:0019585,0.722226491504739,0.653459134223174,1,12,glucuronate metabolic process,BP,CRYL1
15051,GO:0070977,0.722273311615642,0.655260233715234,1,11,bone maturation,BP,THBS3
20224,GO:2001038,0.72235875050814,0.546133265438285,2,24,regulation of cellular response to drug,BP,ENDOG;HMGA2
2584,GO:0005875,0.722368006378406,0.390143151846499,11,119,microtubule associated complex,CC,CLIP2;KLC2;NUDCD3;EML2;MAP1B;DYNLRB1;KIF17;KIF13B;NDE1;KIFC3;PXN
1357,GO:0003222,0.722482159953743,0.65500226568647,1,11,ventricular trabecula myocardium morphogenesis,BP,CHD7
17602,GO:1901201,0.722511455928716,0.65496606665912,1,11,regulation of extracellular matrix assembly,BP,TGFB1
2535,GO:0005790,0.72257758893463,0.54585748459001,2,24,smooth endoplasmic reticulum,CC,SYVN1;MYO1D
16524,GO:0097202,0.722702869448124,0.652868587007868,1,12,activation of cysteine-type endopeptidase activity,BP,ASPH
1915,GO:0004602,0.722886574983528,0.64858760687477,1,15,glutathione peroxidase activity,MF,GPX3
7272,GO:0031235,0.722984765332927,0.65438079251192,1,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASA3
9899,GO:0042168,0.723174150753463,0.544505396865806,2,25,heme metabolic process,BP,ALAS1;UROS
10287,GO:0043022,0.723177795693371,0.465428991849122,4,47,ribosome binding,MF,ZNF598;OXA1L;PYM1;IMPACT
13398,GO:0052629,0.723758815129191,0.653421854169293,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,MTMR4
11732,GO:0046519,0.723877558577488,0.651408799153504,1,12,sphingoid metabolic process,BP,SPTLC2
14289,GO:0061337,0.723909766657281,0.429486451051366,6,66,cardiac conduction,BP,NOS1;PRKACA;EHD3;ITPR3;ASPH;STIM1
9141,GO:0035458,0.724157102483891,0.65106065908041,1,12,cellular response to interferon-beta,BP,CDC34
14311,GO:0061384,0.724295928242218,0.544343282531965,2,23,heart trabecula morphogenesis,BP,FKBP1A;CHD7
1122,GO:0002708,0.724497632863557,0.463807143004426,4,47,positive regulation of lymphocyte mediated immunity,BP,PRKCZ;GATA3;ZP3;TGFB1
12138,GO:0048188,0.72503040705368,0.64997119350716,1,12,Set1C/COMPASS complex,CC,ASH2L
7288,GO:0031268,0.725095370986493,0.649890036604233,1,12,pseudopodium organization,BP,RAB25
13036,GO:0051452,0.725132719830835,0.492452893218529,3,37,intracellular pH reduction,BP,DMXL2;TCIRG1;ATP6V1C2
17970,GO:1902287,0.725592640893045,0.651141143139486,1,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,SEMA3F
538,GO:0001656,0.725960750738343,0.441986929854889,5,56,metanephros development,BP,WWTR1;LAMB2;RET;PKD1;GATA3
7109,GO:0030900,0.726137019814313,0.352513083904343,22,229,forebrain development,BP,WNT7A;PTPRS;BNIP3;BBS2;EGFR;LAMB1;SHANK3;DKK1;TACC1;NUMB;ALDH1A2;SRC;FYN;ANXA3;MBOAT7;FGFR1;LRP1;MYO1D;CHD7;NDE1;EPHB2;SOCS7
5264,GO:0015893,0.726460269366502,0.397405724345148,9,100,drug transport,BP,RAB3B;CYGB;SLC13A3;SLC6A9;GAL;SLC13A5;NTSR1;PRAF2;ARG1
4231,GO:0009408,0.726487369106775,0.376170326468189,13,140,response to heat,BP,NOS1;PRKACA;AKT1;IRAK1;BAG3;MYOF;HSF1;HSF4;STUB1;HSPA2;HSPA13;MAPK3;EP300
6506,GO:0021872,0.726722713383236,0.491138771422783,3,35,forebrain generation of neurons,BP,SHANK3;NUMB;FGFR1
14310,GO:0061383,0.726832709129219,0.491370357363992,3,34,trabecula morphogenesis,BP,FKBP1A;CHD7;THBS3
9552,GO:0036296,0.726964118049828,0.540302958780555,2,24,response to increased oxygen levels,BP,BNIP3;CAT
12276,GO:0048545,0.727378363830779,0.344728110207702,26,272,response to steroid hormone,BP,CCND1;SDC1;PCK2;NR1D1;EGFR;TGFBR2;PPARA;PAK1;PTPRU;IGFBP2;EIF4EBP1;SRC;PAQR7;ANXA3;VDR;THRA;PMEPA1;SLIT3;RXRA;ARG1;KANK2;CCNE1;TGFB1;WBP2;ANXA1;EP300
19748,GO:2000059,0.728170793001359,0.488647164611652,3,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,PANO1;SUFU;GIPC1
2829,GO:0006296,0.72832768135117,0.488450096349635,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,ERCC1;POLD4;DDB2
3757,GO:0008298,0.728385269994807,0.645759509804482,1,12,intracellular mRNA localization,BP,ZNF385A
10544,GO:0043476,0.728666596144327,0.645404417030263,1,12,pigment accumulation,BP,AP3D1
10545,GO:0043482,0.728666596144327,0.645404417030263,1,12,cellular pigment accumulation,BP,AP3D1
6792,GO:0030224,0.728819630741512,0.537938016101439,2,24,monocyte differentiation,BP,CTNNBIP1;IRF7
18294,GO:1903131,0.728819630741512,0.537938016101439,2,24,mononuclear cell differentiation,BP,CTNNBIP1;IRF7
13938,GO:0060575,0.728821918080894,0.645208240348465,1,12,intestinal epithelial cell differentiation,BP,PTK6
1671,GO:0004129,0.729092563670066,0.638052634939301,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4951,GO:0015002,0.729092563670066,0.638052634939301,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5624,GO:0016676,0.729092563670066,0.638052634939301,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
4983,GO:0015103,0.729105938920824,0.411521653789309,7,77,inorganic anion transmembrane transporter activity,MF,TTYH3;SLC12A7;SLC20A1;ANO8;SLC12A4;LRRC8A;PCYOX1
16538,GO:0097228,0.729722539151678,0.64406893228342,1,12,sperm principal piece,CC,HK1
5194,GO:0015780,0.729828126436608,0.643935160985627,1,12,nucleotide-sugar transmembrane transport,BP,SLC35B4
8898,GO:0034707,0.730635954020005,0.642910305376279,1,12,chloride channel complex,CC,TTYH3
3355,GO:0007093,0.730660787488523,0.367416932141873,14,154,mitotic cell cycle checkpoint,BP,CCND1;DLG1;XPC;VPS4A;ZNF385A;PCBP4;HMGA2;BRSK1;BCL2L1;TAOK1;CNOT11;TGFB1;PPP1R10;EP300
8595,GO:0034086,0.730837905683801,0.64265371126312,1,12,maintenance of sister chromatid cohesion,BP,MAU2
8597,GO:0034088,0.730837905683801,0.64265371126312,1,12,maintenance of mitotic sister chromatid cohesion,BP,MAU2
12239,GO:0048477,0.730920467427278,0.456099576177525,4,46,oogenesis,BP,ERCC1;SRC;PAQR7;ZP3
10733,GO:0044058,0.730924174666487,0.642544053077014,1,12,regulation of digestive system process,BP,STK39
10564,GO:0043508,0.730988651245268,0.642462077168577,1,12,negative regulation of JUN kinase activity,BP,AIDA
3335,GO:0007050,0.73128077812059,0.350457074991417,20,215,cell cycle arrest,BP,CCND1;MAP2K1;PRNP;PRKACA;PPP2R3B;PPP2R5B;BIN1;ZNF385A;DDIT3;GAS2L1;PCBP4;PKD1;HMGA2;CGREF1;MIF;APBB1;CNOT11;MLF1;TGFB1;EP300
12270,GO:0048535,0.731312454607774,0.642050152507498,1,12,lymph node development,BP,TGFB1
906,GO:0002285,0.731373543003364,0.391609677131941,9,100,lymphocyte activation involved in immune response,BP,ERCC1;XBP1;PRKCZ;GATA3;MFNG;ZFPM1;CEACAM1;TGFB1;ANXA1
4502,GO:0010528,0.731606674424704,0.641675516240984,1,12,regulation of transposition,BP,APOBEC3C
4503,GO:0010529,0.731606674424704,0.641675516240984,1,12,negative regulation of transposition,BP,APOBEC3C
876,GO:0002224,0.731987669000946,0.398521456943569,8,90,toll-like receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;MAPKAPK3;CTSB;IRAK1;IRF7;CTSL
12267,GO:0048531,0.732186649154372,0.640936055513268,1,12,beta-1,3-galactosyltransferase activity,MF,B3GNT3
6941,GO:0030544,0.732300177265813,0.483770958201268,3,36,Hsp70 protein binding,MF,FKBP1A;STUB1;DNAJB9
5411,GO:0016248,0.732306608302871,0.532863625431679,2,25,channel inhibitor activity,MF,PCSK9;SLC30A1
13645,GO:0060119,0.732445579636786,0.533289907608407,2,24,inner ear receptor cell development,BP,NAGLU;FGFR1
14524,GO:0065002,0.732527701128663,0.453237362459835,4,50,intracellular protein transmembrane transport,BP,BCR;RTN2;SEC63;PEX10
962,GO:0002381,0.732573479205656,0.483773707097234,3,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,ERCC1;POU2F2;TGFB1
10229,GO:0042866,0.732644483900055,0.407168504229836,7,78,pyruvate biosynthetic process,BP,PGM1;HK1;PFKP;PPARA;DHTKD1;ALDOC;LDHA
20111,GO:2000727,0.732783392672012,0.640173873224851,1,12,positive regulation of cardiac muscle cell differentiation,BP,TGFB1
6862,GO:0030326,0.733055440430528,0.39741779278387,8,88,embryonic limb morphogenesis,BP,WNT7A;LRP5;DKK1;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
9003,GO:0035113,0.733055440430528,0.39741779278387,8,88,embryonic appendage morphogenesis,BP,WNT7A;LRP5;DKK1;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
11766,GO:0046597,0.733575485866513,0.63755762232238,1,13,negative regulation of viral entry into host cell,BP,IFITM1
13974,GO:0060644,0.733576824532463,0.639158360577535,1,12,mammary gland epithelial cell differentiation,BP,AKT1
10815,GO:0044291,0.73358425492436,0.453026634160853,4,45,cell-cell contact zone,CC,DLG1;OBSL1;PAK1;FHOD1
8710,GO:0034341,0.733713752033831,0.376614010522721,11,125,response to interferon-gamma,BP,CYP27B1;RAB43;IFITM1;CD44;OASL;MT2A;FLNB;IRF7;STXBP1;OAS1;ARG1
4037,GO:0009068,0.733892886305977,0.6387531601338,1,12,aspartate family amino acid catabolic process,BP,ALDH7A1
17449,GO:1900182,0.733988126668721,0.431990155697539,5,57,positive regulation of protein localization to nucleus,BP,SESN2;AKT1;SRC;FYN;TGFB1
1,GO:0000002,0.734159868128037,0.531079980566763,2,24,mitochondrial genome maintenance,BP,SESN2;PRIMPOL
14931,GO:0070742,0.734502088991068,0.637971059658158,1,12,C2H2 zinc finger domain binding,MF,HMGA2
6238,GO:0019787,0.73452908665085,0.323673613657983,39,400,ubiquitin-like protein transferase activity,MF,GID4;RBCK1;NEURL1;SHARPIN;SMURF2;HECW2;FBXW8;SYVN1;RNF135;TMEM129;FBXO2;ZNF598;FBXW5;UBE2J1;KLHL29;CDC34;ANKIB1;RAG1;FBXL6;HLTF;UBR4;LRSAM1;ZNF862;RMND5A;FBXL15;RNF44;RNF187;MIB2;STUB1;DDB2;RMND5B;MGRN1;KLHL17;RNF222;SPSB3;CBL;RNF103;TRAF7;RNF10
7223,GO:0031112,0.734819277677544,0.53022779029784,2,24,positive regulation of microtubule polymerization or depolymerization,BP,PAK1;ARL2
20292,GO:2001222,0.735536762642692,0.529962033405918,2,23,regulation of neuron migration,BP,ZNF609;ARHGEF2
15582,GO:0072012,0.735858672484211,0.636224316068005,1,12,glomerulus vasculature development,BP,ACTA2
8144,GO:0032838,0.736217899173264,0.373828641586196,11,122,plasma membrane bounded cell projection cytoplasm,CC,AP3D1;DLG4;PRKACA;WDR66;DYNLRB1;TULP3;KIF17;ARFGEF2;KLHL17;MAP1LC3B;GAS8
15765,GO:0072332,0.736218586037691,0.413837884395729,6,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,BOK;CD44;ZNF385A;SHISA5;MIF;EP300
8826,GO:0034593,0.736247368443508,0.529041386544929,2,23,phosphatidylinositol bisphosphate phosphatase activity,MF,MTMR4;OCRL
2434,GO:0005622,0.73653837711752,0.293121560710533,1081,10528,intracellular,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;ADGRL1;SDC1;DVL1;MAP2K1;ADM2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;NYAP1;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;ADGRF1;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;ITGB5;H6PD;XYLT1;GPT2;ADCY7;XBP1;MYCBPAP;MARCKSL1;PGLS;EVI5L;MAP4K4;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;DHTKD1;KDELR1;NADK;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;ISYNA1;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;NAV1;DDIT3;TNFSF15;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;TBC1D9B;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;MYH16;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;CNFN;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;RGL2;INTS8;MYH15;HMGA2;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;PAG1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;EIF2S2;HEXIM1;AMIGO2;TIMP1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZP3;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;ERBB3;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
10685,GO:0043921,0.736666224591686,0.527834549316147,2,24,modulation by host of viral transcription,BP,HMGA2;EP300
13356,GO:0052312,0.736666224591686,0.527834549316147,2,24,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2;EP300
13375,GO:0052472,0.736666224591686,0.527834549316147,2,24,modulation by host of symbiont transcription,BP,HMGA2;EP300
8303,GO:0033127,0.736747595971577,0.635075865307184,1,12,regulation of histone phosphorylation,BP,MAPK3
3748,GO:0008287,0.736882839627675,0.448661937813236,4,46,protein serine/threonine phosphatase complex,CC,STRN4;PPP2R3B;PPP2R5B;PPP1R10
18359,GO:1903293,0.736882839627675,0.448661937813236,4,46,phosphatase complex,CC,STRN4;PPP2R3B;PPP2R5B;PPP1R10
10341,GO:0043124,0.737031329423065,0.478111888792076,3,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;MAPKBP1;CARD19
7306,GO:0031300,0.737044386534157,0.360007715059492,14,155,intrinsic component of organelle membrane,CC,QSOX1;RAB3B;PTPRS;BNIP3;ATP13A2;YIF1A;RFNG;OXA1L;PEX10;SLC35B4;MFNG;LEMD2;P2RX4;TBC1D20
19976,GO:2000479,0.737242435992615,0.634435221319386,1,12,regulation of cAMP-dependent protein kinase activity,BP,SESN2
12269,GO:0048534,0.737519982515959,0.309622851599823,59,621,hematopoietic or lymphoid organ development,BP,ERCC1;CTNNBIP1;MAP2K1;AP3D1;PSMD2;BCR;LRP5;XBP1;CMTM7;MKNK2;MMP14;CARD11;FAM210B;PKN1;PRKCZ;FAM20C;POU2F2;FZD8;RRAS;TGFBR2;DHTKD1;KDELR1;WASF2;TFE3;ZNF385A;RAG1;SATB1;RET;GATA3;ADAM8;SRC;TAZ;AGO4;IRF7;PSMD7;TNRC6B;THRA;LRRC8A;MFNG;ZFPM1;SMPD3;LRRK1;PNP;CHD7;L3MBTL3;POLM;MYL9;CIB1;MAPK3;DNAJB9;GLO1;MLF1;CEACAM1;TGFB1;SH3PXD2A;ANXA1;ASH2L;GNAS;EP300
3211,GO:0006855,0.737604611480989,0.447757025464251,4,46,drug transmembrane transport,BP,SLC13A3;SLC13A5;NTSR1;PRAF2
11540,GO:0046040,0.737796731265723,0.633716469381849,1,12,IMP metabolic process,BP,AMPD2
8968,GO:0035025,0.737800792607629,0.633711198628898,1,12,positive regulation of Rho protein signal transduction,BP,F2R
5564,GO:0016573,0.737876984877031,0.367147689661776,12,131,histone acetylation,BP,NOS1;JADE2;GATA3;CTBP1;BRPF3;MSL1;APBB1;MAPK3;MBD3;TGFB1;WBP2;EP300
13230,GO:0051861,0.737971385784739,0.633489746986324,1,12,glycolipid binding,MF,HSPA2
139,GO:0000289,0.738307743813386,0.476482651653622,3,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B;SAMD4B;CNOT11
10702,GO:0043970,0.738405993723364,0.63292505586766,1,12,histone H3-K9 acetylation,BP,GATA3
20168,GO:2000826,0.738578551161874,0.525346705767527,2,24,regulation of heart morphogenesis,BP,TGFBR2;DKK1
6220,GO:0019748,0.738638093240387,0.475381755783219,3,37,secondary metabolic process,BP,CBS;AKR7A2;CBR4
7199,GO:0031083,0.738832583753588,0.630749794364147,1,13,BLOC-1 complex,CC,PI4K2A
5555,GO:0016558,0.738958445172165,0.632206180475334,1,12,protein import into peroxisome matrix,BP,PEX10
15396,GO:0071622,0.739383502286167,0.523127780077341,2,26,regulation of granulocyte chemotaxis,BP,RAC2;MAPK3
5729,GO:0016866,0.739669819305596,0.523313323065204,2,25,intramolecular transferase activity,MF,PGM1;RPUSD3
12817,GO:0051092,0.739739858097778,0.375103657904511,10,113,positive regulation of NF-kappaB transcription factor activity,BP,RBCK1;CARD11;IRAK1;PRKCZ;IL1RAP;ADAM8;CIB1;ARHGEF2;TGFB1;CAT
1462,GO:0003705,0.740050886948202,0.424499242932886,5,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,MEF2D;SOX7;TLE4;USF2;PBX3
995,GO:0002449,0.740286518083147,0.364190961864174,12,134,lymphocyte mediated immunity,BP,ERCC1;DLG1;SERPING1;PRKCZ;POU2F2;KDELR1;GATA3;IRF7;ZP3;ARG1;CEACAM1;TGFB1
15345,GO:0071545,0.740363881052534,0.630371950853502,1,12,inositol phosphate catabolic process,BP,NTSR1
8999,GO:0035102,0.740486121279752,0.630212047237298,1,12,PRC1 complex,CC,PHC2
4221,GO:0009394,0.740538713061295,0.521099599813163,2,27,2'-deoxyribonucleotide metabolic process,BP,NEIL1;GUK1
3581,GO:0007628,0.74058073824725,0.630088237314031,1,12,adult walking behavior,BP,CHD7
2954,GO:0006486,0.740782094477162,0.341816085371819,19,204,protein glycosylation,BP,LMF1;SYVN1;RFNG;UBE2J1;ADAMTS7;SRD5A3;B4GALT2;B3GNT3;MPI;MCFD2;MFNG;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1;VEGFB;POMT1;B4GALT6;GALNT3
10519,GO:0043413,0.740782094477162,0.341816085371819,19,204,macromolecule glycosylation,BP,LMF1;SYVN1;RFNG;UBE2J1;ADAMTS7;SRD5A3;B4GALT2;B3GNT3;MPI;MCFD2;MFNG;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1;VEGFB;POMT1;B4GALT6;GALNT3
2943,GO:0006471,0.741035046410687,0.522136061796363,2,24,protein ADP-ribosylation,BP,PARP10;ADNP
7902,GO:0032465,0.741089986663342,0.408361083453467,6,68,regulation of cytokinesis,BP,VPS4A;GIT1;SDCCAG3;GIPC1;RAB11FIP4;BCL2L1
1102,GO:0002688,0.741192844957398,0.422452374821669,5,61,regulation of leukocyte chemotaxis,BP,PGF;RAC2;MIF;VEGFB;MAPK3
4240,GO:0009437,0.741214557336454,0.629257947048009,1,12,carnitine metabolic process,BP,CRAT
11809,GO:0046660,0.741261726871674,0.396650199344562,7,79,female sex differentiation,BP,MMP14;ARID5B;SRC;BCL2L1;ZP3;CHD7;SLIT3
8375,GO:0033262,0.741353508679484,0.629075710820324,1,12,regulation of nuclear cell cycle DNA replication,BP,FGFR1
6149,GO:0019432,0.741396059230006,0.521662800792835,2,24,triglyceride biosynthetic process,BP,PCK2;LPIN3
19766,GO:2000105,0.7415873968815,0.628768790811017,1,12,positive regulation of DNA-dependent DNA replication,BP,FGFR1
4187,GO:0009263,0.741694316790775,0.626998520525091,1,13,deoxyribonucleotide biosynthetic process,BP,GUK1
6758,GO:0030176,0.741819000518996,0.367185531466448,11,123,integral component of endoplasmic reticulum membrane,CC,EDEM1;RTN2;SYVN1;SEC63;ELOVL1;WFS1;SARAF;SLC35B4;RRBP1;HM13;STIM1
8324,GO:0033151,0.742008900088202,0.628215124087251,1,12,V(D)J recombination,BP,RAG1
13114,GO:0051606,0.742089141150289,0.372260426741265,10,114,detection of stimulus,BP,SERPINE2;PITPNM1;GNB1;PKD1;HMGA2;POLD4;REEP6;FYN;NTSR1;STIM1
697,GO:0001914,0.742484713390359,0.625956728075035,1,13,regulation of T cell mediated cytotoxicity,BP,CEACAM1
5307,GO:0016010,0.742536567316003,0.627521008755637,1,12,dystrophin-associated glycoprotein complex,CC,SNTB2
16381,GO:0090665,0.742536567316003,0.627521008755637,1,12,glycoprotein complex,CC,SNTB2
11446,GO:0045851,0.742671924685067,0.469893643151942,3,38,pH reduction,BP,DMXL2;TCIRG1;ATP6V1C2
61,GO:0000124,0.743042864221489,0.625219552792504,1,13,SAGA complex,CC,TAF6
11118,GO:0045120,0.743332097087151,0.62647243631675,1,12,pronucleus,CC,HSF1
4202,GO:0009309,0.743405449235723,0.624740004482464,1,13,amine biosynthetic process,BP,AZIN2
10001,GO:0042401,0.743405449235723,0.624740004482464,1,13,cellular biogenic amine biosynthetic process,BP,AZIN2
13186,GO:0051764,0.743488304492211,0.626266245197627,1,12,actin crosslink formation,BP,BAIAP2L1
17182,GO:0102567,0.74349638015159,0.626255582808118,1,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,TMEM8A
17183,GO:0102568,0.74349638015159,0.626255582808118,1,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,TMEM8A
152,GO:0000307,0.743567844011211,0.469050294697423,3,37,cyclin-dependent protein kinase holoenzyme complex,CC,CCND1;CCND2;CCNE1
14415,GO:0061659,0.743835039690989,0.338349042958472,19,203,ubiquitin-like protein ligase activity,MF,GID4;NEURL1;SMURF2;HECW2;SYVN1;TMEM129;ZNF598;UBE2J1;CDC34;ANKIB1;RAG1;HLTF;LRSAM1;RNF44;MIB2;STUB1;MGRN1;RNF222;CBL
11079,GO:0045063,0.743860960446467,0.625773951009913,1,12,T-helper 1 cell differentiation,BP,ANXA1
17913,GO:1902170,0.743874730405285,0.625755749649718,1,12,cellular response to reactive nitrogen species,BP,DNM2
4787,GO:0010972,0.744088043866646,0.392481526051048,7,87,negative regulation of G2/M transition of mitotic cell cycle,BP,FHL1;PSMD2;VPS4A;HMGA2;PSMD7;BRSK1;TAOK1
10322,GO:0043090,0.744342590913336,0.625136871801855,1,12,amino acid import,BP,NTSR1
7877,GO:0032433,0.744386590339242,0.625078624895054,1,12,filopodium tip,CC,CIB1
32,GO:0000060,0.744553150346513,0.467778273554823,3,37,protein import into nucleus, translocation,BP,AKT1;PARP10;TGFB1
11937,GO:0046965,0.744674302849689,0.624697556168101,1,12,retinoid X receptor binding,MF,VDR
16136,GO:0090103,0.744956363221325,0.624323650230079,1,12,cochlea morphogenesis,BP,DVL1
10034,GO:0042462,0.744999487756413,0.624266455083696,1,12,eye photoreceptor cell development,BP,NAGLU
3919,GO:0008585,0.745345527987396,0.402998740599393,6,69,female gonad development,BP,MMP14;ARID5B;SRC;BCL2L1;ZP3;SLIT3
12122,GO:0048146,0.745569124280438,0.466464356290371,3,37,positive regulation of fibroblast proliferation,BP,EGFR;MIF;TGFB1
10636,GO:0043624,0.745639959362703,0.346299180033298,15,179,cellular protein complex disassembly,BP,TMOD2;MRPS6;VPS4A;MAP1B;TWF2;TTBK2;ASPH;MICAL2;CAPG;SH3BP1;MICAL1;CAMSAP3;CIB1;ARHGEF2;PLEKHH2
12413,GO:0048839,0.745674281956378,0.374643588034984,9,99,inner ear development,BP,DVL1;BCR;LRP10;NAGLU;GATA3;FGFR1;CHD7;EPHB2;TGFB1
17493,GO:1900363,0.745751507166585,0.623267861861455,1,12,regulation of mRNA polyadenylation,BP,HSF1
5926,GO:0018198,0.746754632711028,0.464616454185174,3,38,peptidyl-cysteine modification,BP,NOS1;RAB3B;RAB6A
5078,GO:0015299,0.746824012368425,0.621839744295535,1,12,solute:proton antiporter activity,MF,TMCO3
724,GO:0001947,0.747347697699252,0.46483914897976,3,35,heart looping,BP,TGFBR2;SUFU;MICAL2
7889,GO:0032451,0.747390762914464,0.464783236397387,3,35,demethylase activity,MF,ARID5B;KDM4B;PHF2
16156,GO:0090148,0.74750410280454,0.620931736273929,1,12,membrane fission,BP,DNM2
7810,GO:0032354,0.747525037066624,0.620903756492122,1,12,response to follicle-stimulating hormone,BP,ASNS
8351,GO:0033194,0.748121886488291,0.618453981844026,1,13,response to hydroperoxide,BP,GPX3
17091,GO:0099563,0.748307998262724,0.619856002826407,1,12,modification of synaptic structure,BP,ARHGAP44
7110,GO:0030901,0.748450230244893,0.413692669650305,5,59,midbrain development,BP,CSNK1E;DKK1;GLUD1;FGFR1;CSNK1D
14749,GO:0070402,0.748540596624769,0.617891573506236,1,13,NADPH binding,MF,CBR4
4510,GO:0010558,0.748716363942641,0.285114905084749,114,1161,negative regulation of macromolecule biosynthetic process,BP,MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;MAP2K1;SHC1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;SESN2;ZC3H6;NACC2;VLDLR;ACVR2B;EGFR;MAP2K2;PPP1R13L;ATF4;PEG3;BAG3;ELK3;WWTR1;PHF21A;TSPYL2;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;EIF4EBP1;TSC22D4;SRC;AGO4;IRF7;HIST3H2A;PER3;RERE;RSF1;GSK3A;ZNF692;PPM1F;NELFCD;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;TRIB2;MXD4;SAMD4B;ZP3;RCOR1;ABCA7;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;PAIP2;ZNF256;MBD3;IGF2BP3;CCNE1;TGFB1;KLF12;ZNF318;EP300
7926,GO:0032495,0.748757875617174,0.619252846998495,1,12,response to muramyl dipeptide,BP,ARHGEF2
448,GO:0001221,0.749061632489648,0.462260086363789,3,36,transcription cofactor binding,MF,NR1D1;PPARA;PER3
4369,GO:0009982,0.7492121419543,0.616988063439243,1,13,pseudouridine synthase activity,MF,RPUSD3
1117,GO:0002703,0.749551466599662,0.369706945147692,9,103,regulation of leukocyte mediated immunity,BP,RAC2;BCR;PRKCZ;GATA3;STXBP1;ZP3;ARG1;CEACAM1;TGFB1
16574,GO:0097329,0.750039136407023,0.617530498913329,1,12,response to antimetabolite,BP,ASNS
5400,GO:0016234,0.7501700717748,0.397154148689425,6,68,inclusion body,CC,EDEM1;PRNP;ATF4;RNF32;WDFY3;STUB1
1952,GO:0004653,0.750423342795873,0.617012709792046,1,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT3
5944,GO:0018243,0.750423342795873,0.617012709792046,1,12,protein O-linked glycosylation via threonine,BP,GALNT3
4812,GO:0012510,0.750508394449757,0.615238832683858,1,13,trans-Golgi network transport vesicle membrane,CC,LDLRAP1
11691,GO:0046459,0.750618923022383,0.615089360041362,1,13,short-chain fatty acid metabolic process,BP,PCK2
10004,GO:0042405,0.750756163177693,0.616563680704705,1,12,nuclear inclusion body,CC,STUB1
11929,GO:0046949,0.750956804295194,0.508380429806184,2,25,fatty-acyl-CoA biosynthetic process,BP,ELOVL1;CBR4
1341,GO:0003197,0.751128863847308,0.508764934339171,2,24,endocardial cushion development,BP,TGFBR2;ERBB3
819,GO:0002089,0.751291429882467,0.615840558525781,1,12,lens morphogenesis in camera-type eye,BP,TBC1D20
11308,GO:0045604,0.751330191118614,0.429906222755242,4,48,regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B;VDR;CTSL
16178,GO:0090179,0.751606040343433,0.6154149800799,1,12,planar cell polarity pathway involved in neural tube closure,BP,DVL1
2293,GO:0005249,0.751708816782861,0.507987818529128,2,24,voltage-gated potassium channel activity,MF,KCNG1;KCNC4
8618,GO:0034121,0.751815045838167,0.458665513348967,3,36,regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS;IRF7
17524,GO:1900543,0.752000080154707,0.506981805400435,2,25,negative regulation of purine nucleotide metabolic process,BP,PPARA;GNAI2
14403,GO:0061631,0.752216623747329,0.506125534161406,2,26,ubiquitin conjugating enzyme activity,MF,UBE2J1;CDC34
12380,GO:0048745,0.752248069279815,0.614545223806562,1,12,smooth muscle tissue development,BP,DLG1
4170,GO:0009235,0.752403822960082,0.612668575241153,1,13,cobalamin metabolic process,BP,PRSS3
7622,GO:0032007,0.75242771057824,0.457863288316027,3,36,negative regulation of TOR signaling,BP,SESN2;GSK3A;C12ORF66
14214,GO:0061099,0.752537587930095,0.50625998673729,2,25,negative regulation of protein tyrosine kinase activity,BP,PTK6;CBL
11531,GO:0046031,0.752660019669314,0.382612202721394,7,80,ADP metabolic process,BP,PGM1;HK1;PFKP;PPARA;DHTKD1;ALDOC;LDHA
12841,GO:0051127,0.752742354952287,0.613874447960062,1,12,positive regulation of actin nucleation,BP,WIPF1
11462,GO:0045898,0.752923064048935,0.611961871116996,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
6591,GO:0022600,0.75312041318423,0.456955207330459,3,36,digestive system process,BP,STK39;VDR;SLC5A1
1392,GO:0003299,0.753723621990281,0.612539790150978,1,12,muscle hypertrophy in response to stress,BP,CAMTA2
4932,GO:0014887,0.753723621990281,0.612539790150978,1,12,cardiac muscle adaptation,BP,CAMTA2
4940,GO:0014898,0.753723621990281,0.612539790150978,1,12,cardiac muscle hypertrophy in response to stress,BP,CAMTA2
7045,GO:0030813,0.753903409743848,0.612294817909667,1,12,positive regulation of nucleotide catabolic process,BP,RAPGEF3
93,GO:0000183,0.75401056695029,0.499085058578969,2,39,chromatin silencing at rDNA,BP,BAZ2A;PHF2
13595,GO:0060042,0.754153172324045,0.50470171814838,2,24,retina morphogenesis in camera-type eye,BP,SDK2;LRP5
4306,GO:0009755,0.754548924814879,0.336416625346182,15,162,hormone-mediated signaling pathway,BP,NR1D1;PPARA;PAK1;SRC;PAQR7;VDR;THRA;ADIPOR1;SLC27A1;PMEPA1;RXRA;KANK2;CCNE1;WBP2;EP300
9009,GO:0035136,0.75460377012645,0.503477482039245,2,25,forelimb morphogenesis,BP,WNT7A;ALDH1A2
18321,GO:1903201,0.755110223669241,0.424838628239605,4,49,regulation of oxidative stress-induced cell death,BP,ATF4;P4HB;AKT1;ENDOG
14638,GO:0070192,0.755360813110088,0.454010519516392,3,36,chromosome organization involved in meiotic cell cycle,BP,AGO4;LEMD2;CCNE1
5478,GO:0016408,0.755675518387096,0.608196891899443,1,13,C-acyltransferase activity,MF,SPTLC2
16155,GO:0090141,0.755703462225875,0.60815850559317,1,13,positive regulation of mitochondrial fission,BP,BNIP3
2884,GO:0006388,0.755765651287558,0.606644285211926,1,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1
15312,GO:0071480,0.755974037914966,0.501058130457949,2,26,cellular response to gamma radiation,BP,HSF1;BCL2L1
19217,GO:1905269,0.756052375226029,0.378427530451219,7,80,positive regulation of chromatin organization,BP,NOS1;GATA3;PHF1;CTBP1;MAPK3;TGFB1;WBP2
3041,GO:0006595,0.75613755690846,0.606131970233455,1,14,polyamine metabolic process,BP,AZIN2
17969,GO:1902285,0.75624327629321,0.609094216742482,1,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,SEMA3F
8045,GO:0032688,0.756442131593031,0.607142605340998,1,13,negative regulation of interferon-beta production,BP,PTPRS
8439,GO:0033540,0.756541225690538,0.607006144855847,1,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CRAT
10282,GO:0043015,0.756628377277695,0.500738840530364,2,25,gamma-tubulin binding,MF,MARK4;BRSK1
10699,GO:0043967,0.757024161991098,0.402867775798262,5,59,histone H4 acetylation,BP,JADE2;CTBP1;MSL1;APBB1;EP300
4345,GO:0009895,0.757397970315959,0.322636074123158,19,208,negative regulation of catabolic process,BP,QSOX1;CST3;SERPINE2;DAP;EGFR;PANO1;AKT1;ATP13A2;UBE2J1;PPARA;TBC1D14;SUFU;GIPC1;CPTP;GSK3A;FYN;TIMP1;FURIN;AZIN2
5510,GO:0016458,0.757538065420098,0.320061389258664,20,237,gene silencing,BP,MAP2K1;DNMT3A;EGFR;MAP2K2;H2AFJ;SCMH1;TNRC18;BAZ2A;BCDIN3D;AGO4;HIST3H2A;PUM1;TNRC6B;PHF2;HIST2H2AC;BAHCC1;CNOT11;HIST1H2AG;MBD3;TGFB1
5833,GO:0017110,0.757558317608343,0.605603124742746,1,13,nucleoside-diphosphatase activity,MF,ENTPD6
7068,GO:0030850,0.757582437364698,0.451078836250306,3,36,prostate gland development,BP,ALOX15B;RXRA;ANXA1
18637,GO:1903894,0.757717937391453,0.605382540011616,1,13,regulation of IRE1-mediated unfolded protein response,BP,DNAJB9
6932,GO:0030520,0.757751835348138,0.421858994356435,4,47,intracellular estrogen receptor signaling pathway,BP,PAK1;SRC;KANK2;WBP2
6614,GO:0022829,0.757812957997332,0.605251175957548,1,13,wide pore channel activity,MF,GJC2
5623,GO:0016675,0.757867376571192,0.598890244275952,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
16893,GO:0098803,0.758202596853746,0.418284278644006,4,66,respiratory chain complex,CC,SDHA;NDUFA4L2;SDHAF4;NDUFS2
10455,GO:0043302,0.758208379262926,0.604704101614796,1,13,positive regulation of leukocyte degranulation,BP,STXBP1
18808,GO:1904293,0.75821909398385,0.604689268290284,1,13,negative regulation of ERAD pathway,BP,UBE2J1
14164,GO:0061014,0.758351738882803,0.45006093012232,3,36,positive regulation of mRNA catabolic process,BP,GTPBP1;PUM1;TNRC6B
16187,GO:0090189,0.758502689436457,0.604296484497415,1,13,regulation of branching involved in ureteric bud morphogenesis,BP,TGFB1
5120,GO:0015459,0.759193364798272,0.497251858422792,2,25,potassium channel regulator activity,MF,DLG1;PRKCZ
7481,GO:0031640,0.759593118733018,0.599021182857081,1,16,killing of cells of other organism,BP,ARG1
10869,GO:0044364,0.759593118733018,0.599021182857081,1,16,disruption of cells of other organism,BP,ARG1
4423,GO:0010225,0.759708796755173,0.602622171452464,1,13,response to UV-C,BP,IMPACT
3482,GO:0007346,0.759825936603552,0.286908895179958,55,577,regulation of mitotic cell cycle,BP,FHL1;CCND1;MAP2K1;DLG1;PSMD2;NACC2;LRP5;MAP4K4;EGFR;CSNK1E;PRKACA;MAP2K2;STK25;HECW2;AKT1;XPC;VPS4A;FBXW5;STK39;OBSL1;CCND2;PAK1;ZNF385A;CUL7;PCBP4;PKD1;HSF1;HMGA2;EIF4EBP1;CHMP5;NINL;STK24;PAK6;TOM1L2;SDCCAG8;ASNS;PSMD7;BRSK1;GJC2;FGFR1;TUBG1;HYAL1;BCL2L1;PAK4;TAOK1;TGFA;NDE1;CNOT11;KANK2;CSNK1D;MINK1;TGFB1;ANXA1;PPP1R10;EP300
5136,GO:0015630,0.76041267226379,0.275375397354388,96,967,microtubule cytoskeleton,CC,DVL1;MAP2K1;CLIP2;KLC2;DLG1;DYSF;PITPNM1;MTA1;SCYL1;TMEM214;SNPH;BBS2;TUBB6;USP20;NUDCD3;MARK4;SEPT10;PRKACA;MAP2K2;TUBG2;ATF4;HECW2;AKT1;ACOT13;PRKCZ;VPS4A;CCDC92;EML2;SEPT5;MAP1B;OBSL1;PRKACB;TACC1;CCDC88C;TTBK2;NAV1;PODXL;CUL7;TUBB3;REEP2;PROCR;SEPT8;PHF1;ARL8A;GNAI2;HSF1;ADGRB2;NEK9;MAPKBP1;NEIL1;DYNLRB1;FAM110C;ARL2;CAPG;DNM2;NINL;UBR4;SDCCAG8;SPECC1L;REEP4;KIF17;KIF13B;BRSK1;PSKH1;TUBG1;CEP170;TTC19;VPS37A;RAB11FIP4;BCL2L1;RAD23A;ARFGEF2;HSPA2;MAP1LC3B;SNTB2;PBXIP1;NDE1;CAMSAP3;INVS;GSDMC;SNAP29;GAS8;CIB1;WRAP73;CSNK1D;KIFC3;ARHGEF2;MPLKIP;ENKD1;MAP6;SAC3D1;CCDC113;PXN;RAP1GAP2;STIM1;MZT2B
7863,GO:0032418,0.760436475462774,0.417946761046667,4,49,lysosome localization,BP,RAC2;STXBP1;CBL;MAP6
13709,GO:0060231,0.760453824035008,0.601584813062099,1,13,mesenchymal to epithelial transition,BP,GATA3
8795,GO:0034472,0.760464387429673,0.600128509991501,1,14,snRNA 3'-end processing,BP,INTS1
13826,GO:0060395,0.760533764056344,0.447166092976137,3,36,SMAD protein signal transduction,BP,WWTR1;SLC33A1;TGFB1
298,GO:0000803,0.760647833205504,0.495265878245313,2,25,sex chromosome,CC,DNMT3A;SIN3B
7576,GO:0031932,0.760928139337732,0.600923143912606,1,13,TORC2 complex,CC,SESN2
12418,GO:0048844,0.760943351621183,0.446621433146279,3,36,artery morphogenesis,BP,APOE;LRP1;CHD7
3075,GO:0006643,0.761331703370083,0.325359717382324,16,178,membrane lipid metabolic process,BP,SERINC2;ESYT2;ELOVL1;FUCA1;PIGQ;CPTP;SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;VAPB;ARSK;UGCG;B4GALT6;NAGA;ARSD
2787,GO:0006221,0.761507888209905,0.492508788194211,2,28,pyrimidine nucleotide biosynthetic process,BP,NME4;UCKL1
3441,GO:0007252,0.761576665694676,0.600016880258896,1,13,I-kappaB phosphorylation,BP,AKT1
3700,GO:0008209,0.761945193134109,0.599501082571456,1,13,androgen metabolic process,BP,SRD5A3
18409,GO:1903391,0.762137764333566,0.416164235073116,4,47,regulation of adherens junction organization,BP,MMP14;SRC;PPM1F;CAMSAP3
10366,GO:0043169,0.762398358458249,0.259599367127264,303,2968,cation binding,MF,NT5E;EDEM1;XDH;FHL1;CBS;ZMYND8;NOS1;ADAM19;LTBP2;CAPN2;LTBP4;RBCK1;ASAP2;PYGL;CYP27B1;NEURL1;SHARPIN;PCK2;ARAP1;OBSCN;NR1D1;TRIM65;DYSF;MMP1;PITPNM1;ZKSCAN1;DNMT3A;PGM1;DGKA;POSTN;MTA1;RPS6KA2;ITGA6;PRSS3;NAGS;PRNP;IDH2;PC;NME4;PLCH2;PCDH1;CYGB;LCN2;SESN2;TNNT1;RNPEPL1;MARCH9;ZC3H6;FKBP9;HAGH;USP20;CHPF;LPCAT1;VLDLR;AARS;ACVR2B;FBLN1;HTR7;ADCY7;ZCCHC14;MKNK2;MMP14;FYCO1;THBS2;ADARB1;CARS;MAP2K2;STK25;SHANK3;ZKSCAN2;PEG3;APOE;EHD3;ATP13A2;ARG2;ZSCAN30;SYVN1;PHF21A;NPEPL1;RABGGTA;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;DGKQ;RFNG;VPS11;PPP2R3B;PITRM1;PI4K2A;ZMIZ2;PFKP;TMEM129;LENG9;ENDOG;ZNF598;GIT2;NMRK1;DEAF1;SALL2;SEC23A;TGFBR2;LIMK1;PPARA;DHTKD1;NADK;PRKACB;LTBP1;ZNF516;ESYT2;PLCG1;IDE;MSRB2;JADE2;ANKIB1;GIT1;HMGCL;SP6;MMP10;ZNF385A;DTD1;RAG1;BAZ2A;GLUL;TBC1D9B;ADAMTS7;SYTL1;RET;NID1;HLTF;ATP11A;GATA3;NUCB2;PHF1;GNAI2;PPM1M;ZNF165;ANTXR2;GRIN3B;GLUD1;ALOX15B;NEK9;CNDP2;FAT1;ASPH;MT2A;ADAM8;NEIL1;RAI1;MICAL2;PLCB3;P4HA1;B4GALT2;APLP2;KDM4B;FKBP10;PEX10;TGM2;NINL;UBR4;LRSAM1;NUCB1;CDC42BPB;NCS1;STK24;ZCCHC24;YPEL3;RERE;RSF1;OAS1;FYN;PRIMPOL;MPI;ISG20;CLSTN1;AGRN;ZNF692;PPM1F;ZNF862;YPEL5;MICAL1;THOP1;ANXA3;VDR;BRPF3;BRSK1;CGREF1;RNF44;ITGA1;COMT;THRA;MCFD2;PLTP;RCN1;EIF2S2;TIMP1;ZSCAN18;RNF32;RNF187;ZNF71;LOXL1;LHPP;WDFY3;SEC24C;RREB1;ZBED4;ATP2C2;ADNP;PHF2;MIB2;TENM2;F12;MFNG;MTMR4;RAB11FIP4;AMPD2;ZDBF2;ADIPOR1;NT5DC2;ZFPL1;PITPNM2;ZFPM1;LRP1;AOX1;ZNF609;PLCD3;MGRN1;P2RX4;ACP7;SMPD3;GPATCH8;ZNF419;LRRK1;EHD4;ZNF570;ZNF398;ARAP3;RNF222;ZNF687;LMAN1;PHYH;SLIT3;RXRA;ARG1;L3MBTL3;ZHX3;TSHZ1;NEURL1B;ZBTB4;CYB561;ZNF624;ARSK;VAT1;ACY1;HGS;POLM;MYL9;CBL;CIB1;LACTB2;USP32;POMT1;LITAF;GLO1;FURIN;S100A16;ARHGEF2;RNF103;ZNF444;NDUFS2;B4GALT6;MATN3;ZFP30;ADAM15;GALNT3;ZNF256;AGAP1;ADCY6;ZFP28;ITSN1;CAT;ANXA1;ARSD;PPP1R10;ASH2L;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PXN;ZNF318;EP300;THBS3;WDFY2;STIM1;RASA3;ASAP1;TRAF7;RNF10
8512,GO:0033683,0.762404402615117,0.443735445965796,3,39,nucleotide-excision repair, DNA incision,BP,ERCC1;POLD4;DDB2
2907,GO:0006418,0.762637080248239,0.41508246967002,4,49,tRNA aminoacylation for protein translation,BP,AARS;CARS;GARS;SARS2
8232,GO:0032984,0.762709848377883,0.307372263797944,24,275,protein-containing complex disassembly,BP,DVL1;BNIP3;TMOD2;LRP5;FYCO1;MRPS6;VPS4A;MAP1B;TWF2;TTBK2;ASPH;MICAL2;CHMP5;CAPG;HIST3H2A;SH3BP1;MICAL1;MAP1LC3B;PYM1;CAMSAP3;SNAP29;CIB1;ARHGEF2;PLEKHH2
13890,GO:0060487,0.763399570683712,0.597459757837551,1,13,lung epithelial cell differentiation,BP,THRA
11539,GO:0046039,0.763445262436477,0.49033273156202,2,27,GTP metabolic process,BP,NME4;GTPBP1
7708,GO:0032182,0.763602179757238,0.368863455055461,7,82,ubiquitin-like protein binding,MF,RBCK1;SHARPIN;MARK4;UBTD1;OTUB2;UBXN7;SIMC1
14842,GO:0070566,0.764068362845912,0.490570325405597,2,25,adenylyltransferase activity,MF,OASL;OAS1
2686,GO:0006047,0.764227019871044,0.596294260138673,1,13,UDP-N-acetylglucosamine metabolic process,BP,UAP1
9093,GO:0035338,0.764269079258553,0.596234937745535,1,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ELOVL1
18830,GO:1904353,0.764413341936873,0.490094788849589,2,25,regulation of telomere capping,BP,ERCC1;MAPK3
15209,GO:0071333,0.764633502734202,0.367396559816879,7,84,cellular response to glucose stimulus,BP,PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;ENDOG
7154,GO:0031000,0.764761765897469,0.595539453981853,1,13,response to caffeine,BP,FKBP1A
9544,GO:0036270,0.764761765897469,0.595539453981853,1,13,response to diuretic,BP,FKBP1A
11185,GO:0045239,0.765081443083261,0.595087623351678,1,13,tricarboxylic acid cycle enzyme complex,CC,DHTKD1
4233,GO:0009410,0.765115685224106,0.323778242250343,15,169,response to xenobiotic stimulus,BP,PCK2;DNMT3A;FKBP1A;EGFR;PRKACB;HSF1;EIF4EBP1;AKR7A2;DNM2;HOMER2;ARG1;BPHL;ACY1;GGT1;TGFB1
736,GO:0001963,0.765305067229991,0.593316714916628,1,14,synaptic transmission, dopaminergic,BP,RAB3B
14456,GO:0061756,0.76537348477143,0.594674460162052,1,13,leukocyte adhesion to vascular endothelial cell,BP,PODXL2
9356,GO:0035859,0.765728647356461,0.594171491542816,1,13,Seh1-associated complex,CC,SESN2
5968,GO:0018393,0.765757446475843,0.333988620521149,12,134,internal peptidyl-lysine acetylation,BP,NOS1;JADE2;GATA3;CTBP1;BRPF3;MSL1;APBB1;MAPK3;MBD3;TGFB1;WBP2;EP300
11514,GO:0045980,0.765826460282532,0.487572228070653,2,26,negative regulation of nucleotide metabolic process,BP,PPARA;GNAI2
3362,GO:0007100,0.76587810250727,0.593959672339183,1,13,mitotic centrosome separation,BP,NDE1
9391,GO:0035914,0.765916795340983,0.439644130773462,3,37,skeletal muscle cell differentiation,BP,MEF2D;BCL9L;LEMD2
7795,GO:0032330,0.766216936537835,0.48760272028209,2,25,regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7
8153,GO:0032873,0.766357309076673,0.439052569004178,3,37,negative regulation of stress-activated MAPK cascade,BP,DLG1;AKT1;AIDA
14701,GO:0070303,0.766357309076673,0.439052569004178,3,37,negative regulation of stress-activated protein kinase signaling cascade,BP,DLG1;AKT1;AIDA
1874,GO:0004536,0.76640093527921,0.390578169991714,5,61,deoxyribonuclease activity,MF,ERCC1;ENDOG;DNASE1L1;NEIL1;ISG20
13169,GO:0051721,0.766659906951402,0.486989136682109,2,25,protein phosphatase 2A binding,MF,AKT1;STRN4
3034,GO:0006584,0.76667192087271,0.486401328786625,2,26,catecholamine metabolic process,BP,GATA3;COMT
4292,GO:0009712,0.76667192087271,0.486401328786625,2,26,catechol-containing compound metabolic process,BP,GATA3;COMT
16920,GO:0098847,0.76679300899489,0.592660847464982,1,13,sequence-specific single stranded DNA binding,MF,HSF1
4333,GO:0009880,0.766997705789726,0.438523167106409,3,36,embryonic pattern specification,BP,WNT7A;SEMA3F;PCSK6
14155,GO:0061001,0.767134369924779,0.486331263213485,2,25,regulation of dendritic spine morphogenesis,BP,SHANK3;ARHGAP44
7148,GO:0030983,0.76741703076286,0.591772844435822,1,13,mismatched DNA binding,MF,XPC
14413,GO:0061650,0.767691200356523,0.484459855529294,2,27,ubiquitin-like protein conjugating enzyme activity,MF,UBE2J1;CDC34
734,GO:0001960,0.767863666216709,0.436417257297915,3,39,negative regulation of cytokine-mediated signaling pathway,BP,SLIT3;ARG1;ECM1
927,GO:0002320,0.768026042510062,0.590904533500095,1,13,lymphoid progenitor cell differentiation,BP,GATA3
20159,GO:2000811,0.768041763433254,0.59088209722142,1,13,negative regulation of anoikis,BP,SRC
2786,GO:0006220,0.768604952680663,0.434871860226284,3,41,pyrimidine nucleotide metabolic process,BP,NME4;NEIL1;UCKL1
9470,GO:0036064,0.76892865795012,0.353427791829693,8,92,ciliary basal body,CC,BBS2;MARK4;AKT1;TTBK2;KIF17;TUBG1;GAS8;WRAP73
6934,GO:0030522,0.769112033125137,0.305205047266263,21,225,intracellular receptor signaling pathway,BP,CYP27B1;NR1D1;DCBLD2;IRAK1;PPARA;PAK1;ALOX15B;ALDH1A2;SRC;IRF7;VDR;PUM1;THRA;PMEPA1;RXRA;SEC14L1;KANK2;CCNE1;WBP2;STARD10;EP300
18809,GO:1904294,0.769437359360595,0.588885961557167,1,13,positive regulation of ERAD pathway,BP,EDEM1
15113,GO:0071108,0.769540688816724,0.48298406621855,2,25,protein K48-linked deubiquitination,BP,USP20;OTUB2
16378,GO:0090659,0.769562750233064,0.588706186952536,1,13,walking behavior,BP,CHD7
11749,GO:0046545,0.769873964262716,0.372018916848685,6,71,development of primary female sexual characteristics,BP,MMP14;ARID5B;SRC;BCL2L1;ZP3;SLIT3
10419,GO:0043247,0.770508462550337,0.587348031228255,1,13,telomere maintenance in response to DNA damage,BP,ERCC1
10558,GO:0043500,0.770591585518007,0.385316095066996,5,60,muscle adaptation,BP,TNNT1;PAK1;GSK3A;CAMTA2;P2RX4
7573,GO:0031929,0.770613547019401,0.351333558876268,8,92,TOR signaling,BP,SESN2;AKT1;CARD11;DGKQ;GATA3;EIF4EBP1;GSK3A;C12ORF66
18194,GO:1902932,0.770681175460242,0.587099560185858,1,13,positive regulation of alcohol biosynthetic process,BP,NTSR1
3760,GO:0008301,0.770701714739172,0.58707000268891,1,13,DNA binding, bending,MF,HMGA2
4140,GO:0009200,0.770841937011603,0.584132151591432,1,15,deoxyribonucleoside triphosphate metabolic process,BP,GUK1
13074,GO:0051546,0.771052543400271,0.586564841076221,1,13,keratinocyte migration,BP,FERMT1
11365,GO:0045683,0.771230072428787,0.586309003476531,1,13,negative regulation of epidermis development,BP,FERMT1
4139,GO:0009199,0.771243710621286,0.304158557897457,20,239,ribonucleoside triphosphate metabolic process,BP,PGM1;NME4;HK1;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;SDHA;TAZ;UCKL1;GUK1;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
4540,GO:0010611,0.771685492625441,0.431859575793434,3,37,regulation of cardiac muscle hypertrophy,BP,PAK1;GSK3A;P2RX4
4883,GO:0014743,0.771685492625441,0.431859575793434,3,37,regulation of muscle hypertrophy,BP,PAK1;GSK3A;P2RX4
11359,GO:0045668,0.771828557647635,0.479212116050198,2,26,negative regulation of osteoblast differentiation,BP,LRP5;SUFU
14822,GO:0070536,0.772017789930171,0.479519638057818,2,25,protein K63-linked deubiquitination,BP,USP20;OTUB2
9250,GO:0035637,0.772115850291718,0.349540696144083,8,91,multicellular organismal signaling,BP,NOS1;SCN8A;PRKACA;EHD3;ITPR3;ASPH;P2RX4;STIM1
12810,GO:0051085,0.772530617440218,0.478226936768428,2,26,chaperone cofactor-dependent protein refolding,BP,HSPA2;HSPA13
5333,GO:0016056,0.772549264329682,0.584403440415899,1,13,rhodopsin mediated signaling pathway,BP,GNB1
8071,GO:0032733,0.772765312846916,0.582616423267276,1,14,positive regulation of interleukin-10 production,BP,PRKCZ
19245,GO:1905331,0.772847122743044,0.583972092180534,1,13,negative regulation of morphogenesis of an epithelium,BP,GATA3
8706,GO:0034333,0.772852694827579,0.368455877502072,6,69,adherens junction assembly,BP,LAMA5;MMP14;PIP5K1C;SRC;PPM1F;CAMSAP3
8083,GO:0032757,0.772980604948483,0.477066178843598,2,27,positive regulation of interleukin-8 production,BP,F2R;DDIT3
2662,GO:0006004,0.773357121948271,0.5832325900934,1,13,fucose metabolic process,BP,FUCA1
11415,GO:0045787,0.77376245640314,0.28969822054325,28,303,positive regulation of cell cycle,BP,CCND1;LRP5;EGFR;PRKACA;AKT1;PTK6;PPP2R5B;CCND2;ZNF385A;PCBP4;PKD1;HSF1;HMGA2;EIF4EBP1;GIPC1;SRC;ASNS;FGFR1;HYAL1;MIF;RAB11FIP4;RAD23A;TGFA;CNOT11;TGFB1;ANXA1;PPP1R10;EP300
4692,GO:0010839,0.77426310585698,0.58191597627683,1,13,negative regulation of keratinocyte proliferation,BP,VDR
13529,GO:0055078,0.774452946916967,0.581639614706734,1,13,sodium ion homeostasis,BP,COMT
4551,GO:0010629,0.774614389919387,0.254774197706494,137,1429,negative regulation of gene expression,BP,XDH;MDFI;ZMYND8;CHAC1;CCND1;CTNNBIP1;NFATC4;MAP2K1;SHC1;SERPINE2;NR1D1;DLG1;DAP;DNMT3A;PSMD2;PRNP;PC;WWC3;SMURF2;FAM129B;SESN2;ZC3H6;BBS2;NACC2;VLDLR;ACVR2B;EGFR;MAP2K2;PPP1R13L;ATF4;AKT1;PEG3;SERPING1;BAG3;ELK3;WWTR1;PHF21A;DGKQ;FZD8;CTSZ;FERMT1;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;GTPBP1;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;PCBP4;PARP10;GATA3;APLN;PHF1;TCFL5;HSF1;SIN3B;BCL7A;WFS1;CTBP1;HMGA2;ARID5B;EIF4EBP1;TSC22D4;SRC;AGO4;IRF7;HIST3H2A;PER3;RERE;RSF1;FYN;ZNF692;PPM1F;NELFCD;PSMD7;TLE4;VDR;PUM1;TNRC6B;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;ADNP;PHF2;TENM2;MIF;HES2;TRIB3;ZFPM1;MXD4;SAMD4B;ZP3;RNH1;PYM1;RCOR1;APBB1;SLIT3;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;RPL28;BAHCC1;ZBTB4;CNOT11;TCF25;HIST1H2AG;IMPACT;CARHSP1;KANK2;PAIP2;ZNF256;CD59;MBD3;IGF2BP3;CCNE1;TGFB1;KLF12;ZNF318;EP300
12277,GO:0048546,0.774931031063524,0.475420603902777,2,25,digestive tract morphogenesis,BP,ACVR2B;EGFR
3313,GO:0007018,0.774985500966052,0.298326715079333,21,228,microtubule-based movement,BP,AP3D1;KLC2;COPG1;BBS2;FYCO1;AP2A2;PRKCZ;DNAAF5;MAP1B;WDR66;MYH15;DYNLRB1;KIF17;KIF13B;MYO1D;NDE1;CAMSAP3;GAS8;KIFC3;APBA1;RAB6A
2852,GO:0006338,0.774987269613957,0.318515807647836,13,155,chromatin remodeling,BP,SMARCA1;SCMH1;TNRC18;BAZ2A;SATB1;GATA3;HMGA2;TOP1;RERE;RSF1;CHD7;BAHCC1;MBD3
2619,GO:0005929,0.775077550080777,0.284108001000985,32,340,cilium,CC,BBS2;MARK4;PRKACA;TUB;HK1;SHANK3;AKT1;EHD3;MAP1B;PRKACB;SUFU;TTBK2;GNB1;SHANK2;PKD1;WDR66;DYNLRB1;ANKS6;TULP3;KIF17;TUBG1;CEP170;ARFGEF2;UNC119B;MAP1LC3B;INVS;SNAP29;GAS8;WRAP73;OCRL;ADCY6;ANXA1
15539,GO:0071901,0.775093381929751,0.332306678622179,10,116,negative regulation of protein serine/threonine kinase activity,BP,SORL1;LRP5;AKT1;APOE;DUSP4;DUSP6;HEXIM1;CIB1;AIDA;SPRED2
18807,GO:1904292,0.775175060275043,0.474502161078047,2,26,regulation of ERAD pathway,BP,EDEM1;UBE2J1
14174,GO:0061035,0.775311789810721,0.426923677856077,3,37,regulation of cartilage development,BP,PTHLH;ADAMTS7;TGFB1
15205,GO:0071326,0.775772196666956,0.353307277409884,7,85,cellular response to monosaccharide stimulus,BP,PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;ENDOG
15207,GO:0071331,0.775772196666956,0.353307277409884,7,85,cellular response to hexose stimulus,BP,PCK2;NR1D1;LRP5;XBP1;MAP4K4;PRKACA;ENDOG
7879,GO:0032435,0.775890548758122,0.472961297432777,2,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,PANO1;GIPC1
9692,GO:0038061,0.776158909253352,0.3367155339889,9,111,NIK/NF-kappaB signaling,BP,PSMD2;EGFR;AKT1;IRAK1;TMSB4X;UACA;TNFSF15;PSMD7;ADIPOR1
11692,GO:0046460,0.776273933487756,0.472947861150798,2,26,neutral lipid biosynthetic process,BP,PCK2;LPIN3
11695,GO:0046463,0.776273933487756,0.472947861150798,2,26,acylglycerol biosynthetic process,BP,PCK2;LPIN3
6687,GO:0030049,0.776304591113828,0.576173184080113,1,15,muscle filament sliding,BP,TNNT1
8384,GO:0033275,0.776304591113828,0.576173184080113,1,15,actin-myosin filament sliding,BP,TNNT1
16084,GO:0090023,0.776339272095983,0.57612221873402,1,15,positive regulation of neutrophil chemotaxis,BP,RAC2
12679,GO:0050864,0.776351940609773,0.363622026609753,6,72,regulation of B cell activation,BP,XBP1;MMP14;CARD11;PKN1;MIF;TGFB1
6137,GO:0019400,0.776357667688305,0.577374197719049,1,14,alditol metabolic process,BP,PCK2
8385,GO:0033276,0.776527534619265,0.577124846421711,1,14,transcription factor TFTC complex,CC,TAF6
7709,GO:0032183,0.776731528913458,0.578309608966655,1,13,SUMO binding,MF,SIMC1
13621,GO:0060071,0.77687707265486,0.343016584094354,8,99,Wnt signaling pathway, planar cell polarity pathway,BP,DVL1;PSMD2;SMURF2;GPC4;AP2A2;DKK1;PFN1;PSMD7
7347,GO:0031369,0.776939093950015,0.471475610599502,2,27,translation initiation factor binding,MF,EIF4EBP1;ANGEL1
5943,GO:0018242,0.777205745001876,0.577613550758736,1,13,protein O-linked glycosylation via serine,BP,GALNT3
19642,GO:1990752,0.777437030056069,0.471873042866063,2,25,microtubule end,CC,CLIP2;CAMSAP3
7919,GO:0032486,0.777480533137086,0.577209735909082,1,13,Rap protein signal transduction,BP,RAPGEF3
4077,GO:0009129,0.777605417088345,0.575539484041281,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,UCKL1
4078,GO:0009130,0.777605417088345,0.575539484041281,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UCKL1
5997,GO:0018995,0.778021047587742,0.375497644154715,5,61,host,CC,PI4K2A;MVB12B;RAB29;VPS37A;LMAN1
10656,GO:0043657,0.778021047587742,0.375497644154715,5,61,host cell,CC,PI4K2A;MVB12B;RAB29;VPS37A;LMAN1
10779,GO:0044215,0.778021047587742,0.375497644154715,5,61,other organism,CC,PI4K2A;MVB12B;RAB29;VPS37A;LMAN1
10780,GO:0044216,0.778021047587742,0.375497644154715,5,61,other organism cell,CC,PI4K2A;MVB12B;RAB29;VPS37A;LMAN1
10781,GO:0044217,0.778021047587742,0.375497644154715,5,61,other organism part,CC,PI4K2A;MVB12B;RAB29;VPS37A;LMAN1
11369,GO:0045687,0.778160629153635,0.470270249848907,2,26,positive regulation of glial cell differentiation,BP,SERPINE2;BIN1
17612,GO:1901224,0.778198988425279,0.422657105973422,3,38,positive regulation of NIK/NF-kappaB signaling,BP,EGFR;IRAK1;TNFSF15
15002,GO:0070897,0.778239698613957,0.422305309493583,3,39,DNA-templated transcriptional preinitiation complex assembly,BP,BAZ2A;THRA;TAF6
2858,GO:0006349,0.778410149160263,0.575841008177142,1,13,regulation of gene expression by genetic imprinting,BP,DNMT3A
1883,GO:0004559,0.778501784466427,0.575705869521877,1,13,alpha-mannosidase activity,MF,EDEM1
4554,GO:0010633,0.778625787408312,0.393967904558477,4,49,negative regulation of epithelial cell migration,BP,APOE;ADIPOR1;FGF2;TGFB1
8828,GO:0034595,0.778846768311298,0.575196753785613,1,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,OCRL
6204,GO:0019692,0.778872887597746,0.467781473462061,2,29,deoxyribose phosphate metabolic process,BP,NEIL1;GUK1
16176,GO:0090177,0.779263692403148,0.574580726096226,1,13,establishment of planar polarity involved in neural tube closure,BP,DVL1
16177,GO:0090178,0.779263692403148,0.574580726096226,1,13,regulation of establishment of planar polarity involved in neural tube closure,BP,DVL1
75,GO:0000152,0.779312027364863,0.420551201861119,3,40,nuclear ubiquitin ligase complex,CC,PHC2;CUL7;RNF222
16621,GO:0097431,0.77970083672879,0.468075912024609,2,26,mitotic spindle pole,CC,HSF1;MAPKBP1
14308,GO:0061371,0.779735249900288,0.420857628045522,3,37,determination of heart left/right asymmetry,BP,TGFBR2;SUFU;MICAL2
13527,GO:0055076,0.780136601130573,0.338925351299159,8,99,transition metal ion homeostasis,BP,AP3D1;PRNP;LCN2;ATP13A2;ATP7B;SFXN3;MT2A;SLC30A1
17523,GO:1900542,0.780163617962358,0.32611776120668,10,115,regulation of purine nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;TMSB4X;PPARA;GNAI2;CAP1;TAZ;ADNP
8921,GO:0034754,0.780743255092947,0.371649599934477,5,63,cellular hormone metabolic process,BP,DGKQ;RETSAT;SRD5A3;ALDH1A2;COMT
1466,GO:0003713,0.780761042521672,0.286783637851052,24,261,transcription coactivator activity,MF,NFATC4;NR1D1;SOX12;MTA1;CITED4;FAM129B;PKN1;WWTR1;ZMIZ2;SCAND1;PPARA;BCL9L;GATA3;ARID5B;RERE;VDR;THRA;PHF2;FGF2;RXRA;LPIN3;CCNE1;WBP2;EP300
8066,GO:0032728,0.781049167143519,0.466148653990468,2,26,positive regulation of interferon-beta production,BP,RNF135;IRF7
4487,GO:0010507,0.781084794993187,0.371625410378637,5,60,negative regulation of autophagy,BP,QSOX1;DAP;AKT1;TBC1D14;CPTP
4728,GO:0010888,0.781393944215494,0.569924214996606,1,14,negative regulation of lipid storage,BP,PPARA
1098,GO:0002684,0.781499871961079,0.261469774426039,59,623,positive regulation of immune system process,BP,TNIP1;PGF;RAC2;RBCK1;CTNNBIP1;AP3D1;NR1D1;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;XBP1;MMP14;PRKACA;HK1;AKT1;CARD11;IRAK1;ARPC1A;SERPING1;FAM210B;PRKCZ;TGFBR2;LIMK1;PRKACB;WASF2;PLCG1;PAK1;RAG1;RAB29;GATA3;ADAM8;IGFBP2;SRC;IRF7;STXBP1;PAG1;FYN;PSMD7;PUM1;CTSL;HEXIM1;MIF;ZP3;PNP;ARG1;VEGFB;SEC14L1;WIPF1;MAPK3;CEACAM1;SKAP2;CD59;TGFB1;PIK3R2;ANXA1;GNAS;EP300
7448,GO:0031573,0.781710462067864,0.56945201929776,1,14,intra-S DNA damage checkpoint,BP,XPC
18169,GO:1902882,0.781809177910711,0.370384680608076,5,62,regulation of response to oxidative stress,BP,SESN2;ATF4;P4HB;AKT1;ENDOG
15773,GO:0072347,0.782087125655146,0.417299150767125,3,38,response to anesthetic,BP,DNMT3A;DNM2;HOMER2
3304,GO:0007006,0.78222035483201,0.336301687575254,8,99,mitochondrial membrane organization,BP,BOK;BNIP3;BNIP3L;TAZ;STPG1;GSK3A;MOAP1;BCL2L1
4915,GO:0014850,0.782221309266155,0.56868891132588,1,14,response to muscle activity,BP,POSTN
12500,GO:0050432,0.782313615158146,0.568550891675278,1,14,catecholamine secretion,BP,NISCH
11441,GO:0045840,0.782314301943381,0.416689107376275,3,39,positive regulation of mitotic nuclear division,BP,LRP5;TGFA;TGFB1
16426,GO:0097035,0.782690266327232,0.463794950391279,2,26,regulation of membrane lipid distribution,BP,ATP11A;ABCA7
13971,GO:0060632,0.783361600052925,0.566981052921911,1,14,regulation of microtubule-based movement,BP,BBS2
13196,GO:0051782,0.78345461758151,0.566841463024175,1,14,negative regulation of cell division,BP,VPS4A
4660,GO:0010803,0.783471500439674,0.386883779353224,4,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,RBCK1;SHARPIN;TNFRSF1A;CASP4
10451,GO:0043297,0.783651453689878,0.387217595699114,4,49,apical junction assembly,BP,DLG1;PRKACA;RHOC;ARL2
11534,GO:0046034,0.7839240150147,0.295660804035258,17,208,ATP metabolic process,BP,PGM1;HK1;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;SDHA;TAZ;GUK1;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
15486,GO:0071806,0.783956920946226,0.385882645462122,4,54,protein transmembrane transport,BP,BCR;RTN2;SEC63;PEX10
16371,GO:0090630,0.784087166021101,0.353864572132949,6,70,activation of GTPase activity,BP,EVI5L;EPHA1;TBC1D16;TBC1D14;TBC1D9B;TBC1D2B
5341,GO:0016075,0.784117363311049,0.564550023943122,1,15,rRNA catabolic process,BP,DEDD2
3395,GO:0007175,0.784400955775474,0.565418951909925,1,14,negative regulation of epidermal growth factor-activated receptor activity,BP,CBL
12502,GO:0050434,0.784702780243478,0.413096970837019,3,40,positive regulation of viral transcription,BP,RSF1;NELFCD;EP300
14574,GO:0070085,0.784707207522499,0.290696579395924,19,210,glycosylation,BP,LMF1;SYVN1;RFNG;UBE2J1;ADAMTS7;SRD5A3;B4GALT2;B3GNT3;MPI;MCFD2;MFNG;ST3GAL3;ST3GAL5;ST6GALNAC2;LMAN1;VEGFB;POMT1;B4GALT6;GALNT3
9322,GO:0035773,0.784818860904452,0.412935626864276,3,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;LRP5;MAP4K4
11938,GO:0046966,0.784858018618542,0.460141019148649,2,27,thyroid hormone receptor binding,MF,GAS2L1;OASL
256,GO:0000722,0.785030310764426,0.564470539103588,1,14,telomere maintenance via recombination,BP,ERCC1
7430,GO:0031526,0.785081984236212,0.460348897656098,2,26,brush border membrane,CC,SHANK2;SLC6A14
8612,GO:0034114,0.785496037555863,0.563767477907395,1,14,regulation of heterotypic cell-cell adhesion,BP,CD44
8698,GO:0034312,0.785602605354544,0.562307670231874,1,15,diol biosynthetic process,BP,SPTLC2
18241,GO:1903008,0.785842778864316,0.331926340477568,8,96,organelle disassembly,BP,BNIP3;ATP13A2;BNIP3L;ZDHHC8;ATG13;STX5;GSK3A;MAP1LC3B
12585,GO:0050718,0.78627050117819,0.562596024801798,1,14,positive regulation of interleukin-1 beta secretion,BP,HK1
10941,GO:0044550,0.786320446989724,0.562520377016294,1,14,secondary metabolite biosynthetic process,BP,CBS
920,GO:0002312,0.786443574951751,0.383243090090899,4,50,B cell activation involved in immune response,BP,ERCC1;XBP1;MFNG;TGFB1
2104,GO:0004869,0.786571094282848,0.456714213019896,2,29,cysteine-type endopeptidase inhibitor activity,MF,CST3;PRDX5
20136,GO:2000773,0.786659789295338,0.562006089313148,1,14,negative regulation of cellular senescence,BP,HMGA2
948,GO:0002360,0.78671928473042,0.561915863785886,1,14,T cell lineage commitment,BP,ZFPM1
1120,GO:0002706,0.787004982167533,0.349628091401613,6,74,regulation of lymphocyte mediated immunity,BP,PRKCZ;GATA3;ZP3;ARG1;CEACAM1;TGFB1
10006,GO:0042407,0.787053256641771,0.560107263674031,1,15,cristae formation,BP,TAZ
2945,GO:0006474,0.787062621512622,0.561394853006538,1,14,N-terminal protein amino acid acetylation,BP,EP300
1156,GO:0002761,0.787249611031684,0.349523710340904,6,72,regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;TFE3;IRF7;ZFPM1;CEACAM1;GNAS
10617,GO:0043586,0.787336810559888,0.560978360911102,1,14,tongue development,BP,EGFR
11738,GO:0046527,0.787684140248256,0.560450241774669,1,14,glucosyltransferase activity,MF,UGCG
7157,GO:0031011,0.787748341122075,0.559049310844634,1,15,Ino80 complex,CC,TFPT
8354,GO:0033202,0.787748341122075,0.559049310844634,1,15,DNA helicase complex,CC,TFPT
8747,GO:0034389,0.788423173126951,0.559324569719397,1,14,lipid particle organization,BP,TBC1D20
16313,GO:0090398,0.788436451186755,0.380347086338934,4,51,cellular senescence,BP,MAP2K1;ARG2;HMGA2;YPEL3
4862,GO:0014074,0.788502345874595,0.328694431354323,8,94,response to purine-containing compound,BP,SDC1;BSG;FKBP1A;RAPGEF3;SSH1;DGKQ;P2RX4;LDHA
17436,GO:1900151,0.788556435775859,0.55912130331672,1,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B
17438,GO:1900153,0.788556435775859,0.55912130331672,1,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B
5964,GO:0018345,0.788912684295282,0.454257890677331,2,27,protein palmitoylation,BP,ZDHHC8;ABHD17C
13883,GO:0060479,0.78915984762699,0.558199823225256,1,14,lung cell differentiation,BP,THRA
11600,GO:0046148,0.789246107168503,0.406755601589668,3,40,pigment biosynthetic process,BP,AP3D1;ALAS1;UROS
9016,GO:0035173,0.789266909685604,0.558036139877841,1,14,histone kinase activity,MF,PKN1
3297,GO:0006996,0.789590330965003,0.230860179229722,308,3096,organelle organization,BP,SH3KBP1;ERCC1;ZMYND8;NOS1;H1F0;CAPN2;F2R;RAC2;SDC1;DVL1;MAP2K1;SHC1;NEURL1;SNX9;AP3D1;BOK;SHARPIN;ARAP1;DLG4;OBSCN;SERPINE2;DLG1;DYSF;IFI6;DNMT3A;MTA1;RAPGEF3;IDH2;BNIP3;LAMA5;SSH1;RAB43;SMARCA1;TMOD2;BCORL1;ESPN;SESN2;TNNT1;PLEK2;BBS2;TUBB6;NACC2;BCR;SYNE3;RAB31;NUDCD3;MARK4;LRP5;ITGB5;EVI5L;CSNK1E;FYCO1;RFX2;SEPT10;PRKACA;CORO1B;MAP2K2;TUBG2;STK25;PARVB;SHANK3;MIER2;HECW2;FBXW8;SNX33;AKT1;XPC;BRD3;ARPC1A;APOE;ATG16L2;EHD3;FMNL2;ATP13A2;PKN1;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;TFEB;NAGLU;VPS11;VPS4A;HIST2H2BE;PITRM1;CTSZ;EPHA1;PI4K2A;DNAAF5;PTPDC1;SH3PXD2B;FBXW5;EML2;SEPT5;SEC23A;MSN;MAP1B;LIMK1;CORO2A;BNIP3L;OBSL1;H2AFJ;SIPA1;ZDHHC8;WASF2;TBC1D16;RAP1GDS1;ATG13;MSRB2;JADE2;COA5;TWF2;SURF4;TBC1D14;TACC1;BIN1;FSCN1;HMGCL;CCDC88C;PAK1;TTBK2;SCMH1;ZNF385A;NLGN2;TNRC18;RAG1;BAZ2A;NAV1;CUL7;TBC1D9B;TUBB3;SYTL1;SATB1;RAB29;CORO7;RHOC;REEP2;TMED3;HLTF;SEPT8;SHANK2;PKD1;PARP10;GATA3;PHF1;OXA1L;DOPEY2;GLUD1;HSF1;SIN3B;NEK9;FAT1;EFS;CTBP1;HMGA2;ALAS1;ARID5B;RHOBTB2;DYNLRB1;TOP1;ARL2;MICAL2;CAP1;VAMP2;FLNB;PIP5K1C;SRC;CHMP5;KDM4B;CAPG;POLD4;TAZ;FKBP10;PEX10;DNM2;NINL;AGO4;FAM162A;LRSAM1;HIST3H2A;STPG1;RAB1B;CDC42BPB;MARK3;PAK6;STX5;TOM1L2;SDCCAG8;RERE;RSF1;GSK3A;STXBP1;SPECC1L;SH3BP1;PRIMPOL;FUZ;AGRN;PPM1F;REEP4;PFN1;NISCH;MICAL1;KIF17;BRPF3;BRSK1;STX10;MOAP1;MCFD2;FRYL;HSF4;SEC24C;TUBG1;MSL1;PHF2;TTC19;VPS37A;BCL2L1;MAU2;DDB2;AFAP1;TCIRG1;LEMD2;ZFPM1;ARFIP2;HLCS;ARFGEF2;UNC119B;ULK1;LRP1;HSPA2;PAK4;USO1;ULK2;TBC1D20;SPIRE1;KLHL17;MAP1LC3B;VAPB;MAPK9;COG1;SDHAF4;RCOR1;MAP3K12;VASP;ARAP3;CHD7;ATXN10;TAOK1;LMAN1;APBB1;RHOBTB1;EPS8L1;WDR18;HIST2H2AC;L3MBTL3;TBC1D2B;TAF6;TGFA;NDE1;CAMSAP3;BAHCC1;BAIAP2L1;ATP6V1C2;HIST1H2AG;WIPF1;VAT1;SNAP29;LONP2;HGS;GAS8;TRAPPC1;CIB1;TMSB10;IQSEC1;PACS2;WRAP73;MAPK3;KANK2;CSNK1D;KIFC3;ARHGEF2;UGCG;LLGL1;NDUFS2;OCRL;MINK1;ARHGAP44;CD59;MBD3;MAP6;CCNE1;TGFB1;WBP2;PPP6R1;SH3PXD2A;RMI2;ANXA1;PPP1R10;ASH2L;CCDC113;PXN;ARHGEF10L;PLEKHH2;EP300;TCF7L1;ASAP1;FHOD1
14324,GO:0061437,0.790249798204652,0.556530793797645,1,14,renal system vasculature development,BP,ACTA2
14327,GO:0061440,0.790249798204652,0.556530793797645,1,14,kidney vasculature development,BP,ACTA2
11082,GO:0045066,0.790561330711563,0.556052667913125,1,14,regulatory T cell differentiation,BP,TGFB1
11296,GO:0045589,0.790561330711563,0.556052667913125,1,14,regulation of regulatory T cell differentiation,BP,TGFB1
14955,GO:0070822,0.790597771003426,0.55599670958387,1,14,Sin3-type complex,CC,SIN3B
2269,GO:0005198,0.790664939138164,0.257650986153346,44,509,structural molecule activity,MF,OBSCN;SMTN;DLG1;SLC9A3R2;WWC3;COPG1;MARVELD1;TUBB6;FBLN1;LAMB1;SEPT10;TUBG2;SHANK3;MRPS6;APOE;SEPT5;MSN;MAP1B;LAMB2;OBSL1;DEDD2;MALL;TUBB3;SEPT8;SHANK2;ASPH;TFPI2;LDLRAP1;AGRN;LAMB3;TUBG1;PRR9;KLHL17;SNTB2;HOMER2;RPL28;KRT23;MYL9;LLGL1;MATN3;GRIP2;ITSN1;ANXA1;CLDN12
13102,GO:0051591,0.790750556259362,0.35868016626974,5,61,response to cAMP,BP,SDC1;BSG;RAPGEF3;DGKQ;LDHA
2223,GO:0005123,0.790885384546735,0.555554814100843,1,14,death receptor binding,MF,TMBIM1
4512,GO:0010560,0.790923695757605,0.555495920951992,1,14,positive regulation of glycoprotein biosynthetic process,BP,POMT1
4175,GO:0009247,0.790972547853271,0.376533190827047,4,53,glycolipid biosynthetic process,BP,PIGQ;ST3GAL5;UGCG;B4GALT6
1149,GO:0002753,0.791126015845882,0.376874422042303,4,50,cytoplasmic pattern recognition receptor signaling pathway,BP,IRAK1;IRF7;PUM1;SEC14L1
5640,GO:0016722,0.791283441794402,0.554942552505831,1,14,oxidoreductase activity, oxidizing metal ions,MF,CYB561
12837,GO:0051123,0.791316489247905,0.450251586381319,2,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA;TAF6
5506,GO:0016446,0.791470612965124,0.554654387406628,1,14,somatic hypermutation of immunoglobulin genes,BP,POLM
12959,GO:0051299,0.791585862056792,0.554476865314899,1,14,centrosome separation,BP,NDE1
15339,GO:0071539,0.791659383534189,0.450773900336326,2,26,protein localization to centrosome,BP,NUDCD3;CSNK1D
3333,GO:0007045,0.792243675981201,0.356831844646513,5,60,cell-substrate adherens junction assembly,BP,LAMA5;MMP14;SRC;PPM1F;CAMSAP3
12103,GO:0048041,0.792243675981201,0.356831844646513,5,60,focal adhesion assembly,BP,LAMA5;MMP14;SRC;PPM1F;CAMSAP3
1706,GO:0004190,0.792311289540366,0.553357942851005,1,14,aspartic-type endopeptidase activity,MF,HM13
14532,GO:0070001,0.792311289540366,0.553357942851005,1,14,aspartic-type peptidase activity,MF,HM13
3120,GO:0006700,0.792382804591789,0.551934782497619,1,15,C21-steroid hormone biosynthetic process,BP,DGKQ
5863,GO:0017160,0.792514351647007,0.55304426203715,1,14,Ral GTPase binding,MF,EXOC2
4958,GO:0015020,0.792583056072115,0.552938083909217,1,14,glucuronosyltransferase activity,MF,CHPF
6077,GO:0019226,0.79264578376794,0.44879259535742,2,27,transmission of nerve impulse,BP,SCN8A;P2RX4
3328,GO:0007040,0.792800336271346,0.37439400268067,4,51,lysosome organization,BP,TFEB;NAGLU;VPS11;CHMP5
16003,GO:0080171,0.792800336271346,0.37439400268067,4,51,lytic vacuole organization,BP,TFEB;NAGLU;VPS11;CHMP5
1401,GO:0003323,0.792912550979004,0.552428542474008,1,14,type B pancreatic cell development,BP,GSK3A
5250,GO:0015872,0.792939718529653,0.5510726742641,1,15,dopamine transport,BP,RAB3B
2526,GO:0005779,0.792954973497151,0.551049037584546,1,15,integral component of peroxisomal membrane,CC,PEX10
7268,GO:0031231,0.792954973497151,0.551049037584546,1,15,intrinsic component of peroxisomal membrane,CC,PEX10
13498,GO:0055013,0.792973901480081,0.402086187267911,3,38,cardiac muscle cell development,BP,OBSL1;PAK1;GSK3A
7487,GO:0031646,0.793554771636926,0.551433824737127,1,14,positive regulation of neurological system process,BP,RNF10
8984,GO:0035067,0.793625203425831,0.551324608613415,1,14,negative regulation of histone acetylation,BP,CTBP1
15398,GO:0071624,0.793759409458993,0.548655362381248,1,16,positive regulation of granulocyte chemotaxis,BP,RAC2
17672,GO:1901385,0.7939096699871,0.55088324178028,1,14,regulation of voltage-gated calcium channel activity,BP,EHD3
8705,GO:0034332,0.793989040394016,0.321847309721722,8,92,adherens junction organization,BP,LAMA5;MMP14;NUMB;PIP5K1C;SRC;PPM1F;CAMSAP3;KIFC3
483,GO:0001533,0.793991254167138,0.399089944868732,3,44,cornified envelope,CC,CNFN;PRR9;ANXA1
15641,GO:0072111,0.794128569582901,0.550543328032529,1,14,cell proliferation involved in kidney development,BP,GATA3
19845,GO:2000269,0.794438481875631,0.550061673057857,1,14,regulation of fibroblast apoptotic process,BP,STK17A
8296,GO:0033108,0.794912765465031,0.337996790192314,6,89,mitochondrial respiratory chain complex assembly,BP,COA5;OXA1L;TAZ;TTC19;SDHAF4;NDUFS2
9000,GO:0035107,0.794969159043655,0.313555905902423,9,104,appendage morphogenesis,BP,WNT7A;LRP5;DKK1;ASPH;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
9001,GO:0035108,0.794969159043655,0.313555905902423,9,104,limb morphogenesis,BP,WNT7A;LRP5;DKK1;ASPH;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
12377,GO:0048741,0.795000242878091,0.549187364104744,1,14,skeletal muscle fiber development,BP,FAM129B
12552,GO:0050681,0.795607676331097,0.398063083757276,3,39,androgen receptor binding,MF,PKN1;CCNE1;EP300
5709,GO:0016835,0.795646286000654,0.370129650734106,4,53,carbon-oxygen lyase activity,MF,CBS;NEIL1;HMGA2;UROS
12248,GO:0048490,0.796071622306097,0.546195394027354,1,15,anterograde synaptic vesicle transport,BP,AP3D1
17060,GO:0099514,0.796071622306097,0.546195394027354,1,15,synaptic vesicle cytoskeletal transport,BP,AP3D1
17063,GO:0099517,0.796071622306097,0.546195394027354,1,15,synaptic vesicle transport along microtubule,BP,AP3D1
8114,GO:0032794,0.796079967258512,0.547502410283251,1,14,GTPase activating protein binding,MF,AKT1
3522,GO:0007498,0.796174609377678,0.337819673599299,6,72,mesoderm development,BP,ITGB4;ACVR2B;DKK1;HMGA2;FGFR1;ITGA3
2827,GO:0006294,0.796253229824042,0.442515521942315,2,29,nucleotide-excision repair, preincision complex assembly,BP,XPC;DDB2
3604,GO:0008045,0.796256656751728,0.547226113539235,1,14,motor neuron axon guidance,BP,SEMA3F
13467,GO:0052866,0.796319483420273,0.443901138562197,2,26,phosphatidylinositol phosphate phosphatase activity,MF,MTMR4;OCRL
14587,GO:0070102,0.796379033374519,0.54703465462616,1,14,interleukin-6-mediated signaling pathway,BP,CBL
8947,GO:0034975,0.796946986833043,0.546145085378864,1,14,protein folding in endoplasmic reticulum,BP,ERO1B
6000,GO:0019003,0.796992711785033,0.368450969961716,4,52,GDP binding,MF,RAB3B;RAB31;RRAS;RAB29
10440,GO:0043276,0.797072113168774,0.442250736703147,2,27,anoikis,BP,AKT1;SRC
10301,GO:0043039,0.797138371065061,0.368250119307676,4,52,tRNA aminoacylation,BP,AARS;CARS;GARS;SARS2
16174,GO:0090175,0.797233000217153,0.317079910354659,8,101,regulation of establishment of planar polarity,BP,DVL1;PSMD2;SMURF2;GPC4;AP2A2;DKK1;PFN1;PSMD7
1483,GO:0003774,0.797235597104548,0.317539898671758,8,94,motor activity,MF,KLC2;MYH16;MYH15;DYNLRB1;KIF17;KIF13B;MYO1D;KIFC3
7942,GO:0032516,0.797920891381604,0.544615834348906,1,14,positive regulation of phosphoprotein phosphatase activity,BP,ITGA1
3322,GO:0007031,0.797979077800339,0.440408570618994,2,28,peroxisome organization,BP,PEX10;LONP2
16330,GO:0090482,0.797999579982245,0.544492062308617,1,14,vitamin transmembrane transporter activity,MF,SLC2A3
1484,GO:0003777,0.798121166245671,0.324873643824494,7,82,microtubule motor activity,MF,KLC2;MYH15;DYNLRB1;KIF17;KIF13B;MYO1D;KIFC3
9738,GO:0038179,0.798255945649706,0.440489598762504,2,27,neurotrophin signaling pathway,BP,PPP2R5B;SRC
19854,GO:2000279,0.798522404443741,0.440092523859884,2,27,negative regulation of DNA biosynthetic process,BP,FAM129B;SRC
8533,GO:0033764,0.798563574866665,0.541125318502483,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD11B1
12320,GO:0048643,0.798677400846063,0.543424570997872,1,14,positive regulation of skeletal muscle tissue development,BP,FAM129B
7498,GO:0031664,0.798762315473352,0.541965355956388,1,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,MIF
9893,GO:0042158,0.798785407332079,0.308367224981077,9,110,lipoprotein biosynthetic process,BP,LY6K;APOE;ZDHHC8;PIGQ;LY6E;ABHD17C;LYPD5;MSLN;NTNG1
2192,GO:0005048,0.799127334282979,0.393051525617756,3,39,signal sequence binding,MF,KDELR1;IPO13;CEMIP
19945,GO:2000406,0.799171099808056,0.541319448088219,1,15,positive regulation of T cell migration,BP,ADAM8
2878,GO:0006378,0.799201303985811,0.392945833903391,3,39,mRNA polyadenylation,BP,SYMPK;HSF1;SSU72
4722,GO:0010882,0.799321561784489,0.541081490007726,1,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,PRKACA
10404,GO:0043226,0.799522349026899,0.222255391629901,999,9782,organelle,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;BTBD2;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;MPRIP;THSD4;MST1R;RAC2;LTBP4;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;MXRA5;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;LRP5;AARS;FBLN1;ITGB5;H6PD;XYLT1;GPT2;XBP1;MARCKSL1;PGLS;EGFR;RTN2;CSNK1E;TTYH3;PANO1;MKNK2;TK2;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;OAF;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;METTL23;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;UACA;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FERMT1;ABHD8;GIT2;ACAD10;TYSND1;RRAS;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;LAMB2;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;DHTKD1;KDELR1;PRSS8;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;MSRB2;DEDD2;JADE2;COA5;TWF2;SLC38A10;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PSD3;TACC1;CMIP;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;CERCAM;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;NAV1;DDIT3;PODXL;GLUL;BCDIN3D;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;PTOV1;CORO7;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;NID1;CYTH3;REEP2;TMED3;PROCR;HLTF;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;NIPA1;WDR66;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;TCFL5;SH2D5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;MYH16;GGACT;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;ASPH;MT2A;SDHA;CNFN;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;MYH15;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;SDCCAG8;GPX3;GARS;COG8;RERE;RSF1;GSK3A;STXBP1;SPECC1L;CAMTA2;SH3BP1;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ZNF692;RALGDS;TMPRSS11D;ZNF862;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;HEXIM1;AMIGO2;TIMP1;CRIM1;SLC46A3;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;CDK18;MIF;MTMR4;HES2;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;SNX25;PTPN12;SLC27A1;CPNE8;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;GGT1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;CAMK2N1;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
5159,GO:0015695,0.799749621400052,0.438260517612073,2,27,organic cation transport,BP,SEC14L1;AZIN2
1379,GO:0003272,0.799836966587155,0.541592869046216,1,14,endocardial cushion formation,BP,TGFBR2
9085,GO:0035329,0.800509399424857,0.391368691156283,3,38,hippo signaling,BP,WWC3;WWTR1;MARK3
4145,GO:0009205,0.800520664317205,0.271499934960075,19,233,purine ribonucleoside triphosphate metabolic process,BP,PGM1;NME4;HK1;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;SDHA;TAZ;GUK1;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
6731,GO:0030140,0.800774697017304,0.43623259140354,2,28,trans-Golgi network transport vesicle,CC,LDLRAP1;FURIN
1613,GO:0004033,0.800892594297058,0.537432246173447,1,16,aldo-keto reductase (NADP) activity,MF,AKR7A2
19720,GO:2000008,0.801010913842629,0.43587847992103,2,28,regulation of protein localization to cell surface,BP,SNX33;AKT1
1386,GO:0003283,0.801090671541778,0.539604583032149,1,14,atrial septum development,BP,ZFPM1
11705,GO:0046475,0.801152448193036,0.538176491316276,1,15,glycerophospholipid catabolic process,BP,PNPLA6
7106,GO:0030897,0.801200176127522,0.539430526196964,1,14,HOPS complex,CC,VPS11
15569,GO:0071985,0.801388253999484,0.435312401428641,2,28,multivesicular body sorting pathway,BP,CHMP5;VPS37A
9076,GO:0035306,0.801389676840659,0.38981206228306,3,39,positive regulation of dephosphorylation,BP,SYMPK;ITGA1;TGFB1
1393,GO:0003300,0.801533762844847,0.362537960944867,4,50,cardiac muscle hypertrophy,BP,PAK1;GSK3A;CAMTA2;P2RX4
4939,GO:0014897,0.801533762844847,0.362537960944867,4,50,striated muscle hypertrophy,BP,PAK1;GSK3A;CAMTA2;P2RX4
8285,GO:0033081,0.801592006002918,0.53747645819614,1,15,regulation of T cell differentiation in thymus,BP,ADAM8
11102,GO:0045088,0.801713358497872,0.259633701856375,26,291,regulation of innate immune response,BP,TNIP1;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;SERPING1;RNF135;FAM3A;PRKACB;PAK1;ADAM8;SRC;IRF7;FYN;PSMD7;PUM1;CTSL;HEXIM1;ARG1;SEC14L1;CEACAM1;EP300
11804,GO:0046653,0.801812512276999,0.537124901886891,1,15,tetrahydrofolate metabolic process,BP,ALDH1L2
11363,GO:0045672,0.802063647280372,0.53672420290637,1,15,positive regulation of osteoclast differentiation,BP,GNAS
3505,GO:0007413,0.802241494275569,0.537772209807298,1,14,axonal fasciculation,BP,EPHB2
17223,GO:0106030,0.802241494275569,0.537772209807298,1,14,neuron projection fasciculation,BP,EPHB2
11352,GO:0045661,0.802424370456031,0.433755440858134,2,28,regulation of myoblast differentiation,BP,DDIT3;TGFB1
12207,GO:0048339,0.802480456742779,0.537390852467948,1,14,paraxial mesoderm development,BP,FGFR1
5276,GO:0015923,0.802549906448329,0.537279961976527,1,14,mannosidase activity,MF,EDEM1
12439,GO:0048872,0.803215330838526,0.277961970269088,15,172,homeostasis of number of cells,BP,F2R;BCR;AKT1;CARD11;FAM210B;PKN1;RAG1;GATA3;TSC22D4;THRA;MIF;ZFPM1;L3MBTL3;TGFB1;ANXA1
18369,GO:1903307,0.803232996646148,0.432537671313123,2,28,positive regulation of regulated secretory pathway,BP,STXBP1;ZP3
12657,GO:0050830,0.803253830113676,0.430180161017062,2,34,defense response to Gram-positive bacterium,BP,HIST2H2BE;RNASE7
7997,GO:0032609,0.803367130864024,0.359439871145048,4,53,interferon-gamma production,BP,PRNP;GATA3;ZFPM1;ZP3
7298,GO:0031290,0.803504977810061,0.535752408530409,1,14,retinal ganglion cell axon guidance,BP,EPHB2
3358,GO:0007096,0.803639910428414,0.534201605501569,1,15,regulation of exit from mitosis,BP,TGFB1
9922,GO:0042249,0.803926763862447,0.535076257897034,1,14,establishment of planar polarity of embryonic epithelium,BP,DVL1
11817,GO:0046683,0.804666745096603,0.316054354854783,7,85,response to organophosphorus,BP,SDC1;BSG;RAPGEF3;SSH1;DGKQ;P2RX4;LDHA
12374,GO:0048736,0.804929362859048,0.290223568147895,11,126,appendage development,BP,ITGB4;WNT7A;ITGA6;LRP5;DKK1;ASPH;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
13680,GO:0060173,0.804929362859048,0.290223568147895,11,126,limb development,BP,ITGB4;WNT7A;ITGA6;LRP5;DKK1;ASPH;TULP3;ALDH1A2;FGFR1;CHD7;GNAS
1801,GO:0004438,0.805130051585893,0.53314209714024,1,14,phosphatidylinositol-3-phosphatase activity,MF,MTMR4
13427,GO:0052744,0.805130051585893,0.53314209714024,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,MTMR4
16357,GO:0090575,0.806471503635098,0.288070892062702,11,131,RNA polymerase II transcription factor complex,CC,ERCC1;NR1D1;ATF4;PPARA;BCL9L;DDIT3;TLE4;VDR;THRA;RXRA;TAF6
18710,GO:1904030,0.8065209826094,0.427561871583123,2,28,negative regulation of cyclin-dependent protein kinase activity,BP,HEXIM1;CAMK2N1
2680,GO:0006040,0.806668020725058,0.427338441851929,2,28,amino sugar metabolic process,BP,UAP1;CTBS
10086,GO:0042575,0.80688188469977,0.52780450075723,1,16,DNA polymerase complex,CC,POLD4
2296,GO:0005253,0.806923107217942,0.381549719042939,3,40,anion channel activity,MF,TTYH3;ANO8;LRRC8A
3196,GO:0006826,0.807114782164833,0.380757543999876,3,42,iron ion transport,BP,DNM2;TCIRG1;ATP6V1C2
3661,GO:0008146,0.807170275489248,0.42657465439935,2,28,sulfotransferase activity,MF,NDST2;CHST14
4511,GO:0010559,0.807386565906831,0.4262454547528,2,28,regulation of glycoprotein biosynthetic process,BP,ABCA7;POMT1
18504,GO:1903579,0.807672666138201,0.527687501129446,1,15,negative regulation of ATP metabolic process,BP,PPARA
13521,GO:0055067,0.807677276581783,0.31201094444524,7,86,monovalent inorganic cation homeostasis,BP,SLC12A7;DMXL2;SLC12A4;COMT;TCIRG1;ATP6V1C2;MAPK3
12175,GO:0048268,0.807854635800267,0.527391502235151,1,15,clathrin coat assembly,BP,FCHO1
8752,GO:0034394,0.808185711417489,0.37971577564071,3,40,protein localization to cell surface,BP,SNX33;AKT1;PTPRU
1958,GO:0004659,0.808564422710603,0.526235216833432,1,15,prenyltransferase activity,MF,RABGGTA
4938,GO:0014896,0.808910158295717,0.352032553577412,4,51,muscle hypertrophy,BP,PAK1;GSK3A;CAMTA2;P2RX4
70,GO:0000146,0.80891087338334,0.527014089628849,1,14,microfilament motor activity,MF,MYO1D
10894,GO:0044424,0.80895548137406,0.215126125086153,1065,10404,intracellular part,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;SH2D2A;BTBD2;SH3KBP1;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;FAM83A;ADAM19;CHAC1;H1F0;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;RBCK1;ASAP2;SORL1;CTNNBIP1;DDIT4L;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;NEURL1;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;WWC3;MICALCL;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PLCH2;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;RNPEPL1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;CCNG2;LRP5;AARS;ACVR2B;ITGB5;H6PD;XYLT1;GPT2;ADCY7;XBP1;MYCBPAP;MARCKSL1;PGLS;MAP4K4;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;ACOT1;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CARS;CORO1B;TUB;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;MIER2;ANKRD13D;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;STRN4;FMNL2;ATP13A2;ARG2;UAP1;METTL23;RIN2;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;EPHA1;PI4K2A;UACA;ZMIZ2;PTK6;DNAAF5;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FBXW5;FERMT1;GIT2;ACAD10;NMRK1;TYSND1;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;TGFBR2;LAMB2;CD99;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;CORO2A;BNIP3L;KLHL29;PPARA;DHTKD1;KDELR1;NADK;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;SHC2;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;DEDD2;JADE2;ANKIB1;COA5;TWF2;SLC38A10;SURF4;TMEM134;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;PPP1R12C;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;RHPN1;CERCAM;ISYNA1;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;NAV1;DDIT3;PODXL;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;DOCK9;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;CORO7;LAMC2;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;GRB10;CYTH3;REEP2;TMED3;PROCR;HLTF;PCBP4;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;DLG3;ATP11A;GATA3;APLN;NIPA1;WDR66;PIGQ;NUCB2;PHF1;GSDMA;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;DOCK6;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;MYH16;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;PPCS;SIN3B;ANKS1A;PANK4;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;EFS;ASPH;MT2A;SDHA;CNFN;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;MYH15;HMGA2;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;PPP1R14A;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;ARHGEF4;IGFBP2;ANKS6;CAP1;P4HA1;MYDGF;PLIN3;CLEC11A;B4GALT2;GPRC5C;EIF4EBP1;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;RBMS2;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;SPECC1L;CAMTA2;SH3BP1;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ASNS;ZNF692;PPM1F;RALGDS;ZNF862;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;WISP1;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;ELMO3;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;MAP3K10;EIF2S2;HEXIM1;AMIGO2;TIMP1;FRYL;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;LRRC8A;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;SIGMAR1;RAB11FIP4;AMPD2;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;UNC119B;PIP5KL1;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZNF419;LRRK1;TBC1D20;SPIRE1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;MAP3K12;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;ATXN10;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;BICC1;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TBC1D2B;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;IMPACT;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;AIDA;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;SRGAP2B;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;GRIP2;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;ERBB3;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;PXN;ZNF318;ARCN1;ARHGEF10L;PLEKHH2;EP300;ERP44;THBS3;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;RASA3;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
5969,GO:0018394,0.809280836708876,0.280409623157831,12,140,peptidyl-lysine acetylation,BP,NOS1;JADE2;GATA3;CTBP1;BRPF3;MSL1;APBB1;MAPK3;MBD3;TGFB1;WBP2;EP300
19314,GO:1905508,0.809379362801687,0.423698376416205,2,27,protein localization to microtubule organizing center,BP,NUDCD3;CSNK1D
10300,GO:0043038,0.80997978902718,0.350171112556689,4,53,amino acid activation,BP,AARS;CARS;GARS;SARS2
9233,GO:0035613,0.810339128678959,0.52333208342595,1,15,RNA stem-loop binding,MF,LARP6
17918,GO:1902176,0.810598883064279,0.521732740718863,1,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
7714,GO:0032196,0.810725227771793,0.522698198771263,1,15,transposition,BP,APOBEC3C
11758,GO:0046579,0.810758151395516,0.421091631152928,2,28,positive regulation of Ras protein signal transduction,BP,F2R;RASGEF1A
15075,GO:0071011,0.811081724978546,0.419313137272845,2,31,precatalytic spliceosome,CC,MAPKBP1;SF3B6
3950,GO:0008649,0.811126964268542,0.52086399087756,1,16,rRNA methyltransferase activity,MF,RRNAD1
17328,GO:0140102,0.811126964268542,0.52086399087756,1,16,catalytic activity, acting on a rRNA,MF,RRNAD1
6257,GO:0019835,0.811262766337893,0.519609012007503,1,17,cytolysis,BP,TSTA3
8317,GO:0033143,0.811398821540365,0.330430185917235,5,63,regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1;SRC;KANK2;WBP2;EP300
8067,GO:0032729,0.811589348502518,0.419356374758534,2,29,positive regulation of interferon-gamma production,BP,ZFPM1;ZP3
11641,GO:0046329,0.811617999755382,0.419770541348229,2,28,negative regulation of JNK cascade,BP,AKT1;AIDA
18324,GO:1903204,0.811744752676544,0.521020421884773,1,15,negative regulation of oxidative stress-induced neuron death,BP,ATF4
4356,GO:0009948,0.812703960975585,0.418098108863215,2,28,anterior/posterior axis specification,BP,DDIT3;PCSK6
17127,GO:0099738,0.812768401504059,0.41799872873305,2,28,cell cortex region,CC,PRKCZ;CTSZ
15472,GO:0071786,0.813210185542136,0.518598734347614,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
10621,GO:0043596,0.813223357786257,0.372089548515501,3,41,nuclear replication fork,CC,ZMIZ2;TOP1;POLD4
13934,GO:0060571,0.813266849787388,0.518504853905456,1,15,morphogenesis of an epithelial fold,BP,EGFR
3477,GO:0007339,0.813378691815984,0.517142353584591,1,16,binding of sperm to zona pellucida,BP,ZP3
10211,GO:0042809,0.813432803580586,0.518229800903256,1,15,vitamin D receptor binding,MF,RXRA
801,GO:0002067,0.813539637939125,0.416808119482764,2,28,glandular epithelial cell differentiation,BP,GSK3A;RXRA
15217,GO:0071346,0.813647389325971,0.28924926521018,9,111,cellular response to interferon-gamma,BP,RAB43;CD44;OASL;MT2A;FLNB;IRF7;STXBP1;OAS1;ARG1
4186,GO:0009262,0.814241504212782,0.414441070832036,2,31,deoxyribonucleotide metabolic process,BP,NEIL1;GUK1
2288,GO:0005244,0.814654553274569,0.325936492160857,5,63,voltage-gated ion channel activity,MF,KCNG1;SCN8A;NCS1;TPCN1;KCNC4
6615,GO:0022832,0.814654553274569,0.325936492160857,5,63,voltage-gated channel activity,MF,KCNG1;SCN8A;NCS1;TPCN1;KCNC4
1047,GO:0002566,0.814771096441546,0.516006057199523,1,15,somatic diversification of immune receptors via somatic mutation,BP,POLM
4578,GO:0010661,0.814821759501294,0.51592167608204,1,15,positive regulation of muscle cell apoptotic process,BP,BNIP3
1398,GO:0003309,0.815072271298471,0.515504226888124,1,15,type B pancreatic cell differentiation,BP,GSK3A
10706,GO:0043981,0.815248627776759,0.515210136350265,1,15,histone H4-K5 acetylation,BP,JADE2
10707,GO:0043982,0.815248627776759,0.515210136350265,1,15,histone H4-K8 acetylation,BP,JADE2
12287,GO:0048566,0.815457218643113,0.514862064892313,1,15,embryonic digestive tract development,BP,ALDH1A2
12381,GO:0048747,0.815481890144768,0.413799801688532,2,28,muscle fiber development,BP,FLNC;FAM129B
4785,GO:0010970,0.815833239794639,0.276226086773963,11,131,transport along microtubule,BP,AP3D1;COPG1;FYCO1;PRKCZ;MAP1B;DYNLRB1;KIF17;NDE1;CAMSAP3;APBA1;RAB6A
17030,GO:0099111,0.815833239794639,0.276226086773963,11,131,microtubule-based transport,BP,AP3D1;COPG1;FYCO1;PRKCZ;MAP1B;DYNLRB1;KIF17;NDE1;CAMSAP3;APBA1;RAB6A
17448,GO:1900181,0.816008098870885,0.513941636361179,1,15,negative regulation of protein localization to nucleus,BP,PARP10
15046,GO:0070971,0.816541873994636,0.513048142851617,1,15,endoplasmic reticulum exit site,CC,SEC23A
2810,GO:0006270,0.816614109799511,0.367091671015545,3,41,DNA replication initiation,BP,CDC34;WDR18;CCNE1
11860,GO:0046823,0.816696557879364,0.511606926321312,1,16,negative regulation of nucleocytoplasmic transport,BP,PARP10
5800,GO:0017046,0.816710709520173,0.512765188927963,1,15,peptide hormone binding,MF,IDE
18189,GO:1902914,0.816794681496776,0.512624398521164,1,15,regulation of protein polyubiquitination,BP,PARP10
2347,GO:0005385,0.817149067535664,0.512029778670906,1,15,zinc ion transmembrane transporter activity,MF,SLC30A1
15365,GO:0071577,0.817149067535664,0.512029778670906,1,15,zinc ion transmembrane transport,BP,SLC30A1
11861,GO:0046824,0.817199971557212,0.340100081522818,4,52,positive regulation of nucleocytoplasmic transport,BP,RAPGEF3;BAG3;CAMK1;TGFB1
3029,GO:0006576,0.817234322643014,0.410189058360308,2,30,cellular biogenic amine metabolic process,BP,ALDH7A1;AZIN2
14516,GO:0061980,0.817501464419317,0.410656518893148,2,28,regulatory RNA binding,MF,AGO4;PUM1
13958,GO:0060602,0.817578604472597,0.511308100954984,1,15,branch elongation of an epithelium,BP,TGFB1
4453,GO:0010389,0.817648279920136,0.26002037921529,15,180,regulation of G2/M transition of mitotic cell cycle,BP,FHL1;CCND1;PSMD2;CSNK1E;PRKACA;VPS4A;HMGA2;NINL;SDCCAG8;PSMD7;BRSK1;TUBG1;TAOK1;NDE1;CSNK1D
3469,GO:0007292,0.81780895405237,0.308520538110028,6,75,female gamete generation,BP,ERCC1;HSF1;SRC;PAQR7;ZP3;SPIRE1
10963,GO:0044665,0.818214443442183,0.409085025788551,2,29,MLL1/2 complex,CC,TAF6;ASH2L
15213,GO:0071339,0.818214443442183,0.409085025788551,2,29,MLL1 complex,CC,TAF6;ASH2L
7018,GO:0030705,0.818241998634543,0.265492131851695,13,152,cytoskeleton-dependent intracellular transport,BP,AP3D1;COPG1;FYCO1;PRKCZ;MAP1B;CCDC88C;DYNLRB1;KIF17;KIF13B;NDE1;CAMSAP3;APBA1;RAB6A
18377,GO:1903321,0.81866590276954,0.319881773123946,5,67,negative regulation of protein modification by small protein conjugation or removal,BP,AKT1;LIMK1;PARP10;FYN;RNF222
6663,GO:0030014,0.819204271034382,0.508567168971015,1,15,CCR4-NOT complex,CC,CNOT11
12927,GO:0051254,0.819350347323527,0.209317781720051,110,1121,positive regulation of RNA metabolic process,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;GTPBP1;MC1R;TFE3;BCL9L;DDIT3;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;PUM1;EHF;TNRC6B;THRA;RNF187;HSF4;RREB1;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
11279,GO:0045540,0.819918596409167,0.362187678226055,3,41,regulation of cholesterol biosynthetic process,BP,APOE;PMVK;SEC14L2
2746,GO:0006140,0.819984289089349,0.275632526727779,10,120,regulation of nucleotide metabolic process,BP,NOS1;PTHLH;RAPGEF3;APOE;TMSB4X;PPARA;GNAI2;CAP1;TAZ;ADNP
10184,GO:0042762,0.820261005890946,0.506777280347477,1,15,regulation of sulfur metabolic process,BP,COMT
11739,GO:0046530,0.820368856643786,0.406166745699568,2,28,photoreceptor cell differentiation,BP,SDK2;NAGLU
17110,GO:0099622,0.820975248295353,0.505563820693178,1,15,cardiac muscle cell membrane repolarization,BP,DLG1
2218,GO:0005112,0.821196225922378,0.505187787587074,1,15,Notch binding,MF,CHAC1
18267,GO:1903051,0.821664173548634,0.333204365991424,4,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,PANO1;UBE2J1;SUFU;GIPC1
19262,GO:1905368,0.821950899063636,0.302016930799037,6,85,peptidase complex,CC,PSMD2;IDE;WFS1;PSMD7;RAD23A;TAF6
1306,GO:0003143,0.822031466217859,0.3592958896616,3,40,embryonic heart tube morphogenesis,BP,TGFBR2;SUFU;MICAL2
6759,GO:0030177,0.822120464614229,0.268011585593831,11,136,positive regulation of Wnt signaling pathway,BP,DVL1;WNT7A;PSMD2;SMURF2;CSNK1E;DKK1;SRC;PSMD7;LRRK1;ATP6V1C2;CSNK1D
8021,GO:0032648,0.822439078616562,0.358424768180211,3,41,regulation of interferon-beta production,BP,PTPRS;RNF135;IRF7
460,GO:0001325,0.822558237419131,0.502863751016031,1,15,formation of extrachromosomal circular DNA,BP,ERCC1
16376,GO:0090656,0.822558237419131,0.502863751016031,1,15,t-circle formation,BP,ERCC1
16404,GO:0090737,0.822558237419131,0.502863751016031,1,15,telomere maintenance via telomere trimming,BP,ERCC1
12812,GO:0051087,0.822671765316751,0.301511647330246,6,79,chaperone binding,MF,PRNP;BAG3;SYVN1;DNAJB5;BIN1;DNAJB9
19216,GO:1905268,0.822871416234343,0.358038438996663,3,40,negative regulation of chromatin organization,BP,PHF1;CTBP1;PHF2
4693,GO:0010842,0.823039914901368,0.502039234011655,1,15,retina layer formation,BP,SDK2
693,GO:0001910,0.823047680228555,0.401059882213048,2,30,regulation of leukocyte mediated cytotoxicity,BP,ARG1;CEACAM1
6701,GO:0030097,0.823096692267656,0.21664609323567,54,592,hemopoiesis,BP,ERCC1;CTNNBIP1;AP3D1;PSMD2;BCR;XBP1;CMTM7;MKNK2;MMP14;CARD11;FAM210B;PRKCZ;FAM20C;POU2F2;FZD8;RRAS;TGFBR2;DHTKD1;KDELR1;WASF2;TFE3;ZNF385A;RAG1;SATB1;GATA3;ADAM8;SRC;TAZ;AGO4;IRF7;PSMD7;TNRC6B;THRA;LRRC8A;MFNG;ZFPM1;SMPD3;LRRK1;PNP;CHD7;L3MBTL3;POLM;MYL9;CIB1;DNAJB9;GLO1;MLF1;CEACAM1;TGFB1;SH3PXD2A;ANXA1;ASH2L;GNAS;EP300
10535,GO:0043457,0.823360410636669,0.500298664247673,1,16,regulation of cellular respiration,BP,BNIP3
3496,GO:0007398,0.823417032956664,0.501392738849514,1,15,ectoderm development,BP,ITGA6
11272,GO:0045503,0.823543466516465,0.501175804347286,1,15,dynein light chain binding,MF,GLUL
19917,GO:2000369,0.823577994914697,0.501116544071174,1,15,regulation of clathrin-dependent endocytosis,BP,ARAP3
11367,GO:0045685,0.824199124402307,0.355785492022995,3,41,regulation of glial cell differentiation,BP,SERPINE2;BIN1;SLC45A3
7471,GO:0031624,0.824374856787529,0.39984037107429,2,28,ubiquitin conjugating enzyme binding,MF,PPARA;ANKIB1
14052,GO:0060761,0.824460366703575,0.354909875174506,3,43,negative regulation of response to cytokine stimulus,BP,SLIT3;ARG1;ECM1
10209,GO:0042805,0.824658313533164,0.499258832524627,1,15,actinin binding,MF,OBSL1
110,GO:0000226,0.824842392848847,0.221153494001137,40,427,microtubule cytoskeleton organization,BP,DVL1;NEURL1;DLG1;BBS2;TUBB6;MARK4;TUBG2;PRKCZ;VPS4A;DNAAF5;FBXW5;EML2;MAP1B;OBSL1;TACC1;CCDC88C;PAK1;TTBK2;NAV1;CUL7;TUBB3;PKD1;ARL2;CHMP5;NINL;MARK3;SDCCAG8;BRSK1;TUBG1;SPIRE1;TAOK1;NDE1;CAMSAP3;GAS8;CIB1;WRAP73;CSNK1D;ARHGEF2;LLGL1;MAP6
10206,GO:0042800,0.824848025801454,0.497738729259388,1,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L
8697,GO:0034311,0.824875105409233,0.496644021081583,1,17,diol metabolic process,BP,SPTLC2
14758,GO:0070412,0.824988849758973,0.498689051159513,1,15,R-SMAD binding,MF,PMEPA1
9865,GO:0042104,0.825115669188028,0.49622850290458,1,17,positive regulation of activated T cell proliferation,BP,IGFBP2
6769,GO:0030199,0.825250391001048,0.398449244920141,2,28,collagen fibril organization,BP,P4HA1;LOXL1
17854,GO:1901989,0.825304394747475,0.310704297381403,5,66,positive regulation of cell cycle phase transition,BP,CCND1;CCND2;HYAL1;TGFB1;ANXA1
25,GO:0000049,0.825325493679935,0.328076224026845,4,54,tRNA binding,MF,XPOT;AARS;CARS;DTD1
16013,GO:0086005,0.825492244376861,0.497820036419673,1,15,ventricular cardiac muscle cell action potential,BP,DLG1
2297,GO:0005254,0.825492877116725,0.397605906164722,2,29,chloride channel activity,MF,TTYH3;ANO8
16114,GO:0090075,0.825679916533203,0.496301431644057,1,16,relaxation of muscle,BP,P2RX4
13029,GO:0051443,0.825930412560654,0.396483796298372,2,30,positive regulation of ubiquitin-protein transferase activity,BP,STUB1;TRIB3
9932,GO:0042269,0.826487597377699,0.494901988675973,1,16,regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
7379,GO:0031424,0.826663864518641,0.295697521671409,6,83,keratinization,BP,SHARPIN;PRSS8;CNFN;PCSK6;KRT23;FURIN
182,GO:0000394,0.826696658528526,0.493489095457616,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1
10643,GO:0043631,0.827122596631071,0.351380174502186,3,41,RNA polyadenylation,BP,SYMPK;HSF1;SSU72
8684,GO:0034249,0.82713391247644,0.239386800642891,19,230,negative regulation of cellular amide metabolic process,BP,SORL1;MAP2K1;PRNP;SESN2;EGFR;MAP2K2;ATF4;APOE;BIN1;BCDIN3D;EIF4EBP1;AGO4;PUM1;TNRC6B;SAMD4B;ABCA7;PAIP2;IGF2BP3;TGFB1
6866,GO:0030330,0.827295928718732,0.277755899232704,8,101,DNA damage response, signal transduction by p53 class mediator,BP,SESN2;CD44;ZNF385A;PCBP4;MIF;CNOT11;SPRED2;EP300
8037,GO:0032675,0.82782170970363,0.307271665473544,5,65,regulation of interleukin-6 production,BP,F2R;XBP1;MAPK13;IL1RAP;ARHGEF2
8685,GO:0034250,0.827909728317251,0.265227418228101,10,123,positive regulation of cellular amide metabolic process,BP,LARP6;BCDIN3D;GSK3A;TNFRSF1A;SMPD3;PYM1;RXRA;IMPACT;MAPK3;TGFB1
17625,GO:1901264,0.828318368819554,0.323571029305794,4,55,carbohydrate derivative transport,BP,VLDLR;SLC29A4;SLC35B4;GUK1
2851,GO:0006337,0.828434306628629,0.491512778301553,1,16,nucleosome disassembly,BP,HIST3H2A
2712,GO:0006084,0.828452150058175,0.392878622129438,2,29,acetyl-CoA metabolic process,BP,PMVK;MLYCD
17921,GO:1902186,0.828598079157946,0.392644592239747,2,29,regulation of viral release from host cell,BP,PC;VPS4A
5407,GO:0016242,0.82890637115153,0.39214989242385,2,29,negative regulation of macroautophagy,BP,QSOX1;AKT1
4430,GO:0010257,0.829004022630182,0.345930253103239,3,55,NADH dehydrogenase complex assembly,BP,OXA1L;TAZ;NDUFS2
8230,GO:0032981,0.829004022630182,0.345930253103239,3,55,mitochondrial respiratory chain complex I assembly,BP,OXA1L;TAZ;NDUFS2
5413,GO:0016254,0.82909694760838,0.489301239834233,1,17,preassembly of GPI anchor in ER membrane,BP,PIGQ
407,GO:0001091,0.829254712774405,0.49007754243997,1,16,RNA polymerase II basal transcription factor binding,MF,ERCC1
12880,GO:0051181,0.829435076939317,0.39087563207557,2,30,cofactor transport,BP,LCN2;SLC33A1
18186,GO:1902911,0.829578181931831,0.282538856635081,7,88,protein kinase complex,CC,CCND1;SESN2;TGFBR2;ATG13;CCND2;ULK1;CCNE1
10509,GO:0043401,0.829677722207804,0.251086445422454,13,151,steroid hormone mediated signaling pathway,BP,NR1D1;PPARA;PAK1;SRC;PAQR7;VDR;THRA;PMEPA1;RXRA;KANK2;CCNE1;WBP2;EP300
14960,GO:0070830,0.829884833920921,0.347192926244429,3,41,bicellular tight junction assembly,BP,DLG1;PRKACA;ARL2
17559,GO:1901031,0.830029991593043,0.389918704392964,2,30,regulation of response to reactive oxygen species,BP,SESN2;ENDOG
6703,GO:0030099,0.830057866436595,0.227140324919252,25,292,myeloid cell differentiation,BP,CTNNBIP1;FAM210B;FAM20C;TGFBR2;WASF2;TFE3;ZNF385A;GATA3;SRC;AGO4;IRF7;TNRC6B;THRA;ZFPM1;LRRK1;L3MBTL3;MYL9;CIB1;GLO1;CEACAM1;TGFB1;SH3PXD2A;ASH2L;GNAS;EP300
16052,GO:0086064,0.830123225215309,0.488553647836438,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,PRKACA
11433,GO:0045830,0.830277264803974,0.488282884366131,1,16,positive regulation of isotype switching,BP,TGFB1
9751,GO:0038201,0.830762120755052,0.487429670509684,1,16,TOR complex,CC,SESN2
4454,GO:0010390,0.831301032004097,0.388294074181878,2,29,histone monoubiquitination,BP,RAG1;DDB2
13543,GO:0055094,0.831376711058374,0.48634606647945,1,16,response to lipoprotein particle,BP,APOE
1228,GO:0002902,0.831666999172409,0.484778129475645,1,17,regulation of B cell apoptotic process,BP,MIF
18832,GO:1904355,0.831953487076897,0.485326997886199,1,16,positive regulation of telomere capping,BP,MAPK3
9376,GO:0035883,0.832033822722722,0.485184893434394,1,16,enteroendocrine cell differentiation,BP,GSK3A
19713,GO:2000001,0.83207330728627,0.485115035047151,1,16,regulation of DNA damage checkpoint,BP,PPP1R10
1157,GO:0002762,0.832191119852212,0.386854861190404,2,29,negative regulation of myeloid leukocyte differentiation,BP,ZFPM1;CEACAM1
19199,GO:1905209,0.832564445350584,0.484245270433735,1,16,positive regulation of cardiocyte differentiation,BP,TGFB1
1980,GO:0004693,0.832730773144388,0.385556186521466,2,30,cyclin-dependent protein serine/threonine kinase activity,MF,CCND1;CDK18
17796,GO:1901799,0.832918161080301,0.342087004429541,3,43,negative regulation of proteasomal protein catabolic process,BP,PANO1;UBE2J1;GIPC1
3165,GO:0006778,0.833000795709529,0.384722689238704,2,31,porphyrin-containing compound metabolic process,BP,ALAS1;UROS
5738,GO:0016881,0.833701977706715,0.482224984107888,1,16,acid-amino acid ligase activity,MF,PPCS
478,GO:0001522,0.833756191738143,0.480135101629112,1,18,pseudouridine synthesis,BP,RPUSD3
3691,GO:0008198,0.834039216348631,0.480566787001273,1,17,ferrous iron binding,MF,PHYH
8249,GO:0033013,0.834721032064735,0.339101825426719,3,44,tetrapyrrole metabolic process,BP,PRSS3;ALAS1;UROS
10589,GO:0043543,0.834725814978602,0.234125123723973,17,198,protein acylation,BP,NOS1;RAPGEF3;MDH2;ZDHHC8;JADE2;GATA3;CTBP1;BRPF3;ABHD17C;MSL1;APBB1;CAMK1;MAPK3;MBD3;TGFB1;WBP2;EP300
4228,GO:0009404,0.835147643871362,0.478586887147082,1,17,toxin metabolic process,BP,CBS
4350,GO:0009913,0.835270073802261,0.23800176476615,15,181,epidermal cell differentiation,BP,MAP2K1;CYP27B1;SHARPIN;PRSS8;ALOX15B;CNFN;FLNB;PCSK6;VDR;CTSL;FGFR1;PRR9;KRT23;FURIN;ANXA1
695,GO:0001912,0.835362592181381,0.47820203960519,1,17,positive regulation of leukocyte mediated cytotoxicity,BP,ARG1
3561,GO:0007603,0.835454951077664,0.479095650453128,1,16,phototransduction, visible light,BP,GNB1
3267,GO:0006940,0.835480526650459,0.38108343757365,2,30,regulation of smooth muscle contraction,BP,F2R;DOCK4
10687,GO:0043923,0.835602907308491,0.47883063089409,1,16,positive regulation by host of viral transcription,BP,EP300
2565,GO:0005847,0.835722143911403,0.478616952249831,1,16,mRNA cleavage and polyadenylation specificity factor complex,CC,SSU72
12551,GO:0050680,0.835758782828383,0.274173560095728,7,87,negative regulation of epithelial cell proliferation,BP,XDH;DLG1;APOE;GATA3;VDR;CEACAM1;TGFB1
5274,GO:0015919,0.835774738155373,0.478522671544998,1,16,peroxisomal membrane transport,BP,PEX10
874,GO:0002221,0.835806927525898,0.254936439512111,10,122,pattern recognition receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;MAPKAPK3;CTSB;IRAK1;IRF7;PUM1;CTSL;SEC14L1
3701,GO:0008210,0.83595984752867,0.477131158213883,1,17,estrogen metabolic process,BP,COMT
99,GO:0000209,0.836067709107918,0.221181988353555,24,275,protein polyubiquitination,BP,RBCK1;SHARPIN;PSMD2;SMURF2;HECW2;FBXW8;SYVN1;TMEM129;FBXO2;FBXW5;CDC34;ANKIB1;PARP10;BLMH;LRSAM1;PSMD7;THOP1;FBXL15;RNF187;MIB2;STUB1;DDB2;MGRN1;CBL
11883,GO:0046872,0.836141920555347,0.181738650854214,295,2926,metal ion binding,MF,NT5E;EDEM1;XDH;FHL1;CBS;ZMYND8;NOS1;ADAM19;LTBP2;CAPN2;LTBP4;RBCK1;ASAP2;CYP27B1;NEURL1;SHARPIN;PCK2;ARAP1;OBSCN;NR1D1;TRIM65;DYSF;MMP1;PITPNM1;ZKSCAN1;DNMT3A;PGM1;DGKA;POSTN;MTA1;RPS6KA2;ITGA6;PRSS3;PRNP;IDH2;PC;NME4;PLCH2;PCDH1;CYGB;LCN2;TNNT1;RNPEPL1;MARCH9;ZC3H6;FKBP9;HAGH;USP20;CHPF;LPCAT1;VLDLR;AARS;ACVR2B;FBLN1;ADCY7;ZCCHC14;MKNK2;MMP14;FYCO1;THBS2;ADARB1;CARS;MAP2K2;STK25;SHANK3;ZKSCAN2;PEG3;APOE;EHD3;ATP13A2;ARG2;ZSCAN30;SYVN1;PHF21A;NPEPL1;RABGGTA;PRKCZ;GALNS;PHC2;RNF135;ATP7B;FAM20C;ITPR3;DGKQ;RFNG;VPS11;PPP2R3B;PITRM1;PI4K2A;ZMIZ2;PFKP;TMEM129;LENG9;ENDOG;ZNF598;GIT2;NMRK1;DEAF1;SALL2;SEC23A;TGFBR2;LIMK1;PPARA;NADK;PRKACB;LTBP1;ZNF516;ESYT2;PLCG1;IDE;MSRB2;JADE2;ANKIB1;GIT1;HMGCL;SP6;MMP10;ZNF385A;DTD1;RAG1;BAZ2A;GLUL;TBC1D9B;ADAMTS7;SYTL1;RET;NID1;HLTF;ATP11A;GATA3;NUCB2;PHF1;GNAI2;PPM1M;ZNF165;ANTXR2;ALOX15B;NEK9;CNDP2;FAT1;ASPH;MT2A;ADAM8;NEIL1;RAI1;MICAL2;PLCB3;P4HA1;B4GALT2;APLP2;KDM4B;FKBP10;PEX10;TGM2;NINL;UBR4;LRSAM1;NUCB1;CDC42BPB;NCS1;STK24;ZCCHC24;YPEL3;RERE;RSF1;OAS1;FYN;PRIMPOL;MPI;ISG20;CLSTN1;AGRN;ZNF692;PPM1F;ZNF862;YPEL5;MICAL1;THOP1;ANXA3;VDR;BRPF3;BRSK1;CGREF1;RNF44;ITGA1;COMT;THRA;MCFD2;RCN1;EIF2S2;TIMP1;ZSCAN18;RNF32;RNF187;ZNF71;LOXL1;LHPP;WDFY3;SEC24C;RREB1;ZBED4;ATP2C2;ADNP;PHF2;MIB2;TENM2;F12;MFNG;MTMR4;RAB11FIP4;AMPD2;ZDBF2;ADIPOR1;NT5DC2;ZFPL1;PITPNM2;ZFPM1;LRP1;AOX1;ZNF609;PLCD3;MGRN1;P2RX4;ACP7;SMPD3;GPATCH8;ZNF419;LRRK1;EHD4;ZNF570;ZNF398;ARAP3;RNF222;ZNF687;LMAN1;PHYH;SLIT3;RXRA;ARG1;L3MBTL3;ZHX3;TSHZ1;NEURL1B;ZBTB4;CYB561;ZNF624;ARSK;VAT1;ACY1;HGS;POLM;MYL9;CBL;CIB1;LACTB2;USP32;POMT1;LITAF;GLO1;FURIN;S100A16;ARHGEF2;RNF103;ZNF444;NDUFS2;B4GALT6;MATN3;ZFP30;ADAM15;GALNT3;ZNF256;AGAP1;ADCY6;ZFP28;ITSN1;CAT;ANXA1;ARSD;PPP1R10;ASH2L;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PXN;ZNF318;EP300;THBS3;WDFY2;STIM1;RASA3;ASAP1;TRAF7;RNF10
16943,GO:0098900,0.836230263519927,0.380282284214828,2,29,regulation of action potential,BP,DLG1;NTSR1
7446,GO:0031571,0.836371382814945,0.294761096063245,5,68,mitotic G1 DNA damage checkpoint,BP,CCND1;ZNF385A;PCBP4;CNOT11;EP300
11015,GO:0044819,0.836371382814945,0.294761096063245,5,68,mitotic G1/S transition checkpoint,BP,CCND1;ZNF385A;PCBP4;CNOT11;EP300
13838,GO:0060412,0.836465423311486,0.379897508972061,2,29,ventricular septum morphogenesis,BP,TGFBR2;ZFPM1
6948,GO:0030551,0.836683791663947,0.47689029727932,1,16,cyclic nucleotide binding,MF,RAPGEF3
4315,GO:0009791,0.837086828942936,0.281803938857429,6,76,post-embryonic development,BP,ERCC1;ACVR2B;PPP1R13L;GATA3;ARID5B;GNAS
4188,GO:0009264,0.837359740243678,0.473673209457362,1,18,deoxyribonucleotide catabolic process,BP,NEIL1
19785,GO:2000142,0.837581653529991,0.377644269255164,2,30,regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
7150,GO:0030990,0.837854033606308,0.377197056147346,2,30,intraciliary transport particle,CC,TULP3;KIF17
10698,GO:0043966,0.83785540402716,0.30955590634056,4,55,histone H3 acetylation,BP,JADE2;GATA3;BRPF3;WBP2
4091,GO:0009144,0.837904797401853,0.226010744854456,19,240,purine nucleoside triphosphate metabolic process,BP,PGM1;NME4;HK1;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;SDHA;TAZ;GUK1;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
4158,GO:0009219,0.837981517009898,0.472549848229845,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,NEIL1
4972,GO:0015079,0.838248819143185,0.309289106696809,4,53,potassium ion transmembrane transporter activity,MF,KCNG1;SLC12A7;SLC12A4;KCNC4
6349,GO:0021522,0.838303601752433,0.47396843162447,1,16,spinal cord motor neuron differentiation,BP,SUFU
11839,GO:0046718,0.838351173806422,0.279766091666453,6,79,viral entry into host cell,BP,CTSB;ITGB5;EGFR;P4HB;IFITM1;IDE
2959,GO:0006491,0.838719317367211,0.473215806843895,1,16,N-glycan processing,BP,EDEM1
1307,GO:0003148,0.838803581177326,0.473063115729562,1,16,outflow tract septum morphogenesis,BP,TGFBR2
7184,GO:0031061,0.838815847706026,0.473040884175561,1,16,negative regulation of histone methylation,BP,PHF1
11103,GO:0045089,0.838842887990608,0.22184074497216,21,246,positive regulation of innate immune response,BP,TNIP1;NR1D1;PSMD2;PTPRS;MAPKAPK3;CTSB;PRKACA;CARD11;IRAK1;PRKACB;PAK1;ADAM8;SRC;IRF7;FYN;PSMD7;PUM1;CTSL;HEXIM1;SEC14L1;EP300
8065,GO:0032727,0.839129282591755,0.472472489372985,1,16,positive regulation of interferon-alpha production,BP,IRF7
12583,GO:0050716,0.839576201658127,0.47059805043749,1,17,positive regulation of interleukin-1 secretion,BP,HK1
8203,GO:0032941,0.83967039434724,0.470426753301782,1,17,secretion by tissue,BP,STK39
19942,GO:2000403,0.839731608649763,0.470315398955072,1,17,positive regulation of lymphocyte migration,BP,ADAM8
10443,GO:0043279,0.840035631582978,0.289712025225594,5,66,response to alkaloid,BP,DNMT3A;FKBP1A;DNM2;BCL2L1;HOMER2
8997,GO:0035098,0.840064992616364,0.470771811454288,1,16,ESC/E(Z) complex,CC,PHF1
12882,GO:0051184,0.840238236149741,0.470456305936037,1,16,cofactor transmembrane transporter activity,MF,SLC33A1
3195,GO:0006825,0.840383435860927,0.468186785303205,1,18,copper ion transport,BP,ATP7B
18111,GO:1902692,0.840787494056437,0.46945470746785,1,16,regulation of neuroblast proliferation,BP,TGFB1
12845,GO:0051131,0.840961770332557,0.468072411872796,1,17,chaperone-mediated protein complex assembly,BP,STUB1
7388,GO:0031435,0.840991863678806,0.469081520941135,1,16,mitogen-activated protein kinase kinase kinase binding,MF,TGFBR2
11872,GO:0046839,0.841040571123078,0.372364331896881,2,29,phospholipid dephosphorylation,BP,MTMR4;OCRL
16361,GO:0090596,0.841107589894963,0.239780765678469,12,142,sensory organ morphogenesis,BP,DVL1;SDK2;BCR;LRP5;NAGLU;GATA3;FGFR1;TBC1D20;CHD7;TSHZ1;EPHB2;MAPK3
16133,GO:0090100,0.841276437930475,0.287919635401441,5,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ACVR2B;FERMT1;GIPC1;FBXL15;TGFB1
16083,GO:0090022,0.84129572660566,0.4665197383472,1,18,regulation of neutrophil chemotaxis,BP,RAC2
2776,GO:0006206,0.841490599932578,0.46710511841565,1,17,pyrimidine nucleobase metabolic process,BP,UCKL1
8276,GO:0033059,0.8415707913935,0.328506877279575,3,44,cellular pigmentation,BP,AP3D1;BBS2;RAB29
868,GO:0002200,0.842076525463063,0.303425997139462,4,54,somatic diversification of immune receptors,BP,ERCC1;RAG1;POLM;TGFB1
13755,GO:0060306,0.84224776106382,0.466782122465789,1,16,regulation of membrane repolarization,BP,DLG1
18515,GO:1903599,0.842536135402273,0.465187251184241,1,17,positive regulation of autophagy of mitochondrion,BP,BNIP3
164,GO:0000339,0.84262519005717,0.465023558535701,1,17,RNA cap binding,MF,EIF4G3
17508,GO:1900407,0.842768734607281,0.302087852469875,4,56,regulation of cellular response to oxidative stress,BP,ATF4;P4HB;AKT1;ENDOG
6456,GO:0021772,0.842885574155428,0.465610337432744,1,16,olfactory bulb development,BP,CHD7
17822,GO:1901888,0.842989937178886,0.285553011881101,5,65,regulation of cell junction assembly,BP,MMP14;PRKACA;SRC;PPM1F;CAMSAP3
2623,GO:0005942,0.843212843247827,0.465008023469384,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R2
12666,GO:0050851,0.843281543792319,0.233368839591919,13,162,antigen receptor-mediated signaling pathway,BP,RBCK1;PSMD2;PRNP;CARD11;PLCG1;PAK1;RAB29;GATA3;PAG1;FYN;PSMD7;CEACAM1;PIK3R2
11217,GO:0045333,0.844415348153333,0.238516932600948,11,155,cellular respiration,BP,NFATC4;IDH2;BNIP3;MDH2;DHTKD1;OXA1L;SDHA;TAZ;SDHAF4;NDUFS2;CAT
9320,GO:0035770,0.844882233899619,0.22848010743394,14,169,ribonucleoprotein granule,CC,BTBD2;PITPNM1;CKAP4;SYMPK;HSF1;TOP1;AGO4;PUM1;TNRC6B;SAMD4B;SHB;RPL28;CARHSP1;APOBEC3C
7360,GO:0031397,0.845007609917625,0.298450456309013,4,58,negative regulation of protein ubiquitination,BP,AKT1;LIMK1;PARP10;FYN
18134,GO:1902750,0.845160171762534,0.260540223368094,7,97,negative regulation of cell cycle G2/M phase transition,BP,FHL1;PSMD2;VPS4A;HMGA2;PSMD7;BRSK1;TAOK1
3359,GO:0007097,0.8452696882668,0.461206019204362,1,16,nuclear migration,BP,FHOD1
3431,GO:0007221,0.845655653289721,0.460489377056955,1,16,positive regulation of transcription of Notch receptor target,BP,EP300
5531,GO:0016504,0.845680634300435,0.363448778603301,2,32,peptidase activator activity,MF,FBLN1;MMP14
3009,GO:0006555,0.84578936837294,0.459172855787647,1,17,methionine metabolic process,BP,AHCY
16116,GO:0090079,0.845807536247244,0.459139066926445,1,17,translation regulator activity, nucleic acid binding,MF,MIF4GD
20127,GO:2000757,0.8458087386747,0.459136830558459,1,17,negative regulation of peptidyl-lysine acetylation,BP,CTBP1
1868,GO:0004529,0.845852937609125,0.45905461901856,1,17,exodeoxyribonuclease activity,MF,ISG20
5751,GO:0016895,0.845852937609125,0.45905461901856,1,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20
7996,GO:0032608,0.846057089247849,0.321700352937679,3,43,interferon-beta production,BP,PTPRS;RNF135;IRF7
10996,GO:0044783,0.846180502902898,0.280475623201092,5,69,G1 DNA damage checkpoint,BP,CCND1;ZNF385A;PCBP4;CNOT11;EP300
10291,GO:0043027,0.846454117210614,0.457935079465693,1,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,PRDX5
10898,GO:0044429,0.846472292194256,0.184472007081996,75,851,mitochondrial part,CC,SHC1;CYP27B1;BOK;PCK2;CPT2;NAGS;IDH2;BNIP3;PC;NME4;OCIAD2;SNPH;HAGH;CHPF;GPT2;TK2;CRAT;HK1;MRPS6;CDS2;MDH2;ARMCX2;ALDH1L2;FAM210B;ARG2;PITRM1;ACAD10;HADH;BNIP3L;DHTKD1;TST;ABCB8;PRDX5;HMGCL;SFXN3;ACSF2;MLXIP;IFI27;OXA1L;RPUSD3;GLUD1;SDHA;MPG;PYCR2;ALAS1;ARL2;SRC;CBR4;TAZ;DNM2;NDUFA4L2;ACADVL;CARD19;GARS;PRIMPOL;ALDH4A1;SLC25A43;ALDH7A1;THOP1;MOAP1;TTC19;BCL2L1;SARS2;ULK1;SDHAF4;MLYCD;ARG1;BPHL;VAT1;LACTB2;CPT1B;NDUFS2;CAT;ANXA1;NIPSNAP1
2114,GO:0004896,0.846635021363536,0.320790037249345,3,43,cytokine receptor activity,MF,EPOR;CD44;IL1RAP
16641,GO:0097472,0.84664988769529,0.362189029241256,2,31,cyclin-dependent protein kinase activity,MF,CCND1;CDK18
15734,GO:0072273,0.846880878243978,0.457138847217984,1,17,metanephric nephron morphogenesis,BP,PKD1
15352,GO:0071556,0.846929928038428,0.456101303478903,1,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,HM13
16781,GO:0098553,0.846929928038428,0.456101303478903,1,18,lumenal side of endoplasmic reticulum membrane,CC,HM13
11806,GO:0046655,0.846969327136567,0.456973666723227,1,17,folic acid metabolic process,BP,ALDH1L2
7418,GO:0031498,0.847042191844922,0.456837549681707,1,17,chromatin disassembly,BP,HIST3H2A
137,GO:0000287,0.847521140309546,0.228052703526732,13,156,magnesium ion binding,MF,PGM1;RPS6KA2;IDH2;PI4K2A;PRKACB;HMGCL;GLUL;ATP11A;CDC42BPB;NCS1;BRSK1;COMT;LHPP
8328,GO:0033158,0.847582906823994,0.455826309372749,1,17,regulation of protein import into nucleus, translocation,BP,PARP10
9115,GO:0035384,0.84801753869293,0.318607618162701,3,43,thioester biosynthetic process,BP,ELOVL1;CBR4;MLYCD
15392,GO:0071616,0.84801753869293,0.318607618162701,3,43,acyl-CoA biosynthetic process,BP,ELOVL1;CBR4;MLYCD
8683,GO:0034248,0.84821680106527,0.195471822974719,37,425,regulation of cellular amide metabolic process,BP,SORL1;MAP2K1;NEURL1;PRNP;SESN2;EGFR;MKNK2;MAP2K2;ATF4;AKT1;APOE;ATP13A2;ZNF598;LARP6;BIN1;ZNF385A;BCDIN3D;EIF4EBP1;AGO4;GSK3A;TNFRSF1A;PUM1;TNRC6B;SECISBP2L;MIF4GD;SAMD4B;SMPD3;PYM1;ABCA7;RXRA;CNOT11;IMPACT;MAPK3;PAIP2;IGF2BP3;EIF4G3;TGFB1
4269,GO:0009615,0.848513544230573,0.213066272566978,19,225,response to virus,BP,MST1R;BNIP3;ADARB1;ACTA2;IFITM1;BNIP3L;HTRA1;GATA3;OASL;HMGA2;SRC;IRF7;OAS1;ISG20;PUM1;HYAL1;BCL2L1;SEC14L1;APOBEC3C
16877,GO:0098780,0.849302578800407,0.452596742098094,1,17,response to mitochondrial depolarisation,BP,ATG13
285,GO:0000788,0.850134548695654,0.443434528772149,1,31,nuclear nucleosome,CC,HIST3H2A
12809,GO:0051084,0.850138972675133,0.356296886024823,2,31,'de novo' posttranslational protein folding,BP,HSPA2;HSPA13
5339,GO:0016073,0.851231263883406,0.261110241188119,6,84,snRNA metabolic process,BP,POU2F2;INTS8;INTS1;TAF6;RPRD2;RPRD1A
291,GO:0000795,0.851281787124365,0.448854174422886,1,17,synaptonemal complex,CC,HSPA2
17023,GO:0099086,0.851281787124365,0.448854174422886,1,17,synaptonemal structure,CC,HSPA2
9171,GO:0035518,0.851302689840777,0.448814501196382,1,17,histone H2A monoubiquitination,BP,DDB2
9057,GO:0035268,0.851745750791529,0.447024015716553,1,18,protein mannosylation,BP,POMT1
17565,GO:1901071,0.852412349433772,0.446703918026209,1,17,glucosamine-containing compound metabolic process,BP,CTBS
5847,GO:0017134,0.852450890306022,0.445681241433819,1,18,fibroblast growth factor binding,MF,FGFR1
450,GO:0001223,0.852552486899411,0.446436751245328,1,17,transcription coactivator binding,MF,PPARA
802,GO:0002068,0.852873161869476,0.445824868068113,1,17,glandular epithelial cell development,BP,GSK3A
4944,GO:0014904,0.852944058084175,0.445689490877017,1,17,myotube cell development,BP,FAM129B
3287,GO:0006978,0.852949294882923,0.444730010129176,1,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ZNF385A
6283,GO:0019884,0.853404136932762,0.22695316325601,11,144,antigen processing and presentation of exogenous antigen,BP,AP3D1;KLC2;PSMD2;ITGB5;AP1B1;AP2A2;SEC23A;DNM2;PSMD7;CTSL;SEC24C
7198,GO:0031082,0.853685944551385,0.443320821339518,1,18,BLOC complex,CC,PI4K2A
10860,GO:0044346,0.85376093593622,0.444127048312467,1,17,fibroblast apoptotic process,BP,STK17A
13590,GO:0060037,0.85384764104322,0.443960925416705,1,17,pharyngeal system development,BP,GATA3
9862,GO:0042100,0.854028286547913,0.308616148113752,3,45,B cell proliferation,BP,CARD11;PKN1;MIF
6555,GO:0021983,0.854148305629034,0.443384445796725,1,17,pituitary gland development,BP,ALDH1A2
4980,GO:0015095,0.854491064960583,0.442726458203157,1,17,magnesium ion transmembrane transporter activity,MF,NIPA1
5157,GO:0015693,0.854491064960583,0.442726458203157,1,17,magnesium ion transport,BP,NIPA1
18611,GO:1903830,0.854491064960583,0.442726458203157,1,17,magnesium ion transmembrane transport,BP,NIPA1
17855,GO:1901990,0.854766781175123,0.191769153303425,31,357,regulation of mitotic cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;EGFR;CSNK1E;PRKACA;HECW2;AKT1;XPC;VPS4A;CCND2;ZNF385A;PCBP4;PKD1;HMGA2;NINL;SDCCAG8;PSMD7;BRSK1;GJC2;TUBG1;HYAL1;TAOK1;NDE1;CNOT11;KANK2;CSNK1D;TGFB1;ANXA1;EP300
5463,GO:0016339,0.854925480430982,0.441891296169311,1,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ARVCF
11667,GO:0046386,0.854985261778421,0.439978700607831,1,19,deoxyribose phosphate catabolic process,BP,NEIL1
2471,GO:0005686,0.855162032029839,0.438878569355845,1,20,U2 snRNP,CC,SF3B6
3198,GO:0006829,0.85519400737533,0.441374368015838,1,17,zinc ion transport,BP,SLC30A1
8233,GO:0032986,0.855483813927091,0.439865132777288,1,18,protein-DNA complex disassembly,BP,HIST3H2A
2978,GO:0006521,0.855524580014576,0.305156327254272,3,51,regulation of cellular amino acid metabolic process,BP,PSMD2;PSMD7;COMT
6344,GO:0021515,0.856374531317931,0.439095551836645,1,17,cell differentiation in spinal cord,BP,SUFU
12684,GO:0050869,0.85642465756673,0.438998564876735,1,17,negative regulation of B cell activation,BP,PKN1
1554,GO:0003950,0.856436975238372,0.438974729158128,1,17,NAD+ ADP-ribosyltransferase activity,MF,PARP10
858,GO:0002183,0.856728297516012,0.437459340897545,1,18,cytoplasmic translational initiation,BP,EIF4EBP1
14517,GO:0061982,0.856976440064568,0.264581759540357,5,69,meiosis I cell cycle process,BP,ERCC1;AGO4;LEMD2;HSPA2;CCNE1
17850,GO:1901984,0.85717710613441,0.436588932836871,1,18,negative regulation of protein acetylation,BP,CTBP1
799,GO:0002065,0.857574910637662,0.263792957634643,5,68,columnar/cuboidal epithelial cell differentiation,BP,FAM20C;PTK6;GSK3A;FGFR1;RXRA
10298,GO:0043034,0.858086028478986,0.435773558766294,1,17,costamere,CC,FLNC
1129,GO:0002715,0.858194479632317,0.434610357477127,1,18,regulation of natural killer cell mediated immunity,BP,CEACAM1
13491,GO:0055006,0.858256368575124,0.302229635357711,3,43,cardiac cell development,BP,OBSL1;PAK1;GSK3A
20158,GO:2000810,0.85829131015566,0.435373650536063,1,17,regulation of bicellular tight junction assembly,BP,PRKACA
15403,GO:0071634,0.858569459927353,0.434831286928779,1,17,regulation of transforming growth factor beta production,BP,FURIN
1860,GO:0004520,0.858627553224852,0.301208261007744,3,45,endodeoxyribonuclease activity,MF,ERCC1;DNASE1L1;NEIL1
468,GO:0001508,0.858922512651793,0.261888770101917,5,67,action potential,BP,SCN8A;DLG1;NTSR1;TPCN1;P2RX4
2271,GO:0005200,0.858922757142587,0.25031806113394,6,80,structural constituent of cytoskeleton,MF,TUBB6;TUBG2;MSN;TUBB3;AGRN;TUBG1
11896,GO:0046888,0.859021636836587,0.340677235778573,2,32,negative regulation of hormone secretion,BP,MAP4K4;HADH
7326,GO:0031330,0.859136203559032,0.207563652437356,15,181,negative regulation of cellular catabolic process,BP,QSOX1;CST3;DAP;PANO1;AKT1;ATP13A2;UBE2J1;PPARA;TBC1D14;SUFU;GIPC1;CPTP;GSK3A;TIMP1;FURIN
1349,GO:0003209,0.859359759950033,0.433287124064761,1,17,cardiac atrium morphogenesis,BP,ZFPM1
5785,GO:0017004,0.859427247760737,0.33931266321978,2,34,cytochrome complex assembly,BP,COA5;TTC19
5283,GO:0015932,0.859572633043203,0.339718624540346,2,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4;SLC35B4
524,GO:0001618,0.859818464889075,0.299481858726809,3,44,virus receptor activity,MF,ITGB5;EGFR;IDE
17209,GO:0104005,0.859818464889075,0.299481858726809,3,44,hijacked molecular function,MF,ITGB5;EGFR;IDE
5560,GO:0016569,0.859922330115847,0.182298135041345,36,396,covalent chromatin modification,BP,ZMYND8;NOS1;DNMT3A;MTA1;NACC2;MIER2;PKN1;PHF21A;JADE2;RAG1;BAZ2A;SATB1;GATA3;PHF1;SIN3B;CTBP1;HMGA2;ARID5B;KDM4B;FKBP10;PPM1F;BRPF3;HSF4;MSL1;PHF2;DDB2;HLCS;RCOR1;MAP3K12;APBB1;MAPK3;MBD3;TGFB1;WBP2;ASH2L;EP300
6559,GO:0021988,0.859956914016831,0.432117235788432,1,17,olfactory lobe development,BP,CHD7
13199,GO:0051785,0.860056885938524,0.298889896673687,3,45,positive regulation of nuclear division,BP,LRP5;TGFA;TGFB1
5673,GO:0016780,0.860116508159416,0.430851386440196,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,PTDSS2
363,GO:0000981,0.860123358601766,0.170586352363843,68,714,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;NACC2;ETV5;KIAA1549;XBP1;RFX2;ATF4;ZKSCAN2;PEG3;ELK3;POU2F2;TFEB;DEAF1;SALL2;DRAP1;CREB3L2;SOX7;PPARA;TFE3;SP6;ZNF385A;DDIT3;SATB1;MLXIP;HLTF;GATA3;TCFL5;HSF1;HMGA2;ARID5B;TSC22D4;IRF7;RERE;CAMTA2;ZNF692;TLE4;VDR;EHF;THRA;ZSCAN18;HSF4;RREB1;ZBED4;ADNP;USF2;PBX3;HES2;ZFPM1;MXD4;E2F5;RCOR1;ZNF398;RXRA;ZHX3;TSHZ1;ZBTB4;CARHSP1;DBP;LITAF;ZNF444;KLF12;EP300;TCF7L1
1258,GO:0003009,0.860540157456234,0.429170017318879,1,19,skeletal muscle contraction,BP,TNNT1
12879,GO:0051180,0.860862959510452,0.429384043775386,1,18,vitamin transport,BP,SLC2A3
7756,GO:0032266,0.861163725084293,0.337304582611778,2,31,phosphatidylinositol-3-phosphate binding,MF,SH3PXD2B;SNX27
18372,GO:1903313,0.861617232349017,0.273346312684644,4,56,positive regulation of mRNA metabolic process,BP,GTPBP1;HSF1;PUM1;TNRC6B
8981,GO:0035064,0.861699557597869,0.273218348336783,4,56,methylated histone binding,MF,ZMYND8;PHF1;PHF2;CDYL2
17306,GO:0140034,0.861699557597869,0.273218348336783,4,56,methylation-dependent protein binding,MF,ZMYND8;PHF1;PHF2;CDYL2
14564,GO:0070069,0.861720722438913,0.424205328166611,1,23,cytochrome complex,CC,NDUFA4L2
797,GO:0002063,0.86179850713816,0.428492350678892,1,17,chondrocyte development,BP,TGFBR2
11614,GO:0046189,0.861894733185727,0.427348867976252,1,18,phenol-containing compound biosynthetic process,BP,GATA3
17687,GO:1901505,0.861983978461484,0.335505882741899,2,32,carbohydrate derivative transmembrane transporter activity,MF,SLC29A4;SLC35B4
3286,GO:0006977,0.862090422724826,0.272211783630703,4,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,ZNF385A;PCBP4;CNOT11;EP300
11699,GO:0046467,0.862320269003385,0.223985101541601,9,117,membrane lipid biosynthetic process,BP,ELOVL1;PIGQ;SPTLC2;TNFRSF1A;ST3GAL5;SMPD3;VAPB;UGCG;B4GALT6
8013,GO:0032635,0.862395399155582,0.256484510526755,5,69,interleukin-6 production,BP,F2R;XBP1;MAPK13;IL1RAP;ARHGEF2
10485,GO:0043368,0.86243299233232,0.426283926611833,1,18,positive T cell selection,BP,ZFPM1
10011,GO:0042417,0.862682122956123,0.425790271841978,1,18,dopamine metabolic process,BP,COMT
17876,GO:1902041,0.862848732063341,0.294338987525617,3,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1;ARHGEF2;TMBIM1
2546,GO:0005813,0.862945278278164,0.176502339954867,40,440,centrosome,CC,USP20;MARK4;PRKACA;TUBG2;ATF4;VPS4A;CCDC92;OBSL1;PRKACB;CCDC88C;CUL7;PROCR;PHF1;GNAI2;HSF1;ADGRB2;NEK9;DYNLRB1;ARL2;DNM2;UBR4;SDCCAG8;BRSK1;TUBG1;CEP170;TTC19;VPS37A;RAB11FIP4;BCL2L1;NDE1;CAMSAP3;SNAP29;CIB1;WRAP73;CSNK1D;KIFC3;MPLKIP;CCDC113;RAP1GAP2;MZT2B
16507,GO:0097178,0.863242894601791,0.333295039576153,2,32,ruffle assembly,BP,PFN1;EPS8L1
3699,GO:0008207,0.863697717470473,0.422922930738539,1,19,C21-steroid hormone metabolic process,BP,DGKQ
12656,GO:0050829,0.863968727951,0.420310776070827,1,22,defense response to Gram-negative bacterium,BP,RNASE7
2846,GO:0006325,0.863980436361759,0.168258076917364,59,660,chromatin organization,BP,ZMYND8;NOS1;H1F0;DNMT3A;MTA1;SMARCA1;BCORL1;NACC2;MIER2;BRD3;PKN1;PHF21A;TSPYL2;HIST2H2BE;H2AFJ;JADE2;SCMH1;TNRC18;RAG1;BAZ2A;SATB1;HLTF;PARP10;GATA3;PHF1;SIN3B;CTBP1;HMGA2;ARID5B;TOP1;KDM4B;FKBP10;HIST3H2A;RERE;RSF1;PPM1F;BRPF3;HSF4;MSL1;PHF2;DDB2;ZFPM1;HLCS;RCOR1;MAP3K12;CHD7;APBB1;HIST2H2AC;L3MBTL3;TAF6;BAHCC1;HIST1H2AG;MAPK3;MBD3;TGFB1;WBP2;ASH2L;EP300;TCF7L1
11517,GO:0045987,0.86415797168382,0.422856048731874,1,18,positive regulation of smooth muscle contraction,BP,F2R
3900,GO:0008536,0.864527252878151,0.331031325704513,2,32,Ran GTPase binding,MF,XPOT;IPO13
14019,GO:0060713,0.864696966047371,0.421780230667357,1,18,labyrinthine layer morphogenesis,BP,SPINT2
10190,GO:0042772,0.86495125891957,0.42042160160388,1,19,DNA damage response, signal transduction resulting in transcription,BP,ZNF385A
7324,GO:0031328,0.864976987150539,0.157328111013889,127,1312,positive regulation of cellular biosynthetic process,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;RAPGEF3;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;ELK3;WWTR1;TMSB4X;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;LARP6;TFE3;BCL9L;DDIT3;BCDIN3D;RET;MLXIP;HLTF;PKD1;ASS1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;TAZ;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;NTSR1;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;USF2;PBX3;ZFPM1;ZNF609;P2RX4;E2F5;SMPD3;ZP3;FGF2;PYM1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;IMPACT;CAMK1;MAPK3;POMT1;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ANXA1;SLC45A3;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
9699,GO:0038084,0.865079866431596,0.421014594598348,1,18,vascular endothelial growth factor signaling pathway,BP,XDH
13643,GO:0060113,0.865462379942766,0.329377893719552,2,32,inner ear receptor cell differentiation,BP,NAGLU;FGFR1
12859,GO:0051150,0.865606787431124,0.419959101606257,1,18,regulation of smooth muscle cell differentiation,BP,TGFB1
11010,GO:0044804,0.865748076470944,0.419675710036705,1,18,autophagy of nucleus,BP,ATG13
15261,GO:0071402,0.865971158571316,0.419227941435993,1,18,cellular response to lipoprotein particle stimulus,BP,APOE
15453,GO:0071709,0.866093850452028,0.41898150805473,1,18,membrane assembly,BP,NLGN2
4088,GO:0009141,0.866112226633991,0.189147547228702,20,257,nucleoside triphosphate metabolic process,BP,PGM1;NME4;HK1;TMSB4X;FAM20C;PFKP;PPARA;DHTKD1;NADK;GTPBP1;SDHA;TAZ;UCKL1;GUK1;VPS9D1;TCIRG1;ALDOC;NDUFS2;TGFB1;LDHA
1097,GO:0002683,0.86611419461547,0.186615603715993,22,265,negative regulation of immune system process,BP,NR1D1;DLG1;PTPRS;PRNP;BCR;SERPING1;ARG2;PKN1;FAM3A;HTRA1;TSC22D4;PAG1;GAL;MIF;ZFPM1;ARG1;SEC14L1;CIB1;CEACAM1;CD59;TGFB1;ANXA1
8131,GO:0032813,0.866346342490476,0.327473443468016,2,33,tumor necrosis factor receptor superfamily binding,MF,TNFSF15;TMBIM1
13111,GO:0051602,0.866662324635374,0.417838144030541,1,18,response to electrical stimulus,BP,SRC
149,GO:0000303,0.866872353142186,0.415801679077242,1,20,response to superoxide,BP,ERCC6
2867,GO:0006360,0.867130783458331,0.264332801447571,4,59,transcription by RNA polymerase I,BP,ERCC6;ATF4;BAZ2A;MAPK3
10788,GO:0044232,0.867217099949866,0.416719862104089,1,18,organelle membrane contact site,CC,ESYT2
5561,GO:0016570,0.867670897206366,0.173607659460228,35,388,histone modification,BP,ZMYND8;NOS1;MTA1;NACC2;MIER2;PKN1;PHF21A;JADE2;RAG1;BAZ2A;SATB1;GATA3;PHF1;SIN3B;CTBP1;HMGA2;ARID5B;KDM4B;FKBP10;PPM1F;BRPF3;HSF4;MSL1;PHF2;DDB2;HLCS;RCOR1;MAP3K12;APBB1;MAPK3;MBD3;TGFB1;WBP2;ASH2L;EP300
11609,GO:0046174,0.867856797735296,0.415427355542358,1,18,polyol catabolic process,BP,NTSR1
2566,GO:0005849,0.868491790488609,0.414141116131011,1,18,mRNA cleavage factor complex,CC,SSU72
4982,GO:0015101,0.868857337333867,0.413399195384397,1,18,organic cation transmembrane transporter activity,MF,AZIN2
18550,GO:1903706,0.868964799866708,0.177709896566058,27,330,regulation of hemopoiesis,BP,CTNNBIP1;AP3D1;PSMD2;XBP1;MMP14;CARD11;FAM210B;PRKCZ;TGFBR2;TFE3;RAG1;GATA3;ADAM8;AGO4;IRF7;PSMD7;TNRC6B;ZFPM1;PNP;MYL9;CIB1;CEACAM1;TGFB1;ANXA1;ASH2L;GNAS;EP300
3888,GO:0008519,0.869108117162795,0.412889584559919,1,18,ammonium transmembrane transporter activity,MF,AZIN2
10033,GO:0042461,0.869197705884031,0.412707407702596,1,18,photoreceptor cell development,BP,NAGLU
2483,GO:0005720,0.869354819108566,0.322111221961594,2,33,nuclear heterochromatin,CC,DNMT3A;SATB1
8481,GO:0033617,0.869815602238903,0.409834976702759,1,20,mitochondrial respiratory chain complex IV assembly,BP,COA5
20208,GO:2001020,0.87002521620989,0.198358461193319,13,162,regulation of response to DNA damage stimulus,BP,ERCC1;NACC2;EGFR;NSMCE4A;CD44;ZNF385A;HSF1;HMGA2;MIF;BCL2L1;APBB1;SPRED2;PPP1R10
13028,GO:0051438,0.870163795053708,0.281720028666518,3,48,regulation of ubiquitin-protein transferase activity,BP,LIMK1;STUB1;TRIB3
6313,GO:0019955,0.87070952866191,0.258812686014405,4,58,cytokine binding,MF,LTBP4;TGFBR2;LTBP1;TNFRSF1A
5505,GO:0016445,0.871329988445092,0.280325611120204,3,45,somatic diversification of immunoglobulins,BP,ERCC1;POLM;TGFB1
15829,GO:0072509,0.871331760244403,0.408348547413392,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC30A1
15815,GO:0072431,0.871575209160468,0.257194051680361,4,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
18007,GO:1902400,0.871575209160468,0.257194051680361,4,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
15907,GO:0072655,0.871665613926997,0.198959779332631,12,158,establishment of protein localization to mitochondrion,BP,RAC2;HK1;AKT1;VPS11;PITRM1;BNIP3L;ZDHHC8;ATG13;DDIT3;GSK3A;MOAP1;UGCG
12362,GO:0048709,0.871721948919454,0.257207302651907,4,58,oligodendrocyte differentiation,BP,BOK;BNIP3;TGFB1;SLC45A3
2961,GO:0006497,0.871786829708311,0.216170668276332,8,108,protein lipidation,BP,LY6K;ZDHHC8;PIGQ;LY6E;ABHD17C;LYPD5;MSLN;NTNG1
11850,GO:0046782,0.871815170455439,0.256813296715683,4,60,regulation of viral transcription,BP,HMGA2;RSF1;NELFCD;EP300
12440,GO:0048873,0.871867699935989,0.406396727140491,1,19,homeostasis of number of cells within a tissue,BP,F2R
1046,GO:0002562,0.872008627952689,0.279191727398948,3,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ERCC1;RAG1;TGFB1
5504,GO:0016444,0.872008627952689,0.279191727398948,3,45,somatic cell DNA recombination,BP,ERCC1;RAG1;TGFB1
2713,GO:0006085,0.872055437877098,0.406861937038081,1,18,acetyl-CoA biosynthetic process,BP,MLYCD
11492,GO:0045934,0.872643514108728,0.150967662434633,103,1096,negative regulation of nucleobase-containing compound metabolic process,BP,ERCC1;MDFI;ZMYND8;CCND1;CTNNBIP1;NFATC4;SHC1;NR1D1;DLG1;DAP;DNMT3A;MTA1;WWC3;SMURF2;FAM129B;ZC3H6;NACC2;VLDLR;ACVR2B;PPP1R13L;PEG3;BAG3;ELK3;WWTR1;PHF21A;TSPYL2;FZD8;DEAF1;SALL2;DRAP1;DKK1;SOX7;PPARA;H2AFJ;WDTC1;DNAJB5;DEDD2;PRDX5;SUFU;SCMH1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;IFI27;GATA3;TCFL5;GNAI2;HSF1;SIN3B;BCL7A;WFS1;CTBP1;NEIL1;HMGA2;ARID5B;TSC22D4;SRC;IRF7;HIST3H2A;PER3;RERE;RSF1;GSK3A;ZNF692;PPM1F;NELFCD;TLE4;VDR;THRA;MAP3K10;HEXIM1;HSF4;FGFR1;RREB1;PHF2;TENM2;HES2;TRIB3;ZFPM1;MXD4;ZP3;RCOR1;APBB1;RXRA;HIST2H2AC;PBXIP1;ZHX3;TSHZ1;BAHCC1;ZBTB4;TCF25;HIST1H2AG;IMPACT;KANK2;ZNF256;MBD3;CCNE1;TGFB1;KLF12;ZNF318;EP300
17296,GO:0120111,0.872774546144689,0.255409537127873,4,59,neuron projection cytoplasm,CC,AP3D1;DLG4;KIF17;KLHL17
20212,GO:2001024,0.872901820464234,0.404266416690401,1,19,negative regulation of response to drug,BP,STK39
1040,GO:0002548,0.872957998520774,0.403387175800377,1,20,monocyte chemotaxis,BP,ANXA1
7152,GO:0030992,0.873473101380406,0.403085757279244,1,19,intraciliary transport particle B,CC,KIF17
2868,GO:0006361,0.87358926142676,0.313875184334069,2,35,transcription initiation from RNA polymerase I promoter,BP,BAZ2A;MAPK3
14807,GO:0070507,0.873924521060741,0.196171461455185,12,148,regulation of microtubule cytoskeleton organization,BP,FBXW5;EML2;MAP1B;PAK1;TTBK2;PKD1;ARL2;CHMP5;TAOK1;CAMSAP3;CIB1;ARHGEF2
1344,GO:0003203,0.873984893192011,0.402877096214975,1,18,endocardial cushion morphogenesis,BP,TGFBR2
17509,GO:1900408,0.87414728683095,0.313157811833006,2,34,negative regulation of cellular response to oxidative stress,BP,ATF4;AKT1
18322,GO:1903202,0.87414728683095,0.313157811833006,2,34,negative regulation of oxidative stress-induced cell death,BP,ATF4;AKT1
15383,GO:0071604,0.874319826657215,0.4021821918108,1,18,transforming growth factor beta production,BP,FURIN
7181,GO:0031057,0.874488631550955,0.313184673850622,2,32,negative regulation of histone modification,BP,PHF1;CTBP1
9868,GO:0042108,0.874536319654708,0.31276428977733,2,33,positive regulation of cytokine biosynthetic process,BP,CARD11;ZFPM1
12399,GO:0048791,0.874670569691455,0.401453471555357,1,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYTL1
18264,GO:1903046,0.874787068998752,0.206668662972327,9,116,meiotic cell cycle process,BP,ERCC1;TUBG2;HSF1;AGO4;TUBG1;LEMD2;HSPA2;SPIRE1;CCNE1
14038,GO:0060740,0.874979194635471,0.400811396674805,1,18,prostate gland epithelium morphogenesis,BP,RXRA
8856,GO:0034643,0.875106855438768,0.399694202759216,1,19,establishment of mitochondrion localization, microtubule-mediated,BP,MAP1B
12024,GO:0047497,0.875106855438768,0.399694202759216,1,19,mitochondrion transport along microtubule,BP,MAP1B
696,GO:0001913,0.875561798319136,0.397982519389545,1,20,T cell mediated cytotoxicity,BP,CEACAM1
16238,GO:0090263,0.875636809263187,0.210548935074652,8,111,positive regulation of canonical Wnt signaling pathway,BP,DVL1;WNT7A;PSMD2;SMURF2;SRC;PSMD7;LRRK1;CSNK1D
735,GO:0001961,0.875657665290927,0.310722470269262,2,33,positive regulation of cytokine-mediated signaling pathway,BP,IRF7;CASP4
13932,GO:0060563,0.875658927027393,0.310720168944455,2,33,neuroepithelial cell differentiation,BP,FAM20C;FGFR1
6831,GO:0030286,0.875698523873257,0.310335420108329,2,34,dynein complex,CC,NUDCD3;DYNLRB1
1023,GO:0002520,0.87613497972613,0.154176584471286,59,658,immune system development,BP,ERCC1;CTNNBIP1;MAP2K1;AP3D1;PSMD2;BCR;LRP5;XBP1;CMTM7;MKNK2;MMP14;CARD11;FAM210B;PKN1;PRKCZ;FAM20C;POU2F2;FZD8;RRAS;TGFBR2;DHTKD1;KDELR1;WASF2;TFE3;ZNF385A;RAG1;SATB1;RET;GATA3;ADAM8;SRC;TAZ;AGO4;IRF7;PSMD7;TNRC6B;THRA;LRRC8A;MFNG;ZFPM1;SMPD3;LRRK1;PNP;CHD7;L3MBTL3;POLM;MYL9;CIB1;MAPK3;DNAJB9;GLO1;MLF1;CEACAM1;TGFB1;SH3PXD2A;ANXA1;ASH2L;GNAS;EP300
19775,GO:2000114,0.876199645832348,0.398264385169262,1,18,regulation of establishment of cell polarity,BP,GATA3
10023,GO:0042440,0.876262029368842,0.271498631403775,3,48,pigment metabolic process,BP,AP3D1;ALAS1;UROS
3665,GO:0008156,0.876327718566156,0.309499105607401,2,33,negative regulation of DNA replication,BP,TSPYL2;TGFB1
2458,GO:0005669,0.87635722686137,0.308839470984701,2,35,transcription factor TFIID complex,CC,ERCC1;TAF6
9108,GO:0035371,0.876479835228456,0.397677848052616,1,18,microtubule plus-end,CC,CLIP2
5745,GO:0016889,0.877094842513881,0.39477359866282,1,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,NEIL1
7603,GO:0031970,0.877146303919545,0.233261499080618,5,78,organelle envelope lumen,CC,SORL1;NME4;ARL2;THOP1;CAT
6867,GO:0030331,0.877469588455035,0.307408600918231,2,33,estrogen receptor binding,MF,SRC;WBP2
7850,GO:0032402,0.877800545863564,0.394052777983638,1,19,melanosome transport,BP,BBS2
13260,GO:0051904,0.877800545863564,0.394052777983638,1,19,pigment granule transport,BP,BBS2
14965,GO:0070840,0.877900949891336,0.394692519287228,1,18,dynein complex binding,MF,RAB29
4786,GO:0010971,0.878032017925642,0.393565089811478,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,CCND1
22,GO:0000041,0.878165725865203,0.231994870681488,5,74,transition metal ion transport,BP,ATP7B;DNM2;TCIRG1;ATP6V1C2;SLC30A1
6023,GO:0019076,0.878202284972544,0.306063383751266,2,33,viral release from host cell,BP,PC;VPS4A
9379,GO:0035890,0.878202284972544,0.306063383751266,2,33,exit from host,BP,PC;VPS4A
9380,GO:0035891,0.878202284972544,0.306063383751266,2,33,exit from host cell,BP,PC;VPS4A
13330,GO:0052126,0.878202284972544,0.306063383751266,2,33,movement in host environment,BP,PC;VPS4A
13339,GO:0052192,0.878202284972544,0.306063383751266,2,33,movement in environment of other organism involved in symbiotic interaction,BP,PC;VPS4A
1128,GO:0002714,0.878393793592637,0.392801932846865,1,19,positive regulation of B cell mediated immunity,BP,TGFB1
1224,GO:0002891,0.878393793592637,0.392801932846865,1,19,positive regulation of immunoglobulin mediated immune response,BP,TGFB1
16154,GO:0090140,0.87854513178715,0.392482350565315,1,19,regulation of mitochondrial fission,BP,BNIP3
2456,GO:0005667,0.878615945814056,0.170933015310192,22,260,transcription factor complex,CC,ERCC1;NFATC4;NR1D1;ATF4;WWTR1;DEAF1;PPARA;BCL9L;DDIT3;GATA3;CTBP1;TLE4;VDR;THRA;PBX3;ZFPM1;E2F5;RCOR1;RXRA;TAF6;EP300;TCF7L1
17763,GO:1901673,0.878639157912483,0.392283694103046,1,19,regulation of mitotic spindle assembly,BP,CHMP5
6281,GO:0019882,0.879393857704686,0.185620834484012,13,171,antigen processing and presentation,BP,AP3D1;KLC2;PSMD2;RAB3B;ITGB5;AP1B1;AP2A2;SEC23A;DNM2;PSMD7;CTSL;SEC24C;RAB6A
532,GO:0001650,0.879627819970806,0.199761119428836,9,118,fibrillar center,CC,DEAF1;CDCA7L;TOP1;MBD6;PAK6;RAI14;RREB1;E2F5;USO1
128,GO:0000266,0.879630363572803,0.303432809678165,2,33,mitochondrial fission,BP,BNIP3;DNM2
3119,GO:0006699,0.87973088493109,0.389971448569447,1,19,bile acid biosynthetic process,BP,NR1D1
19819,GO:2000209,0.879837391915457,0.389745309123808,1,19,regulation of anoikis,BP,SRC
10877,GO:0044390,0.879899488410016,0.302935783259723,2,33,ubiquitin-like protein conjugating enzyme binding,MF,PPARA;ANKIB1
11471,GO:0045911,0.880102499650189,0.389181988111732,1,19,positive regulation of DNA recombination,BP,TGFB1
15808,GO:0072413,0.880159939314276,0.24333226126535,4,61,signal transduction involved in mitotic cell cycle checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
18008,GO:1902402,0.880159939314276,0.24333226126535,4,61,signal transduction involved in mitotic DNA damage checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
18009,GO:1902403,0.880159939314276,0.24333226126535,4,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
869,GO:0002204,0.880192017105494,0.302395068092103,2,33,somatic recombination of immunoglobulin genes involved in immune response,BP,ERCC1;TGFB1
870,GO:0002208,0.880192017105494,0.302395068092103,2,33,somatic diversification of immunoglobulins involved in immune response,BP,ERCC1;TGFB1
11158,GO:0045190,0.880192017105494,0.302395068092103,2,33,isotype switching,BP,ERCC1;TGFB1
2872,GO:0006366,0.880303371589266,0.137712735966284,171,1761,transcription by RNA polymerase II,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;CTNNBIP1;NFATC4;DVL1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;TEF;DNMT3A;SOX12;PSMD2;ITGA6;WWC3;CITED4;SMURF2;SESN2;ZC3H6;NACC2;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;PPP1R13L;ATF4;ZKSCAN2;AKT1;BRD3;PEG3;BAG3;APOE;METTL23;PKN1;ELK3;WWTR1;PHF21A;POU2F2;TFEB;DGKQ;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;WDTC1;DNAJB5;ZNF516;MC1R;TFE3;HTRA1;SUFU;SP6;BCL9L;ZNF385A;DDIT3;SATB1;MLXIP;IFI27;HLTF;PKD1;GATA3;APLN;TCFL5;HSF1;SIN3B;WFS1;CTBP1;RAI1;INTS8;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;IRF7;RFXANK;PER3;RERE;CAMTA2;PCSK6;AGRN;ZNF692;PFN1;NELFCD;PSMD7;TNFRSF1A;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;HEXIM1;ZSCAN18;HSF4;FGFR1;RREB1;ZBED4;ADNP;TENM2;USF2;PBX3;HES2;TRIB3;LEMD2;ZFPM1;ZNF609;MXD4;E2F5;FGF2;MED15;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;INTS1;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;ZBTB4;TCF25;IMPACT;RPRD1A;CAMK1;CARHSP1;MAPK3;KANK2;DBP;LITAF;GLO1;ARHGEF2;ZNF444;LPIN3;ECM1;MBD3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;KLF12;ITGA3;ARHGEF10L;EP300;TCF7L1;FHOD1;RNF10
20319,GO:2001258,0.881050024614461,0.386400831378439,1,20,negative regulation of cation channel activity,BP,EPHB2
7414,GO:0031491,0.881237572100439,0.241074076667543,4,66,nucleosome binding,MF,SMARCA1;PHF1;HMGA2;MBD3
8357,GO:0033209,0.881251797308133,0.192793469482894,10,139,tumor necrosis factor-mediated signaling pathway,BP,RBCK1;SHARPIN;PSMD2;TMSB4X;TNFSF15;TNFRSF6B;PSMD7;TNFRSF1A;TNFRSF19;CASP4
202,GO:0000423,0.881370913452539,0.386478140802196,1,19,mitophagy,BP,ATG13
18960,GO:1904680,0.881385816984845,0.38499612138847,1,21,peptide transmembrane transporter activity,MF,SLC15A1
5559,GO:0016567,0.881433298999504,0.146852013199502,64,705,protein ubiquitination,BP,GID4;RBCK1;NEURL1;SHARPIN;FKBP1A;PSMD2;MTA1;SMURF2;MARCH9;HECW2;FBXW8;AKT1;SYVN1;WWTR1;RNF135;TMEM129;FBXO2;ZNF598;FBXW5;LIMK1;UBE2J1;ARRDC1;KLHL29;WDTC1;CDC34;JADE2;ANKIB1;RAG1;CUL7;FBXL6;HLTF;PARP10;DCAF7;WFS1;BLMH;PEX10;UBR4;LRSAM1;GSK3A;FYN;RMND5A;PSMD7;THOP1;FBXL15;RNF44;UBA1;RNF187;MIB2;SOCS2;ASB13;STUB1;TRIB3;DDB2;RMND5B;MGRN1;KLHL17;RNF222;SPSB3;NEURL1B;CBL;SOCS7;RNF103;TRAF7;RNF10
10630,GO:0043616,0.881452602172682,0.300059401232685,2,33,keratinocyte proliferation,BP,FERMT1;VDR
5055,GO:0015248,0.881528714736401,0.385378145986368,1,20,sterol transporter activity,MF,APOE
5578,GO:0016592,0.88207206608275,0.298308336013833,2,35,mediator complex,CC,MED15;MED29
18323,GO:1903203,0.882171731781941,0.384763656683961,1,19,regulation of oxidative stress-induced neuron death,BP,ATF4
2300,GO:0005267,0.882334498882167,0.298419964587671,2,33,potassium channel activity,MF,KCNG1;KCNC4
7726,GO:0032211,0.882662919808533,0.383709209617941,1,19,negative regulation of telomere maintenance via telomerase,BP,SRC
9811,GO:0040029,0.882797874763997,0.164320928834513,23,291,regulation of gene expression, epigenetic,BP,MAP2K1;ERCC6;DNMT3A;MTA1;EGFR;MAP2K2;H2AFJ;TNRC18;BAZ2A;BCDIN3D;PHF1;AGO4;HIST3H2A;PUM1;TNRC6B;PHF2;HIST2H2AC;BAHCC1;HIST1H2AG;MBD3;TGFB1;WBP2;EP300
11493,GO:0045935,0.883050158782042,0.137489352650581,123,1279,positive regulation of nucleobase-containing compound metabolic process,BP,TNIP1;ERCC1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;RAPGEF3;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;APOE;METTL23;ELK3;WWTR1;TMSB4X;POU2F2;TFEB;FZD8;ZMIZ2;ENDOG;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;GTPBP1;MC1R;TFE3;BCL9L;DDIT3;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;TAZ;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;ANXA3;VDR;GAL;PUM1;EHF;TNRC6B;THRA;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;VAPB;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;CAMK1;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;PPP1R10;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
5470,GO:0016363,0.883383699178277,0.205935179704872,7,94,nuclear matrix,CC,XPOT;DNMT3A;PRKCZ;DGKQ;SATB1;DCAF7;HLCS
2465,GO:0005680,0.883682518575644,0.380064183989781,1,21,anaphase-promoting complex,CC,CUL7
1158,GO:0002763,0.883702303901257,0.295559978859311,2,34,positive regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;GNAS
17558,GO:1901030,0.884001202873324,0.29471140835576,2,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK;GSK3A
4675,GO:0010821,0.884098820678444,0.174666310426694,15,190,regulation of mitochondrion organization,BP,RAC2;BOK;BNIP3;AKT1;ATP13A2;VPS11;BNIP3L;ZDHHC8;ATG13;FAM162A;GSK3A;MOAP1;BCL2L1;VAT1;UGCG
10047,GO:0042490,0.884307589278307,0.294427675316025,2,34,mechanoreceptor differentiation,BP,NAGLU;FGFR1
12160,GO:0048247,0.884387199234377,0.378541396371035,1,21,lymphocyte chemotaxis,BP,ADAM8
10709,GO:0043984,0.88457084197753,0.379592627962333,1,19,histone H4-K16 acetylation,BP,MSL1
40,GO:0000082,0.885606365931306,0.167308715384595,18,221,G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;NACC2;EGFR;AKT1;CDC34;CCND2;ZNF385A;PCBP4;PKD1;EIF4EBP1;GJC2;HYAL1;CNOT11;KANK2;CCNE1;ANXA1;EP300
8364,GO:0033233,0.886022991554957,0.375675467280567,1,20,regulation of protein sumoylation,BP,RNF222
10542,GO:0043473,0.886030857122445,0.21980332792142,5,73,pigmentation,BP,AP3D1;BBS2;MC1R;RAB29;ARCN1
7938,GO:0032509,0.886307233821967,0.37505558195848,1,20,endosome transport via multivesicular body sorting pathway,BP,VPS37A
4550,GO:0010628,0.886535230780116,0.133065232791776,130,1367,positive regulation of gene expression,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;ACTA2;MAP2K2;ATF4;AKT1;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;DGKQ;FZD8;ZMIZ2;SH3PXD2B;DEAF1;SALL2;MSN;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;LARP6;TFE3;BCL9L;DDIT3;BCDIN3D;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;ADAM8;RAI1;HMGA2;MICAL2;MYDGF;ALDH1A2;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;GSK3A;CAMTA2;AGRN;PPM1F;TNFRSF1A;VDR;GJC2;GAL;EHF;THRA;RNF187;HSF4;RREB1;PHF2;F12;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;MAPK9;PYM1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;IMPACT;CAMK1;EPHB2;HGS;MAPK3;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;CAMK2N1;ERBB3;ASH2L;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
12854,GO:0051145,0.886630483074831,0.290062198317402,2,34,smooth muscle cell differentiation,BP,NFATC4;TGFB1
14855,GO:0070584,0.886698273501711,0.3735152552953,1,21,mitochondrion morphogenesis,BP,BCL2L1
5600,GO:0016628,0.886744091945414,0.373415108562871,1,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,SRD5A3
16944,GO:0098901,0.886819166916367,0.374698535599349,1,19,regulation of cardiac muscle cell action potential,BP,DLG1
13774,GO:0060330,0.886841572595546,0.373888236783494,1,20,regulation of response to interferon-gamma,BP,ARG1
13778,GO:0060334,0.886841572595546,0.373888236783494,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,ARG1
14818,GO:0070530,0.886975804889564,0.37435581187838,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,PARP10
13428,GO:0052745,0.887182620115686,0.373902946651514,1,19,inositol phosphate phosphatase activity,MF,OCRL
4047,GO:0009083,0.887250455724073,0.372993162490935,1,20,branched-chain amino acid catabolic process,BP,HMGCL
17447,GO:1900180,0.887544967177702,0.207395452933867,6,84,regulation of protein localization to nucleus,BP,SESN2;AKT1;PARP10;SRC;FYN;TGFB1
1096,GO:0002682,0.887710787255961,0.136009875483852,85,933,regulation of immune system process,BP,TNIP1;PGF;RAC2;RBCK1;CTNNBIP1;SHC1;AP3D1;NR1D1;DLG1;FKBP1A;PSMD2;PTPRS;PRNP;MAPKAPK3;CTSB;BCR;XBP1;MMP14;PRKACA;HK1;AKT1;IFITM1;CARD11;IRAK1;ARPC1A;SERPING1;FAM210B;ARG2;PKN1;PRKCZ;RNF135;MSN;TGFBR2;CD99;LIMK1;FAM3A;PRKACB;WASF2;PLCG1;TFE3;HTRA1;PAK1;RAG1;RAB29;GATA3;ADAM8;IGFBP2;TSC22D4;SRC;AGO4;IRF7;STXBP1;PAG1;FYN;PSMD7;GAL;PUM1;FCGRT;CTSL;TNRC6B;HEXIM1;MIF;ZFPM1;ZP3;PNP;MAPK9;ARG1;VEGFB;SEC14L1;WIPF1;MYL9;GGT1;CIB1;MAPK3;MAPK10;CEACAM1;SKAP2;ECM1;CD59;TGFB1;PIK3R2;ANXA1;ASH2L;GNAS;EP300
637,GO:0001824,0.887754801048423,0.251798902909001,3,48,blastocyst development,BP,CAPN2;ZP3;SF3B6
19675,GO:1990841,0.887826874630062,0.288107127050838,2,33,promoter-specific chromatin binding,MF,HSF1;CHD7
13948,GO:0060590,0.888043233112089,0.287104004592152,2,35,ATPase regulator activity,MF,BAG3;PFN1
14856,GO:0070585,0.888193178808359,0.176394116445637,12,161,protein localization to mitochondrion,BP,RAC2;HK1;AKT1;VPS11;PITRM1;BNIP3L;ZDHHC8;ATG13;DDIT3;GSK3A;MOAP1;UGCG
2956,GO:0006488,0.888234231256955,0.370833152649928,1,20,dolichol-linked oligosaccharide biosynthetic process,BP,SRD5A3
7248,GO:0031167,0.888261280843605,0.370087822389412,1,21,rRNA methylation,BP,RRNAD1
13901,GO:0060512,0.888315933331782,0.371414139733355,1,19,prostate gland morphogenesis,BP,RXRA
18566,GO:1903747,0.888463078607076,0.198125639580633,7,99,regulation of establishment of protein localization to mitochondrion,BP,RAC2;VPS11;BNIP3L;ZDHHC8;ATG13;GSK3A;UGCG
3305,GO:0007007,0.888566116803224,0.368795396374737,1,22,inner mitochondrial membrane organization,BP,TAZ
7336,GO:0031341,0.888813445093818,0.285373051968282,2,36,regulation of cell killing,BP,ARG1;CEACAM1
13137,GO:0051654,0.888849167520507,0.369478317328719,1,20,establishment of mitochondrion localization,BP,MAP1B
8374,GO:0033260,0.889108200319683,0.249279574612225,3,49,nuclear DNA replication,BP,POLD4;FGFR1;WDR18
12121,GO:0048145,0.889346727662832,0.228216380472959,4,62,regulation of fibroblast proliferation,BP,EGFR;PARP10;MIF;TGFB1
1932,GO:0004623,0.889571793009019,0.367881603612845,1,20,phospholipase A2 activity,MF,TMEM8A
9716,GO:0038111,0.889681034295506,0.364341097815964,1,26,interleukin-7-mediated signaling pathway,BP,SOCS2
16870,GO:0098760,0.889681034295506,0.364341097815964,1,26,response to interleukin-7,BP,SOCS2
16871,GO:0098761,0.889681034295506,0.364341097815964,1,26,cellular response to interleukin-7,BP,SOCS2
3626,GO:0008088,0.889841071731011,0.248158485869138,3,48,axo-dendritic transport,BP,AP3D1;KIF17;APBA1
19733,GO:2000036,0.89004968355609,0.36758301738866,1,19,regulation of stem cell population maintenance,BP,HMGA2
10164,GO:0042733,0.890116429318023,0.247843259642659,3,47,embryonic digit morphogenesis,BP,WNT7A;LRP5;TULP3
2834,GO:0006303,0.890161825064118,0.226385475945734,4,67,double-strand break repair via nonhomologous end joining,BP,ERCC1;HSF1;HMGA2;POLM
1407,GO:0003338,0.891029385727484,0.364645593715955,1,20,metanephros morphogenesis,BP,PKD1
3545,GO:0007569,0.891162718949398,0.201716869424172,6,86,cell aging,BP,ERCC1;MAP2K1;ARG2;HMGA2;YPEL3;MIF
2824,GO:0006289,0.891337093125971,0.187716279152324,8,113,nucleotide-excision repair,BP,ERCC1;ERCC6;XPC;NEIL1;POLD4;DDB2;RAD23A;EP300
10187,GO:0042769,0.891424347045995,0.280142457451854,2,37,DNA damage response, detection of DNA damage,BP,HMGA2;POLD4
7849,GO:0032401,0.891460264772182,0.36368504318085,1,20,establishment of melanosome localization,BP,BBS2
13261,GO:0051905,0.891460264772182,0.36368504318085,1,20,establishment of pigment granule localization,BP,BBS2
4341,GO:0009891,0.891747581713464,0.127434717957977,127,1326,positive regulation of biosynthetic process,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;RAPGEF3;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;CARD11;IRAK1;PEG3;APOE;METTL23;ELK3;WWTR1;TMSB4X;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;LARP6;TFE3;BCL9L;DDIT3;BCDIN3D;RET;MLXIP;HLTF;PKD1;ASS1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;TAZ;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;NTSR1;RNF187;HSF4;FGFR1;RREB1;ADNP;PHF2;USF2;PBX3;ZFPM1;ZNF609;P2RX4;E2F5;SMPD3;ZP3;FGF2;PYM1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;IMPACT;CAMK1;MAPK3;POMT1;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ANXA1;SLC45A3;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
11290,GO:0045581,0.891938150725368,0.362617574886968,1,20,negative regulation of T cell differentiation,BP,ANXA1
7415,GO:0031492,0.892300218919115,0.277386892064077,2,42,nucleosomal DNA binding,MF,HMGA2;MBD3
19704,GO:1990939,0.892397488880334,0.279083093628398,2,34,ATP-dependent microtubule motor activity,MF,KIF17;KIFC3
2252,GO:0005164,0.892439443319609,0.360811227961406,1,21,tumor necrosis factor receptor binding,MF,TNFSF15
7312,GO:0031307,0.892727587622183,0.36016521013098,1,21,integral component of mitochondrial outer membrane,CC,BNIP3
5710,GO:0016836,0.893042304915369,0.277290544580469,2,36,hydro-lyase activity,MF,CBS;UROS
13861,GO:0060441,0.893136940117636,0.359929895025275,1,20,epithelial tube branching involved in lung morphogenesis,BP,CTSZ
10048,GO:0042491,0.893170603288188,0.359854216713446,1,20,inner ear auditory receptor cell differentiation,BP,FGFR1
5401,GO:0016235,0.894566269072112,0.274900612016377,2,34,aggresome,CC,EDEM1;RNF32
18170,GO:1902883,0.89494809638188,0.273611435169918,2,36,negative regulation of response to oxidative stress,BP,ATF4;AKT1
9049,GO:0035257,0.894979553257482,0.173632774206052,10,131,nuclear hormone receptor binding,MF,PKN1;BAZ2A;GAS2L1;OASL;SRC;VDR;RXRA;CCNE1;WBP2;EP300
13837,GO:0060411,0.895438998196148,0.238451637509276,3,47,cardiac septum morphogenesis,BP,TGFBR2;ZFPM1;CHD7
18325,GO:1903205,0.895498348649725,0.353910952170132,1,21,regulation of hydrogen peroxide-induced cell death,BP,ENDOG
9366,GO:0035869,0.895564085432981,0.237908121112116,3,49,ciliary transition zone,CC,TTBK2;KIF17;UNC119B
8976,GO:0035050,0.895991791152123,0.237468260626207,3,47,embryonic heart tube development,BP,TGFBR2;SUFU;MICAL2
13250,GO:0051894,0.896546117747644,0.352207793063875,1,20,positive regulation of focal adhesion assembly,BP,PPM1F
16012,GO:0086004,0.89665168385848,0.351966786937089,1,20,regulation of cardiac muscle cell contraction,BP,DLG1
14996,GO:0070888,0.89703429596425,0.351092324716356,1,20,E-box binding,MF,GATA3
12120,GO:0048144,0.89706843393143,0.215247094793683,4,63,fibroblast proliferation,BP,EGFR;PARP10;MIF;TGFB1
2411,GO:0005581,0.897851998242868,0.268506362782232,2,34,collagen trimer,CC,COL13A1;C1QTNF6
5814,GO:0017069,0.898093453017871,0.267002771167977,2,38,snRNA binding,MF,ISG20;HEXIM1
12653,GO:0050821,0.898125859361945,0.169010301890429,10,135,protein stabilization,BP,TSPAN1;DVL1;CRTAP;BAG3;SYVN1;WFS1;PER3;STXBP1;PFN1;EP300
10251,GO:0042974,0.898258630198064,0.348283893160101,1,20,retinoic acid receptor binding,MF,VDR
17325,GO:0140097,0.8984330703777,0.157454669988943,14,178,catalytic activity, acting on DNA,MF,ERCC1;DNMT3A;SMARCA1;ENDOG;DNASE1L1;NEIL1;MPG;HMGA2;TOP1;POLD4;PRIMPOL;ISG20;POLM;ANXA1
7592,GO:0031954,0.898655338762603,0.347370545946674,1,20,positive regulation of protein autophosphorylation,BP,SRC
16017,GO:0086009,0.898661005055417,0.347357488391038,1,20,membrane repolarization,BP,DLG1
1007,GO:0002478,0.898689826261013,0.168041023249061,10,141,antigen processing and presentation of exogenous peptide antigen,BP,KLC2;PSMD2;ITGB5;AP1B1;AP2A2;SEC23A;DNM2;PSMD7;CTSL;SEC24C
7338,GO:0031343,0.898707890559363,0.345951849577497,1,22,positive regulation of cell killing,BP,ARG1
13712,GO:0060236,0.898914101061508,0.266143898619322,2,35,regulation of mitotic spindle organization,BP,PKD1;CHMP5
18133,GO:1902749,0.899139509498771,0.15437071956859,15,195,regulation of cell cycle G2/M phase transition,BP,FHL1;CCND1;PSMD2;CSNK1E;PRKACA;VPS4A;HMGA2;NINL;SDCCAG8;PSMD7;BRSK1;TUBG1;TAOK1;NDE1;CSNK1D
5614,GO:0016655,0.899280516387347,0.262746420287692,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,CBR4;NDUFS2
5077,GO:0015298,0.899399590757022,0.345652572386133,1,20,solute:cation antiporter activity,MF,TMCO3
9066,GO:0035282,0.899588361304772,0.211305342973065,4,60,segmentation,BP,SEMA3F;DKK1;PCSK6;EP300
15024,GO:0070936,0.899880171235956,0.230190800195338,3,49,protein K48-linked ubiquitination,BP,SYVN1;CDC34;RNF187
2467,GO:0005682,0.900101486109334,0.342731152748974,1,22,U5 snRNP,CC,MAPKBP1
2958,GO:0006490,0.90012349327603,0.343296041815332,1,21,oligosaccharide-lipid intermediate biosynthetic process,BP,SRD5A3
7578,GO:0031935,0.900219855234327,0.343752331906388,1,20,regulation of chromatin silencing,BP,PHF2
11007,GO:0044798,0.900580786866898,0.159262798119405,12,157,nuclear transcription factor complex,CC,ERCC1;NFATC4;NR1D1;ATF4;PPARA;BCL9L;DDIT3;TLE4;VDR;THRA;RXRA;TAF6
8170,GO:0032897,0.90064315562728,0.342089353752284,1,21,negative regulation of viral transcription,BP,HMGA2
3049,GO:0006607,0.900822782116213,0.342350994769585,1,20,NLS-bearing protein import into nucleus,BP,RERE
8069,GO:0032731,0.901069670485745,0.341096799403751,1,21,positive regulation of interleukin-1 beta production,BP,HK1
16,GO:0000030,0.901806697263959,0.338762197195747,1,22,mannosyltransferase activity,MF,POMT1
7417,GO:0031497,0.902073306739569,0.171155395157182,8,134,chromatin assembly,BP,H1F0;TSPYL2;HIST2H2BE;TNRC18;PARP10;HMGA2;RSF1;BAHCC1
11425,GO:0045815,0.902097737925309,0.205631998624055,4,77,positive regulation of gene expression, epigenetic,BP,ERCC6;PHF2;WBP2;EP300
9011,GO:0035145,0.902282023916417,0.3382647801602,1,21,exon-exon junction complex,CC,PYM1
11126,GO:0045132,0.902933735762777,0.224672922608312,3,49,meiotic chromosome segregation,BP,AGO4;LEMD2;CCNE1
4036,GO:0009067,0.90332840000663,0.335807606065437,1,21,aspartate family amino acid biosynthetic process,BP,ASNS
12958,GO:0051298,0.903626905620382,0.20432368205795,4,61,centrosome duplication,BP,FBXW5;CHMP5;BRSK1;NDE1
19666,GO:1990823,0.903646937432647,0.191466111117132,5,74,response to leukemia inhibitory factor,BP,XBP1;RFX2;PFKP;ARID5B;TLE4
19669,GO:1990830,0.903646937432647,0.191466111117132,5,74,cellular response to leukemia inhibitory factor,BP,XBP1;RFX2;PFKP;ARID5B;TLE4
11488,GO:0045930,0.903857656475652,0.138369466736115,22,275,negative regulation of mitotic cell cycle,BP,FHL1;CCND1;DLG1;PSMD2;NACC2;EGFR;XPC;VPS4A;ZNF385A;PCBP4;HMGA2;TOM1L2;PSMD7;BRSK1;GJC2;BCL2L1;TAOK1;CNOT11;KANK2;TGFB1;PPP1R10;EP300
7403,GO:0031461,0.903860218224333,0.154669869971206,12,156,cullin-RING ubiquitin ligase complex,CC,BTBD2;ABTB1;FBXW8;FBXO2;FBXW5;KLHL29;CUL7;DCAF7;FBXL15;DDB2;KLHL17;SPSB3
7721,GO:0032205,0.903868870460495,0.256333522411762,2,35,negative regulation of telomere maintenance,BP,ERCC1;SRC
9999,GO:0042393,0.903955207752702,0.151964407246497,13,172,histone binding,MF,ZMYND8;BRD3;PKN1;PHF21A;WDTC1;RAG1;BAZ2A;PHF1;RSF1;CTSL;PHF2;CDYL2;APBB1
7722,GO:0032206,0.904109026829681,0.222535983501897,3,49,positive regulation of telomere maintenance,BP,ERCC1;MAPK3;PPP1R10
12555,GO:0050685,0.904190548636152,0.33377398504996,1,21,positive regulation of mRNA processing,BP,HSF1
7914,GO:0032481,0.904255914745649,0.203046992326209,4,63,positive regulation of type I interferon production,BP,IRAK1;RNF135;IRF7;EP300
8994,GO:0035094,0.904352635837251,0.333390735342259,1,21,response to nicotine,BP,PPARA
7311,GO:0031306,0.904680164015374,0.332002631858152,1,22,intrinsic component of mitochondrial outer membrane,CC,BNIP3
1453,GO:0003682,0.904872376202157,0.126716737352404,38,436,chromatin binding,MF,ZMYND8;H1F0;NFATC4;ERCC6;DNMT3A;MTA1;SMARCA1;EGFR;BRD3;PKN1;PHF21A;TNRC18;SATB1;GATA3;PHF1;HSF1;SIN3B;HMGA2;TOP1;MBD6;RERE;CAMTA2;PRIMPOL;TLE4;THRA;MSL1;ADNP;LEMD2;CHD7;APBB1;RXRA;TSHZ1;BAHCC1;MBD3;WBP2;ASH2L;EP300;TCF7L1
74,GO:0000151,0.904958462793496,0.137021275762622,22,265,ubiquitin ligase complex,CC,BTBD2;RBCK1;SHARPIN;SMURF2;ABTB1;FBXW8;SYVN1;PHC2;FBXO2;FBXW5;KLHL29;ANKIB1;CUL7;DCAF7;FBXL15;MIB2;STUB1;DDB2;KLHL17;RNF222;SPSB3;TRAF7
150,GO:0000305,0.905061150008161,0.330542145154929,1,23,response to oxygen radical,BP,ERCC6
1003,GO:0002474,0.905205491694393,0.18832295466387,5,83,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMD2;ITGB5;SEC23A;PSMD7;SEC24C
19923,GO:2000378,0.905459186975612,0.252644772181723,2,37,negative regulation of reactive oxygen species metabolic process,BP,BNIP3;BCR
2814,GO:0006275,0.905728678128288,0.171916486559786,7,99,regulation of DNA replication,BP,SHC1;CST3;EGFR;TSPYL2;FGFR1;WDR18;TGFB1
12797,GO:0051053,0.906090730442615,0.165900713614977,8,109,negative regulation of DNA metabolic process,BP,ERCC1;FAM129B;TSPYL2;GATA3;HSF1;HMGA2;SRC;TGFB1
13041,GO:0051457,0.906131387306697,0.328553934775357,1,22,maintenance of protein location in nucleus,BP,ARL2
4360,GO:0009954,0.906277540715752,0.32881682755072,1,21,proximal/distal pattern formation,BP,ALDH1A2
11337,GO:0045646,0.906587028865401,0.250620630197189,2,36,regulation of erythrocyte differentiation,BP,FAM210B;ZFPM1
16158,GO:0090150,0.906598261804516,0.137913831493567,19,266,establishment of protein localization to membrane,BP,PRNP;BBS2;SYNE3;RAB31;EGFR;GDI1;SEC63;PAK1;STOM;REEP2;CEMIP;OXA1L;GRIN3B;VAMP2;FYN;MOAP1;RPL28;CIB1;ARHGAP44
13085,GO:0051569,0.906607216818204,0.328029253064979,1,21,regulation of histone H3-K4 methylation,BP,GATA3
8163,GO:0032886,0.906763592219293,0.148150524422115,13,166,regulation of microtubule-based process,BP,BBS2;FBXW5;EML2;MAP1B;PAK1;TTBK2;PKD1;ARL2;CHMP5;TAOK1;CAMSAP3;CIB1;ARHGEF2
11498,GO:0045943,0.906988657759613,0.327116465438943,1,21,positive regulation of transcription by RNA polymerase I,BP,ATF4
5577,GO:0016591,0.907091010892463,0.16963851133227,7,103,DNA-directed RNA polymerase II, holoenzyme,CC,ERCC1;INTS8;ZNF609;INTS1;TAF6;RPRD2;RPRD1A
3551,GO:0007588,0.907152797153963,0.326112356895951,1,22,excretion,BP,COMT
3047,GO:0006605,0.907442954023035,0.128652916244296,28,367,protein targeting,BP,LTBP2;RAC2;SORL1;AP3D1;PRNP;VPS11;VPS4A;PITRM1;GDI1;BNIP3L;AKAP12;ZDHHC8;ATG13;SEC63;PAK1;STOM;CEMIP;GIPC1;PEX10;NUCB1;GSK3A;FYN;KIF13B;RPL28;LONP2;HGS;CIB1;UGCG
5052,GO:0015238,0.907842287035143,0.196970399437428,4,62,drug transmembrane transporter activity,MF,SLC13A3;TMEM44;SLC6A9;SLC13A5
9191,GO:0035561,0.907983160155216,0.324728751244238,1,21,regulation of chromatin binding,BP,NFATC4
6981,GO:0030641,0.908003131067382,0.196502335364958,4,64,regulation of cellular pH,BP,DMXL2;TCIRG1;ATP6V1C2;MAPK3
6452,GO:0021766,0.909555100056015,0.212392216849784,3,50,hippocampus development,BP,PTPRS;BBS2;ANXA3
8694,GO:0034308,0.909738262964438,0.24399151857824,2,37,primary alcohol metabolic process,BP,RETSAT;ALDH1A2
14241,GO:0061157,0.909928210300888,0.320025547049401,1,21,mRNA destabilization,BP,PUM1
3156,GO:0006760,0.909935936529851,0.319398425267958,1,22,folic acid-containing compound metabolic process,BP,ALDH1L2
16583,GO:0097346,0.910339715346336,0.317863575385089,1,23,INO80-type complex,CC,TFPT
9613,GO:0036464,0.910575630343901,0.145062681753378,12,160,cytoplasmic ribonucleoprotein granule,CC,BTBD2;PITPNM1;CKAP4;TOP1;AGO4;PUM1;TNRC6B;SAMD4B;SHB;RPL28;CARHSP1;APOBEC3C
2525,GO:0005778,0.910581322198237,0.210353134040131,3,51,peroxisomal membrane,CC,MAP2K2;PEX10;CAT
7566,GO:0031903,0.910581322198237,0.210353134040131,3,51,microbody membrane,CC,MAP2K2;PEX10;CAT
12953,GO:0051291,0.910820366285957,0.170100155186594,6,101,protein heterooligomerization,BP,PRKCZ;ITPR3;IDE;GNB1;CBR4;C1QTNF6
7084,GO:0030867,0.910852779068057,0.315645329579862,1,25,rough endoplasmic reticulum membrane,CC,UBA1
2830,GO:0006297,0.911098154444474,0.316015190814712,1,23,nucleotide-excision repair, DNA gap filling,BP,POLD4
14056,GO:0060765,0.911132429795042,0.316484040967642,1,22,regulation of androgen receptor signaling pathway,BP,EP300
1362,GO:0003230,0.911146257274239,0.317057458345392,1,21,cardiac atrium development,BP,ZFPM1
14129,GO:0060964,0.911405686807789,0.169083818087664,6,103,regulation of gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;PUM1;TGFB1
9083,GO:0035326,0.911501309662377,0.17841994012403,5,75,enhancer binding,MF,XBP1;GATA3;RAI1;PBX3;MBD3
11260,GO:0045445,0.911753512366583,0.208173308680567,3,51,myoblast differentiation,BP,SDC1;DDIT3;TGFB1
3116,GO:0006694,0.912014860117064,0.152384415320479,9,126,steroid biosynthetic process,BP,CYP27B1;NR1D1;APOE;DGKQ;SRD5A3;PMVK;HSD11B1;VDR;SEC14L2
18568,GO:1903749,0.912208977766051,0.168309936134917,6,91,positive regulation of establishment of protein localization to mitochondrion,BP,RAC2;VPS11;ZDHHC8;ATG13;GSK3A;UGCG
14,GO:0000027,0.912222141671774,0.311871146435938,1,26,ribosomal large subunit assembly,BP,WDR18
2506,GO:0005758,0.912245439512344,0.188557038617018,4,71,mitochondrial intermembrane space,CC,NME4;ARL2;THOP1;CAT
14051,GO:0060760,0.912274126190914,0.238799672280313,2,37,positive regulation of response to cytokine stimulus,BP,IRF7;CASP4
7848,GO:0032400,0.91338467307144,0.310951273022957,1,22,melanosome localization,BP,BBS2
13236,GO:0051875,0.91338467307144,0.310951273022957,1,22,pigment granule localization,BP,BBS2
2843,GO:0006312,0.913471872788766,0.310735814864589,1,22,mitotic recombination,BP,ERCC1
2474,GO:0005689,0.913696335569056,0.308242125235987,1,26,U12-type spliceosomal complex,CC,SF3B6
3344,GO:0007064,0.913713928734291,0.310137236691261,1,22,mitotic sister chromatid cohesion,BP,MAU2
11332,GO:0045637,0.913966124863296,0.137718423743816,13,183,regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;TFE3;AGO4;IRF7;TNRC6B;ZFPM1;MYL9;CIB1;CEACAM1;ASH2L;GNAS;EP300
15194,GO:0071312,0.913982803964823,0.309471486856521,1,22,cellular response to alkaloid,BP,BCL2L1
5796,GO:0017025,0.914124628548633,0.308570239934674,1,23,TBP-class protein binding,MF,THRA
3181,GO:0006805,0.914331272809064,0.185206201326502,4,67,xenobiotic metabolic process,BP,AKR7A2;BPHL;ACY1;GGT1
13115,GO:0051607,0.9145064902129,0.139418983960149,12,161,defense response to virus,BP,BNIP3;ADARB1;IFITM1;BNIP3L;HTRA1;OASL;IRF7;OAS1;ISG20;PUM1;SEC14L1;APOBEC3C
9050,GO:0035258,0.914760711098775,0.172894430174862,5,76,steroid hormone receptor binding,MF,PKN1;SRC;CCNE1;WBP2;EP300
4678,GO:0010824,0.914823396222129,0.233530897538903,2,37,regulation of centrosome duplication,BP,FBXW5;CHMP5
13983,GO:0060669,0.914967877956203,0.307024695951792,1,22,embryonic placenta morphogenesis,BP,SPINT2
2806,GO:0006266,0.91502077625715,0.30634414519644,1,23,DNA ligation,BP,POLD4
156,GO:0000314,0.915081195591123,0.304055206772673,1,28,organellar small ribosomal subunit,CC,MRPS6
2511,GO:0005763,0.915081195591123,0.304055206772673,1,28,mitochondrial small ribosomal subunit,CC,MRPS6
12798,GO:0051054,0.915153581524881,0.134220490423542,14,181,positive regulation of DNA metabolic process,BP,ERCC1;SHC1;CST3;EGFR;AKT1;ENDOG;HSF1;SRC;ANXA3;FGFR1;APBB1;MAPK3;TGFB1;PPP1R10
8870,GO:0034661,0.915169177348536,0.305974537020186,1,23,ncRNA catabolic process,BP,DEDD2
6926,GO:0030513,0.915178479814004,0.306500011553522,1,22,positive regulation of BMP signaling pathway,BP,FBXL15
18288,GO:1903115,0.915233079286975,0.306363893581578,1,22,regulation of actin filament-based movement,BP,DLG1
3899,GO:0008535,0.91533550930065,0.305058737450505,1,24,respiratory chain complex IV assembly,BP,COA5
4676,GO:0010822,0.915341474195647,0.143794237378837,10,140,positive regulation of mitochondrion organization,BP,RAC2;BOK;BNIP3;VPS11;ZDHHC8;ATG13;FAM162A;GSK3A;MOAP1;UGCG
5507,GO:0016447,0.915890312297338,0.231310750293407,2,37,somatic recombination of immunoglobulin gene segments,BP,ERCC1;TGFB1
3476,GO:0007338,0.915975673604505,0.200003857737271,3,53,single fertilization,BP,MST1R;ZP3;SPESP1
6325,GO:0019985,0.916448608754797,0.229711854616027,2,39,translesion synthesis,BP,POLD4;PRIMPOL
9852,GO:0042088,0.917045008678135,0.301278555616415,1,23,T-helper 1 type immune response,BP,ANXA1
431,GO:0001158,0.917111209730875,0.180548304895127,4,64,enhancer sequence-specific DNA binding,MF,XBP1;GATA3;PBX3;MBD3
1472,GO:0003725,0.917371921134026,0.180174785009045,4,63,double-stranded RNA binding,MF,MSN;OASL;AGO4;OAS1
11339,GO:0045648,0.917607550174146,0.300407548435453,1,22,positive regulation of erythrocyte differentiation,BP,FAM210B
18411,GO:1903393,0.91826458275493,0.298746539325037,1,22,positive regulation of adherens junction organization,BP,PPM1F
3733,GO:0008270,0.918422742342497,0.10593839826816,51,575,zinc ion binding,MF,NR1D1;TRIM65;MMP1;MTA1;RNPEPL1;MARCH9;USP20;ZCCHC14;MMP14;SHANK3;ATP13A2;RABGGTA;PHC2;ZMIZ2;SEC23A;PPARA;IDE;MSRB2;MMP10;ZNF385A;RAG1;HLTF;GATA3;MT2A;ADAM8;NEIL1;PEX10;UBR4;ZCCHC24;RERE;MPI;VDR;THRA;TIMP1;SEC24C;PHF2;MIB2;ZDBF2;ZFPL1;P2RX4;RXRA;L3MBTL3;VAT1;LACTB2;LITAF;GLO1;ARHGEF2;APOBEC3C;ZNF318;EP300;TRAF7
7393,GO:0031440,0.918483958490644,0.298190690005938,1,22,regulation of mRNA 3'-end processing,BP,HSF1
10294,GO:0043030,0.918881189966233,0.296637997756489,1,23,regulation of macrophage activation,BP,MIF
4260,GO:0009593,0.919175924986197,0.295391718981866,1,24,detection of chemical stimulus,BP,STIM1
12431,GO:0048863,0.919326374734419,0.12806717829789,14,201,stem cell differentiation,BP,WNT7A;PSMD2;LAMA5;SEMA3F;SEMA4B;RET;GATA3;HMGA2;EDNRA;ALDH1A2;PSMD7;PUM1;SEMA4G;MAPK3
7361,GO:0031398,0.919433088063675,0.156575163631607,6,91,positive regulation of protein ubiquitination,BP,FKBP1A;MTA1;WFS1;GSK3A;STUB1;TRIB3
12622,GO:0050779,0.919601368591266,0.295349570213021,1,22,RNA destabilization,BP,PUM1
6208,GO:0019706,0.919761903099856,0.294396491490495,1,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC8
6209,GO:0019707,0.919761903099856,0.294396491490495,1,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC8
9499,GO:0036126,0.91996420413435,0.222321498378922,2,39,sperm flagellum,CC,HK1;GAS8
16744,GO:0097729,0.91996420413435,0.222321498378922,2,39,9+2 motile cilium,CC,HK1;GAS8
17856,GO:1901991,0.920070045711381,0.125418778607659,15,202,negative regulation of mitotic cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;VPS4A;ZNF385A;PCBP4;HMGA2;PSMD7;BRSK1;GJC2;TAOK1;CNOT11;KANK2;EP300
3063,GO:0006626,0.920117414106733,0.144028916909382,8,121,protein targeting to mitochondrion,BP,RAC2;VPS11;PITRM1;BNIP3L;ZDHHC8;ATG13;GSK3A;UGCG
4045,GO:0009081,0.920864575399347,0.291575496928412,1,23,branched-chain amino acid metabolic process,BP,HMGCL
14835,GO:0070555,0.920865967955872,0.135465774971867,10,145,response to interleukin-1,BP,PSMD2;IRAK1;MAPK13;ADAMTS7;IL1RAP;SRC;PSMD7;HYAL1;MAPK3;ANXA1
800,GO:0002066,0.920866823687781,0.220614768919381,2,38,columnar/cuboidal epithelial cell development,BP,GSK3A;FGFR1
18135,GO:1902751,0.920985912989811,0.291264076715573,1,23,positive regulation of cell cycle G2/M phase transition,BP,CCND1
10744,GO:0044091,0.92153648774563,0.289848485264733,1,23,membrane biogenesis,BP,NLGN2
6448,GO:0021761,0.921856121506527,0.171987385117138,4,65,limbic system development,BP,PTPRS;BBS2;ANXA3;FGFR1
12123,GO:0048147,0.922247935554819,0.287519356196453,1,24,negative regulation of fibroblast proliferation,BP,PARP10
9303,GO:0035735,0.922287544844522,0.217381308729738,2,39,intraciliary transport involved in cilium assembly,BP,DYNLRB1;KIF17
7842,GO:0032391,0.922487840787984,0.287392688381146,1,23,photoreceptor connecting cilium,CC,KIF17
12732,GO:0050931,0.922972823075392,0.286135968693508,1,23,pigment cell differentiation,BP,AP3D1
11159,GO:0045191,0.92318129393734,0.285594761114362,1,23,regulation of isotype switching,BP,TGFB1
10749,GO:0044106,0.923409739621512,0.157631956007637,5,86,cellular amine metabolic process,BP,PSMD2;PSMD7;ALDH7A1;COMT;AZIN2
17896,GO:1902106,0.923523366119855,0.18570241672579,3,52,negative regulation of leukocyte differentiation,BP,ZFPM1;CEACAM1;ANXA1
13291,GO:0051959,0.923572079098182,0.284578617085033,1,23,dynein light intermediate chain binding,MF,CCDC88C
733,GO:0001959,0.923572092251846,0.13483047983667,9,128,regulation of cytokine-mediated signaling pathway,BP,RBCK1;SHARPIN;IRAK1;IRF7;TNFRSF1A;SLIT3;ARG1;CASP4;ECM1
16214,GO:0090224,0.923599908917294,0.214775183993143,2,38,regulation of spindle organization,BP,PKD1;CHMP5
13662,GO:0060147,0.924155976199025,0.148206959723484,6,106,regulation of posttranscriptional gene silencing,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;PUM1;TGFB1
14131,GO:0060966,0.924155976199025,0.148206959723484,6,106,regulation of gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;PUM1;TGFB1
12366,GO:0048713,0.924271754582199,0.282753923645635,1,23,regulation of oligodendrocyte differentiation,BP,SLC45A3
12832,GO:0051117,0.924312942554981,0.183940828900267,3,54,ATPase binding,MF,SYVN1;WFS1;TCIRG1
7300,GO:0031293,0.924334559586936,0.282589795814524,1,23,membrane protein intracellular domain proteolysis,BP,TGFB1
60,GO:0000123,0.92442914778261,0.156249975573973,5,79,histone acetyltransferase complex,CC,JADE2;BRPF3;MSL1;TAF6;EP300
16878,GO:0098781,0.924693713600409,0.147766041198293,6,94,ncRNA transcription,BP,POU2F2;INTS8;INTS1;TAF6;RPRD2;RPRD1A
11869,GO:0046835,0.924732162430906,0.281549445246606,1,23,carbohydrate phosphorylation,BP,HK1
12328,GO:0048663,0.924790322834418,0.281397076800874,1,23,neuron fate commitment,BP,SUFU
16108,GO:0090068,0.924842831955445,0.115916598803659,17,219,positive regulation of cell cycle process,BP,CCND1;LRP5;PRKACA;PPP2R5B;CCND2;ZNF385A;PCBP4;HMGA2;GIPC1;FGFR1;HYAL1;RAB11FIP4;TGFA;CNOT11;TGFB1;ANXA1;EP300
3312,GO:0007017,0.924880326998718,0.0974093221785037,54,605,microtubule-based process,BP,DVL1;NEURL1;AP3D1;KLC2;DLG1;COPG1;BBS2;TUBB6;MARK4;FYCO1;TUBG2;AP2A2;PRKCZ;VPS4A;DNAAF5;FBXW5;EML2;MAP1B;OBSL1;TACC1;CCDC88C;PAK1;TTBK2;NAV1;CUL7;TUBB3;PKD1;WDR66;MYH15;DYNLRB1;ARL2;CHMP5;NINL;MARK3;SDCCAG8;KIF17;KIF13B;BRSK1;TUBG1;SPIRE1;MYO1D;TAOK1;NDE1;CAMSAP3;GAS8;CIB1;WRAP73;CSNK1D;KIFC3;ARHGEF2;LLGL1;APBA1;MAP6;RAB6A
20131,GO:2000765,0.924892450254391,0.281129407041764,1,23,regulation of cytoplasmic translation,BP,ZNF385A
105,GO:0000217,0.92490645732095,0.281092683769496,1,23,DNA secondary structure binding,MF,XPC
3915,GO:0008574,0.924916581004771,0.281066140081949,1,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,KIF17
1489,GO:0003823,0.925028625938366,0.280281952111694,1,24,antigen binding,MF,TGFB1
3714,GO:0008234,0.925132162742834,0.126415714713574,11,150,cysteine-type peptidase activity,MF,CAPN2;CTSB;USP20;JOSD2;CTSZ;OTUB2;BLMH;CAPN5;CTSL;CASP4;USP32
17852,GO:1901987,0.925874626780477,0.103424777124809,31,379,regulation of cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;EGFR;CSNK1E;PRKACA;HECW2;AKT1;XPC;VPS4A;CCND2;ZNF385A;PCBP4;PKD1;HMGA2;NINL;SDCCAG8;PSMD7;BRSK1;GJC2;TUBG1;HYAL1;TAOK1;NDE1;CNOT11;KANK2;CSNK1D;TGFB1;ANXA1;EP300
14681,GO:0070268,0.925882010778304,0.164259929333341,4,71,cornification,BP,PRSS8;PCSK6;KRT23;FURIN
12558,GO:0050688,0.926120560240262,0.180536356428785,3,53,regulation of defense response to virus,BP,HTRA1;PUM1;SEC14L1
9266,GO:0035666,0.9262147682278,0.277161434922785,1,24,TRIF-dependent toll-like receptor signaling pathway,BP,IRF7
5834,GO:0017111,0.926286406365261,0.094916289216677,58,648,nucleoside-triphosphatase activity,MF,RAC2;ERCC6;KLC2;RAB3B;RAB43;SMARCA1;TNNT1;TUBB6;RAB31;SEPT10;TUBG2;ATP13A2;ATP7B;VPS4A;RRAS;SEPT5;ABCB8;GTPBP1;IDE;TUBB3;GNB1;RAB29;RHOC;HLTF;SEPT8;ATP11A;ARL8A;GNAI2;MYH16;MYH15;RHOBTB2;DYNLRB1;ARL2;DNM2;RAB1B;RAB25;KIF17;KIF13B;GNB2;TUBG1;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;CHD7;ABCA7;ENTPD6;RHOBTB1;ATP6V1C2;LONP2;RAB4B;KIFC3;AGAP1;PCYOX1;ANXA1;RAB6A;GNAS
10622,GO:0043601,0.92653443906853,0.276316966048614,1,24,nuclear replisome,CC,POLD4
6793,GO:0030225,0.926673765517859,0.276436560240817,1,23,macrophage differentiation,BP,L3MBTL3
14930,GO:0070741,0.927162301583485,0.275141455581259,1,23,response to interleukin-6,BP,CBL
15225,GO:0071354,0.927162301583485,0.275141455581259,1,23,cellular response to interleukin-6,BP,CBL
3364,GO:0007127,0.927184109811739,0.162171043522398,4,67,meiosis I,BP,AGO4;LEMD2;HSPA2;CCNE1
20061,GO:2000648,0.927268367395087,0.274859812265819,1,23,positive regulation of stem cell proliferation,BP,HMGA2
7601,GO:0031967,0.927300461907009,0.0901220184010323,84,972,organelle envelope,CC,RAC2;SORL1;CST3;CYP27B1;BOK;CPT2;XPOT;SLC16A3;MTA1;SLC2A9;PRNP;IDH2;BNIP3;AGPAT3;NME4;OCIAD2;SNPH;SYNE3;EGFR;CRAT;HK1;MRPS6;CDS2;MDH2;ARMCX2;FAM210B;PRKCZ;ITPR3;RETSAT;HADH;BNIP3L;TST;SCRN1;IPO13;ABCB8;CCND2;BIN1;HMGCL;SFXN3;PAK1;TNRC18;MLXIP;IFI27;NUCB2;OXA1L;UBXN4;MYOF;SDHA;ARL2;SRC;TAZ;DNM2;KLHDC2;NDUFA4L2;CPTP;ACADVL;CARD19;SLC25A43;THOP1;MOAP1;SHISA5;WDFY3;TTC19;SIGMAR1;BCL2L1;LEMD2;ULK1;P2RX4;TBC1D20;SH3BGRL2;SDHAF4;INTS1;ARG1;BPHL;VAT1;MAPK3;CPT1B;NDUFS2;TFPT;SLC30A1;CAT;ANXA1;RAP1GAP2;NIPSNAP1
7605,GO:0031975,0.927300461907009,0.0901220184010323,84,972,envelope,CC,RAC2;SORL1;CST3;CYP27B1;BOK;CPT2;XPOT;SLC16A3;MTA1;SLC2A9;PRNP;IDH2;BNIP3;AGPAT3;NME4;OCIAD2;SNPH;SYNE3;EGFR;CRAT;HK1;MRPS6;CDS2;MDH2;ARMCX2;FAM210B;PRKCZ;ITPR3;RETSAT;HADH;BNIP3L;TST;SCRN1;IPO13;ABCB8;CCND2;BIN1;HMGCL;SFXN3;PAK1;TNRC18;MLXIP;IFI27;NUCB2;OXA1L;UBXN4;MYOF;SDHA;ARL2;SRC;TAZ;DNM2;KLHDC2;NDUFA4L2;CPTP;ACADVL;CARD19;SLC25A43;THOP1;MOAP1;SHISA5;WDFY3;TTC19;SIGMAR1;BCL2L1;LEMD2;ULK1;P2RX4;TBC1D20;SH3BGRL2;SDHAF4;INTS1;ARG1;BPHL;VAT1;MAPK3;CPT1B;NDUFS2;TFPT;SLC30A1;CAT;ANXA1;RAP1GAP2;NIPSNAP1
12963,GO:0051303,0.927342887506056,0.161957259721336,4,66,establishment of chromosome localization,BP,VPS4A;CHMP5;LEMD2;NDE1
42,GO:0000086,0.927391091303466,0.112313370930194,17,225,G2/M transition of mitotic cell cycle,BP,FHL1;CCND1;PSMD2;CSNK1E;PRKACA;VPS4A;HMGA2;DNM2;NINL;SDCCAG8;PSMD7;FBXL15;BRSK1;TUBG1;TAOK1;NDE1;CSNK1D
10624,GO:0043603,0.927577577091831,0.0906419315876506,76,907,cellular amide metabolic process,BP,TNIP1;CHAC1;SORL1;MAP2K1;NEURL1;NAGS;PRNP;PC;SESN2;ABTB1;RNPEPL1;HAGH;AARS;EGFR;MKNK2;CARS;MAP2K2;ATF4;MRPS6;AKT1;ALDH1L2;APOE;ATP13A2;ARG2;CTSZ;ZNF598;GTPBP1;IDE;LARP6;BIN1;ERO1B;ZNF385A;BCDIN3D;ASS1;CNDP2;EIF4EBP1;SCG5;AGO4;GARS;GSK3A;PCSK6;SPTLC2;ASNS;TNFRSF1A;THOP1;PUM1;TNRC6B;EIF2S2;SECISBP2L;RRBP1;MIF4GD;PCSK1N;HLCS;SARS2;ST3GAL5;SAMD4B;SMPD3;PYM1;ABCA7;RXRA;ARG1;RPL28;CNOT11;IMPACT;GGT1;MAPK3;GLO1;FURIN;UGCG;B4GALT6;HM13;PAIP2;NAGA;IGF2BP3;EIF4G3;TGFB1
11023,GO:0044843,0.927678972463441,0.110742013300956,18,233,cell cycle G1/S phase transition,BP,FHL1;CCND1;NACC2;EGFR;AKT1;CDC34;CCND2;ZNF385A;PCBP4;PKD1;EIF4EBP1;GJC2;HYAL1;CNOT11;KANK2;CCNE1;ANXA1;EP300
8367,GO:0033238,0.927806780972974,0.176537788029281,3,60,regulation of cellular amine metabolic process,BP,PSMD2;PSMD7;COMT
11382,GO:0045727,0.927899717569514,0.136573879891899,7,106,positive regulation of translation,BP,LARP6;BCDIN3D;PYM1;RXRA;IMPACT;MAPK3;TGFB1
4255,GO:0009566,0.927933751597912,0.160725883784024,4,68,fertilization,BP,MST1R;BCL2L1;ZP3;SPESP1
4753,GO:0010922,0.928339368782505,0.272006568504999,1,23,positive regulation of phosphatase activity,BP,ITGA1
1431,GO:0003401,0.928448063185411,0.271716040379572,1,23,axis elongation,BP,TGFB1
8782,GO:0034453,0.928716959295772,0.270996548088409,1,23,microtubule anchoring,BP,CAMSAP3
8107,GO:0032786,0.928866562885079,0.270110769454509,1,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6
11361,GO:0045670,0.929605191315521,0.201512992125068,2,39,regulation of osteoclast differentiation,BP,TFE3;GNAS
4193,GO:0009295,0.92962004907835,0.201291713444057,2,40,nucleoid,CC,MPG;ACADVL
10132,GO:0042645,0.92962004907835,0.201291713444057,2,40,mitochondrial nucleoid,CC,MPG;ACADVL
3656,GO:0008139,0.930248322140858,0.266878136810392,1,23,nuclear localization sequence binding,MF,IPO13
7346,GO:0031365,0.93050380795645,0.265704989266623,1,24,N-terminal protein amino acid modification,BP,EP300
12071,GO:0048002,0.93059186073516,0.120701403730597,10,149,antigen processing and presentation of peptide antigen,BP,KLC2;PSMD2;ITGB5;AP1B1;AP2A2;SEC23A;DNM2;PSMD7;CTSL;SEC24C
2866,GO:0006359,0.930890656991001,0.264657985459503,1,24,regulation of transcription by RNA polymerase III,BP,PRDX5
11859,GO:0046822,0.930908630966456,0.13745000345661,6,92,regulation of nucleocytoplasmic transport,BP,RAPGEF3;BAG3;IFI27;PARP10;CAMK1;TGFB1
9907,GO:0042181,0.931200447840401,0.263376295917385,1,25,ketone biosynthetic process,BP,DGKQ
41,GO:0000083,0.931452645744712,0.263132825606248,1,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,CCNE1
16593,GO:0097366,0.931502598874557,0.26299702107993,1,24,response to bronchodilator,BP,DNM2
14820,GO:0070534,0.9323304732862,0.195290868549669,2,40,protein K63-linked ubiquitination,BP,PARP10;STUB1
12271,GO:0048536,0.932487309189948,0.260311930817279,1,24,spleen development,BP,PKN1
11388,GO:0045739,0.932509694042113,0.194891573510072,2,40,positive regulation of DNA repair,BP,EGFR;APBB1
12452,GO:0050000,0.932717762095321,0.151969713517852,4,67,chromosome localization,BP,VPS4A;CHMP5;LEMD2;NDE1
12297,GO:0048593,0.932801318996018,0.151887966240162,4,66,camera-type eye morphogenesis,BP,SDK2;LRP5;TBC1D20;EPHB2
260,GO:0000726,0.933463337789834,0.150125995989748,4,74,non-recombinational repair,BP,ERCC1;HSF1;HMGA2;POLM
5750,GO:0016894,0.934229516779809,0.254684198399691,1,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,NEIL1
1859,GO:0004519,0.934332863463726,0.125989189929595,7,108,endonuclease activity,MF,ERCC1;ENDOG;RAG1;DNASE1L1;NEIL1;RNASE7;LACTB2
17330,GO:0140104,0.934341125503266,0.254004857252738,1,27,molecular carrier activity,MF,CYGB
11491,GO:0045933,0.934561772339089,0.254168106679893,1,25,positive regulation of muscle contraction,BP,F2R
4690,GO:0010837,0.935332054658785,0.252467453883301,1,24,regulation of keratinocyte proliferation,BP,VDR
18378,GO:1903322,0.935333420171641,0.124368494445051,7,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;FKBP1A;MTA1;WFS1;GSK3A;STUB1;TRIB3
10640,GO:0043628,0.935350721596332,0.251209969404388,1,27,ncRNA 3'-end processing,BP,INTS1
594,GO:0001756,0.93539309936429,0.188606361639816,2,39,somitogenesis,BP,DKK1;EP300
3230,GO:0006885,0.935555396932513,0.146528145692837,4,69,regulation of pH,BP,DMXL2;TCIRG1;ATP6V1C2;MAPK3
16683,GO:0097542,0.935824450617899,0.187275807714911,2,41,ciliary tip,CC,SUFU;DYNLRB1
11317,GO:0045620,0.936926273599934,0.247580307096884,1,25,negative regulation of lymphocyte differentiation,BP,ANXA1
5611,GO:0016651,0.937962082524355,0.141235556524524,4,83,oxidoreductase activity, acting on NAD(P)H,MF,NOS1;CBR4;NDOR1;NDUFS2
6787,GO:0030218,0.938275810784092,0.131786230080931,5,81,erythrocyte differentiation,BP,FAM210B;GATA3;THRA;ZFPM1;L3MBTL3
2818,GO:0006283,0.938426120116115,0.14086649780762,4,73,transcription-coupled nucleotide-excision repair,BP,ERCC1;ERCC6;POLD4;EP300
283,GO:0000785,0.938535492733551,0.0849980438897859,36,457,chromatin,CC,H1F0;CAPN2;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;PHC2;HIST2H2BE;SALL2;H2AFJ;CCND2;ZNF385A;TNRC18;BAZ2A;SATB1;GATA3;HSF1;APPL2;SIN3B;HMGA2;HIST3H2A;RSF1;UBA1;MAU2;LEMD2;HLCS;RXRA;HIST2H2AC;BAHCC1;HIST1H2AG;TFPT;MBD3;WBP2;PPP1R10;ASH2L
7904,GO:0032467,0.9387206785471,0.242517534130303,1,25,positive regulation of cytokinesis,BP,GIPC1
4704,GO:0010862,0.939183613485985,0.241202301570955,1,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,TGFB1
2589,GO:0005882,0.939281614338422,0.13948856707795,4,69,intermediate filament,CC,SHANK2;LDLRAP1;MICAL1;KRT23
16010,GO:0086002,0.93929983844093,0.241299876168243,1,24,cardiac muscle cell action potential involved in contraction,BP,DLG1
4466,GO:0010458,0.939527496939037,0.239829009373916,1,26,exit from mitosis,BP,TGFB1
6692,GO:0030057,0.939553978960324,0.240575245302956,1,24,desmosome,CC,UBA1
16171,GO:0090169,0.939744263926494,0.23960437568416,1,25,regulation of spindle assembly,BP,CHMP5
14783,GO:0070461,0.939960030605652,0.238594816922747,1,26,SAGA-type complex,CC,TAF6
7103,GO:0030894,0.940022551700138,0.238416143129285,1,26,replisome,CC,POLD4
10893,GO:0044422,0.940778015160947,0.066706020931875,712,7174,organelle part,CC,TNIP1;NT5E;EDEM1;FLNC;SH3KBP1;PYGB;TSPAN1;ERCC1;NOS1;CHAC1;H1F0;CCND1;CAPN2;MST1R;RAC2;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;DNMT3A;PGM1;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;CD68;SBF1;PC;AGPAT3;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;LCN2;ESPN;MAPKAPK3;CTSB;ACOT7;ABTB1;TNNT1;TMEM214;SNPH;MARCH9;BBS2;HAGH;TUBB6;USP20;NACC2;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;H6PD;XYLT1;GPT2;XBP1;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CORO1B;RHBDF2;HK1;MAP2K2;FAM114A1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;PARVB;SHANK3;ATF4;P4HB;HECW2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;MDH2;ACOT13;ARMCX2;GPC4;IRAK1;ARPC1A;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;PKN1;TMEM92;AP1B1;SYVN1;ELK3;YIF1A;AFAP1L1;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;NAGLU;DGKQ;RFNG;VPS11;PPP2R3B;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;ZMIZ2;PTK6;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;NSMCE4A;FERMT1;GIT2;ACAD10;EML2;SEPT5;DEAF1;SALL2;SEC23A;B4GALNT4;MAP1B;LAMB2;PLD3;HADH;NDST2;MVB12B;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;SOX7;UBE2J1;BNIP3L;PPARA;DHTKD1;KDELR1;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;YIPF2;ZDHHC8;WDTC1;CDC34;CD44;SCRN1;IPO13;ESYT2;PLCG1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;DEDD2;JADE2;TWF2;SURF4;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;MALL;BIN1;FSCN1;HMGCL;SFXN3;SUFU;CCDC88C;PAK1;TTBK2;CERCAM;ERO1B;BCL9L;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;NAV1;DDIT3;PODXL;PTDSS2;CUL7;DMXL2;GGA3;GGA1;TUBB3;ADAMTS7;STOM;DUSP4;GNB1;PTPN9;SATB1;FUCA1;RET;RAB29;DNASE1L1;CORO7;MLXIP;RHOC;IFI27;CYTH3;REEP2;TMED3;PROCR;HLTF;CEMIP;SEPT8;SHANK2;PKD1;PARP10;DLG3;ATP11A;GATA3;WDR66;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;GNAI2;SLC2A3;ANTXR2;MYH16;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;ASPH;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;MYH15;HMGA2;ALAS1;ARID5B;DYNLRB1;TOP1;FAM110C;ARL2;PLCB3;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;VAMP2;FLNB;PIP5K1C;GIPC1;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;CBR4;CAPG;POLD4;TAZ;FKBP10;PEX10;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NDUFA4L2;TMEM9;TMEM44;STK24;CPTP;ACADVL;CARD19;RALY;PAK6;YPEL3;STX5;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;RSF1;STXBP1;SPECC1L;PCSK6;TALDO1;DUSP6;OAS1;FYN;PRIMPOL;ISG20;SPTLC2;CLSTN1;AGRN;ZNF692;YPEL5;REEP4;WNT5B;NELFCD;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;ANXA3;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;BRSK1;SSU72;STX10;CHST14;MOAP1;PUM1;RNF44;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;MCFD2;RCN1;HEXIM1;TIMP1;UBA1;MGLL;SLC35B4;RNF187;HSF4;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;HYAL1;PHF2;CEP170;TENM2;USF2;MFNG;MIF;MTMR4;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;DDB2;PRAF2;ANGEL1;TCIRG1;SNX25;PTPN12;LEMD2;ZFPM1;TPCN1;PMEPA1;ARFIP2;LRCH4;HLCS;SARS2;PRRC2A;ST3GAL5;RAD23A;ARFGEF2;UNC119B;AGPAT4;ULK1;LRP1;HSPA2;ZNF609;P2RX4;HPSE;E2F5;USO1;ULK2;SMPD3;TBC1D20;SPIRE1;PNP;EHD4;MAP1LC3B;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;COG1;SH3BGRL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;MYO1D;CHD7;SNTB2;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;HOMER2;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TAF6;VEGFB;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;BAIAP2L1;ATP6V1C2;CYB561;HIST1H2AG;WIPF1;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;SNAP29;LONP2;KLHDC10;RPRD1A;KRT23;HGS;DRG2;POLM;MYL9;GAS8;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;RAB4B;IQSEC1;WRAP73;MAPK3;CPT1B;POMT1;MAPK10;CSNK1D;KIFC3;DRAM2;DNAJB9;LITAF;ALDOC;FURIN;S100A16;ARHGEF2;RNF103;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;HM13;MED29;CEACAM1;PNPLA6;GALNT3;SKAP2;ENKD1;LPIN3;TFPT;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;CCNE1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;CAT;RMI2;SPRED2;AZIN2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;IKBIP;ZFYVE21;KLF12;CCDC113;PXN;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;FHOD1
8435,GO:0033522,0.94088546186065,0.23633441980978,1,25,histone H2A ubiquitination,BP,DDB2
17556,GO:1901028,0.940893747400641,0.175367072056105,2,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK;GSK3A
10188,GO:0042770,0.9411046371575,0.110633944174275,8,121,signal transduction in response to DNA damage,BP,SESN2;CD44;ZNF385A;PCBP4;MIF;CNOT11;SPRED2;EP300
12973,GO:0051321,0.941120127433153,0.102218897621775,11,153,meiotic cell cycle,BP,ERCC1;TUBG2;PRKACB;HSF1;AGO4;TUBG1;LEMD2;HSPA2;SPIRE1;CCNE1;ZNF318
10477,GO:0043330,0.941126240829666,0.235250419198335,1,26,response to exogenous dsRNA,BP,MAPK3
17824,GO:1901890,0.941231963505458,0.235336891664843,1,25,positive regulation of cell junction assembly,BP,PPM1F
1151,GO:0002756,0.941794507852255,0.233322849955959,1,26,MyD88-independent toll-like receptor signaling pathway,BP,IRF7
265,GO:0000732,0.94215961577367,0.23265544862943,1,25,strand displacement,BP,RMI2
4814,GO:0014003,0.942317742968366,0.231807866724024,1,26,oligodendrocyte development,BP,TGFB1
3654,GO:0008137,0.94249706144582,0.228259698403642,1,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFS2
12464,GO:0050136,0.94249706144582,0.228259698403642,1,38,NADH dehydrogenase (quinone) activity,MF,NDUFS2
10999,GO:0044786,0.942616945129178,0.146945257459169,3,57,cell cycle DNA replication,BP,POLD4;FGFR1;WDR18
4205,GO:0009312,0.942826634703584,0.230329521178766,1,26,oligosaccharide biosynthetic process,BP,GALNT3
9024,GO:0035195,0.943100846137326,0.107088679943934,8,134,gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TNRC6B;TGFB1
10407,GO:0043229,0.943141990393493,0.0652915420395859,938,9301,intracellular organelle,CC,TNIP1;NT5E;EDEM1;XDH;FLNC;FHL1;BTBD2;SH3KBP1;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;SH3TC2;CAPN2;F2R;MPRIP;MST1R;RAC2;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;SMTN;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;SSH1;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;ESPN;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TNNT1;TMEM214;LY6K;SNPH;MARCH9;PLEK2;ZC3H6;BBS2;FKBP9;HAGH;OSBPL10;TUBB6;USP20;NACC2;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;LRP5;AARS;ITGB5;H6PD;XYLT1;GPT2;XBP1;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;FYCO1;THBS2;RFX2;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;PARVB;MIER2;ANKRD13D;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;METTL23;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;TNS4;YIF1A;AFAP1L1;WWTR1;PHF21A;NPEPL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;UACA;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;PCSK9;ENDOG;NSMCE4A;FERMT1;GIT2;ACAD10;TYSND1;EML2;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;MAP1B;LAMB2;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;RIN1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;UBE2J1;ARRDC1;CORO2A;BNIP3L;PPARA;DHTKD1;KDELR1;AKAP12;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;MSRB2;DEDD2;JADE2;COA5;TWF2;SLC38A10;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;MALL;GIT1;BIN1;FSCN1;HMGCL;SFXN3;SUFU;CCDC88C;PAK1;SP6;TTBK2;CERCAM;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;NAV1;DDIT3;PODXL;GLUL;BCDIN3D;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;FARP1;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;PTOV1;CORO7;GAS2L1;MLXIP;RHOC;PLEKHH3;IFI27;CYTH3;REEP2;TMED3;PROCR;HLTF;YIPF3;CEMIP;SEPT8;SHANK2;PKD1;ASS1;PARP10;ATP11A;GATA3;NIPA1;WDR66;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;MYH16;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;ASPH;MT2A;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;MYH15;HMGA2;ALAS1;C19ORF33;ARID5B;RHOBTB2;DYNLRB1;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;IGFBP2;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;DENND2A;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;RBMS2;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;RSF1;GSK3A;STXBP1;SPECC1L;CAMTA2;SH3BP1;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ZNF692;RALGDS;ZNF862;YPEL5;REEP4;WNT5B;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;NTSR1;RCN1;HEXIM1;AMIGO2;TIMP1;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;PHF2;MIB2;CEP170;TENM2;F12;USF2;PBX3;MFNG;CDK18;MIF;MTMR4;HES2;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;AFAP1;ANGEL1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;WDR18;SLIT3;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;HIST1H2AG;WIPF1;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;SPESP1;KRT23;HGS;CARHSP1;DRG2;POLM;MYL9;GAS8;CBL;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;WRAP73;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;ZNF444;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ENKD1;ZNF256;ARHGAP44;LPIN3;AGAP1;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;NAGA;IGF2BP3;CCNE1;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;IKBIP;ZFYVE21;KLF12;CCDC113;PLGRKT;PXN;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
3698,GO:0008206,0.943343291087756,0.228823637419659,1,26,bile acid metabolic process,BP,NR1D1
11385,GO:0045736,0.943868717341436,0.227286995617984,1,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,HEXIM1
7717,GO:0032201,0.944236539129356,0.225852407765278,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
9955,GO:0042306,0.944360093499496,0.167428046368529,2,42,regulation of protein import into nucleus,BP,PARP10;TGFB1
2847,GO:0006333,0.944643324396306,0.101259355091133,9,156,chromatin assembly or disassembly,BP,H1F0;TSPYL2;HIST2H2BE;TNRC18;PARP10;HMGA2;HIST3H2A;RSF1;BAHCC1
13303,GO:0051972,0.944686587798615,0.166658822677506,2,42,regulation of telomerase activity,BP,SRC;MAPK3
1460,GO:0003697,0.944777363250191,0.113420275819123,6,96,single-stranded DNA binding,MF,ERCC1;XPC;HSF1;TOP1;RAD23A;ANXA1
4201,GO:0009308,0.944910235145755,0.119324414701535,5,91,amine metabolic process,BP,PSMD2;PSMD7;ALDH7A1;COMT;AZIN2
12691,GO:0050879,0.9451847531332,0.223060831213461,1,27,multicellular organismal movement,BP,TNNT1
12693,GO:0050881,0.9451847531332,0.223060831213461,1,27,musculoskeletal movement,BP,TNNT1
6545,GO:0021954,0.945338710191212,0.165118617992422,2,42,central nervous system neuron development,BP,ADARB1;EPHB2
3331,GO:0007043,0.945377904176786,0.118879151885923,5,81,cell-cell junction assembly,BP,DLG1;PRKACA;FSCN1;RHOC;ARL2
9081,GO:0035315,0.945805508288577,0.221576625428525,1,26,hair cell differentiation,BP,FGFR1
15806,GO:0072401,0.946370498507694,0.125656275517403,4,72,signal transduction involved in DNA integrity checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
15810,GO:0072422,0.946370498507694,0.125656275517403,4,72,signal transduction involved in DNA damage checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
3350,GO:0007080,0.946556588295122,0.162083030779492,2,43,mitotic metaphase plate congression,BP,VPS4A;CHMP5
8756,GO:0034399,0.946818338357541,0.101271319868294,8,119,nuclear periphery,CC,XPOT;DNMT3A;ATF4;PRKCZ;DGKQ;SATB1;DCAF7;HLCS
7304,GO:0031297,0.947213886491444,0.217377534570625,1,26,replication fork processing,BP,PRIMPOL
2585,GO:0005876,0.947303588400081,0.137203059937869,3,56,spindle microtubule,CC,TUBG2;TUBG1;CSNK1D
3680,GO:0008180,0.947361924189972,0.21658397206218,1,27,COP9 signalosome,CC,PLCG1
10405,GO:0043227,0.947588755109606,0.0602609327665983,930,9246,membrane-bounded organelle,CC,TNIP1;NT5E;EDEM1;XDH;FHL1;SH3KBP1;ITGB4;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;LTBP2;CCND1;SH3TC2;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;SHC1;PITPNC1;DOCK4;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;EPN3;SNX9;AP3D1;LMF1;SCN8A;NAPRT;BOK;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;MXRA5;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;NET1;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;BCORL1;FAM222B;PCDH1;MARVELD1;CYGB;FAM129B;LCN2;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TMEM214;LY6K;SNPH;MARCH9;ZC3H6;BBS2;FKBP9;HAGH;TUBB6;NACC2;HEBP1;BCR;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;VLDLR;ETV5;LRP5;AARS;FBLN1;ITGB5;H6PD;XYLT1;GPT2;XBP1;MARCKSL1;PGLS;EGFR;RTN2;CSNK1E;TTYH3;PANO1;MKNK2;TK2;MMP14;LAMB1;FYCO1;THBS2;RFX2;ARHGAP23;PRKACA;ADARB1;FCHO1;PTPRF;CRAT;CORO1B;TUB;RHBDF2;ACTA2;HK1;MAP2K2;FAM114A1;EPN1;OAF;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;SHANK3;MIER2;ANKRD13D;ATF4;P4HB;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;ARMCX2;GPC4;IRAK1;ARPC1A;PEG3;SERPING1;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;METTL23;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;UACA;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;PCSK9;ENDOG;NSMCE4A;ABHD8;GIT2;ACAD10;TYSND1;RRAS;SEPT5;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;LAMB2;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;UBE2J1;ARRDC1;BNIP3L;PPARA;DHTKD1;KDELR1;PRSS8;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;WASF2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;TBC1D16;RAP1GDS1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;MSRB2;DEDD2;JADE2;COA5;TWF2;SLC38A10;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;MALL;GIT1;BIN1;FSCN1;HMGCL;HTRA1;SFXN3;SUFU;PAK1;SP6;TSTA3;TTBK2;CERCAM;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;PODXL;GLUL;BCDIN3D;PTDSS2;CUL7;DMXL2;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;DUSP4;GNB1;SYTL1;PTPN9;SATB1;FUCA1;SDCCAG3;RET;RAB29;DNASE1L1;PTOV1;CORO7;MLXIP;RHOC;IFI27;NID1;CYTH3;REEP2;TMED3;PROCR;HLTF;YIPF3;CEMIP;SHANK2;PKD1;ASS1;PARP10;ATP11A;GATA3;NIPA1;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;CADM4;MYOF;GNAI2;PPM1M;SLC2A3;ZNF165;ANTXR2;GGACT;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;PPCS;SIN3B;ANKS1A;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;ASPH;MT2A;SDHA;CNFN;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;HMGA2;SLC13A3;ALAS1;C19ORF33;ARID5B;RHOBTB2;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;IGFBP2;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;AKR7A2;VAMP2;FLNB;PIP5K1C;TSC22D4;GIPC1;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;CAPG;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;SARAF;REEP6;UBR4;AGO4;FAM162A;CAPN5;IRF7;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;CDC42BPB;NDUFA4L2;NCS1;MARK3;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;TOM1L2;RBMS2;ESRP1;C6ORF120;GPX3;GARS;COG8;RERE;RSF1;GSK3A;STXBP1;CAMTA2;SH3BP1;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;RAB25;PRIMPOL;MPI;ISG20;SPTLC2;CLSTN1;SUGCT;FUZ;AGRN;ZNF692;RALGDS;TMPRSS11D;ZNF862;YPEL5;REEP4;WNT5B;GALE;GRINA;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;SLC25A43;TNFRSF1A;ALDH7A1;THOP1;NRSN2;ANXA3;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;PLEKHG5;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;ITGA1;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;THRA;MCFD2;NTSR1;RCN1;HEXIM1;AMIGO2;TIMP1;CRIM1;SLC46A3;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF32;RNF187;ZNF71;HSF4;LOXL1;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;F12;USF2;PBX3;MFNG;CDK18;MIF;MTMR4;HES2;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;PRAF2;ANGEL1;TCIRG1;SNX25;PTPN12;SLC27A1;CPNE8;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ULK2;SMPD3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;VASP;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;SNTB2;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;EPS8L1;WDR18;SLIT3;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;NEURL1B;VSIG10L;TGFA;RPL28;INVS;NCCRP1;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;NDRG3;HIST1H2AG;WIPF1;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;ACY1;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;SPESP1;HGS;CARHSP1;DRG2;POLM;GAS8;CBL;TRAPPC1;GGT1;FAM193B;CIB1;LACTB2;SOCS7;USP32;RAB4B;IQSEC1;PACS2;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;SLC5A1;ARHGEF2;RNF103;ZNF444;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;HM13;EHBP1L1;MED29;CEACAM1;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ZNF256;ARHGAP44;LPIN3;AGAP1;TFPT;UROS;ECM1;CD59;MBD3;MAP6;SLC30A1;NAGA;IGF2BP3;CCNE1;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;MANF;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;IKBIP;ZFYVE21;KLF12;CCDC113;ITGA3;PLGRKT;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;WDFY2;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
18834,GO:1904357,0.947993348651666,0.215036212696396,1,26,negative regulation of telomere maintenance via telomere lengthening,BP,SRC
13174,GO:0051726,0.948353741574735,0.0646690776898749,90,1003,regulation of cell cycle,BP,FHL1;CCND1;MAP2K1;DLG1;PSMD2;RPS6KA2;PRNP;CCNI;NACC2;BCR;CCNG2;LRP5;MAP4K4;EGFR;CSNK1E;PRKACA;ADARB1;MAP2K2;STK25;HECW2;AKT1;XPC;TSPYL2;PPP2R3B;VPS4A;PTK6;FBXW5;STK39;PPP2R5B;OBSL1;PRKACB;SIPA1;CCND2;GIT1;BIN1;PAK1;ZNF385A;DDIT3;CUL7;SDCCAG3;GAS2L1;PCBP4;PKD1;GATA3;HSF1;ALOX15B;CTBP1;HMGA2;EIF4EBP1;GIPC1;SRC;CHMP5;NINL;STK24;PAK6;TOM1L2;SDCCAG8;ASNS;PSMD7;BRSK1;CGREF1;GJC2;PUM1;HEXIM1;FGFR1;TUBG1;HYAL1;MIF;RAB11FIP4;BCL2L1;RAD23A;PAK4;E2F5;TAOK1;APBB1;TAF6;TGFA;NDE1;CNOT11;KANK2;CSNK1D;MLF1;MINK1;CCNE1;TGFB1;RMI2;CAMK2N1;ANXA1;PPP1R10;EP300
8318,GO:0033144,0.948436235781593,0.21370027984681,1,26,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,KANK2
8843,GO:0034622,0.948497633169284,0.065761065857039,74,885,cellular protein-containing complex assembly,BP,H1F0;RAC2;SNX9;DLG1;FKBP1A;SOX12;TMOD2;SEPT10;FCHO1;CORO1B;TUBG2;XPC;ARPC1A;TMSB4X;TSPYL2;DGKQ;VPS11;HIST2H2BE;DNAAF5;EML2;SEPT5;SEC23A;OBSL1;RAP1GDS1;MSRB2;COA5;TWF2;BIN1;PAK1;BAZ2A;DMXL2;CORO7;SEPT8;OXA1L;HSF1;ARL2;SRC;CAPG;TAZ;DNM2;AGO4;CPTP;EXOC2;RSF1;STXBP1;PFN1;THRA;SEC24C;TUBG1;PSMG4;TTC19;STUB1;DDB2;TCIRG1;PMEPA1;ARFIP2;TBC1D20;SPIRE1;SDHAF4;VASP;EPS8L1;WDR18;TAF6;NDE1;CAMSAP3;BAIAP2L1;WIPF1;SNAP29;TMSB10;KANK2;CSNK1D;NDUFS2;TGFB1;PXN
17793,GO:1901796,0.948915851117569,0.0900073955074662,11,161,regulation of signal transduction by p53 class mediator,BP,PPP1R13L;AKT1;CD44;ZNF385A;HEXIM1;MIF;TAF6;MBD3;RMI2;SPRED2;EP300
7913,GO:0032480,0.949011280052736,0.156068966564652,2,44,negative regulation of type I interferon production,BP,PTPRS;RNF135
6509,GO:0021879,0.949044869680975,0.211511209904572,1,27,forebrain neuron differentiation,BP,SHANK3
15218,GO:0071347,0.949116321563004,0.0972316414928248,8,129,cellular response to interleukin-1,BP,PSMD2;IRAK1;MAPK13;ADAMTS7;IL1RAP;PSMD7;HYAL1;MAPK3
5486,GO:0016417,0.949224645589746,0.210965823217015,1,27,S-acyltransferase activity,MF,ZDHHC8
6686,GO:0030048,0.949656364606071,0.119315488585208,4,70,actin filament-based movement,BP,DLG1;TNNT1;WASF2;WIPF1
2086,GO:0004843,0.949697240365721,0.119234641558172,4,70,thiol-dependent ubiquitin-specific protease activity,MF,USP20;JOSD2;OTUB2;USP32
16287,GO:0090329,0.94977947336917,0.15434944955137,2,43,regulation of DNA-dependent DNA replication,BP,FGFR1;WDR18
10075,GO:0042558,0.949824875402456,0.208820594366769,1,28,pteridine-containing compound metabolic process,BP,ALDH1L2
2869,GO:0006362,0.950009280539379,0.207962238457004,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
13065,GO:0051536,0.950045698787381,0.130964868977457,3,61,iron-sulfur cluster binding,MF,XDH;AOX1;NDUFS2
13069,GO:0051540,0.950045698787381,0.130964868977457,3,61,metal cluster binding,MF,XDH;AOX1;NDUFS2
3052,GO:0006612,0.950311628653465,0.0919805716303542,9,164,protein targeting to membrane,BP,PRNP;GDI1;SEC63;PAK1;STOM;CEMIP;FYN;RPL28;CIB1
5514,GO:0016462,0.950431861911872,0.0649897924474118,60,686,pyrophosphatase activity,MF,RAC2;ERCC6;KLC2;RAB3B;RAB43;SMARCA1;TNNT1;TUBB6;RAB31;SEPT10;TUBG2;ATP13A2;ATP7B;VPS4A;RRAS;SEPT5;ABCB8;GTPBP1;IDE;TUBB3;GNB1;RAB29;RHOC;HLTF;SEPT8;ATP11A;ARL8A;GNAI2;MYH16;MYH15;RHOBTB2;DYNLRB1;ARL2;DNM2;RAB1B;GARS;RAB25;KIF17;KIF13B;GNB2;LHPP;TUBG1;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;CHD7;ABCA7;ENTPD6;RHOBTB1;ATP6V1C2;LONP2;RAB4B;KIFC3;AGAP1;PCYOX1;ANXA1;RAB6A;GNAS
15804,GO:0072395,0.950442937416777,0.117594176134659,4,73,signal transduction involved in cell cycle checkpoint,BP,ZNF385A;PCBP4;CNOT11;EP300
14050,GO:0060759,0.950528679190155,0.0920317180225477,9,136,regulation of response to cytokine stimulus,BP,RBCK1;SHARPIN;IRAK1;IRF7;TNFRSF1A;SLIT3;ARG1;CASP4;ECM1
1474,GO:0003727,0.950535625826528,0.11751746552898,4,71,single-stranded RNA binding,MF,AGO4;THRA;LACTB2;ANXA1
1008,GO:0002479,0.950676578170247,0.129284675327791,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMD2;ITGB5;PSMD7
1126,GO:0002712,0.950753516460287,0.206299718328251,1,27,regulation of B cell mediated immunity,BP,TGFB1
1222,GO:0002889,0.950753516460287,0.206299718328251,1,27,regulation of immunoglobulin mediated immune response,BP,TGFB1
8070,GO:0032732,0.950832697913454,0.205739345284098,1,28,positive regulation of interleukin-1 production,BP,HK1
16660,GO:0097502,0.951151421085736,0.204760300035775,1,28,mannosylation,BP,POMT1
7359,GO:0031396,0.951394356002661,0.0861003433648583,11,162,regulation of protein ubiquitination,BP,FKBP1A;MTA1;AKT1;FBXO2;LIMK1;PARP10;WFS1;GSK3A;FYN;STUB1;TRIB3
18060,GO:1902555,0.951666057888068,0.20288161933447,1,29,endoribonuclease complex,CC,AGO4
19254,GO:1905348,0.951666057888068,0.20288161933447,1,29,endonuclease complex,CC,AGO4
38,GO:0000077,0.951766474033922,0.0876062787632978,10,147,DNA damage checkpoint,BP,CCND1;XPC;ZNF385A;PCBP4;HMGA2;BRSK1;TAOK1;CNOT11;PPP1R10;EP300
6928,GO:0030515,0.951964186736066,0.201688610863852,1,30,snoRNA binding,MF,ISG20
11334,GO:0045639,0.952059163704427,0.126853424092583,3,58,positive regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;GNAS
5699,GO:0016817,0.952256020104252,0.0627218637582911,60,688,hydrolase activity, acting on acid anhydrides,MF,RAC2;ERCC6;KLC2;RAB3B;RAB43;SMARCA1;TNNT1;TUBB6;RAB31;SEPT10;TUBG2;ATP13A2;ATP7B;VPS4A;RRAS;SEPT5;ABCB8;GTPBP1;IDE;TUBB3;GNB1;RAB29;RHOC;HLTF;SEPT8;ATP11A;ARL8A;GNAI2;MYH16;MYH15;RHOBTB2;DYNLRB1;ARL2;DNM2;RAB1B;GARS;RAB25;KIF17;KIF13B;GNB2;LHPP;TUBG1;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;CHD7;ABCA7;ENTPD6;RHOBTB1;ATP6V1C2;LONP2;RAB4B;KIFC3;AGAP1;PCYOX1;ANXA1;RAB6A;GNAS
5700,GO:0016818,0.952256020104252,0.0627218637582911,60,688,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RAC2;ERCC6;KLC2;RAB3B;RAB43;SMARCA1;TNNT1;TUBB6;RAB31;SEPT10;TUBG2;ATP13A2;ATP7B;VPS4A;RRAS;SEPT5;ABCB8;GTPBP1;IDE;TUBB3;GNB1;RAB29;RHOC;HLTF;SEPT8;ATP11A;ARL8A;GNAI2;MYH16;MYH15;RHOBTB2;DYNLRB1;ARL2;DNM2;RAB1B;GARS;RAB25;KIF17;KIF13B;GNB2;LHPP;TUBG1;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;CHD7;ABCA7;ENTPD6;RHOBTB1;ATP6V1C2;LONP2;RAB4B;KIFC3;AGAP1;PCYOX1;ANXA1;RAB6A;GNAS
6933,GO:0030521,0.952353243720771,0.126216461383207,3,58,androgen receptor signaling pathway,BP,PMEPA1;CCNE1;EP300
10231,GO:0042887,0.952370807297411,0.200702097099561,1,29,amide transmembrane transporter activity,MF,SLC15A1
13031,GO:0051445,0.952429019048484,0.201127243676709,1,27,regulation of meiotic cell cycle,BP,PRKACB
286,GO:0000790,0.952517054136984,0.0725845137696887,22,304,nuclear chromatin,CC,H1F0;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;SALL2;H2AFJ;ZNF385A;SATB1;GATA3;APPL2;SIN3B;HIST3H2A;RSF1;RXRA;HIST2H2AC;HIST1H2AG;TFPT;MBD3;WBP2;ASH2L
10910,GO:0044446,0.952573680299067,0.0537048331301926,700,7078,intracellular organelle part,CC,TNIP1;NT5E;EDEM1;SH3KBP1;PYGB;TSPAN1;ERCC1;NOS1;CHAC1;H1F0;CCND1;CAPN2;MST1R;RAC2;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PITPNC1;DOCK4;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CLIP2;CYP27B1;LPCAT4;EPN3;SNX9;AP3D1;LMF1;NAPRT;BOK;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;BSG;NR1D1;KLC2;DLG1;TRIM65;DYSF;XPOT;IGFBP4;SLC16A3;PITPNM1;DNMT3A;PGM1;FKBP1A;SOX12;POSTN;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;CD68;SBF1;PC;AGPAT3;TXNDC11;RAB43;DBNDD1;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;OCIAD2;COPG1;TMOD2;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;LCN2;ESPN;MAPKAPK3;CTSB;ACOT7;ABTB1;TNNT1;TMEM214;SNPH;MARCH9;BBS2;HAGH;TUBB6;USP20;NACC2;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;NUDCD3;VLDLR;ETV5;MARK4;H6PD;XYLT1;GPT2;XBP1;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;SEPT10;PRKACA;ADARB1;FCHO1;CRAT;CORO1B;RHBDF2;HK1;MAP2K2;FAM114A1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;ATF4;P4HB;HECW2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;MDH2;ACOT13;ARMCX2;GPC4;IRAK1;ARPC1A;SERPING1;ALDH1L2;EPN2;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;PKN1;TMEM92;AP1B1;SYVN1;ELK3;YIF1A;AFAP1L1;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;NAGLU;DGKQ;RFNG;VPS11;PPP2R3B;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;ZMIZ2;PTK6;TMEM129;RETSAT;PTPDC1;SH3PXD2B;PCSK9;NSMCE4A;FERMT1;GIT2;ACAD10;EML2;SEPT5;DEAF1;SALL2;SEC23A;B4GALNT4;MAP1B;LAMB2;PLD3;HADH;NDST2;MVB12B;SERPINB6;LIMK1;STK39;DKK1;CREB3L2;SOX7;UBE2J1;BNIP3L;PPARA;DHTKD1;KDELR1;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;YIPF2;ZDHHC8;WDTC1;CDC34;CD44;SCRN1;IPO13;ESYT2;PLCG1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;DEDD2;JADE2;TWF2;SURF4;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;MALL;BIN1;FSCN1;HMGCL;SFXN3;CCDC88C;PAK1;TTBK2;CERCAM;ERO1B;BCL9L;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;NAV1;DDIT3;PODXL;PTDSS2;CUL7;DMXL2;GGA3;GGA1;TUBB3;ADAMTS7;STOM;DUSP4;GNB1;PTPN9;SATB1;FUCA1;RET;RAB29;DNASE1L1;CORO7;MLXIP;IFI27;CYTH3;REEP2;TMED3;PROCR;HLTF;CEMIP;SEPT8;SHANK2;PKD1;PARP10;ATP11A;GATA3;WDR66;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;GNAI2;SLC2A3;ANTXR2;MYH16;RPUSD3;GLUD1;HSF1;APPL2;ADGRB2;SIN3B;ANKS1A;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;ASPH;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;MYH15;HMGA2;ALAS1;ARID5B;DYNLRB1;TOP1;FAM110C;ARL2;PLCB3;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;GPRC5C;VAMP2;FLNB;PIP5K1C;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;CBR4;CAPG;POLD4;TAZ;FKBP10;PEX10;DNM2;KLHDC2;NINL;SARAF;REEP6;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NDUFA4L2;TMEM9;TMEM44;STK24;CPTP;ACADVL;CARD19;RALY;PAK6;YPEL3;STX5;ESRP1;C6ORF120;SDCCAG8;GARS;COG8;RERE;RSF1;STXBP1;SPECC1L;PCSK6;TALDO1;DUSP6;OAS1;FYN;PRIMPOL;ISG20;SPTLC2;CLSTN1;AGRN;ZNF692;YPEL5;REEP4;WNT5B;NELFCD;ALDH4A1;PSMD7;MICAL1;SLC25A43;KIF17;TNFRSF1A;ALDH7A1;THOP1;ANXA3;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;KIF13B;BRSK1;SSU72;STX10;CHST14;MOAP1;PUM1;RNF44;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;MCFD2;RCN1;HEXIM1;TIMP1;UBA1;MGLL;SLC35B4;RNF187;HSF4;LGALS3BP;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;HYAL1;PHF2;CEP170;TENM2;USF2;MFNG;MIF;MTMR4;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;DDB2;PRAF2;ANGEL1;TCIRG1;SNX25;PTPN12;LEMD2;ZFPM1;TPCN1;PMEPA1;ARFIP2;LRCH4;HLCS;SARS2;PRRC2A;ST3GAL5;RAD23A;ARFGEF2;AGPAT4;ULK1;LRP1;HSPA2;ZNF609;P2RX4;HPSE;E2F5;USO1;ULK2;SMPD3;TBC1D20;SPIRE1;PNP;EHD4;MAP1LC3B;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;COG1;SH3BGRL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;MYO1D;CHD7;SNTB2;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TAF6;VEGFB;VSIG10L;TGFA;NDE1;CAMSAP3;RPL28;INVS;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;BAIAP2L1;ATP6V1C2;CYB561;HIST1H2AG;WIPF1;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;SNAP29;LONP2;KLHDC10;RPRD1A;KRT23;HGS;DRG2;POLM;MYL9;GAS8;TRAPPC1;FAM193B;CIB1;TMSB10;LACTB2;RAB4B;IQSEC1;WRAP73;MAPK3;CPT1B;POMT1;MAPK10;CSNK1D;KIFC3;DRAM2;DNAJB9;LITAF;ALDOC;FURIN;S100A16;ARHGEF2;RNF103;C12ORF66;MYZAP;SNX27;UGCG;TMBIM1;LLGL1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;HM13;MED29;CEACAM1;PNPLA6;GALNT3;SKAP2;ENKD1;LPIN3;TFPT;ECM1;CD59;MBD3;MAP6;SAC3D1;SLC30A1;CCNE1;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;SH3PXD2A;CAT;RMI2;SPRED2;AZIN2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;IKBIP;ZFYVE21;KLF12;CCDC113;PXN;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;FHOD1
9956,GO:0042307,0.952886576950115,0.199703728479793,1,27,positive regulation of protein import into nucleus,BP,TGFB1
3225,GO:0006879,0.952940585924512,0.146256727699314,2,46,cellular iron ion homeostasis,BP,LCN2;ATP13A2
6658,GO:0030004,0.953192820922426,0.112111366901265,4,73,cellular monovalent inorganic cation homeostasis,BP,DMXL2;TCIRG1;ATP6V1C2;MAPK3
3117,GO:0006695,0.953405484131997,0.123854583347416,3,59,cholesterol biosynthetic process,BP,APOE;PMVK;SEC14L2
1558,GO:0003954,0.953503087303165,0.194972253220646,1,40,NADH dehydrogenase activity,MF,NDUFS2
5399,GO:0016233,0.954083911979401,0.14291756152717,2,51,telomere capping,BP,ERCC1;MAPK3
13084,GO:0051568,0.954924644058768,0.141467013624283,2,45,histone H3-K4 methylation,BP,GATA3;ASH2L
17853,GO:1901988,0.955072751109573,0.0746217152008003,15,215,negative regulation of cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;VPS4A;ZNF385A;PCBP4;HMGA2;PSMD7;BRSK1;GJC2;TAOK1;CNOT11;KANK2;EP300
17369,GO:1900034,0.955248369069602,0.10802057727533,4,72,regulation of cellular response to heat,BP,BAG3;HSF1;MAPK3;EP300
4509,GO:0010557,0.955558824232879,0.0547487681695965,115,1252,positive regulation of macromolecule biosynthetic process,BP,TNIP1;NOS1;F2R;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;TEF;SOX12;ITGA6;CITED4;SMARCA1;FAM129B;SESN2;ETV5;LRP5;XBP1;EGFR;RFX2;MAP2K2;ATF4;AKT1;CARD11;IRAK1;PEG3;METTL23;ELK3;WWTR1;POU2F2;TFEB;FZD8;ZMIZ2;DEAF1;SALL2;CREB3L2;SOX7;PPP2R5B;PPARA;ZNF516;MC1R;LARP6;TFE3;BCL9L;DDIT3;BCDIN3D;RET;MLXIP;HLTF;PKD1;GATA3;APLN;PHF1;HSF1;RAI1;HMGA2;MICAL2;MYDGF;SRC;DNM2;IRF7;RFXANK;RERE;RSF1;CAMTA2;AGRN;TNFRSF1A;VDR;GAL;EHF;THRA;RNF187;HSF4;FGFR1;RREB1;PHF2;USF2;PBX3;ZFPM1;ZNF609;E2F5;ZP3;FGF2;PYM1;ABHD14B;ZNF398;CHD7;RNF222;APBB1;RXRA;SEC14L2;IMPACT;CAMK1;MAPK3;POMT1;DBP;LITAF;ARHGEF2;LPIN3;CCNE1;TGFB1;WBP2;PIK3R2;ASH2L;ZNF318;ARHGEF10L;EP300;FHOD1;RNF10
2873,GO:0006367,0.956094539759004,0.0805313446549037,10,152,transcription initiation from RNA polymerase II promoter,BP,CCND1;CTNNBIP1;NR1D1;WWTR1;PPARA;VDR;THRA;MED15;RXRA;TAF6
10606,GO:0043565,0.956478533723722,0.0567130548531867,67,752,sequence-specific DNA binding,MF,ZMYND8;H1F0;NFATC4;ETV4;MEF2D;NR1D1;TEF;SOX12;MTA1;ZC3H6;NACC2;ETV5;XBP1;RFX2;ATF4;ELK3;PHF21A;TSPYL2;POU2F2;TFEB;DEAF1;SALL2;CREB3L2;SOX7;PPARA;ZNF516;TFE3;TNRC18;RAG1;BAZ2A;DDIT3;SATB1;MLXIP;HLTF;GATA3;PHF1;TCFL5;HSF1;HMGA2;ARID5B;TOP1;IRF7;PER3;RERE;CAMTA2;ZNF692;VDR;EHF;THRA;HSF4;RREB1;ZBED4;USF2;PBX3;HES2;ZFPM1;CHD7;RXRA;ZHX3;BAHCC1;ZBTB4;DBP;LITAF;MBD3;WBP2;EP300;TCF7L1
12301,GO:0048599,0.956771504155039,0.187114495203576,1,28,oocyte development,BP,ZP3
18097,GO:1902653,0.957037504191122,0.115804046819433,3,60,secondary alcohol biosynthetic process,BP,APOE;PMVK;SEC14L2
11333,GO:0045638,0.957271829981,0.114857464957183,3,67,negative regulation of myeloid cell differentiation,BP,ZFPM1;CIB1;CEACAM1
18376,GO:1903320,0.95730118853029,0.0736527688032653,13,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;FKBP1A;MTA1;AKT1;FBXO2;LIMK1;PARP10;WFS1;GSK3A;FYN;STUB1;TRIB3;RNF222
10099,GO:0042590,0.957395049168085,0.114531144865238,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMD2;ITGB5;PSMD7
14133,GO:0060968,0.957794637201769,0.0855542568905756,7,127,regulation of gene silencing,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;PUM1;PHF2;TGFB1
13037,GO:0051453,0.95792022686274,0.113776132734231,3,61,regulation of intracellular pH,BP,DMXL2;TCIRG1;ATP6V1C2
5477,GO:0016407,0.958000598521636,0.0948448426706186,5,88,acetyltransferase activity,MF,LPCAT4;NAGS;LPCAT1;CRAT;EP300
14805,GO:0070498,0.958039809370882,0.0945797560916001,5,94,interleukin-1-mediated signaling pathway,BP,PSMD2;IRAK1;IL1RAP;PSMD7;MAPK3
7274,GO:0031248,0.958241049862845,0.0943810390484306,5,88,protein acetyltransferase complex,CC,JADE2;BRPF3;MSL1;TAF6;EP300
18035,GO:1902493,0.958241049862845,0.0943810390484306,5,88,acetyltransferase complex,CC,JADE2;BRPF3;MSL1;TAF6;EP300
2547,GO:0005814,0.958465188927564,0.0846804268890988,7,111,centriole,CC,CCDC92;TTBK2;CAPG;SDCCAG8;TUBG1;CEP170;WRAP73
10914,GO:0044450,0.958539771274642,0.0766018637390127,10,147,microtubule organizing center part,CC,TUBG2;CCDC92;TTBK2;CAPG;SDCCAG8;TUBG1;CEP170;WRAP73;CCDC113;MZT2B
10193,GO:0042775,0.958616735854543,0.111329223498614,3,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHA;TAZ;NDUFS2
9023,GO:0035194,0.958773632272152,0.0806843188107208,8,140,posttranscriptional gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TNRC6B;TGFB1
656,GO:0001844,0.958868800327205,0.17979607624126,1,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,MOAP1
8603,GO:0034101,0.958909051256844,0.0930900285056338,5,88,erythrocyte homeostasis,BP,FAM210B;GATA3;THRA;ZFPM1;L3MBTL3
11414,GO:0045786,0.958913678389039,0.0566742727465486,44,535,negative regulation of cell cycle,BP,FHL1;CCND1;MAP2K1;DLG1;PSMD2;RPS6KA2;PRNP;NACC2;EGFR;PRKACA;XPC;TSPYL2;PPP2R3B;VPS4A;PPP2R5B;PRKACB;SIPA1;BIN1;ZNF385A;DDIT3;GAS2L1;PCBP4;PKD1;GATA3;ALOX15B;HMGA2;TOM1L2;PSMD7;BRSK1;CGREF1;GJC2;HEXIM1;MIF;BCL2L1;TAOK1;APBB1;TAF6;CNOT11;KANK2;MLF1;TGFB1;CAMK2N1;PPP1R10;EP300
6814,GO:0030261,0.959286705323384,0.178967384930759,1,28,chromosome condensation,BP,HMGA2
10304,GO:0043044,0.959675074641949,0.109400436939528,3,69,ATP-dependent chromatin remodeling,BP,SMARCA1;RSF1;MBD3
2500,GO:0005747,0.959819796349668,0.17458681478514,1,42,mitochondrial respiratory chain complex I,CC,NDUFS2
7140,GO:0030964,0.959819796349668,0.17458681478514,1,42,NADH dehydrogenase complex,CC,NDUFS2
11194,GO:0045271,0.959819796349668,0.17458681478514,1,42,respiratory chain complex I,CC,NDUFS2
11113,GO:0045111,0.959898587458194,0.0859967624811081,6,101,intermediate filament cytoskeleton,CC,MMP14;SHANK2;LDLRAP1;MICAL1;NDOR1;KRT23
18928,GO:1904589,0.960102479576631,0.128269917237427,2,46,regulation of protein import,BP,PARP10;TGFB1
6303,GO:0019915,0.960409048586416,0.127482312914356,2,46,lipid storage,BP,APOE;PPARA
87,GO:0000175,0.960688370343356,0.173827009309228,1,30,3'-5'-exoribonuclease activity,MF,ISG20
12296,GO:0048592,0.960700155474657,0.0896766968115558,5,86,eye morphogenesis,BP,SDK2;LRP5;NAGLU;TBC1D20;EPHB2
20262,GO:2001169,0.960709706263395,0.107585114849731,3,60,regulation of ATP biosynthetic process,BP,TMSB4X;PPARA;TAZ
11022,GO:0044839,0.960905233857082,0.0640052461345182,17,239,cell cycle G2/M phase transition,BP,FHL1;CCND1;PSMD2;CSNK1E;PRKACA;VPS4A;HMGA2;DNM2;NINL;SDCCAG8;PSMD7;FBXL15;BRSK1;TUBG1;TAOK1;NDE1;CSNK1D
5565,GO:0016574,0.961086816023599,0.12584514750218,2,45,histone ubiquitination,BP,RAG1;DDB2
5502,GO:0016441,0.961326089655516,0.076258228940469,8,141,posttranscriptional gene silencing,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TNRC6B;TGFB1
4375,GO:0009994,0.961416562369795,0.171665721941626,1,29,oocyte differentiation,BP,ZP3
10578,GO:0043531,0.961723553366487,0.170642850624332,1,29,ADP binding,MF,GLUD1
10191,GO:0042773,0.961958568039358,0.103797940099226,3,80,ATP synthesis coupled electron transport,BP,SDHA;TAZ;NDUFS2
7600,GO:0031966,0.962123379465311,0.0524391899886069,44,578,mitochondrial membrane,CC,CYP27B1;BOK;CPT2;IDH2;BNIP3;NME4;OCIAD2;SNPH;CRAT;HK1;MRPS6;CDS2;MDH2;ARMCX2;FAM210B;HADH;BNIP3L;TST;ABCB8;HMGCL;SFXN3;MLXIP;IFI27;OXA1L;SDHA;SRC;TAZ;DNM2;NDUFA4L2;ACADVL;CARD19;SLC25A43;MOAP1;TTC19;BCL2L1;ULK1;SDHAF4;ARG1;BPHL;VAT1;CPT1B;NDUFS2;ANXA1;NIPSNAP1
6262,GO:0019843,0.962138172081967,0.122149824260422,2,56,rRNA binding,MF,MRPS6;TST
13782,GO:0060338,0.962466362931469,0.168156793768055,1,29,regulation of type I interferon-mediated signaling pathway,BP,IRF7
17661,GO:1901361,0.96259085145641,0.0518412002787571,44,569,organic cyclic compound catabolic process,BP,NT5E;XDH;H1F0;CYP27B1;PGM1;PSMD2;RAPGEF3;HK1;AKT1;ALDH1L2;APOE;PFKP;ENDOG;PPARA;DHTKD1;GTPBP1;DEDD2;AHCY;DNASE1L1;PCBP4;HSF1;NEIL1;AGO4;GSK3A;ISG20;ALDH4A1;PSMD7;HSD11B1;PUM1;COMT;TNRC6B;AOX1;SAMD4B;PNP;RNH1;PYM1;ENTPD6;RPL28;CNOT11;CARHSP1;ALDOC;IGF2BP3;LDHA;APOBEC3C
3595,GO:0008023,0.962690372673772,0.121572136496992,2,46,transcription elongation factor complex,CC,ERCC6;NELFCD
4723,GO:0010883,0.963301325977916,0.165095144803339,1,30,regulation of lipid storage,BP,PPARA
12952,GO:0051290,0.963488042229328,0.162319106463639,1,43,protein heterotetramerization,BP,CBR4
3352,GO:0007088,0.963504280846858,0.0702765482955499,9,141,regulation of mitotic nuclear division,BP,LRP5;HECW2;FBXW5;OBSL1;CUL7;CHMP5;TOM1L2;TGFA;TGFB1
2864,GO:0006356,0.963705286766668,0.163727611557032,1,30,regulation of transcription by RNA polymerase I,BP,ATF4
15932,GO:0072686,0.963885201004802,0.0833511893474841,5,88,mitotic spindle,CC,HECW2;EML2;HSF1;MAPKBP1;CAPG
12107,GO:0048066,0.963920007254798,0.162998739771326,1,30,developmental pigmentation,BP,AP3D1
6449,GO:0021762,0.963943972660692,0.16268726931051,1,31,substantia nigra development,BP,GLUD1
17843,GO:1901976,0.964028190421898,0.162630987249797,1,30,regulation of cell cycle checkpoint,BP,PPP1R10
1478,GO:0003743,0.964289834268783,0.117086087757776,2,49,translation initiation factor activity,MF,EIF2S2;EIF4G3
2967,GO:0006506,0.964792270489025,0.159582328395948,1,32,GPI anchor biosynthetic process,BP,PIGQ
18930,GO:1904591,0.964815535485272,0.159943851410429,1,30,positive regulation of protein import,BP,TGFB1
5993,GO:0018958,0.964977746004842,0.115455763836367,2,47,phenol-containing compound metabolic process,BP,GATA3;COMT
1310,GO:0003151,0.96527902435799,0.114755751231148,2,46,outflow tract morphogenesis,BP,TGFBR2;ZFPM1
16011,GO:0086003,0.965292487811396,0.1585497837276,1,29,cardiac muscle cell contraction,BP,DLG1
2832,GO:0006301,0.965953682391507,0.112676980514623,2,49,postreplication repair,BP,POLD4;PRIMPOL
7172,GO:0031047,0.965977126833913,0.0658706331708418,9,155,gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;BCDIN3D;AGO4;PUM1;TNRC6B;CNOT11;TGFB1
2493,GO:0005740,0.965988826956637,0.0469287498590058,47,617,mitochondrial envelope,CC,CYP27B1;BOK;CPT2;IDH2;BNIP3;NME4;OCIAD2;SNPH;CRAT;HK1;MRPS6;CDS2;MDH2;ARMCX2;FAM210B;HADH;BNIP3L;TST;ABCB8;HMGCL;SFXN3;MLXIP;IFI27;OXA1L;SDHA;ARL2;SRC;TAZ;DNM2;NDUFA4L2;ACADVL;CARD19;SLC25A43;THOP1;MOAP1;TTC19;BCL2L1;ULK1;SDHAF4;ARG1;BPHL;VAT1;CPT1B;NDUFS2;CAT;ANXA1;NIPSNAP1
8611,GO:0034113,0.966099298158819,0.155521369505436,1,30,heterotypic cell-cell adhesion,BP,CD44
6076,GO:0019222,0.966199263398169,0.0386581610780859,480,4909,regulation of metabolic process,BP,TNIP1;EDEM1;ANGPTL4;XDH;BTBD2;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;PLAT;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;LMF1;BOK;CRTC1;ARAP1;MEF2D;DLG4;CPT2;SERPINE2;NR1D1;DLG1;TRIM65;DAP;IGFBP4;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;BNIP3;PC;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;CYGB;FAM129B;G0S2;MAPKAPK3;SESN2;ABTB1;ZC3H6;BBS2;NACC2;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;FYCO1;RFX2;PRKACA;ADARB1;ACTA2;MAP2K2;PPP1R13L;STK25;MN1;MIER2;ATF4;HECW2;ZKSCAN2;SNX33;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;ARG2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;CTSZ;EPHA1;ZMIZ2;PTK6;FBXO2;SH3PXD2B;PCSK9;ENDOG;ZNF598;FERMT1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;DRAP1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;BNIP3L;PPARA;SYMPK;PRKACB;H2AFJ;ZDHHC8;WDTC1;SHC2;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PPP1R12C;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;FARP1;DUSP4;SATB1;RET;RAB29;PTOV1;MLXIP;IFI27;GRB10;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PHF1;OXA1L;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;SRC;LDLRAP1;CHMP5;APLP2;KDM4B;TAZ;DNM2;AGO4;FAM162A;IRF7;LRSAM1;HIST3H2A;RFXANK;RAB1B;STK24;CPTP;ACADVL;RALY;PAK6;PER3;STX5;ESRP1;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;PMVK;OAS1;FYN;SPTLC2;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;NELFCD;PSMD7;MICAL1;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;FRYL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;SOCS2;MTMR4;HES2;STUB1;PCSK1N;STK17A;ADIPOR1;TRIB3;ZFPL1;SNX25;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;RAD23A;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;P2RX4;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;FGF2;EHD4;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;MLYCD;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;CAMSAP3;RPL28;BAHCC1;ZBTB4;SEC14L2;ATP6V1C2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;CASP4;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;DRAM2;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;AIDA;MLF1;ZFP30;SRPX2;MED29;CEACAM1;PAIP2;APBA1;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;WBP2;PPP6R1;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;GNAS;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;WDFY2;FHOD1;TRAF7;RNF10
7428,GO:0031519,0.96627803847796,0.111994421900531,2,47,PcG protein complex,CC,PHC2;PHF1
17300,GO:0140013,0.966524235270772,0.0734886088016819,6,103,meiotic nuclear division,BP,HSF1;AGO4;LEMD2;HSPA2;SPIRE1;CCNE1
7185,GO:0031062,0.966595286641611,0.153798715400446,1,30,positive regulation of histone methylation,BP,PHF1
12895,GO:0051204,0.966725309018757,0.152914116190231,1,32,protein insertion into mitochondrial membrane,BP,MOAP1
14163,GO:0061013,0.967069256557084,0.0622496078098787,10,160,regulation of mRNA catabolic process,BP,PSMD2;AKT1;GTPBP1;PCBP4;PSMD7;PUM1;TNRC6B;SAMD4B;CARHSP1;IGF2BP3
13524,GO:0055072,0.967088590104532,0.0926258272024224,3,65,iron ion homeostasis,BP,LCN2;ATP13A2;SFXN3
7621,GO:0032006,0.967294153015696,0.0827588393157791,4,76,regulation of TOR signaling,BP,SESN2;DGKQ;GSK3A;C12ORF66
2976,GO:0006518,0.967327286040996,0.0436166650878273,61,783,peptide metabolic process,BP,TNIP1;CHAC1;SORL1;MAP2K1;NEURL1;PRNP;SESN2;ABTB1;RNPEPL1;HAGH;AARS;EGFR;MKNK2;CARS;MAP2K2;ATF4;MRPS6;AKT1;APOE;ATP13A2;CTSZ;ZNF598;GTPBP1;IDE;LARP6;BIN1;ERO1B;ZNF385A;BCDIN3D;CNDP2;EIF4EBP1;SCG5;AGO4;GARS;GSK3A;PCSK6;THOP1;PUM1;TNRC6B;EIF2S2;SECISBP2L;RRBP1;MIF4GD;PCSK1N;SARS2;SAMD4B;PYM1;ABCA7;RXRA;RPL28;CNOT11;IMPACT;GGT1;MAPK3;GLO1;FURIN;HM13;PAIP2;IGF2BP3;EIF4G3;TGFB1
6931,GO:0030518,0.967577325085672,0.0681164175080164,7,115,intracellular steroid hormone receptor signaling pathway,BP,PAK1;SRC;PMEPA1;KANK2;CCNE1;WBP2;EP300
5855,GO:0017148,0.96784572007063,0.0559165327450901,14,215,negative regulation of translation,BP,MAP2K1;SESN2;EGFR;MAP2K2;ATF4;BCDIN3D;EIF4EBP1;AGO4;PUM1;TNRC6B;SAMD4B;PAIP2;IGF2BP3;TGFB1
7720,GO:0032204,0.967923643360145,0.0814050827517628,4,76,regulation of telomere maintenance,BP,ERCC1;SRC;MAPK3;PPP1R10
9847,GO:0042073,0.967948014662422,0.107322730342653,2,49,intraciliary transport,BP,DYNLRB1;KIF17
19587,GO:1990542,0.968053681131758,0.0902626510086012,3,67,mitochondrial transmembrane transport,BP,CPT2;TST;CPT1B
8593,GO:0034080,0.968100703756446,0.146834643595111,1,40,CENP-A containing nucleosome assembly,BP,RSF1
14406,GO:0061641,0.968100703756446,0.146834643595111,1,40,CENP-A containing chromatin organization,BP,RSF1
15201,GO:0071320,0.968228339393152,0.148069708380716,1,30,cellular response to cAMP,BP,RAPGEF3
2966,GO:0006505,0.968500560437211,0.146492192190905,1,33,GPI anchor metabolic process,BP,PIGQ
10292,GO:0043028,0.968507653534373,0.146658426699802,1,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PRDX5
12911,GO:0051233,0.968514823176453,0.146837159584723,1,31,spindle midzone,CC,ARL8A
14763,GO:0070423,0.968570342779846,0.146640418629182,1,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,IRAK1
9439,GO:0036002,0.968663920257993,0.146104848658492,1,32,pre-mRNA binding,MF,EP300
5358,GO:0016126,0.968677457485678,0.0889360551575562,3,64,sterol biosynthetic process,BP,APOE;PMVK;SEC14L2
5752,GO:0016896,0.96899287143626,0.144936772539394,1,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20
7319,GO:0031323,0.968996566765156,0.0355880631140475,451,4613,regulation of cellular metabolic process,BP,TNIP1;EDEM1;XDH;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;LMF1;BOK;CRTC1;ARAP1;MEF2D;DLG4;SERPINE2;NR1D1;DLG1;TRIM65;DAP;IGFBP4;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;BNIP3;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;MAPKAPK3;SESN2;ZC3H6;NACC2;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;FYCO1;RFX2;PRKACA;ADARB1;MAP2K2;PPP1R13L;STK25;MN1;MIER2;ATF4;ZKSCAN2;SNX33;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;ARG2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;CTSZ;EPHA1;ZMIZ2;PTK6;FBXO2;PCSK9;ENDOG;ZNF598;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;DRAP1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;BNIP3L;PPARA;SYMPK;PRKACB;H2AFJ;ZDHHC8;WDTC1;SHC2;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PPP1R12C;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;FARP1;DUSP4;SATB1;RET;RAB29;PTOV1;MLXIP;IFI27;GRB10;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;HMGA2;ARID5B;PPP1R14A;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;SRC;CHMP5;APLP2;KDM4B;TAZ;DNM2;AGO4;FAM162A;IRF7;LRSAM1;HIST3H2A;RFXANK;RAB1B;STK24;CPTP;ACADVL;RALY;PAK6;PER3;ESRP1;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;OAS1;FYN;SPTLC2;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;NELFCD;PSMD7;MICAL1;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;FRYL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;SOCS2;MTMR4;HES2;STUB1;PCSK1N;STK17A;ADIPOR1;TRIB3;ZFPL1;SNX25;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;RAD23A;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;P2RX4;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;FGF2;EHD4;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;MLYCD;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;CAMSAP3;BAHCC1;ZBTB4;SEC14L2;ATP6V1C2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;CASP4;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;DRAM2;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;AIDA;MLF1;ZFP30;SRPX2;MED29;CEACAM1;PAIP2;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;WBP2;PPP6R1;CAT;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;WDFY2;FHOD1;TRAF7;RNF10
16053,GO:0086065,0.969279002836158,0.144119781609375,1,31,cell communication involved in cardiac conduction,BP,PRKACA
77,GO:0000154,0.969685079425063,0.142101083369129,1,34,rRNA modification,BP,RRNAD1
893,GO:0002262,0.9700076028424,0.0667247905460199,6,106,myeloid cell homeostasis,BP,FAM210B;GATA3;THRA;ZFPM1;L3MBTL3;ANXA1
14318,GO:0061418,0.970427464739223,0.0844620153908927,3,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMD2;PSMD7;EP300
2740,GO:0006120,0.971285104801006,0.134950420653475,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFS2
3653,GO:0008135,0.971615398933061,0.073200507566778,4,81,translation factor activity, RNA binding,MF,ABTB1;GTPBP1;EIF2S2;EIF4G3
16890,GO:0098800,0.971637749232965,0.0727045252205432,4,99,inner mitochondrial membrane protein complex,CC,SDHA;NDUFA4L2;SDHAF4;NDUFS2
17965,GO:1902275,0.971653647967881,0.0561353124270149,9,141,regulation of chromatin organization,BP,NOS1;PARP10;GATA3;PHF1;CTBP1;PHF2;MAPK3;TGFB1;WBP2
9369,GO:0035872,0.971816030901312,0.134752216102427,1,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,IRAK1
7180,GO:0031056,0.97194244541567,0.0599547682338507,7,117,regulation of histone modification,BP,NOS1;GATA3;PHF1;CTBP1;MAPK3;TGFB1;WBP2
20141,GO:2000779,0.972190764604549,0.0956591543436852,2,49,regulation of double-strand break repair,BP,HSF1;HMGA2
3203,GO:0006839,0.972498706572887,0.0463581694112767,17,250,mitochondrial transport,BP,RAC2;BOK;CPT2;BNIP3;VPS11;PITRM1;BNIP3L;TST;ZDHHC8;ATG13;STPG1;GSK3A;SLC25A43;MOAP1;BCL2L1;CPT1B;UGCG
2901,GO:0006409,0.972545964410042,0.132070253221408,1,32,tRNA export from nucleus,BP,XPOT
15278,GO:0071431,0.972545964410042,0.132070253221408,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,XPOT
9930,GO:0042267,0.972578339205945,0.131600394704964,1,34,natural killer cell mediated cytotoxicity,BP,CEACAM1
11047,GO:0045005,0.972599921206145,0.131871172405028,1,32,DNA-dependent DNA replication maintenance of fidelity,BP,PRIMPOL
7445,GO:0031570,0.972835184926217,0.0524233730935713,10,157,DNA integrity checkpoint,BP,CCND1;XPC;ZNF385A;PCBP4;HMGA2;BRSK1;TAOK1;CNOT11;PPP1R10;EP300
7179,GO:0031055,0.973899619837259,0.125661051171135,1,42,chromatin remodeling at centromere,BP,RSF1
9358,GO:0035861,0.973968910357277,0.126780835935458,1,32,site of double-strand break,CC,PHF1
3299,GO:0006998,0.974282672122513,0.0673135855417268,4,80,nuclear envelope organization,BP,VPS4A;NEK9;REEP4;LEMD2
11773,GO:0046605,0.974457594459149,0.0891857574670423,2,50,regulation of centrosome cycle,BP,FBXW5;CHMP5
692,GO:0001909,0.97449775213442,0.088865685854286,2,53,leukocyte mediated cytotoxicity,BP,ARG1;CEACAM1
7727,GO:0032212,0.974550241979716,0.124420781430633,1,33,positive regulation of telomere maintenance via telomerase,BP,MAPK3
13304,GO:0051973,0.974872115300554,0.123205736408789,1,33,positive regulation of telomerase activity,BP,MAPK3
1871,GO:0004532,0.974875097130719,0.123031024055261,1,34,exoribonuclease activity,MF,ISG20
6358,GO:0021536,0.975049863421275,0.122532835740912,1,33,diencephalon development,BP,ALDH1A2
36,GO:0000075,0.975413251157634,0.0438424894508405,14,208,cell cycle checkpoint,BP,CCND1;DLG1;XPC;VPS4A;ZNF385A;PCBP4;HMGA2;BRSK1;BCL2L1;TAOK1;CNOT11;TGFB1;PPP1R10;EP300
3627,GO:0008089,0.975427641762143,0.120936248751346,1,34,anterograde axonal transport,BP,AP3D1
10286,GO:0043021,0.9754700599024,0.0559050538478158,6,110,ribonucleoprotein complex binding,MF,RNF135;ZNF598;OXA1L;SECISBP2L;PYM1;IMPACT
12781,GO:0051031,0.975536389988909,0.120683924122699,1,33,tRNA transport,BP,XPOT
2860,GO:0006352,0.97571824832388,0.0441032483637356,13,207,DNA-templated transcription, initiation,BP,CCND1;CTNNBIP1;NR1D1;WWTR1;PPARA;BAZ2A;RSF1;VDR;THRA;MED15;RXRA;TAF6;MAPK3
2551,GO:0005819,0.975935575626877,0.0387882654954568,22,299,spindle,CC,TUBG2;HECW2;AKT1;ACOT13;VPS4A;EML2;ARL8A;HSF1;MAPKBP1;FAM110C;CAPG;SPECC1L;TUBG1;CEP170;RAB11FIP4;HSPA2;NDE1;INVS;CSNK1D;ARHGEF2;SAC3D1;MZT2B
14670,GO:0070252,0.976012427442239,0.0846558218334076,2,51,actin-mediated cell contraction,BP,DLG1;TNNT1
10550,GO:0043488,0.976060809439074,0.049869199228955,8,141,regulation of mRNA stability,BP,PSMD2;AKT1;PCBP4;PSMD7;PUM1;SAMD4B;CARHSP1;IGF2BP3
15981,GO:0075733,0.976121622995839,0.0842741786229001,2,52,intracellular transport of virus,BP,MVB12B;VPS37A
362,GO:0000980,0.976142698723188,0.0842793887241232,2,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,PBX3;MBD3
10986,GO:0044766,0.976609235947081,0.0694747062713946,3,68,multi-organism transport,BP,MVB12B;RAB29;VPS37A
18073,GO:1902579,0.976609235947081,0.0694747062713946,3,68,multi-organism localization,BP,MVB12B;RAB29;VPS37A
7843,GO:0032392,0.976650331613345,0.0619427034396027,4,81,DNA geometric change,BP,SMARCA1;XPC;DDB2;ANXA1
7725,GO:0032210,0.976898307764003,0.0820869021786976,2,51,regulation of telomere maintenance via telomerase,BP,SRC;MAPK3
16337,GO:0090503,0.977156417937828,0.11414627483926,1,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,ISG20
3360,GO:0007098,0.977202230453036,0.0524576847479186,6,108,centrosome cycle,BP,FBXW5;ARL2;CHMP5;SDCCAG8;BRSK1;NDE1
20315,GO:2001252,0.977228178406263,0.046113809982308,9,146,positive regulation of chromosome organization,BP,ERCC1;NOS1;GATA3;PHF1;CTBP1;MAPK3;TGFB1;WBP2;PPP1R10
264,GO:0000731,0.97732212151483,0.0676854902419106,3,68,DNA synthesis involved in DNA repair,BP,POLD4;PRIMPOL;RMI2
7405,GO:0031463,0.977655234730721,0.0798747089062859,2,51,Cul3-RING ubiquitin ligase complex,CC,KLHL29;KLHL17
2906,GO:0006417,0.977687330822833,0.034419562703706,28,387,regulation of translation,BP,MAP2K1;NEURL1;SESN2;EGFR;MKNK2;MAP2K2;ATF4;AKT1;ZNF598;LARP6;ZNF385A;BCDIN3D;EIF4EBP1;AGO4;PUM1;TNRC6B;SECISBP2L;MIF4GD;SAMD4B;PYM1;RXRA;CNOT11;IMPACT;MAPK3;PAIP2;IGF2BP3;EIF4G3;TGFB1
2449,GO:0005657,0.977920222074656,0.0661761713876638,3,68,replication fork,CC,ZMIZ2;TOP1;POLD4
13511,GO:0055029,0.977923408707928,0.0483942083635861,7,127,nuclear DNA-directed RNA polymerase complex,CC,ERCC1;INTS8;ZNF609;INTS1;TAF6;RPRD2;RPRD1A
5672,GO:0016779,0.978025507831892,0.0481959287437432,7,127,nucleotidyltransferase activity,MF,CDS2;UAP1;OASL;POLD4;OAS1;PRIMPOL;POLM
3912,GO:0008565,0.978189295849304,0.0653904105902464,3,71,protein transporter activity,MF,IPO13;LRP1;USO1
879,GO:0002228,0.978273220455712,0.109647677548386,1,36,natural killer cell mediated immunity,BP,CEACAM1
7183,GO:0031060,0.978421008733518,0.0776199367342332,2,51,regulation of histone methylation,BP,GATA3;PHF1
13718,GO:0060249,0.978471207150586,0.0356775169754683,20,288,anatomical structure homeostasis,BP,ERCC1;F2R;RAC2;ERCC6;BBS2;LPCAT1;EGFR;TUB;STK39;ADAM8;SRC;POLD4;P2RX4;LRRK1;HOMER2;MAPK3;DRAM2;CCNE1;PPP1R10;GNAS
18159,GO:1902850,0.979323018247221,0.0457219721542199,7,122,microtubule cytoskeleton organization involved in mitosis,BP,TUBG2;PKD1;CHMP5;TUBG1;NDE1;WRAP73;ARHGEF2
203,GO:0000428,0.979407480185991,0.0454888791570266,7,128,DNA-directed RNA polymerase complex,CC,ERCC1;INTS8;ZNF609;INTS1;TAF6;RPRD2;RPRD1A
14426,GO:0061695,0.979609096379028,0.0357293028738054,16,239,transferase complex, transferring phosphorus-containing groups,CC,ERCC1;CCND1;SESN2;TGFBR2;ATG13;CCND2;INTS8;POLD4;ULK1;ZNF609;INTS1;TAF6;RPRD2;RPRD1A;CCNE1;PIK3R2
10981,GO:0044743,0.979674925424997,0.103845517775025,1,38,protein transmembrane import into intracellular organelle,BP,PEX10
18835,GO:1904358,0.979871526035328,0.103430262798425,1,35,positive regulation of telomere maintenance via telomere lengthening,BP,MAPK3
14562,GO:0070063,0.979995754402512,0.0728100106248315,2,53,RNA polymerase binding,MF,BIN1;STOM
10805,GO:0044270,0.980186402142944,0.0288737507038074,40,544,cellular nitrogen compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;PSMD2;RAPGEF3;HK1;AKT1;ALDH1L2;PFKP;ENDOG;PPARA;DHTKD1;TST;GTPBP1;DEDD2;AHCY;DNASE1L1;PCBP4;HSF1;NEIL1;AGO4;GSK3A;ISG20;PSMD7;PUM1;TNRC6B;AOX1;SAMD4B;PNP;RNH1;PYM1;ENTPD6;RPL28;CNOT11;CARHSP1;ALDOC;IGF2BP3;LDHA;APOBEC3C
2817,GO:0006282,0.980243390321921,0.0536073353409555,4,83,regulation of DNA repair,BP,EGFR;HSF1;HMGA2;APBB1
7885,GO:0032446,0.98049473981924,0.0264809105742456,65,785,protein modification by small protein conjugation,BP,GID4;RBCK1;NEURL1;SHARPIN;FKBP1A;PSMD2;MTA1;SMURF2;MARCH9;HECW2;FBXW8;AKT1;SYVN1;WWTR1;RNF135;TMEM129;FBXO2;ZNF598;FBXW5;LIMK1;UBE2J1;ARRDC1;KLHL29;WDTC1;CDC34;JADE2;ANKIB1;RAG1;CUL7;FBXL6;HLTF;PARP10;DCAF7;WFS1;TOP1;BLMH;PEX10;UBR4;LRSAM1;GSK3A;FYN;RMND5A;PSMD7;THOP1;FBXL15;RNF44;UBA1;RNF187;MIB2;SOCS2;ASB13;STUB1;TRIB3;DDB2;RMND5B;MGRN1;KLHL17;RNF222;SPSB3;NEURL1B;CBL;SOCS7;RNF103;TRAF7;RNF10
11828,GO:0046700,0.980516580888013,0.0284189533963125,40,544,heterocycle catabolic process,BP,NT5E;XDH;H1F0;PGM1;PSMD2;RAPGEF3;HK1;AKT1;ALDH1L2;PFKP;ENDOG;PPARA;DHTKD1;GTPBP1;DEDD2;AHCY;DNASE1L1;PCBP4;HSF1;NEIL1;AGO4;GSK3A;ISG20;ALDH4A1;PSMD7;PUM1;TNRC6B;AOX1;SAMD4B;PNP;RNH1;PYM1;ENTPD6;RPL28;CNOT11;CARHSP1;ALDOC;IGF2BP3;LDHA;APOBEC3C
13130,GO:0051646,0.980557376432759,0.100662296853554,1,35,mitochondrion localization,BP,MAP1B
10625,GO:0043604,0.980949564310449,0.0264699034849281,55,734,amide biosynthetic process,BP,TNIP1;CHAC1;MAP2K1;NEURL1;NAGS;SESN2;ABTB1;HAGH;AARS;EGFR;MKNK2;CARS;MAP2K2;ATF4;MRPS6;AKT1;ARG2;ZNF598;GTPBP1;LARP6;ZNF385A;BCDIN3D;ASS1;CNDP2;EIF4EBP1;AGO4;GARS;SPTLC2;ASNS;TNFRSF1A;PUM1;TNRC6B;EIF2S2;SECISBP2L;RRBP1;MIF4GD;SARS2;ST3GAL5;SAMD4B;SMPD3;PYM1;RXRA;ARG1;RPL28;CNOT11;IMPACT;GGT1;MAPK3;FURIN;UGCG;B4GALT6;PAIP2;IGF2BP3;EIF4G3;TGFB1
7091,GO:0030880,0.981299627622456,0.0417386467495795,7,130,RNA polymerase complex,CC,ERCC1;INTS8;ZNF609;INTS1;TAF6;RPRD2;RPRD1A
12969,GO:0051310,0.981431626918232,0.0684141388167292,2,54,metaphase plate congression,BP,VPS4A;CHMP5
138,GO:0000288,0.981463400438681,0.0569455101568204,3,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B;SAMD4B;CNOT11
18737,GO:1904115,0.98157612684,0.096257546413103,1,37,axon cytoplasm,CC,AP3D1
16402,GO:0090734,0.981596715093229,0.0964171343450028,1,35,site of DNA damage,CC,PHF1
7751,GO:0032259,0.981737815125376,0.0306427553169127,20,285,methylation,BP,DNMT3A;RAB3B;FAM129B;METTL23;RRNAD1;AHCY;BAZ2A;GAMT;BCDIN3D;SATB1;GATA3;PHF1;NSUN7;COMT;PCMTD2;MBD3;ASH2L;RAB6A;COMTD1;GNAS
14191,GO:0061053,0.981829322744823,0.0673069289778061,2,52,somite development,BP,DKK1;EP300
1475,GO:0003729,0.981898879522251,0.0353341295632691,11,180,mRNA binding,MF,ADARB1;LARP6;ZNF385A;PCBP4;ESRP1;PUM1;SECISBP2L;SAMD4B;CARHSP1;PAIP2;IGF2BP3
8686,GO:0034260,0.981915384621434,0.0949783220370297,1,36,negative regulation of GTPase activity,BP,ARL2
3674,GO:0008173,0.982154769303914,0.0661516902107931,2,55,RNA methyltransferase activity,MF,RRNAD1;BCDIN3D
16009,GO:0086001,0.98218136584816,0.0940012081760138,1,35,cardiac muscle cell action potential,BP,DLG1
11855,GO:0046794,0.982231334953899,0.0659164857414868,2,55,transport of virus,BP,MVB12B;VPS37A
5570,GO:0016579,0.982536589052089,0.0309720537437174,16,243,protein deubiquitination,BP,TNIP1;PSMD2;SMURF2;USP20;JOSD2;RNF135;OTUB2;GATA3;MBD6;PSMD7;DDB2;RAD23A;HGS;USP32;TFPT;EP300
8996,GO:0035097,0.982779785872394,0.0535467286804419,3,70,histone methyltransferase complex,CC,PHF1;TAF6;ASH2L
14411,GO:0061647,0.983281602358136,0.089277458722966,1,36,histone H3-K9 modification,BP,GATA3
16445,GO:0097064,0.983524019139881,0.0881411307927837,1,37,ncRNA export from nucleus,BP,XPOT
13197,GO:0051783,0.9836335266097,0.0342230111551137,9,154,regulation of nuclear division,BP,LRP5;HECW2;FBXW5;OBSL1;CUL7;CHMP5;TOM1L2;TGFA;TGFB1
7937,GO:0032508,0.983791101090427,0.0508291016658734,3,71,DNA duplex unwinding,BP,XPC;DDB2;ANXA1
17327,GO:0140101,0.984077640498686,0.038130547437477,6,117,catalytic activity, acting on a tRNA,MF,AARS;CARS;DTD1;GARS;SARS2;TRPT1
14710,GO:0070317,0.984140526911621,0.0855213503813239,1,37,negative regulation of G0 to G1 transition,BP,PPP2R5B
18551,GO:1903707,0.984180341274053,0.0440448816759809,4,94,negative regulation of hemopoiesis,BP,ZFPM1;CIB1;CEACAM1;ANXA1
12906,GO:0051225,0.98418883800579,0.0405371003484638,5,99,spindle assembly,BP,TUBG2;CHMP5;TUBG1;WRAP73;CSNK1D
6705,GO:0030101,0.98437469009552,0.0843181194368805,1,39,natural killer cell activation,BP,SNX27
10549,GO:0043487,0.984925284177269,0.0329355220953595,8,148,regulation of RNA stability,BP,PSMD2;AKT1;PCBP4;PSMD7;PUM1;SAMD4B;CARHSP1;IGF2BP3
2903,GO:0006413,0.985045259384702,0.0313930536516225,9,185,translational initiation,BP,ATF4;EIF4EBP1;EIF2S2;MIF4GD;RXRA;RPL28;IMPACT;PAIP2;EIF4G3
20017,GO:2000573,0.985149476947661,0.0567433990675085,2,56,positive regulation of DNA biosynthetic process,BP,SRC;MAPK3
7043,GO:0030811,0.985193090748348,0.0566477016415379,2,55,regulation of nucleotide catabolic process,BP,RAPGEF3;PPARA
9872,GO:0042116,0.985207395298152,0.0808247782322749,1,38,macrophage activation,BP,MIF
15764,GO:0072331,0.985220405914382,0.026550912125597,16,246,signal transduction by p53 class mediator,BP,BOK;SESN2;PPP1R13L;AKT1;CD44;ZNF385A;PCBP4;SHISA5;HEXIM1;MIF;TAF6;CNOT11;MBD3;RMI2;SPRED2;EP300
1528,GO:0003899,0.985224449307308,0.0804794624648323,1,41,DNA-directed 5'-3' RNA polymerase activity,MF,PRIMPOL
3334,GO:0007049,0.985344242708625,0.018463198735656,138,1549,cell cycle,BP,FHL1;ERCC1;CCND1;MAP2K1;CYP27B1;SNX9;ARAP1;DLG1;DNMT3A;PSMD2;RPS6KA2;PRNP;CCNI;MARVELD1;TUBB6;NACC2;BCR;MARK4;CCNG2;LRP5;MAP4K4;EGFR;CSNK1E;SEPT10;PRKACA;ADARB1;MAP2K2;TUBG2;STK25;HECW2;SNX33;AKT1;XPC;TSPYL2;MAPK13;PPP2R3B;VPS4A;PTK6;FBXW5;SEPT5;STK39;PPP2R5B;OBSL1;PRKACB;SIPA1;CDC34;CCND2;TACC1;GIT1;BIN1;PAK1;ZNF385A;DDIT3;CUL7;TUBB3;SDCCAG3;GAS2L1;RHOC;PCBP4;SEPT8;PKD1;GATA3;ARL8A;GNAI2;HSF1;APPL2;ALOX15B;NEK9;CTBP1;HMGA2;RHOBTB2;ARL2;EIF4EBP1;GIPC1;SRC;CHMP5;POLD4;DNM2;NINL;AGO4;STK24;PAK6;TOM1L2;SDCCAG8;SPECC1L;ASNS;REEP4;PSMD7;FBXL15;BRSK1;CGREF1;GJC2;PUM1;HEXIM1;MISP;FGFR1;TUBG1;HYAL1;MIF;TTC19;RAB11FIP4;BCL2L1;MAU2;LEMD2;RAD23A;HSPA2;PAK4;E2F5;SMPD3;SPIRE1;TAOK1;APBB1;RHOBTB1;WDR18;TAF6;TGFA;NDE1;CNOT11;CAMK1;CIB1;WRAP73;MAPK3;KANK2;CSNK1D;ARHGEF2;LLGL1;MLF1;MPLKIP;MINK1;SAC3D1;CCNE1;TGFB1;RMI2;CAMK2N1;ANXA1;PPP1R10;ZNF318;EP300
3048,GO:0006606,0.985476340446364,0.035168350466801,6,115,protein import into nucleus,BP,AKT1;IPO13;PARP10;RERE;TGFB1;PPP1R10
6152,GO:0019439,0.985525773551597,0.0214485019041412,40,553,aromatic compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;PSMD2;RAPGEF3;HK1;AKT1;ALDH1L2;PFKP;ENDOG;PPARA;DHTKD1;GTPBP1;DEDD2;AHCY;DNASE1L1;PCBP4;HSF1;NEIL1;AGO4;GSK3A;ISG20;PSMD7;PUM1;COMT;TNRC6B;AOX1;SAMD4B;PNP;RNH1;PYM1;ENTPD6;RPL28;CNOT11;CARHSP1;ALDOC;IGF2BP3;LDHA;APOBEC3C
8866,GO:0034655,0.985542566760983,0.0217200303302313,37,518,nucleobase-containing compound catabolic process,BP,NT5E;XDH;H1F0;PGM1;PSMD2;RAPGEF3;HK1;AKT1;PFKP;ENDOG;PPARA;DHTKD1;GTPBP1;DEDD2;AHCY;DNASE1L1;PCBP4;HSF1;NEIL1;AGO4;GSK3A;ISG20;PSMD7;PUM1;TNRC6B;SAMD4B;PNP;RNH1;PYM1;ENTPD6;RPL28;CNOT11;CARHSP1;ALDOC;IGF2BP3;LDHA;APOBEC3C
10548,GO:0043486,0.98622146262451,0.0756406042850176,1,48,histone exchange,BP,RSF1
2845,GO:0006323,0.986221534840377,0.0302816593615756,8,166,DNA packaging,BP,H1F0;TSPYL2;HIST2H2BE;TNRC18;PARP10;HMGA2;RSF1;BAHCC1
16670,GO:0097525,0.986360192283114,0.0526359962648376,2,62,spliceosomal snRNP complex,CC,MAPKBP1;SF3B6
7166,GO:0031023,0.986404531078969,0.033167438734133,6,115,microtubule organizing center organization,BP,FBXW5;ARL2;CHMP5;SDCCAG8;BRSK1;NDE1
3663,GO:0008152,0.986422732256497,0.0159425059081211,818,8267,metabolic process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;BTBD2;ITGB4;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;SNX9;AP3D1;LMF1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;DLG1;TRIM65;DAP;IGFBP4;SLC16A3;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;AGPAT3;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;PLCH2;CYGB;FAM129B;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;MRC2;BBS2;FKBP9;HAGH;OSBPL10;USP20;NACC2;ADGRF1;BCR;RAB31;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;PGLS;MAP4K4;EGFR;LRP10;CSNK1E;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;FYCO1;RFX2;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;GPC4;IRAK1;PEG3;SERPING1;ALDH1L2;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;CRYL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;PI4K2A;ZMIZ2;PTK6;SLC20A1;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;ACAD10;NMRK1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;PLD3;DRAP1;HADH;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;PRSS8;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;ESYT2;PLCG1;TBC1D16;ATG13;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TSPAN5;PPP1R12C;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;ISYNA1;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;KIAA1191;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;FARP1;DUSP4;PTPN9;SATB1;FUCA1;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;GRB10;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;SLC2A3;ZNF165;GGACT;RPUSD3;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;PLCB3;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;AKR7A2;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NDUFA4L2;MARK3;STK24;CPTP;ACADVL;RGS19;RALY;PAK6;PER3;STX5;RBMS2;ESRP1;NSUN7;GPX3;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;PRIMPOL;MPI;ISG20;SPTLC2;SUGCT;AGRN;ASNS;ZNF692;PPM1F;TMPRSS11D;ZNF862;LPAR3;GALE;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;ANXA3;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;TSPAN33;UCKL1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;DHRS4L2;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LOXL1;LHPP;WDFY3;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;TTC19;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ADIPOR1;ST3GAL3;NT5DC2;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;NDOR1;RAD23A;ARFGEF2;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;CDYL2;SDHAF4;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;TMX4;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;CAMSAP3;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;ATP6V1C2;CNOT11;CYB561;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;BPHL;ARSK;KLK6;VAT1;CASP4;ACY1;SNAP29;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;PACS2;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DRAM2;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;UGCG;AIDA;MLF1;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;SRPX2;HM13;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;ZNF256;LPIN3;TFPT;UROS;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
4516,GO:0010564,0.986635723915748,0.0192426332392464,49,622,regulation of cell cycle process,BP,FHL1;CCND1;PSMD2;NACC2;LRP5;EGFR;CSNK1E;PRKACA;HECW2;AKT1;XPC;VPS4A;FBXW5;PPP2R5B;OBSL1;CCND2;GIT1;BIN1;ZNF385A;CUL7;SDCCAG3;PCBP4;PKD1;HMGA2;GIPC1;CHMP5;NINL;TOM1L2;SDCCAG8;PSMD7;BRSK1;GJC2;FGFR1;TUBG1;HYAL1;MIF;RAB11FIP4;BCL2L1;TAOK1;TGFA;NDE1;CNOT11;KANK2;CSNK1D;TGFB1;RMI2;ANXA1;PPP1R10;EP300
9610,GO:0036459,0.986764709973521,0.0378243947690452,4,87,thiol-dependent ubiquitinyl hydrolase activity,MF,USP20;JOSD2;OTUB2;USP32
17133,GO:0101005,0.986764709973521,0.0378243947690452,4,87,ubiquitinyl hydrolase activity,MF,USP20;JOSD2;OTUB2;USP32
8589,GO:0034062,0.987349533704986,0.0709462895347505,1,43,5'-3' RNA polymerase activity,MF,PRIMPOL
16753,GO:0097747,0.987349533704986,0.0709462895347505,1,43,RNA polymerase activity,MF,PRIMPOL
13068,GO:0051539,0.987349731147948,0.0710922133889978,1,41,4 iron, 4 sulfur cluster binding,MF,NDUFS2
10990,GO:0044772,0.987414764225248,0.019161501649936,36,484,mitotic cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;EGFR;CSNK1E;PRKACA;HECW2;AKT1;XPC;VPS4A;CDC34;CCND2;ZNF385A;PCBP4;PKD1;HMGA2;EIF4EBP1;DNM2;NINL;SDCCAG8;PSMD7;FBXL15;BRSK1;GJC2;TUBG1;HYAL1;TAOK1;NDE1;CNOT11;KANK2;CSNK1D;CCNE1;TGFB1;ANXA1;EP300
17873,GO:1902036,0.987422796918722,0.0404966403801443,3,95,regulation of hematopoietic stem cell differentiation,BP,PSMD2;GATA3;PSMD7
18503,GO:1903578,0.987457140038749,0.0407524485836896,3,74,regulation of ATP metabolic process,BP,TMSB4X;PPARA;TAZ
6636,GO:0022904,0.98747452071389,0.0403663195471285,3,94,respiratory electron transport chain,BP,SDHA;TAZ;NDUFS2
8105,GO:0032784,0.988381584652377,0.0664737361695934,1,40,regulation of DNA-templated transcription, elongation,BP,ERCC6
5650,GO:0016741,0.988492952481214,0.0233799002656786,11,185,transferase activity, transferring one-carbon groups,MF,DNMT3A;ALDH1L2;METTL23;RRNAD1;GAMT;BCDIN3D;NSUN7;COMT;PCMTD2;ASH2L;COMTD1
18833,GO:1904356,0.988500310106665,0.0457384088211215,2,58,regulation of telomere maintenance via telomere lengthening,BP,SRC;MAPK3
12427,GO:0048857,0.988599504025029,0.0653942637656064,1,41,neural nucleus development,BP,GLUD1
10916,GO:0044452,0.98860646264419,0.0246306558462613,9,163,nucleolar part,CC,DEAF1;CDCA7L;TOP1;MBD6;PAK6;RAI14;RREB1;E2F5;USO1
2562,GO:0005844,0.988710318139604,0.0447267304252836,2,69,polysome,CC,LARP6;IMPACT
10406,GO:0043228,0.988714609335985,0.0134887833312166,302,3275,non-membrane-bounded organelle,CC,FLNC;BTBD2;SH3KBP1;ERCC1;NOS1;H1F0;CAPN2;MPRIP;MST1R;RAC2;DVL1;MAP2K1;DOCK4;ETV4;ERCC6;CST3;CLIP2;SCN8A;MEF2D;DLG4;OBSCN;CPT2;SMTN;NR1D1;KLC2;DLG1;DYSF;PITPNM1;DNMT3A;PGM1;FKBP1A;MTA1;CKAP4;RAPGEF3;SSH1;SCYL1;SMARCA1;TMOD2;PCDH1;MARVELD1;ESPN;G0S2;CTSB;ABTB1;TNNT1;TMEM214;SNPH;PLEK2;BBS2;OSBPL10;TUBB6;USP20;NACC2;LPCAT1;NUDCD3;MARK4;PANO1;MMP14;SEPT10;PRKACA;ADARB1;CORO1B;ACTA2;MAP2K2;TUBG2;PARVB;ATF4;HECW2;MRPS6;AKT1;XPC;ACOT13;IRAK1;ARPC1A;BAG3;TNS4;AFAP1L1;TMSB4X;TSPYL2;PRKCZ;PHC2;ITPR3;DGKQ;VPS4A;HIST2H2BE;CCDC92;UACA;ZMIZ2;SH3PXD2B;NSMCE4A;FERMT1;EML2;SEPT5;DEAF1;SALL2;MSN;MAP1B;RIN1;STK39;CORO2A;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;WASF2;ABCB8;DEDD2;TWF2;CCND2;TACC1;BIN1;FSCN1;CCDC88C;PAK1;TTBK2;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;NAV1;PODXL;CUL7;ARHGAP39;TUBB3;STOM;FARP1;SATB1;RAB29;GAS2L1;PLEKHH3;REEP2;PROCR;HLTF;SEPT8;SHANK2;PARP10;GATA3;WDR66;PHF1;ARL8A;OASL;GNAI2;MYH16;HSF1;APPL2;ADGRB2;SIN3B;ALOX15B;NEK9;SDHA;CDCA7L;ADAM8;MAPKBP1;NEIL1;MPG;MYH15;HMGA2;DYNLRB1;TOP1;FAM110C;ARL2;CAP1;PLIN3;FLNB;TULP3;SRC;LDLRAP1;MBD6;DENND2A;CAPG;POLD4;FKBP10;DNM2;NINL;UBR4;AGO4;HIST3H2A;CDC42BPB;STK24;ACADVL;PAK6;YPEL3;SDCCAG8;RSF1;STXBP1;SPECC1L;FYN;ISG20;FUZ;ZNF692;REEP4;PFN1;MICAL1;KIF17;KIF13B;BRSK1;PUM1;RAI14;PSKH1;TNRC6B;UBA1;MISP;WDFY3;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;PHF2;CEP170;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;MAU2;DNMBP;AFAP1;PTPN12;LEMD2;HLCS;NDOR1;RAD23A;ARFGEF2;TRIB2;HSPA2;E2F5;SAMD4B;USO1;SPIRE1;PNP;KLHL17;MAP1LC3B;SHB;PYM1;VASP;ABHD14B;ARAP3;MYO1D;CHD7;SNTB2;LMAN1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;NDE1;CAMSAP3;RPL28;INVS;BAHCC1;GSDMC;ZBTB4;BAIAP2L1;HIST1H2AG;WIPF1;KLK6;SNAP29;KRT23;CARHSP1;MYL9;GAS8;CIB1;TMSB10;IQSEC1;WRAP73;MAPK3;KANK2;CSNK1D;KIFC3;DNAJB9;ALDOC;S100A16;ARHGEF2;MYZAP;LLGL1;MPLKIP;ENKD1;TFPT;MBD3;MAP6;SAC3D1;WBP2;SH3PXD2A;ANXA1;PPP1R10;ASH2L;APOBEC3C;CCDC113;PXN;PLEKHH2;EP300;RAP1GAP2;STIM1;MZT2B;ASAP1;FHOD1
10410,GO:0043232,0.988714609335985,0.0134887833312166,302,3275,intracellular non-membrane-bounded organelle,CC,FLNC;BTBD2;SH3KBP1;ERCC1;NOS1;H1F0;CAPN2;MPRIP;MST1R;RAC2;DVL1;MAP2K1;DOCK4;ETV4;ERCC6;CST3;CLIP2;SCN8A;MEF2D;DLG4;OBSCN;CPT2;SMTN;NR1D1;KLC2;DLG1;DYSF;PITPNM1;DNMT3A;PGM1;FKBP1A;MTA1;CKAP4;RAPGEF3;SSH1;SCYL1;SMARCA1;TMOD2;PCDH1;MARVELD1;ESPN;G0S2;CTSB;ABTB1;TNNT1;TMEM214;SNPH;PLEK2;BBS2;OSBPL10;TUBB6;USP20;NACC2;LPCAT1;NUDCD3;MARK4;PANO1;MMP14;SEPT10;PRKACA;ADARB1;CORO1B;ACTA2;MAP2K2;TUBG2;PARVB;ATF4;HECW2;MRPS6;AKT1;XPC;ACOT13;IRAK1;ARPC1A;BAG3;TNS4;AFAP1L1;TMSB4X;TSPYL2;PRKCZ;PHC2;ITPR3;DGKQ;VPS4A;HIST2H2BE;CCDC92;UACA;ZMIZ2;SH3PXD2B;NSMCE4A;FERMT1;EML2;SEPT5;DEAF1;SALL2;MSN;MAP1B;RIN1;STK39;CORO2A;AKAP12;SYMPK;OBSL1;PRKACB;H2AFJ;WASF2;ABCB8;DEDD2;TWF2;CCND2;TACC1;BIN1;FSCN1;CCDC88C;PAK1;TTBK2;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;NAV1;PODXL;CUL7;ARHGAP39;TUBB3;STOM;FARP1;SATB1;RAB29;GAS2L1;PLEKHH3;REEP2;PROCR;HLTF;SEPT8;SHANK2;PARP10;GATA3;WDR66;PHF1;ARL8A;OASL;GNAI2;MYH16;HSF1;APPL2;ADGRB2;SIN3B;ALOX15B;NEK9;SDHA;CDCA7L;ADAM8;MAPKBP1;NEIL1;MPG;MYH15;HMGA2;DYNLRB1;TOP1;FAM110C;ARL2;CAP1;PLIN3;FLNB;TULP3;SRC;LDLRAP1;MBD6;DENND2A;CAPG;POLD4;FKBP10;DNM2;NINL;UBR4;AGO4;HIST3H2A;CDC42BPB;STK24;ACADVL;PAK6;YPEL3;SDCCAG8;RSF1;STXBP1;SPECC1L;FYN;ISG20;FUZ;ZNF692;REEP4;PFN1;MICAL1;KIF17;KIF13B;BRSK1;PUM1;RAI14;PSKH1;TNRC6B;UBA1;MISP;WDFY3;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;PHF2;CEP170;TTC19;VPS37A;SIGMAR1;RAB11FIP4;BCL2L1;STUB1;MAU2;DNMBP;AFAP1;PTPN12;LEMD2;HLCS;NDOR1;RAD23A;ARFGEF2;TRIB2;HSPA2;E2F5;SAMD4B;USO1;SPIRE1;PNP;KLHL17;MAP1LC3B;SHB;PYM1;VASP;ABHD14B;ARAP3;MYO1D;CHD7;SNTB2;LMAN1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;NDE1;CAMSAP3;RPL28;INVS;BAHCC1;GSDMC;ZBTB4;BAIAP2L1;HIST1H2AG;WIPF1;KLK6;SNAP29;KRT23;CARHSP1;MYL9;GAS8;CIB1;TMSB10;IQSEC1;WRAP73;MAPK3;KANK2;CSNK1D;KIFC3;DNAJB9;ALDOC;S100A16;ARHGEF2;MYZAP;LLGL1;MPLKIP;ENKD1;TFPT;MBD3;MAP6;SAC3D1;WBP2;SH3PXD2A;ANXA1;PPP1R10;ASH2L;APOBEC3C;CCDC113;PXN;PLEKHH2;EP300;RAP1GAP2;STIM1;MZT2B;ASAP1;FHOD1
16968,GO:0098930,0.988836095193433,0.0642992547323259,1,41,axonal transport,BP,AP3D1
5889,GO:0018024,0.988836261604056,0.0643725046830607,1,40,histone-lysine N-methyltransferase activity,MF,ASH2L
11440,GO:0045839,0.989059444769215,0.0631909027686766,1,42,negative regulation of mitotic nuclear division,BP,TOM1L2
7912,GO:0032479,0.989085359932129,0.0291705209626724,5,107,regulation of type I interferon production,BP,PTPRS;IRAK1;RNF135;IRF7;EP300
18063,GO:1902562,0.989170652435164,0.0627414596809863,1,41,H4 histone acetyltransferase complex,CC,MSL1
346,GO:0000959,0.989327045361068,0.0620093972598034,1,41,mitochondrial RNA metabolic process,BP,GARS
15989,GO:0080090,0.989357600431106,0.0125275254587215,433,4506,regulation of primary metabolic process,BP,TNIP1;EDEM1;ANGPTL4;XDH;BTBD2;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;SNX9;LMF1;BOK;CRTC1;MEF2D;DLG4;CPT2;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;G0S2;MAPKAPK3;SESN2;ABTB1;ZC3H6;NACC2;ADGRF1;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;RFX2;PRKACA;ADARB1;MAP2K2;PPP1R13L;STK25;MN1;MIER2;ATF4;HECW2;ZKSCAN2;SNX33;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;CTSZ;EPHA1;ZMIZ2;PTK6;FBXO2;PCSK9;ENDOG;ZNF598;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;DRAP1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;SHC2;CD44;DNAJB5;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;LARP6;TFE3;PRDX5;CCND2;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;DUSP4;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;HMGA2;ALAS1;ARID5B;PPP1R14A;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;SRC;LDLRAP1;APLP2;KDM4B;TAZ;DNM2;AGO4;FAM162A;IRF7;HIST3H2A;RFXANK;RAB1B;STK24;ACADVL;RALY;PAK6;PER3;STX5;ESRP1;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;PMVK;OAS1;FYN;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;NELFCD;PSMD7;MICAL1;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;TIMP1;CRIM1;FRYL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;SOCS2;MTMR4;HES2;STUB1;PCSK1N;ADIPOR1;TRIB3;ZFPL1;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;LRRK1;FGF2;EHD4;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;MLYCD;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;CASP4;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;AIDA;MLF1;ZFP30;MED29;CEACAM1;PAIP2;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;PPP6R1;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;SLC45A3;PPP1R10;ASH2L;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;WDFY2;FHOD1;TRAF7;RNF10
2850,GO:0006336,0.989405616309762,0.0611265330443027,1,50,DNA replication-independent nucleosome assembly,BP,RSF1
10115,GO:0042623,0.989455763521561,0.018384546065224,20,290,ATPase activity, coupled,MF,ERCC6;SMARCA1;TNNT1;ATP13A2;ATP7B;VPS4A;ABCB8;ATP11A;KIF17;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;ABCA7;ATP6V1C2;LONP2;KIFC3;PCYOX1;ANXA1
2739,GO:0006119,0.989605024524567,0.0343486361123282,3,96,oxidative phosphorylation,BP,SDHA;TAZ;NDUFS2
4482,GO:0010494,0.989620979330874,0.0606978634464785,1,40,cytoplasmic stress granule,CC,PUM1
469,GO:0001510,0.989676572626538,0.0416751235981734,2,61,RNA methylation,BP,RRNAD1;BCDIN3D
10540,GO:0043470,0.98969195417197,0.0416819026976933,2,59,regulation of carbohydrate catabolic process,BP,PPARA;GSK3A
8812,GO:0034508,0.989738667803281,0.0595653194744856,1,50,centromere complex assembly,BP,RSF1
2848,GO:0006334,0.989755413029063,0.0299502348338134,4,116,nucleosome assembly,BP,H1F0;TSPYL2;HIST2H2BE;RSF1
14709,GO:0070316,0.989772666260105,0.0599096161465923,1,41,regulation of G0 to G1 transition,BP,PPP2R5B
7994,GO:0032606,0.989788944224126,0.0274919159605057,5,108,type I interferon production,BP,PTPRS;IRAK1;RNF135;IRF7;EP300
2904,GO:0006414,0.989842896417254,0.0272332880917883,5,125,translational elongation,BP,ABTB1;MRPS6;ZNF598;GTPBP1;SECISBP2L
3337,GO:0007052,0.990004631309933,0.0270044517326338,5,105,mitotic spindle organization,BP,TUBG2;PKD1;CHMP5;TUBG1;WRAP73
14526,GO:0065004,0.990049690494239,0.0203937085976827,11,213,protein-DNA complex assembly,BP,H1F0;SOX12;XPC;TSPYL2;HIST2H2BE;BAZ2A;RSF1;THRA;DDB2;WDR18;TAF6
412,GO:0001098,0.990214238398722,0.0577424608871412,1,42,basal transcription machinery binding,MF,ERCC1
413,GO:0001099,0.990214238398722,0.0577424608871412,1,42,basal RNA polymerase II transcription machinery binding,MF,ERCC1
4485,GO:0010501,0.990498683503747,0.0564426401681438,1,41,RNA secondary structure unwinding,BP,AGO4
8911,GO:0034724,0.990588988468608,0.0554828814688722,1,51,DNA replication-independent nucleosome organization,BP,RSF1
6253,GO:0019827,0.990600953643154,0.0238333687308683,6,121,stem cell population maintenance,BP,WNT7A;LRP5;EPHA1;BCL9L;HMGA2;FGF2
4767,GO:0010948,0.990682086867966,0.0165665225802264,19,295,negative regulation of cell cycle process,BP,FHL1;CCND1;PSMD2;NACC2;VPS4A;PPP2R5B;ZNF385A;PCBP4;HMGA2;TOM1L2;PSMD7;BRSK1;GJC2;MIF;TAOK1;CNOT11;KANK2;PPP1R10;EP300
3348,GO:0007077,0.990817251783335,0.0548392179268618,1,42,mitotic nuclear envelope disassembly,BP,NEK9
3054,GO:0006614,0.990877282201262,0.037013804654432,2,91,SRP-dependent cotranslational protein targeting to membrane,BP,SEC63;RPL28
11057,GO:0045023,0.990918031730216,0.0543498553817478,1,42,G0 to G1 transition,BP,PPP2R5B
5663,GO:0016765,0.990973167799279,0.0538098137924517,1,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,RABGGTA
690,GO:0001906,0.991167946769895,0.0363817933374969,2,67,cell killing,BP,ARG1;CEACAM1
133,GO:0000278,0.991179082385653,0.0121346930086274,75,913,mitotic cell cycle,BP,FHL1;CCND1;MAP2K1;SNX9;DLG1;DNMT3A;PSMD2;TUBB6;NACC2;LRP5;MAP4K4;EGFR;CSNK1E;SEPT10;PRKACA;MAP2K2;TUBG2;STK25;HECW2;SNX33;AKT1;XPC;VPS4A;FBXW5;SEPT5;STK39;OBSL1;CDC34;CCND2;PAK1;ZNF385A;CUL7;TUBB3;RHOC;PCBP4;SEPT8;PKD1;HSF1;NEK9;HMGA2;EIF4EBP1;CHMP5;DNM2;NINL;STK24;PAK6;TOM1L2;SDCCAG8;ASNS;REEP4;PSMD7;FBXL15;BRSK1;GJC2;FGFR1;TUBG1;HYAL1;BCL2L1;MAU2;PAK4;TAOK1;TGFA;NDE1;CNOT11;CIB1;WRAP73;KANK2;CSNK1D;ARHGEF2;MINK1;CCNE1;TGFB1;ANXA1;PPP1R10;EP300
3303,GO:0007005,0.991180882888379,0.0138227984842302,34,487,mitochondrion organization,BP,RAC2;BOK;SHARPIN;IFI6;IDH2;BNIP3;SESN2;AKT1;ATP13A2;VPS11;PITRM1;BNIP3L;ZDHHC8;ATG13;COA5;HMGCL;RAB29;OXA1L;GLUD1;ALAS1;TAZ;DNM2;FAM162A;STPG1;GSK3A;PRIMPOL;MOAP1;TTC19;BCL2L1;MAP1LC3B;SDHAF4;VAT1;UGCG;NDUFS2
10539,GO:0043467,0.99124426599516,0.026287242118043,4,93,regulation of generation of precursor metabolites and energy,BP,BNIP3;AKT1;PPARA;GSK3A
3669,GO:0008168,0.99125997133032,0.0187135226000797,10,177,methyltransferase activity,MF,DNMT3A;METTL23;RRNAD1;GAMT;BCDIN3D;NSUN7;COMT;PCMTD2;ASH2L;COMTD1
784,GO:0002039,0.991531876875392,0.035242737330114,2,61,p53 binding,MF,ZNF385A;EP300
7984,GO:0032592,0.991570668719384,0.035011310300835,2,65,integral component of mitochondrial membrane,CC,BNIP3;OXA1L
16270,GO:0090307,0.991601237090254,0.0349976228556278,2,61,mitotic spindle assembly,BP,CHMP5;WRAP73
6275,GO:0019866,0.991849815605281,0.0132383001816736,29,451,organelle inner membrane,CC,BOK;CPT2;IDH2;NME4;OCIAD2;CRAT;MRPS6;CDS2;MDH2;HADH;TST;ABCB8;HMGCL;IFI27;OXA1L;SDHA;SRC;TAZ;NDUFA4L2;ACADVL;SLC25A43;TTC19;SIGMAR1;BCL2L1;LEMD2;P2RX4;SDHAF4;NDUFS2;NIPSNAP1
16851,GO:0098727,0.991937569386754,0.0207652906151059,6,123,maintenance of cell number,BP,WNT7A;LRP5;EPHA1;BCL9L;HMGA2;FGF2
17301,GO:0140014,0.991991175775429,0.0153184340363453,15,240,mitotic nuclear division,BP,LRP5;TUBG2;HECW2;VPS4A;FBXW5;OBSL1;CUL7;CHMP5;TOM1L2;TUBG1;MAU2;TGFA;NDE1;WRAP73;TGFB1
13704,GO:0060218,0.992048954306842,0.0271906123955513,3,100,hematopoietic stem cell differentiation,BP,PSMD2;GATA3;PSMD7
14883,GO:0070646,0.992077985016881,0.0148914107904862,16,258,protein modification by small protein removal,BP,TNIP1;PSMD2;SMURF2;USP20;JOSD2;RNF135;OTUB2;GATA3;MBD6;PSMD7;DDB2;RAD23A;HGS;USP32;TFPT;EP300
5798,GO:0017038,0.992096366645873,0.0176557179251477,9,167,protein import,BP,SNX33;AKT1;APOE;IPO13;PARP10;PEX10;RERE;TGFB1;PPP1R10
5480,GO:0016410,0.992258667358165,0.0267784944589252,3,80,N-acyltransferase activity,MF,NAGS;ALAS1;EP300
16788,GO:0098573,0.992398923169958,0.032043243564156,2,66,intrinsic component of mitochondrial membrane,CC,BNIP3;OXA1L
775,GO:0002027,0.99242910598536,0.0467517480659804,1,44,regulation of heart rate,BP,PRKACA
3302,GO:0007004,0.992459793002732,0.0318657171970879,2,64,telomere maintenance via telomerase,BP,SRC;MAPK3
883,GO:0002244,0.992462991483534,0.0183784067629639,7,158,hematopoietic progenitor cell differentiation,BP,PSMD2;DHTKD1;GATA3;PSMD7;SMPD3;MLF1;TGFB1
3298,GO:0006997,0.992513543484945,0.0194250899553992,6,124,nucleus organization,BP,VPS4A;BIN1;NEK9;CHMP5;REEP4;LEMD2
2496,GO:0005743,0.992570132327742,0.0125289548959489,25,407,mitochondrial inner membrane,CC,BOK;CPT2;IDH2;NME4;OCIAD2;CRAT;MRPS6;CDS2;MDH2;HADH;TST;ABCB8;HMGCL;OXA1L;SDHA;SRC;TAZ;NDUFA4L2;ACADVL;SLC25A43;TTC19;BCL2L1;SDHAF4;NDUFS2;NIPSNAP1
15177,GO:0071277,0.992589058486072,0.0459923314248561,1,43,cellular response to calcium ion,BP,ENDOG
3632,GO:0008094,0.992864925424237,0.0249583754826572,3,79,DNA-dependent ATPase activity,MF,ERCC6;SMARCA1;ANXA1
9925,GO:0042255,0.992880843430033,0.0440618844852337,1,54,ribosome assembly,BP,WDR18
14884,GO:0070647,0.992970193614716,0.00971676228613457,77,945,protein modification by small protein conjugation or removal,BP,TNIP1;GID4;RBCK1;NEURL1;SHARPIN;FKBP1A;PSMD2;MTA1;SMURF2;MARCH9;USP20;JOSD2;HECW2;FBXW8;AKT1;SYVN1;WWTR1;RNF135;TMEM129;FBXO2;ZNF598;FBXW5;LIMK1;UBE2J1;ARRDC1;KLHL29;WDTC1;OTUB2;CDC34;JADE2;ANKIB1;RAG1;CUL7;FBXL6;HLTF;PARP10;GATA3;DCAF7;WFS1;TOP1;BLMH;MBD6;PEX10;UBR4;LRSAM1;GSK3A;FYN;ZNF862;RMND5A;PSMD7;THOP1;FBXL15;RNF44;UBA1;RNF187;MIB2;SOCS2;ASB13;STUB1;TRIB3;DDB2;RMND5B;RAD23A;MGRN1;KLHL17;RNF222;SPSB3;NEURL1B;HGS;CBL;SOCS7;USP32;RNF103;TFPT;EP300;TRAF7;RNF10
1861,GO:0004521,0.992975071366812,0.0438359201577901,1,47,endoribonuclease activity,MF,LACTB2
6936,GO:0030532,0.993034115048691,0.0296915309429019,2,69,small nuclear ribonucleoprotein complex,CC,MAPKBP1;SF3B6
8809,GO:0034504,0.993144313461459,0.0141496969360729,12,205,protein localization to nucleus,BP,DVL1;SESN2;AKT1;IPO13;PARP10;ARL2;SRC;RERE;FYN;ABCA7;TGFB1;PPP1R10
6697,GO:0030071,0.993194174186113,0.0427514527528939,1,46,regulation of mitotic metaphase/anaphase transition,BP,HECW2
17890,GO:1902099,0.993194174186113,0.0427514527528939,1,46,regulation of metaphase/anaphase transition of cell cycle,BP,HECW2
6607,GO:0022625,0.993265708788756,0.041856133020752,1,63,cytosolic large ribosomal subunit,CC,RPL28
12872,GO:0051171,0.993477164253061,0.00776607038733871,418,4389,regulation of nitrogen compound metabolic process,BP,TNIP1;EDEM1;XDH;BTBD2;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;PLAT;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;SNX9;BOK;CRTC1;MEF2D;DLG4;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;MAPKAPK3;SESN2;ABTB1;ZC3H6;NACC2;ADGRF1;BCR;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;RFX2;PRKACA;ADARB1;MAP2K2;PPP1R13L;STK25;MN1;MIER2;ATF4;HECW2;ZKSCAN2;SNX33;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;CTSZ;EPHA1;ZMIZ2;PTK6;FBXO2;PCSK9;ENDOG;ZNF598;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;DRAP1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;SHC2;CD44;DNAJB5;ZNF516;PLCG1;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;LARP6;TFE3;PRDX5;CCND2;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;DUSP4;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;HMGA2;ARID5B;PPP1R14A;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;SRC;APLP2;KDM4B;TAZ;DNM2;AGO4;FAM162A;IRF7;HIST3H2A;RFXANK;RAB1B;STK24;RALY;PAK6;PER3;STX5;ESRP1;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;OAS1;FYN;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;NELFCD;PSMD7;MICAL1;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;ITGA1;EHF;COMT;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;SOCS2;HES2;STUB1;PCSK1N;TRIB3;ZFPL1;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;LRRK1;FGF2;EHD4;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;CASP4;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;AIDA;MLF1;ZFP30;MED29;CEACAM1;PAIP2;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;PPP6R1;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;ASH2L;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;WDFY2;FHOD1;TRAF7;RNF10
3817,GO:0008408,0.99351870818793,0.0410673970933311,1,46,3'-5' exonuclease activity,MF,ISG20
17695,GO:1901532,0.993728196025644,0.0220882099976469,3,103,regulation of hematopoietic progenitor cell differentiation,BP,PSMD2;GATA3;PSMD7
20314,GO:2001251,0.993743053126663,0.0177700791776262,5,111,negative regulation of chromosome organization,BP,ERCC1;PHF1;CTBP1;SRC;PHF2
2815,GO:0006278,0.993837937658571,0.0267860482628559,2,66,RNA-dependent DNA biosynthetic process,BP,SRC;MAPK3
13198,GO:0051784,0.993855371195005,0.0392619549979901,1,47,negative regulation of nuclear division,BP,TOM1L2
134,GO:0000280,0.994073419342193,0.0105863959606944,21,318,nuclear division,BP,LRP5;TUBG2;HECW2;VPS4A;FBXW5;OBSL1;CUL7;HSF1;CHMP5;AGO4;TOM1L2;TUBG1;MAU2;LEMD2;HSPA2;SPIRE1;TGFA;NDE1;WRAP73;CCNE1;TGFB1
1875,GO:0004540,0.994111599490636,0.0210375294605476,3,86,ribonuclease activity,MF,ISG20;RNASE7;LACTB2
6235,GO:0019783,0.9941261456271,0.0184566650340723,4,97,ubiquitin-like protein-specific protease activity,MF,USP20;JOSD2;OTUB2;USP32
6892,GO:0030397,0.994196157548885,0.03749351770079,1,46,membrane disassembly,BP,NEK9
12806,GO:0051081,0.994196157548885,0.03749351770079,1,46,nuclear envelope disassembly,BP,NEK9
3053,GO:0006613,0.994352835793843,0.0245201584133261,2,96,cotranslational protein targeting to membrane,BP,SEC63;RPL28
2875,GO:0006369,0.994421569820594,0.0245495327432759,2,69,termination of RNA polymerase II transcription,BP,SYMPK;SSU72
10520,GO:0043414,0.994448191292682,0.011114248706925,14,234,macromolecule methylation,BP,DNMT3A;RAB3B;FAM129B;RRNAD1;BAZ2A;BCDIN3D;SATB1;GATA3;PHF1;PCMTD2;MBD3;ASH2L;RAB6A;GNAS
4253,GO:0009451,0.994477589065173,0.0147440201748522,6,132,RNA modification,BP,AARS;ADARB1;RRNAD1;BCDIN3D;RPUSD3;APOBEC3C
8913,GO:0034728,0.994567000008975,0.0155442108064248,5,139,nucleosome organization,BP,H1F0;TSPYL2;HIST2H2BE;HIST3H2A;RSF1
15496,GO:0071824,0.994748355128709,0.0110201955925167,12,237,protein-DNA complex subunit organization,BP,H1F0;SOX12;XPC;TSPYL2;HIST2H2BE;BAZ2A;HIST3H2A;RSF1;THRA;DDB2;WDR18;TAF6
15108,GO:0071103,0.994777382281417,0.0107060321194201,13,245,DNA conformation change,BP,H1F0;SMARCA1;XPC;TSPYL2;HIST2H2BE;TNRC18;PARP10;HMGA2;TOP1;RSF1;DDB2;BAHCC1;ANXA1
290,GO:0000794,0.994793843471273,0.0231801557583231,2,66,condensed nuclear chromosome,CC,TUBG1;HSPA2
5685,GO:0016796,0.994860732257668,0.0338334234518825,1,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,ISG20
18265,GO:1903047,0.994918160830728,0.00740326578124204,59,760,mitotic cell cycle process,BP,FHL1;CCND1;SNX9;DLG1;PSMD2;NACC2;LRP5;EGFR;CSNK1E;SEPT10;PRKACA;TUBG2;HECW2;SNX33;AKT1;XPC;VPS4A;FBXW5;SEPT5;OBSL1;CDC34;CCND2;ZNF385A;CUL7;RHOC;PCBP4;SEPT8;PKD1;NEK9;HMGA2;EIF4EBP1;CHMP5;DNM2;NINL;TOM1L2;SDCCAG8;REEP4;PSMD7;FBXL15;BRSK1;GJC2;FGFR1;TUBG1;HYAL1;BCL2L1;MAU2;TAOK1;TGFA;NDE1;CNOT11;WRAP73;KANK2;CSNK1D;ARHGEF2;CCNE1;TGFB1;ANXA1;PPP1R10;EP300
5429,GO:0016279,0.994945396784446,0.0334038820859565,1,47,protein-lysine N-methyltransferase activity,MF,ASH2L
7242,GO:0031145,0.995055088803222,0.0220346384761212,2,77,anaphase-promoting complex-dependent catabolic process,BP,PSMD2;PSMD7
2881,GO:0006383,0.99507751795859,0.0325818847857254,1,50,transcription by RNA polymerase III,BP,PRDX5
19853,GO:2000278,0.995136513415429,0.01781104956836,3,84,regulation of DNA biosynthetic process,BP,FAM129B;SRC;MAPK3
9553,GO:0036297,0.995193257596591,0.0320048991471765,1,48,interstrand cross-link repair,BP,ERCC1
3354,GO:0007091,0.995209712856566,0.0318825203698205,1,49,metaphase/anaphase transition of mitotic cell cycle,BP,HECW2
10997,GO:0044784,0.995209712856566,0.0318825203698205,1,49,metaphase/anaphase transition of cell cycle,BP,HECW2
10790,GO:0044237,0.995280144454007,0.00564346619503038,772,7891,cellular metabolic process,BP,TNIP1;NT5E;EDEM1;XDH;BTBD2;ITGB4;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;MST1R;RAC2;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;SNX9;LMF1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;DLG1;TRIM65;DAP;IGFBP4;SLC16A3;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;AGPAT3;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;PLCH2;CYGB;FAM129B;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;FKBP9;HAGH;OSBPL10;USP20;NACC2;ADGRF1;BCR;RAB31;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;PGLS;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;FYCO1;RFX2;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;HK1;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;GPC4;IRAK1;PEG3;SERPING1;ALDH1L2;BAG3;APOE;ATG16L2;EHD3;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;CRYL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;PI4K2A;ZMIZ2;PTK6;SLC20A1;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;ACAD10;NMRK1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;DRAP1;HADH;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;ESYT2;PLCG1;TBC1D16;ATG13;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TBC1D14;TFE3;PRDX5;CCND2;PPP1R12C;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;ISYNA1;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;FARP1;DUSP4;PTPN9;SATB1;FUCA1;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;GRB10;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;SLC2A3;ZNF165;RPUSD3;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;PLCB3;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;AKR7A2;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;NDUFA4L2;MARK3;STK24;CPTP;ACADVL;RGS19;RALY;PAK6;PER3;RBMS2;ESRP1;GPX3;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;PRIMPOL;MPI;ISG20;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;RMND5A;NELFCD;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;ANXA3;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;UCKL1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LOXL1;LHPP;WDFY3;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ADIPOR1;ST3GAL3;NT5DC2;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ARFGEF2;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;ACP7;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;MAP1LC3B;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;SDHAF4;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;CAMSAP3;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;ATP6V1C2;CNOT11;CYB561;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;BPHL;ARSK;CASP4;ACY1;SNAP29;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;PACS2;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DRAM2;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;UGCG;AIDA;MLF1;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;SRPX2;HM13;MED29;CEACAM1;PNPLA6;PAIP2;GALNT3;MINK1;ZNF256;LPIN3;TFPT;UROS;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;ITSN1;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;SH3PXD2A;ADCK2;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
3969,GO:0008757,0.995374670710108,0.0125649734617682,6,132,S-adenosylmethionine-dependent methyltransferase activity,MF,DNMT3A;RRNAD1;GAMT;COMT;PCMTD2;ASH2L
4960,GO:0015030,0.995418223059583,0.0306660850061904,1,51,Cajal body,CC,ISG20
5764,GO:0016925,0.995466860234213,0.0167364689090497,3,85,protein sumoylation,BP,MTA1;TOP1;RNF222
5428,GO:0016278,0.995489412457321,0.0303551435592335,1,48,lysine N-methyltransferase activity,MF,ASH2L
4781,GO:0010965,0.995518738185996,0.0301318899693381,1,50,regulation of mitotic sister chromatid separation,BP,HECW2
1461,GO:0003700,0.995666552415155,0.00595469102103794,91,1081,DNA binding transcription factor activity,MF,NFATC4;ETV4;MEF2D;NR1D1;TEF;ZKSCAN1;SOX12;MTA1;ZC3H6;NACC2;ETV5;KIAA1549;XBP1;RFX2;ATF4;ZKSCAN2;PEG3;ZSCAN30;ELK3;POU2F2;TFEB;DEAF1;SALL2;DRAP1;SCAND1;CREB3L2;SOX7;PPARA;ZNF516;MSRB2;TFE3;SP6;ZNF385A;DDIT3;SATB1;MLXIP;HLTF;GATA3;PHF1;TCFL5;ZNF165;HSF1;CTBP1;RAI1;HMGA2;ARID5B;TSC22D4;IRF7;RFXANK;RERE;CAMTA2;ZNF692;TLE4;VDR;EHF;THRA;ZSCAN18;ZNF71;HSF4;RREB1;ZBED4;ADNP;USF2;PBX3;HES2;ZFPM1;MXD4;E2F5;ZNF419;ZNF570;RCOR1;ZNF398;RXRA;L3MBTL3;ZHX3;TSHZ1;TAF6;ZBTB4;TCF25;ZNF624;CARHSP1;CBL;DBP;LITAF;ZNF444;ZFP30;ZNF256;ZFP28;KLF12;EP300;TCF7L1
8271,GO:0033045,0.995723741539961,0.0195152380590233,2,70,regulation of sister chromatid segregation,BP,HECW2;RMI2
5285,GO:0015935,0.995770262292054,0.0283580884870817,1,68,small ribosomal subunit,CC,MRPS6
10988,GO:0044770,0.995827617259739,0.00671381665891095,36,511,cell cycle phase transition,BP,FHL1;CCND1;PSMD2;NACC2;EGFR;CSNK1E;PRKACA;HECW2;AKT1;XPC;VPS4A;CDC34;CCND2;ZNF385A;PCBP4;PKD1;HMGA2;EIF4EBP1;DNM2;NINL;SDCCAG8;PSMD7;FBXL15;BRSK1;GJC2;TUBG1;HYAL1;TAOK1;NDE1;CNOT11;KANK2;CSNK1D;CCNE1;TGFB1;ANXA1;EP300
12871,GO:0051170,0.996081285569106,0.010807122424591,6,135,import into nucleus,BP,AKT1;IPO13;PARP10;RERE;TGFB1;PPP1R10
9840,GO:0042054,0.996228103985213,0.0260907670718916,1,50,histone methyltransferase activity,MF,ASH2L
11068,GO:0045047,0.99624058478773,0.0172223272503439,2,101,protein targeting to ER,BP,SEC63;RPL28
856,GO:0002181,0.996267566109967,0.0172139193182977,2,85,cytoplasmic translation,BP,ZNF385A;EIF4EBP1
7234,GO:0031124,0.996269604582421,0.0140785998472234,3,88,mRNA 3'-end processing,BP,SYMPK;HSF1;SSU72
8899,GO:0034708,0.99627552340051,0.014045933678133,3,90,methyltransferase complex,CC,PHF1;TAF6;ASH2L
12966,GO:0051306,0.996432242840372,0.0248548634492934,1,52,mitotic sister chromatid separation,BP,HECW2
13308,GO:0051983,0.996493915806435,0.0133229923790818,3,89,regulation of chromosome segregation,BP,HECW2;PUM1;RMI2
2950,GO:0006479,0.996499958702244,0.00918023301011462,7,149,protein methylation,BP,RAB3B;SATB1;GATA3;PHF1;PCMTD2;ASH2L;RAB6A
3704,GO:0008213,0.996499958702244,0.00918023301011462,7,149,protein alkylation,BP,RAB3B;SATB1;GATA3;PHF1;PCMTD2;ASH2L;RAB6A
15449,GO:0071704,0.99657863506958,0.00411679486505385,773,7911,organic substance metabolic process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;BTBD2;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;SNX9;LMF1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;BSG;NR1D1;DLG1;DAP;IGFBP4;SLC16A3;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;AGPAT3;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;PLCH2;CYGB;FAM129B;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;BBS2;FKBP9;HAGH;OSBPL10;USP20;NACC2;ADGRF1;BCR;RAB31;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;PGLS;MAP4K4;EGFR;LRP10;CSNK1E;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;ACTA2;HK1;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;CARD11;GPC4;IRAK1;PEG3;SERPING1;ALDH1L2;BAG3;APOE;EHD3;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;CRYL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;PI4K2A;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;ACAD10;NMRK1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;PLD3;DRAP1;HADH;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;PRSS8;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;ESYT2;PLCG1;TBC1D16;ATG13;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TFE3;PRDX5;CCND2;TSPAN5;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;ISYNA1;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;SLC2A3;ZNF165;GGACT;RPUSD3;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;PLCB3;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;AKR7A2;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;CPTP;ACADVL;RALY;PAK6;PER3;STX5;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;PRIMPOL;MPI;ISG20;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;TMPRSS11D;ZNF862;LPAR3;GALE;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;ANXA3;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;TSPAN33;UCKL1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ARFGEF2;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;BPHL;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;UGCG;AIDA;MLF1;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;HM13;MED29;CEACAM1;PNPLA6;PAIP2;APBA1;GALNT3;MINK1;ZNF256;LPIN3;TFPT;UROS;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
3623,GO:0008080,0.996606395046864,0.0159557278391104,2,72,N-acetyltransferase activity,MF,NAGS;EP300
10800,GO:0044260,0.996609314745487,0.00405338505943983,599,6228,cellular macromolecule metabolic process,BP,TNIP1;NT5E;EDEM1;XDH;BTBD2;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;MST1R;RAC2;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;ETV4;ERCC6;CST3;NEURL1;SNX9;LMF1;BOK;SHARPIN;CRTC1;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRNP;BNIP3;SBF1;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;MAPKAPK3;CTSB;SESN2;ABTB1;LY6K;MARCH9;ZC3H6;FKBP9;USP20;NACC2;ADGRF1;BCR;RAB31;CHPF;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;XYLT1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CARS;JOSD2;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;EHD3;ATP13A2;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;RNF135;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;CTSZ;EPHA1;ZMIZ2;PTK6;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;DRAP1;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TFE3;PRDX5;CCND2;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;TTBK2;ERO1B;BCL9L;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;UBXN4;TCFL5;DCAF7;ANO8;GNAI2;PPM1M;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;NEK9;SRD5A3;ASPH;CTBP1;PTPRU;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;MPG;INTS8;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;IGFBP2;P4HA1;MYDGF;B4GALT2;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;POLD4;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;FYN;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;RMND5A;NELFCD;PSMD7;MICAL1;TNFRSF1A;THOP1;ANXA3;TLE4;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;TNRC6B;THRA;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;ZSCAN18;RNF187;ZNF71;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;STUB1;PCSK1N;STK17A;ST3GAL3;TRIB3;DDB2;ZFPL1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ARFGEF2;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;MGRN1;HPSE;E2F5;SAMD4B;ULK2;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;ARSK;CASP4;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;SOCS7;USP32;MAPK3;EEPD1;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DNAJB9;LITAF;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;AIDA;MLF1;B4GALT6;MATN3;ZFP30;HM13;MED29;CEACAM1;PAIP2;GALNT3;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;RMI2;SPRED2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
1787,GO:0004402,0.996695844977485,0.0233244759594844,1,51,histone acetyltransferase activity,MF,EP300
8808,GO:0034502,0.996754213006119,0.0153505561598461,2,72,protein localization to chromosome,BP,MAU2;LEMD2
19401,GO:1905818,0.9967930259283,0.02270396561546,1,53,regulation of chromosome separation,BP,HECW2
3739,GO:0008276,0.996800308043232,0.0151609976581423,2,72,protein methyltransferase activity,MF,PCMTD2;ASH2L
5076,GO:0015297,0.99680474798488,0.0226760752753688,1,51,antiporter activity,MF,TMCO3
8943,GO:0034968,0.996833653058384,0.01217608955006,3,89,histone lysine methylation,BP,GATA3;PHF1;ASH2L
6579,GO:0022402,0.996885577990448,0.00431045713920349,93,1140,cell cycle process,BP,FHL1;ERCC1;CCND1;MAP2K1;CYP27B1;SNX9;ARAP1;DLG1;PSMD2;PRNP;NACC2;LRP5;EGFR;CSNK1E;SEPT10;PRKACA;TUBG2;HECW2;SNX33;AKT1;XPC;PPP2R3B;VPS4A;FBXW5;SEPT5;PPP2R5B;OBSL1;CDC34;CCND2;GIT1;BIN1;PAK1;ZNF385A;DDIT3;CUL7;SDCCAG3;GAS2L1;RHOC;PCBP4;SEPT8;PKD1;HSF1;NEK9;HMGA2;RHOBTB2;ARL2;EIF4EBP1;GIPC1;CHMP5;POLD4;DNM2;NINL;AGO4;PAK6;TOM1L2;SDCCAG8;REEP4;PSMD7;FBXL15;BRSK1;CGREF1;GJC2;FGFR1;TUBG1;HYAL1;MIF;TTC19;RAB11FIP4;BCL2L1;MAU2;LEMD2;HSPA2;PAK4;SPIRE1;TAOK1;APBB1;RHOBTB1;WDR18;TGFA;NDE1;CNOT11;WRAP73;KANK2;CSNK1D;ARHGEF2;LLGL1;MLF1;CCNE1;TGFB1;RMI2;ANXA1;PPP1R10;EP300
2892,GO:0006400,0.996933084290852,0.0145949271902468,2,74,tRNA modification,BP,AARS;RPUSD3
12182,GO:0048285,0.99695850130269,0.00551655322958893,23,355,organelle fission,BP,BNIP3;LRP5;TUBG2;HECW2;VPS4A;FBXW5;OBSL1;CUL7;HSF1;CHMP5;DNM2;AGO4;TOM1L2;TUBG1;MAU2;LEMD2;HSPA2;SPIRE1;TGFA;NDE1;WRAP73;CCNE1;TGFB1
275,GO:0000777,0.997010143216034,0.0115578652008016,3,92,condensed chromosome kinetochore,CC,HSF1;PHF2;NDE1
5743,GO:0016887,0.997060405412877,0.00534417405645445,23,349,ATPase activity,MF,ERCC6;SMARCA1;TNNT1;ATP13A2;ATP7B;VPS4A;ABCB8;IDE;HLTF;ATP11A;KIF17;KIF13B;ATP2C2;TCIRG1;HSPA2;HSPA13;MYO1D;ABCA7;ATP6V1C2;LONP2;KIFC3;PCYOX1;ANXA1
2803,GO:0006261,0.997075633717338,0.00828338553845714,6,137,DNA-dependent DNA replication,BP,CDC34;POLD4;PRIMPOL;FGFR1;WDR18;CCNE1
17297,GO:0120114,0.997138335027732,0.0137026972668117,2,79,Sm-like protein family complex,CC,MAPKBP1;SF3B6
2732,GO:0006110,0.99724138261231,0.0200142921919352,1,52,regulation of glycolytic process,BP,PPARA
15893,GO:0072599,0.997255475092516,0.0130815457723383,2,104,establishment of protein localization to endoplasmic reticulum,BP,SEC63;RPL28
4687,GO:0010833,0.997275403101924,0.0131657959160219,2,74,telomere maintenance via telomere lengthening,BP,SRC;MAPK3
13722,GO:0060255,0.997349829244398,0.00320676233031213,430,4573,regulation of macromolecule metabolic process,BP,TNIP1;EDEM1;XDH;BTBD2;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;PLAT;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;SNX9;BOK;CRTC1;ARAP1;MEF2D;DLG4;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;TEF;IFI6;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;PC;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;MAPKAPK3;SESN2;ABTB1;ZC3H6;BBS2;NACC2;ADGRF1;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;FBLN1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;MMP14;RFX2;PRKACA;ADARB1;ACTA2;MAP2K2;PPP1R13L;STK25;MN1;MIER2;ATF4;HECW2;ZKSCAN2;SNX33;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;VPS11;ARHGAP22;PPP2R3B;FZD8;CTSZ;EPHA1;ZMIZ2;PTK6;FBXO2;SH3PXD2B;PCSK9;ENDOG;ZNF598;FERMT1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;DRAP1;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;SHC2;CD44;DNAJB5;ZNF516;PLCG1;TBC1D16;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;ANKIB1;LARP6;TFE3;PRDX5;CCND2;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;TNFSF15;BCDIN3D;GGA3;GGA1;DUSP4;SATB1;RET;RAB29;PTOV1;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;NEIL1;TFPI2;RAI1;HMGA2;ARID5B;TOP1;PPP1R14A;MICAL2;MYDGF;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;SRC;CHMP5;APLP2;KDM4B;DNM2;AGO4;FAM162A;IRF7;HIST3H2A;RFXANK;RAB1B;STK24;RALY;PAK6;PER3;STX5;ESRP1;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;OAS1;FYN;AGRN;ZNF692;PPM1F;ZNF862;LPAR3;PFN1;NELFCD;PSMD7;MICAL1;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;ITGA1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;TIMP1;CRIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;SOCS2;MTMR4;HES2;STUB1;PCSK1N;TRIB3;ZFPL1;SNX25;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;LRRK1;FGF2;EHD4;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;CASP4;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;SOCS7;MAPK3;KANK2;POMT1;MAPK10;CSNK1D;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;AIDA;MLF1;ZFP30;MED29;CEACAM1;PAIP2;APBA1;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;PPP6R1;CAT;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;PPP1R10;ASH2L;GNAS;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;WDFY2;FHOD1;TRAF7;RNF10
15077,GO:0071013,0.997364871107849,0.0103164806920482,3,96,catalytic step 2 spliceosome,CC,MAPKBP1;RALY;SF3B6
14442,GO:0061733,0.997380646142692,0.0191385578406254,1,53,peptide-lysine-N-acetyltransferase activity,MF,EP300
3051,GO:0006611,0.997441538387368,0.00653942171354449,8,170,protein export from nucleus,BP,XPOT;RAPGEF3;BAG3;SYMPK;IFI27;PKD1;CAMK1;TGFB1
10791,GO:0044238,0.997517153105157,0.00299989112249126,749,7698,primary metabolic process,BP,TNIP1;NT5E;EDEM1;ANGPTL4;XDH;BTBD2;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;SNX9;LMF1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;OBSCN;CPT2;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;PITPNM1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;DGKA;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;AGPAT3;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;PLCH2;CYGB;FAM129B;G0S2;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;FKBP9;OSBPL10;USP20;NACC2;ADGRF1;BCR;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;PGLS;MAP4K4;EGFR;LRP10;CSNK1E;PANO1;MKNK2;TK2;ACOT1;CCDC71L;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;HK1;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;TTC7B;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;CARD11;GPC4;IRAK1;PEG3;SERPING1;BAG3;APOE;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;CRYL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;RNF135;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;PI4K2A;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;ACAD10;NMRK1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;PLD3;DRAP1;HADH;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;PLCXD1;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;PRSS8;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;ESYT2;PLCG1;ATG13;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TFE3;PRDX5;CCND2;TSPAN5;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;ISYNA1;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;RET;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;SLC2A3;ZNF165;RPUSD3;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;PLCB3;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;AKR7A2;PIP5K1C;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;APLP2;MBD6;KDM4B;GLRX;CBR4;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;CPTP;ACADVL;RALY;PAK6;PER3;STX5;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;TALDO1;DUSP6;PMVK;OAS1;FYN;PRIMPOL;MPI;ISG20;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;TMPRSS11D;ZNF862;LPAR3;GALE;PFN1;RMND5A;NELFCD;NISCH;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;ANXA3;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;TSPAN33;UCKL1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;PLTP;NTSR1;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;PITPNM2;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;PIP5KL1;SLC6A14;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PLCD3;PAK4;TNFRSF19;MXD4;MGRN1;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;BPHL;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;MAPK3;EEPD1;CPT1B;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;UGCG;AIDA;MLF1;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;ADAM15;HM13;MED29;CEACAM1;PNPLA6;PAIP2;GALNT3;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;SLC45A3;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;ZFYVE21;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
2469,GO:0005684,0.997530008981916,0.0181325192105239,1,58,U2-type spliceosomal complex,CC,SF3B6
3671,GO:0008170,0.997810994512439,0.0108616904625202,2,76,N-methyltransferase activity,MF,RRNAD1;ASH2L
6025,GO:0019080,0.997832347256548,0.00588270181493352,7,185,viral gene expression,BP,HMGA2;RSF1;NELFCD;USF2;RPL28;FURIN;EP300
4538,GO:0010608,0.997851084339157,0.00363094924677532,33,506,posttranscriptional regulation of gene expression,BP,MAP2K1;NEURL1;PSMD2;SESN2;NACC2;EGFR;MKNK2;MAP2K2;ATF4;AKT1;ZNF598;LARP6;ZNF385A;BCDIN3D;PCBP4;EIF4EBP1;AGO4;PSMD7;PUM1;TNRC6B;SECISBP2L;MIF4GD;SAMD4B;PYM1;RXRA;CNOT11;IMPACT;CARHSP1;MAPK3;PAIP2;IGF2BP3;EIF4G3;TGFB1
12796,GO:0051052,0.997882426780995,0.00406694961312149,20,323,regulation of DNA metabolic process,BP,ERCC1;SHC1;CST3;FAM129B;EGFR;AKT1;TSPYL2;ENDOG;GATA3;HSF1;HMGA2;SRC;ANXA3;FGFR1;APBB1;WDR18;MAPK3;MBD3;TGFB1;PPP1R10
35,GO:0000070,0.997897976364455,0.00612520666095621,6,142,mitotic sister chromatid segregation,BP,TUBG2;HECW2;VPS4A;CHMP5;TUBG1;MAU2
10303,GO:0043043,0.997932505701763,0.00328738578139021,44,673,peptide biosynthetic process,BP,TNIP1;CHAC1;MAP2K1;NEURL1;SESN2;ABTB1;HAGH;AARS;EGFR;MKNK2;CARS;MAP2K2;ATF4;MRPS6;AKT1;ZNF598;GTPBP1;LARP6;ZNF385A;BCDIN3D;CNDP2;EIF4EBP1;AGO4;GARS;PUM1;TNRC6B;EIF2S2;SECISBP2L;RRBP1;MIF4GD;SARS2;SAMD4B;PYM1;RXRA;RPL28;CNOT11;IMPACT;GGT1;MAPK3;FURIN;PAIP2;IGF2BP3;EIF4G3;TGFB1
6028,GO:0019083,0.99793625901132,0.00598577443311493,6,171,viral transcription,BP,HMGA2;RSF1;NELFCD;USF2;RPL28;EP300
15047,GO:0070972,0.998022631263989,0.00791530629640961,3,125,protein localization to endoplasmic reticulum,BP,KDELR1;SEC63;RPL28
16336,GO:0090502,0.998043126121284,0.0148625890148063,1,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,LACTB2
10909,GO:0044445,0.998044175738772,0.0050790916869325,8,203,cytosolic part,CC,PSMD2;ADCY7;FYCO1;PI4K2A;IDE;RPL28;CASP4;ADCY6
7604,GO:0031974,0.99805682218256,0.00237344008739249,395,4311,membrane-enclosed lumen,CC,TNIP1;NT5E;PYGB;TSPAN1;ERCC1;NOS1;H1F0;CCND1;SORL1;CTNNBIP1;NFATC4;SDC1;SHC1;PITPNC1;DOCK4;PYGL;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;EPN3;NAPRT;CRTC1;PCK2;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;IGFBP4;DNMT3A;PGM1;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;PRSS3;NAGS;IDH2;BNIP3;SBF1;PC;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;ACOT7;ABTB1;HAGH;NACC2;VWA5A;CHPF;ETV5;H6PD;GPT2;XBP1;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;PRKACA;ADARB1;FCHO1;CRAT;FAM114A1;PPP1R13L;FAM50A;ATF4;P4HB;PDIA5;MRPS6;AKT1;XPC;MDH2;GPC4;SERPING1;ALDH1L2;APOE;ATG16L2;ATP13A2;ARG2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;GALNS;PHC2;FAM20C;ITPR3;POU2F2;NAGLU;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;PITRM1;CTSZ;ZMIZ2;PTK6;PTPDC1;PCSK9;NSMCE4A;GIT2;ACAD10;DEAF1;SALL2;LAMB2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;DHTKD1;SYMPK;TST;PRKACB;H2AFJ;LTBP1;WDTC1;CDC34;ABCB8;IDE;DEDD2;JADE2;TBC1D14;TFE3;PRDX5;CCND2;CMIP;HMGCL;CERCAM;BCL9L;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;PODXL;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;DNASE1L1;CYTH3;HLTF;PARP10;GATA3;PHF1;DCAF7;OASL;ANO8;GNAI2;RPUSD3;GLUD1;HSF1;APPL2;SIN3B;ANKS1A;WFS1;SH3GLB2;CNDP2;SDHA;CTBP1;CDCA7L;NEIL1;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;ARL2;PLCB3;CAP1;P4HA1;MYDGF;B4GALT2;PIP5K1C;TULP3;SRC;APLP2;MBD6;KDM4B;CBR4;CAPG;POLD4;FKBP10;KLHDC2;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;STK24;ACADVL;PAK6;YPEL3;ESRP1;C6ORF120;GARS;RERE;RSF1;STXBP1;PCSK6;TALDO1;DUSP6;OAS1;PRIMPOL;ISG20;AGRN;ZNF692;YPEL5;WNT5B;NELFCD;ALDH4A1;PSMD7;ALDH7A1;THOP1;TLE4;VDR;BRPF3;VWA1;BRSK1;SSU72;PUM1;RNF44;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;RCN1;HEXIM1;TIMP1;UBA1;MGLL;RNF187;HSF4;LGALS3BP;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;HYAL1;PHF2;TENM2;USF2;MIF;VPS37A;BCL2L1;STUB1;STK17A;MAU2;DDB2;PTPN12;ZFPM1;LRCH4;HLCS;SARS2;PRRC2A;RAD23A;HSPA2;ZNF609;HPSE;E2F5;USO1;SPIRE1;PNP;RNH1;MED15;MAPK9;SH3BGRL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;CHD7;RNF222;ZNF687;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;L3MBTL3;ZHX3;TAF6;VEGFB;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;HIST1H2AG;ARSK;KLK6;NOL4L;VAT1;SNAP29;LONP2;KLHDC10;RPRD1A;DRG2;POLM;TRAPPC1;FAM193B;CIB1;LACTB2;IQSEC1;MAPK3;MAPK10;CSNK1D;DNAJB9;LITAF;ALDOC;FURIN;S100A16;SNX27;MPLKIP;NDUFS2;MATN3;MED29;SKAP2;TFPT;ECM1;MBD3;CCNE1;TGFB1;SF3B6;WBP2;TM2D1;CAT;RMI2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;ERP44;TCF7L1;MZT2B
10411,GO:0043233,0.99805682218256,0.00237344008739249,395,4311,organelle lumen,CC,TNIP1;NT5E;PYGB;TSPAN1;ERCC1;NOS1;H1F0;CCND1;SORL1;CTNNBIP1;NFATC4;SDC1;SHC1;PITPNC1;DOCK4;PYGL;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;EPN3;NAPRT;CRTC1;PCK2;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;IGFBP4;DNMT3A;PGM1;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;PRSS3;NAGS;IDH2;BNIP3;SBF1;PC;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;ACOT7;ABTB1;HAGH;NACC2;VWA5A;CHPF;ETV5;H6PD;GPT2;XBP1;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;PRKACA;ADARB1;FCHO1;CRAT;FAM114A1;PPP1R13L;FAM50A;ATF4;P4HB;PDIA5;MRPS6;AKT1;XPC;MDH2;GPC4;SERPING1;ALDH1L2;APOE;ATG16L2;ATP13A2;ARG2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;GALNS;PHC2;FAM20C;ITPR3;POU2F2;NAGLU;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;PITRM1;CTSZ;ZMIZ2;PTK6;PTPDC1;PCSK9;NSMCE4A;GIT2;ACAD10;DEAF1;SALL2;LAMB2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;DHTKD1;SYMPK;TST;PRKACB;H2AFJ;LTBP1;WDTC1;CDC34;ABCB8;IDE;DEDD2;JADE2;TBC1D14;TFE3;PRDX5;CCND2;CMIP;HMGCL;CERCAM;BCL9L;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;PODXL;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;DNASE1L1;CYTH3;HLTF;PARP10;GATA3;PHF1;DCAF7;OASL;ANO8;GNAI2;RPUSD3;GLUD1;HSF1;APPL2;SIN3B;ANKS1A;WFS1;SH3GLB2;CNDP2;SDHA;CTBP1;CDCA7L;NEIL1;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;ARL2;PLCB3;CAP1;P4HA1;MYDGF;B4GALT2;PIP5K1C;TULP3;SRC;APLP2;MBD6;KDM4B;CBR4;CAPG;POLD4;FKBP10;KLHDC2;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;STK24;ACADVL;PAK6;YPEL3;ESRP1;C6ORF120;GARS;RERE;RSF1;STXBP1;PCSK6;TALDO1;DUSP6;OAS1;PRIMPOL;ISG20;AGRN;ZNF692;YPEL5;WNT5B;NELFCD;ALDH4A1;PSMD7;ALDH7A1;THOP1;TLE4;VDR;BRPF3;VWA1;BRSK1;SSU72;PUM1;RNF44;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;RCN1;HEXIM1;TIMP1;UBA1;MGLL;RNF187;HSF4;LGALS3BP;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;HYAL1;PHF2;TENM2;USF2;MIF;VPS37A;BCL2L1;STUB1;STK17A;MAU2;DDB2;PTPN12;ZFPM1;LRCH4;HLCS;SARS2;PRRC2A;RAD23A;HSPA2;ZNF609;HPSE;E2F5;USO1;SPIRE1;PNP;RNH1;MED15;MAPK9;SH3BGRL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;CHD7;RNF222;ZNF687;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;L3MBTL3;ZHX3;TAF6;VEGFB;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;HIST1H2AG;ARSK;KLK6;NOL4L;VAT1;SNAP29;LONP2;KLHDC10;RPRD1A;DRG2;POLM;TRAPPC1;FAM193B;CIB1;LACTB2;IQSEC1;MAPK3;MAPK10;CSNK1D;DNAJB9;LITAF;ALDOC;FURIN;S100A16;SNX27;MPLKIP;NDUFS2;MATN3;MED29;SKAP2;TFPT;ECM1;MBD3;CCNE1;TGFB1;SF3B6;WBP2;TM2D1;CAT;RMI2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;ERP44;TCF7L1;MZT2B
14539,GO:0070013,0.99805682218256,0.00237344008739249,395,4311,intracellular organelle lumen,CC,TNIP1;NT5E;PYGB;TSPAN1;ERCC1;NOS1;H1F0;CCND1;SORL1;CTNNBIP1;NFATC4;SDC1;SHC1;PITPNC1;DOCK4;PYGL;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;EPN3;NAPRT;CRTC1;PCK2;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;IGFBP4;DNMT3A;PGM1;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;PRSS3;NAGS;IDH2;BNIP3;SBF1;PC;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;LCN2;MAPKAPK3;CTSB;ACOT7;ABTB1;HAGH;NACC2;VWA5A;CHPF;ETV5;H6PD;GPT2;XBP1;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;PRKACA;ADARB1;FCHO1;CRAT;FAM114A1;PPP1R13L;FAM50A;ATF4;P4HB;PDIA5;MRPS6;AKT1;XPC;MDH2;GPC4;SERPING1;ALDH1L2;APOE;ATG16L2;ATP13A2;ARG2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;GALNS;PHC2;FAM20C;ITPR3;POU2F2;NAGLU;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;PITRM1;CTSZ;ZMIZ2;PTK6;PTPDC1;PCSK9;NSMCE4A;GIT2;ACAD10;DEAF1;SALL2;LAMB2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;DHTKD1;SYMPK;TST;PRKACB;H2AFJ;LTBP1;WDTC1;CDC34;ABCB8;IDE;DEDD2;JADE2;TBC1D14;TFE3;PRDX5;CCND2;CMIP;HMGCL;CERCAM;BCL9L;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;PODXL;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;DNASE1L1;CYTH3;HLTF;PARP10;GATA3;PHF1;DCAF7;OASL;ANO8;GNAI2;RPUSD3;GLUD1;HSF1;APPL2;SIN3B;ANKS1A;WFS1;SH3GLB2;CNDP2;SDHA;CTBP1;CDCA7L;NEIL1;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;ARL2;PLCB3;CAP1;P4HA1;MYDGF;B4GALT2;PIP5K1C;TULP3;SRC;APLP2;MBD6;KDM4B;CBR4;CAPG;POLD4;FKBP10;KLHDC2;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;STK24;ACADVL;PAK6;YPEL3;ESRP1;C6ORF120;GARS;RERE;RSF1;STXBP1;PCSK6;TALDO1;DUSP6;OAS1;PRIMPOL;ISG20;AGRN;ZNF692;YPEL5;WNT5B;NELFCD;ALDH4A1;PSMD7;ALDH7A1;THOP1;TLE4;VDR;BRPF3;VWA1;BRSK1;SSU72;PUM1;RNF44;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;RCN1;HEXIM1;TIMP1;UBA1;MGLL;RNF187;HSF4;LGALS3BP;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;HYAL1;PHF2;TENM2;USF2;MIF;VPS37A;BCL2L1;STUB1;STK17A;MAU2;DDB2;PTPN12;ZFPM1;LRCH4;HLCS;SARS2;PRRC2A;RAD23A;HSPA2;ZNF609;HPSE;E2F5;USO1;SPIRE1;PNP;RNH1;MED15;MAPK9;SH3BGRL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;CHD7;RNF222;ZNF687;MLYCD;MSLN;PHYH;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;L3MBTL3;ZHX3;TAF6;VEGFB;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;HIST1H2AG;ARSK;KLK6;NOL4L;VAT1;SNAP29;LONP2;KLHDC10;RPRD1A;DRG2;POLM;TRAPPC1;FAM193B;CIB1;LACTB2;IQSEC1;MAPK3;MAPK10;CSNK1D;DNAJB9;LITAF;ALDOC;FURIN;S100A16;SNX27;MPLKIP;NDUFS2;MATN3;MED29;SKAP2;TFPT;ECM1;MBD3;CCNE1;TGFB1;SF3B6;WBP2;TM2D1;CAT;RMI2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;ERP44;TCF7L1;MZT2B
3336,GO:0007051,0.998085254430656,0.00528098089636198,7,155,spindle organization,BP,DLG1;TUBG2;PKD1;CHMP5;TUBG1;WRAP73;CSNK1D
10919,GO:0044455,0.998123021011769,0.00549413023969627,6,166,mitochondrial membrane part,CC,BNIP3;OXA1L;SDHA;NDUFA4L2;SDHAF4;NDUFS2
332,GO:0000922,0.99812566539514,0.00551686338244569,6,142,spindle pole,CC,VPS4A;HSF1;MAPKBP1;FAM110C;TUBG1;NDE1
5562,GO:0016571,0.998129625678495,0.00660507193391471,4,111,histone methylation,BP,SATB1;GATA3;PHF1;ASH2L
5887,GO:0018022,0.998190982764619,0.00738640264159777,3,95,peptidyl-lysine methylation,BP,GATA3;PHF1;ASH2L
12889,GO:0051193,0.998296434422844,0.0087121287077749,2,77,regulation of cofactor metabolic process,BP,RAC2;PPARA
9936,GO:0042273,0.998351248830402,0.0127650905616273,1,67,ribosomal large subunit biogenesis,BP,WDR18
257,GO:0000723,0.998376785875713,0.00482418639057157,6,153,telomere maintenance,BP,ERCC1;SRC;POLD4;MAPK3;CCNE1;PPP1R10
1858,GO:0004518,0.998452433001109,0.00411066909137673,8,177,nuclease activity,MF,ERCC1;ENDOG;RAG1;DNASE1L1;NEIL1;ISG20;RNASE7;LACTB2
9,GO:0000018,0.998528463679415,0.0116559663019733,1,58,regulation of DNA recombination,BP,TGFB1
7420,GO:0031503,0.998643271471349,0.00323072826176807,11,219,protein-containing complex localization,BP,AP3D1;DLG4;DLG1;XPOT;NACC2;SYMPK;DLG3;DYNLRB1;DNM2;KIF17;ARHGAP44
8273,GO:0033047,0.998695306593822,0.0104849191672167,1,61,regulation of mitotic sister chromatid segregation,BP,HECW2
15535,GO:0071897,0.998717379774676,0.00345548156379034,8,178,DNA biosynthetic process,BP,FAM129B;TK2;SRC;POLD4;PRIMPOL;POLM;MAPK3;RMI2
2863,GO:0006355,0.99873682282039,0.00160185622600442,253,2826,regulation of transcription, DNA-templated,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
8665,GO:0034212,0.998741168464034,0.0101751169226998,1,60,peptide N-acetyltransferase activity,MF,EP300
7233,GO:0031123,0.998771686516226,0.00450558796764719,4,119,RNA 3'-end processing,BP,SYMPK;HSF1;SSU72;INTS1
2802,GO:0006260,0.998917665748382,0.00240698146824908,14,260,DNA replication,BP,SHC1;CST3;EGFR;TSPYL2;CDC34;DTD1;TOP1;POLD4;PRIMPOL;FGFR1;WDR18;CCNE1;TGFB1;RMI2
20114,GO:2000736,0.998930195324068,0.00456937314937005,3,122,regulation of stem cell differentiation,BP,PSMD2;GATA3;PSMD7
15891,GO:0072594,0.999016985943456,0.00180595036392028,27,462,establishment of protein localization to organelle,BP,RAC2;SORL1;AP3D1;HK1;AKT1;VPS11;VPS4A;PITRM1;BNIP3L;ZDHHC8;IPO13;ATG13;SEC63;DDIT3;PARP10;PEX10;LRSAM1;RERE;GSK3A;MOAP1;NEURL1B;RPL28;LONP2;HGS;UGCG;TGFB1;PPP1R10
277,GO:0000779,0.999020690691626,0.00424678304626663,3,104,condensed chromosome, centromeric region,CC,HSF1;PHF2;NDE1
7716,GO:0032200,0.999141330757412,0.00268195429472984,6,166,telomere organization,BP,ERCC1;SRC;POLD4;MAPK3;CCNE1;PPP1R10
18452,GO:1903506,0.99915251769936,0.00108315505132184,253,2843,regulation of nucleic acid-templated transcription,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
20248,GO:2001141,0.999189794108383,0.00103641116398993,253,2845,regulation of RNA biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
12869,GO:0051168,0.999284805229397,0.00200784222190371,8,187,nuclear export,BP,XPOT;RAPGEF3;BAG3;SYMPK;IFI27;PKD1;CAMK1;TGFB1
10918,GO:0044454,0.999308019140664,0.00128036818882043,28,464,nuclear chromosome part,CC,ERCC1;H1F0;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;ZMIZ2;SALL2;H2AFJ;ZNF385A;SATB1;GATA3;APPL2;SIN3B;TOP1;POLD4;HIST3H2A;RSF1;HSPA2;RXRA;HIST2H2AC;HIST1H2AG;TFPT;MBD3;WBP2;PPP1R10;ASH2L
3284,GO:0006974,0.999336987771655,0.00106487026711637,52,740,cellular response to DNA damage stimulus,BP,ERCC1;CCND1;NFATC4;ERCC6;BOK;MTA1;SESN2;NACC2;EGFR;CSNK1E;AKT1;XPC;NSMCE4A;CD44;MC1R;ZNF385A;DDIT3;PCBP4;PHF1;HSF1;NEIL1;MPG;HMGA2;POLD4;IRF7;HIST3H2A;PRIMPOL;TNFRSF1A;BRSK1;MOAP1;SHISA5;UBA1;MIF;BCL2L1;STUB1;DDB2;RAD23A;TAOK1;APBB1;ZBTB4;CNOT11;POLM;CBL;CIB1;MAPK3;EEPD1;TFPT;RMI2;SPRED2;PPP1R10;ASH2L;EP300
17331,GO:0140110,0.99933756294087,0.000929783866029505,115,1398,transcription regulator activity,MF,ZMYND8;CCND1;NFATC4;ETV4;MEF2D;NR1D1;TEF;ZKSCAN1;SOX12;MTA1;CITED4;FAM129B;ZC3H6;NACC2;ETV5;KIAA1549;XBP1;RFX2;PPP1R13L;ATF4;ZKSCAN2;PEG3;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;POU2F2;TFEB;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;CREB3L2;SOX7;PPARA;ZNF516;MSRB2;TFE3;SUFU;SP6;BCL9L;ZNF385A;DDIT3;SATB1;MLXIP;HLTF;GATA3;PHF1;TCFL5;ZNF165;HSF1;SIN3B;CTBP1;RAI1;HMGA2;ARID5B;TSC22D4;IRF7;RFXANK;RALY;PER3;RERE;CAMTA2;ZNF692;TLE4;VDR;EHF;THRA;MAP3K10;ZSCAN18;ZNF71;HSF4;RREB1;ZBED4;ADNP;PHF2;USF2;PBX3;HES2;TRIB3;ZFPM1;MXD4;E2F5;ZNF419;FGF2;MED15;ZNF570;CDYL2;RCOR1;ZNF398;RXRA;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;ZBTB4;TCF25;ZNF624;CARHSP1;CBL;DBP;LITAF;ZNF444;ZFP30;ZNF256;LPIN3;CCNE1;ZFP28;WBP2;KLF12;EP300;TCF7L1
19511,GO:1990234,0.999339989682404,0.00106896589286171,50,711,transferase complex,CC,BTBD2;ERCC1;CCND1;RBCK1;SHARPIN;SMURF2;SESN2;ABTB1;FBXW8;SYVN1;RABGGTA;PHC2;FBXO2;NSMCE4A;FBXW5;TGFBR2;KLHL29;DHTKD1;ATG13;JADE2;ANKIB1;CCND2;CUL7;PIGQ;PHF1;DCAF7;INTS8;POLD4;SPTLC2;FBXL15;BRPF3;WDFY3;MSL1;MIB2;STUB1;DDB2;ULK1;ZNF609;KLHL17;RNF222;INTS1;SPSB3;TAF6;RPRD2;RPRD1A;CCNE1;PIK3R2;ASH2L;EP300;TRAF7
155,GO:0000313,0.999353149380267,0.00562619184609463,1,84,organellar ribosome,CC,MRPS6
2509,GO:0005761,0.999353149380267,0.00562619184609463,1,84,mitochondrial ribosome,CC,MRPS6
3182,GO:0006807,0.999378485850419,0.000767120290272819,708,7380,nitrogen compound metabolic process,BP,TNIP1;NT5E;EDEM1;XDH;BTBD2;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SERINC2;ADM2;SHC1;PLAT;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;LPCAT4;NEURL1;SNX9;LMF1;NAPRT;BOK;SHARPIN;CRTC1;PCK2;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;SLC2A9;RAPGEF3;PTPRS;PRSS3;NAGS;PRNP;IDH2;BNIP3;SBF1;PC;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;BCORL1;FAM129B;MAPKAPK3;CTSB;SESN2;ACOT7;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;FKBP9;HAGH;OSBPL10;USP20;NACC2;ADGRF1;BCR;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;H6PD;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;PGLS;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CRAT;CARS;JOSD2;RHBDF2;HK1;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;PSAT1;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;BRD3;MDH2;CARD11;GPC4;IRAK1;PEG3;SERPING1;ALDH1L2;BAG3;APOE;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;PTPDC1;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;NMRK1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;DRAP1;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;DHTKD1;NADK;PRSS8;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;ESYT2;PLCG1;ATG13;SEC63;GTPBP1;ELOVL1;MAP3K9;OSBPL5;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TFE3;PRDX5;CCND2;TSPAN5;BIN1;HMGCL;HTRA1;SUFU;CCDC88C;PAK1;SP6;TSTA3;TTBK2;ERO1B;MMP10;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;TNFSF15;GLUL;BCDIN3D;PTDSS2;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;RET;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;ZNF165;GGACT;RPUSD3;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;SDHA;SLC6A6;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;IGFBP2;CAP1;P4HA1;MYDGF;B4GALT2;EIF4EBP1;AKR7A2;TSC22D4;GIPC1;TNFRSF6B;TULP3;B3GNT3;SRC;LDLRAP1;APLP2;MBD6;KDM4B;GLRX;CBR4;POLD4;SCG5;TAZ;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;CPTP;RALY;PAK6;PER3;STX5;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;TALDO1;DUSP6;OAS1;FYN;PRIMPOL;MPI;ISG20;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;TMPRSS11D;ZNF862;LPAR3;PFN1;RMND5A;NELFCD;ALDH4A1;PSMD7;MICAL1;TNFRSF1A;ALDH7A1;THOP1;ANXA3;TLE4;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;TSPAN33;UCKL1;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;COMT;TNRC6B;THRA;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;ZSCAN18;RNF187;ZNF71;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;GUK1;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;AMPD2;STUB1;PCSK1N;STK17A;ST3GAL3;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;SLC6A14;ULK1;LRP1;TRIB2;HSPA2;AOX1;ZNF609;PAK4;TNFRSF19;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;PNP;FGF2;KLHL17;EHD4;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;BPHL;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;MAPK3;EEPD1;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DNAJB9;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;UGCG;AIDA;MLF1;NDUFS2;B4GALT6;MATN3;ZFP30;ADAM15;HM13;MED29;CEACAM1;PNPLA6;PAIP2;GALNT3;MINK1;ZNF256;LPIN3;TFPT;UROS;ECM1;CD59;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;RMI2;LDHA;SPRED2;AZIN2;PIK3R2;STARD10;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
2902,GO:0006412,0.999387070320568,0.00104287555385306,40,654,translation,BP,TNIP1;MAP2K1;NEURL1;SESN2;ABTB1;AARS;EGFR;MKNK2;CARS;MAP2K2;ATF4;MRPS6;AKT1;ZNF598;GTPBP1;LARP6;ZNF385A;BCDIN3D;EIF4EBP1;AGO4;GARS;PUM1;TNRC6B;EIF2S2;SECISBP2L;RRBP1;MIF4GD;SARS2;SAMD4B;PYM1;RXRA;RPL28;CNOT11;IMPACT;GGT1;MAPK3;PAIP2;IGF2BP3;EIF4G3;TGFB1
2801,GO:0006259,0.999403352061898,0.000931895820833951,61,844,DNA metabolic process,BP,NT5E;CBS;ERCC1;H1F0;SHC1;ERCC6;CST3;IGFBP4;DNMT3A;MTA1;SMARCA1;FAM129B;SESN2;EGFR;CSNK1E;TK2;AKT1;XPC;TSPYL2;ENDOG;NSMCE4A;CDC34;MC1R;DTD1;RAG1;BAZ2A;DNASE1L1;GATA3;HSF1;NEIL1;MPG;HMGA2;TOP1;SRC;POLD4;HIST3H2A;PRIMPOL;ISG20;ANXA3;FGFR1;STUB1;DDB2;RAD23A;TAOK1;APBB1;WDR18;NYNRIN;POLM;CIB1;MAPK3;EEPD1;TFPT;MBD3;CCNE1;TGFB1;RMI2;ANXA1;PPP1R10;APOBEC3C;GNAS;EP300
2893,GO:0006401,0.999454805739051,0.00117803731027291,17,346,RNA catabolic process,BP,PSMD2;AKT1;GTPBP1;DEDD2;PCBP4;AGO4;ISG20;PSMD7;PUM1;TNRC6B;SAMD4B;RNH1;PYM1;RPL28;CNOT11;CARHSP1;IGF2BP3
12942,GO:0051276,0.999481206935208,0.000778146425447949,78,1048,chromosome organization,BP,ERCC1;ZMYND8;NOS1;H1F0;DNMT3A;MTA1;SMARCA1;BCORL1;NACC2;TUBG2;MIER2;HECW2;XPC;BRD3;PKN1;PHF21A;TSPYL2;VPS4A;HIST2H2BE;H2AFJ;JADE2;SCMH1;TNRC18;RAG1;BAZ2A;SATB1;HLTF;PARP10;GATA3;PHF1;SIN3B;CTBP1;HMGA2;ARID5B;TOP1;SRC;CHMP5;KDM4B;POLD4;FKBP10;AGO4;HIST3H2A;RERE;RSF1;PPM1F;BRPF3;HSF4;TUBG1;MSL1;PHF2;MAU2;DDB2;LEMD2;ZFPM1;HLCS;HSPA2;RCOR1;MAP3K12;CHD7;TAOK1;APBB1;HIST2H2AC;L3MBTL3;TAF6;NDE1;BAHCC1;HIST1H2AG;MAPK3;MBD3;CCNE1;TGFB1;WBP2;RMI2;ANXA1;PPP1R10;ASH2L;EP300;TCF7L1
14598,GO:0070125,0.99948543682248,0.0046006877236176,1,86,mitochondrial translational elongation,BP,MRPS6
12964,GO:0051304,0.999488028129923,0.00462531528959993,1,69,chromosome separation,BP,HECW2
5589,GO:0016604,0.999504204785195,0.000829806835598285,45,652,nuclear body,CC,H1F0;NFATC4;CRTC1;OBSCN;NR1D1;CKAP4;SBF1;SMURF2;CYGB;NACC2;MKNK2;PRKACA;WWTR1;DGKQ;PTK6;NSMCE4A;LIMK1;BNIP3L;CDC34;UBXN7;BAZ2A;SATB1;DCAF7;HSF1;KLHDC2;AGO4;ESRP1;ISG20;PUM1;PSKH1;HSF4;LHPP;WDFY3;RREB1;TENM2;STK17A;MAU2;LRCH4;RNF222;APBB1;UNC45A;ZBTB4;RMI2;PPP1R10;PLEKHH2
8415,GO:0033365,0.999524269347116,0.000782026026267376,49,731,protein localization to organelle,BP,RAC2;SORL1;DVL1;AP3D1;OBSCN;SESN2;BBS2;NUDCD3;TUB;HK1;AKT1;VPS11;VPS4A;PITRM1;MSN;BNIP3L;KDELR1;OBSL1;ZDHHC8;IPO13;ATG13;SEC63;TTBK2;DDIT3;RAB29;PARP10;ARL2;TULP3;SRC;PEX10;LRSAM1;RERE;GSK3A;FYN;ABHD17C;MOAP1;MAU2;LEMD2;ABCA7;NEURL1B;RPL28;LONP2;HGS;CSNK1D;C12ORF66;UGCG;TGFB1;PPP1R10;RAB6A
94,GO:0000184,0.999526857743306,0.00274183883927546,2,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PYM1;RPL28
1866,GO:0004527,0.999529009280219,0.00429922673749278,1,69,exonuclease activity,MF,ISG20
111,GO:0000228,0.999535664756643,0.000858271126764022,30,495,nuclear chromosome,CC,ERCC1;H1F0;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;ZMIZ2;SALL2;H2AFJ;ZNF385A;SATB1;GATA3;APPL2;SIN3B;HMGA2;TOP1;POLD4;HIST3H2A;RSF1;TUBG1;HSPA2;RXRA;HIST2H2AC;HIST1H2AG;TFPT;MBD3;WBP2;PPP1R10;ASH2L
2894,GO:0006402,0.999535784545291,0.00105404275673423,15,322,mRNA catabolic process,BP,PSMD2;AKT1;GTPBP1;PCBP4;AGO4;PSMD7;PUM1;TNRC6B;SAMD4B;RNH1;PYM1;RPL28;CNOT11;CARHSP1;IGF2BP3
5591,GO:0016607,0.999550312651606,0.000949879725378337,19,341,nuclear speck,CC,NFATC4;CKAP4;SMURF2;CYGB;PRKACA;DGKQ;LIMK1;BNIP3L;CDC34;BAZ2A;PUM1;PSKH1;HSF4;LHPP;RREB1;STK17A;APBB1;UNC45A;RMI2
2891,GO:0006399,0.999582923110554,0.00128490114613176,7,183,tRNA metabolic process,BP,AARS;CARS;DTD1;RPUSD3;GARS;SARS2;TRPT1
14599,GO:0070126,0.999585163973777,0.00380383223458351,1,88,mitochondrial translational termination,BP,MRPS6
12892,GO:0051196,0.999593735529905,0.00377599767955909,1,69,regulation of coenzyme metabolic process,BP,PPARA
2874,GO:0006368,0.999633398208916,0.00219850484742989,2,97,transcription elongation from RNA polymerase II promoter,BP,NELFCD;TAF6
16898,GO:0098813,0.99965263779834,0.000870491755566993,12,253,nuclear chromosome segregation,BP,TUBG2;HECW2;VPS4A;CHMP5;AGO4;TUBG1;MAU2;LEMD2;TAOK1;NDE1;CCNE1;RMI2
10915,GO:0044451,0.999714473940481,0.000442064901166725,72,975,nucleoplasm part,CC,ERCC1;H1F0;NFATC4;ERCC6;CRTC1;OBSCN;NR1D1;CKAP4;SBF1;SMURF2;CYGB;NACC2;MKNK2;PRKACA;WWTR1;PHF21A;DGKQ;PTK6;NSMCE4A;SALL2;LIMK1;BNIP3L;CDC34;JADE2;UBXN7;TNRC18;BAZ2A;SATB1;PHF1;DCAF7;HSF1;APPL2;SIN3B;INTS8;KLHDC2;AGO4;ESRP1;RERE;ISG20;NELFCD;BRPF3;SSU72;PUM1;PSKH1;HSF4;LHPP;WDFY3;RREB1;MSL1;TENM2;STK17A;MAU2;LRCH4;ZNF609;MED15;RNF222;APBB1;WDR18;UNC45A;INTS1;TAF6;RPRD2;BAHCC1;ZBTB4;RPRD1A;MED29;MBD3;RMI2;PPP1R10;ASH2L;PLEKHH2;EP300
3599,GO:0008033,0.999714557167977,0.00138223249802889,3,120,tRNA processing,BP,AARS;RPUSD3;TRPT1
8270,GO:0033044,0.999731866516193,0.000644456754848172,14,279,regulation of chromosome organization,BP,ERCC1;NOS1;HECW2;PARP10;GATA3;PHF1;CTBP1;SRC;PHF2;MAPK3;TGFB1;WBP2;RMI2;PPP1R10
5931,GO:0018205,0.999753613172063,0.000545170406112099,18,337,peptidyl-lysine modification,BP,NOS1;MTA1;JADE2;GATA3;PHF1;CTBP1;TOP1;TGM2;BRPF3;MSL1;RNF222;APBB1;MAPK3;MBD3;TGFB1;WBP2;ASH2L;EP300
2862,GO:0006354,0.999755481722182,0.0011998805532806,3,121,DNA-templated transcription, elongation,BP,ERCC6;NELFCD;TAF6
308,GO:0000819,0.999756600315288,0.000697603042023542,9,216,sister chromatid segregation,BP,TUBG2;HECW2;VPS4A;CHMP5;TUBG1;MAU2;TAOK1;NDE1;RMI2
16268,GO:0090305,0.999757253831149,0.000641358598079974,11,248,nucleic acid phosphodiester bond hydrolysis,BP,ERCC1;H1F0;ENDOG;RAG1;DNASE1L1;HSF1;POLD4;ISG20;DDB2;RNASE7;LACTB2
16335,GO:0090501,0.999772477078251,0.00112271671329763,3,123,RNA phosphodiester bond hydrolysis,BP,ISG20;RNASE7;LACTB2
3340,GO:0007059,0.99978092450421,0.000518770640462874,15,301,chromosome segregation,BP,TUBG2;HECW2;VPS4A;ARL8A;TOP1;CHMP5;AGO4;PUM1;TUBG1;MAU2;LEMD2;TAOK1;NDE1;CCNE1;RMI2
3342,GO:0007062,0.999781383682766,0.00108368019599764,3,120,sister chromatid cohesion,BP,MAU2;TAOK1;NDE1
2444,GO:0005643,0.999790895622161,0.0020899520313452,1,76,nuclear pore,CC,XPOT
2487,GO:0005730,0.999800959923837,0.000325983838808993,57,835,nucleolus,CC,DOCK4;ETV4;ERCC6;CPT2;PCDH1;CTSB;ABTB1;NACC2;PANO1;ADARB1;XPC;TSPYL2;ITPR3;DEAF1;ABCB8;DEDD2;CCND2;BCL9L;ZNF385A;DTD1;BAZ2A;PODXL;HLTF;PARP10;OASL;SDHA;CDCA7L;TOP1;ARL2;TULP3;MBD6;CAPG;POLD4;FKBP10;STK24;ACADVL;PAK6;YPEL3;ISG20;ZNF692;RAI14;WDFY3;FGFR1;RREB1;MIF4GD;PHF2;E2F5;USO1;PYM1;ABHD14B;CHD7;WDR18;L3MBTL3;KLK6;IQSEC1;DNAJB9;S100A16
274,GO:0000776,0.99980793600613,0.000962383561872645,3,121,kinetochore,CC,HSF1;PHF2;NDE1
18370,GO:1903311,0.999816178343953,0.000493312106200705,11,251,regulation of mRNA metabolic process,BP,PSMD2;AKT1;GTPBP1;PCBP4;HSF1;PSMD7;PUM1;TNRC6B;SAMD4B;CARHSP1;IGF2BP3
12533,GO:0050657,0.999821441411152,0.000625836260857546,6,173,nucleic acid transport,BP,XPOT;TGFBR2;SYMPK;TST;HSF1;IGF2BP3
12534,GO:0050658,0.999821441411152,0.000625836260857546,6,173,RNA transport,BP,XPOT;TGFBR2;SYMPK;TST;HSF1;IGF2BP3
6608,GO:0022626,0.999831987144517,0.00169317086689514,1,110,cytosolic ribosome,CC,RPL28
5911,GO:0018130,0.999834338002995,0.000214738631847472,303,3428,heterocycle biosynthetic process,BP,TNIP1;NT5E;XDH;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;NAPRT;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;ADCY7;XBP1;EGFR;TK2;RFX2;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;POLD4;TAZ;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;CAMTA2;PCSK6;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;EHF;THRA;PLTP;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;VPS9D1;TRIB3;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;CCNE1;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
2833,GO:0006302,0.999836505235926,0.000535751828807251,7,194,double-strand break repair,BP,ERCC1;MTA1;HSF1;HMGA2;APBB1;POLM;CIB1
8865,GO:0034654,0.999847020264155,0.000198826297467304,298,3379,nucleobase-containing compound biosynthetic process,BP,TNIP1;NT5E;XDH;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;NAPRT;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;ADCY7;XBP1;EGFR;TK2;RFX2;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;INTS8;HMGA2;ARID5B;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;POLD4;TAZ;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;CAMTA2;PCSK6;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;VPS9D1;TRIB3;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;ADCY6;CCNE1;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
2861,GO:0006353,0.999847741977666,0.000989905500044975,2,107,DNA-templated transcription, termination,BP,SYMPK;SSU72
5282,GO:0015931,0.999857030819024,0.000445131427147121,8,207,nucleobase-containing compound transport,BP,XPOT;TGFBR2;SYMPK;TST;SLC29A4;HSF1;SLC35B4;IGF2BP3
289,GO:0000793,0.99986035011363,0.000497577642805503,6,175,condensed chromosome,CC,NSMCE4A;HSF1;TUBG1;PHF2;HSPA2;NDE1
12914,GO:0051236,0.99986325669727,0.000487806440436526,6,176,establishment of RNA localization,BP,XPOT;TGFBR2;SYMPK;TST;HSF1;IGF2BP3
10409,GO:0043231,0.999867723345949,0.000168755613773767,798,8298,intracellular membrane-bounded organelle,CC,TNIP1;NT5E;EDEM1;XDH;FHL1;PYGB;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;CAPN2;F2R;MST1R;RAC2;ASAP2;SORL1;CTNNBIP1;NFATC4;SDC1;MAP2K1;SHC1;PITPNC1;DOCK4;QSOX1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;EPN3;SNX9;AP3D1;LMF1;NAPRT;BOK;CRTC1;PCK2;ARAP1;MEF2D;DLG4;OBSCN;CPT2;BSG;NR1D1;KLC2;DLG1;TRIM65;XPOT;IGFBP4;SLC16A3;PITPNM1;TEF;IFI6;SLC9A3R2;ZKSCAN1;DNMT3A;FKBP1A;SOX12;POSTN;PSMD2;MTA1;CKAP4;RPS6KA2;NET1;SLC2A9;NAGS;PRNP;IDH2;BNIP3;PDZD2;CD68;SBF1;PC;R3HDM4;LAMA5;AGPAT3;TXNDC11;RAB43;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;NME4;C2CD2;OCIAD2;COPG1;BCORL1;FAM222B;PCDH1;MARVELD1;CYGB;FAM129B;G0S2;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;TMEM214;SNPH;MARCH9;ZC3H6;FKBP9;HAGH;TUBB6;NACC2;SYNE3;RAB31;VWA5A;CHPF;LPCAT1;VLDLR;ETV5;LRP5;AARS;H6PD;XYLT1;GPT2;XBP1;EGFR;RTN2;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;FYCO1;RFX2;PRKACA;ADARB1;FCHO1;CRAT;TUB;RHBDF2;HK1;MAP2K2;FAM114A1;EPN1;PPP1R13L;FAM50A;TUBG2;XYLT2;STK25;MIER2;ATF4;P4HB;FBXW8;ZKSCAN2;PDIA5;MRPS6;AKT1;XPC;CDS2;BRD3;MDH2;ACOT13;ARMCX2;GPC4;IRAK1;PEG3;ALDH1L2;EPN2;BAG3;APOE;ATG16L2;EHD3;FAM210B;ATP13A2;ARG2;UAP1;METTL23;PKN1;TMEM92;AP1B1;ZSCAN30;SYVN1;ELK3;YIF1A;WWTR1;PHF21A;NPEPL1;COL13A1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;PHC2;ATP7B;FAM20C;ITPR3;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;HIST2H2BE;CCDC92;PITRM1;CTSZ;PI4K2A;UACA;ZMIZ2;PTK6;PFKP;TMEM129;FBXO2;RETSAT;PTPDC1;PCSK9;ENDOG;NSMCE4A;GIT2;ACAD10;TYSND1;DEAF1;HS1BP3;SALL2;SEC23A;B4GALNT4;RABAC1;MSN;LAMB2;PLD3;DRAP1;GDI1;HADH;NDST2;MVB12B;LIMK1;SCAND1;STK39;CREB3L2;SOX7;UBE2J1;BNIP3L;PPARA;DHTKD1;KDELR1;SYMPK;OBSL1;TST;PRKACB;H2AFJ;LTBP1;SIPA1;YIPF2;ZDHHC8;WDTC1;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;IPO13;ESYT2;PLCG1;RAP1GDS1;ATG13;ABCB8;SEC63;ELOVL1;OSBPL5;IDE;MSRB2;DEDD2;JADE2;COA5;SLC38A10;SURF4;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;MALL;GIT1;BIN1;HMGCL;SFXN3;SUFU;PAK1;SP6;TTBK2;CERCAM;LARP1B;ERO1B;BCL9L;AHCY;SCMH1;ACSF2;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;GAMT;DDIT3;PODXL;GLUL;BCDIN3D;PTDSS2;CUL7;OXLD1;GGA3;ARHGAP39;GGA1;TUBB3;ADAMTS7;STOM;DUSP4;GNB1;PTPN9;SATB1;FUCA1;RET;RAB29;DNASE1L1;PTOV1;CORO7;MLXIP;RHOC;IFI27;CYTH3;REEP2;TMED3;HLTF;YIPF3;CEMIP;PKD1;ASS1;PARP10;ATP11A;GATA3;PIGQ;NUCB2;PHF1;OXA1L;UBXN4;TCFL5;DCAF7;ARL8A;DOPEY2;OASL;ANO8;MYOF;GNAI2;PPM1M;ZNF165;ANTXR2;ASIC1;RPUSD3;GLUD1;FNDC4;HSF1;APPL2;SIN3B;ANKS1A;ALOX15B;WFS1;NEK9;SH3GLB2;CNDP2;SRD5A3;SLC12A4;FAT1;ASPH;MT2A;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;TMEM8A;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;C19ORF33;ARID5B;RHOBTB2;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;CAP1;P4HA1;MYDGF;PLIN3;B4GALT2;AKR7A2;VAMP2;PIP5K1C;TSC22D4;TULP3;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;CBR4;CAPG;POLD4;TAZ;FKBP10;PEX10;TGM2;DNM2;KLHDC2;SARAF;REEP6;UBR4;AGO4;FAM162A;IRF7;HIST3H2A;RFXANK;NUCB1;STPG1;RAB1B;NDUFA4L2;NCS1;TMEM9;TMEM44;STK24;CPTP;ACADVL;RGS19;CARD19;RALY;PAK6;PER3;YPEL3;STX5;RBMS2;ESRP1;C6ORF120;GARS;COG8;RERE;RSF1;GSK3A;STXBP1;CAMTA2;SH3BP1;PCSK6;TALDO1;DUSP6;PMVK;OAS1;SLFN5;FYN;PRIMPOL;ISG20;SPTLC2;CLSTN1;SUGCT;AGRN;ZNF692;RALGDS;ZNF862;REEP4;WNT5B;GRINA;PFN1;RMND5A;NELFCD;ALDH4A1;PSMD7;SLC25A43;TNFRSF1A;ALDH7A1;THOP1;HSD11B1;TLE4;MBOAT7;SLC33A1;VDR;BRPF3;VWA1;UCKL1;BRSK1;SSU72;STX10;CHST14;MOAP1;GAL;PUM1;RNF44;GNB2;SHISA5;RAI14;PSKH1;CTSL;EHF;COMT;THRA;MCFD2;NTSR1;RCN1;HEXIM1;AMIGO2;TIMP1;UBA1;MGLL;ZSCAN18;MISP;SLC35B4;RNF187;ZNF71;HSF4;LHPP;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;MSL1;ADNP;HYAL1;PHF2;TENM2;F12;USF2;PBX3;MFNG;CDK18;MIF;HES2;TTC19;VPS37A;SIGMAR1;BCL2L1;STUB1;PCSK1N;STK17A;MAU2;ST3GAL3;DNMBP;TRIB3;DDB2;ZFPL1;ANGEL1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;TPCN1;PMEPA1;ZNF783;ARFIP2;LRCH4;HLCS;SARS2;RMND5B;PRRC2A;ST3GAL5;NDOR1;RAD23A;ARFGEF2;AGPAT4;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;SMPD3;ZNF419;LRRK1;TBC1D20;SPIRE1;PNP;FGF2;EHD4;MAP1LC3B;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;COG1;SH3BGRL2;CDYL2;SDHAF4;SHB;PYM1;RCOR1;ABHD14B;ZNF398;TMX4;HSPA13;ARAP3;MYO1D;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;ENTPD6;MLYCD;MSLN;PHYH;APBB1;RHOBTB1;WDR18;SLIT3;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VSIG10L;TGFA;INVS;RPRD2;BAHCC1;GSDMC;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;ATP6V1C2;CNOT11;CYB561;TCF25;TPBG;HIST1H2AG;ZNF624;BPHL;ARSK;KLK6;NOL4L;VAT1;CASP4;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;HGS;DRG2;POLM;GAS8;CBL;TRAPPC1;FAM193B;CIB1;LACTB2;SOCS7;USP32;IQSEC1;PACS2;MAPK3;CPT1B;KANK2;POMT1;MAPK10;CSNK1D;DBP;KIFC3;DRAM2;ARVCF;DNAJB9;LITAF;ALDOC;GLO1;FURIN;SLC35G2;S100A16;ARHGEF2;RNF103;ZNF444;C12ORF66;SNX27;UGCG;TMBIM1;LLGL1;MLF1;MPLKIP;NDUFS2;B4GALT6;MATN3;OCRL;ZFP30;HM13;MED29;PNPLA6;APBA1;GALNT3;MINK1;SKAP2;ZNF256;LPIN3;AGAP1;TFPT;UROS;CD59;MBD3;MAP6;SLC30A1;NAGA;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;TM2D1;PCYOX1;PPP6R1;MANF;CAT;RMI2;LDHA;AZIN2;PIK3R2;ANXA1;ARSD;PODXL2;PPP1R10;ASH2L;RAB6A;COMTD1;APOBEC3C;IKBIP;KLF12;CCDC113;PLGRKT;ZNF318;ARCN1;PLEKHH2;EP300;ERP44;TCF7L1;RAP1GAP2;STIM1;MZT2B;ASAP1;NIPSNAP1;TIGD5;FHOD1;TRAF7;RNF10
1781,GO:0004386,0.999870932598954,0.000569800913654215,4,137,helicase activity,MF,SMARCA1;HLTF;CHD7;ANXA1
10367,GO:0043170,0.999880750811622,0.000150576896686944,648,6855,macromolecule metabolic process,BP,TNIP1;NT5E;EDEM1;XDH;BTBD2;PYGB;CBS;ERCC1;MDFI;ZMYND8;NOS1;ADAM19;CHAC1;H1F0;CCND1;GID4;CAPN2;F2R;THSD4;MST1R;RAC2;LTBP4;RBCK1;SORL1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;ADM2;SHC1;PLAT;PYGL;QSOX1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;SNX9;LMF1;BOK;SHARPIN;CRTC1;ARAP1;MEF2D;DLG4;OBSCN;SERPINE2;NR1D1;DLG1;DAP;IGFBP4;MMP1;TEF;IFI6;ZKSCAN1;DNMT3A;PGM1;FKBP1A;SOX12;PSMD2;MTA1;RAB3B;CKAP4;RPS6KA2;ITGA6;RAPGEF3;PTPRS;PRSS3;PRNP;BNIP3;SBF1;PC;SSH1;WWC3;SCYL1;CITED4;SMARCA1;CRTAP;SMURF2;BCORL1;FAM129B;MAPKAPK3;CTSB;SESN2;ABTB1;RNPEPL1;LY6K;MARCH9;ZC3H6;BBS2;FKBP9;USP20;NACC2;ADGRF1;BCR;RAB31;CHPF;LPCAT1;VLDLR;ETV5;MARK4;LRP5;AARS;ACVR2B;FBLN1;XYLT1;KIAA1549;ADCY7;XBP1;MAP4K4;EGFR;CSNK1E;PANO1;MKNK2;TK2;MMP14;LAMB1;RFX2;PRKACA;ADARB1;PTPRF;CARS;JOSD2;RHBDF2;ACTA2;MAP2K2;PPP1R13L;XYLT2;STK25;SHANK3;MN1;MIER2;ATF4;P4HB;HECW2;FBXW8;ZKSCAN2;SNX33;MRPS6;AKT1;XPC;BRD3;MDH2;CARD11;GPC4;IRAK1;PEG3;SERPING1;BAG3;APOE;EHD3;ATP13A2;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;RABGGTA;TMSB4X;AP2A2;TSPYL2;PRKCZ;GALNS;RNF135;FAM20C;POU2F2;TFEB;NAGLU;DGKQ;MAPK13;RFNG;VPS11;ARHGAP22;PPP2R3B;FZD8;VPS4A;PITRM1;CTSZ;EPHA1;ZMIZ2;PTK6;TMEM129;FBXO2;PTPDC1;SH3PXD2B;GRK6;PCSK9;ENDOG;ZNF598;NSMCE4A;FBXW5;FERMT1;TYSND1;RRAS;DEAF1;SALL2;MSN;PPP1R35;TGFBR2;LAMB2;DRAP1;NDST2;MVB12B;SERPINB6;LIMK1;SCAND1;STK39;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;ARRDC1;BNIP3L;KLHL29;PPARA;PRSS8;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;ZDHHC8;WDTC1;SHC2;OTUB2;CDC34;CD44;DNAJB5;ZNF516;SCRN1;PLCG1;TBC1D16;ATG13;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;JADE2;ANKIB1;RRNAD1;LARP6;TFE3;PRDX5;CCND2;TSPAN5;BIN1;HTRA1;SUFU;CCDC88C;PAK1;SP6;TTBK2;ERO1B;MMP10;BCL9L;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;CTBS;DDIT3;TNFSF15;BCDIN3D;CUL7;GGA3;GGA1;ADAMTS7;DUSP4;PTPN9;SATB1;FUCA1;RET;RAB29;RASGEF1A;DNASE1L1;PTOV1;FBXL6;MLXIP;IFI27;HLTF;PCBP4;CEMIP;PKD1;PARP10;DLG3;GATA3;APLN;PIGQ;PHF1;UBXN4;TCFL5;DCAF7;OASL;ANO8;GNAI2;PPM1M;ZNF165;RPUSD3;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;NEK9;CNDP2;SRD5A3;ASPH;CTBP1;PTPRU;CDCA7L;ADAM8;MAPKBP1;NEIL1;TFPI2;RAI1;MPG;INTS8;HMGA2;ARID5B;TOP1;PPP1R14A;BLMH;LY6E;MICAL2;IGFBP2;P4HA1;MYDGF;B4GALT2;EIF4EBP1;TSC22D4;GIPC1;TNFRSF6B;TULP3;ALDH1A2;B3GNT3;SRC;LDLRAP1;CHMP5;APLP2;MBD6;KDM4B;GLRX;POLD4;SCG5;FKBP10;PEX10;TGM2;DNM2;UBR4;AGO4;FAM162A;CAPN5;IRF7;LRSAM1;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;RALY;PAK6;PER3;STX5;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;SPINT2;PCSK6;DUSP6;OAS1;FYN;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;TMPRSS11D;ZNF862;LPAR3;PFN1;RMND5A;NELFCD;PSMD7;MICAL1;TNFRSF1A;THOP1;ANXA3;TLE4;FBXL15;SLC33A1;VDR;BRPF3;ABHD17C;VWA1;TSPAN33;BRSK1;SSU72;CHST14;GJC2;GAL;PUM1;RNF44;ITGA1;SHISA5;PSKH1;CTSL;EHF;TNRC6B;THRA;MCFD2;RCN1;MAP3K10;LYPD5;EIF2S2;HEXIM1;TIMP1;CRIM1;FRYL;UBA1;ZSCAN18;RNF187;ZNF71;HSF4;LOXL1;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;HYAL1;PHF2;MIB2;TENM2;TTLL12;F12;USF2;PBX3;MFNG;CDK18;MIF;SOCS2;MTMR4;HES2;ASB13;VPS37A;STUB1;PCSK1N;STK17A;ST3GAL3;TRIB3;DDB2;ZFPL1;TCIRG1;SNX25;PTPN12;SLC27A1;LEMD2;ZFPM1;PMEPA1;ZNF783;HLCS;SARS2;RMND5B;ST3GAL5;RAD23A;ARFGEF2;ULK1;LRP1;TRIB2;HSPA2;ZNF609;PAK4;TNFRSF19;MXD4;MGRN1;HPSE;E2F5;SAMD4B;ULK2;SMPD3;ZP3;ZNF419;LRRK1;PCMTD2;PRR9;FGF2;KLHL17;EHD4;RNASE7;RNH1;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;LMAN1;MSLN;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;SPSB3;TAF6;VEGFB;NEURL1B;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;ARSK;KLK6;CASP4;ACY1;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;SOCS7;USP32;MAPK3;EEPD1;KANK2;NTNG1;POMT1;MAPK10;CSNK1D;DBP;DNAJB9;LITAF;GLO1;FURIN;ARHGEF2;RNF103;ZNF444;AIDA;MLF1;B4GALT6;MATN3;ZFP30;ADAM15;HM13;MED29;CEACAM1;PAIP2;APBA1;GALNT3;MINK1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;PCYOX1;PPP6R1;ADCK2;CAT;RMI2;SPRED2;AZIN2;PIK3R2;CAMK2N1;PPP1R37;ERBB3;ANXA1;ARSD;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ITGA3;PLGRKT;ZNF318;ASPHD1;ARHGEF10L;EP300;ERP44;TCF7L1;WDFY2;RASA3;FHOD1;TRAF7;RNF10
2905,GO:0006415,0.999889167884866,0.00117171016986031,1,100,translational termination,BP,MRPS6
6151,GO:0019438,0.999895134471313,0.000137016130199377,301,3425,aromatic compound biosynthetic process,BP,TNIP1;NT5E;XDH;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;NAPRT;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;ADCY7;XBP1;EGFR;TK2;RFX2;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;INTS8;HMGA2;ALAS1;ARID5B;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;POLD4;TAZ;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;CAMTA2;PCSK6;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;VPS9D1;TRIB3;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;CCNE1;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
282,GO:0000784,0.999900958550663,0.000667708255876539,2,114,nuclear chromosome, telomeric region,CC,ERCC1;PPP1R10
2859,GO:0006351,0.999904992067504,0.000126101065704328,257,2972,transcription, DNA-templated,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;INTS8;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
8097,GO:0032774,0.999911221919129,0.000117877658061967,259,2996,RNA biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;INTS8;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;PRIMPOL;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
12925,GO:0051252,0.999914579802771,0.000113370138765117,262,3021,regulation of RNA metabolic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;OASL;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;ESRP1;RERE;RSF1;CAMTA2;PCSK6;OAS1;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
18036,GO:1902494,0.999915730621923,0.000129525149330203,89,1227,catalytic complex,CC,BTBD2;ERCC1;CCND1;RBCK1;SHARPIN;PSMD2;SMARCA1;SMURF2;SESN2;ABTB1;NACC2;NUDCD3;P4HB;FBXW8;STRN4;SYVN1;PHF21A;RABGGTA;PHC2;PPP2R3B;FBXO2;NSMCE4A;FBXW5;SALL2;TGFBR2;PPP2R5B;KLHL29;DHTKD1;ATG13;ABCB8;GTPBP1;IDE;JADE2;ANKIB1;CCND2;CUL7;GNB1;PIGQ;PHF1;DCAF7;GNAI2;APPL2;SIN3B;WFS1;SDHA;MAPKBP1;INTS8;DYNLRB1;P4HA1;CBR4;POLD4;AGO4;RGS19;RALY;RERE;RSF1;SPTLC2;PSMD7;FBXL15;BRPF3;WDFY3;MSL1;MIB2;STUB1;DDB2;RAD23A;ULK1;ZNF609;KLHL17;SDHAF4;RNF222;ABCA7;INTS1;SPSB3;TAF6;RPRD2;RPRD1A;CARHSP1;NDUFS2;TFPT;MBD3;CCNE1;SF3B6;PIK3R2;PPP1R10;ASH2L;GNAS;EP300;TRAF7
1477,GO:0003735,0.999928434840637,0.000490546039537043,2,154,structural constituent of ribosome,MF,MRPS6;RPL28
5284,GO:0015934,0.99993012337551,0.00076996055263678,1,115,large ribosomal subunit,CC,RPL28
7954,GO:0032543,0.99993138227885,0.000475178744475079,2,129,mitochondrial translation,BP,MRPS6;GARS
16721,GO:0097659,0.999934241115901,8.78107268729989e-05,257,2986,nucleic acid-templated transcription,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;INTS8;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;EHF;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
2841,GO:0006310,0.999938042459912,0.00020257904057947,8,215,DNA recombination,BP,ERCC1;ENDOG;NSMCE4A;RAG1;POLM;TFPT;TGFB1;RMI2
4339,GO:0009889,0.999947992553212,6.87858138497275e-05,297,3397,regulation of biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;CYGB;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;MKNK2;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;ARG2;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;ASS1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;RERE;RSF1;GSK3A;CAMTA2;PCSK6;PMVK;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;FRYL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;ADIPOR1;TRIB3;ZFPL1;SLC27A1;LEMD2;ZFPM1;ZNF783;TRIB2;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;POMT1;MAPK10;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;CEACAM1;PAIP2;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ANXA1;SLC45A3;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
4474,GO:0010468,0.999948248277436,6.82746839534875e-05,306,3510,regulation of gene expression,BP,TNIP1;XDH;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;WNT7A;PTHLH;ETV4;ERCC6;NEURL1;CRTC1;MEF2D;SERPINE2;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;PC;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;BBS2;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;CSNK1E;MKNK2;RFX2;ACTA2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;CTSZ;ZMIZ2;SH3PXD2B;ZNF598;FERMT1;DEAF1;SALL2;MSN;TGFBR2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;PRKACB;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;TOP1;MICAL2;MYDGF;EIF4EBP1;TSC22D4;TULP3;ALDH1A2;SRC;KDM4B;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;ESRP1;RERE;RSF1;GSK3A;CAMTA2;PCSK6;FYN;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GJC2;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;RNH1;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;SLIT3;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;EPHB2;HGS;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;CSNK1D;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;PAIP2;APBA1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;PIK3R2;CAMK2N1;ERBB3;ASH2L;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
7322,GO:0031326,0.99995035118074,6.58112835251296e-05,292,3347,regulation of cellular biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;NEURL1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;LPCAT1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;MKNK2;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;ASS1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;RERE;RSF1;GSK3A;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;NTSR1;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;ADIPOR1;TRIB3;ZFPL1;SLC27A1;LEMD2;ZFPM1;ZNF783;TRIB2;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;POMT1;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;CEACAM1;PAIP2;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ANXA1;SLC45A3;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
343,GO:0000956,0.999952015391234,0.000199551696565144,5,200,nuclear-transcribed mRNA catabolic process,BP,TNRC6B;SAMD4B;PYM1;RPL28;CNOT11
17662,GO:1901362,0.999957453405915,5.62836452842648e-05,307,3521,organic cyclic compound biosynthetic process,BP,TNIP1;NT5E;XDH;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CYP27B1;NAPRT;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;ADCY7;XBP1;EGFR;TK2;RFX2;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;SRD5A3;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;POLD4;TAZ;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;CAMTA2;PCSK6;PMVK;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;HSD11B1;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;EHF;THRA;PLTP;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;VPS9D1;TRIB3;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;MED15;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;CCNE1;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
12778,GO:0051028,0.999959066989511,0.000231003600973374,3,135,mRNA transport,BP,SYMPK;HSF1;IGF2BP3
2895,GO:0006403,0.999963036752729,0.000132430456858686,7,209,RNA localization,BP,XPOT;TGFBR2;SYMPK;TST;ZNF385A;HSF1;IGF2BP3
2816,GO:0006281,0.999963394900084,7.78068166919548e-05,26,484,DNA repair,BP,ERCC1;ERCC6;MTA1;EGFR;CSNK1E;XPC;NSMCE4A;MC1R;HSF1;NEIL1;MPG;HMGA2;POLD4;HIST3H2A;PRIMPOL;STUB1;DDB2;RAD23A;TAOK1;APBB1;POLM;CIB1;EEPD1;TFPT;RMI2;EP300
279,GO:0000781,0.999965439504832,0.000196818633261252,3,146,chromosome, telomeric region,CC,ERCC1;NSMCE4A;PPP1R10
3251,GO:0006913,0.999970785570943,8.04156657112434e-05,13,303,nucleocytoplasmic transport,BP,XPOT;RAPGEF3;AKT1;BAG3;SYMPK;IPO13;IFI27;PKD1;PARP10;RERE;CAMK1;TGFB1;PPP1R10
15275,GO:0071426,0.999973172743021,0.000201396168599269,2,121,ribonucleoprotein complex export from nucleus,BP,XPOT;SYMPK
15129,GO:0071166,0.999975811347451,0.000183020625760521,2,122,ribonucleoprotein complex localization,BP,XPOT;SYMPK
12870,GO:0051169,0.999976189329523,6.61500498457585e-05,13,306,nuclear transport,BP,XPOT;RAPGEF3;AKT1;BAG3;SYMPK;IPO13;IFI27;PKD1;PARP10;RERE;CAMK1;TGFB1;PPP1R10
16888,GO:0098798,0.999978437051721,9.40648333068132e-05,5,218,mitochondrial protein complex,CC,MRPS6;SDHA;NDUFA4L2;SDHAF4;NDUFS2
10896,GO:0044427,0.999980038503259,3.65544907833151e-05,47,772,chromosomal part,CC,ERCC1;H1F0;CAPN2;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;PHC2;HIST2H2BE;ZMIZ2;NSMCE4A;SALL2;H2AFJ;CCND2;SCMH1;ZNF385A;TNRC18;BAZ2A;SATB1;GATA3;PHF1;HSF1;APPL2;SIN3B;HMGA2;TOP1;MBD6;POLD4;HIST3H2A;RSF1;UBA1;PHF2;MAU2;LEMD2;HLCS;HSPA2;RXRA;HIST2H2AC;NDE1;BAHCC1;HIST1H2AG;TFPT;MBD3;WBP2;PPP1R10;ASH2L
10806,GO:0044271,0.999980772005946,2.55062137039114e-05,342,3945,cellular nitrogen compound biosynthetic process,BP,TNIP1;NT5E;XDH;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;NEURL1;NAPRT;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;NAGS;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ABTB1;ZC3H6;HAGH;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;KIAA1549;ADCY7;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;MRPS6;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;ARG2;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;ZNF598;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;ASS1;PARP10;GATA3;APLN;PHF1;TCFL5;GNAI2;ZNF165;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;CNDP2;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;INTS8;HMGA2;ALAS1;ARID5B;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;CAMTA2;PCSK6;PRIMPOL;MPI;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;EIF2S2;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;VPS9D1;TRIB3;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;PNP;FGF2;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;ZNF444;UGCG;MLF1;B4GALT6;ZFP30;MED29;PAIP2;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;AZIN2;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
10546,GO:0043484,0.999987584500582,0.000161516444151554,1,101,regulation of RNA splicing,BP,ESRP1
12554,GO:0050684,0.999987737978465,0.000159775583693863,1,100,regulation of mRNA processing,BP,HSF1
2871,GO:0006364,0.999988136515327,4.49681318268639e-05,7,255,rRNA processing,BP,CSNK1E;RRNAD1;ISG20;CHD7;WDR18;RPL28;CSNK1D
19773,GO:2000112,0.999988382443963,1.58403110801918e-05,273,3203,regulation of cellular macromolecule biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;NEURL1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;MKNK2;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;GSK3A;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;POMT1;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;PAIP2;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
2898,GO:0006406,0.999988972191837,0.000144790681816199,1,103,mRNA export from nucleus,BP,SYMPK
15276,GO:0071427,0.999988972191837,0.000144790681816199,1,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SYMPK
4508,GO:0010556,0.999990839383436,1.2515354649041e-05,277,3252,regulation of macromolecule biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;NEURL1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;MKNK2;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;RAI1;HMGA2;ARID5B;MICAL2;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RERE;RSF1;GSK3A;CAMTA2;PCSK6;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;TRIB2;ZNF609;MXD4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;FGF2;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;POMT1;MAPK10;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;PAIP2;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
2897,GO:0006405,0.999992356818236,6.28594128197462e-05,2,133,RNA export from nucleus,BP,XPOT;SYMPK
273,GO:0000775,0.999992937150348,3.76324717069834e-05,4,173,chromosome, centromeric region,CC,DNMT3A;HSF1;PHF2;NDE1
17719,GO:1901576,0.999992975941072,9.295684768303e-06,434,4894,organic substance biosynthetic process,BP,TNIP1;NT5E;XDH;CBS;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PYGL;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;LMF1;NAPRT;CRTC1;PCK2;MEF2D;NR1D1;DLG1;DAP;PITPNM1;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;DGKA;PSMD2;MTA1;ITGA6;RAPGEF3;NAGS;PRNP;IDH2;SBF1;PC;AGPAT3;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ABTB1;LY6K;ZC3H6;HAGH;NACC2;ADGRF1;CHPF;LPCAT1;VLDLR;ETV5;LRP5;AARS;ACVR2B;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;HK1;MAP2K2;PPP1R13L;XYLT2;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;MRPS6;AKT1;CDS2;BRD3;MDH2;CARD11;GPC4;IRAK1;PEG3;BAG3;APOE;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;CRYL1;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;PI4K2A;ZMIZ2;PFKP;ZNF598;NMRK1;DEAF1;SALL2;DRAP1;NDST2;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;ZDHHC8;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;ELOVL1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HMGCL;HTRA1;SUFU;SP6;TSTA3;ISYNA1;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;GAMT;DDIT3;GLUL;BCDIN3D;PTDSS2;ADAMTS7;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;PARP10;GATA3;APLN;PIGQ;PHF1;TCFL5;GNAI2;ZNF165;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;CNDP2;SRD5A3;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;LY6E;MICAL2;CAP1;MYDGF;B4GALT2;EIF4EBP1;PIP5K1C;TSC22D4;TULP3;ALDH1A2;B3GNT3;SRC;KDM4B;CBR4;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;PMVK;PRIMPOL;MPI;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;ABHD17C;UCKL1;SSU72;CHST14;GAL;PUM1;EHF;TNRC6B;THRA;MCFD2;PLTP;NTSR1;MAP3K10;LYPD5;EIF2S2;HEXIM1;FRYL;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;PHF2;TENM2;USF2;PBX3;MFNG;GUK1;MIF;MTMR4;HES2;AMPD2;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;ZFPL1;TCIRG1;PITPNM2;SLC27A1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;AGPAT4;TRIB2;ZNF609;MXD4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;PNP;FGF2;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;NTNG1;POMT1;MAPK10;DBP;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;ZNF444;UGCG;MLF1;B4GALT6;OCRL;ZFP30;MED29;CEACAM1;PAIP2;GALNT3;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;AZIN2;PIK3R2;STARD10;ANXA1;SLC45A3;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
17311,GO:0140053,0.999994287963278,4.7661828321541e-05,2,153,mitochondrial gene expression,BP,MRPS6;GARS
10878,GO:0044391,0.999994727008314,4.39422697123344e-05,2,182,ribosomal subunit,CC,MRPS6;RPL28
4027,GO:0009058,0.99999514773546,6.44951042948051e-06,437,4937,biosynthetic process,BP,TNIP1;NT5E;XDH;CBS;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;PYGL;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;LMF1;NAPRT;CRTC1;PCK2;MEF2D;NR1D1;DLG1;DAP;PITPNM1;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;DGKA;PSMD2;MTA1;ITGA6;RAPGEF3;NAGS;PRNP;IDH2;SBF1;PC;AGPAT3;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;CYGB;FAM129B;SESN2;ACOT7;ABTB1;LY6K;ZC3H6;HAGH;NACC2;ADGRF1;CHPF;LPCAT1;VLDLR;ETV5;LRP5;AARS;ACVR2B;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;HK1;MAP2K2;PPP1R13L;XYLT2;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;MRPS6;AKT1;CDS2;BRD3;MDH2;CARD11;GPC4;IRAK1;PEG3;ALDH1L2;BAG3;APOE;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;CRYL1;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;PI4K2A;ZMIZ2;PFKP;ZNF598;NMRK1;DEAF1;SALL2;DRAP1;NDST2;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;ZDHHC8;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;ELOVL1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HMGCL;HTRA1;SUFU;SP6;TSTA3;ISYNA1;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;GAMT;DDIT3;GLUL;BCDIN3D;PTDSS2;ADAMTS7;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;PARP10;GATA3;APLN;PIGQ;PHF1;TCFL5;GNAI2;ZNF165;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;CNDP2;SRD5A3;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;LY6E;MICAL2;CAP1;MYDGF;B4GALT2;EIF4EBP1;PIP5K1C;TSC22D4;TULP3;ALDH1A2;B3GNT3;SRC;KDM4B;CBR4;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;PMVK;PRIMPOL;MPI;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;HSD11B1;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;ABHD17C;UCKL1;SSU72;CHST14;GAL;PUM1;EHF;TNRC6B;THRA;MCFD2;PLTP;NTSR1;MAP3K10;LYPD5;EIF2S2;HEXIM1;FRYL;MGLL;ZSCAN18;SLC35B4;RNF187;ZNF71;HSF4;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;PHF2;TENM2;USF2;PBX3;MFNG;GUK1;MIF;MTMR4;HES2;AMPD2;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;ZFPL1;TCIRG1;PITPNM2;SLC27A1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;AGPAT4;TRIB2;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;PNP;FGF2;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;NTNG1;POMT1;MAPK10;DBP;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;ZNF444;UGCG;MLF1;B4GALT6;OCRL;ZFP30;MED29;CEACAM1;PAIP2;GALNT3;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;AZIN2;PIK3R2;STARD10;ANXA1;SLC45A3;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
10797,GO:0044249,0.999995576688726,5.89468468137657e-06,426,4831,cellular biosynthetic process,BP,TNIP1;NT5E;XDH;CBS;MDFI;ZMYND8;NOS1;CHAC1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;MBOAT2;ETV4;ERCC6;CST3;CYP27B1;LPCAT4;NEURL1;LMF1;NAPRT;CRTC1;PCK2;MEF2D;NR1D1;DLG1;DAP;PITPNM1;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;DGKA;PSMD2;MTA1;ITGA6;RAPGEF3;NAGS;PRNP;IDH2;SBF1;AGPAT3;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ABTB1;LY6K;ZC3H6;HAGH;NACC2;ADGRF1;CHPF;LPCAT1;VLDLR;ETV5;LRP5;AARS;ACVR2B;XYLT1;GPT2;KIAA1549;ADCY7;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;HK1;MAP2K2;PPP1R13L;XYLT2;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;MRPS6;AKT1;CDS2;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;ARG2;UAP1;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;PI4K2A;ZMIZ2;PFKP;ZNF598;NMRK1;DEAF1;SALL2;DRAP1;NDST2;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;ZDHHC8;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;ELOVL1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HMGCL;HTRA1;SUFU;SP6;TSTA3;ISYNA1;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;GAMT;DDIT3;GLUL;BCDIN3D;PTDSS2;ADAMTS7;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;CEMIP;PKD1;ASS1;PARP10;GATA3;APLN;PIGQ;PHF1;TCFL5;GNAI2;ZNF165;GLUD1;HSF1;PPCS;SIN3B;PANK4;BCL7A;ALOX15B;IL1RAP;WFS1;CNDP2;SRD5A3;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;LY6E;MICAL2;CAP1;MYDGF;B4GALT2;EIF4EBP1;PIP5K1C;TSC22D4;TULP3;ALDH1A2;B3GNT3;SRC;KDM4B;CBR4;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;PMVK;PRIMPOL;MPI;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ALDH7A1;ANXA3;TLE4;MBOAT7;FBXL15;SLC33A1;VDR;ABHD17C;UCKL1;SSU72;CHST14;GAL;PUM1;EHF;TNRC6B;THRA;MCFD2;PLTP;NTSR1;MAP3K10;LYPD5;EIF2S2;HEXIM1;FRYL;MGLL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;PHF2;TENM2;USF2;PBX3;MFNG;GUK1;MIF;MTMR4;HES2;AMPD2;ADIPOR1;ST3GAL3;VPS9D1;TRIB3;ZFPL1;TCIRG1;PITPNM2;SLC27A1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;AGPAT4;TRIB2;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;PNP;FGF2;MED15;ST6GALNAC2;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;LMAN1;MLYCD;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;NTNG1;POMT1;MAPK10;DBP;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;ZNF444;UGCG;MLF1;B4GALT6;OCRL;ZFP30;MED29;CEACAM1;PAIP2;GALNT3;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;LDHA;AZIN2;PIK3R2;STARD10;ANXA1;SLC45A3;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
5338,GO:0016072,0.999995975606443,1.50570346664611e-05,8,284,rRNA metabolic process,BP,CSNK1E;DEDD2;RRNAD1;ISG20;CHD7;WDR18;RPL28;CSNK1D
6073,GO:0019219,0.999997085548872,4.04967399546015e-06,275,3265,regulation of nucleobase-containing compound metabolic process,BP,TNIP1;ERCC1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;ACVR2B;KIAA1549;XBP1;EGFR;RFX2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ENDOG;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;NEIL1;RAI1;HMGA2;ARID5B;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;TAZ;DNM2;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;ESRP1;RERE;RSF1;GSK3A;CAMTA2;PCSK6;OAS1;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;VAPB;MAPK9;ZNF570;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;CBL;CIB1;MAPK3;KANK2;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;ZFP28;TGFB1;WBP2;CAT;PIK3R2;PPP1R10;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
17326,GO:0140098,0.999998429129273,5.06310594591154e-06,12,330,catalytic activity, acting on RNA,MF,AARS;CARS;RRNAD1;DTD1;BCDIN3D;GARS;PRIMPOL;ISG20;SARS2;RNASE7;TRPT1;LACTB2
8793,GO:0034470,0.99999896345785,3.15925772473661e-06,14,396,ncRNA processing,BP,AARS;CSNK1E;RRNAD1;BCDIN3D;RPUSD3;INTS8;AGO4;ISG20;CHD7;WDR18;INTS1;RPL28;TRPT1;CSNK1D
16496,GO:0097159,0.999999041137012,1.30701815158214e-06,402,4612,organic cyclic compound binding,MF,NT5E;XDH;PYGB;CBS;ERCC1;ZMYND8;NOS1;H1F0;MST1R;RAC2;NFATC4;MAP2K1;PYGL;ETV4;ERCC6;CYP27B1;SCN8A;PCK2;MEF2D;OBSCN;NR1D1;XPOT;SLC16A3;TEF;ZKSCAN1;DNMT3A;FKBP1A;SOX12;DGKA;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;IDH2;PC;R3HDM4;RAB43;SCYL1;SMARCA1;NME4;CYGB;MAPKAPK3;ABTB1;ZC3H6;FKBP9;OSBPL10;TUBB6;NACC2;HEBP1;BCR;RAB31;OSBP2;ETV5;MARK4;AARS;ACVR2B;H6PD;HTR7;GPT2;ADCY7;XBP1;ZCCHC14;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;RFX2;SEPT10;PRKACA;ADARB1;CARS;ACTA2;HK1;MAP2K2;FAM50A;TUBG2;STK25;MIER2;ATF4;P4HB;ZKSCAN2;MRPS6;AKT1;XPC;MDH2;IRAK1;PEG3;BAG3;APOE;EHD3;ATP13A2;PKN1;ZSCAN30;ELK3;PHF21A;CRYL1;TMSB4X;TSPYL2;PRKCZ;PHC2;ATP7B;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;VPS11;VPS4A;HIST2H2BE;EPHA1;PI4K2A;PTK6;PFKP;GRK6;PCSK9;ENDOG;ZNF598;ACAD10;NMRK1;RRAS;SEPT5;DEAF1;SALL2;MSN;TGFBR2;DRAP1;HADH;LIMK1;STK39;CREB3L2;SOX7;UBE2J1;PPARA;DHTKD1;NADK;TST;PRKACB;H2AFJ;CDC34;ZNF516;ABCB8;SEC63;GTPBP1;MAP3K9;OSBPL5;IDE;DEDD2;TWF2;LARP6;TFE3;PRDX5;FSCN1;PAK1;SP6;TTBK2;LARP1B;AHCY;ACSF2;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;DDIT3;GLUL;TUBB3;SATB1;RET;RAB29;DNASE1L1;MLXIP;RHOC;HLTF;PCBP4;SEPT8;ASS1;ATP11A;GATA3;NUCB2;PHF1;TCFL5;ARL8A;OASL;GNAI2;ZNF165;RPUSD3;GLUD1;HSF1;PANK4;NEK9;SDHA;CTBP1;MAPKBP1;NEIL1;RAI1;MPG;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;TOP1;ARL2;MICAL2;FLNB;PIP5K1C;SRC;APLP2;CBR4;SCG5;FKBP10;TGM2;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;PAQR7;MARK3;STK24;ACADVL;RALY;PAK6;ZCCHC24;PER3;RBMS2;ESRP1;NSUN7;GARS;RERE;GSK3A;STXBP1;CAMTA2;PMVK;OAS1;SLFN5;FYN;RAB25;ISG20;SPTLC2;ASNS;ZNF692;ZNF862;PFN1;NELFCD;MICAL1;KIF17;HSD11B1;VDR;KIF13B;UCKL1;BRSK1;PUM1;PSKH1;EHF;TNRC6B;C11ORF95;THRA;MAP3K10;EIF2S2;HEXIM1;UBA1;ZSCAN18;ZNF71;HSF4;SECISBP2L;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;ADNP;TTLL12;USF2;PBX3;GUK1;CDK18;HES2;ZDBF2;STK17A;MAU2;TRIB3;DDB2;ZFPL1;TPD52L2;SLC27A1;LEMD2;ZFPM1;ZNF783;ARFIP2;HLCS;SARS2;PRRC2A;NDOR1;RAD23A;PIP5KL1;ULK1;LRP1;HSPA2;AOX1;ZNF609;PAK4;MXD4;P2RX4;E2F5;SAMD4B;USO1;ULK2;GPATCH8;ZNF419;LRRK1;PNP;EHD4;RNASE7;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ZNF398;HSPA13;MYO1D;CHD7;SNTB2;TAOK1;ABCA7;ZNF687;BICC1;RHOBTB1;RXRA;HIST2H2AC;ZHX3;TSHZ1;TAF6;RPL28;BAHCC1;ZBTB4;SEC14L2;TCF25;HIST1H2AG;NYNRIN;ZNF624;LONP2;CAMK1;EPHB2;CARHSP1;DRG2;POLM;LACTB2;RAB4B;MAPK3;EEPD1;MAPK10;CSNK1D;DBP;KIFC3;LITAF;S100A16;ZNF444;MLF1;NDUFS2;ZFP30;PAIP2;MINK1;ZNF256;AGAP1;TFPT;MBD3;ADCY6;IGF2BP3;EIF4G3;ZFP28;SF3B6;WBP2;ADCK2;MANF;CAT;RMI2;LDHA;ERBB3;ANXA1;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ZNF318;ARCN1;EP300;TCF7L1;TIGD5;RNF10
2446,GO:0005654,0.999999097395463,1.29034911810471e-06,246,3043,nucleoplasm,CC,TNIP1;NT5E;TSPAN1;ERCC1;NOS1;H1F0;CCND1;CTNNBIP1;NFATC4;PITPNC1;PTHLH;ETV4;ERCC6;EPN3;CRTC1;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;DNMT3A;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;BNIP3;SBF1;CITED4;SMARCA1;SMURF2;BCORL1;FAM222B;CYGB;FAM129B;MAPKAPK3;ACOT7;NACC2;VWA5A;ETV5;XBP1;CSNK1E;MKNK2;PRKACA;ADARB1;FCHO1;FAM114A1;PPP1R13L;FAM50A;ATF4;AKT1;XPC;ATG16L2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;RABGGTA;TSPYL2;PHC2;ITPR3;POU2F2;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;ZMIZ2;PTK6;PTPDC1;NSMCE4A;GIT2;SALL2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;SYMPK;PRKACB;WDTC1;CDC34;JADE2;TBC1D14;TFE3;CCND2;CMIP;BCL9L;SCMH1;ZNF385A;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;GGA1;DUSP4;PTPN9;SATB1;CYTH3;HLTF;GATA3;PHF1;DCAF7;OASL;GNAI2;HSF1;APPL2;SIN3B;ANKS1A;SH3GLB2;CNDP2;CTBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;ARID5B;TOP1;PLCB3;B4GALT2;PIP5K1C;SRC;MBD6;KDM4B;CAPG;POLD4;KLHDC2;UBR4;AGO4;IRF7;RFXANK;STK24;ESRP1;RERE;RSF1;STXBP1;TALDO1;DUSP6;OAS1;ISG20;NELFCD;PSMD7;TLE4;VDR;BRPF3;BRSK1;SSU72;PUM1;RNF44;PSKH1;EHF;THRA;HEXIM1;UBA1;MGLL;RNF187;HSF4;LHPP;WDFY3;RREB1;ZBED4;MSL1;PHF2;TENM2;USF2;MIF;VPS37A;STUB1;STK17A;MAU2;DDB2;PTPN12;ZFPM1;LRCH4;PRRC2A;RAD23A;ZNF609;HPSE;E2F5;SPIRE1;RNH1;MED15;MAPK9;SH3BGRL2;SHB;PYM1;RCOR1;CHD7;RNF222;ZNF687;APBB1;WDR18;RXRA;UNC45A;INTS1;ZHX3;TAF6;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;NOL4L;SNAP29;KLHDC10;RPRD1A;DRG2;POLM;FAM193B;CIB1;MAPK3;MAPK10;CSNK1D;LITAF;SNX27;MPLKIP;NDUFS2;MED29;SKAP2;TFPT;MBD3;CCNE1;SF3B6;TM2D1;RMI2;ANXA1;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;TCF7L1;MZT2B
2466,GO:0005681,0.999999126503094,6.25887108351515e-06,3,181,spliceosomal complex,CC,MAPKBP1;RALY;SF3B6
10897,GO:0044428,0.999999235339181,1.06584759544881e-06,317,3796,nuclear part,CC,TNIP1;NT5E;TSPAN1;ERCC1;NOS1;H1F0;CCND1;RAC2;SORL1;CTNNBIP1;NFATC4;PITPNC1;DOCK4;PTHLH;ETV4;ERCC6;CST3;EPN3;BOK;CRTC1;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;SLC16A3;DNMT3A;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;SLC2A9;PRNP;BNIP3;SBF1;AGPAT3;CITED4;SMARCA1;SMURF2;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;MAPKAPK3;CTSB;ACOT7;ABTB1;NACC2;SYNE3;VWA5A;ETV5;XBP1;EGFR;CSNK1E;PANO1;MKNK2;PRKACA;ADARB1;FCHO1;FAM114A1;PPP1R13L;FAM50A;ATF4;AKT1;XPC;ATG16L2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;RABGGTA;TSPYL2;PRKCZ;PHC2;ITPR3;POU2F2;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;ZMIZ2;PTK6;RETSAT;PTPDC1;NSMCE4A;GIT2;DEAF1;SALL2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;CDC34;SCRN1;IPO13;PLCG1;ABCB8;DEDD2;JADE2;TBC1D14;TFE3;CCND2;CMIP;BIN1;PAK1;BCL9L;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;PODXL;CUL7;GGA1;DUSP4;PTPN9;SATB1;IFI27;CYTH3;HLTF;PARP10;GATA3;NUCB2;PHF1;UBXN4;DCAF7;OASL;MYOF;GNAI2;HSF1;APPL2;SIN3B;ANKS1A;SH3GLB2;CNDP2;SDHA;CTBP1;CDCA7L;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;ARID5B;TOP1;ARL2;PLCB3;B4GALT2;PIP5K1C;TULP3;SRC;MBD6;KDM4B;CAPG;POLD4;FKBP10;KLHDC2;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;STK24;CPTP;ACADVL;RALY;PAK6;YPEL3;ESRP1;RERE;RSF1;STXBP1;TALDO1;DUSP6;OAS1;ISG20;ZNF692;NELFCD;PSMD7;TLE4;VDR;BRPF3;BRSK1;SSU72;PUM1;RNF44;SHISA5;RAI14;PSKH1;EHF;THRA;HEXIM1;UBA1;MGLL;RNF187;HSF4;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;PHF2;TENM2;USF2;MIF;VPS37A;SIGMAR1;BCL2L1;STUB1;STK17A;MAU2;DDB2;PTPN12;LEMD2;ZFPM1;LRCH4;HLCS;PRRC2A;RAD23A;HSPA2;ZNF609;P2RX4;HPSE;E2F5;USO1;TBC1D20;SPIRE1;RNH1;MED15;MAPK9;SH3BGRL2;SHB;PYM1;RCOR1;ABHD14B;CHD7;RNF222;ZNF687;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;L3MBTL3;ZHX3;TAF6;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;HIST1H2AG;KLK6;NOL4L;SNAP29;KLHDC10;RPRD1A;DRG2;POLM;FAM193B;CIB1;IQSEC1;MAPK3;MAPK10;CSNK1D;DNAJB9;LITAF;S100A16;SNX27;MPLKIP;NDUFS2;MED29;SKAP2;TFPT;MBD3;SLC30A1;CCNE1;SF3B6;WBP2;TM2D1;RMI2;ANXA1;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;TCF7L1;RAP1GAP2;MZT2B
2561,GO:0005840,0.999999313814095,4.93937516986567e-06,3,225,ribosome,CC,MRPS6;RRBP1;RPL28
2477,GO:0005694,0.999999329959585,1.30944514936995e-06,51,882,chromosome,CC,ERCC1;H1F0;CAPN2;MEF2D;NR1D1;DNMT3A;SMARCA1;NACC2;PHC2;HIST2H2BE;ZMIZ2;NSMCE4A;SALL2;H2AFJ;CCND2;SCMH1;ZNF385A;TNRC18;BAZ2A;SATB1;GATA3;PHF1;HSF1;APPL2;SIN3B;NEIL1;HMGA2;TOP1;MBD6;POLD4;HIST3H2A;RSF1;UBA1;TUBG1;PHF2;MAU2;LEMD2;HLCS;HSPA2;RXRA;HIST2H2AC;NDE1;BAHCC1;ZBTB4;HIST1H2AG;TFPT;MBD3;WBP2;PPP1R10;ASH2L;EP300
8237,GO:0032991,0.999999382542368,8.63127269983429e-07,316,3841,protein-containing complex,CC,BTBD2;ITGB4;ERCC1;NOS1;H1F0;CCND1;MST1R;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;SHC1;KCNG1;ERCC6;CLIP2;AP3D1;SCN8A;SHARPIN;DLG4;NR1D1;KLC2;DLG1;XPOT;PITPNM1;FKBP1A;SOX12;PSMD2;CKAP4;ITGA6;PRNP;LAMA5;SCYL1;SMARCA1;CRTAP;SMURF2;COPG1;ESPN;SESN2;ABTB1;TNNT1;BBS2;NACC2;SYNE3;NUDCD3;VLDLR;LRP5;ACVR2B;FBLN1;ITGB5;ADCY7;EGFR;TTYH3;LAMB1;FYCO1;SEPT10;PRKACA;TUBG2;SHANK3;MIER2;ATF4;P4HB;FBXW8;MRPS6;AKT1;XPC;CARD11;IRAK1;ARPC1A;EPN2;APOE;STRN4;METTL23;AP1B1;SYVN1;AFAP1L1;WWTR1;PHF21A;COL13A1;RABGGTA;TMSB4X;AP2A2;PRKCZ;PHC2;ITPR3;VPS11;PPP2R3B;FZD8;VPS4A;HIST2H2BE;EPHA1;PI4K2A;FBXO2;SH3PXD2B;PCSK9;NSMCE4A;FBXW5;FERMT1;EML2;SEPT5;DEAF1;SALL2;SEC23A;MAP1B;TGFBR2;LAMB2;MVB12B;SERPINB6;PPP2R5B;CORO2A;KLHL29;PPARA;DHTKD1;SYMPK;OBSL1;PRKACB;H2AFJ;LTBP1;WASF2;CD44;PLCG1;ATG13;ABCB8;GTPBP1;IDE;JADE2;ANKIB1;LARP6;CCND2;BIN1;FSCN1;PAK1;BCL9L;UBXN7;TNRC18;BAZ2A;DDIT3;CUL7;DMXL2;GGA3;GGA1;GNB1;SDCCAG3;RET;LAMC2;GRB10;TMED3;SEPT8;SHANK2;PKD1;DLG3;GATA3;WDR66;PIGQ;PHF1;OXA1L;DCAF7;GNAI2;GRIN3B;MYH16;HSF1;APPL2;SIN3B;WFS1;SDHA;CTBP1;ADAM8;MAPKBP1;INTS8;MYH15;HMGA2;DYNLRB1;TOP1;P4HA1;GPRC5C;VAMP2;TULP3;SRC;LDLRAP1;CBR4;CAPG;POLD4;AGO4;HIST3H2A;NDUFA4L2;RGS19;RALY;STX5;COG8;RERE;EXOC2;RSF1;GSK3A;STXBP1;SPECC1L;SH3BP1;SPTLC2;PPM1F;RMND5A;NELFCD;PSMD7;KIF17;TNFRSF1A;TLE4;FBXL15;VDR;BRPF3;KIF13B;SSU72;STX10;GJC2;PUM1;ITGA1;TNRC6B;THRA;PLTP;EIF2S2;LAMB3;WDFY3;SEC24C;FGFR1;TUBG1;RRBP1;MSL1;LRRC8A;PHF2;MIB2;CEP170;PBX3;VPS37A;BCL2L1;STUB1;MAU2;DDB2;TCIRG1;PTPN12;ZFPM1;RMND5B;RAD23A;ULK1;LRP1;HSPA2;ZNF609;E2F5;SAMD4B;KLHL17;RNH1;MED15;COG1;SDHAF4;SHB;PYM1;RCOR1;MYO1D;SNTB2;RNF222;ABCA7;EPS8L1;WDR18;RXRA;HIST2H2AC;C1QTNF6;INTS1;SPSB3;TAF6;NDE1;RPL28;RPRD2;BAHCC1;ATP6V1C2;CNOT11;HIST1H2AG;IMPACT;CASP4;SNAP29;RPRD1A;KCNC4;EPHB2;HGS;CARHSP1;MYL9;CBL;TRAPPC1;TMSB10;KIFC3;ARHGEF2;C12ORF66;GIGYF1;SNX27;NDUFS2;HM13;MED29;CEACAM1;TFPT;MBD3;ADCY6;CCNE1;EIF4G3;SF3B6;PCYOX1;SH3PXD2A;PIK3R2;ERBB3;PPP1R10;ASH2L;APOBEC3C;GNAS;CCDC113;ITGA3;PXN;ARCN1;EP300;TCF7L1;MZT2B;ASAP1;TRAF7
17663,GO:1901363,0.99999952867201,6.48621946429533e-07,396,4574,heterocyclic compound binding,MF,NT5E;XDH;PYGB;CBS;ERCC1;ZMYND8;NOS1;H1F0;MST1R;RAC2;NFATC4;MAP2K1;PYGL;ETV4;ERCC6;CYP27B1;SCN8A;PCK2;MEF2D;OBSCN;NR1D1;XPOT;SLC16A3;TEF;ZKSCAN1;DNMT3A;FKBP1A;SOX12;DGKA;MTA1;RAB3B;CKAP4;RPS6KA2;RAPGEF3;IDH2;PC;R3HDM4;RAB43;SCYL1;SMARCA1;NME4;CYGB;MAPKAPK3;ABTB1;ZC3H6;FKBP9;TUBB6;NACC2;HEBP1;BCR;RAB31;ETV5;MARK4;AARS;ACVR2B;H6PD;HTR7;GPT2;ADCY7;XBP1;ZCCHC14;MAP4K4;EGFR;CSNK1E;MKNK2;TK2;FYCO1;RFX2;SEPT10;PRKACA;ADARB1;CARS;ACTA2;HK1;MAP2K2;FAM50A;TUBG2;STK25;MIER2;ATF4;P4HB;ZKSCAN2;MRPS6;AKT1;XPC;MDH2;IRAK1;PEG3;BAG3;EHD3;ATP13A2;PKN1;ZSCAN30;ELK3;PHF21A;CRYL1;TMSB4X;TSPYL2;PRKCZ;PHC2;ATP7B;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;VPS11;VPS4A;HIST2H2BE;EPHA1;PI4K2A;PTK6;PFKP;GRK6;PCSK9;ENDOG;ZNF598;ACAD10;NMRK1;RRAS;SEPT5;DEAF1;SALL2;MSN;TGFBR2;DRAP1;HADH;LIMK1;STK39;CREB3L2;SOX7;UBE2J1;PPARA;DHTKD1;NADK;TST;PRKACB;H2AFJ;CDC34;ZNF516;ABCB8;SEC63;GTPBP1;MAP3K9;IDE;DEDD2;TWF2;LARP6;TFE3;PRDX5;FSCN1;PAK1;SP6;TTBK2;LARP1B;AHCY;ACSF2;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;DDIT3;GLUL;TUBB3;SATB1;RET;RAB29;DNASE1L1;MLXIP;RHOC;HLTF;PCBP4;SEPT8;ASS1;ATP11A;GATA3;NUCB2;PHF1;TCFL5;ARL8A;OASL;GNAI2;ZNF165;RPUSD3;GLUD1;HSF1;PANK4;NEK9;SDHA;CTBP1;MAPKBP1;NEIL1;RAI1;MPG;MYH15;HMGA2;ALAS1;ARID5B;RHOBTB2;TOP1;ARL2;MICAL2;FLNB;PIP5K1C;SRC;APLP2;CBR4;SCG5;FKBP10;TGM2;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;RAB1B;CDC42BPB;MARK3;STK24;ACADVL;RALY;PAK6;ZCCHC24;PER3;RBMS2;ESRP1;NSUN7;GARS;RERE;GSK3A;STXBP1;CAMTA2;PMVK;OAS1;SLFN5;FYN;RAB25;ISG20;SPTLC2;ASNS;ZNF692;ZNF862;PFN1;NELFCD;MICAL1;KIF17;VDR;KIF13B;UCKL1;BRSK1;PUM1;PSKH1;EHF;TNRC6B;C11ORF95;THRA;MAP3K10;EIF2S2;HEXIM1;UBA1;ZSCAN18;ZNF71;HSF4;SECISBP2L;FGFR1;SPATS2;TUBG1;RRBP1;RREB1;MIF4GD;ZBED4;ATP2C2;ADNP;TTLL12;USF2;PBX3;GUK1;CDK18;HES2;ZDBF2;STK17A;MAU2;TRIB3;DDB2;ZFPL1;TPD52L2;SLC27A1;LEMD2;ZFPM1;ZNF783;ARFIP2;HLCS;SARS2;PRRC2A;NDOR1;RAD23A;PIP5KL1;ULK1;LRP1;HSPA2;AOX1;ZNF609;PAK4;MXD4;P2RX4;E2F5;SAMD4B;USO1;ULK2;GPATCH8;ZNF419;LRRK1;PNP;EHD4;RNASE7;MAPK9;ZNF570;PYM1;RCOR1;MAP3K12;ZNF398;HSPA13;MYO1D;CHD7;SNTB2;TAOK1;ABCA7;ZNF687;BICC1;RHOBTB1;RXRA;HIST2H2AC;ZHX3;TSHZ1;TAF6;RPL28;BAHCC1;ZBTB4;SEC14L2;TCF25;HIST1H2AG;NYNRIN;ZNF624;LONP2;CAMK1;EPHB2;CARHSP1;DRG2;POLM;LACTB2;RAB4B;MAPK3;EEPD1;MAPK10;CSNK1D;DBP;KIFC3;LITAF;S100A16;ZNF444;MLF1;NDUFS2;ZFP30;PAIP2;MINK1;ZNF256;AGAP1;TFPT;MBD3;ADCY6;IGF2BP3;EIF4G3;ZFP28;SF3B6;WBP2;ADCK2;MANF;CAT;RMI2;LDHA;ERBB3;ANXA1;PPP1R10;ASH2L;RAB6A;APOBEC3C;GNAS;KLF12;ZNF318;ARCN1;EP300;TCF7L1;TIGD5;RNF10
8869,GO:0034660,0.999999681252216,8.24355238887145e-07,23,545,ncRNA metabolic process,BP,AARS;CSNK1E;CARS;POU2F2;DEDD2;RRNAD1;DTD1;BCDIN3D;RPUSD3;INTS8;AGO4;GARS;ISG20;SARS2;CHD7;WDR18;INTS1;TAF6;RPL28;RPRD2;RPRD1A;TRPT1;CSNK1D
16838,GO:0098687,0.999999849866268,6.09989970247427e-07,9,312,chromosomal region,CC,ERCC1;DNMT3A;NSMCE4A;SCMH1;HSF1;MBD6;PHF2;NDE1;PPP1R10
7606,GO:0031981,0.999999865008012,1.9441627405851e-07,285,3518,nuclear lumen,CC,TNIP1;NT5E;TSPAN1;ERCC1;NOS1;H1F0;CCND1;CTNNBIP1;NFATC4;PITPNC1;DOCK4;PTHLH;ETV4;ERCC6;EPN3;CRTC1;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;TRIM65;XPOT;DNMT3A;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;BNIP3;SBF1;CITED4;SMARCA1;SMURF2;BCORL1;FAM222B;PCDH1;CYGB;FAM129B;MAPKAPK3;CTSB;ACOT7;ABTB1;NACC2;VWA5A;ETV5;XBP1;CSNK1E;PANO1;MKNK2;PRKACA;ADARB1;FCHO1;FAM114A1;PPP1R13L;FAM50A;ATF4;AKT1;XPC;ATG16L2;UAP1;PKN1;TMEM92;SYVN1;ELK3;WWTR1;PHF21A;RABGGTA;TSPYL2;PRKCZ;PHC2;ITPR3;POU2F2;DGKQ;PPP2R3B;HIST2H2BE;CCDC92;ZMIZ2;PTK6;PTPDC1;NSMCE4A;GIT2;DEAF1;SALL2;HADH;LIMK1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;CDC34;ABCB8;DEDD2;JADE2;TBC1D14;TFE3;CCND2;CMIP;BCL9L;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;DDIT3;PODXL;GGA1;DUSP4;PTPN9;SATB1;CYTH3;HLTF;PARP10;GATA3;PHF1;DCAF7;OASL;GNAI2;HSF1;APPL2;SIN3B;ANKS1A;SH3GLB2;CNDP2;SDHA;CTBP1;CDCA7L;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;ARID5B;TOP1;ARL2;PLCB3;B4GALT2;PIP5K1C;TULP3;SRC;MBD6;KDM4B;CAPG;POLD4;FKBP10;KLHDC2;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;STK24;ACADVL;PAK6;YPEL3;ESRP1;RERE;RSF1;STXBP1;TALDO1;DUSP6;OAS1;ISG20;ZNF692;NELFCD;PSMD7;TLE4;VDR;BRPF3;BRSK1;SSU72;PUM1;RNF44;RAI14;PSKH1;EHF;THRA;HEXIM1;UBA1;MGLL;RNF187;HSF4;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;PHF2;TENM2;USF2;MIF;VPS37A;STUB1;STK17A;MAU2;DDB2;PTPN12;ZFPM1;LRCH4;HLCS;PRRC2A;RAD23A;HSPA2;ZNF609;HPSE;E2F5;USO1;SPIRE1;RNH1;MED15;MAPK9;SH3BGRL2;SHB;PYM1;RCOR1;ABHD14B;CHD7;RNF222;ZNF687;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;L3MBTL3;ZHX3;TAF6;VSIG10L;RPRD2;BAHCC1;SEC14L1;ZBTB4;BAIAP2L1;HIST1H2AG;KLK6;NOL4L;SNAP29;KLHDC10;RPRD1A;DRG2;POLM;FAM193B;CIB1;IQSEC1;MAPK3;MAPK10;CSNK1D;DNAJB9;LITAF;S100A16;SNX27;MPLKIP;NDUFS2;MED29;SKAP2;TFPT;MBD3;CCNE1;SF3B6;WBP2;TM2D1;RMI2;ANXA1;PPP1R10;ASH2L;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;TCF7L1;MZT2B
9924,GO:0042254,0.999999936942082,3.02633984420063e-07,7,317,ribosome biogenesis,BP,CSNK1E;RRNAD1;ISG20;CHD7;WDR18;RPL28;CSNK1D
1450,GO:0003677,0.999999956449214,7.1201541296169e-08,137,1910,DNA binding,MF,ERCC1;ZMYND8;H1F0;NFATC4;ETV4;ERCC6;MEF2D;NR1D1;TEF;ZKSCAN1;DNMT3A;SOX12;MTA1;SCYL1;SMARCA1;ZC3H6;NACC2;ETV5;XBP1;EGFR;RFX2;MIER2;ATF4;ZKSCAN2;XPC;ZSCAN30;ELK3;PHF21A;TSPYL2;PHC2;POU2F2;TFEB;HIST2H2BE;DEAF1;SALL2;DRAP1;CREB3L2;SOX7;PPARA;H2AFJ;ZNF516;DEDD2;TFE3;PRDX5;SP6;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;DDIT3;SATB1;DNASE1L1;MLXIP;HLTF;PCBP4;GATA3;NUCB2;PHF1;TCFL5;OASL;ZNF165;HSF1;NEIL1;RAI1;MPG;HMGA2;ARID5B;TOP1;APLP2;IRF7;HIST3H2A;RFXANK;NUCB1;PER3;RERE;CAMTA2;ZNF692;VDR;EHF;THRA;ZSCAN18;ZNF71;HSF4;RREB1;ZBED4;ADNP;USF2;PBX3;HES2;MAU2;DDB2;ZFPL1;LEMD2;ZFPM1;ZNF783;RAD23A;MXD4;E2F5;ZNF419;ZNF570;RCOR1;ZNF398;CHD7;ZNF687;RXRA;HIST2H2AC;ZHX3;TSHZ1;TAF6;BAHCC1;ZBTB4;TCF25;HIST1H2AG;ZNF624;CARHSP1;POLM;EEPD1;DBP;LITAF;ZNF444;MLF1;ZFP30;ZNF256;TFPT;MBD3;ZFP28;WBP2;RMI2;ANXA1;PPP1R10;ASH2L;KLF12;EP300;TCF7L1;TIGD5;RNF10
6604,GO:0022618,0.999999970699764,3.32504533775757e-07,2,194,ribonucleoprotein complex assembly,BP,AGO4;WDR18
15498,GO:0071826,0.9999999906888,1.11663268525811e-07,2,205,ribonucleoprotein complex subunit organization,BP,AGO4;WDR18
2436,GO:0005634,0.999999990793882,1.31124394393475e-08,495,5698,nucleus,CC,TNIP1;NT5E;FHL1;TSPAN1;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;CAPN2;RAC2;SORL1;CTNNBIP1;NFATC4;MAP2K1;PITPNC1;DOCK4;PTHLH;ETV4;ERCC6;CST3;EPN3;BOK;CRTC1;ARAP1;MEF2D;OBSCN;CPT2;NR1D1;KLC2;DLG1;TRIM65;XPOT;SLC16A3;TEF;SLC9A3R2;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;CKAP4;RPS6KA2;NET1;SLC2A9;PRNP;BNIP3;PDZD2;SBF1;R3HDM4;LAMA5;AGPAT3;SCYL1;CITED4;SMARCA1;SMURF2;C2CD2;BCORL1;FAM222B;PCDH1;MARVELD1;CYGB;FAM129B;MAPKAPK3;CTSB;FAM214B;SESN2;ACOT7;ABTB1;ZC3H6;TUBB6;NACC2;SYNE3;VWA5A;ETV5;XBP1;EGFR;CSNK1E;PANO1;MKNK2;MMP14;RFX2;PRKACA;ADARB1;FCHO1;TUB;MAP2K2;FAM114A1;EPN1;PPP1R13L;FAM50A;TUBG2;MIER2;ATF4;ZKSCAN2;AKT1;XPC;BRD3;MDH2;ACOT13;GPC4;IRAK1;PEG3;ALDH1L2;BAG3;APOE;ATG16L2;EHD3;ARG2;UAP1;METTL23;PKN1;TMEM92;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;NPEPL1;RABGGTA;TMSB4X;TSPYL2;PRKCZ;PHC2;ITPR3;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;PPP2R3B;VPS4A;HIST2H2BE;CCDC92;UACA;ZMIZ2;PTK6;PFKP;RETSAT;PTPDC1;ENDOG;NSMCE4A;GIT2;DEAF1;SALL2;MSN;DRAP1;HADH;MVB12B;LIMK1;SCAND1;STK39;CREB3L2;SOX7;BNIP3L;PPARA;SYMPK;PRKACB;H2AFJ;SIPA1;WDTC1;OTUB2;CDC34;DNAJB5;ZNF516;SCRN1;IPO13;PLCG1;ABCB8;IDE;DEDD2;JADE2;LARP6;TBC1D14;TFE3;PRDX5;CCND2;TACC1;CMIP;BIN1;SUFU;PAK1;SP6;TTBK2;LARP1B;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;UBXN7;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;PODXL;GLUL;BCDIN3D;CUL7;ARHGAP39;GGA1;TUBB3;DUSP4;PTPN9;SATB1;DNASE1L1;PTOV1;MLXIP;RHOC;IFI27;CYTH3;HLTF;CEMIP;PKD1;PARP10;GATA3;NUCB2;PHF1;UBXN4;TCFL5;DCAF7;OASL;MYOF;GNAI2;PPM1M;ZNF165;HSF1;APPL2;SIN3B;ANKS1A;ALOX15B;NEK9;SH3GLB2;CNDP2;FAT1;MT2A;SDHA;CTBP1;CDCA7L;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;C19ORF33;ARID5B;TOP1;BLMH;FAM110C;ARL2;MICAL2;PLCB3;NUMB;B4GALT2;PIP5K1C;TSC22D4;TULP3;SRC;CHMP5;APLP2;MBD6;KDM4B;GLRX;CAPG;POLD4;TAZ;FKBP10;DNM2;KLHDC2;REEP6;UBR4;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;STPG1;STK24;CPTP;ACADVL;CARD19;RALY;PAK6;PER3;YPEL3;RBMS2;ESRP1;RERE;RSF1;STXBP1;CAMTA2;SH3BP1;TALDO1;DUSP6;OAS1;SLFN5;FYN;PRIMPOL;ISG20;CLSTN1;ZNF692;RALGDS;ZNF862;PFN1;RMND5A;NELFCD;PSMD7;ALDH7A1;TLE4;VDR;BRPF3;UCKL1;BRSK1;SSU72;PUM1;RNF44;SHISA5;RAI14;PSKH1;CTSL;EHF;THRA;HEXIM1;AMIGO2;UBA1;MGLL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;WDFY3;FGFR1;TUBG1;RREB1;MIF4GD;ZBED4;MSL1;ADNP;PHF2;TENM2;USF2;PBX3;CDK18;MIF;HES2;VPS37A;SIGMAR1;BCL2L1;STUB1;STK17A;MAU2;TRIB3;DDB2;ZFPL1;ANGEL1;PTPN12;LEMD2;ZFPM1;ZNF783;LRCH4;HLCS;RMND5B;PRRC2A;NDOR1;RAD23A;LRP1;TRIB2;HSPA2;ZNF609;MXD4;MGRN1;P2RX4;HPSE;E2F5;SAMD4B;USO1;ZNF419;TBC1D20;SPIRE1;PNP;FGF2;EHD4;RNH1;MED15;MAPK9;ZNF570;SH3BGRL2;CDYL2;SHB;PYM1;RCOR1;ABHD14B;ZNF398;HSPA13;CHD7;TAOK1;RNF222;ZNF687;APBB1;WDR18;RXRA;UNC45A;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VSIG10L;INVS;RPRD2;BAHCC1;SEC14L1;ZBTB4;SEC14L2;BAIAP2L1;CNOT11;TCF25;HIST1H2AG;ZNF624;KLK6;NOL4L;SNAP29;LONP2;KLHDC10;RPRD1A;CAMK1;EPHB2;DRG2;POLM;CBL;FAM193B;CIB1;SOCS7;IQSEC1;MAPK3;MAPK10;CSNK1D;DBP;ARVCF;DNAJB9;LITAF;GLO1;S100A16;ZNF444;SNX27;MLF1;MPLKIP;NDUFS2;OCRL;ZFP30;MED29;APBA1;SKAP2;ZNF256;LPIN3;AGAP1;TFPT;MBD3;SLC30A1;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;TM2D1;MANF;RMI2;LDHA;AZIN2;PIK3R2;ANXA1;PPP1R10;ASH2L;APOBEC3C;KLF12;CCDC113;ZNF318;PLEKHH2;EP300;TCF7L1;RAP1GAP2;MZT2B;TIGD5;FHOD1;RNF10
4473,GO:0010467,0.999999992799633,1.05464777572877e-08,350,4265,gene expression,BP,TNIP1;XDH;MDFI;ZMYND8;NOS1;CHAC1;CCND1;CAPN2;F2R;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;ADM2;SHC1;PLAT;WNT7A;PTHLH;ETV4;ERCC6;NEURL1;LMF1;CRTC1;MEF2D;SERPINE2;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;FKBP1A;SOX12;PSMD2;MTA1;ITGA6;PRSS3;PRNP;PC;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ABTB1;ZC3H6;BBS2;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;KIAA1549;XBP1;EGFR;CSNK1E;MKNK2;MMP14;RFX2;PRKACA;ADARB1;CARS;RHBDF2;ACTA2;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;MRPS6;AKT1;BRD3;CARD11;IRAK1;PEG3;SERPING1;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;CTSZ;ZMIZ2;SH3PXD2B;PCSK9;ZNF598;FERMT1;TYSND1;DEAF1;SALL2;MSN;TGFBR2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;PRKACB;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;TSPAN5;HTRA1;SUFU;SP6;ERO1B;BCL9L;SCMH1;ZNF385A;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;ZNF165;RPUSD3;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;ASPH;CTBP1;CDCA7L;ADAM8;MAPKBP1;RAI1;INTS8;HMGA2;ARID5B;TOP1;MICAL2;MYDGF;EIF4EBP1;TSC22D4;TULP3;ALDH1A2;SRC;KDM4B;SCG5;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;FYN;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;TSPAN33;SSU72;GJC2;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;EIF2S2;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;F12;USF2;PBX3;MIF;HES2;STUB1;PCSK1N;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;RNH1;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;WDR18;SLIT3;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;KLK6;LONP2;RPRD1A;TRPT1;CAMK1;EPHB2;HGS;CARHSP1;CBL;GGT1;CIB1;MAPK3;KANK2;MAPK10;CSNK1D;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;MLF1;ZFP30;HM13;MED29;PAIP2;APBA1;ZNF256;LPIN3;TFPT;ECM1;CD59;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;CAT;PIK3R2;CAMK2N1;ERBB3;ASH2L;KLF12;ITGA3;PLGRKT;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
4028,GO:0009059,0.999999995188284,7.1265965076362e-09,335,4112,macromolecule biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;SDC1;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;NEURL1;LMF1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ABTB1;LY6K;ZC3H6;NACC2;ADGRF1;CHPF;VLDLR;ETV5;LRP5;AARS;ACVR2B;XYLT1;KIAA1549;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;MAP2K2;PPP1R13L;XYLT2;MN1;MIER2;ATF4;ZKSCAN2;MRPS6;AKT1;BRD3;CARD11;GPC4;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;NDST2;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;SYMPK;H2AFJ;ZDHHC8;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;DDIT3;BCDIN3D;ADAMTS7;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;CEMIP;PKD1;PARP10;GATA3;APLN;PIGQ;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;SRD5A3;CTBP1;CDCA7L;ADAM8;RAI1;INTS8;HMGA2;ARID5B;TOP1;LY6E;MICAL2;MYDGF;B4GALT2;EIF4EBP1;TSC22D4;TULP3;B3GNT3;SRC;KDM4B;POLD4;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;ABHD17C;SSU72;CHST14;GAL;PUM1;EHF;TNRC6B;THRA;MCFD2;MAP3K10;LYPD5;EIF2S2;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;HYAL1;PHF2;TENM2;USF2;PBX3;MFNG;HES2;ST3GAL3;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;TRIB2;ZNF609;MXD4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;FGF2;MED15;ST6GALNAC2;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;LMAN1;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;NTNG1;POMT1;MAPK10;DBP;LITAF;GLO1;FURIN;ARHGEF2;ZNF444;MLF1;B4GALT6;ZFP30;MED29;PAIP2;GALNT3;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
8858,GO:0034645,0.999999995364169,6.91317905346446e-09,328,4041,cellular macromolecule biosynthetic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;NEURL1;LMF1;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ABTB1;LY6K;ZC3H6;NACC2;ADGRF1;CHPF;VLDLR;ETV5;LRP5;AARS;ACVR2B;XYLT1;KIAA1549;XBP1;EGFR;MKNK2;TK2;RFX2;CARS;MAP2K2;PPP1R13L;XYLT2;MN1;MIER2;ATF4;ZKSCAN2;MRPS6;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;SYVN1;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;RFNG;ARHGAP22;FZD8;ZMIZ2;ZNF598;DEAF1;SALL2;DRAP1;NDST2;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;UBE2J1;PPARA;SYMPK;H2AFJ;ZDHHC8;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;DDIT3;BCDIN3D;ADAMTS7;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PKD1;PARP10;GATA3;APLN;PIGQ;PHF1;TCFL5;ZNF165;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;SRD5A3;CTBP1;CDCA7L;ADAM8;RAI1;INTS8;HMGA2;ARID5B;TOP1;LY6E;MICAL2;MYDGF;B4GALT2;EIF4EBP1;TSC22D4;TULP3;B3GNT3;SRC;KDM4B;POLD4;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;PRIMPOL;MPI;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;ABHD17C;SSU72;CHST14;GAL;PUM1;EHF;TNRC6B;THRA;MCFD2;MAP3K10;LYPD5;EIF2S2;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;MFNG;HES2;ST3GAL3;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;ST3GAL5;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;MED15;ST6GALNAC2;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ABCA7;ZNF687;LMAN1;MSLN;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;VEGFB;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;MAPK3;KANK2;NTNG1;POMT1;MAPK10;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;B4GALT6;ZFP30;MED29;PAIP2;GALNT3;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;WBP2;CAT;RMI2;PIK3R2;ASH2L;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
824,GO:0002094,0.999999999967893,0.805661990813234,0,2,polyprenyltransferase activity,MF,
1840,GO:0004492,0.999999999971786,0.896271404168996,0,1,methylmalonyl-CoA decarboxylase activity,MF,
5533,GO:0016507,0.999999999972562,0.892358058463003,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9498,GO:0036125,0.999999999972562,0.892358058463003,0,1,fatty acid beta-oxidation multienzyme complex,CC,
1656,GO:0004105,0.999999999972945,0.803960322443936,0,2,choline-phosphate cytidylyltransferase activity,MF,
14148,GO:0060994,0.999999999972964,0.80202496534859,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
5841,GO:0017125,0.999999999973007,0.888653200389245,0,1,deoxycytidyl transferase activity,MF,
19,GO:0000035,0.999999999973636,0.880481992125012,0,2,acyl binding,MF,
20,GO:0000036,0.999999999973636,0.880481992125012,0,2,acyl carrier activity,MF,
4174,GO:0009245,0.999999999973636,0.880481992125012,0,2,lipid A biosynthetic process,BP,
10960,GO:0044620,0.999999999973636,0.880481992125012,0,2,ACP phosphopantetheine attachment site binding,MF,
11717,GO:0046493,0.999999999973636,0.880481992125012,0,2,lipid A metabolic process,BP,
12888,GO:0051192,0.999999999973636,0.880481992125012,0,2,prosthetic group binding,MF,
17627,GO:1901269,0.999999999973636,0.880481992125012,0,2,lipooligosaccharide metabolic process,BP,
17628,GO:1901271,0.999999999973636,0.880481992125012,0,2,lipooligosaccharide biosynthetic process,BP,
7612,GO:0031990,0.999999999973912,0.794875633104957,0,2,mRNA export from nucleus in response to heat stress,BP,
8757,GO:0034402,0.999999999973912,0.794875633104957,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
2133,GO:0004935,0.999999999973985,0.80349848052804,0,2,adrenergic receptor activity,MF,
512,GO:0001575,0.999999999974171,0.805752230362083,0,2,globoside metabolic process,BP,
17139,GO:0102005,0.999999999974284,0.906815623834849,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
14721,GO:0070336,0.999999999974511,0.793150784438344,0,2,flap-structured DNA binding,MF,
16043,GO:0086045,0.99999999997463,0.791088820595232,0,2,membrane depolarization during AV node cell action potential,BP,
14033,GO:0060734,0.999999999974986,0.888727330044037,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
18788,GO:1904245,0.999999999975043,0.804371051055095,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
9263,GO:0035663,0.999999999975967,0.800169528708064,0,2,Toll-like receptor 2 binding,MF,
4210,GO:0009331,0.999999999976102,0.79057783760259,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
11236,GO:0045355,0.999999999976143,0.820321002732317,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
1851,GO:0004511,0.999999999976207,0.898732015037262,0,1,tyrosine 3-monooxygenase activity,MF,
3035,GO:0006585,0.999999999976207,0.898732015037262,0,1,dopamine biosynthetic process from tyrosine,BP,
8280,GO:0033076,0.999999999976207,0.898732015037262,0,1,isoquinoline alkaloid metabolic process,BP,
9034,GO:0035240,0.999999999976207,0.898732015037262,0,1,dopamine binding,MF,
9909,GO:0042214,0.999999999976207,0.898732015037262,0,1,terpene metabolic process,BP,
10012,GO:0042418,0.999999999976207,0.898732015037262,0,1,epinephrine biosynthetic process,BP,
13357,GO:0052314,0.999999999976207,0.898732015037262,0,1,phytoalexin metabolic process,BP,
10271,GO:0043000,0.999999999976214,0.807530016169909,0,2,Golgi to plasma membrane CFTR protein transport,BP,
6229,GO:0019777,0.999999999976524,0.818238414134798,0,2,Atg12 transferase activity,MF,
8978,GO:0035054,0.999999999976689,0.892073402888645,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12785,GO:0051040,0.999999999976689,0.892073402888645,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12786,GO:0051042,0.999999999976689,0.892073402888645,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13653,GO:0060128,0.999999999976689,0.892073402888645,0,1,corticotropin hormone secreting cell differentiation,BP,
14068,GO:0060804,0.999999999976689,0.892073402888645,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14921,GO:0070724,0.999999999976689,0.892073402888645,0,1,BMP receptor complex,CC,
4611,GO:0010726,0.999999999977193,0.800302568194042,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
1580,GO:0003987,0.99999999997722,0.79336681162042,0,2,acetate-CoA ligase activity,MF,
6144,GO:0019413,0.99999999997722,0.79336681162042,0,2,acetate biosynthetic process,BP,
6147,GO:0019427,0.99999999997722,0.79336681162042,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6178,GO:0019542,0.99999999997722,0.79336681162042,0,2,propionate biosynthetic process,BP,
10674,GO:0043849,0.999999999977368,0.892733641631911,0,1,Ras palmitoyltransferase activity,MF,
12191,GO:0048297,0.999999999977389,0.896107287144816,0,1,negative regulation of isotype switching to IgA isotypes,BP,
15980,GO:0075732,0.999999999977433,0.789687445986741,0,2,viral penetration into host nucleus,BP,
18076,GO:1902594,0.999999999977433,0.789687445986741,0,2,multi-organism nuclear import,BP,
5809,GO:0017060,0.999999999977533,0.799013626914403,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
1634,GO:0004070,0.999999999977837,0.789235781449284,0,2,aspartate carbamoyltransferase activity,MF,
1646,GO:0004087,0.999999999977837,0.789235781449284,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1647,GO:0004088,0.999999999977837,0.789235781449284,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1687,GO:0004151,0.999999999977837,0.789235781449284,0,2,dihydroorotase activity,MF,
5652,GO:0016743,0.999999999977837,0.789235781449284,0,2,carboxyl- or carbamoyltransferase activity,MF,
7666,GO:0032090,0.999999999977929,0.82675108757299,0,2,Pyrin domain binding,MF,
12763,GO:0051012,0.999999999977954,0.801374620435327,0,2,microtubule sliding,BP,
18531,GO:1903650,0.999999999977981,0.853975541534563,0,2,negative regulation of cytoplasmic transport,BP,
20055,GO:2000642,0.999999999977981,0.853975541534563,0,2,negative regulation of early endosome to late endosome transport,BP,
5415,GO:0016256,0.999999999978094,0.812543223927434,0,2,N-glycan processing to lysosome,BP,
2254,GO:0005166,0.999999999978101,0.92394947202725,0,1,neurotrophin p75 receptor binding,MF,
3498,GO:0007402,0.999999999978101,0.92394947202725,0,1,ganglion mother cell fate determination,BP,
3610,GO:0008052,0.999999999978101,0.92394947202725,0,1,sensory organ boundary specification,BP,
4410,GO:0010160,0.999999999978101,0.92394947202725,0,1,formation of animal organ boundary,BP,
12435,GO:0048867,0.999999999978101,0.92394947202725,0,1,stem cell fate determination,BP,
14252,GO:0061193,0.999999999978101,0.92394947202725,0,1,taste bud development,BP,
17020,GO:0099082,0.999999999978101,0.92394947202725,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17021,GO:0099083,0.999999999978101,0.92394947202725,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17078,GO:0099538,0.999999999978101,0.92394947202725,0,1,synaptic signaling via neuropeptide,BP,
17079,GO:0099540,0.999999999978101,0.92394947202725,0,1,trans-synaptic signaling by neuropeptide,BP,
17087,GO:0099551,0.999999999978101,0.92394947202725,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
13675,GO:0060166,0.999999999978197,0.810208611499114,0,2,olfactory pit development,BP,
13173,GO:0051725,0.9999999999782,0.814757930843291,0,2,protein de-ADP-ribosylation,BP,
1247,GO:0002944,0.999999999978205,0.79514226427403,0,2,cyclin K-CDK12 complex,CC,
1248,GO:0002945,0.999999999978205,0.79514226427403,0,2,cyclin K-CDK13 complex,CC,
4272,GO:0009624,0.999999999978247,0.893563837561294,0,1,response to nematode,BP,
4290,GO:0009692,0.999999999978247,0.893563837561294,0,1,ethylene metabolic process,BP,
4291,GO:0009698,0.999999999978247,0.893563837561294,0,1,phenylpropanoid metabolic process,BP,
4320,GO:0009804,0.999999999978247,0.893563837561294,0,1,coumarin metabolic process,BP,
5634,GO:0016711,0.999999999978247,0.893563837561294,0,1,flavonoid 3'-monooxygenase activity,MF,
6108,GO:0019341,0.999999999978247,0.893563837561294,0,1,dibenzo-p-dioxin catabolic process,BP,
10532,GO:0043449,0.999999999978247,0.893563837561294,0,1,cellular alkene metabolic process,BP,
16301,GO:0090362,0.999999999978397,0.796757759607535,0,2,positive regulation of platelet-derived growth factor production,BP,
7429,GO:0031523,0.999999999978398,0.793551929824077,0,2,Myb complex,CC,
1511,GO:0003867,0.99999999997841,0.888547090878329,0,1,4-aminobutyrate transaminase activity,MF,
4848,GO:0014053,0.99999999997841,0.888547090878329,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7697,GO:0032144,0.99999999997841,0.888547090878329,0,1,4-aminobutyrate transaminase complex,CC,
7698,GO:0032145,0.99999999997841,0.888547090878329,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8471,GO:0033602,0.99999999997841,0.888547090878329,0,1,negative regulation of dopamine secretion,BP,
8745,GO:0034386,0.99999999997841,0.888547090878329,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
12001,GO:0047298,0.99999999997841,0.888547090878329,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14358,GO:0061528,0.99999999997841,0.888547090878329,0,1,aspartate secretion,BP,
18872,GO:1904448,0.99999999997841,0.888547090878329,0,1,regulation of aspartate secretion,BP,
18873,GO:1904450,0.99999999997841,0.888547090878329,0,1,positive regulation of aspartate secretion,BP,
5950,GO:0018282,0.999999999978515,0.794610776552349,0,2,metal incorporation into metallo-sulfur cluster,BP,
5951,GO:0018283,0.999999999978515,0.794610776552349,0,2,iron incorporation into metallo-sulfur cluster,BP,
13528,GO:0055077,0.99999999997853,0.796695863595863,0,2,gap junction hemi-channel activity,MF,
15056,GO:0070984,0.999999999978536,0.889367111674261,0,1,SET domain binding,MF,
5320,GO:0016035,0.99999999997867,0.815987366931477,0,2,zeta DNA polymerase complex,CC,
13482,GO:0052925,0.999999999978708,0.906591659412978,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
7689,GO:0032129,0.999999999978772,0.804325957200915,0,2,histone deacetylase activity (H3-K9 specific),MF,
11941,GO:0046969,0.999999999978772,0.804325957200915,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19609,GO:1990619,0.999999999978772,0.804325957200915,0,2,histone H3-K9 deacetylation,BP,
477,GO:0001520,0.999999999978837,0.792862325402482,0,2,outer dense fiber,CC,
681,GO:0001888,0.999999999978925,0.793210985209228,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
9678,GO:0038028,0.999999999979022,0.630381293123563,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
13593,GO:0060040,0.999999999979028,0.797884754134223,0,2,retinal bipolar neuron differentiation,BP,
2150,GO:0004965,0.999999999979118,0.790653839749759,0,2,G-protein coupled GABA receptor activity,MF,
19660,GO:1990791,0.999999999979144,0.79674476641011,0,2,dorsal root ganglion development,BP,
14236,GO:0061152,0.999999999979228,0.816967339753163,0,2,trachea submucosa development,BP,
14237,GO:0061153,0.999999999979228,0.816967339753163,0,2,trachea gland development,BP,
1939,GO:0004637,0.999999999979322,0.89118061839258,0,1,phosphoribosylamine-glycine ligase activity,MF,
1942,GO:0004641,0.999999999979322,0.89118061839258,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1945,GO:0004644,0.999999999979322,0.89118061839258,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2072,GO:0004823,0.999999999979429,0.790178901600323,0,2,leucine-tRNA ligase activity,MF,
2918,GO:0006429,0.999999999979429,0.790178901600323,0,2,leucyl-tRNA aminoacylation,BP,
8880,GO:0034678,0.999999999979612,0.791262029493309,0,2,integrin alpha8-beta1 complex,CC,
6841,GO:0030299,0.999999999979952,0.808846867285519,0,2,intestinal cholesterol absorption,BP,
10792,GO:0044241,0.999999999979952,0.808846867285519,0,2,lipid digestion,BP,
16922,GO:0098856,0.999999999979952,0.808846867285519,0,2,intestinal lipid absorption,BP,
19938,GO:2000395,0.999999999979993,0.836717699829387,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19939,GO:2000397,0.999999999979993,0.836717699829387,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
1740,GO:0004335,0.99999999998002,0.812622879960345,0,2,galactokinase activity,MF,
15079,GO:0071020,0.999999999980057,0.812881695538481,0,2,post-spliceosomal complex,CC,
18077,GO:1902595,0.999999999980114,0.812355484544466,0,2,regulation of DNA replication origin binding,BP,
8279,GO:0033065,0.999999999980197,0.827673489213097,0,2,Rad51C-XRCC3 complex,CC,
6092,GO:0019255,0.999999999980255,0.804167860434426,0,2,glucose 1-phosphate metabolic process,BP,
16591,GO:0097362,0.999999999980261,0.796084004677709,0,2,MCM8-MCM9 complex,CC,
20146,GO:2000790,0.999999999980265,0.790725714341757,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20147,GO:2000791,0.999999999980265,0.790725714341757,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
1140,GO:0002729,0.999999999980325,0.821686847092893,0,2,positive regulation of natural killer cell cytokine production,BP,
6315,GO:0019957,0.999999999980351,0.803655114173517,0,2,C-C chemokine binding,MF,
18145,GO:1902805,0.999999999980388,0.789626090943837,0,2,positive regulation of synaptic vesicle transport,BP,
19868,GO:2000302,0.999999999980388,0.789626090943837,0,2,positive regulation of synaptic vesicle exocytosis,BP,
10954,GO:0044609,0.999999999980406,0.800021482000398,0,2,DBIRD complex,CC,
14798,GO:0070488,0.999999999980481,0.894966316518537,0,2,neutrophil aggregation,BP,
5767,GO:0016936,0.999999999980528,0.812813461420373,0,2,galactoside binding,MF,
3857,GO:0008470,0.999999999980577,0.88875579574733,0,1,isovaleryl-CoA dehydrogenase activity,MF,
18055,GO:1902544,0.999999999980581,0.829544271235503,0,2,regulation of DNA N-glycosylase activity,BP,
673,GO:0001880,0.999999999980712,0.79125524611336,0,2,Mullerian duct regression,BP,
6800,GO:0030237,0.999999999980752,0.794476965845525,0,2,female sex determination,BP,
10773,GO:0044209,0.999999999980754,0.83823320851089,0,2,AMP salvage,BP,
8229,GO:0032980,0.999999999980851,0.894264173200949,0,1,keratinocyte activation,BP,
8017,GO:0032641,0.999999999980856,0.796977546119168,0,2,lymphotoxin A production,BP,
9869,GO:0042109,0.999999999980856,0.796977546119168,0,2,lymphotoxin A biosynthetic process,BP,
5609,GO:0016647,0.999999999980861,0.80915091412356,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11764,GO:0046592,0.999999999980861,0.80915091412356,0,2,polyamine oxidase activity,MF,
13472,GO:0052901,0.999999999980861,0.80915091412356,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
2457,GO:0005668,0.999999999980962,0.817810281827125,0,2,RNA polymerase transcription factor SL1 complex,CC,
519,GO:0001595,0.999999999980995,0.916956417475734,0,1,angiotensin receptor activity,MF,
2138,GO:0004945,0.999999999980995,0.916956417475734,0,1,angiotensin type II receptor activity,MF,
1290,GO:0003096,0.999999999980999,0.638965868164102,0,4,renal sodium ion transport,BP,
19631,GO:1990730,0.999999999981074,0.792872499794184,0,2,VCP-NSFL1C complex,CC,
15181,GO:0071283,0.999999999981126,0.828641815821349,0,2,cellular response to iron(III) ion,BP,
349,GO:0000962,0.999999999981156,0.794546559003713,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11058,GO:0045025,0.999999999981156,0.794546559003713,0,2,mitochondrial degradosome,CC,
8969,GO:0035026,0.999999999981213,0.792391272359682,0,2,leading edge cell differentiation,BP,
10159,GO:0042727,0.999999999981251,0.802023658376181,0,2,flavin-containing compound biosynthetic process,BP,
17291,GO:0120092,0.999999999981253,0.891423813918298,0,1,crotonyl-CoA hydratase activity,MF,
17292,GO:0120093,0.999999999981253,0.891423813918298,0,1,regulation of peptidyl-lysine crotonylation,BP,
17293,GO:0120094,0.999999999981253,0.891423813918298,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
1816,GO:0004463,0.999999999981301,0.896680783443055,0,1,leukotriene-A4 hydrolase activity,MF,
4278,GO:0009637,0.999999999981482,0.793109626558019,0,2,response to blue light,BP,
4310,GO:0009785,0.999999999981482,0.793109626558019,0,2,blue light signaling pathway,BP,
4335,GO:0009882,0.999999999981482,0.793109626558019,0,2,blue light photoreceptor activity,MF,
15315,GO:0071483,0.999999999981482,0.793109626558019,0,2,cellular response to blue light,BP,
11853,GO:0046786,0.99999999998153,0.88855024894501,0,1,viral replication complex formation and maintenance,BP,
20072,GO:2000661,0.99999999998153,0.88855024894501,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
1769,GO:0004370,0.999999999981574,0.791182723708496,0,2,glycerol kinase activity,MF,
11606,GO:0046167,0.999999999981574,0.791182723708496,0,2,glycerol-3-phosphate biosynthetic process,BP,
6525,GO:0021902,0.999999999981603,0.789255701426969,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
7348,GO:0031370,0.999999999981612,0.888652087254553,0,1,eukaryotic initiation factor 4G binding,MF,
5449,GO:0016314,0.99999999998163,0.789407688229309,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
7696,GO:0032143,0.999999999981636,0.793125623822934,0,2,single thymine insertion binding,MF,
7782,GO:0032301,0.999999999981636,0.793125623822934,0,2,MutSalpha complex,CC,
4327,GO:0009826,0.999999999981667,0.799188950241648,0,2,unidimensional cell growth,BP,
8282,GO:0033078,0.999999999981785,0.801586142988712,0,2,extrathymic T cell differentiation,BP,
8286,GO:0033082,0.999999999981798,0.888546829648938,0,1,regulation of extrathymic T cell differentiation,BP,
19616,GO:1990654,0.999999999981798,0.888546829648938,0,1,sebum secreting cell proliferation,BP,
17938,GO:1902226,0.999999999981804,0.806787763059518,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18679,GO:1903969,0.999999999981804,0.806787763059518,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18682,GO:1903972,0.999999999981804,0.806787763059518,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
14582,GO:0070097,0.999999999981929,0.78942575434974,0,2,delta-catenin binding,MF,
19327,GO:1905550,0.999999999981968,0.81774745834213,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19328,GO:1905552,0.999999999981968,0.81774745834213,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
1622,GO:0004052,0.999999999982033,0.799576798740106,0,2,arachidonate 12-lipoxygenase activity,MF,
503,GO:0001560,0.999999999982034,0.790302490295661,0,2,regulation of cell growth by extracellular stimulus,BP,
9217,GO:0035596,0.999999999982154,0.800013337603404,0,2,methylthiotransferase activity,MF,
9220,GO:0035600,0.999999999982154,0.800013337603404,0,2,tRNA methylthiolation,BP,
12509,GO:0050497,0.999999999982154,0.800013337603404,0,2,transferase activity, transferring alkylthio groups,MF,
17992,GO:1902359,0.999999999982239,0.800453556350311,0,2,Notch signaling pathway involved in somitogenesis,BP,
17996,GO:1902366,0.999999999982239,0.800453556350311,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17997,GO:1902367,0.999999999982239,0.800453556350311,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
10163,GO:0042732,0.999999999982251,0.82866076798649,0,2,D-xylose metabolic process,BP,
3924,GO:0008594,0.999999999982378,0.791403364624258,0,2,photoreceptor cell morphogenesis,BP,
245,GO:0000701,0.999999999982393,0.820324603972983,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
3524,GO:0007500,0.999999999982486,0.804063091356686,0,2,mesodermal cell fate determination,BP,
15126,GO:0071159,0.999999999982491,0.831295037674453,0,2,NF-kappaB complex,CC,
370,GO:0000991,0.99999999998251,0.80695925946984,0,2,transcription factor activity, core RNA polymerase II binding,MF,
18528,GO:1903644,0.999999999982603,0.8425433944035,0,2,regulation of chaperone-mediated protein folding,BP,
10269,GO:0042998,0.999999999982616,0.791270455676373,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
16269,GO:0090306,0.999999999982625,0.633493448996647,0,4,spindle assembly involved in meiosis,BP,
13071,GO:0051542,0.999999999982683,0.79470581429874,0,2,elastin biosynthetic process,BP,
9657,GO:0036518,0.999999999982687,0.793024443953657,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14408,GO:0061643,0.999999999982687,0.793024443953657,0,2,chemorepulsion of axon,BP,
18047,GO:1902524,0.999999999982768,0.808040822922536,0,2,positive regulation of protein K48-linked ubiquitination,BP,
14395,GO:0061622,0.999999999982787,0.812504655889121,0,2,glycolytic process through glucose-1-phosphate,BP,
4738,GO:0010900,0.999999999982802,0.947398483838957,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
11997,GO:0047288,0.999999999982807,0.80127503757125,0,2,monosialoganglioside sialyltransferase activity,MF,
9094,GO:0035339,0.999999999982822,0.658619606150466,0,4,SPOTS complex,CC,
8513,GO:0033684,0.999999999982836,0.793106968227146,0,2,regulation of luteinizing hormone secretion,BP,
8514,GO:0033686,0.999999999982836,0.793106968227146,0,2,positive regulation of luteinizing hormone secretion,BP,
17117,GO:0099631,0.999999999982873,0.842377203329337,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
19066,GO:1904880,0.9999999999829,0.798675504809629,0,2,response to hydrogen sulfide,BP,
3468,GO:0007290,0.999999999982972,0.888634355272031,0,1,spermatid nucleus elongation,BP,
11625,GO:0046293,0.999999999982972,0.888634355272031,0,1,formaldehyde biosynthetic process,BP,
2181,GO:0005025,0.999999999982974,0.704472230791488,0,3,transforming growth factor beta receptor activity, type I,MF,
9257,GO:0035650,0.99999999998298,0.662265200097099,0,4,AP-1 adaptor complex binding,MF,
19811,GO:2000195,0.999999999983004,0.801671723663558,0,2,negative regulation of female gonad development,BP,
9063,GO:0035279,0.999999999983007,0.795255233896252,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16885,GO:0098795,0.999999999983007,0.795255233896252,0,2,mRNA cleavage involved in gene silencing,BP,
14637,GO:0070191,0.999999999983032,0.801964690941948,0,2,methionine-R-sulfoxide reductase activity,MF,
18985,GO:1904720,0.999999999983095,0.797911879802599,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
13562,GO:0060002,0.999999999983101,0.790786537940552,0,2,plus-end directed microfilament motor activity,MF,
84,GO:0000171,0.999999999983178,0.794473908534518,0,2,ribonuclease MRP activity,MF,
1965,GO:0004671,0.999999999983264,0.888608820525635,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
20256,GO:2001160,0.999999999983308,0.814892869690647,0,2,regulation of histone H3-K79 methylation,BP,
20257,GO:2001162,0.999999999983308,0.814892869690647,0,2,positive regulation of histone H3-K79 methylation,BP,
3825,GO:0008422,0.999999999983308,0.791257761558753,0,2,beta-glucosidase activity,MF,
2196,GO:0005055,0.999999999983363,0.821882850498169,0,2,laminin receptor activity,MF,
2179,GO:0005021,0.999999999983475,0.794213790501623,0,2,vascular endothelial growth factor-activated receptor activity,MF,
3810,GO:0008396,0.999999999983477,0.894361540416952,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
1365,GO:0003245,0.999999999983483,0.806399582784648,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
3216,GO:0006864,0.999999999983557,0.807060193995954,0,2,pyrimidine nucleotide transport,BP,
5042,GO:0015218,0.999999999983557,0.807060193995954,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19584,GO:1990519,0.999999999983557,0.807060193995954,0,2,pyrimidine nucleotide import into mitochondrion,BP,
8508,GO:0033679,0.99999999998358,0.888756260197899,0,1,3'-5' DNA/RNA helicase activity,MF,
8510,GO:0033681,0.99999999998358,0.888756260197899,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8788,GO:0034459,0.99999999998358,0.888756260197899,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9792,GO:0039695,0.99999999998358,0.888756260197899,0,1,DNA-templated viral transcription,BP,
19109,GO:1904971,0.99999999998358,0.888756260197899,0,1,regulation of viral translation,BP,
19110,GO:1904973,0.99999999998358,0.888756260197899,0,1,positive regulation of viral translation,BP,
19189,GO:1905172,0.99999999998358,0.888756260197899,0,1,RISC complex binding,MF,
19375,GO:1905698,0.99999999998358,0.888756260197899,0,1,positive regulation of polysome binding,BP,
19583,GO:1990518,0.99999999998358,0.888756260197899,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19478,GO:1990111,0.99999999998362,0.690591770075037,0,4,spermatoproteasome complex,CC,
1771,GO:0004372,0.999999999983632,0.800429570140452,0,2,glycine hydroxymethyltransferase activity,MF,
2048,GO:0004793,0.999999999983632,0.800429570140452,0,2,threonine aldolase activity,MF,
2999,GO:0006545,0.999999999983632,0.800429570140452,0,2,glycine biosynthetic process,BP,
3963,GO:0008732,0.999999999983632,0.800429570140452,0,2,L-allo-threonine aldolase activity,MF,
6094,GO:0019264,0.999999999983632,0.800429570140452,0,2,glycine biosynthetic process from serine,BP,
500,GO:0001555,0.999999999983651,0.797041172419306,0,2,oocyte growth,BP,
7459,GO:0031590,0.999999999983651,0.797041172419306,0,2,wybutosine metabolic process,BP,
7460,GO:0031591,0.999999999983651,0.797041172419306,0,2,wybutosine biosynthetic process,BP,
13302,GO:0051971,0.999999999983674,0.794503899412085,0,2,positive regulation of transmission of nerve impulse,BP,
14436,GO:0061723,0.999999999983727,0.794327326551437,0,2,glycophagy,BP,
7201,GO:0031085,0.999999999983756,0.794323292707443,0,2,BLOC-3 complex,CC,
19507,GO:1990189,0.9999999999838,0.827619465740027,0,2,peptide-serine-N-acetyltransferase activity,MF,
15237,GO:0071373,0.99999999998381,0.797833948411359,0,2,cellular response to luteinizing hormone stimulus,BP,
6983,GO:0030644,0.999999999983833,0.807538688150772,0,2,cellular chloride ion homeostasis,BP,
14746,GO:0070390,0.999999999983907,0.902058983875752,0,1,transcription export complex 2,CC,
19898,GO:2000342,0.999999999983958,0.798526756964187,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
14379,GO:0061588,0.999999999983979,0.630696405328613,0,4,calcium activated phospholipid scrambling,BP,
14380,GO:0061589,0.999999999983979,0.630696405328613,0,4,calcium activated phosphatidylserine scrambling,BP,
14381,GO:0061590,0.999999999983979,0.630696405328613,0,4,calcium activated phosphatidylcholine scrambling,BP,
14382,GO:0061591,0.999999999983979,0.630696405328613,0,4,calcium activated galactosylceramide scrambling,BP,
4832,GO:0014034,0.999999999984,0.791029091979742,0,2,neural crest cell fate commitment,BP,
10155,GO:0042720,0.99999999998405,0.84495085869211,0,2,mitochondrial inner membrane peptidase complex,CC,
9876,GO:0042126,0.99999999998414,0.637434365191849,0,4,nitrate metabolic process,BP,
14766,GO:0070426,0.999999999984195,0.799317211435041,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14773,GO:0070434,0.999999999984195,0.799317211435041,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15191,GO:0071306,0.999999999984258,0.799069076195179,0,2,cellular response to vitamin E,BP,
5403,GO:0016237,0.999999999984327,0.888518733513903,0,1,lysosomal microautophagy,BP,
6230,GO:0019778,0.999999999984327,0.888518733513903,0,1,Atg12 activating enzyme activity,MF,
6231,GO:0019779,0.999999999984327,0.888518733513903,0,1,Atg8 activating enzyme activity,MF,
8912,GO:0034727,0.999999999984327,0.888518733513903,0,1,piecemeal microautophagy of the nucleus,BP,
9771,GO:0039521,0.999999999984327,0.888518733513903,0,1,suppression by virus of host autophagy,BP,
1699,GO:0004174,0.999999999984353,0.797759626027324,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5610,GO:0016649,0.999999999984353,0.797759626027324,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
8765,GO:0034423,0.999999999984416,0.893491017973972,0,1,autophagosome lumen,CC,
19957,GO:2000422,0.999999999984416,0.893491017973972,0,1,regulation of eosinophil chemotaxis,BP,
19958,GO:2000424,0.999999999984416,0.893491017973972,0,1,positive regulation of eosinophil chemotaxis,BP,
4049,GO:0009085,0.999999999984474,0.793227700547135,0,2,lysine biosynthetic process,BP,
6280,GO:0019878,0.999999999984474,0.793227700547135,0,2,lysine biosynthetic process via aminoadipic acid,BP,
12282,GO:0048560,0.999999999984477,0.802012465910931,0,2,establishment of anatomical structure orientation,BP,
1390,GO:0003294,0.999999999984541,0.795803690021367,0,2,atrial ventricular junction remodeling,BP,
4566,GO:0010645,0.999999999984541,0.795803690021367,0,2,regulation of cell communication by chemical coupling,BP,
4572,GO:0010652,0.999999999984541,0.795803690021367,0,2,positive regulation of cell communication by chemical coupling,BP,
2413,GO:0005584,0.999999999984642,0.789243445164484,0,2,collagen type I trimer,CC,
6014,GO:0019060,0.99999999998468,0.842397645279086,0,2,intracellular transport of viral protein in host cell,BP,
6959,GO:0030581,0.99999999998468,0.842397645279086,0,2,symbiont intracellular protein transport in host,BP,
13161,GO:0051708,0.99999999998468,0.842397645279086,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
15869,GO:0072566,0.999999999984698,0.803458078055052,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19895,GO:2000338,0.999999999984698,0.803458078055052,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19896,GO:2000340,0.999999999984698,0.803458078055052,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
7149,GO:0030984,0.999999999984717,0.819220063258162,0,2,kininogen binding,MF,
579,GO:0001729,0.999999999984777,0.793537984602329,0,2,ceramide kinase activity,MF,
16993,GO:0098989,0.999999999984778,0.805684875144337,0,2,NMDA selective glutamate receptor signaling pathway,BP,
12054,GO:0047756,0.999999999984789,0.796689589064908,0,2,chondroitin 4-sulfotransferase activity,MF,
11212,GO:0045322,0.999999999984847,0.796901864517032,0,2,unmethylated CpG binding,MF,
5023,GO:0015184,0.999999999984866,0.79065602166679,0,2,L-cystine transmembrane transporter activity,MF,
5214,GO:0015811,0.999999999984866,0.79065602166679,0,2,L-cystine transport,BP,
20235,GO:2001069,0.99999999998487,0.798154147175094,0,2,glycogen binding,MF,
1005,GO:0002476,0.999999999984887,0.803134753454034,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
17916,GO:1902174,0.99999999998495,0.805231189307231,0,2,positive regulation of keratinocyte apoptotic process,BP,
4747,GO:0010915,0.999999999984977,0.857586732046077,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4748,GO:0010916,0.999999999984977,0.857586732046077,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
12058,GO:0047801,0.999999999985022,0.896143186941256,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
11033,GO:0044860,0.999999999985107,0.637564071785766,0,4,protein localization to plasma membrane raft,BP,
8916,GO:0034739,0.999999999985133,0.810100372684051,0,2,histone deacetylase activity (H4-K16 specific),MF,
18875,GO:1904455,0.999999999985151,0.789341863482777,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
2421,GO:0005594,0.999999999985227,0.798139386190393,0,2,collagen type IX trimer,CC,
17013,GO:0099073,0.999999999985277,0.792505713651939,0,2,mitochondrion-derived vesicle,CC,
12064,GO:0047894,0.999999999985279,0.823651364290861,0,2,flavonol 3-sulfotransferase activity,MF,
3,GO:0000009,0.999999999985336,0.894459088941076,0,1,alpha-1,6-mannosyltransferase activity,MF,
13480,GO:0052917,0.999999999985336,0.894459088941076,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
12262,GO:0048521,0.99999999998534,0.666751108788262,0,4,negative regulation of behavior,BP,
5311,GO:0016015,0.999999999985344,0.808923596160792,0,2,morphogen activity,MF,
19330,GO:1905555,0.999999999985366,0.8028077958232,0,2,positive regulation blood vessel branching,BP,
2124,GO:0004915,0.999999999985403,0.793302437454755,0,2,interleukin-6 receptor activity,MF,
6324,GO:0019981,0.999999999985403,0.793302437454755,0,2,interleukin-6 binding,MF,
14591,GO:0070110,0.999999999985403,0.793302437454755,0,2,ciliary neurotrophic factor receptor complex,CC,
19491,GO:1990145,0.999999999985455,0.794999973556262,0,2,maintenance of translational fidelity,BP,
18595,GO:1903796,0.999999999985494,0.793153205798492,0,2,negative regulation of inorganic anion transmembrane transport,BP,
2146,GO:0004957,0.999999999985529,0.891283277351368,0,1,prostaglandin E receptor activity,MF,
15929,GO:0072682,0.999999999985529,0.891283277351368,0,1,eosinophil extravasation,BP,
19953,GO:2000417,0.999999999985529,0.891283277351368,0,1,negative regulation of eosinophil migration,BP,
19955,GO:2000419,0.999999999985529,0.891283277351368,0,1,regulation of eosinophil extravasation,BP,
19956,GO:2000420,0.999999999985529,0.891283277351368,0,1,negative regulation of eosinophil extravasation,BP,
16023,GO:0086015,0.999999999985552,0.79246357822995,0,2,SA node cell action potential,BP,
16026,GO:0086018,0.999999999985552,0.79246357822995,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16028,GO:0086020,0.999999999985552,0.79246357822995,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16029,GO:0086021,0.999999999985552,0.79246357822995,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16047,GO:0086053,0.999999999985552,0.79246357822995,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16063,GO:0086077,0.999999999985552,0.79246357822995,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
14080,GO:0060838,0.99999999998559,0.794909170636388,0,2,lymphatic endothelial cell fate commitment,BP,
3608,GO:0008049,0.999999999985617,0.898703326164158,0,1,male courtship behavior,BP,
3852,GO:0008460,0.999999999985617,0.898703326164158,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
16756,GO:0097753,0.999999999985638,0.890186160528189,0,1,membrane bending,BP,
2595,GO:0005889,0.999999999985657,0.793493309157157,0,2,potassium:proton exchanging ATPase complex,CC,
18340,GO:1903238,0.999999999985669,0.790146328249059,0,2,positive regulation of leukocyte tethering or rolling,BP,
4797,GO:0010986,0.999999999985679,0.639012039526304,0,4,positive regulation of lipoprotein particle clearance,BP,
5558,GO:0016561,0.999999999985681,0.800485702506117,0,2,protein import into peroxisome matrix, translocation,BP,
2056,GO:0004803,0.999999999985748,0.790759152018382,0,2,transposase activity,MF,
18480,GO:1903542,0.999999999985787,0.798052557088658,0,2,negative regulation of exosomal secretion,BP,
14555,GO:0070053,0.999999999985791,0.793847940332829,0,2,thrombospondin receptor activity,MF,
1961,GO:0004662,0.999999999985803,0.807903359060487,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2628,GO:0005953,0.999999999985803,0.807903359060487,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
180,GO:0000390,0.999999999985867,0.818113609282813,0,2,spliceosomal complex disassembly,BP,
4998,GO:0015136,0.99999999998593,0.891561820309545,0,1,sialic acid transmembrane transporter activity,MF,
5129,GO:0015538,0.99999999998593,0.891561820309545,0,1,sialic acid:proton symporter activity,MF,
5180,GO:0015739,0.99999999998593,0.891561820309545,0,1,sialic acid transport,BP,
19226,GO:1905286,0.999999999985937,0.800028293725459,0,2,serine-type peptidase complex,CC,
1516,GO:0003874,0.999999999985963,0.926379696324248,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
5959,GO:0018323,0.999999999985963,0.926379696324248,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8695,GO:0034309,0.999999999985963,0.926379696324248,0,1,primary alcohol biosynthetic process,BP,
9616,GO:0036470,0.999999999985963,0.926379696324248,0,1,tyrosine 3-monooxygenase activator activity,MF,
9617,GO:0036471,0.999999999985963,0.926379696324248,0,1,cellular response to glyoxal,BP,
9623,GO:0036478,0.999999999985963,0.926379696324248,0,1,L-dopa decarboxylase activator activity,MF,
9658,GO:0036524,0.999999999985963,0.926379696324248,0,1,protein deglycase activity,MF,
9659,GO:0036525,0.999999999985963,0.926379696324248,0,1,protein deglycation,BP,
9660,GO:0036526,0.999999999985963,0.926379696324248,0,1,peptidyl-cysteine deglycation,BP,
9661,GO:0036527,0.999999999985963,0.926379696324248,0,1,peptidyl-arginine deglycation,BP,
9662,GO:0036528,0.999999999985963,0.926379696324248,0,1,peptidyl-lysine deglycation,BP,
9663,GO:0036529,0.999999999985963,0.926379696324248,0,1,protein deglycation, glyoxal removal,BP,
9664,GO:0036530,0.999999999985963,0.926379696324248,0,1,protein deglycation, methylglyoxal removal,BP,
9665,GO:0036531,0.999999999985963,0.926379696324248,0,1,glutathione deglycation,BP,
11222,GO:0045340,0.999999999985963,0.926379696324248,0,1,mercury ion binding,MF,
11627,GO:0046295,0.999999999985963,0.926379696324248,0,1,glycolate biosynthetic process,BP,
17224,GO:0106044,0.999999999985963,0.926379696324248,0,1,guanine deglycation,BP,
17225,GO:0106045,0.999999999985963,0.926379696324248,0,1,guanine deglycation, methylglyoxal removal,BP,
17226,GO:0106046,0.999999999985963,0.926379696324248,0,1,guanine deglycation, glyoxal removal,BP,
17309,GO:0140041,0.999999999985963,0.926379696324248,0,1,cellular detoxification of methylglyoxal,BP,
18277,GO:1903072,0.999999999985963,0.926379696324248,0,1,regulation of death-inducing signaling complex assembly,BP,
18278,GO:1903073,0.999999999985963,0.926379696324248,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18292,GO:1903122,0.999999999985963,0.926379696324248,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18304,GO:1903167,0.999999999985963,0.926379696324248,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18305,GO:1903168,0.999999999985963,0.926379696324248,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18309,GO:1903176,0.999999999985963,0.926379696324248,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18310,GO:1903178,0.999999999985963,0.926379696324248,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18314,GO:1903184,0.999999999985963,0.926379696324248,0,1,L-dopa metabolic process,BP,
18315,GO:1903185,0.999999999985963,0.926379696324248,0,1,L-dopa biosynthetic process,BP,
18316,GO:1903189,0.999999999985963,0.926379696324248,0,1,glyoxal metabolic process,BP,
18317,GO:1903195,0.999999999985963,0.926379696324248,0,1,regulation of L-dopa biosynthetic process,BP,
18318,GO:1903197,0.999999999985963,0.926379696324248,0,1,positive regulation of L-dopa biosynthetic process,BP,
18319,GO:1903198,0.999999999985963,0.926379696324248,0,1,regulation of L-dopa decarboxylase activity,BP,
18320,GO:1903200,0.999999999985963,0.926379696324248,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19852,GO:2000277,0.999999999985963,0.926379696324248,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19858,GO:2000284,0.999999999985963,0.926379696324248,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
12161,GO:0048250,0.999999999985992,0.81455316555795,0,2,iron import into the mitochondrion,BP,
1073,GO:0002636,0.999999999986017,0.906085790837331,0,1,positive regulation of germinal center formation,BP,
2753,GO:0006157,0.999999999986017,0.906085790837331,0,1,deoxyadenosine catabolic process,BP,
9963,GO:0042321,0.999999999986017,0.906085790837331,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9964,GO:0042323,0.999999999986017,0.906085790837331,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11569,GO:0046090,0.999999999986017,0.906085790837331,0,1,deoxyadenosine metabolic process,BP,
11580,GO:0046111,0.999999999986017,0.906085790837331,0,1,xanthine biosynthetic process,BP,
11586,GO:0046124,0.999999999986017,0.906085790837331,0,1,purine deoxyribonucleoside catabolic process,BP,
13676,GO:0060167,0.999999999986017,0.906085790837331,0,1,regulation of adenosine receptor signaling pathway,BP,
13677,GO:0060169,0.999999999986017,0.906085790837331,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13836,GO:0060407,0.999999999986017,0.906085790837331,0,1,negative regulation of penile erection,BP,
14673,GO:0070256,0.999999999986017,0.906085790837331,0,1,negative regulation of mucus secretion,BP,
9431,GO:0035989,0.999999999986026,0.634641583920609,0,4,tendon development,BP,
9135,GO:0035442,0.999999999986048,0.806763806351552,0,2,dipeptide transmembrane transport,BP,
10243,GO:0042938,0.999999999986048,0.806763806351552,0,2,dipeptide transport,BP,
16125,GO:0090088,0.999999999986048,0.806763806351552,0,2,regulation of oligopeptide transport,BP,
16126,GO:0090089,0.999999999986048,0.806763806351552,0,2,regulation of dipeptide transport,BP,
20190,GO:2000878,0.999999999986048,0.806763806351552,0,2,positive regulation of oligopeptide transport,BP,
20191,GO:2000880,0.999999999986048,0.806763806351552,0,2,positive regulation of dipeptide transport,BP,
20252,GO:2001148,0.999999999986048,0.806763806351552,0,2,regulation of dipeptide transmembrane transport,BP,
20253,GO:2001150,0.999999999986048,0.806763806351552,0,2,positive regulation of dipeptide transmembrane transport,BP,
1625,GO:0004056,0.999999999986055,0.897582421875012,0,1,argininosuccinate lyase activity,MF,
10029,GO:0042450,0.999999999986055,0.897582421875012,0,1,arginine biosynthetic process via ornithine,BP,
20139,GO:2000777,0.999999999986084,0.803405507306044,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
14007,GO:0060699,0.999999999986103,0.646346802730575,0,4,regulation of endoribonuclease activity,BP,
13003,GO:0051387,0.999999999986105,0.801606516330801,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
8760,GO:0034414,0.99999999998617,0.796958850317605,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10195,GO:0042779,0.99999999998617,0.796958850317605,0,2,tRNA 3'-trailer cleavage,BP,
10197,GO:0042781,0.99999999998617,0.796958850317605,0,2,3'-tRNA processing endoribonuclease activity,MF,
19215,GO:1905267,0.99999999998617,0.796958850317605,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
17705,GO:1901552,0.999999999986237,0.792504758059064,0,2,positive regulation of endothelial cell development,BP,
18299,GO:1903142,0.999999999986237,0.792504758059064,0,2,positive regulation of establishment of endothelial barrier,BP,
18431,GO:1903433,0.99999999998628,0.794833623028471,0,2,regulation of constitutive secretory pathway,BP,
8452,GO:0033566,0.999999999986344,0.79838369463299,0,2,gamma-tubulin complex localization,BP,
8197,GO:0032929,0.999999999986384,0.810853329224266,0,2,negative regulation of superoxide anion generation,BP,
14693,GO:0070292,0.999999999986453,0.793190597997032,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
7641,GO:0032044,0.999999999986475,0.807899534583722,0,2,DSIF complex,CC,
6472,GO:0021798,0.999999999986477,0.789370989485083,0,2,forebrain dorsal/ventral pattern formation,BP,
1576,GO:0003980,0.999999999986513,0.789352446005733,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16588,GO:0097359,0.999999999986513,0.789352446005733,0,2,UDP-glucosylation,BP,
18046,GO:1902523,0.999999999986516,0.791414607964827,0,2,positive regulation of protein K63-linked ubiquitination,BP,
833,GO:0002118,0.999999999986545,0.891226677312943,0,1,aggressive behavior,BP,
834,GO:0002121,0.999999999986545,0.891226677312943,0,1,inter-male aggressive behavior,BP,
16863,GO:0098749,0.999999999986556,0.888759055263336,0,1,cerebellar neuron development,BP,
6361,GO:0021539,0.999999999986578,0.810206405827834,0,2,subthalamus development,BP,
5754,GO:0016899,0.999999999986596,0.790903238023839,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
7165,GO:0031022,0.999999999986639,0.790560970621668,0,2,nuclear migration along microfilament,BP,
9248,GO:0035634,0.999999999986648,0.93192518583355,0,1,response to stilbenoid,BP,
15388,GO:0071611,0.999999999986669,0.799251118538134,0,2,granulocyte colony-stimulating factor production,BP,
15417,GO:0071655,0.999999999986669,0.799251118538134,0,2,regulation of granulocyte colony-stimulating factor production,BP,
14675,GO:0070259,0.999999999986678,0.795124904279885,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
5970,GO:0018395,0.999999999986695,0.890667371043118,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6562,GO:0021998,0.999999999986695,0.890667371043118,0,1,neural plate mediolateral regionalization,BP,
8528,GO:0033746,0.999999999986695,0.890667371043118,0,1,histone demethylase activity (H3-R2 specific),MF,
8529,GO:0033749,0.999999999986695,0.890667371043118,0,1,histone demethylase activity (H4-R3 specific),MF,
12206,GO:0048338,0.999999999986695,0.890667371043118,0,1,mesoderm structural organization,BP,
12210,GO:0048352,0.999999999986695,0.890667371043118,0,1,paraxial mesoderm structural organization,BP,
14569,GO:0070077,0.999999999986695,0.890667371043118,0,1,histone arginine demethylation,BP,
14570,GO:0070078,0.999999999986695,0.890667371043118,0,1,histone H3-R2 demethylation,BP,
14571,GO:0070079,0.999999999986695,0.890667371043118,0,1,histone H4-R3 demethylation,BP,
18856,GO:1904412,0.999999999986695,0.890667371043118,0,1,regulation of cardiac ventricle development,BP,
18857,GO:1904414,0.999999999986695,0.890667371043118,0,1,positive regulation of cardiac ventricle development,BP,
19225,GO:1905285,0.999999999986695,0.890667371043118,0,1,fibrous ring of heart morphogenesis,BP,
15686,GO:0072190,0.999999999986697,0.801522714257867,0,2,ureter urothelium development,BP,
15687,GO:0072191,0.999999999986697,0.801522714257867,0,2,ureter smooth muscle development,BP,
15689,GO:0072193,0.999999999986697,0.801522714257867,0,2,ureter smooth muscle cell differentiation,BP,
15691,GO:0072197,0.999999999986697,0.801522714257867,0,2,ureter morphogenesis,BP,
11989,GO:0047237,0.999999999986719,0.794990718498543,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
835,GO:0002127,0.999999999986735,0.90885245746732,0,1,tRNA wobble base cytosine methylation,BP,
1249,GO:0002946,0.999999999986735,0.90885245746732,0,1,tRNA C5-cytosine methylation,BP,
15319,GO:0071492,0.999999999986791,0.7993472678679,0,2,cellular response to UV-A,BP,
19978,GO:2000481,0.999999999986812,0.630142352154522,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
9346,GO:0035822,0.999999999986817,0.792483370208365,0,2,gene conversion,BP,
2653,GO:0005991,0.999999999986848,0.892626471539034,0,1,trehalose metabolic process,BP,
14759,GO:0070413,0.999999999986848,0.892626471539034,0,1,trehalose metabolism in response to stress,BP,
10066,GO:0042539,0.999999999986863,0.792479413698698,0,2,hypotonic salinity response,BP,
15309,GO:0071477,0.999999999986863,0.792479413698698,0,2,cellular hypotonic salinity response,BP,
10786,GO:0044228,0.999999999986927,0.888662601456942,0,1,host cell surface,CC,
14499,GO:0061890,0.999999999986943,0.81239256037872,0,2,positive regulation of astrocyte activation,BP,
18690,GO:1903980,0.999999999986943,0.81239256037872,0,2,positive regulation of microglial cell activation,BP,
5830,GO:0017102,0.999999999986951,0.797244916826575,0,2,methionyl glutamyl tRNA synthetase complex,CC,
10628,GO:0043614,0.999999999986971,0.790126225185841,0,2,multi-eIF complex,CC,
6455,GO:0021771,0.999999999987002,0.888394477422778,0,1,lateral geniculate nucleus development,BP,
9962,GO:0042320,0.999999999987002,0.888394477422778,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13633,GO:0060084,0.999999999987002,0.888394477422778,0,1,synaptic transmission involved in micturition,BP,
348,GO:0000961,0.999999999987039,0.793150782936916,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
646,GO:0001834,0.999999999987039,0.793150782936916,0,2,trophectodermal cell proliferation,BP,
6479,GO:0021816,0.999999999987039,0.793150782936916,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
7648,GO:0032053,0.999999999987039,0.793150782936916,0,2,ciliary basal body organization,BP,
9199,GO:0035574,0.999999999987039,0.793150782936916,0,2,histone H4-K20 demethylation,BP,
9200,GO:0035575,0.999999999987039,0.793150782936916,0,2,histone demethylase activity (H4-K20 specific),MF,
9502,GO:0036135,0.999999999987039,0.793150782936916,0,2,Schwann cell migration,BP,
17432,GO:1900147,0.999999999987039,0.793150782936916,0,2,regulation of Schwann cell migration,BP,
17443,GO:1900169,0.999999999987039,0.793150782936916,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18822,GO:1904327,0.999999999987039,0.793150782936916,0,2,protein localization to cytosolic proteasome complex,BP,
18840,GO:1904379,0.999999999987039,0.793150782936916,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
19477,GO:1990108,0.999999999987039,0.793150782936916,0,2,protein linear deubiquitination,BP,
13076,GO:0051548,0.999999999987063,0.789238713010172,0,2,negative regulation of keratinocyte migration,BP,
9695,GO:0038064,0.999999999987081,0.790745861853997,0,2,collagen receptor activity,MF,
12473,GO:0050220,0.999999999987108,0.678920284727566,0,4,prostaglandin-E synthase activity,MF,
11597,GO:0046136,0.99999999998712,0.81913124530691,0,2,positive regulation of vitamin metabolic process,BP,
13926,GO:0060557,0.99999999998712,0.81913124530691,0,2,positive regulation of vitamin D biosynthetic process,BP,
13928,GO:0060559,0.99999999998712,0.81913124530691,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
9477,GO:0036085,0.999999999987121,0.891885770636619,0,1,GDP-fucose import into Golgi lumen,BP,
8879,GO:0034677,0.999999999987143,0.890277781198969,0,1,integrin alpha7-beta1 complex,CC,
8882,GO:0034681,0.999999999987143,0.890277781198969,0,1,integrin alpha11-beta1 complex,CC,
7862,GO:0032417,0.99999999998716,0.794508023922546,0,2,positive regulation of sodium:proton antiporter activity,BP,
17840,GO:1901963,0.999999999987191,0.802750214353255,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
963,GO:0002384,0.999999999987239,0.81556568745751,0,2,hepatic immune response,BP,
420,GO:0001112,0.999999999987259,0.892412994532555,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,0.999999999987259,0.892412994532555,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,0.999999999987259,0.892412994532555,0,1,protein-DNA complex remodeling,BP,
11761,GO:0046586,0.999999999987274,0.827746937580145,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
14125,GO:0060947,0.999999999987277,0.628280729195345,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14836,GO:0070557,0.999999999987291,0.816545252848549,0,2,PCNA-p21 complex,CC,
14054,GO:0060763,0.9999999999873,0.79440341209418,0,2,mammary duct terminal end bud growth,BP,
18687,GO:1903977,0.9999999999873,0.79440341209418,0,2,positive regulation of glial cell migration,BP,
18444,GO:1903461,0.999999999987307,0.892197421471587,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
7366,GO:0031403,0.999999999987313,0.791834279524876,0,2,lithium ion binding,MF,
4018,GO:0009020,0.99999999998732,0.898008221039698,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13410,GO:0052666,0.99999999998732,0.898008221039698,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17228,GO:0106050,0.99999999998732,0.898008221039698,0,1,tRNA 2'-O-methyltransferase activity,MF,
12062,GO:0047874,0.99999999998734,0.896299404755696,0,1,dolichyldiphosphatase activity,MF,
9103,GO:0035359,0.999999999987373,0.889586753343487,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
5310,GO:0016013,0.999999999987396,0.794776794508002,0,2,syntrophin complex,CC,
2692,GO:0006055,0.999999999987402,0.914962290422487,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11665,GO:0046381,0.999999999987402,0.914962290422487,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12017,GO:0047444,0.999999999987402,0.914962290422487,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12506,GO:0050462,0.999999999987402,0.914962290422487,0,1,N-acetylneuraminate synthase activity,MF,
1684,GO:0004146,0.999999999987475,0.819543968441899,0,2,dihydrofolate reductase activity,MF,
2462,GO:0005674,0.999999999987516,0.811796491660538,0,2,transcription factor TFIIF complex,CC,
12002,GO:0047322,0.999999999987516,0.789300106887805,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12495,GO:0050405,0.999999999987516,0.789300106887805,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
9241,GO:0035623,0.999999999987547,0.891795954452649,0,1,renal glucose absorption,BP,
8972,GO:0035034,0.999999999987555,0.799703184030747,0,2,histone acetyltransferase regulator activity,MF,
4459,GO:0010430,0.999999999987574,0.888684480320611,0,1,fatty acid omega-oxidation,BP,
10224,GO:0042835,0.999999999987574,0.888684480320611,0,1,BRE binding,MF,
15456,GO:0071713,0.999999999987574,0.888684480320611,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
7520,GO:0031700,0.999999999987575,0.908511694786529,0,1,adrenomedullin receptor binding,MF,
838,GO:0002135,0.999999999987633,0.893765696449618,0,1,CTP binding,MF,
5827,GO:0017098,0.999999999987633,0.893765696449618,0,1,sulfonylurea receptor binding,MF,
17675,GO:1901388,0.999999999987633,0.893765696449618,0,1,regulation of transforming growth factor beta activation,BP,
17676,GO:1901389,0.999999999987633,0.893765696449618,0,1,negative regulation of transforming growth factor beta activation,BP,
18533,GO:1903659,0.999999999987633,0.893765696449618,0,1,regulation of complement-dependent cytotoxicity,BP,
18534,GO:1903660,0.999999999987633,0.893765696449618,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19693,GO:1990913,0.999999999987633,0.893765696449618,0,1,sperm head plasma membrane,CC,
19694,GO:1990917,0.999999999987633,0.893765696449618,0,1,ooplasm,CC,
9456,GO:0036034,0.999999999987674,0.799210638615427,0,2,mediator complex assembly,BP,
20266,GO:2001176,0.999999999987674,0.799210638615427,0,2,regulation of mediator complex assembly,BP,
20267,GO:2001178,0.999999999987674,0.799210638615427,0,2,positive regulation of mediator complex assembly,BP,
6384,GO:0021569,0.999999999987701,0.904623579373225,0,1,rhombomere 3 development,BP,
6385,GO:0021570,0.999999999987701,0.904623579373225,0,1,rhombomere 4 development,BP,
8288,GO:0033084,0.999999999987701,0.800423386992765,0,2,regulation of immature T cell proliferation in thymus,BP,
8291,GO:0033088,0.999999999987701,0.800423386992765,0,2,negative regulation of immature T cell proliferation in thymus,BP,
1718,GO:0004307,0.999999999987702,0.824217276916769,0,2,ethanolaminephosphotransferase activity,MF,
4880,GO:0014740,0.999999999987708,0.798117967675004,0,2,negative regulation of muscle hyperplasia,BP,
2257,GO:0005169,0.999999999987719,0.82084571119648,0,2,neurotrophin TRKB receptor binding,MF,
1940,GO:0004638,0.999999999987733,0.891486780167184,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1941,GO:0004639,0.999999999987733,0.891486780167184,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
5222,GO:0015822,0.999999999987746,0.62804282264023,0,4,ornithine transport,BP,
18389,GO:1903352,0.999999999987746,0.62804282264023,0,4,L-ornithine transmembrane transport,BP,
10759,GO:0044130,0.999999999987764,0.656324367382464,0,4,negative regulation of growth of symbiont in host,BP,
10762,GO:0044146,0.999999999987764,0.656324367382464,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
7022,GO:0030729,0.999999999987766,0.891513786954641,0,1,acetoacetate-CoA ligase activity,MF,
12056,GO:0047760,0.999999999987766,0.891513786954641,0,1,butyrate-CoA ligase activity,MF,
6976,GO:0030626,0.999999999987793,0.800130113518939,0,2,U12 snRNA binding,MF,
7596,GO:0031959,0.999999999987847,0.793174678149461,0,2,mineralocorticoid receptor signaling pathway,BP,
5351,GO:0016098,0.999999999987895,0.892129632430481,0,1,monoterpenoid metabolic process,BP,
8522,GO:0033695,0.999999999987895,0.892129632430481,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8939,GO:0034875,0.999999999987895,0.892129632430481,0,1,caffeine oxidase activity,MF,
15391,GO:0071615,0.999999999987895,0.892129632430481,0,1,oxidative deethylation,BP,
15487,GO:0071812,0.999999999987895,0.892129632430481,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15506,GO:0071848,0.999999999987895,0.892129632430481,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
19157,GO:1905071,0.999999999987895,0.792406719027565,0,2,occluding junction disassembly,BP,
19158,GO:1905073,0.999999999987895,0.792406719027565,0,2,regulation of occluding junction disassembly,BP,
19159,GO:1905075,0.999999999987895,0.792406719027565,0,2,positive regulation of occluding junction disassembly,BP,
3056,GO:0006617,0.999999999988047,0.831086898996513,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
6016,GO:0019062,0.999999999988063,0.646232532926895,0,4,virion attachment to host cell,BP,
10962,GO:0044650,0.999999999988063,0.646232532926895,0,4,adhesion of symbiont to host cell,BP,
8946,GO:0034971,0.999999999988117,0.892567287069176,0,1,histone H3-R17 methylation,BP,
9255,GO:0035642,0.999999999988117,0.892567287069176,0,1,histone methyltransferase activity (H3-R17 specific),MF,
11914,GO:0046922,0.999999999988128,0.795393605051738,0,2,peptide-O-fucosyltransferase activity,MF,
1880,GO:0004556,0.99999999998813,0.895685066610282,0,1,alpha-amylase activity,MF,
17200,GO:0103025,0.99999999998813,0.895685066610282,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17629,GO:1901291,0.999999999988169,0.898610846124019,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
10479,GO:0043335,0.999999999988188,0.81039436285699,0,2,protein unfolding,BP,
9718,GO:0038113,0.999999999988203,0.789319613096764,0,2,interleukin-9-mediated signaling pathway,BP,
15109,GO:0071104,0.999999999988203,0.789319613096764,0,2,response to interleukin-9,BP,
15226,GO:0071355,0.999999999988203,0.789319613096764,0,2,cellular response to interleukin-9,BP,
5501,GO:0016436,0.999999999988209,0.794951946413433,0,2,rRNA (uridine) methyltransferase activity,MF,
582,GO:0001732,0.999999999988226,0.797810474724459,0,2,formation of cytoplasmic translation initiation complex,BP,
9146,GO:0035473,0.999999999988255,0.804597296494014,0,2,lipase binding,MF,
13614,GO:0060061,0.999999999988267,0.805934175156343,0,2,Spemann organizer formation,BP,
13665,GO:0060151,0.999999999988272,0.790206774395734,0,2,peroxisome localization,BP,
13666,GO:0060152,0.999999999988272,0.790206774395734,0,2,microtubule-based peroxisome localization,BP,
8885,GO:0034685,0.999999999988278,0.794491512247634,0,2,integrin alphav-beta6 complex,CC,
1503,GO:0003846,0.999999999988409,0.796104362407872,0,2,2-acylglycerol O-acyltransferase activity,MF,
1682,GO:0004144,0.999999999988409,0.796104362407872,0,2,diacylglycerol O-acyltransferase activity,MF,
12475,GO:0050252,0.999999999988409,0.796104362407872,0,2,retinol O-fatty-acyltransferase activity,MF,
18751,GO:1904170,0.999999999988428,0.888626320523331,0,1,regulation of bleb assembly,BP,
18752,GO:1904172,0.999999999988428,0.888626320523331,0,1,positive regulation of bleb assembly,BP,
16258,GO:0090290,0.999999999988431,0.92220544950456,0,1,positive regulation of osteoclast proliferation,BP,
4839,GO:0014043,0.999999999988486,0.801123124248432,0,2,negative regulation of neuron maturation,BP,
11826,GO:0046696,0.999999999988489,0.798327699496942,0,2,lipopolysaccharide receptor complex,CC,
15361,GO:0071567,0.999999999988544,0.826581122189878,0,2,UFM1 hydrolase activity,MF,
18293,GO:1903126,0.999999999988552,0.896116231797622,0,1,negative regulation of centriole-centriole cohesion,BP,
20265,GO:2001173,0.999999999988552,0.896116231797622,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
16262,GO:0090297,0.999999999988599,0.913700336753403,0,1,positive regulation of mitochondrial DNA replication,BP,
17813,GO:1901860,0.999999999988599,0.913700336753403,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19464,GO:1990046,0.999999999988599,0.913700336753403,0,1,stress-induced mitochondrial fusion,BP,
3438,GO:0007231,0.999999999988625,0.805856011954406,0,2,osmosensory signaling pathway,BP,
3637,GO:0008108,0.999999999988633,0.911782033192834,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5319,GO:0016034,0.999999999988633,0.911782033192834,0,1,maleylacetoacetate isomerase activity,MF,
17137,GO:0101030,0.999999999988633,0.911782033192834,0,1,tRNA-guanine transglycosylation,BP,
5419,GO:0016263,0.999999999988656,0.808728809187362,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5422,GO:0016267,0.999999999988656,0.808728809187362,0,2,O-glycan processing, core 1,BP,
2305,GO:0005287,0.999999999988656,0.79466447683201,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2306,GO:0005289,0.999999999988656,0.79466447683201,0,2,high-affinity arginine transmembrane transporter activity,MF,
2308,GO:0005292,0.999999999988656,0.79466447683201,0,2,high-affinity lysine transmembrane transporter activity,MF,
8881,GO:0034680,0.999999999988663,0.790952832522105,0,2,integrin alpha10-beta1 complex,CC,
16689,GO:0097574,0.999999999988672,0.792780515832483,0,2,lateral part of cell,CC,
16690,GO:0097575,0.999999999988672,0.792780515832483,0,2,lateral cell cortex,CC,
16794,GO:0098582,0.999999999988675,0.791200152059094,0,2,innate vocalization behavior,BP,
15296,GO:0071460,0.999999999988681,0.838798651398721,0,2,cellular response to cell-matrix adhesion,BP,
11240,GO:0045359,0.999999999988694,0.632134275362415,0,4,positive regulation of interferon-beta biosynthetic process,BP,
17034,GO:0099130,0.999999999988698,0.895380844479521,0,1,estrogen binding,MF,
18658,GO:1903924,0.999999999988698,0.895380844479521,0,1,estradiol binding,MF,
6878,GO:0030350,0.999999999988746,0.791410316739995,0,2,iron-responsive element binding,MF,
17563,GO:1901069,0.999999999988753,0.82443641185192,0,2,guanosine-containing compound catabolic process,BP,
16366,GO:0090615,0.999999999988764,0.798589666336649,0,2,mitochondrial mRNA processing,BP,
16419,GO:0097020,0.999999999988769,0.89142081763492,0,1,COPII adaptor activity,MF,
12852,GO:0051140,0.999999999988773,0.846760654254718,0,2,regulation of NK T cell proliferation,BP,
12853,GO:0051142,0.999999999988773,0.846760654254718,0,2,positive regulation of NK T cell proliferation,BP,
9621,GO:0036476,0.999999999988775,0.664577625314054,0,4,neuron death in response to hydrogen peroxide,BP,
18327,GO:1903207,0.999999999988775,0.664577625314054,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
18328,GO:1903208,0.999999999988775,0.664577625314054,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
3079,GO:0006651,0.999999999988803,0.821420304074224,0,2,diacylglycerol biosynthetic process,BP,
13182,GO:0051747,0.999999999988829,0.838171017640593,0,2,cytosine C-5 DNA demethylase activity,MF,
2335,GO:0005350,0.999999999988837,0.799073717747036,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5239,GO:0015855,0.999999999988837,0.799073717747036,0,2,pyrimidine nucleobase transport,BP,
19036,GO:1904823,0.999999999988837,0.799073717747036,0,2,purine nucleobase transmembrane transport,BP,
7750,GO:0032258,0.999999999988841,0.799912044948928,0,2,protein localization by the Cvt pathway,BP,
4923,GO:0014859,0.99999999998887,0.89153479875318,0,1,negative regulation of skeletal muscle cell proliferation,BP,
18118,GO:1902723,0.99999999998887,0.89153479875318,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
2089,GO:0004850,0.999999999988886,0.900226567199059,0,1,uridine phosphorylase activity,MF,
2785,GO:0006218,0.999999999988886,0.900226567199059,0,1,uridine catabolic process,BP,
11578,GO:0046108,0.999999999988886,0.900226567199059,0,1,uridine metabolic process,BP,
3767,GO:0008311,0.999999999988902,0.814569474721193,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
7093,GO:0030882,0.999999999988918,0.890230417414118,0,1,lipid antigen binding,MF,
7094,GO:0030883,0.999999999988918,0.890230417414118,0,1,endogenous lipid antigen binding,MF,
7095,GO:0030884,0.999999999988918,0.890230417414118,0,1,exogenous lipid antigen binding,MF,
12073,GO:0048006,0.999999999988918,0.890230417414118,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
8787,GO:0034458,0.999999999988921,0.794526206199564,0,2,3'-5' RNA helicase activity,MF,
3144,GO:0006740,0.999999999988932,0.711325311567833,0,3,NADPH regeneration,BP,
3851,GO:0008459,0.999999999988952,0.794958297229342,0,2,chondroitin 6-sulfotransferase activity,MF,
17014,GO:0099074,0.99999999998896,0.796588703230448,0,2,mitochondrion to lysosome transport,BP,
17015,GO:0099075,0.99999999998896,0.796588703230448,0,2,mitochondrion-derived vesicle mediated transport,BP,
4852,GO:0014062,0.99999999998898,0.815428928869006,0,2,regulation of serotonin secretion,BP,
622,GO:0001794,0.999999999989005,0.888459128338454,0,1,type IIa hypersensitivity,BP,
623,GO:0001796,0.999999999989005,0.888459128338454,0,1,regulation of type IIa hypersensitivity,BP,
624,GO:0001798,0.999999999989005,0.888459128338454,0,1,positive regulation of type IIa hypersensitivity,BP,
742,GO:0001970,0.999999999989005,0.888459128338454,0,1,positive regulation of activation of membrane attack complex,BP,
991,GO:0002445,0.999999999989005,0.888459128338454,0,1,type II hypersensitivity,BP,
1225,GO:0002892,0.999999999989005,0.888459128338454,0,1,regulation of type II hypersensitivity,BP,
1226,GO:0002894,0.999999999989005,0.888459128338454,0,1,positive regulation of type II hypersensitivity,BP,
7527,GO:0031714,0.999999999989005,0.888459128338454,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7528,GO:0031715,0.999999999989005,0.888459128338454,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
5985,GO:0018812,0.999999999989015,0.635318713618558,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
17151,GO:0102158,0.999999999989015,0.635318713618558,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17163,GO:0102343,0.999999999989015,0.635318713618558,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17164,GO:0102344,0.999999999989015,0.635318713618558,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17165,GO:0102345,0.999999999989015,0.635318713618558,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
19513,GO:1990246,0.999999999989015,0.635318713618558,0,4,uniplex complex,CC,
1062,GO:0002587,0.999999999989028,0.910736483323791,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
16412,GO:0097010,0.99999999998909,0.70646214767527,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
13921,GO:0060545,0.999999999989103,0.799639748140938,0,2,positive regulation of necroptotic process,BP,
17697,GO:1901534,0.999999999989186,0.79293878390248,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18006,GO:1902396,0.999999999989191,0.889914463139981,0,1,protein localization to bicellular tight junction,BP,
13168,GO:0051717,0.999999999989203,0.793266263247529,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
17929,GO:1902214,0.999999999989252,0.80153961600762,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
1243,GO:0002933,0.999999999989261,0.806021666765529,0,2,lipid hydroxylation,BP,
17135,GO:0101020,0.999999999989261,0.806021666765529,0,2,estrogen 16-alpha-hydroxylase activity,MF,
6252,GO:0019826,0.999999999989262,0.796225974376209,0,2,oxygen sensor activity,MF,
16956,GO:0098914,0.99999999998928,0.793148358870154,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17112,GO:0099624,0.99999999998928,0.793148358870154,0,2,atrial cardiac muscle cell membrane repolarization,BP,
19469,GO:1990070,0.999999999989293,0.933350078033235,0,1,TRAPPI protein complex,CC,
237,GO:0000494,0.999999999989293,0.917449768792958,0,1,box C/D snoRNA 3'-end processing,BP,
8563,GO:0033967,0.999999999989293,0.917449768792958,0,1,box C/D snoRNA metabolic process,BP,
8941,GO:0034963,0.999999999989293,0.917449768792958,0,1,box C/D snoRNA processing,BP,
9444,GO:0036009,0.999999999989293,0.917449768792958,0,1,protein-glutamine N-methyltransferase activity,MF,
19518,GO:1990258,0.999999999989293,0.917449768792958,0,1,histone glutamine methylation,BP,
19519,GO:1990259,0.999999999989293,0.917449768792958,0,1,histone-glutamine methyltransferase activity,MF,
2320,GO:0005324,0.999999999989313,0.796906188793512,0,2,long-chain fatty acid transporter activity,MF,
5268,GO:0015910,0.999999999989313,0.796906188793512,0,2,peroxisomal long-chain fatty acid import,BP,
17255,GO:0110025,0.999999999989325,0.892340646749462,0,1,DNA strand resection involved in replication fork processing,BP,
17256,GO:0110026,0.999999999989325,0.892340646749462,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
19117,GO:1904983,0.999999999989328,0.896179411103563,0,1,glycine import into mitochondrion,BP,
4363,GO:0009957,0.999999999989342,0.794703493475465,0,2,epidermal cell fate specification,BP,
13889,GO:0060486,0.999999999989342,0.794703493475465,0,2,Clara cell differentiation,BP,
2194,GO:0005052,0.999999999989349,0.794536422606142,0,2,peroxisome matrix targeting signal-1 binding,MF,
2365,GO:0005471,0.999999999989371,0.735348381162433,0,3,ATP:ADP antiporter activity,MF,
5037,GO:0015207,0.999999999989371,0.735348381162433,0,3,adenine transmembrane transporter activity,MF,
18982,GO:1904716,0.999999999989373,0.894504588419458,0,1,positive regulation of chaperone-mediated autophagy,BP,
12757,GO:0051001,0.999999999989383,0.663842025866639,0,4,negative regulation of nitric-oxide synthase activity,BP,
15886,GO:0072589,0.999999999989386,0.722125492761142,0,4,box H/ACA scaRNP complex,CC,
2964,GO:0006500,0.999999999989388,0.896089458238442,0,1,N-terminal protein palmitoylation,BP,
5882,GO:0018009,0.999999999989388,0.896089458238442,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5451,GO:0016320,0.999999999989396,0.811937994072267,0,2,endoplasmic reticulum membrane fusion,BP,
1343,GO:0003199,0.999999999989398,0.906279043234698,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4827,GO:0014028,0.999999999989398,0.906279043234698,0,1,notochord formation,BP,
9314,GO:0035752,0.999999999989412,0.898753604084078,0,1,lysosomal lumen pH elevation,BP,
15262,GO:0071403,0.999999999989421,0.795101339719343,0,2,cellular response to high density lipoprotein particle stimulus,BP,
8887,GO:0034693,0.999999999989438,0.894067580870529,0,1,U11/U12 snRNP,CC,
11171,GO:0045213,0.99999999998944,0.808991242687051,0,2,neurotransmitter receptor metabolic process,BP,
1491,GO:0003826,0.999999999989491,0.804891603882061,0,2,alpha-ketoacid dehydrogenase activity,MF,
1509,GO:0003863,0.999999999989491,0.804891603882061,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
5898,GO:0018094,0.9999999999895,0.891292226997726,0,1,protein polyglycylation,BP,
14926,GO:0070735,0.9999999999895,0.891292226997726,0,1,protein-glycine ligase activity,MF,
14927,GO:0070736,0.9999999999895,0.891292226997726,0,1,protein-glycine ligase activity, initiating,MF,
4295,GO:0009720,0.999999999989509,0.892546033186222,0,1,detection of hormone stimulus,BP,
7585,GO:0031944,0.999999999989509,0.631706294221007,0,4,negative regulation of glucocorticoid metabolic process,BP,
7588,GO:0031947,0.999999999989509,0.631706294221007,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
8581,GO:0034041,0.999999999989509,0.892546033186222,0,1,sterol-transporting ATPase activity,MF,
16091,GO:0090032,0.999999999989509,0.631706294221007,0,4,negative regulation of steroid hormone biosynthetic process,BP,
7748,GO:0032252,0.99999999998953,0.704711446485578,0,3,secretory granule localization,BP,
7532,GO:0031731,0.999999999989538,0.881309213951342,0,2,CCR6 chemokine receptor binding,MF,
20228,GO:2001045,0.99999999998954,0.790890351081241,0,2,negative regulation of integrin-mediated signaling pathway,BP,
3205,GO:0006843,0.999999999989578,0.904480725095101,0,1,mitochondrial citrate transmembrane transport,BP,
16099,GO:0090044,0.999999999989578,0.904480725095101,0,1,positive regulation of tubulin deacetylation,BP,
19588,GO:1990546,0.999999999989578,0.904480725095101,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
20162,GO:2000819,0.999999999989599,0.795321608851894,0,2,regulation of nucleotide-excision repair,BP,
3771,GO:0008321,0.999999999989602,0.789295963096912,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
5637,GO:0016715,0.999999999989603,0.794538293471188,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
17809,GO:1901856,0.999999999989628,0.798190907406776,0,2,negative regulation of cellular respiration,BP,
928,GO:0002322,0.99999999998963,0.790302352444104,0,2,B cell proliferation involved in immune response,BP,
17390,GO:1900084,0.999999999989659,0.628247977958014,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17179,GO:0102521,0.999999999989704,0.797348849394125,0,2,tRNA-4-demethylwyosine synthase activity,MF,
2684,GO:0006045,0.999999999989786,0.790865803451832,0,2,N-acetylglucosamine biosynthetic process,BP,
17567,GO:1901073,0.999999999989786,0.790865803451832,0,2,glucosamine-containing compound biosynthetic process,BP,
2307,GO:0005290,0.999999999989806,0.797596309802874,0,2,L-histidine transmembrane transporter activity,MF,
9219,GO:0035598,0.999999999989863,0.891678939673076,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14434,GO:0061712,0.999999999989863,0.891678939673076,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
12154,GO:0048239,0.999999999989866,0.800188344418678,0,2,negative regulation of DNA recombination at telomere,BP,
15934,GO:0072695,0.999999999989866,0.800188344418678,0,2,regulation of DNA recombination at telomere,BP,
8128,GO:0032808,0.999999999989875,0.626651745474038,0,4,lacrimal gland development,BP,
12676,GO:0050861,0.999999999989892,0.633566442142135,0,4,positive regulation of B cell receptor signaling pathway,BP,
19687,GO:1990889,0.999999999989897,0.899375950777765,0,1,H4K20me3 modified histone binding,MF,
6351,GO:0021524,0.999999999989905,0.804331165713351,0,2,visceral motor neuron differentiation,BP,
8399,GO:0033306,0.999999999989911,0.800488786963943,0,2,phytol metabolic process,BP,
18308,GO:1903173,0.999999999989911,0.800488786963943,0,2,fatty alcohol metabolic process,BP,
4922,GO:0014858,0.999999999989912,0.789373724967162,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18119,GO:1902724,0.999999999989912,0.789373724967162,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18121,GO:1902728,0.999999999989912,0.789373724967162,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
5965,GO:0018352,0.99999999998995,0.806317517898471,0,2,protein-pyridoxal-5-phosphate linkage,BP,
17147,GO:0102121,0.999999999990014,0.798001294426551,0,2,ceramidase activity,MF,
15626,GO:0072095,0.999999999990025,0.800185521618849,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15634,GO:0072103,0.999999999990025,0.800185521618849,0,2,glomerulus vasculature morphogenesis,BP,
15635,GO:0072104,0.999999999990025,0.800185521618849,0,2,glomerular capillary formation,BP,
19783,GO:2000137,0.999999999990025,0.800185521618849,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
9365,GO:0035868,0.999999999990032,0.79177068143274,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
7555,GO:0031859,0.999999999990037,0.898746400832445,0,1,platelet activating factor receptor binding,MF,
9885,GO:0042137,0.999999999990037,0.898746400832445,0,1,sequestering of neurotransmitter,BP,
3868,GO:0008488,0.999999999990054,0.892005092139209,0,1,gamma-glutamyl carboxylase activity,MF,
14459,GO:0061762,0.999999999990056,0.78930908378875,0,2,CAMKK-AMPK signaling cascade,BP,
16997,GO:0099004,0.999999999990056,0.78930908378875,0,2,calmodulin dependent kinase signaling pathway,BP,
9147,GO:0035482,0.999999999990069,0.841128546819214,0,2,gastric motility,BP,
19247,GO:1905333,0.999999999990069,0.841128546819214,0,2,regulation of gastric motility,BP,
19399,GO:1905799,0.999999999990071,0.937506798023927,0,1,regulation of intraciliary retrograde transport,BP,
14610,GO:0070143,0.999999999990112,0.888618129824438,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
5495,GO:0016428,0.999999999990147,0.644204911629864,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
13604,GO:0060051,0.999999999990151,0.805744742843138,0,2,negative regulation of protein glycosylation,BP,
16253,GO:0090285,0.999999999990151,0.805744742843138,0,2,negative regulation of protein glycosylation in Golgi,BP,
2498,GO:0005745,0.999999999990175,0.79734000954737,0,2,m-AAA complex,CC,
13246,GO:0051890,0.999999999990237,0.790013460617063,0,2,regulation of cardioblast differentiation,BP,
1033,GO:0002538,0.999999999990243,0.892031851871481,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1034,GO:0002540,0.999999999990243,0.892031851871481,0,1,leukotriene production involved in inflammatory response,BP,
9150,GO:0035490,0.999999999990243,0.892031851871481,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9151,GO:0035491,0.999999999990243,0.892031851871481,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14182,GO:0061044,0.999999999990243,0.892031851871481,0,1,negative regulation of vascular wound healing,BP,
17649,GO:1901331,0.999999999990243,0.892031851871481,0,1,positive regulation of odontoblast differentiation,BP,
18188,GO:1902913,0.999999999990243,0.892031851871481,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19762,GO:2000098,0.999999999990243,0.892031851871481,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
15728,GO:0072262,0.999999999990244,0.796202239703125,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15746,GO:0072301,0.999999999990244,0.796202239703125,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
14588,GO:0070103,0.999999999990248,0.902242811628729,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14589,GO:0070104,0.999999999990248,0.902242811628729,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17925,GO:1902205,0.999999999990248,0.902242811628729,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17926,GO:1902206,0.999999999990248,0.902242811628729,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17930,GO:1902215,0.999999999990248,0.902242811628729,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17939,GO:1902227,0.999999999990248,0.902242811628729,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17945,GO:1902233,0.999999999990248,0.902242811628729,0,1,negative regulation of positive thymic T cell selection,BP,
18680,GO:1903970,0.999999999990248,0.902242811628729,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18683,GO:1903973,0.999999999990248,0.902242811628729,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
16809,GO:0098625,0.999999999990275,0.890180984983795,0,1,methylselenol reductase activity,MF,
16810,GO:0098626,0.999999999990275,0.890180984983795,0,1,methylseleninic acid reductase activity,MF,
16910,GO:0098833,0.999999999990282,0.888530481400308,0,1,presynaptic endocytic zone,CC,
16911,GO:0098835,0.999999999990282,0.888530481400308,0,1,presynaptic endocytic zone membrane,CC,
7187,GO:0031064,0.999999999990298,0.789235898467883,0,2,negative regulation of histone deacetylation,BP,
10616,GO:0043585,0.999999999990298,0.789235898467883,0,2,nose morphogenesis,BP,
4694,GO:0010845,0.9999999999903,0.89349960732927,0,1,positive regulation of reciprocal meiotic recombination,BP,
17872,GO:1902035,0.9999999999903,0.637239071580194,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
18446,GO:1903464,0.999999999990314,0.801197870070574,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
11512,GO:0045976,0.999999999990356,0.793111758488929,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
2625,GO:0005945,0.999999999990373,0.79554371982189,0,2,6-phosphofructokinase complex,CC,
2934,GO:0006452,0.999999999990375,0.810775270452546,0,2,translational frameshifting,BP,
11467,GO:0045905,0.999999999990375,0.810775270452546,0,2,positive regulation of translational termination,BP,
19522,GO:1990264,0.999999999990395,0.798165354488679,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
9390,GO:0035912,0.999999999990406,0.631933177695858,0,4,dorsal aorta morphogenesis,BP,
2630,GO:0005955,0.999999999990433,0.628539269162941,0,4,calcineurin complex,CC,
15065,GO:0070993,0.999999999990463,0.790548594625469,0,2,translation preinitiation complex,CC,
5116,GO:0015433,0.999999999990484,0.792675143908069,0,2,peptide antigen-transporting ATPase activity,MF,
9693,GO:0038062,0.999999999990492,0.890094039777401,0,1,protein tyrosine kinase collagen receptor activity,MF,
7303,GO:0031296,0.999999999990533,0.916763863630268,0,1,B cell costimulation,BP,
16082,GO:0090009,0.999999999990537,0.624871498716762,0,4,primitive streak formation,BP,
12032,GO:0047578,0.999999999990541,0.894112621495625,0,1,4-hydroxyglutamate transaminase activity,MF,
2229,GO:0005129,0.999999999990577,0.932829792545491,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8570,GO:0034021,0.999999999990577,0.932829792545491,0,1,response to silicon dioxide,BP,
4700,GO:0010856,0.99999999999058,0.891663926066239,0,1,adenylate cyclase activator activity,MF,
10008,GO:0042414,0.999999999990589,0.798420396051393,0,2,epinephrine metabolic process,BP,
16611,GO:0097409,0.999999999990611,0.898014702475644,0,1,glial cytoplasmic inclusion,CC,
16614,GO:0097414,0.999999999990611,0.898014702475644,0,1,classical Lewy body,CC,
16637,GO:0097462,0.999999999990611,0.898014702475644,0,1,Lewy neurite,CC,
19463,GO:1990038,0.999999999990611,0.898014702475644,0,1,Lewy body corona,CC,
1269,GO:0003032,0.999999999990627,0.798439585100591,0,2,detection of oxygen,BP,
16391,GO:0090677,0.999999999990654,0.803021658561373,0,2,reversible differentiation,BP,
16392,GO:0090678,0.999999999990654,0.803021658561373,0,2,cell dedifferentiation involved in phenotypic switching,BP,
19190,GO:1905174,0.999999999990654,0.803021658561373,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19702,GO:1990936,0.999999999990654,0.803021658561373,0,2,vascular smooth muscle cell dedifferentiation,BP,
5099,GO:0015373,0.999999999990677,0.791351474483284,0,2,anion:sodium symporter activity,MF,
8558,GO:0033906,0.999999999990702,0.804367154887894,0,2,hyaluronoglucuronidase activity,MF,
19151,GO:1905064,0.999999999990704,0.795226636473497,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
15086,GO:0071030,0.999999999990711,0.805680012540519,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15098,GO:0071048,0.999999999990711,0.805680012540519,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
5539,GO:0016520,0.999999999990718,0.888783884673449,0,1,growth hormone-releasing hormone receptor activity,MF,
14307,GO:0061370,0.999999999990752,0.795044559981685,0,2,testosterone biosynthetic process,BP,
5954,GO:0018307,0.999999999990753,0.828274301224631,0,2,enzyme active site formation,BP,
9919,GO:0042245,0.999999999990841,0.79457424719526,0,2,RNA repair,BP,
3807,GO:0008391,0.999999999990844,0.803644431655955,0,2,arachidonic acid monooxygenase activity,MF,
3808,GO:0008392,0.999999999990844,0.803644431655955,0,2,arachidonic acid epoxygenase activity,MF,
8130,GO:0032810,0.999999999990857,0.80457453983714,0,2,sterol response element binding,MF,
13651,GO:0060126,0.999999999990857,0.796746954718377,0,2,somatotropin secreting cell differentiation,BP,
19102,GO:1904954,0.999999999990872,0.808517279765217,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
3004,GO:0006550,0.999999999990883,0.810096621771098,0,2,isoleucine catabolic process,BP,
3636,GO:0008107,0.999999999990904,0.793412460917798,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7237,GO:0031127,0.999999999990904,0.793412460917798,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
3523,GO:0007499,0.999999999990935,0.88874476785534,0,1,ectoderm and mesoderm interaction,BP,
12403,GO:0048807,0.999999999990935,0.88874476785534,0,1,female genitalia morphogenesis,BP,
19304,GO:1905462,0.999999999990943,0.790225471414567,0,2,regulation of DNA duplex unwinding,BP,
9638,GO:0036497,0.999999999990945,0.894439190661698,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17982,GO:1902310,0.999999999990945,0.894439190661698,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18652,GO:1903916,0.999999999990945,0.894439190661698,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18653,GO:1903917,0.999999999990945,0.894439190661698,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
6087,GO:0019240,0.999999999990948,0.624766389649648,0,4,citrulline biosynthetic process,BP,
16951,GO:0098908,0.999999999991004,0.795084251722167,0,2,regulation of neuronal action potential,BP,
10150,GO:0042704,0.999999999991016,0.792449763242448,0,2,uterine wall breakdown,BP,
1354,GO:0003219,0.99999999999102,0.801798249004563,0,2,cardiac right ventricle formation,BP,
8579,GO:0034039,0.999999999991055,0.808459787827655,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
2168,GO:0005000,0.999999999991066,0.792914891628432,0,2,vasopressin receptor activity,MF,
5122,GO:0015467,0.999999999991072,0.79716006688281,0,2,G-protein activated inward rectifier potassium channel activity,MF,
3464,GO:0007284,0.999999999991102,0.79065479383423,0,2,spermatogonial cell division,BP,
15733,GO:0072272,0.999999999991103,0.803566194925768,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
7442,GO:0031547,0.999999999991106,0.789508772165501,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
10829,GO:0044308,0.999999999991106,0.789508772165501,0,2,axonal spine,CC,
7374,GO:0031416,0.999999999991108,0.818397830777184,0,2,NatB complex,CC,
11053,GO:0045016,0.999999999991128,0.891477780379267,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11066,GO:0045041,0.999999999991154,0.8112422161847,0,2,protein import into mitochondrial intermembrane space,BP,
13873,GO:0060456,0.999999999991178,0.711142305812288,0,3,positive regulation of digestive system process,BP,
19010,GO:1904768,0.999999999991192,0.824574319580331,0,2,all-trans-retinol binding,MF,
1653,GO:0004098,0.999999999991196,0.898760814244269,0,1,cerebroside-sulfatase activity,MF,
11046,GO:0045004,0.999999999991198,0.791654659261609,0,2,DNA replication proofreading,BP,
15867,GO:0072563,0.999999999991199,0.806823206594897,0,2,endothelial microparticle,CC,
16059,GO:0086072,0.999999999991222,0.89403159840333,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16067,GO:0086082,0.999999999991222,0.89403159840333,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16517,GO:0097195,0.999999999991224,0.796078993775149,0,2,pilomotor reflex,BP,
17685,GO:1901492,0.999999999991228,0.796534983184559,0,2,positive regulation of lymphangiogenesis,BP,
6968,GO:0030617,0.99999999999124,0.892259017259729,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7909,GO:0032472,0.999999999991242,0.800057426876398,0,2,Golgi calcium ion transport,BP,
16382,GO:0090666,0.999999999991247,0.646125114655766,0,4,scaRNA localization to Cajal body,BP,
4505,GO:0010536,0.99999999999125,0.84421159991597,0,2,positive regulation of activation of Janus kinase activity,BP,
13910,GO:0060529,0.999999999991262,0.79053187112027,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
3317,GO:0007023,0.999999999991262,0.676087676396043,0,4,post-chaperonin tubulin folding pathway,BP,
12338,GO:0048674,0.999999999991286,0.89415036947165,0,1,collateral sprouting of injured axon,BP,
12346,GO:0048686,0.999999999991286,0.89415036947165,0,1,regulation of sprouting of injured axon,BP,
12347,GO:0048687,0.999999999991286,0.89415036947165,0,1,positive regulation of sprouting of injured axon,BP,
12348,GO:0048688,0.999999999991286,0.89415036947165,0,1,negative regulation of sprouting of injured axon,BP,
12349,GO:0048689,0.999999999991286,0.89415036947165,0,1,formation of growth cone in injured axon,BP,
12350,GO:0048693,0.999999999991286,0.89415036947165,0,1,regulation of collateral sprouting of injured axon,BP,
12351,GO:0048694,0.999999999991286,0.89415036947165,0,1,positive regulation of collateral sprouting of injured axon,BP,
19340,GO:1905578,0.999999999991286,0.89415036947165,0,1,regulation of ERBB3 signaling pathway,BP,
19341,GO:1905580,0.999999999991286,0.89415036947165,0,1,positive regulation of ERBB3 signaling pathway,BP,
19441,GO:1905942,0.999999999991286,0.89415036947165,0,1,regulation of formation of growth cone in injured axon,BP,
19442,GO:1905943,0.999999999991286,0.89415036947165,0,1,negative regulation of formation of growth cone in injured axon,BP,
1621,GO:0004047,0.999999999991298,0.81324277283171,0,2,aminomethyltransferase activity,MF,
14193,GO:0061055,0.999999999991304,0.789623278815787,0,2,myotome development,BP,
9117,GO:0035400,0.999999999991321,0.888421134173538,0,1,histone tyrosine kinase activity,MF,
9118,GO:0035401,0.999999999991321,0.888421134173538,0,1,histone kinase activity (H3-Y41 specific),MF,
9123,GO:0035406,0.999999999991321,0.888421134173538,0,1,histone-tyrosine phosphorylation,BP,
9126,GO:0035409,0.999999999991321,0.888421134173538,0,1,histone H3-Y41 phosphorylation,BP,
1842,GO:0004494,0.999999999991328,0.892609611901067,0,1,methylmalonyl-CoA mutase activity,MF,
6304,GO:0019918,0.999999999991352,0.637375569183848,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9037,GO:0035243,0.999999999991352,0.637375569183848,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
14170,GO:0061030,0.999999999991354,0.889694868396496,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
13372,GO:0052422,0.99999999999137,0.809742367174833,0,2,modulation by host of symbiont catalytic activity,BP,
1321,GO:0003166,0.999999999991378,0.888648767013572,0,1,bundle of His development,BP,
1322,GO:0003167,0.999999999991378,0.888648767013572,0,1,atrioventricular bundle cell differentiation,BP,
13953,GO:0060596,0.999999999991378,0.888648767013572,0,1,mammary placode formation,BP,
14119,GO:0060932,0.999999999991378,0.888648767013572,0,1,His-Purkinje system cell differentiation,BP,
9188,GO:0035552,0.99999999999138,0.719220461465189,0,3,oxidative single-stranded DNA demethylation,BP,
1725,GO:0004314,0.999999999991385,0.797899470385594,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5488,GO:0016419,0.999999999991385,0.797899470385594,0,2,S-malonyltransferase activity,MF,
5489,GO:0016420,0.999999999991385,0.797899470385594,0,2,malonyltransferase activity,MF,
19814,GO:2000199,0.999999999991386,0.892217986700081,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19815,GO:2000200,0.999999999991386,0.892217986700081,0,1,regulation of ribosomal subunit export from nucleus,BP,
19816,GO:2000202,0.999999999991386,0.892217986700081,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19817,GO:2000206,0.999999999991386,0.892217986700081,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19818,GO:2000208,0.999999999991386,0.892217986700081,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
18814,GO:1904304,0.999999999991414,0.82833389542149,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18815,GO:1904306,0.999999999991414,0.82833389542149,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
896,GO:0002266,0.999999999991428,0.802462968399089,0,2,follicular dendritic cell activation,BP,
897,GO:0002268,0.999999999991428,0.802462968399089,0,2,follicular dendritic cell differentiation,BP,
8373,GO:0033257,0.999999999991428,0.802462968399089,0,2,Bcl3/NF-kappaB2 complex,CC,
17203,GO:0103053,0.999999999991431,0.827477588779167,0,2,1-ethyladenine demethylase activity,MF,
16284,GO:0090325,0.999999999991441,0.792991014017959,0,2,regulation of locomotion involved in locomotory behavior,BP,
16678,GO:0097534,0.999999999991451,0.793607968010451,0,2,lymphoid lineage cell migration,BP,
16679,GO:0097535,0.999999999991451,0.793607968010451,0,2,lymphoid lineage cell migration into thymus,BP,
2821,GO:0006286,0.999999999991463,0.829314273963684,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
20173,GO:2000832,0.999999999991464,0.792193995136087,0,2,negative regulation of steroid hormone secretion,BP,
20180,GO:2000847,0.999999999991464,0.792193995136087,0,2,negative regulation of corticosteroid hormone secretion,BP,
20183,GO:2000850,0.999999999991464,0.792193995136087,0,2,negative regulation of glucocorticoid secretion,BP,
4521,GO:0010572,0.999999999991474,0.797492999000578,0,2,positive regulation of platelet activation,BP,
17786,GO:1901731,0.999999999991474,0.797492999000578,0,2,positive regulation of platelet aggregation,BP,
80,GO:0000160,0.9999999999915,0.791040364625262,0,2,phosphorelay signal transduction system,BP,
13911,GO:0060532,0.999999999991504,0.791203250408218,0,2,bronchus cartilage development,BP,
14231,GO:0061145,0.999999999991504,0.791203250408218,0,2,lung smooth muscle development,BP,
19639,GO:1990745,0.999999999991513,0.632042786516838,0,4,EARP complex,CC,
8557,GO:0033897,0.999999999991515,0.914626727383454,0,1,ribonuclease T2 activity,MF,
1058,GO:0002583,0.999999999991524,0.683227707157595,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
16431,GO:0097045,0.999999999991526,0.888627011965493,0,1,phosphatidylserine exposure on blood platelet,BP,
17976,GO:1902304,0.999999999991526,0.888627011965493,0,1,positive regulation of potassium ion export,BP,
16168,GO:0090164,0.999999999991536,0.793662721597632,0,2,asymmetric Golgi ribbon formation,BP,
1832,GO:0004484,0.999999999991542,0.888916699280066,0,1,mRNA guanylyltransferase activity,MF,
12493,GO:0050355,0.999999999991542,0.888916699280066,0,1,triphosphatase activity,MF,
813,GO:0002083,0.999999999991554,0.903601503700952,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
12000,GO:0047293,0.999999999991554,0.903601503700952,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
16157,GO:0090149,0.999999999991554,0.795248572329334,0,2,mitochondrial membrane fission,BP,
8010,GO:0032632,0.999999999991593,0.794969788188587,0,2,interleukin-3 production,BP,
8034,GO:0032672,0.999999999991593,0.794969788188587,0,2,regulation of interleukin-3 production,BP,
4978,GO:0015093,0.999999999991594,0.790364109104773,0,2,ferrous iron transmembrane transporter activity,MF,
5152,GO:0015684,0.999999999991594,0.790364109104773,0,2,ferrous iron transport,BP,
18627,GO:1903874,0.999999999991594,0.790364109104773,0,2,ferrous iron transmembrane transport,BP,
4389,GO:0010040,0.999999999991598,0.659135519449703,0,4,response to iron(II) ion,BP,
14538,GO:0070012,0.999999999991626,0.798604364268166,0,2,oligopeptidase activity,MF,
2587,GO:0005880,0.999999999991628,0.90821681808437,0,1,nuclear microtubule,CC,
14071,GO:0060819,0.999999999991629,0.789236166328777,0,2,inactivation of X chromosome by genetic imprinting,BP,
3791,GO:0008355,0.999999999991651,0.888996412693692,0,1,olfactory learning,BP,
2240,GO:0005146,0.999999999991663,0.803736615788682,0,2,leukemia inhibitory factor receptor binding,MF,
5986,GO:0018872,0.999999999991698,0.894039528254252,0,1,arsonoacetate metabolic process,BP,
7029,GO:0030791,0.999999999991698,0.894039528254252,0,1,arsenite methyltransferase activity,MF,
7030,GO:0030792,0.999999999991698,0.894039528254252,0,1,methylarsonite methyltransferase activity,MF,
5460,GO:0016333,0.999999999991709,0.892672620672047,0,1,morphogenesis of follicular epithelium,BP,
5461,GO:0016334,0.999999999991709,0.892672620672047,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9921,GO:0042247,0.999999999991709,0.892672620672047,0,1,establishment of planar polarity of follicular epithelium,BP,
10131,GO:0042643,0.999999999991709,0.892672620672047,0,1,actomyosin, actin portion,CC,
15473,GO:0071787,0.999999999991712,0.638527598298994,0,4,endoplasmic reticulum tubular network formation,BP,
1688,GO:0004152,0.99999999999173,0.896732067053367,0,1,dihydroorotate dehydrogenase activity,MF,
18502,GO:1903576,0.99999999999173,0.896732067053367,0,1,response to L-arginine,BP,
8750,GO:0034392,0.999999999991733,0.635838405724661,0,4,negative regulation of smooth muscle cell apoptotic process,BP,
13856,GO:0060435,0.999999999991781,0.912063872991327,0,1,bronchiole development,BP,
13884,GO:0060480,0.999999999991781,0.912063872991327,0,1,lung goblet cell differentiation,BP,
4876,GO:0014735,0.999999999991786,0.808844614152689,0,2,regulation of muscle atrophy,BP,
4877,GO:0014736,0.999999999991786,0.808844614152689,0,2,negative regulation of muscle atrophy,BP,
1238,GO:0002923,0.999999999991826,0.808356195353657,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
3514,GO:0007439,0.999999999991828,0.892603982979485,0,1,ectodermal digestive tract development,BP,
9527,GO:0036215,0.999999999991828,0.892603982979485,0,1,response to stem cell factor,BP,
9528,GO:0036216,0.999999999991828,0.892603982979485,0,1,cellular response to stem cell factor stimulus,BP,
9714,GO:0038109,0.999999999991828,0.892603982979485,0,1,Kit signaling pathway,BP,
12304,GO:0048611,0.999999999991828,0.892603982979485,0,1,embryonic ectodermal digestive tract development,BP,
1432,GO:0003402,0.99999999999185,0.623253355697093,0,4,planar cell polarity pathway involved in axis elongation,BP,
1967,GO:0004673,0.99999999999185,0.83061605245704,0,2,protein histidine kinase activity,MF,
6321,GO:0019964,0.999999999991854,0.891113969184341,0,1,interferon-gamma binding,MF,
19539,GO:1990390,0.999999999991854,0.891113969184341,0,1,protein K33-linked ubiquitination,BP,
3499,GO:0007403,0.99999999999186,0.891241557827339,0,1,glial cell fate determination,BP,
14060,GO:0060769,0.99999999999186,0.891241557827339,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14285,GO:0061324,0.99999999999186,0.891241557827339,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18888,GO:1904499,0.99999999999186,0.891241557827339,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18889,GO:1904501,0.99999999999186,0.891241557827339,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
19022,GO:1904793,0.99999999999186,0.891241557827339,0,1,regulation of euchromatin binding,BP,
15006,GO:0070901,0.999999999991867,0.660550865534193,0,4,mitochondrial tRNA methylation,BP,
6453,GO:0021768,0.999999999991873,0.891019676143501,0,1,nucleus accumbens development,BP,
4208,GO:0009328,0.99999999999188,0.641940799327971,0,4,phenylalanine-tRNA ligase complex,CC,
9913,GO:0042222,0.999999999991889,0.829882030153576,0,2,interleukin-1 biosynthetic process,BP,
11241,GO:0045360,0.999999999991889,0.829882030153576,0,2,regulation of interleukin-1 biosynthetic process,BP,
11242,GO:0045362,0.999999999991889,0.829882030153576,0,2,positive regulation of interleukin-1 biosynthetic process,BP,
12352,GO:0048696,0.999999999991903,0.907189047238031,0,1,regulation of collateral sprouting in absence of injury,BP,
12353,GO:0048697,0.999999999991903,0.907189047238031,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13615,GO:0060064,0.999999999991903,0.907189047238031,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19309,GO:1905474,0.999999999991903,0.907189047238031,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
4006,GO:0008962,0.999999999991905,0.802004191721774,0,2,phosphatidylglycerophosphatase activity,MF,
1006,GO:0002477,0.999999999991914,0.924303314334893,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1010,GO:0002481,0.999999999991914,0.924303314334893,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
6382,GO:0021564,0.999999999991916,0.804976778419339,0,2,vagus nerve development,BP,
47,GO:0000099,0.999999999991932,0.627294177851612,0,4,sulfur amino acid transmembrane transporter activity,MF,
4492,GO:0010512,0.999999999991934,0.797410557211159,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9325,GO:0035788,0.999999999991934,0.797410557211159,0,2,cell migration involved in metanephros development,BP,
9326,GO:0035789,0.999999999991934,0.797410557211159,0,2,metanephric mesenchymal cell migration,BP,
9329,GO:0035793,0.999999999991934,0.797410557211159,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17473,GO:1900238,0.999999999991934,0.797410557211159,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
20027,GO:2000589,0.999999999991934,0.797410557211159,0,2,regulation of metanephric mesenchymal cell migration,BP,
20028,GO:2000591,0.999999999991934,0.797410557211159,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
2040,GO:0004778,0.99999999999194,0.903897301854123,0,1,succinyl-CoA hydrolase activity,MF,
8109,GO:0032788,0.99999999999194,0.903897301854123,0,1,saturated monocarboxylic acid metabolic process,BP,
8110,GO:0032789,0.99999999999194,0.903897301854123,0,1,unsaturated monocarboxylic acid metabolic process,BP,
13753,GO:0060302,0.999999999991946,0.81257167116103,0,2,negative regulation of cytokine activity,BP,
9133,GO:0035438,0.999999999991951,0.90253391250843,0,1,cyclic-di-GMP binding,MF,
14348,GO:0061507,0.999999999991951,0.90253391250843,0,1,cyclic-GMP-AMP binding,MF,
10534,GO:0043456,0.999999999991978,0.65303960529631,0,4,regulation of pentose-phosphate shunt,BP,
8860,GO:0034648,0.99999999999198,0.626679894836448,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
3933,GO:0008612,0.999999999991989,0.668216048822259,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
1443,GO:0003419,0.999999999991997,0.797850069102503,0,2,growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003420,0.999999999991997,0.797850069102503,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
3875,GO:0008503,0.99999999999201,0.832941520412837,0,2,benzodiazepine receptor activity,MF,
15547,GO:0071920,0.999999999992017,0.801436060480218,0,2,cleavage body,CC,
8541,GO:0033857,0.999999999992028,0.789260524311901,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17145,GO:0102092,0.999999999992028,0.789260524311901,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
15137,GO:0071207,0.999999999992029,0.801443188239008,0,2,histone pre-mRNA stem-loop binding,MF,
5468,GO:0016361,0.999999999992064,0.803956755369796,0,2,activin receptor activity, type I,MF,
12135,GO:0048179,0.999999999992064,0.803956755369796,0,2,activin receptor complex,CC,
17530,GO:1900673,0.999999999992067,0.800177663231118,0,2,olefin metabolic process,BP,
640,GO:0001827,0.999999999992088,0.789463367259453,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,0.999999999992088,0.789463367259453,0,2,inner cell mass cellular morphogenesis,BP,
2911,GO:0006422,0.999999999992089,0.894685941102444,0,1,aspartyl-tRNA aminoacylation,BP,
12147,GO:0048209,0.999999999992091,0.79586760854095,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
11071,GO:0045054,0.999999999992091,0.718471118432932,0,3,constitutive secretory pathway,BP,
4793,GO:0010982,0.999999999992102,0.795965624797012,0,2,regulation of high-density lipoprotein particle clearance,BP,
4794,GO:0010983,0.999999999992102,0.795965624797012,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
8450,GO:0033564,0.999999999992117,0.789333052969202,0,2,anterior/posterior axon guidance,BP,
4405,GO:0010139,0.999999999992129,0.904174961219766,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4411,GO:0010164,0.999999999992129,0.904174961219766,0,1,response to cesium ion,BP,
6874,GO:0030343,0.999999999992129,0.904174961219766,0,1,vitamin D3 25-hydroxylase activity,MF,
14881,GO:0070643,0.999999999992129,0.904174961219766,0,1,vitamin D 25-hydroxylase activity,MF,
17638,GO:1901301,0.999999999992158,0.793906410934665,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18526,GO:1903636,0.99999999999216,0.9427261474642,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18527,GO:1903638,0.99999999999216,0.9427261474642,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18529,GO:1903645,0.99999999999216,0.9427261474642,0,1,negative regulation of chaperone-mediated protein folding,BP,
16715,GO:0097644,0.999999999992163,0.824101255596014,0,2,calcitonin family binding,MF,
18436,GO:1903439,0.999999999992163,0.824101255596014,0,2,calcitonin family receptor complex,CC,
19548,GO:1990406,0.999999999992163,0.824101255596014,0,2,CGRP receptor complex,CC,
19550,GO:1990408,0.999999999992163,0.824101255596014,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
17482,GO:1900248,0.999999999992163,0.789237555175184,0,2,negative regulation of cytoplasmic translational elongation,BP,
14523,GO:0065001,0.999999999992177,0.789238623594845,0,2,specification of axis polarity,BP,
17025,GO:0099093,0.99999999999219,0.793157765939637,0,2,calcium export from the mitochondrion,BP,
19621,GO:1990698,0.999999999992193,0.801406692338019,0,2,palmitoleoyltransferase activity,MF,
976,GO:0002424,0.999999999992204,0.797464527178151,0,2,T cell mediated immune response to tumor cell,BP,
1196,GO:0002840,0.999999999992204,0.797464527178151,0,2,regulation of T cell mediated immune response to tumor cell,BP,
12061,GO:0047860,0.999999999992262,0.913897201871519,0,1,diiodophenylpyruvate reductase activity,MF,
13072,GO:0051543,0.999999999992292,0.894551115283546,0,1,regulation of elastin biosynthetic process,BP,
13073,GO:0051545,0.999999999992292,0.894551115283546,0,1,negative regulation of elastin biosynthetic process,BP,
19636,GO:1990742,0.999999999992295,0.841910203078252,0,2,microvesicle,CC,
16592,GO:0097363,0.999999999992322,0.793156844348795,0,2,protein O-GlcNAc transferase activity,MF,
15031,GO:0070944,0.999999999992334,0.806001393940259,0,2,neutrophil mediated killing of bacterium,BP,
15032,GO:0070945,0.999999999992334,0.806001393940259,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
19628,GO:1990723,0.999999999992344,0.79280873123744,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
7719,GO:0032203,0.999999999992347,0.899462128457874,0,1,telomere formation via telomerase,BP,
14003,GO:0060694,0.999999999992347,0.899462128457874,0,1,regulation of cholesterol transporter activity,BP,
15770,GO:0072343,0.999999999992347,0.899462128457874,0,1,pancreatic stellate cell proliferation,BP,
17707,GO:1901558,0.999999999992347,0.899462128457874,0,1,response to metformin,BP,
19332,GO:1905563,0.999999999992347,0.899462128457874,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19827,GO:2000229,0.999999999992347,0.899462128457874,0,1,regulation of pancreatic stellate cell proliferation,BP,
19828,GO:2000230,0.999999999992347,0.899462128457874,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
8294,GO:0033093,0.99999999999235,0.632273412505677,0,4,Weibel-Palade body,CC,
10194,GO:0042776,0.99999999999237,0.720001123916595,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
6160,GO:0019482,0.999999999992392,0.794727963420911,0,2,beta-alanine metabolic process,BP,
2416,GO:0005589,0.999999999992442,0.806721099643135,0,2,collagen type VI trimer,CC,
16824,GO:0098647,0.999999999992442,0.806721099643135,0,2,collagen beaded filament,CC,
9686,GO:0038042,0.999999999992448,0.67218278586606,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
16716,GO:0097646,0.999999999992448,0.67218278586606,0,4,calcitonin family receptor signaling pathway,BP,
8267,GO:0033038,0.999999999992455,0.712335056995145,0,4,bitter taste receptor activity,MF,
176,GO:0000384,0.999999999992485,0.816669563432826,0,2,first spliceosomal transesterification activity,MF,
8004,GO:0032618,0.999999999992528,0.813096650031819,0,2,interleukin-15 production,BP,
14492,GO:0061857,0.999999999992554,0.794590363138176,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
3174,GO:0006789,0.999999999992572,0.800145065838273,0,2,bilirubin conjugation,BP,
1002,GO:0002468,0.999999999992591,0.640532370499554,0,4,dendritic cell antigen processing and presentation,BP,
1066,GO:0002604,0.999999999992591,0.640532370499554,0,4,regulation of dendritic cell antigen processing and presentation,BP,
9671,GO:0038018,0.999999999992599,0.789614923576522,0,2,Wnt receptor catabolic process,BP,
9334,GO:0035801,0.999999999992603,0.803783122059801,0,2,adrenal cortex development,BP,
9335,GO:0035802,0.999999999992603,0.803783122059801,0,2,adrenal cortex formation,BP,
882,GO:0002238,0.99999999999263,0.88849392733707,0,1,response to molecule of fungal origin,BP,
943,GO:0002351,0.99999999999263,0.88849392733707,0,1,serotonin production involved in inflammatory response,BP,
988,GO:0002442,0.99999999999263,0.88849392733707,0,1,serotonin secretion involved in inflammatory response,BP,
1043,GO:0002554,0.99999999999263,0.88849392733707,0,1,serotonin secretion by platelet,BP,
6249,GO:0019814,0.99999999999263,0.88849392733707,0,1,immunoglobulin complex,CC,
6250,GO:0019815,0.99999999999263,0.88849392733707,0,1,B cell receptor complex,CC,
8079,GO:0032752,0.99999999999263,0.88849392733707,0,1,positive regulation of interleukin-3 production,BP,
9914,GO:0042223,0.99999999999263,0.88849392733707,0,1,interleukin-3 biosynthetic process,BP,
11244,GO:0045399,0.99999999999263,0.88849392733707,0,1,regulation of interleukin-3 biosynthetic process,BP,
11245,GO:0045401,0.99999999999263,0.88849392733707,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11255,GO:0045423,0.99999999999263,0.88849392733707,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11256,GO:0045425,0.99999999999263,0.88849392733707,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15152,GO:0071226,0.99999999999263,0.88849392733707,0,1,cellular response to molecule of fungal origin,BP,
16485,GO:0097145,0.999999999992648,0.895614104356159,0,1,BAK complex,CC,
6554,GO:0021979,0.999999999992651,0.653782058520747,0,4,hypothalamus cell differentiation,BP,
14067,GO:0060800,0.999999999992662,0.793300945781918,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
1147,GO:0002740,0.999999999992697,0.816234594240346,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1211,GO:0002874,0.999999999992697,0.816234594240346,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
10832,GO:0044314,0.9999999999927,0.689389546664536,0,4,protein K27-linked ubiquitination,BP,
1433,GO:0003404,0.999999999992711,0.891615875818236,0,1,optic vesicle morphogenesis,BP,
1437,GO:0003409,0.999999999992711,0.891615875818236,0,1,optic cup structural organization,BP,
6406,GO:0021622,0.999999999992711,0.891615875818236,0,1,oculomotor nerve morphogenesis,BP,
6407,GO:0021623,0.999999999992711,0.891615875818236,0,1,oculomotor nerve formation,BP,
14626,GO:0070172,0.999999999992711,0.891615875818236,0,1,positive regulation of tooth mineralization,BP,
9719,GO:0038114,0.999999999992764,0.624718306185107,0,4,interleukin-21-mediated signaling pathway,BP,
16866,GO:0098756,0.999999999992764,0.624718306185107,0,4,response to interleukin-21,BP,
16867,GO:0098757,0.999999999992764,0.624718306185107,0,4,cellular response to interleukin-21,BP,
19006,GO:1904761,0.999999999992766,0.791264929128245,0,2,negative regulation of myofibroblast differentiation,BP,
7728,GO:0032213,0.999999999992787,0.796973416311675,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7729,GO:0032214,0.999999999992787,0.796973416311675,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18902,GO:1904534,0.999999999992787,0.796973416311675,0,2,negative regulation of telomeric loop disassembly,BP,
19394,GO:1905778,0.999999999992787,0.796973416311675,0,2,negative regulation of exonuclease activity,BP,
19405,GO:1905838,0.999999999992787,0.796973416311675,0,2,regulation of telomeric D-loop disassembly,BP,
19406,GO:1905839,0.999999999992787,0.796973416311675,0,2,negative regulation of telomeric D-loop disassembly,BP,
14498,GO:0061889,0.999999999992795,0.888426167275165,0,1,negative regulation of astrocyte activation,BP,
18689,GO:1903979,0.999999999992795,0.888426167275165,0,1,negative regulation of microglial cell activation,BP,
5242,GO:0015862,0.999999999992805,0.894697092269137,0,1,uridine transport,BP,
16346,GO:0090541,0.999999999992853,0.793720403639116,0,2,MIT domain binding,MF,
11477,GO:0045917,0.999999999992854,0.799551540872632,0,2,positive regulation of complement activation,BP,
19844,GO:2000259,0.999999999992854,0.799551540872632,0,2,positive regulation of protein activation cascade,BP,
6268,GO:0019858,0.999999999992882,0.824047421270103,0,2,cytosine metabolic process,BP,
3183,GO:0006808,0.999999999992894,0.829089745393524,0,2,regulation of nitrogen utilization,BP,
11811,GO:0046666,0.999999999992894,0.829089745393524,0,2,retinal cell programmed cell death,BP,
19880,GO:2000318,0.999999999992908,0.662302021977436,0,4,positive regulation of T-helper 17 type immune response,BP,
2624,GO:0005943,0.99999999999292,0.791008993073692,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
16719,GO:0097651,0.99999999999292,0.791008993073692,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
5238,GO:0015853,0.999999999992929,0.668338793306176,0,4,adenine transport,BP,
15270,GO:0071421,0.999999999992957,0.791503097106327,0,2,manganese ion transmembrane transport,BP,
17542,GO:1900756,0.999999999992972,0.793520757000363,0,2,protein processing in phagocytic vesicle,BP,
18656,GO:1903921,0.999999999992972,0.793520757000363,0,2,regulation of protein processing in phagocytic vesicle,BP,
18657,GO:1903923,0.999999999992972,0.793520757000363,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
293,GO:0000797,0.999999999992994,0.888595974941139,0,1,condensin core heterodimer,CC,
2420,GO:0005593,0.999999999993024,0.629893828071966,0,4,FACIT collagen trimer,CC,
6883,GO:0030372,0.999999999993028,0.888616783747204,0,1,high molecular weight B cell growth factor receptor binding,MF,
16460,GO:0097102,0.999999999993034,0.797044519818192,0,2,endothelial tip cell fate specification,BP,
2108,GO:0004882,0.999999999993057,0.891687947038806,0,1,androgen receptor activity,MF,
9405,GO:0035935,0.999999999993057,0.891687947038806,0,1,androgen secretion,BP,
16498,GO:0097162,0.999999999993057,0.891687947038806,0,1,MADS box domain binding,MF,
20175,GO:2000834,0.999999999993057,0.891687947038806,0,1,regulation of androgen secretion,BP,
20176,GO:2000836,0.999999999993057,0.891687947038806,0,1,positive regulation of androgen secretion,BP,
124,GO:0000254,0.999999999993082,0.797085204315786,0,2,C-4 methylsterol oxidase activity,MF,
1831,GO:0004483,0.999999999993082,0.797085204315786,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2887,GO:0006393,0.999999999993082,0.797085204315786,0,2,termination of mitochondrial transcription,BP,
3208,GO:0006850,0.999999999993082,0.797085204315786,0,2,mitochondrial pyruvate transmembrane transport,BP,
4011,GO:0008988,0.999999999993082,0.797085204315786,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
7731,GO:0032217,0.999999999993082,0.797085204315786,0,2,riboflavin transmembrane transporter activity,MF,
7732,GO:0032218,0.999999999993082,0.797085204315786,0,2,riboflavin transport,BP,
8118,GO:0032798,0.999999999993082,0.797085204315786,0,2,Swi5-Sfr1 complex,CC,
9604,GO:0036451,0.999999999993082,0.797085204315786,0,2,cap mRNA methylation,BP,
15376,GO:0071595,0.999999999993082,0.797085204315786,0,2,Nem1-Spo7 phosphatase complex,CC,
15985,GO:0080023,0.999999999993082,0.797085204315786,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16568,GO:0097309,0.999999999993082,0.797085204315786,0,2,cap1 mRNA methylation,BP,
19479,GO:1990112,0.999999999993082,0.797085204315786,0,2,RQC complex,CC,
19480,GO:1990116,0.999999999993082,0.797085204315786,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19683,GO:1990879,0.999999999993082,0.797085204315786,0,2,CST complex,CC,
20002,GO:2000543,0.999999999993082,0.797085204315786,0,2,positive regulation of gastrulation,BP,
10148,GO:0042700,0.99999999999311,0.888754404781088,0,1,luteinizing hormone signaling pathway,BP,
12127,GO:0048160,0.99999999999311,0.888754404781088,0,1,primary follicle stage,BP,
13691,GO:0060197,0.999999999993114,0.800501151848251,0,2,cloacal septation,BP,
14400,GO:0061628,0.999999999993117,0.795049767959689,0,2,H3K27me3 modified histone binding,MF,
16478,GO:0097124,0.999999999993138,0.799495415374426,0,2,cyclin A2-CDK2 complex,CC,
19830,GO:2000233,0.999999999993146,0.793251468829996,0,2,negative regulation of rRNA processing,BP,
1294,GO:0003104,0.999999999993148,0.635687070420062,0,4,positive regulation of glomerular filtration,BP,
8184,GO:0032914,0.999999999993189,0.714328979172272,0,3,positive regulation of transforming growth factor beta1 production,BP,
9935,GO:0042272,0.999999999993223,0.789249103251776,0,2,nuclear RNA export factor complex,CC,
1867,GO:0004528,0.999999999993233,0.646051775573108,0,4,phosphodiesterase I activity,MF,
15865,GO:0072560,0.999999999993242,0.892135539719802,0,1,type B pancreatic cell maturation,BP,
11655,GO:0046356,0.999999999993242,0.827316060772706,0,2,acetyl-CoA catabolic process,BP,
12177,GO:0048270,0.999999999993243,0.896564919749006,0,1,methionine adenosyltransferase regulator activity,MF,
10106,GO:0042602,0.999999999993254,0.929550645569883,0,1,riboflavin reductase (NADPH) activity,MF,
9948,GO:0042289,0.999999999993255,0.825968009384389,0,2,MHC class II protein binding,MF,
10587,GO:0043541,0.999999999993264,0.794554698561108,0,2,UDP-N-acetylglucosamine transferase complex,CC,
6977,GO:0030627,0.999999999993265,0.818294890247893,0,2,pre-mRNA 5'-splice site binding,MF,
7297,GO:0031289,0.99999999999327,0.892369649677356,0,1,actin phosphorylation,BP,
10585,GO:0043538,0.99999999999327,0.892369649677356,0,1,regulation of actin phosphorylation,BP,
6002,GO:0019008,0.999999999993279,0.808612665152719,0,2,molybdopterin synthase complex,CC,
5746,GO:0016890,0.999999999993304,0.806575667191597,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
3436,GO:0007228,0.999999999993318,0.7910881969104,0,2,positive regulation of hh target transcription factor activity,BP,
17252,GO:0110021,0.999999999993365,0.798318789662838,0,2,cardiac muscle myoblast proliferation,BP,
17253,GO:0110022,0.999999999993365,0.798318789662838,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17254,GO:0110024,0.999999999993365,0.798318789662838,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
18397,GO:1903371,0.999999999993381,0.627669213967477,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19007,GO:1904762,0.999999999993382,0.889701420439392,0,1,positive regulation of myofibroblast differentiation,BP,
13654,GO:0060129,0.999999999993402,0.793873412680326,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
7013,GO:0030692,0.999999999993409,0.806616618243923,0,2,Noc4p-Nop14p complex,CC,
2068,GO:0004819,0.999999999993419,0.794488193406968,0,2,glutamine-tRNA ligase activity,MF,
2914,GO:0006425,0.999999999993419,0.794488193406968,0,2,glutaminyl-tRNA aminoacylation,BP,
595,GO:0001757,0.999999999993431,0.792085286858016,0,2,somite specification,BP,
1037,GO:0002543,0.999999999993441,0.794942021109513,0,2,activation of blood coagulation via clotting cascade,BP,
17981,GO:1902309,0.999999999993446,0.799445555631412,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
16929,GO:0098871,0.999999999993447,0.90245010356123,0,1,postsynaptic actin cytoskeleton,CC,
17095,GO:0099571,0.999999999993447,0.90245010356123,0,1,postsynaptic cytoskeleton,CC,
19176,GO:1905150,0.999999999993453,0.789741077825904,0,2,regulation of voltage-gated sodium channel activity,BP,
20106,GO:2000721,0.999999999993466,0.888790756916611,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
9888,GO:0042144,0.999999999993466,0.794221399181864,0,2,vacuole fusion, non-autophagic,BP,
16691,GO:0097576,0.999999999993466,0.794221399181864,0,2,vacuole fusion,BP,
1774,GO:0004376,0.999999999993468,0.639188260589019,0,4,glycolipid mannosyltransferase activity,MF,
347,GO:0000960,0.999999999993486,0.630168439220981,0,4,regulation of mitochondrial RNA catabolic process,BP,
112,GO:0000229,0.999999999993495,0.90467143971868,0,1,cytoplasmic chromosome,CC,
127,GO:0000262,0.999999999993495,0.90467143971868,0,1,mitochondrial chromosome,CC,
7557,GO:0031862,0.999999999993522,0.790741373514864,0,2,prostanoid receptor binding,MF,
14111,GO:0060916,0.999999999993539,0.62682290835355,0,4,mesenchymal cell proliferation involved in lung development,BP,
9228,GO:0035608,0.999999999993543,0.793776100852975,0,2,protein deglutamylation,BP,
5448,GO:0016312,0.999999999993543,0.631799751903506,0,4,inositol bisphosphate phosphatase activity,MF,
19471,GO:1990072,0.999999999993567,0.833290380922816,0,2,TRAPPIII protein complex,CC,
9691,GO:0038052,0.999999999993571,0.794294270049665,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9226,GO:0035606,0.999999999993581,0.859633592442259,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9159,GO:0035504,0.999999999993584,0.907081780204713,0,1,regulation of myosin light chain kinase activity,BP,
9160,GO:0035505,0.999999999993584,0.907081780204713,0,1,positive regulation of myosin light chain kinase activity,BP,
10343,GO:0043126,0.999999999993584,0.907081780204713,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10344,GO:0043128,0.999999999993584,0.907081780204713,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
9800,GO:0040009,0.999999999993613,0.627450244073819,0,4,regulation of growth rate,BP,
16544,GO:0097238,0.999999999993662,0.842824490276869,0,2,cellular response to methylglyoxal,BP,
13900,GO:0060510,0.99999999999369,0.813534397580187,0,2,Type II pneumocyte differentiation,BP,
13896,GO:0060501,0.999999999993704,0.633546118093674,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
10748,GO:0044105,0.999999999993731,0.930603811497527,0,1,L-xylulose reductase (NAD+) activity,MF,
12455,GO:0050038,0.999999999993731,0.930603811497527,0,1,L-xylulose reductase (NADP+) activity,MF,
20081,GO:2000670,0.999999999993741,0.79272251816012,0,2,positive regulation of dendritic cell apoptotic process,BP,
8548,GO:0033867,0.999999999993741,0.903511540248298,0,1,Fas-activated serine/threonine kinase activity,MF,
19374,GO:1905696,0.999999999993746,0.789592786669703,0,2,regulation of polysome binding,BP,
19213,GO:1905258,0.99999999999377,0.839279396124414,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19214,GO:1905259,0.99999999999377,0.839279396124414,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
6380,GO:0021562,0.999999999993774,0.627459670460058,0,4,vestibulocochlear nerve development,BP,
11947,GO:0046977,0.99999999999378,0.646308708126996,0,4,TAP binding,MF,
11948,GO:0046978,0.99999999999378,0.646308708126996,0,4,TAP1 binding,MF,
9018,GO:0035175,0.999999999993821,0.902119971118483,0,1,histone kinase activity (H3-S10 specific),MF,
15777,GO:0072354,0.999999999993821,0.902119971118483,0,1,histone kinase activity (H3-T3 specific),MF,
15778,GO:0072355,0.999999999993821,0.902119971118483,0,1,histone H3-T3 phosphorylation,BP,
3645,GO:0008119,0.999999999993834,0.891768970658077,0,1,thiopurine S-methyltransferase activity,MF,
8309,GO:0033133,0.999999999993842,0.664207444964557,0,4,positive regulation of glucokinase activity,BP,
17236,GO:0106073,0.99999999999389,0.792570152081036,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
15238,GO:0071374,0.999999999993911,0.792562284878731,0,2,cellular response to parathyroid hormone stimulus,BP,
15739,GO:0072284,0.999999999993914,0.635638638035568,0,4,metanephric S-shaped body morphogenesis,BP,
18567,GO:1903748,0.999999999993946,0.641954118118254,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
5118,GO:0015440,0.999999999993946,0.630346611572,0,4,peptide-transporting ATPase activity,MF,
8362,GO:0033220,0.999999999993946,0.630346611572,0,4,amide-transporting ATPase activity,MF,
17518,GO:1900453,0.999999999993958,0.810523448319777,0,2,negative regulation of long term synaptic depression,BP,
7419,GO:0031501,0.999999999993973,0.708146639006767,0,4,mannosyltransferase complex,CC,
1864,GO:0004525,0.999999999994028,0.635536466762127,0,4,ribonuclease III activity,MF,
7778,GO:0032296,0.999999999994028,0.635536466762127,0,4,double-stranded RNA-specific ribonuclease activity,MF,
1501,GO:0003844,0.999999999994028,0.892185655573395,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17188,GO:0102752,0.999999999994028,0.892185655573395,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
3641,GO:0008113,0.999999999994031,0.827558426533849,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
8993,GO:0035093,0.999999999994057,0.789239496425427,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
19108,GO:1904970,0.999999999994073,0.795525462218189,0,2,brush border assembly,BP,
11078,GO:0045062,0.999999999994075,0.902140364403799,0,1,extrathymic T cell selection,BP,
15080,GO:0071021,0.999999999994075,0.902140364403799,0,1,U2-type post-spliceosomal complex,CC,
1751,GO:0004348,0.999999999994077,0.796539379956703,0,2,glucosylceramidase activity,MF,
11060,GO:0045027,0.999999999994087,0.896413289802951,0,1,DNA end binding,MF,
11541,GO:0046041,0.999999999994113,0.821887963557753,0,2,ITP metabolic process,BP,
14493,GO:0061880,0.99999999999412,0.902284014587746,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14494,GO:0061881,0.99999999999412,0.902284014587746,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14454,GO:0061752,0.999999999994121,0.802641803117456,0,2,telomeric repeat-containing RNA binding,MF,
12225,GO:0048388,0.999999999994155,0.808436870092813,0,2,endosomal lumen acidification,BP,
10241,GO:0042923,0.999999999994159,0.804741939997421,0,2,neuropeptide binding,MF,
16947,GO:0098904,0.999999999994162,0.797492521044027,0,2,regulation of AV node cell action potential,BP,
3864,GO:0008482,0.999999999994163,0.894680386184867,0,1,sulfite oxidase activity,MF,
9878,GO:0042128,0.999999999994163,0.894680386184867,0,1,nitrate assimilation,BP,
2633,GO:0005960,0.999999999994169,0.807270784077119,0,2,glycine cleavage complex,CC,
9333,GO:0035800,0.999999999994203,0.810312658265456,0,2,deubiquitinase activator activity,MF,
19794,GO:2000158,0.999999999994203,0.810312658265456,0,2,positive regulation of ubiquitin-specific protease activity,BP,
3872,GO:0008495,0.999999999994235,0.892504776010405,0,1,protoheme IX farnesyltransferase activity,MF,
12097,GO:0048033,0.999999999994235,0.892504776010405,0,1,heme o metabolic process,BP,
12098,GO:0048034,0.999999999994235,0.892504776010405,0,1,heme O biosynthetic process,BP,
18497,GO:1903569,0.999999999994243,0.894494389454732,0,1,positive regulation of protein localization to ciliary membrane,BP,
11741,GO:0046533,0.999999999994244,0.633142100924525,0,4,negative regulation of photoreceptor cell differentiation,BP,
5220,GO:0015820,0.999999999994259,0.795800475465558,0,2,leucine transport,BP,
19026,GO:1904799,0.999999999994271,0.889802160425812,0,1,regulation of neuron remodeling,BP,
19027,GO:1904800,0.999999999994271,0.889802160425812,0,1,negative regulation of neuron remodeling,BP,
19799,GO:2000173,0.999999999994271,0.889802160425812,0,1,negative regulation of branching morphogenesis of a nerve,BP,
16572,GO:0097325,0.999999999994307,0.79337288620498,0,2,melanocyte proliferation,BP,
13423,GO:0052739,0.999999999994328,0.8967423903861,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13424,GO:0052740,0.999999999994328,0.8967423903861,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18906,GO:1904550,0.999999999994328,0.8967423903861,0,1,response to arachidonic acid,BP,
19886,GO:2000324,0.999999999994328,0.8967423903861,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
9645,GO:0036505,0.999999999994332,0.892637688424923,0,1,prosaposin receptor activity,MF,
6522,GO:0021896,0.999999999994348,0.789252352939468,0,2,forebrain astrocyte differentiation,BP,
6523,GO:0021897,0.999999999994348,0.789252352939468,0,2,forebrain astrocyte development,BP,
16868,GO:0098758,0.999999999994358,0.797541934888878,0,2,response to interleukin-8,BP,
16869,GO:0098759,0.999999999994358,0.797541934888878,0,2,cellular response to interleukin-8,BP,
7593,GO:0031956,0.999999999994364,0.627395435202997,0,4,medium-chain fatty acid-CoA ligase activity,MF,
17168,GO:0102391,0.999999999994364,0.627395435202997,0,4,decanoate-CoA ligase activity,MF,
12772,GO:0051021,0.999999999994375,0.639608583891725,0,4,GDP-dissociation inhibitor binding,MF,
12773,GO:0051022,0.999999999994375,0.639608583891725,0,4,Rho GDP-dissociation inhibitor binding,MF,
8473,GO:0033604,0.999999999994405,0.792761353142979,0,2,negative regulation of catecholamine secretion,BP,
1838,GO:0004490,0.999999999994405,0.904767523014245,0,1,methylglutaconyl-CoA hydratase activity,MF,
12453,GO:0050011,0.999999999994405,0.904767523014245,0,1,itaconyl-CoA hydratase activity,MF,
13687,GO:0060187,0.999999999994483,0.78953343100565,0,2,cell pole,CC,
14890,GO:0070662,0.999999999994498,0.792735470148529,0,2,mast cell proliferation,BP,
14894,GO:0070666,0.999999999994498,0.792735470148529,0,2,regulation of mast cell proliferation,BP,
14896,GO:0070668,0.999999999994498,0.792735470148529,0,2,positive regulation of mast cell proliferation,BP,
1947,GO:0004647,0.999999999994503,0.804348162804059,0,2,phosphoserine phosphatase activity,MF,
14685,GO:0070278,0.999999999994513,0.798108589823837,0,2,extracellular matrix constituent secretion,BP,
9991,GO:0042374,0.999999999994516,0.820239108920181,0,2,phylloquinone metabolic process,BP,
9992,GO:0042376,0.999999999994516,0.820239108920181,0,2,phylloquinone catabolic process,BP,
17757,GO:1901662,0.999999999994516,0.820239108920181,0,2,quinone catabolic process,BP,
18116,GO:1902715,0.999999999994539,0.789344227890839,0,2,positive regulation of interferon-gamma secretion,BP,
1414,GO:0003345,0.999999999994564,0.890002988761977,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
10081,GO:0042567,0.999999999994567,0.793810276242265,0,2,insulin-like growth factor ternary complex,CC,
15493,GO:0071819,0.999999999994592,0.839313849866492,0,2,DUBm complex,CC,
189,GO:0000406,0.999999999994593,0.79279637038945,0,2,double-strand/single-strand DNA junction binding,MF,
7707,GO:0032181,0.999999999994593,0.79279637038945,0,2,dinucleotide repeat insertion binding,MF,
7783,GO:0032302,0.999999999994593,0.79279637038945,0,2,MutSbeta complex,CC,
1268,GO:0003025,0.999999999994599,0.795723926866327,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
18957,GO:1904674,0.999999999994602,0.793360788018718,0,2,positive regulation of somatic stem cell population maintenance,BP,
168,GO:0000349,0.999999999994616,0.79921820504721,0,2,generation of catalytic spliceosome for first transesterification step,BP,
6520,GO:0021894,0.999999999994626,0.921406223047397,0,1,cerebral cortex GABAergic interneuron development,BP,
14460,GO:0061763,0.999999999994646,0.797716789366341,0,2,multivesicular body-lysosome fusion,BP,
4941,GO:0014900,0.999999999994648,0.645238799108859,0,4,muscle hyperplasia,BP,
16530,GO:0097212,0.999999999994653,0.803739459849365,0,2,lysosomal membrane organization,BP,
2079,GO:0004830,0.999999999994671,0.797738068269044,0,2,tryptophan-tRNA ligase activity,MF,
2925,GO:0006436,0.999999999994671,0.797738068269044,0,2,tryptophanyl-tRNA aminoacylation,BP,
17235,GO:0106072,0.999999999994671,0.798964861789367,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
14221,GO:0061110,0.999999999994681,0.791160390566724,0,2,dense core granule biogenesis,BP,
20101,GO:2000705,0.999999999994681,0.791160390566724,0,2,regulation of dense core granule biogenesis,BP,
3341,GO:0007060,0.999999999994685,0.798194716652599,0,2,male meiosis chromosome segregation,BP,
18702,GO:1904021,0.999999999994688,0.891280294871713,0,1,negative regulation of G-protein coupled receptor internalization,BP,
16844,GO:0098706,0.999999999994689,0.626436649086232,0,4,ferric iron import across plasma membrane,BP,
3973,GO:0008781,0.999999999994703,0.824800376031183,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
1763,GO:0004363,0.999999999994729,0.898717656825458,0,1,glutathione synthase activity,MF,
15117,GO:0071139,0.999999999994736,0.793836595166412,0,2,resolution of recombination intermediates,BP,
15118,GO:0071140,0.999999999994736,0.793836595166412,0,2,resolution of mitotic recombination intermediates,BP,
1825,GO:0004475,0.999999999994745,0.904433349685492,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
4001,GO:0008905,0.999999999994745,0.904433349685492,0,1,mannose-phosphate guanylyltransferase activity,MF,
1953,GO:0004654,0.999999999994751,0.8887790248913,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16367,GO:0090616,0.999999999994751,0.8887790248913,0,1,mitochondrial mRNA 3'-end processing,BP,
16532,GO:0097222,0.999999999994751,0.8887790248913,0,1,mitochondrial mRNA polyadenylation,BP,
6484,GO:0021824,0.999999999994756,0.794199687030269,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6488,GO:0021828,0.999999999994756,0.794199687030269,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6499,GO:0021856,0.999999999994756,0.794199687030269,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13818,GO:0060385,0.999999999994756,0.794199687030269,0,2,axonogenesis involved in innervation,BP,
18399,GO:1903375,0.999999999994756,0.794199687030269,0,2,facioacoustic ganglion development,BP,
3556,GO:0007598,0.999999999994765,0.894582715421058,0,1,blood coagulation, extrinsic pathway,BP,
17603,GO:1901202,0.999999999994765,0.894582715421058,0,1,negative regulation of extracellular matrix assembly,BP,
18412,GO:1903394,0.999999999994765,0.894582715421058,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
9642,GO:0036501,0.999999999994767,0.889021549339244,0,1,UFD1-NPL4 complex,CC,
3742,GO:0008281,0.999999999994779,0.88868931840466,0,1,sulfonylurea receptor activity,MF,
6335,GO:0021501,0.999999999994785,0.896559947689031,0,1,prechordal plate formation,BP,
6369,GO:0021547,0.999999999994785,0.896559947689031,0,1,midbrain-hindbrain boundary initiation,BP,
20120,GO:2000742,0.999999999994785,0.896559947689031,0,1,regulation of anterior head development,BP,
20121,GO:2000744,0.999999999994785,0.896559947689031,0,1,positive regulation of anterior head development,BP,
18254,GO:1903031,0.999999999994806,0.803491913088286,0,2,regulation of microtubule plus-end binding,BP,
18255,GO:1903033,0.999999999994806,0.803491913088286,0,2,positive regulation of microtubule plus-end binding,BP,
8387,GO:0033278,0.999999999994832,0.628244168121529,0,4,cell proliferation in midbrain,BP,
15654,GO:0072134,0.999999999994833,0.790337790973571,0,2,nephrogenic mesenchyme morphogenesis,BP,
18033,GO:1902480,0.999999999994851,0.894223959250812,0,1,protein localization to mitotic spindle,BP,
377,GO:0001007,0.999999999994919,0.631070400398398,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
4667,GO:0010813,0.999999999994924,0.806513790243356,0,2,neuropeptide catabolic process,BP,
8596,GO:0034087,0.999999999994933,0.791374448846607,0,2,establishment of mitotic sister chromatid cohesion,BP,
16207,GO:0090210,0.999999999994954,0.794072519679562,0,2,regulation of establishment of blood-brain barrier,BP,
15106,GO:0071074,0.999999999994983,0.898646278361839,0,1,eukaryotic initiation factor eIF2 binding,MF,
18539,GO:1903674,0.999999999994983,0.898646278361839,0,1,regulation of cap-dependent translational initiation,BP,
18540,GO:1903676,0.999999999994983,0.898646278361839,0,1,positive regulation of cap-dependent translational initiation,BP,
11615,GO:0046203,0.999999999995009,0.827286071902231,0,2,spermidine catabolic process,BP,
11323,GO:0045626,0.999999999995011,0.794575452047224,0,2,negative regulation of T-helper 1 cell differentiation,BP,
9174,GO:0035521,0.999999999995029,0.631949325816724,0,4,monoubiquitinated histone deubiquitination,BP,
9175,GO:0035522,0.999999999995029,0.631949325816724,0,4,monoubiquitinated histone H2A deubiquitination,BP,
5824,GO:0017089,0.99999999999503,0.803060126448477,0,2,glycolipid transporter activity,MF,
12003,GO:0047323,0.999999999995031,0.896125196626514,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13365,GO:0052381,0.999999999995031,0.896125196626514,0,1,tRNA dimethylallyltransferase activity,MF,
1669,GO:0004127,0.999999999995033,0.796945487376445,0,2,cytidylate kinase activity,MF,
13109,GO:0051599,0.999999999995038,0.631371696489317,0,4,response to hydrostatic pressure,BP,
2158,GO:0004979,0.999999999995044,0.899344831305052,0,1,beta-endorphin receptor activity,MF,
7478,GO:0031635,0.999999999995044,0.899344831305052,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7673,GO:0032097,0.999999999995044,0.899344831305052,0,1,positive regulation of response to food,BP,
7676,GO:0032100,0.999999999995044,0.899344831305052,0,1,positive regulation of appetite,BP,
9688,GO:0038047,0.999999999995044,0.899344831305052,0,1,morphine receptor activity,MF,
11734,GO:0046521,0.999999999995044,0.899344831305052,0,1,sphingoid catabolic process,BP,
14303,GO:0061358,0.999999999995044,0.899344831305052,0,1,negative regulation of Wnt protein secretion,BP,
8850,GO:0034635,0.999999999995054,0.797282120930515,0,2,glutathione transport,BP,
10244,GO:0042939,0.999999999995054,0.797282120930515,0,2,tripeptide transport,BP,
3419,GO:0007206,0.999999999995054,0.889285059908566,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
15467,GO:0071765,0.999999999995054,0.889285059908566,0,1,nuclear inner membrane organization,BP,
13835,GO:0060406,0.99999999999507,0.79322638068996,0,2,positive regulation of penile erection,BP,
7228,GO:0031117,0.999999999995079,0.796958667199301,0,2,positive regulation of microtubule depolymerization,BP,
14945,GO:0070780,0.99999999999508,0.817029412291652,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
6820,GO:0030274,0.999999999995083,0.635282641109585,0,4,LIM domain binding,MF,
1590,GO:0003998,0.999999999995089,0.859688617750506,0,2,acylphosphatase activity,MF,
4835,GO:0014038,0.999999999995094,0.715608546474314,0,3,regulation of Schwann cell differentiation,BP,
1721,GO:0004310,0.999999999995097,0.896346489269109,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7170,GO:0031038,0.999999999995097,0.896346489269109,0,1,myosin II filament organization,BP,
10572,GO:0043519,0.999999999995097,0.896346489269109,0,1,regulation of myosin II filament organization,BP,
13314,GO:0051996,0.999999999995097,0.896346489269109,0,1,squalene synthase activity,MF,
6542,GO:0021943,0.999999999995111,0.628187767628712,0,4,formation of radial glial scaffolds,BP,
315,GO:0000827,0.999999999995129,0.639938782328418,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,0.999999999995129,0.639938782328418,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,0.999999999995129,0.639938782328418,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,0.999999999995129,0.639938782328418,0,4,inositol hexakisphosphate 5-kinase activity,MF,
13418,GO:0052723,0.999999999995129,0.639938782328418,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13419,GO:0052724,0.999999999995129,0.639938782328418,0,4,inositol hexakisphosphate 3-kinase activity,MF,
9172,GO:0035519,0.99999999999516,0.687136186514267,0,4,protein K29-linked ubiquitination,BP,
20261,GO:2001168,0.999999999995177,0.628912429407792,0,4,positive regulation of histone H2B ubiquitination,BP,
2139,GO:0004947,0.999999999995182,0.812364396417502,0,2,bradykinin receptor activity,MF,
5466,GO:0016344,0.999999999995191,0.794874500852328,0,2,meiotic chromosome movement towards spindle pole,BP,
14024,GO:0060720,0.999999999995206,0.823561587890797,0,2,spongiotrophoblast cell proliferation,BP,
14025,GO:0060721,0.999999999995206,0.823561587890797,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14026,GO:0060722,0.999999999995206,0.823561587890797,0,2,cell proliferation involved in embryonic placenta development,BP,
14027,GO:0060723,0.999999999995206,0.823561587890797,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
16209,GO:0090214,0.999999999995206,0.823561587890797,0,2,spongiotrophoblast layer developmental growth,BP,
18178,GO:1902896,0.999999999995206,0.794290564308181,0,2,terminal web assembly,BP,
16732,GO:0097698,0.999999999995208,0.907323775203715,0,1,telomere maintenance via base-excision repair,BP,
12166,GO:0048257,0.999999999995208,0.798424331478727,0,2,3'-flap endonuclease activity,MF,
5826,GO:0017095,0.999999999995214,0.790935737653148,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
1054,GO:0002579,0.999999999995216,0.669074915076455,0,4,positive regulation of antigen processing and presentation,BP,
4214,GO:0009368,0.999999999995224,0.82120394547847,0,2,endopeptidase Clp complex,CC,
7569,GO:0031906,0.999999999995235,0.809491079432316,0,2,late endosome lumen,CC,
16648,GO:0097486,0.999999999995235,0.809491079432316,0,2,multivesicular body lumen,CC,
3353,GO:0007089,0.999999999995263,0.637656116670755,0,4,traversing start control point of mitotic cell cycle,BP,
17453,GO:1900195,0.999999999995281,0.804115526708864,0,2,positive regulation of oocyte maturation,BP,
14865,GO:0070611,0.999999999995286,0.893482466597974,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14866,GO:0070612,0.999999999995286,0.893482466597974,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
7895,GO:0032458,0.999999999995287,0.889996842974934,0,1,slow endocytic recycling,BP,
5473,GO:0016403,0.999999999995296,0.811372680039288,0,2,dimethylargininase activity,MF,
18769,GO:1904210,0.999999999995306,0.910314880317263,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18786,GO:1904239,0.999999999995306,0.910314880317263,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18787,GO:1904240,0.999999999995306,0.910314880317263,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19034,GO:1904815,0.999999999995309,0.802078520778383,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
1822,GO:0004470,0.999999999995333,0.648198792450517,0,4,malic enzyme activity,MF,
9412,GO:0035962,0.999999999995337,0.890083943312109,0,1,response to interleukin-13,BP,
9413,GO:0035963,0.999999999995337,0.890083943312109,0,1,cellular response to interleukin-13,BP,
12479,GO:0050277,0.999999999995337,0.890083943312109,0,1,sedoheptulokinase activity,MF,
15545,GO:0071914,0.999999999995337,0.890083943312109,0,1,prominosome,CC,
20129,GO:2000759,0.999999999995375,0.888572422144747,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20130,GO:2000761,0.999999999995375,0.888572422144747,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
9764,GO:0039506,0.999999999995385,0.793502303534335,0,2,modulation by virus of host molecular function,BP,
9765,GO:0039507,0.999999999995385,0.793502303534335,0,2,suppression by virus of host molecular function,BP,
13325,GO:0052055,0.999999999995385,0.793502303534335,0,2,modulation by symbiont of host molecular function,BP,
13326,GO:0052056,0.999999999995385,0.793502303534335,0,2,negative regulation by symbiont of host molecular function,BP,
2121,GO:0004909,0.99999999999539,0.797792055351946,0,2,interleukin-1, Type I, activating receptor activity,MF,
14511,GO:0061944,0.999999999995402,0.889096792495047,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15057,GO:0070985,0.999999999995406,0.825306471023925,0,2,TFIIK complex,CC,
17875,GO:1902038,0.999999999995419,0.891191009057115,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17955,GO:1902257,0.999999999995419,0.891191009057115,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
1430,GO:0003400,0.999999999995423,0.895814943482458,0,1,regulation of COPII vesicle coating,BP,
2208,GO:0005090,0.999999999995423,0.895814943482458,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13976,GO:0060661,0.999999999995423,0.895814943482458,0,1,submandibular salivary gland formation,BP,
15210,GO:0071335,0.999999999995423,0.895814943482458,0,1,hair follicle cell proliferation,BP,
15211,GO:0071336,0.999999999995423,0.895814943482458,0,1,regulation of hair follicle cell proliferation,BP,
15212,GO:0071338,0.999999999995423,0.895814943482458,0,1,positive regulation of hair follicle cell proliferation,BP,
16141,GO:0090113,0.999999999995423,0.895814943482458,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17000,GO:0099022,0.999999999995443,0.807279416980801,0,2,vesicle tethering,BP,
17004,GO:0099044,0.999999999995443,0.807279416980801,0,2,vesicle tethering to endoplasmic reticulum,BP,
19063,GO:1904877,0.999999999995454,0.896290050447912,0,1,positive regulation of DNA ligase activity,BP,
456,GO:0001300,0.999999999995457,0.795779982829826,0,2,chronological cell aging,BP,
1318,GO:0003163,0.999999999995462,0.789468549119403,0,2,sinoatrial node development,BP,
14113,GO:0060921,0.999999999995462,0.789468549119403,0,2,sinoatrial node cell differentiation,BP,
14118,GO:0060931,0.999999999995462,0.789468549119403,0,2,sinoatrial node cell development,BP,
18115,GO:1902714,0.999999999995467,0.797504671325763,0,2,negative regulation of interferon-gamma secretion,BP,
16590,GO:0097361,0.99999999999547,0.6627059668541,0,4,CIA complex,CC,
15655,GO:0072135,0.99999999999547,0.792489702240721,0,2,kidney mesenchymal cell proliferation,BP,
15656,GO:0072136,0.99999999999547,0.792489702240721,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
3961,GO:0008721,0.9999999999955,0.894000250400036,0,1,D-serine ammonia-lyase activity,MF,
5721,GO:0016855,0.9999999999955,0.894000250400036,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5906,GO:0018114,0.9999999999955,0.894000250400036,0,1,threonine racemase activity,MF,
6887,GO:0030378,0.9999999999955,0.894000250400036,0,1,serine racemase activity,MF,
9576,GO:0036361,0.9999999999955,0.894000250400036,0,1,racemase activity, acting on amino acids and derivatives,MF,
11676,GO:0046416,0.9999999999955,0.894000250400036,0,1,D-amino acid metabolic process,BP,
11681,GO:0046437,0.9999999999955,0.894000250400036,0,1,D-amino acid biosynthetic process,BP,
12041,GO:0047661,0.9999999999955,0.894000250400036,0,1,amino-acid racemase activity,MF,
14628,GO:0070178,0.9999999999955,0.894000250400036,0,1,D-serine metabolic process,BP,
14629,GO:0070179,0.9999999999955,0.894000250400036,0,1,D-serine biosynthetic process,BP,
2064,GO:0004815,0.9999999999955,0.797549609594978,0,2,aspartate-tRNA ligase activity,MF,
1317,GO:0003162,0.999999999995513,0.789235848066954,0,2,atrioventricular node development,BP,
19985,GO:2000501,0.999999999995516,0.821964386109138,0,2,regulation of natural killer cell chemotaxis,BP,
19986,GO:2000503,0.999999999995516,0.821964386109138,0,2,positive regulation of natural killer cell chemotaxis,BP,
4864,GO:0014701,0.999999999995518,0.62497443261947,0,4,junctional sarcoplasmic reticulum membrane,CC,
16558,GO:0097278,0.999999999995551,0.798164319648892,0,2,complement-dependent cytotoxicity,BP,
18106,GO:1902683,0.999999999995553,0.795837632402163,0,2,regulation of receptor localization to synapse,BP,
1606,GO:0004022,0.999999999995553,0.893459842115807,0,1,alcohol dehydrogenase (NAD) activity,MF,
5978,GO:0018467,0.999999999995553,0.893459842115807,0,1,formaldehyde dehydrogenase activity,MF,
13259,GO:0051903,0.999999999995553,0.893459842115807,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13367,GO:0052405,0.999999999995564,0.673743448802309,0,4,negative regulation by host of symbiont molecular function,BP,
18349,GO:1903276,0.999999999995573,0.80875493622573,0,2,regulation of sodium ion export across plasma membrane,BP,
18350,GO:1903278,0.999999999995573,0.80875493622573,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18357,GO:1903288,0.999999999995573,0.80875493622573,0,2,positive regulation of potassium ion import,BP,
9305,GO:0035740,0.999999999995581,0.804222880498571,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
20011,GO:2000564,0.999999999995581,0.804222880498571,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
14692,GO:0070291,0.999999999995581,0.637726836618284,0,4,N-acylethanolamine metabolic process,BP,
15646,GO:0072126,0.999999999995604,0.641103883841218,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
1778,GO:0004382,0.999999999995619,0.799167667349522,0,2,guanosine-diphosphatase activity,MF,
5057,GO:0015252,0.999999999995627,0.892167987739641,0,1,proton channel activity,MF,
9137,GO:0035445,0.999999999995627,0.892167987739641,0,1,borate transmembrane transport,BP,
11835,GO:0046713,0.999999999995627,0.892167987739641,0,1,borate transport,BP,
11836,GO:0046715,0.999999999995627,0.892167987739641,0,1,active borate transmembrane transporter activity,MF,
18492,GO:1903564,0.999999999995661,0.629202160047148,0,4,regulation of protein localization to cilium,BP,
566,GO:0001705,0.999999999995665,0.792617330208417,0,2,ectoderm formation,BP,
573,GO:0001712,0.999999999995665,0.792617330208417,0,2,ectodermal cell fate commitment,BP,
914,GO:0002296,0.999999999995666,0.790416571589984,0,2,T-helper 1 cell lineage commitment,BP,
20244,GO:2001136,0.999999999995669,0.891468781978318,0,1,negative regulation of endocytic recycling,BP,
13394,GO:0052593,0.999999999995669,0.794925278950682,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13395,GO:0052594,0.999999999995669,0.794925278950682,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13396,GO:0052595,0.999999999995669,0.794925278950682,0,2,aliphatic-amine oxidase activity,MF,
13397,GO:0052596,0.999999999995669,0.794925278950682,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
5786,GO:0017005,0.999999999995679,0.890605360601191,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6446,GO:0021757,0.999999999995679,0.890605360601191,0,1,caudate nucleus development,BP,
6447,GO:0021758,0.999999999995679,0.890605360601191,0,1,putamen development,BP,
2529,GO:0005784,0.999999999995682,0.718131144684454,0,4,Sec61 translocon complex,CC,
15165,GO:0071256,0.999999999995682,0.718131144684454,0,4,translocon complex,CC,
6482,GO:0021822,0.999999999995742,0.896049636465189,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
3434,GO:0007225,0.999999999995745,0.888655810162412,0,1,patched ligand maturation,BP,
9251,GO:0035638,0.999999999995745,0.888655810162412,0,1,signal maturation,BP,
5918,GO:0018171,0.999999999995757,0.675738574732739,0,4,peptidyl-cysteine oxidation,BP,
13262,GO:0051908,0.999999999995758,0.891915654110893,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
4,GO:0000010,0.999999999995759,0.805342944539573,0,2,trans-hexaprenyltranstransferase activity,MF,
12490,GO:0050347,0.999999999995759,0.805342944539573,0,2,trans-octaprenyltranstransferase activity,MF,
861,GO:0002189,0.999999999995769,0.893791078328196,0,1,ribose phosphate diphosphokinase complex,CC,
8116,GO:0032796,0.999999999995772,0.803070877767672,0,2,uropod organization,BP,
4280,GO:0009644,0.999999999995773,0.796519762923568,0,2,response to high light intensity,BP,
18289,GO:1903116,0.999999999995779,0.791478426441158,0,2,positive regulation of actin filament-based movement,BP,
18588,GO:1903781,0.999999999995779,0.791478426441158,0,2,positive regulation of cardiac conduction,BP,
18669,GO:1903949,0.999999999995779,0.791478426441158,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
14329,GO:0061443,0.999999999995779,0.792987103389226,0,2,endocardial cushion cell differentiation,BP,
9107,GO:0035370,0.999999999995813,0.799695609361547,0,2,UBC13-UEV1A complex,CC,
2123,GO:0004913,0.999999999995825,0.894395134236975,0,1,interleukin-4 receptor activity,MF,
9274,GO:0035686,0.999999999995841,0.751457285540119,0,3,sperm fibrous sheath,CC,
2238,GO:0005142,0.999999999995876,0.894572129736489,0,1,interleukin-11 receptor binding,MF,
5846,GO:0017133,0.999999999995876,0.894572129736489,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10669,GO:0043783,0.999999999995876,0.894572129736489,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11188,GO:0045251,0.999999999995876,0.894572129736489,0,1,electron transfer flavoprotein complex,CC,
1732,GO:0004324,0.99999999999588,0.89884787651548,0,1,ferredoxin-NADP+ reductase activity,MF,
4966,GO:0015039,0.99999999999588,0.89884787651548,0,1,NADPH-adrenodoxin reductase activity,MF,
5647,GO:0016730,0.99999999999588,0.89884787651548,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5648,GO:0016731,0.99999999999588,0.89884787651548,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
297,GO:0000801,0.999999999995894,0.889397070899369,0,1,central element,CC,
15505,GO:0071847,0.999999999995904,0.792996496213086,0,2,TNFSF11-mediated signaling pathway,BP,
17543,GO:1900825,0.999999999995909,0.655645015122871,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
11011,GO:0044805,0.999999999995916,0.791037502516131,0,2,late nucleophagy,BP,
6374,GO:0021555,0.999999999995921,0.807037069914704,0,2,midbrain-hindbrain boundary morphogenesis,BP,
19343,GO:1905590,0.999999999995948,0.892126677926448,0,1,fibronectin fibril organization,BP,
19890,GO:2000329,0.999999999995948,0.892126677926448,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
8553,GO:0033878,0.999999999995949,0.890160349571645,0,1,hormone-sensitive lipase activity,MF,
1508,GO:0003860,0.999999999995953,0.898401818101813,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
5309,GO:0016012,0.999999999995981,0.802069263581668,0,2,sarcoglycan complex,CC,
2294,GO:0005250,0.999999999996003,0.888674963504101,0,1,A-type (transient outward) potassium channel activity,MF,
7535,GO:0031752,0.999999999996005,0.789804992796026,0,2,D5 dopamine receptor binding,MF,
1549,GO:0003941,0.999999999996015,0.813442575135338,0,2,L-serine ammonia-lyase activity,MF,
1300,GO:0003130,0.999999999996025,0.803499525202967,0,2,BMP signaling pathway involved in heart induction,BP,
1302,GO:0003133,0.999999999996025,0.803499525202967,0,2,endodermal-mesodermal cell signaling,BP,
1303,GO:0003134,0.999999999996025,0.803499525202967,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
15658,GO:0072138,0.999999999996025,0.803499525202967,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
20254,GO:2001151,0.999999999996029,0.891858849895576,0,1,regulation of renal water transport,BP,
20255,GO:2001153,0.999999999996029,0.891858849895576,0,1,positive regulation of renal water transport,BP,
5977,GO:0018455,0.999999999996038,0.913667613793382,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19537,GO:1990384,0.999999999996038,0.913667613793382,0,1,hyaloid vascular plexus regression,BP,
10713,GO:0043990,0.999999999996052,0.892229723553353,0,1,histone H2A-S1 phosphorylation,BP,
12055,GO:0047757,0.999999999996059,0.790360482768109,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
118,GO:0000246,0.999999999996073,0.889166990677439,0,1,delta24(24-1) sterol reductase activity,MF,
12524,GO:0050614,0.999999999996073,0.889166990677439,0,1,delta24-sterol reductase activity,MF,
16326,GO:0090461,0.999999999996073,0.889166990677439,0,1,glutamate homeostasis,BP,
4593,GO:0010698,0.999999999996074,0.839698821625716,0,2,acetyltransferase activator activity,MF,
2273,GO:0005212,0.999999999996107,0.671879245003536,0,4,structural constituent of eye lens,MF,
13565,GO:0060005,0.999999999996109,0.790110169293893,0,2,vestibular reflex,BP,
19295,GO:1905448,0.999999999996111,0.668785889525981,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
11807,GO:0046657,0.999999999996136,0.825108699442178,0,2,folic acid catabolic process,BP,
1898,GO:0004578,0.999999999996153,0.889841380109126,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6053,GO:0019187,0.999999999996153,0.889841380109126,0,1,beta-1,4-mannosyltransferase activity,MF,
12782,GO:0051032,0.999999999996153,0.889841380109126,0,1,nucleic acid transmembrane transporter activity,MF,
12783,GO:0051033,0.999999999996153,0.889841380109126,0,1,RNA transmembrane transporter activity,MF,
12996,GO:0051379,0.99999999999617,0.802768361082773,0,2,epinephrine binding,MF,
11157,GO:0045188,0.999999999996176,0.804954065496158,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
7015,GO:0030696,0.999999999996189,0.892030366178486,0,1,tRNA (m5U54) methyltransferase activity,MF,
7016,GO:0030697,0.999999999996189,0.892030366178486,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
10180,GO:0042758,0.999999999996196,0.64427387859488,0,4,long-chain fatty acid catabolic process,BP,
2372,GO:0005497,0.99999999999621,0.836995514962706,0,2,androgen binding,MF,
1571,GO:0003975,0.999999999996211,0.896010218358152,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4007,GO:0008963,0.999999999996211,0.896010218358152,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
5169,GO:0015712,0.999999999996211,0.642694339541822,0,4,hexose phosphate transport,BP,
5189,GO:0015760,0.999999999996211,0.642694339541822,0,4,glucose-6-phosphate transport,BP,
215,GO:0000448,0.999999999996215,0.794588868758147,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
19470,GO:1990071,0.999999999996227,0.829177380926378,0,2,TRAPPII protein complex,CC,
1089,GO:0002674,0.999999999996232,0.663234379407338,0,4,negative regulation of acute inflammatory response,BP,
15337,GO:0071535,0.999999999996233,0.648219861224226,0,4,RING-like zinc finger domain binding,MF,
10727,GO:0044035,0.999999999996235,0.903680628251832,0,1,multi-organism catabolic process,BP,
10754,GO:0044115,0.999999999996235,0.903680628251832,0,1,development of symbiont involved in interaction with host,BP,
10761,GO:0044145,0.999999999996235,0.903680628251832,0,1,modulation of development of symbiont involved in interaction with host,BP,
10763,GO:0044147,0.999999999996235,0.903680628251832,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10978,GO:0044730,0.999999999996235,0.903680628251832,0,1,bone sialoprotein binding,MF,
13345,GO:0052214,0.999999999996235,0.903680628251832,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13346,GO:0052227,0.999999999996235,0.903680628251832,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13347,GO:0052229,0.999999999996235,0.903680628251832,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13359,GO:0052360,0.999999999996235,0.903680628251832,0,1,catabolism by host of symbiont macromolecule,BP,
13360,GO:0052361,0.999999999996235,0.903680628251832,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13361,GO:0052362,0.999999999996235,0.903680628251832,0,1,catabolism by host of symbiont protein,BP,
13362,GO:0052363,0.999999999996235,0.903680628251832,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13363,GO:0052364,0.999999999996235,0.903680628251832,0,1,catabolism by host of substance in symbiont,BP,
13368,GO:0052416,0.999999999996235,0.903680628251832,0,1,metabolism by host of symbiont macromolecule,BP,
13369,GO:0052417,0.999999999996235,0.903680628251832,0,1,metabolism by host of symbiont protein,BP,
13370,GO:0052418,0.999999999996235,0.903680628251832,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13371,GO:0052419,0.999999999996235,0.903680628251832,0,1,metabolism by host of substance in symbiont,BP,
19342,GO:1905581,0.999999999996235,0.903680628251832,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19347,GO:1905597,0.999999999996235,0.903680628251832,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19349,GO:1905599,0.999999999996235,0.903680628251832,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
7871,GO:0032427,0.999999999996241,0.796229890596081,0,2,GBD domain binding,MF,
5980,GO:0018479,0.999999999996263,0.896394098371598,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
17618,GO:1901252,0.999999999996269,0.823405976910222,0,2,regulation of intracellular transport of viral material,BP,
7516,GO:0031694,0.999999999996299,0.918920765875325,0,1,alpha-2A adrenergic receptor binding,MF,
17600,GO:1901193,0.999999999996299,0.918920765875325,0,1,regulation of formation of translation preinitiation complex,BP,
17601,GO:1901194,0.999999999996299,0.918920765875325,0,1,negative regulation of formation of translation preinitiation complex,BP,
18966,GO:1904689,0.999999999996299,0.918920765875325,0,1,negative regulation of cytoplasmic translational initiation,BP,
10525,GO:0043423,0.999999999996303,0.889078157003738,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19999,GO:2000537,0.999999999996303,0.889078157003738,0,1,regulation of B cell chemotaxis,BP,
20000,GO:2000538,0.999999999996303,0.889078157003738,0,1,positive regulation of B cell chemotaxis,BP,
17621,GO:1901255,0.999999999996307,0.803911588135102,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
10483,GO:0043366,0.999999999996323,0.798345920631606,0,2,beta selection,BP,
12488,GO:0050337,0.999999999996324,0.941612246961221,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
18968,GO:1904691,0.999999999996337,0.896152212491801,0,1,negative regulation of type B pancreatic cell proliferation,BP,
14627,GO:0070176,0.999999999996343,0.900434498865926,0,1,DRM complex,CC,
4736,GO:0010898,0.999999999996343,0.79659724321221,0,2,positive regulation of triglyceride catabolic process,BP,
575,GO:0001715,0.999999999996362,0.890066343469471,0,1,ectodermal cell fate specification,BP,
10139,GO:0042665,0.999999999996362,0.890066343469471,0,1,regulation of ectodermal cell fate specification,BP,
10140,GO:0042666,0.999999999996362,0.890066343469471,0,1,negative regulation of ectodermal cell fate specification,BP,
19928,GO:2000383,0.999999999996362,0.890066343469471,0,1,regulation of ectoderm development,BP,
19929,GO:2000384,0.999999999996362,0.890066343469471,0,1,negative regulation of ectoderm development,BP,
1796,GO:0004422,0.999999999996398,0.816993766975521,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2765,GO:0006178,0.999999999996398,0.816993766975521,0,2,guanine salvage,BP,
7754,GO:0032263,0.999999999996398,0.816993766975521,0,2,GMP salvage,BP,
11572,GO:0046099,0.999999999996398,0.816993766975521,0,2,guanine biosynthetic process,BP,
19250,GO:1905340,0.999999999996402,0.644125198112741,0,4,regulation of protein localization to kinetochore,BP,
19252,GO:1905342,0.999999999996402,0.644125198112741,0,4,positive regulation of protein localization to kinetochore,BP,
11398,GO:0045759,0.999999999996402,0.807034265079862,0,2,negative regulation of action potential,BP,
9626,GO:0036482,0.999999999996404,0.827633420492274,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18213,GO:1902958,0.999999999996404,0.827633420492274,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18405,GO:1903383,0.999999999996404,0.827633420492274,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18406,GO:1903384,0.999999999996404,0.827633420492274,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
5574,GO:0016586,0.999999999996414,0.789685228692746,0,2,RSC-type complex,CC,
7101,GO:0030891,0.999999999996415,0.669407862613798,0,4,VCB complex,CC,
5810,GO:0017061,0.999999999996425,0.88854500938138,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
16502,GO:0097167,0.999999999996428,0.639050079784256,0,4,circadian regulation of translation,BP,
17806,GO:1901842,0.999999999996429,0.813615614871707,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
1493,GO:0003828,0.999999999996431,0.790250078556616,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
17383,GO:1900062,0.999999999996435,0.890409187974551,0,1,regulation of replicative cell aging,BP,
2044,GO:0004784,0.999999999996438,0.703988475799394,0,4,superoxide dismutase activity,MF,
5639,GO:0016721,0.999999999996438,0.703988475799394,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6880,GO:0030366,0.999999999996439,0.821351989773795,0,2,molybdopterin synthase activity,MF,
1409,GO:0003340,0.99999999999645,0.793921186007414,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
20095,GO:2000697,0.99999999999645,0.793921186007414,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
16046,GO:0086048,0.999999999996464,0.791731767847717,0,2,membrane depolarization during bundle of His cell action potential,BP,
9897,GO:0042166,0.999999999996473,0.634429534908789,0,4,acetylcholine binding,MF,
3420,GO:0007207,0.999999999996473,0.800393192457854,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
981,GO:0002432,0.999999999996473,0.888988616778342,0,1,granuloma formation,BP,
8076,GO:0032741,0.999999999996502,0.792162172304324,0,2,positive regulation of interleukin-18 production,BP,
16216,GO:0090230,0.999999999996536,0.629119880841656,0,4,regulation of centromere complex assembly,BP,
3171,GO:0006784,0.99999999999655,0.792887714700772,0,2,heme a biosynthetic process,BP,
11602,GO:0046160,0.99999999999655,0.792887714700772,0,2,heme a metabolic process,BP,
12220,GO:0048382,0.999999999996556,0.794868093667594,0,2,mesendoderm development,BP,
10350,GO:0043137,0.999999999996565,0.660402291826335,0,4,DNA replication, removal of RNA primer,BP,
1655,GO:0004104,0.999999999996571,0.798754802925743,0,2,cholinesterase activity,MF,
8377,GO:0033265,0.999999999996571,0.798754802925743,0,2,choline binding,MF,
3723,GO:0008251,0.999999999996573,0.793526515306304,0,2,tRNA-specific adenosine deaminase activity,MF,
17403,GO:1900107,0.999999999996591,0.801091654539319,0,2,regulation of nodal signaling pathway,BP,
17430,GO:1900145,0.999999999996591,0.801091654539319,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17445,GO:1900175,0.999999999996591,0.801091654539319,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
6311,GO:0019948,0.999999999996598,0.798725388853632,0,2,SUMO activating enzyme activity,MF,
146,GO:0000298,0.999999999996601,0.650194319899706,0,4,endopolyphosphatase activity,MF,
3867,GO:0008486,0.999999999996601,0.650194319899706,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
5296,GO:0015961,0.999999999996601,0.650194319899706,0,4,diadenosine polyphosphate catabolic process,BP,
8767,GO:0034431,0.999999999996601,0.650194319899706,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8768,GO:0034432,0.999999999996601,0.650194319899706,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
13456,GO:0052840,0.999999999996601,0.650194319899706,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13457,GO:0052841,0.999999999996601,0.650194319899706,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13458,GO:0052842,0.999999999996601,0.650194319899706,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13459,GO:0052843,0.999999999996601,0.650194319899706,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13460,GO:0052844,0.999999999996601,0.650194319899706,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13461,GO:0052845,0.999999999996601,0.650194319899706,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13462,GO:0052846,0.999999999996601,0.650194319899706,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13463,GO:0052847,0.999999999996601,0.650194319899706,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13464,GO:0052848,0.999999999996601,0.650194319899706,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
15343,GO:0071543,0.999999999996601,0.650194319899706,0,4,diphosphoinositol polyphosphate metabolic process,BP,
17830,GO:1901906,0.999999999996601,0.650194319899706,0,4,diadenosine pentaphosphate metabolic process,BP,
17831,GO:1901907,0.999999999996601,0.650194319899706,0,4,diadenosine pentaphosphate catabolic process,BP,
17832,GO:1901908,0.999999999996601,0.650194319899706,0,4,diadenosine hexaphosphate metabolic process,BP,
17833,GO:1901909,0.999999999996601,0.650194319899706,0,4,diadenosine hexaphosphate catabolic process,BP,
17834,GO:1901910,0.999999999996601,0.650194319899706,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17835,GO:1901911,0.999999999996601,0.650194319899706,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
6486,GO:0021826,0.999999999996607,0.797343994854154,0,2,substrate-independent telencephalic tangential migration,BP,
6489,GO:0021830,0.999999999996607,0.797343994854154,0,2,interneuron migration from the subpallium to the cortex,BP,
6493,GO:0021843,0.999999999996607,0.797343994854154,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
15452,GO:0071707,0.999999999996608,0.914028946351398,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
6270,GO:0019860,0.999999999996615,0.807299916642701,0,2,uracil metabolic process,BP,
20282,GO:2001200,0.999999999996618,0.812533172585882,0,2,positive regulation of dendritic cell differentiation,BP,
6551,GO:0021966,0.999999999996627,0.888516018434557,0,1,corticospinal neuron axon guidance,BP,
6552,GO:0021972,0.999999999996627,0.888516018434557,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12725,GO:0050924,0.999999999996627,0.888516018434557,0,1,positive regulation of negative chemotaxis,BP,
12730,GO:0050929,0.999999999996627,0.888516018434557,0,1,induction of negative chemotaxis,BP,
15397,GO:0071623,0.999999999996627,0.888516018434557,0,1,negative regulation of granulocyte chemotaxis,BP,
16085,GO:0090024,0.999999999996627,0.888516018434557,0,1,negative regulation of neutrophil chemotaxis,BP,
16236,GO:0090260,0.999999999996627,0.888516018434557,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18089,GO:1902623,0.999999999996627,0.888516018434557,0,1,negative regulation of neutrophil migration,BP,
13333,GO:0052151,0.999999999996627,0.8175575795847,0,2,positive regulation by symbiont of host apoptotic process,BP,
13659,GO:0060139,0.999999999996627,0.8175575795847,0,2,positive regulation of apoptotic process by virus,BP,
4525,GO:0010585,0.999999999996632,0.898436234231038,0,1,glutamine secretion,BP,
18601,GO:1903803,0.999999999996632,0.898436234231038,0,1,L-glutamine import across plasma membrane,BP,
19772,GO:2000111,0.999999999996648,0.816940493298631,0,2,positive regulation of macrophage apoptotic process,BP,
12189,GO:0048295,0.999999999996666,0.801153196318571,0,2,positive regulation of isotype switching to IgE isotypes,BP,
647,GO:0001835,0.999999999996676,0.891765971571158,0,1,blastocyst hatching,BP,
9021,GO:0035188,0.999999999996676,0.891765971571158,0,1,hatching,BP,
15437,GO:0071684,0.999999999996676,0.891765971571158,0,1,organism emergence from protective structure,BP,
9745,GO:0038190,0.99999999999669,0.796495314371082,0,2,VEGF-activated neuropilin signaling pathway,BP,
17986,GO:1902336,0.99999999999669,0.796495314371082,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
9635,GO:0036493,0.9999999999967,0.714402535669307,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
1339,GO:0003193,0.999999999996704,0.89202739444784,0,1,pulmonary valve formation,BP,
9394,GO:0035922,0.999999999996704,0.89202739444784,0,1,foramen ovale closure,BP,
16042,GO:0086044,0.999999999996704,0.89202739444784,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16048,GO:0086054,0.999999999996704,0.89202739444784,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16049,GO:0086055,0.999999999996704,0.89202739444784,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16062,GO:0086076,0.999999999996704,0.89202739444784,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16064,GO:0086078,0.999999999996704,0.89202739444784,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16065,GO:0086079,0.999999999996704,0.89202739444784,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16949,GO:0098906,0.999999999996704,0.89202739444784,0,1,regulation of Purkinje myocyte action potential,BP,
19457,GO:1990029,0.999999999996704,0.89202739444784,0,1,vasomotion,BP,
18223,GO:1902977,0.999999999996712,0.898491649822189,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18311,GO:1903179,0.99999999999673,0.82598560821768,0,2,regulation of dopamine biosynthetic process,BP,
18312,GO:1903181,0.99999999999673,0.82598560821768,0,2,positive regulation of dopamine biosynthetic process,BP,
5471,GO:0016401,0.999999999996744,0.799537691480073,0,2,palmitoyl-CoA oxidase activity,MF,
10018,GO:0042428,0.999999999996746,0.63007367247992,0,4,serotonin metabolic process,BP,
9812,GO:0040030,0.999999999996748,0.890204326921042,0,1,regulation of molecular function, epigenetic,BP,
10299,GO:0043035,0.999999999996748,0.890204326921042,0,1,chromatin insulator sequence binding,MF,
8965,GO:0035022,0.999999999996758,0.656744062468906,0,4,positive regulation of Rac protein signal transduction,BP,
19988,GO:2000508,0.999999999996777,0.657050151105473,0,4,regulation of dendritic cell chemotaxis,BP,
19989,GO:2000510,0.999999999996777,0.657050151105473,0,4,positive regulation of dendritic cell chemotaxis,BP,
6422,GO:0021682,0.999999999996816,0.888394563240906,0,1,nerve maturation,BP,
7737,GO:0032227,0.999999999996828,0.704740032000421,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
924,GO:0002316,0.999999999996849,0.889201397864115,0,1,follicular B cell differentiation,BP,
5956,GO:0018315,0.999999999996849,0.889201397864115,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9834,GO:0042040,0.999999999996849,0.889201397864115,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14383,GO:0061598,0.999999999996849,0.889201397864115,0,1,molybdopterin adenylyltransferase activity,MF,
14384,GO:0061599,0.999999999996849,0.889201397864115,0,1,molybdopterin molybdotransferase activity,MF,
15879,GO:0072579,0.999999999996849,0.889201397864115,0,1,glycine receptor clustering,BP,
16469,GO:0097112,0.999999999996849,0.889201397864115,0,1,gamma-aminobutyric acid receptor clustering,BP,
198,GO:0000416,0.999999999996857,0.89037938665726,0,1,positive regulation of histone H3-K36 methylation,BP,
9296,GO:0035727,0.999999999996872,0.796694659992756,0,2,lysophosphatidic acid binding,MF,
12480,GO:0050290,0.999999999996877,0.888654316725762,0,1,sphingomyelin phosphodiesterase D activity,MF,
4096,GO:0009149,0.999999999996878,0.826668054519922,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4152,GO:0009213,0.999999999996878,0.826668054519922,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7963,GO:0032556,0.999999999996878,0.826668054519922,0,2,pyrimidine deoxyribonucleotide binding,MF,
1586,GO:0003994,0.999999999996891,0.795666817732777,0,2,aconitate hydratase activity,MF,
7197,GO:0031081,0.999999999996896,0.793987609255206,0,2,nuclear pore distribution,BP,
13142,GO:0051664,0.999999999996896,0.793987609255206,0,2,nuclear pore localization,BP,
14338,GO:0061470,0.999999999996905,0.634561325533469,0,4,T follicular helper cell differentiation,BP,
15407,GO:0071638,0.999999999996911,0.822552685159356,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
2475,GO:0005690,0.999999999996917,0.799604027871726,0,2,U4atac snRNP,CC,
15070,GO:0071005,0.999999999996917,0.799604027871726,0,2,U2-type precatalytic spliceosome,CC,
3118,GO:0006696,0.99999999999692,0.803175070080263,0,2,ergosterol biosynthetic process,BP,
3697,GO:0008204,0.99999999999692,0.803175070080263,0,2,ergosterol metabolic process,BP,
13694,GO:0060200,0.999999999996943,0.888607512093709,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13695,GO:0060201,0.999999999996943,0.888607512093709,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16861,GO:0098746,0.999999999996943,0.888607512093709,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
5966,GO:0018364,0.999999999996944,0.864132977030446,0,2,peptidyl-glutamine methylation,BP,
12808,GO:0051083,0.99999999999695,0.806593726266201,0,2,'de novo' cotranslational protein folding,BP,
13306,GO:0051977,0.999999999996971,0.895641523895962,0,1,lysophospholipid transport,BP,
13307,GO:0051978,0.999999999996971,0.895641523895962,0,1,lysophospholipid transporter activity,MF,
14548,GO:0070037,0.999999999996971,0.921785627538716,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
51,GO:0000105,0.999999999996979,0.79711894460513,0,2,histidine biosynthetic process,BP,
8971,GO:0035033,0.999999999997001,0.807834256867467,0,2,histone deacetylase regulator activity,MF,
16669,GO:0097524,0.999999999997003,0.631934921434062,0,4,sperm plasma membrane,CC,
12877,GO:0051177,0.999999999997017,0.657153592052692,0,4,meiotic sister chromatid cohesion,BP,
15071,GO:0071006,0.999999999997018,0.713548667706682,0,3,U2-type catalytic step 1 spliceosome,CC,
1752,GO:0004349,0.999999999997019,0.891105103194209,0,1,glutamate 5-kinase activity,MF,
1753,GO:0004350,0.999999999997019,0.891105103194209,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3040,GO:0006592,0.999999999997019,0.891105103194209,0,1,ornithine biosynthetic process,BP,
5821,GO:0017084,0.999999999997019,0.891105103194209,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6058,GO:0019202,0.999999999997019,0.891105103194209,0,1,amino acid kinase activity,MF,
19739,GO:2000048,0.99999999999703,0.828409418280444,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
4382,GO:0010025,0.999999999997047,0.796387979157272,0,2,wax biosynthetic process,BP,
4413,GO:0010166,0.999999999997047,0.796387979157272,0,2,wax metabolic process,BP,
15984,GO:0080019,0.999999999997047,0.796387979157272,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17198,GO:0102965,0.999999999997047,0.796387979157272,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
15998,GO:0080144,0.999999999997052,0.799348866903276,0,2,amino acid homeostasis,BP,
859,GO:0002184,0.999999999997059,0.793279814955937,0,2,cytoplasmic translational termination,BP,
6717,GO:0030124,0.999999999997064,0.647781889662833,0,4,AP-4 adaptor complex,CC,
5366,GO:0016149,0.999999999997067,0.890477531395639,0,1,translation release factor activity, codon specific,MF,
7350,GO:0031372,0.99999999999708,0.810202687725929,0,2,UBC13-MMS2 complex,CC,
1717,GO:0004306,0.999999999997095,0.899454257715166,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
11183,GO:0045234,0.999999999997103,0.900664821933162,0,1,protein palmitoleylation,BP,
19404,GO:1905832,0.999999999997113,0.626880349495301,0,4,positive regulation of spindle assembly,BP,
17109,GO:0099617,0.999999999997134,0.891334033422121,0,1,matrix side of mitochondrial inner membrane,CC,
18990,GO:1904732,0.99999999999714,0.843322421109519,0,2,regulation of electron transfer activity,BP,
19106,GO:1904959,0.99999999999714,0.843322421109519,0,2,regulation of cytochrome-c oxidase activity,BP,
17762,GO:1901671,0.99999999999714,0.836559406848778,0,2,positive regulation of superoxide dismutase activity,BP,
19041,GO:1904833,0.99999999999714,0.836559406848778,0,2,positive regulation of removal of superoxide radicals,BP,
18747,GO:1904155,0.999999999997142,0.891488280260423,0,1,DN2 thymocyte differentiation,BP,
18748,GO:1904156,0.999999999997142,0.891488280260423,0,1,DN3 thymocyte differentiation,BP,
11081,GO:0045065,0.999999999997144,0.804386026119002,0,2,cytotoxic T cell differentiation,BP,
11292,GO:0045583,0.999999999997144,0.804386026119002,0,2,regulation of cytotoxic T cell differentiation,BP,
11293,GO:0045585,0.999999999997144,0.804386026119002,0,2,positive regulation of cytotoxic T cell differentiation,BP,
13751,GO:0060300,0.999999999997149,0.726410025861744,0,3,regulation of cytokine activity,BP,
13313,GO:0051990,0.999999999997158,0.799499614765407,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13671,GO:0060158,0.999999999997163,0.651679701683844,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
5770,GO:0016941,0.999999999997166,0.891182102413088,0,1,natriuretic peptide receptor activity,MF,
13879,GO:0060465,0.999999999997166,0.891182102413088,0,1,pharynx development,BP,
17452,GO:1900194,0.999999999997166,0.891182102413088,0,1,negative regulation of oocyte maturation,BP,
4901,GO:0014826,0.999999999997172,0.8964470791093,0,1,vein smooth muscle contraction,BP,
6763,GO:0030185,0.999999999997172,0.8964470791093,0,1,nitric oxide transport,BP,
7453,GO:0031583,0.999999999997172,0.8964470791093,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7524,GO:0031705,0.999999999997172,0.8964470791093,0,1,bombesin receptor binding,MF,
7525,GO:0031707,0.999999999997172,0.8964470791093,0,1,endothelin A receptor binding,MF,
7526,GO:0031708,0.999999999997172,0.8964470791093,0,1,endothelin B receptor binding,MF,
9344,GO:0035815,0.999999999997172,0.8964470791093,0,1,positive regulation of renal sodium excretion,BP,
9960,GO:0042313,0.999999999997172,0.8964470791093,0,1,protein kinase C deactivation,BP,
10375,GO:0043179,0.999999999997172,0.8964470791093,0,1,rhythmic excitation,BP,
13649,GO:0060124,0.999999999997179,0.792462638568103,0,2,positive regulation of growth hormone secretion,BP,
6414,GO:0021649,0.99999999999718,0.893980954507611,0,1,vestibulocochlear nerve structural organization,BP,
9700,GO:0038085,0.99999999999718,0.893980954507611,0,1,vascular endothelial growth factor binding,MF,
13752,GO:0060301,0.99999999999718,0.893980954507611,0,1,positive regulation of cytokine activity,BP,
14369,GO:0061552,0.99999999999718,0.893980954507611,0,1,ganglion morphogenesis,BP,
16598,GO:0097374,0.99999999999718,0.893980954507611,0,1,sensory neuron axon guidance,BP,
18000,GO:1902378,0.99999999999718,0.893980954507611,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19042,GO:1904835,0.99999999999718,0.893980954507611,0,1,dorsal root ganglion morphogenesis,BP,
19139,GO:1905040,0.99999999999718,0.893980954507611,0,1,otic placode development,BP,
9262,GO:0035662,0.999999999997187,0.80608890329436,0,3,Toll-like receptor 4 binding,MF,
15092,GO:0071042,0.999999999997191,0.670971287162915,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15097,GO:0071047,0.999999999997191,0.670971287162915,0,4,polyadenylation-dependent mRNA catabolic process,BP,
4902,GO:0014827,0.999999999997195,0.895344799419614,0,1,intestine smooth muscle contraction,BP,
15121,GO:0071148,0.999999999997195,0.789260727928797,0,2,TEAD-1-YAP complex,CC,
954,GO:0002370,0.999999999997196,0.730405927879324,0,3,natural killer cell cytokine production,BP,
1138,GO:0002727,0.999999999997196,0.730405927879324,0,3,regulation of natural killer cell cytokine production,BP,
10852,GO:0044338,0.999999999997205,0.806561004820972,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
4002,GO:0008934,0.99999999999721,0.640655786423227,0,4,inositol monophosphate 1-phosphatase activity,MF,
13450,GO:0052832,0.99999999999721,0.640655786423227,0,4,inositol monophosphate 3-phosphatase activity,MF,
13451,GO:0052833,0.99999999999721,0.640655786423227,0,4,inositol monophosphate 4-phosphatase activity,MF,
13452,GO:0052834,0.99999999999721,0.640655786423227,0,4,inositol monophosphate phosphatase activity,MF,
841,GO:0002144,0.999999999997215,0.89638453438993,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
3427,GO:0007217,0.999999999997221,0.893690268982544,0,1,tachykinin receptor signaling pathway,BP,
2034,GO:0004772,0.999999999997234,0.891310135924785,0,1,sterol O-acyltransferase activity,MF,
8915,GO:0034736,0.999999999997234,0.891310135924785,0,1,cholesterol O-acyltransferase activity,MF,
18493,GO:1903565,0.999999999997234,0.891310135924785,0,1,negative regulation of protein localization to cilium,BP,
18496,GO:1903568,0.999999999997234,0.891310135924785,0,1,negative regulation of protein localization to ciliary membrane,BP,
1142,GO:0002731,0.999999999997244,0.822813480241767,0,2,negative regulation of dendritic cell cytokine production,BP,
14452,GO:0061749,0.999999999997268,0.789630809509951,0,2,forked DNA-dependent helicase activity,MF,
14489,GO:0061849,0.999999999997268,0.789630809509951,0,2,telomeric G-quadruplex DNA binding,MF,
17953,GO:1902255,0.999999999997271,0.814472941421245,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16491,GO:0097154,0.999999999997275,0.661038419843657,0,4,GABAergic neuron differentiation,BP,
19918,GO:2000370,0.999999999997281,0.626032659785941,0,4,positive regulation of clathrin-dependent endocytosis,BP,
1387,GO:0003284,0.999999999997284,0.628546495213381,0,4,septum primum development,BP,
18559,GO:1903722,0.999999999997285,0.826796679728197,0,2,regulation of centriole elongation,BP,
12910,GO:0051232,0.999999999997287,0.894464094424809,0,1,meiotic spindle elongation,BP,
13970,GO:0060631,0.999999999997287,0.709426704992409,0,3,regulation of meiosis I,BP,
3781,GO:0008336,0.999999999997289,0.898965520280323,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4991,GO:0015117,0.999999999997289,0.898965520280323,0,1,thiosulfate transmembrane transporter activity,MF,
4997,GO:0015131,0.999999999997289,0.898965520280323,0,1,oxaloacetate transmembrane transporter activity,MF,
5167,GO:0015709,0.999999999997289,0.898965520280323,0,1,thiosulfate transport,BP,
5177,GO:0015729,0.999999999997289,0.898965520280323,0,1,oxaloacetate transport,BP,
5183,GO:0015743,0.999999999997289,0.898965520280323,0,1,malate transport,BP,
15272,GO:0071423,0.999999999997289,0.898965520280323,0,1,malate transmembrane transport,BP,
17990,GO:1902356,0.999999999997289,0.898965520280323,0,1,oxaloacetate(2-) transmembrane transport,BP,
9281,GO:0035697,0.999999999997291,0.808233738175482,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9282,GO:0035698,0.999999999997291,0.808233738175482,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15930,GO:0072683,0.999999999997291,0.808233738175482,0,2,T cell extravasation,BP,
19946,GO:2000407,0.999999999997291,0.808233738175482,0,2,regulation of T cell extravasation,BP,
19964,GO:2000449,0.999999999997291,0.808233738175482,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19966,GO:2000452,0.999999999997291,0.808233738175482,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19141,GO:1905042,0.999999999997302,0.895253071749395,0,1,negative regulation of epithelium regeneration,BP,
15945,GO:0072714,0.999999999997306,0.901523168295007,0,1,response to selenite ion,BP,
15946,GO:0072715,0.999999999997306,0.901523168295007,0,1,cellular response to selenite ion,BP,
18914,GO:1904569,0.999999999997306,0.901523168295007,0,1,regulation of selenocysteine incorporation,BP,
18915,GO:1904570,0.999999999997306,0.901523168295007,0,1,negative regulation of selenocysteine incorporation,BP,
18916,GO:1904572,0.999999999997306,0.901523168295007,0,1,negative regulation of mRNA binding,BP,
18917,GO:1904573,0.999999999997306,0.901523168295007,0,1,regulation of selenocysteine insertion sequence binding,BP,
18918,GO:1904574,0.999999999997306,0.901523168295007,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19201,GO:1905215,0.999999999997306,0.901523168295007,0,1,negative regulation of RNA binding,BP,
16261,GO:0090296,0.999999999997308,0.646356119083185,0,4,regulation of mitochondrial DNA replication,BP,
17811,GO:1901858,0.999999999997308,0.646356119083185,0,4,regulation of mitochondrial DNA metabolic process,BP,
11329,GO:0045632,0.999999999997317,0.65680508401911,0,4,negative regulation of mechanoreceptor differentiation,BP,
20199,GO:2000981,0.999999999997317,0.65680508401911,0,4,negative regulation of inner ear receptor cell differentiation,BP,
7411,GO:0031475,0.999999999997321,0.906552353473159,0,1,myosin V complex,CC,
5272,GO:0015917,0.999999999997347,0.623616358680033,0,4,aminophospholipid transport,BP,
2994,GO:0006540,0.999999999997349,0.794703958636347,0,2,glutamate decarboxylation to succinate,BP,
3977,GO:0008794,0.999999999997353,0.927315078157173,0,1,arsenate reductase (glutaredoxin) activity,MF,
6964,GO:0030611,0.999999999997353,0.927315078157173,0,1,arsenate reductase activity,MF,
16872,GO:0098770,0.999999999997358,0.790968287185526,0,2,FBXO family protein binding,MF,
11585,GO:0046122,0.999999999997379,0.836570593348938,0,2,purine deoxyribonucleoside metabolic process,BP,
1919,GO:0004609,0.99999999999738,0.800566505351199,0,2,phosphatidylserine decarboxylase activity,MF,
2027,GO:0004757,0.999999999997382,0.908258754533136,0,1,sepiapterin reductase activity,MF,
1683,GO:0004145,0.999999999997388,0.850408029602531,0,2,diamine N-acetyltransferase activity,MF,
6246,GO:0019809,0.999999999997388,0.850408029602531,0,2,spermidine binding,MF,
8187,GO:0032917,0.999999999997388,0.850408029602531,0,2,polyamine acetylation,BP,
8188,GO:0032918,0.999999999997388,0.850408029602531,0,2,spermidine acetylation,BP,
371,GO:0000992,0.9999999999974,0.794380196939688,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0001002,0.9999999999974,0.794380196939688,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,0.9999999999974,0.794380196939688,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
3043,GO:0006597,0.999999999997408,0.804748785522788,0,2,spermine biosynthetic process,BP,
4992,GO:0015119,0.999999999997413,0.711207132089915,0,3,hexose phosphate transmembrane transporter activity,MF,
5081,GO:0015315,0.999999999997413,0.711207132089915,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5128,GO:0015526,0.999999999997413,0.711207132089915,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14351,GO:0061513,0.999999999997413,0.711207132089915,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
7122,GO:0030917,0.999999999997417,0.642772309373054,0,4,midbrain-hindbrain boundary development,BP,
2070,GO:0004821,0.99999999999743,0.802616367719217,0,2,histidine-tRNA ligase activity,MF,
2916,GO:0006427,0.99999999999743,0.802616367719217,0,2,histidyl-tRNA aminoacylation,BP,
3508,GO:0007418,0.999999999997443,0.790963522580953,0,2,ventral midline development,BP,
6537,GO:0021937,0.999999999997443,0.790963522580953,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6538,GO:0021938,0.999999999997443,0.790963522580953,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6539,GO:0021940,0.999999999997443,0.790963522580953,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
10151,GO:0042709,0.999999999997454,0.894561596442314,0,1,succinate-CoA ligase complex,CC,
11187,GO:0045244,0.999999999997454,0.894561596442314,0,1,succinate-CoA ligase complex (GDP-forming),CC,
2324,GO:0005330,0.999999999997462,0.888841139980896,0,1,dopamine:sodium symporter activity,MF,
2326,GO:0005335,0.999999999997462,0.888841139980896,0,1,serotonin:sodium symporter activity,MF,
4854,GO:0014064,0.999999999997462,0.888841139980896,0,1,positive regulation of serotonin secretion,BP,
6248,GO:0019811,0.999999999997462,0.888841139980896,0,1,cocaine binding,MF,
6540,GO:0021941,0.999999999997462,0.888841139980896,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16107,GO:0090067,0.999999999997462,0.888841139980896,0,1,regulation of thalamus size,BP,
1545,GO:0003937,0.999999999997464,0.896442236105529,0,1,IMP cyclohydrolase activity,MF,
1944,GO:0004643,0.999999999997464,0.896442236105529,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13433,GO:0052798,0.999999999997464,0.896442236105529,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
2065,GO:0004816,0.999999999997471,0.799112261535706,0,2,asparagine-tRNA ligase activity,MF,
12414,GO:0048840,0.999999999997486,0.630144521863796,0,4,otolith development,BP,
16541,GO:0097232,0.999999999997502,0.891495781252251,0,1,lamellar body membrane,CC,
16542,GO:0097233,0.999999999997502,0.891495781252251,0,1,alveolar lamellar body membrane,CC,
3911,GO:0008559,0.999999999997507,0.627253286845295,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
5493,GO:0016426,0.999999999997523,0.639510488427125,0,4,tRNA (adenine) methyltransferase activity,MF,
9571,GO:0036343,0.999999999997538,0.943613376939393,0,1,psychomotor behavior,BP,
2094,GO:0004856,0.999999999997541,0.890461053195046,0,1,xylulokinase activity,MF,
2656,GO:0005998,0.999999999997541,0.890461053195046,0,1,xylulose catabolic process,BP,
11996,GO:0047280,0.999999999997541,0.888795714856758,0,1,nicotinamide phosphoribosyltransferase activity,MF,
9424,GO:0035981,0.99999999999756,0.805393368609461,0,2,tongue muscle cell differentiation,BP,
18150,GO:1902811,0.99999999999756,0.805393368609461,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20222,GO:2001035,0.99999999999756,0.805393368609461,0,2,regulation of tongue muscle cell differentiation,BP,
20223,GO:2001037,0.99999999999756,0.805393368609461,0,2,positive regulation of tongue muscle cell differentiation,BP,
543,GO:0001661,0.999999999997565,0.79592571536407,0,2,conditioned taste aversion,BP,
351,GO:0000964,0.999999999997566,0.656306190701033,0,4,mitochondrial RNA 5'-end processing,BP,
12712,GO:0050910,0.999999999997573,0.793855286623443,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12110,GO:0048073,0.999999999997575,0.790493079881374,0,2,regulation of eye pigmentation,BP,
11755,GO:0046573,0.999999999997577,0.903646671318047,0,1,lactonohydrolase activity,MF,
17140,GO:0102007,0.999999999997577,0.903646671318047,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
1167,GO:0002785,0.999999999997578,0.890543903341082,0,1,negative regulation of antimicrobial peptide production,BP,
1169,GO:0002787,0.999999999997578,0.890543903341082,0,1,negative regulation of antibacterial peptide production,BP,
3786,GO:0008348,0.999999999997578,0.890543903341082,0,1,negative regulation of antimicrobial humoral response,BP,
14784,GO:0070463,0.999999999997583,0.891096242328147,0,1,tubulin-dependent ATPase activity,MF,
8127,GO:0032807,0.999999999997592,0.64196114255966,0,4,DNA ligase IV complex,CC,
2245,GO:0005153,0.999999999997594,0.796496425033709,0,2,interleukin-8 receptor binding,MF,
15551,GO:0071929,0.999999999997594,0.796496425033709,0,2,alpha-tubulin acetylation,BP,
5548,GO:0016534,0.999999999997594,0.890058827783153,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6391,GO:0021586,0.999999999997594,0.890058827783153,0,1,pons maturation,BP,
6440,GO:0021718,0.999999999997594,0.890058827783153,0,1,superior olivary nucleus development,BP,
6441,GO:0021722,0.999999999997594,0.890058827783153,0,1,superior olivary nucleus maturation,BP,
17159,GO:0102339,0.999999999997597,0.893775800964278,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17160,GO:0102340,0.999999999997597,0.893775800964278,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17161,GO:0102341,0.999999999997597,0.893775800964278,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17162,GO:0102342,0.999999999997597,0.893775800964278,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
16520,GO:0097198,0.999999999997597,0.792864868254629,0,2,histone H3-K36 trimethylation,BP,
11901,GO:0046900,0.999999999997608,0.811078162278621,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12028,GO:0047536,0.999999999997609,0.895377220633517,0,1,2-aminoadipate transaminase activity,MF,
3389,GO:0007168,0.999999999997629,0.797669352428595,0,2,receptor guanylyl cyclase signaling pathway,BP,
1782,GO:0004392,0.999999999997636,0.816539796517396,0,2,heme oxygenase (decyclizing) activity,MF,
3173,GO:0006788,0.999999999997636,0.816539796517396,0,2,heme oxidation,BP,
8975,GO:0035037,0.999999999997639,0.888862873716004,0,1,sperm entry,BP,
12223,GO:0048386,0.999999999997644,0.634294156083903,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13454,GO:0052836,0.999999999997644,0.810840258350478,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13455,GO:0052839,0.999999999997644,0.810840258350478,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
497,GO:0001552,0.999999999997661,0.898245653957612,0,1,ovarian follicle atresia,BP,
19910,GO:2000355,0.999999999997661,0.898245653957612,0,1,negative regulation of ovarian follicle development,BP,
8937,GO:0034776,0.999999999997664,0.789825786555324,0,2,response to histamine,BP,
15269,GO:0071420,0.999999999997664,0.789825786555324,0,2,cellular response to histamine,BP,
2015,GO:0004739,0.999999999997667,0.807801499790496,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
14124,GO:0060940,0.999999999997675,0.796510764641541,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
18485,GO:1903547,0.999999999997677,0.844415232764904,0,2,regulation of growth hormone activity,BP,
17299,GO:0140009,0.999999999997678,0.890577354786869,0,1,L-aspartate import across plasma membrane,BP,
19742,GO:2000051,0.999999999997682,0.623763174888685,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
2361,GO:0005459,0.999999999997703,0.826687565382733,0,2,UDP-galactose transmembrane transporter activity,MF,
15766,GO:0072334,0.999999999997703,0.826687565382733,0,2,UDP-galactose transmembrane transport,BP,
15110,GO:0071105,0.999999999997711,0.888628746581378,0,1,response to interleukin-11,BP,
15219,GO:0071348,0.999999999997711,0.888628746581378,0,1,cellular response to interleukin-11,BP,
14453,GO:0061750,0.999999999997737,0.894725212773329,0,1,acid sphingomyelin phosphodiesterase activity,MF,
3530,GO:0007518,0.999999999997744,0.89449184761097,0,1,myoblast fate determination,BP,
2145,GO:0004955,0.999999999997757,0.801667720939266,0,2,prostaglandin receptor activity,MF,
16663,GO:0097505,0.999999999997765,0.888394399366642,0,1,Rad6-Rad18 complex,CC,
16656,GO:0097498,0.999999999997769,0.798256458939583,0,2,endothelial tube lumen extension,BP,
6329,GO:0020012,0.999999999997784,0.793624547041904,0,2,evasion or tolerance of host immune response,BP,
7004,GO:0030682,0.999999999997784,0.793624547041904,0,2,evasion or tolerance of host defense response,BP,
7005,GO:0030683,0.999999999997784,0.793624547041904,0,2,evasion or tolerance by virus of host immune response,BP,
13214,GO:0051805,0.999999999997784,0.793624547041904,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13216,GO:0051807,0.999999999997784,0.793624547041904,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14046,GO:0060750,0.999999999997802,0.641592154590505,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
15666,GO:0072161,0.999999999997811,0.637469294511407,0,4,mesenchymal cell differentiation involved in kidney development,BP,
20203,GO:2001012,0.999999999997811,0.637469294511407,0,4,mesenchymal cell differentiation involved in renal system development,BP,
11097,GO:0045083,0.999999999997824,0.889495504785612,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
1487,GO:0003796,0.999999999997827,0.906683626899316,0,1,lysozyme activity,MF,
8538,GO:0033823,0.999999999997833,0.892533252398649,0,1,procollagen glucosyltransferase activity,MF,
13175,GO:0051728,0.999999999997833,0.892533252398649,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13176,GO:0051729,0.999999999997833,0.892533252398649,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13686,GO:0060184,0.999999999997833,0.892533252398649,0,1,cell cycle switching,BP,
123,GO:0000253,0.999999999997834,0.68897002033794,0,4,3-keto sterol reductase activity,MF,
1420,GO:0003357,0.999999999997835,0.789393959323172,0,2,noradrenergic neuron differentiation,BP,
4008,GO:0008967,0.999999999997849,0.800447701410768,0,2,phosphoglycolate phosphatase activity,MF,
19296,GO:1905449,0.99999999999788,0.799013314413692,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19297,GO:1905451,0.99999999999788,0.799013314413692,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
13429,GO:0052746,0.99999999999789,0.79275606422657,0,2,inositol phosphorylation,BP,
8761,GO:0034416,0.999999999997899,0.797198282419267,0,2,bisphosphoglycerate phosphatase activity,MF,
8980,GO:0035063,0.999999999997918,0.890473407446054,0,1,nuclear speck organization,BP,
2576,GO:0005862,0.999999999997924,0.655680035408756,0,4,muscle thin filament tropomyosin,CC,
3490,GO:0007371,0.999999999997944,0.890339025168881,0,1,ventral midline determination,BP,
13715,GO:0060245,0.999999999997944,0.890339025168881,0,1,detection of cell density,BP,
13716,GO:0060246,0.999999999997944,0.890339025168881,0,1,detection of cell density by contact stimulus,BP,
13717,GO:0060248,0.999999999997944,0.890339025168881,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14222,GO:0061113,0.999999999997944,0.890339025168881,0,1,pancreas morphogenesis,BP,
15592,GO:0072036,0.999999999997944,0.890339025168881,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15740,GO:0072285,0.999999999997944,0.890339025168881,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16612,GO:0097411,0.999999999997949,0.64428011212365,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
13020,GO:0051425,0.999999999997973,0.627121494668794,0,4,PTB domain binding,MF,
1950,GO:0004651,0.999999999997973,0.803198739039119,0,2,polynucleotide 5'-phosphatase activity,MF,
16765,GO:0098507,0.999999999997973,0.803198739039119,0,2,polynucleotide 5' dephosphorylation,BP,
7690,GO:0032133,0.999999999997985,0.654941067715184,0,4,chromosome passenger complex,CC,
19324,GO:1905538,0.999999999997996,0.7934739014642,0,2,polysome binding,MF,
9724,GO:0038129,0.999999999998007,0.799750724949418,0,2,ERBB3 signaling pathway,BP,
15018,GO:0070926,0.999999999998016,0.890016551123885,0,1,regulation of ATP:ADP antiporter activity,BP,
4957,GO:0015019,0.999999999998027,0.88843603976425,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
590,GO:0001743,0.999999999998028,0.791835606423926,0,2,optic placode formation,BP,
7116,GO:0030910,0.999999999998028,0.791835606423926,0,2,olfactory placode formation,BP,
12202,GO:0048319,0.999999999998028,0.791835606423926,0,2,axial mesoderm morphogenesis,BP,
15445,GO:0071698,0.999999999998028,0.791835606423926,0,2,olfactory placode development,BP,
15446,GO:0071699,0.999999999998028,0.791835606423926,0,2,olfactory placode morphogenesis,BP,
17170,GO:0102485,0.99999999999803,0.793377489255526,0,2,dATP phosphohydrolase activity,MF,
17171,GO:0102486,0.99999999999803,0.793377489255526,0,2,dCTP phosphohydrolase activity,MF,
17172,GO:0102487,0.99999999999803,0.793377489255526,0,2,dUTP phosphohydrolase activity,MF,
17173,GO:0102488,0.99999999999803,0.793377489255526,0,2,dTTP phosphohydrolase activity,MF,
17174,GO:0102489,0.99999999999803,0.793377489255526,0,2,GTP phosphohydrolase activity,MF,
17175,GO:0102490,0.99999999999803,0.793377489255526,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17176,GO:0102491,0.99999999999803,0.793377489255526,0,2,dGTP phosphohydrolase activity,MF,
18861,GO:1904426,0.99999999999803,0.793377489255526,0,2,positive regulation of GTP binding,BP,
13857,GO:0060437,0.999999999998035,0.800086031840525,0,2,lung growth,BP,
10261,GO:0042986,0.999999999998044,0.800489030424175,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
3667,GO:0008158,0.999999999998048,0.823128300016865,0,2,hedgehog receptor activity,MF,
18618,GO:1903847,0.999999999998062,0.78988589928349,0,2,regulation of aorta morphogenesis,BP,
18619,GO:1903849,0.999999999998062,0.78988589928349,0,2,positive regulation of aorta morphogenesis,BP,
3614,GO:0008063,0.99999999999807,0.633955607333369,0,4,Toll signaling pathway,BP,
6595,GO:0022605,0.999999999998072,0.663775200271233,0,4,mammalian oogenesis stage,BP,
8987,GO:0035087,0.999999999998073,0.649478759243386,0,4,siRNA loading onto RISC involved in RNA interference,BP,
1524,GO:0003883,0.999999999998077,0.794426222366496,0,2,CTP synthase activity,MF,
10774,GO:0044210,0.999999999998077,0.794426222366496,0,2,'de novo' CTP biosynthetic process,BP,
10448,GO:0043293,0.99999999999808,0.800494770467706,0,2,apoptosome,CC,
11345,GO:0045654,0.999999999998094,0.811441764070917,0,2,positive regulation of megakaryocyte differentiation,BP,
5450,GO:0016316,0.999999999998099,0.790228903862152,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5864,GO:0017161,0.999999999998099,0.790228903862152,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
8830,GO:0034597,0.999999999998099,0.790228903862152,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
13446,GO:0052828,0.999999999998099,0.790228903862152,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
2359,GO:0005456,0.999999999998105,0.900175278362626,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5195,GO:0015782,0.999999999998105,0.900175278362626,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
3728,GO:0008263,0.999999999998106,0.797263303686349,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
9649,GO:0036509,0.999999999998113,0.802582244199406,0,2,trimming of terminal mannose on B branch,BP,
9651,GO:0036511,0.999999999998113,0.802582244199406,0,2,trimming of first mannose on A branch,BP,
9652,GO:0036512,0.999999999998113,0.802582244199406,0,2,trimming of second mannose on A branch,BP,
13944,GO:0060584,0.999999999998139,0.796839689069271,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13945,GO:0060585,0.999999999998139,0.796839689069271,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
4904,GO:0014831,0.999999999998141,0.659470280413246,0,4,gastro-intestinal system smooth muscle contraction,BP,
9769,GO:0039519,0.999999999998148,0.789349351202713,0,2,modulation by virus of host autophagy,BP,
2106,GO:0004874,0.99999999999815,0.789436975292072,0,2,aryl hydrocarbon receptor activity,MF,
8304,GO:0033128,0.999999999998155,0.802806618915522,0,2,negative regulation of histone phosphorylation,BP,
3306,GO:0007008,0.99999999999816,0.89136991677244,0,1,outer mitochondrial membrane organization,BP,
5317,GO:0016031,0.99999999999816,0.89136991677244,0,1,tRNA import into mitochondrion,BP,
14581,GO:0070096,0.99999999999816,0.89136991677244,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19207,GO:1905242,0.99999999999816,0.89136991677244,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
1260,GO:0003011,0.999999999998172,0.791388477107898,0,2,involuntary skeletal muscle contraction,BP,
15064,GO:0070992,0.999999999998191,0.849150089355761,0,2,translation initiation complex,CC,
16930,GO:0098875,0.999999999998191,0.88865956876318,0,1,epididymosome,CC,
6419,GO:0021679,0.999999999998205,0.795581947489711,0,2,cerebellar molecular layer development,BP,
6426,GO:0021687,0.999999999998205,0.795581947489711,0,2,cerebellar molecular layer morphogenesis,BP,
4126,GO:0009184,0.999999999998217,0.906578550181213,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4134,GO:0009192,0.999999999998217,0.906578550181213,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10971,GO:0044716,0.999999999998217,0.906578550181213,0,1,8-oxo-GDP phosphatase activity,MF,
10972,GO:0044717,0.999999999998217,0.906578550181213,0,1,8-hydroxy-dADP phosphatase activity,MF,
11546,GO:0046056,0.999999999998217,0.906578550181213,0,1,dADP metabolic process,BP,
11547,GO:0046057,0.999999999998217,0.906578550181213,0,1,dADP catabolic process,BP,
11553,GO:0046067,0.999999999998217,0.906578550181213,0,1,dGDP catabolic process,BP,
11834,GO:0046712,0.999999999998217,0.906578550181213,0,1,GDP catabolic process,BP,
2749,GO:0006147,0.999999999998229,0.888404646845708,0,1,guanine catabolic process,BP,
3995,GO:0008892,0.999999999998229,0.888404646845708,0,1,guanine deaminase activity,MF,
4596,GO:0010705,0.999999999998243,0.888802725209814,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
16039,GO:0086040,0.999999999998243,0.888802725209814,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16071,GO:0086092,0.999999999998243,0.888802725209814,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
19487,GO:1990134,0.999999999998254,0.888491975217924,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
9560,GO:0036313,0.999999999998272,0.797635434857045,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
13914,GO:0060536,0.999999999998272,0.646374018799819,0,4,cartilage morphogenesis,BP,
19577,GO:1990481,0.999999999998273,0.647073566306211,0,4,mRNA pseudouridine synthesis,BP,
15010,GO:0070905,0.999999999998273,0.801342221137742,0,2,serine binding,MF,
6336,GO:0021502,0.999999999998297,0.791494847538777,0,2,neural fold elevation formation,BP,
10610,GO:0043570,0.999999999998298,0.627132567742766,0,4,maintenance of DNA repeat elements,BP,
9923,GO:0042253,0.999999999998299,0.815838902883153,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
18586,GO:1903778,0.999999999998303,0.793866070953277,0,2,protein localization to vacuolar membrane,BP,
1758,GO:0004357,0.999999999998311,0.794464069688251,0,2,glutamate-cysteine ligase activity,MF,
5832,GO:0017109,0.999999999998311,0.794464069688251,0,2,glutamate-cysteine ligase complex,CC,
16450,GO:0097069,0.999999999998311,0.794464069688251,0,2,cellular response to thyroxine stimulus,BP,
18847,GO:1904387,0.999999999998311,0.794464069688251,0,2,cellular response to L-phenylalanine derivative,BP,
4595,GO:0010701,0.99999999999834,0.796913450970429,0,2,positive regulation of norepinephrine secretion,BP,
2629,GO:0005954,0.999999999998344,0.894011936818829,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
6175,GO:0019534,0.999999999998352,0.627279429701658,0,4,toxin transmembrane transporter activity,MF,
15536,GO:0071898,0.999999999998362,0.720704112795225,0,3,regulation of estrogen receptor binding,BP,
15537,GO:0071899,0.999999999998362,0.720704112795225,0,3,negative regulation of estrogen receptor binding,BP,
7408,GO:0031466,0.999999999998368,0.675346280383378,0,4,Cul5-RING ubiquitin ligase complex,CC,
12972,GO:0051316,0.999999999998373,0.799201332505871,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
10331,GO:0043111,0.999999999998376,0.811626517400024,0,2,replication fork arrest,BP,
9545,GO:0036284,0.999999999998387,0.805767662470235,0,2,tubulobulbar complex,CC,
19265,GO:1905371,0.999999999998387,0.805767662470235,0,2,ceramide phosphoethanolamine metabolic process,BP,
19266,GO:1905373,0.999999999998387,0.805767662470235,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
2900,GO:0006408,0.999999999998388,0.808041330052973,0,2,snRNA export from nucleus,BP,
10605,GO:0043564,0.999999999998394,0.798536723973002,0,2,Ku70:Ku80 complex,CC,
1274,GO:0003062,0.999999999998403,0.639545488099632,0,4,regulation of heart rate by chemical signal,BP,
11981,GO:0047179,0.999999999998405,0.844009947533064,0,2,platelet-activating factor acetyltransferase activity,MF,
16895,GO:0098808,0.99999999999842,0.801746265279375,0,2,mRNA cap binding,MF,
7765,GO:0032276,0.999999999998424,0.710442983117987,0,3,regulation of gonadotropin secretion,BP,
7767,GO:0032278,0.999999999998424,0.710442983117987,0,3,positive regulation of gonadotropin secretion,BP,
11888,GO:0046880,0.999999999998424,0.710442983117987,0,3,regulation of follicle-stimulating hormone secretion,BP,
11889,GO:0046881,0.999999999998424,0.710442983117987,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
11933,GO:0046958,0.999999999998427,0.891711962972053,0,1,nonassociative learning,BP,
2696,GO:0006060,0.999999999998437,0.813199732336041,0,2,sorbitol metabolic process,BP,
11662,GO:0046370,0.999999999998437,0.813199732336041,0,2,fructose biosynthetic process,BP,
16595,GO:0097368,0.999999999998438,0.645991397659976,0,4,establishment of Sertoli cell barrier,BP,
16015,GO:0086007,0.999999999998441,0.791526181135326,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17807,GO:1901843,0.999999999998441,0.791526181135326,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
15195,GO:0071313,0.999999999998452,0.639179830964001,0,4,cellular response to caffeine,BP,
15266,GO:0071415,0.999999999998452,0.639179830964001,0,4,cellular response to purine-containing compound,BP,
5547,GO:0016533,0.999999999998462,0.817164169173619,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
2021,GO:0004748,0.999999999998469,0.706451104725127,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2639,GO:0005971,0.999999999998469,0.706451104725127,0,3,ribonucleoside-diphosphate reductase complex,CC,
5646,GO:0016728,0.999999999998469,0.706451104725127,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
14440,GO:0061731,0.999999999998469,0.706451104725127,0,3,ribonucleoside-diphosphate reductase activity,MF,
5063,GO:0015272,0.999999999998471,0.892279480302522,0,1,ATP-activated inward rectifier potassium channel activity,MF,
19128,GO:1905006,0.999999999998489,0.798697620374855,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
18607,GO:1903826,0.999999999998497,0.634635955648189,0,4,arginine transmembrane transport,BP,
6368,GO:0021546,0.999999999998531,0.806425363780226,0,2,rhombomere development,BP,
1691,GO:0004161,0.999999999998535,0.810349880094938,0,2,dimethylallyltranstransferase activity,MF,
1742,GO:0004337,0.999999999998535,0.810349880094938,0,2,geranyltranstransferase activity,MF,
8416,GO:0033383,0.999999999998535,0.810349880094938,0,2,geranyl diphosphate metabolic process,BP,
8417,GO:0033384,0.999999999998535,0.810349880094938,0,2,geranyl diphosphate biosynthetic process,BP,
9787,GO:0039656,0.999999999998535,0.803583882123157,0,2,modulation by virus of host gene expression,BP,
11849,GO:0046778,0.999999999998535,0.803583882123157,0,2,modification by virus of host mRNA processing,BP,
9283,GO:0035700,0.999999999998539,0.900754825141712,0,1,astrocyte chemotaxis,BP,
9507,GO:0036145,0.999999999998539,0.900754825141712,0,1,dendritic cell homeostasis,BP,
19968,GO:2000458,0.999999999998539,0.900754825141712,0,1,regulation of astrocyte chemotaxis,BP,
16145,GO:0090119,0.999999999998541,0.888849750890849,0,1,vesicle-mediated cholesterol transport,BP,
19697,GO:1990926,0.999999999998541,0.888849750890849,0,1,short-term synaptic potentiation,BP,
11143,GO:0045168,0.999999999998544,0.809900306816392,0,2,cell-cell signaling involved in cell fate commitment,BP,
11643,GO:0046331,0.999999999998544,0.809900306816392,0,2,lateral inhibition,BP,
17502,GO:1900376,0.999999999998553,0.623410425855003,0,4,regulation of secondary metabolite biosynthetic process,BP,
11136,GO:0045155,0.999999999998556,0.813722397721637,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
13582,GO:0060025,0.999999999998561,0.793542097090312,0,2,regulation of synaptic activity,BP,
16676,GO:0097532,0.999999999998562,0.804987367486622,0,2,stress response to acid chemical,BP,
16677,GO:0097533,0.999999999998562,0.804987367486622,0,2,cellular stress response to acid chemical,BP,
2235,GO:0005137,0.999999999998588,0.895823221330399,0,1,interleukin-5 receptor binding,MF,
2599,GO:0005895,0.999999999998588,0.895823221330399,0,1,interleukin-5 receptor complex,CC,
9462,GO:0036046,0.999999999998591,0.892064507176179,0,1,protein demalonylation,BP,
9463,GO:0036047,0.999999999998591,0.892064507176179,0,1,peptidyl-lysine demalonylation,BP,
9464,GO:0036048,0.999999999998591,0.892064507176179,0,1,protein desuccinylation,BP,
9465,GO:0036049,0.999999999998591,0.892064507176179,0,1,peptidyl-lysine desuccinylation,BP,
9466,GO:0036054,0.999999999998591,0.892064507176179,0,1,protein-malonyllysine demalonylase activity,MF,
9467,GO:0036055,0.999999999998591,0.892064507176179,0,1,protein-succinyllysine desuccinylase activity,MF,
14427,GO:0061697,0.999999999998591,0.892064507176179,0,1,protein-glutaryllysine deglutarylase activity,MF,
14428,GO:0061698,0.999999999998591,0.892064507176179,0,1,protein deglutarylation,BP,
14429,GO:0061699,0.999999999998591,0.892064507176179,0,1,peptidyl-lysine deglutarylation,BP,
5739,GO:0016882,0.999999999998618,0.827426400036892,0,2,cyclo-ligase activity,MF,
8493,GO:0033633,0.99999999999862,0.888584256796885,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8254,GO:0033023,0.999999999998623,0.791415548202912,0,2,mast cell homeostasis,BP,
8255,GO:0033024,0.999999999998623,0.791415548202912,0,2,mast cell apoptotic process,BP,
8256,GO:0033025,0.999999999998623,0.791415548202912,0,2,regulation of mast cell apoptotic process,BP,
15817,GO:0072434,0.999999999998627,0.79292310946043,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
6169,GO:0019520,0.999999999998634,0.801910822762991,0,2,aldonic acid metabolic process,BP,
6170,GO:0019521,0.999999999998634,0.801910822762991,0,2,D-gluconate metabolic process,BP,
1792,GO:0004418,0.99999999999866,0.907925032095526,0,1,hydroxymethylbilane synthase activity,MF,
5916,GO:0018160,0.99999999999866,0.907925032095526,0,1,peptidyl-pyrromethane cofactor linkage,BP,
14801,GO:0070492,0.999999999998664,0.671500664357269,0,4,oligosaccharide binding,MF,
16356,GO:0090571,0.999999999998667,0.723795495104201,0,3,RNA polymerase II transcription repressor complex,CC,
8485,GO:0033624,0.999999999998669,0.79180245680308,0,2,negative regulation of integrin activation,BP,
16987,GO:0098978,0.999999999998671,0.789269199278804,0,2,glutamatergic synapse,CC,
16991,GO:0098985,0.999999999998671,0.789269199278804,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
6812,GO:0030259,0.999999999998674,0.64181974325527,0,4,lipid glycosylation,BP,
15591,GO:0072034,0.99999999999868,0.791920267553929,0,2,renal vesicle induction,BP,
11169,GO:0045210,0.999999999998708,0.789243934308362,0,2,FasL biosynthetic process,BP,
7665,GO:0032089,0.999999999998711,0.793161573267024,0,2,NACHT domain binding,MF,
9975,GO:0042352,0.999999999998724,0.889876494710022,0,1,GDP-L-fucose salvage,BP,
12471,GO:0050201,0.999999999998724,0.889876494710022,0,1,fucokinase activity,MF,
1976,GO:0004689,0.999999999998725,0.623905483619873,0,4,phosphorylase kinase activity,MF,
2634,GO:0005964,0.999999999998725,0.623905483619873,0,4,phosphorylase kinase complex,CC,
19025,GO:1904798,0.999999999998736,0.640572647049102,0,4,positive regulation of core promoter binding,BP,
6738,GO:0030151,0.999999999998755,0.636952627504396,0,4,molybdenum ion binding,MF,
4836,GO:0014040,0.99999999999877,0.79391139551705,0,2,positive regulation of Schwann cell differentiation,BP,
15153,GO:0071228,0.999999999998782,0.892707365263226,0,1,cellular response to tumor cell,BP,
17405,GO:1900109,0.999999999998791,0.825427520071038,0,2,regulation of histone H3-K9 dimethylation,BP,
17406,GO:1900110,0.999999999998791,0.825427520071038,0,2,negative regulation of histone H3-K9 dimethylation,BP,
14775,GO:0070436,0.999999999998792,0.792855130319386,0,2,Grb2-EGFR complex,CC,
9567,GO:0036335,0.999999999998804,0.888429391994373,0,1,intestinal stem cell homeostasis,BP,
1645,GO:0004085,0.999999999998805,0.898519519617558,0,1,butyryl-CoA dehydrogenase activity,MF,
6188,GO:0019605,0.999999999998805,0.898519519617558,0,1,butyrate metabolic process,BP,
11656,GO:0046359,0.999999999998805,0.898519519617558,0,1,butyrate catabolic process,BP,
13468,GO:0052890,0.999999999998805,0.898519519617558,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
1692,GO:0004163,0.999999999998812,0.900417000701068,0,1,diphosphomevalonate decarboxylase activity,MF,
11037,GO:0044868,0.999999999998814,0.798060280478726,0,2,modulation by host of viral molecular function,BP,
1903,GO:0004584,0.999999999998814,0.894525138808891,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
19936,GO:2000393,0.999999999998827,0.793202875163841,0,2,negative regulation of lamellipodium morphogenesis,BP,
1404,GO:0003335,0.999999999998829,0.893772425704495,0,1,corneocyte development,BP,
1405,GO:0003336,0.999999999998829,0.893772425704495,0,1,corneocyte desquamation,BP,
19380,GO:1905715,0.999999999998829,0.893772425704495,0,1,regulation of cornification,BP,
19381,GO:1905716,0.999999999998829,0.893772425704495,0,1,negative regulation of cornification,BP,
8408,GO:0033341,0.999999999998841,0.794068946873264,0,2,regulation of collagen binding,BP,
6042,GO:0019135,0.999999999998848,0.89901755420571,0,1,deoxyhypusine monooxygenase activity,MF,
9166,GO:0035513,0.999999999998855,0.640971148258259,0,4,oxidative RNA demethylation,BP,
9168,GO:0035515,0.999999999998855,0.640971148258259,0,4,oxidative RNA demethylase activity,MF,
2418,GO:0005591,0.999999999998865,0.893512564440804,0,1,collagen type VIII trimer,CC,
2424,GO:0005598,0.999999999998865,0.893512564440804,0,1,short-chain collagen trimer,CC,
7125,GO:0030935,0.999999999998865,0.893512564440804,0,1,sheet-forming collagen trimer,CC,
16823,GO:0098646,0.999999999998865,0.893512564440804,0,1,collagen sheet,CC,
9950,GO:0042296,0.999999999998874,0.667027499566505,0,4,ISG15 transferase activity,MF,
16977,GO:0098960,0.999999999998885,0.633615870253739,0,4,postsynaptic neurotransmitter receptor activity,MF,
17073,GO:0099529,0.999999999998885,0.633615870253739,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18817,GO:1904315,0.999999999998885,0.633615870253739,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
1304,GO:0003139,0.999999999998893,0.649559857005272,0,4,secondary heart field specification,BP,
16766,GO:0098508,0.999999999998896,0.801886730165338,0,2,endothelial to hematopoietic transition,BP,
18132,GO:1902746,0.9999999999989,0.89429148030481,0,1,regulation of lens fiber cell differentiation,BP,
18899,GO:1904530,0.99999999999891,0.892216518833392,0,1,negative regulation of actin filament binding,BP,
18941,GO:1904617,0.99999999999891,0.892216518833392,0,1,negative regulation of actin binding,BP,
16440,GO:0097058,0.999999999998914,0.900460804530654,0,1,CRLF-CLCF1 complex,CC,
16441,GO:0097059,0.999999999998914,0.900460804530654,0,1,CNTFR-CLCF1 complex,CC,
8380,GO:0033269,0.999999999998921,0.796209035324233,0,2,internode region of axon,CC,
496,GO:0001550,0.999999999998928,0.789558276964464,0,2,ovarian cumulus expansion,BP,
12129,GO:0048165,0.999999999998928,0.789558276964464,0,2,fused antrum stage,BP,
15430,GO:0071676,0.999999999998947,0.797061016877255,0,2,negative regulation of mononuclear cell migration,BP,
16088,GO:0090027,0.999999999998947,0.797061016877255,0,2,negative regulation of monocyte chemotaxis,BP,
13296,GO:0051964,0.999999999998958,0.625288576654616,0,4,negative regulation of synapse assembly,BP,
1031,GO:0002536,0.999999999998962,0.83247817192704,0,2,respiratory burst involved in inflammatory response,BP,
13727,GO:0060264,0.999999999998962,0.83247817192704,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13729,GO:0060266,0.999999999998962,0.83247817192704,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
18884,GO:1904481,0.999999999998962,0.894083822184643,0,1,response to tetrahydrofolate,BP,
18885,GO:1904482,0.999999999998962,0.894083822184643,0,1,cellular response to tetrahydrofolate,BP,
9770,GO:0039520,0.999999999998963,0.888397851868171,0,1,induction by virus of host autophagy,BP,
4212,GO:0009353,0.999999999998981,0.912158287406587,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7435,GO:0031531,0.999999999998981,0.912158287406587,0,1,thyrotropin-releasing hormone receptor binding,MF,
18541,GO:1903677,0.999999999998986,0.720598879865478,0,3,regulation of cap-independent translational initiation,BP,
18542,GO:1903679,0.999999999998986,0.720598879865478,0,3,positive regulation of cap-independent translational initiation,BP,
16417,GO:0097017,0.999999999998987,0.798437645970761,0,2,renal protein absorption,BP,
5423,GO:0016269,0.999999999998993,0.893950544114382,0,1,O-glycan processing, core 3,BP,
11988,GO:0047224,0.999999999998993,0.893950544114382,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
14128,GO:0060957,0.999999999999001,0.892616641716925,0,1,endocardial cell fate commitment,BP,
14331,GO:0061445,0.999999999999001,0.892616641716925,0,1,endocardial cushion cell fate commitment,BP,
4807,GO:0010999,0.999999999999004,0.888919672423888,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11523,GO:0045993,0.999999999999004,0.888919672423888,0,1,negative regulation of translational initiation by iron,BP,
11955,GO:0046986,0.999999999999004,0.888919672423888,0,1,negative regulation of hemoglobin biosynthetic process,BP,
19121,GO:1904995,0.99999999999901,0.83142669707796,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
12188,GO:0048294,0.999999999999036,0.79357106401941,0,2,negative regulation of isotype switching to IgE isotypes,BP,
10402,GO:0043224,0.999999999999041,0.854604635315009,0,2,nuclear SCF ubiquitin ligase complex,CC,
19744,GO:2000053,0.999999999999043,0.789709393565871,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11115,GO:0045113,0.999999999999046,0.836933835272473,0,2,regulation of integrin biosynthetic process,BP,
9721,GO:0038124,0.999999999999049,0.791839587557314,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10051,GO:0042494,0.999999999999049,0.791839587557314,0,2,detection of bacterial lipoprotein,BP,
10053,GO:0042496,0.999999999999049,0.791839587557314,0,2,detection of diacyl bacterial lipopeptide,BP,
14724,GO:0070340,0.999999999999049,0.791839587557314,0,2,detection of bacterial lipopeptide,BP,
15459,GO:0071724,0.999999999999049,0.791839587557314,0,2,response to diacyl bacterial lipopeptide,BP,
15461,GO:0071726,0.999999999999049,0.791839587557314,0,2,cellular response to diacyl bacterial lipopeptide,BP,
12010,GO:0047374,0.999999999999051,0.815549325317316,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
2439,GO:0005638,0.999999999999062,0.638765154068824,0,4,lamin filament,CC,
3743,GO:0008282,0.999999999999062,0.792950742149162,0,2,inward rectifying potassium channel,CC,
6669,GO:0030021,0.999999999999063,0.892273637378118,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6875,GO:0030345,0.999999999999063,0.892273637378118,0,1,structural constituent of tooth enamel,MF,
4393,GO:0010044,0.999999999999064,0.644041434587054,0,4,response to aluminum ion,BP,
2029,GO:0004766,0.999999999999067,0.913765858074459,0,1,spermidine synthase activity,MF,
16014,GO:0086006,0.999999999999091,0.789875460502207,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
4497,GO:0010520,0.999999999999099,0.79703783987883,0,2,regulation of reciprocal meiotic recombination,BP,
8095,GO:0032771,0.9999999999991,0.889171623770876,0,1,regulation of monophenol monooxygenase activity,BP,
8096,GO:0032773,0.9999999999991,0.889171623770876,0,1,positive regulation of monophenol monooxygenase activity,BP,
8182,GO:0032912,0.9999999999991,0.889171623770876,0,1,negative regulation of transforming growth factor beta2 production,BP,
12090,GO:0048023,0.9999999999991,0.889171623770876,0,1,positive regulation of melanin biosynthetic process,BP,
13209,GO:0051796,0.9999999999991,0.889171623770876,0,1,negative regulation of timing of catagen,BP,
14102,GO:0060901,0.9999999999991,0.889171623770876,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18184,GO:1902908,0.9999999999991,0.889171623770876,0,1,regulation of melanosome transport,BP,
18185,GO:1902910,0.9999999999991,0.889171623770876,0,1,positive regulation of melanosome transport,BP,
3736,GO:0008273,0.999999999999101,0.789750062795984,0,2,calcium, potassium:sodium antiporter activity,MF,
1746,GO:0004343,0.999999999999107,0.889869434189855,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
15593,GO:0072038,0.999999999999111,0.791772269207166,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15594,GO:0072039,0.999999999999111,0.791772269207166,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15595,GO:0072040,0.999999999999111,0.791772269207166,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17586,GO:1901145,0.999999999999111,0.791772269207166,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18956,GO:1904673,0.999999999999111,0.791772269207166,0,2,negative regulation of somatic stem cell population maintenance,BP,
3837,GO:0008441,0.99999999999912,0.794276211152036,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
11900,GO:0046899,0.999999999999125,0.797681128975221,0,2,nucleoside triphosphate adenylate kinase activity,MF,
901,GO:0002277,0.999999999999138,0.927971765092169,0,1,myeloid dendritic cell activation involved in immune response,BP,
1057,GO:0002582,0.999999999999138,0.927971765092169,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1060,GO:0002585,0.999999999999138,0.927971765092169,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1063,GO:0002588,0.999999999999138,0.927971765092169,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5795,GO:0017024,0.999999999999138,0.927971765092169,0,1,myosin I binding,MF,
17123,GO:0099640,0.999999999999138,0.927971765092169,0,1,axo-dendritic protein transport,BP,
17124,GO:0099641,0.999999999999138,0.927971765092169,0,1,anterograde axonal protein transport,BP,
6237,GO:0019785,0.999999999999147,0.797960584166924,0,2,ISG15-specific protease activity,MF,
6363,GO:0021541,0.999999999999163,0.889270732482854,0,1,ammon gyrus development,BP,
162,GO:0000333,0.999999999999172,0.842211770526158,0,2,telomerase catalytic core complex,CC,
14215,GO:0061101,0.999999999999192,0.655189123496117,0,4,neuroendocrine cell differentiation,BP,
16446,GO:0097065,0.999999999999206,0.632146117648541,0,4,anterior head development,BP,
1750,GO:0004347,0.999999999999216,0.896540113647271,0,1,glucose-6-phosphate isomerase activity,MF,
6088,GO:0019242,0.999999999999216,0.896540113647271,0,1,methylglyoxal biosynthetic process,BP,
11735,GO:0046523,0.999999999999217,0.892195951297377,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
17958,GO:1902261,0.999999999999218,0.790448254295758,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
14093,GO:0060857,0.999999999999219,0.895019920965759,0,1,establishment of glial blood-brain barrier,BP,
18095,GO:1902636,0.99999999999923,0.826298826982146,0,2,kinociliary basal body,CC,
18358,GO:1903292,0.999999999999242,0.79521534331516,0,2,protein localization to Golgi membrane,BP,
18999,GO:1904749,0.999999999999255,0.657956097466133,0,4,regulation of protein localization to nucleolus,BP,
7370,GO:0031407,0.99999999999926,0.894509706911644,0,1,oxylipin metabolic process,BP,
12069,GO:0047977,0.99999999999926,0.894509706911644,0,1,hepoxilin-epoxide hydrolase activity,MF,
17792,GO:1901751,0.99999999999926,0.894509706911644,0,1,leukotriene A4 metabolic process,BP,
20338,GO:2001300,0.99999999999926,0.894509706911644,0,1,lipoxin metabolic process,BP,
20339,GO:2001301,0.99999999999926,0.894509706911644,0,1,lipoxin biosynthetic process,BP,
20340,GO:2001302,0.99999999999926,0.894509706911644,0,1,lipoxin A4 metabolic process,BP,
20341,GO:2001303,0.99999999999926,0.894509706911644,0,1,lipoxin A4 biosynthetic process,BP,
20342,GO:2001304,0.99999999999926,0.894509706911644,0,1,lipoxin B4 metabolic process,BP,
20343,GO:2001306,0.99999999999926,0.894509706911644,0,1,lipoxin B4 biosynthetic process,BP,
5903,GO:0018106,0.999999999999263,0.934969350352208,0,1,peptidyl-histidine phosphorylation,BP,
9986,GO:0042365,0.999999999999267,0.740501608751313,0,3,water-soluble vitamin catabolic process,BP,
18283,GO:1903094,0.999999999999269,0.846036315470958,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19793,GO:2000157,0.999999999999269,0.846036315470958,0,2,negative regulation of ubiquitin-specific protease activity,BP,
13946,GO:0060586,0.999999999999276,0.635453327772186,0,4,multicellular organismal iron ion homeostasis,BP,
19626,GO:1990715,0.999999999999278,0.88957853638364,0,1,mRNA CDS binding,MF,
3111,GO:0006689,0.999999999999278,0.64115806939914,0,4,ganglioside catabolic process,BP,
14253,GO:0061196,0.999999999999296,0.630510551363186,0,4,fungiform papilla development,BP,
14254,GO:0061197,0.999999999999296,0.630510551363186,0,4,fungiform papilla morphogenesis,BP,
2343,GO:0005372,0.999999999999304,0.652101672232373,0,4,water transmembrane transporter activity,MF,
5056,GO:0015250,0.999999999999304,0.652101672232373,0,4,water channel activity,MF,
16527,GO:0097209,0.999999999999315,0.646139834723787,0,4,epidermal lamellar body,CC,
3061,GO:0006624,0.999999999999334,0.835718622936521,0,2,vacuolar protein processing,BP,
17539,GO:1900748,0.999999999999341,0.623040926786443,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
10205,GO:0042799,0.999999999999346,0.632182235858282,0,4,histone methyltransferase activity (H4-K20 specific),MF,
12279,GO:0048549,0.999999999999348,0.628566828771708,0,4,positive regulation of pinocytosis,BP,
6378,GO:0021560,0.999999999999353,0.797095807225058,0,2,abducens nerve development,BP,
6397,GO:0021598,0.999999999999353,0.797095807225058,0,2,abducens nerve morphogenesis,BP,
6398,GO:0021599,0.999999999999353,0.797095807225058,0,2,abducens nerve formation,BP,
18636,GO:1903893,0.999999999999366,0.893931820833876,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
4172,GO:0009237,0.999999999999371,0.892718442833309,0,1,siderophore metabolic process,BP,
6098,GO:0019290,0.999999999999371,0.892718442833309,0,1,siderophore biosynthetic process,BP,
1319,GO:0003164,0.99999999999938,0.789462257814104,0,2,His-Purkinje system development,BP,
383,GO:0001018,0.999999999999381,0.801407723870581,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
2855,GO:0006344,0.999999999999381,0.627631142085041,0,4,maintenance of chromatin silencing,BP,
11131,GO:0045142,0.999999999999383,0.790835179203988,0,2,triplex DNA binding,MF,
15667,GO:0072162,0.999999999999387,0.79275170562595,0,2,metanephric mesenchymal cell differentiation,BP,
8646,GO:0034165,0.999999999999394,0.794079290760619,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
5012,GO:0015168,0.999999999999395,0.803240463153935,0,2,glycerol transmembrane transporter activity,MF,
5058,GO:0015254,0.999999999999395,0.803240463153935,0,2,glycerol channel activity,MF,
5201,GO:0015793,0.999999999999395,0.803240463153935,0,2,glycerol transport,BP,
5306,GO:0016005,0.999999999999407,0.79399660262204,0,2,phospholipase A2 activator activity,MF,
16180,GO:0090182,0.999999999999409,0.811990681579218,0,2,regulation of secretion of lysosomal enzymes,BP,
8156,GO:0032876,0.999999999999418,0.624963062981492,0,4,negative regulation of DNA endoreduplication,BP,
14652,GO:0070209,0.999999999999419,0.891489780389265,0,1,ASTRA complex,CC,
18665,GO:1903939,0.999999999999419,0.891489780389265,0,1,regulation of TORC2 signaling,BP,
18894,GO:1904515,0.999999999999419,0.891489780389265,0,1,positive regulation of TORC2 signaling,BP,
8801,GO:0034481,0.999999999999421,0.633308626994622,0,4,chondroitin sulfotransferase activity,MF,
19436,GO:1905937,0.999999999999423,0.926825776261004,0,1,negative regulation of germ cell proliferation,BP,
19840,GO:2000255,0.999999999999423,0.926825776261004,0,1,negative regulation of male germ cell proliferation,BP,
15197,GO:0071315,0.999999999999428,0.71083976830376,0,3,cellular response to morphine,BP,
15199,GO:0071317,0.999999999999428,0.71083976830376,0,3,cellular response to isoquinoline alkaloid,BP,
3994,GO:0008890,0.999999999999458,0.904936829447857,0,1,glycine C-acetyltransferase activity,MF,
6167,GO:0019518,0.999999999999458,0.904936829447857,0,1,L-threonine catabolic process to glycine,BP,
4891,GO:0014809,0.999999999999463,0.755388539593486,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
9508,GO:0036146,0.999999999999464,0.71705567966538,0,3,cellular response to mycotoxin,BP,
18719,GO:1904046,0.999999999999465,0.834393409677725,0,2,negative regulation of vascular endothelial growth factor production,BP,
472,GO:0001515,0.999999999999469,0.89777915931344,0,1,opioid peptide activity,MF,
2368,GO:0005483,0.999999999999485,0.712880547569382,0,3,soluble NSF attachment protein activity,MF,
19645,GO:1990758,0.999999999999486,0.899840357851703,0,1,mitotic sister chromatid biorientation,BP,
513,GO:0001576,0.999999999999487,0.896530229088824,0,1,globoside biosynthetic process,BP,
1553,GO:0003948,0.999999999999487,0.896530229088824,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12514,GO:0050512,0.999999999999487,0.896530229088824,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
4504,GO:0010533,0.999999999999491,0.773187465043691,0,3,regulation of activation of Janus kinase activity,BP,
670,GO:0001872,0.999999999999492,0.898326691658585,0,1,(1->3)-beta-D-glucan binding,MF,
3778,GO:0008332,0.999999999999492,0.898326691658585,0,1,low voltage-gated calcium channel activity,MF,
11035,GO:0044866,0.999999999999492,0.898326691658585,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11036,GO:0044867,0.999999999999492,0.898326691658585,0,1,modulation by host of viral catalytic activity,BP,
11038,GO:0044869,0.999999999999492,0.898326691658585,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11039,GO:0044870,0.999999999999492,0.898326691658585,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11040,GO:0044871,0.999999999999492,0.898326691658585,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
13366,GO:0052403,0.999999999999492,0.898326691658585,0,1,negative regulation by host of symbiont catalytic activity,BP,
18245,GO:1903015,0.999999999999492,0.898326691658585,0,1,regulation of exo-alpha-sialidase activity,BP,
18246,GO:1903016,0.999999999999492,0.898326691658585,0,1,negative regulation of exo-alpha-sialidase activity,BP,
8542,GO:0033858,0.999999999999496,0.892009554588741,0,1,N-acetylgalactosamine kinase activity,MF,
3547,GO:0007576,0.999999999999498,0.893762342391054,0,1,nucleolar fragmentation,BP,
236,GO:0000493,0.99999999999952,0.804435586159468,0,2,box H/ACA snoRNP assembly,BP,
17973,GO:1902298,0.999999999999536,0.79533875223815,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19560,GO:1990426,0.999999999999536,0.79533875223815,0,2,mitotic recombination-dependent replication fork processing,BP,
19581,GO:1990505,0.999999999999536,0.79533875223815,0,2,mitotic DNA replication maintenance of fidelity,BP,
11967,GO:0047045,0.999999999999547,0.914928623476389,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
1893,GO:0004572,0.999999999999586,0.789290974856643,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
18842,GO:1904381,0.999999999999599,0.790179919679803,0,2,Golgi apparatus mannose trimming,BP,
12030,GO:0047555,0.999999999999602,0.625524454883059,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
5530,GO:0016503,0.999999999999607,0.912761642586542,0,1,pheromone receptor activity,MF,
2375,GO:0005502,0.999999999999612,0.888701648367617,0,1,11-cis retinal binding,MF,
2376,GO:0005503,0.999999999999612,0.888701648367617,0,1,all-trans retinal binding,MF,
14500,GO:0061896,0.999999999999612,0.888701648367617,0,1,all-trans retinol 3,4-desaturase activity,MF,
14501,GO:0061897,0.999999999999612,0.888701648367617,0,1,all-trans retinal 3,4-desaturase activity,MF,
14502,GO:0061898,0.999999999999612,0.888701648367617,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14503,GO:0061899,0.999999999999612,0.888701648367617,0,1,11-cis-retinal 3,4-desaturase activity,MF,
915,GO:0002299,0.999999999999614,0.905490974065596,0,1,alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002300,0.999999999999614,0.905490974065596,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
917,GO:0002304,0.999999999999614,0.905490974065596,0,1,gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002305,0.999999999999614,0.905490974065596,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
8877,GO:0034673,0.999999999999617,0.789268474493381,0,2,inhibin-betaglycan-ActRII complex,CC,
13340,GO:0052199,0.999999999999619,0.802334002134477,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14684,GO:0070274,0.99999999999963,0.813349342366361,0,2,RES complex,CC,
2055,GO:0004802,0.999999999999631,0.896327592739362,0,1,transketolase activity,MF,
13728,GO:0060265,0.999999999999635,0.929886430172149,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
15995,GO:0080129,0.999999999999655,0.920206734027906,0,1,proteasome core complex assembly,BP,
19111,GO:1904975,0.999999999999672,0.790564201091458,0,2,response to bleomycin,BP,
19112,GO:1904976,0.999999999999672,0.790564201091458,0,2,cellular response to bleomycin,BP,
20096,GO:2000698,0.999999999999677,0.664917110917973,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
16341,GO:0090521,0.999999999999706,0.629487244891497,0,4,glomerular visceral epithelial cell migration,BP,
17694,GO:1901529,0.99999999999973,0.794065856722609,0,2,positive regulation of anion channel activity,BP,
5999,GO:0019002,0.999999999999736,0.803046855194316,0,2,GMP binding,MF,
1543,GO:0003933,0.999999999999745,0.898079872994614,0,1,GTP cyclohydrolase activity,MF,
1544,GO:0003934,0.999999999999745,0.898079872994614,0,1,GTP cyclohydrolase I activity,MF,
9437,GO:0035998,0.999999999999745,0.898079872994614,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
6790,GO:0030222,0.999999999999756,0.890653231016152,0,1,eosinophil differentiation,BP,
11335,GO:0045643,0.999999999999756,0.890653231016152,0,1,regulation of eosinophil differentiation,BP,
11336,GO:0045645,0.999999999999756,0.890653231016152,0,1,positive regulation of eosinophil differentiation,BP,
17972,GO:1902296,0.99999999999979,0.891645908054815,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17985,GO:1902319,0.99999999999979,0.891645908054815,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18224,GO:1902983,0.99999999999979,0.891645908054815,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
4250,GO:0009448,0.999999999999803,0.628831251936127,0,4,gamma-aminobutyric acid metabolic process,BP,
847,GO:0002159,0.999999999999833,0.628683515700539,0,4,desmosome assembly,BP,
2366,GO:0005476,0.999999999999836,0.800019058466884,0,2,carnitine:acyl carnitine antiporter activity,MF,
3982,GO:0008808,0.999999999999845,0.890182278247512,0,1,cardiolipin synthase activity,MF,
6952,GO:0030572,0.999999999999845,0.890182278247512,0,1,phosphatidyltransferase activity,MF,
10480,GO:0043337,0.999999999999845,0.890182278247512,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19379,GO:1905711,0.999999999999845,0.890182278247512,0,1,response to phosphatidylethanolamine,BP,
3487,GO:0007356,0.999999999999858,0.803830983617753,0,2,thorax and anterior abdomen determination,BP,
20237,GO:2001074,0.999999999999858,0.803830983617753,0,2,regulation of metanephric ureteric bud development,BP,
20238,GO:2001076,0.999999999999858,0.803830983617753,0,2,positive regulation of metanephric ureteric bud development,BP,
12674,GO:0050859,0.999999999999909,0.715890906091874,0,3,negative regulation of B cell receptor signaling pathway,BP,
16742,GO:0097724,0.999999999999948,0.899914659988157,0,1,sperm flagellum movement,BP,
19281,GO:1905419,0.999999999999948,0.899914659988157,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
18520,GO:1903621,0.999999999999951,0.898185500449735,0,1,protein localization to photoreceptor connecting cilium,BP,
1897,GO:0004577,0.999999999999989,0.822361243125421,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
7553,GO:0031849,0.999999999999995,0.890296336272603,0,1,olfactory receptor binding,MF,
398,GO:0001074,0.999999999999999,0.893624324189711,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
404,GO:0001084,0.999999999999999,0.893624324189711,0,1,transcription factor activity, TFIID-class binding,MF,
8441,GO:0033552,0.999999999999999,0.893624324189711,0,1,response to vitamin B3,BP,
6,GO:0000012,1,0.400816398469937,0,8,single strand break repair,BP,
11,GO:0000022,1,0.324018568899045,0,10,mitotic spindle elongation,BP,
15,GO:0000028,1,0.244205756645325,0,18,ribosomal small subunit assembly,BP,
29,GO:0000054,1,0.279255709318445,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.450143574069064,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.505492861074917,0,7,ribosomal small subunit export from nucleus,BP,
37,GO:0000076,1,0.170460365195208,0,16,DNA replication checkpoint,BP,
57,GO:0000120,1,0.584441803880975,0,5,RNA polymerase I transcription factor complex,CC,
62,GO:0000125,1,0.610122000341822,0,5,PCAF complex,CC,
64,GO:0000127,1,0.519886308472142,0,6,transcription factor TFIIIC complex,CC,
73,GO:0000150,1,0.421853432651698,0,8,recombinase activity,MF,
81,GO:0000164,1,0.291328111852087,0,11,protein phosphatase type 1 complex,CC,
85,GO:0000172,1,0.549160337824889,0,6,ribonuclease MRP complex,CC,
88,GO:0000176,1,0.294850889441711,0,13,nuclear exosome (RNase complex),CC,
113,GO:0000235,1,0.39724681036116,0,8,astral microtubule,CC,
115,GO:0000243,1,0.446042477144844,0,8,commitment complex,CC,
116,GO:0000244,1,0.253529588319462,0,12,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.00291761368506689,0,54,spliceosomal complex assembly,BP,
140,GO:0000290,1,0.3757270074325,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.0309400930971863,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000295,1,0.29884272083851,0,11,adenine nucleotide transmembrane transporter activity,MF,
157,GO:0000315,1,0.0116916359763251,0,51,organellar large ribosomal subunit,CC,
163,GO:0000338,1,0.346587723013073,0,10,protein deneddylation,BP,
165,GO:0000340,1,0.359542823859772,0,9,RNA 7-methylguanosine cap binding,MF,
166,GO:0000346,1,0.248347521116389,0,13,transcription export complex,CC,
167,GO:0000347,1,0.53856758859019,0,6,THO complex,CC,
171,GO:0000375,1,4.16986194872394e-11,3,302,RNA splicing, via transesterification reactions,BP,SYMPK;RALY;SF3B6
172,GO:0000377,1,5.5254140443254e-11,3,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SYMPK;RALY;SF3B6
174,GO:0000380,1,0.00576523217662176,0,46,alternative mRNA splicing, via spliceosome,BP,
175,GO:0000381,1,0.0219175948742956,0,34,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000387,1,0.0216207296856095,0,37,spliceosomal snRNP assembly,BP,
179,GO:0000389,1,0.513377176510065,0,6,mRNA 3'-splice site recognition,BP,
181,GO:0000393,1,0.582141704267946,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
183,GO:0000395,1,0.519006489546566,0,6,mRNA 5'-splice site recognition,BP,
184,GO:0000398,1,5.5254140443254e-11,3,299,mRNA splicing, via spliceosome,BP,SYMPK;RALY;SF3B6
185,GO:0000400,1,0.169778170209303,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.496638660264143,0,6,Y-form DNA binding,MF,
191,GO:0000408,1,0.6073291478786,0,5,EKC/KEOPS complex,CC,
211,GO:0000439,1,0.372140960928351,0,9,core TFIIH complex,CC,
213,GO:0000445,1,0.53856758859019,0,6,THO complex part of transcription export complex,CC,
214,GO:0000447,1,0.400015564876743,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000459,1,0.493230408674269,0,7,exonucleolytic trimming involved in rRNA processing,BP,
221,GO:0000460,1,0.0330522806123084,0,33,maturation of 5.8S rRNA,BP,
223,GO:0000462,1,0.0239624044739634,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000463,1,0.37766908544813,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.0992258186637,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000467,1,0.493230408674269,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000469,1,0.0672094390996306,0,26,cleavage involved in rRNA processing,BP,
228,GO:0000470,1,0.094094757836741,0,24,maturation of LSU-rRNA,BP,
230,GO:0000478,1,0.19964737455173,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.223313821853806,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000480,1,0.506384116968242,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000491,1,0.389250440035557,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
235,GO:0000492,1,0.483941692554999,0,7,box C/D snoRNP assembly,BP,
246,GO:0000702,1,0.627079175228551,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000707,1,0.421028808666454,0,8,meiotic DNA recombinase assembly,BP,
251,GO:0000712,1,0.362613671380553,0,9,resolution of meiotic recombination intermediates,BP,
258,GO:0000724,1,1.1407072192027e-05,0,101,double-strand break repair via homologous recombination,BP,
259,GO:0000725,1,1.0173696155938e-05,0,102,recombinational repair,BP,
261,GO:0000727,1,0.58488901994801,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000729,1,0.0812485861262335,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.335754721155092,0,10,DNA recombinase assembly,BP,
276,GO:0000778,1,0.26619814984133,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.10919911531154,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.325315841028561,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.325315841028561,0,10,nuclear telomere cap complex,CC,
292,GO:0000796,1,0.437865267159483,0,7,condensin complex,CC,
296,GO:0000800,1,0.444506654741756,0,7,lateral element,CC,
301,GO:0000808,1,0.360522177699106,0,9,origin recognition complex,CC,
303,GO:0000812,1,0.345541667902368,0,10,Swr1 complex,CC,
322,GO:0000900,1,0.317369696512049,0,10,translation repressor activity, mRNA regulatory element binding,MF,
326,GO:0000912,1,0.498905691357245,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
327,GO:0000915,1,0.498905691357245,0,6,actomyosin contractile ring assembly,BP,
333,GO:0000923,1,0.500163336561131,0,6,equatorial microtubule organizing center,CC,
340,GO:0000940,1,0.228747052709807,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000957,1,0.560654291386852,0,5,mitochondrial RNA catabolic process,BP,
350,GO:0000963,1,0.174216720031152,0,16,mitochondrial RNA processing,BP,
352,GO:0000965,1,0.587669988016971,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000966,1,0.117683842733921,0,21,RNA 5'-end processing,BP,
355,GO:0000972,1,0.455491665207094,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
357,GO:0000974,1,0.242076350966762,0,13,Prp19 complex,CC,
365,GO:0000983,1,0.183159883682429,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
369,GO:0000990,1,0.36412453060274,0,9,transcription factor activity, core RNA polymerase binding,MF,
372,GO:0000993,1,0.049798092262399,0,27,RNA polymerase II core binding,MF,
386,GO:0001030,1,0.5647186871707,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1,0.5647186871707,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
390,GO:0001042,1,0.50239175834166,0,6,RNA polymerase I core binding,MF,
393,GO:0001054,1,0.345126345811397,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.343041507194557,0,11,RNA polymerase II activity,MF,
395,GO:0001056,1,0.221679085463801,0,15,RNA polymerase III activity,MF,
399,GO:0001075,1,0.510192618620896,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001083,1,0.564131663914414,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
428,GO:0001135,1,0.445976903881689,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
447,GO:0001206,1,0.553527738857424,0,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
462,GO:0001405,1,0.584961828779578,0,5,presequence translocase-associated import motor,CC,
474,GO:0001517,1,0.56198452991069,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
490,GO:0001542,1,0.497676720801008,0,6,ovulation from ovarian follicle,BP,
498,GO:0001553,1,0.559224402437637,0,5,luteinization,BP,
501,GO:0001556,1,0.15198520130704,0,17,oocyte maturation,BP,
516,GO:0001580,1,0.633376507318411,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
521,GO:0001608,1,0.577201255225757,0,5,G-protein coupled nucleotide receptor activity,MF,
528,GO:0001637,1,0.508359389184094,0,6,G-protein coupled chemoattractant receptor activity,MF,
542,GO:0001660,1,0.464473621929056,0,7,fever generation,BP,
550,GO:0001671,1,0.0922471572963207,0,22,ATPase activator activity,MF,
559,GO:0001682,1,0.312657095720016,0,12,tRNA 5'-leader removal,BP,
562,GO:0001696,1,0.520302143062768,0,6,gastric acid secretion,BP,
578,GO:0001727,1,0.565873854095153,0,5,lipid kinase activity,MF,
581,GO:0001731,1,0.411343547382613,0,8,formation of translation preinitiation complex,BP,
587,GO:0001739,1,0.513231080364098,0,6,sex chromatin,CC,
600,GO:0001765,1,0.379092741922139,0,9,membrane raft assembly,BP,
603,GO:0001768,1,0.559807407847611,0,5,establishment of T cell polarity,BP,
608,GO:0001774,1,0.225715642237378,0,13,microglial cell activation,BP,
613,GO:0001779,1,0.213699411466232,0,14,natural killer cell differentiation,BP,
620,GO:0001787,1,0.603602950485339,0,5,natural killer cell proliferation,BP,
634,GO:0001821,1,0.451763502034976,0,8,histamine secretion,BP,
639,GO:0001826,1,0.5570816664877,0,5,inner cell mass cell differentiation,BP,
642,GO:0001829,1,0.330598355800908,0,10,trophectodermal cell differentiation,BP,
644,GO:0001832,1,0.180442254885683,0,15,blastocyst growth,BP,
645,GO:0001833,1,0.320439867058128,0,10,inner cell mass cell proliferation,BP,
654,GO:0001842,1,0.582334802164024,0,5,neural fold formation,BP,
657,GO:0001845,1,0.380700933076309,0,9,phagolysosome assembly,BP,
658,GO:0001846,1,0.535829761376871,0,6,opsonin binding,MF,
669,GO:0001871,1,0.449984616974081,0,7,pattern binding,MF,
679,GO:0001886,1,0.456827786787627,0,7,endothelial cell morphogenesis,BP,
699,GO:0001916,1,0.43947050587203,0,8,positive regulation of T cell mediated cytotoxicity,BP,
717,GO:0001939,1,0.506985596217477,0,6,female pronucleus,CC,
718,GO:0001940,1,0.567726145806881,0,5,male pronucleus,CC,
739,GO:0001967,1,0.455749307770938,0,7,suckling behavior,BP,
747,GO:0001975,1,0.238269614872864,0,13,response to amphetamine,BP,
772,GO:0002024,1,0.568166867224521,0,5,diet induced thermogenesis,BP,
788,GO:0002043,1,0.334471370312536,0,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
791,GO:0002052,1,0.252040227463358,0,12,positive regulation of neuroblast proliferation,BP,
803,GO:0002069,1,0.523700572821965,0,6,columnar/cuboidal epithelial cell maturation,BP,
806,GO:0002072,1,0.494785504980765,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
812,GO:0002082,1,0.217413399930949,0,14,regulation of oxidative phosphorylation,BP,
823,GO:0002093,1,0.462514524806875,0,7,auditory receptor cell morphogenesis,BP,
825,GO:0002097,1,0.172616443615109,0,16,tRNA wobble base modification,BP,
826,GO:0002098,1,0.269002664886419,0,12,tRNA wobble uridine modification,BP,
832,GO:0002116,1,0.308037216595751,0,10,semaphorin receptor complex,CC,
842,GO:0002151,1,0.504522301525625,0,6,G-quadruplex RNA binding,MF,
857,GO:0002182,1,0.287277181806482,0,11,cytoplasmic translational elongation,BP,
867,GO:0002199,1,0.464057863292236,0,7,zona pellucida receptor complex,CC,
880,GO:0002230,1,0.159071783960596,0,17,positive regulation of defense response to virus by host,BP,
904,GO:0002281,1,0.560583862720162,0,5,macrophage activation involved in immune response,BP,
929,GO:0002323,1,0.389430530992517,0,9,natural killer cell activation involved in immune response,BP,
933,GO:0002328,1,0.364605017156976,0,9,pro-B cell differentiation,BP,
942,GO:0002349,1,0.596313106845122,0,5,histamine production involved in inflammatory response,BP,
968,GO:0002407,1,0.303026439489598,0,11,dendritic cell chemotaxis,BP,
987,GO:0002441,1,0.596313106845122,0,5,histamine secretion involved in inflammatory response,BP,
1009,GO:0002480,1,0.410201842786636,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1011,GO:0002483,1,0.41843907166719,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1029,GO:0002532,1,0.0212101638324788,0,35,production of molecular mediator involved in inflammatory response,BP,
1030,GO:0002534,1,0.0765891151223328,0,23,cytokine production involved in inflammatory response,BP,
1042,GO:0002553,1,0.596313106845122,0,5,histamine secretion by mast cell,BP,
1048,GO:0002568,1,0.558550393994749,0,5,somatic diversification of T cell receptor genes,BP,
1052,GO:0002577,1,0.43756948423008,0,8,regulation of antigen processing and presentation,BP,
1075,GO:0002638,1,0.563660107045038,0,5,negative regulation of immunoglobulin production,BP,
1091,GO:0002676,1,0.540572235334866,0,6,regulation of chronic inflammatory response,BP,
1095,GO:0002681,1,0.558550393994749,0,5,somatic recombination of T cell receptor gene segments,BP,
1131,GO:0002717,1,0.340859481788541,0,10,positive regulation of natural killer cell mediated immunity,BP,
1244,GO:0002934,1,0.352158782218102,0,9,desmosome organization,BP,
1285,GO:0003084,1,0.535889019026167,0,6,positive regulation of systemic arterial blood pressure,BP,
1312,GO:0003157,1,0.40487573622371,0,8,endocardium development,BP,
1314,GO:0003159,1,0.299623756948072,0,11,morphogenesis of an endothelium,BP,
1316,GO:0003161,1,0.352249486748346,0,9,cardiac conduction system development,BP,
1329,GO:0003177,1,0.500431966930282,0,6,pulmonary valve development,BP,
1334,GO:0003184,1,0.500431966930282,0,6,pulmonary valve morphogenesis,BP,
1375,GO:0003263,1,0.601888638504519,0,5,cardioblast proliferation,BP,
1376,GO:0003264,1,0.534688710871295,0,6,regulation of cardioblast proliferation,BP,
1377,GO:0003266,1,0.598589672134789,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1406,GO:0003337,1,0.472547536659857,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1408,GO:0003339,1,0.589312756562693,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1413,GO:0003344,1,0.493122056658165,0,6,pericardium morphogenesis,BP,
1427,GO:0003376,1,0.360877547418413,0,9,sphingosine-1-phosphate signaling pathway,BP,
1451,GO:0003678,1,0.00517357439385482,0,46,DNA helicase activity,MF,
1455,GO:0003688,1,0.203624974072797,0,14,DNA replication origin binding,MF,
1456,GO:0003689,1,0.418555937076997,0,8,DNA clamp loader activity,MF,
1458,GO:0003691,1,0.365631235832429,0,9,double-stranded telomeric DNA binding,MF,
1468,GO:0003720,1,0.434446085309362,0,8,telomerase activity,MF,
1471,GO:0003724,1,0.00102643589696393,0,60,RNA helicase activity,MF,
1480,GO:0003747,1,0.509159659741258,0,6,translation release factor activity,MF,
1532,GO:0003909,1,0.453651199332371,0,7,DNA ligase activity,MF,
1533,GO:0003910,1,0.506173502248211,0,6,DNA ligase (ATP) activity,MF,
1541,GO:0003923,1,0.573135907336874,0,5,GPI-anchor transamidase activity,MF,
1566,GO:0003964,1,0.434446085309362,0,8,RNA-directed DNA polymerase activity,MF,
1581,GO:0003988,1,0.524273247444486,0,6,acetyl-CoA C-acyltransferase activity,MF,
1594,GO:0004003,1,0.0226037419305314,0,33,ATP-dependent DNA helicase activity,MF,
1595,GO:0004004,1,0.00115095724015687,0,59,ATP-dependent RNA helicase activity,MF,
1601,GO:0004017,1,0.567212500136748,0,5,adenylate kinase activity,MF,
1610,GO:0004030,1,0.56608685729859,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1648,GO:0004089,1,0.567155823984662,0,5,carbonate dehydratase activity,MF,
1660,GO:0004112,1,0.285922923404997,0,11,cyclic-nucleotide phosphodiesterase activity,MF,
1662,GO:0004114,1,0.321861264790744,0,10,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1663,GO:0004115,1,0.557407024443479,0,5,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1670,GO:0004128,1,0.468274781740725,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1704,GO:0004181,1,0.399935841953219,0,8,metallocarboxypeptidase activity,MF,
1705,GO:0004185,1,0.407452162846434,0,8,serine-type carboxypeptidase activity,MF,
1711,GO:0004298,1,0.22711813849395,0,18,threonine-type endopeptidase activity,MF,
1712,GO:0004300,1,0.430529773484777,0,8,enoyl-CoA hydratase activity,MF,
1714,GO:0004303,1,0.498762296449658,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1764,GO:0004364,1,0.205259948693003,0,18,glutathione transferase activity,MF,
1804,GO:0004445,1,0.564474236488684,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1863,GO:0004523,1,0.544126653906156,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1865,GO:0004526,1,0.346068225802234,0,11,ribonuclease P activity,MF,
1873,GO:0004535,1,0.250094292350341,0,12,poly(A)-specific ribonuclease activity,MF,
1876,GO:0004549,1,0.19918696734459,0,16,tRNA-specific ribonuclease activity,MF,
1886,GO:0004563,1,0.569358483806515,0,5,beta-N-acetylhexosaminidase activity,MF,
1896,GO:0004576,1,0.36446175017262,0,10,oligosaccharyl transferase activity,MF,
1899,GO:0004579,1,0.397319388621725,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1911,GO:0004596,1,0.341860651423699,0,10,peptide alpha-N-acetyltransferase activity,MF,
1951,GO:0004652,1,0.39553426113632,0,8,polynucleotide adenylyltransferase activity,MF,
1972,GO:0004679,1,0.451027206705056,0,7,AMP-activated protein kinase activity,MF,
2014,GO:0004738,1,0.571502264576848,0,5,pyruvate dehydrogenase activity,MF,
2020,GO:0004745,1,0.475101895930533,0,7,retinol dehydrogenase activity,MF,
2033,GO:0004771,1,0.561658307897378,0,5,sterol esterase activity,MF,
2046,GO:0004791,1,0.547985172196194,0,6,thioredoxin-disulfide reductase activity,MF,
2057,GO:0004806,1,0.318271794384823,0,10,triglyceride lipase activity,MF,
2075,GO:0004826,1,0.577528282380056,0,5,phenylalanine-tRNA ligase activity,MF,
2087,GO:0004844,1,0.597213776098987,0,5,uracil DNA N-glycosylase activity,MF,
2099,GO:0004862,1,0.46681013902858,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2117,GO:0004904,1,0.578981522730339,0,5,interferon receptor activity,MF,
2141,GO:0004950,1,0.508359389184094,0,6,chemokine receptor activity,MF,
2143,GO:0004953,1,0.579865428249859,0,5,icosanoid receptor activity,MF,
2191,GO:0005047,1,0.574326273988353,0,5,signal recognition particle binding,MF,
2193,GO:0005049,1,0.394628105021404,0,8,nuclear export signal receptor activity,MF,
2200,GO:0005072,1,0.395675417614317,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2201,GO:0005078,1,0.440492280439372,0,7,MAP-kinase scaffold activity,MF,
2219,GO:0005113,1,0.56463808575948,0,5,patched binding,MF,
2236,GO:0005138,1,0.534173017806535,0,6,interleukin-6 receptor binding,MF,
2241,GO:0005149,1,0.368640249466669,0,9,interleukin-1 receptor binding,MF,
2251,GO:0005161,1,0.313742242413491,0,10,platelet-derived growth factor receptor binding,MF,
2280,GO:0005227,1,0.233773680190881,0,13,calcium activated cation channel activity,MF,
2286,GO:0005242,1,0.452742125622169,0,7,inward rectifier potassium channel activity,MF,
2291,GO:0005247,1,0.455108931080821,0,7,voltage-gated chloride channel activity,MF,
2315,GO:0005313,1,0.500724482668698,0,6,L-glutamate transmembrane transporter activity,MF,
2332,GO:0005345,1,0.587564995705644,0,5,purine nucleobase transmembrane transporter activity,MF,
2333,GO:0005346,1,0.29884272083851,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2334,GO:0005347,1,0.415765706963374,0,8,ATP transmembrane transporter activity,MF,
2345,GO:0005381,1,0.512635739839811,0,6,iron ion transmembrane transporter activity,MF,
2349,GO:0005391,1,0.56991545607946,0,5,sodium:potassium-exchanging ATPase activity,MF,
2357,GO:0005451,1,0.35268500887559,0,9,monovalent cation:proton antiporter activity,MF,
2358,GO:0005452,1,0.222960042096549,0,13,inorganic anion exchanger activity,MF,
2399,GO:0005542,1,0.551544683683503,0,6,folic acid binding,MF,
2412,GO:0005583,1,0.389522974365961,0,8,fibrillar collagen trimer,CC,
2414,GO:0005587,1,0.55332539744648,0,5,collagen type IV trimer,CC,
2443,GO:0005642,1,0.570582486357674,0,5,annulate lamellae,CC,
2447,GO:0005655,1,0.485732846340552,0,8,nucleolar ribonuclease P complex,CC,
2450,GO:0005658,1,0.51319223711521,0,6,alpha DNA polymerase:primase complex,CC,
2451,GO:0005662,1,0.215775835176853,0,14,DNA replication factor A complex,CC,
2452,GO:0005663,1,0.535365868305634,0,6,DNA replication factor C complex,CC,
2453,GO:0005664,1,0.360522177699106,0,9,nuclear origin of replication recognition complex,CC,
2454,GO:0005665,1,0.188124473886182,0,17,DNA-directed RNA polymerase II, core complex,CC,
2455,GO:0005666,1,0.18129958980185,0,17,DNA-directed RNA polymerase III complex,CC,
2459,GO:0005671,1,0.212516948001475,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2463,GO:0005675,1,0.249272281906504,0,13,holo TFIIH complex,CC,
2468,GO:0005683,1,0.554123195998386,0,7,U7 snRNP,CC,
2470,GO:0005685,1,0.139320819079694,0,20,U1 snRNP,CC,
2472,GO:0005687,1,0.360719217358381,0,11,U4 snRNP,CC,
2473,GO:0005688,1,0.50214929742604,0,8,U6 snRNP,CC,
2478,GO:0005697,1,0.105277549433291,0,22,telomerase holoenzyme complex,CC,
2484,GO:0005721,1,0.129671704633905,0,18,pericentric heterochromatin,CC,
2489,GO:0005732,1,0.119690792120979,0,24,small nucleolar ribonucleoprotein complex,CC,
2490,GO:0005736,1,0.306785624860135,0,12,DNA-directed RNA polymerase I complex,CC,
2495,GO:0005742,1,0.472631967971897,0,8,mitochondrial outer membrane translocase complex,CC,
2497,GO:0005744,1,0.270934639323427,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2502,GO:0005750,1,0.3462421876742,0,11,mitochondrial respiratory chain complex III,CC,
2510,GO:0005762,1,0.0116916359763251,0,51,mitochondrial large ribosomal subunit,CC,
2530,GO:0005785,1,0.485397394916263,0,7,signal recognition particle receptor complex,CC,
2531,GO:0005786,1,0.550173856058598,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2532,GO:0005787,1,0.620638824171088,0,5,signal peptidase complex,CC,
2549,GO:0005816,1,0.446518255720751,0,7,spindle pole body,CC,
2550,GO:0005818,1,0.39724681036116,0,8,aster,CC,
2552,GO:0005826,1,0.562803851551853,0,5,actomyosin contractile ring,CC,
2554,GO:0005828,1,0.443126700700511,0,7,kinetochore microtubule,CC,
2560,GO:0005839,1,0.179097745008722,0,20,proteasome core complex,CC,
2563,GO:0005845,1,0.304338927310509,0,11,mRNA cap binding complex,CC,
2568,GO:0005851,1,0.524861722164056,0,6,eukaryotic translation initiation factor 2B complex,CC,
2569,GO:0005852,1,0.174895545246363,0,17,eukaryotic translation initiation factor 3 complex,CC,
2580,GO:0005869,1,0.43668805833442,0,8,dynactin complex,CC,
2612,GO:0005916,1,0.497980719483191,0,6,fascia adherens,CC,
2626,GO:0005947,1,0.58444816131643,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2649,GO:0005984,1,0.445172762902356,0,7,disaccharide metabolic process,BP,
2683,GO:0006044,1,0.231128354129168,0,13,N-acetylglucosamine metabolic process,BP,
2691,GO:0006054,1,0.333849768388133,0,10,N-acetylneuraminate metabolic process,BP,
2703,GO:0006067,1,0.302161153847523,0,11,ethanol metabolic process,BP,
2704,GO:0006068,1,0.47569662835893,0,7,ethanol catabolic process,BP,
2705,GO:0006069,1,0.507061227812574,0,6,ethanol oxidation,BP,
2707,GO:0006072,1,0.443178807361738,0,7,glycerol-3-phosphate metabolic process,BP,
2714,GO:0006086,1,0.226198040182061,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2726,GO:0006104,1,0.522178467243542,0,6,succinyl-CoA metabolic process,BP,
2742,GO:0006122,1,0.275156576375937,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2743,GO:0006123,1,0.355684412057865,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2757,GO:0006166,1,0.608463806206615,0,5,purine ribonucleoside salvage,BP,
2758,GO:0006167,1,0.607289040101187,0,5,AMP biosynthetic process,BP,
2764,GO:0006177,1,0.589169875526005,0,5,GMP biosynthetic process,BP,
2770,GO:0006189,1,0.511212779110993,0,6,'de novo' IMP biosynthetic process,BP,
2777,GO:0006207,1,0.501504308576059,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2808,GO:0006268,1,0.453275678484855,0,7,DNA unwinding involved in DNA replication,BP,
2811,GO:0006271,1,0.115334767969238,0,20,DNA strand elongation involved in DNA replication,BP,
2813,GO:0006273,1,0.296875309631563,0,11,lagging strand elongation,BP,
2822,GO:0006287,1,0.574739204454111,0,5,base-excision repair, gap-filling,BP,
2849,GO:0006335,1,0.116766188493765,0,32,DNA replication-dependent nucleosome assembly,BP,
2857,GO:0006348,1,0.452680162328475,0,8,chromatin silencing at telomere,BP,
2870,GO:0006363,1,0.0446522100070854,0,30,termination of RNA polymerase I transcription,BP,
2876,GO:0006370,1,0.0367159545441221,0,32,7-methylguanosine mRNA capping,BP,
2877,GO:0006376,1,0.055004997948343,0,26,mRNA splice site selection,BP,
2879,GO:0006379,1,0.0557125102225795,0,27,mRNA cleavage,BP,
2882,GO:0006384,1,0.463295683734638,0,7,transcription initiation from RNA polymerase III promoter,BP,
2885,GO:0006390,1,0.240127667694892,0,13,mitochondrial transcription,BP,
2890,GO:0006398,1,0.569947215023415,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2921,GO:0006432,1,0.577528282380056,0,5,phenylalanyl-tRNA aminoacylation,BP,
2930,GO:0006448,1,0.151571657749892,0,17,regulation of translational elongation,BP,
2931,GO:0006449,1,0.457792625605039,0,7,regulation of translational termination,BP,
2948,GO:0006477,1,0.567328695151721,0,5,protein sulfation,BP,
2962,GO:0006498,1,0.561520062514685,0,5,N-terminal protein lipidation,BP,
2998,GO:0006544,1,0.416909264070678,0,8,glycine metabolic process,BP,
3001,GO:0006547,1,0.588811143301819,0,5,histidine metabolic process,BP,
3003,GO:0006549,1,0.568898749149979,0,5,isoleucine metabolic process,BP,
3022,GO:0006568,1,0.58609633820933,0,5,tryptophan metabolic process,BP,
3026,GO:0006573,1,0.364791927302022,0,9,valine metabolic process,BP,
3033,GO:0006582,1,0.36780662244917,0,9,melanin metabolic process,BP,
3036,GO:0006586,1,0.58609633820933,0,5,indolalkylamine metabolic process,BP,
3044,GO:0006598,1,0.630810446042034,0,5,polyamine catabolic process,BP,
3050,GO:0006610,1,0.414186003851516,0,8,ribosomal protein import into nucleus,BP,
3055,GO:0006616,1,0.576664990550395,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3064,GO:0006627,1,0.544140028721594,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3083,GO:0006657,1,0.467493060651854,0,7,CDP-choline pathway,BP,
3088,GO:0006662,1,0.403065183455527,0,9,glycerol ether metabolic process,BP,
3103,GO:0006681,1,0.509139361821341,0,6,galactosylceramide metabolic process,BP,
3123,GO:0006703,1,0.445560765429758,0,8,estrogen biosynthetic process,BP,
3136,GO:0006729,1,0.501713180789301,0,7,tetrahydrobiopterin biosynthetic process,BP,
3147,GO:0006743,1,0.211113278911592,0,15,ubiquinone metabolic process,BP,
3148,GO:0006744,1,0.237539874003057,0,14,ubiquinone biosynthetic process,BP,
3160,GO:0006771,1,0.513906198766587,0,6,riboflavin metabolic process,BP,
3164,GO:0006777,1,0.513544666397831,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3172,GO:0006787,1,0.559102701224291,0,6,porphyrin-containing compound catabolic process,BP,
3178,GO:0006797,1,0.563748196324602,0,5,polyphosphate metabolic process,BP,
3199,GO:0006833,1,0.511005319836174,0,6,water transport,BP,
3209,GO:0006851,1,0.110218313312322,0,20,mitochondrial calcium ion transmembrane transport,BP,
3214,GO:0006862,1,0.173394353268717,0,16,nucleotide transport,BP,
3215,GO:0006863,1,0.534013123324372,0,6,purine nucleobase transport,BP,
3228,GO:0006883,1,0.399708930403431,0,8,cellular sodium ion homeostasis,BP,
3260,GO:0006930,1,0.401685076758619,0,8,substrate-dependent cell migration, cell extension,BP,
3273,GO:0006953,1,0.146465775761336,0,18,acute-phase response,BP,
3300,GO:0006999,1,0.184923861898463,0,15,nuclear pore organization,BP,
3301,GO:0007000,1,0.46504775525102,0,7,nucleolus organization,BP,
3319,GO:0007028,1,0.397481452081209,0,8,cytoplasm organization,BP,
3330,GO:0007042,1,0.447817702292842,0,8,lysosomal lumen acidification,BP,
3343,GO:0007063,1,0.095884581824586,0,21,regulation of sister chromatid cohesion,BP,
3347,GO:0007076,1,0.157474011050337,0,16,mitotic chromosome condensation,BP,
3356,GO:0007094,1,0.0416663801291338,0,29,mitotic spindle assembly checkpoint,BP,
3361,GO:0007099,1,0.0379098490564029,0,29,centriole replication,BP,
3367,GO:0007131,1,0.0186319609616485,0,36,reciprocal meiotic recombination,BP,
3368,GO:0007135,1,0.523891243901796,0,6,meiosis II,BP,
3372,GO:0007144,1,0.52716610224966,0,6,female meiosis I,BP,
3430,GO:0007220,1,0.189742867493686,0,15,Notch receptor processing,BP,
3467,GO:0007289,1,0.295369259847527,0,11,spermatid nucleus differentiation,BP,
3491,GO:0007379,1,0.292005158066056,0,11,segment specification,BP,
3536,GO:0007530,1,0.266327870336916,0,12,sex determination,BP,
3540,GO:0007549,1,0.255102159134991,0,12,dosage compensation,BP,
3543,GO:0007567,1,0.365522715880856,0,9,parturition,BP,
3564,GO:0007608,1,0.216556183632789,0,14,sensory perception of smell,BP,
3587,GO:0008009,1,0.275117524586265,0,14,chemokine activity,MF,
3596,GO:0008024,1,0.399314474162862,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3597,GO:0008026,1,4.57914239122263e-05,0,87,ATP-dependent helicase activity,MF,
3622,GO:0008079,1,0.509159659741258,0,6,translation termination factor activity,MF,
3628,GO:0008090,1,0.477490468038557,0,7,retrograde axonal transport,BP,
3629,GO:0008091,1,0.493047556171677,0,6,spectrin,CC,
3647,GO:0008121,1,0.530963760823639,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3659,GO:0008143,1,0.205240222522182,0,14,poly(A) binding,MF,
3666,GO:0008157,1,0.212004289967314,0,14,protein phosphatase 1 binding,MF,
3673,GO:0008172,1,0.580894096250398,0,5,S-methyltransferase activity,MF,
3675,GO:0008174,1,0.364391042561226,0,9,mRNA methyltransferase activity,MF,
3676,GO:0008175,1,0.0439084022627937,0,28,tRNA methyltransferase activity,MF,
3682,GO:0008186,1,0.00102351216023733,0,60,RNA-dependent ATPase activity,MF,
3683,GO:0008187,1,0.103471951150287,0,20,poly-pyrimidine tract binding,MF,
3692,GO:0008199,1,0.614457185465479,0,5,ferric iron binding,MF,
3706,GO:0008215,1,0.553702468839017,0,6,spermine metabolic process,BP,
3707,GO:0008216,1,0.513321648533552,0,7,spermidine metabolic process,BP,
3719,GO:0008239,1,0.512968711430267,0,6,dipeptidyl-peptidase activity,MF,
3722,GO:0008250,1,0.316629910065426,0,12,oligosaccharyltransferase complex,CC,
3730,GO:0008266,1,0.164096755007022,0,16,poly(U) RNA binding,MF,
3734,GO:0008271,1,0.561149617986672,0,5,secondary active sulfate transmembrane transporter activity,MF,
3735,GO:0008272,1,0.449686547485768,0,7,sulfate transport,BP,
3741,GO:0008278,1,0.396340448065375,0,8,cohesin complex,CC,
3764,GO:0008308,1,0.271598720844588,0,12,voltage-gated anion channel activity,MF,
3768,GO:0008312,1,0.492695958557004,0,7,7S RNA binding,MF,
3770,GO:0008320,1,0.299600203395509,0,13,protein transmembrane transporter activity,MF,
3775,GO:0008329,1,0.465773075140697,0,7,signaling pattern recognition receptor activity,MF,
3780,GO:0008334,1,0.0854782859714914,0,24,histone mRNA metabolic process,BP,
3789,GO:0008353,1,0.17952383710468,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3806,GO:0008385,1,0.375269640256036,0,9,IkappaB kinase complex,CC,
3809,GO:0008395,1,0.415483472999855,0,8,steroid hydroxylase activity,MF,
3818,GO:0008409,1,0.160007317249518,0,16,5'-3' exonuclease activity,MF,
3821,GO:0008417,1,0.319024441343484,0,10,fucosyltransferase activity,MF,
3834,GO:0008432,1,0.423081945322791,0,8,JUN kinase binding,MF,
3856,GO:0008469,1,0.41416488761378,0,8,histone-arginine N-methyltransferase activity,MF,
3881,GO:0008510,1,0.554787441038309,0,5,sodium:bicarbonate symporter activity,MF,
3894,GO:0008527,1,0.636607901082909,0,5,taste receptor activity,MF,
3903,GO:0008541,1,0.489079896446869,0,7,proteasome regulatory particle, lid subcomplex,CC,
3910,GO:0008556,1,0.56991545607946,0,5,potassium-transporting ATPase activity,MF,
3927,GO:0008603,1,0.572794854027439,0,5,cAMP-dependent protein kinase regulator activity,MF,
3929,GO:0008608,1,0.0434911142610254,0,28,attachment of spindle microtubules to kinetochore,BP,
3932,GO:0008611,1,0.582590520912821,0,5,ether lipid biosynthetic process,BP,
3938,GO:0008622,1,0.600551492369113,0,5,epsilon DNA polymerase complex,CC,
3955,GO:0008656,1,0.230318939254244,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3984,GO:0008821,1,0.381621931568108,0,9,crossover junction endodeoxyribonuclease activity,MF,
3985,GO:0008823,1,0.572522074954185,0,5,cupric reductase activity,MF,
4009,GO:0008970,1,0.451070198990226,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4021,GO:0009048,1,0.317045162526941,0,10,dosage compensation by inactivation of X chromosome,BP,
4041,GO:0009072,1,0.327602527582937,0,11,aromatic amino acid family metabolic process,BP,
4042,GO:0009074,1,0.454956206501317,0,8,aromatic amino acid family catabolic process,BP,
4050,GO:0009086,1,0.299849650339017,0,11,methionine biosynthetic process,BP,
4065,GO:0009113,1,0.248417321539084,0,13,purine nucleobase biosynthetic process,BP,
4081,GO:0009134,1,0.477864864135717,0,7,nucleoside diphosphate catabolic process,BP,
4090,GO:0009143,1,0.325563597367261,0,11,nucleoside triphosphate catabolic process,BP,
4093,GO:0009146,1,0.554438341988039,0,6,purine nucleoside triphosphate catabolic process,BP,
4102,GO:0009155,1,0.546411023452728,0,6,purine deoxyribonucleotide catabolic process,BP,
4119,GO:0009176,1,0.590103502963211,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4120,GO:0009177,1,0.590103502963211,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4133,GO:0009191,1,0.535119832729382,0,6,ribonucleoside diphosphate catabolic process,BP,
4142,GO:0009202,1,0.607038407187092,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4144,GO:0009204,1,0.498228610915217,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4150,GO:0009211,1,0.559502833661629,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4156,GO:0009217,1,0.602742048071806,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4160,GO:0009221,1,0.441342108722144,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4176,GO:0009249,1,0.547988885793496,0,7,protein lipoylation,BP,
4197,GO:0009303,1,0.0541111772344725,0,27,rRNA transcription,BP,
4198,GO:0009304,1,0.463014040692374,0,7,tRNA transcription,BP,
4217,GO:0009378,1,0.557261587030901,0,5,four-way junction helicase activity,MF,
4223,GO:0009396,1,0.387233488385351,0,9,folic acid-containing compound biosynthetic process,BP,
4254,GO:0009452,1,0.0326839617767205,0,33,7-methylguanosine RNA capping,BP,
4261,GO:0009595,1,0.365490571034149,0,9,detection of biotic stimulus,BP,
4262,GO:0009597,1,0.5686522263734,0,5,detection of virus,BP,
4274,GO:0009629,1,0.513650813576177,0,6,response to gravity,BP,
4286,GO:0009651,1,0.195094046605449,0,15,response to salt stress,BP,
4307,GO:0009756,1,0.53306142353532,0,6,carbohydrate mediated signaling,BP,
4308,GO:0009757,1,0.596138034476743,0,5,hexose mediated signaling,BP,
4322,GO:0009812,1,0.380191718747531,0,9,flavonoid metabolic process,BP,
4349,GO:0009912,1,0.585488431892226,0,5,auditory receptor cell fate commitment,BP,
4378,GO:0010002,1,0.397082262230716,0,8,cardioblast differentiation,BP,
4383,GO:0010032,1,0.553779682874556,0,5,meiotic chromosome condensation,BP,
4390,GO:0010041,1,0.588454236526022,0,5,response to iron(III) ion,BP,
4417,GO:0010182,1,0.596138034476743,0,5,sugar mediated signaling pathway,BP,
4421,GO:0010216,1,0.496650011087485,0,6,maintenance of DNA methylation,BP,
4427,GO:0010248,1,0.535026025010269,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4428,GO:0010255,1,0.596138034476743,0,5,glucose mediated signaling pathway,BP,
4433,GO:0010265,1,0.528934494206308,0,6,SCF complex assembly,BP,
4437,GO:0010286,1,0.602253790517704,0,5,heat acclimation,BP,
4451,GO:0010385,1,0.566991430952875,0,5,double-stranded methylated DNA binding,MF,
4461,GO:0010452,1,0.358412489511138,0,9,histone H3-K36 methylation,BP,
4465,GO:0010457,1,0.276648051159364,0,11,centriole-centriole cohesion,BP,
4468,GO:0010460,1,0.349414184321418,0,10,positive regulation of heart rate,BP,
4481,GO:0010485,1,0.128231843626622,0,18,H4 histone acetyltransferase activity,MF,
4484,GO:0010499,1,0.142349471205474,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4490,GO:0010510,1,0.283846266836376,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4519,GO:0010569,1,0.0606150282851442,0,25,regulation of double-strand break repair via homologous recombination,BP,
4527,GO:0010587,1,0.560990410652377,0,5,miRNA catabolic process,BP,
4534,GO:0010603,1,0.439274446690694,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4537,GO:0010606,1,0.55535363804173,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4541,GO:0010612,1,0.495859128578218,0,6,regulation of cardiac muscle adaptation,BP,
4542,GO:0010613,1,0.0910010417553911,0,21,positive regulation of cardiac muscle hypertrophy,BP,
4545,GO:0010616,1,0.557971290701505,0,5,negative regulation of cardiac muscle adaptation,BP,
4547,GO:0010623,1,0.471319844728049,0,7,programmed cell death involved in cell development,BP,
4570,GO:0010649,1,0.363199002921673,0,9,regulation of cell communication by electrical coupling,BP,
4586,GO:0010669,1,0.181965161440381,0,15,epithelial structure maintenance,BP,
4590,GO:0010692,1,0.397606380547654,0,8,regulation of alkaline phosphatase activity,BP,
4592,GO:0010694,1,0.557653352230852,0,5,positive regulation of alkaline phosphatase activity,BP,
4652,GO:0010792,1,0.50552927457522,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4653,GO:0010793,1,0.562826779996852,0,5,regulation of mRNA export from nucleus,BP,
4661,GO:0010804,1,0.245065228533839,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4672,GO:0010818,1,0.371730751625315,0,9,T cell chemotaxis,BP,
4673,GO:0010819,1,0.516809838747144,0,6,regulation of T cell chemotaxis,BP,
4674,GO:0010820,1,0.516809838747144,0,6,positive regulation of T cell chemotaxis,BP,
4679,GO:0010825,1,0.500090148321082,0,6,positive regulation of centrosome duplication,BP,
4680,GO:0010826,1,0.26973454681206,0,12,negative regulation of centrosome duplication,BP,
4691,GO:0010838,1,0.5590285328525,0,5,positive regulation of keratinocyte proliferation,BP,
4706,GO:0010866,1,0.237433321164833,0,13,regulation of triglyceride biosynthetic process,BP,
4707,GO:0010867,1,0.365090680952286,0,9,positive regulation of triglyceride biosynthetic process,BP,
4710,GO:0010870,1,0.339086036036894,0,10,positive regulation of receptor biosynthetic process,BP,
4724,GO:0010884,1,0.260486154113647,0,12,positive regulation of lipid storage,BP,
4745,GO:0010911,1,0.445203617023986,0,7,regulation of isomerase activity,BP,
4746,GO:0010912,1,0.445203617023986,0,7,positive regulation of isomerase activity,BP,
4766,GO:0010944,1,0.480549486107228,0,7,negative regulation of transcription by competitive promoter binding,BP,
4803,GO:0010994,1,0.605024825503292,0,5,free ubiquitin chain polymerization,BP,
4805,GO:0010997,1,0.569124104385738,0,5,anaphase-promoting complex binding,MF,
4842,GO:0014046,1,0.388111500494632,0,9,dopamine secretion,BP,
4850,GO:0014059,1,0.388111500494632,0,9,regulation of dopamine secretion,BP,
4861,GO:0014072,1,0.152676405615801,0,17,response to isoquinoline alkaloid,BP,
4872,GO:0014731,1,0.50016178326507,0,6,spectrin-associated cytoskeleton,CC,
4882,GO:0014742,1,0.0910010417553911,0,21,positive regulation of muscle hypertrophy,BP,
4885,GO:0014745,1,0.360112923991633,0,9,negative regulation of muscle adaptation,BP,
4889,GO:0014807,1,0.511474981151577,0,6,regulation of somitogenesis,BP,
4895,GO:0014819,1,0.636406302828739,0,5,regulation of skeletal muscle contraction,BP,
4934,GO:0014889,1,0.466947194600188,0,7,muscle atrophy,BP,
4985,GO:0015106,1,0.277643797848044,0,11,bicarbonate transmembrane transporter activity,MF,
4990,GO:0015116,1,0.504429294706687,0,6,sulfate transmembrane transporter activity,MF,
5014,GO:0015172,1,0.500724482668698,0,6,acidic amino acid transmembrane transporter activity,MF,
5019,GO:0015180,1,0.562068427542689,0,5,L-alanine transmembrane transporter activity,MF,
5030,GO:0015193,1,0.559114441771949,0,5,L-proline transmembrane transporter activity,MF,
5036,GO:0015205,1,0.521963155528813,0,6,nucleobase transmembrane transporter activity,MF,
5039,GO:0015215,1,0.194387207901815,0,15,nucleotide transmembrane transporter activity,MF,
5040,GO:0015216,1,0.29884272083851,0,11,purine nucleotide transmembrane transporter activity,MF,
5041,GO:0015217,1,0.371566395630739,0,9,ADP transmembrane transporter activity,MF,
5043,GO:0015220,1,0.564562080421659,0,5,choline transmembrane transporter activity,MF,
5050,GO:0015232,1,0.446423884772334,0,7,heme transporter activity,MF,
5061,GO:0015269,1,0.46678966905161,0,7,calcium-activated potassium channel activity,MF,
5069,GO:0015288,1,0.533723846455726,0,6,porin activity,MF,
5079,GO:0015301,1,0.13067631187609,0,18,anion:anion antiporter activity,MF,
5096,GO:0015368,1,0.498044402287918,0,6,calcium:cation antiporter activity,MF,
5104,GO:0015385,1,0.395577363262264,0,8,sodium:proton antiporter activity,MF,
5105,GO:0015386,1,0.443107210847222,0,7,potassium:proton antiporter activity,MF,
5119,GO:0015450,1,0.543300255382666,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5121,GO:0015464,1,0.507513445553739,0,6,acetylcholine receptor activity,MF,
5125,GO:0015491,1,0.124508673170972,0,18,cation:cation antiporter activity,MF,
5133,GO:0015605,1,0.0866031234451096,0,22,organophosphate ester transmembrane transporter activity,MF,
5138,GO:0015643,1,0.5115674886176,0,6,toxic substance binding,MF,
5140,GO:0015651,1,0.507630250557376,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5161,GO:0015697,1,0.400670634331094,0,8,quaternary ammonium group transport,BP,
5164,GO:0015701,1,0.115697867248328,0,19,bicarbonate transport,BP,
5200,GO:0015791,1,0.50310636411845,0,6,polyol transport,BP,
5211,GO:0015808,1,0.562068427542689,0,5,L-alanine transport,BP,
5223,GO:0015824,1,0.497063836187923,0,6,proline transport,BP,
5229,GO:0015838,1,0.504263772317131,0,6,amino-acid betaine transport,BP,
5237,GO:0015851,1,0.474386048559321,0,7,nucleobase transport,BP,
5244,GO:0015865,1,0.266579680339594,0,12,purine nucleotide transport,BP,
5245,GO:0015866,1,0.371566395630739,0,9,ADP transport,BP,
5246,GO:0015867,1,0.370890858421072,0,9,ATP transport,BP,
5247,GO:0015868,1,0.266579680339594,0,12,purine ribonucleotide transport,BP,
5258,GO:0015884,1,0.586349191692351,0,5,folic acid transport,BP,
5259,GO:0015886,1,0.446423884772334,0,7,heme transport,BP,
5279,GO:0015926,1,0.392871724287963,0,8,glucosidase activity,MF,
5289,GO:0015939,1,0.582864060650369,0,5,pantothenate metabolic process,BP,
5305,GO:0016004,1,0.41861647138906,0,8,phospholipase activator activity,MF,
5312,GO:0016018,1,0.35333347439914,0,10,cyclosporin A binding,MF,
5324,GO:0016045,1,0.459583170496808,0,7,detection of bacterium,BP,
5340,GO:0016074,1,0.330577110229903,0,12,snoRNA metabolic process,BP,
5343,GO:0016078,1,0.551735060698959,0,6,tRNA catabolic process,BP,
5394,GO:0016226,1,0.140383288632255,0,20,iron-sulfur cluster assembly,BP,
5409,GO:0016246,1,0.199354717237035,0,15,RNA interference,BP,
5414,GO:0016255,1,0.462669048319528,0,7,attachment of GPI anchor to protein,BP,
5420,GO:0016264,1,0.447477843721153,0,7,gap junction assembly,BP,
5424,GO:0016272,1,0.568634403945018,0,7,prefoldin complex,CC,
5425,GO:0016273,1,0.295433462890377,0,11,arginine N-methyltransferase activity,MF,
5426,GO:0016274,1,0.295433462890377,0,11,protein-arginine N-methyltransferase activity,MF,
5456,GO:0016327,1,0.235194327856471,0,13,apicolateral plasma membrane,CC,
5465,GO:0016342,1,0.222092062255036,0,13,catenin complex,CC,
5490,GO:0016421,1,0.505358718277182,0,6,CoA carboxylase activity,MF,
5492,GO:0016423,1,0.237615614626771,0,13,tRNA (guanine) methyltransferase activity,MF,
5494,GO:0016427,1,0.411364953506144,0,8,tRNA (cytosine) methyltransferase activity,MF,
5513,GO:0016461,1,0.490432070620394,0,7,unconventional myosin complex,CC,
5532,GO:0016505,1,0.185231920586454,0,16,peptidase activator activity involved in apoptotic process,MF,
5536,GO:0016514,1,0.227680510870518,0,13,SWI/SNF complex,CC,
5544,GO:0016530,1,0.605639764026631,0,6,metallochaperone activity,MF,
5545,GO:0016531,1,0.681749253256999,0,5,copper chaperone activity,MF,
5553,GO:0016556,1,0.191708650799619,0,15,mRNA modification,BP,
5556,GO:0016559,1,0.505758933080485,0,7,peroxisome fission,BP,
5569,GO:0016578,1,0.0989824336653239,0,21,histone deubiquitination,BP,
5579,GO:0016593,1,0.407759252617574,0,8,Cdc73/Paf1 complex,CC,
5601,GO:0016634,1,0.513808488946248,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5619,GO:0016668,1,0.317074566722102,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5625,GO:0016679,1,0.474422641138957,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5626,GO:0016681,1,0.530963760823639,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5635,GO:0016712,1,0.329814256004201,0,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5638,GO:0016717,1,0.562021720137295,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5695,GO:0016812,1,0.555919400824525,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5742,GO:0016886,1,0.323835175941019,0,10,ligase activity, forming phosphoric ester bonds,MF,
5744,GO:0016888,1,0.293006209134316,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5747,GO:0016891,1,0.0603061622964243,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5748,GO:0016892,1,0.535697289336652,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5749,GO:0016893,1,0.0248419583847578,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5765,GO:0016926,1,0.449209891206164,0,7,protein desumoylation,BP,
5766,GO:0016929,1,0.497585367899458,0,6,SUMO-specific protease activity,MF,
5775,GO:0016973,1,0.338337786492992,0,10,poly(A)+ mRNA export from nucleus,BP,
5781,GO:0017000,1,0.216965197485911,0,14,antibiotic biosynthetic process,BP,
5806,GO:0017056,1,0.0585014735913085,0,25,structural constituent of nuclear pore,MF,
5815,GO:0017070,1,0.330354297032683,0,11,U6 snRNA binding,MF,
5819,GO:0017081,1,0.31451437460988,0,11,chloride channel regulator activity,MF,
5825,GO:0017091,1,0.100896444443977,0,21,AU-rich element binding,MF,
5829,GO:0017101,1,0.273203599387705,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5831,GO:0017108,1,0.505569043146333,0,6,5'-flap endonuclease activity,MF,
5839,GO:0017121,1,0.455998738502134,0,7,phospholipid scrambling,BP,
5844,GO:0017128,1,0.509005388050241,0,6,phospholipid scramblase activity,MF,
5848,GO:0017136,1,0.165461596728814,0,16,NAD-dependent histone deacetylase activity,MF,
5857,GO:0017151,1,0.45227049176975,0,7,DEAD/H-box RNA helicase binding,MF,
5859,GO:0017154,1,0.308037216595751,0,10,semaphorin receptor activity,MF,
5873,GO:0017182,1,0.364062766646621,0,9,peptidyl-diphthamide metabolic process,BP,
5874,GO:0017183,1,0.364062766646621,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5875,GO:0017185,1,0.401167171395724,0,8,peptidyl-lysine hydroxylation,BP,
5878,GO:0017196,1,0.519178412861385,0,6,N-terminal peptidyl-methionine acetylation,BP,
5888,GO:0018023,1,0.0170972638900851,0,37,peptidyl-lysine trimethylation,BP,
5891,GO:0018026,1,0.362245262250075,0,9,peptidyl-lysine monomethylation,BP,
5892,GO:0018027,1,0.209755156510626,0,14,peptidyl-lysine dimethylation,BP,
5896,GO:0018065,1,0.367433332210051,0,11,protein-cofactor linkage,BP,
5899,GO:0018095,1,0.402228421385769,0,8,protein polyglutamylation,BP,
5901,GO:0018103,1,0.526095495840529,0,6,protein C-linked glycosylation,BP,
5915,GO:0018158,1,0.39436904641776,0,9,protein oxidation,BP,
5923,GO:0018195,1,0.163120671476419,0,17,peptidyl-arginine modification,BP,
5928,GO:0018200,1,0.178379630357432,0,16,peptidyl-glutamic acid modification,BP,
5930,GO:0018202,1,0.302350516210736,0,11,peptidyl-histidine modification,BP,
5932,GO:0018206,1,0.338481957930507,0,10,peptidyl-methionine modification,BP,
5936,GO:0018211,1,0.526095495840529,0,6,peptidyl-tryptophan modification,BP,
5939,GO:0018216,1,0.234516373879016,0,13,peptidyl-arginine methylation,BP,
5941,GO:0018230,1,0.141272994316624,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5942,GO:0018231,1,0.141272994316624,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5957,GO:0018317,1,0.526095495840529,0,6,protein C-linked glycosylation via tryptophan,BP,
5973,GO:0018406,1,0.526095495840529,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5989,GO:0018904,1,0.261980859896934,0,13,ether metabolic process,BP,
6026,GO:0019081,1,0.215545964029066,0,14,viral translation,BP,
6037,GO:0019103,1,0.544608278244983,0,6,pyrimidine nucleotide binding,MF,
6059,GO:0019203,1,0.567756841490072,0,5,carbohydrate phosphatase activity,MF,
6066,GO:0019211,1,0.331927035516549,0,10,phosphatase activator activity,MF,
6069,GO:0019215,1,0.292732917630064,0,11,intermediate filament binding,MF,
6084,GO:0019237,1,0.503529546007559,0,6,centromeric DNA binding,MF,
6085,GO:0019238,1,0.511662258906753,0,6,cyclohydrolase activity,MF,
6093,GO:0019262,1,0.592992065996386,0,5,N-acetylneuraminate catabolic process,BP,
6100,GO:0019317,1,0.499539753787497,0,6,fucose catabolic process,BP,
6126,GO:0019371,1,0.469985353724238,0,7,cyclooxygenase pathway,BP,
6128,GO:0019373,1,0.509631681931727,0,6,epoxygenase P450 pathway,BP,
6129,GO:0019374,1,0.509139361821341,0,6,galactolipid metabolic process,BP,
6140,GO:0019405,1,0.509326057059313,0,6,alditol catabolic process,BP,
6148,GO:0019430,1,0.179131235075512,0,17,removal of superoxide radicals,BP,
6163,GO:0019509,1,0.587174418455776,0,5,L-methionine salvage from methylthioadenosine,BP,
6173,GO:0019531,1,0.561149617986672,0,5,oxalate transmembrane transporter activity,MF,
6174,GO:0019532,1,0.561149617986672,0,5,oxalate transport,BP,
6186,GO:0019563,1,0.569859232624297,0,5,glycerol catabolic process,BP,
6194,GO:0019646,1,0.355684412057865,0,14,aerobic electron transport chain,BP,
6210,GO:0019720,1,0.513544666397831,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6226,GO:0019773,1,0.557520981888172,0,7,proteasome core complex, alpha-subunit complex,CC,
6227,GO:0019774,1,0.455625699764916,0,10,proteasome core complex, beta-subunit complex,CC,
6239,GO:0019788,1,0.562128187022788,0,6,NEDD8 transferase activity,MF,
6240,GO:0019789,1,0.17277639749282,0,16,SUMO transferase activity,MF,
6266,GO:0019856,1,0.501504308576059,0,6,pyrimidine nucleobase biosynthetic process,BP,
6277,GO:0019869,1,0.49584395015263,0,7,chloride channel inhibitor activity,MF,
6278,GO:0019870,1,0.573507149714605,0,5,potassium channel inhibitor activity,MF,
6282,GO:0019883,1,0.303075320407511,0,11,antigen processing and presentation of endogenous antigen,BP,
6284,GO:0019885,1,0.463536616490138,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6289,GO:0019896,1,0.288838937395257,0,11,axonal transport of mitochondrion,BP,
6299,GO:0019907,1,0.474792316881533,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6300,GO:0019908,1,0.17214018070537,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6305,GO:0019919,1,0.463217997377738,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6314,GO:0019956,1,0.295187278620663,0,11,chemokine binding,MF,
6322,GO:0019966,1,0.473739436717692,0,7,interleukin-1 binding,MF,
6364,GO:0021542,1,0.413672156178979,0,8,dentate gyrus development,BP,
6370,GO:0021548,1,0.566035967998371,0,5,pons development,BP,
6429,GO:0021692,1,0.392658918912251,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6431,GO:0021694,1,0.558123420781546,0,5,cerebellar Purkinje cell layer formation,BP,
6438,GO:0021702,1,0.558123420781546,0,5,cerebellar Purkinje cell differentiation,BP,
6463,GO:0021781,1,0.575249763716023,0,5,glial cell fate commitment,BP,
6468,GO:0021794,1,0.449529869211328,0,7,thalamus development,BP,
6474,GO:0021800,1,0.556882798724571,0,5,cerebral cortex tangential migration,BP,
6477,GO:0021814,1,0.444592433189259,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6478,GO:0021815,1,0.55824647438574,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6497,GO:0021854,1,0.31052373660652,0,11,hypothalamus development,BP,
6500,GO:0021859,1,0.564825246628493,0,5,pyramidal neuron differentiation,BP,
6501,GO:0021860,1,0.564825246628493,0,5,pyramidal neuron development,BP,
6502,GO:0021861,1,0.474656608787524,0,7,forebrain radial glial cell differentiation,BP,
6505,GO:0021871,1,0.283510736736607,0,11,forebrain regionalization,BP,
6508,GO:0021877,1,0.563381443684028,0,5,forebrain neuron fate commitment,BP,
6512,GO:0021884,1,0.169513780438012,0,16,forebrain neuron development,BP,
6516,GO:0021889,1,0.507016809498735,0,6,olfactory bulb interneuron differentiation,BP,
6517,GO:0021891,1,0.557607221597669,0,5,olfactory bulb interneuron development,BP,
6521,GO:0021895,1,0.331317468801655,0,10,cerebral cortex neuron differentiation,BP,
6526,GO:0021903,1,0.576584797670367,0,5,rostrocaudal neural tube patterning,BP,
6553,GO:0021978,1,0.569586822513648,0,5,telencephalon regionalization,BP,
6556,GO:0021984,1,0.573541700067161,0,5,adenohypophysis development,BP,
6567,GO:0022010,1,0.409369453030214,0,8,central nervous system myelination,BP,
6577,GO:0022400,1,0.285351055255426,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6602,GO:0022616,1,0.0640168098223119,0,25,DNA strand elongation,BP,
6609,GO:0022627,1,0.038006259309916,0,43,cytosolic small ribosomal subunit,CC,
6612,GO:0022821,1,0.349890399473926,0,9,potassium ion antiporter activity,MF,
6630,GO:0022858,1,0.562068427542689,0,5,alanine transmembrane transporter activity,MF,
6631,GO:0022884,1,0.266566382778758,0,14,macromolecule transmembrane transporter activity,MF,
6639,GO:0023019,1,0.36485466707695,0,9,signal transduction involved in regulation of gene expression,BP,
6641,GO:0023023,1,0.277408884656986,0,12,MHC protein complex binding,MF,
6644,GO:0023026,1,0.347373496895283,0,10,MHC class II protein complex binding,MF,
6656,GO:0030002,1,0.508080822977043,0,6,cellular anion homeostasis,BP,
6659,GO:0030007,1,0.450141254383433,0,7,cellular potassium ion homeostasis,BP,
6664,GO:0030015,1,0.56578363284683,0,5,CCR4-NOT core complex,CC,
6688,GO:0030050,1,0.495804930528398,0,6,vesicle transport along actin filament,BP,
6694,GO:0030061,1,0.571061678578318,0,5,mitochondrial crista,CC,
6695,GO:0030062,1,0.52279978596861,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6737,GO:0030150,1,0.163443847675477,0,18,protein import into mitochondrial matrix,BP,
6791,GO:0030223,1,0.533291940423685,0,6,neutrophil differentiation,BP,
6801,GO:0030238,1,0.466122177670975,0,7,male sex determination,BP,
6805,GO:0030242,1,0.559569159651828,0,5,autophagy of peroxisome,BP,
6807,GO:0030247,1,0.449984616974081,0,7,polysaccharide binding,MF,
6823,GO:0030277,1,0.321934511128096,0,10,maintenance of gastrointestinal epithelium,BP,
6826,GO:0030280,1,0.329834993487017,0,11,structural constituent of epidermis,MF,
6829,GO:0030284,1,0.563368191739981,0,5,estrogen receptor activity,MF,
6855,GO:0030318,1,0.224292762627238,0,13,melanocyte differentiation,BP,
6856,GO:0030320,1,0.508080822977043,0,6,cellular monovalent inorganic anion homeostasis,BP,
6868,GO:0030332,1,0.068721136758953,0,24,cyclin binding,MF,
6876,GO:0030346,1,0.532617595691236,0,6,protein phosphatase 2B binding,MF,
6881,GO:0030368,1,0.502907626476308,0,6,interleukin-17 receptor activity,MF,
6895,GO:0030422,1,0.39765048716364,0,9,production of siRNA involved in RNA interference,BP,
6906,GO:0030473,1,0.556518241274258,0,5,nuclear migration along microtubule,BP,
6911,GO:0030488,1,0.0305990090291598,0,32,tRNA methylation,BP,
6912,GO:0030490,1,0.00432882596795118,0,53,maturation of SSU-rRNA,BP,
6939,GO:0030539,1,0.394859501015903,0,8,male genitalia development,BP,
6954,GO:0030575,1,0.362225723286445,0,9,nuclear body organization,BP,
6972,GO:0030621,1,0.503550570547801,0,6,U4 snRNA binding,MF,
6978,GO:0030628,1,0.555989229153378,0,6,pre-mRNA 3'-splice site binding,MF,
7001,GO:0030677,1,0.285956627472802,0,13,ribonuclease P complex,CC,
7003,GO:0030681,1,0.387325834677899,0,10,multimeric ribonuclease P complex,CC,
7006,GO:0030684,1,0.000348369113147252,0,74,preribosome,CC,
7007,GO:0030686,1,0.0306810802571644,0,32,90S preribosome,CC,
7008,GO:0030687,1,0.0794022133922087,0,24,preribosome, large subunit precursor,CC,
7009,GO:0030688,1,0.263771070623537,0,12,preribosome, small subunit precursor,CC,
7021,GO:0030728,1,0.254820016433829,0,12,ovulation,BP,
7063,GO:0030836,1,0.467957518806937,0,7,positive regulation of actin filament depolymerization,BP,
7072,GO:0030854,1,0.582011513873024,0,5,positive regulation of granulocyte differentiation,BP,
7086,GO:0030870,1,0.561486525388369,0,5,Mre11 complex,CC,
7105,GO:0030896,1,0.57338973241544,0,5,checkpoint clamp complex,CC,
7112,GO:0030903,1,0.291569624945016,0,11,notochord development,BP,
7118,GO:0030913,1,0.454834703225931,0,7,paranodal junction assembly,BP,
7119,GO:0030914,1,0.282177775250684,0,12,STAGA complex,CC,
7136,GO:0030955,1,0.354102183210563,0,9,potassium ion binding,MF,
7138,GO:0030957,1,0.336342499660082,0,10,Tat protein binding,MF,
7177,GO:0031053,1,0.319390861436905,0,10,primary miRNA processing,BP,
7189,GO:0031069,1,0.144051487244402,0,17,hair follicle morphogenesis,BP,
7194,GO:0031077,1,0.478053815439204,0,7,post-embryonic camera-type eye development,BP,
7195,GO:0031078,1,0.284549556959648,0,11,histone deacetylase activity (H3-K14 specific),MF,
7196,GO:0031080,1,0.329075787688868,0,10,nuclear pore outer ring,CC,
7202,GO:0031086,1,0.406034668073774,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7203,GO:0031087,1,0.454998675704766,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7204,GO:0031088,1,0.591318364918056,0,5,platelet dense granule membrane,CC,
7229,GO:0031118,1,0.478247670864583,0,8,rRNA pseudouridine synthesis,BP,
7235,GO:0031125,1,0.333374110157964,0,12,rRNA 3'-end processing,BP,
7236,GO:0031126,1,0.521733455637554,0,7,snoRNA 3'-end processing,BP,
7246,GO:0031163,1,0.140383288632255,0,20,metallo-sulfur cluster assembly,BP,
7283,GO:0031261,1,0.583778143822499,0,5,DNA replication preinitiation complex,CC,
7285,GO:0031264,1,0.369344295445926,0,9,death-inducing signaling complex,CC,
7286,GO:0031265,1,0.511786642150859,0,6,CD95 death-inducing signaling complex,CC,
7289,GO:0031269,1,0.29865788139101,0,11,pseudopodium assembly,BP,
7290,GO:0031272,1,0.376614354893084,0,9,regulation of pseudopodium assembly,BP,
7291,GO:0031274,1,0.376614354893084,0,9,positive regulation of pseudopodium assembly,BP,
7309,GO:0031304,1,0.0233939815295973,0,36,intrinsic component of mitochondrial inner membrane,CC,
7310,GO:0031305,1,0.0233939815295973,0,36,integral component of mitochondrial inner membrane,CC,
7316,GO:0031314,1,0.564389413164671,0,5,extrinsic component of mitochondrial inner membrane,CC,
7353,GO:0031386,1,0.334130251278835,0,12,protein tag,MF,
7355,GO:0031390,1,0.419171913436229,0,8,Ctf18 RFC-like complex,CC,
7365,GO:0031402,1,0.396685543507515,0,8,sodium ion binding,MF,
7372,GO:0031414,1,0.381603275689746,0,9,N-terminal protein acetyltransferase complex,CC,
7377,GO:0031419,1,0.516532479067864,0,6,cobalamin binding,MF,
7378,GO:0031420,1,0.22288887767385,0,13,alkali metal ion binding,MF,
7381,GO:0031428,1,0.59748848239391,0,5,box C/D snoRNP complex,CC,
7382,GO:0031429,1,0.657847292209589,0,5,box H/ACA snoRNP complex,CC,
7394,GO:0031441,1,0.355133445381763,0,9,negative regulation of mRNA 3'-end processing,BP,
7404,GO:0031462,1,0.281687817748281,0,12,Cul2-RING ubiquitin ligase complex,CC,
7406,GO:0031464,1,0.271458512707206,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7449,GO:0031577,1,0.0303241867168186,0,32,spindle checkpoint,BP,
7464,GO:0031595,1,0.447112104480166,0,8,nuclear proteasome complex,CC,
7467,GO:0031618,1,0.408081338922702,0,8,nuclear pericentric heterochromatin,CC,
7483,GO:0031642,1,0.519444235179701,0,6,negative regulation of myelination,BP,
7486,GO:0031645,1,0.469487285756014,0,7,negative regulation of neurological system process,BP,
7495,GO:0031658,1,0.483264970174641,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7499,GO:0031665,1,0.428163800241334,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7531,GO:0031730,1,0.60508912098269,0,5,CCR5 chemokine receptor binding,MF,
7548,GO:0031821,1,0.512708190601139,0,6,G-protein coupled serotonin receptor binding,MF,
7575,GO:0031931,1,0.452369148008335,0,7,TORC1 complex,CC,
7580,GO:0031937,1,0.397846713277998,0,8,positive regulation of chromatin silencing,BP,
7595,GO:0031958,1,0.160103881115629,0,16,corticosteroid receptor signaling pathway,BP,
7611,GO:0031987,1,0.446062753525691,0,7,locomotion involved in locomotory behavior,BP,
7615,GO:0031996,1,0.32357029446754,0,10,thioesterase binding,MF,
7623,GO:0032008,1,0.0354924681928161,0,30,positive regulation of TOR signaling,BP,
7624,GO:0032009,1,0.450597824522504,0,7,early phagosome,CC,
7628,GO:0032020,1,0.557848120626202,0,6,ISG15-protein conjugation,BP,
7636,GO:0032036,1,0.591438039090822,0,5,myosin heavy chain binding,MF,
7638,GO:0032040,1,0.0289067622980664,0,33,small-subunit processome,CC,
7639,GO:0032041,1,0.284549556959648,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7646,GO:0032051,1,0.55638463234034,0,5,clathrin light chain binding,MF,
7745,GO:0032239,1,0.15665256901624,0,16,regulation of nucleobase-containing compound transport,BP,
7747,GO:0032241,1,0.446330205529219,0,7,positive regulation of nucleobase-containing compound transport,BP,
7764,GO:0032275,1,0.560410088160647,0,5,luteinizing hormone secretion,BP,
7773,GO:0032288,1,0.101660070457972,0,20,myelin assembly,BP,
7776,GO:0032291,1,0.409369453030214,0,8,axon ensheathment in central nervous system,BP,
7781,GO:0032300,1,0.251538238307769,0,12,mismatch repair complex,CC,
7792,GO:0032324,1,0.463905145211307,0,7,molybdopterin cofactor biosynthetic process,BP,
7793,GO:0032328,1,0.499404426900313,0,6,alanine transport,BP,
7797,GO:0032332,1,0.312427649286999,0,10,positive regulation of chondrocyte differentiation,BP,
7812,GO:0032356,1,0.334099098601652,0,10,oxidized DNA binding,MF,
7813,GO:0032357,1,0.372790093549116,0,9,oxidized purine DNA binding,MF,
7816,GO:0032364,1,0.581843027168313,0,5,oxygen homeostasis,BP,
7841,GO:0032389,1,0.449753032374626,0,7,MutLalpha complex,CC,
7851,GO:0032404,1,0.416744233760907,0,8,mismatch repair complex binding,MF,
7852,GO:0032405,1,0.58032815442111,0,5,MutLalpha complex binding,MF,
7853,GO:0032407,1,0.576366720308007,0,5,MutSalpha complex binding,MF,
7891,GO:0032453,1,0.494557606782377,0,6,histone demethylase activity (H3-K4 specific),MF,
7925,GO:0032494,1,0.516293593960854,0,6,response to peptidoglycan,BP,
7939,GO:0032510,1,0.50552284538531,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7940,GO:0032511,1,0.443358351678031,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7943,GO:0032525,1,0.50548106136586,0,6,somite rostral/caudal axis specification,BP,
7959,GO:0032552,1,0.548200653843216,0,6,deoxyribonucleotide binding,MF,
7983,GO:0032591,1,0.495646880949909,0,6,dendritic spine membrane,CC,
7993,GO:0032604,1,0.429102960023989,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7998,GO:0032610,1,0.524280302774387,0,7,interleukin-1 alpha production,BP,
8002,GO:0032615,1,0.0303754591708286,0,32,interleukin-12 production,BP,
8006,GO:0032621,1,0.506526573549178,0,6,interleukin-18 production,BP,
8019,GO:0032645,1,0.429102960023989,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8023,GO:0032650,1,0.557434399167766,0,6,regulation of interleukin-1 alpha production,BP,
8027,GO:0032655,1,0.0340226258464114,0,31,regulation of interleukin-12 production,BP,
8031,GO:0032661,1,0.569351189836635,0,5,regulation of interleukin-18 production,BP,
8051,GO:0032695,1,0.300512975770539,0,11,negative regulation of interleukin-12 production,BP,
8060,GO:0032715,1,0.118267301284437,0,19,negative regulation of interleukin-6 production,BP,
8064,GO:0032725,1,0.481240017166696,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8068,GO:0032730,1,0.613284751244091,0,5,positive regulation of interleukin-1 alpha production,BP,
8072,GO:0032735,1,0.143409239858362,0,18,positive regulation of interleukin-12 production,BP,
8106,GO:0032785,1,0.293786249754573,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8111,GO:0032790,1,0.417607150277183,0,8,ribosome disassembly,BP,
8117,GO:0032797,1,0.307285403518084,0,11,SMN complex,CC,
8126,GO:0032806,1,0.0638106518511305,0,25,carboxy-terminal domain protein kinase complex,CC,
8132,GO:0032814,1,0.148725900620104,0,18,regulation of natural killer cell activation,BP,
8133,GO:0032815,1,0.601123041650671,0,5,negative regulation of natural killer cell activation,BP,
8134,GO:0032816,1,0.278640521396552,0,12,positive regulation of natural killer cell activation,BP,
8137,GO:0032823,1,0.378187084165782,0,9,regulation of natural killer cell differentiation,BP,
8139,GO:0032825,1,0.464108624026072,0,7,positive regulation of natural killer cell differentiation,BP,
8155,GO:0032875,1,0.440850998631562,0,7,regulation of DNA endoreduplication,BP,
8176,GO:0032906,1,0.497081719508239,0,6,transforming growth factor beta2 production,BP,
8179,GO:0032909,1,0.497081719508239,0,6,regulation of transforming growth factor beta2 production,BP,
8194,GO:0032926,1,0.461703261452365,0,7,negative regulation of activin receptor signaling pathway,BP,
8211,GO:0032957,1,0.394381527193636,0,8,inositol trisphosphate metabolic process,BP,
8213,GO:0032959,1,0.497883910219648,0,6,inositol trisphosphate biosynthetic process,BP,
8221,GO:0032968,1,0.190047291894502,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8234,GO:0032988,1,0.242827509538794,0,13,ribonucleoprotein complex disassembly,BP,
8248,GO:0033010,1,0.510170550144559,0,6,paranodal junction,CC,
8251,GO:0033015,1,0.559102701224291,0,6,tetrapyrrole catabolic process,BP,
8272,GO:0033046,1,0.0201318034806941,0,36,negative regulation of sister chromatid segregation,BP,
8274,GO:0033048,1,0.025399381756328,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8277,GO:0033061,1,0.375865347265437,0,9,DNA recombinase mediator complex,CC,
8278,GO:0033063,1,0.471614198969986,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8283,GO:0033079,1,0.574162402484957,0,5,immature T cell proliferation,BP,
8289,GO:0033085,1,0.587571646641505,0,5,negative regulation of T cell differentiation in thymus,BP,
8298,GO:0033119,1,0.0845254964232709,0,23,negative regulation of RNA splicing,BP,
8299,GO:0033120,1,0.0592420732074314,0,25,positive regulation of RNA splicing,BP,
8307,GO:0033131,1,0.543579943397625,0,6,regulation of glucokinase activity,BP,
8326,GO:0033153,1,0.558550393994749,0,5,T cell receptor V(D)J recombination,BP,
8330,GO:0033160,1,0.318157910836512,0,10,positive regulation of protein import into nucleus, translocation,BP,
8331,GO:0033162,1,0.544228051508564,0,6,melanosome membrane,CC,
8335,GO:0033170,1,0.418555937076997,0,8,protein-DNA loading ATPase activity,MF,
8343,GO:0033182,1,0.317102882951595,0,10,regulation of histone ubiquitination,BP,
8345,GO:0033184,1,0.561127274577039,0,5,positive regulation of histone ubiquitination,BP,
8360,GO:0033216,1,0.579000077378296,0,5,ferric iron import,BP,
8366,GO:0033235,1,0.341203702771938,0,10,positive regulation of protein sumoylation,BP,
8372,GO:0033256,1,0.461809903434761,0,7,I-kappaB/NF-kappaB complex,CC,
8396,GO:0033299,1,0.577529546751079,0,5,secretion of lysosomal enzymes,BP,
8400,GO:0033313,1,0.566758051797526,0,5,meiotic cell cycle checkpoint,BP,
8401,GO:0033314,1,0.409790731342402,0,8,mitotic DNA replication checkpoint,BP,
8422,GO:0033391,1,0.498430412456895,0,6,chromatoid body,CC,
8436,GO:0033523,1,0.256815946245505,0,12,histone H2B ubiquitination,BP,
8449,GO:0033561,1,0.0747643543322265,0,23,regulation of water loss via skin,BP,
8453,GO:0033567,1,0.589186840888256,0,5,DNA replication, Okazaki fragment processing,BP,
8459,GO:0033588,1,0.57519709753351,0,5,Elongator holoenzyme complex,CC,
8462,GO:0033592,1,0.560896522302521,0,5,RNA strand annealing activity,MF,
8474,GO:0033605,1,0.592796924815682,0,5,positive regulation of catecholamine secretion,BP,
8489,GO:0033629,1,0.462713735632747,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8498,GO:0033647,1,0.567764447739524,0,5,host intracellular organelle,CC,
8499,GO:0033648,1,0.567764447739524,0,5,host intracellular membrane-bounded organelle,CC,
8517,GO:0033689,1,0.497940470540654,0,6,negative regulation of osteoblast proliferation,BP,
8530,GO:0033750,1,0.279255709318445,0,13,ribosome localization,BP,
8562,GO:0033962,1,0.132331552712069,0,18,cytoplasmic mRNA processing body assembly,BP,
8577,GO:0034036,1,0.506626427238198,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8583,GO:0034046,1,0.446608628171037,0,7,poly(G) binding,MF,
8590,GO:0034063,1,0.221745461293499,0,13,stress granule assembly,BP,
8598,GO:0034091,1,0.426826921146092,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8600,GO:0034093,1,0.582641549123124,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8610,GO:0034112,1,0.611531814561759,0,5,positive regulation of homotypic cell-cell adhesion,BP,
8613,GO:0034115,1,0.463443769356531,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8620,GO:0034123,1,0.273913501296747,0,12,positive regulation of toll-like receptor signaling pathway,BP,
8625,GO:0034135,1,0.530849770518849,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8628,GO:0034138,1,0.148038006135221,0,17,toll-like receptor 3 signaling pathway,BP,
8629,GO:0034139,1,0.404328121872692,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8631,GO:0034141,1,0.511435097313035,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8635,GO:0034145,1,0.576137801116304,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8648,GO:0034182,1,0.426826921146092,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8650,GO:0034184,1,0.582641549123124,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8661,GO:0034201,1,0.579929166384589,0,5,response to oleic acid,BP,
8667,GO:0034214,1,0.447446055702772,0,7,protein hexamerization,BP,
8671,GO:0034227,1,0.588122488707293,0,5,tRNA thio-modification,BP,
8672,GO:0034235,1,0.572659267414828,0,5,GPI anchor binding,MF,
8679,GO:0034243,1,0.0610863611127342,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8680,GO:0034244,1,0.329991707225021,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8696,GO:0034310,1,0.47569662835893,0,7,primary alcohol catabolic process,BP,
8715,GO:0034349,1,0.226491671854408,0,13,glial cell apoptotic process,BP,
8716,GO:0034350,1,0.447940225090785,0,7,regulation of glial cell apoptotic process,BP,
8717,GO:0034351,1,0.447940225090785,0,7,negative regulation of glial cell apoptotic process,BP,
8746,GO:0034388,1,0.507682191157847,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8748,GO:0034390,1,0.207640344748104,0,14,smooth muscle cell apoptotic process,BP,
8749,GO:0034391,1,0.207640344748104,0,14,regulation of smooth muscle cell apoptotic process,BP,
8751,GO:0034393,1,0.367074998300908,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
8766,GO:0034427,1,0.380599652025426,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8781,GO:0034452,1,0.313126264661748,0,10,dynactin binding,MF,
8783,GO:0034454,1,0.349887431810855,0,9,microtubule anchoring at centrosome,BP,
8794,GO:0034471,1,0.148814708991088,0,19,ncRNA 5'-end processing,BP,
8798,GO:0034475,1,0.480404805786864,0,8,U4 snRNA 3'-end processing,BP,
8807,GO:0034501,1,0.171070714126623,0,16,protein localization to kinetochore,BP,
8815,GO:0034513,1,0.657847292209589,0,5,box H/ACA snoRNA binding,MF,
8817,GO:0034518,1,0.271684692137815,0,12,RNA cap binding complex,CC,
8823,GO:0034587,1,0.400754168283387,0,8,piRNA metabolic process,BP,
8827,GO:0034594,1,0.560065582740311,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8833,GO:0034603,1,0.571502264576848,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8834,GO:0034604,1,0.571502264576848,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8852,GO:0034638,1,0.550358987173235,0,6,phosphatidylcholine catabolic process,BP,
8900,GO:0034709,1,0.346553739976103,0,12,methylosome,CC,
8904,GO:0034715,1,0.590029888345366,0,6,pICln-Sm protein complex,CC,
8906,GO:0034719,1,0.217458707444002,0,16,SMN-Sm protein complex,CC,
8907,GO:0034720,1,0.494557606782377,0,6,histone H3-K4 demethylation,BP,
8910,GO:0034723,1,0.116766188493765,0,32,DNA replication-dependent nucleosome organization,BP,
8922,GO:0034755,1,0.256626314642774,0,12,iron ion transmembrane transport,BP,
8933,GO:0034770,1,0.354053362583206,0,9,histone H4-K20 methylation,BP,
8934,GO:0034773,1,0.502574076587592,0,6,histone H4-K20 trimethylation,BP,
8944,GO:0034969,1,0.328786375065873,0,10,histone arginine methylation,BP,
8949,GO:0034979,1,0.14757817109894,0,17,NAD-dependent protein deacetylase activity,MF,
8950,GO:0034982,1,0.354756315748359,0,10,mitochondrial protein processing,BP,
8951,GO:0034983,1,0.501533556402048,0,6,peptidyl-lysine deacetylation,BP,
8960,GO:0035005,1,0.494663291466325,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8970,GO:0035032,1,0.508504712103679,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8973,GO:0035035,1,0.0588634633059442,0,25,histone acetyltransferase binding,MF,
9002,GO:0035112,1,0.496463534175854,0,6,genitalia morphogenesis,BP,
9017,GO:0035174,1,0.521470140458335,0,6,histone serine kinase activity,MF,
9026,GO:0035197,1,0.358539978661713,0,9,siRNA binding,MF,
9031,GO:0035234,1,0.529564038031972,0,6,ectopic germ cell programmed cell death,BP,
9036,GO:0035242,1,0.463217997377738,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9038,GO:0035246,1,0.295433462890377,0,11,peptidyl-arginine N-methylation,BP,
9039,GO:0035247,1,0.369737191753101,0,9,peptidyl-arginine omega-N-methylation,BP,
9045,GO:0035253,1,0.358485085212074,0,9,ciliary rootlet,CC,
9051,GO:0035259,1,0.228364191485722,0,13,glucocorticoid receptor binding,MF,
9056,GO:0035267,1,0.126872312614646,0,19,NuA4 histone acetyltransferase complex,CC,
9079,GO:0035312,1,0.50351668860952,0,6,5'-3' exodeoxyribonuclease activity,MF,
9082,GO:0035325,1,0.451891094859694,0,8,Toll-like receptor binding,MF,
9084,GO:0035327,1,0.12170414009157,0,20,transcriptionally active chromatin,CC,
9089,GO:0035333,1,0.267525164870712,0,12,Notch receptor processing, ligand-dependent,BP,
9112,GO:0035376,1,0.578814687466703,0,5,sterol import,BP,
9143,GO:0035461,1,0.403021053299785,0,8,vitamin transmembrane transport,BP,
9161,GO:0035507,1,0.50047916652713,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9165,GO:0035511,1,0.593870666039667,0,5,oxidative DNA demethylation,BP,
9173,GO:0035520,1,0.350766828932573,0,9,monoubiquitinated protein deubiquitination,BP,
9177,GO:0035524,1,0.559114441771949,0,5,proline transmembrane transport,BP,
9180,GO:0035529,1,0.600762690584987,0,5,NADH pyrophosphatase activity,MF,
9193,GO:0035563,1,0.261430843065287,0,12,positive regulation of chromatin binding,BP,
9213,GO:0035589,1,0.577201255225757,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9246,GO:0035631,1,0.289857283075319,0,11,CD40 receptor complex,CC,
9291,GO:0035721,1,0.276992727962537,0,12,intraciliary retrograde transport,BP,
9297,GO:0035728,1,0.288127621933529,0,11,response to hepatocyte growth factor,BP,
9298,GO:0035729,1,0.362513529750246,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9311,GO:0035749,1,0.576689360818014,0,5,myelin sheath adaxonal region,CC,
9313,GO:0035751,1,0.323601379776121,0,11,regulation of lysosomal lumen pH,BP,
9315,GO:0035754,1,0.56552431694475,0,5,B cell chemotaxis,BP,
9321,GO:0035771,1,0.566603458033351,0,5,interleukin-4-mediated signaling pathway,BP,
9323,GO:0035774,1,0.129942200953315,0,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9339,GO:0035810,1,0.567103808252549,0,5,positive regulation of urine volume,BP,
9347,GO:0035825,1,0.0186319609616485,0,36,homologous recombination,BP,
9351,GO:0035845,1,0.458532053527665,0,7,photoreceptor cell outer segment organization,BP,
9377,GO:0035886,1,0.235492792408504,0,13,vascular smooth muscle cell differentiation,BP,
9383,GO:0035900,1,0.548397580303593,0,6,response to isolation stress,BP,
9387,GO:0035907,1,0.563463536457961,0,5,dorsal aorta development,BP,
9396,GO:0035925,1,0.284423071073399,0,11,mRNA 3'-UTR AU-rich region binding,MF,
9414,GO:0035964,1,0.514060169471954,0,6,COPI-coated vesicle budding,BP,
9435,GO:0035994,1,0.228080377173089,0,13,response to muscle stretch,BP,
9438,GO:0035999,1,0.424076738516428,0,8,tetrahydrofolate interconversion,BP,
9459,GO:0036038,1,0.255852893472473,0,13,MKS complex,CC,
9460,GO:0036041,1,0.582102455844858,0,6,long-chain fatty acid binding,MF,
9496,GO:0036123,1,0.584570494878411,0,5,histone H3-K9 dimethylation,BP,
9497,GO:0036124,1,0.203192260124432,0,14,histone H3-K9 trimethylation,BP,
9539,GO:0036260,1,0.0326839617767205,0,33,RNA capping,BP,
9551,GO:0036295,1,0.238934464753021,0,13,cellular response to increased oxygen levels,BP,
9562,GO:0036315,1,0.221781652606995,0,13,cellular response to sterol,BP,
9568,GO:0036336,1,0.191206492372938,0,15,dendritic cell migration,BP,
9570,GO:0036342,1,0.280094591126228,0,11,post-anal tail morphogenesis,BP,
9575,GO:0036353,1,0.413790970872083,0,8,histone H2A-K119 monoubiquitination,BP,
9583,GO:0036376,1,0.449956749701628,0,7,sodium ion export across plasma membrane,BP,
9592,GO:0036402,1,0.55706263389819,0,6,proteasome-activating ATPase activity,MF,
9600,GO:0036444,1,0.400715482756231,0,8,calcium import into the mitochondrion,BP,
9612,GO:0036462,1,0.474811595528506,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9624,GO:0036480,1,0.463114350857178,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9633,GO:0036491,1,0.448135216076522,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9634,GO:0036492,1,0.501054548575881,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9654,GO:0036514,1,0.556940655324001,0,5,dopaminergic neuron axon guidance,BP,
9679,GO:0038030,1,0.498157923407623,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9680,GO:0038031,1,0.559802947367128,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9683,GO:0038036,1,0.507466779547745,0,6,sphingosine-1-phosphate receptor activity,MF,
9694,GO:0038063,1,0.437540434358206,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9696,GO:0038065,1,0.38867820329549,0,8,collagen-activated signaling pathway,BP,
9702,GO:0038089,1,0.581989386262543,0,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9704,GO:0038092,1,0.514480899299565,0,6,nodal signaling pathway,BP,
9739,GO:0038180,1,0.415589767828234,0,8,nerve growth factor signaling pathway,BP,
9743,GO:0038187,1,0.465773075140697,0,7,pattern recognition receptor activity,MF,
9753,GO:0038203,1,0.454756394268473,0,7,TORC2 signaling,BP,
9778,GO:0039533,1,0.513876140682761,0,6,regulation of MDA-5 signaling pathway,BP,
9810,GO:0040020,1,0.164426252483957,0,16,regulation of meiotic nuclear division,BP,
9813,GO:0040031,1,0.571091455669661,0,6,snRNA modification,BP,
9827,GO:0042023,1,0.393562990725219,0,8,DNA endoreduplication,BP,
9831,GO:0042033,1,0.356220273220035,0,10,chemokine biosynthetic process,BP,
9836,GO:0042044,1,0.26907165963148,0,12,fluid transport,BP,
9837,GO:0042045,1,0.590427818551498,0,5,epithelial fluid transport,BP,
9854,GO:0042090,1,0.562247963044545,0,5,interleukin-12 biosynthetic process,BP,
9873,GO:0042117,1,0.564714945449547,0,5,monocyte activation,BP,
9890,GO:0042148,1,0.418949600425675,0,8,strand invasion,BP,
9895,GO:0042162,1,0.0187190227912294,0,35,telomeric DNA binding,MF,
9898,GO:0042167,1,0.559102701224291,0,6,heme catabolic process,BP,
9905,GO:0042178,1,0.362738189550683,0,10,xenobiotic catabolic process,BP,
9915,GO:0042226,1,0.32612355039839,0,10,interleukin-6 biosynthetic process,BP,
9916,GO:0042228,1,0.456878038783476,0,7,interleukin-8 biosynthetic process,BP,
9926,GO:0042256,1,0.603220952771334,0,5,mature ribosome assembly,BP,
9931,GO:0042268,1,0.572733027056579,0,6,regulation of cytolysis,BP,
9937,GO:0042274,1,0.00106903798627501,0,70,ribosomal small subunit biogenesis,BP,
9939,GO:0042276,1,0.138367142366034,0,19,error-prone translesion synthesis,BP,
9946,GO:0042287,1,0.171433189382525,0,16,MHC protein binding,MF,
9947,GO:0042288,1,0.367952839950778,0,9,MHC class I protein binding,MF,
9976,GO:0042354,1,0.499539753787497,0,6,L-fucose metabolic process,BP,
9977,GO:0042355,1,0.499539753787497,0,6,L-fucose catabolic process,BP,
9990,GO:0042373,1,0.61802960624218,0,5,vitamin K metabolic process,BP,
9994,GO:0042379,1,0.12579909890442,0,22,chemokine receptor binding,MF,
9995,GO:0042382,1,0.505425327592246,0,6,paraspeckles,CC,
9998,GO:0042392,1,0.581385389048081,0,5,sphingosine-1-phosphate phosphatase activity,MF,
10010,GO:0042416,1,0.420073140853935,0,8,dopamine biosynthetic process,BP,
10019,GO:0042430,1,0.415627946890812,0,8,indole-containing compound metabolic process,BP,
10021,GO:0042438,1,0.413268468329105,0,8,melanin biosynthetic process,BP,
10022,GO:0042439,1,0.508337097744156,0,6,ethanolamine-containing compound metabolic process,BP,
10045,GO:0042487,1,0.570898215655047,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10049,GO:0042492,1,0.564876163383678,0,5,gamma-delta T cell differentiation,BP,
10059,GO:0042532,1,0.29547059631677,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10064,GO:0042537,1,0.256774456677678,0,13,benzene-containing compound metabolic process,BP,
10065,GO:0042538,1,0.577566511862923,0,5,hyperosmotic salinity response,BP,
10067,GO:0042541,1,0.514833227386863,0,6,hemoglobin biosynthetic process,BP,
10074,GO:0042555,1,0.284987875646936,0,11,MCM complex,CC,
10076,GO:0042559,1,0.243030629261526,0,14,pteridine-containing compound biosynthetic process,BP,
10087,GO:0042577,1,0.452940373943826,0,7,lipid phosphatase activity,MF,
10092,GO:0042583,1,0.566594031043037,0,5,chromaffin granule,CC,
10096,GO:0042587,1,0.577783514491872,0,5,glycogen granule,CC,
10107,GO:0042605,1,0.227143729000937,0,14,peptide antigen binding,MF,
10111,GO:0042611,1,0.320873676076654,0,12,MHC protein complex,CC,
10112,GO:0042612,1,0.421800686907419,0,9,MHC class I protein complex,CC,
10152,GO:0042711,1,0.506333188299002,0,6,maternal behavior,BP,
10154,GO:0042719,1,0.640143192488715,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10156,GO:0042721,1,0.621179136406055,0,5,mitochondrial inner membrane protein insertion complex,CC,
10158,GO:0042726,1,0.457351606817946,0,7,flavin-containing compound metabolic process,BP,
10176,GO:0042753,1,0.500153619613184,0,6,positive regulation of circadian rhythm,BP,
10177,GO:0042754,1,0.359988008729892,0,9,negative regulation of circadian rhythm,BP,
10178,GO:0042755,1,0.223736353504562,0,14,eating behavior,BP,
10185,GO:0042765,1,0.573135907336874,0,5,GPI-anchor transamidase complex,CC,
10196,GO:0042780,1,0.475176327917116,0,7,tRNA 3'-end processing,BP,
10198,GO:0042788,1,0.104427299652433,0,29,polysomal ribosome,CC,
10200,GO:0042790,1,0.264517269509557,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10201,GO:0042791,1,0.519886308472142,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10203,GO:0042796,1,0.509117552183575,0,6,snRNA transcription by RNA polymerase III,BP,
10204,GO:0042797,1,0.519886308472142,0,6,tRNA transcription by RNA polymerase III,BP,
10239,GO:0042921,1,0.201911723857647,0,14,glucocorticoid receptor signaling pathway,BP,
10253,GO:0042976,1,0.484326638529947,0,7,activation of Janus kinase activity,BP,
10267,GO:0042996,1,0.561792510938902,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10288,GO:0043023,1,0.31588678210763,0,11,ribosomal large subunit binding,MF,
10289,GO:0043024,1,0.220688781342982,0,14,ribosomal small subunit binding,MF,
10296,GO:0043032,1,0.297204888618179,0,11,positive regulation of macrophage activation,BP,
10307,GO:0043047,1,0.288830876116388,0,11,single-stranded telomeric DNA binding,MF,
10325,GO:0043096,1,0.618268193481011,0,5,purine nucleobase salvage,BP,
10328,GO:0043102,1,0.527005968497341,0,6,amino acid salvage,BP,
10351,GO:0043138,1,0.256840098552316,0,12,3'-5' DNA helicase activity,MF,
10352,GO:0043139,1,0.461095692152437,0,7,5'-3' DNA helicase activity,MF,
10353,GO:0043140,1,0.439943236728567,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10354,GO:0043141,1,0.57904660099395,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10355,GO:0043142,1,0.2344502049586,0,13,single-stranded DNA-dependent ATPase activity,MF,
10356,GO:0043144,1,0.476464097771669,0,8,snoRNA processing,BP,
10371,GO:0043175,1,0.0200743056266413,0,35,RNA polymerase core enzyme binding,MF,
10381,GO:0043189,1,0.126872312614646,0,19,H4/H2A histone acetyltransferase complex,CC,
10398,GO:0043218,1,0.267308995013295,0,12,compact myelin,CC,
10400,GO:0043220,1,0.365667898493245,0,9,Schmidt-Lanterman incisure,CC,
10415,GO:0043240,1,0.286668900166036,0,11,Fanconi anaemia nuclear complex,CC,
10442,GO:0043278,1,0.152676405615801,0,17,response to morphine,BP,
10449,GO:0043295,1,0.338231730278818,0,11,glutathione binding,MF,
10471,GO:0043320,1,0.509134772751456,0,6,natural killer cell degranulation,BP,
10481,GO:0043353,1,0.497094999123782,0,6,enucleate erythrocyte differentiation,BP,
10494,GO:0043379,1,0.58423928179625,0,5,memory T cell differentiation,BP,
10524,GO:0043422,1,0.330314166992079,0,10,protein kinase B binding,MF,
10527,GO:0043426,1,0.565605521591318,0,5,MRF binding,MF,
10533,GO:0043455,1,0.407046111644801,0,8,regulation of secondary metabolic process,BP,
10551,GO:0043489,1,0.03887129248639,0,29,RNA stabilization,BP,
10568,GO:0043515,1,0.572812354411066,0,5,kinetochore binding,MF,
10577,GO:0043527,1,0.59167690500451,0,5,tRNA methyltransferase complex,CC,
10591,GO:0043545,1,0.463905145211307,0,7,molybdopterin cofactor metabolic process,BP,
10618,GO:0043587,1,0.409686800301708,0,8,tongue morphogenesis,BP,
10620,GO:0043589,1,0.350873328620788,0,9,skin morphogenesis,BP,
10645,GO:0043633,1,0.437740652746969,0,8,polyadenylation-dependent RNA catabolic process,BP,
10646,GO:0043634,1,0.492552111731914,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10663,GO:0043696,1,0.56775038455719,0,5,dedifferentiation,BP,
10664,GO:0043697,1,0.56775038455719,0,5,cell dedifferentiation,BP,
10688,GO:0043928,1,0.0373466568910895,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10700,GO:0043968,1,0.176559045087096,0,16,histone H2A acetylation,BP,
10710,GO:0043985,1,0.515689505598374,0,6,histone H4-R3 methylation,BP,
10715,GO:0043995,1,0.319039533263771,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10716,GO:0043996,1,0.319039533263771,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10752,GO:0044110,1,0.53480345840295,0,6,growth involved in symbiotic interaction,BP,
10755,GO:0044116,1,0.53480345840295,0,6,growth of symbiont involved in interaction with host,BP,
10756,GO:0044117,1,0.53480345840295,0,6,growth of symbiont in host,BP,
10757,GO:0044126,1,0.583103233689684,0,5,regulation of growth of symbiont in host,BP,
10760,GO:0044144,1,0.583103233689684,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10789,GO:0044233,1,0.263826395350965,0,12,ER-mitochondrion membrane contact site,CC,
10816,GO:0044292,1,0.330274214293959,0,10,dendrite terminus,CC,
10817,GO:0044294,1,0.44373141538655,0,7,dendritic growth cone,CC,
10818,GO:0044295,1,0.102288306352349,0,20,axonal growth cone,CC,
10847,GO:0044331,1,0.233467401526526,0,13,cell-cell adhesion mediated by cadherin,BP,
10854,GO:0044340,1,0.569764967166345,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
10867,GO:0044359,1,0.474887630828096,0,7,modulation of molecular function in other organism,BP,
10868,GO:0044362,1,0.534577700528717,0,6,negative regulation of molecular function in other organism,BP,
10875,GO:0044388,1,0.615861346881177,0,5,small protein activating enzyme binding,MF,
10883,GO:0044406,1,0.577290877576595,0,5,adhesion of symbiont to host,BP,
10889,GO:0044417,1,0.383824049079608,0,9,translocation of molecules into host,BP,
10921,GO:0044458,1,0.273514841264708,0,12,motile cilium assembly,BP,
10936,GO:0044545,1,0.571463279724491,0,5,NSL complex,CC,
10938,GO:0044547,1,0.56480456720991,0,5,DNA topoisomerase binding,MF,
10939,GO:0044548,1,0.322652270783711,0,11,S100 protein binding,MF,
10942,GO:0044557,1,0.599482810886774,0,5,relaxation of smooth muscle,BP,
10957,GO:0044613,1,0.27521187974866,0,12,nuclear pore central transport channel,CC,
10959,GO:0044615,1,0.352271941781627,0,9,nuclear pore nuclear basket,CC,
10984,GO:0044754,1,0.444098365624073,0,8,autolysosome,CC,
11003,GO:0044793,1,0.566799626768783,0,5,negative regulation by host of viral process,BP,
11012,GO:0044806,1,0.441551931536333,0,7,G-quadruplex DNA unwinding,BP,
11044,GO:0045002,1,0.454247538101271,0,7,double-strand break repair via single-strand annealing,BP,
11045,GO:0045003,1,0.335754721155092,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11051,GO:0045009,1,0.544228051508564,0,6,chitosome,CC,
11055,GO:0045019,1,0.346407722982152,0,10,negative regulation of nitric oxide biosynthetic process,BP,
11061,GO:0045028,1,0.577201255225757,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11064,GO:0045039,1,0.589543308081007,0,6,protein import into mitochondrial inner membrane,BP,
11065,GO:0045040,1,0.574250861745539,0,6,protein import into mitochondrial outer membrane,BP,
11067,GO:0045046,1,0.506754162842756,0,6,protein import into peroxisome membrane,BP,
11069,GO:0045048,1,0.576842302730542,0,5,protein insertion into ER membrane,BP,
11075,GO:0045059,1,0.517972367178707,0,6,positive thymic T cell selection,BP,
11087,GO:0045073,1,0.38796608080197,0,9,regulation of chemokine biosynthetic process,BP,
11089,GO:0045075,1,0.562247963044545,0,5,regulation of interleukin-12 biosynthetic process,BP,
11094,GO:0045080,1,0.468685606045824,0,7,positive regulation of chemokine biosynthetic process,BP,
11106,GO:0045095,1,0.0736039234821452,0,24,keratin filament,CC,
11108,GO:0045103,1,0.024612941619196,0,33,intermediate filament-based process,BP,
11109,GO:0045104,1,0.0276280426910152,0,32,intermediate filament cytoskeleton organization,BP,
11111,GO:0045109,1,0.163205346835509,0,16,intermediate filament organization,BP,
11112,GO:0045110,1,0.50536115366438,0,6,intermediate filament bundle assembly,BP,
11116,GO:0045116,1,0.260549115745666,0,14,protein neddylation,BP,
11117,GO:0045117,1,0.183647507557844,0,16,azole transport,BP,
11133,GO:0045144,1,0.58824280370139,0,5,meiotic sister chromatid segregation,BP,
11146,GO:0045176,1,0.354455426595747,0,9,apical protein localization,BP,
11150,GO:0045180,1,0.553384243564178,0,5,basal cortex,CC,
11184,GO:0045236,1,0.489644920125291,0,7,CXCR chemokine receptor binding,MF,
11190,GO:0045254,1,0.454518444670826,0,7,pyruvate dehydrogenase complex,CC,
11198,GO:0045275,1,0.3462421876742,0,11,respiratory chain complex III,CC,
11203,GO:0045292,1,0.156296742430438,0,17,mRNA cis splicing, via spliceosome,BP,
11206,GO:0045295,1,0.346923201248149,0,9,gamma-catenin binding,MF,
11214,GO:0045324,1,0.314482700000015,0,11,late endosome to vacuole transport,BP,
11215,GO:0045329,1,0.57317677990068,0,5,carnitine biosynthetic process,BP,
11231,GO:0045350,1,0.518687636868877,0,6,interferon-beta biosynthetic process,BP,
11238,GO:0045357,1,0.518687636868877,0,6,regulation of interferon-beta biosynthetic process,BP,
11249,GO:0045408,1,0.365555986034371,0,9,regulation of interleukin-6 biosynthetic process,BP,
11251,GO:0045410,1,0.512749248300155,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11252,GO:0045414,1,0.514024011160345,0,6,regulation of interleukin-8 biosynthetic process,BP,
11273,GO:0045504,1,0.325540986934657,0,10,dynein heavy chain binding,MF,
11281,GO:0045542,1,0.560579636927802,0,5,positive regulation of cholesterol biosynthetic process,BP,
11307,GO:0045603,1,0.446313456765803,0,7,positive regulation of endothelial cell differentiation,BP,
11309,GO:0045605,1,0.325368187484759,0,10,negative regulation of epidermal cell differentiation,BP,
11311,GO:0045607,1,0.586373725815987,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11314,GO:0045617,1,0.506259211871216,0,6,negative regulation of keratinocyte differentiation,BP,
11328,GO:0045631,1,0.586373725815987,0,5,regulation of mechanoreceptor differentiation,BP,
11330,GO:0045634,1,0.569226537789371,0,5,regulation of melanocyte differentiation,BP,
11338,GO:0045647,1,0.412736072167299,0,8,negative regulation of erythrocyte differentiation,BP,
11340,GO:0045649,1,0.287480933353196,0,11,regulation of macrophage differentiation,BP,
11342,GO:0045651,1,0.355762234477604,0,9,positive regulation of macrophage differentiation,BP,
11347,GO:0045656,1,0.565841451613976,0,5,negative regulation of monocyte differentiation,BP,
11354,GO:0045663,1,0.326237844238641,0,10,positive regulation of myoblast differentiation,BP,
11362,GO:0045671,1,0.156966354954607,0,16,negative regulation of osteoclast differentiation,BP,
11368,GO:0045686,1,0.264925893930503,0,12,negative regulation of glial cell differentiation,BP,
11376,GO:0045721,1,0.452035037167565,0,7,negative regulation of gluconeogenesis,BP,
11392,GO:0045743,1,0.579522350976959,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11399,GO:0045760,1,0.500543519126753,0,6,positive regulation of action potential,BP,
11409,GO:0045777,1,0.25213468321236,0,13,positive regulation of blood pressure,BP,
11411,GO:0045779,1,0.468480918416291,0,7,negative regulation of bone resorption,BP,
11428,GO:0045821,1,0.277046287322608,0,11,positive regulation of glycolytic process,BP,
11429,GO:0045822,1,0.329446324271171,0,10,negative regulation of heart contraction,BP,
11436,GO:0045835,1,0.50223211324996,0,6,negative regulation of meiotic nuclear division,BP,
11437,GO:0045836,1,0.505664249888929,0,6,positive regulation of meiotic nuclear division,BP,
11442,GO:0045841,1,0.0370844628464045,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11443,GO:0045842,1,0.425113183194113,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11455,GO:0045875,1,0.581085111782405,0,5,negative regulation of sister chromatid cohesion,BP,
11456,GO:0045876,1,0.327447715900798,0,10,positive regulation of sister chromatid cohesion,BP,
11458,GO:0045880,1,0.0812626774711775,0,22,positive regulation of smoothened signaling pathway,BP,
11463,GO:0045899,1,0.348941368536045,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11470,GO:0045910,1,0.0892688929848311,0,21,negative regulation of DNA recombination,BP,
11475,GO:0045915,1,0.595729192754378,0,5,positive regulation of catecholamine metabolic process,BP,
11500,GO:0045945,1,0.31789605540332,0,10,positive regulation of transcription by RNA polymerase III,BP,
11505,GO:0045954,1,0.410617352612393,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11506,GO:0045955,1,0.450568881488282,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11509,GO:0045964,1,0.595729192754378,0,5,positive regulation of dopamine metabolic process,BP,
11519,GO:0045989,1,0.479932181559268,0,7,positive regulation of striated muscle contraction,BP,
11573,GO:0046100,1,0.592652671235063,0,5,hypoxanthine metabolic process,BP,
11581,GO:0046112,1,0.124486439830618,0,19,nucleobase biosynthetic process,BP,
11599,GO:0046146,1,0.501713180789301,0,7,tetrahydrobiopterin metabolic process,BP,
11601,GO:0046149,1,0.559102701224291,0,6,pigment catabolic process,BP,
11612,GO:0046184,1,0.324068070358778,0,10,aldehyde biosynthetic process,BP,
11700,GO:0046469,1,0.57426135968177,0,5,platelet activating factor metabolic process,BP,
11711,GO:0046485,1,0.467730670103098,0,7,ether lipid metabolic process,BP,
11727,GO:0046504,1,0.582590520912821,0,5,glycerol ether biosynthetic process,BP,
11740,GO:0046532,1,0.562794779103756,0,5,regulation of photoreceptor cell differentiation,BP,
11745,GO:0046540,1,0.0892027865419308,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11768,GO:0046599,1,0.148188581057842,0,17,regulation of centriole replication,BP,
11769,GO:0046600,1,0.409674280221217,0,8,negative regulation of centriole replication,BP,
11771,GO:0046602,1,0.414598403668799,0,8,regulation of mitotic centrosome separation,BP,
11774,GO:0046606,1,0.241685635930424,0,13,negative regulation of centrosome cycle,BP,
11775,GO:0046607,1,0.367551287502137,0,9,positive regulation of centrosome cycle,BP,
11787,GO:0046629,1,0.36543069633632,0,9,gamma-delta T cell activation,BP,
11805,GO:0046654,1,0.466597043117135,0,7,tetrahydrofolate biosynthetic process,BP,
11829,GO:0046703,1,0.444543390997575,0,9,natural killer cell lectin-like receptor binding,MF,
11837,GO:0046716,1,0.262664550534389,0,12,muscle cell cellular homeostasis,BP,
11851,GO:0046784,1,0.429235865265617,0,8,viral mRNA export from host cell nucleus,BP,
11863,GO:0046826,1,0.506176103101986,0,7,negative regulation of protein export from nucleus,BP,
11865,GO:0046831,1,0.17603926016099,0,15,regulation of RNA export from nucleus,BP,
11867,GO:0046833,1,0.446330205529219,0,7,positive regulation of RNA export from nucleus,BP,
11870,GO:0046836,1,0.591129567662774,0,5,glycolipid transport,BP,
11871,GO:0046838,1,0.320336813663028,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11877,GO:0046851,1,0.416415825981696,0,8,negative regulation of bone remodeling,BP,
11880,GO:0046855,1,0.320336813663028,0,10,inositol phosphate dephosphorylation,BP,
11894,GO:0046886,1,0.459501336178299,0,7,positive regulation of hormone biosynthetic process,BP,
11912,GO:0046920,1,0.567151039548511,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11918,GO:0046930,1,0.315521896302057,0,11,pore complex,CC,
11919,GO:0046931,1,0.191522200776176,0,15,pore complex assembly,BP,
11943,GO:0046972,1,0.319039533263771,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11944,GO:0046974,1,0.560711083900641,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11945,GO:0046975,1,0.50780855467783,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11946,GO:0046976,1,0.563230320607651,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11976,GO:0047134,1,0.615812744529599,0,5,protein-disulfide reductase activity,MF,
12016,GO:0047429,1,0.401377753401824,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12025,GO:0047498,1,0.502407635243378,0,6,calcium-dependent phospholipase A2 activity,MF,
12026,GO:0047499,1,0.57713506514105,0,5,calcium-independent phospholipase A2 activity,MF,
12038,GO:0047631,1,0.633207571059516,0,5,ADP-ribose diphosphatase activity,MF,
12087,GO:0048020,1,0.476057494204893,0,8,CCR chemokine receptor binding,MF,
12091,GO:0048024,1,0.000758409811257273,0,64,regulation of mRNA splicing, via spliceosome,BP,
12092,GO:0048025,1,0.134678731889822,0,18,negative regulation of mRNA splicing, via spliceosome,BP,
12093,GO:0048026,1,0.264530564936237,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12101,GO:0048039,1,0.545955374345735,0,6,ubiquinone binding,MF,
12104,GO:0048048,1,0.0794636700641625,0,22,embryonic eye morphogenesis,BP,
12105,GO:0048050,1,0.55612277961775,0,6,post-embryonic eye morphogenesis,BP,
12109,GO:0048070,1,0.265123330013917,0,12,regulation of developmental pigmentation,BP,
12112,GO:0048087,1,0.463673527132234,0,7,positive regulation of developmental pigmentation,BP,
12113,GO:0048096,1,0.413506852947441,0,8,chromatin-mediated maintenance of transcription,BP,
12134,GO:0048172,1,0.450637152482921,0,7,regulation of short-term neuronal synaptic plasticity,BP,
12142,GO:0048200,1,0.514060169471954,0,6,Golgi transport vesicle coating,BP,
12144,GO:0048205,1,0.514060169471954,0,6,COPI coating of Golgi vesicle,BP,
12151,GO:0048227,1,0.423448134593422,0,8,plasma membrane to endosome transport,BP,
12164,GO:0048255,1,0.0608080965486424,0,25,mRNA stabilization,BP,
12165,GO:0048256,1,0.403208665700433,0,8,flap endonuclease activity,MF,
12178,GO:0048273,1,0.510714768375262,0,6,mitogen-activated protein kinase p38 binding,MF,
12183,GO:0048286,1,0.0716600983783784,0,23,lung alveolus development,BP,
12186,GO:0048291,1,0.405571635005995,0,8,isotype switching to IgG isotypes,BP,
12193,GO:0048302,1,0.453294712445845,0,7,regulation of isotype switching to IgG isotypes,BP,
12194,GO:0048304,1,0.570756512082971,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12198,GO:0048311,1,0.194706079978986,0,14,mitochondrion distribution,BP,
12199,GO:0048312,1,0.496312836944212,0,6,intracellular distribution of mitochondria,BP,
12201,GO:0048318,1,0.604757187665828,0,5,axial mesoderm development,BP,
12208,GO:0048340,1,0.442617908281187,0,7,paraxial mesoderm morphogenesis,BP,
12222,GO:0048385,1,0.300059515986267,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12224,GO:0048387,1,0.570748916944349,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12232,GO:0048407,1,0.441595995228066,0,7,platelet-derived growth factor binding,MF,
12238,GO:0048476,1,0.603248669875106,0,5,Holliday junction resolvase complex,CC,
12240,GO:0048478,1,0.461702866932423,0,7,replication fork protection,BP,
12252,GO:0048500,1,0.402354233353026,0,9,signal recognition particle,CC,
12261,GO:0048520,1,0.56046849698981,0,5,positive regulation of behavior,BP,
12278,GO:0048548,1,0.360632058020696,0,9,regulation of pinocytosis,BP,
12280,GO:0048550,1,0.573855252398495,0,5,negative regulation of pinocytosis,BP,
12281,GO:0048557,1,0.451479907663018,0,7,embryonic digestive tract morphogenesis,BP,
12285,GO:0048563,1,0.494113441868179,0,7,post-embryonic animal organ morphogenesis,BP,
12290,GO:0048570,1,0.571206567132642,0,5,notochord morphogenesis,BP,
12298,GO:0048596,1,0.172618785575707,0,15,embryonic camera-type eye morphogenesis,BP,
12357,GO:0048703,1,0.449158674441269,0,7,embryonic viscerocranium morphogenesis,BP,
12365,GO:0048712,1,0.575695950131096,0,5,negative regulation of astrocyte differentiation,BP,
12367,GO:0048714,1,0.255962669800141,0,12,positive regulation of oligodendrocyte differentiation,BP,
12368,GO:0048715,1,0.418141984705462,0,8,negative regulation of oligodendrocyte differentiation,BP,
12370,GO:0048730,1,0.114733418413106,0,19,epidermis morphogenesis,BP,
12373,GO:0048733,1,0.563195210007305,0,5,sebaceous gland development,BP,
12376,GO:0048739,1,0.504808977320848,0,6,cardiac muscle fiber development,BP,
12416,GO:0048842,1,0.496066722121386,0,6,positive regulation of axon extension involved in axon guidance,BP,
12419,GO:0048845,1,0.399084253562197,0,8,venous blood vessel morphogenesis,BP,
12423,GO:0048853,1,0.448124719041186,0,7,forebrain morphogenesis,BP,
12449,GO:0048934,1,0.507617551560342,0,6,peripheral nervous system neuron differentiation,BP,
12450,GO:0048935,1,0.507617551560342,0,6,peripheral nervous system neuron development,BP,
12457,GO:0050072,1,0.465704376305461,0,7,m7G(5')pppN diphosphatase activity,MF,
12481,GO:0050291,1,0.567189788163609,0,5,sphingosine N-acyltransferase activity,MF,
12483,GO:0050308,1,0.567756841490072,0,5,sugar-phosphatase activity,MF,
12498,GO:0050428,1,0.506626427238198,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12501,GO:0050433,1,0.275875338775316,0,12,regulation of catecholamine secretion,BP,
12540,GO:0050664,1,0.530194937674432,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12541,GO:0050665,1,0.345859832537048,0,10,hydrogen peroxide biosynthetic process,BP,
12556,GO:0050686,1,0.0425947061991659,0,28,negative regulation of mRNA processing,BP,
12559,GO:0050689,1,0.590549790948718,0,5,negative regulation of defense response to virus by host,BP,
12561,GO:0050691,1,0.0480668357135792,0,28,regulation of defense response to virus by host,BP,
12570,GO:0050703,1,0.630975870846959,0,5,interleukin-1 alpha secretion,BP,
12598,GO:0050733,1,0.569540468838396,0,5,RS domain binding,MF,
12599,GO:0050746,1,0.4193861119341,0,8,regulation of lipoprotein metabolic process,BP,
12600,GO:0050747,1,0.59373795179725,0,5,positive regulation of lipoprotein metabolic process,BP,
12603,GO:0050755,1,0.356220273220035,0,10,chemokine metabolic process,BP,
12626,GO:0050786,1,0.607626499154487,0,7,RAGE receptor binding,MF,
12646,GO:0050812,1,0.253165330473005,0,12,regulation of acyl-CoA biosynthetic process,BP,
12647,GO:0050815,1,0.52446807003069,0,6,phosphoserine residue binding,MF,
12668,GO:0050853,1,0.0387594040564082,0,29,B cell receptor signaling pathway,BP,
12670,GO:0050855,1,0.254811478246594,0,12,regulation of B cell receptor signaling pathway,BP,
12694,GO:0050882,1,0.498074305812235,0,6,voluntary musculoskeletal movement,BP,
12709,GO:0050907,1,0.385409642761392,0,10,detection of chemical stimulus involved in sensory perception,BP,
12714,GO:0050912,1,0.566037340186442,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12733,GO:0050932,1,0.453675705551214,0,7,regulation of pigment cell differentiation,BP,
12734,GO:0050942,1,0.559892079395082,0,5,positive regulation of pigment cell differentiation,BP,
12764,GO:0051013,1,0.509868051439582,0,6,microtubule severing,BP,
12765,GO:0051014,1,0.503519803317094,0,6,actin filament severing,BP,
12784,GO:0051036,1,0.585802088693715,0,5,regulation of endosome size,BP,
12803,GO:0051059,1,0.0548386498795074,0,27,NF-kappaB binding,MF,
12820,GO:0051095,1,0.376131586814509,0,9,regulation of helicase activity,BP,
12821,GO:0051096,1,0.5258285856664,0,6,positive regulation of helicase activity,BP,
12828,GO:0051103,1,0.302983374157262,0,11,DNA ligation involved in DNA repair,BP,
12829,GO:0051105,1,0.508267363317552,0,6,regulation of DNA ligation,BP,
12830,GO:0051106,1,0.569331361232411,0,5,positive regulation of DNA ligation,BP,
12846,GO:0051132,1,0.604992905460874,0,5,NK T cell activation,BP,
12860,GO:0051151,1,0.454360888360803,0,7,negative regulation of smooth muscle cell differentiation,BP,
12887,GO:0051189,1,0.463905145211307,0,7,prosthetic group metabolic process,BP,
12890,GO:0051194,1,0.197970753895562,0,14,positive regulation of cofactor metabolic process,BP,
12893,GO:0051197,1,0.277046287322608,0,11,positive regulation of coenzyme metabolic process,BP,
12909,GO:0051231,1,0.28979382822236,0,11,spindle elongation,BP,
12928,GO:0051255,1,0.325722836147775,0,10,spindle midzone assembly,BP,
12929,GO:0051256,1,0.40882200932908,0,8,mitotic spindle midzone assembly,BP,
12954,GO:0051292,1,0.324300714690191,0,10,nuclear pore complex assembly,BP,
12965,GO:0051305,1,0.560327318072289,0,5,chromosome movement towards spindle pole,BP,
12967,GO:0051307,1,0.256587648825598,0,12,meiotic chromosome separation,BP,
12971,GO:0051315,1,0.232047567883698,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12977,GO:0051340,1,0.42675543470059,0,8,regulation of ligase activity,BP,
12979,GO:0051342,1,0.527401779766759,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12988,GO:0051351,1,0.478034158067923,0,7,positive regulation of ligase activity,BP,
12998,GO:0051382,1,0.211384278740986,0,14,kinetochore assembly,BP,
12999,GO:0051383,1,0.11985169437789,0,19,kinetochore organization,BP,
13013,GO:0051410,1,0.593833659141398,0,5,detoxification of nitrogen compound,BP,
13017,GO:0051415,1,0.500163336561131,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13019,GO:0051418,1,0.394695228855854,0,8,microtubule nucleation by microtubule organizing center,BP,
13032,GO:0051446,1,0.359107398532473,0,9,positive regulation of meiotic cell cycle,BP,
13063,GO:0051503,1,0.266579680339594,0,12,adenine nucleotide transport,BP,
13075,GO:0051547,1,0.395519267167725,0,8,regulation of keratinocyte migration,BP,
13077,GO:0051549,1,0.501205511557961,0,6,positive regulation of keratinocyte migration,BP,
13083,GO:0051567,1,0.0519902680217148,0,26,histone H3-K9 methylation,BP,
13086,GO:0051570,1,0.148204352790668,0,17,regulation of histone H3-K9 methylation,BP,
13087,GO:0051571,1,0.202754944822731,0,14,positive regulation of histone H3-K4 methylation,BP,
13089,GO:0051573,1,0.362027035365043,0,9,negative regulation of histone H3-K9 methylation,BP,
13090,GO:0051574,1,0.45955823195561,0,7,positive regulation of histone H3-K9 methylation,BP,
13104,GO:0051593,1,0.420375560606233,0,8,response to folic acid,BP,
13110,GO:0051601,1,0.455864658041058,0,7,exocyst localization,BP,
13116,GO:0051608,1,0.401314303831976,0,9,histamine transport,BP,
13124,GO:0051639,1,0.396028659446273,0,8,actin filament network formation,BP,
13139,GO:0051657,1,0.39354224074609,0,8,maintenance of organelle location,BP,
13141,GO:0051661,1,0.558577540670362,0,5,maintenance of centrosome location,BP,
13188,GO:0051766,1,0.565423375753996,0,5,inositol trisphosphate kinase activity,MF,
13189,GO:0051767,1,0.341858280133674,0,10,nitric-oxide synthase biosynthetic process,BP,
13190,GO:0051769,1,0.341858280133674,0,10,regulation of nitric-oxide synthase biosynthetic process,BP,
13191,GO:0051770,1,0.461477030131824,0,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13193,GO:0051775,1,0.359286311051339,0,10,response to redox state,BP,
13227,GO:0051836,1,0.383824049079608,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13239,GO:0051880,1,0.440575679111895,0,7,G-quadruplex DNA binding,MF,
13257,GO:0051901,1,0.620700327367458,0,5,positive regulation of mitochondrial depolarization,BP,
13267,GO:0051923,1,0.376584917647681,0,9,sulfation,BP,
13309,GO:0051984,1,0.0540899181532246,0,26,positive regulation of chromosome segregation,BP,
13310,GO:0051985,1,0.0201318034806941,0,36,negative regulation of chromosome segregation,BP,
13311,GO:0051987,1,0.570141467878009,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13312,GO:0051988,1,0.256204206550286,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13343,GO:0052204,1,0.534577700528717,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13344,GO:0052205,1,0.474887630828096,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13373,GO:0052428,1,0.598527415370649,0,5,modulation by host of symbiont molecular function,BP,
13400,GO:0052646,1,0.398918814830568,0,8,alditol phosphate metabolic process,BP,
13401,GO:0052650,1,0.477544800939549,0,7,NADP-retinol dehydrogenase activity,MF,
13413,GO:0052695,1,0.455638102336066,0,7,cellular glucuronidation,BP,
13414,GO:0052696,1,0.574092834321963,0,5,flavonoid glucuronidation,BP,
13415,GO:0052697,1,0.574092834321963,0,5,xenobiotic glucuronidation,BP,
13434,GO:0052803,1,0.588811143301819,0,5,imidazole-containing compound metabolic process,BP,
13465,GO:0052851,1,0.572522074954185,0,5,ferric-chelate reductase (NADPH) activity,MF,
13500,GO:0055015,1,0.461318348284186,0,7,ventricular cardiac muscle cell development,BP,
13518,GO:0055062,1,0.498801861899002,0,6,phosphate ion homeostasis,BP,
13549,GO:0055105,1,0.613841645360163,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13560,GO:0055131,1,0.580361714169653,0,5,C3HC4-type RING finger domain binding,MF,
13572,GO:0060013,1,0.55896223547893,0,5,righting reflex,BP,
13576,GO:0060019,1,0.387117833008676,0,9,radial glial cell differentiation,BP,
13585,GO:0060028,1,0.559556200270391,0,5,convergent extension involved in axis elongation,BP,
13592,GO:0060039,1,0.195343515483313,0,14,pericardium development,BP,
13605,GO:0060052,1,0.462615450551048,0,7,neurofilament cytoskeleton organization,BP,
13619,GO:0060068,1,0.520566367101725,0,6,vagina development,BP,
13636,GO:0060088,1,0.582565313595104,0,5,auditory receptor cell stereocilium organization,BP,
13639,GO:0060091,1,0.586591702410741,0,5,kinocilium,CC,
13646,GO:0060120,1,0.585488431892226,0,5,inner ear receptor cell fate commitment,BP,
13647,GO:0060122,1,0.198668943706056,0,15,inner ear receptor cell stereocilium organization,BP,
13658,GO:0060137,1,0.515180488920163,0,6,maternal process involved in parturition,BP,
13681,GO:0060174,1,0.399271241166523,0,8,limb bud formation,BP,
13708,GO:0060229,1,0.41861647138906,0,8,lipase activator activity,MF,
13723,GO:0060259,1,0.409135620709934,0,8,regulation of feeding behavior,BP,
13725,GO:0060261,1,0.159895151527952,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13736,GO:0060281,1,0.451661293130377,0,7,regulation of oocyte development,BP,
13763,GO:0060315,1,0.455564717729489,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13764,GO:0060316,1,0.488860664770905,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13783,GO:0060339,1,0.451841830512858,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13794,GO:0060352,1,0.57867585697414,0,5,cell adhesion molecule production,BP,
13802,GO:0060368,1,0.509878481484165,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13812,GO:0060379,1,0.446975853487819,0,7,cardiac muscle cell myoblast differentiation,BP,
13868,GO:0060449,1,0.508277676246984,0,6,bud elongation involved in lung branching,BP,
13869,GO:0060452,1,0.578017099703074,0,5,positive regulation of cardiac muscle contraction,BP,
13870,GO:0060453,1,0.585023339907182,0,5,regulation of gastric acid secretion,BP,
13902,GO:0060513,1,0.505218956534652,0,6,prostatic bud formation,BP,
13912,GO:0060534,1,0.45410979394989,0,7,trachea cartilage development,BP,
13917,GO:0060539,1,0.567224404642123,0,5,diaphragm development,BP,
13935,GO:0060572,1,0.319356943902584,0,10,morphogenesis of an epithelial bud,BP,
13939,GO:0060576,1,0.382760667171992,0,9,intestinal epithelial cell development,BP,
13956,GO:0060600,1,0.326683632652264,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13957,GO:0060601,1,0.354609310331511,0,9,lateral sprouting from an epithelium,BP,
13980,GO:0060666,1,0.5568385256878,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13990,GO:0060677,1,0.562107647673186,0,5,ureteric bud elongation,BP,
14004,GO:0060696,1,0.60075830552449,0,5,regulation of phospholipid catabolic process,BP,
14016,GO:0060710,1,0.505436749442481,0,6,chorio-allantoic fusion,BP,
14035,GO:0060736,1,0.440415430924441,0,7,prostate gland growth,BP,
14043,GO:0060746,1,0.44985272166464,0,7,parental behavior,BP,
14057,GO:0060766,1,0.402194480351355,0,8,negative regulation of androgen receptor signaling pathway,BP,
14058,GO:0060767,1,0.374478204250265,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14059,GO:0060768,1,0.420853303916168,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14061,GO:0060770,1,0.531600714607296,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14079,GO:0060837,1,0.50629575419287,0,6,blood vessel endothelial cell differentiation,BP,
14081,GO:0060839,1,0.505837313440907,0,6,endothelial cell fate commitment,BP,
14090,GO:0060850,1,0.512429819951607,0,6,regulation of transcription involved in cell fate commitment,BP,
14101,GO:0060900,1,0.439535524001192,0,7,embryonic camera-type eye formation,BP,
14136,GO:0060972,1,0.174933630790059,0,16,left/right pattern formation,BP,
14137,GO:0060973,1,0.283361749043803,0,11,cell migration involved in heart development,BP,
14139,GO:0060977,1,0.315199907547588,0,10,coronary vasculature morphogenesis,BP,
14142,GO:0060982,1,0.449657095118276,0,7,coronary artery morphogenesis,BP,
14157,GO:0061003,1,0.245029914535067,0,12,positive regulation of dendritic spine morphogenesis,BP,
14158,GO:0061004,1,0.470939443865795,0,7,pattern specification involved in kidney development,BP,
14175,GO:0061036,1,0.111906219662805,0,19,positive regulation of cartilage development,BP,
14184,GO:0061046,1,0.577468419934335,0,5,regulation of branching involved in lung morphogenesis,BP,
14189,GO:0061051,1,0.51837682218833,0,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14196,GO:0061072,1,0.514898778449657,0,6,iris morphogenesis,BP,
14224,GO:0061133,1,0.626663636019374,0,5,endopeptidase activator activity,MF,
14238,GO:0061154,1,0.299623756948072,0,11,endothelial tube morphogenesis,BP,
14242,GO:0061158,1,0.282818313666856,0,11,3'-UTR-mediated mRNA destabilization,BP,
14277,GO:0061309,1,0.514303830111005,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14279,GO:0061312,1,0.576454071254499,0,5,BMP signaling pathway involved in heart development,BP,
14280,GO:0061314,1,0.560196159915234,0,5,Notch signaling involved in heart development,BP,
14284,GO:0061323,1,0.30481330455056,0,11,cell proliferation involved in heart morphogenesis,BP,
14319,GO:0061419,1,0.562622517060917,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14323,GO:0061436,1,0.0940655386313793,0,21,establishment of skin barrier,BP,
14356,GO:0061525,1,0.556168337997398,0,5,hindgut development,BP,
14376,GO:0061578,1,0.286047318293638,0,11,Lys63-specific deubiquitinase activity,MF,
14387,GO:0061608,1,0.378019304473354,0,9,nuclear import signal receptor activity,MF,
14391,GO:0061617,1,0.453848375291634,0,8,MICOS complex,CC,
14398,GO:0061626,1,0.517024243762347,0,6,pharyngeal arch artery morphogenesis,BP,
14404,GO:0061635,1,0.467903586158961,0,7,regulation of protein complex stability,BP,
14417,GO:0061665,1,0.573393525364864,0,5,SUMO ligase activity,MF,
14418,GO:0061668,1,0.512814895277166,0,6,mitochondrial ribosome assembly,BP,
14420,GO:0061673,1,0.565339400330239,0,5,mitotic spindle astral microtubule,CC,
14421,GO:0061676,1,0.513279911006321,0,6,importin-alpha family protein binding,MF,
14441,GO:0061732,1,0.512351528245279,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14443,GO:0061734,1,0.555737843378733,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14477,GO:0061820,1,0.354458209752868,0,9,telomeric D-loop disassembly,BP,
14518,GO:0061983,1,0.523891243901796,0,6,meiosis II cell cycle process,BP,
14533,GO:0070003,1,0.22711813849395,0,18,threonine-type peptidase activity,MF,
14536,GO:0070008,1,0.323152536661636,0,10,serine-type exopeptidase activity,MF,
14546,GO:0070034,1,0.110898770980829,0,21,telomerase RNA binding,MF,
14547,GO:0070035,1,4.57914239122263e-05,0,87,purine NTP-dependent helicase activity,MF,
14576,GO:0070087,1,0.496809226407711,0,6,chromo shadow domain binding,MF,
14590,GO:0070106,1,0.392487407415447,0,8,interleukin-27-mediated signaling pathway,BP,
14601,GO:0070129,1,0.141719008561537,0,18,regulation of mitochondrial translation,BP,
14603,GO:0070131,1,0.303937914509956,0,11,positive regulation of mitochondrial translation,BP,
14616,GO:0070162,1,0.569471982765151,0,5,adiponectin secretion,BP,
14617,GO:0070163,1,0.569471982765151,0,5,regulation of adiponectin secretion,BP,
14632,GO:0070182,1,0.150117613437709,0,18,DNA polymerase binding,MF,
14635,GO:0070187,1,0.511244430651644,0,6,shelterin complex,CC,
14643,GO:0070198,1,0.0550831954992666,0,26,protein localization to chromosome, telomeric region,BP,
14644,GO:0070199,1,0.0827522438476881,0,23,establishment of protein localization to chromosome,BP,
14645,GO:0070200,1,0.209870773326328,0,14,establishment of protein localization to telomere,BP,
14647,GO:0070202,1,0.296252864615744,0,11,regulation of establishment of protein localization to chromosome,BP,
14648,GO:0070203,1,0.331857342803775,0,10,regulation of establishment of protein localization to telomere,BP,
14671,GO:0070254,1,0.446510663325217,0,8,mucus secretion,BP,
14672,GO:0070255,1,0.477789314209674,0,7,regulation of mucus secretion,BP,
14674,GO:0070257,1,0.527338227275987,0,6,positive regulation of mucus secretion,BP,
14677,GO:0070262,1,0.214043707792712,0,14,peptidyl-serine dephosphorylation,BP,
14694,GO:0070293,1,0.294186661220169,0,11,renal absorption,BP,
14719,GO:0070330,1,0.364798006036403,0,9,aromatase activity,MF,
14725,GO:0070341,1,0.500494390675948,0,6,fat cell proliferation,BP,
14727,GO:0070344,1,0.500494390675948,0,6,regulation of fat cell proliferation,BP,
14731,GO:0070358,1,0.595566935236363,0,5,actin polymerization-dependent cell motility,BP,
14734,GO:0070370,1,0.602253790517704,0,5,cellular heat acclimation,BP,
14747,GO:0070391,1,0.530202269338459,0,6,response to lipoteichoic acid,BP,
14756,GO:0070410,1,0.448328240148981,0,7,co-SMAD binding,MF,
14757,GO:0070411,1,0.354654452991482,0,9,I-SMAD binding,MF,
14760,GO:0070417,1,0.44968795180064,0,7,cellular response to cold,BP,
14762,GO:0070419,1,0.454831085185383,0,7,nonhomologous end joining complex,CC,
14764,GO:0070424,1,0.500037705296555,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14770,GO:0070431,1,0.407601318850682,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14790,GO:0070475,1,0.402434756365866,0,9,rRNA base methylation,BP,
14808,GO:0070508,1,0.578814687466703,0,5,cholesterol import,BP,
14815,GO:0070525,1,0.249652045953904,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14819,GO:0070531,1,0.565383157051312,0,5,BRCA1-A complex,CC,
14821,GO:0070535,1,0.561042479514097,0,5,histone H2A K63-linked ubiquitination,BP,
14844,GO:0070568,1,0.581719285980042,0,5,guanylyltransferase activity,MF,
14857,GO:0070586,1,0.413967810183662,0,8,cell-cell adhesion involved in gastrulation,BP,
14858,GO:0070587,1,0.463443769356531,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14862,GO:0070601,1,0.418776745264078,0,8,centromeric sister chromatid cohesion,BP,
14873,GO:0070628,1,0.163169065802277,0,18,proteasome binding,MF,
14876,GO:0070633,1,0.301106935262412,0,11,transepithelial transport,BP,
14888,GO:0070652,1,0.423043637717305,0,8,HAUS complex,CC,
14909,GO:0070695,1,0.562656598171815,0,5,FHF complex,CC,
14919,GO:0070717,1,0.0916483770058554,0,21,poly-purine tract binding,MF,
14928,GO:0070739,1,0.504686649244371,0,6,protein-glutamic acid ligase activity,MF,
14929,GO:0070740,1,0.504686649244371,0,6,tubulin-glutamic acid ligase activity,MF,
14933,GO:0070757,1,0.392662379546269,0,8,interleukin-35-mediated signaling pathway,BP,
14934,GO:0070761,1,0.534262427402494,0,6,pre-snoRNP complex,CC,
14936,GO:0070765,1,0.527869134443074,0,6,gamma-secretase complex,CC,
14951,GO:0070816,1,0.18935449155333,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14972,GO:0070847,1,0.442678869183767,0,8,core mediator complex,CC,
14990,GO:0070878,1,0.395318214424252,0,8,primary miRNA binding,MF,
14991,GO:0070883,1,0.594247123652171,0,5,pre-miRNA binding,MF,
15005,GO:0070900,1,0.384211641617249,0,9,mitochondrial tRNA modification,BP,
15020,GO:0070932,1,0.103426997638955,0,20,histone H3 deacetylation,BP,
15023,GO:0070935,1,0.286759501462015,0,11,3'-UTR-mediated mRNA stabilization,BP,
15025,GO:0070937,1,0.56511595617688,0,5,CRD-mediated mRNA stability complex,CC,
15026,GO:0070938,1,0.283287293514205,0,11,contractile ring,CC,
15052,GO:0070979,1,0.0625943315046489,0,27,protein K11-linked ubiquitination,BP,
15058,GO:0070986,1,0.266359650280707,0,12,left/right axis specification,BP,
15059,GO:0070987,1,0.149463006234503,0,18,error-free translesion synthesis,BP,
15061,GO:0070989,1,0.298510045330346,0,11,oxidative demethylation,BP,
15062,GO:0070990,1,0.548423796281809,0,6,snRNP binding,MF,
15069,GO:0071004,1,0.171510983228547,0,17,U2-type prespliceosome,CC,
15072,GO:0071007,1,0.0516589916026379,0,29,U2-type catalytic step 2 spliceosome,CC,
15074,GO:0071010,1,0.102725521431733,0,22,prespliceosome,CC,
15076,GO:0071012,1,0.510586454573071,0,6,catalytic step 1 spliceosome,CC,
15078,GO:0071014,1,0.376946755324659,0,9,post-mRNA release spliceosomal complex,CC,
15081,GO:0071025,1,0.220868908926024,0,15,RNA surveillance,BP,
15083,GO:0071027,1,0.276812037573734,0,13,nuclear RNA surveillance,BP,
15084,GO:0071028,1,0.276812037573734,0,13,nuclear mRNA surveillance,BP,
15085,GO:0071029,1,0.554460671780925,0,6,nuclear ncRNA surveillance,BP,
15088,GO:0071033,1,0.59767160754806,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15090,GO:0071035,1,0.554460671780925,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15091,GO:0071038,1,0.620864886336002,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15094,GO:0071044,1,0.304181441747327,0,11,histone mRNA catabolic process,BP,
15096,GO:0071046,1,0.554460671780925,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15100,GO:0071051,1,0.636400844626365,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15131,GO:0071169,1,0.442193624749007,0,8,establishment of protein localization to chromatin,BP,
15132,GO:0071173,1,0.0416663801291338,0,29,spindle assembly checkpoint,BP,
15133,GO:0071174,1,0.0416663801291338,0,29,mitotic spindle checkpoint,BP,
15135,GO:0071204,1,0.530586913613214,0,6,histone pre-mRNA 3'end processing complex,CC,
15149,GO:0071223,1,0.530202269338459,0,6,cellular response to lipoteichoic acid,BP,
15166,GO:0071257,1,0.560668140175153,0,5,cellular response to electrical stimulus,BP,
15171,GO:0071265,1,0.475036806723798,0,7,L-methionine biosynthetic process,BP,
15173,GO:0071267,1,0.527005968497341,0,6,L-methionine salvage,BP,
15180,GO:0071281,1,0.533926903325663,0,6,cellular response to iron ion,BP,
15198,GO:0071316,1,0.529589281244714,0,6,cellular response to nicotine,BP,
15230,GO:0071360,1,0.269315874341741,0,12,cellular response to exogenous dsRNA,BP,
15235,GO:0071371,1,0.225313034932488,0,13,cellular response to gonadotropin stimulus,BP,
15236,GO:0071372,1,0.39959106955233,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15250,GO:0071389,1,0.520881624407642,0,6,cellular response to mineralocorticoid stimulus,BP,
15257,GO:0071397,1,0.279538858048678,0,11,cellular response to cholesterol,BP,
15263,GO:0071404,1,0.259496370521617,0,12,cellular response to low-density lipoprotein particle stimulus,BP,
15274,GO:0071425,1,0.20271651238839,0,14,hematopoietic stem cell proliferation,BP,
15277,GO:0071428,1,0.227987954120401,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15282,GO:0071439,1,0.410690304625193,0,8,clathrin complex,CC,
15286,GO:0071447,1,0.580807922763303,0,5,cellular response to hydroperoxide,BP,
15288,GO:0071450,1,0.149879011584074,0,19,cellular response to oxygen radical,BP,
15289,GO:0071451,1,0.149879011584074,0,19,cellular response to superoxide,BP,
15292,GO:0071455,1,0.50394390644053,0,6,cellular response to hyperoxia,BP,
15295,GO:0071459,1,0.110773035694668,0,20,protein localization to chromosome, centromeric region,BP,
15305,GO:0071472,1,0.458137381976246,0,7,cellular response to salt stress,BP,
15341,GO:0071541,1,0.494118824963623,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15353,GO:0071557,1,0.556159206701239,0,5,histone H3-K27 demethylation,BP,
15354,GO:0071558,1,0.556159206701239,0,5,histone demethylase activity (H3-K27 specific),MF,
15358,GO:0071564,1,0.259885278256507,0,12,npBAF complex,CC,
15359,GO:0071565,1,0.253701034236812,0,12,nBAF complex,CC,
15363,GO:0071569,1,0.538050312285869,0,6,protein ufmylation,BP,
15378,GO:0071598,1,0.584922284344078,0,5,neuronal ribonucleoprotein granule,CC,
15384,GO:0071605,1,0.483295945361411,0,7,monocyte chemotactic protein-1 production,BP,
15405,GO:0071636,1,0.400439646499899,0,8,positive regulation of transforming growth factor beta production,BP,
15406,GO:0071637,1,0.483295945361411,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15408,GO:0071639,1,0.587605558064172,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15434,GO:0071680,1,0.558282938065488,0,5,response to indole-3-methanol,BP,
15435,GO:0071681,1,0.558282938065488,0,5,cellular response to indole-3-methanol,BP,
15466,GO:0071763,1,0.504318415747961,0,6,nuclear membrane organization,BP,
15491,GO:0071817,1,0.603604397124961,0,5,MMXD complex,CC,
15507,GO:0071850,1,0.216930139290328,0,14,mitotic cell cycle arrest,BP,
15549,GO:0071922,1,0.566253046992424,0,5,regulation of cohesin loading,BP,
15570,GO:0071986,1,0.506910873389476,0,6,Ragulator complex,CC,
15590,GO:0072033,1,0.495881277880526,0,6,renal vesicle formation,BP,
15598,GO:0072048,1,0.470939443865795,0,7,renal system pattern specification,BP,
15600,GO:0072050,1,0.527075032879705,0,6,S-shaped body morphogenesis,BP,
15611,GO:0072074,1,0.255803453218345,0,12,kidney mesenchyme development,BP,
15612,GO:0072075,1,0.355478470443276,0,9,metanephric mesenchyme development,BP,
15614,GO:0072077,1,0.295251545424427,0,11,renal vesicle morphogenesis,BP,
15620,GO:0072087,1,0.295251545424427,0,11,renal vesicle development,BP,
15640,GO:0072110,1,0.458427009543428,0,7,glomerular mesangial cell proliferation,BP,
15644,GO:0072124,1,0.458427009543428,0,7,regulation of glomerular mesangial cell proliferation,BP,
15663,GO:0072148,1,0.295085444489112,0,11,epithelial cell fate commitment,BP,
15697,GO:0072203,1,0.501369919663382,0,6,cell proliferation involved in metanephros development,BP,
15708,GO:0072217,1,0.567970462611478,0,5,negative regulation of metanephros development,BP,
15738,GO:0072283,1,0.372898493681571,0,9,metanephric renal vesicle morphogenesis,BP,
15758,GO:0072318,1,0.562639549854485,0,5,clathrin coat disassembly,BP,
15761,GO:0072321,1,0.377596887966924,0,10,chaperone-mediated protein transport,BP,
15767,GO:0072337,1,0.260737972990569,0,12,modified amino acid transport,BP,
15768,GO:0072338,1,0.554297456405706,0,5,cellular lactam metabolic process,BP,
15775,GO:0072349,1,0.350404291472034,0,9,modified amino acid transmembrane transporter activity,MF,
15803,GO:0072393,1,0.27696263608727,0,11,microtubule anchoring at microtubule organizing center,BP,
15805,GO:0072396,1,0.503259697404359,0,6,response to cell cycle checkpoint signaling,BP,
15807,GO:0072402,1,0.503259697404359,0,6,response to DNA integrity checkpoint signaling,BP,
15811,GO:0072423,1,0.503259697404359,0,6,response to DNA damage checkpoint signaling,BP,
15812,GO:0072425,1,0.282427327923537,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15819,GO:0072488,1,0.460378902030031,0,7,ammonium transmembrane transport,BP,
15821,GO:0072497,1,0.504634899471698,0,6,mesenchymal stem cell differentiation,BP,
15826,GO:0072505,1,0.498801861899002,0,6,divalent inorganic anion homeostasis,BP,
15827,GO:0072506,1,0.498801861899002,0,6,trivalent inorganic anion homeostasis,BP,
15846,GO:0072530,1,0.410027365811407,0,8,purine-containing compound transmembrane transport,BP,
15847,GO:0072531,1,0.463584421127865,0,7,pyrimidine-containing compound transmembrane transport,BP,
15852,GO:0072538,1,0.339753744844607,0,10,T-helper 17 type immune response,BP,
15853,GO:0072539,1,0.424696926878484,0,8,T-helper 17 cell differentiation,BP,
15854,GO:0072540,1,0.601630787788277,0,5,T-helper 17 cell lineage commitment,BP,
15855,GO:0072542,1,0.46874827057402,0,7,protein phosphatase activator activity,MF,
15857,GO:0072546,1,0.320828051338801,0,10,ER membrane protein complex,CC,
15885,GO:0072588,1,0.577116186917421,0,8,box H/ACA RNP complex,CC,
15904,GO:0072641,1,0.496134734627134,0,6,type I interferon secretion,BP,
15905,GO:0072642,1,0.496134734627134,0,6,interferon-alpha secretion,BP,
15917,GO:0072669,1,0.515608257640276,0,7,tRNA-splicing ligase complex,CC,
15935,GO:0072697,1,0.28815224730115,0,11,protein localization to cell cortex,BP,
15943,GO:0072710,1,0.353461408284912,0,9,response to hydroxyurea,BP,
15944,GO:0072711,1,0.395934934751114,0,8,cellular response to hydroxyurea,BP,
15950,GO:0072719,1,0.508541772038309,0,6,cellular response to cisplatin,BP,
15975,GO:0075522,1,0.331014791585374,0,10,IRES-dependent viral translational initiation,BP,
15976,GO:0075525,1,0.587339157817356,0,5,viral translational termination-reinitiation,BP,
15979,GO:0075713,1,0.422308186432107,0,8,establishment of integrated proviral latency,BP,
15983,GO:0080009,1,0.330941923713137,0,10,mRNA methylation,BP,
15988,GO:0080084,1,0.5647186871707,0,5,5S rDNA binding,MF,
16004,GO:0080182,1,0.183235445130431,0,16,histone H3-K4 trimethylation,BP,
16006,GO:0085020,1,0.488465542436988,0,7,protein K6-linked ubiquitination,BP,
16020,GO:0086012,1,0.287649620399124,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16022,GO:0086014,1,0.311632180141602,0,10,atrial cardiac muscle cell action potential,BP,
16024,GO:0086016,1,0.560787690928478,0,5,AV node cell action potential,BP,
16027,GO:0086019,1,0.182296088615518,0,15,cell-cell signaling involved in cardiac conduction,BP,
16032,GO:0086026,1,0.311632180141602,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16033,GO:0086027,1,0.560787690928478,0,5,AV node cell to bundle of His cell signaling,BP,
16040,GO:0086042,1,0.496727294847333,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16054,GO:0086066,1,0.311632180141602,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16055,GO:0086067,1,0.49817346700609,0,6,AV node cell to bundle of His cell communication,BP,
16057,GO:0086069,1,0.365144235361636,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16060,GO:0086073,1,0.55563292427134,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16066,GO:0086080,1,0.391983252406434,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16068,GO:0086083,1,0.55563292427134,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16070,GO:0086091,1,0.138672301245693,0,17,regulation of heart rate by cardiac conduction,BP,
16077,GO:0089701,1,0.624160218979232,0,5,U2AF,CC,
16081,GO:0089720,1,0.54332012530948,0,6,caspase binding,MF,
16086,GO:0090025,1,0.306321676741765,0,11,regulation of monocyte chemotaxis,BP,
16087,GO:0090026,1,0.430799370153229,0,8,positive regulation of monocyte chemotaxis,BP,
16100,GO:0090045,1,0.518563528264071,0,6,positive regulation of deacetylase activity,BP,
16103,GO:0090051,1,0.23094232570617,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16109,GO:0090069,1,0.23647501421924,0,13,regulation of ribosome biogenesis,BP,
16110,GO:0090070,1,0.423257284171108,0,8,positive regulation of ribosome biogenesis,BP,
16113,GO:0090074,1,0.577033130403412,0,5,negative regulation of protein homodimerization activity,BP,
16159,GO:0090151,1,0.338464348942413,0,12,establishment of protein localization to mitochondrial membrane,BP,
16164,GO:0090158,1,0.571877427975296,0,5,endoplasmic reticulum membrane organization,BP,
16166,GO:0090161,1,0.278998257259726,0,11,Golgi ribbon formation,BP,
16205,GO:0090208,1,0.290776945847553,0,11,positive regulation of triglyceride metabolic process,BP,
16217,GO:0090231,1,0.214683498211664,0,14,regulation of spindle checkpoint,BP,
16218,GO:0090232,1,0.412688231251834,0,8,positive regulation of spindle checkpoint,BP,
16221,GO:0090235,1,0.443688320822242,0,7,regulation of metaphase plate congression,BP,
16225,GO:0090240,1,0.481276085603307,0,7,positive regulation of histone H4 acetylation,BP,
16239,GO:0090266,1,0.24080320683152,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16240,GO:0090267,1,0.462870626937869,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16249,GO:0090280,1,0.571264244401055,0,5,positive regulation of calcium ion import,BP,
16271,GO:0090308,1,0.393866645392418,0,8,regulation of methylation-dependent chromatin silencing,BP,
16283,GO:0090324,1,0.56947506653086,0,5,negative regulation of oxidative phosphorylation,BP,
16290,GO:0090335,1,0.404627766280981,0,8,regulation of brown fat cell differentiation,BP,
16308,GO:0090385,1,0.526341838504051,0,6,phagosome-lysosome fusion,BP,
16314,GO:0090399,1,0.292617708183818,0,11,replicative senescence,BP,
16315,GO:0090400,1,0.450628449321498,0,7,stress-induced premature senescence,BP,
16325,GO:0090435,1,0.476605533070188,0,7,protein localization to nuclear envelope,BP,
16340,GO:0090520,1,0.360877547418413,0,9,sphingolipid mediated signaling pathway,BP,
16344,GO:0090533,1,0.451170739547208,0,7,cation-transporting ATPase complex,CC,
16358,GO:0090576,1,0.411309133393385,0,8,RNA polymerase III transcription factor complex,CC,
16362,GO:0090599,1,0.555967028442706,0,5,alpha-glucosidase activity,MF,
16372,GO:0090646,1,0.273438339840756,0,12,mitochondrial tRNA processing,BP,
16377,GO:0090657,1,0.281457411294636,0,11,telomeric loop disassembly,BP,
16379,GO:0090661,1,0.684579667605273,0,5,box H/ACA telomerase RNP complex,CC,
16386,GO:0090670,1,0.136309250131895,0,19,RNA localization to Cajal body,BP,
16387,GO:0090671,1,0.136309250131895,0,19,telomerase RNA localization to Cajal body,BP,
16388,GO:0090672,1,0.136309250131895,0,19,telomerase RNA localization,BP,
16393,GO:0090685,1,0.136309250131895,0,19,RNA localization to nucleus,BP,
16395,GO:0090713,1,0.58423928179625,0,5,immunological memory process,BP,
16396,GO:0090715,1,0.58423928179625,0,5,immunological memory formation process,BP,
16403,GO:0090735,1,0.335754721155092,0,10,DNA repair complex assembly,BP,
16405,GO:0090741,1,0.544228051508564,0,6,pigment granule membrane,CC,
16423,GO:0097027,1,0.472553919058903,0,7,ubiquitin-protein transferase activator activity,MF,
16452,GO:0097084,1,0.518105088813624,0,6,vascular smooth muscle cell development,BP,
16487,GO:0097150,1,0.142891781203107,0,17,neuronal stem cell population maintenance,BP,
16489,GO:0097152,1,0.451804389023449,0,7,mesenchymal cell apoptotic process,BP,
16526,GO:0097208,1,0.577424325627201,0,5,alveolar lamellar body,CC,
16535,GO:0097225,1,0.356958341738938,0,10,sperm midpiece,CC,
16549,GO:0097255,1,0.596321761462402,0,5,R2TP complex,CC,
16559,GO:0097283,1,0.577798609751443,0,5,keratinocyte apoptotic process,BP,
16561,GO:0097286,1,0.297828824598387,0,11,iron ion import,BP,
16563,GO:0097296,1,0.275549347176323,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16577,GO:0097340,1,0.300093666254864,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16578,GO:0097341,1,0.300093666254864,0,11,zymogen inhibition,BP,
16579,GO:0097342,1,0.509543372855503,0,6,ripoptosome,CC,
16603,GO:0097384,1,0.467877714550343,0,7,cellular lipid biosynthetic process,BP,
16615,GO:0097418,1,0.56131694996682,0,5,neurofibrillary tangle,CC,
16617,GO:0097422,1,0.566390077341358,0,5,tubular endosome,CC,
16619,GO:0097427,1,0.559116593455556,0,5,microtubule bundle,CC,
16620,GO:0097428,1,0.403914067649808,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16622,GO:0097433,1,0.572668704642511,0,5,dense body,CC,
16627,GO:0097443,1,0.560752283493374,0,5,sorting endosome,CC,
16630,GO:0097449,1,0.504482023622203,0,6,astrocyte projection,CC,
16640,GO:0097470,1,0.557792839903499,0,5,ribbon synapse,CC,
16646,GO:0097484,1,0.141156866384851,0,17,dendrite extension,BP,
16662,GO:0097504,1,0.305201396213896,0,11,Gemini of coiled bodies,CC,
16664,GO:0097506,1,0.597213776098987,0,5,deaminated base DNA N-glycosylase activity,MF,
16671,GO:0097526,1,0.0599750610257573,0,29,spliceosomal tri-snRNP complex,CC,
16672,GO:0097527,1,0.576538513814271,0,5,necroptotic signaling pathway,BP,
16681,GO:0097539,1,0.313783903850899,0,10,ciliary transition fiber,CC,
16686,GO:0097550,1,0.531096015248623,0,6,transcriptional preinitiation complex,CC,
16695,GO:0097602,1,0.163016154042337,0,17,cullin family protein binding,MF,
16747,GO:0097732,1,0.586591702410741,0,5,9+2 non-motile cilium,CC,
16759,GO:0098501,1,0.600637914654495,0,5,polynucleotide dephosphorylation,BP,
16763,GO:0098505,1,0.325150098180767,0,10,G-rich strand telomeric DNA binding,MF,
16768,GO:0098519,1,0.573756971063061,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16772,GO:0098532,1,0.574295057508948,0,6,histone H3-K27 trimethylation,BP,
16774,GO:0098534,1,0.0339720518239184,0,30,centriole assembly,BP,
16778,GO:0098543,1,0.459583170496808,0,7,detection of other organism,BP,
16783,GO:0098556,1,0.719522727869938,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16793,GO:0098581,1,0.410541106979149,0,8,detection of external biotic stimulus,BP,
16819,GO:0098642,1,0.494376918508262,0,6,network-forming collagen trimer,CC,
16820,GO:0098643,1,0.389522974365961,0,8,banded collagen fibril,CC,
16821,GO:0098644,1,0.170962128243495,0,15,complex of collagen trimers,CC,
16822,GO:0098645,1,0.494376918508262,0,6,collagen network,CC,
16826,GO:0098651,1,0.494376918508262,0,6,basement membrane collagen trimer,CC,
16845,GO:0098711,1,0.5008183103806,0,6,iron ion import across plasma membrane,BP,
16848,GO:0098719,1,0.350118394320715,0,9,sodium ion import across plasma membrane,BP,
16876,GO:0098779,1,0.419181787090363,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16879,GO:0098787,1,0.202684304523138,0,14,mRNA cleavage involved in mRNA processing,BP,
16880,GO:0098789,1,0.285627594480217,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16889,GO:0098799,1,0.302252681347715,0,12,outer mitochondrial membrane protein complex,CC,
16899,GO:0098814,1,0.572680910017281,0,5,spontaneous synaptic transmission,BP,
16909,GO:0098831,1,0.553332730070589,0,5,presynaptic active zone cytoplasmic component,CC,
16919,GO:0098845,1,0.456465880683457,0,7,postsynaptic endosome,CC,
16945,GO:0098902,1,0.582448053378262,0,5,regulation of membrane depolarization during action potential,BP,
16952,GO:0098909,1,0.583636445708917,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16953,GO:0098910,1,0.557168149462289,0,5,regulation of atrial cardiac muscle cell action potential,BP,
17017,GO:0099078,1,0.442409926576824,0,8,BORC complex,CC,
17031,GO:0099116,1,0.20970883111257,0,16,tRNA 5'-end processing,BP,
17061,GO:0099515,1,0.348826674930358,0,9,actin filament-based transport,BP,
17062,GO:0099516,1,0.0162152776045205,0,36,ion antiporter activity,MF,
17108,GO:0099612,1,0.496320990333284,0,6,protein localization to axon,BP,
17249,GO:0110011,1,0.553329505974353,0,5,regulation of basement membrane organization,BP,
17265,GO:0110096,1,0.61795034696743,0,5,cellular response to aldehyde,BP,
17334,GO:0140131,1,0.412502641304487,0,8,positive regulation of lymphocyte chemotaxis,BP,
17336,GO:0140142,1,0.137273783986717,0,18,nucleocytoplasmic carrier activity,MF,
17345,GO:0150005,1,0.34616207537745,0,10,enzyme activator complex,CC,
17358,GO:1900015,1,0.106611558697235,0,20,regulation of cytokine production involved in inflammatory response,BP,
17359,GO:1900016,1,0.417155393393309,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17360,GO:1900017,1,0.363579847824759,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17371,GO:1900037,1,0.35013043584421,0,10,regulation of cellular response to hypoxia,BP,
17372,GO:1900038,1,0.516538110848765,0,6,negative regulation of cellular response to hypoxia,BP,
17374,GO:1900040,1,0.560739586891272,0,5,regulation of interleukin-2 secretion,BP,
17407,GO:1900112,1,0.363804839077199,0,9,regulation of histone H3-K9 trimethylation,BP,
17408,GO:1900113,1,0.580668504153279,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17417,GO:1900122,1,0.533702229763646,0,6,positive regulation of receptor binding,BP,
17451,GO:1900193,1,0.572337088871182,0,5,regulation of oocyte maturation,BP,
17476,GO:1900242,1,0.49943454695757,0,6,regulation of synaptic vesicle endocytosis,BP,
17481,GO:1900247,1,0.287277181806482,0,11,regulation of cytoplasmic translational elongation,BP,
17485,GO:1900262,1,0.527686517548909,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17486,GO:1900264,1,0.527686517548909,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17494,GO:1900364,1,0.397455857160685,0,8,negative regulation of mRNA polyadenylation,BP,
17513,GO:1900426,1,0.487184826811083,0,7,positive regulation of defense response to bacterium,BP,
17533,GO:1900739,1,0.0493982885898803,0,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17534,GO:1900740,1,0.0493982885898803,0,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17540,GO:1900750,1,0.338231730278818,0,11,oligopeptide binding,MF,
17545,GO:1900864,1,0.384211641617249,0,9,mitochondrial RNA modification,BP,
17553,GO:1901020,1,0.186490833162117,0,16,negative regulation of calcium ion transmembrane transporter activity,BP,
17560,GO:1901032,1,0.226059206993572,0,14,negative regulation of response to reactive oxygen species,BP,
17606,GO:1901213,1,0.407245199099514,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17636,GO:1901299,1,0.585851891945668,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17673,GO:1901386,1,0.576255386203598,0,5,negative regulation of voltage-gated calcium channel activity,BP,
17677,GO:1901407,1,0.368467702275412,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17678,GO:1901409,1,0.463916575617744,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17681,GO:1901474,1,0.573403581743985,0,5,azole transmembrane transporter activity,MF,
17686,GO:1901503,1,0.582590520912821,0,5,ether biosynthetic process,BP,
17691,GO:1901524,1,0.209578550695568,0,14,regulation of mitophagy,BP,
17692,GO:1901525,1,0.500211636246631,0,6,negative regulation of mitophagy,BP,
17693,GO:1901526,1,0.419181787090363,0,8,positive regulation of mitophagy,BP,
17696,GO:1901533,1,0.524858171809286,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17709,GO:1901563,1,0.562001387390761,0,5,response to camptothecin,BP,
17737,GO:1901623,1,0.368253128218554,0,9,regulation of lymphocyte chemotaxis,BP,
17755,GO:1901660,1,0.502755455865093,0,6,calcium ion export,BP,
17758,GO:1901663,1,0.237539874003057,0,14,quinone biosynthetic process,BP,
17768,GO:1901679,1,0.413393970150978,0,8,nucleotide transmembrane transport,BP,
17772,GO:1901685,1,0.25284978537251,0,16,glutathione derivative metabolic process,BP,
17773,GO:1901687,1,0.25284978537251,0,16,glutathione derivative biosynthetic process,BP,
17782,GO:1901724,1,0.511963432015895,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17783,GO:1901725,1,0.498182017844136,0,6,regulation of histone deacetylase activity,BP,
17787,GO:1901739,1,0.343225578276592,0,10,regulation of myoblast fusion,BP,
17789,GO:1901741,1,0.382244916891193,0,9,positive regulation of myoblast fusion,BP,
17802,GO:1901836,1,0.29563648884157,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17804,GO:1901838,1,0.367412578028461,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17805,GO:1901841,1,0.577912177691736,0,5,regulation of high voltage-gated calcium channel activity,BP,
17808,GO:1901844,1,0.460258238197681,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17810,GO:1901857,1,0.613042833500649,0,5,positive regulation of cellular respiration,BP,
17821,GO:1901881,1,0.37289132072861,0,9,positive regulation of protein depolymerization,BP,
17842,GO:1901970,1,0.425113183194113,0,8,positive regulation of mitotic sister chromatid separation,BP,
17845,GO:1901978,1,0.368418824011988,0,9,positive regulation of cell cycle checkpoint,BP,
17870,GO:1902031,1,0.517376428482606,0,6,regulation of NADP metabolic process,BP,
17871,GO:1902033,1,0.569215536896103,0,5,regulation of hematopoietic stem cell proliferation,BP,
17878,GO:1902043,1,0.179672008117955,0,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17887,GO:1902083,1,0.557519745785044,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17891,GO:1902100,1,0.0370844628464045,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17892,GO:1902101,1,0.425113183194113,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17914,GO:1902172,1,0.577798609751443,0,5,regulation of keratinocyte apoptotic process,BP,
17919,GO:1902177,1,0.605945584401393,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17922,GO:1902187,1,0.200512254486368,0,14,negative regulation of viral release from host cell,BP,
17991,GO:1902358,1,0.504429294706687,0,6,sulfate transmembrane transport,BP,
17998,GO:1902369,1,0.0137326552616035,0,38,negative regulation of RNA catabolic process,BP,
17999,GO:1902373,1,0.0271133404995415,0,32,negative regulation of mRNA catabolic process,BP,
18010,GO:1902410,1,0.511669146268444,0,6,mitotic cytokinetic process,BP,
18023,GO:1902459,1,0.496598614126814,0,6,positive regulation of stem cell population maintenance,BP,
18044,GO:1902513,1,0.50627321406214,0,6,regulation of organelle transport along microtubule,BP,
18048,GO:1902525,1,0.609149036117175,0,5,regulation of protein monoubiquitination,BP,
18069,GO:1902570,1,0.399615955853035,0,9,protein localization to nucleolus,BP,
18074,GO:1902581,1,0.595550844658733,0,5,multi-organism cellular localization,BP,
18075,GO:1902583,1,0.595550844658733,0,5,multi-organism intracellular transport,BP,
18103,GO:1902669,1,0.445093198883126,0,7,positive regulation of axon guidance,BP,
18126,GO:1902739,1,0.496134734627134,0,6,regulation of interferon-alpha secretion,BP,
18127,GO:1902741,1,0.496134734627134,0,6,positive regulation of interferon-alpha secretion,BP,
18141,GO:1902774,1,0.521000289330844,0,6,late endosome to lysosome transport,BP,
18180,GO:1902902,1,0.303889975479325,0,11,negative regulation of autophagosome assembly,BP,
18191,GO:1902916,1,0.415422159381371,0,8,positive regulation of protein polyubiquitination,BP,
18216,GO:1902961,1,0.511773170186981,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18242,GO:1903010,1,0.281063398789952,0,11,regulation of bone development,BP,
18274,GO:1903069,1,0.371910421415405,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18276,GO:1903071,1,0.459384038123633,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18302,GO:1903147,1,0.417239875592004,0,8,negative regulation of autophagy of mitochondrion,BP,
18326,GO:1903206,1,0.226059206993572,0,14,negative regulation of hydrogen peroxide-induced cell death,BP,
18336,GO:1903232,1,0.617154422195836,0,5,melanosome assembly,BP,
18341,GO:1903242,1,0.495859128578218,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18342,GO:1903243,1,0.557971290701505,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
18346,GO:1903251,1,0.572485295011326,0,5,multi-ciliated epithelial cell differentiation,BP,
18362,GO:1903297,1,0.580604883782893,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18363,GO:1903298,1,0.580604883782893,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18364,GO:1903299,1,0.485281680756065,0,7,regulation of hexokinase activity,BP,
18366,GO:1903301,1,0.592982878443273,0,5,positive regulation of hexokinase activity,BP,
18371,GO:1903312,1,0.00102441976211978,0,61,negative regulation of mRNA metabolic process,BP,
18379,GO:1903332,1,0.476714130851126,0,7,regulation of protein folding,BP,
18380,GO:1903333,1,0.599533001919049,0,5,negative regulation of protein folding,BP,
18391,GO:1903361,1,0.581181293932724,0,5,protein localization to basolateral plasma membrane,BP,
18400,GO:1903376,1,0.463114350857178,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18415,GO:1903405,1,0.372926985978401,0,9,protein localization to nuclear body,BP,
18421,GO:1903421,1,0.227599148616514,0,13,regulation of synaptic vesicle recycling,BP,
18423,GO:1903423,1,0.560779122505697,0,5,positive regulation of synaptic vesicle recycling,BP,
18425,GO:1903427,1,0.147121837134534,0,18,negative regulation of reactive oxygen species biosynthetic process,BP,
18451,GO:1903504,1,0.24080320683152,0,13,regulation of mitotic spindle checkpoint,BP,
18508,GO:1903587,1,0.583590640300067,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18516,GO:1903608,1,0.455689435690574,0,7,protein localization to cytoplasmic stress granule,BP,
18622,GO:1903859,1,0.310664856929573,0,10,regulation of dendrite extension,BP,
18624,GO:1903861,1,0.390541411139536,0,8,positive regulation of dendrite extension,BP,
18625,GO:1903862,1,0.59520150065551,0,5,positive regulation of oxidative phosphorylation,BP,
18639,GO:1903896,1,0.466617072927601,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18641,GO:1903898,1,0.569677940789039,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18714,GO:1904037,1,0.132161310373175,0,18,positive regulation of epithelial cell apoptotic process,BP,
18756,GO:1904181,1,0.490473002750442,0,7,positive regulation of membrane depolarization,BP,
18793,GO:1904259,1,0.553329505974353,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18794,GO:1904261,1,0.553329505974353,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18796,GO:1904263,1,0.422504896801089,0,8,positive regulation of TORC1 signaling,BP,
18853,GO:1904406,1,0.346407722982152,0,10,negative regulation of nitric oxide metabolic process,BP,
18860,GO:1904424,1,0.357085655463274,0,9,regulation of GTP binding,BP,
18881,GO:1904469,1,0.441484640302788,0,7,positive regulation of tumor necrosis factor secretion,BP,
18952,GO:1904666,1,0.182864830910697,0,18,regulation of ubiquitin protein ligase activity,BP,
18953,GO:1904667,1,0.63773232295821,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18954,GO:1904668,1,0.286875100944512,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18965,GO:1904688,1,0.588234733726493,0,5,regulation of cytoplasmic translational initiation,BP,
19012,GO:1904776,1,0.499492397187744,0,6,regulation of protein localization to cell cortex,BP,
19014,GO:1904778,1,0.559496148178011,0,5,positive regulation of protein localization to cell cortex,BP,
19015,GO:1904779,1,0.49812167171822,0,6,regulation of protein localization to centrosome,BP,
19016,GO:1904781,1,0.557053177557474,0,5,positive regulation of protein localization to centrosome,BP,
19023,GO:1904796,1,0.569057197614342,0,5,regulation of core promoter binding,BP,
19033,GO:1904814,1,0.237517909824006,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19035,GO:1904816,1,0.29619170277066,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19051,GO:1904851,1,0.37178352167589,0,9,positive regulation of establishment of protein localization to telomere,BP,
19055,GO:1904867,1,0.372926985978401,0,9,protein localization to Cajal body,BP,
19057,GO:1904869,1,0.414642173025942,0,8,regulation of protein localization to Cajal body,BP,
19058,GO:1904871,1,0.414642173025942,0,8,positive regulation of protein localization to Cajal body,BP,
19059,GO:1904872,1,0.15156970522365,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19060,GO:1904874,1,0.214178768852259,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19070,GO:1904885,1,0.560280272171205,0,5,beta-catenin destruction complex assembly,BP,
19088,GO:1904923,1,0.266203873915559,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19090,GO:1904925,1,0.297695515258412,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19095,GO:1904938,1,0.556940655324001,0,5,planar cell polarity pathway involved in axon guidance,BP,
19120,GO:1904994,1,0.469954494773015,0,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19122,GO:1904996,1,0.565286752376886,0,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
19150,GO:1905063,1,0.570898080290011,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19164,GO:1905097,1,0.504573604325645,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19208,GO:1905244,1,0.398173879780129,0,8,regulation of modification of synaptic structure,BP,
19211,GO:1905247,1,0.511773170186981,0,6,positive regulation of aspartic-type peptidase activity,BP,
19227,GO:1905288,1,0.4992190813531,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19243,GO:1905323,1,0.508530165112255,0,6,telomerase holoenzyme complex assembly,BP,
19293,GO:1905446,1,0.596543344566885,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19298,GO:1905456,1,0.462036663189084,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19301,GO:1905459,1,0.4992190813531,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19303,GO:1905461,1,0.561964620591282,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19358,GO:1905634,1,0.503029030428939,0,6,regulation of protein localization to chromatin,BP,
19402,GO:1905819,1,0.0346960430900985,0,31,negative regulation of chromosome separation,BP,
19403,GO:1905820,1,0.377637579072332,0,9,positive regulation of chromosome separation,BP,
19416,GO:1905879,1,0.451661293130377,0,7,regulation of oogenesis,BP,
19450,GO:1990001,1,0.406365605627601,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19455,GO:1990023,1,0.234995117781032,0,13,mitotic spindle midzone,CC,
19482,GO:1990124,1,0.458385706115696,0,7,messenger ribonucleoprotein complex,CC,
19485,GO:1990130,1,0.571251888249369,0,5,GATOR1 complex,CC,
19500,GO:1990173,1,0.331304183637768,0,10,protein localization to nucleoplasm,BP,
19510,GO:1990226,1,0.574088154797185,0,5,histone methyltransferase binding,MF,
19514,GO:1990247,1,0.443368770949448,0,7,N6-methyladenosine-containing RNA binding,MF,
19535,GO:1990380,1,0.348537625284878,0,9,Lys48-specific deubiquitinase activity,MF,
19545,GO:1990403,1,0.402445447058918,0,8,embryonic brain development,BP,
19555,GO:1990416,1,0.502995152548181,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19574,GO:1990459,1,0.517440585382192,0,6,transferrin receptor binding,MF,
19589,GO:1990564,1,0.598567708345452,0,5,protein polyufmylation,BP,
19602,GO:1990592,1,0.598567708345452,0,5,protein K69-linked ufmylation,BP,
19619,GO:1990668,1,0.520794565498207,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19625,GO:1990712,1,0.583570169481954,0,5,HFE-transferrin receptor complex,CC,
19629,GO:1990726,1,0.682135617820382,0,5,Lsm1-7-Pat1 complex,CC,
19665,GO:1990822,1,0.567852996448648,0,5,basic amino acid transmembrane transport,BP,
19676,GO:1990845,1,0.504729318714723,0,6,adaptive thermogenesis,BP,
19679,GO:1990868,1,0.564500564038139,0,5,response to chemokine,BP,
19680,GO:1990869,1,0.564500564038139,0,5,cellular response to chemokine,BP,
19705,GO:1990948,1,0.684352892938928,0,5,ubiquitin ligase inhibitor activity,MF,
19727,GO:2000018,1,0.524721725567713,0,6,regulation of male gonad development,BP,
19729,GO:2000020,1,0.589651209387557,0,5,positive regulation of male gonad development,BP,
19736,GO:2000042,1,0.354519703449142,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19738,GO:2000047,1,0.591179842355283,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19765,GO:2000104,1,0.11920161488785,0,19,negative regulation of DNA-dependent DNA replication,BP,
19779,GO:2000121,1,0.423685576886093,0,8,regulation of removal of superoxide radicals,BP,
19782,GO:2000136,1,0.302459587655459,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19784,GO:2000138,1,0.568954632109876,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19787,GO:2000144,1,0.0803872608363894,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19796,GO:2000169,1,0.557519745785044,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19813,GO:2000197,1,0.502137900667092,0,6,regulation of ribonucleoprotein complex localization,BP,
19820,GO:2000210,1,0.543998010069676,0,6,positive regulation of anoikis,BP,
19829,GO:2000232,1,0.298212102271055,0,11,regulation of rRNA processing,BP,
19831,GO:2000234,1,0.423257284171108,0,8,positive regulation of rRNA processing,BP,
19846,GO:2000270,1,0.511165671229553,0,6,negative regulation of fibroblast apoptotic process,BP,
19860,GO:2000288,1,0.517402252678946,0,6,positive regulation of myoblast proliferation,BP,
19878,GO:2000316,1,0.469503103819977,0,7,regulation of T-helper 17 type immune response,BP,
19881,GO:2000319,1,0.586851485214407,0,5,regulation of T-helper 17 cell differentiation,BP,
19884,GO:2000322,1,0.451167403404891,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19885,GO:2000323,1,0.503148330002991,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19908,GO:2000353,1,0.398231277897044,0,8,positive regulation of endothelial cell apoptotic process,BP,
19919,GO:2000371,1,0.500882775722307,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19920,GO:2000373,1,0.500882775722307,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19977,GO:2000480,1,0.465762408273303,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
20019,GO:2000576,1,0.613489470383284,0,5,positive regulation of microtubule motor activity,BP,
20031,GO:2000601,1,0.497483261583795,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20040,GO:2000618,1,0.57292632559132,0,5,regulation of histone H4-K16 acetylation,BP,
20047,GO:2000628,1,0.461167781810826,0,7,regulation of miRNA metabolic process,BP,
20048,GO:2000630,1,0.57932032347486,0,5,positive regulation of miRNA metabolic process,BP,
20070,GO:2000659,1,0.476423847059656,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
20071,GO:2000660,1,0.597216945744578,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
20086,GO:2000676,1,0.588231070236813,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
20115,GO:2000737,1,0.14466338136927,0,17,negative regulation of stem cell differentiation,BP,
20116,GO:2000738,1,0.319291778658375,0,10,positive regulation of stem cell differentiation,BP,
20132,GO:2000766,1,0.509492725767812,0,6,negative regulation of cytoplasmic translation,BP,
20133,GO:2000767,1,0.40443848868468,0,8,positive regulation of cytoplasmic translation,BP,
20143,GO:2000781,1,0.203835885645602,0,14,positive regulation of double-strand break repair,BP,
20149,GO:2000794,1,0.500810009410146,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20161,GO:2000816,1,0.0346960430900985,0,31,negative regulation of mitotic sister chromatid separation,BP,
20194,GO:2000973,1,0.519313353433366,0,6,regulation of pro-B cell differentiation,BP,
20198,GO:2000980,1,0.586373725815987,0,5,regulation of inner ear receptor cell differentiation,BP,
20205,GO:2001014,1,0.284337829549294,0,11,regulation of skeletal muscle cell differentiation,BP,
20221,GO:2001034,1,0.562805796715794,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20225,GO:2001039,1,0.226059206993572,0,14,negative regulation of cellular response to drug,BP,
20229,GO:2001046,1,0.580259298845832,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20230,GO:2001053,1,0.508595323581819,0,6,regulation of mesenchymal cell apoptotic process,BP,
20231,GO:2001054,1,0.567955383461238,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20260,GO:2001166,1,0.56355571651864,0,5,regulation of histone H2B ubiquitination,BP,
20279,GO:2001197,1,0.553329505974353,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20286,GO:2001204,1,0.44630681120147,0,7,regulation of osteoclast development,BP,
20293,GO:2001223,1,0.568562107218604,0,5,negative regulation of neuron migration,BP,
20321,GO:2001267,1,0.121255512143355,0,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20322,GO:2001268,1,0.615411797617147,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20323,GO:2001269,1,0.197157109416889,0,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
1449,GO:0003676,1,0,217,3231,nucleic acid binding,MF,ERCC1;ZMYND8;H1F0;NFATC4;ETV4;ERCC6;MEF2D;NR1D1;XPOT;SLC16A3;TEF;ZKSCAN1;DNMT3A;SOX12;MTA1;CKAP4;R3HDM4;SCYL1;SMARCA1;ABTB1;ZC3H6;NACC2;ETV5;AARS;XBP1;ZCCHC14;EGFR;CSNK1E;RFX2;ADARB1;CARS;FAM50A;MIER2;ATF4;P4HB;ZKSCAN2;MRPS6;XPC;MDH2;PEG3;EHD3;ZSCAN30;ELK3;PHF21A;TMSB4X;TSPYL2;PHC2;POU2F2;TFEB;HIST2H2BE;PCSK9;ENDOG;ZNF598;DEAF1;SALL2;MSN;DRAP1;CREB3L2;SOX7;PPARA;TST;H2AFJ;ZNF516;SEC63;GTPBP1;DEDD2;TWF2;LARP6;TFE3;PRDX5;FSCN1;SP6;LARP1B;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;DDIT3;SATB1;DNASE1L1;MLXIP;HLTF;PCBP4;ASS1;GATA3;NUCB2;PHF1;TCFL5;OASL;ZNF165;RPUSD3;HSF1;MAPKBP1;NEIL1;RAI1;MPG;HMGA2;ARID5B;TOP1;FLNB;APLP2;AGO4;IRF7;HIST3H2A;RFXANK;NUCB1;RALY;ZCCHC24;PER3;RBMS2;ESRP1;NSUN7;RERE;STXBP1;CAMTA2;OAS1;ISG20;ZNF692;ZNF862;PFN1;NELFCD;VDR;PUM1;EHF;TNRC6B;C11ORF95;THRA;EIF2S2;HEXIM1;UBA1;ZSCAN18;ZNF71;HSF4;SECISBP2L;SPATS2;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;USF2;PBX3;HES2;ZDBF2;MAU2;DDB2;ZFPL1;TPD52L2;LEMD2;ZFPM1;ZNF783;SARS2;PRRC2A;RAD23A;LRP1;ZNF609;MXD4;E2F5;SAMD4B;USO1;GPATCH8;ZNF419;EHD4;RNASE7;ZNF570;PYM1;RCOR1;ZNF398;CHD7;SNTB2;ZNF687;BICC1;RXRA;HIST2H2AC;ZHX3;TSHZ1;TAF6;RPL28;BAHCC1;ZBTB4;TCF25;HIST1H2AG;NYNRIN;ZNF624;CARHSP1;POLM;LACTB2;EEPD1;DBP;LITAF;S100A16;ZNF444;MLF1;ZFP30;PAIP2;ZNF256;TFPT;MBD3;IGF2BP3;EIF4G3;ZFP28;SF3B6;WBP2;MANF;RMI2;ANXA1;PPP1R10;ASH2L;APOBEC3C;KLF12;ZNF318;ARCN1;EP300;TCF7L1;TIGD5;RNF10
5474,GO:0016404,1.00000000000001,0.888917293008515,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
13006,GO:0051391,1.00000000000001,0.889805595941196,0,1,tRNA acetylation,BP,
13007,GO:0051392,1.00000000000001,0.889805595941196,0,1,tRNA N-acetyltransferase activity,MF,
19031,GO:1904812,1.00000000000001,0.889805595941196,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19684,GO:1990882,1.00000000000001,0.889805595941196,0,1,rRNA acetylation,BP,
19685,GO:1990883,1.00000000000001,0.889805595941196,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19686,GO:1990884,1.00000000000001,0.889805595941196,0,1,RNA acetylation,BP,
2352,GO:0005415,1.00000000000002,0.800483226061479,0,2,nucleoside:sodium symporter activity,MF,
5241,GO:0015860,1.00000000000002,0.800483226061479,0,2,purine nucleoside transmembrane transport,BP,
756,GO:0001993,1.00000000000002,0.64283323934331,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
9611,GO:0036461,1.00000000000004,0.833567170066137,0,2,BLOC-2 complex binding,MF,
10385,GO:0043196,1.00000000000005,0.716821933843773,0,3,varicosity,CC,
120,GO:0000248,1.00000000000005,0.793675610772883,0,2,C-5 sterol desaturase activity,MF,
14917,GO:0070704,1.00000000000005,0.793675610772883,0,2,sterol desaturase activity,MF,
7114,GO:0030905,1.00000000000006,0.637129263373915,0,4,retromer, tubulation complex,CC,
5396,GO:0016230,1.00000000000006,0.810803899107794,0,2,sphingomyelin phosphodiesterase activator activity,MF,
966,GO:0002396,1.00000000000006,0.898603780169884,0,1,MHC protein complex assembly,BP,
967,GO:0002397,1.00000000000006,0.898603780169884,0,1,MHC class I protein complex assembly,BP,
1015,GO:0002501,1.00000000000006,0.898603780169884,0,1,peptide antigen assembly with MHC protein complex,BP,
1016,GO:0002502,1.00000000000006,0.898603780169884,0,1,peptide antigen assembly with MHC class I protein complex,BP,
2228,GO:0005128,1.00000000000007,0.891708961314152,0,1,erythropoietin receptor binding,MF,
2233,GO:0005135,1.00000000000007,0.891708961314152,0,1,interleukin-3 receptor binding,MF,
9425,GO:0035983,1.00000000000007,0.714837547900834,0,3,response to trichostatin A,BP,
9426,GO:0035984,1.00000000000007,0.714837547900834,0,3,cellular response to trichostatin A,BP,
2888,GO:0006396,1.00000000000007,0,31,877,RNA processing,BP,MAP2K1;AARS;EGFR;CSNK1E;PRKACA;ADARB1;MAP2K2;SYMPK;DEDD2;RRNAD1;LARP6;BCDIN3D;RPUSD3;HSF1;MAPKBP1;INTS8;AGO4;RALY;RBMS2;ESRP1;ISG20;SSU72;PUM1;CHD7;WDR18;INTS1;RPL28;TRPT1;CSNK1D;TGFB1;SF3B6
11137,GO:0045159,1.00000000000008,0.635958776693,0,4,myosin II binding,MF,
7231,GO:0031120,1.00000000000009,0.71620448882014,0,4,snRNA pseudouridine synthesis,BP,
1382,GO:0003275,1.0000000000001,0.791763486691468,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
17954,GO:1902256,1.0000000000001,0.791763486691468,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
13081,GO:0051562,1.00000000000011,0.79691945858394,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
11532,GO:0046032,1.00000000000011,0.906175770532169,0,1,ADP catabolic process,BP,
14325,GO:0061438,1.00000000000013,0.635543651502316,0,4,renal system vasculature morphogenesis,BP,
14326,GO:0061439,1.00000000000013,0.635543651502316,0,4,kidney vasculature morphogenesis,BP,
2844,GO:0006313,1.00000000000013,0.889624200880085,0,1,transposition, DNA-mediated,BP,
3814,GO:0008404,1.00000000000013,0.899422847644206,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3815,GO:0008405,1.00000000000013,0.899422847644206,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15390,GO:0071614,1.00000000000013,0.899422847644206,0,1,linoleic acid epoxygenase activity,MF,
15136,GO:0071205,1.00000000000013,0.623245372322436,0,4,protein localization to juxtaparanode region of axon,BP,
14457,GO:0061757,1.00000000000014,0.806142055844615,0,2,leukocyte adhesion to arterial endothelial cell,BP,
19123,GO:1904997,1.00000000000014,0.806142055844615,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
18401,GO:1903377,1.00000000000017,0.656987725614915,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
6857,GO:0030321,1.00000000000018,0.793710206137371,0,2,transepithelial chloride transport,BP,
3638,GO:0008109,1.00000000000019,0.792170727636638,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
10093,GO:0042584,1.0000000000002,0.634559525717683,0,4,chromaffin granule membrane,CC,
10141,GO:0042668,1.00000000000021,0.829262293113059,0,2,auditory receptor cell fate determination,BP,
20196,GO:2000977,1.00000000000021,0.829262293113059,0,2,regulation of forebrain neuron differentiation,BP,
20197,GO:2000978,1.00000000000021,0.829262293113059,0,2,negative regulation of forebrain neuron differentiation,BP,
2781,GO:0006212,1.00000000000021,0.892138492498527,0,1,uracil catabolic process,BP,
2783,GO:0006214,1.00000000000021,0.892138492498527,0,1,thymidine catabolic process,BP,
4425,GO:0010232,1.00000000000021,0.892138492498527,0,1,vascular transport,BP,
5836,GO:0017113,1.00000000000021,0.892138492498527,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6161,GO:0019483,1.00000000000021,0.892138492498527,0,1,beta-alanine biosynthetic process,BP,
11588,GO:0046127,1.00000000000021,0.892138492498527,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
13669,GO:0060156,1.00000000000021,0.892138492498527,0,1,milk ejection reflex,BP,
18396,GO:1903367,1.00000000000021,0.892138492498527,0,1,positive regulation of fear response,BP,
20202,GO:2000987,1.00000000000021,0.892138492498527,0,1,positive regulation of behavioral fear response,BP,
18898,GO:1904529,1.00000000000023,0.792632391563455,0,2,regulation of actin filament binding,BP,
18940,GO:1904616,1.00000000000023,0.792632391563455,0,2,regulation of actin binding,BP,
16427,GO:0097036,1.00000000000023,0.908795386209693,0,1,regulation of plasma membrane sterol distribution,BP,
11993,GO:0047273,1.00000000000024,0.891570828712608,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
1809,GO:0004452,1.00000000000025,0.816465860777132,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12748,GO:0050992,1.00000000000025,0.816465860777132,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12749,GO:0050993,1.00000000000025,0.816465860777132,0,2,dimethylallyl diphosphate metabolic process,BP,
8409,GO:0033342,1.00000000000026,0.89383429716259,0,1,negative regulation of collagen binding,BP,
18804,GO:1904288,1.00000000000026,0.630110516530286,0,4,BAT3 complex binding,MF,
20200,GO:2000983,1.00000000000026,0.858127492365643,0,2,regulation of ATP citrate synthase activity,BP,
20201,GO:2000984,1.00000000000026,0.858127492365643,0,2,negative regulation of ATP citrate synthase activity,BP,
16267,GO:0090304,1.00000000000027,0,320,4171,nucleic acid metabolic process,BP,TNIP1;NT5E;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CST3;CRTC1;MEF2D;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;KIAA1549;XBP1;EGFR;CSNK1E;TK2;RFX2;PRKACA;ADARB1;CARS;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;XPC;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;ENDOG;NSMCE4A;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;OASL;ZNF165;RPUSD3;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ARID5B;TOP1;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;POLD4;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;CAMTA2;PCSK6;OAS1;PRIMPOL;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;STUB1;TRIB3;DDB2;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;RAD23A;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;RNASE7;RNH1;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;PIK3R2;ANXA1;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
1698,GO:0004170,1.00000000000029,0.899221508487784,0,1,dUTP diphosphatase activity,MF,
11562,GO:0046080,1.00000000000029,0.899221508487784,0,1,dUTP metabolic process,BP,
11563,GO:0046081,1.00000000000029,0.899221508487784,0,1,dUTP catabolic process,BP,
7746,GO:0032240,1.0000000000003,0.789235917407954,0,2,negative regulation of nucleobase-containing compound transport,BP,
11866,GO:0046832,1.0000000000003,0.789235917407954,0,2,negative regulation of RNA export from nucleus,BP,
7706,GO:0032173,1.00000000000032,0.892503349532472,0,1,septin collar,CC,
9162,GO:0035508,1.00000000000035,0.888395989541514,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
15259,GO:0071400,1.00000000000037,0.794305223036628,0,2,cellular response to oleic acid,BP,
2577,GO:0005863,1.00000000000037,0.890413264807505,0,1,striated muscle myosin thick filament,CC,
3309,GO:0007014,1.00000000000037,0.890413264807505,0,1,actin ubiquitination,BP,
9588,GO:0036392,1.00000000000037,0.890413264807505,0,1,chemokine (C-C motif) ligand 20 production,BP,
18628,GO:1903881,1.00000000000037,0.890413264807505,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18629,GO:1903883,1.00000000000037,0.890413264807505,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18630,GO:1903884,1.00000000000037,0.890413264807505,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18631,GO:1903886,1.00000000000037,0.890413264807505,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
6046,GO:0019150,1.00000000000037,0.8968310415147,0,1,D-ribulokinase activity,MF,
7620,GO:0032002,1.00000000000038,0.801994824399758,0,2,interleukin-28 receptor complex,CC,
17304,GO:0140031,1.00000000000039,0.798751800390982,0,2,phosphorylation-dependent protein binding,MF,
2651,GO:0005988,1.00000000000039,0.791944995836932,0,2,lactose metabolic process,BP,
2652,GO:0005989,1.00000000000039,0.791944995836932,0,2,lactose biosynthetic process,BP,
11653,GO:0046351,1.00000000000039,0.791944995836932,0,2,disaccharide biosynthetic process,BP,
7779,GO:0032298,1.0000000000004,0.895249600484429,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16477,GO:0097123,1.0000000000004,0.895249600484429,0,1,cyclin A1-CDK2 complex,CC,
1239,GO:0002924,1.0000000000004,0.895150729015994,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9866,GO:0042105,1.0000000000004,0.895150729015994,0,1,alpha-beta T cell receptor complex,CC,
16503,GO:0097168,1.0000000000004,0.888798709380916,0,1,mesenchymal stem cell proliferation,BP,
18024,GO:1902460,1.0000000000004,0.888798709380916,0,1,regulation of mesenchymal stem cell proliferation,BP,
18025,GO:1902462,1.0000000000004,0.888798709380916,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
4265,GO:0009608,1.0000000000004,0.820254996451997,0,2,response to symbiont,BP,
4266,GO:0009609,1.0000000000004,0.820254996451997,0,2,response to symbiotic bacterium,BP,
5367,GO:0016150,1.00000000000044,0.904105132636172,0,1,translation release factor activity, codon nonspecific,MF,
14753,GO:0070407,1.00000000000044,0.892147347330865,0,1,oxidation-dependent protein catabolic process,BP,
16309,GO:0090386,1.00000000000044,0.789824549590943,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16310,GO:0090387,1.00000000000044,0.789824549590943,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16726,GO:0097682,1.00000000000047,0.896365469733087,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
15138,GO:0071208,1.00000000000047,0.702755940604291,0,4,histone pre-mRNA DCP binding,MF,
3862,GO:0008479,1.00000000000047,0.679642174454105,0,4,queuine tRNA-ribosyltransferase activity,MF,
14680,GO:0070267,1.00000000000047,0.890767077082823,0,1,oncosis,BP,
1841,GO:0004493,1.00000000000048,0.929049161345086,0,1,methylmalonyl-CoA epimerase activity,MF,
11716,GO:0046491,1.00000000000048,0.929049161345086,0,1,L-methylmalonyl-CoA metabolic process,BP,
8157,GO:0032877,1.00000000000049,0.791013826237884,0,2,positive regulation of DNA endoreduplication,BP,
3471,GO:0007308,1.0000000000005,0.893677502584343,0,1,oocyte construction,BP,
3472,GO:0007309,1.0000000000005,0.893677502584343,0,1,oocyte axis specification,BP,
3473,GO:0007314,1.0000000000005,0.893677502584343,0,1,oocyte anterior/posterior axis specification,BP,
3474,GO:0007315,1.0000000000005,0.893677502584343,0,1,pole plasm assembly,BP,
3793,GO:0008358,1.0000000000005,0.893677502584343,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7020,GO:0030719,1.0000000000005,0.893677502584343,0,1,P granule organization,BP,
9316,GO:0035755,1.0000000000005,0.893677502584343,0,1,cardiolipin hydrolase activity,MF,
15004,GO:0070899,1.0000000000005,0.892490500024277,0,1,mitochondrial tRNA wobble uridine modification,BP,
12460,GO:0050115,1.0000000000005,0.888564437427738,0,1,myosin-light-chain-phosphatase activity,MF,
5584,GO:0016598,1.0000000000005,0.805751640790993,0,2,protein arginylation,BP,
13108,GO:0051598,1.00000000000051,0.888778541149262,0,1,meiotic recombination checkpoint,BP,
15601,GO:0072053,1.00000000000051,0.793116006887034,0,2,renal inner medulla development,BP,
15602,GO:0072054,1.00000000000051,0.793116006887034,0,2,renal outer medulla development,BP,
18272,GO:1903059,1.00000000000053,0.642599772302691,0,4,regulation of protein lipidation,BP,
18273,GO:1903061,1.00000000000053,0.642599772302691,0,4,positive regulation of protein lipidation,BP,
3813,GO:0008403,1.00000000000053,0.891997652570356,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
6873,GO:0030342,1.00000000000053,0.891997652570356,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
13807,GO:0060373,1.00000000000057,0.631855310848798,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
5877,GO:0017187,1.00000000000057,0.675741244284721,0,4,peptidyl-glutamic acid carboxylation,BP,
5938,GO:0018214,1.00000000000057,0.675741244284721,0,4,protein carboxylation,BP,
1309,GO:0003150,1.00000000000058,0.629933380761791,0,4,muscular septum morphogenesis,BP,
10234,GO:0042903,1.00000000000058,0.798868970585521,0,2,tubulin deacetylase activity,MF,
13852,GO:0060430,1.0000000000006,0.790295156082568,0,2,lung saccule development,BP,
17944,GO:1902232,1.0000000000006,0.805979927347316,0,2,regulation of positive thymic T cell selection,BP,
15599,GO:0072049,1.00000000000061,0.664745796188981,0,4,comma-shaped body morphogenesis,BP,
19322,GO:1905535,1.00000000000061,0.888434305295978,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19323,GO:1905537,1.00000000000061,0.888434305295978,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19354,GO:1905610,1.00000000000061,0.888434305295978,0,1,regulation of mRNA cap binding,BP,
19355,GO:1905612,1.00000000000061,0.888434305295978,0,1,positive regulation of mRNA cap binding,BP,
11250,GO:0045409,1.00000000000063,0.792432900098191,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
7961,GO:0032554,1.00000000000064,0.663186898081639,0,4,purine deoxyribonucleotide binding,MF,
16790,GO:0098575,1.00000000000064,0.803092803045644,0,2,lumenal side of lysosomal membrane,CC,
9072,GO:0035299,1.00000000000064,0.888997718609603,0,1,inositol pentakisphosphate 2-kinase activity,MF,
2119,GO:0004906,1.00000000000065,0.80245984823688,0,2,interferon-gamma receptor activity,MF,
1849,GO:0004505,1.00000000000067,0.826044204164423,0,2,phenylalanine 4-monooxygenase activity,MF,
3648,GO:0008124,1.00000000000067,0.826044204164423,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3516,GO:0007442,1.00000000000067,0.626055615744151,0,4,hindgut morphogenesis,BP,
9367,GO:0035870,1.00000000000068,0.817220237010285,0,2,dITP diphosphatase activity,MF,
3338,GO:0007056,1.00000000000069,0.80198873540088,0,2,spindle assembly involved in female meiosis,BP,
3339,GO:0007057,1.00000000000069,0.80198873540088,0,2,spindle assembly involved in female meiosis I,BP,
1275,GO:0003064,1.00000000000072,0.899693571641461,0,1,regulation of heart rate by hormone,BP,
19431,GO:1905912,1.00000000000072,0.899693571641461,0,1,regulation of calcium ion export across plasma membrane,BP,
19432,GO:1905913,1.00000000000072,0.899693571641461,0,1,negative regulation of calcium ion export across plasma membrane,BP,
2794,GO:0006235,1.00000000000074,0.676857720952573,0,4,dTTP biosynthetic process,BP,
4151,GO:0009212,1.00000000000074,0.676857720952573,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
11559,GO:0046075,1.00000000000074,0.676857720952573,0,4,dTTP metabolic process,BP,
8778,GO:0034448,1.00000000000075,0.662139463878508,0,4,EGO complex,CC,
11223,GO:0045341,1.00000000000076,0.629786483274108,0,4,MHC class I biosynthetic process,BP,
11225,GO:0045343,1.00000000000076,0.629786483274108,0,4,regulation of MHC class I biosynthetic process,BP,
11226,GO:0045345,1.00000000000076,0.629786483274108,0,4,positive regulation of MHC class I biosynthetic process,BP,
15544,GO:0071910,1.00000000000076,0.789327131228337,0,2,determination of liver left/right asymmetry,BP,
2071,GO:0004822,1.00000000000077,0.79186719028615,0,2,isoleucine-tRNA ligase activity,MF,
2917,GO:0006428,1.00000000000077,0.79186719028615,0,2,isoleucyl-tRNA aminoacylation,BP,
7038,GO:0030806,1.00000000000078,0.793145933601198,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7053,GO:0030821,1.00000000000078,0.793145933601198,0,2,negative regulation of cAMP catabolic process,BP,
8301,GO:0033122,1.00000000000078,0.793145933601198,0,2,negative regulation of purine nucleotide catabolic process,BP,
1092,GO:0002677,1.00000000000078,0.803507857987811,0,2,negative regulation of chronic inflammatory response,BP,
10082,GO:0042568,1.00000000000078,0.925095525346641,0,1,insulin-like growth factor binary complex,CC,
7276,GO:0031251,1.00000000000079,0.789258089835405,0,2,PAN complex,CC,
8465,GO:0033596,1.00000000000079,0.703015797613711,0,3,TSC1-TSC2 complex,CC,
6491,GO:0021840,1.0000000000008,0.894434246846912,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6492,GO:0021842,1.0000000000008,0.894434246846912,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
16257,GO:0090289,1.00000000000081,0.81980491925931,0,2,regulation of osteoclast proliferation,BP,
9247,GO:0035633,1.00000000000081,0.795646649969577,0,2,maintenance of permeability of blood-brain barrier,BP,
13994,GO:0060684,1.00000000000082,0.641576680428212,0,4,epithelial-mesenchymal cell signaling,BP,
9710,GO:0038098,1.00000000000082,0.897079148568766,0,1,sequestering of BMP from receptor via BMP binding,BP,
19761,GO:2000097,1.00000000000083,0.797326760648668,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
8627,GO:0034137,1.00000000000084,0.753370125111716,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
4305,GO:0009753,1.00000000000085,0.825979323907926,0,2,response to jasmonic acid,BP,
5982,GO:0018636,1.00000000000085,0.825979323907926,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11963,GO:0047023,1.00000000000085,0.825979323907926,0,2,androsterone dehydrogenase activity,MF,
11970,GO:0047086,1.00000000000085,0.825979323907926,0,2,ketosteroid monooxygenase activity,MF,
11972,GO:0047115,1.00000000000085,0.825979323907926,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15255,GO:0071395,1.00000000000085,0.825979323907926,0,2,cellular response to jasmonic acid stimulus,BP,
3668,GO:0008160,1.00000000000086,0.893543153672205,0,1,protein tyrosine phosphatase activator activity,MF,
7468,GO:0031620,1.00000000000086,0.649544050198728,0,4,regulation of fever generation,BP,
7469,GO:0031622,1.00000000000086,0.649544050198728,0,4,positive regulation of fever generation,BP,
5007,GO:0015152,1.00000000000088,0.896355968993242,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7634,GO:0032028,1.00000000000088,0.896355968993242,0,1,myosin head/neck binding,MF,
439,GO:0001179,1.00000000000088,0.899407186290082,0,1,RNA polymerase I transcription factor binding,MF,
16002,GO:0080163,1.00000000000088,0.894373471485676,0,1,regulation of protein serine/threonine phosphatase activity,BP,
13097,GO:0051585,1.0000000000009,0.892012529009904,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13121,GO:0051620,1.0000000000009,0.892012529009904,0,1,norepinephrine uptake,BP,
13122,GO:0051621,1.0000000000009,0.892012529009904,0,1,regulation of norepinephrine uptake,BP,
13123,GO:0051622,1.0000000000009,0.892012529009904,0,1,negative regulation of norepinephrine uptake,BP,
13282,GO:0051945,1.0000000000009,0.892012529009904,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18212,GO:1902957,1.0000000000009,0.892012529009904,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18353,GO:1903282,1.0000000000009,0.892012529009904,0,1,regulation of glutathione peroxidase activity,BP,
18354,GO:1903284,1.0000000000009,0.892012529009904,0,1,positive regulation of glutathione peroxidase activity,BP,
18355,GO:1903285,1.0000000000009,0.892012529009904,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19294,GO:1905447,1.0000000000009,0.892012529009904,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19862,GO:2000295,1.0000000000009,0.892012529009904,0,1,regulation of hydrogen peroxide catabolic process,BP,
19973,GO:2000468,1.0000000000009,0.892012529009904,0,1,regulation of peroxidase activity,BP,
19974,GO:2000470,1.0000000000009,0.892012529009904,0,1,positive regulation of peroxidase activity,BP,
1374,GO:0003257,1.0000000000009,0.889123150518374,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
4620,GO:0010736,1.0000000000009,0.889123150518374,0,1,serum response element binding,MF,
4907,GO:0014835,1.0000000000009,0.889123150518374,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
17613,GO:1901228,1.0000000000009,0.889123150518374,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
11401,GO:0045762,1.0000000000009,0.791185210388256,0,2,positive regulation of adenylate cyclase activity,BP,
19732,GO:2000035,1.00000000000091,0.648178796970034,0,4,regulation of stem cell division,BP,
18282,GO:1903093,1.00000000000097,0.75160182697393,0,3,regulation of protein K48-linked deubiquitination,BP,
5812,GO:0017064,1.00000000000099,0.896374991521324,0,1,fatty acid amide hydrolase activity,MF,
17143,GO:0102077,1.00000000000099,0.896374991521324,0,1,oleamide hydrolase activity,MF,
17207,GO:0103073,1.00000000000099,0.896374991521324,0,1,anandamide amidohydrolase activity,MF,
16539,GO:0097229,1.00000000000099,0.912032453413611,0,1,sperm end piece,CC,
3133,GO:0006722,1.000000000001,0.894312226858208,0,1,triterpenoid metabolic process,BP,
6218,GO:0019742,1.000000000001,0.894312226858208,0,1,pentacyclic triterpenoid metabolic process,BP,
19089,GO:1904924,1.000000000001,0.894312226858208,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19264,GO:1905370,1.000000000001,0.894312226858208,0,1,serine-type endopeptidase complex,CC,
3970,GO:0008761,1.000000000001,0.888421628242121,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4219,GO:0009384,1.000000000001,0.888421628242121,0,1,N-acylmannosamine kinase activity,MF,
15871,GO:0072570,1.000000000001,0.89179445575244,0,1,ADP-D-ribose binding,MF,
4953,GO:0015014,1.00000000000103,0.627081176588485,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
2231,GO:0005132,1.00000000000104,0.834067617288842,0,2,type I interferon receptor binding,MF,
3578,GO:0007624,1.00000000000104,0.889410889880826,0,1,ultradian rhythm,BP,
15139,GO:0071209,1.00000000000106,0.756589445909384,0,3,U7 snRNA binding,MF,
19272,GO:1905395,1.00000000000106,0.83075298131624,0,2,response to flavonoid,BP,
7115,GO:0030906,1.00000000000107,0.652785260764401,0,4,retromer, cargo-selective complex,CC,
11821,GO:0046687,1.00000000000107,0.920113971649771,0,1,response to chromate,BP,
15162,GO:0071247,1.00000000000107,0.920113971649771,0,1,cellular response to chromate,BP,
17934,GO:1902220,1.00000000000107,0.920113971649771,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
9532,GO:0036228,1.00000000000108,0.795363888550483,0,2,protein localization to nuclear inner membrane,BP,
17573,GO:1901090,1.00000000000108,0.801362788705579,0,2,regulation of protein tetramerization,BP,
17574,GO:1901091,1.00000000000108,0.801362788705579,0,2,negative regulation of protein tetramerization,BP,
17575,GO:1901093,1.00000000000108,0.801362788705579,0,2,regulation of protein homotetramerization,BP,
17576,GO:1901094,1.00000000000108,0.801362788705579,0,2,negative regulation of protein homotetramerization,BP,
7881,GO:0032437,1.00000000000111,0.715110350177531,0,3,cuticular plate,CC,
8355,GO:0033204,1.00000000000112,0.893986719637543,0,1,ribonuclease P RNA binding,MF,
10599,GO:0043553,1.00000000000113,0.709621673931212,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
13750,GO:0060298,1.00000000000114,0.796390310996497,0,2,positive regulation of sarcomere organization,BP,
2239,GO:0005143,1.00000000000114,0.797493373474372,0,2,interleukin-12 receptor binding,MF,
12523,GO:0050613,1.00000000000115,0.805445416757439,0,2,delta14-sterol reductase activity,MF,
12468,GO:0050152,1.00000000000115,0.913798656403368,0,1,omega-amidase activity,MF,
18072,GO:1902576,1.00000000000115,0.638507712921793,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
4361,GO:0009955,1.00000000000116,0.895529377259658,0,1,adaxial/abaxial pattern specification,BP,
9285,GO:0035709,1.00000000000116,0.895529377259658,0,1,memory T cell activation,BP,
16324,GO:0090427,1.00000000000116,0.895529377259658,0,1,activation of meiosis,BP,
19723,GO:2000011,1.00000000000116,0.895529377259658,0,1,regulation of adaxial/abaxial pattern formation,BP,
20013,GO:2000567,1.00000000000116,0.895529377259658,0,1,regulation of memory T cell activation,BP,
20014,GO:2000568,1.00000000000116,0.895529377259658,0,1,positive regulation of memory T cell activation,BP,
20232,GO:2001055,1.00000000000116,0.895529377259658,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
6733,GO:0030144,1.00000000000116,0.710992802069724,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
2122,GO:0004910,1.00000000000116,0.908966931929356,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8047,GO:0032690,1.00000000000116,0.908966931929356,0,1,negative regulation of interleukin-1 alpha production,BP,
12579,GO:0050712,1.00000000000116,0.908966931929356,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13885,GO:0060481,1.00000000000116,0.811649618951578,0,2,lobar bronchus epithelium development,BP,
1767,GO:0004367,1.00000000000118,0.88990492211494,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11607,GO:0046168,1.00000000000118,0.88990492211494,0,1,glycerol-3-phosphate catabolic process,BP,
5243,GO:0015864,1.00000000000119,0.801093246834667,0,2,pyrimidine nucleoside transport,BP,
15127,GO:0071163,1.00000000000121,0.735087181599967,0,3,DNA replication preinitiation complex assembly,BP,
1765,GO:0004365,1.00000000000121,0.912538272597045,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6254,GO:0019828,1.00000000000121,0.912538272597045,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9225,GO:0035605,1.00000000000121,0.912538272597045,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10678,GO:0043891,1.00000000000121,0.912538272597045,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
14410,GO:0061646,1.00000000000121,0.888533406869466,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
17683,GO:1901490,1.00000000000121,0.630606334551036,0,4,regulation of lymphangiogenesis,BP,
4737,GO:0010899,1.00000000000126,0.75191341589785,0,3,regulation of phosphatidylcholine catabolic process,BP,
16482,GO:0097135,1.00000000000127,0.7996572005547,0,2,cyclin E2-CDK2 complex,CC,
16733,GO:0097699,1.00000000000128,0.888931073312655,0,1,vascular endothelial cell response to fluid shear stress,BP,
1786,GO:0004397,1.00000000000128,0.892052639264113,0,1,histidine ammonia-lyase activity,MF,
2113,GO:0004890,1.00000000000128,0.892052639264113,0,1,GABA-A receptor activity,MF,
2285,GO:0005237,1.00000000000128,0.892052639264113,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6184,GO:0019556,1.00000000000128,0.892052639264113,0,1,histidine catabolic process to glutamate and formamide,BP,
6185,GO:0019557,1.00000000000128,0.892052639264113,0,1,histidine catabolic process to glutamate and formate,BP,
6627,GO:0022851,1.00000000000128,0.892052639264113,0,1,GABA-gated chloride ion channel activity,MF,
10626,GO:0043606,1.00000000000128,0.892052639264113,0,1,formamide metabolic process,BP,
17027,GO:0099095,1.00000000000128,0.892052639264113,0,1,ligand-gated anion channel activity,MF,
18112,GO:1902710,1.00000000000128,0.892052639264113,0,1,GABA receptor complex,CC,
18113,GO:1902711,1.00000000000128,0.892052639264113,0,1,GABA-A receptor complex,CC,
922,GO:0002314,1.00000000000129,0.810486090197821,0,2,germinal center B cell differentiation,BP,
10676,GO:0043874,1.00000000000131,0.897333787558396,0,1,acireductone synthase activity,MF,
5952,GO:0018293,1.00000000000133,0.916121455480943,0,1,protein-FAD linkage,BP,
9260,GO:0035658,1.00000000000133,0.714524831288146,0,3,Mon1-Ccz1 complex,CC,
6318,GO:0019960,1.00000000000134,0.70262367901804,0,3,C-X3-C chemokine binding,MF,
1891,GO:0004569,1.00000000000135,0.888806767553034,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
10395,GO:0043208,1.00000000000136,0.638254276582842,0,4,glycosphingolipid binding,MF,
5095,GO:0015367,1.00000000000136,0.900772920917692,0,1,oxoglutarate:malate antiporter activity,MF,
5182,GO:0015742,1.00000000000136,0.900772920917692,0,1,alpha-ketoglutarate transport,BP,
8803,GO:0034485,1.00000000000136,0.630449569346071,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
20324,GO:2001270,1.00000000000137,0.659302621493403,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
9982,GO:0042361,1.00000000000137,0.891944012731865,0,1,menaquinone catabolic process,BP,
9993,GO:0042377,1.00000000000137,0.891944012731865,0,1,vitamin K catabolic process,BP,
18501,GO:1903575,1.0000000000014,0.809354640270547,0,2,cornified envelope assembly,BP,
19778,GO:2000118,1.00000000000141,0.889421104186527,0,1,regulation of sodium-dependent phosphate transport,BP,
5132,GO:0015578,1.00000000000143,0.894100219671065,0,1,mannose transmembrane transporter activity,MF,
5190,GO:0015761,1.00000000000143,0.894100219671065,0,1,mannose transmembrane transport,BP,
12158,GO:0048245,1.00000000000144,0.661532163645975,0,4,eosinophil chemotaxis,BP,
5117,GO:0015439,1.00000000000145,0.8925446141437,0,1,heme-transporting ATPase activity,MF,
18040,GO:1902504,1.00000000000145,0.8925446141437,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
102,GO:0000213,1.00000000000145,0.646941876002361,0,4,tRNA-intron endonuclease activity,MF,
199,GO:0000417,1.00000000000146,0.889634740530883,0,1,HIR complex,CC,
5867,GO:0017168,1.00000000000146,0.889634740530883,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
7017,GO:0030702,1.00000000000146,0.889634740530883,0,1,chromatin silencing at centromere,BP,
19156,GO:1905069,1.00000000000146,0.889634740530883,0,1,allantois development,BP,
1522,GO:0003881,1.00000000000147,0.899206222532699,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
8090,GO:0032765,1.00000000000148,0.792650637796675,0,2,positive regulation of mast cell cytokine production,BP,
8853,GO:0034640,1.00000000000149,0.891837896381178,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
17028,GO:0099098,1.00000000000149,0.891837896381178,0,1,microtubule polymerization based movement,BP,
10717,GO:0043997,1.00000000000149,0.892141444695527,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17238,GO:0106075,1.00000000000149,0.892141444695527,0,1,peptide N-succinyltransferase activity,MF,
17240,GO:0106078,1.00000000000149,0.892141444695527,0,1,histone succinyltransferase activity,MF,
16505,GO:0097176,1.00000000000149,0.650176561560284,0,4,epoxide metabolic process,BP,
15606,GO:0072061,1.0000000000015,0.809641556236802,0,2,inner medullary collecting duct development,BP,
7250,GO:0031177,1.00000000000153,0.782205473055729,0,3,phosphopantetheine binding,MF,
7254,GO:0031205,1.00000000000153,0.837468258934438,0,2,endoplasmic reticulum Sec complex,CC,
16138,GO:0090108,1.00000000000154,0.896711487095972,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16185,GO:0090187,1.00000000000154,0.896711487095972,0,1,positive regulation of pancreatic juice secretion,BP,
16292,GO:0090340,1.00000000000154,0.896711487095972,0,1,positive regulation of secretion of lysosomal enzymes,BP,
1846,GO:0004499,1.00000000000155,0.896027687869561,0,1,N,N-dimethylaniline monooxygenase activity,MF,
3470,GO:0007296,1.00000000000155,0.633126297723052,0,4,vitellogenesis,BP,
14641,GO:0070195,1.00000000000155,0.889058460117151,0,1,growth hormone receptor complex,CC,
6413,GO:0021648,1.00000000000155,0.794199246708633,0,2,vestibulocochlear nerve morphogenesis,BP,
14140,GO:0060978,1.00000000000155,0.794199246708633,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
1161,GO:0002767,1.00000000000155,0.807549945811948,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
4530,GO:0010593,1.00000000000155,0.789343846659452,0,2,negative regulation of lamellipodium assembly,BP,
6483,GO:0021823,1.00000000000155,0.789343846659452,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6487,GO:0021827,1.00000000000155,0.789343846659452,0,2,postnatal olfactory bulb interneuron migration,BP,
6490,GO:0021836,1.00000000000155,0.789343846659452,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
1633,GO:0004069,1.00000000000156,0.801245058771845,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2987,GO:0006532,1.00000000000156,0.801245058771845,0,2,aspartate biosynthetic process,BP,
2988,GO:0006533,1.00000000000156,0.801245058771845,0,2,aspartate catabolic process,BP,
6182,GO:0019550,1.00000000000156,0.801245058771845,0,2,glutamate catabolic process to aspartate,BP,
6183,GO:0019551,1.00000000000156,0.801245058771845,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
3413,GO:0007197,1.00000000000156,0.79409672078779,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5758,GO:0016907,1.00000000000156,0.79409672078779,0,2,G-protein coupled acetylcholine receptor activity,MF,
14999,GO:0070893,1.00000000000157,0.793401994005787,0,2,transposon integration,BP,
15000,GO:0070894,1.00000000000157,0.793401994005787,0,2,regulation of transposon integration,BP,
15001,GO:0070895,1.00000000000157,0.793401994005787,0,2,negative regulation of transposon integration,BP,
14320,GO:0061428,1.00000000000157,0.641562650110708,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
11349,GO:0045658,1.00000000000158,0.710352803483888,0,3,regulation of neutrophil differentiation,BP,
16479,GO:0097125,1.00000000000158,0.808096562617786,0,2,cyclin B1-CDK1 complex,CC,
19365,GO:1905661,1.00000000000158,0.797773126579082,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19366,GO:1905663,1.00000000000158,0.797773126579082,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
1661,GO:0004113,1.00000000000159,0.888437148905682,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
6099,GO:0019303,1.00000000000159,0.916052495735354,0,1,D-ribose catabolic process,BP,
4956,GO:0015018,1.00000000000161,0.908709987150934,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
11574,GO:0046101,1.00000000000161,0.659703102067272,0,4,hypoxanthine biosynthetic process,BP,
2083,GO:0004835,1.00000000000161,0.888452029121271,0,1,tubulin-tyrosine ligase activity,MF,
5917,GO:0018166,1.00000000000161,0.888452029121271,0,1,C-terminal protein-tyrosinylation,BP,
5958,GO:0018322,1.00000000000161,0.888452029121271,0,1,protein tyrosinylation,BP,
18651,GO:1903912,1.00000000000162,0.63467442461293,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19726,GO:2000017,1.00000000000162,0.795528740786625,0,2,positive regulation of determination of dorsal identity,BP,
14851,GO:0070576,1.00000000000163,0.797048655471339,0,2,vitamin D 24-hydroxylase activity,MF,
17465,GO:1900220,1.00000000000164,0.789644702225936,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
2118,GO:0004905,1.00000000000165,0.80797628826693,0,2,type I interferon receptor activity,MF,
14754,GO:0070408,1.00000000000165,0.888394386926179,0,1,carbamoyl phosphate metabolic process,BP,
14755,GO:0070409,1.00000000000165,0.888394386926179,0,1,carbamoyl phosphate biosynthetic process,BP,
18555,GO:1903717,1.00000000000165,0.888394386926179,0,1,response to ammonia,BP,
18556,GO:1903718,1.00000000000165,0.888394386926179,0,1,cellular response to ammonia,BP,
19356,GO:1905616,1.00000000000165,0.793186438223493,0,2,regulation of miRNA mediated inhibition of translation,BP,
19357,GO:1905618,1.00000000000165,0.793186438223493,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
4931,GO:0014886,1.00000000000165,0.792642645834368,0,2,transition between slow and fast fiber,BP,
9163,GO:0035509,1.00000000000166,0.634184716179988,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
18384,GO:1903347,1.00000000000166,0.634184716179988,0,4,negative regulation of bicellular tight junction assembly,BP,
13786,GO:0060342,1.00000000000167,0.899100021024233,0,1,photoreceptor inner segment membrane,CC,
2195,GO:0005053,1.00000000000167,0.907459217045515,0,1,peroxisome matrix targeting signal-2 binding,MF,
13581,GO:0060024,1.00000000000169,0.796393282619211,0,2,rhythmic synaptic transmission,BP,
3863,GO:0008481,1.0000000000017,0.802753553774633,0,2,sphinganine kinase activity,MF,
5803,GO:0017050,1.0000000000017,0.802753553774633,0,2,D-erythro-sphingosine kinase activity,MF,
1677,GO:0004138,1.00000000000171,0.923285651114551,0,1,deoxyguanosine kinase activity,MF,
3937,GO:0008617,1.00000000000171,0.923285651114551,0,1,guanosine metabolic process,BP,
5288,GO:0015938,1.00000000000171,0.923285651114551,0,1,coenzyme A catabolic process,BP,
8549,GO:0033869,1.00000000000171,0.923285651114551,0,1,nucleoside bisphosphate catabolic process,BP,
8572,GO:0034031,1.00000000000171,0.923285651114551,0,1,ribonucleoside bisphosphate catabolic process,BP,
8575,GO:0034034,1.00000000000171,0.923285651114551,0,1,purine nucleoside bisphosphate catabolic process,BP,
14728,GO:0070345,1.00000000000172,0.630197574467655,0,4,negative regulation of fat cell proliferation,BP,
7509,GO:0031682,1.00000000000173,0.89239423583569,0,1,G-protein gamma-subunit binding,MF,
18140,GO:1902773,1.00000000000173,0.89239423583569,0,1,GTPase activator complex,CC,
8457,GO:0033577,1.00000000000173,0.797947620760133,0,2,protein glycosylation in endoplasmic reticulum,BP,
6816,GO:0030263,1.00000000000174,0.628938979996709,0,4,apoptotic chromosome condensation,BP,
2244,GO:0005152,1.00000000000175,0.714406194062059,0,3,interleukin-1 receptor antagonist activity,MF,
14185,GO:0061047,1.00000000000175,0.718647808771792,0,3,positive regulation of branching involved in lung morphogenesis,BP,
1658,GO:0004109,1.00000000000177,0.798512531068835,0,2,coproporphyrinogen oxidase activity,MF,
19553,GO:1990414,1.00000000000177,0.634734325820711,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
3206,GO:0006844,1.00000000000178,0.8043775477815,0,2,acyl carnitine transport,BP,
5046,GO:0015227,1.00000000000178,0.8043775477815,0,2,acyl carnitine transmembrane transporter activity,MF,
7145,GO:0030974,1.00000000000178,0.807258838479856,0,2,thiamine pyrophosphate transmembrane transport,BP,
15374,GO:0071586,1.00000000000178,0.809827769348179,0,2,CAAX-box protein processing,BP,
15992,GO:0080120,1.00000000000178,0.809827769348179,0,2,CAAX-box protein maturation,BP,
16323,GO:0090422,1.00000000000178,0.807258838479856,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
1520,GO:0003878,1.0000000000018,0.889064749395895,0,1,ATP citrate synthase activity,MF,
4013,GO:0009000,1.0000000000018,0.894055501151705,0,1,selenocysteine lyase activity,MF,
4211,GO:0009346,1.0000000000018,0.889064749395895,0,1,citrate lyase complex,CC,
16390,GO:0090675,1.0000000000018,0.891078536326769,0,1,intermicrovillar adhesion,BP,
10458,GO:0043305,1.00000000000181,0.807695665662029,0,2,negative regulation of mast cell degranulation,BP,
7923,GO:0032490,1.00000000000181,0.62876411835787,0,4,detection of molecule of bacterial origin,BP,
4213,GO:0009360,1.00000000000182,0.893310149750874,0,1,DNA polymerase III complex,CC,
216,GO:0000451,1.00000000000185,0.799488019987742,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,1.00000000000185,0.799488019987742,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14549,GO:0070039,1.00000000000185,0.799488019987742,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
2799,GO:0006256,1.00000000000186,0.892696267808671,0,1,UDP catabolic process,BP,
4087,GO:0009140,1.00000000000186,0.892696267808671,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4135,GO:0009193,1.00000000000186,0.892696267808671,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4136,GO:0009195,1.00000000000186,0.892696267808671,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4161,GO:0009222,1.00000000000186,0.892696267808671,0,1,pyrimidine ribonucleotide catabolic process,BP,
11542,GO:0046048,1.00000000000186,0.892696267808671,0,1,UDP metabolic process,BP,
4878,GO:0014738,1.00000000000188,0.712376317683508,0,3,regulation of muscle hyperplasia,BP,
7633,GO:0032027,1.00000000000188,0.712791668872396,0,3,myosin light chain binding,MF,
9098,GO:0035354,1.00000000000188,0.891325069416955,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9720,GO:0038123,1.00000000000188,0.891325069416955,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10052,GO:0042495,1.00000000000188,0.891325069416955,0,1,detection of triacyl bacterial lipopeptide,BP,
10054,GO:0042497,1.00000000000188,0.891325069416955,0,1,triacyl lipopeptide binding,MF,
15460,GO:0071725,1.00000000000188,0.891325069416955,0,1,response to triacyl bacterial lipopeptide,BP,
15462,GO:0071727,1.00000000000188,0.891325069416955,0,1,cellular response to triacyl bacterial lipopeptide,BP,
9242,GO:0035624,1.00000000000188,0.791402617764317,0,2,receptor transactivation,BP,
1599,GO:0004014,1.0000000000019,0.891725469080462,0,1,adenosylmethionine decarboxylase activity,MF,
3011,GO:0006557,1.0000000000019,0.891725469080462,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6247,GO:0019810,1.0000000000019,0.891725469080462,0,1,putrescine binding,MF,
11722,GO:0046499,1.0000000000019,0.891725469080462,0,1,S-adenosylmethioninamine metabolic process,BP,
11503,GO:0045950,1.00000000000191,0.798182507228495,0,2,negative regulation of mitotic recombination,BP,
1154,GO:0002759,1.00000000000192,0.654383458403224,0,4,regulation of antimicrobial humoral response,BP,
17107,GO:0099609,1.00000000000193,0.789235772030547,0,2,microtubule lateral binding,MF,
17016,GO:0099077,1.00000000000194,0.888394376325058,0,1,histone-dependent DNA binding,MF,
19372,GO:1905687,1.00000000000194,0.888394376325058,0,1,regulation of diacylglycerol kinase activity,BP,
19373,GO:1905689,1.00000000000194,0.888394376325058,0,1,positive regulation of diacylglycerol kinase activity,BP,
14479,GO:0061825,1.00000000000194,0.889867084836639,0,1,podosome core,CC,
16564,GO:0097298,1.00000000000194,0.889867084836639,0,1,regulation of nucleus size,BP,
7814,GO:0032358,1.00000000000195,0.930223374218154,0,1,oxidized pyrimidine DNA binding,MF,
14342,GO:0061481,1.00000000000195,0.930223374218154,0,1,response to TNF agonist,BP,
18056,GO:1902546,1.00000000000195,0.930223374218154,0,1,positive regulation of DNA N-glycosylase activity,BP,
20326,GO:2001272,1.00000000000195,0.930223374218154,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
19657,GO:1990784,1.00000000000196,0.889622100150277,0,1,response to dsDNA,BP,
19659,GO:1990786,1.00000000000196,0.889622100150277,0,1,cellular response to dsDNA,BP,
4730,GO:0010890,1.00000000000197,0.822521131873972,0,2,positive regulation of sequestering of triglyceride,BP,
1679,GO:0004140,1.00000000000198,0.802714882167791,0,2,dephospho-CoA kinase activity,MF,
14767,GO:0070427,1.00000000000199,0.719193239184294,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
5588,GO:0016603,1.00000000000199,0.808268981915079,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5876,GO:0017186,1.00000000000199,0.808268981915079,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
12184,GO:0048289,1.00000000000199,0.635745951242832,0,4,isotype switching to IgE isotypes,BP,
12187,GO:0048293,1.00000000000199,0.635745951242832,0,4,regulation of isotype switching to IgE isotypes,BP,
12938,GO:0051267,1.000000000002,0.891783963496384,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13548,GO:0055103,1.000000000002,0.891783963496384,0,1,ligase regulator activity,MF,
17467,GO:1900222,1.00000000000201,0.804831916122504,0,2,negative regulation of amyloid-beta clearance,BP,
19582,GO:1990511,1.00000000000201,0.630122007215187,0,4,piRNA biosynthetic process,BP,
14943,GO:0070778,1.00000000000202,0.631110892189944,0,4,L-aspartate transmembrane transport,BP,
1745,GO:0004342,1.00000000000204,0.804109250575849,0,2,glucosamine-6-phosphate deaminase activity,MF,
2682,GO:0006043,1.00000000000204,0.804109250575849,0,2,glucosamine catabolic process,BP,
5051,GO:0015234,1.00000000000204,0.804710026435934,0,2,thiamine transmembrane transporter activity,MF,
15555,GO:0071934,1.00000000000204,0.804710026435934,0,2,thiamine transmembrane transport,BP,
11350,GO:0045659,1.00000000000205,0.791412087165726,0,2,negative regulation of neutrophil differentiation,BP,
13237,GO:0051877,1.00000000000207,0.797096663399767,0,2,pigment granule aggregation in cell center,BP,
1926,GO:0004617,1.00000000000207,0.897253279959087,0,1,phosphoglycerate dehydrogenase activity,MF,
8523,GO:0033699,1.00000000000207,0.897253279959087,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17295,GO:0120108,1.00000000000207,0.897253279959087,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19493,GO:1990165,1.00000000000207,0.897253279959087,0,1,single-strand break-containing DNA binding,MF,
17477,GO:1900243,1.00000000000207,0.88843138701862,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19179,GO:1905154,1.00000000000207,0.88843138701862,0,1,negative regulation of membrane invagination,BP,
19181,GO:1905161,1.00000000000207,0.88843138701862,0,1,protein localization to phagocytic vesicle,BP,
19182,GO:1905162,1.00000000000207,0.88843138701862,0,1,regulation of phagosome maturation,BP,
19187,GO:1905169,1.00000000000207,0.88843138701862,0,1,regulation of protein localization to phagocytic vesicle,BP,
19188,GO:1905171,1.00000000000207,0.88843138701862,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19307,GO:1905468,1.00000000000207,0.88843138701862,0,1,regulation of clathrin-coated pit assembly,BP,
19308,GO:1905469,1.00000000000207,0.88843138701862,0,1,negative regulation of clathrin-coated pit assembly,BP,
312,GO:0000823,1.00000000000208,0.900522457617693,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1.00000000000208,0.900522457617693,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1.00000000000208,0.900522457617693,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
12005,GO:0047326,1.00000000000208,0.900522457617693,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12400,GO:0048793,1.00000000000208,0.625557619704072,0,4,pronephros development,BP,
1494,GO:0003829,1.00000000000208,0.791753823358209,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
6260,GO:0019841,1.00000000000208,0.706598476653821,0,4,retinol binding,MF,
19412,GO:1905863,1.00000000000209,0.793556566181005,0,2,invadopodium organization,BP,
3727,GO:0008260,1.00000000000209,0.890821701729806,0,1,3-oxoacid CoA-transferase activity,MF,
10302,GO:0043041,1.00000000000209,0.890821701729806,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
4916,GO:0014852,1.0000000000021,0.89287266661555,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4917,GO:0014853,1.0000000000021,0.89287266661555,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5793,GO:0017020,1.0000000000021,0.89287266661555,0,1,myosin phosphatase regulator activity,MF,
16334,GO:0090500,1.0000000000021,0.808118926052229,0,2,endocardial cushion to mesenchymal transition,BP,
17192,GO:0102773,1.0000000000021,0.888943251313323,0,1,dihydroceramide kinase activity,MF,
16961,GO:0098920,1.0000000000021,0.793546146236528,0,2,retrograde trans-synaptic signaling by lipid,BP,
16962,GO:0098921,1.0000000000021,0.793546146236528,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
8201,GO:0032937,1.00000000000211,0.709736952318801,0,3,SREBP-SCAP-Insig complex,CC,
8325,GO:0033152,1.00000000000212,0.642281594489497,0,4,immunoglobulin V(D)J recombination,BP,
9184,GO:0035544,1.00000000000213,0.888913146350895,0,1,negative regulation of SNARE complex assembly,BP,
13913,GO:0060535,1.00000000000213,0.72104875979317,0,3,trachea cartilage morphogenesis,BP,
10849,GO:0044334,1.00000000000213,0.79296580348312,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
3898,GO:0008534,1.00000000000214,0.692692653473838,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
8938,GO:0034777,1.00000000000215,0.895298578966468,0,1,recycling endosome lumen,CC,
19118,GO:1904990,1.00000000000215,0.894165272590624,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19119,GO:1904992,1.00000000000215,0.894165272590624,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
5082,GO:0015317,1.00000000000215,0.90268180052296,0,1,phosphate:proton symporter activity,MF,
4912,GO:0014846,1.00000000000216,0.889240082619903,0,1,esophagus smooth muscle contraction,BP,
2067,GO:0004818,1.00000000000216,0.790651179423089,0,2,glutamate-tRNA ligase activity,MF,
2913,GO:0006424,1.00000000000216,0.790651179423089,0,2,glutamyl-tRNA aminoacylation,BP,
16684,GO:0097543,1.00000000000218,0.793231361267722,0,2,ciliary inversin compartment,CC,
1212,GO:0002875,1.00000000000219,0.90387436313287,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2237,GO:0005141,1.00000000000219,0.90387436313287,0,1,interleukin-10 receptor binding,MF,
18725,GO:1904057,1.00000000000219,0.90387436313287,0,1,negative regulation of sensory perception of pain,BP,
6353,GO:0021527,1.0000000000022,0.888408084542904,0,1,spinal cord association neuron differentiation,BP,
16694,GO:0097598,1.0000000000022,0.888408084542904,0,1,sperm cytoplasmic droplet,CC,
15560,GO:0071947,1.00000000000221,0.701699734462326,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
18337,GO:1903233,1.00000000000221,0.789359295657086,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
3926,GO:0008597,1.00000000000221,0.807023511062128,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
10217,GO:0042823,1.00000000000221,0.791659914146247,0,2,pyridoxal phosphate biosynthetic process,BP,
1565,GO:0003963,1.00000000000223,0.799739675761994,0,2,RNA-3'-phosphate cyclase activity,MF,
3032,GO:0006580,1.00000000000223,0.893324741705471,0,1,ethanolamine metabolic process,BP,
18303,GO:1903165,1.00000000000223,0.893324741705471,0,1,response to polycyclic arene,BP,
18961,GO:1904681,1.00000000000223,0.893324741705471,0,1,response to 3-methylcholanthrene,BP,
19688,GO:1990904,1.00000000000223,0,21,701,ribonucleoprotein complex,CC,BTBD2;PITPNM1;CKAP4;MRPS6;SYMPK;LARP6;HSF1;MAPKBP1;TOP1;AGO4;RALY;PUM1;TNRC6B;RRBP1;SAMD4B;SHB;RPL28;IMPACT;CARHSP1;SF3B6;APOBEC3C
661,GO:0001850,1.00000000000224,0.899939562790367,0,1,complement component C3a binding,MF,
662,GO:0001851,1.00000000000224,0.899939562790367,0,1,complement component C3b binding,MF,
11939,GO:0046967,1.00000000000224,0.794112568576381,0,2,cytosol to ER transport,BP,
19524,GO:1990269,1.00000000000224,0.796038136801329,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
1539,GO:0003921,1.00000000000225,0.894059518143729,0,1,GMP synthase activity,MF,
1540,GO:0003922,1.00000000000225,0.894059518143729,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
19205,GO:1905224,1.00000000000226,0.789654314281872,0,2,clathrin-coated pit assembly,BP,
7905,GO:0032468,1.00000000000227,0.891022613050362,0,1,Golgi calcium ion homeostasis,BP,
5334,GO:0016062,1.00000000000228,0.893696689899311,0,1,adaptation of rhodopsin mediated signaling,BP,
9578,GO:0036367,1.00000000000228,0.893696689899311,0,1,light adaption,BP,
2018,GO:0004742,1.00000000000229,0.889073903877666,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6935,GO:0030523,1.00000000000229,0.889073903877666,0,1,dihydrolipoamide S-acyltransferase activity,MF,
2571,GO:0005854,1.00000000000229,0.8175313774121,0,2,nascent polypeptide-associated complex,CC,
14462,GO:0061768,1.00000000000229,0.888579461957613,0,1,magnesium:sodium antiporter activity,MF,
2258,GO:0005170,1.0000000000023,0.888416517814248,0,1,neurotrophin TRKC receptor binding,MF,
6910,GO:0030485,1.00000000000231,0.804552909845672,0,2,smooth muscle contractile fiber,CC,
4084,GO:0009137,1.00000000000232,0.654425744784612,0,4,purine nucleoside diphosphate catabolic process,BP,
4123,GO:0009181,1.00000000000232,0.654425744784612,0,4,purine ribonucleoside diphosphate catabolic process,BP,
6973,GO:0030622,1.00000000000232,0.710357721200914,0,3,U4atac snRNA binding,MF,
19944,GO:2000405,1.00000000000233,0.888400901559349,0,1,negative regulation of T cell migration,BP,
14339,GO:0061474,1.00000000000233,0.893769057543489,0,1,phagolysosome membrane,CC,
8561,GO:0033961,1.00000000000234,0.901359386050863,0,1,cis-stilbene-oxide hydrolase activity,MF,
14748,GO:0070401,1.00000000000234,0.80835125032628,0,2,NADP+ binding,MF,
20204,GO:2001013,1.00000000000235,0.789361955576695,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
4058,GO:0009106,1.00000000000235,0.804216862383946,0,2,lipoate metabolic process,BP,
17478,GO:1900244,1.00000000000236,0.796720090739479,0,2,positive regulation of synaptic vesicle endocytosis,BP,
1389,GO:0003292,1.00000000000237,0.888394461906929,0,1,cardiac septum cell differentiation,BP,
14114,GO:0060922,1.00000000000237,0.888394461906929,0,1,atrioventricular node cell differentiation,BP,
14117,GO:0060928,1.00000000000237,0.888394461906929,0,1,atrioventricular node cell development,BP,
10970,GO:0044715,1.00000000000238,0.830467705442905,0,2,8-oxo-dGDP phosphatase activity,MF,
18602,GO:1903817,1.00000000000239,0.64170549644846,0,4,negative regulation of voltage-gated potassium channel activity,BP,
11954,GO:0046985,1.00000000000239,0.726789493717257,0,3,positive regulation of hemoglobin biosynthetic process,BP,
10063,GO:0042536,1.00000000000241,0.725167245267714,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
14780,GO:0070458,1.00000000000242,0.745046554558595,0,3,cellular detoxification of nitrogen compound,BP,
7164,GO:0031021,1.00000000000242,0.745094503378119,0,3,interphase microtubule organizing center,CC,
18332,GO:1903223,1.00000000000242,0.7039527146344,0,3,positive regulation of oxidative stress-induced neuron death,BP,
1722,GO:0004311,1.00000000000244,0.714390499612339,0,3,farnesyltranstransferase activity,MF,
6982,GO:0030643,1.00000000000244,0.629222005112054,0,4,cellular phosphate ion homeostasis,BP,
15823,GO:0072501,1.00000000000244,0.629222005112054,0,4,cellular divalent inorganic anion homeostasis,BP,
15824,GO:0072502,1.00000000000244,0.629222005112054,0,4,cellular trivalent inorganic anion homeostasis,BP,
15140,GO:0071211,1.00000000000244,0.633005985939418,0,4,protein targeting to vacuole involved in autophagy,BP,
17504,GO:1900378,1.00000000000245,0.789926328388776,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
4252,GO:0009450,1.00000000000246,0.789424158258786,0,2,gamma-aminobutyric acid catabolic process,BP,
13606,GO:0060053,1.00000000000247,0.794575853770653,0,2,neurofilament cytoskeleton,CC,
4929,GO:0014878,1.00000000000248,0.888417692183202,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
9655,GO:0036515,1.00000000000248,0.623938870597912,0,4,serotonergic neuron axon guidance,BP,
946,GO:0002357,1.00000000000249,0.89314115517471,0,1,defense response to tumor cell,BP,
15347,GO:0071547,1.00000000000249,0.89314115517471,0,1,piP-body,CC,
10342,GO:0043125,1.00000000000249,0.64827422091008,0,4,ErbB-3 class receptor binding,MF,
16104,GO:0090063,1.0000000000025,0.631348075394081,0,4,positive regulation of microtubule nucleation,BP,
8209,GO:0032954,1.0000000000025,0.792051266162458,0,2,regulation of cytokinetic process,BP,
18434,GO:1903436,1.0000000000025,0.792051266162458,0,2,regulation of mitotic cytokinetic process,BP,
18435,GO:1903438,1.0000000000025,0.792051266162458,0,2,positive regulation of mitotic cytokinetic process,BP,
18450,GO:1903490,1.0000000000025,0.792051266162458,0,2,positive regulation of mitotic cytokinesis,BP,
1521,GO:0003880,1.0000000000025,0.724450287249226,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2952,GO:0006481,1.0000000000025,0.724450287249226,0,3,C-terminal protein methylation,BP,
9288,GO:0035712,1.0000000000025,0.891699955741788,0,1,T-helper 2 cell activation,BP,
20015,GO:2000569,1.0000000000025,0.891699955741788,0,1,regulation of T-helper 2 cell activation,BP,
20016,GO:2000570,1.0000000000025,0.891699955741788,0,1,positive regulation of T-helper 2 cell activation,BP,
13905,GO:0060523,1.00000000000251,0.790220168889309,0,2,prostate epithelial cord elongation,BP,
13951,GO:0060594,1.00000000000251,0.790220168889309,0,2,mammary gland specification,BP,
19165,GO:1905098,1.00000000000252,0.639373236215835,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
12,GO:0000023,1.00000000000252,0.703274453631073,0,3,maltose metabolic process,BP,
1882,GO:0004558,1.00000000000252,0.703274453631073,0,3,alpha-1,4-glucosidase activity,MF,
7888,GO:0032450,1.00000000000252,0.703274453631073,0,3,maltose alpha-glucosidase activity,MF,
9938,GO:0042275,1.00000000000253,0.906526185785783,0,1,error-free postreplication DNA repair,BP,
13557,GO:0055120,1.00000000000253,0.921937990892525,0,1,striated muscle dense body,CC,
1517,GO:0003875,1.00000000000254,0.891205862881037,0,1,ADP-ribosylarginine hydrolase activity,MF,
7351,GO:0031379,1.00000000000254,0.853394554916517,0,2,RNA-directed RNA polymerase complex,CC,
20288,GO:2001206,1.00000000000254,0.714659963983986,0,3,positive regulation of osteoclast development,BP,
5308,GO:0016011,1.00000000000255,0.712539124748596,0,3,dystroglycan complex,CC,
11818,GO:0046684,1.00000000000256,0.798556254540422,0,2,response to pyrethroid,BP,
3939,GO:0008623,1.00000000000257,0.794411226322772,0,2,CHRAC,CC,
3399,GO:0007181,1.00000000000257,0.80871137076659,0,2,transforming growth factor beta receptor complex assembly,BP,
14377,GO:0061580,1.00000000000257,0.889454059587144,0,1,colon epithelial cell migration,BP,
14968,GO:0070843,1.00000000000257,0.889454059587144,0,1,misfolded protein transport,BP,
14969,GO:0070844,1.00000000000257,0.889454059587144,0,1,polyubiquitinated protein transport,BP,
14970,GO:0070845,1.00000000000257,0.889454059587144,0,1,polyubiquitinated misfolded protein transport,BP,
14971,GO:0070846,1.00000000000257,0.889454059587144,0,1,Hsp90 deacetylation,BP,
1000,GO:0002461,1.00000000000257,0.894747960799164,0,1,tolerance induction dependent upon immune response,BP,
1022,GO:0002519,1.00000000000257,0.894747960799164,0,1,natural killer cell tolerance induction,BP,
1081,GO:0002652,1.00000000000257,0.894747960799164,0,1,regulation of tolerance induction dependent upon immune response,BP,
8057,GO:0032712,1.00000000000257,0.894747960799164,0,1,negative regulation of interleukin-3 production,BP,
15418,GO:0071656,1.00000000000257,0.894747960799164,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17623,GO:1901257,1.00000000000257,0.894747960799164,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
11762,GO:0046587,1.0000000000026,0.892476199400103,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18912,GO:1904567,1.0000000000026,0.892476199400103,0,1,response to wortmannin,BP,
18913,GO:1904568,1.0000000000026,0.892476199400103,0,1,cellular response to wortmannin,BP,
19615,GO:1990646,1.0000000000026,0.892476199400103,0,1,cellular response to prolactin,BP,
3616,GO:0008065,1.0000000000026,0.792783785331494,0,2,establishment of blood-nerve barrier,BP,
13710,GO:0060232,1.0000000000026,0.639300456130293,0,4,delamination,BP,
17142,GO:0102009,1.0000000000026,0.898891783154936,0,1,proline dipeptidase activity,MF,
8909,GO:0034722,1.00000000000261,0.907296772436171,0,1,gamma-glutamyl-peptidase activity,MF,
5894,GO:0018057,1.00000000000263,0.708964434673631,0,3,peptidyl-lysine oxidation,BP,
9432,GO:0035990,1.00000000000265,0.804154813625839,0,2,tendon cell differentiation,BP,
9433,GO:0035992,1.00000000000265,0.804154813625839,0,2,tendon formation,BP,
20020,GO:2000580,1.00000000000265,0.687175124570472,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20021,GO:2000582,1.00000000000265,0.687175124570472,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
1415,GO:0003348,1.00000000000265,0.630082325733341,0,4,cardiac endothelial cell differentiation,BP,
14127,GO:0060956,1.00000000000265,0.630082325733341,0,4,endocardial cell differentiation,BP,
8376,GO:0033263,1.00000000000265,0.627082938452657,0,4,CORVET complex,CC,
18518,GO:1903613,1.00000000000266,0.888414221555524,0,1,regulation of protein tyrosine phosphatase activity,BP,
18519,GO:1903615,1.00000000000266,0.888414221555524,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
2243,GO:0005151,1.00000000000267,0.800219788182008,0,2,interleukin-1, Type II receptor binding,MF,
8640,GO:0034154,1.00000000000267,0.633739896792598,0,4,toll-like receptor 7 signaling pathway,BP,
805,GO:0002071,1.00000000000268,0.796491152667848,0,2,glandular epithelial cell maturation,BP,
9762,GO:0039502,1.00000000000271,0.88843919464212,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9763,GO:0039503,1.00000000000271,0.88843919464212,0,1,suppression by virus of host innate immune response,BP,
9767,GO:0039514,1.00000000000271,0.88843919464212,0,1,suppression by virus of host JAK-STAT cascade,BP,
9783,GO:0039562,1.00000000000271,0.88843919464212,0,1,suppression by virus of host STAT activity,BP,
9784,GO:0039563,1.00000000000271,0.88843919464212,0,1,suppression by virus of host STAT1 activity,BP,
9785,GO:0039564,1.00000000000271,0.88843919464212,0,1,suppression by virus of host STAT2 activity,BP,
10886,GO:0044414,1.00000000000271,0.88843919464212,0,1,suppression of host defenses,BP,
13224,GO:0051833,1.00000000000271,0.88843919464212,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13317,GO:0052029,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13319,GO:0052037,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host defense response,BP,
13334,GO:0052167,1.00000000000271,0.88843919464212,0,1,modulation by symbiont of host innate immune response,BP,
13335,GO:0052170,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host innate immune response,BP,
13353,GO:0052261,1.00000000000271,0.88843919464212,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13354,GO:0052306,1.00000000000271,0.88843919464212,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13355,GO:0052309,1.00000000000271,0.88843919464212,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13377,GO:0052493,1.00000000000271,0.88843919464212,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13387,GO:0052561,1.00000000000271,0.88843919464212,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13388,GO:0052562,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host immune response,BP,
15966,GO:0075109,1.00000000000271,0.88843919464212,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15967,GO:0075111,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15968,GO:0075112,1.00000000000271,0.88843919464212,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15969,GO:0075114,1.00000000000271,0.88843919464212,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16979,GO:0098968,1.00000000000271,0.88843919464212,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
3720,GO:0008240,1.00000000000272,0.791706790647677,0,2,tripeptidyl-peptidase activity,MF,
1305,GO:0003140,1.00000000000273,0.64232332057627,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
16153,GO:0090138,1.00000000000274,0.890538344966651,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
522,GO:0001609,1.00000000000276,0.720212958668304,0,3,G-protein coupled adenosine receptor activity,MF,
1924,GO:0004615,1.00000000000276,0.817275642392599,0,2,phosphomannomutase activity,MF,
13672,GO:0060159,1.00000000000277,0.646117290039982,0,4,regulation of dopamine receptor signaling pathway,BP,
12738,GO:0050955,1.00000000000279,0.889426704388591,0,1,thermoception,BP,
12740,GO:0050960,1.00000000000279,0.889426704388591,0,1,detection of temperature stimulus involved in thermoception,BP,
12745,GO:0050968,1.00000000000279,0.889426704388591,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13871,GO:0060454,1.00000000000279,0.889426704388591,0,1,positive regulation of gastric acid secretion,BP,
16208,GO:0090212,1.00000000000279,0.889426704388591,0,1,negative regulation of establishment of blood-brain barrier,BP,
16696,GO:0097603,1.00000000000279,0.889426704388591,0,1,temperature-gated ion channel activity,MF,
17724,GO:1901594,1.00000000000279,0.889426704388591,0,1,response to capsazepine,BP,
17498,GO:1900370,1.0000000000028,0.888409381122146,0,1,positive regulation of RNA interference,BP,
14414,GO:0061656,1.0000000000028,0.916294274223532,0,1,SUMO conjugating enzyme activity,MF,
18313,GO:1903182,1.0000000000028,0.916294274223532,0,1,regulation of SUMO transferase activity,BP,
18572,GO:1903755,1.0000000000028,0.916294274223532,0,1,positive regulation of SUMO transferase activity,BP,
19532,GO:1990356,1.0000000000028,0.916294274223532,0,1,sumoylated E2 ligase complex,CC,
2479,GO:0005712,1.00000000000281,0.794254822624085,0,2,chiasma,CC,
13993,GO:0060683,1.00000000000281,0.893123130312636,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19543,GO:1990401,1.00000000000281,0.893123130312636,0,1,embryonic lung development,BP,
17785,GO:1901727,1.00000000000281,0.630546619374138,0,4,positive regulation of histone deacetylase activity,BP,
6511,GO:0021882,1.00000000000283,0.800916743432971,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6519,GO:0021893,1.00000000000283,0.800916743432971,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9375,GO:0035881,1.00000000000283,0.800916743432971,0,2,amacrine cell differentiation,BP,
14198,GO:0061074,1.00000000000283,0.800916743432971,0,2,regulation of neural retina development,BP,
14199,GO:0061075,1.00000000000283,0.800916743432971,0,2,positive regulation of neural retina development,BP,
18165,GO:1902866,1.00000000000283,0.800916743432971,0,2,regulation of retina development in camera-type eye,BP,
18166,GO:1902868,1.00000000000283,0.800916743432971,0,2,positive regulation of retina development in camera-type eye,BP,
18167,GO:1902869,1.00000000000283,0.800916743432971,0,2,regulation of amacrine cell differentiation,BP,
18168,GO:1902871,1.00000000000283,0.800916743432971,0,2,positive regulation of amacrine cell differentiation,BP,
1772,GO:0004373,1.00000000000284,0.891185070815746,0,1,glycogen (starch) synthase activity,MF,
14364,GO:0061547,1.00000000000284,0.891185070815746,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
16175,GO:0090176,1.00000000000285,0.888395597695568,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
4467,GO:0010459,1.00000000000285,0.665273676159021,0,4,negative regulation of heart rate,BP,
2316,GO:0005314,1.00000000000285,0.795419030534775,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5127,GO:0015501,1.00000000000285,0.795419030534775,0,2,glutamate:sodium symporter activity,MF,
12081,GO:0048014,1.00000000000285,0.888427848605338,0,1,Tie signaling pathway,BP,
12729,GO:0050928,1.00000000000285,0.888427848605338,0,1,negative regulation of positive chemotaxis,BP,
10005,GO:0042406,1.00000000000286,0.645801071011376,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
1551,GO:0003944,1.00000000000286,0.895506647386025,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
998,GO:0002457,1.00000000000288,0.635041210779989,0,4,T cell antigen processing and presentation,BP,
11193,GO:0045263,1.00000000000288,0.910076326187222,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
329,GO:0000917,1.00000000000289,0.899597051111397,0,1,division septum assembly,BP,
16343,GO:0090529,1.00000000000289,0.899597051111397,0,1,cell septum assembly,BP,
18114,GO:1902713,1.00000000000289,0.629478843213445,0,4,regulation of interferon-gamma secretion,BP,
1927,GO:0004618,1.00000000000289,0.894219545498714,0,1,phosphoglycerate kinase activity,MF,
14425,GO:0061689,1.0000000000029,0.712614265630712,0,3,tricellular tight junction,CC,
9289,GO:0035718,1.0000000000029,0.828039909264327,0,2,macrophage migration inhibitory factor binding,MF,
5799,GO:0017040,1.0000000000029,0.666426038127523,0,4,N-acylsphingosine amidohydrolase activity,MF,
10,GO:0000019,1.00000000000291,0.709085762564458,0,3,regulation of mitotic recombination,BP,
453,GO:0001226,1.00000000000292,0.891648911156518,0,1,RNA polymerase II transcription corepressor binding,MF,
3826,GO:0008424,1.00000000000292,0.891648911156518,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9473,GO:0036071,1.00000000000292,0.891648911156518,0,1,N-glycan fucosylation,BP,
11913,GO:0046921,1.00000000000292,0.891648911156518,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
1366,GO:0003247,1.00000000000293,0.903669301542644,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1560,GO:0003956,1.00000000000293,0.903669301542644,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2485,GO:0005724,1.00000000000293,0.903669301542644,0,1,nuclear telomeric heterochromatin,CC,
7424,GO:0031509,1.00000000000293,0.903669301542644,0,1,telomeric heterochromatin assembly,BP,
7582,GO:0031940,1.00000000000293,0.903669301542644,0,1,positive regulation of chromatin silencing at telomere,BP,
18124,GO:1902732,1.00000000000293,0.903669301542644,0,1,positive regulation of chondrocyte proliferation,BP,
19325,GO:1905547,1.00000000000293,0.903669301542644,0,1,regulation of telomeric heterochromatin assembly,BP,
19326,GO:1905549,1.00000000000293,0.903669301542644,0,1,positive regulation of telomeric heterochromatin assembly,BP,
8955,GO:0034991,1.00000000000293,0.795957687950223,0,2,nuclear meiotic cohesin complex,CC,
14950,GO:0070815,1.00000000000294,0.631105265632154,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
18086,GO:1902617,1.00000000000294,0.65540441731481,0,4,response to fluoride,BP,
7389,GO:0031436,1.00000000000295,0.793852602442517,0,2,BRCA1-BARD1 complex,CC,
2410,GO:0005579,1.00000000000295,0.888400283060691,0,1,membrane attack complex,CC,
1459,GO:0003696,1.00000000000297,0.63675486580002,0,4,satellite DNA binding,MF,
12706,GO:0050904,1.00000000000298,0.792975856552681,0,2,diapedesis,BP,
6430,GO:0021693,1.00000000000298,0.792063271891414,0,2,cerebellar Purkinje cell layer structural organization,BP,
6435,GO:0021698,1.00000000000298,0.792063271891414,0,2,cerebellar cortex structural organization,BP,
19124,GO:1904998,1.00000000000299,0.892699044024857,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
11125,GO:0045131,1.00000000000299,0.892553124450016,0,1,pre-mRNA branch point binding,MF,
10943,GO:0044565,1.00000000000299,0.810874284957644,0,2,dendritic cell proliferation,BP,
3849,GO:0008457,1.000000000003,0.889461690072499,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11991,GO:0047256,1.000000000003,0.889461690072499,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
9236,GO:0035616,1.00000000000301,0.70426492514782,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
11746,GO:0046541,1.00000000000302,0.893197881371486,0,1,saliva secretion,BP,
19382,GO:1905719,1.00000000000302,0.797330263418992,0,2,protein localization to perinuclear region of cytoplasm,BP,
8509,GO:0033680,1.00000000000302,0.794012710729268,0,2,ATP-dependent DNA/RNA helicase activity,MF,
940,GO:0002339,1.00000000000302,0.834256552843946,0,2,B cell selection,BP,
944,GO:0002352,1.00000000000302,0.834256552843946,0,2,B cell negative selection,BP,
1323,GO:0003169,1.00000000000303,0.791517496335414,0,2,coronary vein morphogenesis,BP,
14126,GO:0060948,1.00000000000303,0.791517496335414,0,2,cardiac vascular smooth muscle cell development,BP,
2949,GO:0006478,1.00000000000303,0.805564400781726,0,2,peptidyl-tyrosine sulfation,BP,
3860,GO:0008476,1.00000000000303,0.805564400781726,0,2,protein-tyrosine sulfotransferase activity,MF,
11237,GO:0045356,1.00000000000305,0.792894002959717,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
12572,GO:0050705,1.00000000000305,0.670870686914852,0,4,regulation of interleukin-1 alpha secretion,BP,
9371,GO:0035877,1.00000000000306,0.649845556794953,0,4,death effector domain binding,MF,
5920,GO:0018192,1.00000000000306,0.894104343682559,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7886,GO:0032447,1.00000000000306,0.894104343682559,0,1,protein urmylation,BP,
9949,GO:0042292,1.00000000000306,0.894104343682559,0,1,URM1 activating enzyme activity,MF,
14385,GO:0061604,1.00000000000306,0.894104343682559,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14386,GO:0061605,1.00000000000306,0.894104343682559,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16903,GO:0098822,1.00000000000306,0.894104343682559,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
9479,GO:0036090,1.00000000000306,0.805170630911944,0,2,cleavage furrow ingression,BP,
1577,GO:0003983,1.00000000000306,0.89601894320325,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13183,GO:0051748,1.00000000000306,0.89601894320325,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
20274,GO:2001185,1.00000000000308,0.643348056302746,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
14957,GO:0070827,1.00000000000308,0.626991214648143,0,4,chromatin maintenance,BP,
3074,GO:0006642,1.00000000000308,0.707297823434381,0,3,triglyceride mobilization,BP,
8992,GO:0035092,1.00000000000308,0.701656850502453,0,3,sperm chromatin condensation,BP,
13737,GO:0060282,1.00000000000308,0.714356984822169,0,3,positive regulation of oocyte development,BP,
19418,GO:1905881,1.00000000000308,0.714356984822169,0,3,positive regulation of oogenesis,BP,
10157,GO:0042723,1.0000000000031,0.724631975828375,0,3,thiamine-containing compound metabolic process,BP,
1470,GO:0003723,1.00000000000311,0,80,1484,RNA binding,MF,H1F0;XPOT;SLC16A3;CKAP4;ABTB1;AARS;CSNK1E;ADARB1;CARS;FAM50A;P4HB;MRPS6;MDH2;TMSB4X;PCSK9;ZNF598;MSN;TST;SEC63;GTPBP1;TWF2;LARP6;FSCN1;LARP1B;ZNF385A;DTD1;BAZ2A;HLTF;PCBP4;ASS1;OASL;RPUSD3;MAPKBP1;TOP1;FLNB;AGO4;RALY;ZCCHC24;RBMS2;ESRP1;NSUN7;STXBP1;OAS1;ISG20;PFN1;NELFCD;PUM1;TNRC6B;THRA;EIF2S2;HEXIM1;UBA1;SECISBP2L;SPATS2;RRBP1;MIF4GD;TPD52L2;SARS2;PRRC2A;LRP1;SAMD4B;USO1;GPATCH8;PYM1;SNTB2;BICC1;RPL28;CARHSP1;LACTB2;S100A16;PAIP2;IGF2BP3;EIF4G3;SF3B6;MANF;ANXA1;PPP1R10;APOBEC3C;ARCN1;EP300
18381,GO:1903335,1.00000000000311,0.659795783512853,0,4,regulation of vacuolar transport,BP,
3836,GO:0008440,1.00000000000311,0.634086146669859,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
129,GO:0000268,1.00000000000313,0.642161829993565,0,4,peroxisome targeting sequence binding,MF,
851,GO:0002174,1.00000000000314,0.892685150683687,0,1,mammary stem cell proliferation,BP,
12013,GO:0047395,1.00000000000314,0.892685150683687,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12035,GO:0047620,1.00000000000314,0.892685150683687,0,1,acylglycerol kinase activity,MF,
18958,GO:1904675,1.00000000000314,0.892685150683687,0,1,regulation of somatic stem cell division,BP,
18959,GO:1904677,1.00000000000314,0.892685150683687,0,1,positive regulation of somatic stem cell division,BP,
19763,GO:2000101,1.00000000000314,0.892685150683687,0,1,regulation of mammary stem cell proliferation,BP,
19764,GO:2000103,1.00000000000314,0.892685150683687,0,1,positive regulation of mammary stem cell proliferation,BP,
10772,GO:0044208,1.00000000000315,0.810630354923044,0,2,'de novo' AMP biosynthetic process,BP,
2038,GO:0004776,1.00000000000316,0.812386450040378,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
20065,GO:2000653,1.00000000000317,0.706595813680456,0,3,regulation of genetic imprinting,BP,
12042,GO:0047676,1.00000000000319,0.888444343441365,0,1,arachidonate-CoA ligase activity,MF,
6886,GO:0030377,1.00000000000319,0.908766892130465,0,1,urokinase plasminogen activator receptor activity,MF,
9750,GO:0038195,1.00000000000319,0.908766892130465,0,1,urokinase plasminogen activator signaling pathway,BP,
1053,GO:0002578,1.00000000000321,0.654081836029139,0,4,negative regulation of antigen processing and presentation,BP,
14444,GO:0061736,1.00000000000321,0.888394501529922,0,1,engulfment of target by autophagosome,BP,
14455,GO:0061753,1.00000000000321,0.888394501529922,0,1,substrate localization to autophagosome,BP,
14197,GO:0061073,1.00000000000321,0.793589182804578,0,2,ciliary body morphogenesis,BP,
14084,GO:0060842,1.00000000000322,0.708524316414906,0,3,arterial endothelial cell differentiation,BP,
16729,GO:0097694,1.00000000000322,0.70452725249697,0,3,establishment of RNA localization to telomere,BP,
16730,GO:0097695,1.00000000000322,0.70452725249697,0,3,establishment of protein-containing complex localization to telomere,BP,
2053,GO:0004799,1.00000000000326,0.904912552534274,0,1,thymidylate synthase activity,MF,
6032,GO:0019088,1.00000000000326,0.904912552534274,0,1,immortalization of host cell by virus,BP,
6332,GO:0020021,1.00000000000326,0.904912552534274,0,1,immortalization of host cell,BP,
9850,GO:0042083,1.00000000000326,0.904912552534274,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
15362,GO:0071568,1.00000000000327,0.820569386724431,0,2,UFM1 transferase activity,MF,
1869,GO:0004530,1.00000000000327,0.792627695157044,0,2,deoxyribonuclease I activity,MF,
919,GO:0002309,1.00000000000327,0.930646171687963,0,1,T cell proliferation involved in immune response,BP,
5587,GO:0016602,1.00000000000328,0.652472870782317,0,4,CCAAT-binding factor complex,CC,
15048,GO:0070973,1.00000000000328,0.635398851327899,0,4,protein localization to endoplasmic reticulum exit site,BP,
19594,GO:1990573,1.00000000000328,0.714652705018403,0,3,potassium ion import across plasma membrane,BP,
10401,GO:0043221,1.00000000000329,0.890019023125579,0,1,SMC family protein binding,MF,
3803,GO:0008380,1.0000000000033,0,6,392,RNA splicing,BP,SYMPK;MAPKBP1;RALY;ESRP1;TRPT1;SF3B6
19096,GO:1904947,1.0000000000033,0.892433153873524,0,1,folic acid import into mitochondrion,BP,
15073,GO:0071008,1.00000000000331,0.651817939536657,0,4,U2-type post-mRNA release spliceosomal complex,CC,
470,GO:0001512,1.00000000000332,0.918414127059798,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
10476,GO:0043328,1.00000000000332,0.691544649058765,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
18855,GO:1904408,1.00000000000332,0.918414127059798,0,1,melatonin binding,MF,
19344,GO:1905594,1.00000000000332,0.918414127059798,0,1,resveratrol binding,MF,
15511,GO:0071865,1.00000000000333,0.652712276511038,0,4,regulation of apoptotic process in bone marrow,BP,
15512,GO:0071866,1.00000000000333,0.652712276511038,0,4,negative regulation of apoptotic process in bone marrow,BP,
8945,GO:0034970,1.00000000000334,0.797485063889222,0,2,histone H3-R2 methylation,BP,
16228,GO:0090245,1.00000000000335,0.626904854699475,0,4,axis elongation involved in somitogenesis,BP,
16628,GO:0097444,1.00000000000338,0.888458980935977,0,1,spine apparatus,CC,
19257,GO:1905355,1.00000000000338,0.888458980935977,0,1,spine apparatus assembly,BP,
17846,GO:1901979,1.00000000000338,0.79367116569121,0,2,regulation of inward rectifier potassium channel activity,BP,
440,GO:0001181,1.00000000000339,0.80497849061489,0,2,transcription factor activity, core RNA polymerase I binding,MF,
1012,GO:0002488,1.0000000000034,0.889645340310836,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1013,GO:0002489,1.0000000000034,0.889645340310836,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8811,GO:0034506,1.0000000000034,0.889645340310836,0,1,chromosome, centromeric core domain,CC,
11940,GO:0046968,1.0000000000034,0.889645340310836,0,1,peptide antigen transport,BP,
11950,GO:0046980,1.0000000000034,0.889645340310836,0,1,tapasin binding,MF,
15779,GO:0072356,1.0000000000034,0.889645340310836,0,1,chromosome passenger complex localization to kinetochore,BP,
13067,GO:0051538,1.00000000000342,0.730596970497268,0,3,3 iron, 4 sulfur cluster binding,MF,
121,GO:0000250,1.00000000000342,0.889216566141779,0,1,lanosterol synthase activity,MF,
7444,GO:0031559,1.00000000000342,0.889216566141779,0,1,oxidosqualene cyclase activity,MF,
4708,GO:0010868,1.00000000000343,0.79122446733972,0,2,negative regulation of triglyceride biosynthetic process,BP,
19661,GO:1990796,1.00000000000346,0.892660066340107,0,1,photoreceptor cell terminal bouton,CC,
2160,GO:0004984,1.00000000000346,0.765694764833135,0,3,olfactory receptor activity,MF,
12713,GO:0050911,1.00000000000346,0.765694764833135,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
4888,GO:0014806,1.00000000000346,0.809814019244278,0,2,smooth muscle hyperplasia,BP,
13670,GO:0060157,1.00000000000348,0.789547082276913,0,2,urinary bladder development,BP,
14711,GO:0070318,1.00000000000348,0.645810530239435,0,4,positive regulation of G0 to G1 transition,BP,
12046,GO:0047708,1.00000000000348,0.896794341887192,0,1,biotinidase activity,MF,
13813,GO:0060380,1.00000000000348,0.896794341887192,0,1,regulation of single-stranded telomeric DNA binding,BP,
13814,GO:0060381,1.00000000000348,0.896794341887192,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
5975,GO:0018423,1.00000000000348,0.81527921080359,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
12532,GO:0050656,1.00000000000349,0.632791811386753,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
19516,GO:1990254,1.00000000000349,0.640262118085941,0,4,keratin filament binding,MF,
1726,GO:0004315,1.0000000000035,0.811777447274923,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
2631,GO:0005956,1.00000000000351,0.820712500811205,0,2,protein kinase CK2 complex,CC,
13632,GO:0060083,1.00000000000351,0.790152958340894,0,2,smooth muscle contraction involved in micturition,BP,
8089,GO:0032764,1.00000000000353,0.806972972023592,0,2,negative regulation of mast cell cytokine production,BP,
1957,GO:0004658,1.00000000000355,0.804631802399896,0,2,propionyl-CoA carboxylase activity,MF,
19889,GO:2000328,1.00000000000356,0.738479011216644,0,3,regulation of T-helper 17 cell lineage commitment,BP,
17751,GO:1901656,1.00000000000356,0.793751221302801,0,2,glycoside transport,BP,
14554,GO:0070052,1.00000000000356,0.792451692006465,0,2,collagen V binding,MF,
1547,GO:0003939,1.00000000000358,0.8938203397287,0,1,L-iditol 2-dehydrogenase activity,MF,
2698,GO:0006062,1.00000000000358,0.8938203397287,0,1,sorbitol catabolic process,BP,
6142,GO:0019407,1.00000000000358,0.8938203397287,0,1,hexitol catabolic process,BP,
6168,GO:0019519,1.00000000000358,0.8938203397287,0,1,pentitol metabolic process,BP,
6171,GO:0019527,1.00000000000358,0.8938203397287,0,1,pentitol catabolic process,BP,
7318,GO:0031320,1.00000000000358,0.8938203397287,0,1,hexitol dehydrogenase activity,MF,
11737,GO:0046526,1.00000000000358,0.8938203397287,0,1,D-xylulose reductase activity,MF,
12866,GO:0051160,1.00000000000358,0.8938203397287,0,1,L-xylitol catabolic process,BP,
12867,GO:0051164,1.00000000000358,0.8938203397287,0,1,L-xylitol metabolic process,BP,
16090,GO:0090031,1.00000000000358,0.795491403422661,0,2,positive regulation of steroid hormone biosynthetic process,BP,
2910,GO:0006421,1.00000000000359,0.712345008870904,0,3,asparaginyl-tRNA aminoacylation,BP,
6969,GO:0030618,1.0000000000036,0.625817547150238,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
10958,GO:0044614,1.0000000000036,0.628978682151841,0,4,nuclear pore cytoplasmic filaments,CC,
18015,GO:1902423,1.00000000000365,0.79596368024013,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18016,GO:1902425,1.00000000000365,0.79596368024013,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
15993,GO:0080121,1.00000000000365,0.798519178088101,0,2,AMP transport,BP,
14959,GO:0070829,1.00000000000366,0.789494232094532,0,2,heterochromatin maintenance,BP,
4557,GO:0010636,1.00000000000366,0.793929640469092,0,2,positive regulation of mitochondrial fusion,BP,
18244,GO:1903012,1.00000000000366,0.635158184834662,0,4,positive regulation of bone development,BP,
1537,GO:0003919,1.00000000000367,0.897835650416225,0,1,FMN adenylyltransferase activity,MF,
3149,GO:0006747,1.00000000000367,0.897835650416225,0,1,FAD biosynthetic process,BP,
11684,GO:0046443,1.00000000000367,0.897835650416225,0,1,FAD metabolic process,BP,
15801,GO:0072388,1.00000000000367,0.897835650416225,0,1,flavin adenine dinucleotide biosynthetic process,BP,
212,GO:0000444,1.00000000000371,0.654471797728229,0,4,MIS12/MIND type complex,CC,
3981,GO:0008803,1.00000000000371,0.924185182823612,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
14988,GO:0070876,1.00000000000371,0.632525226624113,0,4,SOSS complex,CC,
6683,GO:0030043,1.00000000000371,0.657456598749345,0,4,actin filament fragmentation,BP,
19821,GO:2000211,1.00000000000371,0.888491008802528,0,1,regulation of glutamate metabolic process,BP,
19822,GO:2000212,1.00000000000371,0.888491008802528,0,1,negative regulation of glutamate metabolic process,BP,
6090,GO:0019249,1.00000000000372,0.734748130343665,0,3,lactate biosynthetic process,BP,
12153,GO:0048237,1.00000000000373,0.811462022921374,0,2,rough endoplasmic reticulum lumen,CC,
1981,GO:0004694,1.00000000000373,0.626905786954186,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
13623,GO:0060073,1.00000000000373,0.628716716356507,0,4,micturition,BP,
13264,GO:0051918,1.00000000000375,0.634945092800977,0,4,negative regulation of fibrinolysis,BP,
2052,GO:0004798,1.00000000000375,0.819845332838904,0,2,thymidylate kinase activity,MF,
2790,GO:0006227,1.00000000000375,0.819845332838904,0,2,dUDP biosynthetic process,BP,
2793,GO:0006233,1.00000000000375,0.819845332838904,0,2,dTDP biosynthetic process,BP,
4086,GO:0009139,1.00000000000375,0.819845332838904,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4137,GO:0009196,1.00000000000375,0.819845332838904,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4138,GO:0009197,1.00000000000375,0.819845332838904,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11557,GO:0046072,1.00000000000375,0.819845332838904,0,2,dTDP metabolic process,BP,
11560,GO:0046077,1.00000000000375,0.819845332838904,0,2,dUDP metabolic process,BP,
19512,GO:1990239,1.00000000000375,0.646373358193893,0,4,steroid hormone binding,MF,
11479,GO:0045919,1.00000000000376,0.667317362059641,0,4,positive regulation of cytolysis,BP,
16607,GO:0097396,1.00000000000377,0.633806428207566,0,4,response to interleukin-17,BP,
16608,GO:0097398,1.00000000000377,0.633806428207566,0,4,cellular response to interleukin-17,BP,
16609,GO:0097400,1.00000000000377,0.633806428207566,0,4,interleukin-17-mediated signaling pathway,BP,
2080,GO:0004831,1.00000000000378,0.799252696090212,0,2,tyrosine-tRNA ligase activity,MF,
2926,GO:0006437,1.00000000000378,0.799252696090212,0,2,tyrosyl-tRNA aminoacylation,BP,
15063,GO:0070991,1.00000000000378,0.711301530617815,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15340,GO:0071540,1.00000000000379,0.888418446838803,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15101,GO:0071062,1.00000000000379,0.889193490098872,0,1,alphav-beta3 integrin-vitronectin complex,CC,
18569,GO:1903750,1.00000000000383,0.659476274481826,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18570,GO:1903751,1.00000000000383,0.659476274481826,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
1749,GO:0004346,1.00000000000383,0.903691962689661,0,1,glucose-6-phosphatase activity,MF,
12484,GO:0050309,1.00000000000383,0.903691962689661,0,1,sugar-terminal-phosphatase activity,MF,
18495,GO:1903567,1.00000000000383,0.797263743431883,0,2,regulation of protein localization to ciliary membrane,BP,
15249,GO:0071387,1.00000000000386,0.888441304586275,0,1,cellular response to cortisol stimulus,BP,
15364,GO:0071573,1.00000000000386,0.892689321897163,0,1,shelterin complex assembly,BP,
19020,GO:1904790,1.00000000000386,0.892689321897163,0,1,regulation of shelterin complex assembly,BP,
19021,GO:1904792,1.00000000000386,0.892689321897163,0,1,positive regulation of shelterin complex assembly,BP,
19050,GO:1904850,1.00000000000386,0.892689321897163,0,1,negative regulation of establishment of protein localization to telomere,BP,
19084,GO:1904910,1.00000000000386,0.892689321897163,0,1,regulation of establishment of RNA localization to telomere,BP,
19085,GO:1904911,1.00000000000386,0.892689321897163,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19086,GO:1904913,1.00000000000386,0.892689321897163,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19087,GO:1904914,1.00000000000386,0.892689321897163,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
1775,GO:0004377,1.00000000000388,0.893799629205164,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13991,GO:0060678,1.00000000000388,0.895117429758181,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15647,GO:0072127,1.00000000000388,0.895117429758181,0,1,renal capsule development,BP,
15648,GO:0072128,1.00000000000388,0.895117429758181,0,1,renal capsule morphogenesis,BP,
15649,GO:0072129,1.00000000000388,0.895117429758181,0,1,renal capsule formation,BP,
15650,GO:0072130,1.00000000000388,0.895117429758181,0,1,renal capsule specification,BP,
15704,GO:0072213,1.00000000000388,0.895117429758181,0,1,metanephric capsule development,BP,
15729,GO:0072265,1.00000000000388,0.895117429758181,0,1,metanephric capsule morphogenesis,BP,
15730,GO:0072266,1.00000000000388,0.895117429758181,0,1,metanephric capsule formation,BP,
15731,GO:0072267,1.00000000000388,0.895117429758181,0,1,metanephric capsule specification,BP,
11742,GO:0046534,1.00000000000388,0.8889298655222,0,1,positive regulation of photoreceptor cell differentiation,BP,
1416,GO:0003350,1.00000000000388,0.795418796026901,0,2,pulmonary myocardium development,BP,
10758,GO:0044128,1.00000000000389,0.888472996425088,0,1,positive regulation of growth of symbiont in host,BP,
10764,GO:0044148,1.00000000000389,0.888472996425088,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
4326,GO:0009822,1.00000000000391,0.902038719053231,0,1,alkaloid catabolic process,BP,
1716,GO:0004305,1.00000000000392,0.641783961375565,0,4,ethanolamine kinase activity,MF,
4215,GO:0009372,1.00000000000393,0.891675937075868,0,1,quorum sensing,BP,
9590,GO:0036398,1.00000000000393,0.891675937075868,0,1,TCR signalosome,CC,
9591,GO:0036399,1.00000000000393,0.891675937075868,0,1,TCR signalosome assembly,BP,
12441,GO:0048874,1.00000000000393,0.891675937075868,0,1,homeostasis of number of cells in a free-living population,BP,
13328,GO:0052097,1.00000000000393,0.891675937075868,0,1,interspecies quorum sensing,BP,
13329,GO:0052106,1.00000000000393,0.891675937075868,0,1,quorum sensing involved in interaction with host,BP,
14029,GO:0060730,1.00000000000393,0.891675937075868,0,1,regulation of intestinal epithelial structure maintenance,BP,
14030,GO:0060731,1.00000000000393,0.891675937075868,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14918,GO:0070715,1.00000000000393,0.891675937075868,0,1,sodium-dependent organic cation transport,BP,
248,GO:0000706,1.00000000000393,0.793515388588607,0,2,meiotic DNA double-strand break processing,BP,
19695,GO:1990918,1.00000000000393,0.793515388588607,0,2,double-strand break repair involved in meiotic recombination,BP,
19699,GO:1990928,1.00000000000393,0.790633444461288,0,2,response to amino acid starvation,BP,
5373,GO:0016175,1.00000000000394,0.838156892357435,0,2,superoxide-generating NADPH oxidase activity,MF,
10285,GO:0043020,1.00000000000394,0.838156892357435,0,2,NADPH oxidase complex,CC,
14272,GO:0061302,1.00000000000396,0.709680864861025,0,3,smooth muscle cell-matrix adhesion,BP,
1383,GO:0003278,1.00000000000398,0.708559870341415,0,3,apoptotic process involved in heart morphogenesis,BP,
16843,GO:0098705,1.00000000000401,0.888633296899698,0,1,copper ion import across plasma membrane,BP,
14240,GO:0061156,1.00000000000402,0.71116627121914,0,3,pulmonary artery morphogenesis,BP,
19947,GO:2000409,1.00000000000403,0.899581067717974,0,1,positive regulation of T cell extravasation,BP,
19965,GO:2000451,1.00000000000403,0.899581067717974,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19967,GO:2000454,1.00000000000403,0.899581067717974,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
18155,GO:1902824,1.00000000000403,0.828125982187818,0,2,positive regulation of late endosome to lysosome transport,BP,
18383,GO:1903337,1.00000000000403,0.828125982187818,0,2,positive regulation of vacuolar transport,BP,
840,GO:0002143,1.00000000000404,0.6492764437855,0,4,tRNA wobble position uridine thiolation,BP,
705,GO:0001922,1.00000000000404,0.702617831186683,0,3,B-1 B cell homeostasis,BP,
19696,GO:1990923,1.00000000000405,0.794566263759871,0,2,PET complex,CC,
8555,GO:0033883,1.00000000000407,0.824865223977295,0,2,pyridoxal phosphatase activity,MF,
9028,GO:0035226,1.00000000000408,0.89228532025958,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9029,GO:0035227,1.00000000000408,0.89228532025958,0,1,regulation of glutamate-cysteine ligase activity,BP,
9030,GO:0035229,1.00000000000408,0.89228532025958,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
14906,GO:0070682,1.00000000000408,0.723176724465636,0,3,proteasome regulatory particle assembly,BP,
12472,GO:0050211,1.00000000000408,0.796846257733941,0,2,procollagen galactosyltransferase activity,MF,
10666,GO:0043734,1.00000000000408,0.665967203186968,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
1371,GO:0003253,1.00000000000409,0.637345487806701,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
154,GO:0000309,1.0000000000041,0.790876801569563,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
6114,GO:0019355,1.0000000000041,0.790876801569563,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
8846,GO:0034627,1.0000000000041,0.790876801569563,0,2,'de novo' NAD biosynthetic process,BP,
8847,GO:0034628,1.0000000000041,0.790876801569563,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
17688,GO:1901509,1.0000000000041,0.792960067564547,0,2,regulation of endothelial tube morphogenesis,BP,
19193,GO:1905203,1.0000000000041,0.810238624957187,0,2,regulation of connective tissue replacement,BP,
13422,GO:0052735,1.0000000000041,0.711220523331462,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
7455,GO:0031585,1.00000000000411,0.624028730985942,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
18585,GO:1903775,1.00000000000411,0.798787135639477,0,2,regulation of DNA double-strand break processing,BP,
4005,GO:0008948,1.00000000000411,0.640287303965484,0,4,oxaloacetate decarboxylase activity,MF,
19859,GO:2000286,1.00000000000411,0.7107903954854,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
15478,GO:0071798,1.00000000000413,0.805981979397242,0,2,response to prostaglandin D,BP,
15479,GO:0071799,1.00000000000413,0.805981979397242,0,2,cellular response to prostaglandin D stimulus,BP,
16760,GO:0098502,1.00000000000413,0.74784579496274,0,3,DNA dephosphorylation,BP,
20117,GO:2000739,1.00000000000414,0.625712857892372,0,4,regulation of mesenchymal stem cell differentiation,BP,
388,GO:0001032,1.00000000000415,0.638263217936163,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
1039,GO:0002545,1.00000000000416,0.899084963292774,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1214,GO:0002880,1.00000000000416,0.899084963292774,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002882,1.00000000000416,0.899084963292774,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1538,GO:0003920,1.00000000000416,0.899084963292774,0,1,GMP reductase activity,MF,
5292,GO:0015950,1.00000000000416,0.899084963292774,0,1,purine nucleotide interconversion,BP,
5293,GO:0015951,1.00000000000416,0.899084963292774,0,1,purine ribonucleotide interconversion,BP,
5615,GO:0016657,1.00000000000416,0.899084963292774,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18062,GO:1902560,1.00000000000416,0.899084963292774,0,1,GMP reductase complex,CC,
7392,GO:0031439,1.00000000000416,0.794967714670723,0,2,positive regulation of mRNA cleavage,BP,
1943,GO:0004642,1.00000000000417,0.888407567135103,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17267,GO:0120012,1.00000000000417,0.888407567135103,0,1,intermembrane sphingolipid transfer,BP,
17269,GO:0120016,1.00000000000417,0.888407567135103,0,1,intermembrane sphingolipid transfer activity,MF,
17270,GO:0120017,1.00000000000417,0.888407567135103,0,1,intermembrane ceramide transfer activity,MF,
2937,GO:0006463,1.00000000000417,0.890333668282122,0,1,steroid hormone receptor complex assembly,BP,
16399,GO:0090724,1.00000000000418,0.636163171772618,0,4,central region of growth cone,CC,
7078,GO:0030860,1.00000000000419,0.794161778250743,0,2,regulation of polarized epithelial cell differentiation,BP,
11617,GO:0046208,1.00000000000419,0.743785406430413,0,3,spermine catabolic process,BP,
3262,GO:0006933,1.00000000000423,0.806482694513972,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
16400,GO:0090725,1.00000000000424,0.826162516322205,0,2,peripheral region of growth cone,CC,
5044,GO:0015222,1.00000000000424,0.798834737101316,0,2,serotonin transmembrane transporter activity,MF,
8585,GO:0034057,1.00000000000425,0.795193751317242,0,2,RNA strand-exchange activity,MF,
384,GO:0001025,1.00000000000426,0.701136991888024,0,3,RNA polymerase III transcription factor binding,MF,
430,GO:0001156,1.00000000000426,0.701136991888024,0,3,TFIIIC-class transcription factor binding,MF,
2415,GO:0005588,1.00000000000426,0.701136991888024,0,3,collagen type V trimer,CC,
2780,GO:0006211,1.00000000000426,0.701136991888024,0,3,5-methylcytosine catabolic process,BP,
5203,GO:0015798,1.00000000000426,0.701136991888024,0,3,myo-inositol transport,BP,
6267,GO:0019857,1.00000000000426,0.701136991888024,0,3,5-methylcytosine metabolic process,BP,
6670,GO:0030023,1.00000000000426,0.701136991888024,0,3,extracellular matrix constituent conferring elasticity,MF,
9364,GO:0035867,1.00000000000426,0.701136991888024,0,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
14141,GO:0060979,1.00000000000426,0.701136991888024,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
16667,GO:0097513,1.00000000000426,0.701136991888024,0,3,myosin II filament,CC,
13831,GO:0060400,1.00000000000427,0.888742498993632,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
424,GO:0001129,1.00000000000427,0.71064325057216,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,1.00000000000427,0.71064325057216,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
15519,GO:0071873,1.00000000000427,0.89109328986031,0,1,response to norepinephrine,BP,
15520,GO:0071874,1.00000000000427,0.89109328986031,0,1,cellular response to norepinephrine stimulus,BP,
1347,GO:0003207,1.00000000000427,0.632908296631671,0,4,cardiac chamber formation,BP,
1350,GO:0003211,1.00000000000427,0.632908296631671,0,4,cardiac ventricle formation,BP,
15196,GO:0071314,1.00000000000427,0.893050854772589,0,1,cellular response to cocaine,BP,
17993,GO:1902362,1.00000000000427,0.893050854772589,0,1,melanocyte apoptotic process,BP,
19203,GO:1905222,1.00000000000427,0.892107459944788,0,1,atrioventricular canal morphogenesis,BP,
5149,GO:0015679,1.00000000000429,0.789448044349053,0,2,plasma membrane copper ion transport,BP,
17367,GO:1900028,1.00000000000431,0.643738111275229,0,4,negative regulation of ruffle assembly,BP,
8448,GO:0033560,1.00000000000431,0.889893041520296,0,1,folate reductase activity,MF,
13234,GO:0051870,1.00000000000431,0.889893041520296,0,1,methotrexate binding,MF,
18717,GO:1904044,1.00000000000431,0.746365257969588,0,3,response to aldosterone,BP,
665,GO:0001866,1.00000000000431,0.679399935752049,0,4,NK T cell proliferation,BP,
5500,GO:0016435,1.00000000000432,0.670781322008454,0,4,rRNA (guanine) methyltransferase activity,MF,
13891,GO:0060488,1.00000000000433,0.789253703387072,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13892,GO:0060489,1.00000000000433,0.789253703387072,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13893,GO:0060490,1.00000000000433,0.789253703387072,0,2,lateral sprouting involved in lung morphogenesis,BP,
14291,GO:0061341,1.00000000000433,0.789253703387072,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14293,GO:0061346,1.00000000000433,0.789253703387072,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
17960,GO:1902263,1.00000000000434,0.735286639483673,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
14286,GO:0061325,1.00000000000435,0.718689966163203,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
13078,GO:0051552,1.00000000000435,0.894556349361896,0,1,flavone metabolic process,BP,
15053,GO:0070980,1.00000000000435,0.894556349361896,0,1,biphenyl catabolic process,BP,
4385,GO:0010034,1.00000000000435,0.890908597196922,0,1,response to acetate,BP,
11953,GO:0046984,1.00000000000435,0.646038053969299,0,4,regulation of hemoglobin biosynthetic process,BP,
16243,GO:0090271,1.00000000000435,0.789676001451667,0,2,positive regulation of fibroblast growth factor production,BP,
16537,GO:0097227,1.00000000000435,0.631546466184591,0,4,sperm annulus,CC,
3993,GO:0008889,1.00000000000436,0.707360805443216,0,3,glycerophosphodiester phosphodiesterase activity,MF,
169,GO:0000350,1.00000000000437,0.728430458109235,0,3,generation of catalytic spliceosome for second transesterification step,BP,
11114,GO:0045112,1.00000000000437,0.7435146452171,0,3,integrin biosynthetic process,BP,
3971,GO:0008768,1.00000000000437,0.929216028971039,0,1,UDP-sugar diphosphatase activity,MF,
14552,GO:0070050,1.00000000000438,0.635634636989444,0,4,neuron cellular homeostasis,BP,
1917,GO:0004607,1.00000000000438,0.911255447127127,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
15937,GO:0072702,1.0000000000044,0.888395353978085,0,1,response to methyl methanesulfonate,BP,
15938,GO:0072703,1.0000000000044,0.888395353978085,0,1,cellular response to methyl methanesulfonate,BP,
6896,GO:0030423,1.0000000000044,0.64653574929257,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
8714,GO:0034346,1.00000000000441,0.892392791318445,0,1,positive regulation of type III interferon production,BP,
17659,GO:1901355,1.00000000000442,0.795902992883351,0,2,response to rapamycin,BP,
17280,GO:0120043,1.00000000000444,0.888655062730875,0,1,stereocilium shaft,CC,
17281,GO:0120044,1.00000000000444,0.888655062730875,0,1,stereocilium base,CC,
3537,GO:0007538,1.00000000000444,0.790564489555136,0,2,primary sex determination,BP,
3538,GO:0007542,1.00000000000444,0.790564489555136,0,2,primary sex determination, germ-line,BP,
5995,GO:0018992,1.00000000000444,0.790564489555136,0,2,germ-line sex determination,BP,
6035,GO:0019100,1.00000000000444,0.790564489555136,0,2,male germ-line sex determination,BP,
6223,GO:0019755,1.00000000000446,0.645055582568513,0,4,one-carbon compound transport,BP,
16976,GO:0098957,1.00000000000447,0.633851365671207,0,4,anterograde axonal transport of mitochondrion,BP,
11062,GO:0045031,1.00000000000447,0.801066225537013,0,2,ATP-activated adenosine receptor activity,MF,
238,GO:0000495,1.00000000000447,0.893656967207175,0,1,box H/ACA snoRNA 3'-end processing,BP,
2738,GO:0006117,1.00000000000447,0.893656967207175,0,1,acetaldehyde metabolic process,BP,
8564,GO:0033979,1.00000000000447,0.893656967207175,0,1,box H/ACA snoRNA metabolic process,BP,
8942,GO:0034964,1.00000000000447,0.893656967207175,0,1,box H/ACA snoRNA processing,BP,
9178,GO:0035525,1.00000000000447,0.893656967207175,0,1,NF-kappaB p50/p65 complex,CC,
15087,GO:0071031,1.00000000000448,0.822422136399658,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15099,GO:0071049,1.00000000000448,0.822422136399658,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
13026,GO:0051433,1.00000000000448,0.888833695114833,0,1,BH2 domain binding,MF,
3960,GO:0008709,1.0000000000045,0.925674902887763,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6828,GO:0030283,1.0000000000045,0.925674902887763,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11959,GO:0047015,1.0000000000045,0.925674902887763,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
4927,GO:0014876,1.00000000000451,0.910464850494154,0,1,response to injury involved in regulation of muscle adaptation,BP,
6572,GO:0022028,1.00000000000451,0.623985984194699,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
3983,GO:0008817,1.00000000000452,0.889422036141756,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
15447,GO:0071701,1.00000000000453,0.888582449146265,0,1,regulation of MAPK export from nucleus,BP,
16546,GO:0097241,1.00000000000454,0.799978889814357,0,2,hematopoietic stem cell migration to bone marrow,BP,
15122,GO:0071149,1.00000000000454,0.795868575633727,0,2,TEAD-2-YAP complex,CC,
17874,GO:1902037,1.00000000000455,0.712505404435881,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
18697,GO:1904016,1.00000000000456,0.628216430024485,0,4,response to Thyroglobulin triiodothyronine,BP,
11110,GO:0045105,1.00000000000456,0.890772811220595,0,1,intermediate filament polymerization or depolymerization,BP,
18664,GO:1903937,1.00000000000456,0.890772811220595,0,1,response to acrylamide,BP,
8905,GO:0034718,1.00000000000458,0.88840562762179,0,1,SMN-Gemin2 complex,CC,
10069,GO:0042543,1.00000000000459,0.94333269291473,0,1,protein N-linked glycosylation via arginine,BP,
7217,GO:0031104,1.0000000000046,0.889515144732207,0,1,dendrite regeneration,BP,
8764,GO:0034421,1.00000000000462,0.709195890298738,0,3,post-translational protein acetylation,BP,
8587,GO:0034059,1.00000000000462,0.706604206972681,0,3,response to anoxia,BP,
6396,GO:0021592,1.00000000000464,0.888425078261377,0,1,fourth ventricle development,BP,
6560,GO:0021993,1.00000000000464,0.888425078261377,0,1,initiation of neural tube closure,BP,
11018,GO:0044828,1.00000000000464,0.630975392768127,0,4,negative regulation by host of viral genome replication,BP,
18049,GO:1902527,1.00000000000464,0.684119653325732,0,4,positive regulation of protein monoubiquitination,BP,
338,GO:0000938,1.00000000000465,0.629862020586998,0,4,GARP complex,CC,
1241,GO:0002930,1.00000000000465,0.888454802957631,0,1,trabecular meshwork development,BP,
10510,GO:0043402,1.00000000000465,0.70461530348566,0,3,glucocorticoid mediated signaling pathway,BP,
19571,GO:1990452,1.00000000000465,0.794039778112153,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
222,GO:0000461,1.00000000000466,0.873654578287916,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
15541,GO:0071907,1.00000000000467,0.721776733289964,0,3,determination of digestive tract left/right asymmetry,BP,
14478,GO:0061821,1.00000000000468,0.625158116263198,0,4,telomeric D-loop binding,MF,
14751,GO:0070404,1.00000000000469,0.746951451784053,0,3,NADH binding,MF,
9169,GO:0035516,1.0000000000047,0.889159309868429,0,1,oxidative DNA demethylase activity,MF,
14726,GO:0070343,1.0000000000047,0.889159309868429,0,1,white fat cell proliferation,BP,
14730,GO:0070350,1.0000000000047,0.889159309868429,0,1,regulation of white fat cell proliferation,BP,
19701,GO:1990931,1.0000000000047,0.889159309868429,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
3907,GO:0008545,1.0000000000047,0.793614648922597,0,2,JUN kinase kinase activity,MF,
8652,GO:0034186,1.0000000000047,0.647085583399099,0,4,apolipoprotein A-I binding,MF,
2778,GO:0006208,1.00000000000471,0.799059988281348,0,2,pyrimidine nucleobase catabolic process,BP,
2779,GO:0006210,1.00000000000471,0.799059988281348,0,2,thymine catabolic process,BP,
6269,GO:0019859,1.00000000000471,0.799059988281348,0,2,thymine metabolic process,BP,
15175,GO:0071275,1.00000000000471,0.895966890323633,0,1,cellular response to aluminum ion,BP,
19371,GO:1905672,1.00000000000471,0.895966890323633,0,1,negative regulation of lysosome organization,BP,
8789,GO:0034462,1.00000000000472,0.895198028981766,0,1,small-subunit processome assembly,BP,
8257,GO:0033026,1.00000000000472,0.888408885743038,0,1,negative regulation of mast cell apoptotic process,BP,
13149,GO:0051684,1.00000000000472,0.704667754316014,0,3,maintenance of Golgi location,BP,
17041,GO:0099170,1.00000000000472,0.708659277038608,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17084,GO:0099547,1.00000000000472,0.708659277038608,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17097,GO:0099578,1.00000000000472,0.708659277038608,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
8466,GO:0033597,1.00000000000473,0.895936852904234,0,1,mitotic checkpoint complex,CC,
19527,GO:1990298,1.00000000000473,0.895936852904234,0,1,bub1-bub3 complex,CC,
2842,GO:0006311,1.00000000000473,0.892049671065056,0,1,meiotic gene conversion,BP,
5391,GO:0016213,1.00000000000473,0.892049671065056,0,1,linoleoyl-CoA desaturase activity,MF,
11124,GO:0045128,1.00000000000473,0.892049671065056,0,1,negative regulation of reciprocal meiotic recombination,BP,
17258,GO:0110029,1.00000000000473,0.892049671065056,0,1,negative regulation of meiosis I,BP,
12004,GO:0047325,1.00000000000474,0.891750973724617,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13420,GO:0052725,1.00000000000474,0.891750973724617,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13421,GO:0052726,1.00000000000474,0.891750973724617,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13443,GO:0052825,1.00000000000474,0.891750973724617,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13448,GO:0052830,1.00000000000474,0.891750973724617,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13449,GO:0052831,1.00000000000474,0.891750973724617,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13453,GO:0052835,1.00000000000474,0.891750973724617,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14486,GO:0061845,1.00000000000474,0.891750973724617,0,1,neuron projection branch point,CC,
14487,GO:0061846,1.00000000000474,0.891750973724617,0,1,dendritic spine cytoplasm,CC,
4975,GO:0015086,1.00000000000475,0.889361729554604,0,1,cadmium ion transmembrane transporter activity,MF,
4976,GO:0015087,1.00000000000475,0.889361729554604,0,1,cobalt ion transmembrane transporter activity,MF,
4979,GO:0015094,1.00000000000475,0.889361729554604,0,1,lead ion transmembrane transporter activity,MF,
5156,GO:0015692,1.00000000000475,0.889361729554604,0,1,lead ion transport,BP,
14872,GO:0070627,1.00000000000475,0.889361729554604,0,1,ferrous iron import,BP,
14956,GO:0070826,1.00000000000475,0.889361729554604,0,1,paraferritin complex,CC,
17644,GO:1901317,1.00000000000475,0.680786558043239,0,4,regulation of flagellated sperm motility,BP,
12398,GO:0048788,1.00000000000475,0.622873591102,0,4,cytoskeleton of presynaptic active zone,CC,
17094,GO:0099569,1.00000000000475,0.622873591102,0,4,presynaptic cytoskeleton,CC,
2165,GO:0004996,1.00000000000476,0.89000668192439,0,1,thyroid-stimulating hormone receptor activity,MF,
9749,GO:0038194,1.00000000000476,0.89000668192439,0,1,thyroid-stimulating hormone signaling pathway,BP,
9754,GO:0039003,1.00000000000476,0.89000668192439,0,1,pronephric field specification,BP,
9757,GO:0039017,1.00000000000476,0.89000668192439,0,1,pattern specification involved in pronephros development,BP,
10160,GO:0042728,1.00000000000476,0.89000668192439,0,1,flavin-containing compound catabolic process,BP,
14782,GO:0070460,1.00000000000476,0.89000668192439,0,1,thyroid-stimulating hormone secretion,BP,
15575,GO:0072003,1.00000000000476,0.89000668192439,0,1,kidney rudiment formation,BP,
15576,GO:0072004,1.00000000000476,0.89000668192439,0,1,kidney field specification,BP,
15588,GO:0072025,1.00000000000476,0.89000668192439,0,1,distal convoluted tubule development,BP,
15607,GO:0072069,1.00000000000476,0.89000668192439,0,1,DCT cell differentiation,BP,
15711,GO:0072221,1.00000000000476,0.89000668192439,0,1,metanephric distal convoluted tubule development,BP,
15720,GO:0072240,1.00000000000476,0.89000668192439,0,1,metanephric DCT cell differentiation,BP,
15749,GO:0072304,1.00000000000476,0.89000668192439,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15750,GO:0072305,1.00000000000476,0.89000668192439,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15753,GO:0072309,1.00000000000476,0.89000668192439,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15802,GO:0072389,1.00000000000476,0.89000668192439,0,1,flavin adenine dinucleotide catabolic process,BP,
17454,GO:1900200,1.00000000000476,0.89000668192439,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17455,GO:1900204,1.00000000000476,0.89000668192439,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17456,GO:1900205,1.00000000000476,0.89000668192439,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17459,GO:1900211,1.00000000000476,0.89000668192439,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17460,GO:1900212,1.00000000000476,0.89000668192439,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17461,GO:1900214,1.00000000000476,0.89000668192439,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17462,GO:1900215,1.00000000000476,0.89000668192439,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17463,GO:1900217,1.00000000000476,0.89000668192439,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17464,GO:1900218,1.00000000000476,0.89000668192439,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17587,GO:1901147,1.00000000000476,0.89000668192439,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18238,GO:1903004,1.00000000000476,0.89000668192439,0,1,regulation of protein K63-linked deubiquitination,BP,
18239,GO:1903006,1.00000000000476,0.89000668192439,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18240,GO:1903007,1.00000000000476,0.89000668192439,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
20029,GO:2000592,1.00000000000476,0.89000668192439,0,1,regulation of metanephric DCT cell differentiation,BP,
20030,GO:2000594,1.00000000000476,0.89000668192439,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20036,GO:2000612,1.00000000000476,0.89000668192439,0,1,regulation of thyroid-stimulating hormone secretion,BP,
2153,GO:0004969,1.00000000000478,0.793616050902282,0,2,histamine receptor activity,MF,
9354,GO:0035853,1.00000000000478,0.888903750765337,0,1,chromosome passenger complex localization to spindle midzone,BP,
14433,GO:0061711,1.00000000000479,0.810402784870277,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
852,GO:0002175,1.0000000000048,0.626321238697598,0,4,protein localization to paranode region of axon,BP,
18291,GO:1903121,1.0000000000048,0.655794944071056,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
6571,GO:0022027,1.0000000000048,0.62308258906739,0,4,interkinetic nuclear migration,BP,
6302,GO:0019912,1.00000000000481,0.801234887047628,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
14829,GO:0070545,1.00000000000481,0.636714149438922,0,4,PeBoW complex,CC,
9744,GO:0038189,1.00000000000481,0.633848139764278,0,4,neuropilin signaling pathway,BP,
9144,GO:0035469,1.00000000000482,0.888409159584956,0,1,determination of pancreatic left/right asymmetry,BP,
15542,GO:0071908,1.00000000000482,0.888409159584956,0,1,determination of intestine left/right asymmetry,BP,
15543,GO:0071909,1.00000000000482,0.888409159584956,0,1,determination of stomach left/right asymmetry,BP,
19795,GO:2000167,1.00000000000482,0.888409159584956,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
3956,GO:0008670,1.00000000000482,0.827447879725507,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
8308,GO:0033132,1.00000000000482,0.818443088687645,0,2,negative regulation of glucokinase activity,BP,
18365,GO:1903300,1.00000000000482,0.818443088687645,0,2,negative regulation of hexokinase activity,BP,
17491,GO:1900275,1.00000000000483,0.791727859162085,0,2,negative regulation of phospholipase C activity,BP,
7766,GO:0032277,1.00000000000484,0.895790224100051,0,1,negative regulation of gonadotropin secretion,BP,
10565,GO:0043509,1.00000000000484,0.895790224100051,0,1,activin A complex,CC,
10566,GO:0043511,1.00000000000484,0.895790224100051,0,1,inhibin complex,CC,
10567,GO:0043512,1.00000000000484,0.895790224100051,0,1,inhibin A complex,CC,
11091,GO:0045077,1.00000000000484,0.895790224100051,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11890,GO:0046882,1.00000000000484,0.895790224100051,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12136,GO:0048180,1.00000000000484,0.895790224100051,0,1,activin complex,CC,
13734,GO:0060278,1.00000000000484,0.895790224100051,0,1,regulation of ovulation,BP,
13735,GO:0060279,1.00000000000484,0.895790224100051,0,1,positive regulation of ovulation,BP,
17578,GO:1901097,1.00000000000484,0.633925765033443,0,4,negative regulation of autophagosome maturation,BP,
16643,GO:0097475,1.00000000000484,0.707586767864752,0,3,motor neuron migration,BP,
1291,GO:0003097,1.00000000000484,0.640945075067896,0,4,renal water transport,BP,
13187,GO:0051765,1.00000000000486,0.803034048349325,0,2,inositol tetrakisphosphate kinase activity,MF,
15939,GO:0072706,1.00000000000486,0.893685469865714,0,1,response to sodium dodecyl sulfate,BP,
15940,GO:0072707,1.00000000000486,0.893685469865714,0,1,cellular response to sodium dodecyl sulfate,BP,
6228,GO:0019776,1.00000000000486,0.725107231492346,0,3,Atg8 ligase activity,MF,
2216,GO:0005105,1.00000000000487,0.895023114278456,0,1,type 1 fibroblast growth factor receptor binding,MF,
3992,GO:0008887,1.00000000000487,0.891804945596476,0,1,glycerate kinase activity,MF,
5557,GO:0016560,1.00000000000489,0.634470137303179,0,4,protein import into peroxisome matrix, docking,BP,
13679,GO:0060171,1.00000000000489,0.888644747834314,0,1,stereocilium membrane,CC,
12014,GO:0047408,1.00000000000491,0.80292275205496,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12015,GO:0047409,1.00000000000491,0.80292275205496,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
7173,GO:0031048,1.00000000000495,0.793575035269431,0,2,chromatin silencing by small RNA,BP,
3533,GO:0007525,1.00000000000497,0.793876932801851,0,2,somatic muscle development,BP,
15182,GO:0071284,1.00000000000497,0.627731458344208,0,4,cellular response to lead ion,BP,
5517,GO:0016476,1.00000000000499,0.708932192824425,0,3,regulation of embryonic cell shape,BP,
8403,GO:0033319,1.000000000005,0.896490906515376,0,1,UDP-D-xylose metabolic process,BP,
8404,GO:0033320,1.000000000005,0.896490906515376,0,1,UDP-D-xylose biosynthetic process,BP,
12102,GO:0048040,1.000000000005,0.896490906515376,0,1,UDP-glucuronate decarboxylase activity,MF,
2423,GO:0005597,1.000000000005,0.888395056093918,0,1,collagen type XVI trimer,CC,
5678,GO:0016785,1.000000000005,0.888395056093918,0,1,transferase activity, transferring selenium-containing groups,MF,
8293,GO:0033091,1.000000000005,0.893621248353789,0,1,positive regulation of immature T cell proliferation,BP,
16808,GO:0098621,1.000000000005,0.888395056093918,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
5701,GO:0016822,1.00000000000501,0.819945372787135,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5702,GO:0016823,1.00000000000501,0.819945372787135,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
4229,GO:0009405,1.00000000000501,0.78924740106019,0,2,pathogenesis,BP,
15346,GO:0071546,1.00000000000502,0.794974660586847,0,2,pi-body,CC,
9374,GO:0035880,1.00000000000504,0.797254636241299,0,2,embryonic nail plate morphogenesis,BP,
14373,GO:0061574,1.00000000000505,0.713870721217759,0,3,ASAP complex,CC,
5035,GO:0015204,1.00000000000505,0.714363879032997,0,3,urea transmembrane transporter activity,MF,
5230,GO:0015840,1.00000000000505,0.714363879032997,0,3,urea transport,BP,
12584,GO:0050717,1.00000000000505,0.738075774461124,0,3,positive regulation of interleukin-1 alpha secretion,BP,
979,GO:0002430,1.00000000000507,0.89494134149198,0,1,complement receptor mediated signaling pathway,BP,
1930,GO:0004621,1.00000000000507,0.89494134149198,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2968,GO:0006507,1.00000000000507,0.89494134149198,0,1,GPI anchor release,BP,
4735,GO:0010897,1.00000000000507,0.89494134149198,0,1,negative regulation of triglyceride catabolic process,BP,
8569,GO:0034014,1.00000000000507,0.89494134149198,0,1,response to triglyceride,BP,
15260,GO:0071401,1.00000000000507,0.89494134149198,0,1,cellular response to triglyceride,BP,
6450,GO:0021763,1.00000000000507,0.89530210895175,0,1,subthalamic nucleus development,BP,
13652,GO:0060127,1.00000000000507,0.89530210895175,0,1,prolactin secreting cell differentiation,BP,
13875,GO:0060459,1.00000000000507,0.89530210895175,0,1,left lung development,BP,
13876,GO:0060460,1.00000000000507,0.89530210895175,0,1,left lung morphogenesis,BP,
13940,GO:0060577,1.00000000000507,0.89530210895175,0,1,pulmonary vein morphogenesis,BP,
13941,GO:0060578,1.00000000000507,0.89530210895175,0,1,superior vena cava morphogenesis,BP,
14171,GO:0061031,1.00000000000507,0.89530210895175,0,1,endodermal digestive tract morphogenesis,BP,
4613,GO:0010728,1.00000000000508,0.634449970773836,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
16078,GO:0089709,1.00000000000508,0.798876250967624,0,2,L-histidine transmembrane transport,BP,
1817,GO:0004464,1.00000000000509,0.874309192875744,0,2,leukotriene-C4 synthase activity,MF,
7097,GO:0030886,1.00000000000509,0.808732428091477,0,2,negative regulation of myeloid dendritic cell activation,BP,
8146,GO:0032847,1.00000000000511,0.803726865740256,0,2,regulation of cellular pH reduction,BP,
20080,GO:2000669,1.00000000000511,0.794365912927586,0,2,negative regulation of dendritic cell apoptotic process,BP,
701,GO:0001918,1.00000000000511,0.893076723473675,0,1,farnesylated protein binding,MF,
5792,GO:0017018,1.00000000000511,0.789386865189898,0,2,myosin phosphatase activity,MF,
12430,GO:0048861,1.00000000000512,0.636834842669727,0,4,leukemia inhibitory factor signaling pathway,BP,
16273,GO:0090310,1.00000000000512,0.793386685358046,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
14708,GO:0070315,1.00000000000513,0.795454253665839,0,2,G1 to G0 transition involved in cell differentiation,BP,
2854,GO:0006343,1.00000000000513,0.890075132367413,0,1,establishment of chromatin silencing,BP,
10103,GO:0042595,1.00000000000513,0.890075132367413,0,1,behavioral response to starvation,BP,
15284,GO:0071441,1.00000000000513,0.890075132367413,0,1,negative regulation of histone H3-K14 acetylation,BP,
20066,GO:2000654,1.00000000000513,0.890075132367413,0,1,regulation of cellular response to testosterone stimulus,BP,
20067,GO:2000655,1.00000000000513,0.890075132367413,0,1,negative regulation of cellular response to testosterone stimulus,BP,
7440,GO:0031544,1.00000000000514,0.635052882776271,0,4,peptidyl-proline 3-dioxygenase activity,MF,
4851,GO:0014061,1.00000000000514,0.710998791712929,0,3,regulation of norepinephrine secretion,BP,
423,GO:0001128,1.00000000000515,0.911533283501757,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
19993,GO:2000520,1.00000000000515,0.813964749799067,0,2,regulation of immunological synapse formation,BP,
19994,GO:2000521,1.00000000000515,0.813964749799067,0,2,negative regulation of immunological synapse formation,BP,
20277,GO:2001188,1.00000000000515,0.813964749799067,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20278,GO:2001189,1.00000000000515,0.813964749799067,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
2205,GO:0005087,1.00000000000516,0.6732237267594,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
18613,GO:1903837,1.00000000000517,0.894023705946326,0,1,regulation of mRNA 3'-UTR binding,BP,
18614,GO:1903839,1.00000000000517,0.894023705946326,0,1,positive regulation of mRNA 3'-UTR binding,BP,
5092,GO:0015350,1.00000000000517,0.79328216832754,0,2,methotrexate transmembrane transporter activity,MF,
13290,GO:0051958,1.00000000000517,0.79328216832754,0,2,methotrexate transport,BP,
5390,GO:0016212,1.00000000000517,0.80056014727045,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9503,GO:0036137,1.00000000000517,0.80056014727045,0,2,kynurenine aminotransferase activity,MF,
16436,GO:0097052,1.00000000000517,0.80056014727045,0,2,L-kynurenine metabolic process,BP,
7334,GO:0031339,1.00000000000519,0.713845534164396,0,3,negative regulation of vesicle fusion,BP,
122,GO:0000252,1.0000000000052,0.904552015846069,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11958,GO:0047012,1.0000000000052,0.904552015846069,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17204,GO:0103066,1.0000000000052,0.904552015846069,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17205,GO:0103067,1.0000000000052,0.904552015846069,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
8115,GO:0032795,1.0000000000052,0.920728752814083,0,1,heterotrimeric G-protein binding,MF,
16665,GO:0097510,1.0000000000052,0.896915966158416,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
18402,GO:1903378,1.0000000000052,0.792405005949958,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
1776,GO:0004378,1.00000000000522,0.892768040093715,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17185,GO:0102704,1.00000000000522,0.892768040093715,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
19711,GO:1990983,1.00000000000522,0.893633585681415,0,1,tRNA demethylation,BP,
19712,GO:1990984,1.00000000000522,0.893633585681415,0,1,tRNA demethylase activity,MF,
19698,GO:1990927,1.00000000000523,0.789673259401967,0,2,calcium ion regulated lysosome exocytosis,BP,
2460,GO:0005672,1.00000000000525,0.673343049816392,0,4,transcription factor TFIIA complex,CC,
4887,GO:0014805,1.00000000000525,0.688144959132527,0,4,smooth muscle adaptation,BP,
2762,GO:0006172,1.00000000000528,0.894969354067914,0,1,ADP biosynthetic process,BP,
16536,GO:0097226,1.00000000000528,0.894969354067914,0,1,sperm mitochondrial sheath,CC,
9229,GO:0035609,1.00000000000529,0.888959356431073,0,1,C-terminal protein deglutamylation,BP,
9230,GO:0035610,1.00000000000529,0.888959356431073,0,1,protein side chain deglutamylation,BP,
10379,GO:0043185,1.00000000000529,0.896609913033208,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14870,GO:0070625,1.00000000000529,0.896609913033208,0,1,zymogen granule exocytosis,BP,
1139,GO:0002728,1.0000000000053,0.88892685398139,0,1,negative regulation of natural killer cell cytokine production,BP,
8657,GO:0034196,1.0000000000053,0.89360595271127,0,1,acylglycerol transport,BP,
8658,GO:0034197,1.0000000000053,0.89360595271127,0,1,triglyceride transport,BP,
10880,GO:0044395,1.0000000000053,0.89360595271127,0,1,protein targeting to vacuolar membrane,BP,
17520,GO:1900483,1.0000000000053,0.89360595271127,0,1,regulation of protein targeting to vacuolar membrane,BP,
2899,GO:0006407,1.00000000000532,0.743830229147048,0,3,rRNA export from nucleus,BP,
11756,GO:0046577,1.00000000000533,0.89027117261732,0,1,long-chain-alcohol oxidase activity,MF,
14006,GO:0060698,1.00000000000533,0.793511789204331,0,2,endoribonuclease inhibitor activity,MF,
14009,GO:0060701,1.00000000000533,0.793511789204331,0,2,negative regulation of ribonuclease activity,BP,
14010,GO:0060702,1.00000000000533,0.793511789204331,0,2,negative regulation of endoribonuclease activity,BP,
19495,GO:1990167,1.00000000000535,0.712381445426835,0,3,protein K27-linked deubiquitination,BP,
2129,GO:0004923,1.00000000000535,0.79237491300542,0,2,leukemia inhibitory factor receptor activity,MF,
9886,GO:0042138,1.00000000000536,0.894674845001913,0,1,meiotic DNA double-strand break formation,BP,
233,GO:0000481,1.00000000000536,0.890690050557454,0,1,maturation of 5S rRNA,BP,
18022,GO:1902455,1.00000000000538,0.629481706506961,0,4,negative regulation of stem cell population maintenance,BP,
14580,GO:0070095,1.00000000000539,0.891994675998885,0,1,fructose-6-phosphate binding,MF,
3822,GO:0008418,1.0000000000054,0.919395201662595,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
12306,GO:0048619,1.0000000000054,0.892943449241087,0,1,embryonic hindgut morphogenesis,BP,
4879,GO:0014739,1.00000000000541,0.892588480443809,0,1,positive regulation of muscle hyperplasia,BP,
18335,GO:1903231,1.00000000000541,0.892588480443809,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
153,GO:0000308,1.00000000000541,0.790619311606557,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
6017,GO:0019064,1.00000000000542,0.71643639495413,0,3,fusion of virus membrane with host plasma membrane,BP,
9788,GO:0039663,1.00000000000542,0.71643639495413,0,3,membrane fusion involved in viral entry into host cell,BP,
11008,GO:0044800,1.00000000000542,0.71643639495413,0,3,multi-organism membrane fusion,BP,
14938,GO:0070773,1.00000000000542,0.911440434726834,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15344,GO:0071544,1.00000000000542,0.911440434726834,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15522,GO:0071877,1.00000000000542,0.911440434726834,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15526,GO:0071881,1.00000000000542,0.911440434726834,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16072,GO:0086096,1.00000000000542,0.911440434726834,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17339,GO:0140193,1.00000000000542,0.911440434726834,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17340,GO:0140194,1.00000000000542,0.911440434726834,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
10218,GO:0042824,1.00000000000542,0.635786402253662,0,4,MHC class I peptide loading complex,CC,
1954,GO:0004655,1.00000000000543,0.891951470191966,0,1,porphobilinogen synthase activity,MF,
19052,GO:1904854,1.00000000000543,0.891951470191966,0,1,proteasome core complex binding,MF,
219,GO:0000455,1.00000000000543,0.807044081569856,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
1056,GO:0002581,1.00000000000543,0.809085950660488,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
13982,GO:0060668,1.00000000000543,0.890678702345833,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
5464,GO:0016340,1.00000000000545,0.789235938098587,0,2,calcium-dependent cell-matrix adhesion,BP,
1504,GO:0003847,1.00000000000545,0.676934072214568,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
2147,GO:0004960,1.00000000000545,0.895068231175079,0,1,thromboxane receptor activity,MF,
2148,GO:0004961,1.00000000000545,0.895068231175079,0,1,thromboxane A2 receptor activity,MF,
9748,GO:0038193,1.00000000000545,0.895068231175079,0,1,thromboxane A2 signaling pathway,BP,
18991,GO:1904734,1.00000000000545,0.949270777054711,0,1,positive regulation of electron transfer activity,BP,
19107,GO:1904960,1.00000000000545,0.949270777054711,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20026,GO:2000588,1.00000000000546,0.789672954021609,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
5231,GO:0015842,1.00000000000546,0.807724761407178,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16841,GO:0098700,1.00000000000546,0.807724761407178,0,2,neurotransmitter loading into synaptic vesicle,BP,
886,GO:0002249,1.00000000000546,0.789235768064734,0,2,lymphocyte anergy,BP,
1086,GO:0002667,1.00000000000546,0.789235768064734,0,2,regulation of T cell anergy,BP,
1210,GO:0002870,1.00000000000546,0.789235768064734,0,2,T cell anergy,BP,
1233,GO:0002911,1.00000000000546,0.789235768064734,0,2,regulation of lymphocyte anergy,BP,
1351,GO:0003213,1.00000000000546,0.789235768064734,0,2,cardiac right atrium morphogenesis,BP,
1367,GO:0003249,1.00000000000546,0.789235768064734,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003250,1.00000000000546,0.789235768064734,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1436,GO:0003408,1.00000000000546,0.789235768064734,0,2,optic cup formation involved in camera-type eye development,BP,
1582,GO:0003989,1.00000000000546,0.789235768064734,0,2,acetyl-CoA carboxylase activity,MF,
1975,GO:0004687,1.00000000000546,0.789235768064734,0,2,myosin light chain kinase activity,MF,
2338,GO:0005365,1.00000000000546,0.789235768064734,0,2,myo-inositol transmembrane transporter activity,MF,
2602,GO:0005899,1.00000000000546,0.789235768064734,0,2,insulin receptor complex,CC,
4632,GO:0010751,1.00000000000546,0.789235768064734,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4648,GO:0010768,1.00000000000546,0.789235768064734,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4894,GO:0014816,1.00000000000546,0.789235768064734,0,2,skeletal muscle satellite cell differentiation,BP,
6007,GO:0019045,1.00000000000546,0.789235768064734,0,2,latent virus replication,BP,
6008,GO:0019046,1.00000000000546,0.789235768064734,0,2,release from viral latency,BP,
6081,GO:0019230,1.00000000000546,0.789235768064734,0,2,proprioception,BP,
6451,GO:0021764,1.00000000000546,0.789235768064734,0,2,amygdala development,BP,
6561,GO:0021997,1.00000000000546,0.789235768064734,0,2,neural plate axis specification,BP,
6804,GO:0030241,1.00000000000546,0.789235768064734,0,2,skeletal muscle myosin thick filament assembly,BP,
6919,GO:0030505,1.00000000000546,0.789235768064734,0,2,inorganic diphosphate transport,BP,
7124,GO:0030934,1.00000000000546,0.789235768064734,0,2,anchoring collagen complex,CC,
7884,GO:0032444,1.00000000000546,0.789235768064734,0,2,activin responsive factor complex,CC,
8186,GO:0032916,1.00000000000546,0.789235768064734,0,2,positive regulation of transforming growth factor beta3 production,BP,
8394,GO:0033292,1.00000000000546,0.789235768064734,0,2,T-tubule organization,BP,
8859,GO:0034647,1.00000000000546,0.789235768064734,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8886,GO:0034686,1.00000000000546,0.789235768064734,0,2,integrin alphav-beta8 complex,CC,
8908,GO:0034721,1.00000000000546,0.789235768064734,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9052,GO:0035261,1.00000000000546,0.789235768064734,0,2,external genitalia morphogenesis,BP,
9088,GO:0035332,1.00000000000546,0.789235768064734,0,2,positive regulation of hippo signaling,BP,
9363,GO:0035866,1.00000000000546,0.789235768064734,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9516,GO:0036156,1.00000000000546,0.789235768064734,0,2,inner dynein arm,CC,
9579,GO:0036369,1.00000000000546,0.789235768064734,0,2,transcription factor catabolic process,BP,
9689,GO:0038049,1.00000000000546,0.789235768064734,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9830,GO:0042030,1.00000000000546,0.789235768064734,0,2,ATPase inhibitor activity,MF,
11510,GO:0045967,1.00000000000546,0.789235768064734,0,2,negative regulation of growth rate,BP,
12089,GO:0048022,1.00000000000546,0.789235768064734,0,2,negative regulation of melanin biosynthetic process,BP,
12393,GO:0048769,1.00000000000546,0.789235768064734,0,2,sarcomerogenesis,BP,
12421,GO:0048850,1.00000000000546,0.789235768064734,0,2,hypophysis morphogenesis,BP,
12726,GO:0050925,1.00000000000546,0.789235768064734,0,2,negative regulation of negative chemotaxis,BP,
14312,GO:0061386,1.00000000000546,0.789235768064734,0,2,closure of optic fissure,BP,
14977,GO:0070853,1.00000000000546,0.789235768064734,0,2,myosin VI binding,MF,
15114,GO:0071109,1.00000000000546,0.789235768064734,0,2,superior temporal gyrus development,BP,
15120,GO:0071144,1.00000000000546,0.789235768064734,0,2,heteromeric SMAD protein complex,CC,
15248,GO:0071386,1.00000000000546,0.789235768064734,0,2,cellular response to corticosterone stimulus,BP,
15624,GO:0072092,1.00000000000546,0.789235768064734,0,2,ureteric bud invasion,BP,
15657,GO:0072137,1.00000000000546,0.789235768064734,0,2,condensed mesenchymal cell proliferation,BP,
16213,GO:0090222,1.00000000000546,0.789235768064734,0,2,centrosome-templated microtubule nucleation,BP,
16468,GO:0097111,1.00000000000546,0.789235768064734,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16492,GO:0097155,1.00000000000546,0.789235768064734,0,2,fasciculation of sensory neuron axon,BP,
16710,GO:0097638,1.00000000000546,0.789235768064734,0,2,L-arginine import across plasma membrane,BP,
16725,GO:0097681,1.00000000000546,0.789235768064734,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16967,GO:0098928,1.00000000000546,0.789235768064734,0,2,presynaptic signal transduction,BP,
17052,GO:0099403,1.00000000000546,0.789235768064734,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17053,GO:0099404,1.00000000000546,0.789235768064734,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17070,GO:0099526,1.00000000000546,0.789235768064734,0,2,presynapse to nucleus signaling pathway,BP,
17503,GO:1900377,1.00000000000546,0.789235768064734,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18334,GO:1903225,1.00000000000546,0.789235768064734,0,2,negative regulation of endodermal cell differentiation,BP,
18698,GO:1904017,1.00000000000546,0.789235768064734,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18882,GO:1904475,1.00000000000546,0.789235768064734,0,2,regulation of Ras GTPase binding,BP,
18909,GO:1904562,1.00000000000546,0.789235768064734,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18994,GO:1904743,1.00000000000546,0.789235768064734,0,2,negative regulation of telomeric DNA binding,BP,
19056,GO:1904868,1.00000000000546,0.789235768064734,0,2,telomerase catalytic core complex assembly,BP,
19068,GO:1904882,1.00000000000546,0.789235768064734,0,2,regulation of telomerase catalytic core complex assembly,BP,
19069,GO:1904884,1.00000000000546,0.789235768064734,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19082,GO:1904907,1.00000000000546,0.789235768064734,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19083,GO:1904908,1.00000000000546,0.789235768064734,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19563,GO:1990430,1.00000000000546,0.789235768064734,0,2,extracellular matrix protein binding,MF,
19578,GO:1990498,1.00000000000546,0.789235768064734,0,2,mitotic spindle microtubule,CC,
20042,GO:2000620,1.00000000000546,0.789235768064734,0,2,positive regulation of histone H4-K16 acetylation,BP,
20148,GO:2000793,1.00000000000546,0.789235768064734,0,2,cell proliferation involved in heart valve development,BP,
20215,GO:2001027,1.00000000000546,0.789235768064734,0,2,negative regulation of endothelial cell chemotaxis,BP,
20239,GO:2001106,1.00000000000546,0.789235768064734,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20297,GO:2001228,1.00000000000546,0.789235768064734,0,2,regulation of response to gamma radiation,BP,
20337,GO:2001295,1.00000000000546,0.789235768064734,0,2,malonyl-CoA biosynthetic process,BP,
6404,GO:0021615,1.00000000000546,0.891756973332517,0,1,glossopharyngeal nerve morphogenesis,BP,
10865,GO:0044355,1.00000000000546,0.908624837869858,0,1,clearance of foreign intracellular DNA,BP,
10866,GO:0044356,1.00000000000546,0.908624837869858,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
17005,GO:0099046,1.00000000000546,0.908624837869858,0,1,clearance of foreign intracellular nucleic acids,BP,
18943,GO:1904627,1.00000000000546,0.908624837869858,0,1,response to phorbol 13-acetate 12-myristate,BP,
18944,GO:1904628,1.00000000000546,0.908624837869858,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
1536,GO:0003918,1.00000000000549,0.78927404072991,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14347,GO:0061505,1.00000000000549,0.78927404072991,0,2,DNA topoisomerase II activity,MF,
130,GO:0000270,1.00000000000549,0.825299595726048,0,2,peptidoglycan metabolic process,BP,
3964,GO:0008745,1.00000000000549,0.825299595726048,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4179,GO:0009253,1.00000000000549,0.825299595726048,0,2,peptidoglycan catabolic process,BP,
5313,GO:0016019,1.00000000000549,0.825299595726048,0,2,peptidoglycan receptor activity,MF,
13163,GO:0051710,1.00000000000549,0.825299595726048,0,2,regulation of cytolysis in other organism,BP,
13165,GO:0051714,1.00000000000549,0.825299595726048,0,2,positive regulation of cytolysis in other organism,BP,
3842,GO:0008448,1.0000000000055,0.899815725520196,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
6233,GO:0019781,1.0000000000055,0.806652343420051,0,2,NEDD8 activating enzyme activity,MF,
63,GO:0000126,1.00000000000551,0.79124896166595,0,2,transcription factor TFIIIB complex,CC,
385,GO:0001026,1.00000000000551,0.79124896166595,0,2,TFIIIB-type transcription factor activity,MF,
4612,GO:0010727,1.00000000000552,0.628973503601674,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
1618,GO:0004044,1.00000000000552,0.890320301860097,0,1,amidophosphoribosyltransferase activity,MF,
16299,GO:0090360,1.00000000000555,0.714488800963642,0,3,platelet-derived growth factor production,BP,
16300,GO:0090361,1.00000000000555,0.714488800963642,0,3,regulation of platelet-derived growth factor production,BP,
1635,GO:0004074,1.00000000000556,0.855824889033496,0,2,biliverdin reductase activity,MF,
9307,GO:0035744,1.00000000000557,0.918234271520019,0,1,T-helper 1 cell cytokine production,BP,
9917,GO:0042231,1.00000000000557,0.918234271520019,0,1,interleukin-13 biosynthetic process,BP,
2091,GO:0004853,1.00000000000558,0.910255080235005,0,1,uroporphyrinogen decarboxylase activity,MF,
11176,GO:0045219,1.00000000000558,0.888403563279613,0,1,regulation of FasL biosynthetic process,BP,
11177,GO:0045221,1.00000000000558,0.888403563279613,0,1,negative regulation of FasL biosynthetic process,BP,
1512,GO:0003868,1.00000000000558,0.900487180396896,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
16291,GO:0090336,1.00000000000558,0.720813237342169,0,3,positive regulation of brown fat cell differentiation,BP,
6018,GO:0019065,1.0000000000056,0.708044931997626,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15972,GO:0075509,1.0000000000056,0.708044931997626,0,3,endocytosis involved in viral entry into host cell,BP,
15336,GO:0071532,1.0000000000056,0.62958590028358,0,4,ankyrin repeat binding,MF,
4867,GO:0014717,1.0000000000056,0.811664009087135,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4868,GO:0014718,1.0000000000056,0.811664009087135,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4942,GO:0014901,1.0000000000056,0.811664009087135,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
14937,GO:0070772,1.00000000000561,0.892191539805934,0,1,PAS complex,CC,
1629,GO:0004062,1.00000000000562,0.677926277905039,0,4,aryl sulfotransferase activity,MF,
1315,GO:0003160,1.00000000000562,0.719733115892169,0,3,endocardium morphogenesis,BP,
11983,GO:0047186,1.00000000000562,0.889960219939663,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
2461,GO:0005673,1.00000000000563,0.808595427505281,0,2,transcription factor TFIIE complex,CC,
3922,GO:0008592,1.00000000000563,0.891801948752539,0,1,regulation of Toll signaling pathway,BP,
9918,GO:0042241,1.00000000000563,0.891801948752539,0,1,interleukin-18 biosynthetic process,BP,
11243,GO:0045381,1.00000000000563,0.891801948752539,0,1,regulation of interleukin-18 biosynthetic process,BP,
11397,GO:0045751,1.00000000000563,0.891801948752539,0,1,negative regulation of Toll signaling pathway,BP,
17803,GO:1901837,1.00000000000565,0.804784759565847,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
5372,GO:0016174,1.00000000000565,0.632613868811138,0,4,NAD(P)H oxidase activity,MF,
18661,GO:1903929,1.00000000000566,0.892021449619392,0,1,primary palate development,BP,
7402,GO:0031460,1.00000000000566,0.888559983806768,0,1,glycine betaine transport,BP,
5131,GO:0015562,1.00000000000568,0.631571814230286,0,4,efflux transmembrane transporter activity,MF,
2247,GO:0005157,1.00000000000569,0.894210750292062,0,1,macrophage colony-stimulating factor receptor binding,MF,
10046,GO:0042488,1.00000000000569,0.894210750292062,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13962,GO:0060611,1.00000000000569,0.894210750292062,0,1,mammary gland fat development,BP,
17940,GO:1902228,1.00000000000569,0.894210750292062,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18681,GO:1903971,1.00000000000569,0.894210750292062,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18684,GO:1903974,1.00000000000569,0.894210750292062,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18741,GO:1904124,1.00000000000569,0.894210750292062,0,1,microglial cell migration,BP,
18742,GO:1904139,1.00000000000569,0.894210750292062,0,1,regulation of microglial cell migration,BP,
18743,GO:1904141,1.00000000000569,0.894210750292062,0,1,positive regulation of microglial cell migration,BP,
19620,GO:1990682,1.00000000000569,0.894210750292062,0,1,CSF1-CSF1R complex,CC,
16317,GO:0090403,1.00000000000569,0.709023522041015,0,3,oxidative stress-induced premature senescence,BP,
2486,GO:0005726,1.00000000000569,0.625957371024327,0,4,perichromatin fibrils,CC,
14981,GO:0070860,1.0000000000057,0.894835294256616,0,1,RNA polymerase I core factor complex,CC,
16211,GO:0090219,1.00000000000571,0.633042145712314,0,4,negative regulation of lipid kinase activity,BP,
6386,GO:0021571,1.00000000000572,0.891456786422719,0,1,rhombomere 5 development,BP,
6387,GO:0021572,1.00000000000572,0.891456786422719,0,1,rhombomere 6 development,BP,
9067,GO:0035283,1.00000000000572,0.891456786422719,0,1,central nervous system segmentation,BP,
9068,GO:0035284,1.00000000000572,0.891456786422719,0,1,brain segmentation,BP,
782,GO:0002037,1.00000000000572,0.896197645467477,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
8918,GO:0034751,1.00000000000573,0.726663015574797,0,3,aryl hydrocarbon receptor complex,CC,
6643,GO:0023025,1.00000000000574,0.798741979524892,0,2,MHC class Ib protein complex binding,MF,
6646,GO:0023030,1.00000000000574,0.798741979524892,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
17570,GO:1901077,1.00000000000574,0.631378879051961,0,4,regulation of relaxation of muscle,BP,
3125,GO:0006705,1.00000000000575,0.631443582611085,0,4,mineralocorticoid biosynthetic process,BP,
3703,GO:0008212,1.00000000000575,0.631443582611085,0,4,mineralocorticoid metabolic process,BP,
7798,GO:0032341,1.00000000000575,0.631443582611085,0,4,aldosterone metabolic process,BP,
7799,GO:0032342,1.00000000000575,0.631443582611085,0,4,aldosterone biosynthetic process,BP,
7800,GO:0032344,1.00000000000575,0.631443582611085,0,4,regulation of aldosterone metabolic process,BP,
7803,GO:0032347,1.00000000000575,0.631443582611085,0,4,regulation of aldosterone biosynthetic process,BP,
13399,GO:0052642,1.00000000000577,0.900192343950058,0,1,lysophosphatidic acid phosphatase activity,MF,
20344,GO:2001311,1.00000000000577,0.900192343950058,0,1,lysobisphosphatidic acid metabolic process,BP,
1901,GO:0004582,1.00000000000577,0.791662192362866,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8346,GO:0033185,1.00000000000577,0.791662192362866,0,3,dolichol-phosphate-mannose synthase complex,CC,
19472,GO:1990074,1.00000000000578,0.890972778409087,0,1,polyuridylation-dependent mRNA catabolic process,BP,
2017,GO:0004741,1.00000000000578,0.703183809220071,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
14040,GO:0060743,1.00000000000579,0.893732467232666,0,1,epithelial cell maturation involved in prostate gland development,BP,
19147,GO:1905051,1.00000000000579,0.83808476661839,0,2,regulation of base-excision repair,BP,
19148,GO:1905053,1.00000000000579,0.83808476661839,0,2,positive regulation of base-excision repair,BP,
6047,GO:0019153,1.0000000000058,0.90459969458268,0,1,protein-disulfide reductase (glutathione) activity,MF,
15860,GO:0072555,1.0000000000058,0.90459969458268,0,1,17-beta-ketosteroid reductase activity,MF,
15880,GO:0072582,1.0000000000058,0.90459969458268,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
1507,GO:0003858,1.00000000000581,0.795702038039265,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
307,GO:0000818,1.00000000000581,0.800217139414622,0,2,nuclear MIS12/MIND complex,CC,
12515,GO:0050542,1.00000000000582,0.718559221335213,0,4,icosanoid binding,MF,
12516,GO:0050543,1.00000000000582,0.718559221335213,0,4,icosatetraenoic acid binding,MF,
12517,GO:0050544,1.00000000000582,0.718559221335213,0,4,arachidonic acid binding,MF,
12106,GO:0048058,1.00000000000583,0.891566324448035,0,1,compound eye corneal lens development,BP,
12382,GO:0048749,1.00000000000583,0.891566324448035,0,1,compound eye development,BP,
19186,GO:1905168,1.00000000000583,0.890425513798306,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
7373,GO:0031415,1.00000000000584,0.661094667637387,0,4,NatA complex,CC,
19299,GO:1905457,1.00000000000585,0.736698799546759,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20195,GO:2000974,1.00000000000585,0.736698799546759,0,3,negative regulation of pro-B cell differentiation,BP,
18123,GO:1902731,1.00000000000585,0.789238399624998,0,2,negative regulation of chondrocyte proliferation,BP,
7658,GO:0032072,1.00000000000587,0.89124751297257,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7868,GO:0032423,1.00000000000587,0.89124751297257,0,1,regulation of mismatch repair,BP,
7869,GO:0032425,1.00000000000587,0.89124751297257,0,1,positive regulation of mismatch repair,BP,
9287,GO:0035711,1.00000000000587,0.89124751297257,0,1,T-helper 1 cell activation,BP,
19960,GO:2000426,1.00000000000587,0.89124751297257,0,1,negative regulation of apoptotic cell clearance,BP,
13625,GO:0060075,1.00000000000587,0.711081572453699,0,3,regulation of resting membrane potential,BP,
5360,GO:0016128,1.00000000000588,0.717566931506014,0,3,phytosteroid metabolic process,BP,
5361,GO:0016129,1.00000000000588,0.717566931506014,0,3,phytosteroid biosynthetic process,BP,
14745,GO:0070384,1.00000000000588,0.708006716280381,0,3,Harderian gland development,BP,
5432,GO:0016286,1.00000000000588,0.893893190869153,0,1,small conductance calcium-activated potassium channel activity,MF,
2889,GO:0006397,1.00000000000588,0,9,440,mRNA processing,BP,PRKACA;ADARB1;SYMPK;RPUSD3;HSF1;RALY;ESRP1;SSU72;SF3B6
8147,GO:0032848,1.00000000000588,0.890067597671261,0,1,negative regulation of cellular pH reduction,BP,
10492,GO:0043375,1.00000000000588,0.890067597671261,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11812,GO:0046668,1.00000000000588,0.890067597671261,0,1,regulation of retinal cell programmed cell death,BP,
11813,GO:0046671,1.00000000000588,0.890067597671261,0,1,negative regulation of retinal cell programmed cell death,BP,
4544,GO:0010615,1.00000000000589,0.888730858716108,0,1,positive regulation of cardiac muscle adaptation,BP,
18343,GO:1903244,1.00000000000589,0.888730858716108,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19195,GO:1905205,1.00000000000589,0.888730858716108,0,1,positive regulation of connective tissue replacement,BP,
3788,GO:0008352,1.0000000000059,0.893415320440474,0,1,katanin complex,CC,
2582,GO:0005873,1.00000000000591,0.704759785957632,0,3,plus-end kinesin complex,CC,
13015,GO:0051413,1.00000000000592,0.893884127742076,0,1,response to cortisone,BP,
5416,GO:0016259,1.00000000000593,0.638649082956263,0,4,selenocysteine metabolic process,BP,
10660,GO:0043686,1.00000000000593,0.732765104829621,0,3,co-translational protein modification,BP,
17920,GO:1902178,1.00000000000595,0.889151680176941,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
6352,GO:0021526,1.00000000000595,0.899252166463013,0,1,medial motor column neuron differentiation,BP,
18085,GO:1902616,1.00000000000595,0.899252166463013,0,1,acyl carnitine transmembrane transport,BP,
3642,GO:0008116,1.00000000000596,0.88839589077996,0,1,prostaglandin-I synthase activity,MF,
13154,GO:0051697,1.00000000000596,0.647288325162558,0,4,protein delipidation,BP,
14449,GO:0061741,1.00000000000598,0.801045890609929,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
8675,GO:0034238,1.00000000000599,0.889732271683958,0,1,macrophage fusion,BP,
8676,GO:0034239,1.00000000000599,0.889732271683958,0,1,regulation of macrophage fusion,BP,
8677,GO:0034241,1.00000000000599,0.889732271683958,0,1,positive regulation of macrophage fusion,BP,
3838,GO:0008442,1.000000000006,0.897754216435837,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3850,GO:0008458,1.00000000000601,0.891762972319135,0,1,carnitine O-octanoyltransferase activity,MF,
5483,GO:0016414,1.00000000000601,0.891762972319135,0,1,O-octanoyltransferase activity,MF,
5484,GO:0016415,1.00000000000601,0.891762972319135,0,1,octanoyltransferase activity,MF,
7273,GO:0031247,1.00000000000602,0.801498816999112,0,2,actin rod assembly,BP,
11626,GO:0046294,1.00000000000603,0.81882054802096,0,2,formaldehyde catabolic process,BP,
247,GO:0000703,1.00000000000604,0.83387430796976,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
11099,GO:0045085,1.00000000000605,0.901484419149008,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16860,GO:0098745,1.00000000000605,0.901484419149008,0,1,Dcp1-Dcp2 complex,CC,
17800,GO:1901834,1.00000000000605,0.901484419149008,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17801,GO:1901835,1.00000000000605,0.901484419149008,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18789,GO:1904246,1.00000000000605,0.901484419149008,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
17376,GO:1900042,1.00000000000605,0.789236547785328,0,2,positive regulation of interleukin-2 secretion,BP,
553,GO:0001674,1.00000000000607,0.796064084125791,0,2,female germ cell nucleus,CC,
10094,GO:0042585,1.00000000000607,0.796064084125791,0,2,germinal vesicle,CC,
9529,GO:0036219,1.00000000000607,0.935720793705931,0,1,GTP diphosphatase activity,MF,
10968,GO:0044713,1.00000000000607,0.935720793705931,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10969,GO:0044714,1.00000000000607,0.935720793705931,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12044,GO:0047693,1.00000000000607,0.935720793705931,0,1,ATP diphosphatase activity,MF,
13834,GO:0060405,1.00000000000607,0.718717946967005,0,3,regulation of penile erection,BP,
17375,GO:1900041,1.00000000000608,0.710529363471396,0,3,negative regulation of interleukin-2 secretion,BP,
8565,GO:0033981,1.00000000000611,0.93886226810918,0,1,D-dopachrome decarboxylase activity,MF,
5779,GO:0016998,1.00000000000612,0.808349021014185,0,2,cell wall macromolecule catabolic process,BP,
4954,GO:0015015,1.00000000000612,0.631062636061046,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
11800,GO:0046643,1.00000000000612,0.624141091198401,0,4,regulation of gamma-delta T cell activation,BP,
10149,GO:0042701,1.00000000000613,0.795806718552653,0,2,progesterone secretion,BP,
14911,GO:0070697,1.00000000000613,0.795806718552653,0,2,activin receptor binding,MF,
14912,GO:0070699,1.00000000000613,0.795806718552653,0,2,type II activin receptor binding,MF,
6645,GO:0023029,1.00000000000614,0.634264801569295,0,4,MHC class Ib protein binding,MF,
10989,GO:0044771,1.00000000000614,0.796501327065681,0,2,meiotic cell cycle phase transition,BP,
17858,GO:1901993,1.00000000000614,0.796501327065681,0,2,regulation of meiotic cell cycle phase transition,BP,
17859,GO:1901994,1.00000000000614,0.796501327065681,0,2,negative regulation of meiotic cell cycle phase transition,BP,
6890,GO:0030389,1.00000000000615,0.937102794583801,0,1,fructosamine metabolic process,BP,
12907,GO:0051228,1.00000000000616,0.888448159830213,0,1,mitotic spindle disassembly,BP,
12908,GO:0051230,1.00000000000616,0.888448159830213,0,1,spindle disassembly,BP,
18398,GO:1903373,1.00000000000617,0.706544056130835,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
14787,GO:0070471,1.00000000000617,0.705271120578203,0,3,uterine smooth muscle contraction,BP,
14788,GO:0070472,1.00000000000617,0.705271120578203,0,3,regulation of uterine smooth muscle contraction,BP,
14789,GO:0070474,1.00000000000617,0.705271120578203,0,3,positive regulation of uterine smooth muscle contraction,BP,
2222,GO:0005119,1.00000000000618,0.791882091234834,0,2,smoothened binding,MF,
930,GO:0002325,1.00000000000618,0.91720251786504,0,1,natural killer cell differentiation involved in immune response,BP,
8138,GO:0032824,1.00000000000618,0.91720251786504,0,1,negative regulation of natural killer cell differentiation,BP,
8140,GO:0032826,1.00000000000618,0.91720251786504,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8141,GO:0032827,1.00000000000618,0.91720251786504,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8185,GO:0032915,1.00000000000619,0.896252840790056,0,1,positive regulation of transforming growth factor beta2 production,BP,
8591,GO:0034066,1.00000000000619,0.815108125626903,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9167,GO:0035514,1.0000000000062,0.74525505589657,0,3,DNA demethylase activity,MF,
9596,GO:0036435,1.00000000000621,0.724756738423889,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
3886,GO:0008517,1.00000000000621,0.630491762590681,0,4,folic acid transmembrane transporter activity,MF,
20273,GO:2001184,1.00000000000622,0.795197705662112,0,2,positive regulation of interleukin-12 secretion,BP,
19573,GO:1990456,1.00000000000623,0.890091512990262,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
10493,GO:0043376,1.00000000000624,0.890692890227544,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
1297,GO:0003127,1.00000000000626,0.888482415392435,0,1,detection of nodal flow,BP,
15299,GO:0071464,1.00000000000626,0.888482415392435,0,1,cellular response to hydrostatic pressure,BP,
15603,GO:0072055,1.00000000000626,0.888482415392435,0,1,renal cortex development,BP,
15604,GO:0072059,1.00000000000626,0.888482415392435,0,1,cortical collecting duct development,BP,
15690,GO:0072194,1.00000000000626,0.888482415392435,0,1,kidney smooth muscle tissue development,BP,
15701,GO:0072208,1.00000000000626,0.888482415392435,0,1,metanephric smooth muscle tissue development,BP,
15705,GO:0072214,1.00000000000626,0.888482415392435,0,1,metanephric cortex development,BP,
15710,GO:0072219,1.00000000000626,0.888482415392435,0,1,metanephric cortical collecting duct development,BP,
17392,GO:1900086,1.00000000000626,0.703243014979904,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
11160,GO:0045196,1.00000000000626,0.790862380931127,0,2,establishment or maintenance of neuroblast polarity,BP,
11164,GO:0045200,1.00000000000626,0.790862380931127,0,2,establishment of neuroblast polarity,BP,
9353,GO:0035851,1.00000000000627,0.892587069462916,0,1,Krueppel-associated box domain binding,MF,
1380,GO:0003273,1.00000000000629,0.631150565914596,0,4,cell migration involved in endocardial cushion formation,BP,
3027,GO:0006574,1.0000000000063,0.646890715712577,0,4,valine catabolic process,BP,
11647,GO:0046338,1.0000000000063,0.795803134588984,0,2,phosphatidylethanolamine catabolic process,BP,
18688,GO:1903978,1.00000000000631,0.641166961652435,0,4,regulation of microglial cell activation,BP,
3194,GO:0006824,1.00000000000633,0.796991279311312,0,2,cobalt ion transport,BP,
3021,GO:0006567,1.00000000000635,0.823394391492252,0,2,threonine catabolic process,BP,
13815,GO:0060382,1.00000000000635,0.790225403691319,0,2,regulation of DNA strand elongation,BP,
14355,GO:0061519,1.00000000000635,0.89074989767321,0,1,macrophage homeostasis,BP,
1094,GO:0002679,1.00000000000636,0.739565192398849,0,3,respiratory burst involved in defense response,BP,
271,GO:0000773,1.00000000000636,0.923988705918363,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1918,GO:0004608,1.00000000000636,0.923988705918363,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11965,GO:0047035,1.00000000000636,0.923988705918363,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15990,GO:0080101,1.00000000000636,0.923988705918363,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
12478,GO:0050265,1.00000000000636,0.704751169096989,0,3,RNA uridylyltransferase activity,MF,
16631,GO:0097450,1.00000000000636,0.794024134579647,0,2,astrocyte end-foot,CC,
16632,GO:0097451,1.00000000000636,0.794024134579647,0,2,glial limiting end-foot,CC,
15066,GO:0070995,1.00000000000638,0.892036308256334,0,1,NADPH oxidation,BP,
19458,GO:1990031,1.00000000000638,0.892036308256334,0,1,pinceau fiber,CC,
672,GO:0001878,1.00000000000641,0.803841426121912,0,2,response to yeast,BP,
8584,GO:0034056,1.00000000000642,0.70673511896458,0,3,estrogen response element binding,MF,
16714,GO:0097643,1.00000000000642,0.927519769422475,0,1,amylin receptor activity,MF,
18437,GO:1903440,1.00000000000642,0.927519769422475,0,1,amylin receptor complex,CC,
19549,GO:1990407,1.00000000000642,0.927519769422475,0,1,calcitonin gene-related peptide binding,MF,
14696,GO:0070295,1.00000000000643,0.718683742831492,0,3,renal water absorption,BP,
12299,GO:0048597,1.00000000000643,0.761681338866954,0,3,post-embryonic camera-type eye morphogenesis,BP,
8392,GO:0033290,1.00000000000643,0.889372513742001,0,1,eukaryotic 48S preinitiation complex,CC,
10771,GO:0044207,1.00000000000643,0.889372513742001,0,1,translation initiation ternary complex,CC,
12451,GO:0048936,1.00000000000644,0.714375021460692,0,3,peripheral nervous system neuron axonogenesis,BP,
14793,GO:0070481,1.00000000000644,0.892740537464768,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14887,GO:0070651,1.00000000000644,0.892740537464768,0,1,nonfunctional rRNA decay,BP,
11195,GO:0045272,1.00000000000646,0.769858829756391,0,3,plasma membrane respiratory chain complex I,CC,
14204,GO:0061083,1.00000000000646,0.635970904735829,0,4,regulation of protein refolding,BP,
14205,GO:0061084,1.00000000000646,0.635970904735829,0,4,negative regulation of protein refolding,BP,
6797,GO:0030233,1.00000000000647,0.903533984598213,0,1,deoxynucleotide transmembrane transporter activity,MF,
6843,GO:0030302,1.00000000000647,0.903533984598213,0,1,deoxynucleotide transport,BP,
15095,GO:0071045,1.00000000000647,0.903533984598213,0,1,nuclear histone mRNA catabolic process,BP,
15400,GO:0071629,1.00000000000647,0.903533984598213,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16814,GO:0098633,1.00000000000649,0.893806502967259,0,1,collagen fibril binding,MF,
18707,GO:1904027,1.00000000000649,0.893806502967259,0,1,negative regulation of collagen fibril organization,BP,
952,GO:0002368,1.00000000000649,0.894782506990875,0,1,B cell cytokine production,BP,
1197,GO:0002842,1.00000000000649,0.894782506990875,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9573,GO:0036351,1.00000000000649,0.894782506990875,0,1,histone H2A-K13 ubiquitination,BP,
9574,GO:0036352,1.00000000000649,0.894782506990875,0,1,histone H2A-K15 ubiquitination,BP,
17700,GO:1901537,1.0000000000065,0.701145102543532,0,3,positive regulation of DNA demethylation,BP,
3394,GO:0007174,1.00000000000651,0.895316271176689,0,1,epidermal growth factor catabolic process,BP,
7864,GO:0032419,1.00000000000651,0.895316271176689,0,1,extrinsic component of lysosome membrane,CC,
19115,GO:1904979,1.00000000000651,0.895316271176689,0,1,negative regulation of endosome organization,BP,
19260,GO:1905365,1.00000000000651,0.895316271176689,0,1,regulation of intralumenal vesicle formation,BP,
19261,GO:1905366,1.00000000000651,0.895316271176689,0,1,negative regulation of intralumenal vesicle formation,BP,
7079,GO:0030862,1.00000000000652,0.888397585869318,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9755,GO:0039007,1.00000000000652,0.888397585869318,0,1,pronephric nephron morphogenesis,BP,
9756,GO:0039008,1.00000000000652,0.888397585869318,0,1,pronephric nephron tubule morphogenesis,BP,
9759,GO:0039020,1.00000000000652,0.888397585869318,0,1,pronephric nephron tubule development,BP,
9760,GO:0039022,1.00000000000652,0.888397585869318,0,1,pronephric duct development,BP,
9761,GO:0039023,1.00000000000652,0.888397585869318,0,1,pronephric duct morphogenesis,BP,
14594,GO:0070121,1.00000000000652,0.888397585869318,0,1,Kupffer's vesicle development,BP,
15643,GO:0072114,1.00000000000652,0.888397585869318,0,1,pronephros morphogenesis,BP,
7284,GO:0031262,1.00000000000652,0.688288413373014,0,4,Ndc80 complex,CC,
14401,GO:0061629,1.00000000000652,0.712225381213602,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
5431,GO:0016282,1.00000000000652,0.888893317198807,0,1,eukaryotic 43S preinitiation complex,CC,
5445,GO:0016309,1.00000000000652,0.705443619385813,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
16418,GO:0097018,1.00000000000652,0.893898653287992,0,1,renal albumin absorption,BP,
17428,GO:1900141,1.00000000000652,0.893898653287992,0,1,regulation of oligodendrocyte apoptotic process,BP,
17429,GO:1900142,1.00000000000652,0.893898653287992,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19995,GO:2000532,1.00000000000652,0.893898653287992,0,1,regulation of renal albumin absorption,BP,
19996,GO:2000533,1.00000000000652,0.893898653287992,0,1,negative regulation of renal albumin absorption,BP,
1246,GO:0002943,1.00000000000654,0.647697099587527,0,4,tRNA dihydrouridine synthesis,BP,
5856,GO:0017150,1.00000000000654,0.647697099587527,0,4,tRNA dihydrouridine synthase activity,MF,
14161,GO:0061009,1.00000000000654,0.722914199831947,0,3,common bile duct development,BP,
9324,GO:0035787,1.00000000000654,0.708416019437321,0,3,cell migration involved in kidney development,BP,
534,GO:0001652,1.00000000000654,0.652363725588564,0,4,granular component,CC,
5664,GO:0016768,1.00000000000655,0.902471008092452,0,1,spermine synthase activity,MF,
342,GO:0000942,1.00000000000655,0.640830777262327,0,4,condensed nuclear chromosome outer kinetochore,CC,
14273,GO:0061303,1.00000000000655,0.647951038447171,0,4,cornea development in camera-type eye,BP,
9453,GO:0036022,1.00000000000655,0.802070566442754,0,2,limb joint morphogenesis,BP,
9454,GO:0036023,1.00000000000655,0.802070566442754,0,2,embryonic skeletal limb joint morphogenesis,BP,
8253,GO:0033018,1.00000000000655,0.800905310908364,0,2,sarcoplasmic reticulum lumen,CC,
14597,GO:0070124,1.00000000000656,0.823217017889524,0,2,mitochondrial translational initiation,BP,
14419,GO:0061669,1.00000000000661,0.789635613303923,0,2,spontaneous neurotransmitter secretion,BP,
18993,GO:1904742,1.00000000000661,0.652421978951182,0,4,regulation of telomeric DNA binding,BP,
20043,GO:2000622,1.00000000000662,0.628347355274104,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20044,GO:2000623,1.00000000000662,0.628347355274104,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
783,GO:0002038,1.00000000000663,0.895097642856708,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4719,GO:0010879,1.00000000000663,0.895097642856708,0,1,cholesterol transport involved in cholesterol storage,BP,
9097,GO:0035352,1.00000000000663,0.895097642856708,0,1,NAD transmembrane transport,BP,
10348,GO:0043132,1.00000000000663,0.895097642856708,0,1,NAD transport,BP,
10955,GO:0044610,1.00000000000663,0.895097642856708,0,1,FMN transmembrane transporter activity,MF,
13172,GO:0051724,1.00000000000663,0.895097642856708,0,1,NAD transmembrane transporter activity,MF,
11295,GO:0045588,1.00000000000663,0.789389701919051,0,2,positive regulation of gamma-delta T cell differentiation,BP,
6375,GO:0021557,1.00000000000664,0.809935774134208,0,2,oculomotor nerve development,BP,
9607,GO:0036455,1.00000000000664,0.919048122619449,0,1,iron-sulfur transferase activity,MF,
1889,GO:0004567,1.00000000000666,0.891552812455466,0,1,beta-mannosidase activity,MF,
4455,GO:0010412,1.00000000000666,0.891552812455466,0,1,mannan metabolic process,BP,
11654,GO:0046355,1.00000000000666,0.891552812455466,0,1,mannan catabolic process,BP,
8423,GO:0033477,1.00000000000667,0.897570337317508,0,1,S-methylmethionine metabolic process,BP,
11978,GO:0047150,1.00000000000667,0.897570337317508,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14399,GO:0061627,1.00000000000667,0.897570337317508,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
13342,GO:0052203,1.00000000000672,0.723208739760771,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11192,GO:0045259,1.00000000000672,0.815049119889683,0,2,proton-transporting ATP synthase complex,CC,
6832,GO:0030289,1.00000000000674,0.657895240153849,0,4,protein phosphatase 4 complex,CC,
3261,GO:0006931,1.00000000000675,0.728129202801799,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
10870,GO:0044375,1.00000000000677,0.830065444232575,0,2,regulation of peroxisome size,BP,
7159,GO:0031013,1.00000000000677,0.828889805614269,0,2,troponin I binding,MF,
15382,GO:0071603,1.00000000000677,0.791970544419103,0,2,endothelial cell-cell adhesion,BP,
20316,GO:2001253,1.00000000000678,0.892479061476074,0,1,regulation of histone H3-K36 trimethylation,BP,
13566,GO:0060007,1.00000000000678,0.889352803583437,0,1,linear vestibuloocular reflex,BP,
5813,GO:0017065,1.00000000000681,0.905304580183317,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
12163,GO:0048254,1.00000000000681,0.669275043287474,0,4,snoRNA localization,BP,
19496,GO:1990168,1.00000000000681,0.712492952835038,0,3,protein K33-linked deubiquitination,BP,
14374,GO:0061575,1.00000000000682,0.713304169963233,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
1602,GO:0004018,1.00000000000682,0.907622686747882,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
9882,GO:0042134,1.00000000000682,0.827440082630121,0,2,rRNA primary transcript binding,MF,
14871,GO:0070626,1.00000000000682,0.907622686747882,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16540,GO:0097231,1.00000000000682,0.901998285894338,0,1,cell motility in response to calcium ion,BP,
19627,GO:1990716,1.00000000000682,0.901998285894338,0,1,axonemal central apparatus,CC,
2144,GO:0004954,1.00000000000685,0.717533225095709,0,3,prostanoid receptor activity,MF,
18790,GO:1904247,1.00000000000689,0.892282400653699,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
12444,GO:0048880,1.00000000000691,0.709008733988536,0,3,sensory system development,BP,
16096,GO:0090038,1.00000000000692,0.793954599587402,0,2,negative regulation of protein kinase C signaling,BP,
20280,GO:2001198,1.00000000000692,0.735338200061872,0,3,regulation of dendritic cell differentiation,BP,
1630,GO:0004064,1.00000000000694,0.728502782597913,0,3,arylesterase activity,MF,
1843,GO:0004496,1.00000000000694,0.896685886891898,0,1,mevalonate kinase activity,MF,
13469,GO:0052894,1.00000000000694,0.896685886891898,0,1,norspermine:oxygen oxidoreductase activity,MF,
13470,GO:0052895,1.00000000000694,0.896685886891898,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
8662,GO:0034203,1.00000000000695,0.88846903553326,0,1,glycolipid translocation,BP,
17605,GO:1901207,1.00000000000695,0.889759071189827,0,1,regulation of heart looping,BP,
18577,GO:1903762,1.00000000000695,0.889759071189827,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18668,GO:1903947,1.00000000000695,0.889759071189827,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18670,GO:1903952,1.00000000000695,0.889759071189827,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18671,GO:1903954,1.00000000000695,0.889759071189827,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19131,GO:1905026,1.00000000000695,0.889759071189827,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19133,GO:1905033,1.00000000000695,0.889759071189827,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
397,GO:0001069,1.00000000000695,0.789588245867487,0,2,regulatory region RNA binding,MF,
10162,GO:0042731,1.00000000000695,0.648831309656464,0,4,PH domain binding,MF,
461,GO:0001401,1.00000000000695,0.803373050976284,0,2,mitochondrial sorting and assembly machinery complex,CC,
8979,GO:0035061,1.00000000000695,0.62598331870253,0,4,interchromatin granule,CC,
3618,GO:0008073,1.00000000000696,0.825141980476582,0,2,ornithine decarboxylase inhibitor activity,MF,
17962,GO:1902268,1.00000000000696,0.825141980476582,0,2,negative regulation of polyamine transmembrane transport,BP,
4334,GO:0009881,1.00000000000696,0.6323263032587,0,4,photoreceptor activity,MF,
3765,GO:0008309,1.00000000000696,0.650390016851063,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
19504,GO:1990180,1.00000000000697,0.739670619383276,0,3,mitochondrial tRNA 3'-end processing,BP,
11770,GO:0046601,1.00000000000697,0.707375132087682,0,3,positive regulation of centriole replication,BP,
4020,GO:0009041,1.00000000000697,0.732029519991977,0,3,uridylate kinase activity,MF,
8521,GO:0033693,1.00000000000699,0.708114356086347,0,3,neurofilament bundle assembly,BP,
7693,GO:0032138,1.00000000000699,0.629387483202893,0,4,single base insertion or deletion binding,MF,
1949,GO:0004649,1.00000000000699,0.802513736247852,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
8087,GO:0032762,1.00000000000702,0.639622128218992,0,4,mast cell cytokine production,BP,
8088,GO:0032763,1.00000000000702,0.639622128218992,0,4,regulation of mast cell cytokine production,BP,
3823,GO:0008419,1.00000000000702,0.893440249539544,0,1,RNA lariat debranching enzyme activity,MF,
15316,GO:0071484,1.00000000000702,0.792148317021896,0,2,cellular response to light intensity,BP,
13050,GO:0051481,1.00000000000703,0.623216056959213,0,4,negative regulation of cytosolic calcium ion concentration,BP,
18647,GO:1903905,1.00000000000704,0.793756357937279,0,2,positive regulation of establishment of T cell polarity,BP,
4010,GO:0008973,1.00000000000705,0.891777966893494,0,1,phosphopentomutase activity,MF,
8405,GO:0033326,1.00000000000705,0.888545268527419,0,1,cerebrospinal fluid secretion,BP,
15297,GO:0071461,1.00000000000707,0.817791670475045,0,2,cellular response to redox state,BP,
1561,GO:0003957,1.0000000000071,0.888710905563513,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3965,GO:0008746,1.0000000000071,0.888710905563513,0,1,NAD(P)+ transhydrogenase activity,MF,
3967,GO:0008750,1.0000000000071,0.888710905563513,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5612,GO:0016652,1.0000000000071,0.888710905563513,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
17409,GO:1900114,1.0000000000071,0.789768344163359,0,2,positive regulation of histone H3-K9 trimethylation,BP,
19552,GO:1990410,1.00000000000711,0.807211088894206,0,2,adrenomedullin receptor signaling pathway,BP,
4218,GO:0009383,1.00000000000711,0.794096156278447,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
5955,GO:0018312,1.00000000000712,0.799969699175645,0,2,peptidyl-serine ADP-ribosylation,BP,
19546,GO:1990404,1.00000000000712,0.799969699175645,0,2,protein ADP-ribosylase activity,MF,
5440,GO:0016300,1.00000000000713,0.708421783837394,0,3,tRNA (uracil) methyltransferase activity,MF,
19061,GO:1904875,1.00000000000714,0.800190794849243,0,2,regulation of DNA ligase activity,BP,
5045,GO:0015226,1.00000000000715,0.638850043787015,0,4,carnitine transmembrane transporter activity,MF,
5254,GO:0015879,1.00000000000715,0.638850043787015,0,4,carnitine transport,BP,
794,GO:0002055,1.00000000000715,0.934617337332283,0,1,adenine binding,MF,
1591,GO:0003999,1.00000000000715,0.934617337332283,0,1,adenine phosphoribosyltransferase activity,MF,
2600,GO:0005896,1.00000000000715,0.727411921261822,0,3,interleukin-6 receptor complex,CC,
5976,GO:0018444,1.00000000000716,0.706382724857961,0,3,translation release factor complex,CC,
1163,GO:0002774,1.00000000000716,0.89231884108851,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14895,GO:0070667,1.00000000000716,0.89231884108851,0,1,negative regulation of mast cell proliferation,BP,
5823,GO:0017087,1.00000000000717,0.889874139129808,0,1,mitochondrial processing peptidase complex,CC,
12535,GO:0050659,1.00000000000717,0.789514755963481,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
1761,GO:0004361,1.00000000000718,0.902079280838171,0,1,glutaryl-CoA dehydrogenase activity,MF,
2267,GO:0005183,1.00000000000718,0.902079280838171,0,1,gonadotropin hormone-releasing hormone activity,MF,
7434,GO:0031530,1.00000000000718,0.902079280838171,0,1,gonadotropin-releasing hormone receptor binding,MF,
19453,GO:1990008,1.00000000000718,0.902079280838171,0,1,neurosecretory vesicle,CC,
1905,GO:0004587,1.00000000000718,0.897710808607781,0,1,ornithine-oxo-acid transaminase activity,MF,
4401,GO:0010121,1.00000000000718,0.897710808607781,0,1,arginine catabolic process to proline via ornithine,BP,
6162,GO:0019493,1.00000000000718,0.897710808607781,0,1,arginine catabolic process to proline,BP,
6180,GO:0019544,1.00000000000718,0.897710808607781,0,1,arginine catabolic process to glutamate,BP,
12804,GO:0051066,1.00000000000718,0.811298031883744,0,2,dihydrobiopterin metabolic process,BP,
3517,GO:0007468,1.00000000000719,0.896921322258096,0,1,regulation of rhodopsin gene expression,BP,
11454,GO:0045872,1.00000000000719,0.896921322258096,0,1,positive regulation of rhodopsin gene expression,BP,
8681,GO:0034245,1.00000000000719,0.890144943856729,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
4696,GO:0010848,1.00000000000719,0.891684944657731,0,1,regulation of chromatin disassembly,BP,
20160,GO:2000812,1.0000000000072,0.889982141732161,0,1,regulation of barbed-end actin filament capping,BP,
16807,GO:0098619,1.00000000000721,0.89880422050971,0,1,selenocysteine-tRNA ligase activity,MF,
11986,GO:0047220,1.00000000000721,0.893087049406641,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
16234,GO:0090258,1.00000000000722,0.793694259327566,0,2,negative regulation of mitochondrial fission,BP,
3010,GO:0006556,1.00000000000722,0.800621110623613,0,2,S-adenosylmethionine biosynthetic process,BP,
12176,GO:0048269,1.00000000000722,0.800621110623613,0,2,methionine adenosyltransferase complex,CC,
8166,GO:0032889,1.00000000000723,0.893830796380203,0,1,regulation of vacuole fusion, non-autophagic,BP,
7973,GO:0032574,1.00000000000723,0.8897861929011,0,1,5'-3' RNA helicase activity,MF,
7974,GO:0032575,1.00000000000723,0.8897861929011,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
2211,GO:0005094,1.00000000000724,0.823605595633663,0,2,Rho GDP-dissociation inhibitor activity,MF,
5000,GO:0015140,1.00000000000724,0.809756541228802,0,2,malate transmembrane transporter activity,MF,
19962,GO:2000434,1.00000000000725,0.867510301817178,0,2,regulation of protein neddylation,BP,
19963,GO:2000435,1.00000000000725,0.867510301817178,0,2,negative regulation of protein neddylation,BP,
4591,GO:0010693,1.00000000000726,0.713111563007916,0,3,negative regulation of alkaline phosphatase activity,BP,
13823,GO:0060392,1.00000000000726,0.816525974896195,0,2,negative regulation of SMAD protein signal transduction,BP,
12011,GO:0047389,1.00000000000728,0.792413441434309,0,2,glycerophosphocholine phosphodiesterase activity,MF,
4594,GO:0010700,1.00000000000728,0.892209176994716,0,1,negative regulation of norepinephrine secretion,BP,
7512,GO:0031686,1.00000000000728,0.892209176994716,0,1,A1 adenosine receptor binding,MF,
11063,GO:0045032,1.00000000000728,0.892209176994716,0,1,ADP-activated adenosine receptor activity,MF,
295,GO:0000799,1.00000000000728,0.70167820339819,0,3,nuclear condensin complex,CC,
12047,GO:0047710,1.00000000000729,0.920374054774293,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
4703,GO:0010859,1.00000000000729,0.889039145443787,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
13436,GO:0052810,1.00000000000732,0.890355130860093,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13950,GO:0060592,1.00000000000732,0.632477357164768,0,4,mammary gland formation,BP,
13846,GO:0060423,1.00000000000732,0.797875523391437,0,2,foregut regionalization,BP,
13847,GO:0060424,1.00000000000732,0.797875523391437,0,2,lung field specification,BP,
13895,GO:0060492,1.00000000000732,0.797875523391437,0,2,lung induction,BP,
13738,GO:0060283,1.00000000000732,0.791712566492573,0,2,negative regulation of oocyte development,BP,
19417,GO:1905880,1.00000000000732,0.791712566492573,0,2,negative regulation of oogenesis,BP,
10930,GO:0044530,1.00000000000733,0.707732952379074,0,3,supraspliceosomal complex,CC,
8056,GO:0032707,1.00000000000734,0.894489308918335,0,1,negative regulation of interleukin-23 production,BP,
12051,GO:0047747,1.00000000000734,0.894489308918335,0,1,cholate-CoA ligase activity,MF,
525,GO:0001631,1.00000000000735,0.808183249777306,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,1.00000000000735,0.808183249777306,0,2,leukotriene B4 receptor activity,MF,
2156,GO:0004974,1.00000000000735,0.808183249777306,0,2,leukotriene receptor activity,MF,
14445,GO:0061737,1.00000000000735,0.808183249777306,0,2,leukotriene signaling pathway,BP,
2883,GO:0006386,1.00000000000735,0.932182872745402,0,1,termination of RNA polymerase III transcription,BP,
13540,GO:0055091,1.00000000000735,0.626495734200957,0,4,phospholipid homeostasis,BP,
15307,GO:0071475,1.00000000000737,0.726504236557139,0,3,cellular hyperosmotic salinity response,BP,
9566,GO:0036333,1.00000000000737,0.893492446872571,0,1,hepatocyte homeostasis,BP,
19011,GO:1904772,1.00000000000737,0.893492446872571,0,1,response to tetrachloromethane,BP,
1850,GO:0004506,1.00000000000737,0.892524720204207,0,1,squalene monooxygenase activity,MF,
19276,GO:1905404,1.00000000000739,0.906034535029455,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
9153,GO:0035494,1.00000000000739,0.715018887392994,0,3,SNARE complex disassembly,BP,
5205,GO:0015801,1.0000000000074,0.800254168899729,0,2,aromatic amino acid transport,BP,
5226,GO:0015827,1.0000000000074,0.800254168899729,0,2,tryptophan transport,BP,
1293,GO:0003100,1.0000000000074,0.639800353843086,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
3002,GO:0006548,1.0000000000074,0.73871491977085,0,3,histidine catabolic process,BP,
13435,GO:0052805,1.0000000000074,0.73871491977085,0,3,imidazole-containing compound catabolic process,BP,
1614,GO:0004034,1.00000000000741,0.89398479568693,0,1,aldose 1-epimerase activity,MF,
9408,GO:0035945,1.00000000000741,0.89398479568693,0,1,mitochondrial ncRNA surveillance,BP,
9409,GO:0035946,1.00000000000741,0.89398479568693,0,1,mitochondrial mRNA surveillance,BP,
15082,GO:0071026,1.00000000000741,0.89398479568693,0,1,cytoplasmic RNA surveillance,BP,
20169,GO:2000827,1.00000000000741,0.89398479568693,0,1,mitochondrial RNA surveillance,BP,
6146,GO:0019418,1.00000000000742,0.700602463270569,0,4,sulfide oxidation,BP,
14655,GO:0070221,1.00000000000742,0.700602463270569,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
4394,GO:0010046,1.00000000000742,0.642186316146036,0,4,response to mycotoxin,BP,
6427,GO:0021688,1.00000000000743,0.891576834575154,0,1,cerebellar molecular layer formation,BP,
14091,GO:0060853,1.00000000000743,0.891576834575154,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
9290,GO:0035720,1.00000000000744,0.713556929261424,0,3,intraciliary anterograde transport,BP,
10462,GO:0043309,1.00000000000744,0.812626722026697,0,2,regulation of eosinophil degranulation,BP,
10463,GO:0043311,1.00000000000744,0.812626722026697,0,2,positive regulation of eosinophil degranulation,BP,
18067,GO:1902566,1.00000000000744,0.812626722026697,0,2,regulation of eosinophil activation,BP,
18068,GO:1902568,1.00000000000744,0.812626722026697,0,2,positive regulation of eosinophil activation,BP,
13301,GO:0051969,1.00000000000744,0.637911312456799,0,4,regulation of transmission of nerve impulse,BP,
11028,GO:0044854,1.00000000000745,0.642594200838352,0,4,plasma membrane raft assembly,BP,
11031,GO:0044857,1.00000000000745,0.642594200838352,0,4,plasma membrane raft organization,BP,
12052,GO:0047750,1.00000000000746,0.848750668945904,0,2,cholestenol delta-isomerase activity,MF,
19865,GO:2000299,1.00000000000746,0.891432804038389,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
15068,GO:0071001,1.00000000000747,0.739871935500853,0,3,U4/U6 snRNP,CC,
7240,GO:0031134,1.00000000000747,0.71387870681457,0,3,sister chromatid biorientation,BP,
9942,GO:0042281,1.00000000000748,0.804050626846106,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
11134,GO:0045145,1.00000000000749,0.796294823771656,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12780,GO:0051030,1.0000000000075,0.671483573278161,0,4,snRNA transport,BP,
16769,GO:0098528,1.0000000000075,0.638794161858572,0,4,skeletal muscle fiber differentiation,BP,
9419,GO:0035971,1.00000000000751,0.915640758850097,0,1,peptidyl-histidine dephosphorylation,BP,
15458,GO:0071723,1.00000000000752,0.704904444751103,0,3,lipopeptide binding,MF,
5983,GO:0018738,1.00000000000752,0.91646769046507,0,1,S-formylglutathione hydrolase activity,MF,
6891,GO:0030395,1.00000000000752,0.942912541576582,0,1,lactose binding,MF,
8615,GO:0034117,1.00000000000752,0.942912541576582,0,1,erythrocyte aggregation,BP,
8616,GO:0034118,1.00000000000752,0.942912541576582,0,1,regulation of erythrocyte aggregation,BP,
8617,GO:0034120,1.00000000000752,0.942912541576582,0,1,positive regulation of erythrocyte aggregation,BP,
12096,GO:0048030,1.00000000000752,0.942912541576582,0,1,disaccharide binding,MF,
3134,GO:0006725,1.00000000000753,0,379,4721,cellular aromatic compound metabolic process,BP,TNIP1;NT5E;XDH;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NAPRT;CRTC1;PCK2;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;H6PD;KIAA1549;ADCY7;XBP1;PGLS;EGFR;CSNK1E;TK2;RFX2;PRKACA;ADARB1;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;ALDH1L2;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;ENDOG;NSMCE4A;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;RPUSD3;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;ARID5B;TOP1;MICAL2;CAP1;MYDGF;AKR7A2;TSC22D4;TULP3;SRC;KDM4B;GLRX;CBR4;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;OAS1;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;COMT;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;STUB1;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;RAD23A;AOX1;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ZNF687;ENTPD6;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;NDUFS2;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;LDHA;PIK3R2;ANXA1;PODXL2;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
11009,GO:0044803,1.00000000000754,0.636569716868744,0,4,multi-organism membrane organization,BP,
13203,GO:0051790,1.00000000000755,0.649730712926771,0,4,short-chain fatty acid biosynthetic process,BP,
15328,GO:0071502,1.00000000000756,0.730557844288009,0,3,cellular response to temperature stimulus,BP,
4778,GO:0010961,1.00000000000756,0.78940021394304,0,2,cellular magnesium ion homeostasis,BP,
9933,GO:0042270,1.00000000000758,0.724158936429591,0,3,protection from natural killer cell mediated cytotoxicity,BP,
161,GO:0000332,1.00000000000758,0.948020704864243,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
239,GO:0000496,1.00000000000758,0.948020704864243,0,1,base pairing,MF,
240,GO:0000497,1.00000000000758,0.948020704864243,0,1,base pairing with DNA,MF,
1469,GO:0003721,1.00000000000758,0.948020704864243,0,1,telomerase RNA reverse transcriptase activity,MF,
14034,GO:0060735,1.00000000000758,0.910918771719275,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18092,GO:1902629,1.00000000000758,0.910918771719275,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
8775,GO:0034441,1.00000000000761,0.900425745891801,0,1,plasma lipoprotein particle oxidation,BP,
5380,GO:0016191,1.00000000000761,0.62719657031025,0,4,synaptic vesicle uncoating,BP,
4668,GO:0010814,1.00000000000761,0.888460914691438,0,1,substance P catabolic process,BP,
4670,GO:0010816,1.00000000000761,0.888460914691438,0,1,calcitonin catabolic process,BP,
7308,GO:0031302,1.00000000000761,0.888460914691438,0,1,intrinsic component of endosome membrane,CC,
8940,GO:0034959,1.00000000000761,0.888460914691438,0,1,endothelin maturation,BP,
12511,GO:0050508,1.00000000000762,0.793704369715105,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12512,GO:0050509,1.00000000000762,0.793704369715105,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13741,GO:0060287,1.00000000000763,0.64545982916043,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
10703,GO:0043972,1.00000000000763,0.888671060426922,0,1,histone H3-K23 acetylation,BP,
10714,GO:0043994,1.00000000000763,0.888671060426922,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
6485,GO:0021825,1.00000000000763,0.626869415899001,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6015,GO:0019061,1.00000000000764,0.895032717586781,0,1,uncoating of virus,BP,
10842,GO:0044326,1.00000000000765,0.797864501160227,0,2,dendritic spine neck,CC,
20269,GO:2001180,1.00000000000765,0.800696408445792,0,2,negative regulation of interleukin-10 secretion,BP,
13907,GO:0060526,1.00000000000766,0.624016684973164,0,4,prostate glandular acinus morphogenesis,BP,
13908,GO:0060527,1.00000000000766,0.624016684973164,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
6767,GO:0030197,1.00000000000766,0.793680210990741,0,2,extracellular matrix constituent, lubricant activity,MF,
16428,GO:0097037,1.00000000000766,0.891211807629078,0,1,heme export,BP,
11688,GO:0046452,1.00000000000766,0.734660941384178,0,3,dihydrofolate metabolic process,BP,
11754,GO:0046570,1.00000000000767,0.914293633246263,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
3349,GO:0007079,1.00000000000769,0.704970631729542,0,3,mitotic chromosome movement towards spindle pole,BP,
6052,GO:0019185,1.00000000000769,0.793989629644258,0,2,snRNA-activating protein complex,CC,
12143,GO:0048203,1.00000000000769,0.802147941533458,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12627,GO:0050787,1.0000000000077,0.823061705257452,0,2,detoxification of mercury ion,BP,
7847,GO:0032398,1.0000000000077,0.902767004661741,0,1,MHC class Ib protein complex,CC,
8015,GO:0032639,1.0000000000077,0.902767004661741,0,1,TRAIL production,BP,
8039,GO:0032679,1.0000000000077,0.902767004661741,0,1,regulation of TRAIL production,BP,
8084,GO:0032759,1.0000000000077,0.902767004661741,0,1,positive regulation of TRAIL production,BP,
20012,GO:2000566,1.0000000000077,0.902767004661741,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20276,GO:2001187,1.0000000000077,0.902767004661741,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
10711,GO:0043987,1.00000000000771,0.643701671343346,0,4,histone H3-S10 phosphorylation,BP,
15872,GO:0072572,1.00000000000772,0.896054041118754,0,1,poly-ADP-D-ribose binding,MF,
4226,GO:0009400,1.00000000000774,0.892930174576864,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
8727,GO:0034366,1.00000000000774,0.892930174576864,0,1,spherical high-density lipoprotein particle,CC,
14353,GO:0061517,1.00000000000774,0.892930174576864,0,1,macrophage proliferation,BP,
14354,GO:0061518,1.00000000000774,0.892930174576864,0,1,microglial cell proliferation,BP,
18158,GO:1902847,1.00000000000774,0.892930174576864,0,1,regulation of neuronal signal transduction,BP,
18234,GO:1902998,1.00000000000774,0.892930174576864,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19420,GO:1905891,1.00000000000774,0.892930174576864,0,1,regulation of cellular response to thapsigargin,BP,
19421,GO:1905892,1.00000000000774,0.892930174576864,0,1,negative regulation of cellular response to thapsigargin,BP,
19422,GO:1905894,1.00000000000774,0.892930174576864,0,1,regulation of cellular response to tunicamycin,BP,
19423,GO:1905895,1.00000000000774,0.892930174576864,0,1,negative regulation of cellular response to tunicamycin,BP,
8172,GO:0032899,1.00000000000774,0.889965077859999,0,1,regulation of neurotrophin production,BP,
8173,GO:0032901,1.00000000000774,0.889965077859999,0,1,positive regulation of neurotrophin production,BP,
8861,GO:0034649,1.00000000000774,0.889965077859999,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12230,GO:0048403,1.00000000000774,0.889965077859999,0,1,brain-derived neurotrophic factor binding,MF,
8316,GO:0033142,1.00000000000774,0.895629745209424,0,1,progesterone receptor binding,MF,
6004,GO:0019035,1.00000000000776,0.888394447991183,0,1,viral integration complex,CC,
11453,GO:0045870,1.00000000000776,0.888394447991183,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19305,GO:1905463,1.00000000000776,0.888394447991183,0,1,negative regulation of DNA duplex unwinding,BP,
6470,GO:0021796,1.00000000000777,0.708925273379006,0,3,cerebral cortex regionalization,BP,
9672,GO:0038021,1.00000000000777,0.889209357673527,0,1,leptin receptor activity,MF,
11478,GO:0045918,1.00000000000779,0.858305551998914,0,2,negative regulation of cytolysis,BP,
779,GO:0002032,1.0000000000078,0.806234182406933,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
2646,GO:0005981,1.0000000000078,0.639535546305079,0,4,regulation of glycogen catabolic process,BP,
15586,GO:0072019,1.00000000000781,0.896062865392688,0,1,proximal convoluted tubule development,BP,
15714,GO:0072229,1.00000000000781,0.896062865392688,0,1,metanephric proximal convoluted tubule development,BP,
18163,GO:1902858,1.00000000000781,0.896062865392688,0,1,propionyl-CoA metabolic process,BP,
18164,GO:1902860,1.00000000000781,0.896062865392688,0,1,propionyl-CoA biosynthetic process,BP,
2224,GO:0005124,1.00000000000782,0.894323852527834,0,1,scavenger receptor binding,MF,
5427,GO:0016277,1.00000000000782,0.894323852527834,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17798,GO:1901804,1.00000000000782,0.894323852527834,0,1,beta-glucoside metabolic process,BP,
17799,GO:1901805,1.00000000000782,0.894323852527834,0,1,beta-glucoside catabolic process,BP,
18876,GO:1904457,1.00000000000782,0.894323852527834,0,1,positive regulation of neuronal action potential,BP,
12822,GO:0051097,1.00000000000783,0.715435697117024,0,3,negative regulation of helicase activity,BP,
11736,GO:0046525,1.00000000000783,0.901798054051277,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
18107,GO:1902685,1.00000000000783,0.889190341526651,0,1,positive regulation of receptor localization to synapse,BP,
1665,GO:0004118,1.00000000000788,0.889305551734618,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
4169,GO:0009234,1.00000000000789,0.890591343200308,0,1,menaquinone biosynthetic process,BP,
7713,GO:0032194,1.00000000000789,0.890591343200308,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9989,GO:0042371,1.00000000000789,0.890591343200308,0,1,vitamin K biosynthetic process,BP,
18718,GO:1904045,1.00000000000789,0.895476589869098,0,1,cellular response to aldosterone,BP,
2775,GO:0006203,1.00000000000789,0.748828679427687,0,3,dGTP catabolic process,BP,
4853,GO:0014063,1.00000000000789,0.917414377000681,0,1,negative regulation of serotonin secretion,BP,
16025,GO:0086017,1.00000000000789,0.79349637501357,0,2,Purkinje myocyte action potential,BP,
16035,GO:0086029,1.00000000000789,0.79349637501357,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16056,GO:0086068,1.00000000000789,0.79349637501357,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
15633,GO:0072102,1.00000000000789,0.710950986934112,0,3,glomerulus morphogenesis,BP,
18226,GO:1902990,1.0000000000079,0.720407124072536,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
1064,GO:0002589,1.00000000000791,0.808450009514347,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002590,1.00000000000791,0.808450009514347,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
14300,GO:0061355,1.00000000000791,0.637031395049154,0,4,Wnt protein secretion,BP,
14301,GO:0061356,1.00000000000791,0.637031395049154,0,4,regulation of Wnt protein secretion,BP,
9542,GO:0036266,1.00000000000792,0.893747335341672,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15918,GO:0072671,1.00000000000792,0.893747335341672,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
6754,GO:0030172,1.00000000000792,0.918558424339034,0,1,troponin C binding,MF,
8223,GO:0032971,1.00000000000792,0.918558424339034,0,1,regulation of muscle filament sliding,BP,
8224,GO:0032972,1.00000000000792,0.918558424339034,0,1,regulation of muscle filament sliding speed,BP,
19599,GO:1990584,1.00000000000792,0.918558424339034,0,1,cardiac Troponin complex,CC,
19662,GO:1990809,1.00000000000794,0.638371558002423,0,4,endoplasmic reticulum tubular network membrane organization,BP,
9779,GO:0039534,1.00000000000794,0.651158868100619,0,4,negative regulation of MDA-5 signaling pathway,BP,
6049,GO:0019166,1.00000000000796,0.72774990183738,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
16486,GO:0097149,1.00000000000796,0.706925144561799,0,3,centralspindlin complex,CC,
9667,GO:0038002,1.00000000000797,0.888413038769464,0,1,endocrine signaling,BP,
15800,GO:0072387,1.00000000000797,0.79907170094931,0,2,flavin adenine dinucleotide metabolic process,BP,
8682,GO:0034247,1.00000000000797,0.913276904969124,0,1,snoRNA splicing,BP,
12065,GO:0047915,1.00000000000797,0.902703054120303,0,1,ganglioside galactosyltransferase activity,MF,
15476,GO:0071796,1.00000000000797,0.913276904969124,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
9821,GO:0042007,1.00000000000797,0.909342019391015,0,1,interleukin-18 binding,MF,
2323,GO:0005329,1.000000000008,0.789633619241624,0,2,dopamine transmembrane transporter activity,MF,
1959,GO:0004660,1.000000000008,0.807680942979696,0,2,protein farnesyltransferase activity,MF,
2635,GO:0005965,1.000000000008,0.807680942979696,0,2,protein farnesyltransferase complex,CC,
13635,GO:0060087,1.000000000008,0.674818811138568,0,4,relaxation of vascular smooth muscle,BP,
3883,GO:0008513,1.00000000000801,0.895598536480937,0,1,secondary active organic cation transmembrane transporter activity,MF,
850,GO:0002169,1.00000000000801,0.795883728326535,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1833,GO:0004485,1.00000000000801,0.795883728326535,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19192,GO:1905202,1.00000000000801,0.795883728326535,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
18510,GO:1903589,1.00000000000801,0.807008654989051,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
9565,GO:0036324,1.00000000000802,0.816534986539962,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
6350,GO:0021523,1.00000000000803,0.807091376307679,0,2,somatic motor neuron differentiation,BP,
309,GO:0000820,1.00000000000803,0.789321626503066,0,2,regulation of glutamine family amino acid metabolic process,BP,
11402,GO:0045763,1.00000000000803,0.789321626503066,0,2,negative regulation of cellular amino acid metabolic process,BP,
18886,GO:1904491,1.00000000000803,0.655926966113048,0,4,protein localization to ciliary transition zone,BP,
6956,GO:0030578,1.00000000000804,0.640047454439872,0,4,PML body organization,BP,
16321,GO:0090416,1.00000000000805,0.893699909897948,0,1,nicotinate transmembrane transporter activity,MF,
20249,GO:2001142,1.00000000000805,0.893699909897948,0,1,nicotinate transport,BP,
18130,GO:1902744,1.00000000000807,0.626082482129388,0,4,negative regulation of lamellipodium organization,BP,
2681,GO:0006041,1.00000000000807,0.642175260973133,0,4,glucosamine metabolic process,BP,
8543,GO:0033860,1.00000000000807,0.775244586712679,0,3,regulation of NAD(P)H oxidase activity,BP,
8545,GO:0033864,1.00000000000807,0.775244586712679,0,3,positive regulation of NAD(P)H oxidase activity,BP,
5526,GO:0016493,1.00000000000809,0.799040736436117,0,2,C-C chemokine receptor activity,MF,
1739,GO:0004334,1.00000000000809,0.908286747181002,0,1,fumarylacetoacetase activity,MF,
758,GO:0001996,1.00000000000811,0.716609956254773,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1400,GO:0003321,1.00000000000811,0.716609956254773,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
8626,GO:0034136,1.00000000000812,0.704689732591683,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
2697,GO:0006061,1.00000000000813,0.909810018680385,0,1,sorbitol biosynthetic process,BP,
5992,GO:0018931,1.00000000000813,0.909810018680385,0,1,naphthalene metabolic process,BP,
6141,GO:0019406,1.00000000000813,0.909810018680385,0,1,hexitol biosynthetic process,BP,
10670,GO:0043795,1.00000000000813,0.909810018680385,0,1,glyceraldehyde oxidoreductase activity,MF,
16322,GO:0090420,1.00000000000813,0.909810018680385,0,1,naphthalene-containing compound metabolic process,BP,
9189,GO:0035553,1.00000000000813,0.717285392525038,0,3,oxidative single-stranded RNA demethylation,BP,
4689,GO:0010836,1.00000000000814,0.725254329356618,0,3,negative regulation of protein ADP-ribosylation,BP,
6621,GO:0022840,1.00000000000815,0.643977975222808,0,4,leak channel activity,MF,
6623,GO:0022842,1.00000000000815,0.643977975222808,0,4,narrow pore channel activity,MF,
5207,GO:0015803,1.00000000000818,0.710716751821196,0,3,branched-chain amino acid transport,BP,
3916,GO:0008579,1.00000000000819,0.888424366245661,0,1,JUN kinase phosphatase activity,MF,
1963,GO:0004666,1.00000000000821,0.789761395017442,0,2,prostaglandin-endoperoxide synthase activity,MF,
760,GO:0001998,1.00000000000821,0.898547497764491,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
780,GO:0002034,1.00000000000821,0.898547497764491,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1281,GO:0003072,1.00000000000821,0.898547497764491,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18538,GO:1903673,1.00000000000821,0.898547497764491,0,1,mitotic cleavage furrow formation,BP,
18971,GO:1904695,1.00000000000821,0.898547497764491,0,1,positive regulation of vascular smooth muscle contraction,BP,
8578,GO:0034038,1.00000000000821,0.916781338962951,0,1,deoxyhypusine synthase activity,MF,
9234,GO:0035614,1.00000000000822,0.738750925523496,0,3,snRNA stem-loop binding,MF,
14560,GO:0070061,1.00000000000822,0.720838201123547,0,3,fructose binding,MF,
10324,GO:0043095,1.00000000000822,0.935809501293019,0,1,regulation of GTP cyclohydrolase I activity,BP,
10330,GO:0043105,1.00000000000822,0.935809501293019,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10940,GO:0044549,1.00000000000822,0.935809501293019,0,1,GTP cyclohydrolase binding,MF,
17924,GO:1902202,1.00000000000823,0.804397620090321,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
1061,GO:0002586,1.00000000000825,0.845132844759047,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
8917,GO:0034750,1.00000000000825,0.791805341472752,0,2,Scrib-APC-beta-catenin complex,CC,
1715,GO:0004304,1.00000000000828,0.900736761122134,0,1,estrone sulfotransferase activity,MF,
3086,GO:0006660,1.00000000000828,0.900736761122134,0,1,phosphatidylserine catabolic process,BP,
3129,GO:0006711,1.00000000000828,0.900736761122134,0,1,estrogen catabolic process,BP,
11233,GO:0045352,1.00000000000828,0.900736761122134,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11234,GO:0045353,1.00000000000828,0.900736761122134,0,1,interleukin-1 Type II receptor antagonist activity,MF,
14586,GO:0070101,1.00000000000829,0.797556222091308,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
8104,GO:0032783,1.00000000000829,0.64745858592885,0,4,ELL-EAF complex,CC,
1320,GO:0003165,1.00000000000829,0.888394899392177,0,1,Purkinje myocyte development,BP,
13683,GO:0060179,1.0000000000083,0.714458567296406,0,3,male mating behavior,BP,
15360,GO:0071566,1.00000000000831,0.892651683424796,0,1,UFM1 activating enzyme activity,MF,
8711,GO:0034342,1.00000000000832,0.800101798096616,0,2,response to type III interferon,BP,
15546,GO:0071918,1.00000000000833,0.793703136368834,0,2,urea transmembrane transport,BP,
1548,GO:0003940,1.00000000000833,0.895606311312411,0,1,L-iduronidase activity,MF,
3840,GO:0008444,1.00000000000833,0.895606311312411,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6779,GO:0030209,1.00000000000833,0.895606311312411,0,1,dermatan sulfate catabolic process,BP,
6885,GO:0030375,1.00000000000835,0.704526155207754,0,3,thyroid hormone receptor coactivator activity,MF,
1593,GO:0004001,1.00000000000837,0.896878632938539,0,1,adenosine kinase activity,MF,
2006,GO:0004727,1.00000000000837,0.896878632938539,0,1,prenylated protein tyrosine phosphatase activity,MF,
2760,GO:0006169,1.00000000000837,0.896878632938539,0,1,adenosine salvage,BP,
2763,GO:0006175,1.00000000000837,0.896878632938539,0,1,dATP biosynthetic process,BP,
4155,GO:0009216,1.00000000000837,0.896878632938539,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
17648,GO:1901329,1.00000000000837,0.802693184761319,0,2,regulation of odontoblast differentiation,BP,
611,GO:0001777,1.00000000000838,0.93149709429118,0,1,T cell homeostatic proliferation,BP,
947,GO:0002358,1.00000000000838,0.93149709429118,0,1,B cell homeostatic proliferation,BP,
8225,GO:0032976,1.00000000000838,0.93149709429118,0,1,release of matrix enzymes from mitochondria,BP,
16484,GO:0097144,1.00000000000838,0.93149709429118,0,1,BAX complex,CC,
19481,GO:1990117,1.00000000000838,0.93149709429118,0,1,B cell receptor apoptotic signaling pathway,BP,
15044,GO:0070966,1.00000000000838,0.705397722016984,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
1773,GO:0004375,1.00000000000839,0.890116860335564,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
5606,GO:0016642,1.00000000000839,0.890116860335564,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
9536,GO:0036255,1.00000000000839,0.890116860335564,0,1,response to methylamine,BP,
14687,GO:0070280,1.00000000000839,0.890116860335564,0,1,pyridoxal binding,MF,
18439,GO:1903442,1.00000000000839,0.890116860335564,0,1,response to lipoic acid,BP,
18511,GO:1903593,1.00000000000839,0.746439836551632,0,3,regulation of histamine secretion by mast cell,BP,
18512,GO:1903595,1.00000000000839,0.746439836551632,0,3,positive regulation of histamine secretion by mast cell,BP,
18969,GO:1904693,1.0000000000084,0.70381230312398,0,3,midbrain morphogenesis,BP,
15742,GO:0072289,1.00000000000842,0.791989547162191,0,2,metanephric nephron tubule formation,BP,
2505,GO:0005757,1.00000000000843,0.670862146554864,0,4,mitochondrial permeability transition pore complex,CC,
6466,GO:0021784,1.00000000000844,0.93728219937091,0,1,postganglionic parasympathetic fiber development,BP,
7425,GO:0031510,1.00000000000845,0.725571177867328,0,3,SUMO activating enzyme complex,CC,
15490,GO:0071816,1.00000000000846,0.649335344740069,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
9176,GO:0035523,1.00000000000846,0.632954482107884,0,4,protein K29-linked deubiquitination,BP,
7916,GO:0032483,1.00000000000846,0.627377484176246,0,4,regulation of Rab protein signal transduction,BP,
10561,GO:0043504,1.00000000000846,0.706108991890998,0,3,mitochondrial DNA repair,BP,
13412,GO:0052692,1.00000000000846,0.909313001658026,0,1,raffinose alpha-galactosidase activity,MF,
16599,GO:0097376,1.00000000000846,0.909313001658026,0,1,interneuron axon guidance,BP,
18460,GO:1903516,1.00000000000849,0.711913898694725,0,3,regulation of single strand break repair,BP,
6599,GO:0022613,1.00000000000851,0,8,448,ribonucleoprotein complex biogenesis,BP,CSNK1E;RRNAD1;AGO4;ISG20;CHD7;WDR18;RPL28;CSNK1D
14466,GO:0061772,1.00000000000852,0.891265388141253,0,1,drug transport across blood-nerve barrier,BP,
18482,GO:1903544,1.00000000000852,0.891265388141253,0,1,response to butyrate,BP,
18483,GO:1903545,1.00000000000852,0.891265388141253,0,1,cellular response to butyrate,BP,
10472,GO:0043321,1.00000000000852,0.794010983792616,0,2,regulation of natural killer cell degranulation,BP,
10473,GO:0043323,1.00000000000852,0.794010983792616,0,2,positive regulation of natural killer cell degranulation,BP,
19984,GO:2000491,1.00000000000853,0.892002116632622,0,1,positive regulation of hepatic stellate cell activation,BP,
15736,GO:0072278,1.00000000000855,0.801637860779487,0,2,metanephric comma-shaped body morphogenesis,BP,
17044,GO:0099174,1.00000000000856,0.706592342731435,0,3,regulation of presynapse organization,BP,
19353,GO:1905606,1.00000000000856,0.706592342731435,0,3,regulation of presynapse assembly,BP,
12739,GO:0050957,1.00000000000857,0.889768076241609,0,1,equilibrioception,BP,
8214,GO:0032960,1.00000000000857,0.629598610289364,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
18432,GO:1903434,1.00000000000858,0.89003637942724,0,1,negative regulation of constitutive secretory pathway,BP,
9393,GO:0035921,1.0000000000086,0.896461640121758,0,1,desmosome disassembly,BP,
17505,GO:1900387,1.0000000000086,0.896461640121758,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
5713,GO:0016841,1.00000000000861,0.725619858084236,0,3,ammonia-lyase activity,MF,
14103,GO:0060903,1.00000000000863,0.795293742831243,0,2,positive regulation of meiosis I,BP,
14579,GO:0070094,1.00000000000863,0.89363978864578,0,1,positive regulation of glucagon secretion,BP,
18211,GO:1902956,1.00000000000864,0.738246503319355,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
1794,GO:0004420,1.00000000000864,0.888869528675714,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9943,GO:0042282,1.00000000000864,0.888869528675714,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
6946,GO:0030549,1.00000000000867,0.91810871481811,0,1,acetylcholine receptor activator activity,MF,
15534,GO:0071896,1.00000000000867,0.622926930312118,0,4,protein localization to adherens junction,BP,
7511,GO:0031685,1.00000000000869,0.793670753602152,0,2,adenosine receptor binding,MF,
11283,GO:0045569,1.00000000000869,0.650191096829813,0,4,TRAIL binding,MF,
2058,GO:0004807,1.0000000000087,0.908174944711275,0,1,triose-phosphate isomerase activity,MF,
18677,GO:1903964,1.00000000000875,0.793885350093246,0,2,monounsaturated fatty acid metabolic process,BP,
18678,GO:1903966,1.00000000000875,0.793885350093246,0,2,monounsaturated fatty acid biosynthetic process,BP,
15318,GO:0071486,1.00000000000877,0.888426907404805,0,1,cellular response to high light intensity,BP,
16642,GO:0097473,1.00000000000877,0.888426907404805,0,1,retinal rod cell apoptotic process,BP,
19454,GO:1990009,1.00000000000877,0.888426907404805,0,1,retinal cell apoptotic process,BP,
18964,GO:1904685,1.00000000000878,0.795318129189208,0,2,positive regulation of metalloendopeptidase activity,BP,
16495,GO:0097158,1.00000000000878,0.903556459967955,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
1519,GO:0003877,1.00000000000878,0.896322881691323,0,1,ATP adenylyltransferase activity,MF,
2073,GO:0004824,1.00000000000878,0.896322881691323,0,1,lysine-tRNA ligase activity,MF,
2919,GO:0006430,1.00000000000878,0.896322881691323,0,1,lysyl-tRNA aminoacylation,BP,
100,GO:0000210,1.00000000000878,0.891054962004716,0,1,NAD+ diphosphatase activity,MF,
3146,GO:0006742,1.00000000000878,0.891054962004716,0,1,NADP catabolic process,BP,
6120,GO:0019364,1.00000000000878,0.891054962004716,0,1,pyridine nucleotide catabolic process,BP,
6202,GO:0019677,1.00000000000878,0.891054962004716,0,1,NAD catabolic process,BP,
2185,GO:0005034,1.00000000000879,0.892045217864464,0,1,osmosensor activity,MF,
6706,GO:0030103,1.00000000000879,0.892045217864464,0,1,vasopressin secretion,BP,
16655,GO:0097497,1.00000000000879,0.892045217864464,0,1,blood vessel endothelial cell delamination,BP,
18440,GO:1903444,1.00000000000879,0.892045217864464,0,1,negative regulation of brown fat cell differentiation,BP,
18575,GO:1903759,1.00000000000879,0.892045217864464,0,1,signal transduction involved in regulation of aerobic respiration,BP,
2508,GO:0005760,1.0000000000088,0.790227058990845,0,2,gamma DNA polymerase complex,CC,
4477,GO:0010477,1.00000000000881,0.891774968322433,0,1,response to sulfur dioxide,BP,
10667,GO:0043739,1.00000000000881,0.891774968322433,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
345,GO:0000958,1.00000000000882,0.706915048673424,0,3,mitochondrial mRNA catabolic process,BP,
7571,GO:0031914,1.00000000000884,0.729388020162586,0,3,negative regulation of synaptic plasticity,BP,
7121,GO:0030916,1.00000000000885,0.703184836270962,0,3,otic vesicle formation,BP,
14036,GO:0060737,1.00000000000885,0.703184836270962,0,3,prostate gland morphogenetic growth,BP,
15380,GO:0071600,1.00000000000885,0.703184836270962,0,3,otic vesicle morphogenesis,BP,
2302,GO:0005275,1.00000000000885,0.892441779876818,0,1,amine transmembrane transporter activity,MF,
5059,GO:0015265,1.00000000000885,0.892441779876818,0,1,urea channel activity,MF,
11181,GO:0045226,1.00000000000886,0.796585764161487,0,2,extracellular polysaccharide biosynthetic process,BP,
11663,GO:0046379,1.00000000000886,0.796585764161487,0,2,extracellular polysaccharide metabolic process,BP,
12343,GO:0048680,1.00000000000888,0.660200536027866,0,4,positive regulation of axon regeneration,BP,
14848,GO:0070572,1.00000000000888,0.660200536027866,0,4,positive regulation of neuron projection regeneration,BP,
5622,GO:0016672,1.00000000000888,0.846155621417027,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11145,GO:0045174,1.00000000000888,0.846155621417027,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12522,GO:0050610,1.00000000000888,0.846155621417027,0,2,methylarsonate reductase activity,MF,
86,GO:0000173,1.00000000000889,0.903388651521251,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
5711,GO:0016838,1.00000000000889,0.830290555098411,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
11998,GO:0047290,1.00000000000889,0.903466744671619,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
19568,GO:1990446,1.00000000000889,0.669125784446806,0,4,U1 snRNP binding,MF,
12528,GO:0050652,1.0000000000089,0.89038749750154,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12529,GO:0050653,1.0000000000089,0.89038749750154,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
17154,GO:0102200,1.00000000000891,0.888438964185579,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
2367,GO:0005477,1.00000000000891,0.89090568870583,0,1,pyruvate secondary active transmembrane transporter activity,MF,
8240,GO:0032996,1.00000000000892,0.899313827605643,0,1,Bcl3-Bcl10 complex,CC,
11096,GO:0045082,1.00000000000892,0.899313827605643,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
16319,GO:0090409,1.00000000000892,0.894944438792889,0,1,malonyl-CoA synthetase activity,MF,
16320,GO:0090410,1.00000000000892,0.894944438792889,0,1,malonate catabolic process,BP,
15683,GO:0072185,1.00000000000892,0.894530308354472,0,1,metanephric cap development,BP,
15684,GO:0072186,1.00000000000892,0.894530308354472,0,1,metanephric cap morphogenesis,BP,
16130,GO:0090094,1.00000000000892,0.894530308354472,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16131,GO:0090095,1.00000000000892,0.894530308354472,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16132,GO:0090096,1.00000000000892,0.894530308354472,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
11034,GO:0044861,1.00000000000894,0.79876747118479,0,2,protein transport into plasma membrane raft,BP,
18091,GO:1902626,1.00000000000896,0.78774694167422,0,3,assembly of large subunit precursor of preribosome,BP,
9455,GO:0036033,1.00000000000896,0.623593914429586,0,4,mediator complex binding,MF,
1388,GO:0003289,1.00000000000897,0.704649373421829,0,3,atrial septum primum morphogenesis,BP,
4311,GO:0009786,1.00000000000898,0.808341470277586,0,2,regulation of asymmetric cell division,BP,
11432,GO:0045829,1.00000000000899,0.711110392825224,0,3,negative regulation of isotype switching,BP,
12519,GO:0050561,1.000000000009,0.889890671525962,0,1,glutamate-tRNA(Gln) ligase activity,MF,
20045,GO:2000625,1.00000000000901,0.793911805936354,0,2,regulation of miRNA catabolic process,BP,
20046,GO:2000627,1.00000000000901,0.793911805936354,0,2,positive regulation of miRNA catabolic process,BP,
6819,GO:0030272,1.00000000000906,0.928467456405864,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
17247,GO:0110008,1.00000000000907,0.892353708314262,0,1,ncRNA deadenylation,BP,
860,GO:0002188,1.0000000000091,0.704257342890979,0,3,translation reinitiation,BP,
2127,GO:0004920,1.00000000000912,0.640940276873509,0,4,interleukin-10 receptor activity,MF,
5062,GO:0015271,1.00000000000912,0.624643697154365,0,4,outward rectifier potassium channel activity,MF,
15931,GO:0072684,1.00000000000912,0.890137264023639,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
1607,GO:0004027,1.00000000000912,0.915402186925365,0,1,alcohol sulfotransferase activity,MF,
6412,GO:0021644,1.00000000000914,0.906111462714117,0,1,vagus nerve morphogenesis,BP,
19566,GO:1990441,1.00000000000915,0.639709497030099,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
1827,GO:0004477,1.00000000000916,0.635600732192901,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1836,GO:0004488,1.00000000000916,0.635600732192901,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
11571,GO:0046098,1.00000000000916,0.647586876770792,0,4,guanine metabolic process,BP,
13430,GO:0052794,1.00000000000916,0.800930586085015,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13431,GO:0052795,1.00000000000916,0.800930586085015,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13432,GO:0052796,1.00000000000916,0.800930586085015,0,2,exo-alpha-(2->8)-sialidase activity,MF,
2039,GO:0004777,1.00000000000917,0.888453682990606,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4016,GO:0009013,1.00000000000917,0.888453682990606,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10347,GO:0043131,1.00000000000917,0.888453682990606,0,1,erythrocyte enucleation,BP,
10482,GO:0043354,1.00000000000917,0.888453682990606,0,1,enucleate erythrocyte maturation,BP,
14509,GO:0061930,1.00000000000917,0.888453682990606,0,1,regulation of erythrocyte enucleation,BP,
14510,GO:0061931,1.00000000000917,0.888453682990606,0,1,positive regulation of erythrocyte enucleation,BP,
16364,GO:0090601,1.00000000000917,0.888453682990606,0,1,enucleation,BP,
18156,GO:1902838,1.00000000000917,0.888453682990606,0,1,regulation of nuclear migration along microtubule,BP,
9685,GO:0038039,1.00000000000918,0.889054289210535,0,1,G-protein coupled receptor heterodimeric complex,CC,
4298,GO:0009737,1.00000000000919,0.889071078288381,0,1,response to abscisic acid,BP,
4299,GO:0009738,1.00000000000919,0.889071078288381,0,1,abscisic acid-activated signaling pathway,BP,
4312,GO:0009787,1.00000000000919,0.889071078288381,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4313,GO:0009789,1.00000000000919,0.889071078288381,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15142,GO:0071215,1.00000000000919,0.889071078288381,0,1,cellular response to abscisic acid stimulus,BP,
17679,GO:1901419,1.00000000000919,0.889071078288381,0,1,regulation of response to alcohol,BP,
17680,GO:1901421,1.00000000000919,0.889071078288381,0,1,positive regulation of response to alcohol,BP,
19446,GO:1905957,1.00000000000919,0.889071078288381,0,1,regulation of cellular response to alcohol,BP,
19447,GO:1905959,1.00000000000919,0.889071078288381,0,1,positive regulation of cellular response to alcohol,BP,
7801,GO:0032345,1.0000000000092,0.709566547251703,0,3,negative regulation of aldosterone metabolic process,BP,
7804,GO:0032348,1.0000000000092,0.709566547251703,0,3,negative regulation of aldosterone biosynthetic process,BP,
19751,GO:2000065,1.0000000000092,0.709566547251703,0,3,negative regulation of cortisol biosynthetic process,BP,
6172,GO:0019530,1.00000000000921,0.62734261225872,0,4,taurine metabolic process,BP,
6206,GO:0019694,1.00000000000921,0.62734261225872,0,4,alkanesulfonate metabolic process,BP,
1964,GO:0004668,1.00000000000921,0.891927598397337,0,1,protein-arginine deiminase activity,MF,
2128,GO:0004921,1.00000000000921,0.891927598397337,0,1,interleukin-11 receptor activity,MF,
5900,GO:0018101,1.00000000000921,0.891927598397337,0,1,protein citrullination,BP,
6323,GO:0019970,1.00000000000921,0.891927598397337,0,1,interleukin-11 binding,MF,
9595,GO:0036414,1.00000000000921,0.891927598397337,0,1,histone citrullination,BP,
9728,GO:0038154,1.00000000000921,0.891927598397337,0,1,interleukin-11-mediated signaling pathway,BP,
2564,GO:0005846,1.00000000000922,0.796472670130004,0,2,nuclear cap binding complex,CC,
15411,GO:0071642,1.00000000000923,0.796012882831752,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16916,GO:0098842,1.00000000000924,0.801103966673091,0,2,postsynaptic early endosome,CC,
10929,GO:0044528,1.00000000000924,0.638052044290938,0,4,regulation of mitochondrial mRNA stability,BP,
1505,GO:0003854,1.00000000000925,0.723563263771975,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
15215,GO:0071344,1.00000000000926,0.825802003860528,0,2,diphosphate metabolic process,BP,
1855,GO:0004515,1.00000000000926,0.702595669076104,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
16800,GO:0098594,1.00000000000927,0.934573408701142,0,1,mucin granule,CC,
11239,GO:0045358,1.00000000000927,0.820593834027278,0,2,negative regulation of interferon-beta biosynthetic process,BP,
8402,GO:0033316,1.00000000000927,0.892414435954074,0,1,meiotic spindle assembly checkpoint,BP,
10994,GO:0044779,1.00000000000927,0.892414435954074,0,1,meiotic spindle checkpoint,BP,
10998,GO:0044785,1.00000000000927,0.892414435954074,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17893,GO:1902102,1.00000000000927,0.892414435954074,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17894,GO:1902103,1.00000000000927,0.892414435954074,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18285,GO:1903096,1.00000000000927,0.892414435954074,0,1,protein localization to meiotic spindle midzone,BP,
19170,GO:1905132,1.00000000000927,0.892414435954074,0,1,regulation of meiotic chromosome separation,BP,
19171,GO:1905133,1.00000000000927,0.892414435954074,0,1,negative regulation of meiotic chromosome separation,BP,
19258,GO:1905359,1.00000000000927,0.892414435954074,0,1,protein localization to meiotic spindle,BP,
19595,GO:1990575,1.00000000000927,0.795795006464947,0,2,mitochondrial L-ornithine transmembrane transport,BP,
1835,GO:0004487,1.00000000000927,0.713633917477381,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
5134,GO:0015616,1.00000000000928,0.626290189551431,0,4,DNA translocase activity,MF,
9968,GO:0042328,1.00000000000929,0.705107140134827,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
19658,GO:1990785,1.00000000000931,0.703767610102973,0,3,response to water-immersion restraint stress,BP,
14550,GO:0070042,1.00000000000931,0.892401455137511,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14976,GO:0070852,1.00000000000932,0.709533847910403,0,3,cell body fiber,CC,
13730,GO:0060267,1.00000000000932,0.741566192716563,0,3,positive regulation of respiratory burst,BP,
16304,GO:0090370,1.00000000000933,0.889124633890929,0,1,negative regulation of cholesterol efflux,BP,
20313,GO:2001247,1.00000000000933,0.889124633890929,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
1736,GO:0004331,1.00000000000933,0.628287427160439,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
2661,GO:0006003,1.00000000000933,0.628287427160439,0,4,fructose 2,6-bisphosphate metabolic process,BP,
14367,GO:0061550,1.00000000000934,0.62879285774457,0,4,cranial ganglion development,BP,
13082,GO:0051563,1.00000000000934,0.791633659720012,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
16312,GO:0090394,1.00000000000937,0.633969228779943,0,4,negative regulation of excitatory postsynaptic potential,BP,
7976,GO:0032581,1.00000000000937,0.899653225333272,0,1,ER-dependent peroxisome organization,BP,
17245,GO:0106101,1.00000000000937,0.899653225333272,0,1,ER-dependent peroxisome localization,BP,
11464,GO:0045900,1.00000000000938,0.644383880704299,0,4,negative regulation of translational elongation,BP,
12814,GO:0051089,1.00000000000938,0.889846034757191,0,1,constitutive protein ectodomain proteolysis,BP,
12057,GO:0047800,1.00000000000939,0.890401043621059,0,1,cysteamine dioxygenase activity,MF,
8429,GO:0033499,1.0000000000094,0.81511245141088,0,2,galactose catabolic process via UDP-galactose,BP,
19019,GO:1904784,1.0000000000094,0.888400711692644,0,1,NLRP1 inflammasome complex assembly,BP,
18923,GO:1904580,1.00000000000942,0.804522508138403,0,2,regulation of intracellular mRNA localization,BP,
18924,GO:1904582,1.00000000000942,0.804522508138403,0,2,positive regulation of intracellular mRNA localization,BP,
4297,GO:0009726,1.00000000000943,0.793002959058077,0,2,detection of endogenous stimulus,BP,
10692,GO:0043946,1.00000000000944,0.901397710742606,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10693,GO:0043947,1.00000000000944,0.901397710742606,0,1,positive regulation by host of symbiont catalytic activity,BP,
1657,GO:0004108,1.00000000000944,0.892555959105115,0,1,citrate (Si)-synthase activity,MF,
9598,GO:0036440,1.00000000000944,0.892555959105115,0,1,citrate synthase activity,MF,
1245,GO:0002940,1.00000000000945,0.799632089162946,0,2,tRNA N2-guanine methylation,BP,
15651,GO:0072131,1.00000000000945,0.706966309494274,0,3,kidney mesenchyme morphogenesis,BP,
15653,GO:0072133,1.00000000000945,0.706966309494274,0,3,metanephric mesenchyme morphogenesis,BP,
11029,GO:0044855,1.00000000000946,0.893217288904188,0,1,plasma membrane raft distribution,BP,
11030,GO:0044856,1.00000000000946,0.893217288904188,0,1,plasma membrane raft localization,BP,
11032,GO:0044858,1.00000000000946,0.893217288904188,0,1,plasma membrane raft polarization,BP,
18648,GO:1903906,1.00000000000946,0.893217288904188,0,1,regulation of plasma membrane raft polarization,BP,
4168,GO:0009233,1.00000000000947,0.794349220756663,0,2,menaquinone metabolic process,BP,
1492,GO:0003827,1.00000000000949,0.797119000293932,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
58,GO:0000121,1.00000000000951,0.892117811017458,0,1,glycerol-1-phosphatase activity,MF,
10349,GO:0043136,1.00000000000951,0.892117811017458,0,1,glycerol-3-phosphatase activity,MF,
12587,GO:0050720,1.00000000000951,0.892117811017458,0,1,interleukin-1 beta biosynthetic process,BP,
12589,GO:0050722,1.00000000000951,0.892117811017458,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12590,GO:0050725,1.00000000000951,0.892117811017458,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
15748,GO:0072303,1.00000000000951,0.892117811017458,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
10623,GO:0043602,1.00000000000951,0.893891374163915,0,1,nitrate catabolic process,BP,
11619,GO:0046210,1.00000000000951,0.893891374163915,0,1,nitric oxide catabolic process,BP,
12049,GO:0047726,1.00000000000951,0.893891374163915,0,1,iron-cytochrome-c reductase activity,MF,
16297,GO:0090345,1.00000000000951,0.893891374163915,0,1,cellular organohalogen metabolic process,BP,
16298,GO:0090346,1.00000000000951,0.893891374163915,0,1,cellular organofluorine metabolic process,BP,
8029,GO:0032658,1.00000000000951,0.900700728217054,0,1,regulation of interleukin-15 production,BP,
8074,GO:0032738,1.00000000000951,0.900700728217054,0,1,positive regulation of interleukin-15 production,BP,
9264,GO:0035664,1.00000000000951,0.900700728217054,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9265,GO:0035665,1.00000000000951,0.900700728217054,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
11105,GO:0045092,1.00000000000952,0.890721343595014,0,1,interleukin-18 receptor complex,CC,
8135,GO:0032817,1.00000000000954,0.678671079323315,0,4,regulation of natural killer cell proliferation,BP,
8136,GO:0032819,1.00000000000954,0.678671079323315,0,4,positive regulation of natural killer cell proliferation,BP,
16439,GO:0097057,1.00000000000954,0.828157853126844,0,2,TRAF2-GSTP1 complex,CC,
5,GO:0000011,1.00000000000955,0.892800869200789,0,1,vacuole inheritance,BP,
334,GO:0000928,1.00000000000955,0.892800869200789,0,1,gamma-tubulin small complex, spindle pole body,CC,
1568,GO:0003972,1.00000000000955,0.892800869200789,0,1,RNA ligase (ATP) activity,MF,
1643,GO:0004083,1.00000000000955,0.892800869200789,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1770,GO:0004371,1.00000000000955,0.892800869200789,0,1,glycerone kinase activity,MF,
2019,GO:0004743,1.00000000000955,0.892800869200789,0,1,pyruvate kinase activity,MF,
2735,GO:0006113,1.00000000000955,0.892800869200789,0,1,fermentation,BP,
2951,GO:0006480,1.00000000000955,0.892800869200789,0,1,N-terminal protein amino acid methylation,BP,
3373,GO:0007146,1.00000000000955,0.892800869200789,0,1,meiotic recombination nodule assembly,BP,
3844,GO:0008452,1.00000000000955,0.892800869200789,0,1,RNA ligase activity,MF,
3845,GO:0008453,1.00000000000955,0.892800869200789,0,1,alanine-glyoxylate transaminase activity,MF,
3958,GO:0008700,1.00000000000955,0.892800869200789,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4106,GO:0009159,1.00000000000955,0.892800869200789,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4239,GO:0009436,1.00000000000955,0.892800869200789,0,1,glyoxylate catabolic process,BP,
4432,GO:0010260,1.00000000000955,0.892800869200789,0,1,animal organ senescence,BP,
4446,GO:0010348,1.00000000000955,0.892800869200789,0,1,lithium:proton antiporter activity,MF,
4819,GO:0014011,1.00000000000955,0.892800869200789,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5071,GO:0015292,1.00000000000955,0.892800869200789,0,1,uniporter activity,MF,
5497,GO:0016430,1.00000000000955,0.892800869200789,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5582,GO:0016596,1.00000000000955,0.892800869200789,0,1,thienylcyclohexylpiperidine binding,MF,
5692,GO:0016807,1.00000000000955,0.892800869200789,0,1,cysteine-type carboxypeptidase activity,MF,
5715,GO:0016843,1.00000000000955,0.892800869200789,0,1,amine-lyase activity,MF,
5716,GO:0016844,1.00000000000955,0.892800869200789,0,1,strictosidine synthase activity,MF,
5820,GO:0017082,1.00000000000955,0.892800869200789,0,1,mineralocorticoid receptor activity,MF,
5872,GO:0017178,1.00000000000955,0.892800869200789,0,1,diphthine-ammonia ligase activity,MF,
5883,GO:0018011,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-alanine methylation,BP,
5884,GO:0018012,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5885,GO:0018013,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-glycine methylation,BP,
5886,GO:0018016,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-proline dimethylation,BP,
5890,GO:0018025,1.00000000000955,0.892800869200789,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5922,GO:0018194,1.00000000000955,0.892800869200789,0,1,peptidyl-alanine modification,BP,
6195,GO:0019659,1.00000000000955,0.892800869200789,0,1,glucose catabolic process to lactate,BP,
6196,GO:0019660,1.00000000000955,0.892800869200789,0,1,glycolytic fermentation,BP,
6197,GO:0019661,1.00000000000955,0.892800869200789,0,1,glucose catabolic process to lactate via pyruvate,BP,
6198,GO:0019666,1.00000000000955,0.892800869200789,0,1,nitrogenous compound fermentation,BP,
6243,GO:0019799,1.00000000000955,0.892800869200789,0,1,tubulin N-acetyltransferase activity,MF,
6817,GO:0030264,1.00000000000955,0.892800869200789,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6907,GO:0030474,1.00000000000955,0.892800869200789,0,1,spindle pole body duplication,BP,
6979,GO:0030629,1.00000000000955,0.892800869200789,0,1,U6 snRNA 3'-end binding,MF,
7025,GO:0030735,1.00000000000955,0.892800869200789,0,1,carnosine N-methyltransferase activity,MF,
7139,GO:0030961,1.00000000000955,0.892800869200789,0,1,peptidyl-arginine hydroxylation,BP,
7669,GO:0032093,1.00000000000955,0.892800869200789,0,1,SAM domain binding,MF,
7749,GO:0032253,1.00000000000955,0.892800869200789,0,1,dense core granule localization,BP,
8275,GO:0033058,1.00000000000955,0.892800869200789,0,1,directional locomotion,BP,
8477,GO:0033609,1.00000000000955,0.892800869200789,0,1,oxalate metabolic process,BP,
8568,GO:0034012,1.00000000000955,0.892800869200789,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8718,GO:0034353,1.00000000000955,0.892800869200789,0,1,RNA pyrophosphohydrolase activity,MF,
8800,GO:0034477,1.00000000000955,0.892800869200789,0,1,U6 snRNA 3'-end processing,BP,
8814,GO:0034512,1.00000000000955,0.892800869200789,0,1,box C/D snoRNA binding,MF,
8958,GO:0034998,1.00000000000955,0.892800869200789,0,1,oligosaccharyltransferase I complex,CC,
9155,GO:0035498,1.00000000000955,0.892800869200789,0,1,carnosine metabolic process,BP,
9195,GO:0035568,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-proline methylation,BP,
9196,GO:0035570,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-serine methylation,BP,
9197,GO:0035572,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-serine dimethylation,BP,
9198,GO:0035573,1.00000000000955,0.892800869200789,0,1,N-terminal peptidyl-serine trimethylation,BP,
9209,GO:0035585,1.00000000000955,0.892800869200789,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9564,GO:0036317,1.00000000000955,0.892800869200789,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9731,GO:0038161,1.00000000000955,0.892800869200789,0,1,prolactin signaling pathway,BP,
9887,GO:0042140,1.00000000000955,0.892800869200789,0,1,late meiotic recombination nodule assembly,BP,
10192,GO:0042774,1.00000000000955,0.892800869200789,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10210,GO:0042806,1.00000000000955,0.892800869200789,0,1,fucose binding,MF,
10247,GO:0042946,1.00000000000955,0.892800869200789,0,1,glucoside transport,BP,
10248,GO:0042947,1.00000000000955,0.892800869200789,0,1,glucoside transmembrane transporter activity,MF,
10538,GO:0043465,1.00000000000955,0.892800869200789,0,1,regulation of fermentation,BP,
10844,GO:0044328,1.00000000000955,0.892800869200789,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10845,GO:0044329,1.00000000000955,0.892800869200789,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10846,GO:0044330,1.00000000000955,0.892800869200789,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10950,GO:0044599,1.00000000000955,0.892800869200789,0,1,AP-5 adaptor complex,CC,
10961,GO:0044648,1.00000000000955,0.892800869200789,0,1,histone H3-K4 dimethylation,BP,
10979,GO:0044732,1.00000000000955,0.892800869200789,0,1,mitotic spindle pole body,CC,
11610,GO:0046176,1.00000000000955,0.892800869200789,0,1,aldonic acid catabolic process,BP,
11611,GO:0046177,1.00000000000955,0.892800869200789,0,1,D-gluconate catabolic process,BP,
11629,GO:0046316,1.00000000000955,0.892800869200789,0,1,gluconokinase activity,MF,
11846,GO:0046745,1.00000000000955,0.892800869200789,0,1,viral capsid secondary envelopment,BP,
11956,GO:0046996,1.00000000000955,0.892800869200789,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11961,GO:0047017,1.00000000000955,0.892800869200789,0,1,prostaglandin-F synthase activity,MF,
12050,GO:0047734,1.00000000000955,0.892800869200789,0,1,CDP-glycerol diphosphatase activity,MF,
12456,GO:0050046,1.00000000000955,0.892800869200789,0,1,lathosterol oxidase activity,MF,
12465,GO:0050144,1.00000000000955,0.892800869200789,0,1,nucleoside deoxyribosyltransferase activity,MF,
12489,GO:0050346,1.00000000000955,0.892800869200789,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12492,GO:0050354,1.00000000000955,0.892800869200789,0,1,triokinase activity,MF,
12960,GO:0051300,1.00000000000955,0.892800869200789,0,1,spindle pole body organization,BP,
12968,GO:0051308,1.00000000000955,0.892800869200789,0,1,male meiosis chromosome separation,BP,
13018,GO:0051417,1.00000000000955,0.892800869200789,0,1,microtubule nucleation by spindle pole body,BP,
13039,GO:0051455,1.00000000000955,0.892800869200789,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13150,GO:0051685,1.00000000000955,0.892800869200789,0,1,maintenance of ER location,BP,
13478,GO:0052907,1.00000000000955,0.892800869200789,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13479,GO:0052909,1.00000000000955,0.892800869200789,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13773,GO:0060327,1.00000000000955,0.892800869200789,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13966,GO:0060620,1.00000000000955,0.892800869200789,0,1,regulation of cholesterol import,BP,
14098,GO:0060887,1.00000000000955,0.892800869200789,0,1,limb epidermis development,BP,
14107,GO:0060912,1.00000000000955,0.892800869200789,0,1,cardiac cell fate specification,BP,
14194,GO:0061056,1.00000000000955,0.892800869200789,0,1,sclerotome development,BP,
14244,GO:0061163,1.00000000000955,0.892800869200789,0,1,endoplasmic reticulum polarization,BP,
14316,GO:0061400,1.00000000000955,0.892800869200789,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14345,GO:0061495,1.00000000000955,0.892800869200789,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14372,GO:0061573,1.00000000000955,0.892800869200789,0,1,actin filament bundle retrograde transport,BP,
14423,GO:0061685,1.00000000000955,0.892800869200789,0,1,diphthine methylesterase activity,MF,
14534,GO:0070004,1.00000000000955,0.892800869200789,0,1,cysteine-type exopeptidase activity,MF,
14602,GO:0070130,1.00000000000955,0.892800869200789,0,1,negative regulation of mitochondrial translation,BP,
14619,GO:0070165,1.00000000000955,0.892800869200789,0,1,positive regulation of adiponectin secretion,BP,
14676,GO:0070260,1.00000000000955,0.892800869200789,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14832,GO:0070551,1.00000000000955,0.892800869200789,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14834,GO:0070553,1.00000000000955,0.892800869200789,0,1,nicotinic acid receptor activity,MF,
14837,GO:0070560,1.00000000000955,0.892800869200789,0,1,protein secretion by platelet,BP,
14849,GO:0070573,1.00000000000955,0.892800869200789,0,1,metallodipeptidase activity,MF,
14874,GO:0070631,1.00000000000955,0.892800869200789,0,1,spindle pole body localization,BP,
14875,GO:0070632,1.00000000000955,0.892800869200789,0,1,establishment of spindle pole body localization,BP,
14886,GO:0070650,1.00000000000955,0.892800869200789,0,1,actin filament bundle distribution,BP,
14908,GO:0070694,1.00000000000955,0.892800869200789,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14935,GO:0070762,1.00000000000955,0.892800869200789,0,1,nuclear pore transmembrane ring,CC,
15273,GO:0071424,1.00000000000955,0.892800869200789,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15474,GO:0071789,1.00000000000955,0.892800869200789,0,1,spindle pole body localization to nuclear envelope,BP,
15475,GO:0071790,1.00000000000955,0.892800869200789,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15527,GO:0071885,1.00000000000955,0.892800869200789,0,1,N-terminal protein N-methyltransferase activity,MF,
15553,GO:0071931,1.00000000000955,0.892800869200789,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15951,GO:0072720,1.00000000000955,0.892800869200789,0,1,response to dithiothreitol,BP,
16037,GO:0086038,1.00000000000955,0.892800869200789,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16368,GO:0090624,1.00000000000955,0.892800869200789,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16369,GO:0090625,1.00000000000955,0.892800869200789,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16569,GO:0097310,1.00000000000955,0.892800869200789,0,1,cap2 mRNA methylation,BP,
16682,GO:0097541,1.00000000000955,0.892800869200789,0,1,axonemal basal plate,CC,
16704,GO:0097630,1.00000000000955,0.892800869200789,0,1,intrinsic component of omegasome membrane,CC,
16705,GO:0097631,1.00000000000955,0.892800869200789,0,1,integral component of omegasome membrane,CC,
16738,GO:0097712,1.00000000000955,0.892800869200789,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16850,GO:0098725,1.00000000000955,0.892800869200789,0,1,symmetric cell division,BP,
17065,GO:0099519,1.00000000000955,0.892800869200789,0,1,dense core granule cytoskeletal transport,BP,
17114,GO:0099627,1.00000000000955,0.892800869200789,0,1,neurotransmitter receptor cycle,BP,
17116,GO:0099630,1.00000000000955,0.892800869200789,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17181,GO:0102524,1.00000000000955,0.892800869200789,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17282,GO:0120048,1.00000000000955,0.892800869200789,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17283,GO:0120049,1.00000000000955,0.892800869200789,0,1,snRNA (adenine-N6)-methylation,BP,
17433,GO:1900148,1.00000000000955,0.892800869200789,0,1,negative regulation of Schwann cell migration,BP,
17444,GO:1900170,1.00000000000955,0.892800869200789,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17546,GO:1901003,1.00000000000955,0.892800869200789,0,1,negative regulation of fermentation,BP,
17645,GO:1901318,1.00000000000955,0.892800869200789,0,1,negative regulation of flagellated sperm motility,BP,
17690,GO:1901523,1.00000000000955,0.892800869200789,0,1,icosanoid catabolic process,BP,
17838,GO:1901950,1.00000000000955,0.892800869200789,0,1,dense core granule transport,BP,
17905,GO:1902145,1.00000000000955,0.892800869200789,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17906,GO:1902151,1.00000000000955,0.892800869200789,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17907,GO:1902153,1.00000000000955,0.892800869200789,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17927,GO:1902211,1.00000000000955,0.892800869200789,0,1,regulation of prolactin signaling pathway,BP,
17928,GO:1902213,1.00000000000955,0.892800869200789,0,1,positive regulation of prolactin signaling pathway,BP,
18109,GO:1902688,1.00000000000955,0.892800869200789,0,1,regulation of NAD metabolic process,BP,
18110,GO:1902689,1.00000000000955,0.892800869200789,0,1,negative regulation of NAD metabolic process,BP,
18187,GO:1902912,1.00000000000955,0.892800869200789,0,1,pyruvate kinase complex,CC,
18704,GO:1904023,1.00000000000955,0.892800869200789,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18705,GO:1904024,1.00000000000955,0.892800869200789,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18708,GO:1904028,1.00000000000955,0.892800869200789,0,1,positive regulation of collagen fibril organization,BP,
18979,GO:1904713,1.00000000000955,0.892800869200789,0,1,beta-catenin destruction complex binding,MF,
19013,GO:1904777,1.00000000000955,0.892800869200789,0,1,negative regulation of protein localization to cell cortex,BP,
19029,GO:1904806,1.00000000000955,0.892800869200789,0,1,regulation of protein oxidation,BP,
19030,GO:1904808,1.00000000000955,0.892800869200789,0,1,positive regulation of protein oxidation,BP,
19142,GO:1905044,1.00000000000955,0.892800869200789,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19143,GO:1905045,1.00000000000955,0.892800869200789,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19240,GO:1905319,1.00000000000955,0.892800869200789,0,1,mesenchymal stem cell migration,BP,
19241,GO:1905320,1.00000000000955,0.892800869200789,0,1,regulation of mesenchymal stem cell migration,BP,
19242,GO:1905322,1.00000000000955,0.892800869200789,0,1,positive regulation of mesenchymal stem cell migration,BP,
19253,GO:1905344,1.00000000000955,0.892800869200789,0,1,prostaglandin catabolic process,BP,
19288,GO:1905435,1.00000000000955,0.892800869200789,0,1,regulation of histone H3-K4 trimethylation,BP,
19289,GO:1905437,1.00000000000955,0.892800869200789,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19360,GO:1905642,1.00000000000955,0.892800869200789,0,1,negative regulation of DNA methylation,BP,
19466,GO:1990048,1.00000000000955,0.892800869200789,0,1,anterograde neuronal dense core vesicle transport,BP,
19520,GO:1990261,1.00000000000955,0.892800869200789,0,1,pre-mRNA catabolic process,BP,
19592,GO:1990570,1.00000000000955,0.892800869200789,0,1,GDP-mannose transmembrane transport,BP,
19634,GO:1990738,1.00000000000955,0.892800869200789,0,1,pseudouridine 5'-phosphatase activity,MF,
19643,GO:1990755,1.00000000000955,0.892800869200789,0,1,mitotic spindle microtubule depolymerization,BP,
19715,GO:2000003,1.00000000000955,0.892800869200789,0,1,positive regulation of DNA damage checkpoint,BP,
20107,GO:2000722,1.00000000000955,0.892800869200789,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20108,GO:2000724,1.00000000000955,0.892800869200789,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20192,GO:2000909,1.00000000000955,0.892800869200789,0,1,regulation of sterol import,BP,
1839,GO:0004491,1.00000000000957,0.895677108208883,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
5979,GO:0018478,1.00000000000957,0.895677108208883,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
10982,GO:0044752,1.00000000000957,0.71080800381272,0,3,response to human chorionic gonadotropin,BP,
18695,GO:1903999,1.00000000000958,0.827420892379122,0,2,negative regulation of eating behavior,BP,
19837,GO:2000252,1.00000000000958,0.827420892379122,0,2,negative regulation of feeding behavior,BP,
19300,GO:1905458,1.00000000000959,0.889761319104716,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19800,GO:2000174,1.00000000000959,0.889761319104716,0,1,regulation of pro-T cell differentiation,BP,
19801,GO:2000176,1.00000000000959,0.889761319104716,0,1,positive regulation of pro-T cell differentiation,BP,
8506,GO:0033677,1.00000000000961,0.709230720156475,0,3,DNA/RNA helicase activity,MF,
4726,GO:0010886,1.00000000000961,0.707819329768941,0,3,positive regulation of cholesterol storage,BP,
2570,GO:0005853,1.00000000000961,0.752026150915232,0,3,eukaryotic translation elongation factor 1 complex,CC,
2385,GO:0005519,1.00000000000962,0.889754582076011,0,1,cytoskeletal regulatory protein binding,MF,
9669,GO:0038007,1.00000000000963,0.705117035255432,0,3,netrin-activated signaling pathway,BP,
4220,GO:0009386,1.00000000000965,0.894829371047766,0,1,translational attenuation,BP,
14488,GO:0061847,1.00000000000965,0.894829371047766,0,1,response to cholecystokinin,BP,
15338,GO:0071538,1.00000000000965,0.894829371047766,0,1,SH2 domain-mediated complex assembly,BP,
19674,GO:1990839,1.00000000000965,0.894829371047766,0,1,response to endothelin,BP,
19678,GO:1990859,1.00000000000965,0.894829371047766,0,1,cellular response to endothelin,BP,
9637,GO:0036496,1.00000000000967,0.812002608439484,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
6648,GO:0023041,1.00000000000967,0.720420568676396,0,3,neuronal signal transduction,BP,
956,GO:0002373,1.00000000000967,0.926177712588392,0,1,plasmacytoid dendritic cell cytokine production,BP,
1144,GO:0002736,1.00000000000967,0.926177712588392,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1145,GO:0002737,1.00000000000967,0.926177712588392,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17619,GO:1901253,1.00000000000967,0.926177712588392,0,1,negative regulation of intracellular transport of viral material,BP,
6045,GO:0019145,1.00000000000969,0.893902305192672,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8525,GO:0033737,1.00000000000969,0.893902305192672,0,1,1-pyrroline dehydrogenase activity,MF,
11971,GO:0047105,1.00000000000969,0.893902305192672,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
159,GO:0000322,1.0000000000097,0.724335729149866,0,3,storage vacuole,CC,
866,GO:0002196,1.0000000000097,0.898840583133529,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4981,GO:0015098,1.0000000000097,0.898840583133529,0,1,molybdate ion transmembrane transporter activity,MF,
5154,GO:0015689,1.0000000000097,0.898840583133529,0,1,molybdate ion transport,BP,
13213,GO:0051800,1.0000000000097,0.88839768650973,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20156,GO:2000808,1.0000000000097,0.88839768650973,0,1,negative regulation of synaptic vesicle clustering,BP,
8,GO:0000015,1.00000000000971,0.900090409455103,0,1,phosphopyruvate hydratase complex,CC,
1938,GO:0004634,1.00000000000971,0.900090409455103,0,1,phosphopyruvate hydratase activity,MF,
9934,GO:0042271,1.00000000000971,0.78995208801015,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9239,GO:0035621,1.00000000000972,0.797530429281982,0,2,ER to Golgi ceramide transport,BP,
17264,GO:0110095,1.00000000000972,0.758529171513377,0,3,cellular detoxification of aldehyde,BP,
7357,GO:0031393,1.00000000000973,0.794067124859859,0,2,negative regulation of prostaglandin biosynthetic process,BP,
3854,GO:0008466,1.00000000000973,0.90029538293321,0,1,glycogenin glucosyltransferase activity,MF,
17187,GO:0102751,1.00000000000973,0.90029538293321,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
4994,GO:0015127,1.00000000000973,0.888477791637102,0,1,bilirubin transmembrane transporter activity,MF,
5158,GO:0015694,1.00000000000973,0.888477791637102,0,1,mercury ion transport,BP,
5173,GO:0015723,1.00000000000973,0.888477791637102,0,1,bilirubin transport,BP,
6985,GO:0030653,1.00000000000973,0.888477791637102,0,1,beta-lactam antibiotic metabolic process,BP,
9961,GO:0042316,1.00000000000973,0.888477791637102,0,1,penicillin metabolic process,BP,
17572,GO:1901086,1.00000000000973,0.888477791637102,0,1,benzylpenicillin metabolic process,BP,
1628,GO:0004061,1.00000000000974,0.902387581017461,0,1,arylformamidase activity,MF,
4783,GO:0010967,1.00000000000974,0.902387581017461,0,1,regulation of polyamine biosynthetic process,BP,
13471,GO:0052899,1.00000000000974,0.902387581017461,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13473,GO:0052902,1.00000000000974,0.902387581017461,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13474,GO:0052903,1.00000000000974,0.902387581017461,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13475,GO:0052904,1.00000000000974,0.902387581017461,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17640,GO:1901304,1.00000000000974,0.902387581017461,0,1,regulation of spermidine biosynthetic process,BP,
17641,GO:1901307,1.00000000000974,0.902387581017461,0,1,positive regulation of spermidine biosynthetic process,BP,
8892,GO:0034699,1.00000000000975,0.70877608376483,0,3,response to luteinizing hormone,BP,
452,GO:0001225,1.00000000000976,0.789905910423103,0,2,RNA polymerase II transcription coactivator binding,MF,
3219,GO:0006868,1.00000000000977,0.633900125443817,0,4,glutamine transport,BP,
5025,GO:0015186,1.00000000000977,0.633900125443817,0,4,L-glutamine transmembrane transporter activity,MF,
7581,GO:0031938,1.00000000000978,0.811932223869166,0,2,regulation of chromatin silencing at telomere,BP,
2126,GO:0004918,1.00000000000978,0.893996373158924,0,1,interleukin-8 receptor activity,MF,
6317,GO:0019959,1.00000000000978,0.893996373158924,0,1,interleukin-8 binding,MF,
9717,GO:0038112,1.00000000000978,0.893996373158924,0,1,interleukin-8-mediated signaling pathway,BP,
11020,GO:0044830,1.0000000000098,0.79370339768391,0,2,modulation by host of viral RNA genome replication,BP,
1619,GO:0004045,1.0000000000098,0.700744738491188,0,4,aminoacyl-tRNA hydrolase activity,MF,
1271,GO:0003050,1.00000000000981,0.891942520965511,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
6139,GO:0019402,1.00000000000981,0.911010274571341,0,1,galactitol metabolic process,BP,
14396,GO:0061623,1.00000000000981,0.911010274571341,0,1,glycolytic process from galactose,BP,
11278,GO:0045519,1.00000000000982,0.922167177184899,0,1,interleukin-23 receptor binding,MF,
14932,GO:0070743,1.00000000000982,0.922167177184899,0,1,interleukin-23 complex,CC,
451,GO:0001224,1.00000000000983,0.704303564578053,0,3,RNA polymerase II transcription cofactor binding,MF,
119,GO:0000247,1.00000000000983,0.917911982633273,0,1,C-8 sterol isomerase activity,MF,
2032,GO:0004769,1.00000000000983,0.917911982633273,0,1,steroid delta-isomerase activity,MF,
10095,GO:0042586,1.00000000000983,0.917911982633273,0,1,peptide deformylase activity,MF,
1730,GO:0004320,1.00000000000983,0.800594572587388,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5436,GO:0016295,1.00000000000983,0.800594572587388,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5437,GO:0016296,1.00000000000983,0.800594572587388,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5438,GO:0016297,1.00000000000983,0.800594572587388,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
663,GO:0001855,1.00000000000984,0.904924687233781,0,1,complement component C4b binding,MF,
8054,GO:0032701,1.00000000000984,0.805996220489942,0,2,negative regulation of interleukin-18 production,BP,
6548,GO:0021957,1.00000000000985,0.624483793848967,0,4,corticospinal tract morphogenesis,BP,
9758,GO:0039019,1.00000000000986,0.791210499302375,0,2,pronephric nephron development,BP,
8243,GO:0033004,1.00000000000987,0.720938348980069,0,3,negative regulation of mast cell activation,BP,
8246,GO:0033007,1.00000000000987,0.720938348980069,0,3,negative regulation of mast cell activation involved in immune response,BP,
865,GO:0002193,1.0000000000099,0.705994887756759,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
2504,GO:0005753,1.00000000000991,0.895590779829978,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4697,GO:0010849,1.00000000000991,0.895590779829978,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19851,GO:2000276,1.00000000000991,0.895590779829978,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
6872,GO:0030337,1.00000000000993,0.814046832052995,0,2,DNA polymerase processivity factor activity,MF,
2115,GO:0004897,1.00000000000993,0.704750041617184,0,3,ciliary neurotrophic factor receptor activity,MF,
14593,GO:0070120,1.00000000000993,0.704750041617184,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
11341,GO:0045650,1.00000000000994,0.808212930558103,0,2,negative regulation of macrophage differentiation,BP,
20328,GO:2001274,1.00000000000994,0.79363520013677,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
19465,GO:1990047,1.00000000000995,0.895000842605924,0,1,spindle matrix,CC,
15790,GO:0072368,1.00000000000998,0.789884579571567,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
13803,GO:0060369,1.00000000000998,0.636997914425388,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
9711,GO:0038101,1.00000000000999,0.901738614623312,0,1,sequestering of nodal from receptor via nodal binding,BP,
17404,GO:1900108,1.00000000000999,0.901738614623312,0,1,negative regulation of nodal signaling pathway,BP,
17431,GO:1900146,1.00000000000999,0.901738614623312,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17446,GO:1900176,1.00000000000999,0.901738614623312,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
5290,GO:0015942,1.00000000001,0.73768160928353,0,3,formate metabolic process,BP,
18351,GO:1903279,1.00000000001,0.799134656930959,0,2,regulation of calcium:sodium antiporter activity,BP,
18352,GO:1903281,1.00000000001,0.799134656930959,0,2,positive regulation of calcium:sodium antiporter activity,BP,
8314,GO:0033140,1.00000000001,0.803215611099664,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
16061,GO:0086075,1.00000000001,0.70697229092957,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
11166,GO:0045204,1.00000000001001,0.70341263210256,0,3,MAPK export from nucleus,BP,
5049,GO:0015230,1.00000000001001,0.798806755674996,0,2,FAD transmembrane transporter activity,MF,
9096,GO:0035350,1.00000000001001,0.798806755674996,0,2,FAD transmembrane transport,BP,
5769,GO:0016939,1.00000000001002,0.70435902211108,0,3,kinesin II complex,CC,
11228,GO:0045347,1.00000000001003,0.715338182761521,0,3,negative regulation of MHC class II biosynthetic process,BP,
15394,GO:0071619,1.00000000001004,0.895042356034631,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20258,GO:2001163,1.00000000001004,0.895042356034631,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20259,GO:2001165,1.00000000001004,0.895042356034631,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
18955,GO:1904672,1.00000000001005,0.628134015782319,0,4,regulation of somatic stem cell population maintenance,BP,
10977,GO:0044729,1.00000000001006,0.708383848420187,0,3,hemi-methylated DNA-binding,MF,
18844,GO:1904383,1.00000000001008,0.895898584444293,0,1,response to sodium phosphate,BP,
18925,GO:1904585,1.00000000001008,0.895898584444293,0,1,response to putrescine,BP,
18926,GO:1904586,1.00000000001008,0.895898584444293,0,1,cellular response to putrescine,BP,
19668,GO:1990828,1.00000000001008,0.895898584444293,0,1,hepatocyte dedifferentiation,BP,
15948,GO:0072717,1.00000000001008,0.747741256380262,0,3,cellular response to actinomycin D,BP,
15960,GO:0072750,1.00000000001012,0.913471804853961,0,1,cellular response to leptomycin B,BP,
17657,GO:1901344,1.00000000001012,0.913471804853961,0,1,response to leptomycin B,BP,
17779,GO:1901707,1.00000000001012,0.913471804853961,0,1,leptomycin B binding,MF,
2752,GO:0006154,1.00000000001012,0.80974702909165,0,2,adenosine catabolic process,BP,
11576,GO:0046103,1.00000000001012,0.80974702909165,0,2,inosine biosynthetic process,BP,
19558,GO:1990423,1.00000000001012,0.707324168409958,0,3,RZZ complex,CC,
2050,GO:0004795,1.00000000001015,0.896280716929783,0,1,threonine synthase activity,MF,
4051,GO:0009088,1.00000000001015,0.896280716929783,0,1,threonine biosynthetic process,BP,
11657,GO:0046360,1.00000000001015,0.896280716929783,0,1,2-oxobutyrate biosynthetic process,BP,
11658,GO:0046361,1.00000000001015,0.896280716929783,0,1,2-oxobutyrate metabolic process,BP,
1789,GO:0004408,1.00000000001015,0.894950644776587,0,1,holocytochrome-c synthase activity,MF,
5784,GO:0017003,1.00000000001015,0.894950644776587,0,1,protein-heme linkage,BP,
5787,GO:0017006,1.00000000001015,0.894950644776587,0,1,protein-tetrapyrrole linkage,BP,
5895,GO:0018063,1.00000000001015,0.894950644776587,0,1,cytochrome c-heme linkage,BP,
3873,GO:0008496,1.00000000001015,0.889220589168059,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
15889,GO:0072592,1.00000000001016,0.803005394998628,0,2,oxygen metabolic process,BP,
16034,GO:0086028,1.00000000001017,0.657297927011139,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16041,GO:0086043,1.00000000001017,0.657297927011139,0,4,bundle of His cell action potential,BP,
14156,GO:0061002,1.00000000001017,0.71525711952861,0,3,negative regulation of dendritic spine morphogenesis,BP,
2759,GO:0006168,1.00000000001018,0.763567857155801,0,3,adenine salvage,BP,
11564,GO:0046083,1.00000000001018,0.763567857155801,0,3,adenine metabolic process,BP,
11565,GO:0046084,1.00000000001018,0.763567857155801,0,3,adenine biosynthetic process,BP,
4614,GO:0010729,1.00000000001018,0.897196489426641,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
15947,GO:0072716,1.00000000001019,0.667566307561129,0,4,response to actinomycin D,BP,
12226,GO:0048389,1.00000000001019,0.900718728825029,0,1,intermediate mesoderm development,BP,
12227,GO:0048390,1.00000000001019,0.900718728825029,0,1,intermediate mesoderm morphogenesis,BP,
12228,GO:0048391,1.00000000001019,0.900718728825029,0,1,intermediate mesoderm formation,BP,
12229,GO:0048392,1.00000000001019,0.900718728825029,0,1,intermediate mesodermal cell differentiation,BP,
13502,GO:0055018,1.00000000001019,0.900718728825029,0,1,regulation of cardiac muscle fiber development,BP,
13503,GO:0055020,1.00000000001019,0.900718728825029,0,1,positive regulation of cardiac muscle fiber development,BP,
13898,GO:0060503,1.00000000001019,0.900718728825029,0,1,bud dilation involved in lung branching,BP,
14233,GO:0061149,1.00000000001019,0.900718728825029,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14234,GO:0061150,1.00000000001019,0.900718728825029,0,1,renal system segmentation,BP,
14235,GO:0061151,1.00000000001019,0.900718728825029,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14239,GO:0061155,1.00000000001019,0.900718728825029,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14261,GO:0061216,1.00000000001019,0.900718728825029,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14264,GO:0061227,1.00000000001019,0.900718728825029,0,1,pattern specification involved in mesonephros development,BP,
15531,GO:0071893,1.00000000001019,0.900718728825029,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15627,GO:0072096,1.00000000001019,0.900718728825029,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15628,GO:0072097,1.00000000001019,0.900718728825029,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15629,GO:0072098,1.00000000001019,0.900718728825029,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15630,GO:0072099,1.00000000001019,0.900718728825029,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15631,GO:0072100,1.00000000001019,0.900718728825029,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15632,GO:0072101,1.00000000001019,0.900718728825029,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15688,GO:0072192,1.00000000001019,0.900718728825029,0,1,ureter epithelial cell differentiation,BP,
15692,GO:0072198,1.00000000001019,0.900718728825029,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15693,GO:0072199,1.00000000001019,0.900718728825029,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15694,GO:0072200,1.00000000001019,0.900718728825029,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17841,GO:1901964,1.00000000001019,0.900718728825029,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19716,GO:2000004,1.00000000001019,0.900718728825029,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19717,GO:2000005,1.00000000001019,0.900718728825029,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19718,GO:2000006,1.00000000001019,0.900718728825029,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19719,GO:2000007,1.00000000001019,0.900718728825029,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
4984,GO:0015105,1.00000000001021,0.913536973665819,0,1,arsenite transmembrane transporter activity,MF,
5163,GO:0015700,1.00000000001021,0.913536973665819,0,1,arsenite transport,BP,
2125,GO:0004917,1.00000000001022,0.900329975955271,0,1,interleukin-7 receptor activity,MF,
20052,GO:2000638,1.00000000001022,0.795312536036863,0,2,regulation of SREBP signaling pathway,BP,
20053,GO:2000639,1.00000000001022,0.795312536036863,0,2,negative regulation of SREBP signaling pathway,BP,
19313,GO:1905502,1.00000000001022,0.916641702190061,0,1,acetyl-CoA binding,MF,
16799,GO:0098592,1.00000000001024,0.708724612224551,0,3,cytoplasmic side of apical plasma membrane,CC,
1810,GO:0004454,1.00000000001024,0.894259661031475,0,1,ketohexokinase activity,MF,
16551,GO:0097267,1.00000000001024,0.62935137334831,0,4,omega-hydroxylase P450 pathway,BP,
12389,GO:0048763,1.00000000001024,0.701206489876787,0,3,calcium-induced calcium release activity,MF,
16666,GO:0097512,1.00000000001024,0.86049179475106,0,2,cardiac myofibril,CC,
19570,GO:1990450,1.00000000001024,0.896520366128823,0,1,linear polyubiquitin binding,MF,
6850,GO:0030312,1.00000000001025,0.895218546011535,0,1,external encapsulating structure,CC,
9337,GO:0035805,1.00000000001025,0.895218546011535,0,1,egg coat,CC,
16801,GO:0098595,1.00000000001025,0.895218546011535,0,1,perivitelline space,CC,
6219,GO:0019747,1.00000000001025,0.927889413463394,0,1,regulation of isoprenoid metabolic process,BP,
6894,GO:0030421,1.00000000001025,0.927889413463394,0,1,defecation,BP,
7384,GO:0031431,1.00000000001026,0.794693269984461,0,2,Dbf4-dependent protein kinase complex,CC,
19864,GO:2000298,1.00000000001026,0.797259289180088,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
7398,GO:0031445,1.00000000001027,0.802807002704532,0,2,regulation of heterochromatin assembly,BP,
7399,GO:0031453,1.00000000001027,0.802807002704532,0,2,positive regulation of heterochromatin assembly,BP,
11420,GO:0045799,1.00000000001027,0.802807002704532,0,2,positive regulation of chromatin assembly or disassembly,BP,
11748,GO:0046544,1.00000000001027,0.888468066546246,0,1,development of secondary male sexual characteristics,BP,
8914,GO:0034729,1.00000000001028,0.723932180564826,0,3,histone H3-K79 methylation,BP,
6083,GO:0019236,1.00000000001031,0.812240295883982,0,2,response to pheromone,BP,
2024,GO:0004751,1.00000000001032,0.899791160524116,0,1,ribose-5-phosphate isomerase activity,MF,
170,GO:0000354,1.00000000001032,0.792159323833058,0,2,cis assembly of pre-catalytic spliceosome,BP,
2711,GO:0006083,1.00000000001034,0.704854297830434,0,3,acetate metabolic process,BP,
408,GO:0001093,1.00000000001034,0.710565326194381,0,3,TFIIB-class transcription factor binding,MF,
5987,GO:0018879,1.00000000001035,0.715938970884469,0,3,biphenyl metabolic process,BP,
14210,GO:0061091,1.00000000001035,0.888492948055593,0,1,regulation of phospholipid translocation,BP,
14211,GO:0061092,1.00000000001035,0.888492948055593,0,1,positive regulation of phospholipid translocation,BP,
3584,GO:0007634,1.00000000001036,0.894158870049578,0,1,optokinetic behavior,BP,
14097,GO:0060876,1.00000000001036,0.894158870049578,0,1,semicircular canal formation,BP,
16385,GO:0090669,1.00000000001037,0.639885838152361,0,4,telomerase RNA stabilization,BP,
19065,GO:1904879,1.00000000001037,0.795618059691671,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
6908,GO:0030478,1.00000000001038,0.628066825909674,0,4,actin cap,CC,
5337,GO:0016071,1.00000000001039,0,26,738,mRNA metabolic process,BP,PSMD2;PRKACA;ADARB1;ATF4;AKT1;SYMPK;GTPBP1;DDIT3;PCBP4;RPUSD3;HSF1;AGO4;RALY;ESRP1;PSMD7;SSU72;PUM1;TNRC6B;SAMD4B;RNH1;PYM1;RPL28;CNOT11;CARHSP1;IGF2BP3;SF3B6
10956,GO:0044611,1.00000000001039,0.70172587455796,0,3,nuclear pore inner ring,CC,
3095,GO:0006669,1.0000000000104,0.892606798001529,0,1,sphinganine-1-phosphate biosynthetic process,BP,
16220,GO:0090234,1.0000000000104,0.707994730923339,0,3,regulation of kinetochore assembly,BP,
7423,GO:0031508,1.0000000000104,0.818673688352042,0,2,pericentric heterochromatin assembly,BP,
2016,GO:0004740,1.00000000001042,0.706601310428769,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
877,GO:0002225,1.00000000001042,0.816745325527415,0,2,positive regulation of antimicrobial peptide production,BP,
1155,GO:0002760,1.00000000001042,0.816745325527415,0,2,positive regulation of antimicrobial humoral response,BP,
1174,GO:0002803,1.00000000001042,0.816745325527415,0,2,positive regulation of antibacterial peptide production,BP,
17704,GO:1901551,1.00000000001043,0.889310723385564,0,1,negative regulation of endothelial cell development,BP,
18298,GO:1903141,1.00000000001043,0.889310723385564,0,1,negative regulation of establishment of endothelial barrier,BP,
5496,GO:0016429,1.00000000001045,0.71631856581243,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14514,GO:0061953,1.00000000001045,0.71631856581243,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15089,GO:0071034,1.00000000001045,0.652488228007367,0,4,CUT catabolic process,BP,
15093,GO:0071043,1.00000000001045,0.652488228007367,0,4,CUT metabolic process,BP,
10718,GO:0043998,1.00000000001046,0.891507784561552,0,1,H2A histone acetyltransferase activity,MF,
9535,GO:0036250,1.00000000001046,0.898422447640785,0,1,peroxisome transport along microtubule,BP,
10973,GO:0044721,1.00000000001046,0.898422447640785,0,1,protein import into peroxisome matrix, substrate release,BP,
1925,GO:0004616,1.00000000001046,0.717919653005292,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
11209,GO:0045298,1.00000000001046,0.65578339968325,0,4,tubulin complex,CC,
8550,GO:0033871,1.00000000001046,0.89816556769159,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11942,GO:0046970,1.00000000001046,0.89816556769159,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14322,GO:0061433,1.00000000001046,0.89816556769159,0,1,cellular response to caloric restriction,BP,
14778,GO:0070446,1.00000000001046,0.89816556769159,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
16626,GO:0097442,1.00000000001049,0.888394853043647,0,1,CA3 pyramidal cell dendrite,CC,
11854,GO:0046790,1.00000000001051,0.647196161295697,0,4,virion binding,MF,
5370,GO:0016160,1.00000000001051,0.795713289845764,0,2,amylase activity,MF,
11694,GO:0046462,1.00000000001051,0.804170914106199,0,2,monoacylglycerol metabolic process,BP,
13402,GO:0052651,1.00000000001051,0.804170914106199,0,2,monoacylglycerol catabolic process,BP,
18011,GO:1902412,1.00000000001053,0.703638432980406,0,3,regulation of mitotic cytokinesis,BP,
16302,GO:0090365,1.00000000001054,0.895701039046374,0,1,regulation of mRNA modification,BP,
16303,GO:0090367,1.00000000001054,0.895701039046374,0,1,negative regulation of mRNA modification,BP,
18331,GO:1903215,1.00000000001054,0.895701039046374,0,1,negative regulation of protein targeting to mitochondrion,BP,
20250,GO:2001144,1.00000000001054,0.895701039046374,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20251,GO:2001145,1.00000000001054,0.895701039046374,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
10431,GO:0043262,1.00000000001055,0.720341061237233,0,3,adenosine-diphosphatase activity,MF,
9684,GO:0038037,1.00000000001055,0.732657345043389,0,3,G-protein coupled receptor dimeric complex,CC,
16718,GO:0097648,1.00000000001055,0.732657345043389,0,3,G-protein coupled receptor complex,CC,
9495,GO:0036122,1.00000000001057,0.710952006976652,0,3,BMP binding,MF,
2659,GO:0006001,1.00000000001058,0.638205948477932,0,4,fructose catabolic process,BP,
14397,GO:0061624,1.00000000001058,0.638205948477932,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
16528,GO:0097210,1.00000000001058,0.796296736271916,0,2,response to gonadotropin-releasing hormone,BP,
16529,GO:0097211,1.00000000001058,0.796296736271916,0,2,cellular response to gonadotropin-releasing hormone,BP,
13544,GO:0055095,1.00000000001059,0.890101630774614,0,1,lipoprotein particle mediated signaling,BP,
13545,GO:0055096,1.00000000001059,0.890101630774614,0,1,low-density lipoprotein particle mediated signaling,BP,
13937,GO:0060574,1.00000000001059,0.657559913049144,0,4,intestinal epithelial cell maturation,BP,
15022,GO:0070934,1.00000000001059,0.63538789014671,0,4,CRD-mediated mRNA stabilization,BP,
7102,GO:0030893,1.0000000000106,0.707109111115984,0,3,meiotic cohesin complex,CC,
20206,GO:2001015,1.0000000000106,0.792247298530411,0,2,negative regulation of skeletal muscle cell differentiation,BP,
11556,GO:0046070,1.0000000000106,0.691369628769234,0,4,dGTP metabolic process,BP,
4546,GO:0010621,1.00000000001061,0.91994734881634,0,1,negative regulation of transcription by transcription factor localization,BP,
9520,GO:0036164,1.00000000001061,0.91994734881634,0,1,cell-abiotic substrate adhesion,BP,
789,GO:0002046,1.00000000001063,0.924698408708053,0,1,opsin binding,MF,
9581,GO:0036372,1.00000000001063,0.924698408708053,0,1,opsin transport,BP,
15883,GO:0072586,1.00000000001064,0.888877372136209,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15884,GO:0072587,1.00000000001064,0.888877372136209,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
4014,GO:0009007,1.00000000001065,0.890516160631139,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8098,GO:0032775,1.00000000001065,0.890516160631139,0,1,DNA methylation on adenine,BP,
5996,GO:0018993,1.00000000001066,0.892751554098197,0,1,somatic sex determination,BP,
6036,GO:0019101,1.00000000001066,0.892751554098197,0,1,female somatic sex determination,BP,
13573,GO:0060014,1.00000000001066,0.892751554098197,0,1,granulosa cell differentiation,BP,
2074,GO:0004825,1.00000000001068,0.796961952930421,0,2,methionine-tRNA ligase activity,MF,
2920,GO:0006431,1.00000000001068,0.796961952930421,0,2,methionyl-tRNA aminoacylation,BP,
7127,GO:0030942,1.00000000001069,0.735326744845632,0,3,endoplasmic reticulum signal peptide binding,MF,
9299,GO:0035730,1.00000000001069,0.925334759169315,0,1,S-nitrosoglutathione binding,MF,
9300,GO:0035731,1.00000000001069,0.925334759169315,0,1,dinitrosyl-iron complex binding,MF,
9301,GO:0035732,1.00000000001069,0.925334759169315,0,1,nitric oxide storage,BP,
17180,GO:0102522,1.0000000000107,0.895461667239158,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
1250,GO:0002947,1.00000000001072,0.889448360679841,0,1,tumor necrosis factor receptor superfamily complex,CC,
10831,GO:0044313,1.00000000001072,0.702653030947413,0,3,protein K6-linked deubiquitination,BP,
18339,GO:1903237,1.00000000001072,0.931369006901991,0,1,negative regulation of leukocyte tethering or rolling,BP,
1920,GO:0004610,1.00000000001073,0.897498347314601,0,1,phosphoacetylglucosamine mutase activity,MF,
2078,GO:0004829,1.00000000001074,0.712022377623643,0,3,threonine-tRNA ligase activity,MF,
2924,GO:0006435,1.00000000001074,0.712022377623643,0,3,threonyl-tRNA aminoacylation,BP,
18462,GO:1903518,1.00000000001077,0.797422376533034,0,2,positive regulation of single strand break repair,BP,
14695,GO:0070294,1.00000000001079,0.711999641163052,0,3,renal sodium ion absorption,BP,
19792,GO:2000156,1.0000000000108,0.794641097639254,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
557,GO:0001680,1.00000000001082,0.895026311483498,0,1,tRNA 3'-terminal CCA addition,BP,
2060,GO:0004810,1.00000000001082,0.895026311483498,0,1,tRNA adenylyltransferase activity,MF,
13484,GO:0052927,1.00000000001082,0.895026311483498,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13485,GO:0052928,1.00000000001082,0.895026311483498,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13486,GO:0052929,1.00000000001082,0.895026311483498,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19664,GO:1990817,1.00000000001082,0.895026311483498,0,1,RNA adenylyltransferase activity,MF,
20119,GO:2000741,1.00000000001082,0.702628481349192,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
2045,GO:0004790,1.00000000001083,0.893725903028099,0,1,thioether S-methyltransferase activity,MF,
7027,GO:0030748,1.00000000001083,0.893725903028099,0,1,amine N-methyltransferase activity,MF,
17186,GO:0102707,1.00000000001083,0.893725903028099,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
458,GO:0001306,1.00000000001083,0.922820688486701,0,1,age-dependent response to oxidative stress,BP,
459,GO:0001315,1.00000000001083,0.922820688486701,0,1,age-dependent response to reactive oxygen species,BP,
1277,GO:0003068,1.00000000001083,0.922820688486701,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1278,GO:0003069,1.00000000001083,0.922820688486701,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1279,GO:0003070,1.00000000001083,0.922820688486701,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3546,GO:0007571,1.00000000001083,0.922820688486701,0,1,age-dependent general metabolic decline,BP,
438,GO:0001172,1.00000000001083,0.85028812451166,0,2,transcription, RNA-templated,BP,
1567,GO:0003968,1.00000000001083,0.85028812451166,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
17497,GO:1900369,1.00000000001083,0.85028812451166,0,2,negative regulation of RNA interference,BP,
20296,GO:2001226,1.00000000001086,0.796419566308227,0,2,negative regulation of chloride transport,BP,
6851,GO:0030314,1.00000000001088,0.703510911065848,0,3,junctional membrane complex,CC,
6858,GO:0030322,1.00000000001089,0.800428889719869,0,2,stabilization of membrane potential,BP,
17980,GO:1902308,1.00000000001094,0.715041148559788,0,3,regulation of peptidyl-serine dephosphorylation,BP,
14624,GO:0070170,1.00000000001096,0.792097958639407,0,2,regulation of tooth mineralization,BP,
126,GO:0000257,1.00000000001097,0.910979747096425,0,1,nitrilase activity,MF,
5698,GO:0016815,1.00000000001097,0.910979747096425,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
11949,GO:0046979,1.000000000011,0.726500782299559,0,3,TAP2 binding,MF,
9061,GO:0035276,1.000000000011,0.888398616049911,0,1,ethanol binding,MF,
9267,GO:0035668,1.000000000011,0.888398616049911,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9268,GO:0035669,1.000000000011,0.888398616049911,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20217,GO:2001029,1.000000000011,0.888398616049911,0,1,regulation of cellular glucuronidation,BP,
20218,GO:2001031,1.000000000011,0.888398616049911,0,1,positive regulation of cellular glucuronidation,BP,
20333,GO:2001287,1.00000000001102,0.80697031503704,0,2,negative regulation of caveolin-mediated endocytosis,BP,
2031,GO:0004768,1.00000000001102,0.708170266352904,0,3,stearoyl-CoA 9-desaturase activity,MF,
5392,GO:0016215,1.00000000001102,0.708170266352904,0,3,acyl-CoA desaturase activity,MF,
16050,GO:0086056,1.00000000001103,0.889321125380488,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16955,GO:0098912,1.00000000001103,0.889321125380488,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
9181,GO:0035538,1.00000000001105,0.891743473381886,0,1,carbohydrate response element binding,MF,
11381,GO:0045726,1.00000000001105,0.888442626030207,0,1,positive regulation of integrin biosynthetic process,BP,
13247,GO:0051891,1.00000000001105,0.888442626030207,0,1,positive regulation of cardioblast differentiation,BP,
18548,GO:1903701,1.00000000001105,0.888442626030207,0,1,substantia propria of cornea development,BP,
4924,GO:0014866,1.00000000001106,0.708715564247648,0,3,skeletal myofibril assembly,BP,
9185,GO:0035546,1.00000000001107,0.625278904370229,0,4,interferon-beta secretion,BP,
9186,GO:0035547,1.00000000001107,0.625278904370229,0,4,regulation of interferon-beta secretion,BP,
9187,GO:0035549,1.00000000001107,0.625278904370229,0,4,positive regulation of interferon-beta secretion,BP,
11962,GO:0047021,1.00000000001107,0.914861363233131,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12474,GO:0050221,1.00000000001107,0.914861363233131,0,1,prostaglandin-E2 9-reductase activity,MF,
14112,GO:0060920,1.00000000001109,0.701343878261352,0,3,cardiac pacemaker cell differentiation,BP,
14116,GO:0060926,1.00000000001109,0.701343878261352,0,3,cardiac pacemaker cell development,BP,
7010,GO:0030689,1.0000000000111,0.720308371966615,0,3,Noc complex,CC,
7920,GO:0032487,1.0000000000111,0.703261074649653,0,3,regulation of Rap protein signal transduction,BP,
3094,GO:0006668,1.00000000001112,0.795846068223893,0,2,sphinganine-1-phosphate metabolic process,BP,
1803,GO:0004441,1.00000000001113,0.896505612114905,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13447,GO:0052829,1.00000000001113,0.896505612114905,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
6877,GO:0030348,1.00000000001115,0.798708447682496,0,2,syntaxin-3 binding,MF,
18019,GO:1902442,1.00000000001115,0.890344387911694,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
18020,GO:1902443,1.00000000001115,0.890344387911694,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
11816,GO:0046680,1.00000000001115,0.896510524734711,0,1,response to DDT,BP,
20138,GO:2000775,1.00000000001115,0.896510524734711,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
12992,GO:0051365,1.00000000001117,0.891564823054033,0,1,cellular response to potassium ion starvation,BP,
14989,GO:0070877,1.00000000001118,0.793645254866935,0,2,microprocessor complex,CC,
18284,GO:1903095,1.00000000001118,0.793645254866935,0,2,ribonuclease III complex,CC,
5172,GO:0015722,1.00000000001119,0.706388393003886,0,3,canalicular bile acid transport,BP,
6003,GO:0019034,1.0000000000112,0.789950867230053,0,2,viral replication complex,CC,
15416,GO:0071651,1.0000000000112,0.628224207557963,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
14448,GO:0061740,1.00000000001122,0.712550819545914,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
9608,GO:0036457,1.00000000001122,0.624571674820426,0,4,keratohyalin granule,CC,
1200,GO:0002857,1.00000000001122,0.793756369056399,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1203,GO:0002860,1.00000000001122,0.793756369056399,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
19622,GO:1990700,1.00000000001123,0.889832096262921,0,1,nucleolar chromatin organization,BP,
3102,GO:0006680,1.00000000001123,0.711355131067713,0,3,glucosylceramide catabolic process,BP,
8500,GO:0033650,1.00000000001126,0.901273634173006,0,1,host cell mitochondrion,CC,
10767,GO:0044190,1.00000000001126,0.901273634173006,0,1,host cell mitochondrial envelope,CC,
15820,GO:0072492,1.00000000001126,0.901273634173006,0,1,host cell mitochondrial intermembrane space,CC,
13804,GO:0060370,1.00000000001128,0.88839438430512,0,1,susceptibility to T cell mediated cytotoxicity,BP,
8431,GO:0033503,1.00000000001131,0.636603342229178,0,4,HULC complex,CC,
1546,GO:0003938,1.00000000001132,0.806653189114876,0,2,IMP dehydrogenase activity,MF,
5534,GO:0016508,1.00000000001132,0.709389537284338,0,3,long-chain-enoyl-CoA hydratase activity,MF,
4935,GO:0014891,1.00000000001135,0.642831333102711,0,4,striated muscle atrophy,BP,
6400,GO:0021603,1.00000000001136,0.631351335947242,0,4,cranial nerve formation,BP,
3677,GO:0008176,1.00000000001139,0.824215245302065,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17212,GO:0106004,1.00000000001139,0.824215245302065,0,2,tRNA (guanine-N7)-methylation,BP,
20074,GO:2000663,1.00000000001139,0.890636298878767,0,1,negative regulation of interleukin-5 secretion,BP,
14491,GO:0061851,1.0000000000114,0.893257593481095,0,1,leading edge of lamellipodium,CC,
18823,GO:1904328,1.0000000000114,0.893257593481095,0,1,regulation of myofibroblast contraction,BP,
19648,GO:1990764,1.0000000000114,0.893257593481095,0,1,myofibroblast contraction,BP,
8656,GO:0034191,1.00000000001142,0.713614500590879,0,3,apolipoprotein A-I receptor binding,MF,
1423,GO:0003365,1.00000000001142,0.701230554088733,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
10497,GO:0043383,1.00000000001142,0.722968758348827,0,3,negative T cell selection,BP,
11076,GO:0045060,1.00000000001142,0.722968758348827,0,3,negative thymic T cell selection,BP,
3592,GO:0008020,1.00000000001143,0.79730819138803,0,2,G-protein coupled photoreceptor activity,MF,
10823,GO:0044301,1.00000000001143,0.888903167340207,0,1,climbing fiber,CC,
19459,GO:1990032,1.00000000001143,0.888903167340207,0,1,parallel fiber,CC,
2668,GO:0006014,1.00000000001143,0.824249725864927,0,2,D-ribose metabolic process,BP,
7616,GO:0031997,1.00000000001145,0.726634605773992,0,3,N-terminal myristoylation domain binding,MF,
12980,GO:0051343,1.00000000001145,0.726634605773992,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
3218,GO:0006867,1.00000000001146,0.893102521529617,0,1,asparagine transport,BP,
5021,GO:0015182,1.00000000001146,0.893102521529617,0,1,L-asparagine transmembrane transporter activity,MF,
5028,GO:0015190,1.00000000001146,0.893102521529617,0,1,L-leucine transmembrane transporter activity,MF,
5029,GO:0015191,1.00000000001146,0.893102521529617,0,1,L-methionine transmembrane transporter activity,MF,
5141,GO:0015658,1.00000000001146,0.893102521529617,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5221,GO:0015821,1.00000000001146,0.893102521529617,0,1,methionine transport,BP,
10675,GO:0043865,1.00000000001146,0.893102521529617,0,1,methionine transmembrane transporter activity,MF,
13536,GO:0055087,1.00000000001146,0.724151477053934,0,3,Ski complex,CC,
10438,GO:0043273,1.00000000001147,0.8884076695566,0,1,CTPase activity,MF,
15036,GO:0070950,1.00000000001148,0.892841630229205,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15037,GO:0070951,1.00000000001148,0.892841630229205,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15041,GO:0070962,1.00000000001148,0.892841630229205,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15042,GO:0070963,1.00000000001148,0.892841630229205,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16196,GO:0090198,1.00000000001148,0.892841630229205,0,1,negative regulation of chemokine secretion,BP,
16425,GO:0097029,1.00000000001148,0.892841630229205,0,1,mature conventional dendritic cell differentiation,BP,
17425,GO:1900135,1.00000000001148,0.892841630229205,0,1,positive regulation of renin secretion into blood stream,BP,
19113,GO:1904977,1.00000000001148,0.892841630229205,0,1,lymphatic endothelial cell migration,BP,
19614,GO:1990641,1.00000000001151,0.79840077561479,0,2,response to iron ion starvation,BP,
7844,GO:0032393,1.00000000001152,0.82984526328372,0,2,MHC class I receptor activity,MF,
18080,GO:1902605,1.00000000001152,0.893200466227249,0,1,heterotrimeric G-protein complex assembly,BP,
6601,GO:0022615,1.00000000001155,0.654814632240188,0,4,protein to membrane docking,BP,
15552,GO:0071930,1.00000000001156,0.705196613822887,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
14771,GO:0070432,1.00000000001158,0.710552601176369,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
18726,GO:1904058,1.00000000001158,0.735873957249021,0,3,positive regulation of sensory perception of pain,BP,
16722,GO:0097676,1.00000000001159,0.707083984959876,0,3,histone H3-K36 dimethylation,BP,
12777,GO:0051026,1.0000000000116,0.642542820077684,0,4,chiasma assembly,BP,
4448,GO:0010360,1.00000000001162,0.708427058882544,0,3,negative regulation of anion channel activity,BP,
10363,GO:0043163,1.00000000001163,0.793407336044325,0,2,cell envelope organization,BP,
11182,GO:0045229,1.00000000001163,0.793407336044325,0,2,external encapsulating structure organization,BP,
750,GO:0001978,1.00000000001164,0.895697038973053,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,1.00000000001164,0.895697038973053,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,1.00000000001164,0.895697038973053,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
757,GO:0001994,1.00000000001164,0.895697038973053,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001997,1.00000000001164,0.895697038973053,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1292,GO:0003099,1.00000000001164,0.895697038973053,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2134,GO:0004936,1.00000000001164,0.895697038973053,0,1,alpha-adrenergic receptor activity,MF,
2135,GO:0004937,1.00000000001164,0.895697038973053,0,1,alpha1-adrenergic receptor activity,MF,
18692,GO:1903995,1.00000000001164,0.895697038973053,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18693,GO:1903997,1.00000000001164,0.895697038973053,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
9666,GO:0038001,1.00000000001165,0.804273539213053,0,2,paracrine signaling,BP,
13088,GO:0051572,1.00000000001165,0.709118370127823,0,3,negative regulation of histone H3-K4 methylation,BP,
14172,GO:0061032,1.00000000001166,0.89249478542606,0,1,visceral serous pericardium development,BP,
15670,GO:0072166,1.00000000001166,0.89249478542606,0,1,posterior mesonephric tubule development,BP,
15744,GO:0072299,1.00000000001166,0.89249478542606,0,1,negative regulation of metanephric glomerulus development,BP,
15747,GO:0072302,1.00000000001166,0.89249478542606,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
2355,GO:0005432,1.00000000001168,0.709938047394121,0,3,calcium:sodium antiporter activity,MF,
18027,GO:1902464,1.00000000001168,0.888993806521706,0,1,regulation of histone H3-K27 trimethylation,BP,
18028,GO:1902466,1.00000000001168,0.888993806521706,0,1,positive regulation of histone H3-K27 trimethylation,BP,
9065,GO:0035281,1.00000000001175,0.818210901336001,0,2,pre-miRNA export from nucleus,BP,
10080,GO:0042565,1.00000000001175,0.818210901336001,0,2,RNA nuclear export complex,CC,
16776,GO:0098536,1.00000000001176,0.703766590644327,0,3,deuterosome,CC,
4275,GO:0009631,1.00000000001176,0.888466787656481,0,1,cold acclimation,BP,
11630,GO:0046317,1.00000000001176,0.888466787656481,0,1,regulation of glucosylceramide biosynthetic process,BP,
11631,GO:0046318,1.00000000001176,0.888466787656481,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18286,GO:1903108,1.00000000001176,0.888466787656481,0,1,regulation of mitochondrial transcription,BP,
18287,GO:1903109,1.00000000001176,0.888466787656481,0,1,positive regulation of mitochondrial transcription,BP,
494,GO:0001546,1.00000000001178,0.903377526465469,0,1,preantral ovarian follicle growth,BP,
1689,GO:0004155,1.00000000001178,0.903377526465469,0,1,6,7-dihydropteridine reductase activity,MF,
12128,GO:0048162,1.00000000001178,0.903377526465469,0,1,multi-layer follicle stage,BP,
708,GO:0001928,1.00000000001178,0.895144036906335,0,1,regulation of exocyst assembly,BP,
13682,GO:0060178,1.00000000001178,0.895144036906335,0,1,regulation of exocyst localization,BP,
8806,GO:0034499,1.00000000001178,0.789424556008873,0,2,late endosome to Golgi transport,BP,
6626,GO:0022849,1.00000000001179,0.888470340678611,0,1,glutamate-gated calcium ion channel activity,MF,
13053,GO:0051490,1.00000000001179,0.719209362614082,0,3,negative regulation of filopodium assembly,BP,
2771,GO:0006193,1.00000000001183,0.919891907921228,0,1,ITP catabolic process,BP,
4143,GO:0009203,1.00000000001183,0.919891907921228,0,1,ribonucleoside triphosphate catabolic process,BP,
4147,GO:0009207,1.00000000001183,0.919891907921228,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9530,GO:0036220,1.00000000001183,0.919891907921228,0,1,ITP diphosphatase activity,MF,
9531,GO:0036222,1.00000000001183,0.919891907921228,0,1,XTP diphosphatase activity,MF,
20281,GO:2001199,1.00000000001183,0.905009840427147,0,1,negative regulation of dendritic cell differentiation,BP,
16406,GO:0093001,1.00000000001183,0.89187979025352,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
13170,GO:0051722,1.00000000001184,0.894075682132937,0,1,protein C-terminal methylesterase activity,MF,
13171,GO:0051723,1.00000000001184,0.894075682132937,0,1,protein methylesterase activity,MF,
19606,GO:1990604,1.00000000001184,0.707381286340675,0,3,IRE1-TRAF2-ASK1 complex,CC,
374,GO:0000995,1.00000000001186,0.627451639733667,0,4,transcription factor activity, core RNA polymerase III binding,MF,
11801,GO:0046645,1.00000000001187,0.701669499743233,0,3,positive regulation of gamma-delta T cell activation,BP,
3520,GO:0007495,1.00000000001188,0.891963397273622,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
14795,GO:0070483,1.00000000001188,0.891963397273622,0,1,detection of hypoxia,BP,
6134,GO:0019389,1.00000000001188,0.89346829638559,0,1,glucuronoside metabolic process,BP,
6135,GO:0019391,1.00000000001188,0.89346829638559,0,1,glucuronoside catabolic process,BP,
17167,GO:0102390,1.00000000001188,0.89346829638559,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
3687,GO:0008192,1.00000000001188,0.721719713510137,0,3,RNA guanylyltransferase activity,MF,
1182,GO:0002826,1.00000000001189,0.710930235551594,0,3,negative regulation of T-helper 1 type immune response,BP,
18919,GO:1904576,1.0000000000119,0.806605922539578,0,2,response to tunicamycin,BP,
18920,GO:1904577,1.0000000000119,0.806605922539578,0,2,cellular response to tunicamycin,BP,
5953,GO:0018298,1.00000000001191,0.708630651073325,0,3,protein-chromophore linkage,BP,
1902,GO:0004583,1.00000000001191,0.63724069259161,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
7860,GO:0032415,1.00000000001194,0.713017693774003,0,3,regulation of sodium:proton antiporter activity,BP,
4815,GO:0014004,1.00000000001196,0.79424538457033,0,2,microglia differentiation,BP,
4816,GO:0014005,1.00000000001196,0.79424538457033,0,2,microglia development,BP,
517,GO:0001582,1.00000000001197,0.893719365445525,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8268,GO:0033041,1.00000000001197,0.893719365445525,0,1,sweet taste receptor activity,MF,
10673,GO:0043843,1.00000000001197,0.893719365445525,0,1,ADP-specific glucokinase activity,MF,
18580,GO:1903767,1.00000000001197,0.893719365445525,0,1,sweet taste receptor complex,CC,
18581,GO:1903768,1.00000000001197,0.893719365445525,0,1,taste receptor complex,CC,
621,GO:0001792,1.00000000001197,0.889184069237224,0,1,polymeric immunoglobulin receptor activity,MF,
965,GO:0002386,1.00000000001197,0.889184069237224,0,1,immune response in mucosal-associated lymphoid tissue,BP,
971,GO:0002415,1.00000000001197,0.889184069237224,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
3843,GO:0008449,1.00000000001198,0.790045002913525,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
11230,GO:0045349,1.000000000012,0.650403567320897,0,4,interferon-alpha biosynthetic process,BP,
11235,GO:0045354,1.000000000012,0.650403567320897,0,4,regulation of interferon-alpha biosynthetic process,BP,
4884,GO:0014744,1.00000000001201,0.704714514613166,0,3,positive regulation of muscle adaptation,BP,
17314,GO:0140059,1.00000000001201,0.629736611835248,0,4,dendrite arborization,BP,
17373,GO:1900039,1.00000000001202,0.917167290096382,0,1,positive regulation of cellular response to hypoxia,BP,
17883,GO:1902071,1.00000000001202,0.917167290096382,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17884,GO:1902073,1.00000000001202,0.917167290096382,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
18021,GO:1902445,1.00000000001202,0.767134964867307,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
7190,GO:0031071,1.00000000001203,0.894444146746841,0,1,cysteine desulfurase activity,MF,
15625,GO:0072093,1.00000000001204,0.702672022539371,0,3,metanephric renal vesicle formation,BP,
9602,GO:0036446,1.00000000001204,0.703974190631682,0,3,myofibroblast differentiation,BP,
19005,GO:1904760,1.00000000001204,0.703974190631682,0,3,regulation of myofibroblast differentiation,BP,
10778,GO:0044214,1.00000000001205,0.629464964159123,0,4,spanning component of plasma membrane,CC,
4444,GO:0010335,1.00000000001207,0.888889871289247,0,1,response to non-ionic osmotic stress,BP,
8560,GO:0033925,1.00000000001207,0.888889871289247,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15304,GO:0071471,1.00000000001207,0.888889871289247,0,1,cellular response to non-ionic osmotic stress,BP,
4950,GO:0014916,1.00000000001207,0.708782340591657,0,3,regulation of lung blood pressure,BP,
15712,GO:0072223,1.00000000001207,0.710868915682328,0,3,metanephric glomerular mesangium development,BP,
15719,GO:0072239,1.00000000001207,0.710868915682328,0,3,metanephric glomerulus vasculature development,BP,
12813,GO:0051088,1.00000000001209,0.70527187754414,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
14076,GO:0060830,1.0000000000121,0.732461039644424,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15112,GO:0071107,1.0000000000121,0.70409244978714,0,3,response to parathyroid hormone,BP,
11221,GO:0045338,1.00000000001211,0.647199049416566,0,4,farnesyl diphosphate metabolic process,BP,
1556,GO:0003952,1.00000000001211,0.894146134601305,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1583,GO:0003990,1.00000000001211,0.894146134601305,0,1,acetylcholinesterase activity,MF,
4824,GO:0014016,1.00000000001211,0.894146134601305,0,1,neuroblast differentiation,BP,
11686,GO:0046448,1.00000000001211,0.894146134601305,0,1,tropane alkaloid metabolic process,BP,
12624,GO:0050783,1.00000000001211,0.894146134601305,0,1,cocaine metabolic process,BP,
14869,GO:0070618,1.00000000001212,0.893342077175583,0,1,Grb2-Sos complex,CC,
17684,GO:1901491,1.00000000001213,0.791720479727016,0,2,negative regulation of lymphangiogenesis,BP,
4905,GO:0014832,1.00000000001214,0.704846433712607,0,3,urinary bladder smooth muscle contraction,BP,
4914,GO:0014848,1.00000000001214,0.704846433712607,0,3,urinary tract smooth muscle contraction,BP,
9392,GO:0035915,1.00000000001215,0.897002350972217,0,1,pore formation in membrane of other organism,BP,
19921,GO:2000374,1.00000000001215,0.897002350972217,0,1,regulation of oxygen metabolic process,BP,
13120,GO:0051615,1.00000000001215,0.888395399864208,0,1,histamine uptake,BP,
7558,GO:0031867,1.00000000001218,0.890088987981618,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
5106,GO:0015389,1.00000000001219,0.89538810511262,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5107,GO:0015390,1.00000000001219,0.89538810511262,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5108,GO:0015391,1.00000000001219,0.89538810511262,0,1,nucleobase:cation symporter activity,MF,
18801,GO:1904274,1.00000000001219,0.89538810511262,0,1,tricellular tight junction assembly,BP,
1627,GO:0004060,1.00000000001219,0.897299140735507,0,1,arylamine N-acetyltransferase activity,MF,
14592,GO:0070119,1.00000000001222,0.8894342029873,0,1,ciliary neurotrophic factor binding,MF,
17547,GO:1901004,1.00000000001222,0.91386432831805,0,1,ubiquinone-6 metabolic process,BP,
17548,GO:1901006,1.00000000001222,0.91386432831805,0,1,ubiquinone-6 biosynthetic process,BP,
14604,GO:0070137,1.00000000001225,0.625516853416724,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14606,GO:0070139,1.00000000001225,0.625516853416724,0,4,SUMO-specific endopeptidase activity,MF,
18623,GO:1903860,1.00000000001225,0.795608634112195,0,2,negative regulation of dendrite extension,BP,
19798,GO:2000172,1.00000000001225,0.795608634112195,0,2,regulation of branching morphogenesis of a nerve,BP,
11687,GO:0046449,1.00000000001226,0.623900863873207,0,4,creatinine metabolic process,BP,
5990,GO:0018916,1.00000000001226,0.678458223859061,0,4,nitrobenzene metabolic process,BP,
2598,GO:0005892,1.00000000001227,0.631016768467362,0,4,acetylcholine-gated channel complex,CC,
18967,GO:1904690,1.00000000001227,0.640156159621035,0,4,positive regulation of cytoplasmic translational initiation,BP,
5487,GO:0016418,1.00000000001227,0.789839507780691,0,2,S-acetyltransferase activity,MF,
2277,GO:0005219,1.00000000001228,0.729934892339864,0,3,ryanodine-sensitive calcium-release channel activity,MF,
14086,GO:0060844,1.00000000001229,0.797550571786989,0,2,arterial endothelial cell fate commitment,BP,
5032,GO:0015195,1.0000000000123,0.8891448570184,0,1,L-threonine transmembrane transporter activity,MF,
5225,GO:0015826,1.0000000000123,0.8891448570184,0,1,threonine transport,BP,
8824,GO:0034589,1.0000000000123,0.8891448570184,0,1,hydroxyproline transport,BP,
8825,GO:0034590,1.0000000000123,0.8891448570184,0,1,L-hydroxyproline transmembrane transporter activity,MF,
14469,GO:0061783,1.00000000001232,0.748274189106514,0,3,peptidoglycan muralytic activity,MF,
9350,GO:0035844,1.00000000001232,0.711148347312663,0,3,cloaca development,BP,
16263,GO:0090298,1.00000000001233,0.707422800738736,0,3,negative regulation of mitochondrial DNA replication,BP,
17812,GO:1901859,1.00000000001233,0.707422800738736,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
143,GO:0000294,1.00000000001234,0.7935844574881,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
6938,GO:0030538,1.00000000001235,0.794272160147795,0,2,embryonic genitalia morphogenesis,BP,
533,GO:0001651,1.00000000001236,0.819093453615072,0,2,dense fibrillar component,CC,
6444,GO:0021747,1.00000000001237,0.702790595381282,0,3,cochlear nucleus development,BP,
8059,GO:0032714,1.00000000001238,0.793560780562886,0,2,negative regulation of interleukin-5 production,BP,
9643,GO:0036502,1.00000000001238,0.892114854259947,0,1,Derlin-1-VIMP complex,CC,
11555,GO:0046069,1.00000000001239,0.790045318565689,0,2,cGMP catabolic process,BP,
18938,GO:1904612,1.00000000001239,0.790045318565689,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18939,GO:1904613,1.00000000001239,0.790045318565689,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
14480,GO:0061827,1.0000000000124,0.809844119203635,0,2,sperm head,CC,
14108,GO:0060913,1.00000000001241,0.893278529700682,0,1,cardiac cell fate determination,BP,
15419,GO:0071657,1.00000000001241,0.893278529700682,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17624,GO:1901258,1.00000000001241,0.893278529700682,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
476,GO:0001519,1.00000000001241,0.890372637340613,0,1,peptide amidation,BP,
1848,GO:0004504,1.00000000001241,0.890372637340613,0,1,peptidylglycine monooxygenase activity,MF,
1913,GO:0004598,1.00000000001241,0.890372637340613,0,1,peptidylamidoglycolate lyase activity,MF,
5893,GO:0018032,1.00000000001241,0.890372637340613,0,1,protein amidation,BP,
7251,GO:0031179,1.00000000001241,0.890372637340613,0,1,peptide modification,BP,
815,GO:0002085,1.00000000001241,0.71949650638001,0,3,inhibition of neuroepithelial cell differentiation,BP,
11312,GO:0045608,1.00000000001241,0.71949650638001,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
9284,GO:0035701,1.00000000001242,0.710681767720805,0,3,hematopoietic stem cell migration,BP,
11932,GO:0046952,1.00000000001242,0.711469620436474,0,3,ketone body catabolic process,BP,
1766,GO:0004366,1.00000000001243,0.63266469823189,0,4,glycerol-3-phosphate O-acyltransferase activity,MF,
16293,GO:0090341,1.00000000001243,0.905528453453729,0,1,negative regulation of secretion of lysosomal enzymes,BP,
9222,GO:0035602,1.00000000001244,0.889502352411634,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9223,GO:0035603,1.00000000001244,0.889502352411634,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9224,GO:0035604,1.00000000001244,0.889502352411634,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13952,GO:0060595,1.00000000001244,0.889502352411634,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13965,GO:0060615,1.00000000001244,0.889502352411634,0,1,mammary gland bud formation,BP,
13975,GO:0060648,1.00000000001244,0.889502352411634,0,1,mammary gland bud morphogenesis,BP,
13981,GO:0060667,1.00000000001244,0.889502352411634,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14110,GO:0060915,1.00000000001244,0.889502352411634,0,1,mesenchymal cell differentiation involved in lung development,BP,
17915,GO:1902173,1.00000000001244,0.891972338553215,0,1,negative regulation of keratinocyte apoptotic process,BP,
11605,GO:0046166,1.00000000001245,0.814015330750446,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
3128,GO:0006710,1.00000000001245,0.899190965221991,0,1,androgen catabolic process,BP,
5929,GO:0018201,1.00000000001245,0.704835425935255,0,3,peptidyl-glycine modification,BP,
17541,GO:1900753,1.00000000001246,0.889066854619038,0,1,doxorubicin transport,BP,
14618,GO:0070164,1.00000000001247,0.63787481766372,0,4,negative regulation of adiponectin secretion,BP,
6965,GO:0030613,1.00000000001247,0.784644612357302,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6966,GO:0030614,1.00000000001247,0.784644612357302,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
11220,GO:0045337,1.00000000001248,0.722061793054455,0,3,farnesyl diphosphate biosynthetic process,BP,
12412,GO:0048822,1.0000000000125,0.707300822532788,0,3,enucleate erythrocyte development,BP,
19554,GO:1990415,1.0000000000125,0.713402698456977,0,3,Pex17p-Pex14p docking complex,CC,
19562,GO:1990429,1.0000000000125,0.713402698456977,0,3,peroxisomal importomer complex,CC,
8226,GO:0032977,1.00000000001255,0.888859569678403,0,1,membrane insertase activity,MF,
8227,GO:0032978,1.00000000001255,0.888859569678403,0,1,protein insertion into membrane from inner side,BP,
8228,GO:0032979,1.00000000001255,0.888859569678403,0,1,protein insertion into mitochondrial membrane from inner side,BP,
781,GO:0002036,1.00000000001255,0.635056592599836,0,4,regulation of L-glutamate import across plasma membrane,BP,
4775,GO:0010958,1.00000000001255,0.635056592599836,0,4,regulation of amino acid import across plasma membrane,BP,
10219,GO:0042825,1.00000000001256,0.707547917830805,0,3,TAP complex,CC,
339,GO:0000939,1.00000000001256,0.727488574686889,0,3,condensed chromosome inner kinetochore,CC,
11857,GO:0046813,1.00000000001258,0.723065783469438,0,3,receptor-mediated virion attachment to host cell,BP,
4317,GO:0009794,1.00000000001258,0.64380962038,0,4,regulation of mitotic cell cycle, embryonic,BP,
7965,GO:0032558,1.00000000001258,0.743571167375458,0,3,adenyl deoxyribonucleotide binding,MF,
7969,GO:0032564,1.00000000001258,0.743571167375458,0,3,dATP binding,MF,
11262,GO:0045448,1.00000000001258,0.64380962038,0,4,mitotic cell cycle, embryonic,BP,
1575,GO:0003979,1.0000000000126,0.891930583614576,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6642,GO:0023024,1.0000000000126,0.891930583614576,0,1,MHC class I protein complex binding,MF,
3012,GO:0006558,1.00000000001262,0.690893461523581,0,4,L-phenylalanine metabolic process,BP,
3013,GO:0006559,1.00000000001262,0.690893461523581,0,4,L-phenylalanine catabolic process,BP,
17935,GO:1902221,1.00000000001262,0.690893461523581,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17936,GO:1902222,1.00000000001262,0.690893461523581,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
18691,GO:1903984,1.00000000001263,0.707926913279937,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
16518,GO:0097196,1.00000000001265,0.801952678957179,0,2,Shu complex,CC,
14863,GO:0070602,1.00000000001267,0.736517320399986,0,3,regulation of centromeric sister chromatid cohesion,BP,
10495,GO:0043380,1.00000000001268,0.657661168750179,0,4,regulation of memory T cell differentiation,BP,
6245,GO:0019808,1.00000000001269,0.75831902276746,0,3,polyamine binding,MF,
13819,GO:0060386,1.0000000000127,0.888394435588444,0,1,synapse assembly involved in innervation,BP,
10295,GO:0043031,1.00000000001272,0.642658715624932,0,4,negative regulation of macrophage activation,BP,
12724,GO:0050923,1.00000000001278,0.701233014754158,0,3,regulation of negative chemotaxis,BP,
13711,GO:0060235,1.0000000000128,0.710865350808876,0,3,lens induction in camera-type eye,BP,
17472,GO:1900227,1.0000000000128,0.627707604666392,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
12476,GO:0050253,1.00000000001281,0.793525067394696,0,2,retinyl-palmitate esterase activity,MF,
5850,GO:0017143,1.00000000001282,0.798292276241745,0,2,insecticide metabolic process,BP,
18981,GO:1904715,1.00000000001283,0.71741619501126,0,3,negative regulation of chaperone-mediated autophagy,BP,
8363,GO:0033227,1.00000000001286,0.714580837796889,0,3,dsRNA transport,BP,
2557,GO:0005833,1.00000000001286,0.892541775272617,0,1,hemoglobin complex,CC,
8544,GO:0033862,1.00000000001286,0.892541775272617,0,1,UMP kinase activity,MF,
1693,GO:0004164,1.00000000001286,0.900557860112488,0,1,diphthine synthase activity,MF,
1738,GO:0004333,1.00000000001286,0.900557860112488,0,1,fumarate hydratase activity,MF,
2022,GO:0004749,1.00000000001287,0.643808892538063,0,4,ribose phosphate diphosphokinase activity,MF,
5671,GO:0016778,1.00000000001287,0.643808892538063,0,4,diphosphotransferase activity,MF,
18694,GO:1903998,1.00000000001287,0.735062792530156,0,3,regulation of eating behavior,BP,
3092,GO:0006666,1.00000000001288,0.888441543030953,0,1,3-keto-sphinganine metabolic process,BP,
12031,GO:0047560,1.00000000001288,0.888441543030953,0,1,3-dehydrosphinganine reductase activity,MF,
4249,GO:0009447,1.00000000001288,0.76738717530125,0,3,putrescine catabolic process,BP,
10722,GO:0044020,1.0000000000129,0.649548727031915,0,4,histone methyltransferase activity (H4-R3 specific),MF,
244,GO:0000700,1.00000000001291,0.653991079166292,0,4,mismatch base pair DNA N-glycosylase activity,MF,
7692,GO:0032137,1.00000000001294,0.709074115301504,0,3,guanine/thymine mispair binding,MF,
14630,GO:0070180,1.00000000001294,0.941889997693279,0,1,large ribosomal subunit rRNA binding,MF,
14791,GO:0070476,1.00000000001294,0.941889997693279,0,1,rRNA (guanine-N7)-methylation,BP,
12116,GO:0048104,1.00000000001294,0.624416069181768,0,4,establishment of body hair or bristle planar orientation,BP,
12117,GO:0048105,1.00000000001294,0.624416069181768,0,4,establishment of body hair planar orientation,BP,
2480,GO:0005713,1.00000000001294,0.894043507281466,0,1,recombination nodule,CC,
2481,GO:0005715,1.00000000001294,0.894043507281466,0,1,late recombination nodule,CC,
5015,GO:0015173,1.00000000001294,0.894043507281466,0,1,aromatic amino acid transmembrane transporter activity,MF,
5033,GO:0015196,1.00000000001294,0.894043507281466,0,1,L-tryptophan transmembrane transporter activity,MF,
10309,GO:0043060,1.00000000001294,0.894043507281466,0,1,meiotic metaphase I plate congression,BP,
12930,GO:0051257,1.00000000001294,0.894043507281466,0,1,meiotic spindle midzone assembly,BP,
12970,GO:0051311,1.00000000001294,0.894043507281466,0,1,meiotic metaphase plate congression,BP,
18800,GO:1904271,1.00000000001294,0.894043507281466,0,1,L-proline import across plasma membrane,BP,
18907,GO:1904555,1.00000000001294,0.894043507281466,0,1,L-proline transmembrane transport,BP,
18908,GO:1904556,1.00000000001294,0.894043507281466,0,1,L-tryptophan transmembrane transport,BP,
19362,GO:1905647,1.00000000001294,0.894043507281466,0,1,proline import across plasma membrane,BP,
3891,GO:0008523,1.00000000001296,0.891605364391641,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5253,GO:0015878,1.00000000001296,0.891605364391641,0,1,biotin transport,BP,
5260,GO:0015887,1.00000000001296,0.891605364391641,0,1,pantothenate transmembrane transport,BP,
14792,GO:0070478,1.00000000001296,0.889326355798923,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
13177,GO:0051731,1.00000000001298,0.641501238314218,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
8923,GO:0034756,1.00000000001299,0.737517641857736,0,3,regulation of iron ion transport,BP,
8386,GO:0033277,1.000000000013,0.795238549825116,0,2,abortive mitotic cell cycle,BP,
1685,GO:0004148,1.00000000001301,0.890769943676438,0,1,dihydrolipoyl dehydrogenase activity,MF,
10360,GO:0043159,1.00000000001301,0.890769943676438,0,1,acrosomal matrix,CC,
10590,GO:0043544,1.00000000001301,0.890769943676438,0,1,lipoamide binding,MF,
12805,GO:0051068,1.00000000001301,0.890769943676438,0,1,dihydrolipoamide metabolic process,BP,
14578,GO:0070092,1.00000000001301,0.705992318922123,0,3,regulation of glucagon secretion,BP,
14613,GO:0070159,1.00000000001302,0.89441948870503,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
7694,GO:0032139,1.00000000001302,0.722857343059128,0,3,dinucleotide insertion or deletion binding,MF,
8215,GO:0032962,1.00000000001303,0.70817054876588,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
7815,GO:0032361,1.00000000001303,0.897474546944999,0,1,pyridoxal phosphate catabolic process,BP,
10215,GO:0042820,1.00000000001303,0.897474546944999,0,1,vitamin B6 catabolic process,BP,
4230,GO:0009407,1.00000000001307,0.680179244553394,0,4,toxin catabolic process,BP,
19140,GO:1905041,1.00000000001307,0.795329477715657,0,2,regulation of epithelium regeneration,BP,
19542,GO:1990399,1.00000000001307,0.795329477715657,0,2,epithelium regeneration,BP,
13816,GO:0060383,1.00000000001308,0.889508244379996,0,1,positive regulation of DNA strand elongation,BP,
19306,GO:1905464,1.00000000001308,0.889508244379996,0,1,positive regulation of DNA duplex unwinding,BP,
19391,GO:1905774,1.00000000001308,0.889508244379996,0,1,regulation of DNA helicase activity,BP,
19392,GO:1905776,1.00000000001308,0.889508244379996,0,1,positive regulation of DNA helicase activity,BP,
19706,GO:1990955,1.00000000001308,0.889508244379996,0,1,G-rich single-stranded DNA binding,MF,
7492,GO:0031651,1.00000000001308,0.889377935794712,0,1,negative regulation of heat generation,BP,
7519,GO:0031699,1.00000000001308,0.889377935794712,0,1,beta-3 adrenergic receptor binding,MF,
14472,GO:0061798,1.00000000001308,0.889377935794712,0,1,GTP 3',8'-cyclase activity,MF,
14473,GO:0061799,1.00000000001308,0.889377935794712,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16286,GO:0090327,1.00000000001308,0.889377935794712,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
2026,GO:0004756,1.0000000000131,0.799858015783061,0,2,selenide, water dikinase activity,MF,
5417,GO:0016260,1.0000000000131,0.799858015783061,0,2,selenocysteine biosynthetic process,BP,
5674,GO:0016781,1.0000000000131,0.799858015783061,0,2,phosphotransferase activity, paired acceptors,MF,
14718,GO:0070329,1.0000000000131,0.799858015783061,0,2,tRNA seleno-modification,BP,
1164,GO:0002775,1.00000000001312,0.727333864733189,0,3,antimicrobial peptide production,BP,
1165,GO:0002778,1.00000000001312,0.727333864733189,0,3,antibacterial peptide production,BP,
1166,GO:0002784,1.00000000001312,0.727333864733189,0,3,regulation of antimicrobial peptide production,BP,
1168,GO:0002786,1.00000000001312,0.727333864733189,0,3,regulation of antibacterial peptide production,BP,
7586,GO:0031945,1.00000000001312,0.889928835097519,0,1,positive regulation of glucocorticoid metabolic process,BP,
7589,GO:0031948,1.00000000001312,0.889928835097519,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7802,GO:0032346,1.00000000001312,0.889928835097519,0,1,positive regulation of aldosterone metabolic process,BP,
7805,GO:0032349,1.00000000001312,0.889928835097519,0,1,positive regulation of aldosterone biosynthetic process,BP,
14044,GO:0060748,1.00000000001312,0.889928835097519,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14192,GO:0061054,1.00000000001312,0.889928835097519,0,1,dermatome development,BP,
14248,GO:0061183,1.00000000001312,0.889928835097519,0,1,regulation of dermatome development,BP,
14249,GO:0061184,1.00000000001312,0.889928835097519,0,1,positive regulation of dermatome development,BP,
14258,GO:0061205,1.00000000001312,0.889928835097519,0,1,paramesonephric duct development,BP,
14306,GO:0061369,1.00000000001312,0.889928835097519,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
19728,GO:2000019,1.00000000001312,0.889928835097519,0,1,negative regulation of male gonad development,BP,
19752,GO:2000066,1.00000000001312,0.889928835097519,0,1,positive regulation of cortisol biosynthetic process,BP,
19823,GO:2000224,1.00000000001312,0.889928835097519,0,1,regulation of testosterone biosynthetic process,BP,
19824,GO:2000225,1.00000000001312,0.889928835097519,0,1,negative regulation of testosterone biosynthetic process,BP,
4498,GO:0010521,1.00000000001313,0.732547913811458,0,3,telomerase inhibitor activity,MF,
8784,GO:0034455,1.00000000001316,0.709102945500289,0,3,t-UTP complex,CC,
2488,GO:0005731,1.00000000001317,0.901957981491475,0,1,nucleolus organizer region,CC,
3346,GO:0007072,1.00000000001317,0.901957981491475,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7087,GO:0030874,1.00000000001317,0.901957981491475,0,1,nucleolar chromatin,CC,
16597,GO:0097372,1.00000000001317,0.901957981491475,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
14447,GO:0061739,1.00000000001319,0.706605661180897,0,3,protein lipidation involved in autophagosome assembly,BP,
145,GO:0000296,1.00000000001319,0.894938247979529,0,1,spermine transport,BP,
4017,GO:0009019,1.00000000001319,0.63220434857393,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
2023,GO:0004750,1.0000000000132,0.894883208050329,0,1,ribulose-phosphate 3-epimerase activity,MF,
16698,GO:0097621,1.0000000000132,0.894883208050329,0,1,monoamine oxidase activity,MF,
4282,GO:0009646,1.0000000000132,0.89163990175827,0,1,response to absence of light,BP,
6960,GO:0030586,1.0000000000132,0.89163990175827,0,1,[methionine synthase] reductase activity,MF,
7352,GO:0031380,1.0000000000132,0.89163990175827,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12505,GO:0050444,1.0000000000132,0.89163990175827,0,1,aquacobalamin reductase (NADPH) activity,MF,
15317,GO:0071485,1.0000000000132,0.89163990175827,0,1,cellular response to absence of light,BP,
18715,GO:1904041,1.0000000000132,0.89163990175827,0,1,regulation of cystathionine beta-synthase activity,BP,
18716,GO:1904042,1.0000000000132,0.89163990175827,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19605,GO:1990603,1.0000000000132,0.89163990175827,0,1,dark adaptation,BP,
5871,GO:0017177,1.00000000001321,0.889921640090338,0,1,glucosidase II complex,CC,
8559,GO:0033919,1.00000000001321,0.889921640090338,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16363,GO:0090600,1.00000000001321,0.889921640090338,0,1,alpha-1,3-glucosidase activity,MF,
8041,GO:0032681,1.00000000001321,0.89326935723269,0,1,regulation of lymphotoxin A production,BP,
8086,GO:0032761,1.00000000001321,0.89326935723269,0,1,positive regulation of lymphotoxin A production,BP,
10283,GO:0043016,1.00000000001321,0.89326935723269,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10284,GO:0043017,1.00000000001321,0.89326935723269,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11248,GO:0045404,1.00000000001321,0.89326935723269,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
16215,GO:0090226,1.00000000001321,0.930730945496612,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
4434,GO:0010266,1.00000000001326,0.739883706155804,0,3,response to vitamin B1,BP,
6360,GO:0021538,1.00000000001328,0.890928978614338,0,1,epithalamus development,BP,
6557,GO:0021986,1.00000000001328,0.890928978614338,0,1,habenula development,BP,
13233,GO:0051866,1.00000000001328,0.890928978614338,0,1,general adaptation syndrome,BP,
8347,GO:0033186,1.00000000001328,0.708757124254671,0,3,CAF-1 complex,CC,
7718,GO:0032202,1.00000000001329,0.643805149191029,0,4,telomere assembly,BP,
5491,GO:0016422,1.00000000001329,0.718585079906041,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
10507,GO:0043398,1.0000000000133,0.724600285072464,0,3,HLH domain binding,MF,
109,GO:0000225,1.0000000000133,0.917983440701284,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
5080,GO:0015307,1.0000000000133,0.807729479351498,0,2,drug:proton antiporter activity,MF,
11776,GO:0046618,1.0000000000133,0.807729479351498,0,2,drug export,BP,
9795,GO:0039713,1.00000000001331,0.8911984345167,0,1,viral factory,CC,
9796,GO:0039714,1.00000000001331,0.8911984345167,0,1,cytoplasmic viral factory,CC,
15834,GO:0072517,1.00000000001331,0.8911984345167,0,1,host cell viral assembly compartment,CC,
17492,GO:1900276,1.00000000001331,0.8911984345167,0,1,regulation of proteinase activated receptor activity,BP,
17531,GO:1900736,1.00000000001331,0.8911984345167,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17532,GO:1900737,1.00000000001331,0.8911984345167,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18385,GO:1903348,1.00000000001332,0.707425397957223,0,3,positive regulation of bicellular tight junction assembly,BP,
7730,GO:0032216,1.00000000001333,0.895184433100706,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
15265,GO:0071409,1.00000000001333,0.716525612419715,0,3,cellular response to cycloheximide,BP,
15859,GO:0072554,1.00000000001333,0.894548503110311,0,1,blood vessel lumenization,BP,
17599,GO:1901189,1.00000000001333,0.894548503110311,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17634,GO:1901297,1.00000000001333,0.894548503110311,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19155,GO:1905068,1.00000000001333,0.894548503110311,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
17169,GO:0102420,1.00000000001333,0.708226065803764,0,3,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
5527,GO:0016494,1.00000000001334,0.71268214765211,0,3,C-X-C chemokine receptor activity,MF,
3168,GO:0006781,1.00000000001334,0.895806684682947,0,1,succinyl-CoA pathway,BP,
18620,GO:1903850,1.00000000001335,0.893412567794857,0,1,regulation of cristae formation,BP,
18621,GO:1903852,1.00000000001335,0.893412567794857,0,1,positive regulation of cristae formation,BP,
18904,GO:1904542,1.00000000001335,0.893412567794857,0,1,regulation of free ubiquitin chain polymerization,BP,
18905,GO:1904544,1.00000000001335,0.893412567794857,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19067,GO:1904881,1.00000000001335,0.893412567794857,0,1,cellular response to hydrogen sulfide,BP,
10638,GO:0043626,1.00000000001337,0.911797635600492,0,1,PCNA complex,CC,
11006,GO:0044796,1.00000000001337,0.911797635600492,0,1,DNA polymerase processivity factor complex,CC,
16219,GO:0090233,1.00000000001339,0.893366257291558,0,1,negative regulation of spindle checkpoint,BP,
18017,GO:1902426,1.00000000001339,0.893366257291558,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19251,GO:1905341,1.00000000001339,0.893366257291558,0,1,negative regulation of protein localization to kinetochore,BP,
19547,GO:1990405,1.0000000000134,0.629618937329264,0,4,protein antigen binding,MF,
19271,GO:1905394,1.0000000000134,0.711139902566028,0,3,retromer complex binding,MF,
14120,GO:0060935,1.0000000000134,0.707600494731431,0,3,cardiac fibroblast cell differentiation,BP,
14121,GO:0060936,1.0000000000134,0.707600494731431,0,3,cardiac fibroblast cell development,BP,
14122,GO:0060938,1.0000000000134,0.707600494731431,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14123,GO:0060939,1.0000000000134,0.707600494731431,0,3,epicardium-derived cardiac fibroblast cell development,BP,
4480,GO:0010484,1.00000000001342,0.628113915256826,0,4,H3 histone acetyltransferase activity,MF,
14703,GO:0070305,1.00000000001342,0.702209262481947,0,3,response to cGMP,BP,
15202,GO:0071321,1.00000000001342,0.702209262481947,0,3,cellular response to cGMP,BP,
14270,GO:0061300,1.00000000001342,0.805368494661818,0,2,cerebellum vasculature development,BP,
2234,GO:0005136,1.00000000001343,0.892144396307431,0,1,interleukin-4 receptor binding,MF,
9149,GO:0035485,1.00000000001343,0.899685487558264,0,1,adenine/guanine mispair binding,MF,
19838,GO:2000253,1.00000000001345,0.704635700417968,0,3,positive regulation of feeding behavior,BP,
8647,GO:0034166,1.00000000001347,0.891588846806207,0,1,toll-like receptor 10 signaling pathway,BP,
3986,GO:0008832,1.00000000001348,0.891918640688537,0,1,dGTPase activity,MF,
5683,GO:0016793,1.00000000001348,0.891918640688537,0,1,triphosphoric monoester hydrolase activity,MF,
7967,GO:0032560,1.00000000001348,0.891918640688537,0,1,guanyl deoxyribonucleotide binding,MF,
7970,GO:0032567,1.00000000001348,0.891918640688537,0,1,dGTP binding,MF,
16285,GO:0090326,1.0000000000135,0.891633895359601,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18154,GO:1902823,1.0000000000135,0.891633895359601,0,1,negative regulation of late endosome to lysosome transport,BP,
18382,GO:1903336,1.0000000000135,0.891633895359601,0,1,negative regulation of vacuolar transport,BP,
19892,GO:2000331,1.0000000000135,0.891633895359601,0,1,regulation of terminal button organization,BP,
12111,GO:0048075,1.00000000001351,0.889135073944748,0,1,positive regulation of eye pigmentation,BP,
5038,GO:0015211,1.00000000001351,0.894015850629063,0,1,purine nucleoside transmembrane transporter activity,MF,
15814,GO:0072429,1.00000000001352,0.714300446084605,0,3,response to intra-S DNA damage checkpoint signaling,BP,
13496,GO:0055011,1.00000000001353,0.902346058692724,0,1,atrial cardiac muscle cell differentiation,BP,
13499,GO:0055014,1.00000000001353,0.902346058692724,0,1,atrial cardiac muscle cell development,BP,
8393,GO:0033291,1.00000000001354,0.951621755741482,0,1,eukaryotic 80S initiation complex,CC,
8790,GO:0034463,1.00000000001354,0.951621755741482,0,1,90S preribosome assembly,BP,
6950,GO:0030553,1.00000000001356,0.703229380385796,0,3,cGMP binding,MF,
16904,GO:0098826,1.00000000001358,0.638376251724967,0,4,endoplasmic reticulum tubular network membrane,CC,
5459,GO:0016332,1.0000000000136,0.889909688581789,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15605,GO:0072060,1.0000000000136,0.889909688581789,0,1,outer medullary collecting duct development,BP,
34,GO:0000064,1.00000000001364,0.631377050018581,0,4,L-ornithine transmembrane transporter activity,MF,
2701,GO:0006065,1.00000000001365,0.709970809941282,0,3,UDP-glucuronate biosynthetic process,BP,
11672,GO:0046398,1.00000000001365,0.709970809941282,0,3,UDP-glucuronate metabolic process,BP,
3846,GO:0008454,1.00000000001366,0.793625692363294,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
8832,GO:0034602,1.00000000001366,0.889141084160093,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9280,GO:0035695,1.00000000001366,0.889141084160093,0,1,mitophagy by induced vacuole formation,BP,
14173,GO:0061034,1.00000000001366,0.889141084160093,0,1,olfactory bulb mitral cell layer development,BP,
16123,GO:0090086,1.00000000001366,0.760052049056239,0,3,negative regulation of protein deubiquitination,BP,
3870,GO:0008493,1.0000000000137,0.89936816004126,0,1,tetracycline transmembrane transporter activity,MF,
5265,GO:0015904,1.0000000000137,0.89936816004126,0,1,tetracycline transport,BP,
3023,GO:0006569,1.00000000001371,0.731386461824881,0,3,tryptophan catabolic process,BP,
6153,GO:0019441,1.00000000001371,0.731386461824881,0,3,tryptophan catabolic process to kynurenine,BP,
10020,GO:0042436,1.00000000001371,0.731386461824881,0,3,indole-containing compound catabolic process,BP,
11620,GO:0046218,1.00000000001371,0.731386461824881,0,3,indolalkylamine catabolic process,BP,
8427,GO:0033489,1.00000000001371,0.650992144030337,0,4,cholesterol biosynthetic process via desmosterol,BP,
8428,GO:0033490,1.00000000001371,0.650992144030337,0,4,cholesterol biosynthetic process via lathosterol,BP,
2036,GO:0004774,1.00000000001371,0.727727836339409,0,3,succinate-CoA ligase activity,MF,
19003,GO:1904753,1.00000000001372,0.716016514392759,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
11624,GO:0046292,1.00000000001373,0.727618282621474,0,3,formaldehyde metabolic process,BP,
18263,GO:1903045,1.00000000001379,0.88839486436514,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
16111,GO:0090071,1.0000000000138,0.629143449061513,0,4,negative regulation of ribosome biogenesis,BP,
13699,GO:0060212,1.0000000000138,0.900056675480352,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17437,GO:1900152,1.0000000000138,0.900056675480352,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17216,GO:0106017,1.00000000001381,0.702021967200324,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
6319,GO:0019961,1.00000000001381,0.791652032558812,0,2,interferon binding,MF,
9327,GO:0035790,1.00000000001381,0.890071362988981,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
20022,GO:2000583,1.00000000001381,0.890071362988981,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20023,GO:2000584,1.00000000001381,0.890071362988981,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
18099,GO:1902659,1.00000000001382,0.733308318769544,0,3,regulation of glucose mediated signaling pathway,BP,
18100,GO:1902661,1.00000000001382,0.733308318769544,0,3,positive regulation of glucose mediated signaling pathway,BP,
5760,GO:0016917,1.00000000001385,0.705289757553037,0,3,GABA receptor activity,MF,
11351,GO:0045660,1.00000000001387,0.897594531155072,0,1,positive regulation of neutrophil differentiation,BP,
19335,GO:1905573,1.00000000001388,0.802419094999535,0,2,ganglioside GM1 binding,MF,
19338,GO:1905576,1.00000000001388,0.802419094999535,0,2,ganglioside GT1b binding,MF,
8407,GO:0033328,1.00000000001389,0.890685793010089,0,1,peroxisome membrane targeting sequence binding,MF,
9484,GO:0036105,1.00000000001389,0.890685793010089,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17421,GO:1900130,1.00000000001389,0.890685793010089,0,1,regulation of lipid binding,BP,
17422,GO:1900131,1.00000000001389,0.890685793010089,0,1,negative regulation of lipid binding,BP,
341,GO:0000941,1.0000000000139,0.895170902631553,0,1,condensed nuclear chromosome inner kinetochore,CC,
13040,GO:0051456,1.0000000000139,0.895170902631553,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
5879,GO:0017198,1.00000000001391,0.928343280224407,0,1,N-terminal peptidyl-serine acetylation,BP,
5880,GO:0018002,1.00000000001391,0.928343280224407,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7123,GO:0030920,1.00000000001391,0.928343280224407,0,1,peptidyl-serine acetylation,BP,
14490,GO:0061850,1.00000000001391,0.928343280224407,0,1,growth cone leading edge,CC,
15565,GO:0071960,1.00000000001391,0.928343280224407,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19508,GO:1990190,1.00000000001391,0.928343280224407,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20104,GO:2000718,1.00000000001391,0.928343280224407,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20105,GO:2000719,1.00000000001391,0.928343280224407,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
4633,GO:0010752,1.00000000001393,0.789843286529963,0,2,regulation of cGMP-mediated signaling,BP,
14378,GO:0061582,1.00000000001394,0.790177262451249,0,2,intestinal epithelial cell migration,BP,
13830,GO:0060399,1.00000000001396,0.789259545414014,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
4246,GO:0009444,1.00000000001396,0.888420084250035,0,1,pyruvate oxidation,BP,
9709,GO:0038097,1.00000000001396,0.888420084250035,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
5011,GO:0015166,1.00000000001397,0.633919846518373,0,4,polyol transmembrane transporter activity,MF,
1812,GO:0004458,1.00000000001398,0.893618178129143,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
4012,GO:0008995,1.00000000001398,0.893618178129143,0,1,ribonuclease E activity,MF,
5753,GO:0016898,1.00000000001398,0.893618178129143,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6166,GO:0019516,1.00000000001398,0.893618178129143,0,1,lactate oxidation,BP,
10851,GO:0044336,1.00000000001398,0.707299953004257,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
16230,GO:0090247,1.00000000001398,0.893618178129143,0,1,cell motility involved in somitogenic axis elongation,BP,
16231,GO:0090249,1.00000000001398,0.893618178129143,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17614,GO:1901229,1.00000000001398,0.893618178129143,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17615,GO:1901231,1.00000000001398,0.893618178129143,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17616,GO:1901232,1.00000000001398,0.893618178129143,0,1,regulation of convergent extension involved in axis elongation,BP,
17617,GO:1901233,1.00000000001398,0.893618178129143,0,1,negative regulation of convergent extension involved in axis elongation,BP,
15959,GO:0072749,1.000000000014,0.900260913437188,0,1,cellular response to cytochalasin B,BP,
16960,GO:0098918,1.000000000014,0.900260913437188,0,1,structural constituent of synapse,MF,
16984,GO:0098973,1.000000000014,0.900260913437188,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16985,GO:0098974,1.000000000014,0.900260913437188,0,1,postsynaptic actin cytoskeleton organization,BP,
17047,GO:0099186,1.000000000014,0.900260913437188,0,1,structural constituent of postsynapse,MF,
17048,GO:0099188,1.000000000014,0.900260913437188,0,1,postsynaptic cytoskeleton organization,BP,
17647,GO:1901328,1.000000000014,0.900260913437188,0,1,response to cytochalasin B,BP,
389,GO:0001034,1.000000000014,0.900338643543226,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
11275,GO:0045509,1.000000000014,0.795342220742454,0,2,interleukin-27 receptor activity,MF,
19533,GO:1990357,1.00000000001401,0.726015079674699,0,3,terminal web,CC,
9577,GO:0036363,1.00000000001403,0.794369407527209,0,2,transforming growth factor beta activation,BP,
5537,GO:0016517,1.00000000001404,0.897661575572602,0,1,interleukin-12 receptor activity,MF,
9824,GO:0042019,1.00000000001404,0.897661575572602,0,1,interleukin-23 binding,MF,
9825,GO:0042020,1.00000000001404,0.897661575572602,0,1,interleukin-23 receptor activity,MF,
9826,GO:0042022,1.00000000001404,0.897661575572602,0,1,interleukin-12 receptor complex,CC,
15850,GO:0072536,1.00000000001404,0.897661575572602,0,1,interleukin-23 receptor complex,CC,
5047,GO:0015228,1.00000000001406,0.713671949066397,0,3,coenzyme A transmembrane transporter activity,MF,
5255,GO:0015880,1.00000000001406,0.713671949066397,0,3,coenzyme A transport,BP,
9095,GO:0035349,1.00000000001406,0.713671949066397,0,3,coenzyme A transmembrane transport,BP,
15107,GO:0071077,1.00000000001406,0.713671949066397,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15111,GO:0071106,1.00000000001406,0.713671949066397,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15994,GO:0080122,1.00000000001406,0.713671949066397,0,3,AMP transmembrane transporter activity,MF,
16680,GO:0097536,1.00000000001407,0.893315448169006,0,1,thymus epithelium morphogenesis,BP,
1690,GO:0004157,1.00000000001407,0.888832638366132,0,1,dihydropyrimidinase activity,MF,
18721,GO:1904048,1.00000000001407,0.888832638366132,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18722,GO:1904050,1.00000000001407,0.888832638366132,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19230,GO:1905301,1.00000000001407,0.888832638366132,0,1,regulation of macropinocytosis,BP,
19231,GO:1905302,1.00000000001407,0.888832638366132,0,1,negative regulation of macropinocytosis,BP,
13853,GO:0060431,1.00000000001409,0.71084027790073,0,3,primary lung bud formation,BP,
7354,GO:0031389,1.0000000000141,0.892789947582707,0,1,Rad17 RFC-like complex,CC,
12831,GO:0051107,1.0000000000141,0.892789947582707,0,1,negative regulation of DNA ligation,BP,
12989,GO:0051352,1.0000000000141,0.892789947582707,0,1,negative regulation of ligase activity,BP,
19062,GO:1904876,1.0000000000141,0.892789947582707,0,1,negative regulation of DNA ligase activity,BP,
10318,GO:0043084,1.0000000000141,0.638511515368473,0,4,penile erection,BP,
11772,GO:0046604,1.00000000001411,0.735095900414625,0,3,positive regulation of mitotic centrosome separation,BP,
14636,GO:0070189,1.00000000001411,0.653923479166405,0,4,kynurenine metabolic process,BP,
3812,GO:0008401,1.00000000001411,0.794200333505277,0,2,retinoic acid 4-hydroxylase activity,MF,
19791,GO:2000152,1.00000000001412,0.685534241389613,0,4,regulation of ubiquitin-specific protease activity,BP,
4003,GO:0008940,1.00000000001413,0.708754223727529,0,3,nitrate reductase activity,MF,
3972,GO:0008775,1.00000000001413,0.899989572207518,0,1,acetate CoA-transferase activity,MF,
4330,GO:0009850,1.00000000001413,0.899989572207518,0,1,auxin metabolic process,BP,
4331,GO:0009852,1.00000000001413,0.899989572207518,0,1,auxin catabolic process,BP,
4402,GO:0010124,1.00000000001413,0.899989572207518,0,1,phenylacetate catabolic process,BP,
6480,GO:0021817,1.00000000001414,0.703879623424519,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
10613,GO:0043578,1.00000000001414,0.703879623424519,0,3,nuclear matrix organization,BP,
16260,GO:0090292,1.00000000001414,0.703879623424519,0,3,nuclear matrix anchoring at nuclear membrane,BP,
2997,GO:0006543,1.00000000001417,0.70722968133537,0,3,glutamine catabolic process,BP,
1672,GO:0004132,1.00000000001418,0.897145883477723,0,1,dCMP deaminase activity,MF,
8855,GO:0034642,1.00000000001418,0.890139822253746,0,1,mitochondrion migration along actin filament,BP,
1777,GO:0004379,1.0000000000142,0.78948230483822,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5881,GO:0018008,1.0000000000142,0.78948230483822,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6039,GO:0019107,1.0000000000142,0.78948230483822,0,2,myristoyltransferase activity,MF,
17006,GO:0099053,1.00000000001421,0.711743106611629,0,3,activating signal cointegrator 1 complex,CC,
14412,GO:0061649,1.00000000001421,0.707453258698101,0,3,ubiquitin modification-dependent histone binding,MF,
1127,GO:0002713,1.00000000001422,0.636531759965853,0,4,negative regulation of B cell mediated immunity,BP,
1223,GO:0002890,1.00000000001422,0.636531759965853,0,4,negative regulation of immunoglobulin mediated immune response,BP,
12518,GO:0050560,1.00000000001423,0.891438798477123,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14611,GO:0070145,1.00000000001423,0.891438798477123,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
13749,GO:0060297,1.00000000001423,0.70749347711513,0,3,regulation of sarcomere organization,BP,
6840,GO:0030298,1.00000000001424,0.915470228979563,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7529,GO:0031726,1.00000000001424,0.915470228979563,0,1,CCR1 chemokine receptor binding,MF,
7530,GO:0031729,1.00000000001424,0.915470228979563,0,1,CCR4 chemokine receptor binding,MF,
11858,GO:0046817,1.00000000001424,0.915470228979563,0,1,chemokine receptor antagonist activity,MF,
627,GO:0001808,1.00000000001425,0.897018712034229,0,1,negative regulation of type IV hypersensitivity,BP,
1208,GO:0002865,1.00000000001425,0.897018712034229,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1217,GO:0002884,1.00000000001425,0.897018712034229,0,1,negative regulation of hypersensitivity,BP,
1784,GO:0004395,1.00000000001427,0.91409496852604,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3827,GO:0008425,1.00000000001427,0.91409496852604,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3957,GO:0008689,1.00000000001427,0.91409496852604,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4456,GO:0010420,1.00000000001427,0.91409496852604,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4654,GO:0010795,1.00000000001427,0.91409496852604,0,1,regulation of ubiquinone biosynthetic process,BP,
6958,GO:0030580,1.00000000001427,0.91409496852604,0,1,quinone cofactor methyltransferase activity,MF,
10946,GO:0044595,1.00000000001427,0.91409496852604,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10947,GO:0044596,1.00000000001427,0.91409496852604,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13184,GO:0051750,1.00000000001427,0.91409496852604,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14363,GO:0061542,1.00000000001427,0.91409496852604,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
3828,GO:0008426,1.00000000001427,0.754006086640441,0,3,protein kinase C inhibitor activity,MF,
12625,GO:0050785,1.00000000001428,0.911688555852433,0,1,advanced glycation end-product receptor activity,MF,
18933,GO:1904596,1.00000000001428,0.911688555852433,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18934,GO:1904597,1.00000000001428,0.911688555852433,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18935,GO:1904599,1.00000000001428,0.911688555852433,0,1,advanced glycation end-product binding,MF,
18936,GO:1904603,1.00000000001428,0.911688555852433,0,1,regulation of advanced glycation end-product receptor activity,BP,
18937,GO:1904604,1.00000000001428,0.911688555852433,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19194,GO:1905204,1.00000000001428,0.911688555852433,0,1,negative regulation of connective tissue replacement,BP,
6381,GO:0021563,1.00000000001428,0.792223318734784,0,2,glossopharyngeal nerve development,BP,
147,GO:0000301,1.00000000001429,0.711635810147751,0,3,retrograde transport, vesicle recycling within Golgi,BP,
444,GO:0001192,1.0000000000143,0.928882588925313,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,1.0000000000143,0.928882588925313,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
2163,GO:0004992,1.0000000000143,0.889419241968326,0,1,platelet activating factor receptor activity,MF,
4996,GO:0015130,1.0000000000143,0.889419241968326,0,1,mevalonate transmembrane transporter activity,MF,
5176,GO:0015728,1.0000000000143,0.889419241968326,0,1,mevalonate transport,BP,
10467,GO:0043315,1.0000000000143,0.889419241968326,0,1,positive regulation of neutrophil degranulation,BP,
13194,GO:0051780,1.0000000000143,0.889419241968326,0,1,behavioral response to nutrient,BP,
15167,GO:0071258,1.0000000000143,0.889419241968326,0,1,cellular response to gravity,BP,
18066,GO:1902565,1.0000000000143,0.889419241968326,0,1,positive regulation of neutrophil activation,BP,
18199,GO:1902941,1.0000000000143,0.889419241968326,0,1,regulation of voltage-gated chloride channel activity,BP,
18200,GO:1902943,1.0000000000143,0.889419241968326,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18596,GO:1903797,1.0000000000143,0.889419241968326,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18810,GO:1904298,1.0000000000143,0.889419241968326,0,1,regulation of transcytosis,BP,
18811,GO:1904300,1.0000000000143,0.889419241968326,0,1,positive regulation of transcytosis,BP,
18812,GO:1904301,1.0000000000143,0.889419241968326,0,1,regulation of maternal process involved in parturition,BP,
18813,GO:1904303,1.0000000000143,0.889419241968326,0,1,positive regulation of maternal process involved in parturition,BP,
18818,GO:1904316,1.0000000000143,0.889419241968326,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18819,GO:1904317,1.0000000000143,0.889419241968326,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
10142,GO:0042670,1.00000000001431,0.707670792987169,0,3,retinal cone cell differentiation,BP,
11752,GO:0046549,1.00000000001431,0.707670792987169,0,3,retinal cone cell development,BP,
17066,GO:0099522,1.00000000001434,0.897106852426192,0,1,region of cytosol,CC,
17067,GO:0099523,1.00000000001434,0.897106852426192,0,1,presynaptic cytosol,CC,
17068,GO:0099524,1.00000000001434,0.897106852426192,0,1,postsynaptic cytosol,CC,
19008,GO:1904764,1.00000000001434,0.897106852426192,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19670,GO:1990832,1.00000000001434,0.897106852426192,0,1,slow axonal transport,BP,
19671,GO:1990833,1.00000000001434,0.897106852426192,0,1,clathrin-uncoating ATPase activity,MF,
9712,GO:0038107,1.00000000001435,0.721458660589679,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17394,GO:1900094,1.00000000001435,0.721458660589679,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17441,GO:1900164,1.00000000001435,0.721458660589679,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
5837,GO:0017116,1.00000000001435,0.707765462356448,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
11287,GO:0045578,1.00000000001437,0.709366941027763,0,3,negative regulation of B cell differentiation,BP,
10833,GO:0044316,1.00000000001437,0.89039833160797,0,1,cone cell pedicle,CC,
17736,GO:1901622,1.00000000001438,0.893642898813881,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
11935,GO:0046963,1.00000000001439,0.804417153777337,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11936,GO:0046964,1.00000000001439,0.804417153777337,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18061,GO:1902559,1.00000000001439,0.804417153777337,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
3607,GO:0008048,1.0000000000144,0.895077999390155,0,1,calcium sensitive guanylate cyclase activator activity,MF,
4698,GO:0010851,1.0000000000144,0.895077999390155,0,1,cyclase regulator activity,MF,
4699,GO:0010853,1.0000000000144,0.895077999390155,0,1,cyclase activator activity,MF,
6808,GO:0030249,1.0000000000144,0.895077999390155,0,1,guanylate cyclase regulator activity,MF,
6809,GO:0030250,1.0000000000144,0.895077999390155,0,1,guanylate cyclase activator activity,MF,
20207,GO:2001016,1.00000000001441,0.640439339720999,0,4,positive regulation of skeletal muscle cell differentiation,BP,
1205,GO:0002862,1.00000000001441,0.692851885929825,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
16354,GO:0090560,1.00000000001442,0.895911296869871,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
19875,GO:2000312,1.00000000001443,0.707829822416344,0,3,regulation of kainate selective glutamate receptor activity,BP,
5962,GO:0018343,1.00000000001443,0.72130708465445,0,3,protein farnesylation,BP,
11373,GO:0045716,1.00000000001444,0.727019551078881,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
2263,GO:0005175,1.00000000001445,0.937596743652146,0,1,CD27 receptor binding,MF,
1603,GO:0004019,1.00000000001445,0.893143730232105,0,1,adenylosuccinate synthase activity,MF,
15532,GO:0071894,1.00000000001446,0.79865329761281,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
18706,GO:1904026,1.00000000001446,0.797983102967735,0,2,regulation of collagen fibril organization,BP,
2008,GO:0004729,1.00000000001447,0.901416922127288,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14952,GO:0070818,1.00000000001447,0.901416922127288,0,1,protoporphyrinogen oxidase activity,MF,
11856,GO:0046811,1.00000000001447,0.888394518635122,0,1,histone deacetylase inhibitor activity,MF,
10853,GO:0044339,1.00000000001448,0.716745138587794,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
17214,GO:0106014,1.00000000001448,0.813759651389771,0,2,regulation of inflammatory response to wounding,BP,
17215,GO:0106015,1.00000000001448,0.813759651389771,0,2,negative regulation of inflammatory response to wounding,BP,
3411,GO:0007195,1.00000000001449,0.794363006772878,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
7723,GO:0032207,1.0000000000145,0.892787213812197,0,1,regulation of telomere maintenance via recombination,BP,
7724,GO:0032208,1.0000000000145,0.892787213812197,0,1,negative regulation of telomere maintenance via recombination,BP,
18461,GO:1903517,1.0000000000145,0.892787213812197,0,1,negative regulation of single strand break repair,BP,
18582,GO:1903770,1.0000000000145,0.892787213812197,0,1,negative regulation of beta-galactosidase activity,BP,
18604,GO:1903823,1.0000000000145,0.892787213812197,0,1,telomere single strand break repair,BP,
18605,GO:1903824,1.0000000000145,0.892787213812197,0,1,negative regulation of telomere single strand break repair,BP,
7085,GO:0030868,1.0000000000145,0.726720721938372,0,3,smooth endoplasmic reticulum membrane,CC,
16618,GO:0097425,1.0000000000145,0.726720721938372,0,3,smooth endoplasmic reticulum part,CC,
6640,GO:0023021,1.00000000001451,0.714594315599794,0,3,termination of signal transduction,BP,
12125,GO:0048149,1.00000000001452,0.631332921505336,0,4,behavioral response to ethanol,BP,
1720,GO:0004309,1.00000000001452,0.631374474174248,0,4,exopolyphosphatase activity,MF,
3179,GO:0006798,1.00000000001452,0.631374474174248,0,4,polyphosphate catabolic process,BP,
19494,GO:1990166,1.00000000001453,0.713004525688181,0,3,protein localization to site of double-strand break,BP,
17344,GO:0150003,1.00000000001453,0.722066858353309,0,3,regulation of spontaneous synaptic transmission,BP,
16432,GO:0097048,1.00000000001453,0.62968489686479,0,4,dendritic cell apoptotic process,BP,
20079,GO:2000668,1.00000000001453,0.62968489686479,0,4,regulation of dendritic cell apoptotic process,BP,
5412,GO:0016250,1.00000000001454,0.893130855453337,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5703,GO:0016826,1.00000000001454,0.893130855453337,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
12088,GO:0048021,1.00000000001455,0.701750523030216,0,3,regulation of melanin biosynthetic process,BP,
16189,GO:0090191,1.00000000001455,0.807723923342436,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
15675,GO:0072174,1.00000000001455,0.704799065199208,0,3,metanephric tubule formation,BP,
218,GO:0000454,1.00000000001456,0.781166096425253,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
17496,GO:1900368,1.00000000001463,0.755392151860034,0,3,regulation of RNA interference,BP,
17506,GO:1900390,1.00000000001463,0.830183937453711,0,2,regulation of iron ion import,BP,
18867,GO:1904432,1.00000000001463,0.830183937453711,0,2,regulation of ferrous iron binding,BP,
18868,GO:1904434,1.00000000001463,0.830183937453711,0,2,positive regulation of ferrous iron binding,BP,
18869,GO:1904435,1.00000000001463,0.830183937453711,0,2,regulation of transferrin receptor binding,BP,
18870,GO:1904437,1.00000000001463,0.830183937453711,0,2,positive regulation of transferrin receptor binding,BP,
4615,GO:0010730,1.00000000001464,0.707168450272787,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
2166,GO:0004998,1.00000000001465,0.888450540346285,0,1,transferrin receptor activity,MF,
4977,GO:0015091,1.00000000001465,0.888450540346285,0,1,ferric iron transmembrane transporter activity,MF,
8454,GO:0033570,1.00000000001465,0.888450540346285,0,1,transferrin transmembrane transporter activity,MF,
15830,GO:0072510,1.00000000001465,0.888450540346285,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
3936,GO:0008616,1.00000000001465,0.745416314547282,0,3,queuosine biosynthetic process,BP,
11583,GO:0046116,1.00000000001465,0.745416314547282,0,3,queuosine metabolic process,BP,
955,GO:0002371,1.00000000001465,0.652661187740613,0,4,dendritic cell cytokine production,BP,
1141,GO:0002730,1.00000000001465,0.652661187740613,0,4,regulation of dendritic cell cytokine production,BP,
17483,GO:1900259,1.00000000001465,0.898906474552362,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17484,GO:1900260,1.00000000001465,0.898906474552362,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17868,GO:1902022,1.00000000001466,0.714385554535692,0,3,L-lysine transport,BP,
18414,GO:1903401,1.00000000001466,0.714385554535692,0,3,L-lysine transmembrane transport,BP,
12994,GO:0051377,1.00000000001469,0.706611159996094,0,3,mannose-ethanolamine phosphotransferase activity,MF,
11584,GO:0046121,1.00000000001471,0.728936510439441,0,3,deoxyribonucleoside catabolic process,BP,
20038,GO:2000616,1.00000000001471,0.798788328135514,0,2,negative regulation of histone H3-K9 acetylation,BP,
14907,GO:0070685,1.00000000001474,0.896313475268353,0,1,macropinocytic cup,CC,
294,GO:0000798,1.00000000001475,0.708623223671436,0,3,nuclear cohesin complex,CC,
3988,GO:0008852,1.00000000001478,0.892964608777964,0,1,exodeoxyribonuclease I activity,MF,
16016,GO:0086008,1.00000000001479,0.892798140822622,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16069,GO:0086089,1.00000000001479,0.892798140822622,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17966,GO:1902282,1.00000000001479,0.892798140822622,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
13881,GO:0060474,1.00000000001479,0.844590222123222,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
8189,GO:0032919,1.0000000000148,0.925135347601362,0,1,spermine acetylation,BP,
8190,GO:0032920,1.0000000000148,0.925135347601362,0,1,putrescine acetylation,BP,
11616,GO:0046204,1.0000000000148,0.925135347601362,0,1,nor-spermidine metabolic process,BP,
12485,GO:0050313,1.0000000000148,0.925135347601362,0,1,sulfur dioxygenase activity,MF,
6113,GO:0019353,1.0000000000148,0.893286408881436,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8437,GO:0033526,1.0000000000148,0.893286408881436,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
1818,GO:0004465,1.00000000001481,0.712170137453393,0,3,lipoprotein lipase activity,MF,
20236,GO:2001070,1.00000000001481,0.79433406524006,0,2,starch binding,MF,
5303,GO:0015990,1.00000000001481,0.932441179198127,0,1,electron transport coupled proton transport,BP,
14634,GO:0070184,1.00000000001484,0.895890133713445,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15856,GO:0072545,1.00000000001484,0.895890133713445,0,1,tyrosine binding,MF,
18196,GO:1902937,1.00000000001484,0.895890133713445,0,1,inward rectifier potassium channel complex,CC,
16750,GO:0097742,1.00000000001485,0.702580065387148,0,3,de novo centriole assembly,BP,
16775,GO:0098535,1.00000000001485,0.702580065387148,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
520,GO:0001605,1.00000000001485,0.888506401528065,0,1,adrenomedullin receptor activity,MF,
2140,GO:0004948,1.00000000001485,0.888506401528065,0,1,calcitonin receptor activity,MF,
15204,GO:0071324,1.00000000001485,0.888506401528065,0,1,cellular response to disaccharide stimulus,BP,
15206,GO:0071329,1.00000000001485,0.888506401528065,0,1,cellular response to sucrose stimulus,BP,
18300,GO:1903143,1.00000000001485,0.888506401528065,0,1,adrenomedullin receptor complex,CC,
19551,GO:1990409,1.00000000001485,0.888506401528065,0,1,adrenomedullin binding,MF,
2037,GO:0004775,1.00000000001487,0.813517246866916,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
7128,GO:0030943,1.00000000001487,0.719020163008681,0,3,mitochondrion targeting sequence binding,MF,
16634,GO:0097454,1.00000000001489,0.721036070764258,0,3,Schwann cell microvillus,CC,
11924,GO:0046940,1.00000000001491,0.653727794970879,0,4,nucleoside monophosphate phosphorylation,BP,
12466,GO:0050145,1.00000000001491,0.653727794970879,0,4,nucleoside phosphate kinase activity,MF,
6471,GO:0021797,1.00000000001492,0.891320588501089,0,1,forebrain anterior/posterior pattern specification,BP,
6510,GO:0021881,1.00000000001492,0.891320588501089,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12203,GO:0048320,1.00000000001492,0.891320588501089,0,1,axial mesoderm formation,BP,
14073,GO:0060823,1.00000000001492,0.891320588501089,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
5677,GO:0016784,1.00000000001492,0.907773431530928,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6264,GO:0019853,1.00000000001492,0.907773431530928,0,1,L-ascorbic acid biosynthetic process,BP,
6708,GO:0030108,1.00000000001492,0.907773431530928,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7846,GO:0032397,1.00000000001492,0.907773431530928,0,1,activating MHC class I receptor activity,MF,
10225,GO:0042839,1.00000000001492,0.907773431530928,0,1,D-glucuronate metabolic process,BP,
10226,GO:0042840,1.00000000001492,0.907773431530928,0,1,D-glucuronate catabolic process,BP,
12068,GO:0047939,1.00000000001492,0.907773431530928,0,1,L-glucuronate reductase activity,MF,
6549,GO:0021960,1.00000000001495,0.705004852387405,0,3,anterior commissure morphogenesis,BP,
1807,GO:0004449,1.00000000001495,0.732423637815478,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
2155,GO:0004972,1.00000000001495,0.789910834003029,0,2,NMDA glutamate receptor activity,MF,
9158,GO:0035502,1.00000000001495,0.714174963333142,0,3,metanephric part of ureteric bud development,BP,
7019,GO:0030718,1.00000000001496,0.890097833284696,0,1,germ-line stem cell population maintenance,BP,
8822,GO:0034584,1.00000000001496,0.890097833284696,0,1,piRNA binding,MF,
9541,GO:0036265,1.00000000001499,0.689654906833498,0,4,RNA (guanine-N7)-methylation,BP,
3650,GO:0008127,1.000000000015,0.913018458536129,0,1,quercetin 2,3-dioxygenase activity,MF,
1847,GO:0004500,1.00000000001501,0.892375440226198,0,1,dopamine beta-monooxygenase activity,MF,
3037,GO:0006589,1.00000000001501,0.892375440226198,0,1,octopamine biosynthetic process,BP,
11645,GO:0046333,1.00000000001501,0.892375440226198,0,1,octopamine metabolic process,BP,
15813,GO:0072428,1.00000000001503,0.899298369087875,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
18659,GO:1903925,1.00000000001503,0.899298369087875,0,1,response to bisphenol A,BP,
18660,GO:1903926,1.00000000001503,0.899298369087875,0,1,cellular response to bisphenol A,BP,
18408,GO:1903387,1.00000000001503,0.888424720861501,0,1,positive regulation of homophilic cell adhesion,BP,
15597,GO:0072047,1.00000000001506,0.656393246480333,0,4,proximal/distal pattern formation involved in nephron development,BP,
15618,GO:0072081,1.00000000001506,0.656393246480333,0,4,specification of nephron tubule identity,BP,
15619,GO:0072086,1.00000000001506,0.656393246480333,0,4,specification of loop of Henle identity,BP,
15402,GO:0071633,1.00000000001506,0.892911526427863,0,1,dihydroceramidase activity,MF,
12019,GO:0047464,1.00000000001506,0.888490624029837,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12494,GO:0050379,1.00000000001506,0.888490624029837,0,1,UDP-glucuronate 5'-epimerase activity,MF,
7955,GO:0032545,1.00000000001506,0.727476215265686,0,3,CURI complex,CC,
8785,GO:0034456,1.00000000001506,0.727476215265686,0,3,UTP-C complex,CC,
12307,GO:0048625,1.00000000001512,0.707062997688527,0,3,myoblast fate commitment,BP,
5397,GO:0016231,1.00000000001515,0.888460017463869,0,1,beta-N-acetylglucosaminidase activity,MF,
17152,GO:0102166,1.00000000001515,0.888460017463869,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17153,GO:0102167,1.00000000001515,0.888460017463869,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17184,GO:0102571,1.00000000001515,0.888460017463869,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
5960,GO:0018335,1.00000000001516,0.630887783392729,0,4,protein succinylation,BP,
17239,GO:0106077,1.00000000001516,0.630887783392729,0,4,histone succinylation,BP,
1411,GO:0003342,1.00000000001517,0.892450397521269,0,1,proepicardium development,BP,
1412,GO:0003343,1.00000000001517,0.892450397521269,0,1,septum transversum development,BP,
16610,GO:0097403,1.00000000001517,0.892450397521269,0,1,cellular response to raffinose,BP,
17702,GO:1901545,1.00000000001517,0.892450397521269,0,1,response to raffinose,BP,
9822,GO:0042008,1.00000000001517,0.890952317701276,0,1,interleukin-18 receptor activity,MF,
19607,GO:1990613,1.00000000001517,0.890952317701276,0,1,mitochondrial membrane fusion,BP,
6518,GO:0021892,1.00000000001521,0.737958732540009,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
2394,GO:0005534,1.00000000001523,0.724933152186764,0,3,galactose binding,MF,
2685,GO:0006046,1.00000000001524,0.723536765671779,0,3,N-acetylglucosamine catabolic process,BP,
671,GO:0001875,1.00000000001529,0.708193438581555,0,3,lipopolysaccharide receptor activity,MF,
8890,GO:0034696,1.00000000001529,0.801070770750253,0,2,response to prostaglandin F,BP,
173,GO:0000379,1.00000000001534,0.720397307577156,0,3,tRNA-type intron splice site recognition and cleavage,BP,
4450,GO:0010370,1.00000000001534,0.798706803876208,0,2,perinucleolar chromocenter,CC,
17620,GO:1901254,1.00000000001535,0.889043252314677,0,1,positive regulation of intracellular transport of viral material,BP,
18125,GO:1902737,1.00000000001535,0.889043252314677,0,1,dendritic filopodium,CC,
8100,GO:0032777,1.00000000001536,0.642134704860104,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
3869,GO:0008489,1.00000000001538,0.892777635087181,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
11992,GO:0047263,1.00000000001538,0.892777635087181,0,1,N-acylsphingosine galactosyltransferase activity,MF,
4374,GO:0009992,1.00000000001538,0.89572110923546,0,1,cellular water homeostasis,BP,
10753,GO:0044111,1.00000000001539,0.802817066092639,0,2,development involved in symbiotic interaction,BP,
4892,GO:0014810,1.0000000000154,0.93270010154836,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
2076,GO:0004827,1.00000000001542,0.73032265848122,0,3,proline-tRNA ligase activity,MF,
2922,GO:0006433,1.00000000001542,0.73032265848122,0,3,prolyl-tRNA aminoacylation,BP,
846,GO:0002158,1.00000000001544,0.733065255865083,0,3,osteoclast proliferation,BP,
6106,GO:0019323,1.00000000001544,0.729945048776702,0,3,pentose catabolic process,BP,
1887,GO:0004565,1.00000000001544,0.63642482218413,0,4,beta-galactosidase activity,MF,
969,GO:0002408,1.00000000001548,0.888400343072523,0,1,myeloid dendritic cell chemotaxis,BP,
7987,GO:0032595,1.00000000001549,0.895749403735867,0,1,B cell receptor transport within lipid bilayer,BP,
7989,GO:0032597,1.00000000001549,0.895749403735867,0,1,B cell receptor transport into membrane raft,BP,
7990,GO:0032599,1.00000000001549,0.895749403735867,0,1,protein transport out of membrane raft,BP,
7991,GO:0032600,1.00000000001549,0.895749403735867,0,1,chemokine receptor transport out of membrane raft,BP,
8183,GO:0032913,1.00000000001549,0.895749403735867,0,1,negative regulation of transforming growth factor beta3 production,BP,
8475,GO:0033606,1.00000000001549,0.895749403735867,0,1,chemokine receptor transport within lipid bilayer,BP,
15659,GO:0072139,1.00000000001549,0.895749403735867,0,1,glomerular parietal epithelial cell differentiation,BP,
20134,GO:2000768,1.00000000001549,0.895749403735867,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
16548,GO:0097252,1.00000000001549,0.711426850980878,0,3,oligodendrocyte apoptotic process,BP,
18603,GO:1903818,1.0000000000155,0.702214230267283,0,3,positive regulation of voltage-gated potassium channel activity,BP,
786,GO:0002041,1.0000000000155,0.894932072304574,0,1,intussusceptive angiogenesis,BP,
2896,GO:0006404,1.00000000001551,0.738267649306905,0,3,RNA import into nucleus,BP,
16272,GO:0090309,1.00000000001552,0.626617240102617,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
12811,GO:0051086,1.00000000001553,0.897930946455538,0,1,chaperone mediated protein folding independent of cofactor,BP,
15571,GO:0071987,1.00000000001554,0.629853890461331,0,4,WD40-repeat domain binding,MF,
16051,GO:0086057,1.00000000001555,0.890043845672898,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19501,GO:1990174,1.00000000001555,0.890043845672898,0,1,phosphodiesterase decapping endonuclease activity,MF,
11874,GO:0046848,1.0000000000156,0.910494924967729,0,1,hydroxyapatite binding,MF,
9105,GO:0035363,1.0000000000156,0.641266887747736,0,4,histone locus body,CC,
18546,GO:1903697,1.0000000000156,0.891459785053829,0,1,negative regulation of microvillus assembly,BP,
12329,GO:0048664,1.0000000000156,0.742853176489013,0,3,neuron fate determination,BP,
7390,GO:0031437,1.00000000001561,0.709327855635658,0,3,regulation of mRNA cleavage,BP,
2049,GO:0004794,1.00000000001562,0.90989854413027,0,1,L-threonine ammonia-lyase activity,MF,
12429,GO:0048859,1.00000000001562,0.820825248355877,0,2,formation of anatomical boundary,BP,
5535,GO:0016509,1.00000000001563,0.714260692823166,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
2798,GO:0006253,1.00000000001564,0.919321963226784,0,1,dCTP catabolic process,BP,
11551,GO:0046065,1.00000000001564,0.919321963226784,0,1,dCTP metabolic process,BP,
12059,GO:0047840,1.00000000001564,0.919321963226784,0,1,dCTP diphosphatase activity,MF,
13805,GO:0060371,1.00000000001564,0.707092599737795,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
12209,GO:0048341,1.00000000001564,0.629756369059386,0,4,paraxial mesoderm formation,BP,
2601,GO:0005898,1.00000000001565,0.889681827399241,0,1,interleukin-13 receptor complex,CC,
7775,GO:0032290,1.00000000001565,0.62599235084156,0,4,peripheral nervous system myelin formation,BP,
6389,GO:0021577,1.00000000001567,0.889777116882355,0,1,hindbrain structural organization,BP,
6393,GO:0021589,1.00000000001567,0.889777116882355,0,1,cerebellum structural organization,BP,
14104,GO:0060904,1.00000000001567,0.889777116882355,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18816,GO:1904313,1.00000000001567,0.889777116882355,0,1,response to methamphetamine hydrochloride,BP,
13673,GO:0060161,1.00000000001567,0.711067905539231,0,3,positive regulation of dopamine receptor signaling pathway,BP,
5398,GO:0016232,1.00000000001567,0.893009239166159,0,1,HNK-1 sulfotransferase activity,MF,
4988,GO:0015112,1.0000000000157,0.89343746545694,0,1,nitrate transmembrane transporter activity,MF,
5166,GO:0015706,1.0000000000157,0.89343746545694,0,1,nitrate transport,BP,
4325,GO:0009820,1.0000000000157,0.646646667625359,0,4,alkaloid metabolic process,BP,
14349,GO:0061511,1.0000000000157,0.652551956740603,0,4,centriole elongation,BP,
14070,GO:0060816,1.00000000001571,0.791927318512655,0,2,random inactivation of X chromosome,BP,
14165,GO:0061015,1.00000000001572,0.831028104939777,0,2,snRNA import into nucleus,BP,
755,GO:0001992,1.00000000001573,0.889068260548641,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2162,GO:0004990,1.00000000001573,0.889068260548641,0,1,oxytocin receptor activity,MF,
2311,GO:0005298,1.00000000001573,0.889068260548641,0,1,proline:sodium symporter activity,MF,
10079,GO:0042564,1.00000000001573,0.889068260548641,0,1,NLS-dependent protein nuclear import complex,CC,
2227,GO:0005127,1.00000000001574,0.713488602168726,0,3,ciliary neurotrophic factor receptor binding,MF,
7785,GO:0032304,1.00000000001574,0.888491394599284,0,1,negative regulation of icosanoid secretion,BP,
17427,GO:1900139,1.00000000001574,0.888491394599284,0,1,negative regulation of arachidonic acid secretion,BP,
15566,GO:0071962,1.00000000001574,0.744123309666927,0,3,mitotic sister chromatid cohesion, centromeric,BP,
12150,GO:0048213,1.00000000001576,0.892959328189544,0,1,Golgi vesicle prefusion complex stabilization,BP,
2063,GO:0004814,1.00000000001578,0.721613220852851,0,3,arginine-tRNA ligase activity,MF,
2909,GO:0006420,1.00000000001578,0.721613220852851,0,3,arginyl-tRNA aminoacylation,BP,
5354,GO:0016103,1.0000000000158,0.888854097550395,0,1,diterpenoid catabolic process,BP,
5356,GO:0016115,1.0000000000158,0.888854097550395,0,1,terpenoid catabolic process,BP,
8864,GO:0034653,1.0000000000158,0.888854097550395,0,1,retinoic acid catabolic process,BP,
16076,GO:0089700,1.00000000001583,0.705795293933189,0,3,protein kinase D signaling,BP,
3820,GO:0008413,1.00000000001583,0.839584227210959,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9182,GO:0035539,1.00000000001583,0.839584227210959,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
15899,GO:0072610,1.00000000001586,0.636827878680807,0,4,interleukin-12 secretion,BP,
20271,GO:2001182,1.00000000001586,0.636827878680807,0,4,regulation of interleukin-12 secretion,BP,
11550,GO:0046061,1.00000000001586,0.756191501915866,0,3,dATP catabolic process,BP,
17653,GO:1901340,1.00000000001587,0.889439850731746,0,1,negative regulation of store-operated calcium channel activity,BP,
19850,GO:2000275,1.00000000001588,0.82965137777875,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
16435,GO:0097051,1.00000000001589,0.702692137454032,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
14739,GO:0070375,1.00000000001592,0.709474452042629,0,3,ERK5 cascade,BP,
1429,GO:0003383,1.00000000001593,0.701249279250988,0,3,apical constriction,BP,
4564,GO:0010643,1.00000000001595,0.710222256661432,0,3,cell communication by chemical coupling,BP,
11426,GO:0045819,1.00000000001595,0.889855369371103,0,1,positive regulation of glycogen catabolic process,BP,
1828,GO:0004478,1.00000000001597,0.892996160293237,0,1,methionine adenosyltransferase activity,MF,
17651,GO:1901338,1.00000000001605,0.721460040473483,0,3,catecholamine binding,MF,
16045,GO:0086047,1.00000000001607,0.889552092464374,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18761,GO:1904199,1.00000000001607,0.889552092464374,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19632,GO:1990736,1.00000000001607,0.889552092464374,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
4616,GO:0010731,1.00000000001609,0.894644612578773,0,1,protein glutathionylation,BP,
4617,GO:0010732,1.00000000001609,0.894644612578773,0,1,regulation of protein glutathionylation,BP,
4618,GO:0010734,1.00000000001609,0.894644612578773,0,1,negative regulation of protein glutathionylation,BP,
14833,GO:0070552,1.00000000001609,0.71361028470613,0,3,BRISC complex,CC,
7556,GO:0031860,1.0000000000161,0.703157593646038,0,3,telomeric 3' overhang formation,BP,
8901,GO:0034711,1.00000000001611,0.716785360478957,0,3,inhibin binding,MF,
8177,GO:0032907,1.00000000001612,0.706942759656912,0,3,transforming growth factor beta3 production,BP,
8180,GO:0032910,1.00000000001612,0.706942759656912,0,3,regulation of transforming growth factor beta3 production,BP,
411,GO:0001097,1.00000000001614,0.718337178473309,0,3,TFIIH-class transcription factor binding,MF,
12309,GO:0048630,1.00000000001614,0.705880735545795,0,3,skeletal muscle tissue growth,BP,
12310,GO:0048631,1.00000000001614,0.705880735545795,0,3,regulation of skeletal muscle tissue growth,BP,
12311,GO:0048633,1.00000000001614,0.705880735545795,0,3,positive regulation of skeletal muscle tissue growth,BP,
15973,GO:0075519,1.00000000001616,0.936521425822825,0,1,microtubule-dependent intracellular transport of viral material,BP,
15974,GO:0075521,1.00000000001616,0.936521425822825,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15978,GO:0075606,1.00000000001616,0.936521425822825,0,1,transport of viral material towards nucleus,BP,
11830,GO:0046707,1.00000000001617,0.805033913697981,0,2,IDP metabolic process,BP,
11831,GO:0046709,1.00000000001617,0.805033913697981,0,2,IDP catabolic process,BP,
809,GO:0002079,1.00000000001617,0.792252625639393,0,2,inner acrosomal membrane,CC,
1900,GO:0004581,1.00000000001617,0.917361333161323,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
9216,GO:0035594,1.00000000001622,0.715297856238791,0,3,ganglioside binding,MF,
19700,GO:1990930,1.00000000001623,0.905181248700569,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
17310,GO:0140052,1.00000000001626,0.708898173445514,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
15963,GO:0072757,1.00000000001627,0.632579237364406,0,4,cellular response to camptothecin,BP,
13967,GO:0060623,1.00000000001627,0.712857361074718,0,3,regulation of chromosome condensation,BP,
3603,GO:0008043,1.00000000001627,0.850442474395169,0,2,intracellular ferritin complex,CC,
14690,GO:0070288,1.00000000001627,0.850442474395169,0,2,ferritin complex,CC,
6044,GO:0019144,1.00000000001628,0.83009871583793,0,2,ADP-sugar diphosphatase activity,MF,
1373,GO:0003256,1.00000000001629,0.706574067383686,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
773,GO:0002025,1.00000000001632,0.897073625290745,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2136,GO:0004939,1.00000000001632,0.897073625290745,0,1,beta-adrenergic receptor activity,MF,
2137,GO:0004941,1.00000000001632,0.897073625290745,0,1,beta2-adrenergic receptor activity,MF,
12997,GO:0051380,1.00000000001632,0.897073625290745,0,1,norepinephrine binding,MF,
14495,GO:0061884,1.00000000001632,0.897073625290745,0,1,regulation of mini excitatory postsynaptic potential,BP,
14496,GO:0061885,1.00000000001632,0.897073625290745,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16901,GO:0098816,1.00000000001632,0.897073625290745,0,1,mini excitatory postsynaptic potential,BP,
7514,GO:0031691,1.00000000001634,0.804856464593361,0,2,alpha-1A adrenergic receptor binding,MF,
7515,GO:0031692,1.00000000001634,0.804856464593361,0,2,alpha-1B adrenergic receptor binding,MF,
7538,GO:0031762,1.00000000001634,0.804856464593361,0,2,follicle-stimulating hormone receptor binding,MF,
10147,GO:0042699,1.00000000001634,0.804856464593361,0,2,follicle-stimulating hormone signaling pathway,BP,
7245,GO:0031161,1.00000000001638,0.892079330827225,0,1,phosphatidylinositol catabolic process,BP,
3600,GO:0008035,1.00000000001639,0.635132954867681,0,4,high-density lipoprotein particle binding,MF,
4489,GO:0010509,1.00000000001642,0.888398289123779,0,1,polyamine homeostasis,BP,
9022,GO:0035189,1.00000000001643,0.710940954596657,0,3,Rb-E2F complex,CC,
8712,GO:0034343,1.00000000001644,0.706734085799848,0,3,type III interferon production,BP,
8713,GO:0034344,1.00000000001644,0.706734085799848,0,3,regulation of type III interferon production,BP,
8599,GO:0034092,1.00000000001645,0.732671162783258,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8649,GO:0034183,1.00000000001645,0.732671162783258,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
2059,GO:0004809,1.00000000001646,0.718083106515474,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
7192,GO:0031074,1.00000000001647,0.727431565197608,0,3,nucleocytoplasmic transport complex,CC,
14577,GO:0070091,1.00000000001652,0.647348346110495,0,4,glucagon secretion,BP,
1834,GO:0004486,1.00000000001652,0.89110214899846,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1795,GO:0004421,1.00000000001653,0.891066744265887,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
3709,GO:0008218,1.00000000001653,0.891066744265887,0,1,bioluminescence,BP,
4281,GO:0009645,1.00000000001653,0.891066744265887,0,1,response to low light intensity stimulus,BP,
4406,GO:0010142,1.00000000001653,0.891066744265887,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
11824,GO:0046690,1.00000000001653,0.891066744265887,0,1,response to tellurium ion,BP,
18137,GO:1902767,1.00000000001653,0.891066744265887,0,1,isoprenoid biosynthetic process via mevalonate,BP,
429,GO:0001147,1.00000000001658,0.79167569042181,0,2,transcription termination site sequence-specific DNA binding,MF,
432,GO:0001160,1.00000000001658,0.79167569042181,0,2,transcription termination site DNA binding,MF,
6955,GO:0030576,1.00000000001658,0.712249042355769,0,3,Cajal body organization,BP,
8554,GO:0033882,1.00000000001658,0.917804969250381,0,1,choloyl-CoA hydrolase activity,MF,
11178,GO:0045222,1.00000000001658,0.917804969250381,0,1,CD4 biosynthetic process,BP,
11179,GO:0045223,1.00000000001658,0.917804969250381,0,1,regulation of CD4 biosynthetic process,BP,
11180,GO:0045225,1.00000000001658,0.917804969250381,0,1,negative regulation of CD4 biosynthetic process,BP,
13440,GO:0052815,1.00000000001658,0.917804969250381,0,1,medium-chain acyl-CoA hydrolase activity,MF,
7427,GO:0031515,1.00000000001659,0.717904105147201,0,3,tRNA (m1A) methyltransferase complex,CC,
18921,GO:1904578,1.0000000000166,0.741791815596181,0,3,response to thapsigargin,BP,
18922,GO:1904579,1.0000000000166,0.741791815596181,0,3,cellular response to thapsigargin,BP,
1979,GO:0004692,1.00000000001661,0.890132152723219,0,1,cGMP-dependent protein kinase activity,MF,
10530,GO:0043435,1.00000000001663,0.707282519591112,0,3,response to corticotropin-releasing hormone,BP,
15240,GO:0071376,1.00000000001663,0.707282519591112,0,3,cellular response to corticotropin-releasing hormone stimulus,BP,
16942,GO:0098895,1.00000000001664,0.889322866670765,0,1,postsynaptic endosome membrane,CC,
16995,GO:0098999,1.00000000001664,0.889322866670765,0,1,extrinsic component of postsynaptic endosome membrane,CC,
17949,GO:1902238,1.00000000001664,0.889322866670765,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17950,GO:1902239,1.00000000001664,0.889322866670765,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19484,GO:1990127,1.00000000001664,0.889322866670765,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
43,GO:0000095,1.00000000001665,0.89535197412427,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
4085,GO:0009138,1.00000000001665,0.731859589207934,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
5209,GO:0015805,1.00000000001665,0.89535197412427,0,1,S-adenosyl-L-methionine transport,BP,
17839,GO:1901962,1.00000000001665,0.89535197412427,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
7391,GO:0031438,1.00000000001665,0.892291157222487,0,1,negative regulation of mRNA cleavage,BP,
12776,GO:0051025,1.00000000001665,0.892291157222487,0,1,negative regulation of immunoglobulin secretion,BP,
18986,GO:1904721,1.00000000001665,0.892291157222487,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1068,GO:0002606,1.00000000001666,0.721022327916853,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
14343,GO:0061484,1.00000000001666,0.706719607425274,0,3,hematopoietic stem cell homeostasis,BP,
4362,GO:0009956,1.00000000001667,0.889908496205419,0,1,radial pattern formation,BP,
14089,GO:0060849,1.00000000001667,0.889908496205419,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
1496,GO:0003835,1.00000000001667,0.789934610407995,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
527,GO:0001635,1.00000000001667,0.736165060999056,0,3,calcitonin gene-related peptide receptor activity,MF,
16713,GO:0097642,1.00000000001667,0.736165060999056,0,3,calcitonin family receptor activity,MF,
18903,GO:1904535,1.00000000001667,0.888802221782866,0,1,positive regulation of telomeric loop disassembly,BP,
3996,GO:0008893,1.00000000001668,0.922090696426704,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5684,GO:0016794,1.00000000001668,0.922090696426704,0,1,diphosphoric monoester hydrolase activity,MF,
15833,GO:0072513,1.00000000001668,0.931753740546459,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
8284,GO:0033080,1.00000000001669,0.712305085512907,0,3,immature T cell proliferation in thymus,BP,
1870,GO:0004531,1.0000000000167,0.897392013427758,0,1,deoxyribonuclease II activity,MF,
4397,GO:0010070,1.00000000001672,0.894273230853856,0,1,zygote asymmetric cell division,BP,
16453,GO:0097086,1.00000000001676,0.890560607537226,0,1,amniotic stem cell differentiation,BP,
20102,GO:2000706,1.00000000001676,0.890560607537226,0,1,negative regulation of dense core granule biogenesis,BP,
20118,GO:2000740,1.00000000001676,0.890560607537226,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20151,GO:2000797,1.00000000001676,0.890560607537226,0,1,regulation of amniotic stem cell differentiation,BP,
20152,GO:2000798,1.00000000001676,0.890560607537226,0,1,negative regulation of amniotic stem cell differentiation,BP,
8432,GO:0033504,1.00000000001677,0.701236630014638,0,3,floor plate development,BP,
2823,GO:0006288,1.00000000001677,0.730195234273574,0,3,base-excision repair, DNA ligation,BP,
410,GO:0001096,1.00000000001679,0.890518929336662,0,1,TFIIF-class transcription factor binding,MF,
13776,GO:0060332,1.0000000000168,0.703820880955856,0,3,positive regulation of response to interferon-gamma,BP,
13779,GO:0060335,1.0000000000168,0.703820880955856,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
4439,GO:0010309,1.00000000001682,0.902874220422084,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19590,GO:1990565,1.00000000001682,0.902874220422084,0,1,HSP90-CDC37 chaperone complex,CC,
3878,GO:0008507,1.00000000001683,0.890775679712491,0,1,sodium:iodide symporter activity,MF,
15027,GO:0070939,1.00000000001683,0.70790974079968,0,3,Dsl1/NZR complex,CC,
6078,GO:0019227,1.00000000001686,0.729941143125094,0,3,neuronal action potential propagation,BP,
16928,GO:0098870,1.00000000001686,0.729941143125094,0,3,action potential propagation,BP,
16633,GO:0097452,1.00000000001687,0.661859415201859,0,4,GAIT complex,CC,
17033,GO:0099122,1.00000000001691,0.707180586278279,0,3,RNA polymerase II C-terminal domain binding,MF,
11466,GO:0045903,1.00000000001691,0.768343852726892,0,3,positive regulation of translational fidelity,BP,
8708,GO:0034338,1.00000000001694,0.71134693982145,0,3,short-chain carboxylesterase activity,MF,
15377,GO:0071596,1.00000000001696,0.701157604344629,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
2963,GO:0006499,1.00000000001697,0.626659613236387,0,4,N-terminal protein myristoylation,BP,
5967,GO:0018377,1.00000000001697,0.626659613236387,0,4,protein myristoylation,BP,
19291,GO:1905443,1.00000000001701,0.888886441290764,0,1,regulation of clathrin coat assembly,BP,
19292,GO:1905445,1.00000000001701,0.888886441290764,0,1,positive regulation of clathrin coat assembly,BP,
2688,GO:0006049,1.00000000001702,0.892726737833176,0,1,UDP-N-acetylglucosamine catabolic process,BP,
11957,GO:0047006,1.00000000001707,0.910434802811777,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11966,GO:0047042,1.00000000001707,0.910434802811777,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12048,GO:0047718,1.00000000001707,0.910434802811777,0,1,indanol dehydrogenase activity,MF,
1734,GO:0004326,1.00000000001707,0.893958093983075,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3987,GO:0008841,1.00000000001707,0.893958093983075,0,1,dihydrofolate synthase activity,MF,
11902,GO:0046901,1.00000000001707,0.893958093983075,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
18419,GO:1903416,1.00000000001708,0.716766546634815,0,3,response to glycoside,BP,
6234,GO:0019782,1.00000000001709,0.891525793084689,0,1,ISG15 activating enzyme activity,MF,
767,GO:0002016,1.00000000001709,0.936834146870737,0,1,regulation of blood volume by renin-angiotensin,BP,
769,GO:0002019,1.00000000001709,0.936834146870737,0,1,regulation of renal output by angiotensin,BP,
1284,GO:0003083,1.00000000001709,0.936834146870737,0,1,negative regulation of renal output by angiotensin,BP,
1296,GO:0003106,1.00000000001709,0.936834146870737,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4937,GO:0014895,1.00000000001709,0.936834146870737,0,1,smooth muscle hypertrophy,BP,
10116,GO:0042624,1.00000000001709,0.936834146870737,0,1,ATPase activity, uncoupled,MF,
7774,GO:0032289,1.0000000000171,0.712879187955435,0,3,central nervous system myelin formation,BP,
15702,GO:0072209,1.00000000001711,0.892842983542199,0,1,metanephric mesangial cell differentiation,BP,
15725,GO:0072254,1.00000000001711,0.892842983542199,0,1,metanephric glomerular mesangial cell differentiation,BP,
15726,GO:0072255,1.00000000001711,0.892842983542199,0,1,metanephric glomerular mesangial cell development,BP,
17475,GO:1900241,1.00000000001711,0.892842983542199,0,1,positive regulation of phenotypic switching,BP,
19191,GO:1905176,1.00000000001711,0.892842983542199,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
1557,GO:0003953,1.00000000001712,0.907242852630804,0,1,NAD+ nucleosidase activity,MF,
12463,GO:0050135,1.00000000001712,0.907242852630804,0,1,NAD(P)+ nucleosidase activity,MF,
14474,GO:0061809,1.00000000001712,0.907242852630804,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
13192,GO:0051771,1.00000000001712,0.740929976980469,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
8630,GO:0034140,1.00000000001713,0.705932590854919,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
14962,GO:0070836,1.00000000001713,0.714166648685768,0,3,caveola assembly,BP,
1563,GO:0003960,1.00000000001714,0.733993555938035,0,3,NADPH:quinone reductase activity,MF,
2167,GO:0004999,1.00000000001714,0.893056035678756,0,1,vasoactive intestinal polypeptide receptor activity,MF,
14340,GO:0061476,1.00000000001714,0.626983932408101,0,4,response to anticoagulant,BP,
15329,GO:0071503,1.00000000001714,0.626983932408101,0,4,response to heparin,BP,
15330,GO:0071504,1.00000000001714,0.626983932408101,0,4,cellular response to heparin,BP,
10983,GO:0044753,1.00000000001714,0.892776265366507,0,1,amphisome,CC,
18736,GO:1904106,1.00000000001714,0.892776265366507,0,1,protein localization to microvillus,BP,
1615,GO:0004040,1.00000000001716,0.79727791740545,0,2,amidase activity,MF,
19488,GO:1990136,1.00000000001717,0.89388051671532,0,1,linoleate 9S-lipoxygenase activity,MF,
3161,GO:0006772,1.00000000001719,0.900504803364938,0,1,thiamine metabolic process,BP,
9979,GO:0042357,1.00000000001719,0.900504803364938,0,1,thiamine diphosphate metabolic process,BP,
12487,GO:0050333,1.00000000001719,0.900504803364938,0,1,thiamin-triphosphatase activity,MF,
18142,GO:1902775,1.00000000001719,0.7061167153895,0,3,mitochondrial large ribosomal subunit assembly,BP,
437,GO:0001165,1.00000000001719,0.888794719979005,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
11892,GO:0046884,1.00000000001719,0.631313970336724,0,4,follicle-stimulating hormone secretion,BP,
5508,GO:0016453,1.00000000001721,0.655328276149972,0,4,C-acetyltransferase activity,MF,
13105,GO:0051595,1.00000000001721,0.748748250621956,0,3,response to methylglyoxal,BP,
12834,GO:0051120,1.00000000001723,0.797486432086738,0,2,hepoxilin A3 synthase activity,MF,
11268,GO:0045485,1.00000000001723,0.888982171861934,0,1,omega-6 fatty acid desaturase activity,MF,
1649,GO:0004090,1.00000000001726,0.715318575123108,0,4,carbonyl reductase (NADPH) activity,MF,
8636,GO:0034146,1.00000000001726,0.888968157537773,0,1,toll-like receptor 5 signaling pathway,BP,
8637,GO:0034147,1.00000000001726,0.888968157537773,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8638,GO:0034148,1.00000000001726,0.888968157537773,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
14765,GO:0070425,1.00000000001726,0.888968157537773,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14768,GO:0070428,1.00000000001726,0.888968157537773,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14769,GO:0070429,1.00000000001726,0.888968157537773,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14772,GO:0070433,1.00000000001726,0.888968157537773,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15873,GO:0072573,1.00000000001726,0.888968157537773,0,1,tolerance induction to lipopolysaccharide,BP,
16259,GO:0090291,1.00000000001726,0.888968157537773,0,1,negative regulation of osteoclast proliferation,BP,
19905,GO:2000349,1.00000000001726,0.888968157537773,0,1,negative regulation of CD40 signaling pathway,BP,
17660,GO:1901360,1.00000000001727,0,394,4854,organic cyclic compound metabolic process,BP,TNIP1;NT5E;XDH;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;F2R;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;CYP27B1;LMF1;NAPRT;CRTC1;PCK2;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;PC;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;H6PD;KIAA1549;ADCY7;XBP1;PGLS;EGFR;CSNK1E;TK2;RFX2;PRKACA;ADARB1;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;ALDH1L2;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;PCSK9;ENDOG;NSMCE4A;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;OSBPL5;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;RPUSD3;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;SRD5A3;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;MICAL2;CAP1;MYDGF;AKR7A2;TSC22D4;TULP3;SRC;LDLRAP1;KDM4B;GLRX;CBR4;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;ACADVL;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;PMVK;OAS1;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;ALDH4A1;PSMD7;TNFRSF1A;ANXA3;HSD11B1;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;COMT;TNRC6B;THRA;PLTP;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;STUB1;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;HLCS;SARS2;RAD23A;AOX1;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ZNF687;ENTPD6;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;NDUFS2;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;LDHA;PIK3R2;ANXA1;PODXL2;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
3197,GO:0006828,1.00000000001728,0.704067891254028,0,3,manganese ion transport,BP,
12847,GO:0051133,1.00000000001728,0.754039878788018,0,3,regulation of NK T cell activation,BP,
12848,GO:0051135,1.00000000001728,0.754039878788018,0,3,positive regulation of NK T cell activation,BP,
10769,GO:0044205,1.00000000001729,0.711727746470525,0,3,'de novo' UMP biosynthetic process,BP,
3670,GO:0008169,1.0000000000173,0.725867138909592,0,3,C-methyltransferase activity,MF,
8580,GO:0034040,1.0000000000173,0.70640458397117,0,3,lipid-transporting ATPase activity,MF,
19572,GO:1990454,1.00000000001731,0.707050946409355,0,3,L-type voltage-gated calcium channel complex,CC,
16531,GO:0097213,1.00000000001731,0.895273987013848,0,1,regulation of lysosomal membrane permeability,BP,
1762,GO:0004362,1.00000000001733,0.895064983005311,0,1,glutathione-disulfide reductase activity,MF,
5197,GO:0015786,1.00000000001733,0.895064983005311,0,1,UDP-glucose transmembrane transport,BP,
16902,GO:0098821,1.00000000001734,0.702960338014531,0,3,BMP receptor activity,MF,
7964,GO:0032557,1.00000000001734,0.711432716426832,0,3,pyrimidine ribonucleotide binding,MF,
269,GO:0000741,1.00000000001736,0.901388117306848,0,1,karyogamy,BP,
3481,GO:0007344,1.00000000001736,0.901388117306848,0,1,pronuclear fusion,BP,
13178,GO:0051732,1.00000000001736,0.901388117306848,0,1,polyribonucleotide kinase activity,MF,
13181,GO:0051736,1.00000000001736,0.901388117306848,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16534,GO:0097224,1.00000000001736,0.901388117306848,0,1,sperm connecting piece,CC,
8078,GO:0032747,1.00000000001736,0.742653078407176,0,3,positive regulation of interleukin-23 production,BP,
14761,GO:0070418,1.00000000001736,0.888448290281753,0,1,DNA-dependent protein kinase complex,CC,
931,GO:0002326,1.00000000001736,0.703089124440044,0,3,B cell lineage commitment,BP,
3974,GO:0008783,1.00000000001739,0.895575320940455,0,1,agmatinase activity,MF,
8421,GO:0033388,1.00000000001739,0.895575320940455,0,1,putrescine biosynthetic process from arginine,BP,
14733,GO:0070369,1.00000000001741,0.704450957669383,0,3,beta-catenin-TCF7L2 complex,CC,
12454,GO:0050023,1.00000000001741,0.899391554012359,0,1,L-fuconate dehydratase activity,MF,
1694,GO:0004165,1.00000000001742,0.709317926266082,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
196,GO:0000414,1.00000000001745,0.627128431861381,0,4,regulation of histone H3-K36 methylation,BP,
19707,GO:1990966,1.00000000001746,0.645132872529182,0,4,ATP generation from poly-ADP-D-ribose,BP,
3901,GO:0008537,1.00000000001749,0.763836800369299,0,3,proteasome activator complex,CC,
5022,GO:0015183,1.0000000000175,0.708676204743832,0,3,L-aspartate transmembrane transporter activity,MF,
7715,GO:0032197,1.00000000001754,0.889862392380407,0,1,transposition, RNA-mediated,BP,
17321,GO:0140074,1.00000000001754,0.888445468730175,0,1,cardiac endothelial to mesenchymal transition,BP,
13919,GO:0060542,1.00000000001758,0.888394373542859,0,1,regulation of strand invasion,BP,
14722,GO:0070337,1.00000000001758,0.888394373542859,0,1,3'-flap-structured DNA binding,MF,
16770,GO:0098530,1.00000000001758,0.888394373542859,0,1,positive regulation of strand invasion,BP,
2792,GO:0006231,1.0000000000176,0.725831781458735,0,3,dTMP biosynthetic process,BP,
11558,GO:0046073,1.0000000000176,0.725831781458735,0,3,dTMP metabolic process,BP,
7977,GO:0032584,1.0000000000176,0.708315267902415,0,3,growth cone membrane,CC,
6833,GO:0030290,1.00000000001761,0.890790036267099,0,1,sphingolipid activator protein activity,MF,
7872,GO:0032428,1.00000000001761,0.890790036267099,0,1,beta-N-acetylgalactosaminidase activity,MF,
20325,GO:2001271,1.00000000001762,0.708771819931411,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
13477,GO:0052906,1.00000000001763,0.888425438456377,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
12250,GO:0048496,1.00000000001764,0.70634366118531,0,3,maintenance of animal organ identity,BP,
13,GO:0000026,1.00000000001769,0.709311806241871,0,3,alpha-1,2-mannosyltransferase activity,MF,
10671,GO:0043812,1.0000000000177,0.705683666744478,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
8551,GO:0033872,1.00000000001771,0.897162699109248,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
19370,GO:1905671,1.00000000001771,0.712795573236176,0,3,regulation of lysosome organization,BP,
5994,GO:0018963,1.00000000001774,0.802909819488349,0,2,phthalate metabolic process,BP,
5433,GO:0016287,1.00000000001775,0.893336732276475,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5054,GO:0015247,1.00000000001777,0.701982313406626,0,3,aminophospholipid transmembrane transporter activity,MF,
1252,GO:0002950,1.00000000001779,0.717357595941106,0,3,ceramide phosphoethanolamine synthase activity,MF,
8348,GO:0033188,1.00000000001779,0.717357595941106,0,3,sphingomyelin synthase activity,MF,
12022,GO:0047493,1.00000000001779,0.717357595941106,0,3,ceramide cholinephosphotransferase activity,MF,
8873,GO:0034666,1.00000000001779,0.705728060756465,0,3,integrin alpha2-beta1 complex,CC,
8753,GO:0034395,1.00000000001783,0.90578001909233,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
12422,GO:0048852,1.00000000001785,0.7070141419775,0,3,diencephalon morphogenesis,BP,
3751,GO:0008291,1.00000000001785,0.893454225349742,0,1,acetylcholine metabolic process,BP,
3752,GO:0008292,1.00000000001785,0.893454225349742,0,1,acetylcholine biosynthetic process,BP,
5248,GO:0015870,1.00000000001785,0.893454225349742,0,1,acetylcholine transport,BP,
7911,GO:0032475,1.00000000001785,0.893454225349742,0,1,otolith formation,BP,
9273,GO:0035675,1.00000000001785,0.893454225349742,0,1,neuromast hair cell development,BP,
12445,GO:0048882,1.00000000001785,0.893454225349742,0,1,lateral line development,BP,
12446,GO:0048884,1.00000000001785,0.893454225349742,0,1,neuromast development,BP,
12447,GO:0048886,1.00000000001785,0.893454225349742,0,1,neuromast hair cell differentiation,BP,
12448,GO:0048925,1.00000000001785,0.893454225349742,0,1,lateral line system development,BP,
14357,GO:0061526,1.00000000001785,0.893454225349742,0,1,acetylcholine secretion,BP,
17526,GO:1900619,1.00000000001785,0.893454225349742,0,1,acetate ester metabolic process,BP,
17527,GO:1900620,1.00000000001785,0.893454225349742,0,1,acetate ester biosynthetic process,BP,
17665,GO:1901374,1.00000000001785,0.893454225349742,0,1,acetate ester transport,BP,
7780,GO:0032299,1.00000000001785,0.742305529145775,0,3,ribonuclease H2 complex,CC,
17761,GO:1901668,1.0000000000179,0.746868721914639,0,3,regulation of superoxide dismutase activity,BP,
11995,GO:0047277,1.00000000001792,0.898139082470804,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11518,GO:0045988,1.00000000001792,0.712174178405151,0,3,negative regulation of striated muscle contraction,BP,
13555,GO:0055118,1.00000000001792,0.712174178405151,0,3,negative regulation of cardiac muscle contraction,BP,
18198,GO:1902939,1.00000000001793,0.892803596222512,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
14825,GO:0070539,1.00000000001795,0.890975704268665,0,1,linoleic acid binding,MF,
10857,GO:0044343,1.00000000001795,0.888927455383239,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10859,GO:0044345,1.00000000001795,0.888927455383239,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
16229,GO:0090246,1.00000000001795,0.888927455383239,0,1,convergent extension involved in somitogenesis,BP,
19734,GO:2000040,1.00000000001795,0.888927455383239,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19735,GO:2000041,1.00000000001795,0.888927455383239,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19745,GO:2000054,1.00000000001795,0.888927455383239,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19757,GO:2000079,1.00000000001795,0.888927455383239,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19758,GO:2000080,1.00000000001795,0.888927455383239,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
6685,GO:0030047,1.00000000001798,0.70608284415526,0,3,actin modification,BP,
3639,GO:0008111,1.00000000001798,0.897810479952279,0,1,alpha-methylacyl-CoA racemase activity,MF,
4251,GO:0009449,1.00000000001799,0.707804739523698,0,3,gamma-aminobutyric acid biosynthetic process,BP,
18153,GO:1902822,1.00000000001802,0.738372308698677,0,3,regulation of late endosome to lysosome transport,BP,
7299,GO:0031291,1.00000000001803,0.73859370876021,0,3,Ran protein signal transduction,BP,
15287,GO:0071449,1.00000000001805,0.927110865616076,0,1,cellular response to lipid hydroperoxide,BP,
18494,GO:1903566,1.00000000001806,0.705952101011592,0,3,positive regulation of protein localization to cilium,BP,
7910,GO:0032474,1.00000000001806,0.706633601676034,0,3,otolith morphogenesis,BP,
14255,GO:0061198,1.00000000001808,0.709742157939221,0,3,fungiform papilla formation,BP,
12433,GO:0048865,1.00000000001811,0.730859860376185,0,3,stem cell fate commitment,BP,
5261,GO:0015888,1.00000000001812,0.795150011830517,0,2,thiamine transport,BP,
14087,GO:0060846,1.00000000001818,0.712980569626912,0,3,blood vessel endothelial cell fate commitment,BP,
14088,GO:0060847,1.00000000001818,0.712980569626912,0,3,endothelial cell fate specification,BP,
16459,GO:0097101,1.00000000001818,0.712980569626912,0,3,blood vessel endothelial cell fate specification,BP,
17370,GO:1900036,1.00000000001819,0.894669317521746,0,1,positive regulation of cellular response to heat,BP,
2596,GO:0005890,1.0000000000182,0.639817042659806,0,4,sodium:potassium-exchanging ATPase complex,CC,
3738,GO:0008275,1.0000000000182,0.629531962994321,0,4,gamma-tubulin small complex,CC,
13954,GO:0060598,1.00000000001822,0.915097203327365,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14229,GO:0061140,1.00000000001823,0.741983880570591,0,3,lung secretory cell differentiation,BP,
3887,GO:0008518,1.00000000001825,0.892948748394327,0,1,reduced folate carrier activity,MF,
16913,GO:0098838,1.00000000001825,0.892948748394327,0,1,reduced folate transmembrane transport,BP,
6271,GO:0019862,1.0000000000183,0.905329335970619,0,1,IgA binding,MF,
3643,GO:0008117,1.00000000001831,0.888394373076724,0,1,sphinganine-1-phosphate aldolase activity,MF,
12654,GO:0050822,1.00000000001832,0.891010869429819,0,1,peptide stabilization,BP,
12655,GO:0050823,1.00000000001832,0.891010869429819,0,1,peptide antigen stabilization,BP,
12701,GO:0050893,1.00000000001832,0.800681628561055,0,2,sensory processing,BP,
8796,GO:0034473,1.00000000001837,0.754956174602994,0,3,U1 snRNA 3'-end processing,BP,
8799,GO:0034476,1.00000000001837,0.754956174602994,0,3,U5 snRNA 3'-end processing,BP,
6836,GO:0030294,1.00000000001837,0.895495342561709,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
14823,GO:0070537,1.00000000001837,0.712046286226162,0,3,histone H2A K63-linked deubiquitination,BP,
518,GO:0001588,1.00000000001839,0.837105309225772,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2142,GO:0004952,1.00000000001839,0.837105309225772,0,2,dopamine neurotransmitter receptor activity,MF,
18544,GO:1903690,1.0000000000184,0.622867662242987,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
1654,GO:0004103,1.0000000000184,0.807323547574156,0,2,choline kinase activity,MF,
10153,GO:0042713,1.0000000000184,0.702050955086281,0,3,sperm ejaculation,BP,
16708,GO:0097636,1.00000000001841,0.794084226461839,0,2,intrinsic component of autophagosome membrane,CC,
16709,GO:0097637,1.00000000001841,0.794084226461839,0,2,integral component of autophagosome membrane,CC,
18079,GO:1902603,1.00000000001845,0.718107073297248,0,3,carnitine transmembrane transport,BP,
14328,GO:0061441,1.00000000001846,0.794277961803465,0,2,renal artery morphogenesis,BP,
7147,GO:0030981,1.00000000001848,0.705182800109597,0,3,cortical microtubule cytoskeleton,CC,
12334,GO:0048669,1.00000000001849,0.718168198248112,0,3,collateral sprouting in absence of injury,BP,
7695,GO:0032142,1.0000000000185,0.704871262373856,0,3,single guanine insertion binding,MF,
11763,GO:0046588,1.0000000000185,0.927478792971058,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
78,GO:0000155,1.00000000001851,0.888394371861311,0,1,phosphorelay sensor kinase activity,MF,
192,GO:0000409,1.00000000001851,0.888394371861311,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1.00000000001851,0.888394371861311,0,1,positive regulation of transcription by galactose,BP,
197,GO:0000415,1.00000000001851,0.888394371861311,0,1,negative regulation of histone H3-K36 methylation,BP,
206,GO:0000431,1.00000000001851,0.888394371861311,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000435,1.00000000001851,0.888394371861311,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
310,GO:0000821,1.00000000001851,0.888394371861311,0,1,regulation of arginine metabolic process,BP,
379,GO:0001011,1.00000000001851,0.888394371861311,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
406,GO:0001087,1.00000000001851,0.888394371861311,0,1,transcription factor activity, TFIIB-class binding,MF,
491,GO:0001543,1.00000000001851,0.888394371861311,0,1,ovarian follicle rupture,BP,
492,GO:0001544,1.00000000001851,0.888394371861311,0,1,initiation of primordial ovarian follicle growth,BP,
529,GO:0001640,1.00000000001851,0.888394371861311,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1.00000000001851,0.888394371861311,0,1,group III metabotropic glutamate receptor activity,MF,
643,GO:0001831,1.00000000001851,0.888394371861311,0,1,trophectodermal cellular morphogenesis,BP,
811,GO:0002081,1.00000000001851,0.888394371861311,0,1,outer acrosomal membrane,CC,
827,GO:0002100,1.00000000001851,0.888394371861311,0,1,tRNA wobble adenosine to inosine editing,BP,
1032,GO:0002537,1.00000000001851,0.888394371861311,0,1,nitric oxide production involved in inflammatory response,BP,
1067,GO:0002605,1.00000000001851,0.888394371861311,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1072,GO:0002635,1.00000000001851,0.888394371861311,0,1,negative regulation of germinal center formation,BP,
1087,GO:0002669,1.00000000001851,0.888394371861311,0,1,positive regulation of T cell anergy,BP,
1234,GO:0002913,1.00000000001851,0.888394371861311,0,1,positive regulation of lymphocyte anergy,BP,
1266,GO:0003017,1.00000000001851,0.888394371861311,0,1,lymph circulation,BP,
1355,GO:0003220,1.00000000001851,0.888394371861311,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1369,GO:0003251,1.00000000001851,0.888394371861311,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1370,GO:0003252,1.00000000001851,0.888394371861311,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1378,GO:0003270,1.00000000001851,0.888394371861311,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1422,GO:0003363,1.00000000001851,0.888394371861311,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1424,GO:0003366,1.00000000001851,0.888394371861311,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1569,GO:0003973,1.00000000001851,0.888394371861311,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1673,GO:0004133,1.00000000001851,0.888394371861311,0,1,glycogen debranching enzyme activity,MF,
1674,GO:0004134,1.00000000001851,0.888394371861311,0,1,4-alpha-glucanotransferase activity,MF,
1675,GO:0004135,1.00000000001851,0.888394371861311,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1724,GO:0004313,1.00000000001851,0.888394371861311,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1727,GO:0004316,1.00000000001851,0.888394371861311,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1728,GO:0004317,1.00000000001851,0.888394371861311,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1729,GO:0004319,1.00000000001851,0.888394371861311,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1733,GO:0004325,1.00000000001851,0.888394371861311,0,1,ferrochelatase activity,MF,
1743,GO:0004339,1.00000000001851,0.888394371861311,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1760,GO:0004360,1.00000000001851,0.888394371861311,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1768,GO:0004368,1.00000000001851,0.888394371861311,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1797,GO:0004423,1.00000000001851,0.888394371861311,0,1,iduronate-2-sulfatase activity,MF,
1830,GO:0004482,1.00000000001851,0.888394371861311,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1837,GO:0004489,1.00000000001851,0.888394371861311,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1970,GO:0004676,1.00000000001851,0.888394371861311,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1974,GO:0004686,1.00000000001851,0.888394371861311,0,1,elongation factor-2 kinase activity,MF,
1983,GO:0004698,1.00000000001851,0.888394371861311,0,1,calcium-dependent protein kinase C activity,MF,
2025,GO:0004753,1.00000000001851,0.888394371861311,0,1,saccharopine dehydrogenase activity,MF,
2035,GO:0004773,1.00000000001851,0.888394371861311,0,1,steryl-sulfatase activity,MF,
2109,GO:0004883,1.00000000001851,0.888394371861311,0,1,glucocorticoid receptor activity,MF,
2152,GO:0004968,1.00000000001851,0.888394371861311,0,1,gonadotropin-releasing hormone receptor activity,MF,
2171,GO:0005004,1.00000000001851,0.888394371861311,0,1,GPI-linked ephrin receptor activity,MF,
2175,GO:0005008,1.00000000001851,0.888394371861311,0,1,hepatocyte growth factor-activated receptor activity,MF,
2176,GO:0005009,1.00000000001851,0.888394371861311,0,1,insulin-activated receptor activity,MF,
2183,GO:0005030,1.00000000001851,0.888394371861311,0,1,neurotrophin receptor activity,MF,
2221,GO:0005115,1.00000000001851,0.888394371861311,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2309,GO:0005294,1.00000000001851,0.888394371861311,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2339,GO:0005366,1.00000000001851,0.888394371861311,0,1,myo-inositol:proton symporter activity,MF,
2340,GO:0005367,1.00000000001851,0.888394371861311,0,1,myo-inositol:sodium symporter activity,MF,
2362,GO:0005461,1.00000000001851,0.888394371861311,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2417,GO:0005590,1.00000000001851,0.888394371861311,0,1,collagen type VII trimer,CC,
2419,GO:0005592,1.00000000001851,0.888394371861311,0,1,collagen type XI trimer,CC,
2422,GO:0005595,1.00000000001851,0.888394371861311,0,1,collagen type XII trimer,CC,
2638,GO:0005969,1.00000000001851,0.888394371861311,0,1,serine-pyruvate aminotransferase complex,CC,
2647,GO:0005982,1.00000000001851,0.888394371861311,0,1,starch metabolic process,BP,
2648,GO:0005983,1.00000000001851,0.888394371861311,0,1,starch catabolic process,BP,
2744,GO:0006127,1.00000000001851,0.888394371861311,0,1,glycerophosphate shuttle,BP,
3412,GO:0007196,1.00000000001851,0.888394371861311,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3485,GO:0007352,1.00000000001851,0.888394371861311,0,1,zygotic specification of dorsal/ventral axis,BP,
3527,GO:0007509,1.00000000001851,0.888394371861311,0,1,mesoderm migration involved in gastrulation,BP,
3575,GO:0007621,1.00000000001851,0.888394371861311,0,1,negative regulation of female receptivity,BP,
3612,GO:0008057,1.00000000001851,0.888394371861311,0,1,eye pigment granule organization,BP,
3621,GO:0008078,1.00000000001851,0.888394371861311,0,1,mesodermal cell migration,BP,
3726,GO:0008254,1.00000000001851,0.888394371861311,0,1,3'-nucleotidase activity,MF,
3753,GO:0008294,1.00000000001851,0.888394371861311,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3783,GO:0008343,1.00000000001851,0.888394371861311,0,1,adult feeding behavior,BP,
3861,GO:0008478,1.00000000001851,0.888394371861311,0,1,pyridoxal kinase activity,MF,
3882,GO:0008511,1.00000000001851,0.888394371861311,0,1,sodium:potassium:chloride symporter activity,MF,
3889,GO:0008520,1.00000000001851,0.888394371861311,0,1,L-ascorbate:sodium symporter activity,MF,
3930,GO:0008609,1.00000000001851,0.888394371861311,0,1,alkylglycerone-phosphate synthase activity,MF,
3959,GO:0008705,1.00000000001851,0.888394371861311,0,1,methionine synthase activity,MF,
4245,GO:0009443,1.00000000001851,0.888394371861311,0,1,pyridoxal 5'-phosphate salvage,BP,
4289,GO:0009674,1.00000000001851,0.888394371861311,0,1,potassium:sodium symporter activity,MF,
4309,GO:0009758,1.00000000001851,0.888394371861311,0,1,carbohydrate utilization,BP,
4408,GO:0010157,1.00000000001851,0.888394371861311,0,1,response to chlorate,BP,
4471,GO:0010465,1.00000000001851,0.888394371861311,0,1,nerve growth factor receptor activity,MF,
4571,GO:0010650,1.00000000001851,0.888394371861311,0,1,positive regulation of cell communication by electrical coupling,BP,
4609,GO:0010722,1.00000000001851,0.888394371861311,0,1,regulation of ferrochelatase activity,BP,
4634,GO:0010754,1.00000000001851,0.888394371861311,0,1,negative regulation of cGMP-mediated signaling,BP,
4663,GO:0010808,1.00000000001851,0.888394371861311,0,1,positive regulation of synaptic vesicle priming,BP,
4756,GO:0010931,1.00000000001851,0.888394371861311,0,1,macrophage tolerance induction,BP,
4757,GO:0010932,1.00000000001851,0.888394371861311,0,1,regulation of macrophage tolerance induction,BP,
4758,GO:0010933,1.00000000001851,0.888394371861311,0,1,positive regulation of macrophage tolerance induction,BP,
4875,GO:0014734,1.00000000001851,0.888394371861311,0,1,skeletal muscle hypertrophy,BP,
4945,GO:0014908,1.00000000001851,0.888394371861311,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
5048,GO:0015229,1.00000000001851,0.888394371861311,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5087,GO:0015327,1.00000000001851,0.888394371861311,0,1,cystine:glutamate antiporter activity,MF,
5088,GO:0015328,1.00000000001851,0.888394371861311,0,1,cystine secondary active transmembrane transporter activity,MF,
5102,GO:0015378,1.00000000001851,0.888394371861311,0,1,sodium:chloride symporter activity,MF,
5112,GO:0015420,1.00000000001851,0.888394371861311,0,1,cobalamin-transporting ATPase activity,MF,
5114,GO:0015431,1.00000000001851,0.888394371861311,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5198,GO:0015787,1.00000000001851,0.888394371861311,0,1,UDP-glucuronic acid transmembrane transport,BP,
5257,GO:0015882,1.00000000001851,0.888394371861311,0,1,L-ascorbic acid transmembrane transport,BP,
5342,GO:0016077,1.00000000001851,0.888394371861311,0,1,snoRNA catabolic process,BP,
5379,GO:0016189,1.00000000001851,0.888394371861311,0,1,synaptic vesicle to endosome fusion,BP,
5576,GO:0016590,1.00000000001851,0.888394371861311,0,1,ACF complex,CC,
5756,GO:0016901,1.00000000001851,0.888394371861311,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5762,GO:0016920,1.00000000001851,0.888394371861311,0,1,pyroglutamyl-peptidase activity,MF,
5845,GO:0017130,1.00000000001851,0.888394371861311,0,1,poly(C) RNA binding,MF,
6033,GO:0019089,1.00000000001851,0.888394371861311,0,1,transmission of virus,BP,
6050,GO:0019171,1.00000000001851,0.888394371861311,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6232,GO:0019780,1.00000000001851,0.888394371861311,0,1,FAT10 activating enzyme activity,MF,
6320,GO:0019962,1.00000000001851,0.888394371861311,0,1,type I interferon binding,MF,
6337,GO:0021503,1.00000000001851,0.888394371861311,0,1,neural fold bending,BP,
6338,GO:0021508,1.00000000001851,0.888394371861311,0,1,floor plate formation,BP,
6415,GO:0021650,1.00000000001851,0.888394371861311,0,1,vestibulocochlear nerve formation,BP,
6425,GO:0021685,1.00000000001851,0.888394371861311,0,1,cerebellar granular layer structural organization,BP,
6442,GO:0021730,1.00000000001851,0.888394371861311,0,1,trigeminal sensory nucleus development,BP,
6443,GO:0021740,1.00000000001851,0.888394371861311,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6460,GO:0021778,1.00000000001851,0.888394371861311,0,1,oligodendrocyte cell fate specification,BP,
6461,GO:0021779,1.00000000001851,0.888394371861311,0,1,oligodendrocyte cell fate commitment,BP,
6462,GO:0021780,1.00000000001851,0.888394371861311,0,1,glial cell fate specification,BP,
6504,GO:0021870,1.00000000001851,0.888394371861311,0,1,Cajal-Retzius cell differentiation,BP,
6569,GO:0022012,1.00000000001851,0.888394371861311,0,1,subpallium cell proliferation in forebrain,BP,
6570,GO:0022018,1.00000000001851,0.888394371861311,0,1,lateral ganglionic eminence cell proliferation,BP,
6803,GO:0030240,1.00000000001851,0.888394371861311,0,1,skeletal muscle thin filament assembly,BP,
6888,GO:0030379,1.00000000001851,0.888394371861311,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6918,GO:0030504,1.00000000001851,0.888394371861311,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6967,GO:0030616,1.00000000001851,0.888394371861311,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6974,GO:0030623,1.00000000001851,0.888394371861311,0,1,U5 snRNA binding,MF,
7066,GO:0030846,1.00000000001851,0.888394371861311,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7244,GO:0031151,1.00000000001851,0.888394371861311,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7317,GO:0031315,1.00000000001851,0.888394371861311,0,1,extrinsic component of mitochondrial outer membrane,CC,
7368,GO:0031405,1.00000000001851,0.888394371861311,0,1,lipoic acid binding,MF,
7386,GO:0031433,1.00000000001851,0.888394371861311,0,1,telethonin binding,MF,
7396,GO:0031443,1.00000000001851,0.888394371861311,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7437,GO:0031533,1.00000000001851,0.888394371861311,0,1,mRNA cap methyltransferase complex,CC,
7443,GO:0031554,1.00000000001851,0.888394371861311,0,1,regulation of DNA-templated transcription, termination,BP,
7461,GO:0031592,1.00000000001851,0.888394371861311,0,1,centrosomal corona,CC,
7506,GO:0031673,1.00000000001851,0.888394371861311,0,1,H zone,CC,
7543,GO:0031775,1.00000000001851,0.888394371861311,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7544,GO:0031798,1.00000000001851,0.888394371861311,0,1,type 1 metabotropic glutamate receptor binding,MF,
7559,GO:0031870,1.00000000001851,0.888394371861311,0,1,thromboxane A2 receptor binding,MF,
7598,GO:0031962,1.00000000001851,0.888394371861311,0,1,mineralocorticoid receptor binding,MF,
7635,GO:0032029,1.00000000001851,0.888394371861311,0,1,myosin tail binding,MF,
7733,GO:0032222,1.00000000001851,0.888394371861311,0,1,regulation of synaptic transmission, cholinergic,BP,
7734,GO:0032224,1.00000000001851,0.888394371861311,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7907,GO:0032470,1.00000000001851,0.888394371861311,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8164,GO:0032887,1.00000000001851,0.888394371861311,0,1,regulation of spindle elongation,BP,
8165,GO:0032888,1.00000000001851,0.888394371861311,0,1,regulation of mitotic spindle elongation,BP,
8260,GO:0033030,1.00000000001851,0.888394371861311,0,1,negative regulation of neutrophil apoptotic process,BP,
8332,GO:0033167,1.00000000001851,0.888394371861311,0,1,ARC complex,CC,
8333,GO:0033168,1.00000000001851,0.888394371861311,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8370,GO:0033241,1.00000000001851,0.888394371861311,0,1,regulation of cellular amine catabolic process,BP,
8371,GO:0033242,1.00000000001851,0.888394371861311,0,1,negative regulation of cellular amine catabolic process,BP,
8383,GO:0033274,1.00000000001851,0.888394371861311,0,1,response to vitamin B2,BP,
8410,GO:0033343,1.00000000001851,0.888394371861311,0,1,positive regulation of collagen binding,BP,
8414,GO:0033364,1.00000000001851,0.888394371861311,0,1,mast cell secretory granule organization,BP,
8433,GO:0033505,1.00000000001851,0.888394371861311,0,1,floor plate morphogenesis,BP,
8463,GO:0033593,1.00000000001851,0.888394371861311,0,1,BRCA2-MAGE-D1 complex,CC,
8639,GO:0034150,1.00000000001851,0.888394371861311,0,1,toll-like receptor 6 signaling pathway,BP,
8849,GO:0034634,1.00000000001851,0.888394371861311,0,1,glutathione transmembrane transporter activity,MF,
8875,GO:0034669,1.00000000001851,0.888394371861311,0,1,integrin alpha4-beta7 complex,CC,
8876,GO:0034670,1.00000000001851,0.888394371861311,0,1,chemotaxis to arachidonic acid,BP,
8883,GO:0034683,1.00000000001851,0.888394371861311,0,1,integrin alphav-beta3 complex,CC,
8919,GO:0034752,1.00000000001851,0.888394371861311,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8920,GO:0034753,1.00000000001851,0.888394371861311,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8924,GO:0034757,1.00000000001851,0.888394371861311,0,1,negative regulation of iron ion transport,BP,
8925,GO:0034759,1.00000000001851,0.888394371861311,0,1,regulation of iron ion transmembrane transport,BP,
8926,GO:0034760,1.00000000001851,0.888394371861311,0,1,negative regulation of iron ion transmembrane transport,BP,
8936,GO:0034775,1.00000000001851,0.888394371861311,0,1,glutathione transmembrane transport,BP,
8952,GO:0034986,1.00000000001851,0.888394371861311,0,1,iron chaperone activity,MF,
8953,GO:0034987,1.00000000001851,0.888394371861311,0,1,immunoglobulin receptor binding,MF,
8954,GO:0034988,1.00000000001851,0.888394371861311,0,1,Fc-gamma receptor I complex binding,MF,
9006,GO:0035120,1.00000000001851,0.888394371861311,0,1,post-embryonic appendage morphogenesis,BP,
9007,GO:0035127,1.00000000001851,0.888394371861311,0,1,post-embryonic limb morphogenesis,BP,
9008,GO:0035128,1.00000000001851,0.888394371861311,0,1,post-embryonic forelimb morphogenesis,BP,
9053,GO:0035262,1.00000000001851,0.888394371861311,0,1,gonad morphogenesis,BP,
9099,GO:0035355,1.00000000001851,0.888394371861311,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9120,GO:0035403,1.00000000001851,0.888394371861311,0,1,histone kinase activity (H3-T6 specific),MF,
9125,GO:0035408,1.00000000001851,0.888394371861311,0,1,histone H3-T6 phosphorylation,BP,
9134,GO:0035441,1.00000000001851,0.888394371861311,0,1,cell migration involved in vasculogenesis,BP,
9136,GO:0035443,1.00000000001851,0.888394371861311,0,1,tripeptide transmembrane transport,BP,
9349,GO:0035841,1.00000000001851,0.888394371861311,0,1,new growing cell tip,CC,
9359,GO:0035862,1.00000000001851,0.888394371861311,0,1,dITP metabolic process,BP,
9360,GO:0035863,1.00000000001851,0.888394371861311,0,1,dITP catabolic process,BP,
9406,GO:0035936,1.00000000001851,0.888394371861311,0,1,testosterone secretion,BP,
9407,GO:0035938,1.00000000001851,0.888394371861311,0,1,estradiol secretion,BP,
9436,GO:0035995,1.00000000001851,0.888394371861311,0,1,detection of muscle stretch,BP,
9504,GO:0036138,1.00000000001851,0.888394371861311,0,1,peptidyl-histidine hydroxylation,BP,
9505,GO:0036139,1.00000000001851,0.888394371861311,0,1,peptidyl-histidine dioxygenase activity,MF,
9506,GO:0036140,1.00000000001851,0.888394371861311,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9580,GO:0036371,1.00000000001851,0.888394371861311,0,1,protein localization to T-tubule,BP,
9594,GO:0036404,1.00000000001851,0.888394371861311,0,1,conversion of ds siRNA to ss siRNA,BP,
9630,GO:0036487,1.00000000001851,0.888394371861311,0,1,nitric-oxide synthase inhibitor activity,MF,
9656,GO:0036517,1.00000000001851,0.888394371861311,0,1,chemoattraction of serotonergic neuron axon,BP,
9690,GO:0038051,1.00000000001851,0.888394371861311,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9851,GO:0042084,1.00000000001851,0.888394371861311,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9929,GO:0042265,1.00000000001851,0.888394371861311,0,1,peptidyl-asparagine hydroxylation,BP,
10044,GO:0042483,1.00000000001851,0.888394371861311,0,1,negative regulation of odontogenesis,BP,
10186,GO:0042766,1.00000000001851,0.888394371861311,0,1,nucleosome mobilization,BP,
10242,GO:0042937,1.00000000001851,0.888394371861311,0,1,tripeptide transmembrane transporter activity,MF,
10297,GO:0043033,1.00000000001851,0.888394371861311,0,1,isoamylase complex,CC,
10579,GO:0043532,1.00000000001851,0.888394371861311,0,1,angiostatin binding,MF,
10627,GO:0043610,1.00000000001851,0.888394371861311,0,1,regulation of carbohydrate utilization,BP,
10641,GO:0043629,1.00000000001851,0.888394371861311,0,1,ncRNA polyadenylation,BP,
10642,GO:0043630,1.00000000001851,0.888394371861311,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10668,GO:0043754,1.00000000001851,0.888394371861311,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10721,GO:0044007,1.00000000001851,0.888394371861311,0,1,dissemination or transmission of symbiont from host,BP,
10794,GO:0044245,1.00000000001851,0.888394371861311,0,1,polysaccharide digestion,BP,
10821,GO:0044299,1.00000000001851,0.888394371861311,0,1,C-fiber,CC,
10826,GO:0044305,1.00000000001851,0.888394371861311,0,1,calyx of Held,CC,
10828,GO:0044307,1.00000000001851,0.888394371861311,0,1,dendritic branch,CC,
10850,GO:0044335,1.00000000001851,0.888394371861311,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10965,GO:0044691,1.00000000001851,0.888394371861311,0,1,tooth eruption,BP,
10974,GO:0044725,1.00000000001851,0.888394371861311,0,1,chromatin reprogramming in the zygote,BP,
10975,GO:0044727,1.00000000001851,0.888394371861311,0,1,DNA demethylation of male pronucleus,BP,
11140,GO:0045163,1.00000000001851,0.888394371861311,0,1,clustering of voltage-gated potassium channels,BP,
11155,GO:0045186,1.00000000001851,0.888394371861311,0,1,zonula adherens assembly,BP,
11372,GO:0045715,1.00000000001851,0.888394371861311,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11406,GO:0045769,1.00000000001851,0.888394371861311,0,1,negative regulation of asymmetric cell division,BP,
11419,GO:0045795,1.00000000001851,0.888394371861311,0,1,positive regulation of cell volume,BP,
11777,GO:0046619,1.00000000001851,0.888394371861311,0,1,optic placode formation involved in camera-type eye formation,BP,
11781,GO:0046623,1.00000000001851,0.888394371861311,0,1,sphingolipid-translocating ATPase activity,MF,
11973,GO:0047117,1.00000000001851,0.888394371861311,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11974,GO:0047130,1.00000000001851,0.888394371861311,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11975,GO:0047131,1.00000000001851,0.888394371861311,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12018,GO:0047451,1.00000000001851,0.888394371861311,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12029,GO:0047545,1.00000000001851,0.888394371861311,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12066,GO:0047933,1.00000000001851,0.888394371861311,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12425,GO:0048855,1.00000000001851,0.888394371861311,0,1,adenohypophysis morphogenesis,BP,
12470,GO:0050185,1.00000000001851,0.888394371861311,0,1,phosphatidylinositol deacylase activity,MF,
12601,GO:0050748,1.00000000001851,0.888394371861311,0,1,negative regulation of lipoprotein metabolic process,BP,
12703,GO:0050897,1.00000000001851,0.888394371861311,0,1,cobalt ion binding,MF,
13046,GO:0051463,1.00000000001851,0.888394371861311,0,1,negative regulation of cortisol secretion,BP,
13151,GO:0051686,1.00000000001851,0.888394371861311,0,1,establishment of ER localization,BP,
13220,GO:0051821,1.00000000001851,0.888394371861311,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13244,GO:0051885,1.00000000001851,0.888394371861311,0,1,positive regulation of timing of anagen,BP,
13274,GO:0051933,1.00000000001851,0.888394371861311,0,1,amino acid neurotransmitter reuptake,BP,
13276,GO:0051935,1.00000000001851,0.888394371861311,0,1,glutamate reuptake,BP,
13280,GO:0051941,1.00000000001851,0.888394371861311,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13283,GO:0051946,1.00000000001851,0.888394371861311,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13323,GO:0052047,1.00000000001851,0.888394371861311,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13327,GO:0052066,1.00000000001851,0.888394371861311,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13337,GO:0052190,1.00000000001851,0.888394371861311,0,1,modulation by symbiont of host phagocytosis,BP,
13338,GO:0052191,1.00000000001851,0.888394371861311,0,1,positive regulation by symbiont of host phagocytosis,BP,
13348,GO:0052231,1.00000000001851,0.888394371861311,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13364,GO:0052370,1.00000000001851,0.888394371861311,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13381,GO:0052522,1.00000000001851,0.888394371861311,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13392,GO:0052590,1.00000000001851,0.888394371861311,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13393,GO:0052591,1.00000000001851,0.888394371861311,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13416,GO:0052717,1.00000000001851,0.888394371861311,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13417,GO:0052718,1.00000000001851,0.888394371861311,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13481,GO:0052918,1.00000000001851,0.888394371861311,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13483,GO:0052926,1.00000000001851,0.888394371861311,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13510,GO:0055028,1.00000000001851,0.888394371861311,0,1,cortical microtubule,CC,
13514,GO:0055048,1.00000000001851,0.888394371861311,0,1,anastral spindle assembly,BP,
13552,GO:0055113,1.00000000001851,0.888394371861311,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13561,GO:0060001,1.00000000001851,0.888394371861311,0,1,minus-end directed microfilament motor activity,MF,
13587,GO:0060031,1.00000000001851,0.888394371861311,0,1,mediolateral intercalation,BP,
13588,GO:0060032,1.00000000001851,0.888394371861311,0,1,notochord regression,BP,
13613,GO:0060060,1.00000000001851,0.888394371861311,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13618,GO:0060067,1.00000000001851,0.888394371861311,0,1,cervix development,BP,
13622,GO:0060072,1.00000000001851,0.888394371861311,0,1,large conductance calcium-activated potassium channel activity,MF,
13650,GO:0060125,1.00000000001851,0.888394371861311,0,1,negative regulation of growth hormone secretion,BP,
13742,GO:0060290,1.00000000001851,0.888394371861311,0,1,transdifferentiation,BP,
13800,GO:0060366,1.00000000001851,0.888394371861311,0,1,lambdoid suture morphogenesis,BP,
13801,GO:0060367,1.00000000001851,0.888394371861311,0,1,sagittal suture morphogenesis,BP,
13806,GO:0060372,1.00000000001851,0.888394371861311,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13840,GO:0060414,1.00000000001851,0.888394371861311,0,1,aorta smooth muscle tissue morphogenesis,BP,
13866,GO:0060447,1.00000000001851,0.888394371861311,0,1,bud outgrowth involved in lung branching,BP,
13933,GO:0060566,1.00000000001851,0.888394371861311,0,1,positive regulation of DNA-templated transcription, termination,BP,
13955,GO:0060599,1.00000000001851,0.888394371861311,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14037,GO:0060739,1.00000000001851,0.888394371861311,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14062,GO:0060775,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14069,GO:0060809,1.00000000001851,0.888394371861311,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14072,GO:0060821,1.00000000001851,0.888394371861311,0,1,inactivation of X chromosome by DNA methylation,BP,
14085,GO:0060843,1.00000000001851,0.888394371861311,0,1,venous endothelial cell differentiation,BP,
14095,GO:0060873,1.00000000001851,0.888394371861311,0,1,anterior semicircular canal development,BP,
14096,GO:0060875,1.00000000001851,0.888394371861311,0,1,lateral semicircular canal development,BP,
14162,GO:0061010,1.00000000001851,0.888394371861311,0,1,gall bladder development,BP,
14178,GO:0061040,1.00000000001851,0.888394371861311,0,1,female gonad morphogenesis,BP,
14230,GO:0061141,1.00000000001851,0.888394371861311,0,1,lung ciliated cell differentiation,BP,
14271,GO:0061301,1.00000000001851,0.888394371861311,0,1,cerebellum vasculature morphogenesis,BP,
14294,GO:0061347,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14295,GO:0061348,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14296,GO:0061349,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14297,GO:0061350,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14299,GO:0061354,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14330,GO:0061444,1.00000000001851,0.888394371861311,0,1,endocardial cushion cell development,BP,
14335,GO:0061459,1.00000000001851,0.888394371861311,0,1,L-arginine transmembrane transporter activity,MF,
14344,GO:0061485,1.00000000001851,0.888394371861311,0,1,memory T cell proliferation,BP,
14359,GO:0061534,1.00000000001851,0.888394371861311,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14392,GO:0061618,1.00000000001851,0.888394371861311,0,1,sublamina densa,CC,
14407,GO:0061642,1.00000000001851,0.888394371861311,0,1,chemoattraction of axon,BP,
14416,GO:0061663,1.00000000001851,0.888394371861311,0,1,NEDD8 ligase activity,MF,
14432,GO:0061709,1.00000000001851,0.888394371861311,0,1,reticulophagy,BP,
14461,GO:0061767,1.00000000001851,0.888394371861311,0,1,negative regulation of lung blood pressure,BP,
14468,GO:0061780,1.00000000001851,0.888394371861311,0,1,mitotic cohesin loading,BP,
14470,GO:0061789,1.00000000001851,0.888394371861311,0,1,dense core granule priming,BP,
14471,GO:0061792,1.00000000001851,0.888394371861311,0,1,secretory granule maturation,BP,
14481,GO:0061828,1.00000000001851,0.888394371861311,0,1,apical tubulobulbar complex,CC,
14482,GO:0061829,1.00000000001851,0.888394371861311,0,1,basal tubulobulbar complex,CC,
14559,GO:0070060,1.00000000001851,0.888394371861311,0,1,'de novo' actin filament nucleation,BP,
14596,GO:0070123,1.00000000001851,0.888394371861311,0,1,transforming growth factor beta receptor activity, type III,MF,
14625,GO:0070171,1.00000000001851,0.888394371861311,0,1,negative regulation of tooth mineralization,BP,
14720,GO:0070335,1.00000000001851,0.888394371861311,0,1,aspartate binding,MF,
14810,GO:0070510,1.00000000001851,0.888394371861311,0,1,regulation of histone H4-K20 methylation,BP,
14811,GO:0070512,1.00000000001851,0.888394371861311,0,1,positive regulation of histone H4-K20 methylation,BP,
14830,GO:0070548,1.00000000001851,0.888394371861311,0,1,L-glutamine aminotransferase activity,MF,
14831,GO:0070550,1.00000000001851,0.888394371861311,0,1,rDNA condensation,BP,
14861,GO:0070593,1.00000000001851,0.888394371861311,0,1,dendrite self-avoidance,BP,
14914,GO:0070701,1.00000000001851,0.888394371861311,0,1,mucus layer,CC,
14915,GO:0070702,1.00000000001851,0.888394371861311,0,1,inner mucus layer,CC,
14916,GO:0070703,1.00000000001851,0.888394371861311,0,1,outer mucus layer,CC,
14978,GO:0070856,1.00000000001851,0.888394371861311,0,1,myosin VI light chain binding,MF,
14998,GO:0070890,1.00000000001851,0.888394371861311,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15003,GO:0070898,1.00000000001851,0.888394371861311,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
15009,GO:0070904,1.00000000001851,0.888394371861311,0,1,transepithelial L-ascorbic acid transport,BP,
15049,GO:0070975,1.00000000001851,0.888394371861311,0,1,FHA domain binding,MF,
15189,GO:0071301,1.00000000001851,0.888394371861311,0,1,cellular response to vitamin B1,BP,
15291,GO:0071454,1.00000000001851,0.888394371861311,0,1,cellular response to anoxia,BP,
15389,GO:0071612,1.00000000001851,0.888394371861311,0,1,IP-10 production,BP,
15420,GO:0071658,1.00000000001851,0.888394371861311,0,1,regulation of IP-10 production,BP,
15421,GO:0071660,1.00000000001851,0.888394371861311,0,1,positive regulation of IP-10 production,BP,
15432,GO:0071678,1.00000000001851,0.888394371861311,0,1,olfactory bulb axon guidance,BP,
15439,GO:0071691,1.00000000001851,0.888394371861311,0,1,cardiac muscle thin filament assembly,BP,
15495,GO:0071821,1.00000000001851,0.888394371861311,0,1,FANCM-MHF complex,CC,
15523,GO:0071878,1.00000000001851,0.888394371861311,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15572,GO:0071988,1.00000000001851,0.888394371861311,0,1,protein localization to spindle pole body,BP,
15573,GO:0071997,1.00000000001851,0.888394371861311,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15784,GO:0072362,1.00000000001851,0.888394371861311,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15787,GO:0072365,1.00000000001851,0.888394371861311,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15795,GO:0072382,1.00000000001851,0.888394371861311,0,1,minus-end-directed vesicle transport along microtubule,BP,
15809,GO:0072414,1.00000000001851,0.888394371861311,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15816,GO:0072432,1.00000000001851,0.888394371861311,0,1,response to G1 DNA damage checkpoint signaling,BP,
15835,GO:0072518,1.00000000001851,0.888394371861311,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15848,GO:0072534,1.00000000001851,0.888394371861311,0,1,perineuronal net,CC,
15887,GO:0072590,1.00000000001851,0.888394371861311,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15888,GO:0072591,1.00000000001851,0.888394371861311,0,1,citrate-L-glutamate ligase activity,MF,
15910,GO:0072658,1.00000000001851,0.888394371861311,0,1,maintenance of protein location in membrane,BP,
15912,GO:0072660,1.00000000001851,0.888394371861311,0,1,maintenance of protein location in plasma membrane,BP,
15961,GO:0072752,1.00000000001851,0.888394371861311,0,1,cellular response to rapamycin,BP,
16031,GO:0086024,1.00000000001851,0.888394371861311,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16038,GO:0086039,1.00000000001851,0.888394371861311,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16044,GO:0086046,1.00000000001851,0.888394371861311,0,1,membrane depolarization during SA node cell action potential,BP,
16232,GO:0090251,1.00000000001851,0.888394371861311,0,1,protein localization involved in establishment of planar polarity,BP,
16252,GO:0090284,1.00000000001851,0.888394371861311,0,1,positive regulation of protein glycosylation in Golgi,BP,
16311,GO:0090389,1.00000000001851,0.888394371861311,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16383,GO:0090667,1.00000000001851,0.888394371861311,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16384,GO:0090668,1.00000000001851,0.888394371861311,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16389,GO:0090673,1.00000000001851,0.888394371861311,0,1,endothelial cell-matrix adhesion,BP,
16422,GO:0097026,1.00000000001851,0.888394371861311,0,1,dendritic cell dendrite assembly,BP,
16465,GO:0097108,1.00000000001851,0.888394371861311,0,1,hedgehog family protein binding,MF,
16474,GO:0097118,1.00000000001851,0.888394371861311,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16493,GO:0097156,1.00000000001851,0.888394371861311,0,1,fasciculation of motor neuron axon,BP,
16497,GO:0097161,1.00000000001851,0.888394371861311,0,1,DH domain binding,MF,
16501,GO:0097166,1.00000000001851,0.888394371861311,0,1,lens epithelial cell proliferation,BP,
16587,GO:0097356,1.00000000001851,0.888394371861311,0,1,perinucleolar compartment,CC,
16601,GO:0097382,1.00000000001851,0.888394371861311,0,1,deoxynucleoside-diphosphatase activity,MF,
16602,GO:0097383,1.00000000001851,0.888394371861311,0,1,dIDP diphosphatase activity,MF,
16605,GO:0097393,1.00000000001851,0.888394371861311,0,1,telomeric repeat-containing RNA transcription,BP,
16606,GO:0097394,1.00000000001851,0.888394371861311,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16700,GO:0097625,1.00000000001851,0.888394371861311,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16701,GO:0097626,1.00000000001851,0.888394371861311,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16702,GO:0097627,1.00000000001851,0.888394371861311,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16711,GO:0097639,1.00000000001851,0.888394371861311,0,1,L-lysine import across plasma membrane,BP,
16712,GO:0097640,1.00000000001851,0.888394371861311,0,1,L-ornithine import across plasma membrane,BP,
16728,GO:0097692,1.00000000001851,0.888394371861311,0,1,histone H3-K4 monomethylation,BP,
16754,GO:0097749,1.00000000001851,0.888394371861311,0,1,membrane tubulation,BP,
16792,GO:0098577,1.00000000001851,0.888394371861311,0,1,inactive sex chromosome,CC,
16825,GO:0098648,1.00000000001851,0.888394371861311,0,1,collagen anchoring fibril,CC,
16827,GO:0098652,1.00000000001851,0.888394371861311,0,1,collagen type VII anchoring fibril,CC,
16856,GO:0098736,1.00000000001851,0.888394371861311,0,1,negative regulation of the force of heart contraction,BP,
16907,GO:0098829,1.00000000001851,0.888394371861311,0,1,intestinal folate absorption,BP,
16937,GO:0098885,1.00000000001851,0.888394371861311,0,1,modification of postsynaptic actin cytoskeleton,BP,
16940,GO:0098888,1.00000000001851,0.888394371861311,0,1,extrinsic component of presynaptic membrane,CC,
16941,GO:0098890,1.00000000001851,0.888394371861311,0,1,extrinsic component of postsynaptic membrane,CC,
16950,GO:0098907,1.00000000001851,0.888394371861311,0,1,regulation of SA node cell action potential,BP,
16965,GO:0098926,1.00000000001851,0.888394371861311,0,1,postsynaptic signal transduction,BP,
16972,GO:0098939,1.00000000001851,0.888394371861311,0,1,dendritic transport of mitochondrion,BP,
16983,GO:0098972,1.00000000001851,0.888394371861311,0,1,anterograde dendritic transport of mitochondrion,BP,
16992,GO:0098988,1.00000000001851,0.888394371861311,0,1,G-protein coupled glutamate receptor activity,MF,
17003,GO:0099039,1.00000000001851,0.888394371861311,0,1,sphingolipid translocation,BP,
17024,GO:0099089,1.00000000001851,0.888394371861311,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17039,GO:0099159,1.00000000001851,0.888394371861311,0,1,regulation of modification of postsynaptic structure,BP,
17050,GO:0099243,1.00000000001851,0.888394371861311,0,1,extrinsic component of synaptic membrane,CC,
17071,GO:0099527,1.00000000001851,0.888394371861311,0,1,postsynapse to nucleus signaling pathway,BP,
17098,GO:0099580,1.00000000001851,0.888394371861311,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17105,GO:0099606,1.00000000001851,0.888394371861311,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17106,GO:0099607,1.00000000001851,0.888394371861311,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17130,GO:0100057,1.00000000001851,0.888394371861311,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17146,GO:0102113,1.00000000001851,0.888394371861311,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17148,GO:0102131,1.00000000001851,0.888394371861311,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17149,GO:0102132,1.00000000001851,0.888394371861311,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17178,GO:0102500,1.00000000001851,0.888394371861311,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17213,GO:0106005,1.00000000001851,0.888394371861311,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17242,GO:0106088,1.00000000001851,0.888394371861311,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17243,GO:0106089,1.00000000001851,0.888394371861311,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17257,GO:0110028,1.00000000001851,0.888394371861311,0,1,positive regulation of mitotic spindle organization,BP,
17289,GO:0120077,1.00000000001851,0.888394371861311,0,1,angiogenic sprout fusion,BP,
17290,GO:0120078,1.00000000001851,0.888394371861311,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17342,GO:0140199,1.00000000001851,0.888394371861311,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17343,GO:0140200,1.00000000001851,0.888394371861311,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17351,GO:0150031,1.00000000001851,0.888394371861311,0,1,regulation of protein localization to lysosome,BP,
17352,GO:0150033,1.00000000001851,0.888394371861311,0,1,negative regulation of protein localization to lysosome,BP,
17388,GO:1900081,1.00000000001851,0.888394371861311,0,1,regulation of arginine catabolic process,BP,
17389,GO:1900082,1.00000000001851,0.888394371861311,0,1,negative regulation of arginine catabolic process,BP,
17395,GO:1900095,1.00000000001851,0.888394371861311,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17434,GO:1900149,1.00000000001851,0.888394371861311,0,1,positive regulation of Schwann cell migration,BP,
17469,GO:1900224,1.00000000001851,0.888394371861311,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17544,GO:1900827,1.00000000001851,0.888394371861311,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17571,GO:1901078,1.00000000001851,0.888394371861311,0,1,negative regulation of relaxation of muscle,BP,
17658,GO:1901350,1.00000000001851,0.888394371861311,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17706,GO:1901555,1.00000000001851,0.888394371861311,0,1,response to paclitaxel,BP,
17720,GO:1901580,1.00000000001851,0.888394371861311,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17721,GO:1901581,1.00000000001851,0.888394371861311,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17722,GO:1901582,1.00000000001851,0.888394371861311,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17742,GO:1901631,1.00000000001851,0.888394371861311,0,1,positive regulation of presynaptic membrane organization,BP,
17743,GO:1901639,1.00000000001851,0.888394371861311,0,1,XDP catabolic process,BP,
17744,GO:1901640,1.00000000001851,0.888394371861311,0,1,XTP binding,MF,
17745,GO:1901641,1.00000000001851,0.888394371861311,0,1,ITP binding,MF,
17765,GO:1901675,1.00000000001851,0.888394371861311,0,1,negative regulation of histone H3-K27 acetylation,BP,
17769,GO:1901680,1.00000000001851,0.888394371861311,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17784,GO:1901726,1.00000000001851,0.888394371861311,0,1,negative regulation of histone deacetylase activity,BP,
17826,GO:1901895,1.00000000001851,0.888394371861311,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17829,GO:1901898,1.00000000001851,0.888394371861311,0,1,negative regulation of relaxation of cardiac muscle,BP,
17847,GO:1901980,1.00000000001851,0.888394371861311,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17931,GO:1902216,1.00000000001851,0.888394371861311,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17994,GO:1902363,1.00000000001851,0.888394371861311,0,1,regulation of protein localization to spindle pole body,BP,
17995,GO:1902365,1.00000000001851,0.888394371861311,0,1,positive regulation of protein localization to spindle pole body,BP,
18001,GO:1902379,1.00000000001851,0.888394371861311,0,1,chemoattractant activity involved in axon guidance,MF,
18034,GO:1902488,1.00000000001851,0.888394371861311,0,1,cholangiocyte apoptotic process,BP,
18050,GO:1902528,1.00000000001851,0.888394371861311,0,1,regulation of protein linear polyubiquitination,BP,
18051,GO:1902530,1.00000000001851,0.888394371861311,0,1,positive regulation of protein linear polyubiquitination,BP,
18087,GO:1902618,1.00000000001851,0.888394371861311,0,1,cellular response to fluoride,BP,
18120,GO:1902725,1.00000000001851,0.888394371861311,0,1,negative regulation of satellite cell differentiation,BP,
18157,GO:1902846,1.00000000001851,0.888394371861311,0,1,positive regulation of mitotic spindle elongation,BP,
18172,GO:1902889,1.00000000001851,0.888394371861311,0,1,protein localization to spindle microtubule,BP,
18252,GO:1903027,1.00000000001851,0.888394371861311,0,1,regulation of opsonization,BP,
18253,GO:1903028,1.00000000001851,0.888394371861311,0,1,positive regulation of opsonization,BP,
18344,GO:1903248,1.00000000001851,0.888394371861311,0,1,regulation of citrulline biosynthetic process,BP,
18345,GO:1903249,1.00000000001851,0.888394371861311,0,1,negative regulation of citrulline biosynthetic process,BP,
18420,GO:1903420,1.00000000001851,0.888394371861311,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18459,GO:1903515,1.00000000001851,0.888394371861311,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18547,GO:1903699,1.00000000001851,0.888394371861311,0,1,tarsal gland development,BP,
18553,GO:1903709,1.00000000001851,0.888394371861311,0,1,uterine gland development,BP,
18654,GO:1903918,1.00000000001851,0.888394371861311,0,1,regulation of actin filament severing,BP,
18655,GO:1903919,1.00000000001851,0.888394371861311,0,1,negative regulation of actin filament severing,BP,
18696,GO:1904000,1.00000000001851,0.888394371861311,0,1,positive regulation of eating behavior,BP,
18723,GO:1904054,1.00000000001851,0.888394371861311,0,1,regulation of cholangiocyte proliferation,BP,
18724,GO:1904056,1.00000000001851,0.888394371861311,0,1,positive regulation of cholangiocyte proliferation,BP,
18727,GO:1904059,1.00000000001851,0.888394371861311,0,1,regulation of locomotor rhythm,BP,
18731,GO:1904073,1.00000000001851,0.888394371861311,0,1,regulation of trophectodermal cell proliferation,BP,
18732,GO:1904075,1.00000000001851,0.888394371861311,0,1,positive regulation of trophectodermal cell proliferation,BP,
18749,GO:1904167,1.00000000001851,0.888394371861311,0,1,regulation of thyroid hormone receptor activity,BP,
18750,GO:1904168,1.00000000001851,0.888394371861311,0,1,negative regulation of thyroid hormone receptor activity,BP,
18757,GO:1904192,1.00000000001851,0.888394371861311,0,1,regulation of cholangiocyte apoptotic process,BP,
18758,GO:1904193,1.00000000001851,0.888394371861311,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18759,GO:1904195,1.00000000001851,0.888394371861311,0,1,regulation of granulosa cell proliferation,BP,
18760,GO:1904197,1.00000000001851,0.888394371861311,0,1,positive regulation of granulosa cell proliferation,BP,
18762,GO:1904200,1.00000000001851,0.888394371861311,0,1,iodide transmembrane transport,BP,
18763,GO:1904201,1.00000000001851,0.888394371861311,0,1,regulation of iodide transport,BP,
18764,GO:1904202,1.00000000001851,0.888394371861311,0,1,negative regulation of iodide transport,BP,
18765,GO:1904204,1.00000000001851,0.888394371861311,0,1,regulation of skeletal muscle hypertrophy,BP,
18766,GO:1904206,1.00000000001851,0.888394371861311,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18771,GO:1904212,1.00000000001851,0.888394371861311,0,1,regulation of iodide transmembrane transport,BP,
18772,GO:1904213,1.00000000001851,0.888394371861311,0,1,negative regulation of iodide transmembrane transport,BP,
18779,GO:1904229,1.00000000001851,0.888394371861311,0,1,regulation of succinate dehydrogenase activity,BP,
18780,GO:1904231,1.00000000001851,0.888394371861311,0,1,positive regulation of succinate dehydrogenase activity,BP,
18781,GO:1904232,1.00000000001851,0.888394371861311,0,1,regulation of aconitate hydratase activity,BP,
18782,GO:1904234,1.00000000001851,0.888394371861311,0,1,positive regulation of aconitate hydratase activity,BP,
18783,GO:1904235,1.00000000001851,0.888394371861311,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18784,GO:1904237,1.00000000001851,0.888394371861311,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18797,GO:1904265,1.00000000001851,0.888394371861311,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18798,GO:1904266,1.00000000001851,0.888394371861311,0,1,regulation of Schwann cell chemotaxis,BP,
18799,GO:1904268,1.00000000001851,0.888394371861311,0,1,positive regulation of Schwann cell chemotaxis,BP,
18825,GO:1904339,1.00000000001851,0.888394371861311,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18848,GO:1904393,1.00000000001851,0.888394371861311,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18849,GO:1904395,1.00000000001851,0.888394371861311,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18852,GO:1904404,1.00000000001851,0.888394371861311,0,1,response to formaldehyde,BP,
18871,GO:1904447,1.00000000001851,0.888394371861311,0,1,folic acid import across plasma membrane,BP,
18874,GO:1904454,1.00000000001851,0.888394371861311,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18883,GO:1904477,1.00000000001851,0.888394371861311,0,1,positive regulation of Ras GTPase binding,BP,
18931,GO:1904594,1.00000000001851,0.888394371861311,0,1,regulation of termination of RNA polymerase II transcription,BP,
18932,GO:1904595,1.00000000001851,0.888394371861311,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18950,GO:1904647,1.00000000001851,0.888394371861311,0,1,response to rotenone,BP,
19000,GO:1904750,1.00000000001851,0.888394371861311,0,1,negative regulation of protein localization to nucleolus,BP,
19009,GO:1904766,1.00000000001851,0.888394371861311,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
19024,GO:1904797,1.00000000001851,0.888394371861311,0,1,negative regulation of core promoter binding,BP,
19037,GO:1904826,1.00000000001851,0.888394371861311,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19038,GO:1904828,1.00000000001851,0.888394371861311,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19064,GO:1904878,1.00000000001851,0.888394371861311,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19093,GO:1904933,1.00000000001851,0.888394371861311,0,1,regulation of cell proliferation in midbrain,BP,
19094,GO:1904934,1.00000000001851,0.888394371861311,0,1,negative regulation of cell proliferation in midbrain,BP,
19103,GO:1904955,1.00000000001851,0.888394371861311,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19116,GO:1904980,1.00000000001851,0.888394371861311,0,1,positive regulation of endosome organization,BP,
19126,GO:1905000,1.00000000001851,0.888394371861311,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19162,GO:1905089,1.00000000001851,0.888394371861311,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19163,GO:1905090,1.00000000001851,0.888394371861311,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19166,GO:1905099,1.00000000001851,0.888394371861311,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19177,GO:1905152,1.00000000001851,0.888394371861311,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19204,GO:1905223,1.00000000001851,0.888394371861311,0,1,epicardium morphogenesis,BP,
19212,GO:1905255,1.00000000001851,0.888394371861311,0,1,regulation of RNA binding transcription factor activity,BP,
19220,GO:1905274,1.00000000001851,0.888394371861311,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19232,GO:1905304,1.00000000001851,0.888394371861311,0,1,regulation of cardiac myofibril assembly,BP,
19233,GO:1905305,1.00000000001851,0.888394371861311,0,1,negative regulation of cardiac myofibril assembly,BP,
19234,GO:1905309,1.00000000001851,0.888394371861311,0,1,positive regulation of cohesin loading,BP,
19248,GO:1905335,1.00000000001851,0.888394371861311,0,1,regulation of aggrephagy,BP,
19249,GO:1905337,1.00000000001851,0.888394371861311,0,1,positive regulation of aggrephagy,BP,
19277,GO:1905405,1.00000000001851,0.888394371861311,0,1,regulation of mitotic cohesin loading,BP,
19278,GO:1905406,1.00000000001851,0.888394371861311,0,1,positive regulation of mitotic cohesin loading,BP,
19290,GO:1905438,1.00000000001851,0.888394371861311,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19302,GO:1905460,1.00000000001851,0.888394371861311,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
19321,GO:1905524,1.00000000001851,0.888394371861311,0,1,negative regulation of protein autoubiquitination,BP,
19361,GO:1905643,1.00000000001851,0.888394371861311,0,1,positive regulation of DNA methylation,BP,
19376,GO:1905705,1.00000000001851,0.888394371861311,0,1,cellular response to paclitaxel,BP,
19383,GO:1905720,1.00000000001851,0.888394371861311,0,1,cytoplasmic microtubule bundle,CC,
19386,GO:1905767,1.00000000001851,0.888394371861311,0,1,regulation of double-stranded telomeric DNA binding,BP,
19387,GO:1905768,1.00000000001851,0.888394371861311,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19397,GO:1905794,1.00000000001851,0.888394371861311,0,1,response to puromycin,BP,
19398,GO:1905795,1.00000000001851,0.888394371861311,0,1,cellular response to puromycin,BP,
19407,GO:1905843,1.00000000001851,0.888394371861311,0,1,regulation of cellular response to gamma radiation,BP,
19415,GO:1905878,1.00000000001851,0.888394371861311,0,1,invadopodium disassembly,BP,
19433,GO:1905927,1.00000000001851,0.888394371861311,0,1,regulation of invadopodium disassembly,BP,
19434,GO:1905929,1.00000000001851,0.888394371861311,0,1,positive regulation of invadopodium disassembly,BP,
19451,GO:1990003,1.00000000001851,0.888394371861311,0,1,IDP phosphatase activity,MF,
19461,GO:1990036,1.00000000001851,0.888394371861311,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19499,GO:1990172,1.00000000001851,0.888394371861311,0,1,G-protein coupled receptor catabolic process,BP,
19517,GO:1990256,1.00000000001851,0.888394371861311,0,1,signal clustering,BP,
19526,GO:1990280,1.00000000001851,0.888394371861311,0,1,RNA localization to chromatin,BP,
19557,GO:1990421,1.00000000001851,0.888394371861311,0,1,subtelomeric heterochromatin,CC,
19569,GO:1990448,1.00000000001851,0.888394371861311,0,1,exon-exon junction complex binding,MF,
19579,GO:1990502,1.00000000001851,0.888394371861311,0,1,dense core granule maturation,BP,
19596,GO:1990578,1.00000000001851,0.888394371861311,0,1,perinuclear endoplasmic reticulum membrane,CC,
19623,GO:1990705,1.00000000001851,0.888394371861311,0,1,cholangiocyte proliferation,BP,
19624,GO:1990707,1.00000000001851,0.888394371861311,0,1,nuclear subtelomeric heterochromatin,CC,
19635,GO:1990739,1.00000000001851,0.888394371861311,0,1,granulosa cell proliferation,BP,
19641,GO:1990751,1.00000000001851,0.888394371861311,0,1,Schwann cell chemotaxis,BP,
19650,GO:1990771,1.00000000001851,0.888394371861311,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19682,GO:1990876,1.00000000001851,0.888394371861311,0,1,cytoplasmic side of nuclear pore,CC,
19709,GO:1990968,1.00000000001851,0.888394371861311,0,1,modulation by host of RNA binding by virus,BP,
19710,GO:1990969,1.00000000001851,0.888394371861311,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19746,GO:2000055,1.00000000001851,0.888394371861311,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19857,GO:2000283,1.00000000001851,0.888394371861311,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19887,GO:2000325,1.00000000001851,0.888394371861311,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19888,GO:2000327,1.00000000001851,0.888394371861311,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19927,GO:2000382,1.00000000001851,0.888394371861311,0,1,positive regulation of mesoderm development,BP,
19998,GO:2000536,1.00000000001851,0.888394371861311,0,1,negative regulation of entry of bacterium into host cell,BP,
20103,GO:2000707,1.00000000001851,0.888394371861311,0,1,positive regulation of dense core granule biogenesis,BP,
20150,GO:2000795,1.00000000001851,0.888394371861311,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20153,GO:2000804,1.00000000001851,0.888394371861311,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20154,GO:2000806,1.00000000001851,0.888394371861311,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20163,GO:2000820,1.00000000001851,0.888394371861311,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20177,GO:2000843,1.00000000001851,0.888394371861311,0,1,regulation of testosterone secretion,BP,
20178,GO:2000845,1.00000000001851,0.888394371861311,0,1,positive regulation of testosterone secretion,BP,
20189,GO:2000864,1.00000000001851,0.888394371861311,0,1,regulation of estradiol secretion,BP,
20240,GO:2001108,1.00000000001851,0.888394371861311,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20241,GO:2001109,1.00000000001851,0.888394371861311,0,1,regulation of lens epithelial cell proliferation,BP,
20242,GO:2001111,1.00000000001851,0.888394371861311,0,1,positive regulation of lens epithelial cell proliferation,BP,
20284,GO:2001202,1.00000000001851,0.888394371861311,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20298,GO:2001229,1.00000000001851,0.888394371861311,0,1,negative regulation of response to gamma radiation,BP,
20334,GO:2001288,1.00000000001851,0.888394371861311,0,1,positive regulation of caveolin-mediated endocytosis,BP,
3024,GO:0006570,1.00000000001851,0.670194184324341,0,4,tyrosine metabolic process,BP,
9589,GO:0036396,1.00000000001852,0.725827808058665,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11204,GO:0045293,1.00000000001852,0.725827808058665,0,3,mRNA editing complex,CC,
15638,GO:0072108,1.00000000001854,0.742322228288349,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1515,GO:0003873,1.00000000001854,0.703748635075696,0,3,6-phosphofructo-2-kinase activity,MF,
16251,GO:0090283,1.00000000001859,0.715804471046411,0,3,regulation of protein glycosylation in Golgi,BP,
3855,GO:0008467,1.0000000000186,0.723574487925984,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
7574,GO:0031930,1.00000000001861,0.908119211758632,0,1,mitochondria-nucleus signaling pathway,BP,
1719,GO:0004308,1.00000000001862,0.640885330511618,0,4,exo-alpha-sialidase activity,MF,
5778,GO:0016997,1.00000000001862,0.640885330511618,0,4,alpha-sialidase activity,MF,
15401,GO:0071630,1.00000000001862,0.705362406154097,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
7861,GO:0032416,1.00000000001865,0.897450844288514,0,1,negative regulation of sodium:proton antiporter activity,BP,
16562,GO:0097291,1.00000000001865,0.897450844288514,0,1,renal phosphate ion absorption,BP,
13185,GO:0051754,1.00000000001866,0.709486358289594,0,3,meiotic sister chromatid cohesion, centromeric,BP,
5984,GO:0018773,1.00000000001867,0.902745656205833,0,1,acetylpyruvate hydrolase activity,MF,
8818,GO:0034545,1.00000000001867,0.902745656205833,0,1,fumarylpyruvate hydrolase activity,MF,
12036,GO:0047621,1.00000000001867,0.902745656205833,0,1,acylpyruvate hydrolase activity,MF,
13384,GO:0052550,1.00000000001867,0.902745656205833,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13390,GO:0052567,1.00000000001867,0.902745656205833,0,1,response to defense-related host reactive oxygen species production,BP,
10705,GO:0043974,1.00000000001867,0.705806038851595,0,3,histone H3-K27 acetylation,BP,
17764,GO:1901674,1.00000000001867,0.705806038851595,0,3,regulation of histone H3-K27 acetylation,BP,
7142,GO:0030969,1.00000000001868,0.709853848613656,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
14556,GO:0070054,1.00000000001868,0.709853848613656,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14557,GO:0070055,1.00000000001868,0.709853848613656,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14854,GO:0070579,1.00000000001868,0.626539610343999,0,4,methylcytosine dioxygenase activity,MF,
5165,GO:0015705,1.00000000001868,0.62525819291214,0,4,iodide transport,BP,
10934,GO:0044539,1.00000000001869,0.706440663207199,0,3,long-chain fatty acid import,BP,
2636,GO:0005967,1.00000000001872,0.707141882837482,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
10498,GO:0043385,1.00000000001873,0.893208225770913,0,1,mycotoxin metabolic process,BP,
10499,GO:0043387,1.00000000001873,0.893208225770913,0,1,mycotoxin catabolic process,BP,
11621,GO:0046222,1.00000000001873,0.893208225770913,0,1,aflatoxin metabolic process,BP,
11622,GO:0046223,1.00000000001873,0.893208225770913,0,1,aflatoxin catabolic process,BP,
17666,GO:1901376,1.00000000001873,0.893208225770913,0,1,organic heteropentacyclic compound metabolic process,BP,
17667,GO:1901377,1.00000000001873,0.893208225770913,0,1,organic heteropentacyclic compound catabolic process,BP,
18589,GO:1903786,1.00000000001873,0.893208225770913,0,1,regulation of glutathione biosynthetic process,BP,
18590,GO:1903788,1.00000000001873,0.893208225770913,0,1,positive regulation of glutathione biosynthetic process,BP,
18509,GO:1903588,1.00000000001874,0.723193264245001,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
9828,GO:0042025,1.00000000001874,0.706915786908137,0,3,host cell nucleus,CC,
10747,GO:0044094,1.00000000001874,0.706915786908137,0,3,host cell nuclear part,CC,
4329,GO:0009841,1.00000000001875,0.894545894175612,0,1,mitochondrial endopeptidase Clp complex,CC,
16755,GO:0097752,1.00000000001877,0.711835413843906,0,3,regulation of DNA stability,BP,
177,GO:0000386,1.00000000001877,0.713930890597527,0,3,second spliceosomal transesterification activity,MF,
15645,GO:0072125,1.00000000001882,0.715144180505475,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16192,GO:0090194,1.00000000001882,0.715144180505475,0,3,negative regulation of glomerulus development,BP,
19756,GO:2000078,1.00000000001884,0.820860028396149,0,2,positive regulation of type B pancreatic cell development,BP,
7137,GO:0030956,1.00000000001887,0.754267165793862,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12520,GO:0050567,1.00000000001887,0.754267165793862,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14905,GO:0070681,1.00000000001887,0.754267165793862,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
17766,GO:1901676,1.0000000000189,0.889895413560661,0,1,positive regulation of histone H3-K27 acetylation,BP,
18433,GO:1903435,1.00000000001891,0.89304437286193,0,1,positive regulation of constitutive secretory pathway,BP,
3999,GO:0008900,1.00000000001892,0.890784290839273,0,1,potassium:proton exchanging ATPase activity,MF,
5776,GO:0016979,1.00000000001893,0.909516700637636,0,1,lipoate-protein ligase activity,MF,
19975,GO:2000474,1.00000000001893,0.889595008278478,0,1,regulation of opioid receptor signaling pathway,BP,
12553,GO:0050682,1.00000000001895,0.795323313223586,0,2,AF-2 domain binding,MF,
660,GO:0001849,1.00000000001908,0.740698462861164,0,3,complement component C1q binding,MF,
1572,GO:0003976,1.00000000001909,0.728033687598165,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
2325,GO:0005332,1.00000000001911,0.897522245658892,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
3951,GO:0008650,1.00000000001911,0.890810174308629,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
5024,GO:0015185,1.00000000001911,0.897522245658892,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6547,GO:0021956,1.00000000001911,0.897522245658892,0,1,central nervous system interneuron axonogenesis,BP,
16934,GO:0098881,1.00000000001913,0.709700464860507,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16978,GO:0098967,1.00000000001913,0.709700464860507,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
17348,GO:0150018,1.00000000001915,0.705735594571613,0,3,basal dendrite development,BP,
17349,GO:0150019,1.00000000001915,0.705735594571613,0,3,basal dendrite morphogenesis,BP,
17350,GO:0150020,1.00000000001915,0.705735594571613,0,3,basal dendrite arborization,BP,
3097,GO:0006671,1.00000000001915,0.889018871017584,0,1,phytosphingosine metabolic process,BP,
14939,GO:0070774,1.00000000001915,0.889018871017584,0,1,phytoceramidase activity,MF,
15381,GO:0071602,1.00000000001915,0.889018871017584,0,1,phytosphingosine biosynthetic process,BP,
16105,GO:0090065,1.00000000001916,0.957110892140112,0,1,regulation of production of siRNA involved in RNA interference,BP,
16837,GO:0098680,1.00000000001916,0.957110892140112,0,1,template-free RNA nucleotidyltransferase,MF,
18549,GO:1903704,1.00000000001916,0.957110892140112,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19593,GO:1990572,1.00000000001916,0.957110892140112,0,1,TERT-RMRP complex,CC,
1093,GO:0002678,1.00000000001918,0.734952675537152,0,3,positive regulation of chronic inflammatory response,BP,
3811,GO:0008398,1.0000000000192,0.892288239116961,0,1,sterol 14-demethylase activity,MF,
8426,GO:0033488,1.0000000000192,0.892288239116961,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
7367,GO:0031404,1.00000000001923,0.727592067009442,0,3,chloride ion binding,MF,
8670,GO:0034224,1.00000000001923,0.895208268973389,0,1,cellular response to zinc ion starvation,BP,
18149,GO:1902809,1.00000000001925,0.719065868988886,0,3,regulation of skeletal muscle fiber differentiation,BP,
10704,GO:0043973,1.00000000001926,0.895525577788738,0,1,histone H3-K4 acetylation,BP,
13445,GO:0052827,1.00000000001928,0.796260731085073,0,2,inositol pentakisphosphate phosphatase activity,MF,
1686,GO:0004149,1.00000000001928,0.892914194956665,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5658,GO:0016751,1.00000000001928,0.892914194956665,0,1,S-succinyltransferase activity,MF,
9386,GO:0035905,1.0000000000193,0.717110526224794,0,3,ascending aorta development,BP,
9389,GO:0035910,1.0000000000193,0.717110526224794,0,3,ascending aorta morphogenesis,BP,
10062,GO:0042535,1.00000000001931,0.652927151524712,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
14135,GO:0060971,1.00000000001932,0.711919858277464,0,3,embryonic heart tube left/right pattern formation,BP,
13569,GO:0060010,1.00000000001933,0.891560318959946,0,1,Sertoli cell fate commitment,BP,
4734,GO:0010896,1.00000000001933,0.712893414842573,0,3,regulation of triglyceride catabolic process,BP,
3841,GO:0008446,1.00000000001934,0.902809796318477,0,1,GDP-mannose 4,6-dehydratase activity,MF,
2262,GO:0005174,1.00000000001935,0.894988201041259,0,1,CD40 receptor binding,MF,
3277,GO:0006957,1.00000000001935,0.70520494703873,0,3,complement activation, alternative pathway,BP,
4820,GO:0014012,1.00000000001939,0.659677589742259,0,4,peripheral nervous system axon regeneration,BP,
9312,GO:0035750,1.00000000001939,0.888412214410337,0,1,protein localization to myelin sheath abaxonal region,BP,
7011,GO:0030690,1.00000000001939,0.893017067966362,0,1,Noc1p-Noc2p complex,CC,
7012,GO:0030691,1.00000000001939,0.893017067966362,0,1,Noc2p-Noc3p complex,CC,
4900,GO:0014825,1.00000000001943,0.931326346142054,0,1,stomach fundus smooth muscle contraction,BP,
4913,GO:0014847,1.00000000001943,0.931326346142054,0,1,proximal stomach smooth muscle contraction,BP,
7550,GO:0031839,1.00000000001943,0.931326346142054,0,1,type 1 neuromedin U receptor binding,MF,
7551,GO:0031840,1.00000000001943,0.931326346142054,0,1,type 2 neuromedin U receptor binding,MF,
9148,GO:0035483,1.00000000001943,0.931326346142054,0,1,gastric emptying,BP,
10240,GO:0042922,1.00000000001943,0.931326346142054,0,1,neuromedin U receptor binding,MF,
10925,GO:0044495,1.00000000001943,0.931326346142054,0,1,modulation of blood pressure in other organism,BP,
10926,GO:0044497,1.00000000001943,0.931326346142054,0,1,positive regulation of blood pressure in other organism,BP,
17284,GO:0120060,1.00000000001943,0.931326346142054,0,1,regulation of gastric emptying,BP,
17285,GO:0120061,1.00000000001943,0.931326346142054,0,1,negative regulation of gastric emptying,BP,
17286,GO:0120063,1.00000000001943,0.931326346142054,0,1,stomach smooth muscle contraction,BP,
17287,GO:0120068,1.00000000001943,0.931326346142054,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17288,GO:0120069,1.00000000001943,0.931326346142054,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
19575,GO:1990460,1.00000000001944,0.711976478002694,0,3,leptin receptor binding,MF,
1276,GO:0003065,1.00000000001947,0.900593388150296,0,1,positive regulation of heart rate by epinephrine,BP,
14028,GO:0060729,1.00000000001949,0.716794041686897,0,3,intestinal epithelial structure maintenance,BP,
5755,GO:0016900,1.0000000000195,0.850487812821101,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11968,GO:0047057,1.0000000000195,0.850487812821101,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
2745,GO:0006139,1.0000000000195,0,370,4604,nucleobase-containing compound metabolic process,BP,TNIP1;NT5E;XDH;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NAPRT;CRTC1;PCK2;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;RAPGEF3;PRNP;IDH2;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;H6PD;KIAA1549;ADCY7;XBP1;PGLS;EGFR;CSNK1E;TK2;RFX2;PRKACA;ADARB1;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;ENDOG;NSMCE4A;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;RPUSD3;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ARID5B;TOP1;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;GLRX;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;OAS1;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;STUB1;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;SARS2;RAD23A;AOX1;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ZNF687;ENTPD6;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;NDUFS2;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;LDHA;PIK3R2;ANXA1;PODXL2;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
9218,GO:0035597,1.00000000001951,0.897207800112566,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
12043,GO:0047685,1.00000000001951,0.906908451103025,0,1,amine sulfotransferase activity,MF,
1589,GO:0003997,1.00000000001953,0.71390515646105,0,3,acyl-CoA oxidase activity,MF,
10270,GO:0042999,1.00000000001953,0.888788293339161,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10273,GO:0043002,1.00000000001953,0.888788293339161,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10274,GO:0043004,1.00000000001953,0.888788293339161,0,1,cytoplasmic sequestering of CFTR protein,BP,
588,GO:0001740,1.00000000001953,0.71495156848085,0,3,Barr body,CC,
5519,GO:0016479,1.00000000001953,0.71495156848085,0,3,negative regulation of transcription by RNA polymerase I,BP,
10113,GO:0042613,1.00000000001955,0.760870069871558,0,3,MHC class II protein complex,CC,
17150,GO:0102148,1.00000000001957,0.71945563485821,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
7416,GO:0031493,1.00000000001957,0.716573139581042,0,3,nucleosomal histone binding,MF,
9309,GO:0035747,1.00000000001958,0.730224021176881,0,3,natural killer cell chemotaxis,BP,
11649,GO:0046340,1.00000000001962,0.706368165547283,0,3,diacylglycerol catabolic process,BP,
9243,GO:0035625,1.00000000001964,0.890833243408581,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
20041,GO:2000619,1.00000000001964,0.725969457458333,0,3,negative regulation of histone H4-K16 acetylation,BP,
13867,GO:0060448,1.00000000001966,0.716450346362891,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
19152,GO:1905065,1.00000000001967,0.717949722987561,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
18675,GO:1903961,1.00000000001968,0.710751960411904,0,3,positive regulation of anion transmembrane transport,BP,
14902,GO:0070676,1.00000000001969,0.733298148446914,0,3,intralumenal vesicle formation,BP,
19114,GO:1904978,1.00000000001969,0.706803527224453,0,3,regulation of endosome organization,BP,
6498,GO:0021855,1.00000000001972,0.711034171152516,0,3,hypothalamus cell migration,BP,
6029,GO:0019085,1.00000000001973,0.79246583621845,0,2,early viral transcription,BP,
16847,GO:0098713,1.00000000001975,0.895104222510761,0,1,leucine import across plasma membrane,BP,
18600,GO:1903801,1.00000000001975,0.895104222510761,0,1,L-leucine import across plasma membrane,BP,
19603,GO:1990597,1.00000000001978,0.707752040446571,0,3,AIP1-IRE1 complex,CC,
1805,GO:0004446,1.00000000001982,0.892927515079671,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6879,GO:0030351,1.00000000001982,0.892927515079671,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8536,GO:0033787,1.00000000001982,0.892927515079671,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8762,GO:0034417,1.00000000001982,0.892927515079671,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13444,GO:0052826,1.00000000001982,0.892927515079671,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
10173,GO:0042748,1.00000000001982,0.715101989284445,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
6536,GO:0021936,1.00000000001985,0.703025454708149,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
18338,GO:1903236,1.00000000001989,0.735907671030764,0,3,regulation of leukocyte tethering or rolling,BP,
936,GO:0002332,1.00000000001991,0.88839524946673,0,1,transitional stage B cell differentiation,BP,
937,GO:0002333,1.00000000001991,0.88839524946673,0,1,transitional one stage B cell differentiation,BP,
18900,GO:1904531,1.00000000001991,0.88839524946673,0,1,positive regulation of actin filament binding,BP,
18942,GO:1904618,1.00000000001991,0.88839524946673,0,1,positive regulation of actin binding,BP,
19468,GO:1990051,1.00000000001991,0.88839524946673,0,1,activation of protein kinase C activity,BP,
17957,GO:1902260,1.00000000001997,0.718305679657274,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
16580,GO:0097343,1.00000000002,0.703959547448169,0,3,ripoptosome assembly,BP,
17555,GO:1901026,1.00000000002,0.703959547448169,0,3,ripoptosome assembly involved in necroptotic process,BP,
1910,GO:0004595,1.00000000002003,0.894889263768619,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1741,GO:0004336,1.00000000002004,0.892757054650836,0,1,galactosylceramidase activity,MF,
3105,GO:0006683,1.00000000002004,0.892757054650836,0,1,galactosylceramide catabolic process,BP,
6131,GO:0019376,1.00000000002004,0.892757054650836,0,1,galactolipid catabolic process,BP,
19879,GO:2000317,1.00000000002004,0.70897642571545,0,3,negative regulation of T-helper 17 type immune response,BP,
19882,GO:2000320,1.00000000002004,0.70897642571545,0,3,negative regulation of T-helper 17 cell differentiation,BP,
11098,GO:0045084,1.00000000002004,0.711558926037938,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
1273,GO:0003057,1.00000000002008,0.715408347182944,0,3,regulation of the force of heart contraction by chemical signal,BP,
4059,GO:0009107,1.00000000002009,0.90284197289889,0,1,lipoate biosynthetic process,BP,
5777,GO:0016992,1.00000000002009,0.90284197289889,0,1,lipoate synthase activity,MF,
14688,GO:0070283,1.00000000002009,0.90284197289889,0,1,radical SAM enzyme activity,MF,
17442,GO:1900165,1.0000000000201,0.709384397236475,0,3,negative regulation of interleukin-6 secretion,BP,
8566,GO:0033989,1.0000000000201,0.8933340635183,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9486,GO:0036111,1.0000000000201,0.8933340635183,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10945,GO:0044594,1.0000000000201,0.8933340635183,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
9540,GO:0036261,1.00000000002012,0.890458311411718,0,1,7-methylguanosine cap hypermethylation,BP,
15128,GO:0071164,1.00000000002012,0.890458311411718,0,1,RNA trimethylguanosine synthase activity,MF,
3928,GO:0008607,1.00000000002013,0.720208646838021,0,3,phosphorylase kinase regulator activity,MF,
7275,GO:0031249,1.00000000002013,0.894237265483569,0,1,denatured protein binding,MF,
18002,GO:1902380,1.00000000002013,0.894237265483569,0,1,positive regulation of endoribonuclease activity,BP,
18987,GO:1904722,1.00000000002013,0.894237265483569,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18475,GO:1903537,1.00000000002014,0.798733204395326,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18476,GO:1903538,1.00000000002014,0.798733204395326,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
2689,GO:0006050,1.00000000002017,0.905107608353884,0,1,mannosamine metabolic process,BP,
2690,GO:0006051,1.00000000002017,0.905107608353884,0,1,N-acetylmannosamine metabolic process,BP,
11123,GO:0045127,1.00000000002017,0.905107608353884,0,1,N-acetylglucosamine kinase activity,MF,
6625,GO:0022848,1.00000000002018,0.710311936612381,0,3,acetylcholine-gated cation-selective channel activity,MF,
1360,GO:0003228,1.0000000000202,0.718011559446536,0,3,atrial cardiac muscle tissue development,BP,
13494,GO:0055009,1.0000000000202,0.718011559446536,0,3,atrial cardiac muscle tissue morphogenesis,BP,
3998,GO:0008897,1.00000000002021,0.8928874428614,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
18995,GO:1904744,1.00000000002022,0.826680278624892,0,2,positive regulation of telomeric DNA binding,BP,
2011,GO:0004733,1.00000000002023,0.891122840208684,0,1,pyridoxamine-phosphate oxidase activity,MF,
6095,GO:0019276,1.00000000002023,0.892868629120465,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9040,GO:0035248,1.00000000002023,0.892868629120465,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
13206,GO:0051793,1.00000000002024,0.711833684781904,0,3,medium-chain fatty acid catabolic process,BP,
3712,GO:0008228,1.00000000002028,0.708996753336753,0,3,opsonization,BP,
10944,GO:0044571,1.00000000002028,0.697469509516069,0,4,[2Fe-2S] cluster assembly,BP,
1604,GO:0004020,1.00000000002029,0.795473412887939,0,2,adenylylsulfate kinase activity,MF,
2041,GO:0004779,1.00000000002029,0.795473412887939,0,2,sulfate adenylyltransferase activity,MF,
2042,GO:0004781,1.00000000002029,0.795473412887939,0,2,sulfate adenylyltransferase (ATP) activity,MF,
1823,GO:0004471,1.00000000002029,0.709286575412052,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1824,GO:0004473,1.00000000002029,0.709286575412052,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
16201,GO:0090204,1.00000000002029,0.74919491892755,0,3,protein localization to nuclear pore,BP,
8786,GO:0034457,1.0000000000203,0.753999347168131,0,3,Mpp10 complex,CC,
3020,GO:0006566,1.00000000002032,0.737979838380919,0,3,threonine metabolic process,BP,
14605,GO:0070138,1.00000000002035,0.705328336859599,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14607,GO:0070140,1.00000000002035,0.705328336859599,0,3,SUMO-specific isopeptidase activity,MF,
9170,GO:0035517,1.00000000002035,0.70394006062284,0,3,PR-DUB complex,CC,
680,GO:0001887,1.00000000002037,0.636551397611452,0,4,selenium compound metabolic process,BP,
2728,GO:0006106,1.0000000000204,0.721554082417564,0,3,fumarate metabolic process,BP,
4478,GO:0010481,1.00000000002042,0.724129400182667,0,3,epidermal cell division,BP,
4479,GO:0010482,1.00000000002042,0.724129400182667,0,3,regulation of epidermal cell division,BP,
3805,GO:0008384,1.00000000002044,0.706884304834093,0,3,IkappaB kinase activity,MF,
15427,GO:0071673,1.00000000002044,0.892137016181596,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18910,GO:1904565,1.00000000002044,0.892137016181596,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18911,GO:1904566,1.00000000002044,0.892137016181596,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
11253,GO:0045415,1.00000000002045,0.71811240144464,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
17971,GO:1902292,1.00000000002046,0.917061747833652,0,1,cell cycle DNA replication initiation,BP,
17984,GO:1902315,1.00000000002046,0.917061747833652,0,1,nuclear cell cycle DNA replication initiation,BP,
18222,GO:1902975,1.00000000002046,0.917061747833652,0,1,mitotic DNA replication initiation,BP,
1937,GO:0004633,1.00000000002047,0.895417320785025,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1956,GO:0004657,1.00000000002047,0.895417320785025,0,1,proline dehydrogenase activity,MF,
14712,GO:0070320,1.00000000002047,0.893386579529695,0,1,inward rectifier potassium channel inhibitor activity,MF,
17391,GO:1900085,1.00000000002047,0.893386579529695,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18513,GO:1903596,1.00000000002047,0.893386579529695,0,1,regulation of gap junction assembly,BP,
18514,GO:1903598,1.00000000002047,0.893386579529695,0,1,positive regulation of gap junction assembly,BP,
18517,GO:1903609,1.00000000002047,0.893386579529695,0,1,negative regulation of inward rectifier potassium channel activity,BP,
3966,GO:0008747,1.00000000002048,0.905553476795481,0,1,N-acetylneuraminate lyase activity,MF,
13551,GO:0055108,1.00000000002049,0.897766675267795,0,1,Golgi to transport vesicle transport,BP,
19538,GO:1990386,1.00000000002049,0.897766675267795,0,1,mitotic cleavage furrow ingression,BP,
19598,GO:1990583,1.00000000002049,0.897766675267795,0,1,phospholipase D activator activity,MF,
13872,GO:0060455,1.00000000002053,0.828007001232988,0,2,negative regulation of gastric acid secretion,BP,
12467,GO:0050146,1.00000000002055,0.888417766928793,0,1,nucleoside phosphotransferase activity,MF,
6524,GO:0021898,1.00000000002059,0.713859010685564,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
13992,GO:0060681,1.00000000002061,0.71226326607656,0,3,branch elongation involved in ureteric bud branching,BP,
6316,GO:0019958,1.00000000002066,0.711336803212039,0,3,C-X-C chemokine binding,MF,
16912,GO:0098837,1.00000000002066,0.717761057026657,0,3,postsynaptic recycling endosome,CC,
1364,GO:0003241,1.00000000002068,0.716386267343922,0,3,growth involved in heart morphogenesis,BP,
18243,GO:1903011,1.00000000002068,0.703068240876468,0,3,negative regulation of bone development,BP,
20287,GO:2001205,1.00000000002068,0.703068240876468,0,3,negative regulation of osteoclast development,BP,
2242,GO:0005150,1.00000000002069,0.802297677897831,0,2,interleukin-1, Type I receptor binding,MF,
11561,GO:0046078,1.0000000000207,0.660033811463821,0,4,dUMP metabolic process,BP,
18901,GO:1904533,1.00000000002072,0.708336634314376,0,3,regulation of telomeric loop disassembly,BP,
13701,GO:0060214,1.00000000002073,0.905679037900211,0,1,endocardium formation,BP,
19172,GO:1905143,1.00000000002073,0.905679037900211,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
1783,GO:0004394,1.00000000002074,0.889370710833982,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
11135,GO:0045153,1.00000000002078,0.91594923625311,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
7560,GO:0031871,1.0000000000208,0.712493428397287,0,3,proteinase activated receptor binding,MF,
1626,GO:0004057,1.00000000002083,0.895446815019642,0,1,arginyltransferase activity,MF,
11465,GO:0045901,1.00000000002083,0.72364385999578,0,3,positive regulation of translational elongation,BP,
2789,GO:0006226,1.00000000002084,0.729408182100984,0,3,dUMP biosynthetic process,BP,
8287,GO:0033083,1.00000000002084,0.645204236128044,0,4,regulation of immature T cell proliferation,BP,
1531,GO:0003908,1.00000000002085,0.914128017040837,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1680,GO:0004142,1.00000000002086,0.720375018421314,0,3,diacylglycerol cholinephosphotransferase activity,MF,
3688,GO:0008193,1.0000000000209,0.81192523207291,0,2,tRNA guanylyltransferase activity,MF,
12283,GO:0048561,1.00000000002093,0.895402678256946,0,1,establishment of animal organ orientation,BP,
10329,GO:0043103,1.00000000002094,0.736372104509628,0,3,hypoxanthine salvage,BP,
12827,GO:0051102,1.00000000002094,0.889588813513564,0,1,DNA ligation involved in DNA recombination,BP,
16235,GO:0090259,1.00000000002096,0.707683673411814,0,3,regulation of retinal ganglion cell axon guidance,BP,
1664,GO:0004117,1.00000000002098,0.893294304714803,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2043,GO:0004782,1.00000000002098,0.893294304714803,0,1,sulfinoalanine decarboxylase activity,MF,
3847,GO:0008455,1.00000000002098,0.893294304714803,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008531,1.00000000002098,0.893294304714803,0,1,riboflavin kinase activity,MF,
4167,GO:0009231,1.00000000002098,0.893294304714803,0,1,riboflavin biosynthetic process,BP,
4225,GO:0009398,1.00000000002098,0.893294304714803,0,1,FMN biosynthetic process,BP,
10007,GO:0042412,1.00000000002098,0.893294304714803,0,1,taurine biosynthetic process,BP,
11628,GO:0046305,1.00000000002098,0.893294304714803,0,1,alkanesulfonate biosynthetic process,BP,
11685,GO:0046444,1.00000000002098,0.893294304714803,0,1,FMN metabolic process,BP,
5418,GO:0016262,1.00000000002098,0.71323395425102,0,3,protein N-acetylglucosaminyltransferase activity,MF,
748,GO:0001976,1.00000000002101,0.652328444280008,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
19149,GO:1905062,1.00000000002104,0.893289038933421,0,1,positive regulation of cardioblast proliferation,BP,
13849,GO:0060426,1.00000000002106,0.73033374900616,0,3,lung vasculature development,BP,
10268,GO:0042997,1.00000000002107,0.710033370954978,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
1696,GO:0004168,1.00000000002107,0.895567618637683,0,1,dolichol kinase activity,MF,
10308,GO:0043048,1.00000000002107,0.895567618637683,0,1,dolichyl monophosphate biosynthetic process,BP,
3651,GO:0008131,1.00000000002108,0.707097933938325,0,3,primary amine oxidase activity,MF,
17355,GO:1900003,1.00000000002112,0.748465565306283,0,3,regulation of serine-type endopeptidase activity,BP,
17356,GO:1900004,1.00000000002112,0.748465565306283,0,3,negative regulation of serine-type endopeptidase activity,BP,
18070,GO:1902571,1.00000000002112,0.748465565306283,0,3,regulation of serine-type peptidase activity,BP,
18071,GO:1902572,1.00000000002112,0.748465565306283,0,3,negative regulation of serine-type peptidase activity,BP,
9823,GO:0042015,1.00000000002112,0.713342679980911,0,3,interleukin-20 binding,MF,
19740,GO:2000049,1.00000000002114,0.713669058567913,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
7845,GO:0032395,1.00000000002115,0.754647227291717,0,3,MHC class II receptor activity,MF,
3104,GO:0006682,1.00000000002116,0.714300157745669,0,3,galactosylceramide biosynthetic process,BP,
6130,GO:0019375,1.00000000002116,0.714300157745669,0,3,galactolipid biosynthetic process,BP,
15732,GO:0072268,1.00000000002117,0.719272138681233,0,3,pattern specification involved in metanephros development,BP,
5262,GO:0015889,1.00000000002121,0.737426407773883,0,3,cobalamin transport,BP,
11093,GO:0045079,1.00000000002121,0.827870604035217,0,2,negative regulation of chemokine biosynthetic process,BP,
4352,GO:0009918,1.00000000002122,0.893430521016407,0,1,sterol delta7 reductase activity,MF,
5126,GO:0015499,1.00000000002122,0.893430521016407,0,1,formate transmembrane transporter activity,MF,
5142,GO:0015660,1.00000000002122,0.893430521016407,0,1,formate efflux transmembrane transporter activity,MF,
5174,GO:0015724,1.00000000002122,0.893430521016407,0,1,formate transport,BP,
5202,GO:0015797,1.00000000002122,0.893430521016407,0,1,mannitol transport,BP,
5362,GO:0016131,1.00000000002122,0.893430521016407,0,1,brassinosteroid metabolic process,BP,
5363,GO:0016132,1.00000000002122,0.893430521016407,0,1,brassinosteroid biosynthetic process,BP,
11841,GO:0046724,1.00000000002122,0.893430521016407,0,1,oxalic acid secretion,BP,
12033,GO:0047598,1.00000000002122,0.893430521016407,0,1,7-dehydrocholesterol reductase activity,MF,
2259,GO:0005171,1.00000000002123,0.896996908828072,0,1,hepatocyte growth factor receptor binding,MF,
1872,GO:0004534,1.00000000002125,0.70330475109243,0,3,5'-3' exoribonuclease activity,MF,
14014,GO:0060708,1.0000000000213,0.726236625858389,0,3,spongiotrophoblast differentiation,BP,
677,GO:0001884,1.00000000002131,0.794009020045958,0,2,pyrimidine nucleoside binding,MF,
837,GO:0002134,1.00000000002131,0.794009020045958,0,2,UTP binding,MF,
7958,GO:0032551,1.00000000002131,0.794009020045958,0,2,pyrimidine ribonucleoside binding,MF,
4871,GO:0014722,1.00000000002132,0.674448462073469,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
14633,GO:0070183,1.00000000002133,0.893000088145087,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
19001,GO:1904751,1.00000000002133,0.740633760148099,0,3,positive regulation of protein localization to nucleolus,BP,
48,GO:0000101,1.00000000002133,0.706121929579886,0,3,sulfur amino acid transport,BP,
960,GO:0002378,1.00000000002133,0.888921461717081,0,1,immunoglobulin biosynthetic process,BP,
14967,GO:0070842,1.00000000002135,0.704145235905866,0,3,aggresome assembly,BP,
10768,GO:0044194,1.00000000002136,0.71789600302704,0,3,cytolytic granule,CC,
18441,GO:1903445,1.0000000000215,0.739563220384019,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19429,GO:1905907,1.00000000002151,0.667195830396885,0,4,negative regulation of amyloid fibril formation,BP,
1731,GO:0004322,1.00000000002151,0.722482767077453,0,3,ferroxidase activity,MF,
5642,GO:0016724,1.00000000002151,0.722482767077453,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
14947,GO:0070782,1.00000000002152,0.895915544048821,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
2603,GO:0005900,1.00000000002158,0.794344601880325,0,2,oncostatin-M receptor complex,CC,
11994,GO:0047275,1.0000000000216,0.890894062724241,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
2812,GO:0006272,1.00000000002162,0.719616957053302,0,3,leading strand elongation,BP,
1434,GO:0003406,1.00000000002162,0.708238654793683,0,3,retinal pigment epithelium development,BP,
7568,GO:0031905,1.00000000002163,0.73568472445572,0,3,early endosome lumen,CC,
19941,GO:2000402,1.00000000002167,0.705083722639314,0,3,negative regulation of lymphocyte migration,BP,
8641,GO:0034155,1.00000000002168,0.890984486125669,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8642,GO:0034157,1.00000000002168,0.890984486125669,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
6622,GO:0022841,1.00000000002168,0.721049397820873,0,3,potassium ion leak channel activity,MF,
854,GO:0002177,1.00000000002177,0.736919199521064,0,3,manchette,CC,
2264,GO:0005176,1.00000000002177,0.730006354141054,0,3,ErbB-2 class receptor binding,MF,
4452,GO:0010387,1.00000000002179,0.894925911735743,0,1,COP9 signalosome assembly,BP,
302,GO:0000811,1.0000000000218,0.727792935215868,0,3,GINS complex,CC,
3130,GO:0006713,1.00000000002182,0.900611199332099,0,1,glucocorticoid catabolic process,BP,
17190,GO:0102758,1.00000000002184,0.917379008591856,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17788,GO:1901740,1.00000000002188,0.89799527754164,0,1,negative regulation of myoblast fusion,BP,
18666,GO:1903943,1.00000000002188,0.89799527754164,0,1,regulation of hepatocyte apoptotic process,BP,
18667,GO:1903944,1.00000000002188,0.89799527754164,0,1,negative regulation of hepatocyte apoptotic process,BP,
19630,GO:1990729,1.00000000002188,0.89799527754164,0,1,primary miRNA modification,BP,
19638,GO:1990744,1.00000000002188,0.89799527754164,0,1,primary miRNA methylation,BP,
12482,GO:0050294,1.00000000002189,0.753961689063888,0,3,steroid sulfotransferase activity,MF,
8537,GO:0033814,1.00000000002195,0.90928401134136,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12525,GO:0050632,1.00000000002195,0.90928401134136,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14824,GO:0070538,1.00000000002195,0.90928401134136,0,1,oleic acid binding,MF,
17664,GO:1901373,1.00000000002195,0.90928401134136,0,1,lipid hydroperoxide transport,BP,
18561,GO:1903724,1.00000000002195,0.891372908910184,0,1,positive regulation of centriole elongation,BP,
6741,GO:0030156,1.00000000002195,0.934661282224484,0,1,benzodiazepine receptor binding,MF,
16058,GO:0086070,1.00000000002196,0.704004753432575,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16717,GO:0097647,1.00000000002197,0.756551286784677,0,3,amylin receptor signaling pathway,BP,
768,GO:0002017,1.00000000002198,0.899115107167677,0,1,regulation of blood volume by renal aldosterone,BP,
2130,GO:0004924,1.00000000002201,0.705675957304089,0,3,oncostatin-M receptor activity,MF,
9734,GO:0038165,1.00000000002201,0.705675957304089,0,3,oncostatin-M-mediated signaling pathway,BP,
373,GO:0000994,1.00000000002203,0.900809207873996,0,1,RNA polymerase III core binding,MF,
18646,GO:1903903,1.00000000002203,0.708982138116106,0,3,regulation of establishment of T cell polarity,BP,
1160,GO:0002765,1.00000000002203,0.724373895727478,0,3,immune response-inhibiting signal transduction,BP,
7375,GO:0031417,1.00000000002204,0.705485013184065,0,3,NatC complex,CC,
3000,GO:0006546,1.00000000002206,0.723867135882731,0,3,glycine catabolic process,BP,
6155,GO:0019464,1.00000000002206,0.723867135882731,0,3,glycine decarboxylation via glycine cleavage system,BP,
9820,GO:0042000,1.00000000002206,0.894270962266461,0,1,translocation of peptides or proteins into host,BP,
10731,GO:0044053,1.00000000002206,0.894270962266461,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13217,GO:0051808,1.00000000002206,0.894270962266461,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
16554,GO:0097274,1.00000000002222,0.79166254494529,0,2,urea homeostasis,BP,
108,GO:0000224,1.00000000002225,0.89378937362319,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
583,GO:0001733,1.00000000002225,0.89378937362319,0,1,galactosylceramide sulfotransferase activity,MF,
12564,GO:0050694,1.00000000002225,0.89378937362319,0,1,galactose 3-O-sulfotransferase activity,MF,
12565,GO:0050698,1.00000000002225,0.89378937362319,0,1,proteoglycan sulfotransferase activity,MF,
3979,GO:0008798,1.00000000002227,0.888394425908853,0,1,beta-aspartyl-peptidase activity,MF,
15019,GO:0070931,1.00000000002227,0.888394425908853,0,1,Golgi-associated vesicle lumen,CC,
11254,GO:0045416,1.00000000002228,0.715862280007115,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
13570,GO:0060011,1.0000000000223,0.737219289558715,0,3,Sertoli cell proliferation,BP,
816,GO:0002086,1.0000000000223,0.890718493671561,0,1,diaphragm contraction,BP,
1895,GO:0004574,1.0000000000223,0.890718493671561,0,1,oligo-1,6-glucosidase activity,MF,
2650,GO:0005985,1.0000000000223,0.890718493671561,0,1,sucrose metabolic process,BP,
10376,GO:0043181,1.0000000000223,0.890718493671561,0,1,vacuolar sequestering,BP,
3754,GO:0008295,1.0000000000223,0.658473748948184,0,4,spermidine biosynthetic process,BP,
19413,GO:1905867,1.00000000002231,0.729282641333759,0,3,epididymis development,BP,
6418,GO:0021678,1.00000000002234,0.781284009515385,0,3,third ventricle development,BP,
8091,GO:0032767,1.00000000002237,0.748327710477165,0,3,copper-dependent protein binding,MF,
1055,GO:0002580,1.00000000002237,0.750799129810465,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
4171,GO:0009236,1.00000000002237,0.705530606223637,0,3,cobalamin biosynthetic process,BP,
5554,GO:0016557,1.00000000002238,0.737485653597673,0,3,peroxisome membrane biogenesis,BP,
3859,GO:0008475,1.0000000000224,0.708598252338522,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11927,GO:0046946,1.0000000000224,0.708598252338522,0,3,hydroxylysine metabolic process,BP,
11928,GO:0046947,1.0000000000224,0.708598252338522,0,3,hydroxylysine biosynthetic process,BP,
17888,GO:1902093,1.00000000002241,0.762547978906198,0,3,positive regulation of flagellated sperm motility,BP,
1862,GO:0004522,1.00000000002243,0.90540378202452,0,1,ribonuclease A activity,MF,
3975,GO:0008785,1.00000000002243,0.90540378202452,0,1,alkyl hydroperoxide reductase activity,MF,
7002,GO:0030678,1.00000000002246,0.738456915674729,0,3,mitochondrial ribonuclease P complex,CC,
16751,GO:0097745,1.00000000002246,0.738456915674729,0,3,mitochondrial tRNA 5'-end processing,BP,
10871,GO:0044378,1.00000000002248,0.806637239333877,0,2,non-sequence-specific DNA binding, bending,MF,
2795,GO:0006238,1.00000000002249,0.914760657231487,0,1,CMP salvage,BP,
4163,GO:0009224,1.00000000002249,0.914760657231487,0,1,CMP biosynthetic process,BP,
11535,GO:0046035,1.00000000002249,0.914760657231487,0,1,CMP metabolic process,BP,
305,GO:0000814,1.00000000002252,0.748907756074564,0,3,ESCRT II complex,CC,
4019,GO:0009032,1.00000000002268,0.903156662522825,0,1,thymidine phosphorylase activity,MF,
5368,GO:0016154,1.00000000002268,0.903156662522825,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
12491,GO:0050353,1.00000000002271,0.892898161448162,0,1,trimethyllysine dioxygenase activity,MF,
55,GO:0000117,1.00000000002274,0.88839522455193,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
13025,GO:0051431,1.00000000002277,0.907568083161656,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
11920,GO:0046933,1.00000000002277,0.770325472825734,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
20166,GO:2000823,1.00000000002286,0.695849031783793,0,4,regulation of androgen receptor activity,BP,
20167,GO:2000825,1.00000000002286,0.695849031783793,0,4,positive regulation of androgen receptor activity,BP,
13612,GO:0060059,1.00000000002287,0.622865337674332,0,4,embryonic retina morphogenesis in camera-type eye,BP,
7562,GO:0031893,1.00000000002289,0.895540802525635,0,1,vasopressin receptor binding,MF,
7563,GO:0031896,1.00000000002289,0.895540802525635,0,1,V2 vasopressin receptor binding,MF,
16451,GO:0097070,1.0000000000229,0.888394374804468,0,1,ductus arteriosus closure,BP,
16552,GO:0097272,1.0000000000229,0.888394374804468,0,1,ammonia homeostasis,BP,
16553,GO:0097273,1.0000000000229,0.888394374804468,0,1,creatinine homeostasis,BP,
16555,GO:0097275,1.0000000000229,0.888394374804468,0,1,cellular ammonia homeostasis,BP,
16556,GO:0097276,1.0000000000229,0.888394374804468,0,1,cellular creatinine homeostasis,BP,
16557,GO:0097277,1.0000000000229,0.888394374804468,0,1,cellular urea homeostasis,BP,
9701,GO:0038086,1.00000000002291,0.890962543582328,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9703,GO:0038091,1.00000000002291,0.890962543582328,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
18498,GO:1903570,1.00000000002291,0.890962543582328,0,1,regulation of protein kinase D signaling,BP,
18499,GO:1903572,1.00000000002291,0.890962543582328,0,1,positive regulation of protein kinase D signaling,BP,
6031,GO:0019087,1.00000000002292,0.719885179102779,0,3,transformation of host cell by virus,BP,
5213,GO:0015810,1.00000000002297,0.793515838978555,0,2,aspartate transmembrane transport,BP,
10552,GO:0043490,1.00000000002297,0.793515838978555,0,2,malate-aspartate shuttle,BP,
1069,GO:0002625,1.00000000002298,0.898178849632439,0,1,regulation of T cell antigen processing and presentation,BP,
1070,GO:0002626,1.00000000002298,0.898178849632439,0,1,negative regulation of T cell antigen processing and presentation,BP,
4399,GO:0010106,1.00000000002298,0.898178849632439,0,1,cellular response to iron ion starvation,BP,
18802,GO:1904282,1.00000000002298,0.898178849632439,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18803,GO:1904283,1.00000000002298,0.898178849632439,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20275,GO:2001186,1.00000000002298,0.898178849632439,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
4987,GO:0015111,1.00000000002305,0.703830301089824,0,3,iodide transmembrane transporter activity,MF,
9231,GO:0035611,1.00000000002306,0.89293681667558,0,1,protein branching point deglutamylation,BP,
4656,GO:0010797,1.00000000002306,0.915846193321553,0,1,regulation of multivesicular body size involved in endosome transport,BP,
13829,GO:0060398,1.00000000002306,0.701432922675102,0,3,regulation of growth hormone receptor signaling pathway,BP,
1759,GO:0004359,1.0000000000231,0.710269278455079,0,3,glutaminase activity,MF,
15971,GO:0075341,1.00000000002312,0.894904468246776,0,1,host cell PML body,CC,
9501,GO:0036132,1.00000000002313,0.726133955948129,0,3,13-prostaglandin reductase activity,MF,
12027,GO:0047522,1.00000000002313,0.726133955948129,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
9554,GO:0036301,1.00000000002313,0.71198589086185,0,3,macrophage colony-stimulating factor production,BP,
17622,GO:1901256,1.00000000002313,0.71198589086185,0,3,regulation of macrophage colony-stimulating factor production,BP,
11297,GO:0045590,1.00000000002321,0.890850582195934,0,1,negative regulation of regulatory T cell differentiation,BP,
13795,GO:0060353,1.00000000002326,0.729161752446245,0,3,regulation of cell adhesion molecule production,BP,
13796,GO:0060355,1.00000000002326,0.729161752446245,0,3,positive regulation of cell adhesion molecule production,BP,
828,GO:0002101,1.00000000002328,0.722662934185001,0,3,tRNA wobble cytosine modification,BP,
12648,GO:0050816,1.00000000002329,0.730741650375254,0,3,phosphothreonine residue binding,MF,
19439,GO:1905940,1.00000000002333,0.713416091366505,0,3,negative regulation of gonad development,BP,
17479,GO:1900245,1.00000000002334,0.705178228125645,0,3,positive regulation of MDA-5 signaling pathway,BP,
13299,GO:0051967,1.00000000002337,0.730302529217288,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
9237,GO:0035617,1.00000000002338,0.711058304006008,0,3,stress granule disassembly,BP,
1213,GO:0002876,1.00000000002338,0.903047403100076,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1240,GO:0002925,1.00000000002338,0.903047403100076,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
14186,GO:0061048,1.00000000002338,0.903047403100076,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15868,GO:0072564,1.00000000002338,0.903047403100076,0,1,blood microparticle formation,BP,
19078,GO:1904895,1.00000000002338,0.903047403100076,0,1,ESCRT complex assembly,BP,
19080,GO:1904902,1.00000000002338,0.903047403100076,0,1,ESCRT III complex assembly,BP,
19125,GO:1904999,1.00000000002338,0.903047403100076,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19893,GO:2000332,1.00000000002338,0.903047403100076,0,1,regulation of blood microparticle formation,BP,
19894,GO:2000334,1.00000000002338,0.903047403100076,0,1,positive regulation of blood microparticle formation,BP,
2476,GO:0005691,1.00000000002341,0.889030983798525,0,1,U6atac snRNP,CC,
6975,GO:0030624,1.00000000002341,0.889030983798525,0,1,U6atac snRNA binding,MF,
18506,GO:1903584,1.00000000002341,0.889030983798525,0,1,regulation of histone deubiquitination,BP,
18507,GO:1903586,1.00000000002341,0.889030983798525,0,1,positive regulation of histone deubiquitination,BP,
4743,GO:0010908,1.00000000002342,0.707945697881889,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4744,GO:0010909,1.00000000002342,0.707945697881889,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18122,GO:1902730,1.00000000002342,0.707945697881889,0,3,positive regulation of proteoglycan biosynthetic process,BP,
5275,GO:0015920,1.00000000002346,0.89335279738912,0,1,lipopolysaccharide transport,BP,
7928,GO:0032497,1.00000000002346,0.89335279738912,0,1,detection of lipopolysaccharide,BP,
14806,GO:0070506,1.00000000002346,0.89335279738912,0,1,high-density lipoprotein particle receptor activity,MF,
6362,GO:0021540,1.00000000002346,0.668541955999317,0,4,corpus callosum morphogenesis,BP,
1251,GO:0002949,1.00000000002347,0.729193495756967,0,3,tRNA threonylcarbamoyladenosine modification,BP,
7577,GO:0031933,1.00000000002347,0.718911110378637,0,3,telomeric heterochromatin,CC,
9035,GO:0035241,1.00000000002348,0.713382173256428,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
18275,GO:1903070,1.00000000002351,0.724456394536561,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
11331,GO:0045636,1.00000000002355,0.702469246852103,0,3,positive regulation of melanocyte differentiation,BP,
7924,GO:0032493,1.00000000002358,0.713196544453777,0,3,response to bacterial lipoprotein,BP,
14723,GO:0070339,1.00000000002358,0.713196544453777,0,3,response to bacterial lipopeptide,BP,
15146,GO:0071220,1.00000000002358,0.713196544453777,0,3,cellular response to bacterial lipoprotein,BP,
15147,GO:0071221,1.00000000002358,0.713196544453777,0,3,cellular response to bacterial lipopeptide,BP,
19329,GO:1905553,1.00000000002363,0.73197370210536,0,3,regulation of blood vessel branching,BP,
3025,GO:0006572,1.00000000002366,0.745729693686945,0,3,tyrosine catabolic process,BP,
11842,GO:0046725,1.00000000002369,0.890813054815629,0,1,negative regulation by virus of viral protein levels in host cell,BP,
15682,GO:0072183,1.00000000002369,0.890813054815629,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15752,GO:0072308,1.00000000002369,0.890813054815629,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16163,GO:0090156,1.00000000002374,0.732533162057503,0,3,cellular sphingolipid homeostasis,BP,
9970,GO:0042335,1.00000000002377,0.706713819680959,0,3,cuticle development,BP,
10814,GO:0044284,1.00000000002378,0.927766027936105,0,1,mitochondrial crista junction,CC,
4244,GO:0009441,1.00000000002378,0.822984422847126,0,2,glycolate metabolic process,BP,
19856,GO:2000282,1.00000000002378,0.822984422847126,0,2,regulation of cellular amino acid biosynthetic process,BP,
11005,GO:0044795,1.00000000002379,0.917876288327041,0,1,trans-Golgi network to recycling endosome transport,BP,
1644,GO:0004084,1.00000000002379,0.803163295155229,0,2,branched-chain-amino-acid transaminase activity,MF,
4046,GO:0009082,1.00000000002379,0.803163295155229,0,2,branched-chain amino acid biosynthetic process,BP,
4054,GO:0009098,1.00000000002379,0.803163295155229,0,2,leucine biosynthetic process,BP,
4055,GO:0009099,1.00000000002379,0.803163295155229,0,2,valine biosynthetic process,BP,
13404,GO:0052654,1.00000000002379,0.803163295155229,0,2,L-leucine transaminase activity,MF,
13405,GO:0052655,1.00000000002379,0.803163295155229,0,2,L-valine transaminase activity,MF,
13406,GO:0052656,1.00000000002379,0.803163295155229,0,2,L-isoleucine transaminase activity,MF,
5097,GO:0015369,1.0000000000238,0.888402192729209,0,1,calcium:proton antiporter activity,MF,
12851,GO:0051139,1.0000000000238,0.888402192729209,0,1,metal ion:proton antiporter activity,MF,
13490,GO:0055005,1.0000000000238,0.888402192729209,0,1,ventricular cardiac myofibril assembly,BP,
8342,GO:0033181,1.00000000002382,0.902895758156853,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
7104,GO:0030895,1.00000000002383,0.893190131338928,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
9245,GO:0035630,1.00000000002386,0.704225467378319,0,3,bone mineralization involved in bone maturation,BP,
1984,GO:0004699,1.00000000002389,0.706893032647411,0,3,calcium-independent protein kinase C activity,MF,
19255,GO:1905349,1.00000000002397,0.91634623645021,0,1,ciliary transition zone assembly,BP,
15492,GO:0071818,1.00000000002397,0.716225730405686,0,3,BAT3 complex,CC,
15794,GO:0072379,1.00000000002397,0.716225730405686,0,3,ER membrane insertion complex,CC,
19228,GO:1905292,1.00000000002398,0.711898972958193,0,3,regulation of neural crest cell differentiation,BP,
19229,GO:1905294,1.00000000002398,0.711898972958193,0,3,positive regulation of neural crest cell differentiation,BP,
19235,GO:1905310,1.00000000002398,0.711898972958193,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19236,GO:1905312,1.00000000002398,0.711898972958193,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
16948,GO:0098905,1.00000000002403,0.830231899181896,0,2,regulation of bundle of His cell action potential,BP,
2081,GO:0004832,1.00000000002403,0.703636208782295,0,3,valine-tRNA ligase activity,MF,
2927,GO:0006438,1.00000000002403,0.703636208782295,0,3,valyl-tRNA aminoacylation,BP,
11447,GO:0045852,1.00000000002405,0.714679560810008,0,3,pH elevation,BP,
13038,GO:0051454,1.00000000002405,0.714679560810008,0,3,intracellular pH elevation,BP,
18144,GO:1902804,1.00000000002406,0.713726916492799,0,3,negative regulation of synaptic vesicle transport,BP,
19867,GO:2000301,1.00000000002406,0.713726916492799,0,3,negative regulation of synaptic vesicle exocytosis,BP,
1894,GO:0004573,1.00000000002412,0.893230258111342,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
9547,GO:0036290,1.00000000002413,0.889658139436373,0,1,protein trans-autophosphorylation,BP,
17967,GO:1902283,1.00000000002413,0.889658139436373,0,1,negative regulation of primary amine oxidase activity,BP,
19530,GO:1990332,1.00000000002413,0.889658139436373,0,1,Ire1 complex,CC,
19597,GO:1990579,1.00000000002413,0.889658139436373,0,1,peptidyl-serine trans-autophosphorylation,BP,
19611,GO:1990630,1.00000000002413,0.889658139436373,0,1,IRE1-RACK1-PP2A complex,CC,
4409,GO:0010159,1.00000000002414,0.713760818535548,0,3,specification of animal organ position,BP,
254,GO:0000718,1.00000000002419,0.901778208534751,0,1,nucleotide-excision repair, DNA damage removal,BP,
1678,GO:0004139,1.00000000002419,0.901778208534751,0,1,deoxyribose-phosphate aldolase activity,MF,
10861,GO:0044349,1.00000000002419,0.901778208534751,0,1,DNA excision,BP,
11673,GO:0046403,1.00000000002419,0.901778208534751,0,1,polynucleotide 3'-phosphatase activity,MF,
16761,GO:0098503,1.00000000002419,0.901778208534751,0,1,DNA 3' dephosphorylation,BP,
16762,GO:0098504,1.00000000002419,0.901778208534751,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16764,GO:0098506,1.00000000002419,0.901778208534751,0,1,polynucleotide 3' dephosphorylation,BP,
10246,GO:0042942,1.0000000000242,0.893646014814642,0,1,D-serine transport,BP,
7456,GO:0031587,1.0000000000242,0.702446464411883,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
15958,GO:0072741,1.00000000002424,0.706977766855163,0,3,protein localization to cell division site,BP,
18290,GO:1903119,1.00000000002424,0.706977766855163,0,3,protein localization to actin cytoskeleton,BP,
18887,GO:1904498,1.00000000002424,0.706977766855163,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19503,GO:1990179,1.00000000002424,0.706977766855163,0,3,protein localization to actomyosin contractile ring,BP,
17828,GO:1901897,1.00000000002425,0.70354615024793,0,3,regulation of relaxation of cardiac muscle,BP,
2188,GO:0005042,1.00000000002428,0.88850386972517,0,1,netrin receptor activity,MF,
19390,GO:1905773,1.00000000002431,0.70236765371929,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
3226,GO:0006880,1.00000000002432,0.763219381448073,0,3,intracellular sequestering of iron ion,BP,
16692,GO:0097577,1.00000000002432,0.763219381448073,0,3,sequestering of iron ion,BP,
3729,GO:0008265,1.00000000002437,0.893215993442323,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17195,GO:0102867,1.00000000002437,0.893215993442323,0,1,molybdenum cofactor sulfurtransferase activity,MF,
16724,GO:0097680,1.00000000002439,0.708170222892677,0,3,double-strand break repair via classical nonhomologous end joining,BP,
3640,GO:0008112,1.00000000002439,0.905132125219983,0,1,nicotinamide N-methyltransferase activity,MF,
7028,GO:0030760,1.00000000002439,0.905132125219983,0,1,pyridine N-methyltransferase activity,MF,
5145,GO:0015670,1.00000000002439,0.903003918849793,0,1,carbon dioxide transport,BP,
8148,GO:0032849,1.00000000002439,0.903003918849793,0,1,positive regulation of cellular pH reduction,BP,
10993,GO:0044778,1.00000000002441,0.800868979729752,0,2,meiotic DNA integrity checkpoint,BP,
19460,GO:1990034,1.00000000002444,0.713578658556422,0,3,calcium ion export across plasma membrane,BP,
11167,GO:0045208,1.00000000002455,0.890824585821089,0,1,MAPK phosphatase export from nucleus,BP,
11168,GO:0045209,1.00000000002455,0.890824585821089,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
863,GO:0002191,1.00000000002459,0.716948340158257,0,3,cap-dependent translational initiation,BP,
13248,GO:0051892,1.00000000002463,0.889221395346213,0,1,negative regulation of cardioblast differentiation,BP,
20092,GO:2000690,1.00000000002463,0.889221395346213,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20093,GO:2000691,1.00000000002463,0.889221395346213,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
15331,GO:0071505,1.00000000002468,0.796512897084883,0,2,response to mycophenolic acid,BP,
15332,GO:0071506,1.00000000002468,0.796512897084883,0,2,cellular response to mycophenolic acid,BP,
6835,GO:0030292,1.00000000002471,0.715498516256725,0,3,protein tyrosine kinase inhibitor activity,MF,
9128,GO:0035425,1.00000000002472,0.715019401637746,0,3,autocrine signaling,BP,
9411,GO:0035948,1.00000000002473,0.707236215817985,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
8290,GO:0033087,1.00000000002477,0.722032037978801,0,3,negative regulation of immature T cell proliferation,BP,
7883,GO:0032440,1.00000000002479,0.914559910529131,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19359,GO:1905636,1.00000000002479,0.914559910529131,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
103,GO:0000214,1.00000000002483,0.649339790111946,0,4,tRNA-intron endonuclease complex,CC,
1642,GO:0004082,1.00000000002484,0.73147127465951,0,3,bisphosphoglycerate mutase activity,MF,
1928,GO:0004619,1.00000000002484,0.73147127465951,0,3,phosphoglycerate mutase activity,MF,
11743,GO:0046538,1.00000000002484,0.73147127465951,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
14512,GO:0061945,1.00000000002485,0.718412101840763,0,3,regulation of protein K48-linked ubiquitination,BP,
17983,GO:1902311,1.00000000002487,0.900918834405409,0,1,regulation of copper ion transmembrane transport,BP,
8266,GO:0033037,1.0000000000249,0.888394392526539,0,1,polysaccharide localization,BP,
19883,GO:2000321,1.0000000000249,0.827788121470932,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19891,GO:2000330,1.0000000000249,0.827788121470932,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
1906,GO:0004588,1.00000000002492,0.893426365004692,0,1,orotate phosphoribosyltransferase activity,MF,
1907,GO:0004590,1.00000000002492,0.893426365004692,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
8043,GO:0032685,1.00000000002495,0.891720967300175,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
6158,GO:0019474,1.00000000002499,0.710244767174733,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6159,GO:0019477,1.00000000002499,0.710244767174733,0,3,L-lysine catabolic process,BP,
8434,GO:0033512,1.00000000002499,0.710244767174733,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11683,GO:0046440,1.00000000002499,0.710244767174733,0,3,L-lysine metabolic process,BP,
16767,GO:0098518,1.00000000002507,0.724293919555807,0,3,polynucleotide phosphatase activity,MF,
1579,GO:0003986,1.00000000002508,0.764215786063699,0,3,acetyl-CoA hydrolase activity,MF,
7474,GO:0031627,1.00000000002508,0.709767198024183,0,3,telomeric loop formation,BP,
17384,GO:1900063,1.00000000002508,0.708534541771321,0,3,regulation of peroxisome organization,BP,
7096,GO:0030885,1.00000000002509,0.745806960050582,0,3,regulation of myeloid dendritic cell activation,BP,
5546,GO:0016532,1.00000000002509,0.759108645059521,0,3,superoxide dismutase copper chaperone activity,MF,
19525,GO:1990275,1.00000000002519,0.892824005312021,0,1,preribosome binding,MF,
3374,GO:0007147,1.00000000002519,0.890647582588504,0,1,female meiosis II,BP,
17450,GO:1900186,1.00000000002524,0.717886978790966,0,3,negative regulation of clathrin-dependent endocytosis,BP,
4833,GO:0014036,1.00000000002526,0.889878852359302,0,1,neural crest cell fate specification,BP,
9240,GO:0035622,1.00000000002526,0.889878852359302,0,1,intrahepatic bile duct development,BP,
12434,GO:0048866,1.00000000002526,0.889878852359302,0,1,stem cell fate specification,BP,
13575,GO:0060018,1.00000000002526,0.889878852359302,0,1,astrocyte fate commitment,BP,
13706,GO:0060221,1.00000000002526,0.889878852359302,0,1,retinal rod cell differentiation,BP,
13903,GO:0060516,1.00000000002526,0.889878852359302,0,1,primary prostatic bud elongation,BP,
13904,GO:0060517,1.00000000002526,0.889878852359302,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14063,GO:0060784,1.00000000002526,0.889878852359302,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
1230,GO:0002904,1.00000000002532,0.74797249162778,0,3,positive regulation of B cell apoptotic process,BP,
10388,GO:0043199,1.00000000002535,0.720219377652635,0,3,sulfate binding,MF,
12981,GO:0051344,1.00000000002543,0.725874015098747,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14368,GO:0061551,1.00000000002549,0.705547207044961,0,3,trigeminal ganglion development,BP,
14105,GO:0060907,1.0000000000255,0.722735091864233,0,3,positive regulation of macrophage cytokine production,BP,
15357,GO:0071561,1.0000000000255,0.888486832333848,0,1,nucleus-vacuole junction,CC,
12006,GO:0047341,1.00000000002559,0.891244535193169,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
558,GO:0001681,1.00000000002569,0.892938143953017,0,1,sialate O-acetylesterase activity,MF,
3649,GO:0008126,1.00000000002569,0.892938143953017,0,1,acetylesterase activity,MF,
5842,GO:0017126,1.00000000002571,0.888416445755122,0,1,nucleologenesis,BP,
9636,GO:0036494,1.00000000002572,0.888396397933285,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
1143,GO:0002732,1.00000000002575,0.888895623329844,0,1,positive regulation of dendritic cell cytokine production,BP,
7929,GO:0032498,1.00000000002575,0.888895623329844,0,1,detection of muramyl dipeptide,BP,
7930,GO:0032499,1.00000000002575,0.888895623329844,0,1,detection of peptidoglycan,BP,
7931,GO:0032500,1.00000000002575,0.888895623329844,0,1,muramyl dipeptide binding,MF,
19913,GO:2000361,1.00000000002575,0.888895623329844,0,1,regulation of prostaglandin-E synthase activity,BP,
19914,GO:2000363,1.00000000002575,0.888895623329844,0,1,positive regulation of prostaglandin-E synthase activity,BP,
2082,GO:0004833,1.00000000002577,0.905230491738425,0,1,tryptophan 2,3-dioxygenase activity,MF,
8531,GO:0033754,1.00000000002577,0.905230491738425,0,1,indoleamine 2,3-dioxygenase activity,MF,
8690,GO:0034275,1.00000000002577,0.905230491738425,0,1,kynurenic acid metabolic process,BP,
8691,GO:0034276,1.00000000002577,0.905230491738425,0,1,kynurenic acid biosynthetic process,BP,
9543,GO:0036269,1.00000000002577,0.905230491738425,0,1,swimming behavior,BP,
2618,GO:0005927,1.00000000002579,0.905830686770795,0,1,muscle tendon junction,CC,
8666,GO:0034213,1.00000000002579,0.905830686770795,0,1,quinolinate catabolic process,BP,
11885,GO:0046874,1.00000000002579,0.905830686770795,0,1,quinolinate metabolic process,BP,
2270,GO:0005199,1.0000000000258,0.891411830101969,0,1,structural constituent of cell wall,MF,
15423,GO:0071665,1.0000000000258,0.891411830101969,0,1,gamma-catenin-TCF7L2 complex,CC,
1735,GO:0004329,1.00000000002581,0.793679785197912,0,2,formate-tetrahydrofolate ligase activity,MF,
4181,GO:0009257,1.00000000002581,0.793679785197912,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
16743,GO:0097726,1.00000000002582,0.919157506377931,0,1,LEM domain binding,MF,
18865,GO:1904430,1.00000000002589,0.707145179284417,0,3,negative regulation of t-circle formation,BP,
14005,GO:0060697,1.00000000002592,0.893075431978606,0,1,positive regulation of phospholipid catabolic process,BP,
17439,GO:1900161,1.00000000002592,0.893075431978606,0,1,regulation of phospholipid scramblase activity,BP,
17440,GO:1900163,1.00000000002592,0.893075431978606,0,1,positive regulation of phospholipid scramblase activity,BP,
20122,GO:2000752,1.00000000002592,0.893075431978606,0,1,regulation of glucosylceramide catabolic process,BP,
20123,GO:2000753,1.00000000002592,0.893075431978606,0,1,positive regulation of glucosylceramide catabolic process,BP,
20124,GO:2000754,1.00000000002592,0.893075431978606,0,1,regulation of sphingomyelin catabolic process,BP,
20125,GO:2000755,1.00000000002592,0.893075431978606,0,1,positive regulation of sphingomyelin catabolic process,BP,
8507,GO:0033678,1.00000000002593,0.893407072476994,0,1,5'-3' DNA/RNA helicase activity,MF,
8511,GO:0033682,1.00000000002593,0.893407072476994,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
18083,GO:1902612,1.00000000002597,0.893187549400893,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18084,GO:1902613,1.00000000002597,0.893187549400893,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19521,GO:1990262,1.00000000002597,0.893187549400893,0,1,anti-Mullerian hormone signaling pathway,BP,
9646,GO:0036506,1.00000000002598,0.711045840144507,0,3,maintenance of unfolded protein,BP,
18839,GO:1904378,1.00000000002598,0.711045840144507,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
15902,GO:0072616,1.00000000002599,0.88970251448183,0,1,interleukin-18 secretion,BP,
17420,GO:1900127,1.00000000002615,0.708145304183466,0,3,positive regulation of hyaluronan biosynthetic process,BP,
13886,GO:0060482,1.00000000002618,0.722280771037044,0,3,lobar bronchus development,BP,
4321,GO:0009810,1.00000000002629,0.895499106394295,0,1,stilbene metabolic process,BP,
8556,GO:0033885,1.00000000002629,0.895499106394295,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11623,GO:0046272,1.00000000002629,0.895499106394295,0,1,stilbene catabolic process,BP,
5499,GO:0016434,1.00000000002637,0.708954943421047,0,3,rRNA (cytosine) methyltransferase activity,MF,
11664,GO:0046380,1.00000000002641,0.890201726797356,0,1,N-acetylneuraminate biosynthetic process,BP,
12462,GO:0050124,1.00000000002641,0.890201726797356,0,1,N-acylneuraminate-9-phosphatase activity,MF,
15008,GO:0070903,1.00000000002643,0.897879943302292,0,1,mitochondrial tRNA thio-modification,BP,
10216,GO:0042822,1.00000000002647,0.710480263834327,0,3,pyridoxal phosphate metabolic process,BP,
14803,GO:0070494,1.00000000002648,0.716463378984955,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14804,GO:0070495,1.00000000002648,0.716463378984955,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
5988,GO:0018894,1.00000000002648,0.712165563852935,0,3,dibenzo-p-dioxin metabolic process,BP,
10609,GO:0043569,1.00000000002658,0.706651646590658,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
6241,GO:0019797,1.0000000000266,0.711623742119759,0,3,procollagen-proline 3-dioxygenase activity,MF,
8445,GO:0033557,1.0000000000266,0.711623742119759,0,3,Slx1-Slx4 complex,CC,
13476,GO:0052905,1.0000000000266,0.711623742119759,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
16137,GO:0090107,1.00000000002661,0.725916685900411,0,3,regulation of high-density lipoprotein particle assembly,BP,
17988,GO:1902338,1.00000000002669,0.705605199709323,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18996,GO:1904746,1.00000000002669,0.705605199709323,0,3,negative regulation of apoptotic process involved in development,BP,
6514,GO:0021886,1.00000000002671,0.734636590341954,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6515,GO:0021888,1.00000000002671,0.734636590341954,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
19613,GO:1990637,1.00000000002673,0.715210953821781,0,3,response to prolactin,BP,
13995,GO:0060685,1.0000000000268,0.711858022868893,0,3,regulation of prostatic bud formation,BP,
13996,GO:0060686,1.0000000000268,0.711858022868893,0,3,negative regulation of prostatic bud formation,BP,
7153,GO:0030997,1.00000000002681,0.709499297032704,0,3,regulation of centriole-centriole cohesion,BP,
2632,GO:0005958,1.00000000002686,0.71380037789054,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
9627,GO:0036483,1.0000000000269,0.888820089341003,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18403,GO:1903381,1.0000000000269,0.888820089341003,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18404,GO:1903382,1.0000000000269,0.888820089341003,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
3435,GO:0007227,1.00000000002694,0.703909365853984,0,3,signal transduction downstream of smoothened,BP,
8687,GO:0034271,1.00000000002694,0.710264945323749,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8688,GO:0034272,1.00000000002694,0.710264945323749,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
5771,GO:0016942,1.00000000002702,0.734339547609671,0,3,insulin-like growth factor binding protein complex,CC,
9606,GO:0036454,1.00000000002702,0.734339547609671,0,3,growth factor complex,CC,
3853,GO:0008465,1.00000000002705,0.91499598189674,0,1,glycerate dehydrogenase activity,MF,
11674,GO:0046404,1.00000000002709,0.722112847019572,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13179,GO:0051733,1.00000000002709,0.722112847019572,0,3,polydeoxyribonucleotide kinase activity,MF,
13180,GO:0051734,1.00000000002709,0.722112847019572,0,3,ATP-dependent polynucleotide kinase activity,MF,
11538,GO:0046038,1.00000000002721,0.909400137042376,0,1,GMP catabolic process,BP,
13407,GO:0052657,1.00000000002721,0.909400137042376,0,1,guanine phosphoribosyltransferase activity,MF,
125,GO:0000255,1.00000000002722,0.702302212312465,0,3,allantoin metabolic process,BP,
13166,GO:0051715,1.00000000002732,0.781959586779461,0,3,cytolysis in other organism,BP,
15422,GO:0071664,1.00000000002732,0.627935757324518,0,4,catenin-TCF7L2 complex,CC,
14497,GO:0061888,1.00000000002739,0.721736598512225,0,3,regulation of astrocyte activation,BP,
13466,GO:0052858,1.00000000002739,0.890801538226993,0,1,peptidyl-lysine acetyltransferase activity,MF,
1564,GO:0003962,1.0000000000274,0.901436166182876,0,1,cystathionine gamma-synthase activity,MF,
1667,GO:0004123,1.0000000000274,0.901436166182876,0,1,cystathionine gamma-lyase activity,MF,
5947,GO:0018272,1.0000000000274,0.901436166182876,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9378,GO:0035887,1.0000000000274,0.901436166182876,0,1,aortic smooth muscle cell differentiation,BP,
10928,GO:0044524,1.0000000000274,0.901436166182876,0,1,protein sulfhydration,BP,
10935,GO:0044540,1.0000000000274,0.901436166182876,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12070,GO:0047982,1.0000000000274,0.901436166182876,0,1,homocysteine desulfhydrase activity,MF,
15172,GO:0071266,1.0000000000274,0.901436166182876,0,1,'de novo' L-methionine biosynthetic process,BP,
15999,GO:0080146,1.0000000000274,0.901436166182876,0,1,L-cysteine desulfhydrase activity,MF,
19039,GO:1904829,1.0000000000274,0.901436166182876,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19040,GO:1904831,1.0000000000274,0.901436166182876,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
12586,GO:0050719,1.0000000000274,0.930244471522675,0,1,interleukin-1 alpha biosynthetic process,BP,
12588,GO:0050721,1.0000000000274,0.930244471522675,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
12591,GO:0050726,1.0000000000274,0.930244471522675,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
7771,GO:0032286,1.00000000002741,0.70821607575661,0,3,central nervous system myelin maintenance,BP,
11969,GO:0047066,1.0000000000276,0.926097056266098,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16734,GO:0097707,1.0000000000276,0.926097056266098,0,1,ferroptosis,BP,
17262,GO:0110075,1.0000000000276,0.926097056266098,0,1,regulation of ferroptosis,BP,
17263,GO:0110076,1.0000000000276,0.926097056266098,0,1,negative regulation of ferroptosis,BP,
2303,GO:0005280,1.00000000002761,0.707160007681634,0,3,amino acid:proton symporter activity,MF,
6341,GO:0021512,1.00000000002763,0.889218978385005,0,1,spinal cord anterior/posterior patterning,BP,
19334,GO:1905572,1.00000000002777,0.892956685563057,0,1,ganglioside GM1 transport to membrane,BP,
19336,GO:1905574,1.00000000002777,0.892956685563057,0,1,ganglioside GM2 binding,MF,
19337,GO:1905575,1.00000000002777,0.892956685563057,0,1,ganglioside GM3 binding,MF,
19339,GO:1905577,1.00000000002777,0.892956685563057,0,1,ganglioside GP1c binding,MF,
4647,GO:0010767,1.0000000000279,0.705048855003073,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
5115,GO:0015432,1.00000000002798,0.890904234758206,0,1,bile acid-exporting ATPase activity,MF,
8389,GO:0033283,1.00000000002798,0.890904234758206,0,1,organic acid-transporting ATPase activity,MF,
8390,GO:0033284,1.00000000002798,0.890904234758206,0,1,carboxylic acid-transporting ATPase activity,MF,
8391,GO:0033285,1.00000000002798,0.890904234758206,0,1,monocarboxylic acid-transporting ATPase activity,MF,
7661,GO:0032076,1.00000000002799,0.89327328574383,0,1,negative regulation of deoxyribonuclease activity,BP,
9402,GO:0035931,1.00000000002799,0.89327328574383,0,1,mineralocorticoid secretion,BP,
9403,GO:0035932,1.00000000002799,0.89327328574383,0,1,aldosterone secretion,BP,
9563,GO:0036316,1.00000000002799,0.89327328574383,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
14011,GO:0060703,1.00000000002799,0.89327328574383,0,1,deoxyribonuclease inhibitor activity,MF,
14729,GO:0070346,1.00000000002799,0.89327328574383,0,1,positive regulation of fat cell proliferation,BP,
17639,GO:1901303,1.00000000002799,0.89327328574383,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18042,GO:1902511,1.00000000002799,0.89327328574383,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18522,GO:1903625,1.00000000002799,0.89327328574383,0,1,negative regulation of DNA catabolic process,BP,
20185,GO:2000855,1.00000000002799,0.89327328574383,0,1,regulation of mineralocorticoid secretion,BP,
20186,GO:2000857,1.00000000002799,0.89327328574383,0,1,positive regulation of mineralocorticoid secretion,BP,
20187,GO:2000858,1.00000000002799,0.89327328574383,0,1,regulation of aldosterone secretion,BP,
20188,GO:2000860,1.00000000002799,0.89327328574383,0,1,positive regulation of aldosterone secretion,BP,
5538,GO:0016519,1.00000000002801,0.897117974863497,0,1,gastric inhibitory peptide receptor activity,MF,
9747,GO:0038192,1.00000000002801,0.897117974863497,0,1,gastric inhibitory peptide signaling pathway,BP,
5636,GO:0016714,1.00000000002809,0.742380114243478,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
11960,GO:0047016,1.0000000000281,0.895661246878908,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
1192,GO:0002836,1.00000000002811,0.710224741396258,0,3,positive regulation of response to tumor cell,BP,
1195,GO:0002839,1.00000000002811,0.710224741396258,0,3,positive regulation of immune response to tumor cell,BP,
16162,GO:0090155,1.00000000002812,0.650812194661238,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17382,GO:1900060,1.00000000002812,0.650812194661238,0,4,negative regulation of ceramide biosynthetic process,BP,
2695,GO:0006059,1.00000000002822,0.7408217200929,0,3,hexitol metabolic process,BP,
15184,GO:0071286,1.00000000002834,0.701283094496483,0,3,cellular response to magnesium ion,BP,
17912,GO:1902167,1.00000000002839,0.941704776366535,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19028,GO:1904803,1.00000000002839,0.941704776366535,0,1,regulation of translation involved in cellular response to UV,BP,
2312,GO:0005308,1.00000000002841,0.890896968015686,0,1,creatine transmembrane transporter activity,MF,
2313,GO:0005309,1.00000000002841,0.890896968015686,0,1,creatine:sodium symporter activity,MF,
5256,GO:0015881,1.00000000002841,0.890896968015686,0,1,creatine transmembrane transport,BP,
12007,GO:0047349,1.00000000002843,0.888403364049638,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
49,GO:0000103,1.00000000002852,0.728166168625242,0,3,sulfate assimilation,BP,
3207,GO:0006848,1.00000000002857,0.710112893533689,0,3,pyruvate transport,BP,
12659,GO:0050833,1.00000000002857,0.710112893533689,0,3,pyruvate transmembrane transporter activity,MF,
17682,GO:1901475,1.00000000002857,0.710112893533689,0,3,pyruvate transmembrane transport,BP,
5981,GO:0018585,1.00000000002858,0.89586070823104,0,1,fluorene oxygenase activity,MF,
5991,GO:0018917,1.00000000002858,0.89586070823104,0,1,fluorene metabolic process,BP,
12148,GO:0048210,1.00000000002859,0.730538518579664,0,3,Golgi vesicle fusion to target membrane,BP,
5218,GO:0015817,1.00000000002869,0.893071556394636,0,1,histidine transport,BP,
7536,GO:0031753,1.00000000002869,0.893071556394636,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7537,GO:0031755,1.00000000002869,0.893071556394636,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
1421,GO:0003360,1.00000000002886,0.709708917609553,0,3,brainstem development,BP,
11908,GO:0046912,1.00000000002888,0.707074564984192,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
14877,GO:0070634,1.00000000002905,0.717756549538042,0,3,transepithelial ammonium transport,BP,
8623,GO:0034128,1.00000000002905,0.708193054994549,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
15952,GO:0072733,1.00000000002909,0.723660704217818,0,3,response to staurosporine,BP,
15953,GO:0072734,1.00000000002909,0.723660704217818,0,3,cellular response to staurosporine,BP,
11710,GO:0046483,1.00000000002941,0,381,4707,heterocycle metabolic process,BP,TNIP1;NT5E;XDH;CBS;ERCC1;MDFI;ZMYND8;NOS1;H1F0;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NAPRT;CRTC1;PCK2;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;SLC2A9;RAPGEF3;PRSS3;PRNP;IDH2;PC;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;H6PD;KIAA1549;ADCY7;XBP1;PGLS;EGFR;CSNK1E;TK2;RFX2;PRKACA;ADARB1;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;ALDH1L2;BAG3;APOE;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;PFKP;ENDOG;NSMCE4A;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;TSTA3;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;RPUSD3;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;PYCR2;INTS8;HMGA2;ALAS1;ARID5B;TOP1;MICAL2;CAP1;MYDGF;TSC22D4;TULP3;SRC;KDM4B;GLRX;POLD4;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;OAS1;PRIMPOL;MPI;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;ALDH4A1;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;PLTP;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;STUB1;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;HLCS;SARS2;RAD23A;AOX1;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;PNP;FGF2;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ZNF687;ENTPD6;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;ALDOC;GLO1;ARHGEF2;ZNF444;MLF1;NDUFS2;ZFP30;MED29;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;ADCY6;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;LDHA;PIK3R2;ANXA1;PODXL2;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
560,GO:0001692,1.00000000002942,0.927560764939835,0,1,histamine metabolic process,BP,
561,GO:0001695,1.00000000002942,0.927560764939835,0,1,histamine catabolic process,BP,
11744,GO:0046539,1.00000000002942,0.927560764939835,0,1,histamine N-methyltransferase activity,MF,
18560,GO:1903723,1.00000000002942,0.927560764939835,0,1,negative regulation of centriole elongation,BP,
19363,GO:1905651,1.00000000002955,0.705696499463578,0,3,regulation of artery morphogenesis,BP,
19364,GO:1905653,1.00000000002955,0.705696499463578,0,3,positive regulation of artery morphogenesis,BP,
9944,GO:0042284,1.00000000002955,0.899533294061676,0,1,sphingolipid delta-4 desaturase activity,MF,
17260,GO:0110057,1.00000000002962,0.888400965680464,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17261,GO:0110059,1.00000000002962,0.888400965680464,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
16449,GO:0097068,1.00000000002969,0.707202743267729,0,3,response to thyroxine,BP,
18846,GO:1904386,1.00000000002969,0.707202743267729,0,3,response to L-phenylalanine derivative,BP,
3089,GO:0006663,1.00000000002983,0.717935344020994,0,3,platelet activating factor biosynthetic process,BP,
1829,GO:0004479,1.00000000002987,0.893182387445241,0,1,methionyl-tRNA formyltransferase activity,MF,
6326,GO:0019988,1.00000000002987,0.893182387445241,0,1,charged-tRNA amino acid modification,BP,
15562,GO:0071951,1.00000000002987,0.893182387445241,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17836,GO:1901917,1.00000000002987,0.893182387445241,0,1,regulation of exoribonuclease activity,BP,
17837,GO:1901919,1.00000000002987,0.893182387445241,0,1,positive regulation of exoribonuclease activity,BP,
19395,GO:1905779,1.00000000002987,0.893182387445241,0,1,positive regulation of exonuclease activity,BP,
691,GO:0001907,1.00000000002987,0.746041385422411,0,3,killing by symbiont of host cells,BP,
10720,GO:0044004,1.00000000002987,0.746041385422411,0,3,disruption by symbiont of host cell,BP,
10933,GO:0044533,1.00000000002987,0.746041385422411,0,3,positive regulation of apoptotic process in other organism,BP,
13322,GO:0052042,1.00000000002987,0.746041385422411,0,3,positive regulation by symbiont of host programmed cell death,BP,
13358,GO:0052330,1.00000000002987,0.746041385422411,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13378,GO:0052501,1.00000000002987,0.746041385422411,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
19486,GO:1990131,1.00000000002993,0.735641967136964,0,3,Gtr1-Gtr2 GTPase complex,CC,
18945,GO:1904631,1.00000000003009,0.895263510570296,0,1,response to glucoside,BP,
5113,GO:0015421,1.00000000003027,0.890917327406648,0,1,oligopeptide-transporting ATPase activity,MF,
909,GO:0002291,1.00000000003034,0.725859651334687,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20272,GO:2001183,1.00000000003044,0.899025015819789,0,1,negative regulation of interleukin-12 secretion,BP,
14740,GO:0070376,1.00000000003046,0.892795411091208,0,1,regulation of ERK5 cascade,BP,
14741,GO:0070377,1.00000000003046,0.892795411091208,0,1,negative regulation of ERK5 cascade,BP,
18863,GO:1904428,1.00000000003049,0.722711729615551,0,3,negative regulation of tubulin deacetylation,BP,
10496,GO:0043382,1.00000000003049,0.738200244098316,0,3,positive regulation of memory T cell differentiation,BP,
3777,GO:0008331,1.00000000003055,0.714743784303678,0,3,high voltage-gated calcium channel activity,MF,
9441,GO:0036004,1.00000000003059,0.915198644932076,0,1,GAF domain binding,MF,
11276,GO:0045517,1.00000000003059,0.915198644932076,0,1,interleukin-20 receptor binding,MF,
11277,GO:0045518,1.00000000003059,0.915198644932076,0,1,interleukin-22 receptor binding,MF,
6668,GO:0030020,1.00000000003072,0.709047451464901,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
2009,GO:0004730,1.000000000031,0.90302564527884,0,1,pseudouridylate synthase activity,MF,
15007,GO:0070902,1.000000000031,0.90302564527884,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
3345,GO:0007066,1.00000000003105,0.926258447360737,0,1,female meiosis sister chromatid cohesion,BP,
15050,GO:0070976,1.00000000003111,0.893281154296454,0,1,TIR domain binding,MF,
18422,GO:1903422,1.00000000003127,0.702731663893332,0,3,negative regulation of synaptic vesicle recycling,BP,
7549,GO:0031826,1.00000000003147,0.728304452404368,0,3,type 2A serotonin receptor binding,MF,
229,GO:0000472,1.0000000000316,0.709931469642209,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
354,GO:0000967,1.0000000000316,0.709931469642209,0,3,rRNA 5'-end processing,BP,
11294,GO:0045586,1.00000000003161,0.70217667903127,0,3,regulation of gamma-delta T cell differentiation,BP,
9276,GO:0035691,1.00000000003163,0.912570105572769,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9278,GO:0035693,1.00000000003163,0.912570105572769,0,1,NOS2-CD74 complex,CC,
10133,GO:0042658,1.00000000003163,0.912570105572769,0,1,MHC class II protein binding, via antigen binding groove,MF,
8998,GO:0035101,1.00000000003167,0.70834470094466,0,3,FACT complex,CC,
9434,GO:0035993,1.00000000003176,0.719947587980603,0,3,deltoid tuberosity development,BP,
8008,GO:0032625,1.00000000003201,0.890834687110461,0,1,interleukin-21 production,BP,
15903,GO:0072619,1.00000000003201,0.890834687110461,0,1,interleukin-21 secretion,BP,
1636,GO:0004075,1.00000000003208,0.705371610090304,0,3,biotin carboxylase activity,MF,
1059,GO:0002584,1.00000000003229,0.736273054481575,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
8472,GO:0033603,1.00000000003236,0.743906354281735,0,3,positive regulation of dopamine secretion,BP,
9514,GO:0036153,1.00000000003253,0.893027486465518,0,1,triglyceride acyl-chain remodeling,BP,
12936,GO:0051264,1.00000000003253,0.893027486465518,0,1,mono-olein transacylation activity,MF,
12937,GO:0051265,1.00000000003253,0.893027486465518,0,1,diolein transacylation activity,MF,
633,GO:0001820,1.00000000003265,0.724489637359824,0,3,serotonin secretion,BP,
18413,GO:1903400,1.00000000003271,0.705960151670138,0,3,L-arginine transmembrane transport,BP,
4655,GO:0010796,1.00000000003284,0.737642236330904,0,3,regulation of multivesicular body size,BP,
6244,GO:0019800,1.0000000000331,0.907229390551439,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
356,GO:0000973,1.0000000000331,0.714907804397844,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
11107,GO:0045098,1.00000000003315,0.903069192297292,0,1,type III intermediate filament,CC,
5219,GO:0015819,1.00000000003322,0.89899521169103,0,1,lysine transport,BP,
977,GO:0002428,1.00000000003322,0.742329628483429,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
5472,GO:0016402,1.00000000003335,0.892915528659867,0,1,pristanoyl-CoA oxidase activity,MF,
3989,GO:0008853,1.0000000000334,0.71950779416893,0,3,exodeoxyribonuclease III activity,MF,
15863,GO:0072558,1.00000000003344,0.759259801769089,0,3,NLRP1 inflammasome complex,CC,
15613,GO:0072076,1.00000000003344,0.707430406599789,0,3,nephrogenic mesenchyme development,BP,
8344,GO:0033183,1.00000000003354,0.705834147565648,0,3,negative regulation of histone ubiquitination,BP,
17642,GO:1901314,1.00000000003354,0.705834147565648,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17643,GO:1901315,1.00000000003354,0.705834147565648,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
8418,GO:0033385,1.00000000003452,0.893022279953666,0,1,geranylgeranyl diphosphate metabolic process,BP,
8419,GO:0033386,1.00000000003452,0.893022279953666,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9206,GO:0035582,1.00000000003476,0.718628741881982,0,3,sequestering of BMP in extracellular matrix,BP,
19393,GO:1905777,1.00000000003488,0.711828037104615,0,3,regulation of exonuclease activity,BP,
3479,GO:0007341,1.00000000003517,0.717883487755456,0,3,penetration of zona pellucida,BP,
14903,GO:0070678,1.00000000003523,0.893360865158164,0,1,preprotein binding,MF,
9521,GO:0036166,1.00000000003556,0.713385131670539,0,3,phenotypic switching,BP,
17474,GO:1900239,1.00000000003556,0.713385131670539,0,3,regulation of phenotypic switching,BP,
8398,GO:0033301,1.00000000003568,0.890395620986168,0,1,cell cycle comprising mitosis without cytokinesis,BP,
18524,GO:1903630,1.0000000000361,0.915743367375564,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18525,GO:1903632,1.0000000000361,0.915743367375564,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
1399,GO:0003310,1.00000000003668,0.908398997548113,0,1,pancreatic A cell differentiation,BP,
6376,GO:0021558,1.00000000003668,0.908398997548113,0,1,trochlear nerve development,BP,
11513,GO:0045977,1.00000000003668,0.908398997548113,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13674,GO:0060164,1.00000000003668,0.908398997548113,0,1,regulation of timing of neuron differentiation,BP,
14216,GO:0061102,1.00000000003668,0.908398997548113,0,1,stomach neuroendocrine cell differentiation,BP,
14217,GO:0061105,1.00000000003668,0.908398997548113,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14218,GO:0061106,1.00000000003668,0.908398997548113,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15494,GO:0071820,1.00000000003668,0.908398997548113,0,1,N-box binding,MF,
15609,GO:0072071,1.00000000003668,0.908398997548113,0,1,kidney interstitial fibroblast differentiation,BP,
15660,GO:0072141,1.00000000003668,0.908398997548113,0,1,renal interstitial fibroblast development,BP,
19825,GO:2000226,1.00000000003668,0.908398997548113,0,1,regulation of pancreatic A cell differentiation,BP,
19826,GO:2000227,1.00000000003668,0.908398997548113,0,1,negative regulation of pancreatic A cell differentiation,BP,
14020,GO:0060715,1.00000000003675,0.711926868541546,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
10712,GO:0043988,1.00000000003676,0.728279015599181,0,3,histone H3-S28 phosphorylation,BP,
6272,GO:0019863,1.00000000003684,0.909721737526315,0,1,IgE binding,MF,
1578,GO:0003985,1.00000000003755,0.724189024076445,0,3,acetyl-CoA C-acetyltransferase activity,MF,
9766,GO:0039513,1.00000000003829,0.893151456214725,0,1,suppression by virus of host catalytic activity,BP,
9768,GO:0039516,1.00000000003829,0.893151456214725,0,1,modulation by virus of host catalytic activity,BP,
9786,GO:0039650,1.00000000003829,0.893151456214725,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13324,GO:0052053,1.00000000003829,0.893151456214725,0,1,negative regulation by symbiont of host catalytic activity,BP,
13331,GO:0052148,1.00000000003829,0.893151456214725,0,1,modulation by symbiont of host catalytic activity,BP,
18,GO:0000033,1.00000000003838,0.730069171568906,0,3,alpha-1,3-mannosyltransferase activity,MF,
15150,GO:0071224,1.00000000003846,0.709841737260817,0,3,cellular response to peptidoglycan,BP,
4873,GO:0014732,1.00000000003938,0.71970220032486,0,3,skeletal muscle atrophy,BP,
14302,GO:0061357,1.00000000004009,0.708349061910315,0,3,positive regulation of Wnt protein secretion,BP,
7200,GO:0031084,1.00000000004016,0.70577851172552,0,3,BLOC-2 complex,CC,
9681,GO:0038033,1.00000000004028,0.737243613428941,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
13978,GO:0060664,1.00000000004183,0.716238496269786,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
5452,GO:0016321,1.00000000004234,0.714671710417362,0,3,female meiosis chromosome segregation,BP,
2886,GO:0006391,1.00000000004311,0.720194735875103,0,3,transcription initiation from mitochondrial promoter,BP,
8854,GO:0034641,1.00000000004794,0,423,5136,cellular nitrogen compound metabolic process,BP,TNIP1;NT5E;XDH;CBS;ERCC1;MDFI;ZMYND8;NOS1;CHAC1;H1F0;CCND1;F2R;RBCK1;SORL1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;PTHLH;ETV4;ERCC6;CST3;NEURL1;NAPRT;CRTC1;PCK2;MEF2D;DLG4;NR1D1;DLG1;DAP;IGFBP4;TEF;ZKSCAN1;DNMT3A;PGM1;SOX12;PSMD2;MTA1;ITGA6;SLC2A9;RAPGEF3;NAGS;PRNP;IDH2;PC;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;NME4;BCORL1;FAM129B;SESN2;ACOT7;ABTB1;RNPEPL1;ZC3H6;HAGH;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;H6PD;KIAA1549;ADCY7;XBP1;PGLS;EGFR;CSNK1E;MKNK2;TK2;RFX2;PRKACA;ADARB1;CRAT;CARS;HK1;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;PSAT1;ZKSCAN2;MRPS6;AKT1;XPC;BRD3;MDH2;CARD11;IRAK1;PEG3;ALDH1L2;BAG3;APOE;ATP13A2;ARG2;UAP1;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;FAM20C;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;CTSZ;ZMIZ2;PFKP;ENDOG;ZNF598;NSMCE4A;NMRK1;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;DHTKD1;NADK;SYMPK;TST;H2AFJ;WDTC1;CDC34;DNAJB5;ZNF516;GTPBP1;MAP3K9;IDE;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;BIN1;HTRA1;SUFU;SP6;TSTA3;ERO1B;BCL9L;AHCY;SCMH1;ZNF385A;DTD1;TNRC18;RAG1;BAZ2A;GAMT;DDIT3;BCDIN3D;SATB1;RET;DNASE1L1;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;ASS1;PARP10;DLG3;GATA3;APLN;PHF1;TCFL5;OASL;GNAI2;ZNF165;RPUSD3;HSF1;PPCS;SIN3B;PANK4;BCL7A;IL1RAP;WFS1;CNDP2;SDHA;CTBP1;CDCA7L;ADAM8;MAPKBP1;NEIL1;RAI1;MPG;INTS8;HMGA2;ALAS1;ARID5B;TOP1;MICAL2;CAP1;MYDGF;EIF4EBP1;TSC22D4;TULP3;SRC;KDM4B;GLRX;POLD4;SCG5;TAZ;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;GSK3A;CAMTA2;PCSK6;TALDO1;OAS1;PRIMPOL;MPI;ISG20;SPTLC2;AGRN;ASNS;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ALDH7A1;THOP1;ANXA3;TLE4;FBXL15;SLC33A1;VDR;UCKL1;SSU72;GAL;PUM1;EHF;COMT;TNRC6B;THRA;MAP3K10;EIF2S2;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;LHPP;SECISBP2L;FGFR1;RRBP1;RREB1;MIF4GD;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;GUK1;HES2;AMPD2;STUB1;PCSK1N;VPS9D1;TRIB3;DDB2;ZFPL1;TCIRG1;LEMD2;ZFPM1;ZNF783;HLCS;SARS2;ST3GAL5;RAD23A;AOX1;ZNF609;MXD4;P2RX4;E2F5;SAMD4B;SMPD3;ZP3;ZNF419;PNP;FGF2;RNASE7;RNH1;MED15;VAPB;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;TAOK1;RNF222;ABCA7;ZNF687;ENTPD6;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;ARG1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;NYNRIN;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;POLM;CBL;GGT1;CIB1;LACTB2;MAPK3;EEPD1;KANK2;MAPK10;CSNK1D;DBP;LITAF;ALDOC;GLO1;FURIN;ARHGEF2;ZNF444;UGCG;MLF1;NDUFS2;B4GALT6;ZFP30;HM13;MED29;PAIP2;ZNF256;LPIN3;TFPT;UROS;ECM1;MBD3;NAGA;ADCY6;IGF2BP3;CCNE1;EIF4G3;ZFP28;TGFB1;SF3B6;WBP2;CAT;RMI2;LDHA;AZIN2;PIK3R2;ANXA1;PODXL2;PPP1R10;ASH2L;APOBEC3C;GNAS;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
210,GO:0000438,1.00000000005004,0.73429807602827,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
5907,GO:0018117,1.00000000005093,0.903422073367571,0,1,protein adenylylation,BP,
5919,GO:0018175,1.00000000005093,0.903422073367571,0,1,protein nucleotidylation,BP,
10951,GO:0044601,1.00000000005093,0.903422073367571,0,1,protein denucleotidylation,BP,
10952,GO:0044602,1.00000000005093,0.903422073367571,0,1,protein deadenylylation,BP,
10953,GO:0044603,1.00000000005093,0.903422073367571,0,1,protein adenylylhydrolase activity,MF,
14924,GO:0070733,1.00000000005093,0.903422073367571,0,1,protein adenylyltransferase activity,MF,
5336,GO:0016070,1.00000000005747,0,292,3757,RNA metabolic process,BP,TNIP1;MDFI;ZMYND8;NOS1;CCND1;F2R;RBCK1;CTNNBIP1;NFATC4;DVL1;MAP2K1;SHC1;WNT7A;ETV4;ERCC6;CRTC1;MEF2D;NR1D1;DLG1;DAP;TEF;ZKSCAN1;DNMT3A;SOX12;PSMD2;MTA1;ITGA6;PRNP;WWC3;SCYL1;CITED4;SMARCA1;SMURF2;BCORL1;FAM129B;SESN2;ZC3H6;NACC2;ADGRF1;VLDLR;ETV5;LRP5;AARS;ACVR2B;KIAA1549;XBP1;EGFR;CSNK1E;RFX2;PRKACA;ADARB1;CARS;MAP2K2;PPP1R13L;MN1;MIER2;ATF4;ZKSCAN2;AKT1;BRD3;CARD11;IRAK1;PEG3;BAG3;APOE;METTL23;PKN1;ZSCAN30;ELK3;WWTR1;PHF21A;TMSB4X;TSPYL2;PRKCZ;POU2F2;TFEB;DGKQ;MAPK13;ARHGAP22;FZD8;ZMIZ2;DEAF1;SALL2;DRAP1;SCAND1;DKK1;CREB3L2;SOX7;PPP2R5B;PPARA;SYMPK;H2AFJ;WDTC1;DNAJB5;ZNF516;GTPBP1;MAP3K9;MSRB2;MC1R;DEDD2;RRNAD1;LARP6;TFE3;PRDX5;HTRA1;SUFU;SP6;BCL9L;SCMH1;ZNF385A;DTD1;TNRC18;BAZ2A;DDIT3;BCDIN3D;SATB1;RET;PTOV1;MLXIP;IFI27;HLTF;PCBP4;PKD1;PARP10;GATA3;APLN;PHF1;TCFL5;OASL;ZNF165;RPUSD3;HSF1;SIN3B;BCL7A;IL1RAP;WFS1;CTBP1;CDCA7L;ADAM8;MAPKBP1;RAI1;INTS8;HMGA2;ARID5B;MICAL2;MYDGF;TSC22D4;TULP3;SRC;KDM4B;DNM2;AGO4;IRF7;HIST3H2A;RFXANK;RALY;PAK6;PER3;RBMS2;ESRP1;GARS;RERE;RSF1;CAMTA2;PCSK6;OAS1;PRIMPOL;ISG20;AGRN;ZNF692;PPM1F;ZNF862;PFN1;NELFCD;PSMD7;TNFRSF1A;ANXA3;TLE4;FBXL15;SLC33A1;VDR;SSU72;GAL;PUM1;EHF;TNRC6B;THRA;MAP3K10;HEXIM1;FRYL;ZSCAN18;RNF187;ZNF71;HSF4;FGFR1;RREB1;ZBED4;ADNP;PHF2;TENM2;USF2;PBX3;HES2;TRIB3;ZFPL1;LEMD2;ZFPM1;ZNF783;SARS2;ZNF609;MXD4;E2F5;SAMD4B;ZP3;ZNF419;FGF2;RNASE7;RNH1;MED15;MAPK9;ZNF570;PYM1;RCOR1;ABHD14B;ZNF398;CHD7;RNF222;ZNF687;APBB1;WDR18;RXRA;HIST2H2AC;INTS1;PBXIP1;L3MBTL3;ZHX3;TSHZ1;TAF6;TGFA;RPL28;RPRD2;BAHCC1;ZBTB4;SEC14L2;CNOT11;TCF25;HIST1H2AG;IMPACT;ZNF624;RPRD1A;TRPT1;CAMK1;CARHSP1;CBL;CIB1;LACTB2;MAPK3;KANK2;MAPK10;CSNK1D;DBP;LITAF;GLO1;ARHGEF2;ZNF444;MLF1;ZFP30;MED29;ZNF256;LPIN3;TFPT;ECM1;MBD3;IGF2BP3;CCNE1;ZFP28;TGFB1;SF3B6;WBP2;CAT;PIK3R2;ASH2L;APOBEC3C;KLF12;ITGA3;ZNF318;ARHGEF10L;EP300;TCF7L1;FHOD1;TRAF7;RNF10
